Citrus Sinensis ID: 002158
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 958 | 2.2.26 [Sep-21-2011] | |||||||
| C0LGD7 | 953 | Probable LRR receptor-lik | no | no | 0.961 | 0.966 | 0.605 | 0.0 | |
| Q9LFG1 | 937 | Putative leucine-rich rep | no | no | 0.937 | 0.958 | 0.580 | 0.0 | |
| C0LGU1 | 959 | Probable LRR receptor-lik | no | no | 0.974 | 0.973 | 0.519 | 0.0 | |
| Q9LT96 | 946 | Probable leucine-rich rep | no | no | 0.855 | 0.866 | 0.356 | 1e-116 | |
| C0LGG7 | 953 | Probable LRR receptor-lik | no | no | 0.884 | 0.888 | 0.307 | 2e-97 | |
| C0LGH2 | 1032 | Probable LRR receptor-lik | no | no | 0.774 | 0.718 | 0.317 | 6e-85 | |
| Q9FLJ8 | 842 | Probable receptor-like pr | no | no | 0.352 | 0.401 | 0.423 | 4e-67 | |
| Q9FLW0 | 824 | Probable receptor-like pr | no | no | 0.292 | 0.339 | 0.464 | 8e-67 | |
| Q9LK35 | 855 | Receptor-like protein kin | no | no | 0.313 | 0.350 | 0.446 | 2e-66 | |
| Q9LV48 | 652 | Proline-rich receptor-lik | no | no | 0.289 | 0.424 | 0.460 | 2e-66 |
| >sp|C0LGD7|Y1684_ARATH Probable LRR receptor-like serine/threonine-protein kinase At1g06840 OS=Arabidopsis thaliana GN=At1g06840 PE=1 SV=2 | Back alignment and function desciption |
|---|
Score = 1108 bits (2867), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 566/935 (60%), Positives = 707/935 (75%), Gaps = 14/935 (1%)
Query: 30 LAAAQTTDPQEASALRAIKNSLVDSMNHLRNWNKGDPCMSNWTGVLCFDTVETDGHLHVR 89
A T+P E ALR IK SL D ++ LRNW GDPC SNWTGV+CF++ DG+LHV
Sbjct: 27 FAQDDITNPVEVRALRVIKESLNDPVHRLRNWKHGDPCNSNWTGVVCFNSTLDDGYLHVS 86
Query: 90 ELQLLSMNLSGNLAPELGQLSRLQYY-FMWNDLTGTIPKEIGNISSLIFLLLNGNKLSGS 148
ELQL SMNLSGNL+PELG+LSRL FMWN +TG+IPKEIGNI SL LLLNGN L+G+
Sbjct: 87 ELQLFSMNLSGNLSPELGRLSRLTILSFMWNKITGSIPKEIGNIKSLELLLLNGNLLNGN 146
Query: 149 LPDELGYLSNLNRLQVDENNITGTIPKSFANLSRVRHLHLNNNSIGGQIPSELSKLSTLI 208
LP+ELG+L NL+R+Q+DEN I+G +PKSFANL++ +H H+NNNSI GQIP EL L +++
Sbjct: 147 LPEELGFLPNLDRIQIDENRISGPLPKSFANLNKTKHFHMNNNSISGQIPPELGSLPSIV 206
Query: 209 HLLVDNNNLSGNLPPELSELPQLCILQLDNNNFSASEIPATYGNFSKLVKLSLRNCNLQG 268
H+L+DNNNLSG LPPELS +P+L ILQLDNN+F + IP +YGN SKL+K+SLRNC+LQG
Sbjct: 207 HILLDNNNLSGYLPPELSNMPRLLILQLDNNHFDGTTIPQSYGNMSKLLKMSLRNCSLQG 266
Query: 269 AVPDLSRIPNLYYLDLSWNHLTGSIPSKKLSENVTTIDLSDNYLNGSILESISNLPFLQT 328
VPDLS IPNL YLDLS N L GSIP+ KLS+++TTIDLS+N L G+I + S LP LQ
Sbjct: 267 PVPDLSSIPNLGYLDLSQNQLNGSIPAGKLSDSITTIDLSNNSLTGTIPTNFSGLPRLQK 326
Query: 329 LSLENNFLTGSIPATIWQNKSFSTKARLKIDLRNNSFSNIVGDLTLPNNVTLRLGGNPIC 388
LSL NN L+GSIP+ IWQ + ++ + +DLRNN FSNI G L NVT+ L GNP+C
Sbjct: 327 LSLANNALSGSIPSRIWQERELNSTESIIVDLRNNGFSNISGRSDLRPNVTVWLQGNPLC 386
Query: 389 TSANIPNTGRFCGSDAGGDETLTNSKVNCPVQA-CPVDNFFEYVPASPEPCFCAAPLRIG 447
+ N+ R CG D ++ N + + CP +E+ P CFCAAPL +G
Sbjct: 387 SDGNLL---RLCGPITEEDINQGSTNSNTTICSDCPPP--YEFSPEPLRRCFCAAPLLVG 441
Query: 448 YRLKSPSFTYFPPYVYPFEEYLTNTLNLELYQLSIDSFAWEKGPRLEMYLKLFPTL---- 503
YRLKSP F+ F PY FE+Y+T+ L+L LYQL +DSF W+KGPRL MYLK FP
Sbjct: 442 YRLKSPGFSDFVPYRSEFEQYITSGLSLNLYQLRLDSFQWQKGPRLRMYLKFFPVFGSNA 501
Query: 504 NRSSTFDDSEVRQIRDRFTSWKFPGSDIFGPYELLNFTLLGPYSNLNFNSQSKGISGGIL 563
N S F+ SEVR+IR FT W D+FGPYEL+NFTLL Y ++ ++ G+S G +
Sbjct: 502 NNSFIFNRSEVRRIRGMFTGWNIRDEDLFGPYELMNFTLLDVYRDVFPSASPSGLSNGAV 561
Query: 564 AAIVVGAVASAVAITAAVTLLVMRRHARYQHSLSRKRLSTKISMKIDGVKGFKFKELAMA 623
A IV+G+VA+AV +TA + L++MR+ R +++R++ S+K S+KI+GVK F + ELA+A
Sbjct: 562 AGIVLGSVAAAVTLTAIIALIIMRKRMRGYSAVARRKRSSKASLKIEGVKSFTYAELALA 621
Query: 624 TAYFSSSTQVGQGGYGKVYKGILSDNTTVAIKRAEEGSLQGQNEFLTEIKLLSRLHHRNL 683
T F+SSTQ+GQGGYGKVYKG L T VAIKRA+EGSLQG+ EFLTEI+LLSRLHHRNL
Sbjct: 622 TDNFNSSTQIGQGGYGKVYKGTLGSGTVVAIKRAQEGSLQGEKEFLTEIELLSRLHHRNL 681
Query: 684 VSLLGYCDEEGEQMLVYEFVPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEA 743
VSLLG+CDEEGEQMLVYE++ NGTLRD +S + KE L+FAMRLR+AL SAKGILYLHTEA
Sbjct: 682 VSLLGFCDEEGEQMLVYEYMENGTLRDNISVKLKEPLDFAMRLRIALGSAKGILYLHTEA 741
Query: 744 HPPVFHRDIKASNILLDSNLNAKVADFGLSRLAPVLDDEGTMPTHVSTIVKGTPGYLDPE 803
+PP+FHRDIKASNILLDS AKVADFGLSRLAPV D EG P HVST+VKGTPGYLDPE
Sbjct: 742 NPPIFHRDIKASNILLDSRFTAKVADFGLSRLAPVPDMEGISPQHVSTVVKGTPGYLDPE 801
Query: 804 YFLTHKLTDKSDVYSLGVVLLELLTGMQPISHGKNIVREVNVARDSGMVFSIIDNRMGSY 863
YFLTH+LTDKSDVYSLGVVLLEL TGMQPI+HGKNIVRE+N+A +SG + S +D RM S
Sbjct: 802 YFLTHQLTDKSDVYSLGVVLLELFTGMQPITHGKNIVREINIAYESGSILSTVDKRMSSV 861
Query: 864 PSECVERFVTLALRCCHDKPEHRPSMSDVVRELENILKMFPETDTMFSKSESSSLLSGKS 923
P EC+E+F TLALRCC ++ + RPSM++VVRELE I ++ PE+ +K+ S
Sbjct: 862 PDECLEKFATLALRCCREETDARPSMAEVVRELEIIWELMPESHV--AKTADLSETMTHP 919
Query: 924 ASTSSSFLTRDPYASSSNVSGSDLISGAVPSISPR 958
+S+S+S + + Y +S +VSGSDL+SG PS++PR
Sbjct: 920 SSSSNSSIMKHHY-TSMDVSGSDLVSGVAPSVAPR 953
|
Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|Q9LFG1|Y3359_ARATH Putative leucine-rich repeat receptor-like serine/threonine-protein kinase At3g53590 OS=Arabidopsis thaliana GN=At3g53590 PE=3 SV=2 | Back alignment and function description |
|---|
Score = 1008 bits (2607), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 536/924 (58%), Positives = 652/924 (70%), Gaps = 26/924 (2%)
Query: 41 ASALRAIKNSLVDSMNHLRNWNKGDPCMSNWTGVLCFDTVETDGHLHVRELQLLSMNLSG 100
+ALR IK SL+D M +L NW KGDPC SNWTG++CF DGH HVRELQL+ +NLSG
Sbjct: 34 VNALREIKRSLIDPMRNLSNWAKGDPCNSNWTGIICFGRSHNDGHFHVRELQLMRLNLSG 93
Query: 101 NLAPELGQLSRLQYY-FMWNDLTGTIPKEIGNISSLIFLLLNGNKLSGSLPDELGYLSNL 159
LAPE+GQL L+ MWN+LTG IP EIG ISSL LLLNGNK +GSLP ELG L NL
Sbjct: 94 ELAPEVGQLLYLEILDVMWNNLTGRIPLEIGRISSLKLLLLNGNKFTGSLPPELGNLQNL 153
Query: 160 NRLQVDENNITGTIPKSFANLSRVRHLHLNNNSIGGQIPSELSKLSTLIHLLVDNNNLSG 219
NRLQVDENNITG++P SF NL ++HLHLNNN+I G+IP ELSKL L+H+++DNNNL+G
Sbjct: 154 NRLQVDENNITGSVPFSFGNLRSIKHLHLNNNTISGEIPVELSKLPKLVHMILDNNNLTG 213
Query: 220 NLPPELSELPQLCILQLDNNNFSASEIPATYGNFSKLVKLSLRNCNLQGAVPDLSRIPNL 279
LP EL++LP L ILQLDNNNF S IP YG+FS+LVKLSLRNC LQG++PDLSRI NL
Sbjct: 214 TLPLELAQLPSLTILQLDNNNFEGSTIPEAYGHFSRLVKLSLRNCGLQGSIPDLSRIENL 273
Query: 280 YYLDLSWNHLTGSIPSKKLSENVTTIDLSDNYLNGSILESISNLPFLQTLSLENNFLTGS 339
YLDLSWNHLTG+IP KLS+N+TTI+LS N+L GSI +S S+L LQ LSLENN L+GS
Sbjct: 274 SYLDLSWNHLTGTIPESKLSDNMTTIELSYNHLTGSIPQSFSDLNSLQLLSLENNSLSGS 333
Query: 340 IPATIWQNKSFSTKARLKIDLRNNSFSNIVGDLTLPNNVTLRLGGNPICTSANIPNTGRF 399
+P IWQ+KSF DL NN+FS+ G+L P+NVTL L GNPIC S +IP +F
Sbjct: 334 VPTEIWQDKSFENNKLQVYDL-NNNFSDATGNLRTPDNVTLYLRGNPICKSTSIPMVTQF 392
Query: 400 ----CGSDAGGDETLTNSKVNCPVQACPVDNFFEYVPASPEPCFCAAPLRIGYRLKSPSF 455
CG +T TNS C +CP FE V SP C C APL I YRLKSPSF
Sbjct: 393 FEYICGEKK---QTSTNSNTPCSNVSCP----FENVKVSPGICLCTAPLSIDYRLKSPSF 445
Query: 456 TYFPPYV-YPFEEYLTNTLNLELYQLSIDSFAWEKGPRLEMYLKLFPTLNRSSTFDDSEV 514
+F PY+ F EY+T++L LE +QL+ID E R MYLKL P TF+ SEV
Sbjct: 446 FFFTPYIERQFREYITSSLQLETHQLAIDRLVDENRLRPRMYLKLVP--KGRITFNKSEV 503
Query: 515 RQIRDRFTSWKFPGSDIFGPYELLNFTLLGPYSNLNFNSQSKGISGGILAAIVVGAVASA 574
+IRDRF SW F +D FGPYELL+F L GPY++L +Q+ GI + IV G+V +A
Sbjct: 504 IRIRDRFMSWSFNKTDFFGPYELLDFPLQGPYADLL--AQTSGIRTIVWMMIVAGSVVAA 561
Query: 575 VAITAAVTLLVMRRHARYQHSLSRKRLSTKISMKIDGVKGFKFKELAMATAYFSSSTQVG 634
++ TLL +R+ H+L++KR+ IS +I GVK F F EL+ AT F SST +G
Sbjct: 562 TVLSVTATLLYVRKRRENSHTLTKKRVFRTISREIKGVKKFSFVELSDATNGFDSSTLIG 621
Query: 635 QGGYGKVYKGILSDNTTVAIKRAEEGSLQGQNEFLTEIKLLSRLHHRNLVSLLGYCDEEG 694
+G YGKVYKGILS+ T VAIKR EE SLQ + EFL EI LLSRLHHRNLVSL+GY + G
Sbjct: 622 RGSYGKVYKGILSNKTEVAIKRGEETSLQSEKEFLNEIDLLSRLHHRNLVSLIGYSSDIG 681
Query: 695 EQMLVYEFVPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKA 754
EQMLVYE++PNG +RDWLS + L+F+MR VAL SAKGILYLHTEA+PPV HRDIK
Sbjct: 682 EQMLVYEYMPNGNVRDWLSANAADTLSFSMRSHVALGSAKGILYLHTEANPPVIHRDIKT 741
Query: 755 SNILLDSNLNAKVADFGLSRLAPVLDDEGTMPTHVSTIVKGTPGYLDPEYFLTHKLTDKS 814
SNILLD L+AKVADFGLSRLAP + P HVST+V+GTPGYLDPEYF+T +LT +S
Sbjct: 742 SNILLDCQLHAKVADFGLSRLAPAFGEGDGEPAHVSTVVRGTPGYLDPEYFMTQQLTVRS 801
Query: 815 DVYSLGVVLLELLTGMQPISHGKNIVREVNVARDSGMVFSIIDNRMGSYPSECVERFVTL 874
DVYS GVVLLELLTGM P G +I+REV A + G V S+ D+RMG + V++ L
Sbjct: 802 DVYSFGVVLLELLTGMHPFFEGTHIIREVRTANECGTVLSVADSRMGQCSPDKVKKLAEL 861
Query: 875 ALRCCHDKPEHRPSMSDVVRELENILKMFPETDTMFSKSESSSLLSGKSASTSSSFLTRD 934
AL CC D+PE RP MS VV+ELE I + E + MF SE++ LL K++ +SSS
Sbjct: 862 ALWCCEDRPETRPPMSKVVKELEGICQSVREPE-MF--SETTKLLCSKTSPSSSSV---- 914
Query: 935 PYASSSNVSGSDLISGAVPSISPR 958
+ S + GS+L SG ++ PR
Sbjct: 915 -PSPLSLLPGSNLDSGFFHAVKPR 937
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|C0LGU1|Y5374_ARATH Probable LRR receptor-like serine/threonine-protein kinase At5g37450 OS=Arabidopsis thaliana GN=At5g37450 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 965 bits (2494), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 498/959 (51%), Positives = 663/959 (69%), Gaps = 25/959 (2%)
Query: 17 GFVYALLFSYLVLLAAAQTTDPQEASALRAIKNSLVDSMNHLRNWNKGDPCMSNWTGVLC 76
G + + L LL A + T P + SAL+ + L D +NHL++W K DPC SNWTGV+C
Sbjct: 9 GIILVVSSCCLSLLDAQEITHPTDVSALQYVHRKLKDPLNHLQDWKKTDPCASNWTGVIC 68
Query: 77 FDTVETDGHLHVRELQLLSMNLSGNLAPELGQLSRLQYY-FMWNDLTGTIPKEIGNISSL 135
+DG LHV+EL+LL+MNL+G LAPELG LS L FMWNDLTG IP E+GN++ L
Sbjct: 69 IPD-PSDGFLHVKELRLLNMNLTGQLAPELGLLSNLTILNFMWNDLTGQIPPELGNLTHL 127
Query: 136 IFLLLNGNKLSGSLPDELGYLSNLNRLQVDENNITGTIPKSFANLSRVRHLHLNNNSIGG 195
IFLLL+GN+L+GSLP ELG LSNL LQ+D N I+G +P S ANL +++H H+NNNSI G
Sbjct: 128 IFLLLSGNQLTGSLPQELGSLSNLLILQIDYNEISGKLPTSLANLKKLKHFHMNNNSITG 187
Query: 196 QIPSELSKLSTLIHLLVDNNNLSGNLPPELSELPQLCILQLDNNNFSASEIPATYGNFSK 255
QIP E S L+ ++H L+DNN L+GNLPPEL+++P L ILQLD +NF +EIP++YG+
Sbjct: 188 QIPPEYSTLTNVLHFLMDNNKLTGNLPPELAQMPSLRILQLDGSNFDGTEIPSSYGSIPN 247
Query: 256 LVKLSLRNCNLQGAVPDLSRIPNLYYLDLSWNHLTGSIPSKKLSENVTTIDLSDNYLNGS 315
LVKLSLRNCNL+G +PDLS+ LYYLD+S N LTG IP K S N+TTI+L +N L+GS
Sbjct: 248 LVKLSLRNCNLEGPIPDLSKSLVLYYLDISSNKLTGEIPKNKFSANITTINLYNNLLSGS 307
Query: 316 ILESISNLPFLQTLSLENNFLTGSIPATIWQNKSFSTKARLKIDLRNNSFSNIVGD-LTL 374
I + S LP LQ L ++NN L+G IP IW+N+ + +L +DLRNN FSN+ L
Sbjct: 308 IPSNFSGLPRLQRLQVQNNNLSGEIPV-IWENRILKAEEKLILDLRNNMFSNVSSVLLNP 366
Query: 375 PNNVTLRLGGNPICTSANIPNTGRFCG-------SDAGGDETLTNSKVNCPVQACPVDNF 427
P+NVT++L GNP+C + N CG S A ET++ +C Q+CPV
Sbjct: 367 PSNVTVKLYGNPVCANVNAGKLADLCGISTLEVESPATSSETISTG--DCKRQSCPVSEN 424
Query: 428 FEYVPASPEPCFCAAPLRIGYRLKSPSFTYFPPYVYPFEEYLTNTLNLEL--YQLSIDSF 485
++YV SP CFCAAPL I RL+SPSF+ F PY + + + NL + YQ+SID+F
Sbjct: 425 YDYVIGSPVACFCAAPLGIDLRLRSPSFSDFRPYKVSYMLDVASPKNLGINPYQISIDTF 484
Query: 486 AWEKGPRLEMYLKLFPTLNR-SSTFDDSEVRQIRDRFTSWKFPGSDIFGPYELLNFTLLG 544
AW+ GPRL M +K+FP + +S F+ +EV++I D F ++ D GPYE+++ G
Sbjct: 485 AWQSGPRLFMNMKIFPEYSELNSKFNSTEVQRIVDFFATFTLNTDDSLGPYEIISIN-TG 543
Query: 545 PYSNLNFNSQSK-GISGGILAAIVVGAVASAVAITAAVTLLVM----RRHARYQHSLSRK 599
Y ++ K G+S G+ I++GA+A + +++ + + R+ + + ++
Sbjct: 544 AYKDVTIIFPKKSGMSIGVSVGIIIGAIAFFLVLSSLALVFFIKRSKRKRKTREVDMEQE 603
Query: 600 RLSTKISMKIDGVKGFKFKELAMATAYFSSSTQVGQGGYGKVYKGILSDNTTVAIKRAEE 659
K M ++ VKG+ F EL AT+ FS +Q+G+GGYGKVYKG L VA+KRAE+
Sbjct: 604 HPLPKPPMNMESVKGYNFTELDSATSSFSDLSQIGRGGYGKVYKGHLPGGLVVAVKRAEQ 663
Query: 660 GSLQGQNEFLTEIKLLSRLHHRNLVSLLGYCDEEGEQMLVYEFVPNGTLRDWLSGRTKEN 719
GSLQGQ EF TEI+LLSRLHHRNLVSLLGYCD++GEQMLVYE++PNG+L+D LS R ++
Sbjct: 664 GSLQGQKEFFTEIELLSRLHHRNLVSLLGYCDQKGEQMLVYEYMPNGSLQDALSARFRQP 723
Query: 720 LNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSRLAPVL 779
L+ A+RLR+AL SA+GILYLHTEA PP+ HRDIK SNILLDS +N KVADFG+S+L L
Sbjct: 724 LSLALRLRIALGSARGILYLHTEADPPIIHRDIKPSNILLDSKMNPKVADFGISKLI-AL 782
Query: 780 DDEGTMPTHVSTIVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVLLELLTGMQPISHGKNI 839
D G HV+TIVKGTPGY+DPEY+L+H+LT+KSDVYSLG+V LE+LTGM+PISHG+NI
Sbjct: 783 DGGGVQRDHVTTIVKGTPGYVDPEYYLSHRLTEKSDVYSLGIVFLEILTGMRPISHGRNI 842
Query: 840 VREVNVARDSGMVFSIIDNRMGSYPSECVERFVTLALRCCHDKPEHRPSMSDVVRELENI 899
VREVN A D+GM+ S+ID MG Y ECV+RF+ LA+RCC D PE RP M ++VRELENI
Sbjct: 843 VREVNEACDAGMMMSVIDRSMGQYSEECVKRFMELAIRCCQDNPEARPWMLEIVRELENI 902
Query: 900 LKMFPETDTMFSKSESSSLLSGKSASTSSSFLTRDPYASSSNVSGSDLISGAVPSISPR 958
+ P+ + +S S SG S +S R Y + S + + L+SG +PSI+PR
Sbjct: 903 YGLIPKEEKPYSSPSVQSSASGMSGFAVAS--PRSSYTTFSEFTANQLVSGVIPSIAPR 959
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9LT96|Y5977_ARATH Probable leucine-rich repeat receptor-like protein kinase At5g49770 OS=Arabidopsis thaliana GN=At5g49770 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 421 bits (1083), Expect = e-116, Method: Compositional matrix adjust.
Identities = 332/931 (35%), Positives = 493/931 (52%), Gaps = 111/931 (11%)
Query: 36 TDPQEASALRAIKNSLVDSMNHLRNWNKGDPCMSNWTGVLCFDTVETDGHLHVRELQLLS 95
TD + +AL+A+KN D+++ ++W DPC + W G+ C + V + L +
Sbjct: 27 TDGSDFTALQALKNEW-DTLS--KSWKSSDPCGTEWVGITC------NNDNRVVSISLTN 77
Query: 96 MNLSGNLAPELGQLSRLQYYFMWN--DLTGTIPKEIGNISSLIFLLLNGNKLSGSLPDEL 153
NL G L E+ LS LQ + +L+G +P IGN+ L FL L G +G +PD +
Sbjct: 78 RNLKGKLPTEISTLSELQTLDLTGNPELSGPLPANIGNLRKLTFLSLMGCAFNGPIPDSI 137
Query: 154 GYLSNLNRLQVDENNITGTIPKSFANLSRVR----------------------------- 184
G L L RL ++ N +GTIP S LS++
Sbjct: 138 GNLEQLTRLSLNLNKFSGTIPASMGRLSKLYWFDIADNQLEGKLPVSDGASLPGLDMLLQ 197
Query: 185 --HLHLNNNSIGGQIPSEL-SKLSTLIHLLVDNNNLSGNLPPELSELPQLCILQLDNNNF 241
H H NN + G+IP +L S TL+H+L D N +G++P L + L +L+LD N
Sbjct: 198 TGHFHFGNNKLSGEIPEKLFSSEMTLLHVLFDGNQFTGSIPESLGLVQNLTVLRLDRNRL 257
Query: 242 SASEIPATYGNFSKLVKLSLRNCNLQGAVPDLSRIPNLYYLDLSWNHLTGS-IPSK-KLS 299
S +IP++ N + L +L L + G++P+L+ + +LY LD+S N L S +PS
Sbjct: 258 SG-DIPSSLNNLTNLQELHLSDNKFTGSLPNLTSLTSLYTLDVSNNPLALSPVPSWIPFL 316
Query: 300 ENVTTIDLSDNYLNGSILESISNLPFLQTLSLENNFLTGSIPATIWQNKSFSTKARLKID 359
+++T+ L D L+G + S+ + LQT+SL++N I T+ ++S + +D
Sbjct: 317 NSLSTLRLEDIQLDGPVPTSLFSPLQLQTVSLKHNL----INTTLDLGTNYSKQLDF-VD 371
Query: 360 LRNNSFSNIVGDLTLPNN-VTLRLGGNPICTSANIPNTGRFCGSDAGGD--ETLTNSKVN 416
LR+N I G + NN V + L N +C +G +C + TLT +
Sbjct: 372 LRDNF---ITGYKSPANNPVNVMLADNQVCQDPANQLSG-YCNAVQPNSTFSTLTKCGNH 427
Query: 417 CPVQACPVDNFFEYVPASPEPCFCAAPLRIGYRLKSPSFTYFP--PYVYPFEEYLTNTLN 474
C P + C C PL + L+SPSF+ F F E L
Sbjct: 428 CGKGKEP-----------NQGCHCVYPLTGVFTLRSPSFSGFSNNSNFLKFGESLMTFFK 476
Query: 475 LELYQLSIDSFAWE---KGP---RLEMYLKLFPTLNRSSTFDDSEVRQIRDRFTSWKFPG 528
Y +DS A + P L + L +FP+ F+ +E+ I FT +
Sbjct: 477 NGKY--PVDSVAMRNISENPTDYHLLINLLIFPS--GRDRFNQTEMDSINSAFTIQDYKP 532
Query: 529 SDIFGPYELLNFTLLGPYSNLNFNSQSKGISGGILAAIVVGAVASAVAITAAVTLLVMRR 588
FGPY + Y + SK +S ++ +VV V + + A + +R+
Sbjct: 533 PPRFGPY----IFVADQYKTFSDLEDSKTVSMKVIIGVVV-GVVVLLLLLALAGIYALRQ 587
Query: 589 HARYQHSLSR-----KRLSTKISM---KIDGVKGFKFKELAMATAYFSSSTQVGQGGYGK 640
R Q + + K + K M ++ G K F F+EL+ T FS + VG GGYG+
Sbjct: 588 KKRAQRATDQMNPFAKWDAGKNEMDAPQLMGTKAFTFEELSKCTNNFSDANDVGGGGYGQ 647
Query: 641 VYKGILSDNTTVAIKRAEEGSLQGQNEFLTEIKLLSRLHHRNLVSLLGYCDEEGEQMLVY 700
VYKG L + +AIKRA++GS+QG EF TEI+LLSR+HH+N+V LLG+C ++ EQMLVY
Sbjct: 648 VYKGTLPNGQVIAIKRAQQGSMQGAFEFKTEIELLSRVHHKNVVKLLGFCFDQKEQMLVY 707
Query: 701 EFVPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLD 760
E++PNG+LRD LSG+ L++ RL++AL S KG+ YLH A PP+ HRD+K++NILLD
Sbjct: 708 EYIPNGSLRDGLSGKNGVKLDWTRRLKIALGSGKGLAYLHELADPPIIHRDVKSNNILLD 767
Query: 761 SNLNAKVADFGLSRLAPVLDDEGTMPTHVSTIVKGTPGYLDPEYFLTHKLTDKSDVYSLG 820
+L AKVADFGLS+L V D E HV+T VKGT GYLDPEY++T++LT+KSDVY G
Sbjct: 768 EHLTAKVADFGLSKL--VGDPE---KAHVTTQVKGTMGYLDPEYYMTNQLTEKSDVYGFG 822
Query: 821 VVLLELLTGMQPISHGKNIVREVNVARDSG---------MVFSIIDNRMGSYPSECVERF 871
VV+LELLTG PI G +V+EV D + +II N S + E++
Sbjct: 823 VVMLELLTGKSPIDRGSYVVKEVKKKMDKSRNLYDLQELLDTTIIQN---SGNLKGFEKY 879
Query: 872 VTLALRCCHDKPEHRPSMSDVVRELENILKM 902
V +AL+C + +RP+MS+VV+ELE+IL++
Sbjct: 880 VDVALQCVEPEGVNRPTMSEVVQELESILRL 910
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|C0LGG7|Y1534_ARATH Probable LRR receptor-like serine/threonine-protein kinase At1g53420 OS=Arabidopsis thaliana GN=At1g53420 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 358 bits (918), Expect = 2e-97, Method: Compositional matrix adjust.
Identities = 308/1003 (30%), Positives = 472/1003 (47%), Gaps = 156/1003 (15%)
Query: 27 LVLLAAAQTTDPQEASALRAIKNSLVDSMNHLRNWNKGDPCMSNWTGVLCFDTV------ 80
+V A++ T QE A + + +L + L DPC + TG + T+
Sbjct: 18 IVHFASSATLPTQEGEAFKVVLTTLKKTNIDL----NVDPCEVSSTGNE-WSTISRNLKR 72
Query: 81 ---------ETDGHLHVRELQLLSMNLSGNLAPELGQLSRLQYYFMWNDLTGTIPKEIGN 131
E G ++E+ L L+G++ PE G L + + + N LTG IPKE GN
Sbjct: 73 ENLQGSLPKELVGLPLLQEIDLSRNYLNGSIPPEWGVLPLVNIWLLGNRLTGPIPKEFGN 132
Query: 132 ISSLIFLLLNGNKLSGSLPDELGYLSNLNRLQVDENNITGTIPKSFANLSRVRHLHLNNN 191
I++L L+L N+LSG LP ELG L N+ ++ + NN G IP +FA L+ +R +++N
Sbjct: 133 ITTLTSLVLEANQLSGELPLELGNLPNIQQMILSSNNFNGEIPSTFAKLTTLRDFRVSDN 192
Query: 192 SIGGQIPSELSKLSTLIHLLVDNNNLSGNLPPELSELPQLCILQLDNNNFSASEIPATYG 251
+ G IP + K + L L + + L G +P ++ L +L L++ + N S P
Sbjct: 193 QLSGTIPDFIQKWTKLERLFIQASGLVGPIPIAIASLVELKDLRISDLNGPESPFPQLR- 251
Query: 252 NFSKLVKLSLRNCNLQGAVPD-LSRIPNLYYLDLSWNHLTGSIPSKKLSENVTTIDLSDN 310
N K+ L LRNCNL G +PD L +I + +LDLS+N L+G+IP+ T I+L D
Sbjct: 252 NIKKMETLILRNCNLTGDLPDYLGKITSFKFLDLSFNKLSGAIPN-------TYINLRDG 304
Query: 311 ---YLNGSILESISNLPFLQTLSLENNFLTGSIPATIWQ-NKSFSTKARLKIDLRNNSFS 366
Y G N L GS+P W NK + KIDL N+FS
Sbjct: 305 GYIYFTG-------------------NMLNGSVPD--WMVNKGY------KIDLSYNNFS 337
Query: 367 NIVGDLTLPNNVTLRLGGNPICTSANIPNTGRFCGSDAGGDETLTNSKVNCPVQACPVDN 426
+ N L N C P T + GGDE N + + +++
Sbjct: 338 VDPTNAVCKYNNVLSCMRNYQC-----PKTFNALHINCGGDEMSINGTIYESDKYDRLES 392
Query: 427 FFE-----------------YVPA-------SPEPCFCAAPLRIGYRLKSPSFTYFPPYV 462
++E +VP S E L R+ + S TY+ +
Sbjct: 393 WYESRNGWFSNNVGVFVDDKHVPERVTIESNSSELNVVDFGLYTQARISAISLTYYALCL 452
Query: 463 --------YPFEEYLTNTLN---------LELY---QLSIDSF--AWEKGPRLEMYLKLF 500
F E + N N ++Y +L + F A E + +K F
Sbjct: 453 ENGNYNVNLHFAEIMFNGNNNYQSLGRRFFDIYIQRKLEVKDFNIAKEAKDVGNVVIKTF 512
Query: 501 PTLNRSSTFDDSEVRQIRDRFTSWKFPGSDIFGPYELLNFTLLGPYSNLNFNSQSKGISG 560
P + E+R + P ++GP + + S++N S G+S
Sbjct: 513 PVEIKDGKL---EIRLYWAGRGTTVIPKERVYGPL----ISAISVDSSVN-PSPRNGMST 564
Query: 561 GILAAIVVGAVASAVAITAAVTLLVMRRHARYQHSLSRKRLSTKISMKIDGVKGFKFKEL 620
G L +VV + S + L + + R + + + S ++ + F +++
Sbjct: 565 GTLHTLVV--ILSIFIVFLVFGTLWKKGYLRSKSQMEKDFKSLELM-----IASFSLRQI 617
Query: 621 AMATAYFSSSTQVGQGGYGKVYKGILSDNTTVAIKRAEEGSLQGQNEFLTEIKLLSRLHH 680
+AT F S+ ++G+GG+G VYKG L D T +A+K+ GS QG EFL EI ++S LHH
Sbjct: 618 KIATNNFDSANRIGEGGFGPVYKGKLFDGTIIAVKQLSTGSKQGNREFLNEIGMISALHH 677
Query: 681 RNLVSLLGYCDEEGEQMLVYEFVPNGTLRDWLSG--RTKENLNFAMRLRVALDSAKGILY 738
NLV L G C E G+ +LVYEFV N +L L G T+ L++ R ++ + A+G+ Y
Sbjct: 678 PNLVKLYGCCVEGGQLLLVYEFVENNSLARALFGPQETQLRLDWPTRRKICIGVARGLAY 737
Query: 739 LHTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSRLAPVLDDEGTMPTHVSTIVKGTPG 798
LH E+ + HRDIKA+N+LLD LN K++DFGL++ LD+E + TH+ST + GT G
Sbjct: 738 LHEESRLKIVHRDIKATNVLLDKQLNPKISDFGLAK----LDEEDS--THISTRIAGTFG 791
Query: 799 YLDPEYFLTHKLTDKSDVYSLGVVLLELLTGM-QPISHGKN----IVREVNVARDSGMVF 853
Y+ PEY + LTDK+DVYS G+V LE++ G I KN ++ V V R+ +
Sbjct: 792 YMAPEYAMRGHLTDKADVYSFGIVALEIVHGRSNKIERSKNNTFYLIDWVEVLREKNNLL 851
Query: 854 SIIDNRMGS-YPSECVERFVTLALRCCHDKPEHRPSMSDVVRELENILKMFPETDTMFSK 912
++D R+GS Y E + +A+ C +P RPSMS+VV+ LE K E + +
Sbjct: 852 ELVDPRLGSEYNREEAMTMIQIAIMCTSSEPCERPSMSEVVKMLEG--KKMVEVEKLEEA 909
Query: 913 S---ESSSL-----------LSGKSASTSSSFLTRDPYASSSN 941
S E+ L + G+ STS S + D SS++
Sbjct: 910 SVHRETKRLENMNTMKKYYEMIGQEISTSMSMIMSDRSESSAD 952
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|C0LGH2|Y1561_ARATH Probable LRR receptor-like serine/threonine-protein kinase At1g56130 OS=Arabidopsis thaliana GN=At1g56130 PE=1 SV=2 | Back alignment and function description |
|---|
Score = 316 bits (810), Expect = 6e-85, Method: Compositional matrix adjust.
Identities = 281/885 (31%), Positives = 422/885 (47%), Gaps = 143/885 (16%)
Query: 98 LSGNLAPELGQLSRLQYY-FMWNDLTGTIPKEIGNISSLIFLLLNGNKLSGSLPDELGYL 156
L+G+L P +G L+R+Q+ F N L+G +PKEIG ++ L L ++ N SGS+PDE+G
Sbjct: 135 LTGSLPPAIGNLTRMQWMTFGINALSGPVPKEIGLLTDLRLLGISSNNFSGSIPDEIGRC 194
Query: 157 SNLNRLQVDENNITGTIPKSFANLSRVRHLHLNNNSIGGQIPSELSKLSTLIHLLVDNNN 216
+ L ++ +D + ++G IP SFANL ++ + + + QIP + + L L +
Sbjct: 195 TKLQQMYIDSSGLSGRIPLSFANLVQLEQAWIADLEVTDQIPDFIGDWTKLTTLRIIGTG 254
Query: 217 LSGNLPPELSELPQLCILQLDNNNFSASEIPATYGNFSKLVKLSLRNCNLQGAVPD-LSR 275
LSG +P S L L L+L + + +S + + L L LRN NL G +P +
Sbjct: 255 LSGPIPSSFSNLTSLTELRLGDISSGSSSLDFIK-DMKSLSVLVLRNNNLTGTIPSTIGE 313
Query: 276 IPNLYYLDLSWNHLTGSIPSKKLS-ENVTTIDLSDNYLNGSILESISNLPFLQTLSLEN- 333
+L +DLS+N L G IP+ + +T + L +N LNGS P +T SL N
Sbjct: 314 HSSLRQVDLSFNKLHGPIPASLFNLSQLTHLFLGNNTLNGS-------FPTQKTQSLRNV 366
Query: 334 ----NFLTGSIPATIWQNKSFSTKARLKIDLRNNSFSNIVGDLTLPNNVTLRLGGNPICT 389
N L+GS+P S+ + LK++L N+F+ + G L N V L C
Sbjct: 367 DVSYNDLSGSLP-------SWVSLPSLKLNLVANNFT-LEG---LDNRVLPGLN----CL 411
Query: 390 SANIP-NTGRFCGSDAGGDETLTNSKVNC--PVQACPVDNFFEYVPA--SPEPCFCAAPL 444
N P N G+ SD +NC P + FE P F +A
Sbjct: 412 QKNFPCNRGKGIYSDF---------SINCGGPEKRSVTGALFEREDEDFGPASFFVSA-- 460
Query: 445 RIGYRLKSPSFTYFPP-----YVYPFEEYLTNTLNLELYQ-------------------- 479
G R + S F Y+ + NTL+ EL+Q
Sbjct: 461 --GQRWAASSVGLFAGSSNNIYIATSQSQFVNTLDSELFQSARLSASSVRYYGLGLENGG 518
Query: 480 ------------LSIDSFAWEKG---PRLEMYLK---LFPTLNRSSTFDDSEVRQIRDRF 521
L S W KG R ++Y++ + + T DS VR ++ +
Sbjct: 519 YTVTLQFAEIQILGSTSTTW-KGLGRRRFDIYVQGRLVEKDFDVRRTAGDSTVRAVQRVY 577
Query: 522 TS------------WKFPGS---DIFGPYELL--------NFTLLGPYSNLNFNSQSKGI 558
+ W G+ I G Y L +FT P S+ K
Sbjct: 578 KANVSENHLEVHLFWAGKGTCCIPIQGAYGPLISAVSATPDFT---PTVANKPPSKGKNR 634
Query: 559 SGGILAAIV-VGAVASAVAITAAVTLLVMRRHARYQHSLSRKRLSTKISMKIDGVKGFKF 617
+G I+ IV VG ++I A V + +R+ R +++ + L + I F +
Sbjct: 635 TGTIVGVIVGVG----LLSILAGVVMFTIRKR-RKRYTDDEELLGMDVKPYI-----FTY 684
Query: 618 KELAMATAYFSSSTQVGQGGYGKVYKGILSDNTTVAIKRAEEGSLQGQNEFLTEIKLLSR 677
EL AT F S ++G+GG+G VYKG L+D VA+K GS QG+ +F+ EI +S
Sbjct: 685 SELKSATQDFDPSNKLGEGGFGPVYKGNLNDGRVVAVKLLSVGSRQGKGQFVAEIVAISS 744
Query: 678 LHHRNLVSLLGYCDEEGEQMLVYEFVPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGIL 737
+ HRNLV L G C E +MLVYE++PNG+L L G +L+++ R + L A+G++
Sbjct: 745 VLHRNLVKLYGCCFEGEHRMLVYEYLPNGSLDQALFGDKTLHLDWSTRYEICLGVARGLV 804
Query: 738 YLHTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSRLAPVLDDEGTMPTHVSTIVKGTP 797
YLH EA + HRD+KASNILLDS L +++DFGL++L DD+ TH+ST V GT
Sbjct: 805 YLHEEASVRIVHRDVKASNILLDSRLVPQISDFGLAKL---YDDK---KTHISTRVAGTI 858
Query: 798 GYLDPEYFLTHKLTDKSDVYSLGVVLLELLTGMQPIS------HGKNIVREVNVARDSGM 851
GYL PEY + LT+K+DVY+ GVV LEL++G +P S K ++ +
Sbjct: 859 GYLAPEYAMRGHLTEKTDVYAFGVVALELVSG-RPNSDENLEEEKKYLLEWAWNLHEKSR 917
Query: 852 VFSIIDNRMGSYPSECVERFVTLALRCCHDKPEHRPSMSDVVREL 896
+ID+++ + E +R + +AL C RP MS VV L
Sbjct: 918 DIELIDDKLTDFNMEEAKRMIGIALLCTQTSHALRPPMSRVVAML 962
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9FLJ8|Y5613_ARATH Probable receptor-like protein kinase At5g61350 OS=Arabidopsis thaliana GN=At5g61350 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 257 bits (656), Expect = 4e-67, Method: Compositional matrix adjust.
Identities = 168/397 (42%), Positives = 219/397 (55%), Gaps = 59/397 (14%)
Query: 557 GISGGILAAIVVGAVASAVAITAAVTLLV--MRR-----------------HARYQHSLS 597
G+S LA +G V + A V LLV RR HA + +S
Sbjct: 418 GMSSKKLAIAGIGFVMALTAFLGVVVLLVRWQRRPKDWQKQNSFSSWLLPLHASHSSYIS 477
Query: 598 RKRLSTKISMKIDGVKG------------------FKFKELAMATAYFSSSTQVGQGGYG 639
K ST M I G K F F EL AT F + G GG+G
Sbjct: 478 SKGGSTSRRMSIFGSKKSKSNGFSSFFSNQGLGRYFPFTELQTATQNFDENAVCGVGGFG 537
Query: 640 KVYKGILSDNTTVAIKRAEEGSLQGQNEFLTEIKLLSRLHHRNLVSLLGYCDEEGEQMLV 699
KVY G + T VAIKR + S QG NEF TEI++LS+L HR+LVSL+G+CDE E +LV
Sbjct: 538 KVYIGEIDGGTQVAIKRGSQSSEQGINEFQTEIQMLSKLRHRHLVSLIGFCDENKEMILV 597
Query: 700 YEFVPNGTLRDWLSGRTKEN-------LNFAMRLRVALDSAKGILYLHTEAHPPVFHRDI 752
YE++ NG LRD L G +KEN L++ RL + + SA+G+ YLHT A + HRD+
Sbjct: 598 YEYMSNGPLRDHLYG-SKENDPNPIPTLSWKQRLEICIGSARGLHYLHTGAAQGIIHRDV 656
Query: 753 KASNILLDSNLNAKVADFGLSRLAPVLDDEGTMPTHVSTIVKGTPGYLDPEYFLTHKLTD 812
K +NILLD NL AKV+DFGLS+ AP+ DEG HVST VKG+ GYLDPEYF +LTD
Sbjct: 657 KTTNILLDENLVAKVSDFGLSKDAPM--DEG----HVSTAVKGSFGYLDPEYFRRQQLTD 710
Query: 813 KSDVYSLGVVLLELLTGMQPISHGKNIVREVNVAR------DSGMVFSIIDNRM-GSYPS 865
KSDVYS GVVL E+L +P+ + + +VN+A GM+ IID ++ G+
Sbjct: 711 KSDVYSFGVVLFEVLCA-RPVINPQLPREQVNLAEYAMNLHRKGMLEKIIDPKIVGTISK 769
Query: 866 ECVERFVTLALRCCHDKPEHRPSMSDVVRELENILKM 902
+ +FV A +C + RP M DV+ LE L++
Sbjct: 770 GSLRKFVEAAEKCLAEYGVDRPGMGDVLWNLEYALQL 806
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q9FLW0|Y5241_ARATH Probable receptor-like protein kinase At5g24010 OS=Arabidopsis thaliana GN=At5g24010 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 256 bits (653), Expect = 8e-67, Method: Compositional matrix adjust.
Identities = 136/293 (46%), Positives = 188/293 (64%), Gaps = 13/293 (4%)
Query: 617 FKELAMATAYFSSSTQVGQGGYGKVYKGILSDNTTVAIKRAEEGSLQGQNEFLTEIKLLS 676
F EL T F S +G GG+G V++G L DNT VA+KR GS QG EFL+EI +LS
Sbjct: 479 FAELQSGTNNFDRSLVIGVGGFGMVFRGSLKDNTKVAVKRGSPGSRQGLPEFLSEITILS 538
Query: 677 RLHHRNLVSLLGYCDEEGEQMLVYEFVPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGI 736
++ HR+LVSL+GYC+E+ E +LVYE++ G L+ L G T L++ RL V + +A+G+
Sbjct: 539 KIRHRHLVSLVGYCEEQSEMILVYEYMDKGPLKSHLYGSTNPPLSWKQRLEVCIGAARGL 598
Query: 737 LYLHTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSRLAPVLDDEGTMPTHVSTIVKGT 796
YLHT + + HRDIK++NILLD+N AKVADFGLSR P +D+ THVST VKG+
Sbjct: 599 HYLHTGSSQGIIHRDIKSTNILLDNNYVAKVADFGLSRSGPCIDE-----THVSTGVKGS 653
Query: 797 PGYLDPEYFLTHKLTDKSDVYSLGVVLLELLTGMQPISHGKNIVREVNVA------RDSG 850
GYLDPEYF +LTDKSDVYS GVVL E+L +P + +VN+A + G
Sbjct: 654 FGYLDPEYFRRQQLTDKSDVYSFGVVLFEVLCA-RPAVDPLLVREQVNLAEWAIEWQRKG 712
Query: 851 MVFSIIDNRMGSYPSEC-VERFVTLALRCCHDKPEHRPSMSDVVRELENILKM 902
M+ I+D + C +++F A +CC D RP++ DV+ LE++L++
Sbjct: 713 MLDQIVDPNIADEIKPCSLKKFAETAEKCCADYGVDRPTIGDVLWNLEHVLQL 765
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q9LK35|THE1_ARATH Receptor-like protein kinase THESEUS 1 OS=Arabidopsis thaliana GN=THE1 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 255 bits (651), Expect = 2e-66, Method: Compositional matrix adjust.
Identities = 139/311 (44%), Positives = 190/311 (61%), Gaps = 11/311 (3%)
Query: 613 KGFKFKELAMATAYFSSSTQVGQGGYGKVYKGILSDNTTVAIKRAEEGSLQGQNEFLTEI 672
+ F F+E+ AT F S+ +G GG+G+VYKG L D T VA+KR S QG EF TEI
Sbjct: 496 RCFMFQEIMDATNKFDESSLLGVGGFGRVYKGTLEDGTKVAVKRGNPRSEQGMAEFRTEI 555
Query: 673 KLLSRLHHRNLVSLLGYCDEEGEQMLVYEFVPNGTLRDWLSGRTKENLNFAMRLRVALDS 732
++LS+L HR+LVSL+GYCDE E +LVYE++ NG LR L G L++ RL + + +
Sbjct: 556 EMLSKLRHRHLVSLIGYCDERSEMILVYEYMANGPLRSHLYGADLPPLSWKQRLEICIGA 615
Query: 733 AKGILYLHTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSRLAPVLDDEGTMPTHVSTI 792
A+G+ YLHT A + HRD+K +NILLD NL AKVADFGLS+ P LD THVST
Sbjct: 616 ARGLHYLHTGASQSIIHRDVKTTNILLDENLVAKVADFGLSKTGPSLDQ-----THVSTA 670
Query: 793 VKGTPGYLDPEYFLTHKLTDKSDVYSLGVVLLELLT---GMQPI--SHGKNIVREVNVAR 847
VKG+ GYLDPEYF +LT+KSDVYS GVVL+E+L + P+ NI +
Sbjct: 671 VKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLMEVLCCRPALNPVLPREQVNIAEWAMAWQ 730
Query: 848 DSGMVFSIID-NRMGSYPSECVERFVTLALRCCHDKPEHRPSMSDVVRELENILKMFPET 906
G++ I+D N G +++F A +C + RPSM DV+ LE L++ +
Sbjct: 731 KKGLLDQIMDSNLTGKVNPASLKKFGETAEKCLAEYGVDRPSMGDVLWNLEYALQLEETS 790
Query: 907 DTMFSKSESSS 917
+ ++S+
Sbjct: 791 SALMEPDDNST 801
|
Receptor-like protein kinase required for cell elongation during vegetative growth, mostly in a brassinosteroid-(BR-) independent manner. Mediates the response of growing plant cells to the perturbation of cellulose synthesis and may act as a cell-wall-integrity sensor. Controls ectopic-lignin accumulation in cellulose-deficient mutant backgrounds. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q9LV48|PERK1_ARATH Proline-rich receptor-like protein kinase PERK1 OS=Arabidopsis thaliana GN=PERK1 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 254 bits (650), Expect = 2e-66, Method: Compositional matrix adjust.
Identities = 135/293 (46%), Positives = 187/293 (63%), Gaps = 16/293 (5%)
Query: 615 FKFKELAMATAYFSSSTQVGQGGYGKVYKGILSDNTTVAIKRAEEGSLQGQNEFLTEIKL 674
F ++EL+ AT FS + +GQGG+G V+KGIL VA+K+ + GS QG+ EF E+++
Sbjct: 268 FTYEELSRATNGFSEANLLGQGGFGYVHKGILPSGKEVAVKQLKAGSGQGEREFQAEVEI 327
Query: 675 LSRLHHRNLVSLLGYCDEEGEQMLVYEFVPNGTLRDWLSGRTKENLNFAMRLRVALDSAK 734
+SR+HHR+LVSL+GYC +++LVYEFVPN L L G+ + + ++ RL++AL SAK
Sbjct: 328 ISRVHHRHLVSLIGYCMAGVQRLLVYEFVPNNNLEFHLHGKGRPTMEWSTRLKIALGSAK 387
Query: 735 GILYLHTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSRLAPVLDDEGTMPTHVSTIVK 794
G+ YLH + +P + HRDIKASNIL+D AKVADFGL+++A + THVST V
Sbjct: 388 GLSYLHEDCNPKIIHRDIKASNILIDFKFEAKVADFGLAKIASDTN------THVSTRVM 441
Query: 795 GTPGYLDPEYFLTHKLTDKSDVYSLGVVLLELLTGMQPISHGKNIVRE---------VNV 845
GT GYL PEY + KLT+KSDV+S GVVLLEL+TG +P+ V + +N
Sbjct: 442 GTFGYLAPEYAASGKLTEKSDVFSFGVVLLELITGRRPVDANNVYVDDSLVDWARPLLNR 501
Query: 846 ARDSGMVFSIIDNRMGS-YPSECVERFVTLALRCCHDKPEHRPSMSDVVRELE 897
A + G + D++MG+ Y E + R V A C RP MS +VR LE
Sbjct: 502 ASEEGDFEGLADSKMGNEYDREEMARMVACAAACVRHSARRRPRMSQIVRALE 554
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 958 | ||||||
| 225439103 | 948 | PREDICTED: probable LRR receptor-like se | 0.984 | 0.994 | 0.696 | 0.0 | |
| 255582018 | 961 | ATP binding protein, putative [Ricinus c | 0.988 | 0.985 | 0.704 | 0.0 | |
| 296085838 | 1821 | unnamed protein product [Vitis vinifera] | 0.960 | 0.505 | 0.702 | 0.0 | |
| 224069848 | 936 | predicted protein [Populus trichocarpa] | 0.962 | 0.985 | 0.704 | 0.0 | |
| 224139410 | 959 | predicted protein [Populus trichocarpa] | 0.987 | 0.986 | 0.692 | 0.0 | |
| 356568252 | 957 | PREDICTED: probable LRR receptor-like se | 0.987 | 0.988 | 0.661 | 0.0 | |
| 356530159 | 956 | PREDICTED: probable LRR receptor-like se | 0.982 | 0.984 | 0.656 | 0.0 | |
| 357506713 | 1081 | Leucine-rich repeat protein kinase [Medi | 0.956 | 0.847 | 0.640 | 0.0 | |
| 357502773 | 988 | Receptor protein kinase-like protein [Me | 0.986 | 0.956 | 0.618 | 0.0 | |
| 297806013 | 951 | ATP binding protein [Arabidopsis lyrata | 0.983 | 0.990 | 0.643 | 0.0 |
| >gi|225439103|ref|XP_002266206.1| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At1g06840-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 1336 bits (3458), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 664/954 (69%), Positives = 783/954 (82%), Gaps = 11/954 (1%)
Query: 10 MFGLRASGFVYALLFSYLVLLAAAQTTDPQEASALRAIKNSLVDSMNHLRNWNKGDPCMS 69
M G+RA ++AL + VLLA A+TT P E +ALRA+K L+D M ++RNW KGDPC S
Sbjct: 1 MLGVRAGVCIFALSYCCFVLLAVAETTSPSEVTALRAVKKRLIDPMKNIRNWGKGDPCTS 60
Query: 70 NWTGVLCFDTVETDGHLHVRELQLLSMNLSGNLAPELGQLSRLQYY-FMWNDLTGTIPKE 128
W G++C D TDG+LHV L LL MNLSG LAPELGQLS L+ F+WNDL+G+IPKE
Sbjct: 61 KWKGIICKDKNTTDGYLHVNALLLLKMNLSGTLAPELGQLSHLEIIDFLWNDLSGSIPKE 120
Query: 129 IGNISSLIFLLLNGNKLSGSLPDELGYLSNLNRLQVDENNITGTIPKSFANLSRVRHLHL 188
IGNI+ L LLL+GN+LSGSLPDELGYL +L+RLQ+DEN+I+G +PKSFANLSR++HLH+
Sbjct: 121 IGNIAPLRLLLLSGNRLSGSLPDELGYLLHLDRLQIDENHISGPVPKSFANLSRIKHLHM 180
Query: 189 NNNSIGGQIPSELSKLSTLIHLLVDNNNLSGNLPPELSELPQLCILQLDNNNFSASEIPA 248
NNNS+ G+IPSELS STL HLL DNNNLSGNLPPELS LP+L ILQLDNNNFS +EIP
Sbjct: 181 NNNSLSGRIPSELSNASTLRHLLFDNNNLSGNLPPELSHLPELRILQLDNNNFSGAEIPI 240
Query: 249 TYGNFSKLVKLSLRNCNLQGAVPDLSRIPNLYYLDLSWNHLTGSIPSKKLSENVTTIDLS 308
+YGN S LVKLSLRNC+LQGAVPD S+I NL YLDLS N LTG IPS KLS+N+TTIDLS
Sbjct: 241 SYGNLSNLVKLSLRNCSLQGAVPDFSKIANLSYLDLSLNQLTGPIPSNKLSDNMTTIDLS 300
Query: 309 DNYLNGSILESISNLPFLQTLSLENNFLTGSIPATIWQNKSFSTKARLKIDLRNNSFSNI 368
N+LNGSI ES S+LP LQ L LENN L+GS+P IWQN+S ST A+L +DL+NNSFSNI
Sbjct: 301 GNHLNGSIQESFSDLPRLQKLLLENNLLSGSVPTGIWQNRSLSTSAKLTVDLQNNSFSNI 360
Query: 369 VGDLTLPNNVTLRLGGNPICTSANIPNTGRFCGSDAGGD---ETLTNSKVNCPVQACPVD 425
GDL P NVTL L GNPIC++ANI N FCGS++GG+ E+ TNS NC +Q C D
Sbjct: 361 TGDLNPPANVTLWLQGNPICSNANIVNIHLFCGSESGGEENPESSTNSTDNCRIQECLTD 420
Query: 426 NFFEYVPASPEPCFCAAPLRIGYRLKSPSFTYFPPYVYPFEEYLTNTLNLELYQLSIDSF 485
+FFEYVPASP PCFCA+PLR+GYRLKSPSF+YF PY PFE+Y+T+ LN+ELYQL IDSF
Sbjct: 421 DFFEYVPASPIPCFCASPLRVGYRLKSPSFSYFIPYESPFEKYVTSVLNMELYQLHIDSF 480
Query: 486 AWEKGPRLEMYLKLFPTLNRSSTFDDSEVRQIRDRFTSWKFPGSDIFGPYELLNFTLLGP 545
WE+GPRL M+ KLFPT N + TF+ SEV +IR F SW FP +D FGPYELL+F LLGP
Sbjct: 481 FWEEGPRLRMHFKLFPTYN-NHTFNTSEVLRIRGIFASWDFPSNDFFGPYELLSFPLLGP 539
Query: 546 YSNLNFNSQSKGISGGILAAIVVGAVASAVAITAAVTLLVMRRHARYQHSLSRKRLSTKI 605
YS ++ + K +S GI AI++GA+A A+AI+ VTLL++RRH++YQ+++SR+RLS+ I
Sbjct: 540 YSGIDSATHGKSLSMGIWVAILLGAIACAIAISITVTLLIVRRHSKYQNTVSRRRLSSTI 599
Query: 606 SMKIDGVKGFKFKELAMATAYFSSSTQVGQGGYGKVYKGILSDNTTVAIKRAEEGSLQGQ 665
SMKIDGV+ F ++E+A+AT F+ STQVGQGGYG+VYKGIL DNT VAIKRA+EGSLQGQ
Sbjct: 600 SMKIDGVRDFTYREMALATDNFNDSTQVGQGGYGRVYKGILYDNTVVAIKRAQEGSLQGQ 659
Query: 666 NEFLTEIKLLSRLHHRNLVSLLGYCDEEGEQMLVYEFVPNGTLRDWLSGRTKENLNFAMR 725
EFLTEI+LLSRLHHRNLVSL+GYC EEGEQMLVYEF+PNGTLRDWLS ++K L F+ R
Sbjct: 660 KEFLTEIQLLSRLHHRNLVSLIGYCAEEGEQMLVYEFMPNGTLRDWLSAKSK-TLIFSTR 718
Query: 726 LRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSRLAPVLDDEGTM 785
LR+AL SAKGILYLHTEA PP+FHRDIKASNILLDS KVADFGLSRLAP L+DEG +
Sbjct: 719 LRIALGSAKGILYLHTEAQPPIFHRDIKASNILLDSKFTPKVADFGLSRLAPDLEDEGAV 778
Query: 786 PTHVSTIVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVLLELLTGMQPISHGKNIVREVNV 845
P HVSTIVKGTPGYLDPEYFLT KLTDKSDVYSLGVV LE+LTGMQPISHGKNIVREVN+
Sbjct: 779 PNHVSTIVKGTPGYLDPEYFLTRKLTDKSDVYSLGVVFLEILTGMQPISHGKNIVREVNM 838
Query: 846 ARDSGMVFSIIDNRMGSYPSECVERFVTLALRCCHDKPEHRPSMSDVVRELENILKMFPE 905
+ GMVFSIIDN+MGSYPSECVERF+ LALRCCHDKPE RPSM DVVRELENIL+M PE
Sbjct: 839 SHQLGMVFSIIDNKMGSYPSECVERFLALALRCCHDKPEDRPSMLDVVRELENILRMMPE 898
Query: 906 TDTMFSKSESSSLLSGKSAS-TSSSFLTRDPYASSSNVSGSDLISGAVPSISPR 958
+T S+S S SGK S SSS+++RD Y S SN SGSDL+SG +P+I+PR
Sbjct: 899 IETQSSESASH---SGKLLSLPSSSYVSRDLY-SISNASGSDLVSGVIPTIAPR 948
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255582018|ref|XP_002531806.1| ATP binding protein, putative [Ricinus communis] gi|223528540|gb|EEF30563.1| ATP binding protein, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 1321 bits (3418), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 680/965 (70%), Positives = 790/965 (81%), Gaps = 18/965 (1%)
Query: 8 IMMFGLRASGFVYALLFSYLVLLAAAQTTDPQEASALRAIKNSLVDSMNHLRNWNKGDPC 67
+ M LR SG V+ + F YL+LLA AQ+TDP E +AL A+K SL+D M +L NW KGDPC
Sbjct: 1 MKMLRLRISGCVFLVSFCYLLLLALAQSTDPSEVNALLAVKKSLIDPMKNLWNWEKGDPC 60
Query: 68 MSNWTGVLCFDTVETDGHLHVRELQLLSMNLSGNLAPELGQLSRLQYY-FMWNDLTGTIP 126
SNWTGV+C++T TD +LHV ELQLL+MNLSGNLAP+LGQLS+L+ FMWN+L G+IP
Sbjct: 61 TSNWTGVVCYETSGTDKYLHVGELQLLNMNLSGNLAPQLGQLSQLRILDFMWNELDGSIP 120
Query: 127 KEIGNISSLIFLLLNGNKLSGSLPDELGYLSNLNRLQVDENNITGTIPKSFANLSRVRHL 186
KEIGNISSL LLLNGNKLSG+LPDELG+LSNL R QVD+N I+G IPKS+ANLS VRH+
Sbjct: 121 KEIGNISSLRLLLLNGNKLSGALPDELGFLSNLRRFQVDQNKISGPIPKSYANLSSVRHI 180
Query: 187 HLNNNSIGGQIPSELSKLSTLIHLLVDNNNLSGNLPPELSELPQLCILQLDNNNFSASEI 246
H NNNSI GQIP ELSKLS L+HLL+DNNNLSG+LPPELS L +L ILQLDNNNFS SEI
Sbjct: 181 HFNNNSINGQIPPELSKLSALLHLLLDNNNLSGHLPPELSNLSELRILQLDNNNFSGSEI 240
Query: 247 PATYGNFSKLVKLSLRNCNLQGAVPDLSRIPNLYYLDLSWNHLTGSIPSKKLSENVTTID 306
P TYGN SKL KLSLRNC+L+GA+PDLS I NLYY+D+SWN LTG IPS+ LS+N+TTID
Sbjct: 241 PPTYGNISKLAKLSLRNCSLRGAIPDLSNISNLYYIDMSWNQLTGPIPSE-LSDNMTTID 299
Query: 307 LSDNYLNGSILESISNLPFLQTLSLENNFLTGSIPATIWQNKSFSTKARLKIDLRNNSFS 366
LS+N LNGSI S SNLP LQ LSLENN TGS+PA W+N S ST RL +DLRNNS S
Sbjct: 300 LSNNRLNGSIPGSYSNLPLLQRLSLENNLFTGSVPANFWKNMS-STSDRLTLDLRNNSLS 358
Query: 367 NIVGDLTLPNNVTLRLGGNPICTSANIPNTGRFCGSDAGGD---ETLTNSKVNCPVQACP 423
NI+G+L P NVTLRL GNPIC AN+PN +FCG +A D E+ TNS +CP Q CP
Sbjct: 359 NILGELNPPVNVTLRLRGNPICNRANMPNISQFCGPEAEADGTTESSTNSTTSCPTQTCP 418
Query: 424 VDNFFEYVPASPEPCFCAAPLRIGYRLKSPSFTYFPPYVYPFEEYLTNTLNLELYQLSID 483
+DNF+E+VPASP CFCA+PL IGYRLKSPSF+YFP Y+Y FEEYL + L L YQ+ I
Sbjct: 419 IDNFYEFVPASPVWCFCASPLTIGYRLKSPSFSYFPTYIYSFEEYLASALKLNPYQVYIV 478
Query: 484 SFAWEKGPRLEMYLKLFPTLN--RSSTFDDSEVRQIRDRFTSWKFPGSDIFGPYELLNFT 541
SF WEKGPRL MYLKL+P N S+TF+ +EV++IR FTSW FP +D FGPYELLNFT
Sbjct: 479 SFFWEKGPRLRMYLKLYPAWNDAHSNTFNSTEVQRIRGVFTSWTFPRTDFFGPYELLNFT 538
Query: 542 LLGPYSNLNFNSQSKGISGGILAAIVVGAVASAVAITAAVTLLVMRRHARYQHSLSRKRL 601
L GPYS ++ +QS IS G+ AAI++GA++ V + VT+L++RRHA Y+ +LSRKRL
Sbjct: 539 LQGPYSQISIGTQSTKISKGVWAAIIIGAISFTVIASVIVTILILRRHAGYERNLSRKRL 598
Query: 602 STKISMKIDGVKGFKFKELAMATAYFSSSTQVGQGGYGKVYKGILSDNTTVAIKRAEEGS 661
S+KISMKIDGVK F FKE+ +AT F+SSTQVG+GGYGKVY+GIL+DNT VAIKRAEE S
Sbjct: 599 SSKISMKIDGVKFFTFKEMTLATNNFNSSTQVGRGGYGKVYRGILADNTVVAIKRAEEDS 658
Query: 662 LQGQNEFLTEIKLLSRLHHRNLVSLLGYCDEEGEQMLVYEFVPNGTLRDWLSGRTKENLN 721
LQGQ EFLTEI+LLSRLHHRNLVSL+GYCDEE EQMLVYEF+ NGTLRDWLS + KE LN
Sbjct: 659 LQGQKEFLTEIRLLSRLHHRNLVSLVGYCDEEEEQMLVYEFMANGTLRDWLSAKGKEKLN 718
Query: 722 FAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSRLAPVLDD 781
FAMRL++AL SAKGILYLH EA+PPVFHRDIKA+NILLDS L AKVADFGLSRLAPVLDD
Sbjct: 719 FAMRLKIALGSAKGILYLHAEANPPVFHRDIKATNILLDSKLTAKVADFGLSRLAPVLDD 778
Query: 782 EGTMPTHVSTIVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVLLELLTGMQPISHGKNIVR 841
EG +P HVST+VKGTPGYLDPEYFLTHKLTDKSDVYSLG+V LELLTGMQPI+HGKNIVR
Sbjct: 779 EGNLPNHVSTVVKGTPGYLDPEYFLTHKLTDKSDVYSLGIVFLELLTGMQPITHGKNIVR 838
Query: 842 EVNVARDSGMVFSIIDNRMGSYPSECVERFVTLALRCCHDKPEHRPSMSDVVRELENILK 901
EV +A SG++FSIID+RMG+YPSECVERF+ LAL CCHD PE+RPSM +VVRELE ILK
Sbjct: 839 EVTMAHQSGIMFSIIDSRMGAYPSECVERFIALALGCCHDNPENRPSMWEVVRELETILK 898
Query: 902 MFP-ETDTMFSKSESSSLLSGKSAST-------SSSFLTRDPYASSSNVSGSDLISGAVP 953
M P +TD +F SES+SL SG S ST SSSF T + +SS VSGSDLISG +P
Sbjct: 899 MMPAKTDVIF--SESTSLYSGSSTSTHFGNSASSSSFYTVNDEYASSQVSGSDLISGVIP 956
Query: 954 SISPR 958
SISPR
Sbjct: 957 SISPR 961
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|296085838|emb|CBI31162.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 1319 bits (3414), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 654/931 (70%), Positives = 769/931 (82%), Gaps = 11/931 (1%)
Query: 33 AQTTDPQEASALRAIKNSLVDSMNHLRNWNKGDPCMSNWTGVLCFDTVETDGHLHVRELQ 92
A+TT P E +ALRA+K L+D M ++RNW KGDPC S W G++C D TDG+LHV L
Sbjct: 897 AETTSPSEVTALRAVKKRLIDPMKNIRNWGKGDPCTSKWKGIICKDKNTTDGYLHVNALL 956
Query: 93 LLSMNLSGNLAPELGQLSRLQYY-FMWNDLTGTIPKEIGNISSLIFLLLNGNKLSGSLPD 151
LL MNLSG LAPELGQLS L+ F+WNDL+G+IPKEIGNI+ L LLL+GN+LSGSLPD
Sbjct: 957 LLKMNLSGTLAPELGQLSHLEIIDFLWNDLSGSIPKEIGNIAPLRLLLLSGNRLSGSLPD 1016
Query: 152 ELGYLSNLNRLQVDENNITGTIPKSFANLSRVRHLHLNNNSIGGQIPSELSKLSTLIHLL 211
ELGYL +L+RLQ+DEN+I+G +PKSFANLSR++HLH+NNNS+ G+IPSELS STL HLL
Sbjct: 1017 ELGYLLHLDRLQIDENHISGPVPKSFANLSRIKHLHMNNNSLSGRIPSELSNASTLRHLL 1076
Query: 212 VDNNNLSGNLPPELSELPQLCILQLDNNNFSASEIPATYGNFSKLVKLSLRNCNLQGAVP 271
DNNNLSGNLPPELS LP+L ILQLDNNNFS +EIP +YGN S LVKLSLRNC+LQGAVP
Sbjct: 1077 FDNNNLSGNLPPELSHLPELRILQLDNNNFSGAEIPISYGNLSNLVKLSLRNCSLQGAVP 1136
Query: 272 DLSRIPNLYYLDLSWNHLTGSIPSKKLSENVTTIDLSDNYLNGSILESISNLPFLQTLSL 331
D S+I NL YLDLS N LTG IPS KLS+N+TTIDLS N+LNGSI ES S+LP LQ L L
Sbjct: 1137 DFSKIANLSYLDLSLNQLTGPIPSNKLSDNMTTIDLSGNHLNGSIQESFSDLPRLQKLLL 1196
Query: 332 ENNFLTGSIPATIWQNKSFSTKARLKIDLRNNSFSNIVGDLTLPNNVTLRLGGNPICTSA 391
ENN L+GS+P IWQN+S ST A+L +DL+NNSFSNI GDL P NVTL L GNPIC++A
Sbjct: 1197 ENNLLSGSVPTGIWQNRSLSTSAKLTVDLQNNSFSNITGDLNPPANVTLWLQGNPICSNA 1256
Query: 392 NIPNTGRFCGSDAGGD---ETLTNSKVNCPVQACPVDNFFEYVPASPEPCFCAAPLRIGY 448
NI N FCGS++GG+ E+ TNS NC +Q C D+FFEYVPASP PCFCA+PLR+GY
Sbjct: 1257 NIVNIHLFCGSESGGEENPESSTNSTDNCRIQECLTDDFFEYVPASPIPCFCASPLRVGY 1316
Query: 449 RLKSPSFTYFPPYVYPFEEYLTNTLNLELYQLSIDSFAWEKGPRLEMYLKLFPTLNRSST 508
RLKSPSF+YF PY PFE+Y+T+ LN+ELYQL IDSF WE+GPRL M+ KLFPT N + T
Sbjct: 1317 RLKSPSFSYFIPYESPFEKYVTSVLNMELYQLHIDSFFWEEGPRLRMHFKLFPTYN-NHT 1375
Query: 509 FDDSEVRQIRDRFTSWKFPGSDIFGPYELLNFTLLGPYSNLNFNSQSKGISGGILAAIVV 568
F+ SEV +IR F SW FP +D FGPYELL+F LLGPYS ++ + K +S GI AI++
Sbjct: 1376 FNTSEVLRIRGIFASWDFPSNDFFGPYELLSFPLLGPYSGIDSATHGKSLSMGIWVAILL 1435
Query: 569 GAVASAVAITAAVTLLVMRRHARYQHSLSRKRLSTKISMKIDGVKGFKFKELAMATAYFS 628
GA+A A+AI+ VTLL++RRH++YQ+++SR+RLS+ ISMKIDGV+ F ++E+A+AT F+
Sbjct: 1436 GAIACAIAISITVTLLIVRRHSKYQNTVSRRRLSSTISMKIDGVRDFTYREMALATDNFN 1495
Query: 629 SSTQVGQGGYGKVYKGILSDNTTVAIKRAEEGSLQGQNEFLTEIKLLSRLHHRNLVSLLG 688
STQVGQGGYG+VYKGIL DNT VAIKRA+EGSLQGQ EFLTEI+LLSRLHHRNLVSL+G
Sbjct: 1496 DSTQVGQGGYGRVYKGILYDNTVVAIKRAQEGSLQGQKEFLTEIQLLSRLHHRNLVSLIG 1555
Query: 689 YCDEEGEQMLVYEFVPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVF 748
YC EEGEQMLVYEF+PNGTLRDWLS ++K L F+ RLR+AL SAKGILYLHTEA PP+F
Sbjct: 1556 YCAEEGEQMLVYEFMPNGTLRDWLSAKSK-TLIFSTRLRIALGSAKGILYLHTEAQPPIF 1614
Query: 749 HRDIKASNILLDSNLNAKVADFGLSRLAPVLDDEGTMPTHVSTIVKGTPGYLDPEYFLTH 808
HRDIKASNILLDS KVADFGLSRLAP L+DEG +P HVSTIVKGTPGYLDPEYFLT
Sbjct: 1615 HRDIKASNILLDSKFTPKVADFGLSRLAPDLEDEGAVPNHVSTIVKGTPGYLDPEYFLTR 1674
Query: 809 KLTDKSDVYSLGVVLLELLTGMQPISHGKNIVREVNVARDSGMVFSIIDNRMGSYPSECV 868
KLTDKSDVYSLGVV LE+LTGMQPISHGKNIVREVN++ GMVFSIIDN+MGSYPSECV
Sbjct: 1675 KLTDKSDVYSLGVVFLEILTGMQPISHGKNIVREVNMSHQLGMVFSIIDNKMGSYPSECV 1734
Query: 869 ERFVTLALRCCHDKPEHRPSMSDVVRELENILKMFPETDTMFSKSESSSLLSGKSAS-TS 927
ERF+ LALRCCHDKPE RPSM DVVRELENIL+M PE +T S+S S SGK S S
Sbjct: 1735 ERFLALALRCCHDKPEDRPSMLDVVRELENILRMMPEIETQSSESASH---SGKLLSLPS 1791
Query: 928 SSFLTRDPYASSSNVSGSDLISGAVPSISPR 958
SS+++RD Y S SN SGSDL+SG +P+I+PR
Sbjct: 1792 SSYVSRDLY-SISNASGSDLVSGVIPTIAPR 1821
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224069848|ref|XP_002326429.1| predicted protein [Populus trichocarpa] gi|222833622|gb|EEE72099.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 1315 bits (3404), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 669/950 (70%), Positives = 781/950 (82%), Gaps = 28/950 (2%)
Query: 23 LFSYLVLLAAAQTTDPQEASALRAIKNSLVDSMNHLRNWNKGDPCMSNWTGVLCFDTVET 82
+FS L + A +AL A+KNSL+D M HL NWNKGDPC NWTGV C D+ T
Sbjct: 1 MFSILCIFAV---------NALLAVKNSLIDPMKHLSNWNKGDPCAFNWTGVFCSDSTGT 51
Query: 83 DGHLHVRELQLLSMNLSGNLAPELGQLSRLQYY-FMWNDLTGTIPKEIGNISSLIFLLLN 141
DG+LHV+ELQL++MNLSG+LAPELGQLS+L+ FMWN+LTG+IP+EIG++SSL LLLN
Sbjct: 52 DGYLHVQELQLMNMNLSGSLAPELGQLSQLKILDFMWNELTGSIPREIGSLSSLKLLLLN 111
Query: 142 GNKLSGSLPDELGYLSNLNRLQVDENNITGTIPKSFANLSRVRHLHLNNNSIGGQIPSEL 201
GNKLSGSLPDEL YLS L+RLQVD+NNI+G +PKSFAN+S VRHLHLNNNSI GQIP EL
Sbjct: 112 GNKLSGSLPDELSYLSKLDRLQVDQNNISGPLPKSFANMSSVRHLHLNNNSISGQIPPEL 171
Query: 202 SKLSTLIHLLVDNNNLSGNLPPELSELPQLCILQLDNNNFSASEIPATYGNFSKLVKLSL 261
KLSTL HLL+DNNNLSG LPPELS+LP++ I+QLDNNNF+ S IPATYGN S+L KLSL
Sbjct: 172 YKLSTLFHLLLDNNNLSGYLPPELSKLPEIRIIQLDNNNFNGSGIPATYGNLSRLAKLSL 231
Query: 262 RNCNLQGAVPDLSRIPNLYYLDLSWNHLTGSIPSKKLSENVTTIDLSDNYLNGSILESIS 321
RNC+L GA+PDLS IPNLYYLDLS N+L+GS+PSK LS+++ TIDLS+N+L+GSI S S
Sbjct: 232 RNCSLHGAIPDLSSIPNLYYLDLSENNLSGSVPSK-LSDSMRTIDLSENHLSGSIPGSFS 290
Query: 322 NLPFLQTLSLENNFLTGSIPATIWQNKSFSTKARLKIDLRNNSFSNIVGDLTLPNNVTLR 381
NLPFLQ LSLENN L GS+P IWQN +F+ ARL IDLRNNS S I G L P+NVTLR
Sbjct: 291 NLPFLQRLSLENNLLNGSVPTDIWQNVTFTKSARLTIDLRNNSLSTISGALNPPDNVTLR 350
Query: 382 LGGNPICTSANIPNTGRFCGSDAGGD---ETLTNSKVNCPVQACPVDNFFEYVPASPEPC 438
LGGNPIC SANI N +FCGS+AGGD E S + CPVQACP+DNFFEYVPASP PC
Sbjct: 351 LGGNPICKSANIANITQFCGSEAGGDRNAERSRKSTMTCPVQACPIDNFFEYVPASPLPC 410
Query: 439 FCAAPLRIGYRLKSPSFTYFPPYVYPFEEYLTNTLNLELYQLSIDSFAWEKGPRLEMYLK 498
FCA+PL++GYRLKSPSF+YF PYV PFE Y+T++LNL YQL+IDS+ WE+GPRL M+L
Sbjct: 411 FCASPLKVGYRLKSPSFSYFDPYVLPFELYVTSSLNLNPYQLAIDSYFWEEGPRLRMHLN 470
Query: 499 LFPTLN--RSSTFDDSEVRQIRDRFTSWKFPGSDIFGPYELLNFTLLGPYSNLNFNSQSK 556
LFP N S+TF+ SEVR+IR FTSW+FPG FGPYELLNFTL+GPY+ ++F+ + K
Sbjct: 471 LFPPANNMHSNTFNVSEVRRIRGIFTSWQFPGDGFFGPYELLNFTLVGPYAGMHFDRKGK 530
Query: 557 GISGGILAAIVVGAVASAVAITAAVTLLVMRRHARYQHSLSRKRLSTKISMKIDGVKGFK 616
IS G+L AI++GA+A A+AI++ +T L+ R+AR LSR+ LS+K SMKIDGVKGF
Sbjct: 531 SISKGVLVAIILGAIACAIAISSVLTFLIAGRYARNLRKLSRRHLSSKASMKIDGVKGFT 590
Query: 617 FKELAMATAYFSSSTQVGQGGYGKVYKGILSDNTTVAIKRAEEGSLQGQNEFLTEIKLLS 676
FKE+A+AT F+SSTQVG+GGYGKVY+GILSDN+ VAIKR+EEGSLQGQ EFLTEIKLLS
Sbjct: 591 FKEMALATDNFNSSTQVGRGGYGKVYRGILSDNSIVAIKRSEEGSLQGQKEFLTEIKLLS 650
Query: 677 RLHHRNLVSLLGYCDEEGEQMLVYEFVPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGI 736
RLHHRNLVSL+GYCDEE EQMLVYEF+PNGTLRDWLS + K L F RL +AL SAKGI
Sbjct: 651 RLHHRNLVSLVGYCDEE-EQMLVYEFMPNGTLRDWLSDKGKGTLKFGTRLSIALGSAKGI 709
Query: 737 LYLHTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSRLAPVLDDEGTMPTHVSTIVKGT 796
LYLHTEA PPVFHRDIKA+NILLDS LNAKVADFGLS LAPVLDDEG +P HVST+V+GT
Sbjct: 710 LYLHTEAQPPVFHRDIKATNILLDSILNAKVADFGLSLLAPVLDDEGNLPNHVSTVVRGT 769
Query: 797 PGYLDPEYFLTHKLTDKSDVYSLGVVLLELLTGMQPISHGKNIVREVNVARDSGMVFSII 856
PGYLDPEYFLTHKLTDKSDVYSLG+V LELLTGMQPISHGKNIVREVN+A SG++FSII
Sbjct: 770 PGYLDPEYFLTHKLTDKSDVYSLGIVFLELLTGMQPISHGKNIVREVNMAYQSGIMFSII 829
Query: 857 DNRMGSYPSECVERFVTLALRCCHDKPEHRPSMSDVVRELENILKMFPETDTMFSKSESS 916
DNRMG+YPSECVERFV LAL CCHDK + RPSM DVVRELE ILKM PETD ++ +ES+
Sbjct: 830 DNRMGAYPSECVERFVVLALDCCHDKQDKRPSMQDVVRELETILKMMPETDAIY--TEST 887
Query: 917 SLLSGKSAST--------SSSFLTRDPYASSSNVSGSDLISGAVPSISPR 958
SGKS T SS + +RDPY SSS + GSDL SG VP+I+P
Sbjct: 888 PTYSGKSTPTYSGKSASSSSFYSSRDPYGSSS-LLGSDLTSGVVPTITPH 936
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224139410|ref|XP_002323098.1| predicted protein [Populus trichocarpa] gi|222867728|gb|EEF04859.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 1283 bits (3321), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 666/962 (69%), Positives = 778/962 (80%), Gaps = 16/962 (1%)
Query: 10 MFGLRASGFVYALLFSYLVLLAAAQTTDPQEASALRAIKNSLVDSMNHLRNWNKGDPCMS 69
M LR G V+ L + YL+LL AQ T+P E +AL A+KN+L+D M L NWNKGDPC S
Sbjct: 1 MLQLRTWGCVFLLSYCYLLLLTVAQVTNPSEVNALLAVKNNLIDPMKQLSNWNKGDPCTS 60
Query: 70 NWTGVLCFDTVETDGHLHVRELQLLSMNLSGNLAPELGQLSRLQYY-FMWNDLTGTIPKE 128
NWTGV C+D TDG+LHVREL LL++NLSGNLAPELGQLS+L FMWN+LTG+IP+E
Sbjct: 61 NWTGVFCYDATGTDGYLHVRELYLLNLNLSGNLAPELGQLSQLAILDFMWNELTGSIPRE 120
Query: 129 IGNISSLIFLLLNGNKLSGSLPDELGYLSNLNRLQVDENNITGTIPKSFANLSRVRHLHL 188
IGN+SSL LLLNGNKLSGSLPDELGYLS L RLQVD+NNI+G IPKSFAN+S +RH HL
Sbjct: 121 IGNLSSLKLLLLNGNKLSGSLPDELGYLSKLIRLQVDQNNISGRIPKSFANMSSIRHFHL 180
Query: 189 NNNSIGGQIPSELSKLSTLIHLLVDNNNLSGNLPPELSELPQLCILQLDNNNFSASEIPA 248
NNNSI GQIP ELSKLSTL+HLL+DNNNLSG LPPELS+ P++ I+QLDNNNF+ S IPA
Sbjct: 181 NNNSISGQIPPELSKLSTLVHLLLDNNNLSGYLPPELSKFPEMRIIQLDNNNFNGSGIPA 240
Query: 249 TYGNFSKLVKLSLRNCNLQGAVPDLSRIPNLYYLDLSWNHLTGSIPSKKLSENVTTIDLS 308
TYG+ S+LVKLSLRNC+LQG++PDLS IPNLYYLDLS N+L GS+P KLS+ + TIDLS
Sbjct: 241 TYGSLSRLVKLSLRNCSLQGSIPDLSSIPNLYYLDLSKNNLRGSLP-PKLSDTMRTIDLS 299
Query: 309 DNYLNGSILESISNLPFLQTLSLENNFLTGSIPATIWQNKSFSTKARLKIDLRNNSFSNI 368
+N+L+GSI S S+L FLQ LSLENN L GS+PA IWQN + + A IDLRNNS S+I
Sbjct: 300 ENHLSGSIPGSFSDLSFLQRLSLENNQLNGSVPANIWQNMTSTKSACFTIDLRNNSLSSI 359
Query: 369 VGDLTLPNNVTLRLGGNPICTSANIPNTGRFCGSDAGGDETL---TNSKVNCPVQACPVD 425
G L P+NVTLRL GNPIC +ANI N +FCG +AGGD T NS + CPVQACPVD
Sbjct: 360 SGVLNPPDNVTLRLRGNPICENANIANIIQFCGFEAGGDRTTERSMNSTMTCPVQACPVD 419
Query: 426 NFFEYVPASPEPCFCAAPLRIGYRLKSPSFTYFPPYVYPFEEYLTNTLNLELYQLSIDSF 485
NFFEYVPASP PCFCA+PLRIGYRLKSPSF+YF PY +PFE ++T+ L L YQLSIDS+
Sbjct: 420 NFFEYVPASPLPCFCASPLRIGYRLKSPSFSYFDPYAFPFELHVTSALKLNPYQLSIDSY 479
Query: 486 AWEKGPRLEMYLKLFPTLN--RSSTFDDSEVRQIRDRFTSWKFPGSDIFGPYELLNFTLL 543
WE+GPRL M+LK+FP N S+TF+ SEV +IR FTSW FPG D+FGPYELLNFTL+
Sbjct: 480 FWEEGPRLRMHLKIFPPANNVHSNTFNVSEVGRIRGAFTSWHFPGDDLFGPYELLNFTLV 539
Query: 544 GPYSNLNFNSQSKGISGGILAAIVVGAVASAVAITAAVTLLVMRRHARYQHSLSRKRLST 603
GPY+ ++F+++ K IS GI A+++GA+A VA++A VTLL+ RR+AR +LSR+ S+
Sbjct: 540 GPYAAIHFDTKGKNISIGIWVAVILGAIACTVAVSAVVTLLIARRYARKHRNLSRRHSSS 599
Query: 604 KISMKIDGVKGFKFKELAMATAYFSSSTQVGQGGYGKVYKGILSDNTTVAIKRAEEGSLQ 663
K S+KIDGVKGF FKE+A+AT F+ STQVG+GGYGKVY+G+LS N+ VAIKR EEGSLQ
Sbjct: 600 KASIKIDGVKGFTFKEMALATDNFNCSTQVGRGGYGKVYRGVLSGNSIVAIKRTEEGSLQ 659
Query: 664 GQNEFLTEIKLLSRLHHRNLVSLLGYCDEEGEQMLVYEFVPNGTLRDWLSGRTKENLNFA 723
GQ EFLTEIKLLSRLHHRNLVSL+GYC+E+ EQMLVYEF+PNGTLRDWLS + K LNF
Sbjct: 660 GQKEFLTEIKLLSRLHHRNLVSLVGYCEEKEEQMLVYEFMPNGTLRDWLSDKAKGTLNFG 719
Query: 724 MRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSRLAPVLDDEG 783
RL +AL SAKGILYLHTEA PPVFHRDIKA+NILLDS L AKVADFGLSRLAPVLDDEG
Sbjct: 720 TRLSIALGSAKGILYLHTEAQPPVFHRDIKATNILLDSKLTAKVADFGLSRLAPVLDDEG 779
Query: 784 TMPTHVSTIVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVLLELLTGMQPISHGKNIVREV 843
+P HVST+V+GTPGYLDPEYFLTHKLTDKSDVYSLG+V LELLTGM PISHGKNIVREV
Sbjct: 780 NLPNHVSTVVRGTPGYLDPEYFLTHKLTDKSDVYSLGIVFLELLTGMHPISHGKNIVREV 839
Query: 844 NVARDSGMVFSIIDNRMGSYPSECVERFVTLALRCCHDKPEHRPSMSDVVRELENILKMF 903
N+A SG++FSIIDNRMG+YPSECVERFV LAL CCHDK E RPSM DVVRELE ILKM
Sbjct: 840 NMAHQSGIMFSIIDNRMGAYPSECVERFVALALSCCHDKQEKRPSMQDVVRELETILKMM 899
Query: 904 PETDTMFSKSESSSLLSGKSASTSSSFLTRDPYA-------SSSNVSGSDLISGAVPSIS 956
PE D ++ +ES+S SGKS T S SS + GSDL SG VP+I+
Sbjct: 900 PEADAIY--AESTSTYSGKSTPTYSGKSASSSSFYSSQYLYESSCLLGSDLSSGVVPTIN 957
Query: 957 PR 958
PR
Sbjct: 958 PR 959
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356568252|ref|XP_003552327.1| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At1g06840-like isoform 1 [Glycine max] gi|356568254|ref|XP_003552328.1| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At1g06840-like isoform 2 [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 1262 bits (3266), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 635/960 (66%), Positives = 771/960 (80%), Gaps = 14/960 (1%)
Query: 10 MFGLRASGFVYALLFSYLVLLAAAQTTDPQEASALRAIKNSLVDSMNHLRNWNKGDPCMS 69
M LR G+ A+ F + +AA+ TDP E AL IKNSL+D N+L+NWNKGDPC +
Sbjct: 1 MPALRIHGYALAVSFCLITFIAASLPTDPSEVDALIEIKNSLIDPKNNLKNWNKGDPCAA 60
Query: 70 NWTGVLCFDTVETDGHLHVRELQLLSMNLSGNLAPELGQLSRLQYY-FMWNDLTGTIPKE 128
NWTGV CFD DG+ HVRE+ L++MNLSG+L+P+LGQLS L+ FMWNDLTGTIPKE
Sbjct: 61 NWTGVWCFDQKGDDGYFHVREIYLMTMNLSGSLSPQLGQLSHLEILNFMWNDLTGTIPKE 120
Query: 129 IGNISSLIFLLLNGNKLSGSLPDELGYLSNLNRLQVDENNITGTIPKSFANLSRVRHLHL 188
IGNI SL LLLNGNKLSGSLPDELG L NLNR QVDEN ++G IP+SFAN++ +RHLHL
Sbjct: 121 IGNIKSLKLLLLNGNKLSGSLPDELGNLPNLNRFQVDENQLSGPIPESFANMTNIRHLHL 180
Query: 189 NNNSIGGQIPSELSKLSTLIHLLVDNNNLSGNLPPELSELPQLCILQLDNNNFSASEIPA 248
NNNS G++PS LSKLS LIHLLVDNNNLSG+LPPE S L +L ILQLDNN+FS SEIP+
Sbjct: 181 NNNSFSGELPSTLSKLSNLIHLLVDNNNLSGHLPPEYSMLDELAILQLDNNDFSGSEIPS 240
Query: 249 TYGNFSKLVKLSLRNCNLQGAVPDLSRIPNLYYLDLSWNHLTGSIPSKKLSENVTTIDLS 308
TY N ++LVKLSLRNC+LQGA+PD S I L YLDLSWN +TG IPS K+++N+TT DLS
Sbjct: 241 TYANLTRLVKLSLRNCSLQGAIPDFSSISKLTYLDLSWNQITGPIPSNKVADNMTTFDLS 300
Query: 309 DNYLNGSILESISNLPFLQTLSLENNFLTGSIPATIWQNKSFSTKARLKIDLRNNSFSNI 368
+N LNGSI P LQ LSL NN L+GSIP +IWQN SFS K +L IDL+NNSFS++
Sbjct: 301 NNRLNGSIPHFF--YPHLQKLSLANNLLSGSIPGSIWQNMSFSAKDKLTIDLQNNSFSDV 358
Query: 369 VGDLTLPNNVTLRLGGNPICTSANIPNTGRFCG--SDAGGDETLTNSKVNCPVQACPVDN 426
+G+LT P NVTLRL GNPIC ++NI + G++CG +D + TNS CPVQ+CPVD+
Sbjct: 359 LGNLTPPENVTLRLSGNPICKNSNIQSIGQYCGPEADNKAAQDSTNSTF-CPVQSCPVDD 417
Query: 427 FFEYVPASPEPCFCAAPLRIGYRLKSPSFTYFPPYVYPFEEYLTNTLNLELYQLSIDSFA 486
F+EY P+SP PCFCAAPLRIGYRLKSPSF+YF PY FE+Y+T +L+L+LYQLSIDS A
Sbjct: 418 FYEYAPSSPVPCFCAAPLRIGYRLKSPSFSYFAPYRSSFEDYITRSLDLDLYQLSIDSVA 477
Query: 487 WEKGPRLEMYLKLFPTLNRS--STFDDSEVRQIRDRFTSWKFPGSDIFGPYELLNFTLLG 544
WE+GPRL MYLKLFP+ N S S F++SEV +I+ ++SW FP +D FGPYELLNFTLLG
Sbjct: 478 WEEGPRLRMYLKLFPSYNDSGSSMFNESEVHRIKGIYSSWHFPRTDFFGPYELLNFTLLG 537
Query: 545 PYSNLNFNSQSKGISGGILAAIVVGAVASAVAITAAVTLLVMRRHARYQHSLSRKRLSTK 604
PY+NLN +S+ K + GI + V+ AVA A+AI+A + LL+ +R+ +YQ +SRKR+ST
Sbjct: 538 PYANLNVDSKKKKNNVGIKISAVIAAVACALAISAIIILLISKRNMKYQKKISRKRMSTN 597
Query: 605 ISMKIDGVKGFKFKELAMATAYFSSSTQVGQGGYGKVYKGILSDNTTVAIKRAEEGSLQG 664
+S+KIDG+K F +KELA+AT F+ ST+VGQGGYG VYKGILSD T VA+KRAEEGSLQG
Sbjct: 598 VSIKIDGMKAFTYKELAIATNKFNISTKVGQGGYGNVYKGILSDETFVAVKRAEEGSLQG 657
Query: 665 QNEFLTEIKLLSRLHHRNLVSLLGYCDEEGEQMLVYEFVPNGTLRDWLSGR---TKENLN 721
Q EFLTEI+LLSRLHHRNLVSL+GYC+E+ EQMLVYEF+PNGTLRDW+SG+ TK +LN
Sbjct: 658 QKEFLTEIELLSRLHHRNLVSLIGYCNEKEEQMLVYEFMPNGTLRDWISGKSRKTKGSLN 717
Query: 722 FAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSRLAPVLDD 781
F+MRLR+A+ +AKGILYLHTEA+PP+FHRDIKASNILLDS AKVADFGLSRL P L +
Sbjct: 718 FSMRLRIAMGAAKGILYLHTEANPPIFHRDIKASNILLDSKFTAKVADFGLSRLVPDLYE 777
Query: 782 EGTMPTHVSTIVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVLLELLTGMQPISHGKNIVR 841
EGT P +VST+VKGTPGYLDPEY LTHKLTDK DVYSLG+V LELLTGMQPISHGKNIVR
Sbjct: 778 EGTGPKYVSTVVKGTPGYLDPEYLLTHKLTDKCDVYSLGIVYLELLTGMQPISHGKNIVR 837
Query: 842 EVNVARDSGMVFSIIDNRMGSYPSECVERFVTLALRCCHDKPEHRPSMSDVVRELENILK 901
EVN AR SG ++SIID+RMG YPS+C+++F+TLALRCC D PE RPSM DVVRELE+I+
Sbjct: 838 EVNTARQSGTIYSIIDSRMGLYPSDCLDKFLTLALRCCQDNPEERPSMLDVVRELEDIIT 897
Query: 902 MFPETDTMFSKSE---SSSLLSGKSASTSSSFLTRDPYASSSNVSGSDLISGAVPSISPR 958
M PE +T+FS S ++ SA+TS+S +TR+ SS VSGSDL+S +P++ PR
Sbjct: 898 MLPEPETLFSDVSLLNSGNIAPPSSATTSTSNVTREEQHMSSYVSGSDLVSDVIPTVVPR 957
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356530159|ref|XP_003533651.1| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At1g06840-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 1231 bits (3185), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 629/958 (65%), Positives = 766/958 (79%), Gaps = 17/958 (1%)
Query: 13 LRASGFVYALLFSYLVLLAAAQTTDPQEASALRAIKNSLVDSMNHLRNWNKGDPCMSNWT 72
LR G+ A+ F ++ +AA+Q TDP E +AL IK SL+D+ N+L+NWNKGDPC +NWT
Sbjct: 4 LRIHGYALAVSFCLIIFIAASQRTDPSEVNALIEIKKSLIDTDNNLKNWNKGDPCAANWT 63
Query: 73 GVLCFDTVETDGHLHVRELQLLSMNLSGNLAPELGQLSRLQYY-FMWNDLTGTIPKEIGN 131
GV CFD DG+ HVRE+ L++MNLSG+L+P+LGQLS L+ FMWN+LTGTIPKEIGN
Sbjct: 64 GVWCFDKKLDDGNFHVREIYLMTMNLSGSLSPQLGQLSHLEILDFMWNNLTGTIPKEIGN 123
Query: 132 ISSLIFLLLNGNKLSGSLPDELGYLSNLNRLQVDENNITGTIPKSFANLSRVRHLHLNNN 191
I SL LLLNGNKLSGSLPDELG LSNLNR QVDEN ++G IP+SFAN++ V+HLHLNNN
Sbjct: 124 IRSLKLLLLNGNKLSGSLPDELGQLSNLNRFQVDENQLSGPIPESFANMTNVKHLHLNNN 183
Query: 192 SIGGQIPSELSKLSTLIHLLVDNNNLSGNLPPELSELPQLCILQLDNNNFSASEIPATYG 251
S G++PS LSKLS L+HLLVDNNNLSG+LPPE S L L ILQLDNNNFS SEIP+ Y
Sbjct: 184 SFSGELPSTLSKLSNLMHLLVDNNNLSGHLPPEYSMLDGLAILQLDNNNFSGSEIPSAYA 243
Query: 252 NFSKLVKLSLRNCNLQGAVPDLSRIPNLYYLDLSWNHLTGSIPSKKLSENVTTIDLSDNY 311
N ++LVKLSLRNC+LQGA+PD S IP L YLDLSWN +TG IPS K+++++TT DLS+N
Sbjct: 244 NLTRLVKLSLRNCSLQGAIPDFSSIPKLTYLDLSWNQITGPIPSNKVADSMTTFDLSNNR 303
Query: 312 LNGSILESISNLPFLQTLSLENNFLTGSIPATIWQNKSFSTKARLKIDLRNNSFSNIVGD 371
L+GSI + P LQ LSL NN L+GSI A IW N SFS K +L IDL+NNSFS+++G+
Sbjct: 304 LSGSIPHFL--YPHLQKLSLANNLLSGSISANIWLNMSFSAKDKLTIDLQNNSFSDVLGN 361
Query: 372 LTLPNNVTLRLGGNPICTSANIPNTGRFCGSDAG-GDETLTNSKVNCPVQACPVDNFFEY 430
L P NVTLRL GNP+C ++NI + G++CG +A + TNS V CPVQ+CPVD F+EY
Sbjct: 362 LNPPENVTLRLSGNPVCNNSNIQSIGQYCGPEADKAAQDSTNSTV-CPVQSCPVDFFYEY 420
Query: 431 VPASPEPCFCAAPLRIGYRLKSPSFTYFPPYVYPFEEYLTNTLNLELYQLSIDSFAWEKG 490
P+SP PCFCAAPLRIGYRLKSPSF+YF PY FE+Y+T +L+L+LYQLSIDS AWE+G
Sbjct: 421 APSSPVPCFCAAPLRIGYRLKSPSFSYFAPYRTSFEDYITRSLDLDLYQLSIDSVAWEEG 480
Query: 491 PRLEMYLKLFPTLN--RSSTFDDSEVRQIRDRFTSWKFPGSDIFGPYELLNFTLLGPYSN 548
PRL MYLKLFP+ N RS+ F++SEVR+I+ ++SW FP +D FGP ELLNFTLLGPY+N
Sbjct: 481 PRLRMYLKLFPSYNDSRSNMFNESEVRRIKGIYSSWHFPRTDFFGPCELLNFTLLGPYAN 540
Query: 549 LNFNSQSKGISGGILAAIVVGAVASAVAITAAVTLLVMRRHARYQHSLSRKRLSTKISMK 608
LN +S+ K S GI A + A ASA+AI+A + L+ RR+ +YQ + RKR+ST +S+K
Sbjct: 541 LNIDSEKKNNSLGIKIAAGIAAAASALAISAIIIFLISRRNMKYQK-IFRKRMSTNVSIK 599
Query: 609 IDGVKGFKFKELAMATAYFSSSTQVGQGGYGKVYKGILSDNTTVAIKRAEEGSLQGQNEF 668
IDG+K F +KELA+AT F+ ST+VGQGGYG VYKGILSD T VA+KRAE+GSLQGQ EF
Sbjct: 600 IDGMKTFTYKELAIATNKFNISTKVGQGGYGNVYKGILSDETFVAVKRAEKGSLQGQKEF 659
Query: 669 LTEIKLLSRLHHRNLVSLLGYCDEEGEQMLVYEFVPNGTLRDWLSG----RTKENLNFAM 724
LTEI+LLSRLHHRNLVSL+GYC+E GEQMLVYEF+PNGTLRDW+S +TK +LNF+M
Sbjct: 660 LTEIELLSRLHHRNLVSLIGYCNE-GEQMLVYEFMPNGTLRDWISAGKSRKTKGSLNFSM 718
Query: 725 RLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSRLAPVLDDEGT 784
RLR+A+ +AKGILYLHTEA+PP+FHRDIKASNILLDS AKVADFGLSRL LD+EGT
Sbjct: 719 RLRIAMGAAKGILYLHTEANPPIFHRDIKASNILLDSKFTAKVADFGLSRLVLDLDEEGT 778
Query: 785 MPTHVSTIVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVLLELLTGMQPISHGKNIVREVN 844
P +VST+VKGTPGYLDPEY LTHKLTDK DVYSLG+V LELLTGMQPISHGKNIVREVN
Sbjct: 779 APKYVSTVVKGTPGYLDPEYLLTHKLTDKCDVYSLGIVYLELLTGMQPISHGKNIVREVN 838
Query: 845 VARDSGMVFSIIDNRMGSYPSECVERFVTLALRCCHDKPEHRPSMSDVVRELENILKMFP 904
AR SG ++SIID+RMG YPS+C+++F+TLALRCC D PE RPSM DVVRELE+I+ M P
Sbjct: 839 TARQSGTIYSIIDSRMGLYPSDCLDKFLTLALRCCQDNPEERPSMLDVVRELEDIIAMLP 898
Query: 905 ETDTMFSK----SESSSLLSGKSASTSSSFLTRDPYASSSNVSGSDLISGAVPSISPR 958
E +T+ S S ++ ASTS+S +TR+ SS VSGSDL+S +P+I PR
Sbjct: 899 EPETLLSDIVSLDSSGNIAPPSFASTSASNVTREEQHMSSYVSGSDLVSDVIPTIVPR 956
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|357506713|ref|XP_003623645.1| Leucine-rich repeat protein kinase [Medicago truncatula] gi|355498660|gb|AES79863.1| Leucine-rich repeat protein kinase [Medicago truncatula] | Back alignment and taxonomy information |
|---|
Score = 1206 bits (3119), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 598/933 (64%), Positives = 721/933 (77%), Gaps = 17/933 (1%)
Query: 41 ASALRAIKNSLVDSMNHLRNWNKGDPCMSNWTGVLCFDTVETDGHLHVRELQLLSMNLSG 100
AL IK SLVD MN LRNWNKGDPC +NWTGV CFD DG+ H+REL L+++NLSG
Sbjct: 151 VKALIDIKKSLVDPMNKLRNWNKGDPCATNWTGVWCFDKKGDDGYFHIRELYLMTLNLSG 210
Query: 101 NLAPELGQLSRLQYY-FMWNDLTGTIPKEIGNISSLIFLLLNGNKLSGSLPDELGYLSNL 159
L+P+LG LS L FMWN+LTGTIPKEIG I+SL LLLNGNKLSGSLPDELG L NL
Sbjct: 211 TLSPQLGSLSHLVIMDFMWNNLTGTIPKEIGQITSLRLLLLNGNKLSGSLPDELGNLKNL 270
Query: 160 NRLQVDENNITGTIPKSFANLSRVRHLHLNNNSIGGQIPSELSKLSTLIHLLVDNNNLSG 219
RLQ+DEN ++G +PKSFANL VRHLH+NNNS GQ+P ELS L L+HLL+DNNNL+G
Sbjct: 271 TRLQLDENQLSGPVPKSFANLLNVRHLHMNNNSFSGQLPHELSNLPNLMHLLLDNNNLTG 330
Query: 220 NLPPELSELPQLCILQLDNNNFSASEIPATYGNFSKLVKLSLRNCNLQGAVPDLSRIPNL 279
+LPPE S+L L ILQLDNNNFS + IP+TY N +LVKLSLRNC+LQGA+PD S IP L
Sbjct: 331 HLPPEFSKLRGLAILQLDNNNFSGNGIPSTYENLPRLVKLSLRNCSLQGALPDFSLIPRL 390
Query: 280 YYLDLSWNHLTGSIPSKKLSENVTTIDLSDNYLNGSILESISNLPFLQTLSLENNFLTGS 339
YLDLSWN TG IP KL+EN+TT+DLS N LNGSI I P LQ L LENN LTGS
Sbjct: 391 TYLDLSWNQFTGPIPLTKLAENMTTVDLSHNKLNGSIPRGIV-YPHLQRLQLENNLLTGS 449
Query: 340 IPATIWQNKSFSTKARLKIDLRNNSFSNIVGDLTLPNNVTLRLGGNPICTSANIPNTGRF 399
PATIWQN SFS KA+L ID+ NN S++ GDL P NVTLRL GNP+C +NI G++
Sbjct: 450 FPATIWQNLSFSGKAKLIIDVHNNLLSDVFGDLNPPVNVTLRLFGNPVCNKSNIQRIGQY 509
Query: 400 CGSDAG-GDETLTNSKVNCPVQACPVDNFFEYVPASPEPCFCAAPLRIGYRLKSPSFTYF 458
C + DE NS CP+Q CP DNFFEY P S C+CAAPLRIGYRLKSPSF+YF
Sbjct: 510 CVHEGRVSDEEFKNSTTVCPIQGCPTDNFFEYAPPSSLSCYCAAPLRIGYRLKSPSFSYF 569
Query: 459 PPYVYPFEEYLTNTLNLELYQLSIDSFAWEKGPRLEMYLKLFPTLNRSST--FDDSEVRQ 516
PPYV FE Y+ ++L+L+ YQLSIDS+ WE+GPRL MYLK FP+ N S++ F+ SEV +
Sbjct: 570 PPYVNSFESYIADSLHLKSYQLSIDSYEWEEGPRLRMYLKFFPSFNDSNSHEFNISEVLR 629
Query: 517 IRDRFTSWKFPGSDIFGPYELLNFTLLGPYSNLNFNSQSKGISGGILAAIVVGAVASAVA 576
I FTSW+FP +D FGPYELLN TLLGPY+N+ ++ GI+ AI++GAVAS +A
Sbjct: 630 ISGLFTSWRFPRTDFFGPYELLNVTLLGPYANIIIHTVDGKKKTGIIVAIILGAVASVLA 689
Query: 577 ITAAVTLLVMRRHARYQHSLSRKRLSTKISMKIDGVKGFKFKELAMATAYFSSSTQVGQG 636
I+A + LL+ RR+++Y+H +SRKR+S+ + +K+DGVK F KEL AT F +T+VG+G
Sbjct: 690 ISAIIMLLLFRRNSKYKHLISRKRMSSSVCIKVDGVKSFTLKELTHATNKFDITTKVGEG 749
Query: 637 GYGKVYKGILSDNTTVAIKRAEEGSLQGQNEFLTEIKLLSRLHHRNLVSLLGYCDEEGEQ 696
GYG VYKGILSD T VA+KRA E SLQGQ EFLTEI+LLSRLHHRNLVSL+GYC+EEGEQ
Sbjct: 750 GYGSVYKGILSDETFVAVKRAGENSLQGQKEFLTEIELLSRLHHRNLVSLVGYCNEEGEQ 809
Query: 697 MLVYEFVPNGTLRDWLSGRTK---ENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIK 753
MLVYEF+PNGTLR+W+SG++K E L+F MRLR+A+ ++KGILYLHTEA+PP++HRDIK
Sbjct: 810 MLVYEFMPNGTLREWISGKSKKCKEGLSFFMRLRIAMGASKGILYLHTEANPPIYHRDIK 869
Query: 754 ASNILLDSNLNAKVADFGLSRLAPVLDDEGTMPTHVSTIVKGTPGYLDPEYFLTHKLTDK 813
ASNILLD AKVADFGLSRL P D+EGT+P +VST+VKGTPGYLDPEY +THKLTDK
Sbjct: 870 ASNILLDLKFTAKVADFGLSRLIPYSDEEGTVPKYVSTVVKGTPGYLDPEYMMTHKLTDK 929
Query: 814 SDVYSLGVVLLELLTGMQPISHGKNIVREVNVARDSGMVFSIIDNRMGSYPSECVERFVT 873
SDVYSLG+V LELLTGM PIS GKNIVREVN+A +G++ SIID+RMG YPSEC+++F+
Sbjct: 930 SDVYSLGIVFLELLTGMHPISRGKNIVREVNLACQAGLIDSIIDDRMGEYPSECLDKFLA 989
Query: 874 LALRCCHDKPEHRPSMSDVVRELENILKMFPETDTMFSKSESSSLLSGKSA------STS 927
LAL CCHD PE RPSM DVVRELE+I+ + PET+ S S+ S SGK A + +
Sbjct: 990 LALSCCHDHPEERPSMLDVVRELEDIIALLPETEISLS-SDISLDNSGKMAPSSSSSTQT 1048
Query: 928 SSFLT--RDPYASSSNVSGSDLISGAVPSISPR 958
S F+T +D SS VSGSDL+S +P+I PR
Sbjct: 1049 SGFITTRKDQQHMSSYVSGSDLVSDVIPTIVPR 1081
|
Source: Medicago truncatula Species: Medicago truncatula Genus: Medicago Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|357502773|ref|XP_003621675.1| Receptor protein kinase-like protein [Medicago truncatula] gi|355496690|gb|AES77893.1| Receptor protein kinase-like protein [Medicago truncatula] | Back alignment and taxonomy information |
|---|
Score = 1199 bits (3102), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 614/992 (61%), Positives = 735/992 (74%), Gaps = 47/992 (4%)
Query: 10 MFGLRASGFVYALLFSYLVLLAAAQTTDPQEASALRAIKNSLVDSMNHLRNWNKGDPCMS 69
M+ LR G+ A+ F ++ L+AA++ TDP E AL+ IK SL+D + LRNWNKGDPC +
Sbjct: 1 MWALRVHGYALAVSFCFIALVAASRKTDPLEVKALKDIKKSLIDPSDKLRNWNKGDPCAA 60
Query: 70 NWTGVLCFDTVETDGHLHVRELQLLSMNLSGNLAPELGQLSRLQYY-FMWNDLTGTIPKE 128
NWTGV CFD DG+ H+REL L+++NLSG LAP+LG LS L FMWN+L GTIPKE
Sbjct: 61 NWTGVRCFDLKGDDGYFHIRELYLMTLNLSGTLAPQLGMLSHLVIMNFMWNNLIGTIPKE 120
Query: 129 IGNISSLIFL-------------------------LLNGNKLSGSLPDELGYLSNLNRLQ 163
IG+I+SLI L LL+GNKLSGSLPDELG L NLNRLQ
Sbjct: 121 IGHITSLILLELMETAYAMSISCFQLIIQTYFLCRLLSGNKLSGSLPDELGNLKNLNRLQ 180
Query: 164 VDENNITGTIPKSFANLSRVRHLHLNNNSIGGQIPSELSKLSTLIHLLVDNNNLSGNLPP 223
VDEN ++G +PKSFANL V+HLH+NNNS GQ+PSELS +S LIHLL+DNNN SG LPP
Sbjct: 181 VDENQLSGLVPKSFANLVHVKHLHMNNNSFNGQLPSELSNVSNLIHLLLDNNNFSGYLPP 240
Query: 224 ELSELPQLCILQLDNNNFSASEIPATYGNFSKLVKLSLRNCNLQGAVPDLSRIPNLYYLD 283
E S+L L ILQLDNNNFS + IP+T+ N LVKLSLRNC+L+GA+PD S I NL YLD
Sbjct: 241 EFSKLQSLAILQLDNNNFSGNGIPSTFENLLSLVKLSLRNCSLEGAIPDFSSIRNLTYLD 300
Query: 284 LSWNHLTGSIPSKKLSENVTTIDLSDNYLNGSILESISNLPFLQTLSLENNFLTGSIPAT 343
LSWN TG IPSKKL++N+TT DLS N LNGSI + P LQ L LENN L+GS+PAT
Sbjct: 301 LSWNQFTGPIPSKKLADNMTTFDLSHNKLNGSIPRGVV-YPHLQRLQLENNLLSGSVPAT 359
Query: 344 IWQNKSFSTKARLKIDLRNNSFSNIVGDLTLPNNVTLRLGGNPICTSANIPNTGRFCGS- 402
IWQN SFS KA+L IDL NN S+I GDL P NVTLRL GNP+C +NI G+FC
Sbjct: 360 IWQNISFSKKAKLIIDLDNNLLSDIFGDLNPPINVTLRLSGNPVCKKSNIQGIGQFCAHE 419
Query: 403 --DAGGDETLTNSKVNCPVQACPVDNFFEYVPASPEPCFCAAPLRIGYRLKSPSFTYFPP 460
D E+ TNS CP+Q+CPVDNFFEY P+SP CFCAAPLR+GYRLKSPSF+YFPP
Sbjct: 420 RRDVDESES-TNSTDVCPIQSCPVDNFFEYSPSSPVHCFCAAPLRVGYRLKSPSFSYFPP 478
Query: 461 YVYPFEEYLTNTLNLELYQLSIDSFAWEKGPRLEMYLKLFPTLNRSSTFDDSEVRQIRDR 520
Y+ FE Y+T +LNL L+QLSIDS+ WEKGPRL MY K FP+ N S TF+ SE+ +I
Sbjct: 479 YITSFESYITASLNLSLFQLSIDSYEWEKGPRLRMYFKFFPSYNDSYTFNISEILRIGSI 538
Query: 521 FTSWKFPGSDIFGPYELLNFTLLGPYSNLNFNSQS-KGISG-GILAAIVVGAVASAVAIT 578
F SW FP +D FGPYELLN TLLGPY+N+ N++S KG G + I A A+++
Sbjct: 539 FASWGFPRTDFFGPYELLNVTLLGPYANMIINTESGKGKKGIKVAILIAAAASILAISVI 598
Query: 579 AAVTLLVMRRHARYQHSLSRKRLSTKISMKIDGVKGFKFKELAMATAYFSSSTQVGQGGY 638
+ LL+ RR +Y+H +S KR+S+ I +KIDGVK F KEL AT F ST+VG+GGY
Sbjct: 599 IILNLLLFRRKLKYRHLISSKRMSSDIYIKIDGVKSFTLKELTHATNKFDISTKVGEGGY 658
Query: 639 GKVYKGILSDNTTVAIKRAEEGSLQGQNEFLTEIKLLSRLHHRNLVSLLGYCDEEGEQML 698
G VYKGILSD T VA+KRA E SLQGQ EFLTEI+LLSRLHHRNLVSLLGYC+EEGEQML
Sbjct: 659 GNVYKGILSDETVVAVKRAGENSLQGQKEFLTEIELLSRLHHRNLVSLLGYCNEEGEQML 718
Query: 699 VYEFVPNGTLRDWLSGRTK---ENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKAS 755
VYEF+PNGTLR+W+SG++K + L+F MRLR+A+D+AKGILYLHTEA+PPV+HRDIKA+
Sbjct: 719 VYEFMPNGTLREWISGKSKKCNDGLSFFMRLRIAMDAAKGILYLHTEANPPVYHRDIKAT 778
Query: 756 NILLDSNLNAKVADFGLSRLAPVLDDEGTMPTHVSTIVKGTPGYLDPEYFLTHKLTDKSD 815
NILLDS AKVADFGLSRLAP D+EG +P ++ST+VKGTPGYLDPEY +TH LTDKSD
Sbjct: 779 NILLDSKFTAKVADFGLSRLAPYSDEEGNVPKYISTVVKGTPGYLDPEYMMTHMLTDKSD 838
Query: 816 VYSLGVVLLELLTGMQPISHGKNIVREVNVARDSGMVFSIIDNRMGSYPSECVERFVTLA 875
VYSLG+V LELLTGM I+ GKNIVREVN+A SG++ SIIDNRMG YPSEC ++F+ LA
Sbjct: 839 VYSLGIVFLELLTGMHAITRGKNIVREVNLACRSGIMDSIIDNRMGEYPSECTDKFLALA 898
Query: 876 LRCCHDKPEHRPSMSDVVRELENILKMFPETDTMFSKSESSSLLSGKSASTSSSF----- 930
L CCHD PE RPSM DVVRELE+I+ + PET+ S S+ S SGK A +SSS
Sbjct: 899 LSCCHDHPEERPSMLDVVRELEDIIALVPETE--ISLSDVSFDNSGKMAPSSSSSSTITS 956
Query: 931 ---LTR-DPYASSSNVSGSDLISGAVPSISPR 958
+TR D S VSGSDL+S P+I PR
Sbjct: 957 GFTMTRMDQQNMFSYVSGSDLVSDINPTIVPR 988
|
Source: Medicago truncatula Species: Medicago truncatula Genus: Medicago Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|297806013|ref|XP_002870890.1| ATP binding protein [Arabidopsis lyrata subsp. lyrata] gi|297316727|gb|EFH47149.1| ATP binding protein [Arabidopsis lyrata subsp. lyrata] | Back alignment and taxonomy information |
|---|
Score = 1191 bits (3080), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 617/959 (64%), Positives = 753/959 (78%), Gaps = 17/959 (1%)
Query: 9 MMFGLRASGFVYALLFS--YLVLLAAAQTTDPQEASALRAIKNSLVDSMNHLRNWNKGDP 66
M+F R + +ALL + ++LLA AQ T P E SALR++K SL+D ++LRNWN+GDP
Sbjct: 1 MVFPQRL--YPHALLVASCCVLLLADAQRTHPSEVSALRSVKRSLIDPKDYLRNWNRGDP 58
Query: 67 CMSNWTGVLCFDTVETDGHLHVRELQLLSMNLSGNLAPELGQLSRLQYY-FMWNDLTGTI 125
C SNWTGV+CF+ + TD +LHVREL L++MNLSG+L+PEL +L+ L+ FMWN+++G+I
Sbjct: 59 CRSNWTGVICFNEIGTDDYLHVRELLLMNMNLSGSLSPELRKLAHLEILDFMWNNISGSI 118
Query: 126 PKEIGNISSLIFLLLNGNKLSGSLPDELGYLSNLNRLQVDENNITGTIPKSFANLSRVRH 185
P EIG ISSL+ LLLNGNKLSG LP ELGYLSNLNR Q+DENNITG IPKSF+NL V+H
Sbjct: 119 PNEIGQISSLVLLLLNGNKLSGPLPSELGYLSNLNRFQIDENNITGAIPKSFSNLKNVKH 178
Query: 186 LHLNNNSIGGQIPSELSKLSTLIHLLVDNNNLSGNLPPELSELPQLCILQLDNNNFSASE 245
+H NNNS+ GQIP ELS L+ + H+L+DNNNLSGNLPP+LS LP L ILQLDNNNFS S+
Sbjct: 179 IHFNNNSLSGQIPVELSNLTNIFHVLLDNNNLSGNLPPQLSALPNLQILQLDNNNFSGSD 238
Query: 246 IPATYGNFSKLVKLSLRNCNLQGAVPDLSRIPNLYYLDLSWNHLTGSIPSKKLSENVTTI 305
IPA+YGNFS ++KLSLRNC+L+G +PD S+I +L YLDLS N LTG IPS LS++VTTI
Sbjct: 239 IPASYGNFSSILKLSLRNCSLKGTLPDFSKIRHLKYLDLSLNELTGPIPSSNLSKDVTTI 298
Query: 306 DLSDNYLNGSILESISNLPFLQTLSLENNFLTGSIPATIWQNKSFSTKARLKIDLRNNSF 365
+LS+N LNGSI +S S+LP LQ L L+NN L+GS+P ++W+N SF KARL +DLRNNS
Sbjct: 299 NLSNNILNGSIPQSFSDLPLLQMLLLKNNMLSGSVPDSLWKNISFPKKARLLLDLRNNSL 358
Query: 366 SNIVGDLTLPNNVTLRLGGNPICTSANIPNTGRFCGSDAGGDETL----TNSKVNCPVQA 421
S++ GDLT P NVTLRL GNPICT+ +I N FC S +L TNS ++CP A
Sbjct: 359 SHVQGDLTPPQNVTLRLDGNPICTNGSISNANLFCESKGKEWPSLPFNSTNSALDCPPLA 418
Query: 422 CPVDNFFEYVPASPEPCFCAAPLRIGYRLKSPSFTYFPPYVYPFEEYLTNTLNLELYQLS 481
CP +F+EY PASP CFCAAPLRIGYRLKSPSF+YFPPY+ F EY+ + L +E YQ
Sbjct: 419 CPTPDFYEYSPASPLRCFCAAPLRIGYRLKSPSFSYFPPYIDQFGEYVADFLQMEPYQFW 478
Query: 482 IDSFAWEKGPRLEMYLKLFPTLNRS--STFDDSEVRQIRDRFTSWKFPGSDIFGPYELLN 539
IDS+ WEKGPRL MYLKLFP +N + TF+ SEV +IR F SW+FPGSD+FGPYELLN
Sbjct: 479 IDSYQWEKGPRLRMYLKLFPKVNETYTRTFNKSEVLRIRGIFASWRFPGSDLFGPYELLN 538
Query: 540 FTLLGPYSNLNFNSQSKGISGGILAAIVVGAVASAVAITAAVTLLVMRRHARYQHSLSRK 599
FTL GPYS +NFNS+ KG+ G LAAI GAV +AV I+A V L++RR+++ + +SR+
Sbjct: 539 FTLQGPYSYVNFNSERKGVGWGRLAAITAGAVVTAVGISAVVAALLLRRYSKQEREISRR 598
Query: 600 RLSTKISMKIDGVKGFKFKELAMATAYFSSSTQVGQGGYGKVYKGILSDNTTVAIKRAEE 659
R S+K S+ G++GF FKELA AT FSSST VG+GGYGKVY+G+LSD T AIKRA+E
Sbjct: 599 RSSSKASLMNSGIRGFSFKELAEATDDFSSSTLVGRGGYGKVYRGVLSDKTVAAIKRADE 658
Query: 660 GSLQGQNEFLTEIKLLSRLHHRNLVSLLGYCDEEGEQMLVYEFVPNGTLRDWLSGRTKEN 719
GSLQG+ EFL EI+LLSRLHHRNLVSL+GYCDEEGEQMLVYEF+ NGTLRDWLS + KE+
Sbjct: 659 GSLQGEKEFLNEIELLSRLHHRNLVSLIGYCDEEGEQMLVYEFMSNGTLRDWLSAKGKES 718
Query: 720 LNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSRLAPVL 779
L+F MR+RVAL +AKGILYLHTEA+PPVFHRDIKASNILLD N NAKVADFGLSRLAPVL
Sbjct: 719 LSFVMRIRVALGAAKGILYLHTEANPPVFHRDIKASNILLDPNFNAKVADFGLSRLAPVL 778
Query: 780 DDEGTMPTHVSTIVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVLLELLTGMQPISHGKNI 839
+DE +P +VST+V+GTPGYLDPEYFLTHKLTDKSDVYS+GVV LELLTGM ISHGKNI
Sbjct: 779 EDEEDVPKYVSTVVRGTPGYLDPEYFLTHKLTDKSDVYSIGVVFLELLTGMHAISHGKNI 838
Query: 840 VREVNVARDSGMVFSIIDNRMGSYPSECVERFVTLALRCCHDKPEHRPSMSDVVRELENI 899
VREV A M+ S+ID RM + E VE+F LALRC HD PE RP M++VV+ELE +
Sbjct: 839 VREVKTADQRDMMVSLIDKRMEPWSMESVEKFAALALRCSHDSPEMRPGMAEVVKELEAL 898
Query: 900 LKMFPETDTMFSKSESSSLLSGKSASTSSSFLTRDPYASSSNVSGSDLISGAVPSISPR 958
L+ P+ + + SSS+LS S++ +TRD Y SSS + SDL SG VPSI+PR
Sbjct: 899 LQAAPDKEARVEMASSSSVLSTSSSN-----VTRDLYESSSLLG-SDLSSGFVPSIAPR 951
|
Source: Arabidopsis lyrata subsp. lyrata Species: Arabidopsis lyrata Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 958 | ||||||
| TAIR|locus:2181017 | 951 | AT5G01950 [Arabidopsis thalian | 0.981 | 0.988 | 0.586 | 5.8e-295 | |
| TAIR|locus:2084016 | 937 | AT3G53590 [Arabidopsis thalian | 0.939 | 0.960 | 0.528 | 1.8e-236 | |
| TAIR|locus:2019863 | 971 | AT1G79620 [Arabidopsis thalian | 0.886 | 0.874 | 0.333 | 1.1e-110 | |
| TAIR|locus:2157042 | 953 | AT5G49760 [Arabidopsis thalian | 0.896 | 0.901 | 0.330 | 3.5e-107 | |
| TAIR|locus:2156992 | 946 | AT5G49770 [Arabidopsis thalian | 0.890 | 0.901 | 0.323 | 7.5e-105 | |
| TAIR|locus:2157002 | 857 | AT5G49780 [Arabidopsis thalian | 0.298 | 0.333 | 0.479 | 6e-99 | |
| TAIR|locus:2097310 | 1002 | BAM2 "BARELY ANY MERISTEM 2" [ | 0.256 | 0.245 | 0.418 | 1.3e-80 | |
| TAIR|locus:2160791 | 1102 | AT5G63930 [Arabidopsis thalian | 0.312 | 0.271 | 0.370 | 1.7e-80 | |
| TAIR|locus:2009630 | 953 | AT1G53420 [Arabidopsis thalian | 0.292 | 0.293 | 0.401 | 5.5e-80 | |
| TAIR|locus:2182870 | 1192 | EMS1 "EXCESS MICROSPOROCYTES1" | 0.312 | 0.250 | 0.382 | 1.8e-79 |
| TAIR|locus:2181017 AT5G01950 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 2832 (1002.0 bits), Expect = 5.8e-295, P = 5.8e-295
Identities = 564/961 (58%), Positives = 687/961 (71%)
Query: 9 MMFGLRASGFVYALLFSY--LVLLAAAQTTDPQEASALRAIKNSLVDSMNHLRNWNKGDP 66
M+F R +++ALL + ++LLA AQ T P E +ALR++K SL+D ++LRNWN+GDP
Sbjct: 1 MVFPQRL--YLHALLVACCCVLLLADAQRTHPSEVTALRSVKRSLLDPKDYLRNWNRGDP 58
Query: 67 CMSNWTGVLCFDTVETDGHLHVRELQLLSMNLSGNLAPELGQLSRLQYY-FMWNDLTGTI 125
C SNWTGV+CF+ + TD +LHVREL L++MNLSG L+PEL +L+ L+ FMWN+++G+I
Sbjct: 59 CRSNWTGVICFNEIGTDDYLHVRELLLMNMNLSGTLSPELQKLAHLEILDFMWNNISGSI 118
Query: 126 PKEIGNISSLIFXXXXXXXXXXXXPDELGYLSNLNRLQVDENNITGTIPKSFANLSRVRH 185
P EIG ISSL+ P ELGYLSNLNR Q+DENNITG IPKSF+NL +V+H
Sbjct: 119 PNEIGQISSLVLLLLNGNKLSGTLPSELGYLSNLNRFQIDENNITGPIPKSFSNLKKVKH 178
Query: 186 LHLNNNSIGGQIPSELSKLSTLIHLLVDNNNLSGNLPPELSELPQLCILQLDNNNFSASE 245
LH NNNS+ GQIP ELS L+ + H+L+DNN LSGNLPP+LS LP L ILQLDNNNFS S+
Sbjct: 179 LHFNNNSLTGQIPVELSNLTNIFHVLLDNNKLSGNLPPQLSALPNLQILQLDNNNFSGSD 238
Query: 246 IPATYGNFSKLVKLSLRNCNLQGAVPDLSRIPNLYYLDLSWNHLTGSIPSKKLSENVTTI 305
IPA+YGNFS ++KLSLRNC+L+GA+PD S+I +L YLDLSWN LTG IPS S++VTTI
Sbjct: 239 IPASYGNFSNILKLSLRNCSLKGALPDFSKIRHLKYLDLSWNELTGPIPSSNFSKDVTTI 298
Query: 306 DLSDNYLNGSILESISNLPFLQTLSLENNFLTGSIPATIWQNKSFSTKARLKIDLRNNSF 365
+LS+N LNGSI +S S+LP LQ L L+NN L+GS+P ++W+N SF KARL +DLRNNS
Sbjct: 299 NLSNNILNGSIPQSFSDLPLLQMLLLKNNMLSGSVPDSLWKNISFPKKARLLLDLRNNSL 358
Query: 366 SNIVGDLTLPNNVTLRLGGNPICTSANIPNTGRFCGSDAGGDETL------TNSKVNCPV 419
S + GDLT P NVTLRL GN ICT+ +I N FC S G E + TNS ++CP
Sbjct: 359 SRVQGDLTPPQNVTLRLDGNLICTNGSISNANLFCESK--GKEWISLPNNSTNSALDCPP 416
Query: 420 QACPVDNFFEYVPASPEPCFCAAPLRIGYRLKXXXXXXXXXXXXXXXXXXXXXXXXXXXQ 479
ACP +F+EY PASP CFCAAPLRIGYRLK Q
Sbjct: 417 LACPTPDFYEYSPASPLRCFCAAPLRIGYRLKSPSFSYFPPYIDQFGEYVTDFLQMEPYQ 476
Query: 480 LSIDSFAWEKGPRLEMYLKLFPTLNRS--STFDDSEVRQIRDRFTSWKFPGSDIFGPYEL 537
L IDS+ WEKGPRL MYLKLFP +N + TF++SEV +IR F SW+FPGSD+FGPYEL
Sbjct: 477 LWIDSYQWEKGPRLRMYLKLFPKVNETYTRTFNESEVLRIRGIFASWRFPGSDLFGPYEL 536
Query: 538 LNFTLLGPYSNLNFNSQSKXXXXXXXXXXXXXXXXXXXXXXXXXXXXXMRRHARYQHSLS 597
LNFTL GPYS +NFNS+ K +RR+++++ +S
Sbjct: 537 LNFTLQGPYSYVNFNSERKGVSWRRLAAITAGAVVTAVAISAVVAALLLRRYSKHEREIS 596
Query: 598 RKRLSTKISMKIDGVKGFKFKELAMATAYFSSSTXXXXXXXXXXXXXILSDNTTVAIKRA 657
R+R S+K S+ G++GF FKELA AT FSSST +LSDNT AIKRA
Sbjct: 597 RRRSSSKASLLNSGIRGFSFKELAEATDDFSSSTLVGRGGYGKVYRGVLSDNTVAAIKRA 656
Query: 658 EEGSLQGQNEFLTEIKLLSRLHHRNLVSLLGYCDEEGEQMLVYEFVPNGTLRDWLSGRTK 717
+EGSLQG+ EFL EI+LLSRLHHRNLVSL+GYCDEE EQMLVYEF+ NGTLRDWLS + K
Sbjct: 657 DEGSLQGEKEFLNEIELLSRLHHRNLVSLIGYCDEESEQMLVYEFMSNGTLRDWLSAKGK 716
Query: 718 ENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSRLAP 777
E+L+F MR+RVAL +AKGILYLHTEA+PPVFHRDIKASNILLD N NAKVADFGLSRLAP
Sbjct: 717 ESLSFGMRIRVALGAAKGILYLHTEANPPVFHRDIKASNILLDPNFNAKVADFGLSRLAP 776
Query: 778 VLDDEGTMPTHVSTIVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVLLELLTGMQPISHGK 837
VL+DE +P HVST+V+GTPGYLDPEYFLTHKLTDKSDVYS+GVV LELLTGM ISHGK
Sbjct: 777 VLEDEEDVPKHVSTVVRGTPGYLDPEYFLTHKLTDKSDVYSIGVVFLELLTGMHAISHGK 836
Query: 838 NIVREVNVARDSGMVFSIIDNRMGSYPSECVERFVTLALRCCHDKPEHRPSMSDVVRELE 897
NIVREV A M+ S+ID RM + E VE+F LALRC HD PE RP M++VV+ELE
Sbjct: 837 NIVREVKTAEQRDMMVSLIDKRMEPWSMESVEKFAALALRCSHDSPEMRPGMAEVVKELE 896
Query: 898 NILKMFPETDTMFXXXXXXXXXXXXXXXXXXXFLTRDPYASSSNVSGSDLISGAVPSISP 957
++L+ P+ +T +TRD Y SSS + GSDL SG VPSI+P
Sbjct: 897 SLLQASPDRETRVELASSSSVLSTSSSN-----VTRDLYESSS-LLGSDLSSGFVPSIAP 950
Query: 958 R 958
R
Sbjct: 951 R 951
|
|
| TAIR|locus:2084016 AT3G53590 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 2280 (807.7 bits), Expect = 1.8e-236, P = 1.8e-236
Identities = 486/920 (52%), Positives = 583/920 (63%)
Query: 42 SALRAIKNSLVDSMNHLRNWNKGDPCMSNWTGVLCFDTVETDGHLHVRELQLLSMNLSGN 101
+ALR IK SL+D M +L NW KGDPC SNWTG++CF DGH HVRELQL+ +NLSG
Sbjct: 35 NALREIKRSLIDPMRNLSNWAKGDPCNSNWTGIICFGRSHNDGHFHVRELQLMRLNLSGE 94
Query: 102 LAPELGQLSRLQYY-FMWNDLTGTIPKEIGNISSLIFXXXXXXXXXXXXPDELGYLSNLN 160
LAPE+GQL L+ MWN+LTG IP EIG ISSL P ELG L NLN
Sbjct: 95 LAPEVGQLLYLEILDVMWNNLTGRIPLEIGRISSLKLLLLNGNKFTGSLPPELGNLQNLN 154
Query: 161 RLQVDENNITGTIPKSFANLSRVRHLHLNNNSIGGQIPSELSKLSTLIHLLVDNNNLSGN 220
RLQVDENNITG++P SF NL ++HLHLNNN+I G+IP ELSKL L+H+++DNNNL+G
Sbjct: 155 RLQVDENNITGSVPFSFGNLRSIKHLHLNNNTISGEIPVELSKLPKLVHMILDNNNLTGT 214
Query: 221 LPPELSELPQLCILQLDNNNFSASEIPATYGNFSKLVKLSLRNCNLQGAVPDLSRIPNLY 280
LP EL++LP L ILQLDNNNF S IP YG+FS+LVKLSLRNC LQG++PDLSRI NL
Sbjct: 215 LPLELAQLPSLTILQLDNNNFEGSTIPEAYGHFSRLVKLSLRNCGLQGSIPDLSRIENLS 274
Query: 281 YLDLSWNHLTGSIPSKKLSENVTTIDLSDNYLNGSILESISNLPFLQTLSLENNFLTGSI 340
YLDLSWNHLTG+IP KLS+N+TTI+LS N+L GSI +S S+L LQ LSLENN L+GS+
Sbjct: 275 YLDLSWNHLTGTIPESKLSDNMTTIELSYNHLTGSIPQSFSDLNSLQLLSLENNSLSGSV 334
Query: 341 PATIWQNKSFSTKARLKIDLRNNSFSNIVGDLTLPNNVTLRLGGNPICTSANIPNTGRFC 400
P IWQ+KSF DL NN+FS+ G+L P+NVTL L GNPIC S +IP +F
Sbjct: 335 PTEIWQDKSFENNKLQVYDL-NNNFSDATGNLRTPDNVTLYLRGNPICKSTSIPMVTQFF 393
Query: 401 GSDAGGD-ETLTNSKVNCPVQACPVDNFFEYVPASPEPCFCAAPLRIGYRLKXXXXXXXX 459
G +T TNS C +CP FE V SP C C APL I YRLK
Sbjct: 394 EYICGEKKQTSTNSNTPCSNVSCP----FENVKVSPGICLCTAPLSIDYRLKSPSFFFFT 449
Query: 460 -XXXXXXXXXXXXXXXXXXXQLSIDSFAWEKGPRLEMYLKLFPTLNRSSTFDDSEVRQIR 518
QL+ID E R MYLKL P R TF+ SEV +IR
Sbjct: 450 PYIERQFREYITSSLQLETHQLAIDRLVDENRLRPRMYLKLVPK-GRI-TFNKSEVIRIR 507
Query: 519 DRFTSWKFPGSDIFGPYELLNFTLLGPYSNLNFNSQSKXXXXXXXXXXXXXXXXXXXXXX 578
DRF SW F +D FGPYELL+F L GPY++L +Q+
Sbjct: 508 DRFMSWSFNKTDFFGPYELLDFPLQGPYADLL--AQTSGIRTIVWMMIVAGSVVAATVLS 565
Query: 579 XXXXXXXMRRHARYQHSLSRKRLSTKISMKIDGVKGFKFKELAMATAYFSSSTXXXXXXX 638
+R+ H+L++KR+ IS +I GVK F F EL+ AT F SST
Sbjct: 566 VTATLLYVRKRRENSHTLTKKRVFRTISREIKGVKKFSFVELSDATNGFDSSTLIGRGSY 625
Query: 639 XXXXXXILSDNTTVAIKRAEEGSLQGQNEFLTEIKLLSRLHHRNLVSLLGYCDEEGEQML 698
ILS+ T VAIKR EE SLQ + EFL EI LLSRLHHRNLVSL+GY + GEQML
Sbjct: 626 GKVYKGILSNKTEVAIKRGEETSLQSEKEFLNEIDLLSRLHHRNLVSLIGYSSDIGEQML 685
Query: 699 VYEFVPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNIL 758
VYE++PNG +RDWLS + L+F+MR VAL SAKGILYLHTEA+PPV HRDIK SNIL
Sbjct: 686 VYEYMPNGNVRDWLSANAADTLSFSMRSHVALGSAKGILYLHTEANPPVIHRDIKTSNIL 745
Query: 759 LDSNLNAKVADFGLSRLAPVLDDEGTMPTHVSTIVKGTPGYLDPEYFLTHKLTDKSDVYS 818
LD L+AKVADFGLSRLAP + P HVST+V+GTPGYLDPEYF+T +LT +SDVYS
Sbjct: 746 LDCQLHAKVADFGLSRLAPAFGEGDGEPAHVSTVVRGTPGYLDPEYFMTQQLTVRSDVYS 805
Query: 819 LGVVLLELLTGMQPISHGKNIVREVNVARDSGMVFSIIDNRMGSYPSECVERFVTLALRC 878
GVVLLELLTGM P G +I+REV A + G V S+ D+RMG + V++ LAL C
Sbjct: 806 FGVVLLELLTGMHPFFEGTHIIREVRTANECGTVLSVADSRMGQCSPDKVKKLAELALWC 865
Query: 879 CHDKPEHRPSMSDVVRELENILKMFPETDTMFXXXXXXXXXXXXXXXXXXXFLTRDPYAS 938
C D+PE RP MS VV+ELE I + E + MF P +
Sbjct: 866 CEDRPETRPPMSKVVKELEGICQSVREPE-MFSETTKLLCSKTSPSSSSV------P-SP 917
Query: 939 SSNVSGSDLISGAVPSISPR 958
S + GS+L SG ++ PR
Sbjct: 918 LSLLPGSNLDSGFFHAVKPR 937
|
|
| TAIR|locus:2019863 AT1G79620 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1093 (389.8 bits), Expect = 1.1e-110, P = 1.1e-110
Identities = 308/923 (33%), Positives = 467/923 (50%)
Query: 24 FSYLVLLAAAQTTDPQEASALRAIKNSLVDSMNHLRN--------WNKGDPCMSNWTGVL 75
+S+ V + TDP++A+ALR++ + ++ W +G C ++ L
Sbjct: 20 YSFTVFSMISSVTDPRDAAALRSLMDQWDNTPPSWGGSDDPCGTPW-EGVSCNNSRITAL 78
Query: 76 CFDTVETDGHLH--VREL-QLLSMNLS------GNLAPELGQLSRLQYYFMWN-DLTGTI 125
T+ G L + EL +L S++LS G+L LG L +L + TGTI
Sbjct: 79 GLSTMGLKGRLSGDIGELAELRSLDLSFNRGLTGSLTSRLGDLQKLNILILAGCGFTGTI 138
Query: 126 PKEIGNISSLIFXXXXXXXXXXXXPDELGYLSNLNRLQVDENNITGTIPKSFAN------ 179
P E+G + L F P LG L+ + L + +N +TG IP S +
Sbjct: 139 PNELGYLKDLSFLALNSNNFTGKIPASLGNLTKVYWLDLADNQLTGPIPISSGSSPGLDL 198
Query: 180 LSRVRHLHLNNNSIGGQIPSEL-SKLSTLIHLLVDNNNLSGNLPPELSELPQLCILQLDN 238
L + +H H N N + G IP +L S LIH+L D N +G++P L + L +L+LD
Sbjct: 199 LLKAKHFHFNKNQLSGTIPPKLFSSEMILIHVLFDGNRFTGSIPSTLGLIQTLEVLRLDR 258
Query: 239 NNFSASEIPATYGNFSKLVKLSLRNCNLQGAVPDLSRIPNLYYLDLSWNHLTGSIPSKKL 298
N + ++P N + +++L+L + L G++PDLS + ++ Y+DLS N S
Sbjct: 259 NTLTG-KVPENLSNLTNIIELNLAHNKLVGSLPDLSDMKSMNYVDLSNNSFDPSESPLWF 317
Query: 299 SE--NVTTIDLSDNYLNGSILESISNLPFLQTLSLENNFLTGSIPATIWQNKSFSTKARL 356
S ++TT+ + L G + + P LQ + L+ N G T+ + + +L
Sbjct: 318 STLPSLTTLVMEYGSLQGPLPNKLFGFPQLQQVRLKKNAFNG----TLSLGDTVGPELQL 373
Query: 357 KIDLRNNSFSNIVGDLTLPNNVTLRLGGNPICTSANIPNTGRFCGSDAGGDETL-TNSKV 415
+DL++N S++ N TL L GNP+CT+A + NT +C + + + S
Sbjct: 374 -VDLQDNDISSVTLSSGYTN--TLILEGNPVCTTA-LSNTN-YCQIQQQQVKRIYSTSLA 428
Query: 416 NCPVQACPVDNFFEYVPASPEPCFCAAPLR--IGYRLKXXXXXXXXXXXXXXXXXXXXXX 473
NC ++CP+D SP+ C CA P + +R
Sbjct: 429 NCGGKSCPLDQ-----KVSPQSCECAYPYEGTLYFRGPMFRDLSNVNTYHSLEMSLWVKL 483
Query: 474 XXXXXQLSIDSFAWEKGPRLEMYLKLFPTLNRSSTFDDSEVRQIRDRFTSWKFPGSDIFG 533
+S+ + + L++ L LFP + + F+ +EV++I ++ + +FG
Sbjct: 484 GLTPGSVSLQNPFFNNDDYLQIQLALFPPMGKY--FNRTEVQRIGFDLSNQTYKPPPLFG 541
Query: 534 PYELLNFTLLGPYSNLNFNSQSKXXXXXXXXXXXXXXXXXXXXXXXXXXXXXMRRHARYQ 593
PY + + PY+ + +R A
Sbjct: 542 PY----YFIASPYTFPADGNGHSLSSRMVTGIITGCSALVLCLVALGIYAMWQKRRAEQA 597
Query: 594 HSLSRKRLSTKISMKIDG----VKG---FKFKELAMATAYFSSSTXXXXXXXXXXXXXIL 646
LSR +S S K G +KG F ++EL T FS S+ +L
Sbjct: 598 IGLSRPFVSWASSGKDSGGAPQLKGARWFSYEELKKITNNFSVSSELGYGGYGKVYKGML 657
Query: 647 SDNTTVAIKRAEEGSLQGQNEFLTEIKLLSRLHHRNLVSLLGYCDEEGEQMLVYEFVPNG 706
D VAIKRA++GS QG EF TEI+LLSR+HH+NLV L+G+C E+GEQ+LVYE++ NG
Sbjct: 658 QDGHMVAIKRAQQGSTQGGLEFKTEIELLSRVHHKNLVGLVGFCFEQGEQILVYEYMSNG 717
Query: 707 TLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSNLNAK 766
+L+D L+GR+ L++ RLRVAL SA+G+ YLH A PP+ HRD+K++NILLD NL AK
Sbjct: 718 SLKDSLTGRSGITLDWKRRLRVALGSARGLAYLHELADPPIIHRDVKSTNILLDENLTAK 777
Query: 767 VADFGLSRLAPVLDDEGTMPTHVSTIVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVLLEL 826
VADFGLS+L V D HVST VKGT GYLDPEY+ T KLT+KSDVYS GVV++EL
Sbjct: 778 VADFGLSKL--VSD---CTKGHVSTQVKGTLGYLDPEYYTTQKLTEKSDVYSFGVVMMEL 832
Query: 827 LTGMQPISHGKNIVREVN-VARDSGMVFSIIDNRM-------GSYPSECVERFVTLALRC 878
+T QPI GK IVRE+ V S F + ++M G+ P + R++ LAL+C
Sbjct: 833 ITAKQPIEKGKYIVREIKLVMNKSDDDFYGLRDKMDRSLRDVGTLPE--LGRYMELALKC 890
Query: 879 CHDKPEHRPSMSDVVRELENILK 901
+ + RP+MS+VV+E+E I++
Sbjct: 891 VDETADERPTMSEVVKEIEIIIQ 913
|
|
| TAIR|locus:2157042 AT5G49760 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1060 (378.2 bits), Expect = 3.5e-107, P = 3.5e-107
Identities = 309/934 (33%), Positives = 463/934 (49%)
Query: 14 RASGFVYALLFSYLVLLAAAQTTDPQEASALRAIKNSLVDSMNHLR-------NWNKGDP 66
R + +LF + + +A T+ +ASAL A+K+ + NW G
Sbjct: 4 RTGASLLLILFFFQICSVSA-LTNGLDASALNALKSEWTTPPDGWEGSDPCGTNW-VGIT 61
Query: 67 CMSNWTGVLCFDTVETDGHL-----HVRELQLLSMN----LSGNLAPELGQLSRLQYYFM 117
C ++ + ++ +G L + EL++L ++ LSG L P +G L +L+ +
Sbjct: 62 CQNDRVVSISLGNLDLEGKLPADISFLSELRILDLSYNPKLSGPLPPNIGNLGKLRNLIL 121
Query: 118 WN-DLTGTIPKEIGNISSLIFXXXXXXXXXXXXPDELGYLSNLNRLQVDENNITGTIPKS 176
+G IP+ IG + LI+ P +G LS L + +N I G +P S
Sbjct: 122 VGCSFSGQIPESIGTLKELIYLSLNLNKFSGTIPPSIGLLSKLYWFDIADNQIEGELPVS 181
Query: 177 FAN-------LSRVRHLHLNNNSIGGQIPSEL-SKLSTLIHLLVDNNNLSGNLPPELSEL 228
L + +H H N + G IP EL S +LIH+L D N +G +P LS +
Sbjct: 182 NGTSAPGLDMLLQTKHFHFGKNKLSGNIPKELFSSNMSLIHVLFDGNQFTGEIPETLSLV 241
Query: 229 PQLCILQLDNNNFSASEIPATYGNFSKLVKLSLRNCNLQGAVPDLSRIPNLYYLDLSWNH 288
L +L+LD N +IP+ N + L +L L N G +P+L+ + +LY LD+S N
Sbjct: 242 KTLTVLRLDRNKL-IGDIPSYLNNLTNLNELYLANNRFTGTLPNLTSLTSLYTLDVSNNT 300
Query: 289 LTGS-IPSKKLS-ENVTTIDLSDNYLNGSILESISNLPFLQTLSLENNFLTGSIPATIWQ 346
L S IPS S +++T+ + LNG I S + P LQT+ L+ N + S+
Sbjct: 301 LDFSPIPSWISSLPSLSTLRMEGIQLNGPIPISFFSPPQLQTVILKRNSIVESL------ 354
Query: 347 NKSFSTKARLKIDLRNNSFSNIVGDLTLPNNVT-LRLGGNPICTSANIPNTGRFCGSDAG 405
F T +++ + ++ I N V + L NP+C A N +C S
Sbjct: 355 --DFGTDVSSQLEFVDLQYNEITDYKPSANKVLQVILANNPVCLEAG--NGPSYC-SAIQ 409
Query: 406 GDETLTNSKVNCPVQACPVDNFFEYVPASPEPCFCAAPLRIGYRLKXXXXXXXXXXXXXX 465
+ + + NC P + E ASP C CA P +
Sbjct: 410 HNTSFSTLPTNCS----PCEPGME---ASPT-CRCAYPFMGTLYFRSPSFSGLFNSTNFS 461
Query: 466 XXXXXXXXXXXXXQLSIDSFAWE---KGP---RLEMYLKLFPTLNRSSTFDDSEVRQIRD 519
+DS + P +L + L +FP L R S F+ + + +
Sbjct: 462 ILQKAIADFFKKFNYPVDSVGVRNIRENPTDHQLLIDLLVFP-LGRES-FNQTGMSLVGF 519
Query: 520 RFTSWKFPGSDIFGPYELLNFTLLGPYSNLNFNSQSKXXXXXXXXXXXXXXXXXXXXXXX 579
F++ + IFGPY + L +S++ +S+S
Sbjct: 520 AFSNQTYKPPPIFGPY-IFKADLYKQFSDVEVSSKSSNKSILIGAVVGVVVLLLLLTIAG 578
Query: 580 XXXXXXMRRHARY--QHSLSRKRLSTKISM---KIDGVKGFKFKELAMATAYFSSSTXXX 634
+R R Q++ K ++K S+ ++ G K F F+EL T FS +
Sbjct: 579 IYALRQKKRAERATGQNNPFAKWDTSKSSIDAPQLMGAKAFTFEELKKCTDNFSEANDVG 638
Query: 635 XXXXXXXXXXILSDNTTVAIKRAEEGSLQGQNEFLTEIKLLSRLHHRNLVSLLGYCDEEG 694
IL + +AIKRA++GSLQG EF TEI+LLSR+HH+N+V LLG+C +
Sbjct: 639 GGGYGKVYRGILPNGQLIAIKRAQQGSLQGGLEFKTEIELLSRVHHKNVVRLLGFCFDRN 698
Query: 695 EQMLVYEFVPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKA 754
EQMLVYE++ NG+L+D LSG++ L++ RL++AL S KG+ YLH A PP+ HRDIK+
Sbjct: 699 EQMLVYEYISNGSLKDSLSGKSGIRLDWTRRLKIALGSGKGLAYLHELADPPIIHRDIKS 758
Query: 755 SNILLDSNLNAKVADFGLSRLAPVLDDEGTMPTHVSTIVKGTPGYLDPEYFLTHKLTDKS 814
+NILLD NL AKVADFGLS+L V D E THV+T VKGT GYLDPEY++T++LT+KS
Sbjct: 759 NNILLDENLTAKVADFGLSKL--VGDPE---KTHVTTQVKGTMGYLDPEYYMTNQLTEKS 813
Query: 815 DVYSLGVVLLELLTGMQPISHGKNIVREV----NVARDSGMVFSIIDNRM--GSYPSECV 868
DVY GVVLLELLTG PI GK +VREV N +R + ++D + S +
Sbjct: 814 DVYGFGVVLLELLTGRSPIERGKYVVREVKTKMNKSRSLYDLQELLDTTIIASSGNLKGF 873
Query: 869 ERFVTLALRCCHDKPEHRPSMSDVVRELENILKM 902
E++V LALRC ++ +RPSM +VV+E+ENI+++
Sbjct: 874 EKYVDLALRCVEEEGVNRPSMGEVVKEIENIMQL 907
|
|
| TAIR|locus:2156992 AT5G49770 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1038 (370.5 bits), Expect = 7.5e-105, P = 7.5e-105
Identities = 303/936 (32%), Positives = 467/936 (49%)
Query: 17 GFVYALLFSYLVLLAAAQTTDPQEASALRAIKNSLVDSMNHLRNWNKGDPCMSNWTGVLC 76
G L+ + + + TD + +AL+A+KN D+++ ++W DPC + W G+ C
Sbjct: 8 GLFKLLILLFFQIYSVYAFTDGSDFTALQALKNEW-DTLS--KSWKSSDPCGTEWVGITC 64
Query: 77 FD-----TVE-TDGHLH---------VRELQLLSMN----LSGNLAPELGQLSRLQYY-F 116
+ ++ T+ +L + ELQ L + LSG L +G L +L +
Sbjct: 65 NNDNRVVSISLTNRNLKGKLPTEISTLSELQTLDLTGNPELSGPLPANIGNLRKLTFLSL 124
Query: 117 MWNDLTGTIPKEIGNISSLIFXXXXXXXXXXXXPDELGYLSNLNRLQVDENNITGTIPKS 176
M G IP IGN+ L P +G LS L + +N + G +P S
Sbjct: 125 MGCAFNGPIPDSIGNLEQLTRLSLNLNKFSGTIPASMGRLSKLYWFDIADNQLEGKLPVS 184
Query: 177 F-ANLS------RVRHLHLNNNSIGGQIPSEL-SKLSTLIHLLVDNNNLSGNLPPELSEL 228
A+L + H H NN + G+IP +L S TL+H+L D N +G++P L +
Sbjct: 185 DGASLPGLDMLLQTGHFHFGNNKLSGEIPEKLFSSEMTLLHVLFDGNQFTGSIPESLGLV 244
Query: 229 PQLCILQLDNNNFSASEIPATYGNFSKLVKLSLRNCNLQGAVPDLSRIPNLYYLDLSWNH 288
L +L+LD N S +IP++ N + L +L L + G++P+L+ + +LY LD+S N
Sbjct: 245 QNLTVLRLDRNRLSG-DIPSSLNNLTNLQELHLSDNKFTGSLPNLTSLTSLYTLDVSNNP 303
Query: 289 LTGS-IPSK-KLSENVTTIDLSDNYLNGSILESISNLPFLQTLSLENNFLTGSIPATIWQ 346
L S +PS +++T+ L D L+G + S+ + LQT+SL++N + T+
Sbjct: 304 LALSPVPSWIPFLNSLSTLRLEDIQLDGPVPTSLFSPLQLQTVSLKHNLIN----TTLDL 359
Query: 347 NKSFSTKARLKIDLRNNSFSNIVGDLTLPNN-VTLRLGGNPICTSANIPNTGRFCGSDAG 405
++S + +DLR+N F I G + NN V + L N +C +G +C +
Sbjct: 360 GTNYSKQLDF-VDLRDN-F--ITGYKSPANNPVNVMLADNQVCQDPANQLSG-YCNAVQP 414
Query: 406 GD--ETLTNSKVNCPVQACPVDNFFEYVPASPEPCFCAAPLRIGYRLKXXXXXXXXXXXX 463
TLT +C P N + C C PL + L+
Sbjct: 415 NSTFSTLTKCGNHCGKGKEP--N---------QGCHCVYPLTGVFTLRSPSFSGFSNNSN 463
Query: 464 XXXXXXXXXXXXXXXQLSIDSFAWE---KGP---RLEMYLKLFPTLNRSSTFDDSEVRQI 517
+ +DS A + P L + L +FP+ R F+ +E+ I
Sbjct: 464 FLKFGESLMTFFKNGKYPVDSVAMRNISENPTDYHLLINLLIFPS-GRDR-FNQTEMDSI 521
Query: 518 RDRFTSWKFPGSDIFGPYELLNFTLLGPYSNLNFNSQSKXXXXXXXXXXXXXXXXXXXXX 577
FT + FGPY + +S+L +S++
Sbjct: 522 NSAFTIQDYKPPPRFGPY-IFVADQYKTFSDLE-DSKTVSMKVIIGVVVGVVVLLLLLAL 579
Query: 578 XXXXXXXXMRRHARYQHSLS--RKRLSTKISM---KIDGVKGFKFKELAMATAYFSSSTX 632
+R R ++ K + K M ++ G K F F+EL+ T FS +
Sbjct: 580 AGIYALRQKKRAQRATDQMNPFAKWDAGKNEMDAPQLMGTKAFTFEELSKCTNNFSDAND 639
Query: 633 XXXXXXXXXXXXILSDNTTVAIKRAEEGSLQGQNEFLTEIKLLSRLHHRNLVSLLGYCDE 692
L + +AIKRA++GS+QG EF TEI+LLSR+HH+N+V LLG+C +
Sbjct: 640 VGGGGYGQVYKGTLPNGQVIAIKRAQQGSMQGAFEFKTEIELLSRVHHKNVVKLLGFCFD 699
Query: 693 EGEQMLVYEFVPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDI 752
+ EQMLVYE++PNG+LRD LSG+ L++ RL++AL S KG+ YLH A PP+ HRD+
Sbjct: 700 QKEQMLVYEYIPNGSLRDGLSGKNGVKLDWTRRLKIALGSGKGLAYLHELADPPIIHRDV 759
Query: 753 KASNILLDSNLNAKVADFGLSRLAPVLDDEGTMPTHVSTIVKGTPGYLDPEYFLTHKLTD 812
K++NILLD +L AKVADFGLS+L V D E HV+T VKGT GYLDPEY++T++LT+
Sbjct: 760 KSNNILLDEHLTAKVADFGLSKL--VGDPE---KAHVTTQVKGTMGYLDPEYYMTNQLTE 814
Query: 813 KSDVYSLGVVLLELLTGMQPISHGKNIVREVNVARDSGM----VFSIIDNRM--GSYPSE 866
KSDVY GVV+LELLTG PI G +V+EV D + ++D + S +
Sbjct: 815 KSDVYGFGVVMLELLTGKSPIDRGSYVVKEVKKKMDKSRNLYDLQELLDTTIIQNSGNLK 874
Query: 867 CVERFVTLALRCCHDKPEHRPSMSDVVRELENILKM 902
E++V +AL+C + +RP+MS+VV+ELE+IL++
Sbjct: 875 GFEKYVDVALQCVEPEGVNRPTMSEVVQELESILRL 910
|
|
| TAIR|locus:2157002 AT5G49780 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 681 (244.8 bits), Expect = 6.0e-99, Sum P(2) = 6.0e-99
Identities = 143/298 (47%), Positives = 202/298 (67%)
Query: 611 GVKGFKFKELAMATAYFSSSTXXXXXXXXXXXXXILSDNTTVAIKRAEEGSLQGQNEFLT 670
G K F F+E+ FS + IL +AIKRA+ GSLQG EF T
Sbjct: 518 GTKAFTFEEMRKCANNFSVANDVGGGGYGQVYKGILPSGQLIAIKRAQPGSLQGALEFKT 577
Query: 671 EIKLLSRLHHRNLVSLLGYCDEEGEQMLVYEFVPNGTLRDWLSGRTKENLNFAMRLRVAL 730
EI+LLSR+HH+N+V LLG+C + GEQMLVYE++PNG+LRD LSG++ L++ RLR+AL
Sbjct: 578 EIELLSRVHHKNVVKLLGFCFDRGEQMLVYEYIPNGSLRDSLSGKSGIRLDWTRRLRIAL 637
Query: 731 DSAKGILYLHTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSRLAPVLDDEGTMPTHVS 790
S KG+ YLH A PP+ HRD+K+SN+LLD +L AKVADFGLS+L V D E +V+
Sbjct: 638 GSGKGLAYLHELADPPIIHRDVKSSNVLLDESLTAKVADFGLSQL--VEDAE---KANVT 692
Query: 791 TIVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVLLELLTGMQPISHGKNIVREVNVARD-S 849
VKGT GYLDPEY++T++LT+KSDVY GV++LELLTG PI +GK +V+E+ + + S
Sbjct: 693 AQVKGTMGYLDPEYYMTNQLTEKSDVYGFGVMMLELLTGKIPIENGKYVVKEMKMKMNKS 752
Query: 850 GMVFSI---IDNRMGSYPSECV---ERFVTLALRCCHDKPEHRPSMSDVVRELENILK 901
++ + +D + + + + E++V +ALRC + RPSM++VV+E+ENI++
Sbjct: 753 KNLYDLQDFLDTTISATSNRNLKGFEKYVDVALRCVDPEGVKRPSMNEVVKEIENIMQ 810
|
|
| TAIR|locus:2097310 BAM2 "BARELY ANY MERISTEM 2" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 481 (174.4 bits), Expect = 1.3e-80, Sum P(2) = 1.3e-80
Identities = 108/258 (41%), Positives = 158/258 (61%)
Query: 652 VAIKRAEEGSLQGQNE--FLTEIKLLSRLHHRNLVSLLGYCDEEGEQMLVYEFVPNGTLR 709
VA+KR S ++ F EI+ L R+ HR++V LLG+C +LVYE++PNG+L
Sbjct: 715 VAVKRLATMSHGSSHDHGFNAEIQTLGRIRHRHIVRLLGFCSNHETNLLVYEYMPNGSLG 774
Query: 710 DWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSNLNAKVAD 769
+ L G+ +L++ R ++AL++AKG+ YLH + P + HRD+K++NILLDSN A VAD
Sbjct: 775 EVLHGKKGGHLHWNTRYKIALEAAKGLCYLHHDCSPLIVHRDVKSNNILLDSNFEAHVAD 834
Query: 770 FGLSRLAPVLDDEGTMPTHVSTIVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVLLELLTG 829
FGL++ L D GT + + + G+ GY+ PEY T K+ +KSDVYS GVVLLEL+TG
Sbjct: 835 FGLAKF---LQDSGT--SECMSAIAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITG 889
Query: 830 MQPISH---GKNIVREVNVARDSGM--VFSIIDNRMGSYPSECVERFVTLALRCCHDKPE 884
+P+ G +IV+ V DS V +ID R+ S P V +AL C ++
Sbjct: 890 KKPVGEFGDGVDIVQWVRSMTDSNKDCVLKVIDLRLSSVPVHEVTHVFYVALLCVEEQAV 949
Query: 885 HRPSMSDVVRELENILKM 902
RP+M +VV+ L I K+
Sbjct: 950 ERPTMREVVQILTEIPKI 967
|
|
| TAIR|locus:2160791 AT5G63930 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 467 (169.5 bits), Expect = 1.7e-80, Sum P(2) = 1.7e-80
Identities = 120/324 (37%), Positives = 178/324 (54%)
Query: 586 MRRHARYQHSLSRKRLSTKISMKI--DGVKGFKFKELAMATAYFSSSTXXXXXXXXXXXX 643
MRR R S ++ +++S+ I +GF F++L AT F S
Sbjct: 761 MRRPVRTVASSAQDGQPSEMSLDIYFPPKEGFTFQDLVAATDNFDESFVVGRGACGTVYK 820
Query: 644 XILSDNTTVAIKRA---EEGSLQGQ--NEFLTEIKLLSRLHHRNLVSLLGYCDEEGEQML 698
+L T+A+K+ EG N F EI L + HRN+V L G+C+ +G +L
Sbjct: 821 AVLPAGYTLAVKKLASNHEGGNNNNVDNSFRAEILTLGNIRHRNIVKLHGFCNHQGSNLL 880
Query: 699 VYEFVPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNIL 758
+YE++P G+L + L + NL+++ R ++AL +A+G+ YLH + P +FHRDIK++NIL
Sbjct: 881 LYEYMPKGSLGEILHDPSC-NLDWSKRFKIALGAAQGLAYLHHDCKPRIFHRDIKSNNIL 939
Query: 759 LDSNLNAKVADFGLSRLAPVLDDEGTMPTHVS-TIVKGTPGYLDPEYFLTHKLTDKSDVY 817
LD A V DFGL++ V+D MP S + + G+ GY+ PEY T K+T+KSD+Y
Sbjct: 940 LDDKFEAHVGDFGLAK---VID----MPHSKSMSAIAGSYGYIAPEYAYTMKVTEKSDIY 992
Query: 818 SLGVVLLELLTG---MQPISHGKNIVREVN--VARDSGMVFSIIDNRMGSYPSECVERFV 872
S GVVLLELLTG +QPI G ++V V + RD+ + ++D R+ V +
Sbjct: 993 SYGVVLLELLTGKAPVQPIDQGGDVVNWVRSYIRRDA-LSSGVLDARLTLEDERIVSHML 1051
Query: 873 T---LALRCCHDKPEHRPSMSDVV 893
T +AL C P RPSM VV
Sbjct: 1052 TVLKIALLCTSVSPVARPSMRQVV 1075
|
|
| TAIR|locus:2009630 AT1G53420 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 527 (190.6 bits), Expect = 5.5e-80, Sum P(2) = 5.5e-80
Identities = 118/294 (40%), Positives = 171/294 (58%)
Query: 612 VKGFKFKELAMATAYFSSSTXXXXXXXXXXXXXILSDNTTVAIKRAEEGSLQGQNEFLTE 671
+ F +++ +AT F S+ L D T +A+K+ GS QG EFL E
Sbjct: 609 IASFSLRQIKIATNNFDSANRIGEGGFGPVYKGKLFDGTIIAVKQLSTGSKQGNREFLNE 668
Query: 672 IKLLSRLHHRNLVSLLGYCDEEGEQMLVYEFVPNGTLRDWLSG--RTKENLNFAMRLRVA 729
I ++S LHH NLV L G C E G+ +LVYEFV N +L L G T+ L++ R ++
Sbjct: 669 IGMISALHHPNLVKLYGCCVEGGQLLLVYEFVENNSLARALFGPQETQLRLDWPTRRKIC 728
Query: 730 LDSAKGILYLHTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSRLAPVLDDEGTMPTHV 789
+ A+G+ YLH E+ + HRDIKA+N+LLD LN K++DFGL++L D+E + TH+
Sbjct: 729 IGVARGLAYLHEESRLKIVHRDIKATNVLLDKQLNPKISDFGLAKL----DEEDS--THI 782
Query: 790 STIVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVLLELLTGMQ-PISHGKN----IVREVN 844
ST + GT GY+ PEY + LTDK+DVYS G+V LE++ G I KN ++ V
Sbjct: 783 STRIAGTFGYMAPEYAMRGHLTDKADVYSFGIVALEIVHGRSNKIERSKNNTFYLIDWVE 842
Query: 845 VARDSGMVFSIIDNRMGS-YPSECVERFVTLALRCCHDKPEHRPSMSDVVRELE 897
V R+ + ++D R+GS Y E + +A+ C +P RPSMS+VV+ LE
Sbjct: 843 VLREKNNLLELVDPRLGSEYNREEAMTMIQIAIMCTSSEPCERPSMSEVVKMLE 896
|
|
| TAIR|locus:2182870 EMS1 "EXCESS MICROSPOROCYTES1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 516 (186.7 bits), Expect = 1.8e-79, Sum P(2) = 1.8e-79
Identities = 120/314 (38%), Positives = 177/314 (56%)
Query: 595 SLSRKRLSTKISMKIDGVKGFKFKELAMATAYFSSSTXXXXXXXXXXXXXILSDNTTVAI 654
S SR+ LS I+M + + ++ AT +FS L TVA+
Sbjct: 885 SRSREPLSINIAMFEQPLLKVRLGDIVEATDHFSKKNIIGDGGFGTVYKACLPGEKTVAV 944
Query: 655 KRAEEGSLQGQNEFLTEIKLLSRLHHRNLVSLLGYCDEEGEQMLVYEFVPNGTLRDWLSG 714
K+ E QG EF+ E++ L ++ H NLVSLLGYC E++LVYE++ NG+L WL
Sbjct: 945 KKLSEAKTQGNREFMAEMETLGKVKHPNLVSLLGYCSFSEEKLLVYEYMVNGSLDHWLRN 1004
Query: 715 RTK--ENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSNLNAKVADFGL 772
+T E L+++ RL++A+ +A+G+ +LH P + HRDIKASNILLD + KVADFGL
Sbjct: 1005 QTGMLEVLDWSKRLKIAVGAARGLAFLHHGFIPHIIHRDIKASNILLDGDFEPKVADFGL 1064
Query: 773 SRLAPVLDDEGTMPTHVSTIVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVLLELLTGMQP 832
+RL + +HVST++ GT GY+ PEY + + T K DVYS GV+LLEL+TG +P
Sbjct: 1065 ARLISACE------SHVSTVIAGTFGYIPPEYGQSARATTKGDVYSFGVILLELVTGKEP 1118
Query: 833 I------SHGKNIVREVNVARDSGMVFSIIDNRMGSYPSECVE-RFVTLALRCCHDKPEH 885
S G N+V + G +ID + S + + R + +A+ C + P
Sbjct: 1119 TGPDFKESEGGNLVGWAIQKINQGKAVDVIDPLLVSVALKNSQLRLLQIAMLCLAETPAK 1178
Query: 886 RPSMSDVVRELENI 899
RP+M DV++ L+ I
Sbjct: 1179 RPNMLDVLKALKEI 1192
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
No confident hit for EC number transfering in SWISSPROT detected by BLAST
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | LOW CONFIDENCE prediction! |
| 3rd Layer | 2.7.11 | 0.691 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
| Your Input: |  |
 |
 |
 |
 |
 |
 |
 |
 |
||
 | GSVIVG00033651001 | SubName- Full=Chromosome chr8 scaffold_68, whole genome shotgun sequence; (903 aa) | |||||||||
(Vitis vinifera) | |||||||||||
Predicted Functional Partners: | |||||||||||
| Sorry, there are no predicted associations at the current settings. | |||||||||||
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 958 | |||
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 2e-58 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 6e-57 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 7e-57 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 4e-54 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 1e-47 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 2e-46 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 1e-44 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 9e-41 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 1e-40 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 1e-40 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 2e-39 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 2e-38 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 5e-36 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 8e-36 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 9e-36 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 3e-35 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 9e-35 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 1e-34 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 2e-34 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 6e-34 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 7e-34 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 9e-34 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 2e-33 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 2e-33 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 2e-32 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 3e-32 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 3e-32 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 5e-32 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 1e-31 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 2e-31 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 8e-31 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 6e-30 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 5e-29 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 7e-29 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 8e-29 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 8e-29 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 1e-28 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 2e-28 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 2e-28 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 4e-28 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 8e-28 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 8e-28 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 1e-27 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 2e-27 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 2e-27 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 3e-27 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 3e-27 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 4e-27 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 2e-26 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 2e-26 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 5e-26 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 7e-26 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 2e-25 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 3e-25 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 3e-25 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 6e-25 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 6e-25 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 7e-25 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 8e-25 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 8e-25 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 9e-25 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 1e-24 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 2e-24 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 2e-24 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 3e-24 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 3e-24 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 3e-24 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 4e-24 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 1e-23 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 1e-23 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 1e-23 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 1e-23 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 6e-23 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 1e-22 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 2e-22 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 3e-22 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 3e-22 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 3e-22 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 3e-22 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 7e-22 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 1e-21 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 1e-21 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 2e-21 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 2e-21 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 3e-21 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 7e-21 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 8e-21 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 1e-20 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 1e-20 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 1e-20 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 2e-20 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 3e-20 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 4e-20 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 4e-20 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 5e-20 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 6e-20 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 6e-20 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 8e-20 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 8e-20 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 1e-19 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 1e-19 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 2e-19 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 2e-19 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 3e-19 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 3e-19 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 4e-19 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 4e-19 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 4e-19 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 5e-19 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 6e-19 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 6e-19 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 7e-19 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 7e-19 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 8e-19 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 9e-19 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 9e-19 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 1e-18 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 1e-18 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 1e-18 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 1e-18 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 2e-18 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 3e-18 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 3e-18 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 4e-18 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 4e-18 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 4e-18 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 6e-18 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 7e-18 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 9e-18 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 9e-18 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 1e-17 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 1e-17 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 1e-17 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 2e-17 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 3e-17 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 3e-17 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 4e-17 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 6e-17 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 6e-17 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 9e-17 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 9e-17 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 1e-16 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 2e-16 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 2e-16 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 2e-16 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 2e-16 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 4e-16 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 4e-16 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 5e-16 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 1e-15 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 1e-15 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 1e-15 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 2e-15 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 2e-15 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 2e-15 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 2e-15 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 2e-15 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 2e-15 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 2e-15 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 2e-15 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 3e-15 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 4e-15 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 4e-15 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 5e-15 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 5e-15 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 7e-15 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 7e-15 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 9e-15 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 1e-14 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 1e-14 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 2e-14 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 3e-14 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 3e-14 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 4e-14 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 4e-14 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 4e-14 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 5e-14 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 5e-14 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 6e-14 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 8e-14 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 9e-14 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 1e-13 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 1e-13 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 2e-13 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 3e-13 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 3e-13 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 5e-13 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 5e-13 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 7e-13 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 1e-12 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 1e-12 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 1e-12 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 1e-12 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 2e-12 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 2e-12 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 2e-12 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 3e-12 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 3e-12 | |
| COG4886 | 394 | COG4886, COG4886, Leucine-rich repeat (LRR) protei | 3e-12 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 4e-12 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 4e-12 | |
| COG4886 | 394 | COG4886, COG4886, Leucine-rich repeat (LRR) protei | 5e-12 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 5e-12 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 5e-12 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 6e-12 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 7e-12 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 7e-12 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 8e-12 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 1e-11 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 1e-11 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 1e-11 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 2e-11 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 2e-11 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 3e-11 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 3e-11 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 3e-11 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 4e-11 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 4e-11 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 4e-11 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 5e-11 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 5e-11 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 5e-11 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 5e-11 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 5e-11 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 6e-11 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 6e-11 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 9e-11 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 1e-10 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 1e-10 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 1e-10 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 2e-10 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 2e-10 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 3e-10 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 3e-10 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 3e-10 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 3e-10 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 4e-10 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 4e-10 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 4e-10 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 5e-10 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 6e-10 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 6e-10 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 6e-10 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 6e-10 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 7e-10 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 8e-10 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 8e-10 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 8e-10 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 9e-10 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 1e-09 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 1e-09 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 1e-09 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 1e-09 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 1e-09 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 3e-09 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 4e-09 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 4e-09 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 4e-09 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 5e-09 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 6e-09 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 7e-09 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 8e-09 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 9e-09 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 1e-08 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 1e-08 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 1e-08 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 2e-08 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 2e-08 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 2e-08 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 2e-08 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 3e-08 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 3e-08 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 3e-08 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 3e-08 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 3e-08 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 3e-08 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 4e-08 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 4e-08 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 5e-08 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 7e-08 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 7e-08 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 9e-08 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 9e-08 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 1e-07 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 1e-07 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 1e-07 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 1e-07 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 2e-07 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 2e-07 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 2e-07 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 2e-07 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 2e-07 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 2e-07 | |
| pfam08263 | 42 | pfam08263, LRRNT_2, Leucine rich repeat N-terminal | 7e-07 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 7e-07 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 8e-07 | |
| COG4886 | 394 | COG4886, COG4886, Leucine-rich repeat (LRR) protei | 1e-06 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 1e-06 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 1e-06 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 2e-06 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 2e-06 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 2e-06 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 3e-06 | |
| cd05576 | 237 | cd05576, STKc_RPK118_like, Catalytic domain of the | 3e-06 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 3e-06 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 4e-06 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 5e-06 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 7e-06 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 8e-06 | |
| cd00116 | 319 | cd00116, LRR_RI, Leucine-rich repeats (LRRs), ribo | 8e-06 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 1e-05 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 2e-05 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 2e-05 | |
| cd05076 | 274 | cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do | 2e-05 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 2e-05 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 1e-04 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 1e-04 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 1e-04 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 1e-04 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 3e-04 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 7e-04 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 0.001 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 0.001 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 201 bits (513), Expect = 2e-58
Identities = 91/271 (33%), Positives = 133/271 (49%), Gaps = 29/271 (10%)
Query: 634 GQGGYGKVYKGILSDN-----TTVAIKRA-EEGSLQGQNEFLTEIKLLSRLHHRNLVSLL 687
G+G +G+VYKG L VA+K E+ S Q EFL E +++ +L H N+V LL
Sbjct: 8 GEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNVVKLL 67
Query: 688 GYCDEEGEQMLVYEFVPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPV 747
G C EE +V E++ G L +L + + L+ + L AL A+G+ YL ++
Sbjct: 68 GVCTEEEPLYIVMEYMEGGDLLSYLR-KNRPKLSLSDLLSFALQIARGMEYLESK---NF 123
Query: 748 FHRDIKASNILLDSNLNAKVADFGLSRLAPVLDDEGTMPTHVSTIVKGTPGYLDPEYFLT 807
HRD+ A N L+ NL K++DFGLSR + DD+ ++ ++ PE
Sbjct: 124 IHRDLAARNCLVGENLVVKISDFGLSRD--LYDDDYYRKRGGKLPIR----WMAPESLKE 177
Query: 808 HKLTDKSDVYSLGVVLLELLT-GMQPISHGKNI-VREVNVARDSGMVFSIIDNRMGSYPS 865
K T KSDV+S GV+L E+ T G QP N V E + R+ P
Sbjct: 178 GKFTSKSDVWSFGVLLWEIFTLGEQPYPGMSNEEVLE-YLKN---------GYRLPQ-PP 226
Query: 866 ECVERFVTLALRCCHDKPEHRPSMSDVVREL 896
C L L+C + PE RP+ S++V L
Sbjct: 227 NCPPELYDLMLQCWAEDPEDRPTFSELVEIL 257
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 196 bits (502), Expect = 6e-57
Identities = 90/282 (31%), Positives = 131/282 (46%), Gaps = 37/282 (13%)
Query: 632 QVGQGGYGKVYKGILSDN----TTVAIKRA-EEGSLQGQNEFLTEIKLLSRLHHRNLVSL 686
++G+G +G+VYKG L T VA+K E+ S + + +FL E +++ +L H N+V L
Sbjct: 2 KLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRL 61
Query: 687 LGYCDEEGEQMLVYEFVPNGTLRDWLSGRTKE-------NLNFAMRLRVALDSAKGILYL 739
LG C EE LV E++ G L D+L L+ L A+ AKG+ YL
Sbjct: 62 LGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYL 121
Query: 740 HTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSRLAPVLDDEGTMPTHVSTIVKGTPGY 799
HRD+ A N L+ +L K++DFGLSR DD T ++
Sbjct: 122 A---SKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYD-DDYYRKKTGGKLPIRWMA-- 175
Query: 800 LDPEYFLTHKLTDKSDVYSLGVVLLELLT-GMQP---ISHGKNIVREVNVARDSGMVFSI 855
PE T KSDV+S GV+L E+ T G P +S + ++ + G
Sbjct: 176 --PESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLS-NEEVLEYLR----KG----- 223
Query: 856 IDNRMGSYPSECVERFVTLALRCCHDKPEHRPSMSDVVRELE 897
R+ P C + L L C PE RP+ S++V LE
Sbjct: 224 --YRLPK-PEYCPDELYELMLSCWQLDPEDRPTFSELVERLE 262
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 196 bits (501), Expect = 7e-57
Identities = 92/274 (33%), Positives = 136/274 (49%), Gaps = 30/274 (10%)
Query: 632 QVGQGGYGKVYKGILSDN-----TTVAIKRA-EEGSLQGQNEFLTEIKLLSRLHHRNLVS 685
++G+G +G+VYKG L VA+K E+ S Q EFL E +++ +L H N+V
Sbjct: 6 KLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNIVK 65
Query: 686 LLGYCDEEGEQMLVYEFVPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHP 745
LLG C EE M+V E++P G L D+L + L+ + L AL A+G+ YL ++
Sbjct: 66 LLGVCTEEEPLMIVMEYMPGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESK--- 122
Query: 746 PVFHRDIKASNILLDSNLNAKVADFGLSRLAPVLDDEGTMPTHVSTIVKGTPGYLDPEYF 805
HRD+ A N L+ NL K++DFGLSR + DD+ ++ ++ PE
Sbjct: 123 NFIHRDLAARNCLVGENLVVKISDFGLSRD--LYDDDYYKVKGGKLPIR----WMAPESL 176
Query: 806 LTHKLTDKSDVYSLGVVLLELLT-GMQPISHGKNIVREVNVARDSGMVFSIIDN--RMGS 862
K T KSDV+S GV+L E+ T G +P N V + R+
Sbjct: 177 KEGKFTSKSDVWSFGVLLWEIFTLGEEPYPGMSNAE-----------VLEYLKKGYRLPK 225
Query: 863 YPSECVERFVTLALRCCHDKPEHRPSMSDVVREL 896
P C L L+C + PE RP+ S++V L
Sbjct: 226 -PPNCPPELYKLMLQCWAEDPEDRPTFSELVEIL 258
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 188 bits (481), Expect = 4e-54
Identities = 92/273 (33%), Positives = 136/273 (49%), Gaps = 32/273 (11%)
Query: 634 GQGGYGKVYKGIL-----SDNTTVAIKRAEEG-SLQGQNEFLTEIKLLSRLHHRNLVSLL 687
G+G +G+VYKG L T VA+K +EG S + + EFL E ++ +L H N+V LL
Sbjct: 8 GEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHPNIVRLL 67
Query: 688 GYCDEEGEQMLVYEFVPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPV 747
G C + +V E++P G L D+L + E L L++AL AKG+ YL + V
Sbjct: 68 GVCTQGEPLYIVTEYMPGGDLLDFLR-KHGEKLTLKDLLQMALQIAKGMEYLE--SKNFV 124
Query: 748 FHRDIKASNILLDSNLNAKVADFGLSRLAPVLDDEGTMPTHVSTI--VKGTPGYLDPEYF 805
HRD+ A N L+ NL K++DFGLSR + ++ +K PE
Sbjct: 125 -HRDLAARNCLVTENLVVKISDFGLSRD---IYEDDYYRKRGGGKLPIKWMA----PESL 176
Query: 806 LTHKLTDKSDVYSLGVVLLELLT-GMQPISHGKNIVREVNVARDSGMVFSIIDN-RMGSY 863
K T KSDV+S GV+L E+ T G QP ++ ++ + D R+
Sbjct: 177 KDGKFTSKSDVWSFGVLLWEIFTLGEQPYP-------GMSNEE---VLELLEDGYRL-PR 225
Query: 864 PSECVERFVTLALRCCHDKPEHRPSMSDVVREL 896
P C + L L+C PE RP+ S++V +L
Sbjct: 226 PENCPDELYELMLQCWAYDPEDRPTFSELVEDL 258
|
Length = 258 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 170 bits (433), Expect = 1e-47
Identities = 78/265 (29%), Positives = 119/265 (44%), Gaps = 22/265 (8%)
Query: 632 QVGQGGYGKVYKGI-LSDNTTVAIKRAEEGSLQGQNE-FLTEIKLLSRLHHRNLVSLLGY 689
++G+G +GKVY VAIK ++ ++ E L EIK+L +L H N+V L
Sbjct: 6 KLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIVRLYDV 65
Query: 690 CDEEGEQMLVYEFVPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFH 749
++E + LV E+ G L D L + + L+ + YLH++ + H
Sbjct: 66 FEDEDKLYLVMEYCEGGDLFDLL--KKRGRLSEDEARFYLRQILSALEYLHSK---GIVH 120
Query: 750 RDIKASNILLDSNLNAKVADFGLSRLAPVLDDEGTMPTHVSTIVKGTPGYLDPEYFLTHK 809
RD+K NILLD + + K+ADFGL+R LD + +T V GTP Y+ PE L
Sbjct: 121 RDLKPENILLDEDGHVKLADFGLARQ---LDPGEKL----TTFV-GTPEYMAPEVLLGKG 172
Query: 810 LTDKSDVYSLGVVLLELLTGMQPISHGKNIVREVNVARDSGMVFSIIDNRMGSYPSECVE 869
D++SLGV+L ELLTG P ++ F E +
Sbjct: 173 YGKAVDIWSLGVILYELLTGKPPFPGDDQLLELFKKIGKPKPPF---PPPEWDISPEAKD 229
Query: 870 RFVTLALRCCHDKPEHRPSMSDVVR 894
L + PE R + + ++
Sbjct: 230 ----LIRKLLVKDPEKRLTAEEALQ 250
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 165 bits (419), Expect = 2e-46
Identities = 82/268 (30%), Positives = 117/268 (43%), Gaps = 57/268 (21%)
Query: 633 VGQGGYGKVYKGI-LSDNTTVAIKRAE-EGSLQGQNEFLTEIKLLSRLHHRNLVSLLGYC 690
+G+GG+G VY VAIK + E S E L EI++L +L+H N+V L G
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60
Query: 691 DEEGEQMLVYEFVPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHR 750
++E LV E+ G+L+D L + L+ LR+ L +G+ YLH+ + HR
Sbjct: 61 EDENHLYLVMEYCEGGSLKDLLKENEGK-LSEDEILRILLQILEGLEYLHSN---GIIHR 116
Query: 751 DIKASNILLDS-NLNAKVADFGLSRLAPVLDDEGTMPTHVSTIVKGTPGYLDPEYFL-TH 808
D+K NILLDS N K+ADFGLS+L + GTP Y+ PE L
Sbjct: 117 DLKPENILLDSDNGKVKLADFGLSKLLTSDKSL-------LKTIVGTPAYMAPEVLLGKG 169
Query: 809 KLTDKSDVYSLGVVLLELLTGMQPISHGKNIVREVNVARDSGMVFSIIDNRMGSYPSECV 868
++KSD++SLGV+L EL
Sbjct: 170 YYSEKSDIWSLGVILYEL------------------------------------------ 187
Query: 869 ERFVTLALRCCHDKPEHRPSMSDVVREL 896
L + PE RPS +++ L
Sbjct: 188 PELKDLIRKMLQKDPEKRPSAKEILEHL 215
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 161 bits (410), Expect = 1e-44
Identities = 84/267 (31%), Positives = 126/267 (47%), Gaps = 22/267 (8%)
Query: 632 QVGQGGYGKVYKGI-LSDNTTVAIK---RAEEGSLQGQNEFLTEIKLLSRLHHRNLVSLL 687
++G G +G VYK VA+K + E S + Q EI++L RL H N+V L+
Sbjct: 6 KLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQT-ARREIRILRRLSHPNIVRLI 64
Query: 688 GYCDEEGEQMLVYEFVPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPV 747
+++ LV E+ G L D+LS L+ ++AL +G+ YLH+ +
Sbjct: 65 DAFEDKDHLYLVMEYCEGGDLFDYLSRGGP--LSEDEAKKIALQILRGLEYLHSNG---I 119
Query: 748 FHRDIKASNILLDSNLNAKVADFGLSRLAPVLDDEGTMPTHVSTIVKGTPGYLDPEYFLT 807
HRD+K NILLD N K+ADFGL++ + T GTP Y+ PE L
Sbjct: 120 IHRDLKPENILLDENGVVKIADFGLAKK-------LLKSSSSLTTFVGTPWYMAPEVLLG 172
Query: 808 HKL-TDKSDVYSLGVVLLELLTGMQPISHGKNIVREVNVARDSGMVFSIIDNRMGSYPSE 866
K DV+SLGV+L ELLTG P S + + + R G + + S E
Sbjct: 173 GNGYGPKVDVWSLGVILYELLTGKPPFSGENILDQLQLIRRILGPPLEFDEPKWSSGSEE 232
Query: 867 CVERFVTLALRCCHDKPEHRPSMSDVV 893
+ L +C + P RP+ +++
Sbjct: 233 AKD----LIKKCLNKDPSKRPTAEEIL 255
|
Length = 260 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 162 bits (411), Expect = 9e-41
Identities = 118/334 (35%), Positives = 168/334 (50%), Gaps = 38/334 (11%)
Query: 91 LQLLSMNLSGNLAPELGQLSRLQY-YFMWNDLTGTIPKEIGNISSLIFLLLNGNKLSGSL 149
L L S L G + ELGQ+ L++ Y +N+L+G IP EIG ++SL L L N L+G +
Sbjct: 193 LTLASNQLVGQIPRELGQMKSLKWIYLGYNNLSGEIPYEIGGLTSLNHLDLVYNNLTGPI 252
Query: 150 PDELGYLSNLNRLQVDENNITGTIPKSFANLSRVRHLHLNNNSIGGQIPSELSKLSTLIH 209
P LG L NL L + +N ++G IP S +L ++ L L++NS+ G+IP + +L L
Sbjct: 253 PSSLGNLKNLQYLFLYQNKLSGPIPPSIFSLQKLISLDLSDNSLSGEIPELVIQLQNLEI 312
Query: 210 LLVDNNNLSGNLPPELSELPQLCILQLDNNNFSASEIPATYGNFSKLVKLSLRNCNLQGA 269
L + +NN +G +P L+ LP+L +LQL +N FS EIP G + L L L NL G
Sbjct: 313 LHLFSNNFTGKIPVALTSLPRLQVLQLWSNKFSG-EIPKNLGKHNNLTVLDLSTNNLTGE 371
Query: 270 VPD-LSRIPNLYYLDLSWNHLTGSIP-------------------SKKLSENVTT----- 304
+P+ L NL+ L L N L G IP S +L T
Sbjct: 372 IPEGLCSSGNLFKLILFSNSLEGEIPKSLGACRSLRRVRLQDNSFSGELPSEFTKLPLVY 431
Query: 305 -IDLSDNYLNGSILESISNLPFLQTLSLENNFLTGSIPATIWQNKSFSTKARLKIDLRNN 363
+D+S+N L G I ++P LQ LSL N G +P SF +K +DL N
Sbjct: 432 FLDISNNNLQGRINSRKWDMPSLQMLSLARNKFFGGLP------DSFGSKRLENLDLSRN 485
Query: 364 SFSNIV--GDLTLPNNVTLRLGGNPICTSANIPN 395
FS V +L + L+L N + S IP+
Sbjct: 486 QFSGAVPRKLGSLSELMQLKLSENKL--SGEIPD 517
|
Length = 968 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 161 bits (410), Expect = 1e-40
Identities = 112/372 (30%), Positives = 178/372 (47%), Gaps = 41/372 (11%)
Query: 22 LLFSYLVLLAAAQTTDPQEASALRAIKNSLVDSMNHLRNWN-KGDPCMSNWTGVLCFDTV 80
L+F L +E L + K+S+ D + +L NWN D C W G+ C ++
Sbjct: 12 LIFMLFFLFLNFSMLHAEELELLLSFKSSINDPLKYLSNWNSSADVC--LWQGITCNNSS 69
Query: 81 ETDGHLHVRELQLLSMNLSGNLAPELGQLSRLQYYFMW-NDLTGTIPKEI---------- 129
V + L N+SG ++ + +L +Q + N L+G IP +I
Sbjct: 70 ------RVVSIDLSGKNISGKISSAIFRLPYIQTINLSNNQLSGPIPDDIFTTSSSLRYL 123
Query: 130 -------------GNISSLIFLLLNGNKLSGSLPDELGYLSNLNRLQVDENNITGTIPKS 176
G+I +L L L+ N LSG +P+++G S+L L + N + G IP S
Sbjct: 124 NLSNNNFTGSIPRGSIPNLETLDLSNNMLSGEIPNDIGSFSSLKVLDLGGNVLVGKIPNS 183
Query: 177 FANLSRVRHLHLNNNSIGGQIPSELSKLSTLIHLLVDNNNLSGNLPPELSELPQLCILQL 236
NL+ + L L +N + GQIP EL ++ +L + + NNLSG +P E+ L L L L
Sbjct: 184 LTNLTSLEFLTLASNQLVGQIPRELGQMKSLKWIYLGYNNLSGEIPYEIGGLTSLNHLDL 243
Query: 237 DNNNFSASEIPATYGNFSKLVKLSLRNCNLQGAVP-DLSRIPNLYYLDLSWNHLTGSIPS 295
NN + IP++ GN L L L L G +P + + L LDLS N L+G IP
Sbjct: 244 VYNNLTG-PIPSSLGNLKNLQYLFLYQNKLSGPIPPSIFSLQKLISLDLSDNSLSGEIPE 302
Query: 296 KKLS-ENVTTIDLSDNYLNGSILESISNLPFLQTLSLENNFLTGSIPATIWQNKSFSTKA 354
+ +N+ + L N G I ++++LP LQ L L +N +G IP + ++ + +
Sbjct: 303 LVIQLQNLEILHLFSNNFTGKIPVALTSLPRLQVLQLWSNKFSGEIPKNLGKHNNLTV-- 360
Query: 355 RLKIDLRNNSFS 366
+DL N+ +
Sbjct: 361 ---LDLSTNNLT 369
|
Length = 968 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 151 bits (382), Expect = 1e-40
Identities = 87/287 (30%), Positives = 141/287 (49%), Gaps = 31/287 (10%)
Query: 632 QVGQGGYGKVYKG---ILSDNTT--VAIKRAE-EGSLQGQNEFLTEIKLLSRLHHRNLVS 685
Q+G+G +GKV L DNT VA+K G Q +++F EI++L L H N+V
Sbjct: 11 QLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVK 70
Query: 686 LLGYCDEEGEQ--MLVYEFVPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEA 743
G C++ G + L+ E++P+G+LRD+L R ++ +N L + KG+ YL ++
Sbjct: 71 YKGVCEKPGGRSLRLIMEYLPSGSLRDYLQ-RHRDQINLKRLLLFSSQICKGMDYLGSQR 129
Query: 744 HPPVFHRDIKASNILLDSNLNAKVADFGLSRLAPVLDDEGTMPTHVSTIVKGTPG----- 798
HRD+ A NIL++S K++DFGL+++ P D VK PG
Sbjct: 130 ---YIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYY--------VK-EPGESPIF 177
Query: 799 YLDPEYFLTHKLTDKSDVYSLGVVLLELLTGMQPISHG-KNIVREVNVARDSGMVFSII- 856
+ PE T K + SDV+S GV L EL T P +R + +A+ +V ++
Sbjct: 178 WYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLE 237
Query: 857 ---DNRMGSYPSECVERFVTLALRCCHDKPEHRPSMSDVVRELENIL 900
+ P C + L C +P+ RPS +D++ ++ +
Sbjct: 238 LLKEGERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRLR 284
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 157 bits (399), Expect = 2e-39
Identities = 96/278 (34%), Positives = 146/278 (52%), Gaps = 10/278 (3%)
Query: 91 LQLLSMNLSGNLAPELGQLSRLQYYFMW-NDLTGTIPKEIGNISSLIFLLLNGNKLSGSL 149
L L S N +G + L L RLQ +W N +G IPK +G ++L L L+ N L+G +
Sbjct: 313 LHLFSNNFTGKIPVALTSLPRLQVLQLWSNKFSGEIPKNLGKHNNLTVLDLSTNNLTGEI 372
Query: 150 PDELGYLSNLNRLQVDENNITGTIPKSFANLSRVRHLHLNNNSIGGQIPSELSKLSTLIH 209
P+ L NL +L + N++ G IPKS +R + L +NS G++PSE +KL +
Sbjct: 373 PEGLCSSGNLFKLILFSNSLEGEIPKSLGACRSLRRVRLQDNSFSGELPSEFTKLPLVYF 432
Query: 210 LLVDNNNLSGNLPPELSELPQLCILQLDNNNFSASEIPATYGNFSKLVKLSLRNCNLQGA 269
L + NNNL G + ++P L +L L N F +P ++G+ +L L L GA
Sbjct: 433 LDISNNNLQGRINSRKWDMPSLQMLSLARNKFFG-GLPDSFGS-KRLENLDLSRNQFSGA 490
Query: 270 VPD-LSRIPNLYYLDLSWNHLTGSIPSKKLS-ENVTTIDLSDNYLNGSILESISNLPFLQ 327
VP L + L L LS N L+G IP + S + + ++DLS N L+G I S S +P L
Sbjct: 491 VPRKLGSLSELMQLKLSENKLSGEIPDELSSCKKLVSLDLSHNQLSGQIPASFSEMPVLS 550
Query: 328 TLSLENNFLTGSIPATIWQNKSFSTKARLKIDLRNNSF 365
L L N L+G IP + +S +++++ +N
Sbjct: 551 QLDLSQNQLSGEIPKNLGNVESL-----VQVNISHNHL 583
|
Length = 968 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 143 bits (364), Expect = 2e-38
Identities = 65/214 (30%), Positives = 105/214 (49%), Gaps = 19/214 (8%)
Query: 632 QVGQGGYGKVYKGILSDN-TTVAIKRAE--EGSLQGQNEFLTEIKLLSRLHHRNLVSLLG 688
+G+G +G VY + D +A+K E S + EI++LS L H N+V G
Sbjct: 7 LLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYG 66
Query: 689 -YCDEEGEQMLVY-EFVPNGTLRDWLS--GRTKENLNFAMRLRVALDSAKGILYLHTEAH 744
DEE + ++ E+V G+L L G+ E + +R + +G+ YLH+
Sbjct: 67 SERDEEKNTLNIFLEYVSGGSLSSLLKKFGKLPEPV---IR-KYTRQILEGLAYLHSNG- 121
Query: 745 PPVFHRDIKASNILLDSNLNAKVADFGLSRLAPVLDDEGTMPTHVSTIVKGTPGYLDPEY 804
+ HRDIK +NIL+DS+ K+ADFG ++ + V+GTP ++ PE
Sbjct: 122 --IVHRDIKGANILVDSDGVVKLADFGCAKRL-----GDIETGEGTGSVRGTPYWMAPEV 174
Query: 805 FLTHKLTDKSDVYSLGVVLLELLTGMQPISHGKN 838
+ +D++SLG ++E+ TG P S N
Sbjct: 175 IRGEEYGRAADIWSLGCTVIEMATGKPPWSELGN 208
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 137 bits (346), Expect = 5e-36
Identities = 87/256 (33%), Positives = 126/256 (49%), Gaps = 21/256 (8%)
Query: 634 GQGGYGKVYKGILSDNTTVAIKRAEEGSLQGQNEFLTEIKLLSRLHHRNLVSLLGYCDEE 693
G G +G+V+ G + T VA+K + G++ FL E +++ +L H LV L C EE
Sbjct: 15 GAGQFGEVWMGTWNGTTKVAVKTLKPGTMS-PEAFLQEAQIMKKLRHDKLVQLYAVCSEE 73
Query: 694 GEQMLVYEFVPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIK 753
+V E++ G+L D+L + L + +A A+G+ YL + + HRD+
Sbjct: 74 EPIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRNY---IHRDLA 130
Query: 754 ASNILLDSNLNAKVADFGLSRLAPVLDDEGTMPTHVSTIVKGTPGYLDPEYFLTHKLTDK 813
A NIL+ NL K+ADFGL+RL + DDE T +K T PE + T K
Sbjct: 131 ARNILVGENLVCKIADFGLARL--IEDDEYTAREGAKFPIKWTA----PEAANYGRFTIK 184
Query: 814 SDVYSLGVVLLELLT-GMQPISHGKNIVREVNVARDSGMVFSIIDNRMGSYPSECVERFV 872
SDV+S G++L E++T G P N REV + G RM P C E
Sbjct: 185 SDVWSFGILLTEIVTYGRVPYPGMTN--REVLEQVERGY-------RM-PRPPNCPEELY 234
Query: 873 TLALRCCHDKPEHRPS 888
L L+C PE RP+
Sbjct: 235 DLMLQCWDKDPEERPT 250
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 146 bits (370), Expect = 8e-36
Identities = 104/279 (37%), Positives = 146/279 (52%), Gaps = 14/279 (5%)
Query: 94 LSMN-LSGNLAPELGQLSRLQYYFMW-NDLTGTIPKEIGNISSLIFLLLNGNKLSGSLPD 151
LS N LSG + ++G S L+ + N L G IP + N++SL FL L N+L G +P
Sbjct: 147 LSNNMLSGEIPNDIGSFSSLKVLDLGGNVLVGKIPNSLTNLTSLEFLTLASNQLVGQIPR 206
Query: 152 ELGYLSNLNRLQVDENNITGTIPKSFANLSRVRHLHLNNNSIGGQIPSELSKLSTLIHLL 211
ELG + +L + + NN++G IP L+ + HL L N++ G IPS L L L +L
Sbjct: 207 ELGQMKSLKWIYLGYNNLSGEIPYEIGGLTSLNHLDLVYNNLTGPIPSSLGNLKNLQYLF 266
Query: 212 VDNNNLSGNLPPELSELPQLCILQLDNNNFSASEIPATYGNFSKLVKLSLRNCNLQGAVP 271
+ N LSG +PP + L +L L L +N+ S EIP L L L + N G +P
Sbjct: 267 LYQNKLSGPIPPSIFSLQKLISLDLSDNSLSG-EIPELVIQLQNLEILHLFSNNFTGKIP 325
Query: 272 D-LSRIPNLYYLDLSWNHLTGSIPSKKLSE--NVTTIDLSDNYLNGSILESISNLPFLQT 328
L+ +P L L L N +G IP K L + N+T +DLS N L G I E + + L
Sbjct: 326 VALTSLPRLQVLQLWSNKFSGEIP-KNLGKHNNLTVLDLSTNNLTGEIPEGLCSSGNLFK 384
Query: 329 LSLENNFLTGSIPATIWQNKSFSTKARLK-IDLRNNSFS 366
L L +N L G IP KS L+ + L++NSFS
Sbjct: 385 LILFSNSLEGEIP------KSLGACRSLRRVRLQDNSFS 417
|
Length = 968 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 136 bits (343), Expect = 9e-36
Identities = 83/266 (31%), Positives = 128/266 (48%), Gaps = 22/266 (8%)
Query: 632 QVGQGGYGKVYKGILSDNTTVAIKRAEEGSLQGQNEFLTEIKLLSRLHHRNLVSLLGYCD 691
++G G +G V+ G VAIK EG++ +++F+ E K++ +L H NLV L G C
Sbjct: 11 ELGSGQFGVVHLGKWRGKIDVAIKMIREGAMS-EDDFIEEAKVMMKLSHPNLVQLYGVCT 69
Query: 692 EEGEQMLVYEFVPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRD 751
++ +V E++ NG L ++L R K L L + D + + YL + HRD
Sbjct: 70 KQRPIFIVTEYMANGCLLNYLRER-KGKLGTEWLLDMCSDVCEAMEYLESNG---FIHRD 125
Query: 752 IKASNILLDSNLNAKVADFGLSRLAPVLDDEGTMPTHVSTIVKGTPGYLDPEYFLTHKLT 811
+ A N L+ + KV+DFGL+R VLDD+ T VK P PE F + +
Sbjct: 126 LAARNCLVGEDNVVKVSDFGLARY--VLDDQYTSSQGTKFPVKWAP----PEVFDYSRFS 179
Query: 812 DKSDVYSLGVVLLELLT-GMQPISHGKNIVREVNVARDSGMVFSIIDNRMGSYPSECVER 870
KSDV+S GV++ E+ + G P N S +V S+ P
Sbjct: 180 SKSDVWSFGVLMWEVFSEGKMPYERFSN----------SEVVESVSAGYRLYRPKLAPTE 229
Query: 871 FVTLALRCCHDKPEHRPSMSDVVREL 896
T+ C H+KPE RP+ ++ +L
Sbjct: 230 VYTIMYSCWHEKPEDRPAFKKLLSQL 255
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 134 bits (339), Expect = 3e-35
Identities = 82/271 (30%), Positives = 128/271 (47%), Gaps = 26/271 (9%)
Query: 630 STQVGQGGYGKVYKGILSDNTTVAIKRAEEGSLQGQNEFLTEIKLLSRLHHRNLVSLLGY 689
+G+G +G V G VA+K ++ S Q FL E +++ L H NLV LLG
Sbjct: 11 GATIGKGEFGDVMLGDYR-GQKVAVKCLKDDSTAAQ-AFLAEASVMTTLRHPNLVQLLGV 68
Query: 690 CDEEGEQMLVYEFVPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFH 749
+ +V E++ G+L D+L R + + A +L ALD +G+ YL + H
Sbjct: 69 VLQGNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKN---FVH 125
Query: 750 RDIKASNILLDSNLNAKVADFGLSRLAPVLDDEGTMPTHVSTIVKGTPGYLDPEYFLTHK 809
RD+ A N+L+ +L AKV+DFGL++ A D G +P VK T PE K
Sbjct: 126 RDLAARNVLVSEDLVAKVSDFGLAKEASQGQDSGKLP------VKWTA----PEALREKK 175
Query: 810 LTDKSDVYSLGVVLLELLT-GMQPISHGKNIVREVNVARDSGMVFSIIDNRMGSYPSECV 868
+ KSDV+S G++L E+ + G P + + +++V + G RM + P C
Sbjct: 176 FSTKSDVWSFGILLWEIYSFGRVP--YPRIPLKDVVPHVEKGY-------RMEA-PEGCP 225
Query: 869 ERFVTLALRCCHDKPEHRPSMSDVVRELENI 899
+ C P RP+ + +L I
Sbjct: 226 PEVYKVMKDCWELDPAKRPTFKQLREQLALI 256
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 133 bits (336), Expect = 9e-35
Identities = 85/273 (31%), Positives = 131/273 (47%), Gaps = 26/273 (9%)
Query: 632 QVGQGGYGKVYKGILSD-NTTVAIKRAEEGSLQGQNEFLTEIKLLSRLHHRNLVSLLGYC 690
++G G YG+VY+G+ + TVA+K +E +++ EFL E ++ + H NLV LLG C
Sbjct: 13 KLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGVC 71
Query: 691 DEEGEQMLVYEFVPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHR 750
E ++ EF+ G L D+L ++ +N + L +A + + YL + HR
Sbjct: 72 TREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNF---IHR 128
Query: 751 DIKASNILLDSNLNAKVADFGLSRLAPVLDDEGTMPTHVSTIVKGTPGYLDPEYFLTHKL 810
D+ A N L+ N KVADFGLSRL + D T +K T PE +K
Sbjct: 129 DLAARNCLVGENHLVKVADFGLSRL--MTGDTYTAHAGAKFPIKWTA----PESLAYNKF 182
Query: 811 TDKSDVYSLGVVLLELLT-GMQPISHGKNIVREVNVARDSGMVFSIIDN--RMGSYPSEC 867
+ KSDV++ GV+L E+ T GM P D V+ +++ RM P C
Sbjct: 183 SIKSDVWAFGVLLWEIATYGMSPYP-----------GIDLSQVYELLEKGYRM-ERPEGC 230
Query: 868 VERFVTLALRCCHDKPEHRPSMSDVVRELENIL 900
+ L C P RPS +++ + E +
Sbjct: 231 PPKVYELMRACWQWNPSDRPSFAEIHQAFETMF 263
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 132 bits (335), Expect = 1e-34
Identities = 81/268 (30%), Positives = 133/268 (49%), Gaps = 21/268 (7%)
Query: 632 QVGQGGYGKVYKGILSDNTTVAIKRAEEGSLQGQNEFLTEIKLLSRLHHRNLVSLLGYCD 691
++G G +G+V++G+ ++ T VA+K + G++ +FL E +++ +L H L+ L C
Sbjct: 13 KLGAGQFGEVWEGLWNNTTPVAVKTLKPGTMD-PKDFLAEAQIMKKLRHPKLIQLYAVCT 71
Query: 692 EEGEQMLVYEFVPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRD 751
E +V E + G+L ++L G L + +A A G+ YL EA + HRD
Sbjct: 72 LEEPIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYL--EAQNYI-HRD 128
Query: 752 IKASNILLDSNLNAKVADFGLSRLAPVLDDEGTMPTHVSTIVKGTPGYLDPEYFLTHKLT 811
+ A N+L+ N KVADFGL+R+ + +D +K T PE L ++ +
Sbjct: 129 LAARNVLVGENNICKVADFGLARV--IKEDIYEAREGAKFPIKWTA----PEAALYNRFS 182
Query: 812 DKSDVYSLGVVLLELLT-GMQPISHGKNIVREVNVARDSGMVFSIIDNRMGSYPSECVER 870
KSDV+S G++L E++T G P N EV D G RM P C +
Sbjct: 183 IKSDVWSFGILLTEIVTYGRMPYPGMTN--AEVLQQVDQGY-------RMPC-PPGCPKE 232
Query: 871 FVTLALRCCHDKPEHRPSMSDVVRELEN 898
+ L C + P+ RP+ + +LE+
Sbjct: 233 LYDIMLDCWKEDPDDRPTFETLQWKLED 260
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 132 bits (333), Expect = 2e-34
Identities = 92/270 (34%), Positives = 140/270 (51%), Gaps = 25/270 (9%)
Query: 632 QVGQGGYGKVYKGILSDNTTVAIKRAEEGSLQGQNE-FLTEIKLLSRLHHRNLVSLLGYC 690
++G+G +G VYKG+L NT VA+K FL E ++L + H N+V L+G C
Sbjct: 2 KIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVC 61
Query: 691 DEEGEQMLVYEFVPNGTLRDWLSGRTKEN-LNFAMRLRVALDSAKGILYLHTEAHPPVFH 749
++ +V E VP G+L +L R K+N L L+++LD+A G+ YL ++ H
Sbjct: 62 VQKQPIYIVMELVPGGSLLTFL--RKKKNRLTVKKLLQMSLDAAAGMEYLESKN---CIH 116
Query: 750 RDIKASNILLDSNLNAKVADFGLSRLAPVLDDEGTMPTHVSTIVKGTP-GYLDPEYFLTH 808
RD+ A N L+ N K++DFG+SR ++EG + T VS +K P + PE
Sbjct: 117 RDLAARNCLVGENNVLKISDFGMSR-----EEEGGIYT-VSDGLKQIPIKWTAPEALNYG 170
Query: 809 KLTDKSDVYSLGVVLLELLT-GMQPISHGKNIVREVNVARDSGMVFSIIDNRMGSYPSEC 867
+ T +SDV+S G++L E + G P N ++ +SG RM P C
Sbjct: 171 RYTSESDVWSYGILLWETFSLGDTPYPGMSN--QQTRERIESGY-------RM-PAPQLC 220
Query: 868 VERFVTLALRCCHDKPEHRPSMSDVVRELE 897
E L L+C PE+RPS S++ EL+
Sbjct: 221 PEEIYRLMLQCWAYDPENRPSFSEIYNELQ 250
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 130 bits (329), Expect = 6e-34
Identities = 82/267 (30%), Positives = 127/267 (47%), Gaps = 22/267 (8%)
Query: 632 QVGQGGYGKVYKGILSDNTTVAIKRAEEGSLQGQNEFLTEIKLLSRLHHRNLVSLLGYCD 691
++G G +G V G VAIK +EGS+ ++EF+ E K++ +L H LV L G C
Sbjct: 11 ELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMS-EDEFIEEAKVMMKLSHEKLVQLYGVCT 69
Query: 692 EEGEQMLVYEFVPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRD 751
++ +V E++ NG L ++L + + L + D +G+ YL ++ HRD
Sbjct: 70 KQRPIYIVTEYMSNGCLLNYLR-EHGKRFQPSQLLEMCKDVCEGMAYLESKQF---IHRD 125
Query: 752 IKASNILLDSNLNAKVADFGLSRLAPVLDDEGTMPTHVSTIVKGTPGYLDPEYFLTHKLT 811
+ A N L+D KV+DFGLSR VLDDE T V+ +P PE L K +
Sbjct: 126 LAARNCLVDDQGCVKVSDFGLSRY--VLDDEYTSSVGSKFPVRWSP----PEVLLYSKFS 179
Query: 812 DKSDVYSLGVVLLELLT-GMQPISHGKNIVREVNVARDSGMVFSIIDNRMGSYPSECVER 870
KSDV++ GV++ E+ + G P N S V + P E+
Sbjct: 180 SKSDVWAFGVLMWEVYSLGKMPYERFNN----------SETVEKVSQGLRLYRPHLASEK 229
Query: 871 FVTLALRCCHDKPEHRPSMSDVVRELE 897
+ C H+K E RP+ ++ +E
Sbjct: 230 VYAIMYSCWHEKAEERPTFQQLLSSIE 256
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 130 bits (329), Expect = 7e-34
Identities = 86/282 (30%), Positives = 129/282 (45%), Gaps = 34/282 (12%)
Query: 632 QVGQGGYGKVYKGIL----SDNTTVAIKR-AEEGSLQGQNEFLTEIKLLSRLHHRNLVSL 686
++G G +G V KG+ VA+K +E G+ EFL E ++++L H +V L
Sbjct: 2 ELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRL 61
Query: 687 LGYCDEEGEQMLVYEFVPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPP 746
+G C E MLV E P G L +L R + + +A A G+ YL H
Sbjct: 62 IGVCKGEP-LMLVMELAPLGPLLKYLKKR--REIPVSDLKELAHQVAMGMAYLE-SKH-- 115
Query: 747 VFHRDIKASNILLDSNLNAKVADFGLSRLAPVLDDEGTMPTHVSTIVKGTPGYLDPEYFL 806
HRD+ A N+LL + AK++DFG+SR D T +K + PE
Sbjct: 116 FVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTAGRWPLK----WYAPECIN 171
Query: 807 THKLTDKSDVYSLGVVLLELLT-GMQPISHGKNIVREVNVARDSGMVFSIIDN--RMGSY 863
K + KSDV+S GV L E + G +P K V +++++ R+
Sbjct: 172 YGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAE-----------VIAMLESGERLPR- 219
Query: 864 PSECVERFVTLALRCCHDKPEHRPSMSDVVRELENILKMFPE 905
P EC + ++ L C +PE RP+ S ELE+ + PE
Sbjct: 220 PEECPQEIYSIMLSCWKYRPEDRPTFS----ELESTFRRDPE 257
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 130 bits (328), Expect = 9e-34
Identities = 71/211 (33%), Positives = 110/211 (52%), Gaps = 15/211 (7%)
Query: 626 YFSSSTQVGQGGYGKVYKGI-LSDNTTVAIKRAEEGSLQGQNEFLTEIKLLSRLHHRNLV 684
F ++G+GG+G+VYK VAIK + S + + + + EI++L + H N+V
Sbjct: 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIV 60
Query: 685 SLLGYCDEEGEQMLVYEFVPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAH 744
G ++ E +V EF G+L+D L + L + V + KG+ YLH+
Sbjct: 61 KYYGSYLKKDELWIVMEFCSGGSLKDLLKSTNQT-LTESQIAYVCKELLKGLEYLHSNG- 118
Query: 745 PPVFHRDIKASNILLDSNLNAKVADFGLS-RLAPVLDDEGTMPTHVSTIVKGTPGYLDPE 803
+ HRDIKA+NILL S+ K+ DFGLS +L+ T + T+V GTP ++ PE
Sbjct: 119 --IIHRDIKAANILLTSDGEVKLIDFGLSAQLSD------TKARN--TMV-GTPYWMAPE 167
Query: 804 YFLTHKLTDKSDVYSLGVVLLELLTGMQPIS 834
K+D++SLG+ +EL G P S
Sbjct: 168 VINGKPYDYKADIWSLGITAIELAEGKPPYS 198
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 129 bits (325), Expect = 2e-33
Identities = 87/272 (31%), Positives = 135/272 (49%), Gaps = 30/272 (11%)
Query: 630 STQVGQGGYGKVYKGILSDNTTVAIKRAEEGSLQGQNEFLTEIKLLSRLHHRNLVSLLGY 689
++G G +G V+ G + VAIK EG++ + +F+ E +++ +L H LV L G
Sbjct: 9 VQEIGSGQFGLVWLGYWLEKRKVAIKTIREGAMS-EEDFIEEAQVMMKLSHPKLVQLYGV 67
Query: 690 CDEEGEQMLVYEFVPNGTLRDWLSGRTKENLNFAMR--LRVALDSAKGILYLHTEAHPPV 747
C E LV+EF+ +G L D+L R + F+ L + LD +G+ YL + V
Sbjct: 68 CTERSPICLVFEFMEHGCLSDYL--RAQRGK-FSQETLLGMCLDVCEGMAYLESSN---V 121
Query: 748 FHRDIKASNILLDSNLNAKVADFGLSRLAPVLDDEGTMPTHVSTIVKGTPGYLDPEYFLT 807
HRD+ A N L+ N KV+DFG++R VLDD+ T T VK + PE F
Sbjct: 122 IHRDLAARNCLVGENQVVKVSDFGMTRF--VLDDQYTSSTGTKFPVK----WSSPEVFSF 175
Query: 808 HKLTDKSDVYSLGVVLLELLT-GMQPISHGKN--IVREVNVARDSGMVFSIIDNRMGSYP 864
K + KSDV+S GV++ E+ + G P + N +V +N F + R+
Sbjct: 176 SKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSEVVETINAG------FRLYKPRL---- 225
Query: 865 SECVERFVTLALRCCHDKPEHRPSMSDVVREL 896
+ L C ++PE RPS S ++ +L
Sbjct: 226 --ASQSVYELMQHCWKERPEDRPSFSLLLHQL 255
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 128 bits (324), Expect = 2e-33
Identities = 84/267 (31%), Positives = 137/267 (51%), Gaps = 24/267 (8%)
Query: 633 VGQGGYGKVYKGILSDNTTVAIKRAEEGSLQG-QNEFLTEIKLLSRLHHRNLVSLLGYCD 691
+G+G +G+V+KG L D T VA+K +E Q + +FL+E ++L + H N+V L+G C
Sbjct: 3 LGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCT 62
Query: 692 EEGEQMLVYEFVPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRD 751
+ +V E VP G +L + K+ L ++ ALD+A G+ YL ++ HRD
Sbjct: 63 QRQPIYIVMELVPGGDFLSFLR-KKKDELKTKQLVKFALDAAAGMAYLESKN---CIHRD 118
Query: 752 IKASNILLDSNLNAKVADFGLSRLAPVLDDEGTMPTHVSTIVKGTP-GYLDPEYFLTHKL 810
+ A N L+ N K++DFG+SR +D+G + S+ +K P + PE +
Sbjct: 119 LAARNCLVGENNVLKISDFGMSR----QEDDG---IYSSSGLKQIPIKWTAPEALNYGRY 171
Query: 811 TDKSDVYSLGVVLLELLT-GMQPISHGKNIVREVNVARDSGMVFSIIDNRMGSYPSECVE 869
+ +SDV+S G++L E + G+ P N V + M S P +C +
Sbjct: 172 SSESDVWSYGILLWETFSLGVCPYPGMTNQQAREQVEKGYRM----------SCPQKCPD 221
Query: 870 RFVTLALRCCHDKPEHRPSMSDVVREL 896
+ RC KPE+RP S++ +EL
Sbjct: 222 DVYKVMQRCWDYKPENRPKFSELQKEL 248
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 126 bits (319), Expect = 2e-32
Identities = 71/205 (34%), Positives = 104/205 (50%), Gaps = 19/205 (9%)
Query: 633 VGQGGYGKVYKGI-LSDNTTVAIKRAE-EGSLQGQ-NEFLTEIKLLSRLHHRNLVSLLGY 689
+G+G +G VYKG+ L VAIK+ E + + EI LL L H N+V +G
Sbjct: 8 IGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGS 67
Query: 690 CDEEGEQMLVYEFVPNGTLRDWL--SGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPV 747
+ ++ E+ NG+LR + G E+L A+ + L +G+ YLH + V
Sbjct: 68 IETSDSLYIILEYAENGSLRQIIKKFGPFPESL-VAVYVYQVL---QGLAYLHEQG---V 120
Query: 748 FHRDIKASNILLDSNLNAKVADFGLSRLAPVLDDEGTMPTHVSTIVKGTPGYLDPEYFLT 807
HRDIKA+NIL + K+ADFG +A L+D V GTP ++ PE
Sbjct: 121 IHRDIKAANILTTKDGVVKLADFG---VATKLNDVS----KDDASVVGTPYWMAPEVIEM 173
Query: 808 HKLTDKSDVYSLGVVLLELLTGMQP 832
+ SD++SLG ++ELLTG P
Sbjct: 174 SGASTASDIWSLGCTVIELLTGNPP 198
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 126 bits (319), Expect = 3e-32
Identities = 90/296 (30%), Positives = 141/296 (47%), Gaps = 42/296 (14%)
Query: 619 ELAMATAYFSSSTQVGQGGYGKVYKGIL------SDNTTVAIKR-AEEGSLQGQNEFLTE 671
E+ ++ F ++G+G +GKVYKG L T+VAIK E + Q EF E
Sbjct: 1 EIPLSAVRFLE--ELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQE 58
Query: 672 IKLLSRLHHRNLVSLLGYCDEEGEQMLVYEFVPNGTLRDWL--------------SGRTK 717
+L+S L H N+V LLG C +E +++E++ +G L ++L K
Sbjct: 59 AELMSDLQHPNIVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVK 118
Query: 718 ENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSRLAP 777
+L+ + L +A+ A G+ YL +H V HRD+ A N L+ L K++DFGLSR
Sbjct: 119 SSLDCSDFLHIAIQIAAGMEYL--SSHHFV-HRDLAARNCLVGEGLTVKISDFGLSRDIY 175
Query: 778 VLDDEGTMPTHVSTIVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVLLELLT-GMQPISHG 836
D + + ++ PE L K T +SD++S GVVL E+ + G+QP
Sbjct: 176 SADYYRVQSKSLLPV-----RWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGF 230
Query: 837 KNIVREVNVARDSGMVFSIIDNRMGSYPSECVERFVTLALRCCHDKPEHRPSMSDV 892
N +EV + I ++ P +C R L + C ++ P RP D+
Sbjct: 231 SN--QEV--------IEMIRSRQLLPCPEDCPARVYALMIECWNEIPARRPRFKDI 276
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 129 bits (324), Expect = 3e-32
Identities = 93/341 (27%), Positives = 152/341 (44%), Gaps = 24/341 (7%)
Query: 632 QVGQGGYGKVYKGILSDNTTVAIKR---AEEGSLQGQNEFLTEIKLLSRL-HHRNLVSLL 687
++G+G +G+VY D VA+K E + FL EI++L+ L H N+V L
Sbjct: 7 KLGEGSFGEVYLAR--DRKLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLY 64
Query: 688 GYCDEEGEQMLVYEFVPNGTLRDWL-SGRTKENLNFAMRLRVALDSAKGILYLHTEAHPP 746
+ +EG LV E+V G+L D L K L+ + L + + YLH++
Sbjct: 65 DFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSK---G 121
Query: 747 VFHRDIKASNILLDSNLN-AKVADFGLSRLAPVLDDEGTMPTHVSTIVKGTPGYLDPEYF 805
+ HRDIK NILLD + K+ DFGL++L P ++P ST V GTPGY+ PE
Sbjct: 122 IIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSV-GTPGYMAPEVL 180
Query: 806 L---THKLTDKSDVYSLGVVLLELLTGMQP-----ISHGKNIVREVNVARDSGMVFSIID 857
L + SD++SLG+ L ELLTG+ P S + ++ + + + S +
Sbjct: 181 LGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSLASPLS 240
Query: 858 NRMGSYPSECVERFVTLALRCCHDKPEHRPSMSDVV-RELENILKMFPETDTMFSKSESS 916
S+ + + P++R S S + +L LK+ + K + S
Sbjct: 241 PSNPELISKAASDLLK---KLLAKDPKNRLSSSSDLSHDLLAHLKLKESDLSDLLKPDDS 297
Query: 917 SLLSGKSASTSSSFLTRDPYASSSNVSGSDLISGAVPSISP 957
+ L + + ++ + S S ++P
Sbjct: 298 APLRLSLPPSLEALISSLNSLAISGSDLKLDDSNFSKELAP 338
|
Length = 384 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 125 bits (315), Expect = 5e-32
Identities = 92/282 (32%), Positives = 136/282 (48%), Gaps = 38/282 (13%)
Query: 633 VGQGGYGKVYKGILSDN----TTVAIK---RAEEGSLQGQNEFLTEIKLLSRLHHRNLVS 685
+G+G +G VY G L D+ A+K R + L+ +FL E ++ H N++S
Sbjct: 3 IGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITD--LEEVEQFLKEGIIMKDFSHPNVLS 60
Query: 686 LLGYC-DEEGEQMLVYEFVPNGTLRDWLSGRT-----KENLNFAMRLRVALDSAKGILYL 739
LLG C EG ++V ++ +G LR+++ T K+ + F L AKG+ YL
Sbjct: 61 LLGICLPSEGSPLVVLPYMKHGDLRNFIRSETHNPTVKDLIGFG------LQVAKGMEYL 114
Query: 740 HTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSRLAPVLDDEGTMPTHVSTIVKGTPGY 799
A HRD+ A N +LD + KVADFGL+R + D E H T K +
Sbjct: 115 ---ASKKFVHRDLAARNCMLDESFTVKVADFGLAR--DIYDKEYYSV-HNHTGAKLPVKW 168
Query: 800 LDPEYFLTHKLTDKSDVYSLGVVLLELLT-GMQPISHGKNIVREVNVARDSGMVFSIIDN 858
+ E T K T KSDV+S GV+L EL+T G P V+ + D + ++
Sbjct: 169 MALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPD-------VD-SFD--ITVYLLQG 218
Query: 859 RMGSYPSECVERFVTLALRCCHDKPEHRPSMSDVVRELENIL 900
R P C + + L C H KPE RP+ S++V +E I
Sbjct: 219 RRLLQPEYCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQIF 260
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 124 bits (313), Expect = 1e-31
Identities = 92/268 (34%), Positives = 135/268 (50%), Gaps = 22/268 (8%)
Query: 632 QVGQGGYGKVYKGILSDNTTVAIKRAEEGSLQGQNEFLTEIKLLSRLHHRNLVSLLGYCD 691
++GQG +G+V+ G + T VAIK + G++ + FL E +++ +L H LV L
Sbjct: 13 KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPE-AFLQEAQVMKKLRHEKLVQLYAVVS 71
Query: 692 EEGEQMLVYEFVPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRD 751
EE +V E++ G+L D+L G + L + +A A G+ Y+ + HRD
Sbjct: 72 EE-PIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNY---VHRD 127
Query: 752 IKASNILLDSNLNAKVADFGLSRLAPVLDDEGTMPTHVSTIVKGTPGYLDPEYFLTHKLT 811
++A+NIL+ NL KVADFGL+RL + D+E T +K T PE L + T
Sbjct: 128 LRAANILVGENLVCKVADFGLARL--IEDNEYTARQGAKFPIKWTA----PEAALYGRFT 181
Query: 812 DKSDVYSLGVVLLELLT-GMQPISHGKNIVREVNVARDSGMVFSIIDNRMGSYPSECVER 870
KSDV+S G++L EL T G P N REV + G RM P EC E
Sbjct: 182 IKSDVWSFGILLTELTTKGRVPYPGMVN--REVLDQVERGY-------RMPC-PPECPES 231
Query: 871 FVTLALRCCHDKPEHRPSMSDVVRELEN 898
L +C +PE RP+ + LE+
Sbjct: 232 LHDLMCQCWRKEPEERPTFEYLQAFLED 259
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 123 bits (311), Expect = 2e-31
Identities = 84/273 (30%), Positives = 133/273 (48%), Gaps = 19/273 (6%)
Query: 627 FSSSTQVGQGGYGKVYKGILSDNTTVAIKRAEEGSLQGQNEFLTEIKLLSRLHHRNLVSL 686
F+ ++G G +G+V++G+ + VAIK + L Q +F E++ L RL H++L+SL
Sbjct: 8 FTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISL 67
Query: 687 LGYCDEEGEQMLVYEFVPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPP 746
C ++ E + G+L +L + L A + +A A+G+ YL +
Sbjct: 68 FAVCSVGEPVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQN--- 124
Query: 747 VFHRDIKASNILLDSNLNAKVADFGLSRLAPVLDDEGTMPTHVSTIVKGTPGYLDPEYFL 806
HRD+ A NIL+ +L KVADFGL+RL + ++ + + K T PE
Sbjct: 125 SIHRDLAARNILVGEDLVCKVADFGLARL---IKEDVYLSSDKKIPYKWTA----PEAAS 177
Query: 807 THKLTDKSDVYSLGVVLLELLTGMQPISHGKNIVREVNVARDSGMVFSIIDNRMGSYPSE 866
+ KSDV+S G++L E+ T Q G N EV +G RM P++
Sbjct: 178 HGTFSTKSDVWSFGILLYEMFTYGQVPYPGMN-NHEVYDQITAGY-------RMPC-PAK 228
Query: 867 CVERFVTLALRCCHDKPEHRPSMSDVVRELENI 899
C + + L C +PE RPS + EL+NI
Sbjct: 229 CPQEIYKIMLECWAAEPEDRPSFKALREELDNI 261
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 121 bits (306), Expect = 8e-31
Identities = 87/266 (32%), Positives = 132/266 (49%), Gaps = 22/266 (8%)
Query: 632 QVGQGGYGKVYKGILSDNTTVAIKRAEEGSLQGQNEFLTEIKLLSRLHHRNLVSLLGYCD 691
++G G +G V+ G VAIK EG++ + +F+ E K++ +L H LV L G C
Sbjct: 11 ELGSGQFGVVHLGKWRAQIKVAIKAINEGAMS-EEDFIEEAKVMMKLSHPKLVQLYGVCT 69
Query: 692 EEGEQMLVYEFVPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRD 751
++ +V EF+ NG L ++L R + L+ M L + D +G+ YL + HRD
Sbjct: 70 QQKPLYIVTEFMENGCLLNYLRQR-QGKLSKDMLLSMCQDVCEGMEYLERNSF---IHRD 125
Query: 752 IKASNILLDSNLNAKVADFGLSRLAPVLDDEGTMPTHVSTIVKGTPGYLDPEYFLTHKLT 811
+ A N L+ S KV+DFG++R VLDDE T + VK +P PE F K +
Sbjct: 126 LAARNCLVSSTGVVKVSDFGMTRY--VLDDEYTSSSGAKFPVKWSP----PEVFNFSKYS 179
Query: 812 DKSDVYSLGVVLLELLT-GMQPISHGKNIVREVNVARDSGMVFSIIDNRMGSYPSECVER 870
KSDV+S GV++ E+ T G P N EV G R+ P
Sbjct: 180 SKSDVWSFGVLMWEVFTEGKMPFEKKSNY--EVVEMISRG-------FRL-YRPKLASMT 229
Query: 871 FVTLALRCCHDKPEHRPSMSDVVREL 896
+ C H+KPE RP+ ++++R +
Sbjct: 230 VYEVMYSCWHEKPEGRPTFAELLRAI 255
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 119 bits (300), Expect = 6e-30
Identities = 82/271 (30%), Positives = 122/271 (45%), Gaps = 35/271 (12%)
Query: 632 QVGQGGYGKVYKG-ILSDNTTVAIKR--AEEGSLQGQNEFLTEIKLLSRLHHRNLVSLLG 688
Q+G+G +GKVY SD +K S + + + L E+K+L +L+H N++
Sbjct: 7 QIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIK--- 63
Query: 689 YCD---EEGEQMLVYEFVPNGTLRDWLSGRTKENLNF----AMRLRVALDSAKGILYLHT 741
Y + E+G+ +V E+ G L + + KE F + V L + YLH+
Sbjct: 64 YYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQL--CLALKYLHS 121
Query: 742 EAHPPVFHRDIKASNILLDSNLNAKVADFGLSRLAPVLDDEGTMPTHVSTIVKGTPGYLD 801
+ HRDIK NI L SN K+ DFG+S+ VL + T+V GTP YL
Sbjct: 122 RK---ILHRDIKPQNIFLTSNGLVKLGDFGISK---VLSSTVDLAK---TVV-GTPYYLS 171
Query: 802 PEYFLTHKLTDKSDVYSLGVVLLELLTGMQPISHGKNIVREVNVARDSGMVFSIIDNRMG 861
PE KSD++SLG VL EL T P G+N+ + I+ +
Sbjct: 172 PELCQNKPYNYKSDIWSLGCVLYELCTLKHPF-EGENL---------LELALKILKGQYP 221
Query: 862 SYPSECVERFVTLALRCCHDKPEHRPSMSDV 892
PS+ L PE RPS++ +
Sbjct: 222 PIPSQYSSELRNLVSSLLQKDPEERPSIAQI 252
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 117 bits (294), Expect = 5e-29
Identities = 78/292 (26%), Positives = 128/292 (43%), Gaps = 50/292 (17%)
Query: 631 TQVGQGGYGKVYKGILSD------NTTVAIKRAEE-GSLQGQNEFLTEIKLLSRLHHRNL 683
++GQG +G VY+G+ T VAIK E S++ + EFL E ++ + ++
Sbjct: 12 RELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHV 71
Query: 684 VSLLGYCDEEGEQMLVYEFVPNGTLRDWLSGRTKENLNFAMR--------LRVALDSAKG 735
V LLG ++V E + G L+ +L R E N +++A + A G
Sbjct: 72 VRLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADG 131
Query: 736 ILYLHTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSRLAPVLD-----DEGTMPTHVS 790
+ YL HRD+ A N ++ +L K+ DFG++R D +G +P
Sbjct: 132 MAYLA-AKK--FVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRKGGKGLLPVR-- 186
Query: 791 TIVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVLLELLT-GMQP---ISHGKNIVREVNVA 846
++ PE T KSDV+S GVVL E+ T QP +S+
Sbjct: 187 --------WMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSN----------- 227
Query: 847 RDSGMVFSIIDNRMGSYPSECVERFVTLALRCCHDKPEHRPSMSDVVRELEN 898
+ + F +ID P C ++ + L C P+ RP+ ++V L++
Sbjct: 228 -EEVLKF-VIDGGHLDLPENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLKD 277
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 116 bits (293), Expect = 7e-29
Identities = 83/286 (29%), Positives = 129/286 (45%), Gaps = 44/286 (15%)
Query: 633 VGQGGYGKVYKGILS----DNT--TVAIK-RAEEGSLQGQNEFLTEIKLLSRLHHRNLVS 685
+G G +G+VY+G+ D VA+K E S Q +++FL E ++S+ +H+N+V
Sbjct: 14 LGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVR 73
Query: 686 LLGYCDEEGEQMLVYEFVPNGTLRDWL-SGRTKENLNFAMRLR----VALDSAKGILYLH 740
L+G E + ++ E + G L+ +L R + ++ ++ A D AKG YL
Sbjct: 74 LIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLE 133
Query: 741 TEAHPPVFHRDIKASNILLDS---NLNAKVADFGLSRLAPVLD-----DEGTMPTHVSTI 792
E H HRDI A N LL AK+ADFG++R +P
Sbjct: 134 -ENH--FIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYRKGGRAMLP------ 184
Query: 793 VKGTPGYLDPEYFLTHKLTDKSDVYSLGVVLLELLT-GMQPISHGKNIVREVNVARDSGM 851
+K P PE FL T K+DV+S GV+L E+ + G P N +EV M
Sbjct: 185 IKWMP----PEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTN--QEV-------M 231
Query: 852 VFSIIDNRMGSYPSECVERFVTLALRCCHDKPEHRPSMSDVVRELE 897
F R+ P C + C PE RP+ + ++ ++
Sbjct: 232 EFVTGGGRLD-PPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQ 276
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 115 bits (290), Expect = 8e-29
Identities = 85/268 (31%), Positives = 134/268 (50%), Gaps = 30/268 (11%)
Query: 632 QVGQGGYGKVYKGILSDNTTVAIKRAE-EGSLQGQNEFLTEIKLLSRLHHRNLVSLLGYC 690
+G+G +G V +G + VA+K + + + Q FL E ++++LHH+NLV LLG
Sbjct: 13 IIGEGEFGAVLQGEYT-GQKVAVKNIKCDVTAQA---FLEETAVMTKLHHKNLVRLLGVI 68
Query: 691 DEEGEQMLVYEFVPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHR 750
G +V E + G L ++L R + ++ L+ +LD A+G+ YL ++ + HR
Sbjct: 69 LHNG-LYIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKK---LVHR 124
Query: 751 DIKASNILLDSNLNAKVADFGLSRLAPVLDDEGTMPTHVSTIVKGTPGYLDPEYFLTHKL 810
D+ A NIL+ + AKV+DFGL+R+ + D +P VK T PE K
Sbjct: 125 DLAARNILVSEDGVAKVSDFGLARVGSMGVDNSKLP------VKWTA----PEALKHKKF 174
Query: 811 TDKSDVYSLGVVLLELLT-GMQPISHGKNIVREVNVARDSGMVFSIIDNRMGSYPSECVE 869
+ KSDV+S GV+L E+ + G P + K ++EV + G RM P C
Sbjct: 175 SSKSDVWSYGVLLWEVFSYGRAP--YPKMSLKEVKECVEKGY-------RMEP-PEGCPA 224
Query: 870 RFVTLALRCCHDKPEHRPSMSDVVRELE 897
L C +P+ RPS + +LE
Sbjct: 225 DVYVLMTSCWETEPKKRPSFHKLREKLE 252
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 116 bits (293), Expect = 8e-29
Identities = 87/303 (28%), Positives = 132/303 (43%), Gaps = 66/303 (21%)
Query: 633 VGQGGYGKVYK----GILS--DNTTVAIKR-AEEGSLQGQNEFLTEIKLLSRLHHRNLVS 685
+GQG +G+V++ G+L T VA+K EE S Q +F E L++ H N+V
Sbjct: 13 IGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVK 72
Query: 686 LLGYCDEEGEQMLVYEFVPNGTLRDWLSGRTKEN--------------------LNFAMR 725
LLG C L++E++ G L ++L R+ L+ +
Sbjct: 73 LLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQ 132
Query: 726 LRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSR---LAPV--LD 780
L +A A G+ YL +E HRD+ N L+ N+ K+ADFGLSR A
Sbjct: 133 LCIAKQVAAGMAYL-SERK--FVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKAS 189
Query: 781 DEGTMPTHVSTIVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVLLELLT-GMQP---ISHG 836
+ +P ++ PE ++ T +SDV++ GVVL E+ + GMQP ++H
Sbjct: 190 ENDAIPIR----------WMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAHE 239
Query: 837 KNI--VREVNVARDSGMVFSIIDNRMGSYPSECVERFVTLALRCCHDKPEHRPSMSDVVR 894
+ I VR+ NV S P C L C P RPS + + R
Sbjct: 240 EVIYYVRDGNVL---------------SCPDNCPLELYNLMRLCWSKLPSDRPSFASINR 284
Query: 895 ELE 897
L+
Sbjct: 285 ILQ 287
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 115 bits (289), Expect = 1e-28
Identities = 86/268 (32%), Positives = 133/268 (49%), Gaps = 22/268 (8%)
Query: 632 QVGQGGYGKVYKGILSDNTTVAIKRAEEGSLQGQNEFLTEIKLLSRLHHRNLVSLLGYCD 691
++G G +G+V+ G + NT VA+K + G++ ++ FL E +++ +L H LV L
Sbjct: 13 KLGNGQFGEVWMGTWNGNTKVAVKTLKPGTMSPES-FLEEAQIMKKLRHDKLVQLYAVVS 71
Query: 692 EEGEQMLVYEFVPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRD 751
EE +V E++ G+L D+L L + +A A G+ Y+ + HRD
Sbjct: 72 EE-PIYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMNY---IHRD 127
Query: 752 IKASNILLDSNLNAKVADFGLSRLAPVLDDEGTMPTHVSTIVKGTPGYLDPEYFLTHKLT 811
++++NIL+ L K+ADFGL+RL + D+E T +K T PE L + T
Sbjct: 128 LRSANILVGDGLVCKIADFGLARL--IEDNEYTARQGAKFPIKWTA----PEAALYGRFT 181
Query: 812 DKSDVYSLGVVLLELLT-GMQPISHGKNIVREVNVARDSGMVFSIIDNRMGSYPSECVER 870
KSDV+S G++L EL+T G P N REV + G RM P +C
Sbjct: 182 IKSDVWSFGILLTELVTKGRVPYPGMNN--REVLEQVERGY-------RMPC-PQDCPIS 231
Query: 871 FVTLALRCCHDKPEHRPSMSDVVRELEN 898
L L+C PE RP+ + LE+
Sbjct: 232 LHELMLQCWKKDPEERPTFEYLQSFLED 259
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 115 bits (290), Expect = 2e-28
Identities = 83/303 (27%), Positives = 139/303 (45%), Gaps = 54/303 (17%)
Query: 631 TQVGQGGYGKVYKGI------LSDNTTVAIKRAEEGSLQGQ-NEFLTEIKLLSRLHHRNL 683
+G+G +GKV K + TTVA+K +E + + + L+E LL +++H ++
Sbjct: 6 KTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHV 65
Query: 684 VSLLGYCDEEGEQMLVYEFVPNGTLRDWLSGRTK----------------------ENLN 721
+ L G C ++G +L+ E+ G+LR +L K L
Sbjct: 66 IKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALT 125
Query: 722 FAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSRLAPVLDD 781
+ A ++G+ YL A + HRD+ A N+L+ K++DFGLSR V ++
Sbjct: 126 MGDLISFAWQISRGMQYL---AEMKLVHRDLAARNVLVAEGRKMKISDFGLSR--DVYEE 180
Query: 782 EGTMPTHVSTI-VKGTPGYLDPEYFLTHKLTDKSDVYSLGVVLLELLT-GMQPISHGKNI 839
+ + I VK ++ E H T +SDV+S GV+L E++T G P I
Sbjct: 181 DSYVKRSKGRIPVK----WMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYP---GI 233
Query: 840 VREVNVARDSGMVFSIIDN--RMGSYPSECVERFVTLALRCCHDKPEHRPSMSDVVRELE 897
E +F+++ RM P C E L L C +P+ RP+ +D+ +ELE
Sbjct: 234 APE--------RLFNLLKTGYRM-ERPENCSEEMYNLMLTCWKQEPDKRPTFADISKELE 284
Query: 898 NIL 900
++
Sbjct: 285 KMM 287
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 114 bits (288), Expect = 2e-28
Identities = 84/273 (30%), Positives = 131/273 (47%), Gaps = 26/273 (9%)
Query: 632 QVGQGGYGKVYKGILSDNTTVAIKRAEEGSLQGQNEFLTEIKLLSRLHHRNLVSLLGYCD 691
++G G +G+V+ G + +T VAIK ++GS+ FL E L+ +L H LV L
Sbjct: 13 KLGAGQFGEVWMGYYNGHTKVAIKSLKQGSMS-PEAFLAEANLMKQLQHPRLVRLYAVVT 71
Query: 692 EEGEQMLVYEFVPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRD 751
+E ++ E++ NG+L D+L L + +A A+G+ ++ + + HRD
Sbjct: 72 QE-PIYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKNY---IHRD 127
Query: 752 IKASNILLDSNLNAKVADFGLSRLAPVLDDEGTMPTHVSTIVKGTPGYLDPEYFLTHKLT 811
++A+NIL+ L K+ADFGL+RL + D+E T +K T PE T
Sbjct: 128 LRAANILVSETLCCKIADFGLARL--IEDNEYTAREGAKFPIKWTA----PEAINYGTFT 181
Query: 812 DKSDVYSLGVVLLELLT-GMQPISHGKNIVREVNVARDSGMVFSIIDNRMGSYPSECVER 870
KSDV+S G++L E++T G P N N+ R M P C E
Sbjct: 182 IKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQNLERGYRMP----------RPDNCPEE 231
Query: 871 FVTLALRCCHDKPEHRPSMSDVVRELENILKMF 903
L C +KPE RP+ L ++L+ F
Sbjct: 232 LYELMRLCWKEKPEERPTFE----YLRSVLEDF 260
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 114 bits (288), Expect = 4e-28
Identities = 86/286 (30%), Positives = 132/286 (46%), Gaps = 31/286 (10%)
Query: 632 QVGQGGYGKVYK---GILSDNT--TVAIKRAEEGSLQGQNEFLTEIKLLSRLHHRNLVSL 686
Q+G+G +G V L DNT VA+K+ + + + +F EI++L L H N+V
Sbjct: 11 QLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKY 70
Query: 687 LGYCDEEG--EQMLVYEFVPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAH 744
G C G LV E++P G+LRD+L + +E L+ L A KG+ YL ++ +
Sbjct: 71 KGVCYSAGRRNLRLVMEYLPYGSLRDYLQ-KHRERLDHRKLLLYASQICKGMEYLGSKRY 129
Query: 745 PPVFHRDIKASNILLDSNLNAKVADFGLSRLAPVLDDEGTMPTHVSTIVKGTPG-----Y 799
HRD+ NIL++S K+ DFGL+++ P D E PG +
Sbjct: 130 ---VHRDLATRNILVESENRVKIGDFGLTKVLP-QDKEYYKVRE--------PGESPIFW 177
Query: 800 LDPEYFLTHKLTDKSDVYSLGVVLLELLTGMQPISHGKNI-VREVNVARDSGM-VFSIID 857
PE K + SDV+S GVVL EL T +R + + M V+ +I+
Sbjct: 178 YAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHLIE 237
Query: 858 ----NRMGSYPSECVERFVTLALRCCHDKPEHRPSMSDVVRELENI 899
N P C + C ++ P RPS S++ ++E I
Sbjct: 238 LLKNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAI 283
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 113 bits (283), Expect = 8e-28
Identities = 89/268 (33%), Positives = 132/268 (49%), Gaps = 22/268 (8%)
Query: 632 QVGQGGYGKVYKGILSDNTTVAIKRAEEGSLQGQNEFLTEIKLLSRLHHRNLVSLLGYCD 691
++GQG +G+V+ G + T VAIK + G++ + FL E +++ +L H LV L
Sbjct: 13 KLGQGCFGEVWMGTWNGTTKVAIKTLKPGTMMPE-AFLQEAQIMKKLRHDKLVPLYAVVS 71
Query: 692 EEGEQMLVYEFVPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRD 751
EE +V EF+ G+L D+L + L + +A A G+ Y+ + HRD
Sbjct: 72 EE-PIYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMNY---IHRD 127
Query: 752 IKASNILLDSNLNAKVADFGLSRLAPVLDDEGTMPTHVSTIVKGTPGYLDPEYFLTHKLT 811
++A+NIL+ NL K+ADFGL+RL + D+E T +K T PE L + T
Sbjct: 128 LRAANILVGDNLVCKIADFGLARL--IEDNEYTARQGAKFPIKWTA----PEAALYGRFT 181
Query: 812 DKSDVYSLGVVLLELLT-GMQPISHGKNIVREVNVARDSGMVFSIIDNRMGSYPSECVER 870
KSDV+S G++L EL+T G P N REV + G RM P C E
Sbjct: 182 IKSDVWSFGILLTELVTKGRVPYPGMVN--REVLEQVERGY-------RMPC-PQGCPES 231
Query: 871 FVTLALRCCHDKPEHRPSMSDVVRELEN 898
L C P+ RP+ + LE+
Sbjct: 232 LHELMKLCWKKDPDERPTFEYIQSFLED 259
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 113 bits (284), Expect = 8e-28
Identities = 66/210 (31%), Positives = 102/210 (48%), Gaps = 13/210 (6%)
Query: 631 TQVGQGGYGKVYKGILS-DNTTVAIKR-AEEGSLQGQNEFLTEIKLLSRLHHRNLVSLLG 688
+GQG G VYK A+K+ +G + + + L E+K L +V G
Sbjct: 7 KVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYG 66
Query: 689 YCDEEGEQMLVYEFVPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVF 748
+EGE +V E++ G+L D L + + + +A KG+ YLHT+ H +
Sbjct: 67 AFYKEGEISIVLEYMDGGSLADLL--KKVGKIPEPVLAYIARQILKGLDYLHTKRH--II 122
Query: 749 HRDIKASNILLDSNLNAKVADFGLSRLAPVLDDEGTMPTHVSTIVKGTPGYLDPEYFLTH 808
HRDIK SN+L++S K+ADFG+S+ VL++ +T V GT Y+ PE
Sbjct: 123 HRDIKPSNLLINSKGEVKIADFGISK---VLENTLDQ---CNTFV-GTVTYMSPERIQGE 175
Query: 809 KLTDKSDVYSLGVVLLELLTGMQPISHGKN 838
+ +D++SLG+ LLE G P
Sbjct: 176 SYSYAADIWSLGLTLLECALGKFPFLPPGQ 205
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 112 bits (283), Expect = 1e-27
Identities = 83/275 (30%), Positives = 129/275 (46%), Gaps = 27/275 (9%)
Query: 633 VGQGGYGKVYKGILSDNT----TVAIKRAEEGSLQGQN-EFLTEIKLLSRLHHRNLVSLL 687
+G G +G+V +G L VAIK + GS Q +FLTE ++ + H N++ L
Sbjct: 12 IGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLE 71
Query: 688 GYCDEEGEQMLVYEFVPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPV 747
G + M++ E++ NG+L +L + + A G+ YL +
Sbjct: 72 GVVTKSRPVMIITEYMENGSLDKFLR-ENDGKFTVGQLVGMLRGIASGMKYLSEMNY--- 127
Query: 748 FHRDIKASNILLDSNLNAKVADFGLSRLAPVLDDEGTMPTHVSTI-VKGTPGYLDPEYFL 806
HRD+ A NIL++SNL KV+DFGLSR + D E T T I ++ T PE
Sbjct: 128 VHRDLAARNILVNSNLVCKVSDFGLSRR--LEDSEATYTTKGGKIPIRWTA----PEAIA 181
Query: 807 THKLTDKSDVYSLGVVLLELLT-GMQPISHGKNIVREVNVARDSGMVFSIIDNRMGSYPS 865
K T SDV+S G+V+ E+++ G +P N ++V A + G R+ P
Sbjct: 182 YRKFTSASDVWSFGIVMWEVMSYGERPYWDMSN--QDVIKAVEDGY-------RLPP-PM 231
Query: 866 ECVERFVTLALRCCHDKPEHRPSMSDVVRELENIL 900
+C L L C RP+ S +V L+ ++
Sbjct: 232 DCPSALYQLMLDCWQKDRNERPTFSQIVSTLDKMI 266
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 112 bits (283), Expect = 2e-27
Identities = 60/214 (28%), Positives = 104/214 (48%), Gaps = 25/214 (11%)
Query: 626 YFSSSTQVGQGGYGKVYKGI-LSDNTTVAIKRAEEGSLQGQNE--FLTEIKLLSRLHHRN 682
+ + ++G+G G+VYK + VAIK+ L+ QN+ + EI ++ H N
Sbjct: 20 LYKNLEKIGEGASGEVYKATDRATGKEVAIKKM---RLRKQNKELIINEILIMKDCKHPN 76
Query: 683 LVSLLGYCDEEGEQMLVYEFVPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTE 742
+V E +V E++ G+L D ++ + +N V + +G+ YLH++
Sbjct: 77 IVDYYDSYLVGDELWVVMEYMDGGSLTDIIT-QNFVRMNEPQIAYVCREVLQGLEYLHSQ 135
Query: 743 AHPPVFHRDIKASNILLDSNLNAKVADFG----LSRLAPVLDDEGTMPTHVSTIVKGTPG 798
V HRDIK+ NILL + + K+ADFG L++ +++V GTP
Sbjct: 136 ---NVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKS----------KRNSVV-GTPY 181
Query: 799 YLDPEYFLTHKLTDKSDVYSLGVVLLELLTGMQP 832
++ PE K D++SLG++ +E+ G P
Sbjct: 182 WMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPP 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 112 bits (282), Expect = 2e-27
Identities = 84/288 (29%), Positives = 132/288 (45%), Gaps = 25/288 (8%)
Query: 626 YFSSSTQVGQGGYGKV--YKGILSDNTT---VAIKRAEEG-SLQGQNEFLTEIKLLSRLH 679
Y +G+G +GKV Y +++ T VA+K + Q + + EI +L L+
Sbjct: 5 YLKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLY 64
Query: 680 HRNLVSLLGYCDEEGEQ--MLVYEFVPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGIL 737
H N+V G C E+G + L+ E+VP G+LRD+L K LN A L A +G+
Sbjct: 65 HENIVKYKGCCSEQGGKGLQLIMEYVPLGSLRDYLP---KHKLNLAQLLLFAQQICEGMA 121
Query: 738 YLHTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSRLAPVLDDEGTMPTHVSTIVKGTP 797
YLH++ + HRD+ A N+LLD++ K+ DFGL++ P EG V
Sbjct: 122 YLHSQHY---IHRDLAARNVLLDNDRLVKIGDFGLAKAVP----EGHEYYRVREDGDSPV 174
Query: 798 GYLDPEYFLTHKLTDKSDVYSLGVVLLELLTGMQP-ISHGKNIVREVNVARDSGMVFSII 856
+ E +K + SDV+S GV L ELLT S K + + V +I
Sbjct: 175 FWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTVVRLI 234
Query: 857 D-----NRMGSYPSECVERFVTLALRCCHDKPEHRPSMSDVVRELENI 899
+ R+ P C + L C + + RP+ ++ L+ +
Sbjct: 235 ELLERGMRL-PCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEM 281
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 111 bits (280), Expect = 3e-27
Identities = 88/277 (31%), Positives = 137/277 (49%), Gaps = 30/277 (10%)
Query: 633 VGQGGYGKVYKGILS----DNTTVAIKRAEEGSLQGQ-NEFLTEIKLLSRLHHRNLVSLL 687
+G G +G+V++GIL VAIK + G + Q +FL+E ++ + H N++ L
Sbjct: 13 IGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLE 72
Query: 688 GYCDEEGEQMLVYEFVPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPV 747
G + M++ E++ NG L +L E ++ + + + A G+ YL +
Sbjct: 73 GVVTKFKPAMIITEYMENGALDKYLRDHDGEFSSYQL-VGMLRGIAAGMKYLSDMNY--- 128
Query: 748 FHRDIKASNILLDSNLNAKVADFGLSRLAPVLDD--EGTMPTHVSTI-VKGTPGYLDPEY 804
HRD+ A NIL++SNL KV+DFGLSR VL+D EGT T I ++ T PE
Sbjct: 129 VHRDLAARNILVNSNLECKVSDFGLSR---VLEDDPEGTYTTSGGKIPIRWTA----PEA 181
Query: 805 FLTHKLTDKSDVYSLGVVLLELLT-GMQPISHGKNIVREVNVARDSGMVFSIIDNRMGSY 863
K T SDV+S G+V+ E+++ G +P N EV A + G R+ +
Sbjct: 182 IAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSN--HEVMKAINDGF-------RLPA- 231
Query: 864 PSECVERFVTLALRCCHDKPEHRPSMSDVVRELENIL 900
P +C L L+C RP D+V L+ +L
Sbjct: 232 PMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKLL 268
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 111 bits (280), Expect = 3e-27
Identities = 76/264 (28%), Positives = 114/264 (43%), Gaps = 30/264 (11%)
Query: 633 VGQGGYGKVYKGI-LSDNTTVAIKRAE-EGSLQGQNEFLTEIKLLSRLHHRNLVSLLGYC 690
+G+G YG VYK I VAIK E LQ E + EI +L + +V G
Sbjct: 11 LGEGSYGSVYKAIHKETGQVVAIKVVPVEEDLQ---EIIKEISILKQCDSPYIVKYYGSY 67
Query: 691 DEEGEQMLVYEFVPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHR 750
+ + +V E+ G++ D + K L + + KG+ YLH+ HR
Sbjct: 68 FKNTDLWIVMEYCGAGSVSDIMKITNK-TLTEEEIAAILYQTLKGLEYLHSNK---KIHR 123
Query: 751 DIKASNILLDSNLNAKVADFGLS-RLAPVLDDEGTMPTHVSTIVKGTPGYLDPEYFLTHK 809
DIKA NILL+ AK+ADFG+S +L + T V GTP ++ PE
Sbjct: 124 DIKAGNILLNEEGQAKLADFGVSGQLTDTMAKRNT--------VIGTPFWMAPEVIQEIG 175
Query: 810 LTDKSDVYSLGVVLLELLTGMQPISHGKNIVREVNVARDSGMVFSIIDNRMGSY--PSEC 867
+K+D++SLG+ +E+ G P S + + +F I + + P +
Sbjct: 176 YNNKADIWSLGITAIEMAEGKPPYSD----IHPMRA------IFMIPNKPPPTLSDPEKW 225
Query: 868 VERFVTLALRCCHDKPEHRPSMSD 891
F +C PE RPS
Sbjct: 226 SPEFNDFVKKCLVKDPEERPSAIQ 249
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 111 bits (280), Expect = 4e-27
Identities = 79/296 (26%), Positives = 122/296 (41%), Gaps = 56/296 (18%)
Query: 632 QVGQGGYGKVYKGILS------DNTTVAIKRAEEGSLQGQNE-FLTEIKLLSRLHHRNLV 684
++G+G +GKV+ G D VA+K +E + + F E +LL+ H N+V
Sbjct: 12 ELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIV 71
Query: 685 SLLGYCDEEGEQMLVYEFVPNGTLRDWL------------SGRTKENLNFAMRLRVALDS 732
G C E ++V+E++ +G L +L L + L++A+
Sbjct: 72 KFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQI 131
Query: 733 AKGILYLHTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSRLAPVLDDEGTMPTHVSTI 792
A G++YL A HRD+ N L+ +L K+ DFG+SR V T
Sbjct: 132 ASGMVYL---ASQHFVHRDLATRNCLVGYDLVVKIGDFGMSR-------------DVYTT 175
Query: 793 ----VKGTP----GYLDPEYFLTHKLTDKSDVYSLGVVLLELLT-GMQP-ISHGKNIVRE 842
V G ++ PE + K T +SDV+S GVVL E+ T G QP V E
Sbjct: 176 DYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEEVIE 235
Query: 843 VNVARDSGMVFSIIDNRMGSYPSECVERFVTLALRCCHDKPEHRPSMSDVVRELEN 898
I R+ P C + L C P+ R ++ D+ L+
Sbjct: 236 C-----------ITQGRLLQRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQK 280
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 109 bits (273), Expect = 2e-26
Identities = 75/274 (27%), Positives = 117/274 (42%), Gaps = 29/274 (10%)
Query: 632 QVGQGGYGKVYKG----ILSDNTTVAIKRAEEGSLQG-QNEFLTEIKLLSRLHHRNLVSL 686
++G G +G V +G VA+K + L ++FL E ++ L H NL+ L
Sbjct: 2 KLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRL 61
Query: 687 LGYCDEEGEQMLVYEFVPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPP 746
G M+V E P G+L D L + + A+ A G+ YL ++
Sbjct: 62 YGVVLTH-PLMMVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKR--- 117
Query: 747 VFHRDIKASNILLDSNLNAKVADFGLSRLAPVLDDEGTMPTHVSTIVKGTP-GYLDPEYF 805
HRD+ A NILL S+ K+ DFGL R P +D M H P + PE
Sbjct: 118 FIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEH-----LKVPFAWCAPESL 172
Query: 806 LTHKLTDKSDVYSLGVVLLELLT-GMQPISH--GKNIVREVNVARDSGMVFSIIDNRMGS 862
T + SDV+ GV L E+ T G +P + G I+++++ + R+
Sbjct: 173 RTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKIDKEGE----------RL-E 221
Query: 863 YPSECVERFVTLALRCCHDKPEHRPSMSDVVREL 896
P C + + L+C P RP+ + + L
Sbjct: 222 RPEACPQDIYNVMLQCWAHNPADRPTFAALREFL 255
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 108 bits (273), Expect = 2e-26
Identities = 67/274 (24%), Positives = 114/274 (41%), Gaps = 32/274 (11%)
Query: 633 VGQGGYGKVYKGI-LSDNTTVAIKRAEEGSLQGQ--NEFLTEIKLLSRLHHRNLVSLLGY 689
+G+G +G V K SD + K + G++ + + ++E+ +L L H N+V Y
Sbjct: 8 IGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIV---RY 64
Query: 690 CDEE--GEQMLVY---EFVPNGTLRDWLSGRTKENLNFAMR--LRVALDSAKGILYLHTE 742
D +Y E+ G L + KE R+ + H
Sbjct: 65 YDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNR 124
Query: 743 AHPP--VFHRDIKASNILLDSNLNAKVADFGLSRLAPVLDDEGTMPTHVSTIVKGTPGYL 800
+ P V HRD+K +NI LD+N N K+ DFGL+++ + T V GTP Y+
Sbjct: 125 SDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKIL----GHDSSFAK--TYV-GTPYYM 177
Query: 801 DPEYFLTHKLTDKSDVYSLGVVLLELLTGMQPISHGKNIVREVNVARDSGMVFSIIDNRM 860
PE +KSD++SLG ++ EL P +N + ++ G R+
Sbjct: 178 SPEQLNHMSYDEKSDIWSLGCLIYELCALSPPF-TARNQL-QLASKIKEGKF-----RRI 230
Query: 861 GSYPSECVERFVTLALRCCHDKPEHRPSMSDVVR 894
S + + + P+ RPS ++++
Sbjct: 231 PYRYSSELNEVIKS---MLNVDPDKRPSTEELLQ 261
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 108 bits (272), Expect = 5e-26
Identities = 80/283 (28%), Positives = 130/283 (45%), Gaps = 43/283 (15%)
Query: 634 GQGGYGKVYKGI---LSDNTT--VAIKR-AEEGSLQGQNEFLTEIKLLSRLHHRNLVSLL 687
G G +G VYKG+ + VAIK EE S + E L E +++ + H ++V LL
Sbjct: 16 GSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLL 75
Query: 688 GYCDEEGEQ-MLVYEFVPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPP 746
G C Q L+ + +P G L D++ K+N+ L + AKG+ YL E
Sbjct: 76 GIC--LSSQVQLITQLMPLGCLLDYVR-NHKDNIGSQYLLNWCVQIAKGMSYL--EEKRL 130
Query: 747 VFHRDIKASNILLDSNLNAKVADFGLSRLAPVLDDE-----GTMPTHVSTIVKGTPGYLD 801
V HRD+ A N+L+ + + K+ DFGL++L V + E G +P ++
Sbjct: 131 V-HRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIK----------WMA 179
Query: 802 PEYFLTHKLTDKSDVYSLGVVLLELLT-GMQPISHGKNIVREVNVARDSGMVFSIIDN-- 858
E L T KSDV+S GV + EL+T G +P G A + + +++
Sbjct: 180 LESILHRIYTHKSDVWSYGVTVWELMTFGAKPYE-GIP-------AVE---IPDLLEKGE 228
Query: 859 RMGSYPSECVERFVTLALRCCHDKPEHRPSMSDVVRELENILK 901
R+ P C + ++C E RP+ +++ E + +
Sbjct: 229 RL-PQPPICTIDVYMVLVKCWMIDAESRPTFKELINEFSKMAR 270
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 108 bits (272), Expect = 7e-26
Identities = 67/224 (29%), Positives = 105/224 (46%), Gaps = 40/224 (17%)
Query: 632 QVGQGGYGKVYKGI-LSDNTTVAIKRAEEGSLQGQNE-------FLTEIKLLSRLHHRNL 683
Q+G+G YG+VYK VA+K+ ++ +NE + EIKLL +L H N+
Sbjct: 6 QIGEGTYGQVYKARNKKTGELVALKK-----IRMENEKEGFPITAIREIKLLQKLRHPNI 60
Query: 684 VSLLGYCDEE--GEQMLVYEFVP---NGTLRDWLSGRTKENLNFAMR-LRVALDSAKGIL 737
V L + G +V+E++ G L T+ + M+ L +G+
Sbjct: 61 VRLKEIVTSKGKGSIYMVFEYMDHDLTGLLDSPEVKFTESQIKCYMKQL------LEGLQ 114
Query: 738 YLHTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSRLAPVLDDEGTMP--THVSTIVKG 795
YLH+ + HRDIK SNIL++++ K+ADFGL+R + V T+
Sbjct: 115 YLHSNG---ILHRDIKGSNILINNDGVLKLADFGLARP---YTKRNSADYTNRVITL--- 165
Query: 796 TPGYLDPEYFL-THKLTDKSDVYSLGVVLLELLTGMQPISHGKN 838
Y PE L + + D++S+G +L EL G +PI G
Sbjct: 166 --WYRPPELLLGATRYGPEVDMWSVGCILAELFLG-KPIFQGST 206
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 107 bits (268), Expect = 2e-25
Identities = 81/291 (27%), Positives = 131/291 (45%), Gaps = 36/291 (12%)
Query: 632 QVGQGGYGKVYKGIL------SDNTTVAIKRAEEGSLQGQNEFLTEIKLLSRLHHRNLVS 685
++G+G +GKV+ D VA+K ++ S + +F E +LL+ L H ++V
Sbjct: 12 ELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVK 71
Query: 686 LLGYCDEEGEQMLVYEFVPNGTLRDWL-----------SGRTKENLNFAMRLRVALDSAK 734
G C E ++V+E++ +G L +L G L + L +A A
Sbjct: 72 FYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAA 131
Query: 735 GILYLHTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSRLAPVLDDEGTMPTHVSTIVK 794
G++YL ++ HRD+ N L+ NL K+ DFG+SR D + H ++
Sbjct: 132 GMVYLASQH---FVHRDLATRNCLVGENLLVKIGDFGMSRDV-YSTDYYRVGGHTMLPIR 187
Query: 795 GTPGYLDPEYFLTHKLTDKSDVYSLGVVLLELLT-GMQPISHGKNIVREVNVARDSGMVF 853
P PE + K T +SDV+SLGVVL E+ T G QP N + ++
Sbjct: 188 WMP----PESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSN----------NEVIE 233
Query: 854 SIIDNRMGSYPSECVERFVTLALRCCHDKPEHRPSMSDVVRELENILKMFP 904
I R+ P C + L L C +P R ++ ++ L+N+ K P
Sbjct: 234 CITQGRVLQRPRTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLAKASP 284
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 106 bits (266), Expect = 3e-25
Identities = 86/295 (29%), Positives = 139/295 (47%), Gaps = 49/295 (16%)
Query: 633 VGQGGYGKVY------KGILSDNT--TVAIKRAEEGSLQGQ-NEFLTEIKLLSRLHHRNL 683
+G+G +GKV +G DNT VA+K + S + EI++L L+H N+
Sbjct: 12 LGEGHFGKVELCRYDPEG---DNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENI 68
Query: 684 VSLLGYCDEEGEQ--MLVYEFVPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHT 741
V G C E+G L+ EF+P+G+L+++L R K +N +L+ A+ KG+ YL +
Sbjct: 69 VKYKGICTEDGGNGIKLIMEFLPSGSLKEYLP-RNKNKINLKQQLKYAVQICKGMDYLGS 127
Query: 742 EAHPPVFHRDIKASNILLDSNLNAKVADFGLSRLAPVLDDEG--TMPTHVSTIVKGTPGY 799
+ HRD+ A N+L++S K+ DFGL++ + D+ T+ + + V +
Sbjct: 128 RQY---VHRDLAARNVLVESEHQVKIGDFGLTK--AIETDKEYYTVKDDLDSPVF----W 178
Query: 800 LDPEYFLTHKLTDKSDVYSLGVVLLELLT----GMQPIS---------HGK-NIVREVNV 845
PE + K SDV+S GV L ELLT P++ HG+ + R V V
Sbjct: 179 YAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVRV 238
Query: 846 ARDSGMVFSIIDNRMGSYPSECVERFVTLALRCCHDKPEHRPSMSDVVRELENIL 900
+ R+ P C E L +C +P R + +++ E IL
Sbjct: 239 LEEG--------KRL-PRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAIL 284
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 105 bits (264), Expect = 3e-25
Identities = 68/210 (32%), Positives = 104/210 (49%), Gaps = 18/210 (8%)
Query: 633 VGQGGYGKVYKGI-LSDNTTVAIK--RAEEGSLQGQNEFLTEIKLLSRLHHRNLVSLLGY 689
+G G +GKVY + L +A+K R ++ + E E+K+L L H NLV G
Sbjct: 8 IGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYG- 66
Query: 690 CDEEGEQMLVY-EFVPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVF 748
+ E++ ++ E+ GTL + L L+ + L +G+ YLH+ +
Sbjct: 67 VEVHREKVYIFMEYCSGGTLEELL--EHGRILDEHVIRVYTLQLLEGLAYLHSHG---IV 121
Query: 749 HRDIKASNILLDSNLNAKVADFGLSRLAPVLDDEGT-MPTHVSTIVKGTPGYLDPEYFLT 807
HRDIK +NI LD N K+ DFG + L + T M V ++ GTP Y+ PE
Sbjct: 122 HRDIKPANIFLDHNGVIKLGDFGCAV---KLKNNTTTMGEEVQSLA-GTPAYMAPEVITG 177
Query: 808 HKLTDK---SDVYSLGVVLLELLTGMQPIS 834
K +D++SLG V+LE+ TG +P S
Sbjct: 178 GKGKGHGRAADIWSLGCVVLEMATGKRPWS 207
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 104 bits (262), Expect = 6e-25
Identities = 68/271 (25%), Positives = 118/271 (43%), Gaps = 23/271 (8%)
Query: 627 FSSSTQVGQGGYGKVYKGILSDNTTV-AIKRAEEGSLQG--QNEFLTEIKLLSRLHHRNL 683
F ++G+G +G V+K + + V A+K+ + + + E + E ++L++L +
Sbjct: 2 FEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYI 61
Query: 684 VSLLGYCDEEGEQMLVYEFVPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEA 743
+ ++G+ +V E+ NG L L + L R + G+ +LH++
Sbjct: 62 IRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKK 121
Query: 744 HPPVFHRDIKASNILLDSNLNAKVADFGLSRLAPVLDDEGTMPTHVSTIVKGTPGYLDPE 803
+ HRDIK+ N+ LD+ N K+ D G+++L +TIV GTP YL PE
Sbjct: 122 ---ILHRDIKSLNLFLDAYDNVKIGDLGVAKLL------SDNTNFANTIV-GTPYYLSPE 171
Query: 804 YFLTHKLTDKSDVYSLGVVLLELLTGMQPISHGKNIVREVNVARDSGMVFSIIDNRMGSY 863
+KSDV++LGVVL E TG P + ++ II
Sbjct: 172 LCEDKPYNEKSDVWALGVVLYECCTGKHPF----------DANNQGALILKIIRGVFPPV 221
Query: 864 PSECVERFVTLALRCCHDKPEHRPSMSDVVR 894
++ L +C RP ++R
Sbjct: 222 SQMYSQQLAQLIDQCLTKDYRQRPDTFQLLR 252
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 104 bits (262), Expect = 6e-25
Identities = 90/291 (30%), Positives = 129/291 (44%), Gaps = 49/291 (16%)
Query: 633 VGQGGYGKVYKG----ILSDNT---TVAIKRAEEGSL-QGQNEFLTEIKLLSRLHHRNLV 684
+G G +G+VY+G IL + VA+K +G+ Q + EFL E L+S +H N+V
Sbjct: 3 LGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIV 62
Query: 685 SLLGYCDEEGEQMLVYEFVPNGTLRDWLSGRTKEN-----LNFAMRLRVALDSAKGILYL 739
LLG C Q ++ E + G L +L E L L + LD AKG +YL
Sbjct: 63 KLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYL 122
Query: 740 HTEAHPPVFHRDIKASNILL-----DSNLNAKVADFGLSRLAPVLD-----DEGTMPTHV 789
+ H HRD+ A N L+ D++ K+ DFGL+R D EG +P
Sbjct: 123 E-QMH--FIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLLPVR- 178
Query: 790 STIVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVLLELLT-GMQPISHGKNIVREV-NVAR 847
++ PE L K T +SDV+S GV++ E+LT G QP N EV
Sbjct: 179 ---------WMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQ--EVLQHVT 227
Query: 848 DSGMVFSIIDNRMGSYPSECVERFVTLALRCCHDKPEHRPSMSDVVRELEN 898
G R+ P C ++ L C P RP+ + L+N
Sbjct: 228 AGG--------RLQK-PENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQN 269
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 104 bits (261), Expect = 7e-25
Identities = 74/258 (28%), Positives = 124/258 (48%), Gaps = 21/258 (8%)
Query: 632 QVGQGGYGKVYKGILSDNTTVAIKRAEEGSLQGQNEFLTEIKLLSRLHHRNLVSLLGYCD 691
++G G +G+V+ G +++T VA+K + G++ Q FL E L+ L H LV L
Sbjct: 13 KLGAGQFGEVWMGYYNNSTKVAVKTLKPGTMSVQ-AFLEEANLMKTLQHDKLVRLYAVVT 71
Query: 692 EEGEQMLVYEFVPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRD 751
+E ++ E++ G+L D+L + + + A+G+ Y+ + + HRD
Sbjct: 72 KEEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKNY---IHRD 128
Query: 752 IKASNILLDSNLNAKVADFGLSRLAPVLDDEGTMPTHVSTIVKGTPGYLDPEYFLTHKLT 811
++A+N+L+ +L K+ADFGL+R+ + D+E T +K T PE T
Sbjct: 129 LRAANVLVSESLMCKIADFGLARV--IEDNEYTAREGAKFPIKWTA----PEAINFGSFT 182
Query: 812 DKSDVYSLGVVLLELLT-GMQPISHGKNIVREVNVARDSGMVFSIIDNRMGSYPSECVER 870
KSDV+S G++L E++T G P N +V A G RM C +
Sbjct: 183 IKSDVWSFGILLYEIVTYGKIPYPGMSN--SDVMSALQRGY-------RM-PRMENCPDE 232
Query: 871 FVTLALRCCHDKPEHRPS 888
+ C +K E RP+
Sbjct: 233 LYDIMKTCWKEKAEERPT 250
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 104 bits (262), Expect = 8e-25
Identities = 84/276 (30%), Positives = 134/276 (48%), Gaps = 26/276 (9%)
Query: 633 VGQGGYGKVYKGILS----DNTTVAIKRAEEGSLQGQ-NEFLTEIKLLSRLHHRNLVSLL 687
+G G +G+V +G L VAIK + G + Q +FL+E ++ + H N++ L
Sbjct: 12 IGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLE 71
Query: 688 GYCDEEGEQMLVYEFVPNGTLRDWLSGRTKENLNFAMRLRVALDS-AKGILYLHTEAHPP 746
G + M++ EF+ NG L +L R + ++L L A G+ YL +
Sbjct: 72 GVVTKSRPVMIITEFMENGALDSFL--RQNDGQFTVIQLVGMLRGIAAGMKYL---SEMN 126
Query: 747 VFHRDIKASNILLDSNLNAKVADFGLSRLAPVLDDEGTMPTHVSTIVKGTP-GYLDPEYF 805
HRD+ A NIL++SNL KV+DFGLSR L+D+ + PT+ S++ P + PE
Sbjct: 127 YVHRDLAARNILVNSNLVCKVSDFGLSRF---LEDDTSDPTYTSSLGGKIPIRWTAPEAI 183
Query: 806 LTHKLTDKSDVYSLGVVLLELLT-GMQPISHGKNIVREVNVARDSGMVFSIIDNRMGSYP 864
K T SDV+S G+V+ E+++ G +P N ++V A + D R+ P
Sbjct: 184 AYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSN--QDVINAIEQ-------DYRLPP-P 233
Query: 865 SECVERFVTLALRCCHDKPEHRPSMSDVVRELENIL 900
+C L L C RP +V L+ ++
Sbjct: 234 MDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKMI 269
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 104 bits (262), Expect = 8e-25
Identities = 79/286 (27%), Positives = 128/286 (44%), Gaps = 37/286 (12%)
Query: 633 VGQGGYGKVYKGILS-DNTT---VAIK--RAEEGSLQGQNEFLTEIKLLSRLHHRNLVSL 686
+G+G +G V +G LS D+ + VA+K + + + EFL+E + H N++ L
Sbjct: 7 LGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKL 66
Query: 687 LGYCDEEGEQ------MLVYEFVPNGTLRDWL-SGRTK---ENLNFAMRLRVALDSAKGI 736
+G C E M++ F+ +G L +L R E L L+ +D A G+
Sbjct: 67 IGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGM 126
Query: 737 LYLHTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSRLAPVLDDEGTMPTHVSTI-VKG 795
YL HRD+ A N +L ++ VADFGLS+ + + ++ + VK
Sbjct: 127 EYLSNRN---FIHRDLAARNCMLREDMTVCVADFGLSK--KIYSGDYYRQGRIAKMPVK- 180
Query: 796 TPGYLDPEYFLTHKLTDKSDVYSLGVVLLELLT-GMQPISHGKNIVREVNVARDSGMVFS 854
++ E T KSDV++ GV + E+ T G P +N E+ G
Sbjct: 181 ---WIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVEN--HEIYDYLRHG---- 231
Query: 855 IIDNRMGSYPSECVERFVTLALRCCHDKPEHRPSMSDVVRELENIL 900
NR+ P +C++ L C P+ RP+ + + LENIL
Sbjct: 232 ---NRLKQ-PEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENIL 273
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 104 bits (261), Expect = 9e-25
Identities = 78/278 (28%), Positives = 129/278 (46%), Gaps = 31/278 (11%)
Query: 633 VGQGGYGKVYKGIL----SDNTTVAIKRAEEGSLQGQNE-FLTEIKLLSRLHHRNLVSLL 687
+G+G +G VY+G+ ++ VA+K + + E FL E ++ + H ++V L+
Sbjct: 14 IGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLI 73
Query: 688 GYCDEEGEQMLVYEFVPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPV 747
G E +V E P G LR +L K +L+ A + + + + YL ++
Sbjct: 74 GVI-TENPVWIVMELAPLGELRSYLQ-VNKYSLDLASLILYSYQLSTALAYLESKR---F 128
Query: 748 FHRDIKASNILLDSNLNAKVADFGLSRLAPVLDDEGTMPTHVSTIVKGTPGYLDPEYFLT 807
HRDI A N+L+ S K+ DFGLSR L+DE + ++ K ++ PE
Sbjct: 129 VHRDIAARNVLVSSPDCVKLGDFGLSRY---LEDES---YYKASKGKLPIKWMAPESINF 182
Query: 808 HKLTDKSDVYSLGVVLLELLT-GMQPISHGKNIVREVNVARDSGMVFSIIDN--RMGSYP 864
+ T SDV+ GV + E+L G++P KN D V I+N R+ P
Sbjct: 183 RRFTSASDVWMFGVCMWEILMLGVKPFQGVKN--------ND---VIGRIENGERL-PMP 230
Query: 865 SECVERFVTLALRCCHDKPEHRPSMSDVVRELENILKM 902
C +L +C P RP +++ +L +IL+
Sbjct: 231 PNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDILQE 268
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 105 bits (262), Expect = 1e-24
Identities = 81/296 (27%), Positives = 134/296 (45%), Gaps = 42/296 (14%)
Query: 619 ELAMATAYFSSSTQVGQGGYGKVYKGIL-----SDNTTVAIKRAEE-GSLQGQNEFLTEI 672
EL ++ F ++G+ +GK+YKG L VAIK ++ + Q EF E
Sbjct: 1 ELPLSAVRFME--ELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEA 58
Query: 673 KLLSRLHHRNLVSLLGYCDEEGEQMLVYEFVPNGTLRDWL---------------SGRTK 717
L++ LHH N+V LLG +E +++E++ G L ++L G K
Sbjct: 59 SLMAELHHPNIVCLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVK 118
Query: 718 ENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSRLAP 777
+L+ L +A+ A G+ YL + H+D+ A NIL+ L+ K++D GLSR
Sbjct: 119 SSLDHGDFLHIAIQIAAGMEYLSSHF---FVHKDLAARNILIGEQLHVKISDLGLSREIY 175
Query: 778 VLDDEGTMPTHVSTIVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVLLELLT-GMQPISHG 836
D P + I ++ PE + K + SD++S GVVL E+ + G+QP +G
Sbjct: 176 SADYYRVQPKSLLPI-----RWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPY-YG 229
Query: 837 KNIVREVNVARDSGMVFSIIDNRMGSYPSECVERFVTLALRCCHDKPEHRPSMSDV 892
+ + + R ++ +C R +L C + P RP D+
Sbjct: 230 FSNQEVIEMVRKRQLL---------PCSEDCPPRMYSLMTECWQEGPSRRPRFKDI 276
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 104 bits (261), Expect = 2e-24
Identities = 63/221 (28%), Positives = 102/221 (46%), Gaps = 39/221 (17%)
Query: 633 VGQGGYGKVYKGI-LSDNTTVAIKR-----AEEG----SLQGQNEFLTEIKLLSRLHHRN 682
+G+G YG VYK VA+K+ EEG +L+ EI LL L H N
Sbjct: 7 LGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALR-------EISLLKELKHPN 59
Query: 683 LVSLLGYCDEEGEQMLVYEFVPNGTLRDWLSGRTKENLNFAMRLRVALDSA----KGILY 738
+V LL E + LV+E+ L+ +L + + + +G+ Y
Sbjct: 60 IVKLLDVIHTERKLYLVFEYCDM-DLKKYL-----DKRPGPLSPNLIKSIMYQLLRGLAY 113
Query: 739 LHTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSRLAPVLDDEGTMPTHVSTIVKGTPG 798
H+ + HRD+K NIL++ + K+ADFGL+R + + T+ +V T
Sbjct: 114 CHSHR---ILHRDLKPQNILINRDGVLKLADFGLARAFGI-----PLRTYTHEVV--TLW 163
Query: 799 YLDPEYFLTHKLTDKS-DVYSLGVVLLELLTGMQPISHGKN 838
Y PE L K + D++S+G + E++TG +P+ G +
Sbjct: 164 YRAPEILLGSKHYSTAVDIWSVGCIFAEMITG-KPLFPGDS 203
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 104 bits (261), Expect = 2e-24
Identities = 87/299 (29%), Positives = 132/299 (44%), Gaps = 61/299 (20%)
Query: 633 VGQGGYGKVYKGILSDN---TTVAIKRAEE-GSLQGQNEFLTEIKLLSRL-HHRNLVSLL 687
+G+G +G+V K + + AIKR +E S +F E+++L +L HH N+++LL
Sbjct: 15 IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLL 74
Query: 688 GYCDEEGEQMLVYEFVPNGTLRDWL--------------SGRTKENLNFAMRLRVALDSA 733
G C+ G L E+ P+G L D+L + T L+ L A D A
Sbjct: 75 GACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVA 134
Query: 734 KGILYLHTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSRLAPVLDDEGTMPTHVSTIV 793
+G+ YL + HRD+ A NIL+ N AK+ADFGLSR V V
Sbjct: 135 RGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVY-------------V 178
Query: 794 KGTPGYLDPEYFLTHKL-----TDKSDVYSLGVVLLELLT-GMQPISHGKNIVREVNVAR 847
K T G L + L T SDV+S GV+L E+++ G P
Sbjct: 179 KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPY-------------- 224
Query: 848 DSGMVFSIIDNRMG-----SYPSECVERFVTLALRCCHDKPEHRPSMSDVVRELENILK 901
GM + + ++ P C + L +C +KP RPS + ++ L +L+
Sbjct: 225 -CGMTCAELYEKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLE 282
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 102 bits (256), Expect = 3e-24
Identities = 84/273 (30%), Positives = 135/273 (49%), Gaps = 36/273 (13%)
Query: 633 VGQGGYGKV----YKGILSDNTTVAIKRAEEGSLQGQNEFLTEIKLLSRLHHRNLVSLLG 688
+G+G +G V Y+G VA+K + + FL E ++++L H NLV LLG
Sbjct: 14 IGKGEFGDVMLGDYRG-----NKVAVKCIKNDATA--QAFLAEASVMTQLRHSNLVQLLG 66
Query: 689 Y-CDEEGEQMLVYEFVPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPV 747
+E+G +V E++ G+L D+L R + L L+ +LD + + YL EA+ V
Sbjct: 67 VIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYL--EANNFV 124
Query: 748 FHRDIKASNILLDSNLNAKVADFGLSRLAPVLDDEGTMPTHVSTIVKGTPGYLDPEYFLT 807
HRD+ A N+L+ + AKV+DFGL++ A D G +P VK T PE
Sbjct: 125 -HRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLP------VKWTA----PEALRE 173
Query: 808 HKLTDKSDVYSLGVVLLELLT-GMQPISHGKNIVREVNVARDSGMVFSIIDNRMGSYPSE 866
K + KSDV+S G++L E+ + G P + + +++V + G +M + P
Sbjct: 174 KKFSTKSDVWSFGILLWEIYSFGRVP--YPRIPLKDVVPRVEKGY-------KMDA-PDG 223
Query: 867 CVERFVTLALRCCHDKPEHRPSMSDVVRELENI 899
C + +C H RPS + +LE+I
Sbjct: 224 CPPVVYDVMKQCWHLDAATRPSFLQLREQLEHI 256
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 102 bits (257), Expect = 3e-24
Identities = 80/277 (28%), Positives = 124/277 (44%), Gaps = 45/277 (16%)
Query: 633 VGQGGYGKVYKGILSDN-TTVAIKR---AEEGSLQGQ--NEFLTEIKLLSRLHHRNLVSL 686
+G G +G VY+G+ D+ A+K A++G + + EI LLS+L H N+V
Sbjct: 8 LGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQY 67
Query: 687 LGYCDEEGEQMLVYEFVPNGTLRDWLS--GRTKENLNFAMRLRVALDSAKGILYLHTEAH 744
LG EE + E VP G+L L G E + + R L G+ YLH
Sbjct: 68 LGTEREEDNLYIFLELVPGGSLAKLLKKYGSFPEPV-IRLYTRQILL---GLEYLHDRN- 122
Query: 745 PPVFHRDIKASNILLDSNLNAKVADFGLSRLAPVLDDEGTMPTHVSTIVKGTPGYLDPEY 804
HRDIK +NIL+D+N K+ADFG+++ + KG+P ++ PE
Sbjct: 123 --TVHRDIKGANILVDTNGVVKLADFGMAKQVVEFSFAKSF--------KGSPYWMAPEV 172
Query: 805 FL-THKLTDKSDVYSLGVVLLELLTGMQPISHGKNIVREVNVARDSGMVFSIIDNRMGSY 863
+D++SLG +LE+ TG P S + + VF I R
Sbjct: 173 IAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGV----------AAVFKI--GRSKEL 220
Query: 864 P------SECVERFVTLALRCCHDKPEHRPSMSDVVR 894
P S+ + F+ L+C P RP+ ++++
Sbjct: 221 PPIPDHLSDEAKDFI---LKCLQRDPSLRPTAAELLE 254
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 102 bits (257), Expect = 3e-24
Identities = 68/211 (32%), Positives = 96/211 (45%), Gaps = 16/211 (7%)
Query: 632 QVGQGGYGKVYKGI-LSDNTTVAIKRAE-EGSLQGQNEFLTEIKLLSRLHHRNLVSLLGY 689
+G G VY I L +N VAIKR + E +E E++ +S+ +H N+V
Sbjct: 8 VIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTS 67
Query: 690 CDEEGEQMLVYEFVPNGTLRDWLSGRTKENLN----FAMRLRVALDSAKGILYLHTEAHP 745
E LV ++ G+L D + A L+ L KG+ YLH+
Sbjct: 68 FVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVL---KGLEYLHSNGQ- 123
Query: 746 PVFHRDIKASNILLDSNLNAKVADFGLSRLAPVLDDEGTMPTHVSTIVKGTPGYLDPEYF 805
HRDIKA NILL + + K+ADFG+S L D G V GTP ++ PE
Sbjct: 124 --IHRDIKAGNILLGEDGSVKIADFGVS---ASLADGGDRTRKVRKTFVGTPCWMAPEVM 178
Query: 806 LTHK-LTDKSDVYSLGVVLLELLTGMQPISH 835
K+D++S G+ +EL TG P S
Sbjct: 179 EQVHGYDFKADIWSFGITAIELATGAAPYSK 209
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 109 bits (273), Expect = 4e-24
Identities = 65/187 (34%), Positives = 97/187 (51%), Gaps = 7/187 (3%)
Query: 88 VRELQLLSMNLSGNLAPELGQLSRLQYYFM---WNDLTGTIPKEIGNISSLIFLLLNGNK 144
+R ++L + SG L E +L + YF+ N+L G I ++ SL L L NK
Sbjct: 406 LRRVRLQDNSFSGELPSEFTKLPLV--YFLDISNNNLQGRINSRKWDMPSLQMLSLARNK 463
Query: 145 LSGSLPDELGYLSNLNRLQVDENNITGTIPKSFANLSRVRHLHLNNNSIGGQIPSELSKL 204
G LPD G L L + N +G +P+ +LS + L L+ N + G+IP ELS
Sbjct: 464 FFGGLPDSFGS-KRLENLDLSRNQFSGAVPRKLGSLSELMQLKLSENKLSGEIPDELSSC 522
Query: 205 STLIHLLVDNNNLSGNLPPELSELPQLCILQLDNNNFSASEIPATYGNFSKLVKLSLRNC 264
L+ L + +N LSG +P SE+P L L L N S EIP GN LV++++ +
Sbjct: 523 KKLVSLDLSHNQLSGQIPASFSEMPVLSQLDLSQNQLSG-EIPKNLGNVESLVQVNISHN 581
Query: 265 NLQGAVP 271
+L G++P
Sbjct: 582 HLHGSLP 588
|
Length = 968 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 101 bits (252), Expect = 1e-23
Identities = 65/210 (30%), Positives = 103/210 (49%), Gaps = 23/210 (10%)
Query: 633 VGQGGYGKVYKGILSDNTT---VAIKRAEEGSLQGQ-----NEFLTEIKLLSRLHHRNLV 684
+GQG +G+VY + D T +A+K+ + N EI+LL L H +V
Sbjct: 10 LGQGAFGRVY--LCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIV 67
Query: 685 SLLGYCDEEGEQMLVY-EFVPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEA 743
G C + E + ++ E++P G+++D L + L + + +G+ YLH+
Sbjct: 68 QYYG-CLRDDETLSIFMEYMPGGSVKDQL--KAYGALTETVTRKYTRQILEGVEYLHSNM 124
Query: 744 HPPVFHRDIKASNILLDSNLNAKVADFGLS-RLAPVLDDEGTMPTHVSTIVKGTPGYLDP 802
+ HRDIK +NIL DS N K+ DFG S RL + M + V GTP ++ P
Sbjct: 125 ---IVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKS-----VTGTPYWMSP 176
Query: 803 EYFLTHKLTDKSDVYSLGVVLLELLTGMQP 832
E K+DV+S+G ++E+LT P
Sbjct: 177 EVISGEGYGRKADVWSVGCTVVEMLTEKPP 206
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 101 bits (252), Expect = 1e-23
Identities = 87/299 (29%), Positives = 131/299 (43%), Gaps = 61/299 (20%)
Query: 633 VGQGGYGKVYKGILSDN---TTVAIKRAEE-GSLQGQNEFLTEIKLLSRL-HHRNLVSLL 687
+G+G +G+V K + + AIKR +E S +F E+++L +L HH N+++LL
Sbjct: 3 IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLL 62
Query: 688 GYCDEEGEQMLVYEFVPNGTLRDWLSGR--------------TKENLNFAMRLRVALDSA 733
G C+ G L E+ P+G L D+L T L+ L A D A
Sbjct: 63 GACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVA 122
Query: 734 KGILYLHTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSRLAPVLDDEGTMPTHVSTIV 793
+G+ YL + HRD+ A NIL+ N AK+ADFGLSR V V
Sbjct: 123 RGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVY-------------V 166
Query: 794 KGTPGYLDPEYFLTHKL-----TDKSDVYSLGVVLLELLT-GMQPISHGKNIVREVNVAR 847
K T G L + L T SDV+S GV+L E+++ G P
Sbjct: 167 KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYC------------- 213
Query: 848 DSGMVFSIIDNRMGS-----YPSECVERFVTLALRCCHDKPEHRPSMSDVVRELENILK 901
GM + + ++ P C + L +C +KP RPS + ++ L +L+
Sbjct: 214 --GMTCAELYEKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLE 270
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 101 bits (253), Expect = 1e-23
Identities = 76/294 (25%), Positives = 133/294 (45%), Gaps = 39/294 (13%)
Query: 632 QVGQGGYGKVYKG------ILSDNTTVAIKRAEEGSLQGQNEFLTEIKLLSRLHHRNLVS 685
++G+G +GKV+ D VA+K ++ +L + +F E +LL+ L H ++V
Sbjct: 12 ELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVK 71
Query: 686 LLGYCDEEGEQMLVYEFVPNGTLRDWLSG--------------RTKENLNFAMRLRVALD 731
G C + ++V+E++ +G L +L + K L + L +A
Sbjct: 72 FYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQ 131
Query: 732 SAKGILYLHTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSRLAPVLDDEGTMPTHVST 791
A G++YL ++ HRD+ N L+ +NL K+ DFG+SR D + H
Sbjct: 132 IASGMVYLASQH---FVHRDLATRNCLVGANLLVKIGDFGMSR-DVYSTDYYRVGGHTML 187
Query: 792 IVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVLLELLT-GMQPISHGKNIVREVNVARDSG 850
++ P PE + K T +SDV+S GV+L E+ T G QP N +
Sbjct: 188 PIRWMP----PESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSN----------TE 233
Query: 851 MVFSIIDNRMGSYPSECVERFVTLALRCCHDKPEHRPSMSDVVRELENILKMFP 904
++ I R+ P C + + L C +P+ R ++ ++ + L + K P
Sbjct: 234 VIECITQGRVLERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALGKATP 287
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 102 bits (254), Expect = 1e-23
Identities = 83/299 (27%), Positives = 130/299 (43%), Gaps = 61/299 (20%)
Query: 633 VGQGGYGKVYKGILSDN---TTVAIKRAEE-GSLQGQNEFLTEIKLLSRL-HHRNLVSLL 687
+G+G +G+V + ++ + AIK +E S +F E+++L +L HH N+++LL
Sbjct: 10 IGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLL 69
Query: 688 GYCDEEGEQMLVYEFVPNGTLRDWLSGR--------------TKENLNFAMRLRVALDSA 733
G C+ G + E+ P G L D+L T L L+ A D A
Sbjct: 70 GACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVA 129
Query: 734 KGILYLHTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSRLAPVLDDEGTMPTHVSTIV 793
G+ YL + HRD+ A N+L+ NL +K+ADFGLSR V V
Sbjct: 130 TGMQYL---SEKQFIHRDLAARNVLVGENLASKIADFGLSRGEEVY-------------V 173
Query: 794 KGTPGYLDPEYFLTHKL-----TDKSDVYSLGVVLLELLT-GMQPISHGKNIVREVNVAR 847
K T G L + L T KSDV+S GV+L E+++ G P
Sbjct: 174 KKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYC------------- 220
Query: 848 DSGMVFSIIDNRMGS-----YPSECVERFVTLALRCCHDKPEHRPSMSDVVRELENILK 901
GM + + ++ P C + L +C D+P RP + + +L +L+
Sbjct: 221 --GMTCAELYEKLPQGYRMEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRMLE 277
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 99.1 bits (247), Expect = 6e-23
Identities = 71/265 (26%), Positives = 117/265 (44%), Gaps = 25/265 (9%)
Query: 633 VGQGGYGK--VYKGILSDNTTVAIKRAEEGSL--QGQNEFLTEIKLLSRLHHRNLVSLLG 688
+G+G +G+ +Y+ D++ V K L + + + L EI +LS L H N+++
Sbjct: 8 LGKGAFGEATLYRRT-EDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYN 66
Query: 689 YCDEEGEQMLVYEFVPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVF 748
+ ++ ++ E+ GTL D + + + M L + Y+H +
Sbjct: 67 HFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAG---IL 123
Query: 749 HRDIKASNILLDSNLNAKVADFGLSRLAPVLDDEGTMPTHVSTIVKGTPGYLDPEYFLTH 808
HRDIK NI L K+ DFG+S+ +L E +M T+V GTP Y+ PE
Sbjct: 124 HRDIKTLNIFLTKAGLIKLGDFGISK---ILGSEYSM---AETVV-GTPYYMSPELCQGV 176
Query: 809 KLTDKSDVYSLGVVLLELLTGMQPISHGKNIVREVNVARDSGMVFSIIDNRMGSYPSECV 868
K KSD+++LG VL ELLT + R + +V I+ S
Sbjct: 177 KYNFKSDIWALGCVLYELLT----------LKRTFDATNPLNLVVKIVQGNYTPVVSVYS 226
Query: 869 ERFVTLALRCCHDKPEHRPSMSDVV 893
++L PE RP+ +V+
Sbjct: 227 SELISLVHSLLQQDPEKRPTADEVL 251
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 98.1 bits (244), Expect = 1e-22
Identities = 80/274 (29%), Positives = 128/274 (46%), Gaps = 32/274 (11%)
Query: 633 VGQGGYGKVYKGILSDNTTVAIKRAE---EGSLQGQNEFLT---EIKLLSRLHHRNLVSL 686
+G+G YG VY G+ + +A+K+ E L + E+ E+ LL L H N+V
Sbjct: 8 LGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQY 67
Query: 687 LGYCDEEGEQMLVYEFVPNGTLRDWLS--GRTKENLNFAMRLRVALDSAKGILYLHTEAH 744
LG C ++ + EFVP G++ L+ G E + F + LD G+ YLH
Sbjct: 68 LGTCLDDNTISIFMEFVPGGSISSILNRFGPLPEPV-FCKYTKQILD---GVAYLHNNC- 122
Query: 745 PPVFHRDIKASNILLDSNLNAKVADFGLSRLAPVLDDEGTMPTHVSTIVKGTPGYLDPEY 804
V HRDIK +N++L N K+ DFG +R + GT + + + GTP ++ PE
Sbjct: 123 --VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKS-MHGTPYWMAPEV 179
Query: 805 FLTHKLTDKSDVYSLGVVLLELLTGMQPISHGKNIVREVNVARDSGMVFSIIDNRMGSYP 864
KSD++S+G + E+ TG P++ ++ R + M + I G P
Sbjct: 180 INESGYGRKSDIWSIGCTVFEMATGKPPLA---------SMDRLAAMFY--IGAHRGLMP 228
Query: 865 SECVERFVTLA---LRCCHDKPEH-RPSMSDVVR 894
+ F A + C + +H RPS ++R
Sbjct: 229 R-LPDSFSAAAIDFVTSCLTRDQHERPSALQLLR 261
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 97.7 bits (243), Expect = 2e-22
Identities = 85/278 (30%), Positives = 132/278 (47%), Gaps = 32/278 (11%)
Query: 633 VGQGGYGKVYKGILS----DNTTVAIKRAEEGSLQGQN-EFLTEIKLLSRLHHRNLVSLL 687
+G G +G+V G L VAIK + G + Q +FL+E ++ + H N++ L
Sbjct: 12 IGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLE 71
Query: 688 GYCDEEGEQMLVYEFVPNGTLRDWLSGRTKENLNFAMRLRVAL--DSAKGILYLHTEAHP 745
G + M+V E++ NG+L +L K + F + V + A G+ YL +
Sbjct: 72 GVVTKSKPVMIVTEYMENGSLDAFLR---KHDGQFTVIQLVGMLRGIASGMKYLSDMGY- 127
Query: 746 PVFHRDIKASNILLDSNLNAKVADFGLSRLAPVLDDEGTMPTHVSTIVKGT-P-GYLDPE 803
HRD+ A NIL++SNL KV+DFGLSR VL+D+ P T G P + PE
Sbjct: 128 --VHRDLAARNILVNSNLVCKVSDFGLSR---VLEDD---PEAAYTTRGGKIPIRWTAPE 179
Query: 804 YFLTHKLTDKSDVYSLGVVLLELLT-GMQPISHGKNIVREVNVARDSGMVFSIIDNRMGS 862
K T SDV+S G+V+ E+++ G +P N ++V A + G R+ +
Sbjct: 180 AIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSN--QDVIKAIEEGY-------RLPA 230
Query: 863 YPSECVERFVTLALRCCHDKPEHRPSMSDVVRELENIL 900
P +C L L C RP +V L+ ++
Sbjct: 231 -PMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDKLI 267
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 97.0 bits (241), Expect = 3e-22
Identities = 77/268 (28%), Positives = 130/268 (48%), Gaps = 22/268 (8%)
Query: 632 QVGQGGYGKVYKGILSDNTTVAIKRAEEGSLQGQNEFLTEIKLLSRLHHRNLVSLLGYCD 691
++G G +G+V+ + +T VA+K + GS+ FL E ++ L H LV L
Sbjct: 13 KLGAGQFGEVWMATYNKHTKVAVKTMKPGSMS-VEAFLAEANVMKTLQHDKLVKLHAVVT 71
Query: 692 EEGEQMLVYEFVPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRD 751
+E ++ EF+ G+L D+L + + A+G+ ++ + HRD
Sbjct: 72 KE-PIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNY---IHRD 127
Query: 752 IKASNILLDSNLNAKVADFGLSRLAPVLDDEGTMPTHVSTIVKGTPGYLDPEYFLTHKLT 811
++A+NIL+ ++L K+ADFGL+R+ + D+E T +K T PE T
Sbjct: 128 LRAANILVSASLVCKIADFGLARV--IEDNEYTAREGAKFPIKWTA----PEAINFGSFT 181
Query: 812 DKSDVYSLGVVLLELLT-GMQPISHGKNIVREVNVARDSGMVFSIIDNRMGSYPSECVER 870
KSDV+S G++L+E++T G P N EV A + G RM + C E
Sbjct: 182 IKSDVWSFGILLMEIVTYGRIPYPGMSN--PEVIRALERGY-------RMPRPEN-CPEE 231
Query: 871 FVTLALRCCHDKPEHRPSMSDVVRELEN 898
+ +RC ++PE RP+ + L++
Sbjct: 232 LYNIMMRCWKNRPEERPTFEYIQSVLDD 259
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 97.0 bits (241), Expect = 3e-22
Identities = 74/270 (27%), Positives = 130/270 (48%), Gaps = 26/270 (9%)
Query: 632 QVGQGGYGKVYKGIL-SDNTTVAIKRAEEG-SLQGQNEFLTEIKLLSRLHHRNLVSLLGY 689
++G+G +G+V+ G L +DNT VA+K E + +FL E ++L + H N+V L+G
Sbjct: 2 RIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGV 61
Query: 690 CDEEGEQMLVYEFVPNGTLRDWLSGRTKENLNFAMR--LRVALDSAKGILYLHTEAHPPV 747
C ++ +V E V G D+L+ E ++ +++ ++A G+ YL ++
Sbjct: 62 CTQKQPIYIVMELVQGG---DFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKH---C 115
Query: 748 FHRDIKASNILLDSNLNAKVADFGLSRLAPVLDDEGTMPTHVSTIVKGTPGYLDPEYFLT 807
HRD+ A N L+ K++DFG+SR ++E + + + + PE
Sbjct: 116 IHRDLAARNCLVTEKNVLKISDFGMSR-----EEEDGVYASTGGMKQIPVKWTAPEALNY 170
Query: 808 HKLTDKSDVYSLGVVLLELLT-GMQPISHGKNIVREVNVARDSGMVFSIIDNRMGSYPSE 866
+ + +SDV+S G++L E + G P ++ N ++ A + G+ P
Sbjct: 171 GRYSSESDVWSFGILLWEAFSLGAVPYANLSN--QQTREAIEQGVRLPC--------PEL 220
Query: 867 CVERFVTLALRCCHDKPEHRPSMSDVVREL 896
C + L RC P RPS S V +EL
Sbjct: 221 CPDAVYRLMERCWEYDPGQRPSFSTVHQEL 250
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 97.9 bits (244), Expect = 3e-22
Identities = 83/296 (28%), Positives = 139/296 (46%), Gaps = 51/296 (17%)
Query: 633 VGQGGYGKVYKG--ILSDN----TTVAIKRAEEGSLQGQ-NEFLTEIKLLSRL-HHRNLV 684
+G+G +G+V K + DN +TVA+K ++ + + ++ ++E++++ + H+N++
Sbjct: 20 LGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNII 79
Query: 685 SLLGYCDEEGEQMLVYEFVPNGTLRDWLSGR--------------TKENLNFAMRLRVAL 730
+LLG C +EG +V E+ +G LRD+L R +E L + A
Sbjct: 80 NLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAY 139
Query: 731 DSAKGILYLHTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSRLAPVLD-----DEGTM 785
A+G+ +L A HRD+ A N+L+ + K+ADFGL+R +D G +
Sbjct: 140 QVARGMEFL---ASKKCIHRDLAARNVLVTEDHVMKIADFGLARDIHHIDYYRKTTNGRL 196
Query: 786 PTHVSTIVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVLLELLT-GMQPISHGKNIVREVN 844
P VK ++ PE T +SDV+S GV+L E+ T G P V E+
Sbjct: 197 P------VK----WMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIP--VEELF 244
Query: 845 VARDSGMVFSIIDNRMGSYPSECVERFVTLALRCCHDKPEHRPSMSDVVRELENIL 900
G RM P C + L C H+ P RP+ +V +L+ +L
Sbjct: 245 KLLKEG-------YRM-EKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRML 292
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 97.8 bits (243), Expect = 3e-22
Identities = 76/281 (27%), Positives = 118/281 (41%), Gaps = 38/281 (13%)
Query: 632 QVGQGGYGKVY----KGIL--SDNTTVAIKRAEEGSLQGQNEFLTEIKLLSRLHHRNLVS 685
++G+G +GKV+ +L D VA+K +E S + +F E +LL+ L H+++V
Sbjct: 12 ELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVR 71
Query: 686 LLGYCDEEGEQMLVYEFVPNGTLRDWL-------------SGRTKENLNFAMRLRVALDS 732
G C E ++V+E++ +G L +L L L +A
Sbjct: 72 FYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQI 131
Query: 733 AKGILYLHTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSRLAPVLDDEGTMPTHVSTI 792
A G++YL A HRD+ N L+ L K+ DFG+SR D T V
Sbjct: 132 ASGMVYL---ASLHFVHRDLATRNCLVGQGLVVKIGDFGMSR-----DIYSTDYYRVGGR 183
Query: 793 VKGTPGYLDPEYFLTHKLTDKSDVYSLGVVLLELLT-GMQPISHGKNIVREVNVARDSGM 851
++ PE L K T +SD++S GVVL E+ T G QP N +
Sbjct: 184 TMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSN----------TEA 233
Query: 852 VFSIIDNRMGSYPSECVERFVTLALRCCHDKPEHRPSMSDV 892
+ I R P C + C +P+ R + D+
Sbjct: 234 IECITQGRELERPRTCPPEVYAIMQGCWQREPQQRMVIKDI 274
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 96.5 bits (241), Expect = 7e-22
Identities = 72/287 (25%), Positives = 117/287 (40%), Gaps = 44/287 (15%)
Query: 633 VGQGGYGKVYKGIL-SDNTTVAIKRAEEGSLQGQN---EFLTEIKLLSRL-HHRNLVSLL 687
+G+G + V N AIK ++ L + E ++L+RL H ++ L
Sbjct: 9 IGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLY 68
Query: 688 GYCDEEGEQMLVYEFVPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPV 747
+E V E+ PNG L ++ R +L+ A + + YLH++ +
Sbjct: 69 YTFQDEENLYFVLEYAPNGELLQYI--RKYGSLDEKCTRFYAAEILLALEYLHSKG---I 123
Query: 748 FHRDIKASNILLDSNLNAKVADFGLSRLAPVLDDEG-----------------TMPTHVS 790
HRD+K NILLD +++ K+ DFG ++ VLD +
Sbjct: 124 IHRDLKPENILLDKDMHIKITDFGTAK---VLDPNSSPESNKGDATNIDSQIEKNRRRFA 180
Query: 791 TIVKGTPGYLDPEYFLTHKLTDK-SDVYSLGVVLLELLTGMQPISHGKNIVREVNVARDS 849
+ V GT Y+ PE L K K SD+++LG ++ ++LTG P G N E
Sbjct: 181 SFV-GTAEYVSPE-LLNEKPAGKSSDLWALGCIIYQMLTGKPPF-RGSN---EYL----- 229
Query: 850 GMVFSIIDNRMGSYPSECVERFVTLALRCCHDKPEHRPSMSDVVREL 896
F I S+P L + P+ R +++ EL
Sbjct: 230 --TFQKILKLEYSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDEL 274
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 97.0 bits (241), Expect = 1e-21
Identities = 86/329 (26%), Positives = 146/329 (44%), Gaps = 55/329 (16%)
Query: 633 VGQGGYGKVYK----GILSDN----TTVAIKR-AEEGSLQGQNEFLTEIKLLSRL-HHRN 682
+G+G +G+V GI D TVA+K ++ + + ++ ++E++++ + H+N
Sbjct: 20 LGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKN 79
Query: 683 LVSLLGYCDEEGEQMLVYEFVPNGTLRDWLSGR--------------TKENLNFAMRLRV 728
+++LLG C ++G ++ E+ G LR++L R +E L F +
Sbjct: 80 IINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSC 139
Query: 729 ALDSAKGILYLHTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSRLAPVLD-----DEG 783
A A+G+ YL A HRD+ A N+L+ + K+ADFGL+R +D G
Sbjct: 140 AYQVARGMEYL---ASQKCIHRDLAARNVLVTEDNVMKIADFGLARDVHNIDYYKKTTNG 196
Query: 784 TMPTHVSTIVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVLLELLTGMQPISHGKNIVREV 843
+P ++ PE T +SDV+S GV+L E+ T + + V E+
Sbjct: 197 RLPVK----------WMAPEALFDRVYTHQSDVWSFGVLLWEIFT-LGGSPYPGIPVEEL 245
Query: 844 NVARDSGMVFSIIDNRMGSYPSECVERFVTLALRCCHDKPEHRPSMSDVVRELENILKMF 903
G +RM P+ C + C H P RP+ +V +L+ +L +
Sbjct: 246 FKLLKEG-------HRMDK-PANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVLTV- 296
Query: 904 PETDTMFSKS---ESSSLLSGKSASTSSS 929
TD S E S S S+ SS
Sbjct: 297 TSTDEYLDLSVPFEQYSPGCPDSPSSCSS 325
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 95.5 bits (237), Expect = 1e-21
Identities = 85/299 (28%), Positives = 133/299 (44%), Gaps = 48/299 (16%)
Query: 619 ELAMATAYFSSSTQVGQGGYGKVYKGIL------SDNTTVAIKRAE---EGSLQGQNEFL 669
E+ ++T F ++G+ +GKVYKG L VAIK + EG L+ EF
Sbjct: 1 EINLSTVRFME--ELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLR--EEFK 56
Query: 670 TEIKLLSRLHHRNLVSLLGYCDEEGEQMLVYEFVPNGTLRDWLSGRT------------- 716
E + SRL H N+V LLG +E +++ + + L ++L R+
Sbjct: 57 HEAMMRSRLQHPNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKT 116
Query: 717 -KENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSRL 775
K L A + + A G+ +L + V H+D+ N+L+ LN K++D GL R
Sbjct: 117 VKSTLEPADFVHIVTQIAAGMEFLSSHH---VVHKDLATRNVLVFDKLNVKISDLGLFRE 173
Query: 776 APVLDDEGTMPTHVSTIVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVLLELLT-GMQPIS 834
D M + I ++ PE + K + SD++S GVVL E+ + G+QP
Sbjct: 174 VYAADYYKLMGNSLLPI-----RWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYC 228
Query: 835 HGKNIVREVNVARDSGMVFSIIDNR-MGSYPSECVERFVTLALRCCHDKPEHRPSMSDV 892
N +D V +I NR + P +C TL L C ++ P RP D+
Sbjct: 229 GYSN--------QD---VIEMIRNRQVLPCPDDCPAWVYTLMLECWNEFPSRRPRFKDI 276
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 96.2 bits (239), Expect = 2e-21
Identities = 81/309 (26%), Positives = 138/309 (44%), Gaps = 65/309 (21%)
Query: 633 VGQGGYGKVYK----GILSDN----TTVAIKR-AEEGSLQGQNEFLTEIKLLSRL-HHRN 682
+G+G +G+V + GI TVA+K + + + + ++E++L+ + H+N
Sbjct: 20 LGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKN 79
Query: 683 LVSLLGYCDEEGEQMLVYEFVPNGTLRDWLSGR--------------TKENLNFAMRLRV 728
+++LLG C +EG ++ E+ G LR++L R +E L+F +
Sbjct: 80 IINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSC 139
Query: 729 ALDSAKGILYLHTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSRLAPVLD-----DEG 783
A A+G+ YL + HRD+ A N+L+ + K+ADFGL+R +D G
Sbjct: 140 AYQVARGMEYLESRR---CIHRDLAARNVLVTEDNVMKIADFGLARGVHDIDYYKKTSNG 196
Query: 784 TMPTHVSTIVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVLLELLT-------GMQPISHG 836
+P VK ++ PE T +SDV+S G+++ E+ T G+ P+
Sbjct: 197 RLP------VK----WMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGI-PVEEL 245
Query: 837 KNIVREVNVARDSGMVFSIIDNRMGSYPSECVERFVTLALRCCHDKPEHRPSMSDVVREL 896
++RE +RM PS C L C H P RP+ +V L
Sbjct: 246 FKLLRE--------------GHRMDK-PSNCTHELYMLMRECWHAVPTQRPTFKQLVEAL 290
Query: 897 ENILKMFPE 905
+ +L E
Sbjct: 291 DKVLAAVSE 299
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 95.5 bits (237), Expect = 2e-21
Identities = 79/300 (26%), Positives = 136/300 (45%), Gaps = 53/300 (17%)
Query: 633 VGQGGYGKVYK----GILSDN----TTVAIKRAEEGSLQGQ-NEFLTEIKLLSRL-HHRN 682
+G+G +G+V GI D TVA+K ++ + + ++ ++E++++ + H+N
Sbjct: 23 LGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 82
Query: 683 LVSLLGYCDEEGEQMLVYEFVPNGTLRDWLSGR--------------TKENLNFAMRLRV 728
+++LLG C ++G ++ E+ G LR++L R E + F +
Sbjct: 83 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSC 142
Query: 729 ALDSAKGILYLHTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSRLAPVLD-----DEG 783
A+G+ YL A HRD+ A N+L+ N K+ADFGL+R +D G
Sbjct: 143 TYQVARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDVNNIDYYKKTTNG 199
Query: 784 TMPTHVSTIVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVLLELLT-GMQPISHGKNIVRE 842
+P ++ PE T +SDV+S GV++ E+ T G P + V E
Sbjct: 200 RLPVK----------WMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSP--YPGIPVEE 247
Query: 843 VNVARDSGMVFSIIDNRMGSYPSECVERFVTLALRCCHDKPEHRPSMSDVVRELENILKM 902
+ G +RM P+ C + C H P HRP+ +V +L+ IL +
Sbjct: 248 LFKLLKEG-------HRMDK-PANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRILTL 299
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 93.7 bits (234), Expect = 3e-21
Identities = 77/261 (29%), Positives = 114/261 (43%), Gaps = 33/261 (12%)
Query: 633 VGQGGYGKVYK-GILSDNTTVAIKRAEEGSLQGQNEF---LTEIKLLSRLHHRNLVSLLG 688
+G+G +GKV A+K ++ + + E LTE +LSR++H +V L
Sbjct: 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHY 60
Query: 689 YCDEEGEQMLVYEFVPNGTLRDWLS--GRTKENLNFAMRLRVALDSAKGILYLHTEAHPP 746
E + LV E+ P G L LS GR E R A + + YLH+
Sbjct: 61 AFQTEEKLYLVLEYAPGGELFSHLSKEGRFSEE---RARFYAA-EIVLALEYLHSLG--- 113
Query: 747 VFHRDIKASNILLDSNLNAKVADFGLSRLAPVLDDEGTMPTHVSTIVKGTPGYLDPEYFL 806
+ +RD+K NILLD++ + K+ DFGL++ L EG + +T GTP YL PE L
Sbjct: 114 IIYRDLKPENILLDADGHIKLTDFGLAK---ELSSEG---SRTNTFC-GTPEYLAPEVLL 166
Query: 807 THKLTDKSDVYSLGVVLLELLTGMQPISHGKNIVREVNVARDSGMVF-SIIDNRMGSYPS 865
D +SLGV+L E+LTG P A D ++ I+ + + +P
Sbjct: 167 GKGYGKAVDWWSLGVLLYEMLTGKPPFY-----------AEDRKEIYEKILKDPL-RFPE 214
Query: 866 ECVERFVTLALRCCHDKPEHR 886
L P R
Sbjct: 215 FLSPEARDLISGLLQKDPTKR 235
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 93.1 bits (232), Expect = 7e-21
Identities = 67/213 (31%), Positives = 104/213 (48%), Gaps = 31/213 (14%)
Query: 633 VGQGGYGKVYKGI-LSDNTTVAIKRAE-EGSLQGQNEFLTEIKLLSRLHHRNLVSLLGYC 690
+G+G +G+VYK I N VAIK + E + + EI+ LS+ + G
Sbjct: 9 IGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYG-S 67
Query: 691 DEEGEQM-LVYEFVPNGTLRDWL-SGRTKEN-LNFAMRLRVALDSAKGILYLHTEAHPPV 747
+G ++ ++ E+ G+ D L G+ E + F +R + G+ YLH E
Sbjct: 68 FLKGSKLWIIMEYCGGGSCLDLLKPGKLDETYIAFILR-----EVLLGLEYLHEEG---K 119
Query: 748 FHRDIKASNILLDSNLNAKVADFGLSRLAPVLDDEGTMPTHVSTIVK-----GTPGYLDP 802
HRDIKA+NILL + K+ADFG+S G + ST+ K GTP ++ P
Sbjct: 120 IHRDIKAANILLSEEGDVKLADFGVS---------GQL---TSTMSKRNTFVGTPFWMAP 167
Query: 803 EYFLTHKLTDKSDVYSLGVVLLELLTGMQPISH 835
E +K+D++SLG+ +EL G P+S
Sbjct: 168 EVIKQSGYDEKADIWSLGITAIELAKGEPPLSD 200
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 93.9 bits (233), Expect = 8e-21
Identities = 78/300 (26%), Positives = 138/300 (46%), Gaps = 53/300 (17%)
Query: 633 VGQGGYGKVYK----GILSDN----TTVAIKRAE-EGSLQGQNEFLTEIKLLSRL-HHRN 682
+G+G +G+V G+ + T VA+K + + + + ++ ++E++++ + H+N
Sbjct: 26 LGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 85
Query: 683 LVSLLGYCDEEGEQMLVYEFVPNGTLRDWLSGR--------------TKENLNFAMRLRV 728
+++LLG C ++G ++ E+ G LR++L R +E L+F +
Sbjct: 86 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSC 145
Query: 729 ALDSAKGILYLHTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSRLAPVLDDEGTMPTH 788
A A+G+ YL A HRD+ A N+L+ + K+ADFGL+R H
Sbjct: 146 AYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDI----------HH 192
Query: 789 VSTIVKGTPG-----YLDPEYFLTHKLTDKSDVYSLGVVLLELLT-GMQPISHGKNIVRE 842
+ K T G ++ PE T +SDV+S GV+L E+ T G P G +
Sbjct: 193 IDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYP-GVPVEEL 251
Query: 843 VNVARDSGMVFSIIDNRMGSYPSECVERFVTLALRCCHDKPEHRPSMSDVVRELENILKM 902
+ ++ +RM PS C + C H P RP+ +V +L+ IL +
Sbjct: 252 FKLLKEG--------HRMDK-PSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILAL 302
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 92.9 bits (231), Expect = 1e-20
Identities = 76/276 (27%), Positives = 127/276 (46%), Gaps = 39/276 (14%)
Query: 632 QVGQGGYGKVYKGILSDNTTV--AIKRAEEGSLQGQNEFLTEIKLLSRLHHRNLVSLLGY 689
++G G +GKVYK T + A K + S + +F+ EI +LS H N+V L
Sbjct: 12 ELGDGAFGKVYK-AQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEA 70
Query: 690 CDEEGEQMLVYEFVPNGTLRDWL----SGRTKENLNFAMRLRVALDSAKGILYLHTEAHP 745
E + ++ EF G L + G T+ + + R + + +LH+
Sbjct: 71 YFYENKLWILIEFCDGGALDSIMLELERGLTEPQIRYVCR-----QMLEALNFLHSHK-- 123
Query: 746 PVFHRDIKASNILLDSNLNAKVADFGLSRLAPVLDDEGTMPTHVSTIVKGTPGYLDPEYF 805
V HRD+KA NILL + + K+ADFG+S ++ T+ + I GTP ++ PE
Sbjct: 124 -VIHRDLKAGNILLTLDGDVKLADFGVSAK-----NKSTLQKRDTFI--GTPYWMAPEVV 175
Query: 806 LTHKLTD-----KSDVYSLGVVLLELLTGMQPISHGKNIVREVNVARDSGMVFSII--DN 858
D K+D++SLG+ L+E L M+P H E+N R ++ I+ +
Sbjct: 176 ACETFKDNPYDYKADIWSLGITLIE-LAQMEPPHH------ELNPMR---VLLKILKSEP 225
Query: 859 RMGSYPSECVERFVTLALRCCHDKPEHRPSMSDVVR 894
PS+ F C P+ RP+ +++++
Sbjct: 226 PTLDQPSKWSSSFNDFLKSCLVKDPDDRPTAAELLK 261
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 93.2 bits (232), Expect = 1e-20
Identities = 62/226 (27%), Positives = 99/226 (43%), Gaps = 35/226 (15%)
Query: 632 QVGQGGYGKVYKGI-LSDNTTVAIKRAEEGSLQG--QNEFLTEIKLLSRLHHRNLVSLLG 688
++G+G YG VYK VAIK+ + L EIKLL L+H N++ LL
Sbjct: 6 KIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLD 65
Query: 689 YCDEEGEQMLVYEFVPNGTLRDWLSGRTKENLNFAMRLR---VALDSAKGILYL------ 739
+G+ LV+EF+ +L ++ R + K LY
Sbjct: 66 VFRHKGDLYLVFEFM-------------DTDLYKLIKDRQRGLPESLIKSYLYQLLQGLA 112
Query: 740 HTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSRLAPVLDDEGTMPTHVSTIVKGTPGY 799
+H + HRD+K N+L+++ K+ADFGL+R +V T Y
Sbjct: 113 FCHSHG-ILHRDLKPENLLINTEGVLKLADFGLARSFGS--PVRPYTHYVVTR-----WY 164
Query: 800 LDPEYFLTHKLTDKS-DVYSLGVVLLELLTGMQPISHGKNIVREVN 844
PE L K D++S+G + ELL+ +P+ GK+ + ++
Sbjct: 165 RAPELLLGDKGYSTPVDIWSVGCIFAELLSR-RPLFPGKSEIDQLF 209
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 92.5 bits (230), Expect = 1e-20
Identities = 67/210 (31%), Positives = 113/210 (53%), Gaps = 25/210 (11%)
Query: 632 QVGQGGYGKVYK-GILSDNTTVAIKRAEEGSLQGQNE---FLTEIKLLSRLHHRNLVSLL 687
++G+G YG VYK LSDN A+K + GS+ Q E + EI++L+ ++H N++S
Sbjct: 7 KLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMS-QKEREDAVNEIRILASVNHPNIIS-- 63
Query: 688 GYCDE--EGEQM-LVYEFVPNGTLRDWLSGRTKENLNFAMRL--RVALDSAKGILYLHTE 742
Y + +G ++ +V E+ P G L +S R K+ + R+ + +G+ LH +
Sbjct: 64 -YKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQ 122
Query: 743 AHPPVFHRDIKASNILLDSNLNAKVADFGLSRLAPVLDDEGTMPTHVSTIVKGTPGYLDP 802
+ HRD+K++NILL +N K+ D G+S++ + M + GTP Y+ P
Sbjct: 123 K---ILHRDLKSANILLVANDLVKIGDLGISKVL-----KKNM----AKTQIGTPHYMAP 170
Query: 803 EYFLTHKLTDKSDVYSLGVVLLELLTGMQP 832
E + + KSD++SLG +L E+ T P
Sbjct: 171 EVWKGRPYSYKSDIWSLGCLLYEMATFAPP 200
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 91.5 bits (228), Expect = 2e-20
Identities = 70/220 (31%), Positives = 108/220 (49%), Gaps = 29/220 (13%)
Query: 633 VGQGGYGKVY---KGILSDNTTVAIKRAEEGSLQGQNEF---LTEIKLLSRLHHRNLVSL 686
+ +G YG+V+ K D AIK ++ + +N+ LTE +LS+ +V L
Sbjct: 1 ISKGAYGRVFLAKKKSTGD--IYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKL 58
Query: 687 LGYCDEEGEQML--VYEFVPNGTLRDWLS--GRTKENL--NFAMRLRVALDSAKGILYLH 740
Y +G++ L V E++P G L L G E++ + + +AL+ YLH
Sbjct: 59 --YYSFQGKKNLYLVMEYLPGGDLASLLENVGSLDEDVARIYIAEIVLALE------YLH 110
Query: 741 TEAHPPVFHRDIKASNILLDSNLNAKVADFGLSRLAPV--LDDEGTMPTHVSTIVKGTPG 798
+ + HRD+K NIL+DSN + K+ DFGLS++ V + IV GTP
Sbjct: 111 SNG---IIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIV-GTPD 166
Query: 799 YLDPEYFLTHKLTDKSDVYSLGVVLLELLTGMQPISHGKN 838
Y+ PE L + D +SLG +L E L G+ P HG+
Sbjct: 167 YIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPF-HGET 205
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 91.4 bits (227), Expect = 3e-20
Identities = 79/286 (27%), Positives = 118/286 (41%), Gaps = 59/286 (20%)
Query: 633 VGQGGYGKVYKGI-LSDNTTVAIKRAEEGSLQGQNEFLTEIKLLSRLHHRNLVSLLGYCD 691
+G+G YG VY LS +AIK E + EI L S L HRN+V LG
Sbjct: 16 LGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDS 75
Query: 692 EEGEQMLVYEFVPNGTLRD-----WLSGRTKEN-LNFAMRLRVALDSAKGILYLHTEAHP 745
E G + E VP G+L W + E + F + +G+ YLH
Sbjct: 76 ENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTK-----QILEGLKYLHDNQ-- 128
Query: 746 PVFHRDIKASNILLDSNLNA-KVADFGLS-RLAPVLDDEGTMPTHVSTIVKGTPGYLDPE 803
+ HRDIK N+L+++ K++DFG S RLA G P + GT Y+ PE
Sbjct: 129 -IVHRDIKGDNVLVNTYSGVVKISDFGTSKRLA------GINP--CTETFTGTLQYMAPE 179
Query: 804 YFLTHKLTDK--------SDVYSLGVVLLELLTGMQPISHGKNIVREVNVARDSGMVFSI 855
+ DK +D++SLG ++E+ TG P + + +F
Sbjct: 180 ------VIDKGPRGYGAPADIWSLGCTIVEMATGKPPF---------IELGEPQAAMF-- 222
Query: 856 IDNRMGSY------PSECVERFVTLALRCCHDKPEHRPSMSDVVRE 895
++G + P LRC P+ R S D++++
Sbjct: 223 ---KVGMFKIHPEIPESLSAEAKNFILRCFEPDPDKRASAHDLLQD 265
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 90.8 bits (225), Expect = 4e-20
Identities = 78/271 (28%), Positives = 127/271 (46%), Gaps = 32/271 (11%)
Query: 633 VGQGGYGKV----YKGILSDNTTVAIKRA--EEGSLQGQNEFLTEIKLLSRLHHRNLVSL 686
VG+G YG+V ++ +D IK+ S + + E +LLS+L H N+V+
Sbjct: 8 VGKGSYGEVSLVRHR---TDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAY 64
Query: 687 L-GYCDEEGEQMLVYEFVPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHP 745
+ E+G +V F G L L + + L + + A + YLH E H
Sbjct: 65 RESWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLH-EKH- 122
Query: 746 PVFHRDIKASNILLDSNLNAKVADFGLSRLAPVLDDEGTMPTHVSTIVKGTPGYLDPEYF 805
+ HRD+K N+ L KV D G++R VL+++ M ST++ GTP Y+ PE F
Sbjct: 123 -ILHRDLKTQNVFLTRTNIIKVGDLGIAR---VLENQCDM---ASTLI-GTPYYMSPELF 174
Query: 806 LTHKLTDKSDVYSLGVVLLELLTGMQPISHGKNIVREVNVARD-SGMVFSIIDNRMGSYP 864
KSDV++LG + E+ T + H N A+D + +V+ II+ ++ P
Sbjct: 175 SNKPYNYKSDVWALGCCVYEMAT----LKHAFN-------AKDMNSLVYRIIEGKLPPMP 223
Query: 865 SECVERFVTLALRCCHDKPEHRPSMSDVVRE 895
+ L +PE RPS+ ++R+
Sbjct: 224 KDYSPELGELIATMLSKRPEKRPSVKSILRQ 254
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 91.5 bits (227), Expect = 4e-20
Identities = 78/265 (29%), Positives = 119/265 (44%), Gaps = 33/265 (12%)
Query: 652 VAIKRAEEGSLQGQNEFLTEIKLLSRLHHRNLVSLLGYCDEEGEQMLVYEFVPNGTLRDW 711
V I R + + +N+FL E+K+LSRL N++ LLG C +E ++ E++ NG L +
Sbjct: 51 VKILRPD-ANKNARNDFLKEVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQF 109
Query: 712 LSGRTKEN-----------------LNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKA 754
LS ++ ++++ L VAL A G+ YL + HRD+
Sbjct: 110 LSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLN---FVHRDLAT 166
Query: 755 SNILLDSNLNAKVADFGLSRLAPVLDDEGTMPTHVSTIVKGTPGYLDPEYFLTHKLTDKS 814
N L+ NL K+ADFG+SR D V I ++ E L K T S
Sbjct: 167 RNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPI-----RWMAWECILMGKFTTAS 221
Query: 815 DVYSLGVVLLELLTGMQPISHGKNIVREVNVARDSGMVFSIIDNRMGSY---PSECVERF 871
DV++ GV L E+L + +G+ + + V ++G F D Y P C +
Sbjct: 222 DVWAFGVTLWEILMLCKEQPYGE--LTDEQVIENAGEFFR--DQGRQVYLFRPPPCPQGL 277
Query: 872 VTLALRCCHDKPEHRPSMSDVVREL 896
L L+C RPS SD+ L
Sbjct: 278 YELMLQCWSRDCRERPSFSDIHAFL 302
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 90.7 bits (225), Expect = 5e-20
Identities = 75/277 (27%), Positives = 124/277 (44%), Gaps = 23/277 (8%)
Query: 632 QVGQGGYGKVYKG---ILSDNTTVAIKRAEE-GSLQGQNEFLTEIKLLSRLHHRNLVSLL 687
++G G +GKV G V +K + Q FL E++ L+H N++ L
Sbjct: 2 EIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCL 61
Query: 688 GYCDEEGEQMLVYEFVPNGTLRDWL-SGRTKENLNFAMRL--RVALDSAKGILYLHTEAH 744
G C E +LV EF P G L+++L S R + R+A + A G+L+LH +A
Sbjct: 62 GQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLH-QAD 120
Query: 745 PPVFHRDIKASNILLDSNLNAKVADFGLSRLAPVLDDEGTMPTHVSTIVKGTPGYLDP-- 802
H D+ N L ++L+ K+ D+GL+ D T H + P ++
Sbjct: 121 --FIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAVPLRWLAPELVEIRG 178
Query: 803 EYFLTHKLTDKSDVYSLGVVLLELLT-GMQPISHGKN--IVREVNVARDSGMVFSIIDNR 859
+ L T KS+++SLGV + EL T QP + ++++V +D + +D +
Sbjct: 179 QDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQVVREQDIKLPKPQLDLK 238
Query: 860 MGSYPSECVERFVTLALRCCHDKPEHRPSMSDVVREL 896
+R+ + C D PE RP+ +V L
Sbjct: 239 YS-------DRWYEVMQFCWLD-PETRPTAEEVHELL 267
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 90.3 bits (224), Expect = 6e-20
Identities = 64/214 (29%), Positives = 105/214 (49%), Gaps = 24/214 (11%)
Query: 633 VGQGGYGKVYKGI-LSDNTTVAIKRAEEGSLQGQNE---------FLTEIKLLSRLHHRN 682
+G G +G VY G+ S +A+K+ E S+ ++ EI LL L H N
Sbjct: 8 IGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHEN 67
Query: 683 LVSLLGYCDEEGEQMLVYEFVPNGTLRDWLS--GRTKENL--NFAMRLRVALDSAKGILY 738
+V LG + + E+VP G++ L+ G +E L NF ++ KG+ Y
Sbjct: 68 IVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQI------LKGLNY 121
Query: 739 LHTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSRLAPVLDDEGTMPTHVSTIVKGTPG 798
LH + HRDIK +NIL+D+ K++DFG+S+ ++ +G+
Sbjct: 122 LHNRG---IIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSL-QGSVF 177
Query: 799 YLDPEYFLTHKLTDKSDVYSLGVVLLELLTGMQP 832
++ PE T K+D++SLG +++E+LTG P
Sbjct: 178 WMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHP 211
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 90.1 bits (224), Expect = 6e-20
Identities = 62/209 (29%), Positives = 96/209 (45%), Gaps = 27/209 (12%)
Query: 633 VGQGGYGKVYKGILSDNTTV-AIK---RAEEGSLQGQNEFLTEIKLLSRLHHRNLVSL-L 687
+G+G +GKV D + A+K + + L E ++L L+H LV+L
Sbjct: 8 IGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWY 67
Query: 688 GYCDEEGEQMLVYEFVPNGTLRDWLSGRTKENLN----FAMRLRVALDSAKGILYLHTEA 743
+ DEE ++V + + G LR LS + K + + + +AL+ YLH++
Sbjct: 68 SFQDEENMYLVV-DLLLGGDLRYHLSQKVKFSEEQVKFWICEIVLALE------YLHSKG 120
Query: 744 HPPVFHRDIKASNILLDSNLNAKVADFGLSRLAPVLDDEGTMPTHVSTIVKGTPGYLDPE 803
+ HRDIK NILLD + + DF ++ T+ T S GTPGY+ PE
Sbjct: 121 ---IIHRDIKPDNILLDEQGHVHITDFNIATKVT----PDTLTTSTS----GTPGYMAPE 169
Query: 804 YFLTHKLTDKSDVYSLGVVLLELLTGMQP 832
+ D +SLGV E L G +P
Sbjct: 170 VLCRQGYSVAVDWWSLGVTAYECLRGKRP 198
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 90.0 bits (223), Expect = 8e-20
Identities = 74/277 (26%), Positives = 126/277 (45%), Gaps = 28/277 (10%)
Query: 632 QVGQGGYGKVYKGIL---SDNTTVAIKRAEEGSLQG-QNEFLTEIKLLSRLHHRNLVSLL 687
++G G +G V KG+ VAIK + + + ++E + E +++ +L + +V ++
Sbjct: 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMI 61
Query: 688 GYCDEEGEQMLVYEFVPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPV 747
G C+ E MLV E G L +LSG+ K+ + + + + + G+ YL +
Sbjct: 62 GVCEAEA-LMLVMEMASGGPLNKFLSGK-KDEITVSNVVELMHQVSMGMKYLEGKN---F 116
Query: 748 FHRDIKASNILLDSNLNAKVADFGLSRLAPVLDDEGTMPTHVSTIVKGTPGYLDPEYFLT 807
HRD+ A N+LL + AK++DFGLS+ D + +K + PE
Sbjct: 117 VHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGKWPLK----WYAPECINF 172
Query: 808 HKLTDKSDVYSLGVVLLELLT-GMQPISHGKNIVREVNVARDSGMVFSIIDNRMGSYPSE 866
K + +SDV+S G+ + E + G +P K EV M F R+ P+E
Sbjct: 173 RKFSSRSDVWSYGITMWEAFSYGQKPYKKMKG--PEV-------MSFIEQGKRLDC-PAE 222
Query: 867 CVERFVTLALRCCHDKPEHRPSMSDVVRELENILKMF 903
C L C K E RP+ + V E ++ +
Sbjct: 223 CPPEMYALMKDCWIYKWEDRPNFAKV----EERMRTY 255
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 90.2 bits (224), Expect = 8e-20
Identities = 74/284 (26%), Positives = 119/284 (41%), Gaps = 35/284 (12%)
Query: 631 TQVGQGGYGKVYKGILS------DNTTVAIKRAEEGSLQG-QNEFLTEIKLLSRLHHRNL 683
T +G+G +G+V+ T V +K ++ + Q+EF E+ + +L H+N+
Sbjct: 11 TTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNV 70
Query: 684 VSLLGYCDEEGEQMLVYEFVPNGTLRDWL-------SGRTKENLNFAMRLRVALDSAKGI 736
V LLG C E ++ E+ G L+ +L L+ ++ + A G+
Sbjct: 71 VRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGM 130
Query: 737 LYLHTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSRLAPVLDDEGTMPTHVSTIVKGT 796
+L A HRD+ A N L+ S KV+ LS+ V + E + ++
Sbjct: 131 DHLSN-AR--FVHRDLAARNCLVSSQREVKVSLLSLSK--DVYNSE--YYKLRNALI--- 180
Query: 797 P-GYLDPEYFLTHKLTDKSDVYSLGVVLLELLT-GMQPISHGKNIVREVNVARDSGMVFS 854
P +L PE + KSDV+S GV++ E+ T G P EV +G +
Sbjct: 181 PLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELP--FYGLSDEEVLNRLQAGKL-- 236
Query: 855 IIDNRMGSYPSECVERFVTLALRCCHDKPEHRPSMSDVVRELEN 898
P C R L RC P+ RPS S++V L
Sbjct: 237 -----ELPVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALGE 275
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 90.1 bits (224), Expect = 1e-19
Identities = 80/259 (30%), Positives = 116/259 (44%), Gaps = 35/259 (13%)
Query: 652 VAIKR-AEEGSLQGQNEFLTEIKLLSRLHHRNLVSLLGYCDEEGEQMLVYEFVPNGTLRD 710
VA+K + S + +FL E+K+LSRL N+ LLG C + ++ E++ NG L
Sbjct: 49 VAVKVLRPDASDNAREDFLKEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQ 108
Query: 711 WLSGRTKEN---------LNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDS 761
+L E L+F+ L +A A G+ YL E+ V HRD+ N L+
Sbjct: 109 FLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYL--ESLNFV-HRDLATRNCLVGK 165
Query: 762 NLNAKVADFGLSRLAPVLDD---EGTMPTHVSTIVKGTPGYLDPEYFLTHKLTDKSDVYS 818
N K+ADFG+SR D +G P + ++ E L K T KSDV++
Sbjct: 166 NYTIKIADFGMSRNLYSSDYYRVQGRAPLPIR--------WMAWESVLLGKFTTKSDVWA 217
Query: 819 LGVVLLELLT--GMQPISHGKN---IVREVNVARDSGMVFSIIDNRMGSYPSECVERFVT 873
GV L E+LT QP H + I + RD G I R + P + E
Sbjct: 218 FGVTLWEILTLCREQPYEHLTDQQVIENAGHFFRDDGR--QIYLPRPPNCPKDIYE---- 271
Query: 874 LALRCCHDKPEHRPSMSDV 892
L L C E RP+ ++
Sbjct: 272 LMLECWRRDEEDRPTFREI 290
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 89.8 bits (223), Expect = 1e-19
Identities = 82/289 (28%), Positives = 131/289 (45%), Gaps = 42/289 (14%)
Query: 627 FSSSTQVGQGGYGKVYKGILSDNTT-----VAIKRAEEGSLQGQ-NEFLTEIKLLSRLHH 680
+ S + +G +G+++ GIL D V +K ++ + + Q L E LL L H
Sbjct: 8 VTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSH 67
Query: 681 RNLVSLLGYCDEEGEQ-MLVYEFVPNGTLRDWL-SGR-TKENLNFAMRLR----VALDSA 733
+N++ +L C E+GE ++Y ++ G L+ +L R + N A+ + +A+ A
Sbjct: 68 QNILPILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIA 127
Query: 734 KGILYLHTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSR-LAP----VLDDEGTMPTH 788
G+ YLH V H+DI A N ++D L K+ D LSR L P L D P
Sbjct: 128 CGMSYLHKRG---VIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLGDNENRP-- 182
Query: 789 VSTIVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVLLELLT-GMQPISHGKNIVREVNVAR 847
VK ++ E + + + SDV+S GV+L EL+T G P E++
Sbjct: 183 ----VK----WMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYV-------EIDPFE 227
Query: 848 DSGMVFSIIDNRMGSYPSECVERFVTLALRCCHDKPEHRPSMSDVVREL 896
M + D + P C + + C PE RPS S +V+ L
Sbjct: 228 ---MAAYLKDGYRLAQPINCPDELFAVMACCWALDPEERPSFSQLVQCL 273
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 88.9 bits (221), Expect = 2e-19
Identities = 74/275 (26%), Positives = 119/275 (43%), Gaps = 50/275 (18%)
Query: 632 QVGQGGYGKVYKG-ILSDNTTVAIKRAE-EGSLQGQNEFLTEIKLLSRLHHRNLVSLLGY 689
++G G G V K +A+K E + Q + L E+ +L + + +V G
Sbjct: 8 ELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGA 67
Query: 690 CDEEGEQMLVYEFVPNGTLRDWL---SGRTKENLNFAMRL-RVALDSAKGILYLHTEAHP 745
G+ + E++ G+L L GR E + L ++A+ KG+ YLH +
Sbjct: 68 FYNNGDISICMEYMDGGSLDKILKEVQGRIPERI-----LGKIAVAVLKGLTYLHEKHK- 121
Query: 746 PVFHRDIKASNILLDSNLNAKVADFGLSRLAPVLDDEGTMPTHVSTIVK---GTPGYLDP 802
+ HRD+K SNIL++S K+ DFG+S G + V+++ K GT Y+ P
Sbjct: 122 -IIHRDVKPSNILVNSRGQIKLCDFGVS---------GQL---VNSLAKTFVGTSSYMAP 168
Query: 803 EYFLTHKLTDKSDVYSLGVVLLELLTGMQPISHGKNIVREVNVARDSGMVFS----IIDN 858
E + + KSD++SLG+ L+EL TG P +F I++
Sbjct: 169 ERIQGNDYSVKSDIWSLGLSLIELATGRFPYP---------PENDPPDGIFELLQYIVNE 219
Query: 859 R-----MGSYPSECVERFVTLALRCCHDKPEHRPS 888
G + + + FV L C P RPS
Sbjct: 220 PPPRLPSGKFSPDFQD-FVNL---CLIKDPRERPS 250
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 88.6 bits (219), Expect = 2e-19
Identities = 77/270 (28%), Positives = 125/270 (46%), Gaps = 27/270 (10%)
Query: 633 VGQGGYGKVYKGILSDN-TTVAIKRAE--EGSLQGQNE---FLTEIKLLSRLHHRNLVSL 686
+GQG +G+VY D +A K+ + S + E EI+LL L H +V
Sbjct: 10 LGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQY 69
Query: 687 LGYCDEEGEQMLV--YEFVPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAH 744
G + E+ L E++P G+++D L + L ++ + +G+ YLH+
Sbjct: 70 YGCLRDRAEKTLTIFMEYMPGGSVKDQL--KAYGALTESVTRKYTRQILEGMSYLHSNM- 126
Query: 745 PPVFHRDIKASNILLDSNLNAKVADFGLSRLAPVLDDEGTMPTHVSTIVKGTPGYLDPEY 804
+ HRDIK +NIL DS N K+ DFG S+ + GT V+ GTP ++ PE
Sbjct: 127 --IVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVT----GTPYWMSPEV 180
Query: 805 FLTHKLTDKSDVYSLGVVLLELLTGMQPISHGKNIVREVNVARDSGMVFSIIDNRMGSYP 864
K+DV+SLG ++E+LT P + + + +A + ++ S+
Sbjct: 181 ISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFKIATQP------TNPQLPSHI 234
Query: 865 SECVERFVTLALRCCHDKPEHRPSMSDVVR 894
SE F L C + HRPS +++R
Sbjct: 235 SEHARDF----LGCIFVEARHRPSAEELLR 260
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 93.4 bits (232), Expect = 3e-19
Identities = 63/193 (32%), Positives = 93/193 (48%), Gaps = 15/193 (7%)
Query: 652 VAIKRAEEGSLQGQNE---FLTEIKLLSRLHHRNLVSLL--GYCDEEGEQMLVYEFVPNG 706
VAIK + + +++ F E L +RL+H N+V+LL G G V+E+VP
Sbjct: 6 VAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEA-PPGLLFAVFEYVPGR 64
Query: 707 TLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILL---DSNL 763
TLR+ L+ L R+ L + H + + HRD+K NI++
Sbjct: 65 TLREVLA--ADGALPAGETGRLMLQVLDALACAHNQG---IVHRDLKPQNIMVSQTGVRP 119
Query: 764 NAKVADFGLSRLAPVLDDEGTMPTHVSTIVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVL 823
+AKV DFG+ L P + D +T V GTP Y PE +T SD+Y+ G++
Sbjct: 120 HAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVTPNSDLYAWGLIF 179
Query: 824 LELLTGMQPISHG 836
LE LTG Q + G
Sbjct: 180 LECLTG-QRVVQG 191
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 88.3 bits (219), Expect = 3e-19
Identities = 72/283 (25%), Positives = 133/283 (46%), Gaps = 44/283 (15%)
Query: 633 VGQGGYGKVYKGILSDNTTV-AIKRAEEGSLQGQNE----------FLTEIKLLSRLHHR 681
+G+G YG+VY + + A+K+ E + +EI+ L L H
Sbjct: 9 IGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHL 68
Query: 682 NLVSLLGYCDEEGEQMLVYEFVPNGTLRDWLS--GRTKENLNFAMRLRVALDSAKGILYL 739
N+V LG+ E + E+VP G++ L GR +E L +V +G+ YL
Sbjct: 69 NIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVL----EGLAYL 124
Query: 740 HTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSR-LAPVLDDEGTMPTHVSTIVKGTPG 798
H++ + HRD+KA N+L+D++ K++DFG+S+ + D++ M ++G+
Sbjct: 125 HSKG---ILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMS------MQGSVF 175
Query: 799 YLDPEYFLTHK--LTDKSDVYSLGVVLLELLTGMQPISHGKNIVREVNVARDSGMVFSII 856
++ PE ++ + K D++SLG V+LE+ G +P S + I +F +
Sbjct: 176 WMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAI----------AAMFKLG 225
Query: 857 DNRMG-SYPSECVERFVTLALR----CCHDKPEHRPSMSDVVR 894
+ R P + +AL C P++RP+ ++++
Sbjct: 226 NKRSAPPIPPDVSMNLSPVALDFLNACFTINPDNRPTARELLQ 268
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 89.0 bits (220), Expect = 4e-19
Identities = 70/212 (33%), Positives = 107/212 (50%), Gaps = 27/212 (12%)
Query: 633 VGQGGYGKVYKGI-LSDNTTVAIKRA-----EEGSLQGQNEFLTEIKLLSRLHHRNLVSL 686
+G G +G VYKGI + + TV I A E + EF+ E +++ + H +LV L
Sbjct: 15 LGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRL 74
Query: 687 LGYCDEEGEQMLVYEFVPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPP 746
LG C Q LV + +P+G L D++ K+N+ + L + AKG++YL
Sbjct: 75 LGVCLSPTIQ-LVTQLMPHGCLLDYVH-EHKDNIGSQLLLNWCVQIAKGMMYLEERR--- 129
Query: 747 VFHRDIKASNILLDSNLNAKVADFGLSRLAPVLDDE-----GTMPTHVSTIVKGTPGYLD 801
+ HRD+ A N+L+ S + K+ DFGL+RL + E G MP ++
Sbjct: 130 LVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIK----------WMA 179
Query: 802 PEYFLTHKLTDKSDVYSLGVVLLELLT-GMQP 832
E K T +SDV+S GV + EL+T G +P
Sbjct: 180 LECIHYRKFTHQSDVWSYGVTIWELMTFGGKP 211
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 87.6 bits (217), Expect = 4e-19
Identities = 71/271 (26%), Positives = 119/271 (43%), Gaps = 37/271 (13%)
Query: 633 VGQGGYGKVYKGI-LSDNTTVAIKR--AEEGSLQGQNEFLTEIKLLSRLHHRNLVSLLGY 689
VG+G +G V+ +D V IK+ E+ + + E ++L L H N++
Sbjct: 8 VGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYEN 67
Query: 690 CDEEGEQMLVYEFVPNGTLRDWLSGR------TKENLNFAMRLRVALDSAKGILYLHTEA 743
E+ M+V E+ P GTL +++ R L+F +++ +AL ++HT+
Sbjct: 68 FLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALH------HVHTKL 121
Query: 744 HPPVFHRDIKASNILLDSNLNA-KVADFGLSRLAPVLDDEGTMPTHVSTIVKGTPGYLDP 802
+ HRD+K NILLD + K+ DFG+S++ + + T+V GTP Y+ P
Sbjct: 122 ---ILHRDLKTQNILLDKHKMVVKIGDFGISKIL-------SSKSKAYTVV-GTPCYISP 170
Query: 803 EYFLTHKLTDKSDVYSLGVVLLELLTGMQPISHGKNIVREVNVARDSGMVFSIIDNRMGS 862
E KSD+++LG VL EL + + R A +V I+
Sbjct: 171 ELCEGKPYNQKSDIWALGCVLYELAS----------LKRAFEAANLPALVLKIMSGTFAP 220
Query: 863 YPSECVERFVTLALRCCHDKPEHRPSMSDVV 893
L L + P RP +S ++
Sbjct: 221 ISDRYSPDLRQLILSMLNLDPSKRPQLSQIM 251
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 88.1 bits (218), Expect = 4e-19
Identities = 78/281 (27%), Positives = 123/281 (43%), Gaps = 37/281 (13%)
Query: 633 VGQGGYGKVYKGI-LSDNTTVAIKRA-----EEGSLQGQNEFLTEIKLLSRLHHRNLVSL 686
+G G +G VYKGI + D V I A E S + E L E +++ + + L
Sbjct: 15 LGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRL 74
Query: 687 LGYCDEEGEQMLVYEFVPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPP 746
LG C Q LV + +P G L D++ K+ + L + AKG+ YL
Sbjct: 75 LGICLTSTVQ-LVTQLMPYGCLLDYVR-ENKDRIGSQDLLNWCVQIAKGMSYLEEVR--- 129
Query: 747 VFHRDIKASNILLDSNLNAKVADFGLSRLAPVLDDE-----GTMPTHVSTIVKGTPGYLD 801
+ HRD+ A N+L+ S + K+ DFGL+RL + + E G +P ++
Sbjct: 130 LVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIK----------WMA 179
Query: 802 PEYFLTHKLTDKSDVYSLGVVLLELLT-GMQPISHGKNIVREVNVARDSGMVFSIIDNRM 860
E L + T +SDV+S GV + EL+T G +P RE+ + G R+
Sbjct: 180 LESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIP--AREIPDLLEKG-------ERL 230
Query: 861 GSYPSECVERFVTLALRCCHDKPEHRPSMSDVVRELENILK 901
P C + ++C E RP ++V E + +
Sbjct: 231 -PQPPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRMAR 270
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 89.0 bits (221), Expect = 5e-19
Identities = 74/217 (34%), Positives = 108/217 (49%), Gaps = 29/217 (13%)
Query: 627 FSSSTQVGQGGYGKVYKGILSD-NTTVAIKRAEEGSLQGQNE---FLTEIKLLSRLHHRN 682
F TQVGQGGYG+V+ D VA+KR ++ L NE LTE +L+
Sbjct: 3 FQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEW 62
Query: 683 LVSLLGYCDEEGEQM-LVYEFVPNGTLRDWLS--GRTKEN-LNFAM-RLRVALDSAKGIL 737
LV LL Y ++ E + L E+VP G R L+ G E+ F M + A+D+ +
Sbjct: 63 LVKLL-YAFQDDEYLYLAMEYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDALHELG 121
Query: 738 YLHTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSRLAPVLDDEGTMPTHVSTIVKGTP 797
Y+H RD+K N L+D++ + K+ DFGLS+ G + T+ +++V G+P
Sbjct: 122 YIH---------RDLKPENFLIDASGHIKLTDFGLSK--------GIV-TYANSVV-GSP 162
Query: 798 GYLDPEYFLTHKLTDKSDVYSLGVVLLELLTGMQPIS 834
Y+ PE D +SLG +L E L G P S
Sbjct: 163 DYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFS 199
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 87.7 bits (218), Expect = 6e-19
Identities = 72/230 (31%), Positives = 99/230 (43%), Gaps = 52/230 (22%)
Query: 633 VGQGGYGKVYKGILSD-NTTVAIK----RAEEGSLQGQNEFLTEIKLLSRL-HHRNLVSL 686
+G+G YGKVYK VAIK +E + E E +L + +H N+ +
Sbjct: 14 IGEGTYGKVYKARHKKTGQLVAIKIMDIIEDE-----EEEIKEEYNILRKYSNHPNIATF 68
Query: 687 LG------YCDEEGEQMLVYEFVPNGTLRDWLSG------RTKENLNFAMRLRVALDSAK 734
G + + LV E G++ D + G R KE A LR L +
Sbjct: 69 YGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEW-IAYILRETL---R 124
Query: 735 GILYLHTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSRLAPVLDDEGTMPTHVSTIVK 794
G+ YLH E V HRDIK NILL N K+ DFG+S LD ST+ +
Sbjct: 125 GLAYLH-ENK--VIHRDIKGQNILLTKNAEVKLVDFGVSAQ---LD---------STLGR 169
Query: 795 -----GTPGYLDPE-----YFLTHKLTDKSDVYSLGVVLLELLTGMQPIS 834
GTP ++ PE +SDV+SLG+ +EL G P+
Sbjct: 170 RNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLC 219
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 88.7 bits (221), Expect = 6e-19
Identities = 63/224 (28%), Positives = 97/224 (43%), Gaps = 53/224 (23%)
Query: 632 QVGQGGYGKVYKGI-LSDNTTVAIKRAEEGSLQGQNEF---------LTEIKLLSRLHHR 681
+G G YG V + VAIK+ N F L EIKLL L H
Sbjct: 7 PIGSGAYGVVCSAVDKRTGRKVAIKKI-------SNVFDDLIDAKRILREIKLLRHLRHE 59
Query: 682 NLVSLL-----GYCDEEGEQMLVYEFVPNGTLRDWLSGRTKENLNFAMRLRVALDSA--- 733
N++ LL ++ + +V E + +L+ ++ L
Sbjct: 60 NIIGLLDILRPPSPEDFNDVYIVTELMET-------------DLHKVIKSPQPLTDDHIQ 106
Query: 734 -------KGILYLHTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSRLAPVLDDEGTMP 786
+G+ YLH+ A+ V HRD+K SNIL++SN + K+ DFGL+R +D +
Sbjct: 107 YFLYQILRGLKYLHS-AN--VIHRDLKPSNILVNSNCDLKICDFGLAR---GVDPDEDEK 160
Query: 787 THVSTIVKGTPGYLDPEYFLT-HKLTDKSDVYSLGVVLLELLTG 829
++ V T Y PE L+ + T D++S+G + ELLT
Sbjct: 161 GFLTEYVV-TRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTR 203
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 87.4 bits (216), Expect = 7e-19
Identities = 66/211 (31%), Positives = 103/211 (48%), Gaps = 23/211 (10%)
Query: 633 VGQGGYGKVYKGILSDN-TTVAIKRAE------EGSLQGQNEFLTEIKLLSRLHHRNLVS 685
+GQG +G+VY +D +A+K+ + E S + N EI+LL L H +V
Sbjct: 10 LGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKE-VNALECEIQLLKNLLHERIVQ 68
Query: 686 LLGYCDEEGEQML--VYEFVPNGTLRDWLS--GRTKENLNFAMRLRVALDSAKGILYLHT 741
G + E+ L E +P G+++D L G EN+ + +G+ YLH+
Sbjct: 69 YYGCLRDPMERTLSIFMEHMPGGSIKDQLKSYGALTENVT----RKYTRQILEGVSYLHS 124
Query: 742 EAHPPVFHRDIKASNILLDSNLNAKVADFGLSRLAPVLDDEGTMPTHVSTIVKGTPGYLD 801
+ HRDIK +NIL DS N K+ DFG S+ + GT V+ GTP ++
Sbjct: 125 NM---IVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVT----GTPYWMS 177
Query: 802 PEYFLTHKLTDKSDVYSLGVVLLELLTGMQP 832
PE K+D++S+G ++E+LT P
Sbjct: 178 PEVISGEGYGRKADIWSVGCTVVEMLTEKPP 208
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 87.8 bits (218), Expect = 7e-19
Identities = 60/210 (28%), Positives = 90/210 (42%), Gaps = 16/210 (7%)
Query: 633 VGQGGYGKVYKGILSD-NTTVAIK--RAEEGSLQGQNEFLTEIKLLSRLHHRNLVSLLGY 689
VG+G YG V K VAIK + E + L E+K+L +L H N+V+L
Sbjct: 9 VGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEA 68
Query: 690 CDEEGEQMLVYEFVPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFH 749
+G LV+E+V TL + L + L + I Y H+ + H
Sbjct: 69 FRRKGRLYLVFEYVER-TLLELLE-ASPGGLPPDAVRSYIWQLLQAIAYCHSHN---IIH 123
Query: 750 RDIKASNILLDSNLNAKVADFGLSRLAPVLDDEGTMPTHVSTIVKGTPGYLDPEYFLTHK 809
RDIK NIL+ + K+ DFG +R + T Y PE +
Sbjct: 124 RDIKPENILVSESGVLKLCDFGFARALR----ARPASPLTDYVA--TRWYRAPELLVGDT 177
Query: 810 LTDKS-DVYSLGVVLLELLTGMQPISHGKN 838
K DV+++G ++ ELL G +P+ G +
Sbjct: 178 NYGKPVDVWAIGCIMAELLDG-EPLFPGDS 206
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 87.7 bits (217), Expect = 8e-19
Identities = 77/295 (26%), Positives = 129/295 (43%), Gaps = 43/295 (14%)
Query: 632 QVGQGGYGKVYKGILSD------NTTVAIKRA-EEGSLQGQNEFLTEIKLLSRLHHRNLV 684
++GQG +G VY+G D T VA+K E SL+ + EFL E ++ ++V
Sbjct: 13 ELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVV 72
Query: 685 SLLGYCDEEGEQMLVYEFVPNGTLRDWLSGRTKENLNFAMR--------LRVALDSAKGI 736
LLG + ++V E + +G L+ +L E N R +++A + A G+
Sbjct: 73 RLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGM 132
Query: 737 LYLHTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSRLAPVLD-----DEGTMPTHVST 791
YL+ + HRD+ A N ++ + K+ DFG++R D +G +P
Sbjct: 133 AYLNAKK---FVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVR--- 186
Query: 792 IVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVLLELLTGMQPISHGKNIVREVNVARDSGM 851
++ PE T SD++S GVVL E+ + + G + + + D G
Sbjct: 187 -------WMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMDGGY 239
Query: 852 VFSIIDNRMGSYPSECVERFVTLALRCCHDKPEHRPSMSDVVREL-ENILKMFPE 905
+ P C ER L C P+ RP+ ++V L +++ FPE
Sbjct: 240 L---------DQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDLHPSFPE 285
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 87.4 bits (216), Expect = 9e-19
Identities = 73/289 (25%), Positives = 127/289 (43%), Gaps = 42/289 (14%)
Query: 630 STQVGQGGYGKVY----KGILSDN--TTVAIKRAEE-GSLQGQNEFLTEIKLLSRLHHRN 682
S ++GQG +G VY KG++ D T VAIK E S++ + EFL E ++ + +
Sbjct: 11 SRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHH 70
Query: 683 LVSLLGYCDEEGEQMLVYEFVPNGTLRDWL-SGRTKENLN-------FAMRLRVALDSAK 734
+V LLG + +++ E + G L+ +L S R + N +++A + A
Sbjct: 71 VVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIAD 130
Query: 735 GILYLHTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSRLAPVLD-----DEGTMPTHV 789
G+ YL+ HRD+ A N ++ + K+ DFG++R D +G +P
Sbjct: 131 GMAYLNANK---FVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVR- 186
Query: 790 STIVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVLLELLTGMQPISHGKNIVREVNVARDS 849
++ PE T SDV+S GVVL E+ T + G + + + +
Sbjct: 187 ---------WMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVLRFVMEG 237
Query: 850 GMVFSIIDNRMGSYPSECVERFVTLALRCCHDKPEHRPSMSDVVRELEN 898
G++ P C + L C P+ RPS +++ ++
Sbjct: 238 GLL---------DKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKE 277
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 87.4 bits (216), Expect = 9e-19
Identities = 76/272 (27%), Positives = 129/272 (47%), Gaps = 29/272 (10%)
Query: 627 FSSSTQVGQGGYGKVYKGILSDNTT---VAIKRAEEGSLQGQNEFLT-EIKLLSRLHHRN 682
F+ ++G+G +G+V+KGI DN T VAIK + + + E + EI +LS+
Sbjct: 6 FTKLERIGKGSFGEVFKGI--DNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPY 63
Query: 683 LVSLLGYCDEEGEQMLVYEFVPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTE 742
+ G + + ++ E++ G+ D L + A L+ L KG+ YLH+E
Sbjct: 64 VTKYYGSYLKGTKLWIIMEYLGGGSALDLLRAGPFDEFQIATMLKEIL---KGLDYLHSE 120
Query: 743 AHPPVFHRDIKASNILLDSNLNAKVADFGLSRLAPVLDDEGTMPTHVSTIVKGTPGYLDP 802
HRDIKA+N+LL + K+ADFG++ + D + T V GTP ++ P
Sbjct: 121 KK---IHRDIKAANVLLSEQGDVKLADFGVA--GQLTDTQIKRNTFV-----GTPFWMAP 170
Query: 803 EYFLTHKLTDKSDVYSLGVVLLELLTGMQPISHGKNIVREVNVARDSGMVFSIIDNRMGS 862
E K+D++SLG+ +EL G P S +++ R ++F I N +
Sbjct: 171 EVIQQSAYDSKADIWSLGITAIELAKGEPPNS-------DMHPMR---VLFLIPKNNPPT 220
Query: 863 YPSECVERFVTLALRCCHDKPEHRPSMSDVVR 894
E + F C + P RP+ ++++
Sbjct: 221 LTGEFSKPFKEFIDACLNKDPSFRPTAKELLK 252
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 87.3 bits (216), Expect = 1e-18
Identities = 68/209 (32%), Positives = 109/209 (52%), Gaps = 17/209 (8%)
Query: 633 VGQGGYGKVYKGIL-----SDNTTVAIKRAEEGSLQGQNEFLTEIKL-LSRLHHRNLVSL 686
+G G +G V+KGI S VAIK ++ S + + +T+ L + L H +V L
Sbjct: 15 LGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRL 74
Query: 687 LGYCDEEGEQMLVYEFVPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPP 746
LG C Q LV + P G+L D + +++L+ L + AKG+ YL E H
Sbjct: 75 LGICPGASLQ-LVTQLSPLGSLLDHVRQH-RDSLDPQRLLNWCVQIAKGMYYL--EEHRM 130
Query: 747 VFHRDIKASNILLDSNLNAKVADFGLSRLAPVLDDEGTMPTHVSTIVKGTPGYLDPEYFL 806
V HR++ A NILL S+ ++ADFG++ L DD+ + T +K ++ E L
Sbjct: 131 V-HRNLAARNILLKSDSIVQIADFGVADLLYP-DDKKYFYSEHKTPIK----WMALESIL 184
Query: 807 THKLTDKSDVYSLGVVLLELLT-GMQPIS 834
+ T +SDV+S GV + E+++ G +P +
Sbjct: 185 FGRYTHQSDVWSYGVTVWEMMSYGAEPYA 213
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 86.6 bits (214), Expect = 1e-18
Identities = 61/209 (29%), Positives = 103/209 (49%), Gaps = 24/209 (11%)
Query: 633 VGQGGYGKVY--KGILSDNTTVAIKRA--EEGSLQGQNEFLTEIKLLSRLHHRNLVSLLG 688
+G+G +GK+Y K SD+ IK + ++ + E+ LL+++ H N+V+
Sbjct: 8 IGEGSFGKIYLAKA-KSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFA 66
Query: 689 YCDEEGEQMLVYEFVPNGTLRDWLSGRT----KENLNFAMRLRVALDSAKGILYLHTEAH 744
E G +V E+ G L ++ + E+ + ++++L G+ ++H
Sbjct: 67 SFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISL----GLKHIHDRK- 121
Query: 745 PPVFHRDIKASNILLDSN-LNAKVADFGLSRLAPVLDDEGTMPTHVSTIVKGTPGYLDPE 803
+ HRDIK+ NI L N + AK+ DFG++R L+D ++ GTP YL PE
Sbjct: 122 --ILHRDIKSQNIFLSKNGMVAKLGDFGIAR---QLNDS----MELAYTCVGTPYYLSPE 172
Query: 804 YFLTHKLTDKSDVYSLGVVLLELLTGMQP 832
+K+D++SLG VL EL T P
Sbjct: 173 ICQNRPYNNKTDIWSLGCVLYELCTLKHP 201
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 87.8 bits (218), Expect = 1e-18
Identities = 74/240 (30%), Positives = 108/240 (45%), Gaps = 54/240 (22%)
Query: 630 STQVGQGGYGKVYKGI-LSDNTTVAIKR-----AEEGSLQGQNEF----LTEIKLLSRLH 679
++G+G +G+VYK + VA+K+ ++G F L EIK+L +L
Sbjct: 13 LGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDG-------FPITALREIKILKKLK 65
Query: 680 HRNLVSLLG----YCDEEGEQML-VYEFVP------NGTLRDWLSGRTKENLNFAMRLRV 728
H N+V L+ D+ + VY P +G L EN + +L
Sbjct: 66 HPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMDHDLSGLL---------ENPSV--KLTE 114
Query: 729 A------LDSAKGILYLHTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSRL----APV 778
+ L +GI YLH E H + HRDIKA+NIL+D+ K+ADFGL+R P
Sbjct: 115 SQIKCYMLQLLEGINYLH-ENH--ILHRDIKAANILIDNQGILKIADFGLARPYDGPPPN 171
Query: 779 LDDEGTMPTHVSTIVKGTPGYLDPEYFLTHK-LTDKSDVYSLGVVLLELLTGMQPISHGK 837
G T T + T Y PE L + T D++ +G V E+ T +PI GK
Sbjct: 172 PKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTR-RPILQGK 230
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 86.5 bits (214), Expect = 1e-18
Identities = 81/277 (29%), Positives = 127/277 (45%), Gaps = 31/277 (11%)
Query: 632 QVGQGGYGKVYKG-ILSDNTT--VAIKRAE-EGSLQGQNEFLTEIKLLSRLHHRNLVSLL 687
++G G +GKV G + S T V +K S+Q Q +FL E + L H NL+ L
Sbjct: 2 EIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCL 61
Query: 688 GYCDEEGEQMLVYEFVPNGTLRDWL-SGRTKENLNFAMRL--RVALDSAKGILYLHTEAH 744
G C E +LV EF P G L+ +L S R E + R+A + A G+L+LH
Sbjct: 62 GQCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNNF 121
Query: 745 PPVFHRDIKASNILLDSNLNAKVADFGLSRLAPVLDDEGTMPTHVSTIVKGTPGYLDPEY 804
H D+ N LL ++L K+ D+GLS D T + P +D +
Sbjct: 122 ---IHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPLRWIAPELVDEVH 178
Query: 805 --FLTHKLTDKSDVYSLGVVLLELLT-GMQPISHGKNIVREVNVARDSGMVFSIIDNRMG 861
L T +S+V+SLGV + EL G QP H + +V + +++ + ++
Sbjct: 179 GNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSD--EQV-------LTYTVREQQL- 228
Query: 862 SYPSECVERFVTLA------LRCCHDKPEHRPSMSDV 892
P ++ + L+ ++ C +PE RPS +V
Sbjct: 229 KLPKPRLK--LPLSDRWYEVMQFCWLQPEQRPSAEEV 263
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 85.9 bits (212), Expect = 2e-18
Identities = 78/284 (27%), Positives = 127/284 (44%), Gaps = 34/284 (11%)
Query: 633 VGQGGYGKVYKGILSDNTT---VAIKRAEEG--SLQGQNEFLTEIKLLSRLHHRNLVSLL 687
+G+G +G V +G L+ + + VA+K + + +FL+E + H N++ L+
Sbjct: 7 LGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLI 66
Query: 688 GYCDEEGEQ------MLVYEFVPNGTLRDWLS----GRTKENLNFAMRLRVALDSAKGIL 737
G C + E +++ F+ +G L +L G + L M ++ D A G+
Sbjct: 67 GVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGME 126
Query: 738 YLHTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSRLAPVLDDEGTMPTHVSTIVKGTP 797
YL +++ HRD+ A N +L+ N+N VADFGLS+ D I K
Sbjct: 127 YLSSKS---FIHRDLAARNCMLNENMNVCVADFGLSKKIYNGD-----YYRQGRIAKMPV 178
Query: 798 GYLDPEYFLTHKLTDKSDVYSLGVVLLELLT-GMQPISHGKNIVREVNVARDSGMVFSII 856
++ E T KSDV+S GV + E+ T G P +N E+ G
Sbjct: 179 KWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVEN--SEIYDYLRQG------ 230
Query: 857 DNRMGSYPSECVERFVTLALRCCHDKPEHRPSMSDVVRELENIL 900
NR+ P +C++ +L C P+ RPS + ELE L
Sbjct: 231 -NRL-KQPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEKAL 272
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 85.7 bits (212), Expect = 3e-18
Identities = 79/292 (27%), Positives = 132/292 (45%), Gaps = 37/292 (12%)
Query: 627 FSSSTQVGQGGYGKVYKGIL-SDNTT---VAIK--RAEEGSLQGQNEFLTEIKLLSRLHH 680
F+ +G+G +G V + L S++ + VA+K +A+ S EFL E + H
Sbjct: 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDH 60
Query: 681 RNLVSLLGYCDEEGEQ------MLVYEFVPNGTLRDWL----SGRTKENLNFAMRLRVAL 730
N++ L+G + M++ F+ +G L +L G L +R +
Sbjct: 61 PNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMI 120
Query: 731 DSAKGILYLHTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSRLAPVLDDEGTMPTHVS 790
D A G+ YL ++ HRD+ A N +L+ N+ VADFGLS+ + + S
Sbjct: 121 DIASGMEYLSSKN---FIHRDLAARNCMLNENMTVCVADFGLSK--KIYSGDYYRQGCAS 175
Query: 791 TI-VKGTPGYLDPEYFLTHKLTDKSDVYSLGVVLLELLT-GMQPISHGKNIVREVNVARD 848
+ VK +L E + T SDV++ GV + E++T G P + +N E+
Sbjct: 176 KLPVK----WLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVEN--SEI----- 224
Query: 849 SGMVFSIIDNRMGSYPSECVERFVTLALRCCHDKPEHRPSMSDVVRELENIL 900
+ I NR+ P +C+E L +C +P+ RPS + +LE I
Sbjct: 225 --YNYLIKGNRL-KQPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELIW 273
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 85.0 bits (210), Expect = 3e-18
Identities = 79/277 (28%), Positives = 122/277 (44%), Gaps = 32/277 (11%)
Query: 631 TQVGQGGYGKVYKGILS---DNTTVAIK--RAEEGSLQGQNEFLTEIKLLSRLHHRNLVS 685
++G G +G V KG+ TVA+K + + ++E L E ++ +L + +V
Sbjct: 1 GELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVR 60
Query: 686 LLGYCDEEGEQMLVYEFVPNGTLRDWLSGR---TKENLNFAMRLRVALDSAKGILYLHTE 742
++G C+ E MLV E G L +L T++N+ + + G+ YL E
Sbjct: 61 MIGICEAES-WMLVMELAELGPLNKFLQKNKHVTEKNI-----TELVHQVSMGMKYL--E 112
Query: 743 AHPPVFHRDIKASNILLDSNLNAKVADFGLSRLAPVLDDEGTMPTHVSTIVKGTPGYLDP 802
V HRD+ A N+LL + AK++DFGLS+ ++ TH VK + P
Sbjct: 113 ETNFV-HRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKWPVK----WYAP 167
Query: 803 EYFLTHKLTDKSDVYSLGVVLLELLT-GMQPISHGKNIVREVNVARDSGMVFSIIDNRMG 861
E +K + KSDV+S GV++ E + G +P K EV +SG RM
Sbjct: 168 ECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKG--NEVTQMIESG-------ERME 218
Query: 862 SYPSECVERFVTLALRCCHDKPEHRPSMSDVVRELEN 898
P C L C + RP + V L N
Sbjct: 219 C-PQRCPPEMYDLMKLCWTYGVDERPGFAVVELRLRN 254
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 85.5 bits (211), Expect = 4e-18
Identities = 78/272 (28%), Positives = 129/272 (47%), Gaps = 29/272 (10%)
Query: 627 FSSSTQVGQGGYGKVYKGILSDNTT---VAIKRAEEGSLQGQNEFLT-EIKLLSRLHHRN 682
F+ ++G+G +G+VYKGI DN T VAIK + + + E + EI +LS+
Sbjct: 6 FTKLERIGKGSFGEVYKGI--DNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPY 63
Query: 683 LVSLLGYCDEEGEQMLVYEFVPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTE 742
+ G + + ++ E++ G+ D L E A LR L KG+ YLH+E
Sbjct: 64 ITRYYGSYLKGTKLWIIMEYLGGGSALDLLKPGPLEETYIATILREIL---KGLDYLHSE 120
Query: 743 AHPPVFHRDIKASNILLDSNLNAKVADFGLSRLAPVLDDEGTMPTHVSTIVKGTPGYLDP 802
HRDIKA+N+LL + K+ADFG++ + D + T V GTP ++ P
Sbjct: 121 RK---IHRDIKAANVLLSEQGDVKLADFGVA--GQLTDTQIKRNTFV-----GTPFWMAP 170
Query: 803 EYFLTHKLTDKSDVYSLGVVLLELLTGMQPISHGKNIVREVNVARDSGMVFSIIDNRMGS 862
E K+D++SLG+ +EL G P S +++ R ++F I N +
Sbjct: 171 EVIKQSAYDFKADIWSLGITAIELAKGEPPNS-------DLHPMR---VLFLIPKNSPPT 220
Query: 863 YPSECVERFVTLALRCCHDKPEHRPSMSDVVR 894
+ + F C + P RP+ ++++
Sbjct: 221 LEGQYSKPFKEFVEACLNKDPRFRPTAKELLK 252
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 84.8 bits (210), Expect = 4e-18
Identities = 75/278 (26%), Positives = 119/278 (42%), Gaps = 45/278 (16%)
Query: 632 QVGQGGYGKVYKGI-LSDNTTVAIKRA---EEGSLQGQNEFLTEIKLLSRLHHRNLVSLL 687
++G+G + VYK I L D VA+K+ E + + + L EI LL +L H N++ L
Sbjct: 9 KIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYL 68
Query: 688 GYCDEEGEQMLVYEFVPNGTLRDWL-----SGRT---KENLNFAMRLRVALDSAKGILYL 739
E E +V E G L + R + + ++L AL+ ++
Sbjct: 69 ASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALE------HM 122
Query: 740 HTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSRLAPVLDDEGTMPTHVSTIVKGTPGY 799
H++ + HRDIK +N+ + + K+ D GL R T H ++V GTP Y
Sbjct: 123 HSKR---IMHRDIKPANVFITATGVVKLGDLGLGRFF----SSKTTAAH--SLV-GTPYY 172
Query: 800 LDPEYFLTHKLTDKSDVYSLGVVLLELLTGMQPISHGK-NIVREVNVARDSGMVFSIIDN 858
+ PE + KSD++SLG +L E+ P K N+ + I+
Sbjct: 173 MSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYS----------LCKKIEK 222
Query: 859 RMGSYPSECVERFVT----LALRCCHDKPEHRPSMSDV 892
YP + + L RC + PE RP +S V
Sbjct: 223 --CDYPPLPADHYSEELRDLVSRCINPDPEKRPDISYV 258
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 85.4 bits (212), Expect = 4e-18
Identities = 63/221 (28%), Positives = 100/221 (45%), Gaps = 38/221 (17%)
Query: 633 VGQGGYGKVYK-GILSDNTTVAIKRAEEGSLQG--QNEFLTEIKLLSRLHHRNLVSLLGY 689
+G+G +G V+K TVA+K+ L+G N+ L EIK L H +V LL
Sbjct: 8 IGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDV 67
Query: 690 CDEEGEQMLVYEFVPNGTLRDWLSGRTKENLN----------FAMRLRVALDSAKGILYL 739
+LV E++P+ LS ++ M L KG+ Y+
Sbjct: 68 FPHGSGFVLVMEYMPSD-----LSEVLRDEERPLPEAQVKSYMRMLL-------KGVAYM 115
Query: 740 HTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSRLAPVLDDEGTMPTH-VSTIVKGTPG 798
H + HRD+K +N+L+ ++ K+ADFGL+R ++E + +H V T
Sbjct: 116 HANG---IMHRDLKPANLLISADGVLKIADFGLAR--LFSEEEPRLYSHQV-----ATRW 165
Query: 799 YLDPEYFL-THKLTDKSDVYSLGVVLLELLTGMQPISHGKN 838
Y PE K D++++G + ELL G P+ G+N
Sbjct: 166 YRAPELLYGARKYDPGVDLWAVGCIFAELLNG-SPLFPGEN 205
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 86.2 bits (214), Expect = 6e-18
Identities = 66/222 (29%), Positives = 106/222 (47%), Gaps = 38/222 (17%)
Query: 633 VGQGGYGKVYKGI-LSDNTTVAIKRAE--EGSLQGQNEFLTEIKLLSRLHHRNLVSLL-- 687
+G+G YG V VAIK+ E Q L EIK+L R H N++ +L
Sbjct: 13 IGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRT-LREIKILRRFKHENIIGILDI 71
Query: 688 ---GYCDEEGEQMLVYEFVPNGTLRDWLSGRTKENLN------FAMR-LRVALDSAKGIL 737
+ + +V E + + + ++L+ F + LR G+
Sbjct: 72 IRPPSFESFNDVYIVQELMETDLYKLIKT----QHLSNDHIQYFLYQILR-------GLK 120
Query: 738 YLHTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSRLA-PVLDDEGTMPTHVSTIVKGT 796
Y+H+ V HRD+K SN+LL++N + K+ DFGL+R+A P D G + +V+ T
Sbjct: 121 YIHSAN---VLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFLTEYVA-----T 172
Query: 797 PGYLDPEYFLTHKLTDKS-DVYSLGVVLLELLTGMQPISHGK 837
Y PE L K K+ D++S+G +L E+L+ +P+ GK
Sbjct: 173 RWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSN-RPLFPGK 213
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 85.1 bits (210), Expect = 7e-18
Identities = 65/225 (28%), Positives = 112/225 (49%), Gaps = 36/225 (16%)
Query: 632 QVGQGGYGKVYK------GILSDNTTVAIKRAEEGSLQGQNEFLTEIKLLSRLHHRNLVS 685
++G G +GKVYK G L+ + K EE +++ EI++L+ +H +V
Sbjct: 19 ELGDGAFGKVYKAKNKETGALAAAKVIETKSEEE-----LEDYMVEIEILATCNHPYIVK 73
Query: 686 LLGYCDEEGEQMLVYEFVPNG----TLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHT 741
LLG +G+ ++ EF P G + + G T+ + R + + + YLH+
Sbjct: 74 LLGAFYWDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVICRQML-----EALQYLHS 128
Query: 742 EAHPPVFHRDIKASNILLDSNLNAKVADFGLSRLAPVLDDEGTMPTHVSTIVKGTPGYLD 801
+ HRD+KA N+LL + + K+ADFG+S + T+ S I GTP ++
Sbjct: 129 MK---IIHRDLKAGNVLLTLDGDIKLADFGVSA-----KNVKTLQRRDSFI--GTPYWMA 178
Query: 802 PEYFLTHKLTD-----KSDVYSLGVVLLELLTGMQPISHGKNIVR 841
PE + + D K+D++SLG+ L+E + ++P H N +R
Sbjct: 179 PEVVMCETMKDTPYDYKADIWSLGITLIE-MAQIEPPHHELNPMR 222
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 83.9 bits (207), Expect = 9e-18
Identities = 67/212 (31%), Positives = 108/212 (50%), Gaps = 25/212 (11%)
Query: 633 VGQGGYGKVYKGILSDN-TTVAIKR------AEEGSLQGQNEFLTEIKLLSRLHHRNLVS 685
+G+G +G+VY +D +A+K+ ++E S + N EI+LL L H +V
Sbjct: 10 LGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKE-VNALECEIQLLKNLRHDRIVQ 68
Query: 686 LLGYC--DEEGEQMLVY-EFVPNGTLRDWLS--GRTKENLNFAMRLRVALDSAKGILYLH 740
G C D E +++ ++ E++P G+++D L G EN+ R +G+ YLH
Sbjct: 69 YYG-CLRDPEEKKLSIFVEYMPGGSIKDQLKAYGALTENVT----RRYTRQILQGVSYLH 123
Query: 741 TEAHPPVFHRDIKASNILLDSNLNAKVADFGLSRLAPVLDDEGTMPTHVSTIVKGTPGYL 800
+ + HRDIK +NIL DS N K+ DFG S+ + GT V+ GTP ++
Sbjct: 124 SNM---IVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSVT----GTPYWM 176
Query: 801 DPEYFLTHKLTDKSDVYSLGVVLLELLTGMQP 832
PE K+DV+S+ ++E+LT P
Sbjct: 177 SPEVISGEGYGRKADVWSVACTVVEMLTEKPP 208
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 84.1 bits (208), Expect = 9e-18
Identities = 60/232 (25%), Positives = 104/232 (44%), Gaps = 21/232 (9%)
Query: 667 EFLTEIKLLSRLHHRNLVSLLGYCDEEGEQMLVYEFVPNGTLRDWLS--GRTKENLNFAM 724
EI+L++RL+H +++ +LG E+ L E++ G++ LS G KE +
Sbjct: 49 ALRKEIRLMARLNHPHIIRMLGATCEDSHFNLFVEWMAGGSVSHLLSKYGAFKEAVIINY 108
Query: 725 RLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSN-LNAKVADFGLSRLAPVLDDEG 783
++ G+ YLH + HRD+K +N+L+DS ++ADFG A L +G
Sbjct: 109 TEQLLR----GLSYLHENQ---IIHRDVKGANLLIDSTGQRLRIADFG---AAARLAAKG 158
Query: 784 TMPTHVSTIVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVLLELLTGMQPISHGKNIVREV 843
T + GT ++ PE + DV+S+G V++E+ T P +
Sbjct: 159 TGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWN-------AE 211
Query: 844 NVARDSGMVFSIID-NRMGSYPSECVERFVTLALRCCHDKPEHRPSMSDVVR 894
+ ++F I S P + LRC +PE RP ++++
Sbjct: 212 KHSNHLALIFKIASATTAPSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLK 263
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 84.6 bits (209), Expect = 1e-17
Identities = 76/252 (30%), Positives = 117/252 (46%), Gaps = 28/252 (11%)
Query: 652 VAIK--RAEEGSLQGQNEFLTEIKLLSRLHHRNLVSLLGYCDEEGEQMLVYEFVPNGTLR 709
VA+K RA+ +N+FL EIK++SRL + N++ LLG C + ++ E++ NG L
Sbjct: 47 VAVKMLRADVTK-TARNDFLKEIKIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLN 105
Query: 710 DWLSGR------TKEN----LNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILL 759
+LS R T N ++ A L +A+ A G+ YL A HRD+ N L+
Sbjct: 106 QFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYL---ASLNFVHRDLATRNCLV 162
Query: 760 DSNLNAKVADFGLSRLAPVLDDEGTMPTHVSTIVKGTPGYLDPEYFLTHKLTDKSDVYSL 819
++ K+ADFG+SR D V I ++ E L K T SDV++
Sbjct: 163 GNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPI-----RWMAWESILLGKFTTASDVWAF 217
Query: 820 GVVLLEL--LTGMQPISHGKNIVREVNVARDSGMVFSIIDNRMG-SYPSECVERFVTLAL 876
GV L E+ L QP S ++ + V ++G F ++ S C L +
Sbjct: 218 GVTLWEMFTLCKEQPYS----LLSDEQVIENTGEFFRNQGRQIYLSQTPLCPSPVFKLMM 273
Query: 877 RCCHDKPEHRPS 888
RC + RP+
Sbjct: 274 RCWSRDIKDRPT 285
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 83.7 bits (207), Expect = 1e-17
Identities = 70/277 (25%), Positives = 116/277 (41%), Gaps = 37/277 (13%)
Query: 632 QVGQGGYGKVYKGI-LSDNTTVAIKRAEEGSLQG-QNEFLTEIKLLSRLHHRNLVSLLGY 689
+G G G V K + T +A K G+ + + L E++++ +VS G
Sbjct: 12 DLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGA 71
Query: 690 CDEEGEQMLVYEFVPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFH 749
E + EF+ G+L D + + + + ++A+ +G+ YL+ + H
Sbjct: 72 FLNENNICMCMEFMDCGSL-DRIY-KKGGPIPVEILGKIAVAVVEGLTYLYNVHR--IMH 127
Query: 750 RDIKASNILLDSNLNAKVADFGLSRLAPVLDDEGTMPTHVSTIVKGTPGYLDPEYFLTHK 809
RDIK SNIL++S K+ DFG+S G + ++ GT Y+ PE K
Sbjct: 128 RDIKPSNILVNSRGQIKLCDFGVS---------GELINSIADTFVGTSTYMSPERIQGGK 178
Query: 810 LTDKSDVYSLGVVLLELLTGMQPISHGKNIVREVNVARDSGMVFSIID----------NR 859
T KSDV+SLG+ ++EL G P + + +D M I+D R
Sbjct: 179 YTVKSDVWSLGISIIELALGKFPFAFSN----IDDDGQDDPM--GILDLLQQIVQEPPPR 232
Query: 860 M--GSYPSECVERFVTLALRCCHDKPEHRPSMSDVVR 894
+ +P + FV C P RP+ +
Sbjct: 233 LPSSDFPEDL-RDFVD---ACLLKDPTERPTPQQLCA 265
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 84.1 bits (208), Expect = 1e-17
Identities = 74/281 (26%), Positives = 124/281 (44%), Gaps = 34/281 (12%)
Query: 633 VGQGGYGKVYKG-----ILSDNT-TVAIKRAEEGSLQGQNEFL-TEIKLLSRL-HHRNLV 684
+G G +GKV + SD VA+K + + + E L +E+K++S L +H N+V
Sbjct: 43 LGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIV 102
Query: 685 SLLGYCDEEGEQMLVYEFVPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAH 744
+LLG C G +++ E+ G L ++L + + L L + AKG+ +L A
Sbjct: 103 NLLGACTIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFL---AS 159
Query: 745 PPVFHRDIKASNILLDSNLNAKVADFGLSRLAPVLDDEGTMPTHVSTIVKGTP----GYL 800
HRD+ A N+LL K+ DFGL+R +++D + +VKG ++
Sbjct: 160 KNCIHRDLAARNVLLTHGKIVKICDFGLAR--DIMNDS-------NYVVKGNARLPVKWM 210
Query: 801 DPEYFLTHKLTDKSDVYSLGVVLLELLT-GMQPISHGKNIVREVNVARDSGMVFSIIDNR 859
PE T +SDV+S G++L E+ + G P + DS I +
Sbjct: 211 APESIFNCVYTFESDVWSYGILLWEIFSLGSNPYP---------GMPVDSKFYKLIKEGY 261
Query: 860 MGSYPSECVERFVTLALRCCHDKPEHRPSMSDVVRELENIL 900
+ P + C P RP+ +V+ + L
Sbjct: 262 RMAQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGKQL 302
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 84.3 bits (209), Expect = 2e-17
Identities = 63/244 (25%), Positives = 98/244 (40%), Gaps = 67/244 (27%)
Query: 632 QVGQGGYGKVYKGILSDNTT---VAIKRAEEGSLQGQNEFLT---EIKLLSRLHHRNLVS 685
+G+G YG+VYK + AIK+ + Q + EI LL L H N+VS
Sbjct: 7 CIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVS 66
Query: 686 LLGYC--DEEGEQMLVYEF-------------------VPNGTLRDWLSGRTKENLNFAM 724
L+ + L++++ +P ++ L + LN
Sbjct: 67 LVEVFLEHADKSVYLLFDYAEHDLWQIIKFHRQAKRVSIPPSMVKSLL----WQILN--- 119
Query: 725 RLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSNLNA----KVADFGLSR-----L 775
G+ YLH+ V HRD+K +NIL+ K+ D GL+R L
Sbjct: 120 ----------GVHYLHSNW---VLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPL 166
Query: 776 APVLDDEGTMPTHVSTIVKGTPGYLDPEYFL-THKLTDKSDVYSLGVVLLELLTGMQPIS 834
P+ D + V TI Y PE L T D++++G + ELLT ++PI
Sbjct: 167 KPLADLDPV----VVTI-----WYRAPELLLGARHYTKAIDIWAIGCIFAELLT-LEPIF 216
Query: 835 HGKN 838
G+
Sbjct: 217 KGRE 220
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 82.8 bits (205), Expect = 3e-17
Identities = 67/218 (30%), Positives = 106/218 (48%), Gaps = 23/218 (10%)
Query: 627 FSSSTQVGQGGYGKVYKGI-LSDNTTVAIKR-----AEEGSLQGQNEFLTEIKLLSRLHH 680
++ ++G+G YG VYKG VA+K+ EEG + + EI LL L H
Sbjct: 2 YTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGV---PSTAIREISLLKELQH 58
Query: 681 RNLVSLLGYCDEEGEQMLVYEFVPNGTLRDWLSGRTKENLNFAMRLRVAL-DSAKGILYL 739
N+V L +E L++EF+ + L+ +L K A ++ L +GIL+
Sbjct: 59 PNIVCLQDVLMQESRLYLIFEFL-SMDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFC 117
Query: 740 HTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSRLAPVLDDEGTMPTHVSTIVKGTPGY 799
H+ V HRD+K N+L+D+ K+ADFGL+R + P V T T Y
Sbjct: 118 HSRR---VLHRDLKPQNLLIDNKGVIKLADFGLARAFGI-------PVRVYTHEVVTLWY 167
Query: 800 LDPEYFL-THKLTDKSDVYSLGVVLLELLTGMQPISHG 836
PE L + + + D++S+G + E+ T +P+ HG
Sbjct: 168 RAPEVLLGSPRYSTPVDIWSIGTIFAEMAT-KKPLFHG 204
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 83.0 bits (206), Expect = 3e-17
Identities = 62/208 (29%), Positives = 93/208 (44%), Gaps = 31/208 (14%)
Query: 633 VGQGGYGKVYKGI-LSDNTTVAIKRAEEGSLQGQNE-----FLTEIKLLSRLHHRNLVSL 686
+G+G Y VYK VAIK+ + G + + L EIKLL L H N++ L
Sbjct: 8 LGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGL 67
Query: 687 LGYCDEEGEQMLVYEFVPNGTLRDWLSGRTKENLNFAMRLRVA------LDSAKGILYLH 740
L + LV+EF+ D L K+ ++ L A L + +G+ YLH
Sbjct: 68 LDVFGHKSNINLVFEFMET----D-LEKVIKDK---SIVLTPADIKSYMLMTLRGLEYLH 119
Query: 741 TEAHPPVFHRDIKASNILLDSNLNAKVADFGLSRLAPVLDDEGTMPTHVSTIVKGTPGYL 800
+ + HRD+K +N+L+ S+ K+ADFGL+R M V T Y
Sbjct: 120 SNW---ILHRDLKPNNLLIASDGVLKLADFGLARSFG--SPNRKMTHQVVTRW-----YR 169
Query: 801 DPEYFLTHKL-TDKSDVYSLGVVLLELL 827
PE + D++S+G + ELL
Sbjct: 170 APELLFGARHYGVGVDMWSVGCIFAELL 197
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 82.6 bits (204), Expect = 4e-17
Identities = 74/260 (28%), Positives = 115/260 (44%), Gaps = 29/260 (11%)
Query: 652 VAIKR-AEEGSLQGQNEFLTEIKLLSRLHHRNLVSLLGYCDEEGEQMLVYEFVPNGTLRD 710
VA+K E+ + +N+FL EIK++SRL N++ LL C ++ E++ NG L
Sbjct: 49 VAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQ 108
Query: 711 WLSGRTKEN---------LNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDS 761
+LS + ++++ + +A A G+ YL + HRD+ N L+
Sbjct: 109 FLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLN---FVHRDLATRNCLVGK 165
Query: 762 NLNAKVADFGLSRLAPVLDDEGTMPTHVSTIVKGTPGYLDPEYFLTHKLTDKSDVYSLGV 821
N K+ADFG+SR D V I ++ E L K T SDV++ GV
Sbjct: 166 NYTIKIADFGMSRNLYSGDYYRIQGRAVLPI-----RWMSWESILLGKFTTASDVWAFGV 220
Query: 822 VLLELLT--GMQPISHGKNIVREVNVARDSGMVFSIIDNRMGSY---PSECVERFVTLAL 876
L E+LT QP S + + V ++G F D Y P+ C + L L
Sbjct: 221 TLWEILTLCKEQPYSQ----LSDEQVIENTGEFFR--DQGRQVYLPKPALCPDSLYKLML 274
Query: 877 RCCHDKPEHRPSMSDVVREL 896
C + RPS ++ L
Sbjct: 275 SCWRRNAKERPSFQEIHATL 294
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 85.7 bits (212), Expect = 6e-17
Identities = 47/138 (34%), Positives = 78/138 (56%), Gaps = 5/138 (3%)
Query: 90 ELQLLSM---NLSGNLAPELGQLSRLQYY-FMWNDLTGTIPKEIGNISSLIFLLLNGNKL 145
LQ+LS+ G L P+ RL+ N +G +P+++G++S L+ L L+ NKL
Sbjct: 453 SLQMLSLARNKFFGGL-PDSFGSKRLENLDLSRNQFSGAVPRKLGSLSELMQLKLSENKL 511
Query: 146 SGSLPDELGYLSNLNRLQVDENNITGTIPKSFANLSRVRHLHLNNNSIGGQIPSELSKLS 205
SG +PDEL L L + N ++G IP SF+ + + L L+ N + G+IP L +
Sbjct: 512 SGEIPDELSSCKKLVSLDLSHNQLSGQIPASFSEMPVLSQLDLSQNQLSGEIPKNLGNVE 571
Query: 206 TLIHLLVDNNNLSGNLPP 223
+L+ + + +N+L G+LP
Sbjct: 572 SLVQVNISHNHLHGSLPS 589
|
Length = 968 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 81.7 bits (201), Expect = 6e-17
Identities = 80/276 (28%), Positives = 136/276 (49%), Gaps = 37/276 (13%)
Query: 627 FSSSTQVGQGGYGKVYKGILSDNTT---VAIKRAEEGSLQGQNEFLT-EIKLLSRLHHRN 682
F+ ++G+G +G+V+KGI DN T VAIK + + + E + EI +LS+
Sbjct: 6 FTKLEKIGKGSFGEVFKGI--DNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPY 63
Query: 683 LVSLLGYCDEEGEQMLVYEFVPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTE 742
+ G ++ + ++ E++ G+ D L + A LR L KG+ YLH+E
Sbjct: 64 VTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPGPLDETQIATILREIL---KGLDYLHSE 120
Query: 743 AHPPVFHRDIKASNILLDSNLNAKVADFGLSRLAPVLDDEGTMPTHVSTIVKGTPGYLDP 802
HRDIKA+N+LL + K+ADFG++ + D + T V GTP ++ P
Sbjct: 121 KK---IHRDIKAANVLLSEHGEVKLADFGVA--GQLTDTQIKRNTFV-----GTPFWMAP 170
Query: 803 EYFLTHKLTDKSDVYSLGVVLLELLTGMQPISHGKNIVREVNVARDSGMVFSIIDNR--- 859
E K+D++SLG+ +EL G P S E++ + ++F I N
Sbjct: 171 EVIKQSAYDSKADIWSLGITAIELAKGEPPHS-------ELHPMK---VLFLIPKNNPPT 220
Query: 860 -MGSYPSECVERFVTLALRCCHDKPEHRPSMSDVVR 894
G+Y S+ ++ FV C + +P RP+ ++++
Sbjct: 221 LEGNY-SKPLKEFVE---ACLNKEPSFRPTAKELLK 252
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 81.7 bits (202), Expect = 9e-17
Identities = 58/212 (27%), Positives = 87/212 (41%), Gaps = 30/212 (14%)
Query: 634 GQGGYGKVYKGILSDNTTV----AIKRAEEGSLQGQNEFLTEIKLLSRLHHRNLVSLLGY 689
G+G G V K L + + I LQ Q L E+++ +V G
Sbjct: 10 GEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQ--ILRELEINKSCKSPYIVKYYGA 67
Query: 690 CDEEGEQML--VYEFVPNGTLRDWLSGRTKENLNFAMR------LRVALDSAKGILYLHT 741
+E + E+ G+L D + + K+ R ++A KG+ YLH+
Sbjct: 68 FLDESSSSIGIAMEYCEGGSL-DSIYKKVKKR---GGRIGEKVLGKIAESVLKGLSYLHS 123
Query: 742 EAHPPVFHRDIKASNILLDSNLNAKVADFGLSRLAPVLDDEGTMPTHVSTIVKGTPGYLD 801
+ HRDIK SNILL K+ DFG+S G + ++ GT Y+
Sbjct: 124 RK---IIHRDIKPSNILLTRKGQVKLCDFGVS---------GELVNSLAGTFTGTSFYMA 171
Query: 802 PEYFLTHKLTDKSDVYSLGVVLLELLTGMQPI 833
PE + SDV+SLG+ LLE+ P
Sbjct: 172 PERIQGKPYSITSDVWSLGLTLLEVAQNRFPF 203
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 81.3 bits (201), Expect = 9e-17
Identities = 61/209 (29%), Positives = 102/209 (48%), Gaps = 21/209 (10%)
Query: 633 VGQGGYGKVYKGI-LSDNTTVAIKRAEEGSLQGQ-NEFLTEIKLLSRLHH---RNLVSLL 687
+G+G YG VY+G + VA+K + ++ E+ LLS+L N+
Sbjct: 9 IGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYY 68
Query: 688 GYCDEEGEQM-LVYEFVPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPP 746
G +G ++ ++ E+ G++R + ++ +R L + K Y+H
Sbjct: 69 G-SYLKGPRLWIIMEYAEGGSVRTLMKAGPIAEKYISVIIREVLVALK---YIH---KVG 121
Query: 747 VFHRDIKASNILLDSNLNAKVADFGLSRLAPVLDDEGTMPTHVSTIVKGTPGYLDPEYFL 806
V HRDIKA+NIL+ + N K+ DFG++ A + + T V GTP ++ PE
Sbjct: 122 VIHRDIKAANILVTNTGNVKLCDFGVA--ALLNQNSSKRSTFV-----GTPYWMAPEVIT 174
Query: 807 THKLTD-KSDVYSLGVVLLELLTGMQPIS 834
K D K+D++SLG+ + E+ TG P S
Sbjct: 175 EGKYYDTKADIWSLGITIYEMATGNPPYS 203
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 81.4 bits (201), Expect = 1e-16
Identities = 74/277 (26%), Positives = 118/277 (42%), Gaps = 36/277 (12%)
Query: 627 FSSSTQVGQGGYGKVYKGILS-DNTTVAIKRAEEGSLQGQ---NEFLTEIKLLSRLHHRN 682
F+ ++G G +G VY N VAIK+ Q + + E++ L +L H N
Sbjct: 17 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPN 76
Query: 683 LVSLLGYCDEEGEQMLVYEFVPNGTLRDWLSGRTK--ENLNFAMRLRVALDSAKGILYLH 740
+ G E LV E+ G+ D L K + + A + + +G+ YLH
Sbjct: 77 TIEYKGCYLREHTAWLVMEYCL-GSASDILEVHKKPLQEVEIAA---ICHGALQGLAYLH 132
Query: 741 TEAHPPVFHRDIKASNILLDSNLNAKVADFGLSRLAPVLDDEGTMPTHVSTIVKGTPGYL 800
+ HRDIKA NILL K+ADFG + L + ++ V GTP ++
Sbjct: 133 SHER---IHRDIKAGNILLTEPGTVKLADFGSASLV----------SPANSFV-GTPYWM 178
Query: 801 DPEYFLTH---KLTDKSDVYSLGVVLLELLTGMQPISHGKNIVREVNVARDSGMVFSIID 857
PE L + K DV+SLG+ +EL P+ + + ++A++ S D
Sbjct: 179 APEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSPTLSSND 238
Query: 858 NRMGSYPSECVERFVTLALRCCHDKPEHRPSMSDVVR 894
S+ FV C P+ RPS ++++
Sbjct: 239 ------WSDYFRNFVDS---CLQKIPQDRPSSEELLK 266
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 80.9 bits (200), Expect = 2e-16
Identities = 62/202 (30%), Positives = 96/202 (47%), Gaps = 18/202 (8%)
Query: 633 VGQGGYGKVYKGILSD-NTTVAIKRAEEGSLQGQNE--FLTEIKLLSRLHHRNLVSLLGY 689
VG+G YG V K + VAIK+ E + + EI++L +L H NLV+L+
Sbjct: 9 VGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEV 68
Query: 690 CDEEGEQMLVYEFVPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFH 749
+ LV+EFV + T+ D L + L+ + + +GI + H+ + H
Sbjct: 69 FRRKKRLYLVFEFVDH-TVLDDLE-KYPNGLDESRVRKYLFQILRGIEFCHSHN---IIH 123
Query: 750 RDIKASNILLDSNLNAKVADFGLSR-LAPVLDDEGTMPTHVSTIVKGTPGYLDPEYFLTH 808
RDIK NIL+ + K+ DFG +R LA P V T T Y PE +
Sbjct: 124 RDIKPENILVSQSGVVKLCDFGFARTLAA--------PGEVYTDYVATRWYRAPELLVGD 175
Query: 809 -KLTDKSDVYSLGVVLLELLTG 829
K D++++G ++ E+LTG
Sbjct: 176 TKYGRAVDIWAVGCLVTEMLTG 197
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 80.4 bits (199), Expect = 2e-16
Identities = 62/212 (29%), Positives = 103/212 (48%), Gaps = 22/212 (10%)
Query: 632 QVGQGGYGKVYKGI-LSDNTTVAIKRAEEGSLQGQNE-----FLTEIKLLSRLHHRNLVS 685
++G+G YG VYK VA+K+ L+ ++E + EI LL L+H N+V
Sbjct: 6 KIGEGTYGVVYKARDKLTGEIVALKKIR---LETEDEGVPSTAIREISLLKELNHPNIVR 62
Query: 686 LLGYCDEEGEQMLVYEFVPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHP 745
LL E + LV+EF+ + L+ ++ L+ + +GI Y H+
Sbjct: 63 LLDVVHSENKLYLVFEFL-DLDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHR-- 119
Query: 746 PVFHRDIKASNILLDSNLNAKVADFGLSRLAPVLDDEGTMPTHVSTIVKGTPGYLDPEYF 805
V HRD+K N+L+D K+ADFGL+R V + T+ +V T Y PE
Sbjct: 120 -VLHRDLKPQNLLIDREGALKLADFGLARAFGV-----PVRTYTHEVV--TLWYRAPEIL 171
Query: 806 L-THKLTDKSDVYSLGVVLLELLTGMQPISHG 836
L + + + D++S+G + E++ +P+ G
Sbjct: 172 LGSRQYSTPVDIWSIGCIFAEMVNR-RPLFPG 202
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 81.3 bits (200), Expect = 2e-16
Identities = 76/289 (26%), Positives = 126/289 (43%), Gaps = 37/289 (12%)
Query: 627 FSSSTQVGQGGYGKVY-KGILSDNTTVAIKRAEEGSLQGQNEF---LTEIKLLSRLHHRN 682
F+ ++G G +G VY + N VAIK+ Q ++ + E+K L R+ H N
Sbjct: 27 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPN 86
Query: 683 LVSLLGYCDEEGEQMLVYEFVPNGTLRDWLSGRTK--ENLNFAMRLRVALDSAKGILYLH 740
+ G E LV E+ G+ D L K + + A AL +G+ YLH
Sbjct: 87 SIEYKGCYLREHTAWLVMEYCL-GSASDLLEVHKKPLQEVEIAAITHGAL---QGLAYLH 142
Query: 741 TEAHPPVFHRDIKASNILLDSNLNAKVADFGLSRLAPVLDDEGTMPTHVSTIVKGTPGYL 800
+ + HRDIKA NILL K+ADFG ++ + ++ V GTP ++
Sbjct: 143 SHN---MIHRDIKAGNILLTEPGQVKLADFG----------SASIASPANSFV-GTPYWM 188
Query: 801 DPEYFLTH---KLTDKSDVYSLGVVLLELLTGMQPISHGKNIVREVNVARDSGMVFSIID 857
PE L + K DV+SLG+ +EL P+ + + ++A++
Sbjct: 189 APEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPTLQ--- 245
Query: 858 NRMGSYPSECVERFVTLALRCCHDKPEHRPSMSDVVRELENILKMFPET 906
+E + F C P+ RP+ ++++ + +L+ PET
Sbjct: 246 ------SNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHM-FVLRERPET 287
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 80.3 bits (199), Expect = 2e-16
Identities = 65/209 (31%), Positives = 102/209 (48%), Gaps = 29/209 (13%)
Query: 633 VGQGGYGKVYKGILSDNT-TVAIKRAEEGSL--QGQNE-FLTEIKLLSRLHHRNLVSLLG 688
+G G +G+V + A+K + + Q E L E ++L + H LV+L G
Sbjct: 9 LGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYG 68
Query: 689 YCDEEGEQMLVYEFVPNGTLRDWL--SGRTKENLN--FAMRLRVALDSAKGILYLHTEAH 744
++ LV E+VP G L L SGR E + +A ++ +AL+ YLH+
Sbjct: 69 SFQDDSNLYLVMEYVPGGELFSHLRKSGRFPEPVARFYAAQVVLALE------YLHSLD- 121
Query: 745 PPVFHRDIKASNILLDSNLNAKVADFGLSRLAPVLDDEGTMPTHVSTIVKGTPGYLDPEY 804
+ +RD+K N+LLDS+ K+ DFG ++ T T+ GTP YL PE
Sbjct: 122 --IVYRDLKPENLLLDSDGYIKITDFGFAKRV----KGRTY-----TLC-GTPEYLAPEI 169
Query: 805 FLTHKLTDKS-DVYSLGVVLLELLTGMQP 832
L K K+ D ++LG+++ E+L G P
Sbjct: 170 IL-SKGYGKAVDWWALGILIYEMLAGYPP 197
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 79.3 bits (196), Expect = 4e-16
Identities = 64/210 (30%), Positives = 99/210 (47%), Gaps = 21/210 (10%)
Query: 632 QVGQGGYGKVYKGI-LSDNTTVAIKRAEEGSLQGQNEFLT---EIKLLSRLHHRNLVSLL 687
++G G YG VYK ++ VAIK L+ ++F EI +L H N+V+
Sbjct: 10 RIGSGTYGDVYKARDIATGELVAIKVI---KLEPGDDFEIIQQEISMLKECRHPNIVAYF 66
Query: 688 GYCDEEGEQMLVYEFVPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPV 747
G + +V E+ G+L+D T+ L+ V ++ KG+ YLH
Sbjct: 67 GSYLRRDKLWIVMEYCGGGSLQDIYQ-VTRGPLSELQIAYVCRETLKGLAYLHETG---K 122
Query: 748 FHRDIKASNILLDSNLNAKVADFGLSRLAPVLDDEGTMPTHVSTIVKGTPGYLDPEYFLT 807
HRDIK +NILL + + K+ADFG+S L T+ S I GTP ++ PE
Sbjct: 123 IHRDIKGANILLTEDGDVKLADFGVS---AQLTA--TIAKRKSFI--GTPYWMAPEVAAV 175
Query: 808 HKLTD---KSDVYSLGVVLLELLTGMQPIS 834
+ K D+++LG+ +EL P+
Sbjct: 176 ERKGGYDGKCDIWALGITAIELAELQPPMF 205
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 79.4 bits (195), Expect = 4e-16
Identities = 63/213 (29%), Positives = 99/213 (46%), Gaps = 22/213 (10%)
Query: 633 VGQGGYGKVYKGILSDNTTVAIKRAEEGSLQGQNEFLTEIKLLSRL-HHRNLVSLLGYCD 691
VG G YG+VYKG +A + + + + E EI +L + HHRN+ + G
Sbjct: 14 VGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFI 73
Query: 692 EEG-----EQM-LVYEFVPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHP 745
++ +Q+ LV EF G++ D + L + + +G+ +LH
Sbjct: 74 KKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHK-- 131
Query: 746 PVFHRDIKASNILLDSNLNAKVADFGLSRLAPVLDDEGTMPTHVSTIVKGTPGYLDPEYF 805
V HRDIK N+LL N K+ DFG+S A + G T + GTP ++ PE
Sbjct: 132 -VIHRDIKGQNVLLTENAEVKLVDFGVS--AQLDRTVGRRNTFI-----GTPYWMAPEVI 183
Query: 806 LTHKLTD-----KSDVYSLGVVLLELLTGMQPI 833
+ D KSD++SLG+ +E+ G P+
Sbjct: 184 ACDENPDATYDFKSDLWSLGITAIEMAEGAPPL 216
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 79.8 bits (197), Expect = 5e-16
Identities = 73/224 (32%), Positives = 110/224 (49%), Gaps = 41/224 (18%)
Query: 627 FSSSTQVGQGGYGKVYKGILSDNTT---VAIKRAEEGSLQGQNE-----FLTEIKLLSRL 678
F Q+G+G YG+VYK D T VA+K+ L + E + EIK+L +L
Sbjct: 9 FDIIGQIGEGTYGQVYKAR--DKDTGELVALKKVR---LDNEKEGFPITAIREIKILRQL 63
Query: 679 HHRNLVSL----------LGYCDEEGEQMLVYEFVPN---GTLRDWLSGRTKENLNFAMR 725
+HRN+V+L L + ++G LV+E++ + G L L +++++ M+
Sbjct: 64 NHRNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDHIKSFMK 123
Query: 726 LRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSRLAPVLDDEGTM 785
L+ G+ Y H + HRDIK SNILL++ K+ADFGL+RL + E +
Sbjct: 124 Q--LLE---GLNYCHKKN---FLHRDIKCSNILLNNKGQIKLADFGLARL---YNSEESR 172
Query: 786 PTHVSTIVKGTPGYLDPEYFL-THKLTDKSDVYSLGVVLLELLT 828
P I T Y PE L + DV+S G +L EL T
Sbjct: 173 PYTNKVI---TLWYRPPELLLGEERYGPAIDVWSCGCILGELFT 213
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 77.7 bits (192), Expect = 1e-15
Identities = 70/271 (25%), Positives = 107/271 (39%), Gaps = 50/271 (18%)
Query: 633 VGQGGYGKVYKGIL-SDNTTVA---IKRAEEGSLQGQNEFLTEIKLLSRLHHRNLVSLL- 687
+G GG+G+V + S N T A +K+ Q +E ++L +H +V L
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYR 60
Query: 688 GYCDEEGEQMLVYEFVPNGTLRDWLSGRTKENLNFAMRLRVALDSAKG-------IL--- 737
+ D++ ML+ E+ G L +R R D +L
Sbjct: 61 TFKDKKYIYMLM-EYCLGGELWT------------ILRDRGLFDEYTARFYIACVVLAFE 107
Query: 738 YLHTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSRLAPVLDDEGTMPTHVSTIVKGTP 797
YLH + +RD+K N+LLDSN K+ DFG ++ + T T GTP
Sbjct: 108 YLHNRG---IIYRDLKPENLLLDSNGYVKLVDFGFAKKL-----KSGQKTW--TFC-GTP 156
Query: 798 GYLDPEYFLTHKLTDKSDVYSLGVVLLELLTGMQPISHGKNIVREVNVARDSGMVFSII- 856
Y+ PE L D +SLG++L ELLTG P D +++ I
Sbjct: 157 EYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFG---------EDDEDPMEIYNDIL 207
Query: 857 -DNRMGSYPSECVERFVTLALRCCHDKPEHR 886
N +P+ + L + PE R
Sbjct: 208 KGNGKLEFPNYIDKAAKDLIKQLLRRNPEER 238
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 78.1 bits (192), Expect = 1e-15
Identities = 63/213 (29%), Positives = 98/213 (46%), Gaps = 22/213 (10%)
Query: 633 VGQGGYGKVYKGILSDNTTVAIKRAEEGSLQGQNEFLTEIKLLSRL-HHRNLVSLLGY-- 689
VG G YG+VYKG +A + + + + E EI +L + HHRN+ + G
Sbjct: 24 VGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKLEINMLKKYSHHRNIATYYGAFI 83
Query: 690 ----CDEEGEQMLVYEFVPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHP 745
+ + LV EF G++ D + L + + +G+ +LH AH
Sbjct: 84 KKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLH--AHK 141
Query: 746 PVFHRDIKASNILLDSNLNAKVADFGLSRLAPVLDDEGTMPTHVSTIVKGTPGYLDPEYF 805
V HRDIK N+LL N K+ DFG+S A + G T + GTP ++ PE
Sbjct: 142 -VIHRDIKGQNVLLTENAEVKLVDFGVS--AQLDRTVGRRNTFI-----GTPYWMAPEVI 193
Query: 806 LTHKLTD-----KSDVYSLGVVLLELLTGMQPI 833
+ D +SD++SLG+ +E+ G P+
Sbjct: 194 ACDENPDATYDYRSDIWSLGITAIEMAEGAPPL 226
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 79.1 bits (195), Expect = 1e-15
Identities = 63/177 (35%), Positives = 88/177 (49%), Gaps = 31/177 (17%)
Query: 671 EIKLLSRLHHRNLVSLLGYCDEEGEQMLVYEFVPNGTLRDWLSGRTKENLNFAMRLRVAL 730
EI++L ++H N+V D GE ++ EF+ G+L E + A +A
Sbjct: 122 EIEILRDVNHPNVVKCHDMFDHNGEIQVLLEFMDGGSL---------EGTHIADEQFLA- 171
Query: 731 DSAK----GILYLHTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSR-LAPVLDDEGTM 785
D A+ GI YLH + HRDIK SN+L++S N K+ADFG+SR LA +D
Sbjct: 172 DVARQILSGIAYLHRRH---IVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMD----- 223
Query: 786 PTHVSTIVKGTPGYLDPEYF---LTHKLTD--KSDVYSLGVVLLELLTGMQPISHGK 837
P + S GT Y+ PE L H D D++SLGV +LE G P G+
Sbjct: 224 PCNSSV---GTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGR 277
|
Length = 353 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 78.5 bits (193), Expect = 2e-15
Identities = 65/218 (29%), Positives = 103/218 (47%), Gaps = 27/218 (12%)
Query: 627 FSSSTQVGQGGYGKVYKGILSDN-----TTVAIKRAEEG-SLQGQNEFLTEIKLLSRLHH 680
F +G G +G VYKG+ VAIK E S + E L E +++ + +
Sbjct: 9 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 68
Query: 681 RNLVSLLGYCDEEGEQMLVYEFVPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLH 740
++ LLG C Q L+ + +P G L D++ K+N+ L + AKG+ YL
Sbjct: 69 PHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVR-EHKDNIGSQYLLNWCVQIAKGMNYLE 126
Query: 741 TEAHPPVFHRDIKASNILLDSNLNAKVADFGLSRLAPVLDDE-----GTMPTHVSTIVKG 795
E + HRD+ A N+L+ + + K+ DFGL++L + E G +P
Sbjct: 127 -ERR--LVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKVPIK------- 176
Query: 796 TPGYLDPEYFLTHKLTDKSDVYSLGVVLLELLT-GMQP 832
++ E L T +SDV+S GV + EL+T G +P
Sbjct: 177 ---WMALESILHRIYTHQSDVWSYGVTVWELMTFGSKP 211
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 77.9 bits (192), Expect = 2e-15
Identities = 60/206 (29%), Positives = 99/206 (48%), Gaps = 15/206 (7%)
Query: 627 FSSSTQVGQGGYGKVYKGI-LSDNTTVAIK--RAEEGSLQGQNEFLTEIKLLSRLHHRNL 683
F ++G+G YG VYK VA+K R + + + + EI LL L+H N+
Sbjct: 2 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 61
Query: 684 VSLLGYCDEEGEQMLVYEFVPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEA 743
V LL E + LV+EF+ + L+ ++ + + +G+ + H +
Sbjct: 62 VKLLDVIHTENKLYLVFEFL-HQDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCH--S 118
Query: 744 HPPVFHRDIKASNILLDSNLNAKVADFGLSRLAPVLDDEGTMPTHVSTIVKGTPGYLDPE 803
H V HRD+K N+L+++ K+ADFGL+R V + T+ +V T Y PE
Sbjct: 119 HR-VLHRDLKPQNLLINTEGAIKLADFGLARAFGV-----PVRTYTHEVV--TLWYRAPE 170
Query: 804 YFLTHKL-TDKSDVYSLGVVLLELLT 828
L K + D++SLG + E++T
Sbjct: 171 ILLGCKYYSTAVDIWSLGCIFAEMVT 196
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 78.3 bits (193), Expect = 2e-15
Identities = 77/264 (29%), Positives = 116/264 (43%), Gaps = 51/264 (19%)
Query: 624 TAYFSSSTQVGQGGYGKV--YKGILSDNTTVAIKRAEEGSLQGQNEFLT---------EI 672
T + VG G +G V + L+ VAIK+ F T E+
Sbjct: 9 TNRYVDLQPVGMGAFGLVCSARDQLT-GQNVAIKKI-------MKPFSTPVLAKRTYREL 60
Query: 673 KLLSRLHHRNLVSLLGYCDEEGEQM-LVYEFVPNGT-LRDWLSGRTKENLNFAMRLRVAL 730
KLL L H N++SL E + V E + GT L L+ R E F
Sbjct: 61 KLLKHLRHENIISLSDIFISPLEDIYFVTELL--GTDLHRLLTSRPLEK-QFIQYF--LY 115
Query: 731 DSAKGILYLHTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSRLAPVLDDEGTMPTHVS 790
+G+ Y+H+ V HRD+K SNIL++ N + K+ DFGL+R+ + M +VS
Sbjct: 116 QILRGLKYVHSAG---VVHRDLKPSNILINENCDLKICDFGLARI-----QDPQMTGYVS 167
Query: 791 TIVKGTPGYLDPEYFLT-HKLTDKSDVYSLGVVLLELLTGMQPISHGKNIVREVNVARDS 849
T Y PE LT K + D++S G + E+L G +P+ GK+ V +
Sbjct: 168 TRY-----YRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEG-KPLFPGKDHVNQ------- 214
Query: 850 GMVFSIIDNRMGSYPSECVERFVT 873
FSII + +G+ P + + +
Sbjct: 215 ---FSIITDLLGTPPDDVINTICS 235
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 77.9 bits (192), Expect = 2e-15
Identities = 63/221 (28%), Positives = 101/221 (45%), Gaps = 34/221 (15%)
Query: 632 QVGQGGYGKVYKGILSDN-TTVAIKRAEEGSLQGQNE-----FLTEIKLLSRLHHRNLVS 685
++G+G YG V+K + VA+KR L +E L EI LL L H+N+V
Sbjct: 7 KIGEGTYGTVFKAKNRETHEIVALKRV---RLDDDDEGVPSSALREICLLKELKHKNIVR 63
Query: 686 LLGYCDEEGEQMLVYEFVPNGTLR--DWLSGRTKENL--NFAMRLRVALDSAKGILYLHT 741
L + + LV+E+ + D +G + +F +L KG+ + H+
Sbjct: 64 LYDVLHSDKKLTLVFEYCDQDLKKYFDSCNGDIDPEIVKSFMFQL------LKGLAFCHS 117
Query: 742 EAHPPVFHRDIKASNILLDSNLNAKVADFGLSRL--APVLDDEGTMPTHVSTIVKGTPGY 799
V HRD+K N+L++ N K+ADFGL+R PV + + +V T Y
Sbjct: 118 HN---VLHRDLKPQNLLINKNGELKLADFGLARAFGIPV-------RCYSAEVV--TLWY 165
Query: 800 LDPEYFLTHKLTDKS-DVYSLGVVLLELLTGMQPISHGKNI 839
P+ KL S D++S G + EL +P+ G ++
Sbjct: 166 RPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDV 206
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 76.9 bits (189), Expect = 2e-15
Identities = 69/268 (25%), Positives = 113/268 (42%), Gaps = 32/268 (11%)
Query: 633 VGQGGYGK--VYKGILSDNTTVAIKRAEEGSLQGQNEFLTEIKLLSRLHHRNLVSLLGYC 690
VG+G +G+ + + + SD + S + E LL+++ H N+V+
Sbjct: 8 VGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESF 67
Query: 691 DEEGEQMLVYEFVPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHR 750
+ +G +V E+ G L + + + L+ + G+ ++H + V HR
Sbjct: 68 EADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKR---VLHR 124
Query: 751 DIKASNILLDSNLNAKVADFGLSRLAPVLDDEGTMPTHVSTIVKGTPGYLDPEYFLTHKL 810
DIK+ NI L N K+ DFG +RL T P + GTP Y+ PE +
Sbjct: 125 DIKSKNIFLTQNGKVKLGDFGSARLL-------TSPGAYACTYVGTPYYVPPEIWENMPY 177
Query: 811 TDKSDVYSLGVVLLELLTGMQPISHG--KNIVREVNVARDSGMVFSIIDNRMGSY---PS 865
+KSD++SLG +L EL T P KN++ +V GSY PS
Sbjct: 178 NNKSDIWSLGCILYELCTLKHPFQANSWKNLILKVC---------------QGSYKPLPS 222
Query: 866 ECVERFVTLALRCCHDKPEHRPSMSDVV 893
+L + P RPS + ++
Sbjct: 223 HYSYELRSLIKQMFKRNPRSRPSATTIL 250
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 77.7 bits (192), Expect = 2e-15
Identities = 71/218 (32%), Positives = 102/218 (46%), Gaps = 43/218 (19%)
Query: 630 STQVGQGGYGKVYKGI-LSDNTTVAIKR-----AEEGSLQGQNEFLTEIKLLSRL---HH 680
++G+G YG VYK L+ VA+K+ +EEG L EI LL +L H
Sbjct: 4 LAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLST---LREIALLKQLESFEH 60
Query: 681 RNLVSLLGYC-----DEEGEQMLVYEFVPNGTLRDWLS-----GRTKENLNFAMR--LRV 728
N+V LL C D E + LV+E V + L +LS G E + MR LR
Sbjct: 61 PNIVRLLDVCHGPRTDRELKLTLVFEHV-DQDLATYLSKCPKPGLPPETIKDLMRQLLR- 118
Query: 729 ALDSAKGILYLHTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSRLAPVLDDEGTMPTH 788
G+ +LH+ + HRD+K NIL+ S+ K+ADFGL+R + E + +
Sbjct: 119 ------GVDFLHSHR---IVHRDLKPQNILVTSDGQVKIADFGLAR---IYSFEMALTSV 166
Query: 789 VSTIVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVLLEL 826
V T+ Y PE L D++S+G + EL
Sbjct: 167 VVTL-----WYRAPEVLLQSSYATPVDMWSVGCIFAEL 199
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 78.5 bits (194), Expect = 2e-15
Identities = 61/241 (25%), Positives = 100/241 (41%), Gaps = 45/241 (18%)
Query: 627 FSSSTQVGQGGYGKVYKGILSDNTT---VAIKRAEEGSLQGQNE---FLTEIKLLSRLHH 680
F +G+G +G+V+ ++ D T A+K + + +N+ E +L+
Sbjct: 3 FEVIKVIGRGAFGEVW--LVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADS 60
Query: 681 RNLVSLLGYCDEEGEQMLVYEFVPNGTLRDWLS--GRTKENLN--FAMRLRVALDSAKGI 736
+V L +E LV E++P G L + L E + L +ALDS +
Sbjct: 61 PWIVKLYYSFQDEEHLYLVMEYMPGGDLMNLLIRKDVFPEETARFYIAELVLALDSVHKL 120
Query: 737 LYLHTEAHPPVFHRDIKASNILLDSNLNAKVADFGLS--------------RLAPVLDDE 782
++H RDIK NIL+D++ + K+ADFGL +L +
Sbjct: 121 GFIH---------RDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRD 171
Query: 783 GTMP---------THVSTIVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVLLELLTGMQPI 833
+ ++ V GTP Y+ PE + D +SLGV+L E+L G P
Sbjct: 172 NVLVRRRDHKQRRVRANSTV-GTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPF 230
Query: 834 S 834
Sbjct: 231 Y 231
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 77.1 bits (190), Expect = 2e-15
Identities = 63/268 (23%), Positives = 118/268 (44%), Gaps = 37/268 (13%)
Query: 641 VYKGILSDNTTVAI---KRAEEGSLQGQNEFLTEIKLLSRLHHRNLVSLLGY----CDEE 693
+YKGI +N V I K+ +G + EIK L R+ N++ + G+ D+
Sbjct: 36 IYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDL 94
Query: 694 GEQMLVYEFVPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIK 753
L+ E+ G LR+ L +++L+F +L +A+D KG+ L+ + P ++++
Sbjct: 95 PRLSLILEYCTRGYLREVL--DKEKDLSFKTKLDMAIDCCKGLYNLYKYTNKP--YKNLT 150
Query: 754 ASNILLDSNLNAKVADFGLSRLAPVLDDEGTMPTHVSTIVKGTPGYLDPEYFLT--HKLT 811
+ + L+ N K+ GL ++ + +V+ +V Y + + T
Sbjct: 151 SVSFLVTENYKLKIICHGLEKILSSPPFK-----NVNFMV-----YFSYKMLNDIFSEYT 200
Query: 812 DKSDVYSLGVVLLELLTGMQPISHGKNIVREVNVARDSGMVFSIIDNRMGSY--PSECVE 869
K D+YSLGVVL E+ TG P + + ++ +I N+ S P +C
Sbjct: 201 IKDDIYSLGVVLWEIFTGKIPFEN-----------LTTKEIYDLIINKNNSLKLPLDCPL 249
Query: 870 RFVTLALRCCHDKPEHRPSMSDVVRELE 897
+ C RP++ +++ L
Sbjct: 250 EIKCIVEACTSHDSIKRPNIKEILYNLS 277
|
Length = 283 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 76.8 bits (190), Expect = 3e-15
Identities = 60/216 (27%), Positives = 96/216 (44%), Gaps = 27/216 (12%)
Query: 632 QVGQGGYGKVYKGI-LSDNTTVAIKRAEEGSLQGQNEF--LTEIKLLSRL-HHRNLVSLL 687
Q+G G +G VY VAIK+ ++ E L E+K L +L H N+V L
Sbjct: 6 QLGDGTFGSVYLARNKETGELVAIKKMKK-KFYSWEECMNLREVKSLRKLNEHPNIVKLK 64
Query: 688 GYCDEEGEQMLVYEFVPNGTLRDWLSGRTKENLNFAMRLR-VALDSAKGILYLHTEAHPP 746
E E V+E++ G L + R + + +R + +G+ ++H
Sbjct: 65 EVFRENDELYFVFEYM-EGNLYQLMKDRKGKPFS-ESVIRSIIYQILQGLAHIHKHGF-- 120
Query: 747 VFHRDIKASNILLDSNLNAKVADFGLSRLAPVLDDEGTMPTH---VSTIVKGTPGYLDPE 803
FHRD+K N+L+ K+ADFGL+R + P + VS T Y PE
Sbjct: 121 -FHRDLKPENLLVSGPEVVKIADFGLAR--EIRS----RPPYTDYVS-----TRWYRAPE 168
Query: 804 YFLTHKLTDKS-DVYSLGVVLLELLTGMQPISHGKN 838
L D+++LG ++ EL T ++P+ G +
Sbjct: 169 ILLRSTSYSSPVDIWALGCIMAELYT-LRPLFPGSS 203
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 76.9 bits (189), Expect = 4e-15
Identities = 58/203 (28%), Positives = 96/203 (47%), Gaps = 16/203 (7%)
Query: 632 QVGQGGYGKVYKGI-LSDNTTVAIKRAEEGSLQGQNEFLTEIKLLSRLHHRNLVSLLGYC 690
++GQG G VY I ++ VAIK+ + + EI ++ H N+V+ L
Sbjct: 26 KIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSY 85
Query: 691 DEEGEQMLVYEFVPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHR 750
E +V E++ G+L D ++ + A R L + + +LH+ V HR
Sbjct: 86 LVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALE---FLHSNQ---VIHR 139
Query: 751 DIKASNILLDSNLNAKVADFGL-SRLAPVLDDEGTMPTHVSTIVKGTPGYLDPEYFLTHK 809
DIK+ NILL + + K+ DFG +++ P TM GTP ++ PE
Sbjct: 140 DIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTM--------VGTPYWMAPEVVTRKA 191
Query: 810 LTDKSDVYSLGVVLLELLTGMQP 832
K D++SLG++ +E++ G P
Sbjct: 192 YGPKVDIWSLGIMAIEMVEGEPP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 78.8 bits (194), Expect = 4e-15
Identities = 80/274 (29%), Positives = 114/274 (41%), Gaps = 31/274 (11%)
Query: 630 STQVGQGGYGKV-YKGILSDNTTVAIKRAE-EG-SLQGQNEFLTEIKLLSRLHHRNLVSL 686
S +G G G V +SD A+K + EG S +N E+ L ++V
Sbjct: 37 SRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKC 96
Query: 687 ---LGYCDEEGEQM-----LVYEFVPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILY 738
D + LV ++ G LR + R K N F L + +L
Sbjct: 97 HEDFAKKDPRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREH-EAGLLFIQVLLA 155
Query: 739 LHTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSRL--APVLDDEGTMPTHVSTIVKGT 796
+H + HRDIK++NILL SN K+ DFG S++ A V DD V GT
Sbjct: 156 VHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDD-------VGRTFCGT 208
Query: 797 PGYLDPEYFLTHKLTDKSDVYSLGVVLLELLTGMQPISHGKNIVREVNVARDSGMVFSII 856
P Y+ PE + + K+D++SLGV+L ELLT +P G+N+ EV +G
Sbjct: 209 PYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFD-GENM-EEVMHKTLAG------ 260
Query: 857 DNRMGSYPSECVERFVTLALRCCHDKPEHRPSMS 890
R P + P+ RPS S
Sbjct: 261 --RYDPLPPSISPEMQEIVTALLSSDPKRRPSSS 292
|
Length = 496 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 75.8 bits (186), Expect = 5e-15
Identities = 74/281 (26%), Positives = 118/281 (41%), Gaps = 37/281 (13%)
Query: 625 AYFSSSTQVGQGGYGKVYKGI-LSDNTTVAIKRA---EEGSLQGQNEFLTEIKLLSRLHH 680
A F ++G+G + +VY+ L D VA+K+ E + + + + EI LL +L+H
Sbjct: 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNH 61
Query: 681 RNLVSLLGYCDEEGEQMLVYEFVPNGTLRDWLSGRTKENLNFAMR----LRVALDSAKGI 736
N++ L E+ E +V E G L + K+ R V L SA +
Sbjct: 62 PNVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSA--V 119
Query: 737 LYLHTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSRLAPVLDDEGTMPTHVSTIVKGT 796
++H+ V HRDIK +N+ + + K+ D GL R + T ++V GT
Sbjct: 120 EHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFF------SSKTTAAHSLV-GT 169
Query: 797 PGYLDPEYFLTHKLTDKSDVYSLGVVLLELLTGMQPISHGKNIVREVNVARDSGMVFSII 856
P Y+ PE + KSD++SLG +L E+ P D +FS+
Sbjct: 170 PYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYG------------DKMNLFSLC 217
Query: 857 DN-RMGSYP----SECVERFVTLALRCCHDKPEHRPSMSDV 892
YP E+ L C + P+ RP + V
Sbjct: 218 QKIEQCDYPPLPTEHYSEKLRELVSMCIYPDPDQRPDIGYV 258
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 76.2 bits (187), Expect = 5e-15
Identities = 65/221 (29%), Positives = 104/221 (47%), Gaps = 28/221 (12%)
Query: 632 QVGQGGYGKVYK------GILSDNTTVAIKRAEEGSLQGQNEFLTEIKLLSRLHHRNLVS 685
++G G +GKVYK G+L+ + K EE +++ EI +L+ H N+V
Sbjct: 12 ELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEE-----LEDYMVEIDILASCDHPNIVK 66
Query: 686 LLGYCDEEGEQMLVYEFVPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHP 745
LL E ++ EF G + D + + L V + + + YLH
Sbjct: 67 LLDAFYYENNLWILIEFCAGGAV-DAVMLELERPLTEPQIRVVCKQTLEALNYLHENK-- 123
Query: 746 PVFHRDIKASNILLDSNLNAKVADFGLSRLAPVLDDEGTMPTHVSTIVKGTPGYLDPEYF 805
+ HRD+KA NIL + + K+ADFG+S + T+ S I GTP ++ PE
Sbjct: 124 -IIHRDLKAGNILFTLDGDIKLADFGVSA-----KNTRTIQRRDSFI--GTPYWMAPEVV 175
Query: 806 LTHKLTD-----KSDVYSLGVVLLELLTGMQPISHGKNIVR 841
+ D K+DV+SLG+ L+E + ++P H N +R
Sbjct: 176 MCETSKDRPYDYKADVWSLGITLIE-MAQIEPPHHELNPMR 215
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 75.6 bits (186), Expect = 7e-15
Identities = 55/216 (25%), Positives = 99/216 (45%), Gaps = 18/216 (8%)
Query: 633 VGQGGYGKVYKGILSDNTTV-AIKRAEEGSL---QGQNEFLTEIKLLSRLHHRNLVSLLG 688
+G+GG+G+V + + A K+ ++ L +G+ L E K+L ++ R +VSL
Sbjct: 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSL-A 59
Query: 689 YCDEEGEQM-LVYEFVPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPV 747
Y E + + LV + G L+ + + A + A G+ +LH +
Sbjct: 60 YAFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRR---I 116
Query: 748 FHRDIKASNILLDSNLNAKVADFGLSRLAPVLDDEGTMPTHVSTIVKGTPGYLDPEYFLT 807
+RD+K N+LLD + N +++D GL+ ++ +G GTPGY+ PE
Sbjct: 117 VYRDLKPENVLLDDHGNVRISDLGLA-----VELKGGKKIKGRA---GTPGYMAPEVLQG 168
Query: 808 HKLTDKSDVYSLGVVLLELLTGMQPI-SHGKNIVRE 842
D ++LG L E++ G P + + +E
Sbjct: 169 EVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKE 204
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 76.2 bits (187), Expect = 7e-15
Identities = 72/272 (26%), Positives = 119/272 (43%), Gaps = 36/272 (13%)
Query: 632 QVGQGGYGKVYKGILS-DNTTVAIKRAEEGSLQGQNEF---LTEIKLLSRLHHRNLVSLL 687
++G G +G VY S N VA+K+ Q ++ + E+K L +L H N +
Sbjct: 28 EIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYK 87
Query: 688 GYCDEEGEQMLVYEFVPNGTLRDWLSGRTK--ENLNFAMRLRVALDSAKGILYLHTEAHP 745
G +E LV E+ G+ D L K + + A AL +G+ YLH+
Sbjct: 88 GCYLKEHTAWLVMEYCL-GSASDLLEVHKKPLQEVEIAAITHGAL---QGLAYLHSHN-- 141
Query: 746 PVFHRDIKASNILLDSNLNAKVADFGLSRLAPVLDDEGTMPTHVSTIVKGTPGYLDPEYF 805
+ HRDIKA NILL K+ADFG + + + ++ V GTP ++ PE
Sbjct: 142 -MIHRDIKAGNILLTEPGQVKLADFGSASKS----------SPANSFV-GTPYWMAPEVI 189
Query: 806 LTH---KLTDKSDVYSLGVVLLELLTGMQPISHGKNIVREVNVARDSGMVFSIIDNRMGS 862
L + K DV+SLG+ +EL P+ + + ++A++
Sbjct: 190 LAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSPTLQ-------- 241
Query: 863 YPSECVERFVTLALRCCHDKPEHRPSMSDVVR 894
+E + F C P+ RP+ ++++R
Sbjct: 242 -SNEWTDSFRGFVDYCLQKIPQERPASAELLR 272
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 76.6 bits (189), Expect = 9e-15
Identities = 63/220 (28%), Positives = 98/220 (44%), Gaps = 53/220 (24%)
Query: 633 VGQGGYGKVYKGILSD-NTTVAIK---RAEEGSLQGQNEFLTEIKLLSRLHHRNLVSLLG 688
VG G YG+V + VAIK R + ++ + + E++LL + H N++ LL
Sbjct: 23 VGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTY-RELRLLKHMDHENVIGLLD 81
Query: 689 YCDEEGEQMLVYEFVPNGTLRDW--------LSGRTKENLNFAMRLRVALDSA------- 733
F P +L D+ L G +LN ++ + D
Sbjct: 82 V------------FTPASSLEDFQDVYLVTHLMGA---DLNNIVKCQKLSDDHIQFLVYQ 126
Query: 734 --KGILYLHTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSRLAPVLDDEGTMPTHVST 791
+G+ Y+H+ A + HRD+K SNI ++ + K+ DFGL+R DDE M +V
Sbjct: 127 ILRGLKYIHS-AG--IIHRDLKPSNIAVNEDCELKILDFGLARHT---DDE--MTGYV-- 176
Query: 792 IVKGTPGYLDPEYFLT--HKLTDKSDVYSLGVVLLELLTG 829
T Y PE L H D++S+G ++ ELLTG
Sbjct: 177 ---ATRWYRAPEIMLNWMH-YNQTVDIWSVGCIMAELLTG 212
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 75.5 bits (185), Expect = 1e-14
Identities = 61/210 (29%), Positives = 101/210 (48%), Gaps = 18/210 (8%)
Query: 626 YFSSSTQVGQGGYGKVYKGILSDNTT---VAIKRAEEGSLQGQNEFLTEIKLLSRLHHRN 682
Y S ++G+G G V I ++ T VA+K+ + Q + E+ ++ HH N
Sbjct: 23 YLDSFIKIGEGSTGIVC--IATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHEN 80
Query: 683 LVSLLGYCDEEGEQMLVYEFVPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTE 742
+V + E +V EF+ G L D + T +N V L + + YLH +
Sbjct: 81 VVDMYNSYLVGDELWVVMEFLEGGALTDIV---THTRMNEEQIATVCLSVLRALSYLHNQ 137
Query: 743 AHPPVFHRDIKASNILLDSNLNAKVADFGLSRLAPVLDDEGTMPTHVSTIVKGTPGYLDP 802
V HRDIK+ +ILL S+ K++DFG A V + +P S + GTP ++ P
Sbjct: 138 G---VIHRDIKSDSILLTSDGRIKLSDFGFC--AQVSKE---VPKRKSLV--GTPYWMAP 187
Query: 803 EYFLTHKLTDKSDVYSLGVVLLELLTGMQP 832
E + D++SLG++++E++ G P
Sbjct: 188 EVISRLPYGTEVDIWSLGIMVIEMIDGEPP 217
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 75.7 bits (187), Expect = 1e-14
Identities = 68/225 (30%), Positives = 101/225 (44%), Gaps = 56/225 (24%)
Query: 632 QVGQGGYGKVYKGILSD---NTTVAIKR---AEEGSLQGQNEFLTEIKLLSRL-HHRNLV 684
++G+G YG V+K I D VA+K+ A + Q F EI L L H N+V
Sbjct: 14 KLGKGAYGIVWKAI--DRRTKEVVALKKIFDAFRNATDAQRTF-REIMFLQELGDHPNIV 70
Query: 685 SLLGYCDEEGEQ--MLVYEFVPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGIL----- 737
LL E ++ LV+E++ + +L+ +R IL
Sbjct: 71 KLLNVIKAENDKDIYLVFEYM-------------ETDLHAVIR--------ANILEDVHK 109
Query: 738 ------------YLHTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSRLAPVLDDEGTM 785
Y+H+ V HRD+K SNILL+S+ K+ADFGL+R L++
Sbjct: 110 RYIMYQLLKALKYIHSGN---VIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPEN 166
Query: 786 PTHVSTIVKGTPGYLDPEYFL-THKLTDKSDVYSLGVVLLELLTG 829
P V T T Y PE L + + T D++S+G +L E+L G
Sbjct: 167 P--VLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLG 209
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 76.8 bits (189), Expect = 2e-14
Identities = 56/178 (31%), Positives = 87/178 (48%), Gaps = 34/178 (19%)
Query: 29 LLAAAQTTDPQEASALRAIKNSLVDSMNHLRNWNKGDPCMSN---WTGVLC-FDTVETDG 84
++ A T +E SAL+ +K+SL + WN GDPC+ W+G C FD T G
Sbjct: 362 IITAESKTLLEEVSALQTLKSSL--GLPLRFGWN-GDPCVPQQHPWSGADCQFD--STKG 416
Query: 85 HLHVRELQLLSMNLSGNLAPELGQLSRLQYYFMW-NDLTGTIPKEIGNISSLIFLLLNGN 143
+ L L + L G + ++ +L LQ + N + G IP +G+I+SL L L+ N
Sbjct: 417 KWFIDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYN 476
Query: 144 KLSGSLPDELGYLSNLNRLQVDENNITGTIPKSFANLSRVRHLHLNNNSIGGQIPSEL 201
+GS+P+ LG L++L R L+LN NS+ G++P+ L
Sbjct: 477 SFNGSIPESLGQLTSL------------------------RILNLNGNSLSGRVPAAL 510
|
Length = 623 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 73.8 bits (181), Expect = 3e-14
Identities = 82/280 (29%), Positives = 130/280 (46%), Gaps = 47/280 (16%)
Query: 632 QVGQGGYGKVYKGILSDNTTVA------IKRAEEGSLQGQNEFL---TEIKLLSRLHHRN 682
++G+G +G VY ++ D VA +K G L NE + E +LLS+L H
Sbjct: 7 RLGKGSFGTVY--LVKDKKAVAEERLKVLKEIPVGELN-PNETVQANQEAQLLSKLDHPA 63
Query: 683 LVSLLGYCDEEGEQMLVYEFVPNGTLRDWL-----SGRT-KENLNFAMRLRVALDSAKGI 736
+V E ++ E+ L L +G+T EN +++ L G+
Sbjct: 64 IVKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLL----GV 119
Query: 737 LYLHTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSRLAPVLDDEGTMPTHVSTIVKGT 796
Y+H + HRD+KA NI L +NL K+ DFG+SRL D ++T GT
Sbjct: 120 HYMHQRR---ILHRDLKAKNIFLKNNL-LKIGDFGVSRLLMGSCD-------LATTFTGT 168
Query: 797 PGYLDPEYFLTHKLTD-KSDVYSLGVVLLELLTGMQPISHGKNIVREVNVARDSGMVFSI 855
P Y+ PE L H+ D KSD++SLG +L E+ + G+N + +V I
Sbjct: 169 PYYMSPEA-LKHQGYDSKSDIWSLGCILYEMCC-LAHAFEGQNFL---------SVVLRI 217
Query: 856 IDNRMGSYPSECVERFVTLALRCCHDK-PEHRPSMSDVVR 894
++ S P E R + ++ +K P RPS ++++R
Sbjct: 218 VEGPTPSLP-ETYSRQLNSIMQSMLNKDPSLRPSAAEILR 256
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 74.0 bits (182), Expect = 3e-14
Identities = 60/211 (28%), Positives = 102/211 (48%), Gaps = 18/211 (8%)
Query: 625 AYFSSSTQVGQGGYGKVYKGILSDNTT---VAIKRAEEGSLQGQNEFLTEIKLLSRLHHR 681
+Y + ++G+G G V I +D +T VA+K+ + Q + E+ ++ H
Sbjct: 19 SYLDNFVKIGEGSTGIVC--IATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHP 76
Query: 682 NLVSLLGYCDEEGEQMLVYEFVPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHT 741
N+V + E +V EF+ G L D + T +N V L K + +LH
Sbjct: 77 NIVEMYSSYLVGDELWVVMEFLEGGALTDIV---THTRMNEEQIATVCLAVLKALSFLHA 133
Query: 742 EAHPPVFHRDIKASNILLDSNLNAKVADFGLSRLAPVLDDEGTMPTHVSTIVKGTPGYLD 801
+ V HRDIK+ +ILL S+ K++DFG A V + +P S + GTP ++
Sbjct: 134 QG---VIHRDIKSDSILLTSDGRVKLSDFGFC--AQVSKE---VPRRKSLV--GTPYWMA 183
Query: 802 PEYFLTHKLTDKSDVYSLGVVLLELLTGMQP 832
PE + D++SLG++++E++ G P
Sbjct: 184 PEVISRLPYGTEVDIWSLGIMVIEMVDGEPP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 74.5 bits (183), Expect = 4e-14
Identities = 67/216 (31%), Positives = 109/216 (50%), Gaps = 27/216 (12%)
Query: 633 VGQGGYGKVY---KGILSD-NTTVAIKRAEEGSLQGQNEFLT--EIKLLSRLHHRNLVSL 686
+GQG +GKV+ K D A+K ++ +L+ ++ T E +L+ ++H +V L
Sbjct: 4 LGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKL 63
Query: 687 LGYCDEEGEQMLVYEFVPNGTLRDWLSGR---TKENLNFAM-RLRVALDSAKGILYLHTE 742
EG+ L+ +F+ G L LS T+E++ F + L +ALD +LH+
Sbjct: 64 HYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALD------HLHSL 117
Query: 743 AHPPVFHRDIKASNILLDSNLNAKVADFGLSRLAPVLDDEGTMPTHVSTIVKGTPGYLDP 802
+ +RD+K NILLD + K+ DFGLS+ + +D E + GT Y+ P
Sbjct: 118 G---IIYRDLKPENILLDEEGHIKLTDFGLSKES--IDHEKKAYSFC-----GTVEYMAP 167
Query: 803 EYFLTHKLTDKSDVYSLGVVLLELLTGMQPISHGKN 838
E T +D +S GV++ E+LTG P GK+
Sbjct: 168 EVVNRRGHTQSADWWSFGVLMFEMLTGSLPF-QGKD 202
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 73.4 bits (180), Expect = 4e-14
Identities = 81/289 (28%), Positives = 126/289 (43%), Gaps = 48/289 (16%)
Query: 632 QVGQGGYGKVYKGILSDNTTVAIKRAEE----GSLQGQNEFLTEIKLLSRLHHRNLVSLL 687
++G G +GKV + +T VA +E S + QNEFL + L H N++ L
Sbjct: 2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCL 61
Query: 688 GYCDEEGEQMLVYEFVPNGTLRDWLSGRTKENLNFAMRL--RVALDSAKGILYLHTEAHP 745
G C E +LV+E+ G L+ +LS N + L R+A + A G+ ++H
Sbjct: 62 GQCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHN-- 119
Query: 746 PVFHRDIKASNILLDSNLNAKVADFGL--SRLAP---VLDDEGTMPTHVSTIVKGTPGYL 800
H D+ N L S+L KV D+G+ SR +D+ +P +L
Sbjct: 120 -FLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETEDDKCVPLR----------WL 168
Query: 801 DPEY-------FLTHKLTDKSDVYSLGVVLLELL-TGMQPISHGKNIVREVNVARDSGMV 852
PE +T + T S+V++LGV L EL QP SH + REV +
Sbjct: 169 APELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSD--REV--------L 218
Query: 853 FSIIDNRMGSYPSECVE-----RFVTLALRCCHDKPEHRPSMSDVVREL 896
+I ++ +E R+ + L+ C PE R + +V R L
Sbjct: 219 NHVIKDQQVKLFKPQLELPYSERWYEV-LQFCWLSPEKRATAEEVHRLL 266
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 72.9 bits (179), Expect = 4e-14
Identities = 72/281 (25%), Positives = 120/281 (42%), Gaps = 51/281 (18%)
Query: 632 QVGQGGYGKVYKGILSDNTT----VAIKRAEEGSLQGQ--NEFLTEIKLLSRLHHRNLVS 685
++G+G +GK IL + IK + + E E+ +LS + H N+V
Sbjct: 7 KIGEGSFGK---AILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQ 63
Query: 686 LLGYCDEEGEQMLVYEFVPNGTLRDWLSGR------TKENLNFAMRLRVALDSAKGILYL 739
+E G +V ++ G L ++ + + L++ +++ +AL ++
Sbjct: 64 YQESFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALK------HV 117
Query: 740 HTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSRLAPVLDDEGTMPTHVSTIVKGTPGY 799
H + HRDIK+ NI L + K+ DFG++R VL+ T+ + I GTP Y
Sbjct: 118 HDRK---ILHRDIKSQNIFLTKDGTIKLGDFGIAR---VLNS--TVELARTCI--GTPYY 167
Query: 800 LDPEYFLTHKLTDKSDVYSLGVVLLELLTGMQPISHG--KNIVREVNVARDSGMVFSIID 857
L PE +KSD+++LG VL E+ T G KN +V II
Sbjct: 168 LSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKN------------LVLKIIR 215
Query: 858 NRMGSYPSECVE---RFVTLALRCCHDKPEHRPSMSDVVRE 895
GSYP L + P RPS++ ++ +
Sbjct: 216 ---GSYPPVSSHYSYDLRNLVSQLFKRNPRDRPSVNSILEK 253
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 76.4 bits (188), Expect = 5e-14
Identities = 67/242 (27%), Positives = 110/242 (45%), Gaps = 28/242 (11%)
Query: 669 LTEIKLLSRLHHRNLVSLLGYCDEEGEQMLVYEFVPNGTLRDWLSGRTKENLNFAMRLRV 728
+EI + +L H N+V L+G C E L++E++ L + L NL++ R ++
Sbjct: 731 SSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVLR-----NLSWERRRKI 785
Query: 729 ALDSAKGILYLHTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSRLAPVLDDEGTMPTH 788
A+ AK + +LH P V ++ I++D D RL+ G + T
Sbjct: 786 AIGIAKALRFLHCRCSPAVVVGNLSPEKIIID------GKDEPHLRLSL----PGLLCTD 835
Query: 789 VSTIVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVLLELLTGMQPISHGKNIVRE--VNVA 846
+ + Y+ PE T +T+KSD+Y G++L+ELLTG P + + V V A
Sbjct: 836 TKCFI--SSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSP-ADAEFGVHGSIVEWA 892
Query: 847 RDS-------GMVFSIIDNRMGSYPSECVERFVTLALRCCHDKPEHRPSMSDVVRELENI 899
R + I + +E VE + LAL C P RP +DV++ LE+
Sbjct: 893 RYCYSDCHLDMWIDPSIRGDVSVNQNEIVE-VMNLALHCTATDPTARPCANDVLKTLESA 951
Query: 900 LK 901
+
Sbjct: 952 SR 953
|
Length = 968 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 72.7 bits (178), Expect = 5e-14
Identities = 56/214 (26%), Positives = 98/214 (45%), Gaps = 16/214 (7%)
Query: 625 AYFSSSTQVGQGGYGKVYKGI-LSDNTTVAIKRAEEGSL---QGQNEFLTEIKLLSRLHH 680
A F ++G+G + +VY+ L D VA+K+ + L + + + + EI LL +L+H
Sbjct: 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNH 61
Query: 681 RNLVSLLGYCDEEGEQMLVYEFVPNGTLRDWLSGRTKENLNFAMRL--RVALDSAKGILY 738
N++ E+ E +V E G L + K+ + + + + +
Sbjct: 62 PNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEH 121
Query: 739 LHTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSRLAPVLDDEGTMPTHVSTIVKGTPG 798
+H+ V HRDIK +N+ + + K+ D GL R + T ++V GTP
Sbjct: 122 MHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFF------SSKTTAAHSLV-GTPY 171
Query: 799 YLDPEYFLTHKLTDKSDVYSLGVVLLELLTGMQP 832
Y+ PE + KSD++SLG +L E+ P
Sbjct: 172 YMSPERIHENGYNFKSDIWSLGCLLYEMAALQSP 205
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 73.3 bits (180), Expect = 6e-14
Identities = 68/225 (30%), Positives = 105/225 (46%), Gaps = 44/225 (19%)
Query: 632 QVGQGGYGKVYKGI-LSDNTTVAIKR----AEEGSLQGQNEFLTEIKLLSRLHHRNLVSL 686
++G+G Y VYKG + VA+K AEEG+ + + EI L+ L H N+V L
Sbjct: 7 KLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGT---PSTAIREISLMKELKHENIVRL 63
Query: 687 LGYCDEEGEQMLVYEFVPNGTLRDWLSGRTKENLNFAMRLRVALDSA----------KGI 736
E + MLV+E++ + L+ ++ R ALD KGI
Sbjct: 64 HDVIHTENKLMLVFEYM-DKDLKKYMDTHGV---------RGALDPNTVKSFTYQLLKGI 113
Query: 737 LYLHTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSRL--APVLDDEGTMPTHVSTIVK 794
+ H V HRD+K N+L++ K+ADFGL+R PV T V T+
Sbjct: 114 AFCHENR---VLHRDLKPQNLLINKRGELKLADFGLARAFGIPV----NTFSNEVVTL-- 164
Query: 795 GTPGYLDPEYFLTHKLTDKS-DVYSLGVVLLELLTGMQPISHGKN 838
Y P+ L + S D++S+G ++ E++TG +P+ G N
Sbjct: 165 ---WYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITG-RPLFPGTN 205
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 73.2 bits (179), Expect = 8e-14
Identities = 79/293 (26%), Positives = 126/293 (43%), Gaps = 39/293 (13%)
Query: 627 FSSSTQVGQGGYGKVYKGI-LSDNTTVAIKRAEEGSLQGQNEF---LTEIKLLSRLHHRN 682
FS ++G G +G VY + ++ VAIK+ Q ++ + E++ L +L H N
Sbjct: 17 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76
Query: 683 LVSLLGYCDEEGEQMLVYEFVPNGTLRDWLSGRTK--ENLNFAMRLRVALDSAKGILYLH 740
+ G E LV E+ G+ D L K + + A AL +G+ YLH
Sbjct: 77 TIQYRGCYLREHTAWLVMEYCL-GSASDLLEVHKKPLQEVEIAAVTHGAL---QGLAYLH 132
Query: 741 TEAHPPVFHRDIKASNILLDSNLNAKVADFG-LSRLAPVLDDEGTMPTHVSTIVKGTPGY 799
+ + HRD+KA NILL K+ DFG S +AP + GTP +
Sbjct: 133 SHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAP------------ANXFVGTPYW 177
Query: 800 LDPEYFLTH---KLTDKSDVYSLGVVLLELLTGMQPISHGKNIVREVNVARDSGMVFSII 856
+ PE L + K DV+SLG+ +EL P+ + + ++A++
Sbjct: 178 MAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQ-- 235
Query: 857 DNRMGSYPSECVERFVTLALRCCHDKPEHRPSMSDVVRELENILKMFPETDTM 909
+ SE FV C P+ RP+ S+V+ + +L+ P T M
Sbjct: 236 ----SGHWSEYFRNFVD---SCLQKIPQDRPT-SEVLLKHRFVLRERPPTVIM 280
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 72.7 bits (178), Expect = 9e-14
Identities = 73/292 (25%), Positives = 118/292 (40%), Gaps = 54/292 (18%)
Query: 632 QVGQGGYGKVYKG--ILSDNTTVAIKR-----AEEGSLQGQNEFLTEIKLLSRLHHRNLV 684
++G+G YGKV+K + + VA+KR EEG + ++ L H N+V
Sbjct: 8 EIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVV 67
Query: 685 SLLGYC-----DEEGEQMLVYEFVPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYL 739
L C D E + LV+E V + L +L + + + +G+ +L
Sbjct: 68 RLFDVCTVSRTDRETKLTLVFEHV-DQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFL 126
Query: 740 HTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSRLAPVLDDEGTMPTHVSTIVKGTPGY 799
H+ V HRD+K NIL+ S+ K+ADFGL+R+ T V T Y
Sbjct: 127 HSHR---VVHRDLKPQNILVTSSGQIKLADFGLARIYSF--------QMALTSVVVTLWY 175
Query: 800 LDPEYFLTHKLTDKSDVYSLGVVLLELLTGMQPISHGKNIVREVNVARDSGMVFSII--- 856
PE L D++S+G + E+ +P+ G + V ++ G + +I
Sbjct: 176 RAPEVLLQSSYATPVDLWSVGCIFAEMFR-RKPLFRGSSDVDQL------GKILDVIGLP 228
Query: 857 ------------DNRMGSYPSECVERFV--------TLALRCCHDKPEHRPS 888
S ++ +E+FV L L+C P R S
Sbjct: 229 GEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRIS 280
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 72.9 bits (179), Expect = 1e-13
Identities = 76/262 (29%), Positives = 117/262 (44%), Gaps = 59/262 (22%)
Query: 633 VGQGGYGKVYKGILSDNTT---VAIKRAEE--GSLQGQNEFLTEIKLLSRLHHRNLVSLL 687
+G+G YG V I D T VAIK+ + + L EIKLL L H ++V +
Sbjct: 8 IGKGSYGVVCSAI--DTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIK 65
Query: 688 GYC-----DEEGEQMLVYEFV---------PNGTLRDWLSGRTKENLNFAMR--LRVALD 731
E + +V+E + N L T E+ F + LR
Sbjct: 66 HIMLPPSRREFKDIYVVFELMESDLHQVIKANDDL-------TPEHHQFFLYQLLR---- 114
Query: 732 SAKGILYLHTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSRLAPVLDDEGTMPTHVST 791
+ Y+HT VFHRD+K NIL +++ K+ DFGL+R+A +D T T
Sbjct: 115 ---ALKYIHTAN---VFHRDLKPKNILANADCKLKICDFGLARVA--FNDTPT--AIFWT 164
Query: 792 IVKGTPGYLDPEY---FLTHKLTDKSDVYSLGVVLLELLTGMQPISHGKNIVREVNVARD 848
T Y PE F + K T D++S+G + E+LTG +P+ GKN+V +++
Sbjct: 165 DYVATRWYRAPELCGSFFS-KYTPAIDIWSIGCIFAEVLTG-KPLFPGKNVVHQLD---- 218
Query: 849 SGMVFSIIDNRMGSYPSECVER 870
+I + +G+ E + R
Sbjct: 219 ------LITDLLGTPSPETISR 234
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 72.7 bits (178), Expect = 1e-13
Identities = 62/208 (29%), Positives = 95/208 (45%), Gaps = 24/208 (11%)
Query: 633 VGQGGYGKVYKGILSDNTTV----AIKRAEEGSLQGQNEFLTEIKLLSRLHHRNLVSLLG 688
+G+G +GKV + D + I++A S L E +L++++ +V L
Sbjct: 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKF 60
Query: 689 YCDEEGEQMLVYEFVPNGTLRDWLSGRTKENLN----FAMRLRVALDSAKGILYLHTEAH 744
+ LV F+ G L L + +L+ + L AL++ LH
Sbjct: 61 SFQSPEKLYLVLAFINGGELFHHLQREGRFDLSRARFYTAELLCALEN------LHKFN- 113
Query: 745 PPVFHRDIKASNILLDSNLNAKVADFGLSRLAPVLDDEGTMPTHVSTIVKGTPGYLDPEY 804
V +RD+K NILLD + + DFGL +L DD+ + GTP YL PE
Sbjct: 114 --VIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDK-------TNTFCGTPEYLAPEL 164
Query: 805 FLTHKLTDKSDVYSLGVVLLELLTGMQP 832
L H T D ++LGV+L E+LTG+ P
Sbjct: 165 LLGHGYTKAVDWWTLGVLLYEMLTGLPP 192
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 71.3 bits (174), Expect = 2e-13
Identities = 56/208 (26%), Positives = 98/208 (47%), Gaps = 16/208 (7%)
Query: 627 FSSSTQVGQGGYGKVYKGI-LSDNTTVAIKRAEEGSLQGQNEFLTEIKLLSRLHHRNLVS 685
++ ++GQG G V+ I ++ VAIK+ + + EI ++ L + N+V+
Sbjct: 21 YTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVN 80
Query: 686 LLGYCDEEGEQMLVYEFVPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHP 745
L E +V E++ G+L D ++ + A R L + + +LH
Sbjct: 81 FLDSFLVGDELFVVMEYLAGGSLTDVVTETCMDEAQIAAVCRECL---QALEFLHANQ-- 135
Query: 746 PVFHRDIKASNILLDSNLNAKVADFGL-SRLAPVLDDEGTMPTHVSTIVKGTPGYLDPEY 804
V HRDIK+ N+LL + + K+ DFG +++ P TM GTP ++ PE
Sbjct: 136 -VIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRSTM--------VGTPYWMAPEV 186
Query: 805 FLTHKLTDKSDVYSLGVVLLELLTGMQP 832
K D++SLG++ +E++ G P
Sbjct: 187 VTRKAYGPKVDIWSLGIMAIEMVEGEPP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 71.3 bits (174), Expect = 3e-13
Identities = 57/208 (27%), Positives = 98/208 (47%), Gaps = 16/208 (7%)
Query: 627 FSSSTQVGQGGYGKVYKGI-LSDNTTVAIKRAEEGSLQGQNEFLTEIKLLSRLHHRNLVS 685
++ ++GQG G VY I ++ VAIK+ + + EI ++ + N+V+
Sbjct: 21 YTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVN 80
Query: 686 LLGYCDEEGEQMLVYEFVPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHP 745
L E +V E++ G+L D ++ + A R L + + +LH+
Sbjct: 81 YLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECL---QALDFLHSNQ-- 135
Query: 746 PVFHRDIKASNILLDSNLNAKVADFGL-SRLAPVLDDEGTMPTHVSTIVKGTPGYLDPEY 804
V HRDIK+ NILL + + K+ DFG +++ P TM GTP ++ PE
Sbjct: 136 -VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTM--------VGTPYWMAPEV 186
Query: 805 FLTHKLTDKSDVYSLGVVLLELLTGMQP 832
K D++SLG++ +E++ G P
Sbjct: 187 VTRKAYGPKVDIWSLGIMAIEMVEGEPP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 71.5 bits (175), Expect = 3e-13
Identities = 67/207 (32%), Positives = 97/207 (46%), Gaps = 21/207 (10%)
Query: 633 VGQGGYGKVYKGIL-SDNTTVAIKRAEEGSL---QGQNEFLTEIK-LLSRLHHRNLVSLL 687
+G+G +GKV SD + A+K ++ ++ + QN + E LL L H LV L
Sbjct: 3 IGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGL- 61
Query: 688 GYCDEEGEQM-LVYEFVPNGTLRDWLSGRTKENLNFAMRLRV-ALDSAKGILYLHTEAHP 745
Y + E++ V ++V G L L +E R R A + A I YLH+
Sbjct: 62 HYSFQTAEKLYFVLDYVNGGELFFHLQ---RERCFLEPRARFYAAEVASAIGYLHSLN-- 116
Query: 746 PVFHRDIKASNILLDSNLNAKVADFGLSRLAPVLDDEGTMPTHVSTIVKGTPGYLDPEYF 805
+ +RD+K NILLDS + + DFGL + EG P ++ GTP YL PE
Sbjct: 117 -IIYRDLKPENILLDSQGHVVLTDFGLCK-------EGVEPEETTSTFCGTPEYLAPEVL 168
Query: 806 LTHKLTDKSDVYSLGVVLLELLTGMQP 832
D + LG VL E+L G+ P
Sbjct: 169 RKEPYDRTVDWWCLGAVLYEMLYGLPP 195
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 69.8 bits (171), Expect = 5e-13
Identities = 58/218 (26%), Positives = 86/218 (39%), Gaps = 47/218 (21%)
Query: 633 VGQGGYGKVY--KGILSDNTTVAIKRAEEGSLQGQNEFLTEIKLLSRLHH----RNLVSL 686
+ +G +G VY K + + AIK ++ + +N+ +T +K + V+
Sbjct: 4 ISKGAFGSVYLAKKRSTGDY-FAIKVLKKSDMIAKNQ-VTNVKAERAIMMIQGESPYVAK 61
Query: 687 LGYCDEEGEQM-LVYEFVPNGTL-----------RDWLSGRTKENLNFAMRLRVALDSAK 734
L Y + + + LV E++ G DW E +
Sbjct: 62 LYYSFQSKDYLYLVMEYLNGGDCASLIKTLGGLPEDWAKQYIAEVVL------------- 108
Query: 735 GILYLHTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSRLAPVLDDEGTMPTHVSTIVK 794
G+ LH + HRDIK N+L+D + K+ DFGLSR G
Sbjct: 109 GVEDLHQRG---IIHRDIKPENLLIDQTGHLKLTDFGLSRN-------GLENKKFV---- 154
Query: 795 GTPGYLDPEYFLTHKLTDKSDVYSLGVVLLELLTGMQP 832
GTP YL PE L SD +SLG V+ E L G P
Sbjct: 155 GTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPP 192
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 70.6 bits (173), Expect = 5e-13
Identities = 63/208 (30%), Positives = 94/208 (45%), Gaps = 28/208 (13%)
Query: 632 QVGQGGYGKVYKGILSD---NTTVAIK--RAEEGSLQGQNEFLTEIKLLSRLHHRNLVSL 686
++G+G YG VYK D N T+A+K R E+ + + EI LL + H N+V L
Sbjct: 9 KIGEGTYGVVYKA--RDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRL 66
Query: 687 LGYCDEEGEQMLVYEFVPNGTLRDWLSGRTKENLNFAMRLRVA----LDSAKGILYLHTE 742
E LV+E+ L L + +FA R+ +GI Y H+
Sbjct: 67 QDVVHSEKRLYLVFEY-----LDLDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSH 121
Query: 743 AHPPVFHRDIKASNILLDSNLNA-KVADFGLSRLAPVLDDEGTMPTHVSTIVKGTPGYLD 801
V HRD+K N+L+D NA K+ADFGL+R + P T T Y
Sbjct: 122 R---VLHRDLKPQNLLIDRRTNALKLADFGLARAFGI-------PVRTFTHEVVTLWYRA 171
Query: 802 PEYFL-THKLTDKSDVYSLGVVLLELLT 828
PE L + + D++S+G + E++
Sbjct: 172 PEILLGSRHYSTPVDIWSVGCIFAEMVN 199
|
Length = 294 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 69.7 bits (171), Expect = 7e-13
Identities = 61/212 (28%), Positives = 103/212 (48%), Gaps = 19/212 (8%)
Query: 631 TQVGQGGYGKVYKGILSDN-TTVAIKR--AEEGSLQGQNEFLTEIKLLSRLHHRNLVSLL 687
+++G+G YG V+K + VAIK+ E + L EI++L +L H NLV+L+
Sbjct: 7 SKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLI 66
Query: 688 GYCDEEGEQMLVYEFVPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPV 747
+ + LV+E+ + T+ + L + + + ++ + + + + H H
Sbjct: 67 EVFRRKRKLHLVFEYCDH-TVLNELEKNPR-GVPEHLIKKIIWQTLQAVNFCH--KHN-C 121
Query: 748 FHRDIKASNILLDSNLNAKVADFGLSRLAPVLDDEGTMPTHVSTIVKGTPGYL--DPEYF 805
HRD+K NIL+ K+ DFG +R+ D+ T +V+T P L D +Y
Sbjct: 122 IHRDVKPENILITKQGQIKLCDFGFARILTGPGDDYT--DYVATRWYRAPELLVGDTQY- 178
Query: 806 LTHKLTDKSDVYSLGVVLLELLTGMQPISHGK 837
DV+++G V ELLTG QP+ GK
Sbjct: 179 -----GPPVDVWAIGCVFAELLTG-QPLWPGK 204
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 69.2 bits (169), Expect = 1e-12
Identities = 72/271 (26%), Positives = 116/271 (42%), Gaps = 36/271 (13%)
Query: 633 VGQGGYGKVYKGILS----DNTTVAIKRAEEG-SLQGQNEFLTEIKLLSRLHHRNLVSLL 687
+G G +G++ +G L VAI G S + + FL E L + H N+V L
Sbjct: 13 LGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLE 72
Query: 688 GYCDEEGEQMLVYEFVPNGTLRDWLSGRTKENLNFAMRLRVALDS-AKGILYLHTEAHPP 746
G M+V E++ NG L +L R E A +L L A G+ YL +
Sbjct: 73 GVITRGNTMMIVTEYMSNGALDSFL--RKHEGQLVAGQLMGMLPGLASGMKYLSEMGY-- 128
Query: 747 VFHRDIKASNILLDSNLNAKVADFGLSRLAPVLDDEGTMPTHVSTIVKGTPG-YLDPEYF 805
H+ + A +L++S+L K++ F RL E +T+ +P + PE
Sbjct: 129 -VHKGLAAHKVLVNSDLVCKISGFR--RL-----QEDKSEAIYTTMSGKSPVLWAAPEAI 180
Query: 806 LTHKLTDKSDVYSLGVVLLELLT-GMQP---ISHGKNIVREVNVARDSGMVFSIIDNRMG 861
H + SDV+S G+V+ E+++ G +P +S ++V A + G R+
Sbjct: 181 QYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSG-----QDVIKAVEDGF-------RLP 228
Query: 862 SYPSECVERFVTLALRCCHDKPEHRPSMSDV 892
+ P C L L C + RP S +
Sbjct: 229 A-PRNCPNLLHQLMLDCWQKERGERPRFSQI 258
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 69.1 bits (169), Expect = 1e-12
Identities = 63/265 (23%), Positives = 118/265 (44%), Gaps = 34/265 (12%)
Query: 632 QVGQGGYGKVYKGI-LSDNTTVAIKRAE-EGSLQGQNEFLTEIKLLSRLHHRNLVSLLGY 689
+G G G VYK L +A+K + +++ Q + ++E+++L + ++ G
Sbjct: 8 ILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGA 67
Query: 690 CDEEGEQMLVYEFVPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFH 749
E + EF+ G+L + + E++ R+A+ KG+ YL + + H
Sbjct: 68 FFVENRISICTEFMDGGSLD--VYRKIPEHV----LGRIAVAVVKGLTYLWSLK---ILH 118
Query: 750 RDIKASNILLDSNLNAKVADFGLSRLAPVLDDEGTMPTHVSTIVKGTPGYLDPEYFLTHK 809
RD+K SN+L+++ K+ DFG+S + ++ GT Y+ PE +
Sbjct: 119 RDVKPSNMLVNTRGQVKLCDFGVST---------QLVNSIAKTYVGTNAYMAPERISGEQ 169
Query: 810 LTDKSDVYSLGVVLLELLTGMQPI-----SHGKNIVREVNVARDSGMVFSIIDNRMGSYP 864
SDV+SLG+ +EL G P + G + + ++ I+D P
Sbjct: 170 YGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQ--------LLQCIVDEDPPVLP 221
Query: 865 -SECVERFVTLALRCCHDKPEHRPS 888
+ E+FV +C +P+ RP+
Sbjct: 222 VGQFSEKFVHFITQCMRKQPKERPA 246
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 68.9 bits (168), Expect = 1e-12
Identities = 64/212 (30%), Positives = 102/212 (48%), Gaps = 31/212 (14%)
Query: 632 QVGQGGYGKVYK------GILSDNTTVAIKRAEEGSLQGQNEFLTEIKLLSRLHHRNLVS 685
+VG G YG VYK G L+ + ++ ++ SL Q EI ++ H N+V+
Sbjct: 16 RVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQ-----EIFMVKECKHCNIVA 70
Query: 686 LLGYCDEEGEQMLVYEFVPNGTLRD--WLSGRTKENLNFAMRLRVALDSAKGILYLHTEA 743
G + + E+ G+L+D ++G E L A R L +G+ YLH++
Sbjct: 71 YFGSYLSREKLWICMEYCGGGSLQDIYHVTGPLSE-LQIAYVCRETL---QGLAYLHSKG 126
Query: 744 HPPVFHRDIKASNILLDSNLNAKVADFGLSRLAPVLDDEGTMPTHVSTIVKGTPGYLDPE 803
HRDIK +NILL N + K+ADFG++ A + T+ S I GTP ++ PE
Sbjct: 127 K---MHRDIKGANILLTDNGDVKLADFGVA--AKI---TATIAKRKSFI--GTPYWMAPE 176
Query: 804 YFLTHK---LTDKSDVYSLGVVLLELLTGMQP 832
K D++++G+ +E L +QP
Sbjct: 177 VAAVEKNGGYNQLCDIWAVGITAIE-LAELQP 207
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 69.8 bits (171), Expect = 1e-12
Identities = 60/233 (25%), Positives = 98/233 (42%), Gaps = 30/233 (12%)
Query: 633 VGQGGYGKVYKGI-LSDNTTVAIKR--AEEGSLQGQNEF------------LTEIKLLSR 677
+G+G YGKV K VAIK+ E S + L E+K+++
Sbjct: 17 LGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNE 76
Query: 678 LHHRNLVSLLGYCDEEGEQMLVYEFVPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGIL 737
+ H N++ L+ E LV + + L+ + + + L + + L G+
Sbjct: 77 IKHENIMGLVDVYVEGDFINLVMDIM-ASDLKKVVDRKIR--LTESQVKCILLQILNGLN 133
Query: 738 YLHTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSR-------LAPVLDDEGTMPTHVS 790
LH HRD+ +NI ++S K+ADFGL+R + DE
Sbjct: 134 VLHKWY---FMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDETMQRREEM 190
Query: 791 TIVKGTPGYLDPEYFL-THKLTDKSDVYSLGVVLLELLTGMQPISHGKNIVRE 842
T T Y PE + K D++S+G + ELLTG +P+ G+N + +
Sbjct: 191 TSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTG-KPLFPGENEIDQ 242
|
Length = 335 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 68.9 bits (168), Expect = 2e-12
Identities = 57/209 (27%), Positives = 96/209 (45%), Gaps = 14/209 (6%)
Query: 625 AYFSSSTQVGQGGYGKV-YKGILSDNTTVAIKRAEEGSLQGQNEFLTEIKLLSRLHHRNL 683
Y + ++G+G G V + S VA+K+ + Q + E+ ++ H N+
Sbjct: 20 TYLDNFIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENV 79
Query: 684 VSLLGYCDEEGEQMLVYEFVPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEA 743
V + E +V EF+ G L D + T +N V L K + LH +
Sbjct: 80 VEMYNSYLVGDELWVVMEFLEGGALTDIV---THTRMNEEQIAAVCLAVLKALSVLHAQG 136
Query: 744 HPPVFHRDIKASNILLDSNLNAKVADFGLSRLAPVLDDEGTMPTHVSTIVKGTPGYLDPE 803
V HRDIK+ +ILL + K++DFG A V + +P S + GTP ++ PE
Sbjct: 137 ---VIHRDIKSDSILLTHDGRVKLSDFGFC--AQVSKE---VPRRKSLV--GTPYWMAPE 186
Query: 804 YFLTHKLTDKSDVYSLGVVLLELLTGMQP 832
+ D++SLG++++E++ G P
Sbjct: 187 LISRLPYGPEVDIWSLGIMVIEMVDGEPP 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 2e-12
Identities = 58/220 (26%), Positives = 105/220 (47%), Gaps = 17/220 (7%)
Query: 633 VGQGGYGKVYK-GILSDNTTVAIKRAEEGSLQ---GQNEFLTEIKLLSRLHHRNLVSLLG 688
+G+GG+G+V + + A K+ E+ ++ G++ L E ++L +++ R +VSL
Sbjct: 8 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSL-A 66
Query: 689 YCDEEGEQM-LVYEFVPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPV 747
Y E + + LV + G L+ + + + A + G+ LH E +
Sbjct: 67 YAYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQER---I 123
Query: 748 FHRDIKASNILLDSNLNAKVADFGLSRLAPVLDDEGTMPTHVSTIVKGTPGYLDPEYFLT 807
+RD+K NILLD + + +++D GL+ P + T+ V GT GY+ PE
Sbjct: 124 VYRDLKPENILLDDHGHIRISDLGLAVHVP---EGQTIKGRV-----GTVGYMAPEVVKN 175
Query: 808 HKLTDKSDVYSLGVVLLELLTGMQPISHGKNIVREVNVAR 847
+ T D ++LG +L E++ G P K ++ V R
Sbjct: 176 ERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVER 215
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 68.9 bits (169), Expect = 2e-12
Identities = 58/225 (25%), Positives = 102/225 (45%), Gaps = 36/225 (16%)
Query: 633 VGQGGYGKVYKGILSDNTT---VAIKRAEEGS--LQGQNEFLTEIKLLSRLHHRNLVSLL 687
+G G YG V I D + VAIK+ L E+K+L H N++++
Sbjct: 13 IGSGAYGVVCSAI--DTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIR 70
Query: 688 GYCDEEGEQM----LVYEFVPNGTLRDWLSGR--TKENLNFAMR--LRVALDSAKGILYL 739
G +V + + + S + T+E++ + + LR G+ Y+
Sbjct: 71 DILRPPGADFKDVYVVMDLMESDLHHIIHSDQPLTEEHIRYFLYQLLR-------GLKYI 123
Query: 740 HTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSRLA---PVLDDEGTMPTHVSTIVKGT 796
H+ V HRD+K SN+L++ + ++ DFG++R P + + M +V+T
Sbjct: 124 HSAN---VIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPT-EHKYFMTEYVATR---- 175
Query: 797 PGYLDPEYFLT-HKLTDKSDVYSLGVVLLELLTGMQPISHGKNIV 840
Y PE L+ + T D++S+G + E+L G + + GKN V
Sbjct: 176 -WYRAPELLLSLPEYTTAIDMWSVGCIFAEML-GRRQLFPGKNYV 218
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 68.2 bits (166), Expect = 3e-12
Identities = 55/208 (26%), Positives = 98/208 (47%), Gaps = 16/208 (7%)
Query: 627 FSSSTQVGQGGYGKVYKGI-LSDNTTVAIKRAEEGSLQGQNEFLTEIKLLSRLHHRNLVS 685
++ ++GQG G VY + ++ VAI++ + + EI ++ + N+V+
Sbjct: 22 YTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVN 81
Query: 686 LLGYCDEEGEQMLVYEFVPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHP 745
L E +V E++ G+L D ++ + A R L + + +LH+
Sbjct: 82 YLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALE---FLHSNQ-- 136
Query: 746 PVFHRDIKASNILLDSNLNAKVADFGL-SRLAPVLDDEGTMPTHVSTIVKGTPGYLDPEY 804
V HRDIK+ NILL + + K+ DFG +++ P TM GTP ++ PE
Sbjct: 137 -VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTM--------VGTPYWMAPEV 187
Query: 805 FLTHKLTDKSDVYSLGVVLLELLTGMQP 832
K D++SLG++ +E++ G P
Sbjct: 188 VTRKAYGPKVDIWSLGIMAIEMIEGEPP 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 68.7 bits (168), Expect = 3e-12
Identities = 86/339 (25%), Positives = 132/339 (38%), Gaps = 88/339 (25%)
Query: 633 VGQGGYGKVYK----GILSDNT--TVAIKRAEEGSLQGQNEFL-TEIKLLSRL-HHRN-- 682
+G+G +GKV + GI + TVA+K +EG+ + + L TE+K+L + HH N
Sbjct: 15 LGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVV 74
Query: 683 ------------LVSLLGYC----------------------DEEGEQMLVYE------- 701
L+ ++ YC +M E
Sbjct: 75 NLLGACTKPGGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLD 134
Query: 702 ------------FVPNGTLRD-----WLSGRTKENLNFAMRLRVALDSAKGILYLHTEAH 744
F+ + +L D KE L + + A+G+ +L A
Sbjct: 135 SVSSSQSSASSGFIEDKSLSDVEEDEEGDELYKEPLTLEDLISYSFQVARGMEFL---AS 191
Query: 745 PPVFHRDIKASNILLDSNLNAKVADFGLSRLAPVLDDEGTMPTHVSTIVKGTP-GYLDPE 803
HRD+ A NILL N K+ DFGL+R D P +V P ++ PE
Sbjct: 192 RKCIHRDLAARNILLSENNVVKICDFGLAR------DIYKDPDYVRKGDARLPLKWMAPE 245
Query: 804 YFLTHKLTDKSDVYSLGVVLLELLT-GMQPISHGKNIVREVNVARDSGMVFSIIDNRMGS 862
T +SDV+S GV+L E+ + G P G I E G RM +
Sbjct: 246 SIFDKVYTTQSDVWSFGVLLWEIFSLGASPYP-GVQIDEEFCRRLKEGT-------RMRA 297
Query: 863 YPSECVERFVTLALRCCHDKPEHRPSMSDVVRELENILK 901
P ++ L C H+ PE RP+ S++V L ++L+
Sbjct: 298 -PEYATPEIYSIMLDCWHNNPEDRPTFSELVEILGDLLQ 335
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Score = 68.8 bits (168), Expect = 3e-12
Identities = 68/234 (29%), Positives = 103/234 (44%), Gaps = 21/234 (8%)
Query: 129 IGNISSLIFLL--------LNGNKLSGSLPDELGYLSNLNRLQVDENNITGTIPKSFANL 180
I +I LI LL L+ NK+ SLP L L NL L + N+++ +PK +NL
Sbjct: 128 ITDIPPLIGLLKSNLKELDLSDNKIE-SLPSPLRNLPNLKNLDLSFNDLS-DLPKLLSNL 185
Query: 181 SRVRHLHLNNNSIGGQIPSELSKLSTLIHLLVDNNNLSGNLPPELSELPQLCILQLDNNN 240
S + +L L+ N I +P E+ LS L L + NN++ L LS L L L+L NN
Sbjct: 186 SNLNNLDLSGNKI-SDLPPEIELLSALEELDLSNNSII-ELLSSLSNLKNLSGLELSNNK 243
Query: 241 FSASEIPATYGNFSKLVKLSLRNCNLQGAVPDLSRIPNLYYLDLSWNHLTGSIPSKKLSE 300
++P + GN S L L L N N ++ L + NL LDLS N L+ ++P L
Sbjct: 244 L--EDLPESIGNLSNLETLDLSN-NQISSISSLGSLTNLRELDLSGNSLSNALPLIALLL 300
Query: 301 NV--TTIDLSDNYLNG----SILESISNLPFLQTLSLENNFLTGSIPATIWQNK 348
+ ++L + + +N+ S +W
Sbjct: 301 LLLELLLNLLLTLKALELKLNSILLNNNILSNGETSSPEALSILESLNNLWTLD 354
|
Length = 394 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 67.8 bits (166), Expect = 4e-12
Identities = 65/235 (27%), Positives = 98/235 (41%), Gaps = 49/235 (20%)
Query: 630 STQVGQGGYGKVYKG--ILSDNTTVAIKR-----AEEGSLQGQNEF----LTEIKLLSRL 678
++GQG +G+V+K + VA+K+ +EG F L EIK+L L
Sbjct: 17 LAKIGQGTFGEVFKARHKKTKQI-VALKKVLMENEKEG-------FPITALREIKILQLL 68
Query: 679 HHRNLVSLLGYCDEEGEQ--------MLVYEFVPNGTLRDWLSGRTKENLNFAMRL---- 726
H N+V+L+ C + LV+EF + L LS N N L
Sbjct: 69 KHENVVNLIEICRTKATPYNRYKGSFYLVFEFCEH-DLAGLLS-----NKNVKFTLSEIK 122
Query: 727 RVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSR--LAPVLDDEGT 784
+V G+ Y+H + HRD+KA+NIL+ + K+ADFGL+R
Sbjct: 123 KVMKMLLNGLYYIHRNK---ILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNR 179
Query: 785 MPTHVSTIVKGTPGYLDPEYFLTHK-LTDKSDVYSLGVVLLELLTGMQPISHGKN 838
V T+ Y PE L + D++ G ++ E+ T PI G
Sbjct: 180 YTNRVVTL-----WYRPPELLLGERDYGPPIDMWGAGCIMAEMWT-RSPIMQGNT 228
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 67.4 bits (165), Expect = 4e-12
Identities = 71/284 (25%), Positives = 110/284 (38%), Gaps = 57/284 (20%)
Query: 633 VGQGGYGKVYKGILSD-NTTVAIKRAEEGSLQ-GQNEFLTEIKLLSRLHH-RNLVSLLGY 689
+G+G +G V K + T +A+KR + Q L ++ ++ R +V G
Sbjct: 12 IGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGA 71
Query: 690 CDEEG------EQM-----LVYEFVPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILY 738
EG E M Y++V K + + ++A+ + K + Y
Sbjct: 72 LFREGDCWICMELMDISLDKFYKYVYE---------VLKSVIPEEILGKIAVATVKALNY 122
Query: 739 LHTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSRLAPVLDDEGTMPTHVSTIVK---- 794
L E + HRD+K SNILLD N N K+ DFG+S G + V +I K
Sbjct: 123 LKEELK--IIHRDVKPSNILLDRNGNIKLCDFGIS---------GQL---VDSIAKTRDA 168
Query: 795 GTPGYLDPEYFLTHKLTD---KSDVYSLGVVLLELLTGMQPISHGKNIVREVNVARDSGM 851
G Y+ PE +SDV+SLG+ L E+ TG P ++ ++
Sbjct: 169 GCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSVFDQLT------Q 222
Query: 852 VFS----IIDNRMGSYPSECVERFVTLALRCCHDKPEHRPSMSD 891
V I+ N S F+ L C RP +
Sbjct: 223 VVKGDPPILSNSEEREFSPSFVNFINL---CLIKDESKRPKYKE 263
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 5e-12
Identities = 78/282 (27%), Positives = 116/282 (41%), Gaps = 14/282 (4%)
Query: 127 KEIGNISSLIFLLLNGNKLSGSLPDELGYLSNLNRLQVDENNITG--TIPKSFANLSRVR 184
N+ S+ L N S +L LS L L + + ++ NL +
Sbjct: 37 FPDSNLESVAVNRLALNLSSNTLLLLPSSLSRLLSLDLLSPSGISSLDGSENLLNLLPLP 96
Query: 185 HLHLNNNSIGGQIPSELSKLSTLIHLLVDNNNLSGNLPPELSELP-QLCILQLDNNNFSA 243
L LN N + I SEL +L+ L L +DNNN++ ++PP + L L L L +N +
Sbjct: 97 SLDLNLNRLRSNI-SELLELTNLTSLDLDNNNIT-DIPPLIGLLKSNLKELDLSDNKIES 154
Query: 244 SEIPATYGNFSKLVKLSLRNCNLQGAVPDLSRIPNLYYLDLSWNHLTGSIPSKKLSENVT 303
P N L L L +L LS + NL LDLS N ++ P +L +
Sbjct: 155 LPSPL--RNLPNLKNLDLSFNDLSDLPKLLSNLSNLNNLDLSGNKISDLPPEIELLSALE 212
Query: 304 TIDLSDNYLNGSILESISNLPFLQTLSLENNFLTGSIPATIWQNKSFSTKARLKIDLRNN 363
+DLS+N + +L S+SNL L L L NN L + + +DL NN
Sbjct: 213 ELDLSNNSII-ELLSSLSNLKNLSGLELSNNKLEDLP---ESIGNLSNLE---TLDLSNN 265
Query: 364 SFSNIVGDLTLPNNVTLRLGGNPICTSANIPNTGRFCGSDAG 405
S+I +L N L L GN + + +
Sbjct: 266 QISSISSLGSLTNLRELDLSGNSLSNALPLIALLLLLLELLL 307
|
Length = 394 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 67.8 bits (166), Expect = 5e-12
Identities = 66/235 (28%), Positives = 100/235 (42%), Gaps = 53/235 (22%)
Query: 633 VGQGGYGKVYKGILSDNTT---VAIKRA----EEGSLQGQNEFLTEIKLLSRLHHRNLVS 685
+G+G YG VY+ D T+ VA+K+ E + + L EI LL L H N+V
Sbjct: 15 IGEGTYGIVYRA--RDTTSGEIVALKKVRMDNERDGIPISS--LREITLLLNLRHPNIVE 70
Query: 686 LL---------------GYCDEEGEQMLVYEFVPNGTLRDWLSGRTKENLNFAMRLRVAL 730
L YC EQ L +L D + E + + L
Sbjct: 71 LKEVVVGKHLDSIFLVMEYC----EQDL-------ASLLDNMPTPFSE----SQVKCLML 115
Query: 731 DSAKGILYLHTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSRLAPVLDDEGTMPTHVS 790
+G+ YLH + HRD+K SN+LL K+ADFGL+R +P
Sbjct: 116 QLLRGLQYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTY-------GLPAKPM 165
Query: 791 TIVKGTPGYLDPEYFLTHKLTDKS-DVYSLGVVLLELLTGMQPISHGKNIVREVN 844
T T Y PE L + D++++G +L ELL +P+ GK+ + +++
Sbjct: 166 TPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAH-KPLLPGKSEIEQLD 219
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 67.8 bits (166), Expect = 5e-12
Identities = 86/340 (25%), Positives = 137/340 (40%), Gaps = 88/340 (25%)
Query: 626 YFSSSTQVGQGGYGKV----YKGILSDNTTVAIKRAEEGSLQGQNEF---------LTEI 672
+ ++GQG YG V S+ TVAIK+ N F L E+
Sbjct: 1 RYELIKELGQGAYGIVCSARNAET-SEEETVAIKKI-------TNVFSKKILAKRALREL 52
Query: 673 KLLSRLH-HRNLVSLLG------------YCDEEGEQMLVYEFVPNGTLRDWLSGRTKEN 719
KLL H+N+ L Y EE + E + +R SG+ +
Sbjct: 53 KLLRHFRGHKNITCLYDMDIVFPGNFNELYLYEE-----LMEADLHQIIR---SGQPLTD 104
Query: 720 LNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSR-LAPV 778
+F + L G+ Y+H+ V HRD+K N+L++++ K+ DFGL+R +
Sbjct: 105 AHFQSFIYQIL---CGLKYIHSAN---VLHRDLKPGNLLVNADCELKICDFGLARGFSEN 158
Query: 779 -LDDEGTMPTHVSTIVKGTPGYLDPEYFLTHKLTDKS-DVYSLGVVLLELLTGMQPISHG 836
++ G M +V+T Y PE L+ + K+ DV+S+G +L ELL G +P+ G
Sbjct: 159 PGENAGFMTEYVATR-----WYRAPEIMLSFQSYTKAIDVWSVGCILAELL-GRKPVFKG 212
Query: 837 KNIVREVNVARDSGMVFSIIDNRMGSYPSECVERFVTLALRCCHDKPEHRPSMSDVVREL 896
K+ V ++N I +G+ E + R + P + +R L
Sbjct: 213 KDYVDQLN----------QILQVLGTPDEETLSRIGS-------------PKAQNYIRSL 249
Query: 897 ENILKMFPETDTMFSKSESSSLLSGKSASTSSSFLTRDPY 936
NI K E+ + + LL L DP
Sbjct: 250 PNIPKKPFESIFPNANPLALDLL--------EKLLAFDPT 281
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 67.5 bits (165), Expect = 6e-12
Identities = 52/170 (30%), Positives = 86/170 (50%), Gaps = 17/170 (10%)
Query: 666 NEFLTEIKLLSRLHHRNLVSLLGYCDEEGEQMLVYEFVPNGTLRDWL--SGRTKENLNFA 723
N+ + E+K+L + +V G +GE + E + G+L L +GR EN+
Sbjct: 44 NQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPENI--- 100
Query: 724 MRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSRLAPVLDDEG 783
++++ +G+ YL E H + HRD+K SNIL++S K+ DFG+S G
Sbjct: 101 -LGKISIAVLRGLTYLR-EKHK-IMHRDVKPSNILVNSRGEIKLCDFGVS---------G 148
Query: 784 TMPTHVSTIVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVLLELLTGMQPI 833
+ ++ GT Y+ PE T +SD++SLG+ L+E+ G PI
Sbjct: 149 QLIDSMANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPI 198
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 67.8 bits (165), Expect = 7e-12
Identities = 56/211 (26%), Positives = 102/211 (48%), Gaps = 19/211 (9%)
Query: 627 FSSSTQVGQGGYGKVYKGILSDNTTVAIKRAEEGSLQG--QNEFLTEIKLLSRLHHRNLV 684
F +++G G G V+K + + ++ ++ +N+ + E+++L + +V
Sbjct: 7 FEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIV 66
Query: 685 SLLGYCDEEGEQMLVYEFVPNGTLRDWL--SGRTKENLNFAMRLRVALDSAKGILYLHTE 742
G +GE + E + G+L L +GR E + +V++ KG+ YL E
Sbjct: 67 GFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQI----LGKVSIAVIKGLTYLR-E 121
Query: 743 AHPPVFHRDIKASNILLDSNLNAKVADFGLSRLAPVLDDEGTMPTHVSTIVKGTPGYLDP 802
H + HRD+K SNIL++S K+ DFG+S G + ++ GT Y+ P
Sbjct: 122 KHK-IMHRDVKPSNILVNSRGEIKLCDFGVS---------GQLIDSMANSFVGTRSYMSP 171
Query: 803 EYFLTHKLTDKSDVYSLGVVLLELLTGMQPI 833
E + +SD++S+G+ L+E+ G PI
Sbjct: 172 ERLQGTHYSVQSDIWSMGLSLVEMAIGRYPI 202
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 66.8 bits (163), Expect = 7e-12
Identities = 54/206 (26%), Positives = 96/206 (46%), Gaps = 16/206 (7%)
Query: 633 VGQGGYGKVY------KGILSDNTTVAIKRAEEGSLQGQNEFLTEIKLLSRLHHRNLVSL 686
+G+GG+G+V G L + KR ++ +G + E ++L+++H R +VSL
Sbjct: 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKK--RKGYEGAMVEKRILAKVHSRFIVSL 58
Query: 687 LGYCDEEGEQMLVYEFVPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPP 746
+ + LV + G LR + +EN F R +A+ I L
Sbjct: 59 AYAFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFP-EPRACFYTAQIISGLEHLHQRR 117
Query: 747 VFHRDIKASNILLDSNLNAKVADFGLSRLAPVLDDEGTMPTHVSTIVKGTPGYLDPEYFL 806
+ +RD+K N+LLD++ N +++D GL+ + D + + GTPG++ PE
Sbjct: 118 IIYRDLKPENVLLDNDGNVRISDLGLA--VELKDGQSKTKGYA-----GTPGFMAPELLQ 170
Query: 807 THKLTDKSDVYSLGVVLLELLTGMQP 832
+ D ++LGV L E++ P
Sbjct: 171 GEEYDFSVDYFALGVTLYEMIAARGP 196
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 66.6 bits (163), Expect = 8e-12
Identities = 61/209 (29%), Positives = 98/209 (46%), Gaps = 21/209 (10%)
Query: 632 QVGQGGYGKVYKG-ILSDNTTVAIKR-AEEGSLQGQNEFLTEIKLLSRLHH-RNLVSLLG 688
++G G G+VYK +A+K+ G+ + L ++ ++ + H +V G
Sbjct: 22 EIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYG 81
Query: 689 YCDEEGEQMLVYEFVPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVF 748
Y + + + E + T D L R + + + ++ + K + YL E H V
Sbjct: 82 YFITDSDVFICMELM--STCLDKLLKRIQGPIPEDILGKMTVAIVKALHYL-KEKHG-VI 137
Query: 749 HRDIKASNILLDSNLNAKVADFGLS-RLAPVLDDEGTMPTHVSTIVKGTPGYLDPEYFLT 807
HRD+K SNILLD++ N K+ DFG+S RL +D + T G Y+ PE
Sbjct: 138 HRDVKPSNILLDASGNVKLCDFGISGRL---VDSKA------KTRSAGCAAYMAPERIDP 188
Query: 808 HKLTDK----SDVYSLGVVLLELLTGMQP 832
K +DV+SLG+ L+EL TG P
Sbjct: 189 PDPNPKYDIRADVWSLGISLVELATGQFP 217
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 66.3 bits (162), Expect = 1e-11
Identities = 48/165 (29%), Positives = 83/165 (50%), Gaps = 21/165 (12%)
Query: 671 EIKLLSRLHHRNLVSLLGYCDEEGEQML--VYEFVPNGTLRDWLSGRTKENLNFAMRLRV 728
E ++L + H ++ L + E ++ L + E+VP G L +L R + + L
Sbjct: 51 EKRVLKEVSHPFIIRL--FWTEHDQRFLYMLMEYVPGGELFSYL--RNSGRFSNSTGLFY 106
Query: 729 ALDSAKGILYLHTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSRLAPVLDDEGTMPTH 788
A + + YLH++ + +RD+K NILLD + K+ DFG ++ + D T+
Sbjct: 107 ASEIVCALEYLHSKE---IVYRDLKPENILLDKEGHIKLTDFGFAK--KLRDRTWTLC-- 159
Query: 789 VSTIVKGTPGYLDPEYFLTHKLTDKS-DVYSLGVVLLELLTGMQP 832
GTP YL PE + K +K+ D ++LG+++ E+L G P
Sbjct: 160 ------GTPEYLAPE-VIQSKGHNKAVDWWALGILIYEMLVGYPP 197
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 66.6 bits (163), Expect = 1e-11
Identities = 68/228 (29%), Positives = 105/228 (46%), Gaps = 37/228 (16%)
Query: 633 VGQGGYGKVYKGILSD-NTTVAIKRAEEGSLQGQNEF---------LTEIKLLSRLHHRN 682
+G+G YG V S+ N VAIK+ N F L EIKLL L H N
Sbjct: 13 IGRGAYGIVCSAKNSETNEKVAIKKI-------ANAFDNRIDAKRTLREIKLLRHLDHEN 65
Query: 683 LVSLLGYCDEEGEQM-----LVYEFVPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGIL 737
++++ + +VYE + + S +T + + L L +G+
Sbjct: 66 VIAIKDIMPPPHREAFNDVYIVYELMDTDLHQIIRSSQTLSDDHCQYFLYQLL---RGLK 122
Query: 738 YLHTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSRLAPVLDDEGTMPTHVSTIVKGTP 797
Y+H+ V HRD+K SN+LL++N + K+ DFGL+R + M +V T
Sbjct: 123 YIHSAN---VLHRDLKPSNLLLNANCDLKICDFGLAR--TTSEKGDFMTEYVV-----TR 172
Query: 798 GYLDPEYFLT-HKLTDKSDVYSLGVVLLELLTGMQPISHGKNIVREVN 844
Y PE L + T DV+S+G + ELL G +P+ GK+ V ++
Sbjct: 173 WYRAPELLLNCSEYTTAIDVWSVGCIFAELL-GRKPLFPGKDYVHQLK 219
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 68.3 bits (167), Expect = 1e-11
Identities = 62/227 (27%), Positives = 102/227 (44%), Gaps = 41/227 (18%)
Query: 633 VGQGGYGKVYKG---ILSDNTTVAIKRAEEGSLQG----QNEFLTEIKLLSRLHHRNLVS 685
+G+GG G+VY + S VA+K+ E L + FL E K+ + L H +V
Sbjct: 10 IGKGGMGEVYLAYDPVCSRR--VALKKIRE-DLSENPLLKKRFLREAKIAADLIHPGIVP 66
Query: 686 LLGYCDEEGEQMLVY---EFVPNGTLRDWL-SGRTKENL--------NFAMRLRVALDSA 733
+ C + G+ VY ++ TL+ L S KE+L + L +
Sbjct: 67 VYSICSD-GD--PVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKIC 123
Query: 734 KGILYLHTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSRLAPVLDDE---------GT 784
I Y+H++ V HRD+K NILL + D+G + + +++
Sbjct: 124 ATIEYVHSKG---VLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNI 180
Query: 785 MPTHVSTI---VKGTPGYLDPEYFLTHKLTDKSDVYSLGVVLLELLT 828
TI + GTP Y+ PE L ++ +D+Y+LGV+L ++LT
Sbjct: 181 C-YSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLT 226
|
Length = 932 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 66.5 bits (162), Expect = 2e-11
Identities = 62/222 (27%), Positives = 102/222 (45%), Gaps = 24/222 (10%)
Query: 618 KELAMATAYFSSSTQVGQGGYGKV----YKGILSDNTTVAIKRAEEGSLQGQNEF---LT 670
++ M F+ +G G +G+V YK D VAIKR E+ + Q + +
Sbjct: 23 RKNKMKYEDFNFIRTLGTGSFGRVILATYKN--EDFPPVAIKRFEKSKIIKQKQVDHVFS 80
Query: 671 EIKLLSRLHHRNLVSLLGYCDEEGEQMLVYEFVPNGTLRDWLSGRTKENLNFAMRLRVAL 730
E K+L+ ++H V+L G +E LV EFV G +L + N F +
Sbjct: 81 ERKILNYINHPFCVNLYGSFKDESYLYLVLEFVIGGEFFTFL----RRNKRFPNDVG-CF 135
Query: 731 DSAKGILYLHTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSRLAPVLDDEGTMPTHVS 790
+A+ +L + +RD+K N+LLD + K+ DFG +++ + T
Sbjct: 136 YAAQIVLIFEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKV---------VDTRTY 186
Query: 791 TIVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVLLELLTGMQP 832
T+ GTP Y+ PE L +D ++LG+ + E+L G P
Sbjct: 187 TLC-GTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPP 227
|
Length = 340 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 65.5 bits (159), Expect = 2e-11
Identities = 73/279 (26%), Positives = 128/279 (45%), Gaps = 36/279 (12%)
Query: 627 FSSSTQVGQGGYGKVYK------GILSDNTTVAIKRAEEGSLQGQNEFLTEIKLLSRLHH 680
F ++G G YG VYK G L+ + ++ E+ ++ Q EI ++ H
Sbjct: 11 FELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQ-----EIIMMKDCKH 65
Query: 681 RNLVSLLGYCDEEGEQMLVYEFVPNGTLRD--WLSGRTKENLNFAMRLRVALDSAKGILY 738
N+V+ G + + EF G+L+D ++G E A V+ ++ +G+ Y
Sbjct: 66 SNIVAYFGSYLRRDKLWICMEFCGGGSLQDIYHVTGPLSE-SQIAY---VSRETLQGLYY 121
Query: 739 LHTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSRLAPVLDDEGTMPTHVSTIVKGTPG 798
LH++ HRDIK +NILL N + K+ADFG+S A + T+ S I GTP
Sbjct: 122 LHSKGK---MHRDIKGANILLTDNGHVKLADFGVS--AQI---TATIAKRKSFI--GTPY 171
Query: 799 YLDPEYFLTHK---LTDKSDVYSLGVVLLELLTGMQPISHGKNIVREVNVARDSGMVFSI 855
++ PE + D++++G+ +E L +QP + +R + + S
Sbjct: 172 WMAPEVAAVERKGGYNQLCDIWAVGITAIE-LAELQPPMFDLHPMRALFLMTKSNFQPPK 230
Query: 856 IDNRMGSYPSECVERFVTLALRCCHDKPEHRPSMSDVVR 894
+ ++M S FV +AL P+ RP+ +++
Sbjct: 231 LKDKMKW--SNSFHHFVKMALT---KNPKKRPTAEKLLQ 264
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 3e-11
Identities = 63/213 (29%), Positives = 93/213 (43%), Gaps = 35/213 (16%)
Query: 632 QVGQGGYGKVYKGI-LSDNTTVAIK--RAEEGSLQGQNEFLTEIKLLSRLH---HRNLVS 685
++G G YG VYK VA+K R + + E+ LL RL H N+V
Sbjct: 7 EIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVR 66
Query: 686 LLGYC-----DEEGEQMLVYEFVPNGTLRDWLS-----GRTKENLNFAMRLRVALDSAKG 735
L+ C D E + LV+E V + LR +L G E + MR + +G
Sbjct: 67 LMDVCATSRTDRETKVTLVFEHV-DQDLRTYLDKVPPPGLPAETIKDLMRQFL-----RG 120
Query: 736 ILYLHTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSRLAPVLDDEGTMPTHVS-TIVK 794
+ +LH + HRD+K NIL+ S K+ADFGL+R+ ++ T V
Sbjct: 121 LDFLHANC---IVHRDLKPENILVTSGGQVKLADFGLARI---------YSCQMALTPVV 168
Query: 795 GTPGYLDPEYFLTHKLTDKSDVYSLGVVLLELL 827
T Y PE L D++S+G + E+
Sbjct: 169 VTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMF 201
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 65.2 bits (159), Expect = 3e-11
Identities = 39/136 (28%), Positives = 64/136 (47%), Gaps = 16/136 (11%)
Query: 699 VYEFVPNGTLRDWLS--GRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASN 756
V E+V G L + G+ KE + A + A G+ +LH++ + +RD+K N
Sbjct: 79 VMEYVNGGDLMYHIQQVGKFKE----PHAVFYAAEIAIGLFFLHSKG---IIYRDLKLDN 131
Query: 757 ILLDSNLNAKVADFGLSRLAPVLDDEGTMPTHVSTIVKGTPGYLDPEYFLTHKLTDKSDV 816
++LD+ + K+ADFG+ + E + GTP Y+ PE D
Sbjct: 132 VMLDAEGHIKIADFGMCK-------ENIFGGKTTRTFCGTPDYIAPEIIAYQPYGKSVDW 184
Query: 817 YSLGVVLLELLTGMQP 832
++ GV+L E+L G P
Sbjct: 185 WAFGVLLYEMLAGQPP 200
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 64.5 bits (157), Expect = 3e-11
Identities = 67/276 (24%), Positives = 122/276 (44%), Gaps = 33/276 (11%)
Query: 633 VGQGGYGKVYKGILSD--------NTTVAIKRAEEGSLQGQNEFLTEIKLLSRLHHRNLV 684
+GQG + K++KGI + T V +K ++ F ++S+L H++LV
Sbjct: 3 LGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLV 62
Query: 685 SLLGYCDEEGEQMLVYEFVPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAH 744
G C E ++V E+V G+L +L + K +N + +L VA A + +L +
Sbjct: 63 LNYGVCVCGDESIMVQEYVKFGSLDTYLK-KNKNLINISWKLEVAKQLAWALHFLEDKGL 121
Query: 745 PPVFHRDIKASNILLDSNLNAKVADFGLSRLAPVLDDEGTMPTHVST--IVKGTPGYLDP 802
H ++ A N+LL + K + +L+ D G T + +++ P ++ P
Sbjct: 122 T---HGNVCAKNVLLIREEDRKTGNPPFIKLS----DPGISITVLPKEILLERIP-WVPP 173
Query: 803 EYFLTHK-LTDKSDVYSLGVVLLELLTGM-QPISHGKNIVREVNVARDSGMVFSIIDNRM 860
E + L+ +D +S G L E+ +G +P+S A DS ++R
Sbjct: 174 ECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLS-----------ALDSQKKLQFYEDRH 222
Query: 861 GSYPSECVERFVTLALRCCHDKPEHRPSMSDVVREL 896
P+ L +C +P+ RPS ++R+L
Sbjct: 223 -QLPAPKWTELANLINQCMDYEPDFRPSFRAIIRDL 257
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 65.5 bits (159), Expect = 4e-11
Identities = 47/169 (27%), Positives = 85/169 (50%), Gaps = 13/169 (7%)
Query: 665 QNEFLTEIKLLSRLHHRNLVSLLGYCDEEGEQMLVYEFVPNGTLRDWLSGRTKENLNFAM 724
+N+ + E+++L + +V G +GE + E + G+L L + + + +
Sbjct: 47 RNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVL--KEAKRIPEEI 104
Query: 725 RLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSRLAPVLDDEGT 784
+V++ +G+ YL E H + HRD+K SNIL++S K+ DFG+S G
Sbjct: 105 LGKVSIAVLRGLAYLR-EKHQ-IMHRDVKPSNILVNSRGEIKLCDFGVS---------GQ 153
Query: 785 MPTHVSTIVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVLLELLTGMQPI 833
+ ++ GT Y+ PE + +SD++S+G+ L+EL G PI
Sbjct: 154 LIDSMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPI 202
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 64.6 bits (157), Expect = 4e-11
Identities = 62/214 (28%), Positives = 99/214 (46%), Gaps = 23/214 (10%)
Query: 633 VGQGGYGKVYKGILSDNTTVAIKRAEEGSLQGQNEFLTEIKLLSRL-HHRNLVSLLG--Y 689
+G+G YGKVYK + ++A + + E E +L L +H N+V G Y
Sbjct: 30 IGKGTYGKVYKVTNKKDGSLAAVKILDPISDVDEEIEAEYNILQSLPNHPNVVKFYGMFY 89
Query: 690 CDEE---GEQMLVYEFVPNGTLRDWLSG--RTKENLNFAMRLRVALDSAKGILYLHTEAH 744
++ G+ LV E G++ + + G + L+ AM + + G+ +LH
Sbjct: 90 KADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNR- 148
Query: 745 PPVFHRDIKASNILLDSNLNAKVADFGLSRLAPVLDDEGTMPTHVSTIVKGTPGYLDPEY 804
+ HRD+K +NILL + K+ DFG+S A + T V GTP ++ PE
Sbjct: 149 --IIHRDVKGNNILLTTEGGVKLVDFGVS--AQLTSTRLRRNTSV-----GTPFWMAPEV 199
Query: 805 FLTHKLTDKS-----DVYSLGVVLLELLTGMQPI 833
+ D S DV+SLG+ +EL G P+
Sbjct: 200 IACEQQYDYSYDARCDVWSLGITAIELGDGDPPL 233
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 64.6 bits (157), Expect = 4e-11
Identities = 60/215 (27%), Positives = 98/215 (45%), Gaps = 23/215 (10%)
Query: 633 VGQGGYGKVYKGILSDNTTVAIKRAEEGSLQGQNEFLTEIKLLSRLH-HRNLVSLLG-YC 690
+G+G YGKV+K + N + A + + E E +L L H N+V G Y
Sbjct: 26 IGKGTYGKVFKVLNKKNGSKAAVKILDPIHDIDEEIEAEYNILKALSDHPNVVKFYGMYY 85
Query: 691 DEE---GEQM-LVYEFVPNGTLRDWLSGRTK--ENLNFAMRLRVALDSAKGILYLHTEAH 744
++ G+Q+ LV E G++ D + G K E + + + ++ G+ +LH
Sbjct: 86 KKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNK- 144
Query: 745 PPVFHRDIKASNILLDSNLNAKVADFGLSRLAPVLDDEGTMPTHVSTIVKGTPGYLDPEY 804
HRD+K +NILL + K+ DFG+S + T GTP ++ PE
Sbjct: 145 --TIHRDVKGNNILLTTEGGVKLVDFGVSA-------QLTSTRLRRNTSVGTPFWMAPEV 195
Query: 805 FLTHKLTDKS-----DVYSLGVVLLELLTGMQPIS 834
+ D + DV+SLG+ +EL G P++
Sbjct: 196 IACEQQLDSTYDARCDVWSLGITAIELGDGDPPLA 230
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 64.6 bits (157), Expect = 5e-11
Identities = 64/222 (28%), Positives = 108/222 (48%), Gaps = 28/222 (12%)
Query: 632 QVGQGGYGKVYKG--ILSDNTTVAIKRA----EEGSLQGQNEFLTEIKLLSRLHHRNLVS 685
++G+G Y VYKG L+DN VA+K EEG+ + E+ LL L H N+V+
Sbjct: 13 KLGEGTYATVYKGRSKLTDNL-VALKEIRLEHEEGA---PCTAIREVSLLKDLKHANIVT 68
Query: 686 LLGYCDEEGEQMLVYEFVPNGTLRDWLS--GRTKENLNFAMRLRVALDSAKGILYLHTEA 743
L E LV+E++ + L+ +L G + N + L L +G+ Y H
Sbjct: 69 LHDIIHTEKSLTLVFEYL-DKDLKQYLDDCGNSINMHNVKLFLFQLL---RGLNYCHRRK 124
Query: 744 HPPVFHRDIKASNILLDSNLNAKVADFGLSRLAPVLDDEGTMPTHVSTIVKGTPGYLDPE 803
V HRD+K N+L++ K+ADFGL+R ++PT + T Y P+
Sbjct: 125 ---VLHRDLKPQNLLINERGELKLADFGLARAK-------SIPTKTYSNEVVTLWYRPPD 174
Query: 804 YFL-THKLTDKSDVYSLGVVLLELLTGMQPISHGKNIVREVN 844
L + + + D++ +G + E+ TG +P+ G + +++
Sbjct: 175 ILLGSTDYSTQIDMWGVGCIFYEMSTG-RPLFPGSTVEEQLH 215
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 64.6 bits (158), Expect = 5e-11
Identities = 64/226 (28%), Positives = 107/226 (47%), Gaps = 39/226 (17%)
Query: 635 QGGYGKVYKGILSDNTT---VAIKRAE-EGSLQGQNEF----LTEIKLLSRLHHRNLVSL 686
+G YG VY+ D T VA+K+ + E +G F L EI +L +L H N+V++
Sbjct: 15 EGTYGVVYRA--RDKKTGEIVALKKLKMEKEKEG---FPITSLREINILLKLQHPNIVTV 69
Query: 687 LGYCDEE---GEQM----LVYEFVPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYL 739
+E G + +V E+V + L+ + K+ + + L G+ +L
Sbjct: 70 -----KEVVVGSNLDKIYMVMEYVEH-DLKSLME-TMKQPFLQSEVKCLMLQLLSGVAHL 122
Query: 740 HTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSRLAPVLDDEGTMPTHVSTIVKGTPGY 799
H + HRD+K SN+LL++ K+ DFGL+R P T + T Y
Sbjct: 123 H---DNWILHRDLKTSNLLLNNRGILKICDFGLAREYGS-------PLKPYTQLVVTLWY 172
Query: 800 LDPEYFL-THKLTDKSDVYSLGVVLLELLTGMQPISHGKNIVREVN 844
PE L + + D++S+G + ELLT +P+ GK+ + ++N
Sbjct: 173 RAPELLLGAKEYSTAIDMWSVGCIFAELLT-KKPLFPGKSEIDQLN 217
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 64.9 bits (158), Expect = 5e-11
Identities = 53/205 (25%), Positives = 96/205 (46%), Gaps = 17/205 (8%)
Query: 633 VGQGGYGKVYKGIL-SDNTTVAIKRAEEGSLQGQNEF---LTEIKLLSRLHHRNLVSLLG 688
+G+G +GKV L A+K ++ + ++ +TE ++LS + ++ L
Sbjct: 3 LGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLY 62
Query: 689 YCDEEGEQML-VYEFVPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPV 747
C + +++ V EFV G L + + + A + SA +++LH + +
Sbjct: 63 CCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEITSA--LMFLHDKG---I 117
Query: 748 FHRDIKASNILLDSNLNAKVADFGLSRLAPVLDDEGTMPTHVSTIVKGTPGYLDPEYFLT 807
+RD+K N+LLD + K+ADFG+ + EG ++ GTP Y+ PE
Sbjct: 118 IYRDLKLDNVLLDHEGHCKLADFGMCK-------EGIFNGKTTSTFCGTPDYIAPEILQE 170
Query: 808 HKLTDKSDVYSLGVVLLELLTGMQP 832
D +++GV+L E+L G P
Sbjct: 171 MLYGPSVDWWAMGVLLYEMLCGHAP 195
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 5e-11
Identities = 49/163 (30%), Positives = 80/163 (49%), Gaps = 6/163 (3%)
Query: 670 TEIKLLSRLHHRNLVSLLGYCDEEGEQMLVYEFVPNGTLRDWLSGRTKENLNFAMRLRVA 729
+E+ L+ H +V + + +L+ E+ G L + R KE+L F V
Sbjct: 114 SELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGSGGDLNKQIKQRLKEHLPF-QEYEVG 172
Query: 730 LDSAKGILYLHTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSRLAPVLDDEGTMPTHV 789
L + +L L + HRD+K++NI L K+ DFG S+ ++ V
Sbjct: 173 LLFYQIVLALDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSK-----QYSDSVSLDV 227
Query: 790 STIVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVLLELLTGMQP 832
++ GTP YL PE + + + K+D++SLGV+L ELLT +P
Sbjct: 228 ASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRP 270
|
Length = 478 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 64.6 bits (157), Expect = 5e-11
Identities = 61/212 (28%), Positives = 103/212 (48%), Gaps = 20/212 (9%)
Query: 633 VGQGGYGKVYKGILS-DNTTVAIKRAEEGSLQGQNEF---LTEIKLLSRLHHRNLVSLLG 688
+G+G +GKV+ L N AIK ++ + ++ + E ++LS ++ L
Sbjct: 3 LGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHL- 61
Query: 689 YCDEEGEQML--VYEFVPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPP 746
YC + ++ L V E++ G L + K +L A A + G+ +LH++
Sbjct: 62 YCTFQTKENLFFVMEYLNGGDLMFHIQSCHKFDLPRATFY--AAEIICGLQFLHSKG--- 116
Query: 747 VFHRDIKASNILLDSNLNAKVADFGLSRLAPVLDDEGTMPTHVSTIVKGTPGYLDPEYFL 806
+ +RD+K NILLD++ + K+ADFG+ + E + + GTP Y+ PE L
Sbjct: 117 IVYRDLKLDNILLDTDGHIKIADFGMCK-------ENMLGDAKTCTFCGTPDYIAPEILL 169
Query: 807 THKLTDKSDVYSLGVVLLELLTGMQPISHGKN 838
K D +S GV+L E+L G P HG +
Sbjct: 170 GQKYNTSVDWWSFGVLLYEMLIGQSPF-HGHD 200
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 64.4 bits (157), Expect = 6e-11
Identities = 60/206 (29%), Positives = 94/206 (45%), Gaps = 19/206 (9%)
Query: 633 VGQGGYGKVYKGI-LSDNTTVAIKRAEEGSLQGQNE---FLTEIK-LLSRLHHRNLVSLL 687
+G+G +GKV +D A+K ++ ++ + E + E LL + H LV L
Sbjct: 3 IGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGL- 61
Query: 688 GYCDEEGEQM-LVYEFVPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPP 746
Y + +++ V ++V G L L R + R A + A + YLH+
Sbjct: 62 HYSFQTADKLYFVLDYVNGGELFFHLQ-RERSFPEPRARFYAA-EIASALGYLHSLN--- 116
Query: 747 VFHRDIKASNILLDSNLNAKVADFGLSRLAPVLDDEGTMPTHVSTIVKGTPGYLDPEYFL 806
+ +RD+K NILLDS + + DFGL + EG + ++ GTP YL PE
Sbjct: 117 IIYRDLKPENILLDSQGHVVLTDFGLCK-------EGIEHSKTTSTFCGTPEYLAPEVLR 169
Query: 807 THKLTDKSDVYSLGVVLLELLTGMQP 832
D + LG VL E+L G+ P
Sbjct: 170 KQPYDRTVDWWCLGAVLYEMLYGLPP 195
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 64.3 bits (157), Expect = 6e-11
Identities = 60/211 (28%), Positives = 96/211 (45%), Gaps = 29/211 (13%)
Query: 633 VGQGGYGKV----YKGILSDNTTVAIKRAEEGSLQGQNEF---LTEIKLLSRL-HHRNLV 684
+G+G +GKV KG + A+K ++ + ++ +TE ++L+ H L
Sbjct: 3 LGKGSFGKVLLAELKGT---DELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLT 59
Query: 685 SLLGYCDEEGEQMLVYEFVPNGTLRDWL--SGRTKENLNFAMRLRV-ALDSAKGILYLHT 741
L + V E+V G L + SGR E R R A + G+ +LH
Sbjct: 60 QLHSCFQTKDRLFFVMEYVNGGDLMFHIQRSGRFDEP-----RARFYAAEIVLGLQFLHE 114
Query: 742 EAHPPVFHRDIKASNILLDSNLNAKVADFGLSRLAPVLDDEGTMPTHVSTIVKGTPGYLD 801
+ +RD+K N+LLDS + K+ADFG+ + EG + ++ GTP Y+
Sbjct: 115 RG---IIYRDLKLDNVLLDSEGHIKIADFGMCK-------EGILGGVTTSTFCGTPDYIA 164
Query: 802 PEYFLTHKLTDKSDVYSLGVVLLELLTGMQP 832
PE D ++LGV+L E+L G P
Sbjct: 165 PEILSYQPYGPAVDWWALGVLLYEMLAGQSP 195
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 64.1 bits (156), Expect = 9e-11
Identities = 56/206 (27%), Positives = 98/206 (47%), Gaps = 19/206 (9%)
Query: 633 VGQGGYGKVYKGILSDNTTV-AIKRAEEGSLQGQNEF---LTEIKLLSRLHHRNLVSLLG 688
+G+G +GKV L V AIK ++ + ++ +TE ++L+ ++ L
Sbjct: 3 LGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALH 62
Query: 689 YCDEEGEQML-VYEFVPNGTLRDWLSGRTKENLNFAMRLRV-ALDSAKGILYLHTEAHPP 746
C + +++ V E+V G L + K + R R A + +++LH
Sbjct: 63 CCFQTKDRLFFVMEYVNGGDLMFQIQRSRKFDEP---RSRFYAAEVTLALMFLHRHG--- 116
Query: 747 VFHRDIKASNILLDSNLNAKVADFGLSRLAPVLDDEGTMPTHVSTIVKGTPGYLDPEYFL 806
V +RD+K NILLD+ + K+ADFG+ + EG + +T GTP Y+ PE
Sbjct: 117 VIYRDLKLDNILLDAEGHCKLADFGMCK-------EGILNGVTTTTFCGTPDYIAPEILQ 169
Query: 807 THKLTDKSDVYSLGVVLLELLTGMQP 832
+ D ++LGV++ E++ G P
Sbjct: 170 ELEYGPSVDWWALGVLMYEMMAGQPP 195
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 64.8 bits (158), Expect = 1e-10
Identities = 30/92 (32%), Positives = 51/92 (55%)
Query: 138 LLLNGNKLSGSLPDELGYLSNLNRLQVDENNITGTIPKSFANLSRVRHLHLNNNSIGGQI 197
L L+ L G +P+++ L +L + + N+I G IP S +++ + L L+ NS G I
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSI 482
Query: 198 PSELSKLSTLIHLLVDNNNLSGNLPPELSELP 229
P L +L++L L ++ N+LSG +P L
Sbjct: 483 PESLGQLTSLRILNLNGNSLSGRVPAALGGRL 514
|
Length = 623 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 1e-10
Identities = 67/242 (27%), Positives = 107/242 (44%), Gaps = 25/242 (10%)
Query: 633 VGQGGYGKVYKGILSD-NTTVAIKRAE--EGSLQGQNEFLTEIKLLSRLHHRNLVSLLGY 689
VG+G YG V K + VAIK+ + E + + + L E+K+L L N+V L
Sbjct: 9 VGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEA 68
Query: 690 CDEEGEQMLVYEFVPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFH 749
G+ LV+E+V L +E N +V + I +H + H
Sbjct: 69 FRRRGKLYLVFEYVEKNMLE-----LLEEMPNGVPPEKVRSYIYQLIKAIHWCHKNDIVH 123
Query: 750 RDIKASNILLDSNLNAKVADFGLSRLAPVLDDEGTMPTHVSTIVKGTPGYLDPEYFLTHK 809
RDIK N+L+ N K+ DFG +R EG+ + + T Y PE L
Sbjct: 124 RDIKPENLLISHNDVLKLCDFGFARNL----SEGSNANYTEYV--ATRWYRSPELLLGAP 177
Query: 810 LTDKSDVYSLGVVLLELLTGMQPISHGKNIVREVNVARDSGMVFSIIDNRMGSYPSECVE 869
D++S+G +L EL G QP+ G++ + + +F+ I +G P+E ++
Sbjct: 178 YGKAVDMWSVGCILGELSDG-QPLFPGESEIDQ---------LFT-IQKVLGPLPAEQMK 226
Query: 870 RF 871
F
Sbjct: 227 LF 228
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 63.2 bits (154), Expect = 1e-10
Identities = 42/111 (37%), Positives = 61/111 (54%), Gaps = 16/111 (14%)
Query: 727 RVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSRLAPVLDDEGTMP 786
++A+ K + YLH++ V HRD+K SN+L++ N K+ DFG+S G +
Sbjct: 107 KIAVSIVKALEYLHSKLS--VIHRDVKPSNVLINRNGQVKLCDFGIS---------GYLV 155
Query: 787 THVS-TIVKGTPGYLDPEYF---LTHKLTD-KSDVYSLGVVLLELLTGMQP 832
V+ TI G Y+ PE L K D KSDV+SLG+ ++EL TG P
Sbjct: 156 DSVAKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFP 206
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 63.3 bits (154), Expect = 2e-10
Identities = 35/104 (33%), Positives = 55/104 (52%), Gaps = 11/104 (10%)
Query: 735 GILYLHTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSRLAPVLDDEGTMPTHVSTIVK 794
G+ +LH + + +RD+K N+LLD + + K+ADFG+ + + ST
Sbjct: 108 GLQFLHKKG---IIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGE------GKASTFC- 157
Query: 795 GTPGYLDPEYFLTHKLTDKSDVYSLGVVLLELLTGMQPISHGKN 838
GTP Y+ PE K + D +S GV+L E+L G P HG++
Sbjct: 158 GTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPF-HGED 200
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 2e-10
Identities = 56/171 (32%), Positives = 78/171 (45%), Gaps = 20/171 (11%)
Query: 733 AKGILYLHTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSRLAPVLDDEGTMPTHVSTI 792
AKG+ +L A HRD+ A NILL N K+ DFGL+R D P +V
Sbjct: 189 AKGMEFL---ASRKCIHRDLAARNILLSENNVVKICDFGLAR------DIYKDPDYVRKG 239
Query: 793 VKGTP-GYLDPEYFLTHKLTDKSDVYSLGVVLLELLT-GMQPISHGKNIVREVNVARDSG 850
P ++ PE T +SDV+S GV+L E+ + G P G I E G
Sbjct: 240 DARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYP-GVKIDEEFCRRLKEG 298
Query: 851 MVFSIIDNRMGSYPSECVERFVTLALRCCHDKPEHRPSMSDVVRELENILK 901
RM + E + T+ L C H +P RP+ S++V L N+L+
Sbjct: 299 -------TRMRAPDYTTPEMYQTM-LDCWHGEPSQRPTFSELVEHLGNLLQ 341
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 62.5 bits (152), Expect = 3e-10
Identities = 63/210 (30%), Positives = 94/210 (44%), Gaps = 28/210 (13%)
Query: 633 VGQGGYGKVYKGILSDNTTV----AIKRAEEGSLQGQNEF---LTEIKLLSRLHHRNLVS 685
+G+G +GKV IL A+K ++ + ++E LTE ++L H L +
Sbjct: 3 LGKGTFGKV---ILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTA 59
Query: 686 LLGYCDEEGEQMLVYEFVPNGTLRDWLSGRTKENLNFAMRLR---VALDSAKGILYLHTE 742
L V E+ G L LS +E + R R + SA G YLH+
Sbjct: 60 LKYSFQTHDRLCFVMEYANGGELFFHLS---RERVFSEDRARFYGAEIVSALG--YLHSC 114
Query: 743 AHPPVFHRDIKASNILLDSNLNAKVADFGLSRLAPVLDDEGTMPTHVSTIVKGTPGYLDP 802
V +RD+K N++LD + + K+ DFGL + + D TM T GTP YL P
Sbjct: 115 D---VVYRDLKLENLMLDKDGHIKITDFGLCKEG--ISDGATMKTFC-----GTPEYLAP 164
Query: 803 EYFLTHKLTDKSDVYSLGVVLLELLTGMQP 832
E + D + LGVV+ E++ G P
Sbjct: 165 EVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 194
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 61.9 bits (150), Expect = 3e-10
Identities = 59/220 (26%), Positives = 101/220 (45%), Gaps = 17/220 (7%)
Query: 633 VGQGGYGKVYK-GILSDNTTVAIKRAEEGSLQ---GQNEFLTEIKLLSRLHHRNLVSLLG 688
+G+GG+G+V + + A KR E+ ++ G++ L E ++L +++ + +V+L
Sbjct: 8 LGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNL-A 66
Query: 689 YCDEEGEQM-LVYEFVPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPV 747
Y E + + LV + G L+ + L A + G+ LH E
Sbjct: 67 YAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHREN---T 123
Query: 748 FHRDIKASNILLDSNLNAKVADFGLSRLAPVLDDEGTMPTHVSTIVKGTPGYLDPEYFLT 807
+RD+K NILLD + +++D GL+ P EG + V GT GY+ PE
Sbjct: 124 VYRDLKPENILLDDYGHIRISDLGLAVKIP----EGES---IRGRV-GTVGYMAPEVLNN 175
Query: 808 HKLTDKSDVYSLGVVLLELLTGMQPISHGKNIVREVNVAR 847
+ T D + LG ++ E++ G P K V+ V R
Sbjct: 176 QRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDR 215
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 62.0 bits (150), Expect = 3e-10
Identities = 50/181 (27%), Positives = 87/181 (48%), Gaps = 13/181 (7%)
Query: 652 VAIKRAEEGSLQGQNEFLTEIKLLSRLHHRNLVSLLGYCDEEGEQMLVYEFVPNGTLRDW 711
VA+K + Q + E+ ++ H+N+V + E ++ EF+ G L D
Sbjct: 49 VAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGALTDI 108
Query: 712 LSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSNLNAKVADFG 771
+S + LN V + + YLH++ V HRDIK+ +ILL + K++DFG
Sbjct: 109 VS---QTRLNEEQIATVCESVLQALCYLHSQG---VIHRDIKSDSILLTLDGRVKLSDFG 162
Query: 772 LSRLAPVLDDEGTMPTHVSTIVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVLLELLTGMQ 831
A + D +P S + GTP ++ PE + D++SLG++++E++ G
Sbjct: 163 FC--AQISKD---VPKRKSLV--GTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEP 215
Query: 832 P 832
P
Sbjct: 216 P 216
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 61.9 bits (151), Expect = 3e-10
Identities = 67/252 (26%), Positives = 116/252 (46%), Gaps = 43/252 (17%)
Query: 632 QVGQGGYGKVYKGI-LSDNTTVAIKRAEE--GSLQGQNEFLTEIKLLSRL-HHRNLVSLL 687
++G+G + +V K AIK ++ SL+ N L EI+ L RL H N++ L+
Sbjct: 6 KIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNN-LREIQALRRLSPHPNILRLI 64
Query: 688 G--YCDEEGEQMLVYEFVPNGTLRDWLSGRTK---EN--LNFAMRLRVALDSAKGILYLH 740
+ + G LV+E + + L + + GR + E ++ +L +LD ++H
Sbjct: 65 EVLFDRKTGRLALVFELM-DMNLYELIKGRKRPLPEKRVKSYMYQLLKSLD------HMH 117
Query: 741 TEAHPPVFHRDIKASNILLDSNLNAKVADFGLSRLAPVLDDEGTMPTHVSTIVKGTPGYL 800
+FHRDIK NIL+ ++ K+ADFG R G T T Y
Sbjct: 118 ---RNGIFHRDIKPENILIKDDI-LKLADFGSCR--------GIYSKPPYTEYISTRWYR 165
Query: 801 DPEYFLTHKL-TDKSDVYSLGVVLLELLTGMQPISHGKNIVREVNVARDSGMVFSIIDNR 859
PE LT K D++++G V E+L+ + P+ G N + ++ I +
Sbjct: 166 APECLLTDGYYGPKMDIWAVGCVFFEILS-LFPLFPGTNELDQIAK----------IHDV 214
Query: 860 MGSYPSECVERF 871
+G+ +E +++F
Sbjct: 215 LGTPDAEVLKKF 226
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 63.3 bits (154), Expect = 4e-10
Identities = 35/88 (39%), Positives = 54/88 (61%), Gaps = 2/88 (2%)
Query: 259 LSLRNCNLQGAVP-DLSRIPNLYYLDLSWNHLTGSIP-SKKLSENVTTIDLSDNYLNGSI 316
L L N L+G +P D+S++ +L ++LS N + G+IP S ++ +DLS N NGSI
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSI 482
Query: 317 LESISNLPFLQTLSLENNFLTGSIPATI 344
ES+ L L+ L+L N L+G +PA +
Sbjct: 483 PESLGQLTSLRILNLNGNSLSGRVPAAL 510
|
Length = 623 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 61.7 bits (150), Expect = 4e-10
Identities = 61/234 (26%), Positives = 97/234 (41%), Gaps = 46/234 (19%)
Query: 634 GQGGYGKVY----KGILSDNTTVAIKRAEEGSL----QGQNEFLTEIKLLSRLHHRN-LV 684
G G YGKV+ G A+K ++ ++ + TE ++L + LV
Sbjct: 9 GTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLV 68
Query: 685 SLLGYCDEEGEQMLVYEFVPNGTLRDWLSGRTKENLN----FAMRLRVALDS--AKGILY 738
+L + + L+ ++V G L L R + + + +ALD GI+Y
Sbjct: 69 TLHYAFQTDTKLHLILDYVNGGELFTHLYQREHFTESEVRVYIAEIVLALDHLHQLGIIY 128
Query: 739 LHTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSR--LAPVLDDE----GTMPTHVSTI 792
RDIK NILLDS + + DFGLS+ LA + GT+ +
Sbjct: 129 -----------RDIKLENILLDSEGHVVLTDFGLSKEFLAEEEERAYSFCGTIEYMAPEV 177
Query: 793 VK-GTPGYLDPEYFLTHKLTDKSDVYSLGVVLLELLTGMQP--ISHGKNIVREV 843
++ G+ G+ D +SLGV+ ELLTG P + +N E+
Sbjct: 178 IRGGSGGH-----------DKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEI 220
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 61.5 bits (149), Expect = 4e-10
Identities = 53/220 (24%), Positives = 100/220 (45%), Gaps = 17/220 (7%)
Query: 633 VGQGGYGKVYKGILSDNT--TVAIKRAEEGSLQ---GQNEFLTEIKLLSRLHHRNLVSLL 687
+G+GG+G+V + NT A K+ ++ L+ G+ L E ++L +++ +V+L
Sbjct: 1 LGKGGFGEVC-AVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLA 59
Query: 688 GYCDEEGEQMLVYEFVPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPV 747
+ + LV + G L+ + + L + + GIL+LH+ +
Sbjct: 60 YAFESKTHLCLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLHSMD---I 116
Query: 748 FHRDIKASNILLDSNLNAKVADFGLSRLAPVLDDEGTMPTHVSTIVKGTPGYLDPEYFLT 807
+RD+K N+LLD N +++D GL+ +G T + GT GY+ PE
Sbjct: 117 VYRDMKPENVLLDDQGNCRLSDLGLAVELK----DGKTITQRA----GTNGYMAPEILKE 168
Query: 808 HKLTDKSDVYSLGVVLLELLTGMQPISHGKNIVREVNVAR 847
+ D +++G + E++ G P K V + + R
Sbjct: 169 EPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKR 208
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 62.9 bits (153), Expect = 5e-10
Identities = 32/86 (37%), Positives = 50/86 (58%), Gaps = 1/86 (1%)
Query: 186 LHLNNNSIGGQIPSELSKLSTLIHLLVDNNNLSGNLPPELSELPQLCILQLDNNNFSASE 245
L L+N + G IP+++SKL L + + N++ GN+PP L + L +L L N+F+ S
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGS- 481
Query: 246 IPATYGNFSKLVKLSLRNCNLQGAVP 271
IP + G + L L+L +L G VP
Sbjct: 482 IPESLGQLTSLRILNLNGNSLSGRVP 507
|
Length = 623 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 61.6 bits (149), Expect = 6e-10
Identities = 55/209 (26%), Positives = 91/209 (43%), Gaps = 25/209 (11%)
Query: 633 VGQGGYGKVYKGILSDNTTVAIKRAEEGSLQGQNEFL----TEIKLLSRL-HHRNLVSLL 687
+G+G Y KV L + + + L +E + TE + + +H LV L
Sbjct: 3 IGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLH 62
Query: 688 GYCDEEGEQMLVYEFVPNGTLRDWLSGRTK---ENLNF-AMRLRVALDSAKGILYLHTEA 743
E V E+V G L + + K E+ F + + +AL+ YLH
Sbjct: 63 SCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALN------YLHERG 116
Query: 744 HPPVFHRDIKASNILLDSNLNAKVADFGLSRLAPVLDDEGTMPTHVSTIVKGTPGYLDPE 803
+ +RD+K N+LLDS + K+ D+G+ + EG P ++ GTP Y+ PE
Sbjct: 117 ---IIYRDLKLDNVLLDSEGHIKLTDYGMCK-------EGLRPGDTTSTFCGTPNYIAPE 166
Query: 804 YFLTHKLTDKSDVYSLGVVLLELLTGMQP 832
D ++LGV++ E++ G P
Sbjct: 167 ILRGEDYGFSVDWWALGVLMFEMMAGRSP 195
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 61.4 bits (149), Expect = 6e-10
Identities = 67/232 (28%), Positives = 98/232 (42%), Gaps = 58/232 (25%)
Query: 632 QVGQGGYGKVYKGI-LSDNTTVAIKRA-----EEGSLQGQNEFLTEIKLLSRLHHRN-LV 684
++G+G YGKVYK + VA+K+ EEG L EI LL L +V
Sbjct: 8 KIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGI---PPTALREISLLQMLSESIYIV 64
Query: 685 SLLGYCDEEGEQ-------MLVYEFVPNGTLRDWLSGRTKENLN---------FAMRLRV 728
LL E E+ LV+E++ + L+ ++ + F +L
Sbjct: 65 RLL--DVEHVEEKNGKPSLYLVFEYL-DSDLKKFMDSNGRGPGRPLPAKTIKSFMYQL-- 119
Query: 729 ALDSAKGILYLHTEAHPPVFHRDIKASNILLDSNLNA-KVADFGLSRLAPVLDDEGTMP- 786
KG+ + H V HRD+K N+L+D K+AD GL R ++P
Sbjct: 120 ----LKGVAHCHKHG---VMHRDLKPQNLLVDKQKGLLKIADLGLGR-------AFSIPV 165
Query: 787 ---THVSTIVKGTPGYLDPEYFL--THKLTDKSDVYSLGVVLLELLTGMQPI 833
TH IV T Y PE L TH T D++S+G + E+ QP+
Sbjct: 166 KSYTH--EIV--TLWYRAPEVLLGSTHYST-PVDIWSVGCIFAEMSR-KQPL 211
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 6e-10
Identities = 61/223 (27%), Positives = 108/223 (48%), Gaps = 28/223 (12%)
Query: 632 QVGQGGYGKVYKG--ILSDNTTVAIKRA----EEGSLQGQNEFLTEIKLLSRLHHRNLVS 685
++G+G Y V+KG L++N VA+K EEG+ + E+ LL L H N+V+
Sbjct: 13 KLGEGTYATVFKGRSKLTENL-VALKEIRLEHEEGA---PCTAIREVSLLKDLKHANIVT 68
Query: 686 LLGYCDEEGEQMLVYEFVPNGTLRDWLS--GRTKENLNFAMRLRVALDSAKGILYLHTEA 743
L + LV+E++ + L+ ++ G N + L L +G+ Y H
Sbjct: 69 LHDIVHTDKSLTLVFEYL-DKDLKQYMDDCGNIMSMHNVKIFLYQIL---RGLAYCHRRK 124
Query: 744 HPPVFHRDIKASNILLDSNLNAKVADFGLSRLAPVLDDEGTMPTHVSTIVKGTPGYLDPE 803
V HRD+K N+L++ K+ADFGL+R V PT + T Y P+
Sbjct: 125 ---VLHRDLKPQNLLINERGELKLADFGLARAKSV-------PTKTYSNEVVTLWYRPPD 174
Query: 804 YFL-THKLTDKSDVYSLGVVLLELLTGMQPISHGKNIVREVNV 845
L + + + + D++ +G + E+ +G +P+ G + E+++
Sbjct: 175 VLLGSSEYSTQIDMWGVGCIFFEMASG-RPLFPGSTVEDELHL 216
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 61.6 bits (149), Expect = 6e-10
Identities = 59/211 (27%), Positives = 96/211 (45%), Gaps = 29/211 (13%)
Query: 633 VGQGGYGKVYKGILSDNTT---VAIKRAEEGSLQGQNEF---LTEIKLLSRLHHRNLVSL 686
+G+G +GKV ++ + T A+K ++ + ++E LTE ++L H L +L
Sbjct: 3 LGKGTFGKVI--LVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTAL 60
Query: 687 LGYCDEEGEQMLVYEFVPNGTL-----RDWLSGRTKENLNFAMRLRVALDSAKGILYLHT 741
V E+ G L R+ + + + + ALD YLH+
Sbjct: 61 KYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARF-YGAEIVSALD------YLHS 113
Query: 742 EAHPPVFHRDIKASNILLDSNLNAKVADFGLSRLAPVLDDEGTMPTHVSTIVKGTPGYLD 801
E + V +RD+K N++LD + + K+ DFGL + + D TM T GTP YL
Sbjct: 114 EKN--VVYRDLKLENLMLDKDGHIKITDFGLCKEG--IKDGATMKTFC-----GTPEYLA 164
Query: 802 PEYFLTHKLTDKSDVYSLGVVLLELLTGMQP 832
PE + D + LGVV+ E++ G P
Sbjct: 165 PEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 195
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 61.2 bits (149), Expect = 7e-10
Identities = 59/214 (27%), Positives = 90/214 (42%), Gaps = 36/214 (16%)
Query: 634 GQGGYGKV----YKGILSDNTTVAIKRAEEGSLQGQNE---FLTEIKLL---SRLHHRNL 683
G+G +GKV YK AIK ++G + ++E + E ++ + H L
Sbjct: 8 GRGHFGKVLLAEYK---KTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFL 64
Query: 684 VSLLGYCDEEGEQMLVYEFVPNGTL-----RDWLSGRTKENLNFAMRLRVALDSAKGILY 738
V+L E V E+ G L D S + +A + + L Y
Sbjct: 65 VNLFACFQTEDHVCFVMEYAAGGDLMMHIHTDVFS--EPRAVFYAACVVLGLQ------Y 116
Query: 739 LHTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSRLAPVLDDEGTMPTHVSTIVKGTPG 798
LH + +RD+K N+LLD+ K+ADFGL + EG ++ GTP
Sbjct: 117 LHENK---IVYRDLKLDNLLLDTEGFVKIADFGLCK-------EGMGFGDRTSTFCGTPE 166
Query: 799 YLDPEYFLTHKLTDKSDVYSLGVVLLELLTGMQP 832
+L PE T D + LGV++ E+L G P
Sbjct: 167 FLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESP 200
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 60.6 bits (147), Expect = 8e-10
Identities = 55/213 (25%), Positives = 98/213 (46%), Gaps = 26/213 (12%)
Query: 632 QVGQGGYGKVYKGILS-DNTTVAIKRA----EEGSLQGQNEFLTEIKLLSRLHHRNLVSL 686
++G+G YG VYK + T+A+K +E N+ + E+ +L + +V
Sbjct: 8 ELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKF---NQIIMELDILHKAVSPYIVDF 64
Query: 687 LGYCDEEGEQMLVYEFVPNGTL-RDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHP 745
G EG + E++ G+L + + G E + + R+ KG+ +L E +
Sbjct: 65 YGAFFIEGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHN- 123
Query: 746 PVFHRDIKASNILLDSNLNAKVADFGLSRLAPVLDDEGTMPTHVSTIVKGTPGYLDPEYF 805
+ HRD+K +N+L++ N K+ DFG+S G + ++ G Y+ PE
Sbjct: 124 -IIHRDVKPTNVLVNGNGQVKLCDFGVS---------GNLVASLAKTNIGCQSYMAPERI 173
Query: 806 LTHKLTD------KSDVYSLGVVLLELLTGMQP 832
+ +SDV+SLG+ +LE+ G P
Sbjct: 174 KSGGPNQNPTYTVQSDVWSLGLSILEMALGRYP 206
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 61.1 bits (148), Expect = 8e-10
Identities = 34/104 (32%), Positives = 56/104 (53%), Gaps = 11/104 (10%)
Query: 735 GILYLHTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSRLAPVLDDEGTMPTHVSTIVK 794
G+ +LH++ + +RD+K N++LD + + K+ADFG+ + E + ++
Sbjct: 108 GLQFLHSKG---IIYRDLKLDNVMLDRDGHIKIADFGMCK-------ENVFGDNRASTFC 157
Query: 795 GTPGYLDPEYFLTHKLTDKSDVYSLGVVLLELLTGMQPISHGKN 838
GTP Y+ PE K T D +S GV+L E+L G P HG +
Sbjct: 158 GTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPF-HGDD 200
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 8e-10
Identities = 61/208 (29%), Positives = 95/208 (45%), Gaps = 24/208 (11%)
Query: 633 VGQGGYGKVYKGIL----SDNTTVAIKRAEEGSLQGQNEF---LTEIKLLSRLHHRNLVS 685
+G+G +GKV IL + A+K ++ + ++E LTE ++L H L S
Sbjct: 3 LGKGTFGKV---ILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTS 59
Query: 686 LLGYCDEEGEQMLVYEFVPNGTLRDWLSGRTKENLNFAMRLRV-ALDSAKGILYLHTEAH 744
L + V E+V G L LS +E + R R + + YLH+
Sbjct: 60 LKYSFQTKDRLCFVMEYVNGGELFFHLS---RERVFSEDRTRFYGAEIVSALDYLHSGK- 115
Query: 745 PPVFHRDIKASNILLDSNLNAKVADFGLSRLAPVLDDEGTMPTHVSTIVKGTPGYLDPEY 804
+ +RD+K N++LD + + K+ DFGL + + D TM T GTP YL PE
Sbjct: 116 --IVYRDLKLENLMLDKDGHIKITDFGLCKEG--ITDAATMKTFC-----GTPEYLAPEV 166
Query: 805 FLTHKLTDKSDVYSLGVVLLELLTGMQP 832
+ D + LGVV+ E++ G P
Sbjct: 167 LEDNDYGRAVDWWGLGVVMYEMMCGRLP 194
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 9e-10
Identities = 62/225 (27%), Positives = 107/225 (47%), Gaps = 32/225 (14%)
Query: 632 QVGQGGYGKVYKG--ILSDNTTVAIKRA----EEGSLQGQNEFLTEIKLLSRLHHRNLVS 685
++G+G Y V+KG L++N VA+K EEG+ + E+ LL L H N+V+
Sbjct: 12 KLGEGTYATVFKGRSKLTENL-VALKEIRLEHEEGA---PCTAIREVSLLKNLKHANIVT 67
Query: 686 LLGYCDEEGEQMLVYEFVPNGTLRDWLSG----RTKENLNFAMRLRVALDSAKGILYLHT 741
L E LV+E++ + L+ +L + N+ M +G+ Y H
Sbjct: 68 LHDIIHTERCLTLVFEYLDS-DLKQYLDNCGNLMSMHNVKIFM-----FQLLRGLSYCH- 120
Query: 742 EAHPPVFHRDIKASNILLDSNLNAKVADFGLSRLAPVLDDEGTMPTHVSTIVKGTPGYLD 801
+ HRD+K N+L++ K+ADFGL+R V PT + T Y
Sbjct: 121 --KRKILHRDLKPQNLLINEKGELKLADFGLARAKSV-------PTKTYSNEVVTLWYRP 171
Query: 802 PEYFL-THKLTDKSDVYSLGVVLLELLTGMQPISHGKNIVREVNV 845
P+ L + + + D++ +G +L E+ TG +P+ G + E+++
Sbjct: 172 PDVLLGSTEYSTPIDMWGVGCILYEMATG-RPMFPGSTVKEELHL 215
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 61.0 bits (148), Expect = 1e-09
Identities = 56/209 (26%), Positives = 95/209 (45%), Gaps = 29/209 (13%)
Query: 633 VGQGGYGKV----YKGILSDNTTVAIKRAEEGSLQGQNEFLTEIKLLSRLHHRNLVSLL- 687
+G G +G+V +KG +K+ E ++ E +L L H +V+++
Sbjct: 26 LGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMC 85
Query: 688 GYCDEEGEQMLVYEFVPNGTLRDWL--SGRTKENLN--FAMRLRVALDSAKGILYLHTEA 743
+ DE + EFV G L L +GR ++ + L +A + YLH++
Sbjct: 86 SFQDEN-RVYFLLEFVVGGELFTHLRKAGRFPNDVAKFYHAELVLAFE------YLHSKD 138
Query: 744 HPPVFHRDIKASNILLDSNLNAKVADFGLSRLAPVLDDEGTMPTHVSTIVKGTPGYLDPE 803
+ +RD+K N+LLD+ + KV DFG ++ +P T+ GTP YL PE
Sbjct: 139 ---IIYRDLKPENLLLDNKGHVKVTDFGFAK---------KVPDRTFTLC-GTPEYLAPE 185
Query: 804 YFLTHKLTDKSDVYSLGVVLLELLTGMQP 832
+ D +++GV+L E + G P
Sbjct: 186 VIQSKGHGKAVDWWTMGVLLYEFIAGYPP 214
|
Length = 329 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 1e-09
Identities = 60/221 (27%), Positives = 102/221 (46%), Gaps = 19/221 (8%)
Query: 633 VGQGGYGKVYK-GILSDNTTVAIKRAEEGSLQ---GQNEFLTEIKLLSRLHHRNLVSLLG 688
+G+GG+G+V + + A K+ E+ ++ G+ L E ++L +++ R +VSL
Sbjct: 8 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSL-A 66
Query: 689 YCDEEGEQM-LVYEFVPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPV 747
Y E + + LV + G L+ + + + A + G+ L E +
Sbjct: 67 YAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRER---I 123
Query: 748 FHRDIKASNILLDSNLNAKVADFGLSRLAPVLDDEG-TMPTHVSTIVKGTPGYLDPEYFL 806
+RD+K NILLD + +++D GL+ P EG T+ V GT GY+ PE
Sbjct: 124 VYRDLKPENILLDDRGHIRISDLGLAVQIP----EGETVRGRV-----GTVGYMAPEVIN 174
Query: 807 THKLTDKSDVYSLGVVLLELLTGMQPISHGKNIVREVNVAR 847
K T D + LG ++ E++ G P K V+ V R
Sbjct: 175 NEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDR 215
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 1e-09
Identities = 52/209 (24%), Positives = 92/209 (44%), Gaps = 25/209 (11%)
Query: 633 VGQGGYGKVYKGILSDNTTVAIKRAEEGSLQGQNEFLTEIKLLSRLHHRN-----LVSLL 687
+G+G Y KV L N + + + L +E + ++ + + LV L
Sbjct: 3 IGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLH 62
Query: 688 GYCDEEGEQMLVYEFVPNGTLRDWLSGRTK---ENLNF-AMRLRVALDSAKGILYLHTEA 743
LV E+V G L + + K E+ F A + +AL+ +LH
Sbjct: 63 SCFQTTSRLFLVIEYVNGGDLMFHMQRQRKLPEEHARFYAAEICIALN------FLHERG 116
Query: 744 HPPVFHRDIKASNILLDSNLNAKVADFGLSRLAPVLDDEGTMPTHVSTIVKGTPGYLDPE 803
+ +RD+K N+LLD++ + K+ D+G+ + EG P ++ GTP Y+ PE
Sbjct: 117 ---IIYRDLKLDNVLLDADGHIKLTDYGMCK-------EGLGPGDTTSTFCGTPNYIAPE 166
Query: 804 YFLTHKLTDKSDVYSLGVVLLELLTGMQP 832
+ D ++LGV++ E++ G P
Sbjct: 167 ILRGEEYGFSVDWWALGVLMFEMMAGRSP 195
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 1e-09
Identities = 59/207 (28%), Positives = 93/207 (44%), Gaps = 22/207 (10%)
Query: 633 VGQGGYGKVYKGILSDNTT---VAIKRAEEGSLQGQNEF---LTEIKLLSRLHHRNLVSL 686
+G+G +GKV ++ + T A+K + + ++E +TE ++L H L +L
Sbjct: 3 LGKGTFGKVI--LVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTAL 60
Query: 687 LGYCDEEGEQMLVYEFVPNGTLRDWLSGRTKENLNFAMRLRV-ALDSAKGILYLHTEAHP 745
V E+ G L LS +E + R R + + YLH+
Sbjct: 61 KYAFQTHDRLCFVMEYANGGELFFHLS---RERVFTEERARFYGAEIVSALEYLHSRD-- 115
Query: 746 PVFHRDIKASNILLDSNLNAKVADFGLSRLAPVLDDEGTMPTHVSTIVKGTPGYLDPEYF 805
V +RDIK N++LD + + K+ DFGL + + D TM T GTP YL PE
Sbjct: 116 -VVYRDIKLENLMLDKDGHIKITDFGLCKEG--ISDGATMKTFC-----GTPEYLAPEVL 167
Query: 806 LTHKLTDKSDVYSLGVVLLELLTGMQP 832
+ D + LGVV+ E++ G P
Sbjct: 168 EDNDYGRAVDWWGLGVVMYEMMCGRLP 194
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 1e-09
Identities = 57/193 (29%), Positives = 82/193 (42%), Gaps = 25/193 (12%)
Query: 711 WLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSNLNAKVADF 770
W S T E+L + + A+G+ +L A HRD+ A NILL N K+ DF
Sbjct: 167 WKSPLTMEDL-----ICYSFQVARGMEFL---ASRKCIHRDLAARNILLSENNVVKICDF 218
Query: 771 GLSRLAPVLDDEGTMPTHVSTIVKGTP-GYLDPEYFLTHKLTDKSDVYSLGVVLLELLT- 828
GL+R D P +V P ++ PE T +SDV+S GV+L E+ +
Sbjct: 219 GLAR------DIYKDPDYVRKGSARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSL 272
Query: 829 GMQPISHGKNIVREVNVARDSGMVFSIIDNRMGSYPSECVERFVTLALRCCHDKPEHRPS 888
G P G I E G RM + P + L C P+ RP+
Sbjct: 273 GASPYP-GVQINEEFCQRLKDG-------TRMRA-PENATPEIYRIMLACWQGDPKERPT 323
Query: 889 MSDVVRELENILK 901
S +V L ++L+
Sbjct: 324 FSALVEILGDLLQ 336
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 59.6 bits (144), Expect = 3e-09
Identities = 64/207 (30%), Positives = 94/207 (45%), Gaps = 21/207 (10%)
Query: 633 VGQGGYGKVYKGILS-DNTTVAIKRAEEGSL---QGQNEFLTEIK-LLSRLHHRNLVSLL 687
+G+G +GKV D A+K ++ + + Q + E LL + H LV L
Sbjct: 3 IGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGL- 61
Query: 688 GYCDEEGEQM-LVYEFVPNGTLRDWLSGRTKENLNFAMRLRV-ALDSAKGILYLHTEAHP 745
Y + E++ V +FV G L L +E R R A + A + YLH+
Sbjct: 62 HYSFQTTEKLYFVLDFVNGGELFFHLQ---RERSFPEPRARFYAAEIASALGYLHSIN-- 116
Query: 746 PVFHRDIKASNILLDSNLNAKVADFGLSRLAPVLDDEGTMPTHVSTIVKGTPGYLDPEYF 805
+ +RD+K NILLDS + + DFGL + EG + +T GTP YL PE
Sbjct: 117 -IVYRDLKPENILLDSQGHVVLTDFGLCK-------EGIAQSDTTTTFCGTPEYLAPEVI 168
Query: 806 LTHKLTDKSDVYSLGVVLLELLTGMQP 832
+ D + LG VL E+L G+ P
Sbjct: 169 RKQPYDNTVDWWCLGAVLYEMLYGLPP 195
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 58.3 bits (141), Expect = 4e-09
Identities = 59/281 (20%), Positives = 113/281 (40%), Gaps = 44/281 (15%)
Query: 632 QVGQGGYGKVYKGILSDN--TTVAIK----------RAEEGSLQGQNEFLTEIKLL-SRL 678
+G G +G VYK +N +A+K + + + + ++E+ ++ +L
Sbjct: 7 HLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQL 66
Query: 679 HHRNLVSLLGYCDEEGEQMLVYEFVPNGTLRDWLS------GRTKENLNFAMRLRVALDS 732
H N+V E +V + + L + + R E + + +++ L
Sbjct: 67 RHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVL-- 124
Query: 733 AKGILYLHTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSRLAPVLDDEGTMPTHVSTI 792
+ YLH E + HRD+ +NI+L + + DFGL++ E + + V TI
Sbjct: 125 --ALRYLHKEKR--IVHRDLTPNNIMLGEDDKVTITDFGLAKQK---QPESKLTSVVGTI 177
Query: 793 VKGTPGYLDPEYFLTHKLTDKSDVYSLGVVLLELLTGMQPISHGKNIVREVNVARDSGMV 852
+ Y PE +K+DV++ G +L ++ T +QP + N++ +
Sbjct: 178 L-----YSCPEIVKNEPYGEKADVWAFGCILYQMCT-LQPPFYSTNML---------SLA 222
Query: 853 FSIIDNRMGSYPSECVERFVTLAL-RCCHDKPEHRPSMSDV 892
I++ P VT + C E RP + V
Sbjct: 223 TKIVEAVYEPLPEGMYSEDVTDVITSCLTPDAEARPDIIQV 263
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 59.1 bits (143), Expect = 4e-09
Identities = 63/223 (28%), Positives = 101/223 (45%), Gaps = 26/223 (11%)
Query: 627 FSSSTQVGQGGYGKVYKGILSDNTT---VAIKRAEEGSLQGQNE---FLTEIKLLSRLHH 680
F + VG+G +G+V ++ + T A+K ++ L Q F E +LS +
Sbjct: 3 FDVKSLVGRGHFGEVQ--VVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNS 60
Query: 681 RNLVSLLGYCDEEGEQM-LVYEFVPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYL 739
+ L Y ++ + + LV E+ P G L L+ R ++ + M + L A+ +L +
Sbjct: 61 PWIPQLQ-YAFQDKDNLYLVMEYQPGGDLLSLLN-RYEDQFDEDM-AQFYL--AELVLAI 115
Query: 740 HTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSRLAPVLDDEGTMPTHVSTIVKGTPGY 799
H+ HRDIK N+L+D + K+ADFG A L + S + GTP Y
Sbjct: 116 HSVHQMGYVHRDIKPENVLIDRTGHIKLADFG---SAARLTANKMV---NSKLPVGTPDY 169
Query: 800 LDPEYFLTHKLTDKS------DVYSLGVVLLELLTGMQPISHG 836
+ PE T K D +SLGV+ E++ G P G
Sbjct: 170 IAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEG 212
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 59.0 bits (143), Expect = 4e-09
Identities = 42/142 (29%), Positives = 67/142 (47%), Gaps = 22/142 (15%)
Query: 698 LVYEFVPNGTLRDWLSGR---TKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKA 754
+V E++P G L + +S K + + +ALD+ + ++H RD+K
Sbjct: 120 MVMEYMPGGDLVNLMSNYDIPEKWARFYTAEVVLALDAIHSMGFIH---------RDVKP 170
Query: 755 SNILLDSNLNAKVADFGLSRLAPVLDDEGTMPTHVSTIVKGTPGYLDPEYFLTHKLTD-- 812
N+LLD + + K+ADFG +D G + T V GTP Y+ PE +
Sbjct: 171 DNMLLDKSGHLKLADFGTCMK---MDANGMV--RCDTAV-GTPDYISPEVLKSQGGDGYY 224
Query: 813 --KSDVYSLGVVLLELLTGMQP 832
+ D +S+GV L E+L G P
Sbjct: 225 GRECDWWSVGVFLYEMLVGDTP 246
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 58.9 bits (143), Expect = 5e-09
Identities = 46/171 (26%), Positives = 71/171 (41%), Gaps = 46/171 (26%)
Query: 698 LVYEFVPNGTLRDWLSGR---TKENLNFAM-RLRVALDSAKGILYLHTEAHPPVFHRDIK 753
L+ E++P G + L + T+E F + +A+DS + Y+H RDIK
Sbjct: 78 LIMEYLPGGDMMTLLMKKDTFTEEETRFYIAETILAIDSIHKLGYIH---------RDIK 128
Query: 754 ASNILLDSNLNAKVADFGL---------SRLAPVLDDEGTMPTHVSTIVK---------- 794
N+LLD+ + K++DFGL + +L + I K
Sbjct: 129 PDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRIL-SHALPSNFLDFISKPMSSKRKAET 187
Query: 795 -------------GTPGYLDPEYFLTHKLTDKSDVYSLGVVLLELLTGMQP 832
GTP Y+ PE FL + D +SLGV++ E+L G P
Sbjct: 188 WKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVGYPP 238
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 6e-09
Identities = 40/139 (28%), Positives = 65/139 (46%), Gaps = 20/139 (14%)
Query: 698 LVYEFVPNGTLRDWLS--GRTKE--NLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIK 753
V E+V G L + GR KE + +A + + G+ +LH++ + +RD+K
Sbjct: 78 FVMEYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAI------GLFFLHSKG---IIYRDLK 128
Query: 754 ASNILLDSNLNAKVADFGLSRLAPVLDDEGTMPTHVSTIVKGTPGYLDPEYFLTHKLTDK 813
N++LDS + K+ADFG+ + E + GTP Y+ PE
Sbjct: 129 LDNVMLDSEGHIKIADFGMCK-------ENMWDGVTTKTFCGTPDYIAPEIIAYQPYGKS 181
Query: 814 SDVYSLGVVLLELLTGMQP 832
D ++ GV+L E+L G P
Sbjct: 182 VDWWAFGVLLYEMLAGQAP 200
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 7e-09
Identities = 57/206 (27%), Positives = 90/206 (43%), Gaps = 19/206 (9%)
Query: 633 VGQGGYGKVYKGI-LSDNTTVAIKRAEEGSLQGQNE---FLTEIK-LLSRLHHRNLVSLL 687
+G+G +GKV ++ A+K ++ ++ + E ++E LL + H LV L
Sbjct: 3 IGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLH 62
Query: 688 GYCDEEGEQMLVYEFVPNGTLRDWLSGRTKENLNFAMRLRV-ALDSAKGILYLHTEAHPP 746
+ V +++ G L L +E R R A + A + YLH+
Sbjct: 63 FSFQTADKLYFVLDYINGGELFYHLQ---RERCFLEPRARFYAAEIASALGYLHSLN--- 116
Query: 747 VFHRDIKASNILLDSNLNAKVADFGLSRLAPVLDDEGTMPTHVSTIVKGTPGYLDPEYFL 806
+ +RD+K NILLDS + + DFGL + E ++ GTP YL PE
Sbjct: 117 IVYRDLKPENILLDSQGHIVLTDFGLCK-------ENIEHNGTTSTFCGTPEYLAPEVLH 169
Query: 807 THKLTDKSDVYSLGVVLLELLTGMQP 832
D + LG VL E+L G+ P
Sbjct: 170 KQPYDRTVDWWCLGAVLYEMLYGLPP 195
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 58.2 bits (141), Expect = 8e-09
Identities = 34/103 (33%), Positives = 51/103 (49%), Gaps = 22/103 (21%)
Query: 734 KGILYLHTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSRLAPVLDDEGTMPTHVST-- 791
+G+ YLH+ A + HRDIK N+L++SN K+ DFGL+R+ D+ M V T
Sbjct: 114 RGLKYLHS-AG--ILHRDIKPGNLLVNSNCVLKICDFGLARVEE-PDESKHMTQEVVTQY 169
Query: 792 -----IVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVLLELLTG 829
I+ G+ Y T D++S+G + ELL
Sbjct: 170 YRAPEILMGSRHY-----------TSAVDIWSVGCIFAELLGR 201
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 57.8 bits (139), Expect = 9e-09
Identities = 62/222 (27%), Positives = 101/222 (45%), Gaps = 45/222 (20%)
Query: 633 VGQGGYGKVYKGILSDNTTV----------AIKRAEEGSLQGQNEFLT--EIKLLSRLHH 680
+G+G +G+V L + V +KRAE + + + L + + ++ LH+
Sbjct: 9 IGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHY 68
Query: 681 RNLVSLLGYCDEEGEQMLVYEFVPNGTLRDWLS---GRTKENLN--FAMRLRVALDSAKG 735
+E LV ++ G L LS R E++ + + +A+DS
Sbjct: 69 A--------FQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQ 120
Query: 736 ILYLHTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSRLAPVLDDEGTMPTHVSTIVKG 795
+ Y+H RDIK NIL+D N + ++ADFG S L L ++GT+ S++ G
Sbjct: 121 LHYVH---------RDIKPDNILMDMNGHIRLADFG-SCLK--LMEDGTVQ---SSVAVG 165
Query: 796 TPGYLDPEYFLTH-----KLTDKSDVYSLGVVLLELLTGMQP 832
TP Y+ PE K + D +SLGV + E+L G P
Sbjct: 166 TPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETP 207
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 57.4 bits (139), Expect = 1e-08
Identities = 77/321 (23%), Positives = 122/321 (38%), Gaps = 67/321 (20%)
Query: 634 GQGGYGKVYKGI--LSDNTTVAIK----RAEEGSLQGQNEF--LTEIKLLSRLHHRNLVS 685
G+G Y VYKG L+ VA+K EEG+ F + E LL L H N+V+
Sbjct: 14 GEGSYATVYKGRSKLTGQL-VALKEIRLEHEEGA-----PFTAIREASLLKDLKHANIVT 67
Query: 686 LLGYCDEEGEQMLVYEFVPN--GTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEA 743
L + LV+E++ D G + N + L L +G+ Y H
Sbjct: 68 LHDIIHTKKTLTLVFEYLDTDLKQYMDDCGGGLSMH-NVRLFLFQLL---RGLAYCH--- 120
Query: 744 HPPVFHRDIKASNILLDSNLNAKVADFGLSRLAPVLDDEGTMPTHV--STIVKGTPGYLD 801
V HRD+K N+L+ K+ADFGL+R V P+ + +V T Y
Sbjct: 121 QRRVLHRDLKPQNLLISERGELKLADFGLARAKSV-------PSKTYSNEVV--TLWYRP 171
Query: 802 PEYFLTHKLTDKS---DVYSLGVVLLELLTGMQPISHGKNIVREVNVARDSGMVFSIIDN 858
P+ L T+ S D++ +G + E+ TG ++ ++ +F +
Sbjct: 172 PDVLLGS--TEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQL------HKIFRV--- 220
Query: 859 RMGSYPSECV-------ERFVTLALRCCHDKP--EHRPSMSDVVRELENILKMFPETDTM 909
+G+ P+E F + +P H P + + E LK
Sbjct: 221 -LGT-PTEETWPGVSSNPEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFL------ 272
Query: 910 FSKSESSSLLSGKSASTSSSF 930
+ E +S A F
Sbjct: 273 --QYEPKKRISAAEAMKHPYF 291
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 1e-08
Identities = 38/105 (36%), Positives = 57/105 (54%), Gaps = 11/105 (10%)
Query: 733 AKGILYLHTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSRLAPVLDDEGTMPTHVSTI 792
A+ +L +H+ HRDIK N+LLD N + ++ADFG S L ++ +GT+ + V+
Sbjct: 109 AEMVLAIHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFG-SCLK--MNQDGTVQSSVAV- 164
Query: 793 VKGTPGYLDPEYFLTH-----KLTDKSDVYSLGVVLLELLTGMQP 832
GTP Y+ PE K + D +SLGV + E+L G P
Sbjct: 165 --GTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETP 207
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 1e-08
Identities = 68/232 (29%), Positives = 104/232 (44%), Gaps = 35/232 (15%)
Query: 623 ATAYFSSSTQVGQGGYGKVYKGILSDN-TTVAIK----RAEEGSLQGQNEFLTEIKLLSR 677
AT+Y + ++G+G Y VYKGI N VA+K + EEG + E LL
Sbjct: 4 ATSYLNLE-KLGEGSYATVYKGISRINGQLVALKVISMKTEEGV---PFTAIREASLLKG 59
Query: 678 LHHRNLVSLLGYCDEEGEQMLVYEFVPNGTLRDWLS----GRTKENLNFAMRLRVALDSA 733
L H N+V L + V+E++ + L ++ G N+ M
Sbjct: 60 LKHANIVLLHDIIHTKETLTFVFEYM-HTDLAQYMIQHPGGLHPYNVRLFM-----FQLL 113
Query: 734 KGILYLHTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSRLAPVLDDEGTMPTHVSTIV 793
+G+ Y+H + HRD+K N+L+ K+ADFGL+R + T+ S +V
Sbjct: 114 RGLAYIH---GQHILHRDLKPQNLLISYLGELKLADFGLARAKSI-----PSQTYSSEVV 165
Query: 794 KGTPGYLDPEYFLTHKLTDKS---DVYSLGVVLLELLTGMQPISHGKNIVRE 842
T Y P+ L TD S D++ G + +E+L G QP G + V E
Sbjct: 166 --TLWYRPPDVLLGA--TDYSSALDIWGAGCIFIEMLQG-QPAFPGVSDVFE 212
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 57.0 bits (137), Expect = 2e-08
Identities = 80/323 (24%), Positives = 139/323 (43%), Gaps = 68/323 (21%)
Query: 633 VGQGGYGKV---YKGILSDNTTVAIKRAEEGSLQGQN---EFLTEIKLLSRLHHRNLVSL 686
+G G G V Y +L N VAIK+ Q Q E+ L+ ++H+N++SL
Sbjct: 25 IGSGAQGIVCAAYDAVLDRN--VAIKKLSR-PFQNQTHAKRAYRELVLMKCVNHKNIISL 81
Query: 687 LGYCDEEGEQMLVYEFVPNGTLRDWLSGRTKENL---NFAMRLRVALDSAK--------- 734
L F P +L ++ L N +++ LD +
Sbjct: 82 LNV------------FTPQKSLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQML 129
Query: 735 -GILYLHTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSRLAPVLDDEGTMPTHVSTIV 793
GI +LH+ + HRD+K SNI++ S+ K+ DFGL+R A GT +V
Sbjct: 130 CGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTA------GTSFMMTPYVV 180
Query: 794 KGTPGYLDPEYFLTHKLTDKSDVYSLGVVLLELLTGMQPISHGKNIVREVNVARDSGMVF 853
T Y PE L + D++S+G ++ E++ + + G++ + + N
Sbjct: 181 --TRYYRAPEVILGMGYKENVDIWSVGCIMGEMVR-HKILFPGRDYIDQWN--------- 228
Query: 854 SIIDNRMGSYPSECVERFVTLALRCCHDKPEHRPSMSDVVRELENILKMFPETDTMF-SK 912
+I+ ++G + C E F+ + E+RP + + K+FP D++F +
Sbjct: 229 KVIE-QLG---TPCPE-FMKKLQPTVRNYVENRPKYAGL-----TFPKLFP--DSLFPAD 276
Query: 913 SESSSLLSGKSASTSSSFLTRDP 935
SE + L + ++ S L DP
Sbjct: 277 SEHNKLKASQARDLLSKMLVIDP 299
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 56.4 bits (136), Expect = 2e-08
Identities = 58/220 (26%), Positives = 102/220 (46%), Gaps = 17/220 (7%)
Query: 633 VGQGGYGKVYK-GILSDNTTVAIKRAEEGSLQ---GQNEFLTEIKLLSRLHHRNLVSLLG 688
+G+GG+G+V + + A K+ E+ ++ G+ L E ++L +++ R +VSL
Sbjct: 8 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSL-A 66
Query: 689 YCDEEGEQM-LVYEFVPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPV 747
Y E + + LV + G L+ + + + A + G+ LH E +
Sbjct: 67 YAYETKDALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRER---I 123
Query: 748 FHRDIKASNILLDSNLNAKVADFGLSRLAPVLDDEGTMPTHVSTIVKGTPGYLDPEYFLT 807
+RD+K NILLD + +++D GL+ P + T+ V GT GY+ PE
Sbjct: 124 VYRDLKPENILLDDYGHIRISDLGLAVEIP---EGETIRGRV-----GTVGYMAPEVVKN 175
Query: 808 HKLTDKSDVYSLGVVLLELLTGMQPISHGKNIVREVNVAR 847
+ T D + LG ++ E++ G P K V+ V R
Sbjct: 176 ERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVER 215
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 57.1 bits (138), Expect = 2e-08
Identities = 59/237 (24%), Positives = 106/237 (44%), Gaps = 35/237 (14%)
Query: 633 VGQGGYGKVYKGILSD-NTTVAIKRAEEGSLQGQNEFLTEIKLLSRLHHRNLVSLLGYCD 691
+G G G V+ + SD + VA+K+ Q L EIK++ RL H N+V +
Sbjct: 13 LGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLG 72
Query: 692 EEGEQM--------------LVYEFVPNGTLRDWLSGRTKEN---LNFAMRLRVALDSAK 734
G + +V E++ G E L LR
Sbjct: 73 PSGSDLTEDVGSLTELNSVYIVQEYMETDLANVLEQGPLSEEHARLFMYQLLR------- 125
Query: 735 GILYLHTEAHPPVFHRDIKASNILLDS-NLNAKVADFGLSRLAPVLDDEGTMPTHVSTIV 793
G+ Y+H+ V HRD+K +N+ +++ +L K+ DFGL+R ++D + ++S +
Sbjct: 126 GLKYIHSAN---VLHRDLKPANVFINTEDLVLKIGDFGLAR---IVDPHYSHKGYLSEGL 179
Query: 794 KGTPGYLDPEYFLT-HKLTDKSDVYSLGVVLLELLTGMQPISHGKNIVREVNVARDS 849
T Y P L+ + T D+++ G + E+LTG +P+ G + + ++ + +S
Sbjct: 180 V-TKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTG-KPLFAGAHELEQMQLILES 234
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 56.4 bits (136), Expect = 2e-08
Identities = 44/157 (28%), Positives = 71/157 (45%), Gaps = 20/157 (12%)
Query: 680 HRNLVSLLGYCDEEGEQMLVYEFVPNGTLRDWLSGRTK---ENLNF-AMRLRVALDSAKG 735
H LV L E V EFV G L + + K E+ F + + +AL+
Sbjct: 55 HPFLVGLHSCFQTESRLFFVIEFVSGGDLMFHMQRQRKLPEEHARFYSAEISLALN---- 110
Query: 736 ILYLHTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSRLAPVLDDEGTMPTHVSTIVKG 795
+LH + +RD+K N+LLD+ + K+ D+G+ + EG P ++ G
Sbjct: 111 --FLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCK-------EGIRPGDTTSTFCG 158
Query: 796 TPGYLDPEYFLTHKLTDKSDVYSLGVVLLELLTGMQP 832
TP Y+ PE D ++LGV++ E++ G P
Sbjct: 159 TPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSP 195
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 56.3 bits (136), Expect = 3e-08
Identities = 35/89 (39%), Positives = 50/89 (56%), Gaps = 11/89 (12%)
Query: 749 HRDIKASNILLDSNLNAKVADFGLSRLAPVLDDEGTMPTHVSTIVKGTPGYLDPEYFL-- 806
HRDIK N+LLD N + ++ADFG S L L +GT+ ++V+ GTP Y+ PE
Sbjct: 125 HRDIKPDNVLLDKNGHIRLADFG-SCLR--LLADGTVQSNVAV---GTPDYISPEILQAM 178
Query: 807 ---THKLTDKSDVYSLGVVLLELLTGMQP 832
+ + D +SLGV + E+L G P
Sbjct: 179 EDGKGRYGPECDWWSLGVCMYEMLYGETP 207
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 57.4 bits (138), Expect = 3e-08
Identities = 68/251 (27%), Positives = 106/251 (42%), Gaps = 66/251 (26%)
Query: 632 QVGQGGYGKVYKGILSDNTTVAIKRAEEG------SLQG-----QNEFLTEIKLLSRLHH 680
++G G +G+V+ V KR +E S +G +++ + E+ ++ L H
Sbjct: 20 KIGNGRFGEVF--------LVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKH 71
Query: 681 RNLVSLLGYCDEEGEQML--VYEFVPNGTLRDWLS------GRTKEN--LNFAMRLRVAL 730
+N+V + + Q L + EF G L + G+ +E+ ++ +L AL
Sbjct: 72 KNIVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHAL 131
Query: 731 DSAKGILYLHTEAHPP----VFHRDIKASNILLDS-------------NLN----AKVAD 769
Y H P V HRD+K NI L + NLN AK+ D
Sbjct: 132 ------AYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGD 185
Query: 770 FGLSRLAPVLDDEGTMPTHVSTIVKGTPGYLDPEYFL--THKLTDKSDVYSLGVVLLELL 827
FGLS+ + G S + GTP Y PE L T DKSD+++LG ++ EL
Sbjct: 186 FGLSK------NIGIESMAHSCV--GTPYYWSPELLLHETKSYDDKSDMWALGCIIYELC 237
Query: 828 TGMQPISHGKN 838
+G P N
Sbjct: 238 SGKTPFHKANN 248
|
Length = 1021 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 56.1 bits (135), Expect = 3e-08
Identities = 34/87 (39%), Positives = 45/87 (51%), Gaps = 8/87 (9%)
Query: 747 VFHRDIKASNILLDSNLNAKVADFGLSRLAPVLDDEGTMPTHVSTIVKGTPGYLDPEYFL 806
+ +RD+K NILLD+ + + DFGLS+ L D T T GT YL PE L
Sbjct: 117 IVYRDLKPENILLDATGHIALCDFGLSK--ANLTDNKTTNTFC-----GTTEYLAPEVLL 169
Query: 807 THK-LTDKSDVYSLGVVLLELLTGMQP 832
K T D +SLGV++ E+ G P
Sbjct: 170 DEKGYTKHVDFWSLGVLVFEMCCGWSP 196
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 3e-08
Identities = 31/104 (29%), Positives = 51/104 (49%), Gaps = 10/104 (9%)
Query: 729 ALDSAKGILYLHTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSRLAPVLDDEGTMPTH 788
A + + G+ +LH + +RD+K N++LDS + K+ADFG+ + E +
Sbjct: 107 AAEISVGLFFLHRRG---IIYRDLKLDNVMLDSEGHIKIADFGMCK-------EHMVDGV 156
Query: 789 VSTIVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVLLELLTGMQP 832
+ GTP Y+ PE D ++ GV+L E+L G P
Sbjct: 157 TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPP 200
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 55.9 bits (134), Expect = 3e-08
Identities = 59/218 (27%), Positives = 99/218 (45%), Gaps = 29/218 (13%)
Query: 632 QVGQGGYGKVYKGILSDN-TTVAIK----RAEEGSLQGQNEFLTEIKLLSRLHHRNLVSL 686
++G+G Y VYKG N VA+K + EEG+ + E LL L H N+V L
Sbjct: 12 KLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGT---PFTAIREASLLKGLKHANIVLL 68
Query: 687 LGYCDEEGEQMLVYEFVPNGTLRDWLS----GRTKENLNFAMRLRVALDSAKGILYLHTE 742
+ LV+E+V + L ++ G EN+ + +G+ Y+H
Sbjct: 69 HDIIHTKETLTLVFEYV-HTDLCQYMDKHPGGLHPENVKLFL-----FQLLRGLSYIHQR 122
Query: 743 AHPPVFHRDIKASNILLDSNLNAKVADFGLSRLAPVLDDEGTMPTHVSTIVKGTPGYLDP 802
+ HRD+K N+L+ K+ADFGL+R V P+H + T Y P
Sbjct: 123 Y---ILHRDLKPQNLLISDTGELKLADFGLARAKSV-------PSHTYSNEVVTLWYRPP 172
Query: 803 EYFL-THKLTDKSDVYSLGVVLLELLTGMQPISHGKNI 839
+ L + + + D++ +G + +E++ G+ K+I
Sbjct: 173 DVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDI 210
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 56.1 bits (135), Expect = 3e-08
Identities = 56/223 (25%), Positives = 94/223 (42%), Gaps = 48/223 (21%)
Query: 627 FSSSTQVGQGGYGKVYKGI-LSDNTTVAIKRAEEGSLQGQNEFLT-----EIKLLSRLHH 680
++S QVG G YG V I VAIK+ S Q+E E+ LL + H
Sbjct: 17 YTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKL---SRPFQSEIFAKRAYRELTLLKHMQH 73
Query: 681 RNLVSLLGYCDEEGEQMLVYEFVPNGTLRDW-----LSGRTKENLNFAMRLRVALDSA-- 733
N++ LL F + ++ + + +L M ++ D
Sbjct: 74 ENVIGLLDV------------FTSAVSGDEFQDFYLVMPYMQTDLQKIMGHPLSEDKVQY 121
Query: 734 ------KGILYLHTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSRLAPVLDDEGTMPT 787
G+ Y+H+ + HRD+K N+ ++ + K+ DFGL+R A + M
Sbjct: 122 LVYQMLCGLKYIHSAG---IIHRDLKPGNLAVNEDCELKILDFGLARHA-----DAEMTG 173
Query: 788 HVSTIVKGTPGYLDPEYFLTHKLTDKS-DVYSLGVVLLELLTG 829
+V T Y PE L +++ D++S+G ++ E+LTG
Sbjct: 174 YVV-----TRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTG 211
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 4e-08
Identities = 61/250 (24%), Positives = 102/250 (40%), Gaps = 61/250 (24%)
Query: 627 FSSSTQVGQGGYGKVYKGILSDNTTV----------AIKRAEEGSLQGQNEFLTEIKLLS 676
F S +G+G +G+V D V +++ + G ++ + + L E L
Sbjct: 3 FESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLW 62
Query: 677 RLHHRNLVSLLGYCDEEGEQMLVYEFVPNGTLRDWLSGR---TKENLNFAMRLRV-ALDS 732
+V + ++ L+ EF+P G + L + T+E F + V A+DS
Sbjct: 63 ------VVKMFYSFQDKLNLYLIMEFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDS 116
Query: 733 AKGILYLHTEAHPPVFHRDIKASNILLDSNLNAKVADFGLS-------RLAPVLDDEGTM 785
+ ++H RDIK N+LLDS + K++DFGL R + ++
Sbjct: 117 IHQLGFIH---------RDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSL 167
Query: 786 PTH-----------------------VSTIVKGTPGYLDPEYFLTHKLTDKSDVYSLGVV 822
P+ ST+ GTP Y+ PE F+ D +SLGV+
Sbjct: 168 PSDFTFQNMNSKRKAETWKRNRRQLAFSTV--GTPDYIAPEVFMQTGYNKLCDWWSLGVI 225
Query: 823 LLELLTGMQP 832
+ E+L G P
Sbjct: 226 MYEMLIGYPP 235
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 4e-08
Identities = 56/217 (25%), Positives = 96/217 (44%), Gaps = 43/217 (19%)
Query: 631 TQVGQGGYGKVYKGI-LSDNTTVAIKRAEE--GSLQGQNEFLTEIKLLSRLHHRNLVSLL 687
T VG G YG V VA+K+ SL E++LL + H N++ LL
Sbjct: 21 TPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLL 80
Query: 688 GYCDEEGEQMLVYEFVPNGTLRDW-----LSGRTKENLNFAMRLRVALDS---------A 733
F P ++ ++ ++ +LN ++ + D
Sbjct: 81 DV------------FTPATSIENFNEVYLVTNLMGADLNNIVKCQKLSDEHVQFLIYQLL 128
Query: 734 KGILYLHTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSRLAPVLDDEGTMPTHVSTIV 793
+G+ Y+H+ + HRD+K SN+ ++ + ++ DFGL+R A DDE M +V+
Sbjct: 129 RGLKYIHSAG---IIHRDLKPSNVAVNEDCELRILDFGLARQA---DDE--MTGYVA--- 177
Query: 794 KGTPGYLDPEYFLTHKLTDKS-DVYSLGVVLLELLTG 829
T Y PE L +++ D++S+G ++ ELL G
Sbjct: 178 --TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKG 212
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 5e-08
Identities = 70/279 (25%), Positives = 119/279 (42%), Gaps = 59/279 (21%)
Query: 671 EIKLLSRLHHRNLVSLLGYCDEEGEQMLVYEFVPNGTLRDWLSGRTKENL---NFAMRLR 727
E+ LL ++H+N++SLL F P +L ++ L N +
Sbjct: 70 ELVLLKCVNHKNIISLLNV------------FTPQKSLEEFQDVYLVMELMDANLCQVIH 117
Query: 728 VALDSAK----------GILYLHTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSRLAP 777
+ LD + GI +LH+ + HRD+K SNI++ S+ K+ DFGL+R A
Sbjct: 118 MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAC 174
Query: 778 VLDDEGTMPTHVSTIVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVLLELLTGMQPISHGK 837
M +V T Y PE L + D++S+G ++ EL+ G I G
Sbjct: 175 T---NFMMTPYVVTRY-----YRAPEVILGMGYKENVDIWSVGCIMGELVKG-SVIFQGT 225
Query: 838 NIVREVNVARDSGMVFSIIDNRMGSYPSECVERFVTLALRCCHDKPEHRPSMSDVVRELE 897
+ + + N +I+ ++G+ +E F+ + E+RP + E
Sbjct: 226 DHIDQWN---------KVIE-QLGTPSAE----FMNRLQPTVRNYVENRPQYPGISFE-- 269
Query: 898 NILKMFPETDTMF-SKSESSSLLSGKSASTSSSFLTRDP 935
++FP D +F S+SE L + ++ S L DP
Sbjct: 270 ---ELFP--DWIFPSESERDKLKTSQARDLLSKMLVIDP 303
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 56.0 bits (135), Expect = 7e-08
Identities = 30/90 (33%), Positives = 49/90 (54%), Gaps = 1/90 (1%)
Query: 162 LQVDENNITGTIPKSFANLSRVRHLHLNNNSIGGQIPSELSKLSTLIHLLVDNNNLSGNL 221
L +D + G IP + L ++ ++L+ NSI G IP L +++L L + N+ +G++
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSI 482
Query: 222 PPELSELPQLCILQLDNNNFSASEIPATYG 251
P L +L L IL L N N + +PA G
Sbjct: 483 PESLGQLTSLRILNL-NGNSLSGRVPAALG 511
|
Length = 623 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 7e-08
Identities = 53/201 (26%), Positives = 87/201 (43%), Gaps = 21/201 (10%)
Query: 700 YEFVPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILL 759
Y+ + +++ LS E L L A+G+ +L A HRD+ A N+LL
Sbjct: 214 YKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFL---ASKNCVHRDLAARNVLL 270
Query: 760 DSNLNAKVADFGLSRLAPVLDDEGTMPTHVSTIVKGTP-GYLDPEYFLTHKLTDKSDVYS 818
K+ DFGL+R ++ D +VS P ++ PE + T SDV+S
Sbjct: 271 AQGKIVKICDFGLAR--DIMHDS----NYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWS 324
Query: 819 LGVVLLELLTGMQPISHGKNIVREVNVARDSGMVFSIIDNRMGSYPSECVERFVTLALRC 878
G++L E+ + + + IV DS I + P + + ++C
Sbjct: 325 YGILLWEIFS-LGGTPYPGMIV-------DSTFYNKIKSGYRMAKPDHATQEVYDIMVKC 376
Query: 879 CHDKPEHRPS---MSDVVREL 896
+ +PE RPS +SD+V L
Sbjct: 377 WNSEPEKRPSFLHLSDIVESL 397
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 54.9 bits (132), Expect = 9e-08
Identities = 44/193 (22%), Positives = 80/193 (41%), Gaps = 49/193 (25%)
Query: 650 TTVAIKRAEEGSLQGQNEFLTEIKLLSRLHHRNLVSLLGYCDEEGEQMLVYE-----FVP 704
V +K ++G+ L E LL ++H +++ + LV +P
Sbjct: 92 DPVVLKIGQKGTT------LIEAMLLQNVNHPSVIRMK--------DTLVSGAITCMVLP 137
Query: 705 --NGTLRDWLSGRTKENLNFAMRLRVALDSA--------KGILYLHTEAHPPVFHRDIKA 754
+ L +L+ R++ + +D A +G+ YLH + + HRD+K
Sbjct: 138 HYSSDLYTYLTKRSR---------PLPIDQALIIEKQILEGLRYLHAQR---IIHRDVKT 185
Query: 755 SNILLDSNLNAKVADFGLSRLAPVLDDEGTMPTHVSTIVKGTPGYLDPEYFLTHKLTDKS 814
NI ++ + D G ++ PV+ P + + GT PE K K+
Sbjct: 186 ENIFINDVDQVCIGDLGAAQF-PVVA-----PAFLG--LAGTVETNAPEVLARDKYNSKA 237
Query: 815 DVYSLGVVLLELL 827
D++S G+VL E+L
Sbjct: 238 DIWSAGIVLFEML 250
|
Length = 357 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 55.1 bits (132), Expect = 9e-08
Identities = 59/216 (27%), Positives = 93/216 (43%), Gaps = 45/216 (20%)
Query: 633 VGQGGYGKV---YKGILSDNTTVAIKRAEEGSLQGQNEF---LTEIKLLSRLHHRNLVSL 686
+G G G V Y IL N VAIK+ Q Q E+ L+ ++H+N++ L
Sbjct: 32 IGSGAQGIVCAAYDAILERN--VAIKKLSR-PFQNQTHAKRAYRELVLMKCVNHKNIIGL 88
Query: 687 LGYCDEEGEQMLVYEFVPNGTLRDWLSGRTKENL---NFAMRLRVALDSAK--------- 734
L F P +L ++ L N +++ LD +
Sbjct: 89 LNV------------FTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQML 136
Query: 735 -GILYLHTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSRLAPVLDDEGTMPTHVSTIV 793
GI +LH+ + HRD+K SNI++ S+ K+ DFGL+R A GT +V
Sbjct: 137 CGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTA------GTSFMMTPYVV 187
Query: 794 KGTPGYLDPEYFLTHKLTDKSDVYSLGVVLLELLTG 829
T Y PE L + D++S+G ++ E++ G
Sbjct: 188 --TRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKG 221
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 1e-07
Identities = 63/218 (28%), Positives = 96/218 (44%), Gaps = 30/218 (13%)
Query: 632 QVGQGGYGKVYKGI-LSDNTTVAIK---RAEEGSLQGQNEFLTEIKLLSRLHHRNLVSLL 687
QVG G YG V + VAIK R + L + + E++LL + H N++ LL
Sbjct: 22 QVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAY-RELRLLKHMKHENVIGLL 80
Query: 688 GY------CDEEGEQMLVYEFVPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHT 741
D + LV F+ GT D E L+ + KG+ Y+H
Sbjct: 81 DVFTPDLSLDRFHDFYLVMPFM--GT--DLGKLMKHEKLSEDRIQFLVYQMLKGLKYIHA 136
Query: 742 EAHPPVFHRDIKASNILLDSNLNAKVADFGLSRLAPVLDDEGTMPTHVSTIVKGTPGYLD 801
+ HRD+K N+ ++ + K+ DFGL+R D E M +V T Y
Sbjct: 137 AG---IIHRDLKPGNLAVNEDCELKILDFGLARQT---DSE--MTGYVV-----TRWYRA 183
Query: 802 PEYFLT-HKLTDKSDVYSLGVVLLELLTGMQPISHGKN 838
PE L T D++S+G ++ E+LTG +P+ G +
Sbjct: 184 PEVILNWMHYTQTVDIWSVGCIMAEMLTG-KPLFKGHD 220
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 1e-07
Identities = 58/229 (25%), Positives = 105/229 (45%), Gaps = 28/229 (12%)
Query: 616 KFKELAMATAYFSSSTQVGQGGYGKV----YKGILSDNTTVAIKRAEEGSLQGQNE---F 668
K ++L M + +G+G +G+V +K S A+K + + +++ F
Sbjct: 34 KIRKLQMKAEDYDVVKVIGRGAFGEVQLVRHK---SSQKVYAMKLLSKFEMIKRSDSAFF 90
Query: 669 LTEIKLLSRLHHRNLVSLLGYCDEEGEQMLVYEFVPNGTLRDWLSGRTKENLNFAMRLRV 728
E +++ + +V L ++ +V E++P G L + +S N+ + +
Sbjct: 91 WEERDIMAFANSPWVVQLFCAFQDDKYLYMVMEYMPGGDLVNLMS-------NYDVPEKW 143
Query: 729 A-LDSAKGILYLHTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSRLAPVLDDEGTMPT 787
A +A+ +L L + HRD+K N+LLD + + K+ADFG +D+ G +
Sbjct: 144 AKFYTAEVVLALDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFGTCM---KMDETGMV-- 198
Query: 788 HVSTIVKGTPGYLDPEYFLTHK----LTDKSDVYSLGVVLLELLTGMQP 832
T V GTP Y+ PE + + D +S+GV L E+L G P
Sbjct: 199 RCDTAV-GTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTP 246
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 54.7 bits (131), Expect = 1e-07
Identities = 58/223 (26%), Positives = 100/223 (44%), Gaps = 47/223 (21%)
Query: 627 FSSSTQVGQGGYGKVYKGILSDNTT---VAIKRAEE--GSLQGQNEFLTEIKLLSRLHHR 681
+ + + VG G YG V D T VA+K+ S+ E++LL + H
Sbjct: 19 YQNLSPVGSGAYGSVCAAF--DTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 76
Query: 682 NLVSLLGYCDEEGEQMLVYEFVPNGTLRDW-----LSGRTKENLNFAMRLRVALDS---- 732
N++ LL F P +L ++ ++ +LN ++ + D
Sbjct: 77 NVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF 124
Query: 733 -----AKGILYLHTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSRLAPVLDDEGTMPT 787
+G+ Y+H+ + HRD+K SN+ ++ + K+ DFGL+R DDE M
Sbjct: 125 LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHT---DDE--MTG 176
Query: 788 HVSTIVKGTPGYLDPEYFLTHKLTDKS-DVYSLGVVLLELLTG 829
+V+ T Y PE L +++ D++S+G ++ ELLTG
Sbjct: 177 YVA-----TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 214
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 53.9 bits (129), Expect = 1e-07
Identities = 57/216 (26%), Positives = 100/216 (46%), Gaps = 28/216 (12%)
Query: 633 VGQGGYGKVYKGILSDNTTV-AIKRAEEGSL---QGQNEFLTEIKLLSRLHHRN--LVSL 686
+G+GG+G+VY +D + A+K ++ + QG+ L E +LS + + +
Sbjct: 2 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVC 61
Query: 687 LGYCDEEGEQM-LVYEFVPNGTLRDWLSGR---TKENLNFAMRLRVALDSAKGILYLHTE 742
+ Y +++ + + + G L LS +++ + F A + G+ ++H
Sbjct: 62 MTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFSEKEMRF-----YATEIILGLEHMHNR 116
Query: 743 AHPPVFHRDIKASNILLDSNLNAKVADFGLSRLAPVLDDEGTMPTHVSTIVKGTPGYLDP 802
V +RD+K +NILLD + + +++D GL+ D H S GT GY+ P
Sbjct: 117 F---VVYRDLKPANILLDEHGHVRISDLGLAC------DFSKKKPHASV---GTHGYMAP 164
Query: 803 EYFLTHKLTDKS-DVYSLGVVLLELLTGMQPISHGK 837
E D S D +SLG +L +LL G P K
Sbjct: 165 EVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHK 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 54.0 bits (130), Expect = 2e-07
Identities = 58/216 (26%), Positives = 97/216 (44%), Gaps = 25/216 (11%)
Query: 633 VGQGGYGKVYKGILSDNTT---VAIKRAEEGSLQGQNEF---LTEIKLLSRLHHRNLVSL 686
+ G YG VY ++ T A+K+ + +L +N+ E +L+ + +VS+
Sbjct: 9 ISNGAYGAVY--LVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSM 66
Query: 687 LGYCDEEGEQML--VYEFVPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAH 744
+C E ++ L V E+V G L ++ A R+ A ++ + YLH
Sbjct: 67 --FCSFETKRHLCMVMEYVEGGDCATLLKNIGALPVDMA-RMYFA-ETVLALEYLHNYG- 121
Query: 745 PPVFHRDIKASNILLDSNLNAKVADFGLSRLA----PVLDDEGTMPTHVSTI----VKGT 796
+ HRD+K N+L+ S + K+ DFGLS++ EG + V GT
Sbjct: 122 --IVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFLDKQVCGT 179
Query: 797 PGYLDPEYFLTHKLTDKSDVYSLGVVLLELLTGMQP 832
P Y+ PE L D +++G++L E L G P
Sbjct: 180 PEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVP 215
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 53.5 bits (128), Expect = 2e-07
Identities = 59/220 (26%), Positives = 94/220 (42%), Gaps = 36/220 (16%)
Query: 633 VGQGGYGKVY---------------KGILSDNTTVAIKRAEEGSLQGQNEFLTEIKLLSR 677
+G G YGKV+ +L T V + E + TE ++L
Sbjct: 8 LGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTR-------TERQVLEH 60
Query: 678 LHHRNLVSLLGYCDEEGEQM-LVYEFVPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGI 736
+ + L Y + ++ L+ +++ G L LS R + V + S + +
Sbjct: 61 IRQSPFLVTLHYAFQTDTKLHLILDYINGGELFTHLSQRERFKEQ-----EVQIYSGEIV 115
Query: 737 LYLHTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSRLAPVLDDEGTMPTHVSTIVKGT 796
L L + +RDIK NILLDSN + + DFGLS+ +DE + GT
Sbjct: 116 LALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSK--EFHEDE----VERAYSFCGT 169
Query: 797 PGYLDPEYFLTHKLT-DKS-DVYSLGVVLLELLTGMQPIS 834
Y+ P+ DK+ D +S+GV++ ELLTG P +
Sbjct: 170 IEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFT 209
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 54.0 bits (130), Expect = 2e-07
Identities = 45/178 (25%), Positives = 77/178 (43%), Gaps = 48/178 (26%)
Query: 671 EIKLLSRLHHRNLVSLLGYCDEEGEQMLVYEFVPNGTLRDWLSGRTKENLNFAMRLRVA- 729
E+ L+ ++H+N++ LL F P +L ++ +++ M L A
Sbjct: 65 ELVLMKLVNHKNIIGLLNV------------FTPQKSLEEF------QDVYLVMELMDAN 106
Query: 730 --------LDSAK----------GILYLHTEAHPPVFHRDIKASNILLDSNLNAKVADFG 771
LD + GI +LH+ + HRD+K SNI++ S+ K+ DFG
Sbjct: 107 LCQVIQMDLDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFG 163
Query: 772 LSRLAPVLDDEGTMPTHVSTIVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVLLELLTG 829
L+R A M +V T Y PE L + D++S+G ++ E++ G
Sbjct: 164 LARTA---GTSFMMTPYVVTRY-----YRAPEVILGMGYKENVDIWSVGCIMGEMIRG 213
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 53.5 bits (128), Expect = 2e-07
Identities = 64/224 (28%), Positives = 97/224 (43%), Gaps = 34/224 (15%)
Query: 632 QVGQGGYGKVYKGILSD---NTTVAIKRAEEGSLQGQNEFLTEIKLLSRLHHRNLVSL-- 686
+VG+G YG VYK D + A+K+ E + EI LL L H N++SL
Sbjct: 8 KVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGISMSA--CREIALLRELKHPNVISLQK 65
Query: 687 --LGYCDEEGEQMLVYEFVPNGTL------RDWLSGRTKENLNFAMRLRVALDSAKGILY 738
L + D + L++++ + R + + L M + GI Y
Sbjct: 66 VFLSHADRK--VWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHY 123
Query: 739 LHTEAHPPVFHRDIKASNILL----DSNLNAKVADFGLSRL--APVLDDEGTMPTHVSTI 792
LH V HRD+K +NIL+ K+AD G +RL +P+ P V
Sbjct: 124 LHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVV--- 177
Query: 793 VKGTPGYLDPEYFLTHKLTDKS-DVYSLGVVLLELLTGMQPISH 835
T Y PE L + K+ D++++G + ELLT +PI H
Sbjct: 178 ---TFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTS-EPIFH 217
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 52.9 bits (127), Expect = 2e-07
Identities = 73/283 (25%), Positives = 116/283 (40%), Gaps = 48/283 (16%)
Query: 634 GQGGYGKVYKGILSDNTTVAIK-RAEEGSLQ----GQN-----EFLTEIKLLSRLHHRNL 683
GQG + +YKG+L + + I +E S+ G + F L+S+L H++L
Sbjct: 4 GQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSHKHL 63
Query: 684 VSLLGYCDEEGEQMLVYEFVPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEA 743
V L G C + M V E+V G L +L R K N++ +L VA A + YL +
Sbjct: 64 VKLYGVCVRDENIM-VEEYVKFGPLDVFLH-REKNNVSLHWKLDVAKQLASALHYLEDKK 121
Query: 744 HPPVFHRDIKASNILL-------DSNLNAKVADFGLSRLAPVLDDEGTMPTHVSTIVKGT 796
+ H ++ NIL+ K++D G+ VL V+
Sbjct: 122 ---LVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPI--TVLS--------REERVERI 168
Query: 797 PGYLDPEYF--LTHKLTDKSDVYSLGVVLLELLT-GMQPISHGKNIVREVNVARDSGMVF 853
P ++ PE LT +D +S G LLE+ + G +P+S + +E
Sbjct: 169 P-WIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKERFYQDQH--RL 225
Query: 854 SIIDNRMGSYPSECVERFVTLALRCCHDKPEHRPSMSDVVREL 896
+ D C E L +C P RPS ++R+L
Sbjct: 226 PMPD---------CAELA-NLINQCWTYDPTKRPSFRAILRDL 258
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 54.3 bits (130), Expect = 2e-07
Identities = 60/224 (26%), Positives = 110/224 (49%), Gaps = 30/224 (13%)
Query: 633 VGQGGYGKVYKGILSDNT-TVAIKRAEEGSLQGQNEFLTEIKLLSRLHHRNLVSLLGY-- 689
+G G +G VY+ I D + VAIK+ LQ E+ ++ L+H N++ L Y
Sbjct: 74 IGNGSFGVVYEAICIDTSEKVAIKKV----LQDPQYKNRELLIMKNLNHINIIFLKDYYY 129
Query: 690 --CDEEGEQML----VYEFVPNGTLRDWLSGRTKENLNFAMRLRVALDS---AKGILYLH 740
C ++ E+ + V EF+P T+ ++ + N + L V L S + + Y+H
Sbjct: 130 TECFKKNEKNIFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFL-VKLYSYQLCRALAYIH 187
Query: 741 TEAHPPVFHRDIKASNILLDSNLNA-KVADFGLSRLAPVLDDEGTMPTHVSTIVKGTPGY 799
++ + HRD+K N+L+D N + K+ DFG ++ +L + ++ S +
Sbjct: 188 SKF---ICHRDLKPQNLLIDPNTHTLKLCDFGSAK--NLLAGQRSVSYICSRFYRAPELM 242
Query: 800 LDPEYFLTHKLTDKSDVYSLGVVLLELLTGMQPISHGKNIVREV 843
L + TH D++SLG ++ E++ G PI G++ V ++
Sbjct: 243 LGATNYTTH-----IDLWSLGCIIAEMILGY-PIFSGQSSVDQL 280
|
Length = 440 |
| >gnl|CDD|219766 pfam08263, LRRNT_2, Leucine rich repeat N-terminal domain | Back alignment and domain information |
|---|
Score = 46.2 bits (110), Expect = 7e-07
Identities = 18/43 (41%), Positives = 22/43 (51%), Gaps = 5/43 (11%)
Query: 37 DPQEASALRAIKNSLV-DSMNHLRNWNK--GDPCMSNWTGVLC 76
+ AL A K+SL D L +WN DPC +WTGV C
Sbjct: 1 LNDDRDALLAFKSSLNGDPSGALSSWNPSSSDPC--SWTGVTC 41
|
Leucine Rich Repeats pfam00560 are short sequence motifs present in a number of proteins with diverse functions and cellular locations. Leucine Rich Repeats are often flanked by cysteine rich domains. This domain is often found at the N-terminus of tandem leucine rich repeats. Length = 42 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 52.0 bits (125), Expect = 7e-07
Identities = 54/215 (25%), Positives = 86/215 (40%), Gaps = 28/215 (13%)
Query: 634 GQGGYGKVYKGILSDNTTVAIKRAEEGSLQGQNE----FL-TEIKLLSRLHHRNLVSLLG 688
+ K NT VA+K+ +L ++ L EI +L H N++ +
Sbjct: 11 EDLMIVHLAKHK-PTNTLVAVKKI---NLDSCSKEDLKLLQQEIITSRQLQHPNILPYVT 66
Query: 689 YCDEEGEQMLVYEFVPNGTLRDWLSGRTKENLN---FAMRLRVALDSAKGILYLHTEAHP 745
+ E +V + G+ D L E L A L+ L + Y+H++
Sbjct: 67 SFIVDSELYVVSPLMAYGSCEDLLKTHFPEGLPELAIAFILKDVL---NALDYIHSKG-- 121
Query: 746 PVFHRDIKASNILLDSNLNAKVADFGLSRLAPVLD-DEGTMPTHVSTI--VKGTPGYLDP 802
HR +KAS+ILL + ++ GL ++ + H VK P +L P
Sbjct: 122 -FIHRSVKASHILLSGDGKVVLS--GLRYSVSMIKHGKRQRVVHDFPKSSVKNLP-WLSP 177
Query: 803 EYFLTHKL---TDKSDVYSLGVVLLELLTGMQPIS 834
E L L +KSD+YS+G+ EL G P
Sbjct: 178 E-VLQQNLQGYNEKSDIYSVGITACELANGHVPFK 211
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 51.6 bits (123), Expect = 8e-07
Identities = 63/224 (28%), Positives = 97/224 (43%), Gaps = 34/224 (15%)
Query: 632 QVGQGGYGKVYKGIL---SDNTTVAIKRAEEGSLQGQNEFLTEIKLLSRLHHRNLVSL-- 686
+VG+G YG VYK D A+K+ E + EI LL L H N+++L
Sbjct: 8 KVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGISMSA--CREIALLRELKHPNVIALQK 65
Query: 687 --LGYCDEEGEQMLVYEFVPNGTL------RDWLSGRTKENLNFAMRLRVALDSAKGILY 738
L + D + L++++ + R + + L +M + GI Y
Sbjct: 66 VFLSHSDR--KVWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHY 123
Query: 739 LHTEAHPPVFHRDIKASNILL----DSNLNAKVADFGLSRL--APVLDDEGTMPTHVSTI 792
LH V HRD+K +NIL+ K+AD G +RL +P+ P V
Sbjct: 124 LHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVV--- 177
Query: 793 VKGTPGYLDPEYFLTHKLTDKS-DVYSLGVVLLELLTGMQPISH 835
T Y PE L + K+ D++++G + ELLT +PI H
Sbjct: 178 ---TFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTS-EPIFH 217
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Score = 51.9 bits (124), Expect = 1e-06
Identities = 61/221 (27%), Positives = 96/221 (43%), Gaps = 7/221 (3%)
Query: 94 LSMNLSGNLAPELGQLSRLQY-YFMWNDLTGTIPKEIGNISSLIFLLLNGNKLSGSLPDE 152
LS N +L L L L+ +NDL+ +PK + N+S+L L L+GNK+S LP E
Sbjct: 147 LSDNKIESLPSPLRNLPNLKNLDLSFNDLS-DLPKLLSNLSNLNNLDLSGNKIS-DLPPE 204
Query: 153 LGYLSNLNRLQVDENNITGTIPKSFANLSRVRHLHLNNNSIGGQIPSELSKLSTLIHLLV 212
+ LS L L + N+I + S +NL + L L+NN + +P + LS L L +
Sbjct: 205 IELLSALEELDLSNNSII-ELLSSLSNLKNLSGLELSNNKL-EDLPESIGNLSNLETLDL 262
Query: 213 DNNNLSGNLPPELSELPQLCILQLDNNNFSASEIPATYGNFSKLVKLSLRNCNLQGAVPD 272
NN +S L L L L L N+ S + + L+L +
Sbjct: 263 SNNQISS--ISSLGSLTNLRELDLSGNSLSNALPLIALLLLLLELLLNLLLTLKALELKL 320
Query: 273 LSRIPNLYYLDLSWNHLTGSIPSKKLSENVTTIDLSDNYLN 313
S + N L ++ + N+ T+D + + N
Sbjct: 321 NSILLNNNILSNGETSSPEALSILESLNNLWTLDNALDESN 361
|
Length = 394 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 51.5 bits (123), Expect = 1e-06
Identities = 60/212 (28%), Positives = 90/212 (42%), Gaps = 21/212 (9%)
Query: 633 VGQGGYGKVY----KGILSDNTTVAIKRAEEGSL----QGQNEFLTEIKLLSRLHHRNLV 684
+G G YGKV+ A+K ++ +L + TE +L + +
Sbjct: 8 LGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFL 67
Query: 685 SLLGYC-DEEGEQMLVYEFVPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEA 743
L Y E + L+ ++V G + L R NF+ V S + IL L
Sbjct: 68 VTLHYAFQTEAKLHLILDYVSGGEMFTHLYQRD----NFS-EDEVRFYSGEIILALEHLH 122
Query: 744 HPPVFHRDIKASNILLDSNLNAKVADFGLSRLAPVLDDEGTMPTHVSTIVKGTPGYLDPE 803
+ +RDIK NILLDS + + DFGLS+ + E T GT Y+ PE
Sbjct: 123 KLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERTYS------FCGTIEYMAPE 176
Query: 804 YFLTHKLTDKS-DVYSLGVVLLELLTGMQPIS 834
K+ D +SLG+++ ELLTG P +
Sbjct: 177 IIRGKGGHGKAVDWWSLGILIFELLTGASPFT 208
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 50.7 bits (121), Expect = 1e-06
Identities = 33/87 (37%), Positives = 46/87 (52%), Gaps = 10/87 (11%)
Query: 747 VFHRDIKASNILLDSNLNAKVADFGLSRLAPVLDDEGTMPTHVSTIVKGTPGYLDPEYFL 806
V +RD+K +NILLD + + +++D GL+ D P H S GT GY+ PE
Sbjct: 118 VVYRDLKPANILLDEHGHVRISDLGLA-----CDFSKKKP-HASV---GTHGYMAPEVLQ 168
Query: 807 THKLTDKS-DVYSLGVVLLELLTGMQP 832
D S D +SLG +L +LL G P
Sbjct: 169 KGVAYDSSADWFSLGCMLFKLLRGHSP 195
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 51.0 bits (122), Expect = 2e-06
Identities = 35/124 (28%), Positives = 47/124 (37%), Gaps = 40/124 (32%)
Query: 749 HRDIKASNILLDSNLNAKVADFGLSRLAPVLDD--------EGTMPTH---------VST 791
HRDIK NIL+D + K++DFGLS D +G + V +
Sbjct: 124 HRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYYQKLLQGKSNKNRIDNRNSVAVDS 183
Query: 792 I-----------------------VKGTPGYLDPEYFLTHKLTDKSDVYSLGVVLLELLT 828
I GTP Y+ PE FL + D +SLG ++ E L
Sbjct: 184 INLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLGAIMFECLI 243
Query: 829 GMQP 832
G P
Sbjct: 244 GWPP 247
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 50.6 bits (121), Expect = 2e-06
Identities = 61/215 (28%), Positives = 105/215 (48%), Gaps = 30/215 (13%)
Query: 633 VGQGGYGKVY---KGILSDNTTV-AIKRAEEGSLQGQNEFLT-----EIKLLSRLHHRNL 683
+G+GGYGKV+ K +D + A+K ++ ++ +N+ T E +L + H +
Sbjct: 4 LGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIV-RNQKDTAHTKAERNILEAVKHPFI 62
Query: 684 VSLLGYCDEEGEQMLVYEFVPNGTLRDWLS--GRTKENLN--FAMRLRVALDSAKGILYL 739
V L+ G+ L+ E++ G L L G E+ + + +AL+ +L
Sbjct: 63 VDLIYAFQTGGKLYLILEYLSGGELFMHLEREGIFMEDTACFYLSEISLALE------HL 116
Query: 740 HTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSRLAPVLDDEGTMPTHVSTIVKGTPGY 799
H + + +RD+K NILLD+ + K+ DFGL + + EGT+ TH GT Y
Sbjct: 117 HQQG---IIYRDLKPENILLDAQGHVKLTDFGLCKESI---HEGTV-THTFC---GTIEY 166
Query: 800 LDPEYFLTHKLTDKSDVYSLGVVLLELLTGMQPIS 834
+ PE + D +SLG ++ ++LTG P +
Sbjct: 167 MAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFT 201
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 50.8 bits (121), Expect = 2e-06
Identities = 44/169 (26%), Positives = 70/169 (41%), Gaps = 45/169 (26%)
Query: 698 LVYEFVPNGTLRDWLSGR---TKENLNFAMRLRV-ALDSAKGILYLHTEAHPPVFHRDIK 753
L+ EF+P G + L + ++E F + V A+D+ + ++H RDIK
Sbjct: 78 LIMEFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQLGFIH---------RDIK 128
Query: 754 ASNILLDSNLNAKVADFGL------------------------------SRLAPVLDDEG 783
N+LLD+ + K++DFGL S+ +
Sbjct: 129 PDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKN 188
Query: 784 TMPTHVSTIVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVLLELLTGMQP 832
ST+ GTP Y+ PE F+ D +SLGV++ E+L G P
Sbjct: 189 RRQLAYSTV--GTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPP 235
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 50.0 bits (120), Expect = 3e-06
Identities = 58/240 (24%), Positives = 99/240 (41%), Gaps = 42/240 (17%)
Query: 632 QVGQGGYGKVYKGILSDNTTV-AIKRAEEGSLQGQNEF---LTEIKLLSRLHHRNLVSLL 687
+G+G G+V+ L + A+K ++ + +N+ LTE ++L+ L H L +L
Sbjct: 8 LLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLY 67
Query: 688 GYCDEEGEQMLVYEFVPNGTLRDWLSGRTKENLN------FAMRLRVALDSAKGILYLHT 741
E LV ++ P G L L + + L+ +A + +AL+ YLH
Sbjct: 68 ASFQTETYLCLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALE------YLHL 121
Query: 742 EAHPPVFHRDIKASNILLDSNLNAKVADFGLSRLAPV---------LDDEGTMPTH---V 789
+ +RD+K NILL + + ++DF LS+ + V +
Sbjct: 122 LG---IVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNSIPS 178
Query: 790 STIVK----------GTPGYLDPEYFLTHKLTDKSDVYSLGVVLLELLTGMQPISHGKNI 839
T + GT Y+ PE D ++LG++L E+L G P G N
Sbjct: 179 ETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFK-GSNR 237
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Score = 49.1 bits (117), Expect = 3e-06
Identities = 45/154 (29%), Positives = 63/154 (40%), Gaps = 25/154 (16%)
Query: 682 NLVSLLGYCDEEGEQMLVYEFVPNGTLRDWLSG--RTKENL--NFAMRLRVALDSAKGIL 737
N+V L Y E LV + G L +S E +A + VALD+
Sbjct: 46 NMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISKFLNIPEECVKRWAAEMVVALDA----- 100
Query: 738 YLHTEAHPPVFHRDIKASNILLDSNLNAKVADFG-LSRLAPVLDDEGTMPTHVSTIVKGT 796
LH E + RD+ +NILLD + ++ F S + D E V +
Sbjct: 101 -LHREG---IVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSCDGEA-----VENM---- 147
Query: 797 PGYLDPEYFLTHKLTDKSDVYSLGVVLLELLTGM 830
Y PE + T+ D +SLG +L ELLTG
Sbjct: 148 --YCAPEVGGISEETEACDWWSLGAILFELLTGK 179
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 50.3 bits (120), Expect = 3e-06
Identities = 55/198 (27%), Positives = 87/198 (43%), Gaps = 36/198 (18%)
Query: 710 DWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSNLNAKVAD 769
D L+ T++ L+F+ ++ AKG+ +L A HRD+ A NILL K+ D
Sbjct: 207 DELALDTEDLLSFSYQV------AKGMSFL---ASKNCIHRDLAARNILLTHGRITKICD 257
Query: 770 FGLSRLAPVLDDEGTMPTHVSTIVKGTP----GYLDPEYFLTHKLTDKSDVYSLGVVLLE 825
FGL+R + + +VKG ++ PE T +SDV+S G++L E
Sbjct: 258 FGLAR---------DIRNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWE 308
Query: 826 LLT-GMQPISHGKNIVREVNVARDSGMVFSIIDN-RMGSYPSECVERFVTLALRCCHDK- 882
+ + G P + DS I + RM S EC + ++ C D
Sbjct: 309 IFSLGSSPYP---------GMPVDSKFYKMIKEGYRMLS--PECAPSEMYDIMKSCWDAD 357
Query: 883 PEHRPSMSDVVRELENIL 900
P RP+ +V+ +E L
Sbjct: 358 PLKRPTFKQIVQLIEQQL 375
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 44.5 bits (106), Expect = 4e-06
Identities = 18/60 (30%), Positives = 28/60 (46%)
Query: 158 NLNRLQVDENNITGTIPKSFANLSRVRHLHLNNNSIGGQIPSELSKLSTLIHLLVDNNNL 217
NL L + N +T +F L ++ L L+ N++ P S L +L L + NNL
Sbjct: 1 NLKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60
|
Length = 60 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 49.6 bits (118), Expect = 5e-06
Identities = 57/235 (24%), Positives = 100/235 (42%), Gaps = 40/235 (17%)
Query: 616 KFKELAMATAYFSSSTQVGQGGYG-----------KVYKGILSDNTTVAIKRAEEGSLQG 664
K ++L M + +G+G +G KVY L + IKR++
Sbjct: 34 KIRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEM-IKRSDSAF--- 89
Query: 665 QNEFLTEIKLLSRLHHRNLVSLLGYCDEEGEQMLVYEFVPNGTLRDWLSGRT---KENLN 721
F E +++ + +V L ++ +V E++P G L + +S K
Sbjct: 90 ---FWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEKWARF 146
Query: 722 FAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSRLAPVLDD 781
+ + +ALD+ + ++H RD+K N+LLD + + K+ADFG ++
Sbjct: 147 YTAEVVLALDAIHSMGFIH---------RDVKPDNMLLDKSGHLKLADFGTCM---KMNK 194
Query: 782 EGTMPTHVSTIVKGTPGYLDPEYFLTHK----LTDKSDVYSLGVVLLELLTGMQP 832
EG + + GTP Y+ PE + + D +S+GV L E+L G P
Sbjct: 195 EGMVRCDTAV---GTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTP 246
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 43.7 bits (104), Expect = 7e-06
Identities = 21/61 (34%), Positives = 35/61 (57%), Gaps = 2/61 (3%)
Query: 134 SLIFLLLNGNKLSGSLPDE-LGYLSNLNRLQVDENNITGTIPKSFANLSRVRHLHLNNNS 192
+L L L+ N+L+ +PD L NL L + NN+T P++F+ L +R L L+ N+
Sbjct: 1 NLKSLDLSNNRLT-VIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNN 59
Query: 193 I 193
+
Sbjct: 60 L 60
|
Length = 60 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 49.4 bits (118), Expect = 8e-06
Identities = 37/123 (30%), Positives = 54/123 (43%), Gaps = 18/123 (14%)
Query: 282 LDLSWNHLTGSIPS--KKLSENVTTIDLSDNYLNGSILESISNLPFLQTLSLENNFLTGS 339
L L L G IP+ KL ++ +I+LS N + G+I S+ ++ L+ L L N GS
Sbjct: 423 LGLDNQGLRGFIPNDISKL-RHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGS 481
Query: 340 IPATIWQNKSFSTKARLKIDLRNNSFSNIVGDLTLPNNVTLRLGGNPI-CTSANIPNTGR 398
IP ++ Q S L+I N + L V LGG + S N +
Sbjct: 482 IPESLGQLTS------LRILNLNGNS--------LSGRVPAALGGRLLHRASFNFTDNAG 527
Query: 399 FCG 401
CG
Sbjct: 528 LCG 530
|
Length = 623 |
| >gnl|CDD|238064 cd00116, LRR_RI, Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily | Back alignment and domain information |
|---|
Score = 48.5 bits (116), Expect = 8e-06
Identities = 55/258 (21%), Positives = 84/258 (32%), Gaps = 49/258 (18%)
Query: 125 IPKEIGNISSLIFLLLNGNKLS------GSLPDELGYLSNLNRLQVDENNITGTIPKSFA 178
+ + SL L L+ N+ SL L L L + +N +
Sbjct: 43 LASALRPQPSLKELCLSLNETGRIPRGLQSLLQGLTKGCGLQELDLSDNALGPDGCGVLE 102
Query: 179 NLSR---VRHLHLNNNSIGGQI--------PSELSKLSTLIHLLVDNNNLSGN----LPP 223
+L R ++ L LNNN +G + L L+ + N L G L
Sbjct: 103 SLLRSSSLQELKLNNNGLGDRGLRLLAKGLKDLPPALEKLV---LGRNRLEGASCEALAK 159
Query: 224 ELSELPQLCILQLDNNNFSASEIPAT---YGNFSKLVKLSLRNCN--------LQGAVPD 272
L L L L NN + I A L L L N L +
Sbjct: 160 ALRANRDLKELNLANNGIGDAGIRALAEGLKANCNLEVLDLNNNGLTDEGASALAETLAS 219
Query: 273 LSRIPNLYYLDLSWNHLTGSIPS------KKLSENVTTIDLSDNYLN----GSILESISN 322
L +L L+L N+LT + + + ++ T+ LS N + + E ++
Sbjct: 220 L---KSLEVLNLGDNNLTDAGAAALASALLSPNISLLTLSLSCNDITDDGAKDLAEVLAE 276
Query: 323 LPFLQTLSL-ENNFLTGS 339
L L L N F
Sbjct: 277 KESLLELDLRGNKFGEEG 294
|
LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). Length = 319 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 47.9 bits (114), Expect = 1e-05
Identities = 35/118 (29%), Positives = 60/118 (50%), Gaps = 8/118 (6%)
Query: 633 VGQGGYGKVYKGIL-----SDNT-TVAIKRAEEGSLQGQNEFL-TEIKLLSRL-HHRNLV 684
+G G +GKV + DN VA+K + + + E L +E+K+LS L H+N+V
Sbjct: 46 LGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIV 105
Query: 685 SLLGYCDEEGEQMLVYEFVPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTE 742
+LLG C G +++ E+ G L ++L + + LNF M L +++ + E
Sbjct: 106 NLLGACTHGGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLE 163
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 47.3 bits (112), Expect = 2e-05
Identities = 33/96 (34%), Positives = 56/96 (58%), Gaps = 11/96 (11%)
Query: 633 VGQGGYGKVYK----GILSDNT--TVAIKRAEEGSLQGQNE-FLTEIKLLSRL-HHRNLV 684
+G+G +G+V + GI T TVA+K +EG+ ++ ++E+K+L + HH N+V
Sbjct: 15 LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 74
Query: 685 SLLGYCDEE-GEQMLVYEFVPNGTLRDWLSGRTKEN 719
+LLG C + G M++ EF G L ++L R+K
Sbjct: 75 NLLGACTKPGGPLMVIVEFCKFGNLSNYL--RSKRG 108
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 47.9 bits (114), Expect = 2e-05
Identities = 36/112 (32%), Positives = 57/112 (50%), Gaps = 17/112 (15%)
Query: 726 LRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSRLAPVLDDEGTM 785
LR + A+G+ +L A HRD+ A N+LL AK+ DFGL+R +++D
Sbjct: 215 LRFSSQVAQGMDFL---ASKNCIHRDVAARNVLLTDGRVAKICDFGLAR--DIMNDS--- 266
Query: 786 PTHVSTIVKGTP----GYLDPEYFLTHKLTDKSDVYSLGVVLLELLT-GMQP 832
+ +VKG ++ PE T +SDV+S G++L E+ + G P
Sbjct: 267 ----NYVVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSP 314
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 46.8 bits (111), Expect = 2e-05
Identities = 61/236 (25%), Positives = 99/236 (41%), Gaps = 32/236 (13%)
Query: 668 FLTEIKLLSRLHHRNLVSLLGYCDEEGEQMLVYEFVPNGTLRDWLSGRTKENLNFAMRLR 727
F L+S++ H +L + G C E ++V EFV +G L L + K + A ++
Sbjct: 63 FFETASLMSQVSHIHLAFVHGVCVRGSENIMVEEFVEHGPLDVCLR-KEKGRVPVAWKIT 121
Query: 728 VALDSAKGILYLHTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSR-LAPV--LDDEGT 784
VA A + YL + + H ++ A NILL A GL+ +P L D G
Sbjct: 122 VAQQLASALSYLEDKN---LVHGNVCAKNILL--------ARLGLAEGTSPFIKLSDPGV 170
Query: 785 MPTHVS--TIVKGTPGYLDPEYFLT-HKLTDKSDVYSLGVVLLEL-LTGMQPISHGKNIV 840
T +S V+ P ++ PE + L+ +D +S G LLE+ G P+
Sbjct: 171 SFTALSREERVERIP-WIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSE 229
Query: 841 REVNVARDSGMVFSIIDNRMGSYPSECVERFVTLALRCCHDKPEHRPSMSDVVREL 896
+E + + P + TL +C +P RPS ++R+L
Sbjct: 230 KERFYEKKHRL------------PEPSCKELATLISQCLTYEPTQRPSFRTILRDL 273
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 47.5 bits (113), Expect = 2e-05
Identities = 33/121 (27%), Positives = 47/121 (38%), Gaps = 38/121 (31%)
Query: 749 HRDIKASNILLDSNLNAKVADFGL---------SR--------------LAPVLDDEGTM 785
HRDIK NIL+D + + K+ DFGL S+ + +
Sbjct: 124 HRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDRC 183
Query: 786 PTHV--------------STIVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVLLELLTGMQ 831
++V GTP Y+ PE L T D +S+GV+L E+L G
Sbjct: 184 RLKPLERRRKRQHQRCLAHSLV-GTPNYIAPEVLLRTGYTQLCDWWSVGVILYEMLVGQP 242
Query: 832 P 832
P
Sbjct: 243 P 243
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 45.0 bits (106), Expect = 1e-04
Identities = 32/94 (34%), Positives = 56/94 (59%), Gaps = 11/94 (11%)
Query: 633 VGQGGYGKVYK----GILSDNT--TVAIKRAEEGSLQGQNE-FLTEIKLLSRL-HHRNLV 684
+G G +GKV + GI ++ TVA+K +EG+ +++ ++E+K+L + +H N+V
Sbjct: 15 LGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVV 74
Query: 685 SLLGYCDE-EGEQMLVYEFVPNGTLRDWLSGRTK 717
+LLG C + G M++ EF G L ++L R K
Sbjct: 75 NLLGACTKPNGPLMVIVEFCKYGNLSNFL--RAK 106
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 45.7 bits (108), Expect = 1e-04
Identities = 46/157 (29%), Positives = 67/157 (42%), Gaps = 14/157 (8%)
Query: 671 EIKLLSRLHHRNLVSLLGYCDEEGEQMLVYEFVP--NGTLRDWLSGRTKENLNFAMRLRV 728
E +LL RL H +++LL G LV +P L +L R + L A V
Sbjct: 210 EARLLRRLSHPAVLALLDVRVVGGLTCLV---LPKYRSDLYTYLGARLRP-LGLAQVTAV 265
Query: 729 ALDSAKGILYLHTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSRLAPVLDDEGTMPTH 788
A I Y+H E + HRDIK N+L++ + + DFG + A G+ T
Sbjct: 266 ARQLLSAIDYIHGEG---IIHRDIKTENVLVNGPEDICLGDFGAACFA-----RGSWSTP 317
Query: 789 VSTIVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVLLE 825
+ GT PE T D++S G+V+ E
Sbjct: 318 FHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFE 354
|
Length = 461 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 45.4 bits (107), Expect = 1e-04
Identities = 43/173 (24%), Positives = 74/173 (42%), Gaps = 26/173 (15%)
Query: 733 AKGILYLHTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSRLAPVLDDEGTMPTHVSTI 792
A G+ +L A HRD+ A N+L+ K+ DFGL+R ++ D + I
Sbjct: 249 ANGMEFL---ASKNCVHRDLAARNVLICEGKLVKICDFGLAR--DIMRDS-------NYI 296
Query: 793 VKGTP----GYLDPEYFLTHKLTDKSDVYSLGVVLLELLT-GMQPISHGKNIVREVNVAR 847
KG+ ++ PE + T SDV+S G++L E+ T G P +
Sbjct: 297 SKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYP---------ELPM 347
Query: 848 DSGMVFSIIDNRMGSYPSECVERFVTLALRCCHDKPEHRPSMSDVVRELENIL 900
+ +I + P+ + + +C +K E RP S +V + ++L
Sbjct: 348 NEQFYNAIKRGYRMAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDLL 400
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 45.0 bits (106), Expect = 1e-04
Identities = 35/126 (27%), Positives = 47/126 (37%), Gaps = 44/126 (34%)
Query: 749 HRDIKASNILLDSNLNAKVADFGL------------------------------------ 772
HRDIK NIL+D + + K+ DFGL
Sbjct: 124 HRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGDPANC 183
Query: 773 ---SRLAPVLDDEGTMPTHVSTIVK---GTPGYLDPEYFLTHKLTDKSDVYSLGVVLLEL 826
RL P+ + H + GTP Y+ PE L T D +S+GV+L E+
Sbjct: 184 RCGDRLKPL--ERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEM 241
Query: 827 LTGMQP 832
L G P
Sbjct: 242 LVGQPP 247
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 43.7 bits (104), Expect = 3e-04
Identities = 40/161 (24%), Positives = 65/161 (40%), Gaps = 29/161 (18%)
Query: 679 HHRNLVSLLGYCDEEGEQMLVYEFVPNGTLRDWLSGRTKENL------NFAMRLRVALDS 732
+ N + L +L+ +++ +G L D L + + L +L AL+
Sbjct: 67 DNPNFIKLYYSVTTLKGHVLIMDYIKDGDLFDLL--KKEGKLSEAEVKKIIRQLVEALND 124
Query: 733 AKGILYLHTEAHPPVFHRDIKASNILLDSNLN-AKVADFGLSRLAPVLDDEGTMPTHVST 791
L+ H + H DIK N+L D + + D+GL ++ GT +
Sbjct: 125 ----LHKHN-----IIHNDIKLENVLYDRAKDRIYLCDYGLCKI------IGTPSCY--- 166
Query: 792 IVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVLLELLTGMQP 832
GT Y PE H D +++GV+ ELLTG P
Sbjct: 167 --DGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHP 205
|
Length = 267 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 42.6 bits (100), Expect = 7e-04
Identities = 29/88 (32%), Positives = 50/88 (56%), Gaps = 8/88 (9%)
Query: 633 VGQGGYGKVYK----GILSDNT--TVAIKRAEEGSLQGQNEFL-TEIKLLSRL-HHRNLV 684
+G G +GKV + G+ + TVA+K + + + E L +E+K+LS L +H N+V
Sbjct: 43 LGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIV 102
Query: 685 SLLGYCDEEGEQMLVYEFVPNGTLRDWL 712
+LLG C G +++ E+ G L ++L
Sbjct: 103 NLLGACTVGGPTLVITEYCCYGDLLNFL 130
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 41.9 bits (98), Expect = 0.001
Identities = 60/248 (24%), Positives = 97/248 (39%), Gaps = 33/248 (13%)
Query: 670 TEIKLLSRLHHRNLVSLLGYCDEEGEQMLVYEFVPNGTLRDWLSGRTKENLNFAMRLRVA 729
TE +L ++H +++ L G L+ +P + K N+ L +
Sbjct: 132 TEAHILRAINHPSIIQLKGTFTYNKFTCLI---LPRYKTDLYCYLAAKRNIAICDILAIE 188
Query: 730 LDSAKGILYLHTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSRLAPVLDDEGTMPTHV 789
+ I YLH + HRDIKA NI ++ + + DFG + PV +
Sbjct: 189 RSVLRAIQYLHENR---IIHRDIKAENIFINHPGDVCLGDFG-AACFPVDINANKYYGWA 244
Query: 790 STIVKGTPGYL--DPEYFLTHKLTDKSDVYSLGVVLLELLTGMQPISHGKNIVREVNVAR 847
TI P L DP D++S G+VL E+ T + + +
Sbjct: 245 GTIATNAPELLARDP-------YGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDC---- 293
Query: 848 DSGMVFSIIDNRMGSYPSE--------CVERFVTLALRCCHDKPEHRPSMSDVVR---EL 896
DS +I R G++P+E E ++ LA + KP RP +++ +L
Sbjct: 294 DSDRQIKLIIRRSGTHPNEFPIDAQANLDEIYIGLAKKSSR-KPGSRPLWTNLYELPIDL 352
Query: 897 EN-ILKMF 903
E I KM
Sbjct: 353 EYLICKML 360
|
Length = 391 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 42.1 bits (99), Expect = 0.001
Identities = 48/182 (26%), Positives = 71/182 (39%), Gaps = 20/182 (10%)
Query: 648 DNTTVAIKRAEEGSLQGQNEFLTEIKLLSRLHHRNLVSLLGYCDEEGEQMLVYEFVPNGT 707
V +K G G EI +L + HR +++L+ + V +P
Sbjct: 118 QRKKVIVKAVTGGKTPG-----REIDILKTISHRAIINLI---HAYRWKSTVCMVMPKYK 169
Query: 708 --LRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSNLNA 765
L ++ L A+ ++ L A + YLH + HRD+K NI LD NA
Sbjct: 170 CDLFTYVDRSGPLPLEQAITIQRRLLEA--LAYLHGRG---IIHRDVKTENIFLDEPENA 224
Query: 766 KVADFGLSRLAPVLDDEGTMPTHVSTIVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVLLE 825
+ DFG A LD P GT PE K+D++S G+VL E
Sbjct: 225 VLGDFG---AACKLDAHPDTPQCYGWS--GTLETNSPELLALDPYCAKTDIWSAGLVLFE 279
Query: 826 LL 827
+
Sbjct: 280 MS 281
|
Length = 392 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 958 | |||
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG4194 | 873 | consensus Membrane glycoprotein LIG-1 [Signal tran | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 100.0 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 100.0 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 100.0 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 99.98 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 99.98 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 99.98 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 99.98 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 99.97 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 99.97 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 99.97 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 99.97 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 99.97 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.97 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.97 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 99.97 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 99.97 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.97 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 99.97 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 99.97 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 99.97 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.96 | |
| KOG4194 | 873 | consensus Membrane glycoprotein LIG-1 [Signal tran | 99.96 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 99.96 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.95 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.95 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.95 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.95 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.95 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.95 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.94 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.94 | |
| KOG0444 | 1255 | consensus Cytoskeletal regulator Flightless-I (con | 99.94 | |
| KOG0444 | 1255 | consensus Cytoskeletal regulator Flightless-I (con | 99.94 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.93 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.93 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.92 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.92 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.92 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.91 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.91 | |
| KOG0472 | 565 | consensus Leucine-rich repeat protein [Function un | 99.91 | |
| KOG4237 | 498 | consensus Extracellular matrix protein slit, conta | 99.91 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.91 | |
| KOG0472 | 565 | consensus Leucine-rich repeat protein [Function un | 99.91 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.9 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.9 | |
| PRK15387 | 788 | E3 ubiquitin-protein ligase SspH2; Provisional | 99.87 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.86 | |
| KOG0618 | 1081 | consensus Serine/threonine phosphatase 2C containi | 99.86 | |
| PRK15370 | 754 | E3 ubiquitin-protein ligase SlrP; Provisional | 99.86 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.84 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.84 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.83 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.83 | |
| PRK15387 | 788 | E3 ubiquitin-protein ligase SspH2; Provisional | 99.81 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.81 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.81 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.8 | |
| PRK15370 | 754 | E3 ubiquitin-protein ligase SlrP; Provisional | 99.8 | |
| PLN03210 | 1153 | Resistant to P. syringae 6; Provisional | 99.79 | |
| KOG0618 | 1081 | consensus Serine/threonine phosphatase 2C containi | 99.78 | |
| PLN03210 | 1153 | Resistant to P. syringae 6; Provisional | 99.78 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.78 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.77 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.76 | |
| KOG0617 | 264 | consensus Ras suppressor protein (contains leucine | 99.76 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.74 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.74 | |
| cd00116 | 319 | LRR_RI Leucine-rich repeats (LRRs), ribonuclease i | 99.73 | |
| KOG0617 | 264 | consensus Ras suppressor protein (contains leucine | 99.71 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.71 | |
| KOG4237 | 498 | consensus Extracellular matrix protein slit, conta | 99.71 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.7 | |
| cd00116 | 319 | LRR_RI Leucine-rich repeats (LRRs), ribonuclease i | 99.7 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.7 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.7 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.69 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.68 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.65 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.61 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.59 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.58 | |
| PLN03150 | 623 | hypothetical protein; Provisional | 99.58 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.46 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.44 | |
| KOG0532 | 722 | consensus Leucine-rich repeat (LRR) protein, conta | 99.39 | |
| COG4886 | 394 | Leucine-rich repeat (LRR) protein [Function unknow | 99.35 | |
| COG4886 | 394 | Leucine-rich repeat (LRR) protein [Function unknow | 99.34 | |
| KOG3207 | 505 | consensus Beta-tubulin folding cofactor E [Posttra | 99.31 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.3 | |
| KOG0532 | 722 | consensus Leucine-rich repeat (LRR) protein, conta | 99.29 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.29 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.28 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.26 | |
| KOG3207 | 505 | consensus Beta-tubulin folding cofactor E [Posttra | 99.23 | |
| KOG1259 | 490 | consensus Nischarin, modulator of integrin alpha5 | 99.22 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.22 | |
| KOG1909 | 382 | consensus Ran GTPase-activating protein [RNA proce | 99.21 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.2 | |
| KOG0531 | 414 | consensus Protein phosphatase 1, regulatory subuni | 99.19 | |
| KOG1259 | 490 | consensus Nischarin, modulator of integrin alpha5 | 99.15 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 99.13 | |
| KOG1909 | 382 | consensus Ran GTPase-activating protein [RNA proce | 99.12 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.11 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.1 | |
| PF14580 | 175 | LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQ | 99.1 | |
| PF14580 | 175 | LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQ | 99.09 | |
| KOG0531 | 414 | consensus Protein phosphatase 1, regulatory subuni | 99.09 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.08 | |
| PLN03150 | 623 | hypothetical protein; Provisional | 99.03 | |
| KOG4658 | 889 | consensus Apoptotic ATPase [Signal transduction me | 98.97 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 98.96 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 98.92 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 98.91 | |
| KOG2982 | 418 | consensus Uncharacterized conserved protein [Funct | 98.89 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.85 | |
| KOG1859 | 1096 | consensus Leucine-rich repeat proteins [General fu | 98.81 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 98.77 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.75 | |
| KOG4658 | 889 | consensus Apoptotic ATPase [Signal transduction me | 98.64 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.64 | |
| KOG1859 | 1096 | consensus Leucine-rich repeat proteins [General fu | 98.61 | |
| KOG2982 | 418 | consensus Uncharacterized conserved protein [Funct | 98.59 | |
| PF13855 | 61 | LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF | 98.59 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.56 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.48 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.46 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 98.4 |
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-77 Score=763.04 Aligned_cols=820 Identities=25% Similarity=0.384 Sum_probs=436.6
Q ss_pred CCCCHhHHHHHHHHHHHcccCccccCCCCCCCCCCCCCCceeeCccccCCCceeeEEEEccCCcCCCCccccccCCCCcc
Q 002158 34 QTTDPQEASALRAIKNSLVDSMNHLRNWNKGDPCMSNWTGVLCFDTVETDGHLHVRELQLLSMNLSGNLAPELGQLSRLQ 113 (958)
Q Consensus 34 ~~~~~~~~~al~~~k~~~~~~~~~l~~W~~~~~c~~~w~gV~C~~~~~~~~~~~v~~L~L~~~~l~~~~~~~l~~L~~L~ 113 (958)
+..+++|+.||++||+++.+|...+.+|+..++|| .|.||+|.+ ..+|+.|+|+++++++.+++.+..+++|+
T Consensus 24 ~~~~~~~~~~l~~~~~~~~~~~~~~~~w~~~~~~c-~w~gv~c~~------~~~v~~L~L~~~~i~~~~~~~~~~l~~L~ 96 (968)
T PLN00113 24 SMLHAEELELLLSFKSSINDPLKYLSNWNSSADVC-LWQGITCNN------SSRVVSIDLSGKNISGKISSAIFRLPYIQ 96 (968)
T ss_pred cCCCHHHHHHHHHHHHhCCCCcccCCCCCCCCCCC-cCcceecCC------CCcEEEEEecCCCccccCChHHhCCCCCC
Confidence 33478999999999999988888899998777765 899999963 23788999999888888888888888888
Q ss_pred eeeccCc-ccCCCCcccc-CCCCCcEEEeeCCCCCCC----------------------CChhhcCCCCCCEEecccccc
Q 002158 114 YYFMWND-LTGTIPKEIG-NISSLIFLLLNGNKLSGS----------------------LPDELGYLSNLNRLQVDENNI 169 (958)
Q Consensus 114 ~L~l~n~-~~~~ip~~i~-~l~~L~~L~Ls~n~l~~~----------------------~p~~l~~l~~L~~L~L~~N~l 169 (958)
.|++++| +.+.+|..+. ++++|++|+|++|++++. +|..++++++|++|+|++|.+
T Consensus 97 ~L~Ls~n~~~~~ip~~~~~~l~~L~~L~Ls~n~l~~~~p~~~l~~L~~L~Ls~n~~~~~~p~~~~~l~~L~~L~L~~n~l 176 (968)
T PLN00113 97 TINLSNNQLSGPIPDDIFTTSSSLRYLNLSNNNFTGSIPRGSIPNLETLDLSNNMLSGEIPNDIGSFSSLKVLDLGGNVL 176 (968)
T ss_pred EEECCCCccCCcCChHHhccCCCCCEEECcCCccccccCccccCCCCEEECcCCcccccCChHHhcCCCCCEEECccCcc
Confidence 8888744 4567777654 666666666666666544 444455555555555555555
Q ss_pred cccCccccccccccceEecccccccccCchhhcCCccchhhhccCCccccCCCcccCCCCCccEEEccCCCCCCCCcccc
Q 002158 170 TGTIPKSFANLSRVRHLHLNNNSIGGQIPSELSKLSTLIHLLVDNNNLSGNLPPELSELPQLCILQLDNNNFSASEIPAT 249 (958)
Q Consensus 170 ~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~p~~ 249 (958)
.+.+|..+.++++|++|+|++|.+++.+|..+.++++|+.|+|++|++++.+|..+.++++|++|+|++|+++ ..+|..
T Consensus 177 ~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~-~~~p~~ 255 (968)
T PLN00113 177 VGKIPNSLTNLTSLEFLTLASNQLVGQIPRELGQMKSLKWIYLGYNNLSGEIPYEIGGLTSLNHLDLVYNNLT-GPIPSS 255 (968)
T ss_pred cccCChhhhhCcCCCeeeccCCCCcCcCChHHcCcCCccEEECcCCccCCcCChhHhcCCCCCEEECcCceec-cccChh
Confidence 5555555555555555555555555555555555555555555555555555555555555555555555554 244555
Q ss_pred ccCCCCCCEEEcccCCCCCCCC-CCCCCCCcCEEeccCCcCCCcCCCC-CCCCCcCEEEccCCcCCCccchhccCCCCCC
Q 002158 250 YGNFSKLVKLSLRNCNLQGAVP-DLSRIPNLYYLDLSWNHLTGSIPSK-KLSENVTTIDLSDNYLNGSILESISNLPFLQ 327 (958)
Q Consensus 250 ~~~l~~L~~L~L~~N~l~~~~~-~l~~l~~L~~L~Ls~N~l~~~~~~~-~~~~~L~~L~Ls~N~l~~~~~~~~~~l~~L~ 327 (958)
++++++|+.|+|++|++++..+ .+.++++|+.|+|++|.+.+.+|.. ..+++|+.|+|++|.+++..|..+..+++|+
T Consensus 256 l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~~~~~~~l~~L~ 335 (968)
T PLN00113 256 LGNLKNLQYLFLYQNKLSGPIPPSIFSLQKLISLDLSDNSLSGEIPELVIQLQNLEILHLFSNNFTGKIPVALTSLPRLQ 335 (968)
T ss_pred HhCCCCCCEEECcCCeeeccCchhHhhccCcCEEECcCCeeccCCChhHcCCCCCcEEECCCCccCCcCChhHhcCCCCC
Confidence 5555555555555555554443 2455555555555555555444432 2345555555555555555555555555555
Q ss_pred eEeeecccCCCccchhhhcccccCccccceEeccCCCCCCC-cc------------------------CC-CCCCcceEE
Q 002158 328 TLSLENNFLTGSIPATIWQNKSFSTKARLKIDLRNNSFSNI-VG------------------------DL-TLPNNVTLR 381 (958)
Q Consensus 328 ~L~L~~N~l~~~ip~~l~~~~~~~~~~l~~L~Ls~N~l~~l-~~------------------------~~-~l~~L~~L~ 381 (958)
.|+|++|.+++.+|..+..+. .|+.|+|++|+++.. +. .. .+++|+.|+
T Consensus 336 ~L~L~~n~l~~~~p~~l~~~~-----~L~~L~Ls~n~l~~~~p~~~~~~~~L~~L~l~~n~l~~~~p~~~~~~~~L~~L~ 410 (968)
T PLN00113 336 VLQLWSNKFSGEIPKNLGKHN-----NLTVLDLSTNNLTGEIPEGLCSSGNLFKLILFSNSLEGEIPKSLGACRSLRRVR 410 (968)
T ss_pred EEECcCCCCcCcCChHHhCCC-----CCcEEECCCCeeEeeCChhHhCcCCCCEEECcCCEecccCCHHHhCCCCCCEEE
Confidence 555555555555555444332 233444444444321 11 11 333444444
Q ss_pred eCCCCCCCCCCCCCCCcccccCCCCCccccccCCCCCCCC----CCCCCcccccCCCCCCceeeeec-----eee-eeec
Q 002158 382 LGGNPICTSANIPNTGRFCGSDAGGDETLTNSKVNCPVQA----CPVDNFFEYVPASPEPCFCAAPL-----RIG-YRLK 451 (958)
Q Consensus 382 l~~N~l~~~~~~~~~~~~~~~~~~~~~~L~~n~~~C~c~~----~~~~~~~~~~~~~~~~~~c~sp~-----~~~-~~~~ 451 (958)
+.+|++.... + ..+........+.+.+|.+.-..+. .+-..++.- +.+.....-|. ... ..+.
T Consensus 411 L~~n~l~~~~--p--~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L---~~n~~~~~~p~~~~~~~L~~L~ls 483 (968)
T PLN00113 411 LQDNSFSGEL--P--SEFTKLPLVYFLDISNNNLQGRINSRKWDMPSLQMLSL---ARNKFFGGLPDSFGSKRLENLDLS 483 (968)
T ss_pred CcCCEeeeEC--C--hhHhcCCCCCEEECcCCcccCccChhhccCCCCcEEEC---cCceeeeecCcccccccceEEECc
Confidence 4444432110 0 0011111222233333322110000 000000000 00000000000 000 0000
Q ss_pred CCCCCCCCCChh------------------hhHHHHhhhcccceeeeEEeeeeecc------CCCcceEEEeeeccCCCC
Q 002158 452 SPSFTYFPPYVY------------------PFEEYLTNTLNLELYQLSIDSFAWEK------GPRLEMYLKLFPTLNRSS 507 (958)
Q Consensus 452 ~~~~~~~~~~~~------------------~~~~~~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~~~~~~~ 507 (958)
.-.++...|... .......+-..++...++-+.+.... -+.+.. +.+ ..|.-.
T Consensus 484 ~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~-L~L--s~N~l~ 560 (968)
T PLN00113 484 RNQFSGAVPRKLGSLSELMQLKLSENKLSGEIPDELSSCKKLVSLDLSHNQLSGQIPASFSEMPVLSQ-LDL--SQNQLS 560 (968)
T ss_pred CCccCCccChhhhhhhccCEEECcCCcceeeCChHHcCccCCCEEECCCCcccccCChhHhCcccCCE-EEC--CCCccc
Confidence 000000000000 00000000011111111111111000 000000 000 001000
Q ss_pred -ccchhHHHHhhhhccccccCCCcccCCcccc----ce---eecC-------CCCCCCCCCCCCCcccceeeeehhHHHH
Q 002158 508 -TFDDSEVRQIRDRFTSWKFPGSDIFGPYELL----NF---TLLG-------PYSNLNFNSQSKGISGGILAAIVVGAVA 572 (958)
Q Consensus 508 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~---~~~~-------~~~~~~~~~~~~~~~~~~~~~ivv~~~~ 572 (958)
..... ... -.....-.+.++...|.+... .+ .+.| +................ +..+++++++
T Consensus 561 ~~~p~~-l~~-l~~L~~l~ls~N~l~~~~p~~~~~~~~~~~~~~~n~~lc~~~~~~~~~~c~~~~~~~~-~~~~~~~~~~ 637 (968)
T PLN00113 561 GEIPKN-LGN-VESLVQVNISHNHLHGSLPSTGAFLAINASAVAGNIDLCGGDTTSGLPPCKRVRKTPS-WWFYITCTLG 637 (968)
T ss_pred ccCChh-Hhc-CcccCEEeccCCcceeeCCCcchhcccChhhhcCCccccCCccccCCCCCccccccce-eeeehhHHHH
Confidence 00000 000 000000011111111110000 00 0000 00000000000001111 1112222222
Q ss_pred HHHHH-HHHHHHHHHhhhhhccccccccccccccccc---cCCccccChHHHHHHHcCCCCCceeeeeCCeEEEEEEEC-
Q 002158 573 SAVAI-TAAVTLLVMRRHARYQHSLSRKRLSTKISMK---IDGVKGFKFKELAMATAYFSSSTQVGQGGYGKVYKGILS- 647 (958)
Q Consensus 573 ~~~~i-~~~~~~~~~~r~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~el~~~~~~~~~~~~lg~G~~g~Vy~~~~~- 647 (958)
+++++ +++++++++||+++.+.. ..+......... ......+.++++ ...|...+.||+|+||+||+|++.
T Consensus 638 ~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~ig~G~~g~Vy~~~~~~ 713 (968)
T PLN00113 638 AFLVLALVAFGFVFIRGRNNLELK-RVENEDGTWELQFFDSKVSKSITINDI---LSSLKEENVISRGKKGASYKGKSIK 713 (968)
T ss_pred HHHHHHHHHHHHHHHHhhhccccc-ccccccccccccccccccchhhhHHHH---HhhCCcccEEccCCCeeEEEEEECC
Confidence 22222 222222222222211110 000000000000 000112333333 346778899999999999999974
Q ss_pred CCcEEEEEEeccCChhcHHHHHHHHHHHHccCCCCcceEEEEEEeCCeEEEEEEecCCCCHHHHhccCCCCCchHHHHHH
Q 002158 648 DNTTVAIKRAEEGSLQGQNEFLTEIKLLSRLHHRNLVSLLGYCDEEGEQMLVYEFVPNGTLRDWLSGRTKENLNFAMRLR 727 (958)
Q Consensus 648 ~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ 727 (958)
++..||||++...... ..+|++.+++++|||||+++|+|.+++..++||||+++|+|.++++. ++|.++.+
T Consensus 714 ~~~~vavK~~~~~~~~----~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~~-----l~~~~~~~ 784 (968)
T PLN00113 714 NGMQFVVKEINDVNSI----PSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVLRN-----LSWERRRK 784 (968)
T ss_pred CCcEEEEEEccCCccc----cHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEeCCCCCcHHHHHhc-----CCHHHHHH
Confidence 7899999998754322 23568899999999999999999999999999999999999999952 88999999
Q ss_pred HHHHHHHHHHHhhhcCCCCeeccCCCccceEecCCCCeEEeeeeeecccccCCCCCCccceeeeeccCCCCccChhhhcc
Q 002158 728 VALDSAKGILYLHTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSRLAPVLDDEGTMPTHVSTIVKGTPGYLDPEYFLT 807 (958)
Q Consensus 728 i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 807 (958)
++.|+|+||+|||+.+.++|+||||||+||+++.++.+++. ||.+..... .....||++|+|||++.+
T Consensus 785 i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~-----------~~~~~~t~~y~aPE~~~~ 852 (968)
T PLN00113 785 IAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCT-----------DTKCFISSAYVAPETRET 852 (968)
T ss_pred HHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-ecccccccc-----------CCCccccccccCcccccC
Confidence 99999999999997766669999999999999999988875 665543211 112358899999999999
Q ss_pred CCCCCcchhhhHHHHHHHHHhCCCCCCCC----chhHHHHHHHhhcCcchhhhcccC---CCCChHHHHHHHHHHHHccc
Q 002158 808 HKLTDKSDVYSLGVVLLELLTGMQPISHG----KNIVREVNVARDSGMVFSIIDNRM---GSYPSECVERFVTLALRCCH 880 (958)
Q Consensus 808 ~~~~~~~DV~S~Gv~l~elltG~~P~~~~----~~~~~~~~~~~~~~~~~~~i~~~~---~~~~~~~~~~l~~li~~cl~ 880 (958)
..++.++|||||||++|||+||+.||+.. .....+.+...........+++.. ...+.....++.+++.+||+
T Consensus 853 ~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~ 932 (968)
T PLN00113 853 KDITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDCHLDMWIDPSIRGDVSVNQNEIVEVMNLALHCTA 932 (968)
T ss_pred CCCCcccchhhHHHHHHHHHhCCCCCCcccCCCCcHHHHHHHhcCccchhheeCccccCCCCccHHHHHHHHHHHHhhCc
Confidence 99999999999999999999999998532 223334333222222222333332 12345667788999999999
Q ss_pred cCCCCCCCHHHHHHHHHHhHhhCC
Q 002158 881 DKPEHRPSMSDVVRELENILKMFP 904 (958)
Q Consensus 881 ~dP~~RPs~~evl~~L~~~~~~~~ 904 (958)
.||++||+|+|+++.|+++.+..+
T Consensus 933 ~~P~~RPt~~evl~~L~~~~~~~~ 956 (968)
T PLN00113 933 TDPTARPCANDVLKTLESASRSSS 956 (968)
T ss_pred CCchhCcCHHHHHHHHHHhhcccc
Confidence 999999999999999998875443
|
|
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-51 Score=454.38 Aligned_cols=285 Identities=52% Similarity=0.876 Sum_probs=247.8
Q ss_pred CccccChHHHHHHHcCCCCCceeeeeCCeEEEEEEECCCcEEEEEEeccCChhcHHHHHHHHHHHHccCCCCcceEEEEE
Q 002158 611 GVKGFKFKELAMATAYFSSSTQVGQGGYGKVYKGILSDNTTVAIKRAEEGSLQGQNEFLTEIKLLSRLHHRNLVSLLGYC 690 (958)
Q Consensus 611 ~~~~~~~~el~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~ 690 (958)
..+.|+++|+..+|++|...+.||+|+||.||+|..++|+.||||++........++|.+|++++.+++|||+|+++|||
T Consensus 61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGyC 140 (361)
T KOG1187|consen 61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGYC 140 (361)
T ss_pred CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEEE
Confidence 46779999999999999999999999999999999999999999988775443145699999999999999999999999
Q ss_pred EeCC-eEEEEEEecCCCCHHHHhccCCCCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEecCCCCeEEee
Q 002158 691 DEEG-EQMLVYEFVPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSNLNAKVAD 769 (958)
Q Consensus 691 ~~~~-~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~~~~kl~D 769 (958)
.+.+ +.+||||||++|+|.++|+......++|.+|++||.++|+||+|||+...++||||||||+|||+|+++++||+|
T Consensus 141 ~e~~~~~~LVYEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKlsD 220 (361)
T KOG1187|consen 141 LEGGEHRLLVYEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLSD 220 (361)
T ss_pred ecCCceEEEEEEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEccC
Confidence 9998 599999999999999999876543799999999999999999999999999999999999999999999999999
Q ss_pred eeeecccccCCCCCCccceeeeeccCCCCccChhhhccCCCCCcchhhhHHHHHHHHHhCCCCCCCC-----chhHHHHH
Q 002158 770 FGLSRLAPVLDDEGTMPTHVSTIVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVLLELLTGMQPISHG-----KNIVREVN 844 (958)
Q Consensus 770 FGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gv~l~elltG~~P~~~~-----~~~~~~~~ 844 (958)
||+|+..+.. . .+......||.+|+|||++..+..+.|+|||||||+|+||+||+.+.+.. ..+..|..
T Consensus 221 FGLa~~~~~~-~-----~~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~ 294 (361)
T KOG1187|consen 221 FGLAKLGPEG-D-----TSVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAK 294 (361)
T ss_pred ccCcccCCcc-c-----cceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHH
Confidence 9999754321 0 11111117999999999999999999999999999999999999888642 24667766
Q ss_pred HHhhcCcchhhhcccCC--CCCh-HHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHh
Q 002158 845 VARDSGMVFSIIDNRMG--SYPS-ECVERFVTLALRCCHDKPEHRPSMSDVVRELENILK 901 (958)
Q Consensus 845 ~~~~~~~~~~~i~~~~~--~~~~-~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~ 901 (958)
.....+...+++|+.+. .++. .....+..++.+|++.+|++||+|.||++.|+.+..
T Consensus 295 ~~~~~~~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~~~ 354 (361)
T KOG1187|consen 295 PLLEEGKLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELEGILS 354 (361)
T ss_pred HHHHCcchhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhhcc
Confidence 67777788899999874 4554 678889999999999999999999999999966543
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-46 Score=414.60 Aligned_cols=258 Identities=36% Similarity=0.605 Sum_probs=218.4
Q ss_pred ceeeeeCCeEEEEEEECCCcEEEEEEeccCChhc--HHHHHHHHHHHHccCCCCcceEEEEEEeCC-eEEEEEEecCCCC
Q 002158 631 TQVGQGGYGKVYKGILSDNTTVAIKRAEEGSLQG--QNEFLTEIKLLSRLHHRNLVSLLGYCDEEG-EQMLVYEFVPNGT 707 (958)
Q Consensus 631 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~--~~~~~~E~~~l~~l~H~niv~l~~~~~~~~-~~~lV~E~~~~gs 707 (958)
+.||+|+||+||+|.|+....||||++....... .++|.+|+.+|++++|||||+++|+|.... ..++|||||++|+
T Consensus 47 ~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtEy~~~Gs 126 (362)
T KOG0192|consen 47 EVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTEYMPGGS 126 (362)
T ss_pred hhcccCCceeEEEEEeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEEeCCCCc
Confidence 4599999999999999766669999998753222 568999999999999999999999999887 7999999999999
Q ss_pred HHHHhccCCCCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEecCCC-CeEEeeeeeecccccCCCCCCcc
Q 002158 708 LRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSNL-NAKVADFGLSRLAPVLDDEGTMP 786 (958)
Q Consensus 708 L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~~-~~kl~DFGla~~~~~~~~~~~~~ 786 (958)
|.++++......+++..+++++.|||+||.|||+++. ||||||||+|||++.++ ++||+|||+++......
T Consensus 127 L~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~~~--iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~~------ 198 (362)
T KOG0192|consen 127 LSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSEGP--IIHRDLKSDNILVDLKGKTLKIADFGLSREKVISK------ 198 (362)
T ss_pred HHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCC--eeecccChhhEEEcCCCCEEEECCCccceeecccc------
Confidence 9999987545669999999999999999999999874 99999999999999997 99999999998653211
Q ss_pred ceeeeeccCCCCccChhhhc--cCCCCCcchhhhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcCcchhhhcccCCCCC
Q 002158 787 THVSTIVKGTPGYLDPEYFL--THKLTDKSDVYSLGVVLLELLTGMQPISHGKNIVREVNVARDSGMVFSIIDNRMGSYP 864 (958)
Q Consensus 787 ~~~~~~~~gt~~y~aPE~~~--~~~~~~~~DV~S~Gv~l~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~ 864 (958)
...+...||++|||||++. ...|+.|+||||||+++|||+||+.||.+.... +...... .....+.+|
T Consensus 199 -~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~-~~~~~v~--------~~~~Rp~~p 268 (362)
T KOG0192|consen 199 -TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPV-QVASAVV--------VGGLRPPIP 268 (362)
T ss_pred -ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHH-HHHHHHH--------hcCCCCCCC
Confidence 1223367999999999999 568999999999999999999999999876652 2221111 123345567
Q ss_pred hHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHhhCCCC
Q 002158 865 SECVERFVTLALRCCHDKPEHRPSMSDVVRELENILKMFPET 906 (958)
Q Consensus 865 ~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~~~~ 906 (958)
..++..+..++.+||+.||.+||++.+++..|+.+.......
T Consensus 269 ~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~~~~~~~~ 310 (362)
T KOG0192|consen 269 KECPPHLSSLMERCWLVDPSRRPSFLEIVSRLESIMSHISSA 310 (362)
T ss_pred ccCCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHHHHhhccc
Confidence 779999999999999999999999999999999998766543
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-46 Score=386.28 Aligned_cols=243 Identities=28% Similarity=0.434 Sum_probs=211.2
Q ss_pred CceeeeeCCeEEEEEEEC-CCcEEEEEEeccC-ChhcHHHHHHHHHHHHccCCCCcceEEEEEEeCC-eEEEEEEecCCC
Q 002158 630 STQVGQGGYGKVYKGILS-DNTTVAIKRAEEG-SLQGQNEFLTEIKLLSRLHHRNLVSLLGYCDEEG-EQMLVYEFVPNG 706 (958)
Q Consensus 630 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~-~~~lV~E~~~~g 706 (958)
.+.||+|..|+|||+.++ +++.+|+|++... ....++++.+|++++++.+||+||++||.|...+ ...++||||++|
T Consensus 84 ~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~mEYMDgG 163 (364)
T KOG0581|consen 84 LGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICMEYMDGG 163 (364)
T ss_pred hhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeehhhcCCC
Confidence 567999999999999987 6889999999554 4555678999999999999999999999999998 599999999999
Q ss_pred CHHHHhccCCCCCchHHHHHHHHHHHHHHHHHhhh-cCCCCeeccCCCccceEecCCCCeEEeeeeeecccccCCCCCCc
Q 002158 707 TLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHT-EAHPPVFHRDIKASNILLDSNLNAKVADFGLSRLAPVLDDEGTM 785 (958)
Q Consensus 707 sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~-~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~ 785 (958)
+|++++... +.+++...-+++.++++||.|||+ ++ ||||||||+|||++..|++||+|||.++.+..
T Consensus 164 SLd~~~k~~--g~i~E~~L~~ia~~VL~GL~YLh~~~~---IIHRDIKPsNlLvNskGeVKicDFGVS~~lvn------- 231 (364)
T KOG0581|consen 164 SLDDILKRV--GRIPEPVLGKIARAVLRGLSYLHEERK---IIHRDIKPSNLLVNSKGEVKICDFGVSGILVN------- 231 (364)
T ss_pred CHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHhhccC---eeeccCCHHHeeeccCCCEEeccccccHHhhh-------
Confidence 999999765 349999999999999999999996 66 99999999999999999999999999986532
Q ss_pred cceeeeeccCCCCccChhhhccCCCCCcchhhhHHHHHHHHHhCCCCCCCC----chhHHHHHHHhhcCcchhhhcccCC
Q 002158 786 PTHVSTIVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVLLELLTGMQPISHG----KNIVREVNVARDSGMVFSIIDNRMG 861 (958)
Q Consensus 786 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gv~l~elltG~~P~~~~----~~~~~~~~~~~~~~~~~~~i~~~~~ 861 (958)
.....+.||..|||||.+.+..|+.++||||||++++|+.+|+.||... ....+. +..++++..+
T Consensus 232 --S~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~L---------l~~Iv~~ppP 300 (364)
T KOG0581|consen 232 --SIANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFEL---------LCAIVDEPPP 300 (364)
T ss_pred --hhcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHH---------HHHHhcCCCC
Confidence 2445688999999999999999999999999999999999999999753 111111 1233444555
Q ss_pred CCChH-HHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 002158 862 SYPSE-CVERFVTLALRCCHDKPEHRPSMSDVVRE 895 (958)
Q Consensus 862 ~~~~~-~~~~l~~li~~cl~~dP~~RPs~~evl~~ 895 (958)
..|.+ +++++..++..|+++||.+||+++|+++|
T Consensus 301 ~lP~~~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~H 335 (364)
T KOG0581|consen 301 RLPEGEFSPEFRSFVSCCLRKDPSERPSAKQLLQH 335 (364)
T ss_pred CCCcccCCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 66775 89999999999999999999999999986
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-45 Score=398.13 Aligned_cols=252 Identities=35% Similarity=0.576 Sum_probs=213.8
Q ss_pred CceeeeeCCeEEEEEEECCCcEEEEEEeccCChhcHHHHHHHHHHHHccCCCCcceEEEEEEeCCeEEEEEEecCCCCHH
Q 002158 630 STQVGQGGYGKVYKGILSDNTTVAIKRAEEGSLQGQNEFLTEIKLLSRLHHRNLVSLLGYCDEEGEQMLVYEFVPNGTLR 709 (958)
Q Consensus 630 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E~~~~gsL~ 709 (958)
.+.||+|-||+||.|.|+....||||.++.... ..+.|.+|+++|++++|+|||+++|+|..++..+||||||+.|+|.
T Consensus 211 ~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~~m-~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVtE~m~~GsLl 289 (468)
T KOG0197|consen 211 IRELGSGQFGEVWLGKWNGSTKVAVKTIKEGSM-SPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVTEYMPKGSLL 289 (468)
T ss_pred HHHhcCCccceEEEEEEcCCCcccceEEecccc-ChhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEEEecccCcHH
Confidence 457999999999999998888999999987633 3457999999999999999999999999998999999999999999
Q ss_pred HHhccCCCCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEecCCCCeEEeeeeeecccccCCCCCCcccee
Q 002158 710 DWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSRLAPVLDDEGTMPTHV 789 (958)
Q Consensus 710 ~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~ 789 (958)
++|+...+..+...+.+.++.|||+||+||++++ +|||||.++||||+++..+||+|||+||... ++. ...
T Consensus 290 ~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~~---~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~--d~~----Y~~ 360 (468)
T KOG0197|consen 290 DYLRTREGGLLNLPQLLDFAAQIAEGMAYLESKN---YIHRDLAARNILVDEDLVVKISDFGLARLIG--DDE----YTA 360 (468)
T ss_pred HHhhhcCCCccchHHHHHHHHHHHHHHHHHHhCC---ccchhhhhhheeeccCceEEEcccccccccC--CCc----eee
Confidence 9999866777999999999999999999999999 9999999999999999999999999999432 111 112
Q ss_pred eeeccCCCCccChhhhccCCCCCcchhhhHHHHHHHHHh-CCCCCCCCchhHHHHHHHhhcCcchhhhcccCCCCChHHH
Q 002158 790 STIVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVLLELLT-GMQPISHGKNIVREVNVARDSGMVFSIIDNRMGSYPSECV 868 (958)
Q Consensus 790 ~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gv~l~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~ 868 (958)
.....-...|.|||.+....++.|||||||||+||||+| |+.||....+ .+.+.... . +.+-..|..||
T Consensus 361 ~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn-~ev~~~le-~--------GyRlp~P~~CP 430 (468)
T KOG0197|consen 361 SEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSN-EEVLELLE-R--------GYRLPRPEGCP 430 (468)
T ss_pred cCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCH-HHHHHHHh-c--------cCcCCCCCCCC
Confidence 222334568999999999999999999999999999999 8999865443 22222221 1 22234578899
Q ss_pred HHHHHHHHHccccCCCCCCCHHHHHHHHHHhHh
Q 002158 869 ERFVTLALRCCHDKPEHRPSMSDVVRELENILK 901 (958)
Q Consensus 869 ~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~ 901 (958)
+++++||..||+.+|++|||++.+...|+++..
T Consensus 431 ~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~~~ 463 (468)
T KOG0197|consen 431 DEVYELMKSCWHEDPEDRPTFETLREVLEDFFT 463 (468)
T ss_pred HHHHHHHHHHhhCCcccCCCHHHHHHHHHHhhh
Confidence 999999999999999999999999988888654
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-44 Score=377.28 Aligned_cols=249 Identities=28% Similarity=0.472 Sum_probs=204.2
Q ss_pred cCCCCCceeeeeCCeEEEEEEEC-CCcEEEEEEeccC--ChhcHHHHHHHHHHHHccCCCCcceEEEEEEeCCeEEEEEE
Q 002158 625 AYFSSSTQVGQGGYGKVYKGILS-DNTTVAIKRAEEG--SLQGQNEFLTEIKLLSRLHHRNLVSLLGYCDEEGEQMLVYE 701 (958)
Q Consensus 625 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E 701 (958)
.+|...+.||+|+||+||+|+++ ++..||||.+... ..+.++....|+.+|+.++|||||++++++..++..|||||
T Consensus 10 ~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVME 89 (429)
T KOG0595|consen 10 GDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVME 89 (429)
T ss_pred ccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEEE
Confidence 35777778999999999999986 6899999998776 45566778999999999999999999999999999999999
Q ss_pred ecCCCCHHHHhccCCCCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEecCC------CCeEEeeeeeecc
Q 002158 702 FVPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSN------LNAKVADFGLSRL 775 (958)
Q Consensus 702 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~------~~~kl~DFGla~~ 775 (958)
||.||+|.+|++.++. +++.++..++.|+|.||++||+++ ||||||||.|||++.. -.+||+|||+||.
T Consensus 90 yC~gGDLs~yi~~~~~--l~e~t~r~Fm~QLA~alq~L~~~~---IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR~ 164 (429)
T KOG0595|consen 90 YCNGGDLSDYIRRRGR--LPEATARHFMQQLASALQFLHENN---IIHRDLKPQNILLSTTARNDTSPVLKIADFGFARF 164 (429)
T ss_pred eCCCCCHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCcceEEeccCCCCCCCceEEecccchhhh
Confidence 9999999999987654 999999999999999999999999 9999999999999764 4689999999998
Q ss_pred cccCCCCCCccceeeeeccCCCCccChhhhccCCCCCcchhhhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcCcchhh
Q 002158 776 APVLDDEGTMPTHVSTIVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVLLELLTGMQPISHGKNIVREVNVARDSGMVFSI 855 (958)
Q Consensus 776 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gv~l~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~ 855 (958)
+.. .......+|++-|||||+++.++|+.|+|+||.|+++||+++|+.||.... ..+.....+.....
T Consensus 165 L~~--------~~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t-~~eL~~~~~k~~~~--- 232 (429)
T KOG0595|consen 165 LQP--------GSMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAET-PKELLLYIKKGNEI--- 232 (429)
T ss_pred CCc--------hhHHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccC-HHHHHHHHhccccc---
Confidence 752 333456789999999999999999999999999999999999999997433 22322222222111
Q ss_pred hcccCCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002158 856 IDNRMGSYPSECVERFVTLALRCCHDKPEHRPSMSDVVR 894 (958)
Q Consensus 856 i~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 894 (958)
.+..+........+++...++.+|.+|-++.+-..
T Consensus 233 ----~~~~~~~~s~~~~~Ll~~ll~~~~~~~~~~~~~~~ 267 (429)
T KOG0595|consen 233 ----VPVLPAELSNPLRELLISLLQRNPKDRISFEDFFD 267 (429)
T ss_pred ----cCchhhhccCchhhhhhHHHhcCccccCchHHhhh
Confidence 12233344455557777777778888876666543
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-44 Score=394.12 Aligned_cols=248 Identities=25% Similarity=0.443 Sum_probs=216.2
Q ss_pred cCCCCCceeeeeCCeEEEEEEE-CCCcEEEEEEeccC---ChhcHHHHHHHHHHHHccCCCCcceEEEEEEeCCeEEEEE
Q 002158 625 AYFSSSTQVGQGGYGKVYKGIL-SDNTTVAIKRAEEG---SLQGQNEFLTEIKLLSRLHHRNLVSLLGYCDEEGEQMLVY 700 (958)
Q Consensus 625 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~ 700 (958)
..|...+.||+|||+.||+++. ..|+.||+|++.+. .....+...+|+++.+.++|||||+++++|++.+..|+|.
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL 97 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL 97 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence 4688889999999999999998 78999999999764 3344567889999999999999999999999999999999
Q ss_pred EecCCCCHHHHhccCCCCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEecCCCCeEEeeeeeecccccCC
Q 002158 701 EFVPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSRLAPVLD 780 (958)
Q Consensus 701 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~ 780 (958)
|+|++++|.++++. ++.+++.++..+..||+.||.|||+++ |+|||||-.|++++++.++||+|||+|..+...+
T Consensus 98 ELC~~~sL~el~Kr--rk~ltEpEary~l~QIv~GlkYLH~~~---IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~~ 172 (592)
T KOG0575|consen 98 ELCHRGSLMELLKR--RKPLTEPEARYFLRQIVEGLKYLHSLG---IIHRDLKLGNLFLNENMNVKIGDFGLATQLEYDG 172 (592)
T ss_pred EecCCccHHHHHHh--cCCCCcHHHHHHHHHHHHHHHHHHhcC---ceecccchhheeecCcCcEEecccceeeeecCcc
Confidence 99999999999973 345999999999999999999999999 9999999999999999999999999998764322
Q ss_pred CCCCccceeeeeccCCCCccChhhhccCCCCCcchhhhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcCcchhhhcccC
Q 002158 781 DEGTMPTHVSTIVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVLLELLTGMQPISHGKNIVREVNVARDSGMVFSIIDNRM 860 (958)
Q Consensus 781 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gv~l~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~i~~~~ 860 (958)
......+|||.|+|||++....++..+||||+||+||-|+.|++||+. +.+.+.+.... ..-
T Consensus 173 -------Erk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFet-k~vkety~~Ik----------~~~ 234 (592)
T KOG0575|consen 173 -------ERKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFET-KTVKETYNKIK----------LNE 234 (592)
T ss_pred -------cccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCccc-chHHHHHHHHH----------hcC
Confidence 234567899999999999999999999999999999999999999973 33333333222 222
Q ss_pred CCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 002158 861 GSYPSECVERFVTLALRCCHDKPEHRPSMSDVVRE 895 (958)
Q Consensus 861 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 895 (958)
..+|.....+..+||.++++.||.+|||+++|+.+
T Consensus 235 Y~~P~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~h 269 (592)
T KOG0575|consen 235 YSMPSHLSAEAKDLIRKLLRPNPSERPSLDEVLDH 269 (592)
T ss_pred cccccccCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 34577788899999999999999999999999975
|
|
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-44 Score=410.34 Aligned_cols=266 Identities=31% Similarity=0.506 Sum_probs=220.1
Q ss_pred HHHHcCCCCCceeeeeCCeEEEEEEEC------CCcEEEEEEeccCChh-cHHHHHHHHHHHHccCCCCcceEEEEEEeC
Q 002158 621 AMATAYFSSSTQVGQGGYGKVYKGILS------DNTTVAIKRAEEGSLQ-GQNEFLTEIKLLSRLHHRNLVSLLGYCDEE 693 (958)
Q Consensus 621 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~~~~~~~ 693 (958)
+..+.+....+.||+|+||+||+|... +...||||.+++.... .+.+|.+|+++++.++|||||+++|+|..+
T Consensus 482 ~i~r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~ 561 (774)
T KOG1026|consen 482 EIPRSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREG 561 (774)
T ss_pred EechhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccC
Confidence 334455566778999999999999853 3567999999987655 678999999999999999999999999999
Q ss_pred CeEEEEEEecCCCCHHHHhccCC------------CCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEecC
Q 002158 694 GEQMLVYEFVPNGTLRDWLSGRT------------KENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDS 761 (958)
Q Consensus 694 ~~~~lV~E~~~~gsL~~~l~~~~------------~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~ 761 (958)
+..++|+|||..|+|.++|.... +.+++..+.+.||.|||.||+||-++. +|||||..+|+||.+
T Consensus 562 ~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~---FVHRDLATRNCLVge 638 (774)
T KOG1026|consen 562 DPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHH---FVHRDLATRNCLVGE 638 (774)
T ss_pred CeeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCc---ccccchhhhhceecc
Confidence 99999999999999999996432 223889999999999999999999999 999999999999999
Q ss_pred CCCeEEeeeeeecccccCCCCCCccceeeeeccCCCCccChhhhccCCCCCcchhhhHHHHHHHHHh-CCCCCCCCchhH
Q 002158 762 NLNAKVADFGLSRLAPVLDDEGTMPTHVSTIVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVLLELLT-GMQPISHGKNIV 840 (958)
Q Consensus 762 ~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gv~l~ellt-G~~P~~~~~~~~ 840 (958)
+..|||+|||++|.....+-.. ......=..+|||||.++.++|+++||||||||+|||+++ |+.||.+..+.
T Consensus 639 ~l~VKIsDfGLsRdiYssDYYk-----~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~- 712 (774)
T KOG1026|consen 639 NLVVKISDFGLSRDIYSSDYYK-----VRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQ- 712 (774)
T ss_pred ceEEEecccccchhhhhhhhhc-----ccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccchH-
Confidence 9999999999998653322111 1101112468999999999999999999999999999999 99999865442
Q ss_pred HHHHHHhhcCcchhhhcccCCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHhhCC
Q 002158 841 REVNVARDSGMVFSIIDNRMGSYPSECVERFVTLALRCCHDKPEHRPSMSDVVRELENILKMFP 904 (958)
Q Consensus 841 ~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~~ 904 (958)
++...... ...-..|.+||.++++||..||+.+|++||+++||-..|++..+.-+
T Consensus 713 -EVIe~i~~--------g~lL~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~~~~s~ 767 (774)
T KOG1026|consen 713 -EVIECIRA--------GQLLSCPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAWAQASP 767 (774)
T ss_pred -HHHHHHHc--------CCcccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHHHhcCc
Confidence 22222222 22345688999999999999999999999999999999999775444
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-44 Score=372.21 Aligned_cols=251 Identities=27% Similarity=0.423 Sum_probs=205.2
Q ss_pred HHcCCCCCceeeeeCCeEEEEEEEC-CCcEEEEEEeccCChhc-------HHHHHHHHHHHHccCCCCcceEEEEEEeCC
Q 002158 623 ATAYFSSSTQVGQGGYGKVYKGILS-DNTTVAIKRAEEGSLQG-------QNEFLTEIKLLSRLHHRNLVSLLGYCDEEG 694 (958)
Q Consensus 623 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~-------~~~~~~E~~~l~~l~H~niv~l~~~~~~~~ 694 (958)
..+.|...+.||+|+||.|-+|..+ +|+.||||++....... .....+|+++|++++|||||+++++++..+
T Consensus 170 ~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~d 249 (475)
T KOG0615|consen 170 FNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPD 249 (475)
T ss_pred hcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCC
Confidence 4557788899999999999999965 79999999987642221 223579999999999999999999999999
Q ss_pred eEEEEEEecCCCCHHHHhccCCCCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEecCC---CCeEEeeee
Q 002158 695 EQMLVYEFVPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSN---LNAKVADFG 771 (958)
Q Consensus 695 ~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~---~~~kl~DFG 771 (958)
..|+||||++||.|.+.+-..+. +.+..-..++.|++.|+.|||++| |+||||||+|||+..+ ..+||+|||
T Consensus 250 s~YmVlE~v~GGeLfd~vv~nk~--l~ed~~K~~f~Qll~avkYLH~~G---I~HRDiKPeNILl~~~~e~~llKItDFG 324 (475)
T KOG0615|consen 250 SSYMVLEYVEGGELFDKVVANKY--LREDLGKLLFKQLLTAVKYLHSQG---IIHRDIKPENILLSNDAEDCLLKITDFG 324 (475)
T ss_pred ceEEEEEEecCccHHHHHHhccc--cccchhHHHHHHHHHHHHHHHHcC---cccccCCcceEEeccCCcceEEEecccc
Confidence 99999999999999999965543 777778899999999999999999 9999999999999665 779999999
Q ss_pred eecccccCCCCCCccceeeeeccCCCCccChhhhccCCC---CCcchhhhHHHHHHHHHhCCCCCCCCchhHHHHHHHhh
Q 002158 772 LSRLAPVLDDEGTMPTHVSTIVKGTPGYLDPEYFLTHKL---TDKSDVYSLGVVLLELLTGMQPISHGKNIVREVNVARD 848 (958)
Q Consensus 772 la~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~---~~~~DV~S~Gv~l~elltG~~P~~~~~~~~~~~~~~~~ 848 (958)
+|+.... ......++||+.|.|||++.+..+ ..++|+||+||+||-+++|.+||.+.........
T Consensus 325 lAK~~g~--------~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~sl~e---- 392 (475)
T KOG0615|consen 325 LAKVSGE--------GSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPSLKE---- 392 (475)
T ss_pred hhhcccc--------ceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCccHHH----
Confidence 9997532 334456899999999999987653 3388999999999999999999975432211111
Q ss_pred cCcchhhhcccCC---CCChHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 002158 849 SGMVFSIIDNRMG---SYPSECVERFVTLALRCCHDKPEHRPSMSDVVRE 895 (958)
Q Consensus 849 ~~~~~~~i~~~~~---~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 895 (958)
++...+.. .......++..++|.+|+..||++||+++|++++
T Consensus 393 -----QI~~G~y~f~p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~h 437 (475)
T KOG0615|consen 393 -----QILKGRYAFGPLQWDRISEEALDLINWMLVVDPENRPSADEALNH 437 (475)
T ss_pred -----HHhcCcccccChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhcC
Confidence 11112221 2234678899999999999999999999999985
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-43 Score=394.80 Aligned_cols=261 Identities=28% Similarity=0.450 Sum_probs=221.3
Q ss_pred CCCCceeeeeCCeEEEEEEEC----CCcEEEEEEeccCCh-hcHHHHHHHHHHHHccCCCCcceEEEEEEeCCeEEEEEE
Q 002158 627 FSSSTQVGQGGYGKVYKGILS----DNTTVAIKRAEEGSL-QGQNEFLTEIKLLSRLHHRNLVSLLGYCDEEGEQMLVYE 701 (958)
Q Consensus 627 ~~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E 701 (958)
..+.++||.|.||+||+|+++ ....||||.++.... +.+.+|+.|+.+|.++.||||++|.|+.......++|+|
T Consensus 631 i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~PvMIiTE 710 (996)
T KOG0196|consen 631 VKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKPVMIITE 710 (996)
T ss_pred eEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCceeEEEhh
Confidence 456789999999999999986 346799999998754 445689999999999999999999999999999999999
Q ss_pred ecCCCCHHHHhccCCCCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEecCCCCeEEeeeeeecccccCCC
Q 002158 702 FVPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSRLAPVLDD 781 (958)
Q Consensus 702 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~ 781 (958)
||+||+|+.+|+.+.++ +++.+...+..+||.|++||.+.+ +|||||.++|||++.+..+||+|||++|.+.....
T Consensus 711 yMENGsLDsFLR~~DGq-ftviQLVgMLrGIAsGMkYLsdm~---YVHRDLAARNILVNsnLvCKVsDFGLSRvledd~~ 786 (996)
T KOG0196|consen 711 YMENGSLDSFLRQNDGQ-FTVIQLVGMLRGIASGMKYLSDMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPE 786 (996)
T ss_pred hhhCCcHHHHHhhcCCc-eEeehHHHHHHHHHHHhHHHhhcC---chhhhhhhhheeeccceEEEeccccceeecccCCC
Confidence 99999999999877654 999999999999999999999999 99999999999999999999999999997744331
Q ss_pred CCCccceeeeeccCCCCccChhhhccCCCCCcchhhhHHHHHHHHHh-CCCCCCCCchhHHHHHHHhhcCcchhhhcccC
Q 002158 782 EGTMPTHVSTIVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVLLELLT-GMQPISHGKNIVREVNVARDSGMVFSIIDNRM 860 (958)
Q Consensus 782 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gv~l~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~i~~~~ 860 (958)
....+..-.-..+|.|||.+...+++.++|||||||+|||.++ |.+||-+..+-. +... +.+...
T Consensus 787 ----~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQd--VIka--------Ie~gyR 852 (996)
T KOG0196|consen 787 ----AAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQD--VIKA--------IEQGYR 852 (996)
T ss_pred ----ccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccchHH--HHHH--------HHhccC
Confidence 1222222333568999999999999999999999999999999 999997654321 1111 112223
Q ss_pred CCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHhhCCC
Q 002158 861 GSYPSECVERFVTLALRCCHDKPEHRPSMSDVVRELENILKMFPE 905 (958)
Q Consensus 861 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~~~ 905 (958)
...|.+||..+.+||+.||++|-.+||.++||+..|.++++....
T Consensus 853 LPpPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDklIrnP~S 897 (996)
T KOG0196|consen 853 LPPPMDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKLIRNPNS 897 (996)
T ss_pred CCCCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHHhcCchh
Confidence 445889999999999999999999999999999999999875543
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-44 Score=353.89 Aligned_cols=256 Identities=26% Similarity=0.419 Sum_probs=207.6
Q ss_pred CCCCCceeeeeCCeEEEEEEE-CCCcEEEEEEeccC--ChhcHHHHHHHHHHHHccCCCCcceEEE-EEEeCC-eEEEEE
Q 002158 626 YFSSSTQVGQGGYGKVYKGIL-SDNTTVAIKRAEEG--SLQGQNEFLTEIKLLSRLHHRNLVSLLG-YCDEEG-EQMLVY 700 (958)
Q Consensus 626 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~-~~~~~~-~~~lV~ 700 (958)
+|.+.++||+|.||+|||+.. .+|..||.|.+.-+ +.........|+.+|++++|||||++++ .+..+. ..++||
T Consensus 20 ~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlnivm 99 (375)
T KOG0591|consen 20 DYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIVM 99 (375)
T ss_pred HHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHHH
Confidence 455667899999999999995 48999999988644 3344567899999999999999999999 344444 489999
Q ss_pred EecCCCCHHHHhcc--CCCCCchHHHHHHHHHHHHHHHHHhhhcC-CCCeeccCCCccceEecCCCCeEEeeeeeecccc
Q 002158 701 EFVPNGTLRDWLSG--RTKENLNFAMRLRVALDSAKGILYLHTEA-HPPVFHRDIKASNILLDSNLNAKVADFGLSRLAP 777 (958)
Q Consensus 701 E~~~~gsL~~~l~~--~~~~~l~~~~~~~i~~~ia~aL~yLH~~~-~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~~~ 777 (958)
|||..|+|..+++. +.+..+++.++++++.|++.||.++|..- +..|+||||||.||+++.+|.+||+|||+++.+.
T Consensus 100 E~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~l~ 179 (375)
T KOG0591|consen 100 ELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLGRFLS 179 (375)
T ss_pred HhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhHhHhc
Confidence 99999999999964 33456999999999999999999999842 1239999999999999999999999999999874
Q ss_pred cCCCCCCccceeeeeccCCCCccChhhhccCCCCCcchhhhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcCcchhhhc
Q 002158 778 VLDDEGTMPTHVSTIVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVLLELLTGMQPISHGKNIVREVNVARDSGMVFSIID 857 (958)
Q Consensus 778 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gv~l~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~i~ 857 (958)
.. .......+|||.||+||.+.+..|+.|+||||+||++|||+.-++||.+. ++........+
T Consensus 180 s~-------~tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~-n~~~L~~KI~q--------- 242 (375)
T KOG0591|consen 180 SK-------TTFAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGD-NLLSLCKKIEQ--------- 242 (375)
T ss_pred ch-------hHHHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccc-cHHHHHHHHHc---------
Confidence 32 12234578999999999999999999999999999999999999999865 44333322222
Q ss_pred ccCCCCC-hHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 002158 858 NRMGSYP-SECVERFVTLALRCCHDKPEHRPSMSDVVRELEN 898 (958)
Q Consensus 858 ~~~~~~~-~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 898 (958)
...+..| .-.+..+..||..|+..||+.||+.-.+++.+..
T Consensus 243 gd~~~~p~~~YS~~l~~li~~ci~vd~~~RP~t~~~v~di~~ 284 (375)
T KOG0591|consen 243 GDYPPLPDEHYSTDLRELINMCIAVDPEQRPDTVPYVQDIQS 284 (375)
T ss_pred CCCCCCcHHHhhhHHHHHHHHHccCCcccCCCcchHHHHHHH
Confidence 1122344 5678899999999999999999996665555544
|
|
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-42 Score=378.92 Aligned_cols=272 Identities=25% Similarity=0.456 Sum_probs=219.5
Q ss_pred HHHHHHHcCCCCCceeeeeCCeEEEEEEECCCcEEEEEEeccCC--hhcHHHHHHHHHHHHccCCCCcceEEEEEEeCCe
Q 002158 618 KELAMATAYFSSSTQVGQGGYGKVYKGILSDNTTVAIKRAEEGS--LQGQNEFLTEIKLLSRLHHRNLVSLLGYCDEEGE 695 (958)
Q Consensus 618 ~el~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~ 695 (958)
++++..-+.+.....||+|.||+||+|.|.. .||||+++... ....+.|..|+.++++-+|.||+-+.|||..+..
T Consensus 385 ~~WeIp~~ev~l~~rIGsGsFGtV~Rg~whG--dVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~~ 462 (678)
T KOG0193|consen 385 EEWEIPPEEVLLGERIGSGSFGTVYRGRWHG--DVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPPL 462 (678)
T ss_pred cccccCHHHhhccceeccccccceeeccccc--ceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCce
Confidence 4444455556667899999999999999953 59999987653 4456789999999999999999999999998877
Q ss_pred EEEEEEecCCCCHHHHhccCCCCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEecCCCCeEEeeeeeecc
Q 002158 696 QMLVYEFVPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSRL 775 (958)
Q Consensus 696 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~ 775 (958)
.+|+.||+|.+|+.++|... ..++..+.+.||.|||+|+.|||.++ |||||||..||++.+++.|||+|||++..
T Consensus 463 -AIiTqwCeGsSLY~hlHv~e-tkfdm~~~idIAqQiaqGM~YLHAK~---IIHrDLKSnNIFl~~~~kVkIgDFGLatv 537 (678)
T KOG0193|consen 463 -AIITQWCEGSSLYTHLHVQE-TKFDMNTTIDIAQQIAQGMDYLHAKN---IIHRDLKSNNIFLHEDLKVKIGDFGLATV 537 (678)
T ss_pred -eeeehhccCchhhhhccchh-hhhhHHHHHHHHHHHHHhhhhhhhhh---hhhhhccccceEEccCCcEEEecccceee
Confidence 99999999999999999655 45999999999999999999999999 99999999999999999999999999976
Q ss_pred cccCCCCCCccceeeeeccCCCCccChhhhccC---CCCCcchhhhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcCcc
Q 002158 776 APVLDDEGTMPTHVSTIVKGTPGYLDPEYFLTH---KLTDKSDVYSLGVVLLELLTGMQPISHGKNIVREVNVARDSGMV 852 (958)
Q Consensus 776 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~DV~S~Gv~l~elltG~~P~~~~~~~~~~~~~~~~~~~~ 852 (958)
-....... ....-.|...|||||+++.+ +|+..+||||||+++|||+||..||. .....+.+ .....+..
T Consensus 538 k~~w~g~~-----q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPys-i~~~dqIi-fmVGrG~l 610 (678)
T KOG0193|consen 538 KTRWSGEQ-----QLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYS-IQNRDQII-FMVGRGYL 610 (678)
T ss_pred eeeecccc-----ccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcC-CCChhheE-EEeccccc
Confidence 54432211 11223478899999999754 58889999999999999999999997 33322221 11111111
Q ss_pred hhhhcccCCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHhhCCCCC
Q 002158 853 FSIIDNRMGSYPSECVERFVTLALRCCHDKPEHRPSMSDVVRELENILKMFPETD 907 (958)
Q Consensus 853 ~~~i~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~~~~~ 907 (958)
.+.+......+++++.+|+..||..++++||.+.+|+..|+.++...|.-.
T Consensus 611 ----~pd~s~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~~~~pki~ 661 (678)
T KOG0193|consen 611 ----MPDLSKIRSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELLPSLPKIN 661 (678)
T ss_pred ----CccchhhhccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhhhcccccc
Confidence 111223356789999999999999999999999999999999887666543
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-42 Score=357.31 Aligned_cols=249 Identities=24% Similarity=0.356 Sum_probs=208.7
Q ss_pred HcCCCCCceeeeeCCeEEEEEEEC-CCcEEEEEEeccCCh---hcHHHHHHHHHHHHccCCCCcceEEEEEEeCCeEEEE
Q 002158 624 TAYFSSSTQVGQGGYGKVYKGILS-DNTTVAIKRAEEGSL---QGQNEFLTEIKLLSRLHHRNLVSLLGYCDEEGEQMLV 699 (958)
Q Consensus 624 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV 699 (958)
.+.|+..+.||+|+||+||.++.+ .++.+|+|++++... .+.+...+|..+|.+++||.||+++-.|.+.+.+|||
T Consensus 24 ~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLylV 103 (357)
T KOG0598|consen 24 PDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYLV 103 (357)
T ss_pred hhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEEE
Confidence 457889999999999999999976 589999999977532 3456688999999999999999999999999999999
Q ss_pred EEecCCCCHHHHhccCCCCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEecCCCCeEEeeeeeecccccC
Q 002158 700 YEFVPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSRLAPVL 779 (958)
Q Consensus 700 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~~~~~ 779 (958)
+||+.||.|..+|++.+. +++..+.-++..|+.||.|||+.+ ||||||||+|||+|++|.++|+|||+++..-..
T Consensus 104 ld~~~GGeLf~hL~~eg~--F~E~~arfYlaEi~lAL~~LH~~g---IiyRDlKPENILLd~~GHi~LtDFgL~k~~~~~ 178 (357)
T KOG0598|consen 104 LDYLNGGELFYHLQREGR--FSEDRARFYLAEIVLALGYLHSKG---IIYRDLKPENILLDEQGHIKLTDFGLCKEDLKD 178 (357)
T ss_pred EeccCCccHHHHHHhcCC--cchhHHHHHHHHHHHHHHHHHhCC---eeeccCCHHHeeecCCCcEEEeccccchhcccC
Confidence 999999999999976544 999999999999999999999999 999999999999999999999999999854222
Q ss_pred CCCCCccceeeeeccCCCCccChhhhccCCCCCcchhhhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcCcchhhhccc
Q 002158 780 DDEGTMPTHVSTIVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVLLELLTGMQPISHGKNIVREVNVARDSGMVFSIIDNR 859 (958)
Q Consensus 780 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gv~l~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~i~~~ 859 (958)
...+..++||+.|||||++.+..|+..+|.||+|+++|||++|.+||.... ......... ...
T Consensus 179 -------~~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~-~~~~~~~I~---------~~k 241 (357)
T KOG0598|consen 179 -------GDATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAED-VKKMYDKIL---------KGK 241 (357)
T ss_pred -------CCccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCcc-HHHHHHHHh---------cCc
Confidence 122345899999999999999999999999999999999999999997533 222222221 122
Q ss_pred CCCCChHHHHHHHHHHHHccccCCCCCC----CHHHHHH
Q 002158 860 MGSYPSECVERFVTLALRCCHDKPEHRP----SMSDVVR 894 (958)
Q Consensus 860 ~~~~~~~~~~~l~~li~~cl~~dP~~RP----s~~evl~ 894 (958)
....|.-...+..+++.+.+..||++|. ++.+|-+
T Consensus 242 ~~~~p~~ls~~ardll~~LL~rdp~~RLg~~~d~~~ik~ 280 (357)
T KOG0598|consen 242 LPLPPGYLSEEARDLLKKLLKRDPRQRLGGPGDAEEIKR 280 (357)
T ss_pred CCCCCccCCHHHHHHHHHHhccCHHHhcCCCCChHHhhc
Confidence 2333444778899999999999999995 4555443
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-41 Score=361.64 Aligned_cols=256 Identities=23% Similarity=0.350 Sum_probs=214.9
Q ss_pred HcCCCCCceeeeeCCeEEEEEEEC-CCcEEEEEEeccCChh---cHHHHHHHHHHHHcc-CCCCcceEEEEEEeCCeEEE
Q 002158 624 TAYFSSSTQVGQGGYGKVYKGILS-DNTTVAIKRAEEGSLQ---GQNEFLTEIKLLSRL-HHRNLVSLLGYCDEEGEQML 698 (958)
Q Consensus 624 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~l 698 (958)
..+|...+.||+|+|++||+|+.+ .++.||||++.+.... ..+-...|-++|.+| +||.|++|+-.|.++..+|+
T Consensus 72 ~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sLYF 151 (604)
T KOG0592|consen 72 PNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESLYF 151 (604)
T ss_pred hhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccceEE
Confidence 346667788999999999999975 6899999998764221 123356899999999 89999999999999999999
Q ss_pred EEEecCCCCHHHHhccCCCCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEecCCCCeEEeeeeeeccccc
Q 002158 699 VYEFVPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSRLAPV 778 (958)
Q Consensus 699 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~~~~ 778 (958)
|+||+++|+|.++|+..+ .+++..+..++.+|+.||+|||++| ||||||||+|||+|+||++||+|||.|+.+..
T Consensus 152 vLe~A~nGdll~~i~K~G--sfde~caR~YAAeIldAleylH~~G---IIHRDlKPENILLd~dmhikITDFGsAK~l~~ 226 (604)
T KOG0592|consen 152 VLEYAPNGDLLDLIKKYG--SFDETCARFYAAEILDALEYLHSNG---IIHRDLKPENILLDKDGHIKITDFGSAKILSP 226 (604)
T ss_pred EEEecCCCcHHHHHHHhC--cchHHHHHHHHHHHHHHHHHHHhcC---ceeccCChhheeEcCCCcEEEeeccccccCCh
Confidence 999999999999997654 4999999999999999999999999 99999999999999999999999999998854
Q ss_pred CCCCCC------ccceeeeeccCCCCccChhhhccCCCCCcchhhhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcCcc
Q 002158 779 LDDEGT------MPTHVSTIVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVLLELLTGMQPISHGKNIVREVNVARDSGMV 852 (958)
Q Consensus 779 ~~~~~~------~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gv~l~elltG~~P~~~~~~~~~~~~~~~~~~~~ 852 (958)
...... ........++||..|++||++.....++.+|+|+|||++|+|+.|++||.+..+...
T Consensus 227 ~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~Neyli----------- 295 (604)
T KOG0592|consen 227 SQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANEYLI----------- 295 (604)
T ss_pred hhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccHHHH-----------
Confidence 433211 111112568999999999999999999999999999999999999999976543221
Q ss_pred hhhhcccCCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 002158 853 FSIIDNRMGSYPSECVERFVTLALRCCHDKPEHRPSMSDVVRE 895 (958)
Q Consensus 853 ~~~i~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 895 (958)
++.|-.....+|...++.+.+|+.+.+..||.+|++.++|.++
T Consensus 296 FqkI~~l~y~fp~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~H 338 (604)
T KOG0592|consen 296 FQKIQALDYEFPEGFPEDARDLIKKLLVRDPSDRLTSQQIKAH 338 (604)
T ss_pred HHHHHHhcccCCCCCCHHHHHHHHHHHccCccccccHHHHhhC
Confidence 2222233346677888999999999999999999999999876
|
|
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-42 Score=370.19 Aligned_cols=240 Identities=30% Similarity=0.512 Sum_probs=204.8
Q ss_pred CCceeeeeCCeEEEEEEECCCcEEEEEEeccCChhcHHHHHHHHHHHHccCCCCcceEEEEEEeCCeEEEEEEecCCCCH
Q 002158 629 SSTQVGQGGYGKVYKGILSDNTTVAIKRAEEGSLQGQNEFLTEIKLLSRLHHRNLVSLLGYCDEEGEQMLVYEFVPNGTL 708 (958)
Q Consensus 629 ~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E~~~~gsL 708 (958)
+.+-||+|+-|.||+|++ .++.||||+++.-. ..+|+-|++++|+||+.|.|+|.....++||||||+.|-|
T Consensus 128 ELeWlGSGaQGAVF~Grl-~netVAVKKV~elk-------ETdIKHLRkLkH~NII~FkGVCtqsPcyCIiMEfCa~GqL 199 (904)
T KOG4721|consen 128 ELEWLGSGAQGAVFLGRL-HNETVAVKKVRELK-------ETDIKHLRKLKHPNIITFKGVCTQSPCYCIIMEFCAQGQL 199 (904)
T ss_pred hhhhhccCcccceeeeec-cCceehhHHHhhhh-------hhhHHHHHhccCcceeeEeeeecCCceeEEeeeccccccH
Confidence 356799999999999998 57789999986422 2578889999999999999999999999999999999999
Q ss_pred HHHhccCCCCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEecCCCCeEEeeeeeecccccCCCCCCccce
Q 002158 709 RDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSRLAPVLDDEGTMPTH 788 (958)
Q Consensus 709 ~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~ 788 (958)
++.|+..+ .++....+.|..+||.|+.|||.+. |||||||.-||||..+..+||+|||.++..... .
T Consensus 200 ~~VLka~~--~itp~llv~Wsk~IA~GM~YLH~hK---IIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~--------S 266 (904)
T KOG4721|consen 200 YEVLKAGR--PITPSLLVDWSKGIAGGMNYLHLHK---IIHRDLKSPNILISYDDVVKISDFGTSKELSDK--------S 266 (904)
T ss_pred HHHHhccC--ccCHHHHHHHHHHhhhhhHHHHHhh---HhhhccCCCceEeeccceEEeccccchHhhhhh--------h
Confidence 99997654 4888899999999999999999999 999999999999999999999999999865321 2
Q ss_pred eeeeccCCCCccChhhhccCCCCCcchhhhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcCcchhhhcccC-CCCChHH
Q 002158 789 VSTIVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVLLELLTGMQPISHGKNIVREVNVARDSGMVFSIIDNRM-GSYPSEC 867 (958)
Q Consensus 789 ~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gv~l~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~i~~~~-~~~~~~~ 867 (958)
....++||..|||||+++..+.+.|+|||||||+||||+||..||.+-.... .++-+-.+.+ ...|..|
T Consensus 267 TkMSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssA----------IIwGVGsNsL~LpvPstc 336 (904)
T KOG4721|consen 267 TKMSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSA----------IIWGVGSNSLHLPVPSTC 336 (904)
T ss_pred hhhhhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchhe----------eEEeccCCcccccCcccC
Confidence 2345889999999999999999999999999999999999999997533211 1111111222 3458899
Q ss_pred HHHHHHHHHHccccCCCCCCCHHHHHHHHHHh
Q 002158 868 VERFVTLALRCCHDKPEHRPSMSDVVRELENI 899 (958)
Q Consensus 868 ~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 899 (958)
|+.+.-|+++||+..|+.||++.+|+.+|.-.
T Consensus 337 P~GfklL~Kqcw~sKpRNRPSFrqil~HldIa 368 (904)
T KOG4721|consen 337 PDGFKLLLKQCWNSKPRNRPSFRQILLHLDIA 368 (904)
T ss_pred chHHHHHHHHHHhcCCCCCccHHHHHHHHhhc
Confidence 99999999999999999999999999998653
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-41 Score=360.41 Aligned_cols=256 Identities=28% Similarity=0.474 Sum_probs=208.4
Q ss_pred CCCCCceeeeeCCeEEEEEEECC-CcEEEEEEeccCChhcHHHHHHHHHHHHccCCCCcceEEEEEEeCC--eEEEEEEe
Q 002158 626 YFSSSTQVGQGGYGKVYKGILSD-NTTVAIKRAEEGSLQGQNEFLTEIKLLSRLHHRNLVSLLGYCDEEG--EQMLVYEF 702 (958)
Q Consensus 626 ~~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~--~~~lV~E~ 702 (958)
++...+.||+|+||+||++...+ |+..|||.+........+.+.+|+.+|++++|||||+.+|...... .+++.|||
T Consensus 18 ~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~mEy 97 (313)
T KOG0198|consen 18 NWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFMEY 97 (313)
T ss_pred hhhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeeeec
Confidence 45567889999999999999864 8999999987653333566889999999999999999999855444 68999999
Q ss_pred cCCCCHHHHhccCCCCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEecC-CCCeEEeeeeeecccccCCC
Q 002158 703 VPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDS-NLNAKVADFGLSRLAPVLDD 781 (958)
Q Consensus 703 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~-~~~~kl~DFGla~~~~~~~~ 781 (958)
+++|+|.+++.+.+. .+++..+.++..||++||+|||+++ ||||||||+|||++. ++.+||+|||+++.......
T Consensus 98 ~~~GsL~~~~~~~g~-~l~E~~v~~ytr~iL~GL~ylHs~g---~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~~~ 173 (313)
T KOG0198|consen 98 APGGSLSDLIKRYGG-KLPEPLVRRYTRQILEGLAYLHSKG---IVHCDIKPANILLDPSNGDVKLADFGLAKKLESKGT 173 (313)
T ss_pred cCCCcHHHHHHHcCC-CCCHHHHHHHHHHHHHHHHHHHhCC---EeccCcccceEEEeCCCCeEEeccCccccccccccc
Confidence 999999999987765 6999999999999999999999999 999999999999999 79999999999986542111
Q ss_pred CCCccceeeeeccCCCCccChhhhccC-CCCCcchhhhHHHHHHHHHhCCCCCCCC-chhHHHHHHHhhcCcchhhhccc
Q 002158 782 EGTMPTHVSTIVKGTPGYLDPEYFLTH-KLTDKSDVYSLGVVLLELLTGMQPISHG-KNIVREVNVARDSGMVFSIIDNR 859 (958)
Q Consensus 782 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DV~S~Gv~l~elltG~~P~~~~-~~~~~~~~~~~~~~~~~~~i~~~ 859 (958)
.......+.||+.|||||++..+ ....++||||+||++.||+||+.||... ........... ...
T Consensus 174 ----~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~~~~~~~~ig~---------~~~ 240 (313)
T KOG0198|consen 174 ----KSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFFEEAEALLLIGR---------EDS 240 (313)
T ss_pred ----cccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhcchHHHHHHHhc---------cCC
Confidence 12223457799999999999964 3445999999999999999999999752 11111111111 112
Q ss_pred CCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 002158 860 MGSYPSECVERFVTLALRCCHDKPEHRPSMSDVVRELEN 898 (958)
Q Consensus 860 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 898 (958)
.+.+|...+.+..+++.+|+..||++|||+++++++...
T Consensus 241 ~P~ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf~ 279 (313)
T KOG0198|consen 241 LPEIPDSLSDEAKDFLRKCFKRDPEKRPTAEELLEHPFL 279 (313)
T ss_pred CCCCCcccCHHHHHHHHHHhhcCcccCcCHHHHhhChhh
Confidence 346677888999999999999999999999999987443
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-40 Score=350.35 Aligned_cols=264 Identities=24% Similarity=0.336 Sum_probs=215.0
Q ss_pred cCCCCCceeeeeCCeEEEEEEE-CCCcEEEEEEeccCChh-cHHHHHHHHHHHHccCCCCcceEEEEEEeCCeEEEEEEe
Q 002158 625 AYFSSSTQVGQGGYGKVYKGIL-SDNTTVAIKRAEEGSLQ-GQNEFLTEIKLLSRLHHRNLVSLLGYCDEEGEQMLVYEF 702 (958)
Q Consensus 625 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E~ 702 (958)
+.|+..+.||.|..++||+|+. +.++.||||++.-+.-. +.+.+.+|+..|+.++||||++++..|..+..+|+||.|
T Consensus 26 ~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvVmpf 105 (516)
T KOG0582|consen 26 KDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVVMPF 105 (516)
T ss_pred cceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEeehh
Confidence 4677888999999999999995 47899999998765333 357889999999999999999999999999999999999
Q ss_pred cCCCCHHHHhccCCCCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEecCCCCeEEeeeeeecccccCCCC
Q 002158 703 VPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSRLAPVLDDE 782 (958)
Q Consensus 703 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~ 782 (958)
|.+|++.++++..-...+++..+..|..++++||.|||++| .||||||+.||||+.+|.|||+|||.+-.+...
T Consensus 106 Ma~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~G---~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~~--- 179 (516)
T KOG0582|consen 106 MAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQNG---HIHRDVKAGNILIDSDGTVKLADFGVSASLFDS--- 179 (516)
T ss_pred hcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhcC---ceecccccccEEEcCCCcEEEcCceeeeeeccc---
Confidence 99999999998776667999999999999999999999999 999999999999999999999999987654332
Q ss_pred CCccceeeeeccCCCCccChhhhcc--CCCCCcchhhhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcCcchhhhcccC
Q 002158 783 GTMPTHVSTIVKGTPGYLDPEYFLT--HKLTDKSDVYSLGVVLLELLTGMQPISHGKNIVREVNVARDSGMVFSIIDNRM 860 (958)
Q Consensus 783 ~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DV~S~Gv~l~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~i~~~~ 860 (958)
+.........+.||+.|||||+++. ..|+.|+||||||++..||.+|..||.........+........... .....
T Consensus 180 G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvLl~tLqn~pp~~~-t~~~~ 258 (516)
T KOG0582|consen 180 GDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVLLLTLQNDPPTLL-TSGLD 258 (516)
T ss_pred CceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHHHHHhcCCCCCcc-cccCC
Confidence 2222222266789999999999754 46899999999999999999999999876655444443332221111 00000
Q ss_pred CCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 002158 861 GSYPSECVERFVTLALRCCHDKPEHRPSMSDVVRE 895 (958)
Q Consensus 861 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 895 (958)
.+........+.+++..|++.||++|||+++++++
T Consensus 259 ~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh 293 (516)
T KOG0582|consen 259 KDEDKKFSKSFREMIALCLVKDPSKRPTASKLLKH 293 (516)
T ss_pred hHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhcc
Confidence 12233456689999999999999999999999864
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-41 Score=338.49 Aligned_cols=258 Identities=26% Similarity=0.346 Sum_probs=205.2
Q ss_pred CCCCCceeeeeCCeEEEEEEEC-CCcEEEEEEeccCCh--hcHHHHHHHHHHHHccCCCCcceEEEEEEeCCeEEEEEEe
Q 002158 626 YFSSSTQVGQGGYGKVYKGILS-DNTTVAIKRAEEGSL--QGQNEFLTEIKLLSRLHHRNLVSLLGYCDEEGEQMLVYEF 702 (958)
Q Consensus 626 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E~ 702 (958)
.|+...++|+|+||+|||++.+ +|+.||||++..... .-.+-.++|+++|++++|+|+|.++.+|......+||+||
T Consensus 3 kYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE~ 82 (396)
T KOG0593|consen 3 KYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFEY 82 (396)
T ss_pred HHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEeee
Confidence 4556678999999999999987 599999999976432 2234578999999999999999999999999999999999
Q ss_pred cCCCCHHHHhccCCCCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEecCCCCeEEeeeeeecccccCCCC
Q 002158 703 VPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSRLAPVLDDE 782 (958)
Q Consensus 703 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~ 782 (958)
|+. ++-+-|.... ..++.+.+.+++.|+++|+.|+|+++ +|||||||+||||+.+|.+||||||+|+.+...
T Consensus 83 ~dh-TvL~eLe~~p-~G~~~~~vk~~l~Q~l~ai~~cHk~n---~IHRDIKPENILit~~gvvKLCDFGFAR~L~~p--- 154 (396)
T KOG0593|consen 83 CDH-TVLHELERYP-NGVPSELVKKYLYQLLKAIHFCHKNN---CIHRDIKPENILITQNGVVKLCDFGFARTLSAP--- 154 (396)
T ss_pred cch-HHHHHHHhcc-CCCCHHHHHHHHHHHHHHhhhhhhcC---eecccCChhheEEecCCcEEeccchhhHhhcCC---
Confidence 976 4444444332 33889999999999999999999999 999999999999999999999999999987432
Q ss_pred CCccceeeeeccCCCCccChhhhcc-CCCCCcchhhhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcCcch----hhh-
Q 002158 783 GTMPTHVSTIVKGTPGYLDPEYFLT-HKLTDKSDVYSLGVVLLELLTGMQPISHGKNIVREVNVARDSGMVF----SII- 856 (958)
Q Consensus 783 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DV~S~Gv~l~elltG~~P~~~~~~~~~~~~~~~~~~~~~----~~i- 856 (958)
....+..+.|..|.|||.+.+ .+|...+||||.||++.||++|.+-|.+..++.+.......-+... ++.
T Consensus 155 ----gd~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~ 230 (396)
T KOG0593|consen 155 ----GDNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFS 230 (396)
T ss_pred ----cchhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhc
Confidence 223445678999999999988 6899999999999999999999999987777665544333322211 000
Q ss_pred ---------cccC---CCC---ChHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 002158 857 ---------DNRM---GSY---PSECVERFVTLALRCCHDKPEHRPSMSDVVRE 895 (958)
Q Consensus 857 ---------~~~~---~~~---~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 895 (958)
-+.. ... -+....-+.++++.|++.||++|++-+|++.+
T Consensus 231 ~N~~F~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~H 284 (396)
T KOG0593|consen 231 SNPFFHGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLHH 284 (396)
T ss_pred cCCceeeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhcC
Confidence 0000 001 12344578899999999999999999999854
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-41 Score=365.32 Aligned_cols=250 Identities=25% Similarity=0.396 Sum_probs=214.8
Q ss_pred cCCCCCceeeeeCCeEEEEEEEC-CCcEEEEEEeccCChhcHHHHHHHHHHHHccCCCCcceEEEEEEeCCeEEEEEEec
Q 002158 625 AYFSSSTQVGQGGYGKVYKGILS-DNTTVAIKRAEEGSLQGQNEFLTEIKLLSRLHHRNLVSLLGYCDEEGEQMLVYEFV 703 (958)
Q Consensus 625 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E~~ 703 (958)
..|....+||+|+.|.||.|... +++.||||++........+-..+|+.+|+..+|+|||++++.|...+..|+|||||
T Consensus 273 ~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVMEym 352 (550)
T KOG0578|consen 273 SKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVMEYM 352 (550)
T ss_pred hhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEeec
Confidence 45666778999999999999854 78899999998766555666889999999999999999999999999999999999
Q ss_pred CCCCHHHHhccCCCCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEecCCCCeEEeeeeeecccccCCCCC
Q 002158 704 PNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSRLAPVLDDEG 783 (958)
Q Consensus 704 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 783 (958)
+||+|.|.+.... +++.++..|+.++++||+|||.++ |+|||||.+|||++.+|.+||+|||++..+.....
T Consensus 353 ~ggsLTDvVt~~~---~~E~qIA~Icre~l~aL~fLH~~g---IiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~-- 424 (550)
T KOG0578|consen 353 EGGSLTDVVTKTR---MTEGQIAAICREILQGLKFLHARG---IIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQS-- 424 (550)
T ss_pred CCCchhhhhhccc---ccHHHHHHHHHHHHHHHHHHHhcc---eeeeccccceeEeccCCcEEEeeeeeeeccccccC--
Confidence 9999999997543 899999999999999999999999 99999999999999999999999999976543221
Q ss_pred CccceeeeeccCCCCccChhhhccCCCCCcchhhhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcCcchhhhcccCCCC
Q 002158 784 TMPTHVSTIVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVLLELLTGMQPISHGKNIVREVNVARDSGMVFSIIDNRMGSY 863 (958)
Q Consensus 784 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gv~l~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~ 863 (958)
.....+||+.|||||++....|.+|.||||||++++||+.|++||.....+............. -..
T Consensus 425 -----KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrAlyLIa~ng~P~--------lk~ 491 (550)
T KOG0578|consen 425 -----KRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPK--------LKN 491 (550)
T ss_pred -----ccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCChHHHHHHHhhcCCCC--------cCC
Confidence 2345679999999999999999999999999999999999999998766555444332221111 123
Q ss_pred ChHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 002158 864 PSECVERFVTLALRCCHDKPEHRPSMSDVVRE 895 (958)
Q Consensus 864 ~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 895 (958)
+......+.+++.+||+.|+++||++.|++++
T Consensus 492 ~~klS~~~kdFL~~cL~~dv~~RasA~eLL~H 523 (550)
T KOG0578|consen 492 PEKLSPELKDFLDRCLVVDVEQRASAKELLEH 523 (550)
T ss_pred ccccCHHHHHHHHHHhhcchhcCCCHHHHhcC
Confidence 56778899999999999999999999999986
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-40 Score=370.60 Aligned_cols=262 Identities=28% Similarity=0.466 Sum_probs=208.4
Q ss_pred HHcCCCCCceeeeeCCeEEEEEEEC------CCcEEEEEEeccCC-hhcHHHHHHHHHHHHcc-CCCCcceEEEEEEeC-
Q 002158 623 ATAYFSSSTQVGQGGYGKVYKGILS------DNTTVAIKRAEEGS-LQGQNEFLTEIKLLSRL-HHRNLVSLLGYCDEE- 693 (958)
Q Consensus 623 ~~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~- 693 (958)
..++|...+.||+|+||.||+|.+. +++.||||++.... ....+.+.+|+++++++ +||||++++++|...
T Consensus 5 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~ 84 (338)
T cd05102 5 PRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKPN 84 (338)
T ss_pred chhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCCC
Confidence 4567888899999999999999741 35689999987543 23346789999999999 899999999998764
Q ss_pred CeEEEEEEecCCCCHHHHhccCC---------------------------------------------------------
Q 002158 694 GEQMLVYEFVPNGTLRDWLSGRT--------------------------------------------------------- 716 (958)
Q Consensus 694 ~~~~lV~E~~~~gsL~~~l~~~~--------------------------------------------------------- 716 (958)
+..++||||+++|+|.+++....
T Consensus 85 ~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (338)
T cd05102 85 GPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETD 164 (338)
T ss_pred CceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhcc
Confidence 46899999999999999997432
Q ss_pred ---CCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEecCCCCeEEeeeeeecccccCCCCCCccceeeeec
Q 002158 717 ---KENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSRLAPVLDDEGTMPTHVSTIV 793 (958)
Q Consensus 717 ---~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~ 793 (958)
...+++.++..++.|+++||+|||+.+ |+||||||+|||++.++.+||+|||+++....... .......
T Consensus 165 ~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~-----~~~~~~~ 236 (338)
T cd05102 165 DLWKSPLTMEDLICYSFQVARGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPD-----YVRKGSA 236 (338)
T ss_pred ccccCCCCHHHHHHHHHHHHHHHHHHHHCC---EECCCCccceEEEcCCCcEEEeecccccccccCcc-----hhcccCC
Confidence 124788899999999999999999998 99999999999999999999999999985432111 0111223
Q ss_pred cCCCCccChhhhccCCCCCcchhhhHHHHHHHHHh-CCCCCCCCchhHHHHHHHhhcCcchhhhcccCCCCChHHHHHHH
Q 002158 794 KGTPGYLDPEYFLTHKLTDKSDVYSLGVVLLELLT-GMQPISHGKNIVREVNVARDSGMVFSIIDNRMGSYPSECVERFV 872 (958)
Q Consensus 794 ~gt~~y~aPE~~~~~~~~~~~DV~S~Gv~l~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~l~ 872 (958)
.++..|+|||++.+..++.++|||||||++|||++ |..||............... ......+..++..+.
T Consensus 237 ~~~~~y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~---------~~~~~~~~~~~~~l~ 307 (338)
T cd05102 237 RLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRLKD---------GTRMRAPENATPEIY 307 (338)
T ss_pred CCCccccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHhc---------CCCCCCCCCCCHHHH
Confidence 46788999999999999999999999999999997 99999754322111111111 111122445667899
Q ss_pred HHHHHccccCCCCCCCHHHHHHHHHHhHh
Q 002158 873 TLALRCCHDKPEHRPSMSDVVRELENILK 901 (958)
Q Consensus 873 ~li~~cl~~dP~~RPs~~evl~~L~~~~~ 901 (958)
+++.+||+.||++||++.|+++.|++++.
T Consensus 308 ~li~~cl~~dp~~RPs~~el~~~l~~~~~ 336 (338)
T cd05102 308 RIMLACWQGDPKERPTFSALVEILGDLLQ 336 (338)
T ss_pred HHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 99999999999999999999999998775
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-41 Score=356.51 Aligned_cols=259 Identities=23% Similarity=0.336 Sum_probs=211.5
Q ss_pred HcCCCCCceeeeeCCeEEEEEEEC-CCcEEEEEEeccCChh-cHHHHHHHHHHHHccC-CCCcceEEEEEEeCC-eEEEE
Q 002158 624 TAYFSSSTQVGQGGYGKVYKGILS-DNTTVAIKRAEEGSLQ-GQNEFLTEIKLLSRLH-HRNLVSLLGYCDEEG-EQMLV 699 (958)
Q Consensus 624 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~~-~~~lV 699 (958)
.++|...++||.|+||.||+|+.. .|..||||+++..-.. +.---++|+..|++++ |||||++.+++.+.+ .+++|
T Consensus 9 m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~fV 88 (538)
T KOG0661|consen 9 MDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILYFV 88 (538)
T ss_pred HHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEeee
Confidence 345667789999999999999965 6889999999875322 1223468999999998 999999999998887 99999
Q ss_pred EEecCCCCHHHHhccCCCCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEecCCCCeEEeeeeeecccccC
Q 002158 700 YEFVPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSRLAPVL 779 (958)
Q Consensus 700 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~~~~~ 779 (958)
|||| ..+|+++++++ ...+++..+..|+.||.+||+|+|.+| +.|||+||+|||+.....+||+|||+||....
T Consensus 89 fE~M-d~NLYqLmK~R-~r~fse~~irnim~QilqGL~hiHk~G---fFHRDlKPENiLi~~~~~iKiaDFGLARev~S- 162 (538)
T KOG0661|consen 89 FEFM-DCNLYQLMKDR-NRLFSESDIRNIMYQILQGLAHIHKHG---FFHRDLKPENILISGNDVIKIADFGLAREVRS- 162 (538)
T ss_pred HHhh-hhhHHHHHhhc-CCcCCHHHHHHHHHHHHHHHHHHHhcC---cccccCChhheEecccceeEeccccccccccc-
Confidence 9999 57999999987 567999999999999999999999999 99999999999999999999999999996543
Q ss_pred CCCCCccceeeeeccCCCCccChhhhc-cCCCCCcchhhhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcCcchh----
Q 002158 780 DDEGTMPTHVSTIVKGTPGYLDPEYFL-THKLTDKSDVYSLGVVLLELLTGMQPISHGKNIVREVNVARDSGMVFS---- 854 (958)
Q Consensus 780 ~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DV~S~Gv~l~elltG~~P~~~~~~~~~~~~~~~~~~~~~~---- 854 (958)
....+..+.|..|+|||++. .+-|+.+.||||+||+++|+.+-++-|.+..+..+..+.+.--|...+
T Consensus 163 -------kpPYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~ 235 (538)
T KOG0661|consen 163 -------KPPYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWP 235 (538)
T ss_pred -------CCCcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccch
Confidence 22345567899999999986 457899999999999999999999888877776666554433222110
Q ss_pred -------hhcccCC--------CCChHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 002158 855 -------IIDNRMG--------SYPSECVERFVTLALRCCHDKPEHRPSMSDVVRE 895 (958)
Q Consensus 855 -------~i~~~~~--------~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 895 (958)
.+.-.++ ..-+.+..+..+++.+|+..||++|||++|++++
T Consensus 236 eg~~La~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~ 291 (538)
T KOG0661|consen 236 EGYNLASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQH 291 (538)
T ss_pred hHHHHHHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcC
Confidence 1111111 1122477889999999999999999999999985
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=358.70 Aligned_cols=247 Identities=29% Similarity=0.451 Sum_probs=213.5
Q ss_pred cCCCCCceeeeeCCeEEEEEEEC-CCcEEEEEEeccCC--hhcHHHHHHHHHHHHccCCCCcceEEEEEEeCCeEEEEEE
Q 002158 625 AYFSSSTQVGQGGYGKVYKGILS-DNTTVAIKRAEEGS--LQGQNEFLTEIKLLSRLHHRNLVSLLGYCDEEGEQMLVYE 701 (958)
Q Consensus 625 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E 701 (958)
++|...+.||+|+||+||||+.+ +.+.||+|.+.+.. .++.+...+|+++++.++|||||.++++|+...+.++|.|
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte 81 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTE 81 (808)
T ss_pred cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEeh
Confidence 45777788999999999999977 68899999987643 3445678999999999999999999999999999999999
Q ss_pred ecCCCCHHHHhccCCCCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEecCCCCeEEeeeeeecccccCCC
Q 002158 702 FVPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSRLAPVLDD 781 (958)
Q Consensus 702 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~ 781 (958)
|+.| +|..+|.... .++++.+..++.|++.||.|||+.+ |+|||+||+|||++..|.+|++|||+|+....
T Consensus 82 ~a~g-~L~~il~~d~--~lpEe~v~~~a~~LVsaL~yLhs~r---ilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~--- 152 (808)
T KOG0597|consen 82 YAVG-DLFTILEQDG--KLPEEQVRAIAYDLVSALYYLHSNR---ILHRDMKPQNILLEKGGTLKLCDFGLARAMST--- 152 (808)
T ss_pred hhhh-hHHHHHHhcc--CCCHHHHHHHHHHHHHHHHHHHhcC---cccccCCcceeeecCCCceeechhhhhhhccc---
Confidence 9965 9999997654 4999999999999999999999999 99999999999999999999999999996532
Q ss_pred CCCccceeeeeccCCCCccChhhhccCCCCCcchhhhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcCcchhhhcccCC
Q 002158 782 EGTMPTHVSTIVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVLLELLTGMQPISHGKNIVREVNVARDSGMVFSIIDNRMG 861 (958)
Q Consensus 782 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gv~l~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~i~~~~~ 861 (958)
.....+.+.||+-|||||...++.|+..+|.||+||++||+++|++||.. ..+.+.+..... ...
T Consensus 153 ----~t~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a-~si~~Lv~~I~~----------d~v 217 (808)
T KOG0597|consen 153 ----NTSVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYA-RSITQLVKSILK----------DPV 217 (808)
T ss_pred ----CceeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchH-HHHHHHHHHHhc----------CCC
Confidence 24556778999999999999999999999999999999999999999963 333333333222 222
Q ss_pred CCChHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 002158 862 SYPSECVERFVTLALRCCHDKPEHRPSMSDVVRE 895 (958)
Q Consensus 862 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 895 (958)
..|......+..++...+.+||.+|.+..+++.+
T Consensus 218 ~~p~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~H 251 (808)
T KOG0597|consen 218 KPPSTASSSFVNFLQGLLIKDPAQRLTWTDLLGH 251 (808)
T ss_pred CCcccccHHHHHHHHHHhhcChhhcccHHHHhcC
Confidence 3466788889999999999999999999999876
|
|
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-40 Score=389.50 Aligned_cols=264 Identities=33% Similarity=0.501 Sum_probs=217.3
Q ss_pred cCCCCCceeeeeCCeEEEEEEECC--Cc----EEEEEEeccC-ChhcHHHHHHHHHHHHccCCCCcceEEEEEEeCCeEE
Q 002158 625 AYFSSSTQVGQGGYGKVYKGILSD--NT----TVAIKRAEEG-SLQGQNEFLTEIKLLSRLHHRNLVSLLGYCDEEGEQM 697 (958)
Q Consensus 625 ~~~~~~~~lg~G~~g~Vy~~~~~~--~~----~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~ 697 (958)
...+..+.||+|+||.||+|...+ +. .||||.++.. +.++..+|.+|..+|+.++|||||+++|+|.+.+..+
T Consensus 692 ~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~~~ 771 (1025)
T KOG1095|consen 692 KNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGPPL 771 (1025)
T ss_pred hheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCCcE
Confidence 344556789999999999999653 43 4999999875 4566778999999999999999999999999999999
Q ss_pred EEEEecCCCCHHHHhccCC-----CCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEecCCCCeEEeeeee
Q 002158 698 LVYEFVPNGTLRDWLSGRT-----KENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSNLNAKVADFGL 772 (958)
Q Consensus 698 lV~E~~~~gsL~~~l~~~~-----~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~~~~kl~DFGl 772 (958)
+++|||++|+|..+|++.+ ...++....+.++.|||+|+.||++++ +|||||.++|+|+++...|||+|||+
T Consensus 772 i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~---fvHRDLAaRNCLL~~~r~VKIaDFGl 848 (1025)
T KOG1095|consen 772 ILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKH---FVHRDLAARNCLLDERRVVKIADFGL 848 (1025)
T ss_pred EEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCC---CcCcchhhhheeecccCcEEEcccch
Confidence 9999999999999998652 345899999999999999999999999 99999999999999999999999999
Q ss_pred ecccccCCCCCCccceeeeeccCCCCccChhhhccCCCCCcchhhhHHHHHHHHHh-CCCCCCCCchhHHHHHHHhhcCc
Q 002158 773 SRLAPVLDDEGTMPTHVSTIVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVLLELLT-GMQPISHGKNIVREVNVARDSGM 851 (958)
Q Consensus 773 a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gv~l~ellt-G~~P~~~~~~~~~~~~~~~~~~~ 851 (958)
|+.....+-. .......=..+|||||.++.+.++.|+|||||||++||++| |..||.+..+..-... ..
T Consensus 849 ArDiy~~~yy-----r~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~v~~~-~~---- 918 (1025)
T KOG1095|consen 849 ARDIYDKDYY-----RKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEVLLD-VL---- 918 (1025)
T ss_pred hHhhhhchhe-----eccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchHHHHHH-HH----
Confidence 9943221110 00001122358999999999999999999999999999999 8999976544322221 11
Q ss_pred chhhhcccCCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHhhCCCC
Q 002158 852 VFSIIDNRMGSYPSECVERFVTLALRCCHDKPEHRPSMSDVVRELENILKMFPET 906 (958)
Q Consensus 852 ~~~~i~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~~~~ 906 (958)
.+.+...|..||+.++++|.+||+.+|++||++..+++++.++.......
T Consensus 919 -----~ggRL~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~~~~~~~ 968 (1025)
T KOG1095|consen 919 -----EGGRLDPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAISNAALGT 968 (1025)
T ss_pred -----hCCccCCCCCCChHHHHHHHHHccCChhhCccHHHHHhhhhhhhhhhccC
Confidence 12233458899999999999999999999999999999999988665443
|
|
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-40 Score=367.62 Aligned_cols=269 Identities=30% Similarity=0.479 Sum_probs=220.1
Q ss_pred HHHHHHHcCCCCCceeeeeCCeEEEEEEECC--C--cE-EEEEEeccC---ChhcHHHHHHHHHHHHccCCCCcceEEEE
Q 002158 618 KELAMATAYFSSSTQVGQGGYGKVYKGILSD--N--TT-VAIKRAEEG---SLQGQNEFLTEIKLLSRLHHRNLVSLLGY 689 (958)
Q Consensus 618 ~el~~~~~~~~~~~~lg~G~~g~Vy~~~~~~--~--~~-vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~~~ 689 (958)
..++...++....++||+|+||.||+|.++. + .. ||||..+.. ......+|.+|+++|++++|||||+++|+
T Consensus 150 ~~Wel~H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGV 229 (474)
T KOG0194|consen 150 QKWELSHSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGV 229 (474)
T ss_pred cccEEeccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEE
Confidence 3444455566666899999999999999753 2 23 899998852 35567789999999999999999999999
Q ss_pred EEeCCeEEEEEEecCCCCHHHHhccCCCCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEecCCCCeEEee
Q 002158 690 CDEEGEQMLVYEFVPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSNLNAKVAD 769 (958)
Q Consensus 690 ~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~~~~kl~D 769 (958)
+..+..+++|||+|+||+|.++|+.... .++..++++++.++|+||+|||+++ +|||||.++|+|++.++.+||+|
T Consensus 230 a~~~~Pl~ivmEl~~gGsL~~~L~k~~~-~v~~~ek~~~~~~AA~Gl~YLh~k~---~IHRDIAARNcL~~~~~~vKISD 305 (474)
T KOG0194|consen 230 AVLEEPLMLVMELCNGGSLDDYLKKNKK-SLPTLEKLRFCYDAARGLEYLHSKN---CIHRDIAARNCLYSKKGVVKISD 305 (474)
T ss_pred EcCCCccEEEEEecCCCcHHHHHHhCCC-CCCHHHHHHHHHHHHhHHHHHHHCC---CcchhHhHHHheecCCCeEEeCc
Confidence 9999999999999999999999986554 5999999999999999999999999 99999999999999999999999
Q ss_pred eeeecccccCCCCCCccceeeeeccCCCCccChhhhccCCCCCcchhhhHHHHHHHHHh-CCCCCCCCchhHHHHHHHhh
Q 002158 770 FGLSRLAPVLDDEGTMPTHVSTIVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVLLELLT-GMQPISHGKNIVREVNVARD 848 (958)
Q Consensus 770 FGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gv~l~ellt-G~~P~~~~~~~~~~~~~~~~ 848 (958)
||+++....... ......-..+|+|||.+....|+.++|||||||++||+++ |..||.+........... .
T Consensus 306 FGLs~~~~~~~~-------~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~v~~kI~-~ 377 (474)
T KOG0194|consen 306 FGLSRAGSQYVM-------KKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNYEVKAKIV-K 377 (474)
T ss_pred cccccCCcceee-------ccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHHHHHHHHH-h
Confidence 999875431110 0001124568999999999999999999999999999999 889998665432221111 1
Q ss_pred cCcchhhhcccCCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHhhCCCC
Q 002158 849 SGMVFSIIDNRMGSYPSECVERFVTLALRCCHDKPEHRPSMSDVVRELENILKMFPET 906 (958)
Q Consensus 849 ~~~~~~~i~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~~~~ 906 (958)
.......+...|..+..++.+||..+|++||+|.++.+.++.+.+.....
T Consensus 378 --------~~~r~~~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~~~~~~~ 427 (474)
T KOG0194|consen 378 --------NGYRMPIPSKTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEALEKKKEAF 427 (474)
T ss_pred --------cCccCCCCCCCHHHHHHHHHHhccCChhhccCHHHHHHHHHHHHhccccc
Confidence 12223446678899999999999999999999999999999988766543
|
|
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-40 Score=355.54 Aligned_cols=265 Identities=29% Similarity=0.438 Sum_probs=216.3
Q ss_pred HHcCCCCCceeeeeCCeEEEEEEECCCcEEEEEEeccCChhc-HHHHHHHHHHHHccCCCCcceEEEEEEeCCeEEEEEE
Q 002158 623 ATAYFSSSTQVGQGGYGKVYKGILSDNTTVAIKRAEEGSLQG-QNEFLTEIKLLSRLHHRNLVSLLGYCDEEGEQMLVYE 701 (958)
Q Consensus 623 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~-~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E 701 (958)
........++||+|-||+|..+....+..||||+++...... +++|.+|+++|.+++||||++++|+|..++.+++|+|
T Consensus 536 PRs~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~E 615 (807)
T KOG1094|consen 536 PRSRLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMITE 615 (807)
T ss_pred chhheehhhhhcCcccceeEEEEecCceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHHH
Confidence 334456678999999999999999888999999998865444 5789999999999999999999999999999999999
Q ss_pred ecCCCCHHHHhccCCCCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEecCCCCeEEeeeeeecccccCCC
Q 002158 702 FVPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSRLAPVLDD 781 (958)
Q Consensus 702 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~ 781 (958)
||++|+|..++.......+..+...+|+.|||.|++||.+.. +||||+.++|+|+|.++++||+|||++|-+...+.
T Consensus 616 YmEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes~n---fVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg~y 692 (807)
T KOG1094|consen 616 YMENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLESLN---FVHRDLATRNCLVDGEFTIKIADFGMSRNLYSGDY 692 (807)
T ss_pred HHhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHhhc---hhhccccccceeecCcccEEecCcccccccccCCc
Confidence 999999999998775544566777899999999999999998 99999999999999999999999999996543321
Q ss_pred CCCccceeeeeccCCCCccChhhhccCCCCCcchhhhHHHHHHHHHh--CCCCCCCCchhHHHHHHHhhcCcchh-hhcc
Q 002158 782 EGTMPTHVSTIVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVLLELLT--GMQPISHGKNIVREVNVARDSGMVFS-IIDN 858 (958)
Q Consensus 782 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gv~l~ellt--G~~P~~~~~~~~~~~~~~~~~~~~~~-~i~~ 858 (958)
.+.....+=..+|||||.+..+++++++|||+||+++||+++ ...||....+.... ...+.+.. .-..
T Consensus 693 -----y~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~vv----en~~~~~~~~~~~ 763 (807)
T KOG1094|consen 693 -----YRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQVV----ENAGEFFRDQGRQ 763 (807)
T ss_pred -----eeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHHHH----HhhhhhcCCCCcc
Confidence 222223445679999999999999999999999999999987 67788654322111 11111111 0011
Q ss_pred cCCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHh
Q 002158 859 RMGSYPSECVERFVTLALRCCHDKPEHRPSMSDVVRELENI 899 (958)
Q Consensus 859 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 899 (958)
.....|.-|+..+++++.+||..|-++||+++++...|++.
T Consensus 764 ~~l~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~~ 804 (807)
T KOG1094|consen 764 VVLSRPPACPQGLYELMLRCWRRESEQRPSFEQLHLFLQED 804 (807)
T ss_pred eeccCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHHh
Confidence 11345788999999999999999999999999999988764
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-40 Score=330.50 Aligned_cols=236 Identities=25% Similarity=0.369 Sum_probs=206.1
Q ss_pred cCCCCCceeeeeCCeEEEEEEEC-CCcEEEEEEeccCChh---cHHHHHHHHHHHHccCCCCcceEEEEEEeCCeEEEEE
Q 002158 625 AYFSSSTQVGQGGYGKVYKGILS-DNTTVAIKRAEEGSLQ---GQNEFLTEIKLLSRLHHRNLVSLLGYCDEEGEQMLVY 700 (958)
Q Consensus 625 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~ 700 (958)
++|+..+.||.|+||+|..++.+ +|..+|+|++.....- ..+...+|..+|+.+.||.++++++.+.+.+..||||
T Consensus 44 ~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymvm 123 (355)
T KOG0616|consen 44 QDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMVM 123 (355)
T ss_pred hhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEEE
Confidence 35777889999999999999987 6889999999875433 3445778999999999999999999999999999999
Q ss_pred EecCCCCHHHHhccCCCCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEecCCCCeEEeeeeeecccccCC
Q 002158 701 EFVPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSRLAPVLD 780 (958)
Q Consensus 701 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~ 780 (958)
||++||.|..+++..++ +++..+..+|.||+.||+|||+.+ |++||+||+|||+|.+|.+||+|||.|+...
T Consensus 124 eyv~GGElFS~Lrk~~r--F~e~~arFYAAeivlAleylH~~~---iiYRDLKPENiLlD~~G~iKitDFGFAK~v~--- 195 (355)
T KOG0616|consen 124 EYVPGGELFSYLRKSGR--FSEPHARFYAAEIVLALEYLHSLD---IIYRDLKPENLLLDQNGHIKITDFGFAKRVS--- 195 (355)
T ss_pred eccCCccHHHHHHhcCC--CCchhHHHHHHHHHHHHHHHHhcC---eeeccCChHHeeeccCCcEEEEeccceEEec---
Confidence 99999999999976554 999999999999999999999999 9999999999999999999999999998762
Q ss_pred CCCCccceeeeeccCCCCccChhhhccCCCCCcchhhhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcCcchhhhcccC
Q 002158 781 DEGTMPTHVSTIVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVLLELLTGMQPISHGKNIVREVNVARDSGMVFSIIDNRM 860 (958)
Q Consensus 781 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gv~l~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~i~~~~ 860 (958)
..+.+.+||+.|+|||++....|..++|.|||||++|||+.|.+||.....+.. ++.|-..-
T Consensus 196 -------~rT~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~~~i-----------Y~KI~~~~ 257 (355)
T KOG0616|consen 196 -------GRTWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNPIQI-----------YEKILEGK 257 (355)
T ss_pred -------CcEEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCChHHH-----------HHHHHhCc
Confidence 235678999999999999999999999999999999999999999986554222 12222233
Q ss_pred CCCChHHHHHHHHHHHHccccCCCCC
Q 002158 861 GSYPSECVERFVTLALRCCHDKPEHR 886 (958)
Q Consensus 861 ~~~~~~~~~~l~~li~~cl~~dP~~R 886 (958)
-.+|.-....+.+|+...++.|-.+|
T Consensus 258 v~fP~~fs~~~kdLl~~LL~vD~t~R 283 (355)
T KOG0616|consen 258 VKFPSYFSSDAKDLLKKLLQVDLTKR 283 (355)
T ss_pred ccCCcccCHHHHHHHHHHHhhhhHhh
Confidence 35677888899999999999999999
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-40 Score=323.37 Aligned_cols=258 Identities=26% Similarity=0.366 Sum_probs=208.2
Q ss_pred CCCCCceeeeeCCeEEEEEEEC-CCcEEEEEEeccCChhc--HHHHHHHHHHHHccCCCCcceEEEEEEeCCeEEEEEEe
Q 002158 626 YFSSSTQVGQGGYGKVYKGILS-DNTTVAIKRAEEGSLQG--QNEFLTEIKLLSRLHHRNLVSLLGYCDEEGEQMLVYEF 702 (958)
Q Consensus 626 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~--~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E~ 702 (958)
+|...+.||+|.||.||+|++. +|+.||||+++.....+ .....+|++.|+.++|+||+.++++|...+..-||+||
T Consensus 3 rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfEf 82 (318)
T KOG0659|consen 3 RYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFEF 82 (318)
T ss_pred hhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEEe
Confidence 4566778999999999999965 79999999998764433 34578999999999999999999999999999999999
Q ss_pred cCCCCHHHHhccCCCCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEecCCCCeEEeeeeeecccccCCCC
Q 002158 703 VPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSRLAPVLDDE 782 (958)
Q Consensus 703 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~ 782 (958)
|+ .+|+..++++. ..++..++..++.++.+|++|||++. |+||||||.|+|++++|.+||+|||+|+.+...+..
T Consensus 83 m~-tdLe~vIkd~~-i~l~pa~iK~y~~m~LkGl~y~H~~~---IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~~~ 157 (318)
T KOG0659|consen 83 MP-TDLEVVIKDKN-IILSPADIKSYMLMTLKGLAYCHSKW---ILHRDLKPNNLLISSDGQLKIADFGLARFFGSPNRI 157 (318)
T ss_pred cc-ccHHHHhcccc-cccCHHHHHHHHHHHHHHHHHHHhhh---hhcccCCccceEEcCCCcEEeecccchhccCCCCcc
Confidence 95 69999998664 45999999999999999999999999 999999999999999999999999999987543332
Q ss_pred CCccceeeeeccCCCCccChhhhccC-CCCCcchhhhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcCcchhhhccc--
Q 002158 783 GTMPTHVSTIVKGTPGYLDPEYFLTH-KLTDKSDVYSLGVVLLELLTGMQPISHGKNIVREVNVARDSGMVFSIIDNR-- 859 (958)
Q Consensus 783 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DV~S~Gv~l~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~i~~~-- 859 (958)
. +..+-|..|.|||.+.+. .|+...||||.||++.||+-|.+-|.+..++.+.......-+......-+.
T Consensus 158 ~-------~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~~~ 230 (318)
T KOG0659|consen 158 Q-------THQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPEMT 230 (318)
T ss_pred c-------ccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCcccc
Confidence 1 222578899999999875 689999999999999999998877766666655544333222211100000
Q ss_pred ---------------CCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 002158 860 ---------------MGSYPSECVERFVTLALRCCHDKPEHRPSMSDVVRE 895 (958)
Q Consensus 860 ---------------~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 895 (958)
....-..+.....+++.+++..||.+|.++.|++++
T Consensus 231 ~lpdY~~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~ 281 (318)
T KOG0659|consen 231 SLPDYVKIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKH 281 (318)
T ss_pred ccccHHHHhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcc
Confidence 011223456677999999999999999999999974
|
|
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-39 Score=341.79 Aligned_cols=263 Identities=28% Similarity=0.439 Sum_probs=199.7
Q ss_pred CceeeeeCCeEEEEEEECCCcEEEEEEeccCChhcHHHHHHHHHHHHcc--CCCCcceEEEEEEeCC----eEEEEEEec
Q 002158 630 STQVGQGGYGKVYKGILSDNTTVAIKRAEEGSLQGQNEFLTEIKLLSRL--HHRNLVSLLGYCDEEG----EQMLVYEFV 703 (958)
Q Consensus 630 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l--~H~niv~l~~~~~~~~----~~~lV~E~~ 703 (958)
.++||+|+||.||||.+ +++.||||++.. .+...|++|-++++-. +|+||++++++-.... +++||+||.
T Consensus 215 ~eli~~Grfg~V~KaqL-~~~~VAVKifp~---~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywLVt~fh 290 (534)
T KOG3653|consen 215 LELIGRGRFGCVWKAQL-DNRLVAVKIFPE---QEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWLVTEFH 290 (534)
T ss_pred HHHhhcCccceeehhhc-cCceeEEEecCH---HHHHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeEEeeec
Confidence 45799999999999998 458999999964 4456788888888865 7999999999976655 899999999
Q ss_pred CCCCHHHHhccCCCCCchHHHHHHHHHHHHHHHHHhhhc------CCCCeeccCCCccceEecCCCCeEEeeeeeecccc
Q 002158 704 PNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTE------AHPPVFHRDIKASNILLDSNLNAKVADFGLSRLAP 777 (958)
Q Consensus 704 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~------~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~~~ 777 (958)
+.|+|.+||+... ++|....+|+..+++||+|||+. .+|+|+|||||++||||..|+++.|+|||+|..+.
T Consensus 291 ~kGsL~dyL~~nt---isw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFGLAl~~~ 367 (534)
T KOG3653|consen 291 PKGSLCDYLKANT---ISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFGLALRLE 367 (534)
T ss_pred cCCcHHHHHHhcc---ccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeeccceeEEec
Confidence 9999999998665 99999999999999999999975 36789999999999999999999999999998876
Q ss_pred cCCCCCCccceeeeeccCCCCccChhhhccCC-C-----CCcchhhhHHHHHHHHHhCCCCCCCCc------hhHHHHHH
Q 002158 778 VLDDEGTMPTHVSTIVKGTPGYLDPEYFLTHK-L-----TDKSDVYSLGVVLLELLTGMQPISHGK------NIVREVNV 845 (958)
Q Consensus 778 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~-----~~~~DV~S~Gv~l~elltG~~P~~~~~------~~~~~~~~ 845 (958)
.....+ .....+||.+|||||++.+.- + -.+.||||+|.+||||+++..-++.+. .....+..
T Consensus 368 p~~~~~-----d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~evG~ 442 (534)
T KOG3653|consen 368 PGKPQG-----DTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEVGN 442 (534)
T ss_pred CCCCCc-----chhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHhcC
Confidence 433322 223468999999999997642 1 237999999999999999765442110 01111100
Q ss_pred HhhcCcchh-hh-cccCCCCCh-----HHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHhhCC
Q 002158 846 ARDSGMVFS-II-DNRMGSYPS-----ECVERFVTLALRCCHDKPEHRPSMSDVVRELENILKMFP 904 (958)
Q Consensus 846 ~~~~~~~~~-~i-~~~~~~~~~-----~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~~ 904 (958)
...-+.+.+ ++ ++.++.+|. ..+..+.+.+..||+.||+.|.|+.=+.+.+.++....+
T Consensus 443 hPt~e~mq~~VV~kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l~~~~~ 508 (534)
T KOG3653|consen 443 HPTLEEMQELVVRKKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAGCVEERMAELMMLWE 508 (534)
T ss_pred CCCHHHHHHHHHhhccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHHhccCC
Confidence 000000000 01 122233332 345678999999999999999999998888887664433
|
|
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-39 Score=351.23 Aligned_cols=261 Identities=22% Similarity=0.338 Sum_probs=210.7
Q ss_pred CCccccChHHHHHHHcCCCCCceeeeeCCeEEEEEEECCCcEEEEEEeccCChhc---HHHHHHHHHHHHccCCCCcceE
Q 002158 610 DGVKGFKFKELAMATAYFSSSTQVGQGGYGKVYKGILSDNTTVAIKRAEEGSLQG---QNEFLTEIKLLSRLHHRNLVSL 686 (958)
Q Consensus 610 ~~~~~~~~~el~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~---~~~~~~E~~~l~~l~H~niv~l 686 (958)
.+++.++.+++ +......||+|++|.||+|.+ +|+.||||+++...... .+.|.+|++++++++||||+++
T Consensus 10 ~~~~~i~~~~i-----~~~~~~~i~~g~~~~v~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~ 83 (283)
T PHA02988 10 NDIKCIESDDI-----DKYTSVLIKENDQNSIYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKI 83 (283)
T ss_pred CcceecCHHHc-----CCCCCeEEeeCCceEEEEEEE-CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEE
Confidence 34555666666 233346899999999999998 78899999987643332 4678899999999999999999
Q ss_pred EEEEEe----CCeEEEEEEecCCCCHHHHhccCCCCCchHHHHHHHHHHHHHHHHHhhhc-CCCCeeccCCCccceEecC
Q 002158 687 LGYCDE----EGEQMLVYEFVPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTE-AHPPVFHRDIKASNILLDS 761 (958)
Q Consensus 687 ~~~~~~----~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~-~~~~iiH~Dikp~NILl~~ 761 (958)
+|++.+ ....++||||+++|+|.+++.... .+++..+.+++.|++.||.|||+. + ++||||||+||++++
T Consensus 84 ~g~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~~~~--~~~~~~~~~i~~~i~~~l~~lH~~~~---~~Hrdlkp~nill~~ 158 (283)
T PHA02988 84 YGFIIDIVDDLPRLSLILEYCTRGYLREVLDKEK--DLSFKTKLDMAIDCCKGLYNLYKYTN---KPYKNLTSVSFLVTE 158 (283)
T ss_pred eeeEEecccCCCceEEEEEeCCCCcHHHHHhhCC--CCChhHHHHHHHHHHHHHHHHHhcCC---CCCCcCChhhEEECC
Confidence 999876 347899999999999999997643 488999999999999999999985 6 889999999999999
Q ss_pred CCCeEEeeeeeecccccCCCCCCccceeeeeccCCCCccChhhhcc--CCCCCcchhhhHHHHHHHHHhCCCCCCCCchh
Q 002158 762 NLNAKVADFGLSRLAPVLDDEGTMPTHVSTIVKGTPGYLDPEYFLT--HKLTDKSDVYSLGVVLLELLTGMQPISHGKNI 839 (958)
Q Consensus 762 ~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DV~S~Gv~l~elltG~~P~~~~~~~ 839 (958)
++.+||+|||+++..... .....|+..|+|||++.+ ..++.++|||||||++|||++|+.||......
T Consensus 159 ~~~~kl~dfg~~~~~~~~----------~~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~ 228 (283)
T PHA02988 159 NYKLKIICHGLEKILSSP----------PFKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTK 228 (283)
T ss_pred CCcEEEcccchHhhhccc----------cccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHH
Confidence 999999999998854221 112358899999999976 67899999999999999999999999754322
Q ss_pred HHHHHHHhhcCcchhhhcccCCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhH
Q 002158 840 VREVNVARDSGMVFSIIDNRMGSYPSECVERFVTLALRCCHDKPEHRPSMSDVVRELENIL 900 (958)
Q Consensus 840 ~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~ 900 (958)
......... ......+..++..+.+++.+||+.||++||+++|+++.|+...
T Consensus 229 -~~~~~i~~~--------~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~~~ 280 (283)
T PHA02988 229 -EIYDLIINK--------NNSLKLPLDCPLEIKCIVEACTSHDSIKRPNIKEILYNLSLYK 280 (283)
T ss_pred -HHHHHHHhc--------CCCCCCCCcCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHH
Confidence 211111111 1112234467889999999999999999999999999998865
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-40 Score=350.48 Aligned_cols=259 Identities=26% Similarity=0.348 Sum_probs=205.1
Q ss_pred CCCCCceeeeeCCeEEEEEEEC-CCcEEEEEEeccCC--hhcHHHHHHHHHHHHccCCCCcceEEEEEEeC--CeEEEEE
Q 002158 626 YFSSSTQVGQGGYGKVYKGILS-DNTTVAIKRAEEGS--LQGQNEFLTEIKLLSRLHHRNLVSLLGYCDEE--GEQMLVY 700 (958)
Q Consensus 626 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~--~~~~lV~ 700 (958)
.|+..++||+|+||.||+|++. +|+.||+|++.-.. .....-..+||.+|++++||||+++.+...+. +.+|||+
T Consensus 118 ~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYlVF 197 (560)
T KOG0600|consen 118 SFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYLVF 197 (560)
T ss_pred HHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEEEE
Confidence 3444578999999999999964 79999999987643 33344568999999999999999999998776 7899999
Q ss_pred EecCCCCHHHHhccCCCCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEecCCCCeEEeeeeeecccccCC
Q 002158 701 EFVPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSRLAPVLD 780 (958)
Q Consensus 701 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~ 780 (958)
|||+. +|.-++... ...|+..++..++.|++.||+|||++| |+|||||.+|||||.+|.+||+|||+|+++....
T Consensus 198 eYMdh-DL~GLl~~p-~vkft~~qIKc~mkQLl~Gl~~cH~~g---vlHRDIK~SNiLidn~G~LKiaDFGLAr~y~~~~ 272 (560)
T KOG0600|consen 198 EYMDH-DLSGLLSSP-GVKFTEPQIKCYMKQLLEGLEYCHSRG---VLHRDIKGSNILIDNNGVLKIADFGLARFYTPSG 272 (560)
T ss_pred ecccc-hhhhhhcCC-CcccChHHHHHHHHHHHHHHHHHhhcC---eeeccccccceEEcCCCCEEeccccceeeccCCC
Confidence 99975 888888643 345999999999999999999999999 9999999999999999999999999999875433
Q ss_pred CCCCccceeeeeccCCCCccChhhhccC-CCCCcchhhhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcCcchhhhcc-
Q 002158 781 DEGTMPTHVSTIVKGTPGYLDPEYFLTH-KLTDKSDVYSLGVVLLELLTGMQPISHGKNIVREVNVARDSGMVFSIIDN- 858 (958)
Q Consensus 781 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DV~S~Gv~l~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~i~~- 858 (958)
. ...+..+-|..|.|||.+.+. .|+.+.|+||.||+|.||++|++.|.+..++.+.-....-.+...+...+
T Consensus 273 ~------~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W~~ 346 (560)
T KOG0600|consen 273 S------APYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYWPV 346 (560)
T ss_pred C------cccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhcccc
Confidence 2 123455678999999999886 69999999999999999999999998766655543332222211110000
Q ss_pred -cC---------CCCC-------hHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 002158 859 -RM---------GSYP-------SECVERFVTLALRCCHDKPEHRPSMSDVVRE 895 (958)
Q Consensus 859 -~~---------~~~~-------~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 895 (958)
.+ ..+. ...+....+|+..++..||++|.|+.++++.
T Consensus 347 ~kLP~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~s 400 (560)
T KOG0600|consen 347 SKLPHATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQS 400 (560)
T ss_pred ccCCcccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhcC
Confidence 00 0111 1345567889999999999999999999863
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-39 Score=359.62 Aligned_cols=249 Identities=27% Similarity=0.402 Sum_probs=209.4
Q ss_pred HHcCCCCCceeeeeCCeEEEEEEEC-CCcEEEEEEeccC----Ch-hcHHHHHHHHHHHHccC-CCCcceEEEEEEeCCe
Q 002158 623 ATAYFSSSTQVGQGGYGKVYKGILS-DNTTVAIKRAEEG----SL-QGQNEFLTEIKLLSRLH-HRNLVSLLGYCDEEGE 695 (958)
Q Consensus 623 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~----~~-~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~~~ 695 (958)
....|...+.||+|+||+||.|.+. +++.||||++... .. ...+...+|+.++++++ ||||+++++++.....
T Consensus 15 ~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~~ 94 (370)
T KOG0583|consen 15 SIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPTK 94 (370)
T ss_pred ccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCCe
Confidence 3457888899999999999999865 6899999977653 11 22445668999999998 9999999999999999
Q ss_pred EEEEEEecCCCCHHHHhccCCCCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEecCC-CCeEEeeeeeec
Q 002158 696 QMLVYEFVPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSN-LNAKVADFGLSR 774 (958)
Q Consensus 696 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~-~~~kl~DFGla~ 774 (958)
.++||||+.+|+|.+++... .++.+.++.+++.|++.|++|||++| |+||||||+|||+|.+ +++||+|||++.
T Consensus 95 ~~ivmEy~~gGdL~~~i~~~--g~l~E~~ar~~F~Qlisav~y~H~~g---i~HRDLK~ENilld~~~~~~Kl~DFG~s~ 169 (370)
T KOG0583|consen 95 IYIVMEYCSGGDLFDYIVNK--GRLKEDEARKYFRQLISAVAYCHSRG---IVHRDLKPENILLDGNEGNLKLSDFGLSA 169 (370)
T ss_pred EEEEEEecCCccHHHHHHHc--CCCChHHHHHHHHHHHHHHHHHHhCC---EeeCCCCHHHEEecCCCCCEEEecccccc
Confidence 99999999999999999873 44888999999999999999999999 9999999999999999 999999999998
Q ss_pred ccccCCCCCCccceeeeeccCCCCccChhhhccCC-CC-CcchhhhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcCcc
Q 002158 775 LAPVLDDEGTMPTHVSTIVKGTPGYLDPEYFLTHK-LT-DKSDVYSLGVVLLELLTGMQPISHGKNIVREVNVARDSGMV 852 (958)
Q Consensus 775 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~-~~~DV~S~Gv~l~elltG~~P~~~~~~~~~~~~~~~~~~~~ 852 (958)
..+. ........+||+.|+|||++.+.. |+ .++||||+||+||.|++|+.||++.. .......
T Consensus 170 ~~~~-------~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~-~~~l~~k------- 234 (370)
T KOG0583|consen 170 ISPG-------EDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSN-VPNLYRK------- 234 (370)
T ss_pred ccCC-------CCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCcc-HHHHHHH-------
Confidence 7631 122345678999999999999977 86 58999999999999999999998633 2222211
Q ss_pred hhhhcccCCCCChHH-HHHHHHHHHHccccCCCCCCCHHHHHH
Q 002158 853 FSIIDNRMGSYPSEC-VERFVTLALRCCHDKPEHRPSMSDVVR 894 (958)
Q Consensus 853 ~~~i~~~~~~~~~~~-~~~l~~li~~cl~~dP~~RPs~~evl~ 894 (958)
+......+|... ..++..++.+|+..||.+|+++.+|++
T Consensus 235 ---i~~~~~~~p~~~~S~~~~~Li~~mL~~~P~~R~t~~~i~~ 274 (370)
T KOG0583|consen 235 ---IRKGEFKIPSYLLSPEARSLIEKMLVPDPSTRITLLEILE 274 (370)
T ss_pred ---HhcCCccCCCCcCCHHHHHHHHHHcCCCcccCCCHHHHhh
Confidence 222333445556 889999999999999999999999994
|
|
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-40 Score=354.66 Aligned_cols=263 Identities=30% Similarity=0.475 Sum_probs=222.7
Q ss_pred HHHHHHHcCCCCCceeeeeCCeEEEEEEECC-CcEEEEEEeccCChhcHHHHHHHHHHHHccCCCCcceEEEEEEeCCeE
Q 002158 618 KELAMATAYFSSSTQVGQGGYGKVYKGILSD-NTTVAIKRAEEGSLQGQNEFLTEIKLLSRLHHRNLVSLLGYCDEEGEQ 696 (958)
Q Consensus 618 ~el~~~~~~~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~ 696 (958)
.+++....++...++||-|-||.||.|.|+. .-.||||.++.+ .-..++|+.|+.+|+.++|||+|+++|+|..+..+
T Consensus 260 DkWEmeRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKED-tMeveEFLkEAAvMKeikHpNLVqLLGVCT~EpPF 338 (1157)
T KOG4278|consen 260 DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPF 338 (1157)
T ss_pred chhhccchheeeeeccCCCcccceeeeeeeccceeeehhhhhhc-chhHHHHHHHHHHHHhhcCccHHHHhhhhccCCCe
Confidence 5666677777888999999999999999985 568999999874 34567899999999999999999999999999999
Q ss_pred EEEEEecCCCCHHHHhccCCCCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEecCCCCeEEeeeeeeccc
Q 002158 697 MLVYEFVPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSRLA 776 (958)
Q Consensus 697 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~~ 776 (958)
|||+|||.+|+|.|||++..+..++....+.++.||+.|++||..++ +|||||.++|+|+.++..+||+|||+++++
T Consensus 339 YIiTEfM~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEkkn---FIHRDLAARNCLVgEnhiVKvADFGLsRlM 415 (1157)
T KOG4278|consen 339 YIITEFMCYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHIVKVADFGLSRLM 415 (1157)
T ss_pred EEEEecccCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHHhh---hhhhhhhhhhccccccceEEeeccchhhhh
Confidence 99999999999999999988888999999999999999999999998 999999999999999999999999999987
Q ss_pred ccCCCCCCccceeeeeccCCCCccChhhhccCCCCCcchhhhHHHHHHHHHh-CCCCCCCCchhHHHHHHHhhcCcchhh
Q 002158 777 PVLDDEGTMPTHVSTIVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVLLELLT-GMQPISHGKNIVREVNVARDSGMVFSI 855 (958)
Q Consensus 777 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gv~l~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~ 855 (958)
..+. +.. .....-.+.|.|||.+....++.|+|||+|||+|||+.| |..||.+-+ +.+.+. ....+.
T Consensus 416 tgDT----YTA--HAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGid-lSqVY~-LLEkgy---- 483 (1157)
T KOG4278|consen 416 TGDT----YTA--HAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGID-LSQVYG-LLEKGY---- 483 (1157)
T ss_pred cCCc----eec--ccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCcc-HHHHHH-HHhccc----
Confidence 3211 111 112223467999999999999999999999999999999 899996432 222211 111111
Q ss_pred hcccCCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhH
Q 002158 856 IDNRMGSYPSECVERFVTLALRCCHDKPEHRPSMSDVVRELENIL 900 (958)
Q Consensus 856 i~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~ 900 (958)
+-+.|..||+.+++||+.||+.+|.+||+++|+-+.++.+.
T Consensus 484 ----RM~~PeGCPpkVYeLMraCW~WsPsDRPsFaeiHqafEtmf 524 (1157)
T KOG4278|consen 484 ----RMDGPEGCPPKVYELMRACWNWSPSDRPSFAEIHQAFETMF 524 (1157)
T ss_pred ----cccCCCCCCHHHHHHHHHHhcCCcccCccHHHHHHHHHHHh
Confidence 12447889999999999999999999999999999988765
|
|
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-40 Score=319.11 Aligned_cols=250 Identities=28% Similarity=0.402 Sum_probs=215.7
Q ss_pred HHcCCCCCceeeeeCCeEEEEEEEC-CCcEEEEEEeccCCh---hcHHHHHHHHHHHHccCCCCcceEEEEEEeCCeEEE
Q 002158 623 ATAYFSSSTQVGQGGYGKVYKGILS-DNTTVAIKRAEEGSL---QGQNEFLTEIKLLSRLHHRNLVSLLGYCDEEGEQML 698 (958)
Q Consensus 623 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~l 698 (958)
+-++|++.+.||+|.||.||.|+.+ ++-.||+|++.+... .-..++.+|+++-+.++||||+++|+++.+....||
T Consensus 20 ~l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyL 99 (281)
T KOG0580|consen 20 TLDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYL 99 (281)
T ss_pred chhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEE
Confidence 3457889999999999999999975 678999999876432 224568899999999999999999999999999999
Q ss_pred EEEecCCCCHHHHhccCCCCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEecCCCCeEEeeeeeeccccc
Q 002158 699 VYEFVPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSRLAPV 778 (958)
Q Consensus 699 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~~~~ 778 (958)
++||.++|.++..|+++....+++.....+..|+|.|+.|+|..+ ||||||||+|+|++.++..||+|||.+...+
T Consensus 100 ilEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k~---VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p- 175 (281)
T KOG0580|consen 100 ILEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHLKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAP- 175 (281)
T ss_pred EEEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhccCC---cccCCCCHHHhccCCCCCeeccCCCceeecC-
Confidence 999999999999999777777999999999999999999999998 9999999999999999999999999987542
Q ss_pred CCCCCCccceeeeeccCCCCccChhhhccCCCCCcchhhhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcCcchhhhcc
Q 002158 779 LDDEGTMPTHVSTIVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVLLELLTGMQPISHGKNIVREVNVARDSGMVFSIIDN 858 (958)
Q Consensus 779 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gv~l~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~i~~ 858 (958)
.......+||..|.+||...+..++..+|+|++|++.||++.|.+||.... ..+.. +.|..
T Consensus 176 --------~~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~-~~etY----------krI~k 236 (281)
T KOG0580|consen 176 --------SNKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQS-HSETY----------KRIRK 236 (281)
T ss_pred --------CCCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhh-hHHHH----------HHHHH
Confidence 223456789999999999999999999999999999999999999997433 11211 22222
Q ss_pred cCCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 002158 859 RMGSYPSECVERFVTLALRCCHDKPEHRPSMSDVVRE 895 (958)
Q Consensus 859 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 895 (958)
....+|...+....++|.+|+..+|.+|....|++++
T Consensus 237 ~~~~~p~~is~~a~dlI~~ll~~~p~~r~~l~~v~~h 273 (281)
T KOG0580|consen 237 VDLKFPSTISGGAADLISRLLVKNPIERLALTEVMDH 273 (281)
T ss_pred ccccCCcccChhHHHHHHHHhccCccccccHHHHhhh
Confidence 2234567788899999999999999999999999986
|
|
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=349.03 Aligned_cols=251 Identities=24% Similarity=0.359 Sum_probs=204.5
Q ss_pred CCCCceeeeeCCeEEEEEEEC-CCcEEEEEEeccCCh---hcHHHHHHHHHHHHccCCCCcceEEEEEEeCCeEEEEEEe
Q 002158 627 FSSSTQVGQGGYGKVYKGILS-DNTTVAIKRAEEGSL---QGQNEFLTEIKLLSRLHHRNLVSLLGYCDEEGEQMLVYEF 702 (958)
Q Consensus 627 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E~ 702 (958)
|...+.||+|+||+||+|.+. +++.||||.+..... .....+.+|++++++++|+||+++++++.+.+..++||||
T Consensus 2 f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05631 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLTI 81 (285)
T ss_pred ceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEEe
Confidence 667789999999999999975 789999999865322 2334678999999999999999999999999999999999
Q ss_pred cCCCCHHHHhccCCCCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEecCCCCeEEeeeeeecccccCCCC
Q 002158 703 VPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSRLAPVLDDE 782 (958)
Q Consensus 703 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~ 782 (958)
+++|+|.+++.......+++..+..++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||+++......
T Consensus 82 ~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~-- 156 (285)
T cd05631 82 MNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRER---IVYRDLKPENILLDDRGHIRISDLGLAVQIPEGE-- 156 (285)
T ss_pred cCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCCC--
Confidence 99999999886554446899999999999999999999999 9999999999999999999999999987642211
Q ss_pred CCccceeeeeccCCCCccChhhhccCCCCCcchhhhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcCcchhhhcccCCC
Q 002158 783 GTMPTHVSTIVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVLLELLTGMQPISHGKNIVREVNVARDSGMVFSIIDNRMGS 862 (958)
Q Consensus 783 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gv~l~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~ 862 (958)
......||..|+|||++.+..++.++|||||||++|||++|+.||............. ..+......
T Consensus 157 ------~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~-------~~~~~~~~~ 223 (285)
T cd05631 157 ------TVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVD-------RRVKEDQEE 223 (285)
T ss_pred ------eecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHHHHH-------HHhhccccc
Confidence 1123468999999999999999999999999999999999999997543211110000 011111123
Q ss_pred CChHHHHHHHHHHHHccccCCCCCCC-----HHHHHHH
Q 002158 863 YPSECVERFVTLALRCCHDKPEHRPS-----MSDVVRE 895 (958)
Q Consensus 863 ~~~~~~~~l~~li~~cl~~dP~~RPs-----~~evl~~ 895 (958)
++...+..+.+++.+||+.||++||+ +++++++
T Consensus 224 ~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h 261 (285)
T cd05631 224 YSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQH 261 (285)
T ss_pred CCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhcC
Confidence 34556778999999999999999997 7888764
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-40 Score=346.99 Aligned_cols=249 Identities=27% Similarity=0.417 Sum_probs=212.3
Q ss_pred cCCCCCceeeeeCCeEEEEEEEC-CCcEEEEEEeccCCh-hcHHHHHHHHHHHHccCCCCcceEEEEEEeCCeEEEEEEe
Q 002158 625 AYFSSSTQVGQGGYGKVYKGILS-DNTTVAIKRAEEGSL-QGQNEFLTEIKLLSRLHHRNLVSLLGYCDEEGEQMLVYEF 702 (958)
Q Consensus 625 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E~ 702 (958)
..|...+.||+|.||.||+|.+. .++.||+|++.-... .+.++.++|+.++.+.+++||.++||.+..+..++++|||
T Consensus 13 ~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMey 92 (467)
T KOG0201|consen 13 LLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIMEY 92 (467)
T ss_pred cccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHHH
Confidence 35666789999999999999975 689999999986543 3456789999999999999999999999999999999999
Q ss_pred cCCCCHHHHhccCCCCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEecCCCCeEEeeeeeecccccCCCC
Q 002158 703 VPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSRLAPVLDDE 782 (958)
Q Consensus 703 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~ 782 (958)
|.||++.+.++... .+++..+.-+..++..|+.|||.++ .+|||||+.|||+..+|.+||+|||.+-.+....
T Consensus 93 ~~gGsv~~lL~~~~--~~~E~~i~~ilre~l~~l~ylH~~~---kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~-- 165 (467)
T KOG0201|consen 93 CGGGSVLDLLKSGN--ILDEFEIAVILREVLKGLDYLHSEK---KIHRDIKAANILLSESGDVKLADFGVAGQLTNTV-- 165 (467)
T ss_pred hcCcchhhhhccCC--CCccceeeeehHHHHHHhhhhhhcc---eecccccccceeEeccCcEEEEecceeeeeechh--
Confidence 99999999997544 2578888889999999999999999 9999999999999999999999999987653221
Q ss_pred CCccceeeeeccCCCCccChhhhccCCCCCcchhhhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcCcchhhhcccCCC
Q 002158 783 GTMPTHVSTIVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVLLELLTGMQPISHGKNIVREVNVARDSGMVFSIIDNRMGS 862 (958)
Q Consensus 783 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gv~l~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~ 862 (958)
.....++||+.|||||++....|+.|+||||||++.+||.+|.+|+.+... ...++.+.....+.
T Consensus 166 -----~rr~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hP----------mrvlflIpk~~PP~ 230 (467)
T KOG0201|consen 166 -----KRRKTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHP----------MRVLFLIPKSAPPR 230 (467)
T ss_pred -----hccccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCc----------ceEEEeccCCCCCc
Confidence 122568899999999999988999999999999999999999999975332 22333333444455
Q ss_pred CChHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 002158 863 YPSECVERFVTLALRCCHDKPEHRPSMSDVVRE 895 (958)
Q Consensus 863 ~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 895 (958)
+...+.+.+.+++..|++.||+.||++.+++++
T Consensus 231 L~~~~S~~~kEFV~~CL~k~P~~RpsA~~LLKh 263 (467)
T KOG0201|consen 231 LDGDFSPPFKEFVEACLDKNPEFRPSAKELLKH 263 (467)
T ss_pred cccccCHHHHHHHHHHhhcCcccCcCHHHHhhh
Confidence 556788899999999999999999999999864
|
|
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=361.53 Aligned_cols=259 Identities=27% Similarity=0.425 Sum_probs=206.3
Q ss_pred HcCCCCCceeeeeCCeEEEEEEE------CCCcEEEEEEeccCC-hhcHHHHHHHHHHHHcc-CCCCcceEEEEEEeCCe
Q 002158 624 TAYFSSSTQVGQGGYGKVYKGIL------SDNTTVAIKRAEEGS-LQGQNEFLTEIKLLSRL-HHRNLVSLLGYCDEEGE 695 (958)
Q Consensus 624 ~~~~~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~ 695 (958)
.++|+..+.||+|+||.||+|++ ..+..||||+++... ....+.+.+|+++++.+ +||||++++++|...+.
T Consensus 34 ~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~~ 113 (375)
T cd05104 34 RNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVGGP 113 (375)
T ss_pred hHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCCc
Confidence 44677889999999999999974 235689999987542 33456788999999999 89999999999999999
Q ss_pred EEEEEEecCCCCHHHHhccCC-----------------------------------------------------------
Q 002158 696 QMLVYEFVPNGTLRDWLSGRT----------------------------------------------------------- 716 (958)
Q Consensus 696 ~~lV~E~~~~gsL~~~l~~~~----------------------------------------------------------- 716 (958)
.++||||+++|+|.++++...
T Consensus 114 ~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 193 (375)
T cd05104 114 TLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSGS 193 (375)
T ss_pred ceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccccce
Confidence 999999999999999996432
Q ss_pred --------------CCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEecCCCCeEEeeeeeecccccCCCC
Q 002158 717 --------------KENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSRLAPVLDDE 782 (958)
Q Consensus 717 --------------~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~ 782 (958)
...+++..+.+++.|+++||+|||+.+ |+||||||+|||++.++.+||+|||+++.......
T Consensus 194 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~- 269 (375)
T cd05104 194 YIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKN---CIHRDLAARNILLTHGRITKICDFGLARDIRNDSN- 269 (375)
T ss_pred ecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCchhhEEEECCCcEEEecCccceeccCccc-
Confidence 124788899999999999999999998 99999999999999999999999999976532211
Q ss_pred CCccceeeeeccCCCCccChhhhccCCCCCcchhhhHHHHHHHHHh-CCCCCCCCchhHHHHHHHhhcCcchhhhcccCC
Q 002158 783 GTMPTHVSTIVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVLLELLT-GMQPISHGKNIVREVNVARDSGMVFSIIDNRMG 861 (958)
Q Consensus 783 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gv~l~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~i~~~~~ 861 (958)
........++..|+|||++.+..++.++|||||||++|||++ |..||............... + ...
T Consensus 270 ----~~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~~~~~~~~~-~--------~~~ 336 (375)
T cd05104 270 ----YVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSKFYKMIKE-G--------YRM 336 (375)
T ss_pred ----ccccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchHHHHHHHHh-C--------ccC
Confidence 011112335678999999999999999999999999999998 88898654322222211111 1 011
Q ss_pred CCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHh
Q 002158 862 SYPSECVERFVTLALRCCHDKPEHRPSMSDVVRELENI 899 (958)
Q Consensus 862 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 899 (958)
..+...+.++.+++.+||+.||++||+++|+++.|++.
T Consensus 337 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~l~~~ 374 (375)
T cd05104 337 LSPECAPSEMYDIMKSCWDADPLKRPTFKQIVQLIEQQ 374 (375)
T ss_pred CCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHhh
Confidence 12334567899999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-38 Score=348.26 Aligned_cols=262 Identities=29% Similarity=0.432 Sum_probs=203.4
Q ss_pred cCCCCCceeeeeCCeEEEEEEECC-----------------CcEEEEEEeccCC-hhcHHHHHHHHHHHHccCCCCcceE
Q 002158 625 AYFSSSTQVGQGGYGKVYKGILSD-----------------NTTVAIKRAEEGS-LQGQNEFLTEIKLLSRLHHRNLVSL 686 (958)
Q Consensus 625 ~~~~~~~~lg~G~~g~Vy~~~~~~-----------------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l 686 (958)
.+|...+.||+|+||.||+|.+++ +..||+|.+.... .....+|.+|++++++++||||+++
T Consensus 5 ~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~ 84 (304)
T cd05096 5 GHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRL 84 (304)
T ss_pred hhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeEE
Confidence 467778899999999999998642 3369999987643 3345679999999999999999999
Q ss_pred EEEEEeCCeEEEEEEecCCCCHHHHhccCC-----------------CCCchHHHHHHHHHHHHHHHHHhhhcCCCCeec
Q 002158 687 LGYCDEEGEQMLVYEFVPNGTLRDWLSGRT-----------------KENLNFAMRLRVALDSAKGILYLHTEAHPPVFH 749 (958)
Q Consensus 687 ~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~-----------------~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH 749 (958)
++++...+..++||||+++|+|.+++.... ...+++.++.+++.|++.||+|||+.+ |+|
T Consensus 85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---ivH 161 (304)
T cd05096 85 LGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLN---FVH 161 (304)
T ss_pred EEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCC---ccc
Confidence 999999999999999999999999986432 123688899999999999999999999 999
Q ss_pred cCCCccceEecCCCCeEEeeeeeecccccCCCCCCccceeeeeccCCCCccChhhhccCCCCCcchhhhHHHHHHHHHh-
Q 002158 750 RDIKASNILLDSNLNAKVADFGLSRLAPVLDDEGTMPTHVSTIVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVLLELLT- 828 (958)
Q Consensus 750 ~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gv~l~ellt- 828 (958)
|||||+|||+++++.+||+|||+++....... ........++..|+|||++....++.++||||||+++|||++
T Consensus 162 ~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~ 236 (304)
T cd05096 162 RDLATRNCLVGENLTIKIADFGMSRNLYAGDY-----YRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILML 236 (304)
T ss_pred cCcchhheEEcCCccEEECCCccceecccCce-----eEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHc
Confidence 99999999999999999999999875422111 111223346789999999998999999999999999999997
Q ss_pred -CCCCCCCCchhHHHHHHHhhcCcchhhhcccCCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 002158 829 -GMQPISHGKNIVREVNVARDSGMVFSIIDNRMGSYPSECVERFVTLALRCCHDKPEHRPSMSDVVRELE 897 (958)
Q Consensus 829 -G~~P~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 897 (958)
+..||........ ...... .............+..++..+.+++.+||+.||++||++.+|.+.|+
T Consensus 237 ~~~~p~~~~~~~~~-~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l~ 303 (304)
T cd05096 237 CKEQPYGELTDEQV-IENAGE--FFRDQGRQVYLFRPPPCPQGLYELMLQCWSRDCRERPSFSDIHAFLT 303 (304)
T ss_pred cCCCCCCcCCHHHH-HHHHHH--HhhhccccccccCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHh
Confidence 5567764332111 111000 00000000011224456788999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-38 Score=351.67 Aligned_cols=242 Identities=22% Similarity=0.285 Sum_probs=200.7
Q ss_pred ceeeeeCCeEEEEEEEC-CCcEEEEEEeccCC---hhcHHHHHHHHHHHHccCCCCcceEEEEEEeCCeEEEEEEecCCC
Q 002158 631 TQVGQGGYGKVYKGILS-DNTTVAIKRAEEGS---LQGQNEFLTEIKLLSRLHHRNLVSLLGYCDEEGEQMLVYEFVPNG 706 (958)
Q Consensus 631 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E~~~~g 706 (958)
+.||+|+||.||+|..+ +|+.||||+++... ......+.+|++++++++||||+++++++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~ 80 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence 36999999999999975 68999999987532 223456789999999999999999999999999999999999999
Q ss_pred CHHHHhccCCCCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEecCCCCeEEeeeeeecccccCCCCCCcc
Q 002158 707 TLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSRLAPVLDDEGTMP 786 (958)
Q Consensus 707 sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~ 786 (958)
+|.+++.... .+++.++..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++......
T Consensus 81 ~L~~~l~~~~--~~~~~~~~~~~~qi~~~L~~lH~~~---ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~------ 149 (323)
T cd05571 81 ELFFHLSRER--VFSEDRARFYGAEIVSALGYLHSCD---VVYRDLKLENLMLDKDGHIKITDFGLCKEGISDG------ 149 (323)
T ss_pred cHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHEEECCCCCEEEeeCCCCcccccCC------
Confidence 9999997543 4899999999999999999999999 9999999999999999999999999987432111
Q ss_pred ceeeeeccCCCCccChhhhccCCCCCcchhhhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcCcchhhhcccCCCCChH
Q 002158 787 THVSTIVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVLLELLTGMQPISHGKNIVREVNVARDSGMVFSIIDNRMGSYPSE 866 (958)
Q Consensus 787 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gv~l~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~ 866 (958)
.......||+.|+|||++.+..++.++||||+||++|||++|+.||...... ...... ......++..
T Consensus 150 -~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~-~~~~~~----------~~~~~~~p~~ 217 (323)
T cd05571 150 -ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE-KLFELI----------LMEEIRFPRT 217 (323)
T ss_pred -CcccceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCHH-HHHHHH----------HcCCCCCCCC
Confidence 1123456999999999999999999999999999999999999999754322 111111 1111233556
Q ss_pred HHHHHHHHHHHccccCCCCCC-----CHHHHHHH
Q 002158 867 CVERFVTLALRCCHDKPEHRP-----SMSDVVRE 895 (958)
Q Consensus 867 ~~~~l~~li~~cl~~dP~~RP-----s~~evl~~ 895 (958)
.+.++.+++.+||+.||++|| ++.+++++
T Consensus 218 ~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h 251 (323)
T cd05571 218 LSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIMEH 251 (323)
T ss_pred CCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHcC
Confidence 678899999999999999999 78998864
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-38 Score=352.35 Aligned_cols=245 Identities=23% Similarity=0.334 Sum_probs=203.7
Q ss_pred cCCCCCceeeeeCCeEEEEEEEC-CCcEEEEEEeccCC---hhcHHHHHHHHHHHHccCCCCcceEEEEEEeCCeEEEEE
Q 002158 625 AYFSSSTQVGQGGYGKVYKGILS-DNTTVAIKRAEEGS---LQGQNEFLTEIKLLSRLHHRNLVSLLGYCDEEGEQMLVY 700 (958)
Q Consensus 625 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~ 700 (958)
++|...+.||+|+||+||+|+++ +++.||||++.... ....+.+.+|++++++++||||+++++++..++..++||
T Consensus 18 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 97 (329)
T PTZ00263 18 SDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLL 97 (329)
T ss_pred hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEEE
Confidence 45777889999999999999986 68999999986532 223456889999999999999999999999999999999
Q ss_pred EecCCCCHHHHhccCCCCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEecCCCCeEEeeeeeecccccCC
Q 002158 701 EFVPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSRLAPVLD 780 (958)
Q Consensus 701 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~ 780 (958)
||+++|+|.+++.... .+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 98 e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~- 171 (329)
T PTZ00263 98 EFVVGGELFTHLRKAG--RFPNDVAKFYHAELVLAFEYLHSKD---IIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDR- 171 (329)
T ss_pred cCCCCChHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHEEECCCCCEEEeeccCceEcCCC-
Confidence 9999999999997543 4888899999999999999999999 999999999999999999999999998754211
Q ss_pred CCCCccceeeeeccCCCCccChhhhccCCCCCcchhhhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcCcchhhhcccC
Q 002158 781 DEGTMPTHVSTIVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVLLELLTGMQPISHGKNIVREVNVARDSGMVFSIIDNRM 860 (958)
Q Consensus 781 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gv~l~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~i~~~~ 860 (958)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||.+...... ..... ...
T Consensus 172 ---------~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~-~~~i~----------~~~ 231 (329)
T PTZ00263 172 ---------TFTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRI-YEKIL----------AGR 231 (329)
T ss_pred ---------cceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCHHHH-HHHHh----------cCC
Confidence 1234699999999999999999999999999999999999999975443211 11111 111
Q ss_pred CCCChHHHHHHHHHHHHccccCCCCCCC-----HHHHHHH
Q 002158 861 GSYPSECVERFVTLALRCCHDKPEHRPS-----MSDVVRE 895 (958)
Q Consensus 861 ~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~evl~~ 895 (958)
..+|...+..+.+++.+||+.||.+||+ +++++++
T Consensus 232 ~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h 271 (329)
T PTZ00263 232 LKFPNWFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKNH 271 (329)
T ss_pred cCCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence 1234445677899999999999999987 6777765
|
|
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-38 Score=358.90 Aligned_cols=262 Identities=26% Similarity=0.420 Sum_probs=207.8
Q ss_pred HHHcCCCCCceeeeeCCeEEEEEEEC------CCcEEEEEEeccCC-hhcHHHHHHHHHHHHcc-CCCCcceEEEEEEeC
Q 002158 622 MATAYFSSSTQVGQGGYGKVYKGILS------DNTTVAIKRAEEGS-LQGQNEFLTEIKLLSRL-HHRNLVSLLGYCDEE 693 (958)
Q Consensus 622 ~~~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~ 693 (958)
...++|+..+.||+|+||.||+|++. ++..||||++.... ......+.+|+++++.+ +|+||++++++|...
T Consensus 35 ~~~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~ 114 (374)
T cd05106 35 FPRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHG 114 (374)
T ss_pred ccHHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecCC
Confidence 34457888899999999999999852 24579999997643 33345688999999999 899999999999999
Q ss_pred CeEEEEEEecCCCCHHHHhccCC---------------------------------------------------------
Q 002158 694 GEQMLVYEFVPNGTLRDWLSGRT--------------------------------------------------------- 716 (958)
Q Consensus 694 ~~~~lV~E~~~~gsL~~~l~~~~--------------------------------------------------------- 716 (958)
+..++||||+++|+|.++++...
T Consensus 115 ~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 194 (374)
T cd05106 115 GPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQS 194 (374)
T ss_pred CCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCcccccccc
Confidence 99999999999999999985421
Q ss_pred -----------CCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEecCCCCeEEeeeeeecccccCCCCCCc
Q 002158 717 -----------KENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSRLAPVLDDEGTM 785 (958)
Q Consensus 717 -----------~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~ 785 (958)
...+++.++++++.|+++||+|||+.+ |+||||||+|||+++++.+||+|||+++.......
T Consensus 195 ~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~g---iiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~---- 267 (374)
T cd05106 195 SDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKN---CIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSN---- 267 (374)
T ss_pred ccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---EEeccCchheEEEeCCCeEEEeeceeeeeccCCcc----
Confidence 124788899999999999999999998 99999999999999999999999999975432111
Q ss_pred cceeeeeccCCCCccChhhhccCCCCCcchhhhHHHHHHHHHh-CCCCCCCCchhHHHHHHHhhcCcchhhhcccCCCCC
Q 002158 786 PTHVSTIVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVLLELLT-GMQPISHGKNIVREVNVARDSGMVFSIIDNRMGSYP 864 (958)
Q Consensus 786 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gv~l~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~ 864 (958)
........++..|+|||++.+..++.++|||||||++|||++ |+.||............. ..+ .....+
T Consensus 268 -~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~~~~~~-~~~--------~~~~~~ 337 (374)
T cd05106 268 -YVVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSKFYKMV-KRG--------YQMSRP 337 (374)
T ss_pred -eeeccCCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccHHHHHHH-Hcc--------cCccCC
Confidence 111122345678999999999999999999999999999997 999996533211111111 100 011123
Q ss_pred hHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhH
Q 002158 865 SECVERFVTLALRCCHDKPEHRPSMSDVVRELENIL 900 (958)
Q Consensus 865 ~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~ 900 (958)
...+.++.+++.+||+.||++||++.++++.|++++
T Consensus 338 ~~~~~~l~~li~~cl~~dp~~RPs~~~l~~~l~~~~ 373 (374)
T cd05106 338 DFAPPEIYSIMKMCWNLEPTERPTFSQISQLIQRQL 373 (374)
T ss_pred CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHh
Confidence 334678999999999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=346.17 Aligned_cols=260 Identities=28% Similarity=0.501 Sum_probs=218.5
Q ss_pred HHHHcCCCCCceeeeeCCeEEEEEEECC---C--cEEEEEEeccC-ChhcHHHHHHHHHHHHccCCCCcceEEEEEEeCC
Q 002158 621 AMATAYFSSSTQVGQGGYGKVYKGILSD---N--TTVAIKRAEEG-SLQGQNEFLTEIKLLSRLHHRNLVSLLGYCDEEG 694 (958)
Q Consensus 621 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~---~--~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~ 694 (958)
+..++.....++||+|-||.||+|++.+ | -.||||.-+.+ ...+.+.|+.|..+|+.++||||++++|+|.+.
T Consensus 385 el~Re~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e~- 463 (974)
T KOG4257|consen 385 ELRRELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVEQ- 463 (974)
T ss_pred eeehhhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeecc-
Confidence 3445556667899999999999999642 2 35899988874 555677899999999999999999999999875
Q ss_pred eEEEEEEecCCCCHHHHhccCCCCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEecCCCCeEEeeeeeec
Q 002158 695 EQMLVYEFVPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSR 774 (958)
Q Consensus 695 ~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~ 774 (958)
..++|||.++-|.|++||+.+. ..++......++.|+..||+|||+.. +|||||..+|||+.....+||+|||++|
T Consensus 464 P~WivmEL~~~GELr~yLq~nk-~sL~l~tL~ly~~Qi~talaYLeSkr---fVHRDIAaRNiLVsSp~CVKLaDFGLSR 539 (974)
T KOG4257|consen 464 PMWIVMELAPLGELREYLQQNK-DSLPLRTLTLYCYQICTALAYLESKR---FVHRDIAARNILVSSPQCVKLADFGLSR 539 (974)
T ss_pred ceeEEEecccchhHHHHHHhcc-ccchHHHHHHHHHHHHHHHHHHHhhc---hhhhhhhhhheeecCcceeeecccchhh
Confidence 7899999999999999998654 45999999999999999999999999 9999999999999999999999999999
Q ss_pred ccccCCCCCCccceeeeeccCCCCccChhhhccCCCCCcchhhhHHHHHHHHHh-CCCCCCCCchhHHHHHHHhhcCcch
Q 002158 775 LAPVLDDEGTMPTHVSTIVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVLLELLT-GMQPISHGKNIVREVNVARDSGMVF 853 (958)
Q Consensus 775 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gv~l~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~ 853 (958)
.+....- ...+...=...|||||.+.-..++.++|||.|||.+||++. |..||.+-++ .+.+.
T Consensus 540 ~~ed~~y------YkaS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkN----------sDVI~ 603 (974)
T KOG4257|consen 540 YLEDDAY------YKASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKN----------SDVIG 603 (974)
T ss_pred hccccch------hhccccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccc----------cceEE
Confidence 8754321 11222334567999999999999999999999999999999 9999976433 22233
Q ss_pred hhhcccCCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHh
Q 002158 854 SIIDNRMGSYPSECVERFVTLALRCCHDKPEHRPSMSDVVRELENILK 901 (958)
Q Consensus 854 ~~i~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~ 901 (958)
.+-.+.+...|+.||..++.|+.+||..+|.+||.+.|+...|.+++.
T Consensus 604 ~iEnGeRlP~P~nCPp~LYslmskcWayeP~kRPrftei~~~lsdv~q 651 (974)
T KOG4257|consen 604 HIENGERLPCPPNCPPALYSLMSKCWAYEPSKRPRFTEIKAILSDVLQ 651 (974)
T ss_pred EecCCCCCCCCCCCChHHHHHHHHHhccCcccCCcHHHHHHHHHHHHH
Confidence 333344566789999999999999999999999999999999998875
|
|
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-38 Score=350.27 Aligned_cols=245 Identities=22% Similarity=0.303 Sum_probs=203.8
Q ss_pred cCCCCCceeeeeCCeEEEEEEEC-CCcEEEEEEeccCC---hhcHHHHHHHHHHHHccCCCCcceEEEEEEeCCeEEEEE
Q 002158 625 AYFSSSTQVGQGGYGKVYKGILS-DNTTVAIKRAEEGS---LQGQNEFLTEIKLLSRLHHRNLVSLLGYCDEEGEQMLVY 700 (958)
Q Consensus 625 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~ 700 (958)
++|...+.||+|+||+||+|... +++.||+|++.... ....+.+.+|++++++++||||+++++++.+++..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLM 80 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence 36788899999999999999986 68999999986432 223456889999999999999999999999999999999
Q ss_pred EecCCCCHHHHhccCCCCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEecCCCCeEEeeeeeecccccCC
Q 002158 701 EFVPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSRLAPVLD 780 (958)
Q Consensus 701 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~ 780 (958)
||+++|+|.+++.... .+++..+..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+++....
T Consensus 81 e~~~~~~L~~~~~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~-- 153 (291)
T cd05612 81 EYVPGGELFSYLRNSG--RFSNSTGLFYASEIVCALEYLHSKE---IVYRDLKPENILLDKEGHIKLTDFGFAKKLRD-- 153 (291)
T ss_pred eCCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEEEecCcchhccC--
Confidence 9999999999997544 4889999999999999999999999 99999999999999999999999999875421
Q ss_pred CCCCccceeeeeccCCCCccChhhhccCCCCCcchhhhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcCcchhhhcccC
Q 002158 781 DEGTMPTHVSTIVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVLLELLTGMQPISHGKNIVREVNVARDSGMVFSIIDNRM 860 (958)
Q Consensus 781 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gv~l~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~i~~~~ 860 (958)
......||+.|+|||++.+..++.++|||||||++|||++|+.||...... ....... ...
T Consensus 154 --------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~-~~~~~i~----------~~~ 214 (291)
T cd05612 154 --------RTWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPF-GIYEKIL----------AGK 214 (291)
T ss_pred --------CcccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHH----------hCC
Confidence 112346899999999999999999999999999999999999999754332 1111111 111
Q ss_pred CCCChHHHHHHHHHHHHccccCCCCCCC-----HHHHHHH
Q 002158 861 GSYPSECVERFVTLALRCCHDKPEHRPS-----MSDVVRE 895 (958)
Q Consensus 861 ~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~evl~~ 895 (958)
..++...+..+.+++.+||+.||.+||+ +++++++
T Consensus 215 ~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h 254 (291)
T cd05612 215 LEFPRHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNH 254 (291)
T ss_pred cCCCccCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhcC
Confidence 2234455678899999999999999995 7787764
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-38 Score=339.57 Aligned_cols=255 Identities=24% Similarity=0.381 Sum_probs=207.3
Q ss_pred cCCCCCceeeeeCCeEEEEEEEC----CCcEEEEEEeccCC-hhcHHHHHHHHHHHHccCCCCcceEEEEEEeCCeEEEE
Q 002158 625 AYFSSSTQVGQGGYGKVYKGILS----DNTTVAIKRAEEGS-LQGQNEFLTEIKLLSRLHHRNLVSLLGYCDEEGEQMLV 699 (958)
Q Consensus 625 ~~~~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV 699 (958)
++|+..+.||+|+||.||+|.++ .+..||+|.++... ....+.|.+|+..+++++||||+++++++..++..++|
T Consensus 5 ~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 84 (266)
T cd05064 5 KSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMIV 84 (266)
T ss_pred HHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcEEE
Confidence 46778889999999999999864 36689999988653 33346799999999999999999999999999999999
Q ss_pred EEecCCCCHHHHhccCCCCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEecCCCCeEEeeeeeecccccC
Q 002158 700 YEFVPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSRLAPVL 779 (958)
Q Consensus 700 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~~~~~ 779 (958)
|||+++|+|.+++.... ..+++.+++.++.|++.||+|||+.+ ++||||||+||+++.++.++++|||.+......
T Consensus 85 ~e~~~~~~L~~~l~~~~-~~l~~~~~~~~~~~i~~al~~lH~~~---iiH~dikp~nili~~~~~~~l~dfg~~~~~~~~ 160 (266)
T cd05064 85 TEYMSNGALDSFLRKHE-GQLVAGQLMGMLPGLASGMKYLSEMG---YVHKGLAAHKVLVNSDLVCKISGFRRLQEDKSE 160 (266)
T ss_pred EEeCCCCcHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHHCC---EeeccccHhhEEEcCCCcEEECCCccccccccc
Confidence 99999999999997543 35899999999999999999999999 999999999999999999999999987643111
Q ss_pred CCCCCccceeeeeccCCCCccChhhhccCCCCCcchhhhHHHHHHHHHh-CCCCCCCCchhHHHHHHHhhcCcchhhhcc
Q 002158 780 DDEGTMPTHVSTIVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVLLELLT-GMQPISHGKNIVREVNVARDSGMVFSIIDN 858 (958)
Q Consensus 780 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gv~l~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~i~~ 858 (958)
. ........++..|+|||.+.+..++.++|||||||++||+++ |..||...... ....... +.
T Consensus 161 ~------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~-~~~~~~~---------~~ 224 (266)
T cd05064 161 A------IYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQ-DVIKAVE---------DG 224 (266)
T ss_pred c------hhcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHH-HHHHHHH---------CC
Confidence 0 011112335678999999999999999999999999999875 99999754322 1111111 11
Q ss_pred cCCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHh
Q 002158 859 RMGSYPSECVERFVTLALRCCHDKPEHRPSMSDVVRELENI 899 (958)
Q Consensus 859 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 899 (958)
.....+..++..+.+++.+||+.+|++||+++++.+.|+++
T Consensus 225 ~~~~~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~~ 265 (266)
T cd05064 225 FRLPAPRNCPNLLHQLMLDCWQKERGERPRFSQIHSILSKM 265 (266)
T ss_pred CCCCCCCCCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHhh
Confidence 11223556778899999999999999999999999988764
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-38 Score=340.16 Aligned_cols=249 Identities=37% Similarity=0.624 Sum_probs=198.7
Q ss_pred CceeeeeCCeEEEEEEEC-----CCcEEEEEEeccC-ChhcHHHHHHHHHHHHccCCCCcceEEEEEEeCCeEEEEEEec
Q 002158 630 STQVGQGGYGKVYKGILS-----DNTTVAIKRAEEG-SLQGQNEFLTEIKLLSRLHHRNLVSLLGYCDEEGEQMLVYEFV 703 (958)
Q Consensus 630 ~~~lg~G~~g~Vy~~~~~-----~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E~~ 703 (958)
.+.||.|.||.||+|.+. .+..|+||.++.. .....+.|.+|++.+++++||||++++|++...+..++||||+
T Consensus 4 ~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e~~ 83 (259)
T PF07714_consen 4 IKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVMEYC 83 (259)
T ss_dssp EEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE--
T ss_pred eeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeeccccccccccccccccccccccccccccccccc
Confidence 468999999999999986 2678999999664 3344678999999999999999999999999888899999999
Q ss_pred CCCCHHHHhccCCCCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEecCCCCeEEeeeeeecccccCCCCC
Q 002158 704 PNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSRLAPVLDDEG 783 (958)
Q Consensus 704 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 783 (958)
++|+|.++|+......+++.++..|+.|+|+||+|||+.+ ++|+||+++||++++++.+||+|||+++.......
T Consensus 84 ~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~---iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~-- 158 (259)
T PF07714_consen 84 PGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSNN---IIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKSK-- 158 (259)
T ss_dssp TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHTT---EEEST-SGGGEEEETTTEEEEESTTTGEETTTSSS--
T ss_pred cccccccccccccccccccccccccccccccccccccccc---ccccccccccccccccccccccccccccccccccc--
Confidence 9999999999875566999999999999999999999998 99999999999999999999999999876511110
Q ss_pred CccceeeeeccCCCCccChhhhccCCCCCcchhhhHHHHHHHHHh-CCCCCCCCchhHHHHHHHhhcCcchhhhcccCCC
Q 002158 784 TMPTHVSTIVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVLLELLT-GMQPISHGKNIVREVNVARDSGMVFSIIDNRMGS 862 (958)
Q Consensus 784 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gv~l~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~ 862 (958)
........+...|+|||.+....++.++||||||+++|||++ |+.||.+... ........ +.....
T Consensus 159 ---~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~-~~~~~~~~---------~~~~~~ 225 (259)
T PF07714_consen 159 ---YKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDN-EEIIEKLK---------QGQRLP 225 (259)
T ss_dssp ---EEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCH-HHHHHHHH---------TTEETT
T ss_pred ---ccccccccccccccccccccccccccccccccccccccccccccccccccccc-cccccccc---------ccccce
Confidence 122223446778999999999999999999999999999999 7888865432 22221111 111223
Q ss_pred CChHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 002158 863 YPSECVERFVTLALRCCHDKPEHRPSMSDVVREL 896 (958)
Q Consensus 863 ~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 896 (958)
.+..++..+.+++.+||+.+|++||++.++++.|
T Consensus 226 ~~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~~L 259 (259)
T PF07714_consen 226 IPDNCPKDIYSLIQQCWSHDPEKRPSFQEILQEL 259 (259)
T ss_dssp SBTTSBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred eccchhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence 3556778899999999999999999999999876
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=350.63 Aligned_cols=245 Identities=27% Similarity=0.379 Sum_probs=210.5
Q ss_pred CCCCceeeeeCCeEEEEEEEC-CCcEEEEEEeccCC---hhcHHHHHHHHHHHHccCCCCcceEEEEEEeCCeEEEEEEe
Q 002158 627 FSSSTQVGQGGYGKVYKGILS-DNTTVAIKRAEEGS---LQGQNEFLTEIKLLSRLHHRNLVSLLGYCDEEGEQMLVYEF 702 (958)
Q Consensus 627 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E~ 702 (958)
|...+.||+|+-|.|..|++. +|+.+|||++.+.. ......+.+|+-+|+-+.|||++++|+++++..++|+|.||
T Consensus 14 wkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvlEy 93 (786)
T KOG0588|consen 14 WKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVLEY 93 (786)
T ss_pred eeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEEEe
Confidence 455678999999999999975 79999999987652 12234578999999999999999999999999999999999
Q ss_pred cCCCCHHHHhccCCCCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEecCCCCeEEeeeeeecccccCCCC
Q 002158 703 VPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSRLAPVLDDE 782 (958)
Q Consensus 703 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~ 782 (958)
+++|-|.+++-.++ ++++.++.+++.||+.|+.|+|..+ |+|||+||+|+|+|..+++||+|||+|.+...
T Consensus 94 v~gGELFdylv~kG--~l~e~eaa~ff~QIi~gv~yCH~~~---icHRDLKpENlLLd~~~nIKIADFGMAsLe~~---- 164 (786)
T KOG0588|consen 94 VPGGELFDYLVRKG--PLPEREAAHFFRQILDGVSYCHAFN---ICHRDLKPENLLLDVKNNIKIADFGMASLEVP---- 164 (786)
T ss_pred cCCchhHHHHHhhC--CCCCHHHHHHHHHHHHHHHHHhhhc---ceeccCCchhhhhhcccCEeeeccceeecccC----
Confidence 99999999997654 4999999999999999999999999 99999999999999999999999999986422
Q ss_pred CCccceeeeeccCCCCccChhhhccCCCCC-cchhhhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcCcchhhhcccCC
Q 002158 783 GTMPTHVSTIVKGTPGYLDPEYFLTHKLTD-KSDVYSLGVVLLELLTGMQPISHGKNIVREVNVARDSGMVFSIIDNRMG 861 (958)
Q Consensus 783 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~-~~DV~S~Gv~l~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~i~~~~~ 861 (958)
......-+|++.|.|||++++.+|+- ++||||.||+||.|+||+.||++ +++...+... .....
T Consensus 165 ----gklLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdD-dNir~LLlKV----------~~G~f 229 (786)
T KOG0588|consen 165 ----GKLLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDD-DNIRVLLLKV----------QRGVF 229 (786)
T ss_pred ----CccccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCC-ccHHHHHHHH----------HcCcc
Confidence 23344568999999999999999875 99999999999999999999984 4443333222 22223
Q ss_pred CCChHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 002158 862 SYPSECVERFVTLALRCCHDKPEHRPSMSDVVRE 895 (958)
Q Consensus 862 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 895 (958)
++|...+.+..+|+.+|+..||++|-|++||++|
T Consensus 230 ~MPs~Is~eaQdLLr~ml~VDp~~RiT~~eI~kH 263 (786)
T KOG0588|consen 230 EMPSNISSEAQDLLRRMLDVDPSTRITTEEILKH 263 (786)
T ss_pred cCCCcCCHHHHHHHHHHhccCccccccHHHHhhC
Confidence 5578889999999999999999999999999987
|
|
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-38 Score=331.03 Aligned_cols=270 Identities=22% Similarity=0.364 Sum_probs=205.4
Q ss_pred HHHHHcCCCCCceeeeeCCeEEEEEEECCCcEEEEEEeccCChhcHHHHHHHHHHHHcc--CCCCcceEEEEEEeC----
Q 002158 620 LAMATAYFSSSTQVGQGGYGKVYKGILSDNTTVAIKRAEEGSLQGQNEFLTEIKLLSRL--HHRNLVSLLGYCDEE---- 693 (958)
Q Consensus 620 l~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l--~H~niv~l~~~~~~~---- 693 (958)
...........+.||+|.||+||+|.| .|+.||||++... +.+.+.+|.++++.. +|+||+.+++.-..+
T Consensus 206 QRTiarqI~L~e~IGkGRyGEVwrG~w-rGe~VAVKiF~sr---dE~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~ 281 (513)
T KOG2052|consen 206 QRTIARQIVLQEIIGKGRFGEVWRGRW-RGEDVAVKIFSSR---DERSWFRETEIYQTVMLRHENILGFIAADNKDNGSW 281 (513)
T ss_pred HHhhhheeEEEEEecCccccceeeccc-cCCceEEEEeccc---chhhhhhHHHHHHHHHhccchhhhhhhccccCCCce
Confidence 344455677889999999999999999 6889999999753 344567888888765 999999999986543
Q ss_pred CeEEEEEEecCCCCHHHHhccCCCCCchHHHHHHHHHHHHHHHHHhhh-----cCCCCeeccCCCccceEecCCCCeEEe
Q 002158 694 GEQMLVYEFVPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHT-----EAHPPVFHRDIKASNILLDSNLNAKVA 768 (958)
Q Consensus 694 ~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~-----~~~~~iiH~Dikp~NILl~~~~~~kl~ 768 (958)
.+++||++|.+.|||+|||... .++.+..++++..+|.||+|||. +|+|.|.|||||+.|||+..++.+.|+
T Consensus 282 TQLwLvTdYHe~GSL~DyL~r~---tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IA 358 (513)
T KOG2052|consen 282 TQLWLVTDYHEHGSLYDYLNRN---TVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIA 358 (513)
T ss_pred EEEEEeeecccCCcHHHHHhhc---cCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEe
Confidence 3689999999999999999764 38999999999999999999995 578999999999999999999999999
Q ss_pred eeeeecccccCCCCCCccceeeeeccCCCCccChhhhccCC------CCCcchhhhHHHHHHHHHhC----------CCC
Q 002158 769 DFGLSRLAPVLDDEGTMPTHVSTIVKGTPGYLDPEYFLTHK------LTDKSDVYSLGVVLLELLTG----------MQP 832 (958)
Q Consensus 769 DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~------~~~~~DV~S~Gv~l~elltG----------~~P 832 (958)
|+|+|...+...+.-..+ ....+||.+|||||++...- .-..+||||||.++||+..+ +.|
T Consensus 359 DLGLAv~h~~~t~~idi~---~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~P 435 (513)
T KOG2052|consen 359 DLGLAVRHDSDTDTIDIP---PNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLP 435 (513)
T ss_pred eceeeEEecccCCcccCC---CCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCC
Confidence 999998765544332222 23457999999999996431 12379999999999999874 446
Q ss_pred CCCC---chhHHHHHHHhhcCcchhhhcccCCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHh
Q 002158 833 ISHG---KNIVREVNVARDSGMVFSIIDNRMGSYPSECVERFVTLALRCCHDKPEHRPSMSDVVRELENILK 901 (958)
Q Consensus 833 ~~~~---~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~ 901 (958)
|.+- +...+.++...-.......+.+++ ...++...+.++|+.||..+|..|-++-.+-+.|.++.+
T Consensus 436 yyd~Vp~DPs~eeMrkVVCv~~~RP~ipnrW--~s~~~l~~m~klMkeCW~~Np~aRltALriKKtl~~l~~ 505 (513)
T KOG2052|consen 436 YYDVVPSDPSFEEMRKVVCVQKLRPNIPNRW--KSDPALRVMAKLMKECWYANPAARLTALRIKKTLAKLSN 505 (513)
T ss_pred cccCCCCCCCHHHHhcceeecccCCCCCccc--ccCHHHHHHHHHHHHhhcCCchhhhHHHHHHHHHHHHhc
Confidence 6432 111222221111111111111111 123677889999999999999999999999988888764
|
|
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-38 Score=319.22 Aligned_cols=258 Identities=24% Similarity=0.279 Sum_probs=205.8
Q ss_pred CCCCCceeeeeCCeEEEEEEEC-CCcEEEEEEeccCChhc--HHHHHHHHHHHHccCCCCcceEEEEEEe--CCeEEEEE
Q 002158 626 YFSSSTQVGQGGYGKVYKGILS-DNTTVAIKRAEEGSLQG--QNEFLTEIKLLSRLHHRNLVSLLGYCDE--EGEQMLVY 700 (958)
Q Consensus 626 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~--~~~~~~E~~~l~~l~H~niv~l~~~~~~--~~~~~lV~ 700 (958)
.|+..+.|++|+||.||+|+++ +++.||+|+++-..... --..++|+.+|.+++|||||.+-.+... -+..|+||
T Consensus 77 efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~VM 156 (419)
T KOG0663|consen 77 EFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYIVM 156 (419)
T ss_pred HHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeeeeH
Confidence 4666789999999999999986 68999999987543222 1235799999999999999999988754 45799999
Q ss_pred EecCCCCHHHHhccCCCCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEecCCCCeEEeeeeeecccccCC
Q 002158 701 EFVPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSRLAPVLD 780 (958)
Q Consensus 701 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~ 780 (958)
|||+. +|...++.-. +++...++.-+..|+++|++|||++. |+|||||++|+|+.+.|.+||+|||+||.+...
T Consensus 157 e~~Eh-DLksl~d~m~-q~F~~~evK~L~~QlL~glk~lH~~w---ilHRDLK~SNLLm~~~G~lKiaDFGLAR~ygsp- 230 (419)
T KOG0663|consen 157 EYVEH-DLKSLMETMK-QPFLPGEVKTLMLQLLRGLKHLHDNW---ILHRDLKTSNLLLSHKGILKIADFGLAREYGSP- 230 (419)
T ss_pred HHHHh-hHHHHHHhcc-CCCchHHHHHHHHHHHHHHHHHhhce---eEecccchhheeeccCCcEEecccchhhhhcCC-
Confidence 99965 9999997554 56999999999999999999999999 999999999999999999999999999976432
Q ss_pred CCCCccceeeeeccCCCCccChhhhccC-CCCCcchhhhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcCcchhhhccc
Q 002158 781 DEGTMPTHVSTIVKGTPGYLDPEYFLTH-KLTDKSDVYSLGVVLLELLTGMQPISHGKNIVREVNVARDSGMVFSIIDNR 859 (958)
Q Consensus 781 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DV~S~Gv~l~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~i~~~ 859 (958)
....+..+-|..|.|||.+.+. .|++..|+||+||++.||+++++-|.+...+.+.......-+...+.+.+.
T Consensus 231 ------~k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~iwpg 304 (419)
T KOG0663|consen 231 ------LKPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIWPG 304 (419)
T ss_pred ------cccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccccCCC
Confidence 2233456679999999999876 589999999999999999999988877666555544433333332222222
Q ss_pred CCC--------------------CChH-HHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 002158 860 MGS--------------------YPSE-CVERFVTLALRCCHDKPEHRPSMSDVVRE 895 (958)
Q Consensus 860 ~~~--------------------~~~~-~~~~l~~li~~cl~~dP~~RPs~~evl~~ 895 (958)
... ++.. ..+.-.+++...+..||++|-|++|.+++
T Consensus 305 ~~~lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h 361 (419)
T KOG0663|consen 305 YSELPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKH 361 (419)
T ss_pred ccccchhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhcc
Confidence 111 1111 34667899999999999999999999974
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-38 Score=338.73 Aligned_cols=261 Identities=21% Similarity=0.324 Sum_probs=206.5
Q ss_pred HHHcCCCCCceeeeeCCeEEEEEEEC-CCcEEEEEEeccCCh---hcHHHHHHHHHHHHccCCCCcceEEEEEEeCCeEE
Q 002158 622 MATAYFSSSTQVGQGGYGKVYKGILS-DNTTVAIKRAEEGSL---QGQNEFLTEIKLLSRLHHRNLVSLLGYCDEEGEQM 697 (958)
Q Consensus 622 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~ 697 (958)
...++|+..++||+|+||.||.|+-+ +|..+|+|++++... .+.+....|-.+|....+|+||+++-.|.+.+.+|
T Consensus 138 ~~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LY 217 (550)
T KOG0605|consen 138 LSLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLY 217 (550)
T ss_pred CCcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeE
Confidence 35678999999999999999999965 699999999987533 33456889999999999999999999999999999
Q ss_pred EEEEecCCCCHHHHhccCCCCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEecCCCCeEEeeeeeecccc
Q 002158 698 LVYEFVPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSRLAP 777 (958)
Q Consensus 698 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~~~ 777 (958)
|||||+|||++..+|...+ .|++..+..++.+++-|++.+|+.| +|||||||+|+|||..|++||+|||++.-+.
T Consensus 218 LiMEylPGGD~mTLL~~~~--~L~e~~arfYiaE~vlAI~~iH~~g---yIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~ 292 (550)
T KOG0605|consen 218 LIMEYLPGGDMMTLLMRKD--TLTEDWARFYIAETVLAIESIHQLG---YIHRDIKPDNLLIDAKGHIKLSDFGLSTGLD 292 (550)
T ss_pred EEEEecCCccHHHHHHhcC--cCchHHHHHHHHHHHHHHHHHHHcC---cccccCChhheeecCCCCEeeccccccchhh
Confidence 9999999999999997544 4999999999999999999999999 9999999999999999999999999995432
Q ss_pred cCC------------------CCCCcc-----ce-----------------eeeeccCCCCccChhhhccCCCCCcchhh
Q 002158 778 VLD------------------DEGTMP-----TH-----------------VSTIVKGTPGYLDPEYFLTHKLTDKSDVY 817 (958)
Q Consensus 778 ~~~------------------~~~~~~-----~~-----------------~~~~~~gt~~y~aPE~~~~~~~~~~~DV~ 817 (958)
... .....+ .. .....+|||.|||||++.+..|+..+|.|
T Consensus 293 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDwW 372 (550)
T KOG0605|consen 293 KKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDWW 372 (550)
T ss_pred hhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccHH
Confidence 100 000011 00 11235799999999999999999999999
Q ss_pred hHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcCcchhhhcccCCCCChHHHHHHHHHHHHccccCCCCCCC---HHHHHH
Q 002158 818 SLGVVLLELLTGMQPISHGKNIVREVNVARDSGMVFSIIDNRMGSYPSECVERFVTLALRCCHDKPEHRPS---MSDVVR 894 (958)
Q Consensus 818 S~Gv~l~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs---~~evl~ 894 (958)
|+||++|||+.|-+||........+-... ........ .-...+..+..++|.+|+. ||++|-- ++||-+
T Consensus 373 SLG~ImyEmLvGyPPF~s~tp~~T~rkI~-nwr~~l~f------P~~~~~s~eA~DLI~rll~-d~~~RLG~~G~~EIK~ 444 (550)
T KOG0605|consen 373 SLGCIMYEMLVGYPPFCSETPQETYRKIV-NWRETLKF------PEEVDLSDEAKDLITRLLC-DPENRLGSKGAEEIKK 444 (550)
T ss_pred HHHHHHHHHHhCCCCCCCCCHHHHHHHHH-HHhhhccC------CCcCcccHHHHHHHHHHhc-CHHHhcCcccHHHHhc
Confidence 99999999999999998655433222211 10000000 0012344888999999999 9999964 666654
Q ss_pred H
Q 002158 895 E 895 (958)
Q Consensus 895 ~ 895 (958)
+
T Consensus 445 H 445 (550)
T KOG0605|consen 445 H 445 (550)
T ss_pred C
Confidence 3
|
|
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=341.73 Aligned_cols=259 Identities=24% Similarity=0.284 Sum_probs=202.2
Q ss_pred CCCCCceeeeeCCeEEEEEEEC-CCcEEEEEEeccCC--hhcHHHHHHHHHHHHccCCCCcceEEEEEEeCCeEEEEEEe
Q 002158 626 YFSSSTQVGQGGYGKVYKGILS-DNTTVAIKRAEEGS--LQGQNEFLTEIKLLSRLHHRNLVSLLGYCDEEGEQMLVYEF 702 (958)
Q Consensus 626 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E~ 702 (958)
+|...+.||+|+||+||+|+++ +++.||||++.... ....+.+.+|++++++++||||+++++++..++..++||||
T Consensus 2 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (287)
T cd07848 2 KFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFEY 81 (287)
T ss_pred CceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEec
Confidence 6788899999999999999986 68899999987542 22345688999999999999999999999999999999999
Q ss_pred cCCCCHHHHhccCCCCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEecCCCCeEEeeeeeecccccCCCC
Q 002158 703 VPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSRLAPVLDDE 782 (958)
Q Consensus 703 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~ 782 (958)
++++.+..+.... ..+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+++.......
T Consensus 82 ~~~~~l~~~~~~~--~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~- 155 (287)
T cd07848 82 VEKNMLELLEEMP--NGVPPEKVRSYIYQLIKAIHWCHKND---IVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSN- 155 (287)
T ss_pred CCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEEeeccCccccccccc-
Confidence 9987776655332 34889999999999999999999999 99999999999999999999999999986532111
Q ss_pred CCccceeeeeccCCCCccChhhhccCCCCCcchhhhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcCcc----------
Q 002158 783 GTMPTHVSTIVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVLLELLTGMQPISHGKNIVREVNVARDSGMV---------- 852 (958)
Q Consensus 783 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gv~l~elltG~~P~~~~~~~~~~~~~~~~~~~~---------- 852 (958)
.......||+.|+|||++.+..++.++|||||||++|||++|+.||................+..
T Consensus 156 -----~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (287)
T cd07848 156 -----ANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYS 230 (287)
T ss_pred -----ccccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhc
Confidence 11123468999999999999899999999999999999999999997644322211111100000
Q ss_pred ----hhhhcccC-------CCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 002158 853 ----FSIIDNRM-------GSYPSECVERFVTLALRCCHDKPEHRPSMSDVVRE 895 (958)
Q Consensus 853 ----~~~i~~~~-------~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 895 (958)
.....+.. .......+..+.+++.+|++.||++|||++|++++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~h 284 (287)
T cd07848 231 NPRFHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNH 284 (287)
T ss_pred cchhcccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence 00000000 00112356679999999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-37 Score=344.85 Aligned_cols=242 Identities=23% Similarity=0.285 Sum_probs=199.6
Q ss_pred ceeeeeCCeEEEEEEEC-CCcEEEEEEeccCC---hhcHHHHHHHHHHHHccCCCCcceEEEEEEeCCeEEEEEEecCCC
Q 002158 631 TQVGQGGYGKVYKGILS-DNTTVAIKRAEEGS---LQGQNEFLTEIKLLSRLHHRNLVSLLGYCDEEGEQMLVYEFVPNG 706 (958)
Q Consensus 631 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E~~~~g 706 (958)
+.||+|+||.||++... +|+.||+|++.... ......+.+|+++++.++||||+++++++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence 36999999999999975 68999999987532 233456788999999999999999999999999999999999999
Q ss_pred CHHHHhccCCCCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEecCCCCeEEeeeeeecccccCCCCCCcc
Q 002158 707 TLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSRLAPVLDDEGTMP 786 (958)
Q Consensus 707 sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~ 786 (958)
+|.+++.... .+++..+..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+++......
T Consensus 81 ~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~------ 149 (323)
T cd05595 81 ELFFHLSRER--VFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG------ 149 (323)
T ss_pred cHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEEcCCCCEEecccHHhccccCCC------
Confidence 9999986543 4899999999999999999999999 9999999999999999999999999987431111
Q ss_pred ceeeeeccCCCCccChhhhccCCCCCcchhhhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcCcchhhhcccCCCCChH
Q 002158 787 THVSTIVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVLLELLTGMQPISHGKNIVREVNVARDSGMVFSIIDNRMGSYPSE 866 (958)
Q Consensus 787 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gv~l~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~ 866 (958)
.......||+.|+|||++.+..++.++|||||||++|||++|+.||........ ..... .....+|..
T Consensus 150 -~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~-~~~~~----------~~~~~~p~~ 217 (323)
T cd05595 150 -ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERL-FELIL----------MEEIRFPRT 217 (323)
T ss_pred -CccccccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHHHH-HHHHh----------cCCCCCCCC
Confidence 112235699999999999999999999999999999999999999975432211 11111 111123455
Q ss_pred HHHHHHHHHHHccccCCCCCC-----CHHHHHHH
Q 002158 867 CVERFVTLALRCCHDKPEHRP-----SMSDVVRE 895 (958)
Q Consensus 867 ~~~~l~~li~~cl~~dP~~RP-----s~~evl~~ 895 (958)
++..+.+++.+||+.||++|| ++.+++++
T Consensus 218 ~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~h 251 (323)
T cd05595 218 LSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH 251 (323)
T ss_pred CCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHcC
Confidence 678899999999999999998 88888864
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=352.93 Aligned_cols=244 Identities=26% Similarity=0.406 Sum_probs=206.8
Q ss_pred HHHcCCCCCceeeeeCCeEEEEEEEC-CCcEEEEEEeccCC---hhcHHHHHHHHHHHHcc-CCCCcceEEEEEEeCCeE
Q 002158 622 MATAYFSSSTQVGQGGYGKVYKGILS-DNTTVAIKRAEEGS---LQGQNEFLTEIKLLSRL-HHRNLVSLLGYCDEEGEQ 696 (958)
Q Consensus 622 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~ 696 (958)
...++|...++||+|.||+|+++..+ +++.+|||++++.. ..+.+..+.|.+++... +||.++.++.++...+++
T Consensus 365 ~~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l 444 (694)
T KOG0694|consen 365 LTLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHL 444 (694)
T ss_pred ccccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCeE
Confidence 34567888999999999999999987 68899999998864 33455678898888887 599999999999999999
Q ss_pred EEEEEecCCCCHHHHhccCCCCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEecCCCCeEEeeeeeeccc
Q 002158 697 MLVYEFVPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSRLA 776 (958)
Q Consensus 697 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~~ 776 (958)
|+||||+.||++..+.+. ..+++..+.-++..++.||+|||+++ ||+||||-+|||+|.+|.+||+|||+++..
T Consensus 445 ~fvmey~~Ggdm~~~~~~---~~F~e~rarfyaAev~l~L~fLH~~~---IIYRDlKLdNiLLD~eGh~kiADFGlcKe~ 518 (694)
T KOG0694|consen 445 FFVMEYVAGGDLMHHIHT---DVFSEPRARFYAAEVVLGLQFLHENG---IIYRDLKLDNLLLDTEGHVKIADFGLCKEG 518 (694)
T ss_pred EEEEEecCCCcEEEEEec---ccccHHHHHHHHHHHHHHHHHHHhcC---ceeeecchhheEEcccCcEEeccccccccc
Confidence 999999999995555543 34999999999999999999999999 999999999999999999999999999853
Q ss_pred ccCCCCCCccceeeeeccCCCCccChhhhccCCCCCcchhhhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcCcchhhh
Q 002158 777 PVLDDEGTMPTHVSTIVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVLLELLTGMQPISHGKNIVREVNVARDSGMVFSII 856 (958)
Q Consensus 777 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gv~l~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~i 856 (958)
.. ....+.+++||+.|||||++.+..|+.++|.|||||+||||+.|+.||.++... +. ++.|
T Consensus 519 m~-------~g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEe-e~----------FdsI 580 (694)
T KOG0694|consen 519 MG-------QGDRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEE-EV----------FDSI 580 (694)
T ss_pred CC-------CCCccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHH-HH----------HHHH
Confidence 21 233456789999999999999999999999999999999999999999754432 11 2222
Q ss_pred cccCCCCChHHHHHHHHHHHHccccCCCCCCCH
Q 002158 857 DNRMGSYPSECVERFVTLALRCCHDKPEHRPSM 889 (958)
Q Consensus 857 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~ 889 (958)
-..-..+|..++.+..+|+.+++..+|++|.-+
T Consensus 581 ~~d~~~yP~~ls~ea~~il~~ll~k~p~kRLG~ 613 (694)
T KOG0694|consen 581 VNDEVRYPRFLSKEAIAIMRRLLRKNPEKRLGS 613 (694)
T ss_pred hcCCCCCCCcccHHHHHHHHHHhccCcccccCC
Confidence 222345688899999999999999999999765
|
|
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-38 Score=349.91 Aligned_cols=252 Identities=27% Similarity=0.339 Sum_probs=205.0
Q ss_pred CCCCCceeeeeCCeEEEEEEEC-CCcEEEEEEeccCC---hhcHHHHHHHHHHHHccCCCCcceEEEEEEeCCeEEEEEE
Q 002158 626 YFSSSTQVGQGGYGKVYKGILS-DNTTVAIKRAEEGS---LQGQNEFLTEIKLLSRLHHRNLVSLLGYCDEEGEQMLVYE 701 (958)
Q Consensus 626 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E 701 (958)
+|+..+.||+|+||.||+|.+. +++.||||++.... ....+.+.+|+++++.++||||+++++++...+..++|||
T Consensus 2 ~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e 81 (333)
T cd05600 2 DFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAME 81 (333)
T ss_pred CcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEEe
Confidence 5788899999999999999986 58899999987532 2234568899999999999999999999999999999999
Q ss_pred ecCCCCHHHHhccCCCCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEecCCCCeEEeeeeeecccccCCC
Q 002158 702 FVPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSRLAPVLDD 781 (958)
Q Consensus 702 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~ 781 (958)
|+++|+|.+++.... .+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++....
T Consensus 82 ~~~g~~L~~~l~~~~--~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~--- 153 (333)
T cd05600 82 YVPGGDFRTLLNNLG--VLSEDHARFYMAEMFEAVDALHELG---YIHRDLKPENFLIDASGHIKLTDFGLSKGIVT--- 153 (333)
T ss_pred CCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCCEEEEeCcCCccccc---
Confidence 999999999997543 4889999999999999999999999 99999999999999999999999999875422
Q ss_pred CCCccceeeeeccCCCCccChhhhccCCCCCcchhhhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcCcchhhhcccCC
Q 002158 782 EGTMPTHVSTIVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVLLELLTGMQPISHGKNIVREVNVARDSGMVFSIIDNRMG 861 (958)
Q Consensus 782 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gv~l~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~i~~~~~ 861 (958)
......||+.|+|||++.+..++.++|||||||++|||++|+.||........ ............ .+...
T Consensus 154 -------~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~-~~~i~~~~~~~~--~~~~~ 223 (333)
T cd05600 154 -------YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNET-WENLKYWKETLQ--RPVYD 223 (333)
T ss_pred -------ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHHH-HHHHHhcccccc--CCCCC
Confidence 12335699999999999999999999999999999999999999975433221 111111000000 00000
Q ss_pred CCChHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 002158 862 SYPSECVERFVTLALRCCHDKPEHRPSMSDVVRE 895 (958)
Q Consensus 862 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 895 (958)
......+.++.+++.+|+..+|++||++++++++
T Consensus 224 ~~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h 257 (333)
T cd05600 224 DPRFNLSDEAWDLITKLINDPSRRFGSLEDIKNH 257 (333)
T ss_pred ccccccCHHHHHHHHHHhhChhhhcCCHHHHHhC
Confidence 0012456788999999999999999999999976
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-38 Score=359.71 Aligned_cols=263 Identities=24% Similarity=0.395 Sum_probs=213.6
Q ss_pred cCCCCCceeeeeCCeEEEEEEECCC-cEEEEEEeccCChhcHHHHHHHHHHHHccC-CCCcceEEEE-EE---e---CCe
Q 002158 625 AYFSSSTQVGQGGYGKVYKGILSDN-TTVAIKRAEEGSLQGQNEFLTEIKLLSRLH-HRNLVSLLGY-CD---E---EGE 695 (958)
Q Consensus 625 ~~~~~~~~lg~G~~g~Vy~~~~~~~-~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~~~-~~---~---~~~ 695 (958)
.+.++.+.|.+|||+.||.|.+..+ ..||+|++...+..+.+...+|+++|+.+. |+|||.+++. .. . .-+
T Consensus 37 ~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~~E 116 (738)
T KOG1989|consen 37 HRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGVWE 116 (738)
T ss_pred EEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCceeE
Confidence 3455678999999999999998765 999999998878888888999999999996 9999999993 21 1 236
Q ss_pred EEEEEEecCCCCHHHHhccCCCCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEecCCCCeEEeeeeeecc
Q 002158 696 QMLVYEFVPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSRL 775 (958)
Q Consensus 696 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~ 775 (958)
++|.||||+||.|-|++..+....|++.++++|+.|+++|+++||... +||||||||-+||||..++..||||||.|.-
T Consensus 117 vllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~~-pPiIHRDLKiENvLls~~g~~KLCDFGSatt 195 (738)
T KOG1989|consen 117 VLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYLK-PPIIHRDLKIENVLLSADGNYKLCDFGSATT 195 (738)
T ss_pred EEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcCC-CccchhhhhhhheEEcCCCCEEeCccccccc
Confidence 789999999999999998776666999999999999999999999875 8999999999999999999999999999863
Q ss_pred cccCC--CCCCccceeeeeccCCCCccChhhh---ccCCCCCcchhhhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcC
Q 002158 776 APVLD--DEGTMPTHVSTIVKGTPGYLDPEYF---LTHKLTDKSDVYSLGVVLLELLTGMQPISHGKNIVREVNVARDSG 850 (958)
Q Consensus 776 ~~~~~--~~~~~~~~~~~~~~gt~~y~aPE~~---~~~~~~~~~DV~S~Gv~l~elltG~~P~~~~~~~~~~~~~~~~~~ 850 (958)
-.... ..+...-.......-|+-|+|||++ .+...+.|+||||+||+||-|+-...||++...+
T Consensus 196 ~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~l----------- 264 (738)
T KOG1989|consen 196 KILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGKL----------- 264 (738)
T ss_pred ccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcce-----------
Confidence 21111 0010001112233478999999998 4668899999999999999999999999864321
Q ss_pred cchhhhcccCCCCC--hHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHhhC
Q 002158 851 MVFSIIDNRMGSYP--SECVERFVTLALRCCHDKPEHRPSMSDVVRELENILKMF 903 (958)
Q Consensus 851 ~~~~~i~~~~~~~~--~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~ 903 (958)
.++.... .+| +.+...+.+||..||+.||.+||++.+|+.++.++...-
T Consensus 265 ---aIlng~Y-~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~~~~ 315 (738)
T KOG1989|consen 265 ---AILNGNY-SFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELANKP 315 (738)
T ss_pred ---eEEeccc-cCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHhcCC
Confidence 1222222 222 478899999999999999999999999999998887544
|
|
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-38 Score=350.51 Aligned_cols=245 Identities=24% Similarity=0.347 Sum_probs=203.1
Q ss_pred cCCCCCceeeeeCCeEEEEEEECC--CcEEEEEEeccCC---hhcHHHHHHHHHHHHccCCCCcceEEEEEEeCCeEEEE
Q 002158 625 AYFSSSTQVGQGGYGKVYKGILSD--NTTVAIKRAEEGS---LQGQNEFLTEIKLLSRLHHRNLVSLLGYCDEEGEQMLV 699 (958)
Q Consensus 625 ~~~~~~~~lg~G~~g~Vy~~~~~~--~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV 699 (958)
++|...+.||+|+||.||+|.++. +..||+|++.... ....+.+.+|+++++.++||||+++++++.+++..++|
T Consensus 30 ~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv 109 (340)
T PTZ00426 30 EDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYLV 109 (340)
T ss_pred hhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEEEE
Confidence 467888999999999999998653 3689999986432 22345688999999999999999999999999999999
Q ss_pred EEecCCCCHHHHhccCCCCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEecCCCCeEEeeeeeecccccC
Q 002158 700 YEFVPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSRLAPVL 779 (958)
Q Consensus 700 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~~~~~ 779 (958)
|||+++|+|.+++.... .+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++....
T Consensus 110 ~Ey~~~g~L~~~i~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~~- 183 (340)
T PTZ00426 110 LEFVIGGEFFTFLRRNK--RFPNDVGCFYAAQIVLIFEYLQSLN---IVYRDLKPENLLLDKDGFIKMTDFGFAKVVDT- 183 (340)
T ss_pred EeCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC---eEccCCCHHHEEECCCCCEEEecCCCCeecCC-
Confidence 99999999999997544 4889999999999999999999999 99999999999999999999999999975421
Q ss_pred CCCCCccceeeeeccCCCCccChhhhccCCCCCcchhhhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcCcchhhhccc
Q 002158 780 DDEGTMPTHVSTIVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVLLELLTGMQPISHGKNIVREVNVARDSGMVFSIIDNR 859 (958)
Q Consensus 780 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gv~l~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~i~~~ 859 (958)
......||+.|+|||++.+..++.++|||||||++|||++|..||......... .... ..
T Consensus 184 ---------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~-~~i~----------~~ 243 (340)
T PTZ00426 184 ---------RTYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPLLIY-QKIL----------EG 243 (340)
T ss_pred ---------CcceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHHHHH-HHHh----------cC
Confidence 112356999999999999988999999999999999999999999765432211 1111 11
Q ss_pred CCCCChHHHHHHHHHHHHccccCCCCCC-----CHHHHHHH
Q 002158 860 MGSYPSECVERFVTLALRCCHDKPEHRP-----SMSDVVRE 895 (958)
Q Consensus 860 ~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~~ 895 (958)
...+|...+..+.+++.+|++.||++|+ ++++++++
T Consensus 244 ~~~~p~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~h 284 (340)
T PTZ00426 244 IIYFPKFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEH 284 (340)
T ss_pred CCCCCCCCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcC
Confidence 1223445567789999999999999995 88888765
|
|
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=335.23 Aligned_cols=255 Identities=26% Similarity=0.445 Sum_probs=209.3
Q ss_pred HcCCCCCceeeeeCCeEEEEEEECCCcEEEEEEeccCChhcHHHHHHHHHHHHccCCCCcceEEEEEEeCCeEEEEEEec
Q 002158 624 TAYFSSSTQVGQGGYGKVYKGILSDNTTVAIKRAEEGSLQGQNEFLTEIKLLSRLHHRNLVSLLGYCDEEGEQMLVYEFV 703 (958)
Q Consensus 624 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E~~ 703 (958)
.++|+..+.||+|+||.||+|...++..||+|.+.... ...+.+.+|+.++++++|+||+++++++...+..++||||+
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 83 (261)
T cd05072 5 RESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGT-MSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEYM 83 (261)
T ss_pred hHHeEEeeecCCcCCceEEEEEecCCceEEEEEccCCc-hhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEecC
Confidence 35678889999999999999998888899999987543 23567999999999999999999999999999999999999
Q ss_pred CCCCHHHHhccCCCCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEecCCCCeEEeeeeeecccccCCCCC
Q 002158 704 PNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSRLAPVLDDEG 783 (958)
Q Consensus 704 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 783 (958)
++++|.++++......+++.+++.++.|++.||+|||+.+ ++||||||+||+++.++.++|+|||+++.......
T Consensus 84 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~-- 158 (261)
T cd05072 84 AKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKN---YIHRDLRAANVLVSESLMCKIADFGLARVIEDNEY-- 158 (261)
T ss_pred CCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhhEEecCCCcEEECCCccceecCCCce--
Confidence 9999999997665556899999999999999999999998 99999999999999999999999999986532110
Q ss_pred CccceeeeeccCCCCccChhhhccCCCCCcchhhhHHHHHHHHHh-CCCCCCCCchhHHHHHHHhhcCcchhhhcccCCC
Q 002158 784 TMPTHVSTIVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVLLELLT-GMQPISHGKNIVREVNVARDSGMVFSIIDNRMGS 862 (958)
Q Consensus 784 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gv~l~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~ 862 (958)
.......++..|+|||++....++.++|||||||++|||+| |..||....... ..... .... ...
T Consensus 159 ----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~-~~~~~-~~~~--------~~~ 224 (261)
T cd05072 159 ----TAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSD-VMSAL-QRGY--------RMP 224 (261)
T ss_pred ----eccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHHH-HHHHH-HcCC--------CCC
Confidence 11122346678999999998889999999999999999999 999996533211 11111 1110 111
Q ss_pred CChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 002158 863 YPSECVERFVTLALRCCHDKPEHRPSMSDVVRELEN 898 (958)
Q Consensus 863 ~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 898 (958)
.+..++..+.+++.+|++.+|++||+++++.+.|++
T Consensus 225 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 260 (261)
T cd05072 225 RMENCPDELYDIMKTCWKEKAEERPTFDYLQSVLDD 260 (261)
T ss_pred CCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 223456788999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=340.57 Aligned_cols=255 Identities=33% Similarity=0.566 Sum_probs=207.8
Q ss_pred CCCCCceeeeeCCeEEEEEEECC------CcEEEEEEeccCC-hhcHHHHHHHHHHHHccCCCCcceEEEEEEeCCeEEE
Q 002158 626 YFSSSTQVGQGGYGKVYKGILSD------NTTVAIKRAEEGS-LQGQNEFLTEIKLLSRLHHRNLVSLLGYCDEEGEQML 698 (958)
Q Consensus 626 ~~~~~~~lg~G~~g~Vy~~~~~~------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~l 698 (958)
+|+..+.||+|+||.||+|.... ...||+|.+.... .....+|.+|++++++++||||+++++++...+..++
T Consensus 6 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~ 85 (283)
T cd05048 6 AVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTCM 85 (283)
T ss_pred HcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCceEE
Confidence 56778899999999999998643 2579999987543 3334678999999999999999999999999999999
Q ss_pred EEEecCCCCHHHHhccCCC--------------CCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEecCCCC
Q 002158 699 VYEFVPNGTLRDWLSGRTK--------------ENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSNLN 764 (958)
Q Consensus 699 V~E~~~~gsL~~~l~~~~~--------------~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~~~ 764 (958)
+|||+++++|.+++..... ..+++.++..++.|++.||+|||+.+ ++||||||+||++++++.
T Consensus 86 ~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~---i~H~dlkp~Nil~~~~~~ 162 (283)
T cd05048 86 LFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHH---FVHRDLAARNCLVGEGLT 162 (283)
T ss_pred EEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccccceEEEcCCCc
Confidence 9999999999999975421 45888999999999999999999999 999999999999999999
Q ss_pred eEEeeeeeecccccCCCCCCccceeeeeccCCCCccChhhhccCCCCCcchhhhHHHHHHHHHh-CCCCCCCCchhHHHH
Q 002158 765 AKVADFGLSRLAPVLDDEGTMPTHVSTIVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVLLELLT-GMQPISHGKNIVREV 843 (958)
Q Consensus 765 ~kl~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gv~l~ellt-G~~P~~~~~~~~~~~ 843 (958)
+||+|||+++.....+. ........+++.|+|||++.+..++.++|||||||++|||++ |..||...... +..
T Consensus 163 ~~L~dfg~~~~~~~~~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~-~~~ 236 (283)
T cd05048 163 VKISDFGLSRDIYSADY-----YRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQ-EVI 236 (283)
T ss_pred EEECCCcceeecccccc-----ccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHH-HHH
Confidence 99999999975432111 111223346788999999998999999999999999999998 99999753321 111
Q ss_pred HHHhhcCcchhhhcccCCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 002158 844 NVARDSGMVFSIIDNRMGSYPSECVERFVTLALRCCHDKPEHRPSMSDVVRELEN 898 (958)
Q Consensus 844 ~~~~~~~~~~~~i~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 898 (958)
... ........+..++.++.+++.+||+.||++||+++||+++|++
T Consensus 237 ~~i---------~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05048 237 EMI---------RSRQLLPCPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRS 282 (283)
T ss_pred HHH---------HcCCcCCCcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhc
Confidence 111 1112233456778999999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-37 Score=345.03 Aligned_cols=259 Identities=22% Similarity=0.344 Sum_probs=205.6
Q ss_pred HcCCCCCceeeeeCCeEEEEEEEC-CCcEEEEEEeccCC-hhcHHHHHHHHHHHHccCCCCcceEEEEEEeCCeEEEEEE
Q 002158 624 TAYFSSSTQVGQGGYGKVYKGILS-DNTTVAIKRAEEGS-LQGQNEFLTEIKLLSRLHHRNLVSLLGYCDEEGEQMLVYE 701 (958)
Q Consensus 624 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E 701 (958)
.++|+..+.||+|+||.||+++++ ++..||+|.+.... ....+++.+|++++++++||||+++++++..++..++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 83 (331)
T cd06649 4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 83 (331)
T ss_pred cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEee
Confidence 467888999999999999999986 68899999987642 3345679999999999999999999999999999999999
Q ss_pred ecCCCCHHHHhccCCCCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEecCCCCeEEeeeeeecccccCCC
Q 002158 702 FVPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSRLAPVLDD 781 (958)
Q Consensus 702 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~ 781 (958)
|+++|+|.+++.... .+++..+..++.|++.||.|||+.+. |+||||||+|||++.++.+||+|||+++.....
T Consensus 84 ~~~~~~L~~~l~~~~--~~~~~~~~~~~~~i~~~l~~lH~~~~--ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~-- 157 (331)
T cd06649 84 HMDGGSLDQVLKEAK--RIPEEILGKVSIAVLRGLAYLREKHQ--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-- 157 (331)
T ss_pred cCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHhhcCC--EEcCCCChhhEEEcCCCcEEEccCccccccccc--
Confidence 999999999997543 38899999999999999999998532 999999999999999999999999998754211
Q ss_pred CCCccceeeeeccCCCCccChhhhccCCCCCcchhhhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhc-----C-c----
Q 002158 782 EGTMPTHVSTIVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVLLELLTGMQPISHGKNIVREVNVARDS-----G-M---- 851 (958)
Q Consensus 782 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gv~l~elltG~~P~~~~~~~~~~~~~~~~~-----~-~---- 851 (958)
......||..|+|||++.+..++.++|||||||++|||++|+.||....... ........ . .
T Consensus 158 -------~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~ 229 (331)
T cd06649 158 -------MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKE-LEAIFGRPVVDGEEGEPHSI 229 (331)
T ss_pred -------ccccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHhcccccccccCCcccc
Confidence 1123468999999999999999999999999999999999999996433211 11000000 0 0
Q ss_pred -----------------------chh----hhcccCCCC-ChHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 002158 852 -----------------------VFS----IIDNRMGSY-PSECVERFVTLALRCCHDKPEHRPSMSDVVREL 896 (958)
Q Consensus 852 -----------------------~~~----~i~~~~~~~-~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 896 (958)
..+ ++....... ....+.++.+++.+||+.||++||+++|++++-
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h~ 302 (331)
T cd06649 230 SPRPRPPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNHT 302 (331)
T ss_pred CcccccccccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcCh
Confidence 000 000001111 123567899999999999999999999999863
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-37 Score=352.50 Aligned_cols=262 Identities=25% Similarity=0.394 Sum_probs=208.5
Q ss_pred HHcCCCCCceeeeeCCeEEEEEEEC------CCcEEEEEEeccCC-hhcHHHHHHHHHHHHccC-CCCcceEEEEEEeCC
Q 002158 623 ATAYFSSSTQVGQGGYGKVYKGILS------DNTTVAIKRAEEGS-LQGQNEFLTEIKLLSRLH-HRNLVSLLGYCDEEG 694 (958)
Q Consensus 623 ~~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~~ 694 (958)
..++|.+.+.||+|+||.||+|++. .+..||||++.... ....+.|.+|+++++++. ||||++++++|...+
T Consensus 35 ~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~~ 114 (400)
T cd05105 35 PRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTKSG 114 (400)
T ss_pred cccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccCC
Confidence 3457788899999999999999863 13469999997543 333467999999999996 999999999999999
Q ss_pred eEEEEEEecCCCCHHHHhccCC----------------------------------------------------------
Q 002158 695 EQMLVYEFVPNGTLRDWLSGRT---------------------------------------------------------- 716 (958)
Q Consensus 695 ~~~lV~E~~~~gsL~~~l~~~~---------------------------------------------------------- 716 (958)
..++||||+++|+|.++++...
T Consensus 115 ~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 194 (400)
T cd05105 115 PIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLEI 194 (400)
T ss_pred ceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhhh
Confidence 9999999999999999986431
Q ss_pred ------------------------------------CCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEec
Q 002158 717 ------------------------------------KENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLD 760 (958)
Q Consensus 717 ------------------------------------~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~ 760 (958)
...+++.++..++.|+++||+|||+.+ |+||||||+|||++
T Consensus 195 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivH~dikp~Nill~ 271 (400)
T cd05105 195 KEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKN---CVHRDLAARNVLLA 271 (400)
T ss_pred hhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChHhEEEe
Confidence 123778888999999999999999998 99999999999999
Q ss_pred CCCCeEEeeeeeecccccCCCCCCccceeeeeccCCCCccChhhhccCCCCCcchhhhHHHHHHHHHh-CCCCCCCCchh
Q 002158 761 SNLNAKVADFGLSRLAPVLDDEGTMPTHVSTIVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVLLELLT-GMQPISHGKNI 839 (958)
Q Consensus 761 ~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gv~l~ellt-G~~P~~~~~~~ 839 (958)
.++.+||+|||+++....... ........++..|+|||.+.+..++.++|||||||++|||++ |..||......
T Consensus 272 ~~~~~kL~DfGla~~~~~~~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~ 346 (400)
T cd05105 272 QGKIVKICDFGLARDIMHDSN-----YVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVD 346 (400)
T ss_pred CCCEEEEEeCCcceecccccc-----ccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchh
Confidence 999999999999976532111 111122346788999999999999999999999999999997 99998653221
Q ss_pred HHHHHHHhhcCcchhhhcccCCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHh
Q 002158 840 VREVNVARDSGMVFSIIDNRMGSYPSECVERFVTLALRCCHDKPEHRPSMSDVVRELENILK 901 (958)
Q Consensus 840 ~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~ 901 (958)
......... ......+..++..+.+++.+||+.||++||++.++.+.|+++.+
T Consensus 347 ~~~~~~~~~---------~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~l~~ 399 (400)
T cd05105 347 STFYNKIKS---------GYRMAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESLLP 399 (400)
T ss_pred HHHHHHHhc---------CCCCCCCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHHHcC
Confidence 111111111 11112345567889999999999999999999999999988653
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-37 Score=333.12 Aligned_cols=251 Identities=31% Similarity=0.493 Sum_probs=204.7
Q ss_pred cCCCCCceeeeeCCeEEEEEEECCCcEEEEEEeccCChhcHHHHHHHHHHHHccCCCCcceEEEEEEeCCeEEEEEEecC
Q 002158 625 AYFSSSTQVGQGGYGKVYKGILSDNTTVAIKRAEEGSLQGQNEFLTEIKLLSRLHHRNLVSLLGYCDEEGEQMLVYEFVP 704 (958)
Q Consensus 625 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E~~~ 704 (958)
++|+..+.||+|+||.||+|.++++..+|+|.+.... ...++|.+|++++++++||||+++++++...+..++||||++
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~ 82 (256)
T cd05114 4 SELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEGA-MSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFME 82 (256)
T ss_pred HHcEEeeEecCCcCceEEEEEeccCceEEEEecccCC-ccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcCC
Confidence 3567778999999999999999888899999887543 334678999999999999999999999999999999999999
Q ss_pred CCCHHHHhccCCCCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEecCCCCeEEeeeeeecccccCCCCCC
Q 002158 705 NGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSRLAPVLDDEGT 784 (958)
Q Consensus 705 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 784 (958)
+|+|.++++... ..+++..+..++.|++.||+|||+.+ |+||||||+||++++++.+||+|||.++......
T Consensus 83 ~~~L~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~---- 154 (256)
T cd05114 83 NGCLLNYLRQRQ-GKLSKDMLLSMCQDVCEGMEYLERNS---FIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDE---- 154 (256)
T ss_pred CCcHHHHHHhCc-cCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccCcceEEEcCCCeEEECCCCCccccCCCc----
Confidence 999999997543 24899999999999999999999999 9999999999999999999999999987542211
Q ss_pred ccceeeeeccCCCCccChhhhccCCCCCcchhhhHHHHHHHHHh-CCCCCCCCchhHHHHHHHhhcCcchhhhcccCCCC
Q 002158 785 MPTHVSTIVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVLLELLT-GMQPISHGKNIVREVNVARDSGMVFSIIDNRMGSY 863 (958)
Q Consensus 785 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gv~l~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~ 863 (958)
........++..|+|||++.+..++.++||||||+++|||++ |+.||...... ......... .....
T Consensus 155 --~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~-~~~~~i~~~---------~~~~~ 222 (256)
T cd05114 155 --YTSSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNY-EVVEMISRG---------FRLYR 222 (256)
T ss_pred --eeccCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCHH-HHHHHHHCC---------CCCCC
Confidence 111122335678999999988889999999999999999999 89999654322 222211111 11112
Q ss_pred ChHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 002158 864 PSECVERFVTLALRCCHDKPEHRPSMSDVVREL 896 (958)
Q Consensus 864 ~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 896 (958)
+...+..+.+++.+||+.+|++||+++++++.|
T Consensus 223 ~~~~~~~~~~li~~c~~~~p~~Rps~~~l~~~l 255 (256)
T cd05114 223 PKLASMTVYEVMYSCWHEKPEGRPTFAELLRAI 255 (256)
T ss_pred CCCCCHHHHHHHHHHccCCcccCcCHHHHHHhh
Confidence 333457889999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-38 Score=332.35 Aligned_cols=257 Identities=29% Similarity=0.415 Sum_probs=202.9
Q ss_pred HHcCCCCCceeeeeCCeEEEEEEEC-CCcEEEEEEeccCChh--------------cHHHHHHHHHHHHccCCCCcceEE
Q 002158 623 ATAYFSSSTQVGQGGYGKVYKGILS-DNTTVAIKRAEEGSLQ--------------GQNEFLTEIKLLSRLHHRNLVSLL 687 (958)
Q Consensus 623 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--------------~~~~~~~E~~~l~~l~H~niv~l~ 687 (958)
.-++|.+.+.||+|.||.|-+|+.. +++.||||++.+.... ..+...+|+.+|++++|||||+++
T Consensus 95 ~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~Li 174 (576)
T KOG0585|consen 95 QLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKLI 174 (576)
T ss_pred ehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEEE
Confidence 3467888899999999999999975 7999999998653211 124678999999999999999999
Q ss_pred EEEEeC--CeEEEEEEecCCCCHHHHhccCCCCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEecCCCCe
Q 002158 688 GYCDEE--GEQMLVYEFVPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSNLNA 765 (958)
Q Consensus 688 ~~~~~~--~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~~~~ 765 (958)
.+..+. +.+|||+|||..|.+...=.. ...++..++.+++.++..||+|||.+| ||||||||+|+|++++|++
T Consensus 175 EvLDDP~s~~~YlVley~s~G~v~w~p~d--~~els~~~Ar~ylrDvv~GLEYLH~Qg---iiHRDIKPsNLLl~~~g~V 249 (576)
T KOG0585|consen 175 EVLDDPESDKLYLVLEYCSKGEVKWCPPD--KPELSEQQARKYLRDVVLGLEYLHYQG---IIHRDIKPSNLLLSSDGTV 249 (576)
T ss_pred EeecCcccCceEEEEEeccCCccccCCCC--cccccHHHHHHHHHHHHHHHHHHHhcC---eeccccchhheEEcCCCcE
Confidence 998764 579999999998877554322 222999999999999999999999999 9999999999999999999
Q ss_pred EEeeeeeecccccCCCCCCccceeeeeccCCCCccChhhhccCC----CCCcchhhhHHHHHHHHHhCCCCCCCCchhHH
Q 002158 766 KVADFGLSRLAPVLDDEGTMPTHVSTIVKGTPGYLDPEYFLTHK----LTDKSDVYSLGVVLLELLTGMQPISHGKNIVR 841 (958)
Q Consensus 766 kl~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~~DV~S~Gv~l~elltG~~P~~~~~~~~~ 841 (958)
||+|||.+.......+.+.. .......||+.|+|||...++. .+.+.||||+||+||-|+.|+.||.+...+.-
T Consensus 250 KIsDFGVs~~~~~~~~~~~d--~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~~~l 327 (576)
T KOG0585|consen 250 KISDFGVSNEFPQGSDEGSD--DQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFELEL 327 (576)
T ss_pred EeeccceeeecccCCccccH--HHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchHHHH
Confidence 99999999876443322221 1122367999999999998743 24589999999999999999999975443322
Q ss_pred HHHHHhhcCcchhhhcccCCCCC--hHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 002158 842 EVNVARDSGMVFSIIDNRMGSYP--SECVERFVTLALRCCHDKPEHRPSMSDVVRELE 897 (958)
Q Consensus 842 ~~~~~~~~~~~~~~i~~~~~~~~--~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 897 (958)
.-. ++...+ .+| ++..+.+.+||++++++||++|.+..+|..+..
T Consensus 328 ~~K----------Ivn~pL-~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpw 374 (576)
T KOG0585|consen 328 FDK----------IVNDPL-EFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHPW 374 (576)
T ss_pred HHH----------HhcCcc-cCCCcccccHHHHHHHHHHhhcChhheeehhhheecce
Confidence 211 111111 222 246788999999999999999999999987754
|
|
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-37 Score=333.33 Aligned_cols=255 Identities=31% Similarity=0.485 Sum_probs=209.6
Q ss_pred cCCCCCceeeeeCCeEEEEEEEC-CCcEEEEEEeccCChhcHHHHHHHHHHHHccCCCCcceEEEEEEeCCeEEEEEEec
Q 002158 625 AYFSSSTQVGQGGYGKVYKGILS-DNTTVAIKRAEEGSLQGQNEFLTEIKLLSRLHHRNLVSLLGYCDEEGEQMLVYEFV 703 (958)
Q Consensus 625 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E~~ 703 (958)
.+|...+.||+|+||.||+|.++ .++.||+|.+... ....+++.+|++++++++|+||+++++++..++..++||||+
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (263)
T cd05052 6 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFM 84 (263)
T ss_pred HHeEEeeecCCcccceEEEEEEecCCceEEEEEecCC-chHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEEeC
Confidence 34667789999999999999976 5889999998754 334567899999999999999999999999999999999999
Q ss_pred CCCCHHHHhccCCCCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEecCCCCeEEeeeeeecccccCCCCC
Q 002158 704 PNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSRLAPVLDDEG 783 (958)
Q Consensus 704 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 783 (958)
++++|.+++.......+++..++.++.|+++||+|||+.+ ++||||||+||++++++.+||+|||+++.......
T Consensus 85 ~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~-- 159 (263)
T cd05052 85 TYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY-- 159 (263)
T ss_pred CCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccCcceEEEcCCCcEEeCCCcccccccccee--
Confidence 9999999997665566899999999999999999999998 99999999999999999999999999876532110
Q ss_pred CccceeeeeccCCCCccChhhhccCCCCCcchhhhHHHHHHHHHh-CCCCCCCCchhHHHHHHHhhcCcchhhhcccCCC
Q 002158 784 TMPTHVSTIVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVLLELLT-GMQPISHGKNIVREVNVARDSGMVFSIIDNRMGS 862 (958)
Q Consensus 784 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gv~l~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~ 862 (958)
.......++..|+|||++.+..++.++||||||+++|||++ |..||..... ......... . ....
T Consensus 160 ----~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~-~~~~~~~~~-~--------~~~~ 225 (263)
T cd05052 160 ----TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDL-SQVYELLEK-G--------YRME 225 (263)
T ss_pred ----eccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCH-HHHHHHHHC-C--------CCCC
Confidence 11112234668999999999999999999999999999998 8999865332 222111111 0 1123
Q ss_pred CChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHh
Q 002158 863 YPSECVERFVTLALRCCHDKPEHRPSMSDVVRELENI 899 (958)
Q Consensus 863 ~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 899 (958)
.+..++..+.+++.+||+.+|++||++.++++.|+.+
T Consensus 226 ~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 262 (263)
T cd05052 226 RPEGCPPKVYELMRACWQWNPSDRPSFAEIHQAFETM 262 (263)
T ss_pred CCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHhh
Confidence 3455678899999999999999999999999998865
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=336.68 Aligned_cols=256 Identities=30% Similarity=0.498 Sum_probs=214.4
Q ss_pred HHcCCCCCceeeeeCCeEEEEEEECCCcEEEEEEeccCChhcHHHHHHHHHHHHccCCCCcceEEEEEEeCCeEEEEEEe
Q 002158 623 ATAYFSSSTQVGQGGYGKVYKGILSDNTTVAIKRAEEGSLQGQNEFLTEIKLLSRLHHRNLVSLLGYCDEEGEQMLVYEF 702 (958)
Q Consensus 623 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E~ 702 (958)
...+|+..+.||+|+||.||+|.+.+++.||+|.+..........+.+|+++++.++|+||+++++++...+..++||||
T Consensus 4 ~~~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 83 (261)
T cd05148 4 PREEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITEL 83 (261)
T ss_pred cHHHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEee
Confidence 44567788899999999999999988999999999876665667899999999999999999999999999999999999
Q ss_pred cCCCCHHHHhccCCCCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEecCCCCeEEeeeeeecccccCCCC
Q 002158 703 VPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSRLAPVLDDE 782 (958)
Q Consensus 703 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~ 782 (958)
+++++|.++++......+++.++..++.|++.||+|||+.+ ++||||||+||++++++.+||+|||.+.......
T Consensus 84 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~-- 158 (261)
T cd05148 84 MEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQN---SIHRDLAARNILVGEDLVCKVADFGLARLIKEDV-- 158 (261)
T ss_pred cccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccCcceEEEcCCceEEEccccchhhcCCcc--
Confidence 99999999998766566899999999999999999999999 9999999999999999999999999997653211
Q ss_pred CCccceeeeeccCCCCccChhhhccCCCCCcchhhhHHHHHHHHHh-CCCCCCCCchhHHHHHHHhhcCcchhhhcccCC
Q 002158 783 GTMPTHVSTIVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVLLELLT-GMQPISHGKNIVREVNVARDSGMVFSIIDNRMG 861 (958)
Q Consensus 783 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gv~l~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~i~~~~~ 861 (958)
.......++..|+|||++....++.++||||||+++|||++ |+.||...... ....... .....
T Consensus 159 -----~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~-~~~~~~~---------~~~~~ 223 (261)
T cd05148 159 -----YLSSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNH-EVYDQIT---------AGYRM 223 (261)
T ss_pred -----ccccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHH-HHHHHHH---------hCCcC
Confidence 11112346678999999998899999999999999999998 89999654321 1111111 11112
Q ss_pred CCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 002158 862 SYPSECVERFVTLALRCCHDKPEHRPSMSDVVRELEN 898 (958)
Q Consensus 862 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 898 (958)
..+..++..+.+++.+||+.||++||+++++.+.|+.
T Consensus 224 ~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~ 260 (261)
T cd05148 224 PCPAKCPQEIYKIMLECWAAEPEDRPSFKALREELDN 260 (261)
T ss_pred CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhc
Confidence 2345667889999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=345.11 Aligned_cols=240 Identities=25% Similarity=0.337 Sum_probs=197.5
Q ss_pred eeeeCCeEEEEEEEC-CCcEEEEEEeccC---ChhcHHHHHHHHHHHHccCCCCcceEEEEEEeCCeEEEEEEecCCCCH
Q 002158 633 VGQGGYGKVYKGILS-DNTTVAIKRAEEG---SLQGQNEFLTEIKLLSRLHHRNLVSLLGYCDEEGEQMLVYEFVPNGTL 708 (958)
Q Consensus 633 lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E~~~~gsL 708 (958)
||+|+||+||+|... +++.||+|++... .......+.+|++++++++||||+++++++..++..++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L 80 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL 80 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence 699999999999986 5889999998653 233345788999999999999999999999999999999999999999
Q ss_pred HHHhccCCCCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEecCCCCeEEeeeeeecccccCCCCCCccce
Q 002158 709 RDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSRLAPVLDDEGTMPTH 788 (958)
Q Consensus 709 ~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~ 788 (958)
.+++.... .+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++...... .
T Consensus 81 ~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~---i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~-------~ 148 (312)
T cd05585 81 FHHLQREG--RFDLSRARFYTAELLCALENLHKFN---VIYRDLKPENILLDYQGHIALCDFGLCKLNMKDD-------D 148 (312)
T ss_pred HHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHeEECCCCcEEEEECcccccCccCC-------C
Confidence 99997543 4899999999999999999999999 9999999999999999999999999987532111 1
Q ss_pred eeeeccCCCCccChhhhccCCCCCcchhhhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcCcchhhhcccCCCCChHHH
Q 002158 789 VSTIVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVLLELLTGMQPISHGKNIVREVNVARDSGMVFSIIDNRMGSYPSECV 868 (958)
Q Consensus 789 ~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gv~l~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~ 868 (958)
......||+.|+|||++.+..++.++|||||||++|||++|+.||..... ........ .....++...+
T Consensus 149 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~-~~~~~~~~----------~~~~~~~~~~~ 217 (312)
T cd05585 149 KTNTFCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENV-NEMYRKIL----------QEPLRFPDGFD 217 (312)
T ss_pred ccccccCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCH-HHHHHHHH----------cCCCCCCCcCC
Confidence 12345699999999999999999999999999999999999999975432 22211111 11123455667
Q ss_pred HHHHHHHHHccccCCCCCCC---HHHHHHH
Q 002158 869 ERFVTLALRCCHDKPEHRPS---MSDVVRE 895 (958)
Q Consensus 869 ~~l~~li~~cl~~dP~~RPs---~~evl~~ 895 (958)
..+.+++.+||+.||++||+ +.|++.+
T Consensus 218 ~~~~~li~~~L~~dp~~R~~~~~~~e~l~h 247 (312)
T cd05585 218 RDAKDLLIGLLSRDPTRRLGYNGAQEIKNH 247 (312)
T ss_pred HHHHHHHHHHcCCCHHHcCCCCCHHHHHcC
Confidence 88999999999999999985 5566543
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-37 Score=342.31 Aligned_cols=260 Identities=25% Similarity=0.437 Sum_probs=207.1
Q ss_pred HcCCCCCceeeeeCCeEEEEEEEC-CCc----EEEEEEeccCC-hhcHHHHHHHHHHHHccCCCCcceEEEEEEeCCeEE
Q 002158 624 TAYFSSSTQVGQGGYGKVYKGILS-DNT----TVAIKRAEEGS-LQGQNEFLTEIKLLSRLHHRNLVSLLGYCDEEGEQM 697 (958)
Q Consensus 624 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~----~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~ 697 (958)
..+|+..+.||+|+||+||+|++. ++. .||||+++... ....++|.+|+.+++.++||||++++|+|... ..+
T Consensus 6 ~~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~~ 84 (316)
T cd05108 6 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQ 84 (316)
T ss_pred hhhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-Cce
Confidence 346888899999999999999864 333 48999987543 34456799999999999999999999999865 577
Q ss_pred EEEEecCCCCHHHHhccCCCCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEecCCCCeEEeeeeeecccc
Q 002158 698 LVYEFVPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSRLAP 777 (958)
Q Consensus 698 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~~~ 777 (958)
+|+||+++|+|.+++.... ..+++..++.++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||+++...
T Consensus 85 ~v~e~~~~g~l~~~l~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~---iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~ 160 (316)
T cd05108 85 LITQLMPFGCLLDYVREHK-DNIGSQYLLNWCVQIAKGMNYLEERR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLG 160 (316)
T ss_pred eeeecCCCCCHHHHHHhcc-ccCCHHHHHHHHHHHHHHHHHHHhcC---eeccccchhheEecCCCcEEEcccccccccc
Confidence 9999999999999997643 34888999999999999999999999 9999999999999999999999999998654
Q ss_pred cCCCCCCccceeeeeccCCCCccChhhhccCCCCCcchhhhHHHHHHHHHh-CCCCCCCCchhHHHHHHHhhcCcchhhh
Q 002158 778 VLDDEGTMPTHVSTIVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVLLELLT-GMQPISHGKNIVREVNVARDSGMVFSII 856 (958)
Q Consensus 778 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gv~l~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~i 856 (958)
.... ........++..|+|||++.+..++.++||||||+++|||++ |..||.+.... ........ +
T Consensus 161 ~~~~-----~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~-~~~~~~~~-~------ 227 (316)
T cd05108 161 ADEK-----EYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS-EISSILEK-G------ 227 (316)
T ss_pred CCCc-----ceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHH-HHHHHHhC-C------
Confidence 3221 111112234678999999999999999999999999999998 99999653321 11111111 1
Q ss_pred cccCCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHhhC
Q 002158 857 DNRMGSYPSECVERFVTLALRCCHDKPEHRPSMSDVVRELENILKMF 903 (958)
Q Consensus 857 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~ 903 (958)
.....+..++..+.+++.+||..+|.+||++.+++..+.++.+..
T Consensus 228 --~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~~~~~ 272 (316)
T cd05108 228 --ERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDP 272 (316)
T ss_pred --CCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHcCC
Confidence 111123345677899999999999999999999999998876443
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=347.43 Aligned_cols=242 Identities=23% Similarity=0.296 Sum_probs=200.4
Q ss_pred ceeeeeCCeEEEEEEEC-CCcEEEEEEeccCC---hhcHHHHHHHHHHHHccCCCCcceEEEEEEeCCeEEEEEEecCCC
Q 002158 631 TQVGQGGYGKVYKGILS-DNTTVAIKRAEEGS---LQGQNEFLTEIKLLSRLHHRNLVSLLGYCDEEGEQMLVYEFVPNG 706 (958)
Q Consensus 631 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E~~~~g 706 (958)
+.||+|+||.||++... +++.||||++.... ......+.+|+++++.++||||+++++++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g 80 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG 80 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence 46999999999999976 68999999987532 233457889999999999999999999999999999999999999
Q ss_pred CHHHHhccCCCCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEecCCCCeEEeeeeeecccccCCCCCCcc
Q 002158 707 TLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSRLAPVLDDEGTMP 786 (958)
Q Consensus 707 sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~ 786 (958)
+|.+++.... .+++.++..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+++.....
T Consensus 81 ~L~~~l~~~~--~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~------- 148 (328)
T cd05593 81 ELFFHLSRER--VFSEDRTRFYGAEIVSALDYLHSGK---IVYRDLKLENLMLDKDGHIKITDFGLCKEGITD------- 148 (328)
T ss_pred CHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCC---eEecccCHHHeEECCCCcEEEecCcCCccCCCc-------
Confidence 9999996543 4899999999999999999999999 999999999999999999999999998743211
Q ss_pred ceeeeeccCCCCccChhhhccCCCCCcchhhhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcCcchhhhcccCCCCChH
Q 002158 787 THVSTIVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVLLELLTGMQPISHGKNIVREVNVARDSGMVFSIIDNRMGSYPSE 866 (958)
Q Consensus 787 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gv~l~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~ 866 (958)
........||+.|+|||++.+..++.++|||||||++|||++|+.||...... ...... ......+|..
T Consensus 149 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~-~~~~~~----------~~~~~~~p~~ 217 (328)
T cd05593 149 AATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE-KLFELI----------LMEDIKFPRT 217 (328)
T ss_pred ccccccccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHH-HHHHHh----------ccCCccCCCC
Confidence 11122356999999999999999999999999999999999999999754321 111111 1111233555
Q ss_pred HHHHHHHHHHHccccCCCCCC-----CHHHHHHH
Q 002158 867 CVERFVTLALRCCHDKPEHRP-----SMSDVVRE 895 (958)
Q Consensus 867 ~~~~l~~li~~cl~~dP~~RP-----s~~evl~~ 895 (958)
.+.++.+++.+||+.||++|| ++.|++++
T Consensus 218 ~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h 251 (328)
T cd05593 218 LSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRH 251 (328)
T ss_pred CCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhcC
Confidence 677899999999999999997 89998875
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-37 Score=332.96 Aligned_cols=256 Identities=29% Similarity=0.505 Sum_probs=210.1
Q ss_pred HHcCCCCCceeeeeCCeEEEEEEECCCcEEEEEEeccCChhcHHHHHHHHHHHHccCCCCcceEEEEEEeCCeEEEEEEe
Q 002158 623 ATAYFSSSTQVGQGGYGKVYKGILSDNTTVAIKRAEEGSLQGQNEFLTEIKLLSRLHHRNLVSLLGYCDEEGEQMLVYEF 702 (958)
Q Consensus 623 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E~ 702 (958)
..++|+..+.||+|+||.||+|.+.+++.||+|.++... ...++|.+|++++++++|+||+++++++...+..++||||
T Consensus 4 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 82 (261)
T cd05068 4 DRTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGT-MDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTEL 82 (261)
T ss_pred chhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCc-ccHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeeec
Confidence 345688889999999999999998888899999987643 3356789999999999999999999999999999999999
Q ss_pred cCCCCHHHHhccCCCCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEecCCCCeEEeeeeeecccccCCCC
Q 002158 703 VPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSRLAPVLDDE 782 (958)
Q Consensus 703 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~ 782 (958)
+++++|.+++.......+++..+..++.|++.|+.|||+.+ |+||||||+||++++++.+||+|||+++.......
T Consensus 83 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~- 158 (261)
T cd05068 83 MKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQN---YIHRDLAARNVLVGENNICKVADFGLARVIKEDIY- 158 (261)
T ss_pred ccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCCcceEEEcCCCCEEECCcceEEEccCCcc-
Confidence 99999999997655456899999999999999999999999 99999999999999999999999999986542110
Q ss_pred CCccceeeeeccCCCCccChhhhccCCCCCcchhhhHHHHHHHHHh-CCCCCCCCchhHHHHHHHhhcCcchhhhcccCC
Q 002158 783 GTMPTHVSTIVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVLLELLT-GMQPISHGKNIVREVNVARDSGMVFSIIDNRMG 861 (958)
Q Consensus 783 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gv~l~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~i~~~~~ 861 (958)
........+..|+|||++.+..++.++||||||+++|||++ |+.||....... ..... ... ...
T Consensus 159 -----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~-~~~~~-~~~--------~~~ 223 (261)
T cd05068 159 -----EAREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAE-VLQQV-DQG--------YRM 223 (261)
T ss_pred -----cccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHHH-HHHHH-HcC--------CCC
Confidence 01111223467999999998899999999999999999999 999996543221 11111 111 011
Q ss_pred CCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 002158 862 SYPSECVERFVTLALRCCHDKPEHRPSMSDVVRELEN 898 (958)
Q Consensus 862 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 898 (958)
..+..++..+.+++.+|++.+|++||+++++.+.|+.
T Consensus 224 ~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~ 260 (261)
T cd05068 224 PCPPGCPKELYDIMLDCWKEDPDDRPTFETLQWKLED 260 (261)
T ss_pred CCCCcCCHHHHHHHHHHhhcCcccCCCHHHHHHHHhc
Confidence 2234566889999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-37 Score=337.37 Aligned_cols=261 Identities=28% Similarity=0.511 Sum_probs=212.7
Q ss_pred CCCCCceeeeeCCeEEEEEEEC------CCcEEEEEEeccCChhcHHHHHHHHHHHHccCCCCcceEEEEEEeCCeEEEE
Q 002158 626 YFSSSTQVGQGGYGKVYKGILS------DNTTVAIKRAEEGSLQGQNEFLTEIKLLSRLHHRNLVSLLGYCDEEGEQMLV 699 (958)
Q Consensus 626 ~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV 699 (958)
+|...+.||+|+||.||+|.+. ++..|++|.+........+.+.+|++++++++|+||+++++++...+..++|
T Consensus 6 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 85 (291)
T cd05094 6 DIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIMV 85 (291)
T ss_pred HeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceEEE
Confidence 4666789999999999999853 3557999998876666667899999999999999999999999999999999
Q ss_pred EEecCCCCHHHHhccCC--------------CCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEecCCCCe
Q 002158 700 YEFVPNGTLRDWLSGRT--------------KENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSNLNA 765 (958)
Q Consensus 700 ~E~~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~~~~ 765 (958)
|||+++++|.+++.... ...+++..++.++.|++.||+|||+++ |+||||||+||+++.++.+
T Consensus 86 ~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~Nil~~~~~~~ 162 (291)
T cd05094 86 FEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQH---FVHRDLATRNCLVGANLLV 162 (291)
T ss_pred EecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccCcceEEEccCCcE
Confidence 99999999999996532 234889999999999999999999999 9999999999999999999
Q ss_pred EEeeeeeecccccCCCCCCccceeeeeccCCCCccChhhhccCCCCCcchhhhHHHHHHHHHh-CCCCCCCCchhHHHHH
Q 002158 766 KVADFGLSRLAPVLDDEGTMPTHVSTIVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVLLELLT-GMQPISHGKNIVREVN 844 (958)
Q Consensus 766 kl~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gv~l~ellt-G~~P~~~~~~~~~~~~ 844 (958)
+|+|||+++....... ........|+..|+|||++.+..++.++||||||+++|||+| |+.||....... ...
T Consensus 163 ~l~dfg~a~~~~~~~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~-~~~ 236 (291)
T cd05094 163 KIGDFGMSRDVYSTDY-----YRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTE-VIE 236 (291)
T ss_pred EECCCCcccccCCCce-----eecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH-HHH
Confidence 9999999875422111 111223446788999999999999999999999999999999 999986543321 111
Q ss_pred HHhhcCcchhhhcccCCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHhhCC
Q 002158 845 VARDSGMVFSIIDNRMGSYPSECVERFVTLALRCCHDKPEHRPSMSDVVRELENILKMFP 904 (958)
Q Consensus 845 ~~~~~~~~~~~i~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~~ 904 (958)
.. . .......+..++..+.+++.+||+.+|++||+++++++.|+++.+..|
T Consensus 237 ~~-~--------~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~~~~~ 287 (291)
T cd05094 237 CI-T--------QGRVLERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALGKATP 287 (291)
T ss_pred HH-h--------CCCCCCCCccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHhhcC
Confidence 11 1 111122234467789999999999999999999999999999876544
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-37 Score=342.11 Aligned_cols=245 Identities=25% Similarity=0.384 Sum_probs=197.1
Q ss_pred CCCCceeeeeCCeEEEEEEEC-CCcEEEEEEeccCC---hhcHHHHHHHHHHH---HccCCCCcceEEEEEEeCCeEEEE
Q 002158 627 FSSSTQVGQGGYGKVYKGILS-DNTTVAIKRAEEGS---LQGQNEFLTEIKLL---SRLHHRNLVSLLGYCDEEGEQMLV 699 (958)
Q Consensus 627 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l---~~l~H~niv~l~~~~~~~~~~~lV 699 (958)
|...+.||+|+||.||+|.+. +++.||||+++... ....+.+.+|++++ +.++||||+++++++...+..++|
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv 80 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV 80 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence 556789999999999999976 68999999987532 22234566676655 566899999999999999999999
Q ss_pred EEecCCCCHHHHhccCCCCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEecCCCCeEEeeeeeecccccC
Q 002158 700 YEFVPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSRLAPVL 779 (958)
Q Consensus 700 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~~~~~ 779 (958)
|||+++++|..+++.. .+++..+..++.|++.||+|||+.+ |+||||||+||++++++.+||+|||+++.....
T Consensus 81 ~E~~~~~~L~~~~~~~---~l~~~~~~~~~~qi~~al~~lH~~~---ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~~ 154 (324)
T cd05589 81 MEYAAGGDLMMHIHTD---VFSEPRAVFYAACVVLGLQYLHENK---IVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGF 154 (324)
T ss_pred EcCCCCCcHHHHhhcC---CCCHHHHHHHHHHHHHHHHHHHhCC---eEecCCCHHHeEECCCCcEEeCcccCCccCCCC
Confidence 9999999999988643 4899999999999999999999999 999999999999999999999999998643211
Q ss_pred CCCCCccceeeeeccCCCCccChhhhccCCCCCcchhhhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcCcchhhhccc
Q 002158 780 DDEGTMPTHVSTIVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVLLELLTGMQPISHGKNIVREVNVARDSGMVFSIIDNR 859 (958)
Q Consensus 780 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gv~l~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~i~~~ 859 (958)
. .......|++.|+|||++.+..++.++|||||||++|||++|+.||....... ...... ..
T Consensus 155 ~-------~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~~-~~~~i~----------~~ 216 (324)
T cd05589 155 G-------DRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEE-VFDSIV----------ND 216 (324)
T ss_pred C-------CcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHHH-HHHHHH----------hC
Confidence 1 11234569999999999999999999999999999999999999997543321 111111 11
Q ss_pred CCCCChHHHHHHHHHHHHccccCCCCCC-----CHHHHHHH
Q 002158 860 MGSYPSECVERFVTLALRCCHDKPEHRP-----SMSDVVRE 895 (958)
Q Consensus 860 ~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~~ 895 (958)
....+...+..+.+++.+||+.||.+|| ++.+++++
T Consensus 217 ~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~~ 257 (324)
T cd05589 217 EVRYPRFLSREAISIMRRLLRRNPERRLGSGEKDAEDVKKQ 257 (324)
T ss_pred CCCCCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhhC
Confidence 1223455678889999999999999999 46666553
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-37 Score=341.47 Aligned_cols=242 Identities=22% Similarity=0.323 Sum_probs=198.3
Q ss_pred ceeeeeCCeEEEEEEEC----CCcEEEEEEeccCC----hhcHHHHHHHHHHHHccCCCCcceEEEEEEeCCeEEEEEEe
Q 002158 631 TQVGQGGYGKVYKGILS----DNTTVAIKRAEEGS----LQGQNEFLTEIKLLSRLHHRNLVSLLGYCDEEGEQMLVYEF 702 (958)
Q Consensus 631 ~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E~ 702 (958)
+.||+|+||.||++... .++.||||+++... ......+.+|+++++.++||||+++++++..++..++||||
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~ 81 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY 81 (323)
T ss_pred ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence 57999999999999852 57899999987532 22334678899999999999999999999999999999999
Q ss_pred cCCCCHHHHhccCCCCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEecCCCCeEEeeeeeecccccCCCC
Q 002158 703 VPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSRLAPVLDDE 782 (958)
Q Consensus 703 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~ 782 (958)
+++++|.+++.... .+.+..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++......
T Consensus 82 ~~~~~L~~~~~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-- 154 (323)
T cd05584 82 LSGGELFMHLEREG--IFMEDTACFYLSEISLALEHLHQQG---IIYRDLKPENILLDAQGHVKLTDFGLCKESIHEG-- 154 (323)
T ss_pred CCCchHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEeeCcCCeecccCC--
Confidence 99999999997543 3788889999999999999999999 9999999999999999999999999987432111
Q ss_pred CCccceeeeeccCCCCccChhhhccCCCCCcchhhhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcCcchhhhcccCCC
Q 002158 783 GTMPTHVSTIVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVLLELLTGMQPISHGKNIVREVNVARDSGMVFSIIDNRMGS 862 (958)
Q Consensus 783 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gv~l~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~ 862 (958)
.......||+.|+|||++.+..++.++|||||||++|||++|+.||....... ...... .....
T Consensus 155 -----~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~~-~~~~~~----------~~~~~ 218 (323)
T cd05584 155 -----TVTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKK-TIDKIL----------KGKLN 218 (323)
T ss_pred -----CcccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHHH-HHHHHH----------cCCCC
Confidence 11223569999999999999889999999999999999999999997544321 111111 11123
Q ss_pred CChHHHHHHHHHHHHccccCCCCCC-----CHHHHHHH
Q 002158 863 YPSECVERFVTLALRCCHDKPEHRP-----SMSDVVRE 895 (958)
Q Consensus 863 ~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~~ 895 (958)
.+...+..+.+++.+||+.+|++|| ++++++++
T Consensus 219 ~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~h 256 (323)
T cd05584 219 LPPYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQSH 256 (323)
T ss_pred CCCCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhcC
Confidence 3455667889999999999999999 78888764
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-37 Score=337.56 Aligned_cols=252 Identities=23% Similarity=0.346 Sum_probs=205.6
Q ss_pred CCCCCceeeeeCCeEEEEEEEC-CCcEEEEEEeccCCh---hcHHHHHHHHHHHHccCCCCcceEEEEEEeCCeEEEEEE
Q 002158 626 YFSSSTQVGQGGYGKVYKGILS-DNTTVAIKRAEEGSL---QGQNEFLTEIKLLSRLHHRNLVSLLGYCDEEGEQMLVYE 701 (958)
Q Consensus 626 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E 701 (958)
+|+..+.||+|+||+||++... +++.||||++..... .....+.+|++++++++|+||+++++++..++..++|||
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence 3677889999999999999975 689999999865322 223457889999999999999999999999999999999
Q ss_pred ecCCCCHHHHhccCCCCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEecCCCCeEEeeeeeecccccCCC
Q 002158 702 FVPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSRLAPVLDD 781 (958)
Q Consensus 702 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~ 781 (958)
|+++|+|.+++.......+++..+..++.|++.||+|||+.+ |+||||||+||++++++.++|+|||+++......
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~- 156 (285)
T cd05605 81 LMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRER---IVYRDLKPENILLDDYGHIRISDLGLAVEIPEGE- 156 (285)
T ss_pred ccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHCC---cEecCCCHHHEEECCCCCEEEeeCCCceecCCCC-
Confidence 999999999987554456899999999999999999999999 9999999999999999999999999987643211
Q ss_pred CCCccceeeeeccCCCCccChhhhccCCCCCcchhhhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcCcchhhhcccCC
Q 002158 782 EGTMPTHVSTIVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVLLELLTGMQPISHGKNIVREVNVARDSGMVFSIIDNRMG 861 (958)
Q Consensus 782 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gv~l~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~i~~~~~ 861 (958)
......|+..|+|||++.+..++.++||||+||++|||++|+.||......... ... ...+.....
T Consensus 157 -------~~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~-~~~------~~~~~~~~~ 222 (285)
T cd05605 157 -------TIRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKR-EEV------ERRVKEDQE 222 (285)
T ss_pred -------ccccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhhHH-HHH------HHHhhhccc
Confidence 112346899999999999889999999999999999999999999754321111 000 011112223
Q ss_pred CCChHHHHHHHHHHHHccccCCCCCC-----CHHHHHHH
Q 002158 862 SYPSECVERFVTLALRCCHDKPEHRP-----SMSDVVRE 895 (958)
Q Consensus 862 ~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~~ 895 (958)
..+...+..+.+++.+||+.||++|| ++++++++
T Consensus 223 ~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~ 261 (285)
T cd05605 223 EYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAH 261 (285)
T ss_pred ccCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhcC
Confidence 34556778899999999999999999 78888764
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-37 Score=330.88 Aligned_cols=257 Identities=30% Similarity=0.478 Sum_probs=209.2
Q ss_pred HcCCCCCceeeeeCCeEEEEEEECC----CcEEEEEEeccCC-hhcHHHHHHHHHHHHccCCCCcceEEEEEEeCCeEEE
Q 002158 624 TAYFSSSTQVGQGGYGKVYKGILSD----NTTVAIKRAEEGS-LQGQNEFLTEIKLLSRLHHRNLVSLLGYCDEEGEQML 698 (958)
Q Consensus 624 ~~~~~~~~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~l 698 (958)
.++|+..+.||+|+||+||+|.++. ...||||.++... .....+|.+|+.++++++|+||+++++++...+..++
T Consensus 3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~i 82 (266)
T cd05033 3 PSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMI 82 (266)
T ss_pred hHHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEE
Confidence 3568888999999999999999752 4579999987643 3345679999999999999999999999999999999
Q ss_pred EEEecCCCCHHHHhccCCCCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEecCCCCeEEeeeeeeccccc
Q 002158 699 VYEFVPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSRLAPV 778 (958)
Q Consensus 699 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~~~~ 778 (958)
||||+++++|.+++..... .+++.++..++.|++.|++|||+.+ |+||||||+||++++++.++|+|||+++....
T Consensus 83 v~e~~~~~~L~~~~~~~~~-~~~~~~~~~~~~~l~~~l~~Lh~~~---i~H~di~p~nili~~~~~~~l~dfg~~~~~~~ 158 (266)
T cd05033 83 ITEYMENGSLDKFLRENDG-KFTVGQLVGMLRGIASGMKYLSEMN---YVHRDLAARNILVNSNLVCKVSDFGLSRRLED 158 (266)
T ss_pred EEEcCCCCCHHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCCEEECccchhhcccc
Confidence 9999999999999975433 5899999999999999999999998 99999999999999999999999999987641
Q ss_pred CCCCCCccceeeeeccCCCCccChhhhccCCCCCcchhhhHHHHHHHHHh-CCCCCCCCchhHHHHHHHhhcCcchhhhc
Q 002158 779 LDDEGTMPTHVSTIVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVLLELLT-GMQPISHGKNIVREVNVARDSGMVFSIID 857 (958)
Q Consensus 779 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gv~l~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~i~ 857 (958)
... ........++..|+|||.+.+..++.++||||||+++|||++ |..||........ ..... .
T Consensus 159 ~~~-----~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~~-~~~~~---------~ 223 (266)
T cd05033 159 SEA-----TYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQDV-IKAVE---------D 223 (266)
T ss_pred ccc-----ceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHHHH-HHHHH---------c
Confidence 111 111112345678999999998899999999999999999998 9999965432211 11111 1
Q ss_pred ccCCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHh
Q 002158 858 NRMGSYPSECVERFVTLALRCCHDKPEHRPSMSDVVRELENI 899 (958)
Q Consensus 858 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 899 (958)
......+..++..+.+++.+||+.+|++||+++|++++|+++
T Consensus 224 ~~~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~~ 265 (266)
T cd05033 224 GYRLPPPMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDKM 265 (266)
T ss_pred CCCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 111122345677899999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-38 Score=326.84 Aligned_cols=247 Identities=28% Similarity=0.406 Sum_probs=209.1
Q ss_pred cCCCCCceeeeeCCeEEEEEEE-CCCcEEEEEEeccCCh---hcHHHHHHHHHHHHccCCCCcceEEEEEEeCCeEEEEE
Q 002158 625 AYFSSSTQVGQGGYGKVYKGIL-SDNTTVAIKRAEEGSL---QGQNEFLTEIKLLSRLHHRNLVSLLGYCDEEGEQMLVY 700 (958)
Q Consensus 625 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~ 700 (958)
.+|++.+.||+|.||+|-+|+. ..|+.||||.+++... ++.-.+.+|+++|+.++||||+.++.+|+..+...+||
T Consensus 53 HRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIvivM 132 (668)
T KOG0611|consen 53 HRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIVM 132 (668)
T ss_pred hHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEEE
Confidence 3566667899999999999985 5899999999877543 34456789999999999999999999999999999999
Q ss_pred EecCCCCHHHHhccCCCCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEecCCCCeEEeeeeeecccccCC
Q 002158 701 EFVPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSRLAPVLD 780 (958)
Q Consensus 701 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~ 780 (958)
||..+|.|+||+.+++. +++.++.+++.||..|+.|+|.++ ++|||||-+|||+|.++++||+|||++.++..
T Consensus 133 EYaS~GeLYDYiSer~~--LsErEaRhfFRQIvSAVhYCHknr---VvHRDLKLENILLD~N~NiKIADFGLSNly~~-- 205 (668)
T KOG0611|consen 133 EYASGGELYDYISERGS--LSEREARHFFRQIVSAVHYCHKNR---VVHRDLKLENILLDQNNNIKIADFGLSNLYAD-- 205 (668)
T ss_pred EecCCccHHHHHHHhcc--ccHHHHHHHHHHHHHHHHHHhhcc---ceecccchhheeecCCCCeeeeccchhhhhcc--
Confidence 99999999999987655 999999999999999999999999 99999999999999999999999999987632
Q ss_pred CCCCccceeeeeccCCCCccChhhhccCCCC-CcchhhhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcCcchhhhccc
Q 002158 781 DEGTMPTHVSTIVKGTPGYLDPEYFLTHKLT-DKSDVYSLGVVLLELLTGMQPISHGKNIVREVNVARDSGMVFSIIDNR 859 (958)
Q Consensus 781 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DV~S~Gv~l~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~i~~~ 859 (958)
......++|++-|.+||++.+.+|. +.+|-||+||+||-|+-|..||++. +....++.... +...
T Consensus 206 ------~kfLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~-Dhk~lvrQIs~-GaYr------ 271 (668)
T KOG0611|consen 206 ------KKFLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGR-DHKRLVRQISR-GAYR------ 271 (668)
T ss_pred ------ccHHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCc-hHHHHHHHhhc-cccc------
Confidence 2344578999999999999999886 5899999999999999999999753 33333333222 2111
Q ss_pred CCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 002158 860 MGSYPSECVERFVTLALRCCHDKPEHRPSMSDVVREL 896 (958)
Q Consensus 860 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 896 (958)
.++.|....-||.+|+..+|++|.|+.+|..+-
T Consensus 272 ----EP~~PSdA~gLIRwmLmVNP~RRATieDiAsHW 304 (668)
T KOG0611|consen 272 ----EPETPSDASGLIRWMLMVNPERRATIEDIASHW 304 (668)
T ss_pred ----CCCCCchHHHHHHHHHhcCcccchhHHHHhhhh
Confidence 223345567899999999999999999999764
|
|
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-37 Score=338.10 Aligned_cols=261 Identities=30% Similarity=0.495 Sum_probs=211.2
Q ss_pred cCCCCCceeeeeCCeEEEEEEEC------CCcEEEEEEeccCChhcHHHHHHHHHHHHccCCCCcceEEEEEEeCCeEEE
Q 002158 625 AYFSSSTQVGQGGYGKVYKGILS------DNTTVAIKRAEEGSLQGQNEFLTEIKLLSRLHHRNLVSLLGYCDEEGEQML 698 (958)
Q Consensus 625 ~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~l 698 (958)
.+|...+.||+|+||+||++... ++..||+|.+........+.+.+|++++++++|+||+++++++...+..++
T Consensus 5 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (288)
T cd05093 5 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIM 84 (288)
T ss_pred HHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEE
Confidence 46778889999999999999852 345689999887665566789999999999999999999999999999999
Q ss_pred EEEecCCCCHHHHhccCC-----------CCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEecCCCCeEE
Q 002158 699 VYEFVPNGTLRDWLSGRT-----------KENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSNLNAKV 767 (958)
Q Consensus 699 V~E~~~~gsL~~~l~~~~-----------~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~~~~kl 767 (958)
||||+++++|.+++.... ...+++.++..++.|++.||+|||+++ ++||||||+||++++++.+||
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~---i~H~dlkp~Nili~~~~~~kl 161 (288)
T cd05093 85 VFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQH---FVHRDLATRNCLVGENLLVKI 161 (288)
T ss_pred EEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccCcceEEEccCCcEEe
Confidence 999999999999996432 234899999999999999999999999 999999999999999999999
Q ss_pred eeeeeecccccCCCCCCccceeeeeccCCCCccChhhhccCCCCCcchhhhHHHHHHHHHh-CCCCCCCCchhHHHHHHH
Q 002158 768 ADFGLSRLAPVLDDEGTMPTHVSTIVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVLLELLT-GMQPISHGKNIVREVNVA 846 (958)
Q Consensus 768 ~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gv~l~ellt-G~~P~~~~~~~~~~~~~~ 846 (958)
+|||+++....... ........++..|+|||++.+..++.++|||||||++|||++ |..||....... .....
T Consensus 162 ~dfg~~~~~~~~~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~-~~~~i 235 (288)
T cd05093 162 GDFGMSRDVYSTDY-----YRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNE-VIECI 235 (288)
T ss_pred ccCCccccccCCce-----eecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH-HHHHH
Confidence 99999875422111 111122345778999999998899999999999999999999 899986543211 11111
Q ss_pred hhcCcchhhhcccCCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHhhC
Q 002158 847 RDSGMVFSIIDNRMGSYPSECVERFVTLALRCCHDKPEHRPSMSDVVRELENILKMF 903 (958)
Q Consensus 847 ~~~~~~~~~i~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~ 903 (958)
. .+ .....+..++..+.+++.+||+.+|.+||++.++++.|+++.+..
T Consensus 236 ~-~~--------~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~~~~ 283 (288)
T cd05093 236 T-QG--------RVLQRPRTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLAKAS 283 (288)
T ss_pred H-cC--------CcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHHhc
Confidence 1 11 111223345678999999999999999999999999999987653
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-37 Score=345.42 Aligned_cols=261 Identities=30% Similarity=0.484 Sum_probs=206.3
Q ss_pred HcCCCCCceeeeeCCeEEEEEEEC------CCcEEEEEEeccCC-hhcHHHHHHHHHHHHcc-CCCCcceEEEEEEe-CC
Q 002158 624 TAYFSSSTQVGQGGYGKVYKGILS------DNTTVAIKRAEEGS-LQGQNEFLTEIKLLSRL-HHRNLVSLLGYCDE-EG 694 (958)
Q Consensus 624 ~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~-~~ 694 (958)
.++|.+.+.||+|+||.||+|.+. .++.||+|+++... ....+.+..|+++++++ +|+||++++++|.. +.
T Consensus 6 ~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~~ 85 (337)
T cd05054 6 RDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKPGG 85 (337)
T ss_pred HHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecCCC
Confidence 456888899999999999999742 24789999987543 23345688999999999 89999999998865 45
Q ss_pred eEEEEEEecCCCCHHHHhccCC----------------------------------------------------------
Q 002158 695 EQMLVYEFVPNGTLRDWLSGRT---------------------------------------------------------- 716 (958)
Q Consensus 695 ~~~lV~E~~~~gsL~~~l~~~~---------------------------------------------------------- 716 (958)
..+++|||+++++|.+++....
T Consensus 86 ~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (337)
T cd05054 86 PLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDEL 165 (337)
T ss_pred CEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhHH
Confidence 7889999999999999986432
Q ss_pred -CCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEecCCCCeEEeeeeeecccccCCCCCCccceeeeeccC
Q 002158 717 -KENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSRLAPVLDDEGTMPTHVSTIVKG 795 (958)
Q Consensus 717 -~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~g 795 (958)
...+++..+.+++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||+++.+...... .......+
T Consensus 166 ~~~~l~~~~~~~~~~qi~~aL~~lH~~~---ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~-----~~~~~~~~ 237 (337)
T cd05054 166 YKEPLTLEDLISYSFQVARGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDY-----VRKGDARL 237 (337)
T ss_pred hhcCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCcceEEEeCCCcEEEeccccchhcccCcch-----hhccCCCC
Confidence 125889999999999999999999998 999999999999999999999999999865322110 11122346
Q ss_pred CCCccChhhhccCCCCCcchhhhHHHHHHHHHh-CCCCCCCCchhHHHHHHHhhcCcchhhhcccCCCCChHHHHHHHHH
Q 002158 796 TPGYLDPEYFLTHKLTDKSDVYSLGVVLLELLT-GMQPISHGKNIVREVNVARDSGMVFSIIDNRMGSYPSECVERFVTL 874 (958)
Q Consensus 796 t~~y~aPE~~~~~~~~~~~DV~S~Gv~l~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~l~~l 874 (958)
+..|+|||++.+..++.++|||||||++|||++ |..||............. ..+ .....+...+.++.++
T Consensus 238 ~~~y~aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~~~~~~-~~~--------~~~~~~~~~~~~~~~l 308 (337)
T cd05054 238 PLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRRL-KEG--------TRMRAPEYATPEIYSI 308 (337)
T ss_pred CccccCcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccHHHHHHH-hcc--------CCCCCCccCCHHHHHH
Confidence 778999999999999999999999999999998 999996432211111111 111 1112234456789999
Q ss_pred HHHccccCCCCCCCHHHHHHHHHHhHh
Q 002158 875 ALRCCHDKPEHRPSMSDVVRELENILK 901 (958)
Q Consensus 875 i~~cl~~dP~~RPs~~evl~~L~~~~~ 901 (958)
+.+||+.+|++||++.|++++|++++.
T Consensus 309 ~~~cl~~~p~~RPs~~ell~~l~~~~~ 335 (337)
T cd05054 309 MLDCWHNNPEDRPTFSELVEILGDLLQ 335 (337)
T ss_pred HHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-37 Score=336.32 Aligned_cols=258 Identities=25% Similarity=0.366 Sum_probs=198.3
Q ss_pred CCCCCceeeeeCCeEEEEEEEC--CCcEEEEEEeccCCh--hcHHHHHHHHHHHHcc---CCCCcceEEEEEE-----eC
Q 002158 626 YFSSSTQVGQGGYGKVYKGILS--DNTTVAIKRAEEGSL--QGQNEFLTEIKLLSRL---HHRNLVSLLGYCD-----EE 693 (958)
Q Consensus 626 ~~~~~~~lg~G~~g~Vy~~~~~--~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l---~H~niv~l~~~~~-----~~ 693 (958)
+|...+.||+|+||+||+|.+. +++.||||++..... .....+.+|+++++.+ +||||++++++|. ..
T Consensus 2 ~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~~ 81 (290)
T cd07862 2 QYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRE 81 (290)
T ss_pred CcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCCC
Confidence 6788899999999999999873 468899998865322 2234566788777766 6999999999985 24
Q ss_pred CeEEEEEEecCCCCHHHHhccCCCCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEecCCCCeEEeeeeee
Q 002158 694 GEQMLVYEFVPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSNLNAKVADFGLS 773 (958)
Q Consensus 694 ~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla 773 (958)
...++||||++ ++|.+++.......+++.++..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||++
T Consensus 82 ~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~---iiH~dlkp~Nil~~~~~~~kl~Dfg~~ 157 (290)
T cd07862 82 TKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLA 157 (290)
T ss_pred CcEEEEEccCC-CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEEcCCCCEEEccccce
Confidence 56899999995 69999997665556899999999999999999999999 999999999999999999999999999
Q ss_pred cccccCCCCCCccceeeeeccCCCCccChhhhccCCCCCcchhhhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcCc--
Q 002158 774 RLAPVLDDEGTMPTHVSTIVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVLLELLTGMQPISHGKNIVREVNVARDSGM-- 851 (958)
Q Consensus 774 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gv~l~elltG~~P~~~~~~~~~~~~~~~~~~~-- 851 (958)
+..... .......||+.|+|||++.+..++.++|||||||++|||++|+.||................+.
T Consensus 158 ~~~~~~--------~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~~~~~ 229 (290)
T cd07862 158 RIYSFQ--------MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPG 229 (290)
T ss_pred EeccCC--------cccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCC
Confidence 764321 1123456899999999999889999999999999999999999999765443222111111000
Q ss_pred ---ch-------hhhcccC----CCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 002158 852 ---VF-------SIIDNRM----GSYPSECVERFVTLALRCCHDKPEHRPSMSDVVRE 895 (958)
Q Consensus 852 ---~~-------~~i~~~~----~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 895 (958)
.. ....... .......+..+.+++.+|++.||++||++.|++++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~h 287 (290)
T cd07862 230 EEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH 287 (290)
T ss_pred hhhchhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhcC
Confidence 00 0000000 00112345678899999999999999999999863
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-37 Score=335.95 Aligned_cols=259 Identities=22% Similarity=0.300 Sum_probs=199.8
Q ss_pred cCCCCCceeeeeCCeEEEEEEEC-CCcEEEEEEeccCC-hhcHHHHHHHHHHHHccCCCCcceEEEEEEeCCeEEEEEEe
Q 002158 625 AYFSSSTQVGQGGYGKVYKGILS-DNTTVAIKRAEEGS-LQGQNEFLTEIKLLSRLHHRNLVSLLGYCDEEGEQMLVYEF 702 (958)
Q Consensus 625 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E~ 702 (958)
++|...+.||+|+||+||+|..+ +++.||+|+++... ......+.+|++++++++||||+++++++..++..++||||
T Consensus 5 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 84 (288)
T cd07871 5 ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFEY 84 (288)
T ss_pred ccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEeC
Confidence 45788899999999999999976 68899999987543 22345678999999999999999999999999999999999
Q ss_pred cCCCCHHHHhccCCCCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEecCCCCeEEeeeeeecccccCCCC
Q 002158 703 VPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSRLAPVLDDE 782 (958)
Q Consensus 703 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~ 782 (958)
++ ++|.+++.... ..+++..+..++.|++.||+|||+++ |+||||||+|||+++++.+||+|||+++......
T Consensus 85 ~~-~~l~~~l~~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~-- 157 (288)
T cd07871 85 LD-SDLKQYLDNCG-NLMSMHNVKIFMFQLLRGLSYCHKRK---ILHRDLKPQNLLINEKGELKLADFGLARAKSVPT-- 157 (288)
T ss_pred CC-cCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEECcCcceeeccCCC--
Confidence 97 59999986543 34788999999999999999999999 9999999999999999999999999987542211
Q ss_pred CCccceeeeeccCCCCccChhhhcc-CCCCCcchhhhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcCc----------
Q 002158 783 GTMPTHVSTIVKGTPGYLDPEYFLT-HKLTDKSDVYSLGVVLLELLTGMQPISHGKNIVREVNVARDSGM---------- 851 (958)
Q Consensus 783 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DV~S~Gv~l~elltG~~P~~~~~~~~~~~~~~~~~~~---------- 851 (958)
.......|++.|+|||++.+ ..++.++||||+||++|||++|+.||................+.
T Consensus 158 -----~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (288)
T cd07871 158 -----KTYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGIT 232 (288)
T ss_pred -----ccccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhccc
Confidence 11123457899999999875 56889999999999999999999999754432211111100000
Q ss_pred ----chhhhcccCC-----CCChHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 002158 852 ----VFSIIDNRMG-----SYPSECVERFVTLALRCCHDKPEHRPSMSDVVRE 895 (958)
Q Consensus 852 ----~~~~i~~~~~-----~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 895 (958)
......+... ........+..+++.+|++.||.+|||++|++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~h 285 (288)
T cd07871 233 SNEEFRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALRH 285 (288)
T ss_pred cchhhhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence 0000000000 0011234678899999999999999999999864
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-37 Score=334.99 Aligned_cols=255 Identities=29% Similarity=0.515 Sum_probs=207.4
Q ss_pred cCCCCCceeeeeCCeEEEEEEECC------CcEEEEEEeccCChh-cHHHHHHHHHHHHccCCCCcceEEEEEEeCCeEE
Q 002158 625 AYFSSSTQVGQGGYGKVYKGILSD------NTTVAIKRAEEGSLQ-GQNEFLTEIKLLSRLHHRNLVSLLGYCDEEGEQM 697 (958)
Q Consensus 625 ~~~~~~~~lg~G~~g~Vy~~~~~~------~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~ 697 (958)
..|...+.||+|+||.||+|.+.+ ++.||||.++..... ..+.|.+|++++++++|+||+++++++...+..+
T Consensus 5 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 84 (280)
T cd05049 5 DTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPPI 84 (280)
T ss_pred HHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCeE
Confidence 456677899999999999998643 478999999765444 4568999999999999999999999999999999
Q ss_pred EEEEecCCCCHHHHhccCC------------CCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEecCCCCe
Q 002158 698 LVYEFVPNGTLRDWLSGRT------------KENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSNLNA 765 (958)
Q Consensus 698 lV~E~~~~gsL~~~l~~~~------------~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~~~~ 765 (958)
+||||+++++|.+++.... ...+++.++..++.|++.|++|||+.+ ++||||||+||+++.++.+
T Consensus 85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~h~dlkp~nili~~~~~~ 161 (280)
T cd05049 85 MVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQH---FVHRDLATRNCLVGYDLVV 161 (280)
T ss_pred EEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC---eeccccccceEEEcCCCeE
Confidence 9999999999999997542 234789999999999999999999999 9999999999999999999
Q ss_pred EEeeeeeecccccCCCCCCccceeeeeccCCCCccChhhhccCCCCCcchhhhHHHHHHHHHh-CCCCCCCCchhHHHHH
Q 002158 766 KVADFGLSRLAPVLDDEGTMPTHVSTIVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVLLELLT-GMQPISHGKNIVREVN 844 (958)
Q Consensus 766 kl~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gv~l~ellt-G~~P~~~~~~~~~~~~ 844 (958)
||+|||+++....... ........+++.|+|||++.+..++.++||||||+++|||++ |..||...... ....
T Consensus 162 kl~d~g~~~~~~~~~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~-~~~~ 235 (280)
T cd05049 162 KIGDFGMSRDVYTTDY-----YRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNE-EVIE 235 (280)
T ss_pred EECCcccceecccCcc-----eecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHH-HHHH
Confidence 9999999875422111 111122345788999999999999999999999999999999 99998654322 1111
Q ss_pred HHhhcCcchhhhcccCCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 002158 845 VARDSGMVFSIIDNRMGSYPSECVERFVTLALRCCHDKPEHRPSMSDVVRELE 897 (958)
Q Consensus 845 ~~~~~~~~~~~i~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 897 (958)
... .......+..++..+.+++.+||+.||++||++.|+++.|+
T Consensus 236 ~~~---------~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~ 279 (280)
T cd05049 236 CIT---------QGRLLQRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQ 279 (280)
T ss_pred HHH---------cCCcCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhh
Confidence 111 11122234456788999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-37 Score=359.57 Aligned_cols=252 Identities=21% Similarity=0.293 Sum_probs=206.4
Q ss_pred CCCCCceeeeeCCeEEEEEEEC-C-CcEEEEEEeccCChhcHHHHHHHHHHHHccCCCCcceEEEEEEeCCeEEEEEEec
Q 002158 626 YFSSSTQVGQGGYGKVYKGILS-D-NTTVAIKRAEEGSLQGQNEFLTEIKLLSRLHHRNLVSLLGYCDEEGEQMLVYEFV 703 (958)
Q Consensus 626 ~~~~~~~lg~G~~g~Vy~~~~~-~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E~~ 703 (958)
.|...+.||+|+||.||+|... + ++.||+|.+..........+.+|+++++.++||||+++++++..++..++||||+
T Consensus 68 ~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~~ 147 (478)
T PTZ00267 68 MYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYG 147 (478)
T ss_pred eEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEECC
Confidence 3777889999999999999865 3 6788999876655555567888999999999999999999999999999999999
Q ss_pred CCCCHHHHhccC--CCCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEecCCCCeEEeeeeeecccccCCC
Q 002158 704 PNGTLRDWLSGR--TKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSRLAPVLDD 781 (958)
Q Consensus 704 ~~gsL~~~l~~~--~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~ 781 (958)
++|+|.++++.. ....+++.++..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++.......
T Consensus 148 ~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~---ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~ 224 (478)
T PTZ00267 148 SGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRK---MMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVS 224 (478)
T ss_pred CCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC---EEECCcCHHhEEECCCCcEEEEeCcCceecCCccc
Confidence 999999988643 2345889999999999999999999998 99999999999999999999999999986532111
Q ss_pred CCCccceeeeeccCCCCccChhhhccCCCCCcchhhhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcCcchhhhcccCC
Q 002158 782 EGTMPTHVSTIVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVLLELLTGMQPISHGKNIVREVNVARDSGMVFSIIDNRMG 861 (958)
Q Consensus 782 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gv~l~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~i~~~~~ 861 (958)
........||++|+|||++.+..++.++|||||||++|||++|+.||...... ...... ......
T Consensus 225 -----~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~-~~~~~~---------~~~~~~ 289 (478)
T PTZ00267 225 -----LDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQR-EIMQQV---------LYGKYD 289 (478)
T ss_pred -----cccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHH---------HhCCCC
Confidence 11233456999999999999999999999999999999999999999754321 111111 111112
Q ss_pred CCChHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 002158 862 SYPSECVERFVTLALRCCHDKPEHRPSMSDVVRE 895 (958)
Q Consensus 862 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 895 (958)
..+..++..+.+++.+||+.||++||++++++++
T Consensus 290 ~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~~ 323 (478)
T PTZ00267 290 PFPCPVSSGMKALLDPLLSKNPALRPTTQQLLHT 323 (478)
T ss_pred CCCccCCHHHHHHHHHHhccChhhCcCHHHHHhC
Confidence 2344566789999999999999999999998753
|
|
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-37 Score=344.27 Aligned_cols=253 Identities=22% Similarity=0.269 Sum_probs=203.2
Q ss_pred cCCCCCceeeeeCCeEEEEEEEC-CCcEEEEEEeccCC---hhcHHHHHHHHHHHHccCCCCcceEEEEEEeCCeEEEEE
Q 002158 625 AYFSSSTQVGQGGYGKVYKGILS-DNTTVAIKRAEEGS---LQGQNEFLTEIKLLSRLHHRNLVSLLGYCDEEGEQMLVY 700 (958)
Q Consensus 625 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~ 700 (958)
++|...+.||+|+||+||+|... +++.||+|+++... ....+.+.+|+.+++.++|+||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM 80 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence 36788899999999999999976 68999999987542 223456889999999999999999999999999999999
Q ss_pred EecCCCCHHHHhccCCCCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEecCCCCeEEeeeeeecccccCC
Q 002158 701 EFVPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSRLAPVLD 780 (958)
Q Consensus 701 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~ 780 (958)
||+++|+|.+++.... ..+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++......
T Consensus 81 e~~~~~~L~~~l~~~~-~~l~~~~~~~~~~qi~~aL~~lH~~~---i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~ 156 (330)
T cd05601 81 EYQPGGDLLSLLNRYE-DQFDEDMAQFYLAELVLAIHSVHQMG---YVHRDIKPENVLIDRTGHIKLADFGSAARLTANK 156 (330)
T ss_pred CCCCCCCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eEcccCchHheEECCCCCEEeccCCCCeECCCCC
Confidence 9999999999997652 34899999999999999999999999 9999999999999999999999999997653211
Q ss_pred CCCCccceeeeeccCCCCccChhhhc------cCCCCCcchhhhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcCcchh
Q 002158 781 DEGTMPTHVSTIVKGTPGYLDPEYFL------THKLTDKSDVYSLGVVLLELLTGMQPISHGKNIVREVNVARDSGMVFS 854 (958)
Q Consensus 781 ~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~~DV~S~Gv~l~elltG~~P~~~~~~~~~~~~~~~~~~~~~~ 854 (958)
........||+.|+|||++. ...++.++|||||||++|||++|+.||.......... ..........
T Consensus 157 ------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~-~i~~~~~~~~ 229 (330)
T cd05601 157 ------MVNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYN-NIMNFQRFLK 229 (330)
T ss_pred ------ceeeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHHHHH-HHHcCCCccC
Confidence 11223346999999999987 4567889999999999999999999997654332211 1111100000
Q ss_pred hhcccCCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 002158 855 IIDNRMGSYPSECVERFVTLALRCCHDKPEHRPSMSDVVRE 895 (958)
Q Consensus 855 ~i~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 895 (958)
. ......+..+.+++.+|++ +|++||++++++++
T Consensus 230 -----~-~~~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~h 263 (330)
T cd05601 230 -----F-PEDPKVSSDFLDLIQSLLC-GQKERLGYEGLCCH 263 (330)
T ss_pred -----C-CCCCCCCHHHHHHHHHHcc-ChhhCCCHHHHhCC
Confidence 0 0112356778899999998 99999999999864
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-37 Score=343.45 Aligned_cols=242 Identities=22% Similarity=0.288 Sum_probs=199.0
Q ss_pred ceeeeeCCeEEEEEEEC-CCcEEEEEEeccCC---hhcHHHHHHHHHHHHccCCCCcceEEEEEEeCCeEEEEEEecCCC
Q 002158 631 TQVGQGGYGKVYKGILS-DNTTVAIKRAEEGS---LQGQNEFLTEIKLLSRLHHRNLVSLLGYCDEEGEQMLVYEFVPNG 706 (958)
Q Consensus 631 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E~~~~g 706 (958)
+.||+|+||.||++... +++.||+|++.... ......+.+|+++++.++||||+++++++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence 46999999999999975 68999999987532 233456788999999999999999999999999999999999999
Q ss_pred CHHHHhccCCCCCchHHHHHHHHHHHHHHHHHhhh-cCCCCeeccCCCccceEecCCCCeEEeeeeeecccccCCCCCCc
Q 002158 707 TLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHT-EAHPPVFHRDIKASNILLDSNLNAKVADFGLSRLAPVLDDEGTM 785 (958)
Q Consensus 707 sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~-~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~ 785 (958)
+|.+++.... .+++.++..++.|++.||+|||+ .+ |+||||||+|||++.++.+||+|||+++......
T Consensus 81 ~L~~~l~~~~--~l~~~~~~~~~~qi~~aL~~lH~~~~---ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~----- 150 (325)
T cd05594 81 ELFFHLSRER--VFSEDRARFYGAEIVSALDYLHSEKN---VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDG----- 150 (325)
T ss_pred cHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhcCC---EEecCCCCCeEEECCCCCEEEecCCCCeecCCCC-----
Confidence 9999986543 48999999999999999999997 67 9999999999999999999999999987432111
Q ss_pred cceeeeeccCCCCccChhhhccCCCCCcchhhhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcCcchhhhcccCCCCCh
Q 002158 786 PTHVSTIVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVLLELLTGMQPISHGKNIVREVNVARDSGMVFSIIDNRMGSYPS 865 (958)
Q Consensus 786 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gv~l~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~ 865 (958)
.......||+.|+|||++.+..++.++|||||||++|||++|+.||...... ...... ......++.
T Consensus 151 --~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~-~~~~~i----------~~~~~~~p~ 217 (325)
T cd05594 151 --ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE-KLFELI----------LMEEIRFPR 217 (325)
T ss_pred --cccccccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHH-HHHHHH----------hcCCCCCCC
Confidence 1122356999999999999999999999999999999999999999754321 111111 111122344
Q ss_pred HHHHHHHHHHHHccccCCCCCC-----CHHHHHHH
Q 002158 866 ECVERFVTLALRCCHDKPEHRP-----SMSDVVRE 895 (958)
Q Consensus 866 ~~~~~l~~li~~cl~~dP~~RP-----s~~evl~~ 895 (958)
..+.++.+++.+|++.||++|+ ++.+++++
T Consensus 218 ~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h 252 (325)
T cd05594 218 TLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQH 252 (325)
T ss_pred CCCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhcC
Confidence 5667899999999999999996 89999865
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-38 Score=309.01 Aligned_cols=267 Identities=24% Similarity=0.351 Sum_probs=213.2
Q ss_pred HcCCCCCceeeeeCCeEEEEEE-ECCCcEEEEEEeccCChhcHHHHHHHHHHHHccCCCCcceEEEEEEe-----CCeEE
Q 002158 624 TAYFSSSTQVGQGGYGKVYKGI-LSDNTTVAIKRAEEGSLQGQNEFLTEIKLLSRLHHRNLVSLLGYCDE-----EGEQM 697 (958)
Q Consensus 624 ~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~-----~~~~~ 697 (958)
.++|.+.+.+|+|||+.||.+. ..+++.+|+|++.-...++.+..++|++..++++|||++++++++.. ..+.|
T Consensus 20 ~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~~y 99 (302)
T KOG2345|consen 20 NKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHEAY 99 (302)
T ss_pred CceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCceeEE
Confidence 4578888999999999999998 45788999999988777788889999999999999999999998743 34589
Q ss_pred EEEEecCCCCHHHHhccCC--CCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEecCCCCeEEeeeeeecc
Q 002158 698 LVYEFVPNGTLRDWLSGRT--KENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSRL 775 (958)
Q Consensus 698 lV~E~~~~gsL~~~l~~~~--~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~ 775 (958)
++++|...|+|.+.+.... +..+++.+.++|+.++++||++||+.. +|++||||||.|||+.+++.+++.|||.++.
T Consensus 100 ll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~-~~yAH~DiKP~NILls~~~~~vl~D~GS~~~ 178 (302)
T KOG2345|consen 100 LLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKE-PPYAHRDIKPANILLSDSGLPVLMDLGSATQ 178 (302)
T ss_pred EEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccC-CcccccCCCcceeEecCCCceEEEeccCccc
Confidence 9999999999999997543 346999999999999999999999986 6899999999999999999999999999986
Q ss_pred cccCCCCC--CccceeeeeccCCCCccChhhhcc---CCCCCcchhhhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcC
Q 002158 776 APVLDDEG--TMPTHVSTIVKGTPGYLDPEYFLT---HKLTDKSDVYSLGVVLLELLTGMQPISHGKNIVREVNVARDSG 850 (958)
Q Consensus 776 ~~~~~~~~--~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DV~S~Gv~l~elltG~~P~~~~~~~~~~~~~~~~~~ 850 (958)
.+..-... ...-........|..|.|||.+.- ...+.++|||||||+||+|+-|..||+.. ..+.+
T Consensus 179 a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~---------~~~Gg 249 (302)
T KOG2345|consen 179 APIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERI---------YQQGG 249 (302)
T ss_pred cceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHH---------hhcCC
Confidence 64322211 111122334468999999999853 45678999999999999999999999621 11222
Q ss_pred cchhhhcccCCCCC--hHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhH
Q 002158 851 MVFSIIDNRMGSYP--SECVERFVTLALRCCHDKPEHRPSMSDVVRELENIL 900 (958)
Q Consensus 851 ~~~~~i~~~~~~~~--~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~ 900 (958)
.+.-.+......+| ...++.+.+++++|++.||.+||+..+++..+.++.
T Consensus 250 SlaLAv~n~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~Li 301 (302)
T KOG2345|consen 250 SLALAVQNAQISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSKLDDLI 301 (302)
T ss_pred eEEEeeeccccccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHHHHhhc
Confidence 22111111111111 227889999999999999999999999999988754
|
|
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-37 Score=336.30 Aligned_cols=257 Identities=27% Similarity=0.461 Sum_probs=206.0
Q ss_pred HHcCCCCCceeeeeCCeEEEEEEEC------CCcEEEEEEeccC-ChhcHHHHHHHHHHHHccCCCCcceEEEEEEeCCe
Q 002158 623 ATAYFSSSTQVGQGGYGKVYKGILS------DNTTVAIKRAEEG-SLQGQNEFLTEIKLLSRLHHRNLVSLLGYCDEEGE 695 (958)
Q Consensus 623 ~~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~ 695 (958)
.+++|+..+.||+|+||.||+|.+. .+..||||++... ......+|.+|+.+++.++|+||+++++++...+.
T Consensus 4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~ 83 (277)
T cd05062 4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQP 83 (277)
T ss_pred cHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence 5667889999999999999999863 2567999998653 23345678999999999999999999999999999
Q ss_pred EEEEEEecCCCCHHHHhccCC--------CCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEecCCCCeEE
Q 002158 696 QMLVYEFVPNGTLRDWLSGRT--------KENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSNLNAKV 767 (958)
Q Consensus 696 ~~lV~E~~~~gsL~~~l~~~~--------~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~~~~kl 767 (958)
.++||||+++++|.+++.... ...+++..+..++.|++.||+|||+.+ ++||||||+||++++++.++|
T Consensus 84 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---~vH~dlkp~Nil~~~~~~~~l 160 (277)
T cd05062 84 TLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKI 160 (277)
T ss_pred eEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCcchheEEEcCCCCEEE
Confidence 999999999999999996532 123678889999999999999999998 999999999999999999999
Q ss_pred eeeeeecccccCCCCCCccceeeeeccCCCCccChhhhccCCCCCcchhhhHHHHHHHHHh-CCCCCCCCchhHHHHHHH
Q 002158 768 ADFGLSRLAPVLDDEGTMPTHVSTIVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVLLELLT-GMQPISHGKNIVREVNVA 846 (958)
Q Consensus 768 ~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gv~l~ellt-G~~P~~~~~~~~~~~~~~ 846 (958)
+|||+++....... ........++..|+|||++.+..++.++|||||||++|||++ |..||..... .......
T Consensus 161 ~dfg~~~~~~~~~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~-~~~~~~~ 234 (277)
T cd05062 161 GDFGMTRDIYETDY-----YRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSN-EQVLRFV 234 (277)
T ss_pred CCCCCccccCCcce-----eecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCH-HHHHHHH
Confidence 99999875422111 011112245778999999998899999999999999999999 7888864332 2211111
Q ss_pred hhcCcchhhhcccCCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 002158 847 RDSGMVFSIIDNRMGSYPSECVERFVTLALRCCHDKPEHRPSMSDVVRELE 897 (958)
Q Consensus 847 ~~~~~~~~~i~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 897 (958)
. .......+..++..+.+++.+||+.+|++||++.|+++.|+
T Consensus 235 ~---------~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~ 276 (277)
T cd05062 235 M---------EGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIK 276 (277)
T ss_pred H---------cCCcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhh
Confidence 1 11122334456778999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=338.24 Aligned_cols=241 Identities=24% Similarity=0.354 Sum_probs=195.0
Q ss_pred ceeeeeCCeEEEEEEEC-CCcEEEEEEeccCC---hhcHHHHHHHHHHHHcc-CCCCcceEEEEEEeCCeEEEEEEecCC
Q 002158 631 TQVGQGGYGKVYKGILS-DNTTVAIKRAEEGS---LQGQNEFLTEIKLLSRL-HHRNLVSLLGYCDEEGEQMLVYEFVPN 705 (958)
Q Consensus 631 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lV~E~~~~ 705 (958)
+.||+|+||+||+|.+. +++.||||+++... ....+.+..|..++... +||||+++++++..++..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g 80 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 36999999999999976 57899999987532 22334566777777654 899999999999999999999999999
Q ss_pred CCHHHHhccCCCCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEecCCCCeEEeeeeeecccccCCCCCCc
Q 002158 706 GTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSRLAPVLDDEGTM 785 (958)
Q Consensus 706 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~ 785 (958)
|+|.+++.... .+++.++..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++......
T Consensus 81 g~L~~~~~~~~--~~~~~~~~~~~~qi~~al~~LH~~~---ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~----- 150 (316)
T cd05592 81 GDLMFHIQSSG--RFDEARARFYAAEIICGLQFLHKKG---IIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGE----- 150 (316)
T ss_pred CcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC---EEeCCCCHHHeEECCCCCEEEccCcCCeECCCCC-----
Confidence 99999997543 4889999999999999999999999 9999999999999999999999999987532211
Q ss_pred cceeeeeccCCCCccChhhhccCCCCCcchhhhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcCcchhhhcccCCCCCh
Q 002158 786 PTHVSTIVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVLLELLTGMQPISHGKNIVREVNVARDSGMVFSIIDNRMGSYPS 865 (958)
Q Consensus 786 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gv~l~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~ 865 (958)
.......||+.|+|||++.+..++.++|||||||++|||++|+.||...... ..... +......++.
T Consensus 151 --~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~-~~~~~----------i~~~~~~~~~ 217 (316)
T cd05592 151 --GKASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDED-ELFDS----------ILNDRPHFPR 217 (316)
T ss_pred --CccccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHH-HHHHH----------HHcCCCCCCC
Confidence 1123456999999999999999999999999999999999999999754321 11111 1112233455
Q ss_pred HHHHHHHHHHHHccccCCCCCCCHH-HHHH
Q 002158 866 ECVERFVTLALRCCHDKPEHRPSMS-DVVR 894 (958)
Q Consensus 866 ~~~~~l~~li~~cl~~dP~~RPs~~-evl~ 894 (958)
.++.++.+++.+||+.||++||++. ++.+
T Consensus 218 ~~~~~~~~ll~~~l~~~P~~R~~~~~~l~~ 247 (316)
T cd05592 218 WISKEAKDCLSKLFERDPTKRLGVDGDIRQ 247 (316)
T ss_pred CCCHHHHHHHHHHccCCHHHcCCChHHHHc
Confidence 5677889999999999999999875 4544
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=340.42 Aligned_cols=250 Identities=25% Similarity=0.293 Sum_probs=199.9
Q ss_pred CCCCCceeeeeCCeEEEEEEEC----CCcEEEEEEeccCC----hhcHHHHHHHHHHHHcc-CCCCcceEEEEEEeCCeE
Q 002158 626 YFSSSTQVGQGGYGKVYKGILS----DNTTVAIKRAEEGS----LQGQNEFLTEIKLLSRL-HHRNLVSLLGYCDEEGEQ 696 (958)
Q Consensus 626 ~~~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~ 696 (958)
+|+..+.||+|+||+||++... +++.||+|++.... ....+.+.+|+++++++ +|+||+++++++..++..
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL 80 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence 4677889999999999999853 57899999986432 22345678899999999 599999999999999999
Q ss_pred EEEEEecCCCCHHHHhccCCCCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEecCCCCeEEeeeeeeccc
Q 002158 697 MLVYEFVPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSRLA 776 (958)
Q Consensus 697 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~~ 776 (958)
++||||+++|+|.+++..+. .+++.++..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++..
T Consensus 81 ~lv~e~~~~g~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~---ivHrDlkp~Nili~~~~~~kl~DfG~~~~~ 155 (332)
T cd05614 81 HLILDYVSGGEMFTHLYQRD--NFSEDEVRFYSGEIILALEHLHKLG---IVYRDIKLENILLDSEGHVVLTDFGLSKEF 155 (332)
T ss_pred EEEEeCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC---cEecCCCHHHeEECCCCCEEEeeCcCCccc
Confidence 99999999999999997543 4889999999999999999999999 999999999999999999999999998754
Q ss_pred ccCCCCCCccceeeeeccCCCCccChhhhccC-CCCCcchhhhHHHHHHHHHhCCCCCCCCch--hHHHHHHHhhcCcch
Q 002158 777 PVLDDEGTMPTHVSTIVKGTPGYLDPEYFLTH-KLTDKSDVYSLGVVLLELLTGMQPISHGKN--IVREVNVARDSGMVF 853 (958)
Q Consensus 777 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DV~S~Gv~l~elltG~~P~~~~~~--~~~~~~~~~~~~~~~ 853 (958)
..... .......||+.|+|||++.+. .++.++|||||||++|||++|+.||..... ....+..
T Consensus 156 ~~~~~------~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~-------- 221 (332)
T cd05614 156 LSEEK------ERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSR-------- 221 (332)
T ss_pred cccCC------CccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHHHH--------
Confidence 22111 112245699999999999865 478899999999999999999999964221 1111111
Q ss_pred hhhcccCCCCChHHHHHHHHHHHHccccCCCCCC-----CHHHHHHH
Q 002158 854 SIIDNRMGSYPSECVERFVTLALRCCHDKPEHRP-----SMSDVVRE 895 (958)
Q Consensus 854 ~~i~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~~ 895 (958)
.+.......+...+..+.+++.+||+.||++|| ++++++++
T Consensus 222 -~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h 267 (332)
T cd05614 222 -RILKCDPPFPSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEH 267 (332)
T ss_pred -HHhcCCCCCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHcC
Confidence 011111233445677889999999999999999 77788764
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=341.17 Aligned_cols=248 Identities=30% Similarity=0.464 Sum_probs=209.4
Q ss_pred CceeeeeCCeEEEEEEEC--CCc--EEEEEEeccCChh-cHHHHHHHHHHHHccCCCCcceEEEEEEeCCeEEEEEEecC
Q 002158 630 STQVGQGGYGKVYKGILS--DNT--TVAIKRAEEGSLQ-GQNEFLTEIKLLSRLHHRNLVSLLGYCDEEGEQMLVYEFVP 704 (958)
Q Consensus 630 ~~~lg~G~~g~Vy~~~~~--~~~--~vavK~~~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E~~~ 704 (958)
.++||+|.||.|++|.|+ .|+ .||||.++..... ...+|++|+.+|.+++|+|++++||+..+ ....+|||+++
T Consensus 115 ~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mMV~ELap 193 (1039)
T KOG0199|consen 115 YELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMMVFELAP 193 (1039)
T ss_pred HHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc-chhhHHhhhcc
Confidence 457999999999999996 343 6899999887655 56789999999999999999999999987 67889999999
Q ss_pred CCCHHHHhccCCCCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEecCCCCeEEeeeeeecccccCCCCCC
Q 002158 705 NGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSRLAPVLDDEGT 784 (958)
Q Consensus 705 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 784 (958)
.|+|.+.|+...+..|-......++.|||.||.||.+++ +|||||..+|+|+-....+||+|||+.|.+...++...
T Consensus 194 lGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLeskr---lvHRDLAARNlllasprtVKI~DFGLmRaLg~ned~Yv 270 (1039)
T KOG0199|consen 194 LGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESKR---LVHRDLAARNLLLASPRTVKICDFGLMRALGENEDMYV 270 (1039)
T ss_pred cchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhhh---hhhhhhhhhhheecccceeeeecccceeccCCCCcceE
Confidence 999999999866677999999999999999999999999 99999999999999999999999999998765444322
Q ss_pred ccceeeeeccCCCCccChhhhccCCCCCcchhhhHHHHHHHHHh-CCCCCCCCchhHHHHHHHhhcCcchhhhc-ccCCC
Q 002158 785 MPTHVSTIVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVLLELLT-GMQPISHGKNIVREVNVARDSGMVFSIID-NRMGS 862 (958)
Q Consensus 785 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gv~l~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~i~-~~~~~ 862 (958)
+. ....-.+.|+|||.+....++.++|||+|||++|||+| |+.||.+-.... .+ +.+| ..+..
T Consensus 271 m~----p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~q-IL----------~~iD~~erLp 335 (1039)
T KOG0199|consen 271 MA----PQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGIQ-IL----------KNIDAGERLP 335 (1039)
T ss_pred ec----CCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCHHH-HH----------HhccccccCC
Confidence 22 22334567999999999999999999999999999999 899997543321 11 1222 22334
Q ss_pred CChHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 002158 863 YPSECVERFVTLALRCCHDKPEHRPSMSDVVREL 896 (958)
Q Consensus 863 ~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 896 (958)
.|+.|++.++++++.||..+|++||++..|.+.+
T Consensus 336 RPk~csedIY~imk~cWah~paDRptFsair~~~ 369 (1039)
T KOG0199|consen 336 RPKYCSEDIYQIMKNCWAHNPADRPTFSAIREDL 369 (1039)
T ss_pred CCCCChHHHHHHHHHhccCCccccccHHHHHHhH
Confidence 5889999999999999999999999999998543
|
|
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=348.40 Aligned_cols=255 Identities=29% Similarity=0.439 Sum_probs=211.7
Q ss_pred CCCceeeeeCCeEEEEEEEC-CC----cEEEEEEeccC-ChhcHHHHHHHHHHHHccCCCCcceEEEEEEeCCeEEEEEE
Q 002158 628 SSSTQVGQGGYGKVYKGILS-DN----TTVAIKRAEEG-SLQGQNEFLTEIKLLSRLHHRNLVSLLGYCDEEGEQMLVYE 701 (958)
Q Consensus 628 ~~~~~lg~G~~g~Vy~~~~~-~~----~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E 701 (958)
...++||+|+||+||+|.|- +| -+||||++... ..+...++++|+-.|.+++|||++|++|+|.... ..||++
T Consensus 699 kk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlvtq 777 (1177)
T KOG1025|consen 699 KKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLVTQ 777 (1177)
T ss_pred hhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHHHH
Confidence 34579999999999999973 33 47899988664 4555678999999999999999999999998775 889999
Q ss_pred ecCCCCHHHHhccCCCCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEecCCCCeEEeeeeeecccccCCC
Q 002158 702 FVPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSRLAPVLDD 781 (958)
Q Consensus 702 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~ 781 (958)
|||.|+|.||++..+ .++.....+.|..|||+||.|||++. ++||||.++|||+.+-..+||.|||+++.+...+.
T Consensus 778 ~mP~G~LlDyvr~hr-~~igsq~lLnw~~QIAkgM~YLe~qr---lVHrdLaaRNVLVksP~hvkitdfgla~ll~~d~~ 853 (1177)
T KOG1025|consen 778 LMPLGCLLDYVREHR-DNIGSQDLLNWCYQIAKGMKYLEEQR---LVHRDLAARNVLVKSPNHVKITDFGLAKLLAPDEK 853 (1177)
T ss_pred hcccchHHHHHHHhh-ccccHHHHHHHHHHHHHHHHHHHhcc---hhhhhhhhhheeecCCCeEEEEecchhhccCcccc
Confidence 999999999998654 45888999999999999999999998 99999999999999999999999999998865544
Q ss_pred CCCccceeeeeccCCCCccChhhhccCCCCCcchhhhHHHHHHHHHh-CCCCCCCCchhHHHHHHHhhcCcchhhhcccC
Q 002158 782 EGTMPTHVSTIVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVLLELLT-GMQPISHGKNIVREVNVARDSGMVFSIIDNRM 860 (958)
Q Consensus 782 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gv~l~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~i~~~~ 860 (958)
+-. .....-.+.|||-|.+....|+.++|||||||++||++| |..|+++... .+.-...+ ++.+
T Consensus 854 ey~-----~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~-~eI~dlle---------~geR 918 (1177)
T KOG1025|consen 854 EYS-----APGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPA-EEIPDLLE---------KGER 918 (1177)
T ss_pred ccc-----ccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCH-HHhhHHHh---------cccc
Confidence 322 122233567999999999999999999999999999999 9999975331 11111111 1222
Q ss_pred CCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHhh
Q 002158 861 GSYPSECVERFVTLALRCCHDKPEHRPSMSDVVRELENILKM 902 (958)
Q Consensus 861 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~ 902 (958)
...|+.|+.+++.++.+||..|++.||+++++...+.++.+.
T Consensus 919 LsqPpiCtiDVy~~mvkCwmid~~~rp~fkel~~~fs~~ard 960 (1177)
T KOG1025|consen 919 LSQPPICTIDVYMVMVKCWMIDADSRPTFKELAEEFSRMARD 960 (1177)
T ss_pred CCCCCCccHHHHHHHHHHhccCcccCccHHHHHHHHHHHhcC
Confidence 455888999999999999999999999999999988887654
|
|
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-37 Score=328.88 Aligned_cols=251 Identities=30% Similarity=0.479 Sum_probs=204.3
Q ss_pred CCCCCceeeeeCCeEEEEEEECCCcEEEEEEeccCChhcHHHHHHHHHHHHccCCCCcceEEEEEEeCCeEEEEEEecCC
Q 002158 626 YFSSSTQVGQGGYGKVYKGILSDNTTVAIKRAEEGSLQGQNEFLTEIKLLSRLHHRNLVSLLGYCDEEGEQMLVYEFVPN 705 (958)
Q Consensus 626 ~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E~~~~ 705 (958)
+|...+.||+|+||+||+|.++++..||||.+.... ...++|.+|+.++++++||||+++++++...+..++||||+++
T Consensus 5 ~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 83 (256)
T cd05113 5 DLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMSN 83 (256)
T ss_pred HeEEeeEecCcccceEEEEEecCCCcEEEEEcCCCc-ccHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcCCC
Confidence 466678899999999999998777789999987543 3346799999999999999999999999998899999999999
Q ss_pred CCHHHHhccCCCCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEecCCCCeEEeeeeeecccccCCCCCCc
Q 002158 706 GTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSRLAPVLDDEGTM 785 (958)
Q Consensus 706 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~ 785 (958)
|+|.+++..... .+++.+++.++.|++.||+|||+.+ ++|+||||+||+++.++.+||+|||.++......
T Consensus 84 ~~l~~~i~~~~~-~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~----- 154 (256)
T cd05113 84 GCLLNYLREHGK-RFQPSQLLEMCKDVCEGMAYLESKQ---FIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDE----- 154 (256)
T ss_pred CcHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHHhCC---eeccccCcceEEEcCCCCEEECCCccceecCCCc-----
Confidence 999999975433 5899999999999999999999999 9999999999999999999999999987542211
Q ss_pred cceeeeeccCCCCccChhhhccCCCCCcchhhhHHHHHHHHHh-CCCCCCCCchhHHHHHHHhhcCcchhhhcccCCCCC
Q 002158 786 PTHVSTIVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVLLELLT-GMQPISHGKNIVREVNVARDSGMVFSIIDNRMGSYP 864 (958)
Q Consensus 786 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gv~l~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~ 864 (958)
........++..|+|||++.+..++.++||||||+++|||++ |..||........ ..... .......+
T Consensus 155 -~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~-~~~~~---------~~~~~~~~ 223 (256)
T cd05113 155 -YTSSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSET-VEKVS---------QGLRLYRP 223 (256)
T ss_pred -eeecCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHH-HHHHh---------cCCCCCCC
Confidence 111122346678999999998889999999999999999999 9999865432211 11111 11111123
Q ss_pred hHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 002158 865 SECVERFVTLALRCCHDKPEHRPSMSDVVRELE 897 (958)
Q Consensus 865 ~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 897 (958)
...+..+.+++.+||+.+|.+||++.++++.|+
T Consensus 224 ~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~~ 256 (256)
T cd05113 224 HLASEKVYAIMYSCWHEKAEERPTFQQLLSSIE 256 (256)
T ss_pred CCCCHHHHHHHHHHcCCCcccCCCHHHHHHhhC
Confidence 334678999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=345.99 Aligned_cols=256 Identities=23% Similarity=0.286 Sum_probs=199.7
Q ss_pred cCCCCCceeeeeCCeEEEEEEEC-CCcEEEEEEeccCC---hhcHHHHHHHHHHHHccCCCCcceEEEEEEeCCeEEEEE
Q 002158 625 AYFSSSTQVGQGGYGKVYKGILS-DNTTVAIKRAEEGS---LQGQNEFLTEIKLLSRLHHRNLVSLLGYCDEEGEQMLVY 700 (958)
Q Consensus 625 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~ 700 (958)
++|...+.||+|+||+||+|... +++.||||++.... ....+.+.+|++++++++||||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM 80 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence 36788899999999999999975 68999999986432 223456889999999999999999999999999999999
Q ss_pred EecCCCCHHHHhccCCCCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEecCCCCeEEeeeeeecccccCC
Q 002158 701 EFVPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSRLAPVLD 780 (958)
Q Consensus 701 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~ 780 (958)
||+++|+|.+++.... .+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++.+....
T Consensus 81 E~~~gg~L~~~l~~~~--~~~~~~~~~~~~ql~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~ 155 (377)
T cd05629 81 EFLPGGDLMTMLIKYD--TFSEDVTRFYMAECVLAIEAVHKLG---FIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQH 155 (377)
T ss_pred eCCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEECCCCCEEEeeccccccccccc
Confidence 9999999999997543 4888999999999999999999999 9999999999999999999999999996432111
Q ss_pred CCC---------Ccc-------------------------------ceeeeeccCCCCccChhhhccCCCCCcchhhhHH
Q 002158 781 DEG---------TMP-------------------------------THVSTIVKGTPGYLDPEYFLTHKLTDKSDVYSLG 820 (958)
Q Consensus 781 ~~~---------~~~-------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~G 820 (958)
... ... ........||+.|+|||++.+..++.++||||||
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG 235 (377)
T cd05629 156 DSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLG 235 (377)
T ss_pred ccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEecc
Confidence 000 000 0000124699999999999999999999999999
Q ss_pred HHHHHHHhCCCCCCCCchhHHHHHHHhhcCcchhhhcccCCCCC--hHHHHHHHHHHHHccccCCCCC---CCHHHHHHH
Q 002158 821 VVLLELLTGMQPISHGKNIVREVNVARDSGMVFSIIDNRMGSYP--SECVERFVTLALRCCHDKPEHR---PSMSDVVRE 895 (958)
Q Consensus 821 v~l~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~--~~~~~~l~~li~~cl~~dP~~R---Ps~~evl~~ 895 (958)
|++|||++|..||........ ......... . ..+| ...+.++.+++.+|+. +|.+| +++.|++++
T Consensus 236 vil~elltG~~Pf~~~~~~~~-~~~i~~~~~-------~-~~~p~~~~~s~~~~dli~~lL~-~~~~r~~r~~~~~~l~h 305 (377)
T cd05629 236 AIMFECLIGWPPFCSENSHET-YRKIINWRE-------T-LYFPDDIHLSVEAEDLIRRLIT-NAENRLGRGGAHEIKSH 305 (377)
T ss_pred hhhhhhhcCCCCCCCCCHHHH-HHHHHccCC-------c-cCCCCCCCCCHHHHHHHHHHhc-CHhhcCCCCCHHHHhcC
Confidence 999999999999975443221 111111000 0 0111 1245678899999997 67665 599999876
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=336.71 Aligned_cols=245 Identities=28% Similarity=0.454 Sum_probs=205.2
Q ss_pred CCCCCceeeeeCCeEEEEEEEC-CCcEEEEEEeccCCh---hcHHHHHHHHHHHHccCCCCcceEEEEEEeCCeEEEEEE
Q 002158 626 YFSSSTQVGQGGYGKVYKGILS-DNTTVAIKRAEEGSL---QGQNEFLTEIKLLSRLHHRNLVSLLGYCDEEGEQMLVYE 701 (958)
Q Consensus 626 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E 701 (958)
.|...+.||.|+||.||.|++. +.+.||||++.-... ....+++.|+.+|++++|||+|.+-|+|..+...|||||
T Consensus 27 lf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVME 106 (948)
T KOG0577|consen 27 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVME 106 (948)
T ss_pred HHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHH
Confidence 3555678999999999999975 678999999865433 334578999999999999999999999999999999999
Q ss_pred ecCCCCHHHHhccCCCCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEecCCCCeEEeeeeeecccccCCC
Q 002158 702 FVPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSRLAPVLDD 781 (958)
Q Consensus 702 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~ 781 (958)
|| -|+-.|++.-. ++++.+.++..|+.+.++||+|||+++ -||||||+.|||+.+.|.|||+|||.|.+..
T Consensus 107 YC-lGSAsDlleVh-kKplqEvEIAAi~~gaL~gLaYLHS~~---~IHRDiKAGNILLse~g~VKLaDFGSAsi~~---- 177 (948)
T KOG0577|consen 107 YC-LGSASDLLEVH-KKPLQEVEIAAITHGALQGLAYLHSHN---RIHRDIKAGNILLSEPGLVKLADFGSASIMA---- 177 (948)
T ss_pred HH-hccHHHHHHHH-hccchHHHHHHHHHHHHHHHHHHHHhh---HHhhhccccceEecCCCeeeeccccchhhcC----
Confidence 99 57888888643 345899999999999999999999999 9999999999999999999999999998642
Q ss_pred CCCccceeeeeccCCCCccChhhhc---cCCCCCcchhhhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcCcchhhhcc
Q 002158 782 EGTMPTHVSTIVKGTPGYLDPEYFL---THKLTDKSDVYSLGVVLLELLTGMQPISHGKNIVREVNVARDSGMVFSIIDN 858 (958)
Q Consensus 782 ~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DV~S~Gv~l~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~i~~ 858 (958)
+...++|||.|||||++. .+.|+-|+||||+|++-.|+...++|+.....+...+..+.......
T Consensus 178 -------PAnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMSALYHIAQNesPtL----- 245 (948)
T KOG0577|consen 178 -------PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPTL----- 245 (948)
T ss_pred -------chhcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHHHHHHHHhcCCCCC-----
Confidence 234578999999999996 46799999999999999999999999986655444433332211111
Q ss_pred cCCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 002158 859 RMGSYPSECVERFVTLALRCCHDKPEHRPSMSDVVRE 895 (958)
Q Consensus 859 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 895 (958)
...++.+.+.+++..|+++-|.+|||.++++.+
T Consensus 246 ----qs~eWS~~F~~Fvd~CLqKipqeRptse~ll~H 278 (948)
T KOG0577|consen 246 ----QSNEWSDYFRNFVDSCLQKIPQERPTSEELLKH 278 (948)
T ss_pred ----CCchhHHHHHHHHHHHHhhCcccCCcHHHHhhc
Confidence 145788999999999999999999999988754
|
|
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=344.79 Aligned_cols=258 Identities=22% Similarity=0.303 Sum_probs=202.7
Q ss_pred cCCCCCceeeeeCCeEEEEEEEC-CCcEEEEEEeccCC---hhcHHHHHHHHHHHHccCCCCcceEEEEEEeCCeEEEEE
Q 002158 625 AYFSSSTQVGQGGYGKVYKGILS-DNTTVAIKRAEEGS---LQGQNEFLTEIKLLSRLHHRNLVSLLGYCDEEGEQMLVY 700 (958)
Q Consensus 625 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~ 700 (958)
++|+..+.||+|+||+||+|... +++.||||++.... ......+.+|+++++.++||||+++++++.+++..++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM 80 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence 36888899999999999999986 68999999987532 223456789999999999999999999999999999999
Q ss_pred EecCCCCHHHHhccCCCCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEecCCCCeEEeeeeeecccccCC
Q 002158 701 EFVPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSRLAPVLD 780 (958)
Q Consensus 701 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~ 780 (958)
||+++|+|.+++.... .+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++.+....
T Consensus 81 E~~~~g~L~~~l~~~~--~l~~~~~~~~~~qi~~aL~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~ 155 (364)
T cd05599 81 EYLPGGDMMTLLMKKD--TFTEEETRFYIAETILAIDSIHKLG---YIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSH 155 (364)
T ss_pred CCCCCcHHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEeecccceeccccc
Confidence 9999999999997543 4899999999999999999999999 9999999999999999999999999987543211
Q ss_pred CCCCcc-------------------------------ceeeeeccCCCCccChhhhccCCCCCcchhhhHHHHHHHHHhC
Q 002158 781 DEGTMP-------------------------------THVSTIVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVLLELLTG 829 (958)
Q Consensus 781 ~~~~~~-------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gv~l~elltG 829 (958)
...... ........||+.|+|||++....++.++|||||||++|||++|
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~G 235 (364)
T cd05599 156 RTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVG 235 (364)
T ss_pred cccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhhcC
Confidence 100000 0011124699999999999999999999999999999999999
Q ss_pred CCCCCCCchhHHHHHHHhhcCcchhhhcccCCCCChHHHHHHHHHHHHccccCCCCCCC---HHHHHHH
Q 002158 830 MQPISHGKNIVREVNVARDSGMVFSIIDNRMGSYPSECVERFVTLALRCCHDKPEHRPS---MSDVVRE 895 (958)
Q Consensus 830 ~~P~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs---~~evl~~ 895 (958)
..||.......... ........... ......+..+.+++.+|+. +|.+|++ ++|++++
T Consensus 236 ~~Pf~~~~~~~~~~-~i~~~~~~~~~------~~~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~h 296 (364)
T cd05599 236 YPPFCSDNPQETYR-KIINWKETLQF------PDEVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKSH 296 (364)
T ss_pred CCCCCCCCHHHHHH-HHHcCCCccCC------CCCCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhcC
Confidence 99997654322211 11110000000 0011345678899999996 9999997 8888875
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=339.81 Aligned_cols=258 Identities=24% Similarity=0.376 Sum_probs=203.3
Q ss_pred HcCCCCCceeeeeCCeEEEEEEEC-CCcEEEEEEeccCC-hhcHHHHHHHHHHHHccCCCCcceEEEEEEeCCeEEEEEE
Q 002158 624 TAYFSSSTQVGQGGYGKVYKGILS-DNTTVAIKRAEEGS-LQGQNEFLTEIKLLSRLHHRNLVSLLGYCDEEGEQMLVYE 701 (958)
Q Consensus 624 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E 701 (958)
.++|+..+.||+|+||.||+|.++ ++..||+|.+.... ......+.+|++++++++|+||+++++++..++..++|||
T Consensus 4 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 83 (333)
T cd06650 4 DDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 83 (333)
T ss_pred hhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEEe
Confidence 467888999999999999999987 68889999887642 3334678999999999999999999999999999999999
Q ss_pred ecCCCCHHHHhccCCCCCchHHHHHHHHHHHHHHHHHhhhc-CCCCeeccCCCccceEecCCCCeEEeeeeeecccccCC
Q 002158 702 FVPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTE-AHPPVFHRDIKASNILLDSNLNAKVADFGLSRLAPVLD 780 (958)
Q Consensus 702 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~-~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~ 780 (958)
|+++|+|.+++.... .+++..+..++.|++.||.|||+. + |+||||||+|||+++++.+||+|||++......
T Consensus 84 ~~~~~~L~~~l~~~~--~~~~~~~~~~~~~l~~~l~~lH~~~~---ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~- 157 (333)
T cd06650 84 HMDGGSLDQVLKKAG--RIPEQILGKVSIAVIKGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS- 157 (333)
T ss_pred cCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhcCC---EEecCCChhhEEEcCCCCEEEeeCCcchhhhhh-
Confidence 999999999997543 388899999999999999999975 5 999999999999999999999999998754211
Q ss_pred CCCCccceeeeeccCCCCccChhhhccCCCCCcchhhhHHHHHHHHHhCCCCCCCCchhHHHHHHH-hhcCc--------
Q 002158 781 DEGTMPTHVSTIVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVLLELLTGMQPISHGKNIVREVNVA-RDSGM-------- 851 (958)
Q Consensus 781 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gv~l~elltG~~P~~~~~~~~~~~~~~-~~~~~-------- 851 (958)
......|+..|+|||++.+..++.++|||||||++|||++|+.||............. ...+.
T Consensus 158 --------~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (333)
T cd06650 158 --------MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEGDPAESETSP 229 (333)
T ss_pred --------ccccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcchhHHHHHhcCcccCCccccccCc
Confidence 1123468999999999998889999999999999999999999997533211100000 00000
Q ss_pred ---------------------chh----hhcccCCCCC-hHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 002158 852 ---------------------VFS----IIDNRMGSYP-SECVERFVTLALRCCHDKPEHRPSMSDVVRE 895 (958)
Q Consensus 852 ---------------------~~~----~i~~~~~~~~-~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 895 (958)
... ++.......+ ...+.++.+++.+||+.||++||+++|++++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~h 299 (333)
T cd06650 230 RPRPPGRPLSSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMVH 299 (333)
T ss_pred ccCCccchhhhhcccccccccHHHHHHHHhcCCCccCCCCCcCHHHHHHHHHhccCCcccCcCHHHHhhC
Confidence 000 0000001111 1235678999999999999999999999875
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-37 Score=343.93 Aligned_cols=260 Identities=24% Similarity=0.337 Sum_probs=197.5
Q ss_pred CCCCCceeeeeCCeEEEEEEEC-CCcEEEEEEeccC--ChhcHHHHHHHHHHHHccCCCCcceEEEEEEeC-----CeEE
Q 002158 626 YFSSSTQVGQGGYGKVYKGILS-DNTTVAIKRAEEG--SLQGQNEFLTEIKLLSRLHHRNLVSLLGYCDEE-----GEQM 697 (958)
Q Consensus 626 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~-----~~~~ 697 (958)
+|+..+.||+|+||.||+|+.. +++.||||++... ......++.+|++++++++||||+++++++... ...+
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 80 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY 80 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence 4677889999999999999976 6899999998743 223345788999999999999999999988543 2479
Q ss_pred EEEEecCCCCHHHHhccCCCCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEecCCCCeEEeeeeeecccc
Q 002158 698 LVYEFVPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSRLAP 777 (958)
Q Consensus 698 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~~~ 777 (958)
+||||++ ++|.+++.... .+++..+..++.|+++||+|||+.+ |+||||||+|||++.++.+||+|||+++...
T Consensus 81 lv~e~~~-~~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~~ 154 (338)
T cd07859 81 VVFELME-SDLHQVIKAND--DLTPEHHQFFLYQLLRALKYIHTAN---VFHRDLKPKNILANADCKLKICDFGLARVAF 154 (338)
T ss_pred EEEecCC-CCHHHHHHhcc--cCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCcEEEccCccccccc
Confidence 9999994 79999986543 4899999999999999999999999 9999999999999999999999999997542
Q ss_pred cCCCCCCccceeeeeccCCCCccChhhhcc--CCCCCcchhhhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcC-----
Q 002158 778 VLDDEGTMPTHVSTIVKGTPGYLDPEYFLT--HKLTDKSDVYSLGVVLLELLTGMQPISHGKNIVREVNVARDSG----- 850 (958)
Q Consensus 778 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DV~S~Gv~l~elltG~~P~~~~~~~~~~~~~~~~~~----- 850 (958)
..... ........||+.|+|||++.+ ..++.++|||||||++|||++|+.||................+
T Consensus 155 ~~~~~----~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~ 230 (338)
T cd07859 155 NDTPT----AIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPE 230 (338)
T ss_pred cccCc----cccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHH
Confidence 21111 111233569999999999876 6788999999999999999999999975442211100000000
Q ss_pred -----------cchhhhcccCC-C---CChHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 002158 851 -----------MVFSIIDNRMG-S---YPSECVERFVTLALRCCHDKPEHRPSMSDVVRE 895 (958)
Q Consensus 851 -----------~~~~~i~~~~~-~---~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 895 (958)
.....+..... . .....+..+.+++.+||+.||++||+++|++++
T Consensus 231 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~h 290 (338)
T cd07859 231 TISRVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALAD 290 (338)
T ss_pred HHHHhhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcC
Confidence 00000000000 0 001234667899999999999999999999975
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=337.88 Aligned_cols=251 Identities=27% Similarity=0.426 Sum_probs=215.4
Q ss_pred cCCCCCceeeeeCCeEEEEEEEC-CCcEEEEEEeccCChh--cHHHHHHHHHHHHccCCCCcceEEEEEEeCCe-EEEEE
Q 002158 625 AYFSSSTQVGQGGYGKVYKGILS-DNTTVAIKRAEEGSLQ--GQNEFLTEIKLLSRLHHRNLVSLLGYCDEEGE-QMLVY 700 (958)
Q Consensus 625 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~-~~lV~ 700 (958)
++|...+++|+|+||.++..+++ ++..+++|.+...... ..+....|+.++++++|||||.+.+.+..++. .++||
T Consensus 4 ~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Ivm 83 (426)
T KOG0589|consen 4 DNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIVM 83 (426)
T ss_pred chhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEEE
Confidence 45777889999999999999876 6789999988765333 34467899999999999999999999999888 99999
Q ss_pred EecCCCCHHHHhccCCCCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEecCCCCeEEeeeeeecccccCC
Q 002158 701 EFVPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSRLAPVLD 780 (958)
Q Consensus 701 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~ 780 (958)
+||+||++.+.+....+..++++++.+|+.|++.|+.|||+.. |+|||||+.||+++.++.|||+|||+|+.+....
T Consensus 84 ~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~~---iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~~ 160 (426)
T KOG0589|consen 84 EYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHENR---VLHRDLKCANIFLTKDKKVKLGDFGLAKILNPED 160 (426)
T ss_pred eecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhhh---hhcccchhhhhhccccCceeecchhhhhhcCCch
Confidence 9999999999998877778999999999999999999999888 9999999999999999999999999999764322
Q ss_pred CCCCccceeeeeccCCCCccChhhhccCCCCCcchhhhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcCcchhhhcccC
Q 002158 781 DEGTMPTHVSTIVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVLLELLTGMQPISHGKNIVREVNVARDSGMVFSIIDNRM 860 (958)
Q Consensus 781 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gv~l~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~i~~~~ 860 (958)
.....+.||+.||.||.+.+.+|..|+||||+||++|||++-+++|... +....+.. +.....
T Consensus 161 -------~~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~-~m~~Li~k---------i~~~~~ 223 (426)
T KOG0589|consen 161 -------SLASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKAS-NMSELILK---------INRGLY 223 (426)
T ss_pred -------hhhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCcc-chHHHHHH---------HhhccC
Confidence 1234578999999999999999999999999999999999999999643 33332222 222223
Q ss_pred CCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 002158 861 GSYPSECVERFVTLALRCCHDKPEHRPSMSDVVRE 895 (958)
Q Consensus 861 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 895 (958)
...|.....++..++..|++.+|+.||++.+++.+
T Consensus 224 ~Plp~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~ 258 (426)
T KOG0589|consen 224 SPLPSMYSSELRSLVKSMLRKNPEHRPSALELLRR 258 (426)
T ss_pred CCCCccccHHHHHHHHHHhhcCCccCCCHHHHhhC
Confidence 45577888999999999999999999999999976
|
|
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=332.84 Aligned_cols=256 Identities=30% Similarity=0.522 Sum_probs=205.3
Q ss_pred cCCCCCceeeeeCCeEEEEEEE-----CCCcEEEEEEeccCC-hhcHHHHHHHHHHHHccCCCCcceEEEEEEeCCeEEE
Q 002158 625 AYFSSSTQVGQGGYGKVYKGIL-----SDNTTVAIKRAEEGS-LQGQNEFLTEIKLLSRLHHRNLVSLLGYCDEEGEQML 698 (958)
Q Consensus 625 ~~~~~~~~lg~G~~g~Vy~~~~-----~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~l 698 (958)
..|+..+.||+|+||+||+|.+ .++..||+|.+.... .....+|.+|++++++++||||+++++++..+...++
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 84 (283)
T cd05090 5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCM 84 (283)
T ss_pred hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceEE
Confidence 3566778999999999999985 246789999987543 3344678999999999999999999999999999999
Q ss_pred EEEecCCCCHHHHhccCC---------------CCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEecCCC
Q 002158 699 VYEFVPNGTLRDWLSGRT---------------KENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSNL 763 (958)
Q Consensus 699 V~E~~~~gsL~~~l~~~~---------------~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~~ 763 (958)
||||+++++|.+++.... ...+++.+++.++.|++.||+|||+++ ++||||||+|||+++++
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~nili~~~~ 161 (283)
T cd05090 85 LFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHF---FVHKDLAARNILIGEQL 161 (283)
T ss_pred EEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcC---eehhccccceEEEcCCC
Confidence 999999999999985321 234788999999999999999999999 99999999999999999
Q ss_pred CeEEeeeeeecccccCCCCCCccceeeeeccCCCCccChhhhccCCCCCcchhhhHHHHHHHHHh-CCCCCCCCchhHHH
Q 002158 764 NAKVADFGLSRLAPVLDDEGTMPTHVSTIVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVLLELLT-GMQPISHGKNIVRE 842 (958)
Q Consensus 764 ~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gv~l~ellt-G~~P~~~~~~~~~~ 842 (958)
.+||+|||+++....... ........++..|+|||++.+..++.++||||||+++|||++ |..||..... ...
T Consensus 162 ~~kl~dfg~~~~~~~~~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~-~~~ 235 (283)
T cd05090 162 HVKISDLGLSREIYSADY-----YRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSN-QEV 235 (283)
T ss_pred cEEeccccccccccCCcc-----eecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCH-HHH
Confidence 999999999976432111 111223346778999999988889999999999999999999 9989864332 111
Q ss_pred HHHHhhcCcchhhhcccCCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 002158 843 VNVARDSGMVFSIIDNRMGSYPSECVERFVTLALRCCHDKPEHRPSMSDVVRELEN 898 (958)
Q Consensus 843 ~~~~~~~~~~~~~i~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 898 (958)
...... . .....+..++..+.+++.+||+.||++||++.++.++|.+
T Consensus 236 ~~~~~~-~--------~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05090 236 IEMVRK-R--------QLLPCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLRS 282 (283)
T ss_pred HHHHHc-C--------CcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHhhc
Confidence 111111 1 1112344567889999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=327.66 Aligned_cols=255 Identities=32% Similarity=0.493 Sum_probs=207.1
Q ss_pred cCCCCCceeeeeCCeEEEEEEECCCcEEEEEEeccCChhcHHHHHHHHHHHHccCCCCcceEEEEEEeCCeEEEEEEecC
Q 002158 625 AYFSSSTQVGQGGYGKVYKGILSDNTTVAIKRAEEGSLQGQNEFLTEIKLLSRLHHRNLVSLLGYCDEEGEQMLVYEFVP 704 (958)
Q Consensus 625 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E~~~ 704 (958)
.+|...+.||+|+||.||+|.++++..||+|++..... ..++|.+|++++++++|+||+++++++.. +..++||||++
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~~-~~~~lv~e~~~ 83 (262)
T cd05071 6 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM-SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMS 83 (262)
T ss_pred HHeeEeeecCCCCCCcEEEEEecCCceEEEEecccCcc-CHHHHHHHHHHHHhCCCCCcceEEEEECC-CCcEEEEEcCC
Confidence 46788899999999999999987777899999875332 34578999999999999999999998754 56899999999
Q ss_pred CCCHHHHhccCCCCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEecCCCCeEEeeeeeecccccCCCCCC
Q 002158 705 NGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSRLAPVLDDEGT 784 (958)
Q Consensus 705 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 784 (958)
+|+|.+++.......+++..+..++.|+++||+|||+.+ ++||||||+||++++++.++|+|||.++.......
T Consensus 84 ~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~--- 157 (262)
T cd05071 84 KGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEY--- 157 (262)
T ss_pred CCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccCcccEEEcCCCcEEeccCCceeecccccc---
Confidence 999999997654455899999999999999999999998 99999999999999999999999999976532211
Q ss_pred ccceeeeeccCCCCccChhhhccCCCCCcchhhhHHHHHHHHHh-CCCCCCCCchhHHHHHHHhhcCcchhhhcccCCCC
Q 002158 785 MPTHVSTIVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVLLELLT-GMQPISHGKNIVREVNVARDSGMVFSIIDNRMGSY 863 (958)
Q Consensus 785 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gv~l~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~ 863 (958)
.......++..|+|||+..+..++.++||||||+++|||++ |..||....... ....... ......
T Consensus 158 ---~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~-~~~~~~~---------~~~~~~ 224 (262)
T cd05071 158 ---TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE-VLDQVER---------GYRMPC 224 (262)
T ss_pred ---ccccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHH-HHHHHhc---------CCCCCC
Confidence 11112346778999999998899999999999999999999 888886543221 1111110 111122
Q ss_pred ChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhH
Q 002158 864 PSECVERFVTLALRCCHDKPEHRPSMSDVVRELENIL 900 (958)
Q Consensus 864 ~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~ 900 (958)
+..++..+.+++.+|++.+|++||+++++.+.|++..
T Consensus 225 ~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~~~ 261 (262)
T cd05071 225 PPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYF 261 (262)
T ss_pred ccccCHHHHHHHHHHccCCcccCCCHHHHHHHHHHhc
Confidence 4456788999999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-37 Score=338.64 Aligned_cols=244 Identities=29% Similarity=0.433 Sum_probs=206.5
Q ss_pred eeeeeCCeEEEEEEECC-CcEEEEEEeccCChhcHHHHHHHHHHHHccCCCCcceEEEEEEeCCeEEEEEEecCCCCHHH
Q 002158 632 QVGQGGYGKVYKGILSD-NTTVAIKRAEEGSLQGQNEFLTEIKLLSRLHHRNLVSLLGYCDEEGEQMLVYEFVPNGTLRD 710 (958)
Q Consensus 632 ~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E~~~~gsL~~ 710 (958)
+||+|.||+||.|++.+ ...+|||-+..........+.+|+..-++++|.|||+++|.|..+++.-+.||-+|||+|.+
T Consensus 582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLSs 661 (1226)
T KOG4279|consen 582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLSS 661 (1226)
T ss_pred EeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHHH
Confidence 79999999999999764 56789999987766666778899999999999999999999999999999999999999999
Q ss_pred HhccCCCCCc--hHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEec-CCCCeEEeeeeeecccccCCCCCCccc
Q 002158 711 WLSGRTKENL--NFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLD-SNLNAKVADFGLSRLAPVLDDEGTMPT 787 (958)
Q Consensus 711 ~l~~~~~~~l--~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~-~~~~~kl~DFGla~~~~~~~~~~~~~~ 787 (958)
+|+.+.+. + .+.+.-.+..||++||.|||+.. |||||||-+||||+ -.|.+||+|||.++.+... .
T Consensus 662 LLrskWGP-lKDNEstm~fYtkQILeGLkYLHen~---IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAgi-------n 730 (1226)
T KOG4279|consen 662 LLRSKWGP-LKDNESTMNFYTKQILEGLKYLHENK---IVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGI-------N 730 (1226)
T ss_pred HHHhccCC-CccchhHHHHHHHHHHHHhhhhhhcc---eeeccccCCcEEEeeccceEEecccccchhhccC-------C
Confidence 99877643 4 67788889999999999999999 99999999999996 5799999999999876332 2
Q ss_pred eeeeeccCCCCccChhhhccC--CCCCcchhhhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcCcchhhhcccCCCCCh
Q 002158 788 HVSTIVKGTPGYLDPEYFLTH--KLTDKSDVYSLGVVLLELLTGMQPISHGKNIVREVNVARDSGMVFSIIDNRMGSYPS 865 (958)
Q Consensus 788 ~~~~~~~gt~~y~aPE~~~~~--~~~~~~DV~S~Gv~l~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~ 865 (958)
..+..+.||.-|||||++..+ .|..++|||||||++.||.||++||....+....+- +.+ +-+.-+.+|.
T Consensus 731 P~TETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAAMF---kVG-----myKvHP~iPe 802 (1226)
T KOG4279|consen 731 PCTETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAAMF---KVG-----MYKVHPPIPE 802 (1226)
T ss_pred ccccccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHhhh---hhc-----ceecCCCCcH
Confidence 234567899999999999766 488899999999999999999999975443322211 011 1122356788
Q ss_pred HHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002158 866 ECVERFVTLALRCCHDKPEHRPSMSDVVR 894 (958)
Q Consensus 866 ~~~~~l~~li~~cl~~dP~~RPs~~evl~ 894 (958)
+...+..++|.+|+.+||.+||++.++++
T Consensus 803 elsaeak~FilrcFepd~~~R~sA~~LL~ 831 (1226)
T KOG4279|consen 803 ELSAEAKNFILRCFEPDPCDRPSAKDLLQ 831 (1226)
T ss_pred HHHHHHHHHHHHHcCCCcccCccHHHhcc
Confidence 99999999999999999999999999986
|
|
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=346.99 Aligned_cols=258 Identities=21% Similarity=0.310 Sum_probs=200.6
Q ss_pred CCCCCceeeeeCCeEEEEEEEC-CCcEEEEEEeccCC---hhcHHHHHHHHHHHHccCCCCcceEEEEEEeCCeEEEEEE
Q 002158 626 YFSSSTQVGQGGYGKVYKGILS-DNTTVAIKRAEEGS---LQGQNEFLTEIKLLSRLHHRNLVSLLGYCDEEGEQMLVYE 701 (958)
Q Consensus 626 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E 701 (958)
.|...+.||+|+||+||+|+.. +++.||||++.... ......+.+|++++++++|+||+++++++.+.+..++|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E 81 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD 81 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEe
Confidence 5777889999999999999975 68899999987532 2334568899999999999999999999999999999999
Q ss_pred ecCCCCHHHHhccCCCCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEecCCCCeEEeeeeeecccccCCC
Q 002158 702 FVPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSRLAPVLDD 781 (958)
Q Consensus 702 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~ 781 (958)
|+++|+|.+++.... .+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++.......
T Consensus 82 ~~~gg~L~~~l~~~~--~~~e~~~~~~~~qi~~aL~~LH~~g---ivHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~~ 156 (381)
T cd05626 82 YIPGGDMMSLLIRME--VFPEVLARFYIAELTLAIESVHKMG---FIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHN 156 (381)
T ss_pred cCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCcHHHEEECCCCCEEEeeCcCCcccccccc
Confidence 999999999997543 4888999999999999999999999 99999999999999999999999999864321100
Q ss_pred CCC----------------------------------------ccceeeeeccCCCCccChhhhccCCCCCcchhhhHHH
Q 002158 782 EGT----------------------------------------MPTHVSTIVKGTPGYLDPEYFLTHKLTDKSDVYSLGV 821 (958)
Q Consensus 782 ~~~----------------------------------------~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gv 821 (958)
... ..........||+.|+|||++.+..++.++|||||||
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG~ 236 (381)
T cd05626 157 SKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGV 236 (381)
T ss_pred cccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeehhh
Confidence 000 0000112357999999999999999999999999999
Q ss_pred HHHHHHhCCCCCCCCchhHHHHHHHhhcCcchhhhcccCCCCChHHHHHHHHHHHH--ccccCCCCCCCHHHHHHH
Q 002158 822 VLLELLTGMQPISHGKNIVREVNVARDSGMVFSIIDNRMGSYPSECVERFVTLALR--CCHDKPEHRPSMSDVVRE 895 (958)
Q Consensus 822 ~l~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~l~~li~~--cl~~dP~~RPs~~evl~~ 895 (958)
++|||++|+.||.................. .. . ......+.++.+++.+ |+..+|..||+++|++++
T Consensus 237 il~elltG~~Pf~~~~~~~~~~~i~~~~~~-~~-----~-~~~~~~s~~~~dli~~ll~~~~~~~~R~~~~~~l~h 305 (381)
T cd05626 237 ILFEMLVGQPPFLAPTPTETQLKVINWENT-LH-----I-PPQVKLSPEAVDLITKLCCSAEERLGRNGADDIKAH 305 (381)
T ss_pred HHHHHHhCCCCCcCCCHHHHHHHHHccccc-cC-----C-CCCCCCCHHHHHHHHHHccCcccccCCCCHHHHhcC
Confidence 999999999999765432222111110000 00 0 0111345677788877 566677779999999975
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=326.67 Aligned_cols=253 Identities=30% Similarity=0.488 Sum_probs=206.6
Q ss_pred cCCCCCceeeeeCCeEEEEEEECCCcEEEEEEeccCChhcHHHHHHHHHHHHccCCCCcceEEEEEEeCCeEEEEEEecC
Q 002158 625 AYFSSSTQVGQGGYGKVYKGILSDNTTVAIKRAEEGSLQGQNEFLTEIKLLSRLHHRNLVSLLGYCDEEGEQMLVYEFVP 704 (958)
Q Consensus 625 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E~~~ 704 (958)
++|+..+.||+|+||.||+|.++++..||+|.+..... ..+.|.+|+.++++++|+|++++++++. ....++||||++
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~~ 83 (260)
T cd05070 6 ESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTM-SPESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIYIVTEYMS 83 (260)
T ss_pred HHhhhhheeccccCceEEEEEecCCceeEEEEecCCCC-CHHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcEEEEEecC
Confidence 46777889999999999999988888999999876433 3457999999999999999999999885 456899999999
Q ss_pred CCCHHHHhccCCCCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEecCCCCeEEeeeeeecccccCCCCCC
Q 002158 705 NGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSRLAPVLDDEGT 784 (958)
Q Consensus 705 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 784 (958)
+++|.++++......+++.++..++.|++.||+|||+.+ |+||||||+||++++++.++|+|||++........
T Consensus 84 ~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~~--- 157 (260)
T cd05070 84 KGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMN---YIHRDLRSANILVGDGLVCKIADFGLARLIEDNEY--- 157 (260)
T ss_pred CCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCccceEEEeCCceEEeCCceeeeeccCccc---
Confidence 999999998655556899999999999999999999999 99999999999999999999999999976532111
Q ss_pred ccceeeeeccCCCCccChhhhccCCCCCcchhhhHHHHHHHHHh-CCCCCCCCchhHHHHHHHhhcCcchhhhcccCCCC
Q 002158 785 MPTHVSTIVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVLLELLT-GMQPISHGKNIVREVNVARDSGMVFSIIDNRMGSY 863 (958)
Q Consensus 785 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gv~l~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~ 863 (958)
.......++..|+|||++.+..++.++||||||+++|||++ |..||.+.... ....... .......
T Consensus 158 ---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~-~~~~~~~---------~~~~~~~ 224 (260)
T cd05070 158 ---TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNR-EVLEQVE---------RGYRMPC 224 (260)
T ss_pred ---ccccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHH-HHHHHHH---------cCCCCCC
Confidence 11112235678999999988899999999999999999999 88898654322 1111111 1111223
Q ss_pred ChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 002158 864 PSECVERFVTLALRCCHDKPEHRPSMSDVVRELEN 898 (958)
Q Consensus 864 ~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 898 (958)
+...+..+.+++.+|+..+|++||+++++.+.|++
T Consensus 225 ~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 259 (260)
T cd05070 225 PQDCPISLHELMLQCWKKDPEERPTFEYLQSFLED 259 (260)
T ss_pred CCcCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 44567789999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-36 Score=340.46 Aligned_cols=259 Identities=22% Similarity=0.308 Sum_probs=198.2
Q ss_pred cCCCCCceeeeeCCeEEEEEEEC-CCcEEEEEEeccCC---hhcHHHHHHHHHHHHccCCCCcceEEEEEEeCCeEEEEE
Q 002158 625 AYFSSSTQVGQGGYGKVYKGILS-DNTTVAIKRAEEGS---LQGQNEFLTEIKLLSRLHHRNLVSLLGYCDEEGEQMLVY 700 (958)
Q Consensus 625 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~ 700 (958)
++|+..+.||+|+||+||+|... +++.||||++.... ......+.+|+.++.+++|+||+++++++.+....++||
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~ 80 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM 80 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence 36888899999999999999976 58899999987532 222356788999999999999999999999999999999
Q ss_pred EecCCCCHHHHhccCCCCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEecCCCCeEEeeeeeecccccCC
Q 002158 701 EFVPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSRLAPVLD 780 (958)
Q Consensus 701 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~ 780 (958)
||+++|+|.+++.... .+++..+..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+++......
T Consensus 81 E~~~gg~L~~~l~~~~--~l~~~~~~~~~~qi~~aL~~lH~~g---ivHrDlKp~NILi~~~~~vkL~DFGla~~~~~~~ 155 (363)
T cd05628 81 EFLPGGDMMTLLMKKD--TLTEEETQFYIAETVLAIDSIHQLG---FIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAH 155 (363)
T ss_pred cCCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCC---eEecCCCHHHeEECCCCCEEEeeccCcccccccc
Confidence 9999999999997543 4899999999999999999999999 9999999999999999999999999987543211
Q ss_pred CCCC----------------------------ccceeeeeccCCCCccChhhhccCCCCCcchhhhHHHHHHHHHhCCCC
Q 002158 781 DEGT----------------------------MPTHVSTIVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVLLELLTGMQP 832 (958)
Q Consensus 781 ~~~~----------------------------~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gv~l~elltG~~P 832 (958)
.... ..........||+.|+|||++.+..++.++|||||||++|||++|+.|
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~P 235 (363)
T cd05628 156 RTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPP 235 (363)
T ss_pred cccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCCC
Confidence 0000 000011245799999999999999999999999999999999999999
Q ss_pred CCCCchhHHHHHHHhhcCcchhhhcccCCCCChHHHHHHHHHHHHccc--cCCCCCCCHHHHHHH
Q 002158 833 ISHGKNIVREVNVARDSGMVFSIIDNRMGSYPSECVERFVTLALRCCH--DKPEHRPSMSDVVRE 895 (958)
Q Consensus 833 ~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~l~~li~~cl~--~dP~~RPs~~evl~~ 895 (958)
|.......... .......... .+. ......++.+++.+++. .++..||+++|++++
T Consensus 236 f~~~~~~~~~~-~i~~~~~~~~-----~p~-~~~~s~~~~~li~~l~~~~~~r~~r~~~~ei~~h 293 (363)
T cd05628 236 FCSETPQETYK-KVMNWKETLI-----FPP-EVPISEKAKDLILRFCCEWEHRIGAPGVEEIKTN 293 (363)
T ss_pred CCCCCHHHHHH-HHHcCcCccc-----CCC-cCCCCHHHHHHHHHHcCChhhcCCCCCHHHHhCC
Confidence 97544322211 1111000000 000 01134566677776433 344467999999976
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-37 Score=342.14 Aligned_cols=236 Identities=24% Similarity=0.344 Sum_probs=193.9
Q ss_pred ceeeeeCCeEEEEEEEC-CCcEEEEEEeccCC---hhcHHHHHHHHHHHHcc-CCCCcceEEEEEEeCCeEEEEEEecCC
Q 002158 631 TQVGQGGYGKVYKGILS-DNTTVAIKRAEEGS---LQGQNEFLTEIKLLSRL-HHRNLVSLLGYCDEEGEQMLVYEFVPN 705 (958)
Q Consensus 631 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lV~E~~~~ 705 (958)
+.||+|+||+||+|..+ +++.||||++.... ....+.+..|..++..+ +||||+++++++...+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~ 80 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG 80 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence 36999999999999986 58899999987532 23345677899988877 699999999999999999999999999
Q ss_pred CCHHHHhccCCCCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEecCCCCeEEeeeeeecccccCCCCCCc
Q 002158 706 GTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSRLAPVLDDEGTM 785 (958)
Q Consensus 706 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~ 785 (958)
|+|.+++.... .+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 81 g~L~~~i~~~~--~l~~~~~~~~~~ql~~~L~~lH~~~---ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~------ 149 (320)
T cd05590 81 GDLMFHIQKSR--RFDEARARFYAAEITSALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFN------ 149 (320)
T ss_pred chHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHeEECCCCcEEEeeCCCCeecCcC------
Confidence 99999997543 4899999999999999999999999 999999999999999999999999998743211
Q ss_pred cceeeeeccCCCCccChhhhccCCCCCcchhhhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcCcchhhhcccCCCCCh
Q 002158 786 PTHVSTIVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVLLELLTGMQPISHGKNIVREVNVARDSGMVFSIIDNRMGSYPS 865 (958)
Q Consensus 786 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gv~l~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~ 865 (958)
........||+.|+|||++.+..++.++|||||||++|||++|+.||...... ....... ......+.
T Consensus 150 -~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~-~~~~~i~----------~~~~~~~~ 217 (320)
T cd05590 150 -GKTTSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENED-DLFEAIL----------NDEVVYPT 217 (320)
T ss_pred -CCcccccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHH-HHHHHHh----------cCCCCCCC
Confidence 11123456999999999999999999999999999999999999999754422 1111111 11122344
Q ss_pred HHHHHHHHHHHHccccCCCCCCCH
Q 002158 866 ECVERFVTLALRCCHDKPEHRPSM 889 (958)
Q Consensus 866 ~~~~~l~~li~~cl~~dP~~RPs~ 889 (958)
..+.++.+++.+|++.||++||++
T Consensus 218 ~~~~~~~~li~~~L~~dP~~R~~~ 241 (320)
T cd05590 218 WLSQDAVDILKAFMTKNPTMRLGS 241 (320)
T ss_pred CCCHHHHHHHHHHcccCHHHCCCC
Confidence 566788999999999999999998
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-37 Score=348.57 Aligned_cols=253 Identities=23% Similarity=0.298 Sum_probs=197.6
Q ss_pred cCCCCCceeeeeCCeEEEEEEEC-CCcEEEEEEeccCChhcHHHHHHHHHHHHccCCCCcceEEEEEEeCCeEEEEEEec
Q 002158 625 AYFSSSTQVGQGGYGKVYKGILS-DNTTVAIKRAEEGSLQGQNEFLTEIKLLSRLHHRNLVSLLGYCDEEGEQMLVYEFV 703 (958)
Q Consensus 625 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E~~ 703 (958)
.+|...+.||+|+||.||+|.+. .++.||+|.... ..+.+|++++++++||||+++++++......++|||++
T Consensus 92 ~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~~------~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~ 165 (391)
T PHA03212 92 AGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQR------GGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILPRY 165 (391)
T ss_pred CCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechhh------hhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEecC
Confidence 56888999999999999999975 688999997542 34678999999999999999999999999999999999
Q ss_pred CCCCHHHHhccCCCCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEecCCCCeEEeeeeeecccccCCCCC
Q 002158 704 PNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSRLAPVLDDEG 783 (958)
Q Consensus 704 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 783 (958)
+++|.+++.... .+++.+++.++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+++......
T Consensus 166 -~~~L~~~l~~~~--~l~~~~~~~i~~qi~~aL~ylH~~~---IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~--- 236 (391)
T PHA03212 166 -KTDLYCYLAAKR--NIAICDILAIERSVLRAIQYLHENR---IIHRDIKAENIFINHPGDVCLGDFGAACFPVDIN--- 236 (391)
T ss_pred -CCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHhEEEcCCCCEEEEeCCccccccccc---
Confidence 479999986543 4889999999999999999999999 9999999999999999999999999997532211
Q ss_pred CccceeeeeccCCCCccChhhhccCCCCCcchhhhHHHHHHHHHhCCCCCCCCchh------HHHHHHH-hhcCc-----
Q 002158 784 TMPTHVSTIVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVLLELLTGMQPISHGKNI------VREVNVA-RDSGM----- 851 (958)
Q Consensus 784 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gv~l~elltG~~P~~~~~~~------~~~~~~~-~~~~~----- 851 (958)
........||+.|+|||++.+..++.++|||||||++|||++|+.||...... ....... ...+.
T Consensus 237 ---~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~ 313 (391)
T PHA03212 237 ---ANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEF 313 (391)
T ss_pred ---ccccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhc
Confidence 11223457999999999999999999999999999999999999887542210 0011000 00000
Q ss_pred -------chhhh----c---ccCCCC-----ChHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 002158 852 -------VFSII----D---NRMGSY-----PSECVERFVTLALRCCHDKPEHRPSMSDVVRE 895 (958)
Q Consensus 852 -------~~~~i----~---~~~~~~-----~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 895 (958)
..... . ...... ....+.++.+++.+||+.||++|||++|++++
T Consensus 314 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~h 376 (391)
T PHA03212 314 PIDAQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLDF 376 (391)
T ss_pred CcchhHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhcC
Confidence 00000 0 000000 11346688999999999999999999999974
|
|
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=326.94 Aligned_cols=250 Identities=30% Similarity=0.479 Sum_probs=203.5
Q ss_pred CCCCCceeeeeCCeEEEEEEECCCcEEEEEEeccCChhcHHHHHHHHHHHHccCCCCcceEEEEEEeCCeEEEEEEecCC
Q 002158 626 YFSSSTQVGQGGYGKVYKGILSDNTTVAIKRAEEGSLQGQNEFLTEIKLLSRLHHRNLVSLLGYCDEEGEQMLVYEFVPN 705 (958)
Q Consensus 626 ~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E~~~~ 705 (958)
+|+..+.||+|+||.||+|.++++..+|+|.+.... ....+|.+|++++++++|+||+++++++...+..++||||+++
T Consensus 5 ~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~ 83 (256)
T cd05059 5 ELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGA-MSEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMAN 83 (256)
T ss_pred HcchhhhhccCCCceEEEeEecCCccEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecCCC
Confidence 466778999999999999998877889999986533 2345788999999999999999999999999999999999999
Q ss_pred CCHHHHhccCCCCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEecCCCCeEEeeeeeecccccCCCCCCc
Q 002158 706 GTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSRLAPVLDDEGTM 785 (958)
Q Consensus 706 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~ 785 (958)
++|.+++..... .+++..+..++.|++.||+|||+.+ ++||||||+||++++++.+||+|||+++......
T Consensus 84 ~~L~~~l~~~~~-~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~----- 154 (256)
T cd05059 84 GCLLNYLRERKG-KLGTEWLLDMCSDVCEAMEYLESNG---FIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQ----- 154 (256)
T ss_pred CCHHHHHHhccc-CCCHHHHHHHHHHHHHHHHHHHHCC---cccccccHhhEEECCCCcEEECCcccceeccccc-----
Confidence 999999975433 5899999999999999999999999 9999999999999999999999999987542111
Q ss_pred cceeeeeccCCCCccChhhhccCCCCCcchhhhHHHHHHHHHh-CCCCCCCCchhHHHHHHHhhcCcchhhhcccCCCCC
Q 002158 786 PTHVSTIVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVLLELLT-GMQPISHGKNIVREVNVARDSGMVFSIIDNRMGSYP 864 (958)
Q Consensus 786 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gv~l~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~ 864 (958)
........++..|+|||.+.+..++.++||||||+++|||++ |+.||....... ....... . .....+
T Consensus 155 -~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~-~~~~~~~-~--------~~~~~~ 223 (256)
T cd05059 155 -YTSSQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSE-VVESVSA-G--------YRLYRP 223 (256)
T ss_pred -ccccCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHH-HHHHHHc-C--------CcCCCC
Confidence 001111224567999999999999999999999999999999 899986543321 1111111 1 011223
Q ss_pred hHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 002158 865 SECVERFVTLALRCCHDKPEHRPSMSDVVREL 896 (958)
Q Consensus 865 ~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 896 (958)
..++..+.+++.+||..+|++||++.|+++.|
T Consensus 224 ~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l 255 (256)
T cd05059 224 KLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQL 255 (256)
T ss_pred CCCCHHHHHHHHHHhcCChhhCcCHHHHHHHh
Confidence 45678899999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=336.76 Aligned_cols=241 Identities=22% Similarity=0.335 Sum_probs=195.6
Q ss_pred ceeeeeCCeEEEEEEEC-CCcEEEEEEeccCC---hhcHHHHHHHHHHHHcc-CCCCcceEEEEEEeCCeEEEEEEecCC
Q 002158 631 TQVGQGGYGKVYKGILS-DNTTVAIKRAEEGS---LQGQNEFLTEIKLLSRL-HHRNLVSLLGYCDEEGEQMLVYEFVPN 705 (958)
Q Consensus 631 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lV~E~~~~ 705 (958)
+.||+|+||.||+|.++ +|+.||+|+++... ......+..|..++... +||||+++++++...+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~ 80 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence 46999999999999986 68899999987532 12344567788888765 899999999999999999999999999
Q ss_pred CCHHHHhccCCCCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEecCCCCeEEeeeeeecccccCCCCCCc
Q 002158 706 GTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSRLAPVLDDEGTM 785 (958)
Q Consensus 706 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~ 785 (958)
|+|.+++.... .+++.++..++.|+++||+|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 81 g~L~~~i~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~---ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~------ 149 (316)
T cd05620 81 GDLMFHIQDKG--RFDLYRATFYAAEIVCGLQFLHSKG---IIYRDLKLDNVMLDRDGHIKIADFGMCKENVFG------ 149 (316)
T ss_pred CcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEeCccCCCeecccC------
Confidence 99999997543 4889999999999999999999999 999999999999999999999999998743111
Q ss_pred cceeeeeccCCCCccChhhhccCCCCCcchhhhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcCcchhhhcccCCCCCh
Q 002158 786 PTHVSTIVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVLLELLTGMQPISHGKNIVREVNVARDSGMVFSIIDNRMGSYPS 865 (958)
Q Consensus 786 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gv~l~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~ 865 (958)
........||+.|+|||++.+..++.++||||+||++|||++|+.||...... ...... .......+.
T Consensus 150 -~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~-~~~~~~----------~~~~~~~~~ 217 (316)
T cd05620 150 -DNRASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDED-ELFESI----------RVDTPHYPR 217 (316)
T ss_pred -CCceeccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHH-HHHHHH----------HhCCCCCCC
Confidence 11223456999999999999999999999999999999999999999754321 111111 111123344
Q ss_pred HHHHHHHHHHHHccccCCCCCCCHH-HHHH
Q 002158 866 ECVERFVTLALRCCHDKPEHRPSMS-DVVR 894 (958)
Q Consensus 866 ~~~~~l~~li~~cl~~dP~~RPs~~-evl~ 894 (958)
....++.+++.+||+.||++||++. ++.+
T Consensus 218 ~~~~~~~~li~~~l~~dP~~R~~~~~~~~~ 247 (316)
T cd05620 218 WITKESKDILEKLFERDPTRRLGVVGNIRG 247 (316)
T ss_pred CCCHHHHHHHHHHccCCHHHcCCChHHHHc
Confidence 4667889999999999999999985 5553
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=330.11 Aligned_cols=248 Identities=22% Similarity=0.343 Sum_probs=197.6
Q ss_pred eeeeCCeEEEEEEEC-CCcEEEEEEeccCCh---hcHHHHHHHHHHHHccCCCCcceEEEEEEeCCeEEEEEEecCCCCH
Q 002158 633 VGQGGYGKVYKGILS-DNTTVAIKRAEEGSL---QGQNEFLTEIKLLSRLHHRNLVSLLGYCDEEGEQMLVYEFVPNGTL 708 (958)
Q Consensus 633 lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E~~~~gsL 708 (958)
||+|+||.||++..+ +|+.||+|++..... ...+.+..|++++++++||||+++++++..+...++||||+++++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L 80 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL 80 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence 699999999999976 689999999864321 2234466799999999999999999999999999999999999999
Q ss_pred HHHhccCCCCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEecCCCCeEEeeeeeecccccCCCCCCccce
Q 002158 709 RDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSRLAPVLDDEGTMPTH 788 (958)
Q Consensus 709 ~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~ 788 (958)
.+++.......+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.++|+|||++...... .
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~--------~ 149 (277)
T cd05607 81 KYHIYNVGERGLEMERVIHYSAQITCGILHLHSMD---IVYRDMKPENVLLDDQGNCRLSDLGLAVELKDG--------K 149 (277)
T ss_pred HHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCC---EEEccCChHhEEEcCCCCEEEeeceeeeecCCC--------c
Confidence 99987655556899999999999999999999999 999999999999999999999999998754321 1
Q ss_pred eeeeccCCCCccChhhhccCCCCCcchhhhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcCcchhhhcccCCCCChHHH
Q 002158 789 VSTIVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVLLELLTGMQPISHGKNIVREVNVARDSGMVFSIIDNRMGSYPSECV 868 (958)
Q Consensus 789 ~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gv~l~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~ 868 (958)
......|+..|+|||++.+..++.++||||+||++|||++|+.||.............. ..............+
T Consensus 150 ~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~~~~~~------~~~~~~~~~~~~~~~ 223 (277)
T cd05607 150 TITQRAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKR------RTLEDEVKFEHQNFT 223 (277)
T ss_pred eeeccCCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhhHHHHHH------HhhccccccccccCC
Confidence 12234689999999999998999999999999999999999999965322111100000 001111111122456
Q ss_pred HHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 002158 869 ERFVTLALRCCHDKPEHRPSMSDVVRELE 897 (958)
Q Consensus 869 ~~l~~li~~cl~~dP~~RPs~~evl~~L~ 897 (958)
.++.+++.+||+.||++||+++|+++.+.
T Consensus 224 ~~~~~li~~~L~~~P~~R~~~~~~~~~~~ 252 (277)
T cd05607 224 EESKDICRLFLAKKPEDRLGSREKNDDPR 252 (277)
T ss_pred HHHHHHHHHHhccCHhhCCCCccchhhhh
Confidence 77899999999999999999988765433
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-37 Score=339.59 Aligned_cols=242 Identities=23% Similarity=0.336 Sum_probs=197.4
Q ss_pred ceeeeeCCeEEEEEEEC-CCcEEEEEEeccCC---hhcHHHHHHHHHHHHcc-CCCCcceEEEEEEeCCeEEEEEEecCC
Q 002158 631 TQVGQGGYGKVYKGILS-DNTTVAIKRAEEGS---LQGQNEFLTEIKLLSRL-HHRNLVSLLGYCDEEGEQMLVYEFVPN 705 (958)
Q Consensus 631 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lV~E~~~~ 705 (958)
+.||+|+||+||+|+++ +++.||||++.... ....+.+..|.++++.+ +||||+++++++..++..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~ 80 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG 80 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence 36999999999999986 57899999987532 23345677899999876 799999999999999999999999999
Q ss_pred CCHHHHhccCCCCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEecCCCCeEEeeeeeecccccCCCCCCc
Q 002158 706 GTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSRLAPVLDDEGTM 785 (958)
Q Consensus 706 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~ 785 (958)
|+|.+++.... .+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++......
T Consensus 81 ~~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~----- 150 (321)
T cd05591 81 GDLMFQIQRSR--KFDEPRSRFYAAEVTLALMFLHRHG---VIYRDLKLDNILLDAEGHCKLADFGMCKEGILNG----- 150 (321)
T ss_pred CcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEeecccceecccCC-----
Confidence 99999996543 4889999999999999999999999 9999999999999999999999999987432111
Q ss_pred cceeeeeccCCCCccChhhhccCCCCCcchhhhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcCcchhhhcccCCCCCh
Q 002158 786 PTHVSTIVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVLLELLTGMQPISHGKNIVREVNVARDSGMVFSIIDNRMGSYPS 865 (958)
Q Consensus 786 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gv~l~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~ 865 (958)
.......||+.|+|||++.+..++.++|||||||++|||++|+.||....... ....... .....|.
T Consensus 151 --~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~-~~~~i~~----------~~~~~p~ 217 (321)
T cd05591 151 --VTTTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDD-LFESILH----------DDVLYPV 217 (321)
T ss_pred --ccccccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHHH-HHHHHHc----------CCCCCCC
Confidence 11234569999999999999999999999999999999999999997544322 1111111 1112344
Q ss_pred HHHHHHHHHHHHccccCCCCCC-------CHHHHHHH
Q 002158 866 ECVERFVTLALRCCHDKPEHRP-------SMSDVVRE 895 (958)
Q Consensus 866 ~~~~~l~~li~~cl~~dP~~RP-------s~~evl~~ 895 (958)
..+.++.+++.+|++.||++|| ++++++++
T Consensus 218 ~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~h 254 (321)
T cd05591 218 WLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQH 254 (321)
T ss_pred CCCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhcC
Confidence 4567889999999999999999 77777754
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=334.40 Aligned_cols=260 Identities=24% Similarity=0.344 Sum_probs=200.2
Q ss_pred HcCCCCCceeeeeCCeEEEEEEEC-CCcEEEEEEeccCCh-hcHHHHHHHHHHHHccCCCCcceEEEEEEeCCeEEEEEE
Q 002158 624 TAYFSSSTQVGQGGYGKVYKGILS-DNTTVAIKRAEEGSL-QGQNEFLTEIKLLSRLHHRNLVSLLGYCDEEGEQMLVYE 701 (958)
Q Consensus 624 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E 701 (958)
.++|...+.||+|+||+||+|..+ +++.||||++..... .....+.+|+++++.++||||+++++++..++..++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 83 (303)
T cd07869 4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFE 83 (303)
T ss_pred cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEE
Confidence 357888999999999999999986 688999999875432 223467889999999999999999999999999999999
Q ss_pred ecCCCCHHHHhccCCCCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEecCCCCeEEeeeeeecccccCCC
Q 002158 702 FVPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSRLAPVLDD 781 (958)
Q Consensus 702 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~ 781 (958)
|++ ++|.+++.... ..++...+..++.|++.||+|||+++ |+||||||+|||+++++.+||+|||+++......
T Consensus 84 ~~~-~~l~~~~~~~~-~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~- 157 (303)
T cd07869 84 YVH-TDLCQYMDKHP-GGLHPENVKLFLFQLLRGLSYIHQRY---ILHRDLKPQNLLISDTGELKLADFGLARAKSVPS- 157 (303)
T ss_pred CCC-cCHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECCCCcceeccCCC-
Confidence 995 68888886543 34888999999999999999999999 9999999999999999999999999987532111
Q ss_pred CCCccceeeeeccCCCCccChhhhcc-CCCCCcchhhhHHHHHHHHHhCCCCCCCCchhHHHHHHHhh-cCcch------
Q 002158 782 EGTMPTHVSTIVKGTPGYLDPEYFLT-HKLTDKSDVYSLGVVLLELLTGMQPISHGKNIVREVNVARD-SGMVF------ 853 (958)
Q Consensus 782 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DV~S~Gv~l~elltG~~P~~~~~~~~~~~~~~~~-~~~~~------ 853 (958)
.......||+.|+|||++.+ ..++.++||||+||++|||++|+.||.+..+.......... .+...
T Consensus 158 ------~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (303)
T cd07869 158 ------HTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPG 231 (303)
T ss_pred ------ccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhCCCChhhccc
Confidence 11123458899999999875 45788999999999999999999999765443332221110 00000
Q ss_pred --h---hhcccCC-CCCh---------HHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 002158 854 --S---IIDNRMG-SYPS---------ECVERFVTLALRCCHDKPEHRPSMSDVVRE 895 (958)
Q Consensus 854 --~---~i~~~~~-~~~~---------~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 895 (958)
. ....... ..+. ..+..+.+++.+|++.||++|||++|++++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~h 288 (303)
T cd07869 232 VHSLPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALSH 288 (303)
T ss_pred hhhccccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhcC
Confidence 0 0000000 0010 123567899999999999999999999864
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=338.96 Aligned_cols=237 Identities=26% Similarity=0.337 Sum_probs=190.8
Q ss_pred ceeeeeCCeEEEEEEEC-CCcEEEEEEeccCC---hhcHHHHHHHHH-HHHccCCCCcceEEEEEEeCCeEEEEEEecCC
Q 002158 631 TQVGQGGYGKVYKGILS-DNTTVAIKRAEEGS---LQGQNEFLTEIK-LLSRLHHRNLVSLLGYCDEEGEQMLVYEFVPN 705 (958)
Q Consensus 631 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~-~l~~l~H~niv~l~~~~~~~~~~~lV~E~~~~ 705 (958)
+.||+|+||.||+|++. +++.||+|++.... .....++.+|.. +++.++||||+++++++.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG 80 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 36999999999999986 68899999986532 122344555654 67889999999999999999999999999999
Q ss_pred CCHHHHhccCCCCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEecCCCCeEEeeeeeecccccCCCCCCc
Q 002158 706 GTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSRLAPVLDDEGTM 785 (958)
Q Consensus 706 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~ 785 (958)
|+|.+++... ..+++.++..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+++.....
T Consensus 81 ~~L~~~l~~~--~~~~~~~~~~~~~qi~~~L~~lH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~------ 149 (321)
T cd05603 81 GELFFHLQRE--RCFLEPRARFYAAEVASAIGYLHSLN---IIYRDLKPENILLDSQGHVVLTDFGLCKEGVEP------ 149 (321)
T ss_pred CCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEccCCCCccCCCC------
Confidence 9999988654 34888899999999999999999999 999999999999999999999999998742111
Q ss_pred cceeeeeccCCCCccChhhhccCCCCCcchhhhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcCcchhhhcccCCCCCh
Q 002158 786 PTHVSTIVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVLLELLTGMQPISHGKNIVREVNVARDSGMVFSIIDNRMGSYPS 865 (958)
Q Consensus 786 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gv~l~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~ 865 (958)
........||+.|+|||++.+..++.++|||||||++|||++|+.||..... ........ ......+.
T Consensus 150 -~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~-~~~~~~i~----------~~~~~~~~ 217 (321)
T cd05603 150 -EETTSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDV-SQMYDNIL----------HKPLQLPG 217 (321)
T ss_pred -CCccccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCH-HHHHHHHh----------cCCCCCCC
Confidence 1112345699999999999999999999999999999999999999975432 12111111 11122344
Q ss_pred HHHHHHHHHHHHccccCCCCCCCHH
Q 002158 866 ECVERFVTLALRCCHDKPEHRPSMS 890 (958)
Q Consensus 866 ~~~~~l~~li~~cl~~dP~~RPs~~ 890 (958)
..+..+.+++.+|++.||++||+..
T Consensus 218 ~~~~~~~~li~~~l~~~p~~R~~~~ 242 (321)
T cd05603 218 GKTVAACDLLVGLLHKDQRRRLGAK 242 (321)
T ss_pred CCCHHHHHHHHHHccCCHhhcCCCC
Confidence 5567889999999999999999764
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=338.77 Aligned_cols=238 Identities=24% Similarity=0.303 Sum_probs=195.8
Q ss_pred ceeeeeCCeEEEEEEE----CCCcEEEEEEeccCCh--hcHHHHHHHHHHHHccCCCCcceEEEEEEeCCeEEEEEEecC
Q 002158 631 TQVGQGGYGKVYKGIL----SDNTTVAIKRAEEGSL--QGQNEFLTEIKLLSRLHHRNLVSLLGYCDEEGEQMLVYEFVP 704 (958)
Q Consensus 631 ~~lg~G~~g~Vy~~~~----~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E~~~ 704 (958)
+.||+|+||.||++.. .+|+.||+|++..... .....+..|++++++++||||+++++++..++..++||||++
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 81 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR 81 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence 5799999999999875 3578999999875322 234467889999999999999999999999999999999999
Q ss_pred CCCHHHHhccCCCCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEecCCCCeEEeeeeeecccccCCCCCC
Q 002158 705 NGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSRLAPVLDDEGT 784 (958)
Q Consensus 705 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 784 (958)
+|+|.+++.... .+++..+..++.|+++||+|||+.+ |+||||||+||+++.++.+||+|||+++......
T Consensus 82 ~~~L~~~l~~~~--~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~---- 152 (318)
T cd05582 82 GGDLFTRLSKEV--MFTEEDVKFYLAELALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHE---- 152 (318)
T ss_pred CCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHeEECCCCcEEEeeccCCcccCCCC----
Confidence 999999996543 4899999999999999999999999 9999999999999999999999999987542211
Q ss_pred ccceeeeeccCCCCccChhhhccCCCCCcchhhhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcCcchhhhcccCCCCC
Q 002158 785 MPTHVSTIVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVLLELLTGMQPISHGKNIVREVNVARDSGMVFSIIDNRMGSYP 864 (958)
Q Consensus 785 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gv~l~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~ 864 (958)
.......||+.|+|||++.+..++.++|||||||++|||++|+.||........ ..... ......+
T Consensus 153 ---~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~-~~~i~----------~~~~~~p 218 (318)
T cd05582 153 ---KKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKET-MTMIL----------KAKLGMP 218 (318)
T ss_pred ---CceecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCHHHH-HHHHH----------cCCCCCC
Confidence 112345699999999999988899999999999999999999999975433211 11111 1112334
Q ss_pred hHHHHHHHHHHHHccccCCCCCCCHHH
Q 002158 865 SECVERFVTLALRCCHDKPEHRPSMSD 891 (958)
Q Consensus 865 ~~~~~~l~~li~~cl~~dP~~RPs~~e 891 (958)
...+..+.+++.+||+.||++||++.+
T Consensus 219 ~~~~~~~~~li~~~l~~~P~~R~~a~~ 245 (318)
T cd05582 219 QFLSPEAQSLLRALFKRNPANRLGAGP 245 (318)
T ss_pred CCCCHHHHHHHHHHhhcCHhHcCCCCC
Confidence 556778899999999999999999554
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-36 Score=329.10 Aligned_cols=259 Identities=26% Similarity=0.398 Sum_probs=203.8
Q ss_pred cCCCCCceeeeeCCeEEEEEEEC-CCc----EEEEEEeccCC-hhcHHHHHHHHHHHHccCCCCcceEEEEEEeCCeEEE
Q 002158 625 AYFSSSTQVGQGGYGKVYKGILS-DNT----TVAIKRAEEGS-LQGQNEFLTEIKLLSRLHHRNLVSLLGYCDEEGEQML 698 (958)
Q Consensus 625 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~----~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~l 698 (958)
.+|...+.||+|+||+||+|.+. +++ .|++|.+.... .....++..|+..+++++||||+++++++.. ...++
T Consensus 7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~-~~~~~ 85 (279)
T cd05111 7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICPG-ASLQL 85 (279)
T ss_pred hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEECC-CccEE
Confidence 35667789999999999999975 344 47788876432 2234568889999999999999999999864 46789
Q ss_pred EEEecCCCCHHHHhccCCCCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEecCCCCeEEeeeeeeccccc
Q 002158 699 VYEFVPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSRLAPV 778 (958)
Q Consensus 699 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~~~~ 778 (958)
++||+++|+|.+++.... ..+++..+..++.|++.||+|||+.+ ++||||||+||++++++.+||+|||+++....
T Consensus 86 i~e~~~~gsL~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~---iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~~ 161 (279)
T cd05111 86 VTQLSPLGSLLDHVRQHR-DSLDPQRLLNWCVQIAKGMYYLEEHR---MVHRNLAARNILLKSDSIVQIADFGVADLLYP 161 (279)
T ss_pred EEEeCCCCcHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHCC---EeccccCcceEEEcCCCcEEEcCCccceeccC
Confidence 999999999999997543 34899999999999999999999998 99999999999999999999999999986532
Q ss_pred CCCCCCccceeeeeccCCCCccChhhhccCCCCCcchhhhHHHHHHHHHh-CCCCCCCCchhHHHHHHHhhcCcchhhhc
Q 002158 779 LDDEGTMPTHVSTIVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVLLELLT-GMQPISHGKNIVREVNVARDSGMVFSIID 857 (958)
Q Consensus 779 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gv~l~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~i~ 857 (958)
... ........++..|+|||++.+..++.++||||||+++|||++ |..||.+..... ... ....+.
T Consensus 162 ~~~-----~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~-~~~-~~~~~~------ 228 (279)
T cd05111 162 DDK-----KYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHE-VPD-LLEKGE------ 228 (279)
T ss_pred CCc-----ccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHH-HHH-HHHCCC------
Confidence 211 111223457789999999998999999999999999999998 999996543211 111 111111
Q ss_pred ccCCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHhhC
Q 002158 858 NRMGSYPSECVERFVTLALRCCHDKPEHRPSMSDVVRELENILKMF 903 (958)
Q Consensus 858 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~ 903 (958)
....+..++..+..++.+||..+|++||++.|+++.|..+.+..
T Consensus 229 --~~~~~~~~~~~~~~li~~c~~~~p~~Rps~~el~~~l~~~~~~~ 272 (279)
T cd05111 229 --RLAQPQICTIDVYMVMVKCWMIDENVRPTFKELANEFTRMARDP 272 (279)
T ss_pred --cCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHhCC
Confidence 11123335567889999999999999999999999998877543
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-36 Score=326.15 Aligned_cols=257 Identities=24% Similarity=0.365 Sum_probs=208.5
Q ss_pred cCCCCCceeeeeCCeEEEEEEEC-CCcEEEEEEeccC---ChhcHHHHHHHHHHHHccCCCCcceEEEEEEeCCeEEEEE
Q 002158 625 AYFSSSTQVGQGGYGKVYKGILS-DNTTVAIKRAEEG---SLQGQNEFLTEIKLLSRLHHRNLVSLLGYCDEEGEQMLVY 700 (958)
Q Consensus 625 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~ 700 (958)
++|+..+.||+|+||.||+|+.. +++.||||.+... .......|.+|++++++++||||+++++++...+..++||
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVL 81 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEE
Confidence 46888899999999999999975 7899999987542 2333457899999999999999999999999999999999
Q ss_pred EecCCCCHHHHhccC--CCCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEecCCCCeEEeeeeeeccccc
Q 002158 701 EFVPNGTLRDWLSGR--TKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSRLAPV 778 (958)
Q Consensus 701 E~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~~~~ 778 (958)
||+++++|.+++... ....+++..+..++.|+++||+|||+++ ++||||||+||+++.++.++|+|||++.....
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~ 158 (267)
T cd08228 82 ELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred EecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCCHHHEEEcCCCCEEECccccceeccc
Confidence 999999999988532 2344788999999999999999999999 99999999999999999999999999876532
Q ss_pred CCCCCCccceeeeeccCCCCccChhhhccCCCCCcchhhhHHHHHHHHHhCCCCCCCCchh-HHHHHHHhhcCcchhhhc
Q 002158 779 LDDEGTMPTHVSTIVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVLLELLTGMQPISHGKNI-VREVNVARDSGMVFSIID 857 (958)
Q Consensus 779 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gv~l~elltG~~P~~~~~~~-~~~~~~~~~~~~~~~~i~ 857 (958)
... ......|+..|+|||.+.+..++.++||||||+++|||++|+.||...... ...........
T Consensus 159 ~~~-------~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~------- 224 (267)
T cd08228 159 KTT-------AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKIEQCD------- 224 (267)
T ss_pred hhH-------HHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccccHHHHHHHHhcCC-------
Confidence 111 112345888999999999888999999999999999999999999654321 11111111100
Q ss_pred ccCCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHh
Q 002158 858 NRMGSYPSECVERFVTLALRCCHDKPEHRPSMSDVVRELENI 899 (958)
Q Consensus 858 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 899 (958)
.....+...+..+.+++.+||+.+|++||++++|++.++++
T Consensus 225 -~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~ 265 (267)
T cd08228 225 -YPPLPTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQM 265 (267)
T ss_pred -CCCCChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHh
Confidence 01112335667899999999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=326.29 Aligned_cols=254 Identities=30% Similarity=0.483 Sum_probs=208.3
Q ss_pred HcCCCCCceeeeeCCeEEEEEEECCCcEEEEEEeccCChhcHHHHHHHHHHHHccCCCCcceEEEEEEeCCeEEEEEEec
Q 002158 624 TAYFSSSTQVGQGGYGKVYKGILSDNTTVAIKRAEEGSLQGQNEFLTEIKLLSRLHHRNLVSLLGYCDEEGEQMLVYEFV 703 (958)
Q Consensus 624 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E~~ 703 (958)
.+.|...++||+|+||.||+|..++++.||+|.+..... ...+|.+|++++++++|+|++++++++. .+..++||||+
T Consensus 5 ~~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~ 82 (260)
T cd05067 5 RETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSM-SPEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYIITEYM 82 (260)
T ss_pred hHHceeeeeeccCccceEEeeecCCCceEEEEEecCCCC-cHHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEEEEEcC
Confidence 456788899999999999999988899999999876433 3467899999999999999999999874 45789999999
Q ss_pred CCCCHHHHhccCCCCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEecCCCCeEEeeeeeecccccCCCCC
Q 002158 704 PNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSRLAPVLDDEG 783 (958)
Q Consensus 704 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 783 (958)
++++|.+++.......+++.++..++.|++.||+|||+.+ ++||||||+||++++++.++|+|||++........
T Consensus 83 ~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~-- 157 (260)
T cd05067 83 ENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKN---YIHRDLRAANILVSETLCCKIADFGLARLIEDNEY-- 157 (260)
T ss_pred CCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCC---eecccccHHhEEEcCCCCEEEccCcceeecCCCCc--
Confidence 9999999997665566899999999999999999999998 99999999999999999999999999876532111
Q ss_pred CccceeeeeccCCCCccChhhhccCCCCCcchhhhHHHHHHHHHh-CCCCCCCCchhHHHHHHHhhcCcchhhhcccCCC
Q 002158 784 TMPTHVSTIVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVLLELLT-GMQPISHGKNIVREVNVARDSGMVFSIIDNRMGS 862 (958)
Q Consensus 784 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gv~l~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~ 862 (958)
.......++..|+|||++....++.++||||||+++|||++ |+.||...... ........ + ....
T Consensus 158 ----~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~-~~~~~~~~-~--------~~~~ 223 (260)
T cd05067 158 ----TAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNP-EVIQNLER-G--------YRMP 223 (260)
T ss_pred ----ccccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChH-HHHHHHHc-C--------CCCC
Confidence 11122346778999999998889999999999999999999 99999754322 11111111 1 1112
Q ss_pred CChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 002158 863 YPSECVERFVTLALRCCHDKPEHRPSMSDVVRELEN 898 (958)
Q Consensus 863 ~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 898 (958)
.+...+.++.+++.+||+.+|++||+++++.+.|+.
T Consensus 224 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 259 (260)
T cd05067 224 RPDNCPEELYELMRLCWKEKPEERPTFEYLRSVLED 259 (260)
T ss_pred CCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHhhc
Confidence 234456789999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-37 Score=341.70 Aligned_cols=251 Identities=21% Similarity=0.307 Sum_probs=198.1
Q ss_pred ceeeeeCCeEEEEEEEC-CCcEEEEEEeccCC---hhcHHHHHHHHHHHHcc-CCCCcceEEEEEEeCCeEEEEEEecCC
Q 002158 631 TQVGQGGYGKVYKGILS-DNTTVAIKRAEEGS---LQGQNEFLTEIKLLSRL-HHRNLVSLLGYCDEEGEQMLVYEFVPN 705 (958)
Q Consensus 631 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lV~E~~~~ 705 (958)
+.||+|+||+||+|.++ +++.||||+++... ....+.+.+|..+++++ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG 80 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence 36999999999999976 68899999997532 22345688999999998 799999999999999999999999999
Q ss_pred CCHHHHhccCCCCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEecCCCCeEEeeeeeecccccCCCCCCc
Q 002158 706 GTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSRLAPVLDDEGTM 785 (958)
Q Consensus 706 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~ 785 (958)
|+|.+++.... .+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 81 g~L~~~~~~~~--~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~------ 149 (329)
T cd05588 81 GDLMFHMQRQR--KLPEEHARFYSAEISLALNFLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRP------ 149 (329)
T ss_pred CCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEECcCccccccccC------
Confidence 99999986543 4899999999999999999999999 999999999999999999999999998742111
Q ss_pred cceeeeeccCCCCccChhhhccCCCCCcchhhhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcCcchhhhcccCCCCCh
Q 002158 786 PTHVSTIVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVLLELLTGMQPISHGKNIVREVNVARDSGMVFSIIDNRMGSYPS 865 (958)
Q Consensus 786 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gv~l~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~ 865 (958)
........||+.|+|||++.+..++.++|||||||++|||++|+.||.......... ........+.+.......|.
T Consensus 150 -~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~--~~~~~~~~~~~~~~~~~~p~ 226 (329)
T cd05588 150 -GDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPD--QNTEDYLFQVILEKQIRIPR 226 (329)
T ss_pred -CCccccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCccccccccccc--ccchHHHHHHHHcCCCCCCC
Confidence 111234569999999999999999999999999999999999999996311000000 00000011112222223455
Q ss_pred HHHHHHHHHHHHccccCCCCCCC------HHHHHHH
Q 002158 866 ECVERFVTLALRCCHDKPEHRPS------MSDVVRE 895 (958)
Q Consensus 866 ~~~~~l~~li~~cl~~dP~~RPs------~~evl~~ 895 (958)
.++..+.+++.+|++.||.+||+ +++++++
T Consensus 227 ~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~h 262 (329)
T cd05588 227 SLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKSH 262 (329)
T ss_pred CCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhcC
Confidence 66778999999999999999997 6677654
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=322.82 Aligned_cols=254 Identities=23% Similarity=0.344 Sum_probs=197.2
Q ss_pred CCCCCceeeeeCCeEEEEEEEC-CCcEEEEEEeccCChhcHHHHHHHHHHHHccCCCCcceEEEEEEeCC-----eEEEE
Q 002158 626 YFSSSTQVGQGGYGKVYKGILS-DNTTVAIKRAEEGSLQGQNEFLTEIKLLSRLHHRNLVSLLGYCDEEG-----EQMLV 699 (958)
Q Consensus 626 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~-----~~~lV 699 (958)
.|...+++|.|+||.||+|... .++.||||+.-.+.... .+|+++|+.+.|||||++.-++.... ...+|
T Consensus 25 ~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r~k----nrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnlV 100 (364)
T KOG0658|consen 25 SYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKRYK----NRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNLV 100 (364)
T ss_pred EEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCCcC----cHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHHH
Confidence 4555689999999999999975 57999999886543322 37999999999999999999885432 34589
Q ss_pred EEecCCCCHHHHhccC--CCCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEecCC-CCeEEeeeeeeccc
Q 002158 700 YEFVPNGTLRDWLSGR--TKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSN-LNAKVADFGLSRLA 776 (958)
Q Consensus 700 ~E~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~-~~~kl~DFGla~~~ 776 (958)
||||| .+|+++++.. .+..++...+.-+..|+.+||+|||+.+ |+||||||.|+|+|.+ |.+||||||.|+.+
T Consensus 101 leymP-~tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~---IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L 176 (364)
T KOG0658|consen 101 LEYMP-ETLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHG---ICHRDIKPQNLLVDPDTGVLKICDFGSAKVL 176 (364)
T ss_pred HHhch-HHHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcC---cccCCCChheEEEcCCCCeEEeccCCcceee
Confidence 99996 5999999742 2344788888899999999999999999 9999999999999987 99999999999987
Q ss_pred ccCCCCCCccceeeeeccCCCCccChhhhccC-CCCCcchhhhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcCcc---
Q 002158 777 PVLDDEGTMPTHVSTIVKGTPGYLDPEYFLTH-KLTDKSDVYSLGVVLLELLTGMQPISHGKNIVREVNVARDSGMV--- 852 (958)
Q Consensus 777 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DV~S~Gv~l~elltG~~P~~~~~~~~~~~~~~~~~~~~--- 852 (958)
..... ......|..|+|||.+.+. .|+.+.||||.||++.||+-|++-|.+.....+.+....--|..
T Consensus 177 ~~~ep--------niSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt~e 248 (364)
T KOG0658|consen 177 VKGEP--------NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPTRE 248 (364)
T ss_pred ccCCC--------ceeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCCHH
Confidence 54332 2334467889999999876 69999999999999999999999888765544443332221111
Q ss_pred --------------hhhhcccCCC-CChHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 002158 853 --------------FSIIDNRMGS-YPSECVERFVTLALRCCHDKPEHRPSMSDVVRE 895 (958)
Q Consensus 853 --------------~~~i~~~~~~-~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 895 (958)
.++....+.. +....+.+..+++.+++..+|.+|.++.|++.+
T Consensus 249 ~I~~mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h 306 (364)
T KOG0658|consen 249 DIKSMNPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAH 306 (364)
T ss_pred HHhhcCcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcc
Confidence 0000111111 334567889999999999999999999999864
|
|
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-37 Score=341.07 Aligned_cols=241 Identities=22% Similarity=0.320 Sum_probs=197.2
Q ss_pred CCCCCceeeeeCCeEEEEEEEC-CCcEEEEEEeccCC---hhcHHHHHHHHHHHHccCC-CCcceEEEEEEeCCeEEEEE
Q 002158 626 YFSSSTQVGQGGYGKVYKGILS-DNTTVAIKRAEEGS---LQGQNEFLTEIKLLSRLHH-RNLVSLLGYCDEEGEQMLVY 700 (958)
Q Consensus 626 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H-~niv~l~~~~~~~~~~~lV~ 700 (958)
+|+..+.||+|+||.||+|..+ +++.||||++.... ....+.+..|.++++.++| ++|+++++++...+..++||
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM 80 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence 4677889999999999999976 57899999987532 2334568889999999976 56888999999999999999
Q ss_pred EecCCCCHHHHhccCCCCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEecCCCCeEEeeeeeecccccCC
Q 002158 701 EFVPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSRLAPVLD 780 (958)
Q Consensus 701 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~ 780 (958)
||+++|+|.+++.... .+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 81 E~~~~g~L~~~~~~~~--~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~- 154 (324)
T cd05587 81 EYVNGGDLMYHIQQVG--KFKEPHAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDAEGHIKIADFGMCKENIFG- 154 (324)
T ss_pred cCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEEcCCCCEEEeecCcceecCCC-
Confidence 9999999999997543 3889999999999999999999999 999999999999999999999999998643111
Q ss_pred CCCCccceeeeeccCCCCccChhhhccCCCCCcchhhhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcCcchhhhcccC
Q 002158 781 DEGTMPTHVSTIVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVLLELLTGMQPISHGKNIVREVNVARDSGMVFSIIDNRM 860 (958)
Q Consensus 781 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gv~l~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~i~~~~ 860 (958)
........||+.|+|||++.+..++.++||||+||++|||++|+.||........ .... ....
T Consensus 155 ------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~-~~~i----------~~~~ 217 (324)
T cd05587 155 ------GKTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDEL-FQSI----------MEHN 217 (324)
T ss_pred ------CCceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHH-HHHH----------HcCC
Confidence 1122345699999999999999999999999999999999999999975443211 1111 1112
Q ss_pred CCCChHHHHHHHHHHHHccccCCCCCCCH
Q 002158 861 GSYPSECVERFVTLALRCCHDKPEHRPSM 889 (958)
Q Consensus 861 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~ 889 (958)
..++...+..+.+++.+|++.||.+|++.
T Consensus 218 ~~~~~~~~~~~~~li~~~l~~~P~~R~~~ 246 (324)
T cd05587 218 VSYPKSLSKEAVSICKGLLTKHPAKRLGC 246 (324)
T ss_pred CCCCCCCCHHHHHHHHHHhhcCHHHcCCC
Confidence 23345567788999999999999999986
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=333.85 Aligned_cols=261 Identities=28% Similarity=0.525 Sum_probs=209.9
Q ss_pred HHHcCCCCCceeeeeCCeEEEEEEECC------CcEEEEEEeccC-ChhcHHHHHHHHHHHHcc-CCCCcceEEEEEEeC
Q 002158 622 MATAYFSSSTQVGQGGYGKVYKGILSD------NTTVAIKRAEEG-SLQGQNEFLTEIKLLSRL-HHRNLVSLLGYCDEE 693 (958)
Q Consensus 622 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~------~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~ 693 (958)
...++|+..+.||+|+||.||+|.+.+ ...||+|.+... ......++.+|+++++++ +|+||+++++++..+
T Consensus 9 ~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~ 88 (293)
T cd05053 9 LPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQE 88 (293)
T ss_pred cCHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCC
Confidence 345567888999999999999998642 367999998754 233445788999999999 799999999999999
Q ss_pred CeEEEEEEecCCCCHHHHhccC--------------CCCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEe
Q 002158 694 GEQMLVYEFVPNGTLRDWLSGR--------------TKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILL 759 (958)
Q Consensus 694 ~~~~lV~E~~~~gsL~~~l~~~--------------~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl 759 (958)
+..++||||+++|+|.++++.. ....+++..+++++.|++.||+|||+.+ |+||||||+||++
T Consensus 89 ~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivH~dlkp~Nil~ 165 (293)
T cd05053 89 GPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKK---CIHRDLAARNVLV 165 (293)
T ss_pred CCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCC---ccccccceeeEEE
Confidence 9999999999999999999642 2345899999999999999999999998 9999999999999
Q ss_pred cCCCCeEEeeeeeecccccCCCCCCccceeeeeccCCCCccChhhhccCCCCCcchhhhHHHHHHHHHh-CCCCCCCCch
Q 002158 760 DSNLNAKVADFGLSRLAPVLDDEGTMPTHVSTIVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVLLELLT-GMQPISHGKN 838 (958)
Q Consensus 760 ~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gv~l~ellt-G~~P~~~~~~ 838 (958)
++++.+||+|||+++....... ........++..|+|||++.+..++.++|||||||++|||++ |..||.....
T Consensus 166 ~~~~~~kL~Dfg~~~~~~~~~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~ 240 (293)
T cd05053 166 TEDHVMKIADFGLARDIHHIDY-----YRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPV 240 (293)
T ss_pred cCCCeEEeCccccccccccccc-----eeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCH
Confidence 9999999999999986532211 111122235678999999988899999999999999999998 9999864332
Q ss_pred hHHHHHHHhhcCcchhhhcccCCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhH
Q 002158 839 IVREVNVARDSGMVFSIIDNRMGSYPSECVERFVTLALRCCHDKPEHRPSMSDVVRELENIL 900 (958)
Q Consensus 839 ~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~ 900 (958)
.+....... ......+..++..+.+++.+||+.+|++|||++|+++.|++++
T Consensus 241 -~~~~~~~~~---------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~~ 292 (293)
T cd05053 241 -EELFKLLKE---------GYRMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRML 292 (293)
T ss_pred -HHHHHHHHc---------CCcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHhh
Confidence 121111111 1112234456778999999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=342.67 Aligned_cols=258 Identities=22% Similarity=0.304 Sum_probs=206.4
Q ss_pred cCCCCCceeeeeCCeEEEEEEEC-CCcEEEEEEeccCC---hhcHHHHHHHHHHHHccCCCCcceEEEEEEeCCeEEEEE
Q 002158 625 AYFSSSTQVGQGGYGKVYKGILS-DNTTVAIKRAEEGS---LQGQNEFLTEIKLLSRLHHRNLVSLLGYCDEEGEQMLVY 700 (958)
Q Consensus 625 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~ 700 (958)
++|...+.||+|+||+||+|... +++.||||++.... ......+.+|+++++.++|+||+++++++.+++..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM 80 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence 36788899999999999999986 68999999987532 133456889999999999999999999999999999999
Q ss_pred EecCCCCHHHHhccCCCCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEecCCCCeEEeeeeeecccccCC
Q 002158 701 EFVPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSRLAPVLD 780 (958)
Q Consensus 701 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~ 780 (958)
||+++++|.+++... ..+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++......
T Consensus 81 e~~~~~~L~~~l~~~--~~l~~~~~~~i~~qi~~aL~~LH~~g---iiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~ 155 (350)
T cd05573 81 EYMPGGDLMNLLIRK--DVFPEETARFYIAELVLALDSVHKLG---FIHRDIKPDNILIDADGHIKLADFGLCKKMNKAK 155 (350)
T ss_pred cCCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEeecCCCCccCcccC
Confidence 999999999999765 34899999999999999999999998 9999999999999999999999999997653322
Q ss_pred CC----------------------CCccceeeeeccCCCCccChhhhccCCCCCcchhhhHHHHHHHHHhCCCCCCCCch
Q 002158 781 DE----------------------GTMPTHVSTIVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVLLELLTGMQPISHGKN 838 (958)
Q Consensus 781 ~~----------------------~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gv~l~elltG~~P~~~~~~ 838 (958)
.. ............||+.|+|||++.+..++.++|||||||++|||++|+.||.....
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~ 235 (350)
T cd05573 156 DREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDTL 235 (350)
T ss_pred cccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCCCH
Confidence 00 00001122345699999999999999999999999999999999999999976553
Q ss_pred hHHHHHHHhhcCcchhhhcccCCCCChHHHHHHHHHHHHccccCCCCCCC-HHHHHHH
Q 002158 839 IVREVNVARDSGMVFSIIDNRMGSYPSECVERFVTLALRCCHDKPEHRPS-MSDVVRE 895 (958)
Q Consensus 839 ~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs-~~evl~~ 895 (958)
........ ...... ..+. ...++..+.+++.+|+. ||.+||+ +++++++
T Consensus 236 ~~~~~~i~-~~~~~~-----~~p~-~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~h 285 (350)
T cd05573 236 QETYNKII-NWKESL-----RFPP-DPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSH 285 (350)
T ss_pred HHHHHHHh-ccCCcc-----cCCC-CCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcC
Confidence 22221111 100000 0111 11256788999999997 9999999 9999975
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-36 Score=332.93 Aligned_cols=260 Identities=25% Similarity=0.409 Sum_probs=208.9
Q ss_pred HHcCCCCCceeeeeCCeEEEEEEEC------CCcEEEEEEeccCC-hhcHHHHHHHHHHHHcc-CCCCcceEEEEEEeCC
Q 002158 623 ATAYFSSSTQVGQGGYGKVYKGILS------DNTTVAIKRAEEGS-LQGQNEFLTEIKLLSRL-HHRNLVSLLGYCDEEG 694 (958)
Q Consensus 623 ~~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~ 694 (958)
..++|...+.||+|+||.||+|.+. .+..||||+++... ....+.+.+|+++++++ +|+||+++++++...+
T Consensus 33 ~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 112 (302)
T cd05055 33 PRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGG 112 (302)
T ss_pred cHHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecCC
Confidence 3456888899999999999999752 34579999987643 33346789999999999 7999999999999999
Q ss_pred eEEEEEEecCCCCHHHHhccCCCCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEecCCCCeEEeeeeeec
Q 002158 695 EQMLVYEFVPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSR 774 (958)
Q Consensus 695 ~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~ 774 (958)
..++||||+++|+|.++++......+++.++..++.|++.||+|||+.+ |+|+||||+||+++.++.++++|||+++
T Consensus 113 ~~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~l~dfg~~~ 189 (302)
T cd05055 113 PILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNVLLTHGKIVKICDFGLAR 189 (302)
T ss_pred ceEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eehhhhccceEEEcCCCeEEECCCcccc
Confidence 9999999999999999997655445899999999999999999999998 9999999999999999999999999987
Q ss_pred ccccCCCCCCccceeeeeccCCCCccChhhhccCCCCCcchhhhHHHHHHHHHh-CCCCCCCCchhHHHHHHHhhcCcch
Q 002158 775 LAPVLDDEGTMPTHVSTIVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVLLELLT-GMQPISHGKNIVREVNVARDSGMVF 853 (958)
Q Consensus 775 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gv~l~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~ 853 (958)
....... ........++..|+|||++.+..++.++|||||||++|||++ |..||............. ..+.
T Consensus 190 ~~~~~~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~~~~~~-~~~~-- 261 (302)
T cd05055 190 DIMNDSN-----YVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSKFYKLI-KEGY-- 261 (302)
T ss_pred cccCCCc-----eeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHHHHHHH-HcCC--
Confidence 5532211 111122346788999999999999999999999999999998 999986543221111111 1110
Q ss_pred hhhcccCCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHh
Q 002158 854 SIIDNRMGSYPSECVERFVTLALRCCHDKPEHRPSMSDVVRELENI 899 (958)
Q Consensus 854 ~~i~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 899 (958)
....+...+..+.+++.+|++.+|++||++.|+++.|+++
T Consensus 262 ------~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~~ 301 (302)
T cd05055 262 ------RMAQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGKQ 301 (302)
T ss_pred ------cCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHhh
Confidence 1112334467899999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-37 Score=344.53 Aligned_cols=246 Identities=28% Similarity=0.393 Sum_probs=194.0
Q ss_pred CCCCceeeeeCCeEEEEEEEC-CCcEEEEEEeccCC-hhcHHHHHHHHHHHHccCCCCcceEEEEEEeCCeEEEEEEecC
Q 002158 627 FSSSTQVGQGGYGKVYKGILS-DNTTVAIKRAEEGS-LQGQNEFLTEIKLLSRLHHRNLVSLLGYCDEEGEQMLVYEFVP 704 (958)
Q Consensus 627 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E~~~ 704 (958)
|+..+.||+|+||+||+|++. +++.||||++.... ....+.+.+|+++++.++|+||+++++++...+..++||||++
T Consensus 76 ~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 155 (353)
T PLN00034 76 LERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEFMD 155 (353)
T ss_pred HhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEecCC
Confidence 344578999999999999976 68999999986543 2334678999999999999999999999999999999999999
Q ss_pred CCCHHHHhccCCCCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEecCCCCeEEeeeeeecccccCCCCCC
Q 002158 705 NGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSRLAPVLDDEGT 784 (958)
Q Consensus 705 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 784 (958)
+|+|.+.. ...+..+..++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||+++......
T Consensus 156 ~~~L~~~~------~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~---- 222 (353)
T PLN00034 156 GGSLEGTH------IADEQFLADVARQILSGIAYLHRRH---IVHRDIKPSNLLINSAKNVKIADFGVSRILAQTM---- 222 (353)
T ss_pred CCcccccc------cCCHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCEEEcccccceeccccc----
Confidence 99986543 2456778899999999999999999 9999999999999999999999999998653211
Q ss_pred ccceeeeeccCCCCccChhhhcc-----CCCCCcchhhhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcCcchhhhccc
Q 002158 785 MPTHVSTIVKGTPGYLDPEYFLT-----HKLTDKSDVYSLGVVLLELLTGMQPISHGKNIVREVNVARDSGMVFSIIDNR 859 (958)
Q Consensus 785 ~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DV~S~Gv~l~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~i~~~ 859 (958)
.......||..|+|||++.. ...+.++|||||||++|||++|+.||...... .+..... .+....
T Consensus 223 ---~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~-~~~~~~~------~~~~~~ 292 (353)
T PLN00034 223 ---DPCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQG-DWASLMC------AICMSQ 292 (353)
T ss_pred ---ccccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCc-cHHHHHH------HHhccC
Confidence 11223469999999998743 22346899999999999999999999632211 1100000 000111
Q ss_pred CCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 002158 860 MGSYPSECVERFVTLALRCCHDKPEHRPSMSDVVRE 895 (958)
Q Consensus 860 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 895 (958)
....+..++.++.+++.+||+.||++||+++|++++
T Consensus 293 ~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~h 328 (353)
T PLN00034 293 PPEAPATASREFRHFISCCLQREPAKRWSAMQLLQH 328 (353)
T ss_pred CCCCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 122344567889999999999999999999999974
|
|
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=330.86 Aligned_cols=246 Identities=23% Similarity=0.346 Sum_probs=197.3
Q ss_pred eeeeCCeEEEEEEEC-CCcEEEEEEeccCCh---hcHHHHHHHHHHHHccCCCCcceEEEEEEeCCeEEEEEEecCCCCH
Q 002158 633 VGQGGYGKVYKGILS-DNTTVAIKRAEEGSL---QGQNEFLTEIKLLSRLHHRNLVSLLGYCDEEGEQMLVYEFVPNGTL 708 (958)
Q Consensus 633 lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E~~~~gsL 708 (958)
||+|+||+||++.+. +++.||+|++..... ...+.+..|+++++.++|+||+++.+++..+...++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L 80 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL 80 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence 699999999999976 688999999865322 2235678899999999999999999999999999999999999999
Q ss_pred HHHhccC--CCCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEecCCCCeEEeeeeeecccccCCCCCCcc
Q 002158 709 RDWLSGR--TKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSRLAPVLDDEGTMP 786 (958)
Q Consensus 709 ~~~l~~~--~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~ 786 (958)
.+++... ....+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.++|+|||+++.......
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~----- 152 (280)
T cd05608 81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRR---IIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQS----- 152 (280)
T ss_pred HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEeeCccceecCCCCc-----
Confidence 9888542 2345899999999999999999999999 99999999999999999999999999875432111
Q ss_pred ceeeeeccCCCCccChhhhccCCCCCcchhhhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcCcchhhhcccCCCCChH
Q 002158 787 THVSTIVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVLLELLTGMQPISHGKNIVREVNVARDSGMVFSIIDNRMGSYPSE 866 (958)
Q Consensus 787 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gv~l~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~ 866 (958)
......||+.|+|||++.+..++.++|||||||++|||++|+.||.............. .+.......+..
T Consensus 153 --~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~-------~~~~~~~~~~~~ 223 (280)
T cd05608 153 --KTKGYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQ-------RILNDSVTYPDK 223 (280)
T ss_pred --cccccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhHHHHHH-------hhcccCCCCccc
Confidence 12235689999999999999999999999999999999999999975332111100000 000111223455
Q ss_pred HHHHHHHHHHHccccCCCCCC-----CHHHHHHH
Q 002158 867 CVERFVTLALRCCHDKPEHRP-----SMSDVVRE 895 (958)
Q Consensus 867 ~~~~l~~li~~cl~~dP~~RP-----s~~evl~~ 895 (958)
.+..+.+++.+||+.||++|| ++++++++
T Consensus 224 ~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~h 257 (280)
T cd05608 224 FSPASKSFCEALLAKDPEKRLGFRDGNCDGLRTH 257 (280)
T ss_pred CCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhcC
Confidence 678899999999999999999 66677653
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-37 Score=341.75 Aligned_cols=251 Identities=22% Similarity=0.325 Sum_probs=197.5
Q ss_pred ceeeeeCCeEEEEEEEC-CCcEEEEEEeccC---ChhcHHHHHHHHHHHHcc-CCCCcceEEEEEEeCCeEEEEEEecCC
Q 002158 631 TQVGQGGYGKVYKGILS-DNTTVAIKRAEEG---SLQGQNEFLTEIKLLSRL-HHRNLVSLLGYCDEEGEQMLVYEFVPN 705 (958)
Q Consensus 631 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lV~E~~~~ 705 (958)
+.||+|+||+||+|..+ +++.||+|+++.. .....+.+.+|+.++.++ +||||+++++++..++..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~ 80 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG 80 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence 46999999999999976 6889999998753 223345678899988877 799999999999999999999999999
Q ss_pred CCHHHHhccCCCCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEecCCCCeEEeeeeeecccccCCCCCCc
Q 002158 706 GTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSRLAPVLDDEGTM 785 (958)
Q Consensus 706 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~ 785 (958)
|+|.+++.... .+++..+..++.|++.||+|||+++ |+||||||+||+++.++.+||+|||+++......
T Consensus 81 ~~L~~~~~~~~--~l~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~----- 150 (329)
T cd05618 81 GDLMFHMQRQR--KLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPG----- 150 (329)
T ss_pred CCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEECCCCCEEEeeCCccccccCCC-----
Confidence 99999986543 4899999999999999999999999 9999999999999999999999999987432111
Q ss_pred cceeeeeccCCCCccChhhhccCCCCCcchhhhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcCcchhhhcccCCCCCh
Q 002158 786 PTHVSTIVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVLLELLTGMQPISHGKNIVREVNVARDSGMVFSIIDNRMGSYPS 865 (958)
Q Consensus 786 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gv~l~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~ 865 (958)
.......||+.|+|||++.+..++.++|||||||++|||++|+.||.......... ........+.+.......|.
T Consensus 151 --~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~--~~~~~~~~~~i~~~~~~~p~ 226 (329)
T cd05618 151 --DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPD--QNTEDYLFQVILEKQIRIPR 226 (329)
T ss_pred --CccccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcc--cccHHHHHHHHhcCCCCCCC
Confidence 11234569999999999999999999999999999999999999995211000000 00000011111222233456
Q ss_pred HHHHHHHHHHHHccccCCCCCCC------HHHHHHH
Q 002158 866 ECVERFVTLALRCCHDKPEHRPS------MSDVVRE 895 (958)
Q Consensus 866 ~~~~~l~~li~~cl~~dP~~RPs------~~evl~~ 895 (958)
..+..+.+++.+||+.||++||+ +++++++
T Consensus 227 ~~~~~~~~ll~~~L~~dP~~R~~~~~~~~~~~i~~h 262 (329)
T cd05618 227 SLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGH 262 (329)
T ss_pred CCCHHHHHHHHHHhcCCHHHcCCCCCCCCHHHHhcC
Confidence 66788899999999999999998 4676654
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-36 Score=329.83 Aligned_cols=265 Identities=28% Similarity=0.461 Sum_probs=205.1
Q ss_pred CCCCCceeeeeCCeEEEEEEE-----CCCcEEEEEEeccCC-hhcHHHHHHHHHHHHccCCCCcceEEEEEEeC--CeEE
Q 002158 626 YFSSSTQVGQGGYGKVYKGIL-----SDNTTVAIKRAEEGS-LQGQNEFLTEIKLLSRLHHRNLVSLLGYCDEE--GEQM 697 (958)
Q Consensus 626 ~~~~~~~lg~G~~g~Vy~~~~-----~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~--~~~~ 697 (958)
+|...+.||+|+||+||++.. .+++.||+|.+.... ......|.+|++++++++||||+++++++... ...+
T Consensus 5 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 84 (283)
T cd05080 5 YLKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQ 84 (283)
T ss_pred hceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEE
Confidence 347788999999999988653 357889999987643 23456788999999999999999999998653 4689
Q ss_pred EEEEecCCCCHHHHhccCCCCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEecCCCCeEEeeeeeecccc
Q 002158 698 LVYEFVPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSRLAP 777 (958)
Q Consensus 698 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~~~ 777 (958)
+||||+++++|.+++... .+++.++..++.|+++||+|||+.+ |+||||||+||++++++.+||+|||+++...
T Consensus 85 lv~e~~~~~~l~~~~~~~---~l~~~~~~~i~~~l~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~ 158 (283)
T cd05080 85 LIMEYVPLGSLRDYLPKH---KLNLAQLLLFAQQICEGMAYLHSQH---YIHRDLAARNVLLDNDRLVKIGDFGLAKAVP 158 (283)
T ss_pred EEecCCCCCCHHHHHHHc---CCCHHHHHHHHHHHHHHHHHHHHCC---eeccccChheEEEcCCCcEEEeecccccccC
Confidence 999999999999999754 3899999999999999999999999 9999999999999999999999999998654
Q ss_pred cCCCCCCccceeeeeccCCCCccChhhhccCCCCCcchhhhHHHHHHHHHhCCCCCCCCchhHHHHHHHhh----cCcch
Q 002158 778 VLDDEGTMPTHVSTIVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVLLELLTGMQPISHGKNIVREVNVARD----SGMVF 853 (958)
Q Consensus 778 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gv~l~elltG~~P~~~~~~~~~~~~~~~~----~~~~~ 853 (958)
..... ........++..|+|||.+.+..++.++||||||+++|||++|..|+............... .....
T Consensus 159 ~~~~~----~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (283)
T cd05080 159 EGHEY----YRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTVVRLI 234 (283)
T ss_pred Ccchh----hccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhhhhhcccccccchhhhh
Confidence 32111 01111223566799999999888999999999999999999999998643321111110000 00011
Q ss_pred hhhcccC-CCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhH
Q 002158 854 SIIDNRM-GSYPSECVERFVTLALRCCHDKPEHRPSMSDVVRELENIL 900 (958)
Q Consensus 854 ~~i~~~~-~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~ 900 (958)
+.++... ...+..++..+.+++.+||+.+|++||+++++++.|+++.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~~ 282 (283)
T cd05080 235 ELLERGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEMH 282 (283)
T ss_pred hhhhcCCCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHhh
Confidence 1111111 2234556789999999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=325.18 Aligned_cols=250 Identities=26% Similarity=0.430 Sum_probs=208.4
Q ss_pred CCCCCceeeeeCCeEEEEEEEC-CCcEEEEEEeccC--ChhcHHHHHHHHHHHHccCCCCcceEEEEEEeCCeEEEEEEe
Q 002158 626 YFSSSTQVGQGGYGKVYKGILS-DNTTVAIKRAEEG--SLQGQNEFLTEIKLLSRLHHRNLVSLLGYCDEEGEQMLVYEF 702 (958)
Q Consensus 626 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E~ 702 (958)
+|+..+.||+|++|.||+|.++ +++.|++|.+... .....+++.+|++++++++|||++++++++...+..++||||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEY 80 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEe
Confidence 3667789999999999999986 6899999988643 344566799999999999999999999999999999999999
Q ss_pred cCCCCHHHHhccCCCCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEecCCCCeEEeeeeeecccccCCCC
Q 002158 703 VPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSRLAPVLDDE 782 (958)
Q Consensus 703 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~ 782 (958)
+++++|.++++......+++.++..++.|++.||.|||+.+ ++||||||+||+++.++.++|+|||+++......
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~---i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~-- 155 (256)
T cd08529 81 AENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKK---ILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNT-- 155 (256)
T ss_pred CCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEEeCCCCEEEcccccceeccCcc--
Confidence 99999999998765556899999999999999999999998 9999999999999999999999999987653211
Q ss_pred CCccceeeeeccCCCCccChhhhccCCCCCcchhhhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcCcchhhhcccCCC
Q 002158 783 GTMPTHVSTIVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVLLELLTGMQPISHGKNIVREVNVARDSGMVFSIIDNRMGS 862 (958)
Q Consensus 783 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gv~l~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~ 862 (958)
.......|++.|+|||+..+..++.++||||||+++|||++|+.||....... .... ........
T Consensus 156 -----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~-~~~~---------~~~~~~~~ 220 (256)
T cd08529 156 -----NFANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQGA-LILK---------IIRGVFPP 220 (256)
T ss_pred -----chhhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHH-HHHH---------HHcCCCCC
Confidence 11123458899999999999999999999999999999999999997544211 1111 11122223
Q ss_pred CChHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 002158 863 YPSECVERFVTLALRCCHDKPEHRPSMSDVVRE 895 (958)
Q Consensus 863 ~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 895 (958)
.+...+..+.+++.+||+.+|++||++.+++++
T Consensus 221 ~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~ 253 (256)
T cd08529 221 VSQMYSQQLAQLIDQCLTKDYRQRPDTFQLLRN 253 (256)
T ss_pred CccccCHHHHHHHHHHccCCcccCcCHHHHhhC
Confidence 344567889999999999999999999999874
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-37 Score=358.20 Aligned_cols=256 Identities=24% Similarity=0.328 Sum_probs=207.9
Q ss_pred HHHcCCCCCceeeeeCCeEEEEEEEC-CCcEEEEEEeccC--ChhcHHHHHHHHHHHHccCCCCcceEEEEEEeCC----
Q 002158 622 MATAYFSSSTQVGQGGYGKVYKGILS-DNTTVAIKRAEEG--SLQGQNEFLTEIKLLSRLHHRNLVSLLGYCDEEG---- 694 (958)
Q Consensus 622 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~---- 694 (958)
....+|...+.||+|+||+||+|.+. +++.||||++... .......+.+|+.++..++|+|++++++.+...+
T Consensus 29 ~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~~ 108 (496)
T PTZ00283 29 EQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNP 108 (496)
T ss_pred ccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccCc
Confidence 34568889999999999999999865 7899999998654 2344567889999999999999999988765432
Q ss_pred ----eEEEEEEecCCCCHHHHhccCC--CCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEecCCCCeEEe
Q 002158 695 ----EQMLVYEFVPNGTLRDWLSGRT--KENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSNLNAKVA 768 (958)
Q Consensus 695 ----~~~lV~E~~~~gsL~~~l~~~~--~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~~~~kl~ 768 (958)
..++||||+++|+|.++++.+. ...+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+
T Consensus 109 ~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~---IiHrDLKP~NILl~~~~~vkL~ 185 (496)
T PTZ00283 109 ENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKH---MIHRDIKSANILLCSNGLVKLG 185 (496)
T ss_pred ccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEeCCCCEEEE
Confidence 3689999999999999997532 345899999999999999999999998 9999999999999999999999
Q ss_pred eeeeecccccCCCCCCccceeeeeccCCCCccChhhhccCCCCCcchhhhHHHHHHHHHhCCCCCCCCchhHHHHHHHhh
Q 002158 769 DFGLSRLAPVLDDEGTMPTHVSTIVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVLLELLTGMQPISHGKNIVREVNVARD 848 (958)
Q Consensus 769 DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gv~l~elltG~~P~~~~~~~~~~~~~~~~ 848 (958)
|||+++.+..... ........||+.|+|||++.+..++.++|||||||++|||++|+.||..... ...+...
T Consensus 186 DFGls~~~~~~~~-----~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~-~~~~~~~-- 257 (496)
T PTZ00283 186 DFGFSKMYAATVS-----DDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENM-EEVMHKT-- 257 (496)
T ss_pred ecccCeecccccc-----ccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCH-HHHHHHH--
Confidence 9999986532211 1122345699999999999999999999999999999999999999975432 2221111
Q ss_pred cCcchhhhcccCCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 002158 849 SGMVFSIIDNRMGSYPSECVERFVTLALRCCHDKPEHRPSMSDVVRE 895 (958)
Q Consensus 849 ~~~~~~~i~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 895 (958)
........+..++.++.+++.+||+.||++||++.+++++
T Consensus 258 -------~~~~~~~~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~ 297 (496)
T PTZ00283 258 -------LAGRYDPLPPSISPEMQEIVTALLSSDPKRRPSSSKLLNM 297 (496)
T ss_pred -------hcCCCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHhC
Confidence 1112223455677889999999999999999999999864
|
|
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-36 Score=330.13 Aligned_cols=258 Identities=29% Similarity=0.511 Sum_probs=207.0
Q ss_pred CCCCCceeeeeCCeEEEEEEEC------CCcEEEEEEeccCC-hhcHHHHHHHHHHHHccCCCCcceEEEEEEeCCeEEE
Q 002158 626 YFSSSTQVGQGGYGKVYKGILS------DNTTVAIKRAEEGS-LQGQNEFLTEIKLLSRLHHRNLVSLLGYCDEEGEQML 698 (958)
Q Consensus 626 ~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~l 698 (958)
+|+..+.||+|+||.||+|... ....||+|.+.... .....++.+|+++++.++||||+++++.+..++..++
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 80 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLL 80 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEE
Confidence 3667789999999999999863 23578999887543 3345678999999999999999999999999999999
Q ss_pred EEEecCCCCHHHHhccCC----------------------CCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccc
Q 002158 699 VYEFVPNGTLRDWLSGRT----------------------KENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASN 756 (958)
Q Consensus 699 V~E~~~~gsL~~~l~~~~----------------------~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~N 756 (958)
||||+++++|.+++.... ...+++.+++.++.|++.||+|||+.+ ++||||||+|
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~---ivH~dikp~n 157 (290)
T cd05045 81 IVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMK---LVHRDLAARN 157 (290)
T ss_pred EEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCC---eehhhhhhhe
Confidence 999999999999986421 134789999999999999999999998 9999999999
Q ss_pred eEecCCCCeEEeeeeeecccccCCCCCCccceeeeeccCCCCccChhhhccCCCCCcchhhhHHHHHHHHHh-CCCCCCC
Q 002158 757 ILLDSNLNAKVADFGLSRLAPVLDDEGTMPTHVSTIVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVLLELLT-GMQPISH 835 (958)
Q Consensus 757 ILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gv~l~ellt-G~~P~~~ 835 (958)
|++++++.+||+|||+++........ .......++..|+|||++.+..++.++||||||+++|||++ |..||..
T Consensus 158 ill~~~~~~kl~dfg~~~~~~~~~~~-----~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~ 232 (290)
T cd05045 158 VLVAEGRKMKISDFGLSRDVYEEDSY-----VKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPG 232 (290)
T ss_pred EEEcCCCcEEeccccccccccCccch-----hcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCC
Confidence 99999999999999998754322111 11122346678999999998899999999999999999999 9999964
Q ss_pred CchhHHHHHHHhhcCcchhhhcccCCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHh
Q 002158 836 GKNIVREVNVARDSGMVFSIIDNRMGSYPSECVERFVTLALRCCHDKPEHRPSMSDVVRELENILK 901 (958)
Q Consensus 836 ~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~ 901 (958)
... ......... . .....+..++..+.+++.+||+.+|++||+++++++.|++++.
T Consensus 233 ~~~-~~~~~~~~~-~--------~~~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~~~ 288 (290)
T cd05045 233 IAP-ERLFNLLKT-G--------YRMERPENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKMMV 288 (290)
T ss_pred CCH-HHHHHHHhC-C--------CCCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHHHHh
Confidence 332 221211111 1 0112244566789999999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=344.44 Aligned_cols=263 Identities=25% Similarity=0.410 Sum_probs=208.2
Q ss_pred HHHHcCCCCCceeeeeCCeEEEEEEEC------CCcEEEEEEeccCCh-hcHHHHHHHHHHHHccC-CCCcceEEEEEEe
Q 002158 621 AMATAYFSSSTQVGQGGYGKVYKGILS------DNTTVAIKRAEEGSL-QGQNEFLTEIKLLSRLH-HRNLVSLLGYCDE 692 (958)
Q Consensus 621 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~ 692 (958)
....++|...+.||+|+||.||+|++. .++.||||+++.... ...+.+.+|++++.++. ||||++++++|..
T Consensus 33 ~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~ 112 (401)
T cd05107 33 EMPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACTK 112 (401)
T ss_pred eecHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEcc
Confidence 334456777889999999999999864 246899999976432 23457899999999997 9999999999999
Q ss_pred CCeEEEEEEecCCCCHHHHhccCCC-------------------------------------------------------
Q 002158 693 EGEQMLVYEFVPNGTLRDWLSGRTK------------------------------------------------------- 717 (958)
Q Consensus 693 ~~~~~lV~E~~~~gsL~~~l~~~~~------------------------------------------------------- 717 (958)
.+..++||||+++|+|.++++....
T Consensus 113 ~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 192 (401)
T cd05107 113 GGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPM 192 (401)
T ss_pred CCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccch
Confidence 9999999999999999999964321
Q ss_pred -----------------------------------------CCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccc
Q 002158 718 -----------------------------------------ENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASN 756 (958)
Q Consensus 718 -----------------------------------------~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~N 756 (958)
..+++..+..++.|++.||+|||+.+ |+||||||+|
T Consensus 193 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrdlkp~N 269 (401)
T cd05107 193 QDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKN---CVHRDLAARN 269 (401)
T ss_pred hcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCC---cCcccCCcce
Confidence 23677888999999999999999988 9999999999
Q ss_pred eEecCCCCeEEeeeeeecccccCCCCCCccceeeeeccCCCCccChhhhccCCCCCcchhhhHHHHHHHHHh-CCCCCCC
Q 002158 757 ILLDSNLNAKVADFGLSRLAPVLDDEGTMPTHVSTIVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVLLELLT-GMQPISH 835 (958)
Q Consensus 757 ILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gv~l~ellt-G~~P~~~ 835 (958)
||+++++.+||+|||+++........ .......++..|+|||.+....++.++||||||+++|||++ |..||..
T Consensus 270 iLl~~~~~~kL~DfGla~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~ 344 (401)
T cd05107 270 VLICEGKLVKICDFGLARDIMRDSNY-----ISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPE 344 (401)
T ss_pred EEEeCCCEEEEEecCcceeccccccc-----ccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCC
Confidence 99999999999999999754221110 11122346788999999998889999999999999999998 8889864
Q ss_pred CchhHHHHHHHhhcCcchhhhcccCCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhH
Q 002158 836 GKNIVREVNVARDSGMVFSIIDNRMGSYPSECVERFVTLALRCCHDKPEHRPSMSDVVRELENIL 900 (958)
Q Consensus 836 ~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~ 900 (958)
........... ..+ .....+..++..+.+++.+||..+|.+||+++|+++.|++++
T Consensus 345 ~~~~~~~~~~~-~~~--------~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~~~ 400 (401)
T cd05107 345 LPMNEQFYNAI-KRG--------YRMAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDLL 400 (401)
T ss_pred CCchHHHHHHH-HcC--------CCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHh
Confidence 33221111111 111 111234456788999999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-37 Score=345.70 Aligned_cols=252 Identities=21% Similarity=0.289 Sum_probs=202.6
Q ss_pred HHcCCCCCceeeeeCCeEEEEEEEC-CCcEEEEEEeccC---ChhcHHHHHHHHHHHHccCCCCcceEEEEEEeCCeEEE
Q 002158 623 ATAYFSSSTQVGQGGYGKVYKGILS-DNTTVAIKRAEEG---SLQGQNEFLTEIKLLSRLHHRNLVSLLGYCDEEGEQML 698 (958)
Q Consensus 623 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~l 698 (958)
..++|+..+.||+|+||+||+|..+ +++.||+|++... .....+.+.+|+.+++.++||||+++++++.++...++
T Consensus 41 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~l 120 (370)
T cd05596 41 KAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYM 120 (370)
T ss_pred CHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEE
Confidence 4567888999999999999999976 6889999998642 12233457899999999999999999999999999999
Q ss_pred EEEecCCCCHHHHhccCCCCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEecCCCCeEEeeeeeeccccc
Q 002158 699 VYEFVPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSRLAPV 778 (958)
Q Consensus 699 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~~~~ 778 (958)
||||+++|+|.+++... .++...+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++....
T Consensus 121 v~Ey~~gg~L~~~l~~~---~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~~ 194 (370)
T cd05596 121 VMEYMPGGDLVNLMSNY---DIPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCMKMDA 194 (370)
T ss_pred EEcCCCCCcHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEcCCCCEEEEeccceeeccC
Confidence 99999999999999654 3788889999999999999999999 99999999999999999999999999875432
Q ss_pred CCCCCCccceeeeeccCCCCccChhhhccC----CCCCcchhhhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcCcchh
Q 002158 779 LDDEGTMPTHVSTIVKGTPGYLDPEYFLTH----KLTDKSDVYSLGVVLLELLTGMQPISHGKNIVREVNVARDSGMVFS 854 (958)
Q Consensus 779 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~~DV~S~Gv~l~elltG~~P~~~~~~~~~~~~~~~~~~~~~~ 854 (958)
.. ........||+.|+|||++.+. .++.++|||||||++|||++|+.||....... ..........
T Consensus 195 ~~------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~-~~~~i~~~~~--- 264 (370)
T cd05596 195 NG------MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVG-TYSKIMDHKN--- 264 (370)
T ss_pred CC------cccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHH-HHHHHHcCCC---
Confidence 11 1112245699999999998754 37889999999999999999999997544322 1111111000
Q ss_pred hhcccCCCCCh--HHHHHHHHHHHHccccCCCC--CCCHHHHHHH
Q 002158 855 IIDNRMGSYPS--ECVERFVTLALRCCHDKPEH--RPSMSDVVRE 895 (958)
Q Consensus 855 ~i~~~~~~~~~--~~~~~l~~li~~cl~~dP~~--RPs~~evl~~ 895 (958)
...++. ..+..+.+++.+|++.+|++ ||+++|++++
T Consensus 265 -----~~~~~~~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h 304 (370)
T cd05596 265 -----SLTFPDDIEISKQAKDLICAFLTDREVRLGRNGVDEIKSH 304 (370)
T ss_pred -----cCCCCCcCCCCHHHHHHHHHHccChhhccCCCCHHHHhcC
Confidence 011121 35678899999999999988 9999999876
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-36 Score=323.83 Aligned_cols=248 Identities=28% Similarity=0.473 Sum_probs=199.4
Q ss_pred ceeeeeCCeEEEEEEEC-CCcEEEEEEeccCC-hhcHHHHHHHHHHHHccCCCCcceEEEEEEeCCeEEEEEEecCCCCH
Q 002158 631 TQVGQGGYGKVYKGILS-DNTTVAIKRAEEGS-LQGQNEFLTEIKLLSRLHHRNLVSLLGYCDEEGEQMLVYEFVPNGTL 708 (958)
Q Consensus 631 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E~~~~gsL 708 (958)
+.||+|+||.||+|++. +++.||+|.+.... ......|.+|++++++++||||+++++++...+..++||||+++++|
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDF 80 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcH
Confidence 36899999999999975 78999999876543 33456799999999999999999999999999999999999999999
Q ss_pred HHHhccCCCCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEecCCCCeEEeeeeeecccccCCCCCCccce
Q 002158 709 RDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSRLAPVLDDEGTMPTH 788 (958)
Q Consensus 709 ~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~ 788 (958)
.+++.... ..+++.++..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+++...... . ..
T Consensus 81 ~~~~~~~~-~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~----~-~~ 151 (252)
T cd05084 81 LTFLRTEG-PRLKVKELIQMVENAAAGMEYLESKH---CIHRDLAARNCLVTEKNVLKISDFGMSREEEDGV----Y-AS 151 (252)
T ss_pred HHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchheEEEcCCCcEEECccccCccccccc----c-cc
Confidence 99997543 34889999999999999999999999 9999999999999999999999999987542110 0 00
Q ss_pred eeeeccCCCCccChhhhccCCCCCcchhhhHHHHHHHHHh-CCCCCCCCchhHHHHHHHhhcCcchhhhcccCCCCChHH
Q 002158 789 VSTIVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVLLELLT-GMQPISHGKNIVREVNVARDSGMVFSIIDNRMGSYPSEC 867 (958)
Q Consensus 789 ~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gv~l~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~ 867 (958)
......++..|+|||.+.+..++.++||||||+++|||++ |..||........ ...... ......+..+
T Consensus 152 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~~-~~~~~~---------~~~~~~~~~~ 221 (252)
T cd05084 152 TGGMKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQT-REAIEQ---------GVRLPCPELC 221 (252)
T ss_pred cCCCCCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHHHH-HHHHHc---------CCCCCCcccC
Confidence 0111123457999999999899999999999999999998 8888864332111 111110 1112234456
Q ss_pred HHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 002158 868 VERFVTLALRCCHDKPEHRPSMSDVVRELE 897 (958)
Q Consensus 868 ~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 897 (958)
+..+.+++.+|++.+|++||++.++.+.|+
T Consensus 222 ~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 251 (252)
T cd05084 222 PDAVYRLMERCWEYDPGQRPSFSTVHQELQ 251 (252)
T ss_pred CHHHHHHHHHHcCCChhhCcCHHHHHHHHh
Confidence 788999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-36 Score=329.37 Aligned_cols=262 Identities=27% Similarity=0.429 Sum_probs=211.0
Q ss_pred HHcCCCCCceeeeeCCeEEEEEEECC-----CcEEEEEEeccC-ChhcHHHHHHHHHHHHccCCCCcceEEEEEEe-CCe
Q 002158 623 ATAYFSSSTQVGQGGYGKVYKGILSD-----NTTVAIKRAEEG-SLQGQNEFLTEIKLLSRLHHRNLVSLLGYCDE-EGE 695 (958)
Q Consensus 623 ~~~~~~~~~~lg~G~~g~Vy~~~~~~-----~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~-~~~ 695 (958)
..++|...+.||+|+||.||+|.+.+ +..|++|++... .....+.+.+|+.++++++|+||+++++++.. +..
T Consensus 4 ~~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~ 83 (280)
T cd05043 4 SRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEP 83 (280)
T ss_pred chhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCC
Confidence 45678888999999999999999865 688999998754 33445678999999999999999999998866 567
Q ss_pred EEEEEEecCCCCHHHHhccCCC------CCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEecCCCCeEEee
Q 002158 696 QMLVYEFVPNGTLRDWLSGRTK------ENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSNLNAKVAD 769 (958)
Q Consensus 696 ~~lV~E~~~~gsL~~~l~~~~~------~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~~~~kl~D 769 (958)
.++++||+++++|.+++..... ..+++.++..++.|++.||+|||+.+ ++||||||+||++++++.+||+|
T Consensus 84 ~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~---i~H~di~p~nil~~~~~~~kl~d 160 (280)
T cd05043 84 PFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRG---VIHKDIAARNCVIDEELQVKITD 160 (280)
T ss_pred CEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccCHhhEEEcCCCcEEECC
Confidence 8999999999999999975422 45899999999999999999999998 99999999999999999999999
Q ss_pred eeeecccccCCCCCCccceeeeeccCCCCccChhhhccCCCCCcchhhhHHHHHHHHHh-CCCCCCCCchhHHHHHHHhh
Q 002158 770 FGLSRLAPVLDDEGTMPTHVSTIVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVLLELLT-GMQPISHGKNIVREVNVARD 848 (958)
Q Consensus 770 FGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gv~l~ellt-G~~P~~~~~~~~~~~~~~~~ 848 (958)
||+++.+..... ........++..|+|||++.+..++.++||||||+++||+++ |+.||...... ........
T Consensus 161 ~g~~~~~~~~~~-----~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~-~~~~~~~~ 234 (280)
T cd05043 161 NALSRDLFPMDY-----HCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPF-EMAAYLKD 234 (280)
T ss_pred CCCcccccCCce-----EEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCHH-HHHHHHHc
Confidence 999975432111 011122346778999999998889999999999999999999 99999754322 11111111
Q ss_pred cCcchhhhcccCCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHhh
Q 002158 849 SGMVFSIIDNRMGSYPSECVERFVTLALRCCHDKPEHRPSMSDVVRELENILKM 902 (958)
Q Consensus 849 ~~~~~~~i~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~ 902 (958)
+. ....+..++..+.+++.+||+.||++||++.++++.|+++.+.
T Consensus 235 -~~--------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~~~~ 279 (280)
T cd05043 235 -GY--------RLAQPINCPDELFAVMACCWALDPEERPSFSQLVQCLTDFHAQ 279 (280)
T ss_pred -CC--------CCCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhc
Confidence 10 1112334567899999999999999999999999999988653
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=337.62 Aligned_cols=241 Identities=26% Similarity=0.395 Sum_probs=195.2
Q ss_pred ceeeeeCCeEEEEEEEC-CCcEEEEEEeccCC---hhcHHHHHHHHHHHHcc-CCCCcceEEEEEEeCCeEEEEEEecCC
Q 002158 631 TQVGQGGYGKVYKGILS-DNTTVAIKRAEEGS---LQGQNEFLTEIKLLSRL-HHRNLVSLLGYCDEEGEQMLVYEFVPN 705 (958)
Q Consensus 631 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lV~E~~~~ 705 (958)
+.||+|+||+||+|.+. +++.||||+++... ......+..|..++... +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~ 80 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence 36999999999999986 57899999987542 22334567788888764 899999999999999999999999999
Q ss_pred CCHHHHhccCCCCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEecCCCCeEEeeeeeecccccCCCCCCc
Q 002158 706 GTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSRLAPVLDDEGTM 785 (958)
Q Consensus 706 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~ 785 (958)
|+|.+++.... .+++.++..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++......
T Consensus 81 g~L~~~l~~~~--~~~~~~~~~~~~qi~~al~~LH~~~---ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~----- 150 (316)
T cd05619 81 GDLMFHIQSCH--KFDLPRATFYAAEIICGLQFLHSKG---IVYRDLKLDNILLDTDGHIKIADFGMCKENMLGD----- 150 (316)
T ss_pred CcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHEEECCCCCEEEccCCcceECCCCC-----
Confidence 99999997543 4889999999999999999999999 9999999999999999999999999987432111
Q ss_pred cceeeeeccCCCCccChhhhccCCCCCcchhhhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcCcchhhhcccCCCCCh
Q 002158 786 PTHVSTIVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVLLELLTGMQPISHGKNIVREVNVARDSGMVFSIIDNRMGSYPS 865 (958)
Q Consensus 786 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gv~l~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~ 865 (958)
.......||+.|+|||++.+..++.++|||||||++|||++|+.||...... ....... .....++.
T Consensus 151 --~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~-~~~~~i~----------~~~~~~~~ 217 (316)
T cd05619 151 --AKTCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEE-ELFQSIR----------MDNPCYPR 217 (316)
T ss_pred --CceeeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHH-HHHHHHH----------hCCCCCCc
Confidence 1123456999999999999999999999999999999999999999754321 1111111 11112344
Q ss_pred HHHHHHHHHHHHccccCCCCCCCHH-HHHH
Q 002158 866 ECVERFVTLALRCCHDKPEHRPSMS-DVVR 894 (958)
Q Consensus 866 ~~~~~l~~li~~cl~~dP~~RPs~~-evl~ 894 (958)
..+..+.+++.+||+.||++||++. ++.+
T Consensus 218 ~~~~~~~~li~~~l~~~P~~R~~~~~~l~~ 247 (316)
T cd05619 218 WLTREAKDILVKLFVREPERRLGVKGDIRQ 247 (316)
T ss_pred cCCHHHHHHHHHHhccCHhhcCCChHHHHc
Confidence 4567889999999999999999997 5544
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-36 Score=324.11 Aligned_cols=253 Identities=31% Similarity=0.470 Sum_probs=205.6
Q ss_pred cCCCCCceeeeeCCeEEEEEEECCCcEEEEEEeccCChhcHHHHHHHHHHHHccCCCCcceEEEEEEeCCeEEEEEEecC
Q 002158 625 AYFSSSTQVGQGGYGKVYKGILSDNTTVAIKRAEEGSLQGQNEFLTEIKLLSRLHHRNLVSLLGYCDEEGEQMLVYEFVP 704 (958)
Q Consensus 625 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E~~~ 704 (958)
++|.....||+|+||.||+|.++++..||+|.+.... ...+.|.+|++++++++|+|++++++++. .+..++||||++
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~~ 83 (260)
T cd05069 6 ESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGT-MMPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIYIVTEFMG 83 (260)
T ss_pred HHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCC-ccHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcEEEEEcCC
Confidence 3577778999999999999998877789999886543 23457889999999999999999999885 456889999999
Q ss_pred CCCHHHHhccCCCCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEecCCCCeEEeeeeeecccccCCCCCC
Q 002158 705 NGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSRLAPVLDDEGT 784 (958)
Q Consensus 705 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 784 (958)
+++|.++++......+++..+..++.|++.||+|||+.+ ++||||||+||++++++.++|+|||+++.......
T Consensus 84 ~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~--- 157 (260)
T cd05069 84 KGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMN---YIHRDLRAANILVGDNLVCKIADFGLARLIEDNEY--- 157 (260)
T ss_pred CCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccCcceEEEcCCCeEEECCCccceEccCCcc---
Confidence 999999997655555899999999999999999999998 99999999999999999999999999976432111
Q ss_pred ccceeeeeccCCCCccChhhhccCCCCCcchhhhHHHHHHHHHh-CCCCCCCCchhHHHHHHHhhcCcchhhhcccCCCC
Q 002158 785 MPTHVSTIVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVLLELLT-GMQPISHGKNIVREVNVARDSGMVFSIIDNRMGSY 863 (958)
Q Consensus 785 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gv~l~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~ 863 (958)
.......++..|+|||+..+..++.++||||||+++|||++ |..||.+...... ...... ......
T Consensus 158 ---~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~-~~~~~~---------~~~~~~ 224 (260)
T cd05069 158 ---TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNREV-LEQVER---------GYRMPC 224 (260)
T ss_pred ---cccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHH-HHHHHc---------CCCCCC
Confidence 11112346678999999998899999999999999999999 8999975433221 111111 111123
Q ss_pred ChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 002158 864 PSECVERFVTLALRCCHDKPEHRPSMSDVVRELEN 898 (958)
Q Consensus 864 ~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 898 (958)
+...+..+.+++.+||+.+|++||+++++++.|++
T Consensus 225 ~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 259 (260)
T cd05069 225 PQGCPESLHELMKLCWKKDPDERPTFEYIQSFLED 259 (260)
T ss_pred CcccCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 44567889999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=345.62 Aligned_cols=257 Identities=22% Similarity=0.317 Sum_probs=200.0
Q ss_pred CCCCCceeeeeCCeEEEEEEEC-CCcEEEEEEeccCC---hhcHHHHHHHHHHHHccCCCCcceEEEEEEeCCeEEEEEE
Q 002158 626 YFSSSTQVGQGGYGKVYKGILS-DNTTVAIKRAEEGS---LQGQNEFLTEIKLLSRLHHRNLVSLLGYCDEEGEQMLVYE 701 (958)
Q Consensus 626 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E 701 (958)
.|+..+.||+|+||.||+|... +++.||||++.... ......+.+|++++++++|+||+++++.+.+++..++|||
T Consensus 2 ~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E 81 (376)
T cd05598 2 MFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD 81 (376)
T ss_pred CceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEEe
Confidence 5788899999999999999975 68999999986532 1234568899999999999999999999999999999999
Q ss_pred ecCCCCHHHHhccCCCCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEecCCCCeEEeeeeeecccccCCC
Q 002158 702 FVPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSRLAPVLDD 781 (958)
Q Consensus 702 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~ 781 (958)
|+++|+|.+++.... .+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+|..+.....
T Consensus 82 ~~~~g~L~~~i~~~~--~~~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~~ 156 (376)
T cd05598 82 YIPGGDMMSLLIRLG--IFEEDLARFYIAELTCAIESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHD 156 (376)
T ss_pred CCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHEEECCCCCEEEEeCCCCcccccccc
Confidence 999999999997543 4788889999999999999999999 99999999999999999999999999753321100
Q ss_pred CC------------------------------------CccceeeeeccCCCCccChhhhccCCCCCcchhhhHHHHHHH
Q 002158 782 EG------------------------------------TMPTHVSTIVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVLLE 825 (958)
Q Consensus 782 ~~------------------------------------~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gv~l~e 825 (958)
.. ...........||+.|+|||++.+..++.++|||||||++||
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilye 236 (376)
T cd05598 157 SKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYE 236 (376)
T ss_pred ccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccceeee
Confidence 00 000011123579999999999999999999999999999999
Q ss_pred HHhCCCCCCCCchhHHHHHHHhhcCcchhhhcccCCCCChHHHHHHHHHHHHccccCCCCCC---CHHHHHHH
Q 002158 826 LLTGMQPISHGKNIVREVNVARDSGMVFSIIDNRMGSYPSECVERFVTLALRCCHDKPEHRP---SMSDVVRE 895 (958)
Q Consensus 826 lltG~~P~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP---s~~evl~~ 895 (958)
|++|+.||............. ....... .......+..+.+++.+|+ .+|.+|+ ++.+++++
T Consensus 237 ll~G~~Pf~~~~~~~~~~~i~-~~~~~~~------~~~~~~~s~~~~~li~~l~-~~p~~R~~~~t~~ell~h 301 (376)
T cd05598 237 MLVGQPPFLADTPAETQLKVI-NWETTLH------IPSQAKLSREASDLILRLC-CGAEDRLGKNGADEIKAH 301 (376)
T ss_pred hhhCCCCCCCCCHHHHHHHHh-ccCcccc------CCCCCCCCHHHHHHHHHHh-cCHhhcCCCCCHHHHhCC
Confidence 999999997654322211111 0000000 0011234566778888866 5999999 88999876
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-36 Score=331.31 Aligned_cols=258 Identities=29% Similarity=0.484 Sum_probs=206.7
Q ss_pred cCCCCCceeeeeCCeEEEEEEECC-C--cEEEEEEeccC-ChhcHHHHHHHHHHHHcc-CCCCcceEEEEEEeCCeEEEE
Q 002158 625 AYFSSSTQVGQGGYGKVYKGILSD-N--TTVAIKRAEEG-SLQGQNEFLTEIKLLSRL-HHRNLVSLLGYCDEEGEQMLV 699 (958)
Q Consensus 625 ~~~~~~~~lg~G~~g~Vy~~~~~~-~--~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lV 699 (958)
++|+..+.||+|+||.||+|.+++ + ..+++|.++.. .....+.|.+|+++++++ +||||+++++++...+..++|
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 81 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIA 81 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEE
Confidence 467888899999999999999753 3 35788888753 333456789999999999 799999999999999999999
Q ss_pred EEecCCCCHHHHhccCC--------------CCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEecCCCCe
Q 002158 700 YEFVPNGTLRDWLSGRT--------------KENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSNLNA 765 (958)
Q Consensus 700 ~E~~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~~~~ 765 (958)
|||+++++|.++++... ...+++..+..++.|++.||+|||+.+ |+||||||+|||+++++.+
T Consensus 82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~ 158 (297)
T cd05089 82 IEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQ---FIHRDLAARNVLVGENLAS 158 (297)
T ss_pred EEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCcCCcceEEECCCCeE
Confidence 99999999999996532 124888999999999999999999998 9999999999999999999
Q ss_pred EEeeeeeecccccCCCCCCccceeeeeccCCCCccChhhhccCCCCCcchhhhHHHHHHHHHh-CCCCCCCCchhHHHHH
Q 002158 766 KVADFGLSRLAPVLDDEGTMPTHVSTIVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVLLELLT-GMQPISHGKNIVREVN 844 (958)
Q Consensus 766 kl~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gv~l~ellt-G~~P~~~~~~~~~~~~ 844 (958)
||+|||++...... ........+..|+|||++.+..++.++|||||||++|||++ |..||...... ....
T Consensus 159 kl~dfg~~~~~~~~--------~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~-~~~~ 229 (297)
T cd05089 159 KIADFGLSRGEEVY--------VKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCA-ELYE 229 (297)
T ss_pred EECCcCCCccccce--------eccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHH-HHHH
Confidence 99999998632110 01111223567999999998889999999999999999998 99999654322 1111
Q ss_pred HHhhcCcchhhhcccCCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHhhC
Q 002158 845 VARDSGMVFSIIDNRMGSYPSECVERFVTLALRCCHDKPEHRPSMSDVVRELENILKMF 903 (958)
Q Consensus 845 ~~~~~~~~~~~i~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~ 903 (958)
.. ........+..++..+.+++.+||+.+|.+||+++++++.|+.+....
T Consensus 230 ~~---------~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~~~~ 279 (297)
T cd05089 230 KL---------PQGYRMEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRMLEAR 279 (297)
T ss_pred HH---------hcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhh
Confidence 11 111112234456678999999999999999999999999999988655
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-36 Score=328.63 Aligned_cols=254 Identities=29% Similarity=0.482 Sum_probs=206.3
Q ss_pred CCCCCceeeeeCCeEEEEEEEC------CCcEEEEEEeccCChhcHHHHHHHHHHHHccCCCCcceEEEEEEeCCeEEEE
Q 002158 626 YFSSSTQVGQGGYGKVYKGILS------DNTTVAIKRAEEGSLQGQNEFLTEIKLLSRLHHRNLVSLLGYCDEEGEQMLV 699 (958)
Q Consensus 626 ~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV 699 (958)
+|...++||+|+||.||++... ++..||+|.+..........|.+|++++++++|+||+++++++...+..++|
T Consensus 6 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 85 (280)
T cd05092 6 DIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLLMV 85 (280)
T ss_pred hceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceEEE
Confidence 4566789999999999999742 3568999998876666677899999999999999999999999999999999
Q ss_pred EEecCCCCHHHHhccCCC-------------CCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEecCCCCeE
Q 002158 700 YEFVPNGTLRDWLSGRTK-------------ENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSNLNAK 766 (958)
Q Consensus 700 ~E~~~~gsL~~~l~~~~~-------------~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~~~~k 766 (958)
|||+++++|.+++..... ..+++.+++.++.|++.|++|||+.+ ++||||||+||++++++.+|
T Consensus 86 ~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~---i~H~dlkp~nil~~~~~~~k 162 (280)
T cd05092 86 FEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLH---FVHRDLATRNCLVGQGLVVK 162 (280)
T ss_pred EecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCC---eecccccHhhEEEcCCCCEE
Confidence 999999999999975431 34889999999999999999999999 99999999999999999999
Q ss_pred EeeeeeecccccCCCCCCccceeeeeccCCCCccChhhhccCCCCCcchhhhHHHHHHHHHh-CCCCCCCCchhHHHHHH
Q 002158 767 VADFGLSRLAPVLDDEGTMPTHVSTIVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVLLELLT-GMQPISHGKNIVREVNV 845 (958)
Q Consensus 767 l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gv~l~ellt-G~~P~~~~~~~~~~~~~ 845 (958)
|+|||+++....... ........+++.|+|||++.+..++.++|||||||++|||++ |..||........ ...
T Consensus 163 L~dfg~~~~~~~~~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~-~~~ 236 (280)
T cd05092 163 IGDFGMSRDIYSTDY-----YRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEA-IEC 236 (280)
T ss_pred ECCCCceeEcCCCce-----eecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHHHH-HHH
Confidence 999999875422110 111122335678999999999999999999999999999998 8999865433211 111
Q ss_pred HhhcCcchhhhcccCCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 002158 846 ARDSGMVFSIIDNRMGSYPSECVERFVTLALRCCHDKPEHRPSMSDVVRELE 897 (958)
Q Consensus 846 ~~~~~~~~~~i~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 897 (958)
.. .......+..++..+.+++.+||+.||.+||+++|+.+.|+
T Consensus 237 ~~---------~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~ 279 (280)
T cd05092 237 IT---------QGRELERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQ 279 (280)
T ss_pred HH---------cCccCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHh
Confidence 11 11112234456778999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=332.67 Aligned_cols=254 Identities=29% Similarity=0.478 Sum_probs=204.2
Q ss_pred CCCCceeeeeCCeEEEEEEEC------CCcEEEEEEeccCChh-cHHHHHHHHHHHHccCCCCcceEEEEEEeCCeEEEE
Q 002158 627 FSSSTQVGQGGYGKVYKGILS------DNTTVAIKRAEEGSLQ-GQNEFLTEIKLLSRLHHRNLVSLLGYCDEEGEQMLV 699 (958)
Q Consensus 627 ~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV 699 (958)
|...+.||+|+||+||+|.+. ++..||+|++...... ..+.|.+|+.+++.++||||+++++++...+..+++
T Consensus 7 ~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~~~ 86 (283)
T cd05091 7 VRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLSMI 86 (283)
T ss_pred HHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceEEE
Confidence 455678999999999999863 2578999999764332 345688999999999999999999999999999999
Q ss_pred EEecCCCCHHHHhccCC--------------CCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEecCCCCe
Q 002158 700 YEFVPNGTLRDWLSGRT--------------KENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSNLNA 765 (958)
Q Consensus 700 ~E~~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~~~~ 765 (958)
+||+++++|.+++.... ...+++..+.+++.|++.||+|||+.+ |+||||||+||++++++.+
T Consensus 87 ~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~g---i~H~dlkp~Nil~~~~~~~ 163 (283)
T cd05091 87 FSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHH---VVHKDLATRNVLVFDKLNV 163 (283)
T ss_pred EEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcC---ccccccchhheEecCCCce
Confidence 99999999999985321 234788899999999999999999999 9999999999999999999
Q ss_pred EEeeeeeecccccCCCCCCccceeeeeccCCCCccChhhhccCCCCCcchhhhHHHHHHHHHh-CCCCCCCCchhHHHHH
Q 002158 766 KVADFGLSRLAPVLDDEGTMPTHVSTIVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVLLELLT-GMQPISHGKNIVREVN 844 (958)
Q Consensus 766 kl~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gv~l~ellt-G~~P~~~~~~~~~~~~ 844 (958)
||+|||+++....... ........+++.|+|||++.+..++.++||||||+++|||++ |..||.+.... ....
T Consensus 164 kl~Dfg~~~~~~~~~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~-~~~~ 237 (283)
T cd05091 164 KISDLGLFREVYAADY-----YKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQ-DVIE 237 (283)
T ss_pred Eecccccccccccchh-----eeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHH-HHHH
Confidence 9999999875432111 111223346788999999998889999999999999999998 88888654321 2221
Q ss_pred HHhhcCcchhhhcccCCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 002158 845 VARDSGMVFSIIDNRMGSYPSECVERFVTLALRCCHDKPEHRPSMSDVVRELEN 898 (958)
Q Consensus 845 ~~~~~~~~~~~i~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 898 (958)
... .......+..++..+.+++.+||+.+|++||++++|++.|+.
T Consensus 238 ~i~---------~~~~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~~ 282 (283)
T cd05091 238 MIR---------NRQVLPCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLRT 282 (283)
T ss_pred HHH---------cCCcCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhhC
Confidence 111 112223456678889999999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=338.77 Aligned_cols=242 Identities=24% Similarity=0.341 Sum_probs=198.5
Q ss_pred ceeeeeCCeEEEEEEEC-CCcEEEEEEeccCC---hhcHHHHHHHHHHHHcc-CCCCcceEEEEEEeCCeEEEEEEecCC
Q 002158 631 TQVGQGGYGKVYKGILS-DNTTVAIKRAEEGS---LQGQNEFLTEIKLLSRL-HHRNLVSLLGYCDEEGEQMLVYEFVPN 705 (958)
Q Consensus 631 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lV~E~~~~ 705 (958)
+.||+|+||+||+|.++ +++.||||+++... ......+..|.++++.+ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG 80 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999986 57899999987532 23345678899999888 799999999999999999999999999
Q ss_pred CCHHHHhccCCCCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEecCCCCeEEeeeeeecccccCCCCCCc
Q 002158 706 GTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSRLAPVLDDEGTM 785 (958)
Q Consensus 706 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~ 785 (958)
|+|.+++.... .+++.++..++.|++.||+|||+.+ |+||||||+||++++++.+||+|||+++......
T Consensus 81 ~~L~~~~~~~~--~l~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~----- 150 (318)
T cd05570 81 GDLMFHIQRSG--RFDEPRARFYAAEIVLGLQFLHERG---IIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGG----- 150 (318)
T ss_pred CCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhCC---eEccCCCHHHeEECCCCcEEecccCCCeecCcCC-----
Confidence 99999987553 4899999999999999999999999 9999999999999999999999999986421111
Q ss_pred cceeeeeccCCCCccChhhhccCCCCCcchhhhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcCcchhhhcccCCCCCh
Q 002158 786 PTHVSTIVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVLLELLTGMQPISHGKNIVREVNVARDSGMVFSIIDNRMGSYPS 865 (958)
Q Consensus 786 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gv~l~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~ 865 (958)
.......||+.|+|||++.+..++.++|||||||++|||++|+.||...... ....... ......+.
T Consensus 151 --~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~-~~~~~i~----------~~~~~~~~ 217 (318)
T cd05570 151 --VTTSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDED-ELFQSIL----------EDEVRYPR 217 (318)
T ss_pred --CcccceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHH-HHHHHHH----------cCCCCCCC
Confidence 1122346899999999999999999999999999999999999999754322 1111111 11122344
Q ss_pred HHHHHHHHHHHHccccCCCCCCCH-----HHHHHH
Q 002158 866 ECVERFVTLALRCCHDKPEHRPSM-----SDVVRE 895 (958)
Q Consensus 866 ~~~~~l~~li~~cl~~dP~~RPs~-----~evl~~ 895 (958)
..+..+.+++.+||+.||++||++ .+++++
T Consensus 218 ~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~~ 252 (318)
T cd05570 218 WLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKGH 252 (318)
T ss_pred cCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhcC
Confidence 567889999999999999999999 777754
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-36 Score=325.73 Aligned_cols=254 Identities=29% Similarity=0.473 Sum_probs=200.3
Q ss_pred CCCceeeeeCCeEEEEEEECC-Cc--EEEEEEeccC--ChhcHHHHHHHHHHHHccCCCCcceEEEEEEeC------CeE
Q 002158 628 SSSTQVGQGGYGKVYKGILSD-NT--TVAIKRAEEG--SLQGQNEFLTEIKLLSRLHHRNLVSLLGYCDEE------GEQ 696 (958)
Q Consensus 628 ~~~~~lg~G~~g~Vy~~~~~~-~~--~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~------~~~ 696 (958)
...+.||+|+||.||+|.+.+ +. .||+|.++.. .....+.|.+|+++++.++|+||+++++++... ...
T Consensus 2 ~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 81 (272)
T cd05075 2 ALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPSP 81 (272)
T ss_pred ccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCCc
Confidence 456789999999999999764 32 6899988654 334456789999999999999999999987432 256
Q ss_pred EEEEEecCCCCHHHHhccC----CCCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEecCCCCeEEeeeee
Q 002158 697 MLVYEFVPNGTLRDWLSGR----TKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSNLNAKVADFGL 772 (958)
Q Consensus 697 ~lV~E~~~~gsL~~~l~~~----~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~~~~kl~DFGl 772 (958)
++||||+++|+|.+++... ....+++..+..++.|++.||+|||+++ |+||||||+|||+++++.+||+|||+
T Consensus 82 ~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~ 158 (272)
T cd05075 82 VVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKS---FIHRDLAARNCMLNENMNVCVADFGL 158 (272)
T ss_pred EEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhheEEcCCCCEEECCCCc
Confidence 8999999999999987422 2234889999999999999999999998 99999999999999999999999999
Q ss_pred ecccccCCCCCCccceeeeeccCCCCccChhhhccCCCCCcchhhhHHHHHHHHHh-CCCCCCCCchhHHHHHHHhhcCc
Q 002158 773 SRLAPVLDDEGTMPTHVSTIVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVLLELLT-GMQPISHGKNIVREVNVARDSGM 851 (958)
Q Consensus 773 a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gv~l~ellt-G~~P~~~~~~~~~~~~~~~~~~~ 851 (958)
++....... ........+++.|+|||++.+..++.++||||||+++|||++ |+.||...... ........ +
T Consensus 159 ~~~~~~~~~-----~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~-~~~~~~~~-~- 230 (272)
T cd05075 159 SKKIYNGDY-----YRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENS-EIYDYLRQ-G- 230 (272)
T ss_pred ccccCcccc-----eecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHH-HHHHHHHc-C-
Confidence 986532111 111122346778999999999999999999999999999999 78888653322 21111111 1
Q ss_pred chhhhcccCCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHh
Q 002158 852 VFSIIDNRMGSYPSECVERFVTLALRCCHDKPEHRPSMSDVVRELENI 899 (958)
Q Consensus 852 ~~~~i~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 899 (958)
.....+..++..+.+++.+||+.+|++||++.++++.|+++
T Consensus 231 -------~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~~ 271 (272)
T cd05075 231 -------NRLKQPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEKA 271 (272)
T ss_pred -------CCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 11122345667899999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-36 Score=336.29 Aligned_cols=241 Identities=22% Similarity=0.315 Sum_probs=197.0
Q ss_pred CCCCCceeeeeCCeEEEEEEEC-CCcEEEEEEeccCC---hhcHHHHHHHHHHHHcc-CCCCcceEEEEEEeCCeEEEEE
Q 002158 626 YFSSSTQVGQGGYGKVYKGILS-DNTTVAIKRAEEGS---LQGQNEFLTEIKLLSRL-HHRNLVSLLGYCDEEGEQMLVY 700 (958)
Q Consensus 626 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lV~ 700 (958)
+|...+.||+|+||+||+|... +++.||||++.... ....+.+..|..++..+ +|++|+++++++...+..++||
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM 80 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence 4677889999999999999976 57899999987542 22234567788888877 5899999999999999999999
Q ss_pred EecCCCCHHHHhccCCCCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEecCCCCeEEeeeeeecccccCC
Q 002158 701 EFVPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSRLAPVLD 780 (958)
Q Consensus 701 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~ 780 (958)
||+++|+|.+++.... .+++.++..++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||+++.....
T Consensus 81 E~~~~g~L~~~~~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~- 154 (323)
T cd05616 81 EYVNGGDLMYQIQQVG--RFKEPHAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENMWD- 154 (323)
T ss_pred cCCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC---EEecCCCHHHeEECCCCcEEEccCCCceecCCC-
Confidence 9999999999996543 3889999999999999999999999 999999999999999999999999998743211
Q ss_pred CCCCccceeeeeccCCCCccChhhhccCCCCCcchhhhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcCcchhhhcccC
Q 002158 781 DEGTMPTHVSTIVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVLLELLTGMQPISHGKNIVREVNVARDSGMVFSIIDNRM 860 (958)
Q Consensus 781 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gv~l~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~i~~~~ 860 (958)
........||+.|+|||++.+..++.++|||||||++|||++|+.||...... ....... ...
T Consensus 155 ------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~-~~~~~i~----------~~~ 217 (323)
T cd05616 155 ------GVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDED-ELFQSIM----------EHN 217 (323)
T ss_pred ------CCccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHH-HHHHHHH----------hCC
Confidence 11123456999999999999999999999999999999999999999754432 1111111 111
Q ss_pred CCCChHHHHHHHHHHHHccccCCCCCCCH
Q 002158 861 GSYPSECVERFVTLALRCCHDKPEHRPSM 889 (958)
Q Consensus 861 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~ 889 (958)
..+|...+.++.+++.+|++.||.+|++.
T Consensus 218 ~~~p~~~s~~~~~li~~~l~~~p~~R~~~ 246 (323)
T cd05616 218 VAYPKSMSKEAVAICKGLMTKHPGKRLGC 246 (323)
T ss_pred CCCCCcCCHHHHHHHHHHcccCHHhcCCC
Confidence 23345567788999999999999999984
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-36 Score=329.75 Aligned_cols=267 Identities=28% Similarity=0.444 Sum_probs=205.6
Q ss_pred cCCCCCceeeeeCCeEEEEEEEC-----CCcEEEEEEeccCChhcHHHHHHHHHHHHccCCCCcceEEEEEEe--CCeEE
Q 002158 625 AYFSSSTQVGQGGYGKVYKGILS-----DNTTVAIKRAEEGSLQGQNEFLTEIKLLSRLHHRNLVSLLGYCDE--EGEQM 697 (958)
Q Consensus 625 ~~~~~~~~lg~G~~g~Vy~~~~~-----~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~--~~~~~ 697 (958)
..|...+.||+|+||+||+|..+ +++.||+|++........+.|.+|++++++++||||+++++++.. ....+
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 83 (284)
T cd05081 4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLR 83 (284)
T ss_pred ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCceE
Confidence 36777889999999999999853 578999999987666666789999999999999999999998754 34689
Q ss_pred EEEEecCCCCHHHHhccCCCCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEecCCCCeEEeeeeeecccc
Q 002158 698 LVYEFVPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSRLAP 777 (958)
Q Consensus 698 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~~~ 777 (958)
+||||+++++|.+++.... ..+++..+..++.|++.||+|||+.+ |+||||||+||++++++.+||+|||+++...
T Consensus 84 lv~e~~~~~~L~~~l~~~~-~~l~~~~~~~~~~~l~~aL~~LH~~~---i~H~dlkp~nili~~~~~~~l~dfg~~~~~~ 159 (284)
T cd05081 84 LVMEYLPYGSLRDYLQKHR-ERLDHRKLLLYASQICKGMEYLGSKR---YVHRDLATRNILVESENRVKIGDFGLTKVLP 159 (284)
T ss_pred EEEEecCCCCHHHHHHhcC-cCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCCHhhEEECCCCeEEECCCccccccc
Confidence 9999999999999997543 34899999999999999999999999 9999999999999999999999999998654
Q ss_pred cCCCCCCccceeeeeccCCCCccChhhhccCCCCCcchhhhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhc--Cc---c
Q 002158 778 VLDDEGTMPTHVSTIVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVLLELLTGMQPISHGKNIVREVNVARDS--GM---V 852 (958)
Q Consensus 778 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gv~l~elltG~~P~~~~~~~~~~~~~~~~~--~~---~ 852 (958)
..... ........++..|+|||++.+..++.++||||||+++|||++|..|+................ .. .
T Consensus 160 ~~~~~----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (284)
T cd05081 160 QDKEY----YKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHL 235 (284)
T ss_pred CCCcc----eeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhcccccccccchHHH
Confidence 32211 011111224456999999998889999999999999999999987764322111000000000 00 0
Q ss_pred hhhhcc-cCCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHh
Q 002158 853 FSIIDN-RMGSYPSECVERFVTLALRCCHDKPEHRPSMSDVVRELENI 899 (958)
Q Consensus 853 ~~~i~~-~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 899 (958)
.+.+.. .....+..++..+.+++.+||+.+|++|||++|+++.|+++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~ 283 (284)
T cd05081 236 IELLKNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAI 283 (284)
T ss_pred HHHHhcCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHhc
Confidence 011111 11122345677899999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-36 Score=322.93 Aligned_cols=249 Identities=27% Similarity=0.464 Sum_probs=199.3
Q ss_pred eeeeeCCeEEEEEEEC---CCcEEEEEEeccCC-hhcHHHHHHHHHHHHccCCCCcceEEEEEEeCCeEEEEEEecCCCC
Q 002158 632 QVGQGGYGKVYKGILS---DNTTVAIKRAEEGS-LQGQNEFLTEIKLLSRLHHRNLVSLLGYCDEEGEQMLVYEFVPNGT 707 (958)
Q Consensus 632 ~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E~~~~gs 707 (958)
.||+|+||.||+|.+. .+..||+|++.... ....++|.+|+.++++++|+||+++++++.. ...++||||+++++
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~-~~~~lv~e~~~~~~ 80 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCEA-EALMLVMEMASGGP 80 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEcC-CCeEEEEEeCCCCC
Confidence 3899999999999864 35579999987653 2334679999999999999999999999864 57899999999999
Q ss_pred HHHHhccCCCCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEecCCCCeEEeeeeeecccccCCCCCCccc
Q 002158 708 LRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSRLAPVLDDEGTMPT 787 (958)
Q Consensus 708 L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~ 787 (958)
|.+++.... ..+++.++++++.|++.||+|||+++ ++||||||+||+++.++.+||+|||+++........ .
T Consensus 81 L~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~----~ 152 (257)
T cd05115 81 LNKFLSGKK-DEITVSNVVELMHQVSMGMKYLEGKN---FVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSY----Y 152 (257)
T ss_pred HHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhcC---eeecccchheEEEcCCCcEEeccCCccccccCCccc----e
Confidence 999997543 35899999999999999999999999 999999999999999999999999998754322111 0
Q ss_pred eeeeeccCCCCccChhhhccCCCCCcchhhhHHHHHHHHHh-CCCCCCCCchhHHHHHHHhhcCcchhhhcccCCCCChH
Q 002158 788 HVSTIVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVLLELLT-GMQPISHGKNIVREVNVARDSGMVFSIIDNRMGSYPSE 866 (958)
Q Consensus 788 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gv~l~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~ 866 (958)
.......++..|+|||++....++.++||||||+++||+++ |..||....... ....... ......+..
T Consensus 153 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~-~~~~~~~---------~~~~~~~~~ 222 (257)
T cd05115 153 KARSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPE-VMSFIEQ---------GKRLDCPAE 222 (257)
T ss_pred eccCCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHH-HHHHHHC---------CCCCCCCCC
Confidence 11112234678999999988889999999999999999997 999997543321 1111111 111234556
Q ss_pred HHHHHHHHHHHccccCCCCCCCHHHHHHHHHHh
Q 002158 867 CVERFVTLALRCCHDKPEHRPSMSDVVRELENI 899 (958)
Q Consensus 867 ~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 899 (958)
++.++.+++.+||..+|++||++.+|.+.|+.+
T Consensus 223 ~~~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~~ 255 (257)
T cd05115 223 CPPEMYALMKDCWIYKWEDRPNFAKVEERMRTY 255 (257)
T ss_pred CCHHHHHHHHHHcCCChhhCcCHHHHHHHHhhh
Confidence 778999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-36 Score=323.64 Aligned_cols=248 Identities=27% Similarity=0.423 Sum_probs=199.3
Q ss_pred eeeeeCCeEEEEEEEC---CCcEEEEEEeccCC--hhcHHHHHHHHHHHHccCCCCcceEEEEEEeCCeEEEEEEecCCC
Q 002158 632 QVGQGGYGKVYKGILS---DNTTVAIKRAEEGS--LQGQNEFLTEIKLLSRLHHRNLVSLLGYCDEEGEQMLVYEFVPNG 706 (958)
Q Consensus 632 ~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E~~~~g 706 (958)
.||+|+||+||+|.++ ++..||+|+++... ....+++.+|+.+++.++|+||+++++++.. +..++||||+++|
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv~e~~~~~ 80 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICEA-ESWMLVMELAELG 80 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCcEEEEecCCCC
Confidence 5899999999999763 57889999986543 2335678999999999999999999999864 4678999999999
Q ss_pred CHHHHhccCCCCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEecCCCCeEEeeeeeecccccCCCCCCcc
Q 002158 707 TLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSRLAPVLDDEGTMP 786 (958)
Q Consensus 707 sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~ 786 (958)
+|.+++.... .+++..+..++.|++.||+|||+.+ |+||||||+||++++++.+||+|||+++........
T Consensus 81 ~L~~~l~~~~--~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~---- 151 (257)
T cd05116 81 PLNKFLQKNK--HVTEKNITELVHQVSMGMKYLEETN---FVHRDLAARNVLLVTQHYAKISDFGLSKALGADENY---- 151 (257)
T ss_pred cHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC---EeecccchhhEEEcCCCeEEECCCccccccCCCCCe----
Confidence 9999996543 4889999999999999999999999 999999999999999999999999999765322110
Q ss_pred ceeeeeccCCCCccChhhhccCCCCCcchhhhHHHHHHHHHh-CCCCCCCCchhHHHHHHHhhcCcchhhhcccCCCCCh
Q 002158 787 THVSTIVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVLLELLT-GMQPISHGKNIVREVNVARDSGMVFSIIDNRMGSYPS 865 (958)
Q Consensus 787 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gv~l~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~ 865 (958)
........++..|+|||.+....++.++||||||+++|||++ |..||...... ........ ......+.
T Consensus 152 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~-~~~~~i~~---------~~~~~~~~ 221 (257)
T cd05116 152 YKAKTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGN-EVTQMIES---------GERMECPQ 221 (257)
T ss_pred eeecCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHH-HHHHHHHC---------CCCCCCCC
Confidence 011112234678999999988889999999999999999998 99999754321 11111111 11123355
Q ss_pred HHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHh
Q 002158 866 ECVERFVTLALRCCHDKPEHRPSMSDVVRELENI 899 (958)
Q Consensus 866 ~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 899 (958)
.++.++.+++.+||+.||++||++++|.+.|++.
T Consensus 222 ~~~~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~~ 255 (257)
T cd05116 222 RCPPEMYDLMKLCWTYGVDERPGFAVVELRLRNY 255 (257)
T ss_pred CCCHHHHHHHHHHhccCchhCcCHHHHHHHHhcc
Confidence 6778899999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-36 Score=325.57 Aligned_cols=255 Identities=29% Similarity=0.475 Sum_probs=204.2
Q ss_pred CCCCceeeeeCCeEEEEEEECC----CcEEEEEEeccCC--hhcHHHHHHHHHHHHccCCCCcceEEEEEEeCCe-----
Q 002158 627 FSSSTQVGQGGYGKVYKGILSD----NTTVAIKRAEEGS--LQGQNEFLTEIKLLSRLHHRNLVSLLGYCDEEGE----- 695 (958)
Q Consensus 627 ~~~~~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~----- 695 (958)
|.+.+.||+|+||.||+|.+.. +..||||+++... ......+.+|++.++.++|+||+++++++...+.
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 80 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP 80 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence 4567899999999999998742 3679999987542 3344679999999999999999999999866554
Q ss_pred -EEEEEEecCCCCHHHHhccC----CCCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEecCCCCeEEeee
Q 002158 696 -QMLVYEFVPNGTLRDWLSGR----TKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSNLNAKVADF 770 (958)
Q Consensus 696 -~~lV~E~~~~gsL~~~l~~~----~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~~~~kl~DF 770 (958)
.++||||+++|+|.+++... ....+++..+..++.|++.||+|||+.+ ++||||||+||++++++.+||+||
T Consensus 81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~df 157 (273)
T cd05035 81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRN---FIHRDLAARNCMLREDMTVCVADF 157 (273)
T ss_pred ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCC---eeccccchheEEECCCCeEEECCc
Confidence 79999999999999998543 2235899999999999999999999998 999999999999999999999999
Q ss_pred eeecccccCCCCCCccceeeeeccCCCCccChhhhccCCCCCcchhhhHHHHHHHHHh-CCCCCCCCchhHHHHHHHhhc
Q 002158 771 GLSRLAPVLDDEGTMPTHVSTIVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVLLELLT-GMQPISHGKNIVREVNVARDS 849 (958)
Q Consensus 771 Gla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gv~l~ellt-G~~P~~~~~~~~~~~~~~~~~ 849 (958)
|+++........ .......++..|+|||++.+..++.++||||||+++|||++ |..||.+.... +......
T Consensus 158 g~~~~~~~~~~~-----~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~-~~~~~~~-- 229 (273)
T cd05035 158 GLSKKIYSGDYY-----RQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENH-EIYDYLR-- 229 (273)
T ss_pred cceeeccccccc-----cccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHH-HHHHHHH--
Confidence 999865322211 11112335678999999988889999999999999999999 88888654432 1111111
Q ss_pred CcchhhhcccCCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHh
Q 002158 850 GMVFSIIDNRMGSYPSECVERFVTLALRCCHDKPEHRPSMSDVVRELENI 899 (958)
Q Consensus 850 ~~~~~~i~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 899 (958)
.......+..++..+.+++.+||+.||++||++.|+++.|+++
T Consensus 230 -------~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~ 272 (273)
T cd05035 230 -------HGNRLKQPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENI 272 (273)
T ss_pred -------cCCCCCCCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 1112233556778899999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=343.06 Aligned_cols=256 Identities=21% Similarity=0.298 Sum_probs=202.4
Q ss_pred HHHHHHcCCCCCceeeeeCCeEEEEEEEC-CCcEEEEEEeccC---ChhcHHHHHHHHHHHHccCCCCcceEEEEEEeCC
Q 002158 619 ELAMATAYFSSSTQVGQGGYGKVYKGILS-DNTTVAIKRAEEG---SLQGQNEFLTEIKLLSRLHHRNLVSLLGYCDEEG 694 (958)
Q Consensus 619 el~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~ 694 (958)
++....++|+..+.||+|+||.||+|.+. +++.||+|++... .......+.+|+.+++.++||||+++++++..++
T Consensus 37 ~~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~ 116 (370)
T cd05621 37 KLQMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDK 116 (370)
T ss_pred hcCCCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCC
Confidence 33445567889999999999999999986 5889999998642 2223456889999999999999999999999999
Q ss_pred eEEEEEEecCCCCHHHHhccCCCCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEecCCCCeEEeeeeeec
Q 002158 695 EQMLVYEFVPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSR 774 (958)
Q Consensus 695 ~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~ 774 (958)
..++||||+++|+|.+++... .+++..+..++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||+++
T Consensus 117 ~~~lv~Ey~~gg~L~~~l~~~---~~~~~~~~~~~~qil~aL~~LH~~~---IvHrDLKp~NILl~~~~~~kL~DFG~a~ 190 (370)
T cd05621 117 YLYMVMEYMPGGDLVNLMSNY---DVPEKWAKFYTAEVVLALDAIHSMG---LIHRDVKPDNMLLDKHGHLKLADFGTCM 190 (370)
T ss_pred EEEEEEcCCCCCcHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEECCCCCEEEEecccce
Confidence 999999999999999999654 3788899999999999999999999 9999999999999999999999999998
Q ss_pred ccccCCCCCCccceeeeeccCCCCccChhhhccCC----CCCcchhhhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcC
Q 002158 775 LAPVLDDEGTMPTHVSTIVKGTPGYLDPEYFLTHK----LTDKSDVYSLGVVLLELLTGMQPISHGKNIVREVNVARDSG 850 (958)
Q Consensus 775 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~~DV~S~Gv~l~elltG~~P~~~~~~~~~~~~~~~~~~ 850 (958)
...... ........||+.|+|||++.+.. ++.++||||+||++|||++|+.||....... .........
T Consensus 191 ~~~~~~------~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~-~~~~i~~~~ 263 (370)
T cd05621 191 KMDETG------MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVG-TYSKIMDHK 263 (370)
T ss_pred ecccCC------ceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHH-HHHHHHhCC
Confidence 653211 11123456999999999997643 7789999999999999999999997544322 111111110
Q ss_pred cchhhhcccCCCCC--hHHHHHHHHHHHHccccCCCC--CCCHHHHHHH
Q 002158 851 MVFSIIDNRMGSYP--SECVERFVTLALRCCHDKPEH--RPSMSDVVRE 895 (958)
Q Consensus 851 ~~~~~i~~~~~~~~--~~~~~~l~~li~~cl~~dP~~--RPs~~evl~~ 895 (958)
. ....| ...+..+.+++.+|+..++.+ |++++|++++
T Consensus 264 ~--------~~~~p~~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~h 304 (370)
T cd05621 264 N--------SLNFPEDVEISKHAKNLICAFLTDREVRLGRNGVEEIKQH 304 (370)
T ss_pred c--------ccCCCCcccCCHHHHHHHHHHccCchhccCCCCHHHHhcC
Confidence 0 01112 234677889999999755543 8899999876
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-36 Score=326.95 Aligned_cols=258 Identities=29% Similarity=0.487 Sum_probs=207.2
Q ss_pred HcCCCCCceeeeeCCeEEEEEEEC-CC---cEEEEEEeccC-ChhcHHHHHHHHHHHHccCCCCcceEEEEEEeCCeEEE
Q 002158 624 TAYFSSSTQVGQGGYGKVYKGILS-DN---TTVAIKRAEEG-SLQGQNEFLTEIKLLSRLHHRNLVSLLGYCDEEGEQML 698 (958)
Q Consensus 624 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~---~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~l 698 (958)
.++|+..+.||+|+||.||+|..+ ++ ..||+|.++.. .....+++..|++++++++|+|++++.+++...+..++
T Consensus 4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 83 (268)
T cd05063 4 PSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMI 83 (268)
T ss_pred hHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEE
Confidence 346777899999999999999975 33 37999998754 23345678999999999999999999999999999999
Q ss_pred EEEecCCCCHHHHhccCCCCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEecCCCCeEEeeeeeeccccc
Q 002158 699 VYEFVPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSRLAPV 778 (958)
Q Consensus 699 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~~~~ 778 (958)
||||+++++|.+++.... ..+++.++..++.|++.|++|||+.+ ++||||||+||+++.++.+||+|||++.....
T Consensus 84 v~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~ 159 (268)
T cd05063 84 ITEYMENGALDKYLRDHD-GEFSSYQLVGMLRGIAAGMKYLSDMN---YVHRDLAARNILVNSNLECKVSDFGLSRVLED 159 (268)
T ss_pred EEEcCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhhEEEcCCCcEEECCCccceeccc
Confidence 999999999999997543 34899999999999999999999999 99999999999999999999999999875532
Q ss_pred CCCCCCccceeeeeccCCCCccChhhhccCCCCCcchhhhHHHHHHHHHh-CCCCCCCCchhHHHHHHHhhcCcchhhhc
Q 002158 779 LDDEGTMPTHVSTIVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVLLELLT-GMQPISHGKNIVREVNVARDSGMVFSIID 857 (958)
Q Consensus 779 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gv~l~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~i~ 857 (958)
.... .........+..|+|||++....++.++|||||||++|||++ |..||..... .........
T Consensus 160 ~~~~----~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~-~~~~~~i~~--------- 225 (268)
T cd05063 160 DPEG----TYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSN-HEVMKAIND--------- 225 (268)
T ss_pred cccc----ceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCH-HHHHHHHhc---------
Confidence 2111 111112224567999999998889999999999999999998 9999964332 112211111
Q ss_pred ccCCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHh
Q 002158 858 NRMGSYPSECVERFVTLALRCCHDKPEHRPSMSDVVRELENI 899 (958)
Q Consensus 858 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 899 (958)
......+..++..+.+++.+||+.+|++||++.+|++.|+++
T Consensus 226 ~~~~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~ 267 (268)
T cd05063 226 GFRLPAPMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKL 267 (268)
T ss_pred CCCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 111122334667899999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=317.39 Aligned_cols=259 Identities=25% Similarity=0.373 Sum_probs=203.4
Q ss_pred CCCCCceeeeeCCeEEEEEEEC-CCcEEEEEEeccCChh--cHHHHHHHHHHHHccCCCC-cceEEEEEEeCC------e
Q 002158 626 YFSSSTQVGQGGYGKVYKGILS-DNTTVAIKRAEEGSLQ--GQNEFLTEIKLLSRLHHRN-LVSLLGYCDEEG------E 695 (958)
Q Consensus 626 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~H~n-iv~l~~~~~~~~------~ 695 (958)
.|...++||+|+||+||+|+.+ +|+.||+|++...... .-....+|+.++++++|+| |+++++++...+ .
T Consensus 12 ~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~~ 91 (323)
T KOG0594|consen 12 DYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIGK 91 (323)
T ss_pred HHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccce
Confidence 3444567999999999999976 7899999998765332 1234579999999999999 999999998877 7
Q ss_pred EEEEEEecCCCCHHHHhccCCC--CCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEecCCCCeEEeeeeee
Q 002158 696 QMLVYEFVPNGTLRDWLSGRTK--ENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSNLNAKVADFGLS 773 (958)
Q Consensus 696 ~~lV~E~~~~gsL~~~l~~~~~--~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla 773 (958)
.++|+||+ .-+|.+++..... ..++...+..++.|+++||+|||+++ |+||||||.||||+++|.+||+|||+|
T Consensus 92 l~lvfe~~-d~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~---IlHRDLKPQNlLi~~~G~lKlaDFGlA 167 (323)
T KOG0594|consen 92 LYLVFEFL-DRDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHG---ILHRDLKPQNLLISSSGVLKLADFGLA 167 (323)
T ss_pred EEEEEEee-cccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCC---eecccCCcceEEECCCCcEeeeccchH
Confidence 89999999 5699999987653 35777889999999999999999999 999999999999999999999999999
Q ss_pred cccccCCCCCCccceeeeeccCCCCccChhhhccC-CCCCcchhhhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcCcc
Q 002158 774 RLAPVLDDEGTMPTHVSTIVKGTPGYLDPEYFLTH-KLTDKSDVYSLGVVLLELLTGMQPISHGKNIVREVNVARDSGMV 852 (958)
Q Consensus 774 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DV~S~Gv~l~elltG~~P~~~~~~~~~~~~~~~~~~~~ 852 (958)
+.... +....+...+|..|.|||++.+. .|++..||||+||++.||++++.-|.+..+..+.......-+..
T Consensus 168 ra~~i-------p~~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGtP 240 (323)
T KOG0594|consen 168 RAFSI-------PMRTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGTP 240 (323)
T ss_pred HHhcC-------CcccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCCC
Confidence 96532 22234456688999999999987 79999999999999999999988887766655444333222211
Q ss_pred hhhh--------cc--cCCCC--ChH----H---HHHHHHHHHHccccCCCCCCCHHHHHHH
Q 002158 853 FSII--------DN--RMGSY--PSE----C---VERFVTLALRCCHDKPEHRPSMSDVVRE 895 (958)
Q Consensus 853 ~~~i--------~~--~~~~~--~~~----~---~~~l~~li~~cl~~dP~~RPs~~evl~~ 895 (958)
.+.. +- ..... +.. . .....+++.+|++.+|.+|.|++.++++
T Consensus 241 ~e~~Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h 302 (323)
T KOG0594|consen 241 NEKDWPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTH 302 (323)
T ss_pred CccCCCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcC
Confidence 1100 00 00000 111 1 1378899999999999999999999975
|
|
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-36 Score=358.65 Aligned_cols=270 Identities=24% Similarity=0.357 Sum_probs=209.4
Q ss_pred cCCCCCceeeeeCCeEEEEEEEC-CCcEEEEEEeccCC---hhcHHHHHHHHHHHHccCCCCcceEEEEEEeCCeEEEEE
Q 002158 625 AYFSSSTQVGQGGYGKVYKGILS-DNTTVAIKRAEEGS---LQGQNEFLTEIKLLSRLHHRNLVSLLGYCDEEGEQMLVY 700 (958)
Q Consensus 625 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~ 700 (958)
.+|...++||+|+||.||+|.+. +++.||||++.... ....++|.+|++++++++||||+++++++.+.+..++||
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVM 81 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTM 81 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEE
Confidence 36788899999999999999976 58999999987532 223467999999999999999999999999999999999
Q ss_pred EecCCCCHHHHhccCC---------CCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEecCCCCeEEeeee
Q 002158 701 EFVPNGTLRDWLSGRT---------KENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSNLNAKVADFG 771 (958)
Q Consensus 701 E~~~~gsL~~~l~~~~---------~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~~~~kl~DFG 771 (958)
||+++|+|.+++.... ....++..+++++.|+++||+|||+.+ |+||||||+||+++.++.+||+|||
T Consensus 82 EY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~G---IIHRDLKPeNILLd~dg~vKLiDFG 158 (932)
T PRK13184 82 PYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKG---VLHRDLKPDNILLGLFGEVVILDWG 158 (932)
T ss_pred EcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchheEEEcCCCCEEEEecC
Confidence 9999999999986421 123567788999999999999999999 9999999999999999999999999
Q ss_pred eecccccCCCCCC-----------ccceeeeeccCCCCccChhhhccCCCCCcchhhhHHHHHHHHHhCCCCCCCCchhH
Q 002158 772 LSRLAPVLDDEGT-----------MPTHVSTIVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVLLELLTGMQPISHGKNIV 840 (958)
Q Consensus 772 la~~~~~~~~~~~-----------~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gv~l~elltG~~P~~~~~~~~ 840 (958)
+++.......... ..........||+.|+|||++.+..++.++|||||||++|||+||+.||.......
T Consensus 159 LAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~k 238 (932)
T PRK13184 159 AAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGRK 238 (932)
T ss_pred cceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchhh
Confidence 9986522111000 00011123569999999999999999999999999999999999999996532211
Q ss_pred HHHHHHhhcCcchhhhcccCCCCChHHHHHHHHHHHHccccCCCCCC-CHHHHHHHHHHhHhhCCC
Q 002158 841 REVNVARDSGMVFSIIDNRMGSYPSECVERFVTLALRCCHDKPEHRP-SMSDVVRELENILKMFPE 905 (958)
Q Consensus 841 ~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-s~~evl~~L~~~~~~~~~ 905 (958)
...... ...+.........+..+.+++.+|++.||++|| +++++.+.|+..+...+.
T Consensus 239 i~~~~~--------i~~P~~~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~~lq~~p~ 296 (932)
T PRK13184 239 ISYRDV--------ILSPIEVAPYREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEPHLQGSPE 296 (932)
T ss_pred hhhhhh--------ccChhhccccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhcCcc
Confidence 111000 000000011134567789999999999999995 677788888887765443
|
|
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-36 Score=322.44 Aligned_cols=249 Identities=29% Similarity=0.474 Sum_probs=207.8
Q ss_pred cCCCCCceeeeeCCeEEEEEEECCCcEEEEEEeccCChhcHHHHHHHHHHHHccCCCCcceEEEEEEeCCeEEEEEEecC
Q 002158 625 AYFSSSTQVGQGGYGKVYKGILSDNTTVAIKRAEEGSLQGQNEFLTEIKLLSRLHHRNLVSLLGYCDEEGEQMLVYEFVP 704 (958)
Q Consensus 625 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E~~~ 704 (958)
++|+..+.||+|+||.||+|... |+.||+|.+..... ..+++.+|+.++++++|+||+++++++...+..++||||++
T Consensus 6 ~~~~~~~~ig~g~~g~v~~~~~~-~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~ 83 (256)
T cd05039 6 KELKLGATIGKGEFGDVMLGDYR-GQKVAVKCLKDDST-AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYMA 83 (256)
T ss_pred hhccceeeeecCCCceEEEEEec-CcEEEEEEeccchh-HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEecC
Confidence 46777889999999999999874 78999999987644 56689999999999999999999999998999999999999
Q ss_pred CCCHHHHhccCCCCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEecCCCCeEEeeeeeecccccCCCCCC
Q 002158 705 NGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSRLAPVLDDEGT 784 (958)
Q Consensus 705 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 784 (958)
+++|.+++.......+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||.++......
T Consensus 84 ~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~---i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~---- 156 (256)
T cd05039 84 KGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKN---FVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQ---- 156 (256)
T ss_pred CCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccchhcccceEEEeCCCCEEEccccccccccccc----
Confidence 999999998766556999999999999999999999999 9999999999999999999999999987552111
Q ss_pred ccceeeeeccCCCCccChhhhccCCCCCcchhhhHHHHHHHHHh-CCCCCCCCchhHHHHHHHhhcCcchhhhcccCCCC
Q 002158 785 MPTHVSTIVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVLLELLT-GMQPISHGKNIVREVNVARDSGMVFSIIDNRMGSY 863 (958)
Q Consensus 785 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gv~l~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~ 863 (958)
....++..|+|||++.+..++.++||||||+++|||++ |..||..... ....... ..+ .....
T Consensus 157 ------~~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~-~~~~~~~-~~~--------~~~~~ 220 (256)
T cd05039 157 ------DSGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL-KDVVPHV-EKG--------YRMEA 220 (256)
T ss_pred ------ccCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCH-HHHHHHH-hcC--------CCCCC
Confidence 12234567999999998889999999999999999998 9999864432 1111111 111 11122
Q ss_pred ChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 002158 864 PSECVERFVTLALRCCHDKPEHRPSMSDVVRELEN 898 (958)
Q Consensus 864 ~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 898 (958)
+..++..+.+++.+|+..+|++||+++|++++|+.
T Consensus 221 ~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 255 (256)
T cd05039 221 PEGCPPEVYKVMKDCWELDPAKRPTFKQLREQLAL 255 (256)
T ss_pred ccCCCHHHHHHHHHHhccChhhCcCHHHHHHHHhc
Confidence 44567889999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-36 Score=324.20 Aligned_cols=256 Identities=30% Similarity=0.497 Sum_probs=210.6
Q ss_pred HHcCCCCCceeeeeCCeEEEEEEECCCcEEEEEEeccCChhcHHHHHHHHHHHHccCCCCcceEEEEEEeCCeEEEEEEe
Q 002158 623 ATAYFSSSTQVGQGGYGKVYKGILSDNTTVAIKRAEEGSLQGQNEFLTEIKLLSRLHHRNLVSLLGYCDEEGEQMLVYEF 702 (958)
Q Consensus 623 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E~ 702 (958)
..++|.+.+.||+|+||.||+|.+++++.||||.+.... ...+++.+|+.++++++|+|++++++++......++||||
T Consensus 4 ~~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 82 (261)
T cd05034 4 PRESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGT-MSPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTEY 82 (261)
T ss_pred chhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCCc-cCHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEec
Confidence 456788899999999999999998888899999987643 3456799999999999999999999999998999999999
Q ss_pred cCCCCHHHHhccCCCCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEecCCCCeEEeeeeeecccccCCCC
Q 002158 703 VPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSRLAPVLDDE 782 (958)
Q Consensus 703 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~ 782 (958)
+++++|.+++.......+++.++..++.|++.|++|||+.+ ++|+||||+||++++++.+||+|||+++......
T Consensus 83 ~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~~---i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~-- 157 (261)
T cd05034 83 MSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRN---YIHRDLAARNILVGENLVCKIADFGLARLIEDDE-- 157 (261)
T ss_pred cCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcchheEEEcCCCCEEECccccceeccchh--
Confidence 99999999998765556899999999999999999999999 9999999999999999999999999987653211
Q ss_pred CCccceeeeeccCCCCccChhhhccCCCCCcchhhhHHHHHHHHHh-CCCCCCCCchhHHHHHHHhhcCcchhhhcccCC
Q 002158 783 GTMPTHVSTIVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVLLELLT-GMQPISHGKNIVREVNVARDSGMVFSIIDNRMG 861 (958)
Q Consensus 783 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gv~l~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~i~~~~~ 861 (958)
........++..|+|||.+.+..++.++||||+|+++|||++ |+.||....... ....... ....
T Consensus 158 ----~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~-~~~~~~~---------~~~~ 223 (261)
T cd05034 158 ----YTAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNRE-VLEQVER---------GYRM 223 (261)
T ss_pred ----hhhhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHH-HHHHHHc---------CCCC
Confidence 011112235678999999998889999999999999999999 999996543221 1111111 0011
Q ss_pred CCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 002158 862 SYPSECVERFVTLALRCCHDKPEHRPSMSDVVRELEN 898 (958)
Q Consensus 862 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 898 (958)
..+...+..+.+++.+|++.+|++||+++++.+.|+.
T Consensus 224 ~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~ 260 (261)
T cd05034 224 PRPPNCPEELYDLMLQCWDKDPEERPTFEYLQSFLED 260 (261)
T ss_pred CCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHhc
Confidence 2233456789999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-36 Score=328.44 Aligned_cols=251 Identities=24% Similarity=0.361 Sum_probs=202.8
Q ss_pred CCCCceeeeeCCeEEEEEEEC-CCcEEEEEEeccCCh---hcHHHHHHHHHHHHccCCCCcceEEEEEEeCCeEEEEEEe
Q 002158 627 FSSSTQVGQGGYGKVYKGILS-DNTTVAIKRAEEGSL---QGQNEFLTEIKLLSRLHHRNLVSLLGYCDEEGEQMLVYEF 702 (958)
Q Consensus 627 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E~ 702 (958)
|+..+.||+|+||+||+|.+. +++.||+|.+..... .....+.+|++++++++|+|++++.+++..++..++||||
T Consensus 2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05632 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTI 81 (285)
T ss_pred ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEe
Confidence 556788999999999999975 688999999865422 2234578899999999999999999999999999999999
Q ss_pred cCCCCHHHHhccCCCCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEecCCCCeEEeeeeeecccccCCCC
Q 002158 703 VPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSRLAPVLDDE 782 (958)
Q Consensus 703 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~ 782 (958)
+++++|.+++.......+++..+..++.|++.||.|||+.+ |+||||||+||++++++.+||+|||++.......
T Consensus 82 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~---iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~-- 156 (285)
T cd05632 82 MNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHREN---TVYRDLKPENILLDDYGHIRISDLGLAVKIPEGE-- 156 (285)
T ss_pred ccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCCHHHEEECCCCCEEEecCCcceecCCCC--
Confidence 99999999987655456999999999999999999999999 9999999999999999999999999987542211
Q ss_pred CCccceeeeeccCCCCccChhhhccCCCCCcchhhhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcCcchhhhcccCCC
Q 002158 783 GTMPTHVSTIVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVLLELLTGMQPISHGKNIVREVNVARDSGMVFSIIDNRMGS 862 (958)
Q Consensus 783 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gv~l~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~ 862 (958)
......|+..|+|||++.+..++.++|+||||+++|||++|..||.............. .+......
T Consensus 157 ------~~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~~~~-------~~~~~~~~ 223 (285)
T cd05632 157 ------SIRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDR-------RVLETEEV 223 (285)
T ss_pred ------cccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH-------hhhccccc
Confidence 11234689999999999999999999999999999999999999975443221111100 01111112
Q ss_pred CChHHHHHHHHHHHHccccCCCCCCC-----HHHHHHH
Q 002158 863 YPSECVERFVTLALRCCHDKPEHRPS-----MSDVVRE 895 (958)
Q Consensus 863 ~~~~~~~~l~~li~~cl~~dP~~RPs-----~~evl~~ 895 (958)
.+...+..+.+++.+|++.||++||+ +++++++
T Consensus 224 ~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~ 261 (285)
T cd05632 224 YSAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKRH 261 (285)
T ss_pred cCccCCHHHHHHHHHHccCCHhHcCCCcccChHHHHcC
Confidence 34456677899999999999999999 6666653
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-36 Score=337.99 Aligned_cols=262 Identities=29% Similarity=0.472 Sum_probs=204.8
Q ss_pred HcCCCCCceeeeeCCeEEEEEEE------CCCcEEEEEEeccCC-hhcHHHHHHHHHHHHcc-CCCCcceEEEEEEeC-C
Q 002158 624 TAYFSSSTQVGQGGYGKVYKGIL------SDNTTVAIKRAEEGS-LQGQNEFLTEIKLLSRL-HHRNLVSLLGYCDEE-G 694 (958)
Q Consensus 624 ~~~~~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~-~ 694 (958)
.++|...+.||+|+||+||+|.+ .+++.||||+++... ......+.+|+.++.++ +|+||+++++++... .
T Consensus 6 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~ 85 (343)
T cd05103 6 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGG 85 (343)
T ss_pred hhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCCC
Confidence 45788899999999999999974 246889999997643 23345688999999999 689999999988654 4
Q ss_pred eEEEEEEecCCCCHHHHhccCC----------------------------------------------------------
Q 002158 695 EQMLVYEFVPNGTLRDWLSGRT---------------------------------------------------------- 716 (958)
Q Consensus 695 ~~~lV~E~~~~gsL~~~l~~~~---------------------------------------------------------- 716 (958)
..++||||+++|+|.++++...
T Consensus 86 ~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (343)
T cd05103 86 PLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEE 165 (343)
T ss_pred ceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhhh
Confidence 6789999999999999986432
Q ss_pred -------CCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEecCCCCeEEeeeeeecccccCCCCCCcccee
Q 002158 717 -------KENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSRLAPVLDDEGTMPTHV 789 (958)
Q Consensus 717 -------~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~ 789 (958)
...+++..+.+++.|+++||+|||+.+ |+||||||+||++++++.+||+|||+++....... ...
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~-----~~~ 237 (343)
T cd05103 166 AEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPD-----YVR 237 (343)
T ss_pred hhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCccCeEEEcCCCcEEEEecccccccccCcc-----hhh
Confidence 123678888999999999999999999 99999999999999999999999999876422111 011
Q ss_pred eeeccCCCCccChhhhccCCCCCcchhhhHHHHHHHHHh-CCCCCCCCchhHHHHHHHhhcCcchhhhcccCCCCChHHH
Q 002158 790 STIVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVLLELLT-GMQPISHGKNIVREVNVARDSGMVFSIIDNRMGSYPSECV 868 (958)
Q Consensus 790 ~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gv~l~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~ 868 (958)
.....++..|+|||++.+..++.++||||||+++|||++ |..||.............. .+ .....+...+
T Consensus 238 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~-~~--------~~~~~~~~~~ 308 (343)
T cd05103 238 KGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLK-EG--------TRMRAPDYTT 308 (343)
T ss_pred cCCCCCCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccHHHHHHHh-cc--------CCCCCCCCCC
Confidence 112345678999999999999999999999999999997 9999865332211111111 11 1111222345
Q ss_pred HHHHHHHHHccccCCCCCCCHHHHHHHHHHhHhh
Q 002158 869 ERFVTLALRCCHDKPEHRPSMSDVVRELENILKM 902 (958)
Q Consensus 869 ~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~ 902 (958)
..+.+++.+||+.+|++||++.|++++|+.+++.
T Consensus 309 ~~~~~~~~~cl~~~p~~Rps~~eil~~l~~~~~~ 342 (343)
T cd05103 309 PEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA 342 (343)
T ss_pred HHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence 6789999999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-36 Score=335.62 Aligned_cols=237 Identities=24% Similarity=0.314 Sum_probs=191.2
Q ss_pred ceeeeeCCeEEEEEEEC-CCcEEEEEEeccCC---hhcHHHHHHHHH-HHHccCCCCcceEEEEEEeCCeEEEEEEecCC
Q 002158 631 TQVGQGGYGKVYKGILS-DNTTVAIKRAEEGS---LQGQNEFLTEIK-LLSRLHHRNLVSLLGYCDEEGEQMLVYEFVPN 705 (958)
Q Consensus 631 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~-~l~~l~H~niv~l~~~~~~~~~~~lV~E~~~~ 705 (958)
+.||+|+||+||+|.+. +|+.||||++.... .....++.+|.. +++.++||||+++++++...+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence 36999999999999986 68999999986532 122344555554 56789999999999999999999999999999
Q ss_pred CCHHHHhccCCCCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEecCCCCeEEeeeeeecccccCCCCCCc
Q 002158 706 GTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSRLAPVLDDEGTM 785 (958)
Q Consensus 706 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~ 785 (958)
|+|.+++.... .+++..+..++.|+++||+|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 81 g~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~g---ivH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~------ 149 (323)
T cd05575 81 GELFFHLQRER--SFPEPRARFYAAEIASALGYLHSLN---IIYRDLKPENILLDSQGHVVLTDFGLCKEGIEH------ 149 (323)
T ss_pred CCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHeEECCCCcEEEeccCCCcccccC------
Confidence 99999997543 4889999999999999999999999 999999999999999999999999998743211
Q ss_pred cceeeeeccCCCCccChhhhccCCCCCcchhhhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcCcchhhhcccCCCCCh
Q 002158 786 PTHVSTIVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVLLELLTGMQPISHGKNIVREVNVARDSGMVFSIIDNRMGSYPS 865 (958)
Q Consensus 786 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gv~l~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~ 865 (958)
........||+.|+|||++.+..++.++|||||||++|||++|+.||..... ......... .....+.
T Consensus 150 -~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~-~~~~~~i~~----------~~~~~~~ 217 (323)
T cd05575 150 -SKTTSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDT-AEMYDNILN----------KPLRLKP 217 (323)
T ss_pred -CCccccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCH-HHHHHHHHc----------CCCCCCC
Confidence 1112345699999999999999999999999999999999999999975432 221111111 1112233
Q ss_pred HHHHHHHHHHHHccccCCCCCCCHH
Q 002158 866 ECVERFVTLALRCCHDKPEHRPSMS 890 (958)
Q Consensus 866 ~~~~~l~~li~~cl~~dP~~RPs~~ 890 (958)
..+..+.+++.+|++.||++||++.
T Consensus 218 ~~~~~~~~li~~~l~~~p~~R~~~~ 242 (323)
T cd05575 218 NISVSARHLLEGLLQKDRTKRLGAK 242 (323)
T ss_pred CCCHHHHHHHHHHhhcCHHhCCCCC
Confidence 4567889999999999999999985
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-36 Score=329.24 Aligned_cols=250 Identities=24% Similarity=0.381 Sum_probs=206.4
Q ss_pred cCCCCCceeeeeCCeEEEEEEEC-CCcEEEEEEeccCChhcHHHHHHHHHHHHccCCCCcceEEEEEEeCCeEEEEEEec
Q 002158 625 AYFSSSTQVGQGGYGKVYKGILS-DNTTVAIKRAEEGSLQGQNEFLTEIKLLSRLHHRNLVSLLGYCDEEGEQMLVYEFV 703 (958)
Q Consensus 625 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E~~ 703 (958)
.+|+..+.||+|+||.||+|... +++.||+|.+........+.+.+|+.+++.++|+|++++++++..+...++||||+
T Consensus 20 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e~~ 99 (296)
T cd06654 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL 99 (296)
T ss_pred cceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeeccc
Confidence 36777789999999999999975 68899999987765555677899999999999999999999999999999999999
Q ss_pred CCCCHHHHhccCCCCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEecCCCCeEEeeeeeecccccCCCCC
Q 002158 704 PNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSRLAPVLDDEG 783 (958)
Q Consensus 704 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 783 (958)
++++|.+++.+. .+++.++..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+++.......
T Consensus 100 ~~~~L~~~~~~~---~~~~~~~~~i~~ql~~aL~~LH~~g---i~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~~-- 171 (296)
T cd06654 100 AGGSLTDVVTET---CMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS-- 171 (296)
T ss_pred CCCCHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCEEECccccchhcccccc--
Confidence 999999999643 3788999999999999999999999 99999999999999999999999999875422111
Q ss_pred CccceeeeeccCCCCccChhhhccCCCCCcchhhhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcCcchhhhcccCCCC
Q 002158 784 TMPTHVSTIVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVLLELLTGMQPISHGKNIVREVNVARDSGMVFSIIDNRMGSY 863 (958)
Q Consensus 784 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gv~l~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~ 863 (958)
......|++.|+|||.+.+..++.++|||||||++|||++|+.||............... .. .....
T Consensus 172 -----~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~~~~~~~-~~-------~~~~~ 238 (296)
T cd06654 172 -----KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATN-GT-------PELQN 238 (296)
T ss_pred -----ccCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHhHHHHhcC-CC-------CCCCC
Confidence 112345889999999999888999999999999999999999999755432222111110 00 00122
Q ss_pred ChHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 002158 864 PSECVERFVTLALRCCHDKPEHRPSMSDVVRE 895 (958)
Q Consensus 864 ~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 895 (958)
+...+..+.+++.+||..+|++||++.+++++
T Consensus 239 ~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~~ 270 (296)
T cd06654 239 PEKLSAIFRDFLNRCLDMDVEKRGSAKELLQH 270 (296)
T ss_pred ccccCHHHHHHHHHHCcCCcccCcCHHHHhhC
Confidence 44566789999999999999999999999974
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-36 Score=322.71 Aligned_cols=253 Identities=26% Similarity=0.418 Sum_probs=207.0
Q ss_pred cCCCCCceeeeeCCeEEEEEEEC-CCcEEEEEEeccCCh-----hcHHHHHHHHHHHHccCCCCcceEEEEEEeCCeEEE
Q 002158 625 AYFSSSTQVGQGGYGKVYKGILS-DNTTVAIKRAEEGSL-----QGQNEFLTEIKLLSRLHHRNLVSLLGYCDEEGEQML 698 (958)
Q Consensus 625 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-----~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~l 698 (958)
++|...+.||+|++|.||+|... +++.||+|.+..... ...+.+.+|++++++++||||+++++++..++..++
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 81 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI 81 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence 46888999999999999999975 689999998864321 123568899999999999999999999999999999
Q ss_pred EEEecCCCCHHHHhccCCCCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEecCCCCeEEeeeeeeccccc
Q 002158 699 VYEFVPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSRLAPV 778 (958)
Q Consensus 699 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~~~~ 778 (958)
||||+++++|.+++.... .+++..+.+++.|++.||+|||+.+ |+||||||+||++++++.++|+|||+++....
T Consensus 82 v~e~~~~~~l~~~~~~~~--~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~~ 156 (263)
T cd06625 82 FMEYMPGGSVKDQLKAYG--ALTETVTRKYTRQILEGVEYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRLQT 156 (263)
T ss_pred EEEECCCCcHHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeecccceeccc
Confidence 999999999999997543 4888999999999999999999999 99999999999999999999999999875432
Q ss_pred CCCCCCccceeeeeccCCCCccChhhhccCCCCCcchhhhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcCcchhhhcc
Q 002158 779 LDDEGTMPTHVSTIVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVLLELLTGMQPISHGKNIVREVNVARDSGMVFSIIDN 858 (958)
Q Consensus 779 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gv~l~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~i~~ 858 (958)
.... ........|+..|+|||++.+..++.++||||+|+++|||++|+.||............... .
T Consensus 157 ~~~~----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~---------~ 223 (263)
T cd06625 157 ICSS----GTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQ---------P 223 (263)
T ss_pred cccc----cccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchHHHHHHHhcc---------C
Confidence 2111 11112345788999999999999999999999999999999999999765433222211111 1
Q ss_pred cCCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 002158 859 RMGSYPSECVERFVTLALRCCHDKPEHRPSMSDVVRE 895 (958)
Q Consensus 859 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 895 (958)
.....+..++..+.+++.+||..+|.+||++.+++++
T Consensus 224 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 260 (263)
T cd06625 224 TNPQLPSHVSPDARNFLRRTFVENAKKRPSAEELLRH 260 (263)
T ss_pred CCCCCCccCCHHHHHHHHHHhhcCcccCCCHHHHhhC
Confidence 1123455667889999999999999999999999874
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-36 Score=326.66 Aligned_cols=255 Identities=22% Similarity=0.313 Sum_probs=203.3
Q ss_pred HcCCCCCceeeeeCCeEEEEEEEC-CCcEEEEEEeccCChhcHHHHHHHHHHHHccCCCCcceEEEEEEeCCeEEEEEEe
Q 002158 624 TAYFSSSTQVGQGGYGKVYKGILS-DNTTVAIKRAEEGSLQGQNEFLTEIKLLSRLHHRNLVSLLGYCDEEGEQMLVYEF 702 (958)
Q Consensus 624 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E~ 702 (958)
..+|+..+.||+|+||.||+|+.. +++.||+|++..........+.+|+.++++++||||+++++++..++..++||||
T Consensus 8 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e~ 87 (267)
T cd06646 8 QHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEY 87 (267)
T ss_pred hhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEeC
Confidence 346888899999999999999975 6889999998765444556788999999999999999999999999999999999
Q ss_pred cCCCCHHHHhccCCCCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEecCCCCeEEeeeeeecccccCCCC
Q 002158 703 VPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSRLAPVLDDE 782 (958)
Q Consensus 703 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~ 782 (958)
+++++|.++++... .+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.++|+|||+++......
T Consensus 88 ~~~~~L~~~~~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~-- 160 (267)
T cd06646 88 CGGGSLQDIYHVTG--PLSELQIAYVCRETLQGLAYLHSKG---KMHRDIKGANILLTDNGDVKLADFGVAAKITATI-- 160 (267)
T ss_pred CCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCCEEECcCccceeecccc--
Confidence 99999999997543 4889999999999999999999998 9999999999999999999999999987542211
Q ss_pred CCccceeeeeccCCCCccChhhhc---cCCCCCcchhhhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcCcchhhhccc
Q 002158 783 GTMPTHVSTIVKGTPGYLDPEYFL---THKLTDKSDVYSLGVVLLELLTGMQPISHGKNIVREVNVARDSGMVFSIIDNR 859 (958)
Q Consensus 783 ~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DV~S~Gv~l~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~i~~~ 859 (958)
.......|+..|+|||.+. ...++.++|||||||++|||++|+.||............. ... ....
T Consensus 161 -----~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~~~~-~~~-----~~~~ 229 (267)
T cd06646 161 -----AKRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMS-KSN-----FQPP 229 (267)
T ss_pred -----cccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhheeee-cCC-----CCCC
Confidence 1112345889999999984 3457789999999999999999999986433221111000 000 0000
Q ss_pred CCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 002158 860 MGSYPSECVERFVTLALRCCHDKPEHRPSMSDVVREL 896 (958)
Q Consensus 860 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 896 (958)
........+..+.+++.+||+.+|++||+++++++++
T Consensus 230 ~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l 266 (267)
T cd06646 230 KLKDKTKWSSTFHNFVKISLTKNPKKRPTAERLLTHL 266 (267)
T ss_pred CCccccccCHHHHHHHHHHhhCChhhCcCHHHHhcCC
Confidence 0011223567899999999999999999999998754
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-37 Score=317.06 Aligned_cols=262 Identities=24% Similarity=0.347 Sum_probs=206.1
Q ss_pred HHcCCCCCceeeeeCCeEEEEEEEC-CCcEEEEEEecc--CChhcHHHHHHHHHHHHccCCCCcceEEEEEEe-----CC
Q 002158 623 ATAYFSSSTQVGQGGYGKVYKGILS-DNTTVAIKRAEE--GSLQGQNEFLTEIKLLSRLHHRNLVSLLGYCDE-----EG 694 (958)
Q Consensus 623 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~-----~~ 694 (958)
....|...+.||+|+||.|.+|..+ +|+.||||++.. ......++-.+|+.+|+.++|+||+.+.+.+.. -.
T Consensus 20 i~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~ 99 (359)
T KOG0660|consen 20 IPRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFN 99 (359)
T ss_pred ccceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccc
Confidence 3445555788999999999999976 789999999874 345556788999999999999999999999865 34
Q ss_pred eEEEEEEecCCCCHHHHhccCCCCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEecCCCCeEEeeeeeec
Q 002158 695 EQMLVYEFVPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSR 774 (958)
Q Consensus 695 ~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~ 774 (958)
..|+|+|+| +.+|...++.+.. ++...+..+..|+++||.|+|+.+ |+|||+||+|++++.+..+||+|||+||
T Consensus 100 DvYiV~elM-etDL~~iik~~~~--L~d~H~q~f~YQiLrgLKyiHSAn---ViHRDLKPsNll~n~~c~lKI~DFGLAR 173 (359)
T KOG0660|consen 100 DVYLVFELM-ETDLHQIIKSQQD--LTDDHAQYFLYQILRGLKYIHSAN---VIHRDLKPSNLLLNADCDLKICDFGLAR 173 (359)
T ss_pred eeEEehhHH-hhHHHHHHHcCcc--ccHHHHHHHHHHHHHhcchhhccc---ccccccchhheeeccCCCEEecccccee
Confidence 689999999 6799999976543 899999999999999999999999 9999999999999999999999999999
Q ss_pred ccccCCCCCCccceeeeeccCCCCccChhhhcc-CCCCCcchhhhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcCcc-
Q 002158 775 LAPVLDDEGTMPTHVSTIVKGTPGYLDPEYFLT-HKLTDKSDVYSLGVVLLELLTGMQPISHGKNIVREVNVARDSGMV- 852 (958)
Q Consensus 775 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DV~S~Gv~l~elltG~~P~~~~~~~~~~~~~~~~~~~~- 852 (958)
....... ....+..+.|..|.|||++.. ..|+.+.||||.||++.||++|++-|.+.+.+.+.-....--+..
T Consensus 174 ~~~~~~~-----~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~ 248 (359)
T KOG0660|consen 174 YLDKFFE-----DGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPS 248 (359)
T ss_pred eccccCc-----ccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCC
Confidence 7754311 122345567899999999864 579999999999999999999999887655443322111111110
Q ss_pred ------------hhhhcccC--CC-----CChHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 002158 853 ------------FSIIDNRM--GS-----YPSECVERFVTLALRCCHDKPEHRPSMSDVVRE 895 (958)
Q Consensus 853 ------------~~~i~~~~--~~-----~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 895 (958)
...+.... +. .-+.......+|+.+|+..||.+|+|++|++++
T Consensus 249 ~e~l~~i~s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~h 310 (359)
T KOG0660|consen 249 EEDLQKIRSEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAH 310 (359)
T ss_pred HHHHHHhccHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcC
Confidence 11111110 11 112455678899999999999999999999975
|
|
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=318.56 Aligned_cols=247 Identities=29% Similarity=0.437 Sum_probs=210.3
Q ss_pred CCCCCceeeeeCCeEEEEEEEC-CCcEEEEEEeccCChhcHHHHHHHHHHHHccCCCCcceEEEEEEeCCeEEEEEEecC
Q 002158 626 YFSSSTQVGQGGYGKVYKGILS-DNTTVAIKRAEEGSLQGQNEFLTEIKLLSRLHHRNLVSLLGYCDEEGEQMLVYEFVP 704 (958)
Q Consensus 626 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E~~~ 704 (958)
-|.+..+||+|+||.||+|.++ .|+.||||.+... .+..++..|+.+|++.+.+++|++||.+-....+++|||||.
T Consensus 34 VFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~--sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYCG 111 (502)
T KOG0574|consen 34 VFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVD--TDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYCG 111 (502)
T ss_pred HHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCcc--chHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhcC
Confidence 4566778999999999999987 6999999998753 456789999999999999999999999988889999999999
Q ss_pred CCCHHHHhccCCCCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEecCCCCeEEeeeeeecccccCCCCCC
Q 002158 705 NGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSRLAPVLDDEGT 784 (958)
Q Consensus 705 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 784 (958)
.|++.|.++.++ +++++.++..++...++||+|||... -||||||+.|||++.+|.+||+|||.|-.+.. +
T Consensus 112 AGSiSDI~R~R~-K~L~E~EIs~iL~~TLKGL~YLH~~~---KIHRDIKAGNILLNT~G~AKLADFGVAGQLTD-----T 182 (502)
T KOG0574|consen 112 AGSISDIMRARR-KPLSEQEISAVLRDTLKGLQYLHDLK---KIHRDIKAGNILLNTDGIAKLADFGVAGQLTD-----T 182 (502)
T ss_pred CCcHHHHHHHhc-CCccHHHHHHHHHHHHhHHHHHHHHH---HHHhhcccccEEEcccchhhhhhccccchhhh-----h
Confidence 999999998654 46999999999999999999999998 89999999999999999999999999865421 1
Q ss_pred ccceeeeeccCCCCccChhhhccCCCCCcchhhhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcCcchhhhcccCC--C
Q 002158 785 MPTHVSTIVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVLLELLTGMQPISHGKNIVREVNVARDSGMVFSIIDNRMG--S 862 (958)
Q Consensus 785 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gv~l~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~i~~~~~--~ 862 (958)
......+.||+.|||||++....|+.++||||+|++..||..|++||.+-.... .++-+..+..+ .
T Consensus 183 --MAKRNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMR----------AIFMIPT~PPPTF~ 250 (502)
T KOG0574|consen 183 --MAKRNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMR----------AIFMIPTKPPPTFK 250 (502)
T ss_pred --HHhhCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccccc----------eeEeccCCCCCCCC
Confidence 222345779999999999999999999999999999999999999997643321 12222222222 2
Q ss_pred CChHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 002158 863 YPSECVERFVTLALRCCHDKPEHRPSMSDVVRE 895 (958)
Q Consensus 863 ~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 895 (958)
.|..+..++.+++++|+-++|++|-++.+++++
T Consensus 251 KPE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~H 283 (502)
T KOG0574|consen 251 KPEEWSSEFNDFIRSCLIKKPEERKTALRLCEH 283 (502)
T ss_pred ChHhhhhHHHHHHHHHhcCCHHHHHHHHHHhhh
Confidence 367889999999999999999999999998875
|
|
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-36 Score=324.42 Aligned_cols=256 Identities=23% Similarity=0.363 Sum_probs=208.3
Q ss_pred CCCCCceeeeeCCeEEEEEEEC-CCcEEEEEEeccC---ChhcHHHHHHHHHHHHccCCCCcceEEEEEEeCCeEEEEEE
Q 002158 626 YFSSSTQVGQGGYGKVYKGILS-DNTTVAIKRAEEG---SLQGQNEFLTEIKLLSRLHHRNLVSLLGYCDEEGEQMLVYE 701 (958)
Q Consensus 626 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E 701 (958)
+|...+.||+|+||.||+|... +++.||||.+... ......++.+|+++++.++|+||+++++++..++..++|||
T Consensus 3 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e 82 (267)
T cd08229 3 NFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLE 82 (267)
T ss_pred hhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEEE
Confidence 5677789999999999999965 7899999987643 22334578999999999999999999999999999999999
Q ss_pred ecCCCCHHHHhccC--CCCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEecCCCCeEEeeeeeecccccC
Q 002158 702 FVPNGTLRDWLSGR--TKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSRLAPVL 779 (958)
Q Consensus 702 ~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~~~~~ 779 (958)
|+++++|.+++... ....+++.++..++.|+++||+|||+.+ ++|+||||+||+++.++.++|+|||++......
T Consensus 83 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~ 159 (267)
T cd08229 83 LADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSSK 159 (267)
T ss_pred ecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEECcchhhhccccC
Confidence 99999999998632 2345899999999999999999999999 999999999999999999999999998765321
Q ss_pred CCCCCccceeeeeccCCCCccChhhhccCCCCCcchhhhHHHHHHHHHhCCCCCCCCchh-HHHHHHHhhcCcchhhhcc
Q 002158 780 DDEGTMPTHVSTIVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVLLELLTGMQPISHGKNI-VREVNVARDSGMVFSIIDN 858 (958)
Q Consensus 780 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gv~l~elltG~~P~~~~~~~-~~~~~~~~~~~~~~~~i~~ 858 (958)
.. ......|+..|+|||++.+..++.++||||||+++|||++|..||...... ........ ..
T Consensus 160 ~~-------~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~---------~~ 223 (267)
T cd08229 160 TT-------AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIE---------QC 223 (267)
T ss_pred Cc-------ccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccchHHHHhhhhh---------cC
Confidence 11 112345889999999999888999999999999999999999999643321 11111110 01
Q ss_pred cCCC-CChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhH
Q 002158 859 RMGS-YPSECVERFVTLALRCCHDKPEHRPSMSDVVRELENIL 900 (958)
Q Consensus 859 ~~~~-~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~ 900 (958)
..+. .+...+..+.+++.+||+.+|++|||+.+|++.++++.
T Consensus 224 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~~~ 266 (267)
T cd08229 224 DYPPLPSDHYSEELRQLVNMCINPDPEKRPDITYVYDVAKRMH 266 (267)
T ss_pred CCCCCCcccccHHHHHHHHHhcCCCcccCCCHHHHHHHHhhhc
Confidence 1111 12356788999999999999999999999999988764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-36 Score=344.25 Aligned_cols=257 Identities=21% Similarity=0.323 Sum_probs=198.4
Q ss_pred CCCCCceeeeeCCeEEEEEEEC-CCcEEEEEEeccCC---hhcHHHHHHHHHHHHccCCCCcceEEEEEEeCCeEEEEEE
Q 002158 626 YFSSSTQVGQGGYGKVYKGILS-DNTTVAIKRAEEGS---LQGQNEFLTEIKLLSRLHHRNLVSLLGYCDEEGEQMLVYE 701 (958)
Q Consensus 626 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E 701 (958)
.|...+.||+|+||+||+|+.. +++.||+|++.... ......+.+|++++++++|+||+++++++.+++..++|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E 81 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD 81 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEe
Confidence 5778899999999999999975 68899999987532 2234568899999999999999999999999999999999
Q ss_pred ecCCCCHHHHhccCCCCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEecCCCCeEEeeeeeecccccCCC
Q 002158 702 FVPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSRLAPVLDD 781 (958)
Q Consensus 702 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~ 781 (958)
|+++|+|.+++.... .+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++.......
T Consensus 82 ~~~gg~L~~~l~~~~--~~~e~~~~~~~~qi~~al~~lH~~~---ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~~ 156 (382)
T cd05625 82 YIPGGDMMSLLIRMG--IFPEDLARFYIAELTCAVESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHD 156 (382)
T ss_pred CCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEEeECCCCcccccccc
Confidence 999999999997543 4788899999999999999999999 99999999999999999999999999754321100
Q ss_pred CC----------------------------------------CccceeeeeccCCCCccChhhhccCCCCCcchhhhHHH
Q 002158 782 EG----------------------------------------TMPTHVSTIVKGTPGYLDPEYFLTHKLTDKSDVYSLGV 821 (958)
Q Consensus 782 ~~----------------------------------------~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gv 821 (958)
.. ...........||+.|+|||++.+..++.++||||+||
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGv 236 (382)
T cd05625 157 SKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGV 236 (382)
T ss_pred ccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEechH
Confidence 00 00000112356999999999999999999999999999
Q ss_pred HHHHHHhCCCCCCCCchhHHHHHHHhhcCcchhhhcccCCCCChHHHHHHHHHHHHccccCCCCCCC---HHHHHHH
Q 002158 822 VLLELLTGMQPISHGKNIVREVNVARDSGMVFSIIDNRMGSYPSECVERFVTLALRCCHDKPEHRPS---MSDVVRE 895 (958)
Q Consensus 822 ~l~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs---~~evl~~ 895 (958)
++|||++|+.||.................. . .. ......+.+..+++.+++ .+|++|++ +++++++
T Consensus 237 il~elltG~~Pf~~~~~~~~~~~i~~~~~~-~-----~~-p~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~h 305 (382)
T cd05625 237 ILYEMLVGQPPFLAQTPLETQMKVINWQTS-L-----HI-PPQAKLSPEASDLIIKLC-RGPEDRLGKNGADEIKAH 305 (382)
T ss_pred HHHHHHhCCCCCCCCCHHHHHHHHHccCCC-c-----CC-CCcccCCHHHHHHHHHHc-cCHhHcCCCCCHHHHhcC
Confidence 999999999999765433222211110000 0 00 011234566777777765 59999987 8877754
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-36 Score=330.83 Aligned_cols=260 Identities=27% Similarity=0.447 Sum_probs=206.8
Q ss_pred HHcCCCCCceeeeeCCeEEEEEEEC------CCcEEEEEEeccCC-hhcHHHHHHHHHHHHccCCCCcceEEEEEEeCCe
Q 002158 623 ATAYFSSSTQVGQGGYGKVYKGILS------DNTTVAIKRAEEGS-LQGQNEFLTEIKLLSRLHHRNLVSLLGYCDEEGE 695 (958)
Q Consensus 623 ~~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~ 695 (958)
..++|++.+.||+|+||.||+|..+ .+..||+|.+.... .....++.+|+.++++++|+||+++++++...+.
T Consensus 4 ~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 83 (288)
T cd05061 4 SREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQP 83 (288)
T ss_pred cHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence 4668888999999999999999754 24589999886543 3334568899999999999999999999999999
Q ss_pred EEEEEEecCCCCHHHHhccCC--------CCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEecCCCCeEE
Q 002158 696 QMLVYEFVPNGTLRDWLSGRT--------KENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSNLNAKV 767 (958)
Q Consensus 696 ~~lV~E~~~~gsL~~~l~~~~--------~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~~~~kl 767 (958)
.++||||+++|+|.+++.... ....++..+..++.|++.||.|||+++ |+||||||+||++++++.++|
T Consensus 84 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dikp~nili~~~~~~~L 160 (288)
T cd05061 84 TLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKK---FVHRDLAARNCMVAHDFTVKI 160 (288)
T ss_pred cEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---CcCCCCChheEEEcCCCcEEE
Confidence 999999999999999996432 233567788999999999999999999 999999999999999999999
Q ss_pred eeeeeecccccCCCCCCccceeeeeccCCCCccChhhhccCCCCCcchhhhHHHHHHHHHh-CCCCCCCCchhHHHHHHH
Q 002158 768 ADFGLSRLAPVLDDEGTMPTHVSTIVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVLLELLT-GMQPISHGKNIVREVNVA 846 (958)
Q Consensus 768 ~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gv~l~ellt-G~~P~~~~~~~~~~~~~~ 846 (958)
+|||+++....... ........++..|+|||.+.+..++.++|||||||++|||++ |..||..... .......
T Consensus 161 ~Dfg~~~~~~~~~~-----~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~-~~~~~~~ 234 (288)
T cd05061 161 GDFGMTRDIYETDY-----YRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSN-EQVLKFV 234 (288)
T ss_pred CcCCcccccccccc-----ccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCH-HHHHHHH
Confidence 99999875432111 111112235678999999999899999999999999999999 7888864322 1111111
Q ss_pred hhcCcchhhhcccCCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhH
Q 002158 847 RDSGMVFSIIDNRMGSYPSECVERFVTLALRCCHDKPEHRPSMSDVVRELENIL 900 (958)
Q Consensus 847 ~~~~~~~~~i~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~ 900 (958)
.+......+..++..+.+++.+|++.+|++||++.++++.|++.+
T Consensus 235 ---------~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~ 279 (288)
T cd05061 235 ---------MDGGYLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDL 279 (288)
T ss_pred ---------HcCCCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhc
Confidence 111112234455688999999999999999999999999988754
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-36 Score=322.04 Aligned_cols=248 Identities=29% Similarity=0.472 Sum_probs=203.0
Q ss_pred cCCCCCceeeeeCCeEEEEEEECCCcEEEEEEeccCChhcHHHHHHHHHHHHccCCCCcceEEEEEE-eCCeEEEEEEec
Q 002158 625 AYFSSSTQVGQGGYGKVYKGILSDNTTVAIKRAEEGSLQGQNEFLTEIKLLSRLHHRNLVSLLGYCD-EEGEQMLVYEFV 703 (958)
Q Consensus 625 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~-~~~~~~lV~E~~ 703 (958)
.+|...+.||+|+||.||+|.. .+..||+|.+.... ..+.|.+|+.++++++|+|++++++++. .++..++||||+
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~-~~~~~~~k~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~ 82 (256)
T cd05082 6 KELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM 82 (256)
T ss_pred HhCeeeeeecccCCCeEEEEEE-cCCcEEEEEeCCCc--hHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEECC
Confidence 3677788999999999999987 47889999986533 3457899999999999999999999764 456789999999
Q ss_pred CCCCHHHHhccCCCCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEecCCCCeEEeeeeeecccccCCCCC
Q 002158 704 PNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSRLAPVLDDEG 783 (958)
Q Consensus 704 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 783 (958)
++++|.++++......+++..++.++.|++.||+|||+++ ++||||||+||++++++.+||+|||+++......
T Consensus 83 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~--- 156 (256)
T cd05082 83 AKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ--- 156 (256)
T ss_pred CCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeccccchheEEEcCCCcEEecCCccceeccccC---
Confidence 9999999998765556899999999999999999999999 9999999999999999999999999987542211
Q ss_pred CccceeeeeccCCCCccChhhhccCCCCCcchhhhHHHHHHHHHh-CCCCCCCCchhHHHHHHHhhcCcchhhhcccCCC
Q 002158 784 TMPTHVSTIVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVLLELLT-GMQPISHGKNIVREVNVARDSGMVFSIIDNRMGS 862 (958)
Q Consensus 784 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gv~l~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~ 862 (958)
....++..|+|||++.+..++.++||||||+++|||++ |+.||.... .......... + ....
T Consensus 157 -------~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~-~~~~~~~~~~-~--------~~~~ 219 (256)
T cd05082 157 -------DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIP-LKDVVPRVEK-G--------YKMD 219 (256)
T ss_pred -------CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCC-HHHHHHHHhc-C--------CCCC
Confidence 12234567999999998899999999999999999998 999986432 2221111111 0 1122
Q ss_pred CChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 002158 863 YPSECVERFVTLALRCCHDKPEHRPSMSDVVRELEN 898 (958)
Q Consensus 863 ~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 898 (958)
.+..++..+.+++.+||+.+|++||+++++++.|++
T Consensus 220 ~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 255 (256)
T cd05082 220 APDGCPPVVYDVMKQCWHLDAATRPSFLQLREQLEH 255 (256)
T ss_pred CCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHhc
Confidence 344567889999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-36 Score=322.01 Aligned_cols=250 Identities=28% Similarity=0.450 Sum_probs=203.8
Q ss_pred ceeeeeCCeEEEEEEECC--C--cEEEEEEeccCCh-hcHHHHHHHHHHHHccCCCCcceEEEEEEeCCeEEEEEEecCC
Q 002158 631 TQVGQGGYGKVYKGILSD--N--TTVAIKRAEEGSL-QGQNEFLTEIKLLSRLHHRNLVSLLGYCDEEGEQMLVYEFVPN 705 (958)
Q Consensus 631 ~~lg~G~~g~Vy~~~~~~--~--~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E~~~~ 705 (958)
+.||+|++|.||+|.+.+ + ..||||.+..... ...++|.+|++++++++|+||+++++++.. ...++||||+++
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~ 79 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPL 79 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCC
Confidence 368999999999999753 3 3699999987665 556789999999999999999999999988 889999999999
Q ss_pred CCHHHHhccCCCCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEecCCCCeEEeeeeeecccccCCCCCCc
Q 002158 706 GTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSRLAPVLDDEGTM 785 (958)
Q Consensus 706 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~ 785 (958)
++|.+++.......+++..+..++.|++.||+|||+.+ ++||||||+||+++.++.+||+|||+++........
T Consensus 80 ~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~--- 153 (257)
T cd05040 80 GSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKR---FIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDH--- 153 (257)
T ss_pred CcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhCC---ccccccCcccEEEecCCEEEeccccccccccccccc---
Confidence 99999997654345899999999999999999999998 999999999999999999999999999865432211
Q ss_pred cceeeeeccCCCCccChhhhccCCCCCcchhhhHHHHHHHHHh-CCCCCCCCchhHHHHHHHhhcCcchhhhcccCCCCC
Q 002158 786 PTHVSTIVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVLLELLT-GMQPISHGKNIVREVNVARDSGMVFSIIDNRMGSYP 864 (958)
Q Consensus 786 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gv~l~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~ 864 (958)
........++..|+|||++.+..++.++||||||+++|||++ |+.||....... ........ ......+
T Consensus 154 -~~~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~-~~~~~~~~--------~~~~~~~ 223 (257)
T cd05040 154 -YVMEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQ-ILKKIDKE--------GERLERP 223 (257)
T ss_pred -eecccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHH-HHHHHHhc--------CCcCCCC
Confidence 111123457889999999998899999999999999999999 999996543322 11111110 0111223
Q ss_pred hHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 002158 865 SECVERFVTLALRCCHDKPEHRPSMSDVVRELE 897 (958)
Q Consensus 865 ~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 897 (958)
...+..+.+++.+||+.+|++||+++++++.|.
T Consensus 224 ~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 256 (257)
T cd05040 224 EACPQDIYNVMLQCWAHNPADRPTFAALREFLP 256 (257)
T ss_pred ccCCHHHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence 456788999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-36 Score=331.13 Aligned_cols=258 Identities=31% Similarity=0.489 Sum_probs=205.0
Q ss_pred cCCCCCceeeeeCCeEEEEEEEC-CCc--EEEEEEeccC-ChhcHHHHHHHHHHHHcc-CCCCcceEEEEEEeCCeEEEE
Q 002158 625 AYFSSSTQVGQGGYGKVYKGILS-DNT--TVAIKRAEEG-SLQGQNEFLTEIKLLSRL-HHRNLVSLLGYCDEEGEQMLV 699 (958)
Q Consensus 625 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~--~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lV 699 (958)
++|+..+.||+|+||.||+|.++ ++. .+|+|.+... .......|.+|++++.++ +|+||+++++++..++..++|
T Consensus 7 ~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~lv 86 (303)
T cd05088 7 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 86 (303)
T ss_pred hhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceEE
Confidence 46777889999999999999975 444 4678877653 233456788999999999 899999999999999999999
Q ss_pred EEecCCCCHHHHhccCC--------------CCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEecCCCCe
Q 002158 700 YEFVPNGTLRDWLSGRT--------------KENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSNLNA 765 (958)
Q Consensus 700 ~E~~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~~~~ 765 (958)
|||+++++|.++++... ...+++.+++.++.|++.||+|||+.+ ++||||||+|||+++++.+
T Consensus 87 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g---i~H~dlkp~Nili~~~~~~ 163 (303)
T cd05088 87 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVA 163 (303)
T ss_pred EEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchheEEecCCCcE
Confidence 99999999999997432 235789999999999999999999999 9999999999999999999
Q ss_pred EEeeeeeecccccCCCCCCccceeeeeccCCCCccChhhhccCCCCCcchhhhHHHHHHHHHh-CCCCCCCCchhHHHHH
Q 002158 766 KVADFGLSRLAPVLDDEGTMPTHVSTIVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVLLELLT-GMQPISHGKNIVREVN 844 (958)
Q Consensus 766 kl~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gv~l~ellt-G~~P~~~~~~~~~~~~ 844 (958)
||+|||+++..... .......++..|+|||++.+..++.++|||||||++|||+| |..||...... ....
T Consensus 164 kl~dfg~~~~~~~~--------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~-~~~~ 234 (303)
T cd05088 164 KIADFGLSRGQEVY--------VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA-ELYE 234 (303)
T ss_pred EeCccccCcccchh--------hhcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChH-HHHH
Confidence 99999998632110 01111234668999999988889999999999999999998 99999643321 1111
Q ss_pred HHhhcCcchhhhcccCCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHhhC
Q 002158 845 VARDSGMVFSIIDNRMGSYPSECVERFVTLALRCCHDKPEHRPSMSDVVRELENILKMF 903 (958)
Q Consensus 845 ~~~~~~~~~~~i~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~ 903 (958)
.... ......+...+..+.+++.+||+.+|++||+++++++.|+++....
T Consensus 235 ~~~~---------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~~~~~ 284 (303)
T cd05088 235 KLPQ---------GYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEER 284 (303)
T ss_pred HHhc---------CCcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhh
Confidence 1110 1011223345678899999999999999999999999998876543
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-36 Score=326.78 Aligned_cols=256 Identities=28% Similarity=0.465 Sum_probs=204.7
Q ss_pred HcCCCCCceeeeeCCeEEEEEEECC------CcEEEEEEeccCC-hhcHHHHHHHHHHHHccCCCCcceEEEEEEeCCeE
Q 002158 624 TAYFSSSTQVGQGGYGKVYKGILSD------NTTVAIKRAEEGS-LQGQNEFLTEIKLLSRLHHRNLVSLLGYCDEEGEQ 696 (958)
Q Consensus 624 ~~~~~~~~~lg~G~~g~Vy~~~~~~------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~ 696 (958)
+++|...+.||+|+||.||+|.+.+ +..||+|.+.... ......|.+|+.++++++|+||+++++++.+.+..
T Consensus 5 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 84 (277)
T cd05036 5 RDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLPR 84 (277)
T ss_pred HHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCc
Confidence 4568888999999999999999753 5678999886543 33345799999999999999999999999999999
Q ss_pred EEEEEecCCCCHHHHhccCCC-----CCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEecCCC---CeEEe
Q 002158 697 MLVYEFVPNGTLRDWLSGRTK-----ENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSNL---NAKVA 768 (958)
Q Consensus 697 ~lV~E~~~~gsL~~~l~~~~~-----~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~~---~~kl~ 768 (958)
++||||+++++|.++++.... ..+++..+++++.|++.||+|||+.+ ++||||||+||+++.++ .+||+
T Consensus 85 ~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~nil~~~~~~~~~~kl~ 161 (277)
T cd05036 85 FILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENH---FIHRDIAARNCLLTCKGPGRVAKIA 161 (277)
T ss_pred EEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccchheEEEeccCCCcceEec
Confidence 999999999999999975431 25899999999999999999999999 99999999999998754 59999
Q ss_pred eeeeecccccCCCCCCccceeeeeccCCCCccChhhhccCCCCCcchhhhHHHHHHHHHh-CCCCCCCCchhHHHHHHHh
Q 002158 769 DFGLSRLAPVLDDEGTMPTHVSTIVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVLLELLT-GMQPISHGKNIVREVNVAR 847 (958)
Q Consensus 769 DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gv~l~ellt-G~~P~~~~~~~~~~~~~~~ 847 (958)
|||+++....... ........++..|+|||++.+..++.++|||||||++|||++ |..||...... .......
T Consensus 162 dfg~~~~~~~~~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~-~~~~~~~ 235 (277)
T cd05036 162 DFGMARDIYRASY-----YRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQ-EVMEFVT 235 (277)
T ss_pred cCccccccCCccc-----eecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHH-HHHHHHH
Confidence 9999986521110 001111223567999999999999999999999999999997 99999754321 1111111
Q ss_pred hcCcchhhhcccCCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 002158 848 DSGMVFSIIDNRMGSYPSECVERFVTLALRCCHDKPEHRPSMSDVVRELE 897 (958)
Q Consensus 848 ~~~~~~~~i~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 897 (958)
. ......+..++..+.+++.+|++.+|++||++.+++++|+
T Consensus 236 ~---------~~~~~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~ 276 (277)
T cd05036 236 G---------GGRLDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQ 276 (277)
T ss_pred c---------CCcCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhh
Confidence 1 1112334556788999999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=333.25 Aligned_cols=264 Identities=26% Similarity=0.514 Sum_probs=210.1
Q ss_pred HcCCCCCceeeeeCCeEEEEEEECC--------CcEEEEEEeccCC-hhcHHHHHHHHHHHHcc-CCCCcceEEEEEEeC
Q 002158 624 TAYFSSSTQVGQGGYGKVYKGILSD--------NTTVAIKRAEEGS-LQGQNEFLTEIKLLSRL-HHRNLVSLLGYCDEE 693 (958)
Q Consensus 624 ~~~~~~~~~lg~G~~g~Vy~~~~~~--------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~ 693 (958)
..+|.+.+.||+|+||.||+|.+.. +..||+|.++... ....+++.+|+++++++ +|+||+++++++..+
T Consensus 11 ~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~ 90 (334)
T cd05100 11 RTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 90 (334)
T ss_pred HhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEccC
Confidence 3467888999999999999997521 2368999887542 33456799999999999 799999999999999
Q ss_pred CeEEEEEEecCCCCHHHHhccCC--------------CCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEe
Q 002158 694 GEQMLVYEFVPNGTLRDWLSGRT--------------KENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILL 759 (958)
Q Consensus 694 ~~~~lV~E~~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl 759 (958)
+..++||||+++|+|.+++.... ...+++.+++.++.|++.||+|||+.+ |+||||||+||++
T Consensus 91 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g---ivH~dlkp~Nill 167 (334)
T cd05100 91 GPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQK---CIHRDLAARNVLV 167 (334)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC---eeccccccceEEE
Confidence 99999999999999999997532 234788999999999999999999999 9999999999999
Q ss_pred cCCCCeEEeeeeeecccccCCCCCCccceeeeeccCCCCccChhhhccCCCCCcchhhhHHHHHHHHHh-CCCCCCCCch
Q 002158 760 DSNLNAKVADFGLSRLAPVLDDEGTMPTHVSTIVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVLLELLT-GMQPISHGKN 838 (958)
Q Consensus 760 ~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gv~l~ellt-G~~P~~~~~~ 838 (958)
+.++.+||+|||+++....... ........++..|+|||++.+..++.++||||||+++|||++ |..||....
T Consensus 168 ~~~~~~kL~Dfg~~~~~~~~~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~- 241 (334)
T cd05100 168 TEDNVMKIADFGLARDVHNIDY-----YKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIP- 241 (334)
T ss_pred cCCCcEEECCcccceecccccc-----cccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCC-
Confidence 9999999999999875532111 011112234567999999999999999999999999999999 888886432
Q ss_pred hHHHHHHHhhcCcchhhhcccCCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHhhCCC
Q 002158 839 IVREVNVARDSGMVFSIIDNRMGSYPSECVERFVTLALRCCHDKPEHRPSMSDVVRELENILKMFPE 905 (958)
Q Consensus 839 ~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~~~ 905 (958)
.......... ......+..++..+.+++.+||+.+|++||++.|+++.|+++......
T Consensus 242 ~~~~~~~~~~---------~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~~~~~~ 299 (334)
T cd05100 242 VEELFKLLKE---------GHRMDKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVLTVTST 299 (334)
T ss_pred HHHHHHHHHc---------CCCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHhhhcCC
Confidence 2222221111 111223445667899999999999999999999999999998754443
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-36 Score=329.66 Aligned_cols=262 Identities=26% Similarity=0.530 Sum_probs=210.6
Q ss_pred HHcCCCCCceeeeeCCeEEEEEEEC--------CCcEEEEEEeccCC-hhcHHHHHHHHHHHHcc-CCCCcceEEEEEEe
Q 002158 623 ATAYFSSSTQVGQGGYGKVYKGILS--------DNTTVAIKRAEEGS-LQGQNEFLTEIKLLSRL-HHRNLVSLLGYCDE 692 (958)
Q Consensus 623 ~~~~~~~~~~lg~G~~g~Vy~~~~~--------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~ 692 (958)
...+|...+.||+|+||.||+|++. ++..||+|.+.... ....+++.+|+.+++.+ +||||+++++++..
T Consensus 13 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~ 92 (304)
T cd05101 13 SRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ 92 (304)
T ss_pred cHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEec
Confidence 3556778899999999999999741 24579999987542 34456789999999999 89999999999999
Q ss_pred CCeEEEEEEecCCCCHHHHhccCC--------------CCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceE
Q 002158 693 EGEQMLVYEFVPNGTLRDWLSGRT--------------KENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNIL 758 (958)
Q Consensus 693 ~~~~~lV~E~~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NIL 758 (958)
.+..++||||+++|+|.+++.... ...+++.++..++.|+++||+|||+.+ |+||||||+||+
T Consensus 93 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~g---ivH~dlkp~Nil 169 (304)
T cd05101 93 DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQK---CIHRDLAARNVL 169 (304)
T ss_pred CCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCC---eeecccccceEE
Confidence 999999999999999999997542 234788999999999999999999999 999999999999
Q ss_pred ecCCCCeEEeeeeeecccccCCCCCCccceeeeeccCCCCccChhhhccCCCCCcchhhhHHHHHHHHHh-CCCCCCCCc
Q 002158 759 LDSNLNAKVADFGLSRLAPVLDDEGTMPTHVSTIVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVLLELLT-GMQPISHGK 837 (958)
Q Consensus 759 l~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gv~l~ellt-G~~P~~~~~ 837 (958)
+++++.+||+|||+++........ .......++..|+|||++.+..++.++||||||+++|||++ |..||...
T Consensus 170 i~~~~~~kl~D~g~~~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~- 243 (304)
T cd05101 170 VTENNVMKIADFGLARDVNNIDYY-----KKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGI- 243 (304)
T ss_pred EcCCCcEEECCCccceeccccccc-----ccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccC-
Confidence 999999999999999865332211 11122346678999999998889999999999999999999 77887543
Q ss_pred hhHHHHHHHhhcCcchhhhcccCCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHhh
Q 002158 838 NIVREVNVARDSGMVFSIIDNRMGSYPSECVERFVTLALRCCHDKPEHRPSMSDVVRELENILKM 902 (958)
Q Consensus 838 ~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~ 902 (958)
............ .....+..++..+.+++.+||+.+|++||++.|+++.|+++...
T Consensus 244 ~~~~~~~~~~~~---------~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~~~~ 299 (304)
T cd05101 244 PVEELFKLLKEG---------HRMDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRILTL 299 (304)
T ss_pred CHHHHHHHHHcC---------CcCCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHHHHh
Confidence 222222222111 11123445678899999999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-36 Score=325.09 Aligned_cols=259 Identities=28% Similarity=0.444 Sum_probs=205.5
Q ss_pred HcCCCCCceeeeeCCeEEEEEEEC-CCc----EEEEEEeccC-ChhcHHHHHHHHHHHHccCCCCcceEEEEEEeCCeEE
Q 002158 624 TAYFSSSTQVGQGGYGKVYKGILS-DNT----TVAIKRAEEG-SLQGQNEFLTEIKLLSRLHHRNLVSLLGYCDEEGEQM 697 (958)
Q Consensus 624 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~----~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~ 697 (958)
.++|+..+.||+|+||+||+|.+. +++ .||+|++... .....+++.+|+.+++.++|+||+++++++... ..+
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~ 84 (279)
T cd05109 6 ETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLTS-TVQ 84 (279)
T ss_pred hhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcCC-CcE
Confidence 346778899999999999999864 444 4899998754 333456789999999999999999999999764 578
Q ss_pred EEEEecCCCCHHHHhccCCCCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEecCCCCeEEeeeeeecccc
Q 002158 698 LVYEFVPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSRLAP 777 (958)
Q Consensus 698 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~~~ 777 (958)
++|||+++|+|.++++... ..+++.+++.++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||+++...
T Consensus 85 l~~~~~~~g~l~~~l~~~~-~~~~~~~~~~~~~qi~~~L~~lH~~~---iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~~ 160 (279)
T cd05109 85 LVTQLMPYGCLLDYVRENK-DRIGSQDLLNWCVQIAKGMSYLEEVR---LVHRDLAARNVLVKSPNHVKITDFGLARLLD 160 (279)
T ss_pred EEEEcCCCCCHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccccceEEEcCCCcEEECCCCceeecc
Confidence 9999999999999997543 34899999999999999999999999 9999999999999999999999999998653
Q ss_pred cCCCCCCccceeeeeccCCCCccChhhhccCCCCCcchhhhHHHHHHHHHh-CCCCCCCCchhHHHHHHHhhcCcchhhh
Q 002158 778 VLDDEGTMPTHVSTIVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVLLELLT-GMQPISHGKNIVREVNVARDSGMVFSII 856 (958)
Q Consensus 778 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gv~l~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~i 856 (958)
..... .......++..|+|||...+..++.++|||||||++|||++ |..||....... ..... ..+
T Consensus 161 ~~~~~-----~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~-~~~~~-~~~------ 227 (279)
T cd05109 161 IDETE-----YHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPARE-IPDLL-EKG------ 227 (279)
T ss_pred cccce-----eecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHH-HHHHH-HCC------
Confidence 22111 11112235678999999999999999999999999999998 899986433211 11111 111
Q ss_pred cccCCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHhh
Q 002158 857 DNRMGSYPSECVERFVTLALRCCHDKPEHRPSMSDVVRELENILKM 902 (958)
Q Consensus 857 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~ 902 (958)
.....+..++..+.+++.+||+.||++||++.++++.|+.+...
T Consensus 228 --~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~~~~ 271 (279)
T cd05109 228 --ERLPQPPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRMARD 271 (279)
T ss_pred --CcCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhcC
Confidence 11122345667899999999999999999999999998877543
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-36 Score=323.64 Aligned_cols=257 Identities=28% Similarity=0.456 Sum_probs=206.3
Q ss_pred cCCCCCceeeeeCCeEEEEEEEC----CCcEEEEEEeccCC-hhcHHHHHHHHHHHHccCCCCcceEEEEEEeCCeEEEE
Q 002158 625 AYFSSSTQVGQGGYGKVYKGILS----DNTTVAIKRAEEGS-LQGQNEFLTEIKLLSRLHHRNLVSLLGYCDEEGEQMLV 699 (958)
Q Consensus 625 ~~~~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV 699 (958)
.+|...+.||+|+||.||+|.+. .+..||+|.++... ....+.|.+|+.++++++||||+++++++..++..++|
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 83 (267)
T cd05066 4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIV 83 (267)
T ss_pred HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEE
Confidence 46777899999999999999864 23479999987543 33456789999999999999999999999999999999
Q ss_pred EEecCCCCHHHHhccCCCCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEecCCCCeEEeeeeeecccccC
Q 002158 700 YEFVPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSRLAPVL 779 (958)
Q Consensus 700 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~~~~~ 779 (958)
|||+++++|.+++.... ..+++.++..++.|++.||+|||+.+ ++||||||+||+++.++.++|+|||+++.....
T Consensus 84 ~e~~~~~~L~~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~---i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~~ 159 (267)
T cd05066 84 TEYMENGSLDAFLRKHD-GQFTVIQLVGMLRGIASGMKYLSDMG---YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDD 159 (267)
T ss_pred EEcCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCC---EeehhhchhcEEECCCCeEEeCCCCcccccccc
Confidence 99999999999997543 34899999999999999999999999 999999999999999999999999999865322
Q ss_pred CCCCCccceeeeeccCCCCccChhhhccCCCCCcchhhhHHHHHHHHHh-CCCCCCCCchhHHHHHHHhhcCcchhhhcc
Q 002158 780 DDEGTMPTHVSTIVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVLLELLT-GMQPISHGKNIVREVNVARDSGMVFSIIDN 858 (958)
Q Consensus 780 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gv~l~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~i~~ 858 (958)
... ........++..|+|||++.+..++.++||||||+++||+++ |..||...... .......+ .
T Consensus 160 ~~~----~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~-~~~~~~~~---------~ 225 (267)
T cd05066 160 PEA----AYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQ-DVIKAIEE---------G 225 (267)
T ss_pred cce----eeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHH-HHHHHHhC---------C
Confidence 110 111112224568999999998899999999999999999887 99999654322 11111111 1
Q ss_pred cCCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHh
Q 002158 859 RMGSYPSECVERFVTLALRCCHDKPEHRPSMSDVVRELENI 899 (958)
Q Consensus 859 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 899 (958)
.....+..++..+.+++.+||+.+|.+||++.++++.|+++
T Consensus 226 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 266 (267)
T cd05066 226 YRLPAPMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDKL 266 (267)
T ss_pred CcCCCCCCCCHHHHHHHHHHcccCchhCCCHHHHHHHHHhh
Confidence 01122334567889999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-36 Score=328.04 Aligned_cols=251 Identities=24% Similarity=0.360 Sum_probs=202.8
Q ss_pred CCCCceeeeeCCeEEEEEEEC-CCcEEEEEEeccCC---hhcHHHHHHHHHHHHccCCCCcceEEEEEEeCCeEEEEEEe
Q 002158 627 FSSSTQVGQGGYGKVYKGILS-DNTTVAIKRAEEGS---LQGQNEFLTEIKLLSRLHHRNLVSLLGYCDEEGEQMLVYEF 702 (958)
Q Consensus 627 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E~ 702 (958)
|+..+.||+|+||.||+|.+. +++.||||.+.... ....+.+.+|+.++++++|+|++++++.+...+..++||||
T Consensus 2 f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05630 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTL 81 (285)
T ss_pred ceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEEe
Confidence 566789999999999999976 68899999886532 22234578899999999999999999999999999999999
Q ss_pred cCCCCHHHHhccCCCCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEecCCCCeEEeeeeeecccccCCCC
Q 002158 703 VPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSRLAPVLDDE 782 (958)
Q Consensus 703 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~ 782 (958)
+++++|.+++.......+++..+..++.|++.||.|||+.+ |+||||||+||++++++.++|+|||++.......
T Consensus 82 ~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~-- 156 (285)
T cd05630 82 MNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQER---IVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ-- 156 (285)
T ss_pred cCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHEEECCCCCEEEeeccceeecCCCc--
Confidence 99999999997655556899999999999999999999998 9999999999999999999999999987542111
Q ss_pred CCccceeeeeccCCCCccChhhhccCCCCCcchhhhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcCcchhhhcccCCC
Q 002158 783 GTMPTHVSTIVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVLLELLTGMQPISHGKNIVREVNVARDSGMVFSIIDNRMGS 862 (958)
Q Consensus 783 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gv~l~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~ 862 (958)
......|+..|+|||++.+..++.++||||||+++|||++|+.||............. .........
T Consensus 157 ------~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~~-------~~~~~~~~~ 223 (285)
T cd05630 157 ------TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVE-------RLVKEVQEE 223 (285)
T ss_pred ------cccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchHHHHH-------hhhhhhhhh
Confidence 1123468999999999999999999999999999999999999997543211110000 000001112
Q ss_pred CChHHHHHHHHHHHHccccCCCCCCC-----HHHHHHH
Q 002158 863 YPSECVERFVTLALRCCHDKPEHRPS-----MSDVVRE 895 (958)
Q Consensus 863 ~~~~~~~~l~~li~~cl~~dP~~RPs-----~~evl~~ 895 (958)
.+...+..+.+++.+||+.||++||+ ++|++++
T Consensus 224 ~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~h 261 (285)
T cd05630 224 YSEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKEH 261 (285)
T ss_pred cCccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHcC
Confidence 23445677899999999999999999 7888864
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-36 Score=326.11 Aligned_cols=253 Identities=26% Similarity=0.424 Sum_probs=203.0
Q ss_pred HHcCCCCCceeeeeCCeEEEEEEEC-CCcEEEEEEeccCChhcHHHHHHHHHHHHcc-CCCCcceEEEEEEeC------C
Q 002158 623 ATAYFSSSTQVGQGGYGKVYKGILS-DNTTVAIKRAEEGSLQGQNEFLTEIKLLSRL-HHRNLVSLLGYCDEE------G 694 (958)
Q Consensus 623 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~------~ 694 (958)
++..|+..+.||+|+||+||+|.+. +++.||+|++.... .....+.+|+.+++++ +|+||+++++++... .
T Consensus 4 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~ 82 (272)
T cd06637 4 PAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDD 82 (272)
T ss_pred hhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCC-ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCCc
Confidence 5567788889999999999999976 68899999986543 3445788999999999 799999999998653 4
Q ss_pred eEEEEEEecCCCCHHHHhccCCCCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEecCCCCeEEeeeeeec
Q 002158 695 EQMLVYEFVPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSR 774 (958)
Q Consensus 695 ~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~ 774 (958)
..++||||+++++|.+++.......+++..+..++.|++.|++|||+++ |+||||||+||++++++.++|+|||+++
T Consensus 83 ~~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~---ivh~dl~~~nili~~~~~~~l~Dfg~~~ 159 (272)
T cd06637 83 QLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHK---VIHRDIKGQNVLLTENAEVKLVDFGVSA 159 (272)
T ss_pred EEEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHEEECCCCCEEEccCCCce
Confidence 6899999999999999998655556899999999999999999999998 9999999999999999999999999987
Q ss_pred ccccCCCCCCccceeeeeccCCCCccChhhhc-----cCCCCCcchhhhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhc
Q 002158 775 LAPVLDDEGTMPTHVSTIVKGTPGYLDPEYFL-----THKLTDKSDVYSLGVVLLELLTGMQPISHGKNIVREVNVARDS 849 (958)
Q Consensus 775 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DV~S~Gv~l~elltG~~P~~~~~~~~~~~~~~~~~ 849 (958)
...... .......|+..|+|||++. ...++.++|||||||++|||++|..||...............
T Consensus 160 ~~~~~~-------~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~~~~~~~- 231 (272)
T cd06637 160 QLDRTV-------GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRN- 231 (272)
T ss_pred eccccc-------ccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhcC-
Confidence 542211 1123356899999999986 335788999999999999999999999754432222211110
Q ss_pred CcchhhhcccCCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 002158 850 GMVFSIIDNRMGSYPSECVERFVTLALRCCHDKPEHRPSMSDVVRE 895 (958)
Q Consensus 850 ~~~~~~i~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 895 (958)
......+..++..+.+++.+||..+|.+||++++++++
T Consensus 232 --------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~ 269 (272)
T cd06637 232 --------PAPRLKSKKWSKKFQSFIESCLVKNHSQRPTTEQLMKH 269 (272)
T ss_pred --------CCCCCCCCCcCHHHHHHHHHHcCCChhhCCCHHHHhhC
Confidence 01111123456788999999999999999999999863
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=319.01 Aligned_cols=247 Identities=31% Similarity=0.530 Sum_probs=200.9
Q ss_pred ceeeeeCCeEEEEEEECCCcEEEEEEeccCCh-hcHHHHHHHHHHHHccCCCCcceEEEEEEeCCeEEEEEEecCCCCHH
Q 002158 631 TQVGQGGYGKVYKGILSDNTTVAIKRAEEGSL-QGQNEFLTEIKLLSRLHHRNLVSLLGYCDEEGEQMLVYEFVPNGTLR 709 (958)
Q Consensus 631 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E~~~~gsL~ 709 (958)
+.||+|+||.||+|..++++.||+|.+..... .....|.+|++++++++||||+++++++...+..++||||+++++|.
T Consensus 1 ~~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 80 (250)
T cd05085 1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFL 80 (250)
T ss_pred CccCCCCCceEEEEEecCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcHH
Confidence 36899999999999988899999999876543 23456899999999999999999999999999999999999999999
Q ss_pred HHhccCCCCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEecCCCCeEEeeeeeecccccCCCCCCcccee
Q 002158 710 DWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSRLAPVLDDEGTMPTHV 789 (958)
Q Consensus 710 ~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~ 789 (958)
+++.... ..+++.++..++.|++.||.|+|+.+ ++||||||+||+++.++.+||+|||++....... ...
T Consensus 81 ~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~---~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~------~~~ 150 (250)
T cd05085 81 SFLRKKK-DELKTKQLVKFALDAAAGMAYLESKN---CIHRDLAARNCLVGENNVLKISDFGMSRQEDDGI------YSS 150 (250)
T ss_pred HHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccChheEEEcCCCeEEECCCccceeccccc------ccc
Confidence 9997543 34889999999999999999999999 9999999999999999999999999987432111 001
Q ss_pred eeeccCCCCccChhhhccCCCCCcchhhhHHHHHHHHHh-CCCCCCCCchhHHHHHHHhhcCcchhhhcccCCCCChHHH
Q 002158 790 STIVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVLLELLT-GMQPISHGKNIVREVNVARDSGMVFSIIDNRMGSYPSECV 868 (958)
Q Consensus 790 ~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gv~l~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~ 868 (958)
.....++..|+|||++.+..++.++||||||+++||+++ |..||........ ..... .. .....+..++
T Consensus 151 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~~-~~~~~-~~--------~~~~~~~~~~ 220 (250)
T cd05085 151 SGLKQIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQA-REQVE-KG--------YRMSCPQKCP 220 (250)
T ss_pred CCCCCCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHHH-HHHHH-cC--------CCCCCCCCCC
Confidence 112234678999999998889999999999999999999 9999965432211 11111 11 1112244567
Q ss_pred HHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 002158 869 ERFVTLALRCCHDKPEHRPSMSDVVRELE 897 (958)
Q Consensus 869 ~~l~~li~~cl~~dP~~RPs~~evl~~L~ 897 (958)
..+.+++.+|++.+|++||++.|+++.|.
T Consensus 221 ~~~~~li~~~l~~~p~~Rp~~~~l~~~l~ 249 (250)
T cd05085 221 DDVYKVMQRCWDYKPENRPKFSELQKELA 249 (250)
T ss_pred HHHHHHHHHHcccCcccCCCHHHHHHHhc
Confidence 88999999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=320.41 Aligned_cols=257 Identities=26% Similarity=0.408 Sum_probs=210.4
Q ss_pred cCCCCCceeeeeCCeEEEEEEEC-CCcEEEEEEeccC---ChhcHHHHHHHHHHHHccCCCCcceEEEEEEeCCeEEEEE
Q 002158 625 AYFSSSTQVGQGGYGKVYKGILS-DNTTVAIKRAEEG---SLQGQNEFLTEIKLLSRLHHRNLVSLLGYCDEEGEQMLVY 700 (958)
Q Consensus 625 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~ 700 (958)
++|+..+.||+|+||.||+|... +|+.||+|.++.. .....+++.+|++++++++|+|++++++++...+..++||
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 81 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL 81 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence 46888899999999999999987 7899999988632 2333567899999999999999999999999999999999
Q ss_pred EecCCCCHHHHhccC--CCCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEecCCCCeEEeeeeeeccccc
Q 002158 701 EFVPNGTLRDWLSGR--TKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSRLAPV 778 (958)
Q Consensus 701 E~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~~~~ 778 (958)
||+++++|.+++... ....+++.++..++.|+++||+|||+.+ ++||||||+||+++.++.++|+|||+++....
T Consensus 82 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~ 158 (267)
T cd08224 82 ELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKR---IMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred ecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCC---EecCCcChhhEEECCCCcEEEeccceeeeccC
Confidence 999999999998642 2345899999999999999999999999 99999999999999999999999999875432
Q ss_pred CCCCCCccceeeeeccCCCCccChhhhccCCCCCcchhhhHHHHHHHHHhCCCCCCCCch-hHHHHHHHhhcCcchhhhc
Q 002158 779 LDDEGTMPTHVSTIVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVLLELLTGMQPISHGKN-IVREVNVARDSGMVFSIID 857 (958)
Q Consensus 779 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gv~l~elltG~~P~~~~~~-~~~~~~~~~~~~~~~~~i~ 857 (958)
... ......|+..|+|||.+.+..++.++||||||+++|||++|+.||..... ......... .
T Consensus 159 ~~~-------~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~---------~ 222 (267)
T cd08224 159 KTT-------AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIE---------K 222 (267)
T ss_pred CCc-------ccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCccHHHHHhhhh---------c
Confidence 111 11234588899999999988899999999999999999999999964432 111111110 1
Q ss_pred ccCCCCCh-HHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhH
Q 002158 858 NRMGSYPS-ECVERFVTLALRCCHDKPEHRPSMSDVVRELENIL 900 (958)
Q Consensus 858 ~~~~~~~~-~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~ 900 (958)
......+. ..+..+.+++.+||..+|++||++.+|++.|+++.
T Consensus 223 ~~~~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~~ 266 (267)
T cd08224 223 CDYPPLPADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEMH 266 (267)
T ss_pred CCCCCCChhhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHhc
Confidence 11122233 56678999999999999999999999999998763
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-36 Score=320.13 Aligned_cols=250 Identities=24% Similarity=0.360 Sum_probs=206.9
Q ss_pred CCCCCceeeeeCCeEEEEEEEC-CCcEEEEEEeccC-ChhcHHHHHHHHHHHHccCCCCcceEEEEEEeCCeEEEEEEec
Q 002158 626 YFSSSTQVGQGGYGKVYKGILS-DNTTVAIKRAEEG-SLQGQNEFLTEIKLLSRLHHRNLVSLLGYCDEEGEQMLVYEFV 703 (958)
Q Consensus 626 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E~~ 703 (958)
+|+..+.||+|+||.||++.+. +++.||+|.++.. .....+.+.+|+.+++.++|+||+++++++..++..++||||+
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYC 80 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeC
Confidence 3677889999999999999976 6889999988643 3344567889999999999999999999999999999999999
Q ss_pred CCCCHHHHhccCCCCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEecCCCCeEEeeeeeecccccCCCCC
Q 002158 704 PNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSRLAPVLDDEG 783 (958)
Q Consensus 704 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 783 (958)
++++|.+++.......++...+..++.|++.||.|||+.+ |+|+||||+||++++++.++++|||.++......
T Consensus 81 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~--- 154 (255)
T cd08219 81 DGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKR---VLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPG--- 154 (255)
T ss_pred CCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCcceEEECCCCcEEEcccCcceeecccc---
Confidence 9999999997655556899999999999999999999999 9999999999999999999999999987553211
Q ss_pred CccceeeeeccCCCCccChhhhccCCCCCcchhhhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcCcchhhhcccCCCC
Q 002158 784 TMPTHVSTIVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVLLELLTGMQPISHGKNIVREVNVARDSGMVFSIIDNRMGSY 863 (958)
Q Consensus 784 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gv~l~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~ 863 (958)
.......|+..|+|||++.+..++.++||||||+++|+|++|..||..... ........ .......
T Consensus 155 ----~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~-~~~~~~~~---------~~~~~~~ 220 (255)
T cd08219 155 ----AYACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSW-KNLILKVC---------QGSYKPL 220 (255)
T ss_pred ----cccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCH-HHHHHHHh---------cCCCCCC
Confidence 112235688999999999988899999999999999999999999975332 11111111 1111223
Q ss_pred ChHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 002158 864 PSECVERFVTLALRCCHDKPEHRPSMSDVVRE 895 (958)
Q Consensus 864 ~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 895 (958)
+...+..+.+++.+||+.||++||++.+++..
T Consensus 221 ~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 252 (255)
T cd08219 221 PSHYSYELRSLIKQMFKRNPRSRPSATTILSR 252 (255)
T ss_pred CcccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence 44566789999999999999999999999863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-36 Score=334.49 Aligned_cols=242 Identities=23% Similarity=0.301 Sum_probs=192.9
Q ss_pred ceeeeeCCeEEEEEEEC-CCcEEEEEEeccCC---hhcHHHHHHHHH-HHHccCCCCcceEEEEEEeCCeEEEEEEecCC
Q 002158 631 TQVGQGGYGKVYKGILS-DNTTVAIKRAEEGS---LQGQNEFLTEIK-LLSRLHHRNLVSLLGYCDEEGEQMLVYEFVPN 705 (958)
Q Consensus 631 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~-~l~~l~H~niv~l~~~~~~~~~~~lV~E~~~~ 705 (958)
+.||+|+||+||+|++. +++.||+|++.... ......+..|.. +++.++|+||+++++++...+..++||||+++
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING 80 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence 36999999999999986 57889999986532 122234445544 56888999999999999999999999999999
Q ss_pred CCHHHHhccCCCCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEecCCCCeEEeeeeeecccccCCCCCCc
Q 002158 706 GTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSRLAPVLDDEGTM 785 (958)
Q Consensus 706 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~ 785 (958)
|+|.+++.... .+....+..++.|+++||+|||+.+ |+||||||+|||++.++.+||+|||+++......
T Consensus 81 ~~L~~~~~~~~--~~~~~~~~~~~~qi~~~L~~lH~~g---iiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~----- 150 (325)
T cd05602 81 GELFYHLQRER--CFLEPRARFYAAEIASALGYLHSLN---IVYRDLKPENILLDSQGHIVLTDFGLCKENIEHN----- 150 (325)
T ss_pred CcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEEccCCCCcccccCC-----
Confidence 99999997543 3788888999999999999999999 9999999999999999999999999987432111
Q ss_pred cceeeeeccCCCCccChhhhccCCCCCcchhhhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcCcchhhhcccCCCCCh
Q 002158 786 PTHVSTIVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVLLELLTGMQPISHGKNIVREVNVARDSGMVFSIIDNRMGSYPS 865 (958)
Q Consensus 786 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gv~l~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~ 865 (958)
.......||+.|+|||++.+..++.++||||+||++|||++|+.||....... ....... .....+.
T Consensus 151 --~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~-~~~~i~~----------~~~~~~~ 217 (325)
T cd05602 151 --GTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAE-MYDNILN----------KPLQLKP 217 (325)
T ss_pred --CCcccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHHH-HHHHHHh----------CCcCCCC
Confidence 11234569999999999999999999999999999999999999997544322 1111111 1112234
Q ss_pred HHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 002158 866 ECVERFVTLALRCCHDKPEHRPSMSDVVRE 895 (958)
Q Consensus 866 ~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 895 (958)
..+..+.+++.+|++.||.+||++.+.+..
T Consensus 218 ~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ 247 (325)
T cd05602 218 NITNSARHLLEGLLQKDRTKRLGAKDDFME 247 (325)
T ss_pred CCCHHHHHHHHHHcccCHHHCCCCCCCHHH
Confidence 566788999999999999999998754443
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=329.70 Aligned_cols=255 Identities=24% Similarity=0.268 Sum_probs=198.0
Q ss_pred cCCCCCceeeeeCCeEEEEEEEC-CCcEEEEEEeccC---ChhcHHHHHHHHHHHHccCCCCcceEEEEEEeCCeEEEEE
Q 002158 625 AYFSSSTQVGQGGYGKVYKGILS-DNTTVAIKRAEEG---SLQGQNEFLTEIKLLSRLHHRNLVSLLGYCDEEGEQMLVY 700 (958)
Q Consensus 625 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~ 700 (958)
++|+..+.||+|+||+||++... +++.||+|++... .....+.|.+|+.+++.++|+||+++++++.+++..++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM 80 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence 36788899999999999999976 5899999998642 2223456889999999999999999999999999999999
Q ss_pred EecCCCCHHHHhccCCCCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEecCCCCeEEeeeeeecccccCC
Q 002158 701 EFVPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSRLAPVLD 780 (958)
Q Consensus 701 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~ 780 (958)
||+++|+|.+++.... ..+++..+..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+++......
T Consensus 81 e~~~g~~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 156 (331)
T cd05597 81 DYYVGGDLLTLLSKFE-DRLPEDMARFYLAEMVLAIDSVHQLG---YVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADG 156 (331)
T ss_pred ecCCCCcHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCC---eEECCCCHHHEEECCCCCEEEEECCceeecCCCC
Confidence 9999999999997532 34889999999999999999999999 9999999999999999999999999987543211
Q ss_pred CCCCccceeeeeccCCCCccChhhhcc-----CCCCCcchhhhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcCcchhh
Q 002158 781 DEGTMPTHVSTIVKGTPGYLDPEYFLT-----HKLTDKSDVYSLGVVLLELLTGMQPISHGKNIVREVNVARDSGMVFSI 855 (958)
Q Consensus 781 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DV~S~Gv~l~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~ 855 (958)
........||+.|+|||++.. ..++.++|||||||++|||++|+.||........ ............
T Consensus 157 ------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~-~~~i~~~~~~~~- 228 (331)
T cd05597 157 ------TVQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVET-YGKIMNHKEHFQ- 228 (331)
T ss_pred ------CccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHHH-HHHHHcCCCccc-
Confidence 111123469999999999973 4577899999999999999999999975432221 111111111010
Q ss_pred hcccCCCCChHHHHHHHHHHHHcccc--CCCCCCCHHHHHHH
Q 002158 856 IDNRMGSYPSECVERFVTLALRCCHD--KPEHRPSMSDVVRE 895 (958)
Q Consensus 856 i~~~~~~~~~~~~~~l~~li~~cl~~--dP~~RPs~~evl~~ 895 (958)
........+..+.+++.+|+.. ++..||++++++++
T Consensus 229 ----~~~~~~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~h 266 (331)
T cd05597 229 ----FPPDVTDVSEEAKDLIRRLICSPETRLGRNGLQDFKDH 266 (331)
T ss_pred ----CCCccCCCCHHHHHHHHHHccCcccccCCCCHHHHhcC
Confidence 1111223566788888887754 33447899999876
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-36 Score=327.76 Aligned_cols=256 Identities=28% Similarity=0.468 Sum_probs=207.0
Q ss_pred HcCCCCCceeeeeCCeEEEEEEECC------CcEEEEEEeccCC-hhcHHHHHHHHHHHHccCCCCcceEEEEEEeCCeE
Q 002158 624 TAYFSSSTQVGQGGYGKVYKGILSD------NTTVAIKRAEEGS-LQGQNEFLTEIKLLSRLHHRNLVSLLGYCDEEGEQ 696 (958)
Q Consensus 624 ~~~~~~~~~lg~G~~g~Vy~~~~~~------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~ 696 (958)
.++|...+.||+|+||.||+|.+++ +..||+|.+.... ......+.+|+.+++.++|+||+++++++......
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~ 84 (277)
T cd05032 5 REKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQPT 84 (277)
T ss_pred hHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCCc
Confidence 4577888999999999999998742 3689999987543 34455789999999999999999999999999999
Q ss_pred EEEEEecCCCCHHHHhccCC--------CCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEecCCCCeEEe
Q 002158 697 MLVYEFVPNGTLRDWLSGRT--------KENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSNLNAKVA 768 (958)
Q Consensus 697 ~lV~E~~~~gsL~~~l~~~~--------~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~~~~kl~ 768 (958)
++||||+++|+|.+++.... ...+++..++.++.|++.||.|||+.+ ++||||||+||+++.++.+||+
T Consensus 85 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~di~p~nill~~~~~~kl~ 161 (277)
T cd05032 85 LVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKK---FVHRDLAARNCMVAEDLTVKIG 161 (277)
T ss_pred EEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccChheEEEcCCCCEEEC
Confidence 99999999999999996532 123788899999999999999999998 9999999999999999999999
Q ss_pred eeeeecccccCCCCCCccceeeeeccCCCCccChhhhccCCCCCcchhhhHHHHHHHHHh-CCCCCCCCchhHHHHHHHh
Q 002158 769 DFGLSRLAPVLDDEGTMPTHVSTIVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVLLELLT-GMQPISHGKNIVREVNVAR 847 (958)
Q Consensus 769 DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gv~l~ellt-G~~P~~~~~~~~~~~~~~~ 847 (958)
|||+++....... ........++..|+|||.+.+..++.++|||||||++||+++ |..||..... ........
T Consensus 162 dfg~~~~~~~~~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~-~~~~~~~~ 235 (277)
T cd05032 162 DFGMTRDIYETDY-----YRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSN-EEVLKFVI 235 (277)
T ss_pred CcccchhhccCcc-----cccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCH-HHHHHHHh
Confidence 9999875432111 011122346788999999998889999999999999999998 8999864332 12111111
Q ss_pred hcCcchhhhcccCCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 002158 848 DSGMVFSIIDNRMGSYPSECVERFVTLALRCCHDKPEHRPSMSDVVRELE 897 (958)
Q Consensus 848 ~~~~~~~~i~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 897 (958)
.......+..++..+.+++.+||+.+|++||++.++++.|+
T Consensus 236 ---------~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~ 276 (277)
T cd05032 236 ---------DGGHLDLPENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLK 276 (277)
T ss_pred ---------cCCCCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHhc
Confidence 11122334556788999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-36 Score=323.91 Aligned_cols=258 Identities=29% Similarity=0.452 Sum_probs=205.1
Q ss_pred CCCCCceeeeeCCeEEEEEEECC-C---cEEEEEEeccC-ChhcHHHHHHHHHHHHccCCCCcceEEEEEEeCCeEEEEE
Q 002158 626 YFSSSTQVGQGGYGKVYKGILSD-N---TTVAIKRAEEG-SLQGQNEFLTEIKLLSRLHHRNLVSLLGYCDEEGEQMLVY 700 (958)
Q Consensus 626 ~~~~~~~lg~G~~g~Vy~~~~~~-~---~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~ 700 (958)
.|...+.||+|+||.||+|.+.. + ..||||.+... ......+|..|+.++++++||||+++++++..++..++||
T Consensus 5 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~ 84 (269)
T cd05065 5 CVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMIIT 84 (269)
T ss_pred HeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEEE
Confidence 45677899999999999999753 3 36999998764 3444568999999999999999999999999999999999
Q ss_pred EecCCCCHHHHhccCCCCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEecCCCCeEEeeeeeecccccCC
Q 002158 701 EFVPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSRLAPVLD 780 (958)
Q Consensus 701 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~ 780 (958)
||+++++|.+++.... ..+++.+++.++.|++.||+|||+.+ ++||||||+||+++.++.+||+|||+++......
T Consensus 85 e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~~l~~al~~lH~~g---~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~~ 160 (269)
T cd05065 85 EFMENGALDSFLRQND-GQFTVIQLVGMLRGIAAGMKYLSEMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDT 160 (269)
T ss_pred ecCCCCcHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccChheEEEcCCCcEEECCCccccccccCc
Confidence 9999999999997543 34899999999999999999999999 9999999999999999999999999987653322
Q ss_pred CCCCccceeeeeccCCCCccChhhhccCCCCCcchhhhHHHHHHHHHh-CCCCCCCCchhHHHHHHHhhcCcchhhhccc
Q 002158 781 DEGTMPTHVSTIVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVLLELLT-GMQPISHGKNIVREVNVARDSGMVFSIIDNR 859 (958)
Q Consensus 781 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gv~l~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~i~~~ 859 (958)
..... ........+..|+|||++.+..++.++||||||+++|||++ |..||....... ....... . .
T Consensus 161 ~~~~~--~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~~-~~~~i~~-~--------~ 228 (269)
T cd05065 161 SDPTY--TSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQD-VINAIEQ-D--------Y 228 (269)
T ss_pred ccccc--ccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHHH-HHHHHHc-C--------C
Confidence 11110 00111112457999999999999999999999999999987 999996543221 1111110 0 0
Q ss_pred CCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHh
Q 002158 860 MGSYPSECVERFVTLALRCCHDKPEHRPSMSDVVRELENI 899 (958)
Q Consensus 860 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 899 (958)
....+.+++..+.+++.+||+.+|++||+++++++.|+++
T Consensus 229 ~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 268 (269)
T cd05065 229 RLPPPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKM 268 (269)
T ss_pred cCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 1122345677889999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=322.01 Aligned_cols=255 Identities=27% Similarity=0.468 Sum_probs=206.4
Q ss_pred CCCCCceeeeeCCeEEEEEEECCCcEEEEEEeccCC------hhcHHHHHHHHHHHHccCCCCcceEEEEEEeCCeEEEE
Q 002158 626 YFSSSTQVGQGGYGKVYKGILSDNTTVAIKRAEEGS------LQGQNEFLTEIKLLSRLHHRNLVSLLGYCDEEGEQMLV 699 (958)
Q Consensus 626 ~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~------~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV 699 (958)
+|...+.||+|+||+||+|...+++.||||.+.... ......+.+|++++++++|+||+++++++.+.+..++|
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 80 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIF 80 (265)
T ss_pred CccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEE
Confidence 367788999999999999998889999999876432 12234688999999999999999999999999999999
Q ss_pred EEecCCCCHHHHhccCCCCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEecCCCCeEEeeeeeecccccC
Q 002158 700 YEFVPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSRLAPVL 779 (958)
Q Consensus 700 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~~~~~ 779 (958)
|||+++++|.+++.... .+++..+..++.|++.||+|||+.+ |+|+||||+||++++++.++|+|||+++.....
T Consensus 81 ~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~ 155 (265)
T cd06631 81 MEFVPGGSISSILNRFG--PLPEPVFCKYTKQILDGVAYLHNNC---VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWV 155 (265)
T ss_pred EecCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcCHHhEEECCCCeEEeccchhhHhhhhc
Confidence 99999999999996543 4789999999999999999999999 999999999999999999999999998765322
Q ss_pred CCCCCccceeeeeccCCCCccChhhhccCCCCCcchhhhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcCcchhhhccc
Q 002158 780 DDEGTMPTHVSTIVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVLLELLTGMQPISHGKNIVREVNVARDSGMVFSIIDNR 859 (958)
Q Consensus 780 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gv~l~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~i~~~ 859 (958)
...... ........|+..|+|||++.+..++.++||||||+++|||++|+.||................ ..
T Consensus 156 ~~~~~~-~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~--------~~ 226 (265)
T cd06631 156 GLHGTH-SNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYIGAHR--------GL 226 (265)
T ss_pred cccccc-cccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHHHHHHhhhcc--------CC
Confidence 111111 112233568999999999999889999999999999999999999997544332221111110 11
Q ss_pred CCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002158 860 MGSYPSECVERFVTLALRCCHDKPEHRPSMSDVVR 894 (958)
Q Consensus 860 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 894 (958)
....+...+..+.+++.+||+.+|++||++.++++
T Consensus 227 ~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~ 261 (265)
T cd06631 227 MPRLPDSFSAAAIDFVTSCLTRDQHERPSALQLLR 261 (265)
T ss_pred CCCCCCCCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 12334556788999999999999999999999886
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-36 Score=316.74 Aligned_cols=257 Identities=25% Similarity=0.314 Sum_probs=210.3
Q ss_pred CCCCceeeeeCCeEEEEEEECC-CcEEEEEEeccCChh---cHHHHHHHHHHHHccCCCCcceEEEEEEeCCeEEEEEEe
Q 002158 627 FSSSTQVGQGGYGKVYKGILSD-NTTVAIKRAEEGSLQ---GQNEFLTEIKLLSRLHHRNLVSLLGYCDEEGEQMLVYEF 702 (958)
Q Consensus 627 ~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E~ 702 (958)
|...+.||+|.-|+||.+..++ +..+|+|++.+.... ...+.+.|-+||+.++||.++.+|+.++.++..++||||
T Consensus 79 f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~mey 158 (459)
T KOG0610|consen 79 FRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLVMEY 158 (459)
T ss_pred HHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEEEec
Confidence 3445679999999999999874 689999999876433 345678899999999999999999999999999999999
Q ss_pred cCCCCHHHHhccCCCCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEecCCCCeEEeeeeeecccccCC--
Q 002158 703 VPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSRLAPVLD-- 780 (958)
Q Consensus 703 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~-- 780 (958)
|+||+|....+.+....+++..+..++..++-||+|||-.| ||.|||||+||||.++|.+.|+||.++.......
T Consensus 159 CpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHmlG---ivYRDLKPENILvredGHIMLsDFDLS~~~~~~Pt~ 235 (459)
T KOG0610|consen 159 CPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHMLG---IVYRDLKPENILVREDGHIMLSDFDLSLRCPVSPTL 235 (459)
T ss_pred CCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhhc---eeeccCCcceeEEecCCcEEeeeccccccCCCCCee
Confidence 99999999999988888999999999999999999999999 9999999999999999999999999985442100
Q ss_pred -----------------------------CCCC-----------------cc-ceeeeeccCCCCccChhhhccCCCCCc
Q 002158 781 -----------------------------DEGT-----------------MP-THVSTIVKGTPGYLDPEYFLTHKLTDK 813 (958)
Q Consensus 781 -----------------------------~~~~-----------------~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~ 813 (958)
.... .+ ...+..++||-.|+|||++.+...+.+
T Consensus 236 ~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~GHgsA 315 (459)
T KOG0610|consen 236 VKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEGHGSA 315 (459)
T ss_pred eccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCCCCch
Confidence 0000 00 112345789999999999999999999
Q ss_pred chhhhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcCcchhhhcccCCCCChHHHHHHHHHHHHccccCCCCCCC----H
Q 002158 814 SDVYSLGVVLLELLTGMQPISHGKNIVREVNVARDSGMVFSIIDNRMGSYPSECVERFVTLALRCCHDKPEHRPS----M 889 (958)
Q Consensus 814 ~DV~S~Gv~l~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs----~ 889 (958)
+|.|+|||++|||+.|.-||.+..+.....+...+.-. .+.. +..+..+.+||++.+.+||.+|-- +
T Consensus 316 VDWWtfGIflYEmLyG~TPFKG~~~~~Tl~NIv~~~l~--------Fp~~-~~vs~~akDLIr~LLvKdP~kRlg~~rGA 386 (459)
T KOG0610|consen 316 VDWWTFGIFLYEMLYGTTPFKGSNNKETLRNIVGQPLK--------FPEE-PEVSSAAKDLIRKLLVKDPSKRLGSKRGA 386 (459)
T ss_pred hhHHHHHHHHHHHHhCCCCcCCCCchhhHHHHhcCCCc--------CCCC-CcchhHHHHHHHHHhccChhhhhccccch
Confidence 99999999999999999999876554333222221111 1122 256678999999999999999988 7
Q ss_pred HHHHHH
Q 002158 890 SDVVRE 895 (958)
Q Consensus 890 ~evl~~ 895 (958)
+||-++
T Consensus 387 ~eIK~H 392 (459)
T KOG0610|consen 387 AEIKRH 392 (459)
T ss_pred HHhhcC
Confidence 777765
|
|
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-36 Score=331.72 Aligned_cols=264 Identities=27% Similarity=0.512 Sum_probs=209.8
Q ss_pred HHcCCCCCceeeeeCCeEEEEEEEC--------CCcEEEEEEeccCC-hhcHHHHHHHHHHHHcc-CCCCcceEEEEEEe
Q 002158 623 ATAYFSSSTQVGQGGYGKVYKGILS--------DNTTVAIKRAEEGS-LQGQNEFLTEIKLLSRL-HHRNLVSLLGYCDE 692 (958)
Q Consensus 623 ~~~~~~~~~~lg~G~~g~Vy~~~~~--------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~ 692 (958)
..++|.+.+.||+|+||.||+|... ....||+|.+.... .....++.+|+++++++ +||||+++++++..
T Consensus 10 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~ 89 (314)
T cd05099 10 PRDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQ 89 (314)
T ss_pred cHHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEcc
Confidence 3456778899999999999999752 24579999987542 33456788999999999 69999999999999
Q ss_pred CCeEEEEEEecCCCCHHHHhccCC--------------CCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceE
Q 002158 693 EGEQMLVYEFVPNGTLRDWLSGRT--------------KENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNIL 758 (958)
Q Consensus 693 ~~~~~lV~E~~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NIL 758 (958)
.+..++||||+++|+|.+++.... ...+++.++.+++.|++.||+|||+++ ++||||||+||+
T Consensus 90 ~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g---i~H~dlkp~Nil 166 (314)
T cd05099 90 EGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRR---CIHRDLAARNVL 166 (314)
T ss_pred CCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCC---eeeccccceeEE
Confidence 999999999999999999996532 234889999999999999999999999 999999999999
Q ss_pred ecCCCCeEEeeeeeecccccCCCCCCccceeeeeccCCCCccChhhhccCCCCCcchhhhHHHHHHHHHh-CCCCCCCCc
Q 002158 759 LDSNLNAKVADFGLSRLAPVLDDEGTMPTHVSTIVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVLLELLT-GMQPISHGK 837 (958)
Q Consensus 759 l~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gv~l~ellt-G~~P~~~~~ 837 (958)
+++++.+||+|||+++........ .......++..|+|||++.+..++.++||||||+++|||++ |..||....
T Consensus 167 l~~~~~~kL~Dfg~~~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~ 241 (314)
T cd05099 167 VTEDNVMKIADFGLARGVHDIDYY-----KKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIP 241 (314)
T ss_pred EcCCCcEEEccccccccccccccc-----cccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCC
Confidence 999999999999999765322111 01111234567999999999899999999999999999999 888886432
Q ss_pred hhHHHHHHHhhcCcchhhhcccCCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHhhCC
Q 002158 838 NIVREVNVARDSGMVFSIIDNRMGSYPSECVERFVTLALRCCHDKPEHRPSMSDVVRELENILKMFP 904 (958)
Q Consensus 838 ~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~~ 904 (958)
. ......... ......+..++..+.+++.+||+.+|++||++.++++.|+++.....
T Consensus 242 ~-~~~~~~~~~---------~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~~~~~ 298 (314)
T cd05099 242 V-EELFKLLRE---------GHRMDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVLAAVS 298 (314)
T ss_pred H-HHHHHHHHc---------CCCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHHhc
Confidence 2 121111111 11122344567789999999999999999999999999999876543
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=328.92 Aligned_cols=261 Identities=28% Similarity=0.527 Sum_probs=209.2
Q ss_pred HcCCCCCceeeeeCCeEEEEEEEC--------CCcEEEEEEeccCC-hhcHHHHHHHHHHHHcc-CCCCcceEEEEEEeC
Q 002158 624 TAYFSSSTQVGQGGYGKVYKGILS--------DNTTVAIKRAEEGS-LQGQNEFLTEIKLLSRL-HHRNLVSLLGYCDEE 693 (958)
Q Consensus 624 ~~~~~~~~~lg~G~~g~Vy~~~~~--------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~ 693 (958)
.++|.+.+.||+|+||.||+|.+. +...||+|.+.... .....++.+|+++++++ +|+||+++++++...
T Consensus 17 ~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~ 96 (307)
T cd05098 17 RDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD 96 (307)
T ss_pred hHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecC
Confidence 356888899999999999999853 23579999987542 33455788999999999 799999999999999
Q ss_pred CeEEEEEEecCCCCHHHHhccCC--------------CCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEe
Q 002158 694 GEQMLVYEFVPNGTLRDWLSGRT--------------KENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILL 759 (958)
Q Consensus 694 ~~~~lV~E~~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl 759 (958)
+..++||||+++|+|.+++..+. ...+++.++++++.|++.||+|||+.+ ++||||||+||++
T Consensus 97 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g---i~H~dlkp~Nill 173 (307)
T cd05098 97 GPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKK---CIHRDLAARNVLV 173 (307)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC---cccccccHHheEE
Confidence 99999999999999999997542 134889999999999999999999998 9999999999999
Q ss_pred cCCCCeEEeeeeeecccccCCCCCCccceeeeeccCCCCccChhhhccCCCCCcchhhhHHHHHHHHHh-CCCCCCCCch
Q 002158 760 DSNLNAKVADFGLSRLAPVLDDEGTMPTHVSTIVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVLLELLT-GMQPISHGKN 838 (958)
Q Consensus 760 ~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gv~l~ellt-G~~P~~~~~~ 838 (958)
+.++.+||+|||.++........ .......++..|+|||++.+..++.++|||||||++|||++ |..||... .
T Consensus 174 ~~~~~~kL~dfg~a~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~-~ 247 (307)
T cd05098 174 TEDNVMKIADFGLARDIHHIDYY-----KKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGV-P 247 (307)
T ss_pred cCCCcEEECCCcccccccccchh-----hccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcC-C
Confidence 99999999999998754321110 11112234568999999999889999999999999999998 88888543 2
Q ss_pred hHHHHHHHhhcCcchhhhcccCCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHhh
Q 002158 839 IVREVNVARDSGMVFSIIDNRMGSYPSECVERFVTLALRCCHDKPEHRPSMSDVVRELENILKM 902 (958)
Q Consensus 839 ~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~ 902 (958)
.......... . .....+..++..+.+++.+||..+|++||++.++++.|+++.+.
T Consensus 248 ~~~~~~~~~~-~--------~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~~~~ 302 (307)
T cd05098 248 VEELFKLLKE-G--------HRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILAL 302 (307)
T ss_pred HHHHHHHHHc-C--------CCCCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHHH
Confidence 2222221111 1 11233455678899999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=330.07 Aligned_cols=255 Identities=24% Similarity=0.274 Sum_probs=198.9
Q ss_pred cCCCCCceeeeeCCeEEEEEEEC-CCcEEEEEEeccCC---hhcHHHHHHHHHHHHccCCCCcceEEEEEEeCCeEEEEE
Q 002158 625 AYFSSSTQVGQGGYGKVYKGILS-DNTTVAIKRAEEGS---LQGQNEFLTEIKLLSRLHHRNLVSLLGYCDEEGEQMLVY 700 (958)
Q Consensus 625 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~ 700 (958)
++|...+.||+|+||+||++.++ .++.||+|++.... ......|.+|+.++..++|+||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM 80 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence 36788899999999999999986 57889999986421 222345888999999999999999999999999999999
Q ss_pred EecCCCCHHHHhccCCCCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEecCCCCeEEeeeeeecccccCC
Q 002158 701 EFVPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSRLAPVLD 780 (958)
Q Consensus 701 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~ 780 (958)
||+++|+|.++++... ..+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++......
T Consensus 81 ey~~~g~L~~~l~~~~-~~l~~~~~~~~~~qi~~al~~lH~~~---iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~~ 156 (332)
T cd05623 81 DYYVGGDLLTLLSKFE-DRLPEDMARFYLAEMVIAIDSVHQLH---YVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDG 156 (332)
T ss_pred eccCCCcHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEECCCCCEEEeecchheecccCC
Confidence 9999999999997532 34889999999999999999999999 9999999999999999999999999987542211
Q ss_pred CCCCccceeeeeccCCCCccChhhhc-----cCCCCCcchhhhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcCcchhh
Q 002158 781 DEGTMPTHVSTIVKGTPGYLDPEYFL-----THKLTDKSDVYSLGVVLLELLTGMQPISHGKNIVREVNVARDSGMVFSI 855 (958)
Q Consensus 781 ~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DV~S~Gv~l~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~ 855 (958)
........||+.|+|||++. ...++.++|||||||++|||++|+.||........ ...........
T Consensus 157 ------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~~-~~~i~~~~~~~-- 227 (332)
T cd05623 157 ------TVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVET-YGKIMNHKERF-- 227 (332)
T ss_pred ------cceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHHH-HHHHhCCCccc--
Confidence 11122356999999999986 34578899999999999999999999975443222 22111111000
Q ss_pred hcccCCCCChHHHHHHHHHHHHccccCCC--CCCCHHHHHHH
Q 002158 856 IDNRMGSYPSECVERFVTLALRCCHDKPE--HRPSMSDVVRE 895 (958)
Q Consensus 856 i~~~~~~~~~~~~~~l~~li~~cl~~dP~--~RPs~~evl~~ 895 (958)
..+.....++..+.+++.+|+..+++ .|++++|++++
T Consensus 228 ---~~p~~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h 266 (332)
T cd05623 228 ---QFPAQVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQH 266 (332)
T ss_pred ---cCCCccccCCHHHHHHHHHHccChhhhcCCCCHHHHhCC
Confidence 01112234567888999998865444 46899999876
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-36 Score=339.57 Aligned_cols=261 Identities=20% Similarity=0.286 Sum_probs=204.9
Q ss_pred hHHHHHHHcCCCCCceeeeeCCeEEEEEEEC-CCcEEEEEEeccC---ChhcHHHHHHHHHHHHccCCCCcceEEEEEEe
Q 002158 617 FKELAMATAYFSSSTQVGQGGYGKVYKGILS-DNTTVAIKRAEEG---SLQGQNEFLTEIKLLSRLHHRNLVSLLGYCDE 692 (958)
Q Consensus 617 ~~el~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~ 692 (958)
++++....++|+..+.||+|+||.||+|.++ +++.||+|++... .......+.+|+.+++.++||||+++++++..
T Consensus 35 ~~~~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~ 114 (371)
T cd05622 35 IRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQD 114 (371)
T ss_pred HhhcCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEc
Confidence 4455666789999999999999999999986 6889999998642 22234457899999999999999999999999
Q ss_pred CCeEEEEEEecCCCCHHHHhccCCCCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEecCCCCeEEeeeee
Q 002158 693 EGEQMLVYEFVPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSNLNAKVADFGL 772 (958)
Q Consensus 693 ~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~~~~kl~DFGl 772 (958)
++..++||||+++|+|.+++... .++...+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 115 ~~~~~lv~Ey~~gg~L~~~~~~~---~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NIll~~~~~ikL~DfG~ 188 (371)
T cd05622 115 DRYLYMVMEYMPGGDLVNLMSNY---DVPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGT 188 (371)
T ss_pred CCEEEEEEcCCCCCcHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHHCC---EEeCCCCHHHEEECCCCCEEEEeCCc
Confidence 99999999999999999999654 3788889999999999999999999 99999999999999999999999999
Q ss_pred ecccccCCCCCCccceeeeeccCCCCccChhhhccCC----CCCcchhhhHHHHHHHHHhCCCCCCCCchhHHHHHHHhh
Q 002158 773 SRLAPVLDDEGTMPTHVSTIVKGTPGYLDPEYFLTHK----LTDKSDVYSLGVVLLELLTGMQPISHGKNIVREVNVARD 848 (958)
Q Consensus 773 a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~~DV~S~Gv~l~elltG~~P~~~~~~~~~~~~~~~~ 848 (958)
++...... ........||+.|+|||++.... ++.++|||||||++|||++|+.||....... .......
T Consensus 189 a~~~~~~~------~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~-~~~~i~~ 261 (371)
T cd05622 189 CMKMNKEG------MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVG-TYSKIMN 261 (371)
T ss_pred eeEcCcCC------cccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHH-HHHHHHc
Confidence 98653211 11123456999999999997543 7889999999999999999999997544322 1111111
Q ss_pred cCcchhhhcccCCCCChHHHHHHHHHHHHccccCCCC--CCCHHHHHHHH
Q 002158 849 SGMVFSIIDNRMGSYPSECVERFVTLALRCCHDKPEH--RPSMSDVVREL 896 (958)
Q Consensus 849 ~~~~~~~i~~~~~~~~~~~~~~l~~li~~cl~~dP~~--RPs~~evl~~L 896 (958)
...... . ......+..+.+++.+|+..++.+ ||+++|++++.
T Consensus 262 ~~~~~~-----~-~~~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h~ 305 (371)
T cd05622 262 HKNSLT-----F-PDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHL 305 (371)
T ss_pred CCCccc-----C-CCcCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcCc
Confidence 110000 0 112245678889999999844433 78999988763
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=322.30 Aligned_cols=257 Identities=26% Similarity=0.377 Sum_probs=207.1
Q ss_pred HHHHHcCCCCCceeeeeCCeEEEEEEEC-CCcEEEEEEeccCChhcHHHHHHHHHHHHccCCCCcceEEEEEEeCCeEEE
Q 002158 620 LAMATAYFSSSTQVGQGGYGKVYKGILS-DNTTVAIKRAEEGSLQGQNEFLTEIKLLSRLHHRNLVSLLGYCDEEGEQML 698 (958)
Q Consensus 620 l~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~l 698 (958)
++.+++.+.....||+|+||.||+|.+. ++..||+|.+........+.+.+|++++++++|+||+++++++..++..++
T Consensus 3 ~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 82 (268)
T cd06624 3 YEYEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKI 82 (268)
T ss_pred cccccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEE
Confidence 3445667777789999999999999965 678899999887666667789999999999999999999999999999999
Q ss_pred EEEecCCCCHHHHhccCCCCCc--hHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEecC-CCCeEEeeeeeecc
Q 002158 699 VYEFVPNGTLRDWLSGRTKENL--NFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDS-NLNAKVADFGLSRL 775 (958)
Q Consensus 699 V~E~~~~gsL~~~l~~~~~~~l--~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~-~~~~kl~DFGla~~ 775 (958)
||||+++++|.+++..... .+ ++..+..++.|++.||+|||+.+ |+||||||+||+++. ++.++|+|||++..
T Consensus 83 v~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~~~qi~~al~~lH~~~---i~h~dl~p~nil~~~~~~~~~l~dfg~~~~ 158 (268)
T cd06624 83 FMEQVPGGSLSALLRSKWG-PLKDNEQTIIFYTKQILEGLKYLHDNQ---IVHRDIKGDNVLVNTYSGVVKISDFGTSKR 158 (268)
T ss_pred EEecCCCCCHHHHHHHhcc-cCCCcHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCeEEEecchhhee
Confidence 9999999999999975432 24 78888999999999999999998 999999999999986 67999999999875
Q ss_pred cccCCCCCCccceeeeeccCCCCccChhhhccCC--CCCcchhhhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcCcch
Q 002158 776 APVLDDEGTMPTHVSTIVKGTPGYLDPEYFLTHK--LTDKSDVYSLGVVLLELLTGMQPISHGKNIVREVNVARDSGMVF 853 (958)
Q Consensus 776 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DV~S~Gv~l~elltG~~P~~~~~~~~~~~~~~~~~~~~~ 853 (958)
...... ......|+..|+|||++.... ++.++||||||+++|||++|+.||.............
T Consensus 159 ~~~~~~-------~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~~~~~------- 224 (268)
T cd06624 159 LAGINP-------CTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFKV------- 224 (268)
T ss_pred cccCCC-------ccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhhHhhh-------
Confidence 422111 112235889999999986644 7889999999999999999999996433211111100
Q ss_pred hhhcccCCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 002158 854 SIIDNRMGSYPSECVERFVTLALRCCHDKPEHRPSMSDVVRE 895 (958)
Q Consensus 854 ~~i~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 895 (958)
.........+...+.++.+++.+||+.+|++||++.|++++
T Consensus 225 -~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 265 (268)
T cd06624 225 -GMFKIHPEIPESLSAEAKNFILRCFEPDPDKRASAHDLLQD 265 (268)
T ss_pred -hhhccCCCCCcccCHHHHHHHHHHcCCCchhCCCHHHHHhC
Confidence 01111233455677889999999999999999999999864
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-36 Score=333.04 Aligned_cols=241 Identities=24% Similarity=0.298 Sum_probs=192.8
Q ss_pred ceeeeeCCeEEEEEEEC-CCcEEEEEEeccCC---hhcHHHHHHHHH-HHHccCCCCcceEEEEEEeCCeEEEEEEecCC
Q 002158 631 TQVGQGGYGKVYKGILS-DNTTVAIKRAEEGS---LQGQNEFLTEIK-LLSRLHHRNLVSLLGYCDEEGEQMLVYEFVPN 705 (958)
Q Consensus 631 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~-~l~~l~H~niv~l~~~~~~~~~~~lV~E~~~~ 705 (958)
+.||+|+||+||+|... +|+.||+|++.... .....++..|.. +++.++||||+++++++..++..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG 80 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence 36999999999999976 68999999986532 223345566655 56778999999999999999999999999999
Q ss_pred CCHHHHhccCCCCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEecCCCCeEEeeeeeecccccCCCCCCc
Q 002158 706 GTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSRLAPVLDDEGTM 785 (958)
Q Consensus 706 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~ 785 (958)
|+|.+++.... .+++.++..++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||+++......
T Consensus 81 ~~L~~~l~~~~--~~~~~~~~~~~~qi~~al~~lH~~g---ivH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~----- 150 (325)
T cd05604 81 GELFFHLQRER--SFPEPRARFYAAEIASALGYLHSIN---IVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQS----- 150 (325)
T ss_pred CCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEEeecCCcccCCCCC-----
Confidence 99999986543 4899999999999999999999999 9999999999999999999999999987432111
Q ss_pred cceeeeeccCCCCccChhhhccCCCCCcchhhhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcCcchhhhcccCCCCCh
Q 002158 786 PTHVSTIVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVLLELLTGMQPISHGKNIVREVNVARDSGMVFSIIDNRMGSYPS 865 (958)
Q Consensus 786 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gv~l~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~ 865 (958)
.......||+.|+|||++.+..++.++|||||||++|||++|+.||...... ........ . ....+.
T Consensus 151 --~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~-~~~~~~~~---------~-~~~~~~ 217 (325)
T cd05604 151 --DTTTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVA-EMYDNILH---------K-PLVLRP 217 (325)
T ss_pred --CCcccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHH-HHHHHHHc---------C-CccCCC
Confidence 1123456999999999999999999999999999999999999999754322 21111111 1 111223
Q ss_pred HHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002158 866 ECVERFVTLALRCCHDKPEHRPSMSDVVR 894 (958)
Q Consensus 866 ~~~~~l~~li~~cl~~dP~~RPs~~evl~ 894 (958)
..+..+.+++.+|++.+|.+||++.+.++
T Consensus 218 ~~~~~~~~ll~~ll~~~p~~R~~~~~~~~ 246 (325)
T cd05604 218 GASLTAWSILEELLEKDRQRRLGAKEDFL 246 (325)
T ss_pred CCCHHHHHHHHHHhccCHHhcCCCCCCHH
Confidence 45677889999999999999998864443
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-36 Score=327.78 Aligned_cols=263 Identities=27% Similarity=0.398 Sum_probs=202.5
Q ss_pred HcCCCCCceeeeeCCeEEEEEEECC---------------CcEEEEEEeccC-ChhcHHHHHHHHHHHHccCCCCcceEE
Q 002158 624 TAYFSSSTQVGQGGYGKVYKGILSD---------------NTTVAIKRAEEG-SLQGQNEFLTEIKLLSRLHHRNLVSLL 687 (958)
Q Consensus 624 ~~~~~~~~~lg~G~~g~Vy~~~~~~---------------~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~ 687 (958)
..+|...+.||+|+||.||++...+ ...||+|.+... .......|.+|++++++++|+|+++++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~ 83 (295)
T cd05097 4 RQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLL 83 (295)
T ss_pred hHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEE
Confidence 3568888999999999999987642 235899998764 333445799999999999999999999
Q ss_pred EEEEeCCeEEEEEEecCCCCHHHHhccCC----------CCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccce
Q 002158 688 GYCDEEGEQMLVYEFVPNGTLRDWLSGRT----------KENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNI 757 (958)
Q Consensus 688 ~~~~~~~~~~lV~E~~~~gsL~~~l~~~~----------~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NI 757 (958)
+++...+..++||||+++++|.+++.... ...+++..++.++.|++.||+|||+.+ ++||||||+||
T Consensus 84 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~Ni 160 (295)
T cd05097 84 GVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLN---FVHRDLATRNC 160 (295)
T ss_pred EEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcC---eeccccChhhE
Confidence 99999999999999999999999996432 123688999999999999999999999 99999999999
Q ss_pred EecCCCCeEEeeeeeecccccCCCCCCccceeeeeccCCCCccChhhhccCCCCCcchhhhHHHHHHHHHh--CCCCCCC
Q 002158 758 LLDSNLNAKVADFGLSRLAPVLDDEGTMPTHVSTIVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVLLELLT--GMQPISH 835 (958)
Q Consensus 758 Ll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gv~l~ellt--G~~P~~~ 835 (958)
++++++.+||+|||+++....... ........++..|+|||++.+..++.++|||||||++|||++ |..||..
T Consensus 161 ll~~~~~~kl~dfg~~~~~~~~~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~ 235 (295)
T cd05097 161 LVGNHYTIKIADFGMSRNLYSGDY-----YRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSL 235 (295)
T ss_pred EEcCCCcEEecccccccccccCcc-----eeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcc
Confidence 999999999999999875432111 111122345778999999999999999999999999999998 5667754
Q ss_pred CchhHHHHHHHhhcCcchhhhcccCCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 002158 836 GKNIVREVNVARDSGMVFSIIDNRMGSYPSECVERFVTLALRCCHDKPEHRPSMSDVVRELE 897 (958)
Q Consensus 836 ~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 897 (958)
.... ........ .............+...+..+.+++.+||+.+|++||++++|++.|+
T Consensus 236 ~~~~-~~~~~~~~--~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~ 294 (295)
T cd05097 236 LSDE-QVIENTGE--FFRNQGRQIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLR 294 (295)
T ss_pred cChH-HHHHHHHH--hhhhccccccCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHh
Confidence 3221 11111000 00000000011223345678999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-36 Score=334.66 Aligned_cols=242 Identities=23% Similarity=0.323 Sum_probs=196.7
Q ss_pred CCCCCceeeeeCCeEEEEEEEC-CCcEEEEEEeccCC---hhcHHHHHHHHHHHHccC-CCCcceEEEEEEeCCeEEEEE
Q 002158 626 YFSSSTQVGQGGYGKVYKGILS-DNTTVAIKRAEEGS---LQGQNEFLTEIKLLSRLH-HRNLVSLLGYCDEEGEQMLVY 700 (958)
Q Consensus 626 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~~~~~lV~ 700 (958)
+|+..+.||+|+||+||+|... +++.||+|++.... ....+.+..|.++++.+. |++|+++++++...+..++||
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM 80 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence 3667789999999999999976 68899999987532 223456788999998885 577888999999999999999
Q ss_pred EecCCCCHHHHhccCCCCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEecCCCCeEEeeeeeecccccCC
Q 002158 701 EFVPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSRLAPVLD 780 (958)
Q Consensus 701 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~ 780 (958)
||+++|+|.+++.... .+++.++..++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||+++......
T Consensus 81 Ey~~~g~L~~~i~~~~--~l~~~~~~~i~~qi~~al~~lH~~~---ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~~ 155 (323)
T cd05615 81 EYVNGGDLMYHIQQVG--KFKEPQAVFYAAEISVGLFFLHRRG---IIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDG 155 (323)
T ss_pred cCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEeccccccccCCCC
Confidence 9999999999996543 4899999999999999999999999 9999999999999999999999999987432111
Q ss_pred CCCCccceeeeeccCCCCccChhhhccCCCCCcchhhhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcCcchhhhcccC
Q 002158 781 DEGTMPTHVSTIVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVLLELLTGMQPISHGKNIVREVNVARDSGMVFSIIDNRM 860 (958)
Q Consensus 781 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gv~l~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~i~~~~ 860 (958)
.......||+.|+|||++.+..++.++||||+||++|||++|+.||...... ....... ...
T Consensus 156 -------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~-~~~~~i~----------~~~ 217 (323)
T cd05615 156 -------VTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDED-ELFQSIM----------EHN 217 (323)
T ss_pred -------ccccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCHH-HHHHHHH----------hCC
Confidence 1123456999999999999999999999999999999999999999754432 1111111 111
Q ss_pred CCCChHHHHHHHHHHHHccccCCCCCCCHH
Q 002158 861 GSYPSECVERFVTLALRCCHDKPEHRPSMS 890 (958)
Q Consensus 861 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ 890 (958)
...|...+..+.+++.+|++.+|.+|++..
T Consensus 218 ~~~p~~~~~~~~~li~~~l~~~p~~R~~~~ 247 (323)
T cd05615 218 VSYPKSLSKEAVSICKGLMTKHPSKRLGCG 247 (323)
T ss_pred CCCCccCCHHHHHHHHHHcccCHhhCCCCC
Confidence 233455667889999999999999999853
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-36 Score=325.52 Aligned_cols=250 Identities=24% Similarity=0.373 Sum_probs=202.6
Q ss_pred CCCCceeeeeCCeEEEEEEEC-CCcEEEEEEeccCChhcHHHHHHHHHHHHccCCCCcceEEEEEEeCCeEEEEEEecCC
Q 002158 627 FSSSTQVGQGGYGKVYKGILS-DNTTVAIKRAEEGSLQGQNEFLTEIKLLSRLHHRNLVSLLGYCDEEGEQMLVYEFVPN 705 (958)
Q Consensus 627 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E~~~~ 705 (958)
|+..+.||+|+||.||+|.+. ++..+++|.+........+.+.+|+++++.++|+|++++++++..++..++||||+++
T Consensus 7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~~~ 86 (282)
T cd06643 7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAG 86 (282)
T ss_pred HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEecCC
Confidence 556678999999999999986 5788899998766666667899999999999999999999999999999999999999
Q ss_pred CCHHHHhccCCCCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEecCCCCeEEeeeeeecccccCCCCCCc
Q 002158 706 GTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSRLAPVLDDEGTM 785 (958)
Q Consensus 706 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~ 785 (958)
++|.+++.... ..+++..+..++.|+++||+|||+.+ ++||||||+||+++.++.+||+|||++.......
T Consensus 87 ~~l~~~~~~~~-~~l~~~~~~~~~~qi~~~L~~LH~~~---i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~----- 157 (282)
T cd06643 87 GAVDAVMLELE-RPLTEPQIRVVCKQTLEALNYLHENK---IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI----- 157 (282)
T ss_pred CcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCcccEEEccCCCEEEccccccccccccc-----
Confidence 99999886432 35899999999999999999999999 9999999999999999999999999987542111
Q ss_pred cceeeeeccCCCCccChhhhc-----cCCCCCcchhhhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcCcchhhhcccC
Q 002158 786 PTHVSTIVKGTPGYLDPEYFL-----THKLTDKSDVYSLGVVLLELLTGMQPISHGKNIVREVNVARDSGMVFSIIDNRM 860 (958)
Q Consensus 786 ~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DV~S~Gv~l~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~i~~~~ 860 (958)
.......|+..|+|||++. +..++.++|||||||++|||++|+.||................ ...
T Consensus 158 --~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~--------~~~ 227 (282)
T cd06643 158 --QRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSE--------PPT 227 (282)
T ss_pred --cccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHHHHHHHhhcC--------CCC
Confidence 1122345899999999984 3457789999999999999999999997543322211111100 001
Q ss_pred CCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 002158 861 GSYPSECVERFVTLALRCCHDKPEHRPSMSDVVRE 895 (958)
Q Consensus 861 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 895 (958)
...+..++..+.+++.+||+.+|.+||++++++++
T Consensus 228 ~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 262 (282)
T cd06643 228 LAQPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQH 262 (282)
T ss_pred CCCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 11234566789999999999999999999999864
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-36 Score=335.29 Aligned_cols=238 Identities=22% Similarity=0.310 Sum_probs=193.6
Q ss_pred ceeeeeCCeEEEEEEEC-CCcEEEEEEeccCC---hhcHHHHHHHHHHHHcc-CCCCcceEEEEEEeCCeEEEEEEecCC
Q 002158 631 TQVGQGGYGKVYKGILS-DNTTVAIKRAEEGS---LQGQNEFLTEIKLLSRL-HHRNLVSLLGYCDEEGEQMLVYEFVPN 705 (958)
Q Consensus 631 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lV~E~~~~ 705 (958)
+.||+|+||+||+|... +++.||+|+++... ....+.+.+|+.++.++ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG 80 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence 46999999999999976 57899999997642 22345688999999888 699999999999999999999999999
Q ss_pred CCHHHHhccCCCCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEecCCCCeEEeeeeeecccccCCCCCCc
Q 002158 706 GTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSRLAPVLDDEGTM 785 (958)
Q Consensus 706 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~ 785 (958)
|+|.+++.... .+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 81 ~~L~~~~~~~~--~l~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~------ 149 (327)
T cd05617 81 GDLMFHMQRQR--KLPEEHARFYAAEICIALNFLHERG---IIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGP------ 149 (327)
T ss_pred CcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEeCCCCEEEeccccceeccCC------
Confidence 99999986543 4899999999999999999999999 999999999999999999999999998742111
Q ss_pred cceeeeeccCCCCccChhhhccCCCCCcchhhhHHHHHHHHHhCCCCCCCCc-----hhHHHHHHHhhcCcchhhhcccC
Q 002158 786 PTHVSTIVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVLLELLTGMQPISHGK-----NIVREVNVARDSGMVFSIIDNRM 860 (958)
Q Consensus 786 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gv~l~elltG~~P~~~~~-----~~~~~~~~~~~~~~~~~~i~~~~ 860 (958)
........||+.|+|||++.+..++.++|||||||++|||++|+.||.... ...... .+.+....
T Consensus 150 -~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~---------~~~~~~~~ 219 (327)
T cd05617 150 -GDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYL---------FQVILEKP 219 (327)
T ss_pred -CCceecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHH---------HHHHHhCC
Confidence 111234569999999999999999999999999999999999999995321 111111 11111122
Q ss_pred CCCChHHHHHHHHHHHHccccCCCCCCCH
Q 002158 861 GSYPSECVERFVTLALRCCHDKPEHRPSM 889 (958)
Q Consensus 861 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~ 889 (958)
...|...+..+.+++.+|++.||++|+++
T Consensus 220 ~~~p~~~~~~~~~li~~~L~~dP~~R~~~ 248 (327)
T cd05617 220 IRIPRFLSVKASHVLKGFLNKDPKERLGC 248 (327)
T ss_pred CCCCCCCCHHHHHHHHHHhccCHHHcCCC
Confidence 23455566788999999999999999984
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-36 Score=337.28 Aligned_cols=256 Identities=23% Similarity=0.309 Sum_probs=198.1
Q ss_pred HcCCCCCceeeeeCCeEEEEEEEC-CCcEEEEEEeccC--ChhcHHHHHHHHHHHHccCCCCcceEEEEEEeCC------
Q 002158 624 TAYFSSSTQVGQGGYGKVYKGILS-DNTTVAIKRAEEG--SLQGQNEFLTEIKLLSRLHHRNLVSLLGYCDEEG------ 694 (958)
Q Consensus 624 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~------ 694 (958)
.++|...+.||+|+||.||+|... +|+.||||++... ......++.+|+.+++.++||||+++++++...+
T Consensus 20 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 99 (359)
T cd07876 20 LKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEFQ 99 (359)
T ss_pred hhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCccccc
Confidence 467888999999999999999975 6899999998653 2333567889999999999999999999986543
Q ss_pred eEEEEEEecCCCCHHHHhccCCCCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEecCCCCeEEeeeeeec
Q 002158 695 EQMLVYEFVPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSR 774 (958)
Q Consensus 695 ~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~ 774 (958)
..++||||++ ++|.+.++. .++...+..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+++
T Consensus 100 ~~~lv~e~~~-~~l~~~~~~----~~~~~~~~~~~~qi~~~L~~LH~~~---ivHrDlkp~NIl~~~~~~~kl~Dfg~a~ 171 (359)
T cd07876 100 DVYLVMELMD-ANLCQVIHM----ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR 171 (359)
T ss_pred eeEEEEeCCC-cCHHHHHhc----cCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEecCCCcc
Confidence 4799999996 567777642 2788889999999999999999999 9999999999999999999999999987
Q ss_pred ccccCCCCCCccceeeeeccCCCCccChhhhccCCCCCcchhhhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcCcc--
Q 002158 775 LAPVLDDEGTMPTHVSTIVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVLLELLTGMQPISHGKNIVREVNVARDSGMV-- 852 (958)
Q Consensus 775 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gv~l~elltG~~P~~~~~~~~~~~~~~~~~~~~-- 852 (958)
..... .......||+.|+|||++.+..++.++|||||||++|||++|+.||........+.......+..
T Consensus 172 ~~~~~--------~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~ 243 (359)
T cd07876 172 TACTN--------FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSA 243 (359)
T ss_pred ccccC--------ccCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcH
Confidence 53211 11223468999999999999999999999999999999999999997654332221111110000
Q ss_pred ----------hhhhcc--cC-----------------CCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 002158 853 ----------FSIIDN--RM-----------------GSYPSECVERFVTLALRCCHDKPEHRPSMSDVVRE 895 (958)
Q Consensus 853 ----------~~~i~~--~~-----------------~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 895 (958)
...... .. .......+..+.+++.+||+.||++|||++|++++
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 315 (359)
T cd07876 244 EFMNRLQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRH 315 (359)
T ss_pred HHHHHHHHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcC
Confidence 000000 00 00111234678999999999999999999999975
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=319.73 Aligned_cols=254 Identities=33% Similarity=0.519 Sum_probs=197.5
Q ss_pred ceeeeeCCeEEEEEEEC----CCcEEEEEEeccC-ChhcHHHHHHHHHHHHccCCCCcceEEEEEE-eCCeEEEEEEecC
Q 002158 631 TQVGQGGYGKVYKGILS----DNTTVAIKRAEEG-SLQGQNEFLTEIKLLSRLHHRNLVSLLGYCD-EEGEQMLVYEFVP 704 (958)
Q Consensus 631 ~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~-~~~~~~lV~E~~~ 704 (958)
+.||+|+||.||+|.+. ++..||+|.+... .....+.+.+|+.+++.++||||+++++++. .++..++||||++
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~ 80 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMK 80 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCC
Confidence 36899999999999863 2457999988643 3344567899999999999999999999875 4556899999999
Q ss_pred CCCHHHHhccCCCCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEecCCCCeEEeeeeeecccccCCCCCC
Q 002158 705 NGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSRLAPVLDDEGT 784 (958)
Q Consensus 705 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 784 (958)
+|+|.+++.... ...++..+..++.|++.||+|||+.+ ++||||||+|||+++++.+||+|||+++.......
T Consensus 81 ~~~L~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~--- 153 (262)
T cd05058 81 HGDLRNFIRSET-HNPTVKDLIGFGLQVAKGMEYLASKK---FVHRDLAARNCMLDESFTVKVADFGLARDIYDKEY--- 153 (262)
T ss_pred CCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccCcceEEEcCCCcEEECCccccccccCCcc---
Confidence 999999997543 23677888999999999999999998 99999999999999999999999999875422110
Q ss_pred ccceeeeeccCCCCccChhhhccCCCCCcchhhhHHHHHHHHHhC-CCCCCCCchhHHHHHHHhhcCcchhhhcccCCCC
Q 002158 785 MPTHVSTIVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVLLELLTG-MQPISHGKNIVREVNVARDSGMVFSIIDNRMGSY 863 (958)
Q Consensus 785 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gv~l~elltG-~~P~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~ 863 (958)
..........++..|+|||++.+..++.++||||||+++|||++| ..||..... ......... ......
T Consensus 154 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~-~~~~~~~~~---------~~~~~~ 223 (262)
T cd05058 154 YSVHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDS-FDITVYLLQ---------GRRLLQ 223 (262)
T ss_pred eeecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCCH-HHHHHHHhc---------CCCCCC
Confidence 001111233467789999999988999999999999999999995 555643322 222211111 111122
Q ss_pred ChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHh
Q 002158 864 PSECVERFVTLALRCCHDKPEHRPSMSDVVRELENILK 901 (958)
Q Consensus 864 ~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~ 901 (958)
+..++..+.+++.+||+.+|++||++.|+++.|+++..
T Consensus 224 ~~~~~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~~~~ 261 (262)
T cd05058 224 PEYCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQIFS 261 (262)
T ss_pred CCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHhc
Confidence 33456789999999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=319.01 Aligned_cols=250 Identities=30% Similarity=0.519 Sum_probs=200.7
Q ss_pred ceeeeeCCeEEEEEEECC----CcEEEEEEeccCCh-hcHHHHHHHHHHHHccCCCCcceEEEEEEeCCeEEEEEEecCC
Q 002158 631 TQVGQGGYGKVYKGILSD----NTTVAIKRAEEGSL-QGQNEFLTEIKLLSRLHHRNLVSLLGYCDEEGEQMLVYEFVPN 705 (958)
Q Consensus 631 ~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E~~~~ 705 (958)
+.||+|+||.||+|.+.. +..||+|.+..... ...+++.+|+++++++.|+||+++++++.. +..++||||+++
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~ 79 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCKG-EPLMLVMELAPL 79 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEcC-CceEEEEEeCCC
Confidence 469999999999998642 26899999876543 345679999999999999999999998764 468999999999
Q ss_pred CCHHHHhccCCCCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEecCCCCeEEeeeeeecccccCCCCCCc
Q 002158 706 GTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSRLAPVLDDEGTM 785 (958)
Q Consensus 706 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~ 785 (958)
|+|.+++.... .+++..+..++.|++.||+|||+.+ ++||||||+||+++.++.+||+|||+++........
T Consensus 80 ~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lh~~~---i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~--- 151 (257)
T cd05060 80 GPLLKYLKKRR--EIPVSDLKELAHQVAMGMAYLESKH---FVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDY--- 151 (257)
T ss_pred CcHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHhhcC---eeccCcccceEEEcCCCcEEeccccccceeecCCcc---
Confidence 99999997654 5899999999999999999999999 999999999999999999999999999865322211
Q ss_pred cceeeeeccCCCCccChhhhccCCCCCcchhhhHHHHHHHHHh-CCCCCCCCchhHHHHHHHhhcCcchhhhcccCCCCC
Q 002158 786 PTHVSTIVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVLLELLT-GMQPISHGKNIVREVNVARDSGMVFSIIDNRMGSYP 864 (958)
Q Consensus 786 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gv~l~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~ 864 (958)
........++..|+|||.+.+..++.++||||||+++|||++ |..||...... ........ . .....+
T Consensus 152 -~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~-~~~~~~~~-~--------~~~~~~ 220 (257)
T cd05060 152 -YRATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGA-EVIAMLES-G--------ERLPRP 220 (257)
T ss_pred -cccccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCHH-HHHHHHHc-C--------CcCCCC
Confidence 111112234568999999998899999999999999999998 99999654332 11111111 1 111234
Q ss_pred hHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhH
Q 002158 865 SECVERFVTLALRCCHDKPEHRPSMSDVVRELENIL 900 (958)
Q Consensus 865 ~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~ 900 (958)
..++..+.+++.+||..+|++||++.++++.|+++.
T Consensus 221 ~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~~ 256 (257)
T cd05060 221 EECPQEIYSIMLSCWKYRPEDRPTFSELESTFRRDP 256 (257)
T ss_pred CCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhcc
Confidence 456678999999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-36 Score=327.67 Aligned_cols=257 Identities=30% Similarity=0.484 Sum_probs=206.1
Q ss_pred HcCCCCCceeeeeCCeEEEEEEEC------CCcEEEEEEeccCC-hhcHHHHHHHHHHHHccCCCCcceEEEEEEeCCeE
Q 002158 624 TAYFSSSTQVGQGGYGKVYKGILS------DNTTVAIKRAEEGS-LQGQNEFLTEIKLLSRLHHRNLVSLLGYCDEEGEQ 696 (958)
Q Consensus 624 ~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~ 696 (958)
.++|+..+.||+|+||.||+|.++ ++..||+|++.... ....++|.+|++++++++||||+++++++..+...
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~~ 83 (288)
T cd05050 4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPM 83 (288)
T ss_pred hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCcc
Confidence 457888899999999999999863 46789999987643 33456799999999999999999999999999999
Q ss_pred EEEEEecCCCCHHHHhccCC--------------------CCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccc
Q 002158 697 MLVYEFVPNGTLRDWLSGRT--------------------KENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASN 756 (958)
Q Consensus 697 ~lV~E~~~~gsL~~~l~~~~--------------------~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~N 756 (958)
++||||+++|+|.+++.... ...+++.+++.++.|++.||+|||+.+ ++||||||+|
T Consensus 84 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~---i~H~dl~p~n 160 (288)
T cd05050 84 CLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERK---FVHRDLATRN 160 (288)
T ss_pred EEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC---eecccccHhh
Confidence 99999999999999996421 124788899999999999999999998 9999999999
Q ss_pred eEecCCCCeEEeeeeeecccccCCCCCCccceeeeeccCCCCccChhhhccCCCCCcchhhhHHHHHHHHHh-CCCCCCC
Q 002158 757 ILLDSNLNAKVADFGLSRLAPVLDDEGTMPTHVSTIVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVLLELLT-GMQPISH 835 (958)
Q Consensus 757 ILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gv~l~ellt-G~~P~~~ 835 (958)
|++++++.++|+|||+++....... ........++..|+|||.+.+..++.++|||||||++|||++ |..||.+
T Consensus 161 il~~~~~~~~l~dfg~~~~~~~~~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~ 235 (288)
T cd05050 161 CLVGENMVVKIADFGLSRNIYSADY-----YKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYG 235 (288)
T ss_pred eEecCCCceEECccccceecccCcc-----ccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCC
Confidence 9999999999999999875422111 011112234667999999998899999999999999999998 8888864
Q ss_pred CchhHHHHHHHhhcCcchhhhcccCCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 002158 836 GKNIVREVNVARDSGMVFSIIDNRMGSYPSECVERFVTLALRCCHDKPEHRPSMSDVVRELEN 898 (958)
Q Consensus 836 ~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 898 (958)
... ......... ......+..++.++.+++.+||+.+|++||++.|+++.|++
T Consensus 236 ~~~-~~~~~~~~~---------~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~~ 288 (288)
T cd05050 236 MAH-EEVIYYVRD---------GNVLSCPDNCPLELYNLMRLCWSKLPSDRPSFASINRILQR 288 (288)
T ss_pred CCH-HHHHHHHhc---------CCCCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhhC
Confidence 332 222221111 11112244567889999999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=320.21 Aligned_cols=254 Identities=25% Similarity=0.437 Sum_probs=205.7
Q ss_pred CCCCCceeeeeCCeEEEEEEEC-CCcEEEEEEeccCChh---------cHHHHHHHHHHHHccCCCCcceEEEEEEeCCe
Q 002158 626 YFSSSTQVGQGGYGKVYKGILS-DNTTVAIKRAEEGSLQ---------GQNEFLTEIKLLSRLHHRNLVSLLGYCDEEGE 695 (958)
Q Consensus 626 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~---------~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~ 695 (958)
+|...+.||+|+||.||+|... +++.||+|.+...... ..+.+.+|++++++++||||+++++++...+.
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 80 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH 80 (267)
T ss_pred CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence 3667789999999999999975 6889999988654221 12468899999999999999999999999999
Q ss_pred EEEEEEecCCCCHHHHhccCCCCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEecCCCCeEEeeeeeecc
Q 002158 696 QMLVYEFVPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSRL 775 (958)
Q Consensus 696 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~ 775 (958)
.++||||+++++|.+++... ..+++..+..++.|++.||+|||+.+ ++||||||+||++++++.++|+|||.++.
T Consensus 81 ~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~~l~~~l~~lH~~~---ivH~di~p~nil~~~~~~~~l~dfg~~~~ 155 (267)
T cd06628 81 LNIFLEYVPGGSVAALLNNY--GAFEETLVRNFVRQILKGLNYLHNRG---IIHRDIKGANILVDNKGGIKISDFGISKK 155 (267)
T ss_pred cEEEEEecCCCCHHHHHHhc--cCccHHHHHHHHHHHHHHHHHHHhcC---cccccCCHHHEEEcCCCCEEecccCCCcc
Confidence 99999999999999999754 34888999999999999999999998 99999999999999999999999999986
Q ss_pred cccCCCCCCccceeeeeccCCCCccChhhhccCCCCCcchhhhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcCcchhh
Q 002158 776 APVLDDEGTMPTHVSTIVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVLLELLTGMQPISHGKNIVREVNVARDSGMVFSI 855 (958)
Q Consensus 776 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gv~l~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~ 855 (958)
.......... ........|+..|+|||.+.+..++.++||||+|+++|||++|+.||........... .
T Consensus 156 ~~~~~~~~~~-~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~----------~ 224 (267)
T cd06628 156 LEANSLSTKT-NGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAIFK----------I 224 (267)
T ss_pred cccccccCCc-cccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHHHHHHH----------H
Confidence 6421111111 1111234588999999999988899999999999999999999999976443222111 1
Q ss_pred hcccCCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 002158 856 IDNRMGSYPSECVERFVTLALRCCHDKPEHRPSMSDVVRE 895 (958)
Q Consensus 856 i~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 895 (958)
........+...+..+.+++.+||+.||.+||++.|++++
T Consensus 225 ~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 264 (267)
T cd06628 225 GENASPEIPSNISSEAIDFLEKTFEIDHNKRPTAAELLKH 264 (267)
T ss_pred hccCCCcCCcccCHHHHHHHHHHccCCchhCcCHHHHhhC
Confidence 1111233455677889999999999999999999999863
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=321.03 Aligned_cols=257 Identities=26% Similarity=0.446 Sum_probs=207.4
Q ss_pred HcCCCCCceeeeeCCeEEEEEEECC----CcEEEEEEeccCC-hhcHHHHHHHHHHHHccCCCCcceEEEEEEeCCeEEE
Q 002158 624 TAYFSSSTQVGQGGYGKVYKGILSD----NTTVAIKRAEEGS-LQGQNEFLTEIKLLSRLHHRNLVSLLGYCDEEGEQML 698 (958)
Q Consensus 624 ~~~~~~~~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~l 698 (958)
.++|...+.||+|+||.||+|.+.+ ...||||...... ....+.|.+|+.++++++||||+++++++.. +..++
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~l 83 (270)
T cd05056 5 REDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVWI 83 (270)
T ss_pred hhhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCcEE
Confidence 3457778899999999999998643 3468999887654 4455689999999999999999999999876 46789
Q ss_pred EEEecCCCCHHHHhccCCCCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEecCCCCeEEeeeeeeccccc
Q 002158 699 VYEFVPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSRLAPV 778 (958)
Q Consensus 699 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~~~~ 778 (958)
||||+++|+|.+++.... ..+++.++..++.|++.||+|||+.+ ++||||||+||+++.++.+||+|||+++....
T Consensus 84 v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~l~~~l~~lH~~~---~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~ 159 (270)
T cd05056 84 VMELAPLGELRSYLQVNK-YSLDLASLILYSYQLSTALAYLESKR---FVHRDIAARNVLVSSPDCVKLGDFGLSRYLED 159 (270)
T ss_pred EEEcCCCCcHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccChheEEEecCCCeEEccCceeeeccc
Confidence 999999999999997543 34899999999999999999999998 99999999999999999999999999876532
Q ss_pred CCCCCCccceeeeeccCCCCccChhhhccCCCCCcchhhhHHHHHHHHHh-CCCCCCCCchhHHHHHHHhhcCcchhhhc
Q 002158 779 LDDEGTMPTHVSTIVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVLLELLT-GMQPISHGKNIVREVNVARDSGMVFSIID 857 (958)
Q Consensus 779 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gv~l~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~i~ 857 (958)
.. ........++..|+|||.+....++.++||||||+++|||++ |..||.......... ....
T Consensus 160 ~~------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~-~~~~--------- 223 (270)
T cd05056 160 ES------YYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVIG-RIEN--------- 223 (270)
T ss_pred cc------ceecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHHHHH-HHHc---------
Confidence 21 111122235568999999988889999999999999999996 999997554322211 1111
Q ss_pred ccCCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHh
Q 002158 858 NRMGSYPSECVERFVTLALRCCHDKPEHRPSMSDVVRELENILK 901 (958)
Q Consensus 858 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~ 901 (958)
......+..++..+.+++.+|+..+|++||++.++++.|+++..
T Consensus 224 ~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~~~ 267 (270)
T cd05056 224 GERLPMPPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDILQ 267 (270)
T ss_pred CCcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence 11112345567889999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=321.60 Aligned_cols=249 Identities=32% Similarity=0.512 Sum_probs=198.8
Q ss_pred ceeeeeCCeEEEEEEECC-Cc--EEEEEEeccCC-hhcHHHHHHHHHHHHcc-CCCCcceEEEEEEeCCeEEEEEEecCC
Q 002158 631 TQVGQGGYGKVYKGILSD-NT--TVAIKRAEEGS-LQGQNEFLTEIKLLSRL-HHRNLVSLLGYCDEEGEQMLVYEFVPN 705 (958)
Q Consensus 631 ~~lg~G~~g~Vy~~~~~~-~~--~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lV~E~~~~ 705 (958)
+.||+|+||.||+|.+++ +. .+|+|.++... ....+.+.+|+++++++ +||||+++++++...+..++||||+++
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPH 80 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCC
Confidence 368999999999999864 43 46888887533 34456789999999999 799999999999999999999999999
Q ss_pred CCHHHHhccCC--------------CCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEecCCCCeEEeeee
Q 002158 706 GTLRDWLSGRT--------------KENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSNLNAKVADFG 771 (958)
Q Consensus 706 gsL~~~l~~~~--------------~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~~~~kl~DFG 771 (958)
|+|.+++.... ...+++.++..++.|++.||+|||+.+ ++||||||+||++++++.+||+|||
T Consensus 81 ~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~---i~H~dikp~nili~~~~~~kl~dfg 157 (270)
T cd05047 81 GNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVAKIADFG 157 (270)
T ss_pred CcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccccceEEEcCCCeEEECCCC
Confidence 99999997532 124789999999999999999999998 9999999999999999999999999
Q ss_pred eecccccCCCCCCccceeeeeccCCCCccChhhhccCCCCCcchhhhHHHHHHHHHh-CCCCCCCCchhHHHHHHHhhcC
Q 002158 772 LSRLAPVLDDEGTMPTHVSTIVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVLLELLT-GMQPISHGKNIVREVNVARDSG 850 (958)
Q Consensus 772 la~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gv~l~ellt-G~~P~~~~~~~~~~~~~~~~~~ 850 (958)
+++..... ........+..|+|||++....++.++||||||+++|||++ |..||..... .........
T Consensus 158 l~~~~~~~--------~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~-~~~~~~~~~-- 226 (270)
T cd05047 158 LSRGQEVY--------VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTC-AELYEKLPQ-- 226 (270)
T ss_pred Cccccchh--------hhccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCH-HHHHHHHhC--
Confidence 98632110 01111234567999999988889999999999999999997 9999964332 111111111
Q ss_pred cchhhhcccCCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhH
Q 002158 851 MVFSIIDNRMGSYPSECVERFVTLALRCCHDKPEHRPSMSDVVRELENIL 900 (958)
Q Consensus 851 ~~~~~i~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~ 900 (958)
......+..++..+.+++.+||+.+|.+||++.++++.|++++
T Consensus 227 -------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~~ 269 (270)
T cd05047 227 -------GYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML 269 (270)
T ss_pred -------CCCCCCCCcCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHhh
Confidence 0111223445678899999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-35 Score=329.23 Aligned_cols=255 Identities=24% Similarity=0.276 Sum_probs=198.9
Q ss_pred cCCCCCceeeeeCCeEEEEEEEC-CCcEEEEEEeccC---ChhcHHHHHHHHHHHHccCCCCcceEEEEEEeCCeEEEEE
Q 002158 625 AYFSSSTQVGQGGYGKVYKGILS-DNTTVAIKRAEEG---SLQGQNEFLTEIKLLSRLHHRNLVSLLGYCDEEGEQMLVY 700 (958)
Q Consensus 625 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~ 700 (958)
++|...+.||+|+||+||+++.. +++.||+|++... .......+.+|..++..++|+||+++++++..++..++||
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~ 80 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM 80 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 36788899999999999999976 6889999998652 1223345888999999999999999999999999999999
Q ss_pred EecCCCCHHHHhccCCCCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEecCCCCeEEeeeeeecccccCC
Q 002158 701 EFVPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSRLAPVLD 780 (958)
Q Consensus 701 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~ 780 (958)
||+++|+|.+++.... ..+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++......
T Consensus 81 Ey~~gg~L~~~l~~~~-~~l~~~~~~~~~~qi~~~L~~lH~~~---iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~ 156 (331)
T cd05624 81 DYYVGGDLLTLLSKFE-DRLPEDMARFYIAEMVLAIHSIHQLH---YVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDG 156 (331)
T ss_pred eCCCCCcHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCchHHEEEcCCCCEEEEeccceeeccCCC
Confidence 9999999999997532 34889999999999999999999999 9999999999999999999999999987543211
Q ss_pred CCCCccceeeeeccCCCCccChhhhcc-----CCCCCcchhhhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcCcchhh
Q 002158 781 DEGTMPTHVSTIVKGTPGYLDPEYFLT-----HKLTDKSDVYSLGVVLLELLTGMQPISHGKNIVREVNVARDSGMVFSI 855 (958)
Q Consensus 781 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DV~S~Gv~l~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~ 855 (958)
........||++|+|||++.+ ..++.++|||||||++|||++|+.||........ ...........
T Consensus 157 ------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~-~~~i~~~~~~~-- 227 (331)
T cd05624 157 ------TVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVET-YGKIMNHEERF-- 227 (331)
T ss_pred ------ceeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHHH-HHHHHcCCCcc--
Confidence 111223569999999999875 4678899999999999999999999975443221 11111111000
Q ss_pred hcccCCCCChHHHHHHHHHHHHccccCCCC--CCCHHHHHHH
Q 002158 856 IDNRMGSYPSECVERFVTLALRCCHDKPEH--RPSMSDVVRE 895 (958)
Q Consensus 856 i~~~~~~~~~~~~~~l~~li~~cl~~dP~~--RPs~~evl~~ 895 (958)
..+......+.++.+++.+|+..++++ |+++++++++
T Consensus 228 ---~~p~~~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h 266 (331)
T cd05624 228 ---QFPSHITDVSEEAKDLIQRLICSRERRLGQNGIEDFKKH 266 (331)
T ss_pred ---cCCCccccCCHHHHHHHHHHccCchhhcCCCCHHHHhcC
Confidence 011112234678889999998865544 4688888765
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=325.21 Aligned_cols=267 Identities=26% Similarity=0.457 Sum_probs=205.1
Q ss_pred cCCCCCceeeeeCCeEEEEEEEC-----CCcEEEEEEeccCC-hhcHHHHHHHHHHHHccCCCCcceEEEEEEeC--CeE
Q 002158 625 AYFSSSTQVGQGGYGKVYKGILS-----DNTTVAIKRAEEGS-LQGQNEFLTEIKLLSRLHHRNLVSLLGYCDEE--GEQ 696 (958)
Q Consensus 625 ~~~~~~~~lg~G~~g~Vy~~~~~-----~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~--~~~ 696 (958)
..|...+.||+|+||.||++.+. ++..||+|.++... ......+.+|++++++++|+|++++++++... ...
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (284)
T cd05079 4 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI 83 (284)
T ss_pred hhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCce
Confidence 35677889999999999999842 47889999987543 33346799999999999999999999998775 568
Q ss_pred EEEEEecCCCCHHHHhccCCCCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEecCCCCeEEeeeeeeccc
Q 002158 697 MLVYEFVPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSRLA 776 (958)
Q Consensus 697 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~~ 776 (958)
++||||+++++|.+++.... ..+++.++..++.|++.||+|||+.+ ++||||||+||+++.++.++|+|||+++..
T Consensus 84 ~lv~e~~~g~~L~~~l~~~~-~~~~~~~~~~i~~~i~~aL~~lH~~g---i~H~dlkp~Nil~~~~~~~~l~dfg~~~~~ 159 (284)
T cd05079 84 KLIMEFLPSGSLKEYLPRNK-NKINLKQQLKYAVQICKGMDYLGSRQ---YVHRDLAARNVLVESEHQVKIGDFGLTKAI 159 (284)
T ss_pred EEEEEccCCCCHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccchheEEEcCCCCEEECCCcccccc
Confidence 99999999999999996543 34899999999999999999999999 999999999999999999999999999865
Q ss_pred ccCCCCCCccceeeeeccCCCCccChhhhccCCCCCcchhhhHHHHHHHHHhCCCCCCCCchhHHHHHH-HhhcCc---c
Q 002158 777 PVLDDEGTMPTHVSTIVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVLLELLTGMQPISHGKNIVREVNV-ARDSGM---V 852 (958)
Q Consensus 777 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gv~l~elltG~~P~~~~~~~~~~~~~-~~~~~~---~ 852 (958)
...... ........|+..|+|||++.+..++.++||||||+++|||++++.|............. ...... .
T Consensus 160 ~~~~~~----~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (284)
T cd05079 160 ETDKEY----YTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRL 235 (284)
T ss_pred ccCccc----eeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHH
Confidence 322111 11112345777899999999888999999999999999999987765322111000000 000000 0
Q ss_pred hhhh-cccCCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHh
Q 002158 853 FSII-DNRMGSYPSECVERFVTLALRCCHDKPEHRPSMSDVVRELENI 899 (958)
Q Consensus 853 ~~~i-~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 899 (958)
...+ .......+..++..+.+++.+||+.+|++||+++++++.++++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~ 283 (284)
T cd05079 236 VRVLEEGKRLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAI 283 (284)
T ss_pred HHHHHcCccCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHhh
Confidence 0000 1111122445678899999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-36 Score=338.92 Aligned_cols=258 Identities=24% Similarity=0.314 Sum_probs=199.5
Q ss_pred CCCCCceeeeeCCeEEEEEEEC-CCcEEEEEEeccC--ChhcHHHHHHHHHHHHccCCCCcceEEEEEEeCC-----eEE
Q 002158 626 YFSSSTQVGQGGYGKVYKGILS-DNTTVAIKRAEEG--SLQGQNEFLTEIKLLSRLHHRNLVSLLGYCDEEG-----EQM 697 (958)
Q Consensus 626 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~-----~~~ 697 (958)
+|+..+.||+|+||+||+|... +++.||||++... .....+++.+|+++++.++|+||+++++++...+ ..+
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 80 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY 80 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence 4778899999999999999975 7899999998653 2334567889999999999999999999998776 789
Q ss_pred EEEEecCCCCHHHHhccCCCCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEecCCCCeEEeeeeeecccc
Q 002158 698 LVYEFVPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSRLAP 777 (958)
Q Consensus 698 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~~~ 777 (958)
+||||+. ++|.+++.... .+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++...
T Consensus 81 lv~e~~~-~~l~~~~~~~~--~l~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~ 154 (372)
T cd07853 81 VVTELMQ-SDLHKIIVSPQ--PLSSDHVKVFLYQILRGLKYLHSAG---ILHRDIKPGNLLVNSNCVLKICDFGLARVEE 154 (372)
T ss_pred EEeeccc-cCHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChHHEEECCCCCEEeccccceeecc
Confidence 9999995 68888886443 4899999999999999999999999 9999999999999999999999999998643
Q ss_pred cCCCCCCccceeeeeccCCCCccChhhhccC-CCCCcchhhhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcC--c---
Q 002158 778 VLDDEGTMPTHVSTIVKGTPGYLDPEYFLTH-KLTDKSDVYSLGVVLLELLTGMQPISHGKNIVREVNVARDSG--M--- 851 (958)
Q Consensus 778 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DV~S~Gv~l~elltG~~P~~~~~~~~~~~~~~~~~~--~--- 851 (958)
.... .......++..|+|||++.+. .++.++||||+||++|||++|+.||................+ .
T Consensus 155 ~~~~------~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~ 228 (372)
T cd07853 155 PDES------KHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEA 228 (372)
T ss_pred cCcc------ccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHH
Confidence 2211 111234578999999999874 478899999999999999999999975443221111100000 0
Q ss_pred -------chhhhcccC---------CCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 002158 852 -------VFSIIDNRM---------GSYPSECVERFVTLALRCCHDKPEHRPSMSDVVRE 895 (958)
Q Consensus 852 -------~~~~i~~~~---------~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 895 (958)
....+.... .......++++.+++.+|++.||++||++.|++++
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 288 (372)
T cd07853 229 MRSACEGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAH 288 (372)
T ss_pred HHHhhHHHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcC
Confidence 000000000 01122345678999999999999999999999875
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=319.00 Aligned_cols=254 Identities=27% Similarity=0.472 Sum_probs=207.0
Q ss_pred HcCCCCCceeeeeCCeEEEEEEECCCcEEEEEEeccCChhcHHHHHHHHHHHHccCCCCcceEEEEEEeCCeEEEEEEec
Q 002158 624 TAYFSSSTQVGQGGYGKVYKGILSDNTTVAIKRAEEGSLQGQNEFLTEIKLLSRLHHRNLVSLLGYCDEEGEQMLVYEFV 703 (958)
Q Consensus 624 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E~~ 703 (958)
.++|...+.||+|+||.||+|.+.++..||+|.+.... ...+.|.+|++++++++|+||+++++++.. ...++||||+
T Consensus 5 ~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~e~~ 82 (260)
T cd05073 5 RESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITEFM 82 (260)
T ss_pred ccceeEEeEecCccceEEEEEEecCCccEEEEecCCCh-hHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEEEeC
Confidence 45778889999999999999998788889999887543 334678999999999999999999999887 7889999999
Q ss_pred CCCCHHHHhccCCCCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEecCCCCeEEeeeeeecccccCCCCC
Q 002158 704 PNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSRLAPVLDDEG 783 (958)
Q Consensus 704 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 783 (958)
++++|.+++.......+++.+++.++.|++.||+|||+.+ ++||||||+||+++.++.+||+|||.++.......
T Consensus 83 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~-- 157 (260)
T cd05073 83 AKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRN---YIHRDLRAANILVSASLVCKIADFGLARVIEDNEY-- 157 (260)
T ss_pred CCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhCC---ccccccCcceEEEcCCCcEEECCCcceeeccCCCc--
Confidence 9999999997655556889999999999999999999998 99999999999999999999999999875432111
Q ss_pred CccceeeeeccCCCCccChhhhccCCCCCcchhhhHHHHHHHHHh-CCCCCCCCchhHHHHHHHhhcCcchhhhcccCCC
Q 002158 784 TMPTHVSTIVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVLLELLT-GMQPISHGKNIVREVNVARDSGMVFSIIDNRMGS 862 (958)
Q Consensus 784 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gv~l~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~ 862 (958)
.......++..|+|||++....++.++|+||||+++||+++ |..||....... ....... + ....
T Consensus 158 ----~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~-~~~~~~~-~--------~~~~ 223 (260)
T cd05073 158 ----TAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPE-VIRALER-G--------YRMP 223 (260)
T ss_pred ----ccccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHHH-HHHHHhC-C--------CCCC
Confidence 11112345678999999998889999999999999999999 899996543221 1111111 1 0112
Q ss_pred CChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 002158 863 YPSECVERFVTLALRCCHDKPEHRPSMSDVVRELEN 898 (958)
Q Consensus 863 ~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 898 (958)
.+...+..+.+++.+||+.+|++||++.++.+.|+.
T Consensus 224 ~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~ 259 (260)
T cd05073 224 RPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDD 259 (260)
T ss_pred CcccCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 234456789999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=331.33 Aligned_cols=261 Identities=19% Similarity=0.258 Sum_probs=197.2
Q ss_pred Cceeeee--CCeEEEEEEEC-CCcEEEEEEeccCC--hhcHHHHHHHHHHHHccCCCCcceEEEEEEeCCeEEEEEEecC
Q 002158 630 STQVGQG--GYGKVYKGILS-DNTTVAIKRAEEGS--LQGQNEFLTEIKLLSRLHHRNLVSLLGYCDEEGEQMLVYEFVP 704 (958)
Q Consensus 630 ~~~lg~G--~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E~~~ 704 (958)
.++||+| +||+||++..+ +|+.||+|++.... ....+.+.+|+++++.++||||+++++++..++..++||||++
T Consensus 3 ~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~ 82 (327)
T cd08227 3 LTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFMA 82 (327)
T ss_pred hhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEeccC
Confidence 4679999 78899999975 78999999987542 2233467789999999999999999999999999999999999
Q ss_pred CCCHHHHhccCCCCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEecCCCCeEEeeeeeecccccCCCCCC
Q 002158 705 NGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSRLAPVLDDEGT 784 (958)
Q Consensus 705 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 784 (958)
+|+|.+++.......+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.++++|||.+...........
T Consensus 83 ~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~---iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~~~ 159 (327)
T cd08227 83 YGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHMG---YVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQRLR 159 (327)
T ss_pred CCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCChhhEEEecCCcEEEcccchhhcccccccccc
Confidence 999999997654445899999999999999999999999 99999999999999999999999987543321111000
Q ss_pred ccceeeeeccCCCCccChhhhcc--CCCCCcchhhhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcCcchhhhc-----
Q 002158 785 MPTHVSTIVKGTPGYLDPEYFLT--HKLTDKSDVYSLGVVLLELLTGMQPISHGKNIVREVNVARDSGMVFSIID----- 857 (958)
Q Consensus 785 ~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DV~S~Gv~l~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~i~----- 857 (958)
..........++..|+|||++.+ ..++.++|||||||++|||++|+.||.............. +.....++
T Consensus 160 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~--~~~~~~~~~~~~~ 237 (327)
T cd08227 160 VVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLN--GTVPCLLDTTTIP 237 (327)
T ss_pred ccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHHHHHhc--CCccccccccchh
Confidence 00011122346778999999976 4588999999999999999999999975332111111110 00000000
Q ss_pred --------------c------------------cCCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 002158 858 --------------N------------------RMGSYPSECVERFVTLALRCCHDKPEHRPSMSDVVRE 895 (958)
Q Consensus 858 --------------~------------------~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 895 (958)
. .........+..+.+++.+||+.||++|||++|++++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~~ 307 (327)
T cd08227 238 AEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLNH 307 (327)
T ss_pred hhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhcC
Confidence 0 0001122345688999999999999999999999974
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=325.66 Aligned_cols=262 Identities=29% Similarity=0.438 Sum_probs=205.6
Q ss_pred HcCCCCCceeeeeCCeEEEEEEECC-----------------CcEEEEEEeccCC-hhcHHHHHHHHHHHHccCCCCcce
Q 002158 624 TAYFSSSTQVGQGGYGKVYKGILSD-----------------NTTVAIKRAEEGS-LQGQNEFLTEIKLLSRLHHRNLVS 685 (958)
Q Consensus 624 ~~~~~~~~~lg~G~~g~Vy~~~~~~-----------------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~ 685 (958)
..+|...+.||+|+||.||+|.+.+ +..||+|.+.... ....+.+.+|++++++++|+||++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~ 83 (296)
T cd05051 4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIAR 83 (296)
T ss_pred hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeE
Confidence 3567888999999999999998642 2468999987653 344567899999999999999999
Q ss_pred EEEEEEeCCeEEEEEEecCCCCHHHHhccCC---------CCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccc
Q 002158 686 LLGYCDEEGEQMLVYEFVPNGTLRDWLSGRT---------KENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASN 756 (958)
Q Consensus 686 l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~---------~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~N 756 (958)
+++++..++..++||||+++++|.+++.... ...+++..++.++.|++.||+|||+.+ ++||||||+|
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~---i~H~dlkp~N 160 (296)
T cd05051 84 LLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLN---FVHRDLATRN 160 (296)
T ss_pred EEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcC---ccccccchhc
Confidence 9999999999999999999999999997543 125899999999999999999999999 9999999999
Q ss_pred eEecCCCCeEEeeeeeecccccCCCCCCccceeeeeccCCCCccChhhhccCCCCCcchhhhHHHHHHHHHh--CCCCCC
Q 002158 757 ILLDSNLNAKVADFGLSRLAPVLDDEGTMPTHVSTIVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVLLELLT--GMQPIS 834 (958)
Q Consensus 757 ILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gv~l~ellt--G~~P~~ 834 (958)
|+++.++.++|+|||+++....... ........++..|+|||++.+..++.++|||||||++|||++ |..||.
T Consensus 161 ili~~~~~~~l~dfg~~~~~~~~~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~ 235 (296)
T cd05051 161 CLVGKNYTIKIADFGMSRNLYSSDY-----YRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYE 235 (296)
T ss_pred eeecCCCceEEccccceeecccCcc-----eeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCC
Confidence 9999999999999999875432111 111223446788999999998889999999999999999998 677876
Q ss_pred CCchhHHHHHHHhhcCcchhhhccc-CCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 002158 835 HGKNIVREVNVARDSGMVFSIIDNR-MGSYPSECVERFVTLALRCCHDKPEHRPSMSDVVRELE 897 (958)
Q Consensus 835 ~~~~~~~~~~~~~~~~~~~~~i~~~-~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 897 (958)
...... ....... ........ ....+..++.++.+++.+||+.||++||++.|+++.|+
T Consensus 236 ~~~~~~-~~~~~~~---~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~ 295 (296)
T cd05051 236 HLTDQQ-VIENAGH---FFRDDGRQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQ 295 (296)
T ss_pred CcChHH-HHHHHHh---ccccccccccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhc
Confidence 433211 1111110 00000000 01123345678999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-36 Score=346.14 Aligned_cols=256 Identities=22% Similarity=0.357 Sum_probs=194.5
Q ss_pred HcCCCCCceeeeeCCeEEEEEEEC-CCcEEEEEEeccCChhcHHHHHHHHHHHHccCCCCcceEEEEEEeC--------C
Q 002158 624 TAYFSSSTQVGQGGYGKVYKGILS-DNTTVAIKRAEEGSLQGQNEFLTEIKLLSRLHHRNLVSLLGYCDEE--------G 694 (958)
Q Consensus 624 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~--------~ 694 (958)
..+|...+.||+|+||+||+|... +++.||||++.... ....+|+.+++.++||||+++++++... .
T Consensus 65 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~----~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~~ 140 (440)
T PTZ00036 65 NKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP----QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKNI 140 (440)
T ss_pred CCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc----chHHHHHHHHHhcCCCCCcceeeeEeecccccCCCce
Confidence 356888999999999999999975 68899999886432 2234799999999999999999986432 2
Q ss_pred eEEEEEEecCCCCHHHHhcc--CCCCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEecCCC-CeEEeeee
Q 002158 695 EQMLVYEFVPNGTLRDWLSG--RTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSNL-NAKVADFG 771 (958)
Q Consensus 695 ~~~lV~E~~~~gsL~~~l~~--~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~~-~~kl~DFG 771 (958)
..++||||++ ++|.+++.. .....+++..+..++.|++.||+|||+.+ |+||||||+|||++.++ .+||+|||
T Consensus 141 ~l~lvmE~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~---IiHrDLKp~NILl~~~~~~vkL~DFG 216 (440)
T PTZ00036 141 FLNVVMEFIP-QTVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKF---ICHRDLKPQNLLIDPNTHTLKLCDFG 216 (440)
T ss_pred EEEEEEecCC-ccHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCcCHHHEEEcCCCCceeeeccc
Confidence 4679999996 578777753 22345899999999999999999999999 99999999999999665 79999999
Q ss_pred eecccccCCCCCCccceeeeeccCCCCccChhhhccC-CCCCcchhhhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcC
Q 002158 772 LSRLAPVLDDEGTMPTHVSTIVKGTPGYLDPEYFLTH-KLTDKSDVYSLGVVLLELLTGMQPISHGKNIVREVNVARDSG 850 (958)
Q Consensus 772 la~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DV~S~Gv~l~elltG~~P~~~~~~~~~~~~~~~~~~ 850 (958)
+|+...... ......||+.|+|||++.+. .++.++|||||||++|||++|.+||.+..............+
T Consensus 217 la~~~~~~~--------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~ 288 (440)
T PTZ00036 217 SAKNLLAGQ--------RSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLG 288 (440)
T ss_pred cchhccCCC--------CcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhC
Confidence 998653211 11234689999999998764 689999999999999999999999976543322222111100
Q ss_pred cc-h---hhhc--------cc-----C-CCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 002158 851 MV-F---SIID--------NR-----M-GSYPSECVERFVTLALRCCHDKPEHRPSMSDVVRE 895 (958)
Q Consensus 851 ~~-~---~~i~--------~~-----~-~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 895 (958)
.. . .... +. + ..+|...+.++.+++.+||+.||.+||++.|++++
T Consensus 289 ~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~h 351 (440)
T PTZ00036 289 TPTEDQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALAD 351 (440)
T ss_pred CCCHHHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCC
Confidence 00 0 0000 00 0 11233456789999999999999999999999965
|
|
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=324.82 Aligned_cols=258 Identities=26% Similarity=0.336 Sum_probs=196.8
Q ss_pred CCCCCceeeeeCCeEEEEEEEC-CCcEEEEEEeccCCh--hcHHHHHHHHHHHHcc---CCCCcceEEEEEEe-----CC
Q 002158 626 YFSSSTQVGQGGYGKVYKGILS-DNTTVAIKRAEEGSL--QGQNEFLTEIKLLSRL---HHRNLVSLLGYCDE-----EG 694 (958)
Q Consensus 626 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l---~H~niv~l~~~~~~-----~~ 694 (958)
+|+..+.||+|+||+||+|.+. +++.||+|.+..... .....+.+|+++++++ +||||+++++++.. ..
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~ 80 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET 80 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence 4677889999999999999976 688999998875322 1223466777777665 69999999998864 34
Q ss_pred eEEEEEEecCCCCHHHHhccCCCCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEecCCCCeEEeeeeeec
Q 002158 695 EQMLVYEFVPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSR 774 (958)
Q Consensus 695 ~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~ 774 (958)
..++||||++ ++|.+++.......+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+++
T Consensus 81 ~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dikp~Nili~~~~~~kl~dfg~~~ 156 (288)
T cd07863 81 KVTLVFEHVD-QDLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGQVKLADFGLAR 156 (288)
T ss_pred eEEEEEcccc-cCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECccCccc
Confidence 5799999997 58999997655556899999999999999999999999 9999999999999999999999999997
Q ss_pred ccccCCCCCCccceeeeeccCCCCccChhhhccCCCCCcchhhhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcCc---
Q 002158 775 LAPVLDDEGTMPTHVSTIVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVLLELLTGMQPISHGKNIVREVNVARDSGM--- 851 (958)
Q Consensus 775 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gv~l~elltG~~P~~~~~~~~~~~~~~~~~~~--- 851 (958)
...... ......||..|+|||++.+..++.++||||+||++|||++|+.||................+.
T Consensus 157 ~~~~~~--------~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~ 228 (288)
T cd07863 157 IYSCQM--------ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPE 228 (288)
T ss_pred cccCcc--------cCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhCCCCh
Confidence 653211 112345889999999999999999999999999999999999999654432211111110000
Q ss_pred --chhhh---cccC--------CCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 002158 852 --VFSII---DNRM--------GSYPSECVERFVTLALRCCHDKPEHRPSMSDVVRE 895 (958)
Q Consensus 852 --~~~~i---~~~~--------~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 895 (958)
..... .... .......+..+.+++.+|++.||++||++.|++++
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~h 285 (288)
T cd07863 229 DDWPRDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQH 285 (288)
T ss_pred hhCcccccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 00000 0000 01112356778999999999999999999999863
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=320.52 Aligned_cols=252 Identities=29% Similarity=0.408 Sum_probs=193.3
Q ss_pred eeeeeCCeEEEEEEECC---CcEEEEEEeccCC-hhcHHHHHHHHHHHHccCCCCcceEEEEEEeCCeEEEEEEecCCCC
Q 002158 632 QVGQGGYGKVYKGILSD---NTTVAIKRAEEGS-LQGQNEFLTEIKLLSRLHHRNLVSLLGYCDEEGEQMLVYEFVPNGT 707 (958)
Q Consensus 632 ~lg~G~~g~Vy~~~~~~---~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E~~~~gs 707 (958)
.||+|+||.||+|.+.+ +..+|+|.++... ......|.+|+.++++++||||+++++++.+....++||||+++|+
T Consensus 2 ~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~ 81 (269)
T cd05087 2 EIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLGD 81 (269)
T ss_pred cccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCCc
Confidence 58999999999998653 4579999887643 3334578999999999999999999999999999999999999999
Q ss_pred HHHHhccCC---CCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEecCCCCeEEeeeeeecccccCCCCCC
Q 002158 708 LRDWLSGRT---KENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSRLAPVLDDEGT 784 (958)
Q Consensus 708 L~~~l~~~~---~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 784 (958)
|.++++... ....++..+..++.|++.|++|||+.+ ++||||||+||+++.++.+||+|||+++.......
T Consensus 82 L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~--- 155 (269)
T cd05087 82 LKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNN---FIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDY--- 155 (269)
T ss_pred HHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC---EeccccCcceEEEcCCCcEEECCccccccccCcce---
Confidence 999997532 224677788899999999999999999 99999999999999999999999999864321110
Q ss_pred ccceeeeeccCCCCccChhhhccC-------CCCCcchhhhHHHHHHHHHh-CCCCCCCCchhHHHHHHHhhcCcchhhh
Q 002158 785 MPTHVSTIVKGTPGYLDPEYFLTH-------KLTDKSDVYSLGVVLLELLT-GMQPISHGKNIVREVNVARDSGMVFSII 856 (958)
Q Consensus 785 ~~~~~~~~~~gt~~y~aPE~~~~~-------~~~~~~DV~S~Gv~l~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~i 856 (958)
........|+..|+|||++... .++.++||||||+++|||++ |+.||.............. .......
T Consensus 156 --~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~~~~--~~~~~~~ 231 (269)
T cd05087 156 --YVTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYTVR--EQQLKLP 231 (269)
T ss_pred --eecCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHhh--cccCCCC
Confidence 1111234578889999998642 35789999999999999997 9999975443222111111 1001111
Q ss_pred cccCCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 002158 857 DNRMGSYPSECVERFVTLALRCCHDKPEHRPSMSDVVRELE 897 (958)
Q Consensus 857 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 897 (958)
. +......++.+.+++.+|| .+|++||+++||++.|+
T Consensus 232 ~---~~~~~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~ 268 (269)
T cd05087 232 K---PRLKLPLSDRWYEVMQFCW-LQPEQRPSAEEVHLLLS 268 (269)
T ss_pred C---CccCCCCChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence 1 1112234567889999999 68999999999998764
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=323.44 Aligned_cols=238 Identities=26% Similarity=0.380 Sum_probs=188.8
Q ss_pred eeeeeCCeEEEEEEECC-------------------------CcEEEEEEeccCChhcHHHHHHHHHHHHccCCCCcceE
Q 002158 632 QVGQGGYGKVYKGILSD-------------------------NTTVAIKRAEEGSLQGQNEFLTEIKLLSRLHHRNLVSL 686 (958)
Q Consensus 632 ~lg~G~~g~Vy~~~~~~-------------------------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l 686 (958)
.||+|+||.||+|.+.. ...||+|++.........+|.+|+.+++.++||||+++
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~ 81 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV 81 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence 58999999999998521 23589999876554445678999999999999999999
Q ss_pred EEEEEeCCeEEEEEEecCCCCHHHHhccCCCCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEecCCC---
Q 002158 687 LGYCDEEGEQMLVYEFVPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSNL--- 763 (958)
Q Consensus 687 ~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~~--- 763 (958)
+++|......++||||+++|+|.+++.... ..+++..++.++.|+++||+|||+.+ |+||||||+||++++++
T Consensus 82 ~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~---iiH~dlkp~Nill~~~~~~~ 157 (274)
T cd05076 82 HGVCVRGSENIMVEEFVEHGPLDVCLRKEK-GRVPVAWKITVAQQLASALSYLEDKN---LVHGNVCAKNILLARLGLAE 157 (274)
T ss_pred EEEEEeCCceEEEEecCCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHcCC---ccCCCCCcccEEEeccCccc
Confidence 999999999999999999999999996532 35889999999999999999999998 99999999999997654
Q ss_pred ----CeEEeeeeeecccccCCCCCCccceeeeeccCCCCccChhhhcc-CCCCCcchhhhHHHHHHHHH-hCCCCCCCCc
Q 002158 764 ----NAKVADFGLSRLAPVLDDEGTMPTHVSTIVKGTPGYLDPEYFLT-HKLTDKSDVYSLGVVLLELL-TGMQPISHGK 837 (958)
Q Consensus 764 ----~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DV~S~Gv~l~ell-tG~~P~~~~~ 837 (958)
.+|++|||++...... ....++..|+|||.+.+ ..++.++||||||+++|||+ +|+.||....
T Consensus 158 ~~~~~~kl~d~g~~~~~~~~-----------~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~ 226 (274)
T cd05076 158 GTSPFIKLSDPGVSFTALSR-----------EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERT 226 (274)
T ss_pred CccceeeecCCccccccccc-----------cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccC
Confidence 3899999987643110 11247788999999875 56889999999999999995 6999986533
Q ss_pred hhHHHHHHHhhcCcchhhhcccCCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 002158 838 NIVREVNVARDSGMVFSIIDNRMGSYPSECVERFVTLALRCCHDKPEHRPSMSDVVREL 896 (958)
Q Consensus 838 ~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 896 (958)
.... ..... . ....+......+.+++.+||+.+|++||+++++++.|
T Consensus 227 ~~~~-~~~~~----------~-~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~il~~L 273 (274)
T cd05076 227 PSEK-ERFYE----------K-KHRLPEPSCKELATLISQCLTYEPTQRPSFRTILRDL 273 (274)
T ss_pred hHHH-HHHHH----------h-ccCCCCCCChHHHHHHHHHcccChhhCcCHHHHHHhh
Confidence 2111 11000 0 0111222345789999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=324.55 Aligned_cols=262 Identities=27% Similarity=0.419 Sum_probs=203.3
Q ss_pred cCCCCCceeeeeCCeEEEEEEEC-----------------CCcEEEEEEeccCC-hhcHHHHHHHHHHHHccCCCCcceE
Q 002158 625 AYFSSSTQVGQGGYGKVYKGILS-----------------DNTTVAIKRAEEGS-LQGQNEFLTEIKLLSRLHHRNLVSL 686 (958)
Q Consensus 625 ~~~~~~~~lg~G~~g~Vy~~~~~-----------------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l 686 (958)
++|+..+.||+|+||.||++.+. ++..||+|++.... .....+|.+|+++++.++|+||+++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~ 84 (296)
T cd05095 5 KRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRL 84 (296)
T ss_pred hhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceE
Confidence 46888899999999999998643 23468999987643 3345679999999999999999999
Q ss_pred EEEEEeCCeEEEEEEecCCCCHHHHhccCCC---------CCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccce
Q 002158 687 LGYCDEEGEQMLVYEFVPNGTLRDWLSGRTK---------ENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNI 757 (958)
Q Consensus 687 ~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~---------~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NI 757 (958)
++++...+..++||||+++++|.+++..... ..+++.++..++.|++.||+|||+.+ ++||||||+||
T Consensus 85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dlkp~Ni 161 (296)
T cd05095 85 LAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLN---FVHRDLATRNC 161 (296)
T ss_pred EEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCC---eecccCChheE
Confidence 9999999999999999999999999975421 23778899999999999999999999 99999999999
Q ss_pred EecCCCCeEEeeeeeecccccCCCCCCccceeeeeccCCCCccChhhhccCCCCCcchhhhHHHHHHHHHh--CCCCCCC
Q 002158 758 LLDSNLNAKVADFGLSRLAPVLDDEGTMPTHVSTIVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVLLELLT--GMQPISH 835 (958)
Q Consensus 758 Ll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gv~l~ellt--G~~P~~~ 835 (958)
+++.++.++|+|||+++....... ........++..|+|||....+.++.++|||||||++|||++ |..||..
T Consensus 162 li~~~~~~~l~dfg~~~~~~~~~~-----~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~ 236 (296)
T cd05095 162 LVGKNYTIKIADFGMSRNLYSGDY-----YRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQ 236 (296)
T ss_pred EEcCCCCEEeccCcccccccCCcc-----eeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccc
Confidence 999999999999999875422111 011112334678999999988899999999999999999998 6788864
Q ss_pred CchhHHHHHHHhhcCcchhhh-cccCCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 002158 836 GKNIVREVNVARDSGMVFSII-DNRMGSYPSECVERFVTLALRCCHDKPEHRPSMSDVVRELEN 898 (958)
Q Consensus 836 ~~~~~~~~~~~~~~~~~~~~i-~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 898 (958)
.... ..+.... ..+... .......+..++..+.+++.+||+.||++||++.+|++.|++
T Consensus 237 ~~~~-~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 296 (296)
T cd05095 237 LSDE-QVIENTG---EFFRDQGRQVYLPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHATLLE 296 (296)
T ss_pred cChH-HHHHHHH---HHHhhccccccCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence 3321 1111000 000000 000112234566889999999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=319.12 Aligned_cols=249 Identities=36% Similarity=0.558 Sum_probs=206.1
Q ss_pred ceeeeeCCeEEEEEEECC----CcEEEEEEeccCChhc-HHHHHHHHHHHHccCCCCcceEEEEEEeCCeEEEEEEecCC
Q 002158 631 TQVGQGGYGKVYKGILSD----NTTVAIKRAEEGSLQG-QNEFLTEIKLLSRLHHRNLVSLLGYCDEEGEQMLVYEFVPN 705 (958)
Q Consensus 631 ~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~~-~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E~~~~ 705 (958)
+.||+|+||.||+|.+.. +..||+|.+....... .+.+.+|++.++.++|+|++++++++...+..++||||+++
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEG 80 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccC
Confidence 469999999999999763 7899999987654333 57899999999999999999999999999999999999999
Q ss_pred CCHHHHhccCC-------CCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEecCCCCeEEeeeeeeccccc
Q 002158 706 GTLRDWLSGRT-------KENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSRLAPV 778 (958)
Q Consensus 706 gsL~~~l~~~~-------~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~~~~ 778 (958)
++|.+++.... ...+++.++..++.|+++||+|||+.+ ++||||||+||++++++.+||+|||.++....
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~di~p~nili~~~~~~~l~dfg~~~~~~~ 157 (262)
T cd00192 81 GDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKK---FVHRDLAARNCLVGEDLVVKISDFGLSRDVYD 157 (262)
T ss_pred CcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCC---cccCccCcceEEECCCCcEEEccccccccccc
Confidence 99999997652 245999999999999999999999998 99999999999999999999999999986543
Q ss_pred CCCCCCccceeeeeccCCCCccChhhhccCCCCCcchhhhHHHHHHHHHh-CCCCCCCCchhHHHHHHHhhcCcchhhhc
Q 002158 779 LDDEGTMPTHVSTIVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVLLELLT-GMQPISHGKNIVREVNVARDSGMVFSIID 857 (958)
Q Consensus 779 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gv~l~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~i~ 857 (958)
... ........++..|+|||.+....++.++||||+|+++|||++ |..||...... ....... .
T Consensus 158 ~~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~-~~~~~~~---------~ 222 (262)
T cd00192 158 DDY-----YRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNE-EVLEYLR---------K 222 (262)
T ss_pred ccc-----cccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCHH-HHHHHHH---------c
Confidence 221 111233457889999999998889999999999999999999 69999765321 1111111 1
Q ss_pred ccCCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 002158 858 NRMGSYPSECVERFVTLALRCCHDKPEHRPSMSDVVRELE 897 (958)
Q Consensus 858 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 897 (958)
......+..++..+.+++.+||+.+|++||++.|++++|+
T Consensus 223 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~ 262 (262)
T cd00192 223 GYRLPKPEYCPDELYELMLSCWQLDPEDRPTFSELVERLE 262 (262)
T ss_pred CCCCCCCccCChHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 1122335556788999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=328.22 Aligned_cols=259 Identities=20% Similarity=0.319 Sum_probs=199.1
Q ss_pred cCCCCCceeeeeCCeEEEEEEEC-CCcEEEEEEeccCCh-hcHHHHHHHHHHHHccCCCCcceEEEEEEeCCeEEEEEEe
Q 002158 625 AYFSSSTQVGQGGYGKVYKGILS-DNTTVAIKRAEEGSL-QGQNEFLTEIKLLSRLHHRNLVSLLGYCDEEGEQMLVYEF 702 (958)
Q Consensus 625 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E~ 702 (958)
++|...+.||+|+||+||+|+.+ +++.||+|.++.... .....+.+|++++++++||||+++++++..++..++||||
T Consensus 6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 85 (309)
T cd07872 6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEY 85 (309)
T ss_pred CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeC
Confidence 45778889999999999999976 678899999875432 2334678999999999999999999999999999999999
Q ss_pred cCCCCHHHHhccCCCCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEecCCCCeEEeeeeeecccccCCCC
Q 002158 703 VPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSRLAPVLDDE 782 (958)
Q Consensus 703 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~ 782 (958)
++ ++|.+++.... ..+++..+..++.|++.||+|||+++ |+||||||+||+++.++.+||+|||+++......
T Consensus 86 ~~-~~l~~~~~~~~-~~~~~~~~~~~~~qi~~aL~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~-- 158 (309)
T cd07872 86 LD-KDLKQYMDDCG-NIMSMHNVKIFLYQILRGLAYCHRRK---VLHRDLKPQNLLINERGELKLADFGLARAKSVPT-- 158 (309)
T ss_pred CC-CCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECccccceecCCCc--
Confidence 96 58988886543 34788999999999999999999999 9999999999999999999999999987542211
Q ss_pred CCccceeeeeccCCCCccChhhhcc-CCCCCcchhhhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcCc----chhhh-
Q 002158 783 GTMPTHVSTIVKGTPGYLDPEYFLT-HKLTDKSDVYSLGVVLLELLTGMQPISHGKNIVREVNVARDSGM----VFSII- 856 (958)
Q Consensus 783 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DV~S~Gv~l~elltG~~P~~~~~~~~~~~~~~~~~~~----~~~~i- 856 (958)
.......+|+.|+|||++.+ ..++.++|||||||++|||+||+.||................+. ....+
T Consensus 159 -----~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (309)
T cd07872 159 -----KTYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGIS 233 (309)
T ss_pred -----cccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhc
Confidence 11122457899999999865 45788999999999999999999999754422111111100000 00000
Q ss_pred ------cccCC--------CCChHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 002158 857 ------DNRMG--------SYPSECVERFVTLALRCCHDKPEHRPSMSDVVRE 895 (958)
Q Consensus 857 ------~~~~~--------~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 895 (958)
+.... ......+.++.+++.+|++.||++|||++|++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 286 (309)
T cd07872 234 SNDEFKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKH 286 (309)
T ss_pred chhhhhhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhcC
Confidence 00000 0112345678899999999999999999999974
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=319.57 Aligned_cols=239 Identities=21% Similarity=0.384 Sum_probs=190.5
Q ss_pred ceeeeeCCeEEEEEEECC-------------CcEEEEEEeccCChhcHHHHHHHHHHHHccCCCCcceEEEEEEeCCeEE
Q 002158 631 TQVGQGGYGKVYKGILSD-------------NTTVAIKRAEEGSLQGQNEFLTEIKLLSRLHHRNLVSLLGYCDEEGEQM 697 (958)
Q Consensus 631 ~~lg~G~~g~Vy~~~~~~-------------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~ 697 (958)
+.||+|+||.||+|++.. ...||+|.+..........|.+|+.+++.++||||+++++++..+...+
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~ 80 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENI 80 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCE
Confidence 368999999999998632 2358899887655555567899999999999999999999999999999
Q ss_pred EEEEecCCCCHHHHhccCCCCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEecCCCC-------eEEeee
Q 002158 698 LVYEFVPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSNLN-------AKVADF 770 (958)
Q Consensus 698 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~~~-------~kl~DF 770 (958)
+||||+++|+|..++.... ..+++..+.+++.|+++||+|||+.+ |+||||||+|||++.++. ++++||
T Consensus 81 lv~e~~~~~~l~~~~~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~~~~~~~~~l~d~ 156 (262)
T cd05077 81 MVEEFVEFGPLDLFMHRKS-DVLTTPWKFKVAKQLASALSYLEDKD---LVHGNVCTKNILLAREGIDGECGPFIKLSDP 156 (262)
T ss_pred EEEecccCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHhhhCC---eECCCCCcccEEEecCCccCCCCceeEeCCC
Confidence 9999999999999987543 34899999999999999999999999 999999999999987664 899999
Q ss_pred eeecccccCCCCCCccceeeeeccCCCCccChhhhc-cCCCCCcchhhhHHHHHHHHH-hCCCCCCCCchhHHHHHHHhh
Q 002158 771 GLSRLAPVLDDEGTMPTHVSTIVKGTPGYLDPEYFL-THKLTDKSDVYSLGVVLLELL-TGMQPISHGKNIVREVNVARD 848 (958)
Q Consensus 771 Gla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DV~S~Gv~l~ell-tG~~P~~~~~~~~~~~~~~~~ 848 (958)
|++..... .....|+..|+|||++. +..++.++|||||||++|||+ +|..|+..... ........
T Consensus 157 g~~~~~~~-----------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~-~~~~~~~~- 223 (262)
T cd05077 157 GIPITVLS-----------RQECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTL-AEKERFYE- 223 (262)
T ss_pred CCCccccC-----------cccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcch-hHHHHHHh-
Confidence 99864321 11234788899999986 466888999999999999998 58888764321 11111100
Q ss_pred cCcchhhhcccCCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 002158 849 SGMVFSIIDNRMGSYPSECVERFVTLALRCCHDKPEHRPSMSDVVREL 896 (958)
Q Consensus 849 ~~~~~~~i~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 896 (958)
... ......+..+.+++.+||+.||++||++.++++.+
T Consensus 224 ---------~~~-~~~~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~ 261 (262)
T cd05077 224 ---------GQC-MLVTPSCKELADLMTHCMNYDPNQRPFFRAIMRDI 261 (262)
T ss_pred ---------cCc-cCCCCChHHHHHHHHHHcCCChhhCcCHHHHHHhc
Confidence 000 11122346789999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=325.23 Aligned_cols=249 Identities=24% Similarity=0.398 Sum_probs=206.7
Q ss_pred CCCCCceeeeeCCeEEEEEEEC-CCcEEEEEEeccCChhcHHHHHHHHHHHHccCCCCcceEEEEEEeCCeEEEEEEecC
Q 002158 626 YFSSSTQVGQGGYGKVYKGILS-DNTTVAIKRAEEGSLQGQNEFLTEIKLLSRLHHRNLVSLLGYCDEEGEQMLVYEFVP 704 (958)
Q Consensus 626 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E~~~ 704 (958)
+|+..+.||.|+||.||+|... +++.||+|.+........+.+.+|+.+++.++|+|++++++++...+..++||||++
T Consensus 20 ~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 99 (296)
T cd06655 20 KYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEYLA 99 (296)
T ss_pred eEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEEecC
Confidence 5777889999999999999964 789999999876555556778999999999999999999999999999999999999
Q ss_pred CCCHHHHhccCCCCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEecCCCCeEEeeeeeecccccCCCCCC
Q 002158 705 NGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSRLAPVLDDEGT 784 (958)
Q Consensus 705 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 784 (958)
+++|.+++... .+++.++..++.|++.||+|||+.+ ++||||||+||+++.++.+||+|||++........
T Consensus 100 ~~~L~~~~~~~---~l~~~~~~~i~~~l~~al~~LH~~~---i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~--- 170 (296)
T cd06655 100 GGSLTDVVTET---CMDEAQIAAVCRECLQALEFLHANQ---VIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQS--- 170 (296)
T ss_pred CCcHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEccCccchhcccccc---
Confidence 99999999643 3899999999999999999999999 99999999999999999999999999875432111
Q ss_pred ccceeeeeccCCCCccChhhhccCCCCCcchhhhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcCcchhhhcccCCCCC
Q 002158 785 MPTHVSTIVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVLLELLTGMQPISHGKNIVREVNVARDSGMVFSIIDNRMGSYP 864 (958)
Q Consensus 785 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gv~l~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~ 864 (958)
......|+..|+|||.+.+..++.++|||||||++|||++|+.||............... . ......+
T Consensus 171 ----~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~~~~~~~-~-------~~~~~~~ 238 (296)
T cd06655 171 ----KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATN-G-------TPELQNP 238 (296)
T ss_pred ----cCCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc-C-------CcccCCc
Confidence 112345888999999999888999999999999999999999999765543322211110 0 0011224
Q ss_pred hHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 002158 865 SECVERFVTLALRCCHDKPEHRPSMSDVVRE 895 (958)
Q Consensus 865 ~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 895 (958)
..++..+.+++.+||..||++||++.+++++
T Consensus 239 ~~~~~~~~~li~~~l~~dp~~Rpt~~~il~~ 269 (296)
T cd06655 239 EKLSPIFRDFLNRCLEMDVEKRGSAKELLQH 269 (296)
T ss_pred ccCCHHHHHHHHHHhhcChhhCCCHHHHhhC
Confidence 4566788999999999999999999999964
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-35 Score=325.72 Aligned_cols=256 Identities=23% Similarity=0.371 Sum_probs=202.2
Q ss_pred cCCCCCceeeeeCCeEEEEEEEC-CCcEEEEEEeccCC-hhcHHHHHHHHHHHHccCCCCcceEEEEEEeCCeEEEEEEe
Q 002158 625 AYFSSSTQVGQGGYGKVYKGILS-DNTTVAIKRAEEGS-LQGQNEFLTEIKLLSRLHHRNLVSLLGYCDEEGEQMLVYEF 702 (958)
Q Consensus 625 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E~ 702 (958)
++|+..+.||+|+||.||+|.+. ++..||+|.+.... .....++.+|++++++++||||+++++++..++..++||||
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey 80 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEH 80 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeec
Confidence 36888899999999999999976 57889999887542 33345688999999999999999999999999999999999
Q ss_pred cCCCCHHHHhccCCCCCchHHHHHHHHHHHHHHHHHhhh-cCCCCeeccCCCccceEecCCCCeEEeeeeeecccccCCC
Q 002158 703 VPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHT-EAHPPVFHRDIKASNILLDSNLNAKVADFGLSRLAPVLDD 781 (958)
Q Consensus 703 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~-~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~ 781 (958)
+++++|.++++.. ..+++..+..++.|+++||.|||+ .+ ++||||||+||+++.++.+||+|||++......
T Consensus 81 ~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~-- 153 (308)
T cd06615 81 MDGGSLDQVLKKA--GRIPENILGKISIAVLRGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-- 153 (308)
T ss_pred cCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhhCC---EEECCCChHHEEEecCCcEEEccCCCccccccc--
Confidence 9999999999755 348899999999999999999997 46 999999999999999999999999998644211
Q ss_pred CCCccceeeeeccCCCCccChhhhccCCCCCcchhhhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcCc-c--------
Q 002158 782 EGTMPTHVSTIVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVLLELLTGMQPISHGKNIVREVNVARDSGM-V-------- 852 (958)
Q Consensus 782 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gv~l~elltG~~P~~~~~~~~~~~~~~~~~~~-~-------- 852 (958)
......|+..|+|||++.+..++.++||||||+++|||++|+.||...... ........... .
T Consensus 154 -------~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~ 225 (308)
T cd06615 154 -------MANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAK-ELEAMFGRPVSEGEAKESHRP 225 (308)
T ss_pred -------ccccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchh-hHHHhhcCccccccccCCccc
Confidence 112346889999999998888999999999999999999999998643321 11110000000 0
Q ss_pred --------------hh----hhcccCCCCC-hHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 002158 853 --------------FS----IIDNRMGSYP-SECVERFVTLALRCCHDKPEHRPSMSDVVRE 895 (958)
Q Consensus 853 --------------~~----~i~~~~~~~~-~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 895 (958)
.+ ......+..+ ...+.++.+++.+||..+|++||++++++++
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~ 287 (308)
T cd06615 226 VSGHPPDSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKH 287 (308)
T ss_pred ccCCCCCccchhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 00 0000011111 1245679999999999999999999999976
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=334.87 Aligned_cols=257 Identities=23% Similarity=0.302 Sum_probs=199.0
Q ss_pred HHcCCCCCceeeeeCCeEEEEEEEC-CCcEEEEEEeccC--ChhcHHHHHHHHHHHHccCCCCcceEEEEEEeC------
Q 002158 623 ATAYFSSSTQVGQGGYGKVYKGILS-DNTTVAIKRAEEG--SLQGQNEFLTEIKLLSRLHHRNLVSLLGYCDEE------ 693 (958)
Q Consensus 623 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~------ 693 (958)
..++|...+.||+|+||.||+|... .++.||||++... .......+.+|+.+++.++||||+++++++...
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 94 (355)
T cd07874 15 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEF 94 (355)
T ss_pred hhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeecccccccc
Confidence 4467888999999999999999875 6889999998754 223345788999999999999999999988643
Q ss_pred CeEEEEEEecCCCCHHHHhccCCCCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEecCCCCeEEeeeeee
Q 002158 694 GEQMLVYEFVPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSNLNAKVADFGLS 773 (958)
Q Consensus 694 ~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla 773 (958)
...++||||++ +++.+.+.. .+++..+..++.|+++||+|||+.+ |+||||||+|||++.++.+||+|||++
T Consensus 95 ~~~~lv~e~~~-~~l~~~~~~----~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDikp~Nill~~~~~~kl~Dfg~~ 166 (355)
T cd07874 95 QDVYLVMELMD-ANLCQVIQM----ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLA 166 (355)
T ss_pred ceeEEEhhhhc-ccHHHHHhh----cCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHHEEECCCCCEEEeeCccc
Confidence 35799999996 577777743 3788899999999999999999999 999999999999999999999999999
Q ss_pred cccccCCCCCCccceeeeeccCCCCccChhhhccCCCCCcchhhhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcCc--
Q 002158 774 RLAPVLDDEGTMPTHVSTIVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVLLELLTGMQPISHGKNIVREVNVARDSGM-- 851 (958)
Q Consensus 774 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gv~l~elltG~~P~~~~~~~~~~~~~~~~~~~-- 851 (958)
+..... .......||..|+|||++.+..++.++|||||||++|||++|+.||................+.
T Consensus 167 ~~~~~~--------~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~ 238 (355)
T cd07874 167 RTAGTS--------FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPC 238 (355)
T ss_pred ccCCCc--------cccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCC
Confidence 754211 1122346899999999999999999999999999999999999999765433222111111000
Q ss_pred ----------chhhhccc----------------C---CCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 002158 852 ----------VFSIIDNR----------------M---GSYPSECVERFVTLALRCCHDKPEHRPSMSDVVRE 895 (958)
Q Consensus 852 ----------~~~~i~~~----------------~---~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 895 (958)
....+... . ...+......+.+++.+|++.||++|||+.|++++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~h 311 (355)
T cd07874 239 PEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQH 311 (355)
T ss_pred HHHHHhhcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcC
Confidence 00000000 0 00111234578899999999999999999999985
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=299.76 Aligned_cols=254 Identities=24% Similarity=0.400 Sum_probs=204.9
Q ss_pred HHHcCCCCCceeeeeCCeEEEEEEEC-CCcEEEEEEeccCCh----hc----HHHHHHHHHHHHcc-CCCCcceEEEEEE
Q 002158 622 MATAYFSSSTQVGQGGYGKVYKGILS-DNTTVAIKRAEEGSL----QG----QNEFLTEIKLLSRL-HHRNLVSLLGYCD 691 (958)
Q Consensus 622 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~----~~----~~~~~~E~~~l~~l-~H~niv~l~~~~~ 691 (958)
..-+.|...+.||.|..++|.+...+ +|..+|+|++..... .. .+.-.+|+.+|+++ .||+|+++.++++
T Consensus 14 ~fy~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~ye 93 (411)
T KOG0599|consen 14 GFYAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYE 93 (411)
T ss_pred hHHhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeecc
Confidence 34456777789999999999998876 688999998864311 11 23456799999999 6999999999999
Q ss_pred eCCeEEEEEEecCCCCHHHHhccCCCCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEecCCCCeEEeeee
Q 002158 692 EEGEQMLVYEFVPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSNLNAKVADFG 771 (958)
Q Consensus 692 ~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~~~~kl~DFG 771 (958)
.+...++|+|.|+.|.|.|+|.+.. .+++.+..+|+.|+.+|++|||... |||||+||+|||+|++.++||+|||
T Consensus 94 s~sF~FlVFdl~prGELFDyLts~V--tlSEK~tR~iMrqlfegVeylHa~~---IVHRDLKpENILlddn~~i~isDFG 168 (411)
T KOG0599|consen 94 SDAFVFLVFDLMPRGELFDYLTSKV--TLSEKETRRIMRQLFEGVEYLHARN---IVHRDLKPENILLDDNMNIKISDFG 168 (411)
T ss_pred CcchhhhhhhhcccchHHHHhhhhe--eecHHHHHHHHHHHHHHHHHHHHhh---hhhcccChhheeeccccceEEeccc
Confidence 9999999999999999999997654 4999999999999999999999999 9999999999999999999999999
Q ss_pred eecccccCCCCCCccceeeeeccCCCCccChhhhcc------CCCCCcchhhhHHHHHHHHHhCCCCCCCCchhHHHHHH
Q 002158 772 LSRLAPVLDDEGTMPTHVSTIVKGTPGYLDPEYFLT------HKLTDKSDVYSLGVVLLELLTGMQPISHGKNIVREVNV 845 (958)
Q Consensus 772 la~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~~DV~S~Gv~l~elltG~~P~~~~~~~~~~~~~ 845 (958)
+|+.++. .......+||++|+|||.+.. ..|+...|+||.||+||-++.|.+||...+.+... +.
T Consensus 169 Fa~~l~~--------GekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQmlML-R~ 239 (411)
T KOG0599|consen 169 FACQLEP--------GEKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQMLML-RM 239 (411)
T ss_pred eeeccCC--------chhHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHHHHHH-HH
Confidence 9987643 233456789999999999853 25778999999999999999999999654432211 11
Q ss_pred HhhcCcchhhhcccCCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 002158 846 ARDSGMVFSIIDNRMGSYPSECVERFVTLALRCCHDKPEHRPSMSDVVRE 895 (958)
Q Consensus 846 ~~~~~~~~~~i~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 895 (958)
... +. ++.- ...-.+......+||.+|++.||.+|-|++|++++
T Consensus 240 Ime-Gk-yqF~----speWadis~~~KdLIsrlLqVdp~~Ritake~LaH 283 (411)
T KOG0599|consen 240 IME-GK-YQFR----SPEWADISATVKDLISRLLQVDPTKRITAKEALAH 283 (411)
T ss_pred HHh-cc-cccC----CcchhhccccHHHHHHHHHeeCchhcccHHHHhcC
Confidence 111 10 0000 11124566788999999999999999999999976
|
|
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=302.74 Aligned_cols=252 Identities=23% Similarity=0.357 Sum_probs=202.7
Q ss_pred HcCCCCCceeeeeCCeEEEEEEEC-CCcEEEEEEeccC--ChhcHHHHHHHHHHHHccCCCCcceEEEEEEeCCeEEEEE
Q 002158 624 TAYFSSSTQVGQGGYGKVYKGILS-DNTTVAIKRAEEG--SLQGQNEFLTEIKLLSRLHHRNLVSLLGYCDEEGEQMLVY 700 (958)
Q Consensus 624 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~ 700 (958)
++.|+..+.||+|.|+.||+.... .|+.+|+|.+... ...+.+++.+|+++-+.++||||+++.+.+.+.+..|+|+
T Consensus 10 ~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylvF 89 (355)
T KOG0033|consen 10 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF 89 (355)
T ss_pred chhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEEE
Confidence 345666778999999999999865 7899999977543 2335567889999999999999999999999999999999
Q ss_pred EecCCCCHHHHhccCCCCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEecC---CCCeEEeeeeeecccc
Q 002158 701 EFVPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDS---NLNAKVADFGLSRLAP 777 (958)
Q Consensus 701 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~---~~~~kl~DFGla~~~~ 777 (958)
|+|.|++|..-|-.+ ..+++..+-+...||++||.|+|.++ |||||+||+|+++-. .--+||+|||+|..+.
T Consensus 90 e~m~G~dl~~eIV~R--~~ySEa~aSH~~rQiLeal~yCH~n~---IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~ 164 (355)
T KOG0033|consen 90 DLVTGGELFEDIVAR--EFYSEADASHCIQQILEALAYCHSNG---IVHRDLKPENLLLASKAKGAAVKLADFGLAIEVN 164 (355)
T ss_pred ecccchHHHHHHHHH--HHHHHHHHHHHHHHHHHHHHHHHhcC---ceeccCChhheeeeeccCCCceeecccceEEEeC
Confidence 999999997666433 34888889999999999999999999 999999999999943 3459999999998664
Q ss_pred cCCCCCCccceeeeeccCCCCccChhhhccCCCCCcchhhhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcCcchhhhc
Q 002158 778 VLDDEGTMPTHVSTIVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVLLELLTGMQPISHGKNIVREVNVARDSGMVFSIID 857 (958)
Q Consensus 778 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gv~l~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~i~ 857 (958)
. ......+.||++|||||++...+|+..+|||+-||+||-++.|..||.+.... ........... +.
T Consensus 165 ----~----g~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~-rlye~I~~g~y--d~-- 231 (355)
T KOG0033|consen 165 ----D----GEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQH-RLYEQIKAGAY--DY-- 231 (355)
T ss_pred ----C----ccccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccHH-HHHHHHhcccc--CC--
Confidence 1 23345678999999999999999999999999999999999999999763321 11111111000 00
Q ss_pred ccCCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 002158 858 NRMGSYPSECVERFVTLALRCCHDKPEHRPSMSDVVRE 895 (958)
Q Consensus 858 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 895 (958)
.+..-+...++..+|+.+|+..||.+|.|+.|.+++
T Consensus 232 --~~~~w~~is~~Ak~LvrrML~~dP~kRIta~EAL~H 267 (355)
T KOG0033|consen 232 --PSPEWDTVTPEAKSLIRRMLTVNPKKRITADEALKH 267 (355)
T ss_pred --CCcccCcCCHHHHHHHHHHhccChhhhccHHHHhCC
Confidence 011223556788999999999999999999998864
|
|
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=325.77 Aligned_cols=250 Identities=24% Similarity=0.369 Sum_probs=205.9
Q ss_pred cCCCCCceeeeeCCeEEEEEEEC-CCcEEEEEEeccCChhcHHHHHHHHHHHHccCCCCcceEEEEEEeCCeEEEEEEec
Q 002158 625 AYFSSSTQVGQGGYGKVYKGILS-DNTTVAIKRAEEGSLQGQNEFLTEIKLLSRLHHRNLVSLLGYCDEEGEQMLVYEFV 703 (958)
Q Consensus 625 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E~~ 703 (958)
.+|+..+.||+|+||.||+|... +++.||+|.+........+.+.+|+.+++.++|+||+++++++..++..++||||+
T Consensus 19 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~ 98 (297)
T cd06656 19 KKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL 98 (297)
T ss_pred hhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeeccc
Confidence 57888899999999999999974 78999999987655555667899999999999999999999999999999999999
Q ss_pred CCCCHHHHhccCCCCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEecCCCCeEEeeeeeecccccCCCCC
Q 002158 704 PNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSRLAPVLDDEG 783 (958)
Q Consensus 704 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 783 (958)
++++|.+++... .+++.++..++.|++.||.|||+.+ ++||||||+||+++.++.++|+|||++........
T Consensus 99 ~~~~L~~~~~~~---~~~~~~~~~~~~~l~~~L~~LH~~~---i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~~-- 170 (297)
T cd06656 99 AGGSLTDVVTET---CMDEGQIAAVCRECLQALDFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS-- 170 (297)
T ss_pred CCCCHHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEECcCccceEccCCcc--
Confidence 999999999643 3788999999999999999999998 99999999999999999999999999875422111
Q ss_pred CccceeeeeccCCCCccChhhhccCCCCCcchhhhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcCcchhhhcccCCCC
Q 002158 784 TMPTHVSTIVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVLLELLTGMQPISHGKNIVREVNVARDSGMVFSIIDNRMGSY 863 (958)
Q Consensus 784 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gv~l~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~ 863 (958)
......|++.|+|||.+.+..++.++|||||||++|+|++|..||.............. . .......
T Consensus 171 -----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~~~~-~-------~~~~~~~ 237 (297)
T cd06656 171 -----KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIAT-N-------GTPELQN 237 (297)
T ss_pred -----CcCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheeeecc-C-------CCCCCCC
Confidence 11234588899999999998899999999999999999999999965432211110000 0 0000122
Q ss_pred ChHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 002158 864 PSECVERFVTLALRCCHDKPEHRPSMSDVVRE 895 (958)
Q Consensus 864 ~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 895 (958)
+...+..+.+++.+||+.+|++||++++++++
T Consensus 238 ~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 269 (297)
T cd06656 238 PERLSAVFRDFLNRCLEMDVDRRGSAKELLQH 269 (297)
T ss_pred ccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 44566778999999999999999999999974
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-36 Score=322.55 Aligned_cols=239 Identities=26% Similarity=0.438 Sum_probs=191.9
Q ss_pred ceeeeeCCeEEEEEEECC--------CcEEEEEEeccCChhcHHHHHHHHHHHHccCCCCcceEEEEEEeCCeEEEEEEe
Q 002158 631 TQVGQGGYGKVYKGILSD--------NTTVAIKRAEEGSLQGQNEFLTEIKLLSRLHHRNLVSLLGYCDEEGEQMLVYEF 702 (958)
Q Consensus 631 ~~lg~G~~g~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E~ 702 (958)
+.||+|+||.||+|..+. ...||+|.+........+++.+|+.+++.++|||++++++++..++..++||||
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~ 80 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEY 80 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEec
Confidence 368999999999998642 234888888765555566889999999999999999999999998999999999
Q ss_pred cCCCCHHHHhccCCCCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEecCCCC--------eEEeeeeeec
Q 002158 703 VPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSNLN--------AKVADFGLSR 774 (958)
Q Consensus 703 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~~~--------~kl~DFGla~ 774 (958)
+++|+|.++++.... .+++..++.++.|++.||+|||+.+ |+||||||+||+++.++. ++++|||++.
T Consensus 81 ~~~g~L~~~l~~~~~-~~~~~~~~~~~~qi~~~l~~lH~~~---iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~~ 156 (258)
T cd05078 81 VKFGSLDTYLKKNKN-LINISWKLEVAKQLAWALHFLEDKG---LTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISI 156 (258)
T ss_pred CCCCcHHHHHhcCCC-CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCccceEEEecccccccCCCceEEeccccccc
Confidence 999999999976543 5889999999999999999999999 999999999999987765 5899999876
Q ss_pred ccccCCCCCCccceeeeeccCCCCccChhhhccC-CCCCcchhhhHHHHHHHHHhCC-CCCCCCchhHHHHHHHhhcCcc
Q 002158 775 LAPVLDDEGTMPTHVSTIVKGTPGYLDPEYFLTH-KLTDKSDVYSLGVVLLELLTGM-QPISHGKNIVREVNVARDSGMV 852 (958)
Q Consensus 775 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DV~S~Gv~l~elltG~-~P~~~~~~~~~~~~~~~~~~~~ 852 (958)
.... .....++..|+|||++.+. .++.++||||||+++|||++|. .|+...... .......
T Consensus 157 ~~~~-----------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~-~~~~~~~----- 219 (258)
T cd05078 157 TVLP-----------KEILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQ-KKLQFYE----- 219 (258)
T ss_pred ccCC-----------chhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHH-HHHHHHH-----
Confidence 4311 1224578899999999864 5788999999999999999985 555432221 1111111
Q ss_pred hhhhcccCCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 002158 853 FSIIDNRMGSYPSECVERFVTLALRCCHDKPEHRPSMSDVVREL 896 (958)
Q Consensus 853 ~~~i~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 896 (958)
.....+.....++.+++.+||+.+|++||+++++++.|
T Consensus 220 ------~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l 257 (258)
T cd05078 220 ------DRHQLPAPKWTELANLINQCMDYEPDFRPSFRAIIRDL 257 (258)
T ss_pred ------ccccCCCCCcHHHHHHHHHHhccChhhCCCHHHHHHhc
Confidence 11123334456789999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=322.98 Aligned_cols=253 Identities=26% Similarity=0.370 Sum_probs=206.3
Q ss_pred HcCCCCCceeeeeCCeEEEEEEEC-CCcEEEEEEeccCChhcHHHHHHHHHHHHccCCCCcceEEEEEEeCCeEEEEEEe
Q 002158 624 TAYFSSSTQVGQGGYGKVYKGILS-DNTTVAIKRAEEGSLQGQNEFLTEIKLLSRLHHRNLVSLLGYCDEEGEQMLVYEF 702 (958)
Q Consensus 624 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E~ 702 (958)
.++|++.+.||+|+||.||+|.+. ++..||+|.+........+.|.+|++++++++|+||+++++++..+...++||||
T Consensus 4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (280)
T cd06611 4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEF 83 (280)
T ss_pred hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEeec
Confidence 346777889999999999999975 6889999999876666667899999999999999999999999999999999999
Q ss_pred cCCCCHHHHhccCCCCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEecCCCCeEEeeeeeecccccCCCC
Q 002158 703 VPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSRLAPVLDDE 782 (958)
Q Consensus 703 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~ 782 (958)
+++++|.+++.... ..+++..+..++.|++.||+|||+.+ |+|+||||+||+++.++.++|+|||++.......
T Consensus 84 ~~~~~L~~~~~~~~-~~l~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~-- 157 (280)
T cd06611 84 CDGGALDSIMLELE-RGLTEPQIRYVCRQMLEALNFLHSHK---VIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTL-- 157 (280)
T ss_pred cCCCcHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEECCCCCEEEccCccchhhcccc--
Confidence 99999999987543 34899999999999999999999999 9999999999999999999999999986542211
Q ss_pred CCccceeeeeccCCCCccChhhhc-----cCCCCCcchhhhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcCcchhhhc
Q 002158 783 GTMPTHVSTIVKGTPGYLDPEYFL-----THKLTDKSDVYSLGVVLLELLTGMQPISHGKNIVREVNVARDSGMVFSIID 857 (958)
Q Consensus 783 ~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DV~S~Gv~l~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~i~ 857 (958)
.......|++.|+|||++. ...++.++||||||+++|||++|+.||........... ... ...
T Consensus 158 -----~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~~~~~-~~~-~~~----- 225 (280)
T cd06611 158 -----QKRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRVLLK-ILK-SEP----- 225 (280)
T ss_pred -----cccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHHHHHH-Hhc-CCC-----
Confidence 1122345899999999985 34467799999999999999999999975433221111 111 000
Q ss_pred ccCCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 002158 858 NRMGSYPSECVERFVTLALRCCHDKPEHRPSMSDVVRE 895 (958)
Q Consensus 858 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 895 (958)
.....+..++..+.+++.+||+.+|++||++.+++++
T Consensus 226 -~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 262 (280)
T cd06611 226 -PTLDQPSKWSSSFNDFLKSCLVKDPDDRPTAAELLKH 262 (280)
T ss_pred -CCcCCcccCCHHHHHHHHHHhccChhhCcCHHHHhcC
Confidence 0011234566789999999999999999999999875
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-35 Score=315.09 Aligned_cols=250 Identities=26% Similarity=0.378 Sum_probs=207.5
Q ss_pred CCCCCceeeeeCCeEEEEEEEC-CCcEEEEEEeccC--ChhcHHHHHHHHHHHHccCCCCcceEEEEEEeCCeEEEEEEe
Q 002158 626 YFSSSTQVGQGGYGKVYKGILS-DNTTVAIKRAEEG--SLQGQNEFLTEIKLLSRLHHRNLVSLLGYCDEEGEQMLVYEF 702 (958)
Q Consensus 626 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E~ 702 (958)
+|+..+.||+|+||.||.+... +++.|++|.+... .....+++.+|++++++++|+||+++++++.+.+..++||||
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~ 80 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEY 80 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEe
Confidence 4777889999999999999865 6889999987653 344456789999999999999999999999999999999999
Q ss_pred cCCCCHHHHhccCCCCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEecCCCCeEEeeeeeecccccCCCC
Q 002158 703 VPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSRLAPVLDDE 782 (958)
Q Consensus 703 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~ 782 (958)
+++++|.+++.......+++.++..++.|+++||+|||+.+ ++||||||+||++++++.+||+|||+++.......
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~- 156 (256)
T cd08221 81 ANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAG---ILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYS- 156 (256)
T ss_pred cCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCChHhEEEeCCCCEEECcCcceEEcccccc-
Confidence 99999999998664556899999999999999999999998 99999999999999999999999999976532221
Q ss_pred CCccceeeeeccCCCCccChhhhccCCCCCcchhhhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcCcchhhhcccCCC
Q 002158 783 GTMPTHVSTIVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVLLELLTGMQPISHGKNIVREVNVARDSGMVFSIIDNRMGS 862 (958)
Q Consensus 783 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gv~l~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~ 862 (958)
......|++.|+|||++.+..++.++||||||+++|||++|..||..... ........ ......
T Consensus 157 ------~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~-~~~~~~~~---------~~~~~~ 220 (256)
T cd08221 157 ------MAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNP-LNLVVKIV---------QGNYTP 220 (256)
T ss_pred ------cccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCH-HHHHHHHH---------cCCCCC
Confidence 11234589999999999888889999999999999999999999965332 22221111 111222
Q ss_pred CChHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 002158 863 YPSECVERFVTLALRCCHDKPEHRPSMSDVVRE 895 (958)
Q Consensus 863 ~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 895 (958)
.+...+..+.+++.+||+.+|++||++.+++++
T Consensus 221 ~~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~ 253 (256)
T cd08221 221 VVSVYSSELISLVHSLLQQDPEKRPTADEVLDQ 253 (256)
T ss_pred CccccCHHHHHHHHHHcccCcccCCCHHHHhhC
Confidence 234567789999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-35 Score=334.10 Aligned_cols=256 Identities=22% Similarity=0.290 Sum_probs=198.4
Q ss_pred HcCCCCCceeeeeCCeEEEEEEEC-CCcEEEEEEeccC--ChhcHHHHHHHHHHHHccCCCCcceEEEEEEeC------C
Q 002158 624 TAYFSSSTQVGQGGYGKVYKGILS-DNTTVAIKRAEEG--SLQGQNEFLTEIKLLSRLHHRNLVSLLGYCDEE------G 694 (958)
Q Consensus 624 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~------~ 694 (958)
.++|...+.||+|+||.||+|... .++.||||++... .......+.+|+.+++.++||||+++++++... .
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~~ 102 (364)
T cd07875 23 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ 102 (364)
T ss_pred hcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeecccccccccC
Confidence 467888999999999999999975 6889999998753 233345788999999999999999999987543 3
Q ss_pred eEEEEEEecCCCCHHHHhccCCCCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEecCCCCeEEeeeeeec
Q 002158 695 EQMLVYEFVPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSR 774 (958)
Q Consensus 695 ~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~ 774 (958)
..++||||++ ++|.+++.. .+++..+..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+++
T Consensus 103 ~~~lv~e~~~-~~l~~~~~~----~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~a~ 174 (364)
T cd07875 103 DVYIVMELMD-ANLCQVIQM----ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR 174 (364)
T ss_pred eEEEEEeCCC-CCHHHHHHh----cCCHHHHHHHHHHHHHHHHHHhhCC---eecCCCCHHHEEECCCCcEEEEeCCCcc
Confidence 5799999996 578887743 2788899999999999999999999 9999999999999999999999999997
Q ss_pred ccccCCCCCCccceeeeeccCCCCccChhhhccCCCCCcchhhhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcCcc--
Q 002158 775 LAPVLDDEGTMPTHVSTIVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVLLELLTGMQPISHGKNIVREVNVARDSGMV-- 852 (958)
Q Consensus 775 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gv~l~elltG~~P~~~~~~~~~~~~~~~~~~~~-- 852 (958)
..... .......||..|+|||++.+..++.++|||||||++|||++|+.||................+..
T Consensus 175 ~~~~~--------~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~ 246 (364)
T cd07875 175 TAGTS--------FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCP 246 (364)
T ss_pred ccCCC--------CcccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCH
Confidence 54211 11223468999999999999999999999999999999999999997654433222211110100
Q ss_pred ----------hhhhcccC-------------------CCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 002158 853 ----------FSIIDNRM-------------------GSYPSECVERFVTLALRCCHDKPEHRPSMSDVVRE 895 (958)
Q Consensus 853 ----------~~~i~~~~-------------------~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 895 (958)
........ ..........+.+++.+|++.||.+|||+.|++++
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~h 318 (364)
T cd07875 247 EFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH 318 (364)
T ss_pred HHHHhhhHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence 00000000 00011124578899999999999999999999975
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=322.34 Aligned_cols=249 Identities=24% Similarity=0.395 Sum_probs=198.0
Q ss_pred CCCCCceeeeeCCeEEEEEEEC-CCcEEEEEEeccC-ChhcHHHHHHHHHHHHccCCCCcceEEEEEEeCCeEEEEEEec
Q 002158 626 YFSSSTQVGQGGYGKVYKGILS-DNTTVAIKRAEEG-SLQGQNEFLTEIKLLSRLHHRNLVSLLGYCDEEGEQMLVYEFV 703 (958)
Q Consensus 626 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E~~ 703 (958)
+|+..+.||+|+||.||+|.+. +++.||+|++... ......+|.+|++++++++||||+++++++...+..++||||+
T Consensus 2 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 81 (279)
T cd06619 2 DIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEFM 81 (279)
T ss_pred cchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEecC
Confidence 5677889999999999999975 6889999998654 3334567999999999999999999999999999999999999
Q ss_pred CCCCHHHHhccCCCCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEecCCCCeEEeeeeeecccccCCCCC
Q 002158 704 PNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSRLAPVLDDEG 783 (958)
Q Consensus 704 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 783 (958)
++++|..+. .+++..+..++.|++.||+|||+.+ |+|+||||+||+++.++.++|+|||++......
T Consensus 82 ~~~~l~~~~------~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~---- 148 (279)
T cd06619 82 DGGSLDVYR------KIPEHVLGRIAVAVVKGLTYLWSLK---ILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNS---- 148 (279)
T ss_pred CCCChHHhh------cCCHHHHHHHHHHHHHHHHHHHHCC---EeeCCCCHHHEEECCCCCEEEeeCCcceecccc----
Confidence 999997653 2678888999999999999999999 999999999999999999999999998754211
Q ss_pred CccceeeeeccCCCCccChhhhccCCCCCcchhhhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcCcchhhhcccCCCC
Q 002158 784 TMPTHVSTIVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVLLELLTGMQPISHGKNIVREVNVARDSGMVFSIIDNRMGSY 863 (958)
Q Consensus 784 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gv~l~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~ 863 (958)
......|+..|+|||++.+..++.++||||||+++|||++|+.||............. .......+......
T Consensus 149 -----~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~---~~~~~~~~~~~~~~ 220 (279)
T cd06619 149 -----IAKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPL---QLLQCIVDEDPPVL 220 (279)
T ss_pred -----cccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchH---HHHHHHhccCCCCC
Confidence 1223468999999999999899999999999999999999999996422110000000 00000001111111
Q ss_pred -ChHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 002158 864 -PSECVERFVTLALRCCHDKPEHRPSMSDVVRE 895 (958)
Q Consensus 864 -~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 895 (958)
....+.++.+++.+||+.+|++||+++|++++
T Consensus 221 ~~~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~ 253 (279)
T cd06619 221 PVGQFSEKFVHFITQCMRKQPKERPAPENLMDH 253 (279)
T ss_pred CCCcCCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence 12345678999999999999999999999875
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=319.89 Aligned_cols=253 Identities=23% Similarity=0.340 Sum_probs=201.6
Q ss_pred cCCCCCceeeeeCCeEEEEEEEC-CCcEEEEEEeccCChhcHHHHHHHHHHHHccCCCCcceEEEEEEeCCeEEEEEEec
Q 002158 625 AYFSSSTQVGQGGYGKVYKGILS-DNTTVAIKRAEEGSLQGQNEFLTEIKLLSRLHHRNLVSLLGYCDEEGEQMLVYEFV 703 (958)
Q Consensus 625 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E~~ 703 (958)
++|...+.||+|+||.||+|.+. +++.||+|.++.........+.+|+.+++.++||||+++++++...+..++||||+
T Consensus 9 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e~~ 88 (267)
T cd06645 9 EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEFC 88 (267)
T ss_pred HHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEecc
Confidence 35566678999999999999975 68899999987655455567889999999999999999999999999999999999
Q ss_pred CCCCHHHHhccCCCCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEecCCCCeEEeeeeeecccccCCCCC
Q 002158 704 PNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSRLAPVLDDEG 783 (958)
Q Consensus 704 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 783 (958)
++++|.+++.... .+++.++..++.|++.|++|||+.+ ++|+||||+||+++.++.++|+|||++.......
T Consensus 89 ~~~~L~~~~~~~~--~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~--- 160 (267)
T cd06645 89 GGGSLQDIYHVTG--PLSESQIAYVSRETLQGLYYLHSKG---KMHRDIKGANILLTDNGHVKLADFGVSAQITATI--- 160 (267)
T ss_pred CCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECcceeeeEccCcc---
Confidence 9999999996543 4899999999999999999999999 9999999999999999999999999987542211
Q ss_pred CccceeeeeccCCCCccChhhhc---cCCCCCcchhhhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcCcchhhhcccC
Q 002158 784 TMPTHVSTIVKGTPGYLDPEYFL---THKLTDKSDVYSLGVVLLELLTGMQPISHGKNIVREVNVARDSGMVFSIIDNRM 860 (958)
Q Consensus 784 ~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DV~S~Gv~l~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~i~~~~ 860 (958)
.......|+..|+|||++. ...++.++|||||||++|||++|..||............... .... ...
T Consensus 161 ----~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~~~~~~-~~~~----~~~ 231 (267)
T cd06645 161 ----AKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTKS-NFQP----PKL 231 (267)
T ss_pred ----cccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhHHhhhcc-CCCC----Ccc
Confidence 1122346899999999984 456888999999999999999999998654322211111110 0000 000
Q ss_pred CCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 002158 861 GSYPSECVERFVTLALRCCHDKPEHRPSMSDVVRE 895 (958)
Q Consensus 861 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 895 (958)
.....++..+.+++.+|++.+|++||++++++++
T Consensus 232 -~~~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~~ 265 (267)
T cd06645 232 -KDKMKWSNSFHHFVKMALTKNPKKRPTAEKLLQH 265 (267)
T ss_pred -cccCCCCHHHHHHHHHHccCCchhCcCHHHHhcC
Confidence 0011345678999999999999999999998864
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-35 Score=314.63 Aligned_cols=250 Identities=26% Similarity=0.390 Sum_probs=205.2
Q ss_pred CCCCCceeeeeCCeEEEEEEEC-CCcEEEEEEeccCC--hhcHHHHHHHHHHHHccCCCCcceEEEEEEe-CCeEEEEEE
Q 002158 626 YFSSSTQVGQGGYGKVYKGILS-DNTTVAIKRAEEGS--LQGQNEFLTEIKLLSRLHHRNLVSLLGYCDE-EGEQMLVYE 701 (958)
Q Consensus 626 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~-~~~~~lV~E 701 (958)
+|+..+.||+|++|.||++..+ +++.||+|++.... ....+.+.+|++++++++|+|++++++.+.. ....++|||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e 80 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMG 80 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEec
Confidence 4777889999999999999976 57899999986532 3345578899999999999999999998764 446899999
Q ss_pred ecCCCCHHHHhccCCCCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEecCCCCeEEeeeeeecccccCCC
Q 002158 702 FVPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSRLAPVLDD 781 (958)
Q Consensus 702 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~ 781 (958)
|+++++|.+++.......+++.++..++.|++.|++|||+.+ ++||||||+||+++.++.++|+|||++........
T Consensus 81 ~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~---i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~~ 157 (257)
T cd08223 81 FCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKH---ILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCD 157 (257)
T ss_pred ccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCchhEEEecCCcEEEecccceEEecccCC
Confidence 999999999998655556899999999999999999999999 99999999999999999999999999876532111
Q ss_pred CCCccceeeeeccCCCCccChhhhccCCCCCcchhhhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcCcchhhhcccCC
Q 002158 782 EGTMPTHVSTIVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVLLELLTGMQPISHGKNIVREVNVARDSGMVFSIIDNRMG 861 (958)
Q Consensus 782 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gv~l~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~i~~~~~ 861 (958)
......|++.|+|||++.+..++.++||||||++++||++|+.||..... ....... ......
T Consensus 158 -------~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~-~~~~~~~---------~~~~~~ 220 (257)
T cd08223 158 -------MASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDM-NSLVYRI---------IEGKLP 220 (257)
T ss_pred -------ccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCH-HHHHHHH---------HhcCCC
Confidence 12234588999999999999999999999999999999999999964332 1211111 111222
Q ss_pred CCChHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 002158 862 SYPSECVERFVTLALRCCHDKPEHRPSMSDVVRE 895 (958)
Q Consensus 862 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 895 (958)
..+...+..+.+++.+||+.+|++||++.+++++
T Consensus 221 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 254 (257)
T cd08223 221 PMPKDYSPELGELIATMLSKRPEKRPSVKSILRQ 254 (257)
T ss_pred CCccccCHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 3345677889999999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-35 Score=316.25 Aligned_cols=250 Identities=28% Similarity=0.427 Sum_probs=205.9
Q ss_pred cCCCCCceeeeeCCeEEEEEEECC-CcEEEEEEeccCChhcHHHHHHHHHHHHccCCCCcceEEEEEEeCCeEEEEEEec
Q 002158 625 AYFSSSTQVGQGGYGKVYKGILSD-NTTVAIKRAEEGSLQGQNEFLTEIKLLSRLHHRNLVSLLGYCDEEGEQMLVYEFV 703 (958)
Q Consensus 625 ~~~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E~~ 703 (958)
++|+..+.||+|+||.||+|.+.+ ++.||+|.+..... .+++.+|++++++++|+||+++++++..+...+++|||+
T Consensus 3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~ 80 (256)
T cd06612 3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED--LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEYC 80 (256)
T ss_pred ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH--HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEecC
Confidence 568888899999999999999874 88999999875432 668999999999999999999999999999999999999
Q ss_pred CCCCHHHHhccCCCCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEecCCCCeEEeeeeeecccccCCCCC
Q 002158 704 PNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSRLAPVLDDEG 783 (958)
Q Consensus 704 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 783 (958)
++++|.+++.... ..+++..+..++.|++.||.|||+.+ ++||||+|+||+++.++.++|+|||++........
T Consensus 81 ~~~~L~~~l~~~~-~~l~~~~~~~~~~~l~~~l~~lh~~~---i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~-- 154 (256)
T cd06612 81 GAGSVSDIMKITN-KTLTEEEIAAILYQTLKGLEYLHSNK---KIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMA-- 154 (256)
T ss_pred CCCcHHHHHHhCc-cCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEECCCCcEEEcccccchhcccCcc--
Confidence 9999999996543 35899999999999999999999999 99999999999999999999999999876532211
Q ss_pred CccceeeeeccCCCCccChhhhccCCCCCcchhhhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcCcchhhhcccCCCC
Q 002158 784 TMPTHVSTIVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVLLELLTGMQPISHGKNIVREVNVARDSGMVFSIIDNRMGSY 863 (958)
Q Consensus 784 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gv~l~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~ 863 (958)
......|+..|+|||++.+..++.++||||||+++|||++|+.||............... .......
T Consensus 155 -----~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~~~~~~--------~~~~~~~ 221 (256)
T cd06612 155 -----KRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMIPNK--------PPPTLSD 221 (256)
T ss_pred -----ccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhhhhccC--------CCCCCCc
Confidence 122345888999999999989999999999999999999999999754332211110000 0001112
Q ss_pred ChHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 002158 864 PSECVERFVTLALRCCHDKPEHRPSMSDVVRE 895 (958)
Q Consensus 864 ~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 895 (958)
+...+..+.+++.+||+.+|++||++.|++++
T Consensus 222 ~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~~ 253 (256)
T cd06612 222 PEKWSPEFNDFVKKCLVKDPEERPSAIQLLQH 253 (256)
T ss_pred hhhcCHHHHHHHHHHHhcChhhCcCHHHHhcC
Confidence 34456789999999999999999999999863
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-35 Score=313.89 Aligned_cols=248 Identities=32% Similarity=0.523 Sum_probs=201.3
Q ss_pred ceeeeeCCeEEEEEEECCCcEEEEEEeccCChh-cHHHHHHHHHHHHccCCCCcceEEEEEEeCCeEEEEEEecCCCCHH
Q 002158 631 TQVGQGGYGKVYKGILSDNTTVAIKRAEEGSLQ-GQNEFLTEIKLLSRLHHRNLVSLLGYCDEEGEQMLVYEFVPNGTLR 709 (958)
Q Consensus 631 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E~~~~gsL~ 709 (958)
+.||+|+||.||+|.+.+++.||+|.+...... ....|.+|++++++++|+||+++++++...+..++||||+++++|.
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~ 80 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLL 80 (251)
T ss_pred CccccCCCceEEEEEEeCCCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcHH
Confidence 368999999999999877999999998765433 4567999999999999999999999999999999999999999999
Q ss_pred HHhccCCCCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEecCCCCeEEeeeeeecccccCCCCCCcccee
Q 002158 710 DWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSRLAPVLDDEGTMPTHV 789 (958)
Q Consensus 710 ~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~ 789 (958)
+++.... ..+++..+..++.+++.||+|||+++ ++||||||+||+++.++.+||+|||+++....... ...
T Consensus 81 ~~l~~~~-~~~~~~~~~~~~~~~~~~l~~lH~~~---i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~-----~~~ 151 (251)
T cd05041 81 TFLRKKK-NRLTVKKLLQMSLDAAAGMEYLESKN---CIHRDLAARNCLVGENNVLKISDFGMSREEEGGIY-----TVS 151 (251)
T ss_pred HHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCC---EehhhcCcceEEEcCCCcEEEeeccccccccCCcc-----eec
Confidence 9997543 34789999999999999999999999 99999999999999999999999999875421110 000
Q ss_pred eeeccCCCCccChhhhccCCCCCcchhhhHHHHHHHHHh-CCCCCCCCchhHHHHHHHhhcCcchhhhcccCCCCChHHH
Q 002158 790 STIVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVLLELLT-GMQPISHGKNIVREVNVARDSGMVFSIIDNRMGSYPSECV 868 (958)
Q Consensus 790 ~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gv~l~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~ 868 (958)
.....++..|+|||++.+..++.++||||||+++|||+| |..||......... ..... . .....+...+
T Consensus 152 ~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~~-~~~~~-~--------~~~~~~~~~~ 221 (251)
T cd05041 152 DGLKQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQTR-ERIES-G--------YRMPAPQLCP 221 (251)
T ss_pred cccCcceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHHHHH-HHHhc-C--------CCCCCCccCC
Confidence 111224567999999998899999999999999999999 88888654321111 11110 0 0112344567
Q ss_pred HHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 002158 869 ERFVTLALRCCHDKPEHRPSMSDVVRELE 897 (958)
Q Consensus 869 ~~l~~li~~cl~~dP~~RPs~~evl~~L~ 897 (958)
..+.+++.+||+.+|++||++.|+++.|+
T Consensus 222 ~~~~~li~~~l~~~p~~Rp~~~ell~~l~ 250 (251)
T cd05041 222 EEIYRLMLQCWAYDPENRPSFSEIYNELQ 250 (251)
T ss_pred HHHHHHHHHHhccChhhCcCHHHHHHHhh
Confidence 88999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=346.30 Aligned_cols=261 Identities=20% Similarity=0.307 Sum_probs=195.6
Q ss_pred HHHHHHHcCCCCCceeeeeCCeEEEEEEEC-CCcEEEEEEeccCChhcHHHHHHHHHHHHccCC------CCcceEEEEE
Q 002158 618 KELAMATAYFSSSTQVGQGGYGKVYKGILS-DNTTVAIKRAEEGSLQGQNEFLTEIKLLSRLHH------RNLVSLLGYC 690 (958)
Q Consensus 618 ~el~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H------~niv~l~~~~ 690 (958)
+++...+.+|.+.+.||+|+||+||+|.+. .++.||||+++... ...+.+..|+++++.++| .+++++++++
T Consensus 122 ~~~~~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~ 200 (467)
T PTZ00284 122 EDIDVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP-KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYF 200 (467)
T ss_pred CccccCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch-hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEE
Confidence 344456678999999999999999999975 57889999986532 223456677777777754 4588999988
Q ss_pred EeC-CeEEEEEEecCCCCHHHHhccCCCCCchHHHHHHHHHHHHHHHHHhhhc-CCCCeeccCCCccceEecCCC-----
Q 002158 691 DEE-GEQMLVYEFVPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTE-AHPPVFHRDIKASNILLDSNL----- 763 (958)
Q Consensus 691 ~~~-~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~-~~~~iiH~Dikp~NILl~~~~----- 763 (958)
..+ +..++|||++ +++|.+++.... .+++..+..++.|++.||+|||++ + ||||||||+|||++.++
T Consensus 201 ~~~~~~~~iv~~~~-g~~l~~~l~~~~--~l~~~~~~~i~~qi~~aL~yLH~~~g---IiHrDlKP~NILl~~~~~~~~~ 274 (467)
T PTZ00284 201 QNETGHMCIVMPKY-GPCLLDWIMKHG--PFSHRHLAQIIFQTGVALDYFHTELH---LMHTDLKPENILMETSDTVVDP 274 (467)
T ss_pred EcCCceEEEEEecc-CCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhcCC---eecCCCCHHHEEEecCCccccc
Confidence 764 5789999998 789999886543 489999999999999999999984 7 99999999999998765
Q ss_pred -----------CeEEeeeeeecccccCCCCCCccceeeeeccCCCCccChhhhccCCCCCcchhhhHHHHHHHHHhCCCC
Q 002158 764 -----------NAKVADFGLSRLAPVLDDEGTMPTHVSTIVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVLLELLTGMQP 832 (958)
Q Consensus 764 -----------~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gv~l~elltG~~P 832 (958)
.+||+|||.+.... .......||+.|+|||++.+..++.++|||||||++|||++|+.|
T Consensus 275 ~~~~~~~~~~~~vkl~DfG~~~~~~----------~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~p 344 (467)
T PTZ00284 275 VTNRALPPDPCRVRICDLGGCCDER----------HSRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLL 344 (467)
T ss_pred ccccccCCCCceEEECCCCccccCc----------cccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCC
Confidence 49999999875321 112346799999999999999999999999999999999999999
Q ss_pred CCCCchhHHHHHHHhhcCcchh-------------hh---cccCCCC-C--------------hHHHHHHHHHHHHcccc
Q 002158 833 ISHGKNIVREVNVARDSGMVFS-------------II---DNRMGSY-P--------------SECVERFVTLALRCCHD 881 (958)
Q Consensus 833 ~~~~~~~~~~~~~~~~~~~~~~-------------~i---~~~~~~~-~--------------~~~~~~l~~li~~cl~~ 881 (958)
|................+.... .. ....... + ......+.+|+.+||+.
T Consensus 345 f~~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~ 424 (467)
T PTZ00284 345 YDTHDNLEHLHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHY 424 (467)
T ss_pred CCCCChHHHHHHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCc
Confidence 9765433221111111010000 00 0000000 0 01134577999999999
Q ss_pred CCCCCCCHHHHHHH
Q 002158 882 KPEHRPSMSDVVRE 895 (958)
Q Consensus 882 dP~~RPs~~evl~~ 895 (958)
||++|||++|++++
T Consensus 425 dP~~R~ta~e~L~H 438 (467)
T PTZ00284 425 DRQKRLNARQMTTH 438 (467)
T ss_pred ChhhCCCHHHHhcC
Confidence 99999999999975
|
|
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=342.42 Aligned_cols=256 Identities=24% Similarity=0.268 Sum_probs=196.7
Q ss_pred HcCCCCCceeeeeCCeEEEEEEEC-CCcEEEEEEeccCChhcHHHHHHHHHHHHccCCCCcceEEEEEEeCCeEEEEEEe
Q 002158 624 TAYFSSSTQVGQGGYGKVYKGILS-DNTTVAIKRAEEGSLQGQNEFLTEIKLLSRLHHRNLVSLLGYCDEEGEQMLVYEF 702 (958)
Q Consensus 624 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E~ 702 (958)
..+|.+.+.||+|+||.||+|.+. .++.||||.... ..+.+|++++++++|+||+++++++..++..++|||+
T Consensus 168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~------~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e~ 241 (461)
T PHA03211 168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWY------ASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPK 241 (461)
T ss_pred cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEecccc------cCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEEc
Confidence 457888899999999999999986 578999996432 2356899999999999999999999999999999999
Q ss_pred cCCCCHHHHhccCCCCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEecCCCCeEEeeeeeecccccCCCC
Q 002158 703 VPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSRLAPVLDDE 782 (958)
Q Consensus 703 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~ 782 (958)
+ .++|.+++.... ..+++.+++.++.|+++||+|||+.+ |+||||||+|||++.++.+||+|||+++.......
T Consensus 242 ~-~~~L~~~l~~~~-~~l~~~~~~~i~~qi~~aL~yLH~~g---IvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~- 315 (461)
T PHA03211 242 Y-RSDLYTYLGARL-RPLGLAQVTAVARQLLSAIDYIHGEG---IIHRDIKTENVLVNGPEDICLGDFGAACFARGSWS- 315 (461)
T ss_pred c-CCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCC---EEECcCCHHHEEECCCCCEEEcccCCceecccccc-
Confidence 9 579999886543 35999999999999999999999999 99999999999999999999999999986532111
Q ss_pred CCccceeeeeccCCCCccChhhhccCCCCCcchhhhHHHHHHHHHhCCCCCCCCch-------hHHHHHHHhhcCcc---
Q 002158 783 GTMPTHVSTIVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVLLELLTGMQPISHGKN-------IVREVNVARDSGMV--- 852 (958)
Q Consensus 783 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gv~l~elltG~~P~~~~~~-------~~~~~~~~~~~~~~--- 852 (958)
........||+.|+|||++.+..++.++|||||||++|||++|..|+..... .....+.....+..
T Consensus 316 ----~~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~ 391 (461)
T PHA03211 316 ----TPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDE 391 (461)
T ss_pred ----cccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhcccccc
Confidence 1112245699999999999999999999999999999999998876543210 01111111110000
Q ss_pred -h--------hhh-----cccCCCCC-------hHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 002158 853 -F--------SII-----DNRMGSYP-------SECVERFVTLALRCCHDKPEHRPSMSDVVRE 895 (958)
Q Consensus 853 -~--------~~i-----~~~~~~~~-------~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 895 (958)
. ... ........ ......+.+++.+||+.||++|||+.|++++
T Consensus 392 ~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~h 455 (461)
T PHA03211 392 FPQHAGSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRL 455 (461)
T ss_pred CCCCcchHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhC
Confidence 0 000 00000000 0123468899999999999999999999975
|
|
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=319.69 Aligned_cols=249 Identities=31% Similarity=0.497 Sum_probs=199.9
Q ss_pred ceeeeeCCeEEEEEEECC-------CcEEEEEEeccCC-hhcHHHHHHHHHHHHccCCCCcceEEEEEEeCCeEEEEEEe
Q 002158 631 TQVGQGGYGKVYKGILSD-------NTTVAIKRAEEGS-LQGQNEFLTEIKLLSRLHHRNLVSLLGYCDEEGEQMLVYEF 702 (958)
Q Consensus 631 ~~lg~G~~g~Vy~~~~~~-------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E~ 702 (958)
+.||+|+||.||+|++.+ +..||||.+.... ......|.+|+++++.++||||+++++++...+..++||||
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMEL 80 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEec
Confidence 368999999999998753 2579999886543 23456789999999999999999999999999999999999
Q ss_pred cCCCCHHHHhccCC-----CCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEecCCC-----CeEEeeeee
Q 002158 703 VPNGTLRDWLSGRT-----KENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSNL-----NAKVADFGL 772 (958)
Q Consensus 703 ~~~gsL~~~l~~~~-----~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~~-----~~kl~DFGl 772 (958)
+++++|.+++.... ...+++.+++.++.|++.||+|||+.+ ++|+||||+||+++.++ .++++|||+
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~ 157 (269)
T cd05044 81 MEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMH---FIHRDLAARNCLVSEKGYDADRVVKIGDFGL 157 (269)
T ss_pred cCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCC---cccCCCChheEEEecCCCCCCcceEECCccc
Confidence 99999999997532 234789999999999999999999998 99999999999999877 899999999
Q ss_pred ecccccCCCCCCccceeeeeccCCCCccChhhhccCCCCCcchhhhHHHHHHHHHh-CCCCCCCCchhHHHHHHHhhcCc
Q 002158 773 SRLAPVLDDEGTMPTHVSTIVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVLLELLT-GMQPISHGKNIVREVNVARDSGM 851 (958)
Q Consensus 773 a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gv~l~ellt-G~~P~~~~~~~~~~~~~~~~~~~ 851 (958)
++....... ........++..|+|||++.+..++.++||||||+++|||++ |+.||........ ......
T Consensus 158 ~~~~~~~~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~~~-~~~~~~--- 228 (269)
T cd05044 158 ARDIYKSDY-----YRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQEV-LQHVTA--- 228 (269)
T ss_pred ccccccccc-----cccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCHHHH-HHHHhc---
Confidence 875432111 011112345678999999999999999999999999999998 9999965443221 111111
Q ss_pred chhhhcccCCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 002158 852 VFSIIDNRMGSYPSECVERFVTLALRCCHDKPEHRPSMSDVVRELE 897 (958)
Q Consensus 852 ~~~~i~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 897 (958)
......+...+..+.+++.+||+.+|.+||+++++++.|+
T Consensus 229 ------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~ 268 (269)
T cd05044 229 ------GGRLQKPENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQ 268 (269)
T ss_pred ------CCccCCcccchHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence 1112234456788999999999999999999999999886
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-35 Score=353.18 Aligned_cols=259 Identities=20% Similarity=0.322 Sum_probs=203.3
Q ss_pred HHHHHHcCCCCCceeeeeCCeEEEEEEEC-CCcEEEEEEeccC--ChhcHHHHHHHHHHHHccCCCCcceEEEEEEe--C
Q 002158 619 ELAMATAYFSSSTQVGQGGYGKVYKGILS-DNTTVAIKRAEEG--SLQGQNEFLTEIKLLSRLHHRNLVSLLGYCDE--E 693 (958)
Q Consensus 619 el~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~--~ 693 (958)
+......+|.+.+.||+|+||+||+|.+. .+..||+|.+... .......|..|+.++++++||||+++++++.. .
T Consensus 7 ~ge~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~ 86 (1021)
T PTZ00266 7 DGESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKAN 86 (1021)
T ss_pred CCccccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCC
Confidence 33445568899999999999999999986 5778999988653 23345678999999999999999999998854 3
Q ss_pred CeEEEEEEecCCCCHHHHhccCC--CCCchHHHHHHHHHHHHHHHHHhhhcCC----CCeeccCCCccceEecC------
Q 002158 694 GEQMLVYEFVPNGTLRDWLSGRT--KENLNFAMRLRVALDSAKGILYLHTEAH----PPVFHRDIKASNILLDS------ 761 (958)
Q Consensus 694 ~~~~lV~E~~~~gsL~~~l~~~~--~~~l~~~~~~~i~~~ia~aL~yLH~~~~----~~iiH~Dikp~NILl~~------ 761 (958)
...++||||+++|+|.++|.... ...+++..++.|+.||+.||+|||+.+. .+||||||||+|||++.
T Consensus 87 ~~lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg 166 (1021)
T PTZ00266 87 QKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIG 166 (1021)
T ss_pred CEEEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccccc
Confidence 56899999999999999997532 2458999999999999999999998542 34999999999999964
Q ss_pred -----------CCCeEEeeeeeecccccCCCCCCccceeeeeccCCCCccChhhhcc--CCCCCcchhhhHHHHHHHHHh
Q 002158 762 -----------NLNAKVADFGLSRLAPVLDDEGTMPTHVSTIVKGTPGYLDPEYFLT--HKLTDKSDVYSLGVVLLELLT 828 (958)
Q Consensus 762 -----------~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DV~S~Gv~l~ellt 828 (958)
.+.+||+|||+++...... ......||+.|+|||++.+ ..++.++|||||||++|||++
T Consensus 167 ~i~~~~~n~ng~~iVKLsDFGlAr~l~~~s--------~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLT 238 (1021)
T PTZ00266 167 KITAQANNLNGRPIAKIGDFGLSKNIGIES--------MAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCS 238 (1021)
T ss_pred cccccccccCCCCceEEccCCccccccccc--------cccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHH
Confidence 2358999999997542211 1223569999999999864 458889999999999999999
Q ss_pred CCCCCCCCchhHHHHHHHhhcCcchhhhcccCCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 002158 829 GMQPISHGKNIVREVNVARDSGMVFSIIDNRMGSYPSECVERFVTLALRCCHDKPEHRPSMSDVVRE 895 (958)
Q Consensus 829 G~~P~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 895 (958)
|+.||.........+....... .......+..+.+||..||+.+|.+||++.|++++
T Consensus 239 Gk~PF~~~~~~~qli~~lk~~p----------~lpi~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~h 295 (1021)
T PTZ00266 239 GKTPFHKANNFSQLISELKRGP----------DLPIKGKSKELNILIKNLLNLSAKERPSALQCLGY 295 (1021)
T ss_pred CCCCCCcCCcHHHHHHHHhcCC----------CCCcCCCCHHHHHHHHHHhcCChhHCcCHHHHhcc
Confidence 9999976554433332221110 00112345778999999999999999999999854
|
|
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-35 Score=315.90 Aligned_cols=252 Identities=27% Similarity=0.434 Sum_probs=200.4
Q ss_pred cCCCCCceeeeeCCeEEEEEEEC-CCcEEEEEEeccCC-----hhcHHHHHHHHHHHHccCCCCcceEEEEEEe--CCeE
Q 002158 625 AYFSSSTQVGQGGYGKVYKGILS-DNTTVAIKRAEEGS-----LQGQNEFLTEIKLLSRLHHRNLVSLLGYCDE--EGEQ 696 (958)
Q Consensus 625 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~--~~~~ 696 (958)
.+|...+.||+|+||.||+|... +++.||+|++.... ......+.+|+.++++++||||+++++++.. ....
T Consensus 2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (266)
T cd06651 2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL 81 (266)
T ss_pred CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence 36888899999999999999975 58899999876432 2234568899999999999999999998865 3578
Q ss_pred EEEEEecCCCCHHHHhccCCCCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEecCCCCeEEeeeeeeccc
Q 002158 697 MLVYEFVPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSRLA 776 (958)
Q Consensus 697 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~~ 776 (958)
+++|||+++++|.+++.... .+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+++..
T Consensus 82 ~l~~e~~~~~~L~~~l~~~~--~l~~~~~~~~~~qi~~~l~~LH~~~---i~H~~l~p~nil~~~~~~~~l~dfg~~~~~ 156 (266)
T cd06651 82 TIFMEYMPGGSVKDQLKAYG--ALTESVTRKYTRQILEGMSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRL 156 (266)
T ss_pred EEEEeCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEccCCCcccc
Confidence 89999999999999997543 3888999999999999999999998 999999999999999999999999998755
Q ss_pred ccCCCCCCccceeeeeccCCCCccChhhhccCCCCCcchhhhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcCcchhhh
Q 002158 777 PVLDDEGTMPTHVSTIVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVLLELLTGMQPISHGKNIVREVNVARDSGMVFSII 856 (958)
Q Consensus 777 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gv~l~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~i 856 (958)
....... .......|+.+|+|||++.+..++.++|||||||++|||++|+.||........... ...
T Consensus 157 ~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~~~~~-~~~-------- 223 (266)
T cd06651 157 QTICMSG----TGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFK-IAT-------- 223 (266)
T ss_pred ccccccC----CccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchHHHHHH-Hhc--------
Confidence 3211110 111234588999999999988899999999999999999999999975433222211 110
Q ss_pred cccCCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 002158 857 DNRMGSYPSECVERFVTLALRCCHDKPEHRPSMSDVVRE 895 (958)
Q Consensus 857 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 895 (958)
.......+....+.+..++ +||..+|++||+++|++++
T Consensus 224 ~~~~~~~~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~h 261 (266)
T cd06651 224 QPTNPQLPSHISEHARDFL-GCIFVEARHRPSAEELLRH 261 (266)
T ss_pred CCCCCCCchhcCHHHHHHH-HHhcCChhhCcCHHHHhcC
Confidence 0111233555667777887 6888999999999999863
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-35 Score=322.13 Aligned_cols=252 Identities=26% Similarity=0.389 Sum_probs=203.9
Q ss_pred cCCCCCceeeeeCCeEEEEEEEC-CCcEEEEEEeccCChhcHHHHHHHHHHHHccCCCCcceEEEEEEeCCeEEEEEEec
Q 002158 625 AYFSSSTQVGQGGYGKVYKGILS-DNTTVAIKRAEEGSLQGQNEFLTEIKLLSRLHHRNLVSLLGYCDEEGEQMLVYEFV 703 (958)
Q Consensus 625 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E~~ 703 (958)
+.|+..+.||+|+||.||+|.+. +++.||+|.+........+.+.+|+++++.++|+|++++++++..++..++||||+
T Consensus 12 ~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 91 (292)
T cd06644 12 EVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEFC 91 (292)
T ss_pred hhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEecC
Confidence 45777889999999999999986 58899999998776666778999999999999999999999999999999999999
Q ss_pred CCCCHHHHhccCCCCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEecCCCCeEEeeeeeecccccCCCCC
Q 002158 704 PNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSRLAPVLDDEG 783 (958)
Q Consensus 704 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 783 (958)
++++|..++.+.. ..+++..+..++.|++.|++|||+.+ ++||||||+||+++.++.+||+|||++......
T Consensus 92 ~~~~l~~~~~~~~-~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~---- 163 (292)
T cd06644 92 PGGAVDAIMLELD-RGLTEPQIQVICRQMLEALQYLHSMK---IIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKT---- 163 (292)
T ss_pred CCCcHHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHhcCC---eeecCCCcceEEEcCCCCEEEccCccceecccc----
Confidence 9999998886443 34899999999999999999999998 999999999999999999999999988643211
Q ss_pred CccceeeeeccCCCCccChhhhc-----cCCCCCcchhhhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcCcchhhhcc
Q 002158 784 TMPTHVSTIVKGTPGYLDPEYFL-----THKLTDKSDVYSLGVVLLELLTGMQPISHGKNIVREVNVARDSGMVFSIIDN 858 (958)
Q Consensus 784 ~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DV~S~Gv~l~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~i~~ 858 (958)
........++..|+|||++. ...++.++|||||||++|||++|..||........... ..... .
T Consensus 164 ---~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~-~~~~~-------~ 232 (292)
T cd06644 164 ---LQRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLK-IAKSE-------P 232 (292)
T ss_pred ---ccccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHHHHHH-HhcCC-------C
Confidence 11112345888999999985 34467899999999999999999999965432211111 11100 0
Q ss_pred cCCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 002158 859 RMGSYPSECVERFVTLALRCCHDKPEHRPSMSDVVRE 895 (958)
Q Consensus 859 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 895 (958)
.....+..++..+.+++.+||+.+|++||++++++++
T Consensus 233 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 269 (292)
T cd06644 233 PTLSQPSKWSMEFRDFLKTALDKHPETRPSAAQLLEH 269 (292)
T ss_pred ccCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence 0111234556788999999999999999999999864
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-35 Score=319.76 Aligned_cols=260 Identities=27% Similarity=0.456 Sum_probs=207.5
Q ss_pred cCCCCCceeeeeCCeEEEEEEEC-CCc----EEEEEEeccCC-hhcHHHHHHHHHHHHccCCCCcceEEEEEEeCCeEEE
Q 002158 625 AYFSSSTQVGQGGYGKVYKGILS-DNT----TVAIKRAEEGS-LQGQNEFLTEIKLLSRLHHRNLVSLLGYCDEEGEQML 698 (958)
Q Consensus 625 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~----~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~l 698 (958)
.+|...+.||+|+||+||+|.++ +|+ .||+|...... .....++.+|+.++++++|+||+++++++.. ...++
T Consensus 7 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~ 85 (279)
T cd05057 7 TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQVQL 85 (279)
T ss_pred HHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-CceEE
Confidence 45677789999999999999975 333 58999887653 3345678999999999999999999999987 78999
Q ss_pred EEEecCCCCHHHHhccCCCCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEecCCCCeEEeeeeeeccccc
Q 002158 699 VYEFVPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSRLAPV 778 (958)
Q Consensus 699 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~~~~ 778 (958)
||||+++|+|.+++..... .+++..+..++.|++.||+|||+.+ ++||||||+||++++++.+||+|||+++....
T Consensus 86 v~e~~~~g~L~~~l~~~~~-~~~~~~~~~~~~qi~~~l~~LH~~~---i~H~di~p~nil~~~~~~~kL~dfg~~~~~~~ 161 (279)
T cd05057 86 ITQLMPLGCLLDYVRNHKD-NIGSQYLLNWCVQIAKGMSYLEEKR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLDV 161 (279)
T ss_pred EEecCCCCcHHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHHhCC---EEecccCcceEEEcCCCeEEECCCcccccccC
Confidence 9999999999999976433 4899999999999999999999988 99999999999999999999999999986542
Q ss_pred CCCCCCccceeeeeccCCCCccChhhhccCCCCCcchhhhHHHHHHHHHh-CCCCCCCCchhHHHHHHHhhcCcchhhhc
Q 002158 779 LDDEGTMPTHVSTIVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVLLELLT-GMQPISHGKNIVREVNVARDSGMVFSIID 857 (958)
Q Consensus 779 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gv~l~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~i~ 857 (958)
.... .......++..|+|||.+....++.++||||||+++||+++ |+.||..... .........
T Consensus 162 ~~~~-----~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~-~~~~~~~~~--------- 226 (279)
T cd05057 162 DEKE-----YHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPA-VEIPDLLEK--------- 226 (279)
T ss_pred cccc-----eecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCH-HHHHHHHhC---------
Confidence 2111 11112224578999999988889999999999999999999 9999965432 111111111
Q ss_pred ccCCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHhhCC
Q 002158 858 NRMGSYPSECVERFVTLALRCCHDKPEHRPSMSDVVRELENILKMFP 904 (958)
Q Consensus 858 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~~ 904 (958)
......+..++..+.+++.+||..+|.+||++.++++.|+++.+..+
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~~~~~~ 273 (279)
T cd05057 227 GERLPQPPICTIDVYMVLVKCWMIDAESRPTFKELINEFSKMARDPQ 273 (279)
T ss_pred CCCCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhCCc
Confidence 11112233455778999999999999999999999999999876443
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-35 Score=316.90 Aligned_cols=251 Identities=27% Similarity=0.401 Sum_probs=191.8
Q ss_pred eeeeeCCeEEEEEEECC---CcEEEEEEeccCC-hhcHHHHHHHHHHHHccCCCCcceEEEEEEeCCeEEEEEEecCCCC
Q 002158 632 QVGQGGYGKVYKGILSD---NTTVAIKRAEEGS-LQGQNEFLTEIKLLSRLHHRNLVSLLGYCDEEGEQMLVYEFVPNGT 707 (958)
Q Consensus 632 ~lg~G~~g~Vy~~~~~~---~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E~~~~gs 707 (958)
.||+|+||+||+|...+ ...||+|.+.... ......|.+|+++++.++|+||+++++++......++||||+++|+
T Consensus 2 ~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g~ 81 (269)
T cd05042 2 EIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLGD 81 (269)
T ss_pred cCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCCc
Confidence 58999999999997543 4578888876543 3334578999999999999999999999999999999999999999
Q ss_pred HHHHhccCCC---CCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEecCCCCeEEeeeeeecccccCCCCCC
Q 002158 708 LRDWLSGRTK---ENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSRLAPVLDDEGT 784 (958)
Q Consensus 708 L~~~l~~~~~---~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 784 (958)
|.+++..... ...++..+..++.|++.||+|||+.+ |+||||||+||++++++.+||+|||+++.......
T Consensus 82 L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~--- 155 (269)
T cd05042 82 LKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQAD---FIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDY--- 155 (269)
T ss_pred HHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcC---EecccccHhheEecCCCcEEEeccccccccccchh---
Confidence 9999975432 23567888999999999999999999 99999999999999999999999999864322110
Q ss_pred ccceeeeeccCCCCccChhhhcc-------CCCCCcchhhhHHHHHHHHHh-CCCCCCCCchhHHHHHHHhhcCcchhhh
Q 002158 785 MPTHVSTIVKGTPGYLDPEYFLT-------HKLTDKSDVYSLGVVLLELLT-GMQPISHGKNIVREVNVARDSGMVFSII 856 (958)
Q Consensus 785 ~~~~~~~~~~gt~~y~aPE~~~~-------~~~~~~~DV~S~Gv~l~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~i 856 (958)
........++..|+|||++.. ..++.++|||||||++|||++ |..||............... . .....
T Consensus 156 --~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~-~-~~~~~ 231 (269)
T cd05042 156 --YITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQVVRE-Q-DIKLP 231 (269)
T ss_pred --eeccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhhc-c-CccCC
Confidence 011122346678999999753 356779999999999999999 78888654432221111111 1 00110
Q ss_pred cccCCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 002158 857 DNRMGSYPSECVERFVTLALRCCHDKPEHRPSMSDVVREL 896 (958)
Q Consensus 857 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 896 (958)
.+..+..++..+.+++..|| .||++||++++|++.|
T Consensus 232 ---~~~~~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l 267 (269)
T cd05042 232 ---KPQLDLKYSDRWYEVMQFCW-LDPETRPTAEEVHELL 267 (269)
T ss_pred ---CCcccccCCHHHHHHHHHHh-cCcccccCHHHHHHHh
Confidence 12234456677888999999 5999999999999876
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=317.83 Aligned_cols=253 Identities=31% Similarity=0.517 Sum_probs=200.6
Q ss_pred CCCCceeeeeCCeEEEEEEEC-CCcEEEEEEeccCChhcHH--HHHHHHHHHHccCCCCcceEEEEEEeCCeEEEEEEec
Q 002158 627 FSSSTQVGQGGYGKVYKGILS-DNTTVAIKRAEEGSLQGQN--EFLTEIKLLSRLHHRNLVSLLGYCDEEGEQMLVYEFV 703 (958)
Q Consensus 627 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~--~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E~~ 703 (958)
|+..+.||+|+||+||++... +++.||+|++......... ...+|+.++++++||||+++++++......++||||+
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~ 80 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYC 80 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccc
Confidence 345689999999999999987 4678999999876544432 3456999999999999999999999999999999999
Q ss_pred CCCCHHHHhccCCCCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEecCCCCeEEeeeeeecccccCCCCC
Q 002158 704 PNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSRLAPVLDDEG 783 (958)
Q Consensus 704 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 783 (958)
++++|.+++.. ...+++.++..++.|+++||+|||+.+ |+|+||||+||++++++.++|+|||.+.....
T Consensus 81 ~~~~L~~~l~~--~~~~~~~~~~~~~~qi~~~L~~Lh~~~---i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~----- 150 (260)
T PF00069_consen 81 PGGSLQDYLQK--NKPLSEEEILKIAYQILEALAYLHSKG---IVHRDIKPENILLDENGEVKLIDFGSSVKLSE----- 150 (260)
T ss_dssp TTEBHHHHHHH--HSSBBHHHHHHHHHHHHHHHHHHHHTT---EEESSBSGGGEEESTTSEEEESSGTTTEESTS-----
T ss_pred ccccccccccc--ccccccccccccccccccccccccccc---cccccccccccccccccccccccccccccccc-----
Confidence 99999999973 234899999999999999999999999 99999999999999999999999999875311
Q ss_pred CccceeeeeccCCCCccChhhhc-cCCCCCcchhhhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcCcchhhhcccCCC
Q 002158 784 TMPTHVSTIVKGTPGYLDPEYFL-THKLTDKSDVYSLGVVLLELLTGMQPISHGKNIVREVNVARDSGMVFSIIDNRMGS 862 (958)
Q Consensus 784 ~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DV~S~Gv~l~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~ 862 (958)
.........++..|+|||++. +..++.++||||+|+++|+|++|..||..................... ... .
T Consensus 151 --~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~---~~~-~ 224 (260)
T PF00069_consen 151 --NNENFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKILKRPLP---SSS-Q 224 (260)
T ss_dssp --TTSEBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHHHTHHH---HHT-T
T ss_pred --cccccccccccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhccccccc---ccc-c
Confidence 012233456899999999998 788999999999999999999999999865211111111111000000 000 0
Q ss_pred CChHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 002158 863 YPSECVERFVTLALRCCHDKPEHRPSMSDVVRE 895 (958)
Q Consensus 863 ~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 895 (958)
........+.+++.+||+.||++||++.+++++
T Consensus 225 ~~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~~ 257 (260)
T PF00069_consen 225 QSREKSEELRDLIKKMLSKDPEQRPSAEELLKH 257 (260)
T ss_dssp SHTTSHHHHHHHHHHHSSSSGGGSTTHHHHHTS
T ss_pred ccchhHHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 011123789999999999999999999999863
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-35 Score=315.03 Aligned_cols=250 Identities=32% Similarity=0.534 Sum_probs=202.6
Q ss_pred CCCCCceeeeeCCeEEEEEEECCCcEEEEEEeccCChhcHHHHHHHHHHHHccCCCCcceEEEEEEeCCeEEEEEEecCC
Q 002158 626 YFSSSTQVGQGGYGKVYKGILSDNTTVAIKRAEEGSLQGQNEFLTEIKLLSRLHHRNLVSLLGYCDEEGEQMLVYEFVPN 705 (958)
Q Consensus 626 ~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E~~~~ 705 (958)
+|+..+.||+|+||.||+|.+.+++.+|+|.+..... ...+|.+|++++++++|||++++++++......++||||+++
T Consensus 5 ~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~ 83 (256)
T cd05112 5 ELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGAM-SEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFMEH 83 (256)
T ss_pred HeEEEeeecCcccceEEEEEEeCCCeEEEEECCCCCC-CHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcCCC
Confidence 5666789999999999999987788999999875432 345789999999999999999999999999999999999999
Q ss_pred CCHHHHhccCCCCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEecCCCCeEEeeeeeecccccCCCCCCc
Q 002158 706 GTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSRLAPVLDDEGTM 785 (958)
Q Consensus 706 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~ 785 (958)
++|.+++.... ..++++.+..++.|++.|++|||+.+ ++||||||+||+++.++.+||+|||+++......
T Consensus 84 ~~L~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lH~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~----- 154 (256)
T cd05112 84 GCLSDYLRAQR-GKFSQETLLGMCLDVCEGMAYLESSN---VIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQ----- 154 (256)
T ss_pred CcHHHHHHhCc-cCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccccceEEEcCCCeEEECCCcceeecccCc-----
Confidence 99999997543 34789999999999999999999999 9999999999999999999999999987542111
Q ss_pred cceeeeeccCCCCccChhhhccCCCCCcchhhhHHHHHHHHHh-CCCCCCCCchhHHHHHHHhhcCcchhhhcccCCCCC
Q 002158 786 PTHVSTIVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVLLELLT-GMQPISHGKNIVREVNVARDSGMVFSIIDNRMGSYP 864 (958)
Q Consensus 786 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gv~l~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~ 864 (958)
........++.+|+|||++.+..++.++||||||+++|||++ |..||..... ......... + .....+
T Consensus 155 -~~~~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~-~~~~~~~~~-~--------~~~~~~ 223 (256)
T cd05112 155 -YTSSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSN-SEVVETINA-G--------FRLYKP 223 (256)
T ss_pred -ccccCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCH-HHHHHHHhC-C--------CCCCCC
Confidence 111112335678999999998889999999999999999998 9999864332 111111111 0 011112
Q ss_pred hHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 002158 865 SECVERFVTLALRCCHDKPEHRPSMSDVVREL 896 (958)
Q Consensus 865 ~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 896 (958)
...+..+.+++.+||+.+|++||++.+++++|
T Consensus 224 ~~~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l 255 (256)
T cd05112 224 RLASQSVYELMQHCWKERPEDRPSFSLLLHQL 255 (256)
T ss_pred CCCCHHHHHHHHHHcccChhhCCCHHHHHHhh
Confidence 33467899999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-35 Score=315.12 Aligned_cols=250 Identities=24% Similarity=0.370 Sum_probs=207.3
Q ss_pred CCCCCceeeeeCCeEEEEEEEC-CCcEEEEEEeccC--ChhcHHHHHHHHHHHHccCCCCcceEEEEEEeCCeEEEEEEe
Q 002158 626 YFSSSTQVGQGGYGKVYKGILS-DNTTVAIKRAEEG--SLQGQNEFLTEIKLLSRLHHRNLVSLLGYCDEEGEQMLVYEF 702 (958)
Q Consensus 626 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E~ 702 (958)
+|+..+.||+|+||.||++... +++.||+|.+... .....+++.+|++++++++|+||+++++++...+..++||||
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDY 80 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEec
Confidence 4677889999999999999975 6889999998643 233456789999999999999999999999999999999999
Q ss_pred cCCCCHHHHhccCCCCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEecCCCCeEEeeeeeecccccCCCC
Q 002158 703 VPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSRLAPVLDDE 782 (958)
Q Consensus 703 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~ 782 (958)
+++++|.+++.......+++.++..++.|++.|++|||+.+ ++|+||+|+||+++.++.++|+|||++.......
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~-- 155 (256)
T cd08218 81 CEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRK---ILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTV-- 155 (256)
T ss_pred CCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEEeeccceeecCcch--
Confidence 99999999997655455889999999999999999999998 9999999999999999999999999987543211
Q ss_pred CCccceeeeeccCCCCccChhhhccCCCCCcchhhhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcCcchhhhcccCCC
Q 002158 783 GTMPTHVSTIVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVLLELLTGMQPISHGKNIVREVNVARDSGMVFSIIDNRMGS 862 (958)
Q Consensus 783 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gv~l~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~ 862 (958)
.......|++.|+|||++.+..++.++||||||++++||++|+.||...... ..+.. ++......
T Consensus 156 -----~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~-~~~~~---------~~~~~~~~ 220 (256)
T cd08218 156 -----ELARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMK-NLVLK---------IIRGSYPP 220 (256)
T ss_pred -----hhhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCHH-HHHHH---------HhcCCCCC
Confidence 1112345888999999999888999999999999999999999999754332 11111 11122223
Q ss_pred CChHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 002158 863 YPSECVERFVTLALRCCHDKPEHRPSMSDVVRE 895 (958)
Q Consensus 863 ~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 895 (958)
.+...+..+.+++.+||+.+|++||++.+|+++
T Consensus 221 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~~ 253 (256)
T cd08218 221 VSSHYSYDLRNLVSQLFKRNPRDRPSVNSILEK 253 (256)
T ss_pred CcccCCHHHHHHHHHHhhCChhhCcCHHHHhhC
Confidence 345567889999999999999999999999974
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-36 Score=332.13 Aligned_cols=244 Identities=24% Similarity=0.437 Sum_probs=198.5
Q ss_pred CceeeeeCCeEEEEEEEC-CCcEEEE---EEecc-CChhcHHHHHHHHHHHHccCCCCcceEEEEEEeCCe--EEEEEEe
Q 002158 630 STQVGQGGYGKVYKGILS-DNTTVAI---KRAEE-GSLQGQNEFLTEIKLLSRLHHRNLVSLLGYCDEEGE--QMLVYEF 702 (958)
Q Consensus 630 ~~~lg~G~~g~Vy~~~~~-~~~~vav---K~~~~-~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~--~~lV~E~ 702 (958)
...||+|+|-+||||.+. +|-.||- |.-+. .+....++|..|+++|+.|+|+||++++.++.+... .-+|+|.
T Consensus 45 ~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iTEL 124 (632)
T KOG0584|consen 45 DEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFITEL 124 (632)
T ss_pred hhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeeeec
Confidence 347999999999999985 5777773 32211 244556789999999999999999999999977654 7899999
Q ss_pred cCCCCHHHHhccCCCCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEecC-CCCeEEeeeeeecccccCCC
Q 002158 703 VPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDS-NLNAKVADFGLSRLAPVLDD 781 (958)
Q Consensus 703 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~-~~~~kl~DFGla~~~~~~~~ 781 (958)
+..|+|+.|+++.++ ++...+..|+.||++||.|||++. |||||||||.+||+|+. -|.|||+|.|+|.....
T Consensus 125 ~TSGtLr~Y~kk~~~--vn~kaik~W~RQILkGL~yLHs~~-PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~--- 198 (632)
T KOG0584|consen 125 FTSGTLREYRKKHRR--VNIKAIKSWCRQILKGLVYLHSQD-PPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRK--- 198 (632)
T ss_pred ccCCcHHHHHHHhcc--CCHHHHHHHHHHHHHHhhhhhcCC-CCccccccccceEEEcCCcCceeecchhHHHHhhc---
Confidence 999999999987655 788899999999999999999975 89999999999999975 48999999999987632
Q ss_pred CCCccceeeeeccCCCCccChhhhccCCCCCcchhhhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcCcchhhhcccCC
Q 002158 782 EGTMPTHVSTIVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVLLELLTGMQPISHGKNIVREVNVARDSGMVFSIIDNRMG 861 (958)
Q Consensus 782 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gv~l~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~i~~~~~ 861 (958)
.....+.|||.|||||++. ..|+..+||||||+.|+||+|+..||..-.+..+.++.... |......
T Consensus 199 ------s~aksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~AQIYKKV~S-GiKP~sl----- 265 (632)
T KOG0584|consen 199 ------SHAKSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECTNPAQIYKKVTS-GIKPAAL----- 265 (632)
T ss_pred ------cccceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhCCHHHHHHHHHc-CCCHHHh-----
Confidence 1223478999999999986 77999999999999999999999999877776666554332 2111111
Q ss_pred CCChHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 002158 862 SYPSECVERFVTLALRCCHDKPEHRPSMSDVVRE 895 (958)
Q Consensus 862 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 895 (958)
..--..++.++|.+|+.. ..+|||+.|+++.
T Consensus 266 --~kV~dPevr~fIekCl~~-~~~R~sa~eLL~d 296 (632)
T KOG0584|consen 266 --SKVKDPEVREFIEKCLAT-KSERLSAKELLKD 296 (632)
T ss_pred --hccCCHHHHHHHHHHhcC-chhccCHHHHhhC
Confidence 111135789999999999 9999999999864
|
|
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-35 Score=315.57 Aligned_cols=247 Identities=30% Similarity=0.492 Sum_probs=201.3
Q ss_pred cCCCCCceeeeeCCeEEEEEEECCCcEEEEEEeccCChhcHHHHHHHHHHHHccCCCCcceEEEEEEeCCeEEEEEEecC
Q 002158 625 AYFSSSTQVGQGGYGKVYKGILSDNTTVAIKRAEEGSLQGQNEFLTEIKLLSRLHHRNLVSLLGYCDEEGEQMLVYEFVP 704 (958)
Q Consensus 625 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E~~~ 704 (958)
..|...+.||+|+||.||+|.. .++.||+|.+.... ....+.+|+.++++++|||++++++++... ..++||||++
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~-~~~~~~iK~~~~~~--~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~e~~~ 81 (254)
T cd05083 6 QKLTLGEIIGEGEFGAVLQGEY-TGQKVAVKNIKCDV--TAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIVMELMS 81 (254)
T ss_pred HHceeeeeeccCCCCceEeccc-CCCceEEEeecCcc--hHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEEECCC
Confidence 3577788999999999999975 67889999986542 245789999999999999999999998765 4799999999
Q ss_pred CCCHHHHhccCCCCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEecCCCCeEEeeeeeecccccCCCCCC
Q 002158 705 NGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSRLAPVLDDEGT 784 (958)
Q Consensus 705 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 784 (958)
+++|.+++.......+++..+..++.|++.|++|||+.+ ++||||||+||+++.++.+||+|||+++......
T Consensus 82 ~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~~---- 154 (254)
T cd05083 82 KGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKK---LVHRDLAARNILVSEDGVAKVSDFGLARVGSMGV---- 154 (254)
T ss_pred CCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccCcceEEEcCCCcEEECCCccceeccccC----
Confidence 999999998665556899999999999999999999998 9999999999999999999999999987532111
Q ss_pred ccceeeeeccCCCCccChhhhccCCCCCcchhhhHHHHHHHHHh-CCCCCCCCchhHHHHHHHhhcCcchhhhcccCCCC
Q 002158 785 MPTHVSTIVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVLLELLT-GMQPISHGKNIVREVNVARDSGMVFSIIDNRMGSY 863 (958)
Q Consensus 785 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gv~l~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~ 863 (958)
.....+..|+|||++.+..++.++||||||+++|||++ |+.||...... ...... ..+ .....
T Consensus 155 ------~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~-~~~~~~-~~~--------~~~~~ 218 (254)
T cd05083 155 ------DNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLK-EVKECV-EKG--------YRMEP 218 (254)
T ss_pred ------CCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHH-HHHHHH-hCC--------CCCCC
Confidence 11234567999999998899999999999999999998 99998654321 111111 111 11122
Q ss_pred ChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 002158 864 PSECVERFVTLALRCCHDKPEHRPSMSDVVRELEN 898 (958)
Q Consensus 864 ~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 898 (958)
+..++..+.+++.+||+.+|++||+++++++.|++
T Consensus 219 ~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 253 (254)
T cd05083 219 PEGCPADVYVLMTSCWETEPKKRPSFHKLREKLEK 253 (254)
T ss_pred CCcCCHHHHHHHHHHcCCChhhCcCHHHHHHHHcc
Confidence 34567889999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-35 Score=314.62 Aligned_cols=253 Identities=25% Similarity=0.359 Sum_probs=207.3
Q ss_pred cCCCCCceeeeeCCeEEEEEEEC-CCcEEEEEEeccCChhcHHHHHHHHHHHHccCCCCcceEEEEEEeCCeEEEEEEec
Q 002158 625 AYFSSSTQVGQGGYGKVYKGILS-DNTTVAIKRAEEGSLQGQNEFLTEIKLLSRLHHRNLVSLLGYCDEEGEQMLVYEFV 703 (958)
Q Consensus 625 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E~~ 703 (958)
++|...+.||+|+||.||+|... +++.+|+|.+........+.+.+|++++++++||||+++++++...+..+++|||+
T Consensus 3 ~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~~ 82 (262)
T cd06613 3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEYC 82 (262)
T ss_pred cceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeCC
Confidence 56788899999999999999975 57889999998765556678999999999999999999999999999999999999
Q ss_pred CCCCHHHHhccCCCCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEecCCCCeEEeeeeeecccccCCCCC
Q 002158 704 PNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSRLAPVLDDEG 783 (958)
Q Consensus 704 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 783 (958)
++++|.+++.... ..+++.++..++.|++.||+|||+.+ |+|+||||+||++++++.+||+|||++.......
T Consensus 83 ~~~~l~~~~~~~~-~~l~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~--- 155 (262)
T cd06613 83 GGGSLQDIYQVTR-GPLSELQIAYVCRETLKGLAYLHETG---KIHRDIKGANILLTEDGDVKLADFGVSAQLTATI--- 155 (262)
T ss_pred CCCcHHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHhCC---ceecCCChhhEEECCCCCEEECccccchhhhhhh---
Confidence 9999999997542 34889999999999999999999999 9999999999999999999999999987543211
Q ss_pred CccceeeeeccCCCCccChhhhccC---CCCCcchhhhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcCcchhhhcccC
Q 002158 784 TMPTHVSTIVKGTPGYLDPEYFLTH---KLTDKSDVYSLGVVLLELLTGMQPISHGKNIVREVNVARDSGMVFSIIDNRM 860 (958)
Q Consensus 784 ~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~DV~S~Gv~l~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~i~~~~ 860 (958)
.......|+..|+|||.+... .++.++||||||+++|||++|+.||............... .. ....
T Consensus 156 ----~~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~~~~~~-~~-----~~~~ 225 (262)
T cd06613 156 ----AKRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALFLISKS-NF-----PPPK 225 (262)
T ss_pred ----hccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc-cC-----CCcc
Confidence 111234688899999999777 7889999999999999999999999764432222111111 00 0001
Q ss_pred CCCChHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002158 861 GSYPSECVERFVTLALRCCHDKPEHRPSMSDVVR 894 (958)
Q Consensus 861 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 894 (958)
...+...+.++.+++.+||..+|.+||++.+++.
T Consensus 226 ~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 259 (262)
T cd06613 226 LKDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQ 259 (262)
T ss_pred ccchhhhhHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 1123456778999999999999999999999985
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-35 Score=319.10 Aligned_cols=259 Identities=26% Similarity=0.354 Sum_probs=200.3
Q ss_pred CCCCCceeeeeCCeEEEEEEEC-CCcEEEEEEeccCC--hhcHHHHHHHHHHHHccCCCCcceEEEEEEeCCeEEEEEEe
Q 002158 626 YFSSSTQVGQGGYGKVYKGILS-DNTTVAIKRAEEGS--LQGQNEFLTEIKLLSRLHHRNLVSLLGYCDEEGEQMLVYEF 702 (958)
Q Consensus 626 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E~ 702 (958)
+|...+.||+|++|.||+|+.. ++..||||++.... ....+.+.+|+.++++++||||+++++++..++..++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEF 80 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEec
Confidence 3677789999999999999976 68999999986532 22345688999999999999999999999999999999999
Q ss_pred cCCCCHHHHhccCC-CCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEecCCCCeEEeeeeeecccccCCC
Q 002158 703 VPNGTLRDWLSGRT-KENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSRLAPVLDD 781 (958)
Q Consensus 703 ~~~gsL~~~l~~~~-~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~ 781 (958)
++ ++|.+++.... ...+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||++.......
T Consensus 81 ~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~- 155 (285)
T cd07861 81 LS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRR---VLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPV- 155 (285)
T ss_pred CC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCCHHHEEEcCCCcEEECcccceeecCCCc-
Confidence 96 68999886543 256899999999999999999999999 9999999999999999999999999987542211
Q ss_pred CCCccceeeeeccCCCCccChhhhccC-CCCCcchhhhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcCcch-------
Q 002158 782 EGTMPTHVSTIVKGTPGYLDPEYFLTH-KLTDKSDVYSLGVVLLELLTGMQPISHGKNIVREVNVARDSGMVF------- 853 (958)
Q Consensus 782 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DV~S~Gv~l~elltG~~P~~~~~~~~~~~~~~~~~~~~~------- 853 (958)
.......+++.|+|||++.+. .++.++||||||+++|||+||+.||................+...
T Consensus 156 ------~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (285)
T cd07861 156 ------RVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGV 229 (285)
T ss_pred ------ccccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcc
Confidence 111223478899999998754 468899999999999999999999976544322221111100000
Q ss_pred -------hhhc----ccCCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 002158 854 -------SIID----NRMGSYPSECVERFVTLALRCCHDKPEHRPSMSDVVRE 895 (958)
Q Consensus 854 -------~~i~----~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 895 (958)
.... ..........+.++.+++.+||+.||++||++.+++++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~~ 282 (285)
T cd07861 230 TSLPDYKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNH 282 (285)
T ss_pred hhhHHHHhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhcC
Confidence 0000 00001112346778899999999999999999999863
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=335.05 Aligned_cols=256 Identities=23% Similarity=0.332 Sum_probs=199.0
Q ss_pred cCCCCCceeeeeCCeEEEEEEEC-CCcEEEEEEeccCC---hhcHHHHHHHHHHHHccCCCCcceEEEEEEeCCeEEEEE
Q 002158 625 AYFSSSTQVGQGGYGKVYKGILS-DNTTVAIKRAEEGS---LQGQNEFLTEIKLLSRLHHRNLVSLLGYCDEEGEQMLVY 700 (958)
Q Consensus 625 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~ 700 (958)
++|+..+.||+|+||+||+|..+ +++.||+|++.... ......+.+|++++..++|+||+++++++.+++..++||
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~ 80 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIM 80 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 36778899999999999999976 68999999986432 223456888999999999999999999999999999999
Q ss_pred EecCCCCHHHHhccCCCCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEecCCCCeEEeeeeeecccccCC
Q 002158 701 EFVPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSRLAPVLD 780 (958)
Q Consensus 701 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~ 780 (958)
||+++|+|.+++.... .+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++......
T Consensus 81 E~~~gg~L~~~l~~~~--~l~~~~~~~~~~qi~~~L~~lH~~g---ivHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~~ 155 (360)
T cd05627 81 EFLPGGDMMTLLMKKD--TLSEEATQFYIAETVLAIDAIHQLG---FIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAH 155 (360)
T ss_pred eCCCCccHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC---eEccCCCHHHEEECCCCCEEEeeccCCccccccc
Confidence 9999999999997543 4899999999999999999999999 9999999999999999999999999987543211
Q ss_pred CCCC----------------------------ccceeeeeccCCCCccChhhhccCCCCCcchhhhHHHHHHHHHhCCCC
Q 002158 781 DEGT----------------------------MPTHVSTIVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVLLELLTGMQP 832 (958)
Q Consensus 781 ~~~~----------------------------~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gv~l~elltG~~P 832 (958)
.... ..........||+.|+|||++.+..++.++|||||||++|||++|+.|
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~P 235 (360)
T cd05627 156 RTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPP 235 (360)
T ss_pred ccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCCCC
Confidence 0000 000011235799999999999999999999999999999999999999
Q ss_pred CCCCchhHHHHHHHhhcCcchhhhcccCCCCCh--HHHHHHHHHHHHccccCCCCCCC---HHHHHHH
Q 002158 833 ISHGKNIVREVNVARDSGMVFSIIDNRMGSYPS--ECVERFVTLALRCCHDKPEHRPS---MSDVVRE 895 (958)
Q Consensus 833 ~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~--~~~~~l~~li~~cl~~dP~~RPs---~~evl~~ 895 (958)
|......... ........ ...+|. ..+.++.+++.+++ .||.+|++ +.|++++
T Consensus 236 f~~~~~~~~~-~~i~~~~~--------~~~~p~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~h 293 (360)
T cd05627 236 FCSETPQETY-RKVMNWKE--------TLVFPPEVPISEKAKDLILRFC-TDSENRIGSNGVEEIKSH 293 (360)
T ss_pred CCCCCHHHHH-HHHHcCCC--------ceecCCCCCCCHHHHHHHHHhc-cChhhcCCCCCHHHHhcC
Confidence 9754432221 11111000 001111 24567788888866 49999985 6666654
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-35 Score=325.27 Aligned_cols=252 Identities=24% Similarity=0.359 Sum_probs=211.2
Q ss_pred HHcCCCCCceeeeeCCeEEEEEEEC-CCcEEEEEEeccCChh---cHHHHHHHHHHHHccC-CCCcceEEEEEEeCCeEE
Q 002158 623 ATAYFSSSTQVGQGGYGKVYKGILS-DNTTVAIKRAEEGSLQ---GQNEFLTEIKLLSRLH-HRNLVSLLGYCDEEGEQM 697 (958)
Q Consensus 623 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~~~~~ 697 (958)
....|+..+.||+|.||.||+++.+ +|+.+|+|.+.+.... ......+|+++|+++. |||||.+++++++....+
T Consensus 33 ~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~ 112 (382)
T KOG0032|consen 33 IKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVY 112 (382)
T ss_pred ccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEE
Confidence 3456777789999999999999987 4999999999765443 3457889999999998 999999999999999999
Q ss_pred EEEEecCCCCHHHHhccCCCCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEecCC----CCeEEeeeeee
Q 002158 698 LVYEFVPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSN----LNAKVADFGLS 773 (958)
Q Consensus 698 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~----~~~kl~DFGla 773 (958)
+|||++.||.|.+.+... .+++..+..++.|++.|++|||+.| |+|||+||+|+|+... +.+|++|||++
T Consensus 113 lvmEL~~GGeLfd~i~~~---~~sE~da~~~~~~il~av~~lH~~g---vvHrDlKpEN~L~~~~~~~~~~ik~~DFGla 186 (382)
T KOG0032|consen 113 LVMELCEGGELFDRIVKK---HYSERDAAGIIRQILEAVKYLHSLG---VVHRDLKPENLLLASKDEGSGRIKLIDFGLA 186 (382)
T ss_pred EEEEecCCchHHHHHHHc---cCCHHHHHHHHHHHHHHHHHHHhCC---ceeccCCHHHeeeccccCCCCcEEEeeCCCc
Confidence 999999999999999766 3999999999999999999999999 9999999999999543 57999999999
Q ss_pred cccccCCCCCCccceeeeeccCCCCccChhhhccCCCCCcchhhhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcCcch
Q 002158 774 RLAPVLDDEGTMPTHVSTIVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVLLELLTGMQPISHGKNIVREVNVARDSGMVF 853 (958)
Q Consensus 774 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gv~l~elltG~~P~~~~~~~~~~~~~~~~~~~~~ 853 (958)
..... .......+||+.|+|||++....|+..+||||+||++|.|++|..||.+..............-
T Consensus 187 ~~~~~--------~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~~i~~~~~--- 255 (382)
T KOG0032|consen 187 KFIKP--------GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFLAILRGDF--- 255 (382)
T ss_pred eEccC--------CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHHHHHcCCC---
Confidence 87633 2234567899999999999999999999999999999999999999986554333222111110
Q ss_pred hhhcccCCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 002158 854 SIIDNRMGSYPSECVERFVTLALRCCHDKPEHRPSMSDVVRE 895 (958)
Q Consensus 854 ~~i~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 895 (958)
.. ....-......+.+++..++..||.+|+++.+++++
T Consensus 256 ~f----~~~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~H 293 (382)
T KOG0032|consen 256 DF----TSEPWDDISESAKDFIRKLLEFDPRKRLTAAQALQH 293 (382)
T ss_pred CC----CCCCccccCHHHHHHHHHhcccCcccCCCHHHHhcC
Confidence 00 012234567889999999999999999999999996
|
|
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-35 Score=320.51 Aligned_cols=260 Identities=26% Similarity=0.415 Sum_probs=207.5
Q ss_pred cChHHHHHHHcCCCCCceeeeeCCeEEEEEEEC-CCcEEEEEEeccCChhcHHHHHHHHHHHHcc-CCCCcceEEEEEEe
Q 002158 615 FKFKELAMATAYFSSSTQVGQGGYGKVYKGILS-DNTTVAIKRAEEGSLQGQNEFLTEIKLLSRL-HHRNLVSLLGYCDE 692 (958)
Q Consensus 615 ~~~~el~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~ 692 (958)
.++.++......|+..+.||+|+||.||+|.+. +++.||+|.+.... ....++..|+.+++++ +|+||+++++++..
T Consensus 6 ~~~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 84 (282)
T cd06636 6 IDLSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE-DEEEEIKLEINMLKKYSHHRNIATYYGAFIK 84 (282)
T ss_pred hhhhhhcChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecCh-HHHHHHHHHHHHHHHhcCCCcEEEEeeehhc
Confidence 456666667788999999999999999999975 68899999886543 3345688999999999 79999999999853
Q ss_pred ------CCeEEEEEEecCCCCHHHHhccCCCCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEecCCCCeE
Q 002158 693 ------EGEQMLVYEFVPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSNLNAK 766 (958)
Q Consensus 693 ------~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~~~~k 766 (958)
....++||||+++|+|.+++.......+++..+..++.|++.||+|||+.+ |+||||||+||++++++.++
T Consensus 85 ~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~---ivH~dl~~~nili~~~~~~~ 161 (282)
T cd06636 85 KSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAHK---VIHRDIKGQNVLLTENAEVK 161 (282)
T ss_pred ccccCCCCEEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEE
Confidence 457899999999999999997655556888899999999999999999999 99999999999999999999
Q ss_pred EeeeeeecccccCCCCCCccceeeeeccCCCCccChhhhc-----cCCCCCcchhhhHHHHHHHHHhCCCCCCCCchhHH
Q 002158 767 VADFGLSRLAPVLDDEGTMPTHVSTIVKGTPGYLDPEYFL-----THKLTDKSDVYSLGVVLLELLTGMQPISHGKNIVR 841 (958)
Q Consensus 767 l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DV~S~Gv~l~elltG~~P~~~~~~~~~ 841 (958)
|+|||+++...... .......|+..|+|||.+. ...++.++|||||||++|||++|..||........
T Consensus 162 l~dfg~~~~~~~~~-------~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~ 234 (282)
T cd06636 162 LVDFGVSAQLDRTV-------GRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRA 234 (282)
T ss_pred EeeCcchhhhhccc-------cCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhh
Confidence 99999987542211 1112345889999999986 34578899999999999999999999975433222
Q ss_pred HHHHHhhcCcchhhhcccCCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002158 842 EVNVARDSGMVFSIIDNRMGSYPSECVERFVTLALRCCHDKPEHRPSMSDVVR 894 (958)
Q Consensus 842 ~~~~~~~~~~~~~~i~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 894 (958)
....... .........++..+.+++.+||+.||.+||++.|+++
T Consensus 235 ~~~~~~~---------~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~ 278 (282)
T cd06636 235 LFLIPRN---------PPPKLKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLK 278 (282)
T ss_pred hhhHhhC---------CCCCCcccccCHHHHHHHHHHhCCChhhCcCHHHHhc
Confidence 1110000 0011112346678999999999999999999999986
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-35 Score=318.58 Aligned_cols=255 Identities=27% Similarity=0.422 Sum_probs=204.7
Q ss_pred cCCCCCceeeeeCCeEEEEEEEC------CCcEEEEEEeccCChh-cHHHHHHHHHHHHccCCCCcceEEEEEEeCCeEE
Q 002158 625 AYFSSSTQVGQGGYGKVYKGILS------DNTTVAIKRAEEGSLQ-GQNEFLTEIKLLSRLHHRNLVSLLGYCDEEGEQM 697 (958)
Q Consensus 625 ~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~ 697 (958)
++|.....||+|+||+||+|+.+ +.+.|++|.+...... ..+++.+|++++++++|+||+++++++.+.+..+
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 84 (275)
T cd05046 5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHY 84 (275)
T ss_pred HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcce
Confidence 56788889999999999999964 2467999988764433 4567999999999999999999999999999999
Q ss_pred EEEEecCCCCHHHHhccCCC-------CCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEecCCCCeEEeee
Q 002158 698 LVYEFVPNGTLRDWLSGRTK-------ENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSNLNAKVADF 770 (958)
Q Consensus 698 lV~E~~~~gsL~~~l~~~~~-------~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~~~~kl~DF 770 (958)
+||||+++|+|.++++.... ..+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.++++||
T Consensus 85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~---i~H~dlkp~Nili~~~~~~~l~~~ 161 (275)
T cd05046 85 MILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNAR---FVHRDLAARNCLVSSQREVKVSLL 161 (275)
T ss_pred EEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcC---cccCcCccceEEEeCCCcEEEccc
Confidence 99999999999999975441 25899999999999999999999999 999999999999999999999999
Q ss_pred eeecccccCCCCCCccceeeeeccCCCCccChhhhccCCCCCcchhhhHHHHHHHHHh-CCCCCCCCchhHHHHHHHhhc
Q 002158 771 GLSRLAPVLDDEGTMPTHVSTIVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVLLELLT-GMQPISHGKNIVREVNVARDS 849 (958)
Q Consensus 771 Gla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gv~l~ellt-G~~P~~~~~~~~~~~~~~~~~ 849 (958)
|+++...... ........++..|+|||.+.+..++.++||||||+++|||++ |..||...... ..+.....
T Consensus 162 ~~~~~~~~~~------~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~-~~~~~~~~- 233 (275)
T cd05046 162 SLSKDVYNSE------YYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDE-EVLNRLQA- 233 (275)
T ss_pred ccccccCccc------ccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccchH-HHHHHHHc-
Confidence 9986432111 111122345678999999988888999999999999999999 78888643321 11111111
Q ss_pred CcchhhhcccCCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 002158 850 GMVFSIIDNRMGSYPSECVERFVTLALRCCHDKPEHRPSMSDVVRELE 897 (958)
Q Consensus 850 ~~~~~~i~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 897 (958)
+.. ....+..++..+.+++.+||+.+|++||++.|+++.|+
T Consensus 234 ~~~-------~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~ 274 (275)
T cd05046 234 GKL-------ELPVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALG 274 (275)
T ss_pred CCc-------CCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhc
Confidence 100 01123346678999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=314.03 Aligned_cols=252 Identities=25% Similarity=0.398 Sum_probs=201.3
Q ss_pred cCCCCCceeeeeCCeEEEEEEEC-CCcEEEEEEeccCC-----hhcHHHHHHHHHHHHccCCCCcceEEEEEEeC--CeE
Q 002158 625 AYFSSSTQVGQGGYGKVYKGILS-DNTTVAIKRAEEGS-----LQGQNEFLTEIKLLSRLHHRNLVSLLGYCDEE--GEQ 696 (958)
Q Consensus 625 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~--~~~ 696 (958)
++|...+.||+|+||.||+|... +++.||||.+.... ....+.+.+|++++++++||||+++++++.+. ...
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL 81 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence 46788899999999999999975 58999999875321 22345788999999999999999999998663 467
Q ss_pred EEEEEecCCCCHHHHhccCCCCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEecCCCCeEEeeeeeeccc
Q 002158 697 MLVYEFVPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSRLA 776 (958)
Q Consensus 697 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~~ 776 (958)
++||||+++++|.+++.... .+++..+.+++.|++.||+|||+.+ ++|+||||+||+++.++.++|+|||+++..
T Consensus 82 ~~v~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~ 156 (265)
T cd06652 82 SIFMEHMPGGSIKDQLKSYG--ALTENVTRKYTRQILEGVSYLHSNM---IVHRDIKGANILRDSVGNVKLGDFGASKRL 156 (265)
T ss_pred EEEEEecCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEecCCCCEEECcCcccccc
Confidence 89999999999999997543 3788889999999999999999999 999999999999999999999999998754
Q ss_pred ccCCCCCCccceeeeeccCCCCccChhhhccCCCCCcchhhhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcCcchhhh
Q 002158 777 PVLDDEGTMPTHVSTIVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVLLELLTGMQPISHGKNIVREVNVARDSGMVFSII 856 (958)
Q Consensus 777 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gv~l~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~i 856 (958)
...... ........|+..|+|||++.+..++.++||||||+++|||++|+.||..............
T Consensus 157 ~~~~~~----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~--------- 223 (265)
T cd06652 157 QTICLS----GTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIFKIAT--------- 223 (265)
T ss_pred cccccc----ccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchHHHHHHHhc---------
Confidence 321111 1111234588999999999888899999999999999999999999975433322211110
Q ss_pred cccCCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 002158 857 DNRMGSYPSECVERFVTLALRCCHDKPEHRPSMSDVVRE 895 (958)
Q Consensus 857 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 895 (958)
.......|......+.+++.+|+. +|++||+++|++++
T Consensus 224 ~~~~~~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~~ 261 (265)
T cd06652 224 QPTNPVLPPHVSDHCRDFLKRIFV-EAKLRPSADELLRH 261 (265)
T ss_pred CCCCCCCchhhCHHHHHHHHHHhc-ChhhCCCHHHHhcC
Confidence 111233455667788899999994 99999999999864
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-35 Score=321.22 Aligned_cols=266 Identities=27% Similarity=0.453 Sum_probs=206.6
Q ss_pred CCCCCceeeeeCCeEEEEEEEC-----CCcEEEEEEeccCChh-cHHHHHHHHHHHHccCCCCcceEEEEEEe--CCeEE
Q 002158 626 YFSSSTQVGQGGYGKVYKGILS-----DNTTVAIKRAEEGSLQ-GQNEFLTEIKLLSRLHHRNLVSLLGYCDE--EGEQM 697 (958)
Q Consensus 626 ~~~~~~~lg~G~~g~Vy~~~~~-----~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~~~~~~--~~~~~ 697 (958)
.|...+.||+|+||.||+|.+. .+..||||.+...... ..+.|.+|+++++.++|+||+++++++.. ....+
T Consensus 5 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~~ 84 (284)
T cd05038 5 HLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSLR 84 (284)
T ss_pred hchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCceE
Confidence 5666789999999999999864 3678999999865443 45679999999999999999999999877 55789
Q ss_pred EEEEecCCCCHHHHhccCCCCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEecCCCCeEEeeeeeecccc
Q 002158 698 LVYEFVPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSRLAP 777 (958)
Q Consensus 698 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~~~ 777 (958)
+||||+++++|.+++.... ..+++..+..++.|++.||+|||+.+ ++||||||+||+++.++.++|+|||++....
T Consensus 85 lv~e~~~~~~l~~~l~~~~-~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~ 160 (284)
T cd05038 85 LIMEYLPSGSLRDYLQRHR-DQINLKRLLLFSSQICKGMDYLGSQR---YIHRDLAARNILVESEDLVKISDFGLAKVLP 160 (284)
T ss_pred EEEecCCCCCHHHHHHhCc-cccCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHhEEEcCCCCEEEcccccccccc
Confidence 9999999999999997544 24899999999999999999999999 9999999999999999999999999998654
Q ss_pred cCCCCCCccceeeeeccCCCCccChhhhccCCCCCcchhhhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhc----Ccch
Q 002158 778 VLDDEGTMPTHVSTIVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVLLELLTGMQPISHGKNIVREVNVARDS----GMVF 853 (958)
Q Consensus 778 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gv~l~elltG~~P~~~~~~~~~~~~~~~~~----~~~~ 853 (958)
..... ........++..|+|||.+.+..++.++||||||+++|||++|..|+................ ....
T Consensus 161 ~~~~~----~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (284)
T cd05038 161 EDKDY----YYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLL 236 (284)
T ss_pred cCCcc----eeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHHHH
Confidence 22111 111112335567999999998899999999999999999999999986432211000000000 0000
Q ss_pred hhhccc-CCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHh
Q 002158 854 SIIDNR-MGSYPSECVERFVTLALRCCHDKPEHRPSMSDVVRELENI 899 (958)
Q Consensus 854 ~~i~~~-~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 899 (958)
..+... ....+..++.++.+++.+||+.+|++||++.|++++|+++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i 283 (284)
T cd05038 237 ELLKEGERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRL 283 (284)
T ss_pred HHHHcCCcCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhc
Confidence 111111 1122345668899999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=316.04 Aligned_cols=246 Identities=24% Similarity=0.361 Sum_probs=208.5
Q ss_pred CCCCCceeeeeCCeEEEEEEEC-CCcEEEEEEeccCChhc--HHHHHHHHHHHHccCCCCcceEEEEEEeCCeEEEEEEe
Q 002158 626 YFSSSTQVGQGGYGKVYKGILS-DNTTVAIKRAEEGSLQG--QNEFLTEIKLLSRLHHRNLVSLLGYCDEEGEQMLVYEF 702 (958)
Q Consensus 626 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~--~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E~ 702 (958)
-|...+.||+|.|+.|-.|++- .|..||||++.+..... ...+..|+++|+-++|||||++|.+......+|||+|+
T Consensus 19 LYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiLEL 98 (864)
T KOG4717|consen 19 LYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLILEL 98 (864)
T ss_pred eehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEEEe
Confidence 3555678999999999999865 79999999998754333 34688999999999999999999999999999999999
Q ss_pred cCCCCHHHHhccCCCCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEec-CCCCeEEeeeeeecccccCCC
Q 002158 703 VPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLD-SNLNAKVADFGLSRLAPVLDD 781 (958)
Q Consensus 703 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~-~~~~~kl~DFGla~~~~~~~~ 781 (958)
-++|+|+|||-... ..+.+.-+.+++.||..|+.|+|+.+ +|||||||+||.+- .-|-+||.|||++-.+..
T Consensus 99 GD~GDl~DyImKHe-~Gl~E~La~kYF~QI~~AI~YCHqLH---VVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~P--- 171 (864)
T KOG4717|consen 99 GDGGDLFDYIMKHE-EGLNEDLAKKYFAQIVHAISYCHQLH---VVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQP--- 171 (864)
T ss_pred cCCchHHHHHHhhh-ccccHHHHHHHHHHHHHHHHHHhhhh---hhcccCCcceeEEeeecCceEeeeccccccCCC---
Confidence 99999999997554 34999999999999999999999999 99999999999774 568999999999865532
Q ss_pred CCCccceeeeeccCCCCccChhhhccCCCCC-cchhhhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcCcchhhhcccC
Q 002158 782 EGTMPTHVSTIVKGTPGYLDPEYFLTHKLTD-KSDVYSLGVVLLELLTGMQPISHGKNIVREVNVARDSGMVFSIIDNRM 860 (958)
Q Consensus 782 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~-~~DV~S~Gv~l~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~i~~~~ 860 (958)
.......+|+..|-|||++.+..|+. ++||||+||+||.|++|+.||....+. +.+..++| .-
T Consensus 172 -----G~kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDS----------ETLTmImD-CK 235 (864)
T KOG4717|consen 172 -----GKKLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDS----------ETLTMIMD-CK 235 (864)
T ss_pred -----cchhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccch----------hhhhhhhc-cc
Confidence 33455678999999999999999985 899999999999999999999754332 12222222 23
Q ss_pred CCCChHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002158 861 GSYPSECVERFVTLALRCCHDKPEHRPSMSDVVR 894 (958)
Q Consensus 861 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 894 (958)
...|.....+..+||..|+..||++|.+.+||+.
T Consensus 236 YtvPshvS~eCrdLI~sMLvRdPkkRAslEeI~s 269 (864)
T KOG4717|consen 236 YTVPSHVSKECRDLIQSMLVRDPKKRASLEEIVS 269 (864)
T ss_pred ccCchhhhHHHHHHHHHHHhcCchhhccHHHHhc
Confidence 4568889999999999999999999999999985
|
|
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=320.53 Aligned_cols=253 Identities=23% Similarity=0.377 Sum_probs=201.7
Q ss_pred cCCCCCceeeeeCCeEEEEEEECCCcEEEEEEecc--CChhcHHHHHHHHHHHHccC-CCCcceEEEEEEeCCeEEEEEE
Q 002158 625 AYFSSSTQVGQGGYGKVYKGILSDNTTVAIKRAEE--GSLQGQNEFLTEIKLLSRLH-HRNLVSLLGYCDEEGEQMLVYE 701 (958)
Q Consensus 625 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~~~~~lV~E 701 (958)
..|++.++||+||.++||++...+.+.||+|++.. .+.+....|..|++.|.+++ |.+||++++|-..++.+|||||
T Consensus 361 ~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYmvmE 440 (677)
T KOG0596|consen 361 REYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYMVME 440 (677)
T ss_pred chhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEEEee
Confidence 35677789999999999999988889999997654 34455677999999999994 9999999999999999999999
Q ss_pred ecCCCCHHHHhccCCCCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEecCCCCeEEeeeeeecccccCCC
Q 002158 702 FVPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSRLAPVLDD 781 (958)
Q Consensus 702 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~ 781 (958)
|= ..+|..+|+.+......| .+..+..||+.|+.++|++| |||.||||.|+|+- .|.+||+|||+|........
T Consensus 441 ~G-d~DL~kiL~k~~~~~~~~-~lk~ywkqML~aV~~IH~~g---IVHSDLKPANFLlV-kG~LKLIDFGIA~aI~~DTT 514 (677)
T KOG0596|consen 441 CG-DIDLNKILKKKKSIDPDW-FLKFYWKQMLLAVKTIHQHG---IVHSDLKPANFLLV-KGRLKLIDFGIANAIQPDTT 514 (677)
T ss_pred cc-cccHHHHHHhccCCCchH-HHHHHHHHHHHHHHHHHHhc---eeecCCCcccEEEE-eeeEEeeeechhcccCcccc
Confidence 86 679999998877654555 78889999999999999999 99999999999995 68999999999987643322
Q ss_pred CCCccceeeeeccCCCCccChhhhccCC-----------CCCcchhhhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcC
Q 002158 782 EGTMPTHVSTIVKGTPGYLDPEYFLTHK-----------LTDKSDVYSLGVVLLELLTGMQPISHGKNIVREVNVARDSG 850 (958)
Q Consensus 782 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~-----------~~~~~DV~S~Gv~l~elltG~~P~~~~~~~~~~~~~~~~~~ 850 (958)
.-.....+||+.||+||.+.... .++++||||+||+||+|+-|+.||..-.+....+....+.+
T Consensus 515 -----sI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n~~aKl~aI~~P~ 589 (677)
T KOG0596|consen 515 -----SIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIINQIAKLHAITDPN 589 (677)
T ss_pred -----ceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHHHHHHHHhhcCCC
Confidence 22334568999999999996443 55799999999999999999999975444333332222211
Q ss_pred cchhhhcccCCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 002158 851 MVFSIIDNRMGSYPSECVERFVTLALRCCHDKPEHRPSMSDVVRE 895 (958)
Q Consensus 851 ~~~~~i~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 895 (958)
... ..+..+.. .++.++++.|+..||++||+..|++++
T Consensus 590 ~~I-----efp~~~~~--~~li~~mK~CL~rdPkkR~si~eLLqh 627 (677)
T KOG0596|consen 590 HEI-----EFPDIPEN--DELIDVMKCCLARDPKKRWSIPELLQH 627 (677)
T ss_pred ccc-----cccCCCCc--hHHHHHHHHHHhcCcccCCCcHHHhcC
Confidence 100 11222322 238999999999999999999999975
|
|
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-35 Score=316.64 Aligned_cols=247 Identities=26% Similarity=0.416 Sum_probs=205.4
Q ss_pred CCCCCceeeeeCCeEEEEEEEC-CCcEEEEEEeccCC-hhcHHHHHHHHHHHHccCCCCcceEEEEEEeCCeEEEEEEec
Q 002158 626 YFSSSTQVGQGGYGKVYKGILS-DNTTVAIKRAEEGS-LQGQNEFLTEIKLLSRLHHRNLVSLLGYCDEEGEQMLVYEFV 703 (958)
Q Consensus 626 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E~~ 703 (958)
.|+..+.||+|+||.||+|.+. +++.||+|.+.... ......+.+|++++++++|+||+++++++.++...++||||+
T Consensus 5 ~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (277)
T cd06640 5 LFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEYL 84 (277)
T ss_pred hhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEecC
Confidence 4666788999999999999976 58899999987543 344567899999999999999999999999999999999999
Q ss_pred CCCCHHHHhccCCCCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEecCCCCeEEeeeeeecccccCCCCC
Q 002158 704 PNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSRLAPVLDDEG 783 (958)
Q Consensus 704 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 783 (958)
++++|.+++... .+++.++..++.|++.||+|||+.+ ++|+||+|+||+++.++.++|+|||++.......
T Consensus 85 ~~~~L~~~i~~~---~l~~~~~~~~~~~l~~~l~~lh~~~---ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~--- 155 (277)
T cd06640 85 GGGSALDLLRAG---PFDEFQIATMLKEILKGLDYLHSEK---KIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQ--- 155 (277)
T ss_pred CCCcHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCC---ccCcCCChhhEEEcCCCCEEEcccccceeccCCc---
Confidence 999999999643 3888999999999999999999998 9999999999999999999999999987543211
Q ss_pred CccceeeeeccCCCCccChhhhccCCCCCcchhhhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcCcchhhhcccCCCC
Q 002158 784 TMPTHVSTIVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVLLELLTGMQPISHGKNIVREVNVARDSGMVFSIIDNRMGSY 863 (958)
Q Consensus 784 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gv~l~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~ 863 (958)
.......++..|+|||++.+..++.++||||||+++|||++|..||.......... . .........
T Consensus 156 ----~~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~-~---------~~~~~~~~~ 221 (277)
T cd06640 156 ----IKRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLF-L---------IPKNNPPTL 221 (277)
T ss_pred ----cccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhHhh-h---------hhcCCCCCC
Confidence 11223458889999999998889999999999999999999999997543221110 0 001112334
Q ss_pred ChHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 002158 864 PSECVERFVTLALRCCHDKPEHRPSMSDVVRE 895 (958)
Q Consensus 864 ~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 895 (958)
+..++..+.+++.+||+.+|++||++++++++
T Consensus 222 ~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06640 222 TGEFSKPFKEFIDACLNKDPSFRPTAKELLKH 253 (277)
T ss_pred chhhhHHHHHHHHHHcccCcccCcCHHHHHhC
Confidence 55778899999999999999999999999876
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-35 Score=312.68 Aligned_cols=248 Identities=28% Similarity=0.487 Sum_probs=204.3
Q ss_pred CCCCCceeeeeCCeEEEEEEEC-CCcEEEEEEeccCC-----hhcHHHHHHHHHHHHccCCCCcceEEEEEEeCCeEEEE
Q 002158 626 YFSSSTQVGQGGYGKVYKGILS-DNTTVAIKRAEEGS-----LQGQNEFLTEIKLLSRLHHRNLVSLLGYCDEEGEQMLV 699 (958)
Q Consensus 626 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV 699 (958)
+|...+.||+|+||.||+|... +++.|++|.+.... ....+.+.+|+++++.++|+||+++++++..+...++|
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF 80 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence 3666789999999999999987 78999999876532 22346789999999999999999999999999999999
Q ss_pred EEecCCCCHHHHhccCCCCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEecCCCCeEEeeeeeecccccC
Q 002158 700 YEFVPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSRLAPVL 779 (958)
Q Consensus 700 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~~~~~ 779 (958)
|||+++++|.+++.... .+++..+..++.|++.|++|||+.+ ++|+||+|+||+++.++.+||+|||++......
T Consensus 81 ~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~~ 155 (258)
T cd06632 81 LELVPGGSLAKLLKKYG--SFPEPVIRLYTRQILLGLEYLHDRN---TVHRDIKGANILVDTNGVVKLADFGMAKQVVEF 155 (258)
T ss_pred EEecCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEccCccceecccc
Confidence 99999999999997543 4889999999999999999999999 999999999999999999999999998764321
Q ss_pred CCCCCccceeeeeccCCCCccChhhhccCC-CCCcchhhhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcCcchhhhcc
Q 002158 780 DDEGTMPTHVSTIVKGTPGYLDPEYFLTHK-LTDKSDVYSLGVVLLELLTGMQPISHGKNIVREVNVARDSGMVFSIIDN 858 (958)
Q Consensus 780 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DV~S~Gv~l~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~i~~ 858 (958)
. ......|+..|+|||.+.... ++.++|+||||+++|||++|+.||.............. ..
T Consensus 156 ~--------~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~---------~~ 218 (258)
T cd06632 156 S--------FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKIGR---------SK 218 (258)
T ss_pred c--------cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHHHHHHHHh---------cc
Confidence 1 122345889999999997766 88999999999999999999999975443222111110 01
Q ss_pred cCCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 002158 859 RMGSYPSECVERFVTLALRCCHDKPEHRPSMSDVVRE 895 (958)
Q Consensus 859 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 895 (958)
.....+...+..+.+++.+||+.+|++||++.+++++
T Consensus 219 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 255 (258)
T cd06632 219 ELPPIPDHLSDEAKDFILKCLQRDPSLRPTAAELLEH 255 (258)
T ss_pred cCCCcCCCcCHHHHHHHHHHhhcCcccCcCHHHHhcC
Confidence 1223345567888999999999999999999999863
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=329.91 Aligned_cols=251 Identities=25% Similarity=0.399 Sum_probs=208.8
Q ss_pred CCCCCceeeeeCCeEEEEEEECCC-cEEEEEEeccCChhcHHHHHHHHHHHHccCCCCcceEEEEEEeCCeEEEEEEecC
Q 002158 626 YFSSSTQVGQGGYGKVYKGILSDN-TTVAIKRAEEGSLQGQNEFLTEIKLLSRLHHRNLVSLLGYCDEEGEQMLVYEFVP 704 (958)
Q Consensus 626 ~~~~~~~lg~G~~g~Vy~~~~~~~-~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E~~~ 704 (958)
.|.++..||.|+||.||+|..++. -..|.|++...+....++|+-|+++|+...||+||++++.|..++.++++.|||+
T Consensus 33 ~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEFC~ 112 (1187)
T KOG0579|consen 33 HWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEFCG 112 (1187)
T ss_pred HHHHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEeecC
Confidence 455566799999999999998753 4456788888788888899999999999999999999999999999999999999
Q ss_pred CCCHHHHhccCCCCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEecCCCCeEEeeeeeecccccCCCCCC
Q 002158 705 NGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSRLAPVLDDEGT 784 (958)
Q Consensus 705 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 784 (958)
||-++..+-.-+ ..+++.++.-++.|++.||.|||++. |||||||+.|||++-+|.++|+|||.+....
T Consensus 113 GGAVDaimlEL~-r~LtE~QIqvvc~q~ldALn~LHs~~---iIHRDLKAGNiL~TldGdirLADFGVSAKn~------- 181 (1187)
T KOG0579|consen 113 GGAVDAIMLELG-RVLTEDQIQVVCYQVLDALNWLHSQN---IIHRDLKAGNILLTLDGDIRLADFGVSAKNK------- 181 (1187)
T ss_pred CchHhHHHHHhc-cccchHHHHHHHHHHHHHHHHHhhcc---hhhhhccccceEEEecCcEeeecccccccch-------
Confidence 999998886543 34999999999999999999999999 9999999999999999999999999875321
Q ss_pred ccceeeeeccCCCCccChhhhc-----cCCCCCcchhhhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcCcchhhhccc
Q 002158 785 MPTHVSTIVKGTPGYLDPEYFL-----THKLTDKSDVYSLGVVLLELLTGMQPISHGKNIVREVNVARDSGMVFSIIDNR 859 (958)
Q Consensus 785 ~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DV~S~Gv~l~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~i~~~ 859 (958)
........+.||+.|||||+.+ ..+|++++||||||++|.||..+.+|...-..+...+...... +.
T Consensus 182 ~t~qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpMRVllKiaKSe--------PP 253 (1187)
T KOG0579|consen 182 STRQKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSE--------PP 253 (1187)
T ss_pred hHHhhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchHHHHHHHhhcC--------CC
Confidence 1122334678999999999985 4579999999999999999999999987554433333222211 11
Q ss_pred CCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 002158 860 MGSYPSECVERFVTLALRCCHDKPEHRPSMSDVVRE 895 (958)
Q Consensus 860 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 895 (958)
-.-.|..+...+.+++.+|+..||+.||++++++++
T Consensus 254 TLlqPS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~H 289 (1187)
T KOG0579|consen 254 TLLQPSHWSRSFSDFLKRCLVKNPRNRPPAAQLLKH 289 (1187)
T ss_pred cccCcchhhhHHHHHHHHHHhcCCccCCCHHHHhhC
Confidence 122477889999999999999999999999999864
|
|
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-35 Score=322.38 Aligned_cols=263 Identities=24% Similarity=0.395 Sum_probs=205.8
Q ss_pred cChHHHHHHHcCCCCCceeeeeCCeEEEEEEEC-CCcEEEEEEeccCChhcHHHHHHHHHHHHcc-CCCCcceEEEEEE-
Q 002158 615 FKFKELAMATAYFSSSTQVGQGGYGKVYKGILS-DNTTVAIKRAEEGSLQGQNEFLTEIKLLSRL-HHRNLVSLLGYCD- 691 (958)
Q Consensus 615 ~~~~el~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~- 691 (958)
+.+..+..+.++|+..+.||+|+||.||+|... +++.||+|++.... .....+.+|+.+++++ +|+||+++++++.
T Consensus 8 ~~~~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~ 86 (286)
T cd06638 8 IIFDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIH-DIDEEIEAEYNILKALSDHPNVVKFYGMYYK 86 (286)
T ss_pred EEeecCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeecccc-chHHHHHHHHHHHHHHhcCCCeeeeeeeeee
Confidence 344556667889999999999999999999975 68899999876532 2235688899999999 6999999999884
Q ss_pred ----eCCeEEEEEEecCCCCHHHHhccC--CCCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEecCCCCe
Q 002158 692 ----EEGEQMLVYEFVPNGTLRDWLSGR--TKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSNLNA 765 (958)
Q Consensus 692 ----~~~~~~lV~E~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~~~~ 765 (958)
.++..++||||+++++|.++++.. ....+++..+..++.|+++||.|||+.+ |+||||||+||++++++.+
T Consensus 87 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nili~~~~~~ 163 (286)
T cd06638 87 KDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNK---TIHRDVKGNNILLTTEGGV 163 (286)
T ss_pred cccCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCC---ccccCCCHHhEEECCCCCE
Confidence 345789999999999999988632 2345889999999999999999999998 9999999999999999999
Q ss_pred EEeeeeeecccccCCCCCCccceeeeeccCCCCccChhhhcc-----CCCCCcchhhhHHHHHHHHHhCCCCCCCCchhH
Q 002158 766 KVADFGLSRLAPVLDDEGTMPTHVSTIVKGTPGYLDPEYFLT-----HKLTDKSDVYSLGVVLLELLTGMQPISHGKNIV 840 (958)
Q Consensus 766 kl~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DV~S~Gv~l~elltG~~P~~~~~~~~ 840 (958)
||+|||+++...... .......|+..|+|||++.. ..++.++||||+||++|||++|+.||.......
T Consensus 164 kl~dfg~~~~~~~~~-------~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~ 236 (286)
T cd06638 164 KLVDFGVSAQLTSTR-------LRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMR 236 (286)
T ss_pred EEccCCceeecccCC-------CccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhH
Confidence 999999987543211 11123458999999999853 447889999999999999999999997654322
Q ss_pred HHHHHHhhcCcchhhhcccCCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 002158 841 REVNVARDSGMVFSIIDNRMGSYPSECVERFVTLALRCCHDKPEHRPSMSDVVREL 896 (958)
Q Consensus 841 ~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 896 (958)
....... ... . ....+..++..+.+++.+||+.||++||++.|++++.
T Consensus 237 ~~~~~~~--~~~-----~-~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~~ 284 (286)
T cd06638 237 ALFKIPR--NPP-----P-TLHQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHV 284 (286)
T ss_pred HHhhccc--cCC-----C-cccCCCCcCHHHHHHHHHHccCCcccCCCHHHHhhcc
Confidence 2211100 000 0 0011233456799999999999999999999999753
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-35 Score=326.81 Aligned_cols=255 Identities=25% Similarity=0.353 Sum_probs=202.2
Q ss_pred CCCCCceeeeeCCeEEEEEEEC-CCcEEEEEEeccCChhcHHHHHHHHHHHHccC-C-----CCcceEEEEEEeCCeEEE
Q 002158 626 YFSSSTQVGQGGYGKVYKGILS-DNTTVAIKRAEEGSLQGQNEFLTEIKLLSRLH-H-----RNLVSLLGYCDEEGEQML 698 (958)
Q Consensus 626 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-H-----~niv~l~~~~~~~~~~~l 698 (958)
+|.+.+.||+|+||.|-+|.+. +++.||||+++... .-..+-..|+.+|..++ | -|+|++++|+...++.+|
T Consensus 187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k-~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~Hlci 265 (586)
T KOG0667|consen 187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKK-RFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHLCI 265 (586)
T ss_pred EEEEEEEecccccceeEEEEecCCCcEEEEEeeccCh-HHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccceee
Confidence 7888999999999999999975 69999999998743 23345678999999996 3 579999999999999999
Q ss_pred EEEecCCCCHHHHhccCCCCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEecCC--CCeEEeeeeeeccc
Q 002158 699 VYEFVPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSN--LNAKVADFGLSRLA 776 (958)
Q Consensus 699 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~--~~~kl~DFGla~~~ 776 (958)
|+|.+ .-+|+++|+......++...+..++.||+.||.+||+.+ |||+||||+|||+.+. ..+||+|||.|+..
T Consensus 266 VfELL-~~NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l~---IIHcDLKPENILL~~~~r~~vKVIDFGSSc~~ 341 (586)
T KOG0667|consen 266 VFELL-STNLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHELG---IIHCDLKPENILLKDPKRSRIKVIDFGSSCFE 341 (586)
T ss_pred eehhh-hhhHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCChhheeeccCCcCceeEEeccccccc
Confidence 99999 579999999888888999999999999999999999999 9999999999999654 36999999999864
Q ss_pred ccCCCCCCccceeeeeccCCCCccChhhhccCCCCCcchhhhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcC------
Q 002158 777 PVLDDEGTMPTHVSTIVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVLLELLTGMQPISHGKNIVREVNVARDSG------ 850 (958)
Q Consensus 777 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gv~l~elltG~~P~~~~~~~~~~~~~~~~~~------ 850 (958)
.. .. .....+..|+|||++.+.+|+.+.|||||||++.||++|.+-|.+.....+......--+
T Consensus 342 ~q---------~v-ytYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~e~lG~Pp~~m 411 (586)
T KOG0667|consen 342 SQ---------RV-YTYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDNEYDQLARIIEVLGLPPPKM 411 (586)
T ss_pred CC---------cc-eeeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCCHHHHHHHHHHHhCCCCHHH
Confidence 21 11 144577889999999999999999999999999999999766655443322211111000
Q ss_pred --------cchhh-----------------------------hcccC-C--------CCChHHHHHHHHHHHHccccCCC
Q 002158 851 --------MVFSI-----------------------------IDNRM-G--------SYPSECVERFVTLALRCCHDKPE 884 (958)
Q Consensus 851 --------~~~~~-----------------------------i~~~~-~--------~~~~~~~~~l~~li~~cl~~dP~ 884 (958)
..++. .+... + ..+......+.+++++|++.||.
T Consensus 412 L~~~~~~~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~dflk~~L~~dP~ 491 (586)
T KOG0667|consen 412 LDTAKKAHKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFIDFLKRCLEWDPA 491 (586)
T ss_pred HHhccccceehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHHHHHHHhccCch
Confidence 00000 00000 0 01113456789999999999999
Q ss_pred CCCCHHHHHHH
Q 002158 885 HRPSMSDVVRE 895 (958)
Q Consensus 885 ~RPs~~evl~~ 895 (958)
+|+|..|++++
T Consensus 492 ~R~tp~qal~H 502 (586)
T KOG0667|consen 492 ERITPAQALNH 502 (586)
T ss_pred hcCCHHHHhcC
Confidence 99999999986
|
|
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-35 Score=317.52 Aligned_cols=247 Identities=27% Similarity=0.413 Sum_probs=204.4
Q ss_pred CCCCCceeeeeCCeEEEEEEEC-CCcEEEEEEeccCC-hhcHHHHHHHHHHHHccCCCCcceEEEEEEeCCeEEEEEEec
Q 002158 626 YFSSSTQVGQGGYGKVYKGILS-DNTTVAIKRAEEGS-LQGQNEFLTEIKLLSRLHHRNLVSLLGYCDEEGEQMLVYEFV 703 (958)
Q Consensus 626 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E~~ 703 (958)
+|+..+.||.|+||.||+|.+. +++.||+|.+.... ......+.+|+++++.++|+|++++++++.++...++|+||+
T Consensus 2 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~ 81 (274)
T cd06609 2 LFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEYC 81 (274)
T ss_pred hhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEee
Confidence 5677789999999999999976 68899999987543 334567889999999999999999999999999999999999
Q ss_pred CCCCHHHHhccCCCCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEecCCCCeEEeeeeeecccccCCCCC
Q 002158 704 PNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSRLAPVLDDEG 783 (958)
Q Consensus 704 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 783 (958)
++++|.+++... .+++..+..++.|++.|+.|||+.+ ++||||+|+||++++++.++|+|||+++......
T Consensus 82 ~~~~L~~~~~~~---~~~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~--- 152 (274)
T cd06609 82 GGGSCLDLLKPG---KLDETYIAFILREVLLGLEYLHEEG---KIHRDIKAANILLSEEGDVKLADFGVSGQLTSTM--- 152 (274)
T ss_pred CCCcHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEcccccceeecccc---
Confidence 999999999754 5899999999999999999999999 9999999999999999999999999998654321
Q ss_pred CccceeeeeccCCCCccChhhhccCCCCCcchhhhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcCcchhhhcccCCCC
Q 002158 784 TMPTHVSTIVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVLLELLTGMQPISHGKNIVREVNVARDSGMVFSIIDNRMGSY 863 (958)
Q Consensus 784 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gv~l~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~ 863 (958)
.......|+..|+|||++.+..++.++||||||+++|||++|+.||......... .... .......
T Consensus 153 ----~~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~~~-~~~~---------~~~~~~~ 218 (274)
T cd06609 153 ----SKRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMRVL-FLIP---------KNNPPSL 218 (274)
T ss_pred ----cccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchHHHH-HHhh---------hcCCCCC
Confidence 1122345888999999999988999999999999999999999999654322111 1100 0111122
Q ss_pred ChH-HHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 002158 864 PSE-CVERFVTLALRCCHDKPEHRPSMSDVVRE 895 (958)
Q Consensus 864 ~~~-~~~~l~~li~~cl~~dP~~RPs~~evl~~ 895 (958)
+.. ++..+.+++.+||..+|++||++++++++
T Consensus 219 ~~~~~~~~~~~~l~~~l~~~p~~Rpt~~~il~~ 251 (274)
T cd06609 219 EGNKFSKPFKDFVSLCLNKDPKERPSAKELLKH 251 (274)
T ss_pred cccccCHHHHHHHHHHhhCChhhCcCHHHHhhC
Confidence 222 56789999999999999999999999874
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-35 Score=321.46 Aligned_cols=259 Identities=28% Similarity=0.469 Sum_probs=203.3
Q ss_pred HcCCCCCceeeeeCCeEEEEEEEC-CCc----EEEEEEeccCC-hhcHHHHHHHHHHHHccCCCCcceEEEEEEeCCeEE
Q 002158 624 TAYFSSSTQVGQGGYGKVYKGILS-DNT----TVAIKRAEEGS-LQGQNEFLTEIKLLSRLHHRNLVSLLGYCDEEGEQM 697 (958)
Q Consensus 624 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~----~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~ 697 (958)
.++|...+.||+|+||.||+|.+. ++. .||+|.+.... .....++.+|+.+++.++||||++++++|... ..+
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~~ 84 (303)
T cd05110 6 ETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TIQ 84 (303)
T ss_pred hhhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-Cce
Confidence 345677889999999999999874 343 57889886543 23345788999999999999999999998754 567
Q ss_pred EEEEecCCCCHHHHhccCCCCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEecCCCCeEEeeeeeecccc
Q 002158 698 LVYEFVPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSRLAP 777 (958)
Q Consensus 698 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~~~ 777 (958)
+++||+++|+|.+++.... ..+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+++...
T Consensus 85 ~v~e~~~~g~l~~~~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~dikp~Nill~~~~~~kL~Dfg~~~~~~ 160 (303)
T cd05110 85 LVTQLMPHGCLLDYVHEHK-DNIGSQLLLNWCVQIAKGMMYLEERR---LVHRDLAARNVLVKSPNHVKITDFGLARLLE 160 (303)
T ss_pred eeehhcCCCCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHhhcC---eeccccccceeeecCCCceEEcccccccccc
Confidence 9999999999999997543 34889999999999999999999998 9999999999999999999999999998653
Q ss_pred cCCCCCCccceeeeeccCCCCccChhhhccCCCCCcchhhhHHHHHHHHHh-CCCCCCCCchhHHHHHHHhhcCcchhhh
Q 002158 778 VLDDEGTMPTHVSTIVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVLLELLT-GMQPISHGKNIVREVNVARDSGMVFSII 856 (958)
Q Consensus 778 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gv~l~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~i 856 (958)
..... .......++..|+|||++.+..++.++||||||+++|||++ |..||..... ....... ..+.
T Consensus 161 ~~~~~-----~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~-~~~~~~~-~~~~----- 228 (303)
T cd05110 161 GDEKE-----YNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPT-REIPDLL-EKGE----- 228 (303)
T ss_pred Ccccc-----cccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCH-HHHHHHH-HCCC-----
Confidence 22111 11122345778999999998999999999999999999998 8899864321 1111111 1110
Q ss_pred cccCCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHhh
Q 002158 857 DNRMGSYPSECVERFVTLALRCCHDKPEHRPSMSDVVRELENILKM 902 (958)
Q Consensus 857 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~ 902 (958)
....+..++..+.+++.+||..+|++||+++++++.|+++.+.
T Consensus 229 ---~~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~~~~ 271 (303)
T cd05110 229 ---RLPQPPICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRMARD 271 (303)
T ss_pred ---CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence 1112234556789999999999999999999999999987544
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-35 Score=321.23 Aligned_cols=246 Identities=26% Similarity=0.418 Sum_probs=201.7
Q ss_pred CCCCceeeeeCCeEEEEEEEC-CCcEEEEEEeccCC-hhcHHHHHHHHHHHHccCCCCcceEEEEEEeCCeEEEEEEecC
Q 002158 627 FSSSTQVGQGGYGKVYKGILS-DNTTVAIKRAEEGS-LQGQNEFLTEIKLLSRLHHRNLVSLLGYCDEEGEQMLVYEFVP 704 (958)
Q Consensus 627 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E~~~ 704 (958)
|+..+.||+|+||.||+|.+. +++.||+|.+.... ....+.+.+|++++++++|+||+++++++..+...++||||++
T Consensus 6 y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 85 (277)
T cd06642 6 FTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEYLG 85 (277)
T ss_pred HHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEccC
Confidence 445567999999999999875 57899999987543 3345678999999999999999999999999999999999999
Q ss_pred CCCHHHHhccCCCCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEecCCCCeEEeeeeeecccccCCCCCC
Q 002158 705 NGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSRLAPVLDDEGT 784 (958)
Q Consensus 705 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 784 (958)
+++|.+++... .+++..+..++.|+++|+.|||+.+ ++|+||+|+||++++++.++|+|||++.......
T Consensus 86 ~~~L~~~~~~~---~~~~~~~~~~~~~i~~~l~~lH~~~---ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~---- 155 (277)
T cd06642 86 GGSALDLLKPG---PLEETYIATILREILKGLDYLHSER---KIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQ---- 155 (277)
T ss_pred CCcHHHHhhcC---CCCHHHHHHHHHHHHHHHHHHhcCC---eeccCCChheEEEeCCCCEEEccccccccccCcc----
Confidence 99999998643 4889999999999999999999998 9999999999999999999999999987543211
Q ss_pred ccceeeeeccCCCCccChhhhccCCCCCcchhhhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcCcchhhhcccCCCCC
Q 002158 785 MPTHVSTIVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVLLELLTGMQPISHGKNIVREVNVARDSGMVFSIIDNRMGSYP 864 (958)
Q Consensus 785 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gv~l~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~ 864 (958)
.......|+..|+|||++.+..++.++||||||+++|||++|+.|+.......... . .........+
T Consensus 156 ---~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~-~---------~~~~~~~~~~ 222 (277)
T cd06642 156 ---IKRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVLF-L---------IPKNSPPTLE 222 (277)
T ss_pred ---hhhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhhHHh-h---------hhcCCCCCCC
Confidence 11123458889999999999889999999999999999999999986433211110 0 1111122234
Q ss_pred hHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 002158 865 SECVERFVTLALRCCHDKPEHRPSMSDVVRE 895 (958)
Q Consensus 865 ~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 895 (958)
..++..+.+++.+||+.+|++||++.+++++
T Consensus 223 ~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06642 223 GQYSKPFKEFVEACLNKDPRFRPTAKELLKH 253 (277)
T ss_pred cccCHHHHHHHHHHccCCcccCcCHHHHHHh
Confidence 4567789999999999999999999999985
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-35 Score=320.46 Aligned_cols=258 Identities=25% Similarity=0.346 Sum_probs=203.7
Q ss_pred cCCCCCceeeeeCCeEEEEEEEC-CCcEEEEEEeccCC-hhcHHHHHHHHHHHHccCCCCcceEEEEEEeCCeEEEEEEe
Q 002158 625 AYFSSSTQVGQGGYGKVYKGILS-DNTTVAIKRAEEGS-LQGQNEFLTEIKLLSRLHHRNLVSLLGYCDEEGEQMLVYEF 702 (958)
Q Consensus 625 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E~ 702 (958)
++|+..+.||+|+||+||+|.+. +++.||+|++.... ....+.+.+|+++++.++||||+++++++...+..++||||
T Consensus 5 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 84 (284)
T cd06620 5 EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCMEF 84 (284)
T ss_pred HHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEec
Confidence 45666778999999999999976 58899999876543 33456799999999999999999999999999999999999
Q ss_pred cCCCCHHHHhccCCCCCchHHHHHHHHHHHHHHHHHhhh-cCCCCeeccCCCccceEecCCCCeEEeeeeeecccccCCC
Q 002158 703 VPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHT-EAHPPVFHRDIKASNILLDSNLNAKVADFGLSRLAPVLDD 781 (958)
Q Consensus 703 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~-~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~ 781 (958)
+++++|.+++.... .+++..+..++.+++.||.|||+ .+ ++||||||+||++++++.++|+|||++......
T Consensus 85 ~~~~~L~~~~~~~~--~~~~~~~~~~~~~i~~~l~~LH~~~~---i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~-- 157 (284)
T cd06620 85 MDCGSLDRIYKKGG--PIPVEILGKIAVAVVEGLTYLYNVHR---IMHRDIKPSNILVNSRGQIKLCDFGVSGELINS-- 157 (284)
T ss_pred CCCCCHHHHHHhcc--CCCHHHHHHHHHHHHHHHHHHHHhcC---eeccCCCHHHEEECCCCcEEEccCCcccchhhh--
Confidence 99999999987543 48999999999999999999997 46 999999999999999999999999998643211
Q ss_pred CCCccceeeeeccCCCCccChhhhccCCCCCcchhhhHHHHHHHHHhCCCCCCCCchhHHHHHHHh-hcCcchhhhcccC
Q 002158 782 EGTMPTHVSTIVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVLLELLTGMQPISHGKNIVREVNVAR-DSGMVFSIIDNRM 860 (958)
Q Consensus 782 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gv~l~elltG~~P~~~~~~~~~~~~~~~-~~~~~~~~i~~~~ 860 (958)
......|+..|+|||++.+..++.++|||||||++|||++|+.||.............. ........+....
T Consensus 158 -------~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (284)
T cd06620 158 -------IADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEPP 230 (284)
T ss_pred -------ccCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhccC
Confidence 11234689999999999888899999999999999999999999975332100000000 0000111111112
Q ss_pred CCCCh-HHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 002158 861 GSYPS-ECVERFVTLALRCCHDKPEHRPSMSDVVREL 896 (958)
Q Consensus 861 ~~~~~-~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 896 (958)
...+. .++..+.+++.+||+.||++||++.|++++.
T Consensus 231 ~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~ 267 (284)
T cd06620 231 PRLPSSDFPEDLRDFVDACLLKDPTERPTPQQLCAMP 267 (284)
T ss_pred CCCCchhcCHHHHHHHHHHhcCCcccCcCHHHHhcCc
Confidence 22222 3677899999999999999999999999863
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-35 Score=329.84 Aligned_cols=256 Identities=23% Similarity=0.337 Sum_probs=197.4
Q ss_pred HHcCCCCCceeeeeCCeEEEEEEEC-CCcEEEEEEeccCC--hhcHHHHHHHHHHHHccCCCCcceEEEEEEeC------
Q 002158 623 ATAYFSSSTQVGQGGYGKVYKGILS-DNTTVAIKRAEEGS--LQGQNEFLTEIKLLSRLHHRNLVSLLGYCDEE------ 693 (958)
Q Consensus 623 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~------ 693 (958)
..++|...+.||+|+||+||+|... +++.||||++.... ....+.+.+|++++++++|+||+++++++...
T Consensus 13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 92 (343)
T cd07878 13 VPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIENF 92 (343)
T ss_pred hhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhccccccccc
Confidence 4567888999999999999999975 68899999987542 22345678999999999999999999987543
Q ss_pred CeEEEEEEecCCCCHHHHhccCCCCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEecCCCCeEEeeeeee
Q 002158 694 GEQMLVYEFVPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSNLNAKVADFGLS 773 (958)
Q Consensus 694 ~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla 773 (958)
...+++||++ +++|.+++... .+++..+..++.|++.||+|||+.+ |+||||||+||++++++.+||+|||++
T Consensus 93 ~~~~~~~~~~-~~~l~~~~~~~---~l~~~~~~~i~~qi~~aL~~LH~~~---ivHrdikp~Nil~~~~~~~kl~Dfg~~ 165 (343)
T cd07878 93 NEVYLVTNLM-GADLNNIVKCQ---KLSDEHVQFLIYQLLRGLKYIHSAG---IIHRDLKPSNVAVNEDCELRILDFGLA 165 (343)
T ss_pred CcEEEEeecC-CCCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eecccCChhhEEECCCCCEEEcCCccc
Confidence 3578999998 78999988643 3899999999999999999999999 999999999999999999999999999
Q ss_pred cccccCCCCCCccceeeeeccCCCCccChhhhcc-CCCCCcchhhhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcCcc
Q 002158 774 RLAPVLDDEGTMPTHVSTIVKGTPGYLDPEYFLT-HKLTDKSDVYSLGVVLLELLTGMQPISHGKNIVREVNVARDSGMV 852 (958)
Q Consensus 774 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DV~S~Gv~l~elltG~~P~~~~~~~~~~~~~~~~~~~~ 852 (958)
+.... ......||..|+|||++.+ ..++.++|||||||++|||++|+.||................+..
T Consensus 166 ~~~~~----------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~ 235 (343)
T cd07878 166 RQADD----------EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTP 235 (343)
T ss_pred eecCC----------CcCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCC
Confidence 75421 1123468999999999977 568889999999999999999999997544322111111100000
Q ss_pred -hhhh-----------cccCCCCC--------hHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 002158 853 -FSII-----------DNRMGSYP--------SECVERFVTLALRCCHDKPEHRPSMSDVVRE 895 (958)
Q Consensus 853 -~~~i-----------~~~~~~~~--------~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 895 (958)
.+.. ...+...+ ......+.+++.+|++.||++|||++|++++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~h 298 (343)
T cd07878 236 SPEVLKKISSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAH 298 (343)
T ss_pred CHHHHHhcchhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 0000 00011111 1123457899999999999999999999975
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=330.43 Aligned_cols=239 Identities=22% Similarity=0.308 Sum_probs=188.5
Q ss_pred eeeeCCeEEEEEEEC-CCcEEEEEEeccCCh---hcHHHHHHHHHHHHcc---CCCCcceEEEEEEeCCeEEEEEEecCC
Q 002158 633 VGQGGYGKVYKGILS-DNTTVAIKRAEEGSL---QGQNEFLTEIKLLSRL---HHRNLVSLLGYCDEEGEQMLVYEFVPN 705 (958)
Q Consensus 633 lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l---~H~niv~l~~~~~~~~~~~lV~E~~~~ 705 (958)
||+|+||+||+|... +++.||||++..... .....+..|..++... +||||+++++++......++||||+++
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~ 80 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG 80 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence 699999999999976 689999999864321 2233456677777665 699999999999999999999999999
Q ss_pred CCHHHHhccCCCCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEecCCCCeEEeeeeeecccccCCCCCCc
Q 002158 706 GTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSRLAPVLDDEGTM 785 (958)
Q Consensus 706 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~ 785 (958)
|+|.+++.... .+++..+..++.|+++||+|||+++ |+||||||+|||++.++.+||+|||+++......
T Consensus 81 g~L~~~l~~~~--~~~~~~~~~~~~qil~al~~LH~~~---ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~----- 150 (330)
T cd05586 81 GELFWHLQKEG--RFSEDRAKFYIAELVLALEHLHKYD---IVYRDLKPENILLDATGHIALCDFGLSKANLTDN----- 150 (330)
T ss_pred ChHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEecCCcCcCCCCCC-----
Confidence 99999997543 4899999999999999999999999 9999999999999999999999999987432111
Q ss_pred cceeeeeccCCCCccChhhhccC-CCCCcchhhhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcCcchhhhcccCCCCC
Q 002158 786 PTHVSTIVKGTPGYLDPEYFLTH-KLTDKSDVYSLGVVLLELLTGMQPISHGKNIVREVNVARDSGMVFSIIDNRMGSYP 864 (958)
Q Consensus 786 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DV~S~Gv~l~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~ 864 (958)
.......||..|+|||++.+. .++.++||||+||++|||++|+.||..... ........... . .++
T Consensus 151 --~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~-~~~~~~i~~~~---------~-~~~ 217 (330)
T cd05586 151 --KTTNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDT-QQMYRNIAFGK---------V-RFP 217 (330)
T ss_pred --CCccCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCH-HHHHHHHHcCC---------C-CCC
Confidence 112345699999999999765 478999999999999999999999975432 12111111100 0 111
Q ss_pred -hHHHHHHHHHHHHccccCCCCCC----CHHHHHH
Q 002158 865 -SECVERFVTLALRCCHDKPEHRP----SMSDVVR 894 (958)
Q Consensus 865 -~~~~~~l~~li~~cl~~dP~~RP----s~~evl~ 894 (958)
...+..+.+++.+||+.||++|| ++.++++
T Consensus 218 ~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~ 252 (330)
T cd05586 218 KNVLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKE 252 (330)
T ss_pred CccCCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhc
Confidence 23457788999999999999998 4666655
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-35 Score=324.73 Aligned_cols=196 Identities=30% Similarity=0.393 Sum_probs=160.5
Q ss_pred CceeeeeCCeEEEEEEEC---CCcEEEEEEeccCChhcHHHHHHHHHHHHccCCCCcceEEEEEEe--CCeEEEEEEecC
Q 002158 630 STQVGQGGYGKVYKGILS---DNTTVAIKRAEEGSLQGQNEFLTEIKLLSRLHHRNLVSLLGYCDE--EGEQMLVYEFVP 704 (958)
Q Consensus 630 ~~~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~--~~~~~lV~E~~~ 704 (958)
.++||+|+||+||+|..+ +++.||+|.+.... ....+.+|++++++++||||+++++++.. +...++||||++
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~ 83 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTG--ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAE 83 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCC--CcHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEeccC
Confidence 468999999999999965 46789999987543 23457789999999999999999999854 456899999995
Q ss_pred CCCHHHHhccC-------CCCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEe----cCCCCeEEeeeeee
Q 002158 705 NGTLRDWLSGR-------TKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILL----DSNLNAKVADFGLS 773 (958)
Q Consensus 705 ~gsL~~~l~~~-------~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl----~~~~~~kl~DFGla 773 (958)
++|.+++... ....+++..+..++.|++.||+|||+.+ |+||||||+|||+ +.++.+||+|||++
T Consensus 84 -~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a 159 (317)
T cd07868 84 -HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFA 159 (317)
T ss_pred -CCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCC---EEcCCCCHHHEEEecCCCCcCcEEEeecCce
Confidence 6898887532 1234889999999999999999999999 9999999999999 45678999999999
Q ss_pred cccccCCCCCCccceeeeeccCCCCccChhhhccC-CCCCcchhhhHHHHHHHHHhCCCCCCC
Q 002158 774 RLAPVLDDEGTMPTHVSTIVKGTPGYLDPEYFLTH-KLTDKSDVYSLGVVLLELLTGMQPISH 835 (958)
Q Consensus 774 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DV~S~Gv~l~elltG~~P~~~ 835 (958)
+....... +........||+.|+|||++.+. .++.++||||+||++|||++|+.||..
T Consensus 160 ~~~~~~~~----~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~ 218 (317)
T cd07868 160 RLFNSPLK----PLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHC 218 (317)
T ss_pred eccCCCCc----cccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccC
Confidence 86532111 11122345689999999999774 588899999999999999999999964
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-35 Score=320.70 Aligned_cols=251 Identities=25% Similarity=0.423 Sum_probs=203.5
Q ss_pred CCCCCceeeeeCCeEEEEEEEC-CCcEEEEEEeccC-ChhcHHHHHHHHHHHHccCCCCcceEEEEEEeCCeEEEEEEec
Q 002158 626 YFSSSTQVGQGGYGKVYKGILS-DNTTVAIKRAEEG-SLQGQNEFLTEIKLLSRLHHRNLVSLLGYCDEEGEQMLVYEFV 703 (958)
Q Consensus 626 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E~~ 703 (958)
+|+..+.||+|+||.||+|.++ ++..||+|.+... .......+.+|++++++++|+||+++++++...+..++||||+
T Consensus 2 ~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~ 81 (286)
T cd06622 2 EIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEYM 81 (286)
T ss_pred hhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEeec
Confidence 5677889999999999999986 7899999988754 3334567899999999999999999999999999999999999
Q ss_pred CCCCHHHHhccCC-CCCchHHHHHHHHHHHHHHHHHhhhc-CCCCeeccCCCccceEecCCCCeEEeeeeeecccccCCC
Q 002158 704 PNGTLRDWLSGRT-KENLNFAMRLRVALDSAKGILYLHTE-AHPPVFHRDIKASNILLDSNLNAKVADFGLSRLAPVLDD 781 (958)
Q Consensus 704 ~~gsL~~~l~~~~-~~~l~~~~~~~i~~~ia~aL~yLH~~-~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~ 781 (958)
++++|.++++... ...+++..+..++.|++.||.|||+. + |+||||||+||+++.++.+||+|||++......
T Consensus 82 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~-- 156 (286)
T cd06622 82 DAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHN---IIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVAS-- 156 (286)
T ss_pred CCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCC---EeeCCCCHHHEEECCCCCEEEeecCCcccccCC--
Confidence 9999999987532 23589999999999999999999974 6 999999999999999999999999998754211
Q ss_pred CCCccceeeeeccCCCCccChhhhccCC------CCCcchhhhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcCcchhh
Q 002158 782 EGTMPTHVSTIVKGTPGYLDPEYFLTHK------LTDKSDVYSLGVVLLELLTGMQPISHGKNIVREVNVARDSGMVFSI 855 (958)
Q Consensus 782 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~------~~~~~DV~S~Gv~l~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~ 855 (958)
......|+..|+|||++.+.. ++.++|||||||++|||++|+.||....... .... ...+
T Consensus 157 -------~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~-~~~~------~~~~ 222 (286)
T cd06622 157 -------LAKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYAN-IFAQ------LSAI 222 (286)
T ss_pred -------ccccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhh-HHHH------HHHH
Confidence 112235788999999986543 4789999999999999999999996432211 1110 0111
Q ss_pred hcccCCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 002158 856 IDNRMGSYPSECVERFVTLALRCCHDKPEHRPSMSDVVRE 895 (958)
Q Consensus 856 i~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 895 (958)
........+..++..+.+++.+||+.+|++||++++++++
T Consensus 223 ~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~ 262 (286)
T cd06622 223 VDGDPPTLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLEH 262 (286)
T ss_pred hhcCCCCCCcccCHHHHHHHHHHcccCcccCCCHHHHhcC
Confidence 2222234456678889999999999999999999999974
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-35 Score=321.25 Aligned_cols=246 Identities=24% Similarity=0.379 Sum_probs=200.8
Q ss_pred CCceeeeeCCeEEEEEEEC-CCcEEEEEEeccCChhcHHHHHHHHHHHHccCCCCcceEEEEEEeCCeEEEEEEecCCCC
Q 002158 629 SSTQVGQGGYGKVYKGILS-DNTTVAIKRAEEGSLQGQNEFLTEIKLLSRLHHRNLVSLLGYCDEEGEQMLVYEFVPNGT 707 (958)
Q Consensus 629 ~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E~~~~gs 707 (958)
....||+|+||.||++... ++..||||.+........+.+.+|+.+++.++|+||+++++.+...+..++||||+++++
T Consensus 26 ~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~~~~~ 105 (292)
T cd06658 26 SFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEGGA 105 (292)
T ss_pred hhhcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCCCCCc
Confidence 3457999999999999975 688999999876555556678999999999999999999999999999999999999999
Q ss_pred HHHHhccCCCCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEecCCCCeEEeeeeeecccccCCCCCCccc
Q 002158 708 LRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSRLAPVLDDEGTMPT 787 (958)
Q Consensus 708 L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~ 787 (958)
|.+++... .+++.++..++.|++.||+|||+.+ |+||||||+||++++++.++|+|||++........
T Consensus 106 L~~~~~~~---~l~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~------ 173 (292)
T cd06658 106 LTDIVTHT---RMNEEQIATVCLSVLRALSYLHNQG---VIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVP------ 173 (292)
T ss_pred HHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCEEEccCcchhhcccccc------
Confidence 99998543 3889999999999999999999998 99999999999999999999999999875422111
Q ss_pred eeeeeccCCCCccChhhhccCCCCCcchhhhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcCcchhhhcccCCCCChHH
Q 002158 788 HVSTIVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVLLELLTGMQPISHGKNIVREVNVARDSGMVFSIIDNRMGSYPSEC 867 (958)
Q Consensus 788 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gv~l~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~ 867 (958)
......|+..|+|||.+.+..++.++||||||+++|||++|+.||........ ...... ...... ......
T Consensus 174 -~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~-~~~~~~------~~~~~~-~~~~~~ 244 (292)
T cd06658 174 -KRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQA-MRRIRD------NLPPRV-KDSHKV 244 (292)
T ss_pred -cCceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHh------cCCCcc-cccccc
Confidence 11234588999999999888899999999999999999999999975443221 111110 000111 111234
Q ss_pred HHHHHHHHHHccccCCCCCCCHHHHHHH
Q 002158 868 VERFVTLALRCCHDKPEHRPSMSDVVRE 895 (958)
Q Consensus 868 ~~~l~~li~~cl~~dP~~RPs~~evl~~ 895 (958)
+..+.+++.+||..||.+||+++|++++
T Consensus 245 ~~~~~~li~~~l~~~P~~Rpt~~~il~~ 272 (292)
T cd06658 245 SSVLRGFLDLMLVREPSQRATAQELLQH 272 (292)
T ss_pred CHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence 5678899999999999999999999975
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-35 Score=332.39 Aligned_cols=254 Identities=20% Similarity=0.293 Sum_probs=193.2
Q ss_pred HHcCCCCCceeeeeCCeEEEEEEEC-CCcEEEEEEeccCChhcHHHHHHHHHHHHccCCCCcceEEEEEEeCCeEEEEEE
Q 002158 623 ATAYFSSSTQVGQGGYGKVYKGILS-DNTTVAIKRAEEGSLQGQNEFLTEIKLLSRLHHRNLVSLLGYCDEEGEQMLVYE 701 (958)
Q Consensus 623 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E 701 (958)
...+|...+.||+|+||.||+|.+. +++.||+|+.... ....|+.++++++|+||+++++++...+..++|||
T Consensus 64 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 137 (357)
T PHA03209 64 ASLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG------TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVLP 137 (357)
T ss_pred hhcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc------ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEEE
Confidence 4457999999999999999999986 5788999975432 23469999999999999999999999999999999
Q ss_pred ecCCCCHHHHhccCCCCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEecCCCCeEEeeeeeecccccCCC
Q 002158 702 FVPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSRLAPVLDD 781 (958)
Q Consensus 702 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~ 781 (958)
|+ .++|.+++.... ..+++.++..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++....
T Consensus 138 ~~-~~~l~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~--- 209 (357)
T PHA03209 138 HY-SSDLYTYLTKRS-RPLPIDQALIIEKQILEGLRYLHAQR---IIHRDVKTENIFINDVDQVCIGDLGAAQFPVV--- 209 (357)
T ss_pred cc-CCcHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEecCcccccccc---
Confidence 99 578999886543 35899999999999999999999999 99999999999999999999999999874321
Q ss_pred CCCccceeeeeccCCCCccChhhhccCCCCCcchhhhHHHHHHHHHhCCCCCCCCchhH---------HHHH-HHhhcCc
Q 002158 782 EGTMPTHVSTIVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVLLELLTGMQPISHGKNIV---------REVN-VARDSGM 851 (958)
Q Consensus 782 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gv~l~elltG~~P~~~~~~~~---------~~~~-~~~~~~~ 851 (958)
........||..|+|||++.+..++.++|||||||++|||+++..|+....... ..+. .....+.
T Consensus 210 -----~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~f~~~~~~~~~~~~~~~~~l~~~~~~~~~ 284 (357)
T PHA03209 210 -----APAFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIISTLKV 284 (357)
T ss_pred -----CcccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCccccCCCCcHHHHHHHHHHHHHHHHHHhcc
Confidence 111224569999999999999999999999999999999999666553221100 0000 0000000
Q ss_pred c-------------hhhhcc-cCC--CC-------ChHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 002158 852 V-------------FSIIDN-RMG--SY-------PSECVERFVTLALRCCHDKPEHRPSMSDVVRE 895 (958)
Q Consensus 852 ~-------------~~~i~~-~~~--~~-------~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 895 (958)
. ...++. ... .. ....+....+++.+||+.||++|||+.|++++
T Consensus 285 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rpta~e~l~h 351 (357)
T PHA03209 285 HPEEFPRDPGSRLVRGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMRPSAEEILNY 351 (357)
T ss_pred ChhhcCCCCccHHHHHHHhhcccCCCcccccHHHhccCCCchHHHHHHHHHcCCcccCcCHHHHhcC
Confidence 0 000000 000 00 01234456679999999999999999999975
|
|
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=312.16 Aligned_cols=249 Identities=26% Similarity=0.386 Sum_probs=205.0
Q ss_pred CCCCCceeeeeCCeEEEEEEEC-CCcEEEEEEeccCC--hhcHHHHHHHHHHHHccCCCCcceEEEEEEeCCeEEEEEEe
Q 002158 626 YFSSSTQVGQGGYGKVYKGILS-DNTTVAIKRAEEGS--LQGQNEFLTEIKLLSRLHHRNLVSLLGYCDEEGEQMLVYEF 702 (958)
Q Consensus 626 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E~ 702 (958)
+|+..+.||+|+||.||+|... +++.||||.+.... ......+.+|++++++++|||++++++.+..++..++||||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEY 80 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEec
Confidence 4677889999999999999975 68899999986542 33456789999999999999999999999999999999999
Q ss_pred cCCCCHHHHhccCCCCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEecCC-CCeEEeeeeeecccccCCC
Q 002158 703 VPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSN-LNAKVADFGLSRLAPVLDD 781 (958)
Q Consensus 703 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~-~~~kl~DFGla~~~~~~~~ 781 (958)
+++++|.+++.......+++..+.+++.|+++||+|||+++ ++||||||+||+++++ +.+||+|||.+.......
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~---i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~- 156 (256)
T cd08220 81 APGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKL---ILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKS- 156 (256)
T ss_pred CCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEEccCCCceecCCCc-
Confidence 99999999998765556899999999999999999999998 9999999999999865 458999999987653211
Q ss_pred CCCccceeeeeccCCCCccChhhhccCCCCCcchhhhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcCcchhhhcccCC
Q 002158 782 EGTMPTHVSTIVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVLLELLTGMQPISHGKNIVREVNVARDSGMVFSIIDNRMG 861 (958)
Q Consensus 782 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gv~l~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~i~~~~~ 861 (958)
......|+..|+|||.+.+..++.++||||||+++|+|++|+.||...... ....... .....
T Consensus 157 -------~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~-~~~~~~~---------~~~~~ 219 (256)
T cd08220 157 -------KAYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLP-ALVLKIM---------SGTFA 219 (256)
T ss_pred -------cccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchH-HHHHHHH---------hcCCC
Confidence 112345888999999999888899999999999999999999999654322 1111111 11112
Q ss_pred CCChHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 002158 862 SYPSECVERFVTLALRCCHDKPEHRPSMSDVVRE 895 (958)
Q Consensus 862 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 895 (958)
..+...+..+.+++.+||+.+|++||++.|++++
T Consensus 220 ~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~~ 253 (256)
T cd08220 220 PISDRYSPDLRQLILSMLNLDPSKRPQLSQIMAQ 253 (256)
T ss_pred CCCCCcCHHHHHHHHHHccCChhhCCCHHHHhhC
Confidence 2344567789999999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-35 Score=321.87 Aligned_cols=259 Identities=22% Similarity=0.310 Sum_probs=199.5
Q ss_pred cCCCCCceeeeeCCeEEEEEEEC-CCcEEEEEEeccCC-hhcHHHHHHHHHHHHccCCCCcceEEEEEEeCCeEEEEEEe
Q 002158 625 AYFSSSTQVGQGGYGKVYKGILS-DNTTVAIKRAEEGS-LQGQNEFLTEIKLLSRLHHRNLVSLLGYCDEEGEQMLVYEF 702 (958)
Q Consensus 625 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E~ 702 (958)
++|...+.||+|+||.||+|.++ +++.||+|.+.... ......+.+|++++++++|+||+++++++..++..++||||
T Consensus 6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~ 85 (301)
T cd07873 6 ETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY 85 (301)
T ss_pred cceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEec
Confidence 45778889999999999999976 68899999987543 22345678999999999999999999999999999999999
Q ss_pred cCCCCHHHHhccCCCCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEecCCCCeEEeeeeeecccccCCCC
Q 002158 703 VPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSRLAPVLDDE 782 (958)
Q Consensus 703 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~ 782 (958)
++ ++|.+++.... ..+++..+..++.|+++||+|||+.+ |+||||||+||++++++.+||+|||++.......
T Consensus 86 ~~-~~l~~~l~~~~-~~~~~~~~~~~~~qi~~aL~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~-- 158 (301)
T cd07873 86 LD-KDLKQYLDDCG-NSINMHNVKLFLFQLLRGLNYCHRRK---VLHRDLKPQNLLINERGELKLADFGLARAKSIPT-- 158 (301)
T ss_pred cc-cCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHHHEEECCCCcEEECcCcchhccCCCC--
Confidence 96 69999887543 34889999999999999999999999 9999999999999999999999999987542211
Q ss_pred CCccceeeeeccCCCCccChhhhccC-CCCCcchhhhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhc-----Ccchhhh
Q 002158 783 GTMPTHVSTIVKGTPGYLDPEYFLTH-KLTDKSDVYSLGVVLLELLTGMQPISHGKNIVREVNVARDS-----GMVFSII 856 (958)
Q Consensus 783 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DV~S~Gv~l~elltG~~P~~~~~~~~~~~~~~~~~-----~~~~~~i 856 (958)
.......+++.|+|||++.+. .++.++|||||||++|||++|+.||................ .......
T Consensus 159 -----~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (301)
T cd07873 159 -----KTYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGIL 233 (301)
T ss_pred -----CcccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhchhhh
Confidence 111223468899999998754 47889999999999999999999997544321111110000 0000000
Q ss_pred cc------cCCC--------CChHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 002158 857 DN------RMGS--------YPSECVERFVTLALRCCHDKPEHRPSMSDVVRE 895 (958)
Q Consensus 857 ~~------~~~~--------~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 895 (958)
.. ..+. .....+..+.+++.+|++.||++|||++|++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~h 286 (301)
T cd07873 234 SNEEFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKH 286 (301)
T ss_pred ccccccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence 00 0000 112345678999999999999999999999974
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=312.86 Aligned_cols=258 Identities=27% Similarity=0.394 Sum_probs=208.0
Q ss_pred cCCCCCceeeeeCCeEEEEEEEC-CCcEEEEEEeccCC-hhcHHHHHHHHHHHHccCCCCcceEEEEEEeCCeEEEEEEe
Q 002158 625 AYFSSSTQVGQGGYGKVYKGILS-DNTTVAIKRAEEGS-LQGQNEFLTEIKLLSRLHHRNLVSLLGYCDEEGEQMLVYEF 702 (958)
Q Consensus 625 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E~ 702 (958)
++|+..+.||.|+||+||+|... ++..||+|++.... ....+.+.+|+++++.++|+|++++++.+..++..++||||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~ 80 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPY 80 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEec
Confidence 36788899999999999999975 67899999987543 23456799999999999999999999999999999999999
Q ss_pred cCCCCHHHHhccCCC-CCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEecCCCCeEEeeeeeecccccCCC
Q 002158 703 VPNGTLRDWLSGRTK-ENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSRLAPVLDD 781 (958)
Q Consensus 703 ~~~gsL~~~l~~~~~-~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~ 781 (958)
+++++|.++++.... ..+++..+..++.|++.||+|||+.+ ++||||||+||++++++.++|+|||++..+.....
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~---i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~ 157 (267)
T cd06610 81 LSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNG---QIHRDIKAGNILLGEDGSVKIADFGVSASLADGGD 157 (267)
T ss_pred cCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHhEEEcCCCCEEEcccchHHHhccCcc
Confidence 999999999976432 45899999999999999999999999 99999999999999999999999999876543222
Q ss_pred CCCccceeeeeccCCCCccChhhhccC-CCCCcchhhhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcCcchhhhcccC
Q 002158 782 EGTMPTHVSTIVKGTPGYLDPEYFLTH-KLTDKSDVYSLGVVLLELLTGMQPISHGKNIVREVNVARDSGMVFSIIDNRM 860 (958)
Q Consensus 782 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DV~S~Gv~l~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~i~~~~ 860 (958)
.. ........|+..|+|||++... .++.++||||||+++|||++|+.||................ ....
T Consensus 158 ~~---~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~-------~~~~ 227 (267)
T cd06610 158 RT---RKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQND-------PPSL 227 (267)
T ss_pred cc---ccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhhhHHHHhcCC-------CCCc
Confidence 11 1122345689999999999877 78889999999999999999999997544322211111110 0011
Q ss_pred CCC--ChHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 002158 861 GSY--PSECVERFVTLALRCCHDKPEHRPSMSDVVRE 895 (958)
Q Consensus 861 ~~~--~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 895 (958)
... ....+..+.+++.+||+.||++||++++++++
T Consensus 228 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~~ 264 (267)
T cd06610 228 ETGADYKKYSKSFRKMISLCLQKDPSKRPTAEELLKH 264 (267)
T ss_pred CCccccccccHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence 110 12556788999999999999999999999864
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-35 Score=321.37 Aligned_cols=245 Identities=23% Similarity=0.336 Sum_probs=200.8
Q ss_pred CceeeeeCCeEEEEEEEC-CCcEEEEEEeccCChhcHHHHHHHHHHHHccCCCCcceEEEEEEeCCeEEEEEEecCCCCH
Q 002158 630 STQVGQGGYGKVYKGILS-DNTTVAIKRAEEGSLQGQNEFLTEIKLLSRLHHRNLVSLLGYCDEEGEQMLVYEFVPNGTL 708 (958)
Q Consensus 630 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E~~~~gsL 708 (958)
...||+|+||.||+|... +++.||+|.+........+.+.+|+.+++.++|||++++++++..++..++||||+++++|
T Consensus 26 ~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~~~~L 105 (297)
T cd06659 26 YIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGAL 105 (297)
T ss_pred hhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCCCCCH
Confidence 447999999999999975 6899999998765445566788999999999999999999999999999999999999999
Q ss_pred HHHhccCCCCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEecCCCCeEEeeeeeecccccCCCCCCccce
Q 002158 709 RDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSRLAPVLDDEGTMPTH 788 (958)
Q Consensus 709 ~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~ 788 (958)
.+++... .+++..+..++.|++.||+|||+.+ ++||||||+||+++.++.+||+|||++....... .
T Consensus 106 ~~~~~~~---~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~-------~ 172 (297)
T cd06659 106 TDIVSQT---RLNEEQIATVCESVLQALCYLHSQG---VIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDV-------P 172 (297)
T ss_pred HHHHhhc---CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHeEEccCCcEEEeechhHhhccccc-------c
Confidence 9988543 3889999999999999999999999 9999999999999999999999999987542211 1
Q ss_pred eeeeccCCCCccChhhhccCCCCCcchhhhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcCcchhhhcccCCCCChHHH
Q 002158 789 VSTIVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVLLELLTGMQPISHGKNIVREVNVARDSGMVFSIIDNRMGSYPSECV 868 (958)
Q Consensus 789 ~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gv~l~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~ 868 (958)
......|+..|+|||++.+..++.++||||||+++|||++|+.||.......... ...... ......+...+
T Consensus 173 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~-~~~~~~-------~~~~~~~~~~~ 244 (297)
T cd06659 173 KRKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMK-RLRDSP-------PPKLKNAHKIS 244 (297)
T ss_pred cccceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH-HHhccC-------CCCccccCCCC
Confidence 1223568999999999998899999999999999999999999997544332221 111100 00011122345
Q ss_pred HHHHHHHHHccccCCCCCCCHHHHHHH
Q 002158 869 ERFVTLALRCCHDKPEHRPSMSDVVRE 895 (958)
Q Consensus 869 ~~l~~li~~cl~~dP~~RPs~~evl~~ 895 (958)
..+.+++.+||+.+|++||++++++++
T Consensus 245 ~~l~~~i~~~l~~~P~~Rps~~~ll~~ 271 (297)
T cd06659 245 PVLRDFLERMLTREPQERATAQELLDH 271 (297)
T ss_pred HHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence 678899999999999999999999985
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=321.56 Aligned_cols=256 Identities=23% Similarity=0.311 Sum_probs=205.2
Q ss_pred CCCCCceeeeeCCeEEEEEEEC-CCcEEEEEEeccCChh---cHHHHHHHHHHHHccCCCCcceEEEEEEeCCeEEEEEE
Q 002158 626 YFSSSTQVGQGGYGKVYKGILS-DNTTVAIKRAEEGSLQ---GQNEFLTEIKLLSRLHHRNLVSLLGYCDEEGEQMLVYE 701 (958)
Q Consensus 626 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E 701 (958)
+|+..+.||+|+||+||+|... +++.||+|.+...... ..+.+.+|+++++.++|+||+++++.+...+..++|||
T Consensus 2 ~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 81 (316)
T cd05574 2 HFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVMD 81 (316)
T ss_pred ceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEEE
Confidence 5777889999999999999986 4899999998764322 34578899999999999999999999999999999999
Q ss_pred ecCCCCHHHHhccCCCCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEecCCCCeEEeeeeeecccccCCC
Q 002158 702 FVPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSRLAPVLDD 781 (958)
Q Consensus 702 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~ 781 (958)
|+.+++|.+++.......+++..+..++.|+++||+|||+.+ ++||||||+||+++.++.++|+|||++........
T Consensus 82 ~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~ 158 (316)
T cd05574 82 YCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLG---IVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPP 158 (316)
T ss_pred ecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHCC---eeccCCChHHeEEcCCCCEEEeecchhhccccccc
Confidence 999999999998655566999999999999999999999999 99999999999999999999999999875532211
Q ss_pred CCCc----------------------cceeeeeccCCCCccChhhhccCCCCCcchhhhHHHHHHHHHhCCCCCCCCchh
Q 002158 782 EGTM----------------------PTHVSTIVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVLLELLTGMQPISHGKNI 839 (958)
Q Consensus 782 ~~~~----------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gv~l~elltG~~P~~~~~~~ 839 (958)
.... .........||..|+|||++.+..++.++||||||+++|||++|+.||......
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~ 238 (316)
T cd05574 159 PVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSNRD 238 (316)
T ss_pred ccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCCchH
Confidence 1000 001112346899999999999988999999999999999999999999754432
Q ss_pred HHHHHHHhhcCcchhhhcccCC-CCChHHHHHHHHHHHHccccCCCCCCC----HHHHHH
Q 002158 840 VREVNVARDSGMVFSIIDNRMG-SYPSECVERFVTLALRCCHDKPEHRPS----MSDVVR 894 (958)
Q Consensus 840 ~~~~~~~~~~~~~~~~i~~~~~-~~~~~~~~~l~~li~~cl~~dP~~RPs----~~evl~ 894 (958)
....... ..... ......+..+.+++.+||+.+|++||+ ++|+++
T Consensus 239 ~~~~~~~----------~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~ 288 (316)
T cd05574 239 ETFSNIL----------KKEVTFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQ 288 (316)
T ss_pred HHHHHHh----------cCCccCCCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHc
Confidence 2221111 11110 011125788999999999999999999 666655
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-35 Score=333.47 Aligned_cols=256 Identities=20% Similarity=0.237 Sum_probs=197.8
Q ss_pred HcCCCCCceeeeeCCeEEEEEEEC---CCcEEEEEEeccCChhcHHHHHHHHHHHHccCCCCcceEEEEEEeCCeEEEEE
Q 002158 624 TAYFSSSTQVGQGGYGKVYKGILS---DNTTVAIKRAEEGSLQGQNEFLTEIKLLSRLHHRNLVSLLGYCDEEGEQMLVY 700 (958)
Q Consensus 624 ~~~~~~~~~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~ 700 (958)
..+|...+.||+|+||.||++... .+..||||.+... +.+.+|++++++++||||+++++++......++||
T Consensus 91 ~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-----~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 165 (392)
T PHA03207 91 RMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-----KTPGREIDILKTISHRAIINLIHAYRWKSTVCMVM 165 (392)
T ss_pred cCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc-----ccHHHHHHHHHhcCCCCccceeeeEeeCCEEEEEe
Confidence 346888899999999999999854 3578999988653 23458999999999999999999999999999999
Q ss_pred EecCCCCHHHHhccCCCCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEecCCCCeEEeeeeeecccccCC
Q 002158 701 EFVPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSRLAPVLD 780 (958)
Q Consensus 701 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~ 780 (958)
|++. ++|.+++... ..+++.+++.++.|++.||+|||+.+ |+||||||+|||++.++.++|+|||+++......
T Consensus 166 e~~~-~~l~~~l~~~--~~l~~~~~~~i~~ql~~aL~~LH~~g---ivHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~~ 239 (392)
T PHA03207 166 PKYK-CDLFTYVDRS--GPLPLEQAITIQRRLLEALAYLHGRG---IIHRDVKTENIFLDEPENAVLGDFGAACKLDAHP 239 (392)
T ss_pred hhcC-CCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEcCCCCEEEccCccccccCccc
Confidence 9995 7899998433 45899999999999999999999999 9999999999999999999999999997553221
Q ss_pred CCCCccceeeeeccCCCCccChhhhccCCCCCcchhhhHHHHHHHHHhCCCCCCCCch------hHHHHHHHhhcCcc--
Q 002158 781 DEGTMPTHVSTIVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVLLELLTGMQPISHGKN------IVREVNVARDSGMV-- 852 (958)
Q Consensus 781 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gv~l~elltG~~P~~~~~~------~~~~~~~~~~~~~~-- 852 (958)
. ........||+.|+|||++....++.++|||||||++|||++|+.||.+... +.............
T Consensus 240 ~-----~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~ 314 (392)
T PHA03207 240 D-----TPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFP 314 (392)
T ss_pred c-----cccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccC
Confidence 1 1122345799999999999999999999999999999999999999965321 11111100000000
Q ss_pred ----h-------hhhcccCC--CCC-----hHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 002158 853 ----F-------SIIDNRMG--SYP-----SECVERFVTLALRCCHDKPEHRPSMSDVVRE 895 (958)
Q Consensus 853 ----~-------~~i~~~~~--~~~-----~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 895 (958)
. +....... ..+ ...+..+.+++.+|+..||++||++.|++.+
T Consensus 315 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~ 375 (392)
T PHA03207 315 QNGSTNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSL 375 (392)
T ss_pred CccchhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhC
Confidence 0 00000000 001 1234578889999999999999999999975
|
|
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-34 Score=315.36 Aligned_cols=259 Identities=23% Similarity=0.342 Sum_probs=201.3
Q ss_pred cCCCCCceeeeeCCeEEEEEEEC-CCcEEEEEEeccCC--hhcHHHHHHHHHHHHccCCCCcceEEEEEEeCCeEEEEEE
Q 002158 625 AYFSSSTQVGQGGYGKVYKGILS-DNTTVAIKRAEEGS--LQGQNEFLTEIKLLSRLHHRNLVSLLGYCDEEGEQMLVYE 701 (958)
Q Consensus 625 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E 701 (958)
++|+..+.||+|+||.||+|.++ +++.||+|++.... ....+.+.+|++++++++|+|++++++++......++|||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e 80 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFE 80 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEe
Confidence 35778889999999999999987 68999999886532 2234568899999999999999999999999999999999
Q ss_pred ecCCCCHHHHhccCCCCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEecCCCCeEEeeeeeecccccCCC
Q 002158 702 FVPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSRLAPVLDD 781 (958)
Q Consensus 702 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~ 781 (958)
|+++++|..++.... .+++..+..++.|++.||+|||+.+ ++||||||+||+++.++.++|+|||++........
T Consensus 81 ~~~~~~l~~~~~~~~--~~~~~~~~~~~~ql~~~l~~LH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~ 155 (286)
T cd07847 81 YCDHTVLNELEKNPR--GVPEHLIKKIIWQTLQAVNFCHKHN---CIHRDVKPENILITKQGQIKLCDFGFARILTGPGD 155 (286)
T ss_pred ccCccHHHHHHhCCC--CCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCChhhEEEcCCCcEEECccccceecCCCcc
Confidence 999988888875433 4899999999999999999999998 99999999999999999999999999986533221
Q ss_pred CCCccceeeeeccCCCCccChhhhcc-CCCCCcchhhhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcCcchh----hh
Q 002158 782 EGTMPTHVSTIVKGTPGYLDPEYFLT-HKLTDKSDVYSLGVVLLELLTGMQPISHGKNIVREVNVARDSGMVFS----II 856 (958)
Q Consensus 782 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DV~S~Gv~l~elltG~~P~~~~~~~~~~~~~~~~~~~~~~----~i 856 (958)
......++..|+|||++.+ ..++.++||||||+++|||++|+.||.+..............+.... ..
T Consensus 156 -------~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (286)
T cd07847 156 -------DYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIF 228 (286)
T ss_pred -------cccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhc
Confidence 1122347888999999876 45788999999999999999999999765443222211110000000 00
Q ss_pred ----------cccCCC------CChHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 002158 857 ----------DNRMGS------YPSECVERFVTLALRCCHDKPEHRPSMSDVVRE 895 (958)
Q Consensus 857 ----------~~~~~~------~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 895 (958)
.+.... .....+..+.+++.+||+.+|++||++.|++.+
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~ 283 (286)
T cd07847 229 STNQFFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEH 283 (286)
T ss_pred ccccccccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhcC
Confidence 000000 011235778999999999999999999999863
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=313.18 Aligned_cols=252 Identities=28% Similarity=0.404 Sum_probs=189.9
Q ss_pred eeeeeCCeEEEEEEECCC---cEEEEEEeccCC-hhcHHHHHHHHHHHHccCCCCcceEEEEEEeCCeEEEEEEecCCCC
Q 002158 632 QVGQGGYGKVYKGILSDN---TTVAIKRAEEGS-LQGQNEFLTEIKLLSRLHHRNLVSLLGYCDEEGEQMLVYEFVPNGT 707 (958)
Q Consensus 632 ~lg~G~~g~Vy~~~~~~~---~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E~~~~gs 707 (958)
.||+|+||+||+|...++ ..+++|.+.... ....+.|.+|+.+++.++||||++++++|......++||||+++|+
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~ 81 (268)
T cd05086 2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELGD 81 (268)
T ss_pred cCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCCc
Confidence 589999999999986433 346677666433 3445689999999999999999999999999999999999999999
Q ss_pred HHHHhccCC--CCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEecCCCCeEEeeeeeecccccCCCCCCc
Q 002158 708 LRDWLSGRT--KENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSRLAPVLDDEGTM 785 (958)
Q Consensus 708 L~~~l~~~~--~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~ 785 (958)
|.++++... ....++..+..++.|+++||+|||+.+ ++||||||+|||++.++.+||+|||++........
T Consensus 82 L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~---- 154 (268)
T cd05086 82 LKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHN---FLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDY---- 154 (268)
T ss_pred HHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC---eeccCCccceEEEcCCccEEecccccccccCcchh----
Confidence 999997542 234667778899999999999999998 99999999999999999999999999763211100
Q ss_pred cceeeeeccCCCCccChhhhcc-------CCCCCcchhhhHHHHHHHHHh-CCCCCCCCchhHHHHHHHhhcCcchhhhc
Q 002158 786 PTHVSTIVKGTPGYLDPEYFLT-------HKLTDKSDVYSLGVVLLELLT-GMQPISHGKNIVREVNVARDSGMVFSIID 857 (958)
Q Consensus 786 ~~~~~~~~~gt~~y~aPE~~~~-------~~~~~~~DV~S~Gv~l~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~i~ 857 (958)
........|+..|+|||++.. ..++.++||||||+++|||++ |..||............... ......+
T Consensus 155 -~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~--~~~~~~~ 231 (268)
T cd05086 155 -IETEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLNHVIKD--QQVKLFK 231 (268)
T ss_pred -hhcccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhh--cccccCC
Confidence 111123457889999999753 245779999999999999997 56687644332211111111 1111111
Q ss_pred ccCCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 002158 858 NRMGSYPSECVERFVTLALRCCHDKPEHRPSMSDVVRELE 897 (958)
Q Consensus 858 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 897 (958)
+..+......+.+++..|| .+|++||++++|++.|.
T Consensus 232 ---~~~~~~~~~~~~~l~~~c~-~~P~~Rp~~~~i~~~l~ 267 (268)
T cd05086 232 ---PQLELPYSERWYEVLQFCW-LSPEKRATAEEVHRLLT 267 (268)
T ss_pred ---CccCCCCcHHHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence 1222335677888999999 67999999999998763
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=313.63 Aligned_cols=255 Identities=24% Similarity=0.434 Sum_probs=201.9
Q ss_pred CCCCCceeeeeCCeEEEEEEEC-CCcEEEEEEeccCCh----------hcHHHHHHHHHHHHccCCCCcceEEEEEEeCC
Q 002158 626 YFSSSTQVGQGGYGKVYKGILS-DNTTVAIKRAEEGSL----------QGQNEFLTEIKLLSRLHHRNLVSLLGYCDEEG 694 (958)
Q Consensus 626 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~----------~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~ 694 (958)
+|...+.||+|+||.||+|... +++.||+|.++.... ...+.+.+|++++++++|+|++++++++...+
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 81 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE 81 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence 3566789999999999999865 688999998753211 11245788999999999999999999999999
Q ss_pred eEEEEEEecCCCCHHHHhccCCCCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEecCCCCeEEeeeeeec
Q 002158 695 EQMLVYEFVPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSR 774 (958)
Q Consensus 695 ~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~ 774 (958)
..++||||+++++|.+++... ..+++..+..++.|++.||.|||+.+ ++||||+|+||+++.++.++|+|||+++
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~~~nil~~~~~~~~l~d~~~~~ 156 (272)
T cd06629 82 YLSIFLEYVPGGSIGSCLRTY--GRFEEQLVRFFTEQVLEGLAYLHSKG---ILHRDLKADNLLVDADGICKISDFGISK 156 (272)
T ss_pred ceEEEEecCCCCcHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHhhCC---eeecCCChhhEEEcCCCeEEEeeccccc
Confidence 999999999999999999765 34889999999999999999999998 9999999999999999999999999987
Q ss_pred ccccCCCCCCccceeeeeccCCCCccChhhhccCC--CCCcchhhhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcCcc
Q 002158 775 LAPVLDDEGTMPTHVSTIVKGTPGYLDPEYFLTHK--LTDKSDVYSLGVVLLELLTGMQPISHGKNIVREVNVARDSGMV 852 (958)
Q Consensus 775 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DV~S~Gv~l~elltG~~P~~~~~~~~~~~~~~~~~~~~ 852 (958)
....... ........|+..|+|||.+.... ++.++||||||+++||+++|..||............... ...
T Consensus 157 ~~~~~~~-----~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~-~~~ 230 (272)
T cd06629 157 KSDDIYD-----NDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFKLGNK-RSA 230 (272)
T ss_pred ccccccc-----ccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHHHHHHhhcc-ccC
Confidence 5432111 11123356889999999987654 788999999999999999999999754443322211111 000
Q ss_pred hhhhcccCCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 002158 853 FSIIDNRMGSYPSECVERFVTLALRCCHDKPEHRPSMSDVVRE 895 (958)
Q Consensus 853 ~~~i~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 895 (958)
... . ......++..+.+++.+||+.+|++||++++++++
T Consensus 231 ~~~-~---~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 269 (272)
T cd06629 231 PPI-P---PDVSMNLSPVALDFLNACFTINPDNRPTARELLQH 269 (272)
T ss_pred CcC-C---ccccccCCHHHHHHHHHHhcCChhhCCCHHHHhhC
Confidence 000 0 11223456889999999999999999999999874
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=318.22 Aligned_cols=262 Identities=26% Similarity=0.400 Sum_probs=205.9
Q ss_pred cChHHHHHHHcCCCCCceeeeeCCeEEEEEEEC-CCcEEEEEEeccCChhcHHHHHHHHHHHHcc-CCCCcceEEEEEEe
Q 002158 615 FKFKELAMATAYFSSSTQVGQGGYGKVYKGILS-DNTTVAIKRAEEGSLQGQNEFLTEIKLLSRL-HHRNLVSLLGYCDE 692 (958)
Q Consensus 615 ~~~~el~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~ 692 (958)
+...++..++++|...+.||+|+||.||+|... +++.+|+|++.... .....+.+|+.+++++ +|||++++++++..
T Consensus 12 ~~~~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~ 90 (291)
T cd06639 12 LGLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS-DVDEEIEAEYNILQSLPNHPNVVKFYGMFYK 90 (291)
T ss_pred hhcccCCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccc-cHHHHHHHHHHHHHHhcCCCCeEEEEEEEEe
Confidence 444555667888999999999999999999975 68899999986532 2245678899999999 89999999999865
Q ss_pred C-----CeEEEEEEecCCCCHHHHhccC--CCCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEecCCCCe
Q 002158 693 E-----GEQMLVYEFVPNGTLRDWLSGR--TKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSNLNA 765 (958)
Q Consensus 693 ~-----~~~~lV~E~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~~~~ 765 (958)
. +..++||||+++++|.++++.. ....+++..+..++.|++.||+|||+.+ ++||||||+||++++++.+
T Consensus 91 ~~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~nili~~~~~~ 167 (291)
T cd06639 91 ADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNR---IIHRDVKGNNILLTTEGGV 167 (291)
T ss_pred ccccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEEcCCCCE
Confidence 3 3589999999999999998642 2345899999999999999999999998 9999999999999999999
Q ss_pred EEeeeeeecccccCCCCCCccceeeeeccCCCCccChhhhccC-----CCCCcchhhhHHHHHHHHHhCCCCCCCCchhH
Q 002158 766 KVADFGLSRLAPVLDDEGTMPTHVSTIVKGTPGYLDPEYFLTH-----KLTDKSDVYSLGVVLLELLTGMQPISHGKNIV 840 (958)
Q Consensus 766 kl~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~DV~S~Gv~l~elltG~~P~~~~~~~~ 840 (958)
||+|||+++....... ......|+..|+|||++... .++.++|||||||++|||++|+.||.......
T Consensus 168 kl~dfg~~~~~~~~~~-------~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~ 240 (291)
T cd06639 168 KLVDFGVSAQLTSTRL-------RRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVK 240 (291)
T ss_pred EEeecccchhcccccc-------cccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHH
Confidence 9999999875432111 11234588999999998644 36789999999999999999999997544322
Q ss_pred HHHHHHhhcCcchhhhcccCCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 002158 841 REVNVARDSGMVFSIIDNRMGSYPSECVERFVTLALRCCHDKPEHRPSMSDVVRE 895 (958)
Q Consensus 841 ~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 895 (958)
........ ... . ...+......+.+++.+||+.+|++||++.|++++
T Consensus 241 ~~~~~~~~--~~~-----~-~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~ 287 (291)
T cd06639 241 TLFKIPRN--PPP-----T-LLHPEKWCRSFNHFISQCLIKDFEARPSVTHLLEH 287 (291)
T ss_pred HHHHHhcC--CCC-----C-CCcccccCHHHHHHHHHHhhcChhhCcCHHHHhcC
Confidence 22111111 000 0 01133455679999999999999999999999874
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-35 Score=319.50 Aligned_cols=259 Identities=26% Similarity=0.386 Sum_probs=201.5
Q ss_pred cCCCCCceeeeeCCeEEEEEEEC-CCcEEEEEEeccCCh--hcHHHHHHHHHHHHccCCCCcceEEEEEEeCCeEEEEEE
Q 002158 625 AYFSSSTQVGQGGYGKVYKGILS-DNTTVAIKRAEEGSL--QGQNEFLTEIKLLSRLHHRNLVSLLGYCDEEGEQMLVYE 701 (958)
Q Consensus 625 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E 701 (958)
++|+..+.||+|+||.||+|.++ +++.||+|++..... ...+.+.+|+++++.++||||+++++++..++..++|||
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFE 80 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEe
Confidence 35778899999999999999986 589999998765322 234568899999999999999999999999999999999
Q ss_pred ecCCCCHHHHhccCCCCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEecCCCCeEEeeeeeecccccCCC
Q 002158 702 FVPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSRLAPVLDD 781 (958)
Q Consensus 702 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~ 781 (958)
|+++++|.++..... .+++.++..++.|+++||+|||+.+ ++||||+|+||++++++.++|+|||++........
T Consensus 81 ~~~~~~l~~~~~~~~--~~~~~~~~~~~~~i~~~l~~LH~~~---i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~~ 155 (286)
T cd07846 81 FVDHTVLDDLEKYPN--GLDESRVRKYLFQILRGIEFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGE 155 (286)
T ss_pred cCCccHHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCcEEEEeeeeeeeccCCcc
Confidence 999999998876433 3899999999999999999999998 99999999999999999999999999876432111
Q ss_pred CCCccceeeeeccCCCCccChhhhccC-CCCCcchhhhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcCcch----h--
Q 002158 782 EGTMPTHVSTIVKGTPGYLDPEYFLTH-KLTDKSDVYSLGVVLLELLTGMQPISHGKNIVREVNVARDSGMVF----S-- 854 (958)
Q Consensus 782 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DV~S~Gv~l~elltG~~P~~~~~~~~~~~~~~~~~~~~~----~-- 854 (958)
......++..|+|||++.+. .++.++||||||+++|||++|+.||................+... .
T Consensus 156 -------~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (286)
T cd07846 156 -------VYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIF 228 (286)
T ss_pred -------ccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHh
Confidence 11234578899999998753 467899999999999999999999875443322111111000000 0
Q ss_pred ----hhccc-CC---------CCChHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 002158 855 ----IIDNR-MG---------SYPSECVERFVTLALRCCHDKPEHRPSMSDVVRE 895 (958)
Q Consensus 855 ----~i~~~-~~---------~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 895 (958)
..... .. .....++..+.+++.+||+.+|++||++++++++
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 283 (286)
T cd07846 229 QKNPLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHH 283 (286)
T ss_pred ccchHhhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhcC
Confidence 00000 00 0122456789999999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=312.23 Aligned_cols=237 Identities=27% Similarity=0.442 Sum_probs=190.3
Q ss_pred ceeeeeCCeEEEEEEECCCc-----------EEEEEEeccCChhcHHHHHHHHHHHHccCCCCcceEEEEEEeCCeEEEE
Q 002158 631 TQVGQGGYGKVYKGILSDNT-----------TVAIKRAEEGSLQGQNEFLTEIKLLSRLHHRNLVSLLGYCDEEGEQMLV 699 (958)
Q Consensus 631 ~~lg~G~~g~Vy~~~~~~~~-----------~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV 699 (958)
+.||+|+||.||+|.+.+.. .|++|.+...... ...|.+|+.++++++|+||+++++++.. +..++|
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv 78 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD-SLAFFETASLMSQLSHKHLVKLYGVCVR-DENIMV 78 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh-HHHHHHHHHHHHcCCCcchhheeeEEec-CCcEEE
Confidence 36899999999999986433 5788877654433 6789999999999999999999999988 788999
Q ss_pred EEecCCCCHHHHhccCCCCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEecCCC-------CeEEeeeee
Q 002158 700 YEFVPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSNL-------NAKVADFGL 772 (958)
Q Consensus 700 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~~-------~~kl~DFGl 772 (958)
|||+++|+|.+++..... .+++..++.++.|++.||+|||+++ |+||||||+||+++.++ .+||+|||+
T Consensus 79 ~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~ 154 (259)
T cd05037 79 EEYVKFGPLDVFLHREKN-NVSLHWKLDVAKQLASALHYLEDKK---LVHGNVCGKNILVARYGLNEGYVPFIKLSDPGI 154 (259)
T ss_pred EEcCCCCcHHHHHHhhcc-CCCHHHHHHHHHHHHHHHHHHhhCC---eecccCccceEEEecCccccCCceeEEeCCCCc
Confidence 999999999999976442 5889999999999999999999998 99999999999999888 799999999
Q ss_pred ecccccCCCCCCccceeeeeccCCCCccChhhhccC--CCCCcchhhhHHHHHHHHHh-CCCCCCCCchhHHHHHHHhhc
Q 002158 773 SRLAPVLDDEGTMPTHVSTIVKGTPGYLDPEYFLTH--KLTDKSDVYSLGVVLLELLT-GMQPISHGKNIVREVNVARDS 849 (958)
Q Consensus 773 a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DV~S~Gv~l~ellt-G~~P~~~~~~~~~~~~~~~~~ 849 (958)
++.... .....++..|+|||++... .++.++||||||+++|||++ |..||...... ........
T Consensus 155 a~~~~~-----------~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~-~~~~~~~~- 221 (259)
T cd05037 155 PITVLS-----------REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSS-EKERFYQD- 221 (259)
T ss_pred cccccc-----------ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCch-hHHHHHhc-
Confidence 875422 1123467789999999876 78899999999999999999 57777544311 11111110
Q ss_pred CcchhhhcccCCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 002158 850 GMVFSIIDNRMGSYPSECVERFVTLALRCCHDKPEHRPSMSDVVREL 896 (958)
Q Consensus 850 ~~~~~~i~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 896 (958)
.. ..+......+.+++.+||..+|.+||++.++++.|
T Consensus 222 --------~~--~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l 258 (259)
T cd05037 222 --------QH--RLPMPDCAELANLINQCWTYDPTKRPSFRAILRDL 258 (259)
T ss_pred --------CC--CCCCCCchHHHHHHHHHhccChhhCCCHHHHHHhc
Confidence 00 01111127889999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=322.06 Aligned_cols=256 Identities=23% Similarity=0.306 Sum_probs=187.2
Q ss_pred CceeeeeCCeEEEEEEEC---CCcEEEEEEeccCChhcHHHHHHHHHHHHccCCCCcceEEEEEEe--CCeEEEEEEecC
Q 002158 630 STQVGQGGYGKVYKGILS---DNTTVAIKRAEEGSLQGQNEFLTEIKLLSRLHHRNLVSLLGYCDE--EGEQMLVYEFVP 704 (958)
Q Consensus 630 ~~~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~--~~~~~lV~E~~~ 704 (958)
..+||+|+||+||+|..+ ++..||+|.+.... ....+.+|++++++++||||+++++++.. +...++||||++
T Consensus 6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~ 83 (317)
T cd07867 6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTG--ISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAE 83 (317)
T ss_pred ceEeccCCCeeEEEEEecCCCccceEEEEEecCCC--CcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeC
Confidence 357999999999999975 35789999987543 23457899999999999999999999853 557899999995
Q ss_pred CCCHHHHhccC-------CCCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEe----cCCCCeEEeeeeee
Q 002158 705 NGTLRDWLSGR-------TKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILL----DSNLNAKVADFGLS 773 (958)
Q Consensus 705 ~gsL~~~l~~~-------~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl----~~~~~~kl~DFGla 773 (958)
++|.+++... ....+++..+..++.|++.||+|||+.+ |+||||||+|||+ ++++.+||+|||++
T Consensus 84 -~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a 159 (317)
T cd07867 84 -HDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFA 159 (317)
T ss_pred -CcHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCC---EEcCCCCHHHEEEccCCCCCCcEEEeeccce
Confidence 5888877422 1234889999999999999999999999 9999999999999 56679999999999
Q ss_pred cccccCCCCCCccceeeeeccCCCCccChhhhccC-CCCCcchhhhHHHHHHHHHhCCCCCCCCchhH--------HHHH
Q 002158 774 RLAPVLDDEGTMPTHVSTIVKGTPGYLDPEYFLTH-KLTDKSDVYSLGVVLLELLTGMQPISHGKNIV--------REVN 844 (958)
Q Consensus 774 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DV~S~Gv~l~elltG~~P~~~~~~~~--------~~~~ 844 (958)
+........ ........||+.|+|||++.+. .++.++|||||||++|||+||+.||....... ....
T Consensus 160 ~~~~~~~~~----~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~ 235 (317)
T cd07867 160 RLFNSPLKP----LADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLD 235 (317)
T ss_pred eccCCCccc----ccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccccccccccccccHHHHH
Confidence 865322111 1112345689999999999764 57889999999999999999999996432110 0000
Q ss_pred -HHh--------------hcCcchhhhcc-------------cCCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 002158 845 -VAR--------------DSGMVFSIIDN-------------RMGSYPSECVERFVTLALRCCHDKPEHRPSMSDVVRE 895 (958)
Q Consensus 845 -~~~--------------~~~~~~~~i~~-------------~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 895 (958)
... ........... ............+.+++.+|++.||.+|||++|++++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~e~l~h 314 (317)
T cd07867 236 RIFSVMGFPADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVFLLLQKLLTMDPTKRITSEQALQD 314 (317)
T ss_pred HHHHhcCCCChhhhhhhhhcccchhhhhhhcccccCCchhhhhhhcccCCCChHHHHHHHHHhccCcccccCHHHHhcC
Confidence 000 00000000000 0000011123457889999999999999999999863
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=316.11 Aligned_cols=259 Identities=25% Similarity=0.370 Sum_probs=201.4
Q ss_pred CCCCCceeeeeCCeEEEEEEEC-CCcEEEEEEeccCC--hhcHHHHHHHHHHHHccCCCCcceEEEEEEeCCeEEEEEEe
Q 002158 626 YFSSSTQVGQGGYGKVYKGILS-DNTTVAIKRAEEGS--LQGQNEFLTEIKLLSRLHHRNLVSLLGYCDEEGEQMLVYEF 702 (958)
Q Consensus 626 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E~ 702 (958)
+|+..+.||+|++|.||+|+.. +++.||||++.... ......+.+|++++++++||||+++++++.+.+..++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEF 80 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeec
Confidence 4778899999999999999976 68999999886542 22235788999999999999999999999999999999999
Q ss_pred cCCCCHHHHhccCCCCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEecCCCCeEEeeeeeecccccCCCC
Q 002158 703 VPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSRLAPVLDDE 782 (958)
Q Consensus 703 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~ 782 (958)
++ ++|.+++.......+++..+..++.|++.||+|||+.+ ++||||+|+||++++++.+||+|||+++.......
T Consensus 81 ~~-~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~---i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~~- 155 (284)
T cd07860 81 LH-QDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR- 155 (284)
T ss_pred cc-cCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEeeccchhhcccCcc-
Confidence 95 68999997665566899999999999999999999998 99999999999999999999999999875422111
Q ss_pred CCccceeeeeccCCCCccChhhhccCC-CCCcchhhhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcCcchhhh-----
Q 002158 783 GTMPTHVSTIVKGTPGYLDPEYFLTHK-LTDKSDVYSLGVVLLELLTGMQPISHGKNIVREVNVARDSGMVFSII----- 856 (958)
Q Consensus 783 ~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DV~S~Gv~l~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~i----- 856 (958)
......++..|+|||++.+.. ++.++||||||+++|||+||+.||................+.....+
T Consensus 156 ------~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (284)
T cd07860 156 ------TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVT 229 (284)
T ss_pred ------ccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhhh
Confidence 112234688999999887654 57899999999999999999999976554332222111111100000
Q ss_pred -------------cccCCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 002158 857 -------------DNRMGSYPSECVERFVTLALRCCHDKPEHRPSMSDVVRE 895 (958)
Q Consensus 857 -------------~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 895 (958)
...........+..+.+++.+||+.||++||++++++++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~ 281 (284)
T cd07860 230 SLPDYKPSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAH 281 (284)
T ss_pred HHHHHHhhcccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhcC
Confidence 000000112345677899999999999999999999863
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-34 Score=309.53 Aligned_cols=251 Identities=35% Similarity=0.561 Sum_probs=203.8
Q ss_pred CCCCceeeeeCCeEEEEEEECC-----CcEEEEEEeccCChh-cHHHHHHHHHHHHccCCCCcceEEEEEEeCCeEEEEE
Q 002158 627 FSSSTQVGQGGYGKVYKGILSD-----NTTVAIKRAEEGSLQ-GQNEFLTEIKLLSRLHHRNLVSLLGYCDEEGEQMLVY 700 (958)
Q Consensus 627 ~~~~~~lg~G~~g~Vy~~~~~~-----~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~ 700 (958)
|+..+.||+|+||.||++.+.+ +..||+|++...... ..+.+..|+++++.++|+||+++++++...+..+++|
T Consensus 1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~ 80 (258)
T smart00219 1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVM 80 (258)
T ss_pred CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEE
Confidence 3456789999999999999864 388999999765433 5668999999999999999999999999999999999
Q ss_pred EecCCCCHHHHhccCCCCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEecCCCCeEEeeeeeecccccCC
Q 002158 701 EFVPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSRLAPVLD 780 (958)
Q Consensus 701 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~ 780 (958)
||+++++|.+++.......+++.++..++.|++.||+|||+.+ ++||||||+||+++.++.++|+|||+++......
T Consensus 81 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~---~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~ 157 (258)
T smart00219 81 EYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESKN---FIHRDLAARNCLVGENLVVKISDFGLSRDLYDDD 157 (258)
T ss_pred eccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcCC---eeecccccceEEEccCCeEEEcccCCceeccccc
Confidence 9999999999997654433899999999999999999999999 9999999999999999999999999987653321
Q ss_pred CCCCccceeeeeccCCCCccChhhhccCCCCCcchhhhHHHHHHHHHh-CCCCCCCCchhHHHHHHHhhcCcchhhhccc
Q 002158 781 DEGTMPTHVSTIVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVLLELLT-GMQPISHGKNIVREVNVARDSGMVFSIIDNR 859 (958)
Q Consensus 781 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gv~l~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~i~~~ 859 (958)
.. ......+++.|+|||.+.+..++.++||||+|++++||++ |..||..... ......... ..
T Consensus 158 ~~------~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~-~~~~~~~~~---------~~ 221 (258)
T smart00219 158 YY------KKKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSN-EEVLEYLKK---------GY 221 (258)
T ss_pred cc------ccccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCH-HHHHHHHhc---------CC
Confidence 11 0112237789999999988889999999999999999999 7888864222 121111111 11
Q ss_pred CCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 002158 860 MGSYPSECVERFVTLALRCCHDKPEHRPSMSDVVREL 896 (958)
Q Consensus 860 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 896 (958)
....+...+..+.+++.+|+..+|++||++.|+++.|
T Consensus 222 ~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l 258 (258)
T smart00219 222 RLPKPENCPPEIYKLMLQCWAEDPEDRPTFSELVEIL 258 (258)
T ss_pred CCCCCCcCCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence 1222344678899999999999999999999998753
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-34 Score=318.53 Aligned_cols=260 Identities=21% Similarity=0.310 Sum_probs=203.4
Q ss_pred CCCCCceeeeeCCeEEEEEEEC-CCcEEEEEEeccCCh---hcHHHHHHHHHHHHccCCCCcceEEEEEEeCCeEEEEEE
Q 002158 626 YFSSSTQVGQGGYGKVYKGILS-DNTTVAIKRAEEGSL---QGQNEFLTEIKLLSRLHHRNLVSLLGYCDEEGEQMLVYE 701 (958)
Q Consensus 626 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E 701 (958)
+|...+.||+|+||.||++... .++.||+|.+..... .....+.+|+++++.++||||+++++.+..++..++|||
T Consensus 2 ~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e 81 (305)
T cd05609 2 DFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVME 81 (305)
T ss_pred CceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEEe
Confidence 6778899999999999999986 578999999876432 234578899999999999999999999999999999999
Q ss_pred ecCCCCHHHHhccCCCCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEecCCCCeEEeeeeeecccccCCC
Q 002158 702 FVPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSRLAPVLDD 781 (958)
Q Consensus 702 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~ 781 (958)
|+++++|.+++.... .+++..+..++.|++.||+|||+.+ ++||||||+||+++.++.+||+|||+++.......
T Consensus 82 ~~~g~~L~~~l~~~~--~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~~~ 156 (305)
T cd05609 82 YVEGGDCATLLKNIG--ALPVDMARMYFAETVLALEYLHNYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLT 156 (305)
T ss_pred cCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchHHEEECCCCCEEEeeCCCccccCcCcc
Confidence 999999999996543 4889999999999999999999998 99999999999999999999999999874211000
Q ss_pred CC--------CccceeeeeccCCCCccChhhhccCCCCCcchhhhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcCcch
Q 002158 782 EG--------TMPTHVSTIVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVLLELLTGMQPISHGKNIVREVNVARDSGMVF 853 (958)
Q Consensus 782 ~~--------~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gv~l~elltG~~P~~~~~~~~~~~~~~~~~~~~~ 853 (958)
.. ...........|+..|+|||++....++.++|+||||+++|||++|..||.+... .+..........
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~-~~~~~~~~~~~~-- 233 (305)
T cd05609 157 TNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTP-EELFGQVISDDI-- 233 (305)
T ss_pred ccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH-HHHHHHHHhccc--
Confidence 00 0001111234578899999999988899999999999999999999999975432 121111111000
Q ss_pred hhhcccCCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 002158 854 SIIDNRMGSYPSECVERFVTLALRCCHDKPEHRPSMSDVVRELEN 898 (958)
Q Consensus 854 ~~i~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 898 (958)
.....+...+..+.+++.+||+.+|++||++.++.+.|+.
T Consensus 234 -----~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~ 273 (305)
T cd05609 234 -----EWPEGDEALPADAQDLISRLLRQNPLERLGTGGAFEVKQH 273 (305)
T ss_pred -----CCCCccccCCHHHHHHHHHHhccChhhccCccCHHHHHhC
Confidence 0111122456788999999999999999997666665544
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=316.99 Aligned_cols=244 Identities=25% Similarity=0.366 Sum_probs=202.8
Q ss_pred CCCCCceeeeeCCeEEEEEEEC-CCcEEEEEEeccCC---hhcHHHHHHHHHHHHccCCCCcceEEEEEEeCCeEEEEEE
Q 002158 626 YFSSSTQVGQGGYGKVYKGILS-DNTTVAIKRAEEGS---LQGQNEFLTEIKLLSRLHHRNLVSLLGYCDEEGEQMLVYE 701 (958)
Q Consensus 626 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E 701 (958)
+|+..+.||+|+||.||++.+. +++.||+|++.... ....+.+.+|++++++++||||+++++++..++..++|||
T Consensus 2 ~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 81 (290)
T cd05580 2 DFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVME 81 (290)
T ss_pred ceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEEe
Confidence 5778889999999999999976 68999999986532 2334578899999999999999999999999999999999
Q ss_pred ecCCCCHHHHhccCCCCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEecCCCCeEEeeeeeecccccCCC
Q 002158 702 FVPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSRLAPVLDD 781 (958)
Q Consensus 702 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~ 781 (958)
|+++++|.+++... ..++...+..++.|++.||+|||+.+ ++||||+|+||+++.++.+||+|||+++.....
T Consensus 82 ~~~~~~L~~~~~~~--~~l~~~~~~~~~~qil~~l~~lH~~~---i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~-- 154 (290)
T cd05580 82 YVPGGELFSHLRKS--GRFPEPVARFYAAQVVLALEYLHSLD---IVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR-- 154 (290)
T ss_pred cCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEECCCCCEEEeeCCCccccCCC--
Confidence 99999999999765 34899999999999999999999998 999999999999999999999999998764221
Q ss_pred CCCccceeeeeccCCCCccChhhhccCCCCCcchhhhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcCcchhhhcccCC
Q 002158 782 EGTMPTHVSTIVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVLLELLTGMQPISHGKNIVREVNVARDSGMVFSIIDNRMG 861 (958)
Q Consensus 782 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gv~l~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~i~~~~~ 861 (958)
.....|++.|+|||.+.+...+.++||||||+++|||++|+.||........ ..... ....
T Consensus 155 --------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~-~~~~~----------~~~~ 215 (290)
T cd05580 155 --------TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQI-YEKIL----------EGKV 215 (290)
T ss_pred --------CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHh----------cCCc
Confidence 1234588999999999888889999999999999999999999975442111 11111 1112
Q ss_pred CCChHHHHHHHHHHHHccccCCCCCC-----CHHHHHHH
Q 002158 862 SYPSECVERFVTLALRCCHDKPEHRP-----SMSDVVRE 895 (958)
Q Consensus 862 ~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~~ 895 (958)
..+...+..+.+++.+||+.||.+|+ +++|++++
T Consensus 216 ~~~~~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~~ 254 (290)
T cd05580 216 RFPSFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKNH 254 (290)
T ss_pred cCCccCCHHHHHHHHHHccCCHHHccCcccCCHHHHHcC
Confidence 23445578899999999999999998 66777653
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-34 Score=314.72 Aligned_cols=259 Identities=25% Similarity=0.318 Sum_probs=202.5
Q ss_pred CCCCCceeeeeCCeEEEEEEEC-CCcEEEEEEeccCC--hhcHHHHHHHHHHHHccCCCCcceEEEEEEeCCeEEEEEEe
Q 002158 626 YFSSSTQVGQGGYGKVYKGILS-DNTTVAIKRAEEGS--LQGQNEFLTEIKLLSRLHHRNLVSLLGYCDEEGEQMLVYEF 702 (958)
Q Consensus 626 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E~ 702 (958)
+|...+.||+|+||.||+|.+. +|+.||||++.... ....+.+.+|+.++++++|+||+++++++..+...++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~ 80 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEY 80 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEecc
Confidence 4677889999999999999975 68999999987654 23346789999999999999999999999999999999999
Q ss_pred cCCCCHHHHhccCCCCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEecCCCCeEEeeeeeecccccCCCC
Q 002158 703 VPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSRLAPVLDDE 782 (958)
Q Consensus 703 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~ 782 (958)
+ +++|.+++.... ..+++.++..++.|+++||+|||+.+ ++|+||||+||+++.++.++|+|||++........
T Consensus 81 ~-~~~L~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~- 154 (286)
T cd07832 81 M-PSDLSEVLRDEE-RPLPEAQVKSYMRMLLKGVAYMHANG---IMHRDLKPANLLISADGVLKIADFGLARLFSEEEP- 154 (286)
T ss_pred c-CCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCcCHHHEEEcCCCcEEEeeeeecccccCCCC-
Confidence 9 999999997544 45899999999999999999999999 99999999999999999999999999886533221
Q ss_pred CCccceeeeeccCCCCccChhhhccC-CCCCcchhhhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcCcch--------
Q 002158 783 GTMPTHVSTIVKGTPGYLDPEYFLTH-KLTDKSDVYSLGVVLLELLTGMQPISHGKNIVREVNVARDSGMVF-------- 853 (958)
Q Consensus 783 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DV~S~Gv~l~elltG~~P~~~~~~~~~~~~~~~~~~~~~-------- 853 (958)
.......|+..|+|||++.+. .++.++||||+|+++|||++|..||................+...
T Consensus 155 -----~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (286)
T cd07832 155 -----RLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLT 229 (286)
T ss_pred -----CccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHHHHHHHcCCCChHHHhhcc
Confidence 111234588999999998654 468899999999999999999877765443222211111100000
Q ss_pred ------hhhccc-----CCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 002158 854 ------SIIDNR-----MGSYPSECVERFVTLALRCCHDKPEHRPSMSDVVRE 895 (958)
Q Consensus 854 ------~~i~~~-----~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 895 (958)
...... ......+.+..+.+++.+|++.+|++||++++++++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h 282 (286)
T cd07832 230 SLPDYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRH 282 (286)
T ss_pred CcchhhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 000000 001112345889999999999999999999999874
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=313.94 Aligned_cols=254 Identities=28% Similarity=0.432 Sum_probs=202.9
Q ss_pred HHcCCCCCceeeeeCCeEEEEEEEC-CCcEEEEEEeccCChhcHHHHHHHHHHHHcc-CCCCcceEEEEEEeCC------
Q 002158 623 ATAYFSSSTQVGQGGYGKVYKGILS-DNTTVAIKRAEEGSLQGQNEFLTEIKLLSRL-HHRNLVSLLGYCDEEG------ 694 (958)
Q Consensus 623 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~------ 694 (958)
.+++|+..+.||+|+||.||+|..+ +++.|++|++..... ..+.|.+|+++++++ +|+||+++++++....
T Consensus 4 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~ 82 (275)
T cd06608 4 PTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED-EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDD 82 (275)
T ss_pred chhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCch-hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcce
Confidence 4678999999999999999999986 678999999876443 346789999999999 7999999999997644
Q ss_pred eEEEEEEecCCCCHHHHhccCC--CCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEecCCCCeEEeeeee
Q 002158 695 EQMLVYEFVPNGTLRDWLSGRT--KENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSNLNAKVADFGL 772 (958)
Q Consensus 695 ~~~lV~E~~~~gsL~~~l~~~~--~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~~~~kl~DFGl 772 (958)
..++||||+++++|.+++.... ...+++..+..++.|+++||+|||+.+ ++|+||+|+||++++++.+||+|||+
T Consensus 83 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~---i~H~~l~p~ni~~~~~~~~~l~d~~~ 159 (275)
T cd06608 83 QLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENK---VIHRDIKGQNILLTKNAEVKLVDFGV 159 (275)
T ss_pred EEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHHHEEEccCCeEEECCCcc
Confidence 4899999999999999987533 456899999999999999999999999 99999999999999999999999999
Q ss_pred ecccccCCCCCCccceeeeeccCCCCccChhhhcc-----CCCCCcchhhhHHHHHHHHHhCCCCCCCCchhHHHHHHHh
Q 002158 773 SRLAPVLDDEGTMPTHVSTIVKGTPGYLDPEYFLT-----HKLTDKSDVYSLGVVLLELLTGMQPISHGKNIVREVNVAR 847 (958)
Q Consensus 773 a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DV~S~Gv~l~elltG~~P~~~~~~~~~~~~~~~ 847 (958)
+....... .......|+..|+|||++.. ..++.++||||||+++|||++|+.||..............
T Consensus 160 ~~~~~~~~-------~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~ 232 (275)
T cd06608 160 SAQLDSTL-------GRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRALFKIPR 232 (275)
T ss_pred ceecccch-------hhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHHHHHHhhc
Confidence 87543211 11123458899999999854 3467799999999999999999999975433222211111
Q ss_pred hcCcchhhhcccCCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 002158 848 DSGMVFSIIDNRMGSYPSECVERFVTLALRCCHDKPEHRPSMSDVVRE 895 (958)
Q Consensus 848 ~~~~~~~~i~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 895 (958)
. . .. ....+..++..+.+++.+||..||++||++.+++++
T Consensus 233 ~--~-----~~-~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~~ 272 (275)
T cd06608 233 N--P-----PP-TLKSPENWSKKFNDFISECLIKNYEQRPFMEELLEH 272 (275)
T ss_pred c--C-----CC-CCCchhhcCHHHHHHHHHHhhcChhhCcCHHHHhcC
Confidence 0 0 00 011133466789999999999999999999999863
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-34 Score=308.90 Aligned_cols=252 Identities=27% Similarity=0.410 Sum_probs=204.1
Q ss_pred CCCCCceeeeeCCeEEEEEEEC-CCcEEEEEEeccCCh--hcHHHHHHHHHHHHccCCCCcceEEEEEEeCCeEEEEEEe
Q 002158 626 YFSSSTQVGQGGYGKVYKGILS-DNTTVAIKRAEEGSL--QGQNEFLTEIKLLSRLHHRNLVSLLGYCDEEGEQMLVYEF 702 (958)
Q Consensus 626 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E~ 702 (958)
+|...+.||+|+||.||+|... +++.||+|.+..... ...+.+.+|++++++++|+||+++++++...+..++|+||
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEY 80 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEec
Confidence 4677889999999999999975 688999999876543 3567899999999999999999999999999999999999
Q ss_pred cCCCCHHHHhccCCCCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEecCCCCeEEeeeeeecccccCCCC
Q 002158 703 VPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSRLAPVLDDE 782 (958)
Q Consensus 703 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~ 782 (958)
+++++|.+++.... .+++..+..++.|+++||+|||+.+ ++|+||+|+||++++++.+||+|||++.........
T Consensus 81 ~~~~~L~~~~~~~~--~~~~~~~~~i~~~i~~~l~~lh~~~---i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~~ 155 (264)
T cd06626 81 CSGGTLEELLEHGR--ILDEHVIRVYTLQLLEGLAYLHSHG---IVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTT 155 (264)
T ss_pred CCCCcHHHHHhhcC--CCChHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEcccccccccCCCCCc
Confidence 99999999997543 3788999999999999999999999 999999999999999999999999998865432221
Q ss_pred CCccceeeeeccCCCCccChhhhccCC---CCCcchhhhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcCcchhhhccc
Q 002158 783 GTMPTHVSTIVKGTPGYLDPEYFLTHK---LTDKSDVYSLGVVLLELLTGMQPISHGKNIVREVNVARDSGMVFSIIDNR 859 (958)
Q Consensus 783 ~~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~~~DV~S~Gv~l~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~i~~~ 859 (958)
. ........++..|+|||++.+.. ++.++||||||+++|||++|+.||............... ..
T Consensus 156 ~---~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~~~~~~~~---------~~ 223 (264)
T cd06626 156 M---GEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFHVGA---------GH 223 (264)
T ss_pred c---cccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHHHHHHHhc---------CC
Confidence 1 11012345888999999998766 888999999999999999999999754322221111110 11
Q ss_pred CCCCCh--HHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002158 860 MGSYPS--ECVERFVTLALRCCHDKPEHRPSMSDVVR 894 (958)
Q Consensus 860 ~~~~~~--~~~~~l~~li~~cl~~dP~~RPs~~evl~ 894 (958)
....+. .++..+.+++.+||+.+|++||++.+++.
T Consensus 224 ~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~ 260 (264)
T cd06626 224 KPPIPDSLQLSPEGKDFLDRCLESDPKKRPTASELLQ 260 (264)
T ss_pred CCCCCcccccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 112222 23677889999999999999999999875
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=315.15 Aligned_cols=250 Identities=25% Similarity=0.395 Sum_probs=196.8
Q ss_pred cCCCCCceeeeeCCeEEEEEEEC-CCcEEEEEEeccCC-hhcHHHHHHHHHH-HHccCCCCcceEEEEEEeCCeEEEEEE
Q 002158 625 AYFSSSTQVGQGGYGKVYKGILS-DNTTVAIKRAEEGS-LQGQNEFLTEIKL-LSRLHHRNLVSLLGYCDEEGEQMLVYE 701 (958)
Q Consensus 625 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~-l~~l~H~niv~l~~~~~~~~~~~lV~E 701 (958)
++|+..+.||+|+||.||+|.++ +|+.||+|+++... .....++..|+.. ++..+||||+++++++..++..++|||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e 80 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICME 80 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhh
Confidence 36788899999999999999986 69999999987642 2334456667665 666789999999999999999999999
Q ss_pred ecCCCCHHHHhccC--CCCCchHHHHHHHHHHHHHHHHHhhhc-CCCCeeccCCCccceEecCCCCeEEeeeeeeccccc
Q 002158 702 FVPNGTLRDWLSGR--TKENLNFAMRLRVALDSAKGILYLHTE-AHPPVFHRDIKASNILLDSNLNAKVADFGLSRLAPV 778 (958)
Q Consensus 702 ~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~~ia~aL~yLH~~-~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~~~~ 778 (958)
|++ |+|.+++... ....+++..+..++.|++.||+|||++ + ++||||||+||+++.++.+||+|||+++....
T Consensus 81 ~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~---i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~ 156 (283)
T cd06617 81 VMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLS---VIHRDVKPSNVLINRNGQVKLCDFGISGYLVD 156 (283)
T ss_pred hhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCC---eecCCCCHHHEEECCCCCEEEeeccccccccc
Confidence 995 7898887642 234689999999999999999999987 7 99999999999999999999999999875421
Q ss_pred CCCCCCccceeeeeccCCCCccChhhhcc----CCCCCcchhhhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcCcchh
Q 002158 779 LDDEGTMPTHVSTIVKGTPGYLDPEYFLT----HKLTDKSDVYSLGVVLLELLTGMQPISHGKNIVREVNVARDSGMVFS 854 (958)
Q Consensus 779 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~~DV~S~Gv~l~elltG~~P~~~~~~~~~~~~~~~~~~~~~~ 854 (958)
. .......|+..|+|||++.+ ..++.++|+||||+++|||++|+.||..............
T Consensus 157 ~--------~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~------- 221 (283)
T cd06617 157 S--------VAKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVV------- 221 (283)
T ss_pred c--------cccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCHHHHHHHH-------
Confidence 1 11122458889999998865 4568899999999999999999999965332222221111
Q ss_pred hhcccCCCCC-hHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 002158 855 IIDNRMGSYP-SECVERFVTLALRCCHDKPEHRPSMSDVVRE 895 (958)
Q Consensus 855 ~i~~~~~~~~-~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 895 (958)
.......+ ..++.++.+++.+||..+|++||++++++++
T Consensus 222 --~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~ 261 (283)
T cd06617 222 --EEPSPQLPAEKFSPEFQDFVNKCLKKNYKERPNYPELLQH 261 (283)
T ss_pred --hcCCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 11111112 2356789999999999999999999999874
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-34 Score=311.11 Aligned_cols=251 Identities=20% Similarity=0.335 Sum_probs=200.9
Q ss_pred CCCCCceeeeeCCeEEEEEEECC--CcEEEEEEeccC----------ChhcHHHHHHHHHHHHc-cCCCCcceEEEEEEe
Q 002158 626 YFSSSTQVGQGGYGKVYKGILSD--NTTVAIKRAEEG----------SLQGQNEFLTEIKLLSR-LHHRNLVSLLGYCDE 692 (958)
Q Consensus 626 ~~~~~~~lg~G~~g~Vy~~~~~~--~~~vavK~~~~~----------~~~~~~~~~~E~~~l~~-l~H~niv~l~~~~~~ 692 (958)
+|+..+.||+|+||.||+|.++. ++.+|+|.+... ......++.+|+.++.+ ++|+||+++++++..
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 80 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE 80 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence 46778899999999999999865 688999987532 12223457789988875 799999999999999
Q ss_pred CCeEEEEEEecCCCCHHHHhcc--CCCCCchHHHHHHHHHHHHHHHHHhhh-cCCCCeeccCCCccceEecCCCCeEEee
Q 002158 693 EGEQMLVYEFVPNGTLRDWLSG--RTKENLNFAMRLRVALDSAKGILYLHT-EAHPPVFHRDIKASNILLDSNLNAKVAD 769 (958)
Q Consensus 693 ~~~~~lV~E~~~~gsL~~~l~~--~~~~~l~~~~~~~i~~~ia~aL~yLH~-~~~~~iiH~Dikp~NILl~~~~~~kl~D 769 (958)
.+..++||||+++++|.+++.. .....+++..+++++.|++.||.|||+ .+ ++|+||||+||+++.++.+||+|
T Consensus 81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~---i~H~dl~~~nil~~~~~~~~l~d 157 (269)
T cd08528 81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKR---IVHRDLTPNNIMLGEDDKVTITD 157 (269)
T ss_pred CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCc---eeecCCCHHHEEECCCCcEEEec
Confidence 9999999999999999998853 223458999999999999999999996 56 99999999999999999999999
Q ss_pred eeeecccccCCCCCCccceeeeeccCCCCccChhhhccCCCCCcchhhhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhc
Q 002158 770 FGLSRLAPVLDDEGTMPTHVSTIVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVLLELLTGMQPISHGKNIVREVNVARDS 849 (958)
Q Consensus 770 FGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gv~l~elltG~~P~~~~~~~~~~~~~~~~~ 849 (958)
||.+....... ......|+..|+|||.+.+..++.++||||||+++|||++|+.||...... ........
T Consensus 158 fg~~~~~~~~~--------~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~-~~~~~~~~- 227 (269)
T cd08528 158 FGLAKQKQPES--------KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNML-SLATKIVE- 227 (269)
T ss_pred ccceeeccccc--------ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCHH-HHHHHHhh-
Confidence 99997643211 123356889999999999888999999999999999999999999654322 11111111
Q ss_pred CcchhhhcccCCCC-ChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 002158 850 GMVFSIIDNRMGSY-PSECVERFVTLALRCCHDKPEHRPSMSDVVRELE 897 (958)
Q Consensus 850 ~~~~~~i~~~~~~~-~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 897 (958)
...... ....+..+.+++.+||+.||++||++.|+.++++
T Consensus 228 --------~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~ 268 (269)
T cd08528 228 --------AVYEPLPEGMYSEDVTDVITSCLTPDAEARPDIIQVSAMIS 268 (269)
T ss_pred --------ccCCcCCcccCCHHHHHHHHHHCCCCCccCCCHHHHHHHhc
Confidence 111111 1234578999999999999999999999998875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-34 Score=316.44 Aligned_cols=258 Identities=25% Similarity=0.343 Sum_probs=200.1
Q ss_pred CCCCCceeeeeCCeEEEEEEEC-CCcEEEEEEeccCChh-----cHHHHHHHHHHHHccCCCCcceEEEEEEeCCeEEEE
Q 002158 626 YFSSSTQVGQGGYGKVYKGILS-DNTTVAIKRAEEGSLQ-----GQNEFLTEIKLLSRLHHRNLVSLLGYCDEEGEQMLV 699 (958)
Q Consensus 626 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-----~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV 699 (958)
+|+..+.||+|+||.||+|.+. +++.||||.+...... ....+..|++++++++|+||+++++++.+.+..++|
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV 80 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence 3667789999999999999976 6899999998765332 234577899999999999999999999999999999
Q ss_pred EEecCCCCHHHHhccCCCCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEecCCCCeEEeeeeeecccccC
Q 002158 700 YEFVPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSRLAPVL 779 (958)
Q Consensus 700 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~~~~~ 779 (958)
|||+ +++|.+++.... ..+++..+..++.|+++||+|||+++ |+||||||+||+++.++.++|+|||+++.....
T Consensus 81 ~e~~-~~~L~~~i~~~~-~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~ 155 (298)
T cd07841 81 FEFM-ETDLEKVIKDKS-IVLTPADIKSYMLMTLRGLEYLHSNW---ILHRDLKPNNLLIASDGVLKLADFGLARSFGSP 155 (298)
T ss_pred Eccc-CCCHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCChhhEEEcCCCCEEEccceeeeeccCC
Confidence 9999 899999997654 35899999999999999999999999 999999999999999999999999999865332
Q ss_pred CCCCCccceeeeeccCCCCccChhhhcc-CCCCCcchhhhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcCcch-----
Q 002158 780 DDEGTMPTHVSTIVKGTPGYLDPEYFLT-HKLTDKSDVYSLGVVLLELLTGMQPISHGKNIVREVNVARDSGMVF----- 853 (958)
Q Consensus 780 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DV~S~Gv~l~elltG~~P~~~~~~~~~~~~~~~~~~~~~----- 853 (958)
.. ......++..|+|||.+.+ ..++.++|||||||++|||++|..||................+...
T Consensus 156 ~~-------~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (298)
T cd07841 156 NR-------KMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWP 228 (298)
T ss_pred Cc-------cccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHHHHHcCCCchhhhh
Confidence 11 1122346788999999865 4578899999999999999999777765443222111111000000
Q ss_pred ------hhhc-ccCC-----CCChHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 002158 854 ------SIID-NRMG-----SYPSECVERFVTLALRCCHDKPEHRPSMSDVVRE 895 (958)
Q Consensus 854 ------~~i~-~~~~-----~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 895 (958)
.... .... ......+..+.+++.+||+.+|++||+++|++++
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~ 282 (298)
T cd07841 229 GVTSLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEH 282 (298)
T ss_pred hcccccccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence 0000 0000 1112346788999999999999999999999973
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-34 Score=312.83 Aligned_cols=248 Identities=23% Similarity=0.361 Sum_probs=202.7
Q ss_pred CCCCceeeeeCCeEEEEEEEC-CCcEEEEEEeccCChhcHHHHHHHHHHHHccCCCCcceEEEEEEeCCeEEEEEEecCC
Q 002158 627 FSSSTQVGQGGYGKVYKGILS-DNTTVAIKRAEEGSLQGQNEFLTEIKLLSRLHHRNLVSLLGYCDEEGEQMLVYEFVPN 705 (958)
Q Consensus 627 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E~~~~ 705 (958)
|...+.||+|++|.||+|... +++.||+|++........+.+.+|+.+++.++|+||+++++++...+..++|+||+++
T Consensus 21 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~~ 100 (285)
T cd06648 21 LDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLEG 100 (285)
T ss_pred hhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEeccCC
Confidence 444579999999999999975 6889999998765555566789999999999999999999999999999999999999
Q ss_pred CCHHHHhccCCCCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEecCCCCeEEeeeeeecccccCCCCCCc
Q 002158 706 GTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSRLAPVLDDEGTM 785 (958)
Q Consensus 706 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~ 785 (958)
++|.+++.. ..+++.++..++.|++.||+|||+.+ |+||||+|+||+++.++.++|+|||.+.......
T Consensus 101 ~~L~~~~~~---~~~~~~~~~~~~~ql~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~----- 169 (285)
T cd06648 101 GALTDIVTH---TRMNEEQIATVCLAVLKALSFLHAQG---VIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEV----- 169 (285)
T ss_pred CCHHHHHHh---CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCChhhEEEcCCCcEEEcccccchhhccCC-----
Confidence 999999976 24889999999999999999999999 9999999999999999999999999886542211
Q ss_pred cceeeeeccCCCCccChhhhccCCCCCcchhhhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcCcchhhhcccCCCCCh
Q 002158 786 PTHVSTIVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVLLELLTGMQPISHGKNIVREVNVARDSGMVFSIIDNRMGSYPS 865 (958)
Q Consensus 786 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gv~l~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~ 865 (958)
.......|++.|+|||.+.+..++.++||||||+++|||++|+.||........ ........ ......+.
T Consensus 170 --~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~~~-~~~~~~~~-------~~~~~~~~ 239 (285)
T cd06648 170 --PRRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQA-MKRIRDNL-------PPKLKNLH 239 (285)
T ss_pred --cccccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCHHHH-HHHHHhcC-------CCCCcccc
Confidence 111234588999999999988899999999999999999999999975443221 11111110 00011122
Q ss_pred HHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 002158 866 ECVERFVTLALRCCHDKPEHRPSMSDVVRE 895 (958)
Q Consensus 866 ~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 895 (958)
..+..+.+++.+||+.+|++||++.+++++
T Consensus 240 ~~~~~l~~li~~~l~~~p~~Rpt~~~il~~ 269 (285)
T cd06648 240 KVSPRLRSFLDRMLVRDPAQRATAAELLNH 269 (285)
T ss_pred cCCHHHHHHHHHHcccChhhCcCHHHHccC
Confidence 356789999999999999999999999963
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-34 Score=310.26 Aligned_cols=256 Identities=23% Similarity=0.394 Sum_probs=204.2
Q ss_pred CCCCCceeeeeCCeEEEEEEEC-CCcEEEEEEeccCC------hhcHHHHHHHHHHHHccCCCCcceEEEEEEeCCeEEE
Q 002158 626 YFSSSTQVGQGGYGKVYKGILS-DNTTVAIKRAEEGS------LQGQNEFLTEIKLLSRLHHRNLVSLLGYCDEEGEQML 698 (958)
Q Consensus 626 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~------~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~l 698 (958)
+|+..+.||+|+||.||+|... +++.||+|++.... ....+.+.+|++++++++|+||+++++++.+.+..++
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 80 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL 80 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence 4677889999999999999864 68999999886432 1124578899999999999999999999999999999
Q ss_pred EEEecCCCCHHHHhccCCCCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEecCCC-CeEEeeeeeecccc
Q 002158 699 VYEFVPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSNL-NAKVADFGLSRLAP 777 (958)
Q Consensus 699 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~~-~~kl~DFGla~~~~ 777 (958)
||||+++++|.+++.... .+++..+..++.|++.||+|||+.+ ++|+||||+||+++.++ .+||+|||.+....
T Consensus 81 v~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~ql~~al~~LH~~~---i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~ 155 (268)
T cd06630 81 FVEWMAGGSVSHLLSKYG--AFKEAVIINYTEQLLRGLSYLHENQ---IIHRDVKGANLLIDSTGQRLRIADFGAAARLA 155 (268)
T ss_pred EEeccCCCcHHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEEcccccccccc
Confidence 999999999999997543 4889999999999999999999999 99999999999998776 59999999987654
Q ss_pred cCCCCCCccceeeeeccCCCCccChhhhccCCCCCcchhhhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcCcchhhhc
Q 002158 778 VLDDEGTMPTHVSTIVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVLLELLTGMQPISHGKNIVREVNVARDSGMVFSIID 857 (958)
Q Consensus 778 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gv~l~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~i~ 857 (958)
...... ........|+..|+|||.+.+..++.++||||+|+++|||++|..||............... ...
T Consensus 156 ~~~~~~---~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~------~~~ 226 (268)
T cd06630 156 AKGTGA---GEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKI------ASA 226 (268)
T ss_pred cccccC---CccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcchHHHHHHH------hcc
Confidence 321111 11122345889999999998888999999999999999999999999643321111000000 000
Q ss_pred ccCCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 002158 858 NRMGSYPSECVERFVTLALRCCHDKPEHRPSMSDVVRE 895 (958)
Q Consensus 858 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 895 (958)
......+...+.++.+++.+|++.+|++||++.+++++
T Consensus 227 ~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~~ 264 (268)
T cd06630 227 TTAPSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLKH 264 (268)
T ss_pred CCCCCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhcC
Confidence 11234456677889999999999999999999999863
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=300.23 Aligned_cols=269 Identities=27% Similarity=0.355 Sum_probs=220.6
Q ss_pred ChHHHHHHHcCCCCCceeeeeCCeEEEEEEECC------CcEEEEEEeccC-ChhcHHHHHHHHHHHHccCCCCcceEEE
Q 002158 616 KFKELAMATAYFSSSTQVGQGGYGKVYKGILSD------NTTVAIKRAEEG-SLQGQNEFLTEIKLLSRLHHRNLVSLLG 688 (958)
Q Consensus 616 ~~~el~~~~~~~~~~~~lg~G~~g~Vy~~~~~~------~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~~ 688 (958)
+.+|+.....+++....+.+|.||+||+|.|.+ .+.|.||.++.. +.-+...|+.|.-.+..+.|||+.++.+
T Consensus 275 r~~~l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~ 354 (563)
T KOG1024|consen 275 RLQELTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLG 354 (563)
T ss_pred hHHhhhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeE
Confidence 346778888889999999999999999998753 456778888765 3444567999999999999999999999
Q ss_pred EEEe-CCeEEEEEEecCCCCHHHHhccC------CCCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEecC
Q 002158 689 YCDE-EGEQMLVYEFVPNGTLRDWLSGR------TKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDS 761 (958)
Q Consensus 689 ~~~~-~~~~~lV~E~~~~gsL~~~l~~~------~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~ 761 (958)
++.+ .+..+.+|.++.-|+|..++... ..+.++..+...++.|++.|++|||+++ |||.||.++|++||+
T Consensus 355 V~ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~---ViHkDiAaRNCvIdd 431 (563)
T KOG1024|consen 355 VSIEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHG---VIHKDIAARNCVIDD 431 (563)
T ss_pred EEeeccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcC---cccchhhhhcceehh
Confidence 9865 45778999999999999999732 2345888899999999999999999999 999999999999999
Q ss_pred CCCeEEeeeeeecccccCCCCCCccceeeeeccCCCCccChhhhccCCCCCcchhhhHHHHHHHHHh-CCCCCCCCchhH
Q 002158 762 NLNAKVADFGLSRLAPVLDDEGTMPTHVSTIVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVLLELLT-GMQPISHGKNIV 840 (958)
Q Consensus 762 ~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gv~l~ellt-G~~P~~~~~~~~ 840 (958)
..++||+|=.++|.+-..+- ............||+||.+....|+.++|||||||+||||+| |+.|+.+-+..+
T Consensus 432 ~LqVkltDsaLSRDLFP~DY-----hcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPfE 506 (563)
T KOG1024|consen 432 QLQVKLTDSALSRDLFPGDY-----HCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFE 506 (563)
T ss_pred heeEEeccchhccccCcccc-----cccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHHH
Confidence 99999999999987633221 111222335678999999999999999999999999999999 999997654432
Q ss_pred HHHHHHhhcCcchhhhcccCCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHhh
Q 002158 841 REVNVARDSGMVFSIIDNRMGSYPSECVERFVTLALRCCHDKPEHRPSMSDVVRELENILKM 902 (958)
Q Consensus 841 ~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~ 902 (958)
.. .. +.|+.+-..|-+||+++..+|..||..+|++||+++|++.-|.+.-.+
T Consensus 507 m~--~y--------lkdGyRlaQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLseF~~q 558 (563)
T KOG1024|consen 507 ME--HY--------LKDGYRLAQPFNCPDELFTVMACCWALLPEERPSFSQLVICLSEFHTQ 558 (563)
T ss_pred HH--HH--------HhccceecCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHHHH
Confidence 22 11 223334456889999999999999999999999999999998876543
|
|
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-34 Score=311.52 Aligned_cols=255 Identities=28% Similarity=0.431 Sum_probs=199.9
Q ss_pred CCCCceeeeeCCeEEEEEEEC----CCcEEEEEEeccC--ChhcHHHHHHHHHHHHccCCCCcceEEEEEEeCC------
Q 002158 627 FSSSTQVGQGGYGKVYKGILS----DNTTVAIKRAEEG--SLQGQNEFLTEIKLLSRLHHRNLVSLLGYCDEEG------ 694 (958)
Q Consensus 627 ~~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~------ 694 (958)
|...+.||+|+||+||+|.+. .++.||||++... .....+++.+|++++++++||||+++++++....
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 80 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP 80 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence 456778999999999999864 3688999998754 2334567899999999999999999999886532
Q ss_pred eEEEEEEecCCCCHHHHhccCC----CCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEecCCCCeEEeee
Q 002158 695 EQMLVYEFVPNGTLRDWLSGRT----KENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSNLNAKVADF 770 (958)
Q Consensus 695 ~~~lV~E~~~~gsL~~~l~~~~----~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~~~~kl~DF 770 (958)
..++++||+++|+|.+++.... ...+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+||
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~nili~~~~~~kl~df 157 (273)
T cd05074 81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKN---FIHRDLAARNCMLNENMTVCVADF 157 (273)
T ss_pred ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccchhhEEEcCCCCEEECcc
Confidence 3478999999999998875321 224788999999999999999999998 999999999999999999999999
Q ss_pred eeecccccCCCCCCccceeeeeccCCCCccChhhhccCCCCCcchhhhHHHHHHHHHh-CCCCCCCCchhHHHHHHHhhc
Q 002158 771 GLSRLAPVLDDEGTMPTHVSTIVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVLLELLT-GMQPISHGKNIVREVNVARDS 849 (958)
Q Consensus 771 Gla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gv~l~ellt-G~~P~~~~~~~~~~~~~~~~~ 849 (958)
|+++....... ........++..|++||.+....++.++||||||+++|||++ |+.||...... .........
T Consensus 158 g~~~~~~~~~~-----~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~~-~~~~~~~~~ 231 (273)
T cd05074 158 GLSKKIYSGDY-----YRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENS-EIYNYLIKG 231 (273)
T ss_pred cccccccCCcc-----eecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCHH-HHHHHHHcC
Confidence 99885432111 011112345678999999998889999999999999999999 88888644321 111111111
Q ss_pred CcchhhhcccCCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHh
Q 002158 850 GMVFSIIDNRMGSYPSECVERFVTLALRCCHDKPEHRPSMSDVVRELENI 899 (958)
Q Consensus 850 ~~~~~~i~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 899 (958)
.....+...+..+.+++.+||+.+|++||++.++++.|+++
T Consensus 232 ---------~~~~~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~ 272 (273)
T cd05074 232 ---------NRLKQPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI 272 (273)
T ss_pred ---------CcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 11112334567899999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-34 Score=311.23 Aligned_cols=248 Identities=26% Similarity=0.400 Sum_probs=204.5
Q ss_pred CCCCCceeeeeCCeEEEEEEEC-CCcEEEEEEeccCC-hhcHHHHHHHHHHHHccCCCCcceEEEEEEeCCeEEEEEEec
Q 002158 626 YFSSSTQVGQGGYGKVYKGILS-DNTTVAIKRAEEGS-LQGQNEFLTEIKLLSRLHHRNLVSLLGYCDEEGEQMLVYEFV 703 (958)
Q Consensus 626 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E~~ 703 (958)
+|+..+.||+|+||.||+|.++ +++.||+|.+.... ....+++.+|++++++++||||+++++++..++..++||||+
T Consensus 2 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~ 81 (265)
T cd06605 2 DLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEYM 81 (265)
T ss_pred cchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEec
Confidence 4666788999999999999986 68999999987653 344567899999999999999999999999999999999999
Q ss_pred CCCCHHHHhccCCCCCchHHHHHHHHHHHHHHHHHhhh-cCCCCeeccCCCccceEecCCCCeEEeeeeeecccccCCCC
Q 002158 704 PNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHT-EAHPPVFHRDIKASNILLDSNLNAKVADFGLSRLAPVLDDE 782 (958)
Q Consensus 704 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~-~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~ 782 (958)
++++|.+++.... ..++...+.+++.|++.||+|||+ .+ ++||||||+||++++++.++|+|||.+.......
T Consensus 82 ~~~~L~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lH~~~~---i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~-- 155 (265)
T cd06605 82 DGGSLDKILKEVQ-GRIPERILGKIAVAVLKGLTYLHEKHK---IIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSL-- 155 (265)
T ss_pred CCCcHHHHHHHcc-CCCCHHHHHHHHHHHHHHHHHHcCCCC---eecCCCCHHHEEECCCCCEEEeecccchhhHHHH--
Confidence 9999999997543 458899999999999999999999 88 9999999999999999999999999987542111
Q ss_pred CCccceeeeeccCCCCccChhhhccCCCCCcchhhhHHHHHHHHHhCCCCCCCCc----hhHHHHHHHhhcCcchhhhcc
Q 002158 783 GTMPTHVSTIVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVLLELLTGMQPISHGK----NIVREVNVARDSGMVFSIIDN 858 (958)
Q Consensus 783 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gv~l~elltG~~P~~~~~----~~~~~~~~~~~~~~~~~~i~~ 858 (958)
.....|+..|+|||++.+..++.++||||||+++|+|++|+.||.... ......... ...
T Consensus 156 -------~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~---------~~~ 219 (265)
T cd06605 156 -------AKTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYI---------VNE 219 (265)
T ss_pred -------hhcccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccccccccHHHHHHHH---------hcC
Confidence 111568889999999999999999999999999999999999996542 111111111 111
Q ss_pred cCCCCChH-HHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 002158 859 RMGSYPSE-CVERFVTLALRCCHDKPEHRPSMSDVVRE 895 (958)
Q Consensus 859 ~~~~~~~~-~~~~l~~li~~cl~~dP~~RPs~~evl~~ 895 (958)
.....+.. .+..+.+++.+||..+|++||++.+++.+
T Consensus 220 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 257 (265)
T cd06605 220 PPPRLPSGKFSPDFQDFVNLCLIKDPRERPSYKELLEH 257 (265)
T ss_pred CCCCCChhhcCHHHHHHHHHHcCCCchhCcCHHHHhhC
Confidence 11222333 67789999999999999999999999864
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-34 Score=309.56 Aligned_cols=249 Identities=29% Similarity=0.426 Sum_probs=208.3
Q ss_pred CCCCCceeeeeCCeEEEEEEEC-CCcEEEEEEeccCCh-hcHHHHHHHHHHHHccCCCCcceEEEEEEeCCeEEEEEEec
Q 002158 626 YFSSSTQVGQGGYGKVYKGILS-DNTTVAIKRAEEGSL-QGQNEFLTEIKLLSRLHHRNLVSLLGYCDEEGEQMLVYEFV 703 (958)
Q Consensus 626 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E~~ 703 (958)
+|+..+.||+|++|.||+|+.. +++.||||++..... .....+.+|++.+++++|+|++++++++...+..++||||+
T Consensus 2 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~ 81 (264)
T cd06623 2 DLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEYM 81 (264)
T ss_pred cceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEec
Confidence 5778899999999999999987 599999999876543 34567999999999999999999999999999999999999
Q ss_pred CCCCHHHHhccCCCCCchHHHHHHHHHHHHHHHHHhhh-cCCCCeeccCCCccceEecCCCCeEEeeeeeecccccCCCC
Q 002158 704 PNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHT-EAHPPVFHRDIKASNILLDSNLNAKVADFGLSRLAPVLDDE 782 (958)
Q Consensus 704 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~-~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~ 782 (958)
++++|.+++... ..+++..+..++.|+++|++|||+ .+ ++||||+|+||+++.++.++|+|||.+.........
T Consensus 82 ~~~~L~~~l~~~--~~l~~~~~~~~~~~l~~~l~~lh~~~~---~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~~~ 156 (264)
T cd06623 82 DGGSLADLLKKV--GKIPEPVLAYIARQILKGLDYLHTKRH---IIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQ 156 (264)
T ss_pred CCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHhccCC---CccCCCCHHHEEECCCCCEEEccCccceecccCCCc
Confidence 999999999754 348999999999999999999999 88 999999999999999999999999998765322211
Q ss_pred CCccceeeeeccCCCCccChhhhccCCCCCcchhhhHHHHHHHHHhCCCCCCCCc--hhHHHHHHHhhcCcchhhhcccC
Q 002158 783 GTMPTHVSTIVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVLLELLTGMQPISHGK--NIVREVNVARDSGMVFSIIDNRM 860 (958)
Q Consensus 783 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gv~l~elltG~~P~~~~~--~~~~~~~~~~~~~~~~~~i~~~~ 860 (958)
.....++..|+|||.+.+..++.++||||||+++|||++|+.||.... .......... ....
T Consensus 157 -------~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~---------~~~~ 220 (264)
T cd06623 157 -------CNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAIC---------DGPP 220 (264)
T ss_pred -------ccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHHHh---------cCCC
Confidence 123457889999999999989999999999999999999999997654 2222221111 1122
Q ss_pred CCCChH-HHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 002158 861 GSYPSE-CVERFVTLALRCCHDKPEHRPSMSDVVRE 895 (958)
Q Consensus 861 ~~~~~~-~~~~l~~li~~cl~~dP~~RPs~~evl~~ 895 (958)
...+.. ++..+.+++.+||+.+|++||++.+++++
T Consensus 221 ~~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~~ 256 (264)
T cd06623 221 PSLPAEEFSPEFRDFISACLQKDPKKRPSAAELLQH 256 (264)
T ss_pred CCCCcccCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 233344 67889999999999999999999999974
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-34 Score=316.20 Aligned_cols=250 Identities=24% Similarity=0.380 Sum_probs=204.6
Q ss_pred cCCCCCceeeeeCCeEEEEEEEC-CCcEEEEEEeccCChhcHHHHHHHHHHHHccCCCCcceEEEEEEeCCeEEEEEEec
Q 002158 625 AYFSSSTQVGQGGYGKVYKGILS-DNTTVAIKRAEEGSLQGQNEFLTEIKLLSRLHHRNLVSLLGYCDEEGEQMLVYEFV 703 (958)
Q Consensus 625 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E~~ 703 (958)
.+|...+.||+|+||.||+|... +++.||+|.+........+.+.+|+.++++++|||++++++++...+..++||||+
T Consensus 19 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~ 98 (293)
T cd06647 19 KKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEYL 98 (293)
T ss_pred hhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEecC
Confidence 46778899999999999999865 68899999987655455567899999999999999999999999999999999999
Q ss_pred CCCCHHHHhccCCCCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEecCCCCeEEeeeeeecccccCCCCC
Q 002158 704 PNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSRLAPVLDDEG 783 (958)
Q Consensus 704 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 783 (958)
++++|.+++.+. .+++.++..++.|++.||.|||+.+ ++||||||+||+++.++.++|+|||++........
T Consensus 99 ~~~~L~~~~~~~---~l~~~~~~~i~~~l~~al~~LH~~g---i~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~-- 170 (293)
T cd06647 99 AGGSLTDVVTET---CMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS-- 170 (293)
T ss_pred CCCcHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHHhCC---EeeccCCHHHEEEcCCCCEEEccCcceeccccccc--
Confidence 999999999653 3788999999999999999999999 99999999999999999999999998875432111
Q ss_pred CccceeeeeccCCCCccChhhhccCCCCCcchhhhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcCcchhhhcccCCCC
Q 002158 784 TMPTHVSTIVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVLLELLTGMQPISHGKNIVREVNVARDSGMVFSIIDNRMGSY 863 (958)
Q Consensus 784 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gv~l~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~ 863 (958)
......|++.|+|||.+....++.++||||||+++||+++|+.||........... ....+ ......
T Consensus 171 -----~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~-~~~~~-------~~~~~~ 237 (293)
T cd06647 171 -----KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYL-IATNG-------TPELQN 237 (293)
T ss_pred -----ccccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhheee-hhcCC-------CCCCCC
Confidence 11234588899999999888899999999999999999999999975433211110 00000 000112
Q ss_pred ChHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 002158 864 PSECVERFVTLALRCCHDKPEHRPSMSDVVRE 895 (958)
Q Consensus 864 ~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 895 (958)
+...+..+.+++.+||+.+|++||++.+++.+
T Consensus 238 ~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h 269 (293)
T cd06647 238 PEKLSAIFRDFLNRCLEMDVEKRGSAKELLQH 269 (293)
T ss_pred ccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 33456778999999999999999999999975
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-34 Score=314.49 Aligned_cols=258 Identities=24% Similarity=0.353 Sum_probs=201.9
Q ss_pred CCCCCceeeeeCCeEEEEEEEC-CCcEEEEEEeccCC--hhcHHHHHHHHHHHHccCCCCcceEEEEEEeCCeEEEEEEe
Q 002158 626 YFSSSTQVGQGGYGKVYKGILS-DNTTVAIKRAEEGS--LQGQNEFLTEIKLLSRLHHRNLVSLLGYCDEEGEQMLVYEF 702 (958)
Q Consensus 626 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E~ 702 (958)
+|+..+.||+|+||.||+|.++ +++.||||+++... ....+.+.+|++++++++|+||+++++++..++..++||||
T Consensus 2 ~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~ 81 (288)
T cd07833 2 KYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFEY 81 (288)
T ss_pred ceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEec
Confidence 5778889999999999999986 58899999886532 23346789999999999999999999999999999999999
Q ss_pred cCCCCHHHHhccCCCCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEecCCCCeEEeeeeeecccccCCCC
Q 002158 703 VPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSRLAPVLDDE 782 (958)
Q Consensus 703 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~ 782 (958)
++++.+..+.... ..+++.++..++.|++.||+|||+.+ ++||||+|+||++++++.+||+|||++........
T Consensus 82 ~~~~~l~~~~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~~- 155 (288)
T cd07833 82 VERTLLELLEASP--GGLPPDAVRSYIWQLLQAIAYCHSHN---IIHRDIKPENILVSESGVLKLCDFGFARALRARPA- 155 (288)
T ss_pred CCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEEeeecccccCCCcc-
Confidence 9987777666433 34899999999999999999999999 99999999999999999999999999876533221
Q ss_pred CCccceeeeeccCCCCccChhhhccC-CCCCcchhhhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcCcchh----hh-
Q 002158 783 GTMPTHVSTIVKGTPGYLDPEYFLTH-KLTDKSDVYSLGVVLLELLTGMQPISHGKNIVREVNVARDSGMVFS----II- 856 (958)
Q Consensus 783 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DV~S~Gv~l~elltG~~P~~~~~~~~~~~~~~~~~~~~~~----~i- 856 (958)
.......++..|+|||++.+. .++.++||||||+++|||++|+.||................+.... ..
T Consensus 156 -----~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (288)
T cd07833 156 -----SPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFS 230 (288)
T ss_pred -----ccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhcc
Confidence 112234578899999999888 7889999999999999999999999754332221111110000000 00
Q ss_pred -cc-----cC----------CCCChHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002158 857 -DN-----RM----------GSYPSECVERFVTLALRCCHDKPEHRPSMSDVVR 894 (958)
Q Consensus 857 -~~-----~~----------~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 894 (958)
+. .. ..++..++.++.+++.+||..+|++||+++++++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 284 (288)
T cd07833 231 SNPRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQ 284 (288)
T ss_pred cCccccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhc
Confidence 00 00 0122334788999999999999999999999986
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-34 Score=316.23 Aligned_cols=245 Identities=28% Similarity=0.453 Sum_probs=199.2
Q ss_pred cCCCCCceeeeeCCeEEEEEEEC-CCcEEEEEEeccCC---hhcHHHHHHHHHHHHccCCCCcceEEEEEEeCCeEEEEE
Q 002158 625 AYFSSSTQVGQGGYGKVYKGILS-DNTTVAIKRAEEGS---LQGQNEFLTEIKLLSRLHHRNLVSLLGYCDEEGEQMLVY 700 (958)
Q Consensus 625 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~ 700 (958)
..|...+.||+|+||+||+|... +++.||+|.+.... ....+++.+|+++++.++|||++++++++...+..++||
T Consensus 15 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv~ 94 (307)
T cd06607 15 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVM 94 (307)
T ss_pred hhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEEH
Confidence 45777889999999999999976 68999999886432 233457889999999999999999999999999999999
Q ss_pred EecCCCCHHHHhccCCCCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEecCCCCeEEeeeeeecccccCC
Q 002158 701 EFVPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSRLAPVLD 780 (958)
Q Consensus 701 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~ 780 (958)
||++ |++.+++.... ..+++..+..++.|++.||.|||+.+ |+||||+|+||++++++.++|+|||++.....
T Consensus 95 e~~~-g~l~~~~~~~~-~~l~~~~~~~~~~ql~~~L~~LH~~~---i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~-- 167 (307)
T cd06607 95 EYCL-GSASDILEVHK-KPLQEVEIAAICHGALQGLAYLHSHE---RIHRDIKAGNILLTEPGTVKLADFGSASLVSP-- 167 (307)
T ss_pred HhhC-CCHHHHHHHcc-cCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcccEEECCCCCEEEeecCcceecCC--
Confidence 9996 68878775433 34899999999999999999999999 99999999999999999999999999875421
Q ss_pred CCCCccceeeeeccCCCCccChhhhc---cCCCCCcchhhhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcCcchhhhc
Q 002158 781 DEGTMPTHVSTIVKGTPGYLDPEYFL---THKLTDKSDVYSLGVVLLELLTGMQPISHGKNIVREVNVARDSGMVFSIID 857 (958)
Q Consensus 781 ~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DV~S~Gv~l~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~i~ 857 (958)
.....|+..|+|||++. ...++.++||||||+++|||++|+.||..............
T Consensus 168 ---------~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~~~~~~~---------- 228 (307)
T cd06607 168 ---------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQ---------- 228 (307)
T ss_pred ---------CCCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHHHHHHhc----------
Confidence 11245788999999884 35678899999999999999999999975443222111111
Q ss_pred ccCCC-CChHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 002158 858 NRMGS-YPSECVERFVTLALRCCHDKPEHRPSMSDVVRE 895 (958)
Q Consensus 858 ~~~~~-~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 895 (958)
..... .+..++..+.+++.+||+.+|++||++.+++.+
T Consensus 229 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 267 (307)
T cd06607 229 NDSPTLSSNDWSDYFRNFVDSCLQKIPQDRPSSEELLKH 267 (307)
T ss_pred CCCCCCCchhhCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 11111 133467789999999999999999999999975
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-34 Score=307.55 Aligned_cols=250 Identities=22% Similarity=0.397 Sum_probs=203.8
Q ss_pred CCCCCceeeeeCCeEEEEEEEC-CCcEEEEEEeccC--ChhcHHHHHHHHHHHHccCCCCcceEEEEEEe--CCeEEEEE
Q 002158 626 YFSSSTQVGQGGYGKVYKGILS-DNTTVAIKRAEEG--SLQGQNEFLTEIKLLSRLHHRNLVSLLGYCDE--EGEQMLVY 700 (958)
Q Consensus 626 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~--~~~~~lV~ 700 (958)
+|+..+.||+|+||.||+|... +++.||+|.+... .....+++.+|++++++++|+||+++++++.. +...+++|
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM 80 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence 3677789999999999999975 6889999988653 33345678899999999999999999998754 45679999
Q ss_pred EecCCCCHHHHhccC--CCCCchHHHHHHHHHHHHHHHHHhh-----hcCCCCeeccCCCccceEecCCCCeEEeeeeee
Q 002158 701 EFVPNGTLRDWLSGR--TKENLNFAMRLRVALDSAKGILYLH-----TEAHPPVFHRDIKASNILLDSNLNAKVADFGLS 773 (958)
Q Consensus 701 E~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~~ia~aL~yLH-----~~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla 773 (958)
||+++++|.+++... ....+++..++.++.|++.||+||| +.+ ++|+||||+||+++.++.+||+|||++
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~---i~h~dl~p~nili~~~~~~kl~d~g~~ 157 (265)
T cd08217 81 EYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNT---VLHRDLKPANIFLDANNNVKLGDFGLA 157 (265)
T ss_pred hhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCc---ceecCCCHHHEEEecCCCEEEeccccc
Confidence 999999999999653 2345899999999999999999999 666 999999999999999999999999998
Q ss_pred cccccCCCCCCccceeeeeccCCCCccChhhhccCCCCCcchhhhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcCcch
Q 002158 774 RLAPVLDDEGTMPTHVSTIVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVLLELLTGMQPISHGKNIVREVNVARDSGMVF 853 (958)
Q Consensus 774 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gv~l~elltG~~P~~~~~~~~~~~~~~~~~~~~~ 853 (958)
........ ......|+..|+|||++.+..++.++||||||+++|+|++|+.||..... .......
T Consensus 158 ~~~~~~~~-------~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~-~~~~~~~------- 222 (265)
T cd08217 158 KILGHDSS-------FAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQ-LQLASKI------- 222 (265)
T ss_pred ccccCCcc-------cccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCH-HHHHHHH-------
Confidence 86532211 11234589999999999988899999999999999999999999975432 1111111
Q ss_pred hhhcccCCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 002158 854 SIIDNRMGSYPSECVERFVTLALRCCHDKPEHRPSMSDVVRE 895 (958)
Q Consensus 854 ~~i~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 895 (958)
........+...+..+.+++.+|++.+|++||++++|+++
T Consensus 223 --~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~ 262 (265)
T cd08217 223 --KEGKFRRIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQL 262 (265)
T ss_pred --hcCCCCCCccccCHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence 1112234455677889999999999999999999999874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-34 Score=311.21 Aligned_cols=247 Identities=25% Similarity=0.420 Sum_probs=203.6
Q ss_pred CCCCCceeeeeCCeEEEEEEEC-CCcEEEEEEeccCC-hhcHHHHHHHHHHHHccCCCCcceEEEEEEeCCeEEEEEEec
Q 002158 626 YFSSSTQVGQGGYGKVYKGILS-DNTTVAIKRAEEGS-LQGQNEFLTEIKLLSRLHHRNLVSLLGYCDEEGEQMLVYEFV 703 (958)
Q Consensus 626 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E~~ 703 (958)
-|+..+.||+|+||.||+|.+. +++.||+|.+.... ....+.+.+|++++++++||||+++++++..++..++||||+
T Consensus 5 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 84 (277)
T cd06641 5 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYL 84 (277)
T ss_pred hhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEeC
Confidence 4667789999999999999875 68899999886543 333467889999999999999999999999999999999999
Q ss_pred CCCCHHHHhccCCCCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEecCCCCeEEeeeeeecccccCCCCC
Q 002158 704 PNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSRLAPVLDDEG 783 (958)
Q Consensus 704 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 783 (958)
++++|.+++... .+++..+..++.|++.|+.|||+.+ ++|+||||+||+++.++.++|+|||++.......
T Consensus 85 ~~~~l~~~i~~~---~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~--- 155 (277)
T cd06641 85 GGGSALDLLEPG---PLDETQIATILREILKGLDYLHSEK---KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQ--- 155 (277)
T ss_pred CCCcHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHccCC---eecCCCCHHhEEECCCCCEEEeecccceecccch---
Confidence 999999999643 3889999999999999999999999 9999999999999999999999999987543211
Q ss_pred CccceeeeeccCCCCccChhhhccCCCCCcchhhhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcCcchhhhcccCCCC
Q 002158 784 TMPTHVSTIVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVLLELLTGMQPISHGKNIVREVNVARDSGMVFSIIDNRMGSY 863 (958)
Q Consensus 784 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gv~l~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~ 863 (958)
.......|+..|+|||++.+..++.++|||||||++|||++|..||...... ...... ........
T Consensus 156 ----~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~-~~~~~~---------~~~~~~~~ 221 (277)
T cd06641 156 ----IKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPM-KVLFLI---------PKNNPPTL 221 (277)
T ss_pred ----hhhccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchH-HHHHHH---------hcCCCCCC
Confidence 1112345788999999998888899999999999999999999999643321 111111 01112233
Q ss_pred ChHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 002158 864 PSECVERFVTLALRCCHDKPEHRPSMSDVVRE 895 (958)
Q Consensus 864 ~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 895 (958)
+..++..+.+++.+||+.+|.+||++.+++++
T Consensus 222 ~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~ 253 (277)
T cd06641 222 EGNYSKPLKEFVEACLNKEPSFRPTAKELLKH 253 (277)
T ss_pred CcccCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 44567889999999999999999999999985
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=315.74 Aligned_cols=258 Identities=23% Similarity=0.346 Sum_probs=198.5
Q ss_pred CCCCCceeeeeCCeEEEEEEEC-CCcEEEEEEeccCCh--hcHHHHHHHHHHHHccCCCCcceEEEEEEeCCeEEEEEEe
Q 002158 626 YFSSSTQVGQGGYGKVYKGILS-DNTTVAIKRAEEGSL--QGQNEFLTEIKLLSRLHHRNLVSLLGYCDEEGEQMLVYEF 702 (958)
Q Consensus 626 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E~ 702 (958)
+|+..+.||+|+||.||+|++. +|+.||+|++..... .....+.+|++++++++|+||+++++++.+.+..++||||
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEY 80 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEec
Confidence 3677789999999999999986 689999999865322 2234678899999999999999999999999999999999
Q ss_pred cCCCCHHHHhccCCCCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEecCCCCeEEeeeeeecccccCCCC
Q 002158 703 VPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSRLAPVLDDE 782 (958)
Q Consensus 703 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~ 782 (958)
++ ++|.+++.... ..+++..+..++.|+++||+|||+.+ |+||||||+||+++.++.+||+|||+++......
T Consensus 81 ~~-~~l~~~~~~~~-~~~~~~~~~~~~~qi~~al~~LH~~~---i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~-- 153 (284)
T cd07839 81 CD-QDLKKYFDSCN-GDIDPEIVKSFMFQLLKGLAFCHSHN---VLHRDLKPQNLLINKNGELKLADFGLARAFGIPV-- 153 (284)
T ss_pred CC-CCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEEcCCCcEEECccchhhccCCCC--
Confidence 96 58888886533 34899999999999999999999999 9999999999999999999999999987542211
Q ss_pred CCccceeeeeccCCCCccChhhhccCC-CCCcchhhhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhc-Cc--------c
Q 002158 783 GTMPTHVSTIVKGTPGYLDPEYFLTHK-LTDKSDVYSLGVVLLELLTGMQPISHGKNIVREVNVARDS-GM--------V 852 (958)
Q Consensus 783 ~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DV~S~Gv~l~elltG~~P~~~~~~~~~~~~~~~~~-~~--------~ 852 (958)
.......++..|+|||++.+.. ++.++|||||||++|||+||..|+..+.+........... +. .
T Consensus 154 -----~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (284)
T cd07839 154 -----RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGV 228 (284)
T ss_pred -----CCcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChHHhHHh
Confidence 1112235788999999987754 6889999999999999999999875544433222211100 00 0
Q ss_pred hhhhcc-cC---------CCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 002158 853 FSIIDN-RM---------GSYPSECVERFVTLALRCCHDKPEHRPSMSDVVRE 895 (958)
Q Consensus 853 ~~~i~~-~~---------~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 895 (958)
....+. .. .......+..+.+++.+||+.||.+|||+++++++
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~h 281 (284)
T cd07839 229 SKLPDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQH 281 (284)
T ss_pred hhcccccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhcC
Confidence 000000 00 01112345788899999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=310.33 Aligned_cols=250 Identities=25% Similarity=0.409 Sum_probs=204.3
Q ss_pred CCCCCceeeeeCCeEEEEEEEC-CCcEEEEEEeccCC--hhcHHHHHHHHHHHHccCCCCcceEEEEEEeCCeEEEEEEe
Q 002158 626 YFSSSTQVGQGGYGKVYKGILS-DNTTVAIKRAEEGS--LQGQNEFLTEIKLLSRLHHRNLVSLLGYCDEEGEQMLVYEF 702 (958)
Q Consensus 626 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E~ 702 (958)
+|...+.||+|+||.||+|..+ +|..||+|.+.... ....+.+.+|++++++++|+||+++++.+...+..++||||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~ 80 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEY 80 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEec
Confidence 4677889999999999999986 58899999986532 23445788999999999999999999999999999999999
Q ss_pred cCCCCHHHHhccCCCCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEecCCC-CeEEeeeeeecccccCCC
Q 002158 703 VPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSNL-NAKVADFGLSRLAPVLDD 781 (958)
Q Consensus 703 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~~-~~kl~DFGla~~~~~~~~ 781 (958)
+++++|.+++.......+++..+..++.|+++||+|||+.+ ++|+||||+||++++++ .+||+|||.+.......
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~- 156 (257)
T cd08225 81 CDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRK---ILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSM- 156 (257)
T ss_pred CCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEEcCCCCeEEecccccchhccCCc-
Confidence 99999999997655556899999999999999999999999 99999999999999886 46999999987653211
Q ss_pred CCCccceeeeeccCCCCccChhhhccCCCCCcchhhhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcCcchhhhcccCC
Q 002158 782 EGTMPTHVSTIVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVLLELLTGMQPISHGKNIVREVNVARDSGMVFSIIDNRMG 861 (958)
Q Consensus 782 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gv~l~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~i~~~~~ 861 (958)
.......|++.|+|||+..+..++.++||||||+++|||++|..||..... ....... ......
T Consensus 157 ------~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~-~~~~~~~---------~~~~~~ 220 (257)
T cd08225 157 ------ELAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNL-HQLVLKI---------CQGYFA 220 (257)
T ss_pred ------ccccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccH-HHHHHHH---------hcccCC
Confidence 111224588999999999888899999999999999999999999964332 2222111 111122
Q ss_pred CCChHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 002158 862 SYPSECVERFVTLALRCCHDKPEHRPSMSDVVRE 895 (958)
Q Consensus 862 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 895 (958)
..+...+..+.+++.+||+.+|++||++.|++++
T Consensus 221 ~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~ 254 (257)
T cd08225 221 PISPNFSRDLRSLISQLFKVSPRDRPSITSILKR 254 (257)
T ss_pred CCCCCCCHHHHHHHHHHhccChhhCcCHHHHhhC
Confidence 2334456789999999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-34 Score=312.71 Aligned_cols=258 Identities=25% Similarity=0.357 Sum_probs=201.0
Q ss_pred CCCCceeeeeCCeEEEEEEEC-CCcEEEEEEeccCC--hhcHHHHHHHHHHHHccCCCCcceEEEEEEeCCeEEEEEEec
Q 002158 627 FSSSTQVGQGGYGKVYKGILS-DNTTVAIKRAEEGS--LQGQNEFLTEIKLLSRLHHRNLVSLLGYCDEEGEQMLVYEFV 703 (958)
Q Consensus 627 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E~~ 703 (958)
|+..+.||+|++|.||+|.+. +|+.||+|++.... ......+.+|++++++++|+|++++++++.+++..++||||+
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~ 80 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFL 80 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEecc
Confidence 566789999999999999976 79999999986543 222356889999999999999999999999999999999999
Q ss_pred CCCCHHHHhccCCCCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEecCCCCeEEeeeeeecccccCCCCC
Q 002158 704 PNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSRLAPVLDDEG 783 (958)
Q Consensus 704 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 783 (958)
+++|.+++.......+++..+..++.|+++||+|||+.+ ++||||+|+||+++.++.++|+|||+++.......
T Consensus 81 -~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~---~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~-- 154 (283)
T cd07835 81 -DLDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHR---VLHRDLKPQNLLIDREGALKLADFGLARAFGVPVR-- 154 (283)
T ss_pred -CcCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCHHHEEEcCCCcEEEeecccccccCCCcc--
Confidence 479999997665456899999999999999999999998 99999999999999999999999999875422111
Q ss_pred CccceeeeeccCCCCccChhhhccC-CCCCcchhhhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcCcchhhh------
Q 002158 784 TMPTHVSTIVKGTPGYLDPEYFLTH-KLTDKSDVYSLGVVLLELLTGMQPISHGKNIVREVNVARDSGMVFSII------ 856 (958)
Q Consensus 784 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DV~S~Gv~l~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~i------ 856 (958)
......++..|+|||++.+. .++.++||||||+++|||++|+.||................+......
T Consensus 155 -----~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (283)
T cd07835 155 -----TYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTS 229 (283)
T ss_pred -----ccCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhhhhh
Confidence 11122468899999988664 568899999999999999999999976554333222111101000000
Q ss_pred ------------cccCCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 002158 857 ------------DNRMGSYPSECVERFVTLALRCCHDKPEHRPSMSDVVRE 895 (958)
Q Consensus 857 ------------~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 895 (958)
...........+..+.+++.+|++.+|++||+++|++++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~ 280 (283)
T cd07835 230 LPDYKPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQH 280 (283)
T ss_pred chhhhhhcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 000011122344678899999999999999999999863
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-34 Score=310.97 Aligned_cols=253 Identities=26% Similarity=0.424 Sum_probs=207.7
Q ss_pred HHcCCCCCceeeeeCCeEEEEEEEC-CCcEEEEEEeccCChhcHHHHHHHHHHHHccCCCCcceEEEEEEeCCeEEEEEE
Q 002158 623 ATAYFSSSTQVGQGGYGKVYKGILS-DNTTVAIKRAEEGSLQGQNEFLTEIKLLSRLHHRNLVSLLGYCDEEGEQMLVYE 701 (958)
Q Consensus 623 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E 701 (958)
.++.|+..+.||+|+||.||+|.++ +++.||+|++..... ..+.+.+|++.++.++|+|++++++++...+..++|||
T Consensus 17 ~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 95 (286)
T cd06614 17 PRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ-NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVME 95 (286)
T ss_pred ccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch-hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEEe
Confidence 4556777788999999999999987 688999999976544 45678899999999999999999999999999999999
Q ss_pred ecCCCCHHHHhccCCCCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEecCCCCeEEeeeeeecccccCCC
Q 002158 702 FVPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSRLAPVLDD 781 (958)
Q Consensus 702 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~ 781 (958)
|+++++|.+++.... ..+++..+..++.|++.||+|||+.+ ++|+||+|+||+++.++.++|+|||++........
T Consensus 96 ~~~~~~L~~~l~~~~-~~l~~~~~~~i~~~i~~~L~~lH~~g---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~ 171 (286)
T cd06614 96 YMDGGSLTDIITQNF-VRMNEPQIAYVCREVLQGLEYLHSQN---VIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKS 171 (286)
T ss_pred ccCCCcHHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCChhhEEEcCCCCEEECccchhhhhccchh
Confidence 999999999998654 35899999999999999999999998 99999999999999999999999999865432111
Q ss_pred CCCccceeeeeccCCCCccChhhhccCCCCCcchhhhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcCcchhhhcccCC
Q 002158 782 EGTMPTHVSTIVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVLLELLTGMQPISHGKNIVREVNVARDSGMVFSIIDNRMG 861 (958)
Q Consensus 782 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gv~l~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~i~~~~~ 861 (958)
......++..|+|||++.+..++.++||||||+++|||++|+.||............... .. . ..
T Consensus 172 -------~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~~~~~~~~-~~------~-~~ 236 (286)
T cd06614 172 -------KRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLITTK-GI------P-PL 236 (286)
T ss_pred -------hhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc-CC------C-CC
Confidence 112335788999999999888999999999999999999999999755433222111110 00 0 00
Q ss_pred CCChHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 002158 862 SYPSECVERFVTLALRCCHDKPEHRPSMSDVVRE 895 (958)
Q Consensus 862 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 895 (958)
..+..++..+.+++.+||+.+|.+||++.+++++
T Consensus 237 ~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~ 270 (286)
T cd06614 237 KNPEKWSPEFKDFLNKCLVKDPEKRPSAEELLQH 270 (286)
T ss_pred cchhhCCHHHHHHHHHHhccChhhCcCHHHHhhC
Confidence 1122366789999999999999999999999864
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-34 Score=311.90 Aligned_cols=258 Identities=22% Similarity=0.361 Sum_probs=197.2
Q ss_pred cCCCCCceeeeeCCeEEEEEEEC-CCcEEEEEEeccCChh-cHHHHHHHHHHHHccCCCCcceEEEEEEeCCeEEEEEEe
Q 002158 625 AYFSSSTQVGQGGYGKVYKGILS-DNTTVAIKRAEEGSLQ-GQNEFLTEIKLLSRLHHRNLVSLLGYCDEEGEQMLVYEF 702 (958)
Q Consensus 625 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E~ 702 (958)
++|+..+.||+|++|.||+|..+ +++.||||.+...... ....+.+|++++++++|+||+++++++..++..++||||
T Consensus 5 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 84 (291)
T cd07844 5 ETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFEY 84 (291)
T ss_pred cceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEec
Confidence 46778899999999999999986 6899999998654322 234577899999999999999999999999999999999
Q ss_pred cCCCCHHHHhccCCCCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEecCCCCeEEeeeeeecccccCCCC
Q 002158 703 VPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSRLAPVLDDE 782 (958)
Q Consensus 703 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~ 782 (958)
++ ++|.+++..... .+++..+..++.|+++||.|||+.+ |+||||||+||+++.++.+||+|||+++......
T Consensus 85 ~~-~~L~~~~~~~~~-~~~~~~~~~~~~ql~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~-- 157 (291)
T cd07844 85 LD-TDLKQYMDDCGG-GLSMHNVRLFLFQLLRGLAYCHQRR---VLHRDLKPQNLLISERGELKLADFGLARAKSVPS-- 157 (291)
T ss_pred CC-CCHHHHHHhCCC-CCCHHHHHHHHHHHHHHHHHHHhCC---eecccCCHHHEEEcCCCCEEECccccccccCCCC--
Confidence 97 599999875433 5889999999999999999999999 9999999999999999999999999987432111
Q ss_pred CCccceeeeeccCCCCccChhhhcc-CCCCCcchhhhHHHHHHHHHhCCCCCCCCchhHHHHHHHhh-cCc----ch-hh
Q 002158 783 GTMPTHVSTIVKGTPGYLDPEYFLT-HKLTDKSDVYSLGVVLLELLTGMQPISHGKNIVREVNVARD-SGM----VF-SI 855 (958)
Q Consensus 783 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DV~S~Gv~l~elltG~~P~~~~~~~~~~~~~~~~-~~~----~~-~~ 855 (958)
.......++..|+|||++.+ ..++.++||||+|+++|||++|+.||.........+..... .+. .. ..
T Consensus 158 -----~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (291)
T cd07844 158 -----KTYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGV 232 (291)
T ss_pred -----ccccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChhhhhhh
Confidence 11122346788999999876 45788999999999999999999999654422222111100 000 00 00
Q ss_pred h------cccCC--------CCChHH--HHHHHHHHHHccccCCCCCCCHHHHHH
Q 002158 856 I------DNRMG--------SYPSEC--VERFVTLALRCCHDKPEHRPSMSDVVR 894 (958)
Q Consensus 856 i------~~~~~--------~~~~~~--~~~l~~li~~cl~~dP~~RPs~~evl~ 894 (958)
. ..... ...... ...+.+++.+|++.+|++||++.|+++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~ 287 (291)
T cd07844 233 SSNPEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMK 287 (291)
T ss_pred hhccccccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhc
Confidence 0 00000 000011 267789999999999999999999886
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-34 Score=315.63 Aligned_cols=258 Identities=22% Similarity=0.266 Sum_probs=196.2
Q ss_pred eeeeeCCeEEEEEEECCCcEEEEEEeccC--ChhcHHHHHHHHHHHHccCCCCcceEEEEEEeCCeEEEEEEecCCCCHH
Q 002158 632 QVGQGGYGKVYKGILSDNTTVAIKRAEEG--SLQGQNEFLTEIKLLSRLHHRNLVSLLGYCDEEGEQMLVYEFVPNGTLR 709 (958)
Q Consensus 632 ~lg~G~~g~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E~~~~gsL~ 709 (958)
.+|.|+++.||++.. +++.||||++... .....+.+.+|++++++++|+||+++++++...+..+++|||+++|+|.
T Consensus 9 ~~~~~~~v~~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~l~ 87 (314)
T cd08216 9 CFEDLMIVHLAKHKP-TNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGSCE 87 (314)
T ss_pred hhcCCceEEEEEecC-CCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCCCHH
Confidence 344555555555544 6899999998754 3445568999999999999999999999999999999999999999999
Q ss_pred HHhccCCCCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEecCCCCeEEeeeeeecccccCCCCCCcccee
Q 002158 710 DWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSRLAPVLDDEGTMPTHV 789 (958)
Q Consensus 710 ~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~ 789 (958)
+++.......+++..+..++.|+++||+|||+++ |+||||||+||+++.++.+||+|||.+................
T Consensus 88 ~~l~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~~---ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~ 164 (314)
T cd08216 88 DLLKTHFPEGLPELAIAFILKDVLNALDYIHSKG---FIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDF 164 (314)
T ss_pred HHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCcceEEEecCCceEEecCccceeeccccccccccccc
Confidence 9998655455889999999999999999999999 9999999999999999999999999987553322211111122
Q ss_pred eeeccCCCCccChhhhccC--CCCCcchhhhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcCcchhhhc----------
Q 002158 790 STIVKGTPGYLDPEYFLTH--KLTDKSDVYSLGVVLLELLTGMQPISHGKNIVREVNVARDSGMVFSIID---------- 857 (958)
Q Consensus 790 ~~~~~gt~~y~aPE~~~~~--~~~~~~DV~S~Gv~l~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~i~---------- 857 (958)
.....++..|+|||++... .++.++|||||||++|||++|+.||................ ....++
T Consensus 165 ~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~ 242 (314)
T cd08216 165 PKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEKVRGT--VPCLLDKSTYPLYEDS 242 (314)
T ss_pred cccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcc--CccccccCchhhhcCC
Confidence 2344578899999998763 57889999999999999999999997654332222111100 000000
Q ss_pred ---------------ccCCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 002158 858 ---------------NRMGSYPSECVERFVTLALRCCHDKPEHRPSMSDVVRE 895 (958)
Q Consensus 858 ---------------~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 895 (958)
............++.+++.+||+.||++||++++++++
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~ 295 (314)
T cd08216 243 MSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNH 295 (314)
T ss_pred cCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcC
Confidence 00011233456788999999999999999999999975
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-34 Score=312.93 Aligned_cols=260 Identities=22% Similarity=0.279 Sum_probs=198.1
Q ss_pred cCCCCCceeeeeCCeEEEEEEEC-CCcEEEEEEeccCCh--hcHHHHHHHHHHHHccC-CCCcceEEEEEEeCCe-----
Q 002158 625 AYFSSSTQVGQGGYGKVYKGILS-DNTTVAIKRAEEGSL--QGQNEFLTEIKLLSRLH-HRNLVSLLGYCDEEGE----- 695 (958)
Q Consensus 625 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~~~----- 695 (958)
++|+..+.||+|+||.||+|.+. +++.||||++..... .....+.+|+.++++++ |+||+++++++...+.
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~ 80 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS 80 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence 36788899999999999999976 689999998765432 22356889999999995 6999999999877665
Q ss_pred EEEEEEecCCCCHHHHhccCC---CCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEecC-CCCeEEeeee
Q 002158 696 QMLVYEFVPNGTLRDWLSGRT---KENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDS-NLNAKVADFG 771 (958)
Q Consensus 696 ~~lV~E~~~~gsL~~~l~~~~---~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~-~~~~kl~DFG 771 (958)
.++||||+++ +|.+++.... ...+++..+..++.|+++||+|||+.+ |+||||||+||+++. ++.+||+|||
T Consensus 81 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~---i~H~dl~~~nil~~~~~~~~kl~dfg 156 (295)
T cd07837 81 LYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHG---VMHRDLKPQNLLVDKQKGLLKIADLG 156 (295)
T ss_pred EEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChHHEEEecCCCeEEEeecc
Confidence 8999999975 8988886532 235899999999999999999999999 999999999999998 8899999999
Q ss_pred eecccccCCCCCCccceeeeeccCCCCccChhhhcc-CCCCCcchhhhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcC
Q 002158 772 LSRLAPVLDDEGTMPTHVSTIVKGTPGYLDPEYFLT-HKLTDKSDVYSLGVVLLELLTGMQPISHGKNIVREVNVARDSG 850 (958)
Q Consensus 772 la~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DV~S~Gv~l~elltG~~P~~~~~~~~~~~~~~~~~~ 850 (958)
+++.+.... .......+++.|+|||++.+ ..++.++||||||+++|||++|..||................+
T Consensus 157 ~~~~~~~~~-------~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~ 229 (295)
T cd07837 157 LGRAFSIPV-------KSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLG 229 (295)
T ss_pred cceecCCCc-------cccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHhC
Confidence 987542211 11112346788999999865 4578899999999999999999999976554433322111100
Q ss_pred cchhhhc------------c-----cCCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 002158 851 MVFSIID------------N-----RMGSYPSECVERFVTLALRCCHDKPEHRPSMSDVVRE 895 (958)
Q Consensus 851 ~~~~~i~------------~-----~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 895 (958)
....... . .........+..+.+++.+||+.||++||+++|++.+
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~~ 291 (295)
T cd07837 230 TPTEQVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTH 291 (295)
T ss_pred CCChhhCcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhcC
Confidence 0000000 0 0000112356778999999999999999999999864
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-34 Score=309.96 Aligned_cols=247 Identities=23% Similarity=0.395 Sum_probs=200.6
Q ss_pred CCCCCceeeeeCCeEEEEEEEC-CCcEEEEEEeccC-ChhcHHHHHHHHHHHHccC---CCCcceEEEEEEeCCeEEEEE
Q 002158 626 YFSSSTQVGQGGYGKVYKGILS-DNTTVAIKRAEEG-SLQGQNEFLTEIKLLSRLH---HRNLVSLLGYCDEEGEQMLVY 700 (958)
Q Consensus 626 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~---H~niv~l~~~~~~~~~~~lV~ 700 (958)
.|+..+.||+|+||.||+|.+. +++.||+|.+... ......++.+|++++++++ |||++++++++..+...++||
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~ 81 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIM 81 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEE
Confidence 4667788999999999999975 7899999998654 2334567889999999996 999999999999999999999
Q ss_pred EecCCCCHHHHhccCCCCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEecCCCCeEEeeeeeecccccCC
Q 002158 701 EFVPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSRLAPVLD 780 (958)
Q Consensus 701 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~ 780 (958)
||+++++|.++++.. .+++..+..++.|++.||.|||+.+ |+||||+|+||+++.++.++|+|||++.......
T Consensus 82 e~~~~~~L~~~~~~~---~l~~~~~~~i~~~i~~~l~~lh~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~ 155 (277)
T cd06917 82 EYAEGGSVRTLMKAG---PIAEKYISVIIREVLVALKYIHKVG---VIHRDIKAANILVTNTGNVKLCDFGVAALLNQNS 155 (277)
T ss_pred ecCCCCcHHHHHHcc---CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcCHHHEEEcCCCCEEEccCCceeecCCCc
Confidence 999999999998653 4899999999999999999999999 9999999999999999999999999987653322
Q ss_pred CCCCccceeeeeccCCCCccChhhhccC-CCCCcchhhhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcCcchhhhccc
Q 002158 781 DEGTMPTHVSTIVKGTPGYLDPEYFLTH-KLTDKSDVYSLGVVLLELLTGMQPISHGKNIVREVNVARDSGMVFSIIDNR 859 (958)
Q Consensus 781 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DV~S~Gv~l~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~i~~~ 859 (958)
.......|+..|+|||.+.++ .++.++||||||+++|||++|..||........ ..... ...
T Consensus 156 -------~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~-~~~~~---------~~~ 218 (277)
T cd06917 156 -------SKRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRA-MMLIP---------KSK 218 (277)
T ss_pred -------cccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhh-hhccc---------cCC
Confidence 111234588999999998754 468899999999999999999999975432211 11000 001
Q ss_pred CCCCCh-HHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 002158 860 MGSYPS-ECVERFVTLALRCCHDKPEHRPSMSDVVRE 895 (958)
Q Consensus 860 ~~~~~~-~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 895 (958)
....+. ..+.++.+++.+||+.||++||++.+++++
T Consensus 219 ~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~il~~ 255 (277)
T cd06917 219 PPRLEDNGYSKLLREFVAACLDEEPKERLSAEELLKS 255 (277)
T ss_pred CCCCCcccCCHHHHHHHHHHcCCCcccCcCHHHHhhC
Confidence 111222 256789999999999999999999999874
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=315.88 Aligned_cols=261 Identities=20% Similarity=0.285 Sum_probs=196.7
Q ss_pred eeeee--CCeEEEEEEEC-CCcEEEEEEeccCC--hhcHHHHHHHHHHHHccCCCCcceEEEEEEeCCeEEEEEEecCCC
Q 002158 632 QVGQG--GYGKVYKGILS-DNTTVAIKRAEEGS--LQGQNEFLTEIKLLSRLHHRNLVSLLGYCDEEGEQMLVYEFVPNG 706 (958)
Q Consensus 632 ~lg~G--~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E~~~~g 706 (958)
.||+| +||+||+|.+. +|+.||||++.... ....+.+.+|+.+++.++||||+++++++..++..++||||++++
T Consensus 5 ~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~~ 84 (328)
T cd08226 5 EIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAYG 84 (328)
T ss_pred HhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccCC
Confidence 46666 99999999975 79999999987532 233467889999999999999999999999999999999999999
Q ss_pred CHHHHhccCCCCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEecCCCCeEEeeeeeecccccCCCCCCcc
Q 002158 707 TLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSRLAPVLDDEGTMP 786 (958)
Q Consensus 707 sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~ 786 (958)
+|.+++.......+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.++++|||.+.............
T Consensus 85 ~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (328)
T cd08226 85 SANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNG---YIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAKVV 161 (328)
T ss_pred CHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEeCCCcEEEechHHHhhhhccCcccccc
Confidence 9999998655455899999999999999999999998 9999999999999999999999998654332211111100
Q ss_pred ceeeeeccCCCCccChhhhccC--CCCCcchhhhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcCcch-----------
Q 002158 787 THVSTIVKGTPGYLDPEYFLTH--KLTDKSDVYSLGVVLLELLTGMQPISHGKNIVREVNVARDSGMVF----------- 853 (958)
Q Consensus 787 ~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DV~S~Gv~l~elltG~~P~~~~~~~~~~~~~~~~~~~~~----------- 853 (958)
........++..|+|||++.+. .++.++|||||||++|||++|+.||....................
T Consensus 162 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (328)
T cd08226 162 YDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPLDITTFPCEES 241 (328)
T ss_pred ccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhcCCCCCCccccccchhhh
Confidence 0011122356779999999764 478899999999999999999999975443222211111000000
Q ss_pred ------------------------hhhcccC-CCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 002158 854 ------------------------SIIDNRM-GSYPSECVERFVTLALRCCHDKPEHRPSMSDVVRE 895 (958)
Q Consensus 854 ------------------------~~i~~~~-~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 895 (958)
....... ...+..++..+.+++.+||+.||++|||++|++++
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~ 308 (328)
T cd08226 242 RMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSH 308 (328)
T ss_pred hhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence 0000000 11133567789999999999999999999999875
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-33 Score=308.12 Aligned_cols=255 Identities=24% Similarity=0.324 Sum_probs=200.5
Q ss_pred CCCCCceeeeeCCeEEEEEEEC-CCcEEEEEEeccCCh-hcHHHHHHHHHHHHccCCCCcceEEEEEEeC--CeEEEEEE
Q 002158 626 YFSSSTQVGQGGYGKVYKGILS-DNTTVAIKRAEEGSL-QGQNEFLTEIKLLSRLHHRNLVSLLGYCDEE--GEQMLVYE 701 (958)
Q Consensus 626 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~--~~~~lV~E 701 (958)
+|...+.||.|++|.||+|.+. +++.||+|.+..... ....++.+|++++++++||||+++++++... +..++|||
T Consensus 2 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e 81 (287)
T cd06621 2 KIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAME 81 (287)
T ss_pred ceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEEE
Confidence 5777889999999999999985 688999999875432 3456799999999999999999999998653 46899999
Q ss_pred ecCCCCHHHHhccC--CCCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEecCCCCeEEeeeeeecccccC
Q 002158 702 FVPNGTLRDWLSGR--TKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSRLAPVL 779 (958)
Q Consensus 702 ~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~~~~~ 779 (958)
|+++++|.+++... ....++...+..++.|+++||.|||+.+ ++|+||+|+||+++.++.++|+|||++......
T Consensus 82 ~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~---i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~ 158 (287)
T cd06621 82 YCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRK---IIHRDIKPSNILLTRKGQVKLCDFGVSGELVNS 158 (287)
T ss_pred ecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEecCCeEEEeecccccccccc
Confidence 99999999987532 2345888999999999999999999999 999999999999999999999999998654211
Q ss_pred CCCCCccceeeeeccCCCCccChhhhccCCCCCcchhhhHHHHHHHHHhCCCCCCCCch----hHHHHHHHhhcCcchhh
Q 002158 780 DDEGTMPTHVSTIVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVLLELLTGMQPISHGKN----IVREVNVARDSGMVFSI 855 (958)
Q Consensus 780 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gv~l~elltG~~P~~~~~~----~~~~~~~~~~~~~~~~~ 855 (958)
......++..|+|||.+.+..++.++||||+|+++|||++|+.||..... .......... ......
T Consensus 159 ---------~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~-~~~~~~ 228 (287)
T cd06621 159 ---------LAGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVN-MPNPEL 228 (287)
T ss_pred ---------ccccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhc-CCchhh
Confidence 11134578899999999999999999999999999999999999975421 1111111111 000000
Q ss_pred hcccCCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 002158 856 IDNRMGSYPSECVERFVTLALRCCHDKPEHRPSMSDVVRE 895 (958)
Q Consensus 856 i~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 895 (958)
... .......++.+.+++.+||+.+|.+||++.|++++
T Consensus 229 -~~~-~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~~ 266 (287)
T cd06621 229 -KDE-PGNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEH 266 (287)
T ss_pred -ccC-CCCCCchHHHHHHHHHHHcCCCcccCCCHHHHHhC
Confidence 000 01112356789999999999999999999999974
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-34 Score=311.42 Aligned_cols=263 Identities=15% Similarity=0.183 Sum_probs=189.3
Q ss_pred cCCCCCceeeeeCCeEEEEEEECC----CcEEEEEEeccCChhc--H---------HHHHHHHHHHHccCCCCcceEEEE
Q 002158 625 AYFSSSTQVGQGGYGKVYKGILSD----NTTVAIKRAEEGSLQG--Q---------NEFLTEIKLLSRLHHRNLVSLLGY 689 (958)
Q Consensus 625 ~~~~~~~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~~--~---------~~~~~E~~~l~~l~H~niv~l~~~ 689 (958)
.+|.+.+.||+|+||+||+|.+.+ +..+|+|+........ . .....+...+..+.|+|+++++++
T Consensus 12 ~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~ 91 (294)
T PHA02882 12 KEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYGC 91 (294)
T ss_pred CceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEEe
Confidence 578888999999999999999764 3456666543221110 0 112334455667789999999998
Q ss_pred EEeCC----eEEEEEEecCCCCHHHHhccCCCCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEecCCCCe
Q 002158 690 CDEEG----EQMLVYEFVPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSNLNA 765 (958)
Q Consensus 690 ~~~~~----~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~~~~ 765 (958)
+.... ..+++||++. .++.+.+.... ..++..+..++.|+++||+|||+.+ |+||||||+|||++.++.+
T Consensus 92 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~--~~~~~~~~~i~~qi~~~l~~lH~~~---iiHrDiKp~Nill~~~~~~ 165 (294)
T PHA02882 92 GSFKRCRMYYRFILLEKLV-ENTKEIFKRIK--CKNKKLIKNIMKDMLTTLEYIHEHG---ISHGDIKPENIMVDGNNRG 165 (294)
T ss_pred eeEecCCceEEEEEEehhc-cCHHHHHHhhc--cCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCcE
Confidence 76543 4578888874 57777775432 2567888999999999999999998 9999999999999999999
Q ss_pred EEeeeeeecccccCCCCCCccceeeeeccCCCCccChhhhccCCCCCcchhhhHHHHHHHHHhCCCCCCCCchhHHHHHH
Q 002158 766 KVADFGLSRLAPVLDDEGTMPTHVSTIVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVLLELLTGMQPISHGKNIVREVNV 845 (958)
Q Consensus 766 kl~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gv~l~elltG~~P~~~~~~~~~~~~~ 845 (958)
+|+|||+|+.+..................||+.|+|||++.+..++.++|||||||++|||++|+.||............
T Consensus 166 ~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~~~~~ 245 (294)
T PHA02882 166 YIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGNLIHA 245 (294)
T ss_pred EEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccchHHHHH
Confidence 99999999866432211111111223456999999999999999999999999999999999999999755322221111
Q ss_pred HhhcCcchhhhcccCCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 002158 846 ARDSGMVFSIIDNRMGSYPSECVERFVTLALRCCHDKPEHRPSMSDVVREL 896 (958)
Q Consensus 846 ~~~~~~~~~~i~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 896 (958)
... +....+..+.. ....+++.+.+++..||+.+|++||+++++++.+
T Consensus 246 ~~~-~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~ 293 (294)
T PHA02882 246 AKC-DFIKRLHEGKI--KIKNANKFIYDFIECVTKLSYEEKPDYDALIKIF 293 (294)
T ss_pred hHH-HHHHHhhhhhh--ccCCCCHHHHHHHHHHHhCCCCCCCCHHHHHHhh
Confidence 110 00011111111 1234568899999999999999999999999865
|
|
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-34 Score=311.46 Aligned_cols=259 Identities=24% Similarity=0.295 Sum_probs=199.0
Q ss_pred cCCCCCceeeeeCCeEEEEEEEC-CCcEEEEEEeccCChh--cHHHHHHHHHHHHccCCCCcceEEEEEEeC--CeEEEE
Q 002158 625 AYFSSSTQVGQGGYGKVYKGILS-DNTTVAIKRAEEGSLQ--GQNEFLTEIKLLSRLHHRNLVSLLGYCDEE--GEQMLV 699 (958)
Q Consensus 625 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~H~niv~l~~~~~~~--~~~~lV 699 (958)
++|+..+.||+|+||.||+|.++ +++.||+|.++..... ....+.+|++++++++||||+++++++... ...++|
T Consensus 5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv 84 (293)
T cd07843 5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMV 84 (293)
T ss_pred hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEE
Confidence 35777789999999999999986 5889999998754322 234577899999999999999999998877 899999
Q ss_pred EEecCCCCHHHHhccCCCCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEecCCCCeEEeeeeeecccccC
Q 002158 700 YEFVPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSRLAPVL 779 (958)
Q Consensus 700 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~~~~~ 779 (958)
|||++ ++|.+++..... .+++.++..++.|++.||+|||+.+ ++||||||+||+++.++.+||+|||+++.....
T Consensus 85 ~e~~~-~~L~~~~~~~~~-~l~~~~~~~i~~qi~~aL~~LH~~~---i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~ 159 (293)
T cd07843 85 MEYVE-HDLKSLMETMKQ-PFLQSEVKCLMLQLLSGVAHLHDNW---ILHRDLKTSNLLLNNRGILKICDFGLAREYGSP 159 (293)
T ss_pred ehhcC-cCHHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHHHEEECCCCcEEEeecCceeeccCC
Confidence 99996 599999875432 5899999999999999999999999 999999999999999999999999998865322
Q ss_pred CCCCCccceeeeeccCCCCccChhhhccCC-CCCcchhhhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcCcc------
Q 002158 780 DDEGTMPTHVSTIVKGTPGYLDPEYFLTHK-LTDKSDVYSLGVVLLELLTGMQPISHGKNIVREVNVARDSGMV------ 852 (958)
Q Consensus 780 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DV~S~Gv~l~elltG~~P~~~~~~~~~~~~~~~~~~~~------ 852 (958)
.. ......++..|+|||.+.+.. ++.++|+||+|+++|||++|..||................+..
T Consensus 160 ~~-------~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (293)
T cd07843 160 LK-------PYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWP 232 (293)
T ss_pred cc-------ccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHH
Confidence 11 112234788999999987654 6889999999999999999999997544322211111000000
Q ss_pred --------h-----hhhcccC-CCCChH-HHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 002158 853 --------F-----SIIDNRM-GSYPSE-CVERFVTLALRCCHDKPEHRPSMSDVVRE 895 (958)
Q Consensus 853 --------~-----~~i~~~~-~~~~~~-~~~~l~~li~~cl~~dP~~RPs~~evl~~ 895 (958)
. ....... ..++.. .++.+.+++.+||+.+|++||++.|++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~~ 290 (293)
T cd07843 233 GFSELPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKH 290 (293)
T ss_pred HhhccchhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhcC
Confidence 0 0000000 112222 46778999999999999999999999863
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-33 Score=301.01 Aligned_cols=248 Identities=31% Similarity=0.514 Sum_probs=206.3
Q ss_pred CCCCCceeeeeCCeEEEEEEEC-CCcEEEEEEeccCChhcHHHHHHHHHHHHccCCCCcceEEEEEEeCCeEEEEEEecC
Q 002158 626 YFSSSTQVGQGGYGKVYKGILS-DNTTVAIKRAEEGSLQGQNEFLTEIKLLSRLHHRNLVSLLGYCDEEGEQMLVYEFVP 704 (958)
Q Consensus 626 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E~~~ 704 (958)
.|+..+.||+|++|.||++.+. +++.|++|++........+.+.+|++++++++|+|++++++++......++++||++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~ 80 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCS 80 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecCC
Confidence 3667789999999999999986 688999999987655566789999999999999999999999999999999999999
Q ss_pred CCCHHHHhccCCCCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEecCCCCeEEeeeeeecccccCCCCCC
Q 002158 705 NGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSRLAPVLDDEGT 784 (958)
Q Consensus 705 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 784 (958)
+++|.+++.... ..+++..+..++.|+++||+|||+.+ ++||||+|+||++++++.++|+|||.+........
T Consensus 81 ~~~L~~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~--- 153 (253)
T cd05122 81 GGSLKDLLKSTN-QTLTESQIAYVCKELLKGLEYLHSNG---IIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA--- 153 (253)
T ss_pred CCcHHHHHhhcC-CCCCHHHHHHHHHHHHHHHHHhhcCC---EecCCCCHHHEEEccCCeEEEeecccccccccccc---
Confidence 999999997653 35899999999999999999999988 99999999999999999999999999876532211
Q ss_pred ccceeeeeccCCCCccChhhhccCCCCCcchhhhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcCcchhhhcccCCCC-
Q 002158 785 MPTHVSTIVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVLLELLTGMQPISHGKNIVREVNVARDSGMVFSIIDNRMGSY- 863 (958)
Q Consensus 785 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gv~l~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~- 863 (958)
.....|+..|+|||++.+..++.++||||||+++|||++|+.||.............. ......
T Consensus 154 -----~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~----------~~~~~~~ 218 (253)
T cd05122 154 -----RNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKALFKIAT----------NGPPGLR 218 (253)
T ss_pred -----ccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHh----------cCCCCcC
Confidence 2234688999999999988899999999999999999999999975432222211111 001111
Q ss_pred -ChHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 002158 864 -PSECVERFVTLALRCCHDKPEHRPSMSDVVRE 895 (958)
Q Consensus 864 -~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 895 (958)
+..++..+.+++.+||+.||++||++.|++++
T Consensus 219 ~~~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~~ 251 (253)
T cd05122 219 NPEKWSDEFKDFLKKCLQKNPEKRPTAEQLLKH 251 (253)
T ss_pred cccccCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 12236789999999999999999999999864
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-34 Score=312.89 Aligned_cols=251 Identities=25% Similarity=0.372 Sum_probs=195.9
Q ss_pred CCCCceeeeeCCeEEEEEEEC-CCcEEEEEEeccCC-hhcHHHHHHHHHHHHccC-CCCcceEEEEEEeCCeEEEEEEec
Q 002158 627 FSSSTQVGQGGYGKVYKGILS-DNTTVAIKRAEEGS-LQGQNEFLTEIKLLSRLH-HRNLVSLLGYCDEEGEQMLVYEFV 703 (958)
Q Consensus 627 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~~~~~lV~E~~ 703 (958)
|...+.||+|+||.||++.+. +++.||+|.+.... ......+.+|+.++.++. |+||+++++++..++..+++|||+
T Consensus 6 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e~~ 85 (288)
T cd06616 6 LKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICMELM 85 (288)
T ss_pred hHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEecc
Confidence 444568999999999999976 68999999987542 344567899999999996 999999999999999999999998
Q ss_pred CCCCHHHHh---ccCCCCCchHHHHHHHHHHHHHHHHHhhhc-CCCCeeccCCCccceEecCCCCeEEeeeeeecccccC
Q 002158 704 PNGTLRDWL---SGRTKENLNFAMRLRVALDSAKGILYLHTE-AHPPVFHRDIKASNILLDSNLNAKVADFGLSRLAPVL 779 (958)
Q Consensus 704 ~~gsL~~~l---~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~-~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~~~~~ 779 (958)
+ +++.++. .......+++..+..++.|++.||+|||+. + ++||||||+||+++.++.+||+|||+++.....
T Consensus 86 ~-~~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~ 161 (288)
T cd06616 86 D-ISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELK---IIHRDVKPSNILLDRNGNIKLCDFGISGQLVDS 161 (288)
T ss_pred c-CCHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCC---eeccCCCHHHEEEccCCcEEEeecchhHHhccC
Confidence 5 4655443 333335589999999999999999999975 7 999999999999999999999999998754221
Q ss_pred CCCCCccceeeeeccCCCCccChhhhccC---CCCCcchhhhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcCcchhhh
Q 002158 780 DDEGTMPTHVSTIVKGTPGYLDPEYFLTH---KLTDKSDVYSLGVVLLELLTGMQPISHGKNIVREVNVARDSGMVFSII 856 (958)
Q Consensus 780 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~DV~S~Gv~l~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~i 856 (958)
. ......|+..|+|||++.+. .++.++|||||||++|||++|+.||................ ..
T Consensus 162 ~--------~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~-~~---- 228 (288)
T cd06616 162 I--------AKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSVFDQLTQVVKG-DP---- 228 (288)
T ss_pred C--------ccccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcchHHHHHhhhcCC-CC----
Confidence 1 11223588999999999776 68899999999999999999999997544222222111110 00
Q ss_pred cccC-CCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 002158 857 DNRM-GSYPSECVERFVTLALRCCHDKPEHRPSMSDVVRE 895 (958)
Q Consensus 857 ~~~~-~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 895 (958)
+.. ...+..++..+.+++.+||+.+|++||++++|+++
T Consensus 229 -~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~ 267 (288)
T cd06616 229 -PILSNSEEREFSPSFVNFINLCLIKDESKRPKYKELLEH 267 (288)
T ss_pred -CcCCCcCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 011 11223467789999999999999999999999974
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-33 Score=312.89 Aligned_cols=247 Identities=28% Similarity=0.451 Sum_probs=198.8
Q ss_pred CCCCceeeeeCCeEEEEEEEC-CCcEEEEEEeccCC---hhcHHHHHHHHHHHHccCCCCcceEEEEEEeCCeEEEEEEe
Q 002158 627 FSSSTQVGQGGYGKVYKGILS-DNTTVAIKRAEEGS---LQGQNEFLTEIKLLSRLHHRNLVSLLGYCDEEGEQMLVYEF 702 (958)
Q Consensus 627 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E~ 702 (958)
|...+.||+|+||.||+|.+. ++..||+|++.... ......+.+|++++++++|+|++++++++..+...++||||
T Consensus 27 f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 106 (317)
T cd06635 27 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVMEY 106 (317)
T ss_pred hhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEEeC
Confidence 556678999999999999975 68899999986432 23345788999999999999999999999999999999999
Q ss_pred cCCCCHHHHhccCCCCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEecCCCCeEEeeeeeecccccCCCC
Q 002158 703 VPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSRLAPVLDDE 782 (958)
Q Consensus 703 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~ 782 (958)
++ |+|.+++... ...+++.++..++.|++.||.|||+.+ |+||||+|+||+++.++.++|+|||++.....
T Consensus 107 ~~-g~l~~~~~~~-~~~l~~~~~~~i~~~i~~~l~~lH~~~---i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~---- 177 (317)
T cd06635 107 CL-GSASDLLEVH-KKPLQEVEIAAITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASIASP---- 177 (317)
T ss_pred CC-CCHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcccEEECCCCCEEEecCCCccccCC----
Confidence 96 5888877543 234899999999999999999999999 99999999999999999999999998864321
Q ss_pred CCccceeeeeccCCCCccChhhhc---cCCCCCcchhhhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcCcchhhhccc
Q 002158 783 GTMPTHVSTIVKGTPGYLDPEYFL---THKLTDKSDVYSLGVVLLELLTGMQPISHGKNIVREVNVARDSGMVFSIIDNR 859 (958)
Q Consensus 783 ~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DV~S~Gv~l~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~i~~~ 859 (958)
.....|+..|+|||++. ...++.++|||||||++|||++|+.||............... . .
T Consensus 178 -------~~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~-~--------~ 241 (317)
T cd06635 178 -------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQN-E--------S 241 (317)
T ss_pred -------cccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhc-c--------C
Confidence 12245888999999984 456888999999999999999999998754332222111111 0 0
Q ss_pred CCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 002158 860 MGSYPSECVERFVTLALRCCHDKPEHRPSMSDVVRELEN 898 (958)
Q Consensus 860 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 898 (958)
.......++..+.+++.+||+.+|.+||++.+++++...
T Consensus 242 ~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~ 280 (317)
T cd06635 242 PTLQSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMFV 280 (317)
T ss_pred CCCCCccccHHHHHHHHHHccCCcccCcCHHHHHhChhh
Confidence 111133456789999999999999999999999987544
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-33 Score=303.79 Aligned_cols=252 Identities=25% Similarity=0.387 Sum_probs=202.6
Q ss_pred cCCCCCceeeeeCCeEEEEEEEC-CCcEEEEEEeccC-----ChhcHHHHHHHHHHHHccCCCCcceEEEEEEeC--CeE
Q 002158 625 AYFSSSTQVGQGGYGKVYKGILS-DNTTVAIKRAEEG-----SLQGQNEFLTEIKLLSRLHHRNLVSLLGYCDEE--GEQ 696 (958)
Q Consensus 625 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~--~~~ 696 (958)
.+|...+.||+|+||.||+|.+. +++.||+|.+... .......+.+|++++++++|+||+++++++.+. +..
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL 81 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence 46888899999999999999975 6899999987532 123345788999999999999999999998664 468
Q ss_pred EEEEEecCCCCHHHHhccCCCCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEecCCCCeEEeeeeeeccc
Q 002158 697 MLVYEFVPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSRLA 776 (958)
Q Consensus 697 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~~ 776 (958)
++||||+++++|.+++.... .+++..+.+++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||+++..
T Consensus 82 ~~v~e~~~~~~L~~~~~~~~--~l~~~~~~~~~~~i~~al~~LH~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~ 156 (264)
T cd06653 82 SIFVEYMPGGSIKDQLKAYG--ALTENVTRRYTRQILQGVSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRI 156 (264)
T ss_pred EEEEEeCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEECcccccccc
Confidence 89999999999999997543 3788899999999999999999999 999999999999999999999999999865
Q ss_pred ccCCCCCCccceeeeeccCCCCccChhhhccCCCCCcchhhhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcCcchhhh
Q 002158 777 PVLDDEGTMPTHVSTIVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVLLELLTGMQPISHGKNIVREVNVARDSGMVFSII 856 (958)
Q Consensus 777 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gv~l~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~i 856 (958)
...... ........|+..|+|||++.+..++.++|||||||++|||++|+.||..............
T Consensus 157 ~~~~~~----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~--------- 223 (264)
T cd06653 157 QTICMS----GTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMAAIFKIAT--------- 223 (264)
T ss_pred cccccc----CccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHHHHHHHHHc---------
Confidence 321111 1111234588999999999988899999999999999999999999975443322211110
Q ss_pred cccCCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 002158 857 DNRMGSYPSECVERFVTLALRCCHDKPEHRPSMSDVVRE 895 (958)
Q Consensus 857 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 895 (958)
.+.....|....+.+.+++.+||+ +|..||+..+++.+
T Consensus 224 ~~~~~~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~~ 261 (264)
T cd06653 224 QPTKPMLPDGVSDACRDFLKQIFV-EEKRRPTAEFLLRH 261 (264)
T ss_pred CCCCCCCCcccCHHHHHHHHHHhc-CcccCccHHHHhcC
Confidence 111234566777889999999999 57999999988764
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-33 Score=302.37 Aligned_cols=252 Identities=26% Similarity=0.434 Sum_probs=209.3
Q ss_pred CCCCCceeeeeCCeEEEEEEEC-CCcEEEEEEeccCCh--hcHHHHHHHHHHHHccCCCCcceEEEEEEeC--CeEEEEE
Q 002158 626 YFSSSTQVGQGGYGKVYKGILS-DNTTVAIKRAEEGSL--QGQNEFLTEIKLLSRLHHRNLVSLLGYCDEE--GEQMLVY 700 (958)
Q Consensus 626 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~--~~~~lV~ 700 (958)
+|...+.||+|++|.||+|... +++.|++|++..... ...+.+.+|++++++++|+||+++++.+... ...++||
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 80 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFL 80 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEE
Confidence 3667789999999999999987 689999999876542 4466799999999999999999999999988 8999999
Q ss_pred EecCCCCHHHHhccCCCCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEecCCCCeEEeeeeeecccccCC
Q 002158 701 EFVPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSRLAPVLD 780 (958)
Q Consensus 701 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~ 780 (958)
||+++++|.+++.... .+++.++..++.|+++||+|||+.+ ++|+||+|+||+++.++.++|+|||.+.......
T Consensus 81 e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~l~~~l~~lh~~~---~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~ 155 (260)
T cd06606 81 EYVSGGSLSSLLKKFG--KLPEPVIRKYTRQILEGLAYLHSNG---IVHRDIKGANILVDSDGVVKLADFGCAKRLGDIE 155 (260)
T ss_pred EecCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEcCCCCEEEcccccEEeccccc
Confidence 9999999999997654 5899999999999999999999998 9999999999999999999999999998654322
Q ss_pred CCCCccceeeeeccCCCCccChhhhccCCCCCcchhhhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcCcchhhhcccC
Q 002158 781 DEGTMPTHVSTIVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVLLELLTGMQPISHGKNIVREVNVARDSGMVFSIIDNRM 860 (958)
Q Consensus 781 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gv~l~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~i~~~~ 860 (958)
.. .......++..|+|||.+.+..++.++||||||+++|+|++|..||............... ....
T Consensus 156 ~~-----~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~--------~~~~ 222 (260)
T cd06606 156 TG-----EGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGNPMAALYKIGS--------SGEP 222 (260)
T ss_pred cc-----ccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHhccc--------cCCC
Confidence 10 0122345888999999998888999999999999999999999999765522222211111 0122
Q ss_pred CCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 002158 861 GSYPSECVERFVTLALRCCHDKPEHRPSMSDVVRE 895 (958)
Q Consensus 861 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 895 (958)
...+...+..+.+++.+|++.+|++||++.+++++
T Consensus 223 ~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~~ 257 (260)
T cd06606 223 PEIPEHLSEEAKDFLRKCLRRDPKKRPTADELLQH 257 (260)
T ss_pred cCCCcccCHHHHHHHHHhCcCChhhCCCHHHHhhC
Confidence 33455668899999999999999999999999864
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-34 Score=308.65 Aligned_cols=246 Identities=25% Similarity=0.338 Sum_probs=204.4
Q ss_pred CCCCCceeeeeCCeEEEEEEEC-CCcEEEEEEeccCC---hhcHHHHHHHHHHHHccCCCCcceEEEEEEeCCeEEEEEE
Q 002158 626 YFSSSTQVGQGGYGKVYKGILS-DNTTVAIKRAEEGS---LQGQNEFLTEIKLLSRLHHRNLVSLLGYCDEEGEQMLVYE 701 (958)
Q Consensus 626 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E 701 (958)
+|+..+.||+|+||.||+|.+. +++.||+|.+.... ....+.+.+|++++++++||||+++++++..+...++|||
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD 80 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence 4677889999999999999986 58999999987542 2345678999999999999999999999999999999999
Q ss_pred ecCCCCHHHHhccCCCCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEecCCCCeEEeeeeeecccccCCC
Q 002158 702 FVPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSRLAPVLDD 781 (958)
Q Consensus 702 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~ 781 (958)
|+++++|.+++... ..+++.++..++.|+++||.|||+.+ ++|+||||+||++++++.++|+|||.+.......
T Consensus 81 ~~~~~~L~~~l~~~--~~l~~~~~~~~~~~i~~~l~~lh~~~---i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~- 154 (258)
T cd05578 81 LLLGGDLRYHLSQK--VKFSEEQVKFWICEIVLALEYLHSKG---IIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT- 154 (258)
T ss_pred CCCCCCHHHHHHhc--CCcCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeEEcCCCCEEEeecccccccCCCc-
Confidence 99999999999755 35899999999999999999999998 9999999999999999999999999987543211
Q ss_pred CCCccceeeeeccCCCCccChhhhccCCCCCcchhhhHHHHHHHHHhCCCCCCCCch--hHHHHHHHhhcCcchhhhccc
Q 002158 782 EGTMPTHVSTIVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVLLELLTGMQPISHGKN--IVREVNVARDSGMVFSIIDNR 859 (958)
Q Consensus 782 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gv~l~elltG~~P~~~~~~--~~~~~~~~~~~~~~~~~i~~~ 859 (958)
......|+..|+|||.+.+..++.++|+||||+++|+|++|..||..... ....... ....
T Consensus 155 -------~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~----------~~~~ 217 (258)
T cd05578 155 -------LTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAK----------QETA 217 (258)
T ss_pred -------cccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccHHHHHHHH----------hccc
Confidence 12234588899999999988899999999999999999999999975442 1111111 1111
Q ss_pred CCCCChHHHHHHHHHHHHccccCCCCCCCH--HHHHH
Q 002158 860 MGSYPSECVERFVTLALRCCHDKPEHRPSM--SDVVR 894 (958)
Q Consensus 860 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~--~evl~ 894 (958)
....+...+..+.+++.+||+.||.+||++ +|+++
T Consensus 218 ~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~~ 254 (258)
T cd05578 218 DVLYPATWSTEAIDAINKLLERDPQKRLGDNLKDLKN 254 (258)
T ss_pred cccCcccCcHHHHHHHHHHccCChhHcCCccHHHHhc
Confidence 223455667899999999999999999999 66543
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-33 Score=308.79 Aligned_cols=260 Identities=22% Similarity=0.322 Sum_probs=197.8
Q ss_pred HcCCCCCceeeeeCCeEEEEEEEC-CCcEEEEEEeccCChh-cHHHHHHHHHHHHccCCCCcceEEEEEEeCCeEEEEEE
Q 002158 624 TAYFSSSTQVGQGGYGKVYKGILS-DNTTVAIKRAEEGSLQ-GQNEFLTEIKLLSRLHHRNLVSLLGYCDEEGEQMLVYE 701 (958)
Q Consensus 624 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E 701 (958)
+++|...+.||+|+||.||+|... +++.||+|++...... ....+.+|+++++.++|+||+++++++..++..++|||
T Consensus 4 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e 83 (291)
T cd07870 4 ATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVFE 83 (291)
T ss_pred cceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEEe
Confidence 467888899999999999999875 6889999998654322 23467899999999999999999999999999999999
Q ss_pred ecCCCCHHHHhccCCCCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEecCCCCeEEeeeeeecccccCCC
Q 002158 702 FVPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSRLAPVLDD 781 (958)
Q Consensus 702 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~ 781 (958)
|++ +++.+++.... ..+.+.++..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+++.......
T Consensus 84 ~~~-~~l~~~~~~~~-~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~ 158 (291)
T cd07870 84 YMH-TDLAQYMIQHP-GGLHPYNVRLFMFQLLRGLAYIHGQH---ILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQ 158 (291)
T ss_pred ccc-CCHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHHEEEcCCCcEEEeccccccccCCCCC
Confidence 995 78877775433 34778888999999999999999998 99999999999999999999999999875422111
Q ss_pred CCCccceeeeeccCCCCccChhhhccC-CCCCcchhhhHHHHHHHHHhCCCCCCCCchhHHHHHHHhh-cCcchh-----
Q 002158 782 EGTMPTHVSTIVKGTPGYLDPEYFLTH-KLTDKSDVYSLGVVLLELLTGMQPISHGKNIVREVNVARD-SGMVFS----- 854 (958)
Q Consensus 782 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DV~S~Gv~l~elltG~~P~~~~~~~~~~~~~~~~-~~~~~~----- 854 (958)
......++..|+|||++.+. .++.++||||||+++|||++|+.||.......+....... .+....
T Consensus 159 -------~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (291)
T cd07870 159 -------TYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPG 231 (291)
T ss_pred -------CCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCChhhhhh
Confidence 11223478899999998764 5788999999999999999999999755433222211110 000000
Q ss_pred ------hhcccC-CCCC---------hHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 002158 855 ------IIDNRM-GSYP---------SECVERFVTLALRCCHDKPEHRPSMSDVVRE 895 (958)
Q Consensus 855 ------~i~~~~-~~~~---------~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 895 (958)
...... ...+ ...+..+.+++.+|+..||++|||++|++.+
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~h 288 (291)
T cd07870 232 VSKLPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALLH 288 (291)
T ss_pred hhhcccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhcC
Confidence 000000 0000 0124578899999999999999999998753
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-34 Score=308.58 Aligned_cols=241 Identities=24% Similarity=0.338 Sum_probs=194.0
Q ss_pred eeeeCCeEEEEEEEC-CCcEEEEEEeccCC---hhcHHHHHHHHHHHHccCCCCcceEEEEEEeCCeEEEEEEecCCCCH
Q 002158 633 VGQGGYGKVYKGILS-DNTTVAIKRAEEGS---LQGQNEFLTEIKLLSRLHHRNLVSLLGYCDEEGEQMLVYEFVPNGTL 708 (958)
Q Consensus 633 lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E~~~~gsL 708 (958)
||+|+||+||++... +|+.||+|.+.... ......+.+|++++++++||||+++++++...+..++||||+++++|
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL 80 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence 689999999999875 68999999986532 22344578899999999999999999999999999999999999999
Q ss_pred HHHhccCCCCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEecCCCCeEEeeeeeecccccCCCCCCccce
Q 002158 709 RDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSRLAPVLDDEGTMPTH 788 (958)
Q Consensus 709 ~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~ 788 (958)
.+++.......+++..+..++.|++.||.|||+.+ ++||||+|+||++++++.++|+|||.++......
T Consensus 81 ~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~---i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~~-------- 149 (277)
T cd05577 81 KYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRR---IVYRDLKPENVLLDDHGNVRISDLGLAVELKGGK-------- 149 (277)
T ss_pred HHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEccCcchhhhccCC--------
Confidence 99997665456899999999999999999999999 9999999999999999999999999987543211
Q ss_pred eeeeccCCCCccChhhhccCCCCCcchhhhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcCcchhhhcccCCCCChHHH
Q 002158 789 VSTIVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVLLELLTGMQPISHGKNIVREVNVARDSGMVFSIIDNRMGSYPSECV 868 (958)
Q Consensus 789 ~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gv~l~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~ 868 (958)
......++..|+|||++.+..++.++||||+|+++|||++|+.||............ ...+.......+...+
T Consensus 150 ~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~-------~~~~~~~~~~~~~~~~ 222 (277)
T cd05577 150 KIKGRAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEEL-------KRRTLEMAVEYPDKFS 222 (277)
T ss_pred ccccccCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHH-------HhccccccccCCccCC
Confidence 112335788999999998888999999999999999999999999654321110000 0001111223344567
Q ss_pred HHHHHHHHHccccCCCCCCCHHH
Q 002158 869 ERFVTLALRCCHDKPEHRPSMSD 891 (958)
Q Consensus 869 ~~l~~li~~cl~~dP~~RPs~~e 891 (958)
..+.+++.+||+.+|++||++++
T Consensus 223 ~~~~~li~~~l~~~p~~R~~~~~ 245 (277)
T cd05577 223 PEAKDLCEALLQKDPEKRLGCRG 245 (277)
T ss_pred HHHHHHHHHHccCChhHccCCCc
Confidence 88999999999999999994444
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-34 Score=308.82 Aligned_cols=241 Identities=23% Similarity=0.306 Sum_probs=189.5
Q ss_pred eeeeeCCeEEEEEEEC-CCcEEEEEEeccCCh---hcHHHHHHHHHHHH---ccCCCCcceEEEEEEeCCeEEEEEEecC
Q 002158 632 QVGQGGYGKVYKGILS-DNTTVAIKRAEEGSL---QGQNEFLTEIKLLS---RLHHRNLVSLLGYCDEEGEQMLVYEFVP 704 (958)
Q Consensus 632 ~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~---~l~H~niv~l~~~~~~~~~~~lV~E~~~ 704 (958)
.||+|+||.||++... +++.||+|.+..... .....+.+|..+++ ..+|+|++.+++++..++..++||||++
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN 80 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence 4899999999999975 689999998865322 22233455554444 3479999999999999999999999999
Q ss_pred CCCHHHHhccCCCCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEecCCCCeEEeeeeeecccccCCCCCC
Q 002158 705 NGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSRLAPVLDDEGT 784 (958)
Q Consensus 705 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 784 (958)
+++|.+++.... .+++..+..++.|++.||+|||+.+ |+||||||+||++++++.++|+|||++.......
T Consensus 81 ~~~L~~~i~~~~--~l~~~~~~~i~~qi~~al~~lH~~~---ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~---- 151 (279)
T cd05633 81 GGDLHYHLSQHG--VFSEKEMRFYATEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKK---- 151 (279)
T ss_pred CCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC---cCCCCCCHHHEEECCCCCEEEccCCcceeccccC----
Confidence 999999997543 4899999999999999999999999 9999999999999999999999999986442111
Q ss_pred ccceeeeeccCCCCccChhhhcc-CCCCCcchhhhHHHHHHHHHhCCCCCCCCchh-HHHHHHHhhcCcchhhhcccCCC
Q 002158 785 MPTHVSTIVKGTPGYLDPEYFLT-HKLTDKSDVYSLGVVLLELLTGMQPISHGKNI-VREVNVARDSGMVFSIIDNRMGS 862 (958)
Q Consensus 785 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DV~S~Gv~l~elltG~~P~~~~~~~-~~~~~~~~~~~~~~~~i~~~~~~ 862 (958)
.....|+..|+|||.+.+ ..++.++||||+||++|||++|..||...... ........ ......
T Consensus 152 -----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~---------~~~~~~ 217 (279)
T cd05633 152 -----PHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMT---------LTVNVE 217 (279)
T ss_pred -----ccCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHHHHHHh---------hcCCcC
Confidence 122358999999999864 56889999999999999999999999643211 11111110 011123
Q ss_pred CChHHHHHHHHHHHHccccCCCCCC-----CHHHHHHH
Q 002158 863 YPSECVERFVTLALRCCHDKPEHRP-----SMSDVVRE 895 (958)
Q Consensus 863 ~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~~ 895 (958)
.+...+.++.+++.+|++.||++|| +++|++++
T Consensus 218 ~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h 255 (279)
T cd05633 218 LPDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEH 255 (279)
T ss_pred CccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhC
Confidence 3556778899999999999999999 58888875
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-35 Score=307.63 Aligned_cols=250 Identities=23% Similarity=0.314 Sum_probs=207.3
Q ss_pred HHHcCCCCCceeeeeCCeEEEEEEEC-CCcEEEEEEeccCC---hhcHHHHHHHHHHHHccCCCCcceEEEEEEeCCeEE
Q 002158 622 MATAYFSSSTQVGQGGYGKVYKGILS-DNTTVAIKRAEEGS---LQGQNEFLTEIKLLSRLHHRNLVSLLGYCDEEGEQM 697 (958)
Q Consensus 622 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~ 697 (958)
...+.|..-++||+||||.||-++.+ +|+.+|.|++.+.. ..+..-.+.|-.+|.+++.+.||.+--.+++.+.++
T Consensus 182 vt~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LC 261 (591)
T KOG0986|consen 182 VTKNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALC 261 (591)
T ss_pred ccccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceE
Confidence 34456788899999999999999865 69999999886543 233345678999999999999999999999999999
Q ss_pred EEEEecCCCCHHHHhccCCCCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEecCCCCeEEeeeeeecccc
Q 002158 698 LVYEFVPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSRLAP 777 (958)
Q Consensus 698 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~~~ 777 (958)
|||..|.||+|.-+|.+.+...++++.++.++.+|+.||++||.+. ||.||+||+|||+|+.|+++|+|.|+|..++
T Consensus 262 lVLtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~~---iVYRDLKPeNILLDd~GhvRISDLGLAvei~ 338 (591)
T KOG0986|consen 262 LVLTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRRR---IVYRDLKPENILLDDHGHVRISDLGLAVEIP 338 (591)
T ss_pred EEEEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhcc---eeeccCChhheeeccCCCeEeeccceEEecC
Confidence 9999999999999998877677999999999999999999999999 9999999999999999999999999998764
Q ss_pred cCCCCCCccceeeeeccCCCCccChhhhccCCCCCcchhhhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcCcchhhhc
Q 002158 778 VLDDEGTMPTHVSTIVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVLLELLTGMQPISHGKNIVREVNVARDSGMVFSIID 857 (958)
Q Consensus 778 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gv~l~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~i~ 857 (958)
.. ......+||.+|||||++.+..|+...|.||+||++|||+.|+.||...+.-..+. .+...+.
T Consensus 339 ~g--------~~~~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~e-------Evdrr~~ 403 (591)
T KOG0986|consen 339 EG--------KPIRGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKRE-------EVDRRTL 403 (591)
T ss_pred CC--------CccccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhhhHH-------HHHHHHh
Confidence 32 22234479999999999999999999999999999999999999996433222111 1111111
Q ss_pred ccCCCCChHHHHHHHHHHHHccccCCCCCCCH
Q 002158 858 NRMGSYPSECVERFVTLALRCCHDKPEHRPSM 889 (958)
Q Consensus 858 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~ 889 (958)
.....++...+++..++....++.||.+|.-.
T Consensus 404 ~~~~ey~~kFS~eakslc~~LL~Kdp~~RLGc 435 (591)
T KOG0986|consen 404 EDPEEYSDKFSEEAKSLCEGLLTKDPEKRLGC 435 (591)
T ss_pred cchhhcccccCHHHHHHHHHHHccCHHHhccC
Confidence 22234567788889999999999999999643
|
|
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=307.67 Aligned_cols=259 Identities=25% Similarity=0.356 Sum_probs=199.9
Q ss_pred CCCCCceeeeeCCeEEEEEEEC-CCcEEEEEEeccCCh-hcHHHHHHHHHHHHccCCCCcceEEEEEEeCCeEEEEEEec
Q 002158 626 YFSSSTQVGQGGYGKVYKGILS-DNTTVAIKRAEEGSL-QGQNEFLTEIKLLSRLHHRNLVSLLGYCDEEGEQMLVYEFV 703 (958)
Q Consensus 626 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E~~ 703 (958)
+|+..+.||+|++|.||+|++. +|+.||||++..... .....+.+|++++++++|+||+++++++...+..++||||+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYM 80 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecC
Confidence 4777899999999999999986 688999999876432 23456788999999999999999999999999999999999
Q ss_pred CCCCHHHHhccCC-CCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEecCCCCeEEeeeeeecccccCCCC
Q 002158 704 PNGTLRDWLSGRT-KENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSRLAPVLDDE 782 (958)
Q Consensus 704 ~~gsL~~~l~~~~-~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~ 782 (958)
+ ++|.+++.... ...+++..+..++.|++.||+|||+.+ ++||||||+||++++++.++|+|||+++......
T Consensus 81 ~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~-- 154 (284)
T cd07836 81 D-KDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENR---VLHRDLKPQNLLINKRGELKLADFGLARAFGIPV-- 154 (284)
T ss_pred C-ccHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEECCCCcEEEeecchhhhhcCCc--
Confidence 7 58999886543 345899999999999999999999999 9999999999999999999999999987542211
Q ss_pred CCccceeeeeccCCCCccChhhhccC-CCCCcchhhhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhc----Ccchhhh-
Q 002158 783 GTMPTHVSTIVKGTPGYLDPEYFLTH-KLTDKSDVYSLGVVLLELLTGMQPISHGKNIVREVNVARDS----GMVFSII- 856 (958)
Q Consensus 783 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DV~S~Gv~l~elltG~~P~~~~~~~~~~~~~~~~~----~~~~~~i- 856 (958)
.......++..|++||++.+. .++.++||||||+++|||++|+.||................ ....+.+
T Consensus 155 -----~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (284)
T cd07836 155 -----NTFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGIS 229 (284)
T ss_pred -----cccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHh
Confidence 111223478899999998664 46889999999999999999999997544322111111000 0000000
Q ss_pred -----ccc--------CCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 002158 857 -----DNR--------MGSYPSECVERFVTLALRCCHDKPEHRPSMSDVVRE 895 (958)
Q Consensus 857 -----~~~--------~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 895 (958)
... ........+..+.+++.+|++.||++||++++++++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~ 281 (284)
T cd07836 230 QLPEYKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQH 281 (284)
T ss_pred cCchhcccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 000 001112345678899999999999999999999863
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=309.32 Aligned_cols=244 Identities=23% Similarity=0.384 Sum_probs=199.3
Q ss_pred ceeeeeCCeEEEEEEEC-CCcEEEEEEeccCChhcHHHHHHHHHHHHccCCCCcceEEEEEEeCCeEEEEEEecCCCCHH
Q 002158 631 TQVGQGGYGKVYKGILS-DNTTVAIKRAEEGSLQGQNEFLTEIKLLSRLHHRNLVSLLGYCDEEGEQMLVYEFVPNGTLR 709 (958)
Q Consensus 631 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E~~~~gsL~ 709 (958)
..||+|+||.||+|..+ +++.||||++........+.+.+|+.+++.++|+|++++++++...+..++||||+++++|.
T Consensus 26 ~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~ 105 (292)
T cd06657 26 IKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALT 105 (292)
T ss_pred HHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCCcHH
Confidence 57999999999999975 78999999987655555667999999999999999999999999999999999999999999
Q ss_pred HHhccCCCCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEecCCCCeEEeeeeeecccccCCCCCCcccee
Q 002158 710 DWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSRLAPVLDDEGTMPTHV 789 (958)
Q Consensus 710 ~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~ 789 (958)
+++... .+++..+..++.|++.|++|||+.+ ++||||||+||++++++.++|+|||++....... ..
T Consensus 106 ~~~~~~---~~~~~~~~~~~~ql~~~l~~lH~~g---ivH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~-------~~ 172 (292)
T cd06657 106 DIVTHT---RMNEEQIAAVCLAVLKALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV-------PR 172 (292)
T ss_pred HHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEcccccceeccccc-------cc
Confidence 988543 3788999999999999999999999 9999999999999999999999999886543211 11
Q ss_pred eeeccCCCCccChhhhccCCCCCcchhhhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcCcchhhhcccCCCCChHHHH
Q 002158 790 STIVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVLLELLTGMQPISHGKNIVREVNVARDSGMVFSIIDNRMGSYPSECVE 869 (958)
Q Consensus 790 ~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gv~l~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~ 869 (958)
.....|++.|+|||++.+..++.++||||+|+++|||++|..||....... ....... . ..... ......+.
T Consensus 173 ~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~-~~~~~~~-~-----~~~~~-~~~~~~~~ 244 (292)
T cd06657 173 RKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLK-AMKMIRD-N-----LPPKL-KNLHKVSP 244 (292)
T ss_pred ccccccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHh-h-----CCccc-CCcccCCH
Confidence 223458899999999988888999999999999999999999997543321 1111111 0 00011 01223456
Q ss_pred HHHHHHHHccccCCCCCCCHHHHHHH
Q 002158 870 RFVTLALRCCHDKPEHRPSMSDVVRE 895 (958)
Q Consensus 870 ~l~~li~~cl~~dP~~RPs~~evl~~ 895 (958)
.+.+++.+||+.+|.+||++.+++++
T Consensus 245 ~l~~li~~~l~~~P~~R~~~~~ll~~ 270 (292)
T cd06657 245 SLKGFLDRLLVRDPAQRATAAELLKH 270 (292)
T ss_pred HHHHHHHHHHhCCcccCcCHHHHhcC
Confidence 78899999999999999999999974
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=319.95 Aligned_cols=385 Identities=22% Similarity=0.216 Sum_probs=256.0
Q ss_pred CCCCCCCCceeeCccc---------cCCCceeeEEEEccCCcCCCCccccccCCCCcceeeccCcccCCCCccccCCCCC
Q 002158 65 DPCMSNWTGVLCFDTV---------ETDGHLHVRELQLLSMNLSGNLAPELGQLSRLQYYFMWNDLTGTIPKEIGNISSL 135 (958)
Q Consensus 65 ~~c~~~w~gV~C~~~~---------~~~~~~~v~~L~L~~~~l~~~~~~~l~~L~~L~~L~l~n~~~~~ip~~i~~l~~L 135 (958)
.+|.|.-.-..|++.- ...-+..++.|||++|.++..-+..|.+|++|+.+.+.+|....||...+...+|
T Consensus 48 a~c~c~~~lldcs~~~lea~~~~~l~g~lp~~t~~LdlsnNkl~~id~~~f~nl~nLq~v~l~~N~Lt~IP~f~~~sghl 127 (873)
T KOG4194|consen 48 ATCPCNTRLLDCSDRELEAIDKSRLKGFLPSQTQTLDLSNNKLSHIDFEFFYNLPNLQEVNLNKNELTRIPRFGHESGHL 127 (873)
T ss_pred CcCCCCceeeecCccccccccccccCCcCccceeeeeccccccccCcHHHHhcCCcceeeeeccchhhhcccccccccce
Confidence 4566666667776421 2223567889999999999999999999999999999999999999887777889
Q ss_pred cEEEeeCCCCCCCCChhhcCCCCCCEEecccccccccCccccccccccceEecccccccccCchhhcCCccchhhhccCC
Q 002158 136 IFLLLNGNKLSGSLPDELGYLSNLNRLQVDENNITGTIPKSFANLSRVRHLHLNNNSIGGQIPSELSKLSTLIHLLVDNN 215 (958)
Q Consensus 136 ~~L~Ls~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N 215 (958)
+.|+|.+|.|+..-..++..++.|+.|||+.|.|+.+.-+.|..-.++++|+|++|.|+..-.+.|.++.+|..|.|++|
T Consensus 128 ~~L~L~~N~I~sv~se~L~~l~alrslDLSrN~is~i~~~sfp~~~ni~~L~La~N~It~l~~~~F~~lnsL~tlkLsrN 207 (873)
T KOG4194|consen 128 EKLDLRHNLISSVTSEELSALPALRSLDLSRNLISEIPKPSFPAKVNIKKLNLASNRITTLETGHFDSLNSLLTLKLSRN 207 (873)
T ss_pred eEEeeeccccccccHHHHHhHhhhhhhhhhhchhhcccCCCCCCCCCceEEeeccccccccccccccccchheeeecccC
Confidence 99999999888666667777778888888888777555556666667777777777777666666666777777777777
Q ss_pred ccccCCCcccCCCCCccEEEccCCCCCCC-----------------------CccccccCCCCCCEEEcccCCCCCCCCC
Q 002158 216 NLSGNLPPELSELPQLCILQLDNNNFSAS-----------------------EIPATYGNFSKLVKLSLRNCNLQGAVPD 272 (958)
Q Consensus 216 ~l~~~~~~~l~~l~~L~~L~L~~N~l~~~-----------------------~~p~~~~~l~~L~~L~L~~N~l~~~~~~ 272 (958)
+|+...+..|..+++|+.|+|..|+|... .-...|..+.++++|+|+.|+++..-.+
T Consensus 208 rittLp~r~Fk~L~~L~~LdLnrN~irive~ltFqgL~Sl~nlklqrN~I~kL~DG~Fy~l~kme~l~L~~N~l~~vn~g 287 (873)
T KOG4194|consen 208 RITTLPQRSFKRLPKLESLDLNRNRIRIVEGLTFQGLPSLQNLKLQRNDISKLDDGAFYGLEKMEHLNLETNRLQAVNEG 287 (873)
T ss_pred cccccCHHHhhhcchhhhhhccccceeeehhhhhcCchhhhhhhhhhcCcccccCcceeeecccceeecccchhhhhhcc
Confidence 77766666666667777776666666421 1123455566667777777777665553
Q ss_pred -CCCCCCcCEEeccCCcCCCc-CCCCCCCCCcCEEEccCCcCCCccchhccCCCCCCeEeeecccCCCccchhhhcc-cc
Q 002158 273 -LSRIPNLYYLDLSWNHLTGS-IPSKKLSENVTTIDLSDNYLNGSILESISNLPFLQTLSLENNFLTGSIPATIWQN-KS 349 (958)
Q Consensus 273 -l~~l~~L~~L~Ls~N~l~~~-~~~~~~~~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~ip~~l~~~-~~ 349 (958)
+.+++.|+.|+||+|.|... +....+.++|++|+|++|+|+...+..|..|..|++|+|++|.|+ .+.+..|.. .+
T Consensus 288 ~lfgLt~L~~L~lS~NaI~rih~d~WsftqkL~~LdLs~N~i~~l~~~sf~~L~~Le~LnLs~Nsi~-~l~e~af~~lss 366 (873)
T KOG4194|consen 288 WLFGLTSLEQLDLSYNAIQRIHIDSWSFTQKLKELDLSSNRITRLDEGSFRVLSQLEELNLSHNSID-HLAEGAFVGLSS 366 (873)
T ss_pred cccccchhhhhccchhhhheeecchhhhcccceeEeccccccccCChhHHHHHHHhhhhcccccchH-HHHhhHHHHhhh
Confidence 67777888888888877643 333456688888888888888877777766666666666666655 333332221 11
Q ss_pred cC----------------------ccccceEeccCCCCCCCccCC--CCCCcceEEeCCCCCCCCCCCCCCCcccccCCC
Q 002158 350 FS----------------------TKARLKIDLRNNSFSNIVGDL--TLPNNVTLRLGGNPICTSANIPNTGRFCGSDAG 405 (958)
Q Consensus 350 ~~----------------------~~~l~~L~Ls~N~l~~l~~~~--~l~~L~~L~l~~N~l~~~~~~~~~~~~~~~~~~ 405 (958)
+. .+.|..|+|.+|+|..|+... ++++|+.|+|.+|++.+.- ...|-.. ..
T Consensus 367 L~~LdLr~N~ls~~IEDaa~~f~gl~~LrkL~l~gNqlk~I~krAfsgl~~LE~LdL~~NaiaSIq----~nAFe~m-~L 441 (873)
T KOG4194|consen 367 LHKLDLRSNELSWCIEDAAVAFNGLPSLRKLRLTGNQLKSIPKRAFSGLEALEHLDLGDNAIASIQ----PNAFEPM-EL 441 (873)
T ss_pred hhhhcCcCCeEEEEEecchhhhccchhhhheeecCceeeecchhhhccCcccceecCCCCcceeec----ccccccc-hh
Confidence 11 334455555555555555433 5555555666555553211 0111111 23
Q ss_pred CCccccccCCCCCCCCCCCCCcccc-cCCCCCCceeeeeceee-eeecCCCC
Q 002158 406 GDETLTNSKVNCPVQACPVDNFFEY-VPASPEPCFCAAPLRIG-YRLKSPSF 455 (958)
Q Consensus 406 ~~~~L~~n~~~C~c~~~~~~~~~~~-~~~~~~~~~c~sp~~~~-~~~~~~~~ 455 (958)
..+.++...+-|||++.|+..|+.. .........|+.|+-.. ..+.+.+.
T Consensus 442 k~Lv~nSssflCDCql~Wl~qWl~~~~lq~sv~a~CayPe~Lad~~i~svd~ 493 (873)
T KOG4194|consen 442 KELVMNSSSFLCDCQLKWLAQWLYRRKLQSSVIAKCAYPEPLADQSIVSVDT 493 (873)
T ss_pred hhhhhcccceEEeccHHHHHHHHHhcccccceeeeccCCcccccceeEeech
Confidence 3445566677899999999999943 33333348999998765 44444443
|
|
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-33 Score=308.46 Aligned_cols=260 Identities=23% Similarity=0.307 Sum_probs=198.9
Q ss_pred cCCCCCceeeeeCCeEEEEEEEC-CCcEEEEEEeccCCh--hcHHHHHHHHHHHHccCCCCcceEEEEEEeCCeEEEEEE
Q 002158 625 AYFSSSTQVGQGGYGKVYKGILS-DNTTVAIKRAEEGSL--QGQNEFLTEIKLLSRLHHRNLVSLLGYCDEEGEQMLVYE 701 (958)
Q Consensus 625 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E 701 (958)
++|+..+.||+|++|+||+|.++ +++.||+|.+..... ...+.+.+|++++++++|+||+++++++......++|||
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 81 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFE 81 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEe
Confidence 36778889999999999999986 688999998865432 223568899999999999999999999999999999999
Q ss_pred ecCCCCHHHHhccCCCCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEecC-CCCeEEeeeeeecccccCC
Q 002158 702 FVPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDS-NLNAKVADFGLSRLAPVLD 780 (958)
Q Consensus 702 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~-~~~~kl~DFGla~~~~~~~ 780 (958)
|++ ++|.+++.......+++..+..++.|++.||+|||+.+ ++||||||+||+++. ++.+||+|||+++......
T Consensus 82 ~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~~ 157 (294)
T PLN00009 82 YLD-LDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHR---VLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPV 157 (294)
T ss_pred ccc-ccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCcceEEEECCCCEEEEcccccccccCCCc
Confidence 995 68888886555445688888999999999999999998 999999999999985 5679999999997542211
Q ss_pred CCCCccceeeeeccCCCCccChhhhccC-CCCCcchhhhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcCcchhhh---
Q 002158 781 DEGTMPTHVSTIVKGTPGYLDPEYFLTH-KLTDKSDVYSLGVVLLELLTGMQPISHGKNIVREVNVARDSGMVFSII--- 856 (958)
Q Consensus 781 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DV~S~Gv~l~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~i--- 856 (958)
.......|++.|+|||++.+. .++.++||||+|+++|||+||+.||................+......
T Consensus 158 -------~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (294)
T PLN00009 158 -------RTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPG 230 (294)
T ss_pred -------cccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhccc
Confidence 111223578899999998764 578899999999999999999999976543322222111100000000
Q ss_pred ----------cccC-----CCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 002158 857 ----------DNRM-----GSYPSECVERFVTLALRCCHDKPEHRPSMSDVVRE 895 (958)
Q Consensus 857 ----------~~~~-----~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 895 (958)
.... .......+..+.+++.+|++.+|++||++.+++++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~~ 284 (294)
T PLN00009 231 VTSLPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEH 284 (294)
T ss_pred cccchhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0000 00112345678899999999999999999999974
|
|
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-33 Score=317.90 Aligned_cols=257 Identities=23% Similarity=0.318 Sum_probs=199.6
Q ss_pred HHcCCCCCceeeeeCCeEEEEEEEC-CCcEEEEEEeccC--ChhcHHHHHHHHHHHHccCCCCcceEEEEEEeC------
Q 002158 623 ATAYFSSSTQVGQGGYGKVYKGILS-DNTTVAIKRAEEG--SLQGQNEFLTEIKLLSRLHHRNLVSLLGYCDEE------ 693 (958)
Q Consensus 623 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~------ 693 (958)
...+|+..+.||+|+||.||+|... +++.||||.+... ......++.+|+.++++++|+||+++++++...
T Consensus 14 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 93 (353)
T cd07850 14 VLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEF 93 (353)
T ss_pred hhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCcccc
Confidence 3467888899999999999999975 7899999998643 233345678899999999999999999998643
Q ss_pred CeEEEEEEecCCCCHHHHhccCCCCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEecCCCCeEEeeeeee
Q 002158 694 GEQMLVYEFVPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSNLNAKVADFGLS 773 (958)
Q Consensus 694 ~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla 773 (958)
...++||||++ ++|.+++... ++...+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||++
T Consensus 94 ~~~~lv~e~~~-~~l~~~~~~~----l~~~~~~~~~~ql~~aL~~LH~~g---i~H~dlkp~Nil~~~~~~~kL~Dfg~~ 165 (353)
T cd07850 94 QDVYLVMELMD-ANLCQVIQMD----LDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLA 165 (353)
T ss_pred CcEEEEEeccC-CCHHHHHhhc----CCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEccCccc
Confidence 35799999995 6898888532 788899999999999999999999 999999999999999999999999999
Q ss_pred cccccCCCCCCccceeeeeccCCCCccChhhhccCCCCCcchhhhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcCcc-
Q 002158 774 RLAPVLDDEGTMPTHVSTIVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVLLELLTGMQPISHGKNIVREVNVARDSGMV- 852 (958)
Q Consensus 774 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gv~l~elltG~~P~~~~~~~~~~~~~~~~~~~~- 852 (958)
+...... ......|+..|+|||.+.+..++.++|||||||++|+|++|+.||........+.......+..
T Consensus 166 ~~~~~~~--------~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~ 237 (353)
T cd07850 166 RTAGTSF--------MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPS 237 (353)
T ss_pred eeCCCCC--------CCCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCC
Confidence 7542211 1123457889999999999999999999999999999999999997554322221111100000
Q ss_pred -------------------------h-hhhcccC-----CCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 002158 853 -------------------------F-SIIDNRM-----GSYPSECVERFVTLALRCCHDKPEHRPSMSDVVRE 895 (958)
Q Consensus 853 -------------------------~-~~i~~~~-----~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 895 (958)
. +...... ...+...+..+.+++.+||+.||++||++.|++++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~ 311 (353)
T cd07850 238 DEFMSRLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQH 311 (353)
T ss_pred HHHHHHhhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 0 0000000 00022346678999999999999999999999975
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-33 Score=299.93 Aligned_cols=247 Identities=27% Similarity=0.482 Sum_probs=207.0
Q ss_pred CCCCCceeeeeCCeEEEEEEEC-CCcEEEEEEeccCCh--hcHHHHHHHHHHHHccCCCCcceEEEEEEeCCeEEEEEEe
Q 002158 626 YFSSSTQVGQGGYGKVYKGILS-DNTTVAIKRAEEGSL--QGQNEFLTEIKLLSRLHHRNLVSLLGYCDEEGEQMLVYEF 702 (958)
Q Consensus 626 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E~ 702 (958)
+|+..+.||+|++|.||+|+.. +++.||+|.+..... ...+.+.+|++++++++|+|++++++++..++..++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEY 80 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEec
Confidence 3677889999999999999976 678999999877543 3456799999999999999999999999999999999999
Q ss_pred cCCCCHHHHhccCCCCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEecCCCCeEEeeeeeecccccCCCC
Q 002158 703 VPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSRLAPVLDDE 782 (958)
Q Consensus 703 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~ 782 (958)
+++++|.+++... ..+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.++|+|||++.........
T Consensus 81 ~~~~~L~~~~~~~--~~l~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~ 155 (254)
T cd06627 81 AENGSLRQIIKKF--GPFPESLVAVYVYQVLQGLAYLHEQG---VIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKD 155 (254)
T ss_pred CCCCcHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCHHHEEECCCCCEEEeccccceecCCCccc
Confidence 9999999999755 34899999999999999999999999 999999999999999999999999999865332211
Q ss_pred CCccceeeeeccCCCCccChhhhccCCCCCcchhhhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcCcchhhhcccCCC
Q 002158 783 GTMPTHVSTIVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVLLELLTGMQPISHGKNIVREVNVARDSGMVFSIIDNRMGS 862 (958)
Q Consensus 783 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gv~l~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~ 862 (958)
.....|+..|+|||...+..++.++||||+|+++|||++|+.||............. ......
T Consensus 156 -------~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~~~~~~~----------~~~~~~ 218 (254)
T cd06627 156 -------DASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPMAALFRIV----------QDDHPP 218 (254)
T ss_pred -------ccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHh----------ccCCCC
Confidence 123458889999999988888899999999999999999999997554332222111 112223
Q ss_pred CChHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002158 863 YPSECVERFVTLALRCCHDKPEHRPSMSDVVR 894 (958)
Q Consensus 863 ~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 894 (958)
.+...+..+.+++.+|+..+|++||++.+++.
T Consensus 219 ~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 250 (254)
T cd06627 219 LPEGISPELKDFLMQCFQKDPNLRPTAKQLLK 250 (254)
T ss_pred CCCCCCHHHHHHHHHHHhCChhhCcCHHHHhc
Confidence 44556788999999999999999999999985
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-33 Score=302.08 Aligned_cols=250 Identities=28% Similarity=0.454 Sum_probs=208.4
Q ss_pred CCCCCceeeeeCCeEEEEEEEC-CCcEEEEEEeccCCh--hcHHHHHHHHHHHHccCCCCcceEEEEEEeCCeEEEEEEe
Q 002158 626 YFSSSTQVGQGGYGKVYKGILS-DNTTVAIKRAEEGSL--QGQNEFLTEIKLLSRLHHRNLVSLLGYCDEEGEQMLVYEF 702 (958)
Q Consensus 626 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E~ 702 (958)
+|...+.||+|+||.||++.+. +++.||+|++..... ...+.+.+|+++++.++|+|++++++.+..++..++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~ 80 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEY 80 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEe
Confidence 4677789999999999999986 688999999876533 4556789999999999999999999999999999999999
Q ss_pred cCCCCHHHHhccCC--CCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEecCCCCeEEeeeeeecccccCC
Q 002158 703 VPNGTLRDWLSGRT--KENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSRLAPVLD 780 (958)
Q Consensus 703 ~~~gsL~~~l~~~~--~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~ 780 (958)
+++++|.+++.... ...+++.++..++.+++.||.|||+.+ ++|+||+|+||++++++.++|+|||.+.......
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~---~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~ 157 (258)
T cd08215 81 ADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRK---ILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTV 157 (258)
T ss_pred cCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCC---EecccCChHHeEEcCCCcEEECCccceeecccCc
Confidence 99999999997643 356999999999999999999999998 9999999999999999999999999987653221
Q ss_pred CCCCccceeeeeccCCCCccChhhhccCCCCCcchhhhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcCcchhhhcccC
Q 002158 781 DEGTMPTHVSTIVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVLLELLTGMQPISHGKNIVREVNVARDSGMVFSIIDNRM 860 (958)
Q Consensus 781 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gv~l~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~i~~~~ 860 (958)
.......|++.|+|||......++.++||||+|+++++|++|+.||..... ....... .....
T Consensus 158 -------~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~-~~~~~~~---------~~~~~ 220 (258)
T cd08215 158 -------DLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENL-LELALKI---------LKGQY 220 (258)
T ss_pred -------ceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcH-HHHHHHH---------hcCCC
Confidence 122234588899999999988899999999999999999999999965432 1111111 11222
Q ss_pred CCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 002158 861 GSYPSECVERFVTLALRCCHDKPEHRPSMSDVVRE 895 (958)
Q Consensus 861 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 895 (958)
...+..++..+.+++.+||..+|++||++.+++++
T Consensus 221 ~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~ 255 (258)
T cd08215 221 PPIPSQYSSELRNLVSSLLQKDPEERPSIAQILQS 255 (258)
T ss_pred CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 33445667889999999999999999999999863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=304.46 Aligned_cols=241 Identities=26% Similarity=0.361 Sum_probs=198.0
Q ss_pred eeeeCCeEEEEEEEC-CCcEEEEEEeccCCh---hcHHHHHHHHHHHHccCCCCcceEEEEEEeCCeEEEEEEecCCCCH
Q 002158 633 VGQGGYGKVYKGILS-DNTTVAIKRAEEGSL---QGQNEFLTEIKLLSRLHHRNLVSLLGYCDEEGEQMLVYEFVPNGTL 708 (958)
Q Consensus 633 lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E~~~~gsL 708 (958)
||+|+||.||+|+.. +++.||+|++..... ...+.+.+|++++++++||||+++++++.++...++||||+++++|
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL 80 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence 699999999999986 489999999875422 3346789999999999999999999999999999999999999999
Q ss_pred HHHhccCCCCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEecCCCCeEEeeeeeecccccCCCCCCccce
Q 002158 709 RDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSRLAPVLDDEGTMPTH 788 (958)
Q Consensus 709 ~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~ 788 (958)
.+++.... .+++..+..++.|++.||+|||+.+ ++|+||||+||+++.++.++|+|||+++......
T Consensus 81 ~~~l~~~~--~l~~~~~~~~~~~i~~~l~~lH~~~---~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~-------- 147 (262)
T cd05572 81 WTILRDRG--LFDEYTARFYIACVVLAFEYLHNRG---IIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ-------- 147 (262)
T ss_pred HHHHhhcC--CCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCHHHEEEcCCCCEEEeeCCcccccCccc--------
Confidence 99997543 3889999999999999999999998 9999999999999999999999999987653211
Q ss_pred eeeeccCCCCccChhhhccCCCCCcchhhhHHHHHHHHHhCCCCCCCCch-hHHHHHHHhhcCcchhhhcccCCCCChHH
Q 002158 789 VSTIVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVLLELLTGMQPISHGKN-IVREVNVARDSGMVFSIIDNRMGSYPSEC 867 (958)
Q Consensus 789 ~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gv~l~elltG~~P~~~~~~-~~~~~~~~~~~~~~~~~i~~~~~~~~~~~ 867 (958)
......|+..|+|||.+.+..++.++|+||+|+++|||++|..||..... .......... .......|...
T Consensus 148 ~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~--------~~~~~~~~~~~ 219 (262)
T cd05572 148 KTWTFCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYNDILK--------GNGKLEFPNYI 219 (262)
T ss_pred ccccccCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCHHHHHHHHhc--------cCCCCCCCccc
Confidence 11234588899999999888899999999999999999999999975542 1111111110 01122344455
Q ss_pred HHHHHHHHHHccccCCCCCCC-----HHHHHH
Q 002158 868 VERFVTLALRCCHDKPEHRPS-----MSDVVR 894 (958)
Q Consensus 868 ~~~l~~li~~cl~~dP~~RPs-----~~evl~ 894 (958)
+..+.+++.+||+.+|++||+ ++|+++
T Consensus 220 ~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~ 251 (262)
T cd05572 220 DKAAKDLIKQLLRRNPEERLGNLKGGIKDIKK 251 (262)
T ss_pred CHHHHHHHHHHccCChhhCcCCcccCHHHHhc
Confidence 788999999999999999999 677665
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-33 Score=305.66 Aligned_cols=255 Identities=24% Similarity=0.290 Sum_probs=194.2
Q ss_pred CCCCceeeeeCCeEEEEEEEC-CCcEEEEEEeccCC-hhcHHHHHHHHHHHHccC-CCCcceEEEEEEeC--CeEEEEEE
Q 002158 627 FSSSTQVGQGGYGKVYKGILS-DNTTVAIKRAEEGS-LQGQNEFLTEIKLLSRLH-HRNLVSLLGYCDEE--GEQMLVYE 701 (958)
Q Consensus 627 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~--~~~~lV~E 701 (958)
|...+.||+|+||.||+|... +++.||+|+++... ........+|+.+++++. |+|++++++++.+. +..++|||
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e 80 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFE 80 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEe
Confidence 456788999999999999975 68899999987542 222334567999999995 99999999999887 89999999
Q ss_pred ecCCCCHHHHhccCCCCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEecCCCCeEEeeeeeecccccCCC
Q 002158 702 FVPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSRLAPVLDD 781 (958)
Q Consensus 702 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~ 781 (958)
|++ ++|.+++.... ..+++.++..++.|++.||+|||+.+ ++||||||+||+++. +.+||+|||+++.......
T Consensus 81 ~~~-~~l~~~l~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~---i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~~ 154 (282)
T cd07831 81 LMD-MNLYELIKGRK-RPLPEKRVKSYMYQLLKSLDHMHRNG---IFHRDIKPENILIKD-DILKLADFGSCRGIYSKPP 154 (282)
T ss_pred cCC-ccHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecccCHHHEEEcC-CCeEEEecccccccccCCC
Confidence 996 68888886543 35899999999999999999999999 999999999999999 9999999999975532111
Q ss_pred CCCccceeeeeccCCCCccChhhhcc-CCCCCcchhhhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcCcchh----hh
Q 002158 782 EGTMPTHVSTIVKGTPGYLDPEYFLT-HKLTDKSDVYSLGVVLLELLTGMQPISHGKNIVREVNVARDSGMVFS----II 856 (958)
Q Consensus 782 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DV~S~Gv~l~elltG~~P~~~~~~~~~~~~~~~~~~~~~~----~i 856 (958)
.....++..|+|||++.. ..++.++|||||||++|||++|..||................+.... ..
T Consensus 155 --------~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (282)
T cd07831 155 --------YTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKF 226 (282)
T ss_pred --------cCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcCCCCHHHHHhh
Confidence 112357889999998754 45788999999999999999999999754432211111100000000 00
Q ss_pred cc------c--------CCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 002158 857 DN------R--------MGSYPSECVERFVTLALRCCHDKPEHRPSMSDVVRE 895 (958)
Q Consensus 857 ~~------~--------~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 895 (958)
.. . ........+..+.+++.+||+.+|++||++++++++
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~ 279 (282)
T cd07831 227 RKSRHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRH 279 (282)
T ss_pred cccccccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhhC
Confidence 00 0 000112456889999999999999999999999864
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-33 Score=309.14 Aligned_cols=260 Identities=25% Similarity=0.293 Sum_probs=197.8
Q ss_pred HcCCCCCceeeeeCCeEEEEEEEC-CCcEEEEEEeccCChh--cHHHHHHHHHHHHccCCCCcceEEEEEEeC--CeEEE
Q 002158 624 TAYFSSSTQVGQGGYGKVYKGILS-DNTTVAIKRAEEGSLQ--GQNEFLTEIKLLSRLHHRNLVSLLGYCDEE--GEQML 698 (958)
Q Consensus 624 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~H~niv~l~~~~~~~--~~~~l 698 (958)
.++|+..+.||+|+||.||+|.+. +|+.||+|+++..... ....+.+|++++++++|+|++++++++... +..++
T Consensus 6 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 85 (309)
T cd07845 6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFL 85 (309)
T ss_pred ccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEE
Confidence 356888899999999999999986 6899999998654322 123567899999999999999999998754 56899
Q ss_pred EEEecCCCCHHHHhccCCCCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEecCCCCeEEeeeeeeccccc
Q 002158 699 VYEFVPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSRLAPV 778 (958)
Q Consensus 699 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~~~~ 778 (958)
||||++ ++|.+++.... ..+++.++..++.|+++||+|||+.+ ++||||||+||++++++.+||+|||+++....
T Consensus 86 v~e~~~-~~l~~~l~~~~-~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~~ 160 (309)
T cd07845 86 VMEYCE-QDLASLLDNMP-TPFSESQVKCLMLQLLRGLQYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTYGL 160 (309)
T ss_pred EEecCC-CCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECccceeeecCC
Confidence 999996 58998887543 45899999999999999999999999 99999999999999999999999999986532
Q ss_pred CCCCCCccceeeeeccCCCCccChhhhcc-CCCCCcchhhhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcCcchhhh-
Q 002158 779 LDDEGTMPTHVSTIVKGTPGYLDPEYFLT-HKLTDKSDVYSLGVVLLELLTGMQPISHGKNIVREVNVARDSGMVFSII- 856 (958)
Q Consensus 779 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DV~S~Gv~l~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~i- 856 (958)
... ......++..|+|||.+.+ ..++.++||||+|+++|||++|+.||................+.....+
T Consensus 161 ~~~-------~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~ 233 (309)
T cd07845 161 PAK-------PMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIW 233 (309)
T ss_pred ccC-------CCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChhhc
Confidence 211 1122335788999999876 4578899999999999999999999975543322211111100000000
Q ss_pred --------------c-ccCCC---CChHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 002158 857 --------------D-NRMGS---YPSECVERFVTLALRCCHDKPEHRPSMSDVVRE 895 (958)
Q Consensus 857 --------------~-~~~~~---~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 895 (958)
. ..... .....++.+.+++.+|++.||++||+++|++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h 290 (309)
T cd07845 234 PGFSDLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALES 290 (309)
T ss_pred hhhhcccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 0 00000 001235678899999999999999999999974
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-33 Score=304.97 Aligned_cols=257 Identities=27% Similarity=0.351 Sum_probs=197.4
Q ss_pred CCCCceeeeeCCeEEEEEEEC-CCcEEEEEEeccCChh--cHHHHHHHHHHHHcc---CCCCcceEEEEEEeCCe-----
Q 002158 627 FSSSTQVGQGGYGKVYKGILS-DNTTVAIKRAEEGSLQ--GQNEFLTEIKLLSRL---HHRNLVSLLGYCDEEGE----- 695 (958)
Q Consensus 627 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l---~H~niv~l~~~~~~~~~----- 695 (958)
|+..+.||+|+||.||+|.++ +++.||+|++...... ....+.+|+.+++++ +|+|++++++++...+.
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~ 80 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK 80 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence 556789999999999999987 4899999998743222 234566788877666 59999999999988776
Q ss_pred EEEEEEecCCCCHHHHhccCCCCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEecCCCCeEEeeeeeecc
Q 002158 696 QMLVYEFVPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSRL 775 (958)
Q Consensus 696 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~ 775 (958)
.+++|||++ ++|.+++.......+++..+..++.|+++||+|||+.+ ++|+||+|+||+++.++.+||+|||++..
T Consensus 81 ~~l~~e~~~-~~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~---i~h~~l~~~nili~~~~~~~l~dfg~~~~ 156 (287)
T cd07838 81 LTLVFEHVD-QDLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSHR---IVHRDLKPQNILVTSDGQVKIADFGLARI 156 (287)
T ss_pred eEEEehhcc-cCHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCChhhEEEccCCCEEEeccCccee
Confidence 999999996 58999987654446899999999999999999999998 99999999999999999999999999876
Q ss_pred cccCCCCCCccceeeeeccCCCCccChhhhccCCCCCcchhhhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcCcc---
Q 002158 776 APVLDDEGTMPTHVSTIVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVLLELLTGMQPISHGKNIVREVNVARDSGMV--- 852 (958)
Q Consensus 776 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gv~l~elltG~~P~~~~~~~~~~~~~~~~~~~~--- 852 (958)
...... .....++..|+|||++.+..++.++||||||+++|||++|+.||...................
T Consensus 157 ~~~~~~--------~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (287)
T cd07838 157 YSFEMA--------LTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEE 228 (287)
T ss_pred ccCCcc--------cccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChHHHHHHHHHHcCCCChH
Confidence 532211 112347889999999999999999999999999999999999987544322111111100000
Q ss_pred ---------hhhhcccC----CCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 002158 853 ---------FSIIDNRM----GSYPSECVERFVTLALRCCHDKPEHRPSMSDVVRE 895 (958)
Q Consensus 853 ---------~~~i~~~~----~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 895 (958)
........ .......+..+.+++.+||+.||++||+++|++++
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~~ 284 (287)
T cd07838 229 EWPRNVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQH 284 (287)
T ss_pred hcCCCcccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhcC
Confidence 00000000 11122455778899999999999999999999863
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=315.38 Aligned_cols=261 Identities=24% Similarity=0.336 Sum_probs=197.8
Q ss_pred HcCCCCCceeeeeCCeEEEEEEEC-CCcEEEEEEeccC-ChhcHHHHHHHHHHHHccCCCCcceEEEEEEeCC-----eE
Q 002158 624 TAYFSSSTQVGQGGYGKVYKGILS-DNTTVAIKRAEEG-SLQGQNEFLTEIKLLSRLHHRNLVSLLGYCDEEG-----EQ 696 (958)
Q Consensus 624 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~-----~~ 696 (958)
.++|...+.||+|+||.||+|.+. +|+.||||++... ......++.+|+.++++++|+||+++++++.... ..
T Consensus 4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 83 (336)
T cd07849 4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDV 83 (336)
T ss_pred ccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceE
Confidence 357888999999999999999975 6899999998643 2233456889999999999999999999876543 57
Q ss_pred EEEEEecCCCCHHHHhccCCCCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEecCCCCeEEeeeeeeccc
Q 002158 697 MLVYEFVPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSRLA 776 (958)
Q Consensus 697 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~~ 776 (958)
++||||++ ++|.+++... .+++..+..++.|+++||+|||+.+ |+||||||+||+++.++.+||+|||+++..
T Consensus 84 ~lv~e~~~-~~l~~~~~~~---~l~~~~~~~i~~ql~~aL~~LH~~~---ivH~dlkp~Nill~~~~~~kl~dfg~~~~~ 156 (336)
T cd07849 84 YIVQELME-TDLYKLIKTQ---HLSNDHIQYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTNCDLKICDFGLARIA 156 (336)
T ss_pred EEEehhcc-cCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEECCCCCEEECcccceeec
Confidence 99999996 5888888643 3899999999999999999999999 999999999999999999999999998765
Q ss_pred ccCCCCCCccceeeeeccCCCCccChhhhcc-CCCCCcchhhhHHHHHHHHHhCCCCCCCCchhHHHHHHHh--hcC---
Q 002158 777 PVLDDEGTMPTHVSTIVKGTPGYLDPEYFLT-HKLTDKSDVYSLGVVLLELLTGMQPISHGKNIVREVNVAR--DSG--- 850 (958)
Q Consensus 777 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DV~S~Gv~l~elltG~~P~~~~~~~~~~~~~~~--~~~--- 850 (958)
...... ........|+..|+|||.+.+ ..++.++||||+||++|||++|+.||.............. ...
T Consensus 157 ~~~~~~----~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~~~~~~~~~~~~~ 232 (336)
T cd07849 157 DPEHDH----TGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQE 232 (336)
T ss_pred cccccc----cCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHH
Confidence 332211 111223568999999998765 4688899999999999999999999965432211111000 000
Q ss_pred cchhhhcc----------cCCC-----CChHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 002158 851 MVFSIIDN----------RMGS-----YPSECVERFVTLALRCCHDKPEHRPSMSDVVRE 895 (958)
Q Consensus 851 ~~~~~i~~----------~~~~-----~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 895 (958)
....+... .... .....+..+.+++.+||+.+|++||++.|++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~h 292 (336)
T cd07849 233 DLNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAH 292 (336)
T ss_pred HHHHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 00000000 0000 011235678999999999999999999999986
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=334.95 Aligned_cols=264 Identities=28% Similarity=0.489 Sum_probs=213.4
Q ss_pred HHHHHcCCCCCceeeeeCCeEEEEEEEC----C----CcEEEEEEeccCC-hhcHHHHHHHHHHHHcc-CCCCcceEEEE
Q 002158 620 LAMATAYFSSSTQVGQGGYGKVYKGILS----D----NTTVAIKRAEEGS-LQGQNEFLTEIKLLSRL-HHRNLVSLLGY 689 (958)
Q Consensus 620 l~~~~~~~~~~~~lg~G~~g~Vy~~~~~----~----~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~~~ 689 (958)
++...++....+.||+|.||.|++|... . ...||||.++... ..+.+.+..|+++|+.+ +|+||+.++|+
T Consensus 291 ~e~~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~ 370 (609)
T KOG0200|consen 291 WEIPRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGA 370 (609)
T ss_pred eeechhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheee
Confidence 4444555566679999999999999843 1 4579999998753 34567899999999999 59999999999
Q ss_pred EEeCCeEEEEEEecCCCCHHHHhccCC------C--------CCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCcc
Q 002158 690 CDEEGEQMLVYEFVPNGTLRDWLSGRT------K--------ENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKAS 755 (958)
Q Consensus 690 ~~~~~~~~lV~E~~~~gsL~~~l~~~~------~--------~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~ 755 (958)
|...+..++|+||+..|+|.++++.++ . ..++....+.++.|||.|++||++.. +||||+.++
T Consensus 371 ~t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~---~vHRDLAaR 447 (609)
T KOG0200|consen 371 CTQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVP---CVHRDLAAR 447 (609)
T ss_pred eccCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCC---ccchhhhhh
Confidence 999999999999999999999998655 0 13888999999999999999999998 999999999
Q ss_pred ceEecCCCCeEEeeeeeecccccCCCCCCccceeeeeccC--CCCccChhhhccCCCCCcchhhhHHHHHHHHHh-CCCC
Q 002158 756 NILLDSNLNAKVADFGLSRLAPVLDDEGTMPTHVSTIVKG--TPGYLDPEYFLTHKLTDKSDVYSLGVVLLELLT-GMQP 832 (958)
Q Consensus 756 NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~g--t~~y~aPE~~~~~~~~~~~DV~S~Gv~l~ellt-G~~P 832 (958)
|||+.++..+||+|||+|+.....+. .....-.| ...|||||.+....|+.|+|||||||+||||+| |..|
T Consensus 448 NVLi~~~~~~kIaDFGlar~~~~~~~------y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~P 521 (609)
T KOG0200|consen 448 NVLITKNKVIKIADFGLARDHYNKDY------YRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTP 521 (609)
T ss_pred hEEecCCCEEEEccccceeccCCCCc------eEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCC
Confidence 99999999999999999985432221 11111122 345999999999999999999999999999999 8889
Q ss_pred CCCCchhHHHHHHHhhcCcchhhhcccCCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHh
Q 002158 833 ISHGKNIVREVNVARDSGMVFSIIDNRMGSYPSECVERFVTLALRCCHDKPEHRPSMSDVVRELENILK 901 (958)
Q Consensus 833 ~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~ 901 (958)
|.+-......+. ... ++.+...|..|..+++++|+.||+.+|++||++.++++.++..+.
T Consensus 522 Yp~~~~~~~l~~-~l~--------~G~r~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~~l~ 581 (609)
T KOG0200|consen 522 YPGIPPTEELLE-FLK--------EGNRMEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVEFFEKHLQ 581 (609)
T ss_pred CCCCCcHHHHHH-HHh--------cCCCCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHHHHHHH
Confidence 975221222221 111 222335578889999999999999999999999999999999664
|
|
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-33 Score=304.38 Aligned_cols=257 Identities=25% Similarity=0.356 Sum_probs=202.2
Q ss_pred CCCCceeeeeCCeEEEEEEEC-CCcEEEEEEeccCChh--cHHHHHHHHHHHHccCCCCcceEEEEEEeCCeEEEEEEec
Q 002158 627 FSSSTQVGQGGYGKVYKGILS-DNTTVAIKRAEEGSLQ--GQNEFLTEIKLLSRLHHRNLVSLLGYCDEEGEQMLVYEFV 703 (958)
Q Consensus 627 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E~~ 703 (958)
|...+.||+|++|.||+|... +++.+++|.+...... ....+.+|++++++++|+||+++++++..++..++||||+
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFM 80 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEecc
Confidence 456788999999999999975 6889999998764322 3567889999999999999999999999999999999999
Q ss_pred CCCCHHHHhccCCCCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEecCCCCeEEeeeeeecccccCCCCC
Q 002158 704 PNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSRLAPVLDDEG 783 (958)
Q Consensus 704 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 783 (958)
+ ++|.+++.... ..+++.++..++.|+++||+|||+.+ |+|+||||+||+++.++.++|+|||.+.......
T Consensus 81 ~-~~l~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~--- 152 (283)
T cd05118 81 D-TDLYKLIKDRQ-RGLPESLIKSYLYQLLQGLAFCHSHG---ILHRDLKPENLLINTEGVLKLADFGLARSFGSPV--- 152 (283)
T ss_pred C-CCHHHHHHhhc-ccCCHHHHHHHHHHHHHHHHHHHHCC---eeecCcCHHHEEECCCCcEEEeeeeeeEecCCCc---
Confidence 6 48988887643 45899999999999999999999999 9999999999999999999999999987653321
Q ss_pred CccceeeeeccCCCCccChhhhccC-CCCCcchhhhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcCcchh----hhcc
Q 002158 784 TMPTHVSTIVKGTPGYLDPEYFLTH-KLTDKSDVYSLGVVLLELLTGMQPISHGKNIVREVNVARDSGMVFS----IIDN 858 (958)
Q Consensus 784 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DV~S~Gv~l~elltG~~P~~~~~~~~~~~~~~~~~~~~~~----~i~~ 858 (958)
.......++..|+|||.+.+. .++.++||||+|+++|+|++|+.||................+.... ....
T Consensus 153 ----~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (283)
T cd05118 153 ----RPYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTS 228 (283)
T ss_pred ----ccccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCchHhcccchh
Confidence 111223578889999999877 7889999999999999999999999765543322211111110000 0000
Q ss_pred ------------c---CCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 002158 859 ------------R---MGSYPSECVERFVTLALRCCHDKPEHRPSMSDVVRE 895 (958)
Q Consensus 859 ------------~---~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 895 (958)
. ........+.++.+++.+||+.||.+||++.+++.+
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~~ 280 (283)
T cd05118 229 LARNYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAH 280 (283)
T ss_pred hhhhhhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhhC
Confidence 0 011123467889999999999999999999999863
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-33 Score=307.20 Aligned_cols=263 Identities=26% Similarity=0.316 Sum_probs=199.7
Q ss_pred HHHcCCCCCceeeeeCCeEEEEEEEC-CCcEEEEEEeccCC--hhcHHHHHHHHHHHHccCCCCcceEEEEEEeCC----
Q 002158 622 MATAYFSSSTQVGQGGYGKVYKGILS-DNTTVAIKRAEEGS--LQGQNEFLTEIKLLSRLHHRNLVSLLGYCDEEG---- 694 (958)
Q Consensus 622 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~---- 694 (958)
...++|+..+.||+|+||.||+|.++ +++.||+|+++... ......+.+|++++++++|||++++++++.+..
T Consensus 4 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~ 83 (302)
T cd07864 4 RCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALD 83 (302)
T ss_pred hhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhh
Confidence 35567888999999999999999986 58899999986542 223356788999999999999999999987654
Q ss_pred ------eEEEEEEecCCCCHHHHhccCCCCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEecCCCCeEEe
Q 002158 695 ------EQMLVYEFVPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSNLNAKVA 768 (958)
Q Consensus 695 ------~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~~~~kl~ 768 (958)
..++||||+++ ++.+.+... ...+++..+..++.|++.||+|||+.+ |+||||||+||++++++.+||+
T Consensus 84 ~~~~~~~~~lv~e~~~~-~l~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~---i~H~dl~p~nili~~~~~~kl~ 158 (302)
T cd07864 84 FKKDKGAFYLVFEYMDH-DLMGLLESG-LVHFSEDHIKSFMKQLLEGLNYCHKKN---FLHRDIKCSNILLNNKGQIKLA 158 (302)
T ss_pred ccccCCcEEEEEcccCc-cHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCcEEeC
Confidence 78999999975 787777654 335899999999999999999999999 9999999999999999999999
Q ss_pred eeeeecccccCCCCCCccceeeeeccCCCCccChhhhccC-CCCCcchhhhHHHHHHHHHhCCCCCCCCchhHHHHHHHh
Q 002158 769 DFGLSRLAPVLDDEGTMPTHVSTIVKGTPGYLDPEYFLTH-KLTDKSDVYSLGVVLLELLTGMQPISHGKNIVREVNVAR 847 (958)
Q Consensus 769 DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DV~S~Gv~l~elltG~~P~~~~~~~~~~~~~~~ 847 (958)
|||+++....... .......++..|+|||.+.+. .++.++|||||||++|||++|+.||..............
T Consensus 159 dfg~~~~~~~~~~------~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~~~~~ 232 (302)
T cd07864 159 DFGLARLYNSEES------RPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISR 232 (302)
T ss_pred cccccccccCCcc------cccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHH
Confidence 9999876533221 111223467789999988653 568899999999999999999999975443222111111
Q ss_pred hcCcc-----hhh--------hccc------CCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 002158 848 DSGMV-----FSI--------IDNR------MGSYPSECVERFVTLALRCCHDKPEHRPSMSDVVRE 895 (958)
Q Consensus 848 ~~~~~-----~~~--------i~~~------~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 895 (958)
..+.. ... .+.. ........+..+.+++.+||+.+|.+||++++++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 299 (302)
T cd07864 233 LCGSPCPAVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALNS 299 (302)
T ss_pred HhCCCChhhcccccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 00000 000 0000 000111246788999999999999999999999863
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-35 Score=344.18 Aligned_cols=257 Identities=26% Similarity=0.351 Sum_probs=210.1
Q ss_pred HHHcCCCCCceeeeeCCeEEEEEEEC-CCcEEEEEEeccC--ChhcHHHHHHHHHHHHccCCCCcceEEEEEEeCCeEEE
Q 002158 622 MATAYFSSSTQVGQGGYGKVYKGILS-DNTTVAIKRAEEG--SLQGQNEFLTEIKLLSRLHHRNLVSLLGYCDEEGEQML 698 (958)
Q Consensus 622 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~l 698 (958)
..+-+++....||.|.||.||.|... +|.-.|+|-++.. .....+...+|..++..++|||+|+++|+-.+.+..+|
T Consensus 1232 nV~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~I 1311 (1509)
T KOG4645|consen 1232 NVTFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYI 1311 (1509)
T ss_pred cceeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHHH
Confidence 34456778889999999999999954 6888999976543 23334567899999999999999999999999999999
Q ss_pred EEEecCCCCHHHHhccCCCCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEecCCCCeEEeeeeeeccccc
Q 002158 699 VYEFVPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSRLAPV 778 (958)
Q Consensus 699 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~~~~ 778 (958)
-||||++|+|.+.+...+ ..++.....+..|++.|++|||++| ||||||||.||+++.+|.+|++|||.|.....
T Consensus 1312 FMEyC~~GsLa~ll~~gr--i~dE~vt~vyt~qll~gla~LH~~g---IVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~ 1386 (1509)
T KOG4645|consen 1312 FMEYCEGGSLASLLEHGR--IEDEMVTRVYTKQLLEGLAYLHEHG---IVHRDIKPANILLDFNGLIKYGDFGSAVKIKN 1386 (1509)
T ss_pred HHHHhccCcHHHHHHhcc--hhhhhHHHHHHHHHHHHHHHHHhcC---ceecCCCccceeeecCCcEEeecccceeEecC
Confidence 999999999999996443 3677777788899999999999999 99999999999999999999999999987643
Q ss_pred CCCCCCccceeeeeccCCCCccChhhhccCC---CCCcchhhhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcCcchhh
Q 002158 779 LDDEGTMPTHVSTIVKGTPGYLDPEYFLTHK---LTDKSDVYSLGVVLLELLTGMQPISHGKNIVREVNVARDSGMVFSI 855 (958)
Q Consensus 779 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~~~DV~S~Gv~l~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~ 855 (958)
. .++.+ ..-....||+-|||||++.+.. ...++||||+||++.||+||+.||...++..+.+. .+
T Consensus 1387 ~--~~~~~-~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~aIMy---------~V 1454 (1509)
T KOG4645|consen 1387 N--AQTMP-GELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEWAIMY---------HV 1454 (1509)
T ss_pred c--hhcCC-HHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchhHHHh---------HH
Confidence 2 11222 2223567999999999997643 55689999999999999999999986555443332 22
Q ss_pred hcccCCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 002158 856 IDNRMGSYPSECVERFVTLALRCCHDKPEHRPSMSDVVRE 895 (958)
Q Consensus 856 i~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 895 (958)
...+.+++|.....+-.+++.+|++.||+.|.++.|++++
T Consensus 1455 ~~gh~Pq~P~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle~ 1494 (1509)
T KOG4645|consen 1455 AAGHKPQIPERLSSEGRDFLEHCLEQDPKMRWTASQLLEH 1494 (1509)
T ss_pred hccCCCCCchhhhHhHHHHHHHHHhcCchhhhHHHHHHHh
Confidence 2334456677788889999999999999999999888764
|
|
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-33 Score=309.89 Aligned_cols=262 Identities=24% Similarity=0.315 Sum_probs=195.9
Q ss_pred CCCCCceeeeeCCeEEEEEEECC---CcEEEEEEeccCC---hhcHHHHHHHHHHHHccCCCCcceEEEEEEeC--CeEE
Q 002158 626 YFSSSTQVGQGGYGKVYKGILSD---NTTVAIKRAEEGS---LQGQNEFLTEIKLLSRLHHRNLVSLLGYCDEE--GEQM 697 (958)
Q Consensus 626 ~~~~~~~lg~G~~g~Vy~~~~~~---~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~--~~~~ 697 (958)
.|...+.||+|+||.||+|.+.. ++.||+|.+.... ....+.+.+|+.++++++||||+++++++... +..+
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 80 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY 80 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence 36777899999999999999754 7899999987632 23345678899999999999999999999888 7899
Q ss_pred EEEEecCCCCHHHHhccCC---CCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEecC----CCCeEEeee
Q 002158 698 LVYEFVPNGTLRDWLSGRT---KENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDS----NLNAKVADF 770 (958)
Q Consensus 698 lV~E~~~~gsL~~~l~~~~---~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~----~~~~kl~DF 770 (958)
+||||++ +++.+++.... ...++...+..++.|++.||+|||+.+ |+||||||+||+++. ++.+||+||
T Consensus 81 lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~h~dlkp~Nil~~~~~~~~~~~kl~Df 156 (316)
T cd07842 81 LLFDYAE-HDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNW---VLHRDLKPANILVMGEGPERGVVKIGDL 156 (316)
T ss_pred EEEeCCC-cCHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCC---EeeCCCCHHHEEEcCCCCccceEEECCC
Confidence 9999996 47777764322 235889999999999999999999999 999999999999999 899999999
Q ss_pred eeecccccCCCCCCccceeeeeccCCCCccChhhhccC-CCCCcchhhhHHHHHHHHHhCCCCCCCCchhH---------
Q 002158 771 GLSRLAPVLDDEGTMPTHVSTIVKGTPGYLDPEYFLTH-KLTDKSDVYSLGVVLLELLTGMQPISHGKNIV--------- 840 (958)
Q Consensus 771 Gla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DV~S~Gv~l~elltG~~P~~~~~~~~--------- 840 (958)
|+++........ ........++..|+|||++.+. .++.++||||||+++|||++|+.||.......
T Consensus 157 g~~~~~~~~~~~----~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~ 232 (316)
T cd07842 157 GLARLFNAPLKP----LADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRD 232 (316)
T ss_pred ccccccCCCccc----ccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHH
Confidence 999865332211 1112234678999999988764 57889999999999999999999996432211
Q ss_pred ---HHHHHHh-----------hcCcchhhh-cccCCCCC-----------hHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002158 841 ---REVNVAR-----------DSGMVFSII-DNRMGSYP-----------SECVERFVTLALRCCHDKPEHRPSMSDVVR 894 (958)
Q Consensus 841 ---~~~~~~~-----------~~~~~~~~i-~~~~~~~~-----------~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 894 (958)
..+.... ......... .......+ ......+.+++.+|++.||++||++.|+++
T Consensus 233 ~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~ 312 (316)
T cd07842 233 QLERIFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALE 312 (316)
T ss_pred HHHHHHHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 0000000 000000000 00000111 023456889999999999999999999986
Q ss_pred H
Q 002158 895 E 895 (958)
Q Consensus 895 ~ 895 (958)
+
T Consensus 313 ~ 313 (316)
T cd07842 313 H 313 (316)
T ss_pred C
Confidence 4
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-33 Score=307.54 Aligned_cols=245 Identities=27% Similarity=0.436 Sum_probs=197.1
Q ss_pred CCCCCceeeeeCCeEEEEEEEC-CCcEEEEEEeccC---ChhcHHHHHHHHHHHHccCCCCcceEEEEEEeCCeEEEEEE
Q 002158 626 YFSSSTQVGQGGYGKVYKGILS-DNTTVAIKRAEEG---SLQGQNEFLTEIKLLSRLHHRNLVSLLGYCDEEGEQMLVYE 701 (958)
Q Consensus 626 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E 701 (958)
.|+..+.||+|+||.||+|+.. +++.||+|.+... ......++.+|+++++.++|+|++++++++......++|||
T Consensus 16 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 95 (308)
T cd06634 16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVME 95 (308)
T ss_pred HHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEEE
Confidence 3555678999999999999976 6788999988642 22334568899999999999999999999999999999999
Q ss_pred ecCCCCHHHHhccCCCCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEecCCCCeEEeeeeeecccccCCC
Q 002158 702 FVPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSRLAPVLDD 781 (958)
Q Consensus 702 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~ 781 (958)
|+. |++.+++.... ..+++.++..++.|++.|+.|||+.+ ++||||||+||+++.++.++|+|||++.....
T Consensus 96 ~~~-~~l~~~~~~~~-~~l~~~~~~~~~~~l~~~l~~LH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~--- 167 (308)
T cd06634 96 YCL-GSASDLLEVHK-KPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAP--- 167 (308)
T ss_pred ccC-CCHHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHhEEECCCCcEEECCcccceeecC---
Confidence 996 68888775433 34889999999999999999999998 99999999999999999999999999875421
Q ss_pred CCCccceeeeeccCCCCccChhhhc---cCCCCCcchhhhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcCcchhhhcc
Q 002158 782 EGTMPTHVSTIVKGTPGYLDPEYFL---THKLTDKSDVYSLGVVLLELLTGMQPISHGKNIVREVNVARDSGMVFSIIDN 858 (958)
Q Consensus 782 ~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DV~S~Gv~l~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~i~~ 858 (958)
.....|+..|+|||++. ...++.++|||||||++|||++|..||.............. .
T Consensus 168 --------~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~----------~ 229 (308)
T cd06634 168 --------ANXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQ----------N 229 (308)
T ss_pred --------cccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHHHHHHhh----------c
Confidence 12245888999999985 34678899999999999999999999865433221111111 1
Q ss_pred cCC-CCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 002158 859 RMG-SYPSECVERFVTLALRCCHDKPEHRPSMSDVVREL 896 (958)
Q Consensus 859 ~~~-~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 896 (958)
... ..+..++..+.+++.+||+.+|++||++++++++-
T Consensus 230 ~~~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~ 268 (308)
T cd06634 230 ESPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHR 268 (308)
T ss_pred CCCCcCcccccHHHHHHHHHHhhCCcccCCCHHHHhhCc
Confidence 111 11335667899999999999999999999999763
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-33 Score=298.78 Aligned_cols=248 Identities=26% Similarity=0.414 Sum_probs=205.8
Q ss_pred CCCCCceeeeeCCeEEEEEEEC-CCcEEEEEEeccCC--hhcHHHHHHHHHHHHccCCCCcceEEEEEEeCCeEEEEEEe
Q 002158 626 YFSSSTQVGQGGYGKVYKGILS-DNTTVAIKRAEEGS--LQGQNEFLTEIKLLSRLHHRNLVSLLGYCDEEGEQMLVYEF 702 (958)
Q Consensus 626 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E~ 702 (958)
+|+..+.||+|+||.||++... +++.+|+|.+.... .....++.+|++++++++|+||+++++++......++||||
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEY 80 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehh
Confidence 4677889999999999999876 68899999987532 33355788999999999999999999999999999999999
Q ss_pred cCCCCHHHHhccCC--CCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEecCCCCeEEeeeeeecccccCC
Q 002158 703 VPNGTLRDWLSGRT--KENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSRLAPVLD 780 (958)
Q Consensus 703 ~~~gsL~~~l~~~~--~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~ 780 (958)
+++++|.+++.... ...+++..+..++.|++.||+|||+.+ ++|+||+|+||++++++.+||+|||+++.....
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~---i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~- 156 (256)
T cd08530 81 APFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQK---ILHRDLKSANILLVANDLVKIGDLGISKVLKKN- 156 (256)
T ss_pred cCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCcceEEEecCCcEEEeeccchhhhccC-
Confidence 99999999986522 345899999999999999999999999 999999999999999999999999999765332
Q ss_pred CCCCccceeeeeccCCCCccChhhhccCCCCCcchhhhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcCcchhhhcccC
Q 002158 781 DEGTMPTHVSTIVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVLLELLTGMQPISHGKNIVREVNVARDSGMVFSIIDNRM 860 (958)
Q Consensus 781 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gv~l~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~i~~~~ 860 (958)
......|+..|+|||.+.+..++.++|+||+|+++|||++|+.||....... .. .. ......
T Consensus 157 --------~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~-~~-~~--------~~~~~~ 218 (256)
T cd08530 157 --------MAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQD-LR-YK--------VQRGKY 218 (256)
T ss_pred --------CcccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-HH-HH--------HhcCCC
Confidence 1112347889999999999999999999999999999999999997544221 11 11 111222
Q ss_pred CCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 002158 861 GSYPSECVERFVTLALRCCHDKPEHRPSMSDVVRE 895 (958)
Q Consensus 861 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 895 (958)
...+...+.++.+++.+|++.+|++||++.+++++
T Consensus 219 ~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 253 (256)
T cd08530 219 PPIPPIYSQDLQNFIRSMLQVKPKLRPNCDKILAS 253 (256)
T ss_pred CCCchhhCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 33445677889999999999999999999999864
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-33 Score=313.62 Aligned_cols=264 Identities=26% Similarity=0.392 Sum_probs=200.5
Q ss_pred HHcCCCCCceeeeeCCeEEEEEEEC-CCcEEEEEEeccC--ChhcHHHHHHHHHHHHcc-CCCCcceEEEEEEeC--CeE
Q 002158 623 ATAYFSSSTQVGQGGYGKVYKGILS-DNTTVAIKRAEEG--SLQGQNEFLTEIKLLSRL-HHRNLVSLLGYCDEE--GEQ 696 (958)
Q Consensus 623 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~--~~~ 696 (958)
..++|+..+.||+|+||.||+|.+. +++.||||++... .......+.+|+.+++++ +|+||+++++++... ...
T Consensus 5 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~ 84 (337)
T cd07852 5 ILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDI 84 (337)
T ss_pred hhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceE
Confidence 3456778889999999999999976 6889999988542 233345678899999999 999999999998653 368
Q ss_pred EEEEEecCCCCHHHHhccCCCCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEecCCCCeEEeeeeeeccc
Q 002158 697 MLVYEFVPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSRLA 776 (958)
Q Consensus 697 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~~ 776 (958)
++||||++ ++|.+++... .+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+++..
T Consensus 85 ~lv~e~~~-~~L~~~~~~~---~~~~~~~~~i~~qi~~~L~~LH~~~---i~H~dl~p~nill~~~~~~kl~d~g~~~~~ 157 (337)
T cd07852 85 YLVFEYME-TDLHAVIRAN---ILEDVHKRYIMYQLLKALKYIHSGN---VIHRDLKPSNILLNSDCRVKLADFGLARSL 157 (337)
T ss_pred EEEecccc-cCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEEeeccchhcc
Confidence 99999996 6999998754 4889999999999999999999998 999999999999999999999999999865
Q ss_pred ccCCCCCCccceeeeeccCCCCccChhhhcc-CCCCCcchhhhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcCcc---
Q 002158 777 PVLDDEGTMPTHVSTIVKGTPGYLDPEYFLT-HKLTDKSDVYSLGVVLLELLTGMQPISHGKNIVREVNVARDSGMV--- 852 (958)
Q Consensus 777 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DV~S~Gv~l~elltG~~P~~~~~~~~~~~~~~~~~~~~--- 852 (958)
....... .........|+..|+|||++.+ ..++.++||||||+++|||++|+.||................+..
T Consensus 158 ~~~~~~~--~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~ 235 (337)
T cd07852 158 SELEENP--ENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAE 235 (337)
T ss_pred ccccccc--cCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHH
Confidence 4322111 0112233568999999998765 457889999999999999999999997544322211111110000
Q ss_pred ----------hhhhc---cc----CCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 002158 853 ----------FSIID---NR----MGSYPSECVERFVTLALRCCHDKPEHRPSMSDVVRE 895 (958)
Q Consensus 853 ----------~~~i~---~~----~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 895 (958)
...++ .. ........+.++.+++.+||+.+|++||++.+++++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~ 295 (337)
T cd07852 236 DIESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEH 295 (337)
T ss_pred HHHHHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhC
Confidence 00000 00 011112256788999999999999999999999975
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-33 Score=306.68 Aligned_cols=263 Identities=23% Similarity=0.335 Sum_probs=195.2
Q ss_pred cCCCCCceeeeeCCeEEEEEEEC-CCcEEEEEEeccCCh--hcHHHHHHHHHHHHccCCCCcceEEEEEEeCC-------
Q 002158 625 AYFSSSTQVGQGGYGKVYKGILS-DNTTVAIKRAEEGSL--QGQNEFLTEIKLLSRLHHRNLVSLLGYCDEEG------- 694 (958)
Q Consensus 625 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~------- 694 (958)
++|+..+.||+|+||.||+|... +++.||||.+..... .....+.+|++++++++||||+++++++...+
T Consensus 12 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 91 (310)
T cd07865 12 SKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRYK 91 (310)
T ss_pred hheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCCC
Confidence 36788899999999999999976 689999998864322 22345678999999999999999999987654
Q ss_pred -eEEEEEEecCCCCHHHHhccCCCCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEecCCCCeEEeeeeee
Q 002158 695 -EQMLVYEFVPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSNLNAKVADFGLS 773 (958)
Q Consensus 695 -~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla 773 (958)
..++||||++ ++|.+++.... ..+++.++..++.|++.||+|||+++ ++|+||||+||+++.++.+||+|||++
T Consensus 92 ~~~~lv~e~~~-~~l~~~l~~~~-~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~ 166 (310)
T cd07865 92 GSFYLVFEFCE-HDLAGLLSNKN-VKFTLSEIKKVMKMLLNGLYYIHRNK---ILHRDMKAANILITKDGILKLADFGLA 166 (310)
T ss_pred ceEEEEEcCCC-cCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEECCCCcEEECcCCCc
Confidence 4599999995 58888886543 34899999999999999999999998 999999999999999999999999999
Q ss_pred cccccCCCCCCccceeeeeccCCCCccChhhhccC-CCCCcchhhhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcCcc
Q 002158 774 RLAPVLDDEGTMPTHVSTIVKGTPGYLDPEYFLTH-KLTDKSDVYSLGVVLLELLTGMQPISHGKNIVREVNVARDSGMV 852 (958)
Q Consensus 774 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DV~S~Gv~l~elltG~~P~~~~~~~~~~~~~~~~~~~~ 852 (958)
.......... ........++..|+|||.+.+. .++.++||||||+++|||++|+.||..............-.+..
T Consensus 167 ~~~~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~~~ 243 (310)
T cd07865 167 RAFSLSKNSK---PNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSI 243 (310)
T ss_pred ccccCCcccC---CCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCC
Confidence 8653322111 1111234578899999998765 36889999999999999999999997544322111111000000
Q ss_pred h----------hhhcc-cCC-CC---------ChHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 002158 853 F----------SIIDN-RMG-SY---------PSECVERFVTLALRCCHDKPEHRPSMSDVVRE 895 (958)
Q Consensus 853 ~----------~~i~~-~~~-~~---------~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 895 (958)
. ...+. ... .. +......+.+++.+||+.||++||+++|++++
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~h 307 (310)
T cd07865 244 TPEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALNH 307 (310)
T ss_pred ChhhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhcC
Confidence 0 00000 000 00 00113456789999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-34 Score=283.41 Aligned_cols=255 Identities=23% Similarity=0.358 Sum_probs=200.0
Q ss_pred cChHHHHHHHcCCCCCceeeeeCCeEEEEEEEC-CCcEEEEEEeccC-ChhcHHHHHHHHHHHHccC-CCCcceEEEEEE
Q 002158 615 FKFKELAMATAYFSSSTQVGQGGYGKVYKGILS-DNTTVAIKRAEEG-SLQGQNEFLTEIKLLSRLH-HRNLVSLLGYCD 691 (958)
Q Consensus 615 ~~~~el~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~-H~niv~l~~~~~ 691 (958)
....|++.. ..||.|+.|.|++++.+ .|...|||.+... ..++.++++..++++..-+ +|.||+-+|||.
T Consensus 89 ~dindl~~l-------~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi 161 (391)
T KOG0983|consen 89 ADINDLENL-------GDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFI 161 (391)
T ss_pred cChHHhhhH-------HhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEe
Confidence 345555543 45999999999999976 5899999998765 4555678889998887775 999999999999
Q ss_pred eCCeEEEEEEecCCCCHHHHhccCCCCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEecCCCCeEEeeee
Q 002158 692 EEGEQMLVYEFVPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSNLNAKVADFG 771 (958)
Q Consensus 692 ~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~~~~kl~DFG 771 (958)
.....++.||.| .-.++.+++. -.+++++..+-++...+..||.||.+++. |+|||+||+|||+|+.|++|+||||
T Consensus 162 ~n~dV~IcMelM-s~C~ekLlkr-ik~piPE~ilGk~tva~v~AL~YLKeKH~--viHRDvKPSNILlDe~GniKlCDFG 237 (391)
T KOG0983|consen 162 TNTDVFICMELM-STCAEKLLKR-IKGPIPERILGKMTVAIVKALYYLKEKHG--VIHRDVKPSNILLDERGNIKLCDFG 237 (391)
T ss_pred eCchHHHHHHHH-HHHHHHHHHH-hcCCchHHhhhhhHHHHHHHHHHHHHhcc--eeecccCccceEEccCCCEEeeccc
Confidence 999999999999 3455666543 34558888889999999999999998764 9999999999999999999999999
Q ss_pred eecccccCCCCCCccceeeeeccCCCCccChhhhcc---CCCCCcchhhhHHHHHHHHHhCCCCCCCCchhHHHHHHHhh
Q 002158 772 LSRLAPVLDDEGTMPTHVSTIVKGTPGYLDPEYFLT---HKLTDKSDVYSLGVVLLELLTGMQPISHGKNIVREVNVARD 848 (958)
Q Consensus 772 la~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DV~S~Gv~l~elltG~~P~~~~~~~~~~~~~~~~ 848 (958)
++-.+.. ....+...|-+.|||||.+.- ..|+.++||||||++++||.||+.||..-+...+.+....+
T Consensus 238 IsGrlvd--------SkAhtrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~ltkvln 309 (391)
T KOG0983|consen 238 ISGRLVD--------SKAHTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFEVLTKVLN 309 (391)
T ss_pred ccceeec--------ccccccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHHHHHHHHh
Confidence 9865532 222334568899999999853 46888999999999999999999999864433332222211
Q ss_pred cCcchhhhcccCCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 002158 849 SGMVFSIIDNRMGSYPSECVERFVTLALRCCHDKPEHRPSMSDVVRE 895 (958)
Q Consensus 849 ~~~~~~~i~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 895 (958)
... +.+ .........+.+++..|+++|+.+||.+.+++++
T Consensus 310 ~eP------P~L-~~~~gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~h 349 (391)
T KOG0983|consen 310 EEP------PLL-PGHMGFSPDFQSFVKDCLTKDHRKRPKYNKLLEH 349 (391)
T ss_pred cCC------CCC-CcccCcCHHHHHHHHHHhhcCcccCcchHHHhcC
Confidence 110 111 1112367889999999999999999999999975
|
|
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-33 Score=299.12 Aligned_cols=242 Identities=24% Similarity=0.296 Sum_probs=189.7
Q ss_pred ceeeeeCCeEEEEEEEC-CCcEEEEEEeccCChh---cHHHHHHHHHHH-HccCCCCcceEEEEEEeCCeEEEEEEecCC
Q 002158 631 TQVGQGGYGKVYKGILS-DNTTVAIKRAEEGSLQ---GQNEFLTEIKLL-SRLHHRNLVSLLGYCDEEGEQMLVYEFVPN 705 (958)
Q Consensus 631 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~~E~~~l-~~l~H~niv~l~~~~~~~~~~~lV~E~~~~ 705 (958)
+.||+|+||.||+|... +++.||||.+...... ....+..|..++ ...+|+|++++++++...+..++||||+++
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG 81 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence 46899999999999975 6889999998754321 223345555544 455899999999999999999999999999
Q ss_pred CCHHHHhccCCCCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEecCCCCeEEeeeeeecccccCCCCCCc
Q 002158 706 GTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSRLAPVLDDEGTM 785 (958)
Q Consensus 706 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~ 785 (958)
++|.++++... .+++..+..++.|++.||.|||+.+ ++||||+|+||++++++.++|+|||+++....
T Consensus 82 ~~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~------- 149 (260)
T cd05611 82 GDCASLIKTLG--GLPEDWAKQYIAEVVLGVEDLHQRG---IIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE------- 149 (260)
T ss_pred CCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCcEEEeecccceeccc-------
Confidence 99999997543 4889999999999999999999998 99999999999999999999999999875321
Q ss_pred cceeeeeccCCCCccChhhhccCCCCCcchhhhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcCcchhhhcccCCCCCh
Q 002158 786 PTHVSTIVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVLLELLTGMQPISHGKNIVREVNVARDSGMVFSIIDNRMGSYPS 865 (958)
Q Consensus 786 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gv~l~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~ 865 (958)
.....|+..|+|||.+.+..++.++||||||+++|||++|..||....... .......... ........
T Consensus 150 ----~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~-~~~~~~~~~~------~~~~~~~~ 218 (260)
T cd05611 150 ----NKKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDA-VFDNILSRRI------NWPEEVKE 218 (260)
T ss_pred ----cccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHHH-HHHHHHhccc------CCCCcccc
Confidence 123458889999999988888999999999999999999999997544321 1111111000 00011223
Q ss_pred HHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 002158 866 ECVERFVTLALRCCHDKPEHRPSMSDVVRE 895 (958)
Q Consensus 866 ~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 895 (958)
.++..+.+++.+||+.+|++||++.++.+.
T Consensus 219 ~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~ 248 (260)
T cd05611 219 FCSPEAVDLINRLLCMDPAKRLGANGYQEI 248 (260)
T ss_pred cCCHHHHHHHHHHccCCHHHccCCCcHHHH
Confidence 457889999999999999999977554443
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-33 Score=303.12 Aligned_cols=258 Identities=25% Similarity=0.340 Sum_probs=198.4
Q ss_pred CCCCceeeeeCCeEEEEEEEC-CCcEEEEEEeccCC--hhcHHHHHHHHHHHHccCCCCcceEEEEEEeC--CeEEEEEE
Q 002158 627 FSSSTQVGQGGYGKVYKGILS-DNTTVAIKRAEEGS--LQGQNEFLTEIKLLSRLHHRNLVSLLGYCDEE--GEQMLVYE 701 (958)
Q Consensus 627 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~--~~~~lV~E 701 (958)
|+..+.||+|+||.||+|.+. +++.||+|++.... ......+.+|++++++++|+|++++++++... +..++|||
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e 80 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE 80 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence 456788999999999999986 58899999997653 33345688999999999999999999999888 89999999
Q ss_pred ecCCCCHHHHhccCCCCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEecCCCCeEEeeeeeecccccCCC
Q 002158 702 FVPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSRLAPVLDD 781 (958)
Q Consensus 702 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~ 781 (958)
|++ ++|.+++.... ..+++..+..++.|+++||+|||+.+ ++|+||||+||++++++.+||+|||++........
T Consensus 81 ~~~-~~l~~~~~~~~-~~~~~~~~~~i~~~i~~al~~LH~~~---~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~~ 155 (287)
T cd07840 81 YMD-HDLTGLLDSPE-VKFTESQIKCYMKQLLEGLQYLHSNG---ILHRDIKGSNILINNDGVLKLADFGLARPYTKRNS 155 (287)
T ss_pred ccc-ccHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCcHHHeEEcCCCCEEEccccceeeccCCCc
Confidence 997 58999987543 35899999999999999999999998 99999999999999999999999999986533221
Q ss_pred CCCccceeeeeccCCCCccChhhhcc-CCCCCcchhhhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcCcc----h---
Q 002158 782 EGTMPTHVSTIVKGTPGYLDPEYFLT-HKLTDKSDVYSLGVVLLELLTGMQPISHGKNIVREVNVARDSGMV----F--- 853 (958)
Q Consensus 782 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DV~S~Gv~l~elltG~~P~~~~~~~~~~~~~~~~~~~~----~--- 853 (958)
.......++..|+|||.+.+ ..++.++||||||+++|||++|+.||................+.. .
T Consensus 156 ------~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (287)
T cd07840 156 ------ADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGV 229 (287)
T ss_pred ------ccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhcccc
Confidence 11122346788999998765 457889999999999999999999997544322111111000000 0
Q ss_pred -h-----hhcccC-------CCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 002158 854 -S-----IIDNRM-------GSYPSECVERFVTLALRCCHDKPEHRPSMSDVVRE 895 (958)
Q Consensus 854 -~-----~i~~~~-------~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 895 (958)
. ...... ..+...++..+.+++.+||+.+|++||++++++++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~ 284 (287)
T cd07840 230 SKLPWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQH 284 (287)
T ss_pred ccchhhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence 0 000000 00011126788999999999999999999999863
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-33 Score=302.70 Aligned_cols=248 Identities=25% Similarity=0.399 Sum_probs=197.9
Q ss_pred eeeeCCeEEEEEEEC-CCcEEEEEEeccCCh---hcHHHHHHHHHHHHccCCCCcceEEEEEEeCCeEEEEEEecCCCCH
Q 002158 633 VGQGGYGKVYKGILS-DNTTVAIKRAEEGSL---QGQNEFLTEIKLLSRLHHRNLVSLLGYCDEEGEQMLVYEFVPNGTL 708 (958)
Q Consensus 633 lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E~~~~gsL 708 (958)
||+|+||.||++.+. +++.||+|.+..... ...+.+.+|++++++++|+||+++++.+..+...++||||+++++|
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL 80 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence 689999999999987 489999999876433 3456788999999999999999999999999999999999999999
Q ss_pred HHHhccCCCCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEecCCCCeEEeeeeeecccccCCCCC-Cccc
Q 002158 709 RDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSRLAPVLDDEG-TMPT 787 (958)
Q Consensus 709 ~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~~-~~~~ 787 (958)
.++++... .+++..+..++.|+++||+|||+.+ ++||||+|+||++++++.++|+|||++.......... ....
T Consensus 81 ~~~l~~~~--~~~~~~~~~i~~qi~~~L~~lH~~~---i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~ 155 (265)
T cd05579 81 ASLLENVG--SLDEDVARIYIAEIVLALEYLHSNG---IIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDE 155 (265)
T ss_pred HHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHcC---eecCCCCHHHeEEcCCCCEEEEecccchhcccCccccccccc
Confidence 99997644 4899999999999999999999999 9999999999999999999999999987543221100 0001
Q ss_pred eeeeeccCCCCccChhhhccCCCCCcchhhhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcCcchhhhcccCCCCChHH
Q 002158 788 HVSTIVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVLLELLTGMQPISHGKNIVREVNVARDSGMVFSIIDNRMGSYPSEC 867 (958)
Q Consensus 788 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gv~l~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~ 867 (958)
.......++..|+|||......++.++||||||+++||+++|..||...... ........ .....+..+
T Consensus 156 ~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~-~~~~~~~~----------~~~~~~~~~ 224 (265)
T cd05579 156 KEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPE-EIFQNILN----------GKIEWPEDV 224 (265)
T ss_pred ccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHhc----------CCcCCCccc
Confidence 1223355888999999999888999999999999999999999999754422 11111111 011122222
Q ss_pred --HHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 002158 868 --VERFVTLALRCCHDKPEHRPSMSDVVREL 896 (958)
Q Consensus 868 --~~~l~~li~~cl~~dP~~RPs~~evl~~L 896 (958)
+..+.+++.+||+.+|++||++.++.+.|
T Consensus 225 ~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l 255 (265)
T cd05579 225 EVSDEAIDLISKLLVPDPEKRLGAKSIEEIK 255 (265)
T ss_pred cCCHHHHHHHHHHhcCCHhhcCCCccHHHHh
Confidence 68889999999999999999995555443
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-33 Score=312.99 Aligned_cols=263 Identities=22% Similarity=0.317 Sum_probs=201.0
Q ss_pred HcCCCCCceeeeeCCeEEEEEEEC-CCcEEEEEEeccCC--hhcHHHHHHHHHHHHccCCCCcceEEEEEEe----CCeE
Q 002158 624 TAYFSSSTQVGQGGYGKVYKGILS-DNTTVAIKRAEEGS--LQGQNEFLTEIKLLSRLHHRNLVSLLGYCDE----EGEQ 696 (958)
Q Consensus 624 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~----~~~~ 696 (958)
..+|+..+.||+|+||.||+|..+ +++.||+|++.... ....+.+.+|+.++++++||||+++++++.. ....
T Consensus 4 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 83 (334)
T cd07855 4 GSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDV 83 (334)
T ss_pred hhceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceE
Confidence 367888899999999999999976 68999999987542 2334567889999999999999999998753 3468
Q ss_pred EEEEEecCCCCHHHHhccCCCCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEecCCCCeEEeeeeeeccc
Q 002158 697 MLVYEFVPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSRLA 776 (958)
Q Consensus 697 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~~ 776 (958)
++||||+. ++|.+++.... .+++..+..++.|++.||+|||+.+ |+||||||+||++++++.+||+|||+++..
T Consensus 84 ~lv~e~~~-~~l~~~~~~~~--~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~ 157 (334)
T cd07855 84 YVVMDLME-SDLHHIIHSDQ--PLTEEHIRYFLYQLLRGLKYIHSAN---VIHRDLKPSNLLVNEDCELRIGDFGMARGL 157 (334)
T ss_pred EEEEehhh-hhHHHHhccCC--CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEecccccceee
Confidence 99999995 69999996543 3899999999999999999999998 999999999999999999999999998765
Q ss_pred ccCCCCCCccceeeeeccCCCCccChhhhcc-CCCCCcchhhhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcCc----
Q 002158 777 PVLDDEGTMPTHVSTIVKGTPGYLDPEYFLT-HKLTDKSDVYSLGVVLLELLTGMQPISHGKNIVREVNVARDSGM---- 851 (958)
Q Consensus 777 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DV~S~Gv~l~elltG~~P~~~~~~~~~~~~~~~~~~~---- 851 (958)
...... .........|+..|+|||.+.+ ..++.++||||||+++|||++|+.||................+.
T Consensus 158 ~~~~~~---~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~ 234 (334)
T cd07855 158 SSSPTE---HKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEE 234 (334)
T ss_pred cccCcC---CCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhH
Confidence 332211 1111223468899999999866 45888999999999999999999999754432211111110000
Q ss_pred ---------chhhhcc--cCCCC-----ChHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 002158 852 ---------VFSIIDN--RMGSY-----PSECVERFVTLALRCCHDKPEHRPSMSDVVRE 895 (958)
Q Consensus 852 ---------~~~~i~~--~~~~~-----~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 895 (958)
....+.. ..... ....+..+.+++.+||+.+|++||++++++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~ 294 (334)
T cd07855 235 VLNRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQH 294 (334)
T ss_pred hhhhhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 0000000 00111 12356789999999999999999999999975
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-33 Score=299.23 Aligned_cols=248 Identities=18% Similarity=0.253 Sum_probs=192.8
Q ss_pred HHHHHHcCCCCCcee--eeeCCeEEEEEEEC-CCcEEEEEEeccCChhcHHHHHHHHHHHHcc-CCCCcceEEEEEEeCC
Q 002158 619 ELAMATAYFSSSTQV--GQGGYGKVYKGILS-DNTTVAIKRAEEGSLQGQNEFLTEIKLLSRL-HHRNLVSLLGYCDEEG 694 (958)
Q Consensus 619 el~~~~~~~~~~~~l--g~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~ 694 (958)
+.....++|...+.+ |+|+||.||++..+ ++..+|+|.+........ |+.....+ +|+|++++++++...+
T Consensus 8 ~~~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~-----e~~~~~~~~~h~~iv~~~~~~~~~~ 82 (267)
T PHA03390 8 ELVQFLKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNAI-----EPMVHQLMKDNPNFIKLYYSVTTLK 82 (267)
T ss_pred HHHHHHHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcchh-----hHHHHHHhhcCCCEEEEEEEEecCC
Confidence 333444566666666 99999999999975 688899999865322211 22222222 7999999999999999
Q ss_pred eEEEEEEecCCCCHHHHhccCCCCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEecCCC-CeEEeeeeee
Q 002158 695 EQMLVYEFVPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSNL-NAKVADFGLS 773 (958)
Q Consensus 695 ~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~~-~~kl~DFGla 773 (958)
..++||||+++++|.+++.... .+++.++..++.|+++||+|||+.+ ++||||||+||+++.++ .++|+|||++
T Consensus 83 ~~~iv~e~~~~~~L~~~l~~~~--~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~~l~dfg~~ 157 (267)
T PHA03390 83 GHVLIMDYIKDGDLFDLLKKEG--KLSEAEVKKIIRQLVEALNDLHKHN---IIHNDIKLENVLYDRAKDRIYLCDYGLC 157 (267)
T ss_pred eeEEEEEcCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEEeCCCCeEEEecCccc
Confidence 9999999999999999997654 5899999999999999999999999 99999999999999998 9999999998
Q ss_pred cccccCCCCCCccceeeeeccCCCCccChhhhccCCCCCcchhhhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcCcch
Q 002158 774 RLAPVLDDEGTMPTHVSTIVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVLLELLTGMQPISHGKNIVREVNVARDSGMVF 853 (958)
Q Consensus 774 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gv~l~elltG~~P~~~~~~~~~~~~~~~~~~~~~ 853 (958)
+..... ....|+..|+|||++.+..++.++||||||+++|||++|+.||..............
T Consensus 158 ~~~~~~-----------~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~------ 220 (267)
T PHA03390 158 KIIGTP-----------SCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLL------ 220 (267)
T ss_pred eecCCC-----------ccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcchhhHHHHH------
Confidence 754211 123588999999999998999999999999999999999999974332110000000
Q ss_pred hhhcccCCCCChHHHHHHHHHHHHccccCCCCCCC-HHHHHH
Q 002158 854 SIIDNRMGSYPSECVERFVTLALRCCHDKPEHRPS-MSDVVR 894 (958)
Q Consensus 854 ~~i~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs-~~evl~ 894 (958)
... ......+...+..+.+++.+||+.+|.+||+ ++|+++
T Consensus 221 ~~~-~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~ 261 (267)
T PHA03390 221 KRQ-QKKLPFIKNVSKNANDFVQSMLKYNINYRLTNYNEIIK 261 (267)
T ss_pred Hhh-cccCCcccccCHHHHHHHHHHhccChhhCCchHHHHhc
Confidence 000 1111233456788999999999999999995 688885
|
|
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-34 Score=287.26 Aligned_cols=269 Identities=23% Similarity=0.351 Sum_probs=210.7
Q ss_pred ChHHHHHHHcCCCCCceeeeeCCeEEEEEE-ECCCcEEEEEEeccCChhcHHHHHHHHHHHHccC-CCCcceEEEEEEeC
Q 002158 616 KFKELAMATAYFSSSTQVGQGGYGKVYKGI-LSDNTTVAIKRAEEGSLQGQNEFLTEIKLLSRLH-HRNLVSLLGYCDEE 693 (958)
Q Consensus 616 ~~~el~~~~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~ 693 (958)
+++++..-|. +.||+|+||.|-.++ ..+|..+|||++.+.....+.+..+|++++.+.+ |+||+.++++|+++
T Consensus 74 ~F~d~YkLt~-----e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd 148 (463)
T KOG0607|consen 74 KFEDMYKLTS-----ELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDD 148 (463)
T ss_pred hHHHHHHhHH-----HHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhccc
Confidence 4666666664 679999999999887 5689999999998876667788999999999995 99999999999999
Q ss_pred CeEEEEEEecCCCCHHHHhccCCCCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEecCCC---CeEEeee
Q 002158 694 GEQMLVYEFVPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSNL---NAKVADF 770 (958)
Q Consensus 694 ~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~~---~~kl~DF 770 (958)
+.+|||||.|.||+|..+|+++. .+++.++-++..+||.||.+||.+| |.|||+||+|||-.+.. -+||+||
T Consensus 149 ~~FYLVfEKm~GGplLshI~~~~--~F~E~EAs~vvkdia~aLdFlH~kg---IAHRDlKPENiLC~~pn~vsPvKiCDf 223 (463)
T KOG0607|consen 149 TRFYLVFEKMRGGPLLSHIQKRK--HFNEREASRVVKDIASALDFLHTKG---IAHRDLKPENILCESPNKVSPVKICDF 223 (463)
T ss_pred ceEEEEEecccCchHHHHHHHhh--hccHHHHHHHHHHHHHHHHHHhhcC---cccccCCccceeecCCCCcCceeeecc
Confidence 99999999999999999997654 4999999999999999999999999 99999999999996654 3899999
Q ss_pred eeecccccCCCCCCccceeeeeccCCCCccChhhhc-----cCCCCCcchhhhHHHHHHHHHhCCCCCCCCch-hHHH--
Q 002158 771 GLSRLAPVLDDEGTMPTHVSTIVKGTPGYLDPEYFL-----THKLTDKSDVYSLGVVLLELLTGMQPISHGKN-IVRE-- 842 (958)
Q Consensus 771 Gla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DV~S~Gv~l~elltG~~P~~~~~~-~~~~-- 842 (958)
.++.-.....+-...........+|+..|||||+.. ...|+.+.|.||+||++|-|++|-+||.+.=. ...|
T Consensus 224 DLgSg~k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdr 303 (463)
T KOG0607|consen 224 DLGSGIKLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDR 303 (463)
T ss_pred ccccccccCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccC
Confidence 987644333322222233344567999999999873 23588899999999999999999999964110 0000
Q ss_pred --HHHHhhcCcchhhhcccCCCCChH----HHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 002158 843 --VNVARDSGMVFSIIDNRMGSYPSE----CVERFVTLALRCCHDKPEHRPSMSDVVRE 895 (958)
Q Consensus 843 --~~~~~~~~~~~~~i~~~~~~~~~~----~~~~l~~li~~cl~~dP~~RPs~~evl~~ 895 (958)
+-...+ ..+++-|.....++|.. ++.+..+++...+..|+.+|.++.+++++
T Consensus 304 Ge~Cr~CQ-~~LFesIQEGkYeFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vlnh 361 (463)
T KOG0607|consen 304 GEVCRVCQ-NKLFESIQEGKYEFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLNH 361 (463)
T ss_pred CCccHHHH-HHHHHHHhccCCcCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccCC
Confidence 000000 12333444444455543 45677889999999999999999999873
|
|
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-34 Score=316.27 Aligned_cols=264 Identities=26% Similarity=0.382 Sum_probs=201.9
Q ss_pred CCCCceeeeeCCeEEEEEEEC-CCcEEEEEEeccC-ChhcHHHHHHHHHHHHccCCCCcceEEEEEEeC------CeEEE
Q 002158 627 FSSSTQVGQGGYGKVYKGILS-DNTTVAIKRAEEG-SLQGQNEFLTEIKLLSRLHHRNLVSLLGYCDEE------GEQML 698 (958)
Q Consensus 627 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~------~~~~l 698 (958)
|...+.||+|+||.||+|+.+ .|+.||||.++.. .....++..+|+++|++++|+|||+++++-++. ....+
T Consensus 15 W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~vl 94 (732)
T KOG4250|consen 15 WEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPVL 94 (732)
T ss_pred eeehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccceE
Confidence 344568999999999999965 7999999999764 344566788999999999999999999986543 35789
Q ss_pred EEEecCCCCHHHHhccCC-CCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEec--CCC--CeEEeeeeee
Q 002158 699 VYEFVPNGTLRDWLSGRT-KENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLD--SNL--NAKVADFGLS 773 (958)
Q Consensus 699 V~E~~~~gsL~~~l~~~~-~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~--~~~--~~kl~DFGla 773 (958)
|||||.+|+|+..+.+-. ...+++.+.+.++.+++.||.|||+++ |+||||||.||++- ++| .-||+|||.|
T Consensus 95 vmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~---IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~A 171 (732)
T KOG4250|consen 95 VMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENG---IVHRDLKPGNIVLQIGEDGQSIYKLTDFGAA 171 (732)
T ss_pred EEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcC---ceeccCCCCcEEEeecCCCceEEeeeccccc
Confidence 999999999999997533 345999999999999999999999999 99999999999993 334 4799999999
Q ss_pred cccccCCCCCCccceeeeeccCCCCccChhhhcc-CCCCCcchhhhHHHHHHHHHhCCCCCCCCchh-----HHHHHHHh
Q 002158 774 RLAPVLDDEGTMPTHVSTIVKGTPGYLDPEYFLT-HKLTDKSDVYSLGVVLLELLTGMQPISHGKNI-----VREVNVAR 847 (958)
Q Consensus 774 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DV~S~Gv~l~elltG~~P~~~~~~~-----~~~~~~~~ 847 (958)
+.++. ......++||..|++||.+.. +.|+..+|.|||||++||.+||..||..-... ..+.....
T Consensus 172 rel~d--------~s~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk~~~~~~~~~~tk 243 (732)
T KOG4250|consen 172 RELDD--------NSLFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGPKNNKEIMWHIITK 243 (732)
T ss_pred ccCCC--------CCeeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCccccchhhhhhhcc
Confidence 96643 224567889999999999985 78899999999999999999999999653322 11111111
Q ss_pred hcCcchhhh---ccc-------C---CCCChHHHHHHHHHHHHccccCCCCCC--CHHHHHHHHHHhHh
Q 002158 848 DSGMVFSII---DNR-------M---GSYPSECVERFVTLALRCCHDKPEHRP--SMSDVVRELENILK 901 (958)
Q Consensus 848 ~~~~~~~~i---~~~-------~---~~~~~~~~~~l~~li~~cl~~dP~~RP--s~~evl~~L~~~~~ 901 (958)
+........ ++. + ....+.....+...+..++..+|++|. .+.+....+.+++.
T Consensus 244 kp~~v~i~~~~~eNgpv~~s~~lP~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~~~~~~~~Fa~~~dIL~ 312 (732)
T KOG4250|consen 244 KPSGVAIGAQEEENGPVEWSSTLPQPNHLSRGLATRLTKWLASMLEWNPRKRGHEGFDRFFAEVDDILN 312 (732)
T ss_pred CCCceeEeeecccCCceeeeccCCCcccccHHHHhhhhHHHHHHHhhhHHHhCCCCcchHHHHHHHHHh
Confidence 111110000 000 0 112234455667777788889999998 77777777666653
|
|
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-33 Score=305.57 Aligned_cols=249 Identities=23% Similarity=0.372 Sum_probs=195.8
Q ss_pred cCCCCCceeeeeCCeEEEEEEECC-CcEEEEEEeccCC-hhcHHHHHHHHHHHHccC-CCCcceEEEEEEeCCeEEEEEE
Q 002158 625 AYFSSSTQVGQGGYGKVYKGILSD-NTTVAIKRAEEGS-LQGQNEFLTEIKLLSRLH-HRNLVSLLGYCDEEGEQMLVYE 701 (958)
Q Consensus 625 ~~~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~~~~~lV~E 701 (958)
++|+..+.||+|+||.||+|.+++ ++.||||.+.... .....++..|+.++.+.. |+||+++++++..+...++|||
T Consensus 15 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e 94 (296)
T cd06618 15 NDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFICME 94 (296)
T ss_pred chheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEEee
Confidence 456778899999999999999874 8999999987643 233456777888777775 9999999999999999999999
Q ss_pred ecCCCCHHHHhccCCCCCchHHHHHHHHHHHHHHHHHhhh-cCCCCeeccCCCccceEecCCCCeEEeeeeeecccccCC
Q 002158 702 FVPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHT-EAHPPVFHRDIKASNILLDSNLNAKVADFGLSRLAPVLD 780 (958)
Q Consensus 702 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~-~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~ 780 (958)
|++ +++.+++.... ..+++..+..++.|++.||+|||+ .+ |+||||+|+||++++++.+||+|||++.......
T Consensus 95 ~~~-~~l~~l~~~~~-~~l~~~~~~~i~~~i~~~l~~lH~~~~---i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~~~ 169 (296)
T cd06618 95 LMS-TCLDKLLKRIQ-GPIPEDILGKMTVAIVKALHYLKEKHG---VIHRDVKPSNILLDASGNVKLCDFGISGRLVDSK 169 (296)
T ss_pred ccC-cCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhhCC---EecCCCcHHHEEEcCCCCEEECccccchhccCCC
Confidence 984 57877775433 358999999999999999999997 47 9999999999999999999999999987542211
Q ss_pred CCCCccceeeeeccCCCCccChhhhccCC----CCCcchhhhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcCcchhhh
Q 002158 781 DEGTMPTHVSTIVKGTPGYLDPEYFLTHK----LTDKSDVYSLGVVLLELLTGMQPISHGKNIVREVNVARDSGMVFSII 856 (958)
Q Consensus 781 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~~DV~S~Gv~l~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~i 856 (958)
. .....++..|+|||++.+.. ++.++||||||+++|||++|+.||.......+.......
T Consensus 170 ~--------~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~-------- 233 (296)
T cd06618 170 A--------KTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKILQ-------- 233 (296)
T ss_pred c--------ccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHHHHHHHHhc--------
Confidence 1 11234788999999987554 788999999999999999999999653332222211111
Q ss_pred cccCCCC--ChHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 002158 857 DNRMGSY--PSECVERFVTLALRCCHDKPEHRPSMSDVVRE 895 (958)
Q Consensus 857 ~~~~~~~--~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 895 (958)
...... ...++.++.+++.+||+.||++||++++++++
T Consensus 234 -~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~ 273 (296)
T cd06618 234 -EEPPSLPPNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQH 273 (296)
T ss_pred -CCCCCCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 111111 12356789999999999999999999999875
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-34 Score=290.11 Aligned_cols=250 Identities=24% Similarity=0.324 Sum_probs=207.9
Q ss_pred HHcCCCCCceeeeeCCeEEEEEEEC-CCcEEEEEEeccCChhcH---HHHHHHHHHHHccCCCCcceEEEEEEeCCeEEE
Q 002158 623 ATAYFSSSTQVGQGGYGKVYKGILS-DNTTVAIKRAEEGSLQGQ---NEFLTEIKLLSRLHHRNLVSLLGYCDEEGEQML 698 (958)
Q Consensus 623 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~---~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~l 698 (958)
.-++|+..++||+|.||+|-.++-+ .++.+|+|++++...-.. ..-+.|-++|+.-+||.+..+--.+...+.+++
T Consensus 166 Tm~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCF 245 (516)
T KOG0690|consen 166 TMEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCF 245 (516)
T ss_pred ccchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEE
Confidence 3456777889999999999999866 799999999987644333 345679999999999999999888999999999
Q ss_pred EEEecCCCCHHHHhccCCCCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEecCCCCeEEeeeeeeccccc
Q 002158 699 VYEFVPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSRLAPV 778 (958)
Q Consensus 699 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~~~~ 778 (958)
||||..||.|.-+|...+ .+++.....+...|+.||.|||+++ ||.||+|-+|.|+|.||.+||+|||+++....
T Consensus 246 VMeyanGGeLf~HLsrer--~FsE~RtRFYGaEIvsAL~YLHs~~---ivYRDlKLENLlLDkDGHIKitDFGLCKE~I~ 320 (516)
T KOG0690|consen 246 VMEYANGGELFFHLSRER--VFSEDRTRFYGAEIVSALGYLHSRN---IVYRDLKLENLLLDKDGHIKITDFGLCKEEIK 320 (516)
T ss_pred EEEEccCceEeeehhhhh--cccchhhhhhhHHHHHHhhhhhhCC---eeeeechhhhheeccCCceEeeecccchhccc
Confidence 999999999999987544 4899999999999999999999998 99999999999999999999999999984322
Q ss_pred CCCCCCccceeeeeccCCCCccChhhhccCCCCCcchhhhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcCcchhhhcc
Q 002158 779 LDDEGTMPTHVSTIVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVLLELLTGMQPISHGKNIVREVNVARDSGMVFSIIDN 858 (958)
Q Consensus 779 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gv~l~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~i~~ 858 (958)
. ......++||+.|+|||++....|..++|.|.+||+||||++|+.||...+. +.++++|--
T Consensus 321 ~-------g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh-----------~kLFeLIl~ 382 (516)
T KOG0690|consen 321 Y-------GDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDH-----------EKLFELILM 382 (516)
T ss_pred c-------cceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccch-----------hHHHHHHHh
Confidence 1 2345678999999999999999999999999999999999999999974332 223333322
Q ss_pred cCCCCChHHHHHHHHHHHHccccCCCCCC-----CHHHHHHH
Q 002158 859 RMGSYPSECVERFVTLALRCCHDKPEHRP-----SMSDVVRE 895 (958)
Q Consensus 859 ~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~~ 895 (958)
.--.+|....++...|+...+.+||.+|. .+.||.++
T Consensus 383 ed~kFPr~ls~eAktLLsGLL~kdP~kRLGgGpdDakEi~~h 424 (516)
T KOG0690|consen 383 EDLKFPRTLSPEAKTLLSGLLKKDPKKRLGGGPDDAKEIMRH 424 (516)
T ss_pred hhccCCccCCHHHHHHHHHHhhcChHhhcCCCchhHHHHHhh
Confidence 22346777888899999999999999994 34555543
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-33 Score=353.46 Aligned_cols=325 Identities=30% Similarity=0.501 Sum_probs=225.6
Q ss_pred eeeEEEEccCCcCCCCccccccCCCCcceeeccCc-ccCCCCccccCCCCCcEEEeeCCCCCCCCChhhcCCCCCCEEec
Q 002158 86 LHVRELQLLSMNLSGNLAPELGQLSRLQYYFMWND-LTGTIPKEIGNISSLIFLLLNGNKLSGSLPDELGYLSNLNRLQV 164 (958)
Q Consensus 86 ~~v~~L~L~~~~l~~~~~~~l~~L~~L~~L~l~n~-~~~~ip~~i~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~L 164 (958)
.+++.|+|.+|++++.+|..++++++|+.|.+++| +.+.+|..+.++++|++|+|++|.+++.+|..+.++++|++|++
T Consensus 236 ~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~l 315 (968)
T PLN00113 236 TSLNHLDLVYNNLTGPIPSSLGNLKNLQYLFLYQNKLSGPIPPSIFSLQKLISLDLSDNSLSGEIPELVIQLQNLEILHL 315 (968)
T ss_pred CCCCEEECcCceeccccChhHhCCCCCCEEECcCCeeeccCchhHhhccCcCEEECcCCeeccCCChhHcCCCCCcEEEC
Confidence 36777788888887777777888888888777644 55677777777777777777777777777777777777777777
Q ss_pred ccccccccCccccccccccceEecccccccccCchhhcCCccchhhhccCCccccCCCcccCCC----------------
Q 002158 165 DENNITGTIPKSFANLSRVRHLHLNNNSIGGQIPSELSKLSTLIHLLVDNNNLSGNLPPELSEL---------------- 228 (958)
Q Consensus 165 ~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~l~~l---------------- 228 (958)
++|.+++.+|..+..+++|+.|+|++|.+++.+|..++.+++|+.|++++|++++.+|..+..+
T Consensus 316 ~~n~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~l~~~~~L~~L~Ls~n~l~~~~p~~~~~~~~L~~L~l~~n~l~~~ 395 (968)
T PLN00113 316 FSNNFTGKIPVALTSLPRLQVLQLWSNKFSGEIPKNLGKHNNLTVLDLSTNNLTGEIPEGLCSSGNLFKLILFSNSLEGE 395 (968)
T ss_pred CCCccCCcCChhHhcCCCCCEEECcCCCCcCcCChHHhCCCCCcEEECCCCeeEeeCChhHhCcCCCCEEECcCCEeccc
Confidence 7777777777777777777777777777776677667767777777776666665555555444
Q ss_pred --------CCccEEEccCCCCCCCCccccccCCCCCCEEEcccCCCCCCCCC-CCCCCCcCEEeccCCcCCCcCCCCCCC
Q 002158 229 --------PQLCILQLDNNNFSASEIPATYGNFSKLVKLSLRNCNLQGAVPD-LSRIPNLYYLDLSWNHLTGSIPSKKLS 299 (958)
Q Consensus 229 --------~~L~~L~L~~N~l~~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~-l~~l~~L~~L~Ls~N~l~~~~~~~~~~ 299 (958)
++|+.|+|++|+++ ..+|..+.++++|+.|+|++|++++.++. +..+++|+.|+|++|++.+.+|.....
T Consensus 396 ~p~~~~~~~~L~~L~L~~n~l~-~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~~~~~~p~~~~~ 474 (968)
T PLN00113 396 IPKSLGACRSLRRVRLQDNSFS-GELPSEFTKLPLVYFLDISNNNLQGRINSRKWDMPSLQMLSLARNKFFGGLPDSFGS 474 (968)
T ss_pred CCHHHhCCCCCCEEECcCCEee-eECChhHhcCCCCCEEECcCCcccCccChhhccCCCCcEEECcCceeeeecCccccc
Confidence 45555555555554 23455555555555666666665555543 555666666666667666666665556
Q ss_pred CCcCEEEccCCcCCCccchhccCCCCCCeEeeecccCCCccchhhhcccccCccccceEeccCCCCCCCccC-C-CCCCc
Q 002158 300 ENVTTIDLSDNYLNGSILESISNLPFLQTLSLENNFLTGSIPATIWQNKSFSTKARLKIDLRNNSFSNIVGD-L-TLPNN 377 (958)
Q Consensus 300 ~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~ip~~l~~~~~~~~~~l~~L~Ls~N~l~~l~~~-~-~l~~L 377 (958)
.+|+.|+|++|++++..|..|.++++|+.|+|++|++++.+|..+..+. .|+.|+|++|+++..... . .+++|
T Consensus 475 ~~L~~L~ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~-----~L~~L~Ls~N~l~~~~p~~~~~l~~L 549 (968)
T PLN00113 475 KRLENLDLSRNQFSGAVPRKLGSLSELMQLKLSENKLSGEIPDELSSCK-----KLVSLDLSHNQLSGQIPASFSEMPVL 549 (968)
T ss_pred ccceEEECcCCccCCccChhhhhhhccCEEECcCCcceeeCChHHcCcc-----CCCEEECCCCcccccCChhHhCcccC
Confidence 7788888888888888888888888888888888888888888775543 456889999988875433 3 78888
Q ss_pred ceEEeCCCCCCCCCCCCCCCcccccCCCCCccccccCCCCCCC
Q 002158 378 VTLRLGGNPICTSANIPNTGRFCGSDAGGDETLTNSKVNCPVQ 420 (958)
Q Consensus 378 ~~L~l~~N~l~~~~~~~~~~~~~~~~~~~~~~L~~n~~~C~c~ 420 (958)
+.|+|++|++...- + ..+........+.+.+|++.+..+
T Consensus 550 ~~L~Ls~N~l~~~~--p--~~l~~l~~L~~l~ls~N~l~~~~p 588 (968)
T PLN00113 550 SQLDLSQNQLSGEI--P--KNLGNVESLVQVNISHNHLHGSLP 588 (968)
T ss_pred CEEECCCCcccccC--C--hhHhcCcccCEEeccCCcceeeCC
Confidence 89999998885321 1 122233445667777777766554
|
|
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-32 Score=305.07 Aligned_cols=244 Identities=28% Similarity=0.455 Sum_probs=195.6
Q ss_pred CCCCceeeeeCCeEEEEEEEC-CCcEEEEEEeccCC---hhcHHHHHHHHHHHHccCCCCcceEEEEEEeCCeEEEEEEe
Q 002158 627 FSSSTQVGQGGYGKVYKGILS-DNTTVAIKRAEEGS---LQGQNEFLTEIKLLSRLHHRNLVSLLGYCDEEGEQMLVYEF 702 (958)
Q Consensus 627 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E~ 702 (958)
|...+.||+|+||+||+|+.. +++.||+|++.... ......+.+|+++++.++|+|++++++++.+....++||||
T Consensus 23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 102 (313)
T cd06633 23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEY 102 (313)
T ss_pred hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEec
Confidence 555678999999999999975 68899999986432 22335688999999999999999999999999999999999
Q ss_pred cCCCCHHHHhccCCCCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEecCCCCeEEeeeeeecccccCCCC
Q 002158 703 VPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSRLAPVLDDE 782 (958)
Q Consensus 703 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~ 782 (958)
++ |++.+++.... ..+++.++..++.|++.|++|||+.+ ++||||||+||+++.++.+||+|||++.....
T Consensus 103 ~~-~~l~~~l~~~~-~~l~~~~~~~~~~qi~~al~~LH~~g---i~H~dl~p~nili~~~~~~kL~dfg~~~~~~~---- 173 (313)
T cd06633 103 CL-GSASDLLEVHK-KPLQEVEIAAITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASKSSP---- 173 (313)
T ss_pred CC-CCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCChhhEEECCCCCEEEeecCCCcccCC----
Confidence 95 68888876433 34899999999999999999999999 99999999999999999999999998763211
Q ss_pred CCccceeeeeccCCCCccChhhhc---cCCCCCcchhhhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcCcchhhhccc
Q 002158 783 GTMPTHVSTIVKGTPGYLDPEYFL---THKLTDKSDVYSLGVVLLELLTGMQPISHGKNIVREVNVARDSGMVFSIIDNR 859 (958)
Q Consensus 783 ~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DV~S~Gv~l~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~i~~~ 859 (958)
.....|+..|+|||++. ...++.++||||||+++|||++|..||............... . .
T Consensus 174 -------~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~-~--------~ 237 (313)
T cd06633 174 -------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQN-D--------S 237 (313)
T ss_pred -------CCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhc-C--------C
Confidence 12345888999999984 356788999999999999999999999765432222211111 0 0
Q ss_pred CCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 002158 860 MGSYPSECVERFVTLALRCCHDKPEHRPSMSDVVRE 895 (958)
Q Consensus 860 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 895 (958)
........+..+.+++.+||+.+|.+||++.+++++
T Consensus 238 ~~~~~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~~ 273 (313)
T cd06633 238 PTLQSNEWTDSFRGFVDYCLQKIPQERPASAELLRH 273 (313)
T ss_pred CCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 011122345678999999999999999999999964
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-33 Score=304.05 Aligned_cols=254 Identities=23% Similarity=0.283 Sum_probs=200.4
Q ss_pred CCCCceeeeeCCeEEEEEEEC----CCcEEEEEEeccCC----hhcHHHHHHHHHHHHcc-CCCCcceEEEEEEeCCeEE
Q 002158 627 FSSSTQVGQGGYGKVYKGILS----DNTTVAIKRAEEGS----LQGQNEFLTEIKLLSRL-HHRNLVSLLGYCDEEGEQM 697 (958)
Q Consensus 627 ~~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~ 697 (958)
|+..+.||+|+||.||++... +++.||||+++... ....+.+.+|+++++++ +|+||+++++.+..+...+
T Consensus 2 ~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~~ 81 (288)
T cd05583 2 FELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKLH 81 (288)
T ss_pred ceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEEE
Confidence 666789999999999999853 57889999987532 22345688999999999 5999999999999999999
Q ss_pred EEEEecCCCCHHHHhccCCCCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEecCCCCeEEeeeeeecccc
Q 002158 698 LVYEFVPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSRLAP 777 (958)
Q Consensus 698 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~~~ 777 (958)
+||||+++++|.+++.... .+++..+..++.|+++||+|||+.+ ++||||||+||+++.++.++|+|||+++...
T Consensus 82 lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~ql~~~l~~lH~~~---~~H~dl~p~nil~~~~~~~~l~dfg~~~~~~ 156 (288)
T cd05583 82 LILDYVNGGELFTHLYQRE--HFTESEVRVYIAEIVLALDHLHQLG---IIYRDIKLENILLDSEGHVVLTDFGLSKEFL 156 (288)
T ss_pred EEEecCCCCcHHHHHhhcC--CcCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEEECccccccc
Confidence 9999999999999996543 4889999999999999999999998 9999999999999999999999999987643
Q ss_pred cCCCCCCccceeeeeccCCCCccChhhhccCC--CCCcchhhhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcCcchhh
Q 002158 778 VLDDEGTMPTHVSTIVKGTPGYLDPEYFLTHK--LTDKSDVYSLGVVLLELLTGMQPISHGKNIVREVNVARDSGMVFSI 855 (958)
Q Consensus 778 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DV~S~Gv~l~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~ 855 (958)
.... .......|+..|+|||.+.+.. .+.++||||||+++|||++|..||.............. .
T Consensus 157 ~~~~------~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~-------~ 223 (288)
T cd05583 157 AEEE------ERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISR-------R 223 (288)
T ss_pred cccc------cccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccchHHHHHH-------H
Confidence 2211 1112345889999999987665 77899999999999999999999953321111000000 0
Q ss_pred hcccCCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 002158 856 IDNRMGSYPSECVERFVTLALRCCHDKPEHRPSMSDVVRELEN 898 (958)
Q Consensus 856 i~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 898 (958)
+.......+...+..+.+++.+||+.+|++|||+.++.+.|+.
T Consensus 224 ~~~~~~~~~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~ 266 (288)
T cd05583 224 ILKSKPPFPKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNH 266 (288)
T ss_pred HHccCCCCCcccCHHHHHHHHHHhcCCHhhccCcchHHHHhcC
Confidence 1111123344566788999999999999999999888776554
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-33 Score=301.76 Aligned_cols=241 Identities=23% Similarity=0.291 Sum_probs=189.2
Q ss_pred eeeeeCCeEEEEEEEC-CCcEEEEEEeccCCh---hcHHHHHHHHH---HHHccCCCCcceEEEEEEeCCeEEEEEEecC
Q 002158 632 QVGQGGYGKVYKGILS-DNTTVAIKRAEEGSL---QGQNEFLTEIK---LLSRLHHRNLVSLLGYCDEEGEQMLVYEFVP 704 (958)
Q Consensus 632 ~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~---~l~~l~H~niv~l~~~~~~~~~~~lV~E~~~ 704 (958)
.||+|+||.||+|... +++.||+|.+..... .....+..|.. .++...||||+++++++...+..++||||++
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN 80 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence 4899999999999875 588999998865322 11223444444 4445579999999999999999999999999
Q ss_pred CCCHHHHhccCCCCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEecCCCCeEEeeeeeecccccCCCCCC
Q 002158 705 NGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSRLAPVLDDEGT 784 (958)
Q Consensus 705 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 784 (958)
+++|.+++... ..+++..+..++.|+++||+|||+.+ |+||||||+||++++++.+||+|||+++......
T Consensus 81 g~~L~~~l~~~--~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~---- 151 (278)
T cd05606 81 GGDLHYHLSQH--GVFSEAEMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKK---- 151 (278)
T ss_pred CCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---EEcCCCCHHHEEECCCCCEEEccCcCccccCccC----
Confidence 99999999654 34899999999999999999999998 9999999999999999999999999987542111
Q ss_pred ccceeeeeccCCCCccChhhhccC-CCCCcchhhhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcCcchhhhcccCCCC
Q 002158 785 MPTHVSTIVKGTPGYLDPEYFLTH-KLTDKSDVYSLGVVLLELLTGMQPISHGKNIVREVNVARDSGMVFSIIDNRMGSY 863 (958)
Q Consensus 785 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DV~S~Gv~l~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~ 863 (958)
.....|+..|+|||++.++ .++.++||||+|+++|||++|+.||........... ...........
T Consensus 152 -----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~--------~~~~~~~~~~~ 218 (278)
T cd05606 152 -----PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEI--------DRMTLTMAVEL 218 (278)
T ss_pred -----CcCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHH--------HHHhhccCCCC
Confidence 1223589999999999754 688999999999999999999999975422111000 00011111233
Q ss_pred ChHHHHHHHHHHHHccccCCCCCC-----CHHHHHH
Q 002158 864 PSECVERFVTLALRCCHDKPEHRP-----SMSDVVR 894 (958)
Q Consensus 864 ~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~ 894 (958)
+...+..+.+++.+|+..+|.+|| ++.++++
T Consensus 219 ~~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~ 254 (278)
T cd05606 219 PDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 254 (278)
T ss_pred CCcCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHh
Confidence 445578899999999999999999 9999885
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-33 Score=303.56 Aligned_cols=251 Identities=24% Similarity=0.309 Sum_probs=197.2
Q ss_pred CCCCCceeeeeCCeEEEEEEE----CCCcEEEEEEeccCCh----hcHHHHHHHHHHHHcc-CCCCcceEEEEEEeCCeE
Q 002158 626 YFSSSTQVGQGGYGKVYKGIL----SDNTTVAIKRAEEGSL----QGQNEFLTEIKLLSRL-HHRNLVSLLGYCDEEGEQ 696 (958)
Q Consensus 626 ~~~~~~~lg~G~~g~Vy~~~~----~~~~~vavK~~~~~~~----~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~ 696 (958)
+|+..+.||+|+||.||+|.. .+|+.||+|++..... ...+++.+|+++++++ +|+||+++++++..+...
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL 80 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence 366778999999999999986 3688999999875322 2345688999999999 599999999999999999
Q ss_pred EEEEEecCCCCHHHHhccCCCCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEecCCCCeEEeeeeeeccc
Q 002158 697 MLVYEFVPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSRLA 776 (958)
Q Consensus 697 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~~ 776 (958)
++||||+++++|.+++.... .+++..+..++.|+++||+|||+.+ ++||||||+||++++++.+||+|||+++..
T Consensus 81 ~lv~e~~~~~~L~~~l~~~~--~l~~~~~~~~~~qi~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~ 155 (290)
T cd05613 81 HLILDYINGGELFTHLSQRE--RFKEQEVQIYSGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSKEF 155 (290)
T ss_pred EEEEecCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeEECCCCCEEEeeCccceec
Confidence 99999999999999997543 4888999999999999999999999 999999999999999999999999998754
Q ss_pred ccCCCCCCccceeeeeccCCCCccChhhhccC--CCCCcchhhhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcCcchh
Q 002158 777 PVLDDEGTMPTHVSTIVKGTPGYLDPEYFLTH--KLTDKSDVYSLGVVLLELLTGMQPISHGKNIVREVNVARDSGMVFS 854 (958)
Q Consensus 777 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DV~S~Gv~l~elltG~~P~~~~~~~~~~~~~~~~~~~~~~ 854 (958)
..... .......|+..|+|||.+... .++.++||||||+++|||++|..||............. .
T Consensus 156 ~~~~~------~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~-------~ 222 (290)
T cd05613 156 HEDEV------ERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEIS-------R 222 (290)
T ss_pred ccccc------cccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccccHHHHH-------H
Confidence 32111 111234588999999998753 46789999999999999999999996322110000000 0
Q ss_pred hhcccCCCCChHHHHHHHHHHHHccccCCCCCC-----CHHHHHH
Q 002158 855 IIDNRMGSYPSECVERFVTLALRCCHDKPEHRP-----SMSDVVR 894 (958)
Q Consensus 855 ~i~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~ 894 (958)
.+.......+..++..+.+++.+||+.||++|| +.++++.
T Consensus 223 ~~~~~~~~~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~ 267 (290)
T cd05613 223 RILKSEPPYPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKK 267 (290)
T ss_pred HhhccCCCCCccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHc
Confidence 111111223455677889999999999999997 6666665
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-33 Score=311.11 Aligned_cols=257 Identities=23% Similarity=0.353 Sum_probs=195.9
Q ss_pred HcCCCCCceeeeeCCeEEEEEEEC-CCcEEEEEEeccCC--hhcHHHHHHHHHHHHccCCCCcceEEEEEEeC------C
Q 002158 624 TAYFSSSTQVGQGGYGKVYKGILS-DNTTVAIKRAEEGS--LQGQNEFLTEIKLLSRLHHRNLVSLLGYCDEE------G 694 (958)
Q Consensus 624 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~------~ 694 (958)
..+|...+.||+|+||.||+|++. +++.||||++.... ......+.+|++++++++|+||+++++++... .
T Consensus 14 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 93 (342)
T cd07879 14 PERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQ 93 (342)
T ss_pred ccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCc
Confidence 367888899999999999999975 68999999986532 22235688999999999999999999998654 2
Q ss_pred eEEEEEEecCCCCHHHHhccCCCCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEecCCCCeEEeeeeeec
Q 002158 695 EQMLVYEFVPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSR 774 (958)
Q Consensus 695 ~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~ 774 (958)
..++||||+. .+|.+++. ..+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+++
T Consensus 94 ~~~lv~e~~~-~~l~~~~~----~~~~~~~~~~~~~qi~~aL~~LH~~~---i~H~dlkp~NIll~~~~~~kL~dfg~~~ 165 (342)
T cd07879 94 DFYLVMPYMQ-TDLQKIMG----HPLSEDKVQYLVYQMLCGLKYIHSAG---IIHRDLKPGNLAVNEDCELKILDFGLAR 165 (342)
T ss_pred eEEEEecccc-cCHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEeeCCCCc
Confidence 4699999995 47877763 23889999999999999999999999 9999999999999999999999999987
Q ss_pred ccccCCCCCCccceeeeeccCCCCccChhhhcc-CCCCCcchhhhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcCcc-
Q 002158 775 LAPVLDDEGTMPTHVSTIVKGTPGYLDPEYFLT-HKLTDKSDVYSLGVVLLELLTGMQPISHGKNIVREVNVARDSGMV- 852 (958)
Q Consensus 775 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DV~S~Gv~l~elltG~~P~~~~~~~~~~~~~~~~~~~~- 852 (958)
.... ......|+..|+|||++.+ ..++.++|||||||++|||++|+.||................+..
T Consensus 166 ~~~~----------~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~ 235 (342)
T cd07879 166 HADA----------EMTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPG 235 (342)
T ss_pred CCCC----------CCCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCC
Confidence 5321 1122357888999999876 468889999999999999999999997644322211111100000
Q ss_pred ------------hhhhcccCCCC--------ChHHHHHHHHHHHHccccCCCCCCCHHHHHHH--HHHh
Q 002158 853 ------------FSIIDNRMGSY--------PSECVERFVTLALRCCHDKPEHRPSMSDVVRE--LENI 899 (958)
Q Consensus 853 ------------~~~i~~~~~~~--------~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~--L~~~ 899 (958)
..... ..... ....+..+.+++.+||+.||++||++++++++ ++..
T Consensus 236 ~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~ 303 (342)
T cd07879 236 PEFVQKLEDKAAKSYIK-SLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSF 303 (342)
T ss_pred HHHHHHhcccchHHHHh-hcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhc
Confidence 00000 00000 11234668899999999999999999999975 4443
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-33 Score=309.85 Aligned_cols=248 Identities=26% Similarity=0.398 Sum_probs=206.1
Q ss_pred HcCCCCCceeeeeCCeEEEEEEEC-CCcEEEEEEeccCC--hhcHHHHHHHHHHHHccCCCCcceEEEEEEeCCeEEEEE
Q 002158 624 TAYFSSSTQVGQGGYGKVYKGILS-DNTTVAIKRAEEGS--LQGQNEFLTEIKLLSRLHHRNLVSLLGYCDEEGEQMLVY 700 (958)
Q Consensus 624 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~ 700 (958)
...|.+...||+|.|++|..|++. .+..||||.+++.. ......+.+|+++|+.++|||||+++.+...+..+|+||
T Consensus 55 vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lylV~ 134 (596)
T KOG0586|consen 55 VGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYLVM 134 (596)
T ss_pred ccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEEEE
Confidence 346778889999999999999976 69999999998753 333455889999999999999999999999999999999
Q ss_pred EecCCCCHHHHhccCCCCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEecCCCCeEEeeeeeecccccCC
Q 002158 701 EFVPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSRLAPVLD 780 (958)
Q Consensus 701 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~ 780 (958)
||+.+|.+++|+...++ ..+..+..++.|+.+|++|||+++ |||||||++|||++.+.++||+|||++..+..
T Consensus 135 eya~~ge~~~yl~~~gr--~~e~~ar~~F~q~vsaveYcH~k~---ivHrdLk~eNilL~~~mnikIaDfgfS~~~~~-- 207 (596)
T KOG0586|consen 135 EYASGGELFDYLVKHGR--MKEKEARAKFRQIVSAVEYCHSKN---IVHRDLKAENILLDENMNIKIADFGFSTFFDY-- 207 (596)
T ss_pred EeccCchhHHHHHhccc--chhhhhhhhhHHHHHHHHHHhhcc---eeccccchhhcccccccceeeeccccceeecc--
Confidence 99999999999986654 566888999999999999999999 99999999999999999999999999987743
Q ss_pred CCCCccceeeeeccCCCCccChhhhccCCCC-CcchhhhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcCcchhhhccc
Q 002158 781 DEGTMPTHVSTIVKGTPGYLDPEYFLTHKLT-DKSDVYSLGVVLLELLTGMQPISHGKNIVREVNVARDSGMVFSIIDNR 859 (958)
Q Consensus 781 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DV~S~Gv~l~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~i~~~ 859 (958)
.......+|++.|.|||++.+.+|+ +++|+||+|+++|-|+.|..||++.. +...- ...+...
T Consensus 208 ------~~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~-lk~Lr---------~rvl~gk 271 (596)
T KOG0586|consen 208 ------GLMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQN-LKELR---------PRVLRGK 271 (596)
T ss_pred ------cccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcc-ccccc---------chheeee
Confidence 3344567899999999999998875 59999999999999999999997432 11100 0001111
Q ss_pred CCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 002158 860 MGSYPSECVERFVTLALRCCHDKPEHRPSMSDVVRE 895 (958)
Q Consensus 860 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 895 (958)
...|--...+..+++.+++-.+|.+|++++++.++
T Consensus 272 -~rIp~~ms~dce~lLrk~lvl~Pskr~~~dqim~~ 306 (596)
T KOG0586|consen 272 -YRIPFYMSCDCEDLLRKFLVLNPSKRGPCDQIMKD 306 (596)
T ss_pred -ecccceeechhHHHHHHhhccCccccCCHHHhhhh
Confidence 11233445667889999999999999999998864
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=329.87 Aligned_cols=259 Identities=26% Similarity=0.359 Sum_probs=193.9
Q ss_pred HHcCCCCCceeeeeCCeEEEEEEEC-CCcEEEEEEeccCC-hhcHHHHHHHHHHHHccCCCCcceEEEEEEe--------
Q 002158 623 ATAYFSSSTQVGQGGYGKVYKGILS-DNTTVAIKRAEEGS-LQGQNEFLTEIKLLSRLHHRNLVSLLGYCDE-------- 692 (958)
Q Consensus 623 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~-------- 692 (958)
...+|++.+.||+||||.||+++.+ ||+.||||++.... ........+|+.++++++|||||+++..+.+
T Consensus 477 Y~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~~ 556 (1351)
T KOG1035|consen 477 YLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTVL 556 (1351)
T ss_pred HhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCccccc
Confidence 4456777789999999999999988 99999999987653 3334568899999999999999999621100
Q ss_pred --------------------------------------------------------------------------------
Q 002158 693 -------------------------------------------------------------------------------- 692 (958)
Q Consensus 693 -------------------------------------------------------------------------------- 692 (958)
T Consensus 557 ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~~ 636 (1351)
T KOG1035|consen 557 EIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSDS 636 (1351)
T ss_pred cccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCccccccccccccccccccc
Confidence
Q ss_pred -----------------------C--------CeEEEEEEecCCCCHHHHhccCCCCCchHHHHHHHHHHHHHHHHHhhh
Q 002158 693 -----------------------E--------GEQMLVYEFVPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHT 741 (958)
Q Consensus 693 -----------------------~--------~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~ 741 (958)
+ ...|+-||||+..+++++++++... -.....++++.+|++||+|+|+
T Consensus 637 e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~-~~~d~~wrLFreIlEGLaYIH~ 715 (1351)
T KOG1035|consen 637 EGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFN-SQRDEAWRLFREILEGLAYIHD 715 (1351)
T ss_pred CCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccc-hhhHHHHHHHHHHHHHHHHHHh
Confidence 0 1258899999998888888765421 1467789999999999999999
Q ss_pred cCCCCeeccCCCccceEecCCCCeEEeeeeeecccc----c-------CCCCCCccceeeeeccCCCCccChhhhccCC-
Q 002158 742 EAHPPVFHRDIKASNILLDSNLNAKVADFGLSRLAP----V-------LDDEGTMPTHVSTIVKGTPGYLDPEYFLTHK- 809 (958)
Q Consensus 742 ~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~~~----~-------~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~- 809 (958)
.| ||||||||.||++|+++.|||+|||+|+... . ............+...||.-|+|||++.+..
T Consensus 716 ~g---iIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~ 792 (1351)
T KOG1035|consen 716 QG---IIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSS 792 (1351)
T ss_pred Cc---eeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhccccc
Confidence 99 9999999999999999999999999998721 0 0111111122345678999999999997654
Q ss_pred --CCCcchhhhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcCcchhhhcccCCCCChHHHHHHHHHHHHccccCCCCCC
Q 002158 810 --LTDKSDVYSLGVVLLELLTGMQPISHGKNIVREVNVARDSGMVFSIIDNRMGSYPSECVERFVTLALRCCHDKPEHRP 887 (958)
Q Consensus 810 --~~~~~DV~S~Gv~l~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP 887 (958)
|+.|+|+||+||+++||+- ||.....-...+...++ +.+... ..+.......=..+|.++++.||.+||
T Consensus 793 ~~Yn~KiDmYSLGIVlFEM~y---PF~TsMERa~iL~~LR~-g~iP~~-----~~f~~~~~~~e~slI~~Ll~hdP~kRP 863 (1351)
T KOG1035|consen 793 NKYNSKIDMYSLGIVLFEMLY---PFGTSMERASILTNLRK-GSIPEP-----ADFFDPEHPEEASLIRWLLSHDPSKRP 863 (1351)
T ss_pred ccccchhhhHHHHHHHHHHhc---cCCchHHHHHHHHhccc-CCCCCC-----cccccccchHHHHHHHHHhcCCCccCC
Confidence 9999999999999999985 67654443333332221 111110 112222333447899999999999999
Q ss_pred CHHHHHH
Q 002158 888 SMSDVVR 894 (958)
Q Consensus 888 s~~evl~ 894 (958)
|+.|++.
T Consensus 864 tA~eLL~ 870 (1351)
T KOG1035|consen 864 TATELLN 870 (1351)
T ss_pred CHHHHhh
Confidence 9999985
|
|
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-35 Score=289.57 Aligned_cols=247 Identities=23% Similarity=0.346 Sum_probs=197.6
Q ss_pred ceeeeeCCeEEEEEEEC-CCcEEEEEEeccCC-hhcHHHHHHHHHHHHcc-CCCCcceEEEEEEeCCeEEEEEEecCCCC
Q 002158 631 TQVGQGGYGKVYKGILS-DNTTVAIKRAEEGS-LQGQNEFLTEIKLLSRL-HHRNLVSLLGYCDEEGEQMLVYEFVPNGT 707 (958)
Q Consensus 631 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lV~E~~~~gs 707 (958)
..||.|+||+|+|-.++ .|+..|||+++... ..+++++..|.+...+- +.||||+++|.+-.++..|+.||+| ..+
T Consensus 70 g~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCMELM-d~S 148 (361)
T KOG1006|consen 70 GEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICMELM-DIS 148 (361)
T ss_pred HHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHHHH-hhh
Confidence 46999999999999986 69999999998754 36678899999865555 7999999999999999999999999 467
Q ss_pred HHHHh---ccCCCCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEecCCCCeEEeeeeeecccccCCCCCC
Q 002158 708 LRDWL---SGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSRLAPVLDDEGT 784 (958)
Q Consensus 708 L~~~l---~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 784 (958)
|+.+. ....+..+++...-+|.....+||.||-+.-+ ||||||||+|||+|..|.+||||||++-.+..
T Consensus 149 lDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~lk--iIHRDvKPSNILldr~G~vKLCDFGIcGqLv~------ 220 (361)
T KOG1006|consen 149 LDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEELK--IIHRDVKPSNILLDRHGDVKLCDFGICGQLVD------ 220 (361)
T ss_pred HHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHhh--hhhccCChhheEEecCCCEeeecccchHhHHH------
Confidence 75544 33344558888889999999999999987754 99999999999999999999999999865421
Q ss_pred ccceeeeeccCCCCccChhhhcc--CCCCCcchhhhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcCcchhhhcccCCC
Q 002158 785 MPTHVSTIVKGTPGYLDPEYFLT--HKLTDKSDVYSLGVVLLELLTGMQPISHGKNIVREVNVARDSGMVFSIIDNRMGS 862 (958)
Q Consensus 785 ~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DV~S~Gv~l~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~ 862 (958)
+...+.-+|-..|||||.+.. ..|+-++||||+|++|||+.||..|+....+..+++......... ...
T Consensus 221 --SiAkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~svfeql~~Vv~gdpp-------~l~ 291 (361)
T KOG1006|consen 221 --SIAKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDSVFEQLCQVVIGDPP-------ILL 291 (361)
T ss_pred --HHHhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHHHHHHHHHHHcCCCC-------eec
Confidence 112233457888999999964 348889999999999999999999998766665555443332211 111
Q ss_pred CC---hHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 002158 863 YP---SECVERFVTLALRCCHDKPEHRPSMSDVVRE 895 (958)
Q Consensus 863 ~~---~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 895 (958)
.+ .+....+..++..|+.+|-.+||++.++.++
T Consensus 292 ~~~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~ 327 (361)
T KOG1006|consen 292 FDKECVHYSFSMVRFINTCLIKDRSDRPKYDDLKKF 327 (361)
T ss_pred CcccccccCHHHHHHHHHHhhcccccCcchhhhhcC
Confidence 12 2366789999999999999999999998764
|
|
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-33 Score=303.63 Aligned_cols=257 Identities=25% Similarity=0.355 Sum_probs=197.4
Q ss_pred CCCCceeeeeCCeEEEEEEEC-CCcEEEEEEeccCCh-hcHHHHHHHHHHHHccC-CCCcceEEEEEEeCCeEEEEEEec
Q 002158 627 FSSSTQVGQGGYGKVYKGILS-DNTTVAIKRAEEGSL-QGQNEFLTEIKLLSRLH-HRNLVSLLGYCDEEGEQMLVYEFV 703 (958)
Q Consensus 627 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~~~~~lV~E~~ 703 (958)
|...+.||+|++|+||+|+.. +++.||||++..... .......+|+..+++++ |+|++++++++..++..++||||+
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM 80 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC
Confidence 556788999999999999986 578999999875432 22334567999999999 999999999999999999999999
Q ss_pred CCCCHHHHhccCCCCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEecCCCCeEEeeeeeecccccCCCCC
Q 002158 704 PNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSRLAPVLDDEG 783 (958)
Q Consensus 704 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 783 (958)
+|+|.+++.......+++.++..++.|++.||.|||+.+ ++|+||+|+||++++++.++|+|||++.......
T Consensus 81 -~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~---i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~--- 153 (283)
T cd07830 81 -EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHG---FFHRDLKPENLLVSGPEVVKIADFGLAREIRSRP--- 153 (283)
T ss_pred -CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEEcCCCCEEEeecccceeccCCC---
Confidence 889999997665456899999999999999999999999 9999999999999999999999999987543211
Q ss_pred CccceeeeeccCCCCccChhhhcc-CCCCCcchhhhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcCcc----------
Q 002158 784 TMPTHVSTIVKGTPGYLDPEYFLT-HKLTDKSDVYSLGVVLLELLTGMQPISHGKNIVREVNVARDSGMV---------- 852 (958)
Q Consensus 784 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DV~S~Gv~l~elltG~~P~~~~~~~~~~~~~~~~~~~~---------- 852 (958)
......|+..|+|||++.. ..++.++|+||||+++|||++|+.||................+..
T Consensus 154 -----~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (283)
T cd07830 154 -----PYTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYK 228 (283)
T ss_pred -----CcCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhh
Confidence 1122457889999998854 457889999999999999999999986543222111110000000
Q ss_pred -hhhhccc--------CCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 002158 853 -FSIIDNR--------MGSYPSECVERFVTLALRCCHDKPEHRPSMSDVVRE 895 (958)
Q Consensus 853 -~~~i~~~--------~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 895 (958)
...+... ........+..+.+++.+||+.+|++||+++|++.+
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~ 280 (283)
T cd07830 229 LASKLGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQH 280 (283)
T ss_pred hhccccccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhhC
Confidence 0000000 000011124678999999999999999999999863
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-32 Score=308.76 Aligned_cols=262 Identities=22% Similarity=0.318 Sum_probs=201.0
Q ss_pred hHHHHHHHcCCCCCceeeeeCCeEEEEEEEC-CCcEEEEEEeccCC--hhcHHHHHHHHHHHHccCCCCcceEEEEEEeC
Q 002158 617 FKELAMATAYFSSSTQVGQGGYGKVYKGILS-DNTTVAIKRAEEGS--LQGQNEFLTEIKLLSRLHHRNLVSLLGYCDEE 693 (958)
Q Consensus 617 ~~el~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~ 693 (958)
.+++...+++|...+.||+|+||.||+|... +++.||+|++.... ....+.+.+|++++++++|+||+++++++...
T Consensus 9 ~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~ 88 (345)
T cd07877 9 NKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPA 88 (345)
T ss_pred HHHHhhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeec
Confidence 4566778899999999999999999999864 68899999987532 22345688999999999999999999988643
Q ss_pred ------CeEEEEEEecCCCCHHHHhccCCCCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEecCCCCeEE
Q 002158 694 ------GEQMLVYEFVPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSNLNAKV 767 (958)
Q Consensus 694 ------~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~~~~kl 767 (958)
...++++|++ +++|.+++... .+++..+..++.|+++||+|||+.+ |+||||||+||++++++.+||
T Consensus 89 ~~~~~~~~~~lv~~~~-~~~L~~~~~~~---~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kl 161 (345)
T cd07877 89 RSLEEFNDVYLVTHLM-GADLNNIVKCQ---KLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKI 161 (345)
T ss_pred ccccccccEEEEehhc-ccCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChHHEEEcCCCCEEE
Confidence 3468888887 78999988643 3899999999999999999999999 999999999999999999999
Q ss_pred eeeeeecccccCCCCCCccceeeeeccCCCCccChhhhcc-CCCCCcchhhhHHHHHHHHHhCCCCCCCCchhHHHHHHH
Q 002158 768 ADFGLSRLAPVLDDEGTMPTHVSTIVKGTPGYLDPEYFLT-HKLTDKSDVYSLGVVLLELLTGMQPISHGKNIVREVNVA 846 (958)
Q Consensus 768 ~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DV~S~Gv~l~elltG~~P~~~~~~~~~~~~~~ 846 (958)
+|||+++.... ......|+..|+|||.+.+ ..++.++|||||||++|||++|+.||.............
T Consensus 162 ~dfg~~~~~~~----------~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~ 231 (345)
T cd07877 162 LDFGLARHTDD----------EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLIL 231 (345)
T ss_pred ecccccccccc----------cccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 99999875321 1123457889999999876 467889999999999999999999996543322111110
Q ss_pred hhcCcc-hhh------------hc--ccCCC-----CChHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 002158 847 RDSGMV-FSI------------ID--NRMGS-----YPSECVERFVTLALRCCHDKPEHRPSMSDVVRE 895 (958)
Q Consensus 847 ~~~~~~-~~~------------i~--~~~~~-----~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 895 (958)
...+.. ... +. ...+. .....+..+.+++.+|++.||.+||++.+++++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 300 (345)
T cd07877 232 RLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 300 (345)
T ss_pred HHhCCCCHHHHhhcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcC
Confidence 000000 000 00 00000 011235678899999999999999999999975
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=308.63 Aligned_cols=261 Identities=23% Similarity=0.281 Sum_probs=195.7
Q ss_pred CCceeeeeCCeEEEEEEEC-CCcEEEEEEeccCChhc--------------HHHHHHHHHHHHccCCCCcceEEEEEEeC
Q 002158 629 SSTQVGQGGYGKVYKGILS-DNTTVAIKRAEEGSLQG--------------QNEFLTEIKLLSRLHHRNLVSLLGYCDEE 693 (958)
Q Consensus 629 ~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~--------------~~~~~~E~~~l~~l~H~niv~l~~~~~~~ 693 (958)
..+.||+|+||+||+|.+. +++.||||++....... ...+.+|++++++++|+||+++++++..+
T Consensus 13 ~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 92 (335)
T PTZ00024 13 KGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVDVYVEG 92 (335)
T ss_pred hhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeEEEecC
Confidence 3467999999999999976 68999999886532211 12477899999999999999999999999
Q ss_pred CeEEEEEEecCCCCHHHHhccCCCCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEecCCCCeEEeeeeee
Q 002158 694 GEQMLVYEFVPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSNLNAKVADFGLS 773 (958)
Q Consensus 694 ~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla 773 (958)
+..++||||++ |+|.+++.... .+++.....++.|++.||+|||+.+ |+||||||+||+++.++.++|+|||++
T Consensus 93 ~~~~lv~e~~~-~~l~~~l~~~~--~~~~~~~~~~~~ql~~aL~~LH~~~---i~H~dl~~~nill~~~~~~kl~dfg~~ 166 (335)
T PTZ00024 93 DFINLVMDIMA-SDLKKVVDRKI--RLTESQVKCILLQILNGLNVLHKWY---FMHRDLSPANIFINSKGICKIADFGLA 166 (335)
T ss_pred CcEEEEEeccc-cCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCC---eecccccHHHeEECCCCCEEECCccce
Confidence 99999999996 69999996543 4889999999999999999999999 999999999999999999999999999
Q ss_pred cccccCCCCC------C-ccceeeeeccCCCCccChhhhccC-CCCCcchhhhHHHHHHHHHhCCCCCCCCchhHHHHHH
Q 002158 774 RLAPVLDDEG------T-MPTHVSTIVKGTPGYLDPEYFLTH-KLTDKSDVYSLGVVLLELLTGMQPISHGKNIVREVNV 845 (958)
Q Consensus 774 ~~~~~~~~~~------~-~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DV~S~Gv~l~elltG~~P~~~~~~~~~~~~~ 845 (958)
+......... . ..........++..|+|||++.+. .++.++||||||+++|||++|+.||............
T Consensus 167 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~i 246 (335)
T PTZ00024 167 RRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEIDQLGRI 246 (335)
T ss_pred eecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 7653111000 0 001111223468899999998764 4688999999999999999999999765543222111
Q ss_pred HhhcCcch-----hhh------------cccCCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 002158 846 ARDSGMVF-----SII------------DNRMGSYPSECVERFVTLALRCCHDKPEHRPSMSDVVRE 895 (958)
Q Consensus 846 ~~~~~~~~-----~~i------------~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 895 (958)
....+... ... ...........+..+.+++.+|++.+|++||+++|++.+
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~~ 313 (335)
T PTZ00024 247 FELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALKH 313 (335)
T ss_pred HHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhcC
Confidence 11000000 000 000001112345678899999999999999999999963
|
|
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-33 Score=326.49 Aligned_cols=263 Identities=19% Similarity=0.258 Sum_probs=189.3
Q ss_pred HHHcCCCCCceeeeeCCeEEEEEEECC--CcEEEEE------------------EeccCChhcHHHHHHHHHHHHccCCC
Q 002158 622 MATAYFSSSTQVGQGGYGKVYKGILSD--NTTVAIK------------------RAEEGSLQGQNEFLTEIKLLSRLHHR 681 (958)
Q Consensus 622 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~--~~~vavK------------------~~~~~~~~~~~~~~~E~~~l~~l~H~ 681 (958)
....+|.+.+.||+|+||+||++.++. +..+++| .+.. .......+.+|++++++++|+
T Consensus 145 ~~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~-~~~~~~~~~~Ei~il~~l~Hp 223 (501)
T PHA03210 145 EFLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKA-GSRAAIQLENEILALGRLNHE 223 (501)
T ss_pred hhhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhc-chHHHHHHHHHHHHHHhCCCC
Confidence 345789999999999999999987642 2222222 1111 112334688999999999999
Q ss_pred CcceEEEEEEeCCeEEEEEEecCCCCHHHHhccCC---CCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceE
Q 002158 682 NLVSLLGYCDEEGEQMLVYEFVPNGTLRDWLSGRT---KENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNIL 758 (958)
Q Consensus 682 niv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~---~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NIL 758 (958)
||+++++++...+..++|+|++ +++|.+++.... .......++..++.|++.||+|||+++ |+||||||+|||
T Consensus 224 nIv~l~~~~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~g---IiHrDLKP~NIL 299 (501)
T PHA03210 224 NILKIEEILRSEANTYMITQKY-DFDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKK---LIHRDIKLENIF 299 (501)
T ss_pred CcCcEeEEEEECCeeEEEEecc-ccCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEE
Confidence 9999999999999999999999 568888775432 122345667889999999999999999 999999999999
Q ss_pred ecCCCCeEEeeeeeecccccCCCCCCccceeeeeccCCCCccChhhhccCCCCCcchhhhHHHHHHHHHhCCCC-CCCCc
Q 002158 759 LDSNLNAKVADFGLSRLAPVLDDEGTMPTHVSTIVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVLLELLTGMQP-ISHGK 837 (958)
Q Consensus 759 l~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gv~l~elltG~~P-~~~~~ 837 (958)
++.++.+||+|||+++.+..... .......||..|+|||++.+..++.++|||||||++|||++|..+ +....
T Consensus 300 l~~~~~vkL~DFGla~~~~~~~~------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~ 373 (501)
T PHA03210 300 LNCDGKIVLGDFGTAMPFEKERE------AFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGG 373 (501)
T ss_pred ECCCCCEEEEeCCCceecCcccc------cccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCC
Confidence 99999999999999986532111 112235699999999999999999999999999999999998764 43221
Q ss_pred --hhHHHHHHHhhcC-----------cchhhhcccC-C----CCC-----hHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002158 838 --NIVREVNVARDSG-----------MVFSIIDNRM-G----SYP-----SECVERFVTLALRCCHDKPEHRPSMSDVVR 894 (958)
Q Consensus 838 --~~~~~~~~~~~~~-----------~~~~~i~~~~-~----~~~-----~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 894 (958)
............. ..++.++... . ..+ ...+..+.+++.+|++.||.+||++.|+++
T Consensus 374 ~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~ 453 (501)
T PHA03210 374 GKPGKQLLKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLA 453 (501)
T ss_pred CCHHHHHHHHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhh
Confidence 1111111111000 0011111000 0 000 012346778899999999999999999997
Q ss_pred H
Q 002158 895 E 895 (958)
Q Consensus 895 ~ 895 (958)
+
T Consensus 454 h 454 (501)
T PHA03210 454 L 454 (501)
T ss_pred C
Confidence 4
|
|
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-33 Score=304.26 Aligned_cols=254 Identities=22% Similarity=0.354 Sum_probs=205.9
Q ss_pred cCCCCCceeeeeCCeEEEEEEEC-CCcEEEEEEeccC---ChhcHHHHHHHHHHHHccC-CCCcceEEEEEEeCCeEEEE
Q 002158 625 AYFSSSTQVGQGGYGKVYKGILS-DNTTVAIKRAEEG---SLQGQNEFLTEIKLLSRLH-HRNLVSLLGYCDEEGEQMLV 699 (958)
Q Consensus 625 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~~~~~lV 699 (958)
++|...+.||+|+||.||+|... +++.||+|++... .....+.+.+|++++++++ |+||+++++++...+..++|
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv 80 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV 80 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence 36778889999999999999976 6899999998653 2233467889999999998 99999999999999999999
Q ss_pred EEecCCCCHHHHhccCCCCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEecCCCCeEEeeeeeecccccC
Q 002158 700 YEFVPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSRLAPVL 779 (958)
Q Consensus 700 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~~~~~ 779 (958)
|||+++++|.+++.... .+++..+..++.|++.||+|||+.+ ++|+||||+||+++.++.++++|||++......
T Consensus 81 ~e~~~~~~L~~~l~~~~--~l~~~~~~~i~~ql~~~l~~Lh~~~---~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~~ 155 (280)
T cd05581 81 LEYAPNGELLQYIRKYG--SLDEKCTRFYAAEILLALEYLHSKG---IIHRDLKPENILLDKDMHIKITDFGTAKVLDPN 155 (280)
T ss_pred EcCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEecCCccccccCCc
Confidence 99999999999997553 4999999999999999999999999 999999999999999999999999998765332
Q ss_pred CCCCC-------------ccceeeeeccCCCCccChhhhccCCCCCcchhhhHHHHHHHHHhCCCCCCCCchhHHHHHHH
Q 002158 780 DDEGT-------------MPTHVSTIVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVLLELLTGMQPISHGKNIVREVNVA 846 (958)
Q Consensus 780 ~~~~~-------------~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gv~l~elltG~~P~~~~~~~~~~~~~~ 846 (958)
..... ..........|+..|+|||......++.++||||||++++|+++|+.||........ ....
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~-~~~~ 234 (280)
T cd05581 156 SSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYLT-FQKI 234 (280)
T ss_pred cccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccHHHH-HHHH
Confidence 21100 001122345688999999999888899999999999999999999999975442111 1111
Q ss_pred hhcCcchhhhcccCCCCChHHHHHHHHHHHHccccCCCCCCCH----HHHHH
Q 002158 847 RDSGMVFSIIDNRMGSYPSECVERFVTLALRCCHDKPEHRPSM----SDVVR 894 (958)
Q Consensus 847 ~~~~~~~~~i~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~----~evl~ 894 (958)
. ......+...+..+.+++.+||+.+|.+||++ +++++
T Consensus 235 ~----------~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~ 276 (280)
T cd05581 235 L----------KLEYSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKA 276 (280)
T ss_pred H----------hcCCCCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhc
Confidence 1 11123345567889999999999999999999 77665
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-32 Score=305.84 Aligned_cols=267 Identities=26% Similarity=0.323 Sum_probs=197.0
Q ss_pred HcCCCCCceeeeeCCeEEEEEEEC-CCcEEEEEEeccCChh--cHHHHHHHHHHHHccCCCCcceEEEEEEeC-------
Q 002158 624 TAYFSSSTQVGQGGYGKVYKGILS-DNTTVAIKRAEEGSLQ--GQNEFLTEIKLLSRLHHRNLVSLLGYCDEE------- 693 (958)
Q Consensus 624 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~H~niv~l~~~~~~~------- 693 (958)
.++|...+.||+|+||.||+|.++ +++.||||++...... ....+.+|++++++++|+||+++++++...
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 86 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK 86 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence 457888899999999999999976 6899999988654322 234577899999999999999999987543
Q ss_pred -CeEEEEEEecCCCCHHHHhccCCCCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEecCCCCeEEeeeee
Q 002158 694 -GEQMLVYEFVPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSNLNAKVADFGL 772 (958)
Q Consensus 694 -~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~~~~kl~DFGl 772 (958)
...++||||++ +++...+.... ..+++.++..++.|+++||+|||+.+ |+||||||+||++++++.++|+|||+
T Consensus 87 ~~~~~lv~~~~~-~~l~~~~~~~~-~~~~~~~~~~i~~~l~~al~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~ 161 (311)
T cd07866 87 RGSVYMVTPYMD-HDLSGLLENPS-VKLTESQIKCYMLQLLEGINYLHENH---ILHRDIKAANILIDNQGILKIADFGL 161 (311)
T ss_pred CceEEEEEecCC-cCHHHHHhccc-cCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECcCcc
Confidence 34699999995 57877776432 35999999999999999999999999 99999999999999999999999999
Q ss_pred ecccccCCCCCCc----cceeeeeccCCCCccChhhhccC-CCCCcchhhhHHHHHHHHHhCCCCCCCCchhHHHHHHHh
Q 002158 773 SRLAPVLDDEGTM----PTHVSTIVKGTPGYLDPEYFLTH-KLTDKSDVYSLGVVLLELLTGMQPISHGKNIVREVNVAR 847 (958)
Q Consensus 773 a~~~~~~~~~~~~----~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DV~S~Gv~l~elltG~~P~~~~~~~~~~~~~~~ 847 (958)
++........... .........|++.|+|||.+.+. .++.++||||||+++|||++|+.||.+............
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~~~~ 241 (311)
T cd07866 162 ARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIFK 241 (311)
T ss_pred chhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence 9865332211110 11122345678899999988654 578899999999999999999999975443221111110
Q ss_pred hcCcc-----------hhhhc-ccCCCCC-------hHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 002158 848 DSGMV-----------FSIID-NRMGSYP-------SECVERFVTLALRCCHDKPEHRPSMSDVVRE 895 (958)
Q Consensus 848 ~~~~~-----------~~~i~-~~~~~~~-------~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 895 (958)
..+.. ....+ ......+ ......+.+++.+|++.||++||++.|++.+
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~~ 308 (311)
T cd07866 242 LCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALEH 308 (311)
T ss_pred HhCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhcC
Confidence 00000 00000 0000011 1223568899999999999999999998863
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-32 Score=309.07 Aligned_cols=257 Identities=22% Similarity=0.322 Sum_probs=198.2
Q ss_pred HHHcCCCCCceeeeeCCeEEEEEEEC-CCcEEEEEEeccCC--hhcHHHHHHHHHHHHccCCCCcceEEEEEEeCC----
Q 002158 622 MATAYFSSSTQVGQGGYGKVYKGILS-DNTTVAIKRAEEGS--LQGQNEFLTEIKLLSRLHHRNLVSLLGYCDEEG---- 694 (958)
Q Consensus 622 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~---- 694 (958)
...++|+..+.||+|+||.||+|... ++..||||++.... ......+.+|++++++++|+||+++++++....
T Consensus 12 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 91 (343)
T cd07880 12 EVPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDR 91 (343)
T ss_pred ccccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCccccc
Confidence 34667888999999999999999965 78999999986432 223456889999999999999999999986543
Q ss_pred --eEEEEEEecCCCCHHHHhccCCCCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEecCCCCeEEeeeee
Q 002158 695 --EQMLVYEFVPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSNLNAKVADFGL 772 (958)
Q Consensus 695 --~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~~~~kl~DFGl 772 (958)
..++||||+ +++|.+++... .+++..+..++.|+++||+|||+.+ |+||||||+||+++.++.++|+|||+
T Consensus 92 ~~~~~lv~e~~-~~~l~~~~~~~---~l~~~~~~~i~~qi~~al~~LH~~g---i~H~dlkp~Nill~~~~~~kl~dfg~ 164 (343)
T cd07880 92 FHDFYLVMPFM-GTDLGKLMKHE---KLSEDRIQFLVYQMLKGLKYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGL 164 (343)
T ss_pred cceEEEEEecC-CCCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeeccc
Confidence 458999999 78999988643 4889999999999999999999999 99999999999999999999999999
Q ss_pred ecccccCCCCCCccceeeeeccCCCCccChhhhcc-CCCCCcchhhhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcCc
Q 002158 773 SRLAPVLDDEGTMPTHVSTIVKGTPGYLDPEYFLT-HKLTDKSDVYSLGVVLLELLTGMQPISHGKNIVREVNVARDSGM 851 (958)
Q Consensus 773 a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DV~S~Gv~l~elltG~~P~~~~~~~~~~~~~~~~~~~ 851 (958)
+..... ......+++.|+|||++.+ ..++.++||||+|+++|++++|..||..................
T Consensus 165 ~~~~~~----------~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~ 234 (343)
T cd07880 165 ARQTDS----------EMTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGT 234 (343)
T ss_pred cccccc----------CccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCC
Confidence 875421 1123457889999999876 45788999999999999999999999765432221111110000
Q ss_pred c-------------hhhhcc-------cCCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 002158 852 V-------------FSIIDN-------RMGSYPSECVERFVTLALRCCHDKPEHRPSMSDVVRE 895 (958)
Q Consensus 852 ~-------------~~~i~~-------~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 895 (958)
. ...+.. .........+..+.+++.+|++.||++||++.+++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~ 298 (343)
T cd07880 235 PSKEFVQKLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAH 298 (343)
T ss_pred CCHHHHHhhcchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 0 000000 0001112345568899999999999999999999964
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=309.29 Aligned_cols=258 Identities=24% Similarity=0.346 Sum_probs=197.8
Q ss_pred cCCCCCceeeeeCCeEEEEEEEC-CCcEEEEEEeccC--ChhcHHHHHHHHHHHHccCCCCcceEEEEEEeC-----CeE
Q 002158 625 AYFSSSTQVGQGGYGKVYKGILS-DNTTVAIKRAEEG--SLQGQNEFLTEIKLLSRLHHRNLVSLLGYCDEE-----GEQ 696 (958)
Q Consensus 625 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~-----~~~ 696 (958)
.+|...+.||+|+||+||+|... +++.||||.+... ......++.+|+.+++.++|+||+++++++... ...
T Consensus 5 ~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~ 84 (337)
T cd07858 5 TKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFNDV 84 (337)
T ss_pred cceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCcE
Confidence 46788899999999999999975 6899999998653 223345678899999999999999999988654 357
Q ss_pred EEEEEecCCCCHHHHhccCCCCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEecCCCCeEEeeeeeeccc
Q 002158 697 MLVYEFVPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSRLA 776 (958)
Q Consensus 697 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~~ 776 (958)
++||||+. ++|.+++.... .+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||+++..
T Consensus 85 ~lv~e~~~-~~L~~~~~~~~--~l~~~~~~~i~~qi~~aL~~LH~~~---i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~ 158 (337)
T cd07858 85 YIVYELMD-TDLHQIIRSSQ--TLSDDHCQYFLYQLLRGLKYIHSAN---VLHRDLKPSNLLLNANCDLKICDFGLARTT 158 (337)
T ss_pred EEEEeCCC-CCHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEECcCcccccc
Confidence 99999995 79999986543 4899999999999999999999999 999999999999999999999999999765
Q ss_pred ccCCCCCCccceeeeeccCCCCccChhhhcc-CCCCCcchhhhHHHHHHHHHhCCCCCCCCchhHHHHHHHh--h-----
Q 002158 777 PVLDDEGTMPTHVSTIVKGTPGYLDPEYFLT-HKLTDKSDVYSLGVVLLELLTGMQPISHGKNIVREVNVAR--D----- 848 (958)
Q Consensus 777 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DV~S~Gv~l~elltG~~P~~~~~~~~~~~~~~~--~----- 848 (958)
.... .......|+..|+|||.+.. ..++.++|||||||++|||++|+.||.............. .
T Consensus 159 ~~~~-------~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 231 (337)
T cd07858 159 SEKG-------DFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEE 231 (337)
T ss_pred CCCc-------ccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChH
Confidence 3211 11123457889999999865 4688899999999999999999999965432111100000 0
Q ss_pred ------cCcchhhhc-------ccCCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 002158 849 ------SGMVFSIID-------NRMGSYPSECVERFVTLALRCCHDKPEHRPSMSDVVRE 895 (958)
Q Consensus 849 ------~~~~~~~i~-------~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 895 (958)
.......+. .........++..+.+++.+||+.+|++||++++++++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h 291 (337)
T cd07858 232 DLGFIRNEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAH 291 (337)
T ss_pred HhhhcCchhhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcC
Confidence 000000000 00001122456778999999999999999999999986
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-32 Score=308.78 Aligned_cols=260 Identities=26% Similarity=0.349 Sum_probs=202.6
Q ss_pred CCCCCceeeeeCCeEEEEEEEC-CCcEEEEEEeccCC--hhcHHHHHHHHHHHHccCCCCcceEEEEEEeCC-----eEE
Q 002158 626 YFSSSTQVGQGGYGKVYKGILS-DNTTVAIKRAEEGS--LQGQNEFLTEIKLLSRLHHRNLVSLLGYCDEEG-----EQM 697 (958)
Q Consensus 626 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~-----~~~ 697 (958)
+|...+.||+|+||.||+|+.. +++.||||++.... ....+.+.+|+++++.++|+||+++++++.... ..+
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY 80 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence 4777889999999999999976 58999999987643 334567899999999999999999999987765 789
Q ss_pred EEEEecCCCCHHHHhccCCCCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEecCCCCeEEeeeeeecccc
Q 002158 698 LVYEFVPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSRLAP 777 (958)
Q Consensus 698 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~~~ 777 (958)
+||||++ ++|.+++.... .+++..+..++.|+++||+|||+.+ |+||||||+||+++.++.++|+|||++....
T Consensus 81 lv~e~~~-~~l~~~l~~~~--~l~~~~~~~i~~~l~~~l~~LH~~g---i~H~dlkp~nili~~~~~~~L~dfg~~~~~~ 154 (330)
T cd07834 81 IVTELME-TDLHKVIKSPQ--PLTDDHIQYFLYQILRGLKYLHSAN---VIHRDLKPSNILVNSNCDLKICDFGLARGVD 154 (330)
T ss_pred EEecchh-hhHHHHHhCCC--CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEcccCceEeec
Confidence 9999997 58999997544 5999999999999999999999999 9999999999999999999999999998654
Q ss_pred cCCCCCCccceeeeeccCCCCccChhhhccC-CCCCcchhhhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcCc-----
Q 002158 778 VLDDEGTMPTHVSTIVKGTPGYLDPEYFLTH-KLTDKSDVYSLGVVLLELLTGMQPISHGKNIVREVNVARDSGM----- 851 (958)
Q Consensus 778 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DV~S~Gv~l~elltG~~P~~~~~~~~~~~~~~~~~~~----- 851 (958)
..... ........++..|+|||++.+. .++.++||||||+++|+|++|+.||................+.
T Consensus 155 ~~~~~----~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 230 (330)
T cd07834 155 PDEDE----KGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEED 230 (330)
T ss_pred ccccc----cccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCChhH
Confidence 32211 0112234578899999999888 7899999999999999999999999754432211111110000
Q ss_pred --------chhhhccc-------CCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 002158 852 --------VFSIIDNR-------MGSYPSECVERFVTLALRCCHDKPEHRPSMSDVVRE 895 (958)
Q Consensus 852 --------~~~~i~~~-------~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 895 (958)
....+... ........+..+.+++.+||+.+|++||++++++++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~ 289 (330)
T cd07834 231 LKFITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAH 289 (330)
T ss_pred hhhccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 00000000 001122356778999999999999999999999975
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-32 Score=307.00 Aligned_cols=259 Identities=24% Similarity=0.329 Sum_probs=199.1
Q ss_pred HHHHHcCCCCCceeeeeCCeEEEEEEEC-CCcEEEEEEeccC--ChhcHHHHHHHHHHHHccCCCCcceEEEEEEe-CCe
Q 002158 620 LAMATAYFSSSTQVGQGGYGKVYKGILS-DNTTVAIKRAEEG--SLQGQNEFLTEIKLLSRLHHRNLVSLLGYCDE-EGE 695 (958)
Q Consensus 620 l~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~-~~~ 695 (958)
+...+++|+..+.||+|+||.||+|... +++.||||++... .....+.+.+|++++++++||||+++++++.. ...
T Consensus 5 ~~~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~ 84 (328)
T cd07856 5 VFEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLED 84 (328)
T ss_pred eeccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCc
Confidence 3446788999999999999999999976 7899999987643 22334568899999999999999999999865 567
Q ss_pred EEEEEEecCCCCHHHHhccCCCCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEecCCCCeEEeeeeeecc
Q 002158 696 QMLVYEFVPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSRL 775 (958)
Q Consensus 696 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~ 775 (958)
.++||||+ +++|.++++.. .+++..+..++.|+++||+|||+.+ |+||||||+||++++++.++|+|||++..
T Consensus 85 ~~lv~e~~-~~~L~~~~~~~---~~~~~~~~~~~~ql~~aL~~LH~~~---iiH~dl~p~Nili~~~~~~~l~dfg~~~~ 157 (328)
T cd07856 85 IYFVTELL-GTDLHRLLTSR---PLEKQFIQYFLYQILRGLKYVHSAG---VVHRDLKPSNILINENCDLKICDFGLARI 157 (328)
T ss_pred EEEEeehh-ccCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEeECCCCCEEeCccccccc
Confidence 89999999 57999988643 3788888899999999999999999 99999999999999999999999999874
Q ss_pred cccCCCCCCccceeeeeccCCCCccChhhhcc-CCCCCcchhhhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhc-----
Q 002158 776 APVLDDEGTMPTHVSTIVKGTPGYLDPEYFLT-HKLTDKSDVYSLGVVLLELLTGMQPISHGKNIVREVNVARDS----- 849 (958)
Q Consensus 776 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DV~S~Gv~l~elltG~~P~~~~~~~~~~~~~~~~~----- 849 (958)
... ......++..|+|||++.+ ..++.++||||||+++|||++|+.||................
T Consensus 158 ~~~----------~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~ 227 (328)
T cd07856 158 QDP----------QMTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPD 227 (328)
T ss_pred cCC----------CcCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCH
Confidence 321 1122357888999998866 568899999999999999999999996544321111000000
Q ss_pred --------Ccchhhhccc--CCCCC-----hHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 002158 850 --------GMVFSIIDNR--MGSYP-----SECVERFVTLALRCCHDKPEHRPSMSDVVRE 895 (958)
Q Consensus 850 --------~~~~~~i~~~--~~~~~-----~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 895 (958)
....+.+... ....+ ...+..+.+++.+|++.+|++||++++++.+
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~ 288 (328)
T cd07856 228 DVINTICSENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAH 288 (328)
T ss_pred HHHHhccchhhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 0000000000 00111 1245789999999999999999999999865
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-33 Score=310.20 Aligned_cols=260 Identities=20% Similarity=0.311 Sum_probs=196.8
Q ss_pred cCCCCCceeeeeCCeEEEEEEEC-CCcEEEEEEeccCChhcHHHHHHHHHHHHccCCCCcceEEEEEEeC----------
Q 002158 625 AYFSSSTQVGQGGYGKVYKGILS-DNTTVAIKRAEEGSLQGQNEFLTEIKLLSRLHHRNLVSLLGYCDEE---------- 693 (958)
Q Consensus 625 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~---------- 693 (958)
.+|...+.||+|+||.||+|... +++.||+|++........+.+.+|++++++++||||+++++++...
T Consensus 5 ~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~ 84 (342)
T cd07854 5 SRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVGS 84 (342)
T ss_pred cceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhccccccccccccc
Confidence 56888899999999999999975 6889999998776555667789999999999999999999876543
Q ss_pred ----CeEEEEEEecCCCCHHHHhccCCCCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEecC-CCCeEEe
Q 002158 694 ----GEQMLVYEFVPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDS-NLNAKVA 768 (958)
Q Consensus 694 ----~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~-~~~~kl~ 768 (958)
...++||||++ ++|.+++... .+++..+..++.|++.||+|||+.+ |+||||||+||+++. ++.+|++
T Consensus 85 ~~~~~~~~lv~e~~~-~~L~~~~~~~---~l~~~~~~~~~~qi~~aL~~LH~~g---ivH~dikp~Nili~~~~~~~kl~ 157 (342)
T cd07854 85 LTELNSVYIVQEYME-TDLANVLEQG---PLSEEHARLFMYQLLRGLKYIHSAN---VLHRDLKPANVFINTEDLVLKIG 157 (342)
T ss_pred ccccceEEEEeeccc-ccHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEcCCCceEEEC
Confidence 35789999996 6999888643 3889999999999999999999999 999999999999974 5678999
Q ss_pred eeeeecccccCCCCCCccceeeeeccCCCCccChhhhcc-CCCCCcchhhhHHHHHHHHHhCCCCCCCCchhHHHHHHHh
Q 002158 769 DFGLSRLAPVLDDEGTMPTHVSTIVKGTPGYLDPEYFLT-HKLTDKSDVYSLGVVLLELLTGMQPISHGKNIVREVNVAR 847 (958)
Q Consensus 769 DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DV~S~Gv~l~elltG~~P~~~~~~~~~~~~~~~ 847 (958)
|||+++........ ........|+..|+|||.+.. ..++.++|||||||++|||++|+.||..............
T Consensus 158 dfg~~~~~~~~~~~----~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~~ 233 (342)
T cd07854 158 DFGLARIVDPHYSH----KGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILE 233 (342)
T ss_pred CcccceecCCcccc----ccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence 99998754321111 111122357889999998754 4578899999999999999999999976543322211111
Q ss_pred hcCc--------ch----hhhc--ccCC-----CCChHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 002158 848 DSGM--------VF----SIID--NRMG-----SYPSECVERFVTLALRCCHDKPEHRPSMSDVVRE 895 (958)
Q Consensus 848 ~~~~--------~~----~~i~--~~~~-----~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 895 (958)
.... .. .... .... ........++.+++.+||+.||++||++.|++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h 300 (342)
T cd07854 234 SVPVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMH 300 (342)
T ss_pred hcCCCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhCC
Confidence 0000 00 0000 0000 0112345678899999999999999999999964
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-32 Score=295.60 Aligned_cols=249 Identities=25% Similarity=0.354 Sum_probs=198.6
Q ss_pred CCCCCceeeeeCCeEEEEEEECC-CcEEEEEEeccC-----ChhcHHHHHHHHHHHHccCCCCcceEEEEEEeCCeEEEE
Q 002158 626 YFSSSTQVGQGGYGKVYKGILSD-NTTVAIKRAEEG-----SLQGQNEFLTEIKLLSRLHHRNLVSLLGYCDEEGEQMLV 699 (958)
Q Consensus 626 ~~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV 699 (958)
+|...+.||+|+||.||++.+.. +..+++|.++.. ......++..|+.++++++||||+++++++.+.+..++|
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII 80 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence 46778899999999999998753 455666665432 122334577899999999999999999999999999999
Q ss_pred EEecCCCCHHHHhccC--CCCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEecCCCCeEEeeeeeecccc
Q 002158 700 YEFVPNGTLRDWLSGR--TKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSRLAP 777 (958)
Q Consensus 700 ~E~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~~~ 777 (958)
|||+++++|.+++... ....+++.++..++.|+++||+|||+.+ ++|+||||+||+++. +.++|+|||+++...
T Consensus 81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~h~~l~~~nili~~-~~~~l~d~g~~~~~~ 156 (260)
T cd08222 81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRR---ILHRDLKAKNIFLKN-NLLKIGDFGVSRLLM 156 (260)
T ss_pred EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcC---ccccCCChhheEeec-CCEeecccCceeecC
Confidence 9999999999998642 2345899999999999999999999999 999999999999975 569999999987653
Q ss_pred cCCCCCCccceeeeeccCCCCccChhhhccCCCCCcchhhhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcCcchhhhc
Q 002158 778 VLDDEGTMPTHVSTIVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVLLELLTGMQPISHGKNIVREVNVARDSGMVFSIID 857 (958)
Q Consensus 778 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gv~l~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~i~ 857 (958)
... .......|+..|+|||.+.+..++.++|+||||+++|+|++|..||...... ..... ...
T Consensus 157 ~~~-------~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~-~~~~~---------~~~ 219 (260)
T cd08222 157 GSC-------DLATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNFL-SVVLR---------IVE 219 (260)
T ss_pred CCc-------ccccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCccHH-HHHHH---------HHc
Confidence 211 1122345888999999998888899999999999999999999999644322 11111 111
Q ss_pred ccCCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 002158 858 NRMGSYPSECVERFVTLALRCCHDKPEHRPSMSDVVRE 895 (958)
Q Consensus 858 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 895 (958)
......+..++.++.+++.+||+.+|++||++.|++++
T Consensus 220 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 257 (260)
T cd08222 220 GPTPSLPETYSRQLNSIMQSMLNKDPSLRPSAAEILRN 257 (260)
T ss_pred CCCCCCcchhcHHHHHHHHHHhcCChhhCcCHHHHhhC
Confidence 22233456677899999999999999999999999874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-33 Score=283.33 Aligned_cols=205 Identities=28% Similarity=0.384 Sum_probs=169.3
Q ss_pred HHcCCCCCceeeeeCCeEEEEEEECC-----CcEEEEEEeccCChhc--HHHHHHHHHHHHccCCCCcceEEEEEEe-CC
Q 002158 623 ATAYFSSSTQVGQGGYGKVYKGILSD-----NTTVAIKRAEEGSLQG--QNEFLTEIKLLSRLHHRNLVSLLGYCDE-EG 694 (958)
Q Consensus 623 ~~~~~~~~~~lg~G~~g~Vy~~~~~~-----~~~vavK~~~~~~~~~--~~~~~~E~~~l~~l~H~niv~l~~~~~~-~~ 694 (958)
....|+....||+|+||.||+|..++ ...+|+|+++...... .....+|+..++.++|||++.+..++.. +.
T Consensus 22 ~l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~ 101 (438)
T KOG0666|consen 22 DLFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDK 101 (438)
T ss_pred HHHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCc
Confidence 34568888999999999999997432 3379999998753221 2356799999999999999999999876 78
Q ss_pred eEEEEEEecCCCCHHHHhccCC---CCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEecCC----CCeEE
Q 002158 695 EQMLVYEFVPNGTLRDWLSGRT---KENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSN----LNAKV 767 (958)
Q Consensus 695 ~~~lV~E~~~~gsL~~~l~~~~---~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~----~~~kl 767 (958)
..++++||.+. +|.+.|+-.+ ...++...+..|..||+.|+.|||++- |+||||||.|||+..+ |.|||
T Consensus 102 ~v~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NW---vlHRDLKPaNIlvmgdgperG~VKI 177 (438)
T KOG0666|consen 102 KVWLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNW---VLHRDLKPANILVMGDGPERGRVKI 177 (438)
T ss_pred eEEEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhh---eeeccCCcceEEEeccCCccCeeEe
Confidence 89999999965 8988886322 345889999999999999999999999 9999999999999877 89999
Q ss_pred eeeeeecccccCCCCCCccceeeeeccCCCCccChhhhccC-CCCCcchhhhHHHHHHHHHhCCCCCCC
Q 002158 768 ADFGLSRLAPVLDDEGTMPTHVSTIVKGTPGYLDPEYFLTH-KLTDKSDVYSLGVVLLELLTGMQPISH 835 (958)
Q Consensus 768 ~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DV~S~Gv~l~elltG~~P~~~ 835 (958)
+|||++|.+...- .+......++-|..|.|||.+.+. .|+.+.||||.||++.||+|-++-|..
T Consensus 178 aDlGlaR~~~~pl----kpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g 242 (438)
T KOG0666|consen 178 ADLGLARLFNNPL----KPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKG 242 (438)
T ss_pred ecccHHHHhhccc----cccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccc
Confidence 9999999874321 122233456778999999999886 588899999999999999998777754
|
|
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-32 Score=303.82 Aligned_cols=261 Identities=25% Similarity=0.293 Sum_probs=194.3
Q ss_pred CCCCCceeeeeCCeEEEEEEEC-C--CcEEEEEEeccCC--hhcHHHHHHHHHHHHcc-CCCCcceEEEEEEeC----Ce
Q 002158 626 YFSSSTQVGQGGYGKVYKGILS-D--NTTVAIKRAEEGS--LQGQNEFLTEIKLLSRL-HHRNLVSLLGYCDEE----GE 695 (958)
Q Consensus 626 ~~~~~~~lg~G~~g~Vy~~~~~-~--~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~----~~ 695 (958)
+|...+.||+|+||.||++... . +..||+|++.... ....+.+.+|+++++++ +|+||+++++++... ..
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~ 80 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE 80 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence 4667789999999999999975 3 7799999886532 22345688999999999 599999999975432 45
Q ss_pred EEEEEEecCCCCHHHHhccCCCCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEecCCCCeEEeeeeeecc
Q 002158 696 QMLVYEFVPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSRL 775 (958)
Q Consensus 696 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~ 775 (958)
.+++|||++ ++|.+++.... .+++..+..++.|++.||+|||+.+ |+||||||+||++++++.+||+|||+++.
T Consensus 81 ~~~~~e~~~-~~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~g---ivH~dlkp~Nili~~~~~~kl~Dfg~a~~ 154 (332)
T cd07857 81 LYLYEELME-ADLHQIIRSGQ--PLTDAHFQSFIYQILCGLKYIHSAN---VLHRDLKPGNLLVNADCELKICDFGLARG 154 (332)
T ss_pred EEEEEeccc-CCHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHeEEcCCCCEEeCcCCCcee
Confidence 789999985 69999996543 4899999999999999999999999 99999999999999999999999999986
Q ss_pred cccCCCCCCccceeeeeccCCCCccChhhhcc-CCCCCcchhhhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcCc---
Q 002158 776 APVLDDEGTMPTHVSTIVKGTPGYLDPEYFLT-HKLTDKSDVYSLGVVLLELLTGMQPISHGKNIVREVNVARDSGM--- 851 (958)
Q Consensus 776 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DV~S~Gv~l~elltG~~P~~~~~~~~~~~~~~~~~~~--- 851 (958)
....... .........||..|+|||++.+ ..++.++||||+|+++|+|++|+.||................+.
T Consensus 155 ~~~~~~~---~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 231 (332)
T cd07857 155 FSENPGE---NAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDE 231 (332)
T ss_pred ccccccc---ccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCH
Confidence 5332211 1111223568999999998866 46889999999999999999999999754422111100000000
Q ss_pred ----------chhhhc---c----cCCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 002158 852 ----------VFSIID---N----RMGSYPSECVERFVTLALRCCHDKPEHRPSMSDVVRE 895 (958)
Q Consensus 852 ----------~~~~i~---~----~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 895 (958)
...... . .........+..+.+++.+|++.||++||++.+++++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~~ 292 (332)
T cd07857 232 ETLSRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALEH 292 (332)
T ss_pred HHHHhhhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence 000000 0 0000111235678999999999999999999999864
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-32 Score=296.64 Aligned_cols=257 Identities=25% Similarity=0.358 Sum_probs=199.2
Q ss_pred CCCCceeeeeCCeEEEEEEEC-CCcEEEEEEeccCC--hhcHHHHHHHHHHHHccCCCCcceEEEEEEeCCeEEEEEEec
Q 002158 627 FSSSTQVGQGGYGKVYKGILS-DNTTVAIKRAEEGS--LQGQNEFLTEIKLLSRLHHRNLVSLLGYCDEEGEQMLVYEFV 703 (958)
Q Consensus 627 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E~~ 703 (958)
|+..+.||+|+||.||+|+.. +++.||+|.+.... ....+.+..|++++++++|+|++++++++...+..++||||+
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYC 80 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCc
Confidence 455678999999999999986 58999999987653 233456889999999999999999999999999999999999
Q ss_pred CCCCHHHHhccCCCCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEecCCCCeEEeeeeeecccccCCCCC
Q 002158 704 PNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSRLAPVLDDEG 783 (958)
Q Consensus 704 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 783 (958)
+ ++|.+++.... ..+++..+..++.|++.||+|||+.+ |+||||+|+||++++++.++|+|||.++.......
T Consensus 81 ~-~~l~~~i~~~~-~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~-- 153 (282)
T cd07829 81 D-MDLKKYLDKRP-GPLSPNLIKSIMYQLLRGLAYCHSHR---ILHRDLKPQNILINRDGVLKLADFGLARAFGIPLR-- 153 (282)
T ss_pred C-cCHHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChheEEEcCCCCEEEecCCcccccCCCcc--
Confidence 7 59999997653 34899999999999999999999999 99999999999999999999999999876532111
Q ss_pred CccceeeeeccCCCCccChhhhccC-CCCCcchhhhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcC----cchhh---
Q 002158 784 TMPTHVSTIVKGTPGYLDPEYFLTH-KLTDKSDVYSLGVVLLELLTGMQPISHGKNIVREVNVARDSG----MVFSI--- 855 (958)
Q Consensus 784 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DV~S~Gv~l~elltG~~P~~~~~~~~~~~~~~~~~~----~~~~~--- 855 (958)
......++..|+|||.+.+. .++.++||||||+++|||++|+.||................+ .....
T Consensus 154 -----~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (282)
T cd07829 154 -----TYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTK 228 (282)
T ss_pred -----ccCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhcc
Confidence 11223457789999999776 788999999999999999999999965443221111110000 00000
Q ss_pred ---hcccCC--------CCChHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 002158 856 ---IDNRMG--------SYPSECVERFVTLALRCCHDKPEHRPSMSDVVRE 895 (958)
Q Consensus 856 ---i~~~~~--------~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 895 (958)
.+.... ...+..+..+.+++.+||+.+|++||++.+++.+
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~ 279 (282)
T cd07829 229 LPDYKPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKH 279 (282)
T ss_pred cccccccccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhhC
Confidence 000000 0011235689999999999999999999999863
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-32 Score=307.11 Aligned_cols=256 Identities=23% Similarity=0.338 Sum_probs=197.8
Q ss_pred HHcCCCCCceeeeeCCeEEEEEEEC-CCcEEEEEEeccC--ChhcHHHHHHHHHHHHccCCCCcceEEEEEEeCCe----
Q 002158 623 ATAYFSSSTQVGQGGYGKVYKGILS-DNTTVAIKRAEEG--SLQGQNEFLTEIKLLSRLHHRNLVSLLGYCDEEGE---- 695 (958)
Q Consensus 623 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~---- 695 (958)
..++|+..+.||+|+||.||+|.+. +++.||||++... .....+.+.+|+.++++++|+|++++++++...+.
T Consensus 13 ~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 92 (343)
T cd07851 13 VPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDF 92 (343)
T ss_pred ccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhcccccccc
Confidence 3567888899999999999999986 5889999998653 22334567889999999999999999998866554
Q ss_pred --EEEEEEecCCCCHHHHhccCCCCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEecCCCCeEEeeeeee
Q 002158 696 --QMLVYEFVPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSNLNAKVADFGLS 773 (958)
Q Consensus 696 --~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla 773 (958)
.++|+||+ +++|.+++... .+++..+..++.|+++||+|||+.+ |+||||||+||+++.++.++|+|||++
T Consensus 93 ~~~~lv~e~~-~~~L~~~~~~~---~l~~~~~~~~~~ql~~aL~~LH~~g---i~H~dlkp~Nill~~~~~~kL~dfg~~ 165 (343)
T cd07851 93 QDVYLVTHLM-GADLNNIVKCQ---KLSDDHIQFLVYQILRGLKYIHSAG---IIHRDLKPSNIAVNEDCELKILDFGLA 165 (343)
T ss_pred ccEEEEEecC-CCCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEcccccc
Confidence 89999999 67999999753 4899999999999999999999999 999999999999999999999999998
Q ss_pred cccccCCCCCCccceeeeeccCCCCccChhhhccC-CCCCcchhhhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcCcc
Q 002158 774 RLAPVLDDEGTMPTHVSTIVKGTPGYLDPEYFLTH-KLTDKSDVYSLGVVLLELLTGMQPISHGKNIVREVNVARDSGMV 852 (958)
Q Consensus 774 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DV~S~Gv~l~elltG~~P~~~~~~~~~~~~~~~~~~~~ 852 (958)
...... .....++..|+|||.+.+. .++.++||||||+++|||++|+.||................+..
T Consensus 166 ~~~~~~----------~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~ 235 (343)
T cd07851 166 RHTDDE----------MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTP 235 (343)
T ss_pred cccccc----------ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCC
Confidence 754211 1233578889999998653 67889999999999999999999997554322111111100000
Q ss_pred h-hh------------hcccC----C---CCChHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 002158 853 F-SI------------IDNRM----G---SYPSECVERFVTLALRCCHDKPEHRPSMSDVVRE 895 (958)
Q Consensus 853 ~-~~------------i~~~~----~---~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 895 (958)
. +. +.... . ......+..+.+++.+|++.+|++||++.+++++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h 298 (343)
T cd07851 236 DEELLQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAH 298 (343)
T ss_pred CHHHHhhccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhcC
Confidence 0 00 00000 0 0011235778999999999999999999999864
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=4.5e-32 Score=290.57 Aligned_cols=236 Identities=28% Similarity=0.354 Sum_probs=195.5
Q ss_pred eeeeCCeEEEEEEEC-CCcEEEEEEeccCChh---cHHHHHHHHHHHHccCCCCcceEEEEEEeCCeEEEEEEecCCCCH
Q 002158 633 VGQGGYGKVYKGILS-DNTTVAIKRAEEGSLQ---GQNEFLTEIKLLSRLHHRNLVSLLGYCDEEGEQMLVYEFVPNGTL 708 (958)
Q Consensus 633 lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E~~~~gsL 708 (958)
||+|+||.||++... +++.||+|.+...... ....+..|++++++++|+||+++++.+..++..++||||+++++|
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L 80 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL 80 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence 699999999999986 5899999998764332 345789999999999999999999999999999999999999999
Q ss_pred HHHhccCCCCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEecCCCCeEEeeeeeecccccCCCCCCccce
Q 002158 709 RDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSRLAPVLDDEGTMPTH 788 (958)
Q Consensus 709 ~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~ 788 (958)
.+++.... .+++..+..++.|+++|+.|||+.+ ++|+||+|+||+++.++.++|+|||++....... .
T Consensus 81 ~~~l~~~~--~l~~~~~~~~~~qi~~~l~~lh~~~---~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~-------~ 148 (250)
T cd05123 81 FSHLSKEG--RFSEERARFYAAEIVLALEYLHSLG---IIYRDLKPENILLDADGHIKLTDFGLAKELSSEG-------S 148 (250)
T ss_pred HHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcceEEEcCCCcEEEeecCcceecccCC-------C
Confidence 99997553 4899999999999999999999988 9999999999999999999999999987653221 1
Q ss_pred eeeeccCCCCccChhhhccCCCCCcchhhhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcCcchhhhcccCCCCChHHH
Q 002158 789 VSTIVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVLLELLTGMQPISHGKNIVREVNVARDSGMVFSIIDNRMGSYPSECV 868 (958)
Q Consensus 789 ~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gv~l~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~ 868 (958)
......|+..|+|||...+...+.++|+||||+++|||++|..||..... ......... .....+...+
T Consensus 149 ~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~-~~~~~~~~~----------~~~~~~~~~~ 217 (250)
T cd05123 149 RTNTFCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDR-KEIYEKILK----------DPLRFPEFLS 217 (250)
T ss_pred cccCCcCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH-HHHHHHHhc----------CCCCCCCCCC
Confidence 12334588899999999888889999999999999999999999965443 111111111 1123344557
Q ss_pred HHHHHHHHHccccCCCCCCCHHH
Q 002158 869 ERFVTLALRCCHDKPEHRPSMSD 891 (958)
Q Consensus 869 ~~l~~li~~cl~~dP~~RPs~~e 891 (958)
..+.+++.+||..||++||++++
T Consensus 218 ~~l~~~i~~~l~~~p~~R~~~~~ 240 (250)
T cd05123 218 PEARDLISGLLQKDPTKRLGSGG 240 (250)
T ss_pred HHHHHHHHHHhcCCHhhCCCccc
Confidence 88899999999999999999944
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=4.3e-33 Score=297.35 Aligned_cols=245 Identities=24% Similarity=0.372 Sum_probs=204.6
Q ss_pred CceeeeeCCeEEEEEEEC-CCcEEEEEEeccC--ChhcHHHHHHHHHHHHccCCCCcceEEEEEEeCCeEEEEEEecCCC
Q 002158 630 STQVGQGGYGKVYKGILS-DNTTVAIKRAEEG--SLQGQNEFLTEIKLLSRLHHRNLVSLLGYCDEEGEQMLVYEFVPNG 706 (958)
Q Consensus 630 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E~~~~g 706 (958)
.+.||+|-||+||-|+++ +|+.||||++.+. .......+.+|+.+|++++||.||.+.--|+..+..++|||.+ +|
T Consensus 569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl-~G 647 (888)
T KOG4236|consen 569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKL-HG 647 (888)
T ss_pred HhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhh-cc
Confidence 478999999999999975 7999999998764 2334467889999999999999999999999999999999999 56
Q ss_pred CHHHHhccCCCCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEecCC---CCeEEeeeeeecccccCCCCC
Q 002158 707 TLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSN---LNAKVADFGLSRLAPVLDDEG 783 (958)
Q Consensus 707 sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~---~~~kl~DFGla~~~~~~~~~~ 783 (958)
+..++|-...++++++.....++.||+.||.|||.++ |+|+||||+|||+... -.+||||||+||+...
T Consensus 648 DMLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~kn---IvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgE----- 719 (888)
T KOG4236|consen 648 DMLEMILSSEKGRLPERITKFLVTQILVALRYLHFKN---IVHCDLKPENVLLASASPFPQVKLCDFGFARIIGE----- 719 (888)
T ss_pred hHHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhhcc---eeeccCCchheeeccCCCCCceeeccccceeecch-----
Confidence 7777766566667999999999999999999999999 9999999999999653 4699999999998642
Q ss_pred CccceeeeeccCCCCccChhhhccCCCCCcchhhhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcCcchhhhcccCCCC
Q 002158 784 TMPTHVSTIVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVLLELLTGMQPISHGKNIVREVNVARDSGMVFSIIDNRMGSY 863 (958)
Q Consensus 784 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gv~l~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~ 863 (958)
......++||+.|+|||+++...|...-|+||.||++|--++|..||..++++...++.+.- ++ .+..
T Consensus 720 ---ksFRrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdEdIndQIQNAaF---My------Pp~P 787 (888)
T KOG4236|consen 720 ---KSFRRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDEDINDQIQNAAF---MY------PPNP 787 (888)
T ss_pred ---hhhhhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCccchhHHhhcccc---cc------CCCc
Confidence 22345678999999999999999999999999999999999999999888776665432211 00 0122
Q ss_pred ChHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 002158 864 PSECVERFVTLALRCCHDKPEHRPSMSDVVRE 895 (958)
Q Consensus 864 ~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 895 (958)
..+......++|...++..-++|-+.+..+.+
T Consensus 788 W~eis~~AidlIn~LLqVkm~kRysvdk~lsh 819 (888)
T KOG4236|consen 788 WSEISPEAIDLINNLLQVKMRKRYSVDKSLSH 819 (888)
T ss_pred hhhcCHHHHHHHHHHHHHHHHHhcchHhhccc
Confidence 34667788999999999999999998876643
|
|
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.5e-31 Score=323.72 Aligned_cols=146 Identities=24% Similarity=0.376 Sum_probs=131.1
Q ss_pred cCCCCCceeeeeCCeEEEEEEEC-CCcEEEEEEeccCC---hhcHHHHHHHHHHHHccCCCCcceEEEEEEeCCeEEEEE
Q 002158 625 AYFSSSTQVGQGGYGKVYKGILS-DNTTVAIKRAEEGS---LQGQNEFLTEIKLLSRLHHRNLVSLLGYCDEEGEQMLVY 700 (958)
Q Consensus 625 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~ 700 (958)
++|.+.+.||+|+||+||+|.+. +++.||||+++... ......+.+|+.+++.++|+||+++++++...+..++||
T Consensus 4 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lVm 83 (669)
T cd05610 4 EEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLVM 83 (669)
T ss_pred CCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEEE
Confidence 46778899999999999999986 68999999987542 223457889999999999999999999999999999999
Q ss_pred EecCCCCHHHHhccCCCCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEecCCCCeEEeeeeeecc
Q 002158 701 EFVPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSRL 775 (958)
Q Consensus 701 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~ 775 (958)
||+++++|.+++.... .+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.
T Consensus 84 Ey~~g~~L~~li~~~~--~l~~~~~~~i~~qil~aL~yLH~~g---IiHrDLKP~NILl~~~g~vkL~DFGls~~ 153 (669)
T cd05610 84 EYLIGGDVKSLLHIYG--YFDEEMAVKYISEVALALDYLHRHG---IIHRDLKPDNMLISNEGHIKLTDFGLSKV 153 (669)
T ss_pred eCCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCccHHHEEEcCCCCEEEEeCCCCcc
Confidence 9999999999997543 4788999999999999999999998 99999999999999999999999999863
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=4.2e-32 Score=308.20 Aligned_cols=260 Identities=27% Similarity=0.435 Sum_probs=215.7
Q ss_pred cChHHHHHHHcCCCCCceeeeeCCeEEEEEEEC-CCcEEEEEEeccCChhcHHHHHHHHHHHHcc-CCCCcceEEEEEEe
Q 002158 615 FKFKELAMATAYFSSSTQVGQGGYGKVYKGILS-DNTTVAIKRAEEGSLQGQNEFLTEIKLLSRL-HHRNLVSLLGYCDE 692 (958)
Q Consensus 615 ~~~~el~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~ 692 (958)
+.++.+...++.|++.+.||+|.+|.||+++.. +++.+|||+..... ...++...|.++++.. +|||++.++|++.-
T Consensus 9 ~~~~~lpdp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~-d~deEiE~eynil~~~~~hpnv~~fyg~~~k 87 (953)
T KOG0587|consen 9 IDLSSLPDPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTE-DEEEEIELEYNMLKKYSHHPNVATFYGAFIK 87 (953)
T ss_pred cchhhCCCCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCc-cccHHHHHHHHHHHhccCCCCcceEEEEEEE
Confidence 445555667778899999999999999999964 78899999887643 3345677899999988 69999999999843
Q ss_pred -----CCeEEEEEEecCCCCHHHHhccCCCCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEecCCCCeEE
Q 002158 693 -----EGEQMLVYEFVPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSNLNAKV 767 (958)
Q Consensus 693 -----~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~~~~kl 767 (958)
++++|||||||.+|+..|+++...+..+.|+.+..|+..++.|+++||... ++|||||-.|||++.++.||+
T Consensus 88 ~~~~~~DqLWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~nk---viHRDikG~NiLLT~e~~VKL 164 (953)
T KOG0587|consen 88 KDPGNGDQLWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHNNK---VIHRDIKGQNVLLTENAEVKL 164 (953)
T ss_pred ecCCCCCeEEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhhcc---eeeecccCceEEEeccCcEEE
Confidence 578999999999999999998777778999999999999999999999998 999999999999999999999
Q ss_pred eeeeeecccccCCCCCCccceeeeeccCCCCccChhhhccC-----CCCCcchhhhHHHHHHHHHhCCCCCCCCchhHHH
Q 002158 768 ADFGLSRLAPVLDDEGTMPTHVSTIVKGTPGYLDPEYFLTH-----KLTDKSDVYSLGVVLLELLTGMQPISHGKNIVRE 842 (958)
Q Consensus 768 ~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~DV~S~Gv~l~elltG~~P~~~~~~~~~~ 842 (958)
+|||.+..++.. ........||+.|||||++... .|+.++|+||+|++..||.-|.+|+.+......
T Consensus 165 vDFGvSaQldsT-------~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmra- 236 (953)
T KOG0587|consen 165 VDFGVSAQLDST-------VGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRA- 236 (953)
T ss_pred eeeeeeeeeecc-------cccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhhh-
Confidence 999998755321 2233456799999999999643 467799999999999999999999986554322
Q ss_pred HHHHhhcCcchhhhcccCC--CCChHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 002158 843 VNVARDSGMVFSIIDNRMG--SYPSECVERFVTLALRCCHDKPEHRPSMSDVVRE 895 (958)
Q Consensus 843 ~~~~~~~~~~~~~i~~~~~--~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 895 (958)
++.+..+..+ ..|..+.+++.++|..|+.+|..+||++.+++++
T Consensus 237 ---------LF~IpRNPPPkLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~h 282 (953)
T KOG0587|consen 237 ---------LFLIPRNPPPKLKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLKH 282 (953)
T ss_pred ---------hccCCCCCCccccchhhHHHHHHHHHHHHHhhccccCcchhhhccC
Confidence 2333332222 2367889999999999999999999999998854
|
|
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-32 Score=317.89 Aligned_cols=259 Identities=25% Similarity=0.303 Sum_probs=211.7
Q ss_pred ChHHHHHHHcCCCCCceeeeeCCeEEEEEEEC-CCcEEEEEEeccCC---hhcHHHHHHHHHHHHccCCCCcceEEEEEE
Q 002158 616 KFKELAMATAYFSSSTQVGQGGYGKVYKGILS-DNTTVAIKRAEEGS---LQGQNEFLTEIKLLSRLHHRNLVSLLGYCD 691 (958)
Q Consensus 616 ~~~el~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~ 691 (958)
..+++....++|.+.++||+|+||.|..++.+ .++.||+|++.++. ..+..-|..|-++|...+.+-|+.++-.|.
T Consensus 66 ~v~~lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQ 145 (1317)
T KOG0612|consen 66 KVKELRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQ 145 (1317)
T ss_pred HHHHHhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhc
Confidence 35677888889999999999999999999986 68899999998742 233446889999999999999999999999
Q ss_pred eCCeEEEEEEecCCCCHHHHhccCCCCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEecCCCCeEEeeee
Q 002158 692 EEGEQMLVYEFVPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSNLNAKVADFG 771 (958)
Q Consensus 692 ~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~~~~kl~DFG 771 (958)
++.++|+|||||+||+|-.++.... .+++..+..++..|.-||.-+|+.| +|||||||+|||+|.+|++||+|||
T Consensus 146 D~~~LYlVMdY~pGGDlltLlSk~~--~~pE~~ArFY~aEiVlAldslH~mg---yVHRDiKPDNvLld~~GHikLADFG 220 (1317)
T KOG0612|consen 146 DERYLYLVMDYMPGGDLLTLLSKFD--RLPEDWARFYTAEIVLALDSLHSMG---YVHRDIKPDNVLLDKSGHIKLADFG 220 (1317)
T ss_pred CccceEEEEecccCchHHHHHhhcC--CChHHHHHHHHHHHHHHHHHHHhcc---ceeccCCcceeEecccCcEeeccch
Confidence 9999999999999999999997665 5899999999999999999999999 9999999999999999999999999
Q ss_pred eecccccCCCCCCccceeeeeccCCCCccChhhhcc-----CCCCCcchhhhHHHHHHHHHhCCCCCCCCchhHHHHHHH
Q 002158 772 LSRLAPVLDDEGTMPTHVSTIVKGTPGYLDPEYFLT-----HKLTDKSDVYSLGVVLLELLTGMQPISHGKNIVREVNVA 846 (958)
Q Consensus 772 la~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DV~S~Gv~l~elltG~~P~~~~~~~~~~~~~~ 846 (958)
.+-.+...+ .-.+...+|||.|++||++.. +.|.+.+|.||+||++|||+.|.-||.. +.+...+...
T Consensus 221 sClkm~~dG------~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYa-dslveTY~KI 293 (1317)
T KOG0612|consen 221 SCLKMDADG------TVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYA-DSLVETYGKI 293 (1317)
T ss_pred hHHhcCCCC------cEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchH-HHHHHHHHHH
Confidence 987653322 233456789999999999953 5688999999999999999999999963 3333333222
Q ss_pred hhcCcchhhhcccCCCCC--hHHHHHHHHHHHHccccCCCCCCC---HHHHHHH
Q 002158 847 RDSGMVFSIIDNRMGSYP--SECVERFVTLALRCCHDKPEHRPS---MSDVVRE 895 (958)
Q Consensus 847 ~~~~~~~~~i~~~~~~~~--~~~~~~l~~li~~cl~~dP~~RPs---~~evl~~ 895 (958)
.... ..-.+| .+.+.+..+||.+.+ -+|+.|.. ++++-.|
T Consensus 294 m~hk--------~~l~FP~~~~VSeeakdLI~~ll-~~~e~RLgrngiedik~H 338 (1317)
T KOG0612|consen 294 MNHK--------ESLSFPDETDVSEEAKDLIEALL-CDREVRLGRNGIEDIKNH 338 (1317)
T ss_pred hchh--------hhcCCCcccccCHHHHHHHHHHh-cChhhhcccccHHHHHhC
Confidence 1111 112334 457788888988766 56888877 8887765
|
|
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.1e-32 Score=251.87 Aligned_cols=257 Identities=25% Similarity=0.404 Sum_probs=195.3
Q ss_pred CCCCceeeeeCCeEEEEEEEC-CCcEEEEEEeccCCh--hcHHHHHHHHHHHHccCCCCcceEEEEEEeCCeEEEEEEec
Q 002158 627 FSSSTQVGQGGYGKVYKGILS-DNTTVAIKRAEEGSL--QGQNEFLTEIKLLSRLHHRNLVSLLGYCDEEGEQMLVYEFV 703 (958)
Q Consensus 627 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E~~ 703 (958)
|...++||+|.||+||+|+.. .++.||+|+++-... .--....+|+-+++.++|.|||+++++...+...-+|+|||
T Consensus 4 ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~c 83 (292)
T KOG0662|consen 4 YDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFC 83 (292)
T ss_pred hHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHHh
Confidence 344568999999999999954 688999998865422 22346789999999999999999999999999999999999
Q ss_pred CCCCHHHHhccCCCCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEecCCCCeEEeeeeeecccccCCCCC
Q 002158 704 PNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSRLAPVLDDEG 783 (958)
Q Consensus 704 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 783 (958)
..+|..+.....+ .++.+.+..++.|+.+||.++|++. +.|||+||.|.||+.+|+.|++|||+++.+..
T Consensus 84 -dqdlkkyfdslng-~~d~~~~rsfmlqllrgl~fchshn---vlhrdlkpqnllin~ngelkladfglarafgi----- 153 (292)
T KOG0662|consen 84 -DQDLKKYFDSLNG-DLDPEIVRSFMLQLLRGLGFCHSHN---VLHRDLKPQNLLINRNGELKLADFGLARAFGI----- 153 (292)
T ss_pred -hHHHHHHHHhcCC-cCCHHHHHHHHHHHHhhhhhhhhhh---hhhccCCcceEEeccCCcEEecccchhhhcCC-----
Confidence 4689999876554 4899999999999999999999999 99999999999999999999999999986532
Q ss_pred CccceeeeeccCCCCccChhhhccCC-CCCcchhhhHHHHHHHHHhCCCCCCCCchhHHHH-HHHhhcCcchh-------
Q 002158 784 TMPTHVSTIVKGTPGYLDPEYFLTHK-LTDKSDVYSLGVVLLELLTGMQPISHGKNIVREV-NVARDSGMVFS------- 854 (958)
Q Consensus 784 ~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DV~S~Gv~l~elltG~~P~~~~~~~~~~~-~~~~~~~~~~~------- 854 (958)
+.......+-|..|.+|.++.+.+ |++..|+||.||++.|+.....|...+.+...+. +..+.-+...+
T Consensus 154 --pvrcysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wps~t 231 (292)
T KOG0662|consen 154 --PVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPSMT 231 (292)
T ss_pred --ceEeeeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCCccc
Confidence 233334456788999999998875 8889999999999999998555554444433333 22222222111
Q ss_pred -hhcccC-CCCCh---------HHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 002158 855 -IIDNRM-GSYPS---------ECVERFVTLALRCCHDKPEHRPSMSDVVRE 895 (958)
Q Consensus 855 -~i~~~~-~~~~~---------~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 895 (958)
..|-.. +.+|. .....=.+++.+.+.-+|.+|.++++.+++
T Consensus 232 ~lpdyk~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalqh 283 (292)
T KOG0662|consen 232 KLPDYKPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQH 283 (292)
T ss_pred cCCCCcccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhcC
Confidence 111000 11121 112233578888888899999999888763
|
|
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-32 Score=286.29 Aligned_cols=241 Identities=24% Similarity=0.370 Sum_probs=201.0
Q ss_pred HcCCCCCceeeeeCCeEEEEEEEC-CCcEEEEEEeccCChhc---HHHHHHHHHHHHcc-CCCCcceEEEEEEeCCeEEE
Q 002158 624 TAYFSSSTQVGQGGYGKVYKGILS-DNTTVAIKRAEEGSLQG---QNEFLTEIKLLSRL-HHRNLVSLLGYCDEEGEQML 698 (958)
Q Consensus 624 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~---~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~l 698 (958)
..+|....+||+|+||+|..|..+ ..+.+|||++++...-+ .+--+.|-++|+-. +-|.+++++.++..-+.+|+
T Consensus 348 ~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRLyF 427 (683)
T KOG0696|consen 348 ATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRLYF 427 (683)
T ss_pred ecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhheee
Confidence 346778899999999999999876 46789999998753322 22234577777766 56889999999999999999
Q ss_pred EEEecCCCCHHHHhccCCCCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEecCCCCeEEeeeeeeccccc
Q 002158 699 VYEFVPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSRLAPV 778 (958)
Q Consensus 699 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~~~~ 778 (958)
||||+.||+|--.+++-++ +.+..+..+|..||-||-+||++| ||.||||-+|||+|.+|.+||+|||+++.-
T Consensus 428 VMEyvnGGDLMyhiQQ~Gk--FKEp~AvFYAaEiaigLFFLh~kg---IiYRDLKLDNvmLd~eGHiKi~DFGmcKEn-- 500 (683)
T KOG0696|consen 428 VMEYVNGGDLMYHIQQVGK--FKEPVAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKEN-- 500 (683)
T ss_pred EEEEecCchhhhHHHHhcc--cCCchhhhhhHHHHHHhhhhhcCC---eeeeeccccceEeccCCceEeeeccccccc--
Confidence 9999999999988876554 888999999999999999999999 999999999999999999999999999742
Q ss_pred CCCCCCccceeeeeccCCCCccChhhhccCCCCCcchhhhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcCcchhhhcc
Q 002158 779 LDDEGTMPTHVSTIVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVLLELLTGMQPISHGKNIVREVNVARDSGMVFSIIDN 858 (958)
Q Consensus 779 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gv~l~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~i~~ 858 (958)
......+..++||+.|+|||++..++|..++|.|||||+||||+.|+.||++.+.. + +++.|..
T Consensus 501 -----i~~~~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~-e----------lF~aI~e 564 (683)
T KOG0696|consen 501 -----IFDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDED-E----------LFQAIME 564 (683)
T ss_pred -----ccCCcceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHH-H----------HHHHHHH
Confidence 22234556799999999999999999999999999999999999999999754432 2 2223333
Q ss_pred cCCCCChHHHHHHHHHHHHccccCCCCCC
Q 002158 859 RMGSYPSECVERFVTLALRCCHDKPEHRP 887 (958)
Q Consensus 859 ~~~~~~~~~~~~l~~li~~cl~~dP~~RP 887 (958)
.--.+|...+.+..++.+..+.+.|.+|.
T Consensus 565 hnvsyPKslSkEAv~ickg~ltK~P~kRL 593 (683)
T KOG0696|consen 565 HNVSYPKSLSKEAVAICKGLLTKHPGKRL 593 (683)
T ss_pred ccCcCcccccHHHHHHHHHHhhcCCcccc
Confidence 33467888889999999999999999994
|
|
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-31 Score=284.78 Aligned_cols=220 Identities=23% Similarity=0.211 Sum_probs=178.8
Q ss_pred eCCeEEEEEEEC-CCcEEEEEEeccCChhcHHHHHHHHHHHHccCCCCcceEEEEEEeCCeEEEEEEecCCCCHHHHhcc
Q 002158 636 GGYGKVYKGILS-DNTTVAIKRAEEGSLQGQNEFLTEIKLLSRLHHRNLVSLLGYCDEEGEQMLVYEFVPNGTLRDWLSG 714 (958)
Q Consensus 636 G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~ 714 (958)
|.+|.||++.+. +++.||+|++.... .+.+|...+....|||++++++++...+..++||||+++|+|.+++..
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~-----~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~ 78 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS-----EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISK 78 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh-----hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHHH
Confidence 899999999976 68899999987643 233455566666799999999999999999999999999999999965
Q ss_pred CCCCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEecCCCCeEEeeeeeecccccCCCCCCccceeeeecc
Q 002158 715 RTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSRLAPVLDDEGTMPTHVSTIVK 794 (958)
Q Consensus 715 ~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~ 794 (958)
.. .+++..+..++.|+++||+|||+.+ |+||||||+||+++.++.++++|||.+...... .....
T Consensus 79 ~~--~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~----------~~~~~ 143 (237)
T cd05576 79 FL--NIPEECVKRWAAEMVVALDALHREG---IVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDS----------CDGEA 143 (237)
T ss_pred hc--CCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEEcCCCCEEEecccchhccccc----------cccCC
Confidence 43 3899999999999999999999998 999999999999999999999999987644211 11234
Q ss_pred CCCCccChhhhccCCCCCcchhhhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcCcchhhhcccCCCCChHHHHHHHHH
Q 002158 795 GTPGYLDPEYFLTHKLTDKSDVYSLGVVLLELLTGMQPISHGKNIVREVNVARDSGMVFSIIDNRMGSYPSECVERFVTL 874 (958)
Q Consensus 795 gt~~y~aPE~~~~~~~~~~~DV~S~Gv~l~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~l~~l 874 (958)
++..|+|||++.+..++.++||||+|+++|||++|+.|+....... .. ......|...+..+.++
T Consensus 144 ~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~~-------~~--------~~~~~~~~~~~~~~~~l 208 (237)
T cd05576 144 VENMYCAPEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSGI-------NT--------HTTLNIPEWVSEEARSL 208 (237)
T ss_pred cCccccCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchhc-------cc--------ccccCCcccCCHHHHHH
Confidence 5678999999988889999999999999999999998874321100 00 00012344566789999
Q ss_pred HHHccccCCCCCCCHH
Q 002158 875 ALRCCHDKPEHRPSMS 890 (958)
Q Consensus 875 i~~cl~~dP~~RPs~~ 890 (958)
+.+|++.||++||++.
T Consensus 209 i~~~l~~dp~~R~~~~ 224 (237)
T cd05576 209 LQQLLQFNPTERLGAG 224 (237)
T ss_pred HHHHccCCHHHhcCCC
Confidence 9999999999999974
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.2e-32 Score=285.24 Aligned_cols=260 Identities=23% Similarity=0.369 Sum_probs=202.8
Q ss_pred HcCCCCCceeeeeCCeEEEEEEEC-CCcEEEEEEeccC-Chh------cHHHHHHHHHHHHccCCCCcceEEEEEEe-CC
Q 002158 624 TAYFSSSTQVGQGGYGKVYKGILS-DNTTVAIKRAEEG-SLQ------GQNEFLTEIKLLSRLHHRNLVSLLGYCDE-EG 694 (958)
Q Consensus 624 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~------~~~~~~~E~~~l~~l~H~niv~l~~~~~~-~~ 694 (958)
.++|-..++||+|||+.||+|.+- ..+.||||+-... +.. ..+...+|.++-+.+.||-||++|+|+.- .+
T Consensus 462 n~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDtd 541 (775)
T KOG1151|consen 462 NDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDTD 541 (775)
T ss_pred HHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeeccc
Confidence 345566678999999999999854 6788999975332 111 12456799999999999999999999864 55
Q ss_pred eEEEEEEecCCCCHHHHhccCCCCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEec---CCCCeEEeeee
Q 002158 695 EQMLVYEFVPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLD---SNLNAKVADFG 771 (958)
Q Consensus 695 ~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~---~~~~~kl~DFG 771 (958)
.++-|+|||+|.+|+-||+...- +++.++..|+.||+.||.||.+.. +||||-||||.|||+- .-|.+||.|||
T Consensus 542 sFCTVLEYceGNDLDFYLKQhkl--mSEKEARSIiMQiVnAL~YLNEik-pPIIHYDLKPgNILLv~GtacGeIKITDFG 618 (775)
T KOG1151|consen 542 SFCTVLEYCEGNDLDFYLKQHKL--MSEKEARSIIMQIVNALKYLNEIK-PPIIHYDLKPGNILLVNGTACGEIKITDFG 618 (775)
T ss_pred cceeeeeecCCCchhHHHHhhhh--hhHHHHHHHHHHHHHHHHHHhccC-CCeeeeccCCccEEEecCcccceeEeeecc
Confidence 77889999999999999976543 899999999999999999999875 8999999999999994 35789999999
Q ss_pred eecccccCCCCCCccceeeeeccCCCCccChhhhccC----CCCCcchhhhHHHHHHHHHhCCCCCCCCchhHHHHHHHh
Q 002158 772 LSRLAPVLDDEGTMPTHVSTIVKGTPGYLDPEYFLTH----KLTDKSDVYSLGVVLLELLTGMQPISHGKNIVREVNVAR 847 (958)
Q Consensus 772 la~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~~DV~S~Gv~l~elltG~~P~~~~~~~~~~~~~~~ 847 (958)
++++++............+....||..|++||.+.-+ +.+.|+||||.||++|..+-|+.||.....-...+..
T Consensus 619 LSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQdILqe-- 696 (775)
T KOG1151|consen 619 LSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQDILQE-- 696 (775)
T ss_pred hhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHHHHHhh--
Confidence 9999876665545555666778999999999998644 4677999999999999999999999765443322211
Q ss_pred hcCcchhhhcccCCCCC--hHHHHHHHHHHHHccccCCCCCCCHHHHH
Q 002158 848 DSGMVFSIIDNRMGSYP--SECVERFVTLALRCCHDKPEHRPSMSDVV 893 (958)
Q Consensus 848 ~~~~~~~~i~~~~~~~~--~~~~~~l~~li~~cl~~dP~~RPs~~evl 893 (958)
..+ +...--.+| +....+..++|.+|++..-++|....++.
T Consensus 697 --NTI---lkAtEVqFP~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA 739 (775)
T KOG1151|consen 697 --NTI---LKATEVQFPPKPVVSSEAKAFIRRCLAYRKEDRIDVQQLA 739 (775)
T ss_pred --hch---hcceeccCCCCCccCHHHHHHHHHHHHhhhhhhhhHHHHc
Confidence 111 111111122 23556788999999999999997766554
|
|
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.7e-32 Score=271.77 Aligned_cols=250 Identities=24% Similarity=0.339 Sum_probs=198.0
Q ss_pred HHcCCCCC-ceeeeeCCeEEEEEEEC-CCcEEEEEEeccCChhcHHHHHHHHHHHHcc-CCCCcceEEEEEEe----CCe
Q 002158 623 ATAYFSSS-TQVGQGGYGKVYKGILS-DNTTVAIKRAEEGSLQGQNEFLTEIKLLSRL-HHRNLVSLLGYCDE----EGE 695 (958)
Q Consensus 623 ~~~~~~~~-~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~----~~~ 695 (958)
.+++|.+. ++||-|-.|.|..+..+ .++.+|+|++.+.. ...+|++.--.. .|||||.+++++.. ...
T Consensus 59 itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds~-----KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkc 133 (400)
T KOG0604|consen 59 ITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDSP-----KARREVELHWMASGHPHIVSIIDVYENSYQGRKC 133 (400)
T ss_pred chhhheehhhhhccccCCceEEEEeccchhhhHHHHHhcCH-----HHHhHhhhhhhhcCCCceEEeehhhhhhccCcee
Confidence 34445443 57999999999999876 68999999987532 234788765444 79999999999854 456
Q ss_pred EEEEEEecCCCCHHHHhccCCCCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEecC---CCCeEEeeeee
Q 002158 696 QMLVYEFVPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDS---NLNAKVADFGL 772 (958)
Q Consensus 696 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~---~~~~kl~DFGl 772 (958)
+.+|||.|+||.|...+++++...+++.++-.|..||+.|+.|||+.. |.||||||+|+|... +..+||+|||+
T Consensus 134 LLiVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~~n---IAHRDlKpENLLyt~t~~na~lKLtDfGF 210 (400)
T KOG0604|consen 134 LLIVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHSMN---IAHRDLKPENLLYTTTSPNAPLKLTDFGF 210 (400)
T ss_pred eEeeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHhcc---hhhccCChhheeeecCCCCcceEeccccc
Confidence 789999999999999999998889999999999999999999999999 999999999999964 55799999999
Q ss_pred ecccccCCCCCCccceeeeeccCCCCccChhhhccCCCCCcchhhhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcCcc
Q 002158 773 SRLAPVLDDEGTMPTHVSTIVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVLLELLTGMQPISHGKNIVREVNVARDSGMV 852 (958)
Q Consensus 773 a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gv~l~elltG~~P~~~~~~~~~~~~~~~~~~~~ 852 (958)
|+.... .......+-|+.|.|||++...+|+...|+||+||++|-|++|-+||...... ....+..
T Consensus 211 AK~t~~--------~~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~------aispgMk 276 (400)
T KOG0604|consen 211 AKETQE--------PGDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGL------AISPGMK 276 (400)
T ss_pred ccccCC--------CccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCc------cCChhHH
Confidence 985422 11223345799999999999999999999999999999999999999643211 0011111
Q ss_pred hhhhcccCCCCC----hHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 002158 853 FSIIDNRMGSYP----SECVERFVTLALRCCHDKPEHRPSMSDVVRE 895 (958)
Q Consensus 853 ~~~i~~~~~~~~----~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 895 (958)
..|......+| ...++...++|+.++..+|.+|.++.++.++
T Consensus 277 -~rI~~gqy~FP~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~h 322 (400)
T KOG0604|consen 277 -RRIRTGQYEFPEPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMDH 322 (400)
T ss_pred -hHhhccCccCCChhHhHHHHHHHHHHHHHhcCCchhheeHHHhhcC
Confidence 11222223343 3466778999999999999999999999875
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-30 Score=299.19 Aligned_cols=264 Identities=20% Similarity=0.301 Sum_probs=184.3
Q ss_pred HHcCCCCCceeeeeCCeEEEEEEE-----------------CCCcEEEEEEeccCChhcHHH--------------HHHH
Q 002158 623 ATAYFSSSTQVGQGGYGKVYKGIL-----------------SDNTTVAIKRAEEGSLQGQNE--------------FLTE 671 (958)
Q Consensus 623 ~~~~~~~~~~lg~G~~g~Vy~~~~-----------------~~~~~vavK~~~~~~~~~~~~--------------~~~E 671 (958)
..++|.+.++||+|+||+||+|.+ ..++.||||++........++ +..|
T Consensus 143 ~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE 222 (507)
T PLN03224 143 SSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVE 222 (507)
T ss_pred cccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHH
Confidence 467899999999999999999974 235689999986543222223 3457
Q ss_pred HHHHHccCCCCc-----ceEEEEEEe--------CCeEEEEEEecCCCCHHHHhccCCC---------------------
Q 002158 672 IKLLSRLHHRNL-----VSLLGYCDE--------EGEQMLVYEFVPNGTLRDWLSGRTK--------------------- 717 (958)
Q Consensus 672 ~~~l~~l~H~ni-----v~l~~~~~~--------~~~~~lV~E~~~~gsL~~~l~~~~~--------------------- 717 (958)
+.++.+++|.++ ++++++|.. ++..+|||||+++++|.++++....
T Consensus 223 ~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~ 302 (507)
T PLN03224 223 AYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMP 302 (507)
T ss_pred HHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcc
Confidence 777778876654 678888753 3568999999999999999974311
Q ss_pred -CCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEecCCCCeEEeeeeeecccccCCCCCCccceeeeeccCC
Q 002158 718 -ENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSRLAPVLDDEGTMPTHVSTIVKGT 796 (958)
Q Consensus 718 -~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~gt 796 (958)
..+++..+..++.|+++||.|||+.+ |+||||||+|||++.++.+||+|||+++....... .......+|
T Consensus 303 ~~~~~~~~~~~i~~ql~~aL~~lH~~~---ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~------~~~~~g~~t 373 (507)
T PLN03224 303 QDKRDINVIKGVMRQVLTGLRKLHRIG---IVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGIN------FNPLYGMLD 373 (507)
T ss_pred cccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCchHhEEECCCCcEEEEeCcCccccccCCc------cCccccCCC
Confidence 12467788999999999999999998 99999999999999999999999999875422111 111122357
Q ss_pred CCccChhhhccCCC----------------------CCcchhhhHHHHHHHHHhCCC-CCCCCchhHHHHHHHhhcCcch
Q 002158 797 PGYLDPEYFLTHKL----------------------TDKSDVYSLGVVLLELLTGMQ-PISHGKNIVREVNVARDSGMVF 853 (958)
Q Consensus 797 ~~y~aPE~~~~~~~----------------------~~~~DV~S~Gv~l~elltG~~-P~~~~~~~~~~~~~~~~~~~~~ 853 (958)
+.|+|||.+..... ..+.||||+||+++||++|.. |+...................+
T Consensus 374 p~Y~aPE~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~ 453 (507)
T PLN03224 374 PRYSPPEELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRW 453 (507)
T ss_pred cceeChhhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHH
Confidence 89999999864321 124799999999999999875 6653222111111100000000
Q ss_pred hhhcccCCC--CChHHHHHHHHHHHHccccCC---CCCCCHHHHHHH
Q 002158 854 SIIDNRMGS--YPSECVERFVTLALRCCHDKP---EHRPSMSDVVRE 895 (958)
Q Consensus 854 ~~i~~~~~~--~~~~~~~~l~~li~~cl~~dP---~~RPs~~evl~~ 895 (958)
......... ..........+++.+++..+| .+|+|++|+++|
T Consensus 454 r~~~~~~~~~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~H 500 (507)
T PLN03224 454 RMYKGQKYDFSLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALSH 500 (507)
T ss_pred HhhcccCCCcccccccChHHHHHHHHHhccCCCCcccCCCHHHHhCC
Confidence 011111111 123456778899999999766 789999999975
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.6e-32 Score=304.30 Aligned_cols=248 Identities=27% Similarity=0.419 Sum_probs=193.7
Q ss_pred CCCCCceeeeeCCe-EEEEEEECCCcEEEEEEeccCChhcHHHHHHHHHHHHcc-CCCCcceEEEEEEeCCeEEEEEEec
Q 002158 626 YFSSSTQVGQGGYG-KVYKGILSDNTTVAIKRAEEGSLQGQNEFLTEIKLLSRL-HHRNLVSLLGYCDEEGEQMLVYEFV 703 (958)
Q Consensus 626 ~~~~~~~lg~G~~g-~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lV~E~~ 703 (958)
-|...+.+|.|+.| .||+|.. +|+.||||++-... ..-..+|+..|+.- +|||||++++.-.++...|++.|.|
T Consensus 510 ~~~~~eilG~Gs~Gt~Vf~G~y-e~R~VAVKrll~e~---~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC 585 (903)
T KOG1027|consen 510 FFSPKEILGYGSNGTVVFRGVY-EGREVAVKRLLEEF---FDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELC 585 (903)
T ss_pred eeccHHHcccCCCCcEEEEEee-CCceehHHHHhhHh---HHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHh
Confidence 35556778999998 6799998 78899999986432 23456899999998 6999999999999999999999999
Q ss_pred CCCCHHHHhccC--CCCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEecC---C--CCeEEeeeeeeccc
Q 002158 704 PNGTLRDWLSGR--TKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDS---N--LNAKVADFGLSRLA 776 (958)
Q Consensus 704 ~~gsL~~~l~~~--~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~---~--~~~kl~DFGla~~~ 776 (958)
..+|.|++... ..........+.+..|++.||++||+.+ ||||||||.||||+. + .+++|+|||+++.+
T Consensus 586 -~~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~---iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl 661 (903)
T KOG1027|consen 586 -ACSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLK---IVHRDLKPQNILISVPSADGTLRAKISDFGLSKKL 661 (903)
T ss_pred -hhhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcc---cccccCCCceEEEEccCCCcceeEEeccccccccc
Confidence 57999999863 1111222445788999999999999998 999999999999975 3 47999999999987
Q ss_pred ccCCCCCCccceeeeeccCCCCccChhhhccCCCCCcchhhhHHHHHHHHHhC-CCCCCCCchhHHHHHHHhhcCcchhh
Q 002158 777 PVLDDEGTMPTHVSTIVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVLLELLTG-MQPISHGKNIVREVNVARDSGMVFSI 855 (958)
Q Consensus 777 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gv~l~elltG-~~P~~~~~~~~~~~~~~~~~~~~~~~ 855 (958)
...... ........||-||+|||++....-+.++||||+||++|+.++| .+||.+ ...+.............+
T Consensus 662 ~~~~sS----~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd--~~~R~~NIl~~~~~L~~L 735 (903)
T KOG1027|consen 662 AGGKSS----FSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGD--SLERQANILTGNYTLVHL 735 (903)
T ss_pred CCCcch----hhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCc--hHHhhhhhhcCccceeee
Confidence 543332 2224567799999999999999888999999999999999995 999964 333433333322222111
Q ss_pred hcccCCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 002158 856 IDNRMGSYPSECVERFVTLALRCCHDKPEHRPSMSDVVRE 895 (958)
Q Consensus 856 i~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 895 (958)
.. ..++ +..+||.+|++++|..||++.+|+.+
T Consensus 736 -----~~-~~d~--eA~dLI~~ml~~dP~~RPsa~~VL~H 767 (903)
T KOG1027|consen 736 -----EP-LPDC--EAKDLISRMLNPDPQLRPSATDVLNH 767 (903)
T ss_pred -----cc-CchH--HHHHHHHHhcCCCcccCCCHHHHhCC
Confidence 11 1122 78899999999999999999999954
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.2e-30 Score=273.13 Aligned_cols=238 Identities=31% Similarity=0.448 Sum_probs=195.9
Q ss_pred CCeEEEEEEEC-CCcEEEEEEeccCChhc-HHHHHHHHHHHHccCCCCcceEEEEEEeCCeEEEEEEecCCCCHHHHhcc
Q 002158 637 GYGKVYKGILS-DNTTVAIKRAEEGSLQG-QNEFLTEIKLLSRLHHRNLVSLLGYCDEEGEQMLVYEFVPNGTLRDWLSG 714 (958)
Q Consensus 637 ~~g~Vy~~~~~-~~~~vavK~~~~~~~~~-~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~ 714 (958)
+||.||+|.+. +++.||+|++....... .+.+.+|++.+++++|+|++++++++......+++|||+++++|.+++..
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~ 80 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKK 80 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHh
Confidence 58999999987 48999999998765544 67899999999999999999999999999999999999999999999976
Q ss_pred CCCCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEecCCCCeEEeeeeeecccccCCCCCCccceeeeecc
Q 002158 715 RTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSRLAPVLDDEGTMPTHVSTIVK 794 (958)
Q Consensus 715 ~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~ 794 (958)
... +++..+..++.++++++.|||+.+ ++|+||+|+||+++.++.++|+|||.+....... ......
T Consensus 81 ~~~--~~~~~~~~~~~~l~~~l~~lh~~~---i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~--------~~~~~~ 147 (244)
T smart00220 81 RGR--LSEDEARFYARQILSALEYLHSNG---IIHRDLKPENILLDEDGHVKLADFGLARQLDPGG--------LLTTFV 147 (244)
T ss_pred ccC--CCHHHHHHHHHHHHHHHHHHHHcC---eecCCcCHHHeEECCCCcEEEccccceeeecccc--------cccccc
Confidence 543 889999999999999999999998 9999999999999999999999999998653321 123345
Q ss_pred CCCCccChhhhccCCCCCcchhhhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcCcchhhhcccCCCCChHHHHHHHHH
Q 002158 795 GTPGYLDPEYFLTHKLTDKSDVYSLGVVLLELLTGMQPISHGKNIVREVNVARDSGMVFSIIDNRMGSYPSECVERFVTL 874 (958)
Q Consensus 795 gt~~y~aPE~~~~~~~~~~~DV~S~Gv~l~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~l~~l 874 (958)
++..|++||.+....++.++||||||+++++|++|..||.................... .......+..+.++
T Consensus 148 ~~~~~~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~-------~~~~~~~~~~~~~~ 220 (244)
T smart00220 148 GTPEYMAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQLLELFKKIGKPKPPF-------PPPEWKISPEAKDL 220 (244)
T ss_pred CCcCCCCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCC-------ccccccCCHHHHHH
Confidence 88899999999988899999999999999999999999975333322222211110000 00011156789999
Q ss_pred HHHccccCCCCCCCHHHHHH
Q 002158 875 ALRCCHDKPEHRPSMSDVVR 894 (958)
Q Consensus 875 i~~cl~~dP~~RPs~~evl~ 894 (958)
+.+|+..+|++||++.++++
T Consensus 221 i~~~l~~~p~~Rp~~~~~~~ 240 (244)
T smart00220 221 IRKLLVKDPEKRLTAEEALQ 240 (244)
T ss_pred HHHHccCCchhccCHHHHhh
Confidence 99999999999999999986
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-31 Score=270.86 Aligned_cols=248 Identities=22% Similarity=0.321 Sum_probs=206.3
Q ss_pred HHcCCCCCceeeeeCCeEEEEEEEC-CCcEEEEEEeccCC---hhcHHHHHHHHHHHHcc-CCCCcceEEEEEEeCCeEE
Q 002158 623 ATAYFSSSTQVGQGGYGKVYKGILS-DNTTVAIKRAEEGS---LQGQNEFLTEIKLLSRL-HHRNLVSLLGYCDEEGEQM 697 (958)
Q Consensus 623 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~ 697 (958)
...+|...++||+|+|++|..++++ ..+.+|+|++++.. .++.+..+.|-.++.+. +||.+|.+..++..+..++
T Consensus 248 ~l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlf 327 (593)
T KOG0695|consen 248 GLQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLF 327 (593)
T ss_pred ccccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEE
Confidence 4467888999999999999999976 67899999988753 33445577888888877 7999999999999999999
Q ss_pred EEEEecCCCCHHHHhccCCCCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEecCCCCeEEeeeeeecccc
Q 002158 698 LVYEFVPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSRLAP 777 (958)
Q Consensus 698 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~~~ 777 (958)
+|.||++||+|--+++++++ ++++.+..+...|.-||.|||++| ||.||+|-+|||+|..|.+|+.|+|+++.-
T Consensus 328 fvieyv~ggdlmfhmqrqrk--lpeeharfys~ei~lal~flh~rg---iiyrdlkldnvlldaeghikltdygmcke~- 401 (593)
T KOG0695|consen 328 FVIEYVNGGDLMFHMQRQRK--LPEEHARFYSAEICLALNFLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCKEG- 401 (593)
T ss_pred EEEEEecCcceeeehhhhhc--CcHHHhhhhhHHHHHHHHHHhhcC---eeeeeccccceEEccCCceeecccchhhcC-
Confidence 99999999999877765544 999999999999999999999999 999999999999999999999999999742
Q ss_pred cCCCCCCccceeeeeccCCCCccChhhhccCCCCCcchhhhHHHHHHHHHhCCCCCCC--CchhHHHHHHHhhcCcchhh
Q 002158 778 VLDDEGTMPTHVSTIVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVLLELLTGMQPISH--GKNIVREVNVARDSGMVFSI 855 (958)
Q Consensus 778 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gv~l~elltG~~P~~~--~~~~~~~~~~~~~~~~~~~~ 855 (958)
-.+...+..++||+.|+|||++++.+|...+|.|++||+|+||+.|+.||+- .++.. ...+..++++
T Consensus 402 ------l~~gd~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d-----~ntedylfqv 470 (593)
T KOG0695|consen 402 ------LGPGDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPD-----MNTEDYLFQV 470 (593)
T ss_pred ------CCCCcccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcc-----cchhHHHHHH
Confidence 2223445678999999999999999999999999999999999999999962 11111 1122344555
Q ss_pred hcccCCCCChHHHHHHHHHHHHccccCCCCCC
Q 002158 856 IDNRMGSYPSECVERFVTLALRCCHDKPEHRP 887 (958)
Q Consensus 856 i~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP 887 (958)
|-.+.-.+|...+-....+++.-+++||.+|.
T Consensus 471 ilekqiriprslsvkas~vlkgflnkdp~erl 502 (593)
T KOG0695|consen 471 ILEKQIRIPRSLSVKASHVLKGFLNKDPKERL 502 (593)
T ss_pred HhhhcccccceeehhhHHHHHHhhcCCcHHhc
Confidence 55555556777777788899999999999994
|
|
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.6e-32 Score=289.14 Aligned_cols=247 Identities=23% Similarity=0.361 Sum_probs=205.7
Q ss_pred CCCCceeeeeCCeEEEEEEECCCc-EEEEEEeccC---ChhcHHHHHHHHHHHHccCCCCcceEEEEEEeCCeEEEEEEe
Q 002158 627 FSSSTQVGQGGYGKVYKGILSDNT-TVAIKRAEEG---SLQGQNEFLTEIKLLSRLHHRNLVSLLGYCDEEGEQMLVYEF 702 (958)
Q Consensus 627 ~~~~~~lg~G~~g~Vy~~~~~~~~-~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E~ 702 (958)
+.....||-||||.|=.+..+... .+|+|.+++. ....++....|-++|...+.|.||++|..|.+....|++||-
T Consensus 422 l~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmLmEa 501 (732)
T KOG0614|consen 422 LKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYMLMEA 501 (732)
T ss_pred hhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhhHHh
Confidence 344557999999999998876433 4888887664 344556788999999999999999999999999999999999
Q ss_pred cCCCCHHHHhccCCCCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEecCCCCeEEeeeeeecccccCCCC
Q 002158 703 VPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSRLAPVLDDE 782 (958)
Q Consensus 703 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~ 782 (958)
|-||.|+..|++++ .++..++..++..+.+|++|||+++ ||.|||||+|.++|.+|-+||.|||+|+....
T Consensus 502 ClGGElWTiLrdRg--~Fdd~tarF~~acv~EAfeYLH~k~---iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~---- 572 (732)
T KOG0614|consen 502 CLGGELWTILRDRG--SFDDYTARFYVACVLEAFEYLHRKG---IIYRDLKPENLLLDNRGYLKLVDFGFAKKIGS---- 572 (732)
T ss_pred hcCchhhhhhhhcC--CcccchhhhhHHHHHHHHHHHHhcC---ceeccCChhheeeccCCceEEeehhhHHHhcc----
Confidence 99999999997655 4999999999999999999999999 99999999999999999999999999997643
Q ss_pred CCccceeeeeccCCCCccChhhhccCCCCCcchhhhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcCcchhhhcccCCC
Q 002158 783 GTMPTHVSTIVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVLLELLTGMQPISHGKNIVREVNVARDSGMVFSIIDNRMGS 862 (958)
Q Consensus 783 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gv~l~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~ 862 (958)
...+..++||+.|.|||++.....+.++|.||+|+++|||++|.+||...+.+...-..... ++ .-.
T Consensus 573 ----g~KTwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~ILkG-------id--~i~ 639 (732)
T KOG0614|consen 573 ----GRKTWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNLILKG-------ID--KIE 639 (732)
T ss_pred ----CCceeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHhh-------hh--hhh
Confidence 23355789999999999999999999999999999999999999999876554332211111 00 124
Q ss_pred CChHHHHHHHHHHHHccccCCCCCCC-----HHHHHHH
Q 002158 863 YPSECVERFVTLALRCCHDKPEHRPS-----MSDVVRE 895 (958)
Q Consensus 863 ~~~~~~~~l~~li~~cl~~dP~~RPs-----~~evl~~ 895 (958)
+|....+...++|++....+|.+|.- ..+|-+|
T Consensus 640 ~Pr~I~k~a~~Lik~LCr~~P~ERLG~~~~gI~DIkkH 677 (732)
T KOG0614|consen 640 FPRRITKTATDLIKKLCRDNPTERLGYQKGGINDIKKH 677 (732)
T ss_pred cccccchhHHHHHHHHHhcCcHhhhccccCChHHHHhh
Confidence 57788888999999999999999965 4455544
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.2e-31 Score=291.75 Aligned_cols=240 Identities=22% Similarity=0.280 Sum_probs=193.6
Q ss_pred HcCCCCCceeeeeCCeEEEEEEEC-CCcEEEEEEeccCChhcHHHHHHHHHHHHcc-CCCCcceEEEEEEeCCeEEEEEE
Q 002158 624 TAYFSSSTQVGQGGYGKVYKGILS-DNTTVAIKRAEEGSLQGQNEFLTEIKLLSRL-HHRNLVSLLGYCDEEGEQMLVYE 701 (958)
Q Consensus 624 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lV~E 701 (958)
++.|.....+|.|+|+.|-++... +++..+||++.+... +-.+|+.++... +||||+++.+.+.+..+.|+|||
T Consensus 321 ~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~~----~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~e 396 (612)
T KOG0603|consen 321 TESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRAD----DNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVME 396 (612)
T ss_pred chhhccccccCCCCccceeeeeccccccchhheecccccc----ccccccchhhhhcCCCcceeecceecCCceeeeeeh
Confidence 345556667999999999999865 688999999987522 223677666666 79999999999999999999999
Q ss_pred ecCCCCHHHHhccCCCCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEe-cCCCCeEEeeeeeecccccCC
Q 002158 702 FVPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILL-DSNLNAKVADFGLSRLAPVLD 780 (958)
Q Consensus 702 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl-~~~~~~kl~DFGla~~~~~~~ 780 (958)
++.++-+.+.+..... +. .++..|+.+|+.|+.|||++| +||||+||+|||+ ++.++++|+|||.++.....
T Consensus 397 ~l~g~ell~ri~~~~~--~~-~e~~~w~~~lv~Av~~LH~~g---vvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~- 469 (612)
T KOG0603|consen 397 LLDGGELLRRIRSKPE--FC-SEASQWAAELVSAVDYLHEQG---VVHRDLKPGNILLDGSAGHLRLTYFGFWSELERS- 469 (612)
T ss_pred hccccHHHHHHHhcch--hH-HHHHHHHHHHHHHHHHHHhcC---eeecCCChhheeecCCCCcEEEEEechhhhCchh-
Confidence 9999988877754432 33 778899999999999999999 9999999999999 68999999999999865332
Q ss_pred CCCCccceeeeeccCCCCccChhhhccCCCCCcchhhhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcCcchhhhcccC
Q 002158 781 DEGTMPTHVSTIVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVLLELLTGMQPISHGKNIVREVNVARDSGMVFSIIDNRM 860 (958)
Q Consensus 781 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gv~l~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~i~~~~ 860 (958)
...-+=|..|.|||+....+|+.++|+||||++||+|++|+.||.....-.+..... ..
T Consensus 470 ---------~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~~ei~~~i------------~~ 528 (612)
T KOG0603|consen 470 ---------CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAGIEIHTRI------------QM 528 (612)
T ss_pred ---------hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCchHHHHHhh------------cC
Confidence 112235778999999999999999999999999999999999997543321111110 11
Q ss_pred CCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 002158 861 GSYPSECVERFVTLALRCCHDKPEHRPSMSDVVRE 895 (958)
Q Consensus 861 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 895 (958)
+.+....++..++|+.+|++.||.+||+|+++..+
T Consensus 529 ~~~s~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~h 563 (612)
T KOG0603|consen 529 PKFSECVSDEAKDLLQQLLQVDPALRLGADEIGAH 563 (612)
T ss_pred CccccccCHHHHHHHHHhccCChhhCcChhhhccC
Confidence 22335677889999999999999999999999875
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=3e-30 Score=304.37 Aligned_cols=258 Identities=19% Similarity=0.230 Sum_probs=170.5
Q ss_pred HHcCCCCCceeeeeCCeEEEEEEEC-C----CcEEEEEEeccCChhcHHHHHHHHHHHHccCCCCcceEEEE------EE
Q 002158 623 ATAYFSSSTQVGQGGYGKVYKGILS-D----NTTVAIKRAEEGSLQGQNEFLTEIKLLSRLHHRNLVSLLGY------CD 691 (958)
Q Consensus 623 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~----~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~------~~ 691 (958)
..++|...+.||+|+||.||+|++. + +..||||++...... +.+..| .++...+.++..++.. +.
T Consensus 130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~~--e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~~ 205 (566)
T PLN03225 130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAV--EIWMNE--RVRRACPNSCADFVYGFLEPVSSK 205 (566)
T ss_pred ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccchh--HHHHHH--HHHhhchhhHHHHHHhhhcccccc
Confidence 5678899999999999999999986 4 689999988653211 111111 1222222222222211 24
Q ss_pred eCCeEEEEEEecCCCCHHHHhccCCCC------------------CchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCC
Q 002158 692 EEGEQMLVYEFVPNGTLRDWLSGRTKE------------------NLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIK 753 (958)
Q Consensus 692 ~~~~~~lV~E~~~~gsL~~~l~~~~~~------------------~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dik 753 (958)
.+...++||||+++++|.++++..... ......+..++.|++.||+|||+++ |+|||||
T Consensus 206 ~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~g---IiHRDLK 282 (566)
T PLN03225 206 KEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTG---IVHRDVK 282 (566)
T ss_pred cCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCC---EEeCcCC
Confidence 566899999999999999998754210 1123445689999999999999998 9999999
Q ss_pred ccceEecC-CCCeEEeeeeeecccccCCCCCCccceeeeeccCCCCccChhhhccC----------------------CC
Q 002158 754 ASNILLDS-NLNAKVADFGLSRLAPVLDDEGTMPTHVSTIVKGTPGYLDPEYFLTH----------------------KL 810 (958)
Q Consensus 754 p~NILl~~-~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----------------------~~ 810 (958)
|+|||+++ ++.+||+|||+|+...... ........||++|+|||.+... .+
T Consensus 283 P~NILl~~~~~~~KL~DFGlA~~l~~~~------~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~ 356 (566)
T PLN03225 283 PQNIIFSEGSGSFKIIDLGAAADLRVGI------NYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNL 356 (566)
T ss_pred HHHEEEeCCCCcEEEEeCCCcccccccc------ccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccC
Confidence 99999986 5799999999998553221 1122345789999999976432 23
Q ss_pred CCcchhhhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcCcchhhhcccC-CCCChH----------HHHHHHHHHHHcc
Q 002158 811 TDKSDVYSLGVVLLELLTGMQPISHGKNIVREVNVARDSGMVFSIIDNRM-GSYPSE----------CVERFVTLALRCC 879 (958)
Q Consensus 811 ~~~~DV~S~Gv~l~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~i~~~~-~~~~~~----------~~~~l~~li~~cl 879 (958)
+.++|||||||++|||+++..|+.. ............+.......... .....+ ......+|+.+|+
T Consensus 357 ~~k~DVwSlGviL~el~~~~~~~~~--~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL 434 (566)
T PLN03225 357 PDRFDIYSAGLIFLQMAFPNLRSDS--NLIQFNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMM 434 (566)
T ss_pred CCCcccHHHHHHHHHHHhCcCCCch--HHHHHHHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHHHc
Confidence 4467999999999999997766542 22221111111111110000000 000111 1223458999999
Q ss_pred ccCCCCCCCHHHHHHH
Q 002158 880 HDKPEHRPSMSDVVRE 895 (958)
Q Consensus 880 ~~dP~~RPs~~evl~~ 895 (958)
+.||++|||++|++++
T Consensus 435 ~~dP~kR~ta~e~L~H 450 (566)
T PLN03225 435 RFKGRQRISAKAALAH 450 (566)
T ss_pred cCCcccCCCHHHHhCC
Confidence 9999999999999975
|
|
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.3e-32 Score=265.36 Aligned_cols=256 Identities=25% Similarity=0.379 Sum_probs=191.6
Q ss_pred CceeeeeCCeEEEEEEEC-CCcEEEEEEecc-C-ChhcHHHHHHHHHHHHccCCCCcceEEEEEEe--------CCeEEE
Q 002158 630 STQVGQGGYGKVYKGILS-DNTTVAIKRAEE-G-SLQGQNEFLTEIKLLSRLHHRNLVSLLGYCDE--------EGEQML 698 (958)
Q Consensus 630 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~-~-~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~--------~~~~~l 698 (958)
..+||+|.||+||+|+.+ .|+.||+|++-- . ...--....+|+++|..++|+|++.++..|.. ...+|+
T Consensus 22 ~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r~t~yl 101 (376)
T KOG0669|consen 22 LAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDRATFYL 101 (376)
T ss_pred HHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCcccccceeee
Confidence 457999999999999976 578899886422 1 22223456799999999999999999988853 235899
Q ss_pred EEEecCCCCHHHHhccCCCCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEecCCCCeEEeeeeeeccccc
Q 002158 699 VYEFVPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSRLAPV 778 (958)
Q Consensus 699 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~~~~ 778 (958)
||++|+. +|.-+|... ...++..++.++..++..||.|+|... |+|||+||.|+||+.+|.+||+|||+++.+..
T Consensus 102 Vf~~ceh-DLaGlLsn~-~vr~sls~Ikk~Mk~Lm~GL~~iHr~k---ilHRDmKaaNvLIt~dgilklADFGlar~fs~ 176 (376)
T KOG0669|consen 102 VFDFCEH-DLAGLLSNR-KVRFSLSEIKKVMKGLMNGLYYIHRNK---ILHRDMKAANVLITKDGILKLADFGLARAFST 176 (376)
T ss_pred eHHHhhh-hHHHHhcCc-cccccHHHHHHHHHHHHHHHHHHHHhh---HHhhcccHhhEEEcCCceEEeeccccccceec
Confidence 9999964 888888654 345999999999999999999999999 99999999999999999999999999987754
Q ss_pred CCCCCCccceeeeeccCCCCccChhhhccC-CCCCcchhhhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcCc------
Q 002158 779 LDDEGTMPTHVSTIVKGTPGYLDPEYFLTH-KLTDKSDVYSLGVVLLELLTGMQPISHGKNIVREVNVARDSGM------ 851 (958)
Q Consensus 779 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DV~S~Gv~l~elltG~~P~~~~~~~~~~~~~~~~~~~------ 851 (958)
..... .+ ..+..+-|..|.+||.+.+. +|+++.|||+.||++.||+||.+-+.+..+..+......-.+.
T Consensus 177 ~~n~~-kp--rytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~tkevW 253 (376)
T KOG0669|consen 177 SKNVV-KP--RYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSITKEVW 253 (376)
T ss_pred ccccC-CC--CcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccCCcccC
Confidence 33321 11 13445568999999999875 6899999999999999999998887765433222111100010
Q ss_pred -------chhhh-------------cccCCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 002158 852 -------VFSII-------------DNRMGSYPSECVERFVTLALRCCHDKPEHRPSMSDVVRE 895 (958)
Q Consensus 852 -------~~~~i-------------~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 895 (958)
.++.+ .+++..+. -.++..+++.+++..||.+|+++++++.+
T Consensus 254 P~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~--kd~~a~dLle~ll~~DP~kR~~ad~alnh 315 (376)
T KOG0669|consen 254 PNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYV--KDDEALDLLEKLLKLDPTKRIDADQALNH 315 (376)
T ss_pred CCcccchHHHhccCCCCCcchhhhhhhhccccc--CChhHHHHHHHHhccCcccCcchHhhhch
Confidence 01111 11111000 12366789999999999999999999975
|
|
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.7e-31 Score=274.80 Aligned_cols=265 Identities=21% Similarity=0.285 Sum_probs=205.9
Q ss_pred cChHHHHHHHcCCCCCceeeeeCCeEEEEEEEC-CCcEEEEEEeccCChhcHHHHHHHHHHHHccC-C-CC----cceEE
Q 002158 615 FKFKELAMATAYFSSSTQVGQGGYGKVYKGILS-DNTTVAIKRAEEGSLQGQNEFLTEIKLLSRLH-H-RN----LVSLL 687 (958)
Q Consensus 615 ~~~~el~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-H-~n----iv~l~ 687 (958)
+.|+.-...+.+|.+...+|+|.||.|-+..+. .+..||||+++.- ....+...-|+++++++. + |+ +|.+.
T Consensus 79 ~v~~~gD~l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V-~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~ 157 (415)
T KOG0671|consen 79 YVYQVGDILTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNV-DKYREAALIEIEVLQKINESDPNGKFRCVQMR 157 (415)
T ss_pred EEEEeccccccceehhhhhcCCcccceEEEeecCCCceehHHHHHHH-HHHhhHHHHHHHHHHHHHhcCCCCceEEEeee
Confidence 334444445788999999999999999999875 4789999998753 334456778999999993 2 23 78888
Q ss_pred EEEEeCCeEEEEEEecCCCCHHHHhccCCCCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEecC------
Q 002158 688 GYCDEEGEQMLVYEFVPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDS------ 761 (958)
Q Consensus 688 ~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~------ 761 (958)
++++..++.++|+|.+ |-|+++++......+++..++..++.|++++++|||+.+ ++|-||||+|||+-+
T Consensus 158 ~wFdyrghiCivfell-G~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~k---l~HTDLKPENILfvss~~~~~ 233 (415)
T KOG0671|consen 158 DWFDYRGHICIVFELL-GLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHDLK---LTHTDLKPENILFVSSEYFKT 233 (415)
T ss_pred hhhhccCceEEEEecc-ChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHhcc---eeecCCChheEEEeccceEEE
Confidence 9999999999999999 679999999888888999999999999999999999999 999999999999932
Q ss_pred --------------CCCeEEeeeeeecccccCCCCCCccceeeeeccCCCCccChhhhccCCCCCcchhhhHHHHHHHHH
Q 002158 762 --------------NLNAKVADFGLSRLAPVLDDEGTMPTHVSTIVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVLLELL 827 (958)
Q Consensus 762 --------------~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gv~l~ell 827 (958)
+..+||+|||.|+.-.. ....++.|..|.|||++.+-.++..+||||+||+|+|+.
T Consensus 234 ~~~k~~~~~~r~~ks~~I~vIDFGsAtf~~e----------~hs~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~Ely 303 (415)
T KOG0671|consen 234 YNPKKKVCFIRPLKSTAIKVIDFGSATFDHE----------HHSTIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELY 303 (415)
T ss_pred eccCCccceeccCCCcceEEEecCCcceecc----------CcceeeeccccCCchheeccCcCCccCceeeeeEEEEee
Confidence 23589999999985421 124567899999999999999999999999999999999
Q ss_pred hCCCCCCCCchhHHH--HHHHhhcCcchhhhccc----------------------------C------CCCChHHHHHH
Q 002158 828 TGMQPISHGKNIVRE--VNVARDSGMVFSIIDNR----------------------------M------GSYPSECVERF 871 (958)
Q Consensus 828 tG~~P~~~~~~~~~~--~~~~~~~~~~~~~i~~~----------------------------~------~~~~~~~~~~l 871 (958)
||..-|..-++.+.. +..... .....++... . -........++
T Consensus 304 tG~~LFqtHen~EHLaMMerIlG-p~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~L 382 (415)
T KOG0671|consen 304 TGETLFQTHENLEHLAMMERILG-PIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQL 382 (415)
T ss_pred ccceecccCCcHHHHHHHHHhhC-CCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHH
Confidence 999988654433221 111111 0000000000 0 00122445679
Q ss_pred HHHHHHccccCCCCCCCHHHHHHH
Q 002158 872 VTLALRCCHDKPEHRPSMSDVVRE 895 (958)
Q Consensus 872 ~~li~~cl~~dP~~RPs~~evl~~ 895 (958)
.+|+.+|+..||.+|+|+.|++.+
T Consensus 383 fDLl~~mL~fDP~~RiTl~EAL~H 406 (415)
T KOG0671|consen 383 FDLLRRMLEFDPARRITLREALSH 406 (415)
T ss_pred HHHHHHHHccCccccccHHHHhcC
Confidence 999999999999999999999874
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.3e-30 Score=247.24 Aligned_cols=209 Identities=24% Similarity=0.377 Sum_probs=169.5
Q ss_pred CCCCceeeeeCCeEEEEEEEC-CCcEEEEEEeccC-ChhcHHHHHHHHHHHHcc-CCCCcceEEEEEEeCCeEEEEEEec
Q 002158 627 FSSSTQVGQGGYGKVYKGILS-DNTTVAIKRAEEG-SLQGQNEFLTEIKLLSRL-HHRNLVSLLGYCDEEGEQMLVYEFV 703 (958)
Q Consensus 627 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lV~E~~ 703 (958)
......||+|++|.|-+-++. +|...|||++... ..+.+++.++|+++..+- .+|.+|.++|....++..++.||.|
T Consensus 48 L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvwIcME~M 127 (282)
T KOG0984|consen 48 LVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVWICMELM 127 (282)
T ss_pred hhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEEEeHHHh
Confidence 334457999999999888765 7999999998764 344567788999866554 7999999999999999999999999
Q ss_pred CCCCHHHHhcc--CCCCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEecCCCCeEEeeeeeecccccCCC
Q 002158 704 PNGTLRDWLSG--RTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSRLAPVLDD 781 (958)
Q Consensus 704 ~~gsL~~~l~~--~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~ 781 (958)
.-||+.+.+. ..+..+++...-+|+..+.+||.|||++-+ +||||+||+|||++.+|++|+||||++-.+...
T Consensus 128 -~tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL~--vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L~dS-- 202 (282)
T KOG0984|consen 128 -DTSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKLS--VIHRDVKPSNILINYDGQVKICDFGISGYLVDS-- 202 (282)
T ss_pred -hhhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHhh--hhhccCCcceEEEccCCcEEEcccccceeehhh--
Confidence 4688776543 234558889999999999999999999864 999999999999999999999999998765321
Q ss_pred CCCccceeeeeccCCCCccChhhhcc----CCCCCcchhhhHHHHHHHHHhCCCCCCCCchhHHHHHHH
Q 002158 782 EGTMPTHVSTIVKGTPGYLDPEYFLT----HKLTDKSDVYSLGVVLLELLTGMQPISHGKNIVREVNVA 846 (958)
Q Consensus 782 ~~~~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~~DV~S~Gv~l~elltG~~P~~~~~~~~~~~~~~ 846 (958)
-..+...|-..|||||.+.. ..|+-|+||||+|+++.||.+++.||+......+.+...
T Consensus 203 ------iAkt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~tpF~qLkqv 265 (282)
T KOG0984|consen 203 ------IAKTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWGTPFQQLKQV 265 (282)
T ss_pred ------hHHHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccCCHHHHHHHH
Confidence 11122457788999999853 368889999999999999999999998766655555443
|
|
| >KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.6e-31 Score=287.75 Aligned_cols=315 Identities=23% Similarity=0.231 Sum_probs=245.4
Q ss_pred ceeeEEEEccCCcCCCCccccccCCCCcceeeccCcccCCCCcc-ccCCCCCcEEEeeCCCCCCCCChhhcCCCCCCEEe
Q 002158 85 HLHVRELQLLSMNLSGNLAPELGQLSRLQYYFMWNDLTGTIPKE-IGNISSLIFLLLNGNKLSGSLPDELGYLSNLNRLQ 163 (958)
Q Consensus 85 ~~~v~~L~L~~~~l~~~~~~~l~~L~~L~~L~l~n~~~~~ip~~-i~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~ 163 (958)
..|++.|+|.+|-++..-.+++..++.|+.|+|+.|.+..+|.. |..-.++++|+|++|+|+..--+.|.+|.+|..|.
T Consensus 124 sghl~~L~L~~N~I~sv~se~L~~l~alrslDLSrN~is~i~~~sfp~~~ni~~L~La~N~It~l~~~~F~~lnsL~tlk 203 (873)
T KOG4194|consen 124 SGHLEKLDLRHNLISSVTSEELSALPALRSLDLSRNLISEIPKPSFPAKVNIKKLNLASNRITTLETGHFDSLNSLLTLK 203 (873)
T ss_pred ccceeEEeeeccccccccHHHHHhHhhhhhhhhhhchhhcccCCCCCCCCCceEEeeccccccccccccccccchheeee
Confidence 45899999999999999999999999999999998888888854 66777899999999999977778899999999999
Q ss_pred cccccccccCccccccccccceEecccccccccCchhhcCCccchhhhccCCccccCCCcccCCCCCccEEEccCCCCCC
Q 002158 164 VDENNITGTIPKSFANLSRVRHLHLNNNSIGGQIPSELSKLSTLIHLLVDNNNLSGNLPPELSELPQLCILQLDNNNFSA 243 (958)
Q Consensus 164 L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~ 243 (958)
|++|+++...+..|.+|++|+.|+|..|+|.-.--..|.+|++|+.|.|..|+|+....+.|..|.++++|+|..|+++.
T Consensus 204 LsrNrittLp~r~Fk~L~~L~~LdLnrN~irive~ltFqgL~Sl~nlklqrN~I~kL~DG~Fy~l~kme~l~L~~N~l~~ 283 (873)
T KOG4194|consen 204 LSRNRITTLPQRSFKRLPKLESLDLNRNRIRIVEGLTFQGLPSLQNLKLQRNDISKLDDGAFYGLEKMEHLNLETNRLQA 283 (873)
T ss_pred cccCcccccCHHHhhhcchhhhhhccccceeeehhhhhcCchhhhhhhhhhcCcccccCcceeeecccceeecccchhhh
Confidence 99999997777888889999999999999884435668888888888888888876666777777777777777777752
Q ss_pred CCccccccCCCCCCEEEcccCCCCCCCCC-CCCCCCcCEEeccCCcCCCcCC-----------------------C--CC
Q 002158 244 SEIPATYGNFSKLVKLSLRNCNLQGAVPD-LSRIPNLYYLDLSWNHLTGSIP-----------------------S--KK 297 (958)
Q Consensus 244 ~~~p~~~~~l~~L~~L~L~~N~l~~~~~~-l~~l~~L~~L~Ls~N~l~~~~~-----------------------~--~~ 297 (958)
.-..++.+++.|+.|+|++|.|..+..+ .+..++|++|+|+.|+|+...+ . +.
T Consensus 284 -vn~g~lfgLt~L~~L~lS~NaI~rih~d~WsftqkL~~LdLs~N~i~~l~~~sf~~L~~Le~LnLs~Nsi~~l~e~af~ 362 (873)
T KOG4194|consen 284 -VNEGWLFGLTSLEQLDLSYNAIQRIHIDSWSFTQKLKELDLSSNRITRLDEGSFRVLSQLEELNLSHNSIDHLAEGAFV 362 (873)
T ss_pred -hhcccccccchhhhhccchhhhheeecchhhhcccceeEeccccccccCChhHHHHHHHhhhhcccccchHHHHhhHHH
Confidence 2244566666666666666666655543 5555666666666666653221 1 13
Q ss_pred CCCCcCEEEccCCcCCCcc---chhccCCCCCCeEeeecccCCCccchhhhcccccCccccceEeccCCCCCCCccCC--
Q 002158 298 LSENVTTIDLSDNYLNGSI---LESISNLPFLQTLSLENNFLTGSIPATIWQNKSFSTKARLKIDLRNNSFSNIVGDL-- 372 (958)
Q Consensus 298 ~~~~L~~L~Ls~N~l~~~~---~~~~~~l~~L~~L~L~~N~l~~~ip~~l~~~~~~~~~~l~~L~Ls~N~l~~l~~~~-- 372 (958)
++.+|++|||++|.|+..+ ...|.+|++|+.|.|.+|+|. .||+-.|.. .+.|+.|||.+|-|.+|..+.
T Consensus 363 ~lssL~~LdLr~N~ls~~IEDaa~~f~gl~~LrkL~l~gNqlk-~I~krAfsg----l~~LE~LdL~~NaiaSIq~nAFe 437 (873)
T KOG4194|consen 363 GLSSLHKLDLRSNELSWCIEDAAVAFNGLPSLRKLRLTGNQLK-SIPKRAFSG----LEALEHLDLGDNAIASIQPNAFE 437 (873)
T ss_pred HhhhhhhhcCcCCeEEEEEecchhhhccchhhhheeecCceee-ecchhhhcc----CcccceecCCCCcceeecccccc
Confidence 3467888888888887644 345778888888888888888 677665442 457889999999999997765
Q ss_pred CCCCcceEEeCCCCCCCCCCCCCCCcccccCCCC
Q 002158 373 TLPNNVTLRLGGNPICTSANIPNTGRFCGSDAGG 406 (958)
Q Consensus 373 ~l~~L~~L~l~~N~l~~~~~~~~~~~~~~~~~~~ 406 (958)
.+ +|+.|.+.--.+.|||.+.|..+|......+
T Consensus 438 ~m-~Lk~Lv~nSssflCDCql~Wl~qWl~~~~lq 470 (873)
T KOG4194|consen 438 PM-ELKELVMNSSSFLCDCQLKWLAQWLYRRKLQ 470 (873)
T ss_pred cc-hhhhhhhcccceEEeccHHHHHHHHHhcccc
Confidence 56 9999999999999999999999887765543
|
|
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.6e-29 Score=272.74 Aligned_cols=213 Identities=23% Similarity=0.337 Sum_probs=175.7
Q ss_pred HHHHcCCCCCceeeeeCCeEEEEEEEC-CCcEEEEEEeccCChh---cHHHHHHHHHHHHccCCCCcceEEEEEEeCCeE
Q 002158 621 AMATAYFSSSTQVGQGGYGKVYKGILS-DNTTVAIKRAEEGSLQ---GQNEFLTEIKLLSRLHHRNLVSLLGYCDEEGEQ 696 (958)
Q Consensus 621 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~ 696 (958)
+....-|..++.||-|+||+|.++.-. ....+|.|.+++.+.- .......|-+||.....+-||+||-.|.+++.+
T Consensus 625 KMdKSmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnL 704 (1034)
T KOG0608|consen 625 KMDKSMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNL 704 (1034)
T ss_pred hccccceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCce
Confidence 344455777889999999999999743 4667899998875433 334577899999999999999999999999999
Q ss_pred EEEEEecCCCCHHHHhccCCCCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEecCCCCeEEeeeeeeccc
Q 002158 697 MLVYEFVPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSRLA 776 (958)
Q Consensus 697 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~~ 776 (958)
|+||||++||++-.+|-+.+ .+.+.-+..++..++.|+++.|..| +|||||||+|||||.+|.+||.|||++.=+
T Consensus 705 YFVMdYIPGGDmMSLLIrmg--IFeE~LARFYIAEltcAiesVHkmG---FIHRDiKPDNILIDrdGHIKLTDFGLCTGf 779 (1034)
T KOG0608|consen 705 YFVMDYIPGGDMMSLLIRMG--IFEEDLARFYIAELTCAIESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGF 779 (1034)
T ss_pred EEEEeccCCccHHHHHHHhc--cCHHHHHHHHHHHHHHHHHHHHhcc---ceecccCccceEEccCCceeeeeccccccc
Confidence 99999999999999886543 4888889999999999999999999 999999999999999999999999998543
Q ss_pred ccCCCCCC-----------------------------------ccceeeeeccCCCCccChhhhccCCCCCcchhhhHHH
Q 002158 777 PVLDDEGT-----------------------------------MPTHVSTIVKGTPGYLDPEYFLTHKLTDKSDVYSLGV 821 (958)
Q Consensus 777 ~~~~~~~~-----------------------------------~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gv 821 (958)
....+... .........+||+.|+|||++....|+..+|.||.||
T Consensus 780 RWTHdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gv 859 (1034)
T KOG0608|consen 780 RWTHDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGV 859 (1034)
T ss_pred eeccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhH
Confidence 21111000 0000122347999999999999999999999999999
Q ss_pred HHHHHHhCCCCCCCCch
Q 002158 822 VLLELLTGMQPISHGKN 838 (958)
Q Consensus 822 ~l~elltG~~P~~~~~~ 838 (958)
+||||+.|+.||.....
T Consensus 860 il~em~~g~~pf~~~tp 876 (1034)
T KOG0608|consen 860 ILYEMLVGQPPFLADTP 876 (1034)
T ss_pred HHHHHhhCCCCccCCCC
Confidence 99999999999975443
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.1e-29 Score=251.34 Aligned_cols=257 Identities=25% Similarity=0.364 Sum_probs=194.3
Q ss_pred CCCCceeeeeCCeEEEEEEEC-CCcEEEEEEeccC--ChhcHHHHHHHHHHHHccCCCCcceEEEEEEeC-----CeEEE
Q 002158 627 FSSSTQVGQGGYGKVYKGILS-DNTTVAIKRAEEG--SLQGQNEFLTEIKLLSRLHHRNLVSLLGYCDEE-----GEQML 698 (958)
Q Consensus 627 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~-----~~~~l 698 (958)
.+..+.||-|+||.||.+++. +|+.||.|++..- .....+++.+|++++..++|.|++..++..... .+.|+
T Consensus 55 i~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV 134 (449)
T KOG0664|consen 55 IQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYV 134 (449)
T ss_pred CCCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHH
Confidence 344678999999999999975 7999999998653 334457899999999999999999998876543 25688
Q ss_pred EEEecCCCCHHHHhccCCCCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEecCCCCeEEeeeeeeccccc
Q 002158 699 VYEFVPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSRLAPV 778 (958)
Q Consensus 699 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~~~~ 778 (958)
|+|.| ..+|...|-. ...++...+.-+..||++||+|||+.+ |.||||||.|.|++.+..+||+|||+++..+.
T Consensus 135 ~TELm-QSDLHKIIVS--PQ~Ls~DHvKVFlYQILRGLKYLHsA~---ILHRDIKPGNLLVNSNCvLKICDFGLARvee~ 208 (449)
T KOG0664|consen 135 LTELM-QSDLHKIIVS--PQALTPDHVKVFVYQILRGLKYLHTAN---ILHRDIKPGNLLVNSNCILKICDFGLARTWDQ 208 (449)
T ss_pred HHHHH-Hhhhhheecc--CCCCCcchhhhhHHHHHhhhHHHhhcc---hhhccCCCccEEeccCceEEecccccccccch
Confidence 99999 5688888853 345888899999999999999999999 99999999999999999999999999997543
Q ss_pred CCCCCCccceeeeeccCCCCccChhhhccC-CCCCcchhhhHHHHHHHHHhCCCCCCCCchhHHHH--------------
Q 002158 779 LDDEGTMPTHVSTIVKGTPGYLDPEYFLTH-KLTDKSDVYSLGVVLLELLTGMQPISHGKNIVREV-------------- 843 (958)
Q Consensus 779 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DV~S~Gv~l~elltG~~P~~~~~~~~~~~-------------- 843 (958)
.+. .+ .+..+-|..|.|||++++. .|+.+.||||.||++.|++.++.-|.....+.+..
T Consensus 209 d~~-----~h-MTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaM 282 (449)
T KOG0664|consen 209 RDR-----LN-MTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAM 282 (449)
T ss_pred hhh-----hh-hHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHH
Confidence 322 11 2233467889999999986 58889999999999999999888886544332221
Q ss_pred HHHhhcCcchhhhcccC--CC--------CChHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 002158 844 NVARDSGMVFSIIDNRM--GS--------YPSECVERFVTLALRCCHDKPEHRPSMSDVVREL 896 (958)
Q Consensus 844 ~~~~~~~~~~~~i~~~~--~~--------~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 896 (958)
+... ++....++.... ++ -+..-..+...+..+++..||++|.+-++.+.++
T Consensus 283 r~AC-EGAk~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~ 344 (449)
T KOG0664|consen 283 KYAC-EGAKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHR 344 (449)
T ss_pred HHHh-hhhHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhcccc
Confidence 1111 111111111111 11 1223345567788889999999999998888754
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.9e-28 Score=237.31 Aligned_cols=253 Identities=20% Similarity=0.352 Sum_probs=193.2
Q ss_pred HcCCCCCceeeeeCCeEEEEEEE-CCCcEEEEEEeccCChhcHHHHHHHHHHHHccC-CCCcceEEEEEEeC--CeEEEE
Q 002158 624 TAYFSSSTQVGQGGYGKVYKGIL-SDNTTVAIKRAEEGSLQGQNEFLTEIKLLSRLH-HRNLVSLLGYCDEE--GEQMLV 699 (958)
Q Consensus 624 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~--~~~~lV 699 (958)
.++|++.+++|+|.+++||.|.. .+++.++||+++.- ..+.+.+|+.+|+.+. ||||+++++...+. ....||
T Consensus 37 ~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPV---kkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaLi 113 (338)
T KOG0668|consen 37 QDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPV---KKKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSLI 113 (338)
T ss_pred cchHHHHHHHcCccHhhHhcccccCCCceEEEeeechH---HHHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchhH
Confidence 35677788999999999999984 57889999999753 3456889999999996 99999999998764 467899
Q ss_pred EEecCCCCHHHHhccCCCCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEecCC-CCeEEeeeeeeccccc
Q 002158 700 YEFVPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSN-LNAKVADFGLSRLAPV 778 (958)
Q Consensus 700 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~-~~~kl~DFGla~~~~~ 778 (958)
+||+.+.+...+.. .++...+..+..+++.||.|+|+.| |+|||+||+|++||.. -.++|+|+|+|.++..
T Consensus 114 FE~v~n~Dfk~ly~-----tl~d~dIryY~~elLkALdyCHS~G---ImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYHp 185 (338)
T KOG0668|consen 114 FEYVNNTDFKQLYP-----TLTDYDIRYYIYELLKALDYCHSMG---IMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHP 185 (338)
T ss_pred hhhhccccHHHHhh-----hhchhhHHHHHHHHHHHHhHHHhcC---cccccCCcceeeechhhceeeeeecchHhhcCC
Confidence 99999888776653 2677788899999999999999999 9999999999999975 4699999999998753
Q ss_pred CCCCCCccceeeeeccCCCCccChhhhcc-CCCCCcchhhhHHHHHHHHHhCCCCCCCCch-hHHHHHHHhhcCc--c--
Q 002158 779 LDDEGTMPTHVSTIVKGTPGYLDPEYFLT-HKLTDKSDVYSLGVVLLELLTGMQPISHGKN-IVREVNVARDSGM--V-- 852 (958)
Q Consensus 779 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DV~S~Gv~l~elltG~~P~~~~~~-~~~~~~~~~~~~~--~-- 852 (958)
... ....+.+..|--||.+-. ..|+.+-|+|||||++.+|+..+.||..+.+ ..+.++.+.--+. +
T Consensus 186 ~~e--------YnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el~~ 257 (338)
T KOG0668|consen 186 GKE--------YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELYA 257 (338)
T ss_pred Cce--------eeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHHHH
Confidence 221 222345666889999865 4588999999999999999999999976653 3333322221111 0
Q ss_pred -------------hhhhccc----CCCC----C-hHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 002158 853 -------------FSIIDNR----MGSY----P-SECVERFVTLALRCCHDKPEHRPSMSDVVRE 895 (958)
Q Consensus 853 -------------~~~i~~~----~~~~----~-~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 895 (958)
..++... +..+ . .-..++..+++.+.+..|-.+|+|++|...+
T Consensus 258 Yl~KY~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~H 322 (338)
T KOG0668|consen 258 YLNKYQIDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMAH 322 (338)
T ss_pred HHHHHccCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhcC
Confidence 0111100 0000 0 1124678899999999999999999998864
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=7e-27 Score=242.17 Aligned_cols=210 Identities=38% Similarity=0.634 Sum_probs=183.0
Q ss_pred eeeeCCeEEEEEEECC-CcEEEEEEeccCChh-cHHHHHHHHHHHHccCCCCcceEEEEEEeCCeEEEEEEecCCCCHHH
Q 002158 633 VGQGGYGKVYKGILSD-NTTVAIKRAEEGSLQ-GQNEFLTEIKLLSRLHHRNLVSLLGYCDEEGEQMLVYEFVPNGTLRD 710 (958)
Q Consensus 633 lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E~~~~gsL~~ 710 (958)
||+|++|.||++...+ ++.+++|++...... ..+.+.+|++.++.++|++++++++++......+++|||+++++|.+
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~ 80 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKD 80 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHH
Confidence 6899999999999864 899999999875433 34678999999999999999999999999999999999999999999
Q ss_pred HhccCCCCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEecC-CCCeEEeeeeeecccccCCCCCCcccee
Q 002158 711 WLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDS-NLNAKVADFGLSRLAPVLDDEGTMPTHV 789 (958)
Q Consensus 711 ~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~-~~~~kl~DFGla~~~~~~~~~~~~~~~~ 789 (958)
++.... ..+++..+..++.+++++++|||+.+ ++|+||+|.||+++. ++.++|+|||.+........ .
T Consensus 81 ~~~~~~-~~~~~~~~~~~~~~l~~~l~~lh~~~---~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~-------~ 149 (215)
T cd00180 81 LLKENE-GKLSEDEILRILLQILEGLEYLHSNG---IIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS-------L 149 (215)
T ss_pred HHHhcc-CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc-------h
Confidence 997542 34889999999999999999999998 999999999999999 89999999999976533211 1
Q ss_pred eeeccCCCCccChhhhccC-CCCCcchhhhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcCcchhhhcccCCCCChHHH
Q 002158 790 STIVKGTPGYLDPEYFLTH-KLTDKSDVYSLGVVLLELLTGMQPISHGKNIVREVNVARDSGMVFSIIDNRMGSYPSECV 868 (958)
Q Consensus 790 ~~~~~gt~~y~aPE~~~~~-~~~~~~DV~S~Gv~l~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~ 868 (958)
.....+...|++||..... .++.+.|+|++|+++++|
T Consensus 150 ~~~~~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l------------------------------------------ 187 (215)
T cd00180 150 LKTIVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL------------------------------------------ 187 (215)
T ss_pred hhcccCCCCccChhHhcccCCCCchhhhHHHHHHHHHH------------------------------------------
Confidence 2234577889999999887 788899999999999998
Q ss_pred HHHHHHHHHccccCCCCCCCHHHHHHH
Q 002158 869 ERFVTLALRCCHDKPEHRPSMSDVVRE 895 (958)
Q Consensus 869 ~~l~~li~~cl~~dP~~RPs~~evl~~ 895 (958)
..+.+++.+|++.+|++||++.+++++
T Consensus 188 ~~~~~~l~~~l~~~p~~R~~~~~l~~~ 214 (215)
T cd00180 188 PELKDLIRKMLQKDPEKRPSAKEILEH 214 (215)
T ss_pred HHHHHHHHHHhhCCcccCcCHHHHhhC
Confidence 456789999999999999999999864
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=6.3e-29 Score=273.85 Aligned_cols=254 Identities=23% Similarity=0.316 Sum_probs=207.5
Q ss_pred HHcCCCCCceeeeeCCeEEEEEEEC-CCcEEEEEEeccCChhcHHHHHHHHHHHHccCCCCcceEEEEEEeCCeEEEEEE
Q 002158 623 ATAYFSSSTQVGQGGYGKVYKGILS-DNTTVAIKRAEEGSLQGQNEFLTEIKLLSRLHHRNLVSLLGYCDEEGEQMLVYE 701 (958)
Q Consensus 623 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E 701 (958)
..++|....++|.|+||.||||++. .++..|||+++-....+..-.+.|+-+++.-+|+||+.++|.+...+..+++||
T Consensus 13 P~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicME 92 (829)
T KOG0576|consen 13 PQDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICME 92 (829)
T ss_pred CccchhheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEEE
Confidence 3456778889999999999999976 689999999987655566667889999999999999999999999999999999
Q ss_pred ecCCCCHHHHhccCCCCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEecCCCCeEEeeeeeecccccCCC
Q 002158 702 FVPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSRLAPVLDD 781 (958)
Q Consensus 702 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~ 781 (958)
||.+|+|.+..+.. .++++.++..++....+|++|||+.+ -+|||||-.||++++.|.+|++|||.+-.+..
T Consensus 93 ycgggslQdiy~~T--gplselqiayvcRetl~gl~ylhs~g---k~hRdiKGanilltd~gDvklaDfgvsaqita--- 164 (829)
T KOG0576|consen 93 YCGGGSLQDIYHVT--GPLSELQIAYVCRETLQGLKYLHSQG---KIHRDIKGANILLTDEGDVKLADFGVSAQITA--- 164 (829)
T ss_pred ecCCCcccceeeec--ccchhHHHHHHHhhhhccchhhhcCC---cccccccccceeecccCceeecccCchhhhhh---
Confidence 99999999998754 45999999999999999999999999 89999999999999999999999998754311
Q ss_pred CCCccceeeeeccCCCCccChhhh---ccCCCCCcchhhhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcCcchhhhcc
Q 002158 782 EGTMPTHVSTIVKGTPGYLDPEYF---LTHKLTDKSDVYSLGVVLLELLTGMQPISHGKNIVREVNVARDSGMVFSIIDN 858 (958)
Q Consensus 782 ~~~~~~~~~~~~~gt~~y~aPE~~---~~~~~~~~~DV~S~Gv~l~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~i~~ 858 (958)
.......+.||+.|||||+. +.+.|..++|||+.|++..|+-.-+.|..+-.............-...
T Consensus 165 ----ti~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr~l~LmTkS~~qpp----- 235 (829)
T KOG0576|consen 165 ----TIAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMRALFLMTKSGFQPP----- 235 (829)
T ss_pred ----hhhhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHHHHHHhhccCCCCC-----
Confidence 12233467899999999987 356789999999999999999998888765444333322221111111
Q ss_pred cCCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002158 859 RMGSYPSECVERFVTLALRCCHDKPEHRPSMSDVVR 894 (958)
Q Consensus 859 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 894 (958)
...-+..+.+.+.++++.|+..+|++||+++.+++
T Consensus 236 -~lkDk~kws~~fh~fvK~altknpKkRptaeklL~ 270 (829)
T KOG0576|consen 236 -TLKDKTKWSEFFHNFVKGALTKNPKKRPTAEKLLQ 270 (829)
T ss_pred -cccCCccchHHHHHHHHHHhcCCCccCCChhhhee
Confidence 11123456788999999999999999999997764
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=6.8e-28 Score=245.54 Aligned_cols=254 Identities=24% Similarity=0.305 Sum_probs=196.6
Q ss_pred cCCCCCceeeeeCCeEEEEEEEC-CCcEEEEEEeccC--ChhcHHHHHHHHHHHHccCCCCcceEEEEEEeCC------e
Q 002158 625 AYFSSSTQVGQGGYGKVYKGILS-DNTTVAIKRAEEG--SLQGQNEFLTEIKLLSRLHHRNLVSLLGYCDEEG------E 695 (958)
Q Consensus 625 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~------~ 695 (958)
.+|.....+|.|.- .|..|.+. .+++||+|++... .....++..+|..++..++|+|+++++.++.-.. .
T Consensus 17 ~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e 95 (369)
T KOG0665|consen 17 KRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQE 95 (369)
T ss_pred eeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHHh
Confidence 35555677888887 56666654 6899999987654 2334567889999999999999999999986543 5
Q ss_pred EEEEEEecCCCCHHHHhccCCCCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEecCCCCeEEeeeeeecc
Q 002158 696 QMLVYEFVPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSRL 775 (958)
Q Consensus 696 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~ 775 (958)
.|+||||| ..+|...++. .++-.+...+..|++.|++|||+.+ |+||||||+||++..++.+||.|||+|+.
T Consensus 96 ~y~v~e~m-~~nl~~vi~~----elDH~tis~i~yq~~~~ik~lhs~~---IihRdLkPsnivv~~~~~lKi~dfg~ar~ 167 (369)
T KOG0665|consen 96 VYLVMELM-DANLCQVILM----ELDHETISYILYQMLCGIKHLHSAG---IIHRDLKPSNIVVNSDCTLKILDFGLART 167 (369)
T ss_pred HHHHHHhh-hhHHHHHHHH----hcchHHHHHHHHHHHHHHHHHHhcc---eeecccCcccceecchhheeeccchhhcc
Confidence 79999999 5799998873 2777888999999999999999999 99999999999999999999999999984
Q ss_pred cccCCCCCCccceeeeeccCCCCccChhhhccCCCCCcchhhhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcCcchh-
Q 002158 776 APVLDDEGTMPTHVSTIVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVLLELLTGMQPISHGKNIVREVNVARDSGMVFS- 854 (958)
Q Consensus 776 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gv~l~elltG~~P~~~~~~~~~~~~~~~~~~~~~~- 854 (958)
... ....+....|..|.|||++.+..+...+||||.||++.||++|+.-|.+...+.+|-+.....+..-.
T Consensus 168 e~~--------~~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~ 239 (369)
T KOG0665|consen 168 EDT--------DFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPS 239 (369)
T ss_pred cCc--------ccccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHH
Confidence 321 12334566888999999999999999999999999999999999988866666555443322221100
Q ss_pred --------------------------hh-cccC---CCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 002158 855 --------------------------II-DNRM---GSYPSECVERFVTLALRCCHDKPEHRPSMSDVVRE 895 (958)
Q Consensus 855 --------------------------~i-~~~~---~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 895 (958)
.. |... .+.+.-......+++.+|+-.+|++|-+.++++++
T Consensus 240 F~~qL~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~H 310 (369)
T KOG0665|consen 240 FMKQLQPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRH 310 (369)
T ss_pred HHHHhhHHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcC
Confidence 00 0000 00111233457889999999999999999999975
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=7.1e-28 Score=261.27 Aligned_cols=198 Identities=26% Similarity=0.394 Sum_probs=168.6
Q ss_pred HHcCCCCCceeeeeCCeEEEEEEEC-CCcEEEEEEeccCChhc--------HHHHHHHHHHHHccC---CCCcceEEEEE
Q 002158 623 ATAYFSSSTQVGQGGYGKVYKGILS-DNTTVAIKRAEEGSLQG--------QNEFLTEIKLLSRLH---HRNLVSLLGYC 690 (958)
Q Consensus 623 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~--------~~~~~~E~~~l~~l~---H~niv~l~~~~ 690 (958)
....|...+.+|+|+||.|+.|+++ +...|+||.+.+...-. .-..-.|+++|..++ |+||+|++++|
T Consensus 559 k~s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfF 638 (772)
T KOG1152|consen 559 KFSDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFF 638 (772)
T ss_pred ccccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhhee
Confidence 3346888899999999999999987 46689999876532111 012457999999997 99999999999
Q ss_pred EeCCeEEEEEEec-CCCCHHHHhccCCCCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEecCCCCeEEee
Q 002158 691 DEEGEQMLVYEFV-PNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSNLNAKVAD 769 (958)
Q Consensus 691 ~~~~~~~lV~E~~-~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~~~~kl~D 769 (958)
++++.+||+||-. ++.+|.++|..+. .+++.++..|+.|++.|+++||+.+ |||||||-+||.++.+|.+||+|
T Consensus 639 Eddd~yyl~te~hg~gIDLFd~IE~kp--~m~E~eAk~IFkQV~agi~hlh~~~---ivhrdikdenvivd~~g~~klid 713 (772)
T KOG1152|consen 639 EDDDYYYLETEVHGEGIDLFDFIEFKP--RMDEPEAKLIFKQVVAGIKHLHDQG---IVHRDIKDENVIVDSNGFVKLID 713 (772)
T ss_pred ecCCeeEEEecCCCCCcchhhhhhccC--ccchHHHHHHHHHHHhccccccccC---ceecccccccEEEecCCeEEEee
Confidence 9999999999986 4558999997554 4999999999999999999999999 99999999999999999999999
Q ss_pred eeeecccccCCCCCCccceeeeeccCCCCccChhhhccCCCCC-cchhhhHHHHHHHHHhCCCCCC
Q 002158 770 FGLSRLAPVLDDEGTMPTHVSTIVKGTPGYLDPEYFLTHKLTD-KSDVYSLGVVLLELLTGMQPIS 834 (958)
Q Consensus 770 FGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~-~~DV~S~Gv~l~elltG~~P~~ 834 (958)
||.|.+.. ..+...++||.+|.|||++.+.+|-- .-|||++|++||-++-...||.
T Consensus 714 fgsaa~~k---------sgpfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyy 770 (772)
T KOG1152|consen 714 FGSAAYTK---------SGPFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYY 770 (772)
T ss_pred ccchhhhc---------CCCcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCc
Confidence 99987542 22334678999999999999988754 6899999999999999888885
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.94 E-value=5.3e-26 Score=238.88 Aligned_cols=199 Identities=34% Similarity=0.522 Sum_probs=172.7
Q ss_pred CCCCceeeeeCCeEEEEEEECC-CcEEEEEEeccCChh-cHHHHHHHHHHHHccCCCCcceEEEEEEeCCeEEEEEEecC
Q 002158 627 FSSSTQVGQGGYGKVYKGILSD-NTTVAIKRAEEGSLQ-GQNEFLTEIKLLSRLHHRNLVSLLGYCDEEGEQMLVYEFVP 704 (958)
Q Consensus 627 ~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E~~~ 704 (958)
|...+.||+|++|.||+|...+ ++.+|+|.+...... ..+.+.+|++.+++++|+|++++++++......++++||++
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCE 80 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccC
Confidence 4566889999999999999875 889999999876544 56788999999999999999999999999999999999999
Q ss_pred CCCHHHHhccCCCCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEecCCCCeEEeeeeeecccccCCCCCC
Q 002158 705 NGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSRLAPVLDDEGT 784 (958)
Q Consensus 705 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 784 (958)
+++|.+++...... +++..+..++.+++.++.|||+.+ ++|+||+|+||+++.++.++|+|||.+........
T Consensus 81 ~~~L~~~~~~~~~~-~~~~~~~~~~~~l~~~l~~lh~~~---i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~--- 153 (225)
T smart00221 81 GGDLFDYLRKKGGK-LSEEEARFYLRQILEALEYLHSLG---IVHRDLKPENILLGMDGLVKLADFGLARFIHRDLA--- 153 (225)
T ss_pred CCCHHHHHHhcccC-CCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeeCceeeEecCccc---
Confidence 99999999764432 788999999999999999999998 99999999999999999999999999986643220
Q ss_pred ccceeeeeccCCCCccChhhh-ccCCCCCcchhhhHHHHHHHHHhCCCCCCC
Q 002158 785 MPTHVSTIVKGTPGYLDPEYF-LTHKLTDKSDVYSLGVVLLELLTGMQPISH 835 (958)
Q Consensus 785 ~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~~DV~S~Gv~l~elltG~~P~~~ 835 (958)
.......++..|++||.+ ....++.++|||+||++++||++|+.||..
T Consensus 154 ---~~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~ 202 (225)
T smart00221 154 ---ALLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG 202 (225)
T ss_pred ---ccccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence 012234578889999998 666788899999999999999999999965
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.4e-27 Score=234.31 Aligned_cols=246 Identities=21% Similarity=0.315 Sum_probs=183.9
Q ss_pred cCCCCCceeeeeCCeEEEEEEEC-CCcEEEEEEeccCChhcHHHHHHHHHHHHcc-CCCCcceEEEE-EEeCCeEEEEEE
Q 002158 625 AYFSSSTQVGQGGYGKVYKGILS-DNTTVAIKRAEEGSLQGQNEFLTEIKLLSRL-HHRNLVSLLGY-CDEEGEQMLVYE 701 (958)
Q Consensus 625 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~-~~~~~~~~lV~E 701 (958)
+.|.+.+.+|+|.||.+-.+.++ ..+.+++|.+.... ...++|.+|..---.+ .|.||+.-|++ +...+.++++||
T Consensus 24 d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~-tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~qE 102 (378)
T KOG1345|consen 24 DVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQ-TTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFVQE 102 (378)
T ss_pred hhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcch-hhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEeec
Confidence 46788889999999999999987 57889999987654 3356899999866666 59999988775 677788999999
Q ss_pred ecCCCCHHHHhccCCCCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEe-cC-CCCeEEeeeeeecccccC
Q 002158 702 FVPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILL-DS-NLNAKVADFGLSRLAPVL 779 (958)
Q Consensus 702 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl-~~-~~~~kl~DFGla~~~~~~ 779 (958)
|+|.|+|.+-+...+ +.+....+++.|++.|+.|+|++. +||||||.+|||| +. ..++||+|||+.+....
T Consensus 103 ~aP~gdL~snv~~~G---igE~~~K~v~~ql~SAi~fMHskn---lVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g~- 175 (378)
T KOG1345|consen 103 FAPRGDLRSNVEAAG---IGEANTKKVFAQLLSAIEFMHSKN---LVHRDLKAENILIFDADFYRVKLCDFGLTRKVGT- 175 (378)
T ss_pred cCccchhhhhcCccc---ccHHHHHHHHHHHHHHHHHhhccc---hhhcccccceEEEecCCccEEEeeecccccccCc-
Confidence 999999999886533 778888999999999999999999 9999999999999 33 34799999999875321
Q ss_pred CCCCCccceeeeeccCCCCccChhhhccC-----CCCCcchhhhHHHHHHHHHhCCCCCCCCc----hhHHHHHHHhhcC
Q 002158 780 DDEGTMPTHVSTIVKGTPGYLDPEYFLTH-----KLTDKSDVYSLGVVLLELLTGMQPISHGK----NIVREVNVARDSG 850 (958)
Q Consensus 780 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~DV~S~Gv~l~elltG~~P~~~~~----~~~~~~~~~~~~~ 850 (958)
.-....-+..|.+||..... ...+.+|||.||++++.++||+.||.... ...++..... +
T Consensus 176 ---------tV~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y~~~~~w~~--r 244 (378)
T KOG1345|consen 176 ---------TVKYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPYWEWEQWLK--R 244 (378)
T ss_pred ---------eehhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCchHHHHHHHhc--c
Confidence 11112245569999987543 35678999999999999999999997422 2222222111 1
Q ss_pred cchhhhcccCCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002158 851 MVFSIIDNRMGSYPSECVERFVTLALRCCHDKPEHRPSMSDVVR 894 (958)
Q Consensus 851 ~~~~~i~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 894 (958)
... ..+..-....+.+.++.++-+..+|++|-...++.+
T Consensus 245 k~~-----~~P~~F~~fs~~a~r~Fkk~lt~~~~drcki~~~kk 283 (378)
T KOG1345|consen 245 KNP-----ALPKKFNPFSEKALRLFKKSLTPRFKDRCKIWTAKK 283 (378)
T ss_pred cCc-----cCchhhcccCHHHHHHHHHhcCCcccccchhHHHHH
Confidence 111 111111234567788889999999999954444443
|
|
| >KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.9e-29 Score=271.73 Aligned_cols=295 Identities=23% Similarity=0.302 Sum_probs=263.2
Q ss_pred eeeEEEEccCCcCC-CCccccccCCCCcceeeccCcccCCCCccccCCCCCcEEEeeCCCCCCCCChhhcCCCCCCEEec
Q 002158 86 LHVRELQLLSMNLS-GNLAPELGQLSRLQYYFMWNDLTGTIPKEIGNISSLIFLLLNGNKLSGSLPDELGYLSNLNRLQV 164 (958)
Q Consensus 86 ~~v~~L~L~~~~l~-~~~~~~l~~L~~L~~L~l~n~~~~~ip~~i~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~L 164 (958)
..|+.+|+++|.++ +..|....++++++.|-|.......+|+.++.+.+|++|.+++|++. .+-..++.|+.|+.+++
T Consensus 7 pFVrGvDfsgNDFsg~~FP~~v~qMt~~~WLkLnrt~L~~vPeEL~~lqkLEHLs~~HN~L~-~vhGELs~Lp~LRsv~~ 85 (1255)
T KOG0444|consen 7 PFVRGVDFSGNDFSGDRFPHDVEQMTQMTWLKLNRTKLEQVPEELSRLQKLEHLSMAHNQLI-SVHGELSDLPRLRSVIV 85 (1255)
T ss_pred ceeecccccCCcCCCCcCchhHHHhhheeEEEechhhhhhChHHHHHHhhhhhhhhhhhhhH-hhhhhhccchhhHHHhh
Confidence 36899999999999 57999999999999999999899999999999999999999999999 78888999999999999
Q ss_pred cccccc-ccCccccccccccceEecccccccccCchhhcCCccchhhhccCCccccCCCcccCCCCCccEEEccCCCCCC
Q 002158 165 DENNIT-GTIPKSFANLSRVRHLHLNNNSIGGQIPSELSKLSTLIHLLVDNNNLSGNLPPELSELPQLCILQLDNNNFSA 243 (958)
Q Consensus 165 ~~N~l~-~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~ 243 (958)
..|++. .-+|..+..|..|..||||+|+++ ..|..+...+++-.|+||+|+|..+....|.+++.|-.|||++|++.
T Consensus 86 R~N~LKnsGiP~diF~l~dLt~lDLShNqL~-EvP~~LE~AKn~iVLNLS~N~IetIPn~lfinLtDLLfLDLS~NrLe- 163 (1255)
T KOG0444|consen 86 RDNNLKNSGIPTDIFRLKDLTILDLSHNQLR-EVPTNLEYAKNSIVLNLSYNNIETIPNSLFINLTDLLFLDLSNNRLE- 163 (1255)
T ss_pred hccccccCCCCchhcccccceeeecchhhhh-hcchhhhhhcCcEEEEcccCccccCCchHHHhhHhHhhhccccchhh-
Confidence 999997 458899999999999999999999 88999999999999999999999777777899999999999999994
Q ss_pred CCccccccCCCCCCEEEcccCCCCCCCC-CCCCCCCcCEEeccCCcCC--CcCCCCCCCCCcCEEEccCCcCCCccchhc
Q 002158 244 SEIPATYGNFSKLVKLSLRNCNLQGAVP-DLSRIPNLYYLDLSWNHLT--GSIPSKKLSENVTTIDLSDNYLNGSILESI 320 (958)
Q Consensus 244 ~~~p~~~~~l~~L~~L~L~~N~l~~~~~-~l~~l~~L~~L~Ls~N~l~--~~~~~~~~~~~L~~L~Ls~N~l~~~~~~~~ 320 (958)
.+|..+..+..|++|.|++|.|....- .+..+++|+.|.+++.+-+ ..+++...+.+|..+|||.|.+. ..|+.+
T Consensus 164 -~LPPQ~RRL~~LqtL~Ls~NPL~hfQLrQLPsmtsL~vLhms~TqRTl~N~Ptsld~l~NL~dvDlS~N~Lp-~vPecl 241 (1255)
T KOG0444|consen 164 -MLPPQIRRLSMLQTLKLSNNPLNHFQLRQLPSMTSLSVLHMSNTQRTLDNIPTSLDDLHNLRDVDLSENNLP-IVPECL 241 (1255)
T ss_pred -hcCHHHHHHhhhhhhhcCCChhhHHHHhcCccchhhhhhhcccccchhhcCCCchhhhhhhhhccccccCCC-cchHHH
Confidence 789999999999999999999986554 4888899999999988643 34555677899999999999998 789999
Q ss_pred cCCCCCCeEeeecccCCCccchhhhcccccCccccceEeccCCCCCCCccCC-CCCCcceEEeCCCCCCCCC
Q 002158 321 SNLPFLQTLSLENNFLTGSIPATIWQNKSFSTKARLKIDLRNNSFSNIVGDL-TLPNNVTLRLGGNPICTSA 391 (958)
Q Consensus 321 ~~l~~L~~L~L~~N~l~~~ip~~l~~~~~~~~~~l~~L~Ls~N~l~~l~~~~-~l~~L~~L~l~~N~l~~~~ 391 (958)
-++++|+.|+||+|+|+ ++-..... ...+++|+||.|+++.+|... .++.|+.|++.+|.+.-..
T Consensus 242 y~l~~LrrLNLS~N~it-eL~~~~~~-----W~~lEtLNlSrNQLt~LP~avcKL~kL~kLy~n~NkL~FeG 307 (1255)
T KOG0444|consen 242 YKLRNLRRLNLSGNKIT-ELNMTEGE-----WENLETLNLSRNQLTVLPDAVCKLTKLTKLYANNNKLTFEG 307 (1255)
T ss_pred hhhhhhheeccCcCcee-eeeccHHH-----HhhhhhhccccchhccchHHHhhhHHHHHHHhccCcccccC
Confidence 99999999999999998 44433333 345779999999999999887 9999999999999996544
|
|
| >KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.94 E-value=8.5e-29 Score=269.15 Aligned_cols=296 Identities=28% Similarity=0.367 Sum_probs=191.5
Q ss_pred eEEEEccCCcCCCCccccccCCCCcceeeccC-cc-cCCCCccccCCCCCcEEEeeCCCCCCCCChhhcCCCCCCEEecc
Q 002158 88 VRELQLLSMNLSGNLAPELGQLSRLQYYFMWN-DL-TGTIPKEIGNISSLIFLLLNGNKLSGSLPDELGYLSNLNRLQVD 165 (958)
Q Consensus 88 v~~L~L~~~~l~~~~~~~l~~L~~L~~L~l~n-~~-~~~ip~~i~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~L~ 165 (958)
+..|.+..|++.. +..++..|+.|+.+.+.. ++ ...||+.|..+..|+.||||+|++. ..|..+..-+++-.|+||
T Consensus 57 LEHLs~~HN~L~~-vhGELs~Lp~LRsv~~R~N~LKnsGiP~diF~l~dLt~lDLShNqL~-EvP~~LE~AKn~iVLNLS 134 (1255)
T KOG0444|consen 57 LEHLSMAHNQLIS-VHGELSDLPRLRSVIVRDNNLKNSGIPTDIFRLKDLTILDLSHNQLR-EVPTNLEYAKNSIVLNLS 134 (1255)
T ss_pred hhhhhhhhhhhHh-hhhhhccchhhHHHhhhccccccCCCCchhcccccceeeecchhhhh-hcchhhhhhcCcEEEEcc
Confidence 3344444444442 233455555555555542 22 3357777777777777777777777 777777777777777777
Q ss_pred cccccccCccccccccccceEecccccccccCchhhcCCccchhhhccCCccccCCCcccCCCCCccEEEccCCCCCCCC
Q 002158 166 ENNITGTIPKSFANLSRVRHLHLNNNSIGGQIPSELSKLSTLIHLLVDNNNLSGNLPPELSELPQLCILQLDNNNFSASE 245 (958)
Q Consensus 166 ~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~ 245 (958)
+|+|..+...-|.+|+.|-.||||+|++. .+|..+..+..|++|.|++|.+...--..+..+++|+.|.+++.+-+...
T Consensus 135 ~N~IetIPn~lfinLtDLLfLDLS~NrLe-~LPPQ~RRL~~LqtL~Ls~NPL~hfQLrQLPsmtsL~vLhms~TqRTl~N 213 (1255)
T KOG0444|consen 135 YNNIETIPNSLFINLTDLLFLDLSNNRLE-MLPPQIRRLSMLQTLKLSNNPLNHFQLRQLPSMTSLSVLHMSNTQRTLDN 213 (1255)
T ss_pred cCccccCCchHHHhhHhHhhhccccchhh-hcCHHHHHHhhhhhhhcCCChhhHHHHhcCccchhhhhhhcccccchhhc
Confidence 77777333344567777777777777777 56666777777777777777766444445556666666777666665566
Q ss_pred ccccccCCCCCCEEEcccCCCCCCCCCCCCCCCcCEEeccCCcCCCcCCCCCCCCCcCEEEccCCcCCCccchhccCCCC
Q 002158 246 IPATYGNFSKLVKLSLRNCNLQGAVPDLSRIPNLYYLDLSWNHLTGSIPSKKLSENVTTIDLSDNYLNGSILESISNLPF 325 (958)
Q Consensus 246 ~p~~~~~l~~L~~L~L~~N~l~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~~~L~~L~Ls~N~l~~~~~~~~~~l~~ 325 (958)
+|.++..+.+|..++|+.|.|.-.+..+.++++|+.|+||+|+|+..--......+|++|+||+|+++ ..|..++.|++
T Consensus 214 ~Ptsld~l~NL~dvDlS~N~Lp~vPecly~l~~LrrLNLS~N~iteL~~~~~~W~~lEtLNlSrNQLt-~LP~avcKL~k 292 (1255)
T KOG0444|consen 214 IPTSLDDLHNLRDVDLSENNLPIVPECLYKLRNLRRLNLSGNKITELNMTEGEWENLETLNLSRNQLT-VLPDAVCKLTK 292 (1255)
T ss_pred CCCchhhhhhhhhccccccCCCcchHHHhhhhhhheeccCcCceeeeeccHHHHhhhhhhccccchhc-cchHHHhhhHH
Confidence 67777777777777777777775555567777777777777777633222233356777777777776 56777777777
Q ss_pred CCeEeeecccCCC-ccchhhhcccccC------------------ccccceEeccCCCCCCCccCC-CCCCcceEEeCCC
Q 002158 326 LQTLSLENNFLTG-SIPATIWQNKSFS------------------TKARLKIDLRNNSFSNIVGDL-TLPNNVTLRLGGN 385 (958)
Q Consensus 326 L~~L~L~~N~l~~-~ip~~l~~~~~~~------------------~~~l~~L~Ls~N~l~~l~~~~-~l~~L~~L~l~~N 385 (958)
|+.|++.+|+|+- -||.+|.++..+. ...|+.|.|+.|.+.++|+.. -++.|+.|++..|
T Consensus 293 L~kLy~n~NkL~FeGiPSGIGKL~~Levf~aanN~LElVPEglcRC~kL~kL~L~~NrLiTLPeaIHlL~~l~vLDlreN 372 (1255)
T KOG0444|consen 293 LTKLYANNNKLTFEGIPSGIGKLIQLEVFHAANNKLELVPEGLCRCVKLQKLKLDHNRLITLPEAIHLLPDLKVLDLREN 372 (1255)
T ss_pred HHHHHhccCcccccCCccchhhhhhhHHHHhhccccccCchhhhhhHHHHHhcccccceeechhhhhhcCCcceeeccCC
Confidence 7777777777653 4666665554432 234456666777776666666 5666677777776
Q ss_pred CC
Q 002158 386 PI 387 (958)
Q Consensus 386 ~l 387 (958)
|=
T Consensus 373 pn 374 (1255)
T KOG0444|consen 373 PN 374 (1255)
T ss_pred cC
Confidence 64
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.2e-25 Score=240.17 Aligned_cols=132 Identities=23% Similarity=0.366 Sum_probs=113.7
Q ss_pred cCCCCCceeeeeCCeEEEEEEEC-CCcEEEEEEeccCChhcHHHHHHHHHHHHccC-----C---CCcceEEEEEEe---
Q 002158 625 AYFSSSTQVGQGGYGKVYKGILS-DNTTVAIKRAEEGSLQGQNEFLTEIKLLSRLH-----H---RNLVSLLGYCDE--- 692 (958)
Q Consensus 625 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----H---~niv~l~~~~~~--- 692 (958)
.+|...++||.|.|++||++.+. +.+.||+|+.+... ...+..+.||++|++++ | .+||+|++.|..
T Consensus 78 gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSAq-hYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~FkhsGp 156 (590)
T KOG1290|consen 78 GRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSAQ-HYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHSGP 156 (590)
T ss_pred ceEEEEEeccccccceeEEEeeccCCeEEEEEEEehhh-HHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceecCC
Confidence 57788899999999999999875 67899999998643 33456778999999983 2 469999999975
Q ss_pred -CCeEEEEEEecCCCCHHHHhccCCCCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEec
Q 002158 693 -EGEQMLVYEFVPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLD 760 (958)
Q Consensus 693 -~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~ 760 (958)
+.+++||+|++ |.+|..+|....-..++...+.+|+.|++.||.|||.++. |||-||||+|||+.
T Consensus 157 NG~HVCMVfEvL-GdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~ecg--IIHTDlKPENvLl~ 222 (590)
T KOG1290|consen 157 NGQHVCMVFEVL-GDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHRECG--IIHTDLKPENVLLC 222 (590)
T ss_pred CCcEEEEEehhh-hhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHhcC--ccccCCCcceeeee
Confidence 44899999999 7899999987776779999999999999999999999875 99999999999993
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.6e-26 Score=227.49 Aligned_cols=256 Identities=21% Similarity=0.381 Sum_probs=203.3
Q ss_pred cccChHHHHHHHcCCCCCceeeeeCCeEEEEEEECCCcEEEEEEeccC--ChhcHHHHHHHHHHHHccCCCCcceEEEEE
Q 002158 613 KGFKFKELAMATAYFSSSTQVGQGGYGKVYKGILSDNTTVAIKRAEEG--SLQGQNEFLTEIKLLSRLHHRNLVSLLGYC 690 (958)
Q Consensus 613 ~~~~~~el~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~ 690 (958)
..+++.++...| +|.+...|+.|+|+|+ |..+++|++... .....++|.+|.-.++.+.||||++++|.|
T Consensus 185 ~gid~~~lnl~t-------kl~e~hsgelwrgrwq-gndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgac 256 (448)
T KOG0195|consen 185 TGIDVSSLNLIT-------KLAESHSGELWRGRWQ-GNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGAC 256 (448)
T ss_pred cCcchhhhhhhh-------hhccCCCccccccccc-CcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhc
Confidence 345555555544 5889999999999995 445667766543 333346799999999999999999999999
Q ss_pred EeCCeEEEEEEecCCCCHHHHhccCCCCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEecCCCCeEEe--
Q 002158 691 DEEGEQMLVYEFVPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSNLNAKVA-- 768 (958)
Q Consensus 691 ~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~~~~kl~-- 768 (958)
.......++..||+.|+|+..+++......+..++.+++.++|+|++|||+.. +-|----+.+..|++|++.+++|+
T Consensus 257 nsppnlv~isq~mp~gslynvlhe~t~vvvd~sqav~faldiargmaflhsle-p~ipr~~lns~hvmidedltarisma 335 (448)
T KOG0195|consen 257 NSPPNLVIISQYMPFGSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSLE-PMIPRFYLNSKHVMIDEDLTARISMA 335 (448)
T ss_pred cCCCCceEeeeeccchHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhcc-hhhhhhhcccceEEecchhhhheecc
Confidence 99999999999999999999999988777899999999999999999999975 334344689999999999998875
Q ss_pred eeeeecccccCCCCCCccceeeeeccCCCCccChhhhccCCCCC---cchhhhHHHHHHHHHhCCCCCCCCchhHHHHHH
Q 002158 769 DFGLSRLAPVLDDEGTMPTHVSTIVKGTPGYLDPEYFLTHKLTD---KSDVYSLGVVLLELLTGMQPISHGKNIVREVNV 845 (958)
Q Consensus 769 DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~---~~DV~S~Gv~l~elltG~~P~~~~~~~~~~~~~ 845 (958)
|--++. +.....=.+.||+||.+...+.+. ++|+|||.+++||+.|...||.+-...+.-+..
T Consensus 336 d~kfsf--------------qe~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgmki 401 (448)
T KOG0195|consen 336 DTKFSF--------------QEVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMKI 401 (448)
T ss_pred cceeee--------------eccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhhh
Confidence 222211 111222357899999998776543 899999999999999999999876655443332
Q ss_pred HhhcCcchhhhcccCCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhH
Q 002158 846 ARDSGMVFSIIDNRMGSYPSECVERFVTLALRCCHDKPEHRPSMSDVVRELENIL 900 (958)
Q Consensus 846 ~~~~~~~~~~i~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~ 900 (958)
.. ......+|+.....+.+++.-|++.||.+||.++.|+-.|+++.
T Consensus 402 al---------eglrv~ippgis~hm~klm~icmnedpgkrpkfdmivpilekm~ 447 (448)
T KOG0195|consen 402 AL---------EGLRVHIPPGISRHMNKLMNICMNEDPGKRPKFDMIVPILEKMI 447 (448)
T ss_pred hh---------ccccccCCCCccHHHHHHHHHHhcCCCCcCCCcceehhhHHHhc
Confidence 21 22334568888999999999999999999999999999998864
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.92 E-value=4.8e-26 Score=243.98 Aligned_cols=259 Identities=21% Similarity=0.231 Sum_probs=196.7
Q ss_pred HHcCCCCCceeeeeCCeEEEEEEEC-CCcEEEEEEeccCChhcHHHHHHHHHHHHccC------CCCcceEEEEEEeCCe
Q 002158 623 ATAYFSSSTQVGQGGYGKVYKGILS-DNTTVAIKRAEEGSLQGQNEFLTEIKLLSRLH------HRNLVSLLGYCDEEGE 695 (958)
Q Consensus 623 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~------H~niv~l~~~~~~~~~ 695 (958)
--.+|.+....|+|-|++|.+|.+. .|..||||++.....- .+.=+.|+++|++++ .-|+++++-.|....+
T Consensus 430 LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~M-~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~hknH 508 (752)
T KOG0670|consen 430 LDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEVM-HKTGLKELEILKKLNDADPEDKFHCLRLFRHFKHKNH 508 (752)
T ss_pred hcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchHH-hhhhhHHHHHHHHhhccCchhhhHHHHHHHHhhhcce
Confidence 4567888888999999999999975 5889999999875332 233468999999994 4579999999999999
Q ss_pred EEEEEEecCCCCHHHHhccCC-CCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEecCC-CCeEEeeeeee
Q 002158 696 QMLVYEFVPNGTLRDWLSGRT-KENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSN-LNAKVADFGLS 773 (958)
Q Consensus 696 ~~lV~E~~~~gsL~~~l~~~~-~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~-~~~kl~DFGla 773 (958)
++||+|-+ .-+|.+.|+.-+ ...|....+..++.|+.-||..|-..+ |+|.||||.|||+++. ..+||||||.|
T Consensus 509 LClVFE~L-slNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~---vlHaDIKPDNiLVNE~k~iLKLCDfGSA 584 (752)
T KOG0670|consen 509 LCLVFEPL-SLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCG---VLHADIKPDNILVNESKNILKLCDFGSA 584 (752)
T ss_pred eEEEehhh-hchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcC---eeecccCccceEeccCcceeeeccCccc
Confidence 99999998 579999998644 345888999999999999999999999 9999999999999876 46899999998
Q ss_pred cccccCCCCCCccceeeeeccCCCCccChhhhccCCCCCcchhhhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcCcc-
Q 002158 774 RLAPVLDDEGTMPTHVSTIVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVLLELLTGMQPISHGKNIVREVNVARDSGMV- 852 (958)
Q Consensus 774 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gv~l~elltG~~P~~~~~~~~~~~~~~~~~~~~- 852 (958)
...... ..+..--+..|.|||++.+..|+...|+||.||+|||+.||+.-|.+..+-...-....-.+.+
T Consensus 585 ~~~~en---------eitPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me~KGk~p 655 (752)
T KOG0670|consen 585 SFASEN---------EITPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFMELKGKFP 655 (752)
T ss_pred cccccc---------cccHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcHHHHHHHHHhcCCCc
Confidence 764221 1122223456999999999999999999999999999999999887644311110000000000
Q ss_pred ------------------------------------hhhhc------------ccCCCCChHHHHHHHHHHHHccccCCC
Q 002158 853 ------------------------------------FSIID------------NRMGSYPSECVERFVTLALRCCHDKPE 884 (958)
Q Consensus 853 ------------------------------------~~~i~------------~~~~~~~~~~~~~l~~li~~cl~~dP~ 884 (958)
...+. +.++.-.......+.+|+.+|+..||+
T Consensus 656 ~KmlRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkml~LdP~ 735 (752)
T KOG0670|consen 656 NKMLRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKMLILDPE 735 (752)
T ss_pred HHHhhhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHHhccChh
Confidence 00000 001111224556788999999999999
Q ss_pred CCCCHHHHHHH
Q 002158 885 HRPSMSDVVRE 895 (958)
Q Consensus 885 ~RPs~~evl~~ 895 (958)
+|.+..+++++
T Consensus 736 KRit~nqAL~H 746 (752)
T KOG0670|consen 736 KRITVNQALKH 746 (752)
T ss_pred hcCCHHHHhcC
Confidence 99999998864
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.92 E-value=2e-25 Score=236.38 Aligned_cols=266 Identities=23% Similarity=0.377 Sum_probs=198.9
Q ss_pred HHHHHcCCCCCceeeeeCCeEEEEEEEC----CCcEEEEEEeccCChhcHHHHHHHHHHHHcc-CCCCcceEEEEEEeCC
Q 002158 620 LAMATAYFSSSTQVGQGGYGKVYKGILS----DNTTVAIKRAEEGSLQGQNEFLTEIKLLSRL-HHRNLVSLLGYCDEEG 694 (958)
Q Consensus 620 l~~~~~~~~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~ 694 (958)
.....+.|..+++||+|.|++||+|++. ..+.||+|.+...+ .-.+..+|+++|..+ .+.||+++.+++...+
T Consensus 31 ~p~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts--~p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd 108 (418)
T KOG1167|consen 31 IPFISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTS--SPSRILNELEMLYRLGGSDNIIKLNGCFRNND 108 (418)
T ss_pred hhhhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeeccccc--CchHHHHHHHHHHHhccchhhhcchhhhccCC
Confidence 4455667888999999999999999853 46789999987643 334688999999999 5999999999999999
Q ss_pred eEEEEEEecCCCCHHHHhccCCCCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEecC-CCCeEEeeeeee
Q 002158 695 EQMLVYEFVPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDS-NLNAKVADFGLS 773 (958)
Q Consensus 695 ~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~-~~~~kl~DFGla 773 (958)
...+|+||++...-.+++.. ++..++..+...+..||+++|..| ||||||||+|+|.+. -+.-.|.|||+|
T Consensus 109 ~v~ivlp~~~H~~f~~l~~~-----l~~~~i~~Yl~~ll~Al~~~h~~G---IvHRDiKpsNFL~n~~t~rg~LvDFgLA 180 (418)
T KOG1167|consen 109 QVAIVLPYFEHDRFRDLYRS-----LSLAEIRWYLRNLLKALAHLHKNG---IVHRDIKPSNFLYNRRTQRGVLVDFGLA 180 (418)
T ss_pred eeEEEecccCccCHHHHHhc-----CCHHHHHHHHHHHHHHhhhhhccC---ccccCCCccccccccccCCceEEechhH
Confidence 99999999999999998853 667889999999999999999999 999999999999975 467899999999
Q ss_pred cccccCC--------------C-CC----------------------CccceeeeeccCCCCccChhhhccC-CCCCcch
Q 002158 774 RLAPVLD--------------D-EG----------------------TMPTHVSTIVKGTPGYLDPEYFLTH-KLTDKSD 815 (958)
Q Consensus 774 ~~~~~~~--------------~-~~----------------------~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~D 815 (958)
..++... . .+ ...........||+||.|||++... ..++++|
T Consensus 181 ~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiD 260 (418)
T KOG1167|consen 181 QRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAID 260 (418)
T ss_pred HHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccc
Confidence 7321110 0 00 0001112235699999999999764 5788999
Q ss_pred hhhHHHHHHHHHhCCCCCCCCch----hHHHH--------H-HHhhcCc--chh---------------hhc-ccCC---
Q 002158 816 VYSLGVVLLELLTGMQPISHGKN----IVREV--------N-VARDSGM--VFS---------------IID-NRMG--- 861 (958)
Q Consensus 816 V~S~Gv~l~elltG~~P~~~~~~----~~~~~--------~-~~~~~~~--~~~---------------~i~-~~~~--- 861 (958)
|||.||+++-+++++.||....+ +.+.+ + .+.-.+. +.+ -++ +...
T Consensus 261 iws~GVI~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~~~ 340 (418)
T KOG1167|consen 261 IWSAGVILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIYKSR 340 (418)
T ss_pred eeeccceeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhccccc
Confidence 99999999999999999965332 11111 0 0111111 100 000 0000
Q ss_pred -------CCChHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 002158 862 -------SYPSECVERFVTLALRCCHDKPEHRPSMSDVVRE 895 (958)
Q Consensus 862 -------~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 895 (958)
......+..+.+++.+|++.||.+|-++++.+++
T Consensus 341 q~n~~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALkH 381 (418)
T KOG1167|consen 341 QPNTEREIGSDVFPALLLDLLDKCLELNPQKRITAEDALKH 381 (418)
T ss_pred ccceeeccccccccHHHHHHHHHHccCChhhcccHHHHhcC
Confidence 0111234578999999999999999999999864
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=5.1e-24 Score=236.28 Aligned_cols=268 Identities=21% Similarity=0.294 Sum_probs=205.8
Q ss_pred CCCCCceeeeeCCeEEEEEEECCC--cEEEEEEeccCChhcHHHHHHHHHHHHccCC----CCcceEEEEE-EeCCeEEE
Q 002158 626 YFSSSTQVGQGGYGKVYKGILSDN--TTVAIKRAEEGSLQGQNEFLTEIKLLSRLHH----RNLVSLLGYC-DEEGEQML 698 (958)
Q Consensus 626 ~~~~~~~lg~G~~g~Vy~~~~~~~--~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H----~niv~l~~~~-~~~~~~~l 698 (958)
.|.+.+.||+|+||.||.+..... ..+|+|............+..|+.++..+.+ +++..+++.. ..+...++
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~i 98 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFI 98 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEE
Confidence 788899999999999999997653 4788888765433322267789999998873 6899999999 57788999
Q ss_pred EEEecCCCCHHHHhccCCCCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEecCC-----CCeEEeeeeee
Q 002158 699 VYEFVPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSN-----LNAKVADFGLS 773 (958)
Q Consensus 699 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~-----~~~kl~DFGla 773 (958)
||+.+ |.+|.++........++..++++++.|++.+|+++|+.| ++||||||.|+++... ..+.|.|||++
T Consensus 99 VM~l~-G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~G---~iHRDiKp~N~~~g~~~~~~~~~~~llDfGla 174 (322)
T KOG1164|consen 99 VMSLL-GPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHSKG---FIHRDIKPENFVVGQSSRSEVRTLYLLDFGLA 174 (322)
T ss_pred EEecc-CccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhcC---cccCCcCHHHeeecCCCCcccceEEEEecCCC
Confidence 99999 889999886655567999999999999999999999999 9999999999999765 46999999999
Q ss_pred cccccCCCCC---CccceeeeeccCCCCccChhhhccCCCCCcchhhhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcC
Q 002158 774 RLAPVLDDEG---TMPTHVSTIVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVLLELLTGMQPISHGKNIVREVNVARDSG 850 (958)
Q Consensus 774 ~~~~~~~~~~---~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gv~l~elltG~~P~~~~~~~~~~~~~~~~~~ 850 (958)
+........+ ..+......+.||.+|.++....+.+.+++.|+||++.++.|++.|..||.................
T Consensus 175 r~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~~~~~~~~ 254 (322)
T KOG1164|consen 175 RRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDLKSKFEKDPR 254 (322)
T ss_pred ccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccchHHHHHHHhh
Confidence 8433222222 1112223457799999999999999999999999999999999999999965443222111111000
Q ss_pred cchhhhcccCCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHhhC
Q 002158 851 MVFSIIDNRMGSYPSECVERFVTLALRCCHDKPEHRPSMSDVVRELENILKMF 903 (958)
Q Consensus 851 ~~~~~i~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~ 903 (958)
.. .........+.++..+...+-..+..++|....+...+++.....
T Consensus 255 ---~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~l~~~~~~~ 301 (322)
T KOG1164|consen 255 ---KL---LTDRFGDLKPEEFAKILEYIDSLDYEDKPDYEKLAELLKDVFDSE 301 (322)
T ss_pred ---hh---ccccccCCChHHHHHHHHHhhccCCcCCCCHHHHHHHHHHHHHhc
Confidence 00 000022334567777777777799999999999999998887654
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.91 E-value=2.9e-25 Score=275.90 Aligned_cols=202 Identities=20% Similarity=0.265 Sum_probs=141.2
Q ss_pred ccCC-CCcceEEEEE-------EeCCeEEEEEEecCCCCHHHHhccCCCCCchHHHHHHHHHHHHHHHHHhhhcCCCCee
Q 002158 677 RLHH-RNLVSLLGYC-------DEEGEQMLVYEFVPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVF 748 (958)
Q Consensus 677 ~l~H-~niv~l~~~~-------~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ii 748 (958)
.++| +||.++++++ ...+..+++|||+ +++|+++|... ...+++.+++.++.||++||+|||+++ |+
T Consensus 28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~al~~lH~~g---Iv 102 (793)
T PLN00181 28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNP-DRSVDAFECFHVFRQIVEIVNAAHSQG---IV 102 (793)
T ss_pred hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcc-cccccHHHHHHHHHHHHHHHHHHHhCC---ee
Confidence 3445 5888888887 2334677889988 67999999743 345999999999999999999999999 99
Q ss_pred ccCCCccceEecCCC-------------------CeEEeeeeeecccccCCC---------CCCccceeeeeccCCCCcc
Q 002158 749 HRDIKASNILLDSNL-------------------NAKVADFGLSRLAPVLDD---------EGTMPTHVSTIVKGTPGYL 800 (958)
Q Consensus 749 H~Dikp~NILl~~~~-------------------~~kl~DFGla~~~~~~~~---------~~~~~~~~~~~~~gt~~y~ 800 (958)
||||||+|||++..+ .+|++|||+++....... .............||+.||
T Consensus 103 HrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~ 182 (793)
T PLN00181 103 VHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYT 182 (793)
T ss_pred eccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceE
Confidence 999999999996544 455666666543211000 0000000112245899999
Q ss_pred ChhhhccCCCCCcchhhhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcCcchhhhcccCCCCChHHHHHHHHHHHHccc
Q 002158 801 DPEYFLTHKLTDKSDVYSLGVVLLELLTGMQPISHGKNIVREVNVARDSGMVFSIIDNRMGSYPSECVERFVTLALRCCH 880 (958)
Q Consensus 801 aPE~~~~~~~~~~~DV~S~Gv~l~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~l~~li~~cl~ 880 (958)
|||++.+..++.++|||||||+||||++|..|+............ ....+ ...........++.+||+
T Consensus 183 APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~~~~~~~~~--------~~~~~----~~~~~~~~~~~~~~~~L~ 250 (793)
T PLN00181 183 SPEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKSRTMSSLRH--------RVLPP----QILLNWPKEASFCLWLLH 250 (793)
T ss_pred ChhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHHHHHHHHHH--------hhcCh----hhhhcCHHHHHHHHHhCC
Confidence 999999999999999999999999999998887532211111100 00000 011122345688899999
Q ss_pred cCCCCCCCHHHHHHH
Q 002158 881 DKPEHRPSMSDVVRE 895 (958)
Q Consensus 881 ~dP~~RPs~~evl~~ 895 (958)
.+|.+||++.|++++
T Consensus 251 ~~P~~Rps~~eil~h 265 (793)
T PLN00181 251 PEPSCRPSMSELLQS 265 (793)
T ss_pred CChhhCcChHHHhhc
Confidence 999999999999864
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.91 E-value=5.5e-24 Score=215.00 Aligned_cols=169 Identities=23% Similarity=0.281 Sum_probs=129.7
Q ss_pred CCHHHHhccCCCCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEecCCCCeEEeeeeeecccccCCCCCCc
Q 002158 706 GTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSRLAPVLDDEGTM 785 (958)
Q Consensus 706 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~ 785 (958)
|+|.++++... ..+++.++..++.|+++||+|||+++ ||+|||++.++.+|+ ||+++.....
T Consensus 1 GsL~~~l~~~~-~~l~~~~~~~i~~qi~~~L~~lH~~~---------kp~Nil~~~~~~~~~--fG~~~~~~~~------ 62 (176)
T smart00750 1 VSLADILEVRG-RPLNEEEIWAVCLQCLRALRELHRQA---------KSGNILLTWDGLLKL--DGSVAFKTPE------ 62 (176)
T ss_pred CcHHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhcC---------CcccEeEcCccceee--ccceEeeccc------
Confidence 78999997543 35999999999999999999999876 999999999999999 9998764221
Q ss_pred cceeeeeccCCCCccChhhhccCCCCCcchhhhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcCcchhhhcccCCCCCh
Q 002158 786 PTHVSTIVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVLLELLTGMQPISHGKNIVREVNVARDSGMVFSIIDNRMGSYPS 865 (958)
Q Consensus 786 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gv~l~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~ 865 (958)
...||+.|||||++.+..++.++|||||||++|||++|+.||................... ........+.
T Consensus 63 ------~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~ 133 (176)
T smart00750 63 ------QSRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELSAILEILLNGMPA---DDPRDRSNLE 133 (176)
T ss_pred ------cCCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHHHhcc---CCccccccHH
Confidence 1258899999999999999999999999999999999999997544332222221110000 0000011223
Q ss_pred HHHH--HHHHHHHHccccCCCCCCCHHHHHHHHHHhHh
Q 002158 866 ECVE--RFVTLALRCCHDKPEHRPSMSDVVRELENILK 901 (958)
Q Consensus 866 ~~~~--~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~ 901 (958)
.... .+.+++.+||+.+|++||++.|+++++.....
T Consensus 134 ~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~~~ 171 (176)
T smart00750 134 SVSAARSFADFMRVCASRLPQRREAANHYLAHCRALFA 171 (176)
T ss_pred HHHhhhhHHHHHHHHHhcccccccCHHHHHHHHHHHHH
Confidence 3444 69999999999999999999999999877653
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >KOG0472 consensus Leucine-rich repeat protein [Function unknown] | Back alignment and domain information |
|---|
Probab=99.91 E-value=4.8e-27 Score=244.81 Aligned_cols=265 Identities=26% Similarity=0.412 Sum_probs=217.7
Q ss_pred CcceeeccCcccCCCCccccCCCCCcEEEeeCCCCCCCCChhhcCCCCCCEEecccccccccCccccccccccceEeccc
Q 002158 111 RLQYYFMWNDLTGTIPKEIGNISSLIFLLLNGNKLSGSLPDELGYLSNLNRLQVDENNITGTIPKSFANLSRVRHLHLNN 190 (958)
Q Consensus 111 ~L~~L~l~n~~~~~ip~~i~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~ 190 (958)
.|+.|.+++|....+.+.+.++..|.+|++.+|+++ .+|.+++.+..++.|+.++|++. .+|..+..+.+|+.|++++
T Consensus 46 ~l~~lils~N~l~~l~~dl~nL~~l~vl~~~~n~l~-~lp~aig~l~~l~~l~vs~n~ls-~lp~~i~s~~~l~~l~~s~ 123 (565)
T KOG0472|consen 46 DLQKLILSHNDLEVLREDLKNLACLTVLNVHDNKLS-QLPAAIGELEALKSLNVSHNKLS-ELPEQIGSLISLVKLDCSS 123 (565)
T ss_pred chhhhhhccCchhhccHhhhcccceeEEEeccchhh-hCCHHHHHHHHHHHhhcccchHh-hccHHHhhhhhhhhhhccc
Confidence 344555555555556666777888888888888887 77778888888888888888887 7777888888888888888
Q ss_pred ccccccCchhhcCCccchhhhccCCccccCCCcccCCCCCccEEEccCCCCCCCCccccccCCCCCCEEEcccCCCCCCC
Q 002158 191 NSIGGQIPSELSKLSTLIHLLVDNNNLSGNLPPELSELPQLCILQLDNNNFSASEIPATYGNFSKLVKLSLRNCNLQGAV 270 (958)
Q Consensus 191 N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~p~~~~~l~~L~~L~L~~N~l~~~~ 270 (958)
|.+. .+|+.++.+..|+.|+..+|+++ ..|..+..+.+|..|++.+|++. .+|....+++.|++|+...|-++.+|
T Consensus 124 n~~~-el~~~i~~~~~l~dl~~~~N~i~-slp~~~~~~~~l~~l~~~~n~l~--~l~~~~i~m~~L~~ld~~~N~L~tlP 199 (565)
T KOG0472|consen 124 NELK-ELPDSIGRLLDLEDLDATNNQIS-SLPEDMVNLSKLSKLDLEGNKLK--ALPENHIAMKRLKHLDCNSNLLETLP 199 (565)
T ss_pred ccee-ecCchHHHHhhhhhhhccccccc-cCchHHHHHHHHHHhhccccchh--hCCHHHHHHHHHHhcccchhhhhcCC
Confidence 8888 66777888888888888888887 56777777888888888888885 45555555888888888888888888
Q ss_pred CCCCCCCCcCEEeccCCcCCCcCCCCCCCCCcCEEEccCCcCCCccchhccCCCCCCeEeeecccCCCccchhhhccccc
Q 002158 271 PDLSRIPNLYYLDLSWNHLTGSIPSKKLSENVTTIDLSDNYLNGSILESISNLPFLQTLSLENNFLTGSIPATIWQNKSF 350 (958)
Q Consensus 271 ~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~ip~~l~~~~~~ 350 (958)
++++.+.+|..|+|.+|++. .+|.+..+..|.+|+++.|+|+....+...++++|..|||.+|+++ ++|++++.+.++
T Consensus 200 ~~lg~l~~L~~LyL~~Nki~-~lPef~gcs~L~Elh~g~N~i~~lpae~~~~L~~l~vLDLRdNklk-e~Pde~clLrsL 277 (565)
T KOG0472|consen 200 PELGGLESLELLYLRRNKIR-FLPEFPGCSLLKELHVGENQIEMLPAEHLKHLNSLLVLDLRDNKLK-EVPDEICLLRSL 277 (565)
T ss_pred hhhcchhhhHHHHhhhcccc-cCCCCCccHHHHHHHhcccHHHhhHHHHhcccccceeeeccccccc-cCchHHHHhhhh
Confidence 88999999999999999998 7788888889999999999998666666779999999999999999 999999887654
Q ss_pred CccccceEeccCCCCCCCccCC-CCCCcceEEeCCCCCCC
Q 002158 351 STKARLKIDLRNNSFSNIVGDL-TLPNNVTLRLGGNPICT 389 (958)
Q Consensus 351 ~~~~l~~L~Ls~N~l~~l~~~~-~l~~L~~L~l~~N~l~~ 389 (958)
+.||+|+|.|+.++... ++ .|+.|-+.|||+.+
T Consensus 278 -----~rLDlSNN~is~Lp~sLgnl-hL~~L~leGNPlrT 311 (565)
T KOG0472|consen 278 -----ERLDLSNNDISSLPYSLGNL-HLKFLALEGNPLRT 311 (565)
T ss_pred -----hhhcccCCccccCCcccccc-eeeehhhcCCchHH
Confidence 49999999999999988 66 99999999999943
|
|
| >KOG4237 consensus Extracellular matrix protein slit, contains leucine-rich and EGF-like repeats [Extracellular structures; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=3e-26 Score=238.97 Aligned_cols=298 Identities=21% Similarity=0.244 Sum_probs=149.9
Q ss_pred EEEeeCCCCCCCCChhhcCCCCCCEEecccccccccCccccccccccceEeccc-ccccccCchhhcCCccchhhhccCC
Q 002158 137 FLLLNGNKLSGSLPDELGYLSNLNRLQVDENNITGTIPKSFANLSRVRHLHLNN-NSIGGQIPSELSKLSTLIHLLVDNN 215 (958)
Q Consensus 137 ~L~Ls~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~-N~l~~~~p~~l~~l~~L~~L~L~~N 215 (958)
.|+|..|.|+.+.|.+|+.+++|++|||++|+|+.+-|++|.++.+|..|-+-+ |+|+...-+.|++|.+|+.|.+.-|
T Consensus 71 eirLdqN~I~~iP~~aF~~l~~LRrLdLS~N~Is~I~p~AF~GL~~l~~Lvlyg~NkI~~l~k~~F~gL~slqrLllNan 150 (498)
T KOG4237|consen 71 EIRLDQNQISSIPPGAFKTLHRLRRLDLSKNNISFIAPDAFKGLASLLSLVLYGNNKITDLPKGAFGGLSSLQRLLLNAN 150 (498)
T ss_pred EEEeccCCcccCChhhccchhhhceecccccchhhcChHhhhhhHhhhHHHhhcCCchhhhhhhHhhhHHHHHHHhcChh
Confidence 344444444433333444444444444444444444444444444443333222 4444333334444444444444444
Q ss_pred ccccCCCcccCCCCCccEEEccCCCCCCCCccc-cccCCCCCCEEEcccCCCCC------------C-CCCCCCCCCcCE
Q 002158 216 NLSGNLPPELSELPQLCILQLDNNNFSASEIPA-TYGNFSKLVKLSLRNCNLQG------------A-VPDLSRIPNLYY 281 (958)
Q Consensus 216 ~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~p~-~~~~l~~L~~L~L~~N~l~~------------~-~~~l~~l~~L~~ 281 (958)
++.-...+.|..+++|..|.+.+|.+. .++. .|..+..++.+++..|.+-. . +..++...-..-
T Consensus 151 ~i~Cir~~al~dL~~l~lLslyDn~~q--~i~~~tf~~l~~i~tlhlA~np~icdCnL~wla~~~a~~~ietsgarc~~p 228 (498)
T KOG4237|consen 151 HINCIRQDALRDLPSLSLLSLYDNKIQ--SICKGTFQGLAAIKTLHLAQNPFICDCNLPWLADDLAMNPIETSGARCVSP 228 (498)
T ss_pred hhcchhHHHHHHhhhcchhcccchhhh--hhccccccchhccchHhhhcCccccccccchhhhHHhhchhhcccceecch
Confidence 444444444444444444444444442 2222 44444444444444443110 0 011333333333
Q ss_pred EeccCCcCCCcCCCCCCCCCcCEE----EccCCcCCCccchhccCCCCCCeEeeecccCCCccchhhhcccccCccccce
Q 002158 282 LDLSWNHLTGSIPSKKLSENVTTI----DLSDNYLNGSILESISNLPFLQTLSLENNFLTGSIPATIWQNKSFSTKARLK 357 (958)
Q Consensus 282 L~Ls~N~l~~~~~~~~~~~~L~~L----~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~ip~~l~~~~~~~~~~l~~ 357 (958)
..|.++++. .++...+...++.+ ....+.........|..|++|+.|+|++|+|++.-+.++.+.. .++.
T Consensus 229 ~rl~~~Ri~-q~~a~kf~c~~esl~s~~~~~d~~d~~cP~~cf~~L~~L~~lnlsnN~i~~i~~~aFe~~a-----~l~e 302 (498)
T KOG4237|consen 229 YRLYYKRIN-QEDARKFLCSLESLPSRLSSEDFPDSICPAKCFKKLPNLRKLNLSNNKITRIEDGAFEGAA-----ELQE 302 (498)
T ss_pred HHHHHHHhc-ccchhhhhhhHHhHHHhhccccCcCCcChHHHHhhcccceEeccCCCccchhhhhhhcchh-----hhhh
Confidence 334444443 22222222112211 1222222323334466666666666666666644444443332 2335
Q ss_pred EeccCCCCCCCccCC--CCCCcceEEeCCCCCCCCCCCCCCCcccccCCCCCccccccCCCCCCCCCCCCCcccccCCCC
Q 002158 358 IDLRNNSFSNIVGDL--TLPNNVTLRLGGNPICTSANIPNTGRFCGSDAGGDETLTNSKVNCPVQACPVDNFFEYVPASP 435 (958)
Q Consensus 358 L~Ls~N~l~~l~~~~--~l~~L~~L~l~~N~l~~~~~~~~~~~~~~~~~~~~~~L~~n~~~C~c~~~~~~~~~~~~~~~~ 435 (958)
|.|..|+|..+.... ++.+|+.|+|.||+++|.. .+.|-.....+.+.|-+|||.|+|.+.|+..|++... ..
T Consensus 303 L~L~~N~l~~v~~~~f~~ls~L~tL~L~~N~it~~~----~~aF~~~~~l~~l~l~~Np~~CnC~l~wl~~Wlr~~~-~~ 377 (498)
T KOG4237|consen 303 LYLTRNKLEFVSSGMFQGLSGLKTLSLYDNQITTVA----PGAFQTLFSLSTLNLLSNPFNCNCRLAWLGEWLRKKS-VV 377 (498)
T ss_pred hhcCcchHHHHHHHhhhccccceeeeecCCeeEEEe----cccccccceeeeeehccCcccCccchHHHHHHHhhCC-CC
Confidence 666666666665544 6777777777777776633 2344445556677788888899999999999999887 66
Q ss_pred CCceeeeeceee
Q 002158 436 EPCFCAAPLRIG 447 (958)
Q Consensus 436 ~~~~c~sp~~~~ 447 (958)
+...|++|..++
T Consensus 378 ~~~~Cq~p~~~~ 389 (498)
T KOG4237|consen 378 GNPRCQSPGFVR 389 (498)
T ss_pred CCCCCCCCchhc
Confidence 668899996554
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=4.8e-24 Score=208.62 Aligned_cols=266 Identities=21% Similarity=0.297 Sum_probs=212.3
Q ss_pred cCCCCCceeeeeCCeEEEEEEE-CCCcEEEEEEeccCChhcHHHHHHHHHHHHccCC-CCcceEEEEEEeCCeEEEEEEe
Q 002158 625 AYFSSSTQVGQGGYGKVYKGIL-SDNTTVAIKRAEEGSLQGQNEFLTEIKLLSRLHH-RNLVSLLGYCDEEGEQMLVYEF 702 (958)
Q Consensus 625 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H-~niv~l~~~~~~~~~~~lV~E~ 702 (958)
..|..++.||+|+||.+|.|.. .+|..||||+-...... ..+..|..+++.++| ..|..+.-|..+...-.+|||.
T Consensus 15 gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~h--pqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlVMdL 92 (341)
T KOG1163|consen 15 GKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAKH--PQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLVMDL 92 (341)
T ss_pred cceEEEEeecCCchhheeeeeeccCCceEEEEeecccCCC--cchhHHHHHHHHhccCCCCchhhhhccccccceeeeec
Confidence 4677889999999999999984 58999999987654322 246789999999975 6788888888888899999999
Q ss_pred cCCCCHHHHhccCCCCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEecC---CCCeEEeeeeeecccccC
Q 002158 703 VPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDS---NLNAKVADFGLSRLAPVL 779 (958)
Q Consensus 703 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~---~~~~kl~DFGla~~~~~~ 779 (958)
. |.+|.+++.-+.+ .++..+++-++.|++.-++|+|.++ +|||||||+|+|..- ...+.++|||+|+.+...
T Consensus 93 L-GPsLEdLfnfC~R-~ftmkTvLMLaDQml~RiEyvH~r~---fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~d~ 167 (341)
T KOG1163|consen 93 L-GPSLEDLFNFCSR-RFTMKTVLMLADQMLSRIEYVHLRN---FIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYRDI 167 (341)
T ss_pred c-CccHHHHHHHHhh-hhhHHhHHHHHHHHHHHHHHHHhhc---cccccCCccceeeccccccceEEEEeccchhhhccc
Confidence 9 7899999875543 3999999999999999999999999 999999999999953 456899999999988766
Q ss_pred CCCCCccceeeeeccCCCCccChhhhccCCCCCcchhhhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcCcchhhhccc
Q 002158 780 DDEGTMPTHVSTIVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVLLELLTGMQPISHGKNIVREVNVARDSGMVFSIIDNR 859 (958)
Q Consensus 780 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gv~l~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~i~~~ 859 (958)
......+........||.+|.+-....+.+.+.+.|+-|+|.+|.++--|..||.+-..-...-. ...+....
T Consensus 168 ~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QK-------yEkI~EkK 240 (341)
T KOG1163|consen 168 RTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQK-------YEKISEKK 240 (341)
T ss_pred cccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhhHHHH-------HHHHHHhh
Confidence 66666666677788899999999999999999999999999999999999999986543211110 11111111
Q ss_pred C----CCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHhhCC
Q 002158 860 M----GSYPSECVERFVTLALRCCHDKPEHRPSMSDVVRELENILKMFP 904 (958)
Q Consensus 860 ~----~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~~ 904 (958)
+ .......|.++.-.+..|-..--++-|...-+-+...-+.....
T Consensus 241 ~s~~ie~LC~G~P~EF~myl~Y~R~L~F~E~Pdy~ylrqlFriLfr~ln 289 (341)
T KOG1163|consen 241 MSTPIEVLCKGFPAEFAMYLNYCRGLGFEEKPDYMYLRQLFRILFRTLN 289 (341)
T ss_pred cCCCHHHHhCCCcHHHHHHHHHHhhcCCCCCCcHHHHHHHHHHHHhhcc
Confidence 1 12234567888889999999999999998877776666655444
|
|
| >KOG0472 consensus Leucine-rich repeat protein [Function unknown] | Back alignment and domain information |
|---|
Probab=99.91 E-value=2.9e-26 Score=239.05 Aligned_cols=193 Identities=28% Similarity=0.399 Sum_probs=128.7
Q ss_pred EEEccCCcCCCCccccccCCCCcceeeccCcccCCCCccccCCCCCcEEEeeCCCCCCCCChhhcCCCCCCEEecccccc
Q 002158 90 ELQLLSMNLSGNLAPELGQLSRLQYYFMWNDLTGTIPKEIGNISSLIFLLLNGNKLSGSLPDELGYLSNLNRLQVDENNI 169 (958)
Q Consensus 90 ~L~L~~~~l~~~~~~~l~~L~~L~~L~l~n~~~~~ip~~i~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~L~~N~l 169 (958)
.++.+.|.+. .++++++++..|..|+..||.+.++|++++++.+|..|++.+|++. .+|...-+++.|++||+..|-+
T Consensus 118 ~l~~s~n~~~-el~~~i~~~~~l~dl~~~~N~i~slp~~~~~~~~l~~l~~~~n~l~-~l~~~~i~m~~L~~ld~~~N~L 195 (565)
T KOG0472|consen 118 KLDCSSNELK-ELPDSIGRLLDLEDLDATNNQISSLPEDMVNLSKLSKLDLEGNKLK-ALPENHIAMKRLKHLDCNSNLL 195 (565)
T ss_pred hhhcccccee-ecCchHHHHhhhhhhhccccccccCchHHHHHHHHHHhhccccchh-hCCHHHHHHHHHHhcccchhhh
Confidence 3444444443 2445566666666666666666666666666666666666666666 3343333466677777777666
Q ss_pred cccCccccccccccceEecccccccccCchhhcCCccchhhhccCCccccCCCcccCCCCCccEEEccCCCCCCCCcccc
Q 002158 170 TGTIPKSFANLSRVRHLHLNNNSIGGQIPSELSKLSTLIHLLVDNNNLSGNLPPELSELPQLCILQLDNNNFSASEIPAT 249 (958)
Q Consensus 170 ~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~p~~ 249 (958)
+ .+|+.++.+.+|..|+|.+|+|. .+| .|.++..|++|+++.|+|+-.......++++|..|||.+|+++ +.|+.
T Consensus 196 ~-tlP~~lg~l~~L~~LyL~~Nki~-~lP-ef~gcs~L~Elh~g~N~i~~lpae~~~~L~~l~vLDLRdNklk--e~Pde 270 (565)
T KOG0472|consen 196 E-TLPPELGGLESLELLYLRRNKIR-FLP-EFPGCSLLKELHVGENQIEMLPAEHLKHLNSLLVLDLRDNKLK--EVPDE 270 (565)
T ss_pred h-cCChhhcchhhhHHHHhhhcccc-cCC-CCCccHHHHHHHhcccHHHhhHHHHhcccccceeeeccccccc--cCchH
Confidence 6 66667777777777777777776 555 5777777777777777776333333447777888888888874 56777
Q ss_pred ccCCCCCCEEEcccCCCCCCCCCCCCCCCcCEEeccCCcCC
Q 002158 250 YGNFSKLVKLSLRNCNLQGAVPDLSRIPNLYYLDLSWNHLT 290 (958)
Q Consensus 250 ~~~l~~L~~L~L~~N~l~~~~~~l~~l~~L~~L~Ls~N~l~ 290 (958)
+.-+.+|+.|++++|.|++.+..++++ +|+.|-+.+|.+.
T Consensus 271 ~clLrsL~rLDlSNN~is~Lp~sLgnl-hL~~L~leGNPlr 310 (565)
T KOG0472|consen 271 ICLLRSLERLDLSNNDISSLPYSLGNL-HLKFLALEGNPLR 310 (565)
T ss_pred HHHhhhhhhhcccCCccccCCcccccc-eeeehhhcCCchH
Confidence 777777888888888888777777777 7777777777654
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.9e-23 Score=212.16 Aligned_cols=265 Identities=19% Similarity=0.273 Sum_probs=214.8
Q ss_pred CCCCCceeeeeCCeEEEEEEE-CCCcEEEEEEeccCChhcHHHHHHHHHHHHcc-CCCCcceEEEEEEeCCeEEEEEEec
Q 002158 626 YFSSSTQVGQGGYGKVYKGIL-SDNTTVAIKRAEEGSLQGQNEFLTEIKLLSRL-HHRNLVSLLGYCDEEGEQMLVYEFV 703 (958)
Q Consensus 626 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lV~E~~ 703 (958)
.|.+.++||+|.||+++.|+. -++++||||.-...+ +..++..|.+.++.+ ..+.|...+-+...+.+-.||||++
T Consensus 29 hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS--~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVidLL 106 (449)
T KOG1165|consen 29 HYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKS--EAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVIDLL 106 (449)
T ss_pred cceeccccccCcceeeecccccccCceEEEEeccccC--CcchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhhhhh
Confidence 677889999999999999984 379999999765432 223466788888888 4789999998888888889999999
Q ss_pred CCCCHHHHhccCCCCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEecCC-----CCeEEeeeeeeccccc
Q 002158 704 PNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSN-----LNAKVADFGLSRLAPV 778 (958)
Q Consensus 704 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~-----~~~kl~DFGla~~~~~ 778 (958)
|-+|.|++.-+++ .++..+++.+|.|++.-++|+|++. +|.|||||+|+||... ..+.++|||+|+.+..
T Consensus 107 -GPSLEDLFD~CgR-~FSvKTV~miA~Qmi~rie~vH~k~---LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~YrD 181 (449)
T KOG1165|consen 107 -GPSLEDLFDLCGR-RFSVKTVAMIAKQMITRIEYVHEKD---LIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEYRD 181 (449)
T ss_pred -CcCHHHHHHHhcC-cccHHhHHHHHHHHHHHHHHHHhcc---eeecccCccceeecCCCCCCCceEEEEeccchhhhcC
Confidence 7899998876554 4999999999999999999999999 9999999999999643 4589999999999987
Q ss_pred CCCCCCccceeeeeccCCCCccChhhhccCCCCCcchhhhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcCcchhhhc-
Q 002158 779 LDDEGTMPTHVSTIVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVLLELLTGMQPISHGKNIVREVNVARDSGMVFSIID- 857 (958)
Q Consensus 779 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gv~l~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~i~- 857 (958)
.......|........||.+||+-....+.+.+.+.|.-|+|-++.+.+-|..||.+-+....-.+ ++.|.
T Consensus 182 p~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK~k--------YeKIGe 253 (449)
T KOG1165|consen 182 PKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKADTNKEK--------YEKIGE 253 (449)
T ss_pred ccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCcchHHH--------HHHhcc
Confidence 777777777777888999999999999999999999999999999999999999986543211110 11111
Q ss_pred ccC----CCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHhhCCC
Q 002158 858 NRM----GSYPSECVERFVTLALRCCHDKPEHRPSMSDVVRELENILKMFPE 905 (958)
Q Consensus 858 ~~~----~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~~~ 905 (958)
... ..+....|.++..-+...-..+-.+-|..+-+...+.++++....
T Consensus 254 ~Kr~T~i~~Lc~g~P~efa~Yl~yvR~L~F~E~PDYdylr~Lf~dvldr~g~ 305 (449)
T KOG1165|consen 254 TKRSTPIEVLCEGFPEEFATYLRYVRRLDFFETPDYDYLRKLFDDVLDRLGE 305 (449)
T ss_pred ccccCCHHHHHhcCHHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHHHhcCC
Confidence 111 112234677888888888889999999999988888888876654
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.3e-23 Score=229.63 Aligned_cols=173 Identities=17% Similarity=0.160 Sum_probs=132.8
Q ss_pred HHHHcCCCCCceeeeeCCeEEEEEEEC--CCcEEEEEEeccC-----ChhcHHHHHHHHHHHHccCCCCcceEEEEEEeC
Q 002158 621 AMATAYFSSSTQVGQGGYGKVYKGILS--DNTTVAIKRAEEG-----SLQGQNEFLTEIKLLSRLHHRNLVSLLGYCDEE 693 (958)
Q Consensus 621 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~--~~~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~ 693 (958)
.....+|...+.||+|+||+||+|.++ +++.||||++... .....+.|.+|++++++++|+|+++.+.. .
T Consensus 14 ~~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~---~ 90 (365)
T PRK09188 14 PALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLA---T 90 (365)
T ss_pred ccccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEE---c
Confidence 334567999999999999999999875 5778899987533 12234568999999999999999853322 2
Q ss_pred CeEEEEEEecCCCCHHHHhccCCCCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCC-CccceEecCCCCeEEeeeee
Q 002158 694 GEQMLVYEFVPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDI-KASNILLDSNLNAKVADFGL 772 (958)
Q Consensus 694 ~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Di-kp~NILl~~~~~~kl~DFGl 772 (958)
+..++||||++|++|... ... . ...++.|+++||+|||+.+ |+|||| ||+|||++.++.+||+|||+
T Consensus 91 ~~~~LVmE~~~G~~L~~~-~~~-~-------~~~~~~~i~~aL~~lH~~g---IiHrDL~KP~NILv~~~~~ikLiDFGl 158 (365)
T PRK09188 91 GKDGLVRGWTEGVPLHLA-RPH-G-------DPAWFRSAHRALRDLHRAG---ITHNDLAKPQNWLMGPDGEAAVIDFQL 158 (365)
T ss_pred CCcEEEEEccCCCCHHHh-Ccc-c-------hHHHHHHHHHHHHHHHHCC---CeeCCCCCcceEEEcCCCCEEEEECcc
Confidence 468999999999999732 111 1 1467889999999999999 999999 99999999999999999999
Q ss_pred ecccccCCCCCCccc-eeeeeccCCCCccChhhhccC
Q 002158 773 SRLAPVLDDEGTMPT-HVSTIVKGTPGYLDPEYFLTH 808 (958)
Q Consensus 773 a~~~~~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~ 808 (958)
|+.+......+.... ..-....+++.|+|||++...
T Consensus 159 A~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~ 195 (365)
T PRK09188 159 ASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTPR 195 (365)
T ss_pred ceecccCcchhhhhhhhhhhhhhccCccCCcccCChh
Confidence 997754332222211 112456789999999998654
|
|
| >PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.3e-21 Score=232.48 Aligned_cols=256 Identities=26% Similarity=0.313 Sum_probs=205.7
Q ss_pred eEEEEccCCcCCCCccccccCCCCcceeeccCcccCCCCccccCCCCCcEEEeeCCCCCCCCChhhcCCCCCCEEecccc
Q 002158 88 VRELQLLSMNLSGNLAPELGQLSRLQYYFMWNDLTGTIPKEIGNISSLIFLLLNGNKLSGSLPDELGYLSNLNRLQVDEN 167 (958)
Q Consensus 88 v~~L~L~~~~l~~~~~~~l~~L~~L~~L~l~n~~~~~ip~~i~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~L~~N 167 (958)
-..|+|++++++ .+|+.+. ++|+.|.+.+|....+|.. +++|++|+|++|+|+ .+|.. .++|+.|+|++|
T Consensus 203 ~~~LdLs~~~Lt-sLP~~l~--~~L~~L~L~~N~Lt~LP~l---p~~Lk~LdLs~N~Lt-sLP~l---p~sL~~L~Ls~N 272 (788)
T PRK15387 203 NAVLNVGESGLT-TLPDCLP--AHITTLVIPDNNLTSLPAL---PPELRTLEVSGNQLT-SLPVL---PPGLLELSIFSN 272 (788)
T ss_pred CcEEEcCCCCCC-cCCcchh--cCCCEEEccCCcCCCCCCC---CCCCcEEEecCCccC-cccCc---ccccceeeccCC
Confidence 456899999998 5777776 4899999998888888863 578999999999999 66753 468999999999
Q ss_pred cccccCccccccccccceEecccccccccCchhhcCCccchhhhccCCccccCCCcccCCCCCccEEEccCCCCCCCCcc
Q 002158 168 NITGTIPKSFANLSRVRHLHLNNNSIGGQIPSELSKLSTLIHLLVDNNNLSGNLPPELSELPQLCILQLDNNNFSASEIP 247 (958)
Q Consensus 168 ~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~p 247 (958)
.++ .+|..+ ++|+.|+|++|+|+ .+|. .+++|+.|+|++|+|++ +|.. ..+|+.|++++|+++ .+|
T Consensus 273 ~L~-~Lp~lp---~~L~~L~Ls~N~Lt-~LP~---~p~~L~~LdLS~N~L~~-Lp~l---p~~L~~L~Ls~N~L~--~LP 338 (788)
T PRK15387 273 PLT-HLPALP---SGLCKLWIFGNQLT-SLPV---LPPGLQELSVSDNQLAS-LPAL---PSELCKLWAYNNQLT--SLP 338 (788)
T ss_pred chh-hhhhch---hhcCEEECcCCccc-cccc---cccccceeECCCCcccc-CCCC---cccccccccccCccc--ccc
Confidence 998 455433 57889999999999 5665 34789999999999996 4432 256889999999996 356
Q ss_pred ccccCCCCCCEEEcccCCCCCCCCCCCCCCCcCEEeccCCcCCCcCCCCCCCCCcCEEEccCCcCCCccchhccCCCCCC
Q 002158 248 ATYGNFSKLVKLSLRNCNLQGAVPDLSRIPNLYYLDLSWNHLTGSIPSKKLSENVTTIDLSDNYLNGSILESISNLPFLQ 327 (958)
Q Consensus 248 ~~~~~l~~L~~L~L~~N~l~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~~~L~~L~Ls~N~l~~~~~~~~~~l~~L~ 327 (958)
.. ..+|+.|+|++|+|+++++. ..+|+.|++++|+|+ .+|.. ..+|+.|+|++|+|++. |.. .++|+
T Consensus 339 ~l---p~~Lq~LdLS~N~Ls~LP~l---p~~L~~L~Ls~N~L~-~LP~l--~~~L~~LdLs~N~Lt~L-P~l---~s~L~ 405 (788)
T PRK15387 339 TL---PSGLQELSVSDNQLASLPTL---PSELYKLWAYNNRLT-SLPAL--PSGLKELIVSGNRLTSL-PVL---PSELK 405 (788)
T ss_pred cc---ccccceEecCCCccCCCCCC---Ccccceehhhccccc-cCccc--ccccceEEecCCcccCC-CCc---ccCCC
Confidence 42 25799999999999986643 357889999999998 45643 46899999999999963 432 36899
Q ss_pred eEeeecccCCCccchhhhcccccCccccceEeccCCCCCCCccCC-CCCCcceEEeCCCCCCC
Q 002158 328 TLSLENNFLTGSIPATIWQNKSFSTKARLKIDLRNNSFSNIVGDL-TLPNNVTLRLGGNPICT 389 (958)
Q Consensus 328 ~L~L~~N~l~~~ip~~l~~~~~~~~~~l~~L~Ls~N~l~~l~~~~-~l~~L~~L~l~~N~l~~ 389 (958)
.|+|++|+|+ .+|... ..+..|+|++|+|+.+|... .+++|+.|+|++|+|+.
T Consensus 406 ~LdLS~N~Ls-sIP~l~--------~~L~~L~Ls~NqLt~LP~sl~~L~~L~~LdLs~N~Ls~ 459 (788)
T PRK15387 406 ELMVSGNRLT-SLPMLP--------SGLLSLSVYRNQLTRLPESLIHLSSETTVNLEGNPLSE 459 (788)
T ss_pred EEEccCCcCC-CCCcch--------hhhhhhhhccCcccccChHHhhccCCCeEECCCCCCCc
Confidence 9999999998 577532 24668999999999999876 89999999999999964
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.86 E-value=3.2e-20 Score=206.54 Aligned_cols=258 Identities=30% Similarity=0.488 Sum_probs=198.8
Q ss_pred CCCCceeeeeCCeEEEEEEECCCcEEEEEEeccCChh---cHHHHHHHHHHHHccCCC-CcceEEEEEEeCCeEEEEEEe
Q 002158 627 FSSSTQVGQGGYGKVYKGILSDNTTVAIKRAEEGSLQ---GQNEFLTEIKLLSRLHHR-NLVSLLGYCDEEGEQMLVYEF 702 (958)
Q Consensus 627 ~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~H~-niv~l~~~~~~~~~~~lV~E~ 702 (958)
|...+.||.|+||.||++.+. ..+++|.+...... ....|.+|+.+++.+.|+ +++++.+++......++++||
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~--~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 79 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEY 79 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec--cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEec
Confidence 556678999999999999986 78999988765333 366799999999999988 799999999877778999999
Q ss_pred cCCCCHHHHhccCCC-CCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEecCCC-CeEEeeeeeecccccCC
Q 002158 703 VPNGTLRDWLSGRTK-ENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSNL-NAKVADFGLSRLAPVLD 780 (958)
Q Consensus 703 ~~~gsL~~~l~~~~~-~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~~-~~kl~DFGla~~~~~~~ 780 (958)
+.++++.+++..... ..+.......+..|++.+++|+|+.+ ++|||+||+||+++..+ .++++|||.++......
T Consensus 80 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~---~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~ 156 (384)
T COG0515 80 VDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKG---IIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPG 156 (384)
T ss_pred CCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeeecCCCCeEEEeccCcceecCCCC
Confidence 999999977764432 25888999999999999999999999 99999999999999988 79999999998543322
Q ss_pred CCCCccceeeeeccCCCCccChhhhcc---CCCCCcchhhhHHHHHHHHHhCCCCCCCCch---hHHHHHHHhhcCcchh
Q 002158 781 DEGTMPTHVSTIVKGTPGYLDPEYFLT---HKLTDKSDVYSLGVVLLELLTGMQPISHGKN---IVREVNVARDSGMVFS 854 (958)
Q Consensus 781 ~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DV~S~Gv~l~elltG~~P~~~~~~---~~~~~~~~~~~~~~~~ 854 (958)
...... .......||..|+|||.+.+ ..+....|+||+|++++++++|..||..... ..............
T Consensus 157 ~~~~~~-~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~-- 233 (384)
T COG0515 157 STSSIP-ALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTP-- 233 (384)
T ss_pred cccccc-ccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhcCCc--
Confidence 111000 12345679999999999987 5788899999999999999999999765442 12222111111110
Q ss_pred hhcccCCCCC----hHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 002158 855 IIDNRMGSYP----SECVERFVTLALRCCHDKPEHRPSMSDVVRE 895 (958)
Q Consensus 855 ~i~~~~~~~~----~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 895 (958)
....... ......+.+++..|+..+|..|.+..+....
T Consensus 234 ---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~ 275 (384)
T COG0515 234 ---SLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSH 275 (384)
T ss_pred ---ccccccCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence 0000111 1223578899999999999999999887765
|
|
| >KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.86 E-value=1.3e-23 Score=240.29 Aligned_cols=197 Identities=24% Similarity=0.237 Sum_probs=117.5
Q ss_pred cchhhhccCCccccCCCcccCCCCCccEEEccCCCCCCCCccccccCCCCCCEEEcccCCCCCCCCCCCCCCCcCEEecc
Q 002158 206 TLIHLLVDNNNLSGNLPPELSELPQLCILQLDNNNFSASEIPATYGNFSKLVKLSLRNCNLQGAVPDLSRIPNLYYLDLS 285 (958)
Q Consensus 206 ~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~l~~l~~L~~L~Ls 285 (958)
+|+++++++|++++ +|+++..+.+|+.|+..+|+++ .+|..+...++|+.|.+.+|.+..+++.+..++.|+.|+|.
T Consensus 242 nl~~~dis~n~l~~-lp~wi~~~~nle~l~~n~N~l~--~lp~ri~~~~~L~~l~~~~nel~yip~~le~~~sL~tLdL~ 318 (1081)
T KOG0618|consen 242 NLQYLDISHNNLSN-LPEWIGACANLEALNANHNRLV--ALPLRISRITSLVSLSAAYNELEYIPPFLEGLKSLRTLDLQ 318 (1081)
T ss_pred cceeeecchhhhhc-chHHHHhcccceEecccchhHH--hhHHHHhhhhhHHHHHhhhhhhhhCCCcccccceeeeeeeh
Confidence 45666677777774 4578888888888888888874 45555555555555555555555555555555555555555
Q ss_pred CCcCC-------------------------------------------------C-cCCCCCCCCCcCEEEccCCcCCCc
Q 002158 286 WNHLT-------------------------------------------------G-SIPSKKLSENVTTIDLSDNYLNGS 315 (958)
Q Consensus 286 ~N~l~-------------------------------------------------~-~~~~~~~~~~L~~L~Ls~N~l~~~ 315 (958)
.|+|. . .+|.....++|+.|+|++|+|...
T Consensus 319 ~N~L~~lp~~~l~v~~~~l~~ln~s~n~l~~lp~~~e~~~~~Lq~LylanN~Ltd~c~p~l~~~~hLKVLhLsyNrL~~f 398 (1081)
T KOG0618|consen 319 SNNLPSLPDNFLAVLNASLNTLNVSSNKLSTLPSYEENNHAALQELYLANNHLTDSCFPVLVNFKHLKVLHLSYNRLNSF 398 (1081)
T ss_pred hccccccchHHHhhhhHHHHHHhhhhccccccccccchhhHHHHHHHHhcCcccccchhhhccccceeeeeecccccccC
Confidence 55544 2 123333445677777777777766
Q ss_pred cchhccCCCCCCeEeeecccCCCccchhhhcccccCccccceEeccCCCCCCCccCCCCCCcceEEeCCCCCCCCCCCCC
Q 002158 316 ILESISNLPFLQTLSLENNFLTGSIPATIWQNKSFSTKARLKIDLRNNSFSNIVGDLTLPNNVTLRLGGNPICTSANIPN 395 (958)
Q Consensus 316 ~~~~~~~l~~L~~L~L~~N~l~~~ip~~l~~~~~~~~~~l~~L~Ls~N~l~~l~~~~~l~~L~~L~l~~N~l~~~~~~~~ 395 (958)
....+.+++.|++|+||+|+|+ .+|..+..+.. |.+|...+|+|..+|+...++.|+.+|++-|.++-..-
T Consensus 399 pas~~~kle~LeeL~LSGNkL~-~Lp~tva~~~~-----L~tL~ahsN~l~~fPe~~~l~qL~~lDlS~N~L~~~~l--- 469 (1081)
T KOG0618|consen 399 PASKLRKLEELEELNLSGNKLT-TLPDTVANLGR-----LHTLRAHSNQLLSFPELAQLPQLKVLDLSCNNLSEVTL--- 469 (1081)
T ss_pred CHHHHhchHHhHHHhcccchhh-hhhHHHHhhhh-----hHHHhhcCCceeechhhhhcCcceEEecccchhhhhhh---
Confidence 6666677777777777777776 66666655433 33555555555555544466666666666666643110
Q ss_pred CCcccccCCCCCccccccCC
Q 002158 396 TGRFCGSDAGGDETLTNSKV 415 (958)
Q Consensus 396 ~~~~~~~~~~~~~~L~~n~~ 415 (958)
.....++..+.+.|+||.|
T Consensus 470 -~~~~p~p~LkyLdlSGN~~ 488 (1081)
T KOG0618|consen 470 -PEALPSPNLKYLDLSGNTR 488 (1081)
T ss_pred -hhhCCCcccceeeccCCcc
Confidence 0111224555666777775
|
|
| >PRK15370 E3 ubiquitin-protein ligase SlrP; Provisional | Back alignment and domain information |
|---|
Probab=99.86 E-value=9e-21 Score=226.94 Aligned_cols=246 Identities=26% Similarity=0.397 Sum_probs=192.3
Q ss_pred CCcceeeccCcccCCCCccccCCCCCcEEEeeCCCCCCCCChhhcCCCCCCEEecccccccccCccccccccccceEecc
Q 002158 110 SRLQYYFMWNDLTGTIPKEIGNISSLIFLLLNGNKLSGSLPDELGYLSNLNRLQVDENNITGTIPKSFANLSRVRHLHLN 189 (958)
Q Consensus 110 ~~L~~L~l~n~~~~~ip~~i~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls 189 (958)
.+...|.++++....+|..+. ++|+.|+|++|+++ .+|..+. ++|++|+|++|+|+ .+|..+. .+|+.|+|+
T Consensus 178 ~~~~~L~L~~~~LtsLP~~Ip--~~L~~L~Ls~N~Lt-sLP~~l~--~nL~~L~Ls~N~Lt-sLP~~l~--~~L~~L~Ls 249 (754)
T PRK15370 178 NNKTELRLKILGLTTIPACIP--EQITTLILDNNELK-SLPENLQ--GNIKTLYANSNQLT-SIPATLP--DTIQEMELS 249 (754)
T ss_pred cCceEEEeCCCCcCcCCcccc--cCCcEEEecCCCCC-cCChhhc--cCCCEEECCCCccc-cCChhhh--ccccEEECc
Confidence 445677887777777887664 47999999999999 6777664 58999999999998 5666553 479999999
Q ss_pred cccccccCchhhcCCccchhhhccCCccccCCCcccCCCCCccEEEccCCCCCCCCccccccCCCCCCEEEcccCCCCCC
Q 002158 190 NNSIGGQIPSELSKLSTLIHLLVDNNNLSGNLPPELSELPQLCILQLDNNNFSASEIPATYGNFSKLVKLSLRNCNLQGA 269 (958)
Q Consensus 190 ~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~p~~~~~l~~L~~L~L~~N~l~~~ 269 (958)
+|++. .+|..+. .+|+.|+|++|+|+ .+|..+. ++|+.|+|++|+|+ .+|..+. ++|+.|+|++|+++..
T Consensus 250 ~N~L~-~LP~~l~--s~L~~L~Ls~N~L~-~LP~~l~--~sL~~L~Ls~N~Lt--~LP~~lp--~sL~~L~Ls~N~Lt~L 319 (754)
T PRK15370 250 INRIT-ELPERLP--SALQSLDLFHNKIS-CLPENLP--EELRYLSVYDNSIR--TLPAHLP--SGITHLNVQSNSLTAL 319 (754)
T ss_pred CCccC-cCChhHh--CCCCEEECcCCccC-ccccccC--CCCcEEECCCCccc--cCcccch--hhHHHHHhcCCccccC
Confidence 99998 6777664 57999999999998 4666664 58999999999996 3565443 4789999999999876
Q ss_pred CCCCCCCCCcCEEeccCCcCCCcCCCCCCCCCcCEEEccCCcCCCccchhccCCCCCCeEeeecccCCCccchhhhcccc
Q 002158 270 VPDLSRIPNLYYLDLSWNHLTGSIPSKKLSENVTTIDLSDNYLNGSILESISNLPFLQTLSLENNFLTGSIPATIWQNKS 349 (958)
Q Consensus 270 ~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~ip~~l~~~~~ 349 (958)
+..+. ++|+.|++++|.+++ +|.. .+++|+.|+|++|+|+. +|..+ .++|+.|+|++|+|+ .+|..+.
T Consensus 320 P~~l~--~sL~~L~Ls~N~Lt~-LP~~-l~~sL~~L~Ls~N~L~~-LP~~l--p~~L~~LdLs~N~Lt-~LP~~l~---- 387 (754)
T PRK15370 320 PETLP--PGLKTLEAGENALTS-LPAS-LPPELQVLDVSKNQITV-LPETL--PPTITTLDVSRNALT-NLPENLP---- 387 (754)
T ss_pred Ccccc--ccceeccccCCcccc-CChh-hcCcccEEECCCCCCCc-CChhh--cCCcCEEECCCCcCC-CCCHhHH----
Confidence 65443 689999999999985 5532 34789999999999984 55555 368999999999998 6787663
Q ss_pred cCccccceEeccCCCCCCCccCC-----CCCCcceEEeCCCCCC
Q 002158 350 FSTKARLKIDLRNNSFSNIVGDL-----TLPNNVTLRLGGNPIC 388 (958)
Q Consensus 350 ~~~~~l~~L~Ls~N~l~~l~~~~-----~l~~L~~L~l~~N~l~ 388 (958)
..++.|++++|+|+.+|... .++++..|++.+||+.
T Consensus 388 ---~sL~~LdLs~N~L~~LP~sl~~~~~~~~~l~~L~L~~Npls 428 (754)
T PRK15370 388 ---AALQIMQASRNNLVRLPESLPHFRGEGPQPTRIIVEYNPFS 428 (754)
T ss_pred ---HHHHHHhhccCCcccCchhHHHHhhcCCCccEEEeeCCCcc
Confidence 25678999999999887654 4578889999999985
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.84 E-value=1.4e-21 Score=227.04 Aligned_cols=253 Identities=20% Similarity=0.215 Sum_probs=185.7
Q ss_pred CCCCCceeeeeCCeEEEEEEECCCcEEEEEEeccCC-hhcHHHHHHHHHH--HHccCCCCcceEEEEEEeCCeEEEEEEe
Q 002158 626 YFSSSTQVGQGGYGKVYKGILSDNTTVAIKRAEEGS-LQGQNEFLTEIKL--LSRLHHRNLVSLLGYCDEEGEQMLVYEF 702 (958)
Q Consensus 626 ~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~--l~~l~H~niv~l~~~~~~~~~~~lV~E~ 702 (958)
++...+.||++.|=+|.+|++++|. |+||++-+.. .-..+.|.++++- ...++|||.+++..+-......|||-+|
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik~~l~~~pn~lPfqk~~~t~kAAylvRqy 102 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDREGL-VVVKVFVKQDPTISLRPFKQRLEEIKFALMKAPNCLPFQKVLVTDKAAYLVRQY 102 (1431)
T ss_pred ceeeecccCchhhhhhhhccCCCce-EEEEEEeccCCCCCchHHHHHHHHHHHHhhcCCcccchHHHHHhhHHHHHHHHH
Confidence 4556778999999999999998887 9999886654 3344555544433 4555899999999888888888999999
Q ss_pred cCCCCHHHHhccCCCCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEecCCCCeEEeeeeeecccccCCCC
Q 002158 703 VPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSRLAPVLDDE 782 (958)
Q Consensus 703 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~ 782 (958)
+. -+|+|.+..+.- +...+...|+.|+..||..+|..| |+|||||.+||||+.-..+.|+||..-+......+.
T Consensus 103 vk-hnLyDRlSTRPF--L~~iEKkWiaFQLL~al~qcH~~g---VcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeDN 176 (1431)
T KOG1240|consen 103 VK-HNLYDRLSTRPF--LVLIEKKWIAFQLLKALSQCHKLG---VCHGDIKSENILITSWNWLYLTDFASFKPTYLPEDN 176 (1431)
T ss_pred Hh-hhhhhhhccchH--HHHHHHHHHHHHHHHHHHHHHHcC---ccccccccceEEEeeechhhhhcccccCCccCCCCC
Confidence 95 599999976543 888899999999999999999999 999999999999999999999999877644333322
Q ss_pred CCccceeeeeccCCCCccChhhhccC----------C-CCCcchhhhHHHHHHHHHh-CCCCCCCCchhHHHHHHHhhcC
Q 002158 783 GTMPTHVSTIVKGTPGYLDPEYFLTH----------K-LTDKSDVYSLGVVLLELLT-GMQPISHGKNIVREVNVARDSG 850 (958)
Q Consensus 783 ~~~~~~~~~~~~gt~~y~aPE~~~~~----------~-~~~~~DV~S~Gv~l~ellt-G~~P~~~~~~~~~~~~~~~~~~ 850 (958)
...-......-..-..|+|||.+... . .+++.||||+||++.||++ |++||.- .+.........
T Consensus 177 Padf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~L----SQL~aYr~~~~ 252 (1431)
T KOG1240|consen 177 PADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTL----SQLLAYRSGNA 252 (1431)
T ss_pred cccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccH----HHHHhHhccCc
Confidence 22112222222344579999988542 1 5678999999999999999 7888852 22221111111
Q ss_pred cchhhhcccCCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 002158 851 MVFSIIDNRMGSYPSECVERFVTLALRCCHDKPEHRPSMSDVVRE 895 (958)
Q Consensus 851 ~~~~~i~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 895 (958)
...+..-+.+ + ...+.+++..|++.||.+|-++++.++.
T Consensus 253 ~~~e~~Le~I---e---d~~~Rnlil~Mi~rdPs~RlSAedyL~~ 291 (1431)
T KOG1240|consen 253 DDPEQLLEKI---E---DVSLRNLILSMIQRDPSKRLSAEDYLQK 291 (1431)
T ss_pred cCHHHHHHhC---c---CccHHHHHHHHHccCchhccCHHHHHHh
Confidence 1111111111 1 1267899999999999999999999986
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.84 E-value=9.5e-22 Score=231.21 Aligned_cols=255 Identities=21% Similarity=0.257 Sum_probs=189.9
Q ss_pred CCceeeeeCCeEEEEEEEC-CCcEEEEEEec----c-CChhc-HHHHHHHHHHHHccCCCCcceEEEEEEeCCeEEEEEE
Q 002158 629 SSTQVGQGGYGKVYKGILS-DNTTVAIKRAE----E-GSLQG-QNEFLTEIKLLSRLHHRNLVSLLGYCDEEGEQMLVYE 701 (958)
Q Consensus 629 ~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~----~-~~~~~-~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E 701 (958)
..+.+|.|++|.|+..... .....+.|.+. . ..... ...+..|+-+-..++|+|++..+..+.+.....-+||
T Consensus 322 ~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~mE 401 (601)
T KOG0590|consen 322 PGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSME 401 (601)
T ss_pred ccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhhh
Confidence 4578999999988877643 34444444332 1 11111 1236678888889999999888877766666666699
Q ss_pred ecCCCCHHHHhccCCCCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEecCCCCeEEeeeeeecccccCCC
Q 002158 702 FVPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSRLAPVLDD 781 (958)
Q Consensus 702 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~ 781 (958)
||++ +|...+.... .+...++..+..|+..|++|+|+.| |.|||+|++|+++..+|.+||+|||.+........
T Consensus 402 ~~~~-Dlf~~~~~~~--~~~~~e~~c~fKqL~~Gv~y~h~~G---iahrdlK~enll~~~~g~lki~Dfg~~~vf~~~~e 475 (601)
T KOG0590|consen 402 YCPY-DLFSLVMSNG--KLTPLEADCFFKQLLRGVKYLHSMG---LAHRDLKLENLLVTENGILKIIDFGAASVFRYPWE 475 (601)
T ss_pred cccH-HHHHHHhccc--ccchhhhhHHHHHHHHHHHHHHhcC---ceeccCccccEEEecCCceEEeecCcceeeccCcc
Confidence 9999 9999997652 3888999999999999999999999 99999999999999999999999999987643332
Q ss_pred CCCccceeeeeccCCCCccChhhhccCCCCC-cchhhhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcCcchhhhcccC
Q 002158 782 EGTMPTHVSTIVKGTPGYLDPEYFLTHKLTD-KSDVYSLGVVLLELLTGMQPISHGKNIVREVNVARDSGMVFSIIDNRM 860 (958)
Q Consensus 782 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~-~~DV~S~Gv~l~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~i~~~~ 860 (958)
.. ......+.|+..|+|||++...+|++ ..||||.|+++..|++|+.||................. ...+....
T Consensus 476 ~~---~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~~~~~~--~~~~~~~~ 550 (601)
T KOG0590|consen 476 KN---IHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKTNNYSD--QRNIFEGP 550 (601)
T ss_pred hh---hhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchhhhcccc--ccccccCh
Confidence 11 24456788999999999999999988 68999999999999999999964332211110000000 00011111
Q ss_pred CCCChHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002158 861 GSYPSECVERFVTLALRCCHDKPEHRPSMSDVVR 894 (958)
Q Consensus 861 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 894 (958)
.......+.....++.++++.||.+|-++++|++
T Consensus 551 ~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~ 584 (601)
T KOG0590|consen 551 NRLLSLLPRETRIIIYRMLQLDPTKRITIEQILN 584 (601)
T ss_pred HHHHHhchhhHHHHHHHHccCChhheecHHHHhh
Confidence 1223466788899999999999999999999986
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.83 E-value=1.8e-20 Score=190.49 Aligned_cols=138 Identities=17% Similarity=0.137 Sum_probs=108.2
Q ss_pred CceeeeeCCeEEEEEEECCCcEEEEEEeccCChh--c-------HHH-----------------HHHHHHHHHccCCCCc
Q 002158 630 STQVGQGGYGKVYKGILSDNTTVAIKRAEEGSLQ--G-------QNE-----------------FLTEIKLLSRLHHRNL 683 (958)
Q Consensus 630 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~--~-------~~~-----------------~~~E~~~l~~l~H~ni 683 (958)
...||+|+||.||+|...+|+.||||+++..... . ..+ ...|++.+.++.|+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v 81 (190)
T cd05147 2 NGCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGI 81 (190)
T ss_pred CCccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCC
Confidence 3579999999999999888999999998754211 1 012 2349999999988776
Q ss_pred ceEEEEEEeCCeEEEEEEecCCCCHHHHhccCCCCCchHHHHHHHHHHHHHHHHHh-hhcCCCCeeccCCCccceEecCC
Q 002158 684 VSLLGYCDEEGEQMLVYEFVPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYL-HTEAHPPVFHRDIKASNILLDSN 762 (958)
Q Consensus 684 v~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yL-H~~~~~~iiH~Dikp~NILl~~~ 762 (958)
.....+... ..++||||++++++....... ..++..++.+++.|++.+|.|+ |+.+ |+||||||+|||++ +
T Consensus 82 ~~p~~~~~~--~~~iVmE~i~g~~l~~~~~~~--~~~~~~~~~~i~~qi~~~L~~l~H~~g---iiHrDlkP~NIli~-~ 153 (190)
T cd05147 82 PCPEPILLK--SHVLVMEFIGDDGWAAPRLKD--APLSESKARELYLQVIQIMRILYQDCR---LVHADLSEYNLLYH-D 153 (190)
T ss_pred CCCcEEEec--CCEEEEEEeCCCCCcchhhhc--CCCCHHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEE-C
Confidence 444333222 238999999988776543222 3488999999999999999999 6888 99999999999998 5
Q ss_pred CCeEEeeeeeecc
Q 002158 763 LNAKVADFGLSRL 775 (958)
Q Consensus 763 ~~~kl~DFGla~~ 775 (958)
+.++|+|||+|..
T Consensus 154 ~~v~LiDFG~a~~ 166 (190)
T cd05147 154 GKLYIIDVSQSVE 166 (190)
T ss_pred CcEEEEEcccccc
Confidence 7899999999874
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.83 E-value=1.5e-20 Score=192.59 Aligned_cols=174 Identities=16% Similarity=0.109 Sum_probs=136.0
Q ss_pred HHHHcCCCCCceeeeeCCeEEEEEEECCCcEEEEEEeccCChhcHH---H------HHHHHHHHHccCCCCcceEEEEEE
Q 002158 621 AMATAYFSSSTQVGQGGYGKVYKGILSDNTTVAIKRAEEGSLQGQN---E------FLTEIKLLSRLHHRNLVSLLGYCD 691 (958)
Q Consensus 621 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~---~------~~~E~~~l~~l~H~niv~l~~~~~ 691 (958)
.....+|...+++|.|+||.||.+.. ++..+|||.+........+ . |.+|++.+.+++|++|..+.+++.
T Consensus 27 ~~l~~~y~~~~~l~~~~f~~v~l~~~-~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~ 105 (232)
T PRK10359 27 DFLSYNIKTIKVFRNIDDTKVSLIDT-DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYL 105 (232)
T ss_pred HHhhCceEEEEEecCCCceEEEEEec-CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeee
Confidence 34577899999999999999999765 6778999999765333222 2 689999999999999999999865
Q ss_pred eC--------CeEEEEEEecCCCCHHHHhccCCCCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEecCCC
Q 002158 692 EE--------GEQMLVYEFVPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSNL 763 (958)
Q Consensus 692 ~~--------~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~~ 763 (958)
.. +..++||||++|.+|.++.. ++. ....+++.++..+|+.| ++|||+||+||+++.++
T Consensus 106 ~~~~~~~~~~~~~~lvmEyi~G~tL~~~~~------~~~----~~~~~i~~~l~~lH~~g---i~H~Dikp~Nili~~~g 172 (232)
T PRK10359 106 LAERKTLRYAHTYIMLIEYIEGVELNDMPE------ISE----DVKAKIKASIESLHQHG---MVSGDPHKGNFIVSKNG 172 (232)
T ss_pred ecccccccccCCeEEEEEEECCccHHHhhh------ccH----HHHHHHHHHHHHHHHcC---CccCCCChHHEEEeCCC
Confidence 33 35789999999999988742 222 24569999999999999 99999999999999988
Q ss_pred CeEEeeeeeecccccCCCCCCccceeeeeccCCCCccChhhhccCCCCCcchhhhHHHHHHHHHh
Q 002158 764 NAKVADFGLSRLAPVLDDEGTMPTHVSTIVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVLLELLT 828 (958)
Q Consensus 764 ~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gv~l~ellt 828 (958)
++|+|||..+...... .-..+.....+..++|+|+||+++.....
T Consensus 173 -i~liDfg~~~~~~e~~-------------------a~d~~vler~y~~~~di~~lg~~~~~~~~ 217 (232)
T PRK10359 173 -LRIIDLSGKRCTAQRK-------------------AKDRIDLERHYGIKNEIKDLGYYLLIYKK 217 (232)
T ss_pred -EEEEECCCcccccchh-------------------hHHHHHHHhHhcccccccceeEeehHHHH
Confidence 9999999876432100 00114455567789999999999876543
|
|
| >PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional | Back alignment and domain information |
|---|
Probab=99.81 E-value=1.4e-19 Score=215.15 Aligned_cols=260 Identities=22% Similarity=0.262 Sum_probs=200.3
Q ss_pred CCcceeeccCcccCCCCccccCCCCCcEEEeeCCCCCCCCChhhcCCCCCCEEecccccccccCccccccccccceEecc
Q 002158 110 SRLQYYFMWNDLTGTIPKEIGNISSLIFLLLNGNKLSGSLPDELGYLSNLNRLQVDENNITGTIPKSFANLSRVRHLHLN 189 (958)
Q Consensus 110 ~~L~~L~l~n~~~~~ip~~i~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls 189 (958)
..-..|+++++....+|+.+. .+|+.|+|++|+++ .+|.. +++|++|+|++|+|+ .+|.. .++|+.|+|+
T Consensus 201 ~~~~~LdLs~~~LtsLP~~l~--~~L~~L~L~~N~Lt-~LP~l---p~~Lk~LdLs~N~Lt-sLP~l---p~sL~~L~Ls 270 (788)
T PRK15387 201 NGNAVLNVGESGLTTLPDCLP--AHITTLVIPDNNLT-SLPAL---PPELRTLEVSGNQLT-SLPVL---PPGLLELSIF 270 (788)
T ss_pred CCCcEEEcCCCCCCcCCcchh--cCCCEEEccCCcCC-CCCCC---CCCCcEEEecCCccC-cccCc---ccccceeecc
Confidence 334567888777778998876 48999999999999 57752 578999999999999 45643 4689999999
Q ss_pred cccccccCchhhcCCccchhhhccCCccccCCCcccCCCCCccEEEccCCCCCCCCccccccCCCCCCEEEcccCCCCCC
Q 002158 190 NNSIGGQIPSELSKLSTLIHLLVDNNNLSGNLPPELSELPQLCILQLDNNNFSASEIPATYGNFSKLVKLSLRNCNLQGA 269 (958)
Q Consensus 190 ~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~p~~~~~l~~L~~L~L~~N~l~~~ 269 (958)
+|.|+ .+|..+ .+|+.|+|++|+|+. +|. .+++|+.|+|++|+++. +|... .+|+.|++++|+|+++
T Consensus 271 ~N~L~-~Lp~lp---~~L~~L~Ls~N~Lt~-LP~---~p~~L~~LdLS~N~L~~--Lp~lp---~~L~~L~Ls~N~L~~L 337 (788)
T PRK15387 271 SNPLT-HLPALP---SGLCKLWIFGNQLTS-LPV---LPPGLQELSVSDNQLAS--LPALP---SELCKLWAYNNQLTSL 337 (788)
T ss_pred CCchh-hhhhch---hhcCEEECcCCcccc-ccc---cccccceeECCCCcccc--CCCCc---ccccccccccCccccc
Confidence 99998 555533 578889999999984 444 24789999999999973 45432 4688899999999875
Q ss_pred CCCCCCCCCcCEEeccCCcCCCcCCCCCCCCCcCEEEccCCcCCCccchhccCCCCCCeEeeecccCCCccchhhhcccc
Q 002158 270 VPDLSRIPNLYYLDLSWNHLTGSIPSKKLSENVTTIDLSDNYLNGSILESISNLPFLQTLSLENNFLTGSIPATIWQNKS 349 (958)
Q Consensus 270 ~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~ip~~l~~~~~ 349 (958)
+. + ..+|+.|+|++|+|++ +|. ...+|+.|++++|+|+. +|.. ..+|+.|+|++|+|+ .+|..
T Consensus 338 P~-l--p~~Lq~LdLS~N~Ls~-LP~--lp~~L~~L~Ls~N~L~~-LP~l---~~~L~~LdLs~N~Lt-~LP~l------ 400 (788)
T PRK15387 338 PT-L--PSGLQELSVSDNQLAS-LPT--LPSELYKLWAYNNRLTS-LPAL---PSGLKELIVSGNRLT-SLPVL------ 400 (788)
T ss_pred cc-c--ccccceEecCCCccCC-CCC--CCcccceehhhcccccc-Cccc---ccccceEEecCCccc-CCCCc------
Confidence 53 2 2589999999999994 554 34789999999999985 4443 357999999999998 46643
Q ss_pred cCccccceEeccCCCCCCCccCCCCCCcceEEeCCCCCCCCCCCCCCCcccccCCCCCccccccCCCCC
Q 002158 350 FSTKARLKIDLRNNSFSNIVGDLTLPNNVTLRLGGNPICTSANIPNTGRFCGSDAGGDETLTNSKVNCP 418 (958)
Q Consensus 350 ~~~~~l~~L~Ls~N~l~~l~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~~~~~~~~~L~~n~~~C~ 418 (958)
...++.|++++|+|+.+|.. ..+|+.|++++|.++.. +. .++.......+.|.+|++...
T Consensus 401 --~s~L~~LdLS~N~LssIP~l--~~~L~~L~Ls~NqLt~L---P~--sl~~L~~L~~LdLs~N~Ls~~ 460 (788)
T PRK15387 401 --PSELKELMVSGNRLTSLPML--PSGLLSLSVYRNQLTRL---PE--SLIHLSSETTVNLEGNPLSER 460 (788)
T ss_pred --ccCCCEEEccCCcCCCCCcc--hhhhhhhhhccCccccc---Ch--HHhhccCCCeEECCCCCCCch
Confidence 24678999999999998864 45788999999999742 22 244455667788999998643
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.81 E-value=1.5e-19 Score=180.84 Aligned_cols=190 Identities=13% Similarity=0.057 Sum_probs=141.1
Q ss_pred CCCceeeeeCCeEEEEEEECCCcEEEEEEeccCChhc----HHHHHHHHHHHHccC-CCCcceEEEEEEeCCeEEEEEEe
Q 002158 628 SSSTQVGQGGYGKVYKGILSDNTTVAIKRAEEGSLQG----QNEFLTEIKLLSRLH-HRNLVSLLGYCDEEGEQMLVYEF 702 (958)
Q Consensus 628 ~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~----~~~~~~E~~~l~~l~-H~niv~l~~~~~~~~~~~lV~E~ 702 (958)
.....|++|+||+||.+.. .+.+++.+.+....... ...|.+|+++|++++ |+++++++++ +..+++|||
T Consensus 5 ~~~~~l~~~~f~~v~~~~~-~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmey 79 (218)
T PRK12274 5 AVNEPLKSDTFGRILLVRG-GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSY 79 (218)
T ss_pred ccceeecCCCcceEEEeec-CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEee
Confidence 3457899999999997765 67888888776643311 235889999999995 5889999987 357999999
Q ss_pred cCCCCHHHHhccCCCCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCC-CccceEecCCCCeEEeeeeeecccccCCC
Q 002158 703 VPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDI-KASNILLDSNLNAKVADFGLSRLAPVLDD 781 (958)
Q Consensus 703 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Di-kp~NILl~~~~~~kl~DFGla~~~~~~~~ 781 (958)
+.|.+|...+.. ....++.|++++|+++|++| |+|||| ||+|||++.++.++|+|||+|........
T Consensus 80 I~G~~L~~~~~~---------~~~~~~~qi~~~L~~lH~~G---IvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~~ 147 (218)
T PRK12274 80 LAGAAMYQRPPR---------GDLAYFRAARRLLQQLHRCG---VAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRAR 147 (218)
T ss_pred ecCccHHhhhhh---------hhHHHHHHHHHHHHHHHHCc---CccCCCCCcceEEEcCCCCEEEEECCCceecCCcch
Confidence 999999765421 11357789999999999999 999999 79999999999999999999985432111
Q ss_pred C------CCccceeeeeccCCCCccChhhhccC-CCC-CcchhhhHHHHHHHHHhCCCCCC
Q 002158 782 E------GTMPTHVSTIVKGTPGYLDPEYFLTH-KLT-DKSDVYSLGVVLLELLTGMQPIS 834 (958)
Q Consensus 782 ~------~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~-~~~DV~S~Gv~l~elltG~~P~~ 834 (958)
. .....-.......++.|++|+...-- ..+ .+.+.++-|+-+|.++|+..+..
T Consensus 148 ~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~ 208 (218)
T PRK12274 148 WMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHW 208 (218)
T ss_pred HHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCcc
Confidence 0 00000001123467888888865432 233 47899999999999999988764
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.81 E-value=2.7e-19 Score=182.59 Aligned_cols=138 Identities=17% Similarity=0.145 Sum_probs=110.5
Q ss_pred CceeeeeCCeEEEEEEECCCcEEEEEEeccCChh--c------------------------HHHHHHHHHHHHccCCCCc
Q 002158 630 STQVGQGGYGKVYKGILSDNTTVAIKRAEEGSLQ--G------------------------QNEFLTEIKLLSRLHHRNL 683 (958)
Q Consensus 630 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~--~------------------------~~~~~~E~~~l~~l~H~ni 683 (958)
...||+|+||.||+|...+|+.||||+++..... . ...+..|.+.+.++.|+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 81 (190)
T cd05145 2 NGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGV 81 (190)
T ss_pred CceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCC
Confidence 4679999999999999878999999998754211 0 1124579999999999987
Q ss_pred ceEEEEEEeCCeEEEEEEecCCCCHHH-HhccCCCCCchHHHHHHHHHHHHHHHHHhhh-cCCCCeeccCCCccceEecC
Q 002158 684 VSLLGYCDEEGEQMLVYEFVPNGTLRD-WLSGRTKENLNFAMRLRVALDSAKGILYLHT-EAHPPVFHRDIKASNILLDS 761 (958)
Q Consensus 684 v~l~~~~~~~~~~~lV~E~~~~gsL~~-~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~-~~~~~iiH~Dikp~NILl~~ 761 (958)
.....+.... .+|||||++++++.. .+.. ..++..++.+++.|++.++.++|+ .| |+||||||+||+++
T Consensus 82 ~~p~~~~~~~--~~lVmE~~~g~~~~~~~l~~---~~~~~~~~~~i~~~l~~~l~~lH~~~g---ivHrDlkP~NIll~- 152 (190)
T cd05145 82 PVPEPILLKK--NVLVMEFIGDDGSPAPRLKD---VPLEEEEAEELYEQVVEQMRRLYQEAG---LVHGDLSEYNILYH- 152 (190)
T ss_pred CCceEEEecC--CEEEEEEecCCCchhhhhhh---ccCCHHHHHHHHHHHHHHHHHHHHhCC---EecCCCChhhEEEE-
Confidence 5554443332 489999998885543 3432 237788899999999999999999 88 99999999999999
Q ss_pred CCCeEEeeeeeeccc
Q 002158 762 NLNAKVADFGLSRLA 776 (958)
Q Consensus 762 ~~~~kl~DFGla~~~ 776 (958)
++.++|+|||+++..
T Consensus 153 ~~~~~liDFG~a~~~ 167 (190)
T cd05145 153 DGKPYIIDVSQAVEL 167 (190)
T ss_pred CCCEEEEEcccceec
Confidence 899999999999754
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.80 E-value=1.4e-18 Score=183.52 Aligned_cols=229 Identities=21% Similarity=0.249 Sum_probs=149.2
Q ss_pred CCceeeeeCCeEEEEEEEC-CCcEEEEEEeccCC---hhcHHHHHHHHHHHHccCC----------CCcceEEEEEE---
Q 002158 629 SSTQVGQGGYGKVYKGILS-DNTTVAIKRAEEGS---LQGQNEFLTEIKLLSRLHH----------RNLVSLLGYCD--- 691 (958)
Q Consensus 629 ~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H----------~niv~l~~~~~--- 691 (958)
..+.||.|+++.||.+++. +++++|||++.... ....+++.+|.-....+.+ -.++.-++...
T Consensus 16 ~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~i~~ 95 (288)
T PF14531_consen 16 RGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLRIPG 95 (288)
T ss_dssp EEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEEETT
T ss_pred EccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEEEcC
Confidence 3468999999999999987 58999999875432 2335667777765555432 12222222211
Q ss_pred ------eC---C-----eEEEEEEecCCCCHHHHhcc---C--CCCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCC
Q 002158 692 ------EE---G-----EQMLVYEFVPNGTLRDWLSG---R--TKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDI 752 (958)
Q Consensus 692 ------~~---~-----~~~lV~E~~~~gsL~~~l~~---~--~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Di 752 (958)
.. . ..+++|+-+ .++|.+++.. . ....+....++.+..|+++.+++||+.| ++|+||
T Consensus 96 ~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~G---lVHgdi 171 (288)
T PF14531_consen 96 KPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYG---LVHGDI 171 (288)
T ss_dssp S-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTT---EEEST-
T ss_pred CCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcc---eEeccc
Confidence 11 1 236788888 5788887642 2 1223666677888899999999999999 999999
Q ss_pred CccceEecCCCCeEEeeeeeecccccCCCCCCccceeeeeccCCCCccChhhhccC--------CCCCcchhhhHHHHHH
Q 002158 753 KASNILLDSNLNAKVADFGLSRLAPVLDDEGTMPTHVSTIVKGTPGYLDPEYFLTH--------KLTDKSDVYSLGVVLL 824 (958)
Q Consensus 753 kp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--------~~~~~~DV~S~Gv~l~ 824 (958)
||+|++++.+|.++|+||+...... ........+..|.+||..... .++.+.|.|++|+++|
T Consensus 172 ~~~nfll~~~G~v~Lg~F~~~~r~g----------~~~~~~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly 241 (288)
T PF14531_consen 172 KPENFLLDQDGGVFLGDFSSLVRAG----------TRYRCSEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLY 241 (288)
T ss_dssp SGGGEEE-TTS-EEE--GGGEEETT----------EEEEGGGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHH
T ss_pred ceeeEEEcCCCCEEEcChHHHeecC----------ceeeccCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHH
Confidence 9999999999999999999876431 111113456789999987442 4778999999999999
Q ss_pred HHHhCCCCCCCCchhHHHHHHHhhcCcchhhhcccCCCCChHHHHHHHHHHHHccccCCCCC
Q 002158 825 ELLTGMQPISHGKNIVREVNVARDSGMVFSIIDNRMGSYPSECVERFVTLALRCCHDKPEHR 886 (958)
Q Consensus 825 elltG~~P~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~l~~li~~cl~~dP~~R 886 (958)
.|++|..||........ .+....... +.|+.+..||..+++.+|.+|
T Consensus 242 ~lWC~~lPf~~~~~~~~--------------~~~~f~~C~-~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 242 SLWCGRLPFGLSSPEAD--------------PEWDFSRCR-DMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp HHHHSS-STCCCGGGST--------------SGGGGTTSS----HHHHHHHHHHT-SSGGGS
T ss_pred HHHHccCCCCCCCcccc--------------ccccchhcC-CcCHHHHHHHHHHccCCcccC
Confidence 99999999974332110 000222334 788999999999999999988
|
|
| >PRK15370 E3 ubiquitin-protein ligase SlrP; Provisional | Back alignment and domain information |
|---|
Probab=99.80 E-value=2e-19 Score=215.36 Aligned_cols=260 Identities=26% Similarity=0.397 Sum_probs=206.2
Q ss_pred eeEEEEccCCcCCCCccccccCCCCcceeeccCcccCCCCccccCCCCCcEEEeeCCCCCCCCChhhcCCCCCCEEeccc
Q 002158 87 HVRELQLLSMNLSGNLAPELGQLSRLQYYFMWNDLTGTIPKEIGNISSLIFLLLNGNKLSGSLPDELGYLSNLNRLQVDE 166 (958)
Q Consensus 87 ~v~~L~L~~~~l~~~~~~~l~~L~~L~~L~l~n~~~~~ip~~i~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~L~~ 166 (958)
+.+.|++.+++++. +|..+. ++|+.|++++|....+|..+. .+|++|+|++|+|+ .+|..+. .+|+.|+|++
T Consensus 179 ~~~~L~L~~~~Lts-LP~~Ip--~~L~~L~Ls~N~LtsLP~~l~--~nL~~L~Ls~N~Lt-sLP~~l~--~~L~~L~Ls~ 250 (754)
T PRK15370 179 NKTELRLKILGLTT-IPACIP--EQITTLILDNNELKSLPENLQ--GNIKTLYANSNQLT-SIPATLP--DTIQEMELSI 250 (754)
T ss_pred CceEEEeCCCCcCc-CCcccc--cCCcEEEecCCCCCcCChhhc--cCCCEEECCCCccc-cCChhhh--ccccEEECcC
Confidence 46789999998885 555553 579999999888889998765 58999999999999 6787664 4799999999
Q ss_pred ccccccCccccccccccceEecccccccccCchhhcCCccchhhhccCCccccCCCcccCCCCCccEEEccCCCCCCCCc
Q 002158 167 NNITGTIPKSFANLSRVRHLHLNNNSIGGQIPSELSKLSTLIHLLVDNNNLSGNLPPELSELPQLCILQLDNNNFSASEI 246 (958)
Q Consensus 167 N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~ 246 (958)
|+++ .+|..+. ++|+.|+|++|+|+ .+|..+. ++|+.|+|++|+|++ +|..+. ++|+.|++++|+++ .+
T Consensus 251 N~L~-~LP~~l~--s~L~~L~Ls~N~L~-~LP~~l~--~sL~~L~Ls~N~Lt~-LP~~lp--~sL~~L~Ls~N~Lt--~L 319 (754)
T PRK15370 251 NRIT-ELPERLP--SALQSLDLFHNKIS-CLPENLP--EELRYLSVYDNSIRT-LPAHLP--SGITHLNVQSNSLT--AL 319 (754)
T ss_pred CccC-cCChhHh--CCCCEEECcCCccC-ccccccC--CCCcEEECCCCcccc-Ccccch--hhHHHHHhcCCccc--cC
Confidence 9999 6777664 58999999999999 5776554 589999999999995 555543 58999999999997 35
Q ss_pred cccccCCCCCCEEEcccCCCCCCCCCCCCCCCcCEEeccCCcCCCcCCCCCCCCCcCEEEccCCcCCCccchhccCCCCC
Q 002158 247 PATYGNFSKLVKLSLRNCNLQGAVPDLSRIPNLYYLDLSWNHLTGSIPSKKLSENVTTIDLSDNYLNGSILESISNLPFL 326 (958)
Q Consensus 247 p~~~~~l~~L~~L~L~~N~l~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~~~L~~L~Ls~N~l~~~~~~~~~~l~~L 326 (958)
|..+. ++|+.|++++|.+++++..+. ++|+.|+|++|+|+ .+|.. ..++|+.|+|++|+|+.. |..+. ..|
T Consensus 320 P~~l~--~sL~~L~Ls~N~Lt~LP~~l~--~sL~~L~Ls~N~L~-~LP~~-lp~~L~~LdLs~N~Lt~L-P~~l~--~sL 390 (754)
T PRK15370 320 PETLP--PGLKTLEAGENALTSLPASLP--PELQVLDVSKNQIT-VLPET-LPPTITTLDVSRNALTNL-PENLP--AAL 390 (754)
T ss_pred Ccccc--ccceeccccCCccccCChhhc--CcccEEECCCCCCC-cCChh-hcCCcCEEECCCCcCCCC-CHhHH--HHH
Confidence 65443 689999999999998766554 79999999999998 45543 347999999999999954 44443 369
Q ss_pred CeEeeecccCCCccchhhhcccccCccccceEeccCCCCCCCccCCCCCCcceE
Q 002158 327 QTLSLENNFLTGSIPATIWQNKSFSTKARLKIDLRNNSFSNIVGDLTLPNNVTL 380 (958)
Q Consensus 327 ~~L~L~~N~l~~~ip~~l~~~~~~~~~~l~~L~Ls~N~l~~l~~~~~l~~L~~L 380 (958)
+.|++++|+|+ .+|..+...... .+.+..|+|.+|.|+. ..+++|+.+
T Consensus 391 ~~LdLs~N~L~-~LP~sl~~~~~~-~~~l~~L~L~~Npls~----~tl~~L~~L 438 (754)
T PRK15370 391 QIMQASRNNLV-RLPESLPHFRGE-GPQPTRIIVEYNPFSE----RTIQNMQRL 438 (754)
T ss_pred HHHhhccCCcc-cCchhHHHHhhc-CCCccEEEeeCCCccH----HHHHHHHHh
Confidence 99999999998 788776554332 3567799999999973 244444444
|
|
| >PLN03210 Resistant to P | Back alignment and domain information |
|---|
Probab=99.79 E-value=2.4e-18 Score=220.58 Aligned_cols=286 Identities=18% Similarity=0.209 Sum_probs=183.4
Q ss_pred eeEEEEccCC------cCCCCccccccCCC-CcceeeccCcccCCCCccccCCCCCcEEEeeCCCCCCCCChhhcCCCCC
Q 002158 87 HVRELQLLSM------NLSGNLAPELGQLS-RLQYYFMWNDLTGTIPKEIGNISSLIFLLLNGNKLSGSLPDELGYLSNL 159 (958)
Q Consensus 87 ~v~~L~L~~~------~l~~~~~~~l~~L~-~L~~L~l~n~~~~~ip~~i~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L 159 (958)
+++.|.+..+ ++...+|..+..++ +|+.|.+.++....+|..| ...+|++|+|++|.+. .++..+..+++|
T Consensus 559 ~L~~L~~~~~~~~~~~~~~~~lp~~~~~lp~~Lr~L~~~~~~l~~lP~~f-~~~~L~~L~L~~s~l~-~L~~~~~~l~~L 636 (1153)
T PLN03210 559 NLLFLKFYTKKWDQKKEVRWHLPEGFDYLPPKLRLLRWDKYPLRCMPSNF-RPENLVKLQMQGSKLE-KLWDGVHSLTGL 636 (1153)
T ss_pred cccEEEEecccccccccceeecCcchhhcCcccEEEEecCCCCCCCCCcC-CccCCcEEECcCcccc-ccccccccCCCC
Confidence 4555555433 22334555555553 4666666666666666665 4566777777776666 566666666677
Q ss_pred CEEecccccccccCccccccccccceEecccccccccCchhhcCCccchhhhccCCccccCCCcccCCCCCccEEEccCC
Q 002158 160 NRLQVDENNITGTIPKSFANLSRVRHLHLNNNSIGGQIPSELSKLSTLIHLLVDNNNLSGNLPPELSELPQLCILQLDNN 239 (958)
Q Consensus 160 ~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N 239 (958)
++|+|++|.....+| .++.+++|+.|+|++|.....+|..+.++++|+.|++++|.....+|..+ ++++|+.|+|++|
T Consensus 637 k~L~Ls~~~~l~~ip-~ls~l~~Le~L~L~~c~~L~~lp~si~~L~~L~~L~L~~c~~L~~Lp~~i-~l~sL~~L~Lsgc 714 (1153)
T PLN03210 637 RNIDLRGSKNLKEIP-DLSMATNLETLKLSDCSSLVELPSSIQYLNKLEDLDMSRCENLEILPTGI-NLKSLYRLNLSGC 714 (1153)
T ss_pred CEEECCCCCCcCcCC-ccccCCcccEEEecCCCCccccchhhhccCCCCEEeCCCCCCcCccCCcC-CCCCCCEEeCCCC
Confidence 777776655443454 36666677777776665444666666666677777776654433455444 5666666666665
Q ss_pred CCCCCCccccccCCCCCCEEEcccCCCCCCCCC------------------------------CCCCCCcCEEeccCCcC
Q 002158 240 NFSASEIPATYGNFSKLVKLSLRNCNLQGAVPD------------------------------LSRIPNLYYLDLSWNHL 289 (958)
Q Consensus 240 ~l~~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~------------------------------l~~l~~L~~L~Ls~N~l 289 (958)
... ..+|.. ..+|+.|+|++|.+...+.. ....++|+.|+|++|..
T Consensus 715 ~~L-~~~p~~---~~nL~~L~L~~n~i~~lP~~~~l~~L~~L~l~~~~~~~l~~~~~~l~~~~~~~~~sL~~L~Ls~n~~ 790 (1153)
T PLN03210 715 SRL-KSFPDI---STNISWLDLDETAIEEFPSNLRLENLDELILCEMKSEKLWERVQPLTPLMTMLSPSLTRLFLSDIPS 790 (1153)
T ss_pred CCc-cccccc---cCCcCeeecCCCccccccccccccccccccccccchhhccccccccchhhhhccccchheeCCCCCC
Confidence 432 223322 23455556665555443321 11235788899998876
Q ss_pred CCcCCCC-CCCCCcCEEEccCCcCCCccchhccCCCCCCeEeeecccCCCccchhhhcccccCccccceEeccCCCCCCC
Q 002158 290 TGSIPSK-KLSENVTTIDLSDNYLNGSILESISNLPFLQTLSLENNFLTGSIPATIWQNKSFSTKARLKIDLRNNSFSNI 368 (958)
Q Consensus 290 ~~~~~~~-~~~~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~ip~~l~~~~~~~~~~l~~L~Ls~N~l~~l 368 (958)
.+.+|.. ..+++|+.|+|++|..-+.+|..+ ++++|+.|+|++|.....+|.. ...++.|+|++|.|+.+
T Consensus 791 l~~lP~si~~L~~L~~L~Ls~C~~L~~LP~~~-~L~sL~~L~Ls~c~~L~~~p~~--------~~nL~~L~Ls~n~i~~i 861 (1153)
T PLN03210 791 LVELPSSIQNLHKLEHLEIENCINLETLPTGI-NLESLESLDLSGCSRLRTFPDI--------STNISDLNLSRTGIEEV 861 (1153)
T ss_pred ccccChhhhCCCCCCEEECCCCCCcCeeCCCC-CccccCEEECCCCCcccccccc--------ccccCEeECCCCCCccC
Confidence 6666654 557899999999986555666655 7899999999998766566542 24577899999999999
Q ss_pred ccCC-CCCCcceEEeCC-CCCCC
Q 002158 369 VGDL-TLPNNVTLRLGG-NPICT 389 (958)
Q Consensus 369 ~~~~-~l~~L~~L~l~~-N~l~~ 389 (958)
|... .+++|+.|+|.+ |.+.+
T Consensus 862 P~si~~l~~L~~L~L~~C~~L~~ 884 (1153)
T PLN03210 862 PWWIEKFSNLSFLDMNGCNNLQR 884 (1153)
T ss_pred hHHHhcCCCCCEEECCCCCCcCc
Confidence 8766 899999999998 44543
|
syringae 6; Provisional |
| >KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.78 E-value=1.2e-20 Score=216.21 Aligned_cols=241 Identities=30% Similarity=0.419 Sum_probs=165.2
Q ss_pred CCCcEEEeeCCCCCCCCChhhcCCCCCCEEecccccccccCccccccccccceEecccccccccCchhhcCCccchhhhc
Q 002158 133 SSLIFLLLNGNKLSGSLPDELGYLSNLNRLQVDENNITGTIPKSFANLSRVRHLHLNNNSIGGQIPSELSKLSTLIHLLV 212 (958)
Q Consensus 133 ~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L 212 (958)
.+|++++++.|+++ .+|++++.+.+|+.|++.+|+|+ .+|..+..+++|+.|++.+|.+. .+|.....++.|++|+|
T Consensus 241 ~nl~~~dis~n~l~-~lp~wi~~~~nle~l~~n~N~l~-~lp~ri~~~~~L~~l~~~~nel~-yip~~le~~~sL~tLdL 317 (1081)
T KOG0618|consen 241 LNLQYLDISHNNLS-NLPEWIGACANLEALNANHNRLV-ALPLRISRITSLVSLSAAYNELE-YIPPFLEGLKSLRTLDL 317 (1081)
T ss_pred ccceeeecchhhhh-cchHHHHhcccceEecccchhHH-hhHHHHhhhhhHHHHHhhhhhhh-hCCCcccccceeeeeee
Confidence 46777777777777 56677777777777777777775 66777777777777777777777 66666777777777777
Q ss_pred cCCccccCCCcccCCCCC-ccEEEccCCCCCCCCccc-cccCCCCCCEEEcccCCCCCCC-CCCCCCCCcCEEeccCCcC
Q 002158 213 DNNNLSGNLPPELSELPQ-LCILQLDNNNFSASEIPA-TYGNFSKLVKLSLRNCNLQGAV-PDLSRIPNLYYLDLSWNHL 289 (958)
Q Consensus 213 ~~N~l~~~~~~~l~~l~~-L~~L~L~~N~l~~~~~p~-~~~~l~~L~~L~L~~N~l~~~~-~~l~~l~~L~~L~Ls~N~l 289 (958)
..|+|....+..|.-+.. |+.|..+.|++. ..|. .-..++.|+.|++.+|.|+... |.+.++.+|+.|+|++|+|
T Consensus 318 ~~N~L~~lp~~~l~v~~~~l~~ln~s~n~l~--~lp~~~e~~~~~Lq~LylanN~Ltd~c~p~l~~~~hLKVLhLsyNrL 395 (1081)
T KOG0618|consen 318 QSNNLPSLPDNFLAVLNASLNTLNVSSNKLS--TLPSYEENNHAALQELYLANNHLTDSCFPVLVNFKHLKVLHLSYNRL 395 (1081)
T ss_pred hhccccccchHHHhhhhHHHHHHhhhhcccc--ccccccchhhHHHHHHHHhcCcccccchhhhccccceeeeeeccccc
Confidence 777777444434444443 666777777764 2332 1223455777777777777543 4577777777777777777
Q ss_pred CCcCCCC--CCCCCcCEEEccCCcCCCccchhccCCCCCCeEeeecccCCCccchhhhcccccCccccceEeccCCCCCC
Q 002158 290 TGSIPSK--KLSENVTTIDLSDNYLNGSILESISNLPFLQTLSLENNFLTGSIPATIWQNKSFSTKARLKIDLRNNSFSN 367 (958)
Q Consensus 290 ~~~~~~~--~~~~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~ip~~l~~~~~~~~~~l~~L~Ls~N~l~~ 367 (958)
. .+|.. ..+..|++|+||+|+|+ .+|..+..++.|++|...+|+|. ..| .+.++ +.++.+|+|.|+|+.
T Consensus 396 ~-~fpas~~~kle~LeeL~LSGNkL~-~Lp~tva~~~~L~tL~ahsN~l~-~fP-e~~~l-----~qL~~lDlS~N~L~~ 466 (1081)
T KOG0618|consen 396 N-SFPASKLRKLEELEELNLSGNKLT-TLPDTVANLGRLHTLRAHSNQLL-SFP-ELAQL-----PQLKVLDLSCNNLSE 466 (1081)
T ss_pred c-cCCHHHHhchHHhHHHhcccchhh-hhhHHHHhhhhhHHHhhcCCcee-ech-hhhhc-----CcceEEecccchhhh
Confidence 6 45544 33467777777777777 45577778888888888888887 666 45443 345578888888877
Q ss_pred Cc--cCCCCCCcceEEeCCCCC
Q 002158 368 IV--GDLTLPNNVTLRLGGNPI 387 (958)
Q Consensus 368 l~--~~~~l~~L~~L~l~~N~l 387 (958)
+. ....-++|++|||+||.+
T Consensus 467 ~~l~~~~p~p~LkyLdlSGN~~ 488 (1081)
T KOG0618|consen 467 VTLPEALPSPNLKYLDLSGNTR 488 (1081)
T ss_pred hhhhhhCCCcccceeeccCCcc
Confidence 43 333447888888888886
|
|
| >PLN03210 Resistant to P | Back alignment and domain information |
|---|
Probab=99.78 E-value=4.3e-18 Score=218.24 Aligned_cols=287 Identities=22% Similarity=0.284 Sum_probs=225.5
Q ss_pred eeeEEEEccCCcCCC--CccccccCCCCcceeeccCc-------ccCCCCccccCCC-CCcEEEeeCCCCCCCCChhhcC
Q 002158 86 LHVRELQLLSMNLSG--NLAPELGQLSRLQYYFMWND-------LTGTIPKEIGNIS-SLIFLLLNGNKLSGSLPDELGY 155 (958)
Q Consensus 86 ~~v~~L~L~~~~l~~--~~~~~l~~L~~L~~L~l~n~-------~~~~ip~~i~~l~-~L~~L~Ls~n~l~~~~p~~l~~ 155 (958)
..+..+.+.-..+.. .....|..+++|+.|.++++ ....+|..+..++ +|+.|++.++.+. .+|..+ .
T Consensus 532 ~~v~~i~l~~~~~~~~~i~~~aF~~m~~L~~L~~~~~~~~~~~~~~~~lp~~~~~lp~~Lr~L~~~~~~l~-~lP~~f-~ 609 (1153)
T PLN03210 532 KKVLGITLDIDEIDELHIHENAFKGMRNLLFLKFYTKKWDQKKEVRWHLPEGFDYLPPKLRLLRWDKYPLR-CMPSNF-R 609 (1153)
T ss_pred ceeeEEEeccCccceeeecHHHHhcCccccEEEEecccccccccceeecCcchhhcCcccEEEEecCCCCC-CCCCcC-C
Confidence 345555544333322 23456888999999977543 2346788888875 7999999999998 888877 5
Q ss_pred CCCCCEEecccccccccCccccccccccceEecccccccccCchhhcCCccchhhhccCCccccCCCcccCCCCCccEEE
Q 002158 156 LSNLNRLQVDENNITGTIPKSFANLSRVRHLHLNNNSIGGQIPSELSKLSTLIHLLVDNNNLSGNLPPELSELPQLCILQ 235 (958)
Q Consensus 156 l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~ 235 (958)
..+|++|++.+|++. .++..+..+++|+.|+|++|...+.+|. +..+++|+.|+|++|.....+|..+..+++|+.|+
T Consensus 610 ~~~L~~L~L~~s~l~-~L~~~~~~l~~Lk~L~Ls~~~~l~~ip~-ls~l~~Le~L~L~~c~~L~~lp~si~~L~~L~~L~ 687 (1153)
T PLN03210 610 PENLVKLQMQGSKLE-KLWDGVHSLTGLRNIDLRGSKNLKEIPD-LSMATNLETLKLSDCSSLVELPSSIQYLNKLEDLD 687 (1153)
T ss_pred ccCCcEEECcCcccc-ccccccccCCCCCEEECCCCCCcCcCCc-cccCCcccEEEecCCCCccccchhhhccCCCCEEe
Confidence 789999999999998 6788889999999999998875557775 88899999999999987778999999999999999
Q ss_pred ccCCCCCCCCccccccCCCCCCEEEcccCCCCCCCCCCCCCCCcCEEeccCCcCCCcCCCCC------------------
Q 002158 236 LDNNNFSASEIPATYGNFSKLVKLSLRNCNLQGAVPDLSRIPNLYYLDLSWNHLTGSIPSKK------------------ 297 (958)
Q Consensus 236 L~~N~l~~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~------------------ 297 (958)
+++|... ..+|..+ ++++|+.|+|++|......|.+ .++|++|+|++|.+. .+|...
T Consensus 688 L~~c~~L-~~Lp~~i-~l~sL~~L~Lsgc~~L~~~p~~--~~nL~~L~L~~n~i~-~lP~~~~l~~L~~L~l~~~~~~~l 762 (1153)
T PLN03210 688 MSRCENL-EILPTGI-NLKSLYRLNLSGCSRLKSFPDI--STNISWLDLDETAIE-EFPSNLRLENLDELILCEMKSEKL 762 (1153)
T ss_pred CCCCCCc-CccCCcC-CCCCCCEEeCCCCCCccccccc--cCCcCeeecCCCccc-cccccccccccccccccccchhhc
Confidence 9987543 3567655 7899999999999765555543 468899999999976 344221
Q ss_pred -------------CCCCcCEEEccCCcCCCccchhccCCCCCCeEeeecccCCCccchhhhcccccCccccceEeccCCC
Q 002158 298 -------------LSENVTTIDLSDNYLNGSILESISNLPFLQTLSLENNFLTGSIPATIWQNKSFSTKARLKIDLRNNS 364 (958)
Q Consensus 298 -------------~~~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~ip~~l~~~~~~~~~~l~~L~Ls~N~ 364 (958)
.+++|+.|+|++|.....+|..++++++|+.|+|++|...+.+|..+ ..+.|+.|+|++|.
T Consensus 763 ~~~~~~l~~~~~~~~~sL~~L~Ls~n~~l~~lP~si~~L~~L~~L~Ls~C~~L~~LP~~~------~L~sL~~L~Ls~c~ 836 (1153)
T PLN03210 763 WERVQPLTPLMTMLSPSLTRLFLSDIPSLVELPSSIQNLHKLEHLEIENCINLETLPTGI------NLESLESLDLSGCS 836 (1153)
T ss_pred cccccccchhhhhccccchheeCCCCCCccccChhhhCCCCCCEEECCCCCCcCeeCCCC------CccccCEEECCCCC
Confidence 12578899999998888899999999999999999987666888765 24578899999964
Q ss_pred -CCCCccCCCCCCcceEEeCCCCCCC
Q 002158 365 -FSNIVGDLTLPNNVTLRLGGNPICT 389 (958)
Q Consensus 365 -l~~l~~~~~l~~L~~L~l~~N~l~~ 389 (958)
+..++.. ..+|+.|+|++|.+..
T Consensus 837 ~L~~~p~~--~~nL~~L~Ls~n~i~~ 860 (1153)
T PLN03210 837 RLRTFPDI--STNISDLNLSRTGIEE 860 (1153)
T ss_pred cccccccc--ccccCEeECCCCCCcc
Confidence 4444432 4689999999999864
|
syringae 6; Provisional |
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.78 E-value=2.1e-18 Score=176.63 Aligned_cols=136 Identities=19% Similarity=0.242 Sum_probs=107.3
Q ss_pred CCCceeeeeCCeEEEEEEECCCcEEEEEEeccCChhcHHHHHHHHHHHHcc-----CCCCcceEEEEEEeCC---eEE-E
Q 002158 628 SSSTQVGQGGYGKVYKGILSDNTTVAIKRAEEGSLQGQNEFLTEIKLLSRL-----HHRNLVSLLGYCDEEG---EQM-L 698 (958)
Q Consensus 628 ~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-----~H~niv~l~~~~~~~~---~~~-l 698 (958)
...+.||+|+||.||. +.+....+||++........+.+.+|+++++.+ .||||++++|++.++. ..+ +
T Consensus 5 ~~~~~LG~G~~~~Vy~--hp~~~~k~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~~ 82 (210)
T PRK10345 5 SEQSPLGTGRHRKCYA--HPEDAQRCIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYDV 82 (210)
T ss_pred CCcceecCCCceEEEE--CCCCcCeEEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEEE
Confidence 4567899999999996 544344479988765444567799999999999 5799999999998863 433 7
Q ss_pred EEEe--cCCCCHHHHhccCCCCCchHHHHHHHHHHHHHHH-HHhhhcCCCCeeccCCCccceEecC----CCCeEEeeee
Q 002158 699 VYEF--VPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGI-LYLHTEAHPPVFHRDIKASNILLDS----NLNAKVADFG 771 (958)
Q Consensus 699 V~E~--~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL-~yLH~~~~~~iiH~Dikp~NILl~~----~~~~kl~DFG 771 (958)
|||| +++|+|.+++.+.. +++. ..++.+++.++ +|||+++ |+||||||+|||++. ++.++|+||+
T Consensus 83 I~e~~G~~~~tL~~~l~~~~---~~e~--~~~~~~~L~~l~~yLh~~~---IvhrDlKp~NILl~~~~~~~~~~~LiDg~ 154 (210)
T PRK10345 83 IADFDGKPSITLTEFAEQCR---YEED--VAQLRQLLKKLKRYLLDNR---IVTMELKPQNILCQRISESEVIPVVCDNI 154 (210)
T ss_pred EecCCCCcchhHHHHHHccc---ccHh--HHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEeccCCCCCcEEEEECC
Confidence 8999 55799999996532 5544 35677888777 9999999 999999999999974 3479999954
Q ss_pred ee
Q 002158 772 LS 773 (958)
Q Consensus 772 la 773 (958)
-+
T Consensus 155 G~ 156 (210)
T PRK10345 155 GE 156 (210)
T ss_pred CC
Confidence 33
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.77 E-value=9.4e-19 Score=196.08 Aligned_cols=216 Identities=27% Similarity=0.448 Sum_probs=161.4
Q ss_pred HHccCCCCcceEEEEEEeCCeEEEEEEecCCCCHHHHhccCCCCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCc
Q 002158 675 LSRLHHRNLVSLLGYCDEEGEQMLVYEFVPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKA 754 (958)
Q Consensus 675 l~~l~H~niv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp 754 (958)
|+.+.|.|+.+++|.+.++...+.|.+||..|+|.|.+... ...+++-....+..+++.||+|+|+.. -..|+.+++
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~-~~~~d~~F~~s~~rdi~~Gl~ylh~s~--i~~hg~l~s 77 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNE-DIKLDYFFILSFIRDISKGLAYLHNSP--IGYHGALKS 77 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhcc-ccCccHHHHHHHHHHHHHHHHHHhcCc--ceeeeeecc
Confidence 45789999999999999999999999999999999999864 345999999999999999999999765 139999999
Q ss_pred cceEecCCCCeEEeeeeeecccccCCCCCCccceeeeeccCCCCccChhhhccCC-------CCCcchhhhHHHHHHHHH
Q 002158 755 SNILLDSNLNAKVADFGLSRLAPVLDDEGTMPTHVSTIVKGTPGYLDPEYFLTHK-------LTDKSDVYSLGVVLLELL 827 (958)
Q Consensus 755 ~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-------~~~~~DV~S~Gv~l~ell 827 (958)
+|+++|....+||+|||+........... ......-..-|.|||.+.... .+.++||||||++++|++
T Consensus 78 ~nClvd~~w~lklt~~Gl~~~~~~~~~~~-----~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~ 152 (484)
T KOG1023|consen 78 SNCLVDSRWVLKLTDFGLNSLLEETAEPE-----AHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEIL 152 (484)
T ss_pred ccceeeeeEEEEechhhhccccccccccc-----ccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHH
Confidence 99999999999999999987664311111 111122344699999997642 356899999999999999
Q ss_pred hCCCCCCCCchh---HHHHHHHhhcCcchhhhcccCCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHh
Q 002158 828 TGMQPISHGKNI---VREVNVARDSGMVFSIIDNRMGSYPSECVERFVTLALRCCHDKPEHRPSMSDVVRELENILK 901 (958)
Q Consensus 828 tG~~P~~~~~~~---~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~ 901 (958)
+.+.||...... .+.+....+.+. ....+..... .+.++.+..++.+||..+|.+||++++|-..++.+.+
T Consensus 153 ~r~~~~~~~~~~~~~~eii~~~~~~~~--~~~rP~i~~~-~e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~~~~ 226 (484)
T KOG1023|consen 153 FRSGPFDLRNLVEDPDEIILRVKKGGS--NPFRPSIELL-NELPPELLLLVARCWEEIPEKRPSIEQIRSKLLTINK 226 (484)
T ss_pred hccCccccccccCChHHHHHHHHhcCC--CCcCcchhhh-hhcchHHHHHHHHhcccChhhCccHHHHHhhhhhhcc
Confidence 999999753221 112222221010 0001111101 1455579999999999999999999999887776654
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.76 E-value=1.6e-19 Score=201.40 Aligned_cols=224 Identities=28% Similarity=0.309 Sum_probs=181.8
Q ss_pred eeeeCCeEEEEEE----ECCCcEEEEEEeccCChhc--HHHHHHHHHHHHccC-CCCcceEEEEEEeCCeEEEEEEecCC
Q 002158 633 VGQGGYGKVYKGI----LSDNTTVAIKRAEEGSLQG--QNEFLTEIKLLSRLH-HRNLVSLLGYCDEEGEQMLVYEFVPN 705 (958)
Q Consensus 633 lg~G~~g~Vy~~~----~~~~~~vavK~~~~~~~~~--~~~~~~E~~~l~~l~-H~niv~l~~~~~~~~~~~lV~E~~~~ 705 (958)
+|+|.||.|+.+. .+.|..+|.|+.++..... ......|..++...+ ||.++++.-.+..+...+++++|..+
T Consensus 2 lg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~rg 81 (612)
T KOG0603|consen 2 LGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLRG 81 (612)
T ss_pred CCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhccc
Confidence 6899999999765 2357788999876643221 125567888999997 99999999999999999999999999
Q ss_pred CCHHHHhccCCCCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEecCCCCeEEeeeeeecccccCCCCCCc
Q 002158 706 GTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSRLAPVLDDEGTM 785 (958)
Q Consensus 706 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~ 785 (958)
|.|...+..... ++......+...+|-|++++|+.+ |+|||+|++||+++.+|.+++.|||+++..-...
T Consensus 82 g~lft~l~~~~~--f~~~~~~~~~aelaLald~lh~l~---iiyrd~k~enilld~~Ghi~~tdfglske~v~~~----- 151 (612)
T KOG0603|consen 82 GDLFTRLSKEVM--FDELDVAFYLAELALALDHLHKLG---IAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEK----- 151 (612)
T ss_pred chhhhccccCCc--hHHHHHHHHHHHHHHHHhhcchhH---HHHhcccccceeecccCccccCCchhhhHhHhhh-----
Confidence 999988865443 777777888889999999999999 9999999999999999999999999998642211
Q ss_pred cceeeeeccCCCCccChhhhccCCCCCcchhhhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcCcchhhhcccCCCCCh
Q 002158 786 PTHVSTIVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVLLELLTGMQPISHGKNIVREVNVARDSGMVFSIIDNRMGSYPS 865 (958)
Q Consensus 786 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gv~l~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~ 865 (958)
..+||..|||||++. ....++|.||||++++||+||..||.. . .+. .|-..-..+|.
T Consensus 152 ------~~cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~--~---~~~----------~Il~~~~~~p~ 208 (612)
T KOG0603|consen 152 ------IACGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG--D---TMK----------RILKAELEMPR 208 (612)
T ss_pred ------hcccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch--H---HHH----------HHhhhccCCch
Confidence 117999999999998 567899999999999999999999975 1 111 11122234577
Q ss_pred HHHHHHHHHHHHccccCCCCCCCH
Q 002158 866 ECVERFVTLALRCCHDKPEHRPSM 889 (958)
Q Consensus 866 ~~~~~l~~li~~cl~~dP~~RPs~ 889 (958)
.......+++.++...+|..|--.
T Consensus 209 ~l~~~a~~~~~~l~~r~p~nrLg~ 232 (612)
T KOG0603|consen 209 ELSAEARSLFRQLFKRNPENRLGA 232 (612)
T ss_pred hhhHHHHHHHHHHHhhCHHHHhcc
Confidence 888888999999999999999654
|
|
| >KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.76 E-value=9e-21 Score=176.38 Aligned_cols=165 Identities=31% Similarity=0.491 Sum_probs=101.7
Q ss_pred CCCCCCEEecccccccccCccccccccccceEecccccccccCchhhcCCccchhhhccCCccccCCCcccCCCCCccEE
Q 002158 155 YLSNLNRLQVDENNITGTIPKSFANLSRVRHLHLNNNSIGGQIPSELSKLSTLIHLLVDNNNLSGNLPPELSELPQLCIL 234 (958)
Q Consensus 155 ~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L 234 (958)
++.+.+.|-|++|+++ .+|+.++.+.+|+.|++.+|+|. .+|..++.+++|+.|+++-|++. ..|..|+.+|.|+.|
T Consensus 31 ~~s~ITrLtLSHNKl~-~vppnia~l~nlevln~~nnqie-~lp~~issl~klr~lnvgmnrl~-~lprgfgs~p~levl 107 (264)
T KOG0617|consen 31 NMSNITRLTLSHNKLT-VVPPNIAELKNLEVLNLSNNQIE-ELPTSISSLPKLRILNVGMNRLN-ILPRGFGSFPALEVL 107 (264)
T ss_pred chhhhhhhhcccCcee-ecCCcHHHhhhhhhhhcccchhh-hcChhhhhchhhhheecchhhhh-cCccccCCCchhhhh
Confidence 3444444555555554 44445555555555555555555 45555555555555555555555 455566666666666
Q ss_pred EccCCCCCCCCccccccCCCCCCEEEcccCCCCCCCCCCCCCCCcCEEeccCCcCCCcCCCCCCCCCcCEEEccCCcCCC
Q 002158 235 QLDNNNFSASEIPATYGNFSKLVKLSLRNCNLQGAVPDLSRIPNLYYLDLSWNHLTGSIPSKKLSENVTTIDLSDNYLNG 314 (958)
Q Consensus 235 ~L~~N~l~~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~~~L~~L~Ls~N~l~~ 314 (958)
||.+|++....+|..|..+..|+.|+|++|.+.-.+++++.+++|+.|.+.+|.+-
T Consensus 108 dltynnl~e~~lpgnff~m~tlralyl~dndfe~lp~dvg~lt~lqil~lrdndll------------------------ 163 (264)
T KOG0617|consen 108 DLTYNNLNENSLPGNFFYMTTLRALYLGDNDFEILPPDVGKLTNLQILSLRDNDLL------------------------ 163 (264)
T ss_pred hccccccccccCCcchhHHHHHHHHHhcCCCcccCChhhhhhcceeEEeeccCchh------------------------
Confidence 66666665555666666666666666666666656666666666666666666654
Q ss_pred ccchhccCCCCCCeEeeecccCCCccchhhhcc
Q 002158 315 SILESISNLPFLQTLSLENNFLTGSIPATIWQN 347 (958)
Q Consensus 315 ~~~~~~~~l~~L~~L~L~~N~l~~~ip~~l~~~ 347 (958)
..|..++.+..|++|.+++|+++ .+|.++..+
T Consensus 164 ~lpkeig~lt~lrelhiqgnrl~-vlppel~~l 195 (264)
T KOG0617|consen 164 SLPKEIGDLTRLRELHIQGNRLT-VLPPELANL 195 (264)
T ss_pred hCcHHHHHHHHHHHHhcccceee-ecChhhhhh
Confidence 45677788888888888888887 777776543
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.74 E-value=1.2e-17 Score=174.90 Aligned_cols=201 Identities=21% Similarity=0.264 Sum_probs=145.6
Q ss_pred CCCCcceEEEEEEe---------------------------CCeEEEEEEecCCCCHHHHhccCCCCCchHHHHHHHHHH
Q 002158 679 HHRNLVSLLGYCDE---------------------------EGEQMLVYEFVPNGTLRDWLSGRTKENLNFAMRLRVALD 731 (958)
Q Consensus 679 ~H~niv~l~~~~~~---------------------------~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ 731 (958)
+|||||++.++|.+ ....|+||...+ .+|+.|+..+. .+...+.-+..|
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~-~tLr~yl~~~~---~s~r~~~~~laQ 349 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYR-QTLREYLWTRH---RSYRTGRVILAQ 349 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcch-hhHHHHHhcCC---CchHHHHHHHHH
Confidence 69999999887633 234689998884 59999997654 556667788999
Q ss_pred HHHHHHHhhhcCCCCeeccCCCccceEe--cCCC--CeEEeeeeeecccccCCCCCCccceeeeeccCCCCccChhhhcc
Q 002158 732 SAKGILYLHTEAHPPVFHRDIKASNILL--DSNL--NAKVADFGLSRLAPVLDDEGTMPTHVSTIVKGTPGYLDPEYFLT 807 (958)
Q Consensus 732 ia~aL~yLH~~~~~~iiH~Dikp~NILl--~~~~--~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 807 (958)
+++|+.|||.+| |.|||+|++|||+ |+|+ .+.|+|||.+-.-+..+-.-.. ........|...-||||+...
T Consensus 350 lLEav~hL~~hg---vAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy-~S~~Vd~GGNa~lmAPEi~ta 425 (598)
T KOG4158|consen 350 LLEAVTHLHKHG---VAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPY-ESDEVDLGGNAKLMAPEIATA 425 (598)
T ss_pred HHHHHHHHHHcc---chhhcccccceEEEecCCCCcEEEEcccceeeecccccccccc-ccccccCCCcceecchhhhhc
Confidence 999999999999 9999999999999 4444 4789999987432221111111 111223457778999999865
Q ss_pred CC-----C-CCcchhhhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcCcchhhhcccCCCCChHHHHHHHHHHHHcccc
Q 002158 808 HK-----L-TDKSDVYSLGVVLLELLTGMQPISHGKNIVREVNVARDSGMVFSIIDNRMGSYPSECVERFVTLALRCCHD 881 (958)
Q Consensus 808 ~~-----~-~~~~DV~S~Gv~l~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~l~~li~~cl~~ 881 (958)
.+ . -.|+|.|+.|.+.||+++...||.......-..+. .-...++.+|..++..+.+++...++.
T Consensus 426 ~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L~~r~---------Yqe~qLPalp~~vpp~~rqlV~~lL~r 496 (598)
T KOG4158|consen 426 VPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLLDTRT---------YQESQLPALPSRVPPVARQLVFDLLKR 496 (598)
T ss_pred CCCCceeeccchhhhhhhhhhHHHHhccCCcccccchheechhh---------hhhhhCCCCcccCChHHHHHHHHHhcC
Confidence 42 1 23899999999999999999999753221111111 112334667888999999999999999
Q ss_pred CCCCCCCHHHHHHHH
Q 002158 882 KPEHRPSMSDVVREL 896 (958)
Q Consensus 882 dP~~RPs~~evl~~L 896 (958)
||.+|++..-....|
T Consensus 497 ~pskRvsp~iAANvl 511 (598)
T KOG4158|consen 497 DPSKRVSPNIAANVL 511 (598)
T ss_pred CccccCCccHHHhHH
Confidence 999999876544443
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.74 E-value=1.3e-17 Score=199.31 Aligned_cols=254 Identities=21% Similarity=0.280 Sum_probs=187.3
Q ss_pred HHHHHHHcCCCCCceeeeeCCeEEEEEEECCCcEEEEEEeccCChhcHHHHHHHHHHHHccC---CCCcceEEEEEEeCC
Q 002158 618 KELAMATAYFSSSTQVGQGGYGKVYKGILSDNTTVAIKRAEEGSLQGQNEFLTEIKLLSRLH---HRNLVSLLGYCDEEG 694 (958)
Q Consensus 618 ~el~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---H~niv~l~~~~~~~~ 694 (958)
.+.+...+.|.+.+.||+|+||+||+|...+|+.||+|+-+.....+ |.-=.+++.+|+ -+-|..+...+...+
T Consensus 691 ~~~~~~~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~WE---fYI~~q~~~RLk~~~~~~~~~~~~a~~~~~ 767 (974)
T KOG1166|consen 691 TEFEVGGEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNPWE---FYICLQVMERLKPQMLPSIMHISSAHVFQN 767 (974)
T ss_pred ceeeecceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCcee---eeehHHHHHhhchhhhcchHHHHHHHccCC
Confidence 45566677888899999999999999998889999999987655432 333444555555 234555556666677
Q ss_pred eEEEEEEecCCCCHHHHhccCCCCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEecC-------CCCeEE
Q 002158 695 EQMLVYEFVPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDS-------NLNAKV 767 (958)
Q Consensus 695 ~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~-------~~~~kl 767 (958)
..+||+||.+.|+|.+++. ..+.+++.-.+.++.|+++-+++||..+ |||+||||+|+||.. ...++|
T Consensus 768 ~S~lv~ey~~~Gtlld~~N--~~~~m~e~lv~~~~~qml~ive~lH~~~---IIHgDiKPDNfll~~~~~~~~~~~~l~l 842 (974)
T KOG1166|consen 768 ASVLVSEYSPYGTLLDLIN--TNKVMDEYLVMFFSCQMLRIVEHLHAMG---IIHGDIKPDNFLLRREICADSDSKGLYL 842 (974)
T ss_pred cceeeeeccccccHHHhhc--cCCCCCchhhhHHHHHHHHHHHHHHhcc---eecccCCcceeEeecccCCCCcccceEE
Confidence 8899999999999999997 3445999999999999999999999999 999999999999942 345899
Q ss_pred eeeeeecccccCCCCCCccceeeeeccCCCCccChhhhccCCCCCcchhhhHHHHHHHHHhCCCCCCCCchhHHHHHHHh
Q 002158 768 ADFGLSRLAPVLDDEGTMPTHVSTIVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVLLELLTGMQPISHGKNIVREVNVAR 847 (958)
Q Consensus 768 ~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gv~l~elltG~~P~~~~~~~~~~~~~~~ 847 (958)
+|||-+-.+....+. ......++|-.+--+|+..+...++.+|-|.+..+++-|+.|+.- . .
T Consensus 843 IDfG~siDm~lfp~~-----~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y~-----------q--~ 904 (974)
T KOG1166|consen 843 IDFGRSIDMKLFPDG-----TKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKYM-----------E--V 904 (974)
T ss_pred EecccceeeeEcCCC-----cEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHHH-----------H--h
Confidence 999998765443332 234567789999999999999999999999999999999998641 1 1
Q ss_pred hcCcchhhhcccCCCCChHH-HHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHh
Q 002158 848 DSGMVFSIIDNRMGSYPSEC-VERFVTLALRCCHDKPEHRPSMSDVVRELENILK 901 (958)
Q Consensus 848 ~~~~~~~~i~~~~~~~~~~~-~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~ 901 (958)
..+....+ +.. ++.-. .+-+.++...+|+.|-..=|...++...++....
T Consensus 905 ~~g~~~~~-~~~---~~Ry~~~~~W~~~F~~lLN~~~~~~p~l~~lr~~~~~~~~ 955 (974)
T KOG1166|consen 905 KNGSSWMV-KTN---FPRYWKRDMWNKFFDLLLNPDCDTLPNLQELRTELEEVLA 955 (974)
T ss_pred cCCcceec-ccc---chhhhhHHHHHHHHHHHhCcCcccchhHHHHHHHHHHHHH
Confidence 11111111 111 11111 1224456666666555555788888777777653
|
|
| >cd00116 LRR_RI Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily | Back alignment and domain information |
|---|
Probab=99.73 E-value=1.6e-19 Score=201.02 Aligned_cols=200 Identities=26% Similarity=0.266 Sum_probs=100.0
Q ss_pred EEccCCcCCC-CccccccCCCCcceeeccCccc-----CCCCccccCCCCCcEEEeeCCCCCC------CCChhhcCCCC
Q 002158 91 LQLLSMNLSG-NLAPELGQLSRLQYYFMWNDLT-----GTIPKEIGNISSLIFLLLNGNKLSG------SLPDELGYLSN 158 (958)
Q Consensus 91 L~L~~~~l~~-~~~~~l~~L~~L~~L~l~n~~~-----~~ip~~i~~l~~L~~L~Ls~n~l~~------~~p~~l~~l~~ 158 (958)
|+|..+.+++ .....+..+..|+.|.+.++.. ..++..+...++|++|+++++.+.+ .++..+..+++
T Consensus 3 l~L~~~~l~~~~~~~~~~~l~~L~~l~l~~~~l~~~~~~~i~~~l~~~~~l~~l~l~~~~~~~~~~~~~~~~~~l~~~~~ 82 (319)
T cd00116 3 LSLKGELLKTERATELLPKLLCLQVLRLEGNTLGEEAAKALASALRPQPSLKELCLSLNETGRIPRGLQSLLQGLTKGCG 82 (319)
T ss_pred cccccCcccccchHHHHHHHhhccEEeecCCCCcHHHHHHHHHHHhhCCCceEEeccccccCCcchHHHHHHHHHHhcCc
Confidence 5566666653 3334444555566666654443 2244455556666666666666552 12334555666
Q ss_pred CCEEecccccccccCccccccccc---cceEecccccccc----cCchhhcCC-ccchhhhccCCccccC----CCcccC
Q 002158 159 LNRLQVDENNITGTIPKSFANLSR---VRHLHLNNNSIGG----QIPSELSKL-STLIHLLVDNNNLSGN----LPPELS 226 (958)
Q Consensus 159 L~~L~L~~N~l~~~~p~~~~~l~~---L~~L~Ls~N~l~~----~~p~~l~~l-~~L~~L~L~~N~l~~~----~~~~l~ 226 (958)
|++|++++|.+.+..+..+..+.+ |+.|++++|++++ .+...+..+ ++|+.|++++|.+++. +...+.
T Consensus 83 L~~L~l~~~~~~~~~~~~~~~l~~~~~L~~L~ls~~~~~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~~~~~~~ 162 (319)
T cd00116 83 LQELDLSDNALGPDGCGVLESLLRSSSLQELKLNNNGLGDRGLRLLAKGLKDLPPALEKLVLGRNRLEGASCEALAKALR 162 (319)
T ss_pred eeEEEccCCCCChhHHHHHHHHhccCcccEEEeeCCccchHHHHHHHHHHHhCCCCceEEEcCCCcCCchHHHHHHHHHH
Confidence 666666666665544444444444 6666666666552 122233444 5555555555555521 222344
Q ss_pred CCCCccEEEccCCCCCCCC---ccccccCCCCCCEEEcccCCCCCCCC-----CCCCCCCcCEEeccCCcCC
Q 002158 227 ELPQLCILQLDNNNFSASE---IPATYGNFSKLVKLSLRNCNLQGAVP-----DLSRIPNLYYLDLSWNHLT 290 (958)
Q Consensus 227 ~l~~L~~L~L~~N~l~~~~---~p~~~~~l~~L~~L~L~~N~l~~~~~-----~l~~l~~L~~L~Ls~N~l~ 290 (958)
.+++|++|+|++|.+++.. ++..+..+++|+.|+|++|.+++... .+..+++|++|++++|.++
T Consensus 163 ~~~~L~~L~l~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~~~~~~~L~~L~ls~n~l~ 234 (319)
T cd00116 163 ANRDLKELNLANNGIGDAGIRALAEGLKANCNLEVLDLNNNGLTDEGASALAETLASLKSLEVLNLGDNNLT 234 (319)
T ss_pred hCCCcCEEECcCCCCchHHHHHHHHHHHhCCCCCEEeccCCccChHHHHHHHHHhcccCCCCEEecCCCcCc
Confidence 4455555555555554211 11223333455555555555543221 1334445555555555544
|
LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). |
| >KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.71 E-value=2.7e-19 Score=166.58 Aligned_cols=154 Identities=29% Similarity=0.470 Sum_probs=71.8
Q ss_pred CCCCcEEEeeCCCCCCCCChhhcCCCCCCEEecccccccccCccccccccccceEecccccccccCchhhcCCccchhhh
Q 002158 132 ISSLIFLLLNGNKLSGSLPDELGYLSNLNRLQVDENNITGTIPKSFANLSRVRHLHLNNNSIGGQIPSELSKLSTLIHLL 211 (958)
Q Consensus 132 l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~ 211 (958)
+++++.|.||+|+++ .+|+.+..|.+|+.|++.+|+++ .+|.+++.+++|+.|+++-|++. ..|..|+.++.|+.||
T Consensus 32 ~s~ITrLtLSHNKl~-~vppnia~l~nlevln~~nnqie-~lp~~issl~klr~lnvgmnrl~-~lprgfgs~p~levld 108 (264)
T KOG0617|consen 32 MSNITRLTLSHNKLT-VVPPNIAELKNLEVLNLSNNQIE-ELPTSISSLPKLRILNVGMNRLN-ILPRGFGSFPALEVLD 108 (264)
T ss_pred hhhhhhhhcccCcee-ecCCcHHHhhhhhhhhcccchhh-hcChhhhhchhhhheecchhhhh-cCccccCCCchhhhhh
Confidence 334444444444444 34444444444444444444444 44444444444444444444444 4444444444444444
Q ss_pred ccCCccc-cCCCcccCCCCCccEEEccCCCCCCCCccccccCCCCCCEEEcccCCCCCCCCCCCCCCCcCEEeccCCcCC
Q 002158 212 VDNNNLS-GNLPPELSELPQLCILQLDNNNFSASEIPATYGNFSKLVKLSLRNCNLQGAVPDLSRIPNLYYLDLSWNHLT 290 (958)
Q Consensus 212 L~~N~l~-~~~~~~l~~l~~L~~L~L~~N~l~~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~l~~l~~L~~L~Ls~N~l~ 290 (958)
|.+|+++ ..+|..|..++.|+-|+|++|.+ ..+|..++++++|+.|.+..|.+-..+.+++.++.|++|.+.+|+++
T Consensus 109 ltynnl~e~~lpgnff~m~tlralyl~dndf--e~lp~dvg~lt~lqil~lrdndll~lpkeig~lt~lrelhiqgnrl~ 186 (264)
T KOG0617|consen 109 LTYNNLNENSLPGNFFYMTTLRALYLGDNDF--EILPPDVGKLTNLQILSLRDNDLLSLPKEIGDLTRLRELHIQGNRLT 186 (264)
T ss_pred ccccccccccCCcchhHHHHHHHHHhcCCCc--ccCChhhhhhcceeEEeeccCchhhCcHHHHHHHHHHHHhcccceee
Confidence 4444443 23344444444444444444444 23444444444444444444444444444444455555555555544
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.71 E-value=6.2e-17 Score=168.61 Aligned_cols=134 Identities=19% Similarity=0.328 Sum_probs=114.4
Q ss_pred ceeeeeCCeEEEEEEECCCcEEEEEEeccCChh--------cHHHHHHHHHHHHccCCCCcceEEEEEEeCCeEEEEEEe
Q 002158 631 TQVGQGGYGKVYKGILSDNTTVAIKRAEEGSLQ--------GQNEFLTEIKLLSRLHHRNLVSLLGYCDEEGEQMLVYEF 702 (958)
Q Consensus 631 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~--------~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E~ 702 (958)
+.||+|++|.||+|.+ .|..|+||+....... ...++.+|++++..++|+++.....++...+..++||||
T Consensus 2 ~~l~~G~~~~vy~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~ 80 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF-LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEY 80 (211)
T ss_pred cccccCceEEEEEEee-CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEE
Confidence 5799999999999988 6778999986543211 124578899999999999998888887777889999999
Q ss_pred cCCCCHHHHhccCCCCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEecCCCCeEEeeeeeecc
Q 002158 703 VPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSRL 775 (958)
Q Consensus 703 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~ 775 (958)
++|++|.+++.... . ++..++.+++.+|.++|+.+ ++|||++|+|||++ ++.++|+|||.++.
T Consensus 81 ~~G~~L~~~~~~~~-----~-~~~~i~~~i~~~l~~lH~~~---i~H~Dl~p~Nil~~-~~~~~liDf~~a~~ 143 (211)
T PRK14879 81 IEGEPLKDLINSNG-----M-EELELSREIGRLVGKLHSAG---IIHGDLTTSNMILS-GGKIYLIDFGLAEF 143 (211)
T ss_pred eCCcCHHHHHHhcc-----H-HHHHHHHHHHHHHHHHHhCC---cccCCCCcccEEEE-CCCEEEEECCcccC
Confidence 99999999986432 1 78899999999999999999 99999999999999 78999999998763
|
|
| >KOG4237 consensus Extracellular matrix protein slit, contains leucine-rich and EGF-like repeats [Extracellular structures; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.71 E-value=3.7e-19 Score=186.31 Aligned_cols=341 Identities=20% Similarity=0.189 Sum_probs=257.1
Q ss_pred EEccCCcCCCCccccccCCCCcceeeccCcccCCCCcc-ccCCCCCcEEEeeCCCCCCCCChhhcCCCCCCEEeccc-cc
Q 002158 91 LQLLSMNLSGNLAPELGQLSRLQYYFMWNDLTGTIPKE-IGNISSLIFLLLNGNKLSGSLPDELGYLSNLNRLQVDE-NN 168 (958)
Q Consensus 91 L~L~~~~l~~~~~~~l~~L~~L~~L~l~n~~~~~ip~~-i~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~L~~-N~ 168 (958)
++-++.+++. +|..+. ..-..+.|..|.+..||+. |+.+++|+.||||+|+|+.+-|++|..|.+|.+|-+.+ |+
T Consensus 51 VdCr~~GL~e-VP~~LP--~~tveirLdqN~I~~iP~~aF~~l~~LRrLdLS~N~Is~I~p~AF~GL~~l~~Lvlyg~Nk 127 (498)
T KOG4237|consen 51 VDCRGKGLTE-VPANLP--PETVEIRLDQNQISSIPPGAFKTLHRLRRLDLSKNNISFIAPDAFKGLASLLSLVLYGNNK 127 (498)
T ss_pred EEccCCCccc-CcccCC--CcceEEEeccCCcccCChhhccchhhhceecccccchhhcChHhhhhhHhhhHHHhhcCCc
Confidence 3445555554 332221 2234567888888888855 99999999999999999999999999999988887777 99
Q ss_pred ccccCccccccccccceEecccccccccCchhhcCCccchhhhccCCccccCCCcccCCCCCccEEEccCCCCCC-----
Q 002158 169 ITGTIPKSFANLSRVRHLHLNNNSIGGQIPSELSKLSTLIHLLVDNNNLSGNLPPELSELPQLCILQLDNNNFSA----- 243 (958)
Q Consensus 169 l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~----- 243 (958)
|+......|.+|..|+.|.+.-|++.-...+.|..+++|..|.+.+|.+..+--..|..+..++.+.+..|.+..
T Consensus 128 I~~l~k~~F~gL~slqrLllNan~i~Cir~~al~dL~~l~lLslyDn~~q~i~~~tf~~l~~i~tlhlA~np~icdCnL~ 207 (498)
T KOG4237|consen 128 ITDLPKGAFGGLSSLQRLLLNANHINCIRQDALRDLPSLSLLSLYDNKIQSICKGTFQGLAAIKTLHLAQNPFICDCNLP 207 (498)
T ss_pred hhhhhhhHhhhHHHHHHHhcChhhhcchhHHHHHHhhhcchhcccchhhhhhccccccchhccchHhhhcCccccccccc
Confidence 997777889999999999999999998888999999999999999999996666699999999999999998421
Q ss_pred ------CCccccccCCCCCCEEEcccCCCCCCCCC-C-CCCCCcCEEeccCCcCCCcCCCC--CCCCCcCEEEccCCcCC
Q 002158 244 ------SEIPATYGNFSKLVKLSLRNCNLQGAVPD-L-SRIPNLYYLDLSWNHLTGSIPSK--KLSENVTTIDLSDNYLN 313 (958)
Q Consensus 244 ------~~~p~~~~~l~~L~~L~L~~N~l~~~~~~-l-~~l~~L~~L~Ls~N~l~~~~~~~--~~~~~L~~L~Ls~N~l~ 313 (958)
...|..++.+.-.....|.++++...... | ..+..+..=..+.+...+..|.. ..+++|+.|+|++|+|+
T Consensus 208 wla~~~a~~~ietsgarc~~p~rl~~~Ri~q~~a~kf~c~~esl~s~~~~~d~~d~~cP~~cf~~L~~L~~lnlsnN~i~ 287 (498)
T KOG4237|consen 208 WLADDLAMNPIETSGARCVSPYRLYYKRINQEDARKFLCSLESLPSRLSSEDFPDSICPAKCFKKLPNLRKLNLSNNKIT 287 (498)
T ss_pred hhhhHHhhchhhcccceecchHHHHHHHhcccchhhhhhhHHhHHHhhccccCcCCcChHHHHhhcccceEeccCCCccc
Confidence 12344455666666666777777766553 3 33333322223333344455543 45689999999999999
Q ss_pred CccchhccCCCCCCeEeeecccCCCccchhhhcccccCccccceEeccCCCCCCCccCC--CCCCcceEEeCCCCCCCCC
Q 002158 314 GSILESISNLPFLQTLSLENNFLTGSIPATIWQNKSFSTKARLKIDLRNNSFSNIVGDL--TLPNNVTLRLGGNPICTSA 391 (958)
Q Consensus 314 ~~~~~~~~~l~~L~~L~L~~N~l~~~ip~~l~~~~~~~~~~l~~L~Ls~N~l~~l~~~~--~l~~L~~L~l~~N~l~~~~ 391 (958)
++.+.+|.++..|++|.|..|+|. .+....|+. ...|++|+|.+|+|+.+.... .+..|.+|+|-+|||.|+|
T Consensus 288 ~i~~~aFe~~a~l~eL~L~~N~l~-~v~~~~f~~----ls~L~tL~L~~N~it~~~~~aF~~~~~l~~l~l~~Np~~CnC 362 (498)
T KOG4237|consen 288 RIEDGAFEGAAELQELYLTRNKLE-FVSSGMFQG----LSGLKTLSLYDNQITTVAPGAFQTLFSLSTLNLLSNPFNCNC 362 (498)
T ss_pred hhhhhhhcchhhhhhhhcCcchHH-HHHHHhhhc----cccceeeeecCCeeEEEecccccccceeeeeehccCcccCcc
Confidence 999999999999999999999998 555555543 235678999999999987654 8889999999999999999
Q ss_pred CCCCCCcccccCCCCCccccccCCCCCCCCCCCCCcccccCCCCCCceeeeeceee
Q 002158 392 NIPNTGRFCGSDAGGDETLTNSKVNCPVQACPVDNFFEYVPASPEPCFCAAPLRIG 447 (958)
Q Consensus 392 ~~~~~~~~~~~~~~~~~~L~~n~~~C~c~~~~~~~~~~~~~~~~~~~~c~sp~~~~ 447 (958)
.+.|...|+.++. ..||| .|+.-.+..-+....+.-+.-+|+.|.+.+
T Consensus 363 ~l~wl~~Wlr~~~-----~~~~~---~Cq~p~~~~~~~~~dv~~~~~~c~~~ee~~ 410 (498)
T KOG4237|consen 363 RLAWLGEWLRKKS-----VVGNP---RCQSPGFVRQIPISDVAFGDFRCGGPEELG 410 (498)
T ss_pred chHHHHHHHhhCC-----CCCCC---CCCCCchhccccchhccccccccCCccccC
Confidence 9999999987655 23433 355444444443333333346677776544
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.70 E-value=7.5e-17 Score=166.33 Aligned_cols=130 Identities=21% Similarity=0.314 Sum_probs=107.6
Q ss_pred eeeeeCCeEEEEEEECCCcEEEEEEeccCCh--------hcHHHHHHHHHHHHccCCCCcceEEEEEEeCCeEEEEEEec
Q 002158 632 QVGQGGYGKVYKGILSDNTTVAIKRAEEGSL--------QGQNEFLTEIKLLSRLHHRNLVSLLGYCDEEGEQMLVYEFV 703 (958)
Q Consensus 632 ~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E~~ 703 (958)
.||+|+||+||+|.+ ++..|++|+...... ....++.+|+++++.++|+++.....++...+..++||||+
T Consensus 1 ~ig~G~~~~vy~~~~-~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~ 79 (199)
T TIGR03724 1 LIAKGAEAIIYLGDF-LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYI 79 (199)
T ss_pred CCCCCceEEEEEeec-CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEE
Confidence 389999999999986 678899998654211 11256788999999999887666555666667789999999
Q ss_pred CCCCHHHHhccCCCCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEecCCCCeEEeeeeeecc
Q 002158 704 PNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSRL 775 (958)
Q Consensus 704 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~ 775 (958)
+|++|.+++.... . .++.+++.+|.++|+.+ ++|||++|+||+++ ++.++++|||+++.
T Consensus 80 ~g~~l~~~~~~~~---~------~~~~~i~~~l~~lH~~g---i~H~Dl~~~Nil~~-~~~~~liDfg~a~~ 138 (199)
T TIGR03724 80 EGKPLKDVIEEGN---D------ELLREIGRLVGKLHKAG---IVHGDLTTSNIIVR-DDKLYLIDFGLGKY 138 (199)
T ss_pred CCccHHHHHhhcH---H------HHHHHHHHHHHHHHHCC---eecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence 9999999885421 1 78999999999999999 99999999999999 89999999999874
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >cd00116 LRR_RI Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily | Back alignment and domain information |
|---|
Probab=99.70 E-value=1e-18 Score=194.59 Aligned_cols=263 Identities=24% Similarity=0.255 Sum_probs=181.1
Q ss_pred CCCccccCCCCCcEEEeeCCCCCCC----CChhhcCCCCCCEEecccccccc------cCccccccccccceEecccccc
Q 002158 124 TIPKEIGNISSLIFLLLNGNKLSGS----LPDELGYLSNLNRLQVDENNITG------TIPKSFANLSRVRHLHLNNNSI 193 (958)
Q Consensus 124 ~ip~~i~~l~~L~~L~Ls~n~l~~~----~p~~l~~l~~L~~L~L~~N~l~~------~~p~~~~~l~~L~~L~Ls~N~l 193 (958)
..+..+..+.+|++|+|+++.++.. ++..+...++|++|+++++.+.+ .++..+..+++|+.|+|++|.+
T Consensus 14 ~~~~~~~~l~~L~~l~l~~~~l~~~~~~~i~~~l~~~~~l~~l~l~~~~~~~~~~~~~~~~~~l~~~~~L~~L~l~~~~~ 93 (319)
T cd00116 14 RATELLPKLLCLQVLRLEGNTLGEEAAKALASALRPQPSLKELCLSLNETGRIPRGLQSLLQGLTKGCGLQELDLSDNAL 93 (319)
T ss_pred chHHHHHHHhhccEEeecCCCCcHHHHHHHHHHHhhCCCceEEeccccccCCcchHHHHHHHHHHhcCceeEEEccCCCC
Confidence 3445566777899999999998542 55567778889999999988762 2345677788999999999998
Q ss_pred cccCchhhcCCcc---chhhhccCCcccc----CCCcccCCC-CCccEEEccCCCCCCC---CccccccCCCCCCEEEcc
Q 002158 194 GGQIPSELSKLST---LIHLLVDNNNLSG----NLPPELSEL-PQLCILQLDNNNFSAS---EIPATYGNFSKLVKLSLR 262 (958)
Q Consensus 194 ~~~~p~~l~~l~~---L~~L~L~~N~l~~----~~~~~l~~l-~~L~~L~L~~N~l~~~---~~p~~~~~l~~L~~L~L~ 262 (958)
.+..+..+..+.+ |++|++++|++++ .+...+..+ ++|+.|+|++|.++.. .+...+..+.+|++|+|+
T Consensus 94 ~~~~~~~~~~l~~~~~L~~L~ls~~~~~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~~~~~~~~~~~L~~L~l~ 173 (319)
T cd00116 94 GPDGCGVLESLLRSSSLQELKLNNNGLGDRGLRLLAKGLKDLPPALEKLVLGRNRLEGASCEALAKALRANRDLKELNLA 173 (319)
T ss_pred ChhHHHHHHHHhccCcccEEEeeCCccchHHHHHHHHHHHhCCCCceEEEcCCCcCCchHHHHHHHHHHhCCCcCEEECc
Confidence 8666666655555 9999999998873 233455666 8889999999988732 234456677789999999
Q ss_pred cCCCCCCCC-----CCCCCCCcCEEeccCCcCCCcCC-----CCCCCCCcCEEEccCCcCCCccchhccC-----CCCCC
Q 002158 263 NCNLQGAVP-----DLSRIPNLYYLDLSWNHLTGSIP-----SKKLSENVTTIDLSDNYLNGSILESISN-----LPFLQ 327 (958)
Q Consensus 263 ~N~l~~~~~-----~l~~l~~L~~L~Ls~N~l~~~~~-----~~~~~~~L~~L~Ls~N~l~~~~~~~~~~-----l~~L~ 327 (958)
+|.+++... .+..+++|+.|+|++|.+++... ....+++|++|++++|.+++.....+.. .+.|+
T Consensus 174 ~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~~~~~~~L~~L~ls~n~l~~~~~~~l~~~~~~~~~~L~ 253 (319)
T cd00116 174 NNGIGDAGIRALAEGLKANCNLEVLDLNNNGLTDEGASALAETLASLKSLEVLNLGDNNLTDAGAAALASALLSPNISLL 253 (319)
T ss_pred CCCCchHHHHHHHHHHHhCCCCCEEeccCCccChHHHHHHHHHhcccCCCCEEecCCCcCchHHHHHHHHHHhccCCCce
Confidence 888875221 24556788889998888864221 1233478888888888887644444332 37888
Q ss_pred eEeeecccCCCccchhhhcccccCccccceEeccCCCCCCCcc-----CC-CC-CCcceEEeCCCCC
Q 002158 328 TLSLENNFLTGSIPATIWQNKSFSTKARLKIDLRNNSFSNIVG-----DL-TL-PNNVTLRLGGNPI 387 (958)
Q Consensus 328 ~L~L~~N~l~~~ip~~l~~~~~~~~~~l~~L~Ls~N~l~~l~~-----~~-~l-~~L~~L~l~~N~l 387 (958)
.|++++|.++......+...... .+.++.+|+++|.++.-.. .. .. +.|+.||+.+|||
T Consensus 254 ~L~l~~n~i~~~~~~~l~~~~~~-~~~L~~l~l~~N~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 319 (319)
T cd00116 254 TLSLSCNDITDDGAKDLAEVLAE-KESLLELDLRGNKFGEEGAQLLAESLLEPGNELESLWVKDDSF 319 (319)
T ss_pred EEEccCCCCCcHHHHHHHHHHhc-CCCccEEECCCCCCcHHHHHHHHHHHhhcCCchhhcccCCCCC
Confidence 88888888873322222221111 1567788888888886422 11 33 6788888888876
|
LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). |
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.70 E-value=1.2e-16 Score=164.53 Aligned_cols=143 Identities=19% Similarity=0.181 Sum_probs=112.0
Q ss_pred HHHHHHcCCCCCceeeeeCCeEEEEEEECCCcEEEEEEeccCChh----------------------cHHHHHHHHHHHH
Q 002158 619 ELAMATAYFSSSTQVGQGGYGKVYKGILSDNTTVAIKRAEEGSLQ----------------------GQNEFLTEIKLLS 676 (958)
Q Consensus 619 el~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~----------------------~~~~~~~E~~~l~ 676 (958)
++......|...+.||+|+||.||+|..++|+.||||++...... ....+..|+.++.
T Consensus 9 ~~~~~~~~~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~ 88 (198)
T cd05144 9 TLVKRGVVESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALK 88 (198)
T ss_pred HHHHcCchhhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHH
Confidence 343334447778899999999999999888999999987543200 1123678899999
Q ss_pred ccCCC--CcceEEEEEEeCCeEEEEEEecCCCCHHHHhccCCCCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCc
Q 002158 677 RLHHR--NLVSLLGYCDEEGEQMLVYEFVPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKA 754 (958)
Q Consensus 677 ~l~H~--niv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp 754 (958)
.+.|+ .+.+.++. ...++||||+++++|.+.... .....++.+++.++.++|+.+ |+||||||
T Consensus 89 ~l~~~~i~v~~~~~~----~~~~lv~e~~~g~~L~~~~~~--------~~~~~~~~~i~~~l~~lh~~g---i~H~Dl~p 153 (198)
T cd05144 89 ALYEEGFPVPKPIDW----NRHAVVMEYIDGVELYRVRVL--------EDPEEVLDEILEEIVKAYKHG---IIHGDLSE 153 (198)
T ss_pred HHHHcCCCCCceeec----CCceEEEEEeCCcchhhcccc--------ccHHHHHHHHHHHHHHHHHCC---CCcCCCCc
Confidence 99887 44555542 356899999999999776431 234678899999999999998 99999999
Q ss_pred cceEecCCCCeEEeeeeeeccc
Q 002158 755 SNILLDSNLNAKVADFGLSRLA 776 (958)
Q Consensus 755 ~NILl~~~~~~kl~DFGla~~~ 776 (958)
+||++++++.++|+|||++...
T Consensus 154 ~Nill~~~~~~~liDfg~~~~~ 175 (198)
T cd05144 154 FNILVDDDEKIYIIDWPQMVST 175 (198)
T ss_pred ccEEEcCCCcEEEEECCccccC
Confidence 9999999999999999998643
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.70 E-value=8.5e-17 Score=169.15 Aligned_cols=141 Identities=18% Similarity=0.169 Sum_probs=110.4
Q ss_pred CCCCCceeeeeCCeEEEEEE--ECCCcEEEEEEeccCChh------------------------cHHHHHHHHHHHHccC
Q 002158 626 YFSSSTQVGQGGYGKVYKGI--LSDNTTVAIKRAEEGSLQ------------------------GQNEFLTEIKLLSRLH 679 (958)
Q Consensus 626 ~~~~~~~lg~G~~g~Vy~~~--~~~~~~vavK~~~~~~~~------------------------~~~~~~~E~~~l~~l~ 679 (958)
.|.+.+.||+|+||.||+|. ..+|+.||||+++..... ....+..|++.++++.
T Consensus 29 ~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~ 108 (237)
T smart00090 29 LSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLY 108 (237)
T ss_pred hHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 36677899999999999998 458999999988753210 0123568999999997
Q ss_pred CC--CcceEEEEEEeCCeEEEEEEecCCCCHHHHhccCCCCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccce
Q 002158 680 HR--NLVSLLGYCDEEGEQMLVYEFVPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNI 757 (958)
Q Consensus 680 H~--niv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NI 757 (958)
+. .+.+++++ ...++||||+++++|..+.... ..+...+...++.|++.++++||+.+. |+||||||+||
T Consensus 109 ~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~~--~~~~~~~~~~i~~qi~~~l~~LH~~g~--iiH~Dikp~NI 180 (237)
T smart00090 109 EAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLKD--VEPEEEEEFELYDDILEEMRKLYKEGE--LVHGDLSEYNI 180 (237)
T ss_pred hcCCCCCeeeEe----cCceEEEEEecCCccccccccc--CCcchHHHHHHHHHHHHHHHHHHhcCC--EEeCCCChhhE
Confidence 53 34455543 2358999999998887765322 235666778999999999999998874 99999999999
Q ss_pred EecCCCCeEEeeeeeecc
Q 002158 758 LLDSNLNAKVADFGLSRL 775 (958)
Q Consensus 758 Ll~~~~~~kl~DFGla~~ 775 (958)
+++ ++.++|+|||.+..
T Consensus 181 li~-~~~i~LiDFg~a~~ 197 (237)
T smart00090 181 LVH-DGKVVIIDVSQSVE 197 (237)
T ss_pred EEE-CCCEEEEEChhhhc
Confidence 999 88999999999874
|
|
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.69 E-value=7.6e-17 Score=191.16 Aligned_cols=145 Identities=19% Similarity=0.280 Sum_probs=116.4
Q ss_pred hHHHHHHHcCCCCCceeeeeCCeEEEEEEECCCcEEEEEE-eccC-Ch------hcHHHHHHHHHHHHccCCCCcceEEE
Q 002158 617 FKELAMATAYFSSSTQVGQGGYGKVYKGILSDNTTVAIKR-AEEG-SL------QGQNEFLTEIKLLSRLHHRNLVSLLG 688 (958)
Q Consensus 617 ~~el~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~-~~~~-~~------~~~~~~~~E~~~l~~l~H~niv~l~~ 688 (958)
+.........|...+.||+|+||+||+|.+.+.. +++|+ .... .. ...+++.+|++++++++|++++....
T Consensus 325 ~~~~~~~~~~~~~~~~iG~G~~g~Vy~~~~~~~~-~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~ 403 (535)
T PRK09605 325 WIKEEEVKRRKIPDHLIGKGAEADIKKGEYLGRD-AVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVI 403 (535)
T ss_pred eccccccccccCccceeccCCcEEEEEEeecCcc-ceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEE
Confidence 3333444455567889999999999999885443 44443 2211 11 12356889999999999999998888
Q ss_pred EEEeCCeEEEEEEecCCCCHHHHhccCCCCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEecCCCCeEEe
Q 002158 689 YCDEEGEQMLVYEFVPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSNLNAKVA 768 (958)
Q Consensus 689 ~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~~~~kl~ 768 (958)
++......++||||+++++|.+++. ....++.+++++|.|||+.+ ++||||||+|||+ +++.++|+
T Consensus 404 ~~~~~~~~~lv~E~~~g~~L~~~l~----------~~~~~~~~i~~~L~~lH~~g---iiHrDlkp~NILl-~~~~~~li 469 (535)
T PRK09605 404 YDVDPEEKTIVMEYIGGKDLKDVLE----------GNPELVRKVGEIVAKLHKAG---IVHGDLTTSNFIV-RDDRLYLI 469 (535)
T ss_pred EEEeCCCCEEEEEecCCCcHHHHHH----------HHHHHHHHHHHHHHHHHhCC---CccCCCChHHEEE-ECCcEEEE
Confidence 8888778899999999999999885 35678999999999999999 9999999999999 67899999
Q ss_pred eeeeeccc
Q 002158 769 DFGLSRLA 776 (958)
Q Consensus 769 DFGla~~~ 776 (958)
|||+++..
T Consensus 470 DFGla~~~ 477 (535)
T PRK09605 470 DFGLGKYS 477 (535)
T ss_pred eCcccccC
Confidence 99998753
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.68 E-value=2.2e-17 Score=180.95 Aligned_cols=177 Identities=29% Similarity=0.426 Sum_probs=130.5
Q ss_pred CeEEEEEEecCCCCHHHHhcc-CCCCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEecCCCCeEEeeeee
Q 002158 694 GEQMLVYEFVPNGTLRDWLSG-RTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSNLNAKVADFGL 772 (958)
Q Consensus 694 ~~~~lV~E~~~~gsL~~~l~~-~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~~~~kl~DFGl 772 (958)
...|+.|++|...+|.+||.. +.....++.....++.|++.|++| ++ .+|||+||.||+...+..+||+|||+
T Consensus 329 ~~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~---~ihrdlkp~nif~~~d~q~kIgDFgl 402 (516)
T KOG1033|consen 329 VYLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KG---LIHRDLKPSNIFFSDDDQLKIGDFGL 402 (516)
T ss_pred cchhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---cc---chhhhccccccccccchhhhhhhhhh
Confidence 357899999999999999974 345568889999999999999999 67 99999999999999999999999999
Q ss_pred ecccccCCCCCCccceeeeeccCCCCccChhhhccCCCCCcchhhhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcCcc
Q 002158 773 SRLAPVLDDEGTMPTHVSTIVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVLLELLTGMQPISHGKNIVREVNVARDSGMV 852 (958)
Q Consensus 773 a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gv~l~elltG~~P~~~~~~~~~~~~~~~~~~~~ 852 (958)
....+... ....+....+...||..||+||.+.+..|+.|+||||+|++|+|++. +|.....-.....
T Consensus 403 ~ts~~~~~-~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~---~f~T~~er~~t~~-------- 470 (516)
T KOG1033|consen 403 VTSQDKDE-TVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLI---QFSTQFERIATLT-------- 470 (516)
T ss_pred eeecccCC-cccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHH---HhccHHHHHHhhh--------
Confidence 87654433 11112223445679999999999999999999999999999999998 2221111001000
Q ss_pred hhhhcccCCCCChHH---HHHHHHHHHHccccCCCCCCCHHHH
Q 002158 853 FSIIDNRMGSYPSEC---VERFVTLALRCCHDKPEHRPSMSDV 892 (958)
Q Consensus 853 ~~~i~~~~~~~~~~~---~~~l~~li~~cl~~dP~~RPs~~ev 892 (958)
++-+ +.+|+.. .+.=+.++.+++.+.|.+||++.++
T Consensus 471 -d~r~---g~ip~~~~~d~p~e~~ll~~lls~~p~~RP~~~~~ 509 (516)
T KOG1033|consen 471 -DIRD---GIIPPEFLQDYPEEYTLLQQLLSPSPEERPSAIEV 509 (516)
T ss_pred -hhhc---CCCChHHhhcCcHHHHHHHHhcCCCcccCchHHHH
Confidence 0111 1222111 1223578899999999999955443
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.65 E-value=9.7e-17 Score=187.34 Aligned_cols=215 Identities=23% Similarity=0.290 Sum_probs=146.1
Q ss_pred HHcCCCCCceeeeeCCeEEEEEEEC-CCcEEEEEEeccCChhcHHHHHHHHHHHHccCCCCcceEEEEEEeCCeEEEEEE
Q 002158 623 ATAYFSSSTQVGQGGYGKVYKGILS-DNTTVAIKRAEEGSLQGQNEFLTEIKLLSRLHHRNLVSLLGYCDEEGEQMLVYE 701 (958)
Q Consensus 623 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E 701 (958)
...+|+.++.|..|+||.||..+++ ..+.+|+|+-+... - .+- ++.....|.+|
T Consensus 81 ~e~df~~IklisngAygavylvrh~~trqrfa~kiNkq~l-i-----lRn--ilt~a~npfvv----------------- 135 (1205)
T KOG0606|consen 81 SESDFNTIKLISNGAYGAVYLVRHKETRQRFAMKINKQNL-I-----LRN--ILTFAGNPFVV----------------- 135 (1205)
T ss_pred CccccceeEeeccCCCCceeeeeccccccchhhcccccch-h-----hhc--cccccCCccee-----------------
Confidence 3457888899999999999999987 36678884433211 0 010 22222333333
Q ss_pred ecCCCCHHHHhccCCCCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEecCCCCeEEeeeeeecccccCCC
Q 002158 702 FVPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSRLAPVLDD 781 (958)
Q Consensus 702 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~ 781 (958)
|+-.+.++.-+. ++.. ++.+++|+|+.+ |+|||+||+|.+|+.-|.+|+.|||+++..-..-.
T Consensus 136 ----gDc~tllk~~g~--lPvd--------mvla~Eylh~yg---ivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~a 198 (1205)
T KOG0606|consen 136 ----GDCATLLKNIGP--LPVD--------MVLAVEYLHSYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLA 198 (1205)
T ss_pred ----chhhhhcccCCC--Ccch--------hhHHhHhhccCC---eecCCCCCCcceeeecccccccchhhhhhhhhhcc
Confidence 444455543222 3322 278999999999 99999999999999999999999999875311100
Q ss_pred C--------CCccceeeeeccCCCCccChhhhccCCCCCcchhhhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcCcch
Q 002158 782 E--------GTMPTHVSTIVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVLLELLTGMQPISHGKNIVREVNVARDSGMVF 853 (958)
Q Consensus 782 ~--------~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gv~l~elltG~~P~~~~~~~~~~~~~~~~~~~~~ 853 (958)
. .....-....++||+.|+|||++....|...+|.|++|+++||.+.|+.||+++....-.-....+...+
T Consensus 199 tnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpeelfg~visd~i~w- 277 (1205)
T KOG0606|consen 199 TNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIEW- 277 (1205)
T ss_pred chhhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHHHHhhhhhhhccc-
Confidence 0 0000112345689999999999999999999999999999999999999998654322111112211111
Q ss_pred hhhcccCCCCChHHHHHHHHHHHHccccCCCCCC
Q 002158 854 SIIDNRMGSYPSECVERFVTLALRCCHDKPEHRP 887 (958)
Q Consensus 854 ~~i~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP 887 (958)
.+-....+.+..+++.+.++.+|..|-
T Consensus 278 -------pE~dea~p~Ea~dli~~LL~qnp~~Rl 304 (1205)
T KOG0606|consen 278 -------PEEDEALPPEAQDLIEQLLRQNPLCRL 304 (1205)
T ss_pred -------cccCcCCCHHHHHHHHHHHHhChHhhc
Confidence 112334567888999999999999993
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.61 E-value=1.8e-15 Score=148.16 Aligned_cols=135 Identities=19% Similarity=0.191 Sum_probs=114.9
Q ss_pred CCceeeeeCCeEEEEEEECCCcEEEEEEeccCChhcHHHHHHHHHHHHccCC--CCcceEEEEEEeCCeEEEEEEecCCC
Q 002158 629 SSTQVGQGGYGKVYKGILSDNTTVAIKRAEEGSLQGQNEFLTEIKLLSRLHH--RNLVSLLGYCDEEGEQMLVYEFVPNG 706 (958)
Q Consensus 629 ~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H--~niv~l~~~~~~~~~~~lV~E~~~~g 706 (958)
+.+.||+|.++.||++...+ ..+++|....... ...+.+|+.+++.++| .++++++++...++..+++|||++++
T Consensus 2 ~~~~i~~g~~~~v~~~~~~~-~~~~iK~~~~~~~--~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g~ 78 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTKD-EDYVLKINPSREK--GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGE 78 (155)
T ss_pred cceecccccccceEEEEecC-CeEEEEecCCCCc--hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCCe
Confidence 35679999999999999854 7899999876443 4578899999999976 58999999998888999999999887
Q ss_pred CHHHHhccCCCCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEecCCCCeEEeeeeeecc
Q 002158 707 TLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSRL 775 (958)
Q Consensus 707 sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~ 775 (958)
.+..+ +......++.+++++++++|....++++|+|++|+||++++.+.++++|||.++.
T Consensus 79 ~~~~~---------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~ 138 (155)
T cd05120 79 TLDEV---------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY 138 (155)
T ss_pred ecccC---------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence 77554 4456678899999999999986545599999999999999989999999998864
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.59 E-value=6.2e-15 Score=150.39 Aligned_cols=135 Identities=20% Similarity=0.235 Sum_probs=98.8
Q ss_pred CceeeeeCCeEEEEEEECCCcEEEEEEeccCChh--cHHHH----------------------HHHHHHHHccCCC--Cc
Q 002158 630 STQVGQGGYGKVYKGILSDNTTVAIKRAEEGSLQ--GQNEF----------------------LTEIKLLSRLHHR--NL 683 (958)
Q Consensus 630 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~--~~~~~----------------------~~E~~~l~~l~H~--ni 683 (958)
.+.||+|+||+||+|...+++.||||++...... ....+ ..|.+.+.++.+. .+
T Consensus 2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~ 81 (187)
T cd05119 2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV 81 (187)
T ss_pred CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence 4679999999999999888999999988653211 11111 3566666666543 34
Q ss_pred ceEEEEEEeCCeEEEEEEecCCCCHHH-HhccCCCCCchHHHHHHHHHHHHHHHHHhhh-cCCCCeeccCCCccceEecC
Q 002158 684 VSLLGYCDEEGEQMLVYEFVPNGTLRD-WLSGRTKENLNFAMRLRVALDSAKGILYLHT-EAHPPVFHRDIKASNILLDS 761 (958)
Q Consensus 684 v~l~~~~~~~~~~~lV~E~~~~gsL~~-~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~-~~~~~iiH~Dikp~NILl~~ 761 (958)
.+.+++ ...++||||++++.+.. .+.... .. .++..++.+++.++.++|. .+ |+||||||+||+++
T Consensus 82 ~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~---~~-~~~~~~~~~~~~~l~~lh~~~~---ivH~Dl~p~Nili~- 149 (187)
T cd05119 82 PKPIDL----NRHVLVMEFIGGDGIPAPRLKDVR---LL-EDPEELYDQILELMRKLYREAG---LVHGDLSEYNILVD- 149 (187)
T ss_pred CceEec----CCCEEEEEEeCCCCccChhhhhhh---hc-ccHHHHHHHHHHHHHHHhhccC---cCcCCCChhhEEEE-
Confidence 555543 24689999999854321 111111 11 5678899999999999999 88 99999999999999
Q ss_pred CCCeEEeeeeeeccc
Q 002158 762 NLNAKVADFGLSRLA 776 (958)
Q Consensus 762 ~~~~kl~DFGla~~~ 776 (958)
++.++|+|||.+...
T Consensus 150 ~~~~~liDfg~a~~~ 164 (187)
T cd05119 150 DGKVYIIDVPQAVEI 164 (187)
T ss_pred CCcEEEEECcccccc
Confidence 899999999998643
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.58 E-value=1.5e-14 Score=152.56 Aligned_cols=135 Identities=21% Similarity=0.229 Sum_probs=106.4
Q ss_pred Cceee-eeCCeEEEEEEECCCcEEEEEEeccCC-------------hhcHHHHHHHHHHHHccCCCCc--ceEEEEEEeC
Q 002158 630 STQVG-QGGYGKVYKGILSDNTTVAIKRAEEGS-------------LQGQNEFLTEIKLLSRLHHRNL--VSLLGYCDEE 693 (958)
Q Consensus 630 ~~~lg-~G~~g~Vy~~~~~~~~~vavK~~~~~~-------------~~~~~~~~~E~~~l~~l~H~ni--v~l~~~~~~~ 693 (958)
...|| .||.|+||++... +..++||.+.... .....++.+|++++.+++|+++ ++.+++...+
T Consensus 36 ~~~lg~~~g~gtv~~v~~~-~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~ 114 (239)
T PRK01723 36 ARVVGSAKGRGTTWFVQTP-GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVR 114 (239)
T ss_pred CceeecCCCCccEEEEEeC-CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeee
Confidence 35788 8999999999874 7789999875421 1223467899999999998875 7777775433
Q ss_pred C----eEEEEEEecCC-CCHHHHhccCCCCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEecCCCCeEEe
Q 002158 694 G----EQMLVYEFVPN-GTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSNLNAKVA 768 (958)
Q Consensus 694 ~----~~~lV~E~~~~-gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~~~~kl~ 768 (958)
. ..++||||+++ .+|.+++... .++.. .+.+++.++.+||+.| |+||||||+|||++.++.++|+
T Consensus 115 ~~~~~~~~lV~e~l~G~~~L~~~l~~~---~l~~~----~~~~i~~~l~~lH~~G---I~HrDlkp~NILv~~~~~v~LI 184 (239)
T PRK01723 115 HGLFYRADILIERIEGARDLVALLQEA---PLSEE----QWQAIGQLIARFHDAG---VYHADLNAHNILLDPDGKFWLI 184 (239)
T ss_pred cCcceeeeEEEEecCCCCCHHHHHhcC---CCCHH----HHHHHHHHHHHHHHCC---CCCCCCCchhEEEcCCCCEEEE
Confidence 2 23599999997 6999998643 24433 3568999999999999 9999999999999999999999
Q ss_pred eeeeecc
Q 002158 769 DFGLSRL 775 (958)
Q Consensus 769 DFGla~~ 775 (958)
|||.++.
T Consensus 185 Dfg~~~~ 191 (239)
T PRK01723 185 DFDRGEL 191 (239)
T ss_pred ECCCccc
Confidence 9998864
|
|
| >PLN03150 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.58 E-value=8.7e-15 Score=175.31 Aligned_cols=159 Identities=30% Similarity=0.524 Sum_probs=105.1
Q ss_pred cCCCCHhHHHHHHHHHHHcccCccccCCCCCCCCCC---CCCCceeeCccccCCCceeeEEEEccCCcCCCCccccccCC
Q 002158 33 AQTTDPQEASALRAIKNSLVDSMNHLRNWNKGDPCM---SNWTGVLCFDTVETDGHLHVRELQLLSMNLSGNLAPELGQL 109 (958)
Q Consensus 33 ~~~~~~~~~~al~~~k~~~~~~~~~l~~W~~~~~c~---~~w~gV~C~~~~~~~~~~~v~~L~L~~~~l~~~~~~~l~~L 109 (958)
...+.++|+.||+++|+++.++.. .+|++ ++|+ +.|.||.|.... ......++.|+|.++++.|.+|+.+
T Consensus 366 ~~~t~~~~~~aL~~~k~~~~~~~~--~~W~g-~~C~p~~~~w~Gv~C~~~~-~~~~~~v~~L~L~~n~L~g~ip~~i--- 438 (623)
T PLN03150 366 ESKTLLEEVSALQTLKSSLGLPLR--FGWNG-DPCVPQQHPWSGADCQFDS-TKGKWFIDGLGLDNQGLRGFIPNDI--- 438 (623)
T ss_pred ccccCchHHHHHHHHHHhcCCccc--CCCCC-CCCCCcccccccceeeccC-CCCceEEEEEECCCCCccccCCHHH---
Confidence 345678999999999999976532 48975 6774 369999995321 1223468888888887776665554
Q ss_pred CCcceeeccCcccCCCCccccCCCCCcEEEeeCCCCCCCCChhhcCCCCCCEEecccccccccCccccccccccceEecc
Q 002158 110 SRLQYYFMWNDLTGTIPKEIGNISSLIFLLLNGNKLSGSLPDELGYLSNLNRLQVDENNITGTIPKSFANLSRVRHLHLN 189 (958)
Q Consensus 110 ~~L~~L~l~n~~~~~ip~~i~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls 189 (958)
+++++|+.|+|++|.++|.+|..++.+++|+.|+|++|+++|.+|..++++++|+.|+|+
T Consensus 439 --------------------~~L~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~LdLs~N~lsg~iP~~l~~L~~L~~L~Ls 498 (623)
T PLN03150 439 --------------------SKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLN 498 (623)
T ss_pred --------------------hCCCCCCEEECCCCcccCcCChHHhCCCCCCEEECCCCCCCCCCchHHhcCCCCCEEECc
Confidence 445555556666666666666666666666666666666666666666666666666666
Q ss_pred cccccccCchhhcCC-ccchhhhccCCccc
Q 002158 190 NNSIGGQIPSELSKL-STLIHLLVDNNNLS 218 (958)
Q Consensus 190 ~N~l~~~~p~~l~~l-~~L~~L~L~~N~l~ 218 (958)
+|+++|.+|..+..+ .++..+++.+|...
T Consensus 499 ~N~l~g~iP~~l~~~~~~~~~l~~~~N~~l 528 (623)
T PLN03150 499 GNSLSGRVPAALGGRLLHRASFNFTDNAGL 528 (623)
T ss_pred CCcccccCChHHhhccccCceEEecCCccc
Confidence 666666666665543 34556666666543
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.46 E-value=3.1e-13 Score=154.92 Aligned_cols=140 Identities=21% Similarity=0.210 Sum_probs=101.0
Q ss_pred CceeeeeCCeEEEEEEECCCcEEEEEEeccCChhcH----------------------------------------HHHH
Q 002158 630 STQVGQGGYGKVYKGILSDNTTVAIKRAEEGSLQGQ----------------------------------------NEFL 669 (958)
Q Consensus 630 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~----------------------------------------~~~~ 669 (958)
.+.||+|++|.||+|++++|+.||||+.+....... -+|.
T Consensus 122 ~~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~ 201 (437)
T TIGR01982 122 EKPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLR 201 (437)
T ss_pred CcceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHH
Confidence 367999999999999999999999999865421110 1255
Q ss_pred HHHHHHHccC----CCCcceEEEEE-EeCCeEEEEEEecCCCCHHHHhccCCCCCchHHHHHHHHHHHHH-HHHHhhhcC
Q 002158 670 TEIKLLSRLH----HRNLVSLLGYC-DEEGEQMLVYEFVPNGTLRDWLSGRTKENLNFAMRLRVALDSAK-GILYLHTEA 743 (958)
Q Consensus 670 ~E~~~l~~l~----H~niv~l~~~~-~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~-aL~yLH~~~ 743 (958)
+|++.+.+++ |.+-+.+-.++ ...+..+|||||++|++|.++....... . .+.+++.++++ .+..+|..|
T Consensus 202 ~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~~-~---~~~~ia~~~~~~~l~ql~~~g 277 (437)
T TIGR01982 202 REAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEAG-L---DRKALAENLARSFLNQVLRDG 277 (437)
T ss_pred HHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhcC-C---CHHHHHHHHHHHHHHHHHhCC
Confidence 5666666652 33323332332 2244679999999999998887532111 2 23456666666 478899988
Q ss_pred CCCeeccCCCccceEecCCCCeEEeeeeeeccc
Q 002158 744 HPPVFHRDIKASNILLDSNLNAKVADFGLSRLA 776 (958)
Q Consensus 744 ~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~~ 776 (958)
++|+|+||.||++++++.++++|||++..+
T Consensus 278 ---~~H~D~hPgNilv~~~g~i~liDfG~~~~l 307 (437)
T TIGR01982 278 ---FFHADLHPGNIFVLKDGKIIALDFGIVGRL 307 (437)
T ss_pred ---ceeCCCCcccEEECCCCcEEEEeCCCeeEC
Confidence 999999999999999999999999998755
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.44 E-value=1.2e-14 Score=171.41 Aligned_cols=254 Identities=24% Similarity=0.270 Sum_probs=187.7
Q ss_pred cCCCCCceeeeeCCeEEEEEEECC--CcEEEEEEeccCC--hhcHHHHHHHHHHHHccC-CCCcceEEEEEEeCCeEEEE
Q 002158 625 AYFSSSTQVGQGGYGKVYKGILSD--NTTVAIKRAEEGS--LQGQNEFLTEIKLLSRLH-HRNLVSLLGYCDEEGEQMLV 699 (958)
Q Consensus 625 ~~~~~~~~lg~G~~g~Vy~~~~~~--~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~~~~~lV 699 (958)
..|...+.||+|+|+.|-...... ...+|+|.+.... ....+....|..+=..+. |+|++.+++.....+..+++
T Consensus 20 ~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~~ 99 (601)
T KOG0590|consen 20 SQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLLS 99 (601)
T ss_pred ccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCcccccc
Confidence 345566779999999998887643 4456666655432 222233445777777776 99999999999999999999
Q ss_pred EEecCCCCHHHHhccCCCCCchHHHHHHHHHHHHHHHHHhh-hcCCCCeeccCCCccceEecCCC-CeEEeeeeeecccc
Q 002158 700 YEFVPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLH-TEAHPPVFHRDIKASNILLDSNL-NAKVADFGLSRLAP 777 (958)
Q Consensus 700 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH-~~~~~~iiH~Dikp~NILl~~~~-~~kl~DFGla~~~~ 777 (958)
+||..++++.+-+........+....-.+..|+..++.|+| ..+ +.||||||+|.+++..+ ..+++|||+|..+.
T Consensus 100 ~~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~~---~~h~~ikP~n~~l~~s~~~l~~~df~~At~~~ 176 (601)
T KOG0590|consen 100 LSYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPENG---VTHRDIKPSNSLLDESGSALKIADFGLATAYR 176 (601)
T ss_pred cCcccccccccccccCCccCCCCcchhhhhhhhccCccccCcccc---cccCCCCCccchhccCCCcccCCCchhhcccc
Confidence 99999999999883222223666777889999999999999 888 99999999999999999 99999999998775
Q ss_pred cCCCCCCccceeeeeccC-CCCccChhhhccC-CCCCcchhhhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcCcchhh
Q 002158 778 VLDDEGTMPTHVSTIVKG-TPGYLDPEYFLTH-KLTDKSDVYSLGVVLLELLTGMQPISHGKNIVREVNVARDSGMVFSI 855 (958)
Q Consensus 778 ~~~~~~~~~~~~~~~~~g-t~~y~aPE~~~~~-~~~~~~DV~S~Gv~l~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~ 855 (958)
..... ........| ++.|+|||...+. ......|+||.|+++.-+++|..||........ .....
T Consensus 177 ~~~g~----~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~---------~~~~~ 243 (601)
T KOG0590|consen 177 NKNGA----ERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDG---------RYSSW 243 (601)
T ss_pred ccCCc----ceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccc---------cceee
Confidence 42111 223344567 9999999999885 445689999999999999999999975432211 11111
Q ss_pred hccc-C--CCCChHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002158 856 IDNR-M--GSYPSECVERFVTLALRCCHDKPEHRPSMSDVVR 894 (958)
Q Consensus 856 i~~~-~--~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 894 (958)
+... . ............++..+++..+|..|.+.+++..
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~ 285 (601)
T KOG0590|consen 244 KSNKGRFTQLPWNSISDQAHDLLHKILKENPSNRLSIEELKL 285 (601)
T ss_pred cccccccccCccccCChhhhhcccccccCCchhccccccccc
Confidence 1111 0 1122344566778888999999999999888764
|
|
| >KOG0532 consensus Leucine-rich repeat (LRR) protein, contains calponin homology domain [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.39 E-value=2.4e-14 Score=156.94 Aligned_cols=184 Identities=28% Similarity=0.440 Sum_probs=140.0
Q ss_pred CCCCCEEecccccccccCccccccccccceEecccccccccCchhhcCCccchhhhccCCccccCCCcccCCCCCccEEE
Q 002158 156 LSNLNRLQVDENNITGTIPKSFANLSRVRHLHLNNNSIGGQIPSELSKLSTLIHLLVDNNNLSGNLPPELSELPQLCILQ 235 (958)
Q Consensus 156 l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~ 235 (958)
|+--...||+.|++. .+|..+..+..|+.+.|.+|.|. .+|..+.++..|++|+|+.|+++ .+|..+..|+ |+.|.
T Consensus 74 ltdt~~aDlsrNR~~-elp~~~~~f~~Le~liLy~n~~r-~ip~~i~~L~~lt~l~ls~NqlS-~lp~~lC~lp-Lkvli 149 (722)
T KOG0532|consen 74 LTDTVFADLSRNRFS-ELPEEACAFVSLESLILYHNCIR-TIPEAICNLEALTFLDLSSNQLS-HLPDGLCDLP-LKVLI 149 (722)
T ss_pred ccchhhhhccccccc-cCchHHHHHHHHHHHHHHhccce-ecchhhhhhhHHHHhhhccchhh-cCChhhhcCc-ceeEE
Confidence 444556677777777 67777777777777777777777 67777788888888888888877 5566666554 77888
Q ss_pred ccCCCCCCCCccccccCCCCCCEEEcccCCCCCCCCCCCCCCCcCEEeccCCcCCCcCCCCCCCCCcCEEEccCCcCCCc
Q 002158 236 LDNNNFSASEIPATYGNFSKLVKLSLRNCNLQGAVPDLSRIPNLYYLDLSWNHLTGSIPSKKLSENVTTIDLSDNYLNGS 315 (958)
Q Consensus 236 L~~N~l~~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~~~L~~L~Ls~N~l~~~ 315 (958)
+++|+++ .+|..++.+..|..|+.+.|.+...++.+.++.+|+.|.+..|++. .+|.....-.|..||+|.|+++ .
T Consensus 150 ~sNNkl~--~lp~~ig~~~tl~~ld~s~nei~slpsql~~l~slr~l~vrRn~l~-~lp~El~~LpLi~lDfScNkis-~ 225 (722)
T KOG0532|consen 150 VSNNKLT--SLPEEIGLLPTLAHLDVSKNEIQSLPSQLGYLTSLRDLNVRRNHLE-DLPEELCSLPLIRLDFSCNKIS-Y 225 (722)
T ss_pred EecCccc--cCCcccccchhHHHhhhhhhhhhhchHHhhhHHHHHHHHHhhhhhh-hCCHHHhCCceeeeecccCcee-e
Confidence 8888885 5677777777788888888888877777888888888888888887 3443333557888888888887 7
Q ss_pred cchhccCCCCCCeEeeecccCCCccchhhhccc
Q 002158 316 ILESISNLPFLQTLSLENNFLTGSIPATIWQNK 348 (958)
Q Consensus 316 ~~~~~~~l~~L~~L~L~~N~l~~~ip~~l~~~~ 348 (958)
+|..|.+|..|++|-|.+|+|+ +-|..++...
T Consensus 226 iPv~fr~m~~Lq~l~LenNPLq-SPPAqIC~kG 257 (722)
T KOG0532|consen 226 LPVDFRKMRHLQVLQLENNPLQ-SPPAQICEKG 257 (722)
T ss_pred cchhhhhhhhheeeeeccCCCC-CChHHHHhcc
Confidence 8889999999999999999998 7777776543
|
|
| >COG4886 Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Probab=99.35 E-value=1.2e-12 Score=150.29 Aligned_cols=200 Identities=36% Similarity=0.443 Sum_probs=147.6
Q ss_pred EEEeeCCCCCCCCChhhcCCCCCCEEecccccccccCcccccccc-ccceEecccccccccCchhhcCCccchhhhccCC
Q 002158 137 FLLLNGNKLSGSLPDELGYLSNLNRLQVDENNITGTIPKSFANLS-RVRHLHLNNNSIGGQIPSELSKLSTLIHLLVDNN 215 (958)
Q Consensus 137 ~L~Ls~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~-~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N 215 (958)
.|+++.|.+. .....+..++.++.|++.+|.++ .++.....+. +|+.|++++|.+. .+|..+..+++|+.|++++|
T Consensus 97 ~l~~~~~~~~-~~~~~~~~~~~l~~L~l~~n~i~-~i~~~~~~~~~nL~~L~l~~N~i~-~l~~~~~~l~~L~~L~l~~N 173 (394)
T COG4886 97 SLDLNLNRLR-SNISELLELTNLTSLDLDNNNIT-DIPPLIGLLKSNLKELDLSDNKIE-SLPSPLRNLPNLKNLDLSFN 173 (394)
T ss_pred eeeccccccc-cCchhhhcccceeEEecCCcccc-cCccccccchhhcccccccccchh-hhhhhhhccccccccccCCc
Confidence 5778888775 33344666778888888888888 5666666664 8888888888888 56666788888888888888
Q ss_pred ccccCCCcccCCCCCccEEEccCCCCCCCCccccccCCCCCCEEEcccCCCCCCCCCCCCCCCcCEEeccCCcCCCcCCC
Q 002158 216 NLSGNLPPELSELPQLCILQLDNNNFSASEIPATYGNFSKLVKLSLRNCNLQGAVPDLSRIPNLYYLDLSWNHLTGSIPS 295 (958)
Q Consensus 216 ~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~ 295 (958)
+++ .++.....+++|+.|++++|+++ .+|........|++|.+++|.+...+..+..+.++..|.+.+|++...+..
T Consensus 174 ~l~-~l~~~~~~~~~L~~L~ls~N~i~--~l~~~~~~~~~L~~l~~~~N~~~~~~~~~~~~~~l~~l~l~~n~~~~~~~~ 250 (394)
T COG4886 174 DLS-DLPKLLSNLSNLNNLDLSGNKIS--DLPPEIELLSALEELDLSNNSIIELLSSLSNLKNLSGLELSNNKLEDLPES 250 (394)
T ss_pred hhh-hhhhhhhhhhhhhheeccCCccc--cCchhhhhhhhhhhhhhcCCcceecchhhhhcccccccccCCceeeeccch
Confidence 887 45555557788888888888885 566665566668888888886655666677788888888888887643444
Q ss_pred CCCCCCcCEEEccCCcCCCccchhccCCCCCCeEeeecccCCCccchhh
Q 002158 296 KKLSENVTTIDLSDNYLNGSILESISNLPFLQTLSLENNFLTGSIPATI 344 (958)
Q Consensus 296 ~~~~~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~ip~~l 344 (958)
...+.+|+.|++++|+++.... ++.+.+|+.|++++|.++...|...
T Consensus 251 ~~~l~~l~~L~~s~n~i~~i~~--~~~~~~l~~L~~s~n~~~~~~~~~~ 297 (394)
T COG4886 251 IGNLSNLETLDLSNNQISSISS--LGSLTNLRELDLSGNSLSNALPLIA 297 (394)
T ss_pred hccccccceecccccccccccc--ccccCccCEEeccCccccccchhhh
Confidence 4556678888888888876555 7788888888888888876555544
|
|
| >COG4886 Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Probab=99.34 E-value=1.5e-12 Score=149.24 Aligned_cols=187 Identities=33% Similarity=0.499 Sum_probs=104.2
Q ss_pred ccccCCCCCcEEEeeCCCCCCCCChhhcCCC-CCCEEecccccccccCccccccccccceEecccccccccCchhhcCCc
Q 002158 127 KEIGNISSLIFLLLNGNKLSGSLPDELGYLS-NLNRLQVDENNITGTIPKSFANLSRVRHLHLNNNSIGGQIPSELSKLS 205 (958)
Q Consensus 127 ~~i~~l~~L~~L~Ls~n~l~~~~p~~l~~l~-~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~ 205 (958)
..+..++.++.|++.+|.++ .+|.....+. +|++|++++|++. .+|..+..+++|+.|++++|+++ .+|.....++
T Consensus 110 ~~~~~~~~l~~L~l~~n~i~-~i~~~~~~~~~nL~~L~l~~N~i~-~l~~~~~~l~~L~~L~l~~N~l~-~l~~~~~~~~ 186 (394)
T COG4886 110 SELLELTNLTSLDLDNNNIT-DIPPLIGLLKSNLKELDLSDNKIE-SLPSPLRNLPNLKNLDLSFNDLS-DLPKLLSNLS 186 (394)
T ss_pred hhhhcccceeEEecCCcccc-cCccccccchhhcccccccccchh-hhhhhhhccccccccccCCchhh-hhhhhhhhhh
Confidence 33444455666666666665 5555555553 5666666666655 44445555666666666666665 4444444555
Q ss_pred cchhhhccCCccccCCCcccCCCCCccEEEccCCCCCCCCccccccCCCCCCEEEcccCCCCCCCCCCCCCCCcCEEecc
Q 002158 206 TLIHLLVDNNNLSGNLPPELSELPQLCILQLDNNNFSASEIPATYGNFSKLVKLSLRNCNLQGAVPDLSRIPNLYYLDLS 285 (958)
Q Consensus 206 ~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~l~~l~~L~~L~Ls 285 (958)
+|+.|++++|+++ .+|.....+..|++|.+++|++ ...+..+.++.++..|.+.+|++...+..+..+++|++|+++
T Consensus 187 ~L~~L~ls~N~i~-~l~~~~~~~~~L~~l~~~~N~~--~~~~~~~~~~~~l~~l~l~~n~~~~~~~~~~~l~~l~~L~~s 263 (394)
T COG4886 187 NLNNLDLSGNKIS-DLPPEIELLSALEELDLSNNSI--IELLSSLSNLKNLSGLELSNNKLEDLPESIGNLSNLETLDLS 263 (394)
T ss_pred hhhheeccCCccc-cCchhhhhhhhhhhhhhcCCcc--eecchhhhhcccccccccCCceeeeccchhccccccceeccc
Confidence 6666666666665 3444433444466666666643 234555556666666666666665444445556666666666
Q ss_pred CCcCCCcCCCCCCCCCcCEEEccCCcCCCccchhc
Q 002158 286 WNHLTGSIPSKKLSENVTTIDLSDNYLNGSILESI 320 (958)
Q Consensus 286 ~N~l~~~~~~~~~~~~L~~L~Ls~N~l~~~~~~~~ 320 (958)
+|.++ .++......+|+.|++++|.++...+...
T Consensus 264 ~n~i~-~i~~~~~~~~l~~L~~s~n~~~~~~~~~~ 297 (394)
T COG4886 264 NNQIS-SISSLGSLTNLRELDLSGNSLSNALPLIA 297 (394)
T ss_pred ccccc-ccccccccCccCEEeccCccccccchhhh
Confidence 66665 34434445666666666666655444443
|
|
| >KOG3207 consensus Beta-tubulin folding cofactor E [Posttranslational modification, protein turnover, chaperones] | Back alignment and domain information |
|---|
Probab=99.31 E-value=2.6e-13 Score=144.90 Aligned_cols=234 Identities=20% Similarity=0.170 Sum_probs=125.7
Q ss_pred cCCCCCCEEecccccccccCc--cccccccccceEeccccccccc--CchhhcCCccchhhhccCCccccCCCcc-cCCC
Q 002158 154 GYLSNLNRLQVDENNITGTIP--KSFANLSRVRHLHLNNNSIGGQ--IPSELSKLSTLIHLLVDNNNLSGNLPPE-LSEL 228 (958)
Q Consensus 154 ~~l~~L~~L~L~~N~l~~~~p--~~~~~l~~L~~L~Ls~N~l~~~--~p~~l~~l~~L~~L~L~~N~l~~~~~~~-l~~l 228 (958)
+++.+|++..|.+..+. ..+ .....+++++.|||++|-|... +-.....+++|+.|+|+.|++....... -..+
T Consensus 118 sn~kkL~~IsLdn~~V~-~~~~~~~~k~~~~v~~LdLS~NL~~nw~~v~~i~eqLp~Le~LNls~Nrl~~~~~s~~~~~l 196 (505)
T KOG3207|consen 118 SNLKKLREISLDNYRVE-DAGIEEYSKILPNVRDLDLSRNLFHNWFPVLKIAEQLPSLENLNLSSNRLSNFISSNTTLLL 196 (505)
T ss_pred hhHHhhhheeecCcccc-ccchhhhhhhCCcceeecchhhhHHhHHHHHHHHHhcccchhcccccccccCCccccchhhh
Confidence 34667777777777665 222 3455677777777777777622 2234566777777777777776322211 1234
Q ss_pred CCccEEEccCCCCCCCCccccccCCCCCCEEEcccCCCCCCC-CCCCCCCCcCEEeccCCcCCCcCCCCCCCCCcCEEEc
Q 002158 229 PQLCILQLDNNNFSASEIPATYGNFSKLVKLSLRNCNLQGAV-PDLSRIPNLYYLDLSWNHLTGSIPSKKLSENVTTIDL 307 (958)
Q Consensus 229 ~~L~~L~L~~N~l~~~~~p~~~~~l~~L~~L~L~~N~l~~~~-~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~~~L~~L~L 307 (958)
+.|+.|.|+.|.+++..+......+++|+.|+|..|...... ....-+..|+.|||++|++-. .+
T Consensus 197 ~~lK~L~l~~CGls~k~V~~~~~~fPsl~~L~L~~N~~~~~~~~~~~i~~~L~~LdLs~N~li~-~~------------- 262 (505)
T KOG3207|consen 197 SHLKQLVLNSCGLSWKDVQWILLTFPSLEVLYLEANEIILIKATSTKILQTLQELDLSNNNLID-FD------------- 262 (505)
T ss_pred hhhheEEeccCCCCHHHHHHHHHhCCcHHHhhhhcccccceecchhhhhhHHhhccccCCcccc-cc-------------
Confidence 666666666666665444445555566666666666321111 123344455555555555542 11
Q ss_pred cCCcCCCccchhccCCCCCCeEeeecccCCC-ccchhhhcccccCccccceEeccCCCCCCCccC---CCCCCcceEEeC
Q 002158 308 SDNYLNGSILESISNLPFLQTLSLENNFLTG-SIPATIWQNKSFSTKARLKIDLRNNSFSNIVGD---LTLPNNVTLRLG 383 (958)
Q Consensus 308 s~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~-~ip~~l~~~~~~~~~~l~~L~Ls~N~l~~l~~~---~~l~~L~~L~l~ 383 (958)
.-...+.++.|+.|+++.|.+.. .+|+.=...+.-..++++.|+++.|+|.+++.. ..+++|+.|.+.
T Consensus 263 --------~~~~~~~l~~L~~Lnls~tgi~si~~~d~~s~~kt~~f~kL~~L~i~~N~I~~w~sl~~l~~l~nlk~l~~~ 334 (505)
T KOG3207|consen 263 --------QGYKVGTLPGLNQLNLSSTGIASIAEPDVESLDKTHTFPKLEYLNISENNIRDWRSLNHLRTLENLKHLRIT 334 (505)
T ss_pred --------cccccccccchhhhhccccCcchhcCCCccchhhhcccccceeeecccCccccccccchhhccchhhhhhcc
Confidence 11223344444444444444442 122221111222344556666666666554433 278889999999
Q ss_pred CCCCCCCCCCCCCCcccccCCCCCccccc
Q 002158 384 GNPICTSANIPNTGRFCGSDAGGDETLTN 412 (958)
Q Consensus 384 ~N~l~~~~~~~~~~~~~~~~~~~~~~L~~ 412 (958)
+|++..... .......+...+...|++
T Consensus 335 ~n~ln~e~~--~a~~~VIAr~~~l~~LN~ 361 (505)
T KOG3207|consen 335 LNYLNKETD--TAKLLVIARISQLVKLND 361 (505)
T ss_pred ccccccccc--ceeEEeeeehhhhhhhcc
Confidence 999976554 222334455555566653
|
|
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.30 E-value=1.9e-12 Score=133.33 Aligned_cols=206 Identities=21% Similarity=0.368 Sum_probs=141.0
Q ss_pred HHHHHccCCCCcceEEEEEEeCC-----eEEEEEEecCCCCHHHHhccCC--CCCchHHHHHHHHHHHHHHHHHhhhcCC
Q 002158 672 IKLLSRLHHRNLVSLLGYCDEEG-----EQMLVYEFVPNGTLRDWLSGRT--KENLNFAMRLRVALDSAKGILYLHTEAH 744 (958)
Q Consensus 672 ~~~l~~l~H~niv~l~~~~~~~~-----~~~lV~E~~~~gsL~~~l~~~~--~~~l~~~~~~~i~~~ia~aL~yLH~~~~ 744 (958)
..-+-++-|.|||+++.|+.+.. ...++.|||.-|++..+|++.. ...+....-.+|+.||..||.|||+..
T Consensus 118 FdnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~- 196 (458)
T KOG1266|consen 118 FDNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCD- 196 (458)
T ss_pred HHHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccC-
Confidence 34455667999999999986543 5789999999999999997532 344777777899999999999999874
Q ss_pred CCeeccCCCccceEecCCCCeEEeeeeeecccccCCCCCCccceeeeeccCCCCccChhhhccCCCCCcchhhhHHHHHH
Q 002158 745 PPVFHRDIKASNILLDSNLNAKVADFGLSRLAPVLDDEGTMPTHVSTIVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVLL 824 (958)
Q Consensus 745 ~~iiH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gv~l~ 824 (958)
|+|+|+++..+-|++..+|-+|++--.-....+.... .. ........|-++|.|||+-.....+..+|||+||+..+
T Consensus 197 PpiihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~--~~-~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAl 273 (458)
T KOG1266|consen 197 PPIIHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNS--TR-EAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCAL 273 (458)
T ss_pred CccccCCcchhheeecCCceEEecccCccccchhhhh--hh-HhhhhccccCCccccCCcCcccccccchhhhhhhHHHH
Confidence 8999999999999999999888752111111000000 00 01112234678999999887777788999999999999
Q ss_pred HHHhCCCCCCCCch-hHHHHHHHhhcCcchhhhcccCCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 002158 825 ELLTGMQPISHGKN-IVREVNVARDSGMVFSIIDNRMGSYPSECVERFVTLALRCCHDKPEHRPSMSDVVRE 895 (958)
Q Consensus 825 elltG~~P~~~~~~-~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 895 (958)
||..|..--..+.. ...+.... ...... .+ ..=...+.+|++..|..||+|.+++.+
T Consensus 274 emailEiq~tnseS~~~~ee~ia---~~i~~l-en----------~lqr~~i~kcl~~eP~~rp~ar~llfH 331 (458)
T KOG1266|consen 274 EMAILEIQSTNSESKVEVEENIA---NVIIGL-EN----------GLQRGSITKCLEGEPNGRPDARLLLFH 331 (458)
T ss_pred HHHHheeccCCCcceeehhhhhh---hheeec-cC----------ccccCcCcccccCCCCCCcchhhhhcC
Confidence 99988654322221 11110000 000000 00 111356789999999999999988754
|
|
| >KOG0532 consensus Leucine-rich repeat (LRR) protein, contains calponin homology domain [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.29 E-value=1.5e-13 Score=150.79 Aligned_cols=169 Identities=25% Similarity=0.417 Sum_probs=87.3
Q ss_pred eeeccCcccCCCCccccCCCCCcEEEeeCCCCCCCCChhhcCCCCCCEEecccccccccCccccccccccceEecccccc
Q 002158 114 YYFMWNDLTGTIPKEIGNISSLIFLLLNGNKLSGSLPDELGYLSNLNRLQVDENNITGTIPKSFANLSRVRHLHLNNNSI 193 (958)
Q Consensus 114 ~L~l~n~~~~~ip~~i~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l 193 (958)
..+++.|...++|..+..+..|+.|.|..|.+. .+|..+.+|..|++|||+.|+++ .+|..+..|+ |+.|.+++|++
T Consensus 79 ~aDlsrNR~~elp~~~~~f~~Le~liLy~n~~r-~ip~~i~~L~~lt~l~ls~NqlS-~lp~~lC~lp-Lkvli~sNNkl 155 (722)
T KOG0532|consen 79 FADLSRNRFSELPEEACAFVSLESLILYHNCIR-TIPEAICNLEALTFLDLSSNQLS-HLPDGLCDLP-LKVLIVSNNKL 155 (722)
T ss_pred hhhccccccccCchHHHHHHHHHHHHHHhccce-ecchhhhhhhHHHHhhhccchhh-cCChhhhcCc-ceeEEEecCcc
Confidence 334444555555555555555555555555555 55555555555555555555555 4444444432 55555555555
Q ss_pred cccCchhhcCCccchhhhccCCccccCCCcccCCCCCccEEEccCCCCCCCCccccccCCCCCCEEEcccCCCCCCCCCC
Q 002158 194 GGQIPSELSKLSTLIHLLVDNNNLSGNLPPELSELPQLCILQLDNNNFSASEIPATYGNFSKLVKLSLRNCNLQGAVPDL 273 (958)
Q Consensus 194 ~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~l 273 (958)
+ .+|..++.+..|..|+.+.|++. .+|..+.++.+|+.|.+..|++. .+|..+.. -.|..||++.|++..++-.|
T Consensus 156 ~-~lp~~ig~~~tl~~ld~s~nei~-slpsql~~l~slr~l~vrRn~l~--~lp~El~~-LpLi~lDfScNkis~iPv~f 230 (722)
T KOG0532|consen 156 T-SLPEEIGLLPTLAHLDVSKNEIQ-SLPSQLGYLTSLRDLNVRRNHLE--DLPEELCS-LPLIRLDFSCNKISYLPVDF 230 (722)
T ss_pred c-cCCcccccchhHHHhhhhhhhhh-hchHHhhhHHHHHHHHHhhhhhh--hCCHHHhC-CceeeeecccCceeecchhh
Confidence 5 44555555555555555555554 34445555555555555555552 34444442 23555555555555444455
Q ss_pred CCCCCcCEEeccCCcCC
Q 002158 274 SRIPNLYYLDLSWNHLT 290 (958)
Q Consensus 274 ~~l~~L~~L~Ls~N~l~ 290 (958)
.+|+.|++|-|.+|.|.
T Consensus 231 r~m~~Lq~l~LenNPLq 247 (722)
T KOG0532|consen 231 RKMRHLQVLQLENNPLQ 247 (722)
T ss_pred hhhhhheeeeeccCCCC
Confidence 55555555555555554
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.29 E-value=8.7e-12 Score=124.90 Aligned_cols=130 Identities=17% Similarity=0.116 Sum_probs=97.5
Q ss_pred CceeeeeCCeEEEEEEECCCcEEEEEEeccCChhcHHHHHHHHHHHHccCCCCcc-eEEEEEEeCCeEEEEEEecCCCCH
Q 002158 630 STQVGQGGYGKVYKGILSDNTTVAIKRAEEGSLQGQNEFLTEIKLLSRLHHRNLV-SLLGYCDEEGEQMLVYEFVPNGTL 708 (958)
Q Consensus 630 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv-~l~~~~~~~~~~~lV~E~~~~gsL 708 (958)
.+.|+.|.++.||++... ++.|++|....... ....+..|+.+++.+.+.+++ +++.+.. +..++||||++|.++
T Consensus 3 ~~~l~~G~~~~vy~~~~~-~~~~~lK~~~~~~~-~~~~~~~E~~~l~~l~~~~~~P~~~~~~~--~~~~lv~e~i~G~~l 78 (170)
T cd05151 3 ISPLKGGMTNKNYRVEVA-NKKYVVRIPGNGTE-LLINRENEAENSKLAAEAGIGPKLYYFDP--ETGVLITEFIEGSEL 78 (170)
T ss_pred eeecCCcccCceEEEEEC-CeEEEEEeCCCCcc-cccCHHHHHHHHHHHHHhCCCCceEEEeC--CCCeEEEEecCCCcc
Confidence 356899999999999874 77899999765432 223467899999998665544 4554433 345899999999887
Q ss_pred HHHhccCCCCCchHHHHHHHHHHHHHHHHHhhhcC--CCCeeccCCCccceEecCCCCeEEeeeeeec
Q 002158 709 RDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEA--HPPVFHRDIKASNILLDSNLNAKVADFGLSR 774 (958)
Q Consensus 709 ~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~--~~~iiH~Dikp~NILl~~~~~~kl~DFGla~ 774 (958)
.+.- . ....++.+++++|+.||+.+ ...++|+|++|.||+++ ++.++++|||.+.
T Consensus 79 ~~~~-------~---~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~ 135 (170)
T cd05151 79 LTED-------F---SDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAG 135 (170)
T ss_pred cccc-------c---cCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEeccccc
Confidence 6530 1 11245678999999999887 22359999999999999 6789999999875
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.28 E-value=4.4e-12 Score=142.68 Aligned_cols=251 Identities=22% Similarity=0.241 Sum_probs=181.9
Q ss_pred CCCCCceeee--eCCeEEEEEEE--C-CCcEEEEEEeccC--ChhcHHHHHHHHHHHHccC-CCCcceEEEEEEeCCeEE
Q 002158 626 YFSSSTQVGQ--GGYGKVYKGIL--S-DNTTVAIKRAEEG--SLQGQNEFLTEIKLLSRLH-HRNLVSLLGYCDEEGEQM 697 (958)
Q Consensus 626 ~~~~~~~lg~--G~~g~Vy~~~~--~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~~~~~ 697 (958)
.|.....+|. |.+|.||.+.. . ++..+|+|+-+.. ......+=.+|+...+.++ |+|.++.+..+...+..+
T Consensus 115 ~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~lf 194 (524)
T KOG0601|consen 115 RFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGILF 194 (524)
T ss_pred hcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCCcce
Confidence 4566778999 99999999986 3 6888999974432 2233334457888888884 999999999999999999
Q ss_pred EEEEecCCCCHHHHhccCCCCCchHHHHHHHHHHHHH----HHHHhhhcCCCCeeccCCCccceEecCC-CCeEEeeeee
Q 002158 698 LVYEFVPNGTLRDWLSGRTKENLNFAMRLRVALDSAK----GILYLHTEAHPPVFHRDIKASNILLDSN-LNAKVADFGL 772 (958)
Q Consensus 698 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~----aL~yLH~~~~~~iiH~Dikp~NILl~~~-~~~kl~DFGl 772 (958)
+-+|++ +.+|.++.+.... .++......+..+..+ |+.++|+.. ++|-|+||.||+...+ ...+++|||+
T Consensus 195 iqtE~~-~~sl~~~~~~~~~-~~p~~~l~~~~~~~~~~~~~al~~~hs~~---~~~~~~kp~~i~~~~~~~s~~~~df~~ 269 (524)
T KOG0601|consen 195 IQTELC-GESLQSYCHTPCN-FLPDNLLWNSLRDWLSRDVTALSHLHSNN---IVHDDLKPANIFTTSDWTSCKLTDFGL 269 (524)
T ss_pred eeeccc-cchhHHhhhcccc-cCCchhhhhHHhhhhhcccccccccCCCc---ccccccchhheecccccceeecCCcce
Confidence 999999 5788888865432 2666777778888888 999999999 9999999999999999 8899999999
Q ss_pred ecccccCCCCCCccceeeeeccCCCCccChhhhccCCCCCcchhhhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcCcc
Q 002158 773 SRLAPVLDDEGTMPTHVSTIVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVLLELLTGMQPISHGKNIVREVNVARDSGMV 852 (958)
Q Consensus 773 a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gv~l~elltG~~P~~~~~~~~~~~~~~~~~~~~ 852 (958)
.......+-... ........|...|++||... .-++..+|+|++|.++.|..++..+...+... .|.. . +...+
T Consensus 270 v~~i~~~~~~~~--~~~~~r~~~~~~Y~~ke~~~-~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~-~W~~-~-r~~~i 343 (524)
T KOG0601|consen 270 VSKISDGNFSSV--FKVSKRPEGDCIYAAKELLN-GLATFASDIFSLGEVILEAILGSHLPSVGKNS-SWSQ-L-RQGYI 343 (524)
T ss_pred eEEccCCccccc--eeeeecCCCCceEeChhhhc-cccchHhhhcchhhhhHhhHhhcccccCCCCC-Cccc-c-ccccC
Confidence 886643321111 11222335788899999874 45788999999999999999988776544211 0100 0 00000
Q ss_pred hhhhcccCCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002158 853 FSIIDNRMGSYPSECVERFVTLALRCCHDKPEHRPSMSDVVR 894 (958)
Q Consensus 853 ~~~i~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 894 (958)
. .++...-...+...+..+++.+|..|++.+.+..
T Consensus 344 p-------~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~ 378 (524)
T KOG0601|consen 344 P-------LEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTA 378 (524)
T ss_pred c-------hhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhc
Confidence 0 0111112234455888999999999999888765
|
|
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.26 E-value=2.6e-11 Score=140.39 Aligned_cols=142 Identities=17% Similarity=0.165 Sum_probs=96.0
Q ss_pred cCCCCCceeeeeCCeEEEEEEECC-CcEEEEEEeccCChhc----------------------------------H----
Q 002158 625 AYFSSSTQVGQGGYGKVYKGILSD-NTTVAIKRAEEGSLQG----------------------------------Q---- 665 (958)
Q Consensus 625 ~~~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~----------------------------------~---- 665 (958)
..|+. +.||+|++|.||+|++++ |+.||||+.+...... .
T Consensus 120 ~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~ 198 (537)
T PRK04750 120 DDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLH 198 (537)
T ss_pred HhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHH
Confidence 45666 789999999999999987 9999999987542100 0
Q ss_pred --HHHHHHHHHHHccC----CCCcceEEEEEEe-CCeEEEEEEecCCCCHHHH--hccCCC--CCchHHHHHHHHHHHHH
Q 002158 666 --NEFLTEIKLLSRLH----HRNLVSLLGYCDE-EGEQMLVYEFVPNGTLRDW--LSGRTK--ENLNFAMRLRVALDSAK 734 (958)
Q Consensus 666 --~~~~~E~~~l~~l~----H~niv~l~~~~~~-~~~~~lV~E~~~~gsL~~~--l~~~~~--~~l~~~~~~~i~~~ia~ 734 (958)
-+|.+|+..+.+++ +...+.+-.++.+ ....+|||||++|+.+.++ +...+. ..+....+..++.|
T Consensus 199 ~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Q--- 275 (537)
T PRK04750 199 DELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQ--- 275 (537)
T ss_pred HhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHH---
Confidence 12455655555552 4444444343322 4567899999999999875 322211 11333333333333
Q ss_pred HHHHhhhcCCCCeeccCCCccceEecCCC----CeEEeeeeeecccc
Q 002158 735 GILYLHTEAHPPVFHRDIKASNILLDSNL----NAKVADFGLSRLAP 777 (958)
Q Consensus 735 aL~yLH~~~~~~iiH~Dikp~NILl~~~~----~~kl~DFGla~~~~ 777 (958)
++..| ++|+|+||.||+++.++ .+++.|||++..++
T Consensus 276 ----if~~G---ffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~ 315 (537)
T PRK04750 276 ----VFRDG---FFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLN 315 (537)
T ss_pred ----HHhCC---eeeCCCChHHeEEecCCCCCCeEEEEecceEEECC
Confidence 34577 99999999999999988 99999999997653
|
|
| >KOG3207 consensus Beta-tubulin folding cofactor E [Posttranslational modification, protein turnover, chaperones] | Back alignment and domain information |
|---|
Probab=99.23 E-value=2.1e-12 Score=138.11 Aligned_cols=208 Identities=21% Similarity=0.228 Sum_probs=103.9
Q ss_pred CCCCcceeeccCcccCCCCc--cccCCCCCcEEEeeCCCCCCCC--ChhhcCCCCCCEEecccccccccCccc-cccccc
Q 002158 108 QLSRLQYYFMWNDLTGTIPK--EIGNISSLIFLLLNGNKLSGSL--PDELGYLSNLNRLQVDENNITGTIPKS-FANLSR 182 (958)
Q Consensus 108 ~L~~L~~L~l~n~~~~~ip~--~i~~l~~L~~L~Ls~n~l~~~~--p~~l~~l~~L~~L~L~~N~l~~~~p~~-~~~l~~ 182 (958)
++.+|+...+.|...+..+. ....|++++.||||.|-|.... -.-...|++|+.|+|+.|++....... -..+++
T Consensus 119 n~kkL~~IsLdn~~V~~~~~~~~~k~~~~v~~LdLS~NL~~nw~~v~~i~eqLp~Le~LNls~Nrl~~~~~s~~~~~l~~ 198 (505)
T KOG3207|consen 119 NLKKLREISLDNYRVEDAGIEEYSKILPNVRDLDLSRNLFHNWFPVLKIAEQLPSLENLNLSSNRLSNFISSNTTLLLSH 198 (505)
T ss_pred hHHhhhheeecCccccccchhhhhhhCCcceeecchhhhHHhHHHHHHHHHhcccchhcccccccccCCccccchhhhhh
Confidence 45555555666655554442 4555666666666666655321 122345666666666666665222111 123456
Q ss_pred cceEeccccccc-ccCchhhcCCccchhhhccCCccccCCCcccCCCCCccEEEccCCCCCCCCccccccCCCCCCEEEc
Q 002158 183 VRHLHLNNNSIG-GQIPSELSKLSTLIHLLVDNNNLSGNLPPELSELPQLCILQLDNNNFSASEIPATYGNFSKLVKLSL 261 (958)
Q Consensus 183 L~~L~Ls~N~l~-~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~p~~~~~l~~L~~L~L 261 (958)
|+.|.|+.|.|+ ..+...+..+|+|+.|+|..|..-........-+..|+.|||++|++.....-...+.++.|+.|++
T Consensus 199 lK~L~l~~CGls~k~V~~~~~~fPsl~~L~L~~N~~~~~~~~~~~i~~~L~~LdLs~N~li~~~~~~~~~~l~~L~~Lnl 278 (505)
T KOG3207|consen 199 LKQLVLNSCGLSWKDVQWILLTFPSLEVLYLEANEIILIKATSTKILQTLQELDLSNNNLIDFDQGYKVGTLPGLNQLNL 278 (505)
T ss_pred hheEEeccCCCCHHHHHHHHHhCCcHHHhhhhcccccceecchhhhhhHHhhccccCCcccccccccccccccchhhhhc
Confidence 666666666665 1122233455666666666664222222333344556666666665532221234455555555555
Q ss_pred ccCCCCCCCC-C------CCCCCCcCEEeccCCcCCCcCCCCCCCCCcCEEEccCCcCCCccchhccCCCCCCeEeeecc
Q 002158 262 RNCNLQGAVP-D------LSRIPNLYYLDLSWNHLTGSIPSKKLSENVTTIDLSDNYLNGSILESISNLPFLQTLSLENN 334 (958)
Q Consensus 262 ~~N~l~~~~~-~------l~~l~~L~~L~Ls~N~l~~~~~~~~~~~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N 334 (958)
+.|.+..+.. + ...+++|++|+++.|++. .. .....+..+++|+.|.+..|
T Consensus 279 s~tgi~si~~~d~~s~~kt~~f~kL~~L~i~~N~I~-~w---------------------~sl~~l~~l~nlk~l~~~~n 336 (505)
T KOG3207|consen 279 SSTGIASIAEPDVESLDKTHTFPKLEYLNISENNIR-DW---------------------RSLNHLRTLENLKHLRITLN 336 (505)
T ss_pred cccCcchhcCCCccchhhhcccccceeeecccCccc-cc---------------------cccchhhccchhhhhhcccc
Confidence 5555554321 1 133444555555555443 11 12233444566666666666
Q ss_pred cCC
Q 002158 335 FLT 337 (958)
Q Consensus 335 ~l~ 337 (958)
.|+
T Consensus 337 ~ln 339 (505)
T KOG3207|consen 337 YLN 339 (505)
T ss_pred ccc
Confidence 665
|
|
| >KOG1259 consensus Nischarin, modulator of integrin alpha5 subunit action [Signal transduction mechanisms; Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.22 E-value=1.5e-12 Score=132.21 Aligned_cols=125 Identities=26% Similarity=0.302 Sum_probs=72.5
Q ss_pred CCCEEEcccCCCCCCCCCCCCCCCcCEEeccCCcCCCcCCCCCCCCCcCEEEccCCcCCCccchhccCCCCCCeEeeecc
Q 002158 255 KLVKLSLRNCNLQGAVPDLSRIPNLYYLDLSWNHLTGSIPSKKLSENVTTIDLSDNYLNGSILESISNLPFLQTLSLENN 334 (958)
Q Consensus 255 ~L~~L~L~~N~l~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N 334 (958)
.|++|+|++|.|+.+.....-+++++.|++|+|.|. .+.....+.+|+.||||+|.++ ....+-..|-+.+.|.|++|
T Consensus 285 ~LtelDLS~N~I~~iDESvKL~Pkir~L~lS~N~i~-~v~nLa~L~~L~~LDLS~N~Ls-~~~Gwh~KLGNIKtL~La~N 362 (490)
T KOG1259|consen 285 ELTELDLSGNLITQIDESVKLAPKLRRLILSQNRIR-TVQNLAELPQLQLLDLSGNLLA-ECVGWHLKLGNIKTLKLAQN 362 (490)
T ss_pred hhhhccccccchhhhhhhhhhccceeEEecccccee-eehhhhhcccceEeecccchhH-hhhhhHhhhcCEeeeehhhh
Confidence 344455555555444444444455555555555554 4444455555555555555554 23333345566666666666
Q ss_pred cCCCccchhhhcccccCccccceEeccCCCCCCCccCC---CCCCcceEEeCCCCCC
Q 002158 335 FLTGSIPATIWQNKSFSTKARLKIDLRNNSFSNIVGDL---TLPNNVTLRLGGNPIC 388 (958)
Q Consensus 335 ~l~~~ip~~l~~~~~~~~~~l~~L~Ls~N~l~~l~~~~---~l~~L~~L~l~~N~l~ 388 (958)
.|. ++.++..+. +|..||+++|+|.++.+-. .+|-|..|.|.|||+.
T Consensus 363 ~iE-----~LSGL~KLY--SLvnLDl~~N~Ie~ldeV~~IG~LPCLE~l~L~~NPl~ 412 (490)
T KOG1259|consen 363 KIE-----TLSGLRKLY--SLVNLDLSSNQIEELDEVNHIGNLPCLETLRLTGNPLA 412 (490)
T ss_pred hHh-----hhhhhHhhh--hheeccccccchhhHHHhcccccccHHHHHhhcCCCcc
Confidence 664 222222222 4557888888887766543 8899999999999994
|
|
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.22 E-value=1.5e-10 Score=131.23 Aligned_cols=165 Identities=20% Similarity=0.245 Sum_probs=126.7
Q ss_pred CCCcEEEEEEeccCChhcHHHHHHHHHHHHccCCCCcceEEEEEEeCCeEEEEEEecCCCCHHHHhccCCCCCchHHHHH
Q 002158 647 SDNTTVAIKRAEEGSLQGQNEFLTEIKLLSRLHHRNLVSLLGYCDEEGEQMLVYEFVPNGTLRDWLSGRTKENLNFAMRL 726 (958)
Q Consensus 647 ~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~ 726 (958)
.++.+|.|...+...........+-++-|+.++||||+++++..+.++..|+|+|-+ ..|..++++. ......
T Consensus 35 ~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV--~Pl~~~lk~l-----~~~~v~ 107 (690)
T KOG1243|consen 35 ADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERV--RPLETVLKEL-----GKEEVC 107 (690)
T ss_pred ccCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeecc--ccHHHHHHHh-----HHHHHH
Confidence 378899999887755433345667888999999999999999999999999999998 4688888653 356677
Q ss_pred HHHHHHHHHHHHhhhcCCCCeeccCCCccceEecCCCCeEEeeeeeecccccCCCCCCccceeeeeccCCCCccChhhhc
Q 002158 727 RVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSRLAPVLDDEGTMPTHVSTIVKGTPGYLDPEYFL 806 (958)
Q Consensus 727 ~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~ 806 (958)
.-+.||+.||.+||+.++ ++|++|.-+-|++++.|..||++|-++...+.... +. ....--..|..|+.+.
T Consensus 108 ~Gl~qIl~AL~FL~~d~~--lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~----~~---~~~~~~~s~~~P~~~~ 178 (690)
T KOG1243|consen 108 LGLFQILAALSFLNDDCN--LVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA----PA---KSLYLIESFDDPEEID 178 (690)
T ss_pred HHHHHHHHHHHHHhccCC--eeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc----cc---ccchhhhcccChhhcC
Confidence 788999999999997765 99999999999999999999999999865422111 00 0011112356666542
Q ss_pred cCCCCCcchhhhHHHHHHHHHhC
Q 002158 807 THKLTDKSDVYSLGVVLLELLTG 829 (958)
Q Consensus 807 ~~~~~~~~DV~S~Gv~l~elltG 829 (958)
... -..|.|.||++++|++.|
T Consensus 179 ~s~--~s~D~~~Lg~li~el~ng 199 (690)
T KOG1243|consen 179 PSE--WSIDSWGLGCLIEELFNG 199 (690)
T ss_pred ccc--cchhhhhHHHHHHHHhCc
Confidence 222 356999999999999999
|
|
| >KOG1909 consensus Ran GTPase-activating protein [RNA processing and modification; Nuclear structure; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.21 E-value=2.1e-12 Score=134.70 Aligned_cols=242 Identities=20% Similarity=0.279 Sum_probs=135.4
Q ss_pred cccCCCCCcEEEeeCCCCCC----CCChhhcCCCCCCEEeccccc---ccccCccc-------cccccccceEecccccc
Q 002158 128 EIGNISSLIFLLLNGNKLSG----SLPDELGYLSNLNRLQVDENN---ITGTIPKS-------FANLSRVRHLHLNNNSI 193 (958)
Q Consensus 128 ~i~~l~~L~~L~Ls~n~l~~----~~p~~l~~l~~L~~L~L~~N~---l~~~~p~~-------~~~l~~L~~L~Ls~N~l 193 (958)
.+..+.++++|+||+|.+.. .+-..+.+.++|+..++++-- +...+|.. +...++|++||||+|-|
T Consensus 25 ~~~~~~s~~~l~lsgnt~G~EAa~~i~~~L~~~~~L~~v~~sd~ftGR~~~Ei~e~L~~l~~aL~~~~~L~~ldLSDNA~ 104 (382)
T KOG1909|consen 25 ELEPMDSLTKLDLSGNTFGTEAARAIAKVLASKKELREVNLSDMFTGRLKDEIPEALKMLSKALLGCPKLQKLDLSDNAF 104 (382)
T ss_pred HhcccCceEEEeccCCchhHHHHHHHHHHHhhcccceeeehHhhhcCCcHHHHHHHHHHHHHHHhcCCceeEeecccccc
Confidence 34556677777777777753 233446666777777776532 22233333 34456788888888887
Q ss_pred cccCchh----hcCCccchhhhccCCccccCCCcc-------------cCCCCCccEEEccCCCCCCC---CccccccCC
Q 002158 194 GGQIPSE----LSKLSTLIHLLVDNNNLSGNLPPE-------------LSELPQLCILQLDNNNFSAS---EIPATYGNF 253 (958)
Q Consensus 194 ~~~~p~~----l~~l~~L~~L~L~~N~l~~~~~~~-------------l~~l~~L~~L~L~~N~l~~~---~~p~~~~~l 253 (958)
....+.. +.++..|++|.|.+|.+....... .+.-+.|++++.++|++-.. .+...|...
T Consensus 105 G~~g~~~l~~ll~s~~~L~eL~L~N~Glg~~ag~~l~~al~~l~~~kk~~~~~~Lrv~i~~rNrlen~ga~~~A~~~~~~ 184 (382)
T KOG1909|consen 105 GPKGIRGLEELLSSCTDLEELYLNNCGLGPEAGGRLGRALFELAVNKKAASKPKLRVFICGRNRLENGGATALAEAFQSH 184 (382)
T ss_pred CccchHHHHHHHHhccCHHHHhhhcCCCChhHHHHHHHHHHHHHHHhccCCCcceEEEEeeccccccccHHHHHHHHHhc
Confidence 7444433 456778888888888776322222 22335566666666655321 112234444
Q ss_pred CCCCEEEcccCCCCCCCC-----CCCCCCCcCEEeccCCcCCCcCCCCCCCCCcCEEEccCCcCCCccchhccCCCCCCe
Q 002158 254 SKLVKLSLRNCNLQGAVP-----DLSRIPNLYYLDLSWNHLTGSIPSKKLSENVTTIDLSDNYLNGSILESISNLPFLQT 328 (958)
Q Consensus 254 ~~L~~L~L~~N~l~~~~~-----~l~~l~~L~~L~Ls~N~l~~~~~~~~~~~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~ 328 (958)
+.|+.+.+..|.|..... .+..+++|+.|||.+|-++..-. ..+...+..+++|++
T Consensus 185 ~~leevr~~qN~I~~eG~~al~eal~~~~~LevLdl~DNtft~egs-------------------~~LakaL~s~~~L~E 245 (382)
T KOG1909|consen 185 PTLEEVRLSQNGIRPEGVTALAEALEHCPHLEVLDLRDNTFTLEGS-------------------VALAKALSSWPHLRE 245 (382)
T ss_pred cccceEEEecccccCchhHHHHHHHHhCCcceeeecccchhhhHHH-------------------HHHHHHhcccchhee
Confidence 555555555555532211 14444555555555554431100 023444555666777
Q ss_pred EeeecccCCCccchhhhcccccCccccceEeccCCCCCCCc-----cCC-CCCCcceEEeCCCCCC
Q 002158 329 LSLENNFLTGSIPATIWQNKSFSTKARLKIDLRNNSFSNIV-----GDL-TLPNNVTLRLGGNPIC 388 (958)
Q Consensus 329 L~L~~N~l~~~ip~~l~~~~~~~~~~l~~L~Ls~N~l~~l~-----~~~-~l~~L~~L~l~~N~l~ 388 (958)
|++++|.+.......+.....-..+.|+.|+|.+|.|+.=. ... ..|.|..|+|+||.+.
T Consensus 246 l~l~dcll~~~Ga~a~~~al~~~~p~L~vl~l~gNeIt~da~~~la~~~~ek~dL~kLnLngN~l~ 311 (382)
T KOG1909|consen 246 LNLGDCLLENEGAIAFVDALKESAPSLEVLELAGNEITRDAALALAACMAEKPDLEKLNLNGNRLG 311 (382)
T ss_pred ecccccccccccHHHHHHHHhccCCCCceeccCcchhHHHHHHHHHHHHhcchhhHHhcCCccccc
Confidence 77777777666655555544444566677777777776411 111 5788889999999884
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.20 E-value=1.7e-10 Score=116.04 Aligned_cols=134 Identities=16% Similarity=0.104 Sum_probs=98.0
Q ss_pred ceeeeeCCeEEEEEEECC-------CcEEEEEEeccCCh----------------------hcHHHH----HHHHHHHHc
Q 002158 631 TQVGQGGYGKVYKGILSD-------NTTVAIKRAEEGSL----------------------QGQNEF----LTEIKLLSR 677 (958)
Q Consensus 631 ~~lg~G~~g~Vy~~~~~~-------~~~vavK~~~~~~~----------------------~~~~~~----~~E~~~l~~ 677 (958)
..||.|.-+.||.|...+ +..+|||+.+.... ...+.+ .+|++.|++
T Consensus 3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r 82 (197)
T cd05146 3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR 82 (197)
T ss_pred CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence 468999999999998643 47999997642100 001122 379999999
Q ss_pred cCC--CCcceEEEEEEeCCeEEEEEEecCCCCHH-HHhccCCCCCchHHHHHHHHHHHHHHHHHh-hhcCCCCeeccCCC
Q 002158 678 LHH--RNLVSLLGYCDEEGEQMLVYEFVPNGTLR-DWLSGRTKENLNFAMRLRVALDSAKGILYL-HTEAHPPVFHRDIK 753 (958)
Q Consensus 678 l~H--~niv~l~~~~~~~~~~~lV~E~~~~gsL~-~~l~~~~~~~l~~~~~~~i~~~ia~aL~yL-H~~~~~~iiH~Dik 753 (958)
+.. -++.+++++ ...++||||+.+..+. ..+++. .++..+...+..+++.+|.++ |+.+ +||||++
T Consensus 83 l~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd~---~~~~~~~~~i~~~i~~~l~~l~H~~g---lVHGDLs 152 (197)
T cd05146 83 MQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKDA---KLNDEEMKNAYYQVLSMMKQLYKECN---LVHADLS 152 (197)
T ss_pred HHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhcc---ccCHHHHHHHHHHHHHHHHHHHHhCC---eecCCCC
Confidence 953 567777765 4678999999765332 223221 244556677889999999999 7888 9999999
Q ss_pred ccceEecCCCCeEEeeeeeecc
Q 002158 754 ASNILLDSNLNAKVADFGLSRL 775 (958)
Q Consensus 754 p~NILl~~~~~~kl~DFGla~~ 775 (958)
+.||+++ ++.+.|+|||.+..
T Consensus 153 ~~NIL~~-~~~v~iIDF~qav~ 173 (197)
T cd05146 153 EYNMLWH-DGKVWFIDVSQSVE 173 (197)
T ss_pred HHHEEEE-CCcEEEEECCCcee
Confidence 9999997 57899999998764
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >KOG0531 consensus Protein phosphatase 1, regulatory subunit, and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.19 E-value=1.5e-12 Score=149.64 Aligned_cols=197 Identities=25% Similarity=0.297 Sum_probs=119.3
Q ss_pred cCCCCCcEEEeeCCCCCCCCChhhcCCCCCCEEecccccccccCccccccccccceEecccccccccCchhhcCCccchh
Q 002158 130 GNISSLIFLLLNGNKLSGSLPDELGYLSNLNRLQVDENNITGTIPKSFANLSRVRHLHLNNNSIGGQIPSELSKLSTLIH 209 (958)
Q Consensus 130 ~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~ 209 (958)
..+..++.+++..|.+. .+-..+..+++|+.|++.+|+|.. +...+..+++|++|+|++|.|+...+ +..++.|+.
T Consensus 69 ~~l~~l~~l~l~~n~i~-~~~~~l~~~~~l~~l~l~~n~i~~-i~~~l~~~~~L~~L~ls~N~I~~i~~--l~~l~~L~~ 144 (414)
T KOG0531|consen 69 ESLTSLKELNLRQNLIA-KILNHLSKLKSLEALDLYDNKIEK-IENLLSSLVNLQVLDLSFNKITKLEG--LSTLTLLKE 144 (414)
T ss_pred HHhHhHHhhccchhhhh-hhhcccccccceeeeeccccchhh-cccchhhhhcchheeccccccccccc--hhhccchhh
Confidence 34566777777777777 344446777788888888888873 33336677788888888888874433 566667778
Q ss_pred hhccCCccccCCCcccCCCCCccEEEccCCCCCCCCcccc-ccCCCCCCEEEcccCCCCCCCCCCCCCCCcCEEeccCCc
Q 002158 210 LLVDNNNLSGNLPPELSELPQLCILQLDNNNFSASEIPAT-YGNFSKLVKLSLRNCNLQGAVPDLSRIPNLYYLDLSWNH 288 (958)
Q Consensus 210 L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~p~~-~~~l~~L~~L~L~~N~l~~~~~~l~~l~~L~~L~Ls~N~ 288 (958)
|++++|.|+.. ..+..+++|+.+++++|+++..+ .. ...+.+|+.+++.+|.+.. +..+..+..+..+++..|.
T Consensus 145 L~l~~N~i~~~--~~~~~l~~L~~l~l~~n~i~~ie--~~~~~~~~~l~~l~l~~n~i~~-i~~~~~~~~l~~~~l~~n~ 219 (414)
T KOG0531|consen 145 LNLSGNLISDI--SGLESLKSLKLLDLSYNRIVDIE--NDELSELISLEELDLGGNSIRE-IEGLDLLKKLVLLSLLDNK 219 (414)
T ss_pred heeccCcchhc--cCCccchhhhcccCCcchhhhhh--hhhhhhccchHHHhccCCchhc-ccchHHHHHHHHhhccccc
Confidence 88888877643 44555777777777777775322 21 3556667777777776652 2233334444445666666
Q ss_pred CCCcCCCCCCCCC--cCEEEccCCcCCCccchhccCCCCCCeEeeecccCC
Q 002158 289 LTGSIPSKKLSEN--VTTIDLSDNYLNGSILESISNLPFLQTLSLENNFLT 337 (958)
Q Consensus 289 l~~~~~~~~~~~~--L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~ 337 (958)
++ .+.....+.. |+.+++++|.+.... ..+..+..+..|++.+|++.
T Consensus 220 i~-~~~~l~~~~~~~L~~l~l~~n~i~~~~-~~~~~~~~l~~l~~~~n~~~ 268 (414)
T KOG0531|consen 220 IS-KLEGLNELVMLHLRELYLSGNRISRSP-EGLENLKNLPVLDLSSNRIS 268 (414)
T ss_pred ce-eccCcccchhHHHHHHhcccCcccccc-ccccccccccccchhhcccc
Confidence 65 3322222222 566666666665321 44445555555555555554
|
|
| >KOG1259 consensus Nischarin, modulator of integrin alpha5 subunit action [Signal transduction mechanisms; Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.15 E-value=6.6e-12 Score=127.52 Aligned_cols=133 Identities=24% Similarity=0.308 Sum_probs=92.2
Q ss_pred hcCCccchhhhccCCccccCCCcccCCCCCccEEEccCCCCCCCCccccccCCCCCCEEEcccCCCCCCCCCCCCCCCcC
Q 002158 201 LSKLSTLIHLLVDNNNLSGNLPPELSELPQLCILQLDNNNFSASEIPATYGNFSKLVKLSLRNCNLQGAVPDLSRIPNLY 280 (958)
Q Consensus 201 l~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~l~~l~~L~ 280 (958)
+.....|++|||++|.|+ .+..+..-+|.++.|++++|.|+. -+.+..+++|+.|+|++|.++....--..+-+.+
T Consensus 280 ~dTWq~LtelDLS~N~I~-~iDESvKL~Pkir~L~lS~N~i~~---v~nLa~L~~L~~LDLS~N~Ls~~~Gwh~KLGNIK 355 (490)
T KOG1259|consen 280 ADTWQELTELDLSGNLIT-QIDESVKLAPKLRRLILSQNRIRT---VQNLAELPQLQLLDLSGNLLAECVGWHLKLGNIK 355 (490)
T ss_pred cchHhhhhhccccccchh-hhhhhhhhccceeEEeccccceee---ehhhhhcccceEeecccchhHhhhhhHhhhcCEe
Confidence 344456777777777776 455566666777777777777752 2336677777777777777775554444556777
Q ss_pred EEeccCCcCCCcCCCCCCCCCcCEEEccCCcCCCc-cchhccCCCCCCeEeeecccCCC
Q 002158 281 YLDLSWNHLTGSIPSKKLSENVTTIDLSDNYLNGS-ILESISNLPFLQTLSLENNFLTG 338 (958)
Q Consensus 281 ~L~Ls~N~l~~~~~~~~~~~~L~~L~Ls~N~l~~~-~~~~~~~l~~L~~L~L~~N~l~~ 338 (958)
.|.|++|.|. .+.....+-+|..||+++|+|... .-..+++||-|+.|.|.+|+|.+
T Consensus 356 tL~La~N~iE-~LSGL~KLYSLvnLDl~~N~Ie~ldeV~~IG~LPCLE~l~L~~NPl~~ 413 (490)
T KOG1259|consen 356 TLKLAQNKIE-TLSGLRKLYSLVNLDLSSNQIEELDEVNHIGNLPCLETLRLTGNPLAG 413 (490)
T ss_pred eeehhhhhHh-hhhhhHhhhhheeccccccchhhHHHhcccccccHHHHHhhcCCCccc
Confidence 7788888776 455555566778888888887652 34567888888888888888884
|
|
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.13 E-value=6.3e-10 Score=106.72 Aligned_cols=143 Identities=22% Similarity=0.252 Sum_probs=106.8
Q ss_pred CCceeeeeCCeEEEEEEECCCcEEEEEE-eccC--C-----hhcHHHHHHHHHHHHccCCCCcceEEEEEEeCCeEEEEE
Q 002158 629 SSTQVGQGGYGKVYKGILSDNTTVAIKR-AEEG--S-----LQGQNEFLTEIKLLSRLHHRNLVSLLGYCDEEGEQMLVY 700 (958)
Q Consensus 629 ~~~~lg~G~~g~Vy~~~~~~~~~vavK~-~~~~--~-----~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~ 700 (958)
....|-+|+-+.|+++.+ .|+...||. +.+. . .-..++-.+|++.+.+.+--.|.-..=++.+...-.++|
T Consensus 11 ~l~likQGAEArv~~~~~-~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~M 89 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSF-SGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYM 89 (229)
T ss_pred cceeeeccceeeEeeecc-CCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEE
Confidence 456899999999999998 577777774 3221 1 112356788999999987555554444555666677999
Q ss_pred EecCC-CCHHHHhccCCCCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEecCCC---CeEEeeeeeecc
Q 002158 701 EFVPN-GTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSNL---NAKVADFGLSRL 775 (958)
Q Consensus 701 E~~~~-gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~~---~~kl~DFGla~~ 775 (958)
||+++ .++.+++..........+.....+..|-+.+.-||..+ |||+||..+||++..++ .+.++|||++..
T Consensus 90 E~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~nd---iiHGDLTTSNill~~~~~~~~~~lIdfgls~~ 165 (229)
T KOG3087|consen 90 EFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHDND---IIHGDLTTSNILLRSDGNQITPILIDFGLSSV 165 (229)
T ss_pred EeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhhCC---eecccccccceEEecCCCcCceEEEeecchhc
Confidence 99976 47888887654433444444788899999999999999 99999999999997655 358999999864
|
|
| >KOG1909 consensus Ran GTPase-activating protein [RNA processing and modification; Nuclear structure; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.12 E-value=2.1e-12 Score=134.67 Aligned_cols=240 Identities=19% Similarity=0.222 Sum_probs=146.6
Q ss_pred eeEEEEccCCcCCCC----ccccccCCCCcceeeccCcccCC----CCcc-------ccCCCCCcEEEeeCCCCCCCCCh
Q 002158 87 HVRELQLLSMNLSGN----LAPELGQLSRLQYYFMWNDLTGT----IPKE-------IGNISSLIFLLLNGNKLSGSLPD 151 (958)
Q Consensus 87 ~v~~L~L~~~~l~~~----~~~~l~~L~~L~~L~l~n~~~~~----ip~~-------i~~l~~L~~L~Ls~n~l~~~~p~ 151 (958)
.++.|+|++|.+... +.+.+.+.++|+.-++++-++|. +|+. +...++|++||||.|.|.-.-+.
T Consensus 31 s~~~l~lsgnt~G~EAa~~i~~~L~~~~~L~~v~~sd~ftGR~~~Ei~e~L~~l~~aL~~~~~L~~ldLSDNA~G~~g~~ 110 (382)
T KOG1909|consen 31 SLTKLDLSGNTFGTEAARAIAKVLASKKELREVNLSDMFTGRLKDEIPEALKMLSKALLGCPKLQKLDLSDNAFGPKGIR 110 (382)
T ss_pred ceEEEeccCCchhHHHHHHHHHHHhhcccceeeehHhhhcCCcHHHHHHHHHHHHHHHhcCCceeEeeccccccCccchH
Confidence 588999999988764 66778888889888888777764 4433 33445777777777777644443
Q ss_pred h----hcCCCCCCEEecccccccccCccccccccccceEecccccccccCchhhcCCccchhhhccCCccccC----CCc
Q 002158 152 E----LGYLSNLNRLQVDENNITGTIPKSFANLSRVRHLHLNNNSIGGQIPSELSKLSTLIHLLVDNNNLSGN----LPP 223 (958)
Q Consensus 152 ~----l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~----~~~ 223 (958)
. +.++..|++|.|.+|.+.-.--..++. .|..|. .|+ ...+-+.|+++...+|++... +..
T Consensus 111 ~l~~ll~s~~~L~eL~L~N~Glg~~ag~~l~~--al~~l~--~~k-------k~~~~~~Lrv~i~~rNrlen~ga~~~A~ 179 (382)
T KOG1909|consen 111 GLEELLSSCTDLEELYLNNCGLGPEAGGRLGR--ALFELA--VNK-------KAASKPKLRVFICGRNRLENGGATALAE 179 (382)
T ss_pred HHHHHHHhccCHHHHhhhcCCCChhHHHHHHH--HHHHHH--HHh-------ccCCCcceEEEEeeccccccccHHHHHH
Confidence 3 345666777777777665111111110 011111 111 112234566666666666522 123
Q ss_pred ccCCCCCccEEEccCCCCCCCC---ccccccCCCCCCEEEcccCCCCCCCC-----CCCCCCCcCEEeccCCcCCCcCCC
Q 002158 224 ELSELPQLCILQLDNNNFSASE---IPATYGNFSKLVKLSLRNCNLQGAVP-----DLSRIPNLYYLDLSWNHLTGSIPS 295 (958)
Q Consensus 224 ~l~~l~~L~~L~L~~N~l~~~~---~p~~~~~l~~L~~L~L~~N~l~~~~~-----~l~~l~~L~~L~Ls~N~l~~~~~~ 295 (958)
.|...+.|+.+.++.|.|.... +...|..+++|+.|+|.+|.++.... .++.+++|+.|++++|.+...-..
T Consensus 180 ~~~~~~~leevr~~qN~I~~eG~~al~eal~~~~~LevLdl~DNtft~egs~~LakaL~s~~~L~El~l~dcll~~~Ga~ 259 (382)
T KOG1909|consen 180 AFQSHPTLEEVRLSQNGIRPEGVTALAEALEHCPHLEVLDLRDNTFTLEGSVALAKALSSWPHLRELNLGDCLLENEGAI 259 (382)
T ss_pred HHHhccccceEEEecccccCchhHHHHHHHHhCCcceeeecccchhhhHHHHHHHHHhcccchheeecccccccccccHH
Confidence 4455566777777777664211 12345667777777777777764332 267778888888888887632110
Q ss_pred -----C-CCCCCcCEEEccCCcCCC----ccchhccCCCCCCeEeeecccCC
Q 002158 296 -----K-KLSENVTTIDLSDNYLNG----SILESISNLPFLQTLSLENNFLT 337 (958)
Q Consensus 296 -----~-~~~~~L~~L~Ls~N~l~~----~~~~~~~~l~~L~~L~L~~N~l~ 337 (958)
. ...++|+.|.|.+|.|+. .+...+...+.|..|+|++|++.
T Consensus 260 a~~~al~~~~p~L~vl~l~gNeIt~da~~~la~~~~ek~dL~kLnLngN~l~ 311 (382)
T KOG1909|consen 260 AFVDALKESAPSLEVLELAGNEITRDAALALAACMAEKPDLEKLNLNGNRLG 311 (382)
T ss_pred HHHHHHhccCCCCceeccCcchhHHHHHHHHHHHHhcchhhHHhcCCccccc
Confidence 1 124688888999998864 34445566889999999999993
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.11 E-value=3.7e-10 Score=118.42 Aligned_cols=142 Identities=24% Similarity=0.348 Sum_probs=111.8
Q ss_pred ceeeeeCCeEEEEEEECCCcEEEEEEeccCCh-hcHHHHHHHHHHHHccCC--CCcceEEEEEEeC---CeEEEEEEecC
Q 002158 631 TQVGQGGYGKVYKGILSDNTTVAIKRAEEGSL-QGQNEFLTEIKLLSRLHH--RNLVSLLGYCDEE---GEQMLVYEFVP 704 (958)
Q Consensus 631 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H--~niv~l~~~~~~~---~~~~lV~E~~~ 704 (958)
+.|+.|.++.||++...+|+.+++|....... .....+..|+++++.+.+ ..+.+++.+.... +..++||||++
T Consensus 4 ~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i~ 83 (223)
T cd05154 4 RQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERVD 83 (223)
T ss_pred eecCCCccceEEEEEecCCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEeC
Confidence 56899999999999987778999999765432 134568899999999975 4467788887664 36789999999
Q ss_pred CCCHHHHhccCCCCCchHHHHHHHHHHHHHHHHHhhhcC-----------------------------------------
Q 002158 705 NGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEA----------------------------------------- 743 (958)
Q Consensus 705 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~----------------------------------------- 743 (958)
|.++.+.+.. ..++..++..++.+++++|.+||+..
T Consensus 84 G~~l~~~~~~---~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (223)
T cd05154 84 GRVLRDRLLR---PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMERL 160 (223)
T ss_pred CEecCCCCCC---CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHHH
Confidence 9888776532 23677778888889999999988531
Q ss_pred ------------CCCeeccCCCccceEecC--CCCeEEeeeeeecc
Q 002158 744 ------------HPPVFHRDIKASNILLDS--NLNAKVADFGLSRL 775 (958)
Q Consensus 744 ------------~~~iiH~Dikp~NILl~~--~~~~kl~DFGla~~ 775 (958)
...++|+|++|.||+++. ++.+.|+||+.+..
T Consensus 161 ~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~ 206 (223)
T cd05154 161 LRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL 206 (223)
T ss_pred HHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence 245899999999999998 66789999998764
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.10 E-value=4.8e-11 Score=134.39 Aligned_cols=247 Identities=20% Similarity=0.215 Sum_probs=178.0
Q ss_pred HHHcCCCCCceeeeeCCeEEEEEEEC--CCcEEEEEEeccCChhc--HHHHHHHHHHHHcc-CCCCcceEEEEEEeCCeE
Q 002158 622 MATAYFSSSTQVGQGGYGKVYKGILS--DNTTVAIKRAEEGSLQG--QNEFLTEIKLLSRL-HHRNLVSLLGYCDEEGEQ 696 (958)
Q Consensus 622 ~~~~~~~~~~~lg~G~~g~Vy~~~~~--~~~~vavK~~~~~~~~~--~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~ 696 (958)
..+.+|..+..||.|.|+.||+...+ ++..+++|.+....... ...-..|+.+...+ .|.++++....+..-...
T Consensus 262 ~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~ 341 (524)
T KOG0601|consen 262 CKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQG 341 (524)
T ss_pred eecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCccccccc
Confidence 34557888899999999999997743 57889999876643222 22235677777777 488999888888777788
Q ss_pred EEEEEecCCCCHHHHhccCCCCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEecCC-CCeEEeeeeeecc
Q 002158 697 MLVYEFVPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSN-LNAKVADFGLSRL 775 (958)
Q Consensus 697 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~-~~~kl~DFGla~~ 775 (958)
|+=-|||.++++...+ .....++...++++..|++.++.++|+.. ++|+|+||+||++..+ +..+++|||.+..
T Consensus 342 ~ip~e~~~~~s~~l~~--~~~~~~d~~~~~~~~~q~~~~l~~i~s~~---~~~~d~~psni~i~~~~~~~~~~~~~~~t~ 416 (524)
T KOG0601|consen 342 YIPLEFCEGGSSSLRS--VTSQMLDEDPRLRLTAQILTALNVIHSKL---FVHLDVKPSNILISNDGFFSKLGDFGCWTR 416 (524)
T ss_pred cCchhhhcCcchhhhh--HHHHhcCcchhhhhHHHHHhccccccchh---hhcccccccceeeccchhhhhccccccccc
Confidence 8999999999887766 22334778889999999999999999988 9999999999999876 7889999998863
Q ss_pred cccCCCCCCccceeeeeccCCCCcc--ChhhhccCCCCCcchhhhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcCcch
Q 002158 776 APVLDDEGTMPTHVSTIVKGTPGYL--DPEYFLTHKLTDKSDVYSLGVVLLELLTGMQPISHGKNIVREVNVARDSGMVF 853 (958)
Q Consensus 776 ~~~~~~~~~~~~~~~~~~~gt~~y~--aPE~~~~~~~~~~~DV~S~Gv~l~elltG~~P~~~~~~~~~~~~~~~~~~~~~ 853 (958)
+.. .. ....+.-+++ +++......+..+.|+||||..+.|.++|..--..+.. + .
T Consensus 417 ~~~---------~~-~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~~---~----------~ 473 (524)
T KOG0601|consen 417 LAF---------SS-GVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGVQ---S----------L 473 (524)
T ss_pred cce---------ec-ccccccccccccchhhccccccccccccccccccccccccCcccCccccc---c----------e
Confidence 211 11 1122333444 55555566788899999999999999998642221111 0 1
Q ss_pred hhhcccCCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 002158 854 SIIDNRMGSYPSECVERFVTLALRCCHDKPEHRPSMSDVVRELE 897 (958)
Q Consensus 854 ~~i~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 897 (958)
.+..+.....+.. ..++..+.+.++.+++..||.+.+...+.+
T Consensus 474 ~i~~~~~p~~~~~-~~~~q~~~kv~~~~~~~~~~l~~~l~~~~~ 516 (524)
T KOG0601|consen 474 TIRSGDTPNLPGL-KLQLQVLLKVMINPDRKRRPSAVELSLHSE 516 (524)
T ss_pred eeecccccCCCch-HHhhhhhhhhhcCCccccchhhhhhcccch
Confidence 1111112222333 377888889999999999999988776543
|
|
| >PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A | Back alignment and domain information |
|---|
Probab=99.10 E-value=1.7e-11 Score=120.83 Aligned_cols=57 Identities=37% Similarity=0.568 Sum_probs=8.5
Q ss_pred CCcEEEeeCCCCCCCCChhhc-CCCCCCEEecccccccccCccccccccccceEeccccccc
Q 002158 134 SLIFLLLNGNKLSGSLPDELG-YLSNLNRLQVDENNITGTIPKSFANLSRVRHLHLNNNSIG 194 (958)
Q Consensus 134 ~L~~L~Ls~n~l~~~~p~~l~-~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~ 194 (958)
++++|+|.+|.|+ .+. .++ .+.+|+.|+|++|.|+.. +.+..+++|+.|++++|.|+
T Consensus 20 ~~~~L~L~~n~I~-~Ie-~L~~~l~~L~~L~Ls~N~I~~l--~~l~~L~~L~~L~L~~N~I~ 77 (175)
T PF14580_consen 20 KLRELNLRGNQIS-TIE-NLGATLDKLEVLDLSNNQITKL--EGLPGLPRLKTLDLSNNRIS 77 (175)
T ss_dssp ------------------S--TT-TT--EEE-TTS--S----TT----TT--EEE--SS---
T ss_pred ccccccccccccc-ccc-chhhhhcCCCEEECCCCCCccc--cCccChhhhhhcccCCCCCC
Confidence 4455555555544 221 233 244444444444444421 12334444444444444444
|
|
| >PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A | Back alignment and domain information |
|---|
Probab=99.09 E-value=3.7e-11 Score=118.52 Aligned_cols=131 Identities=30% Similarity=0.349 Sum_probs=42.1
Q ss_pred CCCCEEEcccCCCCCCCCCCC-CCCCcCEEeccCCcCCCcCCCCCCCCCcCEEEccCCcCCCccchhccCCCCCCeEeee
Q 002158 254 SKLVKLSLRNCNLQGAVPDLS-RIPNLYYLDLSWNHLTGSIPSKKLSENVTTIDLSDNYLNGSILESISNLPFLQTLSLE 332 (958)
Q Consensus 254 ~~L~~L~L~~N~l~~~~~~l~-~l~~L~~L~Ls~N~l~~~~~~~~~~~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~ 332 (958)
.++++|+|.+|+|+.+ ..+. .+.+|+.|+|++|.|+ .++....+++|+.|+|++|.|+.+.+.....+++|++|+|+
T Consensus 19 ~~~~~L~L~~n~I~~I-e~L~~~l~~L~~L~Ls~N~I~-~l~~l~~L~~L~~L~L~~N~I~~i~~~l~~~lp~L~~L~L~ 96 (175)
T PF14580_consen 19 VKLRELNLRGNQISTI-ENLGATLDKLEVLDLSNNQIT-KLEGLPGLPRLKTLDLSNNRISSISEGLDKNLPNLQELYLS 96 (175)
T ss_dssp ------------------S--TT-TT--EEE-TTS--S---TT----TT--EEE--SS---S-CHHHHHH-TT--EEE-T
T ss_pred cccccccccccccccc-cchhhhhcCCCEEECCCCCCc-cccCccChhhhhhcccCCCCCCccccchHHhCCcCCEEECc
Confidence 3455555555555532 2333 3455555556655555 34444444555555555555554322222345555555555
Q ss_pred cccCCCccchhhhcccccCccccceEeccCCCCCCCccCCCCCCcceEEeCCCCCCCCCCCCCCCcccccCCCCCccccc
Q 002158 333 NNFLTGSIPATIWQNKSFSTKARLKIDLRNNSFSNIVGDLTLPNNVTLRLGGNPICTSANIPNTGRFCGSDAGGDETLTN 412 (958)
Q Consensus 333 ~N~l~~~ip~~l~~~~~~~~~~l~~L~Ls~N~l~~l~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~~~~~~~~~L~~ 412 (958)
+|+|.. +.++.....+++|+.|+|.|||++. ...++.+.....+....|++
T Consensus 97 ~N~I~~--------------------------l~~l~~L~~l~~L~~L~L~~NPv~~---~~~YR~~vi~~lP~Lk~LD~ 147 (175)
T PF14580_consen 97 NNKISD--------------------------LNELEPLSSLPKLRVLSLEGNPVCE---KKNYRLFVIYKLPSLKVLDG 147 (175)
T ss_dssp TS---S--------------------------CCCCGGGGG-TT--EEE-TT-GGGG---STTHHHHHHHH-TT-SEETT
T ss_pred CCcCCC--------------------------hHHhHHHHcCCCcceeeccCCcccc---hhhHHHHHHHHcChhheeCC
Confidence 555541 1112222378899999999999954 34556666666666666666
Q ss_pred cCC
Q 002158 413 SKV 415 (958)
Q Consensus 413 n~~ 415 (958)
.++
T Consensus 148 ~~V 150 (175)
T PF14580_consen 148 QDV 150 (175)
T ss_dssp EET
T ss_pred EEc
Confidence 554
|
|
| >KOG0531 consensus Protein phosphatase 1, regulatory subunit, and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.09 E-value=1.2e-11 Score=142.09 Aligned_cols=218 Identities=29% Similarity=0.320 Sum_probs=135.7
Q ss_pred CCCCcceeeccCcccCCCCccccCCCCCcEEEeeCCCCCCCCChhhcCCCCCCEEecccccccccCccccccccccceEe
Q 002158 108 QLSRLQYYFMWNDLTGTIPKEIGNISSLIFLLLNGNKLSGSLPDELGYLSNLNRLQVDENNITGTIPKSFANLSRVRHLH 187 (958)
Q Consensus 108 ~L~~L~~L~l~n~~~~~ip~~i~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ 187 (958)
.+..++.+.+..|.++.+-..+..+++|+.|++.+|.|. .+...+..+++|++|+|++|+|+.+. .+..++.|+.|+
T Consensus 70 ~l~~l~~l~l~~n~i~~~~~~l~~~~~l~~l~l~~n~i~-~i~~~l~~~~~L~~L~ls~N~I~~i~--~l~~l~~L~~L~ 146 (414)
T KOG0531|consen 70 SLTSLKELNLRQNLIAKILNHLSKLKSLEALDLYDNKIE-KIENLLSSLVNLQVLDLSFNKITKLE--GLSTLTLLKELN 146 (414)
T ss_pred HhHhHHhhccchhhhhhhhcccccccceeeeeccccchh-hcccchhhhhcchheecccccccccc--chhhccchhhhe
Confidence 455555566666666665555777777777777777777 44433666777777777777777442 355666677777
Q ss_pred cccccccccCchhhcCCccchhhhccCCccccCCC-cccCCCCCccEEEccCCCCCCCCccccccCCCCCCEEEcccCCC
Q 002158 188 LNNNSIGGQIPSELSKLSTLIHLLVDNNNLSGNLP-PELSELPQLCILQLDNNNFSASEIPATYGNFSKLVKLSLRNCNL 266 (958)
Q Consensus 188 Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~-~~l~~l~~L~~L~L~~N~l~~~~~p~~~~~l~~L~~L~L~~N~l 266 (958)
+++|.|+. + ..+..+.+|+.+++++|++....+ . +..+.+|+.+++.+|.+.. ...+..+..+..+++..|.+
T Consensus 147 l~~N~i~~-~-~~~~~l~~L~~l~l~~n~i~~ie~~~-~~~~~~l~~l~l~~n~i~~---i~~~~~~~~l~~~~l~~n~i 220 (414)
T KOG0531|consen 147 LSGNLISD-I-SGLESLKSLKLLDLSYNRIVDIENDE-LSELISLEELDLGGNSIRE---IEGLDLLKKLVLLSLLDNKI 220 (414)
T ss_pred eccCcchh-c-cCCccchhhhcccCCcchhhhhhhhh-hhhccchHHHhccCCchhc---ccchHHHHHHHHhhcccccc
Confidence 77777772 2 235557777777777777774433 2 4666777777777777752 33344444555557777777
Q ss_pred CCCCCCCCCCC--CcCEEeccCCcCCCcCCCCCCCCCcCEEEccCCcCCCccchhccCCCCCCeEeeecccCC
Q 002158 267 QGAVPDLSRIP--NLYYLDLSWNHLTGSIPSKKLSENVTTIDLSDNYLNGSILESISNLPFLQTLSLENNFLT 337 (958)
Q Consensus 267 ~~~~~~l~~l~--~L~~L~Ls~N~l~~~~~~~~~~~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~ 337 (958)
+...+ +..+. +|+.+++++|.+.........+.++..|++.+|++... ..+...+.+..+.+..|.+.
T Consensus 221 ~~~~~-l~~~~~~~L~~l~l~~n~i~~~~~~~~~~~~l~~l~~~~n~~~~~--~~~~~~~~~~~~~~~~~~~~ 290 (414)
T KOG0531|consen 221 SKLEG-LNELVMLHLRELYLSGNRISRSPEGLENLKNLPVLDLSSNRISNL--EGLERLPKLSELWLNDNKLA 290 (414)
T ss_pred eeccC-cccchhHHHHHHhcccCccccccccccccccccccchhhcccccc--ccccccchHHHhccCcchhc
Confidence 64332 22222 37777777777762223445556777777777777532 22344455555556666554
|
|
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.08 E-value=9.7e-10 Score=106.30 Aligned_cols=131 Identities=19% Similarity=0.302 Sum_probs=100.4
Q ss_pred ceeeeeCCeEEEEEEECCCcEEEEEE-eccC--Chh-----cHHHHHHHHHHHHccCCCCcceEEEEEEeCCeEEEEEEe
Q 002158 631 TQVGQGGYGKVYKGILSDNTTVAIKR-AEEG--SLQ-----GQNEFLTEIKLLSRLHHRNLVSLLGYCDEEGEQMLVYEF 702 (958)
Q Consensus 631 ~~lg~G~~g~Vy~~~~~~~~~vavK~-~~~~--~~~-----~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E~ 702 (958)
..+++|+-+.+|.+.+. |.++++|. +.+. .+. ...+-.+|+.++++++--.|.-.+=+..+.....++|||
T Consensus 2 ~~i~~GAEa~i~~~~~~-g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~ 80 (204)
T COG3642 2 DLIKQGAEAIIYLTDFL-GLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEY 80 (204)
T ss_pred chhhCCcceeEEeeecc-CcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEE
Confidence 35789999999999874 44566764 2221 111 123567899999999766666556666677788999999
Q ss_pred cCCCCHHHHhccCCCCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEecCCCCeEEeeeeeecc
Q 002158 703 VPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSRL 775 (958)
Q Consensus 703 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~ 775 (958)
++|..|.+.+... +..++..+-.-+.-||..| |+|+|+.++||++..+. +.++|||++.+
T Consensus 81 I~G~~lkd~l~~~---------~~~~~r~vG~~vg~lH~~g---ivHGDLTtsNiIl~~~~-i~~IDfGLg~~ 140 (204)
T COG3642 81 IEGELLKDALEEA---------RPDLLREVGRLVGKLHKAG---IVHGDLTTSNIILSGGR-IYFIDFGLGEF 140 (204)
T ss_pred eCChhHHHHHHhc---------chHHHHHHHHHHHHHHhcC---eecCCCccceEEEeCCc-EEEEECCcccc
Confidence 9999999999654 2456777777888999999 99999999999997665 99999999874
|
|
| >PLN03150 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.03 E-value=2.4e-10 Score=137.34 Aligned_cols=108 Identities=28% Similarity=0.519 Sum_probs=94.7
Q ss_pred CCCEEecccccccccCccccccccccceEecccccccccCchhhcCCccchhhhccCCccccCCCcccCCCCCccEEEcc
Q 002158 158 NLNRLQVDENNITGTIPKSFANLSRVRHLHLNNNSIGGQIPSELSKLSTLIHLLVDNNNLSGNLPPELSELPQLCILQLD 237 (958)
Q Consensus 158 ~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~ 237 (958)
.++.|+|++|.++|.+|..+..+++|+.|+|++|.|+|.+|..+..+++|+.|+|++|++++.+|..++++++|+.|+|+
T Consensus 419 ~v~~L~L~~n~L~g~ip~~i~~L~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~LdLs~N~lsg~iP~~l~~L~~L~~L~Ls 498 (623)
T PLN03150 419 FIDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLN 498 (623)
T ss_pred EEEEEECCCCCccccCCHHHhCCCCCCEEECCCCcccCcCChHHhCCCCCCEEECCCCCCCCCCchHHhcCCCCCEEECc
Confidence 37889999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred CCCCCCCCccccccCC-CCCCEEEcccCCC
Q 002158 238 NNNFSASEIPATYGNF-SKLVKLSLRNCNL 266 (958)
Q Consensus 238 ~N~l~~~~~p~~~~~l-~~L~~L~L~~N~l 266 (958)
+|+++ +.+|..+..+ .++..+++.+|..
T Consensus 499 ~N~l~-g~iP~~l~~~~~~~~~l~~~~N~~ 527 (623)
T PLN03150 499 GNSLS-GRVPAALGGRLLHRASFNFTDNAG 527 (623)
T ss_pred CCccc-ccCChHHhhccccCceEEecCCcc
Confidence 99997 5778877653 4677888888864
|
|
| >KOG4658 consensus Apoptotic ATPase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.97 E-value=3.4e-10 Score=138.56 Aligned_cols=247 Identities=23% Similarity=0.308 Sum_probs=146.0
Q ss_pred eeEEEEccCCc--CCCCccccccCCCCcceeeccC-cccCCCCccccCCCCCcEEEeeCCCCCCCCChhhcCCCCCCEEe
Q 002158 87 HVRELQLLSMN--LSGNLAPELGQLSRLQYYFMWN-DLTGTIPKEIGNISSLIFLLLNGNKLSGSLPDELGYLSNLNRLQ 163 (958)
Q Consensus 87 ~v~~L~L~~~~--l~~~~~~~l~~L~~L~~L~l~n-~~~~~ip~~i~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~ 163 (958)
.+++|-+..|. +.......|..++.|++|+++. ...+.+|..|++|-+|++|+|++..+. .+|..+.+|++|.+|+
T Consensus 546 ~L~tLll~~n~~~l~~is~~ff~~m~~LrVLDLs~~~~l~~LP~~I~~Li~LryL~L~~t~I~-~LP~~l~~Lk~L~~Ln 624 (889)
T KOG4658|consen 546 KLRTLLLQRNSDWLLEISGEFFRSLPLLRVLDLSGNSSLSKLPSSIGELVHLRYLDLSDTGIS-HLPSGLGNLKKLIYLN 624 (889)
T ss_pred ccceEEEeecchhhhhcCHHHHhhCcceEEEECCCCCccCcCChHHhhhhhhhcccccCCCcc-ccchHHHHHHhhheec
Confidence 56777777765 3433444467788888888774 445678888888888888888888887 7788888888888888
Q ss_pred cccccccccCccccccccccceEecccccc--cccCchhhcCCccchhhhccCCccccCCCcccCCCCCcc----EEEcc
Q 002158 164 VDENNITGTIPKSFANLSRVRHLHLNNNSI--GGQIPSELSKLSTLIHLLVDNNNLSGNLPPELSELPQLC----ILQLD 237 (958)
Q Consensus 164 L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l--~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~----~L~L~ 237 (958)
+..+.-...+|.....|++|++|.+..-.. +...-..+.++.+|+.|....... .+-..+..++.|. .+.+.
T Consensus 625 l~~~~~l~~~~~i~~~L~~Lr~L~l~~s~~~~~~~~l~el~~Le~L~~ls~~~~s~--~~~e~l~~~~~L~~~~~~l~~~ 702 (889)
T KOG4658|consen 625 LEVTGRLESIPGILLELQSLRVLRLPRSALSNDKLLLKELENLEHLENLSITISSV--LLLEDLLGMTRLRSLLQSLSIE 702 (889)
T ss_pred cccccccccccchhhhcccccEEEeeccccccchhhHHhhhcccchhhheeecchh--HhHhhhhhhHHHHHHhHhhhhc
Confidence 887776555666666678888887765542 222333445555555555533322 1112223333333 22322
Q ss_pred CCCCCCCCccccccCCCCCCEEEcccCCCCCCCCC-CCC------CCCcCEEeccCCcCCCcCCCCCCCCCcCEEEccCC
Q 002158 238 NNNFSASEIPATYGNFSKLVKLSLRNCNLQGAVPD-LSR------IPNLYYLDLSWNHLTGSIPSKKLSENVTTIDLSDN 310 (958)
Q Consensus 238 ~N~l~~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~-l~~------l~~L~~L~Ls~N~l~~~~~~~~~~~~L~~L~Ls~N 310 (958)
++.. ...+..+..+.+|+.|.+.++.+...... ... +++|..+...++..-..+....+.++|+.|.+.++
T Consensus 703 ~~~~--~~~~~~~~~l~~L~~L~i~~~~~~e~~~~~~~~~~~~~~f~~l~~~~~~~~~~~r~l~~~~f~~~L~~l~l~~~ 780 (889)
T KOG4658|consen 703 GCSK--RTLISSLGSLGNLEELSILDCGISEIVIEWEESLIVLLCFPNLSKVSILNCHMLRDLTWLLFAPHLTSLSLVSC 780 (889)
T ss_pred cccc--ceeecccccccCcceEEEEcCCCchhhcccccccchhhhHHHHHHHHhhccccccccchhhccCcccEEEEecc
Confidence 2222 23456677777888888888777643321 111 22222222223222223333456678888888877
Q ss_pred cCCCccchhccCCCCCCeEeeecccCCC
Q 002158 311 YLNGSILESISNLPFLQTLSLENNFLTG 338 (958)
Q Consensus 311 ~l~~~~~~~~~~l~~L~~L~L~~N~l~~ 338 (958)
.....+......+..++.+-+..+.+.+
T Consensus 781 ~~~e~~i~~~k~~~~l~~~i~~f~~~~~ 808 (889)
T KOG4658|consen 781 RLLEDIIPKLKALLELKELILPFNKLEG 808 (889)
T ss_pred cccccCCCHHHHhhhcccEEeccccccc
Confidence 7766666666666666666666666654
|
|
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=98.96 E-value=1.5e-08 Score=108.12 Aligned_cols=140 Identities=14% Similarity=0.132 Sum_probs=102.7
Q ss_pred ceeeeeCCeEEEEEEECCCcEEEEEEeccCChhc-H----------HHHHHHHHHHHccCCCC--cceEEEEEEe-----
Q 002158 631 TQVGQGGYGKVYKGILSDNTTVAIKRAEEGSLQG-Q----------NEFLTEIKLLSRLHHRN--LVSLLGYCDE----- 692 (958)
Q Consensus 631 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~-~----------~~~~~E~~~l~~l~H~n--iv~l~~~~~~----- 692 (958)
+.+-+-....|++..+ +|+.|.||+........ . ..+.+|...+.++...+ .++++++...
T Consensus 28 e~v~~~~~rrvvr~~~-~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~ 106 (268)
T PRK15123 28 EVFRELEGRRTLRFEL-AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPA 106 (268)
T ss_pred cEEecCCCceEEEEEE-CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCc
Confidence 3455444556778766 67889999875433211 1 14789999998884333 3455666543
Q ss_pred CCeEEEEEEecCCC-CHHHHhccCCCCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEecC-------CCC
Q 002158 693 EGEQMLVYEFVPNG-TLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDS-------NLN 764 (958)
Q Consensus 693 ~~~~~lV~E~~~~g-sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~-------~~~ 764 (958)
....+||||++++. +|.+++........+...+..++.+++..+.-||+.| |+|+|++++|||++. +..
T Consensus 107 ~~~s~LVte~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH~~G---i~HgDL~~~NiLl~~~~~~~~~~~~ 183 (268)
T PRK15123 107 TRTSFIITEDLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDMHAAG---INHRDCYICHFLLHLPFPGREEDLK 183 (268)
T ss_pred cceeEEEEeeCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCc---CccCCCChhhEEEeccccCCCCCce
Confidence 23578999999876 8999985432233556677899999999999999999 999999999999975 467
Q ss_pred eEEeeeeeec
Q 002158 765 AKVADFGLSR 774 (958)
Q Consensus 765 ~kl~DFGla~ 774 (958)
+.++||+.++
T Consensus 184 ~~LIDl~r~~ 193 (268)
T PRK15123 184 LSVIDLHRAQ 193 (268)
T ss_pred EEEEECCccc
Confidence 9999999875
|
|
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=98.92 E-value=3.5e-08 Score=108.59 Aligned_cols=214 Identities=15% Similarity=0.201 Sum_probs=149.1
Q ss_pred CeEEEEEEEC-CCcEEEEEEeccCChhcHHHHHHHHHHHHccCCCCcceEEEEEEe----CCeEEEEEEecCC-CCHHHH
Q 002158 638 YGKVYKGILS-DNTTVAIKRAEEGSLQGQNEFLTEIKLLSRLHHRNLVSLLGYCDE----EGEQMLVYEFVPN-GTLRDW 711 (958)
Q Consensus 638 ~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~----~~~~~lV~E~~~~-gsL~~~ 711 (958)
..+.||+... ||..|+.|+++.........-..-+++++++.|.|+|++.+++.. +...++||+|.|+ ++|.++
T Consensus 289 ~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d~ 368 (655)
T KOG3741|consen 289 SITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYDL 368 (655)
T ss_pred cceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHHH
Confidence 3588999865 899999999955433333233456889999999999999998763 4468999999986 478776
Q ss_pred hccCC-------------CCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEecCCCCeEEeeeeeeccccc
Q 002158 712 LSGRT-------------KENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSRLAPV 778 (958)
Q Consensus 712 l~~~~-------------~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~~~~ 778 (958)
..... ....++...+.++.|++.||.++|+.| +.-+-+.+.+|+++.+.+++|+..|....+..
T Consensus 369 ~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssG---LAck~L~~~kIlv~G~~RIriS~C~i~Dvl~~ 445 (655)
T KOG3741|consen 369 YFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSG---LACKTLDLKKILVTGKMRIRISGCGIMDVLQE 445 (655)
T ss_pred HccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcC---ceeecccHhHeEeeCcceEEEecccceeeecC
Confidence 53221 223778899999999999999999999 89999999999999999999998887765432
Q ss_pred CCCCCCccceeeeeccCCCCccChhhhccCCCCCcchhhhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcCcchhhhcc
Q 002158 779 LDDEGTMPTHVSTIVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVLLELLTGMQPISHGKNIVREVNVARDSGMVFSIIDN 858 (958)
Q Consensus 779 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gv~l~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~i~~ 858 (958)
... |-+ +--.+-|.-.||.+++.|.||..--........ ..
T Consensus 446 d~~---------------------~~l---e~~Qq~D~~~lG~ll~aLAt~~~ns~~~d~~~~-s~-------------- 486 (655)
T KOG3741|consen 446 DPT---------------------EPL---ESQQQNDLRDLGLLLLALATGTENSNRTDSTQS-SH-------------- 486 (655)
T ss_pred CCC---------------------cch---hHHhhhhHHHHHHHHHHHhhcccccccccchHH-HH--------------
Confidence 110 001 112367899999999999999653211111000 00
Q ss_pred cCCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 002158 859 RMGSYPSECVERFVTLALRCCHDKPEHRPSMSDVVRE 895 (958)
Q Consensus 859 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 895 (958)
..........++.+++......++++ -+..+++.+
T Consensus 487 -~~~I~~~yS~D~rn~v~yl~s~~~~~-ksI~~llp~ 521 (655)
T KOG3741|consen 487 -LTRITTTYSTDLRNVVEYLESLNFRE-KSIQDLLPM 521 (655)
T ss_pred -HHHhhhhhhHHHHHHHHHHHhcCccc-ccHHHHHHH
Confidence 00112344566667777777777776 456655543
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=98.91 E-value=2.3e-10 Score=134.83 Aligned_cols=253 Identities=19% Similarity=0.229 Sum_probs=170.7
Q ss_pred HHcCCCCCceeeeeCCeEEEEEEEC-CCcEEEEEEeccCC---hhcHHHHHHHHHHHHccCCCCcceEEEEEEeCCeEEE
Q 002158 623 ATAYFSSSTQVGQGGYGKVYKGILS-DNTTVAIKRAEEGS---LQGQNEFLTEIKLLSRLHHRNLVSLLGYCDEEGEQML 698 (958)
Q Consensus 623 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~l 698 (958)
..+.|.+.+-+-+|.++.++.+.-. .|...++|+..... ..+.+....+-.++-..+||-+++..--+......+|
T Consensus 802 S~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~L 881 (1205)
T KOG0606|consen 802 SPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLPL 881 (1205)
T ss_pred CCccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCcch
Confidence 4455666777888999999887633 34344444332211 1111122223333333345666655444455678899
Q ss_pred EEEecCCCCHHHHhccCCCCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEecCCCCeEEeeeeeeccccc
Q 002158 699 VYEFVPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSRLAPV 778 (958)
Q Consensus 699 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~~~~ 778 (958)
|++|..+++|...++... ..+.+.+......+..+++|||... +.|||++|.|.++..++..++.|||.......
T Consensus 882 ~~~~~~~~~~~Skl~~~~--~~saepaRs~i~~~vqs~e~L~s~~---r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg~ 956 (1205)
T KOG0606|consen 882 VGHYLNGGDLPSKLHNSG--CLSAEPARSPILERVQSLESLHSSL---RKHRDLKPDSLLIAYDGHRPLTDFGTLSKVGL 956 (1205)
T ss_pred hhHHhccCCchhhhhcCC--CcccccccchhHHHHhhhhccccch---hhcccccccchhhcccCCcccCcccccccccc
Confidence 999999999999998654 3555555666777888999999987 89999999999999999999999984433211
Q ss_pred C---C------------------CCC---CccceeeeeccCCCCccChhhhccCCCCCcchhhhHHHHHHHHHhCCCCCC
Q 002158 779 L---D------------------DEG---TMPTHVSTIVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVLLELLTGMQPIS 834 (958)
Q Consensus 779 ~---~------------------~~~---~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gv~l~elltG~~P~~ 834 (958)
. . ... ...........||+.|.+||...+......+|.|+.|++++|.++|..||.
T Consensus 957 ~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~pp~n 1036 (1205)
T KOG0606|consen 957 IPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIPPFN 1036 (1205)
T ss_pred ccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCCCCC
Confidence 1 0 000 000122345679999999999999999999999999999999999999997
Q ss_pred CCchhHHHHHHHhhcCcchhhhc--ccCCCCChHHHHHHHHHHHHccccCCCCCCCHH
Q 002158 835 HGKNIVREVNVARDSGMVFSIID--NRMGSYPSECVERFVTLALRCCHDKPEHRPSMS 890 (958)
Q Consensus 835 ~~~~~~~~~~~~~~~~~~~~~i~--~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ 890 (958)
....- +.+ ..++. ..++.-+........+++...+..+|.+|-.+.
T Consensus 1037 a~tpq-~~f---------~ni~~~~~~~p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~ 1084 (1205)
T KOG0606|consen 1037 AETPQ-QIF---------ENILNRDIPWPEGPEEGSYEAQDLINRLLTEEPTQRLGAK 1084 (1205)
T ss_pred Ccchh-hhh---------hccccCCCCCCCCccccChhhhhhhhhhhccCchhccCcc
Confidence 53321 111 11111 112233455667788899999999999997666
|
|
| >KOG2982 consensus Uncharacterized conserved protein [Function unknown] | Back alignment and domain information |
|---|
Probab=98.89 E-value=9.1e-11 Score=119.50 Aligned_cols=224 Identities=17% Similarity=0.181 Sum_probs=129.3
Q ss_pred cccccceEeccccccc--ccCchhhcCCccchhhhccCCccccCCCcccCCCCCccEEEccCCCCCCCCccccccCCCCC
Q 002158 179 NLSRVRHLHLNNNSIG--GQIPSELSKLSTLIHLLVDNNNLSGNLPPELSELPQLCILQLDNNNFSASEIPATYGNFSKL 256 (958)
Q Consensus 179 ~l~~L~~L~Ls~N~l~--~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~p~~~~~l~~L 256 (958)
..+.++.|||.+|.|+ ..+...+.+|+.|++|+|+.|.+...+...-..+.+|+.|.|.+..+.+......+..++++
T Consensus 69 ~~~~v~elDL~~N~iSdWseI~~ile~lP~l~~LNls~N~L~s~I~~lp~p~~nl~~lVLNgT~L~w~~~~s~l~~lP~v 148 (418)
T KOG2982|consen 69 SVTDVKELDLTGNLISDWSEIGAILEQLPALTTLNLSCNSLSSDIKSLPLPLKNLRVLVLNGTGLSWTQSTSSLDDLPKV 148 (418)
T ss_pred HhhhhhhhhcccchhccHHHHHHHHhcCccceEeeccCCcCCCccccCcccccceEEEEEcCCCCChhhhhhhhhcchhh
Confidence 3456777777777776 34445567778888888888887744433224567888888888888776666677788888
Q ss_pred CEEEcccCCCCCCCC---CCCCC-CCcCEEeccCCcCCCcCCCCCCCCCcCEEEccCCcCCCccchhccCCCCCCeEeee
Q 002158 257 VKLSLRNCNLQGAVP---DLSRI-PNLYYLDLSWNHLTGSIPSKKLSENVTTIDLSDNYLNGSILESISNLPFLQTLSLE 332 (958)
Q Consensus 257 ~~L~L~~N~l~~~~~---~l~~l-~~L~~L~Ls~N~l~~~~~~~~~~~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~ 332 (958)
++|+++.|.+..... ..... +.+..|.+-.| +..+.++-|++. .-+|++..+-+.
T Consensus 149 telHmS~N~~rq~n~Dd~c~e~~s~~v~tlh~~~c--------------~~~~w~~~~~l~-------r~Fpnv~sv~v~ 207 (418)
T KOG2982|consen 149 TELHMSDNSLRQLNLDDNCIEDWSTEVLTLHQLPC--------------LEQLWLNKNKLS-------RIFPNVNSVFVC 207 (418)
T ss_pred hhhhhccchhhhhccccccccccchhhhhhhcCCc--------------HHHHHHHHHhHH-------hhcccchheeee
Confidence 888888875432111 01111 12222222222 111222222221 123445555555
Q ss_pred cccCCCccc-hhhhcccccCccccceEeccCCCCCCC---ccCCCCCCcceEEeCCCCCCCCCCCCCCCcccccCCCCCc
Q 002158 333 NNFLTGSIP-ATIWQNKSFSTKARLKIDLRNNSFSNI---VGDLTLPNNVTLRLGGNPICTSANIPNTGRFCGSDAGGDE 408 (958)
Q Consensus 333 ~N~l~~~ip-~~l~~~~~~~~~~l~~L~Ls~N~l~~l---~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~~~~~~~~ 408 (958)
.|+|...-. +..-+ .+.+--|.|+.|+|.+. .....++.|..|.+.+||+...-.....+.+++.+.....
T Consensus 208 e~PlK~~s~ek~se~-----~p~~~~LnL~~~~idswasvD~Ln~f~~l~dlRv~~~Pl~d~l~~~err~llIaRL~~v~ 282 (418)
T KOG2982|consen 208 EGPLKTESSEKGSEP-----FPSLSCLNLGANNIDSWASVDALNGFPQLVDLRVSENPLSDPLRGGERRFLLIARLTKVQ 282 (418)
T ss_pred cCcccchhhcccCCC-----CCcchhhhhcccccccHHHHHHHcCCchhheeeccCCcccccccCCcceEEEEeeccceE
Confidence 555542111 11111 12222466666666653 3444899999999999999766666666777777777777
Q ss_pred cccccCCCCCCCCCCCCCcc
Q 002158 409 TLTNSKVNCPVQACPVDNFF 428 (958)
Q Consensus 409 ~L~~n~~~C~c~~~~~~~~~ 428 (958)
.|+|..+.-+-.--.-+.++
T Consensus 283 vLNGskIss~er~dSEr~fV 302 (418)
T KOG2982|consen 283 VLNGSKISSRERKDSERRFV 302 (418)
T ss_pred EecCcccchhhhhhhHHHHH
Confidence 88887665544444444433
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.85 E-value=1.1e-08 Score=102.68 Aligned_cols=124 Identities=23% Similarity=0.289 Sum_probs=82.5
Q ss_pred EEEEEEECCCcEEEEEEeccCCh---------------------h-----cHHHHHHHHHHHHccCCC--CcceEEEEEE
Q 002158 640 KVYKGILSDNTTVAIKRAEEGSL---------------------Q-----GQNEFLTEIKLLSRLHHR--NLVSLLGYCD 691 (958)
Q Consensus 640 ~Vy~~~~~~~~~vavK~~~~~~~---------------------~-----~~~~~~~E~~~l~~l~H~--niv~l~~~~~ 691 (958)
.||.|...+|..||||..+.... . ......+|++.|.++..- ++.+++++.
T Consensus 1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~- 79 (188)
T PF01163_consen 1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN- 79 (188)
T ss_dssp EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE-
T ss_pred CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe-
Confidence 38999998999999998643100 0 113467899999999765 567777553
Q ss_pred eCCeEEEEEEecC--CCCHHHHhccCCCCCchHHHHHHHHHHHHHHHHH-hhhcCCCCeeccCCCccceEecCCCCeEEe
Q 002158 692 EEGEQMLVYEFVP--NGTLRDWLSGRTKENLNFAMRLRVALDSAKGILY-LHTEAHPPVFHRDIKASNILLDSNLNAKVA 768 (958)
Q Consensus 692 ~~~~~~lV~E~~~--~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~y-LH~~~~~~iiH~Dikp~NILl~~~~~~kl~ 768 (958)
...+||||++ |..+..+.... ++.+....++.+++..+.. +|..| |+|+|+.+.||+++++ .+.|+
T Consensus 80 ---~~~ivME~I~~~G~~~~~l~~~~----~~~~~~~~~~~~il~~~~~~~~~~g---ivHGDLs~~NIlv~~~-~~~iI 148 (188)
T PF01163_consen 80 ---RNVIVMEYIGEDGVPLPRLKDVD----LSPEEPKELLEEILEEIIKMLHKAG---IVHGDLSEYNILVDDG-KVYII 148 (188)
T ss_dssp ---TTEEEEE--EETTEEGGCHHHCG----GGGSTHHHHHHHHHHHHHHHHHCTT---EEESS-STTSEEEETT-CEEE-
T ss_pred ---CCEEEEEecCCCccchhhHHhcc----ccchhHHHHHHHHHHHHHHHHHhcC---ceecCCChhhEEeecc-eEEEE
Confidence 3479999998 54554433211 2234456777788886555 57888 9999999999999887 99999
Q ss_pred eeeeecc
Q 002158 769 DFGLSRL 775 (958)
Q Consensus 769 DFGla~~ 775 (958)
|||.+..
T Consensus 149 Df~qav~ 155 (188)
T PF01163_consen 149 DFGQAVD 155 (188)
T ss_dssp -GTTEEE
T ss_pred ecCccee
Confidence 9998763
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >KOG1859 consensus Leucine-rich repeat proteins [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.81 E-value=6.8e-11 Score=133.18 Aligned_cols=131 Identities=27% Similarity=0.414 Sum_probs=78.4
Q ss_pred CccEEEccCCCCCCCCccccccCCCCCCEEEcccCCCCCCCCCCCCCCCcCEEeccCCcCCCcCCCCCCC-CCcCEEEcc
Q 002158 230 QLCILQLDNNNFSASEIPATYGNFSKLVKLSLRNCNLQGAVPDLSRIPNLYYLDLSWNHLTGSIPSKKLS-ENVTTIDLS 308 (958)
Q Consensus 230 ~L~~L~L~~N~l~~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~-~~L~~L~Ls 308 (958)
.|...+.+.|++. .+...+.-++.|+.|+|++|+++... .+..+++|+.|||++|.+. .+|....- -+|+.|.|+
T Consensus 165 ~L~~a~fsyN~L~--~mD~SLqll~ale~LnLshNk~~~v~-~Lr~l~~LkhLDlsyN~L~-~vp~l~~~gc~L~~L~lr 240 (1096)
T KOG1859|consen 165 KLATASFSYNRLV--LMDESLQLLPALESLNLSHNKFTKVD-NLRRLPKLKHLDLSYNCLR-HVPQLSMVGCKLQLLNLR 240 (1096)
T ss_pred hHhhhhcchhhHH--hHHHHHHHHHHhhhhccchhhhhhhH-HHHhcccccccccccchhc-cccccchhhhhheeeeec
Confidence 4555566666663 34455555666666666666666443 5666667777777777766 45544222 246666666
Q ss_pred CCcCCCccchhccCCCCCCeEeeecccCCCccchhhhcccccCccccceEeccCCCCCCCccCCCCCCcceEEeCCCCCC
Q 002158 309 DNYLNGSILESISNLPFLQTLSLENNFLTGSIPATIWQNKSFSTKARLKIDLRNNSFSNIVGDLTLPNNVTLRLGGNPIC 388 (958)
Q Consensus 309 ~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~ip~~l~~~~~~~~~~l~~L~Ls~N~l~~l~~~~~l~~L~~L~l~~N~l~ 388 (958)
+|.++. ...+.+|.+|+.|||++|-|.+ .+++.....+..|+.|+|.|||++
T Consensus 241 nN~l~t--L~gie~LksL~~LDlsyNll~~--------------------------hseL~pLwsLs~L~~L~LeGNPl~ 292 (1096)
T KOG1859|consen 241 NNALTT--LRGIENLKSLYGLDLSYNLLSE--------------------------HSELEPLWSLSSLIVLWLEGNPLC 292 (1096)
T ss_pred ccHHHh--hhhHHhhhhhhccchhHhhhhc--------------------------chhhhHHHHHHHHHHHhhcCCccc
Confidence 666642 2334556666666666666652 111222336778899999999998
Q ss_pred CCCC
Q 002158 389 TSAN 392 (958)
Q Consensus 389 ~~~~ 392 (958)
|...
T Consensus 293 c~p~ 296 (1096)
T KOG1859|consen 293 CAPW 296 (1096)
T ss_pred cCHH
Confidence 8653
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.77 E-value=2.5e-07 Score=99.34 Aligned_cols=261 Identities=17% Similarity=0.182 Sum_probs=163.5
Q ss_pred CCCceeeeeCCeEEEEEEECCCcEEEEEEeccCChhcHHHHHHHHHHHHcc-CCCCcceEEEE------E-EeCCeEEEE
Q 002158 628 SSSTQVGQGGYGKVYKGILSDNTTVAIKRAEEGSLQGQNEFLTEIKLLSRL-HHRNLVSLLGY------C-DEEGEQMLV 699 (958)
Q Consensus 628 ~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~------~-~~~~~~~lV 699 (958)
.....||+|+.+.+|..- +-...+.|++.........+ .++.|... .||-+-.=+.+ . ..+....++
T Consensus 14 ~~gr~LgqGgea~ly~l~--e~~d~VAKIYh~Pppa~~aq---k~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iGfl 88 (637)
T COG4248 14 PPGRPLGQGGEADLYTLG--EVRDQVAKIYHAPPPAAQAQ---KVAELAATPDAPLLNYRVAWPQATLHGGRRGKVIGFL 88 (637)
T ss_pred CCCccccCCccceeeecc--hhhchhheeecCCCchHHHH---HHHHhccCCCCcchhhhhcccHHHhhCCCccceeEEe
Confidence 345679999999999642 22234557776554433322 23334444 56654331221 1 122347788
Q ss_pred EEecCCC-CHHHHhccC----CCCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEecCCCCeEEeeeeeec
Q 002158 700 YEFVPNG-TLRDWLSGR----TKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSR 774 (958)
Q Consensus 700 ~E~~~~g-sL~~~l~~~----~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~ 774 (958)
|..+++. -+.+++... .-....|...++.+..+|.+.+-||+.| .+-+|+.++|+|+.+++.+.|.|=..-.
T Consensus 89 mP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~G---h~vGDVn~~~~lVsd~~~V~LVdsDsfq 165 (637)
T COG4248 89 MPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHG---HVVGDVNQNSFLVSDDSKVVLVDSDSFQ 165 (637)
T ss_pred cccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcC---CcccccCccceeeecCceEEEEccccee
Confidence 9988764 344444322 2244889999999999999999999999 8889999999999999999998754322
Q ss_pred ccccCCCCCCccceeeeeccCCCCccChhhhc-----cCCCCCcchhhhHHHHHHHHHhC-CCCCCCCchhH---HHHHH
Q 002158 775 LAPVLDDEGTMPTHVSTIVKGTPGYLDPEYFL-----THKLTDKSDVYSLGVVLLELLTG-MQPISHGKNIV---REVNV 845 (958)
Q Consensus 775 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DV~S~Gv~l~elltG-~~P~~~~~~~~---~~~~~ 845 (958)
+. .. ......-+|...|.+||.-. +..-+...|-|.+|+++++++.| ++||.+-.... .-...
T Consensus 166 i~----~n----g~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~ 237 (637)
T COG4248 166 IN----AN----GTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLET 237 (637)
T ss_pred ec----cC----CceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchh
Confidence 21 11 12223346889999999865 33456789999999999999986 99997522100 00000
Q ss_pred HhhcCcchhhhcccC------CCCC-hHHHHHHHHHHHHccccC--CCCCCCHHHHHHHHHHhHhhCC
Q 002158 846 ARDSGMVFSIIDNRM------GSYP-SECVERFVTLALRCCHDK--PEHRPSMSDVVRELENILKMFP 904 (958)
Q Consensus 846 ~~~~~~~~~~i~~~~------~~~~-~~~~~~l~~li~~cl~~d--P~~RPs~~evl~~L~~~~~~~~ 904 (958)
....+.+....+.+. ...| .-.+..+..+..+|+... +.-||+++..+..|..+.+++.
T Consensus 238 ~Ia~g~f~ya~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl~al~~~L~ 305 (637)
T COG4248 238 DIAHGRFAYASDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKAWVAALDALRQQLK 305 (637)
T ss_pred hhhcceeeechhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHHHHhhh
Confidence 001111111111111 1112 234667888999998764 5689999988877766655443
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.75 E-value=3.2e-08 Score=101.55 Aligned_cols=135 Identities=19% Similarity=0.203 Sum_probs=97.1
Q ss_pred CCCCCceeeeeCCeEEEEEEECCCcEEEEEEeccCCh----------------------hcHHHHHHHHHHHHccCCC--
Q 002158 626 YFSSSTQVGQGGYGKVYKGILSDNTTVAIKRAEEGSL----------------------QGQNEFLTEIKLLSRLHHR-- 681 (958)
Q Consensus 626 ~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~----------------------~~~~~~~~E~~~l~~l~H~-- 681 (958)
-..+.+.||.|.-+.||.|....|.++|||.-+.... -......+|.++|.++.-.
T Consensus 92 ve~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~ 171 (304)
T COG0478 92 VEAIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGV 171 (304)
T ss_pred HHhhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCC
Confidence 3456689999999999999999999999995322110 0123357899999999644
Q ss_pred CcceEEEEEEeCCeEEEEEEecCCCCHHHHhccCCCCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEecC
Q 002158 682 NLVSLLGYCDEEGEQMLVYEFVPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDS 761 (958)
Q Consensus 682 niv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~ 761 (958)
.+.+.+++ +...+||||++|--|+..- ++.+..-.++..|++-+..+-..| |||+|+.+-||++++
T Consensus 172 ~VP~P~~~----nRHaVvMe~ieG~eL~~~r-------~~~en~~~il~~il~~~~~~~~~G---iVHGDlSefNIlV~~ 237 (304)
T COG0478 172 KVPKPIAW----NRHAVVMEYIEGVELYRLR-------LDVENPDEILDKILEEVRKAYRRG---IVHGDLSEFNILVTE 237 (304)
T ss_pred CCCCcccc----ccceeeeehcccceeeccc-------CcccCHHHHHHHHHHHHHHHHHcC---ccccCCchheEEEec
Confidence 77777765 4568999999886665432 122233344444444444444667 999999999999999
Q ss_pred CCCeEEeeeeeec
Q 002158 762 NLNAKVADFGLSR 774 (958)
Q Consensus 762 ~~~~kl~DFGla~ 774 (958)
||.+.++||--+.
T Consensus 238 dg~~~vIDwPQ~v 250 (304)
T COG0478 238 DGDIVVIDWPQAV 250 (304)
T ss_pred CCCEEEEeCcccc
Confidence 9999999996543
|
|
| >KOG4658 consensus Apoptotic ATPase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.64 E-value=4.5e-08 Score=120.24 Aligned_cols=176 Identities=24% Similarity=0.315 Sum_probs=98.4
Q ss_pred CcceeeccCcc--cCCCCcc-ccCCCCCcEEEeeCCCCCCCCChhhcCCCCCCEEecccccccccCccccccccccceEe
Q 002158 111 RLQYYFMWNDL--TGTIPKE-IGNISSLIFLLLNGNKLSGSLPDELGYLSNLNRLQVDENNITGTIPKSFANLSRVRHLH 187 (958)
Q Consensus 111 ~L~~L~l~n~~--~~~ip~~-i~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ 187 (958)
+|+.|.+..|. ...++.. |..++.|++|||++|.=-+.+|..+++|-+|++|+|++..+. .+|..+.+|+.|.+|+
T Consensus 546 ~L~tLll~~n~~~l~~is~~ff~~m~~LrVLDLs~~~~l~~LP~~I~~Li~LryL~L~~t~I~-~LP~~l~~Lk~L~~Ln 624 (889)
T KOG4658|consen 546 KLRTLLLQRNSDWLLEISGEFFRSLPLLRVLDLSGNSSLSKLPSSIGELVHLRYLDLSDTGIS-HLPSGLGNLKKLIYLN 624 (889)
T ss_pred ccceEEEeecchhhhhcCHHHHhhCcceEEEECCCCCccCcCChHHhhhhhhhcccccCCCcc-ccchHHHHHHhhheec
Confidence 46666554442 4444443 555777777777766555577777777777777777777776 6677777777777777
Q ss_pred cccccccccCchhhcCCccchhhhccCCccc--cCCCcccCCCCCccEEEccCCCCCCCCccccccCCCCCC----EEEc
Q 002158 188 LNNNSIGGQIPSELSKLSTLIHLLVDNNNLS--GNLPPELSELPQLCILQLDNNNFSASEIPATYGNFSKLV----KLSL 261 (958)
Q Consensus 188 Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~--~~~~~~l~~l~~L~~L~L~~N~l~~~~~p~~~~~l~~L~----~L~L 261 (958)
+..+.-...+|.....|.+|++|.+..-... ...-..+..+.+|+.|....... .+-..+..+.+|. .+.+
T Consensus 625 l~~~~~l~~~~~i~~~L~~Lr~L~l~~s~~~~~~~~l~el~~Le~L~~ls~~~~s~---~~~e~l~~~~~L~~~~~~l~~ 701 (889)
T KOG4658|consen 625 LEVTGRLESIPGILLELQSLRVLRLPRSALSNDKLLLKELENLEHLENLSITISSV---LLLEDLLGMTRLRSLLQSLSI 701 (889)
T ss_pred cccccccccccchhhhcccccEEEeeccccccchhhHHhhhcccchhhheeecchh---HhHhhhhhhHHHHHHhHhhhh
Confidence 7766655455665666777777766554422 12222334444444444422221 0111122222222 3333
Q ss_pred ccCCCCCCCCCCCCCCCcCEEeccCCcCC
Q 002158 262 RNCNLQGAVPDLSRIPNLYYLDLSWNHLT 290 (958)
Q Consensus 262 ~~N~l~~~~~~l~~l~~L~~L~Ls~N~l~ 290 (958)
.++.....+..+..+.+|+.|.+.++.+.
T Consensus 702 ~~~~~~~~~~~~~~l~~L~~L~i~~~~~~ 730 (889)
T KOG4658|consen 702 EGCSKRTLISSLGSLGNLEELSILDCGIS 730 (889)
T ss_pred cccccceeecccccccCcceEEEEcCCCc
Confidence 33444444445667777777777777765
|
|
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.64 E-value=5.5e-07 Score=90.85 Aligned_cols=137 Identities=17% Similarity=0.186 Sum_probs=105.1
Q ss_pred eeeeCCeEEEEEEECCCcEEEEEEeccC---C---hhcHHHHHHHHHHHHccCC--CCcceEEEEEE-e----CCeEEEE
Q 002158 633 VGQGGYGKVYKGILSDNTTVAIKRAEEG---S---LQGQNEFLTEIKLLSRLHH--RNLVSLLGYCD-E----EGEQMLV 699 (958)
Q Consensus 633 lg~G~~g~Vy~~~~~~~~~vavK~~~~~---~---~~~~~~~~~E~~~l~~l~H--~niv~l~~~~~-~----~~~~~lV 699 (958)
-|+||-+-|++-.. +|..+-+|+-... + +.....|.+|+..+.++.. -.+.++. ++. . .-..+||
T Consensus 26 ~~rgG~SgV~r~~~-~g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~~~~rA~LV 103 (216)
T PRK09902 26 YRRNGMSGVQCVER-NGKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVKIEGEWRALLV 103 (216)
T ss_pred cCCCCcceEEEEEe-CCcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeeccCCceEEEEE
Confidence 36688888999776 4457889976521 1 3456789999999999953 2355555 332 1 1246899
Q ss_pred EEecCC-CCHHHHhccCCCCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEecCCCC--eEEeeeeeec
Q 002158 700 YEFVPN-GTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSNLN--AKVADFGLSR 774 (958)
Q Consensus 700 ~E~~~~-gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~~~--~kl~DFGla~ 774 (958)
+|-+++ -+|.+++.+....+.+...+..+..++++.+.-||+.| +.|+|+.+.||+++.++. ++++||.-++
T Consensus 104 Te~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH~~G---v~Hgdly~khIll~~~g~~~v~lIDlEk~r 178 (216)
T PRK09902 104 TEDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMHSVN---RQHGCCYVRHIYVKTEGKAEAGFLDLEKSR 178 (216)
T ss_pred EEeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHhheeecCCCCeeEEEEEhhccc
Confidence 998854 58999997655445778888999999999999999999 999999999999986667 9999998765
|
|
| >KOG1859 consensus Leucine-rich repeat proteins [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.61 E-value=5.2e-10 Score=126.26 Aligned_cols=155 Identities=30% Similarity=0.359 Sum_probs=82.0
Q ss_pred CccccCCCCCcEEEeeCCCCCCCCChhhcCCC-CCCEEeccccccc----------ccCccccccccccceEeccccccc
Q 002158 126 PKEIGNISSLIFLLLNGNKLSGSLPDELGYLS-NLNRLQVDENNIT----------GTIPKSFANLSRVRHLHLNNNSIG 194 (958)
Q Consensus 126 p~~i~~l~~L~~L~Ls~n~l~~~~p~~l~~l~-~L~~L~L~~N~l~----------~~~p~~~~~l~~L~~L~Ls~N~l~ 194 (958)
|-.|..+++|++|.|.++.|.. -..+..+. +|++|-.. |.++ |.+..++. -..|...+++.|.+.
T Consensus 102 pi~ifpF~sLr~LElrg~~L~~--~~GL~~lr~qLe~LIC~-~Sl~Al~~v~ascggd~~ns~~-Wn~L~~a~fsyN~L~ 177 (1096)
T KOG1859|consen 102 PISIFPFRSLRVLELRGCDLST--AKGLQELRHQLEKLICH-NSLDALRHVFASCGGDISNSPV-WNKLATASFSYNRLV 177 (1096)
T ss_pred CceeccccceeeEEecCcchhh--hhhhHHHHHhhhhhhhh-ccHHHHHHHHHHhccccccchh-hhhHhhhhcchhhHH
Confidence 5567777888888888887762 11222222 34444322 2222 11111111 124566666677666
Q ss_pred ccCchhhcCCccchhhhccCCccccCCCcccCCCCCccEEEccCCCCCCCCccccccCCCCCCEEEcccCCCCCCCCCCC
Q 002158 195 GQIPSELSKLSTLIHLLVDNNNLSGNLPPELSELPQLCILQLDNNNFSASEIPATYGNFSKLVKLSLRNCNLQGAVPDLS 274 (958)
Q Consensus 195 ~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~l~ 274 (958)
....++.-++.|+.|+|++|+++.. +.+..++.|++|||++|.++. +|..-..-.+|+.|.|++|.++.. .++.
T Consensus 178 -~mD~SLqll~ale~LnLshNk~~~v--~~Lr~l~~LkhLDlsyN~L~~--vp~l~~~gc~L~~L~lrnN~l~tL-~gie 251 (1096)
T KOG1859|consen 178 -LMDESLQLLPALESLNLSHNKFTKV--DNLRRLPKLKHLDLSYNCLRH--VPQLSMVGCKLQLLNLRNNALTTL-RGIE 251 (1096)
T ss_pred -hHHHHHHHHHHhhhhccchhhhhhh--HHHHhcccccccccccchhcc--ccccchhhhhheeeeecccHHHhh-hhHH
Confidence 5555666666677777777766643 256666666666666666642 333111112356666666655522 2345
Q ss_pred CCCCcCEEeccCCcCC
Q 002158 275 RIPNLYYLDLSWNHLT 290 (958)
Q Consensus 275 ~l~~L~~L~Ls~N~l~ 290 (958)
++.+|+.|||++|-|.
T Consensus 252 ~LksL~~LDlsyNll~ 267 (1096)
T KOG1859|consen 252 NLKSLYGLDLSYNLLS 267 (1096)
T ss_pred hhhhhhccchhHhhhh
Confidence 5555555555555554
|
|
| >KOG2982 consensus Uncharacterized conserved protein [Function unknown] | Back alignment and domain information |
|---|
Probab=98.59 E-value=1.5e-08 Score=103.68 Aligned_cols=229 Identities=18% Similarity=0.184 Sum_probs=136.2
Q ss_pred cccccCCCCcceeeccCcccCCCCc--ccc-CCCCCcEEEeeCCCCCC--CCChhhcCCCCCCEEecccccccccCcccc
Q 002158 103 APELGQLSRLQYYFMWNDLTGTIPK--EIG-NISSLIFLLLNGNKLSG--SLPDELGYLSNLNRLQVDENNITGTIPKSF 177 (958)
Q Consensus 103 ~~~l~~L~~L~~L~l~n~~~~~ip~--~i~-~l~~L~~L~Ls~n~l~~--~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~ 177 (958)
+-.+..+..++.|.+.+..+...-+ .|+ ..+.+++|||.+|.|+. .+-.-+.+|+.|+.|+|+.|.+...|-..-
T Consensus 38 ~~~v~s~ra~ellvln~~~id~~gd~~~~~~~~~~v~elDL~~N~iSdWseI~~ile~lP~l~~LNls~N~L~s~I~~lp 117 (418)
T KOG2982|consen 38 YLGVSSLRALELLVLNGSIIDNEGDVMLFGSSVTDVKELDLTGNLISDWSEIGAILEQLPALTTLNLSCNSLSSDIKSLP 117 (418)
T ss_pred eeeeccccchhhheecCCCCCcchhHHHHHHHhhhhhhhhcccchhccHHHHHHHHhcCccceEeeccCCcCCCccccCc
Confidence 3334445555566666555544332 233 35689999999999983 233346689999999999999985443222
Q ss_pred ccccccceEeccccccc-ccCchhhcCCccchhhhccCCcccc--CCCcccCCC-CCccEEEccCCCCCC-CCccccccC
Q 002158 178 ANLSRVRHLHLNNNSIG-GQIPSELSKLSTLIHLLVDNNNLSG--NLPPELSEL-PQLCILQLDNNNFSA-SEIPATYGN 252 (958)
Q Consensus 178 ~~l~~L~~L~Ls~N~l~-~~~p~~l~~l~~L~~L~L~~N~l~~--~~~~~l~~l-~~L~~L~L~~N~l~~-~~~p~~~~~ 252 (958)
..+.+|+.|-|.+..+. ......+..++.++.|+++.|.+.- ......... +.+++|.+..|.... ......-.-
T Consensus 118 ~p~~nl~~lVLNgT~L~w~~~~s~l~~lP~vtelHmS~N~~rq~n~Dd~c~e~~s~~v~tlh~~~c~~~~w~~~~~l~r~ 197 (418)
T KOG2982|consen 118 LPLKNLRVLVLNGTGLSWTQSTSSLDDLPKVTELHMSDNSLRQLNLDDNCIEDWSTEVLTLHQLPCLEQLWLNKNKLSRI 197 (418)
T ss_pred ccccceEEEEEcCCCCChhhhhhhhhcchhhhhhhhccchhhhhccccccccccchhhhhhhcCCcHHHHHHHHHhHHhh
Confidence 46678999999888876 3344567788899999999985541 111111111 244444444443210 011111234
Q ss_pred CCCCCEEEcccCCCCCCCC--CCCCCCCcCEEeccCCcCCC--cCCCCCCCCCcCEEEccCCcCCCccch------hccC
Q 002158 253 FSKLVKLSLRNCNLQGAVP--DLSRIPNLYYLDLSWNHLTG--SIPSKKLSENVTTIDLSDNYLNGSILE------SISN 322 (958)
Q Consensus 253 l~~L~~L~L~~N~l~~~~~--~l~~l~~L~~L~Ls~N~l~~--~~~~~~~~~~L~~L~Ls~N~l~~~~~~------~~~~ 322 (958)
++++..+.+..|.|..... .+..++.+..|+|+.|+|.. .+.....++.|..|.+++|.|...... .++.
T Consensus 198 Fpnv~sv~v~e~PlK~~s~ek~se~~p~~~~LnL~~~~idswasvD~Ln~f~~l~dlRv~~~Pl~d~l~~~err~llIaR 277 (418)
T KOG2982|consen 198 FPNVNSVFVCEGPLKTESSEKGSEPFPSLSCLNLGANNIDSWASVDALNGFPQLVDLRVSENPLSDPLRGGERRFLLIAR 277 (418)
T ss_pred cccchheeeecCcccchhhcccCCCCCcchhhhhcccccccHHHHHHHcCCchhheeeccCCcccccccCCcceEEEEee
Confidence 5677777788887765543 26666777777888877753 233344556666777777766442211 2345
Q ss_pred CCCCCeEee
Q 002158 323 LPFLQTLSL 331 (958)
Q Consensus 323 l~~L~~L~L 331 (958)
|++++.|+=
T Consensus 278 L~~v~vLNG 286 (418)
T KOG2982|consen 278 LTKVQVLNG 286 (418)
T ss_pred ccceEEecC
Confidence 666665543
|
|
| >PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A | Back alignment and domain information |
|---|
Probab=98.59 E-value=2.3e-08 Score=81.09 Aligned_cols=58 Identities=40% Similarity=0.548 Sum_probs=25.3
Q ss_pred cceEecccccccccCchhhcCCccchhhhccCCccccCCCcccCCCCCccEEEccCCC
Q 002158 183 VRHLHLNNNSIGGQIPSELSKLSTLIHLLVDNNNLSGNLPPELSELPQLCILQLDNNN 240 (958)
Q Consensus 183 L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~ 240 (958)
|++|++++|+|+...+..|.++++|++|++++|+++...+..|.++++|++|++++|+
T Consensus 3 L~~L~l~~n~l~~i~~~~f~~l~~L~~L~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~ 60 (61)
T PF13855_consen 3 LESLDLSNNKLTEIPPDSFSNLPNLETLDLSNNNLTSIPPDAFSNLPNLRYLDLSNNN 60 (61)
T ss_dssp ESEEEETSSTESEECTTTTTTGTTESEEEETSSSESEEETTTTTTSTTESEEEETSSS
T ss_pred CcEEECCCCCCCccCHHHHcCCCCCCEeEccCCccCccCHHHHcCCCCCCEEeCcCCc
Confidence 4444444444443333344444444444444444444444444444444444444443
|
... |
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.56 E-value=5.3e-07 Score=93.13 Aligned_cols=106 Identities=25% Similarity=0.346 Sum_probs=85.5
Q ss_pred HHHHHHHHHHHHccCC--CCcceEEEEEEeCC----eEEEEEEecCCC-CHHHHhccCCCCCchHHHHHHHHHHHHHHHH
Q 002158 665 QNEFLTEIKLLSRLHH--RNLVSLLGYCDEEG----EQMLVYEFVPNG-TLRDWLSGRTKENLNFAMRLRVALDSAKGIL 737 (958)
Q Consensus 665 ~~~~~~E~~~l~~l~H--~niv~l~~~~~~~~----~~~lV~E~~~~g-sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~ 737 (958)
..+..+|...+.++.. -...+.+++..... ..++|+|++++. +|.+++..... .+......++.++++.++
T Consensus 55 ~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~--~~~~~~~~ll~~l~~~i~ 132 (206)
T PF06293_consen 55 RSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQ--LDPSQRRELLRALARLIA 132 (206)
T ss_pred chHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcc--cchhhHHHHHHHHHHHHH
Confidence 3467889988888843 34567777766532 458999999874 89999975333 566678899999999999
Q ss_pred HhhhcCCCCeeccCCCccceEecCCC---CeEEeeeeeecc
Q 002158 738 YLHTEAHPPVFHRDIKASNILLDSNL---NAKVADFGLSRL 775 (958)
Q Consensus 738 yLH~~~~~~iiH~Dikp~NILl~~~~---~~kl~DFGla~~ 775 (958)
-||+.| |+|+|+++.|||++.++ .+.++||+-++.
T Consensus 133 ~lH~~g---i~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~ 170 (206)
T PF06293_consen 133 KLHDAG---IYHGDLNPSNILVDPDDGQYRFYLIDLDRMRF 170 (206)
T ss_pred HHHHCc---CCCCCCCcccEEEeCCCCceeEEEEcchhcee
Confidence 999999 99999999999999887 899999998764
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.48 E-value=5.1e-07 Score=104.24 Aligned_cols=140 Identities=17% Similarity=0.253 Sum_probs=93.4
Q ss_pred ceeeeeCCeEEEEEEECCCcEEEEEEeccCChhc----------------------------------------HHHHHH
Q 002158 631 TQVGQGGYGKVYKGILSDNTTVAIKRAEEGSLQG----------------------------------------QNEFLT 670 (958)
Q Consensus 631 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~----------------------------------------~~~~~~ 670 (958)
+.|+.++-|.||+|++++|+.||||+.+.+-... +-+|.+
T Consensus 131 ~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~~ 210 (517)
T COG0661 131 EPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYRR 210 (517)
T ss_pred CchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHHH
Confidence 6799999999999999999999999865431110 012455
Q ss_pred HHHHHHccC-----CCCcceEEEEEEeCCeEEEEEEecCCCCHHHHhccCCCCCchHHHHHHHHHHHHHH-HHHhhhcCC
Q 002158 671 EIKLLSRLH-----HRNLVSLLGYCDEEGEQMLVYEFVPNGTLRDWLSGRTKENLNFAMRLRVALDSAKG-ILYLHTEAH 744 (958)
Q Consensus 671 E~~~l~~l~-----H~niv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~a-L~yLH~~~~ 744 (958)
|+..+.+++ .+++.=.-=|.+..+...|+|||++|-.+.+...-+. ...+.. .++..++++ +..+=..|
T Consensus 211 EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~-~g~d~k---~ia~~~~~~f~~q~~~dg- 285 (517)
T COG0661 211 EAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKS-AGIDRK---ELAELLVRAFLRQLLRDG- 285 (517)
T ss_pred HHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHh-cCCCHH---HHHHHHHHHHHHHHHhcC-
Confidence 666555552 3333222223334567899999999998988742222 124422 233333332 33333467
Q ss_pred CCeeccCCCccceEecCCCCeEEeeeeeecccc
Q 002158 745 PPVFHRDIKASNILLDSNLNAKVADFGLSRLAP 777 (958)
Q Consensus 745 ~~iiH~Dikp~NILl~~~~~~kl~DFGla~~~~ 777 (958)
++|.|.+|.||+++.+|.+.+.|||+...++
T Consensus 286 --ffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~ 316 (517)
T COG0661 286 --FFHADPHPGNILVRSDGRIVLLDFGIVGRLD 316 (517)
T ss_pred --ccccCCCccceEEecCCcEEEEcCcceecCC
Confidence 9999999999999999999999999987553
|
|
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.46 E-value=1.9e-06 Score=90.17 Aligned_cols=139 Identities=16% Similarity=0.254 Sum_probs=86.9
Q ss_pred ceeeeeCCeEEEEEEECCCcEEEEEEeccCChhcHHHHHHHHHHHHccCCCC--cceEEEEEEeCCeEEEEEEecCCCC-
Q 002158 631 TQVGQGGYGKVYKGILSDNTTVAIKRAEEGSLQGQNEFLTEIKLLSRLHHRN--LVSLLGYCDEEGEQMLVYEFVPNGT- 707 (958)
Q Consensus 631 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~n--iv~l~~~~~~~~~~~lV~E~~~~gs- 707 (958)
..||+|..+.||+. .+..+++|...... ......+|.++++.+..-. +.+.++++...+...+|||+++|.+
T Consensus 7 ~~i~~G~t~~~y~~---~~~~~VlR~~~~~~--~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~~~ 81 (226)
T TIGR02172 7 TQTGEGGNGESYTH---KTGKWMLKLYNPGF--DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGKRS 81 (226)
T ss_pred eeecCCCCcceeEe---cCCCEEEEeCCCCC--CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCccc
Confidence 57999999999984 35567888886533 2334678999999986433 5788888888888899999998863
Q ss_pred HHHH---------------------hccCCCCCchHHHHH-HHHH----------HHHH-HHHHhhh-cCCCCeeccCCC
Q 002158 708 LRDW---------------------LSGRTKENLNFAMRL-RVAL----------DSAK-GILYLHT-EAHPPVFHRDIK 753 (958)
Q Consensus 708 L~~~---------------------l~~~~~~~l~~~~~~-~i~~----------~ia~-aL~yLH~-~~~~~iiH~Dik 753 (958)
+.+. +|.-........... ++-. .+.+ ...+|.. ...+.++|+|+.
T Consensus 82 ~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~HgD~~ 161 (226)
T TIGR02172 82 FSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLHGDFQ 161 (226)
T ss_pred hhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEecCCC
Confidence 2211 121100001111100 0000 0001 1122221 123457999999
Q ss_pred ccceEecCCCCeEEeeeeeecc
Q 002158 754 ASNILLDSNLNAKVADFGLSRL 775 (958)
Q Consensus 754 p~NILl~~~~~~kl~DFGla~~ 775 (958)
|.||++++++ +.|+||+.+..
T Consensus 162 ~~Nii~~~~~-~~iIDwe~a~~ 182 (226)
T TIGR02172 162 IGNLITSGKG-TYWIDLGDFGY 182 (226)
T ss_pred CCcEEEcCCC-cEEEechhcCc
Confidence 9999999888 99999998753
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.40 E-value=9.8e-08 Score=109.26 Aligned_cols=159 Identities=21% Similarity=0.333 Sum_probs=105.4
Q ss_pred HHHHHHHHHHHhhhcCCCCeeccCCCccceEecCCCCeEEeeeeeecccccCCCC--CCccceeeeeccCCCCccChhhh
Q 002158 728 VALDSAKGILYLHTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSRLAPVLDDE--GTMPTHVSTIVKGTPGYLDPEYF 805 (958)
Q Consensus 728 i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~--~~~~~~~~~~~~gt~~y~aPE~~ 805 (958)
=+.+++.|+.|+|...+ +||+.|.|++|.++..+.+||+.|+.+......... ............-...|.|||++
T Consensus 104 nl~~v~dgl~flh~sAk--~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~ 181 (700)
T KOG2137|consen 104 NLGNVADGLAFLHRSAK--VVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYL 181 (700)
T ss_pred hhhcccchhhhhccCcc--eeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhh
Confidence 34456699999997654 999999999999999999999999987643221110 00001111223355689999999
Q ss_pred ccCCCCCcchhhhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcCcchhhhcccCCCCChHHHHHHHHHHHHccccCCCC
Q 002158 806 LTHKLTDKSDVYSLGVVLLELLTGMQPISHGKNIVREVNVARDSGMVFSIIDNRMGSYPSECVERFVTLALRCCHDKPEH 885 (958)
Q Consensus 806 ~~~~~~~~~DV~S~Gv~l~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~l~~li~~cl~~dP~~ 885 (958)
.....+.++|+||+|+++|-+..|..+................ ..+-....+..+.|.++.+=+.+++..++..
T Consensus 182 ~~~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~~~~~------~~~~~~~~~s~~~p~el~~~l~k~l~~~~~~ 255 (700)
T KOG2137|consen 182 LGTTNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYSFSRN------LLNAGAFGYSNNLPSELRESLKKLLNGDSAV 255 (700)
T ss_pred ccccccccccceeeeeEEEEEecCCcchhhccCCcchhhhhhc------ccccccccccccCcHHHHHHHHHHhcCCccc
Confidence 9988889999999999999999544443222211110000000 0001111234567788888889999999999
Q ss_pred CCCHHHHHH
Q 002158 886 RPSMSDVVR 894 (958)
Q Consensus 886 RPs~~evl~ 894 (958)
||++.++..
T Consensus 256 rp~~~~l~~ 264 (700)
T KOG2137|consen 256 RPTLDLLLS 264 (700)
T ss_pred Ccchhhhhc
Confidence 998877664
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 958 | ||||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 5e-45 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 3e-43 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 4e-43 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 2e-42 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 8e-34 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 1e-33 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 6e-33 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 2e-30 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 7e-26 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 2e-25 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 2e-25 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 2e-25 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 2e-25 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 3e-25 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 9e-25 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 2e-24 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 7e-24 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 7e-24 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 1e-23 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 2e-23 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 2e-23 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 2e-23 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 2e-23 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 3e-23 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 5e-23 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 7e-23 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 8e-23 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 9e-23 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 1e-22 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 1e-22 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 1e-22 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 1e-22 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 1e-22 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 1e-22 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 1e-22 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 1e-22 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 1e-22 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 1e-22 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 1e-22 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 1e-22 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 1e-22 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 1e-22 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 2e-22 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 2e-22 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 2e-22 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 2e-22 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 2e-22 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 2e-22 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 2e-22 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 2e-22 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 2e-22 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-22 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 2e-22 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 2e-22 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 2e-22 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 2e-22 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 2e-22 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 3e-22 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 3e-22 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 3e-22 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 3e-22 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 4e-22 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 4e-22 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 4e-22 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 4e-22 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 4e-22 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 5e-22 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 5e-22 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 5e-22 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 5e-22 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 5e-22 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 5e-22 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 5e-22 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 5e-22 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 8e-22 | ||
| 3riz_A | 772 | Crystal Structure Of The Plant Steroid Receptor Bri | 9e-22 | ||
| 3riz_A | 772 | Crystal Structure Of The Plant Steroid Receptor Bri | 5e-17 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 1e-21 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 1e-21 | ||
| 3rgx_A | 768 | Structural Insight Into Brassinosteroid Perception | 1e-21 | ||
| 3rgx_A | 768 | Structural Insight Into Brassinosteroid Perception | 6e-17 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 1e-21 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-21 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 1e-21 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-21 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 1e-21 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 1e-21 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 2e-21 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 2e-21 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 2e-21 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 2e-21 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 2e-21 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 2e-21 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 2e-21 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 2e-21 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 3e-21 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 3e-21 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 3e-21 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 3e-21 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 3e-21 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 4e-21 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 4e-21 | ||
| 1ogq_A | 313 | The Crystal Structure Of Pgip (Polygalacturonase In | 4e-21 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 4e-21 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 5e-21 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 6e-21 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 6e-21 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 6e-21 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 7e-21 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 8e-21 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 9e-21 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 1e-20 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 1e-20 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 1e-20 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 1e-20 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 1e-20 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 1e-20 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 1e-20 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 1e-20 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 1e-20 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 1e-20 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 1e-20 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 1e-20 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 1e-20 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 2e-20 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 2e-20 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 2e-20 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 2e-20 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 3e-20 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 3e-20 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 3e-20 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 4e-20 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 4e-20 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 7e-20 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 8e-20 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 3e-19 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 3e-19 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 3e-19 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 4e-19 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 5e-19 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 6e-19 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 9e-19 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 9e-19 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 9e-19 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 1e-18 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 1e-18 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 1e-18 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 1e-18 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 1e-18 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 1e-18 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 1e-18 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 1e-18 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 2e-18 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-18 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 2e-18 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 2e-18 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-18 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 2e-18 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 2e-18 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 3e-18 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 3e-18 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 3e-18 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-18 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 3e-18 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 3e-18 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 3e-18 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 4e-18 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 4e-18 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 4e-18 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 4e-18 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 4e-18 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 4e-18 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 4e-18 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 4e-18 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 4e-18 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 5e-18 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 5e-18 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 5e-18 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 5e-18 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 5e-18 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 5e-18 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 6e-18 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 6e-18 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 6e-18 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 6e-18 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 6e-18 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 6e-18 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 7e-18 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 7e-18 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 7e-18 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 8e-18 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 8e-18 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 9e-18 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 1e-17 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 1e-17 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 1e-17 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 2e-17 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-17 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 2e-17 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 2e-17 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-17 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 3e-17 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-17 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-17 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 3e-17 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-17 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 4e-17 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 4e-17 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 4e-17 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 5e-17 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 6e-17 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 7e-17 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 7e-17 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 7e-17 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 2e-16 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 3e-16 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 4e-16 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 5e-16 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 1e-15 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 1e-15 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 1e-15 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-15 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 1e-15 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 1e-15 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 2e-15 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 2e-15 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 2e-15 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-15 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 2e-15 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 2e-15 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 2e-15 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 2e-15 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 2e-15 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 3e-15 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 3e-15 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 3e-15 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 3e-15 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 4e-15 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 4e-15 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 4e-15 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 4e-15 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 4e-15 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 5e-15 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 6e-15 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 7e-15 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 7e-15 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 8e-15 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 9e-15 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 1e-14 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 1e-14 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 1e-14 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 1e-14 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 2e-14 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-14 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 2e-14 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 2e-14 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 2e-14 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 2e-14 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 2e-14 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 2e-14 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 2e-14 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 2e-14 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 2e-14 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 3e-14 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 3e-14 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 3e-14 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 3e-14 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 3e-14 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 3e-14 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 3e-14 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 4e-14 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 4e-14 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 4e-14 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 4e-14 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 4e-14 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 4e-14 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 5e-14 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 5e-14 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 5e-14 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 5e-14 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 5e-14 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 6e-14 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 6e-14 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 6e-14 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 6e-14 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 6e-14 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 6e-14 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 6e-14 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 6e-14 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 7e-14 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 7e-14 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 7e-14 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 8e-14 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 8e-14 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 9e-14 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 9e-14 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 9e-14 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 1e-13 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 1e-13 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 1e-13 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 1e-13 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 1e-13 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 1e-13 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 1e-13 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 1e-13 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 1e-13 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 1e-13 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 1e-13 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 1e-13 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 1e-13 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 1e-13 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 1e-13 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 1e-13 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 1e-13 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 1e-13 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 2e-13 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 2e-13 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 2e-13 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 2e-13 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 2e-13 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 2e-13 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 2e-13 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 2e-13 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 2e-13 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 2e-13 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 2e-13 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 2e-13 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 2e-13 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 2e-13 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 2e-13 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 2e-13 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 2e-13 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 3e-13 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 3e-13 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 3e-13 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 3e-13 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 3e-13 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 3e-13 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 3e-13 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 3e-13 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 4e-13 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 4e-13 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 5e-13 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 5e-13 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 5e-13 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 5e-13 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 5e-13 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 5e-13 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 5e-13 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 6e-13 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 6e-13 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 6e-13 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 6e-13 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 9e-13 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 9e-13 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 9e-13 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 1e-12 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 1e-12 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 1e-12 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 1e-12 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 1e-12 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 1e-12 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 1e-12 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 2e-12 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-12 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-12 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 2e-12 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 2e-12 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 2e-12 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 2e-12 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 2e-12 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 2e-12 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 2e-12 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 2e-12 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 2e-12 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 2e-12 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 2e-12 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 2e-12 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 3e-12 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 4e-12 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 4e-12 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 4e-12 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 5e-12 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 5e-12 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 5e-12 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 6e-12 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 6e-12 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 7e-12 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 7e-12 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 7e-12 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 7e-12 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 7e-12 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 7e-12 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 7e-12 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 8e-12 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 8e-12 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 8e-12 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 8e-12 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 9e-12 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 1e-11 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 1e-11 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 1e-11 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 1e-11 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 1e-11 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 1e-11 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 1e-11 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 2e-11 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 2e-11 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 2e-11 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 2e-11 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 2e-11 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 2e-11 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 2e-11 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 2e-11 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 2e-11 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 2e-11 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 3e-11 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 3e-11 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 3e-11 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 3e-11 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 3e-11 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 3e-11 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 3e-11 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 3e-11 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 3e-11 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 3e-11 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 3e-11 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 3e-11 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 4e-11 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 4e-11 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 4e-11 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 4e-11 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 4e-11 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 4e-11 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 4e-11 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 5e-11 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 5e-11 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 5e-11 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 6e-11 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 6e-11 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 6e-11 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 6e-11 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 6e-11 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 6e-11 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 6e-11 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 6e-11 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 7e-11 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 7e-11 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 7e-11 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 7e-11 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 7e-11 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 7e-11 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 8e-11 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 8e-11 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 8e-11 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 8e-11 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 8e-11 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 8e-11 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 9e-11 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 9e-11 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 9e-11 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 9e-11 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 9e-11 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 9e-11 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 9e-11 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 9e-11 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 1e-10 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 1e-10 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 1e-10 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 1e-10 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 1e-10 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 1e-10 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 1e-10 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 1e-10 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 1e-10 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 1e-10 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 2e-10 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 2e-10 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 2e-10 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 2e-10 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 2e-10 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 2e-10 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 2e-10 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 2e-10 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 2e-10 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 2e-10 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 3e-10 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 3e-10 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 3e-10 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 3e-10 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 3e-10 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 4e-10 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 4e-10 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 4e-10 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 4e-10 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 4e-10 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 4e-10 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 4e-10 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 4e-10 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 4e-10 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 4e-10 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 4e-10 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 4e-10 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 5e-10 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 5e-10 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 5e-10 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 5e-10 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 5e-10 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 5e-10 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 5e-10 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 5e-10 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 5e-10 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 5e-10 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 5e-10 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 6e-10 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 6e-10 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 6e-10 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 7e-10 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 7e-10 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 7e-10 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 7e-10 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 7e-10 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 7e-10 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 7e-10 | ||
| 4fvp_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain ( | 7e-10 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 7e-10 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 8e-10 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 8e-10 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 8e-10 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 8e-10 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 8e-10 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 8e-10 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 8e-10 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 9e-10 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 9e-10 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 9e-10 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 9e-10 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 9e-10 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 9e-10 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 9e-10 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 1e-09 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 1e-09 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 1e-09 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 1e-09 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 1e-09 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 1e-09 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 1e-09 | ||
| 4fvr_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain M | 1e-09 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 1e-09 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 1e-09 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 1e-09 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 1e-09 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 1e-09 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-09 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 1e-09 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 1e-09 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 1e-09 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 1e-09 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 1e-09 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 1e-09 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 1e-09 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 1e-09 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 2e-09 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 2e-09 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 2e-09 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 2e-09 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 2e-09 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 2e-09 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 2e-09 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 2e-09 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 2e-09 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 2e-09 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 2e-09 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 2e-09 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 2e-09 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 2e-09 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 2e-09 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 2e-09 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 2e-09 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 2e-09 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 2e-09 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-09 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 2e-09 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 2e-09 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 3e-09 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 3e-09 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 3e-09 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 3e-09 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 3e-09 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 3e-09 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 3e-09 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 3e-09 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 3e-09 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 3e-09 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 3e-09 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 3e-09 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 3e-09 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 3e-09 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 3e-09 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 3e-09 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 3e-09 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 4e-09 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 4e-09 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 4e-09 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 4e-09 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 4e-09 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 4e-09 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 4e-09 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 4e-09 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 4e-09 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 4e-09 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 4e-09 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 4e-09 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 4e-09 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 4e-09 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 4e-09 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 4e-09 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 4e-09 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 4e-09 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 4e-09 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 4e-09 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 5e-09 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 5e-09 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 5e-09 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 5e-09 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 5e-09 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 5e-09 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 5e-09 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 5e-09 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 6e-09 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 6e-09 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 6e-09 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 6e-09 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 6e-09 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 6e-09 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 6e-09 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 6e-09 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 7e-09 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 7e-09 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 7e-09 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 7e-09 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 7e-09 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 7e-09 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 7e-09 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 7e-09 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 8e-09 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 8e-09 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 8e-09 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 9e-09 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 9e-09 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 9e-09 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 9e-09 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 9e-09 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 9e-09 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 1e-08 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 1e-08 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 1e-08 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 1e-08 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 1e-08 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 1e-08 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 1e-08 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 1e-08 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 1e-08 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 1e-08 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 1e-08 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 1e-08 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 1e-08 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 1e-08 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 1e-08 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 1e-08 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 1e-08 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 1e-08 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 1e-08 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 1e-08 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 1e-08 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 1e-08 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 1e-08 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 1e-08 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 1e-08 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 2e-08 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 2e-08 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 2e-08 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 2e-08 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 2e-08 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 2e-08 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 2e-08 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 2e-08 | ||
| 4alu_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 2e-08 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 2e-08 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 2e-08 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 2e-08 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 2e-08 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 2e-08 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 2e-08 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 2e-08 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 2e-08 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 2e-08 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 2e-08 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 2e-08 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 2e-08 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 2e-08 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 2e-08 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 2e-08 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 2e-08 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 2e-08 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 2e-08 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 2e-08 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 2e-08 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 2e-08 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 2e-08 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 2e-08 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 2e-08 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 2e-08 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 3e-08 | ||
| 3kmw_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 3e-08 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 3e-08 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 3e-08 | ||
| 4dtk_A | 276 | Novel And Selective Pan-Pim Kinase Inhibitor Length | 3e-08 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 3e-08 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 3e-08 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 3e-08 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 3e-08 | ||
| 3c4e_A | 273 | Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7 | 4e-08 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 5e-08 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 5e-08 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 5e-08 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 5e-08 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 5e-08 | ||
| 2xix_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-1 Fro | 5e-08 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 5e-08 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 5e-08 | ||
| 3dcv_A | 328 | Crystal Structure Of Human Pim1 Kinase Complexed Wi | 6e-08 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 6e-08 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 6e-08 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 6e-08 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 6e-08 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 6e-08 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 6e-08 | ||
| 2obj_A | 333 | Crystal Structure Of Human Pim-1 Kinase In Complex | 7e-08 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 8e-08 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 8e-08 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 9e-08 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 9e-08 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 9e-08 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 9e-08 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 9e-08 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 1e-07 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 1e-07 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 1e-07 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 1e-07 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 1e-07 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 1e-07 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 1e-07 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 1e-07 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 1e-07 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 1e-07 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 1e-07 | ||
| 4a7c_A | 308 | Crystal Structure Of Pim1 Kinase With Etp46546 Leng | 1e-07 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 1e-07 | ||
| 4as0_A | 273 | Cyclometalated Phthalimides As Protein Kinase Inhib | 2e-07 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 2e-07 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 2e-07 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 2e-07 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 2e-07 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 2e-07 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 2e-07 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 2e-07 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 2e-07 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 2e-07 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 2e-07 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 2e-07 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 3e-07 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 3e-07 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 3e-07 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 3e-07 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 3e-07 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 3e-07 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 3e-07 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 3e-07 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 3e-07 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 3e-07 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 3e-07 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 3e-07 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 3e-07 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 3e-07 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 3e-07 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 3e-07 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 3e-07 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 3e-07 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 3e-07 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 3e-07 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 3e-07 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 3e-07 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 3e-07 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 3e-07 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 3e-07 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 3e-07 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 3e-07 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 3e-07 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 3e-07 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 3e-07 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 3e-07 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 4e-07 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 4e-07 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 4e-07 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 4e-07 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 4e-07 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 4e-07 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 4e-07 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 5e-07 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 5e-07 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 5e-07 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 5e-07 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 5e-07 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 5e-07 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 5e-07 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 6e-07 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 6e-07 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 6e-07 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 6e-07 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 6e-07 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 6e-07 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 6e-07 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 6e-07 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 6e-07 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 8e-07 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 8e-07 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 8e-07 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 9e-07 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 1e-06 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 1e-06 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 1e-06 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 1e-06 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 1e-06 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 2e-06 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 2e-06 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 2e-06 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 2e-06 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 2e-06 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 2e-06 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 2e-06 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 2e-06 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 3e-06 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 3e-06 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 3e-06 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 3e-06 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 3e-06 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 3e-06 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 3e-06 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 4e-06 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 4e-06 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 4e-06 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 4e-06 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 4e-06 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 4e-06 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 4e-06 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 4e-06 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 4e-06 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 4e-06 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 4e-06 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 4e-06 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 4e-06 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 4e-06 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 4e-06 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 4e-06 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 4e-06 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 4e-06 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 4e-06 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 4e-06 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 4e-06 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 4e-06 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 4e-06 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 4e-06 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 4e-06 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 4e-06 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 4e-06 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 4e-06 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 4e-06 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 5e-06 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 5e-06 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 5e-06 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 5e-06 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 5e-06 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 5e-06 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 5e-06 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 5e-06 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 5e-06 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 5e-06 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 5e-06 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 5e-06 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 5e-06 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 5e-06 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 5e-06 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 5e-06 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 5e-06 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 5e-06 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 5e-06 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 5e-06 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 5e-06 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 5e-06 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 5e-06 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 5e-06 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 5e-06 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 5e-06 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 5e-06 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 5e-06 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 5e-06 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 5e-06 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 5e-06 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 5e-06 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 6e-06 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 6e-06 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 6e-06 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 6e-06 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 6e-06 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 6e-06 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 6e-06 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 6e-06 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 7e-06 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 7e-06 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 7e-06 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 7e-06 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 7e-06 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 7e-06 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 7e-06 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 8e-06 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 8e-06 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 8e-06 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 8e-06 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 8e-06 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 8e-06 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 9e-06 | ||
| 3kmu_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 9e-06 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 9e-06 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 9e-06 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 9e-06 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 1e-05 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 1e-05 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 1e-05 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 1e-05 | ||
| 2h34_A | 309 | Apoenzyme Crystal Structure Of The Tuberculosis Ser | 1e-05 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 1e-05 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 1e-05 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 1e-05 | ||
| 3rp9_A | 458 | Crystal Structure Of The Apo Mapk From Toxoplasma G | 1e-05 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 1e-05 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 2e-05 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 2e-05 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 2e-05 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 2e-05 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 2e-05 | ||
| 2rio_A | 434 | Structure Of The Dual Enzyme Ire1 Reveals The Basis | 2e-05 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 2e-05 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 2e-05 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 2e-05 | ||
| 2pzy_A | 324 | Structure Of Mk2 Complexed With Compound 76 Length | 2e-05 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 2e-05 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 2e-05 | ||
| 2jbo_A | 326 | Protein Kinase Mk2 In Complex With An Inhibitor (Cr | 2e-05 | ||
| 3fpm_A | 325 | Crystal Structure Of A Squarate Inhibitor Bound To | 2e-05 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 2e-05 | ||
| 3r2b_A | 318 | Mk2 Kinase Bound To Compound 5b Length = 318 | 3e-05 | ||
| 3sdj_A | 448 | Structure Of Rnase-Inactive Point Mutant Of Oligome | 3e-05 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 3e-05 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 3e-05 | ||
| 3fbv_A | 448 | Crystal Structure Of The Oligomer Formed By The Kin | 3e-05 | ||
| 3r2y_A | 319 | Mk2 Kinase Bound To Compound 1 Length = 319 | 3e-05 | ||
| 3gok_A | 334 | Binding Site Mapping Of Protein Ligands Length = 33 | 3e-05 | ||
| 1kwp_A | 400 | Crystal Structure Of Mapkap2 Length = 400 | 3e-05 | ||
| 2p3g_X | 327 | Crystal Structure Of A Pyrrolopyridine Inhibitor Bo | 3e-05 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 3e-05 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 3e-05 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 3e-05 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 3e-05 | ||
| 2oza_A | 356 | Structure Of P38alpha Complex Length = 356 | 3e-05 | ||
| 2onl_C | 406 | Crystal Structure Of The P38a-Mapkap Kinase 2 Heter | 3e-05 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 3e-05 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 3e-05 | ||
| 3ka0_A | 320 | Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4 | 4e-05 | ||
| 1xcd_A | 329 | Dimeric Bovine Tissue-Extracted Decorin, Crystal Fo | 4e-05 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 4e-05 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 4e-05 | ||
| 1xku_A | 330 | Crystal Structure Of The Dimeric Protein Core Of De | 4e-05 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 4e-05 | ||
| 4eut_A | 396 | Structure Of Bx-795 Complexed With Unphosphorylated | 4e-05 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 4e-05 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 4e-05 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 4e-05 | ||
| 4euu_A | 319 | Structure Of Bx-795 Complexed With Human Tbk1 Kinas | 4e-05 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 4e-05 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 4e-05 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 4e-05 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 4e-05 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 4e-05 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 5e-05 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 5e-05 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 5e-05 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 5e-05 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 5e-05 | ||
| 3ofm_A | 350 | Structure Of A Human Ck2alpha Prime, The Paralog Is | 5e-05 | ||
| 3e3b_X | 339 | Crystal Structure Of Catalytic Subunit Of Human Pro | 6e-05 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 6e-05 |
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|3RIZ|A Chain A, Crystal Structure Of The Plant Steroid Receptor Bri1 Ectodomain Length = 772 | Back alignment and structure |
|
| >pdb|3RIZ|A Chain A, Crystal Structure Of The Plant Steroid Receptor Bri1 Ectodomain Length = 772 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|3RGX|A Chain A, Structural Insight Into Brassinosteroid Perception By Bri1 Length = 768 | Back alignment and structure |
|
| >pdb|3RGX|A Chain A, Structural Insight Into Brassinosteroid Perception By Bri1 Length = 768 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|1OGQ|A Chain A, The Crystal Structure Of Pgip (Polygalacturonase Inhibiting Protein), A Leucine Rich Repeat Protein Involved In Plant Defense Length = 313 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|4ALU|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|3KMU|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Apo) Length = 271 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326 | Back alignment and structure |
|
| >pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318 | Back alignment and structure |
|
| >pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319 | Back alignment and structure |
|
| >pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334 | Back alignment and structure |
|
| >pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400 | Back alignment and structure |
|
| >pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356 | Back alignment and structure |
|
| >pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320 | Back alignment and structure |
|
| >pdb|1XCD|A Chain A, Dimeric Bovine Tissue-Extracted Decorin, Crystal Form 1 Length = 329 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|1XKU|A Chain A, Crystal Structure Of The Dimeric Protein Core Of Decorin, The Archetypal Small Leucine-Rich Repeat Proteoglycan Length = 330 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|3OFM|A Chain A, Structure Of A Human Ck2alpha Prime, The Paralog Isoform Of The Catalytic Subunit Of Protein Kinase Ck2 From Homo Sapiens Length = 350 | Back alignment and structure |
|
| >pdb|3E3B|X Chain X, Crystal Structure Of Catalytic Subunit Of Human Protein Kinase Ck2alpha Prime With A Potent Indazole-Derivative Inhibitor Length = 339 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 451 bits (1162), Expect = e-152
Identities = 121/325 (37%), Positives = 178/325 (54%), Gaps = 17/325 (5%)
Query: 586 MRRHARYQHSLSRKRLSTKISMKIDGVKGFKFKELAMATAYFSSSTQVGQGGYGKVYKGI 645
M + LS+ + + + +L AT F +G G +GKVYKG+
Sbjct: 1 MGSKYSKATNSINDALSSSYLVPFESYR-VPLVDLEEATNNFDHKFLIGHGVFGKVYKGV 59
Query: 646 LSDNTTVAIKRAEEGSLQGQNEFLTEIKLLSRLHHRNLVSLLGYCDEEGEQMLVYEFVPN 705
L D VA+KR S QG EF TEI+ LS H +LVSL+G+CDE E +L+Y+++ N
Sbjct: 60 LRDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMEN 119
Query: 706 GTLRDWLSGRTK--ENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSNL 763
G L+ L G ++++ RL + + +A+G+ YLHT + HRD+K+ NILLD N
Sbjct: 120 GNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHT---RAIIHRDVKSINILLDENF 176
Query: 764 NAKVADFGLSRLAPVLDDEGTMPTHVSTIVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVL 823
K+ DFG+S+ LD TH+ST+VKGT GY+DPEYF+ +LT+KSDVYS GVVL
Sbjct: 177 VPKITDFGISKKGTELDQ-----THLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVL 231
Query: 824 LELLTGMQPISHGK-----NIVREVNVARDSGMVFSIIDNRM-GSYPSECVERFVTLALR 877
E+L I N+ + ++G + I+D + E + +F A++
Sbjct: 232 FEVLCARSAIVQSLPREMVNLAEWAVESHNNGQLEQIVDPNLADKIRPESLRKFGDTAVK 291
Query: 878 CCHDKPEHRPSMSDVVRELENILKM 902
C E RPSM DV+ +LE L++
Sbjct: 292 CLALSSEDRPSMGDVLWKLEYALRL 316
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 378 bits (973), Expect = e-124
Identities = 102/311 (32%), Positives = 164/311 (52%), Gaps = 25/311 (8%)
Query: 605 ISMKIDGVKGFKFKELAMATAYFSSSTQ------VGQGGYGKVYKGILSDNTTVAIKRAE 658
+ + F F EL T F +G+GG+G VYKG + +NTTVA+K+
Sbjct: 5 LEVSDTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLA 63
Query: 659 EG----SLQGQNEFLTEIKLLSRLHHRNLVSLLGYCDEEGEQMLVYEFVPNGTLRDWLSG 714
+ + + +F EIK++++ H NLV LLG+ + + LVY ++PNG+L D LS
Sbjct: 64 AMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSC 123
Query: 715 RTK-ENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSNLNAKVADFGLS 773
L++ MR ++A +A GI +LH HRDIK++NILLD AK++DFGL+
Sbjct: 124 LDGTPPLSWHMRCKIAQGAANGINFLHEN---HHIHRDIKSANILLDEAFTAKISDFGLA 180
Query: 774 RLAPVLDDEGTMPTHVSTIVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVLLELLTGMQPI 833
R + T +++ + GT Y+ PE L ++T KSD+YS GVVLLE++TG+ +
Sbjct: 181 RASEKFAQ-----TVMTSRIVGTTAYMAPEA-LRGEITPKSDIYSFGVVLLEIITGLPAV 234
Query: 834 SHGKNIVREVNVAR----DSGMVFSIIDNRMGSYPSECVERFVTLALRCCHDKPEHRPSM 889
+ +++ + + ID +M S VE ++A +C H+K RP +
Sbjct: 235 DEHREPQLLLDIKEEIEDEEKTIEDYIDKKMNDADSTSVEAMYSVASQCLHEKKNKRPDI 294
Query: 890 SDVVRELENIL 900
V + L+ +
Sbjct: 295 KKVQQLLQEMT 305
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 377 bits (971), Expect = e-124
Identities = 118/297 (39%), Positives = 176/297 (59%), Gaps = 17/297 (5%)
Query: 612 VKGFKFKELAMATAYFSSSTQVGQGGYGKVYKGILSDNTTVAIKRAEEGSLQG-QNEFLT 670
+K F +EL +A+ FS+ +G+GG+GKVYKG L+D T VA+KR +E QG + +F T
Sbjct: 17 LKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQT 76
Query: 671 EIKLLSRLHHRNLVSLLGYCDEEGEQMLVYEFVPNGTLRDWLSGRT--KENLNFAMRLRV 728
E++++S HRNL+ L G+C E++LVY ++ NG++ L R + L++ R R+
Sbjct: 77 EVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRI 136
Query: 729 ALDSAKGILYLHTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSRLAPVLDDEGTMPTH 788
AL SA+G+ YLH P + HRD+KA+NILLD A V DFGL++L D TH
Sbjct: 137 ALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKD------TH 190
Query: 789 VSTIVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVLLELLTGMQPI-------SHGKNIVR 841
V+T V+GT G++ PEY T K ++K+DV+ GV+LLEL+TG + ++
Sbjct: 191 VTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLD 250
Query: 842 EVNVARDSGMVFSIIDNRMGS-YPSECVERFVTLALRCCHDKPEHRPSMSDVVRELE 897
V + +++D + Y E VE+ + +AL C P RP MS+VVR LE
Sbjct: 251 WVKGLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLE 307
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 259 bits (664), Expect = 3e-79
Identities = 64/317 (20%), Positives = 112/317 (35%), Gaps = 38/317 (11%)
Query: 614 GFKFKELAMATAYFSSSTQVGQGGYGKVYKGILSDNTTVAIKRAEEGSLQGQNEFLTEIK 673
+ L + +G +G V+K L N VA+K Q + E+
Sbjct: 13 DLGTENLYFQSMPLQLLEVKARGRFGCVWKAQL-LNEYVAVKIFPIQDKQSW-QNEYEVY 70
Query: 674 LLSRLHHRNLVSLLGYCDE----EGEQMLVYEFVPNGTLRDWLSGRTKENLNFAMRLRVA 729
L + H N++ +G + + L+ F G+L D+L +++ +A
Sbjct: 71 SLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKANV---VSWNELCHIA 127
Query: 730 LDSAKGILYLHTEAH-------PPVFHRDIKASNILLDSNLNAKVADFGLSRLAPVLDDE 782
A+G+ YLH + P + HRDIK+ N+LL +NL A +ADFGL+
Sbjct: 128 ETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSA 187
Query: 783 GTMPTHVSTIVKGTPGYLDPEYF-----LTHKLTDKSDVYSLGVVLLELLTGMQPISHGK 837
G GT Y+ PE + D+Y++G+VL EL +
Sbjct: 188 GDT-----HGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPV 242
Query: 838 -----NIVREVNVARDSGMVFSIIDNRMG-------SYPSECVERFVTLALRCCHDKPEH 885
E+ + ++ ++ + C E
Sbjct: 243 DEYMLPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEA 302
Query: 886 RPSMSDVVRELENILKM 902
R S V + + ++
Sbjct: 303 RLSAGCVGERITQMQRL 319
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 257 bits (658), Expect = 2e-78
Identities = 86/317 (27%), Positives = 137/317 (43%), Gaps = 18/317 (5%)
Query: 34 QTTDPQEASALRAIKNSLVDSMNHLRNWNKG-DPCMSNWTGVLCFDTVETDGHL-HVREL 91
+ +PQ+ AL IK L + L +W D C W GVLC +TD V L
Sbjct: 1 ELCNPQDKQALLQIKKDLGNP-TTLSSWLPTTDCCNRTWLGVLC----DTDTQTYRVNNL 55
Query: 92 QLLSMNLSGNLA--PELGQLSRLQYYFM--WNDLTGTIPKEIGNISSLIFLLLNGNKLSG 147
L +NL L L L + ++ N+L G IP I ++ L +L + +SG
Sbjct: 56 DLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSG 115
Query: 148 SLPDELGYLSNLNRLQVDENNITGTIPKSFANLSRVRHLHLNNNSIGGQIPSELSKLSTL 207
++PD L + L L N ++GT+P S ++L + + + N I G IP S L
Sbjct: 116 AIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKL 175
Query: 208 I-HLLVDNNNLSGNLPPELSELPQLCILQLDNNNFSASEIPATYGNFSKLVKLSLRNCNL 266
+ + N L+G +PP + L L + L N + +G+ K+ L +L
Sbjct: 176 FTSMTISRNRLTGKIPPTFANL-NLAFVDLSRNMLE-GDASVLFGSDKNTQKIHLAKNSL 233
Query: 267 QGAVPDLSRIPNLYYLDLSWNHLTGSIPS--KKLSENVTTIDLSDNYLNGSILESISNLP 324
+ + NL LDL N + G++P +L + ++++S N L G I + NL
Sbjct: 234 AFDLGKVGLSKNLNGLDLRNNRIYGTLPQGLTQLK-FLHSLNVSFNNLCGEIPQG-GNLQ 291
Query: 325 FLQTLSLENNFLTGSIP 341
+ NN P
Sbjct: 292 RFDVSAYANNKCLCGSP 308
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 6e-32
Identities = 56/238 (23%), Positives = 91/238 (38%), Gaps = 65/238 (27%)
Query: 167 NNITGTIPKSFANLSRVRHLHLNNNSIGGQ--IPSELSKLSTLIHL-LVDNNNLSGNLPP 223
G + + RV +L L+ ++ IPS L+ L L L + NNL G +PP
Sbjct: 36 RTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPP 95
Query: 224 ELSELPQLCILQLDNNNFSASEIPATYGNFSKLVKLSLRNCNLQGAVPD-LSRIPNLYYL 282
+++L QL L + + N S GA+PD LS+I L L
Sbjct: 96 AIAKLTQLHYLYITHTNVS-------------------------GAIPDFLSQIKTLVTL 130
Query: 283 DLSWNHLTGSIPSKKLSENVTTIDLSDNYLNGSILESISNLPFLQTLSLENNFLTGSIPA 342
D S+N L+G++P SIS+LP L ++ + N ++G+IP
Sbjct: 131 DFSYNALSGTLPP-----------------------SISSLPNLVGITFDGNRISGAIPD 167
Query: 343 TIWQNKSFSTKARLKIDLRNNSFS-NI---VGDLTLPNNVTLRLGGNPICTSANIPNT 396
+ T + + N + I +L L + L N + +
Sbjct: 168 SYGSFSKLFT----SMTISRNRLTGKIPPTFANLNL---AFVDLSRNML--EGDASVL 216
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 248 bits (634), Expect = 4e-75
Identities = 79/289 (27%), Positives = 128/289 (44%), Gaps = 25/289 (8%)
Query: 632 QVGQGGYGKVYKGILSDNTTVAIKRAEEGSLQGQNEFLTEIKLLSRLHHRNLVSLLGYCD 691
VG+G +G V K VAIK+ E S + F+ E++ LSR++H N+V L G C
Sbjct: 15 VVGRGAFGVVCKAKW-RAKDVAIKQIESESER--KAFIVELRQLSRVNHPNIVKLYGACL 71
Query: 692 EEGEQMLVYEFVPNGTLRDWL-SGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHR 750
LV E+ G+L + L A + L ++G+ YLH+ + HR
Sbjct: 72 NP--VCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHR 129
Query: 751 DIKASNILLDSNLN-AKVADFGLSRLAPVLDDEGTMPTHVSTIVKGTPGYLDPEYFLTHK 809
D+K N+LL + K+ DFG + D + M T KG+ ++ PE F
Sbjct: 130 DLKPPNLLLVAGGTVLKICDFGTAC-----DIQTHM-----TNNKGSAAWMAPEVFEGSN 179
Query: 810 LTDKSDVYSLGVVLLELLTGMQPISHGKNIVREVNVARDSGMVFSIIDNRMGSYPSECVE 869
++K DV+S G++L E++T +P + A +G + +
Sbjct: 180 YSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGTRPPL--------IKNLPK 231
Query: 870 RFVTLALRCCHDKPEHRPSMSDVVRELENILKMFPETDTMFSKSESSSL 918
+L RC P RPSM ++V+ + ++++ FP D SL
Sbjct: 232 PIESLMTRCWSKDPSQRPSMEEIVKIMTHLMRYFPGADEPLQYPCQHSL 280
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 242 bits (621), Expect = 3e-73
Identities = 89/322 (27%), Positives = 144/322 (44%), Gaps = 33/322 (10%)
Query: 588 RHARYQHSLSRKRLSTKISMKIDGVKGF-----KFKELAMATAYFSSSTQVGQGGYGKVY 642
+H + H +S + T ++ G + +L + ++G G +G V+
Sbjct: 2 KHHHHHHPMSDYDIPTTENLYFQGAMDGDDMDIPWCDLNI-------KEKIGAGSFGTVH 54
Query: 643 KGILSDNTTVAIKRAEEGSLQGQ--NEFLTEIKLLSRLHHRNLVSLLGYCDEEGEQMLVY 700
+ + VA+K E + NEFL E+ ++ RL H N+V +G + +V
Sbjct: 55 RAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVT 113
Query: 701 EFVPNGTLRDWL-SGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILL 759
E++ G+L L +E L+ RL +A D AKG+ YLH +PP+ HR++K+ N+L+
Sbjct: 114 EYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNR-NPPIVHRNLKSPNLLV 172
Query: 760 DSNLNAKVADFGLSRLAPVLDDEGTMPTHVSTIVKGTPGYLDPEYFLTHKLTDKSDVYSL 819
D KV DFGLSRL GTP ++ PE +KSDVYS
Sbjct: 173 DKKYTVKVCDFGLSRLKASTFLSSKSAA-------GTPEWMAPEVLRDEPSNEKSDVYSF 225
Query: 820 GVVLLELLTGMQPISHGKNIVREVNVARDSGMVFSIIDNRMGSYPSECVERFVTLALRCC 879
GV+L EL T QP + +N A+ V + P + + C
Sbjct: 226 GVILWELATLQQPWGN-------LNPAQVVAAV--GFKCKRLEIPRNLNPQVAAIIEGCW 276
Query: 880 HDKPEHRPSMSDVVRELENILK 901
++P RPS + ++ L ++K
Sbjct: 277 TNEPWKRPSFATIMDLLRPLIK 298
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 233 bits (596), Expect = 5e-70
Identities = 85/283 (30%), Positives = 136/283 (48%), Gaps = 36/283 (12%)
Query: 632 QVGQGGYGKVYKGI-LSDNTTVAIKRAEEGSLQGQ-------NEFLTEIKLLSRLHHRNL 683
Q+G+GG+G V+KG + D + VAIK G +G+ EF E+ ++S L+H N+
Sbjct: 26 QIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNI 85
Query: 684 VSLLGYCDEEGEQMLVYEFVPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEA 743
V L G +V EFVP G L L + + ++++LR+ LD A GI Y+ +
Sbjct: 86 VKLYGLMHNP--PRMVMEFVPCGDLYHRLLDK-AHPIKWSVKLRLMLDIALGIEYMQNQ- 141
Query: 744 HPPVFHRDIKASNILLDS-----NLNAKVADFGLSRLAPVLDDEGTMPTHVSTIVKGTPG 798
+PP+ HRD+++ NI L S + AKVADFGLS+ + H + + G
Sbjct: 142 NPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQS----------VHSVSGLLGNFQ 191
Query: 799 YLDPEYFLTHKL--TDKSDVYSLGVVLLELLTGMQPISHGKNIVREVNVARDSGMVFSII 856
++ PE + T+K+D YS ++L +LTG P + + +
Sbjct: 192 WMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDE----YSYGKIKFINMIREE-- 245
Query: 857 DNRMGSYPSECVERFVTLALRCCHDKPEHRPSMSDVVRELENI 899
R + P +C R + C P+ RP S +V+EL +
Sbjct: 246 GLRP-TIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSEL 287
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 235 bits (600), Expect = 6e-70
Identities = 73/337 (21%), Positives = 127/337 (37%), Gaps = 43/337 (12%)
Query: 615 FKFKELAMATAYFSSSTQVGQGGYGKVYKGILSDNTTVAIKRAEEGSLQG-QNEFLTEIK 673
E ++ +G+G YG VYKG L D VA+K + Q NE I
Sbjct: 3 AAASEPSLDLDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFANRQNFINE--KNIY 59
Query: 674 LLSRLHHRNLVSLLGYC-----DEEGEQMLVYEFVPNGTLRDWLSGRTKENLNFAMRLRV 728
+ + H N+ + D E +LV E+ PNG+L +LS T ++ R+
Sbjct: 60 RVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLHT---SDWVSSCRL 116
Query: 729 ALDSAKGILYLHTEAH------PPVFHRDIKASNILLDSNLNAKVADFGLSR-LAPVLDD 781
A +G+ YLHTE P + HRD+ + N+L+ ++ ++DFGLS L
Sbjct: 117 AHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLV 176
Query: 782 EGTMPTHVSTIVKGTPGYLDPEYF-------LTHKLTDKSDVYSLGVVLLELLTGMQPIS 834
+ + GT Y+ PE + D+Y+LG++ E+ +
Sbjct: 177 RPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLF 236
Query: 835 HGKNIVREVNVA-------RDSGMVFSIIDNRMGSYP---------SECVERFVTLALRC 878
G++ V E +A + ++ +R P S V C
Sbjct: 237 PGES-VPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDC 295
Query: 879 CHDKPEHRPSMSDVVRELENILKMFPETDTMFSKSES 915
E R + + ++ ++ ++ +
Sbjct: 296 WDQDAEARLTAQXAEERMAELMMIWERNKSVSPTAHH 332
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 231 bits (591), Expect = 1e-69
Identities = 87/280 (31%), Positives = 126/280 (45%), Gaps = 34/280 (12%)
Query: 632 QVGQGGYGKVYKGILSDNTTVAIKRAEEGSLQGQ----NEFLTEIKLLSRLHHRNLVSLL 687
+G GG+GKVY+ VA+K A + E KL + L H N+++L
Sbjct: 14 IIGIGGFGKVYRAFW-IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALR 72
Query: 688 GYCDEEGEQMLVYEFVPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPV 747
G C +E LV EF G L LSG+ + + + A+ A+G+ YLH EA P+
Sbjct: 73 GVCLKEPNLCLVMEFARGGPLNRVLSGK---RIPPDILVNWAVQIARGMNYLHDEAIVPI 129
Query: 748 FHRDIKASNILLD--------SNLNAKVADFGLSRLAPVLDDEGTMPTHVSTIVKGTPGY 799
HRD+K+SNIL+ SN K+ DFGL+R T + G +
Sbjct: 130 IHRDLKSSNILILQKVENGDLSNKILKITDFGLAREW----HRTTKMSAA-----GAYAW 180
Query: 800 LDPEYFLTHKLTDKSDVYSLGVVLLELLTGMQPISHGKNIVREVNVARDSGMVFSIIDNR 859
+ PE + SDV+S GV+L ELLTG P G + + + + I
Sbjct: 181 MAPEVIRASMFSKGSDVWSYGVLLWELLTGEVP-FRGIDGLAVAYGVAMNKLALPI---- 235
Query: 860 MGSYPSECVERFVTLALRCCHDKPEHRPSMSDVVRELENI 899
PS C E F L C + P RPS ++++ +L I
Sbjct: 236 ----PSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTTI 271
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 229 bits (585), Expect = 4e-68
Identities = 68/278 (24%), Positives = 113/278 (40%), Gaps = 20/278 (7%)
Query: 632 QVGQGGYGKVYKGIL-SDNTTVAIKRAEEGSLQGQNEFLTEIKLLSRLHHRNLVSLLGYC 690
+G+G +G+ K + +K + Q FL E+K++ L H N++ +G
Sbjct: 17 VLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVL 76
Query: 691 DEEGEQMLVYEFVPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHR 750
++ + E++ GTLR + ++ R+ A D A G+ YLH+ + HR
Sbjct: 77 YKDKRLNFITEYIKGGTLRGIIK-SMDSQYPWSQRVSFAKDIASGMAYLHSM---NIIHR 132
Query: 751 DIKASNILLDSNLNAKVADFGLSRLAPVLDDEGTMPTH-------VSTIVKGTPGYLDPE 803
D+ + N L+ N N VADFGL+RL + V G P ++ PE
Sbjct: 133 DLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPE 192
Query: 804 YFLTHKLTDKSDVYSLGVVLLELLTGMQPISHGKNIVREVNVARDSGMVFSIIDNRMGSY 863
+K DV+S G+VL E++ + + + +
Sbjct: 193 MINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGFL-------DR-YC 244
Query: 864 PSECVERFVTLALRCCHDKPEHRPSMSDVVRELENILK 901
P C F + +RCC PE RPS + LE +
Sbjct: 245 PPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLRM 282
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 223 bits (570), Expect = 1e-66
Identities = 59/279 (21%), Positives = 116/279 (41%), Gaps = 32/279 (11%)
Query: 631 TQVGQGGYGKVYKGILSDNTTVAIKRAEEGSLQGQ--NEFLTEIKLLSRLHHRNLVSLLG 688
T++ + G+++KG + +K + + +F E L H N++ +LG
Sbjct: 16 TKLNENHSGELWKGRW-QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLG 74
Query: 689 YCDEEGEQ--MLVYEFVPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPP 746
C L+ ++P G+L + L T ++ + ++ ALD A+G+ +LHT P
Sbjct: 75 ACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTL-EPL 133
Query: 747 VFHRDIKASNILLDSNLNAKVADFGLSRLAPVLDDEGTMPTHVSTIVKGTPGYLDPEYFL 806
+ + + ++++D ++ A+++ + G M P ++ PE L
Sbjct: 134 IPRHALNSRSVMIDEDMTARISMADVKF---SFQSPGRM---------YAPAWVAPE-AL 180
Query: 807 THK----LTDKSDVYSLGVVLLELLTGMQPISHGKNIVREVNVARDSGMVFSIIDNRMGS 862
K +D++S V+L EL+T P + N+ + VA + G+ +I
Sbjct: 181 QKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVALE-GLRPTI------- 232
Query: 863 YPSECVERFVTLALRCCHDKPEHRPSMSDVVRELENILK 901
P L C ++ P RP +V LE +
Sbjct: 233 -PPGISPHVSKLMKICMNEDPAKRPKFDMIVPILEKMQD 270
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 222 bits (567), Expect = 6e-66
Identities = 70/276 (25%), Positives = 122/276 (44%), Gaps = 24/276 (8%)
Query: 632 QVGQGGYGKVYKGILSDNTTVAIKRAEEGSLQGQ--NEFLTEIKLLSRLHHRNLVSLLGY 689
++G G +G VYKG + VA+K + Q F E+ +L + H N++ +GY
Sbjct: 31 RIGSGSFGTVYKGKW--HGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY 88
Query: 690 CDEEGEQMLVYEFVPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFH 749
+ +V ++ +L L + + +A +A+G+ YLH + H
Sbjct: 89 STAP-QLAIVTQWCEGSSLYHHLHAS-ETKFEMKKLIDIARQTARGMDYLHA---KSIIH 143
Query: 750 RDIKASNILLDSNLNAKVADFGLSRLAPVLDDEGTMPTHVSTIVKGTPGYLDPE---YFL 806
RD+K++NI L + K+ DFGL+ + G+ ++ PE
Sbjct: 144 RDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQF-----EQLSGSILWMAPEVIRMQD 198
Query: 807 THKLTDKSDVYSLGVVLLELLTGMQPISHGKNIVREV-NVARDSGMVFSIIDNRMGSYPS 865
++ + +SDVY+ G+VL EL+TG P S+ N + + V R S + S
Sbjct: 199 SNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSP------DLSKVRS 252
Query: 866 ECVERFVTLALRCCHDKPEHRPSMSDVVRELENILK 901
C +R L C K + RPS ++ E+E + +
Sbjct: 253 NCPKRMKRLMAECLKKKRDERPSFPRILAEIEELAR 288
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 221 bits (566), Expect = 2e-65
Identities = 61/295 (20%), Positives = 105/295 (35%), Gaps = 31/295 (10%)
Query: 632 QVGQGGYGKVYKGILSDNTTVAIKRAEEGSLQGQ--NEFLTEIKLLSRLHHRNLVSLLGY 689
+G+G +G+VY G + VAI+ + F E+ + H N+V +G
Sbjct: 40 LIGKGRFGQVYHGRW--HGEVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGA 97
Query: 690 CDEEGEQMLVYEFVPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFH 749
C ++ TL + K L+ ++A + KG+ YLH + H
Sbjct: 98 CMSPPHLAIITSLCKGRTLYSVVRDA-KIVLDVNKTRQIAQEIVKGMGYLHA---KGILH 153
Query: 750 RDIKASNILLDSNLNAKVADFGLSRLAPVLDDEGTMPTHVSTIVKGTPGYLDPEYFLTHK 809
+D+K+ N+ D N + DFGL ++ V + I G +L PE
Sbjct: 154 KDLKSKNVFYD-NGKVVITDFGLFSISGV--LQAGRREDKLRIQNGWLCHLAPEIIRQLS 210
Query: 810 L---------TDKSDVYSLGVVLLELLTGMQPISHGKNIVREVNVARDSGMVFSIIDNRM 860
+ SDV++LG + EL P + + +
Sbjct: 211 PDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKT-------QPAEAIIWQMGT--GMKP 261
Query: 861 GSYPSECVERFVTLALRCCHDKPEHRPSMSDVVRELENILKMF--PETDTMFSKS 913
+ + L C + E RP+ + ++ LE + K F KS
Sbjct: 262 NLSQIGMGKEISDILLFCWAFEQEERPTFTKLMDMLEKLPKRNRRLSHPGHFWKS 316
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 231 bits (591), Expect = 2e-64
Identities = 93/418 (22%), Positives = 152/418 (36%), Gaps = 76/418 (18%)
Query: 29 LLAAAQTTDPQEASALRAIKNSLVDSMNHLRNWNKG-DPCMSNWTGVLC----------- 76
A+ + +E L + K+ L D N L +W+ +PC + GV C
Sbjct: 2 FQASPSQSLYREIHQLISFKDVLPDK-NLLPDWSSNKNPC--TFDGVTCRDDKVTSIDLS 58
Query: 77 -FDTVETDGHL-------------------------------HVRELQLLSMNLSGNL-- 102
+ + L L +LSG +
Sbjct: 59 SKPLNVGFSAVSSSLLSLTGLESLFLSNSHINGSVSGFKCSASLTSLDLSRNSLSGPVTT 118
Query: 103 APELGQLSRLQY-YFMWNDLTGTIPKEIG-NISSLIFLLLNGNKLSGSLPDELGYLSNLN 160
LG S L++ N L G ++SL L L+ N +SG+
Sbjct: 119 LTSLGSCSGLKFLNVSSNTLDFPGKVSGGLKLNSLEVLDLSANSISGANVVGWVLSDGCG 178
Query: 161 RLQV---DENNITGTIPKSFANLSRVRHLHLNNNSIGGQIPSELSKLSTLIHLLVDNNNL 217
L+ N I+G + + + L +++N+ IP L S L HL + N L
Sbjct: 179 ELKHLAISGNKISGDVD--VSRCVNLEFLDVSSNNFSTGIPF-LGDCSALQHLDISGNKL 235
Query: 218 SGNLPPELSELPQLCILQLDNNNFSASEIPATYGNFSKLVKLSLRNCNLQGAVPD--LSR 275
SG+ +S +L +L + +N F IP L LSL G +PD
Sbjct: 236 SGDFSRAISTCTELKLLNISSNQFV-GPIPPL--PLKSLQYLSLAENKFTGEIPDFLSGA 292
Query: 276 IPNLYYLDLSWNHLTGSIPS--KKLSENVTTIDLSDNYLNGSI-LESISNLPFLQTLSLE 332
L LDLS NH G++P S + ++ LS N +G + ++++ + L+ L L
Sbjct: 293 CDTLTGLDLSGNHFYGAVPPFFGSCS-LLESLALSSNNFSGELPMDTLLKMRGLKVLDLS 351
Query: 333 NNFLTGSIPATIWQNKSFSTKARLK-IDLRNNSFS----NIVGDLTLPNNVTLRLGGN 385
N +G +P ++ + L +DL +N+FS + L L N
Sbjct: 352 FNEFSGELPESLTNLSA-----SLLTLDLSSNNFSGPILPNLCQNPKNTLQELYLQNN 404
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 230 bits (589), Expect = 3e-64
Identities = 84/309 (27%), Positives = 137/309 (44%), Gaps = 21/309 (6%)
Query: 87 HVRELQLLSMNLSGNLAPELGQLSRLQY-YFMWNDLTGTIPKEIGNISSLIFLLLNGNKL 145
++ L + +SG++ ++ + L++ N+ + IP +G+ S+L L ++GNKL
Sbjct: 179 ELKHLAISGNKISGDV--DVSRCVNLEFLDVSSNNFSTGIP-FLGDCSALQHLDISGNKL 235
Query: 146 SGSLPDELGYLSNLNRLQVDENNITGTIPKSFANLSRVRHLHLNNNSIGGQIPSELS-KL 204
SG + + L L + N G IP L +++L L N G+IP LS
Sbjct: 236 SGDFSRAISTCTELKLLNISSNQFVGPIPPL--PLKSLQYLSLAENKFTGEIPDFLSGAC 293
Query: 205 STLIHLLVDNNNLSGNLPPELSELPQLCILQLDNNNFSASEIPATY-GNFSKLVKLSLRN 263
TL L + N+ G +PP L L L +NNFS E+P L L L
Sbjct: 294 DTLTGLDLSGNHFYGAVPPFFGSCSLLESLALSSNNFS-GELPMDTLLKMRGLKVLDLSF 352
Query: 264 CNLQGAVPD-LSRI-PNLYYLDLSWNHLTGSIPS---KKLSENVTTIDLSDNYLNGSILE 318
G +P+ L+ + +L LDLS N+ +G I + + + L +N G I
Sbjct: 353 NEFSGELPESLTNLSASLLTLDLSSNNFSGPILPNLCQNPKNTLQELYLQNNGFTGKIPP 412
Query: 319 SISNLPFLQTLSLENNFLTGSIPATIWQNKSFSTKARLKIDLRNNSFS-NIVGDLT-LPN 376
++SN L +L L N+L+G+IP+++ + L N I +L +
Sbjct: 413 TLSNCSELVSLHLSFNYLSGTIPSSLGSLSKLRD-----LKLWLNMLEGEIPQELMYVKT 467
Query: 377 NVTLRLGGN 385
TL L N
Sbjct: 468 LETLILDFN 476
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 229 bits (585), Expect = 1e-63
Identities = 82/290 (28%), Positives = 133/290 (45%), Gaps = 31/290 (10%)
Query: 84 GHLHVRELQLLSM---NLSGNLAPELGQLSRLQY-YFMWNDLTGTIPKEIGNISSLIFLL 139
LQ L + +G + P L S L + +N L+GTIP +G++S L L
Sbjct: 389 CQNPKNTLQELYLQNNGFTGKIPPTLSNCSELVSLHLSFNYLSGTIPSSLGSLSKLRDLK 448
Query: 140 LNGNKLSGSLPDELGYLSNLNRLQVDENNITGTIPKSFANLSRVRHLHLNNNSIGGQIPS 199
L N L G +P EL Y+ L L +D N++TG IP +N + + + L+NN + G+IP
Sbjct: 449 LWLNMLEGEIPQELMYVKTLETLILDFNDLTGEIPSGLSNCTNLNWISLSNNRLTGEIPK 508
Query: 200 ELSKLSTLIHLLVDNNNLSGNLPPELSELPQLCILQLDNNNFSASEIPATYGNFSKLVK- 258
+ +L L L + NN+ SGN+P EL + L L L+ N F+ + IPA S +
Sbjct: 509 WIGRLENLAILKLSNNSFSGNIPAELGDCRSLIWLDLNTNLFNGT-IPAAMFKQSGKIAA 567
Query: 259 ---------------------LSLRNCNLQGAVP-DLSRIPNLYYLDLSWNHLTGSIPS- 295
+ QG L+R+ +++ G
Sbjct: 568 NFIAGKRYVYIKNDGMKKECHGAGNLLEFQGIRSEQLNRLSTRNPCNITSRVYGGHTSPT 627
Query: 296 -KKLSENVTTIDLSDNYLNGSILESISNLPFLQTLSLENNFLTGSIPATI 344
++ +D+S N L+G I + I ++P+L L+L +N ++GSIP +
Sbjct: 628 FDNNG-SMMFLDMSYNMLSGYIPKEIGSMPYLFILNLGHNDISGSIPDEV 676
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 222 bits (567), Expect = 3e-61
Identities = 81/286 (28%), Positives = 125/286 (43%), Gaps = 15/286 (5%)
Query: 87 HVRELQLLSMNLSGNLAPELGQ--LSRLQYYFM-WNDLTGTIPKEIGNISSLIFLLLNGN 143
+ L L S N SG + P L Q + LQ ++ N TG IP + N S L+ L L+ N
Sbjct: 369 SLLTLDLSSNNFSGPILPNLCQNPKNTLQELYLQNNGFTGKIPPTLSNCSELVSLHLSFN 428
Query: 144 KLSGSLPDELGYLSNLNRLQVDENNITGTIPKSFANLSRVRHLHLNNNSIGGQIPSELSK 203
LSG++P LG LS L L++ N + G IP+ + + L L+ N + G+IPS LS
Sbjct: 429 YLSGTIPSSLGSLSKLRDLKLWLNMLEGEIPQELMYVKTLETLILDFNDLTGEIPSGLSN 488
Query: 204 LSTLIHLLVDNNNLSGNLPPELSELPQLCILQLDNNNFSASEIPATYGNFSKLVKLSLRN 263
+ L + + NN L+G +P + L L IL+L NN+FS IPA G+ L+ L L
Sbjct: 489 CTNLNWISLSNNRLTGEIPKWIGRLENLAILKLSNNSFS-GNIPAELGDCRSLIWLDLNT 547
Query: 264 CNLQGAVPDLSRIPNLYYLDLSWNHLTGSIP---SKKLSENVTTIDLSDNYLNGSILESI 320
G +P + + ++ N + G + + G E +
Sbjct: 548 NLFNGTIP--AAMFKQ-SGKIAANFIAGKRYVYIKNDGMKKECHGAGNLLEFQGIRSEQL 604
Query: 321 SNLPFLQTLSLENNFLTGSIPATIWQNKSFSTKARLKIDLRNNSFS 366
+ L ++ + G T N S +D+ N S
Sbjct: 605 NRLSTRNPCNITSRVYGGHTSPTFDNNGSMMF-----LDMSYNMLS 645
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 211 bits (540), Expect = 1e-57
Identities = 72/286 (25%), Positives = 124/286 (43%), Gaps = 18/286 (6%)
Query: 89 RELQLLSM---NLSGNLAPELGQLSRLQYYFMW-NDLTGTIPKEIGNISSLIFLLLNGNK 144
+L+ L + L G + EL + L+ + NDLTG IP + N ++L ++ L+ N+
Sbjct: 442 SKLRDLKLWLNMLEGEIPQELMYVKTLETLILDFNDLTGEIPSGLSNCTNLNWISLSNNR 501
Query: 145 LSGSLPDELGYLSNLNRLQVDENNITGTIPKSFANLSRVRHLHLNNNSIGGQIPSELSKL 204
L+G +P +G L NL L++ N+ +G IP + + L LN N G IP+ + K
Sbjct: 502 LTGEIPKWIGRLENLAILKLSNNSFSGNIPAELGDCRSLIWLDLNTNLFNGTIPAAMFKQ 561
Query: 205 STLIHLLVDNNNLSGNLPPELSELPQLCILQLDNNNFSAS-EIPATYGNFSKLVKLSLRN 263
S + N ++G + N S ++ +
Sbjct: 562 S----GKIAANFIAGKRYVYIKNDGMKKECHGAGNLLEFQGIRSEQLNRLSTRNPCNITS 617
Query: 264 CNLQGAVPD-LSRIPNLYYLDLSWNHLTGSIPSK--KLSENVTTIDLSDNYLNGSILESI 320
G ++ +LD+S+N L+G IP + + + ++L N ++GSI + +
Sbjct: 618 RVYGGHTSPTFDNNGSMMFLDMSYNMLSGYIPKEIGSMP-YLFILNLGHNDISGSIPDEV 676
Query: 321 SNLPFLQTLSLENNFLTGSIPATIWQNKSFSTKARLKIDLRNNSFS 366
+L L L L +N L G IP + + IDL NN+ S
Sbjct: 677 GDLRGLNILDLSSNKLDGRIPQAMSALTMLTE-----IDLSNNNLS 717
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 204 bits (522), Expect = 2e-55
Identities = 73/264 (27%), Positives = 119/264 (45%), Gaps = 15/264 (5%)
Query: 89 RELQLLSM---NLSGNLAPELGQLSRLQYYFM-WNDLTGTIPKEIGNISSLIFLLLNGNK 144
+ L+ L + +L+G + L + L + + N LTG IPK IG + +L L L+ N
Sbjct: 466 KTLETLILDFNDLTGEIPSGLSNCTNLNWISLSNNRLTGEIPKWIGRLENLAILKLSNNS 525
Query: 145 LSGSLPDELGYLSNLNRLQVDENNITGTIPKSFANLSRVRHLHLNNNSIGGQIPSELSKL 204
SG++P ELG +L L ++ N GTIP + S + N I G+ +
Sbjct: 526 FSGNIPAELGDCRSLIWLDLNTNLFNGTIPAAMFKQS----GKIAANFIAGKRYVYIKND 581
Query: 205 STLIHLLVDNN--NLSGNLPPELSELPQLCILQLDNNNFSASEIPATYGNFSKLVKLSLR 262
N G +L+ L + + + T+ N ++ L +
Sbjct: 582 GMKKECHGAGNLLEFQGIRSEQLNRLSTRNPCNITSRVYG-GHTSPTFDNNGSMMFLDMS 640
Query: 263 NCNLQGAVPD-LSRIPNLYYLDLSWNHLTGSIPSK--KLSENVTTIDLSDNYLNGSILES 319
L G +P + +P L+ L+L N ++GSIP + L + +DLS N L+G I ++
Sbjct: 641 YNMLSGYIPKEIGSMPYLFILNLGHNDISGSIPDEVGDLR-GLNILDLSSNKLDGRIPQA 699
Query: 320 ISNLPFLQTLSLENNFLTGSIPAT 343
+S L L + L NN L+G IP
Sbjct: 700 MSALTMLTEIDLSNNNLSGPIPEM 723
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 153 bits (389), Expect = 2e-38
Identities = 59/230 (25%), Positives = 91/230 (39%), Gaps = 14/230 (6%)
Query: 89 RELQLLSM---NLSGNLAPELGQLSRLQYYFM-WNDLTGTIPKEIGNISSLIFLLLNGNK 144
L +L + + SGN+ ELG L + + N GTIP + S + N
Sbjct: 514 ENLAILKLSNNSFSGNIPAELGDCRSLIWLDLNTNLFNGTIPAAMFKQS----GKIAANF 569
Query: 145 LSGSLPDELGYLSNLNRLQVDEN--NITGTIPKSFANLSRVRHLHLNNNSIGGQIPSELS 202
++G + N G + LS ++ + GG
Sbjct: 570 IAGKRYVYIKNDGMKKECHGAGNLLEFQGIRSEQLNRLSTRNPCNITSRVYGGHTSPTFD 629
Query: 203 KLSTLIHLLVDNNNLSGNLPPELSELPQLCILQLDNNNFSASEIPATYGNFSKLVKLSL- 261
+++ L + N LSG +P E+ +P L IL L +N+ S IP G+ L L L
Sbjct: 630 NNGSMMFLDMSYNMLSGYIPKEIGSMPYLFILNLGHNDIS-GSIPDEVGDLRGLNILDLS 688
Query: 262 RNCNLQGAVPD-LSRIPNLYYLDLSWNHLTGSIPSKKLSENVTTIDLSDN 310
N L G +P +S + L +DLS N+L+G IP E +N
Sbjct: 689 SN-KLDGRIPQAMSALTMLTEIDLSNNNLSGPIPEMGQFETFPPAKFLNN 737
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 4e-27
Identities = 42/147 (28%), Positives = 71/147 (48%), Gaps = 1/147 (0%)
Query: 77 FDTVETDGHLHVRELQLLSMNLSGNLAPELGQLSRLQY-YFMWNDLTGTIPKEIGNISSL 135
+ ++ DG + G + +L +LS G N S+
Sbjct: 575 YVYIKNDGMKKECHGAGNLLEFQGIRSEQLNRLSTRNPCNITSRVYGGHTSPTFDNNGSM 634
Query: 136 IFLLLNGNKLSGSLPDELGYLSNLNRLQVDENNITGTIPKSFANLSRVRHLHLNNNSIGG 195
+FL ++ N LSG +P E+G + L L + N+I+G+IP +L + L L++N + G
Sbjct: 635 MFLDMSYNMLSGYIPKEIGSMPYLFILNLGHNDISGSIPDEVGDLRGLNILDLSSNKLDG 694
Query: 196 QIPSELSKLSTLIHLLVDNNNLSGNLP 222
+IP +S L+ L + + NNNLSG +P
Sbjct: 695 RIPQAMSALTMLTEIDLSNNNLSGPIP 721
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 206 bits (527), Expect = 4e-60
Identities = 63/298 (21%), Positives = 111/298 (37%), Gaps = 42/298 (14%)
Query: 632 QVGQGGYGKVYKGILSDNTTVAIKRAEEGSLQGQNEFL--TEIKLLSRLHHRNLVSLLGY 689
VG+G YG+V++G VA+K + + + TE+ L H N++ +
Sbjct: 15 CVGKGRYGEVWRGSW-QGENVAVKIFSS---RDEKSWFRETELYNTVMLRHENILGFIAS 70
Query: 690 C----DEEGEQMLVYEFVPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAH- 744
+ L+ + G+L D+L T L+ LR+ L A G+ +LH E
Sbjct: 71 DMTSRHSSTQLWLITHYHEMGSLYDYLQLTT---LDTVSCLRIVLSIASGLAHLHIEIFG 127
Query: 745 ----PPVFHRDIKASNILLDSNLNAKVADFGLSRLAPVLDDEGTMPTHVSTIVKGTPGYL 800
P + HRD+K+ NIL+ N +AD GL+ + + GT Y+
Sbjct: 128 TQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAV---MHSQSTNQLDVGNNPRVGTKRYM 184
Query: 801 DPE------YFLTHKLTDKSDVYSLGVVLLELLTGMQPISHGK-------NIVREVNVAR 847
PE + D+++ G+VL E+ M + ++V
Sbjct: 185 APEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPSFE 244
Query: 848 DSGMVFSIIDNRM------GSYPSECVERFVTLALRCCHDKPEHRPSMSDVVRELENI 899
D M + ++ + + L C + P R + + + L I
Sbjct: 245 D--MRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKI 300
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 204 bits (520), Expect = 8e-59
Identities = 71/300 (23%), Positives = 116/300 (38%), Gaps = 40/300 (13%)
Query: 632 QVGQGGYGKVYKGILSDNTTVAIKR---AEEGSLQGQNEFLTEIKLLSRLHHRNLVSLLG 688
Q+G+G YG+V+ G VA+K EE S E TEI + H N++ +
Sbjct: 44 QIGKGRYGEVWMGKW-RGEKVAVKVFFTTEEASWF--RE--TEIYQTVLMRHENILGFIA 98
Query: 689 YC----DEEGEQMLVYEFVPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAH 744
+ L+ ++ NG+L D+L T L+ L++A S G+ +LHTE
Sbjct: 99 ADIKGTGSWTQLYLITDYHENGSLYDYLKSTT---LDAKSMLKLAYSSVSGLCHLHTEIF 155
Query: 745 -----PPVFHRDIKASNILLDSNLNAKVADFGLSRLAPVLDDEGTMPTHVSTIVKGTPGY 799
P + HRD+K+ NIL+ N +AD GL+ + GT Y
Sbjct: 156 STQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAV---KFISDTNEVDIPPNTRVGTKRY 212
Query: 800 LDPE-----YFLTHKLTD-KSDVYSLGVVLLELLTGMQPISHGKN--IVREVNVARD--- 848
+ PE H + +D+YS G++L E+ + + V D
Sbjct: 213 MPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVPSDPSY 272
Query: 849 SGMVFSIIDNRM------GSYPSECVERFVTLALRCCHDKPEHRPSMSDVVRELENILKM 902
M + ++ EC+ + L C P R + V + L + +
Sbjct: 273 EDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKMSES 332
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 201 bits (512), Expect = 9e-58
Identities = 59/298 (19%), Positives = 115/298 (38%), Gaps = 36/298 (12%)
Query: 632 QVGQGGYGKVYKGILSDNTTVAIKRAEEGSLQG-QNEFLTEIKLLSRLHHRNLVSLLGYC 690
+G+G +G+V++G VA+K + E EI L H N++ +
Sbjct: 49 SIGKGRFGEVWRGKW-RGEEVAVKIFSSREERSWFRE--AEIYQTVMLRHENILGFIAAD 105
Query: 691 ----DEEGEQMLVYEFVPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAH-- 744
+ LV ++ +G+L D+L + + +++AL +A G+ +LH E
Sbjct: 106 NKDNGTWTQLWLVSDYHEHGSLFDYL---NRYTVTVEGMIKLALSTASGLAHLHMEIVGT 162
Query: 745 ---PPVFHRDIKASNILLDSNLNAKVADFGLSRLAPVLDDEGTMPTHVSTIVKGTPGYLD 801
P + HRD+K+ NIL+ N +AD GL+ D GT Y+
Sbjct: 163 QGKPAIAHRDLKSKNILVKKNGTCCIADLGLAV---RHDSATDTIDIAPNHRVGTKRYMA 219
Query: 802 PE-----YFLTHKLTD-KSDVYSLGVVLLELLTGMQPISHGKN--IVREVNVARDSG--- 850
PE + H + ++D+Y++G+V E+ ++ + V D
Sbjct: 220 PEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEE 279
Query: 851 MVFSIIDNRM------GSYPSECVERFVTLALRCCHDKPEHRPSMSDVVRELENILKM 902
M + + ++ E + + C + R + + + L + +
Sbjct: 280 MRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQ 337
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 192 bits (491), Expect = 2e-54
Identities = 78/272 (28%), Positives = 127/272 (46%), Gaps = 24/272 (8%)
Query: 634 GQGGYGKVYKGIL-SDNTTVAIKRAEEG-SLQGQNEFLTEIKLLSRLHHRNLVSLLGYCD 691
G+G +G+V+ G L +DNT VA+K E + +FL E ++L + H N+V L+G C
Sbjct: 123 GRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCT 182
Query: 692 EEGEQMLVYEFVPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRD 751
++ +V E V G +L L L++ D+A G+ YL ++ HRD
Sbjct: 183 QKQPIYIVMELVQGGDFLTFLRTE-GARLRVKTLLQMVGDAAAGMEYLESK---CCIHRD 238
Query: 752 IKASNILLDSNLNAKVADFGLSRLAPVLDDEGTMPTHVSTI-VKGTPGYLDPEYFLTHKL 810
+ A N L+ K++DFG+SR D + + VK T PE +
Sbjct: 239 LAARNCLVTEKNVLKISDFGMSRE--EADGVYAASGGLRQVPVKWTA----PEALNYGRY 292
Query: 811 TDKSDVYSLGVVLLELLT-GMQPISHGKNIVREVNVARDSGMVFSIIDNRMGSYPSECVE 869
+ +SDV+S G++L E + G P + N ++ + G R+ P C +
Sbjct: 293 SSESDVWSFGILLWETFSLGASPYPNLSN--QQTREFVEKG-------GRLPC-PELCPD 342
Query: 870 RFVTLALRCCHDKPEHRPSMSDVVRELENILK 901
L +C +P RPS S + +EL++I K
Sbjct: 343 AVFRLMEQCWAYEPGQRPSFSTIYQELQSIRK 374
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 178 bits (453), Expect = 2e-50
Identities = 85/269 (31%), Positives = 131/269 (48%), Gaps = 22/269 (8%)
Query: 634 GQGGYGKVYKGILSDNTTVAIKRAEEGSLQGQNEFLTEIKLLSRLHHRNLVSLLGYCDEE 693
G G +G V+ G + VAIK EG++ + +F+ E +++ +L H LV L G C E+
Sbjct: 17 GSGQFGLVHLGYWLNKDKVAIKTIREGAMS-EEDFIEEAEVMMKLSHPKLVQLYGVCLEQ 75
Query: 694 GEQMLVYEFVPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIK 753
LV EF+ +G L D+L + + L + LD +G+ YL E + HRD+
Sbjct: 76 APICLVTEFMEHGCLSDYLRTQ-RGLFAAETLLGMCLDVCEGMAYL--EEACVI-HRDLA 131
Query: 754 ASNILLDSNLNAKVADFGLSRLAPVLDDEGTMPTHVSTIVKGTPGYLDPEYFLTHKLTDK 813
A N L+ N KV+DFG++R VLDD+ T T VK PE F + + K
Sbjct: 132 ARNCLVGENQVIKVSDFGMTRF--VLDDQYTSSTGTKFPVKWAS----PEVFSFSRYSSK 185
Query: 814 SDVYSLGVVLLELLT-GMQPISHGKNIVREVNVARDSGMVFSIIDNRMGSYPSECVERFV 872
SDV+S GV++ E+ + G P + N EV +G R+ P
Sbjct: 186 SDVWSFGVLMWEVFSEGKIPYENRSN--SEVVEDISTG-------FRLYK-PRLASTHVY 235
Query: 873 TLALRCCHDKPEHRPSMSDVVRELENILK 901
+ C ++PE RP+ S ++R+L I +
Sbjct: 236 QIMNHCWRERPEDRPAFSRLLRQLAEIAE 264
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 179 bits (455), Expect = 4e-50
Identities = 81/311 (26%), Positives = 139/311 (44%), Gaps = 27/311 (8%)
Query: 632 QVGQGGYGKVYKGIL-----SDNTTVAIKRAEEGSLQGQNEFLTEIKLLSRLHHRNLVSL 686
Q+G+G +G V + VA+K+ + Q +F EI++L LH +V
Sbjct: 30 QLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKY 89
Query: 687 LGYCDEEGEQ--MLVYEFVPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAH 744
G G Q LV E++P+G LRD+L + L+ + L + KG+ YL +
Sbjct: 90 RGVSYGPGRQSLRLVMEYLPSGCLRDFLQRH-RARLDASRLLLYSSQICKGMEYL--GSR 146
Query: 745 PPVFHRDIKASNILLDSNLNAKVADFGLSRLAPVLDDEGTMPTHVSTIVKGTPGYLDPEY 804
V HRD+ A NIL++S + K+ADFGL++L P+ D + + + PE
Sbjct: 147 RCV-HRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYA----PES 201
Query: 805 FLTHKLTDKSDVYSLGVVLLELLT-GMQPISHGKNIVREVNVARDSGM----VFSIIDN- 858
+ + +SDV+S GVVL EL T + S +R + RD + +++
Sbjct: 202 LSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERD-VPALSRLLELLEEG 260
Query: 859 -RMGSYPSECVERFVTLALRCCHDKPEHRPSMSDVVRELENILKMFPETDTMFSKSESSS 917
R+ + P C L C P+ RPS S + +L+ ++ + + + ++
Sbjct: 261 QRLPA-PPACPAEVHELMKLCWAPSPQDRPSFSALGPQLD---MLWSGSRGCETHAFTAH 316
Query: 918 LLSGKSASTSS 928
+ + S
Sbjct: 317 PEGKHHSLSFS 327
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 183 bits (467), Expect = 5e-50
Identities = 84/270 (31%), Positives = 129/270 (47%), Gaps = 22/270 (8%)
Query: 634 GQGGYGKVYKGIL-SDNTTVAIKRAEEGSLQGQNEFLTEIKLLSRLHHRNLVSLLGYCDE 692
G G YG+VY+G+ + TVA+K +E +++ EFL E ++ + H NLV LLG C
Sbjct: 229 GGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGVCTR 287
Query: 693 EGEQMLVYEFVPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDI 752
E ++ EF+ G L D+L ++ ++ + L +A + + YL E + HR++
Sbjct: 288 EPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYL--EKKNFI-HRNL 344
Query: 753 KASNILLDSNLNAKVADFGLSRLAPVLDDEGTMPTHVSTIVKGTPGYLDPEYFLTHKLTD 812
A N L+ N KVADFGLSRL + D T +K T PE +K +
Sbjct: 345 AARNCLVGENHLVKVADFGLSRL--MTGDTYTAHAGAKFPIKWTA----PESLAYNKFSI 398
Query: 813 KSDVYSLGVVLLELLT-GMQPISHGKNIVREVNVARDSGMVFSIIDNRMGSYPSECVERF 871
KSDV++ GV+L E+ T GM P +V + RM P C E+
Sbjct: 399 KSDVWAFGVLLWEIATYGMSPYPGIDL--SQVYELLEKD-------YRMER-PEGCPEKV 448
Query: 872 VTLALRCCHDKPEHRPSMSDVVRELENILK 901
L C P RPS +++ + E + +
Sbjct: 449 YELMRACWQWNPSDRPSFAEIHQAFETMFQ 478
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 182 bits (463), Expect = 6e-50
Identities = 95/270 (35%), Positives = 134/270 (49%), Gaps = 22/270 (8%)
Query: 634 GQGGYGKVYKGILSDNTTVAIKRAEEGSLQGQNEFLTEIKLLSRLHHRNLVSLLGYCDEE 693
GQG +G+V+ G + T VAIK + G++ FL E +++ +L H LV L EE
Sbjct: 193 GQGCFGEVWMGTWNGTTRVAIKTLKPGTMS-PEAFLQEAQVMKKLRHEKLVQLYAVVSEE 251
Query: 694 GEQMLVYEFVPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIK 753
+V E++ G+L D+L G T + L + +A A G+ Y+ E V HRD++
Sbjct: 252 P-IYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYV--ERMNYV-HRDLR 307
Query: 754 ASNILLDSNLNAKVADFGLSRLAPVLDDEGTMPTHVSTIVKGTPGYLDPEYFLTHKLTDK 813
A+NIL+ NL KVADFGL+RL + D+E T +K T PE L + T K
Sbjct: 308 AANILVGENLVCKVADFGLARL--IEDNEYTARQGAKFPIKWTA----PEAALYGRFTIK 361
Query: 814 SDVYSLGVVLLELLT-GMQPISHGKNIVREVNVARDSGMVFSIIDNRMGSYPSECVERFV 872
SDV+S G++L EL T G P N REV + G RM P EC E
Sbjct: 362 SDVWSFGILLTELTTKGRVPYPGMVN--REVLDQVERG-------YRMPC-PPECPESLH 411
Query: 873 TLALRCCHDKPEHRPSMSDVVRELENILKM 902
L +C +PE RP+ + LE+
Sbjct: 412 DLMCQCWRKEPEERPTFEYLQAFLEDYFTS 441
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 176 bits (448), Expect = 1e-49
Identities = 78/270 (28%), Positives = 127/270 (47%), Gaps = 22/270 (8%)
Query: 634 GQGGYGKVYKGILSDNTTVAIKRAEEGSLQGQNEFLTEIKLLSRLHHRNLVSLLGYCDEE 693
G G +G V G VAIK +EGS+ ++EF+ E K++ L H LV L G C ++
Sbjct: 33 GTGQFGVVKYGKWRGQYDVAIKMIKEGSMS-EDEFIEEAKVMMNLSHEKLVQLYGVCTKQ 91
Query: 694 GEQMLVYEFVPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIK 753
++ E++ NG L ++L + L + D + + YL E+ + HRD+
Sbjct: 92 RPIFIITEYMANGCLLNYLREM-RHRFQTQQLLEMCKDVCEAMEYL--ESKQFL-HRDLA 147
Query: 754 ASNILLDSNLNAKVADFGLSRLAPVLDDEGTMPTHVSTIVKGTPGYLDPEYFLTHKLTDK 813
A N L++ KV+DFGLSR VLDDE T V+ +P PE + K + K
Sbjct: 148 ARNCLVNDQGVVKVSDFGLSRY--VLDDEYTSSVGSKFPVRWSP----PEVLMYSKFSSK 201
Query: 814 SDVYSLGVVLLELLT-GMQPISHGKNIVREVNVARDSGMVFSIIDNRMGSYPSECVERFV 872
SD+++ GV++ E+ + G P N E G R+ P E+
Sbjct: 202 SDIWAFGVLMWEIYSLGKMPYERFTN--SETAEHIAQG-------LRLYR-PHLASEKVY 251
Query: 873 TLALRCCHDKPEHRPSMSDVVRELENILKM 902
T+ C H+K + RP+ ++ + +++
Sbjct: 252 TIMYSCWHEKADERPTFKILLSNILDVMDE 281
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 176 bits (448), Expect = 1e-49
Identities = 73/284 (25%), Positives = 126/284 (44%), Gaps = 23/284 (8%)
Query: 632 QVGQGGYGKVYKGIL-----SDNTTVAIKRAEEGSLQGQNEFLTEIKLLSRLHHRNLVSL 686
Q+G+G +G V + VA+K+ + + + +F EI++L L H N+V
Sbjct: 17 QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKY 76
Query: 687 LGYCDEEGEQ--MLVYEFVPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAH 744
G C G + L+ E++P G+LRD+L KE ++ L+ KG+ YL
Sbjct: 77 KGVCYSAGRRNLKLIMEYLPYGSLRDYLQKH-KERIDHIKLLQYTSQICKGMEYL--GTK 133
Query: 745 PPVFHRDIKASNILLDSNLNAKVADFGLSRLAPVLDDEGTMPTHVSTIVKGTPGYLDPEY 804
+ HRD+ NIL+++ K+ DFGL+++ P + + + + PE
Sbjct: 134 RYI-HRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWYA----PES 188
Query: 805 FLTHKLTDKSDVYSLGVVLLELLT-GMQPISHGKNIVREVNVARDSGM----VFSIIDN- 858
K + SDV+S GVVL EL T + S +R + + M + ++ N
Sbjct: 189 LTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNN 248
Query: 859 -RMGSYPSECVERFVTLALRCCHDKPEHRPSMSDVVRELENILK 901
R+ P C + + C ++ RPS D+ ++ I
Sbjct: 249 GRLPR-PDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRD 291
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 175 bits (445), Expect = 2e-49
Identities = 79/270 (29%), Positives = 130/270 (48%), Gaps = 22/270 (8%)
Query: 634 GQGGYGKVYKGILSDNTTVAIKRAEEGSLQGQNEFLTEIKLLSRLHHRNLVSLLGYCDEE 693
G G +G V G VA+K +EGS+ ++EF E + + +L H LV G C +E
Sbjct: 17 GSGQFGVVKLGKWKGQYDVAVKMIKEGSMS-EDEFFQEAQTMMKLSHPKLVKFYGVCSKE 75
Query: 694 GEQMLVYEFVPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIK 753
+V E++ NG L ++L + L + L + D +G+ +L E+H + HRD+
Sbjct: 76 YPIYIVTEYISNGCLLNYLRSH-GKGLEPSQLLEMCYDVCEGMAFL--ESHQFI-HRDLA 131
Query: 754 ASNILLDSNLNAKVADFGLSRLAPVLDDEGTMPTHVSTIVKGTPGYLDPEYFLTHKLTDK 813
A N L+D +L KV+DFG++R VLDD+ VK + PE F K + K
Sbjct: 132 ARNCLVDRDLCVKVSDFGMTRY--VLDDQYVSSVGTKFPVKWSA----PEVFHYFKYSSK 185
Query: 814 SDVYSLGVVLLELLT-GMQPISHGKNIVREVNVARDSGMVFSIIDNRMGSYPSECVERFV 872
SDV++ G+++ E+ + G P N EV + G +R+ P +
Sbjct: 186 SDVWAFGILMWEVFSLGKMPYDLYTN--SEVVLKVSQG-------HRLYR-PHLASDTIY 235
Query: 873 TLALRCCHDKPEHRPSMSDVVRELENILKM 902
+ C H+ PE RP+ ++ +E + +
Sbjct: 236 QIMYSCWHELPEKRPTFQQLLSSIEPLREK 265
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 175 bits (446), Expect = 2e-49
Identities = 85/270 (31%), Positives = 129/270 (47%), Gaps = 22/270 (8%)
Query: 634 GQGGYGKVYKGIL-SDNTTVAIKRAEEGSLQGQNEFLTEIKLLSRLHHRNLVSLLGYCDE 692
G G YG+VY+G+ + TVA+K +E +++ EFL E ++ + H NLV LLG C
Sbjct: 22 GGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGVCTR 80
Query: 693 EGEQMLVYEFVPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDI 752
E ++ EF+ G L D+L ++ ++ + L +A + + YL E + HRD+
Sbjct: 81 EPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYL--EKKNFI-HRDL 137
Query: 753 KASNILLDSNLNAKVADFGLSRLAPVLDDEGTMPTHVSTIVKGTPGYLDPEYFLTHKLTD 812
A N L+ N KVADFGLSRL + D T +K T PE +K +
Sbjct: 138 AARNCLVGENHLVKVADFGLSRL--MTGDTYTAHAGAKFPIKWTA----PESLAYNKFSI 191
Query: 813 KSDVYSLGVVLLELLT-GMQPISHGKNIVREVNVARDSGMVFSIIDNRMGSYPSECVERF 871
KSDV++ GV+L E+ T GM P +V + RM P C E+
Sbjct: 192 KSDVWAFGVLLWEIATYGMSPYPGIDL--SQVYELLEKD-------YRMER-PEGCPEKV 241
Query: 872 VTLALRCCHDKPEHRPSMSDVVRELENILK 901
L C P RPS +++ + E + +
Sbjct: 242 YELMRACWQWNPSDRPSFAEIHQAFETMFQ 271
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 175 bits (445), Expect = 3e-49
Identities = 85/270 (31%), Positives = 133/270 (49%), Gaps = 22/270 (8%)
Query: 634 GQGGYGKVYKGILSDNTTVAIKRAEEGSLQGQNEFLTEIKLLSRLHHRNLVSLLGYCDEE 693
G G +G+V+ G + +T VA+K ++GS+ + FL E L+ +L H+ LV L +E
Sbjct: 22 GAGQFGEVWMGYYNGHTKVAVKSLKQGSMS-PDAFLAEANLMKQLQHQRLVRLYAVVTQE 80
Query: 694 GEQMLVYEFVPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIK 753
++ E++ NG+L D+L + L L +A A+G+ ++ E + HRD++
Sbjct: 81 P-IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFI--EERNYI-HRDLR 136
Query: 754 ASNILLDSNLNAKVADFGLSRLAPVLDDEGTMPTHVSTIVKGTPGYLDPEYFLTHKLTDK 813
A+NIL+ L+ K+ADFGL+RL + D+E T +K T PE T K
Sbjct: 137 AANILVSDTLSCKIADFGLARL--IEDNEYTAREGAKFPIKWTA----PEAINYGTFTIK 190
Query: 814 SDVYSLGVVLLELLT-GMQPISHGKNIVREVNVARDSGMVFSIIDNRMGSYPSECVERFV 872
SDV+S G++L E++T G P N EV + G RM P C E
Sbjct: 191 SDVWSFGILLTEIVTHGRIPYPGMTN--PEVIQNLERG-------YRMVR-PDNCPEELY 240
Query: 873 TLALRCCHDKPEHRPSMSDVVRELENILKM 902
L C ++PE RP+ + LE+
Sbjct: 241 QLMRLCWKERPEDRPTFDYLRSVLEDFFTA 270
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 176 bits (448), Expect = 4e-49
Identities = 73/284 (25%), Positives = 126/284 (44%), Gaps = 23/284 (8%)
Query: 632 QVGQGGYGKVYKGIL-----SDNTTVAIKRAEEGSLQGQNEFLTEIKLLSRLHHRNLVSL 686
Q+G+G +G V + VA+K+ + + + +F EI++L L H N+V
Sbjct: 48 QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKY 107
Query: 687 LGYCDEEGEQ--MLVYEFVPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAH 744
G C G + L+ E++P G+LRD+L KE ++ L+ KG+ YL
Sbjct: 108 KGVCYSAGRRNLKLIMEYLPYGSLRDYLQKH-KERIDHIKLLQYTSQICKGMEYL--GTK 164
Query: 745 PPVFHRDIKASNILLDSNLNAKVADFGLSRLAPVLDDEGTMPTHVSTIVKGTPGYLDPEY 804
+ HRD+ NIL+++ K+ DFGL+++ P + + + + PE
Sbjct: 165 RYI-HRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYA----PES 219
Query: 805 FLTHKLTDKSDVYSLGVVLLELLT-GMQPISHGKNIVREVNVARDSGM----VFSIIDN- 858
K + SDV+S GVVL EL T + S +R + + M + ++ N
Sbjct: 220 LTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNN 279
Query: 859 -RMGSYPSECVERFVTLALRCCHDKPEHRPSMSDVVRELENILK 901
R+ P C + + C ++ RPS D+ ++ I
Sbjct: 280 GRLPR-PDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRD 322
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 181 bits (461), Expect = 7e-49
Identities = 95/270 (35%), Positives = 134/270 (49%), Gaps = 22/270 (8%)
Query: 634 GQGGYGKVYKGILSDNTTVAIKRAEEGSLQGQNEFLTEIKLLSRLHHRNLVSLLGYCDEE 693
GQG +G+V+ G + T VAIK + G++ FL E +++ +L H LV L EE
Sbjct: 276 GQGCFGEVWMGTWNGTTRVAIKTLKPGTMS-PEAFLQEAQVMKKLRHEKLVQLYAVVSEE 334
Query: 694 GEQMLVYEFVPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIK 753
+V E++ G+L D+L G T + L + +A A G+ Y+ E V HRD++
Sbjct: 335 P-IYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYV--ERMNYV-HRDLR 390
Query: 754 ASNILLDSNLNAKVADFGLSRLAPVLDDEGTMPTHVSTIVKGTPGYLDPEYFLTHKLTDK 813
A+NIL+ NL KVADFGL+RL + D+E T +K T PE L + T K
Sbjct: 391 AANILVGENLVCKVADFGLARL--IEDNEYTARQGAKFPIKWTA----PEAALYGRFTIK 444
Query: 814 SDVYSLGVVLLELLT-GMQPISHGKNIVREVNVARDSGMVFSIIDNRMGSYPSECVERFV 872
SDV+S G++L EL T G P N REV + G RM P EC E
Sbjct: 445 SDVWSFGILLTELTTKGRVPYPGMVN--REVLDQVERG-------YRMPC-PPECPESLH 494
Query: 873 TLALRCCHDKPEHRPSMSDVVRELENILKM 902
L +C +PE RP+ + LE+
Sbjct: 495 DLMCQCWRKEPEERPTFEYLQAFLEDYFTS 524
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 179 bits (456), Expect = 7e-49
Identities = 79/270 (29%), Positives = 129/270 (47%), Gaps = 22/270 (8%)
Query: 634 GQGGYGKVYKGILSDNTTVAIKRAEEGSLQGQNEFLTEIKLLSRLHHRNLVSLLGYCDEE 693
G G +G+V+ + +T VA+K + GS+ FL E ++ L H LV L +E
Sbjct: 197 GAGQFGEVWMATYNKHTKVAVKTMKPGSMS-VEAFLAEANVMKTLQHDKLVKLHAVVTKE 255
Query: 694 GEQMLVYEFVPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIK 753
++ EF+ G+L D+L + + A+G+ ++ E + HRD++
Sbjct: 256 P-IYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFI--EQRNYI-HRDLR 311
Query: 754 ASNILLDSNLNAKVADFGLSRLAPVLDDEGTMPTHVSTIVKGTPGYLDPEYFLTHKLTDK 813
A+NIL+ ++L K+ADFGL+R+ + D+E T +K T PE T K
Sbjct: 312 AANILVSASLVCKIADFGLARV--IEDNEYTAREGAKFPIKWTA----PEAINFGSFTIK 365
Query: 814 SDVYSLGVVLLELLT-GMQPISHGKNIVREVNVARDSGMVFSIIDNRMGSYPSECVERFV 872
SDV+S G++L+E++T G P N EV A + G RM P C E
Sbjct: 366 SDVWSFGILLMEIVTYGRIPYPGMSN--PEVIRALERG-------YRMPR-PENCPEELY 415
Query: 873 TLALRCCHDKPEHRPSMSDVVRELENILKM 902
+ +RC ++PE RP+ + L++
Sbjct: 416 NIMMRCWKNRPEERPTFEYIQSVLDDFYTA 445
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 173 bits (442), Expect = 9e-49
Identities = 79/274 (28%), Positives = 119/274 (43%), Gaps = 26/274 (9%)
Query: 634 GQGGYGKVYKGIL---SDNTTVAIK--RAEEGSLQGQNEFLTEIKLLSRLHHRNLVSLLG 688
G G +G V KG TVA+K + E ++E L E ++ +L + +V ++G
Sbjct: 26 GSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIG 85
Query: 689 YCDEEGEQMLVYEFVPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVF 748
C+ E MLV E G L +L + ++ + + + G+ YL E V
Sbjct: 86 ICEAES-WMLVMEMAELGPLNKYL--QQNRHVKDKNIIELVHQVSMGMKYL--EESNFV- 139
Query: 749 HRDIKASNILLDSNLNAKVADFGLSRLAPVLDDEGTMPTHVSTIVKGTPGYLDPEYFLTH 808
HRD+ A N+LL + AK++DFGLS+ ++ TH VK PE +
Sbjct: 140 HRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYA----PECINYY 195
Query: 809 KLTDKSDVYSLGVVLLELLT-GMQPISHGKNIVREVNVARDSGMVFSIIDNRMGSYPSEC 867
K + KSDV+S GV++ E + G +P K EV + G RMG P+ C
Sbjct: 196 KFSSKSDVWSFGVLMWEAFSYGQKPYRGMKG--SEVTAMLEKG-------ERMGC-PAGC 245
Query: 868 VERFVTLALRCCHDKPEHRPSMSDVVRELENILK 901
L C E+RP + V L N
Sbjct: 246 PREMYDLMNLCWTYDVENRPGFAAVELRLRNYYY 279
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 173 bits (441), Expect = 1e-48
Identities = 82/273 (30%), Positives = 128/273 (46%), Gaps = 28/273 (10%)
Query: 632 QVGQGGYGKVYKGILSDNTTVAIKRAEEGSLQGQNEFLTEIKLLSRLHHRNLVSLLGYC- 690
+G+G +G V G VA+K + + FL E ++++L H NLV LLG
Sbjct: 28 TIGKGEFGDVMLGDY-RGNKVAVKCIKNDATA--QAFLAEASVMTQLRHSNLVQLLGVIV 84
Query: 691 DEEGEQMLVYEFVPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHR 750
+E+G +V E++ G+L D+L R + L L+ +LD + + YL E + V HR
Sbjct: 85 EEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYL--EGNNFV-HR 141
Query: 751 DIKASNILLDSNLNAKVADFGLSRLAPVLDDEGTMPTHVSTIVKGTPGYLDPEYFLTHKL 810
D+ A N+L+ + AKV+DFGL++ A D G +P VK T PE K
Sbjct: 142 DLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLP------VKWTA----PEALREKKF 191
Query: 811 TDKSDVYSLGVVLLELLT-GMQPISHGKNIVREVNVARDSGMVFSIIDNRMGSYPSECVE 869
+ KSDV+S G++L E+ + G P ++V + G +M + P C
Sbjct: 192 STKSDVWSFGILLWEIYSFGRVPYPRIPL--KDVVPRVEKG-------YKMDA-PDGCPP 241
Query: 870 RFVTLALRCCHDKPEHRPSMSDVVRELENILKM 902
+ C H RPS + +LE+I
Sbjct: 242 AVYEVMKNCWHLDAAMRPSFLQLREQLEHIKTH 274
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 181 bits (460), Expect = 5e-48
Identities = 45/321 (14%), Positives = 102/321 (31%), Gaps = 29/321 (9%)
Query: 86 LHVRELQLLSMNLSGNLAPELGQLSRLQYYFMWNDLTGTIPKEIGNISSLIFLLLNGNKL 145
+ + + S ++ + ++ + K + ++ L + +
Sbjct: 159 SDLIKDCINSDPQQKSIKKSSRITLKDTQIGQLSNNITFVSKAVMRLTKLRQFYMGNSPF 218
Query: 146 SGSLPDELGYLSNLNRLQVDENNITGTIPKSFANLSRVRHLHLNNNSIGGQIPSELSKLS 205
E N + T + NL + + + N ++P+ L L
Sbjct: 219 VAENICEAWENENS-----EYAQQYKTEDLKWDNLKDLTDVEVYNCPNLTKLPTFLKALP 273
Query: 206 TLIHLLVDNNNL--------SGNLPPELSELPQLCILQLDNNNFSASEIPATYGNFSKLV 257
+ + V N + ++ I+ + NN + + KL
Sbjct: 274 EMQLINVACNRGISGEQLKDDWQALADAPVGEKIQIIYIGYNNLKTFPVETSLQKMKKLG 333
Query: 258 KLSLRNCNLQGAVPDLSRIPNLYYLDLSWNHLTGSIPS-KKLSENVTTIDLSDNYLNG-S 315
L L+G +P L L+L++N +T + +E V + + N L
Sbjct: 334 MLECLYNQLEGKLPAFGSEIKLASLNLAYNQITEIPANFCGFTEQVENLSFAHNKLKYIP 393
Query: 316 ILESISNLPFLQTLSLENNFLTG-------SIPATIWQNKSFSTKARLKIDLRNNSFSNI 368
+ ++ + + N + + T ++ + S+ I+L NN S
Sbjct: 394 NIFDAKSVSVMSAIDFSYNEIGSVDGKNFDPLDPTPFKGINVSS-----INLSNNQISKF 448
Query: 369 VGDL--TLPNNVTLRLGGNPI 387
+L T ++ L GN +
Sbjct: 449 PKELFSTGSPLSSINLMGNML 469
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 152 bits (386), Expect = 1e-38
Identities = 50/277 (18%), Positives = 100/277 (36%), Gaps = 37/277 (13%)
Query: 92 QLLSMNLSGN----LAPEL-GQLSRLQY-YFMWNDLTGTIPK--EIGNISSLIFLLLNGN 143
+L S+NL+ N + G +++ F N L IP + ++S + + + N
Sbjct: 354 KLASLNLAYNQITEIPANFCGFTEQVENLSFAHNKLK-YIPNIFDAKSVSVMSAIDFSYN 412
Query: 144 KLSG-------SLPDELGYLSNLNRLQVDENNITGTIPKSFANLSRVRHLHLNNNSIGG- 195
++ L N++ + + N I+ + F+ S + ++L N +
Sbjct: 413 EIGSVDGKNFDPLDPTPFKGINVSSINLSNNQISKFPKELFSTGSPLSSINLMGNMLTEI 472
Query: 196 ------QIPSELSKLSTLIHLLVDNNNLSGNLPPEL--SELPQLCILQLDNNNFSASEIP 247
L + + N L+ L + + LP L + L N+F S+ P
Sbjct: 473 PKNSLKDENENFKNTYLLTSIDLRFNKLTK-LSDDFRATTLPYLVGIDLSYNSF--SKFP 529
Query: 248 ATYGNFSKLVKLSLRNC------NLQGAVPD-LSRIPNLYYLDLSWNHLTGSIPSKKLSE 300
N S L +RN P+ ++ P+L L + N + + K++
Sbjct: 530 TQPLNSSTLKGFGIRNQRDAQGNRTLREWPEGITLCPSLTQLQIGSNDIR-KVNE-KITP 587
Query: 301 NVTTIDLSDNYLNGSILESISNLPFLQTLSLENNFLT 337
N++ +D+ DN L + L +
Sbjct: 588 NISVLDIKDNPNISIDLSYVCPYIEAGMYMLFYDKTQ 624
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 3e-30
Identities = 23/233 (9%), Positives = 60/233 (25%), Gaps = 14/233 (6%)
Query: 152 ELGYLSNLNRLQVDENNITGTIPKSFANLSRVRHLHLNNNSIGGQ----IPSELSKLSTL 207
L + L ++ +G +P + L+ + L L ++ P +S +
Sbjct: 76 SLNSNGRVTGLSLEGFGASGRVPDAIGQLTELEVLALGSHGEKVNERLFGPKGISANMSD 135
Query: 208 IHLLVDNNNLSGNLPPELSELPQLCILQLD-NNNFSASEIPATYGNFSKLVKLSLRNCNL 266
+ +++ N++ I + K ++ + N+
Sbjct: 136 EQKQKMRMHYQKTFVDYDPREDFSDLIKDCINSDPQQKSIKKSSRITLKDTQIGQLSNNI 195
Query: 267 QGAVPDLSRIPNLYYLDLSWNHLTGSIPSKKLSENVTTIDLSDNYLNGSILESISNLPFL 326
+ R+ L + + E + + NL L
Sbjct: 196 TFVSKAVMRLTKLRQFYMGNSPFVAENI----CEAWENENSEYAQQYKTEDLKWDNLKDL 251
Query: 327 QTLSLENNFLTGSIPATIWQNKSFSTKARLKIDLRNNSFSNIVGDLTLPNNVT 379
+ + N +P + I++ N + +
Sbjct: 252 TDVEVYNCPNLTKLPTFLKALPEMQL-----INVACNRGISGEQLKDDWQALA 299
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 92.4 bits (230), Expect = 2e-19
Identities = 21/159 (13%), Positives = 46/159 (28%), Gaps = 14/159 (8%)
Query: 91 LQLLSMNLSGNLAPELGQLSRLQY-YFMWNDLTGTIPKEI--GNISSLIFLLLNGNKLSG 147
L + N + L +N LT + + + L+ + L+ N S
Sbjct: 469 LTEIPKNSLKDENENFKNTYLLTSIDLRFNKLTK-LSDDFRATTLPYLVGIDLSYNSFSK 527
Query: 148 SLPDELGYLSNLNRLQVDE------NNITGTIPKSFANLSRVRHLHLNNNSIGGQIPSEL 201
P + S L + N P+ + L + +N I + ++
Sbjct: 528 -FPTQPLNSSTLKGFGIRNQRDAQGNRTLREWPEGITLCPSLTQLQIGSNDIRK-VNEKI 585
Query: 202 SKLSTLIHLLVDNNNLSGNLPPELSELPQLCILQLDNNN 240
+ L + +N + + + L +
Sbjct: 586 --TPNISVLDIKDNPNISIDLSYVCPYIEAGMYMLFYDK 622
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 49.7 bits (119), Expect = 4e-06
Identities = 9/109 (8%), Positives = 23/109 (21%), Gaps = 27/109 (24%)
Query: 86 LHVRELQLLSMN-LSGNLAPELGQLSRLQYYFMWNDLTGTIPKEIGNISSLIFLLLNGNK 144
+R + N + L L + N
Sbjct: 541 FGIRNQRDAQGNRTLREWPEGITLCPSLTQ-----------------------LQIGSND 577
Query: 145 LSGSLPDELGYLSNLNRLQVDENNITGTIPKSFANLSRVRHLHLNNNSI 193
+ + +++ N++ L + +N L +
Sbjct: 578 IR-KVNEKI--TPNISVLDIKDNPNISIDLSYVCPYIEAGMYMLFYDKT 623
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 176 bits (449), Expect = 5e-48
Identities = 81/271 (29%), Positives = 127/271 (46%), Gaps = 28/271 (10%)
Query: 634 GQGGYGKVYKGILSDNTTVAIKRAEEGSLQGQNEFLTEIKLLSRLHHRNLVSLLGYC-DE 692
G+G +G V G VA+K + + FL E ++++L H NLV LLG +E
Sbjct: 202 GKGEFGDVMLGDYR-GNKVAVKCIKNDATA--QAFLAEASVMTQLRHSNLVQLLGVIVEE 258
Query: 693 EGEQMLVYEFVPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDI 752
+G +V E++ G+L D+L R + L L+ +LD + + YL E + V HRD+
Sbjct: 259 KGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYL--EGNNFV-HRDL 315
Query: 753 KASNILLDSNLNAKVADFGLSRLAPVLDDEGTMPTHVSTIVKGTPGYLDPEYFLTHKLTD 812
A N+L+ + AKV+DFGL++ A D G +P VK T PE K +
Sbjct: 316 AARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLP------VKWTA----PEALREKKFST 365
Query: 813 KSDVYSLGVVLLELLT-GMQPISHGKNIVREVNVARDSGMVFSIIDNRMGSYPSECVERF 871
KSDV+S G++L E+ + G P ++V + G +M + P C
Sbjct: 366 KSDVWSFGILLWEIYSFGRVPYPRIPL--KDVVPRVEKG-------YKMDA-PDGCPPAV 415
Query: 872 VTLALRCCHDKPEHRPSMSDVVRELENILKM 902
+ C H RP+ + +LE+I
Sbjct: 416 YDVMKNCWHLDAATRPTFLQLREQLEHIRTH 446
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 172 bits (437), Expect = 5e-48
Identities = 77/285 (27%), Positives = 128/285 (44%), Gaps = 25/285 (8%)
Query: 632 QVGQGGYGKVYKGIL-----SDNTTVAIKR-AEEGSLQGQNEFLTEIKLLSRLHHRNLVS 685
+G+G +GKV + VA+K E + EI++L L+H N+V
Sbjct: 28 DLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVK 87
Query: 686 LLGYCDEEGEQ--MLVYEFVPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEA 743
G C E+G L+ EF+P+G+L+++L K +N +L+ A+ KG+ YL +
Sbjct: 88 YKGICTEDGGNGIKLIMEFLPSGSLKEYLPKN-KNKINLKQQLKYAVQICKGMDYL--GS 144
Query: 744 HPPVFHRDIKASNILLDSNLNAKVADFGLSRLAPVLDDEGTMPTHVSTIVKGTPGYLDPE 803
V HRD+ A N+L++S K+ DFGL++ + T+ + V PE
Sbjct: 145 RQYV-HRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDRDSPVFWYA----PE 199
Query: 804 YFLTHKLTDKSDVYSLGVVLLELLT-GMQPISHGKNIVREVNVARDSGM----VFSIIDN 858
+ K SDV+S GV L ELLT S ++ + M + + +
Sbjct: 200 CLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTH-GQMTVTRLVNTLKE 258
Query: 859 --RMGSYPSECVERFVTLALRCCHDKPEHRPSMSDVVRELENILK 901
R+ P C + L +C +P +R S +++ E +LK
Sbjct: 259 GKRLPC-PPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEALLK 302
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 171 bits (436), Expect = 6e-48
Identities = 78/276 (28%), Positives = 120/276 (43%), Gaps = 24/276 (8%)
Query: 631 TQVGQGGYGKVYKGIL---SDNTTVAIKRAEEGSLQGQ-NEFLTEIKLLSRLHHRNLVSL 686
++G G +G V +G+ VAIK ++G+ + E + E +++ +L + +V L
Sbjct: 16 IELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRL 75
Query: 687 LGYCDEEGEQMLVYEFVPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPP 746
+G C E MLV E G L +L G+ +E + + + + G+ YL E
Sbjct: 76 IGVCQAE-ALMLVMEMAGGGPLHKFLVGK-REEIPVSNVAELLHQVSMGMKYL--EEKNF 131
Query: 747 VFHRDIKASNILLDSNLNAKVADFGLSRLAPVLDDEGTMPTHVSTIVKGTPGYLDPEYFL 806
V HRD+ A N+LL + AK++DFGLS+ D T + +K PE
Sbjct: 132 V-HRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYA----PECIN 186
Query: 807 THKLTDKSDVYSLGVVLLELLT-GMQPISHGKNIVREVNVARDSGMVFSIIDNRMGSYPS 865
K + +SDV+S GV + E L+ G +P K EV + G RM P
Sbjct: 187 FRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKG--PEVMAFIEQG-------KRMEC-PP 236
Query: 866 ECVERFVTLALRCCHDKPEHRPSMSDVVRELENILK 901
EC L C K E RP V + +
Sbjct: 237 ECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYY 272
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 170 bits (433), Expect = 2e-47
Identities = 83/290 (28%), Positives = 123/290 (42%), Gaps = 42/290 (14%)
Query: 634 GQGGYGKVYKGILSD----NTTVAIKRAEEG-SLQGQNEFLTEIKLLSRLHHRNLVSLLG 688
G+G +G VY G D AIK +Q FL E L+ L+H N+++L+G
Sbjct: 30 GKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIG 89
Query: 689 YC-DEEGEQMLVYEFVPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPV 747
EG ++ ++ +G L ++ + N + L A+G+ YL V
Sbjct: 90 IMLPPEGLPHVLLPYMCHGDLLQFIRSP-QRNPTVKDLISFGLQVARGMEYL--AEQKFV 146
Query: 748 FHRDIKASNILLDSNLNAKVADFGLSRLAPVLDDE---------GTMPTHVSTIVKGTPG 798
HRD+ A N +LD + KVADFGL+R +LD E +P VK T
Sbjct: 147 -HRDLAARNCMLDESFTVKVADFGLARD--ILDREYYSVQQHRHARLP------VKWTA- 196
Query: 799 YLDPEYFLTHKLTDKSDVYSLGVVLLELLT-GMQPISHGKNIVREVNVARDSGMVFSIID 857
E T++ T KSDV+S GV+L ELLT G P H ++ G
Sbjct: 197 ---LESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDP--FDLTHFLAQG------- 244
Query: 858 NRMGSYPSECVERFVTLALRCCHDKPEHRPSMSDVVRELENILKMFPETD 907
R+ P C + + +C P RP+ +V E+E I+
Sbjct: 245 RRL-PQPEYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQIVSALLGDH 293
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 169 bits (430), Expect = 3e-47
Identities = 78/279 (27%), Positives = 129/279 (46%), Gaps = 29/279 (10%)
Query: 634 GQGGYGKVYKGIL----SDNTTVAIKRAEEGSLQGQ-NEFLTEIKLLSRLHHRNLVSLLG 688
G+G +G+VY+G+ + VA+K ++ +F++E ++ L H ++V L+G
Sbjct: 21 GEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIG 80
Query: 689 YCDEEGEQMLVYEFVPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVF 748
+EE ++ E P G L +L K +L + +L K + YL E+ V
Sbjct: 81 IIEEE-PTWIIMELYPYGELGHYLERN-KNSLKVLTLVLYSLQICKAMAYL--ESINCV- 135
Query: 749 HRDIKASNILLDSNLNAKVADFGLSRLAPVLDDEGTMPTHVSTI-VKGTPGYLDPEYFLT 807
HRDI NIL+ S K+ DFGLSR ++DE V+ + +K PE
Sbjct: 136 HRDIAVRNILVASPECVKLGDFGLSR---YIEDEDYYKASVTRLPIKWMS----PESINF 188
Query: 808 HKLTDKSDVYSLGVVLLELLT-GMQPISHGKNIVREVNVARDSGMVFSIIDNRMGSYPSE 866
+ T SDV+ V + E+L+ G QP +N ++V + G +R+ P
Sbjct: 189 RRFTTASDVWMFAVCMWEILSFGKQPFFWLEN--KDVIGVLEKG-------DRLPK-PDL 238
Query: 867 CVERFVTLALRCCHDKPEHRPSMSDVVRELENILKMFPE 905
C TL RC P RP +++V L ++ +M +
Sbjct: 239 CPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDVYQMEKD 277
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 170 bits (432), Expect = 3e-47
Identities = 78/297 (26%), Positives = 127/297 (42%), Gaps = 48/297 (16%)
Query: 632 QVGQGGYGKVYKGILSD----NTTVAIK--RAEEGSLQGQNEFLTEIKLLSRLHHRNLVS 685
+G+G +G V +G L + VA+K + + S + EFL+E + H N++
Sbjct: 41 ILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIR 100
Query: 686 LLGYCDEEGEQ-----MLVYEFVPNGTLRDWL----SGRTKENLNFAMRLRVALDSAKGI 736
LLG C E Q M++ F+ G L +L +++ L+ +D A G+
Sbjct: 101 LLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGM 160
Query: 737 LYLHTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSRLAPVLDDE-------GTMPTHV 789
YL + HRD+ A N +L ++ VADFGLS+ + + MP
Sbjct: 161 EYL--SNRNFL-HRDLAARNCMLRDDMTVCVADFGLSKK--IYSGDYYRQGRIAKMP--- 212
Query: 790 STIVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVLLELLT-GMQPISHGKNIVREVNVARD 848
VK E T KSDV++ GV + E+ T GM P +N E+
Sbjct: 213 ---VKWIA----IESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQN--HEMYDYLL 263
Query: 849 SGMVFSIIDNRMGSYPSECVERFVTLALRCCHDKPEHRPSMSDVVRELENILKMFPE 905
G +R+ P +C++ + C P RP+ S + +LE +L+ P+
Sbjct: 264 HG-------HRL-KQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLLESLPD 312
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 170 bits (434), Expect = 3e-47
Identities = 74/280 (26%), Positives = 121/280 (43%), Gaps = 37/280 (13%)
Query: 634 GQGGYGKVYKGIL-----SDNTTVAIKRAEEGSLQGQN-EFLTEIKLLSRLHHRNLVSLL 687
G G +G VYKG+ VAIK E + N E L E +++ + + ++ LL
Sbjct: 24 GSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLL 83
Query: 688 GYCDEEGEQMLVYEFVPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPV 747
G C L+ + +P G L D++ K+N+ L + AKG+ YL E V
Sbjct: 84 GICLTS-TVQLITQLMPFGCLLDYVREH-KDNIGSQYLLNWCVQIAKGMNYL--EDRRLV 139
Query: 748 FHRDIKASNILLDSNLNAKVADFGLSRLAPVLDDE-----GTMPTHVSTIVKGTPGYLDP 802
HRD+ A N+L+ + + K+ DFGL++L + E G +P +K
Sbjct: 140 -HRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVP------IKWMA----L 188
Query: 803 EYFLTHKLTDKSDVYSLGVVLLELLT-GMQPISHGKNIVREVNVARDSGMVFSIIDNRMG 861
E L T +SDV+S GV + EL+T G +P E++ + G R+
Sbjct: 189 ESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPA--SEISSILEKG-------ERLP 239
Query: 862 SYPSECVERFVTLALRCCHDKPEHRPSMSDVVRELENILK 901
P C + +C + RP +++ E + +
Sbjct: 240 Q-PPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMAR 278
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 169 bits (430), Expect = 4e-47
Identities = 78/302 (25%), Positives = 131/302 (43%), Gaps = 59/302 (19%)
Query: 634 GQGGYGKVYKGIL------SDNTTVAIKRAEEGSLQGQNEFLTEIKLLSRLHHRNLVSLL 687
G+G +GKV+ D VA+K ++ +L + +F E +LL+ L H ++V
Sbjct: 24 GEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFY 83
Query: 688 GYCDEEGEQMLVYEFVPNGTLRDWLSGR--------------TKENLNFAMRLRVALDSA 733
G C + ++V+E++ +G L +L K L + L +A A
Sbjct: 84 GVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIA 143
Query: 734 KGILYLHTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSRLAPVLDDE-------GTMP 786
G++YL + V HRD+ N L+ +NL K+ DFG+SR V + +P
Sbjct: 144 SGMVYL--ASQHFV-HRDLATRNCLVGANLLVKIGDFGMSRD--VYSTDYYRVGGHTMLP 198
Query: 787 THVSTIVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVLLELLT-GMQP---ISHGKNIVRE 842
++ P PE + K T +SDV+S GV+L E+ T G QP +S+ E
Sbjct: 199 ------IRWMP----PESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSN-----TE 243
Query: 843 VNVARDSGMVFSIIDNRMGSYPSECVERFVTLALRCCHDKPEHRPSMSDVVRELENILKM 902
V G + P C + + L C +P+ R ++ ++ + L + K
Sbjct: 244 VIECITQG-------RVL-ERPRVCPKEVYDVMLGCWQREPQQRLNIKEIYKILHALGKA 295
Query: 903 FP 904
P
Sbjct: 296 TP 297
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 169 bits (430), Expect = 8e-47
Identities = 74/285 (25%), Positives = 128/285 (44%), Gaps = 27/285 (9%)
Query: 632 QVGQGGYGKVYKGIL-----SDNTTVAIKR-AEEGSLQGQNEFLTEIKLLSRLHHRNLVS 685
+G+G +GKV VA+K + Q ++ + EI +L L+H +++
Sbjct: 38 DLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIK 97
Query: 686 LLGYCDEEGEQ--MLVYEFVPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEA 743
G C++ G LV E+VP G+LRD+L + ++ A L A +G+ YL A
Sbjct: 98 YKGCCEDAGAASLQLVMEYVPLGSLRDYLP---RHSIGLAQLLLFAQQICEGMAYL--HA 152
Query: 744 HPPVFHRDIKASNILLDSNLNAKVADFGLSRLAPVLDDEGTMPTHVSTIVKGTPGYLDPE 803
+ HRD+ A N+LLD++ K+ DFGL++ P + + + V PE
Sbjct: 153 QHYI-HRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYA----PE 207
Query: 804 YFLTHKLTDKSDVYSLGVVLLELLT-GMQPISHGKNIVREVNVARDSGM----VFSIIDN 858
+K SDV+S GV L ELLT S + + +A+ M + +++
Sbjct: 208 CLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQ-GQMTVLRLTELLER 266
Query: 859 --RMGSYPSECVERFVTLALRCCHDKPEHRPSMSDVVRELENILK 901
R+ P +C L C + RP+ +++ L+ + +
Sbjct: 267 GERL-PRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVHE 310
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 167 bits (425), Expect = 2e-46
Identities = 90/291 (30%), Positives = 129/291 (44%), Gaps = 42/291 (14%)
Query: 633 VGQGGYGKVYKGILSDN----TTVAIKRAEEG-SLQGQNEFLTEIKLLSRLHHRNLVSLL 687
+G+G +G VY G L DN A+K + ++FLTE ++ H N++SLL
Sbjct: 33 IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 92
Query: 688 GYC-DEEGEQMLVYEFVPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPP 746
G C EG ++V ++ +G LR+++ N + L AKG+ YL +
Sbjct: 93 GICLRSEGSPLVVLPYMKHGDLRNFIRNE-THNPTVKDLIGFGLQVAKGMKYL--ASKKF 149
Query: 747 VFHRDIKASNILLDSNLNAKVADFGLSRLAPVLDDE---------GTMPTHVSTIVKGTP 797
V HRD+ A N +LD KVADFGL+R + D E +P VK
Sbjct: 150 V-HRDLAARNCMLDEKFTVKVADFGLARD--MYDKEYYSVHNKTGAKLP------VKWMA 200
Query: 798 GYLDPEYFLTHKLTDKSDVYSLGVVLLELLT-GMQPISHGKNIVREVNVARDSGMVFSII 856
E T K T KSDV+S GV+L EL+T G P ++ V G
Sbjct: 201 ----LESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNT--FDITVYLLQG------ 248
Query: 857 DNRMGSYPSECVERFVTLALRCCHDKPEHRPSMSDVVRELENILKMFPETD 907
R+ P C + + L+C H K E RPS S++V + I F
Sbjct: 249 -RRL-LQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIGEH 297
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 168 bits (427), Expect = 3e-46
Identities = 83/291 (28%), Positives = 129/291 (44%), Gaps = 31/291 (10%)
Query: 634 GQGGYGKVYKGIL----SDNTTVAIKRAEEGSLQGQ-NEFLTEIKLLSRLHHRNLVSLLG 688
G G G+V G L + VAIK + G + Q +FL+E ++ + H N++ L G
Sbjct: 58 GSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEG 117
Query: 689 YCDEEGEQMLVYEFVPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVF 748
M+V E++ NG+L +L + + G+ YL V
Sbjct: 118 VVTRGRLAMIVTEYMENGSLDTFLRTH-DGQFTIMQLVGMLRGVGAGMRYL--SDLGYV- 173
Query: 749 HRDIKASNILLDSNLNAKVADFGLSRLAPVLDDEGT-MPTHVSTI-VKGTPGYLDPEYFL 806
HRD+ A N+L+DSNL KV+DFGLSR+ + DD T I ++ T PE
Sbjct: 174 HRDLAARNVLVDSNLVCKVSDFGLSRV--LEDDPDAAYTTTGGKIPIRWTA----PEAIA 227
Query: 807 THKLTDKSDVYSLGVVLLELLT-GMQPISHGKNIVREVNVARDSGMVFSIIDNRMGSYPS 865
+ SDV+S GVV+ E+L G +P + N R+V + + G R+ + P
Sbjct: 228 FRTFSSASDVWSFGVVMWEVLAYGERPYWNMTN--RDVISSVEEG-------YRLPA-PM 277
Query: 866 ECVERFVTLALRCCHDKPEHRPSMSDVVRELENILKMFPETDTMFSKSESS 916
C L L C H RP S +V L+ + +++ + + S
Sbjct: 278 GCPHALHQLMLDCWHKDRAQRPRFSQIVSVLD---ALIRSPESLRATATVS 325
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 165 bits (420), Expect = 8e-46
Identities = 77/276 (27%), Positives = 122/276 (44%), Gaps = 29/276 (10%)
Query: 634 GQGGYGKVYKGILSD----NTTVAIKRAEEGSLQGQ-NEFLTEIKLLSRLHHRNLVSLLG 688
G+G +G V++GI VAIK + + +FL E + + H ++V L+G
Sbjct: 24 GEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIG 83
Query: 689 YCDEEGEQMLVYEFVPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVF 748
E ++ E G LR +L R K +L+ A + A + + YL E+ V
Sbjct: 84 VITEN-PVWIIMELCTLGELRSFLQVR-KYSLDLASLILYAYQLSTALAYL--ESKRFV- 138
Query: 749 HRDIKASNILLDSNLNAKVADFGLSRLAPVLDDEGTMPTHVSTI-VKGTPGYLDPEYFLT 807
HRDI A N+L+ SN K+ DFGLSR ++D + +K PE
Sbjct: 139 HRDIAARNVLVSSNDCVKLGDFGLSR---YMEDSTYYKASKGKLPIKWMA----PESINF 191
Query: 808 HKLTDKSDVYSLGVVLLELLT-GMQPISHGKNIVREVNVARDSGMVFSIIDNRMGSYPSE 866
+ T SDV+ GV + E+L G++P KN +V ++G R+ P
Sbjct: 192 RRFTSASDVWMFGVCMWEILMHGVKPFQGVKN--NDVIGRIENG-------ERLPM-PPN 241
Query: 867 CVERFVTLALRCCHDKPEHRPSMSDVVRELENILKM 902
C +L +C P RP +++ +L IL+
Sbjct: 242 CPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEE 277
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 175 bits (445), Expect = 8e-46
Identities = 68/317 (21%), Positives = 115/317 (36%), Gaps = 17/317 (5%)
Query: 87 HVRELQLLSMNLSGNLAPELGQLSRLQY-YFMWNDLTGTIPKEIGNISSLIFLLLNGNKL 145
++ L L L A + S+L +N ++ P+ + L L L N+L
Sbjct: 26 NITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTISKLEPELCQKLPMLKVLNLQHNEL 85
Query: 146 SGSLPDELGYLSNLNRLQVDENNITGTIPKSFANLSRVRHLHLNNNSIGGQIPSELSKLS 205
S + +NL L + N+I F + L L++N + +L
Sbjct: 86 SQLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQKNLITLDLSHNGLSSTKLGTQVQLE 145
Query: 206 TLIHLLVDNNNLSGNLPPELS--ELPQLCILQLDNNNFSASEIPATYGNFSKLVKLSLRN 263
L LL+ NN + EL L L+L +N P + +L L L N
Sbjct: 146 NLQELLLSNNKIQALKSEELDIFANSSLKKLELSSNQIK-EFSPGCFHAIGRLFGLFLNN 204
Query: 264 CNLQGAVPD----LSRIPNLYYLDLSWNHLTGSIPS--KKLSE-NVTTIDLSDNYLNGSI 316
L ++ + ++ L LS + L+ + + L N+T +DLS N LN
Sbjct: 205 VQLGPSLTEKLCLELANTSIRNLSLSNSQLSTTSNTTFLGLKWTNLTMLDLSYNNLNVVG 264
Query: 317 LESISNLPFLQTLSLENNFLTGSIPATIWQNKSFST----KARLKIDLRNNSFSNIVGDL 372
+S + LP L+ LE N + ++ + ++ K + S I
Sbjct: 265 NDSFAWLPQLEYFFLEYNNIQHLFSHSLHGLFNVRYLNLKRSFTKQSISLASLPKIDDFS 324
Query: 373 --TLPNNVTLRLGGNPI 387
L L + N I
Sbjct: 325 FQWLKCLEHLNMEDNDI 341
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 161 bits (409), Expect = 3e-41
Identities = 70/327 (21%), Positives = 111/327 (33%), Gaps = 38/327 (11%)
Query: 92 QLLSMNLSGN----LAPE-LGQLSRLQY-YFMWNDLTGTIPKEIGNISSLIFLLLNGNKL 145
L +NL N L+ + + L + M N + +LI L L+ N L
Sbjct: 74 MLKVLNLQHNELSQLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQKNLITLDLSHNGL 133
Query: 146 SGSLPDELGYLSNLNRLQVDENNITGTIPKSFA--NLSRVRHLHLNNNSIGGQIPSELSK 203
S + L NL L + N I + S ++ L L++N I P
Sbjct: 134 SSTKLGTQVQLENLQELLLSNNKIQALKSEELDIFANSSLKKLELSSNQIKEFSPGCFHA 193
Query: 204 LSTLIHLLVDNNNLSGNLPPELSE---LPQLCILQLDNNNFSASEIPATYGN--FSKLVK 258
+ L L ++N L +L +L + L L N+ S + T+ ++ L
Sbjct: 194 IGRLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQLS-TTSNTTFLGLKWTNLTM 252
Query: 259 LSLRNCNLQGAVPD-LSRIPNLYYLDLSWNHLTGSIPSK----------KLSENVTTIDL 307
L L NL D + +P L Y L +N++ L + T +
Sbjct: 253 LDLSYNNLNVVGNDSFAWLPQLEYFFLEYNNIQHLFSHSLHGLFNVRYLNLKRSFTKQSI 312
Query: 308 SDNYLNGSILESISNLPFLQTLSLENNFLTGSIPATIWQNKSFSTKARLK-IDLRNNSFS 366
S L S L L+ L++E+N + G + LK + L N+ S
Sbjct: 313 SLASLPKIDDFSFQWLKCLEHLNMEDNDIPGIKSNMFTGLIN------LKYLSLSNSFTS 366
Query: 367 ------NIVGDLTLPNNVTLRLGGNPI 387
L L L N I
Sbjct: 367 LRTLTNETFVSLAHSPLHILNLTKNKI 393
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 161 bits (409), Expect = 3e-41
Identities = 63/328 (19%), Positives = 114/328 (34%), Gaps = 28/328 (8%)
Query: 89 RELQLLSMNLSGNLAPELGQLSRLQY-YFMWNDLTGTIPKEIGNISSLIFLLLNGNKLSG 147
+ + +L L L++ ND+ G + +L +L L+ + S
Sbjct: 308 TKQSISLASLPKIDDFSFQWLKCLEHLNMEDNDIPGIKSNMFTGLINLKYLSLSNSFTSL 367
Query: 148 SLPDELG----YLSNLNRLQVDENNITGTIPKSFANLSRVRHLHLNNNSIGGQIP-SELS 202
S L+ L + +N I+ +F+ L + L L N IG ++ E
Sbjct: 368 RTLTNETFVSLAHSPLHILNLTKNKISKIESDAFSWLGHLEVLDLGLNEIGQELTGQEWR 427
Query: 203 KLSTLIHLLVDNNNLSGNLPPELSELPQLCILQLDNNNFSA-SEIPATYGNFSKLVKLSL 261
L + + + N + +P L L L P+ + L L L
Sbjct: 428 GLENIFEIYLSYNKYLQLTRNSFALVPSLQRLMLRRVALKNVDSSPSPFQPLRNLTILDL 487
Query: 262 RNCNLQGAVPD-LSRIPNLYYLDLSWNHLTGSIPSKKLSE---------NVTTIDLSDNY 311
N N+ D L + L LDL N+L ++ ++L N
Sbjct: 488 SNNNIANINDDMLEGLEKLEILDLQHNNLARLWKHANPGGPIYFLKGLSHLHILNLESNG 547
Query: 312 LNGSILESISNLPFLQTLSLENNFLTGSIPATIWQNKSFSTKARLK-IDLRNNSFSNIVG 370
+ +E +L L+ + L N L + F+ + LK ++L+ N +++
Sbjct: 548 FDEIPVEVFKDLFELKIIDLGLNNLNTLPASV------FNNQVSLKSLNLQKNLITSVEK 601
Query: 371 DL---TLPNNVTLRLGGNPI-CTSANIP 394
+ N L + NP CT +I
Sbjct: 602 KVFGPAFRNLTELDMRFNPFDCTCESIA 629
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 160 bits (408), Expect = 4e-41
Identities = 60/281 (21%), Positives = 105/281 (37%), Gaps = 18/281 (6%)
Query: 117 MWNDLTGTIPKEIGNISSLIFLLLNGNKLSGSLPDELGYLSNLNRLQVDENNITGTIPKS 176
LT +P ++ +++ L L N+L S L L V N I+ P+
Sbjct: 12 SHLKLT-QVPDDLP--TNITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTISKLEPEL 68
Query: 177 FANLSRVRHLHLNNNSIGGQIPSELSKLSTLIHLLVDNNNLSGNLPPELSELPQLCILQL 236
L ++ L+L +N + + + L L + +N++ + L L L
Sbjct: 69 CQKLPMLKVLNLQHNELSQLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQKNLITLDL 128
Query: 237 DNNNFSASEIPATYGNFSKLVKLSLRNCNLQGAVPDLSRI---PNLYYLDLSWNHLTGSI 293
+N S S T L +L L N +Q + I +L L+LS N +
Sbjct: 129 SHNGLS-STKLGTQVQLENLQELLLSNNKIQALKSEELDIFANSSLKKLELSSNQIKEFS 187
Query: 294 PS--KKLSENVTTIDLSDNYLNGSILESIS---NLPFLQTLSLENNFLTGSIPATIWQNK 348
P + + + L++ L S+ E + ++ LSL N+ L+ + T K
Sbjct: 188 PGCFHAIG-RLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQLSTTSNTTFLGLK 246
Query: 349 SFSTKARLKIDLRNNSFSNIVGDL--TLPNNVTLRLGGNPI 387
+ +DL N+ + + D LP L N I
Sbjct: 247 WTNLT---MLDLSYNNLNVVGNDSFAWLPQLEYFFLEYNNI 284
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 156 bits (397), Expect = 9e-40
Identities = 75/325 (23%), Positives = 120/325 (36%), Gaps = 28/325 (8%)
Query: 87 HVRELQLLSMNLSGNLAPELG---QLSRLQY-YFMWNDLTGTIPKEIGN--ISSLIFLLL 140
+ L L ++ L +L +L + ++ + L+ T ++L L L
Sbjct: 196 RLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQLSTTSNTTFLGLKWTNLTMLDL 255
Query: 141 NGNKLSGSLPDELGYLSNLNRLQVDENNITGTIPKSFANLSRVRHLHLNNN--------- 191
+ N L+ D +L L ++ NNI S L VR+L+L +
Sbjct: 256 SYNNLNVVGNDSFAWLPQLEYFFLEYNNIQHLFSHSLHGLFNVRYLNLKRSFTKQSISLA 315
Query: 192 SIGGQIPSELSKLSTLIHLLVDNNNLSGNLPPELSELPQLCILQLDNNNFSASEIPA--- 248
S+ L L HL +++N++ G + L L L L N+ S +
Sbjct: 316 SLPKIDDFSFQWLKCLEHLNMEDNDIPGIKSNMFTGLINLKYLSLSNSFTSLRTLTNETF 375
Query: 249 TYGNFSKLVKLSLRNCNLQGAVPD-LSRIPNLYYLDLSWNHLTGSIPSKKLS--ENVTTI 305
S L L+L + D S + +L LDL N + + ++ EN+ I
Sbjct: 376 VSLAHSPLHILNLTKNKISKIESDAFSWLGHLEVLDLGLNEIGQELTGQEWRGLENIFEI 435
Query: 306 DLSDNYLNGSILESISNLPFLQTLSLENNFLTGSIPATIWQNKSFSTKARLKI-DLRNNS 364
LS N S + +P LQ L L L + F L I DL NN+
Sbjct: 436 YLSYNKYLQLTRNSFALVPSLQRLMLRRVALKNVDSSP----SPFQPLRNLTILDLSNNN 491
Query: 365 FSNIVGDL--TLPNNVTLRLGGNPI 387
+NI D+ L L L N +
Sbjct: 492 IANINDDMLEGLEKLEILDLQHNNL 516
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 143 bits (362), Expect = 2e-35
Identities = 52/278 (18%), Positives = 90/278 (32%), Gaps = 25/278 (8%)
Query: 92 QLLSMNLSGNL---------APELGQLSRLQY-YFMWNDLTGTIPKEIGNISSLIFLLLN 141
L ++LS + S L N ++ + L L L
Sbjct: 354 NLKYLSLSNSFTSLRTLTNETFVSLAHSPLHILNLTKNKISKIESDAFSWLGHLEVLDLG 413
Query: 142 GNKLSGSLP-DELGYLSNLNRLQVDENNITGTIPKSFANLSRVRHLHLNNNSIGG--QIP 198
N++ L E L N+ + + N SFA + ++ L L ++ P
Sbjct: 414 LNEIGQELTGQEWRGLENIFEIYLSYNKYLQLTRNSFALVPSLQRLMLRRVALKNVDSSP 473
Query: 199 SELSKLSTLIHLLVDNNNLSGNLPPELSELPQLCILQLDNNNFS-------ASEIPATYG 251
S L L L + NNN++ L L +L IL L +NN +
Sbjct: 474 SPFQPLRNLTILDLSNNNIANINDDMLEGLEKLEILDLQHNNLARLWKHANPGGPIYFLK 533
Query: 252 NFSKLVKLSLRNCNLQGAVPD-LSRIPNLYYLDLSWNHLTGSIPS--KKLSENVTTIDLS 308
S L L+L + + + L +DL N+L S ++ +++L
Sbjct: 534 GLSHLHILNLESNGFDEIPVEVFKDLFELKIIDLGLNNLNTLPASVFNNQV-SLKSLNLQ 592
Query: 309 DNYLNGSILESIS-NLPFLQTLSLENNFLTGSIPATIW 345
N + + L L + N + + W
Sbjct: 593 KNLITSVEKKVFGPAFRNLTELDMRFNPFDCTCESIAW 630
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 1e-31
Identities = 51/257 (19%), Positives = 95/257 (36%), Gaps = 21/257 (8%)
Query: 94 LSMN-LSGNLAPELGQLSRLQY-YFMWNDLTGTIP-KEIGNISSLIFLLLNGNKLSGSLP 150
L+ N +S + L L+ N++ + +E + ++ + L+ NK
Sbjct: 388 LTKNKISKIESDAFSWLGHLEVLDLGLNEIGQELTGQEWRGLENIFEIYLSYNKYLQLTR 447
Query: 151 DELGYLSNLNRLQVDENNITG--TIPKSFANLSRVRHLHLNNNSIGGQIPSELSKLSTLI 208
+ + +L RL + + + P F L + L L+NN+I L L L
Sbjct: 448 NSFALVPSLQRLMLRRVALKNVDSSPSPFQPLRNLTILDLSNNNIANINDDMLEGLEKLE 507
Query: 209 HLLVDNNNLS--------GNLPPELSELPQLCILQLDNNNFSASEIPATYGNFSKLVKLS 260
L + +NNL+ G L L L IL L++N F + + +L +
Sbjct: 508 ILDLQHNNLARLWKHANPGGPIYFLKGLSHLHILNLESNGFD-EIPVEVFKDLFELKIID 566
Query: 261 LRNCNLQGAVPD-LSRIPNLYYLDLSWNHLTGSIPS--KKLSENVTTIDLSDNYLNGSIL 317
L NL + +L L+L N +T N+T +D+ N +
Sbjct: 567 LGLNNLNTLPASVFNNQVSLKSLNLQKNLITSVEKKVFGPAFRNLTELDMRFNPFDC--- 623
Query: 318 ESISNLPFLQTLSLENN 334
+ ++ + E +
Sbjct: 624 -TCESIAWFVNWINETH 639
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 99.3 bits (248), Expect = 2e-21
Identities = 45/238 (18%), Positives = 74/238 (31%), Gaps = 21/238 (8%)
Query: 92 QLLSMNLSGN----LAPE-LGQLSRLQY-YFMWNDLTG--TIPKEIGNISSLIFLLLNGN 143
+ + LS N L + LQ L + P + +L L L+ N
Sbjct: 431 NIFEIYLSYNKYLQLTRNSFALVPSLQRLMLRRVALKNVDSSPSPFQPLRNLTILDLSNN 490
Query: 144 KLSGSLPDELGYLSNLNRLQVDENNIT--------GTIPKSFANLSRVRHLHLNNNSIGG 195
++ D L L L L + NN+ G LS + L+L +N
Sbjct: 491 NIANINDDMLEGLEKLEILDLQHNNLARLWKHANPGGPIYFLKGLSHLHILNLESNGFDE 550
Query: 196 QIPSELSKLSTLIHLLVDNNNLSGNLPPELSELPQLCILQLDNNNFSASEIPATYGNFSK 255
L L + + NNL+ + L L L N ++ E F
Sbjct: 551 IPVEVFKDLFELKIIDLGLNNLNTLPASVFNNQVSLKSLNLQKNLITSVEKKVFGPAFRN 610
Query: 256 LVKLSLRNCNLQG---AVPDLSRIPNLYYLDLS--WNHLTGSIPSKKLSENVTTIDLS 308
L +L +R ++ N + ++ +H + P V D S
Sbjct: 611 LTELDMRFNPFDCTCESIAWFVNWINETHTNIPELSSHYLCNTPPHYHGFPVRLFDTS 668
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 80.8 bits (200), Expect = 9e-16
Identities = 31/179 (17%), Positives = 51/179 (28%), Gaps = 17/179 (9%)
Query: 92 QLLSMNLSGNLAPELGQLSRLQYYFMWNDLTGTIPKEIGNISSLIFLLLNGNKLSGSLPD 151
+L ++L N L+RL + G + +S L L L N +
Sbjct: 505 KLEILDLQHN------NLARLWK----HANPGGPIYFLKGLSHLHILNLESNGFDEIPVE 554
Query: 152 ELGYLSNLNRLQVDENNITGTIPKSFANLSRVRHLHLNNNSIGGQIPSELSK-LSTLIHL 210
L L + + NN+ F N ++ L+L N I L L
Sbjct: 555 VFKDLFELKIIDLGLNNLNTLPASVFNNQVSLKSLNLQKNLITSVEKKVFGPAFRNLTEL 614
Query: 211 LVDNNNLSGNLPPELSELPQLCILQLDNNNFSASEI----PATYGNFSKLVKLSLRNCN 265
+ N ++ N +S P Y F + +C
Sbjct: 615 DMRFNPFDCT-CESIAWFVNWINETHTNIPELSSHYLCNTPPHYHGFP-VRLFDTSSCK 671
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 66.2 bits (162), Expect = 3e-11
Identities = 23/112 (20%), Positives = 41/112 (36%), Gaps = 9/112 (8%)
Query: 278 NLYYLDLSWNHLTGSIPSKKLSENVTTIDLSDNYLNGSILESISNLPFLQTLSLENNFLT 337
+ D S LT +P L N+T ++L+ N L + + L +L + N ++
Sbjct: 5 SHEVADCSHLKLT-QVPD-DLPTNITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTIS 62
Query: 338 GSIPATIWQNKSFSTKARLKIDLRNNSFSNIVGDL--TLPNNVTLRLGGNPI 387
P + ++L++N S + N L L N I
Sbjct: 63 KLEPELCQKLPMLKV-----LNLQHNELSQLSDKTFAFCTNLTELHLMSNSI 109
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 168 bits (427), Expect = 9e-46
Identities = 88/308 (28%), Positives = 138/308 (44%), Gaps = 29/308 (9%)
Query: 634 GQGGYGKVYKGIL----SDNTTVAIKRAEEGSLQGQ-NEFLTEIKLLSRLHHRNLVSLLG 688
G G +G+V G L +VAIK + G + Q +FL E ++ + H N++ L G
Sbjct: 54 GAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEG 113
Query: 689 YCDEEGEQMLVYEFVPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVF 748
+ M+V E++ NG+L +L + + A G+ YL V
Sbjct: 114 VVTKSKPVMIVTEYMENGSLDSFLRKH-DAQFTVIQLVGMLRGIASGMKYL--SDMGYV- 169
Query: 749 HRDIKASNILLDSNLNAKVADFGLSRLAPVLDDEGTMPTHVSTI--VKGTPGYLDPEYFL 806
HRD+ A NIL++SNL KV+DFGL R+ + DD T ++ T PE
Sbjct: 170 HRDLAARNILINSNLVCKVSDFGLGRV--LEDDPEAAYTTRGGKIPIRWTS----PEAIA 223
Query: 807 THKLTDKSDVYSLGVVLLELLT-GMQPISHGKNIVREVNVARDSGMVFSIIDNRMGSYPS 865
K T SDV+S G+VL E+++ G +P N ++V A D G R+ P
Sbjct: 224 YRKFTSASDVWSYGIVLWEVMSYGERPYWEMSN--QDVIKAVDEG-------YRLPP-PM 273
Query: 866 ECVERFVTLALRCCHDKPEHRPSMSDVVRELENILKMFPETDTMFSK-SESSSLLSGKSA 924
+C L L C +RP +V L+ +++ + S + S+LL +S
Sbjct: 274 DCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRNPGSLKIITSAAARPSNLLLDQSN 333
Query: 925 STSSSFLT 932
++F T
Sbjct: 334 VDITTFRT 341
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 166 bits (422), Expect = 1e-45
Identities = 81/337 (24%), Positives = 136/337 (40%), Gaps = 47/337 (13%)
Query: 634 GQGGYGKVYKGILSD-----NTTVAIKRAEEGSLQGQN-EFLTEIKLLSRLHHRNLVSLL 687
G G +G VYKG+ VAIK E + N E L E +++ + + ++ LL
Sbjct: 24 GSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLL 83
Query: 688 GYCDEEGEQMLVYEFVPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPV 747
G C L+ + +P G L D++ K+N+ L + AKG+ YL E V
Sbjct: 84 GICLTS-TVQLITQLMPFGCLLDYVREH-KDNIGSQYLLNWCVQIAKGMNYL--EDRRLV 139
Query: 748 FHRDIKASNILLDSNLNAKVADFGLSRLAPVLDDE-----GTMPTHVSTIVKGTPGYLDP 802
HRD+ A N+L+ + + K+ DFGL++L + E G +P +K
Sbjct: 140 -HRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVP------IKWMA----L 188
Query: 803 EYFLTHKLTDKSDVYSLGVVLLELLT-GMQPISHGKNIVREVNVARDSGMVFSIIDNRMG 861
E L T +SDV+S GV + EL+T G +P E++ + G R+
Sbjct: 189 ESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPA--SEISSILEKG-------ERLP 239
Query: 862 SYPSECVERFVTLALRCCHDKPEHRPSMSDVVRELENILKMFPETDTMFSKSESSSLLSG 921
P C + ++C + RP +++ E M + ++ G
Sbjct: 240 Q-PPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSK----------MARDPQRYLVIQG 288
Query: 922 KSASTSSSFLTRDPYASSSNVSGSDLISGAVPSISPR 958
S + Y + + D + A + P+
Sbjct: 289 DERMHLPSPTDSNFYRALMDEEDMDDVVDADEYLIPQ 325
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 166 bits (422), Expect = 1e-45
Identities = 78/311 (25%), Positives = 133/311 (42%), Gaps = 51/311 (16%)
Query: 632 QVGQGGYGKVYKGILSD------NTTVAIKRAEEG-SLQGQNEFLTEIKLLSRLHHRNLV 684
++GQG +G VY+G+ T VAIK E S++ + EFL E ++ + ++V
Sbjct: 32 ELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVV 91
Query: 685 SLLGYCDEEGEQMLVYEFVPNGTLRDWL--------SGRTKENLNFAMRLRVALDSAKGI 736
LLG + +++ E + G L+ +L + + + +++A + A G+
Sbjct: 92 RLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGM 151
Query: 737 LYLHTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSRLAPVLDDE-------GTMPTHV 789
YL A+ V HRD+ A N ++ + K+ DFG++R + + + G +P
Sbjct: 152 AYL--NANKFV-HRDLAARNCMVAEDFTVKIGDFGMTR--DIYETDYYRKGGKGLLP--- 203
Query: 790 STIVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVLLELLT-GMQPISHGKNIVREVNVARD 848
V+ PE T SDV+S GVVL E+ T QP N +V
Sbjct: 204 ---VRWMS----PESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSN--EQVLRFVM 254
Query: 849 SGMVFSIIDNRMGSYPSECVERFVTLALRCCHDKPEHRPSMSDVVRELENILK-MFPETD 907
G + P C + L C P+ RPS +++ ++ ++ F E
Sbjct: 255 EG-------GLL-DKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPGFREVS 306
Query: 908 TMFSKSESSSL 918
F SE + L
Sbjct: 307 --FYYSEENKL 315
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 165 bits (421), Expect = 2e-45
Identities = 91/303 (30%), Positives = 147/303 (48%), Gaps = 32/303 (10%)
Query: 634 GQGGYGKVYKGIL-----SDNTTVAIKRAEEG-SLQGQNEFLTEIKLLSRLHHRNLVSLL 687
G G +G+VYKG+L VAIK + G + + + +FL E ++ + H N++ L
Sbjct: 53 GAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLE 112
Query: 688 GYCDEEGEQMLVYEFVPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPV 747
G + M++ E++ NG L +L + + + + A G+ YL V
Sbjct: 113 GVISKYKPMMIITEYMENGALDKFLREK-DGEFSVLQLVGMLRGIAAGMKYL--ANMNYV 169
Query: 748 FHRDIKASNILLDSNLNAKVADFGLSRLAPVLDD-EGTMPTHVSTI-VKGTPGYLDPEYF 805
HRD+ A NIL++SNL KV+DFGLSR+ + DD E T T I ++ T PE
Sbjct: 170 -HRDLAARNILVNSNLVCKVSDFGLSRV--LEDDPEATYTTSGGKIPIRWTA----PEAI 222
Query: 806 LTHKLTDKSDVYSLGVVLLELLT-GMQPISHGKNIVREVNVARDSGMVFSIIDNRMGSYP 864
K T SDV+S G+V+ E++T G +P N EV A + G R+ + P
Sbjct: 223 SYRKFTSASDVWSFGIVMWEVMTYGERPYWELSN--HEVMKAINDG-------FRLPT-P 272
Query: 865 SECVERFVTLALRCCHDKPEHRPSMSDVVRELENILKMFPETDTMFSKSESSSLLSGKSA 924
+C L ++C + RP +D+V L+ K+ D++ + ++ +S +
Sbjct: 273 MDCPSAIYQLMMQCWQQERARRPKFADIVSILD---KLIRAPDSLKTLADFDPRVSIRLP 329
Query: 925 STS 927
STS
Sbjct: 330 STS 332
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 164 bits (418), Expect = 2e-45
Identities = 75/283 (26%), Positives = 113/283 (39%), Gaps = 35/283 (12%)
Query: 634 GQGGYGKVYKGIL----SDNTTVAIKRAEEGSLQGQN---EFLTEIKLLSRLHHRNLVSL 686
G G +G V +G +VA+K + L +F+ E+ + L HRNL+ L
Sbjct: 27 GDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRL 86
Query: 687 LGYCDEEGEQMLVYEFVPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPP 746
G +V E P G+L D L + + R A+ A+G+ YL E+
Sbjct: 87 YGVVLTPP-MKMVTELAPLGSLLDRLRKH-QGHFLLGTLSRYAVQVAEGMGYL--ESKRF 142
Query: 747 VFHRDIKASNILLDSNLNAKVADFGLSRLAPVLDDEGTMPTHVSTIVKGTPGYLDPEYFL 806
+ HRD+ A N+LL + K+ DFGL R P DD M H PE
Sbjct: 143 I-HRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCA----PESLK 197
Query: 807 THKLTDKSDVYSLGVVLLELLT-GMQPISHGKNIVREVNVARDSGMVFSIIDN---RMGS 862
T + SD + GV L E+ T G +P + + ID R+
Sbjct: 198 TRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNG--SQ---------ILHKIDKEGERLPR 246
Query: 863 YPSECVERFVTLALRCCHDKPEHRPSMSDVVRELENILKMFPE 905
P +C + + ++C KPE RP+ + L + P
Sbjct: 247 -PEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLL---EAQPT 285
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 165 bits (420), Expect = 2e-45
Identities = 80/299 (26%), Positives = 124/299 (41%), Gaps = 49/299 (16%)
Query: 634 GQGGYGKVYKGILSDN----TTVAIK--RAEEGSLQGQNEFLTEIKLLSRLHHRNLVSLL 687
G+G +G V + L VA+K +A+ + EFL E + H ++ L+
Sbjct: 32 GKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLV 91
Query: 688 GYCDEEGEQ------MLVYEFVPNGTLRDWL----SGRTKENLNFAMRLRVALDSAKGIL 737
G + M++ F+ +G L +L G NL +R +D A G+
Sbjct: 92 GVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGME 151
Query: 738 YLHTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSRLAPVLDDE-------GTMPTHVS 790
YL + + HRD+ A N +L ++ VADFGLSR + + +P
Sbjct: 152 YL--SSRNFI-HRDLAARNCMLAEDMTVCVADFGLSRK--IYSGDYYRQGCASKLP---- 202
Query: 791 TIVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVLLELLT-GMQPISHGKNIVREVNVARDS 849
VK E + T SDV++ GV + E++T G P + +N E+
Sbjct: 203 --VKWLA----LESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIEN--AEIYNYLIG 254
Query: 850 GMVFSIIDNRMGSYPSECVERFVTLALRCCHDKPEHRPSMSDVVRELENILKMFPETDT 908
G NR+ P EC+E L +C P+ RPS + + ELENIL T
Sbjct: 255 G-------NRL-KQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHLSVLST 305
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 165 bits (420), Expect = 2e-45
Identities = 80/296 (27%), Positives = 121/296 (40%), Gaps = 54/296 (18%)
Query: 634 GQGGYGKVYKGIL------SDNTTVAIKRAEEGSLQGQNEFLTEIKLLSRLHHRNLVSLL 687
G+G +GKV+ D VA+K +E S + +F E +LL+ L H+++V
Sbjct: 50 GEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFF 109
Query: 688 GYCDEEGEQMLVYEFVPNGTLRDWLSGR-------------TKENLNFAMRLRVALDSAK 734
G C E ++V+E++ +G L +L L L VA A
Sbjct: 110 GVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAA 169
Query: 735 GILYLHTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSRLAPVLD-----DEGTMPTHV 789
G++YL V HRD+ N L+ L K+ DFG+SR D +P
Sbjct: 170 GMVYL--AGLHFV-HRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLP--- 223
Query: 790 STIVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVLLELLT-GMQP---ISHGKNIVREVNV 845
++ P PE L K T +SDV+S GVVL E+ T G QP +S+ E
Sbjct: 224 ---IRWMP----PESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSN-----TEAID 271
Query: 846 ARDSGMVFSIIDNRMGSYPSECVERFVTLALRCCHDKPEHRPSMSDVVRELENILK 901
G + P C + C +P+ R S+ DV L+ + +
Sbjct: 272 CITQG-------REL-ERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQ 319
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 166 bits (422), Expect = 3e-45
Identities = 86/283 (30%), Positives = 128/283 (45%), Gaps = 26/283 (9%)
Query: 633 VGQGGYGKVYKGILSDN----TTVAIKRAEEG-SLQGQNEFLTEIKLLSRLHHRNLVSLL 687
+G+G +G VY G L DN A+K + ++FLTE ++ H N++SLL
Sbjct: 97 IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 156
Query: 688 GYC-DEEGEQMLVYEFVPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPP 746
G C EG ++V ++ +G LR+++ N + L AKG+ +L +
Sbjct: 157 GICLRSEGSPLVVLPYMKHGDLRNFIRNE-THNPTVKDLIGFGLQVAKGMKFL--ASKKF 213
Query: 747 VFHRDIKASNILLDSNLNAKVADFGLSRLAPVLDDEGTMPTHVSTI-VKGTPGYLDPEYF 805
V HRD+ A N +LD KVADFGL+R + + + + VK E
Sbjct: 214 V-HRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMA----LESL 268
Query: 806 LTHKLTDKSDVYSLGVVLLELLT-GMQPISHGKNIVREVNVARDSGMVFSIIDNRMGSYP 864
T K T KSDV+S GV+L EL+T G P ++ V G R+ P
Sbjct: 269 QTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNT--FDITVYLLQG-------RRL-LQP 318
Query: 865 SECVERFVTLALRCCHDKPEHRPSMSDVVRELENILKMFPETD 907
C + + L+C H K E RPS S++V + I F
Sbjct: 319 EYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIGEH 361
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 164 bits (417), Expect = 6e-45
Identities = 86/319 (26%), Positives = 137/319 (42%), Gaps = 49/319 (15%)
Query: 634 GQGGYGKVYKGILSDN---TTVAIKRAEEG-SLQGQNEFLTEIKLLSRL-HHRNLVSLLG 688
G+G +G+V K + + AIKR +E S +F E+++L +L HH N+++LLG
Sbjct: 34 GEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLG 93
Query: 689 YCDEEGEQMLVYEFVPNGTLRDWL--------------SGRTKENLNFAMRLRVALDSAK 734
C+ G L E+ P+G L D+L + T L+ L A D A+
Sbjct: 94 ACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVAR 153
Query: 735 GILYLHTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSRLAPVLDDEGTMPTHVSTI-V 793
G+ YL + HRD+ A NIL+ N AK+ADFGLSR E + + + V
Sbjct: 154 GMDYL--SQKQFI-HRDLAARNILVGENYVAKIADFGLSR-----GQEVYVKKTMGRLPV 205
Query: 794 KGTPGYLDPEYFLTHKLTDKSDVYSLGVVLLELLT-GMQP---ISHGKNIVREVNVARDS 849
+ E T SDV+S GV+L E+++ G P ++ E+
Sbjct: 206 RWMA----IESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTC-----AELYEKLPQ 256
Query: 850 GMVFSIIDNRMGSYPSECVERFVTLALRCCHDKPEHRPSMSDVVRELENILKMFPETDTM 909
G R+ P C + L +C +KP RPS + ++ L +L+
Sbjct: 257 G-------YRLEK-PLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERKTYVNT 308
Query: 910 FSKSESSSLLSGKSASTSS 928
+ + SA ++
Sbjct: 309 TLYEKFTYAGIDCSAEEAA 327
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 162 bits (413), Expect = 7e-45
Identities = 68/286 (23%), Positives = 116/286 (40%), Gaps = 47/286 (16%)
Query: 634 GQGGYGKVYKGIL--------SDNTTVAIKRAEEGSLQGQNEFLTEIKLLSRLHHRNLVS 685
GQG + K++KG+ T V +K ++ F ++S+L H++LV
Sbjct: 17 GQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVL 76
Query: 686 LLGYCDEEGEQMLVYEFVPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHP 745
G C E +LV EFV G+L +L K +N +L VA A + +L E +
Sbjct: 77 NYGVCVCGDENILVQEFVKFGSLDTYLKKN-KNCINILWKLEVAKQLAAAMHFL--EENT 133
Query: 746 PVFHRDIKASNILLDS--------NLNAKVADFGLSRLAPVLDDEGT-MPTHVSTIVKGT 796
+ H ++ A NILL K++D G+S VL + +
Sbjct: 134 LI-HGNVCAKNILLIREEDRKTGNPPFIKLSDPGISIT--VLPKDILQER------IPWV 184
Query: 797 PGYLDPEYFLTHKL-TDKSDVYSLGVVLLELLT-GMQPISHGKNIVREVNVARDSGMVFS 854
P PE K +D +S G L E+ + G +P+S + + +
Sbjct: 185 P----PECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDS--QRKLQFYEDR---- 234
Query: 855 IIDNRMGSYPSECVERFVTLALRCCHDKPEHRPSMSDVVRELENIL 900
+++ P+ L C +P+HRPS ++R+L ++
Sbjct: 235 ---HQL---PAPKAAELANLINNCMDYEPDHRPSFRAIIRDLNSLF 274
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 162 bits (412), Expect = 2e-44
Identities = 78/303 (25%), Positives = 128/303 (42%), Gaps = 28/303 (9%)
Query: 634 GQGGYGKVYKGILSD-----NTTVAIKRAEEGSLQGQN-EFLTEIKLLSRLHHRNLVSLL 687
G G +G V+KG+ V IK E+ S + + + L H ++V LL
Sbjct: 22 GSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLL 81
Query: 688 GYCDEEGEQMLVYEFVPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPV 747
G C LV +++P G+L D + + L + L + AKG+ YL E H V
Sbjct: 82 GLCPGS-SLQLVTQYLPLGSLLDHVRQH-RGALGPQLLLNWGVQIAKGMYYL--EEHGMV 137
Query: 748 FHRDIKASNILLDSNLNAKVADFGLSRLAPVLDDEGTMPTHVSTIVKGTPGYLDPEYFLT 807
HR++ A N+LL S +VADFG++ L P DD+ + + T +K E
Sbjct: 138 -HRNLAARNVLLKSPSQVQVADFGVADLLPP-DDKQLLYSEAKTPIKWMA----LESIHF 191
Query: 808 HKLTDKSDVYSLGVVLLELLT-GMQPISHGKNIVREVNVARDSGMVFSIIDNRMGSYPSE 866
K T +SDV+S GV + EL+T G +P + + EV + G R+ P
Sbjct: 192 GKYTHQSDVWSYGVTVWELMTFGAEPYAGLRL--AEVPDLLEKG-------ERLAQ-PQI 241
Query: 867 CVERFVTLALRCCHDKPEHRPSMSDVVRELENILKMFPETDTMFSKSESSSLLSGKSAST 926
C + ++C RP+ ++ E + + P + + + G
Sbjct: 242 CTIDVYMVMVKCWMIDENIRPTFKELANEFTRMARDPPRYLVI-KRESGPGIAPGPEPHG 300
Query: 927 SSS 929
++
Sbjct: 301 LTN 303
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 161 bits (409), Expect = 2e-44
Identities = 78/291 (26%), Positives = 124/291 (42%), Gaps = 48/291 (16%)
Query: 632 QVGQGGYGKVYKGI-LSDNTTVAIKRAEEGSLQGQNEFLTEIKLLSRLHHRNLVSLLGYC 690
+G GG+G+V+K D T IKR + + + + E +K L++L H N+V G
Sbjct: 18 LIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKAERE----VKALAKLDHVNIVHYNGCW 73
Query: 691 DEEGEQM----------------LVYEFVPNGTLRDWLSGRTKENLNFAMRLRVALDSAK 734
D + EF GTL W+ R E L+ + L + K
Sbjct: 74 DGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITK 133
Query: 735 GILYLHTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSRLAPVLDDEGTMPTHVSTIVK 794
G+ Y+H++ + +RD+K SNI L K+ DFGL L ++G
Sbjct: 134 GVDYIHSKK---LINRDLKPSNIFLVDTKQVKIGDFGLVT---SLKNDGKRTRSK----- 182
Query: 795 GTPGYLDPEYFLTHKLTDKSDVYSLGVVLLELLTGMQPISHGKNIVREVNVARDSGMVFS 854
GT Y+ PE + + D+Y+LG++L ELL A ++ F+
Sbjct: 183 GTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDT-------------AFETSKFFT 229
Query: 855 IIDNRMGSYPSECVERFVTLALRCCHDKPEHRPSMSDVVRELENILKMFPE 905
+ R G ++ TL + KPE RP+ S+++R L + K PE
Sbjct: 230 DL--RDGIISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLT-VWKKSPE 277
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 169 bits (429), Expect = 3e-44
Identities = 77/276 (27%), Positives = 120/276 (43%), Gaps = 24/276 (8%)
Query: 631 TQVGQGGYGKVYKGIL---SDNTTVAIKRAEEGSLQGQ-NEFLTEIKLLSRLHHRNLVSL 686
++G G +G V +G+ VAIK ++G+ + E + E +++ +L + +V L
Sbjct: 342 IELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRL 401
Query: 687 LGYCDEEGEQMLVYEFVPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPP 746
+G C E MLV E G L +L G+ +E + + + + G+ YL E
Sbjct: 402 IGVCQAE-ALMLVMEMAGGGPLHKFLVGK-REEIPVSNVAELLHQVSMGMKYL--EEKNF 457
Query: 747 VFHRDIKASNILLDSNLNAKVADFGLSRLAPVLDDEGTMPTHVSTIVKGTPGYLDPEYFL 806
V HR++ A N+LL + AK++DFGLS+ D T + +K PE
Sbjct: 458 V-HRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYA----PECIN 512
Query: 807 THKLTDKSDVYSLGVVLLELLT-GMQPISHGKNIVREVNVARDSGMVFSIIDNRMGSYPS 865
K + +SDV+S GV + E L+ G +P K EV + G RM P
Sbjct: 513 FRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKG--PEVMAFIEQG-------KRMEC-PP 562
Query: 866 ECVERFVTLALRCCHDKPEHRPSMSDVVRELENILK 901
EC L C K E RP V + +
Sbjct: 563 ECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYY 598
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 159 bits (405), Expect = 2e-43
Identities = 81/302 (26%), Positives = 126/302 (41%), Gaps = 61/302 (20%)
Query: 634 GQGGYGKVYKGIL------SDNTTVAIKRAEEG-SLQGQNEFLTEIKLLSRL-HHRNLVS 685
G+G +G+V + + TVA+K +EG + ++E+K+L + HH N+V+
Sbjct: 36 GRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVN 95
Query: 686 LLGYC-DEEGEQMLVYEFVPNGTLRDWLSGR--------------TKENLNFAMRLRVAL 730
LLG C G M++ EF G L +L + K+ L + +
Sbjct: 96 LLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSF 155
Query: 731 DSAKGILYLHTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSRLAPVLDDE-------G 783
AKG+ +L A HRD+ A NILL K+ DFGL+R + D
Sbjct: 156 QVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARD--IYKDPDYVRKGDA 210
Query: 784 TMPTHVSTIVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVLLELLT-GMQP---ISHGKNI 839
+P +K PE T +SDV+S GV+L E+ + G P + +
Sbjct: 211 RLP------LKWMA----PETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEF 260
Query: 840 VREVNVARDSGMVFSIIDNRMGSYPSECVERFVTLALRCCHDKPEHRPSMSDVVRELENI 899
R + G RM + P L C H +P RP+ S++V L N+
Sbjct: 261 CRRL----KEG-------TRMRA-PDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 308
Query: 900 LK 901
L+
Sbjct: 309 LQ 310
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 161 bits (409), Expect = 2e-43
Identities = 74/304 (24%), Positives = 133/304 (43%), Gaps = 63/304 (20%)
Query: 634 GQGGYGKVYKGILSD--------NTTVAIKRAEEG-SLQGQNEFLTEIKLLSRL-HHRNL 683
G+G +G+V TVA+K ++ + + ++ ++E++++ + H+N+
Sbjct: 90 GEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNI 149
Query: 684 VSLLGYCDEEGEQMLVYEFVPNGTLRDWL--------------SGRTKENLNFAMRLRVA 729
++LLG C ++G ++ E+ G LR++L + +E + F +
Sbjct: 150 INLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCT 209
Query: 730 LDSAKGILYLHTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSRLAPVLDDE------- 782
A+G+ YL + + HRD+ A N+L+ N K+ADFGL+R + + +
Sbjct: 210 YQLARGMEYL--ASQKCI-HRDLAARNVLVTENNVMKIADFGLARD--INNIDYYKKTTN 264
Query: 783 GTMPTHVSTIVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVLLELLT-GMQP---ISHGKN 838
G +P VK PE T +SDV+S GV++ E+ T G P I
Sbjct: 265 GRLP------VKWMA----PEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPV--- 311
Query: 839 IVREVNVARDSGMVFSIIDNRMGSYPSECVERFVTLALRCCHDKPEHRPSMSDVVRELEN 898
E+ G +RM P+ C + C H P RP+ +V +L+
Sbjct: 312 --EELFKLLKEG-------HRM-DKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDR 361
Query: 899 ILKM 902
IL +
Sbjct: 362 ILTL 365
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 159 bits (405), Expect = 2e-43
Identities = 84/305 (27%), Positives = 130/305 (42%), Gaps = 44/305 (14%)
Query: 634 GQGGYGKVYKGILSD------NTTVAIKRAEEG-SLQGQNEFLTEIKLLSRLHHRNLVSL 686
G G +G+VY+G +S VA+K E S Q + +FL E ++S+ +H+N+V
Sbjct: 39 GHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRC 98
Query: 687 LGYCDEEGEQMLVYEFVPNGTLRDWL---SGRTKENLNFAMR--LRVALDSAKGILYLHT 741
+G + + ++ E + G L+ +L R + + AM L VA D A G YL
Sbjct: 99 IGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYL-- 156
Query: 742 EAHPPVFHRDIKASNILLD---SNLNAKVADFGLSRLAPVLD-----DEGTMPTHVSTIV 793
E + + HRDI A N LL AK+ DFG++R +P V
Sbjct: 157 EENHFI-HRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLP------V 209
Query: 794 KGTPGYLDPEYFLTHKLTDKSDVYSLGVVLLELLT-GMQPISHGKNIVREVNVARDSGMV 852
K P PE F+ T K+D +S GV+L E+ + G P N +EV SG
Sbjct: 210 KWMP----PEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSN--QEVLEFVTSG-- 261
Query: 853 FSIIDNRMGSYPSECVERFVTLALRCCHDKPEHRPSMSDVVRELENILKMFPETDTMFSK 912
RM P C + +C +PE RP+ + ++ +E + +T
Sbjct: 262 -----GRM-DPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDPDVINTALPI 315
Query: 913 SESSS 917
Sbjct: 316 EYGPL 320
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 157 bits (400), Expect = 4e-43
Identities = 74/297 (24%), Positives = 121/297 (40%), Gaps = 60/297 (20%)
Query: 634 GQGGYGKVYKGIL------SDNTTVAIKRAEEG-SLQGQNEFLTEIKLLSRLHHRNLVSL 686
G+ +GKVYKG L VAIK ++ + EF E L +RL H N+V L
Sbjct: 18 GEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCL 77
Query: 687 LGYCDEEGEQMLVYEFVPNGTLRDWLSGR--------------TKENLNFAMRLRVALDS 732
LG ++ +++ + +G L ++L R K L + +
Sbjct: 78 LGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQI 137
Query: 733 AKGILYLHTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSRLAPVLDDE-------GTM 785
A G+ YL +H V H+D+ N+L+ LN K++D GL R V + +
Sbjct: 138 AAGMEYL--SSHHVV-HKDLATRNVLVYDKLNVKISDLGLFRE--VYAADYYKLLGNSLL 192
Query: 786 PTHVSTIVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVLLELLT-GMQP---ISHGKNIVR 841
P ++ PE + K + SD++S GVVL E+ + G+QP S+ +
Sbjct: 193 P------IRWMA----PEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSN-----Q 237
Query: 842 EVNVARDSGMVFSIIDNRMGSYPSECVERFVTLALRCCHDKPEHRPSMSDVVRELEN 898
+V + + P +C L + C ++ P RP D+ L
Sbjct: 238 DVVEMIRNR-------QVL-PCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLRA 286
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 158 bits (401), Expect = 5e-43
Identities = 82/307 (26%), Positives = 132/307 (42%), Gaps = 68/307 (22%)
Query: 634 GQGGYGKVYKGILSD------NTTVAIKRAEEG-SLQGQNEFLTEIKLLSRLHHRNLVSL 686
G+G +GKV K TTVA+K +E S + L+E +L +++H +++ L
Sbjct: 32 GEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKL 91
Query: 687 LGYCDEEGEQMLVYEFVPNGTLRDWL----------------------SGRTKENLNFAM 724
G C ++G +L+ E+ G+LR +L + L
Sbjct: 92 YGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGD 151
Query: 725 RLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSRLAPVLDDE-- 782
+ A ++G+ YL V HRD+ A NIL+ K++DFGLSR V +++
Sbjct: 152 LISFAWQISQGMQYL--AEMKLV-HRDLAARNILVAEGRKMKISDFGLSR--DVYEEDSY 206
Query: 783 -----GTMPTHVSTIVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVLLELLT-GMQP---I 833
G +P VK E H T +SDV+S GV+L E++T G P I
Sbjct: 207 VKRSQGRIP------VKWMA----IESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGI 256
Query: 834 SHGKNIVREVNVARDSGMVFSIIDNRMGSYPSECVERFVTLALRCCHDKPEHRPSMSDVV 893
+ +G +RM P C E L L+C +P+ RP +D+
Sbjct: 257 PP-----ERLFNLLKTG-------HRMER-PDNCSEEMYRLMLQCWKQEPDKRPVFADIS 303
Query: 894 RELENIL 900
++LE ++
Sbjct: 304 KDLEKMM 310
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 158 bits (402), Expect = 7e-43
Identities = 75/307 (24%), Positives = 133/307 (43%), Gaps = 59/307 (19%)
Query: 634 GQGGYGKVYKGILSD--------NTTVAIKRAEEG-SLQGQNEFLTEIKLLSRL-HHRNL 683
G+G +G+V TVA+K ++ + + ++ ++E++++ + H+N+
Sbjct: 44 GEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNI 103
Query: 684 VSLLGYCDEEGEQMLVYEFVPNGTLRDWL--------------SGRTKENLNFAMRLRVA 729
++LLG C ++G ++ E+ G LR++L + +E + F +
Sbjct: 104 INLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCT 163
Query: 730 LDSAKGILYLHTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSRLAPVLD-----DEGT 784
A+G+ YL + + HRD+ A N+L+ N K+ADFGL+R +D G
Sbjct: 164 YQLARGMEYL--ASQKCI-HRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGR 220
Query: 785 MPTHVSTIVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVLLELLT-GMQP---ISHGKNIV 840
+P VK PE T +SDV+S GV++ E+ T G P I
Sbjct: 221 LP------VKWMA----PEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPV----- 265
Query: 841 REVNVARDSGMVFSIIDNRMGSYPSECVERFVTLALRCCHDKPEHRPSMSDVVRELENIL 900
E+ G +RM P+ C + C H P RP+ +V +L+ IL
Sbjct: 266 EELFKLLKEG-------HRM-DKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIL 317
Query: 901 KMFPETD 907
+ +
Sbjct: 318 TLTTNEE 324
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 158 bits (401), Expect = 9e-43
Identities = 70/303 (23%), Positives = 123/303 (40%), Gaps = 53/303 (17%)
Query: 634 GQGGYGKVYKGILSD------NTTVAIKRAEEG-SLQGQNEFLTEIKLLSRL-HHRNLVS 685
G G +GKV + VA+K + + ++E+K++S L H N+V+
Sbjct: 55 GAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVN 114
Query: 686 LLGYCDEEGEQMLVYEFVPNGTLRDWL------------SGRTKENLNFAMRLRVALDSA 733
LLG C G +++ E+ G L ++L + L + A
Sbjct: 115 LLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVA 174
Query: 734 KGILYLHTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSRLAPVLDDE-------GTMP 786
+G+ +L + + HRD+ A N+LL + AK+ DFGL+R +++D +P
Sbjct: 175 QGMAFL--ASKNCI-HRDVAARNVLLTNGHVAKIGDFGLARD--IMNDSNYIVKGNARLP 229
Query: 787 THVSTIVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVLLELLT-GMQPISHGKNIVREVNV 845
VK PE T +SDV+S G++L E+ + G+ P G + +
Sbjct: 230 ------VKWMA----PESIFDCVYTVQSDVWSYGILLWEIFSLGLNP-YPGILVNSKFYK 278
Query: 846 ARDSGMVFSIIDNRMGSYPSECVERFVTLALRCCHDKPEHRPSMSDVVRELENILKM-FP 904
G +M P+ + ++ C +P HRP+ + L+ +
Sbjct: 279 LVKDG-------YQMAQ-PAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQAQEDRR 330
Query: 905 ETD 907
E D
Sbjct: 331 ERD 333
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 157 bits (398), Expect = 1e-42
Identities = 64/291 (21%), Positives = 104/291 (35%), Gaps = 27/291 (9%)
Query: 632 QVGQGGYGKVYKGI-LSDNTTVAIKRAEEGSLQGQNEFLTEIKLLSRLHHRNLVSLLGYC 690
++G+GG+ V L D A+KR Q + E E + +H N++ L+ YC
Sbjct: 36 KLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYC 95
Query: 691 DEEGEQM----LVYEFVPNGTLRDWLSGRTKENLNFAMR--LRVALDSAKGILYLHTEAH 744
E L+ F GTL + + + L + L +G+ +H
Sbjct: 96 LRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIH---A 152
Query: 745 PPVFHRDIKASNILLDSNLNAKVADFGLSRLA--PVLDDEGTMPTHVSTIVKGTPGYLDP 802
HRD+K +NILL + D G A V + + T Y P
Sbjct: 153 KGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAP 212
Query: 803 EYFLTHK---LTDKSDVYSLGVVLLELLTGMQPISHGKNIVREVNVARDSGMVFSIIDNR 859
E F + +++DV+SLG VL ++ G P ++ G ++
Sbjct: 213 ELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPY----------DMVFQKGDSVALAVQN 262
Query: 860 MGSYPSECV--ERFVTLALRCCHDKPEHRPSMSDVVRELENILKMFPETDT 908
S P L P RP + ++ +LE + P T
Sbjct: 263 QLSIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQPPAPGQHT 313
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 158 bits (401), Expect = 2e-42
Identities = 84/305 (27%), Positives = 130/305 (42%), Gaps = 44/305 (14%)
Query: 634 GQGGYGKVYKGILSD------NTTVAIKRAEEG-SLQGQNEFLTEIKLLSRLHHRNLVSL 686
G G +G+VY+G +S VA+K E S Q + +FL E ++S+ +H+N+V
Sbjct: 80 GHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRC 139
Query: 687 LGYCDEEGEQMLVYEFVPNGTLRDWL---SGRTKENLNFAMR--LRVALDSAKGILYLHT 741
+G + + ++ E + G L+ +L R + + AM L VA D A G YL
Sbjct: 140 IGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYL-- 197
Query: 742 EAHPPVFHRDIKASNILLD---SNLNAKVADFGLSRLAPVLD-----DEGTMPTHVSTIV 793
E + + HRDI A N LL AK+ DFG++R +P V
Sbjct: 198 EENHFI-HRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAMLP------V 250
Query: 794 KGTPGYLDPEYFLTHKLTDKSDVYSLGVVLLELLT-GMQPISHGKNIVREVNVARDSGMV 852
K P PE F+ T K+D +S GV+L E+ + G P N +EV SG
Sbjct: 251 KWMP----PEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSN--QEVLEFVTSG-- 302
Query: 853 FSIIDNRMGSYPSECVERFVTLALRCCHDKPEHRPSMSDVVRELENILKMFPETDTMFSK 912
RM P C + +C +PE RP+ + ++ +E + +T
Sbjct: 303 -----GRM-DPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDPDVINTALPI 356
Query: 913 SESSS 917
Sbjct: 357 EYGPL 361
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 164 bits (417), Expect = 2e-42
Identities = 78/275 (28%), Positives = 123/275 (44%), Gaps = 27/275 (9%)
Query: 634 GQGGYGKVYKGIL----SDNTTVAIKRAEEG-SLQGQNEFLTEIKLLSRLHHRNLVSLLG 688
G+G +G V++GI + VAIK + S + +FL E + + H ++V L+G
Sbjct: 399 GEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIG 458
Query: 689 YCDEEGEQMLVYEFVPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVF 748
E ++ E G LR +L R K +L+ A + A + + YL E+ V
Sbjct: 459 VITEN-PVWIIMELCTLGELRSFLQVR-KFSLDLASLILYAYQLSTALAYL--ESKRFV- 513
Query: 749 HRDIKASNILLDSNLNAKVADFGLSRLAPVLDDEGTMPTHVSTIVKGTPGYLDPEYFLTH 808
HRDI A N+L+ SN K+ DFGLSR + D + +K PE
Sbjct: 514 HRDIAARNVLVSSNDCVKLGDFGLSRY--MEDSTYYKASKGKLPIKWMA----PESINFR 567
Query: 809 KLTDKSDVYSLGVVLLELLT-GMQPISHGKNIVREVNVARDSGMVFSIIDNRMGSYPSEC 867
+ T SDV+ GV + E+L G++P KN +V ++G R+ P C
Sbjct: 568 RFTSASDVWMFGVCMWEILMHGVKPFQGVKN--NDVIGRIENG-------ERLPM-PPNC 617
Query: 868 VERFVTLALRCCHDKPEHRPSMSDVVRELENILKM 902
+L +C P RP +++ +L IL+
Sbjct: 618 PPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEE 652
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 156 bits (396), Expect = 2e-42
Identities = 74/304 (24%), Positives = 119/304 (39%), Gaps = 62/304 (20%)
Query: 632 QVGQGGYGKVYKGILSD------NTTVAIKRAEEG-SLQGQNEFLTEIKLLSRL-HHRNL 683
+G G +GKV + TVA+K + L + ++E+K+LS L +H N+
Sbjct: 30 TLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNI 89
Query: 684 VSLLGYCDEEGEQMLVYEFVPNGTLRDWLSGRTKENLNFAMR----------------LR 727
V+LLG C G +++ E+ G L ++L + + L
Sbjct: 90 VNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLS 149
Query: 728 VALDSAKGILYLHTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSRLAPVLDDE----- 782
+ AKG+ +L + + HRD+ A NILL K+ DFGL+R + +D
Sbjct: 150 FSYQVAKGMAFL--ASKNCI-HRDLAARNILLTHGRITKICDFGLARD--IKNDSNYVVK 204
Query: 783 --GTMPTHVSTIVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVLLELLT-GMQP---ISHG 836
+P VK PE T +SDV+S G+ L EL + G P +
Sbjct: 205 GNARLP------VKWMA----PESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVD 254
Query: 837 KNIVREVNVARDSGMVFSIIDNRMGSYPSECVERFVTLALRCCHDKPEHRPSMSDVVREL 896
+ + G RM S P + C P RP+ +V+ +
Sbjct: 255 SKFYKMI----KEG-------FRMLS-PEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLI 302
Query: 897 ENIL 900
E +
Sbjct: 303 EKQI 306
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 158 bits (401), Expect = 3e-42
Identities = 76/315 (24%), Positives = 135/315 (42%), Gaps = 59/315 (18%)
Query: 634 GQGGYGKVYKGIL--------SDNTTVAIKRAEEG-SLQGQNEFLTEIKLLSRL-HHRNL 683
G+G +G+V + T VA+K + + + ++ ++E++++ + H+N+
Sbjct: 78 GEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNI 137
Query: 684 VSLLGYCDEEGEQMLVYEFVPNGTLRDWL--------------SGRTKENLNFAMRLRVA 729
++LLG C ++G ++ E+ G LR++L S +E L+ + A
Sbjct: 138 INLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCA 197
Query: 730 LDSAKGILYLHTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSRLAPVLD-----DEGT 784
A+G+ YL + + HRD+ A N+L+ + K+ADFGL+R +D G
Sbjct: 198 YQVARGMEYL--ASKKCI-HRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGR 254
Query: 785 MPTHVSTIVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVLLELLT-GMQP---ISHGKNIV 840
+P VK PE T +SDV+S GV+L E+ T G P +
Sbjct: 255 LP------VKWMA----PEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV----- 299
Query: 841 REVNVARDSGMVFSIIDNRMGSYPSECVERFVTLALRCCHDKPEHRPSMSDVVRELENIL 900
E+ G +RM PS C + C H P RP+ +V +L+ I+
Sbjct: 300 EELFKLLKEG-------HRMDK-PSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIV 351
Query: 901 KMFPETDTMFSKSES 915
+ + +
Sbjct: 352 ALTSNQEMGYYHHHH 366
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 166 bits (421), Expect = 3e-42
Identities = 58/386 (15%), Positives = 109/386 (28%), Gaps = 62/386 (16%)
Query: 47 IKNSLVDSMNHLRNWNKGDPCMSNWTGVLCFDTVETDGHLHVRELQLLSMNLSGNLAPEL 106
+ +++ H NWN W V+ D + V L L G + +
Sbjct: 288 YYSGTINNTIHSLNWNFNKEL-DMWGDQPG---VDLDNNGRVTGLSLAGFGAKGRVPDAI 343
Query: 107 GQLSRLQY-YFMWNDLTGTIPKEIGNISSLIFLLLNGNKLSGSLPDE-LGYLSNLNRLQV 164
GQL+ L+ F + T + + +++ L Y LN +
Sbjct: 344 GQLTELKVLSFGTHSETVSGRLFGDEELTPDMSEERKHRIRMHYKKMFLDYDQRLNLSDL 403
Query: 165 DENNITG----------------------------TIPKSFANLSRVRHLHLNNNSIGGQ 196
++ I I K+ L++++ ++ N+
Sbjct: 404 LQDAINRNPEMKPIKKDSRISLKDTQIGNLTNRITFISKAIQRLTKLQIIYFANSPFTYD 463
Query: 197 IPSELSKLSTLIHLLVDNNNLSGNLPPELSELPQLCILQLDNNNFSASEIPATYGNFSKL 256
+ D N S L L ++L N +++P + +L
Sbjct: 464 NIAVD-----WEDANSDYAKQYENEELSWSNLKDLTDVELYNCPNM-TQLPDFLYDLPEL 517
Query: 257 VKLSLRNCNLQGAV----------PDLSRIPNLYYLDLSWNHLTGSIPSKKLS--ENVTT 304
L++ A D P + + +N+L S L +
Sbjct: 518 QSLNIACNRGISAAQLKADWTRLADDEDTGPKIQIFYMGYNNLEEFPASASLQKMVKLGL 577
Query: 305 IDLSDNYLNGSILESISNLPFLQTLSLENNFLTGSIPATIWQNKSFSTKARLKIDLRNNS 364
+D N + LE+ L L L+ N + IP T + +N
Sbjct: 578 LDCVHNKV--RHLEAFGTNVKLTDLKLDYNQIE-EIPEDFCAF----TDQVEGLGFSHNK 630
Query: 365 FSNIVGDLTLPNNVTLR---LGGNPI 387
I + + N I
Sbjct: 631 LKYIPNIFNAKSVYVMGSVDFSYNKI 656
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 153 bits (388), Expect = 3e-38
Identities = 49/367 (13%), Positives = 107/367 (29%), Gaps = 63/367 (17%)
Query: 84 GHLHVRELQLLSMNLSGNLAPELGQ-LSRLQYYFMWNDLTGTIPKEIGNISSLIFLLLNG 142
+ + + + + L Q + N +T I K I ++ L +
Sbjct: 399 NLSDLLQDAINRNPEMKPIKKDSRISLKDTQIGNLTNRITF-ISKAIQRLTKLQIIYFAN 457
Query: 143 NKLSG-------------------SLPDELGYLSNLNRLQVDENNITGTIPKSFANLSRV 183
+ + + L +L +++ +P +L +
Sbjct: 458 SPFTYDNIAVDWEDANSDYAKQYENEELSWSNLKDLTDVELYNCPNMTQLPDFLYDLPEL 517
Query: 184 RHLHLNNNSIGG---------QIPSELSKLSTLIHLLVDNNNLSGNLPPE--LSELPQLC 232
+ L++ N ++ + + + NNL P L ++ +L
Sbjct: 518 QSLNIACNRGISAAQLKADWTRLADDEDTGPKIQIFYMGYNNLEE-FPASASLQKMVKLG 576
Query: 233 ILQLDNNNFSASEIPATYGNFSKLVKLSLRNCNLQGAVPD--LSRIPNLYYLDLSWNHLT 290
+L +N + A +G KL L L ++ +P+ + + L S N L
Sbjct: 577 LLDCVHNKV--RHLEA-FGTNVKLTDLKLDYNQIEE-IPEDFCAFTDQVEGLGFSHNKLK 632
Query: 291 GSIPSKKLS--ENVTTIDLSDNYLNGSILESISNLPF-----LQTLSLENNFLTGSIPAT 343
+ ++D S N + ++ T++L N +
Sbjct: 633 YIPNIFNAKSVYVMGSVDFSYNKIGSEGRNISCSMDDYKGINASTVTLSYNEIQKFPTEL 692
Query: 344 IWQNKSFSTKARLKIDLRNNSFSNIVGDL---------TLPNNVTLRLGGNPICTSANIP 394
S I L NN ++I + T+ L N + ++
Sbjct: 693 FATGSPIS-----TIILSNNLMTSIPENSLKPKDGNYKNTYLLTTIDLRFNKL---TSLS 744
Query: 395 NTGRFCG 401
+ R
Sbjct: 745 DDFRATT 751
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 140 bits (354), Expect = 3e-34
Identities = 51/330 (15%), Positives = 106/330 (32%), Gaps = 49/330 (14%)
Query: 92 QLLSMNLSGN------LAPELGQLSRLQYYFMW-NDLTGTIPKEIGNISSLIFLLLNGNK 144
++ + N + L ++ +L N + + G L L L+ N+
Sbjct: 549 KIQIFYMGYNNLEEFPASASLQKMVKLGLLDCVHNKVR-HLE-AFGTNVKLTDLKLDYNQ 606
Query: 145 LSGSLPDELGY-LSNLNRLQVDENNITGTIPK--SFANLSRVRHLHLNNNSIGGQIPS-- 199
+ +P++ + L N + IP + ++ + + + N IG + +
Sbjct: 607 IE-EIPEDFCAFTDQVEGLGFSHNKLK-YIPNIFNAKSVYVMGSVDFSYNKIGSEGRNIS 664
Query: 200 ---ELSKLSTLIHLLVDNNNLSGNLPPELSELPQLCILQLDNNNFSA------SEIPATY 250
+ K + + N + + + + L NN ++ Y
Sbjct: 665 CSMDDYKGINASTVTLSYNEIQKFPTELFATGSPISTIILSNNLMTSIPENSLKPKDGNY 724
Query: 251 GNFSKLVKLSLRNCNLQGAVPD---LSRIPNLYYLDLSWNHLTGSIPS-----KKLSE-- 300
N L + LR L + D + +P L +D+S+N + S P+ +L
Sbjct: 725 KNTYLLTTIDLRFNKLTS-LSDDFRATTLPYLSNMDVSYNCFS-SFPTQPLNSSQLKAFG 782
Query: 301 NVTTIDLSDNYLNGSILESISNLPFLQTLSLENNFLTGSIPATIWQNKSFSTKARLKI-D 359
D N + I+ P L L + +N + + + L I D
Sbjct: 783 IRHQRDAEGNRILRQWPTGITTCPSLIQLQIGSNDIR-KVDEKLTPQ--------LYILD 833
Query: 360 LRNNSFSNIVGDLTLPN--NVTLRLGGNPI 387
+ +N +I P L +
Sbjct: 834 IADNPNISIDVTSVCPYIEAGMYVLLYDKT 863
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 7e-25
Identities = 40/345 (11%), Positives = 87/345 (25%), Gaps = 52/345 (15%)
Query: 84 GHLHVRELQLLSMNLSGNLAPELGQLSRLQYYFMWNDLTG------TIPKEIGNISSLIF 137
G V S + E + + + N LT + + I
Sbjct: 214 GTYQVVAYTTYSQSGIKRSELETQSVRGESFTVIDNKLTKDANVPIQLKETAEYIKDYKA 273
Query: 138 LL-----LNG--NKLSGSLPDELGYLSNLNRLQVDENNITGTIPKSFANLSRVRHLHLNN 190
L L+G + + + N N + + N RV L L
Sbjct: 274 LKAIWEALDGKNWRYYSGTINNTIHSLNWN-FNKELDMWGDQPGVDLDNNGRVTGLSLAG 332
Query: 191 NSIGGQIPSELSKLSTLIHLLVDNNNLSGNLPPELSELPQLCILQLDNNNFSASEIPAT- 249
G++P + +L+ L L ++ + + E + + +
Sbjct: 333 FGAKGRVPDAIGQLTELKVLSFGTHSETVSGRLFGDEELTPDMSEERKHRIRMHYKKMFL 392
Query: 250 ---------------------YGNFSKLVKLSLRNCNLQGAVPDLSRIP-------NLYY 281
K ++SL++ + ++ I L
Sbjct: 393 DYDQRLNLSDLLQDAINRNPEMKPIKKDSRISLKDTQIGNLTNRITFISKAIQRLTKLQI 452
Query: 282 LDLSWNHLTGSIPSKKLSENVTTIDLSDNYLNGSILESISNLPFLQTLSLENNFLTGSIP 341
+ + + T + + + S SNL L + L N +P
Sbjct: 453 IYFANSPFTYDNIAVDW----EDANSDYAKQYENEELSWSNLKDLTDVELYNCPNMTQLP 508
Query: 342 ATIWQNKSFSTKARLKIDLRNNSFSNIVGDLTLPNNVTLRLGGNP 386
++ + +++ N + + P
Sbjct: 509 DFLYDLPELQS-----LNIACNRGISAAQLKADWTRLADDEDTGP 548
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 101 bits (252), Expect = 6e-22
Identities = 27/223 (12%), Positives = 72/223 (32%), Gaps = 23/223 (10%)
Query: 85 HLHVRELQLLSMNLSGNLAPELGQLSRLQY-YFMWNDLTGTIPKEIGNISSLIFLLLNGN 143
+ ++ S + + + + + +N++ + S + ++L+ N
Sbjct: 648 SVDFSYNKIGSEGRNISCSMDDYKGINASTVTLSYNEIQKFPTELFATGSPISTIILSNN 707
Query: 144 KLS-------GSLPDELGYLSNLNRLQVDENNITGTIPKSFA--NLSRVRHLHLNNNSIG 194
++ L + + N +T ++ F L + ++ ++ N
Sbjct: 708 LMTSIPENSLKPKDGNYKNTYLLTTIDLRFNKLT-SLSDDFRATTLPYLSNMDVSYNCFS 766
Query: 195 GQIPSELSKLSTLIHL------LVDNNNLSGNLPPELSELPQLCILQLDNNNFSASEIPA 248
P++ S L + N + P ++ P L LQ+ +N+ ++
Sbjct: 767 S-FPTQPLNSSQLKAFGIRHQRDAEGNRILRQWPTGITTCPSLIQLQIGSNDI--RKVDE 823
Query: 249 TYGNFSKLVKLSLR-NCNLQGAVPDLSRIPNLYYLDLSWNHLT 290
+L L + N N+ V + L ++
Sbjct: 824 --KLTPQLYILDIADNPNISIDVTSVCPYIEAGMYVLLYDKTQ 864
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 156 bits (397), Expect = 3e-42
Identities = 79/308 (25%), Positives = 125/308 (40%), Gaps = 68/308 (22%)
Query: 634 GQGGYGKVYKGILSD------NTTVAIKRAEEG-SLQGQNEFLTEIKLLSRLHHRNLVSL 686
G+G +G+V++ T VA+K +E S Q +F E L++ + N+V L
Sbjct: 56 GEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKL 115
Query: 687 LGYCDEEGEQMLVYEFVPNGTLRDWLSGR----------------------TKENLNFAM 724
LG C L++E++ G L ++L L+ A
Sbjct: 116 LGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAE 175
Query: 725 RLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSRLAPVLDD--- 781
+L +A A G+ YL V HRD+ N L+ N+ K+ADFGLSR +
Sbjct: 176 QLCIARQVAAGMAYL--SERKFV-HRDLATRNCLVGENMVVKIADFGLSR--NIYSADYY 230
Query: 782 ----EGTMPTHVSTIVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVLLELLT-GMQP---I 833
+P ++ P PE ++ T +SDV++ GVVL E+ + G+QP +
Sbjct: 231 KADGNDAIP------IRWMP----PESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGM 280
Query: 834 SHGKNIVREVNVARDSGMVFSIIDNRMGSYPSECVERFVTLALRCCHDKPEHRPSMSDVV 893
+H EV G N + + P C L C P RPS +
Sbjct: 281 AH-----EEVIYYVRDG-------NIL-ACPENCPLELYNLMRLCWSKLPADRPSFCSIH 327
Query: 894 RELENILK 901
R L+ + +
Sbjct: 328 RILQRMCE 335
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 156 bits (397), Expect = 4e-42
Identities = 76/307 (24%), Positives = 118/307 (38%), Gaps = 67/307 (21%)
Query: 634 GQGGYGKVYKGILSD------NTTVAIKRAEEG-SLQGQNEFLTEIKLLSRL-HHRNLVS 685
G G +GKV + VA+K +E + ++E+K++++L H N+V+
Sbjct: 54 GSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVN 113
Query: 686 LLGYCDEEGEQMLVYEFVPNGTLRDWL---------------------SGRTKENLNFAM 724
LLG C G L++E+ G L ++L L F
Sbjct: 114 LLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFED 173
Query: 725 RLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSRLAPVLDDE-- 782
L A AKG+ +L E V HRD+ A N+L+ K+ DFGL+R ++ D
Sbjct: 174 LLCFAYQVAKGMEFL--EFKSCV-HRDLAARNVLVTHGKVVKICDFGLARD--IMSDSNY 228
Query: 783 -----GTMPTHVSTIVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVLLELLT-GMQP---I 833
+P VK PE T KSDV+S G++L E+ + G+ P I
Sbjct: 229 VVRGNARLP------VKWMA----PESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGI 278
Query: 834 SHGKNIVREVNVARDSGMVFSIIDNRMGSYPSECVERFVTLALRCCHDKPEHRPSMSDVV 893
N + + +G +M P E + C RPS ++
Sbjct: 279 PVDANFYKLI----QNG-------FKMDQ-PFYATEEIYIIMQSCWAFDSRKRPSFPNLT 326
Query: 894 RELENIL 900
L L
Sbjct: 327 SFLGCQL 333
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 160 bits (408), Expect = 1e-41
Identities = 72/329 (21%), Positives = 120/329 (36%), Gaps = 19/329 (5%)
Query: 78 DTVETDGHLHVRELQLLSMNLSGNLAPELGQLSRLQY-YFMWNDLTGTIPKEIGNISSLI 136
E + V + L + S LQ L+ +P + +S+L
Sbjct: 246 AVFEGLCEMSVESINLQKHYFFNISSNTFHCFSGLQELDLTATHLS-ELPSGLVGLSTLK 304
Query: 137 FLLLNGNKLSGSLPDELGYLSNLNRLQVDENNITGTI-PKSFANLSRVRHLHLNNNSIG- 194
L+L+ NK +L L + N + NL +R L L+++ I
Sbjct: 305 KLVLSANKFENLCQISASNFPSLTHLSIKGNTKRLELGTGCLENLENLRELDLSHDDIET 364
Query: 195 -GQIPSELSKLSTLIHLLVDNNNLSGNLPPELSELPQLCILQLDNNNFSASEIPATYGNF 253
+L LS L L + N E PQL +L L + + + N
Sbjct: 365 SDCCNLQLRNLSHLQSLNLSYNEPLSLKTEAFKECPQLELLDLAFTRLKVKDAQSPFQNL 424
Query: 254 SKLVKLSLRNCNLQGAVPD-LSRIPNLYYLDLSWNHLTGSIPSKKLS----ENVTTIDLS 308
L L+L + L + +P L +L+L NH K S + + LS
Sbjct: 425 HLLKVLNLSHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTLGRLEILVLS 484
Query: 309 DNYLNGSILESISNLPFLQTLSLENNFLTGSIPATIWQNKSFSTKARLKIDLRNNSFSNI 368
L+ + ++L + + L +N LT S ++ S + ++L +N S I
Sbjct: 485 FCDLSSIDQHAFTSLKMMNHVDLSHNRLTSSSI------EALSHLKGIYLNLASNHISII 538
Query: 369 VGDL--TLPNNVTLRLGGNPI-CTSANIP 394
+ L L T+ L NP+ CT +NI
Sbjct: 539 LPSLLPILSQQRTINLRQNPLDCTCSNIY 567
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 150 bits (381), Expect = 4e-38
Identities = 51/314 (16%), Positives = 93/314 (29%), Gaps = 17/314 (5%)
Query: 87 HVRELQLLSMNLSGNLAPELGQLSRLQY-YFMWNDLTGTIPKEIGNISSLIFLLLNGNKL 145
L+ L +L L + + + L L+L N L
Sbjct: 34 STECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWIHEDTFQSQHRLDTLVLTANPL 93
Query: 146 SGSLPDELGYLSNLNRLQVDENNITGTIPKSFANLSRVRHLHLNNNSIGGQIPSELSKLS 205
L L L + I+ N + L+L +N I +
Sbjct: 94 IFMAETALSGPKALKHLFFIQTGISSIDFIPLHNQKTLESLYLGSNHISSIKLPKGFPTE 153
Query: 206 TLIHLLVDNNNLSGNLPPELSELPQLCILQLDNNNFSASEIPATYGNFSKLVKLSLRNCN 265
L L NN + ++S L Q L L+ N + I + + L+
Sbjct: 154 KLKVLDFQNNAIHYLSKEDMSSLQQATNLSLNLNGNDIAGIEPGAFDSAVFQSLNFGGTQ 213
Query: 266 LQGAVPD------LSRIPNLYYLDLSWNHLTGSIPSKKLSENVTTIDLSDNYLNGSILES 319
+ + + + D+ ++ ++ +V +I+L +Y +
Sbjct: 214 NLLVIFKGLKNSTIQSLWLGTFEDMDDEDISPAVFEGLCEMSVESINLQKHYFFNISSNT 273
Query: 320 ISNLPFLQTLSLENNFLTGSIPATIWQNKSFSTKARLKI-DLRNNSFSNIVGDL--TLPN 376
LQ L L L+ +P+ + + LK L N F N+ P+
Sbjct: 274 FHCFSGLQELDLTATHLS-ELPSGLVGLST------LKKLVLSANKFENLCQISASNFPS 326
Query: 377 NVTLRLGGNPICTS 390
L + GN
Sbjct: 327 LTHLSIKGNTKRLE 340
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 149 bits (377), Expect = 1e-37
Identities = 65/322 (20%), Positives = 114/322 (35%), Gaps = 29/322 (9%)
Query: 87 HVRELQLLSMNLSGN----LAPELGQLSRLQY-YFMWNDLTGTIPKEIGN--ISSLIFLL 139
+++ LS+NL+GN + P + Q F I K + N I SL
Sbjct: 175 SLQQATNLSLNLNGNDIAGIEPGAFDSAVFQSLNFGGTQNLLVIFKGLKNSTIQSLWLGT 234
Query: 140 LNGNKLSGSLPDELGYLSNLNRLQVD--ENNITGTIPKSFANLSRVRHLHLNNNSIGGQI 197
P L ++ ++ ++ +F S ++ L L + ++
Sbjct: 235 FEDMDDEDISPAVFEGLCEMSVESINLQKHYFFNISSNTFHCFSGLQELDLTATHLS-EL 293
Query: 198 PSELSKLSTLIHLLVDNNNLSGNLPPELSELPQLCILQLDNNNFSASEIPATYGNFSKLV 257
PS L LSTL L++ N S P L L + N N L
Sbjct: 294 PSGLVGLSTLKKLVLSANKFENLCQISASNFPSLTHLSIKGNTKRLELGTGCLENLENLR 353
Query: 258 KLSLRNCNLQGAVPD---LSRIPNLYYLDLSWNHLTGSIPSKKLS--ENVTTIDLSDNYL 312
+L L + +++ + L + +L L+LS+N S+ ++ + +DL+ L
Sbjct: 354 ELDLSHDDIETSDCCNLQLRNLSHLQSLNLSYNEPL-SLKTEAFKECPQLELLDLAFTRL 412
Query: 313 NGSILESI-SNLPFLQTLSLENNFLTGSIPATIWQNKSFSTKARLKI-DLRNNSFSNIVG 370
+S NL L+ L+L ++ L S + L+ +L+ N F
Sbjct: 413 KVKDAQSPFQNLHLLKVLNLSHSLLDISSEQLFDGLPA------LQHLNLQGNHFPKGNI 466
Query: 371 DLT-----LPNNVTLRLGGNPI 387
T L L L +
Sbjct: 467 QKTNSLQTLGRLEILVLSFCDL 488
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 135 bits (342), Expect = 4e-33
Identities = 57/277 (20%), Positives = 89/277 (32%), Gaps = 16/277 (5%)
Query: 119 NDLTGTIPKEIGNISSLIFLLLNGNKLSGSLPDELGYLSNLNRLQVDENNITGTIPKSFA 178
L IP + +S L + N L L NL L + I +F
Sbjct: 22 LGLN-EIPGTLP--NSTECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWIHEDTFQ 78
Query: 179 NLSRVRHLHLNNNSIGGQIPSELSKLSTLIHLLVDNNNLSGNLPPELSELPQLCILQLDN 238
+ R+ L L N + + LS L HL +S L L L L +
Sbjct: 79 SQHRLDTLVLTANPLIFMAETALSGPKALKHLFFIQTGISSIDFIPLHNQKTLESLYLGS 138
Query: 239 NNFSASEIPATYGNFSKLVKLSLRNCNLQ----GAVPDLSRIPNLYYLDLSWNHLTGSIP 294
N+ S S KL L +N + + L + NL L+L+ N + G P
Sbjct: 139 NHIS-SIKLPKGFPTEKLKVLDFQNNAIHYLSKEDMSSLQQATNL-SLNLNGNDIAGIEP 196
Query: 295 SKKLSENVTTIDLSDNYLNGSILESISNLPF--LQTLSLENNFLTGSIPATIWQNKSFST 352
S +++ I + + N L + E+ PA S
Sbjct: 197 GAFDSAVFQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDMDDEDISPAVFEGLCEMSV 256
Query: 353 KARLKIDLRNNSFSNIVGDL--TLPNNVTLRLGGNPI 387
+ I+L+ + F NI + L L +
Sbjct: 257 E---SINLQKHYFFNISSNTFHCFSGLQELDLTATHL 290
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 107 bits (268), Expect = 4e-24
Identities = 46/259 (17%), Positives = 90/259 (34%), Gaps = 18/259 (6%)
Query: 92 QLLSMNLSGN-------LAPELGQLSRLQY-YFMWNDLTGTIPKEIGNISSLIFLLLNGN 143
L ++LS + +L LS LQ +N+ + L L L
Sbjct: 351 NLRELDLSHDDIETSDCCNLQLRNLSHLQSLNLSYNEPLSLKTEAFKECPQLELLDLAFT 410
Query: 144 KLSGSLPDE-LGYLSNLNRLQVDENNITGTIPKSFANLSRVRHLHLNNNSIGG---QIPS 199
+L L L L + + + + + F L ++HL+L N Q +
Sbjct: 411 RLKVKDAQSPFQNLHLLKVLNLSHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKTN 470
Query: 200 ELSKLSTLIHLLVDNNNLSGNLPPELSELPQLCILQLDNNNFSASEIPATYGNFSKLVKL 259
L L L L++ +LS + L + + L +N + S + + L
Sbjct: 471 SLQTLGRLEILVLSFCDLSSIDQHAFTSLKMMNHVDLSHNRLT-SSSIEALSHLKGIY-L 528
Query: 260 SLRNCNLQGAVPD-LSRIPNLYYLDLSWNHLTGSIPSKKLSENVTTIDLSDNYLNGSILE 318
+L + ++ +P L + ++L N L + + + + L +
Sbjct: 529 NLASNHISIILPSLLPILSQQRTINLRQNPLDCTCSNIYF---LEWYKENMQKLEDTEDT 585
Query: 319 SISNLPFLQTLSLENNFLT 337
N P L+ + L + L+
Sbjct: 586 LCENPPLLRGVRLSDVTLS 604
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 159 bits (404), Expect = 4e-41
Identities = 52/317 (16%), Positives = 104/317 (32%), Gaps = 26/317 (8%)
Query: 85 HLHVRELQLLSMNLSGNLAPEL-GQLSRLQY-YFMWNDLTGTIPKEIGNISSLIFLLLNG 142
+L + E +L ++ + +L L+ + + + L L
Sbjct: 256 NLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKD--FSYNFGWQHLELVN 313
Query: 143 NKLSGSLPDELGYLSNLNRLQVDENNITGTIPKSFANLSRVRHLHLNNNSIG--GQIPSE 200
K +L L L + G S +L + L L+ N + G
Sbjct: 314 CKFGQFPTLKLKSLKRLTF-----TSNKGGNAFSEVDLPSLEFLDLSRNGLSFKGCCSQS 368
Query: 201 LSKLSTLIHLLVDNNNLSGNLPPELSELPQLCILQLDNNNFSASEIPATYGNFSKLVKLS 260
++L +L + N + + L QL L ++N + + + L+ L
Sbjct: 369 DFGTTSLKYLDLSFNGVIT-MSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLD 427
Query: 261 LRNCNLQGAVPD-LSRIPNLYYLDLSWNHLTGSIPSKKLSE--NVTTIDLSDNYLNGSIL 317
+ + + + A + + +L L ++ N + +E N+T +DLS L
Sbjct: 428 ISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSP 487
Query: 318 ESISNLPFLQTLSLENNFLTGSIPATIWQNKSFSTKARLKI-DLRNNSFSNIVGDL---T 373
+ ++L LQ L++ +N + L++ D N
Sbjct: 488 TAFNSLSSLQVLNMSHNNFFSLDT------FPYKCLNSLQVLDYSLNHIMTSKKQELQHF 541
Query: 374 LPNNVTLRLGGNPI-CT 389
+ L L N CT
Sbjct: 542 PSSLAFLNLTQNDFACT 558
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 157 bits (398), Expect = 3e-40
Identities = 58/304 (19%), Positives = 102/304 (33%), Gaps = 15/304 (4%)
Query: 104 PELGQLSRLQYYFMWNDLTGTIPKEIGNISSLIFLLLNGNKLSGSLPDELGYLSNLNRLQ 163
P + + + Y M + IP + S L L+ N L L L
Sbjct: 2 PCVEVVPNITYQCMELNFY-KIPDNLP--FSTKNLDLSFNPLRHLGSYSFFSFPELQVLD 58
Query: 164 VDENNITGTIPKSFANLSRVRHLHLNNNSIGGQIPSELSKLSTLIHLLVDNNNLSGNLPP 223
+ I ++ +LS + L L N I S LS+L L+ NL+
Sbjct: 59 LSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENF 118
Query: 224 ELSELPQLCILQLDNNNFSASEIPATYGNFSKLVKLSLRNCNLQGAVP-DLSRIPNL--- 279
+ L L L + +N + ++P + N + L L L + +Q DL + +
Sbjct: 119 PIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLL 178
Query: 280 -YYLDLSWNHLTGSIPSKKLSENVTTIDLSDNYLNGSILE-SISNLPFLQTLSLENNFLT 337
LDLS N + P + + L +N+ + ++++ I L L+ L
Sbjct: 179 NLSLDLSLNPMNFIQPGAFKEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFR 238
Query: 338 GSIPATIWQNKSFSTKARLKI-DLRNNSFSNIVGDLT-----LPNNVTLRLGGNPICTSA 391
+ + L I + R + D+ L N + L I
Sbjct: 239 NEGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIERVK 298
Query: 392 NIPN 395
+
Sbjct: 299 DFSY 302
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 153 bits (388), Expect = 5e-39
Identities = 60/340 (17%), Positives = 114/340 (33%), Gaps = 30/340 (8%)
Query: 87 HVRELQLLSMNLSGNLAPELGQLSRLQY-YFMWNDLTGTIPKEIGNISSLIFLLLNGNKL 145
+ L L L + LQ ++ ++S L L+L GN +
Sbjct: 29 STKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPI 88
Query: 146 SGSLPDELGYLSNLNRLQVDENNITGTIPKSFANLSRVRHLHLNNNSI-GGQIPSELSKL 204
LS+L +L E N+ +L ++ L++ +N I ++P S L
Sbjct: 89 QSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNL 148
Query: 205 STLIHLLVDNNNLSGNLPPELSELPQL--CILQLDNNNFSASEIPATYGNFSKLVKLSLR 262
+ L HL + +N + +L L Q+ L LD + + I +L KL+LR
Sbjct: 149 TNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEIRLHKLTLR 208
Query: 263 NCNLQGAVPD--LSRIPNLYYLDLSWNHLTGSIPSKKLS----ENVTTIDLSDNYLN--- 313
N V + + L L +K E + + + + L
Sbjct: 209 NNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLD 268
Query: 314 ---GSILESISNLPFLQTLSLENNFLTGSIPAT--------------IWQNKSFSTKARL 356
I++ + L + + SL + + + Q + K+
Sbjct: 269 YYLDDIIDLFNCLTNVSSFSLVSVTIERVKDFSYNFGWQHLELVNCKFGQFPTLKLKSLK 328
Query: 357 KIDLRNNSFSNIVGDLTLPNNVTLRLGGNPICTSANIPNT 396
++ +N N ++ LP+ L L N + +
Sbjct: 329 RLTFTSNKGGNAFSEVDLPSLEFLDLSRNGLSFKGCCSQS 368
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 152 bits (386), Expect = 1e-38
Identities = 56/261 (21%), Positives = 107/261 (40%), Gaps = 13/261 (4%)
Query: 89 RELQLLSMNLSGNLAPELGQLSRLQYYFMWNDLTGTIPKEIGNISSLIFLLLNGNKLS-- 146
+ L+L++ +L L RL + G ++ SL FL L+ N LS
Sbjct: 307 QHLELVNCKFGQFPTLKLKSLKRLTF----TSNKGGNAFSEVDLPSLEFLDLSRNGLSFK 362
Query: 147 GSLPDELGYLSNLNRLQVDENNITGTIPKSFANLSRVRHLHLNNNSIGGQIP-SELSKLS 205
G ++L L + N + T+ +F L ++ HL ++++ S L
Sbjct: 363 GCCSQSDFGTTSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLR 421
Query: 206 TLIHLLVDNNNLSGNLPPELSELPQLCILQLDNNNFSASEIPATYGNFSKLVKLSLRNCN 265
LI+L + + + + L L +L++ N+F + +P + L L L C
Sbjct: 422 NLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQ 481
Query: 266 LQGAVPD-LSRIPNLYYLDLSWNHLTGSIPS--KKLSENVTTIDLSDNYLNGSILESISN 322
L+ P + + +L L++S N+ K L+ ++ +D S N++ S + + +
Sbjct: 482 LEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLN-SLQVLDYSLNHIMTSKKQELQH 540
Query: 323 LP-FLQTLSLENNFLTGSIPA 342
P L L+L N +
Sbjct: 541 FPSSLAFLNLTQNDFACTCEH 561
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 5e-31
Identities = 43/250 (17%), Positives = 83/250 (33%), Gaps = 10/250 (4%)
Query: 85 HLHVRELQLLSMNLSGNLAPELGQLSRLQY-YFMWNDLTGTIPKEIGNISSLIFLLLNGN 143
L +L ++ G + + L+Y +N + T+ + L L +
Sbjct: 348 SLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHS 406
Query: 144 KLSGSLPDE-LGYLSNLNRLQVDENNITGTIPKSFANLSRVRHLHLNNNSIGGQIPSE-L 201
L L NL L + + F LS + L + NS +
Sbjct: 407 NLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIF 466
Query: 202 SKLSTLIHLLVDNNNLSGNLPPELSELPQLCILQLDNNNFSASEIPATYGNFSKLVKLSL 261
++L L L + L P + L L +L + +NNF S Y + L L
Sbjct: 467 TELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFF-SLDTFPYKCLNSLQVLDY 525
Query: 262 RNCNLQGAVPD-LSRIP-NLYYLDLSWNHLTGSIPSKKLSE---NVTTIDLSDNYLNGSI 316
++ + L P +L +L+L+ N + + + + + + + +
Sbjct: 526 SLNHIMTSKKQELQHFPSSLAFLNLTQNDFACTCEHQSFLQWIKDQRQLLVEVERMECAT 585
Query: 317 LESISNLPFL 326
+P L
Sbjct: 586 PSDKQGMPVL 595
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 5e-29
Identities = 44/227 (19%), Positives = 87/227 (38%), Gaps = 10/227 (4%)
Query: 92 QLLSMNLSGN----LAPELGQLSRLQY-YFMWNDLTGTIPKEI-GNISSLIFLLLNGNKL 145
L ++LS N ++ L +L++ F ++L + ++ +LI+L ++
Sbjct: 374 SLKYLDLSFNGVITMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHT 433
Query: 146 SGSLPDELGYLSNLNRLQVDENNITGTI-PKSFANLSRVRHLHLNNNSIGGQIPSELSKL 204
+ LS+L L++ N+ P F L + L L+ + P+ + L
Sbjct: 434 RVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSL 493
Query: 205 STLIHLLVDNNNLSGNLPPELSELPQLCILQLDNNNFSASEIPATYGNFSKLVKLSLRNC 264
S+L L + +NN L L +L N+ S+ S L L+L
Sbjct: 494 SSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQN 553
Query: 265 NLQG---AVPDLSRIPNLYYLDLSWNHLTGSIPSKKLSENVTTIDLS 308
+ L I + L + + + PS K V +++++
Sbjct: 554 DFACTCEHQSFLQWIKDQRQLLVEVERMECATPSDKQGMPVLSLNIT 600
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 150 bits (382), Expect = 8e-41
Identities = 72/272 (26%), Positives = 113/272 (41%), Gaps = 26/272 (9%)
Query: 632 QVGQGGYGKVYKGI-LSDNTTVAIKRAEEGSL--QGQNEFLTEIKLLSRLHHRNLVSLLG 688
+G G YG+ K SD + K + GS+ + ++E+ LL L H N+V
Sbjct: 13 TIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYD 72
Query: 689 YCDEEGEQML--VYEFVPNGTLRDWLSGRTKENLNFAMR--LRVALDSAKGILYLHTEAH 744
+ L V E+ G L ++ TKE LRV + H +
Sbjct: 73 RIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSD 132
Query: 745 PP--VFHRDIKASNILLDSNLNAKVADFGLSRLAPVLDDEGTMPTHVSTIVKGTPGYLDP 802
V HRD+K +N+ LD N K+ DFGL+R +L+ + + T V GTP Y+ P
Sbjct: 133 GGHTVLHRDLKPANVFLDGKQNVKLGDFGLAR---ILNHDTSF---AKTFV-GTPYYMSP 185
Query: 803 EYFLTHKLTDKSDVYSLGVVLLELLTGMQPISHGKNIVREVNVARDSGMVFSIIDNRMGS 862
E +KSD++SLG +L EL M P + + I + +
Sbjct: 186 EQMNRMSYNEKSDIWSLGCLLYELCALMPPF-TAFSQ---------KELAGKIREGKFRR 235
Query: 863 YPSECVERFVTLALRCCHDKPEHRPSMSDVVR 894
P + + R + K HRPS+ +++
Sbjct: 236 IPYRYSDELNEIITRMLNLKDYHRPSVEEILE 267
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 150 bits (380), Expect = 3e-40
Identities = 67/293 (22%), Positives = 117/293 (39%), Gaps = 30/293 (10%)
Query: 632 QVGQGGYGKVYKGI-LSDNTTVAIKR---AEEGSLQGQNEFLTEIKLLSRLHHRNLVSLL 687
++G+G + +VY+ L D VA+K+ + + + + + EI LL +L+H N++
Sbjct: 39 KIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYY 98
Query: 688 GYCDEEGEQMLVYEFVPNGTLRDWLSGRTKENLNF--AMRLRVALDSAKGILYLHTEAHP 745
E+ E +V E G L + K+ + + + ++H+
Sbjct: 99 ASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRR-- 156
Query: 746 PVFHRDIKASNILLDSNLNAKVADFGLSRLAPVLDDEGTMPTHVSTIVKGTPGYLDPEYF 805
V HRDIK +N+ + + K+ D GL R + T ++V GTP Y+ PE
Sbjct: 157 -VMHRDIKPANVFITATGVVKLGDLGLGR---FFSSKTTAA---HSLV-GTPYYMSPERI 208
Query: 806 LTHKLTDKSDVYSLGVVLLELLTGMQP-ISHGKNIVREVNVARDSGMVFSIIDNRMGSYP 864
+ KSD++SLG +L E+ P N+ + I P
Sbjct: 209 HENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLY---------SLCKKIEQCDYPPLP 259
Query: 865 SECV-ERFVTLALRCCHDKPEHRPSMSDVVRELENILKMFPETDTMFSKSESS 916
S+ E L C + PE RP ++ V + +M T +
Sbjct: 260 SDHYSEELRQLVNMCINPDPEKRPDVTYV---YDVAKRMHACTASSLEHHHHH 309
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 150 bits (381), Expect = 6e-40
Identities = 71/323 (21%), Positives = 121/323 (37%), Gaps = 31/323 (9%)
Query: 632 QVGQGGYGKVYKGI-LSDNTTVAIK--RAEEGSLQGQNEFLTEIKLLSRLHHRNLVSLLG 688
++G+G +GK D IK S + + E E+ +L+ + H N+V
Sbjct: 31 KIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRE 90
Query: 689 YCDEEGEQMLVYEFVPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVF 748
+E G +V ++ G L ++ + L + + ++H +
Sbjct: 91 SFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRK---IL 147
Query: 749 HRDIKASNILLDSNLNAKVADFGLSRLAPVLDDEGTMPTHVSTIVKGTPGYLDPEYFLTH 808
HRDIK+ NI L + ++ DFG++R VL+ + + GTP YL PE
Sbjct: 148 HRDIKSQNIFLTKDGTVQLGDFGIAR---VLNSTVEL---ARACI-GTPYYLSPEICENK 200
Query: 809 KLTDKSDVYSLGVVLLELLTGMQPISHGKNIVREVNVARDSGMVFSIIDNRMGSYPSECV 868
+KSD+++LG VL EL T ++ +V II
Sbjct: 201 PYNNKSDIWALGCVLYELCTLKHAF-EAGSM---------KNLVLKIISGSFPPVSLHYS 250
Query: 869 ERFVTLALRCCHDKPEHRPSMSDVVRELENILKMFPETDTMFSKSESSSLLSGKSASTSS 928
+L + P RPS++ IL+ K S L++ + +
Sbjct: 251 YDLRSLVSQLFKRNPRDRPSVNS-------ILEK-GFIAKRIEKFLSPQLIAEEFCLKTF 302
Query: 929 SFLTRDPYASSSNVSGSDLISGA 951
S P + SG + IS
Sbjct: 303 SKFGSQPIPAKRPASGQNSISVM 325
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 146 bits (370), Expect = 3e-39
Identities = 66/270 (24%), Positives = 110/270 (40%), Gaps = 39/270 (14%)
Query: 632 QVGQGGYGKVYKGI-LSDNTTVAIK--RAEEGSLQGQNEFLTEIKLLSRLHHRNLVSLLG 688
++G+G + VYKG+ VA + + + + F E ++L L H N+V
Sbjct: 33 EIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYD 92
Query: 689 YC-DEEGEQMLVY---EFVPNGTLRDWLSGRTKENLNFAMRL--RVALDSAKGILYLHTE 742
+ + E + +GTL+ +L K +++ KG+ +LHT
Sbjct: 93 SWESTVKGKKCIVLVTELMTSGTLKTYL----KRFKVMKIKVLRSWCRQILKGLQFLHTR 148
Query: 743 AHPPVFHRDIKASNILLDSNL-NAKVADFGLSRLAPVLDDEGTMPTHVSTIVKGTPGYLD 801
PP+ HRD+K NI + + K+ D GL+ L + V GTP ++
Sbjct: 149 -TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATL---------KRASFAKAVIGTPEFMA 198
Query: 802 PEYFLTHKLTDKSDVYSLGVVLLELLTGMQPISHGKN---IVREVNVARDSGMVFSIIDN 858
PE + K + DVY+ G+ +LE+ T P S +N I R V SG+ + D
Sbjct: 199 PEMY-EEKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVT----SGVKPASFDK 253
Query: 859 RMGSYPSECVERFVTLALRCCHDKPEHRPS 888
V+ + C + R S
Sbjct: 254 VA----IPEVKEII---EGCIRQNKDERYS 276
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 146 bits (371), Expect = 4e-39
Identities = 68/288 (23%), Positives = 118/288 (40%), Gaps = 46/288 (15%)
Query: 632 QVGQGGYGKVYKGI-LSDNTTVAIK--RAEEGSLQGQNEFLTEIKLLSRLHHRNLVSLLG 688
+GQG +G+V K D+ AIK R E L L+E+ LL+ L+H+ +V
Sbjct: 13 VLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLS---TILSEVMLLASLNHQYVVRYYA 69
Query: 689 -YCDEEGEQM------------LVYEFVPNGTLRDWL-SGRTKENLNFAMRLRVALDSAK 734
+ + + E+ NGTL D + S + + RL + +
Sbjct: 70 AWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQI--LE 127
Query: 735 GILYLHTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSRL--------APVLDDEGTMP 786
+ Y+H++ + HRD+K NI +D + N K+ DFGL++ +
Sbjct: 128 ALSYIHSQG---IIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSS 184
Query: 787 THVSTIVKGTPGYLDPEYFLTHKLTD--KSDVYSLGVVLLELLTGMQPISHGKNIVREVN 844
++++ + GT Y+ E L K D+YSLG++ E++ P S G V +
Sbjct: 185 DNLTSAI-GTAMYVATE-VLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGMERVNILK 239
Query: 845 VARDSGMVFSIIDNRMGSYPSECVERFVTLALRCCHDKPEHRPSMSDV 892
R + F + ++ + L + HD P RP +
Sbjct: 240 KLRSVSIEF---PPDFDDNKMKVEKKIIRLLI--DHD-PNKRPGARTL 281
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 145 bits (367), Expect = 1e-38
Identities = 65/301 (21%), Positives = 120/301 (39%), Gaps = 36/301 (11%)
Query: 632 QVGQGGYGKVYKGI-LSDNTTVAIKR-AEEGSLQGQNEFLTEIKLLSRLHHRNLVSLLGY 689
+G+GG+G V++ D+ AIKR + + + E+K L++L H +V
Sbjct: 12 CLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNA 71
Query: 690 CDEEGEQM------------LVYEFVPNGTLRDWLSGR-TKENLNFAMRLRVALDSAKGI 736
E+ + + L+DW++GR T E ++ L + L A+ +
Sbjct: 72 WLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAV 131
Query: 737 LYLHTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSRLAPVLDDEGTMPTHVS-----T 791
+LH++ + HRD+K SNI + KV DFGL ++E T+ T + T
Sbjct: 132 EFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHT 188
Query: 792 IVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVLLELLTGMQPISHGKNIVREVNVARDSGM 851
GT Y+ PE + + K D++SLG++L ELL + +
Sbjct: 189 GQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLYPFSTQMERVRTLTD--------- 239
Query: 852 VFSIIDNRMGSYPSECVERFVTLALRCCHDKPEHRPSMSDVVRELENILKMFPETDTMFS 911
+ + + ++ + P RP +++ E + T+
Sbjct: 240 ---VRNLKFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINII-ENAVFEDLDFPGKTVLR 295
Query: 912 K 912
+
Sbjct: 296 Q 296
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 145 bits (369), Expect = 2e-38
Identities = 58/300 (19%), Positives = 121/300 (40%), Gaps = 25/300 (8%)
Query: 92 QLLSMNLSGNL---APELGQLSRLQY-YFMWNDLTGTIPKEIGNISSLIFLLLNGNKLSG 147
L +NL+GN L L +L Y N +T + N+++L L LN + +S
Sbjct: 67 NLEYLNLNGNQITDISPLSNLVKLTNLYIGTNKIT--DISALQNLTNLRELYLNEDNISD 124
Query: 148 SLPDELGYLSNLNRLQVDENNITGTIPKSFANLSRVRHLHLNNNSIGGQIPSELSKLSTL 207
L L+ + L + N+ + +N++ + +L + + + + ++ L+ L
Sbjct: 125 --ISPLANLTKMYSLNLGANHNL-SDLSPLSNMTGLNYLTVTESKVKD--VTPIANLTDL 179
Query: 208 IHLLVDNNNLSGNLPPELSELPQLCILQLDNNNFSASEIPATYGNFSKLVKLSLRNCNLQ 267
L ++ N + L+ L L N + +I N ++L L + N +
Sbjct: 180 YSLSLNYNQIED--ISPLASLTSLHYFTAYVNQIT--DITP-VANMTRLNSLKIGNNKIT 234
Query: 268 GAVPDLSRIPNLYYLDLSWNHLTGSIPSKKLSENVTTIDLSDNYLNGSILESISNLPFLQ 327
+ L+ + L +L++ N ++ I + K + +++ N ++ + ++NL L
Sbjct: 235 D-LSPLANLSQLTWLEIGTNQIS-DINAVKDLTKLKMLNVGSNQISD--ISVLNNLSQLN 290
Query: 328 TLSLENNFLTGSIPATIWQNKSFSTKARLKIDLRNNSFSNIVGDLTLPNNVTLRLGGNPI 387
+L L NN L I + +T + L N ++I +L + I
Sbjct: 291 SLFLNNNQLGNEDMEVIGGLTNLTT-----LFLSQNHITDIRPLASLSKMDSADFANQVI 345
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 135 bits (342), Expect = 1e-34
Identities = 64/300 (21%), Positives = 128/300 (42%), Gaps = 28/300 (9%)
Query: 90 ELQLLSMNLSGNLAPELGQLSRLQY-YFMWNDLTGTIPKEIGNISSLIFLLLNGNKLSGS 148
L L ++ + P L+ +T + + S+ L++ G K++ S
Sbjct: 4 TLATLPAPIN-QIFP-DADLAEGIRAVLQKASVTDVVT--QEELESITKLVVAGEKVA-S 58
Query: 149 LPDELGYLSNLNRLQVDENNITGTIPKSFANLSRVRHLHLNNNSIGGQIPSELSKLSTLI 208
+ + YL+NL L ++ N IT P +NL ++ +L++ N I S L L+ L
Sbjct: 59 IQG-IEYLTNLEYLNLNGNQITDISP--LSNLVKLTNLYIGTNKI--TDISALQNLTNLR 113
Query: 209 HLLVDNNNLSGNLPPELSELPQLCILQLDNNNFSASEIPATYGNFSKLVKLSLRNCNLQG 268
L ++ +N+S L+ L ++ L L N+ + N + L L++ ++
Sbjct: 114 ELYLNEDNISD--ISPLANLTKMYSLNLGANHN--LSDLSPLSNMTGLNYLTVTESKVKD 169
Query: 269 AVPDLSRIPNLYYLDLSWNHLTGSIPSKKLSENVTTIDLSDNYLNGSILESISNLPFLQT 328
V ++ + +LY L L++N + P L+ ++ N + + ++N+ L +
Sbjct: 170 -VTPIANLTDLYSLSLNYNQIEDISPLASLT-SLHYFTAYVNQITD--ITPVANMTRLNS 225
Query: 329 LSLENNFLTGSIPATIWQNKSFSTKARLK-IDLRNNSFSNIVGDLTLPNNVTLRLGGNPI 387
L + NN +T P + ++L +++ N S+I L L +G N I
Sbjct: 226 LKIGNNKITDLSP--------LANLSQLTWLEIGTNQISDINAVKDLTKLKMLNVGSNQI 277
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 127 bits (322), Expect = 4e-32
Identities = 51/252 (20%), Positives = 107/252 (42%), Gaps = 22/252 (8%)
Query: 92 QLLSMNLSGNL---APELGQLSRLQY-YFMWNDLTGTIPKEIGNISSLIFLLLNGNKLSG 147
L + L+ + L L+++ N + + N++ L +L + +K+
Sbjct: 111 NLRELYLNEDNISDISPLANLTKMYSLNLGANHNL-SDLSPLSNMTGLNYLTVTESKVKD 169
Query: 148 SLPDELGYLSNLNRLQVDENNITGTIPKSFANLSRVRHLHLNNNSIGGQIPSELSKLSTL 207
+ L++L L ++ N I P A+L+ + + N I P ++ ++ L
Sbjct: 170 V--TPIANLTDLYSLSLNYNQIEDISP--LASLTSLHYFTAYVNQITDITP--VANMTRL 223
Query: 208 IHLLVDNNNLSGNLPPELSELPQLCILQLDNNNFSASEIPATYGNFSKLVKLSLRNCNLQ 267
L + NN ++ L+ L QL L++ N S +I A + +KL L++ + +
Sbjct: 224 NSLKIGNNKITD--LSPLANLSQLTWLEIGTNQIS--DINAV-KDLTKLKMLNVGSNQIS 278
Query: 268 GAVPDLSRIPNLYYLDLSWNHLTGSIPS--KKLSENVTTIDLSDNYLNGSILESISNLPF 325
+ L+ + L L L+ N L L+ N+TT+ LS N++ + +++L
Sbjct: 279 D-ISVLNNLSQLNSLFLNNNQLGNEDMEVIGGLT-NLTTLFLSQNHITD--IRPLASLSK 334
Query: 326 LQTLSLENNFLT 337
+ + N +
Sbjct: 335 MDSADFANQVIK 346
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 79.1 bits (196), Expect = 8e-16
Identities = 32/194 (16%), Positives = 70/194 (36%), Gaps = 22/194 (11%)
Query: 204 LSTLIHLLVDNNNLSGNLPPELSELPQLCILQLDNNNFSASEIPATYGNFSKLVKLSLRN 263
+TL L + P ++L + L + + T + KL +
Sbjct: 2 AATLATL----PAPINQIFP-DADLAEGIRAVLQKASVTDVV---TQEELESITKLVVAG 53
Query: 264 CNLQGAVPDLSRIPNLYYLDLSWNHLTGSIPSKKLSENVTTIDLSDNYLNGSILESISNL 323
+ + + + NL YL+L+ N +T P L +T + + N + + + ++ NL
Sbjct: 54 EKVAS-IQGIEYLTNLEYLNLNGNQITDISPLSNLV-KLTNLYIGTNKI--TDISALQNL 109
Query: 324 PFLQTLSLENNFLTGSIPATIWQNKSFSTKARLKI-DLRNNSFSNIVGDL-TLPNNVTLR 381
L+ L L + ++ P + ++ +L N + + L + L
Sbjct: 110 TNLRELYLNEDNISDISP--------LANLTKMYSLNLGANHNLSDLSPLSNMTGLNYLT 161
Query: 382 LGGNPICTSANIPN 395
+ + + I N
Sbjct: 162 VTESKVKDVTPIAN 175
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 140 bits (355), Expect = 7e-37
Identities = 67/320 (20%), Positives = 117/320 (36%), Gaps = 47/320 (14%)
Query: 589 HARYQHSLSRKRLSTKISMKIDGVKGFKFKELAMATAYFSSSTQVGQGGYGKVYKGILSD 648
H + HS + + + VKG + L Q+G GG KV++ +
Sbjct: 2 HHHHHHSSGVDLGTENLYFQSMSVKGRIYSILK----------QIGSGGSSKVFQVLNEK 51
Query: 649 NTTVAIKRAEEGSLQGQ--NEFLTEIKLLSRLHHRNL--VSLLGYCDEEGEQMLVYEFVP 704
AIK Q + + EI L++L + + L Y + +V E
Sbjct: 52 KQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMECG- 110
Query: 705 NGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSNLN 764
N L WL + + + + + +H + H D+K +N L+
Sbjct: 111 NIDLNSWLKKKKSIDPWERK--SYWKNMLEAVHTIHQHG---IVHSDLKPANFLIVDG-M 164
Query: 765 AKVADFGLSRLAPVLDDEGTMPTHVSTIVKGTPGYLDPE-----------YFLTHKLTDK 813
K+ DFG++ + + T S + GT Y+ PE K++ K
Sbjct: 165 LKLIDFGIAN---QMQPDTTSVVKDSQV--GTVNYMPPEAIKDMSSSRENGKSKSKISPK 219
Query: 814 SDVYSLGVVLLELLTGMQPISHGKNIVREVNVARDSGMVFSIID-NRMGSYPSECVERFV 872
SDV+SLG +L + G P N + + + +IID N +P +
Sbjct: 220 SDVWSLGCILYYMTYGKTPFQQIINQISK---------LHAIIDPNHEIEFPDIPEKDLQ 270
Query: 873 TLALRCCHDKPEHRPSMSDV 892
+ C P+ R S+ ++
Sbjct: 271 DVLKCCLKRDPKQRISIPEL 290
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 139 bits (352), Expect = 1e-36
Identities = 72/284 (25%), Positives = 130/284 (45%), Gaps = 40/284 (14%)
Query: 632 QVGQGGYGKVYKG---ILSDNTTVAIK--RAEEGSLQGQNEFLT----EIKLLSRLHHRN 682
++G GG VY IL N VAIK + + E L E+ S+L H+N
Sbjct: 18 KLGGGGMSTVYLAEDTIL--NIKVAIKAIFIP---PREKEETLKRFEREVHNSSQLSHQN 72
Query: 683 LVSLLGYCDEEGEQMLVYEFVPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTE 742
+VS++ +E+ LV E++ TL +++ + L+ + GI + H +
Sbjct: 73 IVSMIDVDEEDDCYYLVMEYIEGPTLSEYI--ESHGPLSVDTAINFTNQILDGIKHAH-D 129
Query: 743 AHPPVFHRDIKASNILLDSNLNAKVADFGLSRLAPVLDDEGTMPTHVSTIVKGTPGYLDP 802
+ HRDIK NIL+DSN K+ DFG+++ E ++ T + ++ GT Y P
Sbjct: 130 MR--IVHRDIKPQNILIDSNKTLKIFDFGIAKAL----SETSL-TQTNHVL-GTVQYFSP 181
Query: 803 EYFLTHKLTDKSDVYSLGVVLLELLTGMQPISHGKNIVREVNVARDSGMVFSIIDNRMGS 862
E + +D+YS+G+VL E+L G P + G+ V++A I + + +
Sbjct: 182 EQAKGEATDECTDIYSIGIVLYEMLVGEPPFN-GET---AVSIA------IKHIQDSVPN 231
Query: 863 YPSECVER----FVTLALRCCHDKPEHRP-SMSDVVRELENILK 901
++ + + LR +R ++ ++ +L ++L
Sbjct: 232 VTTDVRKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSSVLH 275
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 140 bits (355), Expect = 1e-36
Identities = 65/316 (20%), Positives = 122/316 (38%), Gaps = 33/316 (10%)
Query: 632 QVGQGGYGKVYKGI-LSDNTTVAIKRAEEGSLQGQNEFLTEIKLLSRL-HHRNLVSLLGY 689
+ +GG+ VY+ + A+KR + + E+ + +L H N+V
Sbjct: 35 VLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSA 94
Query: 690 C-------DEEGEQMLVYEFVPNGTLRDWL-SGRTKENLNFAMRLRVALDSAKGILYLHT 741
D + L+ + G L ++L ++ L+ L++ + + + ++H
Sbjct: 95 ASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMH- 153
Query: 742 EAHPPVFHRDIKASNILLDSNLNAKVADFGLSRLAPVLDDEGTMPTHVSTI-----VKGT 796
PP+ HRD+K N+LL + K+ DFG + D + + T
Sbjct: 154 RQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTT 213
Query: 797 PGYLDPEYFLTHK---LTDKSDVYSLGVVLLELLTGMQPISHGKNIVREVNVARDSGMVF 853
P Y PE + + +K D+++LG +L L P +R VN +
Sbjct: 214 PMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPF-EDGAKLRIVNGK------Y 266
Query: 854 SIIDNRMGSYPSECVERFVTLALRCCHDKPEHRPSMSDVVRELENILKMFPETDTMFSKS 913
SI + + + F +L PE R S+++VV +L+ I + +
Sbjct: 267 SIPPHD--TQYTV----FHSLIRAMLQVNPEERLSIAEVVHQLQEIAAA-RNVNPKSPIT 319
Query: 914 ESSSLLSGKSASTSSS 929
E G ++T S
Sbjct: 320 ELLEQNGGYGSATLSR 335
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 139 bits (351), Expect = 4e-36
Identities = 61/277 (22%), Positives = 104/277 (37%), Gaps = 37/277 (13%)
Query: 632 QVGQGGYGKVYKGILSDNTTVAIKRAEEGSLQGQ--NEFLTEIKLLSRL--HHRNLVSLL 687
Q+G GG KV++ + AIK Q + + EI L++L H ++ L
Sbjct: 16 QIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLY 75
Query: 688 GYCDEEGEQMLVYEFVPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPV 747
Y + +V E N L WL + + + + + +H +
Sbjct: 76 DYEITDQYIYMVMECG-NIDLNSWLKKKKSIDPWERKSYWKNM--LEAVHTIHQHG---I 129
Query: 748 FHRDIKASNILLDSNLNAKVADFGLSRLAPVLDDEGTMPTHVSTIVKGTPGYLDPE---- 803
H D+K +N L+ K+ DFG++ T + V GT Y+ PE
Sbjct: 130 VHSDLKPANFLIVDG-MLKLIDFGIANQM----QPDTTSVVKDSQV-GTVNYMPPEAIKD 183
Query: 804 -------YFLTHKLTDKSDVYSLGVVLLELLTGMQPISHGKNIVREVNVARDSGMVFSII 856
K++ KSDV+SLG +L + G P N + + + +II
Sbjct: 184 MSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISK---------LHAII 234
Query: 857 D-NRMGSYPSECVERFVTLALRCCHDKPEHRPSMSDV 892
D N +P + + C P+ R S+ ++
Sbjct: 235 DPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPEL 271
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 137 bits (348), Expect = 5e-36
Identities = 55/269 (20%), Positives = 98/269 (36%), Gaps = 34/269 (12%)
Query: 632 QVGQGGYGKVYKGI-LSDNTTVAIK--RAEEGSLQGQNEFLTEIKLLSRL-HHRNLVSLL 687
++G G YG+V+K D A+K + + + L E+ ++ H V L
Sbjct: 64 RLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLE 123
Query: 688 GYCDEEGEQM-LVYEFVPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPP 746
EEG + L E +L+ +L A D+ + +LH++
Sbjct: 124 Q-AWEEGGILYLQTELC-GPSLQQHCE-AWGASLPEAQVWGYLRDTLLALAHLHSQG--- 177
Query: 747 VFHRDIKASNILLDSNLNAKVADFGLSRLAPVLDDEGTMPTHVSTIVKGTPGYLDPEYFL 806
+ H D+K +NI L K+ DFGL L G G P Y+ PE L
Sbjct: 178 LVHLDVKPANIFLGPRGRCKLGDFGLLV---ELGTAGAGEVQE-----GDPRYMAPE-LL 228
Query: 807 THKLTDKSDVYSLGVVLLELLTGMQPISHGKNIVREVNVARDSGMVFSIIDNRM-GSYPS 865
+DV+SLG+ +LE+ M+ G+ + + + +
Sbjct: 229 QGSYGTAADVFSLGLTILEVACNMELPHGGEGW-------------QQLRQGYLPPEFTA 275
Query: 866 ECVERFVTLALRCCHDKPEHRPSMSDVVR 894
++ + P+ R + ++
Sbjct: 276 GLSSELRSVLVMMLEPDPKLRATAEALLA 304
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 142 bits (361), Expect = 1e-35
Identities = 65/300 (21%), Positives = 113/300 (37%), Gaps = 16/300 (5%)
Query: 100 GNLAPELGQLSRLQYYFMWNDLTGTIPKEIGNISSLIFLLLNGNKLSGSLPDELGYLSNL 159
G+L P + + + Y M L+ +P +I SS + L+ N L S L
Sbjct: 2 GSLNPCIEVVPNITYQCMDQKLS-KVPDDIP--SSTKNIDLSFNPLKILKSYSFSNFSEL 58
Query: 160 NRLQVDENNITGTIPKSFANLSRVRHLHLNNNSIGGQIPSELSKLSTLIHLLVDNNNLSG 219
L + I K++ L + +L L N I P S L++L +L+ L+
Sbjct: 59 QWLDLSRCEIETIEDKAWHGLHHLSNLILTGNPIQSFSPGSFSGLTSLENLVAVETKLAS 118
Query: 220 NLPPELSELPQLCILQLDNNNFSASEIPATYGNFSKLVKLSLRNCNLQGAVPD----LSR 275
+ +L L L + +N + ++PA + N + LV + L +Q + L
Sbjct: 119 LESFPIGQLITLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQTITVNDLQFLRE 178
Query: 276 IP-NLYYLDLSWNHLTGSIPSKKLSE-NVTTIDLSDNYLNGSILE-SISNLPFLQTLSLE 332
P LD+S N + I + + + L N+ + +I++ + NL L L
Sbjct: 179 NPQVNLSLDMSLNPID-FIQDQAFQGIKLHELTLRGNFNSSNIMKTCLQNLAGLHVHRLI 237
Query: 333 NNFLTGSIPATIWQNKSFSTKARLKIDL----RNNSFSNIVGDLT-LPNNVTLRLGGNPI 387
I++ + ID N FS+ + L N + L G I
Sbjct: 238 LGEFKDERNLEIFEPSIMEGLCDVTIDEFRLTYTNDFSDDIVKFHCLANVSAMSLAGVSI 297
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 134 bits (340), Expect = 6e-33
Identities = 56/322 (17%), Positives = 102/322 (31%), Gaps = 28/322 (8%)
Query: 85 HLHVRELQLLSMNLSGNLAPELGQLSRLQYYFMWNDLTG---TIPKEIGNISSLIFLLLN 141
+ + E +L N + + L+ + L G +++ L +
Sbjct: 260 DVTIDEFRLTYTNDFSDDIVKFHCLANVSA----MSLAGVSIKYLEDVPKHFKWQSLSII 315
Query: 142 GNKLSGSLPDELGYLSNLNRLQVDENNITGTIPKSFANLSRVRHLHLNNNSIGGQIPSEL 201
+L P L L L + N + I L + +L L+ N++
Sbjct: 316 RCQLK-QFPTLD--LPFLKSLTLTMNKGS--ISFKKVALPSLSYLDLSRNALSFSGCCSY 370
Query: 202 SKLST--LIHLLVDNNNLSGNLPPELSELPQLCILQLDNNNFSASEIPATYGNFSKLVKL 259
S L T L HL + N + L +L L ++ + + + KL+ L
Sbjct: 371 SDLGTNSLRHLDLSFNGAII-MSANFMGLEELQHLDFQHSTLKRVTEFSAFLSLEKLLYL 429
Query: 260 SLRNCNLQGAVPD-LSRIPNLYYLDLSWNHLTGSIPSKKLSE--NVTTIDLSDNYLNGSI 316
+ N + + +L L ++ N + S + N+T +DLS L
Sbjct: 430 DISYTNTKIDFDGIFLGLTSLNTLKMAGNSFKDNTLSNVFANTTNLTFLDLSKCQLEQIS 489
Query: 317 LESISNLPFLQTLSLENNFLTGSIPATIWQNKSFSTKARLKI-DLRNNSFSNIVGDL--T 373
L LQ L++ +N L ++ L D N G L
Sbjct: 490 WGVFDTLHRLQLLNMSHNNLLFLDS------SHYNQLYSLSTLDCSFNRIETSKGILQHF 543
Query: 374 LPNNVTLRLGGNPI-CTSANIP 394
+ L N + C +
Sbjct: 544 PKSLAFFNLTNNSVACICEHQK 565
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 6e-30
Identities = 58/343 (16%), Positives = 101/343 (29%), Gaps = 46/343 (13%)
Query: 84 GHLHVRELQLLSMNLSGN----LAPELGQLSRLQY-YFMWNDLTGTIPKE-IGNISSLIF 137
L LS+++S N + + Q +L N + I K + N++ L
Sbjct: 174 QFLRENPQVNLSLDMSLNPIDFIQDQAFQGIKLHELTLRGNFNSSNIMKTCLQNLAGLHV 233
Query: 138 LLLNGNKLSGSL------PDELGYLSNLNRLQVD--ENNITGTIPKSFANLSRVRHLHLN 189
L + P + L ++ + N F L+ V + L
Sbjct: 234 HRLILGEFKDERNLEIFEPSIMEGLCDVTIDEFRLTYTNDFSDDIVKFHCLANVSAMSLA 293
Query: 190 NNSIGGQIPSELSKLSTLIHLLVDNN----------------NLSGN---LPPELSELPQ 230
SI + ++ K L + L+ N + + LP
Sbjct: 294 GVSI--KYLEDVPKHFKWQSLSIIRCQLKQFPTLDLPFLKSLTLTMNKGSISFKKVALPS 351
Query: 231 LCILQLDNNNFSASEIPATYG-NFSKLVKLSLRNCNLQGAVPDLSRIPNLYYLDLSWNHL 289
L L L N S S + + L L L + + L +LD + L
Sbjct: 352 LSYLDLSRNALSFSGCCSYSDLGTNSLRHLDLSFNGAIIMSANFMGLEELQHLDFQHSTL 411
Query: 290 TGSIPSKKLS--ENVTTIDLSDNYLNGSILESISNLPFLQTLSLENNFLTGSIPATIWQN 347
E + +D+S L L TL + N + + ++ N
Sbjct: 412 KRVTEFSAFLSLEKLLYLDISYTNTKIDFDGIFLGLTSLNTLKMAGNSFKDNTLSNVFAN 471
Query: 348 KSFSTKARLK-IDLRNNSFSNIVGDL--TLPNNVTLRLGGNPI 387
+ L +DL I + TL L + N +
Sbjct: 472 TT-----NLTFLDLSKCQLEQISWGVFDTLHRLQLLNMSHNNL 509
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 136 bits (345), Expect = 2e-35
Identities = 78/320 (24%), Positives = 131/320 (40%), Gaps = 55/320 (17%)
Query: 633 VGQGGYGKVYKG---ILSDNTTVAIK--RAEEGSLQGQNEFLT----EIKLLSRLHHRNL 683
+G GG +V+ + VA+K RA+ L F E + + L+H +
Sbjct: 20 LGFGGMSEVHLARDLRD--HRDVAVKVLRAD---LARDPSFYLRFRREAQNAAALNHPAI 74
Query: 684 VSLLGYCDEEGEQM----LVYEFVPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYL 739
V++ + E +V E+V TLRD + T+ + + V D+ + + +
Sbjct: 75 VAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIV--HTEGPMTPKRAIEVIADACQALNFS 132
Query: 740 HTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSRLAPVLDDEGTMPTHVSTIVKGTPGY 799
H + + HRD+K +NI++ + KV DFG++R + D G T + ++ GT Y
Sbjct: 133 H-QNG--IIHRDVKPANIMISATNAVKVMDFGIAR---AIADSGNSVTQTAAVI-GTAQY 185
Query: 800 LDPEYFLTHKLTDKSDVYSLGVVLLELLTGMQP----------ISHGKNIVREVNVARDS 849
L PE + +SDVYSLG VL E+LTG P H VRE + S
Sbjct: 186 LSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQH----VRE-DPIPPS 240
Query: 850 GMVFSIIDNRMGSYPSECVERFVTLALRCCHDKPEHRP-SMSDVVRELENILKMFPETDT 908
+ S ++ V L+ PE+R + +++ +L + P
Sbjct: 241 ARHEGL---------SADLDAVV---LKALAKNPENRYQTAAEMRADLVRVHNGEPPEAP 288
Query: 909 MFSKSESSSLLSGKSASTSS 928
+ L +A S
Sbjct: 289 KVLTDAERTSLLSSAAGNLS 308
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 137 bits (347), Expect = 3e-35
Identities = 60/280 (21%), Positives = 104/280 (37%), Gaps = 43/280 (15%)
Query: 632 QVGQGGYGKVYKGILSDNTTVAIKR-----AEEGSLQGQNEFLTEIKLLSRLHHRNL--V 684
Q+G GG KV++ + AIK A+ +L + EI L++L + +
Sbjct: 63 QIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDS---YRNEIAYLNKLQQHSDKII 119
Query: 685 SLLGYCDEEGEQMLVYEFVPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAH 744
L Y + +V E N L WL + + + + + +H
Sbjct: 120 RLYDYEITDQYIYMVMECG-NIDLNSWLKKKKSIDPWERK--SYWKNMLEAVHTIHQHG- 175
Query: 745 PPVFHRDIKASNILLDSNLNAKVADFGLSRLAPVLDDEGTMPTHVSTIVKGTPGYLDPE- 803
+ H D+K +N L+ K+ DFG++ T + V G Y+ PE
Sbjct: 176 --IVHSDLKPANFLIVDG-MLKLIDFGIANQM----QPDTTSVVKDSQV-GAVNYMPPEA 227
Query: 804 ----------YFLTHKLTDKSDVYSLGVVLLELLTGMQPISHGKNIVREVNVARDSGMVF 853
K++ KSDV+SLG +L + G P N + + +
Sbjct: 228 IKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISK---------LH 278
Query: 854 SIID-NRMGSYPSECVERFVTLALRCCHDKPEHRPSMSDV 892
+IID N +P + + C P+ R S+ ++
Sbjct: 279 AIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPEL 318
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 3e-35
Identities = 57/264 (21%), Positives = 96/264 (36%), Gaps = 34/264 (12%)
Query: 633 VGQGGYGKVYKGI-LSDNTTVAIKRAEEGSLQGQNEFLTEIKLLSRLHHRNLVSLLGYCD 691
VG+G +G+V++ A+K+ + + E+ + L +V L G
Sbjct: 66 VGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFRVE-----ELVACAGLSSPRIVPLYGAVR 120
Query: 692 EEGEQMLVYEFVPNGTLRDWLS--GRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFH 749
E + E + G+L + G E+ L AL +G+ YLHT + H
Sbjct: 121 EGPWVNIFMELLEGGSLGQLIKQMGCLPEDR-ALYYLGQAL---EGLEYLHTRR---ILH 173
Query: 750 RDIKASNILLDSN-LNAKVADFGLSRLAPVLDDEGTMPTHVSTIVKGTPGYLDPEYFLTH 808
D+KA N+LL S+ A + DFG + ++ T + GT ++ PE +
Sbjct: 174 GDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDY--IPGTETHMAPEVVMGK 231
Query: 809 KLTDKSDVYSLGVVLLELLTGMQPISHGKNIVREVNVARDSGM--VFSIIDNR--MGSYP 864
K D++S ++L +L G P + I + P
Sbjct: 232 PCDAKVDIWSSCCMMLHMLNGCHPWTQ------------YFRGPLCLKIASEPPPIREIP 279
Query: 865 SECVERFVTLALRCCHDKPEHRPS 888
C +P HR S
Sbjct: 280 PSCAPLTAQAIQEGLRKEPVHRAS 303
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 138 bits (351), Expect = 4e-35
Identities = 71/322 (22%), Positives = 125/322 (38%), Gaps = 31/322 (9%)
Query: 77 FDTVETDGHL-HVRELQLLSMNLSGNLAPELGQLSRLQY-YFMWNDLTGTIPKEIGNISS 134
+ + TD L + L N++ L ++ + + +++
Sbjct: 14 INQIFTDTALAEKMKTVLGKTNVTDT--VSQTDLDQVTTLQADRLGIK--SIDGVEYLNN 69
Query: 135 LIFLLLNGNKLSGSLPDELGYLSNLNRLQVDENNITGTIPKSFANLSRVRHLHLNNNSIG 194
L + + N+L+ P L L+ L + ++ N I P ANL+ + L L NN I
Sbjct: 70 LTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIADITP--LANLTNLTGLTLFNNQIT 125
Query: 195 GQIPSELSKLSTLIHLLVDNNNLSGNLPPELSELPQLCILQLDNNNFSASEIPATYGNFS 254
P L L+ L L + +N +S LS L L L N + N +
Sbjct: 126 DIDP--LKNLTNLNRLELSSNTISD--ISALSGLTSLQQLSFGNQVTDLKPL----ANLT 177
Query: 255 KLVKLSLRNCNLQGAVPDLSRIPNLYYLDLSWNHLTGSIPSKKLSENVTTIDLSDNYLNG 314
L +L + + + + L+++ NL L + N ++ P L+ N+ + L+ N L
Sbjct: 178 TLERLDISSNKVSD-ISVLAKLTNLESLIATNNQISDITPLGILT-NLDELSLNGNQLKD 235
Query: 315 SILESISNLPFLQTLSLENNFLTGSIPATIWQNKSFSTKARLK-IDLRNNSFSNIVGDLT 373
+ ++++L L L L NN ++ P S +L + L N SNI
Sbjct: 236 --IGTLASLTNLTDLDLANNQISNLAP--------LSGLTKLTELKLGANQISNISPLAG 285
Query: 374 LPNNVTLRLGGNPICTSANIPN 395
L L L N + + I N
Sbjct: 286 LTALTNLELNENQLEDISPISN 307
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 137 bits (348), Expect = 1e-34
Identities = 80/309 (25%), Positives = 135/309 (43%), Gaps = 31/309 (10%)
Query: 92 QLLSMNLSGNL---APELGQLSRLQYYFMW-NDLTGTIPKEIGNISSLIFLLLNGNKLSG 147
+L+ + ++ N L L+ L ++ N +T P + N+++L L L+ N +S
Sbjct: 91 KLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDIDP--LKNLTNLNRLELSSNTISD 148
Query: 148 SLPDELGYLSNLNRLQVDENNITGTIPKSFANLSRVRHLHLNNNSIGGQIPSELSKLSTL 207
L L++L +L N +T P ANL+ + L +++N + S L+KL+ L
Sbjct: 149 --ISALSGLTSLQQLSFG-NQVTDLKP--LANLTTLERLDISSNKV--SDISVLAKLTNL 201
Query: 208 IHLLVDNNNLSGNLPPELSELPQLCILQLDNNNFSASEIPATYGNFSKLVKLSLRNCNLQ 267
L+ NN +S L L L L L+ N +I T + + L L L N +
Sbjct: 202 ESLIATNNQISD--ITPLGILTNLDELSLNGNQLK--DIG-TLASLTNLTDLDLANNQIS 256
Query: 268 GAVPDLSRIPNLYYLDLSWNHLTGSIPSKKLSENVTTIDLSDNYLNGSILESISNLPFLQ 327
+ LS + L L L N ++ P L+ +T ++L++N L + ISNL L
Sbjct: 257 N-LAPLSGLTKLTELKLGANQISNISPLAGLT-ALTNLELNENQLED--ISPISNLKNLT 312
Query: 328 TLSLENNFLTGSIPATIWQNKSFSTKARLK-IDLRNNSFSNIVGDLTLPNNVTLRLGGNP 386
L+L N ++ P S+ +L+ + NN S++ L N L G N
Sbjct: 313 YLTLYFNNISDISP--------VSSLTKLQRLFFYNNKVSDVSSLANLTNINWLSAGHNQ 364
Query: 387 ICTSANIPN 395
I + N
Sbjct: 365 ISDLTPLAN 373
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 137 bits (347), Expect = 1e-34
Identities = 67/301 (22%), Positives = 111/301 (36%), Gaps = 31/301 (10%)
Query: 92 QLLSMNLSGNL---APELGQLSRLQY-YFMWNDLTGTIPKEIGNISSLIFLLLNGNKLSG 147
L + L N L L+ L N ++ + ++SL L N+++
Sbjct: 113 NLTGLTLFNNQITDIDPLKNLTNLNRLELSSNTISD--ISALSGLTSLQQLSFG-NQVTD 169
Query: 148 SLPDELGYLSNLNRLQVDENNITGTIPKSFANLSRVRHLHLNNNSIGGQIPSELSKLSTL 207
P L L+ L RL + N ++ A L+ + L NN I P L L+ L
Sbjct: 170 LKP--LANLTTLERLDISSNKVSD--ISVLAKLTNLESLIATNNQISDITP--LGILTNL 223
Query: 208 IHLLVDNNNLSGNLPPELSELPQLCILQLDNNNFSASEIPATYGNFSKLVKLSLRNCNLQ 267
L ++ N L L+ L L L L NN S + +KL +L L +
Sbjct: 224 DELSLNGNQLKD--IGTLASLTNLTDLDLANNQIS--NLAPL-SGLTKLTELKLGANQIS 278
Query: 268 GAVPDLSRIPNLYYLDLSWNHLTGSIPSKKLSENVTTIDLSDNYLNGSILESISNLPFLQ 327
+ L+ + L L+L+ N L P L N+T + L N ++ + +S+L LQ
Sbjct: 279 N-ISPLAGLTALTNLELNENQLEDISPISNLK-NLTYLTLYFNNISD--ISPVSSLTKLQ 334
Query: 328 TLSLENNFLTGSIPATIWQNKSFSTKARLK-IDLRNNSFSNIVGDLTLPNNVTLRLGGNP 386
L NN ++ + + + +N S++ L L L
Sbjct: 335 RLFFYNNKVSDVSS--------LANLTNINWLSAGHNQISDLTPLANLTRITQLGLNDQA 386
Query: 387 I 387
Sbjct: 387 W 387
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 1e-30
Identities = 67/264 (25%), Positives = 115/264 (43%), Gaps = 21/264 (7%)
Query: 92 QLLSMNLSGNL---APELGQLSRLQY-YFMWNDLTGTIPKEIGNISSLIFLLLNGNKLSG 147
L +++S N L +L+ L+ N ++ P +G +++L L LNGN+L
Sbjct: 178 TLERLDISSNKVSDISVLAKLTNLESLIATNNQISDITP--LGILTNLDELSLNGNQLKD 235
Query: 148 SLPDELGYLSNLNRLQVDENNITGTIPKSFANLSRVRHLHLNNNSIGGQIPSELSKLSTL 207
L L+NL L + N I+ P + L+++ L L N I S L+ L+ L
Sbjct: 236 --IGTLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISN--ISPLAGLTAL 289
Query: 208 IHLLVDNNNLSGNLPPELSELPQLCILQLDNNNFSASEIPATYGNFSKLVKLSLRNCNLQ 267
+L ++ N L +S L L L L NN S +I + +KL +L N +
Sbjct: 290 TNLELNENQLED--ISPISNLKNLTYLTLYFNNIS--DISP-VSSLTKLQRLFFYNNKVS 344
Query: 268 GAVPDLSRIPNLYYLDLSWNHLTGSIPSKKLSENVTTIDLSDNYLNGSILESISNLPFLQ 327
V L+ + N+ +L N ++ P L+ +T + L+D + + +N+
Sbjct: 345 D-VSSLANLTNINWLSAGHNQISDLTPLANLT-RITQLGLNDQAWTNAPVNYKANVSIPN 402
Query: 328 TLSLENNFLTGSIPATIWQNKSFS 351
T+ L PATI S++
Sbjct: 403 TVKNVTGALI--APATISDGGSYT 424
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 78.5 bits (194), Expect = 3e-15
Identities = 44/208 (21%), Positives = 76/208 (36%), Gaps = 17/208 (8%)
Query: 92 QLLSMNLSGNL---APELGQLSRLQY-YFMWNDLTGTIPKEIGNISSLIFLLLNGNKLSG 147
+L + L N L L+ L N L P I N+ +L +L L N +S
Sbjct: 266 KLTELKLGANQISNISPLAGLTALTNLELNENQLEDISP--ISNLKNLTYLTLYFNNISD 323
Query: 148 SLPDELGYLSNLNRLQVDENNITGTIPKSFANLSRVRHLHLNNNSIGGQIPSELSKLSTL 207
P + L+ L RL N ++ S ANL+ + L +N I + L+ L+ +
Sbjct: 324 ISP--VSSLTKLQRLFFYNNKVSD--VSSLANLTNINWLSAGHNQISD--LTPLANLTRI 377
Query: 208 IHLLVDNNNLSGNLPPELSELPQLCILQLDNNNFSASEIPATYGNFSKLVKLSLRNCNLQ 267
L +++ + N P + I N A PAT + + + NL
Sbjct: 378 TQLGLNDQAWT-NAPVNYKAN--VSIPNTVKNVTGALIAPATISDGGSYTEPDI-TWNLP 433
Query: 268 GAVPDLS-RIPNLYYLDLSWNHLTGSIP 294
++S + +G++
Sbjct: 434 SYTNEVSYTFSQPVTIGKGTTTFSGTVT 461
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 62.3 bits (152), Expect = 3e-10
Identities = 26/141 (18%), Positives = 47/141 (33%), Gaps = 12/141 (8%)
Query: 256 LVKLSLRNCNLQGAVPDLSRIPNLYYLDLSWNHLTGSIPSKKLSENVTTIDLSDNYLNGS 315
L ++ + + + L ++T ++ L VTT+ +
Sbjct: 3 LGSATITQDTPINQIFTDTALAEKMKTVLGKTNVTDTVSQTDLD-QVTTLQADRLGI--K 59
Query: 316 ILESISNLPFLQTLSLENNFLTGSIPATIWQNKSFSTKARLK-IDLRNNSFSNIVGDLTL 374
++ + L L ++ NN LT P +L I + NN ++I L
Sbjct: 60 SIDGVEYLNNLTQINFSNNQLTDITP--------LKNLTKLVDILMNNNQIADITPLANL 111
Query: 375 PNNVTLRLGGNPICTSANIPN 395
N L L N I + N
Sbjct: 112 TNLTGLTLFNNQITDIDPLKN 132
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 135 bits (341), Expect = 5e-35
Identities = 54/209 (25%), Positives = 87/209 (41%), Gaps = 25/209 (11%)
Query: 633 VGQGGYGKVYKG---ILSDNTTVAIK--RAEEGSLQGQNEFLT----EIKLLSRLHHRNL 683
VG+GG G VY+ + VA+K L F T E + RL ++
Sbjct: 42 VGRGGMGDVYEAEDTVR--ERIVALKLMSET---LSSDPVFRTRMQREARTAGRLQEPHV 96
Query: 684 VSLLGYCDEEGEQMLVYEFVPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEA 743
V + + + +G+ + + L L R + L + + + H A
Sbjct: 97 VPIHDFGEIDGQLYVDMRLINGVDLAAML--RRQGPLAPPRAVAIVRQIGSALDAAH-AA 153
Query: 744 HPPVFHRDIKASNILLDSNLNAKVADFGLSRLAPVLDDEGTMPTHVSTIVKGTPGYLDPE 803
HRD+K NIL+ ++ A + DFG++ + + T + V GT Y+ PE
Sbjct: 154 G--ATHRDVKPENILVSADDFAYLVDFGIASAT----TDEKL-TQLGNTV-GTLYYMAPE 205
Query: 804 YFLTHKLTDKSDVYSLGVVLLELLTGMQP 832
F T ++D+Y+L VL E LTG P
Sbjct: 206 RFSESHATYRADIYALTCVLYECLTGSPP 234
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 135 bits (342), Expect = 5e-35
Identities = 52/293 (17%), Positives = 96/293 (32%), Gaps = 25/293 (8%)
Query: 89 RELQLLSMNLSGNLAPELGQLSRLQYYFMWNDLTGTIPKEIGNISS--LIFLLLNGNKLS 146
+ N + + Q + + + + L L L
Sbjct: 36 QRHYNADRNRWHSAW-RQANSNNPQIETRTGRALKATADLLEDATQPGRVALELRSVPLP 94
Query: 147 GSLPDELGYLSNLNRLQVDENNITGTIPKSFANLSRVRHLHLNNNSIGGQIPSELSKLST 206
PD+ LS+L + +D + +P + + + L L N + +P+ ++ L+
Sbjct: 95 -QFPDQAFRLSHLQHMTIDAAGLM-ELPDTMQQFAGLETLTLARNPLR-ALPASIASLNR 151
Query: 207 LIHLLVDNNNLSGNLPPEL---------SELPQLCILQLDNNNFSASEIPATYGNFSKLV 257
L L + LP L L L L+L+ +PA+ N L
Sbjct: 152 LRELSIRACPELTELPEPLASTDASGEHQGLVNLQSLRLEWTGIR--SLPASIANLQNLK 209
Query: 258 KLSLRNCNLQGAVPDLSRIPNLYYLDLSWNHLTGSIPSK--KLSENVTTIDLSDNYLNGS 315
L +RN L P + +P L LDL + P + + + L D +
Sbjct: 210 SLKIRNSPLSALGPAIHHLPKLEELDLRGCTALRNYPPIFGGRA-PLKRLILKDCSNLLT 268
Query: 316 ILESISNLPFLQTLSLENNFLTGSIPATIWQNKSFSTKARLKIDLRNNSFSNI 368
+ I L L+ L L +P+ I Q + I + + + +
Sbjct: 269 LPLDIHRLTQLEKLDLRGCVNLSRLPSLIAQLPANCI-----ILVPPHLQAQL 316
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 111 bits (281), Expect = 6e-27
Identities = 50/255 (19%), Positives = 92/255 (36%), Gaps = 40/255 (15%)
Query: 123 GTIPKEIGNISSLIFLLLNGNKLSGSLPDELGYLS-----------------NLNRLQVD 165
G+ + S L G+ D L N N Q++
Sbjct: 2 GSSHHHHHHSSGRENLYFQGSTALRPYHDVLSQWQRHYNADRNRWHSAWRQANSNNPQIE 61
Query: 166 ENNITG--TIPKSFANLSRV--RHLHLNNNSIGGQIPSELSKLSTLIHLLVDNNNLSGNL 221
+ ++ L L + + Q P + +LS L H+ +D L L
Sbjct: 62 TRTGRALKATADLLEDATQPGRVALELRSVPL-PQFPDQAFRLSHLQHMTIDAAGLM-EL 119
Query: 222 PPELSELPQLCILQLDNNNFSASEIPATYGNFSKLVKLSLRNCNLQGAVPD--------- 272
P + + L L L N +PA+ + ++L +LS+R C +P+
Sbjct: 120 PDTMQQFAGLETLTLARNPL--RALPASIASLNRLRELSIRACPELTELPEPLASTDASG 177
Query: 273 -LSRIPNLYYLDLSWNHLTGSIPSK--KLSENVTTIDLSDNYLNGSILESISNLPFLQTL 329
+ NL L L W + S+P+ L N+ ++ + ++ L+ ++ +I +LP L+ L
Sbjct: 178 EHQGLVNLQSLRLEWTGIR-SLPASIANLQ-NLKSLKIRNSPLS-ALGPAIHHLPKLEEL 234
Query: 330 SLENNFLTGSIPATI 344
L + P
Sbjct: 235 DLRGCTALRNYPPIF 249
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 94.2 bits (235), Expect = 5e-21
Identities = 32/147 (21%), Positives = 57/147 (38%), Gaps = 11/147 (7%)
Query: 92 QLLSMNLSGN----LAPELGQLSRLQY-YFMWNDLTGTIPKEIGNISSLIFLLLNGNKLS 146
L S+ L L + L L+ + L+ + I ++ L L L G
Sbjct: 184 NLQSLRLEWTGIRSLPASIANLQNLKSLKIRNSPLS-ALGPAIHHLPKLEELDLRGCTAL 242
Query: 147 GSLPDELGYLSNLNRLQV-DENNITGTIPKSFANLSRVRHLHLNNNSIGGQIPSELSKLS 205
+ P G + L RL + D +N+ T+P L+++ L L ++PS +++L
Sbjct: 243 RNYPPIFGGRAPLKRLILKDCSNLL-TLPLDIHRLTQLEKLDLRGCVNLSRLPSLIAQLP 301
Query: 206 TLIHLLVDNN---NLSGNLPPELSELP 229
+LV + L + P P
Sbjct: 302 ANCIILVPPHLQAQLDQHRPVARPAEP 328
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 88.8 bits (221), Expect = 4e-19
Identities = 39/243 (16%), Positives = 78/243 (32%), Gaps = 31/243 (12%)
Query: 147 GSLPDELGYLSNLNRLQVDENNITGTIPKSFANLSRVRHLHLNNNSIGGQIPSELSKLST 206
GS + S L + + R + N + +
Sbjct: 2 GSSHHHHHHSSGRENLYFQGSTALRPYHDVLSQWQRHYNADRNRWHS----AWRQANSNN 57
Query: 207 LIHLLVDNNNLSGNLPPELSELPQLCILQLDNNNFSASEIPATYGNFSKLVKLSLRNCNL 266
L L + Q + L+ + + P S L +++ L
Sbjct: 58 PQIETRTGRALK-ATADLLEDATQPGRVALELRSVPLPQFPDQAFRLSHLQHMTIDAAGL 116
Query: 267 QGAVPD-LSRIPNLYYLDLSWNHLTGSIPS--KKLSENVTTIDLSDNYLNGSILESISNL 323
+PD + + L L L+ N L ++P+ L+ + + + + E +++
Sbjct: 117 M-ELPDTMQQFAGLETLTLARNPLR-ALPASIASLN-RLRELSIRACPELTELPEPLAST 173
Query: 324 PF---------LQTLSLENNFLTGSIPATIWQNKSFSTKARLKI-DLRNNSFSNI---VG 370
LQ+L LE + S+PA+I ++ LK +RN+ S + +
Sbjct: 174 DASGEHQGLVNLQSLRLEWTGIR-SLPASIANLQN------LKSLKIRNSPLSALGPAIH 226
Query: 371 DLT 373
L
Sbjct: 227 HLP 229
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 4e-34
Identities = 46/231 (19%), Positives = 93/231 (40%), Gaps = 37/231 (16%)
Query: 634 GQGGYGKVYKGILSDNTTVAIK-----------------RAEEGSLQGQNEFLTEIKLLS 676
QG + K+ DN A+K + ++F E+++++
Sbjct: 40 NQGKFNKIILCE-KDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIIT 98
Query: 677 RLHHRNLVSLLGYCDEEGEQMLVYEFVPNGTLRDWLSGRTKENLNFAMRL------RVAL 730
+ + ++ G E ++YE++ N ++ + + N+ + +
Sbjct: 99 DIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIK 158
Query: 731 DSAKGILYLHTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSRLAPVLDDEGTMPTHVS 790
Y+H E + + HRD+K SNIL+D N K++DFG S + +
Sbjct: 159 SVLNSFSYIHNEKN--ICHRDVKPSNILMDKNGRVKLSDFGESEYMV----DKKIKG--- 209
Query: 791 TIVKGTPGYLDPEYFLTHKLTD--KSDVYSLGVVLLELLTGMQPISHGKNI 839
+GT ++ PE+F + K D++SLG+ L + + P S ++
Sbjct: 210 --SRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISL 258
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 7e-34
Identities = 69/268 (25%), Positives = 104/268 (38%), Gaps = 37/268 (13%)
Query: 633 VGQGGYGKVYKGILSDN-TTVAIKRAEEGSLQGQNEFLTEIKLLSRLHHRNLVSLLGYCD 691
+G+G YG VY G N +AIK E + EI L L H+N+V LG
Sbjct: 30 LGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLG-SF 88
Query: 692 EEGEQMLVY-EFVPNGTLRDWLSGR-----TKENLNFAMRLRVALDSAKGILYLHTEAHP 745
E + ++ E VP G+L L + E + L +G+ YLH
Sbjct: 89 SENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQT-IGFYTKQIL---EGLKYLHDNQ-- 142
Query: 746 PVFHRDIKASNILLDS-NLNAKVADFGLS-RLAPVLDDEGTMPTHVSTIVKGTPGYLDPE 803
+ HRDIK N+L+++ + K++DFG S RLA + T GT Y+ PE
Sbjct: 143 -IVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTETF--------TGTLQYMAPE 193
Query: 804 YFLTHKL--TDKSDVYSLGVVLLELLTGMQPISHGKNIVREVNVARDSGMVFSI-IDNRM 860
+D++SLG ++E+ TG P +F + +
Sbjct: 194 IIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQA---------AMFKVGMFKVH 244
Query: 861 GSYPSECVERFVTLALRCCHDKPEHRPS 888
P L+C P+ R
Sbjct: 245 PEIPESMSAEAKAFILKCFEPDPDKRAC 272
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 138 bits (349), Expect = 7e-34
Identities = 58/313 (18%), Positives = 110/313 (35%), Gaps = 48/313 (15%)
Query: 633 VGQGGYGKVYKG---ILSDNTTVAIKR-AEEGSLQGQNEFLTEIKLLSRLHHRNLVSLLG 688
+ GG G +Y + + V +K G + Q + E + L+ + H ++V +
Sbjct: 88 IAHGGLGWIYLALDRNV-NGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFN 146
Query: 689 YCDEEGEQM-----LVYEFVPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEA 743
+ + +V E+V +L+ + L A + L+ + YLH
Sbjct: 147 FVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQK----LPVAEAIAYLLEILPALSYLH--- 199
Query: 744 HPPVFHRDIKASNILLDSNLNAKVADFGLSRLAPVLDDEGTMPTHVSTIVKGTPGYLDPE 803
+ + D+K NI+L K+ D G + + GTPG+ PE
Sbjct: 200 SIGLVYNDLKPENIMLTEE-QLKLIDLGAVS---------RI-NSFGYLY-GTPGFQAPE 247
Query: 804 YFLTHKLTDKSDVYSLGVVLLELLTGMQPISHGKNIVREVNVARDSGMVFSIIDNRMGSY 863
+ T +D+Y++G L L + + R V+ + V Y
Sbjct: 248 I-VRTGPTVATDIYTVGRTLAALTLDLPTRNG-----RYVDGLPEDDPVLKT-------Y 294
Query: 864 PSECVERFVTLALRCCHDKPEHRP-SMSDVVRELENILKMFPETDTMFSKSESSSLLSGK 922
S R + R P R + ++ +L +L+ DT + S++ S
Sbjct: 295 DS--YGRLL---RRAIDPDPRQRFTTAEEMSAQLTGVLREVVAQDTGVPRPGLSTIFSPS 349
Query: 923 SASTSSSFLTRDP 935
++ L
Sbjct: 350 RSTFGVDLLVAHT 362
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 2e-33
Identities = 59/290 (20%), Positives = 100/290 (34%), Gaps = 55/290 (18%)
Query: 632 QVGQGGYGKVYKGI-LSDNTTVAIKR--AEEGSLQGQNEFLTEIKLLSRL-HHRNLVSLL 687
++G G +G V+K + D AIKR + L E+ + L H ++V
Sbjct: 18 KIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYF 77
Query: 688 GYCDEEGEQMLVY-EFVPNGTLRDWLSGRTKENLNF--AMRLRVALDSAKGILYLHTEAH 744
E + ML+ E+ G+L D +S + F A + L +G+ Y+H+ +
Sbjct: 78 S-AWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMS- 135
Query: 745 PPVFHRDIKASNILLDSN-------------------LNAKVADFGLSRLAPVLDDEGTM 785
+ H DIK SNI + + K+ D G T
Sbjct: 136 --LVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHV----------TR 183
Query: 786 PTHVSTIVKGTPGYLDPEYFLTHKL-TDKSDVYSLGVVLLELLTGMQPISHGKNIVREVN 844
+ G +L E + K+D+++L + ++ +G
Sbjct: 184 ISSPQVEE-GDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGD------- 235
Query: 845 VARDSGMVFSIIDNRMGSYPSECVERFVTLALRCCHDKPEHRPSMSDVVR 894
I R+ P + F L H PE RPS +V+
Sbjct: 236 ------QWHEIRQGRLPRIPQVLSQEFTELLKVMIHPDPERRPSAMALVK 279
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 4e-33
Identities = 56/269 (20%), Positives = 98/269 (36%), Gaps = 27/269 (10%)
Query: 125 IPKEIGNISSLIFLLLNGNKLSGSLPDELGYLSNLNRLQVDENNITGTIPKSFANLSRVR 184
I + N + + + L +L N+ L + N ++ A +++
Sbjct: 2 IHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLE 61
Query: 185 HLHLNNNSIGGQIPSELSKLSTLIHLLVDNNNLSGNLPPELSELPQLCILQLDNNNFSAS 244
L+L++N + +L LSTL L ++NN + EL P + L NNN S
Sbjct: 62 LLNLSSNVL--YETLDLESLSTLRTLDLNNNYVQ-----ELLVGPSIETLHAANNNI--S 112
Query: 245 EIPATYGNFSKLVKLSLRNCNLQGAVPD--LSRIPNLYYLDLSWNHLTGSIPSKKL---S 299
+ + L N + + D + YLDL N + ++ +L S
Sbjct: 113 RVSC--SRGQGKKNIYLANNKITM-LRDLDEGCRSRVQYLDLKLNEID-TVNFAELAASS 168
Query: 300 ENVTTIDLSDNYLNGSILESISNLPFLQTLSLENNFLTGSIPATIWQNKSFSTKARLKID 359
+ + ++L N++ ++ L+TL L +N L + + I
Sbjct: 169 DTLEHLNLQYNFI--YDVKGQVVFAKLKTLDLSSNKLA-FMGPEFQSAAGVTW-----IS 220
Query: 360 LRNNSFSNIVGDLT-LPNNVTLRLGGNPI 387
LRNN I L N L GN
Sbjct: 221 LRNNKLVLIEKALRFSQNLEHFDLRGNGF 249
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 1e-32
Identities = 61/298 (20%), Positives = 106/298 (35%), Gaps = 32/298 (10%)
Query: 119 NDLTGTIPKEIGNISSLIFLLLNGNKLSGSLPDELGYLSNLNRLQVDENNITGTIPKSFA 178
+ L + + ++ L L+GN LS +L + L L + N +
Sbjct: 20 SSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLY-ETL-DLE 77
Query: 179 NLSRVRHLHLNNNSIGGQIPSELSKLSTLIHLLVDNNNLSGNLPPELSELPQLCILQLDN 238
+LS +R L LNNN + EL ++ L NNN+S + + L N
Sbjct: 78 SLSTLRTLDLNNNYV-----QELLVGPSIETLHAANNNIS-RVSCSR--GQGKKNIYLAN 129
Query: 239 NNFSASEIPATYGNFSKLVKLSLRNCNLQGAVPD--LSRIPNLYYLDLSWNHLTGSIPSK 296
N + G S++ L L+ + + L +L+L +N + + +
Sbjct: 130 NKITMLR-DLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIY-DVKGQ 187
Query: 297 KLSENVTTIDLSDNYLNGSILESISNLPFLQTLSLENNFLTGSIPATIWQNKSFSTKARL 356
+ + T+DLS N L + + + +SL NN L I + +++
Sbjct: 188 VVFAKLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKLV-LIEKALRFSQNLEH---- 241
Query: 357 KIDLRNNSFSNI-----------VGDLTLPNNVTLRLGGNPICTSANIPNTGRFCGSD 403
DLR N F V + L CT + + G +C D
Sbjct: 242 -FDLRGNGFHCGTLRDFFSKNQRVQTVAKQTVKKLTGQNEEECTVPTLGHYGAYCCED 298
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 1e-26
Identities = 47/253 (18%), Positives = 84/253 (33%), Gaps = 17/253 (6%)
Query: 92 QLLSMNLSGNL---APELGQLSRLQY-YFMWNDLTGTIPKEIGNISSLIFLLLNGNKLSG 147
+L +NLS N+ +L LS L+ N + E+ S+ L N +S
Sbjct: 59 KLELLNLSSNVLYETLDLESLSTLRTLDLNNNYVQ-----ELLVGPSIETLHAANNNIS- 112
Query: 148 SLPDELGYLSNLNRLQVDENNITGTIPKSFANLSRVRHLHLNNNSIGG-QIPSELSKLST 206
+ + + N IT SRV++L L N I + T
Sbjct: 113 RVSCSR--GQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDT 170
Query: 207 LIHLLVDNNNLSGNLPPELSELPQLCILQLDNNNFSASEIPATYGNFSKLVKLSLRNCNL 266
L HL + N + ++ ++ +L L L +N + + + + + + +SLRN L
Sbjct: 171 LEHLNLQYNFIY-DVKGQVV-FAKLKTLDLSSNKLA--FMGPEFQSAAGVTWISLRNNKL 226
Query: 267 QGAVPDLSRIPNLYYLDLSWNHLTGSIPSKKLSENVTTIDLSDNYLNGSILESISNLPFL 326
L NL + DL N S+N ++ + ++
Sbjct: 227 VLIEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQTVKKLTGQNEEECTVP 286
Query: 327 QTLSLENNFLTGS 339
Sbjct: 287 TLGHYGAYCCEDL 299
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 135 bits (341), Expect = 6e-33
Identities = 64/286 (22%), Positives = 100/286 (34%), Gaps = 35/286 (12%)
Query: 634 GQGGYGKVYKGI-LSDNTTVAIKRAEEGSLQGQNEFLT-EIKLLSRLHHRNLVSLL---- 687
G GG+G V + I VAIK+ + E EI+++ +L+H N+VS
Sbjct: 23 GTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPD 82
Query: 688 --GYCDEEGEQMLVYEFVPNGTLRDWLSGRTKEN-LNFAMRLRVALDSAKGILYLHTEAH 744
+L E+ G LR +L+ L + D + + YLH
Sbjct: 83 GLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENR- 141
Query: 745 PPVFHRDIKASNILLDSN---LNAKVADFGLSRLAPVLDDEGTMPTHVSTIVKGTPGYLD 801
+ HRD+K NI+L L K+ D G ++ LD V GT YL
Sbjct: 142 --IIHRDLKPENIVLQPGPQRLIHKIIDLGYAK---ELDQGELCTEFV-----GTLQYLA 191
Query: 802 PEYFLTHKLTDKSDVYSLGVVLLELLTGMQPISHGKNIVREVNVARDSGMVFSIIDNRMG 861
PE K T D +S G + E +TG +P V + +
Sbjct: 192 PELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPV----------QWHGKVREKSN 241
Query: 862 SYPSECVERFVTLALRCCHDKPEHRPSMSDVVRELENILKMFPETD 907
+ + + P H + + +LE L+
Sbjct: 242 EHIVVYDDLTGAVKFSSVLPTPNHLSGI--LAGKLERWLQCMLMWH 285
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 1e-32
Identities = 68/305 (22%), Positives = 106/305 (34%), Gaps = 46/305 (15%)
Query: 633 VGQGGYGKVYKGI-LSDNTTVAIKRAEEGSLQGQNEFLT-EIKLLSRLHHRNLVSLLGYC 690
+GQG V++G AIK S + E ++L +L+H+N+V L
Sbjct: 17 LGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIE 76
Query: 691 DEEGEQM--LVYEFVPNGTLRDWLSGRTKEN-LNFAMRLRVALDSAKGILYLHTEAHPPV 747
+E + L+ EF P G+L L + L + L V D G+ +L +
Sbjct: 77 EETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG---I 133
Query: 748 FHRDIKASNILL----DSNLNAKVADFGLSRLAPVLDDEGTMPTHVSTIVKGTPGYLDPE 803
HR+IK NI+ D K+ DFG +R L+D+ + + GT YL P+
Sbjct: 134 VHRNIKPGNIMRVIGEDGQSVYKLTDFGAAR---ELEDDEQFVS-----LYGTEEYLHPD 185
Query: 804 YFLTHKLTD--------KSDVYSLGVVLLELLTG----------------MQPISHGK-- 837
+ L D++S+GV TG M I GK
Sbjct: 186 MYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPS 245
Query: 838 NIVREVNVARDSGMVFSIIDNRMGSYPSECVERFVTLALRCCHDKPEHRPSMSDVVRELE 897
+ V A + + +S S + E E
Sbjct: 246 GAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETS 305
Query: 898 NILKM 902
+IL
Sbjct: 306 DILHR 310
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 2e-32
Identities = 68/305 (22%), Positives = 105/305 (34%), Gaps = 46/305 (15%)
Query: 633 VGQGGYGKVYKGI-LSDNTTVAIKRAEEGSLQGQNEFLT-EIKLLSRLHHRNLVSLLGYC 690
+GQG V++G AIK S + E ++L +L+H+N+V L
Sbjct: 17 LGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIE 76
Query: 691 DEEGEQM--LVYEFVPNGTLRDWLSGRTKEN-LNFAMRLRVALDSAKGILYLHTEAHPPV 747
+E + L+ EF P G+L L + L + L V D G+ +L +
Sbjct: 77 EETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG---I 133
Query: 748 FHRDIKASNILL----DSNLNAKVADFGLSRLAPVLDDEGTMPTHVSTIVKGTPGYLDPE 803
HR+IK NI+ D K+ DFG +R L+D+ + GT YL P+
Sbjct: 134 VHRNIKPGNIMRVIGEDGQSVYKLTDFGAAR---ELEDDEQFVSLY-----GTEEYLHPD 185
Query: 804 YF--------LTHKLTDKSDVYSLGVVLLELLTG----------------MQPISHGK-- 837
+ K D++S+GV TG M I GK
Sbjct: 186 MYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPS 245
Query: 838 NIVREVNVARDSGMVFSIIDNRMGSYPSECVERFVTLALRCCHDKPEHRPSMSDVVRELE 897
+ V A + + +S S + E E
Sbjct: 246 GAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETS 305
Query: 898 NILKM 902
+IL
Sbjct: 306 DILHR 310
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 3e-32
Identities = 51/210 (24%), Positives = 85/210 (40%), Gaps = 30/210 (14%)
Query: 634 GQGGYGKVYKGI-LSDNTTVAIK-----RAEEGSLQGQNEFLTEIKLLSRLHHRNLVSLL 687
G+GG+ K ++ A K + + + EI + L H+++V
Sbjct: 24 GKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREK--MSMEISIHRSLAHQHVVGFH 81
Query: 688 GYCDEEGEQMLVYEFVPNGTLRDWLS--GRTKENL--NFAMRLRVALDSAKGILYLHTEA 743
G+ ++ +V E +L + E + ++ G YLH
Sbjct: 82 GFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQI------VLGCQYLHRNR 135
Query: 744 HPPVFHRDIKASNILLDSNLNAKVADFGLSRLAPVLDDEGTMPTHVSTIVKGTPGYLDPE 803
V HRD+K N+ L+ +L K+ DFGL+ V D + GTP Y+ PE
Sbjct: 136 ---VIHRDLKLGNLFLNEDLEVKIGDFGLA--TKVEYDGERKKV-----LCGTPNYIAPE 185
Query: 804 YFLTHKLTD-KSDVYSLGVVLLELLTGMQP 832
L+ K + DV+S+G ++ LL G P
Sbjct: 186 -VLSKKGHSFEVDVWSIGCIMYTLLVGKPP 214
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 3e-32
Identities = 51/210 (24%), Positives = 85/210 (40%), Gaps = 30/210 (14%)
Query: 634 GQGGYGKVYKGI-LSDNTTVAIK-----RAEEGSLQGQNEFLTEIKLLSRLHHRNLVSLL 687
G+GG+ K ++ A K + + + EI + L H+++V
Sbjct: 50 GKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREK--MSMEISIHRSLAHQHVVGFH 107
Query: 688 GYCDEEGEQMLVYEFVPNGTLRDWLS--GRTKENL--NFAMRLRVALDSAKGILYLHTEA 743
G+ ++ +V E +L + E + ++ G YLH
Sbjct: 108 GFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQI------VLGCQYLHRNR 161
Query: 744 HPPVFHRDIKASNILLDSNLNAKVADFGLSRLAPVLDDEGTMPTHVSTIVKGTPGYLDPE 803
V HRD+K N+ L+ +L K+ DFGL+ V D + GTP Y+ PE
Sbjct: 162 ---VIHRDLKLGNLFLNEDLEVKIGDFGLA--TKVEYDGERKKV-----LCGTPNYIAPE 211
Query: 804 YFLTHKLTD-KSDVYSLGVVLLELLTGMQP 832
L+ K + DV+S+G ++ LL G P
Sbjct: 212 -VLSKKGHSFEVDVWSIGCIMYTLLVGKPP 240
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 7e-32
Identities = 56/269 (20%), Positives = 97/269 (36%), Gaps = 27/269 (10%)
Query: 125 IPKEIGNISSLIFLLLNGNKLSGSLPDELGYLSNLNRLQVDENNITGTIPKSFANLSRVR 184
I + N + + + L +L N+ L + N ++ A +++
Sbjct: 2 IHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLE 61
Query: 185 HLHLNNNSIGGQIPSELSKLSTLIHLLVDNNNLSGNLPPELSELPQLCILQLDNNNFSAS 244
L+L++N + +L LSTL L +L+ N EL P + L NNN S
Sbjct: 62 LLNLSSNVL--YETLDLESLSTLRTL-----DLNNNYVQELLVGPSIETLHAANNNI--S 112
Query: 245 EIPATYGNFSKLVKLSLRNCNLQGAVPD--LSRIPNLYYLDLSWNHLTGSIPSKKL---S 299
+ + L N + + D + YLDL N + ++ +L S
Sbjct: 113 RVSC--SRGQGKKNIYLANNKITM-LRDLDEGCRSRVQYLDLKLNEID-TVNFAELAASS 168
Query: 300 ENVTTIDLSDNYLNGSILESISNLPFLQTLSLENNFLTGSIPATIWQNKSFSTKARLKID 359
+ + ++L N++ ++ L+TL L +N L + + I
Sbjct: 169 DTLEHLNLQYNFI--YDVKGQVVFAKLKTLDLSSNKLA-FMGPEFQSAAGVTW-----IS 220
Query: 360 LRNNSFSNIVGDLT-LPNNVTLRLGGNPI 387
LRNN I L N L GN
Sbjct: 221 LRNNKLVLIEKALRFSQNLEHFDLRGNGF 249
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 126 bits (317), Expect = 1e-30
Identities = 64/298 (21%), Positives = 111/298 (37%), Gaps = 32/298 (10%)
Query: 119 NDLTGTIPKEIGNISSLIFLLLNGNKLSGSLPDELGYLSNLNRLQVDENNITGTIPKSFA 178
+ L + + ++ L L+GN LS +L + L L + N + T+
Sbjct: 20 SSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYETLD--LE 77
Query: 179 NLSRVRHLHLNNNSIGGQIPSELSKLSTLIHLLVDNNNLSGNLPPELSELPQLCILQLDN 238
+LS +R L LNNN + EL ++ L NNN+S + + L N
Sbjct: 78 SLSTLRTLDLNNNYV-----QELLVGPSIETLHAANNNIS-RVSCSR--GQGKKNIYLAN 129
Query: 239 NNFSASEIPATYGNFSKLVKLSLRNCNLQGAVPD--LSRIPNLYYLDLSWNHLTGSIPSK 296
N + G S++ L L+ + + L +L+L +N + + +
Sbjct: 130 NKITMLR-DLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIY-DVKGQ 187
Query: 297 KLSENVTTIDLSDNYLNGSILESISNLPFLQTLSLENNFLTGSIPATIWQNKSFSTKARL 356
+ + T+DLS N L + + + +SL NN L I + +++
Sbjct: 188 VVFAKLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKLV-LIEKALRFSQNLEH---- 241
Query: 357 KIDLRNN---------SFSNIVGDLTLPNNVTLRLGGNPI--CTSANIPNTGRFCGSD 403
DLR N FS T+ +L G CT + + G +C D
Sbjct: 242 -FDLRGNGFHCGTLRDFFSKNQRVQTVAKQTVKKLTGQNEEECTVPTLGHYGAYCCED 298
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 124 bits (312), Expect = 5e-30
Identities = 49/303 (16%), Positives = 93/303 (30%), Gaps = 20/303 (6%)
Query: 92 QLLSMNLSGNL---APELGQLSRLQY-YFMWNDLTGTIPKEIGNISSLIFLLLNGNKLSG 147
+L +NLS N+ +L LS L+ N + E+ S+ L N +S
Sbjct: 59 KLELLNLSSNVLYETLDLESLSTLRTLDLNNNYVQ-----ELLVGPSIETLHAANNNIS- 112
Query: 148 SLPDELGYLSNLNRLQVDENNITGTIPKSFANLSRVRHLHLNNNSIGG-QIPSELSKLST 206
+ + + N IT SRV++L L N I + T
Sbjct: 113 RVSCSR--GQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDT 170
Query: 207 LIHLLVDNNNLSGNLPPELSELPQLCILQLDNNNFSASEIPATYGNFSKLVKLSLRNCNL 266
L HL + N + ++ ++ +L L L +N + + + + + + +SLRN L
Sbjct: 171 LEHLNLQYNFIY-DVKGQVV-FAKLKTLDLSSNKLA--FMGPEFQSAAGVTWISLRNNKL 226
Query: 267 QGAVPDLSRIPNLYYLDLSWNHLTGSIPSKKLSENVTTIDLSDNYLNGSILESISNLPFL 326
L NL + DL N S+N ++ + ++
Sbjct: 227 VLIEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQTVKKLTGQNEEECTVP 286
Query: 327 QTLSLENNFLTGSIPATIWQNKSFSTKARLKI-DLRNNSFSNI-VGDLTLPNNVTLRLGG 384
+PA + + + + + +
Sbjct: 287 TLGHYGAYCCE-DLPAPFADRLIALKRKEHALLSGQGSETERLECERENQARQREIDALK 345
Query: 385 NPI 387
Sbjct: 346 EQY 348
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 106 bits (265), Expect = 4e-24
Identities = 43/333 (12%), Positives = 92/333 (27%), Gaps = 57/333 (17%)
Query: 92 QLLSMNLSGNLAPELGQLSRLQY----------------------YFMWNDLTGTIPKEI 129
L +++L+ N EL ++ Y N +T +
Sbjct: 81 TLRTLDLNNNYVQELLVGPSIETLHAANNNISRVSCSRGQGKKNIYLANNKITMLRDLDE 140
Query: 130 GNISSLIFLLLNGNKLSG-SLPDELGYLSNLNRLQVDENNITGTIPKSFANLSRVRHLHL 188
G S + +L L N++ + + L L + N I + ++++ L L
Sbjct: 141 GCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIY-DVKGQ-VVFAKLKTLDL 198
Query: 189 NNNSIGGQIPSELSKLSTLIHLLVDNNNLSGNLPPELSELPQLCILQLDNNNFSASEIPA 248
++N + + E + + + + NN L + L L L N F +
Sbjct: 199 SSNKLA-FMGPEFQSAAGVTWISLRNNKLV-LIEKALRFSQNLEHFDLRGNGFHCGTLRD 256
Query: 249 TYGNFSKLVKLSLR-----------------------NCNLQGAVPDLSRIPNLYYLDLS 285
+ ++ ++ + C P R+ L + +
Sbjct: 257 FFSKNQRVQTVAKQTVKKLTGQNEEECTVPTLGHYGAYCCEDLPAPFADRLIALKRKEHA 316
Query: 286 WNHLTGSIPSKKLSE-----NVTTIDLSDNYLNGSILESISNLPFLQTLSLENNFLTGSI 340
GS + E ID I + TL + L +
Sbjct: 317 LLSGQGSETERLECERENQARQREIDALKEQYRTVIDQVTLRKQAKITLEQKKKALDEQV 376
Query: 341 PATIWQNKSFSTKARLKIDLRNNSFSNIVGDLT 373
+ L+ + + + +
Sbjct: 377 SNG--RRAHAELDGTLQQAVGQIELQHATEEQS 407
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 89.9 bits (223), Expect = 8e-19
Identities = 38/269 (14%), Positives = 80/269 (29%), Gaps = 10/269 (3%)
Query: 92 QLLSMNLSGNL---APELGQLSRLQY-YFMWNDLTGTIPKEIGNISSLIFLLLNGNKLSG 147
L +NL N ++L+ N L + E + + + ++ L NKL
Sbjct: 170 TLEHLNLQYNFIYDVKGQVVFAKLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKLV- 227
Query: 148 SLPDELGYLSNLNRLQVDENNI-TGTIPKSFANLSRVRHLHLN-NNSIGGQIPSELSKLS 205
+ L + NL + N GT+ F+ RV+ + + GQ E + +
Sbjct: 228 LIEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQTVKKLTGQNEEECTVPT 287
Query: 206 TLIHLLVDNNNLSGNLPPELSELPQLCILQLDNNNFSASEIPATYGNFSKLVKLSLRNCN 265
+ +L L L + L + N ++ ++
Sbjct: 288 LGHYGAYCCEDLPAPFADRLIALKRKEHALLSGQGSETERLECERENQARQREIDALKEQ 347
Query: 266 LQGAVPDL-SRIPNLYYLDLSWNHLTGSIPSKKLSENVTTIDLSDNYLNGSILESISNLP 324
+ + + R L+ L + + + + L + +
Sbjct: 348 YRTVIDQVTLRKQAKITLEQKKKALDEQVSNGRRAHAELDGTLQQAVGQIELQHATEEQS 407
Query: 325 FLQTLS-LENNFLTGSIPATIWQNKSFST 352
LQ L + + + QN +
Sbjct: 408 PLQLLRAIVKRYEEMYVEQQSVQNNAIRD 436
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 50.6 bits (121), Expect = 2e-06
Identities = 24/209 (11%), Positives = 50/209 (23%), Gaps = 11/209 (5%)
Query: 92 QLLSMNLSGN------LAPELGQLSRLQYYFMWNDLTGTIPKEIGNISSLIFLLLNGNK- 144
L +L GN L + R+Q + + +
Sbjct: 238 NLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAK-QTVKKLTGQNEEECTVPTLGHYGAYCC 296
Query: 145 --LSGSLPDELGYLSNL-NRLQVDENNITGTIPKSFANLSRVRHLHLNNNSIGGQIPSEL 201
L D L L + L + + T + N +R R + I
Sbjct: 297 EDLPAPFADRLIALKRKEHALLSGQGSETERLECERENQARQREIDALKEQYRTVIDQVT 356
Query: 202 SKLSTLIHLLVDNNNLSGNLPPELSELPQLCILQLDNNNFSASEIPATYGNFSKLVKLSL 261
+ I L L + +L + + +L++ +
Sbjct: 357 LRKQAKITLEQKKKALDEQVSNGRRAHAELDGTLQQAVGQIELQHATEEQSPLQLLRAIV 416
Query: 262 RNCNLQGAVPDLSRIPNLYYLDLSWNHLT 290
+ + + D+ + T
Sbjct: 417 KRYEEMYVEQQSVQNNAIRDWDMYQHKET 445
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 125 bits (317), Expect = 1e-31
Identities = 67/289 (23%), Positives = 123/289 (42%), Gaps = 31/289 (10%)
Query: 119 NDLTGTIPKEIGNISSLIFLLLNGNKLSGSLPDELGYLSNLNRLQVDENNITGTIPKSFA 178
L +PK++ L L NK++ + L NL+ L + N I+ P +FA
Sbjct: 41 LGLE-KVPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFA 97
Query: 179 NLSRVRHLHLNNNSIGGQIPSELSKLSTLIHLLVDNNNLSGNLPPE-LSELPQLCILQLD 237
L ++ L+L+ N + ++P ++ TL L V N ++ + + L Q+ +++L
Sbjct: 98 PLVKLERLYLSKNQL-KELPEKM--PKTLQELRVHENEIT-KVRKSVFNGLNQMIVVELG 153
Query: 238 NNNFSASEIPA-TYGNFSKLVKLSLRNCNLQGAVPDLSRIPNLYYLDLSWNHLTGSIPSK 296
N +S I + KL + + + N+ +P P+L L L N +T + +
Sbjct: 154 TNPLKSSGIENGAFQGMKKLSYIRIADTNIT-TIPQGL-PPSLTELHLDGNKIT-KVDAA 210
Query: 297 KLS--ENVTTIDLSDNYLNGSILESISNLPFLQTLSLENNFLTGSIPATIWQNKSFSTKA 354
L N+ + LS N ++ S++N P L+ L L NN L +P + +K
Sbjct: 211 SLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKY----- 264
Query: 355 RLK-IDLRNNSFSNI--------VGDLTLPNNVTLRLGGNPICTSANIP 394
++ + L NN+ S I + + + L NP+ I
Sbjct: 265 -IQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPV-QYWEIQ 311
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 1e-23
Identities = 46/263 (17%), Positives = 102/263 (38%), Gaps = 30/263 (11%)
Query: 92 QLLSMNLSGN----LAPE-LGQLSRLQY-YFMWNDLTGTIPKEIGNISSLIFLLLNGNKL 145
L ++ L N ++P L +L+ Y N L +P+++ +L L ++ N++
Sbjct: 77 NLHTLILINNKISKISPGAFAPLVKLERLYLSKNQLK-ELPEKM--PKTLQELRVHENEI 133
Query: 146 SGSLPDELGYLSNLNRLQVDENNITGTI--PKSFANLSRVRHLHLNNNSIGGQIPSELSK 203
+ L+ + +++ N + + +F + ++ ++ + + +I IP L
Sbjct: 134 TKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNIT-TIPQGL-- 190
Query: 204 LSTLIHLLVDNNNLSGNLPPE-LSELPQLCILQLDNNNFSASEIPA-TYGNFSKLVKLSL 261
+L L +D N ++ + L L L L L N+ S + + N L +L L
Sbjct: 191 PPSLTELHLDGNKIT-KVDAASLKGLNNLAKLGLSFNSIS--AVDNGSLANTPHLRELHL 247
Query: 262 RNCNLQGAVPDLSRIPNLYYLDLSWNHLTGSIPSKKLSE--------NVTTIDLSDNYLN 313
N L L+ + + L N+++ +I S + + + L N +
Sbjct: 248 NNNKLVKVPGGLADHKYIQVVYLHNNNIS-AIGSNDFCPPGYNTKKASYSGVSLFSNPVQ 306
Query: 314 GSILES--ISNLPFLQTLSLENN 334
++ + + L N
Sbjct: 307 YWEIQPSTFRCVYVRAAVQLGNY 329
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 80.4 bits (199), Expect = 2e-16
Identities = 47/187 (25%), Positives = 81/187 (43%), Gaps = 15/187 (8%)
Query: 85 HLHVRELQLLSMNLSGNLAPELGQLSRLQYYFMWNDLTGTIPKEIGNISSLIFLLLNGNK 144
+ + L S + + +LS ++ ++T TIP+ G SL L L+GNK
Sbjct: 149 VVELGTNPLKSSGIENGAFQGMKKLSYIRIAD--TNIT-TIPQ--GLPPSLTELHLDGNK 203
Query: 145 LSGSLPDE-LGYLSNLNRLQVDENNITGTIPKSFANLSRVRHLHLNNNSIGGQIPSELSK 203
++ + L L+NL +L + N+I+ S AN +R LHLNNN + ++P L+
Sbjct: 204 IT-KVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLAD 261
Query: 204 LSTLIHLLVDNNNLSG------NLPPELSELPQLCILQLDNNNFSASEIPA-TYGNFSKL 256
+ + + NNN+S P ++ + L +N EI T+
Sbjct: 262 HKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQPSTFRCVYVR 321
Query: 257 VKLSLRN 263
+ L N
Sbjct: 322 AAVQLGN 328
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 127 bits (320), Expect = 1e-31
Identities = 55/308 (17%), Positives = 100/308 (32%), Gaps = 27/308 (8%)
Query: 86 LHVRELQLLSMNLSGNLAPELGQLSRLQY-YFMWNDLTGTIPKEI-GNISSLIFLLLNGN 143
++ + E L+ + F + + +P + + + L LN
Sbjct: 21 CVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMR-KLPAALLDSFRQVELLNLNDL 79
Query: 144 KLSGSLPDELGYLSNLNRLQVDENNITGTIPKSFANLSRVRHLHLNNNSIGGQIPSEL-S 202
++ Y + +L + N I P F N+ + L L N + +P +
Sbjct: 80 QIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDL-SSLPRGIFH 138
Query: 203 KLSTLIHLLVDNNNLSGNLPPE-LSELPQLCILQLDNNNFSASEIPATYGNFSKLVKLSL 261
L L + NNNL + + L LQL +N + + L ++
Sbjct: 139 NTPKLTTLSMSNNNLE-RIEDDTFQATTSLQNLQLSSNRL--THVDL--SLIPSLFHANV 193
Query: 262 RNCNLQGAVPDLSRIPNLYYLDLSWNHLTGSIPSKKLSENVTTIDLSDNYLNGSILESIS 321
L L+ + LD S N + + +T + L N L + +
Sbjct: 194 SYNLLS----TLAIPIAVEELDASHNSIN-VVRGPVNV-ELTILKLQHNNL--TDTAWLL 245
Query: 322 NLPFLQTLSLENNFLTGSIPATIWQNKSFSTKARLK-IDLRNNSFSNIVGDLT-LPNNVT 379
N P L + L N L I + RL+ + + NN + +P
Sbjct: 246 NYPGLVEVDLSYNELE-KIMYHPFVKMQ-----RLERLYISNNRLVALNLYGQPIPTLKV 299
Query: 380 LRLGGNPI 387
L L N +
Sbjct: 300 LDLSHNHL 307
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 112 bits (281), Expect = 1e-26
Identities = 52/270 (19%), Positives = 103/270 (38%), Gaps = 27/270 (10%)
Query: 124 TIPKEIGNISSLIFLLLNGNKLSGSLPDELGYLSNLNRLQVDENNITGTIPKSFANLSRV 183
I + + ++ E L+N + + + + +V
Sbjct: 12 CIDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAALLDSFRQV 71
Query: 184 RHLHLNNNSIGGQIPSE-LSKLSTLIHLLVDNNNLSGNLPPE-LSELPQLCILQLDNNNF 241
L+LN+ I +I + + T+ L + N + LPP +P L +L L+ N+
Sbjct: 72 ELLNLNDLQI-EEIDTYAFAYAHTIQKLYMGFNAIR-YLPPHVFQNVPLLTVLVLERNDL 129
Query: 242 SASEIPA-TYGNFSKLVKLSLRNCNLQGAVPD--LSRIPNLYYLDLSWNHLTGSIPSKKL 298
S +P + N KL LS+ N NL+ + D +L L LS N LT + +
Sbjct: 130 --SSLPRGIFHNTPKLTTLSMSNNNLE-RIEDDTFQATTSLQNLQLSSNRLT-HVDLSLI 185
Query: 299 SENVTTIDLSDNYLNGSILESISNLPFLQTLSLENNFLTGSIPATIWQNKSFSTKARLK- 357
++ ++S N L +++ ++ L +N + + + L
Sbjct: 186 P-SLFHANVSYNL-----LSTLAIPIAVEELDASHNSIN-VVRGPVNVE--------LTI 230
Query: 358 IDLRNNSFSNIVGDLTLPNNVTLRLGGNPI 387
+ L++N+ ++ L P V + L N +
Sbjct: 231 LKLQHNNLTDTAWLLNYPGLVEVDLSYNEL 260
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 2e-26
Identities = 57/311 (18%), Positives = 122/311 (39%), Gaps = 42/311 (13%)
Query: 89 RELQLLSMNLSGN----LAPELGQ-LSRLQY-YFMWNDLTGTIPKEI-GNISSLIFLLLN 141
+Q L + N L P + Q + L NDL+ ++P+ I N L L ++
Sbjct: 93 HTIQKL--YMGFNAIRYLPPHVFQNVPLLTVLVLERNDLS-SLPRGIFHNTPKLTTLSMS 149
Query: 142 GNKLSGSLPDE-LGYLSNLNRLQVDENNITGTIPKSFANLSRVRHLHLNNNSIGGQIPSE 200
N L + D+ ++L LQ+ N +T + + + + H +++ N + S
Sbjct: 150 NNNLE-RIEDDTFQATTSLQNLQLSSNRLT-HVD--LSLIPSLFHANVSYNLL-----ST 200
Query: 201 LSKLSTLIHLLVDNNNLSGNLPPELSELPQLCILQLDNNNFSASEIPATYGNFSKLVKLS 260
L+ + L +N+++ + + +L IL+L +NN + + N+ LV++
Sbjct: 201 LAIPIAVEELDASHNSIN-VVRGPV--NVELTILKLQHNNLT--DTAW-LLNYPGLVEVD 254
Query: 261 LRNCNLQGAVPD--LSRIPNLYYLDLSWNHLTGSIPS--KKLSENVTTIDLSDNYLNGSI 316
L L+ + ++ L L +S N L ++ + + + +DLS N+L +
Sbjct: 255 LSYNELE-KIMYHPFVKMQRLERLYISNNRLV-ALNLYGQPIP-TLKVLDLSHNHLL-HV 310
Query: 317 LESISNLPFLQTLSLENNFLTGSIPATIWQNKSFSTKARLKIDLRNNSFSNIVGDLTLPN 376
+ L+ L L++N + ++ + + L +N + N
Sbjct: 311 ERNQPQFDRLENLYLDHNSIV-TLKLSTHHTLK-------NLTLSHNDWDCNSLRALFRN 362
Query: 377 NVTLRLGGNPI 387
+
Sbjct: 363 VARPAVDDADQ 373
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 123 bits (312), Expect = 2e-31
Identities = 64/209 (30%), Positives = 90/209 (43%), Gaps = 30/209 (14%)
Query: 634 GQGGYGKVYKGI-LSDNTTVAIK-----RAEEGSLQGQNEFLTEIKLLSRLHHRNLVSLL 687
G+G +G VY + +A+K + E+ ++ Q EI++ S L H N++ +
Sbjct: 23 GKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQ--LRREIEIQSHLRHPNILRMY 80
Query: 688 GYCDEEGEQMLVYEFVPNGTLRDWL--SGRTKENL--NFAMRLRVALDSAKGILYLHTEA 743
Y + L+ EF P G L L GR E F L AL Y H
Sbjct: 81 NYFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFMEELADALH------YCHERK 134
Query: 744 HPPVFHRDIKASNILLDSNLNAKVADFGLSRLAPVLDDEGTMPTHVSTIVKGTPGYLDPE 803
V HRDIK N+L+ K+ADFG S AP ++ T+ GT YL PE
Sbjct: 135 ---VIHRDIKPENLLMGYKGELKIADFGWSVHAP------SLRRR--TMC-GTLDYLPPE 182
Query: 804 YFLTHKLTDKSDVYSLGVVLLELLTGMQP 832
+K D++ GV+ E L GM P
Sbjct: 183 MIEGKTHDEKVDLWCAGVLCYEFLVGMPP 211
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 2e-31
Identities = 63/209 (30%), Positives = 91/209 (43%), Gaps = 30/209 (14%)
Query: 634 GQGGYGKVYKGI-LSDNTTVAIK-----RAEEGSLQGQNEFLTEIKLLSRLHHRNLVSLL 687
G+G +G VY +A+K + E+ ++ Q E+++ S L H N++ L
Sbjct: 18 GKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQ--LRREVEIQSHLRHPNILRLY 75
Query: 688 GYCDEEGEQMLVYEFVPNGTLRDWL--SGRTKENL--NFAMRLRVALDSAKGILYLHTEA 743
GY + L+ E+ P GT+ L + E + L AL Y H++
Sbjct: 76 GYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALS------YCHSKR 129
Query: 744 HPPVFHRDIKASNILLDSNLNAKVADFGLSRLAPVLDDEGTMPTHVSTIVKGTPGYLDPE 803
V HRDIK N+LL S K+ADFG S AP + GT YL PE
Sbjct: 130 ---VIHRDIKPENLLLGSAGELKIADFGWSVHAP---SSRRT-----DLC-GTLDYLPPE 177
Query: 804 YFLTHKLTDKSDVYSLGVVLLELLTGMQP 832
+K D++SLGV+ E L G P
Sbjct: 178 MIEGRMHDEKVDLWSLGVLCYEFLVGKPP 206
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 123 bits (312), Expect = 3e-31
Identities = 58/220 (26%), Positives = 95/220 (43%), Gaps = 25/220 (11%)
Query: 634 GQGGYGKVYKGI-LSDNTTVAIKRAEEGSLQGQNEFLT----EIKLLSRLHHRNLVSLLG 688
G+G YGKV + + A+K ++ L+ EI+LL RL H+N++ L+
Sbjct: 14 GEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVD 73
Query: 689 YCDEEGEQM--LVYEFVPNGT--LRDWLS-GRTKENLNFAMRLRVALDSAKGILYLHTEA 743
E +Q +V E+ G + D + R A L G+ YLH++
Sbjct: 74 VLYNEEKQKMYMVMEYCVCGMQEMLDSVPEKRFPVCQ--AHGYFCQLID--GLEYLHSQG 129
Query: 744 HPPVFHRDIKASNILLDSNLNAKVADFGLSRLAPVLDDEGTMPTHVSTIVKGTPGYLDPE 803
+ H+DIK N+LL + K++ G++ + T T +G+P + PE
Sbjct: 130 ---IVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRT-----SQGSPAFQPPE 181
Query: 804 YFLTHKLTD--KSDVYSLGVVLLELLTGMQPISHGKNIVR 841
K D++S GV L + TG+ P G NI +
Sbjct: 182 IANGLDTFSGFKVDIWSAGVTLYNITTGLYPF-EGDNIYK 220
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 1e-30
Identities = 62/211 (29%), Positives = 96/211 (45%), Gaps = 31/211 (14%)
Query: 634 GQGGYGKVYKGI-LSDNTTVAIK-----RAEEGSLQGQNEFLTEIKLLSRLHHRNLVSLL 687
G+G + VY+ + VAIK + + + E+K+ +L H +++ L
Sbjct: 20 GKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQR--VQNEVKIHCQLKHPSILELY 77
Query: 688 GYCDEEGEQMLVYEFVPNGTLRDWLSGRTK-----ENLNFAMRLRVALDSAKGILYLHTE 742
Y ++ LV E NG + +L R K E +F ++ G+LYLH+
Sbjct: 78 NYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQI------ITGMLYLHSH 131
Query: 743 AHPPVFHRDIKASNILLDSNLNAKVADFGLSRLAPVLDDEGTMPTHVSTIVKGTPGYLDP 802
+ HRD+ SN+LL N+N K+ADFGL+ + T + GTP Y+ P
Sbjct: 132 G---ILHRDLTLSNLLLTRNMNIKIADFGLA--TQLKMPHEKHYT-----LCGTPNYISP 181
Query: 803 EYFLTHKLTD-KSDVYSLGVVLLELLTGMQP 832
E T +SDV+SLG + LL G P
Sbjct: 182 E-IATRSAHGLESDVWSLGCMFYTLLIGRPP 211
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 3e-30
Identities = 67/275 (24%), Positives = 111/275 (40%), Gaps = 42/275 (15%)
Query: 119 NDLTGTIPKEIGNISSLIFLLLNGNKLSGSLPDELGYLSNLNRLQVDENNITGTIPKSFA 178
+L +P I ++ L L+ N++ + +L +L LQ+ N+I +F
Sbjct: 53 KNLR-EVPDGIS--TNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIRTIEIGAFN 109
Query: 179 NLSRVRHLHLNNNSIGGQIPSE-LSKLSTLIHLLVDNNNLSGNLPPEL-SELPQLCILQL 236
L+ + L L +N + IP+ LS L L + NN + ++P + +P L L L
Sbjct: 110 GLANLNTLELFDNRL-TTIPNGAFVYLSKLKELWLRNNPIE-SIPSYAFNRIPSLRRLDL 167
Query: 237 DNNNFSASEIPA-TYGNFSKLVKLSLRNCNLQGAVPDLSRIPNLYYLDLSWNHLTGSIPS 295
S I + S L L+L CNL+ +P+L+ + L LDLS NHL+ +I
Sbjct: 168 GELK-RLSYISEGAFEGLSNLRYLNLAMCNLR-EIPNLTPLIKLDELDLSGNHLS-AIRP 224
Query: 296 KKLSENVTTIDLSDNYLNGSILESISNLPFLQTLSLENNFLTGSIPATIWQNKSFSTKAR 355
S L LQ L + + + I +F
Sbjct: 225 ----------------------GSFQGLMHLQKLWMIQSQIQ-VIER-----NAFDNLQS 256
Query: 356 LK-IDLRNNSFSNIVGDL--TLPNNVTLRLGGNPI 387
L I+L +N+ + + DL L + + L NP
Sbjct: 257 LVEINLAHNNLTLLPHDLFTPLHHLERIHLHHNPW 291
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 53.6 bits (129), Expect = 2e-07
Identities = 22/107 (20%), Positives = 40/107 (37%), Gaps = 6/107 (5%)
Query: 92 QLLSMNLSGNL---APELGQLSRLQY-YFMWNDLTGTIPKEI-GNISSLIFLLLNGNKLS 146
L +NL+ P L L +L N L+ I + L L + +++
Sbjct: 186 NLRYLNLAMCNLREIPNLTPLIKLDELDLSGNHLS-AIRPGSFQGLMHLQKLWMIQSQIQ 244
Query: 147 GSLPDELGYLSNLNRLQVDENNITGTIPKSFANLSRVRHLHLNNNSI 193
+ L +L + + NN+T F L + +HL++N
Sbjct: 245 VIERNAFDNLQSLVEINLAHNNLTLLPHDLFTPLHHLERIHLHHNPW 291
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 4e-30
Identities = 60/278 (21%), Positives = 110/278 (39%), Gaps = 34/278 (12%)
Query: 627 FSSSTQVGQGGYGKVYKGILSDNTTVAIKRAEEGSLQGQNEFLT-EIKLLSRL-HHRNLV 684
F +G G G + + DN VA+KR L F E++LL H N++
Sbjct: 26 FCPKDVLGHGAEGTIVYRGMFDNRDVAVKRI----LPECFSFADREVQLLRESDEHPNVI 81
Query: 685 SLLGYCDEEGEQM--LVYEFVPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTE 742
+C E+ Q + E TL++++ + +L + + G+ +LH+
Sbjct: 82 RY--FCTEKDRQFQYIAIELCA-ATLQEYVEQKDFAHLGLEPI-TLLQQTTSGLAHLHSL 137
Query: 743 AHPPVFHRDIKASNILL-----DSNLNAKVADFGLSRLAPVLDDEGTMPTHVSTIVKGTP 797
+ HRD+K NIL+ + A ++DFGL + L + S + GT
Sbjct: 138 N---IVHRDLKPHNILISMPNAHGKIKAMISDFGLCK---KLAVGRHSFSRRSGVP-GTE 190
Query: 798 GYLDPEYF---LTHKLTDKSDVYSLGVVLLELLTGMQPISHGKNIVREVNVARDSGMVFS 854
G++ PE T D++S G V +++ GK++ R+ N+ + +
Sbjct: 191 GWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHP-FGKSLQRQANILLGACSLDC 249
Query: 855 IIDNRMGSYPSECVERFVTLALRCCHDKPEHRPSMSDV 892
+ + + + + P+ RPS V
Sbjct: 250 LHPEK---HEDVIARELIE---KMIAMDPQKRPSAKHV 281
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 4e-30
Identities = 66/274 (24%), Positives = 109/274 (39%), Gaps = 40/274 (14%)
Query: 119 NDLTGTIPKEIGNISSLIFLLLNGNKLSGSLPDELGYLSNLNRLQVDENNITGTIPKSFA 178
L+ +P+ I S+ +L L N + D +L +L LQ+ N+I +F
Sbjct: 64 RGLS-EVPQGIP--SNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSIRQIEVGAFN 120
Query: 179 NLSRVRHLHLNNNSIGGQIPSE-LSKLSTLIHLLVDNNNLSGNLPPE-LSELPQLCILQL 236
L+ + L L +N + IPS LS L L + NN + ++P + +P L L L
Sbjct: 121 GLASLNTLELFDNWL-TVIPSGAFEYLSKLRELWLRNNPIE-SIPSYAFNRVPSLMRLDL 178
Query: 237 DNNNFSASEIPATYGNFSKLVKLSLRNCNLQGAVPDLSRIPNLYYLDLSWNHLTGSIPSK 296
+ L L+L CN++ +P+L+ + L L++S NH I
Sbjct: 179 GELKKLEYISEGAFEGLFNLKYLNLGMCNIK-DMPNLTPLVGLEELEMSGNHFP-EIRP- 235
Query: 297 KLSENVTTIDLSDNYLNGSILESISNLPFLQTLSLENNFLTGSIPATIWQNKSFSTKARL 356
S L L+ L + N+ ++ I +F A L
Sbjct: 236 ---------------------GSFHGLSSLKKLWVMNSQVS-LIER-----NAFDGLASL 268
Query: 357 K-IDLRNNSFSNIVGDL--TLPNNVTLRLGGNPI 387
++L +N+ S++ DL L V L L NP
Sbjct: 269 VELNLAHNNLSSLPHDLFTPLRYLVELHLHHNPW 302
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 64.0 bits (156), Expect = 1e-10
Identities = 25/131 (19%), Positives = 52/131 (39%), Gaps = 4/131 (3%)
Query: 89 RELQLLSMNLSGNLAPE-LGQLSRLQY-YFMWNDLTGTIPKEIGNISSLIFLLLNGNKLS 146
L L + ++ L L+Y ++ +P + + L L ++GN
Sbjct: 174 MRLDLGELKKLEYISEGAFEGLFNLKYLNLGMCNIK-DMP-NLTPLVGLEELEMSGNHFP 231
Query: 147 GSLPDELGYLSNLNRLQVDENNITGTIPKSFANLSRVRHLHLNNNSIGGQIPSELSKLST 206
P LS+L +L V + ++ +F L+ + L+L +N++ + L
Sbjct: 232 EIRPGSFHGLSSLKKLWVMNSQVSLIERNAFDGLASLVELNLAHNNLSSLPHDLFTPLRY 291
Query: 207 LIHLLVDNNNL 217
L+ L + +N
Sbjct: 292 LVELHLHHNPW 302
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 2e-29
Identities = 70/275 (25%), Positives = 110/275 (40%), Gaps = 47/275 (17%)
Query: 634 GQGGYGKVYKGI-LSDNTTVAIKR------AEEGSLQGQNEFLTEIKLLSRLHHR--NLV 684
G GG+G VY GI +SDN VAIK ++ G L E+ LL ++ ++
Sbjct: 52 GSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVI 111
Query: 685 SLLGYCDEEGEQMLVYEFV-PNGTLRDWLS--GRTKENLNFAMRLRVALDSAKGILYLHT 741
LL + + +L+ E P L D+++ G +E L A + A + + H
Sbjct: 112 RLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEEL--ARSFFWQVLEA--VRHCHN 167
Query: 742 EAHPPVFHRDIKASNILLDSN-LNAKVADFGLSRLAPVLDDEGTMPTHVSTIVKGTPGYL 800
V HRDIK NIL+D N K+ DFG L + GT Y
Sbjct: 168 CG---VLHRDIKDENILIDLNRGELKLIDFGSGALLK----DTVYTDFD-----GTRVYS 215
Query: 801 DPEYFLTHKLT-DKSDVYSLGVVLLELLTGMQPISHGKNIVREVNVARDSGMVFSIIDNR 859
PE+ H+ + V+SLG++L +++ G P H + I+R
Sbjct: 216 PPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRG--------------QVF 261
Query: 860 MGSYPSECVERFVTLALRCCHDKPEHRPSMSDVVR 894
S + + C +P RP+ ++
Sbjct: 262 FRQRVSSECQHLIR---WCLALRPSDRPTFEEIQN 293
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 2e-29
Identities = 62/215 (28%), Positives = 92/215 (42%), Gaps = 19/215 (8%)
Query: 634 GQGGYGKVYKGI-LSDNTTVAIKRAEEGSLQGQNEFLT-EIKLLSRLHHRNLVSLLGYCD 691
G+G YG+V + VA+K + E + EI + L+H N+V G+
Sbjct: 16 GEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRR 75
Query: 692 EEGEQMLVYEFVPNGTLRDWLS--GRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFH 749
E Q L E+ G L D + E A R L + ++YLH + H
Sbjct: 76 EGNIQYLFLEYCSGGELFDRIEPDIGMPEPD--AQRFFHQLMAG--VVYLHGIG---ITH 128
Query: 750 RDIKASNILLDSNLNAKVADFGLSRLAPVLDDEGTMPTHVSTIVKGTPGYLDPEYFLTHK 809
RDIK N+LLD N K++DFGL+ + + E + GT Y+ PE L +
Sbjct: 129 RDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC-----GTLPYVAPE-LLKRR 182
Query: 810 LTD--KSDVYSLGVVLLELLTGMQPISHGKNIVRE 842
DV+S G+VL +L G P + +E
Sbjct: 183 EFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQE 217
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 2e-29
Identities = 61/281 (21%), Positives = 115/281 (40%), Gaps = 25/281 (8%)
Query: 119 NDLTGTIPKEIGNISSLIFLLLNGNKLSGSLPDELGYLSNLNRLQVDENNITGTIPKSFA 178
+P+ I + L L N++ DE +L L+++EN ++ P +F
Sbjct: 21 KRFV-AVPEGIP--TETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVSAVEPGAFN 77
Query: 179 NLSRVRHLHLNNNSIGGQIPSE-LSKLSTLIHLLVDNNNLSGNLPPEL-SELPQLCILQL 236
NL +R L L +N + IP + LS L L + N + L + +L L L++
Sbjct: 78 NLFNLRTLGLRSNRL-KLIPLGVFTGLSNLTKLDISENKIV-ILLDYMFQDLYNLKSLEV 135
Query: 237 DNNNFSASEIPA-TYGNFSKLVKLSLRNCNLQGAVPD--LSRIPNLYYLDLSWNHLTGSI 293
+N+ I + + L +L+L CNL ++P LS + L L L ++ +I
Sbjct: 136 GDNDL--VYISHRAFSGLNSLEQLTLEKCNLT-SIPTEALSHLHGLIVLRLRHLNIN-AI 191
Query: 294 PSKKLS--ENVTTIDLSDNYLNGSILESISNLPFLQTLSLENNFLTGSIPATIWQNKSFS 351
+ +++S ++ + L +LS+ + LT ++P +
Sbjct: 192 RDYSFKRLYRLKVLEISHWPYLDTMTPNCLYGLNLTSLSITHCNLT-AVPY-----LAVR 245
Query: 352 TKARLK-IDLRNNSFSNIVGDL--TLPNNVTLRLGGNPICT 389
L+ ++L N S I G + L ++L G +
Sbjct: 246 HLVYLRFLNLSYNPISTIEGSMLHELLRLQEIQLVGGQLAV 286
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 1e-28
Identities = 69/288 (23%), Positives = 128/288 (44%), Gaps = 24/288 (8%)
Query: 92 QLLSMNLSGN----LAPE-LGQLSRLQY-YFMWNDLTGTIPKEI-GNISSLIFLLLNGNK 144
L + L+ N + P L L+ N L IP + +S+L L ++ NK
Sbjct: 57 HLEELELNENIVSAVEPGAFNNLFNLRTLGLRSNRLK-LIPLGVFTGLSNLTKLDISENK 115
Query: 145 LSGSLPDELGYLSNLNRLQVDENNITGTIPKSFANLSRVRHLHLNNNSIGGQIPSE-LSK 203
+ L L NL L+V +N++ ++F+ L+ + L L ++ IP+E LS
Sbjct: 116 IVILLDYMFQDLYNLKSLEVGDNDLVYISHRAFSGLNSLEQLTLEKCNLT-SIPTEALSH 174
Query: 204 LSTLIHLLVDNNNLSGNLPPELSELPQLCILQLDNNNFSASEIPATYGNFSKLVKLSLRN 263
L LI L + + N++ L +L +L++ + + + P + L LS+ +
Sbjct: 175 LHGLIVLRLRHLNINAIRDYSFKRLYRLKVLEISHWPYLDTMTPNCLYGLN-LTSLSITH 233
Query: 264 CNLQGAVPD--LSRIPNLYYLDLSWNHLTGSIPSKKLS--ENVTTIDLSDNYLNGSILES 319
CNL AVP + + L +L+LS+N ++ +I L + I L L +
Sbjct: 234 CNLT-AVPYLAVRHLVYLRFLNLSYNPIS-TIEGSMLHELLRLQEIQLVGGQLAVVEPYA 291
Query: 320 ISNLPFLQTLSLENNFLTGSIPATIWQNKSFSTKARLK-IDLRNNSFS 366
L +L+ L++ N LT ++ ++ F + L+ + L +N +
Sbjct: 292 FRGLNYLRVLNVSGNQLT-TLEESV-----FHSVGNLETLILDSNPLA 333
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 118 bits (299), Expect = 3e-29
Identities = 68/290 (23%), Positives = 113/290 (38%), Gaps = 32/290 (11%)
Query: 119 NDLTGTIPKEIGNISSLIFLLLNGNKLSGSLPDELGYLSNLNRLQVDENNITGTIPKSFA 178
L +PKEI L L N +S D+ L +L L + N I+ K+F+
Sbjct: 43 LGLK-AVPKEIS--PDTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKISKIHEKAFS 99
Query: 179 NLSRVRHLHLNNNSIGGQIPSELSKLSTLIHLLVDNNNLSGNLPPE-LSELPQLCILQLD 237
L +++ L+++ N + +IP L S+L+ L + +N + +P S L + +++
Sbjct: 100 PLRKLQKLYISKNHL-VEIPPNL--PSSLVELRIHDNRIR-KVPKGVFSGLRNMNCIEMG 155
Query: 238 NNNFSASEIPATYGNFS--KLVKLSLRNCNLQGAVPDLSRIPNLYYLDLSWNHLTGSIPS 295
N S G F KL L + L G DL L L L N + +I
Sbjct: 156 GNPLENSGFEP--GAFDGLKLNYLRISEAKLTGIPKDL--PETLNELHLDHNKIQ-AIEL 210
Query: 296 KKLS--ENVTTIDLSDNYLNGSILESISNLPFLQTLSLENNFLTGSIPATIWQNKSFSTK 353
+ L + + L N + S+S LP L+ L L+NN L+ +PA + K
Sbjct: 211 EDLLRYSKLYRLGLGHNQIRMIENGSLSFLPTLRELHLDNNKLS-RVPAGLPDLKLLQV- 268
Query: 354 ARLKIDLRNN--------SFSNIVGDLTLPNNVTLRLGGNPICTSANIPN 395
+ L N F + + + L NP+ +
Sbjct: 269 ----VYLHTNNITKVGVNDFCPVGFGVKRAYYNGISLFNNPV-PYWEVQP 313
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 92.8 bits (231), Expect = 2e-20
Identities = 53/263 (20%), Positives = 97/263 (36%), Gaps = 31/263 (11%)
Query: 92 QLLSMNLSGN----LAPE-LGQLSRLQY-YFMWNDLTGTIPKEIGNISSLIFLLLNGNKL 145
L ++ L N + + L +LQ Y N L IP + SSL+ L ++ N++
Sbjct: 79 HLYALVLVNNKISKIHEKAFSPLRKLQKLYISKNHLV-EIPPNL--PSSLVELRIHDNRI 135
Query: 146 SGSLPDELGYLSNLNRLQVDENNITGTI--PKSFANLSRVRHLHLNNNSIGGQIPSELSK 203
L N+N +++ N + + P +F L + +L ++ + IP +L
Sbjct: 136 RKVPKGVFSGLRNMNCIEMGGNPLENSGFEPGAFDGLK-LNYLRISEAKLT-GIPKDL-- 191
Query: 204 LSTLIHLLVDNNNLSGNLPPE-LSELPQLCILQLDNNNFSASEIPA-TYGNFSKLVKLSL 261
TL L +D+N + + E L +L L L +N I + L +L L
Sbjct: 192 PETLNELHLDHNKIQ-AIELEDLLRYSKLYRLGLGHNQIR--MIENGSLSFLPTLRELHL 248
Query: 262 RNCNLQGAVPDLSRIPNLYYLDLSWNHLTGSIPSKKLSE--------NVTTIDLSDNYLN 313
N L L + L + L N++T + I L +N +
Sbjct: 249 DNNKLSRVPAGLPDLKLLQVVYLHTNNIT-KVGVNDFCPVGFGVKRAYYNGISLFNNPVP 307
Query: 314 GSILE--SISNLPFLQTLSLENN 334
++ + + + N
Sbjct: 308 YWEVQPATFRCVTDRLAIQFGNY 330
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 117 bits (294), Expect = 5e-29
Identities = 55/209 (26%), Positives = 97/209 (46%), Gaps = 16/209 (7%)
Query: 626 YFSSSTQVGQGGYGKVYKGI-LSDNTTVAIKRAEEGSLQGQNEFLTEIKLLSRLHHRNLV 684
++ ++GQG G VY + ++ VAI++ + + EI ++ + N+V
Sbjct: 21 KYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIV 80
Query: 685 SLLGYCDEEGEQMLVYEFVPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAH 744
+ L E +V E++ G+L D ++ + A R L + + +LH+
Sbjct: 81 NYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECL---QALEFLHSNQ- 136
Query: 745 PPVFHRDIKASNILLDSNLNAKVADFGLS-RLAPVLDDEGTMPTHVSTIVKGTPGYLDPE 803
V HRDIK+ NILL + + K+ DFG ++ P TM GTP ++ PE
Sbjct: 137 --VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTM--------VGTPYWMAPE 186
Query: 804 YFLTHKLTDKSDVYSLGVVLLELLTGMQP 832
K D++SLG++ +E++ G P
Sbjct: 187 VVTRKAYGPKVDIWSLGIMAIEMIEGEPP 215
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 122 bits (307), Expect = 6e-29
Identities = 56/309 (18%), Positives = 101/309 (32%), Gaps = 29/309 (9%)
Query: 86 LHVRELQLLSMNLSGNLAPELGQLSRLQY-YFMWNDLTGTIPKEI-GNISSLIFLLLNGN 143
++ + E L+ + F + + +P + + + L LN
Sbjct: 27 CVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMR-KLPAALLDSFRQVELLNLNDL 85
Query: 144 KLSGSLPDE-LGYLSNLNRLQVDENNITGTIPKSFANLSRVRHLHLNNNSIGGQIPSEL- 201
++ + Y + +L + N I P F N+ + L L N + +P +
Sbjct: 86 QIE-EIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDL-SSLPRGIF 143
Query: 202 SKLSTLIHLLVDNNNLSGNLPPE-LSELPQLCILQLDNNNFSASEIPATYGNFSKLVKLS 260
L L + NNNL + + L LQL +N + + L +
Sbjct: 144 HNTPKLTTLSMSNNNLE-RIEDDTFQATTSLQNLQLSSNRL--THVDL--SLIPSLFHAN 198
Query: 261 LRNCNLQGAVPDLSRIPNLYYLDLSWNHLTGSIPSKKLSENVTTIDLSDNYLNGSILESI 320
+ L L+ + LD S N + + +T + L N L + +
Sbjct: 199 VSYNLLS----TLAIPIAVEELDASHNSIN-VVRGPVNV-ELTILKLQHNNL--TDTAWL 250
Query: 321 SNLPFLQTLSLENNFLTGSIPATIWQNKSFSTKARLK-IDLRNNSFSNIVGDLT-LPNNV 378
N P L + L N L I F RL+ + + NN + +P
Sbjct: 251 LNYPGLVEVDLSYNELE-KIMYH-----PFVKMQRLERLYISNNRLVALNLYGQPIPTLK 304
Query: 379 TLRLGGNPI 387
L L N +
Sbjct: 305 VLDLSHNHL 313
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 7e-27
Identities = 67/334 (20%), Positives = 119/334 (35%), Gaps = 42/334 (12%)
Query: 92 QLLSMNLSGN----LAPE-LGQLSRLQYYFMWNDLTGTIPKEI-GNISSLIFLLLNGNKL 145
Q+ +NL+ + +Q +M + +P + N+ L L+L N L
Sbjct: 76 QVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDL 135
Query: 146 SGSLPDEL-GYLSNLNRLQVDENNITGTIPKSFANLSRVRHLHLNNNSIGGQIPSELSKL 204
S SLP + L L + NN+ +F + +++L L++N + + LS +
Sbjct: 136 S-SLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLT-HVD--LSLI 191
Query: 205 STLIHLLVDNNNLSGNLPPELSELPQLCILQLDNNNFSASEIPATYGNFSKLVKLSLRNC 264
+L H V N LS L+ + L +N+ + + +L L L++
Sbjct: 192 PSLFHANVSYNLLS-----TLAIPIAVEELDASHNSIN--VVRG--PVNVELTILKLQHN 242
Query: 265 NLQGAVPDLSRIPNLYYLDLSWNHLTGSIPSKKLS--ENVTTIDLSDNYLNGSILESISN 322
NL L P L +DLS+N L I + + + +S+N L ++
Sbjct: 243 NLT-DTAWLLNYPGLVEVDLSYNELE-KIMYHPFVKMQRLERLYISNNRLV-ALNLYGQP 299
Query: 323 LPFLQTLSLENNFLTGSIPATIWQNKS---------------FSTKARLK-IDLRNNSFS 366
+P L+ L L +N L + Q ST LK + L +N +
Sbjct: 300 IPTLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSIVTLKLSTHHTLKNLTLSHNDWD 358
Query: 367 NIVGDLTLPNNVTLRLGGNPICTSANIPNTGRFC 400
N + + C
Sbjct: 359 CNSLRALFRNVARPAVDDADQHCKIDYQLEHGLC 392
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 7e-25
Identities = 52/270 (19%), Positives = 103/270 (38%), Gaps = 27/270 (10%)
Query: 124 TIPKEIGNISSLIFLLLNGNKLSGSLPDELGYLSNLNRLQVDENNITGTIPKSFANLSRV 183
I + + ++ E L+N + + + + +V
Sbjct: 18 CIDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAALLDSFRQV 77
Query: 184 RHLHLNNNSIGGQIPSE-LSKLSTLIHLLVDNNNLSGNLPPE-LSELPQLCILQLDNNNF 241
L+LN+ I +I + + T+ L + N + LPP +P L +L L+ N+
Sbjct: 78 ELLNLNDLQI-EEIDTYAFAYAHTIQKLYMGFNAIR-YLPPHVFQNVPLLTVLVLERNDL 135
Query: 242 SASEIPA-TYGNFSKLVKLSLRNCNLQGAVPD--LSRIPNLYYLDLSWNHLTGSIPSKKL 298
S +P + N KL LS+ N NL+ + D +L L LS N LT + +
Sbjct: 136 --SSLPRGIFHNTPKLTTLSMSNNNLE-RIEDDTFQATTSLQNLQLSSNRLT-HVDLSLI 191
Query: 299 SENVTTIDLSDNYLNGSILESISNLPFLQTLSLENNFLTGSIPATIWQNKSFSTKARLK- 357
++ ++S N L +++ ++ L +N + + + L
Sbjct: 192 P-SLFHANVSYNL-----LSTLAIPIAVEELDASHNSIN-VVRGPVNVE--------LTI 236
Query: 358 IDLRNNSFSNIVGDLTLPNNVTLRLGGNPI 387
+ L++N+ ++ L P V + L N +
Sbjct: 237 LKLQHNNLTDTAWLLNYPGLVEVDLSYNEL 266
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 6e-29
Identities = 63/244 (25%), Positives = 110/244 (45%), Gaps = 19/244 (7%)
Query: 595 SLSRKRLSTKISMKIDGVKGFKFKELAMATAYFSSSTQVGQGGYGKVYKGIL-SDNTTVA 653
L L + +++ K K + F +++G G G V+K +A
Sbjct: 3 KLEELELDEQQRKRLEAFLTQKQKVGELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMA 62
Query: 654 IKR-AEEGSLQGQNEFLTEIKLLSRLHHRNLVSLLGYCDEEGEQMLVYEFVPNGTLRDWL 712
K E +N+ + E+++L + +V G +GE + E + G+L L
Sbjct: 63 RKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVL 122
Query: 713 --SGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSNLNAKVADF 770
+GR E + +V++ KG+ YL + + HRD+K SNIL++S K+ DF
Sbjct: 123 KKAGRIPEQ----ILGKVSIAVIKGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDF 176
Query: 771 GLSRLAPVLDDEGTMPTHVSTIVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVLLELLTGM 830
G+S L D + ++ V GT Y+ PE + +SD++S+G+ L+E+ G
Sbjct: 177 GVSG---QLID-----SMANSFV-GTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGR 227
Query: 831 QPIS 834
PI
Sbjct: 228 YPIP 231
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 122 bits (307), Expect = 6e-29
Identities = 73/302 (24%), Positives = 121/302 (40%), Gaps = 52/302 (17%)
Query: 92 QLLSMNLSGN----LAPELGQ-LSRLQYYFMWNDLTGTIPKEIGNISSLIFLLLNGNKLS 146
+N+ + L L ++ L N+LT ++P + +L ++GN+L+
Sbjct: 41 GNAVLNVGESGLTTLPDCLPAHITTL--VIPDNNLT-SLPALPPELRTLE---VSGNQLT 94
Query: 147 GSLPDELGYLSNLNRLQVDENNITGTIPKSFANLSRVRHLHLNNNSIGGQIPSELSKLST 206
SLP L L+ + +P + L L + N + +P L
Sbjct: 95 -SLPVLPPGLLELSIFSNPLTH----LPALPSGL---CKLWIFGNQL-TSLPVLPPGLQE 145
Query: 207 LIHLLVDNNNLSGNLPPELSELPQLCILQLDNNNFSASEIPATYGNFSKLVKLSLRNCNL 266
L V +N L+ +LP S +LC L NN + +P S L +LS+ + L
Sbjct: 146 LS---VSDNQLA-SLPALPS---ELCKLWAYNNQL--TSLPM---LPSGLQELSVSDNQL 193
Query: 267 QGAVPDLSRIPNLYYLDLSWNHLTGSIPSKKLSENVTTIDLSDNYLNGSILESISNLPFL 326
++P L LY L N LT S+P+ L + + +S N L S+ S L
Sbjct: 194 A-SLPTL--PSELYKLWAYNNRLT-SLPA--LPSGLKELIVSGNRLT-SLPVLPSE---L 243
Query: 327 QTLSLENNFLTGSIPATIWQNKSFSTKARLKIDLRNNSFSNIVGDLT-LPNNVTLRLGGN 385
+ L + N LT S+P S + + N + + L L + T+ L GN
Sbjct: 244 KELMVSGNRLT-SLPMLPSGLLS--------LSVYRNQLTRLPESLIHLSSETTVNLEGN 294
Query: 386 PI 387
P+
Sbjct: 295 PL 296
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 98.8 bits (246), Expect = 2e-21
Identities = 58/237 (24%), Positives = 98/237 (41%), Gaps = 41/237 (17%)
Query: 155 YLSNLNRLQVDENNITGTIPKSFANLSRVRHLHLNNNSIGGQIPSELSKLSTLIHLLVDN 214
+ L V E+ +T T+P + + L + +N++ +P+ +L TL V
Sbjct: 38 LNNGNAVLNVGESGLT-TLPDCL--PAHITTLVIPDNNLT-SLPALPPELRTLE---VSG 90
Query: 215 NNLSGNLPPELSELPQLCILQLDNNNFSASEIPATYGNFSKLVKLSLRNCNLQGAVPDLS 274
N L+ +LP L +L I + A S L KL + L ++P L
Sbjct: 91 NQLT-SLPVLPPGLLELSIFSNPLTHLPAL--------PSGLCKLWIFGNQLT-SLPVL- 139
Query: 275 RIPNLYYLDLSWNHLTGSIPSKKLSENVTTIDLSDNYLNGSILESISNLPFLQTLSLENN 334
P L L +S N L S+P+ L + + +N L S+ S LQ LS+ +N
Sbjct: 140 -PPGLQELSVSDNQLA-SLPA--LPSELCKLWAYNNQLT-SLPMLPSG---LQELSVSDN 191
Query: 335 FLTGSIPATIWQNKSFSTKARL-KIDLRNNSFSNIVGDLTLPNNVT-LRLGGNPICT 389
L S+P + L K+ NN +++ LP+ + L + GN + +
Sbjct: 192 QLA-SLPTLP---------SELYKLWAYNNRLTSL---PALPSGLKELIVSGNRLTS 235
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 91.9 bits (228), Expect = 3e-19
Identities = 45/218 (20%), Positives = 77/218 (35%), Gaps = 35/218 (16%)
Query: 87 HVRELQLLSMNLSGNLAPELGQLSRLQYYFMWNDLTGTIPKEIGNISSLIFLLLNGNKLS 146
++EL + L+ +L +L +L + N LT ++P L L ++ N+L+
Sbjct: 142 GLQELSVSDNQLA-SLPALPSELCKL--WAYNNQLT-SLPMLPSG---LQELSVSDNQLA 194
Query: 147 GSLPDELGYLSNLNRLQVDENNITGTIPKSFANLSRVRHLHLNNNSIGGQIPSELSKL-- 204
SLP L +L N +T ++P + L + L ++ N + +P S+L
Sbjct: 195 -SLPTLPS---ELYKLWAYNNRLT-SLPALPSGL---KELIVSGNRLT-SLPVLPSELKE 245
Query: 205 ---------------STLIHLLVDNNNLSGNLPPELSELPQLCILQLDNNNFSASEIPAT 249
S L+ L V N L+ LP L L + L+ N S
Sbjct: 246 LMVSGNRLTSLPMLPSGLLSLSVYRNQLT-RLPESLIHLSSETTVNLEGNPLS-ERTLQA 303
Query: 250 YGNFSKLVKLSLRNCNLQGAVPDLSRIPNLYYLDLSWN 287
+ S A R +L +
Sbjct: 304 LREITSAPGYSGPIIRFDMAGASAPRETRALHLAAADW 341
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 67.6 bits (165), Expect = 1e-11
Identities = 26/153 (16%), Positives = 54/153 (35%), Gaps = 13/153 (8%)
Query: 92 QLLSMNLSGN----LAPELGQLSRLQYYFMWNDLTGTIPKEIGNISSLIFLLLNGNKLSG 147
L + +SGN L +L L N LT ++P L+ L + N+L+
Sbjct: 222 GLKELIVSGNRLTSLPVLPSELKEL--MVSGNRLT-SLPMLPSG---LLSLSVYRNQLT- 274
Query: 148 SLPDELGYLSNLNRLQVDENNITGTIPKSFANLSRVRHLHLNNNSIGGQIPSELSKLSTL 207
LP+ L +LS+ + ++ N ++ + + + +
Sbjct: 275 RLPESLIHLSSETTVNLEGNPLS-ERTLQALREITSAPGYSGPIIRFDMAGASAPRETRA 333
Query: 208 IHLLVDNNNLSGNLPPELSELPQLCILQLDNNN 240
+HL + L E + + + ++N
Sbjct: 334 LHLAA-ADWLVPAREGEPAPADRWHMFGQEDNA 365
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 7e-29
Identities = 57/274 (20%), Positives = 111/274 (40%), Gaps = 46/274 (16%)
Query: 633 VGQGGYGKVYKGI-LSDNTTVAIKR-AEEGSLQGQNEFLTEIK-LLSRLHHRNLVSLLGY 689
+G+G YG V K + +A+KR + Q Q L ++ + + V+ G
Sbjct: 15 LGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGA 74
Query: 690 CDEEGEQMLVYEFVPNGTLRDWLSGRTKENLNFAMRL------RVALDSAKGILYLHTEA 743
EG+ + E + + +L + K+ ++ + ++A+ K + +LH++
Sbjct: 75 LFREGDVWICMELM-DTSLDKFY----KQVIDKGQTIPEDILGKIAVSIVKALEHLHSKL 129
Query: 744 HPPVFHRDIKASNILLDSNLNAKVADFGLSRLAPVLDDEGTMPTHVSTIVKGTPGYLDPE 803
V HRD+K SN+L+++ K+ DFG+S L D+ G Y+ PE
Sbjct: 130 S--VIHRDVKPSNVLINALGQVKMCDFGISG---YLVDDVAKDIDA-----GCKPYMAPE 179
Query: 804 YFLTHKLTD----KSDVYSLGVVLLELLTGMQPISHGKNIVREVNVARDSGMVFSIIDN- 858
KSD++SLG+ ++EL P + + +++
Sbjct: 180 RINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQ---------QLKQVVEEP 230
Query: 859 ----RMGSYPSECVERFVTLALRCCHDKPEHRPS 888
+ +E V+ F + +C + RP+
Sbjct: 231 SPQLPADKFSAEFVD-FTS---QCLKKNSKERPT 260
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 117 bits (294), Expect = 9e-29
Identities = 53/243 (21%), Positives = 97/243 (39%), Gaps = 27/243 (11%)
Query: 661 SLQGQNEFLTEIKLLSRLHHRNLVSLLGYCDEEGEQMLVYEFVPNGTLRDWLSGR-TKEN 719
S + +I+ + +N V L + + + L+DW++ R + E+
Sbjct: 101 SPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLED 160
Query: 720 LNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSRLAPVL 779
+ L + + A+ + +LH++ + HRD+K SNI + KV DFGL
Sbjct: 161 REHGVCLHIFIQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQD 217
Query: 780 DDEGTMPTHVS-----TIVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVLLELLTGMQPIS 834
++E T+ T + T GT Y+ PE + + K D++SLG++L ELL
Sbjct: 218 EEEQTVLTPMPAYATHTGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQM 277
Query: 835 HGKNIVREVNVARDSGMVFSIIDNRMGSYPSECVERFVTLA---LRCCHDKPEHRPSMSD 891
I+ +V R +P +++ P RP +D
Sbjct: 278 ERVRIITDV---------------RNLKFPLLFTQKYPQEHMMVQDMLSPSPTERPEATD 322
Query: 892 VVR 894
++
Sbjct: 323 IIE 325
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 118 bits (296), Expect = 1e-28
Identities = 36/261 (13%), Positives = 74/261 (28%), Gaps = 41/261 (15%)
Query: 592 YQHSLSRKRLSTKISMKIDGVKGFKFKELAMATAYFSSSTQVGQGGYGKVYKGILSDNTT 651
++ + K ++ G K L +G+G + +VY+ D
Sbjct: 45 FEWQCKLPAIKPKTEFQL-GSKLVYVHHL------------LGEGAFAQVYEATQGDLND 91
Query: 652 ------VAIKRAEEGSLQGQNEFLTEIKLLSRLHHRNLVSLLGYCDEEGEQMLVYEFVPN 705
+K + + ++ L + + +LV E
Sbjct: 92 AKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSY 151
Query: 706 GTLRDWL---SGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILL--- 759
GTL + + ++ + + + A+ I +H + H DIK N +L
Sbjct: 152 GTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCE---IIHGDIKPDNFILGNG 208
Query: 760 --------DSNLNAKVADFGLSRLAPVLDDEGTMPTHVSTIVKGTPGYLDPEYFLTHKLT 811
D + + D G S + T G+ E
Sbjct: 209 FLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKC-----ETSGFQCVEMLSNKPWN 263
Query: 812 DKSDVYSLGVVLLELLTGMQP 832
+ D + + + +L G
Sbjct: 264 YQIDYFGVAATVYCMLFGTYM 284
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 1e-28
Identities = 43/211 (20%), Positives = 77/211 (36%), Gaps = 16/211 (7%)
Query: 634 GQGGYGKVYKGI-LSDNTTVAIKRA--EEGSLQGQNEFLTEIKLLSRLHHRNLVSLLGYC 690
G V V ++R E S + E+ + +H N+V
Sbjct: 36 GFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATF 95
Query: 691 DEEGEQMLVYEFVPNGTLRDWLSGRTKENLN---FAMRLRVALDSAKGILYLHTEAHPPV 747
+ E +V F+ G+ +D + + +N A L+ L K + Y+H +
Sbjct: 96 IADNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVL---KALDYIHHMGY--- 149
Query: 748 FHRDIKASNILLDSNLNAKVADFGLS-RLAPVLDDEGTMPTHVSTIVKGTPGYLDPEYFL 806
HR +KAS+IL+ + ++ + + + + V +L PE
Sbjct: 150 VHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSV-KVLPWLSPEVLQ 208
Query: 807 THKL--TDKSDVYSLGVVLLELLTGMQPISH 835
+ KSD+YS+G+ EL G P
Sbjct: 209 QNLQGYDAKSDIYSVGITACELANGHVPFKD 239
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 1e-28
Identities = 50/211 (23%), Positives = 90/211 (42%), Gaps = 16/211 (7%)
Query: 624 TAYFSSSTQVGQGGYGKVYKGI-LSDNTTVAIKRAEEGSLQGQNEFLTEIKLLSRLHHRN 682
S ++G+G G V VA+K + Q + E+ ++ H N
Sbjct: 44 RLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFN 103
Query: 683 LVSLLGYCDEEGEQMLVYEFVPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTE 742
+V + E ++ EF+ G L D +S A L + + YLH +
Sbjct: 104 VVEMYKSYLVGEELWVLMEFLQGGALTDIVSQVRLNEEQIATVCEAVL---QALAYLHAQ 160
Query: 743 AHPPVFHRDIKASNILLDSNLNAKVADFGLS-RLAPVLDDEGTMPTHVSTIVKGTPGYLD 801
V HRDIK+ +ILL + K++DFG +++ + ++ GTP ++
Sbjct: 161 G---VIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSL--------VGTPYWMA 209
Query: 802 PEYFLTHKLTDKSDVYSLGVVLLELLTGMQP 832
PE + D++SLG++++E++ G P
Sbjct: 210 PEVISRSLYATEVDIWSLGIMVIEMVDGEPP 240
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 1e-28
Identities = 62/206 (30%), Positives = 98/206 (47%), Gaps = 17/206 (8%)
Query: 633 VGQGGYGKVYKGI-LSDNTTVAIKRAE-EGSLQGQNEFLTEIKLLSRLHHRNLVSLLGYC 690
+G+G +G+V+KGI VAIK + E + + EI +LS+ + G
Sbjct: 30 IGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSY 89
Query: 691 DEEGEQMLVYEFVPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHR 750
++ + ++ E++ G+ D L + A LR L KG+ YLH+E HR
Sbjct: 90 LKDTKLWIIMEYLGGGSALDLLEPGPLDETQIATILREIL---KGLDYLHSEK---KIHR 143
Query: 751 DIKASNILLDSNLNAKVADFGLS-RLAPVLDDEGTMPTHVSTIVKGTPGYLDPEYFLTHK 809
DIKA+N+LL + K+ADFG++ +L T GTP ++ PE
Sbjct: 144 DIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTF--------VGTPFWMAPEVIKQSA 195
Query: 810 LTDKSDVYSLGVVLLELLTGMQPISH 835
K+D++SLG+ +EL G P S
Sbjct: 196 YDSKADIWSLGITAIELARGEPPHSE 221
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 1e-28
Identities = 59/288 (20%), Positives = 101/288 (35%), Gaps = 43/288 (14%)
Query: 102 LAPELGQLSRLQYYFMW-NDLTGTIPKEIGNISSLIFLLLNGNKLSGSLPDELGYLSNLN 160
+ P + LQ ++LT +P E N+ S ++ + P G +
Sbjct: 3 INPRNVSNTFLQEPLRHSSNLT-EMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMA 61
Query: 161 RLQVDENNITGTIPKSFANLSRVRHLHLNNNSIGGQIPSELSKLSTLIHLLVDNNNLSGN 220
++ + + L LNN + +P L +L+ N+L+
Sbjct: 62 VSRLRDCLDR-----------QAHELELNNLGL-SSLPELPPHLESLV---ASCNSLT-E 105
Query: 221 LPPELSELPQLCILQLDNNNFSASEIPATYGNFSKLVKLSLRNCNLQGAVPDLSRIPNLY 280
LP L L + + S++P L L + N L+ +P+L L
Sbjct: 106 LPELPQSLKSLLVDNNNLKAL--SDLP------PLLEYLGVSNNQLE-KLPELQNSSFLK 156
Query: 281 YLDLSWNHLTGSIPSKKLSENVTTIDLSDNYLNGSILESISNLPFLQTLSLENNFLTGSI 340
+D+ N L +P L ++ I +N L L + NLPFL + +NN L +
Sbjct: 157 IIDVDNNSLK-KLPD--LPPSLEFIAAGNNQL--EELPELQNLPFLTAIYADNNSLK-KL 210
Query: 341 PATIWQNKSFSTKARLK-IDLRNNSFSNIVGDLTLPNNVTLRLGGNPI 387
P L+ I NN + LP T+ N +
Sbjct: 211 PDLP---------LSLESIVAGNNILEELPELQNLPFLTTIYADNNLL 249
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 3e-23
Identities = 60/275 (21%), Positives = 93/275 (33%), Gaps = 51/275 (18%)
Query: 92 QLLSMNLSGNL---APELGQLSRLQY-YFMWNDLTGTIPKEIGNISSLIFLLLNGNKLSG 147
L + N PEL L L Y N L +P + L ++ N L
Sbjct: 174 SLEFIAAGNNQLEELPELQNLPFLTAIYADNNSLK-KLPDLPLS---LESIVAGNNILE- 228
Query: 148 SLPDELGYLSNLNRLQVDENNITGTIPKSFANLSRVRHLHLNNNSIGGQIPSELSKLSTL 207
LP EL L L + D N + T+P +L L++ +N + +P L+ L
Sbjct: 229 ELP-ELQNLPFLTTIYADNNLLK-TLPDLPPSL---EALNVRDNYLT-DLPELPQSLTFL 282
Query: 208 IHLLVDNNNLSGNLPPELSELPQLCILQLDNNNFSASEIPATYGNFSKLVKLSLRNCNLQ 267
+ LS P L L +N + L +L++ N L
Sbjct: 283 DVSENIFSGLS-------ELPPNLYYLNASSNEIR--SLC---DLPPSLEELNVSNNKLI 330
Query: 268 GAVPDLSRIPNLYYLDLSWNHLTGSIPSKKLSENVTTIDLSDNYLNGSILESISNLPF-- 325
+P L P L L S+NHL +P L +N+ + + N L + ++
Sbjct: 331 -ELPAL--PPRLERLIASFNHLA-EVPE--LPQNLKQLHVEYNPLR-EFPDIPESVEDLR 383
Query: 326 --------------LQTLSLENNFLTGSIPATIWQ 346
L+ L +E N L P
Sbjct: 384 MNSHLAEVPELPQNLKQLHVETNPLR-EFPDIPES 417
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 97.0 bits (242), Expect = 3e-21
Identities = 59/264 (22%), Positives = 95/264 (35%), Gaps = 50/264 (18%)
Query: 92 QLLSMNLSGNLA---PELGQLSRLQY-YFMWNDLTGTIPKEIGNISSLIFLLLNGNKLSG 147
L S+ N+ PEL L L Y N L T+P + L L + N L+
Sbjct: 216 SLESIVAGNNILEELPELQNLPFLTTIYADNNLLK-TLPDLPPS---LEALNVRDNYLT- 270
Query: 148 SLPDELGYLSNLNRLQVDENNITGTIPKSFANLSRVRHLHLNNNSIGGQIPSELSKLSTL 207
LP+ +L L V EN + + + NL +L+ ++N I + L L
Sbjct: 271 DLPELPQ---SLTFLDVSENIFS-GLSELPPNL---YYLNASSNEIR-SLCDLPPSLEEL 322
Query: 208 IHLLVDNNNLSGNLPPELSELPQLCILQLDNNNFSASEIPATYGNFSKLVKLSLRNCNLQ 267
V NN L LP + P+L L N+ + E+P N L +L + L+
Sbjct: 323 N---VSNNKLI-ELP---ALPPRLERLIASFNHLA--EVPELPQN---LKQLHVEYNPLR 370
Query: 268 GAVPDL-----------------SRIPNLYYLDLSWNHLTGSIPSKKLSENVTTIDLSDN 310
PD+ NL L + N L P + E+V + ++
Sbjct: 371 -EFPDIPESVEDLRMNSHLAEVPELPQNLKQLHVETNPLR-EFP--DIPESVEDLRMNSE 426
Query: 311 YLNGSILESISNLPFLQTLSLENN 334
+ + L+ E++
Sbjct: 427 RVVDPYEFAHETTDKLEDDVFEHH 450
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 66.2 bits (162), Expect = 2e-11
Identities = 29/155 (18%), Positives = 55/155 (35%), Gaps = 23/155 (14%)
Query: 92 QLLSMNLSGN----LAPELGQLSRLQYYFMWNDLTGTIPKEIGNISSLIFLLLNGNKLSG 147
L +N+S N L +L RL F N L +P+ N+ L + N L
Sbjct: 318 SLEELNVSNNKLIELPALPPRLERLIASF--NHLA-EVPELPQNLKQLH---VEYNPLR- 370
Query: 148 SLPDELGYLSNLNRLQVDENNITGTIPKSFANLSRVRHLHLNNNSIGGQIPSELSKLSTL 207
PD + +L N+ +P+ NL + LH+ N + + P +
Sbjct: 371 EFPDIPESVEDL-----RMNSHLAEVPELPQNL---KQLHVETNPLR-EFPDIPESVE-- 419
Query: 208 IHLLVDNNNLSGNLPPELSELPQLCILQLDNNNFS 242
L +++ + +L ++++
Sbjct: 420 -DLRMNSERVVDPYEFAHETTDKLEDDVFEHHHHH 453
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 1e-28
Identities = 62/215 (28%), Positives = 92/215 (42%), Gaps = 19/215 (8%)
Query: 634 GQGGYGKVYKGI-LSDNTTVAIKRAEEGSLQGQNEFLT-EIKLLSRLHHRNLVSLLGYCD 691
G+G YG+V + VA+K + E + EI + L+H N+V G+
Sbjct: 16 GEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRR 75
Query: 692 EEGEQMLVYEFVPNGTLRDWLS--GRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFH 749
E Q L E+ G L D + E A R L + ++YLH + H
Sbjct: 76 EGNIQYLFLEYCSGGELFDRIEPDIGMPEPD--AQRFFHQLMAG--VVYLHGIG---ITH 128
Query: 750 RDIKASNILLDSNLNAKVADFGLSRLAPVLDDEGTMPTHVSTIVKGTPGYLDPEYFLTHK 809
RDIK N+LLD N K++DFGL+ + + E + GT Y+ PE L +
Sbjct: 129 RDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC-----GTLPYVAPE-LLKRR 182
Query: 810 LTD--KSDVYSLGVVLLELLTGMQPISHGKNIVRE 842
DV+S G+VL +L G P + +E
Sbjct: 183 EFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQE 217
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 2e-28
Identities = 62/214 (28%), Positives = 97/214 (45%), Gaps = 18/214 (8%)
Query: 633 VGQGGYGKVYKGI-LSDNTTVAIKRAE-EGSLQGQNEFLTEIKLLSRLHHRNLVSLLGYC 690
+G G V VAIKR E +E L EI+ +S+ HH N+VS
Sbjct: 23 IGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSF 82
Query: 691 DEEGEQMLVYEFVPNGTLRDWLSGRTKENLNFAMRLR------VALDSAKGILYLHTEAH 744
+ E LV + + G++ D + + + + L + + +G+ YLH
Sbjct: 83 VVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQ 142
Query: 745 PPVFHRDIKASNILLDSNLNAKVADFGLSRLAPVLDDEGTMPTHVS--TIVKGTPGYLDP 802
HRD+KA NILL + + ++ADFG+S L G + + T V GTP ++ P
Sbjct: 143 ---IHRDVKAGNILLGEDGSVQIADFGVSAF---LATGGDITRNKVRKTFV-GTPCWMAP 195
Query: 803 EYFLTHKLTD-KSDVYSLGVVLLELLTGMQPISH 835
E + D K+D++S G+ +EL TG P
Sbjct: 196 EVMEQVRGYDFKADIWSFGITAIELATGAAPYHK 229
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 3e-28
Identities = 69/277 (24%), Positives = 112/277 (40%), Gaps = 49/277 (17%)
Query: 634 GQGGYGKVYKGI-LSDNTTVAIKR------AEEGSLQGQNEFLTEIKLLSRLH----HRN 682
G+GG+G V+ G L+D VAIK L E+ LL ++ H
Sbjct: 40 GKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPG 99
Query: 683 LVSLLGYCDEEGEQMLVYEF-VPNGTLRDWLS--GRTKENLNFAMRLRVALDSAKGILYL 739
++ LL + + + MLV E +P L D+++ G E + + +A I +
Sbjct: 100 VIRLLDWFETQEGFMLVLERPLPAQDLFDYITEKGPLGEGP--SRCFFGQVVAA--IQHC 155
Query: 740 HTEAHPPVFHRDIKASNILLDS-NLNAKVADFGLSRLAPVLDDEGTMPTHVSTIVKGTPG 798
H+ V HRDIK NIL+D AK+ DFG L + GT
Sbjct: 156 HSRG---VVHRDIKDENILIDLRRGCAKLIDFGSGALLH----DEPYTDFD-----GTRV 203
Query: 799 YLDPEYFLTHKLT-DKSDVYSLGVVLLELLTGMQPISHGKNIVREVNVARDSGMVFSIID 857
Y PE+ H+ + V+SLG++L +++ G P + I+ +
Sbjct: 204 YSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQEILEA--------------E 249
Query: 858 NRMGSYPSECVERFVTLALRCCHDKPEHRPSMSDVVR 894
++ S + RC KP RPS+ +++
Sbjct: 250 LHFPAHVSPDCCALIR---RCLAPKPSSRPSLEEILL 283
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 3e-28
Identities = 53/256 (20%), Positives = 94/256 (36%), Gaps = 19/256 (7%)
Query: 119 NDLTGTIPKEIGNISSLIFLLLNGNKLSGSLPDELGYLSNLNRLQVDENNIT--GTIPKS 176
LT ++P I SS L L NKL L+ L +L + N ++ G +S
Sbjct: 17 KGLT-SVPTGIP--SSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFKGCCSQS 73
Query: 177 FANLSRVRHLHLNNNSIGGQIPSELSKLSTLIHLLVDNNNLSGNLPPE--LSELPQLCIL 234
+ +++L L+ N + + S L L HL ++NL + L L L
Sbjct: 74 DFGTTSLKYLDLSFNGV-ITMSSNFLGLEQLEHLDFQHSNLK-QMSEFSVFLSLRNLIYL 131
Query: 235 QLDNNNFSASEIPATYGNFSKLVKLSLRNCNLQGAVPD--LSRIPNLYYLDLSWNHLTGS 292
+ + + + + S L L + + Q + + NL +LDLS L
Sbjct: 132 DISHTHTRVAF-NGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLE-Q 189
Query: 293 IPSKKLS--ENVTTIDLSDNYLNGSILESISNLPFLQTLSLENNFLTGSIPATIWQNKSF 350
+ + ++ +++S N L LQ L N + + Q+
Sbjct: 190 LSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIM-TSKKQELQHFPS 248
Query: 351 STKARLKIDLRNNSFS 366
S ++L N F+
Sbjct: 249 SLA---FLNLTQNDFA 261
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 70.0 bits (172), Expect = 4e-13
Identities = 35/172 (20%), Positives = 64/172 (37%), Gaps = 15/172 (8%)
Query: 82 TDGHLHVRELQLLSMNLSGNL---APELG---QLSRLQY-YFMWNDLTGTIPKEI-GNIS 133
+ L + +L+ L + + E L L Y I +S
Sbjct: 94 SSNFLGLEQLEHL--DFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTR-VAFNGIFNGLS 150
Query: 134 SLIFLLLNGNKLSGSLPDE-LGYLSNLNRLQVDENNITGTIPKSFANLSRVRHLHLNNNS 192
SL L + GN + + L NL L + + + P +F +LS ++ L++++N+
Sbjct: 151 SLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNN 210
Query: 193 IGGQIPSELSKLSTLIHLLVDNNNLSGNLPPE-LSELP-QLCILQLDNNNFS 242
L++L L N++ + L P L L L N+F+
Sbjct: 211 FFSLDTFPYKCLNSLQVLDYSLNHIM-TSKKQELQHFPSSLAFLNLTQNDFA 261
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 1e-27
Identities = 58/250 (23%), Positives = 109/250 (43%), Gaps = 35/250 (14%)
Query: 595 SLSRKRLSTKISMKIDGVKGFKFKELAMATAYFSSSTQVGQGGYGKVYKGI-LSDNTTVA 653
S+ + R + +D + ++ ++G G +GKVYK A
Sbjct: 1 SMRKSREYEHVRRDLDPNEVWEIVG------------ELGDGAFGKVYKAKNKETGALAA 48
Query: 654 IKRAEEGSLQGQNEFLTEIKLLSRLHHRNLVSLLGYCDEEGEQMLVYEFVPNGTLRDWLS 713
K E S + +++ EI++L+ H +V LLG +G+ ++ EF P G + +
Sbjct: 49 AKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIEFCPGGAVDAIML 108
Query: 714 GRTK--ENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSNLNAKVADFG 771
+ + R L + + +LH++ + HRD+KA N+L+ + ++ADFG
Sbjct: 109 ELDRGLTEPQIQVVCRQML---EALNFLHSKR---IIHRDLKAGNVLMTLEGDIRLADFG 162
Query: 772 LS-RLAPVLDDEGTMPTHVSTIVKGTPGYLDPEYFLTHKLTD-----KSDVYSLGVVLLE 825
+S + L + GTP ++ PE + + D K+D++SLG+ L+E
Sbjct: 163 VSAKNLKTLQKRDSF--------IGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIE 214
Query: 826 LLTGMQPISH 835
+ P
Sbjct: 215 MAQIEPPHHE 224
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 1e-27
Identities = 68/253 (26%), Positives = 106/253 (41%), Gaps = 23/253 (9%)
Query: 586 MRRHARYQHSLSRKRLSTKISMKIDGVKGFKFKELAMATAYFSSSTQVGQGGYGKVYKGI 645
M H + + K L + + ++G G YG+V
Sbjct: 1 MHHHHHHSSGRENLYFQGDLQATPGMFITSKKGHL---SEMYQRVKKLGSGAYGEVLLCR 57
Query: 646 -LSDNTTVAIKRAEEGSLQGQNE--FLTEIKLLSRLHHRNLVSLLGYCDEEGEQMLVYEF 702
+ AIK + S+ + L E+ +L L H N++ L + +++ LV E
Sbjct: 58 DKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVMEC 117
Query: 703 VPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDS- 761
G L D + R K N A + + S + YLH + HRD+K N+LL+S
Sbjct: 118 YKGGELFDEIIHRMKFNEVDAAVIIKQVLSG--VTYLHKHN---IVHRDLKPENLLLESK 172
Query: 762 --NLNAKVADFGLSRLAPVLDDEGTMPTHVSTIVKGTPGYLDPEYFLTHKLTDKSDVYSL 819
+ K+ DFGLS V +++ M + GT Y+ PE L K +K DV+S+
Sbjct: 173 EKDALIKIVDFGLSA---VFENQKKMKERL-----GTAYYIAPE-VLRKKYDEKCDVWSI 223
Query: 820 GVVLLELLTGMQP 832
GV+L LL G P
Sbjct: 224 GVILFILLAGYPP 236
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 2e-27
Identities = 55/209 (26%), Positives = 85/209 (40%), Gaps = 30/209 (14%)
Query: 634 GQGGYGKVYKGI-LSDNTTVAIKRAEEGSLQGQNEFLTEIKLLSRLHHRNLVSLLGYCDE 692
G G + +V+ A+K ++ + EI +L ++ H N+V+L +
Sbjct: 18 GSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYES 77
Query: 693 EGEQMLVYEFVPNGTLRDWLSGRTK--ENLNFAMRLRVALDSAKGIL----YLHTEAHPP 746
LV + V G L D + R E + A + +L YLH
Sbjct: 78 TTHYYLVMQLVSGGELFDRILERGVYTE--------KDASLVIQQVLSAVKYLHENG--- 126
Query: 747 VFHRDIKASNILLDS---NLNAKVADFGLSRLAPVLDDEGTMPTHVSTIVKGTPGYLDPE 803
+ HRD+K N+L + N + DFGLS ++ G M T GTPGY+ PE
Sbjct: 127 IVHRDLKPENLLYLTPEENSKIMITDFGLS----KMEQNGIMSTAC-----GTPGYVAPE 177
Query: 804 YFLTHKLTDKSDVYSLGVVLLELLTGMQP 832
+ D +S+GV+ LL G P
Sbjct: 178 VLAQKPYSKAVDCWSIGVITYILLCGYPP 206
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 4e-27
Identities = 51/272 (18%), Positives = 101/272 (37%), Gaps = 29/272 (10%)
Query: 133 SSLIFLLLNGNKLSGSLPDELGYLSNLNRLQVDENNITGTIPKSFANLSRVRHLHLNNNS 192
++ L L+ N+++ +L NL L + N I SF++L + HL L+ N
Sbjct: 52 EAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGINTIEEDSFSSLGSLEHLDLSYNY 111
Query: 193 IGGQIPSEL-SKLSTLIHLLVDNNNLSGNLPPE--LSELPQLCILQLDNNNFSASEIPAT 249
+ + S LS+L L + N L S L +L IL++ N +
Sbjct: 112 L-SNLSSSWFKPLSSLTFLNLLGNPYK-TLGETSLFSHLTKLQILRVGNMDTFTKIQRKD 169
Query: 250 YGNFSKLVKLSLRNCNLQGAVPD--LSRIPNLYYLDLSWNHLTGSIPSK--KLSENVTTI 305
+ + L +L + +LQ + L I N+ +L L + ++ +V +
Sbjct: 170 FAGLTFLEELEIDASDLQ-SYEPKSLKSIQNVSHLILHMKQHI-LLLEIFVDVTSSVECL 227
Query: 306 DLSDNYLNGSILESISNLPF--------LQTLSLENNFLTGSIPATIWQNKSFSTKARLK 357
+L D L+ +S + + + + L + K + + L
Sbjct: 228 ELRDTDLDTFHFSELSTGETNSLIKKFTFRNVKITDESLF-QVM------KLLNQISGLL 280
Query: 358 -IDLRNNSFSNIVGDL--TLPNNVTLRLGGNP 386
++ N ++ + L + + L NP
Sbjct: 281 ELEFSRNQLKSVPDGIFDRLTSLQKIWLHTNP 312
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 73.6 bits (181), Expect = 5e-14
Identities = 37/189 (19%), Positives = 70/189 (37%), Gaps = 20/189 (10%)
Query: 92 QLLSMNLSGN----LAPE--LGQLSRLQYYFM-WNDLTGTIPKEI-GNISSLIFLLLNGN 143
L +NL GN L L++LQ + D I ++ ++ L L ++ +
Sbjct: 125 SLTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNMDTFTKIQRKDFAGLTFLEELEIDAS 184
Query: 144 KLSGSLPDELGYLSNLNRLQVDENNITGTIPKSFANLSRVRHLHLNNNSIGGQIPSELS- 202
L P L + N++ L + + S V L L + + SELS
Sbjct: 185 DLQSYEPKSLKSIQNVSHLILHMKQHILLLEIFVDVTSSVECLELRDTDLDTFHFSELST 244
Query: 203 -------KLSTLIHLLVDNNNLSGNLPPELSELPQLCILQLDNNNFSASEIPA-TYGNFS 254
K T ++ + + +L + L+++ L L+ N + +P + +
Sbjct: 245 GETNSLIKKFTFRNVKITDESLF-QVMKLLNQISGLLELEFSRNQLKS--VPDGIFDRLT 301
Query: 255 KLVKLSLRN 263
L K+ L
Sbjct: 302 SLQKIWLHT 310
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 59.4 bits (144), Expect = 2e-09
Identities = 27/172 (15%), Positives = 68/172 (39%), Gaps = 17/172 (9%)
Query: 83 DGHLHVRELQLLSMNLSGNLAPE-LGQLSRLQY-YFMWNDLTGTIPKEI-GNISSLIFLL 139
++ L++ +M+ + + L+ L+ +DL + + +I ++ L+
Sbjct: 146 SHLTKLQILRVGNMDTFTKIQRKDFAGLTFLEELEIDASDLQ-SYEPKSLKSIQNVSHLI 204
Query: 140 LNGNKLSGSLPDEL-GYLSNLNRLQVDENNITGT--------IPKSFANLSRVRHLHLNN 190
L+ + L + S++ L++ + ++ S R++ + +
Sbjct: 205 LHMKQHI-LLLEIFVDVTSSVECLELRDTDLDTFHFSELSTGETNSLIKKFTFRNVKITD 263
Query: 191 NSIGGQIPSELSKLSTLIHLLVDNNNLSGNLPPE-LSELPQLCILQLDNNNF 241
S+ Q+ L+++S L+ L N L ++P L L + L N +
Sbjct: 264 ESLF-QVMKLLNQISGLLELEFSRNQLK-SVPDGIFDRLTSLQKIWLHTNPW 313
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 5e-27
Identities = 56/280 (20%), Positives = 99/280 (35%), Gaps = 22/280 (7%)
Query: 118 WNDLTGTIPKEIGNISSLIFLLLNGNKLSGSLPDELGYLSNLNRLQVDENNITGTIPKSF 177
+ + + L L L NK++ + L NL L + N + +F
Sbjct: 275 HGFVFSLNSRVFETLKDLKVLNLAYNKINKIADEAFYGLDNLQVLNLSYNLLGELYSSNF 334
Query: 178 ANLSRVRHLHLNNNSIGGQIPSELSKLSTLIHLLVDNNNLSGNLPPELSELPQLCILQLD 237
L +V ++ L N I L L L +L N + +P + + L
Sbjct: 335 YGLPKVAYIDLQKNHIAIIQDQTFKFLEKLQTL-----DLRDNALTTIHFIPSIPDIFLS 389
Query: 238 NNNFSASEIPATYGNFSKLVKLSLRNCNLQGAVPDLSRIPNLYYLDLSWNHLTGSIPSKK 297
N N L + L N ++ + L R+P+L L L+ N + +
Sbjct: 390 GNKLVTLPKINLTANLIHLSENRLENLDI---LYFLLRVPHLQILILNQNRFSSCSGDQT 446
Query: 298 LS--ENVTTIDLSDNYLNGSILESI-----SNLPFLQTLSLENNFLTGSIPATIWQNKSF 350
S ++ + L +N L + + L LQ L L +N+L S+P F
Sbjct: 447 PSENPSLEQLFLGENMLQLAWETELCWDVFEGLSHLQVLYLNHNYLN-SLP-----PGVF 500
Query: 351 STKARLK-IDLRNNSFSNIVGDLTLPNNVTLRLGGNPICT 389
S L+ + L +N + + + N L + N +
Sbjct: 501 SHLTALRGLSLNSNRLTVLSHNDLPANLEILDISRNQLLA 540
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 4e-24
Identities = 53/298 (17%), Positives = 106/298 (35%), Gaps = 38/298 (12%)
Query: 119 NDLTGTIPKEIGNISSLIFLLLNGNKLSGSLPDELGYLSNLNRLQVDENNITGTI-PKSF 177
+LT +P+ +++ LLL+ N + +L L L++ TI ++F
Sbjct: 14 CNLT-QVPQ---VLNTTERLLLSFNYIRTVTASSFPFLEQLQLLELGSQYTPLTIDKEAF 69
Query: 178 ANLSRVRHLHLNNNSIGGQIPSELSKLSTLIHLLVDNNNLSGNLPPE--LSELPQLCILQ 235
NL +R L L ++ I P L L L + LS + + L L L
Sbjct: 70 RNLPNLRILDLGSSKIYFLHPDAFQGLFHLFELRLYFCGLSDAVLKDGYFRNLKALTRLD 129
Query: 236 LDNNNFSASEIPATYGNFSKLVKLSLRNCNLQGAVPDLS----RIPNLYYLDLSWNHLTG 291
L N + + ++G + L + + + V + + L + L+ N L
Sbjct: 130 LSKNQIRSLYLHPSFGKLNSLKSIDFSSNQIF-LVCEHELEPLQGKTLSFFSLAANSLYS 188
Query: 292 SIPSK----------------KLSENVTTIDLSD---NYLNGSILESISNLPFLQTLSLE 332
+ +S N T+D++ N ++ S S+ +
Sbjct: 189 RVSVDWGKCMNPFRNMVLEILDVSGNGWTVDITGNFSNAISKSQAFSLILAHHIMGAGFG 248
Query: 333 NNFLTGSIPATIWQNKSFSTKARLK-IDLRNNSFSNIVGDL--TLPNNVTLRLGGNPI 387
+ + + + S+ ++ +DL + ++ + TL + L L N I
Sbjct: 249 FHNIK-DPDQNTFAGLARSS---VRHLDLSHGFVFSLNSRVFETLKDLKVLNLAYNKI 302
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 9e-22
Identities = 49/274 (17%), Positives = 87/274 (31%), Gaps = 32/274 (11%)
Query: 140 LNGNKLSGSLPDELGYLSNLNRLQVDENNITGTIPKSFANLSRVRHLHLNNNSIGGQIPS 199
L+ +P L + RL + N I SF L +++ L L + I
Sbjct: 11 YRFCNLT-QVPQVL---NTTERLLLSFNYIRTVTASSFPFLEQLQLLELGSQYTPLTIDK 66
Query: 200 E-LSKLSTLIHLLVDNNNLSGNLPPE-LSELPQLCILQLDNNNFSASEIPATY-GNFSKL 256
E L L L + ++ + L P+ L L L+L S + + Y N L
Sbjct: 67 EAFRNLPNLRILDLGSSKIY-FLHPDAFQGLFHLFELRLYFCGLSDAVLKDGYFRNLKAL 125
Query: 257 VKLSLRNCNLQ--GAVPDLSRIPNLYYLDLSWNHLTGSIPSKKLS----ENVTTIDLSDN 310
+L L ++ P ++ +L +D S N + + +L + ++ L+ N
Sbjct: 126 TRLDLSKNQIRSLYLHPSFGKLNSLKSIDFSSNQIF-LVCEHELEPLQGKTLSFFSLAAN 184
Query: 311 YLNGSILESISNLP------FLQTLSLENNFLTGSIPATIWQNKSFSTKARLK------- 357
L + L+ L + N T I S S L
Sbjct: 185 SLYSRVSVDWGKCMNPFRNMVLEILDVSGNGWTVDITGNFSNAISKSQAFSLILAHHIMG 244
Query: 358 IDLRNNSFSNI----VGDLTLPNNVTLRLGGNPI 387
++ + L + L L +
Sbjct: 245 AGFGFHNIKDPDQNTFAGLARSSVRHLDLSHGFV 278
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 85.2 bits (211), Expect = 5e-17
Identities = 53/311 (17%), Positives = 96/311 (30%), Gaps = 42/311 (13%)
Query: 87 HVRELQLLSMNLSGNLAPELGQLSRLQY-YFMWNDLTGTIPKEIGNISSLIFLLLNGNKL 145
++ L L ++ L LQ +N L + + ++ L N +
Sbjct: 291 DLKVLNLAYNKINKIADEAFYGLDNLQVLNLSYNLLGELYSSNFYGLPKVAYIDLQKNHI 350
Query: 146 SGSLPDELGYLSNLNRLQVDENNITGTIPKSFANLSRVRHLHLNNNSIGG---------- 195
+ +L L L + +N +T + + + + L+ N +
Sbjct: 351 AIIQDQTFKFLEKLQTLDLRDNALT-----TIHFIPSIPDIFLSGNKLVTLPKINLTANL 405
Query: 196 -----------QIPSELSKLSTLIHLLVDNNNLSGNLPPEL-SELPQLCILQLDNNNFSA 243
I L ++ L L+++ N S + SE P L L L N
Sbjct: 406 IHLSENRLENLDILYFLLRVPHLQILILNQNRFSSCSGDQTPSENPSLEQLFLGENMLQL 465
Query: 244 SEI----PATYGNFSKLVKLSLRNCNLQGAVPD-LSRIPNLYYLDLSWNHLTGSIPSKKL 298
+ + S L L L + L P S + L L L+ N LT + L
Sbjct: 466 AWETELCWDVFEGLSHLQVLYLNHNYLNSLPPGVFSHLTALRGLSLNSNRLT-VLSHNDL 524
Query: 299 SENVTTIDLSDNYLNGSILESISNLPFLQTLSLENNFLTGSIPATIWQNKSFSTKARLKI 358
N+ +D+S N L + L L + +N + +F
Sbjct: 525 PANLEILDISRNQLLAP---NPDVFVSLSVLDITHNKFICEC-----ELSTFINWLNHTN 576
Query: 359 DLRNNSFSNIV 369
++I
Sbjct: 577 VTIAGPPADIY 587
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 45.2 bits (107), Expect = 1e-04
Identities = 32/169 (18%), Positives = 58/169 (34%), Gaps = 8/169 (4%)
Query: 85 HLHVRELQLLSMNLSGNLAPELGQLSRLQY-YFMWNDLTGTIPKEIGNISSLIFLLLNGN 143
L + E L + LS LQ Y N L P ++++L L LN N
Sbjct: 455 QLFLGENMLQLAWETELCWDVFEGLSHLQVLYLNHNYLNSLPPGVFSHLTALRGLSLNSN 514
Query: 144 KLSGSLPDELGYLSNLNRLQVDENNITGTIPKSFANLSRVRHLHLNNNSIGGQIPSELSK 203
+L+ L +NL L + N + P F +LS + N ++ + ++
Sbjct: 515 RLT-VLSHND-LPANLEILDISRNQLLAPNPDVFVSLSV-LDITHNKFICECELSTFINW 571
Query: 204 LSTLIHLLVDN-NNLSGNLPPELSELPQLCILQLDNNNFSASEIPATYG 251
L+ + ++ P S + + L E+ +
Sbjct: 572 LNHTNVTIAGPPADIYCVYPDSFSGVS---LFSLSTEGCDEEEVLKSLK 617
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 112 bits (281), Expect = 5e-27
Identities = 64/282 (22%), Positives = 106/282 (37%), Gaps = 58/282 (20%)
Query: 633 VGQGGYGKVYKGI-LSDNTTVAIKR-AEEGSLQGQNEFLTEIK-LLSRLHHRNLVSLLGY 689
+G+G YG V K + +A+KR + Q + L ++ ++ +V G
Sbjct: 30 IGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGA 89
Query: 690 CDEEGEQMLVYEFVPNGTLRDWLS-------GRTKENLNFAMRL-RVALDSAKGILYLHT 741
EG+ + E + + + + E + L ++ L + K + +L
Sbjct: 90 LFREGDCWICMELM-STSFDKFYKYVYSVLDDVIPEEI-----LGKITLATVKALNHLKE 143
Query: 742 EAHPPVFHRDIKASNILLDSNLNAKVADFGLSRLAPVLDDEGTMPTHVSTIVK----GTP 797
+ HRDIK SNILLD + N K+ DFG+S G + V +I K G
Sbjct: 144 NLK--IIHRDIKPSNILLDRSGNIKLCDFGIS---------GQL---VDSIAKTRDAGCR 189
Query: 798 GYLDPEYFLTHKLTD----KSDVYSLGVVLLELLTGMQPISHGKNIVREVNVARDSGMVF 853
Y+ PE +SDV+SLG+ L EL TG P ++ +
Sbjct: 190 PYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFD---------QLT 240
Query: 854 SIIDN---RMGSYP----SECVERFVTLALRCCHDKPEHRPS 888
++ ++ + S FV C RP
Sbjct: 241 QVVKGDPPQLSNSEEREFSPSFINFVN---LCLTKDESKRPK 279
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 114 bits (286), Expect = 5e-27
Identities = 64/295 (21%), Positives = 112/295 (37%), Gaps = 45/295 (15%)
Query: 626 YFSSSTQVGQGGYGKVYKGILSDNTTVAIKRAEEGSLQGQNEFLTEIKLLSRL-HHRNLV 684
S +G G G V VA+KR + + L EIKLL+ H N++
Sbjct: 16 LVVSEKILGYGSSGTVVFQGSFQGRPVAVKRM---LIDFCDIALMEIKLLTESDDHPNVI 72
Query: 685 SLLGYCDEEGEQM--LVYEFVPNGTLRDWLSGRTKENLNFAMR-----LRVALDSAKGIL 737
YC E ++ + E N L+D + + + N ++ + + A G+
Sbjct: 73 RY--YCSETTDRFLYIALELC-NLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVA 129
Query: 738 YLHTEAHPPVFHRDIKASNILLDS-------------NLNAKVADFGLSRLAPVLDDEGT 784
+LH+ + HRD+K NIL+ + NL ++DFGL + + + +
Sbjct: 130 HLHSLK---IIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKK--LDSGQSS 184
Query: 785 MPTHVSTIVKGTPGYLDPEYFL-------THKLTDKSDVYSLGVVLLELLTGMQPISHGK 837
T+++ GT G+ PE +LT D++S+G V +L+ + K
Sbjct: 185 FRTNLNNPS-GTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDK 243
Query: 838 NIVREVNVARDSGMVFSIIDNRMGSYPSECVERFVTLALRCCHDKPEHRPSMSDV 892
RE N+ R + ++ + P RP+ V
Sbjct: 244 YS-RESNIIRGI-FSLDEMKCLHDRSLIAEATDLIS---QMIDHDPLKRPTAMKV 293
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 1e-26
Identities = 58/268 (21%), Positives = 98/268 (36%), Gaps = 35/268 (13%)
Query: 633 VGQGGYGKVYKGI-LSDNTTVAIKRAE-EGSLQGQNEFLTEIKLLSRLH-HRNLVSLLGY 689
+G G G+V+K +A+K+ G+ + L ++ ++ + H +V G
Sbjct: 33 MGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGT 92
Query: 690 CDEEGEQMLVYEFVPNGTLRDWL--SGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPV 747
+ + E + + G E + ++ + K + YL + V
Sbjct: 93 FITNTDVFIAMELMGTCAEKLKKRMQGPIPER----ILGKMTVAIVKALYYLKEKHG--V 146
Query: 748 FHRDIKASNILLDSNLNAKVADFGLSRLAPVLDDEGTMPTHVSTIVKGTPGYLDPEYFLT 807
HRD+K SNILLD K+ DFG+S L D+ G Y+ PE
Sbjct: 147 IHRDVKPSNILLDERGQIKLCDFGISG---RLVDDKAKDRSA-----GCAAYMAPERIDP 198
Query: 808 HKLTD-----KSDVYSLGVVLLELLTGMQPISHGKNIVREVNVARDSGMVFSIIDNRMGS 862
T ++DV+SLG+ L+EL TG P + K ++ ++
Sbjct: 199 PDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFE---------VLTKVLQEEPPL 249
Query: 863 YPSECV--ERFVTLALRCCHDKPEHRPS 888
P F + C RP
Sbjct: 250 LPGHMGFSGDFQSFVKDCLTKDHRKRPK 277
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 115 bits (288), Expect = 1e-26
Identities = 65/255 (25%), Positives = 108/255 (42%), Gaps = 31/255 (12%)
Query: 97 NLSGNLAPELGQLSRLQYYFMWNDLTGTIPKEIGNISSLIFLLLNGNKLSGSLPDELGYL 156
+ + + + ++ KE I+ L LN LS SLPD L
Sbjct: 24 GTYADYFSAWDKWEKQALPGENRNEAVSLLKEC-LINQFSELQLNRLNLS-SLPDNLP-- 79
Query: 157 SNLNRLQVDENNITGTIPKSFANLSRVRHLHLNNNSIGGQIPSELSKLSTLIHLLVDNNN 216
+ L++ +N + ++P+ A+L +L +N + +P + L HL VDNN
Sbjct: 80 PQITVLEITQNALI-SLPELPASL---EYLDACDNRLS-TLPELPASLK---HLDVDNNQ 131
Query: 217 LSGNLPPELSELPQLCILQLDNNNFSASEIPATYGNFSKLVKLSLRNCNLQGAVPDLSRI 276
L+ LP + L + DNN + +P + L LS+RN L +P+L
Sbjct: 132 LT-MLPELPA---LLEYINADNNQLT--MLPEL---PTSLEVLSVRNNQLT-FLPEL--P 179
Query: 277 PNLYYLDLSWNHLTGSIPS-----KKLSENVTTIDLSDNYLNGSILESISNLPFLQTLSL 331
+L LD+S N L S+P+ E +N + I E+I +L T+ L
Sbjct: 180 ESLEALDVSTNLLE-SLPAVPVRNHHSEETEIFFRCRENRIT-HIPENILSLDPTCTIIL 237
Query: 332 ENNFLTGSIPATIWQ 346
E+N L+ I ++ Q
Sbjct: 238 EDNPLSSRIRESLSQ 252
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 2e-26
Identities = 59/268 (22%), Positives = 104/268 (38%), Gaps = 31/268 (11%)
Query: 124 TIPKEIGNISSLIFLLLNGNKLSGSLPDELGYLSNLNRLQV---DENNITGTIPKSFANL 180
+I I N SL N +SG+ D + + + N + + +
Sbjct: 2 SIMLPINNNFSLSQNSFY-NTISGTYADYFSAWDKWEKQALPGENRNEAVSLLKECL--I 58
Query: 181 SRVRHLHLNNNSIGGQIPSELSKLSTLIHLLVDNNNLSGNLPPELSELPQLCILQLDNNN 240
++ L LN ++ +P L + L + N L +LP + L L +N
Sbjct: 59 NQFSELQLNRLNLS-SLPDNL--PPQITVLEITQNALI-SLPELPA---SLEYLDACDNR 111
Query: 241 FSASEIPATYGNFSKLVKLSLRNCNLQGAVPDLSRIPNLYYLDLSWNHLTGSIPSKKLSE 300
S +P + L L + N L +P+L L Y++ N LT +P L
Sbjct: 112 LS--TLPEL---PASLKHLDVDNNQLT-MLPEL--PALLEYINADNNQLT-MLPE--LPT 160
Query: 301 NVTTIDLSDNYLNGSILESISNLPFLQTLSLENNFLTGSIPATIWQNKSFSTKARLKIDL 360
++ + + +N L + E +L + L + N L S+PA +N S + +
Sbjct: 161 SLEVLSVRNNQLT-FLPELPESL---EALDVSTNLLE-SLPAVPVRNHH-SEETEIFFRC 214
Query: 361 RNNSFSNI-VGDLTLPNNVTLRLGGNPI 387
R N ++I L+L T+ L NP+
Sbjct: 215 RENRITHIPENILSLDPTCTIILEDNPL 242
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 95.8 bits (238), Expect = 1e-20
Identities = 54/268 (20%), Positives = 96/268 (35%), Gaps = 39/268 (14%)
Query: 92 QLLSMNLSGNL------APELGQLSRLQY-YFMWNDLTGTIPKEIGNISSLIFLLLNGNK 144
+ L G + +++ +L+ ++P + + L + N
Sbjct: 35 KWEKQALPGENRNEAVSLLKECLINQFSELQLNRLNLS-SLPDNLP--PQITVLEITQNA 91
Query: 145 LSGSLPDELGYLSNLNRLQVDENNITGTIPKSFANLSRVRHLHLNNNSIGGQIPSELSKL 204
L SLP+ +L L +N ++ T+P+ A+L +HL ++NN + +P + L
Sbjct: 92 LI-SLPELPA---SLEYLDACDNRLS-TLPELPASL---KHLDVDNNQLT-MLPELPALL 142
Query: 205 STLIHLLVDNNNLSGNLPPELSELPQLCILQLDNNNFSASEIPATYGNFSKLVKLSLRNC 264
+ DNN L+ LP + L +L + NN + +P L L +
Sbjct: 143 EYIN---ADNNQLT-MLPELPT---SLEVLSVRNNQLT--FLPEL---PESLEALDVSTN 190
Query: 265 NLQGAVPDLSRIPNL----YYLDLSWNHLTGSIPS--KKLSENVTTIDLSDNYLNGSILE 318
L+ R + + N +T IP L TI L DN L+ I E
Sbjct: 191 LLESLPAVPVRNHHSEETEIFFRCRENRIT-HIPENILSLD-PTCTIILEDNPLSSRIRE 248
Query: 319 SISNLPFLQTLSLENNFLTGSIPATIWQ 346
S+S + + S
Sbjct: 249 SLSQQTAQPDYHGPRIYFSMSDGQQNTL 276
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 59.2 bits (143), Expect = 4e-09
Identities = 24/160 (15%), Positives = 52/160 (32%), Gaps = 14/160 (8%)
Query: 92 QLLSMNLSGN----LAPELGQLSRLQYYFMWNDLTGTIPKEIGNISSL----IFLLLNGN 143
L +++ N L L L N L ++P IF N
Sbjct: 161 SLEVLSVRNNQLTFLPELPESLEALDVST--NLLE-SLPAVPVRNHHSEETEIFFRCREN 217
Query: 144 KLSGSLPDELGYLSNLNRLQVDENNITGTIPKSFANLSRVRHLHLNNNSIGGQIPSELSK 203
+++ +P+ + L + +++N ++ I +S + + H + +
Sbjct: 218 RIT-HIPENILSLDPTCTIILEDNPLSSRIRESLSQQTAQPDYHGPRIYFSMSDGQQNTL 276
Query: 204 LSTLIHLLVDNNNLSGNLPPELSELPQLCILQLDNNNFSA 243
L + N ++S++ + N FSA
Sbjct: 277 HRPLADAV--TAWFPENKQSDVSQIWHAFEHEEHANTFSA 314
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 2e-26
Identities = 56/282 (19%), Positives = 96/282 (34%), Gaps = 17/282 (6%)
Query: 119 NDLTGTIPKEIGNISSLIFLLLNGNKLSGSLPDELGYLSNLNRLQVDENNITGTIPKSFA 178
+ IP + S L L+ N L L L + I ++
Sbjct: 17 LNFY-KIPDNLP--FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQ 73
Query: 179 NLSRVRHLHLNNNSIGGQIPSELSKLSTLIHLLVDNNNLSGNLPPELSELPQLCILQLDN 238
+LS + L L N I S LS+L L+ NL+ + L L L + +
Sbjct: 74 SLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAH 133
Query: 239 NNFSASEIPATYGNFSKLVKLSLRNCNLQGAVP-DLSRIPNLYY----LDLSWNHLTGSI 293
N + ++P + N + L L L + +Q DL + + LDLS N + I
Sbjct: 134 NLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMN-FI 192
Query: 294 PSKKLSE-NVTTIDLSDNYLNGSILE-SISNLPFLQTLSLENNFLTGSIPATIWQNKSFS 351
E + + L +N+ + ++++ I L L+ L + +
Sbjct: 193 QPGAFKEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALE 252
Query: 352 TKARLKI-DLRNNSFSNIVGDLT-----LPNNVTLRLGGNPI 387
L I + R + D+ L N + L I
Sbjct: 253 GLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTI 294
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 1e-25
Identities = 54/289 (18%), Positives = 108/289 (37%), Gaps = 20/289 (6%)
Query: 85 HLHVRELQLLSMNLSGNLAPEL-GQLSRLQYYFMWNDLTGTIPKEIGNISSLIFLLLNGN 143
+L + E +L ++ + +L L+ + + + + + N L L
Sbjct: 256 NLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKDFSYN-FGWQHLELVNC 314
Query: 144 KLSGSLPDELGYLSNLNRLQVDENNITGTIPKSFANLSRVRHLHLNNNSIG--GQIPSEL 201
K P L +L RL N S +L + L L+ N + G
Sbjct: 315 KFG-QFPT--LKLKSLKRLTFTSNKGGNAF--SEVDLPSLEFLDLSRNGLSFKGCCSQSD 369
Query: 202 SKLSTLIHLLVDNNNLSGNLPPELSELPQLCILQLDNNNFSASEIPATYGNFSKLVKLSL 261
++L +L + N + + L QL L ++N + + + L+ L +
Sbjct: 370 FGTTSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDI 428
Query: 262 RNCNLQGAVPD-LSRIPNLYYLDLSWNHLTGSIPSKKLS--ENVTTIDLSDNYLNGSILE 318
+ + + A + + +L L ++ N + + N+T +DLS L
Sbjct: 429 SHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPT 488
Query: 319 SISNLPFLQTLSLENNFLTGSIPATIWQNKSFSTKARLK-IDLRNNSFS 366
+ ++L LQ L++ +N L S+P I+ + L+ I L N +
Sbjct: 489 AFNSLSSLQVLNMASNQLK-SVPDGIFDRLT-----SLQKIWLHTNPWD 531
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 8e-25
Identities = 62/370 (16%), Positives = 120/370 (32%), Gaps = 40/370 (10%)
Query: 65 DPCMSNWTG--VLC----FDTVETDGHLHVRELQLLSMNLSGNLAPELGQLSRLQY-YFM 117
+PC+ C F + + + L L L + LQ
Sbjct: 1 EPCVEVVPNITYQCMELNFYKIPDNLPFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLS 60
Query: 118 WNDLTGTIPKEIGNISSLIFLLLNGNKLSGSLPDELGYLSNLNRLQVDENNITGTIPKSF 177
++ ++S L L+L GN + LS+L +L E N+
Sbjct: 61 RCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPI 120
Query: 178 ANLSRVRHLHLNNNSIG-GQIPSELSKLSTLIHLLVDNNNLSGNLPPELSELPQL----C 232
+L ++ L++ +N I ++P S L+ L HL + +N + +L L Q+
Sbjct: 121 GHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNL 180
Query: 233 ILQLDNNNFSASEIPATYGNFSKLVKLSLRNCNLQGAVPD--LSRIPNLYYLDLSWNHLT 290
L L N + I +L KL+LRN V + + L L
Sbjct: 181 SLDLSLNPM--NFIQPGAFKEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFR 238
Query: 291 GSIPSKKLSENV----TTIDLSDNYLNG------SILESISNLPFLQTLSLENNFLTGSI 340
+K ++ + + + L I++ + L + + SL + +
Sbjct: 239 NEGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIERVK 298
Query: 341 PATIWQN--------------KSFSTKARLKIDLRNNSFSNIVGDLTLPNNVTLRLGGNP 386
+ + K+ ++ +N N ++ LP+ L L N
Sbjct: 299 DFSYNFGWQHLELVNCKFGQFPTLKLKSLKRLTFTSNKGGNAFSEVDLPSLEFLDLSRNG 358
Query: 387 ICTSANIPNT 396
+ +
Sbjct: 359 LSFKGCCSQS 368
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 1e-24
Identities = 57/346 (16%), Positives = 113/346 (32%), Gaps = 44/346 (12%)
Query: 85 HLHVRELQLLSMNLSGNLAPE-LGQLSRLQY-------YFMWNDLTGTIPKEIGNISSLI 136
+ + +L L + S N+ + L+ L+ + +L + + +L
Sbjct: 199 EIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLT 258
Query: 137 FLLLNGNKLSGSLPDELGYLSNLNRLQVD---ENNITGTIPKSFANLSRVRHLHLNNNSI 193
L L D + + L + I S+ +HL L N
Sbjct: 259 IEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKDFSY--NFGWQHLELVNCKF 316
Query: 194 GGQIPSELSKLSTLIHLLVDNNNLSGNLPPELSELPQLCILQLDNNNFSASEIPA-TYGN 252
G Q P+ KL +L L +N +LP L L L N S + +
Sbjct: 317 G-QFPT--LKLKSLKRLTFTSNKGGN--AFSEVDLPSLEFLDLSRNGLSFKGCCSQSDFG 371
Query: 253 FSKLVKLSLRNCNLQGAVPDLSRIPNLYYLDLSWNHLTGSIPSKKLSE--NVTTIDLSDN 310
+ L L L + + + L +LD ++L N+ +D+S
Sbjct: 372 TTSLKYLDLSFNGVITMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHT 431
Query: 311 YLNGSILESISNLPFLQTLSLENNFLTGSIPATIWQN-------------------KSFS 351
+ + + L L+ L + N + I+ +F+
Sbjct: 432 HTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFN 491
Query: 352 TKARLK-IDLRNNSFSNIVGDL--TLPNNVTLRLGGNPI-CTSANI 393
+ + L+ +++ +N ++ + L + + L NP C+ I
Sbjct: 492 SLSSLQVLNMASNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCPRI 537
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 2e-26
Identities = 66/250 (26%), Positives = 111/250 (44%), Gaps = 32/250 (12%)
Query: 595 SLSRKRLSTKISMKIDGVKGFKFKELAMA---TAYFSSSTQVGQGGYGKVYKGI-LSDNT 650
SL +L ++ K E ++ F ++G+G YG VYK I
Sbjct: 1 SLETVQLRNPPRRQLK-----KLDEDSLTKQPEEVFDVLEKLGEGSYGSVYKAIHKETGQ 55
Query: 651 TVAIKRAEEGSLQGQ-NEFLTEIKLLSRLHHRNLVSLLGYCDEEGEQMLVYEFVPNGTLR 709
VAIK+ ++ E + EI ++ + ++V G + + +V E+ G++
Sbjct: 56 IVAIKQVP---VESDLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVMEYCGAGSVS 112
Query: 710 DWLSGRTKENLN---FAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSNLNAK 766
D + + L A L+ L KG+ YLH HRDIKA NILL++ +AK
Sbjct: 113 D-IIRLRNKTLTEDEIATILQSTL---KGLEYLHFMR---KIHRDIKAGNILLNTEGHAK 165
Query: 767 VADFGLS-RLAPVLDDEGTMPTHVSTIVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVLLE 825
+ADFG++ +L + T+ GTP ++ PE +D++SLG+ +E
Sbjct: 166 LADFGVAGQLTDTMAKRNTV--------IGTPFWMAPEVIQEIGYNCVADIWSLGITAIE 217
Query: 826 LLTGMQPISH 835
+ G P +
Sbjct: 218 MAEGKPPYAD 227
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 112 bits (281), Expect = 2e-26
Identities = 66/259 (25%), Positives = 102/259 (39%), Gaps = 38/259 (14%)
Query: 604 KISMKIDGVKGFKFKELAMA---------TAYFSSSTQVGQGGYGKVYKGI-LSDNTTVA 653
+I++ + K F F +L + + S +G G G+V VA
Sbjct: 105 EIALSLSRNKVFVFFDLTVDDQSVYPKALRDEYIMSKTLGSGACGEVKLAFERKTCKKVA 164
Query: 654 IK--------RAEEGSLQGQNEFLTEIKLLSRLHHRNLVSLLGYCDEEGEQMLVYEFVPN 705
I+ TEI++L +L+H ++ + + D E + +V E +
Sbjct: 165 IRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAE-DYYIVLELMEG 223
Query: 706 GTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDS---N 762
G L D + G + L A + YLH + HRD+K N+LL S +
Sbjct: 224 GELFDKVVGNKR--LKEATCKLYFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEED 278
Query: 763 LNAKVADFGLSRLAPVLDDEGTMPTHVSTIVKGTPGYLDPE---YFLTHKLTDKSDVYSL 819
K+ DFG S+ +L + M T GTP YL PE T D +SL
Sbjct: 279 CLIKITDFGHSK---ILGETSLMRTLC-----GTPTYLAPEVLVSVGTAGYNRAVDCWSL 330
Query: 820 GVVLLELLTGMQPISHGKN 838
GV+L L+G P S +
Sbjct: 331 GVILFICLSGYPPFSEHRT 349
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 2e-26
Identities = 65/206 (31%), Positives = 98/206 (47%), Gaps = 23/206 (11%)
Query: 634 GQGGYGKVYKGI-LSDNTTVAIKRAEEGSLQGQNE--FLTEIKLLSRLHHRNLVSLLGYC 690
G+G + KV + VAIK ++ L + E++++ L+H N+V L
Sbjct: 24 GKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVI 83
Query: 691 DEEGEQMLVYEFVPNGTLRDWL--SGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVF 748
+ E L+ E+ G + D+L GR KE A + SA + Y H + +
Sbjct: 84 ETEKTLYLIMEYASGGEVFDYLVAHGRMKEKE--ARSKFRQIVSA--VQYCHQKR---IV 136
Query: 749 HRDIKASNILLDSNLNAKVADFGLSRLAPVLDDEGTMPTHVSTIVKGTPGYLDPEYFLTH 808
HRD+KA N+LLD+++N K+ADFG S G + G P Y PE F
Sbjct: 137 HRDLKAENLLLDADMNIKIADFGFSNE---FTVGGKLDAFC-----GAPPYAAPELFQ-G 187
Query: 809 KLTD--KSDVYSLGVVLLELLTGMQP 832
K D + DV+SLGV+L L++G P
Sbjct: 188 KKYDGPEVDVWSLGVILYTLVSGSLP 213
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 108 bits (273), Expect = 3e-26
Identities = 65/233 (27%), Positives = 97/233 (41%), Gaps = 49/233 (21%)
Query: 634 GQGGYGKVYKGI-LSDNTTVAIK----------------------RAEEGSLQGQNEFLT 670
G+G YG V +DNT A+K R G +
Sbjct: 22 GKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIE 81
Query: 671 ----EIKLLSRLHHRNLVSLLGYCDEEGEQML--VYEFVPNGTLRDWLS-GRTKENLNFA 723
EI +L +L H N+V L+ D+ E L V+E V G + + + E+ A
Sbjct: 82 QVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTLKPLSEDQ--A 139
Query: 724 MRL-RVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSRLAPVLDDE 782
+ D KGI YLH + + HRDIK SN+L+ + + K+ADFG+S +
Sbjct: 140 RFYFQ---DLIKGIEYLHYQK---IIHRDIKPSNLLVGEDGHIKIADFGVSNE--FKGSD 191
Query: 783 GTMPTHVSTIVKGTPGYLDPEYFL-THKLTD--KSDVYSLGVVLLELLTGMQP 832
+ V GTP ++ PE T K+ DV+++GV L + G P
Sbjct: 192 ALLSNTV-----GTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCP 239
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 4e-26
Identities = 25/299 (8%), Positives = 59/299 (19%), Gaps = 55/299 (18%)
Query: 634 GQGGYGKVYKGI-LSDNTTVAIK---RAEEGSLQGQNEFLTEIKLLSRLHHRNLVSLLGY 689
G V+ + A+K E S +RL +
Sbjct: 71 RVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDR 130
Query: 690 C--------------------------DEEGEQMLVYEFVPNGTLRDWLS-----GRTKE 718
+L+ + L S +
Sbjct: 131 RRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPA-ASVDLELLFSTLDFVYVFRG 189
Query: 719 NLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSRLAPV 778
+ + + L ++ + H N+ + + + D
Sbjct: 190 DEGILALHILTAQLIRLAANLQSKG---LVHGHFTPDNLFIMPDGRLMLGDVSALWK--- 243
Query: 779 LDDEGTMPTHVSTIVKGTPGYLDPEYFLTHKL--TDKSDVYSLGVVLLELLTGMQPISHG 836
Y E+ T + + LG+ + + P
Sbjct: 244 -------VGTRGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLV 296
Query: 837 KNIVRE-VNVARDSGMVFSIIDNRMGSYPSECVERFVTLALRCCHDKPEHRPSMSDVVR 894
++ + + + V+ + L D R + +
Sbjct: 297 TPGIKGSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLN--FD-RRRRLLPLEAME 352
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 4e-26
Identities = 56/218 (25%), Positives = 91/218 (41%), Gaps = 30/218 (13%)
Query: 632 QVGQGGYGKVYKGI-LSDNTTVAIK---------RAEEGSLQGQNEFLTEIKLLSRL-HH 680
+G+G V + I A+K + E + + L E+ +L ++ H
Sbjct: 24 ILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGH 83
Query: 681 RNLVSLLGYCDEEGEQMLVYEFVPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLH 740
N++ L + LV++ + G L D+L+ + + ++ AL + I LH
Sbjct: 84 PNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRAL--LEVICALH 141
Query: 741 TEAHPPVFHRDIKASNILLDSNLNAKVADFGLSRLAPVLDDEGTMPTHVSTIVKGTPGYL 800
+ HRD+K NILLD ++N K+ DFG S LD + GTP YL
Sbjct: 142 KLN---IVHRDLKPENILLDDDMNIKLTDFGFSC---QLDPGEKLREVC-----GTPSYL 190
Query: 801 DPE------YFLTHKLTDKSDVYSLGVVLLELLTGMQP 832
PE + D++S GV++ LL G P
Sbjct: 191 APEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPP 228
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 5e-26
Identities = 70/227 (30%), Positives = 100/227 (44%), Gaps = 34/227 (14%)
Query: 627 FSSSTQVGQGGYGKVYKGI-LSDNTTVAIKRAEEGSLQGQN--EFLTEIKLLSRL-HHRN 682
F VG G YG+VYKG + AIK + + G E EI +L + HHRN
Sbjct: 26 FELVELVGNGTYGQVYKGRHVKTGQLAAIKVMD---VTGDEEEEIKQEINMLKKYSHHRN 82
Query: 683 LVSLLG------YCDEEGEQMLVYEFVPNGTLRDWLSGRTKENLN---FAMRLRVALDSA 733
+ + G + + LV EF G++ D + L A R L
Sbjct: 83 IATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREIL--- 139
Query: 734 KGILYLHTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSRLAPVLDDEGTMPTHVSTIV 793
+G+ +LH V HRDIK N+LL N K+ DFG+S LD T+ + I
Sbjct: 140 RGLSHLHQHK---VIHRDIKGQNVLLTENAEVKLVDFGVSAQ---LDR--TVGRRNTFI- 190
Query: 794 KGTPGYLDPEYFLTHKLTD-----KSDVYSLGVVLLELLTGMQPISH 835
GTP ++ PE + D KSD++SLG+ +E+ G P+
Sbjct: 191 -GTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCD 236
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 112 bits (281), Expect = 5e-26
Identities = 60/208 (28%), Positives = 97/208 (46%), Gaps = 21/208 (10%)
Query: 632 QVGQGGYGKVYKGI-LSDNTTVAIK---RAEEGSLQGQNEFLTEIKLLSRLHHRNLVSLL 687
+G+G +G+V A+K + + + L E++LL +L H N++ L
Sbjct: 33 VLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLY 92
Query: 688 GYCDEEGEQMLVYEFVPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPV 747
+ +++G LV E G L D + R + + A R+ + S I Y+H +
Sbjct: 93 EFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSG--ITYMHKNK---I 147
Query: 748 FHRDIKASNILLDS---NLNAKVADFGLSRLAPVLDDEGTMPTHVSTIVKGTPGYLDPEY 804
HRD+K N+LL+S + N ++ DFGLS + M + GT Y+ PE
Sbjct: 148 VHRDLKPENLLLESKSKDANIRIIDFGLST---HFEASKKMKDKI-----GTAYYIAPE- 198
Query: 805 FLTHKLTDKSDVYSLGVVLLELLTGMQP 832
L +K DV+S GV+L LL+G P
Sbjct: 199 VLHGTYDEKCDVWSTGVILYILLSGCPP 226
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 5e-26
Identities = 66/209 (31%), Positives = 101/209 (48%), Gaps = 28/209 (13%)
Query: 634 GQGGYGKVYKGI-LSDNTTVAIK-----RAEEGSLQGQNEFLTEIKLLSRLHHRNLVSLL 687
G G +GKV G VA+K + + G+ + EI+ L H +++ L
Sbjct: 20 GVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIK--REIQNLKLFRHPHIIKLY 77
Query: 688 GYCDEEGEQMLVYEFVPNGTLRDWLS--GRTKENLNFAMRLRVALDSAKGILYLHTEAHP 745
+ +V E+V G L D++ GR +E A RL + SA + Y H
Sbjct: 78 QVISTPTDFFMVMEYVSGGELFDYICKHGRVEEME--ARRLFQQILSA--VDYCHRHM-- 131
Query: 746 PVFHRDIKASNILLDSNLNAKVADFGLSRLAPVLDDEGTMPTHVSTIVKGTPGYLDPEYF 805
V HRD+K N+LLD+++NAK+ADFGLS + + D + T G+P Y PE
Sbjct: 132 -VVHRDLKPENVLLDAHMNAKIADFGLSNM---MSDGEFLRTSC-----GSPNYAAPE-V 181
Query: 806 LTHKLTD--KSDVYSLGVVLLELLTGMQP 832
++ +L + D++S GV+L LL G P
Sbjct: 182 ISGRLYAGPEVDIWSCGVILYALLCGTLP 210
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 5e-26
Identities = 64/219 (29%), Positives = 99/219 (45%), Gaps = 29/219 (13%)
Query: 627 FSSSTQVGQGGYGKVYKGI-LSDNTTVAIKR---AEEGSLQGQNEFLTEIKLLSRLHHRN 682
FS ++G G +G VY + ++ VAIK+ + + S + + + E++ L +L H N
Sbjct: 56 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 115
Query: 683 LVSLLGYCDEEGEQMLVYEFVPNGTLRDWLSGRTKENLN---FAMRLRVALDSAKGILYL 739
+ G E LV E+ G+ D L K+ L A AL +G+ YL
Sbjct: 116 TIQYRGCYLREHTAWLVMEYCL-GSASD-LLEVHKKPLQEVEIAAVTHGAL---QGLAYL 170
Query: 740 HTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSRLAPVLDDEGTMPTHVSTIVKGTPGY 799
H+ + HRD+KA NILL K+ DFG + M ++ V GTP +
Sbjct: 171 HSHN---MIHRDVKAGNILLSEPGLVKLGDFGSA---------SIM-APANSFV-GTPYW 216
Query: 800 LDPEYFLTHKLTD---KSDVYSLGVVLLELLTGMQPISH 835
+ PE L K DV+SLG+ +EL P+ +
Sbjct: 217 MAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFN 255
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 5e-26
Identities = 51/211 (24%), Positives = 85/211 (40%), Gaps = 25/211 (11%)
Query: 632 QVGQGGYGKVYKGI-LSDNTTVAIKRAEEGSLQGQNE-FLTEIKLLSRLHHRNLVSLLGY 689
++G G +G V+ S IK + Q E EI++L L H N++ +
Sbjct: 29 KLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEV 88
Query: 690 CDEEGEQMLVYEFVPNGTLRDWLSGRTKENLNF-----AMRLRVALDSAKGILYLHTEAH 744
++ +V E G L + + A ++ ++ + Y H++
Sbjct: 89 FEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMN---ALAYFHSQH- 144
Query: 745 PPVFHRDIKASNILLDS---NLNAKVADFGLSRLAPVLDDEGTMPTHVSTIVKGTPGYLD 801
V H+D+K NIL + K+ DFGL+ + + GT Y+
Sbjct: 145 --VVHKDLKPENILFQDTSPHSPIKIIDFGLAE---LFKSDEHSTNAA-----GTALYMA 194
Query: 802 PEYFLTHKLTDKSDVYSLGVVLLELLTGMQP 832
PE +T K D++S GVV+ LLTG P
Sbjct: 195 PE-VFKRDVTFKCDIWSAGVVMYFLLTGCLP 224
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 6e-26
Identities = 52/206 (25%), Positives = 88/206 (42%), Gaps = 20/206 (9%)
Query: 632 QVGQGGYGKVYKGI-LSDNTTVAIKRAEEGSLQGQNEFLTEIKLLSRLHHRNLVSLLGYC 690
+G+G +G+V + A K+ + ++ + F EI+++ L H N++ L
Sbjct: 16 TIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETF 75
Query: 691 DEEGEQMLVYEFVPNGTLRDWLSGRTKENLNFAMRL-RVALDSAKGILYLHTEAHPPVFH 749
++ + LV E G L + + + + A R+ + L + Y H V H
Sbjct: 76 EDNTDIYLVMELCTGGELFERVVHKRVFRESDAARIMKDVLS---AVAYCHKLN---VAH 129
Query: 750 RDIKASNILLDS---NLNAKVADFGLSRLAPVLDDEGTMPTHVSTIVKGTPGYLDPEYFL 806
RD+K N L + + K+ DFGL+ M T V GTP Y+ P+ L
Sbjct: 130 RDLKPENFLFLTDSPDSPLKLIDFGLAA---RFKPGKMMRTKV-----GTPYYVSPQ-VL 180
Query: 807 THKLTDKSDVYSLGVVLLELLTGMQP 832
+ D +S GV++ LL G P
Sbjct: 181 EGLYGPECDEWSAGVMMYVLLCGYPP 206
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 9e-26
Identities = 61/207 (29%), Positives = 97/207 (46%), Gaps = 20/207 (9%)
Query: 632 QVGQGGYGKVYKGI-LSDNTTVAIKRAEEGSLQGQNE--FLTEIKLLSRLHHRNLVSLLG 688
+G+G +G+V K A+K + S + ++ L E++LL +L H N++ L
Sbjct: 29 MLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFE 88
Query: 689 YCDEEGEQMLVYEFVPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVF 748
++ +V E G L D + R + + + A R+ + S I Y+H +
Sbjct: 89 ILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSG--ITYMHKHN---IV 143
Query: 749 HRDIKASNILLDS---NLNAKVADFGLSRLAPVLDDEGTMPTHVSTIVKGTPGYLDPEYF 805
HRD+K NILL+S + + K+ DFGLS M + GT Y+ PE
Sbjct: 144 HRDLKPENILLESKEKDCDIKIIDFGLST---CFQQNTKMKDRI-----GTAYYIAPE-V 194
Query: 806 LTHKLTDKSDVYSLGVVLLELLTGMQP 832
L +K DV+S GV+L LL+G P
Sbjct: 195 LRGTYDEKCDVWSAGVILYILLSGTPP 221
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 1e-25
Identities = 69/262 (26%), Positives = 105/262 (40%), Gaps = 34/262 (12%)
Query: 588 RHARYQHSLSRKRLSTKISMKIDGVKGFKFKELAMATAYFSSSTQVGQGGYGKVYKGI-L 646
H + S I++ K ++ + ++G G YG+V
Sbjct: 2 HHHHHHSSGRENLYFQGIAINPGMYVRKKEGKI---GESYFKVRKLGSGAYGEVLLCKEK 58
Query: 647 SDNTTVAIK-------------RAEEGSLQGQNEFLTEIKLLSRLHHRNLVSLLGYCDEE 693
+ ++ AIK + + E EI LL L H N++ L +++
Sbjct: 59 NGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDVFEDK 118
Query: 694 GEQMLVYEFVPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIK 753
LV EF G L + + R K + A + + S I YLH + HRDIK
Sbjct: 119 KYFYLVTEFYEGGELFEQIINRHKFDECDAANIMKQILSG--ICYLHKHN---IVHRDIK 173
Query: 754 ASNILLDS---NLNAKVADFGLSRLAPVLDDEGTMPTHVSTIVKGTPGYLDPEYFLTHKL 810
NILL++ LN K+ DFGLS + + + GT Y+ PE L K
Sbjct: 174 PENILLENKNSLLNIKIVDFGLSS---FFSKDYKLRDRL-----GTAYYIAPE-VLKKKY 224
Query: 811 TDKSDVYSLGVVLLELLTGMQP 832
+K DV+S GV++ LL G P
Sbjct: 225 NEKCDVWSCGVIMYILLCGYPP 246
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 109 bits (273), Expect = 1e-25
Identities = 46/207 (22%), Positives = 92/207 (44%), Gaps = 25/207 (12%)
Query: 634 GQGGYGKVYKGI-LSDNTTVAIKRAEEGSLQGQNEFLTEIKLLSRLHHRNLVSLLGYCDE 692
G G +G V++ + + K + EI ++++LHH L++L ++
Sbjct: 60 GSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFED 119
Query: 693 EGEQMLVYEFVPNGTLRDWLSGRTKENLNF-----AMRLRVALDSAKGILYLHTEAHPPV 747
+ E +L+ EF+ G L D + E+ +R A + G+ ++H + +
Sbjct: 120 KYEMVLILEFLSGGELFDRI---AAEDYKMSEAEVINYMRQACE---GLKHMHEHS---I 170
Query: 748 FHRDIKASNILLDSNLNA--KVADFGLSRLAPVLDDEGTMPTHVSTIVKGTPGYLDPEYF 805
H DIK NI+ ++ + K+ DFGL+ L+ + + T + PE
Sbjct: 171 VHLDIKPENIMCETKKASSVKIIDFGLAT---KLNPDEIVKVTT-----ATAEFAAPEIV 222
Query: 806 LTHKLTDKSDVYSLGVVLLELLTGMQP 832
+ +D++++GV+ LL+G+ P
Sbjct: 223 DREPVGFYTDMWAIGVLGYVLLSGLSP 249
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 2e-25
Identities = 57/213 (26%), Positives = 88/213 (41%), Gaps = 30/213 (14%)
Query: 634 GQGGYGKVYKGI-LSDNTTVAIK-----RAEEGSLQGQNEFLT---EIKLLSRLHHRNLV 684
G G +G V+ + N V +K + E + EI +LSR+ H N++
Sbjct: 33 GSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANII 92
Query: 685 SLLGYCDEEGEQMLVYEFVPNGT-LRDWLS--GRTKENLNFAMRLRVALDSAKGILYLHT 741
+L + +G LV E +G L ++ R E L A + L SA + YL
Sbjct: 93 KVLDIFENQGFFQLVMEKHGSGLDLFAFIDRHPRLDEPL--ASYIFRQLVSA--VGYLRL 148
Query: 742 EAHPPVFHRDIKASNILLDSNLNAKVADFGLSRLAPVLDDEGTMPTHVSTIVKGTPGYLD 801
+ + HRDIK NI++ + K+ DFG + L+ T GT Y
Sbjct: 149 KD---IIHRDIKDENIVIAEDFTIKLIDFGSAAY---LERGKLFYTFC-----GTIEYCA 197
Query: 802 PEYFLTHKLTD--KSDVYSLGVVLLELLTGMQP 832
PE L + +++SLGV L L+ P
Sbjct: 198 PE-VLMGNPYRGPELEMWSLGVTLYTLVFEENP 229
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 2e-25
Identities = 56/213 (26%), Positives = 88/213 (41%), Gaps = 31/213 (14%)
Query: 632 QVGQGGYGKVYKGI-LSDNTTVAIKRAEEGSLQGQNE--FLTEIKLLSRLHHRNLVSLLG 688
++G+G + V + + + A K L ++ E ++ +L H N+V L
Sbjct: 13 ELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHD 72
Query: 689 YCDEEGEQMLVYEFVPNGTLRDWLSGRTK--ENLNFAMRLRVALDSAKGIL----YLHTE 742
EE LV++ V G L + + R E A + IL Y H+
Sbjct: 73 SIQEESFHYLVFDLVTGGELFEDIVAREFYSE--------ADASHCIQQILESIAYCHSN 124
Query: 743 AHPPVFHRDIKASNILLDS---NLNAKVADFGLSRLAPVLDDEGTMPTHVSTIVKGTPGY 799
+ HR++K N+LL S K+ADFGL+ ++D GTPGY
Sbjct: 125 G---IVHRNLKPENLLLASKAKGAAVKLADFGLAI---EVNDSEAW----HGFA-GTPGY 173
Query: 800 LDPEYFLTHKLTDKSDVYSLGVVLLELLTGMQP 832
L PE + D+++ GV+L LL G P
Sbjct: 174 LSPEVLKKDPYSKPVDIWACGVILYILLVGYPP 206
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 2e-25
Identities = 63/284 (22%), Positives = 100/284 (35%), Gaps = 60/284 (21%)
Query: 597 SRKRLSTKISMKIDGVKGFKFKELAMATAYFSSSTQVGQGGYGKVYKGI-LSDNTTVAIK 655
S + ++ G + ++ + +GQG YG V I AIK
Sbjct: 4 HHHHSSGRENLYFQGGSLLELQK------KYHLKGAIGQGSYGVVRVAIENQTRAIRAIK 57
Query: 656 -----RAEEGSLQGQNEFLTEIKLLSRLHHRNLVSLLGYCDEEGEQMLVYEFVPNGTLRD 710
+ + + + TE++L+ +LHH N+ L ++E LV E G L D
Sbjct: 58 IMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQYICLVMELCHGGHLLD 117
Query: 711 WLSGRTKENLNFAMRLRVALDSAK------------------------------------ 734
L+ ++ V
Sbjct: 118 KLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQI 177
Query: 735 --GILYLHTEAHPPVFHRDIKASNILLDSNLNA--KVADFGLSRLAPVLDDEGTMPTHVS 790
+ YLH + + HRDIK N L +N + K+ DFGLS+ L++ ++
Sbjct: 178 FSALHYLHNQG---ICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEY--YGMT 232
Query: 791 TIVKGTPGYLDPE--YFLTHKLTDKSDVYSLGVVLLELLTGMQP 832
T GTP ++ PE K D +S GV+L LL G P
Sbjct: 233 TKA-GTPYFVAPEVLNTTNESYGPKCDAWSAGVLLHLLLMGAVP 275
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 2e-25
Identities = 50/217 (23%), Positives = 94/217 (43%), Gaps = 29/217 (13%)
Query: 632 QVGQGGYGKVYKGI-LSDNTTVAIK--------RAEEGSLQGQNEFLTEIKLLSRLH-HR 681
+G+G V + + + A+K + E + + E +L ++ H
Sbjct: 101 VIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHP 160
Query: 682 NLVSLLGYCDEEGEQMLVYEFVPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHT 741
++++L+ + LV++ + G L D+L+ + + + +L + + +LH
Sbjct: 161 HIITLIDSYESSSFMFLVFDLMRKGELFDYLTEKVALSEKETRSIMRSL--LEAVSFLHA 218
Query: 742 EAHPPVFHRDIKASNILLDSNLNAKVADFGLSRLAPVLDDEGTMPTHVSTIVKGTPGYLD 801
+ HRD+K NILLD N+ +++DFG S L+ + + GTPGYL
Sbjct: 219 NN---IVHRDLKPENILLDDNMQIRLSDFGFSC---HLEPGEKL----RELC-GTPGYLA 267
Query: 802 PE------YFLTHKLTDKSDVYSLGVVLLELLTGMQP 832
PE + D+++ GV+L LL G P
Sbjct: 268 PEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPP 304
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 3e-25
Identities = 54/214 (25%), Positives = 99/214 (46%), Gaps = 25/214 (11%)
Query: 627 FSSSTQVGQGGYGKVYKGI-LSDNTTVAIKRAEEGSLQGQNEFLTEIKLLSRLHHRNLVS 685
S + +G G +G+V+K + +A K + ++ + E EI ++++L H NL+
Sbjct: 91 VSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQ 150
Query: 686 LLGYCDEEGEQMLVYEFVPNGTLRDWLSGRTKENLNF----AMRL-RVALDSAKGILYLH 740
L + + + +LV E+V G L D + E+ N + + + GI ++H
Sbjct: 151 LYDAFESKNDIVLVMEYVDGGELFDRI---IDESYNLTELDTILFMKQICE---GIRHMH 204
Query: 741 TEAHPPVFHRDIKASNILLDSNLNA--KVADFGLSRLAPVLDDEGTMPTHVSTIVKGTPG 798
+ H D+K NIL + K+ DFGL+R + + GTP
Sbjct: 205 QMY---ILHLDLKPENILCVNRDAKQIKIIDFGLAR---RYKPREKLKVNF-----GTPE 253
Query: 799 YLDPEYFLTHKLTDKSDVYSLGVVLLELLTGMQP 832
+L PE ++ +D++S+GV+ LL+G+ P
Sbjct: 254 FLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSP 287
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 4e-25
Identities = 59/214 (27%), Positives = 86/214 (40%), Gaps = 29/214 (13%)
Query: 634 GQGGYGKVYKGI-LSDNTTVAIK--------RAEEGSLQGQNEFLTEIKLLSRLHHRNLV 684
G G G+V VAIK TEI++L +L+H ++
Sbjct: 19 GSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCII 78
Query: 685 SLLGYCDEEGEQMLVYEFVPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAH 744
+ + D E + +V E + G L D + G + + A + YLH
Sbjct: 79 KIKNFFDAE-DYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLA--VQYLHENG- 134
Query: 745 PPVFHRDIKASNILLDS---NLNAKVADFGLSRLAPVLDDEGTMPTHVSTIVKGTPGYLD 801
+ HRD+K N+LL S + K+ DFG S+ +L + M T GTP YL
Sbjct: 135 --IIHRDLKPENVLLSSQEEDCLIKITDFGHSK---ILGETSLMRTLC-----GTPTYLA 184
Query: 802 PE---YFLTHKLTDKSDVYSLGVVLLELLTGMQP 832
PE T D +SLGV+L L+G P
Sbjct: 185 PEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPP 218
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 4e-25
Identities = 61/227 (26%), Positives = 96/227 (42%), Gaps = 43/227 (18%)
Query: 632 QVGQGGYGKVYKGILSDNTTVAIKRAEEGSLQGQNEFLTEIKLLSRLHHRNLVSLL---- 687
+G G +G V++ L ++ VAIK+ LQ + E++++ + H N+V L
Sbjct: 47 VIGNGSFGVVFQAKLVESDEVAIKKV----LQDKRFKNRELQIMRIVKHPNVVDLKAFFY 102
Query: 688 --GYCDEEGEQMLVYEFVPNGTLRDWLSGRTKENLNFAMR---------LRVALDSAKGI 736
G +E LV E+VP T+ K M LR +
Sbjct: 103 SNGDKKDEVFLNLVLEYVPE-TVYRASRHYAKLKQTMPMLLIKLYMYQLLR-------SL 154
Query: 737 LYLHTEAHPPVFHRDIKASNILLDSNLNA-KVADFGLSR-LAPVLDDEGTMPTHVSTIVK 794
Y+H+ + HRDIK N+LLD K+ DFG ++ L +VS I
Sbjct: 155 AYIHSIG---ICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAG-------EPNVSYIC- 203
Query: 795 GTPGYLDPEYFLTHKL-TDKSDVYSLGVVLLELLTGMQPISHGKNIV 840
+ Y PE T D++S G V+ EL+ G QP+ G++ +
Sbjct: 204 -SRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQG-QPLFPGESGI 248
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 5e-25
Identities = 76/349 (21%), Positives = 125/349 (35%), Gaps = 101/349 (28%)
Query: 632 QVGQGGYGKVYKGIL------SDNTTVAIKRAEEG-SLQGQNEFLTEIKLLSRL-HHRNL 683
+G+G +G+V + + TVA+K +EG + ++E+K+L + HH N+
Sbjct: 29 PLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNV 88
Query: 684 VSLLGYC-DEEGEQMLVYEFVPNGTLRDWLSGRTKENLNFA-----------------MR 725
V+LLG C G M++ EF G L +L + E + + +
Sbjct: 89 VNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVD 148
Query: 726 LRVALDS--------------AKGILYLHTEAHPPVFHRDIKASNILL------------ 759
L+ LDS K + + E P ++D L+
Sbjct: 149 LKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEF 208
Query: 760 ------------------DSNLNAKVADFGLSRLAPVLDD-----EGTMPTHVSTIVKGT 796
K+ DFGL+R D + +P +K
Sbjct: 209 LASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLP------LKWM 262
Query: 797 PGYLDPEYFLTHKLTDKSDVYSLGVVLLELLT-GMQP---ISHGKNIVREVNVARDSGMV 852
PE T +SDV+S GV+L E+ + G P + + R + G
Sbjct: 263 A----PETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLK----EG-- 312
Query: 853 FSIIDNRMGSYPSECVERFVTLALRCCHDKPEHRPSMSDVVRELENILK 901
RM + P L C H +P RP+ S++V L N+L+
Sbjct: 313 -----TRMRA-PDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 355
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 107 bits (267), Expect = 6e-25
Identities = 36/307 (11%), Positives = 76/307 (24%), Gaps = 75/307 (24%)
Query: 634 GQGGYGKVYKGI-LSDNTTVAIK----------------RAE------------EGSLQG 664
GQ + + + + E + +
Sbjct: 82 GQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKV 141
Query: 665 QNEFLTEIKLLSRLHHRNLVSLLGYCDEEGEQMLVYEF-VPNGTLRDWLS-----GRTKE 718
F+ L+ + ++ + + + + L+ + T +
Sbjct: 142 HLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHK 201
Query: 719 NLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSRLAPV 778
+L RL++ L + + LH + H ++ +I+LD + F
Sbjct: 202 SLVHHARLQLTLQVIRLLASLHHYG---LVHTYLRPVDIVLDQRGGVFLTGFEHLVR--- 255
Query: 779 LDDEGTMPTHVSTIVKGTPGYLDPEYFLTHKL-----------TDKSDVYSLGVVLLELL 827
+G + G+ PE T D ++LG+V+ +
Sbjct: 256 ---DGARVV-----SSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIW 307
Query: 828 TGMQPISHGKNIVREVNVARDSGMVFSIIDNRMGSYPSECVERFVTLALRCCHDKPEHRP 887
PI+ S +F N P L E R
Sbjct: 308 CADLPITKD-------AALGGSEWIFRSCKN----IPQPVRA----LLEGFLRYPKEDRL 352
Query: 888 SMSDVVR 894
+
Sbjct: 353 LPLQAME 359
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 1e-24
Identities = 61/207 (29%), Positives = 97/207 (46%), Gaps = 20/207 (9%)
Query: 632 QVGQGGYGKVYKGI-LSDNTTVAIKRAEEGSLQGQNE--FLTEIKLLSRLHHRNLVSLLG 688
+G+G +G+V K A+K + S + ++ L E++LL +L H N++ L
Sbjct: 29 MLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFE 88
Query: 689 YCDEEGEQMLVYEFVPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVF 748
++ +V E G L D + R + + + A R+ + S I Y+H +
Sbjct: 89 ILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSG--ITYMHKHN---IV 143
Query: 749 HRDIKASNILLDS---NLNAKVADFGLSRLAPVLDDEGTMPTHVSTIVKGTPGYLDPEYF 805
HRD+K NILL+S + + K+ DFGLS M + GT Y+ PE
Sbjct: 144 HRDLKPENILLESKEKDCDIKIIDFGLST---CFQQNTKMKDRI-----GTAYYIAPE-V 194
Query: 806 LTHKLTDKSDVYSLGVVLLELLTGMQP 832
L +K DV+S GV+L LL+G P
Sbjct: 195 LRGTYDEKCDVWSAGVILYILLSGTPP 221
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 2e-24
Identities = 56/250 (22%), Positives = 98/250 (39%), Gaps = 30/250 (12%)
Query: 594 HSLSRKRLSTKISMK-IDGVKGFKFKELAMATAYFSSSTQVGQGGYGKVYKGI-LSDNTT 651
H + + + F Y +S ++G+G + V + I S
Sbjct: 2 HHHHHHSSGVDLGTENLYFQSMENFNNF-----YILTSKELGRGKFAVVRQCISKSTGQE 56
Query: 652 VAIK--RAEEGSLQGQNEFLTEIKLLSRL-HHRNLVSLLGYCDEEGEQMLVYEFVPNGTL 708
A K + + E L EI +L +++L + E +L+ E+ G +
Sbjct: 57 YAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYENTSEIILILEYAAGGEI 116
Query: 709 RDWLSGRTKENLN--FAMRL-RVALDSAKGILYLHTEAHPPVFHRDIKASNILL---DSN 762
E ++ +RL + L+ G+ YLH + H D+K NILL
Sbjct: 117 FSLCLPELAEMVSENDVIRLIKQILE---GVYYLHQNN---IVHLDLKPQNILLSSIYPL 170
Query: 763 LNAKVADFGLSRLAPVLDDEGTMPTHVSTIVKGTPGYLDPEYFLTHKLTDKSDVYSLGVV 822
+ K+ DFG+SR + + + GTP YL PE +T +D++++G++
Sbjct: 171 GDIKIVDFGMSR---KIGHACELREIM-----GTPEYLAPEILNYDPITTATDMWNIGII 222
Query: 823 LLELLTGMQP 832
LLT P
Sbjct: 223 AYMLLTHTSP 232
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 2e-24
Identities = 54/329 (16%), Positives = 106/329 (32%), Gaps = 38/329 (11%)
Query: 92 QLLSMNLSGN------LAPELGQLSRLQYYFM--WNDLTGTIPKEIGNISSLIFLLLNGN 143
L +NL GN + L+ LQ + + + ++SL L +
Sbjct: 99 SLKYLNLMGNPYQTLGVTSLFPNLTNLQTLRIGNVETFSEIRRIDFAGLTSLNELEIKAL 158
Query: 144 KLSGSLPDELGYLSNLNRLQVDENNITGTIPKSFANLSRVRHLHLNNNSIGGQIPSELSK 203
L L + +++ L + + + LS VR+L L + ++ S L
Sbjct: 159 SLRNYQSQSLKSIRDIHHLTLHLSESAFLLEIFADILSSVRYLELRDTNLARFQFSPLPV 218
Query: 204 LSTLIHLLVDNNNLSGNLPPELSELPQLCILQLDNNNFSASEIPATY------------G 251
+ S +EL +L L+ + +
Sbjct: 219 DEVSSPMKKLAFRGSVLTDESFNELLKLLRYILELSEVEFDDCTLNGLGDFNPSESDVVS 278
Query: 252 NFSKLVKLSLRNCNLQG----AVPD--LSRIPNLYYLDLSWNHLTGSIPSKKLSE--NVT 303
K+ +++R ++ S + + + + + + +P ++
Sbjct: 279 ELGKVETVTIRRLHIPQFYLFYDLSTVYSLLEKVKRITVENSKVF-LVPCSFSQHLKSLE 337
Query: 304 TIDLSDNYLNGSILES---ISNLPFLQTLSLENNFLTGSIPATIWQNKSFSTKARLK-ID 359
+DLS+N + L++ P LQTL L N L S+ T + L +D
Sbjct: 338 FLDLSENLMVEEYLKNSACKGAWPSLQTLVLSQNHLR-SMQKTGEILLTLK---NLTSLD 393
Query: 360 LRNNSFSNIVGDLTLPNN-VTLRLGGNPI 387
+ N+F + P L L I
Sbjct: 394 ISRNTFHPMPDSCQWPEKMRFLNLSSTGI 422
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 5e-23
Identities = 45/259 (17%), Positives = 85/259 (32%), Gaps = 20/259 (7%)
Query: 85 HLHVRELQLLSMNLSGNLAP----ELGQLSRLQYYFMWNDLTGTIPKEIGNISSLIFLLL 140
+ L + + S ++ E + RL + L + + + + +
Sbjct: 260 DCTLNGLGDFNPSESDVVSELGKVETVTIRRL--HIPQFYLFYDLSTVYSLLEKVKRITV 317
Query: 141 NGNKLSGSLPDELGYLSNLNRLQVDENNITGTIPKS---FANLSRVRHLHLNNNSIG--G 195
+K+ +L +L L + EN + K+ ++ L L+ N +
Sbjct: 318 ENSKVFLVPCSFSQHLKSLEFLDLSENLMVEEYLKNSACKGAWPSLQTLVLSQNHLRSMQ 377
Query: 196 QIPSELSKLSTLIHLLVDNNNLSGNLPPELSELPQLCILQLDNNNFSASEIPATYGNFSK 255
+ L L L L + N +P ++ L L + +
Sbjct: 378 KTGEILLTLKNLTSLDISRNTFH-PMPDSCQWPEKMRFLNLSSTGIR--VVKT--CIPQT 432
Query: 256 LVKLSLRNCNLQGAVPDLSRIPNLYYLDLSWNHLTGSIPSKKLSENVTTIDLSDNYLNGS 315
L L + N NL + +P L L +S N L ++P L + + +S N L
Sbjct: 433 LEVLDVSNNNLD-SFS--LFLPRLQELYISRNKLK-TLPDASLFPVLLVMKISRNQLKSV 488
Query: 316 ILESISNLPFLQTLSLENN 334
L LQ + L N
Sbjct: 489 PDGIFDRLTSLQKIWLHTN 507
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 9e-23
Identities = 63/330 (19%), Positives = 112/330 (33%), Gaps = 29/330 (8%)
Query: 94 LSMNLSGNLAPE-LGQLSRLQY-YFMWNDLTGTIPKEI-GNISSLIFLLLNGNKLSGSLP 150
LS N + L + LQ + + TI + ++ SL L L+ N LS SL
Sbjct: 33 LSFNKITYIGHGDLRACANLQVLILKSSRIN-TIEGDAFYSLGSLEHLDLSDNHLS-SLS 90
Query: 151 DE-LGYLSNLNRLQVDENNITG-TIPKSFANLSRVRHLHLNNNSIGGQIPSE-LSKLSTL 207
G LS+L L + N + F NL+ ++ L + N +I + L++L
Sbjct: 91 SSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQTLRIGNVETFSEIRRIDFAGLTSL 150
Query: 208 IHLLVDNNNLSGNLPPELSELPQLCILQLDNNNFSASEIPATYGNFSKLVKLSLRNCNLQ 267
L + +L L + + L L + + S + L LR+ NL
Sbjct: 151 NELEIKALSLRNYQSQSLKSIRDIHHLTLHLSESAFLL-EIFADILSSVRYLELRDTNLA 209
Query: 268 GAVPD------------LSRIPNLYYLDLSWNHLTGSIPSKKLSENVTTIDLSDN---YL 312
D S+N L + V D + N
Sbjct: 210 RFQFSPLPVDEVSSPMKKLAFRGSVLTDESFNELLKLLRYILELSEVEFDDCTLNGLGDF 269
Query: 313 NGSILESISNLPFLQTLSLENNFLTGSIPATIWQNKSFSTKARLK-IDLRNNSFSNIVGD 371
N S + +S L ++T+++ + + +S ++K I + N+ +
Sbjct: 270 NPSESDVVSELGKVETVTIRRLHIP-QFYLFYDLSTVYSLLEKVKRITVENSKVFLVPCS 328
Query: 372 L--TLPNNVTLRLGGNPICTSANIPNTGRF 399
L + L L N + + N+
Sbjct: 329 FSQHLKSLEFLDLSENLM-VEEYLKNSACK 357
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 102 bits (255), Expect = 1e-22
Identities = 64/341 (18%), Positives = 109/341 (31%), Gaps = 34/341 (9%)
Query: 44 LRAIKNSLVDSMNHLR----NWNKGDPCMSNWTGVLCFDTVETDGHLHVRELQLLSMNLS 99
+ D ++ +R + V + L S N
Sbjct: 184 SAFLLEIFADILSSVRYLELRDTNLARFQFSPLPVDEVSSPMKKLAFRGSVLTDESFNEL 243
Query: 100 GNLAPELGQLSRLQYY-FMWNDLTGTIPKEIGNISSLIF--------LLLNGNKLSGSLP 150
L + +LS +++ N L P E +S L L + L L
Sbjct: 244 LKLLRYILELSEVEFDDCTLNGLGDFNPSESDVVSELGKVETVTIRRLHIPQFYLFYDLS 303
Query: 151 DELGYLSNLNRLQVDENNITGTIPKSFANLSRVRHLHLNNN---SIGGQIPSELSKLSTL 207
L + R+ V+ + + +L + L L+ N + + +L
Sbjct: 304 TVYSLLEKVKRITVENSKVFLVPCSFSQHLKSLEFLDLSENLMVEEYLKNSACKGAWPSL 363
Query: 208 IHLLVDNNNLS--GNLPPELSELPQLCILQLDNNNFSASEIPATYGNFSKLVKLSLRNCN 265
L++ N+L L L L L + N F +P + K+ L+L +
Sbjct: 364 QTLVLSQNHLRSMQKTGEILLTLKNLTSLDISRNTFH--PMPDSCQWPEKMRFLNLSSTG 421
Query: 266 LQGAVPDLSRIPNLYYLDLSWNHLTGSIPSKKLSENVTTIDLSDNYLNGSILESISNLPF 325
++ V L LD+S N+L S + + +S N L L S P
Sbjct: 422 IR-VVKT-CIPQTLEVLDVSNNNLD-SFSLF--LPRLQELYISRNKL--KTLPDASLFPV 474
Query: 326 LQTLSLENNFLTGSIPATIWQNKSFSTKARLK-IDLRNNSF 365
L + + N L S+P I F L+ I L N +
Sbjct: 475 LLVMKISRNQLK-SVPDGI-----FDRLTSLQKIWLHTNPW 509
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 99.8 bits (249), Expect = 7e-22
Identities = 51/322 (15%), Positives = 97/322 (30%), Gaps = 56/322 (17%)
Query: 93 LLSMNLSGNLAPELGQLSRLQYYFMWNDLTGTIPKEIGNISSLIFLLLNGNKLSGSLPDE 152
M L S + + + E + + N ++
Sbjct: 222 SSPMKKLAFRGSVLTDESFNELLKLLRYILELSEVEFDDCTLNGLGDFNPSESDVVSELG 281
Query: 153 LGYLSNLNRLQVDENNITGTIPKSFANLSRVRHLHLNNNSIGGQIPSE-LSKLSTLIHLL 211
+ RL + + + + ++ L +V+ + + N+ + +P L +L L
Sbjct: 282 KVETVTIRRLHIPQFYLFYDLSTVYSLLEKVKRITVENSKVF-LVPCSFSQHLKSLEFLD 340
Query: 212 VDNNNLSGNLPPE---LSELPQLCILQLDNNNFSASEIPATYGNFSKLVKLSLRNCNLQG 268
+ N + P L L L N+ + T L
Sbjct: 341 LSENLMVEEYLKNSACKGAWPSLQTLVLSQNHLR--SMQKTGEILLTL------------ 386
Query: 269 AVPDLSRIPNLYYLDLSWNHLTGSIPSKKLSENVTTIDLSDN----------------YL 312
NL LD+S N S + E + ++LS +
Sbjct: 387 --------KNLTSLDISRNTFHPMPDSCQWPEKMRFLNLSSTGIRVVKTCIPQTLEVLDV 438
Query: 313 NGSILESIS-NLPFLQTLSLENNFLTGSIPATIWQNKSFSTKARLKI-DLRNNSFSNIVG 370
+ + L+S S LP LQ L + N L ++P S L + + N ++
Sbjct: 439 SNNNLDSFSLFLPRLQELYISRNKLK-TLPDA-----SLFPV--LLVMKISRNQLKSVPD 490
Query: 371 DL--TLPNNVTLRLGGNPI-CT 389
+ L + + L NP C+
Sbjct: 491 GIFDRLTSLQKIWLHTNPWDCS 512
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 99.0 bits (247), Expect = 1e-21
Identities = 44/281 (15%), Positives = 97/281 (34%), Gaps = 17/281 (6%)
Query: 119 NDLTGTIPKEIGNISSLIFLLLNGNKLSGSLPDELGYLSNLNRLQVDENNITGTIPKSFA 178
T +IP + +++ L L+ NK++ +L +NL L + + I +F
Sbjct: 15 RSFT-SIPSGL--TAAMKSLDLSFNKITYIGHGDLRACANLQVLILKSSRINTIEGDAFY 71
Query: 179 NLSRVRHLHLNNNSIGGQIPSELSKLSTLIHLLVDNNNLSG-NLPPELSELPQLCILQLD 237
+L + HL L++N + S LS+L +L + N + L L L++
Sbjct: 72 SLGSLEHLDLSDNHLSSLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQTLRIG 131
Query: 238 NNNFSASEIPATYGNFSKLVKLSLRNCNLQGAVP-DLSRIPNLYYLDLSWNHLTGSIPSK 296
N + + + L +L ++ +L+ L I ++++L L + +
Sbjct: 132 NVETFSEIRRIDFAGLTSLNELEIKALSLRNYQSQSLKSIRDIHHLTLHLSESA-FLLEI 190
Query: 297 KLS--ENVTTIDLSDNYLNGSILESISNLPFLQTLSLENNFLTGSIPATIWQNKSFSTKA 354
+V ++L D L + + ++ ++SF+
Sbjct: 191 FADILSSVRYLELRDTNLARFQFSPLPVDEVSSPMKKLAFRG------SVLTDESFNELL 244
Query: 355 RLKIDLRNNSFSNIVGDLTLPNNVTLRLGGNPICTSANIPN 395
+L + S N + + +
Sbjct: 245 KLLRYILELSEVEF---DDCTLNGLGDFNPSESDVVSELGK 282
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 106 bits (265), Expect = 2e-24
Identities = 36/302 (11%), Positives = 76/302 (25%), Gaps = 64/302 (21%)
Query: 633 VGQGGYGKVYKGI-LSDNTTVAIK---RAEEGSLQGQNEFLTEIKLLSRL---------- 678
+GQ + + + E + E+ L L
Sbjct: 86 LGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAK 145
Query: 679 ------------HHRNLVSLLGYCDEEGEQMLVYEFV----PNGTLRDWLS-----GRTK 717
++ +E + ++ F L+ + T
Sbjct: 146 VHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTH 205
Query: 718 ENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSRLAP 777
++L RL++ L + + LH + H ++ +I+LD + F
Sbjct: 206 KSLVHHARLQLTLQVIRLLASLHHYG---LVHTYLRPVDIVLDQRGGVFLTGFEHLVR-- 260
Query: 778 VLDDEGTMPTHVSTIVKGTPGYLDPEYFLTHK-----LTDKSDVYSLGVVLLELLTGMQP 832
+G P + +T D ++LG+ + + P
Sbjct: 261 ----DGASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLP 316
Query: 833 ISHGKNIVREVNVARDSGMVFSIIDNRMGSYPSECVERFVTLALRCCHDKPEHRPSMSDV 892
+ S +F N + V + LR + E R
Sbjct: 317 NTDD-------AALGGSEWIFRSCKN-----IPQPVRALLEGFLR--YP-KEDRLLPLQA 361
Query: 893 VR 894
+
Sbjct: 362 ME 363
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 2e-24
Identities = 54/276 (19%), Positives = 114/276 (41%), Gaps = 26/276 (9%)
Query: 106 LGQLSRLQY-YFMWNDLTGTIPKEIGNISSLIFLLLNGNKLSGSLPDELGYLSNLNRLQV 164
L+ +++T T+ ++ + L G ++ ++ + YL+NL L++
Sbjct: 15 DPALANAIKIAAGKSNVTDTVT--QADLDGITTLSAFGTGVT-TIE-GVQYLNNLIGLEL 70
Query: 165 DENNITGTIPKSFANLSRVRHLHLNNNSIGGQIPSELSKLSTLIHLLVDNNNLSGNLPPE 224
+N IT P NL+++ L L+ N + + S ++ L ++ L + + ++ ++ P
Sbjct: 71 KDNQITDLAP--LKNLTKITELELSGNPL--KNVSAIAGLQSIKTLDLTSTQIT-DVTP- 124
Query: 225 LSELPQLCILQLDNNNFSASEIPATYGNFSKLVKLSLRNCNLQGAVPDLSRIPNLYYLDL 284
L+ L L +L LD N + I + L LS+ N + + L+ + L L
Sbjct: 125 LAGLSNLQVLYLDLNQIT--NISPL-AGLTNLQYLSIGNAQVSD-LTPLANLSKLTTLKA 180
Query: 285 SWNHLTGSIPSKKLSENVTTIDLSDNYLNGSILESISNLPFLQTLSLENNFLTGSIPATI 344
N ++ I N+ + L +N + S + ++N L ++L N +T + P
Sbjct: 181 DDNKIS-DISPLASLPNLIEVHLKNNQI--SDVSPLANTSNLFIVTLTNQTIT-NQPVFY 236
Query: 345 WQNKSFSTKARLKIDLRNNSFSNIVGDLTLPNNVTL 380
N ++ + T+ +N T
Sbjct: 237 NNNLVVP-------NVVKGPSGAPIAPATISDNGTY 265
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 98.2 bits (245), Expect = 2e-22
Identities = 54/250 (21%), Positives = 103/250 (41%), Gaps = 24/250 (9%)
Query: 139 LLNGNKLSGSLPDELGYLSNLNRLQVDENNITGTIPKSFANLSRVRHLHLNNNSIGGQIP 198
+ ++ PD L+N ++ ++N+T T+ A+L + L + I
Sbjct: 3 ITQPTAINVIFPDP--ALANAIKIAAGKSNVTDTVT--QADLDGITTLSAFGTGVT-TI- 56
Query: 199 SELSKLSTLIHLLVDNNNLSGNLPPELSELPQLCILQLDNNNFSASEIPATYGNFSKLVK 258
+ L+ LI L + +N ++ +L P L L ++ L+L N + A +
Sbjct: 57 EGVQYLNNLIGLELKDNQIT-DLAP-LKNLTKITELELSGNPLK--NVSA-IAGLQSIKT 111
Query: 259 LSLRNCNLQGAVPDLSRIPNLYYLDLSWNHLTGSIPSKKLSENVTTIDLSDNYLNGSILE 318
L L + + V L+ + NL L L N +T P L+ N+ + + + + S L
Sbjct: 112 LDLTSTQITD-VTPLAGLSNLQVLYLDLNQITNISPLAGLT-NLQYLSIGNAQV--SDLT 167
Query: 319 SISNLPFLQTLSLENNFLTGSIPATIWQNKSFSTKARLK-IDLRNNSFSNIVGDLTLPNN 377
++NL L TL ++N ++ I ++ L + L+NN S++ N
Sbjct: 168 PLANLSKLTTLKADDNKIS-DISP-------LASLPNLIEVHLKNNQISDVSPLANTSNL 219
Query: 378 VTLRLGGNPI 387
+ L I
Sbjct: 220 FIVTLTNQTI 229
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 52.8 bits (127), Expect = 2e-07
Identities = 20/124 (16%), Positives = 44/124 (35%), Gaps = 12/124 (9%)
Query: 273 LSRIPNLYYLDLSWNHLTGSIPSKKLSENVTTIDLSDNYLNGSILESISNLPFLQTLSLE 332
+ N + +++T ++ L +TT+ + + +E + L L L L+
Sbjct: 15 DPALANAIKIAAGKSNVTDTVTQADLD-GITTLSAFGTGV--TTIEGVQYLNNLIGLELK 71
Query: 333 NNFLTGSIPATIWQNKSFSTKARLK-IDLRNNSFSNIVGDLTLPNNVTLRLGGNPICTSA 391
+N +T + ++ ++L N N+ L + TL L I
Sbjct: 72 DNQIT-DLAP-------LKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDVT 123
Query: 392 NIPN 395
+
Sbjct: 124 PLAG 127
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 47.4 bits (113), Expect = 1e-05
Identities = 35/158 (22%), Positives = 57/158 (36%), Gaps = 27/158 (17%)
Query: 92 QLLSMNLSGNL---APELGQLSRLQY-YFMWNDLTGTIPKEIGNISSLIFLLLNGNKLSG 147
L + L N L L+ LQY ++ P + N+S L L + NK+S
Sbjct: 130 NLQVLYLDLNQITNISPLAGLTNLQYLSIGNAQVSDLTP--LANLSKLTTLKADDNKIS- 186
Query: 148 SLPDELGYLSNLNRLQVDENNITGTIPKSFANLSRVRHLHLNNNSIGGQIPSELSKLSTL 207
+ L L NL + + N I+ P AN S + + L N +I Q + L
Sbjct: 187 DISP-LASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLTNQTITNQPVFYNNNLVVP 243
Query: 208 IHLL-----------------VDNNNLSGNLPPELSEL 228
+ + NL+ NL ++ +
Sbjct: 244 NVVKGPSGAPIAPATISDNGTYASPNLTWNLTSFINNV 281
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 2e-24
Identities = 66/207 (31%), Positives = 99/207 (47%), Gaps = 24/207 (11%)
Query: 634 GQGGYGKVYKGI-LSDNTTVAIK---RAEEGSLQGQNEFLTEIKLLSRLHHRNLVSLLGY 689
G G +GKV G VA+K R + SL + EI+ L H +++ L
Sbjct: 25 GVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQV 84
Query: 690 CDEEGEQMLVYEFVPNGTLRDWLS--GRTKENLNFAMRLRVALDSAKGILYLHTEAHPPV 747
+ +V E+V G L D++ GR E + RL + S + Y H V
Sbjct: 85 ISTPSDIFMVMEYVSGGELFDYICKNGRLDEKE--SRRLFQQILSG--VDYCHRHM---V 137
Query: 748 FHRDIKASNILLDSNLNAKVADFGLSRLAPVLDDEGTMPTHVSTIVKGTPGYLDPEYFLT 807
HRD+K N+LLD+++NAK+ADFGLS + + D + T G+P Y PE ++
Sbjct: 138 VHRDLKPENVLLDAHMNAKIADFGLSNM---MSDGEFLRTSC-----GSPNYAAPE-VIS 188
Query: 808 HKLTD--KSDVYSLGVVLLELLTGMQP 832
+L + D++S GV+L LL G P
Sbjct: 189 GRLYAGPEVDIWSSGVILYALLCGTLP 215
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 3e-24
Identities = 51/212 (24%), Positives = 82/212 (38%), Gaps = 25/212 (11%)
Query: 634 GQGGYGKVYKGI-LSDNTTVAIK-----RAEEGSLQGQNEFLTEIKLLSRLHHRNLVSLL 687
G+G + V + I A+K + + E + L H ++V LL
Sbjct: 33 GKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELL 92
Query: 688 GYCDEEGEQMLVYEFVPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGIL----YLHTEA 743
+G +V+EF+ L + R ++ VA + IL Y H
Sbjct: 93 ETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSE--AVASHYMRQILEALRYCHDNN 150
Query: 744 HPPVFHRDIKASNILLDS---NLNAKVADFGLSRLAPVLDDEGTMPTHVSTIVKGTPGYL 800
+ HRD+K +LL S + K+ FG++ L + G + V GTP ++
Sbjct: 151 ---IIHRDVKPHCVLLASKENSAPVKLGGFGVAI---QLGESGLV---AGGRV-GTPHFM 200
Query: 801 DPEYFLTHKLTDKSDVYSLGVVLLELLTGMQP 832
PE DV+ GV+L LL+G P
Sbjct: 201 APEVVKREPYGKPVDVWGCGVILFILLSGCLP 232
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 3e-24
Identities = 60/234 (25%), Positives = 107/234 (45%), Gaps = 29/234 (12%)
Query: 611 GVKGFKFKELAMATAYFSSSTQVGQGGYGKVYKGI-LSDNTTVAIK----RAEEGSLQGQ 665
G++ FK +++ ++ ++G G + V K S A K R S +G
Sbjct: 1 GMEPFKQQKV---EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGV 57
Query: 666 N--EFLTEIKLLSRLHHRNLVSLLGYCDEEGEQMLVYEFVPNGTLRDWLSGRTKENLNFA 723
+ E E+ +L ++ H N+++L + + +L+ E V G L D+L+ + + A
Sbjct: 58 SREEIEREVSILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEA 117
Query: 724 MRL-RVALDSAKGILYLHTEAHPPVFHRDIKASNILLDS----NLNAKVADFGLSRLAPV 778
+ LD G+ YLHT+ + H D+K NI+L + K+ DFGL+
Sbjct: 118 TSFIKQILD---GVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAH---E 168
Query: 779 LDDEGTMPTHVSTIVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVLLELLTGMQP 832
++D GTP ++ PE L ++D++S+GV+ LL+G P
Sbjct: 169 IEDGVEFKNIF-----GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 217
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 4e-24
Identities = 61/233 (26%), Positives = 97/233 (41%), Gaps = 54/233 (23%)
Query: 632 QVGQGGYGKVYKGILSD-NTTVAIKRAEEGSLQGQNEFLTEIKLLSRLHHRNLVSLLGYC 690
+G G +G VY+ L D VAIK+ LQ + E++++ +L H N+V L +
Sbjct: 61 VIGNGSFGVVYQAKLCDSGELVAIKKV----LQDKRFKNRELQIMRKLDHCNIVRLRYFF 116
Query: 691 DEEGEQM------LVYEFVPNGTLRDWLSGRTKENLNFAMR---------LRVALDSAKG 735
GE+ LV ++VP T+ ++ + R
Sbjct: 117 YSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFR-------S 168
Query: 736 ILYLHTEAHPPVFHRDIKASNILLDSNLNA-KVADFGLSRLAPVLDDEGTMPTHVST--- 791
+ Y+H+ + HRDIK N+LLD + K+ DFG ++ L +++ +
Sbjct: 169 LAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAK---QLVRGEPNVSYICSRYY 222
Query: 792 ----IVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVLLELLTGMQPISHGKNIV 840
++ G Y T DV+S G VL ELL G QPI G + V
Sbjct: 223 RAPELIFGATDY-----------TSSIDVWSAGCVLAELLLG-QPIFPGDSGV 263
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 4e-24
Identities = 56/211 (26%), Positives = 86/211 (40%), Gaps = 31/211 (14%)
Query: 634 GQGGYGKVYKGI-LSDNTTVAIKRAEEGSLQGQNE--FLTEIKLLSRLHHRNLVSLLGYC 690
G+G + V + + + A K L ++ E ++ +L H N+V L
Sbjct: 38 GKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSI 97
Query: 691 DEEGEQMLVYEFVPNGTLRDWLSGRTK--ENLNFAMRLRVALDSAKGIL----YLHTEAH 744
EE LV++ V G L + + R E A + IL Y H+
Sbjct: 98 QEESFHYLVFDLVTGGELFEDIVAREFYSE--------ADASHCIQQILESIAYCHSNG- 148
Query: 745 PPVFHRDIKASNILLDS---NLNAKVADFGLSRLAPVLDDEGTMPTHVSTIVKGTPGYLD 801
+ HR++K N+LL S K+ADFGL+ ++D GTPGYL
Sbjct: 149 --IVHRNLKPENLLLASKAKGAAVKLADFGLAI---EVNDSEAW----HGFA-GTPGYLS 198
Query: 802 PEYFLTHKLTDKSDVYSLGVVLLELLTGMQP 832
PE + D+++ GV+L LL G P
Sbjct: 199 PEVLKKDPYSKPVDIWACGVILYILLVGYPP 229
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 4e-24
Identities = 42/212 (19%), Positives = 87/212 (41%), Gaps = 34/212 (16%)
Query: 633 VGQGGYGKVYKGI-LSDNTTVAIK----RAEEGSLQGQNEFLTEIKLLSRLHHRNLVSLL 687
+G+G +G V++ + S T K + + Q EI +L+ HRN++ L
Sbjct: 13 LGRGEFGIVHRCVETSSKKTYMAKFVKVKGTD-----QVLVKKEISILNIARHRNILHLH 67
Query: 688 GYCDEEGEQMLVYEFVPNGTLRDWLSGRTKENLNF-----AMRLRVALDSAKGILYLHTE 742
+ E ++++EF+ + + + + + + +LH+
Sbjct: 68 ESFESMEELVMIFEFISGLDIFERI---NTSAFELNEREIVSYVHQVCE---ALQFLHSH 121
Query: 743 AHPPVFHRDIKASNILLDSNLNA--KVADFGLSRLAPVLDDEGTMPTHVSTIVKGTPGYL 800
+ H DI+ NI+ + ++ K+ +FG +R L + P Y
Sbjct: 122 N---IGHFDIRPENIIYQTRRSSTIKIIEFGQARQ---LKPGDNF----RLLF-TAPEYY 170
Query: 801 DPEYFLTHKLTDKSDVYSLGVVLLELLTGMQP 832
PE ++ +D++SLG ++ LL+G+ P
Sbjct: 171 APEVHQHDVVSTATDMWSLGTLVYVLLSGINP 202
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 101 bits (255), Expect = 6e-24
Identities = 55/273 (20%), Positives = 85/273 (31%), Gaps = 62/273 (22%)
Query: 119 NDLTGTIPKEIGNISSLIFLLLNGNKLSGSLPDELGYLSNLNRLQVDENNITGTIPKSFA 178
L +P I ++ + L+GN++S NL L + N + +F
Sbjct: 21 QGLQ-AVPVGIP--AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFT 77
Query: 179 NLSRVRHLHLNNNSIGGQIPSE-LSKLSTLIHLLVDNNNLSGNLPPE-LSELPQLCILQL 236
L+ + L L++N+ + L L L +D L L P L L L L
Sbjct: 78 GLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQ-ELGPGLFRGLAALQYLYL 136
Query: 237 DNNNFSASEIPATYGNFSKLVKLSLRNCNLQGAVPDLSRIPNLYYLDLSWNHLTGSIPSK 296
+N +P F L NL +L L N ++ S+P
Sbjct: 137 QDNAL--QALPD--DTFRDL--------------------GNLTHLFLHGNRIS-SVPE- 170
Query: 297 KLSENVTTIDLSDNYLNGSILESISNLPFLQTLSLENNFLTGSIPATIWQNKSFSTKARL 356
+ L L L L N + + +F RL
Sbjct: 171 ---------------------RAFRGLHSLDRLLLHQNRVA-HVHP-----HAFRDLGRL 203
Query: 357 KI-DLRNNSFSNIVGDL--TLPNNVTLRLGGNP 386
L N+ S + + L LRL NP
Sbjct: 204 MTLYLFANNLSALPTEALAPLRALQYLRLNDNP 236
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 77.3 bits (191), Expect = 1e-15
Identities = 44/161 (27%), Positives = 71/161 (44%), Gaps = 15/161 (9%)
Query: 92 QLLSMNLSGN-----LAPE-LGQLSRLQY-YFMWNDLTGTIPKEI-GNISSLIFLLLNGN 143
L ++LS N + P L RL + L + + +++L +L L N
Sbjct: 81 LLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQ-ELGPGLFRGLAALQYLYLQDN 139
Query: 144 KLSGSLPDE-LGYLSNLNRLQVDENNITGTIPKSFANLSRVRHLHLNNNSIGGQIPSE-L 201
L +LPD+ L NL L + N I+ ++F L + L L+ N + +
Sbjct: 140 ALQ-ALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVA-HVHPHAF 197
Query: 202 SKLSTLIHLLVDNNNLSGNLPPE-LSELPQLCILQLDNNNF 241
L L+ L + NNLS LP E L+ L L L+L++N +
Sbjct: 198 RDLGRLMTLYLFANNLS-ALPTEALAPLRALQYLRLNDNPW 237
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 7e-24
Identities = 63/209 (30%), Positives = 93/209 (44%), Gaps = 29/209 (13%)
Query: 634 GQGGYGKVYKGI-LSDNTTVAIK-----RAEEGSLQGQNEFLTEIKLLSRLHHRNLVSLL 687
G+G +GKV VA+K ++ + + E EI L L H +++ L
Sbjct: 18 GEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVE--REISYLKLLRHPHIIKLY 75
Query: 688 GYCDEEGEQMLVYEFVPNGTLRDWLS--GRTKENLNFAMRLRVALDSAKGILYLHTEAHP 745
+ ++V E+ G L D++ R E+ R + A I Y H
Sbjct: 76 DVITTPTDIVMVIEYA-GGELFDYIVEKKRMTEDE--GRRFFQQIICA--IEYCHRHK-- 128
Query: 746 PVFHRDIKASNILLDSNLNAKVADFGLSRLAPVLDDEGTMPTHVSTIVKGTPGYLDPEYF 805
+ HRD+K N+LLD NLN K+ADFGLS + D + T G+P Y PE
Sbjct: 129 -IVHRDLKPENLLLDDNLNVKIADFGLSNIMT---DGNFLKTSC-----GSPNYAAPE-V 178
Query: 806 LTHKLTD--KSDVYSLGVVLLELLTGMQP 832
+ KL + DV+S G+VL +L G P
Sbjct: 179 INGKLYAGPEVDVWSCGIVLYVMLVGRLP 207
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 9e-24
Identities = 54/309 (17%), Positives = 103/309 (33%), Gaps = 41/309 (13%)
Query: 92 QLLSMNLSGN---LAPELGQLSRLQY-YFMWNDLTGTIPKEIGNISSLIFLLLNGNKLSG 147
QL ++ N ++ ++L +N +T + + L L + N ++
Sbjct: 149 QLTELDCHLNKKITKLDVTPQTQLTTLDCSFNKIT-ELD--VSQNKLLNRLNCDTNNIT- 204
Query: 148 SLPDELGYLSNLNRLQVDENNITGTIPKSFANLSRVRHLHLNNNSIGGQIPSELSKLSTL 207
L L L L N +T I L+++ + + N + S LSKL+TL
Sbjct: 205 KLD--LNQNIQLTFLDCSSNKLT-EID--VTPLTQLTYFDCSVNPLTELDVSTLSKLTTL 259
Query: 208 IHLLVDNNNLSGNLPPELSELPQLCILQLDNNNFSASEIPATYGNFSKLVKLSLRNCNLQ 267
+L + L+ QL Q + + ++L L + +
Sbjct: 260 H---CIQTDLL-EID--LTHNTQLIYFQAEGCRKIKEL---DVTHNTQLYLLDCQAAGIT 310
Query: 268 GAVPDLSRIPNLYYLDLSWNHLTGSIPSKKLSENVTTIDLSDNYLNGSILESISNLPFLQ 327
DLS+ P L YL L+ LT + + + ++ + ++ S+ +P L
Sbjct: 311 EL--DLSQNPKLVYLYLNNTELT-ELDVSHNT-KLKSLSCVNAHIQD--FSSVGKIPALN 364
Query: 328 TLSLENNFLTGSIPATIWQNKSFSTKARLKIDLRNNSFSNIVGDLTLPNNVTLRLGGNPI 387
++P N S L I + + N + + G +
Sbjct: 365 NNFEAEGQTI-TMPKETLTNNS------LTIAVSPDLLDQ------FGNPMNIEPGDGGV 411
Query: 388 CTSANIPNT 396
A T
Sbjct: 412 YDQATNTIT 420
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 2e-22
Identities = 52/309 (16%), Positives = 100/309 (32%), Gaps = 40/309 (12%)
Query: 92 QLLSMNLSGNLAPEL--GQLSRLQY-YFMWNDLTGTIPKEIGNISSLIFLLLNGNKLSGS 148
L + N L L++L Y N LT + + L +L N L+
Sbjct: 86 NLTYLACDSNKLTNLDVTPLTKLTYLNCDTNKLT-KLD--VSQNPLLTYLNCARNTLT-E 141
Query: 149 LPDELGYLSNLNRLQVDENNITGTIPKSFANLSRVRHLHLNNNSIGGQIPSELSKLSTLI 208
+ + + + L L N + +++ L + N I ++S+ L
Sbjct: 142 ID--VSHNTQLTELDCHLNKKITKLD--VTPQTQLTTLDCSFNKI---TELDVSQNKLLN 194
Query: 209 HLLVDNNNLSGNLPPELSELPQLCILQLDNNNFSASEIPATYGNFSKLVKLSLRNCNLQG 268
L D NN++ L L++ QL L +N + ++ ++L L
Sbjct: 195 RLNCDTNNIT-KLD--LNQNIQLTFLDCSSNKLTEIDV----TPLTQLTYFDCSVNPLT- 246
Query: 269 AVPDLSRIPNLYYLDLSWNHLTGSIPSKKLSENVTTIDLSDNYLNGSILESISNLPFLQT 328
D+S + L L L I L+ N I +++ L
Sbjct: 247 -ELDVSTLSKLTTLHCIQTDLL-EID---LTHNTQLIYFQAEGCRKIKELDVTHNTQLYL 301
Query: 329 LSLENNFLTGSIPATIWQNKSFSTKARLK-IDLRNNSFSNIVGDLTLPNNVT-LRLGGNP 386
L + +T + S +L + L N + + D++ + L
Sbjct: 302 LDCQAAGIT-ELD--------LSQNPKLVYLYLNNTELTEL--DVSHNTKLKSLSCVNAH 350
Query: 387 ICTSANIPN 395
I +++
Sbjct: 351 IQDFSSVGK 359
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 2e-22
Identities = 60/300 (20%), Positives = 104/300 (34%), Gaps = 37/300 (12%)
Query: 92 QLLSMNLSGNL---APELGQLSRLQY-YFMWNDLTGTIPKEIGNISSLIFLLLNGNKLSG 147
L S++ + + +L+ L N++T T+ + ++L +L + NKL+
Sbjct: 43 TLTSLDCHNSSITDMTGIEKLTGLTKLICTSNNIT-TLD--LSQNTNLTYLACDSNKLT- 98
Query: 148 SLPDELGYLSNLNRLQVDENNITGTIPKSFANLSRVRHLHLNNNSIGGQIPSELSKLSTL 207
+L + L+ L L D N +T L +L+ N++ +I +S + L
Sbjct: 99 NLD--VTPLTKLTYLNCDTNKLTKLDVSQNPLL---TYLNCARNTL-TEID--VSHNTQL 150
Query: 208 IHLLVDNNNLSGNLPPELSELPQLCILQLDNNNFSASEIPATYGNFSKLVKLSLRNCNLQ 267
L N +++ QL L N + ++ L +L+ N+
Sbjct: 151 TELDCHLNKKIT--KLDVTPQTQLTTLDCSFNKITELDV----SQNKLLNRLNCDTNNIT 204
Query: 268 GAVPDLSRIPNLYYLDLSWNHLTGSIPSKKLSENVTTIDLSDNYLNGSILESISNLPFLQ 327
DL++ L +LD S N LT I L+ +T D S N L + +S L L
Sbjct: 205 K--LDLNQNIQLTFLDCSSNKLT-EIDVTPLT-QLTYFDCSVNPLT-EL--DVSTLSKLT 257
Query: 328 TLSLENNFLTGSIPATIWQNKSFSTKARLKIDLRNNSFSNIVGDLTLPNNVTLRLGGNPI 387
TL L I T + + L I
Sbjct: 258 TLHCIQTDLL-EIDLTHNTQL-------IYFQAEGCRKIKELDVTHNTQLYLLDCQAAGI 309
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 90.1 bits (224), Expect = 5e-19
Identities = 52/251 (20%), Positives = 95/251 (37%), Gaps = 29/251 (11%)
Query: 138 LLLNGNKLSGSLPDELGYLSNLNRLQVDENNITGTIPKSFANLSRVRHLHLNNNSIGGQI 197
+ ++ + L+ L L ++IT + L+ + L +N+I
Sbjct: 23 EVAAAFEMQATDTISEEQLATLTSLDCHNSSIT-DMT-GIEKLTGLTKLICTSNNITTL- 79
Query: 198 PSELSKLSTLIHLLVDNNNLSGNLPPELSELPQLCILQLDNNNFSASEIPATYGNFSKLV 257
+LS+ + L +L D+N L+ NL ++ L +L L D N + ++ L
Sbjct: 80 --DLSQNTNLTYLACDSNKLT-NLD--VTPLTKLTYLNCDTNKLTKLDV----SQNPLLT 130
Query: 258 KLSLRNCNLQGAVPDLSRIPNLYYLDLSWNHLTGSIPSKKLSENVTTIDLSDNYLNGSIL 317
L+ L D+S L LD N + + +TT+D S N +
Sbjct: 131 YLNCARNTLT--EIDVSHNTQLTELDCHLNKKITKLDVTPQT-QLTTLDCSFNKITEL-- 185
Query: 318 ESISNLPFLQTLSLENNFLTGSIPATIWQNKSFSTKARLKIDLRNNSFSNIVGDLT-LPN 376
+S L L+ + N +T + + QN + +D +N + I D+T L
Sbjct: 186 -DVSQNKLLNRLNCDTNNIT-KLD--LNQNIQLTF-----LDCSSNKLTEI--DVTPLTQ 234
Query: 377 NVTLRLGGNPI 387
NP+
Sbjct: 235 LTYFDCSVNPL 245
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 85.1 bits (211), Expect = 2e-17
Identities = 50/233 (21%), Positives = 86/233 (36%), Gaps = 28/233 (12%)
Query: 157 SNLNRLQVDENNITGTIPKSFANLSRVRHLHLNNNSIGGQIPSELSKLSTLIHLLVDNNN 216
N + T S L+ + L +N+SI + + KL+ L L+ +NN
Sbjct: 18 DNFASEVAAAFEMQATDTISEEQLATLTSLDCHNSSI--TDMTGIEKLTGLTKLICTSNN 75
Query: 217 LSGNLPPELSELPQLCILQLDNNNFSASEIPATYGNFSKLVKLSLRNCNLQGAVPDLSRI 276
++ L LS+ L L D+N + ++ +KL L+ L D+S+
Sbjct: 76 IT-TLD--LSQNTNLTYLACDSNKLTNLDV----TPLTKLTYLNCDTNKLTKL--DVSQN 126
Query: 277 PNLYYLDLSWNHLTGSIPSKKLSENVTTIDLSDNYLNGSILESISNLPFLQTLSLENNFL 336
P L YL+ + N LT I + +T +D N ++ L TL N +
Sbjct: 127 PLLTYLNCARNTLT-EIDVSHNT-QLTELDCHLN--KKITKLDVTPQTQLTTLDCSFNKI 182
Query: 337 TGSIPATIWQNKSFSTKARLK-IDLRNNSFSNIVGDLT-LPNNVTLRLGGNPI 387
T + S L ++ N+ + + DL L N +
Sbjct: 183 T-ELD--------VSQNKLLNRLNCDTNNITKL--DLNQNIQLTFLDCSSNKL 224
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 85.1 bits (211), Expect = 2e-17
Identities = 52/291 (17%), Positives = 96/291 (32%), Gaps = 24/291 (8%)
Query: 92 QLLSMNLSGNL--APELGQLSRLQY-YFMWNDLTGTIPKEIGNISSLIFLLLNGNKLSGS 148
QL +++ S N ++ Q L N++T + + L FL + NKL+
Sbjct: 171 QLTTLDCSFNKITELDVSQNKLLNRLNCDTNNIT-KLD--LNQNIQLTFLDCSSNKLT-E 226
Query: 149 LPDELGYLSNLNRLQVDENNITGTIPKSFANLSRVRHLHLNNNSIGGQIPSELSKLSTLI 208
+ + L+ L N +T + + L LH + +I L+ + LI
Sbjct: 227 ID--VTPLTQLTYFDCSVNPLTELDVSTLSKL---TTLHCIQTDLL-EID--LTHNTQLI 278
Query: 209 HLLVDNNNLSGNLPPELSELPQLCILQLDNNNFSASEIPATYGNFSKLVKLSLRNCNLQG 268
+ + L +++ QL +L + ++ KLV L L N L
Sbjct: 279 YFQAEGCRKIKEL--DVTHNTQLYLLDCQAAGITELDL----SQNPKLVYLYLNNTELT- 331
Query: 269 AVPDLSRIPNLYYLDLSWNHLTGSIPSKKLSENVTTIDLSDNYLNGSILESISNLPFLQT 328
D+S L L H+ S + ++ E+++N
Sbjct: 332 -ELDVSHNTKLKSLSCVNAHIQ-DFSSVGKIPALNNNFEAEGQTITMPKETLTNNSLTIA 389
Query: 329 LSLENNFLTGSIPATIWQNKSFSTKARLKIDLRNNSFSNIVGDLTLPNNVT 379
+S + G+ + +A I N S N T +
Sbjct: 390 VSPDLLDQFGNPMNIEPGDGGVYDQATNTITWENLSTDNPAVTYTFTSENG 440
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 55.5 bits (134), Expect = 5e-08
Identities = 26/170 (15%), Positives = 57/170 (33%), Gaps = 25/170 (14%)
Query: 91 LQLLSMNLSGNL---APELGQLSRLQY-YFMWNDLTGTIPKEIGNISSLIFLLLNGNKLS 146
QL+ G ++ ++L +T + + L++L LN +L+
Sbjct: 275 TQLIYFQAEGCRKIKELDVTHNTQLYLLDCQAAGIT-ELD--LSQNPKLVYLYLNNTELT 331
Query: 147 GSLPDELGYLSNLNRLQVDENNITGTIPKSFANLSRVRHLHLNNNSIGGQIPSELSKLST 206
L + + + L L +I S + + + + T
Sbjct: 332 -ELD--VSHNTKLKSLSCVNAHIQ-DFS-SVGKIPALNNNFEAEG-----------QTIT 375
Query: 207 LIHLLVDNNNLSGNLPPELSELP--QLCILQLDNNNFSASEIPATYGNFS 254
+ + NN+L+ + P+L + + I D + + T+ N S
Sbjct: 376 MPKETLTNNSLTIAVSPDLLDQFGNPMNIEPGDGGVYDQATNTITWENLS 425
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 1e-23
Identities = 54/210 (25%), Positives = 89/210 (42%), Gaps = 24/210 (11%)
Query: 634 GQGGYGKVYKGI-LSDNTTVAIK------RAEEGSLQGQNEFLTEIKLLSRLHHRNLVSL 686
G G + V K S A K + E E+ +L ++ H N+++L
Sbjct: 21 GSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITL 80
Query: 687 LGYCDEEGEQMLVYEFVPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPP 746
+ + +L+ E V G L D+L KE+L+ G+ YLHT+
Sbjct: 81 HDVYENRTDVVLILELVSGGELFDFL--AQKESLSEEEATSFIKQILDGVNYLHTKK--- 135
Query: 747 VFHRDIKASNILLDS----NLNAKVADFGLSRLAPVLDDEGTMPTHVSTIVKGTPGYLDP 802
+ H D+K NI+L + K+ DFGL+ ++D GTP ++ P
Sbjct: 136 IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAH---EIEDGVEFKNIF-----GTPEFVAP 187
Query: 803 EYFLTHKLTDKSDVYSLGVVLLELLTGMQP 832
E L ++D++S+GV+ LL+G P
Sbjct: 188 EIVNYEPLGLEADMWSIGVITYILLSGASP 217
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 1e-23
Identities = 55/213 (25%), Positives = 85/213 (39%), Gaps = 30/213 (14%)
Query: 632 QVGQGGYGKVYKGI-LSDNTTVAIKRAEEGSLQGQNE--FLTEIKLLSRLHHRNLVSLLG 688
++G+G + V + + + A L ++ E ++ L H N+V L
Sbjct: 18 ELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHD 77
Query: 689 YCDEEGEQMLVYEFVPNGTLRDWLSGRTK--ENLNFAMRLRVALDSAKGIL----YLHTE 742
EEG L+++ V G L + + R E A + IL + H
Sbjct: 78 SISEEGHHYLIFDLVTGGELFEDIVAREYYSE--------ADASHCIQQILEAVLHCHQM 129
Query: 743 AHPPVFHRDIKASNILLDS---NLNAKVADFGLSRLAPVLDDEGTMPTHVSTIVKGTPGY 799
V HR++K N+LL S K+ADFGL+ ++ E GTPGY
Sbjct: 130 G---VVHRNLKPENLLLASKLKGAAVKLADFGLAI---EVEGEQQA---WFGFA-GTPGY 179
Query: 800 LDPEYFLTHKLTDKSDVYSLGVVLLELLTGMQP 832
L PE D+++ GV+L LL G P
Sbjct: 180 LSPEVLRKDPYGKPVDLWACGVILYILLVGYPP 212
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 1e-23
Identities = 48/208 (23%), Positives = 89/208 (42%), Gaps = 25/208 (12%)
Query: 633 VGQGGYGKVYKGI-LSDNTTVAIKRAEEGSLQGQNEFLTEIKLLSRLHHRNLVSLLGYCD 691
+G G +G V++ + A K + EI+ +S L H LV+L +
Sbjct: 165 LGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFE 224
Query: 692 EEGEQMLVYEFVPNGTLRDWLSGRTKENLNF-----AMRLRVALDSAKGILYLHTEAHPP 746
++ E +++YEF+ G L + + E+ +R G+ ++H
Sbjct: 225 DDNEMVMIYEFMSGGELFEKV---ADEHNKMSEDEAVEYMRQVCK---GLCHMHENN--- 275
Query: 747 VFHRDIKASNILLDSNLNA--KVADFGLSRLAPVLDDEGTMPTHVSTIVKGTPGYLDPEY 804
H D+K NI+ + + K+ DFGL+ LD + ++ GT + PE
Sbjct: 276 YVHLDLKPENIMFTTKRSNELKLIDFGLTAH---LDPKQSVKVTT-----GTAEFAAPEV 327
Query: 805 FLTHKLTDKSDVYSLGVVLLELLTGMQP 832
+ +D++S+GV+ LL+G+ P
Sbjct: 328 AEGKPVGYYTDMWSVGVLSYILLSGLSP 355
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 2e-23
Identities = 52/211 (24%), Positives = 92/211 (43%), Gaps = 26/211 (12%)
Query: 634 GQGGYGKVYKGI-LSDNTTVAIK------RAEEGSLQGQNEFLTEIKLLSRLHHRNLVSL 686
G G + V K A K + + E E+ +L + H N+++L
Sbjct: 14 GSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITL 73
Query: 687 LGYCDEEGEQMLVYEFVPNGTLRDWLSGRTKENLNFAMRL-RVALDSAKGILYLHTEAHP 745
+ + + +L+ E V G L D+L+ + + A + + LD G+ YLH++
Sbjct: 74 HDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQILD---GVHYLHSKR-- 128
Query: 746 PVFHRDIKASNILLDS----NLNAKVADFGLSRLAPVLDDEGTMPTHVSTIVKGTPGYLD 801
+ H D+K NI+L N K+ DFG++ ++ I GTP ++
Sbjct: 129 -IAHFDLKPENIMLLDKNVPNPRIKLIDFGIAH---KIEAGNEF----KNIF-GTPEFVA 179
Query: 802 PEYFLTHKLTDKSDVYSLGVVLLELLTGMQP 832
PE L ++D++S+GV+ LL+G P
Sbjct: 180 PEIVNYEPLGLEADMWSIGVITYILLSGASP 210
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 102 bits (255), Expect = 2e-23
Identities = 58/206 (28%), Positives = 84/206 (40%), Gaps = 24/206 (11%)
Query: 634 GQGGYGKVYKGI-LSDNTTVAIKRAEEGSLQGQNEFLTEIKLLSRLHHRNLVSLLGYCDE 692
G G +G VA+K E G+ +N EI L H N+V
Sbjct: 29 GSGNFGVARLMRDKLTKELVAVKYIERGAAIDENVQ-REIINHRSLRHPNIVRFKEVILT 87
Query: 693 EGEQMLVYEFVPNGTLRDWLS--GRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHR 750
++ E+ G L + + GR E+ A L S + Y H+ + HR
Sbjct: 88 PTHLAIIMEYASGGELYERICNAGRFSEDE--ARFFFQQLLSG--VSYCHSMQ---ICHR 140
Query: 751 DIKASNILLDSN--LNAKVADFGLSRLAPVLDDEGTMPTHVSTIVKGTPGYLDPEYFLTH 808
D+K N LLD + K+ DFG S+ + + P + V GTP Y+ PE L
Sbjct: 141 DLKLENTLLDGSPAPRLKICDFGYSKSS----VLHSQP---KSTV-GTPAYIAPE-VLLR 191
Query: 809 KLTD--KSDVYSLGVVLLELLTGMQP 832
+ D +DV+S GV L +L G P
Sbjct: 192 QEYDGKIADVWSCGVTLYVMLVGAYP 217
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 3e-23
Identities = 68/254 (26%), Positives = 105/254 (41%), Gaps = 45/254 (17%)
Query: 593 QHSLSRKRLSTKISMKIDGVKGFKFKELAMATAYFSSSTQVGQGGYGKVYKGI-LSDNTT 651
S + S IDG + +F +++G+G VY+
Sbjct: 27 TASAAPGTASLVPDYWIDGSNRDALSD------FFEVESELGRGATSIVYRCKQKGTQKP 80
Query: 652 VAI----KRAEEGSLQGQNEFLTEIKLLSRLHHRNLVSLLGYCDEEGEQMLVYEFVPNGT 707
A+ K ++ ++ TEI +L RL H N++ L + E LV E V G
Sbjct: 81 YALKVLKKTVDKKIVR------TEIGVLLRLSHPNIIKLKEIFETPTEISLVLELVTGGE 134
Query: 708 LRDWLSGRTK--ENLNFAMRLRVALDSAKGIL----YLHTEAHPPVFHRDIKASNILL-- 759
L D + + E R A D+ K IL YLH + HRD+K N+L
Sbjct: 135 LFDRIVEKGYYSE--------RDAADAVKQILEAVAYLHENG---IVHRDLKPENLLYAT 183
Query: 760 -DSNLNAKVADFGLSRLAPVLDDEGTMPTHVSTIVKGTPGYLDPEYFLTHKLTDKSDVYS 818
+ K+ADFGLS+ +++ + M T GTPGY PE + D++S
Sbjct: 184 PAPDAPLKIADFGLSK---IVEHQVLMKTVC-----GTPGYCAPEILRGCAYGPEVDMWS 235
Query: 819 LGVVLLELLTGMQP 832
+G++ LL G +P
Sbjct: 236 VGIITYILLCGFEP 249
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 99 bits (250), Expect = 5e-23
Identities = 60/222 (27%), Positives = 100/222 (45%), Gaps = 35/222 (15%)
Query: 632 QVGQGGYGKVYKGI-LSDNTTVAIKR----AEEG----SLQGQNEFLTEIKLLSRLHHRN 682
++G G Y VYKG+ + VA+K +EEG +++ EI L+ L H N
Sbjct: 12 KLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIR-------EISLMKELKHEN 64
Query: 683 LVSLLGYCDEEGEQMLVYEFVPN---GTLRDWLSGRTKENLNFAMRLRVALDSAKGILYL 739
+V L E + LV+EF+ N + G T L + +G+ +
Sbjct: 65 IVRLYDVIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFC 124
Query: 740 HTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSRLAPVLDDEGTMPTHVST--IVKGTP 797
H + HRD+K N+L++ K+ DFGL+R + P + + +V T
Sbjct: 125 HENK---ILHRDLKPQNLLINKRGQLKLGDFGLARAFGI-------PVNTFSSEVV--TL 172
Query: 798 GYLDPEYFLTHKLTDKS-DVYSLGVVLLELLTGMQPISHGKN 838
Y P+ + + S D++S G +L E++TG +P+ G N
Sbjct: 173 WYRAPDVLMGSRTYSTSIDIWSCGCILAEMITG-KPLFPGTN 213
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 5e-23
Identities = 48/214 (22%), Positives = 95/214 (44%), Gaps = 29/214 (13%)
Query: 633 VGQGGYGKVYKGI-LSDNTTVAIKRAEEGSLQGQNEFLTEIKLLSRL-HHRNLVSLLG-- 688
+G+G Y +V++ I +++N V +K + + + EIK+L L N+++L
Sbjct: 44 LGRGKYSEVFEAINITNNEKVVVKILK---PVKKKKIKREIKILENLRGGPNIITLADIV 100
Query: 689 YCDEEGEQMLVYEFVPNGTLRDWLSGRTKENLNFAMR--LRVALDSAKGILYLHTEAHPP 746
LV+E V N + T ++ F M L+ + Y H+
Sbjct: 101 KDPVSRTPALVFEHVNNTDFKQLYQTLTDYDIRFYMYEILK-------ALDYCHSMG--- 150
Query: 747 VFHRDIKASNILLDS-NLNAKVADFGLSRLAPVLDDEGTMPTHVSTIVKGTPGYLDPEYF 805
+ HRD+K N+++D + ++ D+GL+ V++ + PE
Sbjct: 151 IMHRDVKPHNVMIDHEHRKLRLIDWGLAE---FYHPGQEYNVRVASRY-----FKGPELL 202
Query: 806 LTHKLTDKS-DVYSLGVVLLELLTGMQPISHGKN 838
+ +++ D S D++SLG +L ++ +P HG +
Sbjct: 203 VDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHD 236
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 6e-23
Identities = 60/227 (26%), Positives = 95/227 (41%), Gaps = 38/227 (16%)
Query: 633 VGQGGYGKVYKGILSD-NTTVAIKRAEEGSLQGQNEFLTEIKLLSRLHHRNLVSLLGYCD 691
GQG +G V G +VAIK+ + E L ++ L+ LHH N+V L Y
Sbjct: 31 AGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRE-LQIMQDLAVLHHPNIVQLQSYFY 89
Query: 692 EEGEQ-------MLVYEFVPNGTLRDWLSGRTKENLNFAMR---------LRVALDSAKG 735
GE+ +V E+VP+ TL + + +R
Sbjct: 90 TLGERDRRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIR-------S 141
Query: 736 ILYLHTEAHPPVFHRDIKASNILLD-SNLNAKVADFGLSRLAPVLDDEGTMPTHVSTIVK 794
I LH + V HRDIK N+L++ ++ K+ DFG ++ L V+ I
Sbjct: 142 IGCLHLPSV-NVCHRDIKPHNVLVNEADGTLKLCDFGSAK---KLSPSEPN---VAYIC- 193
Query: 795 GTPGYLDPEYFLTHKL-TDKSDVYSLGVVLLELLTGMQPISHGKNIV 840
+ Y PE ++ T D++S+G + E++ G +PI G N
Sbjct: 194 -SRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLG-EPIFRGDNSA 238
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 99.6 bits (249), Expect = 9e-23
Identities = 66/231 (28%), Positives = 99/231 (42%), Gaps = 57/231 (24%)
Query: 632 QVGQGGYGKVYKGILSDNTT---VAIKR-----AEEGSLQGQNEF----LTEIKLLSRLH 679
VG+G YG V K + T VAIK+ ++ + EIKLL +L
Sbjct: 32 LVGEGSYGMVMKCR--NKDTGRIVAIKKFLESDDDKM-------VKKIAMREIKLLKQLR 82
Query: 680 HRNLVSLLGYCDEEGEQMLVYEFVPNGTLRDWLSGRTKENLNFAMRLRVALDSA------ 733
H NLV+LL C ++ LV+EFV + T+ D L LD
Sbjct: 83 HENLVNLLEVCKKKKRWYLVFEFVDH-TILDDLE-----------LFPNGLDYQVVQKYL 130
Query: 734 ----KGILYLHTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSRLAPVLDDEGTMPTH- 788
GI + H+ + HRDIK NIL+ + K+ DFG +R L G +
Sbjct: 131 FQIINGIGFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFAR---TLAAPGEVYDDE 184
Query: 789 VSTIVKGTPGYLDPEYFLTHKLTDKS-DVYSLGVVLLELLTGMQPISHGKN 838
V+T Y PE + K+ DV+++G ++ E+ G +P+ G +
Sbjct: 185 VATR-----WYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMG-EPLFPGDS 229
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 99.7 bits (249), Expect = 1e-22
Identities = 56/230 (24%), Positives = 87/230 (37%), Gaps = 41/230 (17%)
Query: 633 VGQGGYGKVYKGILSDNTTVAIKR--AEEGSLQGQNEF---------LTEIKLLSRLHHR 681
+ G YG V G+ S+ VAIKR + N L EI+LL+ HH
Sbjct: 30 ISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHP 89
Query: 682 NLVSLL-----GYCDEEGEQMLVYEFVP---NGTLRDWLSGRTKENLNFAMR--LRVALD 731
N++ L + LV E + + D + +++ + M L
Sbjct: 90 NILGLRDIFVHFEEPAMHKLYLVTELMRTDLAQVIHDQRIVISPQHIQYFMYHILL---- 145
Query: 732 SAKGILYLHTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSRLAPVLDDEGTMPTHVST 791
G+ LH A V HRD+ NILL N + + DF L+R + +V+
Sbjct: 146 ---GLHVLHE-AG--VVHRDLHPGNILLADNNDITICDFNLAR---EDTADANKTHYVTH 196
Query: 792 IVKGTPGYLDPEYFLTHKLTDKS-DVYSLGVVLLELLTGMQPISHGKNIV 840
Y PE + K K D++S G V+ E+ + + G
Sbjct: 197 RW-----YRAPELVMQFKGFTKLVDMWSAGCVMAEMFNR-KALFRGSTFY 240
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 2e-22
Identities = 66/253 (26%), Positives = 106/253 (41%), Gaps = 32/253 (12%)
Query: 632 QVGQGGYGKVYKGILSDNTT---VAIKRAEEGSLQGQNEFLTEIKLLSRLHHRNLVSLLG 688
+VG+G YG VYK D A+K+ E + EI LL L H N++SL
Sbjct: 28 KVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISMSA--CREIALLRELKHPNVISLQK 85
Query: 689 YCDEEGEQ--MLVYEFVPN------GTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLH 740
++ L++++ + R + + L M + GI YLH
Sbjct: 86 VFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLH 145
Query: 741 TEAHPPVFHRDIKASNILLDSNLNA----KVADFGLSRL--APVLDDEGTMPTHVSTIVK 794
V HRD+K +NIL+ K+AD G +RL +P+ + +V
Sbjct: 146 ANW---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPL----KPLADLDPVVV- 197
Query: 795 GTPGYLDPEYFLTHKLTDKS-DVYSLGVVLLELLTGMQPISHGKNIVREVNVARDSGMVF 853
T Y PE L + K+ D++++G + ELLT +PI H + + + +
Sbjct: 198 -TFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTS-EPIFHCRQEDIKTSNPYHHDQLD 255
Query: 854 SIIDNRMGSYPSE 866
I N MG P++
Sbjct: 256 RIF-NVMGF-PAD 266
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 98.0 bits (245), Expect = 2e-22
Identities = 58/221 (26%), Positives = 98/221 (44%), Gaps = 37/221 (16%)
Query: 632 QVGQGGYGKVYKGILSDNTT---VAIKR-----AEEG----SLQGQNEFLTEIKLLSRLH 679
++G+G YG V+K + T VAIK+ + +L+ EI++L +L
Sbjct: 10 KIGEGSYGVVFKCR--NRDTGQIVAIKKFLESEDDPVIKKIALR-------EIRMLKQLK 60
Query: 680 HRNLVSLLGYCDEEGEQMLVYEFVPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYL 739
H NLV+LL + LV+E+ + T+ L R + + + + + + + +
Sbjct: 61 HPNLVNLLEVFRRKRRLHLVFEYCDH-TVLHELD-RYQRGVPEHLVKSITWQTLQAVNFC 118
Query: 740 HTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSRLAPVLDDEGTMPTH-VSTIVKGTPG 798
H HRD+K NIL+ + K+ DFG +R +L V+T
Sbjct: 119 HKHN---CIHRDVKPENILITKHSVIKLCDFGFAR---LLTGPSDYYDDEVATR-----W 167
Query: 799 YLDPEYFLTHKLTDKS-DVYSLGVVLLELLTGMQPISHGKN 838
Y PE + DV+++G V ELL+G P+ GK+
Sbjct: 168 YRSPELLVGDTQYGPPVDVWAIGCVFAELLSG-VPLWPGKS 207
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 98.5 bits (246), Expect = 3e-22
Identities = 60/238 (25%), Positives = 95/238 (39%), Gaps = 59/238 (24%)
Query: 632 QVGQGGYGKVYKGI-LSDNTTVAIKR-----AEEGSLQGQNEF----LTEIKLLSRLHHR 681
++GQG +G+V+K VA+K+ +EG F L EIK+L L H
Sbjct: 24 KIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEG-------FPITALREIKILQLLKHE 76
Query: 682 NLVSLLGYCDEEGEQM--------LVYEFVPNGTLRDWLSGRTKENLNFAMRLRVALDSA 733
N+V+L+ C + LV++F + D L+G + V +
Sbjct: 77 NVVNLIEICRTKASPYNRCKGSIYLVFDFCEH----D-LAG-------LLSNVLVKFTLS 124
Query: 734 ----------KGILYLHTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSRL--APVLDD 781
G+ Y+H + HRD+KA+N+L+ + K+ADFGL+R
Sbjct: 125 EIKRVMQMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQ 181
Query: 782 EGTMPTHVSTIVKGTPGYLDPEYFL-THKLTDKSDVYSLGVVLLELLTGMQPISHGKN 838
V T+ Y PE L D++ G ++ E+ T PI G
Sbjct: 182 PNRYTNRVVTL-----WYRPPELLLGERDYGPPIDLWGAGCIMAEMWTR-SPIMQGNT 233
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 97.2 bits (243), Expect = 3e-22
Identities = 59/225 (26%), Positives = 96/225 (42%), Gaps = 44/225 (19%)
Query: 632 QVGQGGYGKVYKGI-LSDNTTVAIKR-----AEEG----SLQGQNEFLTEIKLLSRLHHR 681
++G+G YG V+K + VA+KR +EG +L+ EI LL L H+
Sbjct: 9 KIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALR-------EICLLKELKHK 61
Query: 682 NLVSLLGYCDEEGEQMLVYEFVPN---GTLRDWLSGRTKENLNFAMR--LRVALDSAKGI 736
N+V L + + LV+EF E + + L+ G+
Sbjct: 62 NIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLK-------GL 114
Query: 737 LYLHTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSRLAPVLDDEGTMPTHVST--IVK 794
+ H+ V HRD+K N+L++ N K+A+FGL+R + P + +V
Sbjct: 115 GFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLARAFGI-------PVRCYSAEVV- 163
Query: 795 GTPGYLDPEYFLTHKLTDKS-DVYSLGVVLLELLTGMQPISHGKN 838
T Y P+ KL S D++S G + EL +P+ G +
Sbjct: 164 -TLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGND 207
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 97.7 bits (244), Expect = 3e-22
Identities = 53/211 (25%), Positives = 91/211 (43%), Gaps = 19/211 (9%)
Query: 634 GQGGYGKVYKGI-LSDNTTVAIKRAEEGSLQGQNEFLTEIKLLSRL-HHRNLVSLLGYCD 691
G+G + +V I L + A+K E+ ++ E+++L + HRN++ L+ + +
Sbjct: 22 GEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFE 81
Query: 692 EEGEQMLVYEFVPNGTLRDWLSGRTKENLNFAMR--LRVALDSAKGILYLHTEAHPPVFH 749
EE LV+E + G++ + +F V D A + +LH + + H
Sbjct: 82 EEDRFYLVFEKMRGGSILS----HIHKRRHFNELEASVVVQDVASALDFLHNKG---IAH 134
Query: 750 RDIKASNILL---DSNLNAKVADFGLSRLAPVLDDEGTMPTHVSTIVKGTPGYLDPEYFL 806
RD+K NIL + K+ DF L + D + T G+ Y+ PE
Sbjct: 135 RDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVE 194
Query: 807 THKLTDKS-----DVYSLGVVLLELLTGMQP 832
D++SLGV+L LL+G P
Sbjct: 195 AFSEEASIYDKRCDLWSLGVILYILLSGYPP 225
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 97.7 bits (244), Expect = 4e-22
Identities = 51/215 (23%), Positives = 85/215 (39%), Gaps = 34/215 (15%)
Query: 634 GQGGYGKVYKGI-LSDNTTVAIK------RAEEGSLQGQNEFLTEIKLLSRLHHRNLVSL 686
G G + V K S A K + + E+ +L + H N+++L
Sbjct: 20 GSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITL 79
Query: 687 LGYCDEEGEQMLVYEFVPNGTLRDWLSGRTKENLNF-----AMRLRVALDSAKGILYLHT 741
+ + + +L+ E V G L D E + L+ L+ G+ YLH+
Sbjct: 80 HEVYENKTDVILILELVAGGELFD----FLAEKESLTEEEATEFLKQILN---GVYYLHS 132
Query: 742 EAHPPVFHRDIKASNILLDS----NLNAKVADFGLSRLAPVLDDEGTMPTHVSTIVKGTP 797
+ H D+K NI+L K+ DFGL+ +D GTP
Sbjct: 133 LQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH---KIDFGNEFKNIF-----GTP 181
Query: 798 GYLDPEYFLTHKLTDKSDVYSLGVVLLELLTGMQP 832
++ PE L ++D++S+GV+ LL+G P
Sbjct: 182 EFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 216
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 97.2 bits (243), Expect = 4e-22
Identities = 67/224 (29%), Positives = 104/224 (46%), Gaps = 44/224 (19%)
Query: 632 QVGQGGYGKVYKGILSDNTTVAIKR-----AEEG----SLQGQNEFLTEIKLLSRLHHRN 682
+VG+G YG VYK S VA+KR +EG +++ EI LL LHH N
Sbjct: 28 KVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIR-------EISLLKELHHPN 80
Query: 683 LVSLLGYCDEEGEQMLVYEFVPN---GTLRDWLSGRTKENLNFAMR--LRVALDSAKGIL 737
+VSL+ E LV+EF+ L + +G + + LR G+
Sbjct: 81 IVSLIDVIHSERCLTLVFEFMEKDLKKVLDENKTGLQDSQIKIYLYQLLR-------GVA 133
Query: 738 YLHTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSRLAPVLDDEGTMPTHVST--IVKG 795
+ H + HRD+K N+L++S+ K+ADFGL+R + P T +V
Sbjct: 134 HCHQHR---ILHRDLKPQNLLINSDGALKLADFGLARAFGI-------PVRSYTHEVV-- 181
Query: 796 TPGYLDPEYFLTHKLTDKS-DVYSLGVVLLELLTGMQPISHGKN 838
T Y P+ + K S D++S+G + E++TG +P+ G
Sbjct: 182 TLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITG-KPLFPGVT 224
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 96.5 bits (241), Expect = 7e-22
Identities = 63/224 (28%), Positives = 94/224 (41%), Gaps = 33/224 (14%)
Query: 632 QVGQGGYGKVYKGI-LSDNTTVAIKR----AEEGSLQGQNEF----LTEIKLLSRLH--- 679
++G G YG VYK VA+K G G + E+ LL RL
Sbjct: 16 EIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGG---GGGGLPISTVREVALLRRLEAFE 72
Query: 680 HRNLVSLL-----GYCDEEGEQMLVYEFVPNGTLRDWLSGRTKENLNFAMRLRVALDSAK 734
H N+V L+ D E + LV+E V LR +L L + +
Sbjct: 73 HPNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDKAPPPGLPAETIKDLMRQFLR 131
Query: 735 GILYLHTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSRLAPVLDDEGTMPTHVSTIVK 794
G+ +LH + HRD+K NIL+ S K+ADFGL+R + + + T V +V
Sbjct: 132 GLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLAR---IYSYQMAL-TPV--VV- 181
Query: 795 GTPGYLDPEYFLTHKLTDKSDVYSLGVVLLELLTGMQPISHGKN 838
T Y PE L D++S+G + E+ +P+ G +
Sbjct: 182 -TLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRR-KPLFCGNS 223
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 95.2 bits (237), Expect = 1e-21
Identities = 28/207 (13%), Positives = 57/207 (27%), Gaps = 49/207 (23%)
Query: 632 QVGQGGYGKVYKGILSDNT---TVAIK--RAEEGSLQG-QNEFLTEIKLLSRLHHRNLVS 685
G + ++ + D VA+ + E L+ LSR+ +
Sbjct: 38 FHGGVPPLQFWQAL--DTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVAR 95
Query: 686 LLGYCDEEGEQMLVYEFVPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHP 745
+L ++V E++ G+L++ + +R A H A
Sbjct: 96 VLDVVHTRAGGLVVAEWIRGGSLQEVADTS----PSPVGAIRAMQSLAAAADAAH-RAG- 149
Query: 746 PVFHRDIKASNILLDSNLNAKVADFGLSRLAPVLDDEGTMPTHVSTIVKGTPGYLDPEYF 805
V S + + + + +A + +P+
Sbjct: 150 -VALSIDHPSRVRVSIDGDVVLAYPAT--MPDA----------------------NPQ-- 182
Query: 806 LTHKLTDKSDVYSLGVVLLELLTGMQP 832
D+ +G L LL P
Sbjct: 183 --------DDIRGIGASLYALLVNRWP 201
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 96.3 bits (240), Expect = 1e-21
Identities = 46/208 (22%), Positives = 78/208 (37%), Gaps = 26/208 (12%)
Query: 634 GQGGYGKVYKGI-LSDNTTVAIKRAEEGSLQGQNEFLTEIKLLSRL-HHRNLVSLLG-YC 690
G G GKV + A+K L + E+ + ++V +L Y
Sbjct: 38 GLGVNGKVLECFHRRTGQKCALK-----LLYDSPKARQEVDHHWQASGGPHIVCILDVYE 92
Query: 691 DEEGEQMLVY---EFVPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPV 747
+ + + E + G L + R + + D I +LH+ +
Sbjct: 93 NMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHN---I 149
Query: 748 FHRDIKASNILL---DSNLNAKVADFGLSRLAPVLDDEGTMPTHVSTIVKGTPGYLDPEY 804
HRD+K N+L + + K+ DFG ++ + + T TP Y+ PE
Sbjct: 150 AHRDVKPENLLYTSKEKDAVLKLTDFGFAKE----TTQNALQTPC-----YTPYYVAPEV 200
Query: 805 FLTHKLTDKSDVYSLGVVLLELLTGMQP 832
K D++SLGV++ LL G P
Sbjct: 201 LGPEKYDKSCDMWSLGVIMYILLCGFPP 228
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 95.3 bits (238), Expect = 1e-21
Identities = 61/224 (27%), Positives = 95/224 (42%), Gaps = 44/224 (19%)
Query: 632 QVGQGGYGKVYKGILSDNTTVAIKR-----AEEG----SLQGQNEFLTEIKLLSRLHHRN 682
++G+G YG VYK + T A+K+ +EG +++ EI +L L H N
Sbjct: 9 KIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIR-------EISILKELKHSN 61
Query: 683 LVSLLGYCDEEGEQMLVYEFVPN---GTLRDWLSGRTKENLNFAMR--LRVALDSAKGIL 737
+V L + +LV+E + L G + L GI
Sbjct: 62 IVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLN-------GIA 114
Query: 738 YLHTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSRL--APVLDDEGTMPTHVSTIVKG 795
Y H V HRD+K N+L++ K+ADFGL+R PV TH IV
Sbjct: 115 YCHDRR---VLHRDLKPQNLLINREGELKIADFGLARAFGIPV----RKY-THE--IV-- 162
Query: 796 TPGYLDPEYFLTHKLTDKS-DVYSLGVVLLELLTGMQPISHGKN 838
T Y P+ + K + D++S+G + E++ G P+ G +
Sbjct: 163 TLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNG-TPLFPGVS 205
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 95.9 bits (239), Expect = 2e-21
Identities = 58/274 (21%), Positives = 108/274 (39%), Gaps = 56/274 (20%)
Query: 633 VGQGGYGKVYKGILSD-NTTVAIKRAEEGSLQGQNEF---------LTEIKLLSRLHHRN 682
+G G G V + VAIK+ F E+ L+ ++H+N
Sbjct: 33 IGSGAQGIVCAAYDAILERNVAIKKL-------SRPFQNQTHAKRAYRELVLMKCVNHKN 85
Query: 683 LVSLL------GYCDEEGEQMLVYEFVP---NGTLRDWLSGRTKENLNFAMRLRVALDSA 733
++ LL +E + +V E + ++ L L + M L
Sbjct: 86 IIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQM-LC------ 138
Query: 734 KGILYLHTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSRLAPVLDDEGTMPTHVSTIV 793
GI +LH+ A + HRD+K SNI++ S+ K+ DFGL+R M +V T
Sbjct: 139 -GIKHLHS-AG--IIHRDLKPSNIVVKSDCTLKILDFGLAR---TAGTSFMMTPYVVTRY 191
Query: 794 KGTPGYLDPEYFLTHKLTDKSDVYSLGVVLLELLTGMQPISHGKNIVREVNVARDSGMVF 853
Y PE L + D++S+G ++ E++ G + G + + + N
Sbjct: 192 -----YRAPEVILGMGYKENVDIWSVGCIMGEMIKG-GVLFPGTDHIDQWN--------- 236
Query: 854 SIIDNRMGSYPSECVERFVTLALRCCHDKPEHRP 887
+ ++G+ E +++ ++P++
Sbjct: 237 -KVIEQLGTPCPEFMKKLQPTVRTYVENRPKYAG 269
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 95.4 bits (238), Expect = 3e-21
Identities = 54/206 (26%), Positives = 89/206 (43%), Gaps = 24/206 (11%)
Query: 634 GQGGYGKVYKGI-LSDNTTVAIKRAEEGSLQGQNEFLTEIKLLSRL-HHRNLVSLLGYCD 691
G G Y + I + N A+K ++ EI++L R H N+++L D
Sbjct: 31 GVGSYSVCKRCIHKATNMEFAVKIIDKSKRDPT----EEIEILLRYGQHPNIITLKDVYD 86
Query: 692 EEGEQMLVYEFVPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRD 751
+ +V E + G L D + ++ + V K + YLH + V HRD
Sbjct: 87 DGKYVYVVTELMKGGELLDKI--LRQKFFSEREASAVLFTITKTVEYLHAQG---VVHRD 141
Query: 752 IKASNILLDSNLNA----KVADFGLSRLAPVLDDEGTMPTHVSTIVKGTPGYLDPEYFLT 807
+K SNIL ++ DFG ++ + + G + T T ++ PE L
Sbjct: 142 LKPSNILYVDESGNPESIRICDFGFAKQ--LRAENGLLMTPC-----YTANFVAPE-VLE 193
Query: 808 HKLTDKS-DVYSLGVVLLELLTGMQP 832
+ D + D++SLGV+L +LTG P
Sbjct: 194 RQGYDAACDIWSLGVLLYTMLTGYTP 219
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 95.0 bits (237), Expect = 3e-21
Identities = 58/218 (26%), Positives = 89/218 (40%), Gaps = 32/218 (14%)
Query: 626 YFSSSTQVGQGGYGKVYKGI-LSDNTTVAIK---RAEEGSLQGQNEFLTEIKLLSRL-HH 680
+G+G + K + N A+K + E + Q EI L H
Sbjct: 12 LDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKRMEANTQ------KEITALKLCEGH 65
Query: 681 RNLVSLLGYCDEEGEQMLVYEFVPNGTLRDWLSGRTKENLNFAMR--LRVALDSAKGILY 738
N+V L ++ LV E + G L + R K+ +F+ + + +
Sbjct: 66 PNIVKLHEVFHDQLHTFLVMELLNGGELFE----RIKKKKHFSETEASYIMRKLVSAVSH 121
Query: 739 LHTEAHPPVFHRDIKASNILL---DSNLNAKVADFGLSRLAPVLDDEGTMPTHVSTIVKG 795
+H V HRD+K N+L + NL K+ DFG +RL P D + T
Sbjct: 122 MHDVG---VVHRDLKPENLLFTDENDNLEIKIIDFGFARLKP--PDNQPLKTPC-----F 171
Query: 796 TPGYLDPEYFLTHKLTDKS-DVYSLGVVLLELLTGMQP 832
T Y PE L D+S D++SLGV+L +L+G P
Sbjct: 172 TLHYAAPE-LLNQNGYDESCDLWSLGVILYTMLSGQVP 208
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 97.2 bits (242), Expect = 3e-21
Identities = 59/280 (21%), Positives = 112/280 (40%), Gaps = 56/280 (20%)
Query: 627 FSSSTQVGQGGYGKVYKGI-LSDNTTVAIKRAEEGSLQGQNEF---------LTEIKLLS 676
+ + +G G G V + VAIK+ F E+ L+
Sbjct: 64 YQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKL-------SRPFQNQTHAKRAYRELVLMK 116
Query: 677 RLHHRNLVSLL------GYCDEEGEQMLVYEFVP---NGTLRDWLSGRTKENLNFAMRLR 727
++H+N++SLL +E + LV E + ++ L L + M L
Sbjct: 117 CVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQM-LC 175
Query: 728 VALDSAKGILYLHTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSRLAPVLDDEGTMPT 787
GI +LH+ A + HRD+K SNI++ S+ K+ DFGL+R M
Sbjct: 176 -------GIKHLHS-AG--IIHRDLKPSNIVVKSDCTLKILDFGLAR---TAGTSFMMTP 222
Query: 788 HVSTIVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVLLELLTGMQPISHGKNIVREVNVAR 847
+V T Y PE L + D++S+G ++ E++ + + G++ + + N
Sbjct: 223 YVVTRY-----YRAPEVILGMGYKENVDIWSVGCIMGEMVRH-KILFPGRDYIDQWN--- 273
Query: 848 DSGMVFSIIDNRMGSYPSECVERFVTLALRCCHDKPEHRP 887
+ ++G+ E +++ ++P++
Sbjct: 274 -------KVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAG 306
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 97.2 bits (242), Expect = 4e-21
Identities = 61/337 (18%), Positives = 111/337 (32%), Gaps = 45/337 (13%)
Query: 42 SALRAIKNSLVDSMNHLRNWNKGDPCMSNWTGVLCFDTVETDGHLHVRELQLLSMNLSGN 101
I + V ++ +L N N + + + L L ++ + N
Sbjct: 176 KEFHFILDVSVKTVANLELSNIKCVLEDNKCSYFLSILAKLQTNPKLSNLTLNNIETTWN 235
Query: 102 LAPELGQL---SRLQY-YFMWNDLTGTIPKEIGNIS-----SLIFLLLNGNKLSGSLPDE 152
+ QL + + Y L G + + S +L + +
Sbjct: 236 SFIRILQLVWHTTVWYFSISNVKLQGQLDFRDFDYSGTSLKALSIHQVVSDVFGFPQSYI 295
Query: 153 LGYLSNLNRLQVDENNITGTIPKSFANLSRVRHLHLNNNSIGGQIPSELSKLSTLIHLLV 212
SN+N + + +S HL +NN + + L+ L L++
Sbjct: 296 YEIFSNMNIKNFTVSGTRMVHMLCPSKISPFLHLDFSNNLLTDTVFENCGHLTELETLIL 355
Query: 213 DNNNLSGNLPPE---LSELPQLCILQLDNNNFSASEIPATYGNFSKLVKLSLRNCNLQGA 269
N L L +++ L L + N+ S E G+ S
Sbjct: 356 QMNQLK-ELSKIAEMTTQMKSLQQLDISQNSVSYDEKK---GDCSWT------------- 398
Query: 270 VPDLSRIPNLYYLDLSWNHLTGSIPSKKLSENVTTIDLSDNYLNGSILESISNLPFLQTL 329
+L L++S N LT + L + +DL N + SI + + L LQ L
Sbjct: 399 -------KSLLSLNMSSNILT-DTIFRCLPPRIKVLDLHSNKIK-SIPKQVVKLEALQEL 449
Query: 330 SLENNFLTGSIPATIWQNKSFSTKARLK-IDLRNNSF 365
++ +N L S+P + F L+ I L N +
Sbjct: 450 NVASNQLK-SVP-----DGIFDRLTSLQKIWLHTNPW 480
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 76.1 bits (187), Expect = 2e-14
Identities = 56/325 (17%), Positives = 106/325 (32%), Gaps = 36/325 (11%)
Query: 92 QLLSMNLSGN--LAPELGQLSRLQYYFMWNDLTGTIPKEI--GNISSLIFLLLNGNKLSG 147
QL + LS + ++ L + L T ++ + L+ +
Sbjct: 116 QLKFLGLSTTHLEKSSVLPIAHLNISKVLLVLGETYGEKEDPEGLQDFNTESLHIVFPTN 175
Query: 148 SLPDELGYLSNLNRLQVDENNITG-----------TIPKSFANLSRVRHLHLNNNSIGGQ 196
+ +S ++ +NI +I ++ +L LNN
Sbjct: 176 KEFHFILDVSVKTVANLELSNIKCVLEDNKCSYFLSILAKLQTNPKLSNLTLNNIETTWN 235
Query: 197 IPSELSKL---STLIHLLVDNNNLSGNLPPELSE-----LPQLCILQLDNNNFSASEIPA 248
+ +L +T+ + + N L G L + L L I Q+ ++ F +
Sbjct: 236 SFIRILQLVWHTTVWYFSISNVKLQGQLDFRDFDYSGTSLKALSIHQVVSDVFGFPQ-SY 294
Query: 249 TYGNFSKLVKLSLRNCNLQG-AVPDLSRIPNLYYLDLSWNHLTGSIPSKKLSE--NVTTI 305
Y FS + + + + S+I +LD S N LT + + T+
Sbjct: 295 IYEIFSNMNIKNFTVSGTRMVHMLCPSKISPFLHLDFSNNLLT-DTVFENCGHLTELETL 353
Query: 306 DLSDNYLN--GSILESISNLPFLQTLSLENNFLTGSIPATIWQNKSFSTKARLKI-DLRN 362
L N L I E + + LQ L + N ++ S L ++ +
Sbjct: 354 ILQMNQLKELSKIAEMTTQMKSLQQLDISQNSVSYDEK-----KGDCSWTKSLLSLNMSS 408
Query: 363 NSFSNIVGDLTLPNNVTLRLGGNPI 387
N ++ + P L L N I
Sbjct: 409 NILTDTIFRCLPPRIKVLDLHSNKI 433
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 69.5 bits (170), Expect = 2e-12
Identities = 48/254 (18%), Positives = 83/254 (32%), Gaps = 21/254 (8%)
Query: 119 NDLTGTIPKEIGNISSLIFLLLNGNKLSGSLPDELGYLSNLNRLQVDENNITGTIPKSFA 178
N L +PK++ L ++ N +S ++ LS L L + N I F
Sbjct: 10 NGLI-HVPKDLS--QKTTILNISQNYISELWTSDILSLSKLRILIISHNRIQYLDISVFK 66
Query: 179 NLSRVRHLHLNNNSIGGQIPSELSKLSTLIHLLVDNNNL-SGNLPPELSELPQLCILQLD 237
+ +L L++N + I L HL + N + + E + QL L L
Sbjct: 67 FNQELEYLDLSHNKLVK-ISCH--PTVNLKHLDLSFNAFDALPICKEFGNMSQLKFLGLS 123
Query: 238 NNNFSASEIPATYGNFSKLVKLSLRNCNLQGAVPDLSRIPNLYYLDLSWNHLT------- 290
+ + + K+ L G D + + L T
Sbjct: 124 TTHL--EKSSVLPIAHLNISKVLLVLGETYGEKEDPEGLQDFNTESLHIVFPTNKEFHFI 181
Query: 291 -----GSIPSKKLSENVTTIDLSDNYLNGSILESISNLPFLQTLSLENNFLTGSIPATIW 345
++ + +LS ++ + SIL + P L L+L N T + I
Sbjct: 182 LDVSVKTVANLELSNIKCVLEDNKCSYFLSILAKLQTNPKLSNLTLNNIETTWNSFIRIL 241
Query: 346 QNKSFSTKARLKID 359
Q +T I
Sbjct: 242 QLVWHTTVWYFSIS 255
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 65.3 bits (159), Expect = 4e-11
Identities = 50/320 (15%), Positives = 95/320 (29%), Gaps = 24/320 (7%)
Query: 87 HVRELQLLSMNLSGNLAPELGQLSRLQY-YFMWNDLTGTIPKEIGNISSLIFLLLNGNKL 145
L + +S ++ LS+L+ N + L +L L+ NKL
Sbjct: 22 KTTILNISQNYISELWTSDILSLSKLRILIISHNRIQYLDISVFKFNQELEYLDLSHNKL 81
Query: 146 SGSLPDELGYLSNLNRLQVDENNITGTIPKS--FANLSRVRHLHLNNNSIGGQIPSELSK 203
+ NL L + N +P F N+S+++ L L+ + ++
Sbjct: 82 V-KIS--CHPTVNLKHLDLSFNAFD-ALPICKEFGNMSQLKFLGLSTTHLEKSSVLPIAH 137
Query: 204 LSTLIHLLVDNNNLSGNLPPE-LSELPQLCILQLDNNNFSASEIPATYGNFSKLVKLSLR 262
L+ LLV PE L + + + N I ++LS
Sbjct: 138 LNISKVLLVLGETYGEKEDPEGLQDFNTESLHIVFPTNKEFHFILDVSVKTVANLELSNI 197
Query: 263 NCNLQGAVPDLS-------------RIPNLYYLDLSWNHLTGSIPSKKLSENVTTIDLSD 309
C L+ L ++ +WN I V +S+
Sbjct: 198 KCVLEDNKCSYFLSILAKLQTNPKLSNLTLNNIETTWNSFI-RILQLVWHTTVWYFSISN 256
Query: 310 NYLNGSILESISNLPF--LQTLSLENNFLTGSIPATIWQNKSFSTKARLKIDLRNNSFSN 367
L G + + L+ LS+ + + FS + +
Sbjct: 257 VKLQGQLDFRDFDYSGTSLKALSIHQVVSDVFGFPQSYIYEIFSNMNIKNFTVSGTRMVH 316
Query: 368 IVGDLTLPNNVTLRLGGNPI 387
++ + + L N +
Sbjct: 317 MLCPSKISPFLHLDFSNNLL 336
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 93.8 bits (234), Expect = 7e-21
Identities = 61/224 (27%), Positives = 98/224 (43%), Gaps = 44/224 (19%)
Query: 632 QVGQGGYGKVYKGI-LSDNTTVAIKR----AEEG----SLQGQNEFLTEIKLLSRLHHRN 682
++G+G Y VYKG + VA+K EEG +++ E+ LL L H N
Sbjct: 9 KLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIR-------EVSLLKDLKHAN 61
Query: 683 LVSLLGYCDEEGEQMLVYEFVPN---GTLRDWLSGRTKENLNFAMR--LRVALDSAKGIL 737
+V+L E LV+E++ L D + N+ + LR G+
Sbjct: 62 IVTLHDIIHTEKSLTLVFEYLDKDLKQYLDDCGNIINMHNVKLFLFQLLR-------GLA 114
Query: 738 YLHTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSRLAPVLDDEGTMPTHVST--IVKG 795
Y H V HRD+K N+L++ K+ADFGL+R + PT +V
Sbjct: 115 YCH---RQKVLHRDLKPQNLLINERGELKLADFGLARAKSI-------PTKTYDNEVV-- 162
Query: 796 TPGYLDPEYFL-THKLTDKSDVYSLGVVLLELLTGMQPISHGKN 838
T Y P+ L + + + D++ +G + E+ TG +P+ G
Sbjct: 163 TLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATG-RPLFPGST 205
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 93.8 bits (234), Expect = 1e-20
Identities = 64/228 (28%), Positives = 97/228 (42%), Gaps = 48/228 (21%)
Query: 632 QVGQGGYGKVYKGI-LSDNTTVAIKR----AEEGSLQGQNEFLT---EIKLLSRLHHRNL 683
+G+G + VYK + N VAIK+ + G N T EIKLL L H N+
Sbjct: 17 FLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGIN--RTALREIKLLQELSHPNI 74
Query: 684 VSLLGYCDEEGEQMLVYEFVPNGTLRDWLSGRTKENLNFAMRLRVALDSA---------- 733
+ LL + LV++F+ D L + L +
Sbjct: 75 IGLLDAFGHKSNISLVFDFME----TD-LEV-------IIKDNSLVLTPSHIKAYMLMTL 122
Query: 734 KGILYLHTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSRL--APVLDDEGTMPTHVST 791
+G+ YLH + HRD+K +N+LLD N K+ADFGL++ +P TH
Sbjct: 123 QGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPN----RAY-TH--Q 172
Query: 792 IVKGTPGYLDPEYFLTHKLTDKS-DVYSLGVVLLELLTGMQPISHGKN 838
+V T Y PE ++ D++++G +L ELL P G +
Sbjct: 173 VV--TRWYRAPELLFGARMYGVGVDMWAVGCILAELLLR-VPFLPGDS 217
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 95.6 bits (238), Expect = 1e-20
Identities = 54/208 (25%), Positives = 101/208 (48%), Gaps = 20/208 (9%)
Query: 633 VGQGGYGKVYKGILSDNTTV-AIKRAEEGSLQGQNEF---LTEIKLLSRLHHRNLVSLLG 688
+G+GG+G+V+ + + A K+ + L+ + + + E K+L+++H R +VSL
Sbjct: 193 LGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLA- 251
Query: 689 YCDEEGEQM-LVYEFVPNGTLRDWLSGRTKENLNFAMRLRVALDSAK---GILYLHTEAH 744
Y E + LV + G +R + ++N F R +A+ G+ +LH
Sbjct: 252 YAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEP-RAIFYTAQIVSGLEHLHQRN- 309
Query: 745 PPVFHRDIKASNILLDSNLNAKVADFGLSRLAPVLDDEGTMPTHVSTIVKGTPGYLDPEY 804
+ +RD+K N+LLD + N +++D GL+ + + + GTPG++ PE
Sbjct: 310 --IIYRDLKPENVLLDDDGNVRISDLGLAVE--LKAGQTKTKGYA-----GTPGFMAPEL 360
Query: 805 FLTHKLTDKSDVYSLGVVLLELLTGMQP 832
L + D ++LGV L E++ P
Sbjct: 361 LLGEEYDFSVDYFALGVTLYEMIAARGP 388
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 93.6 bits (233), Expect = 2e-20
Identities = 56/254 (22%), Positives = 94/254 (37%), Gaps = 25/254 (9%)
Query: 588 RHARYQHSLSRKRLSTKISMKIDGVKGFKFKELAMATAYFSSSTQVGQGGYGKVYKGI-L 646
A + + G + K+ A+ Y +S +G G GKV +
Sbjct: 25 TPALPHPPAQPPPPPPQQFPQFHVKSGLQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNK 84
Query: 647 SDNTTVAIKRAEEGSLQGQNEFLTEIKLLSRL-HHRNLVSLLG-YCDEEGEQMLVY---E 701
A+K LQ + E++L R ++V ++ Y + + + E
Sbjct: 85 RTQEKFALK-----MLQDCPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVME 139
Query: 702 FVPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDS 761
+ G L + R + + + I YLH+ + HRD+K N+L S
Sbjct: 140 CLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTS 196
Query: 762 ---NLNAKVADFGLSRLAPVLDDEGTMPTHVSTIVKGTPGYLDPEYFLTHKLTDKSDVYS 818
N K+ DFG ++ ++ T TP Y+ PE K D++S
Sbjct: 197 KRPNAILKLTDFGFAKE---TTSHNSLTTPC-----YTPYYVAPEVLGPEKYDKSCDMWS 248
Query: 819 LGVVLLELLTGMQP 832
LGV++ LL G P
Sbjct: 249 LGVIMYILLCGYPP 262
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 95.2 bits (236), Expect = 2e-20
Identities = 47/207 (22%), Positives = 89/207 (42%), Gaps = 15/207 (7%)
Query: 131 NISSLIFLLLNGNKLSGSLPDELGYLSNLNRLQVDENNITGTIPKSFANLSRVRHLHLNN 190
+ I L ++ ++ L++++++ + ++I ++ + L V L LN
Sbjct: 19 AFAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIK-SV-QGIQYLPNVTKLFLNG 74
Query: 191 NSIGGQIPSELSKLSTLIHLLVDNNNLSGNLPPELSELPQLCILQLDNNNFSASEIPATY 250
N + I L+ L L L +D N + +L L +L +L L L++N S +I
Sbjct: 75 NKLT-DI-KPLTNLKNLGWLFLDENKIK-DLSS-LKDLKKLKSLSLEHNGIS--DINGL- 127
Query: 251 GNFSKLVKLSLRNCNLQGAVPDLSRIPNLYYLDLSWNHLTGSIPSKKLSENVTTIDLSDN 310
+ +L L L N + + LSR+ L L L N ++ I + + LS N
Sbjct: 128 VHLPQLESLYLGNNKITD-ITVLSRLTKLDTLSLEDNQIS-DIVPLAGLTKLQNLYLSKN 185
Query: 311 YLNGSILESISNLPFLQTLSLENNFLT 337
++ S L +++ L L L L +
Sbjct: 186 HI--SDLRALAGLKNLDVLELFSQECL 210
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 90.2 bits (223), Expect = 1e-18
Identities = 48/251 (19%), Positives = 92/251 (36%), Gaps = 46/251 (18%)
Query: 138 LLLNGNKLSGSLPDELGYLSNLNRLQVDENNITGTIPKSFANLSRVRHLHLNNNSIGGQI 197
+ + PD+ + + + + ++T + L+ + + NN+ I +
Sbjct: 4 TITVSTPIKQIFPDD--AFAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIK-SV 58
Query: 198 PSELSKLSTLIHLLVDNNNLSGNLPPELSELPQLCILQLDNNNFSASEIPATYGNFSKLV 257
+ L + L ++ N L+ ++ P L+ L L L LD N K+
Sbjct: 59 -QGIQYLPNVTKLFLNGNKLT-DIKP-LTNLKNLGWLFLDEN---------------KIK 100
Query: 258 KLSLRNCNLQGAVPDLSRIPNLYYLDLSWNHLTGSIPSKKLSENVTTIDLSDNYLNGSIL 317
LS L + L L L N ++ I + ++ L +N + + +
Sbjct: 101 DLS-----------SLKDLKKLKSLSLEHNGIS-DINGLVHLPQLESLYLGNNKI--TDI 146
Query: 318 ESISNLPFLQTLSLENNFLTGSIPATIWQNKSFSTKARLK-IDLRNNSFSNIVGDLTLPN 376
+S L L TLSLE+N ++ I + +L+ + L N S++ L N
Sbjct: 147 TVLSRLTKLDTLSLEDNQIS-DIV-------PLAGLTKLQNLYLSKNHISDLRALAGLKN 198
Query: 377 NVTLRLGGNPI 387
L L
Sbjct: 199 LDVLELFSQEC 209
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 82.1 bits (202), Expect = 4e-16
Identities = 44/214 (20%), Positives = 78/214 (36%), Gaps = 22/214 (10%)
Query: 184 RHLHLNNNSIGGQIPSELSKLSTLIHLLVDNNNLSGNLPPELSELPQLCILQLDNNNFSA 243
+ I QI + I + +++ + +EL + + +N++ +
Sbjct: 2 GETITVSTPIK-QI-FPDDAFAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIKS 57
Query: 244 -SEIPATYGNFSKLVKLSLRNCNLQGAVPDLSRIPNLYYLDLSWNHLTGSIPSKKLSENV 302
I + KL L L + L+ + NL +L L N + K L +
Sbjct: 58 VQGI----QYLPNVTKLFLNGNKLTD-IKPLTNLKNLGWLFLDENKIKDLSSLKDLK-KL 111
Query: 303 TTIDLSDNYLNGSILESISNLPFLQTLSLENNFLTGSIPATIWQNKSFSTKARLKI-DLR 361
++ L N + S + + +LP L++L L NN +T I S +L L
Sbjct: 112 KSLSLEHNGI--SDINGLVHLPQLESLYLGNNKIT-DIT-------VLSRLTKLDTLSLE 161
Query: 362 NNSFSNIVGDLTLPNNVTLRLGGNPICTSANIPN 395
+N S+IV L L L N I +
Sbjct: 162 DNQISDIVPLAGLTKLQNLYLSKNHISDLRALAG 195
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 43.9 bits (103), Expect = 2e-04
Identities = 37/253 (14%), Positives = 74/253 (29%), Gaps = 21/253 (8%)
Query: 92 QLLSMNLSGNL---APELGQLSRLQY-YFMWNDLTGTIPKEIGNISSLIFLLLNGNKLSG 147
QL S+ L N L +L++L N ++ I + ++ L L L+ N +S
Sbjct: 132 QLESLYLGNNKITDITVLSRLTKLDTLSLEDNQIS-DIV-PLAGLTKLQNLYLSKNHIS- 188
Query: 148 SLPDELGYLSNLNRLQVDENNITGTIPKSFANLSRVRHLHLNNNSIGGQIPSELSKLSTL 207
L L L NL+ L++ +NL + + S+ P +S
Sbjct: 189 DL-RALAGLKNLDVLELFSQECLNKPINHQSNLVVPNTVKNTDGSL--VTPEIISDDGDY 245
Query: 208 IHLLVDNNNLSGNLPPELSELPQLCILQLDNNN----FSASEIPATYGNFSKLVKLSLRN 263
+ N+ +LP +E+ + + F ++ +
Sbjct: 246 -----EKPNVKWHLPEFTNEVSFIFYQPVTIGKAKARFHGRVTQPLKEVYTVSYDVDGTV 300
Query: 264 CNLQGAVPDLSRIPNLYYLDL--SWNHLTGSIPSKKLSENVTTIDLSDNYLNGSILESIS 321
+ P T + + N + +D L +
Sbjct: 301 IKTKVEAGTRITAPKPPTKQGYVFKGWYTEKNGGHEWNFNTDYMSGNDFTLYAVFKAETT 360
Query: 322 NLPFLQTLSLENN 334
T ++
Sbjct: 361 EKTVNLTRYVKYI 373
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 92.3 bits (230), Expect = 2e-20
Identities = 63/226 (27%), Positives = 101/226 (44%), Gaps = 39/226 (17%)
Query: 632 QVGQGGYGKVYKGILSDNT--TVAIKR-----AEEG----SLQGQNEFLTEIKLLSRLH- 679
++G+G YGKV+K N VA+KR EEG +++ E+ +L L
Sbjct: 18 EIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIR-------EVAVLRHLET 70
Query: 680 --HRNLVSLL-----GYCDEEGEQMLVYEFVPNGTLRDWLSGRTKENLNFAMRLRVALDS 732
H N+V L D E + LV+E V L +L + + +
Sbjct: 71 FEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEPGVPTETIKDMMFQL 129
Query: 733 AKGILYLHTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSRLAPVLDDEGTMPTHVSTI 792
+G+ +LH+ V HRD+K NIL+ S+ K+ADFGL+R + + + T V +
Sbjct: 130 LRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLAR---IYSFQMAL-TSV--V 180
Query: 793 VKGTPGYLDPEYFLTHKLTDKSDVYSLGVVLLELLTGMQPISHGKN 838
V T Y PE L D++S+G + E+ +P+ G +
Sbjct: 181 V--TLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRR-KPLFRGSS 223
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 91.9 bits (229), Expect = 2e-20
Identities = 53/209 (25%), Positives = 95/209 (45%), Gaps = 24/209 (11%)
Query: 633 VGQGGYGKVYKGILSDNTTV-AIKRAEEGSLQGQNEF---LTEIKLLSRLHHRNLVSLLG 688
+G+G + V + AIK E+ + +N+ E ++SRL H V L
Sbjct: 38 LGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYF 97
Query: 689 YCDEEGEQMLVYEFVPNGTLRDWL--SGRTKENLN--FAMRLRVALDSAKGILYLHTEAH 744
++ + + NG L ++ G E + + AL+ YLH +
Sbjct: 98 TFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALE------YLHGKG- 150
Query: 745 PPVFHRDIKASNILLDSNLNAKVADFGLSRLAPVLDDEGTMPTHVSTIVKGTPGYLDPEY 804
+ HRD+K NILL+ +++ ++ DFG +++ + + V GT Y+ PE
Sbjct: 151 --IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFV-----GTAQYVSPE- 202
Query: 805 FLTHKLTDKS-DVYSLGVVLLELLTGMQP 832
LT K KS D+++LG ++ +L+ G+ P
Sbjct: 203 LLTEKSACKSSDLWALGCIIYQLVAGLPP 231
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 91.9 bits (228), Expect = 3e-20
Identities = 53/281 (18%), Positives = 88/281 (31%), Gaps = 46/281 (16%)
Query: 77 FDTVETDGHLHVRELQLLSMNLSGNLAPELGQL---SRLQY-YFMWNDLTGTIPKEIGNI 132
+ L ++ L + + + + ++ S LQ ++TGT P +
Sbjct: 59 GQFTDIIKSLSLKRLTVRAARIPSRILFGALRVLGISGLQELTLENLEVTGTAPPPLLEA 118
Query: 133 S--SLIFLLLNGNKLSGSLPDELGYLSN-----LNRLQVDENNITGTIPKSFANLSRVRH 185
+ L L L + L L L L + + + + +
Sbjct: 119 TGPDLNILNLRNVSWAT-RDAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALST 177
Query: 186 LHLNNNSIGGQIPSELS----KLSTLIHLLVDNNN---LSGNLPPELSELPQLCILQLDN 238
L L++N G+ + K TL L + N SG + QL L L +
Sbjct: 178 LDLSDNPELGERGLISALCPLKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSH 237
Query: 239 NNFSASEIPATYGNFSKLVKLSLRNCNLQGAVPDLSRIPNLYYLDLSWNHLTGSIPSKKL 298
N+ + + S+L L+L L+ L L LDLS+N L
Sbjct: 238 NSLRDAAGAPSCDWPSQLNSLNLSFTGLKQVPKGLP--AKLSVLDLSYNRLDR------- 288
Query: 299 SENVTTIDLSDNYLNGSILESISNLPFLQTLSLENNFLTGS 339
S LP + LSL+ N S
Sbjct: 289 ------------------NPSPDELPQVGNLSLKGNPFLDS 311
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 84.6 bits (209), Expect = 8e-18
Identities = 53/278 (19%), Positives = 87/278 (31%), Gaps = 50/278 (17%)
Query: 128 EIGNISSLIFLLLNGNKLSGSLPDELGYLSNLNRLQ---VDENNITGTIPKSFANLS--R 182
+I SL L + ++ + + ++ LQ ++ +TGT P +
Sbjct: 63 DIIKSLSLKRLTVRAARIPSRILFGALRVLGISGLQELTLENLEVTGTAPPPLLEATGPD 122
Query: 183 VRHLHLNNNSIGGQIPSELSKLSTLIH-----LLVDNNNLSGNLPPELSELPQLCILQLD 237
+ L+L N S + L++L + L + + ++ P L L L
Sbjct: 123 LNILNLRNVSWAT-RDAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLS 181
Query: 238 NNNFSASE---IPATYGNFSKLVKLSLRNCNLQGAVPDLSRI----PNLYYLDLSWNHLT 290
+N F L L+LRN ++ S + L LDLS N L
Sbjct: 182 DNPELGERGLISALCPLKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLR 241
Query: 291 GSIPSKKLSENVTTIDLSDNYLNGSILESISNLPFLQTLSLENNFLTGSIPATIWQNKSF 350
+ + S L +L+L L +P +
Sbjct: 242 DAAGA----------------------PSCDWPSQLNSLNLSFTGLK-QVPKGLPAK--- 275
Query: 351 STKARLKI-DLRNNSFSNIVGDLTLPNNVTLRLGGNPI 387
L + DL N LP L L GNP
Sbjct: 276 -----LSVLDLSYNRLDRNPSPDELPQVGNLSLKGNPF 308
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 66.5 bits (162), Expect = 8e-12
Identities = 35/170 (20%), Positives = 54/170 (31%), Gaps = 14/170 (8%)
Query: 85 HLHVRELQLLSMNLSGNLAPELGQLSRLQY-YFMWNDLTGTIPKEI----GNISSLIFLL 139
++ L + + ++ L N G +L L
Sbjct: 148 KPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLISALCPLKFPTLQVLA 207
Query: 140 LNGNK---LSGSLPDELGYLSNLNRLQVDENNITGTIPK-SFANLSRVRHLHLNNNSIGG 195
L SG L L + N++ S S++ L+L+ +
Sbjct: 208 LRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLK- 266
Query: 196 QIPSELSKLSTLIHLLVDNNNLSGNLPPELSELPQLCILQLDNNNFSASE 245
Q+P L + L L + N L N P ELPQ+ L L N F SE
Sbjct: 267 QVPKGLP--AKLSVLDLSYNRLDRN--PSPDELPQVGNLSLKGNPFLDSE 312
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 60.3 bits (146), Expect = 9e-10
Identities = 33/216 (15%), Positives = 57/216 (26%), Gaps = 28/216 (12%)
Query: 179 NLSRVRHLHLNNNSIGGQIPSELSKLSTLIHLLVDNNNLSGNLPPELSEL---PQLCILQ 235
S L + +++ K +L L V + + + L L
Sbjct: 42 GRSLEYLLKRVDTEADLGQFTDIIKSLSLKRLTVRAARIPSRILFGALRVLGISGLQELT 101
Query: 236 LDNNNFS-ASEIPATYGNFSKLVKLSLRNCNLQGAVPDLSRIPNLYYLDLSWNHLTGSIP 294
L+N + + P L L+LRN + L+ +
Sbjct: 102 LENLEVTGTAPPPLLEATGPDLNILNLRNVSWATRDAWLAELQQW--------------- 146
Query: 295 SKKLSENVTTIDLSDNYLNGSILESISNLPFLQTLSLENNFLTGSIPATIWQNKSFSTKA 354
L + + ++ + E + P L TL L +N G
Sbjct: 147 ---LKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLISALCPLKFPTL 203
Query: 355 RLKIDLRNNSFSNIVGDL-----TLPNNVTLRLGGN 385
+ + LRN G L L N
Sbjct: 204 Q-VLALRNAGMETPSGVCSALAAARVQLQGLDLSHN 238
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 91.9 bits (229), Expect = 4e-20
Identities = 58/225 (25%), Positives = 97/225 (43%), Gaps = 41/225 (18%)
Query: 632 QVGQGGYGKVYKGI-LSDNTTVAIKR-----AEEG----SLQGQNEFLTEIKLLSRLHHR 681
++G+G YG+VYK I N TVAIKR EEG +++ E+ LL L HR
Sbjct: 41 KLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIR-------EVSLLKELQHR 93
Query: 682 NLVSLLGYCDEEGEQMLVYEFVPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHT 741
N++ L L++E+ N L+ ++ +++ + G+ + H
Sbjct: 94 NIIELKSVIHHNHRLHLIFEYAEN-DLKKYMD--KNPDVSMRVIKSFLYQLINGVNFCH- 149
Query: 742 EAHPPVFHRDIKASNILLDSNLNA-----KVADFGLSRL--APVLDDEGTMPTHVSTIVK 794
HRD+K N+LL + + K+ DFGL+R P+ + T+
Sbjct: 150 --SRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPI----RQFTHEIITL-- 201
Query: 795 GTPGYLDPEYFLTHKLTDKS-DVYSLGVVLLELLTGMQPISHGKN 838
Y PE L + S D++S+ + E+L P+ G +
Sbjct: 202 ---WYRPPEILLGSRHYSTSVDIWSIACIWAEMLMK-TPLFPGDS 242
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 88.1 bits (219), Expect = 6e-20
Identities = 30/184 (16%), Positives = 75/184 (40%), Gaps = 10/184 (5%)
Query: 157 SNLNRLQVDENNITGTIPKSFANLSRVRHLHLNNNSIGGQIPSELSKLSTLIHLLVDNNN 216
S + T + A ++ + ++ L N ++ + + + L ++N +
Sbjct: 20 STFKAYLNGLLGQSSTANITEAQMNSLTYITLANINV--TDLTGIEYAHNIKDLTINNIH 77
Query: 217 LSGNLPPELSELPQLCILQLDNNNFSASEIPATYGNFSKLVKLSLRNCNLQGA-VPDLSR 275
+ N P +S L L L++ + ++ +IP + L L + + + + ++
Sbjct: 78 AT-NYNP-ISGLSNLERLRIMGKDVTSDKIPN-LSGLTSLTLLDISHSAHDDSILTKINT 134
Query: 276 IPNLYYLDLSWNHLTGSIPS-KKLSENVTTIDLSDNYLNGSILESISNLPFLQTLSLENN 334
+P + +DLS+N I K L + ++++ + ++ I + P L L +
Sbjct: 135 LPKVNSIDLSYNGAITDIMPLKTLP-ELKSLNIQFDGVHD--YRGIEDFPKLNQLYAFSQ 191
Query: 335 FLTG 338
+ G
Sbjct: 192 TIGG 195
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 79.6 bits (197), Expect = 5e-17
Identities = 33/182 (18%), Positives = 73/182 (40%), Gaps = 11/182 (6%)
Query: 89 RELQLLSMNLSGNLAPELGQLSRLQY-YFMWNDLTGTIPKEIGNISSLIFLLLNGNKLSG 147
+ + S Q++ L Y ++T I ++ L +N +
Sbjct: 23 KAYLNGLLGQSSTANITEAQMNSLTYITLANINVTDL--TGIEYAHNIKDLTINNIHATN 80
Query: 148 SLPDELGYLSNLNRLQVDENNITGTIPKSFANLSRVRHLHLNNNSIGGQIPSELSKLSTL 207
P + LSNL RL++ ++T + + L+ + L +++++ I ++++ L +
Sbjct: 81 YNP--ISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKV 138
Query: 208 IHLLVDNNNLSGNLPPELSELPQLCILQLDNNNFS-ASEIPATYGNFSKLVKLSLRNCNL 266
+ + N ++ P L LP+L L + + I +F KL +L + +
Sbjct: 139 NSIDLSYNGAITDIMP-LKTLPELKSLNIQFDGVHDYRGI----EDFPKLNQLYAFSQTI 193
Query: 267 QG 268
G
Sbjct: 194 GG 195
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 76.9 bits (190), Expect = 4e-16
Identities = 26/158 (16%), Positives = 53/158 (33%), Gaps = 9/158 (5%)
Query: 92 QLLSMNLSGNL---APELGQLSRLQY-YFMWNDLTGTIPKEIGNISSLIFLLLNGNKLSG 147
L + L+ + ++ T P I +S+L L + G ++
Sbjct: 45 SLTYITLANINVTDLTGIEYAHNIKDLTINNIHATNYNP--ISGLSNLERLRIMGKDVTS 102
Query: 148 SLPDELGYLSNLNRLQVDENNITGTIPKSFANLSRVRHLHLNNNSIGGQIPSELSKLSTL 207
L L++L L + + +I L +V + L+ N I L L L
Sbjct: 103 DKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSIDLSYNGAITDI-MPLKTLPEL 161
Query: 208 IHLLVDNNNLSGNLPPELSELPQLCILQLDNNNFSASE 245
L + + + + + + P+L L + +
Sbjct: 162 KSLNIQFDGVH-DYRG-IEDFPKLNQLYAFSQTIGGKK 197
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 73.8 bits (182), Expect = 5e-15
Identities = 37/228 (16%), Positives = 76/228 (33%), Gaps = 44/228 (19%)
Query: 163 QVDENNITGTIPKSFANLSRVRHLHLNNNSIGGQIPSELSKLSTLIHLLVDNNNLSGNLP 222
+ + IP + + L +S ++++ L+ + + N N++ +L
Sbjct: 7 GLKASQDNVNIP--DSTFKAYLNGLLGQSSTANITEAQMNSLTYIT---LANINVT-DLT 60
Query: 223 PELSELPQLCILQLDNNNFSASEIPATYGNFSKLVKLSLRNCNLQGAVPDLSRIPNLYYL 282
+ + L ++N + + Y S L NL L
Sbjct: 61 G-IEYAHNIKDLTINNIHAT------NYNPISGL--------------------SNLERL 93
Query: 283 DLSWNHLTGSIPS--KKLSENVTTIDLSDNYLNGSILESISNLPFLQTLSLENNFLTGSI 340
+ +T L+ ++T +D+S + + SIL I+ LP + ++ L N I
Sbjct: 94 RIMGKDVTSDKIPNLSGLT-SLTLLDISHSAHDDSILTKINTLPKVNSIDLSYNGAITDI 152
Query: 341 PATIWQNKSFSTKARLKI-DLRNNSFSNIVGDLTLPNNVTLRLGGNPI 387
T LK +++ + + G P L I
Sbjct: 153 -------MPLKTLPELKSLNIQFDGVHDYRGIEDFPKLNQLYAFSQTI 193
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 92.5 bits (230), Expect = 8e-20
Identities = 50/262 (19%), Positives = 93/262 (35%), Gaps = 35/262 (13%)
Query: 157 SNLNRLQVDENNITGTIPKSFANLSRVRHLHLNNNSIGGQIPSEL-SKLSTLIHLLVDNN 215
+++N + + N+I SF+ L ++ L + + G I + LS+LI L +D N
Sbjct: 30 AHVNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDYN 89
Query: 216 NLSGNLPPE-LSELPQLCILQLDNNNFSASEIPATYGNFSKLVKL---SLRNCNLQGAVP 271
L + L L +L L N + + F L L LR+ N++ P
Sbjct: 90 QFL-QLETGAFNGLANLEVLTLTQCNLDGAVLSG--NFFKPLTSLEMLVLRDNNIKKIQP 146
Query: 272 D--LSRIPNLYYLDLSWNHLTGSIPSKKLS------------ENVTTIDLSDNYLNGSIL 317
+ + LDL++N + SI + L ++T D+++ +L
Sbjct: 147 ASFFLNMRRFHVLDLTFNKVK-SICEEDLLNFQGKHFTLLRLSSITLQDMNEYWLGWEKC 205
Query: 318 ESISNLPFLQTLSLENNFLTGSIPATIWQNKSFSTKARL--------KIDLRNNSFSNIV 369
+ + TL L N S+ + + + L + +F +
Sbjct: 206 GNPFKNTSITTLDLSGNGFKESMAKRFFDAIAGTKIQSLILSNSYNMGSSFGHTNFKDPD 265
Query: 370 ----GDLTLPNNVTLRLGGNPI 387
L T L + I
Sbjct: 266 NFTFKGLEASGVKTCDLSKSKI 287
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 91.3 bits (227), Expect = 2e-19
Identities = 46/306 (15%), Positives = 102/306 (33%), Gaps = 47/306 (15%)
Query: 119 NDLTGTIPKEIGNISSLIFLLLNGNKLSGSLPDEL-GYLSNLNRLQVDENNITGTIPKSF 177
N + + L FL + + + LS+L L++D N +F
Sbjct: 40 NSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDYNQFLQLETGAF 99
Query: 178 ANLSRVRHLHLNNNSI-GGQIPSEL-SKLSTLIHLLVDNNNLSGNLPPE--LSELPQLCI 233
L+ + L L ++ G + L++L L++ +NN+ + P + + +
Sbjct: 100 NGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIK-KIQPASFFLNMRRFHV 158
Query: 234 LQLDNNNFSASEIPATYGNFSKLVKLSLRNCNLQG--------------AVPDLSRIPNL 279
L L N + I + L + + ++
Sbjct: 159 LDLTFNKVKS--ICE--EDLLNFQGKHFTLLRLSSITLQDMNEYWLGWEKCGNPFKNTSI 214
Query: 280 YYLDLSWNHLTGSIPSKKLS----ENVTTIDLSDNY-----LNGSILESISNLPF----- 325
LDLS N S+ + + ++ LS++Y + + N F
Sbjct: 215 TTLDLSGNGFKESMAKRFFDAIAGTKIQSLILSNSYNMGSSFGHTNFKDPDNFTFKGLEA 274
Query: 326 --LQTLSLENNFLTGSIPATIWQNKSFSTKARLKIDLRNNSFSNIVGDL--TLPNNVTLR 381
++T L + + ++ +++ + ++ L N + I + L + + L
Sbjct: 275 SGVKTCDLSKSKIF-ALLKSVFSH----FTDLEQLTLAQNEINKIDDNAFWGLTHLLKLN 329
Query: 382 LGGNPI 387
L N +
Sbjct: 330 LSQNFL 335
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 86.3 bits (214), Expect = 9e-18
Identities = 63/322 (19%), Positives = 109/322 (33%), Gaps = 42/322 (13%)
Query: 85 HLHVRELQLLSMNLSGNLAPELGQLSRLQYYFMWNDLTGTIPKEI-GNISSLIFLLLNGN 143
L + + L LSGN L L L N++ P N+ L L N
Sbjct: 107 VLTLTQCNLDGAVLSGNFFKPLTSLEMLVLR--DNNIKKIQPASFFLNMRRFHVLDLTFN 164
Query: 144 KLSGSLPDELG----------YLSNLNRLQVDENNITGTIPKSFANLSRVRHLHLNNNSI 193
K+ ++L LS++ ++E + + + + L L+ N
Sbjct: 165 KVKSICEEDLLNFQGKHFTLLRLSSITLQDMNEYWLGWEKCGNPFKNTSITTLDLSGNGF 224
Query: 194 GGQIPSELSKLSTLIHLLVDNNNLSGNLPPELSELPQLCILQLDNNNFSASEIPATYGNF 253
+ + + S N+ S DN F E
Sbjct: 225 KESMAKRFFDAIAGTKIQSLILSNSYNM---GSSFGHTNFKDPDNFTFKGLEA------- 274
Query: 254 SKLVKLSLRNCNLQGAVPD--LSRIPNLYYLDLSWNHLTGSIPS---KKLSENVTTIDLS 308
S + L + A+ S +L L L+ N + I L+ ++ ++LS
Sbjct: 275 SGVKTCDLSKSKIF-ALLKSVFSHFTDLEQLTLAQNEIN-KIDDNAFWGLT-HLLKLNLS 331
Query: 309 DNYLNGSILESI-SNLPFLQTLSLENNFLTGSIPATIWQNKSFSTKARLK-IDLRNNSFS 366
N+L GSI + NL L+ L L N + ++ ++SF LK + L N
Sbjct: 332 QNFL-GSIDSRMFENLDKLEVLDLSYNHIR-ALG-----DQSFLGLPNLKELALDTNQLK 384
Query: 367 NIVGDL--TLPNNVTLRLGGNP 386
++ + L + + L NP
Sbjct: 385 SVPDGIFDRLTSLQKIWLHTNP 406
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 65.5 bits (160), Expect = 4e-11
Identities = 36/196 (18%), Positives = 70/196 (35%), Gaps = 24/196 (12%)
Query: 83 DGHLHVRELQLLSMNLSGNLA------PELGQLSRLQYYFMWNDLTGTIPKEIGNISSLI 136
+ + L L ++A ++ L +N + + +
Sbjct: 209 FKNTSITTLDLSGNGFKESMAKRFFDAIAGTKIQSLILSNSYNMGSSFGHTNFKDPDNFT 268
Query: 137 F----------LLLNGNKLSGSLPDEL-GYLSNLNRLQVDENNITGTIPKSFANLSRVRH 185
F L+ +K+ +L + + ++L +L + +N I +F L+ +
Sbjct: 269 FKGLEASGVKTCDLSKSKIF-ALLKSVFSHFTDLEQLTLAQNEINKIDDNAFWGLTHLLK 327
Query: 186 LHLNNNSIGGQIPSELSKLSTLIHLLVDNNNLSGNLPPEL-SELPQLCILQLDNNNFSAS 244
L+L+ N +G L L L + N++ L + LP L L LD N +
Sbjct: 328 LNLSQNFLGSIDSRMFENLDKLEVLDLSYNHIR-ALGDQSFLGLPNLKELALDTNQLKS- 385
Query: 245 EIPATYGNFSKLVKLS 260
+P G F +L L
Sbjct: 386 -VPD--GIFDRLTSLQ 398
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 42.4 bits (100), Expect = 6e-04
Identities = 27/116 (23%), Positives = 37/116 (31%), Gaps = 12/116 (10%)
Query: 283 DLSWNHLTGSIPSKKLSENVTTIDLSDNYLNGSILESISNLPFLQTLSLENNFLTGSIPA 342
L +P L +V +DLS N + S S L LQ L +E I
Sbjct: 16 ICINRGLH-QVPE--LPAHVNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRN 72
Query: 343 TIWQNKSFSTKARLKI-DLRNNSFSNIVGDL--TLPNNVTLRLGGNPICTSANIPN 395
+F + L I L N F + L N L L + A +
Sbjct: 73 -----NTFRGLSSLIILKLDYNQFLQLETGAFNGLANLEVLTLTQCNL-DGAVLSG 122
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 88.9 bits (221), Expect = 1e-19
Identities = 41/243 (16%), Positives = 92/243 (37%), Gaps = 24/243 (9%)
Query: 138 LLLNGNKLSGSLPDELGYLSNLNRLQVDENNITGTIPKSFANLSRVRHLHLNNNSIGGQI 197
+ ++ PD L+N + + + ++T + LS V++ + +N++I Q
Sbjct: 2 SIQRPTPINQVFPDP--GLANAVKQNLGKQSVTDLVS--QKELSGVQNFNGDNSNI--QS 55
Query: 198 PSELSKLSTLIHLLVDNNNLSGNLPPELSELPQLCILQLDNNNFSASEIPATYGNFSKLV 257
+ + + L L + +N +S +L P L +L +L L ++ N + + L
Sbjct: 56 LAGMQFFTNLKELHLSHNQIS-DLSP-LKDLTKLEELSVNRNRL--KNLNG--IPSACLS 109
Query: 258 KLSLRNCNLQGAVPDLSRIPNLYYLDLSWNHLTGSIPSKKLSENVTTIDLSDNYLNGSIL 317
+L L N L+ L + NL L + N L SI + +DL N + +
Sbjct: 110 RLFLDNNELRD-TDSLIHLKNLEILSIRNNKLK-SIVMLGFLSKLEVLDLHGNEI--TNT 165
Query: 318 ESISNLPFLQTLSLENNFLTGSIPATIWQNKSFSTKARLKIDLRNNSFSNIVGDLTLPNN 377
++ L + + L + + + + +++ + + N
Sbjct: 166 GGLTRLKKVNWIDLTGQKCV-------NEPVKYQPELYITNTVKDPD-GRWISPYYISNG 217
Query: 378 VTL 380
+
Sbjct: 218 GSY 220
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 77.4 bits (191), Expect = 8e-16
Identities = 40/203 (19%), Positives = 74/203 (36%), Gaps = 21/203 (10%)
Query: 188 LNNNSIGGQIPSELSKLSTLIHLLVDNNNLSGNLPPELSELPQLCILQLDNNNFSASEIP 247
I Q+ L+ + + +++ +L EL + DN+N +
Sbjct: 4 QRPTPIN-QV-FPDPGLANAVKQNLGKQSVT-DLVS-QKELSGVQNFNGDNSNIQ--SLA 57
Query: 248 ATYGNFSKLVKLSLRNCNLQGAVPDLSRIPNLYYLDLSWNHLTGSIPSKKLSENVTTIDL 307
F+ L +L L + + + L + L L ++ N L ++ + L
Sbjct: 58 GM-QFFTNLKELHLSHNQIS-DLSPLKDLTKLEELSVNRNRLKNLNGIPSA--CLSRLFL 113
Query: 308 SDNYLNGSILESISNLPFLQTLSLENNFLTGSIPATIWQNKSFSTKARLK-IDLRNNSFS 366
+N L +S+ +L L+ LS+ NN L SI ++L+ +DL N +
Sbjct: 114 DNNEL--RDTDSLIHLKNLEILSIRNNKLK-SIV-------MLGFLSKLEVLDLHGNEIT 163
Query: 367 NIVGDLTLPNNVTLRLGGNPICT 389
N G L + L G
Sbjct: 164 NTGGLTRLKKVNWIDLTGQKCVN 186
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 69.3 bits (170), Expect = 5e-13
Identities = 46/252 (18%), Positives = 86/252 (34%), Gaps = 29/252 (11%)
Query: 92 QLLSMNLSGNL---APELGQLSRLQY-YFMWNDLTGTIPKEIGNISSLIFLLLNGNKLSG 147
+ NL +LS +Q +++ ++ + ++L L L+ N++S
Sbjct: 20 NAVKQNLGKQSVTDLVSQKELSGVQNFNGDNSNIQ-SL-AGMQFFTNLKELHLSHNQIS- 76
Query: 148 SLPDELGYLSNLNRLQVDENNITGTIPKSFANLSRVRHLHLNNNSIGGQIPSELSKLSTL 207
L L L+ L L V+ N + A L L L+NN + + L L L
Sbjct: 77 DLSP-LKDLTKLEELSVNRNRLKNLNGIPSACL---SRLFLDNNEL--RDTDSLIHLKNL 130
Query: 208 IHLLVDNNNLSGNLPPELSELPQLCILQLDNNNFSASEIPATYGNFSKLVKLSLRNCNLQ 267
L + NN L ++ L L +L +L L N + K+ + L
Sbjct: 131 EILSIRNNKLK-SIVM-LGFLSKLEVLDLHGNEI--TNTGGL-TRLKKVNWIDLTGQKCV 185
Query: 268 GAVPDLSRIPNLYYLDLSWNHLTGSIPSKKLSENVTTIDLSDNYLNGSILESISNLPFLQ 327
+ P LY + + I +S + Y++G + +
Sbjct: 186 N--EPVKYQPELYITNTVKDPDGRWISPYYISNGGS-------YVDGCV--LWELPVYTD 234
Query: 328 TLSLENNFLTGS 339
+S + +
Sbjct: 235 EVSYKFSEYINV 246
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 90.4 bits (225), Expect = 1e-19
Identities = 61/232 (26%), Positives = 102/232 (43%), Gaps = 45/232 (19%)
Query: 633 VGQGGYGKVYKGI-LSDNTTVAIKRAEEGSLQGQNEF---------LTEIKLLSRLHHRN 682
+G+G YG V VAIK+ F L EIK+L H N
Sbjct: 19 LGEGAYGVVCSATHKPTGEIVAIKKI--------EPFDKPLFALRTLREIKILKHFKHEN 70
Query: 683 LVSLL-----GYCDEEGEQMLVYEFVPNGT-LRDWLSGR--TKENLNFAMR--LRVALDS 732
++++ + E ++ E + T L +S + + +++ + + LR
Sbjct: 71 IITIFNIQRPDSFENFNEVYIIQELM--QTDLHRVISTQMLSDDHIQYFIYQTLR----- 123
Query: 733 AKGILYLHTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSRLAPVLDDEGTMPTHVSTI 792
+ LH ++ V HRD+K SN+L++SN + KV DFGL+R+ + + PT +
Sbjct: 124 --AVKVLHG-SN--VIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSG 178
Query: 793 VKG---TPGYLDPEYFLTHKLTDKS-DVYSLGVVLLELLTGMQPISHGKNIV 840
+ T Y PE LT ++ DV+S G +L EL +PI G++
Sbjct: 179 MVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLR-RPIFPGRDYR 229
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 89.3 bits (222), Expect = 1e-19
Identities = 58/265 (21%), Positives = 104/265 (39%), Gaps = 21/265 (7%)
Query: 106 LGQLSRLQY-YFMWNDLTGTIPKEIGNISSLIFLLLNGNKLSGSLPDELGYLSNLNRLQV 164
+ +T + ++S+ ++ N + + S+ + YL N+ +L +
Sbjct: 20 DDAFAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIK-SV-QGIQYLPNVTKLFL 75
Query: 165 DENNITGTIPKSFANLSRVRHLHLNNNSIGGQIPSELSKLSTLIHLLVDNNNLSGNLPPE 224
+ N +T P ANL + L L+ N + + S L L L L +++N +S ++
Sbjct: 76 NGNKLTDIKP--LANLKNLGWLFLDENKVK-DL-SSLKDLKKLKSLSLEHNGIS-DING- 129
Query: 225 LSELPQLCILQLDNNNFSASEIPATYGNFSKLVKLSLRNCNLQGAVPDLSRIPNLYYLDL 284
L LPQL L L NN + +I +KL LSL + + + L+ + L L L
Sbjct: 130 LVHLPQLESLYLGNNKIT--DITVL-SRLTKLDTLSLEDNQIS-DIVPLAGLTKLQNLYL 185
Query: 285 SWNHLTGSIPSKKLSENVTTIDLSDNYLNGSILESISNLPFLQTLSLENNFLTGSIPATI 344
S NH++ L N+ ++L + SNL T+ + L T
Sbjct: 186 SKNHISDLRALAGLK-NLDVLELFSQECLNKPINHQSNLVVPNTVKNTDGSLV-----TP 239
Query: 345 WQNKSFSTKARLKIDLRNNSFSNIV 369
+ + F+N V
Sbjct: 240 EIISDDGDYEKPNVKWHLPEFTNEV 264
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 85.9 bits (213), Expect = 2e-18
Identities = 41/225 (18%), Positives = 86/225 (38%), Gaps = 22/225 (9%)
Query: 165 DENNITGTIPKSFANLSRVRHLHLNNNSIGGQIPSELSKLSTLIHLLVDNNNLSGNLPPE 224
I + +L S+ + ++L+++ ++ +N+++ ++
Sbjct: 10 VPTPIKQIFS--DDAFAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIK-SVQG- 63
Query: 225 LSELPQLCILQLDNNNFSASEIPATYGNFSKLVKLSLRNCNLQGAVPDLSRIPNLYYLDL 284
+ LP + L L+ N + +I N L L L ++ + L + L L L
Sbjct: 64 IQYLPNVTKLFLNGNKLT--DIKP-LANLKNLGWLFLDENKVK-DLSSLKDLKKLKSLSL 119
Query: 285 SWNHLTGSIPSKKLSENVTTIDLSDNYLNGSILESISNLPFLQTLSLENNFLTGSIPATI 344
N ++ I + ++ L +N + + + +S L L TLSLE+N ++ I
Sbjct: 120 EHNGIS-DINGLVHLPQLESLYLGNNKI--TDITVLSRLTKLDTLSLEDNQIS-DIV--- 172
Query: 345 WQNKSFSTKARLK-IDLRNNSFSNIVGDLTLPNNVTLRLGGNPIC 388
+ +L+ + L N S++ L N L L
Sbjct: 173 ----PLAGLTKLQNLYLSKNHISDLRALAGLKNLDVLELFSQECL 213
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 42.0 bits (99), Expect = 5e-04
Identities = 30/141 (21%), Positives = 54/141 (38%), Gaps = 15/141 (10%)
Query: 92 QLLSMNLSGNL---APELGQLSRLQY-YFMWNDLTGTIPKEIGNISSLIFLLLNGNKLSG 147
QL S+ L N L +L++L N ++ I + ++ L L L+ N +S
Sbjct: 135 QLESLYLGNNKITDITVLSRLTKLDTLSLEDNQIS-DIV-PLAGLTKLQNLYLSKNHIS- 191
Query: 148 SLPDELGYLSNLNRLQVDENNITGTIPKSFANLSRVRHLHLNNNSIGGQIPSELSKLSTL 207
L L L NL+ L++ +NL + + S+ P +S
Sbjct: 192 DL-RALAGLKNLDVLELFSQECLNKPINHQSNLVVPNTVKNTDGSL--VTPEIISDDGDY 248
Query: 208 IHLLVDNNNLSGNLPPELSEL 228
+ N+ +LP +E+
Sbjct: 249 -----EKPNVKWHLPEFTNEV 264
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 88.9 bits (221), Expect = 2e-19
Identities = 51/214 (23%), Positives = 81/214 (37%), Gaps = 19/214 (8%)
Query: 133 SSLIFLLLNGNKLSGSLPDELGYLSNLNRLQVDENNITGTIP-KSFANLSRVRHLHLNNN 191
S L L+ N L L L + I TI ++ +LS + L L N
Sbjct: 28 FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQ-TIEDGAYQSLSHLSTLILTGN 86
Query: 192 SIGGQIPSEL-SKLSTLIHLLVDNNNLSGNLPPEL-SELPQLCILQLDNNNFSASEIPAT 249
I + S LS+L L+ NL+ +L L L L + +N + ++P
Sbjct: 87 PI-QSLALGAFSGLSSLQKLVAVETNLA-SLENFPIGHLKTLKELNVAHNLIQSFKLPEY 144
Query: 250 YGNFSKLVKLSLRNCNLQGAVP--DLSRIPNLYY----LDLSWNHLTGSIPS---KKLSE 300
+ N + L L L + +Q ++ DL + + LDLS N + I K++
Sbjct: 145 FSNLTNLEHLDLSSNKIQ-SIYCTDLRVLHQMPLLNLSLDLSLNPMN-FIQPGAFKEI-- 200
Query: 301 NVTTIDLSDNYLNGSILESISNLPFLQTLSLENN 334
+ + L N L L LQ + L N
Sbjct: 201 RLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTN 234
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 70.8 bits (174), Expect = 2e-13
Identities = 39/209 (18%), Positives = 66/209 (31%), Gaps = 32/209 (15%)
Query: 184 RHLHLNNNSIGGQIPSELSKLSTLIHLLVDNNNLSGNLPPEL-SELPQLCILQLDNNNFS 242
++L L+ N + L L + + + L L L L N
Sbjct: 31 KNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQ-TIEDGAYQSLSHLSTLILTGNPIQ 89
Query: 243 ASEIPA-TYGNFSKLVKLSLRNCNLQGAVPD--LSRIPNLYYLDLSWNHLTGSIPSKKLS 299
+ + + S L KL NL ++ + + + L L+++ N + S +
Sbjct: 90 S--LALGAFSGLSSLQKLVAVETNLA-SLENFPIGHLKTLKELNVAHNLIQ-SFKLPEY- 144
Query: 300 ENVTTIDLSDNYLNGSILESISNLPFLQTLSLENNFLTGSIPATIWQNKSFSTKARLKID 359
SNL L+ L L +N + SI T + L +D
Sbjct: 145 --------------------FSNLTNLEHLDLSSNKIQ-SIYCTDLRVLHQMPLLNLSLD 183
Query: 360 LRNNSFSNI-VGDLTLPNNVTLRLGGNPI 387
L N + I G L L N +
Sbjct: 184 LSLNPMNFIQPGAFKEIRLKELALDTNQL 212
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 90.0 bits (224), Expect = 2e-19
Identities = 59/228 (25%), Positives = 96/228 (42%), Gaps = 49/228 (21%)
Query: 633 VGQGGYGKVYKGI-LSDNTTVAIKRAEEGSLQGQNEF---------LTEIKLLSRLHHRN 682
VG G YG V I VAIK+ F E+ LL + H N
Sbjct: 32 VGSGAYGSVCSAIDKRSGEKVAIKKL-------SRPFQSEIFAKRAYRELLLLKHMQHEN 84
Query: 683 LVSLL------GYCDEEGEQMLVYEFVP---NGTLRDWLSGRTKENLNFAMRLRVALDSA 733
++ LL + LV F+ + S + L + M L+
Sbjct: 85 VIGLLDVFTPASSLRNFYDFYLVMPFMQTDLQKIMGLKFSEEKIQYLVYQM-LK------ 137
Query: 734 KGILYLHTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSRLAPVLDDEGTMPTHVSTIV 793
G+ Y+H+ A V HRD+K N+ ++ + K+ DFGL+R A + M +V T
Sbjct: 138 -GLKYIHS-AG--VVHRDLKPGNLAVNEDCELKILDFGLARHA-----DAEMTGYVVTRW 188
Query: 794 KGTPGYLDPEYFLTHKLTDKS-DVYSLGVVLLELLTGMQPISHGKNIV 840
Y PE L+ +++ D++S+G ++ E+LTG + + GK+ +
Sbjct: 189 -----YRAPEVILSWMHYNQTVDIWSVGCIMAEMLTG-KTLFKGKDYL 230
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 89.1 bits (221), Expect = 4e-19
Identities = 48/332 (14%), Positives = 103/332 (31%), Gaps = 42/332 (12%)
Query: 138 LLLNGNKLSGSLPDELGYLSNLNRLQVDENNITGTIPKSFANLSRVRHLHLNNNSIGGQI 197
L +K++ +P +L N L+ + +F+ + + ++ N + I
Sbjct: 14 FLCQESKVT-EIPSDL--PRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVI 70
Query: 198 PSE-LSKLSTLIHLLVDNNNLSGNLPPE-LSELPQLCILQLDNNNFSASEIPA-TYGNFS 254
++ S L L + ++ N + PE LP L L + N +P +
Sbjct: 71 EADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGI--KHLPDVHKIHSL 128
Query: 255 KLVKLSL-RNCNLQ----GAVPDLSRIPNLYYLDLSWNHLTGSIPSK--KLSENVTTIDL 307
+ V L + N N+ + LS L L+ N + I + ++
Sbjct: 129 QKVLLDIQDNINIHTIERNSFVGLS--FESVILWLNKNGIQ-EIHNSAFNGTQLDELNLS 185
Query: 308 SDNYLNGSILESISNLPFLQTLSLENNFLTGSIPATIWQNKSFSTKARLKI-DLRNN--- 363
+N L + L + + S+P+ +N +L+ N
Sbjct: 186 DNNNLEELPNDVFHGASGPVILDISRTRIH-SLPSYGLENLK-----KLRARSTYNLKKL 239
Query: 364 -SFSNIVG--DLTLPNN---------VTLRLGGNPICTSANIPNTGRFCGSDAGGDETLT 411
+ +V + +L +PIC + + + G +L
Sbjct: 240 PTLEKLVALMEASLTYPSHCCAFANWRRQISELHPICNKSILRQEVDYMTQARGQRSSLA 299
Query: 412 NSKVNCPVQACPVDN--FFEYVPASPEPCFCA 441
+ + + F + C+
Sbjct: 300 EDNESSYSRGFDMTYTEFDYDLCNEVVDVTCS 331
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 77.2 bits (190), Expect = 3e-15
Identities = 45/211 (21%), Positives = 83/211 (39%), Gaps = 19/211 (9%)
Query: 87 HVRELQLLSMNLSGNLAPE----LGQLSRLQYYFMWNDLTGTIPKEI-GNISSLIFLLLN 141
+ ++++ ++ + + L +L + N+L I E N+ +L +LL++
Sbjct: 55 DLEKIEISQNDVLEVIEADVFSNLPKLHEI-RIEKANNLL-YINPEAFQNLPNLQYLLIS 112
Query: 142 GNKLSGSLPDEL-GYLSNLNRLQVDENNITGTIP-KSFANLS-RVRHLHLNNNSIGGQIP 198
+ LPD + L + +N TI SF LS L LN N I +I
Sbjct: 113 NTGIK-HLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGI-QEIH 170
Query: 199 SELSKLSTLIHLLVDNNNLSGNLPPE-LSELPQLCILQLDNNNFSASEIPATYGNFSKLV 257
+ + L L + +NN LP + IL + + +P+ L
Sbjct: 171 NSAFNGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHS--LPS--YGLENLK 226
Query: 258 KL-SLRNCNLQGAVPDLSRIPNLYYLDLSWN 287
KL + NL+ +P L ++ L L++
Sbjct: 227 KLRARSTYNLK-KLPTLEKLVALMEASLTYP 256
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 49.4 bits (118), Expect = 3e-06
Identities = 29/146 (19%), Positives = 47/146 (32%), Gaps = 14/146 (9%)
Query: 91 LQLLSMNLSGNLAPELGQLSRLQYYFMWNDLTGTIPKEIGNISSLI-FLLLNGNKLSGSL 149
+ + N L+ E L + N + I N + L L + N L
Sbjct: 141 IHTIERNSFVGLSFESVIL-----WLNKNGIQ-EIHNSAFNGTQLDELNLSDNNNLEELP 194
Query: 150 PDELGYLSNLNRLQVDENNITGTIPKSFANLSRVRHLHLNNNSIGGQIPSELSKLSTLIH 209
D S L + I NL ++R N ++P+ L KL L+
Sbjct: 195 NDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARSTYNLK---KLPT-LEKLVALME 250
Query: 210 LLVDNN---NLSGNLPPELSELPQLC 232
+ N ++SEL +C
Sbjct: 251 ASLTYPSHCCAFANWRRQISELHPIC 276
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 87.1 bits (216), Expect = 7e-19
Identities = 45/228 (19%), Positives = 79/228 (34%), Gaps = 43/228 (18%)
Query: 140 LNGNKLSGSLPDELGYLSNLNRLQVDENNITGTIPKSFANLSRVRHLHLNNNSIGGQIPS 199
+ L+ +LP +L + L + EN + + +R+ L+L+ +
Sbjct: 17 CDKRNLT-ALPPDL--PKDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAEL--TKLQ 71
Query: 200 ELSKLSTLIHLLVDNNNLSGNLPPELSELPQLCILQLDNNNFSASEIPATYGNFSKLVKL 259
L L L + +N L +LP LP L +L + N ++ +P G L
Sbjct: 72 VDGTLPVLGTLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLTS--LPL--GALRGLG-- 124
Query: 260 SLRNCNLQGAVPDLSRIPNLYYLDLSWNHLTGSIPS---KKLSENVTTIDLSDNYLNGSI 316
L L L N L ++P + + L++N L +
Sbjct: 125 ------------------ELQELYLKGNELK-TLPPGLLTPTP-KLEKLSLANNNLT-EL 163
Query: 317 LESI-SNLPFLQTLSLENNFLTGSIPATIWQNKSFSTKARLKIDLRNN 363
+ + L L TL L+ N L +IP + + L N
Sbjct: 164 PAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPF-----AFLHGN 205
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 67.4 bits (165), Expect = 3e-12
Identities = 47/177 (26%), Positives = 65/177 (36%), Gaps = 8/177 (4%)
Query: 89 RELQLLSMNLSGNLAPELGQLSRLQY-YFMWNDLTGTIPKEIGNISSLIFLLLNGNKLSG 147
L L L L +RL +LT + G + L L L+ N+L
Sbjct: 34 TILHLSENLLYTFSLATLMPYTRLTQLNLDRAELT-KLQ-VDGTLPVLGTLDLSHNQLQ- 90
Query: 148 SLPDELGYLSNLNRLQVDENNITGTIPKSFANLSRVRHLHLNNNSIGGQIPSELSKLSTL 207
SLP L L L V N +T + L ++ L+L N + P L+ L
Sbjct: 91 SLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKL 150
Query: 208 IHLLVDNNNLSGNLPPEL-SELPQLCILQLDNNNFSASEIPATYGNFSKLVKLSLRN 263
L + NNNL+ LP L + L L L L N+ IP + L L
Sbjct: 151 EKLSLANNNLT-ELPAGLLNGLENLDTLLLQENSLYT--IPKGFFGSHLLPFAFLHG 204
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 89.5 bits (222), Expect = 9e-19
Identities = 53/246 (21%), Positives = 88/246 (35%), Gaps = 69/246 (28%)
Query: 633 VGQGGYGKVYKGI-LSDNTTVAIKRAEEGSLQGQNEF---------LTEIKLLSRLHHRN 682
+G G YG V + + VAIK+ F L EI +L+RL+H +
Sbjct: 61 IGTGSYGHVCEAYDKLEKRVVAIKKI-------LRVFEDLIDCKRILREIAILNRLNHDH 113
Query: 683 LVSLL-----GYCDEEGEQMLVYEFVPNGTLRDWLSGRTKENLNFAMRLRVALDSA---- 733
+V +L ++ E +V E D R V L
Sbjct: 114 VVKVLDIVIPKDVEKFDELYVVLEIAD----SD---------FKKLFRTPVYLTELHIKT 160
Query: 734 ------KGILYLHTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSRLAPVLDDEGTMPT 787
G+ Y+H+ A + HRD+K +N L++ + + KV DFGL+R ++ +
Sbjct: 161 LLYNLLVGVKYVHS-AG--ILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLP 217
Query: 788 HVSTIVKGTPGYLDPEYFLTHKLTD--------------------KS-DVYSLGVVLLEL 826
L +LT ++ DV+S+G + EL
Sbjct: 218 ISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAEL 277
Query: 827 LTGMQP 832
L ++
Sbjct: 278 LNMIKE 283
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 88.3 bits (219), Expect = 1e-18
Identities = 53/259 (20%), Positives = 95/259 (36%), Gaps = 58/259 (22%)
Query: 624 TAYFSSSTQVGQGGYGKVYKGILSD-NTTVAIKRAEEGSLQGQNEFLTEIKLLSRLHHRN 682
+ +S +G G +G V + + A+K+ LQ E+ ++ L H N
Sbjct: 6 SKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKV----LQDPRYKNRELDIMKVLDHVN 61
Query: 683 LVSLLGYCDEEGEQMLVYEFVPNGTLRDWLSGRTKEN--------------LNFAMRL-- 726
++ L+ Y G++ P+ + N LN M
Sbjct: 62 IIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP 121
Query: 727 ----RVALDSAK-------------------GILYLHTEAHPPVFHRDIKASNILLDSNL 763
+V + + ++H+ + HRDIK N+L++S
Sbjct: 122 DTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLG---ICHRDIKPQNLLVNSKD 178
Query: 764 NA-KVADFGLSRLAPVLDDEGTMPTHVSTIVKGTPGYLDPEYFLT-HKLTDKSDVYSLGV 821
N K+ DFG ++ L V+ I + Y PE L + T D++S+G
Sbjct: 179 NTLKLCDFGSAK---KLIPSEPS---VAYIC--SRFYRAPELMLGATEYTPSIDLWSIGC 230
Query: 822 VLLELLTGMQPISHGKNIV 840
V EL+ G +P+ G+ +
Sbjct: 231 VFGELILG-KPLFSGETSI 248
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 89.5 bits (222), Expect = 1e-18
Identities = 55/208 (26%), Positives = 99/208 (47%), Gaps = 23/208 (11%)
Query: 633 VGQGGYGKVYKGILSDNTTV-AIKRAEEGSLQGQNEF---LTEIKLLSRLHHRNLVSLLG 688
+G+GG+G+V + + A K+ E+ ++ + L E ++L +++ R +VSL
Sbjct: 192 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSL-A 250
Query: 689 YCDEEGEQM-LVYEFVPNGTLRDWLSGRTKENLNFAMRLRVALDSAK---GILYLHTEAH 744
Y E + + LV + G L+ + + F R +A+ G+ LH E
Sbjct: 251 YAYETKDALCLVLTLMNGGDLKFHIYHMGQAG--FPEA-RAVFYAAEICCGLEDLHRER- 306
Query: 745 PPVFHRDIKASNILLDSNLNAKVADFGLSRLAPVLDDEGTMPTHVSTIVKGTPGYLDPEY 804
+ +RD+K NILLD + + +++D GL+ V + + V GT GY+ PE
Sbjct: 307 --IVYRDLKPENILLDDHGHIRISDLGLAV--HVPEGQTI-----KGRV-GTVGYMAPEV 356
Query: 805 FLTHKLTDKSDVYSLGVVLLELLTGMQP 832
+ T D ++LG +L E++ G P
Sbjct: 357 VKNERYTFSPDWWALGCLLYEMIAGQSP 384
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 87.4 bits (217), Expect = 2e-18
Identities = 62/211 (29%), Positives = 100/211 (47%), Gaps = 28/211 (13%)
Query: 633 VGQGGYGKVYKGILSDNTTV-AIKRAEEGSLQGQNEF---LTEIKLLSRLHHRNLVSLLG 688
+G+G +GKV +D + A+K + +NE E++++ L H LV+L
Sbjct: 23 IGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLW- 81
Query: 689 YCDEEGEQM-LVYEFVPNGTLRDWLS--GRTKENLNFAMRLRVA-LDSAKGILYLHTEAH 744
Y ++ E M +V + + G LR L KE ++L + L A + YL +
Sbjct: 82 YSFQDEEDMFMVVDLLLGGDLRYHLQQNVHFKEE---TVKLFICELVMA--LDYLQNQR- 135
Query: 745 PPVFHRDIKASNILLDSNLNAKVADFGLSRLAPVLDDEGTMPTHVSTIVKGTPGYLDPEY 804
+ HRD+K NILLD + + + DF ++ + P T T ++ GT Y+ PE
Sbjct: 136 --IIHRDMKPDNILLDEHGHVHITDFNIAAMLP----RETQITTMA----GTKPYMAPEM 185
Query: 805 FLTHKLT--DKS-DVYSLGVVLLELLTGMQP 832
F + K + D +SLGV ELL G +P
Sbjct: 186 FSSRKGAGYSFAVDWWSLGVTAYELLRGRRP 216
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 88.8 bits (220), Expect = 2e-18
Identities = 51/291 (17%), Positives = 104/291 (35%), Gaps = 39/291 (13%)
Query: 85 HLHVRELQLLSMNLSGNLAPELGQL---SRLQYYFMWN-DLTGTIPKEIGNIS-----SL 135
+ + L + + + +L Q ++Y ++N +T I +E S SL
Sbjct: 248 GPTLLNVTLQHIETTWKCSVKLFQFFWPRPVEYLNIYNLTITERIDREEFTYSETALKSL 307
Query: 136 IFLLLNGNKLSGSLPDELGYLSNLNRLQVDENNITGTIPKSFANLSRVRHLHLNNNSIGG 195
+ + S + +N + ++ + S L+ N
Sbjct: 308 MIEHVKNQVFLFSKEALYSVFAEMNIKMLSISDTPFIHMVCPPSPSSFTFLNFTQNVFTD 367
Query: 196 QIPSELSKLSTLIHLLVDNNNLSGNLPPELSELPQLCILQLDNNNFSASEIPATYGNFSK 255
+ S L L L++ N L N + L+ + + ++ + +
Sbjct: 368 SVFQGCSTLKRLQTLILQRNGLK-NFFKVALMTKNMSSLETLDVSLNS----LNSHAYDR 422
Query: 256 LVKLSLRNCNLQGAVPDLSRIPNLYYLDLSWNHLTGSIPSKKLSENVTTIDLSDNYLNGS 315
+ ++ L+LS N LTGS+ + L V +DL +N + S
Sbjct: 423 TCAWA----------------ESILVLNLSSNMLTGSVF-RCLPPKVKVLDLHNNRIM-S 464
Query: 316 ILESISNLPFLQTLSLENNFLTGSIPATIWQN-KSFSTKARLKIDLRNNSF 365
I + +++L LQ L++ +N L S+P ++ S I L +N +
Sbjct: 465 IPKDVTHLQALQELNVASNQLK-SVPDGVFDRLTSLQY-----IWLHDNPW 509
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 60.7 bits (147), Expect = 1e-09
Identities = 46/287 (16%), Positives = 99/287 (34%), Gaps = 43/287 (14%)
Query: 138 LLLNGNKLSGSLPDELGYLSNLNRLQVDENNITGTIPKS-FANLSRVRHLHLNNNSIGGQ 196
L L+ N +S ++ +LS L L++ N I ++ F + +L +++N +
Sbjct: 57 LSLSQNSISELRMPDISFLSELRVLRLSHNRIR-SLDFHVFLFNQDLEYLDVSHNRLQN- 114
Query: 197 IPSELSKLSTLIHLLVDNNNL-SGNLPPELSELPQLCILQLDNNNFSASEIPATYGNFSK 255
I +++L HL + N+ + E L +L L L F ++
Sbjct: 115 ISC--CPMASLRHLDLSFNDFDVLPVCKEFGNLTKLTFLGLSAAKFRQLDLLPVAHLHLS 172
Query: 256 LVKLSLRNCNLQGAVPDLSRIPNLYYLDLS------------------------------ 285
+ L L + +++G + +IPN L L
Sbjct: 173 CILLDLVSYHIKGGETESLQIPNTTVLHLVFHPNSLFSVQVNMSVNALGHLQLSNIKLND 232
Query: 286 WNHLTGSIPSKKLSENVTTIDLSDNYLNGSILESISNLPF-----LQTLSLENNFLTGSI 340
N +L+ T ++++ ++ + S+ F ++ L++ N +T I
Sbjct: 233 ENCQRLMTFLSELTRGPTLLNVTLQHIETTWKCSVKLFQFFWPRPVEYLNIYNLTITERI 292
Query: 341 PATIWQNKSFSTKARLKIDLRNNSFSNIVGDL--TLPNNVTLRLGGN 385
+ + K+ + ++N F L L +
Sbjct: 293 DREEFTYSETALKSLMIEHVKNQVFLFSKEALYSVFAEMNIKMLSIS 339
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 86.2 bits (214), Expect = 3e-18
Identities = 59/241 (24%), Positives = 104/241 (43%), Gaps = 61/241 (25%)
Query: 633 VGQGGYGKVYKGILSD-NTTVAIKRAEEGSLQGQNEFLT-----EIKLLSRLHHRNLVSL 686
+G GG G V+ + +D + VAIK+ + + EIK++ RL H N+V +
Sbjct: 19 LGCGGNGLVFSAVDNDCDKRVAIKK-----IVLTDPQSVKHALREIKIIRRLDHDNIVKV 73
Query: 687 L--------------GYCDEEGEQMLVYEFVP--------NGTLRDWLSGRTKENLNFAM 724
G E +V E++ G L +E+ M
Sbjct: 74 FEILGPSGSQLTDDVGSLTELNSVYIVQEYMETDLANVLEQGPL-------LEEHARLFM 126
Query: 725 R--LRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDS-NLNAKVADFGLSR-LAPVLD 780
LR G+ Y+H+ A+ V HRD+K +N+ +++ +L K+ DFGL+R + P
Sbjct: 127 YQLLR-------GLKYIHS-AN--VLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYS 176
Query: 781 DEGTMPTHVSTIVKGTPGYLDPEYFLT-HKLTDKSDVYSLGVVLLELLTGMQPISHGKNI 839
+G + + T Y P L+ + T D+++ G + E+LTG + + G +
Sbjct: 177 HKGHLSEGLVTK-----WYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTG-KTLFAGAHE 230
Query: 840 V 840
+
Sbjct: 231 L 231
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 86.6 bits (215), Expect = 3e-18
Identities = 66/230 (28%), Positives = 112/230 (48%), Gaps = 48/230 (20%)
Query: 633 VGQGGYGKVYKGI-LSDNTTVAIKRAEEGSLQGQNEF---------LTEIKLLSRLHHRN 682
+G+G YG V + VAIK+ + F L EIK+L R H N
Sbjct: 35 IGEGAYGMVCSAYDNLNKVRVAIKKI--------SPFEHQTYCQRTLREIKILLRFRHEN 86
Query: 683 LVSLL-----GYCDEEGEQMLVYEFVPNGT-LRDWLSGR--TKENLNFAMR--LRVALDS 732
++ + ++ + +V + + T L L + + +++ + + LR
Sbjct: 87 IIGINDIIRAPTIEQMKDVYIVQDLM--ETDLYKLLKTQHLSNDHICYFLYQILR----- 139
Query: 733 AKGILYLHTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSRLA-PVLDDEGTMPTHVST 791
G+ Y+H+ A+ V HRD+K SN+LL++ + K+ DFGL+R+A P D G + +V+T
Sbjct: 140 --GLKYIHS-AN--VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVAT 194
Query: 792 IVKGTPGYLDPEYFLTHKLTDKS-DVYSLGVVLLELLTGMQPISHGKNIV 840
Y PE L K KS D++S+G +L E+L+ +PI GK+ +
Sbjct: 195 R-----WYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSN-RPIFPGKHYL 238
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 88.4 bits (219), Expect = 4e-18
Identities = 55/224 (24%), Positives = 98/224 (43%), Gaps = 34/224 (15%)
Query: 633 VGQGGYGKVYKGILSDNTTV-AIKRAEEGSLQGQNEF---LTEIKLLSRLH---HRNLVS 685
+G+GG+G+VY +D + A+K ++ ++ + L E +LS + +V
Sbjct: 197 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVC 256
Query: 686 LLGYCDEEGEQM-LVYEFVPNGTLRDWLS--GRTKENLNFAMRLRVALDSAK---GILYL 739
+ Y +++ + + + G L LS G E + +A+ G+ ++
Sbjct: 257 M-SYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEA-------DMRFYAAEIILGLEHM 308
Query: 740 HTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSRLAPVLDDEGTMPTHVSTIVKGTPGY 799
H V +RD+K +NILLD + + +++D GL+ + V GT GY
Sbjct: 309 HNRF---VVYRDLKPANILLDEHGHVRISDLGLA----CDFSKKKPHASV-----GTHGY 356
Query: 800 LDPEYFLTHKLTDKS-DVYSLGVVLLELLTGMQPISHGKNIVRE 842
+ PE D S D +SLG +L +LL G P K +
Sbjct: 357 MAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKH 400
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 86.7 bits (215), Expect = 6e-18
Identities = 53/250 (21%), Positives = 83/250 (33%), Gaps = 64/250 (25%)
Query: 633 VGQGGYGKVYKGI-LSDNTTVAIKRAEEGSLQGQNEF---------LTEIKLLSRLHHRN 682
+G+G YG VY + VAIK+ F L EI +L+RL
Sbjct: 34 IGRGSYGYVYLAYDKNTEKNVAIKKV-------NRMFEDLIDCKRILREITILNRLKSDY 86
Query: 683 LVSLL-----GYCDEEGEQMLVYEFVPNGTLRDWLSGRTKENLNFAMRLRVALDSA---- 733
++ L + E +V E +L + + L
Sbjct: 87 IIRLYDLIIPDDLLKFDELYIVLEIAD-------------SDLKKLFKTPIFLTEEHIKT 133
Query: 734 ------KGILYLHTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSRLAPVLDDEGTMPT 787
G ++H + + HRD+K +N LL+ + + KV DFGL+R D +
Sbjct: 134 ILYNLLLGENFIHE-SG--IIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVND 190
Query: 788 HVSTIVKGTPGYLD---------------PEYFLTHKLTDKS-DVYSLGVVLLELLTGMQ 831
G PE L + KS D++S G + ELL +Q
Sbjct: 191 LEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQ 250
Query: 832 PISHGKNIVR 841
+
Sbjct: 251 SHINDPTNRF 260
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 85.5 bits (212), Expect = 7e-18
Identities = 55/229 (24%), Positives = 96/229 (41%), Gaps = 50/229 (21%)
Query: 633 VGQGGYGKVYKGI-LSDNTTVAIKRAEEGSLQGQNEF---------LTEIKLLSRLHHRN 682
VG G YG V + VAIK+ F E++LL + H N
Sbjct: 33 VGSGAYGAVCSAVDGRTGAKVAIKKL-------YRPFQSELFAKRAYRELRLLKHMRHEN 85
Query: 683 LVSLL------GYCDEEGEQMLVYEFVPNGTLRDWLSGR--TKENLNFAM--RLRVALDS 732
++ LL D+ + LV F+ L + ++ + F + L+
Sbjct: 86 VIGLLDVFTPDETLDDFTDFYLVMPFMGT-DLGKLMKHEKLGEDRIQFLVYQMLK----- 139
Query: 733 AKGILYLHTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSRLAPVLDDEGTMPTHVSTI 792
G+ Y+H A + HRD+K N+ ++ + K+ DFGL+R A + M +V T
Sbjct: 140 --GLRYIHA-AG--IIHRDLKPGNLAVNEDCELKILDFGLARQA-----DSEMTGYVVTR 189
Query: 793 VKGTPGYLDPEYFLTHKLTDKS-DVYSLGVVLLELLTGMQPISHGKNIV 840
Y PE L ++ D++S+G ++ E++TG + + G + +
Sbjct: 190 W-----YRAPEVILNWMRYTQTVDIWSVGCIMAEMITG-KTLFKGSDHL 232
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 84.3 bits (209), Expect = 2e-17
Identities = 57/229 (24%), Positives = 100/229 (43%), Gaps = 50/229 (21%)
Query: 633 VGQGGYGKVYKGILSD-NTTVAIKRAEEGSLQGQNEF---------LTEIKLLSRLHHRN 682
VG G YG V + VA+K+ F E++LL + H N
Sbjct: 37 VGSGAYGSVCAAFDTKTGLRVAVKK-------LSRPFQSIIHAKRTYRELRLLKHMKHEN 89
Query: 683 LVSLL------GYCDEEGEQMLVYEFVPNGTLRDWLSGR--TKENLNFAMR--LRVALDS 732
++ LL +E + LV + L + + + T +++ F + LR
Sbjct: 90 VIGLLDVFTPARSLEEFNDVYLVTHLMGA-DLNNIVKCQKLTDDHVQFLIYQILR----- 143
Query: 733 AKGILYLHTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSRLAPVLDDEGTMPTHVSTI 792
G+ Y+H+ A + HRD+K SN+ ++ + K+ DFGL+R M +V+T
Sbjct: 144 --GLKYIHS-AD--IIHRDLKPSNLAVNEDCELKILDFGLARHT-----ADEMTGYVATR 193
Query: 793 VKGTPGYLDPEYFLTHKLTDKS-DVYSLGVVLLELLTGMQPISHGKNIV 840
Y PE L +++ D++S+G ++ ELLTG + + G + +
Sbjct: 194 W-----YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG-RTLFPGTDHI 236
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 82.9 bits (205), Expect = 9e-17
Identities = 58/215 (26%), Positives = 95/215 (44%), Gaps = 31/215 (14%)
Query: 633 VGQGGYGKVYKGILSDNTTV-AIKRAEEGSLQGQNE---FLTEIKLLSRLHHRNLVSLLG 688
+G+G +G+V L + V A+K + + + E F E +L + + +L
Sbjct: 82 IGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLH- 140
Query: 689 YCDEEGEQM-LVYEFVPNGTLRDWLS---GRTKENLN--FAMRLRVALDSAKGILYLHTE 742
Y ++ + LV ++ G L LS R E + + + +A+D +H
Sbjct: 141 YAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAID------SVHQL 194
Query: 743 AHPPVFHRDIKASNILLDSNLNAKVADFGLSRLAPVLDDEGTMPTHVSTIVKGTPGYLDP 802
HRDIK NIL+D N + ++ADFG L ++GT+ + V GTP Y+ P
Sbjct: 195 H---YVHRDIKPDNILMDMNGHIRLADFGSCLK---LMEDGTVQSS--VAV-GTPDYISP 245
Query: 803 EYFLTHKLTDKS-----DVYSLGVVLLELLTGMQP 832
E + D +SLGV + E+L G P
Sbjct: 246 EILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETP 280
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 82.1 bits (203), Expect = 1e-16
Identities = 55/220 (25%), Positives = 84/220 (38%), Gaps = 39/220 (17%)
Query: 633 VGQGGYGKVYKGILSDNTTV-AIKRAEEGSLQGQNE---FLTEIKLLSRLHHRNLVSLLG 688
+G+G + +V + V A+K + + + E F E +L R + L
Sbjct: 69 IGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLH- 127
Query: 689 YCDEEGEQM-LVYEFVPNGTLRDWLSGRTKENLNF--------AMRLRVALDSAKGILYL 739
+ ++ + LV E+ G L LS K + +A+D +
Sbjct: 128 FAFQDENYLYLVMEYYVGGDLLTLLS---KFGERIPAEMARFYLAEIVMAID------SV 178
Query: 740 HTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSRLAPVLDDEGTMPTHVSTIVKGTPGY 799
H HRDIK NILLD + ++ADFG L +GT+ + V GTP Y
Sbjct: 179 HRLG---YVHRDIKPDNILLDRCGHIRLADFGSCL---KLRADGTVRSL--VAV-GTPDY 229
Query: 800 LDPEYFLTHKLTDKSDVY-------SLGVVLLELLTGMQP 832
L PE + Y +LGV E+ G P
Sbjct: 230 LSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTP 269
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 82.1 bits (203), Expect = 2e-16
Identities = 61/209 (29%), Positives = 98/209 (46%), Gaps = 25/209 (11%)
Query: 633 VGQGGYGKVYKGILSDNTTV-AIKRAEEGSLQGQNEF---LTEIKLLSRLHHRNLVSLLG 688
+G+G +GKV A+K ++ + ++E LTE ++L H L +L
Sbjct: 156 LGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALK- 214
Query: 689 YCDEEGEQM-LVYEFVPNGTLRDWLS--GRTKENLNFAMRLRV-ALDSAKGILYLHTEAH 744
Y + +++ V E+ G L LS E+ R R + + YLH+E +
Sbjct: 215 YSFQTHDRLCFVMEYANGGELFFHLSRERVFSED-----RARFYGAEIVSALDYLHSEKN 269
Query: 745 PPVFHRDIKASNILLDSNLNAKVADFGLSRLAPVLDDEGTMPTHVSTIVKGTPGYLDPEY 804
V +RD+K N++LD + + K+ DFGL + + D TM T GTP YL PE
Sbjct: 270 --VVYRDLKLENLMLDKDGHIKITDFGLCKEG--IKDGATMKTFC-----GTPEYLAPE- 319
Query: 805 FLTHKLTDKS-DVYSLGVVLLELLTGMQP 832
L ++ D + LGVV+ E++ G P
Sbjct: 320 VLEDNDYGRAVDWWGLGVVMYEMMCGRLP 348
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 80.5 bits (199), Expect = 4e-16
Identities = 64/246 (26%), Positives = 99/246 (40%), Gaps = 63/246 (25%)
Query: 633 VGQGGYGKVYKGI-LSDNTTVAIKRAEEGSLQGQNEF---------LTEIKLLSRLH-HR 681
+G+G YG V+K I VA+K+ + F EI +L+ L H
Sbjct: 17 LGKGAYGIVWKSIDRRTGEVVAVKKI-------FDAFQNSTDAQRTFREIMILTELSGHE 69
Query: 682 NLVSLLG--YCDEEGEQMLVYEFVPNGTLRDWLSGRTKENLNFAMRLRVALDSA------ 733
N+V+LL D + + LV++++ +L+ +R + L+
Sbjct: 70 NIVNLLNVLRADNDRDVYLVFDYME-------------TDLHAVIRANI-LEPVHKQYVV 115
Query: 734 ----KGILYLHTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSRLAPVLDDEGTMPTHV 789
K I YLH+ + HRD+K SNILL++ + KVADFGLSR +
Sbjct: 116 YQLIKVIKYLHS-GG--LLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLS 172
Query: 790 STIVKGTPGYLD--------------PEYFLTHKLTDKS-DVYSLGVVLLELLTGMQPIS 834
PE L K D++SLG +L E+L G +PI
Sbjct: 173 INENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCG-KPIF 231
Query: 835 HGKNIV 840
G + +
Sbjct: 232 PGSSTM 237
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 78.2 bits (193), Expect = 2e-15
Identities = 55/212 (25%), Positives = 97/212 (45%), Gaps = 28/212 (13%)
Query: 633 VGQGGYGKVYKGILSDNTTV-AIKRAEEGSLQGQNE---FLTEIKLLSRLHHRNLVSLLG 688
+G+G +G+V V A+K + + +++ F E +++ + +V L
Sbjct: 77 IGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLF- 135
Query: 689 YCDEEGEQM-LVYEFVPNGTLRDWLS-GRTKENLN--FAMRLRVALDSAKGILYLHTEAH 744
Y ++ + +V E++P G L + +S E + + +ALD +H+
Sbjct: 136 YAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEKWARFYTAEVVLALD------AIHSMG- 188
Query: 745 PPVFHRDIKASNILLDSNLNAKVADFGLSRLAPVLDDEGTMPTHVSTIVKGTPGYLDPEY 804
HRD+K N+LLD + + K+ADFG ++ EG + T V GTP Y+ PE
Sbjct: 189 --FIHRDVKPDNMLLDKSGHLKLADFGTCM---KMNKEGMVRCD--TAV-GTPDYISPEV 240
Query: 805 FLTHKLT---DKS-DVYSLGVVLLELLTGMQP 832
+ + D +S+GV L E+L G P
Sbjct: 241 LKSQGGDGYYGRECDWWSVGVFLYEMLVGDTP 272
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 76.8 bits (190), Expect = 3e-15
Identities = 58/215 (26%), Positives = 104/215 (48%), Gaps = 36/215 (16%)
Query: 633 VGQGGYGKVY---KGILSDNTTV-AIKRAEEGSLQGQNEF--LTEIKLLSRLHHRNLVSL 686
+GQG +GKV+ K SD + A+K ++ +L+ ++ E +L ++H +V L
Sbjct: 32 LGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKL 91
Query: 687 LGYCDEEGEQM-LVYEFVPNGTLRDWLS--GRTKENLNFAMRLR-----VALDSAKGILY 738
Y + ++ L+ +F+ G L LS E ++ +AL + +
Sbjct: 92 H-YAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEE-----DVKFYLAELAL----ALDH 141
Query: 739 LHTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSRLAPVLDDEGTMPTHVSTIVKGTPG 798
LH+ + +RD+K NILLD + K+ DFGLS+ + + ++ + GT
Sbjct: 142 LHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKES-IDHEKKA-----YSFC-GTVE 191
Query: 799 YLDPEYFLTHKLTDKS-DVYSLGVVLLELLTGMQP 832
Y+ PE + + +S D +S GV++ E+LTG P
Sbjct: 192 YMAPE-VVNRRGHTQSADWWSFGVLMFEMLTGTLP 225
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 77.9 bits (191), Expect = 7e-15
Identities = 61/368 (16%), Positives = 107/368 (29%), Gaps = 49/368 (13%)
Query: 36 TDPQEASA-------LRAIKNSLVDSMNHLRNWNKGDPCMSNWTGVLCFDTVETDGHLHV 88
TDP + SA L + V H+ + + +
Sbjct: 221 TDPNDQSAWFYHRWLLGRAEPHDVLCCVHVSREEACLSVCFSRPLTVGSRMGTLLLMVDE 280
Query: 89 RELQLLSMNLSGNLAPELGQLSRLQYYFMWNDLTGTIPKEIGNISSLIFLLLNGNKLSGS 148
L + G P L L + + L + I S +
Sbjct: 281 APLSVEWRTPDGRNRPSHVWLCDLPAASLNDQLPQHTFRVIWTGSDSQKECVLLKDRPEC 340
Query: 149 LPDELGYLSNLNRLQVDENNITGTIPKSFANLSRVRHLHLNNNSIGGQIPSELSKLSTLI 208
+ L R ++ T + + ++ L N I + L L+
Sbjct: 341 WCRDSATDEQLFRCELSVEKST-VLQSELESCKELQELEPENKWCLLTIILLMRALDPLL 399
Query: 209 HLLVDNNNLSGNLPPELSELPQLCILQLDNNNFSAS----EIPATYGNFSKLVKLSLRNC 264
+ S L + ++ + S E ++ + L L +
Sbjct: 400 YEKETLQYFS--------TLKAVDPMRAAYLDDLRSKFLLENSVLKMEYADVRVLHLAHK 451
Query: 265 NLQGAVPDLSRIPNLYYLDLSWNHLTGSIPSKKLSENVTTIDLSDNYLNGSILESISNLP 324
+L + L ++ + +LDLS N L P+ + + SDN L ++ ++NLP
Sbjct: 452 DLT-VLCHLEQLLLVTHLDLSHNRLRALPPALAALRCLEVLQASDNAL--ENVDGVANLP 508
Query: 325 FLQTLSLENNFLTGSIPATIWQNKSFSTKARLKIDLRNNSFSNIVGDLTLPNNVTLRLGG 384
LQ L L NN L + I ++ P V L L G
Sbjct: 509 RLQELLLCNNRLQ--------------------------QSAAIQPLVSCPRLVLLNLQG 542
Query: 385 NPICTSAN 392
N +C
Sbjct: 543 NSLCQEEG 550
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 54.8 bits (131), Expect = 1e-07
Identities = 40/299 (13%), Positives = 89/299 (29%), Gaps = 41/299 (13%)
Query: 128 EIGNISSLIFLLLNGNKLSGSLPDELGYLSNLNRLQVDENNITGTIPKSFANLSRVRHLH 187
E ++ + + LS L S + L + + ++ +
Sbjct: 240 EPHDVLCCVHVSREEACLSVCFSRPLTVGSRMGTLLLMVDEAPLSVEWRTPDGRNRPSHV 299
Query: 188 LNNNSIGGQIPSELSKLSTLIHLLVDNNNLSGNL--------PPELSELPQLCILQLDNN 239
+ + +L + + + ++ L + + QL + + +
Sbjct: 300 WLCDLPAASLNDQLPQHTFRVIWTGSDSQKECVLLKDRPECWCRDSATDEQL--FRCELS 357
Query: 240 NFSASEIPATYGNFSKLVKLSLRN--------------CNLQGAVPDLSRIPNLYYLDLS 285
++ + + + +L +L N L L L +D
Sbjct: 358 VEKSTVLQSELESCKELQELEPENKWCLLTIILLMRALDPLLYEKETLQYFSTLKAVDPM 417
Query: 286 W---------NHLTGSIPSKKLSENVTTIDLSDNYLNGSILESISNLPFLQTLSLENNFL 336
L + K +V + L+ L ++L + L + L L +N L
Sbjct: 418 RAAYLDDLRSKFLLENSVLKMEYADVRVLHLAHKDL--TVLCHLEQLLLVTHLDLSHNRL 475
Query: 337 TGSIPATIWQNKSFSTKARLKIDLRNNSFSNIVGDLTLPNNVTLRLGGNPICTSANIPN 395
++P + + + +N+ N+ G LP L L N + SA I
Sbjct: 476 R-ALPPALAALRCLEV-----LQASDNALENVDGVANLPRLQELLLCNNRLQQSAAIQP 528
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 75.3 bits (186), Expect = 1e-14
Identities = 60/209 (28%), Positives = 94/209 (44%), Gaps = 26/209 (12%)
Query: 633 VGQGGYGKVYKGILSDNTTV-AIKRAEEGSLQGQNEF---LTEIKLLSRLHHRNLVSLLG 688
+G+G +GKV A+K + + ++E +TE ++L H L +L
Sbjct: 13 LGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALK- 71
Query: 689 YCDEEGEQM-LVYEFVPNGTLRDWLS--GRTKENLNFAMRLRV-ALDSAKGILYLHTEAH 744
Y + +++ V E+ G L LS E R R + + YLH+
Sbjct: 72 YAFQTHDRLCFVMEYANGGELFFHLSRERVFTEE-----RARFYGAEIVSALEYLHSRD- 125
Query: 745 PPVFHRDIKASNILLDSNLNAKVADFGLSRLAPVLDDEGTMPTHVSTIVKGTPGYLDPEY 804
V +RDIK N++LD + + K+ DFGL + + D TM T GTP YL PE
Sbjct: 126 --VVYRDIKLENLMLDKDGHIKITDFGLCKEG--ISDGATMKTFC-----GTPEYLAPE- 175
Query: 805 FLTHKLTDKS-DVYSLGVVLLELLTGMQP 832
L ++ D + LGVV+ E++ G P
Sbjct: 176 VLEDNDYGRAVDWWGLGVVMYEMMCGRLP 204
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 75.3 bits (186), Expect = 1e-14
Identities = 54/217 (24%), Positives = 102/217 (47%), Gaps = 38/217 (17%)
Query: 633 VGQGGYGKVY---KGILSDNTTV-AIKRAEEGSL-QGQNEF---LTEIKLLSRLHHRNLV 684
+G+GGYGKV+ K ++ + A+K ++ + + + E +L + H +V
Sbjct: 25 LGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIV 84
Query: 685 SLLGYCDEEGEQM-LVYEFVPNGTLRDWLS--GRTKENLNFAMRLR-----VALDSAKGI 736
L+ Y + G ++ L+ E++ G L L G E+ +++ +
Sbjct: 85 DLI-YAFQTGGKLYLILEYLSGGELFMQLEREGIFMED-----TACFYLAEISM----AL 134
Query: 737 LYLHTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSRLAPVLDDEGTMPTHVSTIVKGT 796
+LH + + +RD+K NI+L+ + K+ DFGL + + + D T T GT
Sbjct: 135 GHLHQKG---IIYRDLKPENIMLNHQGHVKLTDFGLCKES-IHDGTVT-----HTFC-GT 184
Query: 797 PGYLDPEYFLTHKLTDKS-DVYSLGVVLLELLTGMQP 832
Y+ PE L +++ D +SLG ++ ++LTG P
Sbjct: 185 IEYMAPE-ILMRSGHNRAVDWWSLGALMYDMLTGAPP 220
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 73.5 bits (181), Expect = 1e-14
Identities = 48/220 (21%), Positives = 76/220 (34%), Gaps = 30/220 (13%)
Query: 133 SSLIFLLLNGNKLSGSLPDELGYLSNLNRLQVDENNITGTIP-KSFANLSRVRHLHLNNN 191
S L L L L N++R+ V + + SF NLS+V H+ + N
Sbjct: 31 PSTQTLKLIETHLRTIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNT 90
Query: 192 SIGGQIPSE-LSKLSTLIHLLVDNNNLSGNLPPE--LSELPQLCILQLDNNNFSASEIPA 248
I + L +L L L + N L P + IL++ +N + S IP
Sbjct: 91 RNLTYIDPDALKELPLLKFLGIFNTGLK-MFPDLTKVYSTDIFFILEITDNPYMTS-IPV 148
Query: 249 TYGNFSKLVK----LSLRNCNLQGAVPDLS-RIPNLYYLDLSWNHLTGSIPS---KKLSE 300
F L L L N +V + L + L+ N I +
Sbjct: 149 --NAFQGLCNETLTLKLYNNGFT-SVQGYAFNGTKLDAVYLNKNKYLTVIDKDAFGGVYS 205
Query: 301 NVTTIDLSDNYLNGSILESISNLPF-----LQTLSLENNF 335
+ +D+S S++ LP L+ L N +
Sbjct: 206 GPSLLDVSQT--------SVTALPSKGLEHLKELIARNTW 237
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 72.7 bits (179), Expect = 2e-14
Identities = 40/207 (19%), Positives = 78/207 (37%), Gaps = 24/207 (11%)
Query: 156 LSNLNRLQVDENNITGTIPK-SFANLSRVRHLHLNNNSIGGQIPSEL-SKLSTLIHLLVD 213
+ L++ E ++ TIP +F+NL + ++++ + Q+ S LS + H+ +
Sbjct: 30 PPSTQTLKLIETHLR-TIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIR 88
Query: 214 NNNLSGNLPPE-LSELPQLCILQLDNNNFSASEIPATYGNFS--KLVKLSLRNCNLQGAV 270
N + P+ L ELP L L + N P +S L + + ++
Sbjct: 89 NTRNLTYIDPDALKELPLLKFLGIFNTGL--KMFPDLTKVYSTDIFFILEITDNPYMTSI 146
Query: 271 PD--LSRIPN-LYYLDLSWNHLTGSIPSKKLSE-NVTTIDLSDNYLNGSILESISNLPF- 325
P + N L L N T S+ + + + L+ N L I F
Sbjct: 147 PVNAFQGLCNETLTLKLYNNGFT-SVQGYAFNGTKLDAVYLNKN----KYLTVIDKDAFG 201
Query: 326 -----LQTLSLENNFLTGSIPATIWQN 347
L + +T ++P+ ++
Sbjct: 202 GVYSGPSLLDVSQTSVT-ALPSKGLEH 227
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 74.3 bits (183), Expect = 2e-14
Identities = 52/229 (22%), Positives = 83/229 (36%), Gaps = 46/229 (20%)
Query: 613 KGFKFKELAMATAYFSSSTQVGQGGYGKVYKGI-LSDNTTVAIKRAEEGSLQGQNEFLTE 671
G + K+ A+ Y +S +G G GKV + A+K LQ + E
Sbjct: 6 SGLQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALK-----MLQDCPKARRE 60
Query: 672 IKLLSRL-HHRNLVSLLG-YCDEEGEQMLVY---EFVPNGTLRDWLSGRTKENLNFAMRL 726
++L R ++V ++ Y + + + E + G L + R +
Sbjct: 61 VELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREAS 120
Query: 727 RVALDSAKGILYLHTEAHPPVFHRDIKASNILLDS---NLNAKVADFGLSRLAPVLDDEG 783
+ + I YLH+ + HRD+K N+L S N K+ DFG A E
Sbjct: 121 EIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFG---FAKETTGE- 173
Query: 784 TMPTHVSTIVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVLLELLTGMQP 832
Y D D++SLGV++ LL G P
Sbjct: 174 --------------KY-DKS----------CDMWSLGVIMYILLCGYPP 197
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 75.3 bits (185), Expect = 2e-14
Identities = 42/159 (26%), Positives = 68/159 (42%), Gaps = 14/159 (8%)
Query: 94 LSMNLSGNLAPE--LGQLSRLQY-YFMWNDLTGTIPKEI-GNISSLIFLLLNGNKLSGSL 149
LS N L E +L+ L N L I E + +L +L L+ N L +L
Sbjct: 46 LSHNNLSRLRAEWTPTRLTNLHSLLLSHNHLN-FISSEAFVPVPNLRYLDLSSNHLH-TL 103
Query: 150 PDE-LGYLSNLNRLQVDENNITGTIPKSFANLSRVRHLHLNNNSIGGQIPSE----LSKL 204
+ L L L + N+I +F ++++++ L+L+ N I + P E +KL
Sbjct: 104 DEFLFSDLQALEVLLLYNNHIVVVDRNAFEDMAQLQKLYLSQNQI-SRFPVELIKDGNKL 162
Query: 205 STLIHLLVDNNNLSGNLPPELSELPQLC--ILQLDNNNF 241
L+ L + +N L +L +LP L L NN
Sbjct: 163 PKLMLLDLSSNKLKKLPLTDLQKLPAWVKNGLYLHNNPL 201
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 74.9 bits (184), Expect = 2e-14
Identities = 42/177 (23%), Positives = 73/177 (41%), Gaps = 20/177 (11%)
Query: 220 NLPPELSELPQLCILQLDNNNFSASEIPATYGNFSKLVKLSLRNCNLQGAVPD--LSRIP 277
+LP + L L +NN S T + L L L + +L + +P
Sbjct: 36 SLPSYTALL------DLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHLN-FISSEAFVPVP 88
Query: 278 NLYYLDLSWNHLTGSIPSKKLS--ENVTTIDLSDNYLNGSILESI-SNLPFLQTLSLENN 334
NL YLDLS NHL ++ S + + + L +N++ + + ++ LQ L L N
Sbjct: 89 NLRYLDLSSNHLH-TLDEFLFSDLQALEVLLLYNNHIV-VVDRNAFEDMAQLQKLYLSQN 146
Query: 335 FLTGSIPATIWQNKSFSTKARLKIDLRNNSFSNI----VGDLTLPNNVTLRLGGNPI 387
++ P + ++ + K L +DL +N + + L L L NP+
Sbjct: 147 QIS-RFPVELIKDGNKLPKLML-LDLSSNKLKKLPLTDLQKLPAWVKNGLYLHNNPL 201
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 75.0 bits (185), Expect = 2e-14
Identities = 51/209 (24%), Positives = 92/209 (44%), Gaps = 29/209 (13%)
Query: 633 VGQGGYGKVYKGILSDNTTV-AIKRAEEGSLQGQNEF---LTEIKLLSRLHHRNLVSLLG 688
+G G +G+V ++ A+K ++ + + L E ++L ++ LV L
Sbjct: 49 LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 108
Query: 689 YCDEEGEQMLVYEFVPNGTLRDWL--SGRTKENLN--FAMRLRVALDSAKGILYLHTEAH 744
+ +V E+V G + L GR E +A ++ + + YLH+
Sbjct: 109 SFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFE------YLHSLD- 161
Query: 745 PPVFHRDIKASNILLDSNLNAKVADFGLSRLAPVLDDEGTMPTHVSTIVKGTPGYLDPEY 804
+ +RD+K N+L+D +V DFG ++ T T+ GTP L PE
Sbjct: 162 --LIYRDLKPENLLIDQQGYIQVTDFGFAK----RVKGRTW-----TLC-GTPEALAPE- 208
Query: 805 FLTHKLTDKS-DVYSLGVVLLELLTGMQP 832
+ K +K+ D ++LGV++ E+ G P
Sbjct: 209 IILSKGYNKAVDWWALGVLIYEMAAGYPP 237
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 73.1 bits (180), Expect = 3e-14
Identities = 52/188 (27%), Positives = 89/188 (47%), Gaps = 19/188 (10%)
Query: 157 SNLNRLQVDENNITGTIPKSFANLSRVRHLHLNNNSIGGQIPSEL-SKLSTLIHLLVDNN 215
++ +L + N ++ K+F L+++R L+LN+N + +P+ + +L L L V +N
Sbjct: 37 ADTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKL-QTLPAGIFKELKNLETLWVTDN 95
Query: 216 NLSGNLPPEL-SELPQLCILQLDNNNFSASEIPATYGNFSKLVK---LSLRNCNLQGAVP 271
L LP + +L L L+LD N + +P F L K LSL LQ ++P
Sbjct: 96 KLQ-ALPIGVFDQLVNLAELRLDRNQLKS--LPP--RVFDSLTKLTYLSLGYNELQ-SLP 149
Query: 272 D--LSRIPNLYYLDLSWNHLTGSIPS---KKLSENVTTIDLSDNYLNGSILESISNLPFL 326
++ +L L L N L +P KL+ + T+ L +N L + +L L
Sbjct: 150 KGVFDKLTSLKELRLYNNQLK-RVPEGAFDKLT-ELKTLKLDNNQLKRVPEGAFDSLEKL 207
Query: 327 QTLSLENN 334
+ L L+ N
Sbjct: 208 KMLQLQEN 215
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 65.8 bits (161), Expect = 8e-12
Identities = 57/203 (28%), Positives = 87/203 (42%), Gaps = 30/203 (14%)
Query: 197 IPSELSKLSTLIHLLVDNNNLSGNLPPE-LSELPQLCILQLDNNNFSASEIPATYGNFSK 255
IPS + + L + +N LS +LP + L +L +L L++N +PA G F +
Sbjct: 31 IPSNIP--ADTKKLDLQSNKLS-SLPSKAFHRLTKLRLLYLNDNKLQT--LPA--GIFKE 83
Query: 256 LVKL---SLRNCNLQGAVPD--LSRIPNLYYLDLSWNHLTGSIPSK---KLSENVTTIDL 307
L L + + LQ A+P ++ NL L L N L S+P + L+ +T + L
Sbjct: 84 LKNLETLWVTDNKLQ-ALPIGVFDQLVNLAELRLDRNQLK-SLPPRVFDSLT-KLTYLSL 140
Query: 308 SDNYLNGSILESI-SNLPFLQTLSLENNFLTGSIPATIWQNKSFSTKARLKI-DLRNNSF 365
N L S+ + + L L+ L L NN L +P F LK L NN
Sbjct: 141 GYNELQ-SLPKGVFDKLTSLKELRLYNNQLK-RVPEGA-----FDKLTELKTLKLDNNQL 193
Query: 366 SNIVGDL--TLPNNVTLRLGGNP 386
+ +L L+L NP
Sbjct: 194 KRVPEGAFDSLEKLKMLQLQENP 216
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 47.7 bits (114), Expect = 7e-06
Identities = 28/111 (25%), Positives = 49/111 (44%), Gaps = 5/111 (4%)
Query: 108 QLSRLQY-YFMWNDLTGTIPKEI-GNISSLIFLLLNGNKLSGSLPDEL-GYLSNLNRLQV 164
QL L N L ++P + +++ L +L L N+L SLP + L++L L++
Sbjct: 107 QLVNLAELRLDRNQLK-SLPPRVFDSLTKLTYLSLGYNELQ-SLPKGVFDKLTSLKELRL 164
Query: 165 DENNITGTIPKSFANLSRVRHLHLNNNSIGGQIPSELSKLSTLIHLLVDNN 215
N + +F L+ ++ L L+NN + L L L + N
Sbjct: 165 YNNQLKRVPEGAFDKLTELKTLKLDNNQLKRVPEGAFDSLEKLKMLQLQEN 215
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 74.3 bits (182), Expect = 1e-13
Identities = 56/210 (26%), Positives = 99/210 (47%), Gaps = 27/210 (12%)
Query: 633 VGQGGYGKVYKGILSDNTTV-AIKRAEEGSLQGQNEF---LTEIKLLSR-LHHRNLVSLL 687
+G+G +GKV + A+K ++ + ++ + E ++L+ L L
Sbjct: 349 LGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLH 408
Query: 688 GYCDEEGEQM-LVYEFVPNGTLRDWLS--GRTKENLNFAMRLRV-ALDSAKGILYLHTEA 743
C + +++ V E+V G L + GR KE A + A G+ +L ++
Sbjct: 409 -SCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEP-----HAVFYAAEIAIGLFFLQSKG 462
Query: 744 HPPVFHRDIKASNILLDSNLNAKVADFGLSRLAPVLDDEGTMPTHVSTIVKGTPGYLDPE 803
+ +RD+K N++LDS + K+ADFG+ + + D T T GTP Y+ PE
Sbjct: 463 ---IIYRDLKLDNVMLDSEGHIKIADFGMCKEN-IWDGVTT-----KTFC-GTPDYIAPE 512
Query: 804 YFLTHKLTDKS-DVYSLGVVLLELLTGMQP 832
+ ++ KS D ++ GV+L E+L G P
Sbjct: 513 -IIAYQPYGKSVDWWAFGVLLYEMLAGQAP 541
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 71.8 bits (177), Expect = 1e-13
Identities = 54/209 (25%), Positives = 100/209 (47%), Gaps = 29/209 (13%)
Query: 633 VGQGGYGKVYKGILSDNTTV-AIKRAEEGSLQGQNEF---LTEIKLLSRLHHRNLVSLLG 688
+G G +G+V+ N A+K ++ + + E +LS + H ++ + G
Sbjct: 14 LGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWG 73
Query: 689 YCDEEGEQMLVYEFVPNGTLRDWL--SGRTKENLN--FAMRLRVALDSAKGILYLHTEAH 744
+ + ++ +++ G L L S R + +A + +AL+ YLH++
Sbjct: 74 TFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALE------YLHSKD- 126
Query: 745 PPVFHRDIKASNILLDSNLNAKVADFGLSRLAPVLDDEGTMPTHVSTIVKGTPGYLDPEY 804
+ +RD+K NILLD N + K+ DFG ++ + T T+ GTP Y+ PE
Sbjct: 127 --IIYRDLKPENILLDKNGHIKITDFGFAK----YVPDVT-----YTLC-GTPDYIAPE- 173
Query: 805 FLTHKLTDKS-DVYSLGVVLLELLTGMQP 832
++ K +KS D +S G+++ E+L G P
Sbjct: 174 VVSTKPYNKSIDWWSFGILIYEMLAGYTP 202
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 69.9 bits (172), Expect = 7e-13
Identities = 59/217 (27%), Positives = 100/217 (46%), Gaps = 41/217 (18%)
Query: 633 VGQGGYGKV----YKGILSDNTTVAIKRAEEGSLQGQNEF---LTEIKLLSR-LHHRNLV 684
+G+G +GKV +K N AIK ++ + ++ + E ++LS H L
Sbjct: 25 LGKGSFGKVFLAEFKK---TNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLT 81
Query: 685 SLLGYCDEEGEQM-LVYEFVPNGTLRDWLS--GRTKENLNFAMRLR-----VALDSAKGI 736
+ + E + V E++ G L + + + R + L G+
Sbjct: 82 HMF-CTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLS-----RATFYAAEIIL----GL 131
Query: 737 LYLHTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSRLAPVLDDEGTMPTHVSTIVKGT 796
+LH++ + +RD+K NILLD + + K+ADFG+ + +L D T +T GT
Sbjct: 132 QFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCKEN-MLGDAKT-----NTFC-GT 181
Query: 797 PGYLDPEYFLTHKLTDKS-DVYSLGVVLLELLTGMQP 832
P Y+ PE L + + S D +S GV+L E+L G P
Sbjct: 182 PDYIAPE-ILLGQKYNHSVDWWSFGVLLYEMLIGQSP 217
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 70.0 bits (172), Expect = 7e-13
Identities = 62/216 (28%), Positives = 101/216 (46%), Gaps = 32/216 (14%)
Query: 633 VGQGGYGKVY---KGILSDNTTV-AIKRAEEGSLQGQNEF----LTEIKLLSRL-HHRNL 683
+G G YGKV+ K D + A+K ++ ++ + + TE ++L + L
Sbjct: 62 LGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFL 121
Query: 684 VSLLGYCDEEGEQM-LVYEFVPNGTLRDWLS--GRTKENLN--FAMRLRVALDSAKGILY 738
V+L Y + ++ L+ +++ G L LS R E+ + + +AL+ +
Sbjct: 122 VTLH-YAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALE------H 174
Query: 739 LHTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSRLAPVLDDEGTMPTHVSTIVKGTPG 798
LH + +RDIK NILLDSN + + DFGLS+ + E GT
Sbjct: 175 LHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERA-----YDFC-GTIE 225
Query: 799 YLDPEYFLTHKL-TDKS-DVYSLGVVLLELLTGMQP 832
Y+ P+ DK+ D +SLGV++ ELLTG P
Sbjct: 226 YMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASP 261
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 70.4 bits (173), Expect = 1e-12
Identities = 61/352 (17%), Positives = 118/352 (33%), Gaps = 60/352 (17%)
Query: 93 LLSMNLSGN---------LAPELGQLSRLQYYFMWNDLTGTIPKEIGNI----SSLIFLL 139
+ S+++ L P L Q ++ LT K+I + +L L
Sbjct: 5 IQSLDIQCEELSDARWAELLPLLQQCQVVR--LDDCGLTEARCKDISSALRVNPALAELN 62
Query: 140 LNGNKLSGS----LPDELGYLS-NLNRLQVDENNITGT----IPKSFANLSRVRHLHLNN 190
L N+L + L S + +L + +TG + + L ++ LHL++
Sbjct: 63 LRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSD 122
Query: 191 NSIGGQ-----IPSELSKLSTLIHLLVDNNNLS----GNLPPELSELPQLCILQLDNNNF 241
N +G L L L ++ +LS L L P L + NN+
Sbjct: 123 NLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEPLASVLRAKPDFKELTVSNNDI 182
Query: 242 SASEI----PATYGNFSKLVKLSLRNCNL--QGAV---PDLSRIPNLYYLDLSWNHLTGS 292
+ + + + +L L L +C + ++ +L L L N L G
Sbjct: 183 NEAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDLCGIVASKASLRELALGSNKL-GD 241
Query: 293 IPSKKLSE-------NVTTIDLSDNYLN----GSILESISNLPFLQTLSLENNFLTGSIP 341
+ +L + T+ + + + G + + L+ LSL N L
Sbjct: 242 VGMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGA 301
Query: 342 ATIWQNKSFSTKARLKIDLRNNSFSNI-VGDLT--LPNNVTLR---LGGNPI 387
+ + + +++ SF+ + L N L + N +
Sbjct: 302 RLLCETLLEPGCQLESLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRL 353
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 64.2 bits (157), Expect = 1e-10
Identities = 46/273 (16%), Positives = 94/273 (34%), Gaps = 39/273 (14%)
Query: 133 SSLIFLLLNGNKLSGS----LPDELGY-LSNLNRLQVDENNIT----GTIPKSFANLSRV 183
L ++ N ++ + L L L L+++ +T + A+ + +
Sbjct: 170 PDFKELTVSNNDINEAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDLCGIVASKASL 229
Query: 184 RHLHLNNNSIGGQ-----IPSELSKLSTLIHLLVDNNNLS----GNLPPELSELPQLCIL 234
R L L +N +G P L S L L + ++ G+L L L L
Sbjct: 230 RELALGSNKLGDVGMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKEL 289
Query: 235 QLDNNNFSASEI----PATYGNFSKLVKLSLRNCNL--QGAV---PDLSRIPNLYYLDLS 285
L N +L L +++C+ L++ L L +S
Sbjct: 290 SLAGNELGDEGARLLCETLLEPGCQLESLWVKSCSFTAACCSHFSSVLAQNRFLLELQIS 349
Query: 286 WNHLTGSIPSKKLSE-------NVTTIDLSDNYLN----GSILESISNLPFLQTLSLENN 334
N L + ++L + + + L+D ++ S+ ++ L+ L L NN
Sbjct: 350 NNRLEDAG-VRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNN 408
Query: 335 FLTGSIPATIWQNKSFSTKARLKIDLRNNSFSN 367
L + + ++ ++ L + +S
Sbjct: 409 CLGDAGILQLVESVRQPGCLLEQLVLYDIYWSE 441
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 55.0 bits (133), Expect = 8e-08
Identities = 59/292 (20%), Positives = 99/292 (33%), Gaps = 49/292 (16%)
Query: 87 HVRELQLLSMNLSGNLAPELGQL-----SRLQY-YFMWNDLTGTIPKEIGNI----SSLI 136
+EL + + +++ L Q +L+ +T +++ I +SL
Sbjct: 171 DFKELTVSNNDINEAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDLCGIVASKASLR 230
Query: 137 FLLLNGNKLSGS-----LPDELGYLSNLNRLQVDENNIT----GTIPKSFANLSRVRHLH 187
L L NKL P L S L L + E IT G + + ++ L
Sbjct: 231 ELALGSNKLGDVGMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELS 290
Query: 188 LNNNSIGGQIPSELSKL-----STLIHLLVDNNNLSGNLPPELSEL----PQLCILQLDN 238
L N +G + L + L L V + + + S + L LQ+ N
Sbjct: 291 LAGNELGDEGARLLCETLLEPGCQLESLWVKSCSFTAACCSHFSSVLAQNRFLLELQISN 350
Query: 239 NNFS---ASEI-PATYGNFSKLVKLSLRNCNL--QGAVP---DLSRIPNLYYLDLSWNHL 289
N E+ S L L L +C++ L +L LDLS N L
Sbjct: 351 NRLEDAGVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCL 410
Query: 290 TGSIPSKKLSE-------NVTTIDLSDNYLN----GSILESISNLPFLQTLS 330
+ +L E + + L D Y + + + P L+ +S
Sbjct: 411 GDAG-ILQLVESVRQPGCLLEQLVLYDIYWSEEMEDRLQALEKDKPSLRVIS 461
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 69.6 bits (171), Expect = 1e-12
Identities = 57/215 (26%), Positives = 101/215 (46%), Gaps = 37/215 (17%)
Query: 633 VGQGGYGKV----YKGILSDNTTVAIKRAEEGSLQGQNEF---LTEIKLLSR-LHHRNLV 684
+G+G +GKV KG + A+K ++ + ++ + E ++L+ L
Sbjct: 28 LGKGSFGKVMLSERKG---TDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLT 84
Query: 685 SLLGYCDEEGEQM-LVYEFVPNGTLRDWLS--GRTKENLNFAMRLRVALDSAK---GILY 738
L C + +++ V E+V G L + GR KE +A+ G+ +
Sbjct: 85 QLH-SCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEP-------HAVFYAAEIAIGLFF 136
Query: 739 LHTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSRLAPVLDDEGTMPTHVSTIVKGTPG 798
L ++ + +RD+K N++LDS + K+ADFG+ + + D T T GTP
Sbjct: 137 LQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKEN-IWDGVTT-----KTFC-GTPD 186
Query: 799 YLDPEYFLTHKLTDKS-DVYSLGVVLLELLTGMQP 832
Y+ PE + ++ KS D ++ GV+L E+L G P
Sbjct: 187 YIAPE-IIAYQPYGKSVDWWAFGVLLYEMLAGQAP 220
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 69.0 bits (169), Expect = 2e-12
Identities = 66/315 (20%), Positives = 120/315 (38%), Gaps = 60/315 (19%)
Query: 634 GQGGYGKVYKGI-LSDNTTVAIK--RAEEGSLQGQNEFLTEIKLLSRLH----------- 679
G G + V+ + +NT VA+K R ++ EIKLL R++
Sbjct: 28 GWGHFSTVWLAKDMVNNTHVAMKIVRGDK---VYTEAAEDEIKLLQRVNDADNTKEDSMG 84
Query: 680 HRNLVSLLG---YCDEEGEQM-LVYEFV-PNGTLRDWLSGRTKENLNFAMRLRVALDSAK 734
+++ LL + G + +V+E + N L + K+ + + L +K
Sbjct: 85 ANHILKLLDHFNHKGPNGVHVVMVFEVLGEN--LLALI----KKYEHRGIPLIYVKQISK 138
Query: 735 GIL----YLHTEAHPPVFHRDIKASNILLD------SNLNAKVADFGLSRLAPVLDDEGT 784
+L Y+H + H DIK N+L++ + + K+AD G + DE
Sbjct: 139 QLLLGLDYMHRRCG--IIHTDIKPENVLMEIVDSPENLIQIKIADLGNACW----YDE-- 190
Query: 785 MPTHVSTIVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVLLELLTGMQPISHGKNIVREVN 844
H + ++ T Y PE L +D++S ++ EL+TG + +
Sbjct: 191 ---HYTNSIQ-TREYRSPEVLLGAPWGCGADIWSTACLIFELITG-DFLFEPDE---GHS 242
Query: 845 VARDSGMVFSIIDNRMGSYPSECVERFVTLALRCCHDKPEHRPSMSDVVRELENILKMFP 904
+D + II+ +G PS + + + R LE++L
Sbjct: 243 YTKDDDHIAQIIE-LLGELPSYLLRN-GKYTRTFFNSRGLLRNISKLKFWPLEDVLT--- 297
Query: 905 ETDTMFSKSESSSLL 919
FSK E+ +
Sbjct: 298 -EKYKFSKDEAKEIS 311
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 68.4 bits (168), Expect = 2e-12
Identities = 58/246 (23%), Positives = 101/246 (41%), Gaps = 35/246 (14%)
Query: 633 VGQGGYGKVY----KGILSDNTTVAIKRAEEGSLQGQNEF---LTEIKLLSR-LHHRNLV 684
+G+G Y KV K + A+K ++ + + TE + + +H LV
Sbjct: 17 IGRGSYAKVLLVRLKK---TDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLV 73
Query: 685 SLLGYCDE-EGEQMLVYEFVPNGTLRDWLS--GRTKENLNFAMRLRV-ALDSAKGILYLH 740
L C + E V E+V G L + + E R + + + + YLH
Sbjct: 74 GLH-SCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEE-----HARFYSAEISLALNYLH 127
Query: 741 TEAHPPVFHRDIKASNILLDSNLNAKVADFGLSRLAPVLDDEGTMPTHVSTIVKGTPGYL 800
+ +RD+K N+LLDS + K+ D+G+ + + + T ST GTP Y+
Sbjct: 128 ERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEG-LRPGDTT-----STFC-GTPNYI 177
Query: 801 DPEYFLTHKLTDKS-DVYSLGVVLLELLTGMQPISHGKNIVREVNVARDSGMVFSIIDNR 859
PE L + S D ++LGV++ E++ G P + + +F +I +
Sbjct: 178 APE-ILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGS--SDNPDQNTEDYLFQVILEK 234
Query: 860 MGSYPS 865
P
Sbjct: 235 QIRIPR 240
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 68.4 bits (168), Expect = 3e-12
Identities = 59/214 (27%), Positives = 99/214 (46%), Gaps = 35/214 (16%)
Query: 633 VGQGGYGKVY----KGILSDNTTVAIKRAEEGSLQGQNEF---LTEIKLLSR-LHHRNLV 684
+G+G +GKV K A+K ++ + ++ +TE ++LS +H L
Sbjct: 31 LGKGSFGKVMLARVKE---TGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLT 87
Query: 685 SLLGYCDEEGEQM-LVYEFVPNGTLRDWLS--GRTKENLN--FAMRLRVALDSAKGILYL 739
L C + +++ V EFV G L + R E +A + AL +L
Sbjct: 88 QLF-CCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEIISALM------FL 140
Query: 740 HTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSRLAPVLDDEGTMPTHVSTIVKGTPGY 799
H + + +RD+K N+LLD + K+ADFG+ + + + T +T GTP Y
Sbjct: 141 HDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCKEG-ICNGVTT-----ATFC-GTPDY 190
Query: 800 LDPEYFLTHKLTDKS-DVYSLGVVLLELLTGMQP 832
+ PE L L + D +++GV+L E+L G P
Sbjct: 191 IAPE-ILQEMLYGPAVDWWAMGVLLYEMLCGHAP 223
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 67.8 bits (166), Expect = 5e-12
Identities = 57/246 (23%), Positives = 101/246 (41%), Gaps = 35/246 (14%)
Query: 633 VGQGGYGKVY----KGILSDNTTVAIKRAEEGSLQGQNEF---LTEIKLLSR-LHHRNLV 684
+G+G Y KV K + A++ ++ + + TE + + +H LV
Sbjct: 60 IGRGSYAKVLLVRLKK---TDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLV 116
Query: 685 SLLGYCDE-EGEQMLVYEFVPNGTLRDWLS--GRTKENLNFAMRLRV-ALDSAKGILYLH 740
L C + E V E+V G L + + E R + + + + YLH
Sbjct: 117 GLH-SCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEE-----HARFYSAEISLALNYLH 170
Query: 741 TEAHPPVFHRDIKASNILLDSNLNAKVADFGLSRLAPVLDDEGTMPTHVSTIVKGTPGYL 800
+ +RD+K N+LLDS + K+ D+G+ + EG P ++ GTP Y+
Sbjct: 171 ERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCK-------EGLRPGDTTSTFCGTPNYI 220
Query: 801 DPEYFLTHKLTDKS-DVYSLGVVLLELLTGMQPISHGKNIVREVNVARDSGMVFSIIDNR 859
PE L + S D ++LGV++ E++ G P + + +F +I +
Sbjct: 221 APE-ILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGS--SDNPDQNTEDYLFQVILEK 277
Query: 860 MGSYPS 865
P
Sbjct: 278 QIRIPR 283
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 66.9 bits (164), Expect = 9e-12
Identities = 60/214 (28%), Positives = 97/214 (45%), Gaps = 35/214 (16%)
Query: 633 VGQGGYGKVYKGILSDNTTV-AIKRAEEGSLQGQNEF---LTEIK-LLSRLHHRNLVSLL 687
+G+G +GKV A+K ++ ++ + E ++E LL + H LV L
Sbjct: 46 IGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLH 105
Query: 688 GYCDEEGEQM-LVYEFVPNGTLRDWLS--GRTKENLNFAMRLR-----VALDSAKGILYL 739
+ + +++ V +++ G L L E R R +A + YL
Sbjct: 106 -FSFQTADKLYFVLDYINGGELFYHLQRERCFLEP-----RARFYAAEIAS----ALGYL 155
Query: 740 HTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSRLAPVLDDEGTMPTHVSTIVKGTPGY 799
H+ + +RD+K NILLDS + + DFGL + + + T ST GTP Y
Sbjct: 156 HSLN---IVYRDLKPENILLDSQGHIVLTDFGLCKEN-IEHNSTT-----STFC-GTPEY 205
Query: 800 LDPEYFLTHKLTDKS-DVYSLGVVLLELLTGMQP 832
L PE L + D++ D + LG VL E+L G+ P
Sbjct: 206 LAPE-VLHKQPYDRTVDWWCLGAVLYEMLYGLPP 238
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 63.6 bits (155), Expect = 3e-11
Identities = 47/178 (26%), Positives = 74/178 (41%), Gaps = 31/178 (17%)
Query: 161 RLQVDENNITGTIPKSFANLSRVRHLHLNNNSIGGQIPSELSKLSTLIHLLVDNNNLSGN 220
+L + + +F L+++ L+L+ N + L+ L L + NN L+ +
Sbjct: 39 KLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSAGVFDDLTELGTLGLANNQLA-S 97
Query: 221 LPPEL-SELPQLCILQLDNNNFSASEIPATYGNFSKLVKLSLRNCNLQGAVPDLSRIPNL 279
LP + L QL L L N + +P+ G F +L KL
Sbjct: 98 LPLGVFDHLTQLDKLYLGGNQLKS--LPS--GVFDRLTKLK------------------- 134
Query: 280 YYLDLSWNHLTGSIPS---KKLSENVTTIDLSDNYLNGSILESISNLPFLQTLSLENN 334
L L+ N L SIP+ KL+ N+ T+ LS N L + L LQT++L N
Sbjct: 135 -ELRLNTNQLQ-SIPAGAFDKLT-NLQTLSLSTNQLQSVPHGAFDRLGKLQTITLFGN 189
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 48.5 bits (116), Expect = 3e-06
Identities = 40/157 (25%), Positives = 70/157 (44%), Gaps = 7/157 (4%)
Query: 89 RELQLLSMNLSGNLAPELGQLSRLQY-YFMWNDLTGTIPKEI-GNISSLIFLLLNGNKLS 146
+L L S L+ L++L + +N L T+ + +++ L L L N+L+
Sbjct: 38 EKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQ-TLSAGVFDDLTELGTLGLANNQLA 96
Query: 147 GSLPDEL-GYLSNLNRLQVDENNITGTIPKSFANLSRVRHLHLNNNSIGGQIPSEL-SKL 204
SLP + +L+ L++L + N + F L++++ L LN N + IP+ KL
Sbjct: 97 -SLPLGVFDHLTQLDKLYLGGNQLKSLPSGVFDRLTKLKELRLNTNQL-QSIPAGAFDKL 154
Query: 205 STLIHLLVDNNNLSGNLPPELSELPQLCILQLDNNNF 241
+ L L + N L L +L + L N F
Sbjct: 155 TNLQTLSLSTNQLQSVPHGAFDRLGKLQTITLFGNQF 191
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 43.5 bits (103), Expect = 2e-04
Identities = 43/189 (22%), Positives = 59/189 (31%), Gaps = 50/189 (26%)
Query: 210 LLVDNNNLSGNLPPELSELPQLCILQLDNNNFSASEIPATYGNFSKLVKLSLRNCN---- 265
L + + L+ L +L L LD N + A G F L +L
Sbjct: 40 LDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQT--LSA--GVFDDLTELGTLGLANNQL 95
Query: 266 --LQGAVPDLSRIPNLYYLDLSWNHLTGSIPSK---KLSENVTTIDLSDNYLNGSILESI 320
L V D + L L L N L S+PS +L++
Sbjct: 96 ASLPLGVFD--HLTQLDKLYLGGNQLK-SLPSGVFDRLTK-------------------- 132
Query: 321 SNLPFLQTLSLENNFLTGSIPATIWQNKSFSTKARLKI-DLRNNSFSNIVGDL--TLPNN 377
L+ L L N L SIPA F L+ L N ++ L
Sbjct: 133 -----LKELRLNTNQLQ-SIPAGA-----FDKLTNLQTLSLSTNQLQSVPHGAFDRLGKL 181
Query: 378 VTLRLGGNP 386
T+ L GN
Sbjct: 182 QTITLFGNQ 190
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 63.0 bits (152), Expect = 1e-10
Identities = 42/260 (16%), Positives = 69/260 (26%), Gaps = 63/260 (24%)
Query: 615 FKFKELAMATAYFSSSTQVGQGGYGKVYKGILSDNTTVAIK--------RAEEGSLQGQN 666
F + T ++G+G +G+V++ I D+T VAIK +
Sbjct: 11 VPFSHC-LPTEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFE 68
Query: 667 EFLTEIKLLSRLH---------HRNLVSLLGYCDEEGE---------------------- 695
E L EI + L + L +G
Sbjct: 69 EILPEIIISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDR 128
Query: 696 --------QMLVYEFVPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPV 747
+V EF G L + + A + +
Sbjct: 129 PDFFKDDQLFIVLEFEFGGID---LEQMRTKLSSLATAKSILHQLTASLAVAEASLR--F 183
Query: 748 FHRDIKASNILLDSNLNAKVADFGLSR--------LAPVLDDEGTMPTHVSTIVKGTPGY 799
HRD+ N+LL K+ + L + D IV
Sbjct: 184 EHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDGIVVFCDVS 243
Query: 800 LDPEYFLTHKLTDKSDVYSL 819
+D + F + D+Y L
Sbjct: 244 MDEDLFTGDG-DYQFDIYRL 262
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 58.5 bits (142), Expect = 3e-10
Identities = 32/134 (23%), Positives = 48/134 (35%), Gaps = 9/134 (6%)
Query: 156 LSNLNRLQVDENNIT-GTIPKSFANLSRVRHLHLNNNSIGGQIPSELSKLSTLIHLLVDN 214
S++ L +D + G + + L N + I + L KL+ L L + +
Sbjct: 16 PSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLT-SI-ANLPKLNKLKKLELSD 73
Query: 215 NNLSGNLPPELSELPQLCILQLDNNNFSASEIPATYGNFSKLVKLSLRNCNLQGAVPD-- 272
N +SG L + P L L L N L L L NC + + D
Sbjct: 74 NRVSGGLEVLAEKCPNLTHLNLSGNKIKDLSTIEPLKKLENLKSLDLFNCEVT-NLNDYR 132
Query: 273 ---LSRIPNLYYLD 283
+P L YLD
Sbjct: 133 ENVFKLLPQLTYLD 146
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 48.9 bits (117), Expect = 7e-07
Identities = 32/160 (20%), Positives = 52/160 (32%), Gaps = 52/160 (32%)
Query: 234 LQLDNNNFSASEIPATYGNFSKLVKLSLRNCNLQGAVPDLSRIPNLYYLDLSWNHLTGSI 293
L LDN+ + ++ F +L LS N L ++ +L ++ L L+LS N ++
Sbjct: 22 LVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLT-SIANLPKLNKLKKLELSDNRVS--- 77
Query: 294 PSKKLSENVTTIDLSDNYLNGSILESIS-NLPFLQTLSLENNFLTGSIPATIWQNKSFST 352
LE ++ P L L+L N + K ST
Sbjct: 78 ---------------------GGLEVLAEKCPNLTHLNLSGNKI-----------KDLST 105
Query: 353 KARLKIDLRNNSFSNIVGDLTLPNNVTLRLGGNPICTSAN 392
LK L N +L L + +
Sbjct: 106 IEPLK---------------KLENLKSLDLFNCEVTNLND 130
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 42.7 bits (101), Expect = 9e-05
Identities = 23/98 (23%), Positives = 40/98 (40%), Gaps = 11/98 (11%)
Query: 124 TIPKEIGNIS---SLIFLLLNGNKLSGSLPDELGYLSNLNRLQVDENNITGTIPKSFANL 180
K G L FL L+ S+ + L L+ L +L++ +N ++G +
Sbjct: 30 NEGKLEGLTDEFEELEFLSTINVGLT-SIAN-LPKLNKLKKLELSDNRVSGGLEVLAEKC 87
Query: 181 SRVRHLHLNNNSIGGQIPSELSKLSTLIHL----LVDN 214
+ HL+L+ N I S + L L +L L +
Sbjct: 88 PNLTHLNLSGNKIKD--LSTIEPLKKLENLKSLDLFNC 123
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 60.0 bits (146), Expect = 3e-10
Identities = 32/137 (23%), Positives = 59/137 (43%), Gaps = 12/137 (8%)
Query: 157 SNLNRLQVDENNITGTIPKSFANLSRVRHLHLNNNSIGGQIPSELSKLSTLIHLLVDNNN 216
+ +++++N I P +F+ ++R + L+NN I P L +L L++ N
Sbjct: 32 ETITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISELAPDAFQGLRSLNSLVLYGNK 91
Query: 217 LSGNLPPEL-SELPQLCILQLDNNNFSASEIPATYGNFSKLVKL---SLRNCNLQGAVPD 272
++ LP L L L +L L+ N + + F L L SL + LQ +
Sbjct: 92 IT-ELPKSLFEGLFSLQLLLLNANKINC--LRV--DAFQDLHNLNLLSLYDNKLQ-TIAK 145
Query: 273 --LSRIPNLYYLDLSWN 287
S + + + L+ N
Sbjct: 146 GTFSPLRAIQTMHLAQN 162
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 59.7 bits (145), Expect = 4e-10
Identities = 34/133 (25%), Positives = 51/133 (38%), Gaps = 8/133 (6%)
Query: 111 RLQYYFMWNDLTGTIPKEIGNISSLIFLLLNGNKLSGSLPDELGYLSNLNRLQVDENNIT 170
RL+ N + P L + L+ N++S PD L +LN L + N IT
Sbjct: 38 RLEQ----NTIKVIPPGAFSPYKKLRRIDLSNNQISELAPDAFQGLRSLNSLVLYGNKIT 93
Query: 171 GTIPKSFANLSRVRHLHLNNNSIGGQIPSEL-SKLSTLIHLLVDNNNLSGNLPPE-LSEL 228
F L ++ L LN N I + + L L L + +N L + S L
Sbjct: 94 ELPKSLFEGLFSLQLLLLNANKIN-CLRVDAFQDLHNLNLLSLYDNKLQ-TIAKGTFSPL 151
Query: 229 PQLCILQLDNNNF 241
+ + L N F
Sbjct: 152 RAIQTMHLAQNPF 164
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 58.5 bits (142), Expect = 1e-09
Identities = 35/156 (22%), Positives = 53/156 (33%), Gaps = 31/156 (19%)
Query: 183 VRHLHLNNNSIGGQIPSELSKLSTLIHLLVDNNNLSGNLPPEL-SELPQLCILQLDNNNF 241
+ + L N+I P S L + + NN +S L P+ L L L L N
Sbjct: 34 ITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQIS-ELAPDAFQGLRSLNSLVLYGNKI 92
Query: 242 SASEIPATYGNFSKLVKLSLRNCNLQGAVPDLSRIPNLYYLDLSWNHLTGSIPS---KKL 298
+ +P F L L L L+ N + + + L
Sbjct: 93 TE--LPK--SLFEGLFSLQ--------------------LLLLNANKIN-CLRVDAFQDL 127
Query: 299 SENVTTIDLSDNYLNGSILESISNLPFLQTLSLENN 334
N+ + L DN L + S L +QT+ L N
Sbjct: 128 H-NLNLLSLYDNKLQTIAKGTFSPLRAIQTMHLAQN 162
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 53.5 bits (129), Expect = 5e-08
Identities = 35/164 (21%), Positives = 59/164 (35%), Gaps = 41/164 (25%)
Query: 234 LQLDNNNFSASEIPATY-GNFSKLVKLSLRNCNLQGAVPD--LSRIPNLYYLDLSWNHLT 290
++L+ N IP + KL ++ L N + + + +L L L N +T
Sbjct: 37 IRLEQNTIK--VIPPGAFSPYKKLRRIDLSNNQIS-ELAPDAFQGLRSLNSLVLYGNKIT 93
Query: 291 GSIPS---KKLSENVTTIDLSDNYLNGSILESI-SNLPFLQTLSLENNFLTGSIPATIWQ 346
+P + L ++ + L+ N +N + +L L LSL +N L +I
Sbjct: 94 -ELPKSLFEGLF-SLQLLLLNANKIN-CLRVDAFQDLHNLNLLSLYDNKLQ-TIA----- 144
Query: 347 NKSFSTKARLKIDLRNNSFSNIVGDLTLPNNVTLRLGGNP-ICT 389
+FS L T+ L NP IC
Sbjct: 145 ---------------KGTFSP------LRAIQTMHLAQNPFICD 167
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 50.4 bits (121), Expect = 7e-07
Identities = 34/110 (30%), Positives = 53/110 (48%), Gaps = 14/110 (12%)
Query: 92 QLLSMNLSGN----LAP----ELGQLSRLQYYFMWNDLTGTIPKEI-GNISSLIFLLLNG 142
+L ++LS N LAP L L+ L N +T +PK + + SL LLLN
Sbjct: 57 KLRRIDLSNNQISELAPDAFQGLRSLNSL--VLYGNKIT-ELPKSLFEGLFSLQLLLLNA 113
Query: 143 NKLSGSLPDEL-GYLSNLNRLQVDENNITGTIPKSFANLSRVRHLHLNNN 191
NK++ L + L NLN L + +N + +F+ L ++ +HL N
Sbjct: 114 NKIN-CLRVDAFQDLHNLNLLSLYDNKLQTIAKGTFSPLRAIQTMHLAQN 162
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 50.0 bits (120), Expect = 8e-07
Identities = 25/111 (22%), Positives = 47/111 (42%), Gaps = 7/111 (6%)
Query: 109 LSRLQY-YFMWNDLTGTIPKEI-GNISSLIFLLLNGNKLSGSLPDEL-GYLSNLNRLQVD 165
+L+ N ++ + + + SL L+L GNK++ LP L L +L L ++
Sbjct: 55 YKKLRRIDLSNNQIS-ELAPDAFQGLRSLNSLVLYGNKIT-ELPKSLFEGLFSLQLLLLN 112
Query: 166 ENNITGTIPK-SFANLSRVRHLHLNNNSIGGQIPSELSKLSTLIHLLVDNN 215
N I + +F +L + L L +N + S L + + + N
Sbjct: 113 ANKIN-CLRVDAFQDLHNLNLLSLYDNKLQTIAKGTFSPLRAIQTMHLAQN 162
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 59.3 bits (144), Expect = 5e-10
Identities = 31/172 (18%), Positives = 57/172 (33%), Gaps = 29/172 (16%)
Query: 224 ELSELPQLCILQLDNNNFSASEIPATYGNFSKLVKLSLRNCNLQGAVPDLSRIPNLYYLD 283
+ + ++L ++ AT L+L N++ + LS + NL L
Sbjct: 18 KSVVATEAEKVELHGMIPPIEKMDATLSTLKACKHLALSTNNIE-KISSLSGMENLRILS 76
Query: 284 LSWNHLTGSIPSKKLSENVTTIDLSDNYLNGSILESISNLPFLQTLSLENNFLTGSIPAT 343
L N + +++ + + +S N + + L I L L+ L + NN +T
Sbjct: 77 LGRNLIKKIENLDAVADTLEELWISYNQI--ASLSGIEKLVNLRVLYMSNNKIT------ 128
Query: 344 IWQNKSFSTKARLKIDLRNNSFSNIVGDLTLPNNVTLRLGGNPICTSANIPN 395
++ I L L L GNP+ N
Sbjct: 129 --------------------NWGEIDKLAALDKLEDLLLAGNPLYNDYKENN 160
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 55.8 bits (135), Expect = 6e-09
Identities = 31/153 (20%), Positives = 54/153 (35%), Gaps = 34/153 (22%)
Query: 185 HLHLNNNSIGGQIPSELSKLSTLIHLLVDNNNLS---GNLPPELSELPQLCILQLDNNNF 241
LH I + + LS L HL + NN+ LS + L IL L N
Sbjct: 29 ELHGMIPPIEK-MDATLSTLKACKHLALSTNNIEKISS-----LSGMENLRILSLGRNLI 82
Query: 242 SASEIPATYGNFSKLVKLSLRNCNLQGAVPDLSRIPNLYYLDLSWNHLTGSIPSKKLSEN 301
+I L +L + + ++ + ++ NL L +S N +T
Sbjct: 83 K--KIENLDAVADTLEELWISYNQIA-SLSGIEKLVNLRVLYMSNNKIT----------- 128
Query: 302 VTTIDLSDNYLNGSILESISNLPFLQTLSLENN 334
+ + ++ ++ L L+ L L N
Sbjct: 129 ----NWGE-------IDKLAALDKLEDLLLAGN 150
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 51.2 bits (123), Expect = 3e-07
Identities = 36/160 (22%), Positives = 59/160 (36%), Gaps = 17/160 (10%)
Query: 135 LIFLLLNGNKLSGSLPDELGYLSNLNRLQVDENNITGTIPKSFANLSRVRHLHLNNNSIG 194
+ L + + L L L + NNI I S + + +R L L N I
Sbjct: 27 KVELHGMIPPIEK-MDATLSTLKACKHLALSTNNIE-KI-SSLSGMENLRILSLGRNLI- 82
Query: 195 GQIPSELSKLSTLIHLLVDNNNLSGNLPPELSELPQLCILQLDNNNFSASEIPATYGNFS 254
+I + + TL L + N ++ +L + +L L +L + NN +
Sbjct: 83 KKIENLDAVADTLEELWISYNQIA-SLSG-IEKLVNLRVLYMSNNKITNWGEIDKLAALD 140
Query: 255 KLVKLSL------RNCNLQGAVPD-----LSRIPNLYYLD 283
KL L L + A + + R+PNL LD
Sbjct: 141 KLEDLLLAGNPLYNDYKENNATSEYRIEVVKRLPNLKKLD 180
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 58.1 bits (141), Expect = 2e-09
Identities = 29/139 (20%), Positives = 57/139 (41%), Gaps = 17/139 (12%)
Query: 234 LQLDNNNFSASEIPATYGNFSKLVKLSLRNCNLQGAVPD--LSRIPNLYYLDLSWNHLTG 291
L+L+NN F+ E + +L K++ N + + + + + L+ N L
Sbjct: 37 LRLNNNEFTVLEATGIFKKLPQLRKINFSNNKIT-DIEEGAFEGASGVNEILLTSNRLE- 94
Query: 292 SIPS---KKLSENVTTIDLSDNYLNGSILESI-SNLPFLQTLSLENNFLTGSIPATIWQN 347
++ K L ++ T+ L N + + L ++ LSL +N +T ++
Sbjct: 95 NVQHKMFKGLE-SLKTLMLRSNRIT-CVGNDSFIGLSSVRLLSLYDNQIT-TVAPGA--- 148
Query: 348 KSFSTKARLK-IDLRNNSF 365
F T L ++L N F
Sbjct: 149 --FDTLHSLSTLNLLANPF 165
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 54.7 bits (132), Expect = 2e-08
Identities = 31/156 (19%), Positives = 51/156 (32%), Gaps = 36/156 (23%)
Query: 186 LHLNNNSIGGQIPSE--LSKLSTLIHLLVDNNNLSGNLPPE-LSELPQLCILQLDNNNFS 242
L LNNN + + KL L + NN ++ ++ + + L +N
Sbjct: 37 LRLNNNEF-TVLEATGIFKKLPQLRKINFSNNKIT-DIEEGAFEGASGVNEILLTSNRLE 94
Query: 243 ASEIPATYGNFSKLVKLSLRNCNLQGAVPDLSRIPNLYYLDLSWNHLTGSIPS---KKLS 299
+ F L L L L N +T + + LS
Sbjct: 95 N--VQH--KMFKGLESLK--------------------TLMLRSNRIT-CVGNDSFIGLS 129
Query: 300 ENVTTIDLSDNYLNGSILESI-SNLPFLQTLSLENN 334
+V + L DN + ++ L L TL+L N
Sbjct: 130 -SVRLLSLYDNQIT-TVAPGAFDTLHSLSTLNLLAN 163
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 50.8 bits (122), Expect = 5e-07
Identities = 40/158 (25%), Positives = 61/158 (38%), Gaps = 10/158 (6%)
Query: 66 PCMSNWTGVLC----FDTVETDGHLHVRELQLLSMNLSGNLAPE--LGQLSRLQY-YFMW 118
C T V C + + + EL+L + N L +L +L+ F
Sbjct: 8 KCRCEGTTVDCSNQKLNKIPEHIPQYTAELRL-NNNEFTVLEATGIFKKLPQLRKINFSN 66
Query: 119 NDLTGTIPKEIGNISSLIFLLLNGNKLSGSLPDEL-GYLSNLNRLQVDENNITGTIPKSF 177
N +T S + +LL N+L ++ ++ L +L L + N IT SF
Sbjct: 67 NKITDIEEGAFEGASGVNEILLTSNRLE-NVQHKMFKGLESLKTLMLRSNRITCVGNDSF 125
Query: 178 ANLSRVRHLHLNNNSIGGQIPSELSKLSTLIHLLVDNN 215
LS VR L L +N I P L +L L + N
Sbjct: 126 IGLSSVRLLSLYDNQITTVAPGAFDTLHSLSTLNLLAN 163
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386 | Back alignment and structure |
|---|
Score = 59.7 bits (145), Expect = 2e-09
Identities = 43/304 (14%), Positives = 91/304 (29%), Gaps = 68/304 (22%)
Query: 132 ISSLIFLLLNGNKLSG----SLPDELGYLSNLNRLQVDENNITGT----IPKSFANLSRV 183
S+ L + ++ S+ L ++ + + N I + ++ A+ +
Sbjct: 3 RFSIEGKSLKLDAITTEDEKSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDL 62
Query: 184 RHLHLNNNSIGGQIPSELSKLSTLIHLLVDNNNLSGNLPPELSELPQLCILQLDNNNFS- 242
++ G L L+ L+ L ++L +N F
Sbjct: 63 EIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLH--------------TVRLSDNAFGP 108
Query: 243 --ASEIPATYGNFSKLVKLSLRNCNL--QGA------------VPDLSRIPNLYYLDLSW 286
+ + L L L N L Q P L +
Sbjct: 109 TAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGR 168
Query: 287 NHLTGSIPSKKLSE------NVTTIDLSDNYLN-----GSILESISNLPFLQTLSLENNF 335
N L + K+ ++ + T+ + N + +LE ++ L+ L L++N
Sbjct: 169 NRL-ENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNT 227
Query: 336 LTG----SIPATIWQNKSFSTKARLKIDLRNNSFSN-----IVGDLTLPNNVTLR---LG 383
T ++ + + + L + S +V + N+ L+ L
Sbjct: 228 FTHLGSSALAIALKSWPNLRE-----LGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQ 282
Query: 384 GNPI 387
N I
Sbjct: 283 YNEI 286
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386 | Back alignment and structure |
|---|
Score = 56.6 bits (137), Expect = 2e-08
Identities = 45/294 (15%), Positives = 87/294 (29%), Gaps = 82/294 (27%)
Query: 125 IPKEIGNISSLIFLLLNGNKLSG----SLPDELGYLSNLNRLQVDENNI----------T 170
+ + S+ ++L+GN + L + + +L + +
Sbjct: 24 VFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTGRVKDEIPEAL 83
Query: 171 GTIPKSFANLSRVRHLHLNNNSIGGQ----IPSELSKLSTLIHLLVDNNNLS-------- 218
+ ++ ++ + L++N+ G + LSK + L HL + NN L
Sbjct: 84 RLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIA 143
Query: 219 -----GNLPPELSELPQLCILQLDNNNF---SASEIPATYGNFSKLVKLSLRNCNL--QG 268
+ + P L + N S E T+ + L + + + +G
Sbjct: 144 RALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEG 203
Query: 269 AVPDLSRI----PNLYYLDLSWNHLTGSIPSKKLSE------NVTTIDLSDNYL------ 312
L L LDL N + S L+ N+ + L+D L
Sbjct: 204 IEHLLLEGLAYCQELKVLDLQDNTF-THLGSSALAIALKSWPNLRELGLNDCLLSARGAA 262
Query: 313 ---------------------NG-------SILESI-SNLPFLQTLSLENNFLT 337
N ++ I +P L L L N +
Sbjct: 263 AVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFS 316
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386 | Back alignment and structure |
|---|
Score = 45.1 bits (107), Expect = 7e-05
Identities = 44/238 (18%), Positives = 78/238 (32%), Gaps = 55/238 (23%)
Query: 92 QLLSMNLSGN---------LAPELGQLSRLQY-YFMWNDLTGTIPKEIGNISSLIFLLLN 141
+L ++ LS N L L + + L++ Y N L P+ I+ + L
Sbjct: 95 KLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLG---PQAGAKIARALQELAV 151
Query: 142 GNKLSGSLPDELGYLSNLNRLQVDENNITG----TIPKSFANLSRVRHLHLNNNSIGGQ- 196
K + L + N + K+F + + + + N I +
Sbjct: 152 NKKAKNA--------PPLRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEG 203
Query: 197 ----IPSELSKLSTLIHLLVDNNNLSGN---------LPPELSELPQLCILQLDNNNFSA 243
+ L+ L L +L N L L P L L L++ SA
Sbjct: 204 IEHLLLEGLAYCQELKVL-----DLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLSA 258
Query: 244 SEIPA-----TYGNFSKLVKLSLRNCNLQGA-VPDLSR-----IPNLYYLDLSWNHLT 290
A + L L L+ ++ V L +P+L +L+L+ N +
Sbjct: 259 RGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFS 316
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 59.4 bits (143), Expect = 2e-09
Identities = 18/100 (18%), Positives = 38/100 (38%), Gaps = 2/100 (2%)
Query: 119 NDLTGTIPKEIGNISSLIFLLLNGNKLSGSLPDE-LGYLSNLNRLQVDENNITGTIPKSF 177
D + +L L + + L L L L L + ++ + P +F
Sbjct: 17 RDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAF 76
Query: 178 ANLSRVRHLHLNNNSIGGQIPSELSKLSTLIHLLVDNNNL 217
R+ L+L+ N++ + + + +L L++ N L
Sbjct: 77 HFTPRLSRLNLSFNAL-ESLSWKTVQGLSLQELVLSGNPL 115
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 50.5 bits (120), Expect = 1e-06
Identities = 22/102 (21%), Positives = 39/102 (38%), Gaps = 3/102 (2%)
Query: 214 NNNLSGNLPPELSELPQLCILQLDNNNFSASEIPATYGNFSKLVKLSLRNCNLQGAVPD- 272
+ + + L L L ++N +L L++ L+ PD
Sbjct: 16 TRDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDA 75
Query: 273 LSRIPNLYYLDLSWNHLTGSIPSKKLSE-NVTTIDLSDNYLN 313
P L L+LS+N L S+ K + ++ + LS N L+
Sbjct: 76 FHFTPRLSRLNLSFNALE-SLSWKTVQGLSLQELVLSGNPLH 116
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 42.8 bits (100), Expect = 3e-04
Identities = 19/102 (18%), Positives = 41/102 (40%), Gaps = 9/102 (8%)
Query: 289 LTGSIPSKKLSENVTTIDLSDNYLNGSI-LESISNLPFLQTLSLENNFLTGSIPATIWQN 347
S+ +EN+T + + + + L + L L+ L++ + L +
Sbjct: 20 ALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLR-FVAP----- 73
Query: 348 KSFSTKARLK-IDLRNNSFSNIVGD-LTLPNNVTLRLGGNPI 387
+F RL ++L N+ ++ + + L L GNP+
Sbjct: 74 DAFHFTPRLSRLNLSFNALESLSWKTVQGLSLQELVLSGNPL 115
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} Length = 362 | Back alignment and structure |
|---|
Score = 58.6 bits (142), Expect = 4e-09
Identities = 58/281 (20%), Positives = 102/281 (36%), Gaps = 56/281 (19%)
Query: 157 SNLNRLQVDENNITGTIPKSFA-----NLSRVRHLHLNNNSIGGQIPSELSKL-----ST 206
+ L + NN+ + V L+L+ NS+G + EL ++ +
Sbjct: 22 HGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELVQILAAIPAN 81
Query: 207 LIHLLVDNNNLSGNLPPELSEL-----PQLCILQLDNNNFSASEI----PATYGNFSKLV 257
+ L + N LS EL + + +L L N+FS+ A + +
Sbjct: 82 VTSLNLSGNFLSYKSSDELVKTLAAIPFTITVLDLGWNDFSSKSSSEFKQAFSNLPASIT 141
Query: 258 KLSLRNCNL--QGAV---PDLSRIP-NLYYLDLSWNHLTGSIPSKKLSE-------NVTT 304
L+LR +L + + L+ IP N+ L+L N+L S +L++ +VT+
Sbjct: 142 SLNLRGNDLGIKSSDELIQILAAIPANVNSLNLRGNNL-ASKNCAELAKFLASIPASVTS 200
Query: 305 IDLSDNYLNGSILESI-----SNLPFLQTLSLENNFLTGS----IPATIWQNKSFSTKAR 355
+DLS N L + S + +L+L N L G + K T
Sbjct: 201 LDLSANLLGLKSYAELAYIFSSIPNHVVSLNLCLNCLHGPSLENLKLLKDSLKHLQT--- 257
Query: 356 LKIDLRNNSFSNIVGDL------TLPNNVTLR---LGGNPI 387
+ L + N+ + PN + G I
Sbjct: 258 --VYLDYDIVKNMSKEQCKALGAAFPNIQKIILVDKNGKEI 296
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} Length = 362 | Back alignment and structure |
|---|
Score = 49.7 bits (119), Expect = 3e-06
Identities = 49/282 (17%), Positives = 99/282 (35%), Gaps = 48/282 (17%)
Query: 133 SSLIFLLLNGNKLSGSLPDELGYL-----SNLNRLQVDENNITGTIPKSFANL-----SR 182
+++ L L+GN LS DEL + L + N+ + F +
Sbjct: 80 ANVTSLNLSGNFLSYKSSDELVKTLAAIPFTITVLDLGWNDFSSKSSSEFKQAFSNLPAS 139
Query: 183 VRHLHLNNNSIGGQIPSELSKL-----STLIHLLVDNNNLSGNLPPELSEL-----PQLC 232
+ L+L N +G + EL ++ + + L + NNL+ EL++ +
Sbjct: 140 ITSLNLRGNDLGIKSSDELIQILAAIPANVNSLNLRGNNLASKNCAELAKFLASIPASVT 199
Query: 233 ILQLDNNNFS---ASEI-PATYGNFSKLVKLSLRNCNLQGA-VPDLSRI----PNLYYLD 283
L L N +E+ + +V L+L L G + +L + +L +
Sbjct: 200 SLDLSANLLGLKSYAELAYIFSSIPNHVVSLNLCLNCLHGPSLENLKLLKDSLKHLQTVY 259
Query: 284 LSWNHLT--GSIPSKKLSE------NVTTIDLSDNYLNGS----ILESISNLPF-LQTLS 330
L ++ + K L + +D + ++ S I I L S
Sbjct: 260 LDYDIVKNMSKEQCKALGAAFPNIQKIILVDKNGKEIHPSHSIPISNLIRELSGKADVPS 319
Query: 331 LENNFLTGSIPATIWQNKSFSTKARLKIDLRNNSFS-NIVGD 371
L N L ++++ + +LR + + + +
Sbjct: 320 LLNQCLI-----FAQKHQTNIEDLNIPDELRESIQTCKPLLE 356
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} Length = 362 | Back alignment and structure |
|---|
Score = 48.9 bits (117), Expect = 5e-06
Identities = 41/249 (16%), Positives = 84/249 (33%), Gaps = 39/249 (15%)
Query: 178 ANLSRVRHLHLNNNSIGGQIPSELSKL-----STLIHLLVDNNNLSGNLPPELSEL---- 228
+ V L L+ N++ EL + +++ L + N+L EL ++
Sbjct: 19 SIPHGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELVQILAAI 78
Query: 229 -PQLCILQLDNNNFSASEI----PATYGNFSKLVKLSLRNCNLQGA-VPDLSRI-----P 277
+ L L N S + L L + + +
Sbjct: 79 PANVTSLNLSGNFLSYKSSDELVKTLAAIPFTITVLDLGWNDFSSKSSSEFKQAFSNLPA 138
Query: 278 NLYYLDLSWNHLTGSIPSKKLSE-------NVTTIDLSDNYLN----GSILESISNLPF- 325
++ L+L N L G S +L + NV +++L N L + + ++++P
Sbjct: 139 SITSLNLRGNDL-GIKSSDELIQILAAIPANVNSLNLRGNNLASKNCAELAKFLASIPAS 197
Query: 326 LQTLSLENNFLTGSIPATIWQNKSFSTKARLKIDLRNNSFSNIVGDL------TLPNNVT 379
+ +L L N L A + S + ++L N + +L + T
Sbjct: 198 VTSLDLSANLLGLKSYAELAYIFSSIPNHVVSLNLCLNCLHGPSLENLKLLKDSLKHLQT 257
Query: 380 LRLGGNPIC 388
+ L + +
Sbjct: 258 VYLDYDIVK 266
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 57.8 bits (140), Expect = 5e-09
Identities = 50/211 (23%), Positives = 87/211 (41%), Gaps = 22/211 (10%)
Query: 632 QVGQGGYGKVYKGI-LSDNTTVAIKRAEEGSLQGQNEFLTEIKLLSRLHHRNLVSLLGYC 690
++G G +G +Y G ++ VAIK + Q E K+ + + + +C
Sbjct: 16 KIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHI--ESKIYKMMQGGVGIPTIRWC 73
Query: 691 DEEGE-QMLVYEFV-PN-GTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPV 747
EG+ ++V E + P+ L ++ S + + L +A I Y+H++
Sbjct: 74 GAEGDYNVMVMELLGPSLEDLFNFCSRK----FSLKTVLLLADQMISRIEYIHSKN---F 126
Query: 748 FHRDIKASNILLDSNLNAK---VADFGLSRLAPVLDDEGTMPTHVSTIVKGTPGYLDPEY 804
HRD+K N L+ + DFGL++ +P + + GT Y
Sbjct: 127 IHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASIN- 185
Query: 805 FLTHKLTDKS---DVYSLGVVLLELLTGMQP 832
TH ++S D+ SLG VL+ G P
Sbjct: 186 --THLGIEQSRRDDLESLGYVLMYFNLGSLP 214
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362 | Back alignment and structure |
|---|
Score = 58.0 bits (139), Expect = 6e-09
Identities = 32/199 (16%), Positives = 61/199 (30%), Gaps = 37/199 (18%)
Query: 147 GSLPDELGYLSNLNRLQVDENNITGTIPKSFANLSRVRHLHLNNNSIGGQIPSEL--SKL 204
L L + LN L++ N K NL + L + + + + ++ S L
Sbjct: 162 VDLSPVLDAMPLLNNLKIKGTNNLSIGKKPRPNL---KSLEIISGGLPDSVVEDILGSDL 218
Query: 205 STLIHL---LVDNNNLSGNLPPELSELPQLCILQLDNNNFSASEIPATYGNFSKLVKLSL 261
L L + + L F L L +
Sbjct: 219 PNLEKLVLYVGVEDYGFDGDMNVFRPLFSK-------------------DRFPNLKWLGI 259
Query: 262 RNCNLQG----AVPDLSRIPNLYYLDLSWNHLTGS-----IPSKKLSENVTTIDLSDNYL 312
+ Q + +P L +D+S LT + +++ I++ NYL
Sbjct: 260 VDAEEQNVVVEMFLESDILPQLETMDISAGVLTDEGARLLLDHVDKIKHLKFINMKYNYL 319
Query: 313 NGSILESISN-LPFLQTLS 330
+ + + + LP +S
Sbjct: 320 SDEMKKELQKSLPMKIDVS 338
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362 | Back alignment and structure |
|---|
Score = 42.2 bits (98), Expect = 6e-04
Identities = 21/172 (12%), Positives = 53/172 (30%), Gaps = 22/172 (12%)
Query: 51 LVDSMNHLRNWNKGDPCMSNWTGVLCFDTVETDGHLHVRELQLLSMNLSGNLAPELG--- 107
VD L + T L +++ L+++S L ++ ++
Sbjct: 161 QVDLSPVLDAMPLLNNLKIKGTNNLSIGKKP---RPNLKSLEIISGGLPDSVVEDILGSD 217
Query: 108 --QLSRLQYYFMWNDLTGTIPKEI-------GNISSLIFLLLNGNKLSGSLPDELG---Y 155
L +L Y D + +L +L + + + +
Sbjct: 218 LPNLEKLVLYVGVEDYGFDGDMNVFRPLFSKDRFPNLKWLGIVDAEEQNVVVEMFLESDI 277
Query: 156 LSNLNRLQVDENNITGT----IPKSFANLSRVRHLHLNNNSIGGQIPSELSK 203
L L + + +T + + ++ +++ N + ++ EL K
Sbjct: 278 LPQLETMDISAGVLTDEGARLLLDHVDKIKHLKFINMKYNYLSDEMKKELQK 329
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 54.7 bits (132), Expect = 8e-09
Identities = 34/135 (25%), Positives = 45/135 (33%), Gaps = 9/135 (6%)
Query: 155 YLSNLNRLQVDENNIT-GTIPKSFANLSRVRHLHLNNNSIGGQIPSELSKLSTLIHLLVD 213
+ + L +D G I A + L L N + S L KL L L +
Sbjct: 22 TPAAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGL--ISVSNLPKLPKLKKLELS 79
Query: 214 NNNLSGNLPPELSELPQLCILQLDNNNFSASEIPATYGNFSKLVKLSLRNCNLQGAVPD- 272
N + G L +LP L L L N L L L NC + + D
Sbjct: 80 ENRIFGGLDMLAEKLPNLTHLNLSGNKLKDISTLEPLKKLECLKSLDLFNCEVT-NLNDY 138
Query: 273 ----LSRIPNLYYLD 283
+P L YLD
Sbjct: 139 RESVFKLLPQLTYLD 153
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 49.7 bits (119), Expect = 5e-07
Identities = 29/143 (20%), Positives = 47/143 (32%), Gaps = 29/143 (20%)
Query: 252 NFSKLVKLSLRNCNLQGAVPD--LSRIPNLYYLDLSWNHLTGSIPSKKLSENVTTIDLSD 309
+ + +L L NC + + NL +L L L S+ + + ++LS+
Sbjct: 22 TPAAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLI-SVSNLPKLPKLKKLELSE 80
Query: 310 NYLNGSILESISNLPFLQTLSLENNFLTGSIPATIWQNKSFSTKARLKIDLRNNSFSNIV 369
N + G + LP L L+L N L K ST LK
Sbjct: 81 NRIFGGLDMLAEKLPNLTHLNLSGNKL-----------KDISTLEPLK------------ 117
Query: 370 GDLTLPNNVTLRLGGNPICTSAN 392
L +L L + +
Sbjct: 118 ---KLECLKSLDLFNCEVTNLND 137
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 44.0 bits (104), Expect = 5e-05
Identities = 37/132 (28%), Positives = 53/132 (40%), Gaps = 13/132 (9%)
Query: 124 TIPKEIGNIS---SLIFLLLNGNKLSGSLPDELGYLSNLNRLQVDENNITGTIPKSFANL 180
K G + +L FL L L S+ + L L L +L++ EN I G + L
Sbjct: 37 NDGKIEGLTAEFVNLEFLSLINVGLI-SVSN-LPKLPKLKKLELSENRIFGGLDMLAEKL 94
Query: 181 SRVRHLHLNNNSIG--GQIPSELSKLSTLIHLLVDNN---NLSGNLPPELSELPQLCILQ 235
+ HL+L+ N + + L KL L L + N NL+ LPQL
Sbjct: 95 PNLTHLNLSGNKLKDISTL-EPLKKLECLKSLDLFNCEVTNLNDYRESVFKLLPQL--TY 151
Query: 236 LDNNNFSASEIP 247
LD + E P
Sbjct: 152 LDGYDREDQEAP 163
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 56.7 bits (137), Expect = 2e-08
Identities = 58/223 (26%), Positives = 97/223 (43%), Gaps = 41/223 (18%)
Query: 633 VGQGGYGKVYKGI-LSDNTTVAIK--RAEEGSL-QGQNEFLTEIKLLSRLHHR------N 682
+G+G +G+V K + VA+K R E+ Q EI++L L + N
Sbjct: 105 IGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQA----AEEIRILEHLRKQDKDNTMN 160
Query: 683 LVSLLGYCDEEGEQMLVYEFV-PNGTLRDWLSGRTKENLN--FAMRL--RVALDSAKGIL 737
++ +L + +E + N L + + K+N F++ L + A + +
Sbjct: 161 VIHMLENFTFRNHICMTFELLSMN--LYELI----KKNKFQGFSLPLVRKFAHSILQCLD 214
Query: 738 YLHTEAHPPVFHRDIKASNILLDSNLNA--KVADFGLSRLAPVLDDEGTMPTHVSTIVKG 795
LH + H D+K NILL + KV DFG S + + V T ++
Sbjct: 215 ALH---KNRIIHCDLKPENILLKQQGRSGIKVIDFGSS----CYEHQ-----RVYTYIQ- 261
Query: 796 TPGYLDPEYFLTHKLTDKSDVYSLGVVLLELLTGMQPISHGKN 838
+ Y PE L + D++SLG +L ELLTG P+ G++
Sbjct: 262 SRFYRAPEVILGARYGMPIDMWSLGCILAELLTG-YPLLPGED 303
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 56.3 bits (136), Expect = 2e-08
Identities = 53/219 (24%), Positives = 92/219 (42%), Gaps = 31/219 (14%)
Query: 633 VGQGGYGKVYKGI-LSDNTTVAIK--RAEEG-SLQGQNEFLTEIKLLSRLHHR------N 682
+G+G +G+V K + VAIK + ++ Q E++LL ++
Sbjct: 62 IGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQA----QIEVRLLELMNKHDTEMKYY 117
Query: 683 LVSLLGYCDEEGEQMLVYEFV-PNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHT 741
+V L + LV+E + N L D L ++ + + A +L+L T
Sbjct: 118 IVHLKRHFMFRNHLCLVFEMLSYN--LYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLAT 175
Query: 742 EAHPPVFHRDIKASNILLDSNLNA--KVADFGLSRLAPVLDDEGTMPTHVSTIVKGTPGY 799
+ H D+K NILL + + K+ DFG S + + ++ + Y
Sbjct: 176 P-ELSIIHCDLKPENILLCNPKRSAIKIVDFGSS----CQLGQ-----RIYQYIQ-SRFY 224
Query: 800 LDPEYFLTHKLTDKSDVYSLGVVLLELLTGMQPISHGKN 838
PE L D++SLG +L+E+ TG +P+ G N
Sbjct: 225 RSPEVLLGMPYDLAIDMWSLGCILVEMHTG-EPLFSGAN 262
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 56.6 bits (136), Expect = 3e-08
Identities = 53/211 (25%), Positives = 92/211 (43%), Gaps = 22/211 (10%)
Query: 632 QVGQGGYGKVYKGI-LSDNTTVAIKRAEEGSLQGQNEFLTEIKLLSRLHHRNLVSLLGYC 690
++G G +G++Y G + N VAIK + Q + E K+ L + + +
Sbjct: 14 KIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLY--ESKIYRILQGGTGIPNVRWF 71
Query: 691 DEEGE-QMLVYEFV-PN-GTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPV 747
EG+ +LV + + P+ L ++ S + L+ L +A + ++H+++
Sbjct: 72 GVEGDYNVLVMDLLGPSLEDLFNFCSRK----LSLKTVLMLADQMINRVEFVHSKS---F 124
Query: 748 FHRDIKASNILLDSNLNAK---VADFGLSRLAPVLDDEGTMPTHVSTIVKGTPGYLDPEY 804
HRDIK N L+ A + DFGL++ +P + + GT Y
Sbjct: 125 LHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYAS--- 181
Query: 805 FLTHKLTDKS---DVYSLGVVLLELLTGMQP 832
TH ++S D+ SLG VL+ L G P
Sbjct: 182 VNTHLGIEQSRRDDLESLGYVLMYFLRGSLP 212
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 53.5 bits (129), Expect = 3e-08
Identities = 26/138 (18%), Positives = 43/138 (31%), Gaps = 9/138 (6%)
Query: 151 DELGYLSNLNRLQVDENNITGTIPKSFANLSRVRHLHLNNNSIGGQIPSELSKLSTLIHL 210
+ L + I I A L + + ++N I + L L L
Sbjct: 13 AQYTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEI--RKLDGFPLLRRLKTL 69
Query: 211 LVDNNNLSGNLPPELSELPQLCILQLDNNNFSASEIPATYGNFSKLVKLSLRNCNLQGAV 270
LV+NN + LP L L L NN+ + L L + +
Sbjct: 70 LVNNNRICRIGEGLDQALPDLTELILTNNSLVELGDLDPLASLKSLTYLCILRNPVT-NK 128
Query: 271 PD-----LSRIPNLYYLD 283
+ ++P + LD
Sbjct: 129 KHYRLYVIYKVPQVRVLD 146
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 52.7 bits (127), Expect = 6e-08
Identities = 18/125 (14%), Positives = 42/125 (33%), Gaps = 10/125 (8%)
Query: 216 NLSGNL---PPELSELPQLCILQLDNNNFSASEIPATYGNFSKLVKLSLRNCNLQGAVPD 272
L+ L + + + L L I + + + ++ +
Sbjct: 3 KLTAELIEQAAQYTNAVRDRELDLRGYKIP--VIENLGATLDQFDAIDFSDNEIR-KLDG 59
Query: 273 LSRIPNLYYLDLSWNHLTGSIPSKKLS--ENVTTIDLSDNYLNG-SILESISNLPFLQTL 329
+ L L ++ N + I ++T + L++N L L+ +++L L L
Sbjct: 60 FPLLRRLKTLLVNNNRIC-RIGEGLDQALPDLTELILTNNSLVELGDLDPLASLKSLTYL 118
Query: 330 SLENN 334
+ N
Sbjct: 119 CILRN 123
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 50.4 bits (121), Expect = 4e-07
Identities = 33/164 (20%), Positives = 55/164 (33%), Gaps = 38/164 (23%)
Query: 233 ILQLDNNNFSASEIPATYGNFSKLVKLSLRNCNLQGAVPDLSRIPNLYYLDLSWNHLTGS 292
+++L + Y N + +L LR + I NL
Sbjct: 1 MVKLTAELIEQAA---QYTNAVRDRELDLRGYKI-------PVIENL------------- 37
Query: 293 IPSKKLSENVTTIDLSDNYLNGSILESISNLPFLQTLSLENNFLTGSIPATIWQNKSFST 352
+ ID SDN + L+ L L+TL + NN + I + +
Sbjct: 38 ---GATLDQFDAIDFSDNEI--RKLDGFPLLRRLKTLLVNNNRIC-----RIGEGLDQAL 87
Query: 353 KARLKIDLRNNSFSNIVGDLT----LPNNVTLRLGGNPICTSAN 392
++ L NNS + GDL L + L + NP+ +
Sbjct: 88 PDLTELILTNNSLVEL-GDLDPLASLKSLTYLCILRNPVTNKKH 130
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 53.4 bits (128), Expect = 2e-07
Identities = 56/304 (18%), Positives = 92/304 (30%), Gaps = 89/304 (29%)
Query: 633 VGQGGYGKVYKGI-LSDNTTVAIK--RAEEGSLQGQNEFLTEIKLLSRLH--------HR 681
+G G + V+ + VA+K ++ E + L EI+LL +
Sbjct: 45 LGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTE---TALDEIRLLKSVRNSDPNDPNRE 101
Query: 682 NLVSLLGYCDEEGEQMLVYEFVPNGT--------LRDWLSGRTKENLNFAMRLRVALDSA 733
+V LL G NGT L L ++ + L
Sbjct: 102 MVVQLLDDFKISG---------VNGTHICMVFEVLGHHLLKWIIKSNYQGLPLPCVKKII 152
Query: 734 KGIL----YLHTEAHPPVFHRDIKASNILLDSNLNAKVADF------------------- 770
+ +L YLHT+ + H DIK NILL N
Sbjct: 153 QQVLQGLDYLHTKCR--IIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAV 210
Query: 771 ------------------GLSRLAPVLDDEGT---MPTHVSTIVKGTPGYLDPEYFLTHK 809
+L + D G + H + ++ T Y E +
Sbjct: 211 STAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHFTEDIQ-TRQYRSLEVLIGSG 269
Query: 810 LTDKSDVYSLGVVLLELLTG---MQPISHGKNIVREVNVARDSGMVFSIIDNRMGSYPSE 866
+D++S + EL TG +P S + E ++A I +G P +
Sbjct: 270 YNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIAL--------IIELLGKVPRK 321
Query: 867 CVER 870
+
Sbjct: 322 LIVA 325
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 52.7 bits (127), Expect = 2e-07
Identities = 49/215 (22%), Positives = 88/215 (40%), Gaps = 28/215 (13%)
Query: 632 QVGQGGYGKVYKGI-LSDNTTVAIKRAEEGSLQGQNEFLTEIKLLSRLHHRNLVSLLGYC 690
++G+G +G +++G L +N VAIK S Q E + L + + Y
Sbjct: 17 RIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRD--EYRTYKLLAGCTGIPNVYYF 74
Query: 691 DEEGE-QMLVYEFV-PN-GTLRDWLSGRTKENLNFAMR--LRVALDSAKGILYLHTEAHP 745
+EG +LV + + P+ L D + F+++ A + +H ++
Sbjct: 75 GQEGLHNVLVIDLLGPSLEDLLDLCGRK------FSVKTVAMAAKQMLARVQSIHEKS-- 126
Query: 746 PVFHRDIKASNILLDSNLNAK-----VADFGLSRLAPVLDDEGTMPTHVSTIVKGTPGYL 800
+ +RDIK N L+ + V DFG+ + + +P + GT Y+
Sbjct: 127 -LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYM 185
Query: 801 DPEYFLTHKLTDKS---DVYSLGVVLLELLTGMQP 832
TH ++S D+ +LG V + L G P
Sbjct: 186 SIN---THLGREQSRRDDLEALGHVFMYFLRGSLP 217
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272 | Back alignment and structure |
|---|
Score = 52.3 bits (126), Expect = 2e-07
Identities = 51/217 (23%), Positives = 79/217 (36%), Gaps = 44/217 (20%)
Query: 103 APELGQLSRLQYYFMWNDLTGTIPKEIGNISSLIFLLLNGNKLSGSLP--DELGYLSNLN 160
A +L+ + N ++ I + ++ +L L GNKL + EL +NL
Sbjct: 34 AVTQNELNSIDQIIANNSDIKSVQG-IQYLPNVRYLALGGNKLH-DISALKEL---TNLT 88
Query: 161 RLQVDENNITGTIPKSFANLSRVRHLHLNNNSIGGQIPSELSKLSTLIHLLVDNNNLSGN 220
L + N + F L+ ++ L L N + KL+ L +L + +N L +
Sbjct: 89 YLILTGNQLQSLPNGVFDKLTNLKELVLVENQLQSLPDGVFDKLTNLTYLNLAHNQLQ-S 147
Query: 221 LPPEL-SELPQLCILQLDNNNFSASEIPATYGNFSKLVKLSLRNCNLQGAVPDLSRIPNL 279
LP + +L L L L N + +P G F KL +L
Sbjct: 148 LPKGVFDKLTNLTELDLSYNQLQS--LPE--GVFDKLTQLK------------------- 184
Query: 280 YYLDLSWNHLTGSIPS------KKLSENVTTIDLSDN 310
L L N L S+P L I L DN
Sbjct: 185 -DLRLYQNQLK-SVPDGVFDRLTSL----QYIWLHDN 215
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 52.0 bits (125), Expect = 4e-07
Identities = 42/236 (17%), Positives = 85/236 (36%), Gaps = 52/236 (22%)
Query: 632 QVGQGGYGKVYKGI---------LSDNTTVAIKR-AEEGSLQGQNEFLT------EIKLL 675
+ G +Y+ ++K A++G L + F ++
Sbjct: 49 FQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAKPLQVNKW 108
Query: 676 SRLHHRNLV---SLLGYCDEEGE-QMLVYEFV-PNGTLRDWLSGRTKENLNFAMRLRVAL 730
+L+ L+ + +G+ + + + LV + + L+ L K L+ L+VA
Sbjct: 109 KKLYSTPLLAIPTCMGFGVHQDKYRFLVLPSLGRS--LQSALDVSPKHVLSERSVLQVAC 166
Query: 731 DSAKGILYLHTEAHPPVFHRDIKASNILLDSNLNAKV--ADFGLSRL-------APVLDD 781
+ +LH H ++ A NI +D ++V A +G + ++
Sbjct: 167 RLLDALEFLHENE---YVHGNVTAENIFVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEG 223
Query: 782 EGTMPTHVSTIVKGTPGY--LDPEYFLTHK---LTDKSDVYSLGVVLLELLTGMQP 832
+ G + +D HK + +SD+ SLG +L+ L G P
Sbjct: 224 SRSPHE-------GDLEFISMD-----LHKGCGPSRRSDLQSLGYCMLKWLYGFLP 267
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 52.0 bits (125), Expect = 4e-07
Identities = 36/154 (23%), Positives = 66/154 (42%), Gaps = 22/154 (14%)
Query: 632 QVGQGGYGKVYKGI-LSDNTTVAIKRAEEGSLQGQNEFLTEIKLLSRLHHRNLVSLLGYC 690
++G G +G++ G L N VAIK S Q E + +L + + + Y
Sbjct: 16 KIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRAPQLHL--EYRFYKQLGSGDGIPQVYYF 73
Query: 691 DEEGE-QMLVYEFV-PN-GTLRDWLSGRTKENLNFAMR--LRVALDSAKGILYLHTEAHP 745
G+ +V E + P+ L D F+++ L +A+ + Y+H++
Sbjct: 74 GPCGKYNAMVLELLGPSLEDLFDLCDRT------FSLKTVLMIAIQLISRMEYVHSKN-- 125
Query: 746 PVFHRDIKASNILL--DSNLNAKVA---DFGLSR 774
+ +RD+K N L+ N +V DF L++
Sbjct: 126 -LIYRDVKPENFLIGRPGNKTQQVIHIIDFALAK 158
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 48.9 bits (117), Expect = 2e-06
Identities = 37/154 (24%), Positives = 58/154 (37%), Gaps = 30/154 (19%)
Query: 184 RHLHLNNNSIGGQIPSELSKLSTLIHLLVDNNNLSGNLPPEL-SELPQLCILQLDNNNFS 242
+ L+L++N I P L L L + +N L LP + L QL +L L N +
Sbjct: 43 QILYLHDNQITKLEPGVFDSLINLKELYLGSNQLG-ALPVGVFDSLTQLTVLDLGTNQLT 101
Query: 243 ASEIPATYGNFSKLVKLSLRNCNLQGAVPDLSRIPNLYYLDLSWNHLTGSIPS--KKLSE 300
+P+ F +LV L L + N LT +P ++L+
Sbjct: 102 V--LPS--AVFDRLVHLK--------------------ELFMCCNKLT-ELPRGIERLT- 135
Query: 301 NVTTIDLSDNYLNGSILESISNLPFLQTLSLENN 334
++T + L N L + L L L N
Sbjct: 136 HLTHLALDQNQLKSIPHGAFDRLSSLTHAYLFGN 169
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 46.6 bits (111), Expect = 1e-05
Identities = 33/129 (25%), Positives = 51/129 (39%), Gaps = 9/129 (6%)
Query: 115 YFMWNDLTGTIPKEIGNISSLIFLLLNGNKLSGSLP----DELGYLSNLNRLQVDENNIT 170
Y N +T P ++ +L L L N+L +LP D L + L L + N +T
Sbjct: 46 YLHDNQITKLEPGVFDSLINLKELYLGSNQLG-ALPVGVFDSL---TQLTVLDLGTNQLT 101
Query: 171 GTIPKSFANLSRVRHLHLNNNSIGGQIPSELSKLSTLIHLLVDNNNLSGNLPPELSELPQ 230
F L ++ L + N + +P + +L+ L HL +D N L L
Sbjct: 102 VLPSAVFDRLVHLKELFMCCNKLTE-LPRGIERLTHLTHLALDQNQLKSIPHGAFDRLSS 160
Query: 231 LCILQLDNN 239
L L N
Sbjct: 161 LTHAYLFGN 169
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 46.2 bits (110), Expect = 2e-05
Identities = 37/138 (26%), Positives = 55/138 (39%), Gaps = 19/138 (13%)
Query: 233 ILQLDNNNFSASEIPATYGNFSKLVKLSLRNCNLQ---GAVPDLSRIPNLYYLDLSWNHL 289
IL L +N + E P + + L +L L + L V D + L LDL N L
Sbjct: 44 ILYLHDNQITKLE-PGVFDSLINLKELYLGSNQLGALPVGVFD--SLTQLTVLDLGTNQL 100
Query: 290 TGSIPSK---KLSENVTTIDLSDNYLNGSILESISNLPFLQTLSLENNFLTGSIPATIWQ 346
T +PS +L ++ + + N L + I L L L+L+ N L SIP +
Sbjct: 101 T-VLPSAVFDRLV-HLKELFMCCNKLT-ELPRGIERLTHLTHLALDQNQLK-SIPHGAFD 156
Query: 347 N-KSFSTKARLKIDLRNN 363
S + L N
Sbjct: 157 RLSSLTH-----AYLFGN 169
|
| >3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} Length = 372 | Back alignment and structure |
|---|
Score = 48.9 bits (117), Expect = 5e-06
Identities = 30/183 (16%), Positives = 61/183 (33%), Gaps = 26/183 (14%)
Query: 180 LSRVRHLHLNNNSIGGQIPSELSKL-----STLIHLLVDNNNLSGNLPPELSE-LPQLCI 233
LS +R L+L + + ++ + L + + + L L +
Sbjct: 71 LSSLRQLNLAGVRMTPVKCTVVAAVLGSGRHALDEVNLASCQLDPAGLRTLLPVFLRARK 130
Query: 234 LQLDNNNFSASEI----PATYGNFSKLVKLSLRNCNLQGA-VPDLSRI----PNLYYLDL 284
L L N+ + ++ L L N L A V L ++ +L L
Sbjct: 131 LGLQLNSLGPEACKDLRDLLLHDQCQITTLRLSNNPLTAAGVAVLMEGLAGNTSVTHLSL 190
Query: 285 SWNHLT----GSIPSKKLSEN--VTTIDLSDNYLNGS----ILESISNLPFLQTLSLENN 334
L + + +L N + ++++ N + + + P L+ L L N
Sbjct: 191 LHTGLGDEGLELL-AAQLDRNRQLQELNVAYNGAGDTAALALARAAREHPSLELLHLYFN 249
Query: 335 FLT 337
L+
Sbjct: 250 ELS 252
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 48.6 bits (116), Expect = 6e-06
Identities = 48/242 (19%), Positives = 83/242 (34%), Gaps = 64/242 (26%)
Query: 632 QVGQGGYGKVYKGILSDNTTVAIK--------RAEEGSLQGQNEFLTEIKLLSRLHHRNL 683
+GQGG+G +Y ++ + +V ++ G L TE+K R
Sbjct: 42 PIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPL------FTELKFYQRAAKPEQ 95
Query: 684 VSLLG--------------YCDEEGEQMLVYEFV------PN-GTLRDWLSGR--TKENL 720
+ + Y F+ + + + + R K L
Sbjct: 96 IQKWIRTRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRFGSDLQKIYEANAKRFSRKTVL 155
Query: 721 NFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSNLNAKV--ADFGLSRLAPV 778
++R+ L+ Y+H H DIKASN+LL+ +V D+GL+
Sbjct: 156 QLSLRILDILE------YIHEHE---YVHGDIKASNLLLNYKNPDQVYLVDYGLAYR--- 203
Query: 779 LDDEGT---MPTHVSTIVKGTPGY--LDPEYFLTHK---LTDKSDVYSLGVVLLELLTGM 830
EG GT + +D H + + D+ LG +++ LTG
Sbjct: 204 YCPEGVHKAYAADPKRCHDGTIEFTSID-----AHNGVAPSRRGDLEILGYCMIQWLTGH 258
Query: 831 QP 832
P
Sbjct: 259 LP 260
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192 | Back alignment and structure |
|---|
Score = 46.9 bits (112), Expect = 7e-06
Identities = 25/108 (23%), Positives = 45/108 (41%), Gaps = 10/108 (9%)
Query: 233 ILQLDNNNFSASEIPATYGNFSKLVKLSLRNCNLQGAVPD--LSRIPNLYYLDLSWNHLT 290
L L++N +G LVKL L+ L + ++ L L N +
Sbjct: 33 ELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLT-GIEPNAFEGASHIQELQLGENKIK 91
Query: 291 GSIPSK---KLSENVTTIDLSDNYLNGSILESI-SNLPFLQTLSLENN 334
I +K L + T++L DN ++ ++ +L L +L+L +N
Sbjct: 92 -EISNKMFLGLH-QLKTLNLYDNQIS-CVMPGSFEHLNSLTSLNLASN 136
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 48.1 bits (115), Expect = 8e-06
Identities = 53/232 (22%), Positives = 85/232 (36%), Gaps = 58/232 (25%)
Query: 633 VGQGGYGKVYKGI--LSDNTTVAIK--RAEEG-SLQGQNEFLTEIKLLSRLHHR------ 681
+G+G +GKV + + + VA+K R + EI +L ++ +
Sbjct: 27 LGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAAR----LEINVLKKIKEKDKENKF 82
Query: 682 NLVSLLGYCDEEGEQMLVYEFV-PNGTLRDWLSGRTKENLNFAMRLRVALDSAKGIL--- 737
V + + + G + +E + N ++L KEN L A +
Sbjct: 83 LCVLMSDWFNFHGHMCIAFELLGKN--TFEFL----KENNFQPYPLPHVRHMAYQLCHAL 136
Query: 738 -YLHTEAHPPVFHRDIKASNILLDSNLNA-------------------KVADFGLSRLAP 777
+LH + H D+K NIL ++ +VADFG +
Sbjct: 137 RFLH---ENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSA---- 189
Query: 778 VLDDEGTMPTHVSTIVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVLLELLTG 829
D E H +TIV T Y PE L DV+S+G +L E G
Sbjct: 190 TFDHE-----HHTTIVA-TRHYRPPEVILELGWAQPCDVWSIGCILFEYYRG 235
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193 | Back alignment and structure |
|---|
Score = 46.1 bits (110), Expect = 1e-05
Identities = 23/82 (28%), Positives = 43/82 (52%), Gaps = 3/82 (3%)
Query: 138 LLLNGNKLSGSLPDELGYLSNLNRLQVDENNITGTIPKSFANLSRVRHLHLNNNSIGGQI 197
L L+GN+ + +P EL +L + + N I+ +SF+N++++ L L+ N + I
Sbjct: 36 LYLDGNQFT-LVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYNRL-RCI 93
Query: 198 PSEL-SKLSTLIHLLVDNNNLS 218
P L +L L + N++S
Sbjct: 94 PPRTFDGLKSLRLLSLHGNDIS 115
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193 | Back alignment and structure |
|---|
Score = 42.3 bits (100), Expect = 2e-04
Identities = 30/129 (23%), Positives = 51/129 (39%), Gaps = 32/129 (24%)
Query: 210 LLVDNNNLSGNLPPELSELPQLCILQLDNNNFSASEIPATYGNFSKLVKLSLRNCNLQGA 269
L +D N + +P ELS L ++ L NN S + +FS + +L
Sbjct: 36 LYLDGNQFT-LVPKELSNYKHLTLIDLSNNRIST--LSN--QSFSNMTQLL--------- 81
Query: 270 VPDLSRIPNLYYLDLSWNHLTGSIPSK---KLSENVTTIDLSDNYLNGSILESI-SNLPF 325
L LS+N L IP + L ++ + L N ++ + E ++L
Sbjct: 82 -----------TLILSYNRLR-CIPPRTFDGLK-SLRLLSLHGNDIS-VVPEGAFNDLSA 127
Query: 326 LQTLSLENN 334
L L++ N
Sbjct: 128 LSHLAIGAN 136
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 47.4 bits (113), Expect = 1e-05
Identities = 52/243 (21%), Positives = 85/243 (34%), Gaps = 69/243 (28%)
Query: 632 QVGQGGYGKVYKGI-LSDNTTVA-----IKRAEEGSLQGQNEFLTEIKLLSRLHHRNLV- 684
++G GG+G +Y + A ++ E G L +E+K R+ ++ +
Sbjct: 44 KIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPL------FSELKFYQRVAKKDCIK 97
Query: 685 --------SLLG-----YCDEEGEQMLVYEFV------PNGTLRDWLSGRTKENLNFAMR 725
LG + Y F+ + L+ +N F
Sbjct: 98 KWIERKQLDYLGIPLFYGSGLTEFKGRSYRFMVMERLGID--LQKIS----GQNGTFKKS 151
Query: 726 --LRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSNLNAKV--ADFGLSRL------ 775
L++ + + Y+H H DIKA+N+LL +V AD+GLS
Sbjct: 152 TVLQLGIRMLDVLEYIHENE---YVHGDIKAANLLLGYKNPDQVYLADYGLSYRYCPNGN 208
Query: 776 -APVLDDEGTMPTHVSTIVKGTPGY--LDPEYFLTHK---LTDKSDVYSLGVVLLELLTG 829
++ GT + LD HK L+ +SDV LG +L L G
Sbjct: 209 HKQYQENPRKGHN-------GTIEFTSLD-----AHKGVALSRRSDVEILGYCMLRWLCG 256
Query: 830 MQP 832
P
Sbjct: 257 KLP 259
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 46.9 bits (112), Expect = 2e-05
Identities = 46/226 (20%), Positives = 79/226 (34%), Gaps = 44/226 (19%)
Query: 634 GQGGYGKVYKGI-LSDNTTVAIK--RAEEG-SLQGQNEFLTEIKLLSRL-----HHRNLV 684
G G +G+V + + A+K R + + + E +L ++ ++ N+V
Sbjct: 44 GDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTRSAK----IEADILKKIQNDDINNNNIV 99
Query: 685 SLLGYCDEEGEQMLVYEFV-PNGTLRDWLSGRTKENLN--FAMRL--RVALDSAKGILYL 739
G L++E + P+ L + + N F + ++ K + YL
Sbjct: 100 KYHGKFMYYDHMCLIFEPLGPS--LYEII----TRNNYNGFHIEDIKLYCIEILKALNYL 153
Query: 740 HTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSRLAPVLDDEGTMPT------------ 787
+ + H D+K NILLD K +
Sbjct: 154 RKMS---LTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCAT 210
Query: 788 ----HVSTIVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVLLELLTG 829
+ +I+ T Y PE L SD++S G VL EL TG
Sbjct: 211 FKSDYHGSIIN-TRQYRAPEVILNLGWDVSSDMWSFGCVLAELYTG 255
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 47.5 bits (112), Expect = 2e-05
Identities = 93/583 (15%), Positives = 167/583 (28%), Gaps = 176/583 (30%)
Query: 424 VDNFFEYVPASPEPCFCAAPLRIGYRLKSPSFTYFPPYVYPFEEYLTNTLNLELYQLSID 483
V F E V F +P++ + PS + E N
Sbjct: 79 VQKFVEEV-LRINYKFLMSPIK--TEQRQPSMMT-----RMYIEQRDRLYN------DNQ 124
Query: 484 SFAWEKGPRLEMYLKLFPTLNRSSTFDDSEVRQI------------------RDRFTSWK 525
FA RL+ YLKL R + + + + K
Sbjct: 125 VFAKYNVSRLQPYLKL-----RQALLELRPAKNVLIDGVLGSGKTWVALDVCLSYKVQCK 179
Query: 526 FPGSDIFGPYELLNF-------TLLGPYSNL------NFNSQSKGISGGILAAIVVGAVA 572
IF LN T+L L N+ S+S S L
Sbjct: 180 MDFK-IF----WLNLKNCNSPETVLEMLQKLLYQIDPNWTSRSDHSSNIKL--------- 225
Query: 573 SAVAITAAVTLLVMRRHARYQHSLSRKRLSTKISMKIDGV------KGFKF--KELAMAT 624
+I A + L+ + Y++ L L + + V F K L + T
Sbjct: 226 RIHSIQAELRRLLKSK--PYENCL----L---V---LLNVQNAKAWNAFNLSCKIL-LTT 272
Query: 625 AYFSSSTQVGQGGYGKVYKGILSDNTTVAIKRAEEGSLQGQNEFLTEIKLLSRLHHRNLV 684
+ + + + SL + LT ++ S
Sbjct: 273 RFKQVTDFLSAATTTHI-------------------SLDHHSMTLTPDEVKS-------- 305
Query: 685 SLLGYCDEEGEQMLVYEFVPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAH 744
LL + Q L E + R LS A +R L + +++ +
Sbjct: 306 -LLLKYLDCRPQDLPREVLTTNPRR--LSI-------IAESIRDGLATWDNWKHVNCDK- 354
Query: 745 PPVFHRDIKAS-NILLDSNLNAKVADFGLSRLAPVLDDEGTMPTHVSTIVKGTPGYLDPE 803
I++S N+L + V +PT + +++ D
Sbjct: 355 ---LTTIIESSLNVLEPAEYRKMFDRLS------VFPPSAHIPTILLSLIWFDVIKSDVM 405
Query: 804 YFLTHKLTDKSDV--------YSLGVVLLELLTGM--QPISHGKNIVREVNVARD---SG 850
+ +KL S V S+ + LEL + + H ++IV N+ +
Sbjct: 406 VVV-NKLHKYSLVEKQPKESTISIPSIYLELKVKLENEYALH-RSIVDHYNIPKTFDSDD 463
Query: 851 MVFSIIDNRMGSY---------PSECVERFVTLAL-------RCCHDKP--EHRPSMSDV 892
++ +D S+ E + F + L + HD S+ +
Sbjct: 464 LIPPYLDQYFYSHIGHHLKNIEHPERMTLFRMVFLDFRFLEQKIRHDSTAWNASGSILNT 523
Query: 893 VRELEN----ILKMFPETDTM------FSKSESSSLLSGKSAS 925
+++L+ I P+ + + F +L+ K
Sbjct: 524 LQQLKFYKPYICDNDPKYERLVNAILDFLPKIEENLICSKYTD 566
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 45.6 bits (107), Expect = 8e-05
Identities = 90/668 (13%), Positives = 195/668 (29%), Gaps = 180/668 (26%)
Query: 240 NFSASEIPATYGN----FSKLVKLSLRNCNLQGAVPDLSRIPNLYYLDLSWNHLTGSIPS 295
+F E Y + F + +C V D+ + SI S
Sbjct: 8 DFETGEHQYQYKDILSVFEDAFVDNF-DCK---DVQDMPK----------------SILS 47
Query: 296 KKLSENVTTIDLSDN---YLNGSILESISNL--PFLQTLSLENN--FLTGSIPATIWQNK 348
K+ +++ + + L ++L + F++ + L N FL I + +
Sbjct: 48 KEEIDHIIMSKDAVSGTLRLFWTLLSKQEEMVQKFVEEV-LRINYKFLMSPIKT---EQR 103
Query: 349 SFSTKARLKIDLRNNSFSNIVGDLTLPNNVT-------LRLGGNPICTSANIPNTGRF-C 400
S R+ I+ R+ +++ + NV+ LR P
Sbjct: 104 QPSMMTRMYIEQRDRLYND--NQVFAKYNVSRLQPYLKLR-----QALLELRPAKNVLID 156
Query: 401 GSDAG-GDETLTNSKV-NCPVQACPVDNFFEYV----PASPEPCFCAAPLRIGYRLKSPS 454
G G G + + VQ F ++ SPE L+ P+
Sbjct: 157 G-VLGSGKTWVALDVCLSYKVQCKMDFKIF-WLNLKNCNSPETVL--EMLQKLLYQIDPN 212
Query: 455 FT----YFPPYVYPFEE---YLTNTLNLELYQ--LSI-----DSFAWEK---GPRLEMYL 497
+T + L L + Y+ L + ++ AW ++
Sbjct: 213 WTSRSDHSSNIKLRIHSIQAELRRLLKSKPYENCLLVLLNVQNAKAWNAFNLSCKI---- 268
Query: 498 KLFPTLNRSSTFDDSEVRQIRDRFTSWKFPGSDIFGPYELLNFTLLGPYSNLNFNS---Q 554
L T + T D + + P E+ +LL Y + +
Sbjct: 269 -LLTTRFKQVT--DFLSAATTTHISLDHHSMT--LTPDEVK--SLLLKYLDCRPQDLPRE 321
Query: 555 SKGISGGILAAIVVGAVASAVAITAAVTLLVMRRHA----RYQHSLSRKRLSTKISMKID 610
+ ++I A +R ++H ++ +L+T I ++
Sbjct: 322 VLTTN------------PRRLSIIAES----IRDGLATWDNWKH-VNCDKLTTIIESSLN 364
Query: 611 GVKGFKFKELAMATAYFSSSTQVGQGGYGKVYKGILSDNTTVAIKRAEEGSL-QGQNEFL 669
++ +++++ + F S + ++ ++ + V + + + SL + Q +
Sbjct: 365 VLEPAEYRKMFDRLSVFPPSAHIPTILLSLIWFDVIKSDVMVVVNKLHKYSLVEKQPK-- 422
Query: 670 TEIKLLSRLHHRNLVSLLGYCDEEGE--QMLV--YEFVPNGTLRDWLSGRTKENLNFAMR 725
+ + L L + E + +V Y +T ++ +
Sbjct: 423 ---ESTISIPSIYL-ELKVKLENEYALHRSIVDHYNIP-----------KTFDSDDL--- 464
Query: 726 LRVALDSAKGILYLHTEAHPPVFH--------RDIKASNILLDSN-LNAKVADFGLSRLA 776
Y H H R + LD L K+ + A
Sbjct: 465 ---IPPYLDQYFYSHI-----GHHLKNIEHPERMTLFRMVFLDFRFLEQKIRHDSTAWNA 516
Query: 777 P--VLDDEGTMPTHVSTIVKGTPGYLDPEYFLTHKLTDKSDVYSLGV-VLLELLTGMQPI 833
+L+ +++ + + D Y V +L+ L
Sbjct: 517 SGSILNT-----------------LQQLKFYKPY-ICDNDPKYERLVNAILDFL-----P 553
Query: 834 SHGKNIVR 841
+N++
Sbjct: 554 KIEENLIC 561
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 44.8 bits (105), Expect = 1e-04
Identities = 51/310 (16%), Positives = 94/310 (30%), Gaps = 93/310 (30%)
Query: 33 AQTTDPQEASALRAIKNSLVDSMNHLRNWNKGDPCMSNWTGVLCFDTVETDGHLHVRELQ 92
TT+P+ L I S+ D + NW V D + E
Sbjct: 322 VLTTNPR---RLSIIAESIRDGLATWDNWKH----------------VNCDKLTTIIES- 361
Query: 93 LLSMNLSGNLAPELGQLSRLQYYFMWNDLTGTIPKEIGNISSLIFLLLNGNKLSGSLPDE 152
S+N L P + + + + L P +I +++ L+ + + +
Sbjct: 362 --SLN---VLEPAEYR----KMF---DRL-SVFPPSA-HIPTILLSLIWFDVIKSDVMVV 407
Query: 153 LGYLSNLNRLQVDENNITGTIPKSFANLSRVRHLHLNNNSIGGQIPSELSKLSTLIH-LL 211
+ L + ++ T +IP ++L ++ +L L H +
Sbjct: 408 VNKLHKYSLVEKQPKESTISIP----------SIYL-------ELKVKLENEYAL-HRSI 449
Query: 212 VDNNNLSGNLPPELSELPQLCILQLDNNNFSASEIPATYGNFSKLVKLSLRNCNLQGAVP 271
VD+ N+ + L LD + S I + L+N +
Sbjct: 450 VDHYNIPKTFDSD-----DLIPPYLDQ--YFYSHIG--H---------HLKNIEHPERMT 491
Query: 272 DLSRIPNLYYLDLSWNHLTGSIPSKKLSENVTTIDLSDNYLNGSILESISNLPFLQTLSL 331
+ +LD + + K I N S SI N LQ L
Sbjct: 492 LFRMV----FLDFRF------LEQK--------IRHDSTAWNAS--GSILNT--LQQLKF 529
Query: 332 ENNFLTGSIP 341
++ + P
Sbjct: 530 YKPYICDNDP 539
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 42.5 bits (99), Expect = 7e-04
Identities = 90/584 (15%), Positives = 175/584 (29%), Gaps = 196/584 (33%)
Query: 148 SLPDELGYLSNLNRLQVDENNITGTIPKSFA--NLSRVRHLHLNNNSIGGQIPSELSKL- 204
S+ + Y+ +RL D + FA N+SR++ ++ L +L
Sbjct: 106 SMMTRM-YIEQRDRLYND--------NQVFAKYNVSRLQPYL--------KLRQALLELR 148
Query: 205 ---------------STLIHLLVDNNNLSGNLP-------------PE--LSELPQLCIL 234
+ + + + + + PE L L +L
Sbjct: 149 PAKNVLIDGVLGSGKTWVALDVCLSYKVQCKMDFKIFWLNLKNCNSPETVLEMLQKLL-Y 207
Query: 235 QLDNNNFSASEIPATYGNFSKLVKLSLRNCNLQGAVPDLSRIPN-LYYLDLSWN--HLTG 291
Q+D N S S+ + ++ LR L N L L N
Sbjct: 208 QIDPNWTSRSDHSSNIKLRIHSIQAELR--RLL----KSKPYENCLLVLLNVQNAKAWNA 261
Query: 292 -SIPSKKLSENVTTIDLSD-NYLNGSILESISNLPFLQTLSLENNFLTGSIPATIWQNKS 349
++ K L +TT ++L+ + I SL+++ + +
Sbjct: 262 FNLSCKIL---LTTRFKQVTDFLSAATTTHI---------SLDHH------------SMT 297
Query: 350 FSTKARLKIDLRNNSFSNIVG--DLTLPNNVTLRLGGNPICTS---ANIPNTGRFCGSDA 404
+ + + LP V L NP S +I +
Sbjct: 298 LTPDEVKSL------LLKYLDCRPQDLPREV---LTTNPRRLSIIAESIRD--------- 339
Query: 405 GGDETLTNSK-VNCPVQACPVDNFFEYVPASPEPCFCAAPLRIGYRLKSPSFTYFPPYVY 463
G T N K VNC +++ + EP A R + + FPP +
Sbjct: 340 -GLATWDNWKHVNCDKLTTIIESSLNVL----EP----AEYRKMFD----RLSVFPPSAH 386
Query: 464 -PFEEYLTNTLNL-------ELYQLSIDSFA-------WEKGPRLE---MYLKLFPTLNR 505
P T L+L + ++ K + +YL+L L
Sbjct: 387 IP-----TILLSLIWFDVIKSDVMVVVNKLHKYSLVEKQPKESTISIPSIYLELKVKLE- 440
Query: 506 SSTFDDSEV-RQIRDRFTSWK-FPGSDIFGP-----------YELLN---------FTLL 543
++ + R I D + K F D+ P + L N F ++
Sbjct: 441 ----NEYALHRSIVDHYNIPKTFDSDDLIPPYLDQYFYSHIGHHLKNIEHPERMTLFRMV 496
Query: 544 GPYSNLNFNSQSKGISGGILAAIVVGAVASAVAITAAVTLLVMRRHARY--QHSLSRKRL 601
+ + F + K A G++ + TL ++ + Y + +RL
Sbjct: 497 --FLDFRF-LEQKIRHDS-TAWNASGSILN--------TLQQLKFYKPYICDNDPKYERL 544
Query: 602 STKISMKIDGVKGFKFK-ELAMATAYFSSSTQVG-QGGYGKVYK 643
++ + F K E + + ++ ++ +++
Sbjct: 545 -------VNAILDFLPKIEENLICSKYTDLLRIALMAEDEAIFE 581
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208 | Back alignment and structure |
|---|
Score = 44.3 bits (105), Expect = 7e-05
Identities = 32/116 (27%), Positives = 54/116 (46%), Gaps = 10/116 (8%)
Query: 161 RLQVDENNITGTIPKSFANLSRVRHLHLNNNSIGGQIPSELSKLSTLIHLLVDNNNLSGN 220
L ++ N++ F L+ + L+L N + +KL++L +L + N L +
Sbjct: 32 YLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQSLPNGVFNKLTSLTYLNLSTNQLQ-S 90
Query: 221 LPPEL-SELPQLCILQLDNNNFSASEIPATYGNFSKLVKL---SLRNCNLQGAVPD 272
LP + +L QL L L+ N + +P G F KL +L L L+ +VPD
Sbjct: 91 LPNGVFDKLTQLKELALNTNQLQS--LPD--GVFDKLTQLKDLRLYQNQLK-SVPD 141
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208 | Back alignment and structure |
|---|
Score = 40.8 bits (96), Expect = 8e-04
Identities = 32/124 (25%), Positives = 53/124 (42%), Gaps = 6/124 (4%)
Query: 138 LLLNGNKLSGSLPDELGYLSNLNRLQVDENNITGTIPKSFANLSRVRHLHLNNNSIGGQI 197
L L N L L++L +L + N + F L+ + +L+L+ N +
Sbjct: 33 LDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQSLPNGVFNKLTSLTYLNLSTNQLQSLP 92
Query: 198 PSELSKLSTLIHLLVDNNNLSGNLPPEL-SELPQLCILQLDNNNFSASEIPATYGNFSKL 256
KL+ L L ++ N L +LP + +L QL L+L N + +P G F +L
Sbjct: 93 NGVFDKLTQLKELALNTNQLQ-SLPDGVFDKLTQLKDLRLYQNQLKS--VP--DGVFDRL 147
Query: 257 VKLS 260
L
Sbjct: 148 TSLQ 151
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 44.6 bits (106), Expect = 9e-05
Identities = 58/231 (25%), Positives = 91/231 (39%), Gaps = 58/231 (25%)
Query: 634 GQGGYGKVYKGI--LSDNTTVAIK--RAEEG-SLQGQNEFLTEIKLLSRLHHR------N 682
G+G +GKV + I + VA+K + + + +EI++L L+
Sbjct: 23 GEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAAR----SEIQVLEHLNTTDPNSTFR 78
Query: 683 LVSLLGYCDEEGEQMLVYEFV-PNGTLRDWLSGRTKENLNFAMRLRVALDSAKGIL---- 737
V +L + + G +V+E + + D++ KEN RL A I
Sbjct: 79 CVQMLEWFEHHGHICIVFELLGLS--TYDFI----KENGFLPFRLDHIRKMAYQICKSVN 132
Query: 738 YLHTEAHPPVFHRDIKASNILLDSNLNA-------------------KVADFGLSRLAPV 778
+LH+ + H D+K NIL + KV DFG +
Sbjct: 133 FLHSNK---LTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSA----T 185
Query: 779 LDDEGTMPTHVSTIVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVLLELLTG 829
DDE H ST+V T Y PE L + DV+S+G +L+E G
Sbjct: 186 YDDE-----HHSTLVS-TRHYRAPEVILALGWSQPCDVWSIGCILIEYYLG 230
|
| >3rw6_A Nuclear RNA export factor 1; retroviral constitutive transport element (CTE), RNA recogni motif (RRM); HET: GTP CCC; 2.30A {Homo sapiens} PDB: 3rw7_A 1koo_A 1koh_A 1ft8_A 1fo1_A Length = 267 | Back alignment and structure |
|---|
Score = 43.8 bits (103), Expect = 1e-04
Identities = 25/103 (24%), Positives = 37/103 (35%), Gaps = 8/103 (7%)
Query: 236 LDNNNFSASEIPATYGNFSKLVKLSLRNCNLQGAVPDLSRIPNLYYLDLSWNHLTGSIPS 295
LD + L + S L+ IP L L+LS N L
Sbjct: 132 LDLKGLRSDPDLVAQNIDVVLNRRSCMAATLRII---EENIPELLSLNLSNNRLYRLDDM 188
Query: 296 KKLSE---NVTTIDLSDNYLNG-SILESISNLPFLQTLSLENN 334
+ + N+ ++LS N L L+ I L L+ L L+ N
Sbjct: 189 SSIVQKAPNLKILNLSGNELKSERELDKIKGLK-LEELWLDGN 230
|
| >3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* Length = 592 | Back alignment and structure |
|---|
Score = 44.2 bits (104), Expect = 2e-04
Identities = 32/229 (13%), Positives = 73/229 (31%), Gaps = 27/229 (11%)
Query: 134 SLIFLLLNGNKLS-------GSLPDELGYLSNLNRLQVDENNIT-GTIPKSFANLSRVRH 185
+ LL+ + S L L LN + I+ + N +
Sbjct: 165 KIKTLLMEESSFSEKDGKWLHELAQHNTSLEVLNFYMTEFAKISPKDLETIARNCRSLVS 224
Query: 186 LHLNNNSI--GGQIPSELSKLSTLIHLLVDNNNLSGNLPPELSELPQLCILQLDNNNFSA 243
+ + + I + L ++ + L +LC L L
Sbjct: 225 VKVGDFEILELVGFFKAAANLEEFCGGSLNEDIGMPEKYMNLVFPRKLCRLGLSY--MGP 282
Query: 244 SEIPATYGNFSKLVKLSLRNCNLQ--GAVPDLSRIPNLYYLDL-------SWNHLTGSIP 294
+E+P + +++ KL L L+ + + PNL L+ L
Sbjct: 283 NEMPILFPFAAQIRKLDLLYALLETEDHCTLIQKCPNLEVLETRNVIGDRGLEVLAQYCK 342
Query: 295 S-KKLS----ENVTTIDLSDNYLNGSILESIS-NLPFLQTLSLENNFLT 337
K+L + ++ + ++ L +++ L+ +++ + +T
Sbjct: 343 QLKRLRIERGADEQGMEDEEGLVSQRGLIALAQGCQELEYMAVYVSDIT 391
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* Length = 263 | Back alignment and structure |
|---|
Score = 42.7 bits (100), Expect = 3e-04
Identities = 27/206 (13%), Positives = 51/206 (24%), Gaps = 52/206 (25%)
Query: 631 TQVGQGGYG-KVYKGILSDNTTVAIKRAEEGSLQGQNEFLTEIKLLSRLHHRNLV-SLLG 688
+ +G KVYK ++ +N + +K + + E ++ L + V +L
Sbjct: 19 VKDTEGMSPAKVYK-LVGENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLH 77
Query: 689 YCDEEGEQMLVYEFVPNGTLRD-WLSGRTKENLNFAM----------------------- 724
+ +G L+ + + ++ E +
Sbjct: 78 FERHDGWSNLLMSEADGVLCSEEYEDEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDS 137
Query: 725 ------------------------RLRVALDSAKGILYLHTEAHPPVF-HRDIKASNILL 759
L VF H D+ SNI +
Sbjct: 138 RLAELDYLLNNDLADVDCENWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFV 197
Query: 760 DSNLNAKVADFGLSRLAPVLDDEGTM 785
+ D G S A D
Sbjct: 198 KDGKVSGFIDLGRSGRADKWYDIAFC 223
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 958 | |||
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 4ecn_A | 876 | Leucine-rich repeat protein; leucine-rich repeats, | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 100.0 | |
| 1ogq_A | 313 | PGIP-2, polygalacturonase inhibiting protein; inhi | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 2id5_A | 477 | Lingo-1, leucine rich repeat neuronal 6A; CNS-spec | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 3v47_A | 455 | TOLL-like receptor 5B and variable lymphocyte REC | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 3j0a_A | 844 | TOLL-like receptor 5; membrane protein, leucine-ri | 100.0 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 3a79_B | 562 | TLR6, VLRB.59, TOLL-like receptor 6, variable lymp | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 2z7x_B | 520 | TOLL-like receptor 1, variable lymphocyte recepto; | 100.0 | |
| 3o6n_A | 390 | APL1; leucine-rich repeat, protein binding; HET: N | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 100.0 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 100.0 | |
| 3oja_B | 597 | Anopheles plasmodium-responsive leucine-rich REPE | 100.0 | |
| 4g8a_A | 635 | TOLL-like receptor 4; leucine rich repeat MD-2 rel | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 100.0 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 100.0 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 100.0 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 99.98 | |
| 2z7x_B | 520 | TOLL-like receptor 1, variable lymphocyte recepto; | 99.98 | |
| 3a79_B | 562 | TLR6, VLRB.59, TOLL-like receptor 6, variable lymp | 99.97 | |
| 4fcg_A | 328 | Uncharacterized protein; structural genomics, PSI- | 99.97 | |
| 4ecn_A | 876 | Leucine-rich repeat protein; leucine-rich repeats, | 99.97 | |
| 3zyj_A | 440 | Leucine-rich repeat-containing protein 4C; cell ad | 99.97 | |
| 1ogq_A | 313 | PGIP-2, polygalacturonase inhibiting protein; inhi | 99.97 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 99.97 | |
| 3j0a_A | 844 | TOLL-like receptor 5; membrane protein, leucine-ri | 99.97 | |
| 2z80_A | 353 | TOLL-like receptor 2, variable lymphocyte recepto; | 99.97 | |
| 3zyi_A | 452 | Leucine-rich repeat-containing protein 4; cell adh | 99.97 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 99.97 | |
| 3o6n_A | 390 | APL1; leucine-rich repeat, protein binding; HET: N | 99.97 | |
| 2z66_A | 306 | Variable lymphocyte receptor B, TOLL-like recepto; | 99.97 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 99.97 | |
| 2id5_A | 477 | Lingo-1, leucine rich repeat neuronal 6A; CNS-spec | 99.97 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 99.96 | |
| 3v47_A | 455 | TOLL-like receptor 5B and variable lymphocyte REC | 99.96 | |
| 4fmz_A | 347 | Internalin; leucine rich repeat, structural genomi | 99.96 | |
| 1xku_A | 330 | Decorin; proteoglycan, leucine-rich repeat, struct | 99.96 | |
| 3oja_B | 597 | Anopheles plasmodium-responsive leucine-rich REPE | 99.96 | |
| 1xku_A | 330 | Decorin; proteoglycan, leucine-rich repeat, struct | 99.96 | |
| 1o6v_A | 466 | Internalin A; bacterial infection, extracellular r | 99.96 | |
| 2ft3_A | 332 | Biglycan; proteoglycan, dimer interface, structura | 99.96 | |
| 4g8a_A | 635 | TOLL-like receptor 4; leucine rich repeat MD-2 rel | 99.96 | |
| 2ft3_A | 332 | Biglycan; proteoglycan, dimer interface, structura | 99.96 | |
| 4fmz_A | 347 | Internalin; leucine rich repeat, structural genomi | 99.96 | |
| 3bz5_A | 457 | Internalin-J, INLJ; leucine rich repeat (LRR), cys | 99.96 | |
| 1o6v_A | 466 | Internalin A; bacterial infection, extracellular r | 99.95 | |
| 1ozn_A | 285 | Reticulon 4 receptor; NOGO receptor, MAD, myelinat | 99.95 | |
| 3zyi_A | 452 | Leucine-rich repeat-containing protein 4; cell adh | 99.95 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.95 | |
| 3g06_A | 622 | SSPH2 (leucine-rich repeat protein); E3 ubiquitin | 99.95 | |
| 1wwl_A | 312 | Monocyte differentiation antigen CD14; LPS, immune | 99.94 | |
| 1jl5_A | 454 | Outer protein YOPM; leucine-rich repeat, molecular | 99.94 | |
| 1jl5_A | 454 | Outer protein YOPM; leucine-rich repeat, molecular | 99.94 | |
| 4fcg_A | 328 | Uncharacterized protein; structural genomics, PSI- | 99.94 | |
| 3bz5_A | 457 | Internalin-J, INLJ; leucine rich repeat (LRR), cys | 99.94 | |
| 1wwl_A | 312 | Monocyte differentiation antigen CD14; LPS, immune | 99.94 | |
| 1ozn_A | 285 | Reticulon 4 receptor; NOGO receptor, MAD, myelinat | 99.94 | |
| 2z66_A | 306 | Variable lymphocyte receptor B, TOLL-like recepto; | 99.93 | |
| 2z80_A | 353 | TOLL-like receptor 2, variable lymphocyte recepto; | 99.93 | |
| 2o6q_A | 270 | Variable lymphocyte receptor A; leucine-rich repea | 99.93 | |
| 3zyj_A | 440 | Leucine-rich repeat-containing protein 4C; cell ad | 99.93 | |
| 2z62_A | 276 | TOLL-like receptor 4, variable lymphocyte recepto; | 99.93 | |
| 3oja_A | 487 | Leucine-rich immune molecule 1; coiled-coil, helix | 99.92 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.92 | |
| 2z62_A | 276 | TOLL-like receptor 4, variable lymphocyte recepto; | 99.92 | |
| 1p9a_G | 290 | Platelet glycoprotein IB alpha chain precursor; pl | 99.92 | |
| 3o53_A | 317 | Protein LRIM1, AGAP006348-PA; leucine-rich repeat, | 99.92 | |
| 3o53_A | 317 | Protein LRIM1, AGAP006348-PA; leucine-rich repeat, | 99.91 | |
| 3oja_A | 487 | Leucine-rich immune molecule 1; coiled-coil, helix | 99.91 | |
| 1z7x_W | 461 | Ribonuclease inhibitor; leucine-rich repeat, enzym | 99.9 | |
| 3g06_A | 622 | SSPH2 (leucine-rich repeat protein); E3 ubiquitin | 99.9 | |
| 1z7x_W | 461 | Ribonuclease inhibitor; leucine-rich repeat, enzym | 99.9 | |
| 4glp_A | 310 | Monocyte differentiation antigen CD14; alpha beta | 99.89 | |
| 3rfs_A | 272 | Internalin B, repeat modules, variable lymphocyte | 99.89 | |
| 3rfs_A | 272 | Internalin B, repeat modules, variable lymphocyte | 99.89 | |
| 1p9a_G | 290 | Platelet glycoprotein IB alpha chain precursor; pl | 99.89 | |
| 2o6q_A | 270 | Variable lymphocyte receptor A; leucine-rich repea | 99.88 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.87 | |
| 4glp_A | 310 | Monocyte differentiation antigen CD14; alpha beta | 99.87 | |
| 3m19_A | 251 | Variable lymphocyte receptor A diversity region; a | 99.87 | |
| 2ast_B | 336 | S-phase kinase-associated protein 2; SCF-substrate | 99.87 | |
| 1h6u_A | 308 | Internalin H; cell adhesion, leucine rich repeat, | 99.86 | |
| 2xwt_C | 239 | Thyrotropin receptor; signaling protein-immune sys | 99.86 | |
| 2xwt_C | 239 | Thyrotropin receptor; signaling protein-immune sys | 99.86 | |
| 2ca6_A | 386 | RAN GTPase-activating protein 1; GAP, GTPase activ | 99.86 | |
| 3m19_A | 251 | Variable lymphocyte receptor A diversity region; a | 99.85 | |
| 4ay9_X | 350 | Follicle-stimulating hormone receptor; hormone-rec | 99.85 | |
| 3goz_A | 362 | Leucine-rich repeat-containing protein; LEGL7, NES | 99.85 | |
| 3cvr_A | 571 | Invasion plasmid antigen; leucine rich repeat and | 99.85 | |
| 2o6s_A | 208 | Variable lymphocyte receptor B; leucine-rich repea | 99.84 | |
| 3goz_A | 362 | Leucine-rich repeat-containing protein; LEGL7, NES | 99.84 | |
| 2ca6_A | 386 | RAN GTPase-activating protein 1; GAP, GTPase activ | 99.84 | |
| 1h6u_A | 308 | Internalin H; cell adhesion, leucine rich repeat, | 99.84 | |
| 4ay9_X | 350 | Follicle-stimulating hormone receptor; hormone-rec | 99.84 | |
| 2ast_B | 336 | S-phase kinase-associated protein 2; SCF-substrate | 99.82 | |
| 3cvr_A | 571 | Invasion plasmid antigen; leucine rich repeat and | 99.82 | |
| 2v9t_B | 220 | SLIT homolog 2 protein N-product; structural prote | 99.82 | |
| 2v70_A | 220 | SLIT-2, SLIT homolog 2 protein N-product; neurogen | 99.81 | |
| 2xot_A | 361 | Amphoterin-induced protein 1; cell adhesion, neuro | 99.78 | |
| 2o6s_A | 208 | Variable lymphocyte receptor B; leucine-rich repea | 99.78 | |
| 1h6t_A | 291 | Internalin B; cell adhesion, leucine rich repeat, | 99.78 | |
| 3ogk_B | 592 | Coronatine-insensitive protein 1; leucine rich rep | 99.77 | |
| 1h6t_A | 291 | Internalin B; cell adhesion, leucine rich repeat, | 99.77 | |
| 1m9s_A | 605 | Internalin B; cell invasion, GW domains, SH3 domai | 99.77 | |
| 2v9t_B | 220 | SLIT homolog 2 protein N-product; structural prote | 99.76 | |
| 3e6j_A | 229 | Variable lymphocyte receptor diversity region; var | 99.76 | |
| 4b8c_D | 727 | Glucose-repressible alcohol dehydrogenase transcr | 99.76 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.75 | |
| 2v70_A | 220 | SLIT-2, SLIT homolog 2 protein N-product; neurogen | 99.75 | |
| 1m9s_A | 605 | Internalin B; cell invasion, GW domains, SH3 domai | 99.75 | |
| 1dce_A | 567 | Protein (RAB geranylgeranyltransferase alpha subun | 99.74 | |
| 3e6j_A | 229 | Variable lymphocyte receptor diversity region; var | 99.74 | |
| 2xot_A | 361 | Amphoterin-induced protein 1; cell adhesion, neuro | 99.74 | |
| 3ogk_B | 592 | Coronatine-insensitive protein 1; leucine rich rep | 99.74 | |
| 4ezg_A | 197 | Putative uncharacterized protein; internalin-A, le | 99.72 | |
| 1dce_A | 567 | Protein (RAB geranylgeranyltransferase alpha subun | 99.72 | |
| 1xeu_A | 263 | Internalin C; cellular invasion, leucine-rich repe | 99.72 | |
| 1xeu_A | 263 | Internalin C; cellular invasion, leucine-rich repe | 99.71 | |
| 2wfh_A | 193 | SLIT homolog 2 protein C-product; developmental pr | 99.71 | |
| 4ezg_A | 197 | Putative uncharacterized protein; internalin-A, le | 99.7 | |
| 2p1m_B | 594 | Transport inhibitor response 1 protein; F-BOX, leu | 99.67 | |
| 1w8a_A | 192 | SLIT protein; signaling protein, secreted protein, | 99.67 | |
| 2p1m_B | 594 | Transport inhibitor response 1 protein; F-BOX, leu | 99.67 | |
| 4b8c_D | 727 | Glucose-repressible alcohol dehydrogenase transcr | 99.66 | |
| 1w8a_A | 192 | SLIT protein; signaling protein, secreted protein, | 99.64 | |
| 2o6r_A | 177 | Variable lymphocyte receptor B; leucine-rich repea | 99.62 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.61 | |
| 2ell_A | 168 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.6 | |
| 2ell_A | 168 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.59 | |
| 2wfh_A | 193 | SLIT homolog 2 protein C-product; developmental pr | 99.58 | |
| 2je0_A | 149 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.54 | |
| 3sb4_A | 329 | Hypothetical leucine rich repeat protein; LRR, rig | 99.53 | |
| 2o6r_A | 177 | Variable lymphocyte receptor B; leucine-rich repea | 99.52 | |
| 3sb4_A | 329 | Hypothetical leucine rich repeat protein; LRR, rig | 99.52 | |
| 2je0_A | 149 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.51 | |
| 4fdw_A | 401 | Leucine rich hypothetical protein; putative cell s | 99.46 | |
| 1a9n_A | 176 | U2A', U2A'; complex (nuclear protein/RNA), RNA, sn | 99.45 | |
| 1ds9_A | 198 | Outer arm dynein; leucine-rich repeat, beta-BETA-a | 99.45 | |
| 1a9n_A | 176 | U2A', U2A'; complex (nuclear protein/RNA), RNA, sn | 99.42 | |
| 1ds9_A | 198 | Outer arm dynein; leucine-rich repeat, beta-BETA-a | 99.42 | |
| 4fdw_A | 401 | Leucine rich hypothetical protein; putative cell s | 99.42 | |
| 3g39_A | 170 | Variable lymphocyte receptor VLRB.2D; antibody, X- | 99.38 | |
| 2r9u_A | 174 | Variable lymphocyte receptor; adaptive immunity, V | 99.36 | |
| 3g39_A | 170 | Variable lymphocyte receptor VLRB.2D; antibody, X- | 99.33 | |
| 2r9u_A | 174 | Variable lymphocyte receptor; adaptive immunity, V | 99.33 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.28 | |
| 2ifg_A | 347 | High affinity nerve growth factor receptor; TRK, T | 99.21 | |
| 3un9_A | 372 | NLR family member X1; leucine rich repeat (LRR), a | 99.2 | |
| 2ifg_A | 347 | High affinity nerve growth factor receptor; TRK, T | 99.17 | |
| 3un9_A | 372 | NLR family member X1; leucine rich repeat (LRR), a | 99.15 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.09 | |
| 4fs7_A | 394 | Uncharacterized protein; leucine-rich repeats, pro | 99.02 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 98.97 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 98.91 | |
| 4fs7_A | 394 | Uncharacterized protein; leucine-rich repeats, pro | 98.89 | |
| 2ra8_A | 362 | Uncharacterized protein Q64V53_bacfr; WGR domain, | 98.8 | |
| 2ra8_A | 362 | Uncharacterized protein Q64V53_bacfr; WGR domain, | 98.77 | |
| 4gt6_A | 394 | Cell surface protein; leucine rich repeats, putati | 98.74 | |
| 4gt6_A | 394 | Cell surface protein; leucine rich repeats, putati | 98.59 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.58 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.57 | |
| 3rfe_A | 130 | Platelet glycoprotein IB beta chain; platelet surf | 98.47 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.46 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.46 | |
| 1io0_A | 185 | Tropomodulin; LRR protein, right-handed super-heli | 98.29 | |
| 1io0_A | 185 | Tropomodulin; LRR protein, right-handed super-heli | 98.28 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.23 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 98.22 | |
| 4h09_A | 379 | Hypothetical leucine rich repeat protein; two LRR_ | 98.22 | |
| 3rw6_A | 267 | Nuclear RNA export factor 1; retroviral constituti | 98.18 | |
| 3rw6_A | 267 | Nuclear RNA export factor 1; retroviral constituti | 98.15 | |
| 4h09_A | 379 | Hypothetical leucine rich repeat protein; two LRR_ | 98.13 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 97.98 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 97.86 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 97.82 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.82 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 97.6 | |
| 3e4g_A | 176 | ATP synthase subunit S, mitochondrial; leucine-ric | 97.6 | |
| 3e4g_A | 176 | ATP synthase subunit S, mitochondrial; leucine-ric | 97.54 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 97.35 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 97.23 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 97.14 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 97.12 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 97.1 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 97.06 | |
| 1pgv_A | 197 | TMD-1, tropomodulin TMD-1; structural genomics, PS | 97.03 | |
| 1pgv_A | 197 | TMD-1, tropomodulin TMD-1; structural genomics, PS | 96.96 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 96.89 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 96.67 | |
| 3rfe_A | 130 | Platelet glycoprotein IB beta chain; platelet surf | 96.61 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 96.51 | |
| 2k1k_A | 38 | Ephrin type-A receptor 1; EPHA1, receptor tyrosine | 96.37 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 96.04 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 96.01 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 95.11 | |
| 2l2t_A | 44 | Receptor tyrosine-protein kinase ERBB-4; transmemb | 94.26 | |
| 2ks1_B | 44 | Epidermal growth factor receptor; ERBB1, ERBB2, tr | 93.76 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 90.25 | |
| 2jwa_A | 44 | Receptor tyrosine-protein kinase ERBB-2; transmemb | 89.12 |
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-54 Score=467.21 Aligned_cols=263 Identities=30% Similarity=0.500 Sum_probs=221.2
Q ss_pred cCCCCCceeeeeCCeEEEEEEEC------CCcEEEEEEeccCChhcHHHHHHHHHHHHccCCCCcceEEEEEEeCCeEEE
Q 002158 625 AYFSSSTQVGQGGYGKVYKGILS------DNTTVAIKRAEEGSLQGQNEFLTEIKLLSRLHHRNLVSLLGYCDEEGEQML 698 (958)
Q Consensus 625 ~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~l 698 (958)
++|...+.||+|+||+||+|++. ++..||||+++.......++|.+|+++|++++|||||+++|+|.+++..+|
T Consensus 13 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~l 92 (299)
T 4asz_A 13 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIM 92 (299)
T ss_dssp GGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEE
Confidence 45667789999999999999874 477899999988777777889999999999999999999999999999999
Q ss_pred EEEecCCCCHHHHhccCC-----------CCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEecCCCCeEE
Q 002158 699 VYEFVPNGTLRDWLSGRT-----------KENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSNLNAKV 767 (958)
Q Consensus 699 V~E~~~~gsL~~~l~~~~-----------~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~~~~kl 767 (958)
|||||++|+|.++|+... ...+++.++++++.|||+||+|||+++ ||||||||+|||+++++.+||
T Consensus 93 V~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDlKp~NILl~~~~~~Ki 169 (299)
T 4asz_A 93 VFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQH---FVHRDLATRNCLVGENLLVKI 169 (299)
T ss_dssp EEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEE
T ss_pred EEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCccCHhhEEECCCCcEEE
Confidence 999999999999997532 346999999999999999999999998 999999999999999999999
Q ss_pred eeeeeecccccCCCCCCccceeeeeccCCCCccChhhhccCCCCCcchhhhHHHHHHHHHh-CCCCCCCCchhHHHHHHH
Q 002158 768 ADFGLSRLAPVLDDEGTMPTHVSTIVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVLLELLT-GMQPISHGKNIVREVNVA 846 (958)
Q Consensus 768 ~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gv~l~ellt-G~~P~~~~~~~~~~~~~~ 846 (958)
+|||+|+.....+. ........||++|||||++.+..|+.++|||||||++|||+| |+.||.+.... +....
T Consensus 170 ~DFGla~~~~~~~~-----~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~-~~~~~- 242 (299)
T 4asz_A 170 GDFGMSRDVYSTDY-----YRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNN-EVIEC- 242 (299)
T ss_dssp CCCSCHHHHTGGGC-----EEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHH-HHHHH-
T ss_pred CCcccceecCCCCc-----eeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHH-HHHHH-
Confidence 99999986532221 122233569999999999999999999999999999999999 89999764432 21111
Q ss_pred hhcCcchhhhcccCCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHhhCCC
Q 002158 847 RDSGMVFSIIDNRMGSYPSECVERFVTLALRCCHDKPEHRPSMSDVVRELENILKMFPE 905 (958)
Q Consensus 847 ~~~~~~~~~i~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~~~ 905 (958)
+........|..+++++.+|+.+||+.||++|||++||++.|+++.+..|.
T Consensus 243 --------i~~~~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i~~~L~~~~~~~p~ 293 (299)
T 4asz_A 243 --------ITQGRVLQRPRTCPQEVYELMLGCWQREPHMRKNIKGIHTLLQNLAKASPV 293 (299)
T ss_dssp --------HHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHSCC
T ss_pred --------HHcCCCCCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhcCCc
Confidence 112223345677889999999999999999999999999999998876553
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-53 Score=467.07 Aligned_cols=261 Identities=30% Similarity=0.481 Sum_probs=215.0
Q ss_pred CCCCCceeeeeCCeEEEEEEEC------CCcEEEEEEeccCChhcHHHHHHHHHHHHccCCCCcceEEEEEEeCCeEEEE
Q 002158 626 YFSSSTQVGQGGYGKVYKGILS------DNTTVAIKRAEEGSLQGQNEFLTEIKLLSRLHHRNLVSLLGYCDEEGEQMLV 699 (958)
Q Consensus 626 ~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV 699 (958)
+|...++||+|+||+||+|+++ +++.||||+++.......++|.+|+++|++++|||||+++|+|.+++..+||
T Consensus 42 d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~lV 121 (329)
T 4aoj_A 42 DIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMV 121 (329)
T ss_dssp GEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEEE
T ss_pred HeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence 4556678999999999999874 4788999999887777778899999999999999999999999999999999
Q ss_pred EEecCCCCHHHHhccCC-------------CCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEecCCCCeE
Q 002158 700 YEFVPNGTLRDWLSGRT-------------KENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSNLNAK 766 (958)
Q Consensus 700 ~E~~~~gsL~~~l~~~~-------------~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~~~~k 766 (958)
||||++|+|.++++... ..++++.++++|+.|||+||+|||+++ ||||||||+|||+++++.+|
T Consensus 122 ~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDLKp~NILl~~~~~~K 198 (329)
T 4aoj_A 122 FEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLH---FVHRDLATRNCLVGQGLVVK 198 (329)
T ss_dssp EECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTTEEE
T ss_pred EEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCC---eecccccHhhEEECCCCcEE
Confidence 99999999999997542 245999999999999999999999998 99999999999999999999
Q ss_pred EeeeeeecccccCCCCCCccceeeeeccCCCCccChhhhccCCCCCcchhhhHHHHHHHHHh-CCCCCCCCchhHHHHHH
Q 002158 767 VADFGLSRLAPVLDDEGTMPTHVSTIVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVLLELLT-GMQPISHGKNIVREVNV 845 (958)
Q Consensus 767 l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gv~l~ellt-G~~P~~~~~~~~~~~~~ 845 (958)
|+|||+|+.....+. ........||++|||||++.+..|+.++|||||||++|||+| |+.||.+...... +..
T Consensus 199 i~DFGla~~~~~~~~-----~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~~~-~~~ 272 (329)
T 4aoj_A 199 IGDFGMSRDIYSTDY-----YRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEA-IDC 272 (329)
T ss_dssp ECCCC---------------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHHHH-HHH
T ss_pred EcccccceeccCCCc-----ceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCHHHH-HHH
Confidence 999999986532221 122334679999999999999999999999999999999999 8999976543221 111
Q ss_pred HhhcCcchhhhcccCCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHhhCC
Q 002158 846 ARDSGMVFSIIDNRMGSYPSECVERFVTLALRCCHDKPEHRPSMSDVVRELENILKMFP 904 (958)
Q Consensus 846 ~~~~~~~~~~i~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~~ 904 (958)
. ........|..+++++.+|+.+||+.||++||||+||+++|+.+.+..|
T Consensus 273 i---------~~g~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~l~~~pp 322 (329)
T 4aoj_A 273 I---------TQGRELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQAPP 322 (329)
T ss_dssp H---------HHTCCCCCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHHHHHHHHSCC
T ss_pred H---------HcCCCCCCcccccHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHhhCCc
Confidence 1 1122234567788999999999999999999999999999999887654
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-52 Score=456.38 Aligned_cols=264 Identities=26% Similarity=0.466 Sum_probs=212.4
Q ss_pred cCCCCCceeeeeCCeEEEEEEECCCcEEEEEEeccC--ChhcHHHHHHHHHHHHccCCCCcceEEEEEEeCCeEEEEEEe
Q 002158 625 AYFSSSTQVGQGGYGKVYKGILSDNTTVAIKRAEEG--SLQGQNEFLTEIKLLSRLHHRNLVSLLGYCDEEGEQMLVYEF 702 (958)
Q Consensus 625 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E~ 702 (958)
+++...++||+|+||+||+|++++ .||||+++.. .....++|.+|++++++++|||||+++|+|.. +..+|||||
T Consensus 36 ~~l~l~~~iG~G~fG~Vy~~~~~~--~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~~iVmEy 112 (307)
T 3omv_A 36 SEVMLSTRIGSGSFGTVYKGKWHG--DVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNLAIVTQW 112 (307)
T ss_dssp TSCCEEEECCCCSSSEEEEEESSS--EEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEEC
T ss_pred HHeEEeeEEeeCCCcEEEEEEECC--cEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeEEEEEEc
Confidence 456778899999999999998753 6999998753 34456789999999999999999999999865 568999999
Q ss_pred cCCCCHHHHhccCCCCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEecCCCCeEEeeeeeecccccCCCC
Q 002158 703 VPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSRLAPVLDDE 782 (958)
Q Consensus 703 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~ 782 (958)
|++|+|.++|+... ..+++.++++|+.|||+||+|||+++ ||||||||+|||+++++.+||+|||+|+.......
T Consensus 113 ~~gGsL~~~l~~~~-~~l~~~~~~~i~~qia~gL~yLH~~~---IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~- 187 (307)
T 3omv_A 113 CEGSSLYKHLHVQE-TKFQMFQLIDIARQTAQGMDYLHAKN---IIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSG- 187 (307)
T ss_dssp CSSCBHHHHHHTSC-CCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCCSSSEEEETTEEEEECCCSSCBC-------
T ss_pred CCCCCHHHHHhhcC-CCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCccCHHHEEECCCCcEEEeeccCceecccCCc-
Confidence 99999999997543 35999999999999999999999998 99999999999999999999999999986543221
Q ss_pred CCccceeeeeccCCCCccChhhhcc---CCCCCcchhhhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcCcchhhhccc
Q 002158 783 GTMPTHVSTIVKGTPGYLDPEYFLT---HKLTDKSDVYSLGVVLLELLTGMQPISHGKNIVREVNVARDSGMVFSIIDNR 859 (958)
Q Consensus 783 ~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DV~S~Gv~l~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~i~~~ 859 (958)
........||+.|||||++.+ ..|+.++|||||||++|||+||+.||.+............. +. ..+.
T Consensus 188 ----~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~~~~~~~~-~~----~~p~ 258 (307)
T 3omv_A 188 ----SQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGR-GY----ASPD 258 (307)
T ss_dssp ----------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHT-TC----CCCC
T ss_pred ----ceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHHHHHHHhc-CC----CCCC
Confidence 122345679999999999964 35889999999999999999999999765543332222211 11 1122
Q ss_pred CCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHhhCCC
Q 002158 860 MGSYPSECVERFVTLALRCCHDKPEHRPSMSDVVRELENILKMFPE 905 (958)
Q Consensus 860 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~~~ 905 (958)
....+..++..+.+++.+||+.||++||||+||+++|+.+...+|.
T Consensus 259 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~l~~~lpk 304 (307)
T 3omv_A 259 LSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHSLPK 304 (307)
T ss_dssp STTSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHHHHTTCCC
T ss_pred cccccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhccCCC
Confidence 2344667889999999999999999999999999999988766654
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-52 Score=459.18 Aligned_cols=255 Identities=28% Similarity=0.463 Sum_probs=212.8
Q ss_pred CCCCceeeeeCCeEEEEEEEC------CCcEEEEEEeccCC-hhcHHHHHHHHHHHHccCCCCcceEEEEEEeCCeEEEE
Q 002158 627 FSSSTQVGQGGYGKVYKGILS------DNTTVAIKRAEEGS-LQGQNEFLTEIKLLSRLHHRNLVSLLGYCDEEGEQMLV 699 (958)
Q Consensus 627 ~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV 699 (958)
+...+.||+|+||+||+|.+. +++.||||+++... ....++|.+|+.++++++|||||+++|+|.+++..+||
T Consensus 28 ~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~~lV 107 (308)
T 4gt4_A 28 VRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLSMI 107 (308)
T ss_dssp EEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEE
T ss_pred CeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECCEEEEE
Confidence 344678999999999999973 46789999997643 33467899999999999999999999999999999999
Q ss_pred EEecCCCCHHHHhccCC--------------CCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEecCCCCe
Q 002158 700 YEFVPNGTLRDWLSGRT--------------KENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSNLNA 765 (958)
Q Consensus 700 ~E~~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~~~~ 765 (958)
||||++|+|.++|+.+. ...+++.++++++.|||+||+|||+++ ||||||||+|||+++++.+
T Consensus 108 ~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDLK~~NILl~~~~~~ 184 (308)
T 4gt4_A 108 FSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHH---VVHKDLATRNVLVYDKLNV 184 (308)
T ss_dssp EECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCE
T ss_pred EEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---CCCCCccccceEECCCCCE
Confidence 99999999999996532 235899999999999999999999999 9999999999999999999
Q ss_pred EEeeeeeecccccCCCCCCccceeeeeccCCCCccChhhhccCCCCCcchhhhHHHHHHHHHh-CCCCCCCCchhHHHHH
Q 002158 766 KVADFGLSRLAPVLDDEGTMPTHVSTIVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVLLELLT-GMQPISHGKNIVREVN 844 (958)
Q Consensus 766 kl~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gv~l~ellt-G~~P~~~~~~~~~~~~ 844 (958)
||+|||+|+.....+. ........||++|||||++.++.|+.++|||||||++|||+| |+.||.+.... +...
T Consensus 185 Ki~DFGlar~~~~~~~-----~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~~-~~~~ 258 (308)
T 4gt4_A 185 KISDLGLFREVYAADY-----YKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQ-DVVE 258 (308)
T ss_dssp EECCSCCBCGGGGGGC-----BCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCHH-HHHH
T ss_pred EECCcccceeccCCCc-----eeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCHH-HHHH
Confidence 9999999986543221 112234579999999999999999999999999999999999 89999765432 2221
Q ss_pred HHhhcCcchhhhcccCCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHh
Q 002158 845 VARDSGMVFSIIDNRMGSYPSECVERFVTLALRCCHDKPEHRPSMSDVVRELENI 899 (958)
Q Consensus 845 ~~~~~~~~~~~i~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 899 (958)
.. ........|.+++..+.+|+.+||+.||++||||+||+++|+..
T Consensus 259 ~i---------~~~~~~~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~L~a~ 304 (308)
T 4gt4_A 259 MI---------RNRQVLPCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLRAW 304 (308)
T ss_dssp HH---------HTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTS
T ss_pred HH---------HcCCCCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence 11 12223345778889999999999999999999999999999763
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-51 Score=455.33 Aligned_cols=251 Identities=23% Similarity=0.364 Sum_probs=209.1
Q ss_pred cCCCCCceeeeeCCeEEEEEEEC-CCcEEEEEEeccC--ChhcHHHHHHHHHHHHccCCCCcceEEEEEEeCCeEEEEEE
Q 002158 625 AYFSSSTQVGQGGYGKVYKGILS-DNTTVAIKRAEEG--SLQGQNEFLTEIKLLSRLHHRNLVSLLGYCDEEGEQMLVYE 701 (958)
Q Consensus 625 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E 701 (958)
++|+..+.||+|+||+||+|++. +|+.||||++... .....+.|.+|++++++++|||||++++++.+++..|||||
T Consensus 24 e~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVmE 103 (350)
T 4b9d_A 24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMD 103 (350)
T ss_dssp CCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred cceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEe
Confidence 47888899999999999999986 6999999999764 33445679999999999999999999999999999999999
Q ss_pred ecCCCCHHHHhccCCCCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEecCCCCeEEeeeeeecccccCCC
Q 002158 702 FVPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSRLAPVLDD 781 (958)
Q Consensus 702 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~ 781 (958)
||+||+|.++|..+....+++.++..++.||+.||+|||+++ ||||||||+|||+++++.+||+|||+|+.....
T Consensus 104 y~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~-- 178 (350)
T 4b9d_A 104 YCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRK---ILHRDIKSQNIFLTKDGTVQLGDFGIARVLNST-- 178 (350)
T ss_dssp CCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT---CEETTCCGGGEEECTTCCEEECSTTEESCCCHH--
T ss_pred CCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHHHEEECCCCCEEEcccccceeecCC--
Confidence 999999999998766666899999999999999999999999 999999999999999999999999999865321
Q ss_pred CCCccceeeeeccCCCCccChhhhccCCCCCcchhhhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcCcchhhhcccCC
Q 002158 782 EGTMPTHVSTIVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVLLELLTGMQPISHGKNIVREVNVARDSGMVFSIIDNRMG 861 (958)
Q Consensus 782 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gv~l~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~i~~~~~ 861 (958)
.......+||+.|||||++.+..|+.++||||+||++|||+||+.||.+.... ..+... ......
T Consensus 179 -----~~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~-~~~~~i---------~~~~~~ 243 (350)
T 4b9d_A 179 -----VELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMK-NLVLKI---------ISGSFP 243 (350)
T ss_dssp -----HHHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHH-HHHHHH---------HHTCCC
T ss_pred -----cccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHH-HHHHHH---------HcCCCC
Confidence 11234567999999999999999999999999999999999999999765432 222211 112223
Q ss_pred CCChHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 002158 862 SYPSECVERFVTLALRCCHDKPEHRPSMSDVVRE 895 (958)
Q Consensus 862 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 895 (958)
..+..++.++.+++.+||+.||++|||++|++++
T Consensus 244 ~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~h 277 (350)
T 4b9d_A 244 PVSLHYSYDLRSLVSQLFKRNPRDRPSVNSILEK 277 (350)
T ss_dssp CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred CCCccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 3455677889999999999999999999999875
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-51 Score=447.84 Aligned_cols=263 Identities=21% Similarity=0.288 Sum_probs=213.7
Q ss_pred cCCCCCceeeeeCCeEEEEEEEC-CCcEEEEEEeccCChhcHHHHHHHHHHHHccCCCCcceEEEEEEeCCeEEEEEEec
Q 002158 625 AYFSSSTQVGQGGYGKVYKGILS-DNTTVAIKRAEEGSLQGQNEFLTEIKLLSRLHHRNLVSLLGYCDEEGEQMLVYEFV 703 (958)
Q Consensus 625 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E~~ 703 (958)
+.|...++||+|+||+||+|+++ +|+.||||+++.... +.+|+.++++++|||||++++++.+++..|||||||
T Consensus 58 ~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~-----~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~ 132 (336)
T 4g3f_A 58 HWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF-----RVEELVACAGLSSPRIVPLYGAVREGPWVNIFMELL 132 (336)
T ss_dssp TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC-----CTHHHHTTTTCCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred hheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh-----HHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEecc
Confidence 45667788999999999999986 699999999976432 247999999999999999999999999999999999
Q ss_pred CCCCHHHHhccCCCCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEecCCC-CeEEeeeeeecccccCCCC
Q 002158 704 PNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSNL-NAKVADFGLSRLAPVLDDE 782 (958)
Q Consensus 704 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~~-~~kl~DFGla~~~~~~~~~ 782 (958)
+||+|.++++..+ .+++.++..++.|++.||+|||+++ ||||||||+|||++.++ .+||+|||+|+........
T Consensus 133 ~gg~L~~~l~~~~--~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~~~ 207 (336)
T 4g3f_A 133 EGGSLGQLIKQMG--CLPEDRALYYLGQALEGLEYLHTRR---ILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLG 207 (336)
T ss_dssp TTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCCGGGEEECTTSCCEEECCCTTCEEC------
T ss_pred CCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC---ceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCCcc
Confidence 9999999997643 4999999999999999999999999 99999999999999988 6999999999876432211
Q ss_pred CCccceeeeeccCCCCccChhhhccCCCCCcchhhhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcCcchhhhcccCCC
Q 002158 783 GTMPTHVSTIVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVLLELLTGMQPISHGKNIVREVNVARDSGMVFSIIDNRMGS 862 (958)
Q Consensus 783 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gv~l~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~ 862 (958)
.. ......++||+.|||||++.+..|+.++|||||||++|||+||+.||.+............. . .....
T Consensus 208 ~~--~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~-~-------~~~~~ 277 (336)
T 4g3f_A 208 KS--LLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIASE-P-------PPIRE 277 (336)
T ss_dssp --------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCCHHHHHHS-C-------CGGGG
T ss_pred cc--eecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHcC-C-------CCchh
Confidence 11 11223467999999999999999999999999999999999999999754321111111111 0 01123
Q ss_pred CChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHhhCCCCC
Q 002158 863 YPSECVERFVTLALRCCHDKPEHRPSMSDVVRELENILKMFPETD 907 (958)
Q Consensus 863 ~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~~~~~ 907 (958)
.+..++..+.+++.+||+.||++|||++|++++|...+.....-.
T Consensus 278 ~~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~l~~~~~l~ 322 (336)
T 4g3f_A 278 IPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKALQEVGGLK 322 (336)
T ss_dssp SCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTTSSC
T ss_pred cCccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhhhhhcc
Confidence 456678899999999999999999999999999999887765443
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-51 Score=453.19 Aligned_cols=272 Identities=27% Similarity=0.431 Sum_probs=223.6
Q ss_pred ChHHHHHHHcCCCCCceeeeeCCeEEEEEEECC------CcEEEEEEeccCC-hhcHHHHHHHHHHHHccCC-CCcceEE
Q 002158 616 KFKELAMATAYFSSSTQVGQGGYGKVYKGILSD------NTTVAIKRAEEGS-LQGQNEFLTEIKLLSRLHH-RNLVSLL 687 (958)
Q Consensus 616 ~~~el~~~~~~~~~~~~lg~G~~g~Vy~~~~~~------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H-~niv~l~ 687 (958)
...+++...++|...+.||+|+||+||+|.+.. ++.||||++.... ....++|.+|+++|++++| ||||+++
T Consensus 55 ~~~~wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l~ 134 (353)
T 4ase_A 55 DASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLL 134 (353)
T ss_dssp CHHHHBCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred CCcccEecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEEE
Confidence 344566667889999999999999999999642 3689999997654 3445679999999999965 9999999
Q ss_pred EEEEeC-CeEEEEEEecCCCCHHHHhccCC--------------CCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCC
Q 002158 688 GYCDEE-GEQMLVYEFVPNGTLRDWLSGRT--------------KENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDI 752 (958)
Q Consensus 688 ~~~~~~-~~~~lV~E~~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Di 752 (958)
|+|... +..++|||||++|+|.++|+... ...+++.+++.++.|||+||+|||+++ ||||||
T Consensus 135 g~~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~---iiHRDL 211 (353)
T 4ase_A 135 GACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDL 211 (353)
T ss_dssp EEECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCC
T ss_pred EEEEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCC---eecCcc
Confidence 999764 56899999999999999997532 234899999999999999999999999 999999
Q ss_pred CccceEecCCCCeEEeeeeeecccccCCCCCCccceeeeeccCCCCccChhhhccCCCCCcchhhhHHHHHHHHHh-CCC
Q 002158 753 KASNILLDSNLNAKVADFGLSRLAPVLDDEGTMPTHVSTIVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVLLELLT-GMQ 831 (958)
Q Consensus 753 kp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gv~l~ellt-G~~ 831 (958)
||+|||+++++.+||+|||+|+....... ........||++|||||++.+..|+.++|||||||++|||+| |+.
T Consensus 212 K~~NILl~~~~~vKi~DFGlar~~~~~~~-----~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~ 286 (353)
T 4ase_A 212 AARNILLSEKNVVKICDFGLARDIYKDPD-----YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGAS 286 (353)
T ss_dssp SGGGEEECGGGCEEECCCGGGSCTTTCTT-----SEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCC
T ss_pred CccceeeCCCCCEEECcchhhhhcccCCC-----ceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCC
Confidence 99999999999999999999986533221 223345679999999999999999999999999999999998 999
Q ss_pred CCCCCchhHHHHHHHhhcCcchhhhcccCCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHhhCC
Q 002158 832 PISHGKNIVREVNVARDSGMVFSIIDNRMGSYPSECVERFVTLALRCCHDKPEHRPSMSDVVRELENILKMFP 904 (958)
Q Consensus 832 P~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~~ 904 (958)
||.+............ .......|..+++++.+++.+||+.||++|||++||+++|+++++.-.
T Consensus 287 Pf~~~~~~~~~~~~i~---------~g~~~~~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~L~~llq~~~ 350 (353)
T 4ase_A 287 PYPGVKIDEEFCRRLK---------EGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQANA 350 (353)
T ss_dssp SSTTCCCSHHHHHHHH---------HTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTC
T ss_pred CCCCCCHHHHHHHHHH---------cCCCCCCCccCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHHHhh
Confidence 9976443222222111 112234466778899999999999999999999999999999887543
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-51 Score=447.01 Aligned_cols=250 Identities=22% Similarity=0.359 Sum_probs=211.1
Q ss_pred cCCCCCceeeeeCCeEEEEEEEC-CCcEEEEEEeccCChhcHHHHHHHHHHHHccCCCCcceEEEEEEeCCeEEEEEEec
Q 002158 625 AYFSSSTQVGQGGYGKVYKGILS-DNTTVAIKRAEEGSLQGQNEFLTEIKLLSRLHHRNLVSLLGYCDEEGEQMLVYEFV 703 (958)
Q Consensus 625 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E~~ 703 (958)
..|+..++||+|+||+||+|+++ +|+.||||++........+.+.+|+++|++++|||||++++++.+++..|||||||
T Consensus 74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~ 153 (346)
T 4fih_A 74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL 153 (346)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeCC
Confidence 45778889999999999999986 69999999997654445567889999999999999999999999999999999999
Q ss_pred CCCCHHHHhccCCCCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEecCCCCeEEeeeeeecccccCCCCC
Q 002158 704 PNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSRLAPVLDDEG 783 (958)
Q Consensus 704 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 783 (958)
++|+|.+++... .+++.++..++.|++.||+|||+++ ||||||||+|||++.++.+||+|||+|+.+....
T Consensus 154 ~gg~L~~~l~~~---~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~--- 224 (346)
T 4fih_A 154 EGGALTDIVTHT---RMNEEQIAAVCLAVLQALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV--- 224 (346)
T ss_dssp TTEEHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSSS---
T ss_pred CCCcHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEECCCCCEEEecCcCceecCCCC---
Confidence 999999999753 3999999999999999999999999 9999999999999999999999999998653221
Q ss_pred CccceeeeeccCCCCccChhhhccCCCCCcchhhhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcCcchhhhcccCCCC
Q 002158 784 TMPTHVSTIVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVLLELLTGMQPISHGKNIVREVNVARDSGMVFSIIDNRMGSY 863 (958)
Q Consensus 784 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gv~l~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~ 863 (958)
......+||+.|||||++.+..|+.++||||+||++|||++|+.||.+...... ........ .. ....
T Consensus 225 ----~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~-~~~i~~~~------~~-~~~~ 292 (346)
T 4fih_A 225 ----PRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKA-MKMIRDNL------PP-RLKN 292 (346)
T ss_dssp ----CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH-HHHHHHSS------CC-CCSC
T ss_pred ----CcccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHH-HHHHHcCC------CC-CCCc
Confidence 123456899999999999999999999999999999999999999976543322 22211110 00 0122
Q ss_pred ChHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 002158 864 PSECVERFVTLALRCCHDKPEHRPSMSDVVRE 895 (958)
Q Consensus 864 ~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 895 (958)
+..++.++.+++.+||+.||++|||++|++++
T Consensus 293 ~~~~s~~~~dli~~~L~~dP~~R~ta~e~l~H 324 (346)
T 4fih_A 293 LHKVSPSLKGFLDRLLVRDPAQRATAAELLKH 324 (346)
T ss_dssp GGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred cccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 34567889999999999999999999999864
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-50 Score=435.12 Aligned_cols=247 Identities=25% Similarity=0.456 Sum_probs=201.9
Q ss_pred CCCceeeeeCCeEEEEEEEC-CCcEEEEEEeccC--ChhcHHHHHHHHHHHHccCCCCcceEEEEEEe----CCeEEEEE
Q 002158 628 SSSTQVGQGGYGKVYKGILS-DNTTVAIKRAEEG--SLQGQNEFLTEIKLLSRLHHRNLVSLLGYCDE----EGEQMLVY 700 (958)
Q Consensus 628 ~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~----~~~~~lV~ 700 (958)
...+.||+|+||+||+|.+. +++.||||++... .....++|.+|++++++++|||||++++++.+ ++..+|||
T Consensus 29 ~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lvm 108 (290)
T 3fpq_A 29 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT 108 (290)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEEE
T ss_pred EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEEE
Confidence 34567999999999999986 6899999998653 34445679999999999999999999999865 34689999
Q ss_pred EecCCCCHHHHhccCCCCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEecC-CCCeEEeeeeeecccccC
Q 002158 701 EFVPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDS-NLNAKVADFGLSRLAPVL 779 (958)
Q Consensus 701 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~-~~~~kl~DFGla~~~~~~ 779 (958)
|||++|+|.++++... .+++..+..++.||+.||+|||+++ ++||||||||+|||++. ++.+||+|||+|+....
T Consensus 109 Ey~~gg~L~~~l~~~~--~l~~~~~~~~~~qi~~aL~ylH~~~-~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~~- 184 (290)
T 3fpq_A 109 ELMTSGTLKTYLKRFK--VMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA- 184 (290)
T ss_dssp ECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCCCCCGGGEEESSTTSCEEECCTTGGGGCCT-
T ss_pred eCCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC-CCEEecccChhheeEECCCCCEEEEeCcCCEeCCC-
Confidence 9999999999997643 4899999999999999999999875 56999999999999984 79999999999985321
Q ss_pred CCCCCccceeeeeccCCCCccChhhhccCCCCCcchhhhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcCcchhhhccc
Q 002158 780 DDEGTMPTHVSTIVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVLLELLTGMQPISHGKNIVREVNVARDSGMVFSIIDNR 859 (958)
Q Consensus 780 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gv~l~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~i~~~ 859 (958)
......+||+.|||||++.+ .|+.++|||||||++|||+||+.||.+.................
T Consensus 185 --------~~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~~i~~~~~~------- 248 (290)
T 3fpq_A 185 --------SFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKP------- 248 (290)
T ss_dssp --------TSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCC-------
T ss_pred --------CccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCcHHHHHHHHHcCCCC-------
Confidence 12345689999999998864 69999999999999999999999997655544433332221111
Q ss_pred CCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 002158 860 MGSYPSECVERFVTLALRCCHDKPEHRPSMSDVVRE 895 (958)
Q Consensus 860 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 895 (958)
...+...++++.+++.+||+.||++|||++|++++
T Consensus 249 -~~~~~~~~~~~~~li~~~L~~dP~~R~s~~e~l~H 283 (290)
T 3fpq_A 249 -ASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNH 283 (290)
T ss_dssp -GGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred -CCCCccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 11123345678999999999999999999999864
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-50 Score=435.73 Aligned_cols=250 Identities=19% Similarity=0.299 Sum_probs=211.5
Q ss_pred cCCCCCceeeeeCCeEEEEEEEC-CCcEEEEEEeccCC---hhcHHHHHHHHHHHHccCCCCcceEEEEEEeCCeEEEEE
Q 002158 625 AYFSSSTQVGQGGYGKVYKGILS-DNTTVAIKRAEEGS---LQGQNEFLTEIKLLSRLHHRNLVSLLGYCDEEGEQMLVY 700 (958)
Q Consensus 625 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~ 700 (958)
++|+..+.||+|+||+||+|++. +|+.||||++.... ....+.+.+|++++++++|||||++++++.+++..|+||
T Consensus 32 ~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivm 111 (311)
T 4aw0_A 32 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 111 (311)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 46888999999999999999986 69999999997532 233567999999999999999999999999999999999
Q ss_pred EecCCCCHHHHhccCCCCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEecCCCCeEEeeeeeecccccCC
Q 002158 701 EFVPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSRLAPVLD 780 (958)
Q Consensus 701 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~ 780 (958)
|||+||+|.+++...+ .+++.++..++.||+.||+|||+++ |+||||||+|||+++++.+||+|||+|+.+....
T Consensus 112 Ey~~gG~L~~~i~~~~--~l~e~~~~~~~~qi~~al~ylH~~~---IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~~ 186 (311)
T 4aw0_A 112 SYAKNGELLKYIRKIG--SFDETCTRFYTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPES 186 (311)
T ss_dssp CCCTTEEHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECCTTT
T ss_pred ecCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHeEEcCCCCEEEEEcCCceecCCCC
Confidence 9999999999997643 4999999999999999999999999 9999999999999999999999999998764322
Q ss_pred CCCCccceeeeeccCCCCccChhhhccCCCCCcchhhhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcCcchhhhcccC
Q 002158 781 DEGTMPTHVSTIVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVLLELLTGMQPISHGKNIVREVNVARDSGMVFSIIDNRM 860 (958)
Q Consensus 781 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gv~l~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~i~~~~ 860 (958)
. .......+||+.|||||++.+..|+.++||||+||++|||+||+.||.+... ......... ..
T Consensus 187 ~-----~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~-~~~~~~i~~----------~~ 250 (311)
T 4aw0_A 187 K-----QARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNE-GLIFAKIIK----------LE 250 (311)
T ss_dssp T-----CCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSH-HHHHHHHHH----------TC
T ss_pred C-----cccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH-HHHHHHHHc----------CC
Confidence 2 1223456899999999999999999999999999999999999999975433 222221111 11
Q ss_pred CCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 002158 861 GSYPSECVERFVTLALRCCHDKPEHRPSMSDVVRE 895 (958)
Q Consensus 861 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 895 (958)
..+|...+.++.+++.+|++.||++|||++|+..+
T Consensus 251 ~~~p~~~s~~~~dli~~lL~~dp~~R~t~~e~~~~ 285 (311)
T 4aw0_A 251 YDFPEKFFPKARDLVEKLLVLDATKRLGCEEMEGY 285 (311)
T ss_dssp CCCCTTCCHHHHHHHHHHSCSSGGGSTTSGGGTCH
T ss_pred CCCCcccCHHHHHHHHHHccCCHhHCcChHHHcCC
Confidence 23455667889999999999999999999987543
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-49 Score=448.33 Aligned_cols=250 Identities=22% Similarity=0.368 Sum_probs=212.0
Q ss_pred cCCCCCceeeeeCCeEEEEEEEC-CCcEEEEEEeccCChhcHHHHHHHHHHHHccCCCCcceEEEEEEeCCeEEEEEEec
Q 002158 625 AYFSSSTQVGQGGYGKVYKGILS-DNTTVAIKRAEEGSLQGQNEFLTEIKLLSRLHHRNLVSLLGYCDEEGEQMLVYEFV 703 (958)
Q Consensus 625 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E~~ 703 (958)
+.|+..+.||+|+||+||+|+++ +|+.||||++........+.+.+|+++|++++|||||++++++.+++..|||||||
T Consensus 151 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmEy~ 230 (423)
T 4fie_A 151 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL 230 (423)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred HhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEeCC
Confidence 56888899999999999999986 69999999997765555667899999999999999999999999999999999999
Q ss_pred CCCCHHHHhccCCCCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEecCCCCeEEeeeeeecccccCCCCC
Q 002158 704 PNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSRLAPVLDDEG 783 (958)
Q Consensus 704 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 783 (958)
+||+|.++++.. .+++.++..++.|++.||+|||+++ ||||||||+|||++.+|.+||+|||+|+.+....
T Consensus 231 ~gG~L~~~i~~~---~l~e~~~~~~~~qil~aL~ylH~~~---IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~--- 301 (423)
T 4fie_A 231 EGGALTDIVTHT---RMNEEQIAAVCLAVLQALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV--- 301 (423)
T ss_dssp TTEEHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSTTTEEECTTCCEEECCCTTCEECCSSC---
T ss_pred CCCcHHHHHhcc---CCCHHHHHHHHHHHHHHHHHHHHCC---eecccCCHHHEEEcCCCCEEEecCccceECCCCC---
Confidence 999999999754 3899999999999999999999999 9999999999999999999999999998653221
Q ss_pred CccceeeeeccCCCCccChhhhccCCCCCcchhhhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcCcchhhhcccCCCC
Q 002158 784 TMPTHVSTIVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVLLELLTGMQPISHGKNIVREVNVARDSGMVFSIIDNRMGSY 863 (958)
Q Consensus 784 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gv~l~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~ 863 (958)
......+||+.|||||++.+..|+.++|||||||++|||++|+.||.+...... +....... ... ...
T Consensus 302 ----~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~-~~~i~~~~------~~~-~~~ 369 (423)
T 4fie_A 302 ----PRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKA-MKMIRDNL------PPR-LKN 369 (423)
T ss_dssp ----CCBCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH-HHHHHHSC------CCC-CSC
T ss_pred ----ccccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHH-HHHHHcCC------CCC-Ccc
Confidence 123456799999999999999999999999999999999999999976543322 22211110 001 112
Q ss_pred ChHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 002158 864 PSECVERFVTLALRCCHDKPEHRPSMSDVVRE 895 (958)
Q Consensus 864 ~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 895 (958)
+..++.++.+++.+||+.||++|||++|++++
T Consensus 370 ~~~~s~~~~dli~~~L~~dP~~R~ta~ell~H 401 (423)
T 4fie_A 370 LHKVSPSLKGFLDRLLVRDPAQRATAAELLKH 401 (423)
T ss_dssp TTSSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred cccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 34566789999999999999999999999874
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-49 Score=424.66 Aligned_cols=246 Identities=25% Similarity=0.368 Sum_probs=196.8
Q ss_pred cCCCCCceeeeeCCeEEEEEEEC-CCcEEEEEEeccCC---hhcHHHHHHHHHHHHccCCCCcceEEEEEEeCCeEEEEE
Q 002158 625 AYFSSSTQVGQGGYGKVYKGILS-DNTTVAIKRAEEGS---LQGQNEFLTEIKLLSRLHHRNLVSLLGYCDEEGEQMLVY 700 (958)
Q Consensus 625 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~ 700 (958)
++|+..+.||+|+||+||+|++. +|+.||||++.... ....+.+.+|++++++++|||||++++++.+++..|+||
T Consensus 13 g~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivm 92 (275)
T 3hyh_A 13 GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVI 92 (275)
T ss_dssp -CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred eCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEE
Confidence 47889999999999999999975 69999999997542 233567999999999999999999999999999999999
Q ss_pred EecCCCCHHHHhccCCCCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEecCCCCeEEeeeeeecccccCC
Q 002158 701 EFVPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSRLAPVLD 780 (958)
Q Consensus 701 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~ 780 (958)
||+ +|+|.+++..+. .+++.++..++.|++.||+|||+++ |+||||||+|||+++++.+||+|||+|+.....
T Consensus 93 Ey~-~g~L~~~l~~~~--~l~e~~~~~~~~qi~~al~ylH~~~---IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~- 165 (275)
T 3hyh_A 93 EYA-GNELFDYIVQRD--KMSEQEARRFFQQIISAVEYCHRHK---IVHRDLKPENLLLDEHLNVKIADFGLSNIMTDG- 165 (275)
T ss_dssp ECC-CEEHHHHHHHSC--SCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCTTTEEECTTCCEEECCSSCC-------
T ss_pred eCC-CCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC---cccccCChHHeEECCCCCEEEeecCCCeecCCC-
Confidence 999 689999997654 4999999999999999999999999 999999999999999999999999999864321
Q ss_pred CCCCccceeeeeccCCCCccChhhhccCCC-CCcchhhhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcCcchhhhccc
Q 002158 781 DEGTMPTHVSTIVKGTPGYLDPEYFLTHKL-TDKSDVYSLGVVLLELLTGMQPISHGKNIVREVNVARDSGMVFSIIDNR 859 (958)
Q Consensus 781 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DV~S~Gv~l~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~i~~~ 859 (958)
......+||+.|||||++.+..+ +.++||||+||++|||+||+.||.+.. ......... ..
T Consensus 166 -------~~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~-~~~~~~~i~----------~~ 227 (275)
T 3hyh_A 166 -------NFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDES-IPVLFKNIS----------NG 227 (275)
T ss_dssp ----------------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSS-HHHHHHHHH----------HT
T ss_pred -------CccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCC-HHHHHHHHH----------cC
Confidence 12234679999999999998886 479999999999999999999997543 222222211 11
Q ss_pred CCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 002158 860 MGSYPSECVERFVTLALRCCHDKPEHRPSMSDVVRE 895 (958)
Q Consensus 860 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 895 (958)
...+|...++++.+++.+||+.||++|||++|++++
T Consensus 228 ~~~~p~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 263 (275)
T 3hyh_A 228 VYTLPKFLSPGAAGLIKRMLIVNPLNRISIHEIMQD 263 (275)
T ss_dssp CCCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHC
T ss_pred CCCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence 223455667889999999999999999999999985
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-49 Score=431.92 Aligned_cols=264 Identities=21% Similarity=0.334 Sum_probs=199.2
Q ss_pred CCCCCceeeeeCCeEEEEEEECCCcEEEEEEeccCChhcHHHHHHHHHHHHccCCCCcceEEEEEEeCC----eEEEEEE
Q 002158 626 YFSSSTQVGQGGYGKVYKGILSDNTTVAIKRAEEGSLQGQNEFLTEIKLLSRLHHRNLVSLLGYCDEEG----EQMLVYE 701 (958)
Q Consensus 626 ~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~----~~~lV~E 701 (958)
+|...+.||+|+||+||+|++ +|+.||||++..... ....+.+|+..+.+++|||||+++|+|..++ ..+||||
T Consensus 4 ~i~L~~~iG~G~fG~Vy~~~~-~g~~VAvK~l~~~~~-~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV~E 81 (303)
T 3hmm_A 4 TIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSREE-RSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSD 81 (303)
T ss_dssp GEEEEEEEEECSSSEEEEEEE-TTEEEEEEEECGGGH-HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEE
T ss_pred EEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccch-hhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEEec
Confidence 355668899999999999998 689999999965321 1222345666667889999999999998654 5799999
Q ss_pred ecCCCCHHHHhccCCCCCchHHHHHHHHHHHHHHHHHhhhc-----CCCCeeccCCCccceEecCCCCeEEeeeeeeccc
Q 002158 702 FVPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTE-----AHPPVFHRDIKASNILLDSNLNAKVADFGLSRLA 776 (958)
Q Consensus 702 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~-----~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~~ 776 (958)
||++|+|.++++.. .++++++.+++.|+|+||+|||++ +.++||||||||+|||+++++.+||+|||+|+..
T Consensus 82 y~~~gsL~~~l~~~---~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~ 158 (303)
T 3hmm_A 82 YHEHGSLFDYLNRY---TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRH 158 (303)
T ss_dssp CCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCEEE
T ss_pred CCCCCcHHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCCccc
Confidence 99999999999754 389999999999999999999987 2345999999999999999999999999999876
Q ss_pred ccCCCCCCccceeeeeccCCCCccChhhhccC------CCCCcchhhhHHHHHHHHHhCCCCCCCCch------------
Q 002158 777 PVLDDEGTMPTHVSTIVKGTPGYLDPEYFLTH------KLTDKSDVYSLGVVLLELLTGMQPISHGKN------------ 838 (958)
Q Consensus 777 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~------~~~~~~DV~S~Gv~l~elltG~~P~~~~~~------------ 838 (958)
....... ........||++|||||++.+. .++.++|||||||++|||+||+.||.....
T Consensus 159 ~~~~~~~---~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~~ 235 (303)
T 3hmm_A 159 DSATDTI---DIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSD 235 (303)
T ss_dssp ETTTTEE---SCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSS
T ss_pred cCCCCce---eeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhccccc
Confidence 4322210 1122345799999999999764 467799999999999999999877643211
Q ss_pred -hHHHHHH-HhhcCcchhhhcccCCC--CChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHhh
Q 002158 839 -IVREVNV-ARDSGMVFSIIDNRMGS--YPSECVERFVTLALRCCHDKPEHRPSMSDVVRELENILKM 902 (958)
Q Consensus 839 -~~~~~~~-~~~~~~~~~~i~~~~~~--~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~ 902 (958)
....+.. ..... .++..+. ...+++..+.+|+.+||+.||++||||+||++.|+++.+.
T Consensus 236 ~~~~~~~~~~~~~~-----~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~l~~~ 298 (303)
T 3hmm_A 236 PSVEEMRKVVCEQK-----LRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQ 298 (303)
T ss_dssp CCHHHHHHHHTTSC-----CCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred chHHHHHHHHhccc-----CCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHH
Confidence 0111111 11100 0111111 1235778899999999999999999999999999988753
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-49 Score=428.07 Aligned_cols=247 Identities=24% Similarity=0.302 Sum_probs=200.4
Q ss_pred cCCCCCceeeeeCCeEEEEEEEC----CCcEEEEEEeccCC--hhcHHHHHHHHHHHHccCCCCcceEEEEEEeCCeEEE
Q 002158 625 AYFSSSTQVGQGGYGKVYKGILS----DNTTVAIKRAEEGS--LQGQNEFLTEIKLLSRLHHRNLVSLLGYCDEEGEQML 698 (958)
Q Consensus 625 ~~~~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~l 698 (958)
++|+..+.||+|+||+||+|+.. .++.||||+++... .....++.+|++++++++|||||++++++.+++..|+
T Consensus 24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~i 103 (304)
T 3ubd_A 24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYL 103 (304)
T ss_dssp GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEEEE
T ss_pred cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEE
Confidence 46888999999999999999863 47899999987542 2233468899999999999999999999999999999
Q ss_pred EEEecCCCCHHHHhccCCCCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEecCCCCeEEeeeeeeccccc
Q 002158 699 VYEFVPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSRLAPV 778 (958)
Q Consensus 699 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~~~~ 778 (958)
|||||+||+|.+++.... .+++.++..++.|++.||+|||+++ |+||||||+|||+++++.+||+|||+|+....
T Consensus 104 vmEy~~gg~L~~~l~~~~--~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~ 178 (304)
T 3ubd_A 104 ILDFLRGGDLFTRLSKEV--MFTEEDVKFYLAELALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESID 178 (304)
T ss_dssp EECCCTTCEEHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECTTSCEEEESSEEEEC---
T ss_pred EEEcCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHeEEcCCCCEEecccccceeccC
Confidence 999999999999997644 4999999999999999999999999 99999999999999999999999999985422
Q ss_pred CCCCCCccceeeeeccCCCCccChhhhccCCCCCcchhhhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcCcchhhhcc
Q 002158 779 LDDEGTMPTHVSTIVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVLLELLTGMQPISHGKNIVREVNVARDSGMVFSIIDN 858 (958)
Q Consensus 779 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gv~l~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~i~~ 858 (958)
.. ......+||+.|||||++.+..|+.++||||+||++|||+||+.||.+.... +...... .
T Consensus 179 ~~-------~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~-~~~~~i~----------~ 240 (304)
T 3ubd_A 179 HE-------KKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRK-ETMTMIL----------K 240 (304)
T ss_dssp ---------CCCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-HHHHHHH----------H
T ss_pred CC-------ccccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCHH-HHHHHHH----------c
Confidence 11 1223467999999999999999999999999999999999999999754432 2222111 1
Q ss_pred cCCCCChHHHHHHHHHHHHccccCCCCCCCH-----HHHHH
Q 002158 859 RMGSYPSECVERFVTLALRCCHDKPEHRPSM-----SDVVR 894 (958)
Q Consensus 859 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~-----~evl~ 894 (958)
....+|..++.++.+++.+||+.||++|||+ +|+++
T Consensus 241 ~~~~~p~~~s~~~~~li~~~L~~dP~~R~ta~~~~~~eil~ 281 (304)
T 3ubd_A 241 AKLGMPQFLSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKR 281 (304)
T ss_dssp CCCCCCTTSCHHHHHHHHHHTCSSGGGSTTCSTTTHHHHHT
T ss_pred CCCCCCCcCCHHHHHHHHHHcccCHHHCCCCCcCCHHHHHc
Confidence 1223456677889999999999999999984 56664
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-47 Score=417.56 Aligned_cols=256 Identities=26% Similarity=0.425 Sum_probs=191.6
Q ss_pred cCCCCCceeeeeCCeEEEEEEEC-CCcEEEEEEeccCC-hhcHHHHHHHHHHHHccCCCCcceEEEEEEeCC--------
Q 002158 625 AYFSSSTQVGQGGYGKVYKGILS-DNTTVAIKRAEEGS-LQGQNEFLTEIKLLSRLHHRNLVSLLGYCDEEG-------- 694 (958)
Q Consensus 625 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~-------- 694 (958)
++|+..+.||+|+||+||+|+++ +|+.||||+++... ....+.+.+|+++|++++|||||++++++.+.+
T Consensus 5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~ 84 (299)
T 4g31_A 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPS 84 (299)
T ss_dssp HHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC--------
T ss_pred hhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCcccccccc
Confidence 35788899999999999999986 68999999987543 334567999999999999999999999986544
Q ss_pred ----eEEEEEEecCCCCHHHHhccCCC-CCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEecCCCCeEEee
Q 002158 695 ----EQMLVYEFVPNGTLRDWLSGRTK-ENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSNLNAKVAD 769 (958)
Q Consensus 695 ----~~~lV~E~~~~gsL~~~l~~~~~-~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~~~~kl~D 769 (958)
..|+|||||++|+|.+++..+.. ...++..++.++.|+++||+|||+++ |+||||||+|||++.++.+||+|
T Consensus 85 ~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~---IiHRDlKp~NILl~~~~~vKl~D 161 (299)
T 4g31_A 85 SPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGD 161 (299)
T ss_dssp --CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECC
T ss_pred CCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHCc---CccccCcHHHeEECCCCcEEEcc
Confidence 36999999999999999986543 23456778899999999999999999 99999999999999999999999
Q ss_pred eeeecccccCCCCCCc-----cceeeeeccCCCCccChhhhccCCCCCcchhhhHHHHHHHHHhCCCCCCCCchhHHHHH
Q 002158 770 FGLSRLAPVLDDEGTM-----PTHVSTIVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVLLELLTGMQPISHGKNIVREVN 844 (958)
Q Consensus 770 FGla~~~~~~~~~~~~-----~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gv~l~elltG~~P~~~~~~~~~~~~ 844 (958)
||+|+........... ........+||+.|||||++.+..|+.++|||||||++|||++ ||....+......
T Consensus 162 FGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~~~~~~~~~ 238 (299)
T 4g31_A 162 FGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQMERVRTLT 238 (299)
T ss_dssp CCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSHHHHHHHHH
T ss_pred CccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCccHHHHHHH
Confidence 9999876443221111 0112344679999999999999999999999999999999996 7754322212111
Q ss_pred HHhhcCcchhhhcccCCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 002158 845 VARDSGMVFSIIDNRMGSYPSECVERFVTLALRCCHDKPEHRPSMSDVVRE 895 (958)
Q Consensus 845 ~~~~~~~~~~~i~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 895 (958)
.... ...+.......+...+++.+||+.||++|||+.|++++
T Consensus 239 ~~~~---------~~~p~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h 280 (299)
T 4g31_A 239 DVRN---------LKFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIEN 280 (299)
T ss_dssp HHHT---------TCCCHHHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred HHhc---------CCCCCCCcccCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 1111 11111122344567889999999999999999999873
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-45 Score=411.86 Aligned_cols=262 Identities=22% Similarity=0.295 Sum_probs=204.1
Q ss_pred cCCCCCceeeeeCCeEEEEEEEC-CCcEEEEEEeccCC--hhcHHHHHHHHHHHHccCCCCcceEEEEEEe------CCe
Q 002158 625 AYFSSSTQVGQGGYGKVYKGILS-DNTTVAIKRAEEGS--LQGQNEFLTEIKLLSRLHHRNLVSLLGYCDE------EGE 695 (958)
Q Consensus 625 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~------~~~ 695 (958)
++|...+.||+|+||+||+|++. +|+.||||+++... ....+.+.+|+++|++++|||||++++++.. .+.
T Consensus 54 ~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~~ 133 (398)
T 4b99_A 54 DEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKS 133 (398)
T ss_dssp SSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCCC
T ss_pred CCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCCE
Confidence 46888899999999999999986 79999999997542 3345678999999999999999999999764 357
Q ss_pred EEEEEEecCCCCHHHHhccCCCCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEecCCCCeEEeeeeeecc
Q 002158 696 QMLVYEFVPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSRL 775 (958)
Q Consensus 696 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~ 775 (958)
.|||||||+ |+|.+++.... .+++.++..++.|++.||+|||+++ ||||||||+|||++.++.+||+|||+|+.
T Consensus 134 ~~ivmE~~~-g~L~~~i~~~~--~l~~~~~~~~~~qil~al~ylH~~~---iiHRDlKP~NIl~~~~~~~Ki~DFGla~~ 207 (398)
T 4b99_A 134 VYVVLDLME-SDLHQIIHSSQ--PLTLEHVRYFLYQLLRGLKYMHSAQ---VIHRDLKPSNLLVNENCELKIGDFGMARG 207 (398)
T ss_dssp EEEEEECCS-EEHHHHHTSSS--CCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTCCEEECCCTTCBC
T ss_pred EEEEEeCCC-CCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCc---CcCCCcCccccccCCCCCEEEeecceeee
Confidence 899999995 78999997543 5999999999999999999999999 99999999999999999999999999986
Q ss_pred cccCCCCCCccceeeeeccCCCCccChhhhccC-CCCCcchhhhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcCcchh
Q 002158 776 APVLDDEGTMPTHVSTIVKGTPGYLDPEYFLTH-KLTDKSDVYSLGVVLLELLTGMQPISHGKNIVREVNVARDSGMVFS 854 (958)
Q Consensus 776 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DV~S~Gv~l~elltG~~P~~~~~~~~~~~~~~~~~~~~~~ 854 (958)
+...... ........+||+.|||||++.+. .++.++||||+||++|||++|+.||.+..............+....
T Consensus 208 ~~~~~~~---~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I~~~~g~p~~ 284 (398)
T 4b99_A 208 LCTSPAE---HQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPSP 284 (398)
T ss_dssp C----------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCG
T ss_pred cccCccc---cccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCh
Confidence 5322111 12223456899999999998875 4689999999999999999999999765543332222111111100
Q ss_pred -------------hhcccCC--CC-----ChHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 002158 855 -------------IIDNRMG--SY-----PSECVERFVTLALRCCHDKPEHRPSMSDVVRE 895 (958)
Q Consensus 855 -------------~i~~~~~--~~-----~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 895 (958)
.+..... .. .+..+.++.+|+.+||+.||++|||++|++++
T Consensus 285 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H 345 (398)
T 4b99_A 285 AVIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRH 345 (398)
T ss_dssp GGTC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred HHhhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 0000000 00 11235678899999999999999999999875
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-44 Score=401.81 Aligned_cols=264 Identities=19% Similarity=0.274 Sum_probs=201.9
Q ss_pred HHHcCCCCCceeeeeCCeEEEEEEEC----CCcEEEEEEeccCChhcHHHHHHHHHHHHcc-CCCCcceEEEEEEeCCeE
Q 002158 622 MATAYFSSSTQVGQGGYGKVYKGILS----DNTTVAIKRAEEGSLQGQNEFLTEIKLLSRL-HHRNLVSLLGYCDEEGEQ 696 (958)
Q Consensus 622 ~~~~~~~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~ 696 (958)
...+.|++.+.||+|+||+||+|+.+ .++.||||++.... ...++.+|+++++.+ +||||+++++++.+.+..
T Consensus 18 ~l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~--~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~~ 95 (361)
T 4f9c_A 18 QLSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTS--HPIRIAAELQCLTVAGGQDNVMGVKYCFRKNDHV 95 (361)
T ss_dssp GGGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTS--CHHHHHHHHHHHHHTCSBTTBCCCSEEEEETTEE
T ss_pred CccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEcccc--CHHHHHHHHHHHHHhcCCCCCceEEEEEEECCEE
Confidence 34578999999999999999999863 46789999986543 345688999999998 699999999999999999
Q ss_pred EEEEEecCCCCHHHHhccCCCCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEecCC-CCeEEeeeeeecc
Q 002158 697 MLVYEFVPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSN-LNAKVADFGLSRL 775 (958)
Q Consensus 697 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~-~~~kl~DFGla~~ 775 (958)
|+|||||++|+|.+++. .+++.++..++.|++.||+|||+++ |+||||||+|||++.+ +.+||+|||+|+.
T Consensus 96 ~lvmE~~~g~~L~~~~~-----~l~~~~~~~~~~qll~al~ylH~~g---IiHRDiKPeNiLl~~~~~~~kl~DFGla~~ 167 (361)
T 4f9c_A 96 VIAMPYLEHESFLDILN-----SLSFQEVREYMLNLFKALKRIHQFG---IVHRDVKPSNFLYNRRLKKYALVDFGLAQG 167 (361)
T ss_dssp EEEEECCCCCCHHHHHT-----TCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCCTTCEE
T ss_pred EEEEeCCCcccHHHHHc-----CCCHHHHHHHHHHHHHHHHHHHHCC---eEeCcCCHHHeEEeCCCCeEEECcCCCCcc
Confidence 99999999999999994 2889999999999999999999999 9999999999999877 7999999999986
Q ss_pred cccCCCCC---------------------CccceeeeeccCCCCccChhhhccC-CCCCcchhhhHHHHHHHHHhCCCCC
Q 002158 776 APVLDDEG---------------------TMPTHVSTIVKGTPGYLDPEYFLTH-KLTDKSDVYSLGVVLLELLTGMQPI 833 (958)
Q Consensus 776 ~~~~~~~~---------------------~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DV~S~Gv~l~elltG~~P~ 833 (958)
........ ..........+||+.|||||++.+. .|+.++||||+||++|||++|+.||
T Consensus 168 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~Pf 247 (361)
T 4f9c_A 168 THDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPF 247 (361)
T ss_dssp CTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSSS
T ss_pred cCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCCC
Confidence 53221100 0001122345799999999999876 4899999999999999999999999
Q ss_pred CCCchhHHHHHHHhh-cCc------------------------chhh---hc---ccC-------------CCCChHHHH
Q 002158 834 SHGKNIVREVNVARD-SGM------------------------VFSI---ID---NRM-------------GSYPSECVE 869 (958)
Q Consensus 834 ~~~~~~~~~~~~~~~-~~~------------------------~~~~---i~---~~~-------------~~~~~~~~~ 869 (958)
..+.+....+..... .+. .... +. ... .......++
T Consensus 248 ~~~~~~~~~l~~I~~~~G~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~is~ 327 (361)
T 4f9c_A 248 YKASDDLTALAQIMTIRGSRETIQAAKTFGKSILCSKEVPAQDLRKLCERLRGMDSSTPKLTSDIQGHATNLEGWNEVPD 327 (361)
T ss_dssp SCCSSHHHHHHHHHHHHCHHHHHHHHHHTTEEEEESSCCCCCCHHHHHHHHC----------------------CTTCCH
T ss_pred CCCCCHHHHHHHHHHhcCCccchhhhhhccccccccccCcchhhhHHHHhhccccccccccccccccccccccccccCCH
Confidence 766543322211100 000 0000 00 000 001123456
Q ss_pred HHHHHHHHccccCCCCCCCHHHHHHH
Q 002158 870 RFVTLALRCCHDKPEHRPSMSDVVRE 895 (958)
Q Consensus 870 ~l~~li~~cl~~dP~~RPs~~evl~~ 895 (958)
++.+|+.+|++.||++|||++|+++|
T Consensus 328 ~a~DLl~~lL~~dP~~R~ta~eaL~H 353 (361)
T 4f9c_A 328 EAYDLLDKLLDLNPASRITAEEALLH 353 (361)
T ss_dssp HHHHHHHHHTCSCTTTSCCHHHHHTS
T ss_pred HHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 78899999999999999999999864
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-43 Score=420.48 Aligned_cols=252 Identities=20% Similarity=0.304 Sum_probs=212.3
Q ss_pred cCCCCCceeeeeCCeEEEEEEEC-CCcEEEEEEeccCChhcHHHHHHHHHHHHccCCCCcceEEEEEEeCCeEEEEEEec
Q 002158 625 AYFSSSTQVGQGGYGKVYKGILS-DNTTVAIKRAEEGSLQGQNEFLTEIKLLSRLHHRNLVSLLGYCDEEGEQMLVYEFV 703 (958)
Q Consensus 625 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E~~ 703 (958)
++|++.+.||+|+||+||+|+++ +|+.||||++......+.+.+.+|+++|+.++|||||++++++.+++..+||||||
T Consensus 157 ~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E~~ 236 (573)
T 3uto_A 157 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFM 236 (573)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEECC
T ss_pred cccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeec
Confidence 57888999999999999999986 69999999998777667778999999999999999999999999999999999999
Q ss_pred CCCCHHHHhccCCCCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEecCC--CCeEEeeeeeecccccCCC
Q 002158 704 PNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSN--LNAKVADFGLSRLAPVLDD 781 (958)
Q Consensus 704 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~--~~~kl~DFGla~~~~~~~~ 781 (958)
+||+|.+++..+. ..+++.++..++.||+.||+|||+++ |+||||||+|||++.+ +.+||+|||+|+.+..
T Consensus 237 ~gg~L~~~i~~~~-~~l~e~~~~~~~~qi~~al~ylH~~~---iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~--- 309 (573)
T 3uto_A 237 SGGELFEKVADEH-NKMSEDEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDP--- 309 (573)
T ss_dssp CCCBHHHHHTCTT-SCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCSSCEECCT---
T ss_pred CCCcHHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCChhhccccCCCCCCEEEeeccceeEccC---
Confidence 9999999996543 35999999999999999999999999 9999999999999854 8999999999987532
Q ss_pred CCCccceeeeeccCCCCccChhhhccCCCCCcchhhhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcCcchhhhcccCC
Q 002158 782 EGTMPTHVSTIVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVLLELLTGMQPISHGKNIVREVNVARDSGMVFSIIDNRMG 861 (958)
Q Consensus 782 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gv~l~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~i~~~~~ 861 (958)
.......+||+.|||||++.+..|+.++||||+||++|||++|+.||.+...... ........... ..
T Consensus 310 -----~~~~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~~-~~~i~~~~~~~------~~ 377 (573)
T 3uto_A 310 -----KQSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDET-LRNVKSCDWNM------DD 377 (573)
T ss_dssp -----TSEEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHH-HHHHHTTCCCC------CS
T ss_pred -----CCceeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHH-HHHHHhCCCCC------Cc
Confidence 1223456799999999999999999999999999999999999999976544322 22111111000 00
Q ss_pred CCChHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 002158 862 SYPSECVERFVTLALRCCHDKPEHRPSMSDVVRE 895 (958)
Q Consensus 862 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 895 (958)
.....++.++.+|+.+||+.||.+||+++|+++|
T Consensus 378 ~~~~~~s~~~~dli~~~L~~dp~~R~t~~e~l~H 411 (573)
T 3uto_A 378 SAFSGISEDGKDFIRKLLLADPNTRMTIHQALEH 411 (573)
T ss_dssp GGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred ccccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 1123456788999999999999999999999875
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-43 Score=417.25 Aligned_cols=247 Identities=23% Similarity=0.288 Sum_probs=202.5
Q ss_pred cCCCCCceeeeeCCeEEEEEEEC-CCcEEEEEEeccCCh---hcHHHHH---HHHHHHHccCCCCcceEEEEEEeCCeEE
Q 002158 625 AYFSSSTQVGQGGYGKVYKGILS-DNTTVAIKRAEEGSL---QGQNEFL---TEIKLLSRLHHRNLVSLLGYCDEEGEQM 697 (958)
Q Consensus 625 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~---~E~~~l~~l~H~niv~l~~~~~~~~~~~ 697 (958)
++|+..+.||+|+||+||+|+.+ +|+.||||++..... .....+. .++.+++.++|||||++++++.+.+..|
T Consensus 189 ddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~ly 268 (689)
T 3v5w_A 189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLS 268 (689)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEE
T ss_pred HHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEEE
Confidence 46888999999999999999986 699999999864311 1222233 4467777889999999999999999999
Q ss_pred EEEEecCCCCHHHHhccCCCCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEecCCCCeEEeeeeeecccc
Q 002158 698 LVYEFVPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSRLAP 777 (958)
Q Consensus 698 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~~~ 777 (958)
||||||+||+|.++|.... .+++..+..++.||+.||+|||+++ ||||||||+|||++.+|.+||+|||+|+...
T Consensus 269 lVmEy~~GGdL~~~l~~~~--~l~E~~a~~y~~qIl~aL~yLH~~g---IiHRDLKPeNILld~~G~vKL~DFGlA~~~~ 343 (689)
T 3v5w_A 269 FILDLMNGGDLHYHLSQHG--VFSEADMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFS 343 (689)
T ss_dssp EEECCCCSCBHHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECTTSCEEECCCTTCEECS
T ss_pred EEEecCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchHHeEEeCCCCEEecccceeeecC
Confidence 9999999999999997654 4999999999999999999999999 9999999999999999999999999998653
Q ss_pred cCCCCCCccceeeeeccCCCCccChhhhcc-CCCCCcchhhhHHHHHHHHHhCCCCCCCCch--hHHHHHHHhhcCcchh
Q 002158 778 VLDDEGTMPTHVSTIVKGTPGYLDPEYFLT-HKLTDKSDVYSLGVVLLELLTGMQPISHGKN--IVREVNVARDSGMVFS 854 (958)
Q Consensus 778 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DV~S~Gv~l~elltG~~P~~~~~~--~~~~~~~~~~~~~~~~ 854 (958)
.. .....+||+.|||||++.. ..|+.++||||+||++|||++|+.||.+... .......
T Consensus 344 ~~---------~~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i~~~--------- 405 (689)
T 3v5w_A 344 KK---------KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRM--------- 405 (689)
T ss_dssp SC---------CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHHHHH---------
T ss_pred CC---------CCCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHh---------
Confidence 21 1234679999999999975 5799999999999999999999999964321 1111111
Q ss_pred hhcccCCCCChHHHHHHHHHHHHccccCCCCCCC-----HHHHHHH
Q 002158 855 IIDNRMGSYPSECVERFVTLALRCCHDKPEHRPS-----MSDVVRE 895 (958)
Q Consensus 855 ~i~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~evl~~ 895 (958)
+......+|..++.++.+|+.+||+.||.+|++ ++||.+|
T Consensus 406 -i~~~~~~~p~~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~H 450 (689)
T 3v5w_A 406 -TLTMAVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKES 450 (689)
T ss_dssp -HHHCCCCCCTTSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTTS
T ss_pred -hcCCCCCCCccCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhcC
Confidence 111223446667788999999999999999998 6888764
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-43 Score=391.38 Aligned_cols=280 Identities=43% Similarity=0.727 Sum_probs=232.0
Q ss_pred cChHHHHHHHcCCCCCceeeeeCCeEEEEEEECCCcEEEEEEeccCChhcHHHHHHHHHHHHccCCCCcceEEEEEEeCC
Q 002158 615 FKFKELAMATAYFSSSTQVGQGGYGKVYKGILSDNTTVAIKRAEEGSLQGQNEFLTEIKLLSRLHHRNLVSLLGYCDEEG 694 (958)
Q Consensus 615 ~~~~el~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~ 694 (958)
+++.++...+++|...+.||+|+||+||+|.+++++.||||++........+.+.+|++++++++||||+++++++...+
T Consensus 29 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 108 (321)
T 2qkw_B 29 VPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERN 108 (321)
T ss_dssp -CCSCCCCCCCCCSCCCCSCBCSSSEEEEEECTTCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEECCCTT
T ss_pred ecHHHHHHHHhccCccceeecCCCeeEEEEEECCCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCC
Confidence 33444555778999999999999999999998889999999988766666778999999999999999999999999999
Q ss_pred eEEEEEEecCCCCHHHHhccCC--CCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEecCCCCeEEeeeee
Q 002158 695 EQMLVYEFVPNGTLRDWLSGRT--KENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSNLNAKVADFGL 772 (958)
Q Consensus 695 ~~~lV~E~~~~gsL~~~l~~~~--~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~~~~kl~DFGl 772 (958)
..++||||+++|+|.+++.... ...+++.++..++.|+++||+|||+++ |+||||||+||+++.++.+||+|||+
T Consensus 109 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~ 185 (321)
T 2qkw_B 109 EMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRA---IIHRDVKSINILLDENFVPKITDFGI 185 (321)
T ss_dssp CCEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCSTTEEECTTCCEEECCCTT
T ss_pred eEEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCC---eecCCCCHHHEEECCCCCEEEeeccc
Confidence 9999999999999999997544 235899999999999999999999999 99999999999999999999999999
Q ss_pred ecccccCCCCCCccceeeeeccCCCCccChhhhccCCCCCcchhhhHHHHHHHHHhCCCCCCCCc-----hhHHHHHHHh
Q 002158 773 SRLAPVLDDEGTMPTHVSTIVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVLLELLTGMQPISHGK-----NIVREVNVAR 847 (958)
Q Consensus 773 a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gv~l~elltG~~P~~~~~-----~~~~~~~~~~ 847 (958)
++....... ........||+.|+|||++.+..++.++||||||+++|||++|+.||.... ....+.....
T Consensus 186 ~~~~~~~~~-----~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~ 260 (321)
T 2qkw_B 186 SKKGTELDQ-----THLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESH 260 (321)
T ss_dssp CEECSSSSC-----CCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHH
T ss_pred ccccccccc-----cccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhcc
Confidence 986432221 112234568999999999999999999999999999999999999996432 1222222222
Q ss_pred hcCcchhhhcccC-CCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHhh
Q 002158 848 DSGMVFSIIDNRM-GSYPSECVERFVTLALRCCHDKPEHRPSMSDVVRELENILKM 902 (958)
Q Consensus 848 ~~~~~~~~i~~~~-~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~ 902 (958)
..+.....+++.. ...+..++..+.+++.+||+.||++||+++|++++|+.+++.
T Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~l~~ 316 (321)
T 2qkw_B 261 NNGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYALRL 316 (321)
T ss_dssp TTTCCCSSSSSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred ccccHHHhcChhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhhc
Confidence 2233333333333 345778999999999999999999999999999999998764
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-43 Score=390.97 Aligned_cols=286 Identities=42% Similarity=0.716 Sum_probs=232.7
Q ss_pred cccCCccccChHHHHHHHcCCCCCceeeeeCCeEEEEEEECCCcEEEEEEeccCChh-cHHHHHHHHHHHHccCCCCcce
Q 002158 607 MKIDGVKGFKFKELAMATAYFSSSTQVGQGGYGKVYKGILSDNTTVAIKRAEEGSLQ-GQNEFLTEIKLLSRLHHRNLVS 685 (958)
Q Consensus 607 ~~~~~~~~~~~~el~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~H~niv~ 685 (958)
......+.++++++....++|...+.||+|+||+||+|.+++++.||||++...... ....+.+|+++++.++||||++
T Consensus 12 ~~~~~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~ 91 (326)
T 3uim_A 12 VHLGQLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLR 91 (326)
T ss_dssp ---CCCEECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCC
T ss_pred cccCccceecHHHHHHHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccc
Confidence 334456789999999999999999999999999999999888999999998764322 2336899999999999999999
Q ss_pred EEEEEEeCCeEEEEEEecCCCCHHHHhccCC--CCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEecCCC
Q 002158 686 LLGYCDEEGEQMLVYEFVPNGTLRDWLSGRT--KENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSNL 763 (958)
Q Consensus 686 l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~--~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~~ 763 (958)
+++++...+..++||||+++|+|.+++.... ...+++..+..++.|++.||+|||+...++|+||||||+|||++.++
T Consensus 92 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~ 171 (326)
T 3uim_A 92 LRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEF 171 (326)
T ss_dssp CCEEECCSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTC
T ss_pred eEEEEecCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCC
Confidence 9999999999999999999999999998654 33499999999999999999999999222299999999999999999
Q ss_pred CeEEeeeeeecccccCCCCCCccceeeeeccCCCCccChhhhccCCCCCcchhhhHHHHHHHHHhCCCCCCC-------C
Q 002158 764 NAKVADFGLSRLAPVLDDEGTMPTHVSTIVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVLLELLTGMQPISH-------G 836 (958)
Q Consensus 764 ~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gv~l~elltG~~P~~~-------~ 836 (958)
.+||+|||+++...... ........||+.|+|||++.+..++.++||||||+++|||++|+.||.. .
T Consensus 172 ~~kl~Dfg~~~~~~~~~------~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~ 245 (326)
T 3uim_A 172 EAVVGDFGLAKLMDYKD------THVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDD 245 (326)
T ss_dssp CEEECCCSSCEECCSSS------SCEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSC
T ss_pred CEEeccCccccccCccc------ccccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccc
Confidence 99999999998653222 2223445699999999999999999999999999999999999999952 1
Q ss_pred chhHHHHHHHhhcCcchhhhcccC-CCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 002158 837 KNIVREVNVARDSGMVFSIIDNRM-GSYPSECVERFVTLALRCCHDKPEHRPSMSDVVRELEN 898 (958)
Q Consensus 837 ~~~~~~~~~~~~~~~~~~~i~~~~-~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 898 (958)
.....++.............+... ...+...+..+.+++.+||+.||.+|||++|++++|+.
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~ 308 (326)
T 3uim_A 246 VMLLDWVKGLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEG 308 (326)
T ss_dssp SBHHHHHTTTTSSCCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHT
T ss_pred hhHHHHHHHHhhchhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcC
Confidence 112222222222222223333322 45577889999999999999999999999999999987
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-42 Score=375.43 Aligned_cols=251 Identities=23% Similarity=0.369 Sum_probs=212.6
Q ss_pred HcCCCCCceeeeeCCeEEEEEEEC-CCcEEEEEEeccCChhcHHHHHHHHHHHHccCCCCcceEEEEEEeCCeEEEEEEe
Q 002158 624 TAYFSSSTQVGQGGYGKVYKGILS-DNTTVAIKRAEEGSLQGQNEFLTEIKLLSRLHHRNLVSLLGYCDEEGEQMLVYEF 702 (958)
Q Consensus 624 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E~ 702 (958)
..+|...+.||+|+||+||+|.+. +++.||||++........+.+.+|+.++++++||||+++++++..++..++||||
T Consensus 19 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 98 (297)
T 3fxz_A 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY 98 (297)
T ss_dssp GGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred hhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEEEC
Confidence 357889999999999999999964 7899999998765555567799999999999999999999999999999999999
Q ss_pred cCCCCHHHHhccCCCCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEecCCCCeEEeeeeeecccccCCCC
Q 002158 703 VPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSRLAPVLDDE 782 (958)
Q Consensus 703 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~ 782 (958)
+++|+|.+++... .+++.++..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+++.......
T Consensus 99 ~~~~~L~~~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~- 171 (297)
T 3fxz_A 99 LAGGSLTDVVTET---CMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS- 171 (297)
T ss_dssp CTTCBHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSTTC-
T ss_pred CCCCCHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHHhCC---ceeCCCCHHHEEECCCCCEEEeeCCCceecCCccc-
Confidence 9999999999764 3899999999999999999999999 99999999999999999999999999876532211
Q ss_pred CCccceeeeeccCCCCccChhhhccCCCCCcchhhhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcCcchhhhcccCCC
Q 002158 783 GTMPTHVSTIVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVLLELLTGMQPISHGKNIVREVNVARDSGMVFSIIDNRMGS 862 (958)
Q Consensus 783 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gv~l~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~ 862 (958)
......||+.|+|||++.+..++.++|||||||++|||++|+.||.................. ...
T Consensus 172 ------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~--------~~~ 237 (297)
T 3fxz_A 172 ------KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTP--------ELQ 237 (297)
T ss_dssp ------CBCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSC--------CCS
T ss_pred ------ccCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCC--------CCC
Confidence 123456999999999999999999999999999999999999999765543332222111110 112
Q ss_pred CChHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 002158 863 YPSECVERFVTLALRCCHDKPEHRPSMSDVVRE 895 (958)
Q Consensus 863 ~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 895 (958)
.+..++..+.+++.+||+.||++||+++|++++
T Consensus 238 ~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h 270 (297)
T 3fxz_A 238 NPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQH 270 (297)
T ss_dssp CGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred CccccCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence 245567889999999999999999999999874
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-42 Score=379.14 Aligned_cols=263 Identities=28% Similarity=0.433 Sum_probs=215.0
Q ss_pred cCCCCCceeeeeCCeEEEEEEEC----CCcEEEEEEeccC-ChhcHHHHHHHHHHHHccCCCCcceEEEEEEeCCeEEEE
Q 002158 625 AYFSSSTQVGQGGYGKVYKGILS----DNTTVAIKRAEEG-SLQGQNEFLTEIKLLSRLHHRNLVSLLGYCDEEGEQMLV 699 (958)
Q Consensus 625 ~~~~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV 699 (958)
.+|...+.||+|+||+||+|.+. .+..||||+++.. .....+.|.+|++++++++||||+++++++..++..++|
T Consensus 49 ~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 128 (325)
T 3kul_A 49 SRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMIV 128 (325)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCCEEE
T ss_pred hHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCccEEE
Confidence 45667789999999999999985 3556999999865 344456799999999999999999999999999999999
Q ss_pred EEecCCCCHHHHhccCCCCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEecCCCCeEEeeeeeecccccC
Q 002158 700 YEFVPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSRLAPVL 779 (958)
Q Consensus 700 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~~~~~ 779 (958)
|||+++|+|.++++... ..+++.++..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 129 ~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 204 (325)
T 3kul_A 129 TEYMENGSLDTFLRTHD-GQFTIMQLVGMLRGVGAGMRYLSDLG---YVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDD 204 (325)
T ss_dssp EECCTTCBHHHHHHTTT-TCSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCSSCEECC--
T ss_pred eeCCCCCcHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCcceEEECCCCCEEECCCCcccccccC
Confidence 99999999999997543 34999999999999999999999999 999999999999999999999999999875432
Q ss_pred CCCCCccceeeeeccCCCCccChhhhccCCCCCcchhhhHHHHHHHHHh-CCCCCCCCchhHHHHHHHhhcCcchhhhcc
Q 002158 780 DDEGTMPTHVSTIVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVLLELLT-GMQPISHGKNIVREVNVARDSGMVFSIIDN 858 (958)
Q Consensus 780 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gv~l~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~i~~ 858 (958)
... ........+|+.|+|||++.+..++.++||||||+++|||++ |..||......... .... ..
T Consensus 205 ~~~----~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~-~~~~---------~~ 270 (325)
T 3kul_A 205 PDA----AYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVI-SSVE---------EG 270 (325)
T ss_dssp --C----CEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHH-HHHH---------TT
T ss_pred ccc----eeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHHHHH-HHHH---------cC
Confidence 211 122233456888999999999999999999999999999999 99999754432211 1111 11
Q ss_pred cCCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHhhCCC
Q 002158 859 RMGSYPSECVERFVTLALRCCHDKPEHRPSMSDVVRELENILKMFPE 905 (958)
Q Consensus 859 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~~~ 905 (958)
.....+..++..+.+++.+||+.||++||+++++++.|+.+++....
T Consensus 271 ~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~L~~l~~~~~~ 317 (325)
T 3kul_A 271 YRLPAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDALIRSPES 317 (325)
T ss_dssp CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSCC-
T ss_pred CCCCCCCCcCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhCccc
Confidence 12234556778899999999999999999999999999999876543
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-41 Score=369.53 Aligned_cols=281 Identities=36% Similarity=0.626 Sum_probs=232.3
Q ss_pred CccccChHHHHHHHcCCCCC------ceeeeeCCeEEEEEEECCCcEEEEEEeccCC----hhcHHHHHHHHHHHHccCC
Q 002158 611 GVKGFKFKELAMATAYFSSS------TQVGQGGYGKVYKGILSDNTTVAIKRAEEGS----LQGQNEFLTEIKLLSRLHH 680 (958)
Q Consensus 611 ~~~~~~~~el~~~~~~~~~~------~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~H 680 (958)
....+++.++..++.+|... +.||+|+||+||+|.+ +++.||||++.... ....+.+.+|++++++++|
T Consensus 11 ~~~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h 89 (307)
T 2nru_A 11 RFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQH 89 (307)
T ss_dssp CCEECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEES-SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCC
T ss_pred CCCcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEE-CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCC
Confidence 45678999999999999888 8999999999999987 68899999986532 2335679999999999999
Q ss_pred CCcceEEEEEEeCCeEEEEEEecCCCCHHHHhccCC-CCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEe
Q 002158 681 RNLVSLLGYCDEEGEQMLVYEFVPNGTLRDWLSGRT-KENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILL 759 (958)
Q Consensus 681 ~niv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~-~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl 759 (958)
|||+++++++...+..++||||+++++|.+++.... ...+++..+..++.|++.||+|||+.+ |+||||||+||++
T Consensus 90 ~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dlkp~Nili 166 (307)
T 2nru_A 90 ENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENH---HIHRDIKSANILL 166 (307)
T ss_dssp TTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEE
T ss_pred CCeEEEEEEEecCCceEEEEEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCC---eecCCCCHHHEEE
Confidence 999999999999999999999999999999997432 345899999999999999999999999 9999999999999
Q ss_pred cCCCCeEEeeeeeecccccCCCCCCccceeeeeccCCCCccChhhhccCCCCCcchhhhHHHHHHHHHhCCCCCCCCch-
Q 002158 760 DSNLNAKVADFGLSRLAPVLDDEGTMPTHVSTIVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVLLELLTGMQPISHGKN- 838 (958)
Q Consensus 760 ~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gv~l~elltG~~P~~~~~~- 838 (958)
+.++.+||+|||+++....... ........||+.|+|||++.+ .++.++||||||+++|||++|..||.....
T Consensus 167 ~~~~~~kl~Dfg~~~~~~~~~~-----~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~ 240 (307)
T 2nru_A 167 DEAFTAKISDFGLARASEKFAQ-----TVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHREP 240 (307)
T ss_dssp CTTCCEEECCCTTCEECCSCSS-----CEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTBSS
T ss_pred cCCCcEEEeecccccccccccc-----cccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCcch
Confidence 9999999999999986532211 122234569999999998865 588999999999999999999999975432
Q ss_pred --hHHHHHHH-hhcCcchhhhcccCCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHh
Q 002158 839 --IVREVNVA-RDSGMVFSIIDNRMGSYPSECVERFVTLALRCCHDKPEHRPSMSDVVRELENILK 901 (958)
Q Consensus 839 --~~~~~~~~-~~~~~~~~~i~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~ 901 (958)
........ .........++..+...+...+..+.+++.+||+.||.+||++++++++|+++..
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~l~~ 306 (307)
T 2nru_A 241 QLLLDIKEEIEDEEKTIEDYIDKKMNDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMTA 306 (307)
T ss_dssp SBTTHHHHHHHTTSCCHHHHSCSSCSCCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHC-
T ss_pred HHHHHHHHHhhhhhhhhhhhccccccccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhc
Confidence 11111111 1222334445555666788899999999999999999999999999999998753
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-41 Score=375.18 Aligned_cols=263 Identities=31% Similarity=0.489 Sum_probs=210.0
Q ss_pred HHcCCCCCceeeeeCCeEEEEEEECCCcEEEEEEeccCC--hhcHHHHHHHHHHHHccCCCCcceEEEEEEeCCeEEEEE
Q 002158 623 ATAYFSSSTQVGQGGYGKVYKGILSDNTTVAIKRAEEGS--LQGQNEFLTEIKLLSRLHHRNLVSLLGYCDEEGEQMLVY 700 (958)
Q Consensus 623 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~ 700 (958)
...+|...+.||+|+||+||+|.+ +++.||||++.... ....++|.+|++++++++||||+++++++...+..++||
T Consensus 35 ~~~~y~i~~~lG~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 113 (309)
T 3p86_A 35 PWCDLNIKEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVT 113 (309)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEE-TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTCCEEEE
T ss_pred ChhHceeeeEeecCCCeEEEEEEE-CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCceEEEE
Confidence 445778889999999999999987 68899999987653 334567999999999999999999999999999999999
Q ss_pred EecCCCCHHHHhccCCC-CCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEecCCCCeEEeeeeeecccccC
Q 002158 701 EFVPNGTLRDWLSGRTK-ENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSRLAPVL 779 (958)
Q Consensus 701 E~~~~gsL~~~l~~~~~-~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~~~~~ 779 (958)
||+++|+|.+++..... ..+++..++.++.|++.||+|||+.+ ++|+||||||+||+++.++.+||+|||+++.....
T Consensus 114 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~-~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~ 192 (309)
T 3p86_A 114 EYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRN-PPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKAST 192 (309)
T ss_dssp ECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSS-SCCCCTTCCGGGEEECTTCCEEECCCC--------
T ss_pred ecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCC-CCEECCCCChhhEEEeCCCcEEECCCCCCcccccc
Confidence 99999999999976442 34899999999999999999999876 46999999999999999999999999999754221
Q ss_pred CCCCCccceeeeeccCCCCccChhhhccCCCCCcchhhhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcCcchhhhccc
Q 002158 780 DDEGTMPTHVSTIVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVLLELLTGMQPISHGKNIVREVNVARDSGMVFSIIDNR 859 (958)
Q Consensus 780 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gv~l~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~i~~~ 859 (958)
........||+.|+|||++.+..++.++||||||+++|||++|+.||.............. ...
T Consensus 193 -------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~---------~~~ 256 (309)
T 3p86_A 193 -------FLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGF---------KCK 256 (309)
T ss_dssp ----------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHH---------SCC
T ss_pred -------ccccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh---------cCC
Confidence 1122345699999999999999999999999999999999999999976543222111110 111
Q ss_pred CCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHhhC
Q 002158 860 MGSYPSECVERFVTLALRCCHDKPEHRPSMSDVVRELENILKMF 903 (958)
Q Consensus 860 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~ 903 (958)
....+..++..+.+++.+||+.||++||+++++++.|+.+++..
T Consensus 257 ~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~~ 300 (309)
T 3p86_A 257 RLEIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKSA 300 (309)
T ss_dssp CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC--
T ss_pred CCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhC
Confidence 23445667788999999999999999999999999999988643
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-42 Score=388.40 Aligned_cols=263 Identities=26% Similarity=0.505 Sum_probs=216.8
Q ss_pred HcCCCCCceeeeeCCeEEEEEEEC--------CCcEEEEEEeccCC-hhcHHHHHHHHHHHHcc-CCCCcceEEEEEEeC
Q 002158 624 TAYFSSSTQVGQGGYGKVYKGILS--------DNTTVAIKRAEEGS-LQGQNEFLTEIKLLSRL-HHRNLVSLLGYCDEE 693 (958)
Q Consensus 624 ~~~~~~~~~lg~G~~g~Vy~~~~~--------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~ 693 (958)
.++|...+.||+|+||+||+|.+. ++..||||+++... ....+++.+|+++++++ +||||+++++++...
T Consensus 80 ~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 159 (370)
T 2psq_A 80 RDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 159 (370)
T ss_dssp GGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECSS
T ss_pred HHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEccC
Confidence 356778899999999999999862 35679999997653 33456799999999999 899999999999999
Q ss_pred CeEEEEEEecCCCCHHHHhccCC--------------CCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEe
Q 002158 694 GEQMLVYEFVPNGTLRDWLSGRT--------------KENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILL 759 (958)
Q Consensus 694 ~~~~lV~E~~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl 759 (958)
+..++||||+++|+|.+++.... ...+++.+++.++.|+++||+|||+++ |+||||||+|||+
T Consensus 160 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll 236 (370)
T 2psq_A 160 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK---CIHRDLAARNVLV 236 (370)
T ss_dssp SSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEE
T ss_pred CCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---eeccccchhhEEE
Confidence 99999999999999999997643 234889999999999999999999999 9999999999999
Q ss_pred cCCCCeEEeeeeeecccccCCCCCCccceeeeeccCCCCccChhhhccCCCCCcchhhhHHHHHHHHHh-CCCCCCCCch
Q 002158 760 DSNLNAKVADFGLSRLAPVLDDEGTMPTHVSTIVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVLLELLT-GMQPISHGKN 838 (958)
Q Consensus 760 ~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gv~l~ellt-G~~P~~~~~~ 838 (958)
+.++.+||+|||+++........ .......||+.|+|||++.+..++.++|||||||++|||++ |+.||.....
T Consensus 237 ~~~~~~kl~DFG~a~~~~~~~~~-----~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~ 311 (370)
T 2psq_A 237 TENNVMKIADFGLARDINNIDYY-----KKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPV 311 (370)
T ss_dssp CTTCCEEECCCSSCEETTCCCTT-----CTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCG
T ss_pred CCCCCEEEccccCCcccCcccce-----ecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCH
Confidence 99999999999999865332211 11223457889999999999999999999999999999999 9999975432
Q ss_pred hHHHHHHHhhcCcchhhhcccCCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHhhCC
Q 002158 839 IVREVNVARDSGMVFSIIDNRMGSYPSECVERFVTLALRCCHDKPEHRPSMSDVVRELENILKMFP 904 (958)
Q Consensus 839 ~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~~ 904 (958)
. ...... ........+..++..+.+++.+||+.||++||++.|+++.|++++....
T Consensus 312 ~-~~~~~~---------~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~il~~~~ 367 (370)
T 2psq_A 312 E-ELFKLL---------KEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLTT 367 (370)
T ss_dssp G-GHHHHH---------HTTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC
T ss_pred H-HHHHHH---------hcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHhc
Confidence 1 111111 1112234456677899999999999999999999999999999886543
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-42 Score=376.84 Aligned_cols=268 Identities=26% Similarity=0.436 Sum_probs=216.3
Q ss_pred cCCCCCceeeeeCCeEEEEEEEC-CCcEEEEEEeccCChhcHHHHHHHHHHHHccCCCCcceEEEEEEeCCeEEEEEEec
Q 002158 625 AYFSSSTQVGQGGYGKVYKGILS-DNTTVAIKRAEEGSLQGQNEFLTEIKLLSRLHHRNLVSLLGYCDEEGEQMLVYEFV 703 (958)
Q Consensus 625 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E~~ 703 (958)
++|...+.||+|+||+||+|.+. +++.||+|++........+.|.+|++++++++||||+++++++.+++..++||||+
T Consensus 10 ~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~ 89 (310)
T 3s95_A 10 SDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEYI 89 (310)
T ss_dssp GGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred hHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEEEec
Confidence 45777889999999999999986 68999999998777777788999999999999999999999999999999999999
Q ss_pred CCCCHHHHhccCCCCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEecCCCCeEEeeeeeecccccCCCCC
Q 002158 704 PNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSRLAPVLDDEG 783 (958)
Q Consensus 704 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 783 (958)
++|+|.++++... ..+++.++..++.|+++||+|||+.+ |+||||||+||+++.++.+||+|||+++.........
T Consensus 90 ~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~ 165 (310)
T 3s95_A 90 KGGTLRGIIKSMD-SQYPWSQRVSFAKDIASGMAYLHSMN---IIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQP 165 (310)
T ss_dssp TTCBHHHHHHHCC-TTSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEECTTSCEEECCCTTCEECC------
T ss_pred CCCcHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCcCeEEECCCCCEEEeecccceecccccccc
Confidence 9999999998643 34899999999999999999999999 9999999999999999999999999998654322111
Q ss_pred Cc-------cceeeeeccCCCCccChhhhccCCCCCcchhhhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcCcchhhh
Q 002158 784 TM-------PTHVSTIVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVLLELLTGMQPISHGKNIVREVNVARDSGMVFSII 856 (958)
Q Consensus 784 ~~-------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gv~l~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~i 856 (958)
.. .........||+.|+|||++.+..++.++||||||+++|||++|..|+.......... ........
T Consensus 166 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~-----~~~~~~~~ 240 (310)
T 3s95_A 166 EGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDF-----GLNVRGFL 240 (310)
T ss_dssp --------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTS-----SBCHHHHH
T ss_pred cccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHH-----hhhhhccc
Confidence 00 0111124579999999999999999999999999999999999999986422110000 00000011
Q ss_pred cccCCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHhhCC
Q 002158 857 DNRMGSYPSECVERFVTLALRCCHDKPEHRPSMSDVVRELENILKMFP 904 (958)
Q Consensus 857 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~~ 904 (958)
+ ...+..++..+.+++.+||+.||++||+++++++.|+++.+...
T Consensus 241 ~---~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~~L~~l~~~~~ 285 (310)
T 3s95_A 241 D---RYCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLRMHLA 285 (310)
T ss_dssp H---HTCCTTCCTTHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHH
T ss_pred c---ccCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhcc
Confidence 1 11244566789999999999999999999999999999876543
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-41 Score=373.28 Aligned_cols=262 Identities=22% Similarity=0.319 Sum_probs=217.1
Q ss_pred cccChHHHHHHHcC----------CCCCceeeeeCCeEEEEEEEC-CCcEEEEEEeccCChhcHHHHHHHHHHHHccCCC
Q 002158 613 KGFKFKELAMATAY----------FSSSTQVGQGGYGKVYKGILS-DNTTVAIKRAEEGSLQGQNEFLTEIKLLSRLHHR 681 (958)
Q Consensus 613 ~~~~~~el~~~~~~----------~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~ 681 (958)
..++++++..+++. |...+.||+|+||.||+|++. +|+.||||++........+.+.+|+.++++++||
T Consensus 23 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ 102 (321)
T 2c30_A 23 GVVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHF 102 (321)
T ss_dssp --CCHHHHHHHHHTTSCSSCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCCCT
T ss_pred CcCcHHHHHHHHhhccCCCCchhhhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhCCCC
Confidence 45778888777764 556678999999999999987 7999999999876666677899999999999999
Q ss_pred CcceEEEEEEeCCeEEEEEEecCCCCHHHHhccCCCCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEecC
Q 002158 682 NLVSLLGYCDEEGEQMLVYEFVPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDS 761 (958)
Q Consensus 682 niv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~ 761 (958)
||+++++++...+..++||||+++++|.+++... .+++..+..++.|+++||+|||+.+ |+||||||+||+++.
T Consensus 103 niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~---~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~ 176 (321)
T 2c30_A 103 NVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQV---RLNEEQIATVCEAVLQALAYLHAQG---VIHRDIKSDSILLTL 176 (321)
T ss_dssp TBCCEEEEEEETTEEEEEECCCCSCBHHHHHTTC---CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECT
T ss_pred CcceEEEEEEECCEEEEEEecCCCCCHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECC
Confidence 9999999999999999999999999999999643 4899999999999999999999999 999999999999999
Q ss_pred CCCeEEeeeeeecccccCCCCCCccceeeeeccCCCCccChhhhccCCCCCcchhhhHHHHHHHHHhCCCCCCCCchhHH
Q 002158 762 NLNAKVADFGLSRLAPVLDDEGTMPTHVSTIVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVLLELLTGMQPISHGKNIVR 841 (958)
Q Consensus 762 ~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gv~l~elltG~~P~~~~~~~~~ 841 (958)
++.+||+|||+++....... ......||+.|+|||++.+..++.++||||||+++|||++|+.||........
T Consensus 177 ~~~~kl~Dfg~~~~~~~~~~-------~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~~~~ 249 (321)
T 2c30_A 177 DGRVKLSDFGFCAQISKDVP-------KRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQA 249 (321)
T ss_dssp TCCEEECCCTTCEECCSSSC-------CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH
T ss_pred CCcEEEeeeeeeeecccCcc-------ccccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence 99999999999876532211 12345699999999999999999999999999999999999999976543322
Q ss_pred HHHHHhhcCcchhhhcccCCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 002158 842 EVNVARDSGMVFSIIDNRMGSYPSECVERFVTLALRCCHDKPEHRPSMSDVVRE 895 (958)
Q Consensus 842 ~~~~~~~~~~~~~~i~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 895 (958)
. ....... .+. ...+...+..+.+++.+||+.||++||+++|++++
T Consensus 250 ~-~~~~~~~------~~~-~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h 295 (321)
T 2c30_A 250 M-KRLRDSP------PPK-LKNSHKVSPVLRDFLERMLVRDPQERATAQELLDH 295 (321)
T ss_dssp H-HHHHHSS------CCC-CTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred H-HHHhcCC------CCC-cCccccCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 1 1111110 000 11123456789999999999999999999999974
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=373.32 Aligned_cols=270 Identities=26% Similarity=0.434 Sum_probs=213.0
Q ss_pred cCCCCCceeeeeCCeEEEEEEE-----CCCcEEEEEEeccCChhcHHHHHHHHHHHHccCCCCcceEEEEEEe--CCeEE
Q 002158 625 AYFSSSTQVGQGGYGKVYKGIL-----SDNTTVAIKRAEEGSLQGQNEFLTEIKLLSRLHHRNLVSLLGYCDE--EGEQM 697 (958)
Q Consensus 625 ~~~~~~~~lg~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~--~~~~~ 697 (958)
++|+..+.||+|+||+||+|++ .+++.||||++........+.|.+|++++++++||||+++++++.. ....+
T Consensus 10 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 89 (295)
T 3ugc_A 10 RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLK 89 (295)
T ss_dssp GGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHTSCE
T ss_pred HHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCceE
Confidence 4677788999999999999985 2688999999987777777889999999999999999999999865 35689
Q ss_pred EEEEecCCCCHHHHhccCCCCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEecCCCCeEEeeeeeecccc
Q 002158 698 LVYEFVPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSRLAP 777 (958)
Q Consensus 698 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~~~ 777 (958)
+||||+++|+|.+++.... ..+++.++..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++...
T Consensus 90 lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~~~~~~ 165 (295)
T 3ugc_A 90 LIMEYLPYGSLRDYLQKHK-ERIDHIKLLQYTSQICKGMEYLGTKR---YIHRDLATRNILVENENRVKIGDFGLTKVLP 165 (295)
T ss_dssp EEEECCTTCBHHHHHHHCG-GGCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCCSCC---
T ss_pred EEEEeCCCCCHHHHHHhcc-cccCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHhhEEEcCCCeEEEccCccccccc
Confidence 9999999999999997653 34899999999999999999999999 9999999999999999999999999998653
Q ss_pred cCCCCCCccceeeeeccCCCCccChhhhccCCCCCcchhhhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcC-------
Q 002158 778 VLDDEGTMPTHVSTIVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVLLELLTGMQPISHGKNIVREVNVARDSG------- 850 (958)
Q Consensus 778 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gv~l~elltG~~P~~~~~~~~~~~~~~~~~~------- 850 (958)
..... ........|+..|+|||++.+..++.++||||||+++|||++|..|+...... .........
T Consensus 166 ~~~~~----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~--~~~~~~~~~~~~~~~~ 239 (295)
T 3ugc_A 166 QDKEF----FKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAE--FMRMIGNDKQGQMIVF 239 (295)
T ss_dssp --------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHH--HHHHHCTTCCTHHHHH
T ss_pred CCcce----eeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHH--HHhhhcCccccchhHH
Confidence 32211 11223345777899999999999999999999999999999999998643211 111110000
Q ss_pred cchh-hhcccCCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHhhCC
Q 002158 851 MVFS-IIDNRMGSYPSECVERFVTLALRCCHDKPEHRPSMSDVVRELENILKMFP 904 (958)
Q Consensus 851 ~~~~-~i~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~~ 904 (958)
...+ .........+..++..+.+++.+||+.||++|||++|+++.|+++.+..+
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~~l~~~l~ 294 (295)
T 3ugc_A 240 HLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDNMA 294 (295)
T ss_dssp HHHHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHC--
T ss_pred HHHHHHhccCcCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHhcc
Confidence 0011 11122234466778899999999999999999999999999999987653
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-41 Score=375.85 Aligned_cols=247 Identities=25% Similarity=0.376 Sum_probs=208.1
Q ss_pred cCCCCCceeeeeCCeEEEEEEEC-CCcEEEEEEeccC--ChhcHHHHHHHHHHHHccCCCCcceEEEEEEeCCeEEEEEE
Q 002158 625 AYFSSSTQVGQGGYGKVYKGILS-DNTTVAIKRAEEG--SLQGQNEFLTEIKLLSRLHHRNLVSLLGYCDEEGEQMLVYE 701 (958)
Q Consensus 625 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E 701 (958)
.+|...+.||+|+||.||+|.+. +|+.||||++... .....+++.+|+++++.++||||+++++++...+..++|||
T Consensus 15 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e 94 (328)
T 3fe3_A 15 GNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLIME 94 (328)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred CCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEE
Confidence 46788899999999999999984 7999999998654 34445678999999999999999999999999999999999
Q ss_pred ecCCCCHHHHhccCCCCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEecCCCCeEEeeeeeecccccCCC
Q 002158 702 FVPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSRLAPVLDD 781 (958)
Q Consensus 702 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~ 781 (958)
|+++|+|.+++.... .+++.++..++.|+++||+|||+++ |+||||||+|||++.++.+||+|||+++......
T Consensus 95 ~~~~~~L~~~l~~~~--~l~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~- 168 (328)
T 3fe3_A 95 YASGGEVFDYLVAHG--RMKEKEARSKFRQIVSAVQYCHQKR---IVHRDLKAENLLLDADMNIKIADFGFSNEFTVGG- 168 (328)
T ss_dssp CCTTCBHHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSTTCCGGGSSSC-
T ss_pred CCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC---EeccCCCHHHEEEcCCCCEEEeeccCceecCCCC-
Confidence 999999999997653 3899999999999999999999999 9999999999999999999999999997653211
Q ss_pred CCCccceeeeeccCCCCccChhhhccCCCC-CcchhhhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcCcchhhhcccC
Q 002158 782 EGTMPTHVSTIVKGTPGYLDPEYFLTHKLT-DKSDVYSLGVVLLELLTGMQPISHGKNIVREVNVARDSGMVFSIIDNRM 860 (958)
Q Consensus 782 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DV~S~Gv~l~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~i~~~~ 860 (958)
......||+.|+|||++.+..++ .++||||+||++|||++|+.||.+.... ....... ...
T Consensus 169 -------~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~-~~~~~i~----------~~~ 230 (328)
T 3fe3_A 169 -------KLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLK-ELRERVL----------RGK 230 (328)
T ss_dssp -------GGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHH-HHHHHHH----------HCC
T ss_pred -------ccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHH-HHHHHHH----------hCC
Confidence 12345799999999999988875 6999999999999999999999754422 2211111 111
Q ss_pred CCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 002158 861 GSYPSECVERFVTLALRCCHDKPEHRPSMSDVVRE 895 (958)
Q Consensus 861 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 895 (958)
...|...+..+.+++.+||+.||.+|||++|++++
T Consensus 231 ~~~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~h 265 (328)
T 3fe3_A 231 YRIPFYMSTDCENLLKRFLVLNPIKRGTLEQIMKD 265 (328)
T ss_dssp CCCCTTSCHHHHHHHHHHCCSSTTTSCCHHHHTTC
T ss_pred CCCCCCCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 23344567788999999999999999999999874
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-41 Score=382.94 Aligned_cols=261 Identities=28% Similarity=0.453 Sum_probs=204.7
Q ss_pred cCCCCCceeeeeCCeEEEEEEEC----CCcEEEEEEeccC-ChhcHHHHHHHHHHHHccCCCCcceEEEEEEeCCeEEEE
Q 002158 625 AYFSSSTQVGQGGYGKVYKGILS----DNTTVAIKRAEEG-SLQGQNEFLTEIKLLSRLHHRNLVSLLGYCDEEGEQMLV 699 (958)
Q Consensus 625 ~~~~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV 699 (958)
.+|...+.||+|+||+||+|++. ++..||||+++.. .....++|.+|++++++++||||+++++++...+..++|
T Consensus 45 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 124 (373)
T 2qol_A 45 TNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIV 124 (373)
T ss_dssp GGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEE
T ss_pred hhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCceEEE
Confidence 57888999999999999999875 5778999999765 344456899999999999999999999999999999999
Q ss_pred EEecCCCCHHHHhccCCCCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEecCCCCeEEeeeeeecccccC
Q 002158 700 YEFVPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSRLAPVL 779 (958)
Q Consensus 700 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~~~~~ 779 (958)
|||+++|+|.++++... ..+++.+++.++.|+++||+|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 125 ~e~~~~~sL~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 200 (373)
T 2qol_A 125 TEYMENGSLDSFLRKHD-AQFTVIQLVGMLRGIASGMKYLSDMG---YVHRDLAARNILINSNLVCKVSDFGLGRVLEDD 200 (373)
T ss_dssp EECCTTCBHHHHHHTTT-TCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC---------
T ss_pred EeCCCCCcHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCcceEEEcCCCCEEECcCccccccccC
Confidence 99999999999997543 35899999999999999999999999 999999999999999999999999999865432
Q ss_pred CCCCCccceeeeeccCCCCccChhhhccCCCCCcchhhhHHHHHHHHHh-CCCCCCCCchhHHHHHHHhhcCcchhhhcc
Q 002158 780 DDEGTMPTHVSTIVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVLLELLT-GMQPISHGKNIVREVNVARDSGMVFSIIDN 858 (958)
Q Consensus 780 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gv~l~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~i~~ 858 (958)
... ........+++.|+|||++.+..++.++||||||+++|||++ |+.||....... ...... ..
T Consensus 201 ~~~----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~~-~~~~i~---------~~ 266 (373)
T 2qol_A 201 PEA----AYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQD-VIKAVD---------EG 266 (373)
T ss_dssp -----------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHHH-HHHHHH---------TT
T ss_pred Ccc----ceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHHH-HHHHHH---------cC
Confidence 111 111222346788999999999999999999999999999998 999997544321 111111 11
Q ss_pred cCCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHhhC
Q 002158 859 RMGSYPSECVERFVTLALRCCHDKPEHRPSMSDVVRELENILKMF 903 (958)
Q Consensus 859 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~ 903 (958)
.....+..++..+.+++.+||+.||++||+++++++.|+++.+..
T Consensus 267 ~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~~~~~ 311 (373)
T 2qol_A 267 YRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRNP 311 (373)
T ss_dssp EECCCCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCG
T ss_pred CCCCCCccccHHHHHHHHHHhCcChhhCcCHHHHHHHHHHHHhCc
Confidence 112234567788999999999999999999999999999988643
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-41 Score=365.06 Aligned_cols=257 Identities=30% Similarity=0.483 Sum_probs=214.7
Q ss_pred cCCCCCceeeeeCCeEEEEEEECCCcEEEEEEeccCChhcHHHHHHHHHHHHccCCCCcceEEEEEEeCCeEEEEEEecC
Q 002158 625 AYFSSSTQVGQGGYGKVYKGILSDNTTVAIKRAEEGSLQGQNEFLTEIKLLSRLHHRNLVSLLGYCDEEGEQMLVYEFVP 704 (958)
Q Consensus 625 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E~~~ 704 (958)
++|...+.||+|+||+||+|.+.+++.||||++.... ...+++.+|++++++++||||+++++++.+++..++||||++
T Consensus 10 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 88 (269)
T 4hcu_A 10 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFME 88 (269)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTEEEEEEEECTTS-BCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECCT
T ss_pred hhceeeheecCCCccEEEEEEecCCCeEEEEEecccc-cCHHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEEeCC
Confidence 4677788999999999999999889999999998643 334679999999999999999999999999999999999999
Q ss_pred CCCHHHHhccCCCCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEecCCCCeEEeeeeeecccccCCCCCC
Q 002158 705 NGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSRLAPVLDDEGT 784 (958)
Q Consensus 705 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 784 (958)
+++|.+++.... ..+++..+..++.|+++||+|||+.+ |+||||||+||+++.++.+||+|||+++......
T Consensus 89 ~~~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~---- 160 (269)
T 4hcu_A 89 HGCLSDYLRTQR-GLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ---- 160 (269)
T ss_dssp TCBHHHHHHTTT-TCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECGGGCEEECCTTGGGGBCCHH----
T ss_pred CCcHHHHHHhcC-cccCHHHHHHHHHHHHHHHHHHHhCC---eecCCcchheEEEcCCCCEEeccccccccccccc----
Confidence 999999997543 35899999999999999999999999 9999999999999999999999999998643211
Q ss_pred ccceeeeeccCCCCccChhhhccCCCCCcchhhhHHHHHHHHHh-CCCCCCCCchhHHHHHHHhhcCcchhhhcccCCCC
Q 002158 785 MPTHVSTIVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVLLELLT-GMQPISHGKNIVREVNVARDSGMVFSIIDNRMGSY 863 (958)
Q Consensus 785 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gv~l~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~ 863 (958)
........||+.|+|||++.+..++.++||||+|+++|||++ |+.||....... ....... ......
T Consensus 161 --~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~~-~~~~~~~---------~~~~~~ 228 (269)
T 4hcu_A 161 --YTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSE-VVEDIST---------GFRLYK 228 (269)
T ss_dssp --HHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH-HHHHHHT---------TCCCCC
T ss_pred --cccccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHHH-HHHHHhc---------CccCCC
Confidence 111223456778999999999999999999999999999999 999997544322 1111111 111223
Q ss_pred ChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHhh
Q 002158 864 PSECVERFVTLALRCCHDKPEHRPSMSDVVRELENILKM 902 (958)
Q Consensus 864 ~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~ 902 (958)
+...+..+.+++.+||+.||++||+++|++++|+++.+.
T Consensus 229 ~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~l~~~ 267 (269)
T 4hcu_A 229 PRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAES 267 (269)
T ss_dssp CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred CCcCCHHHHHHHHHHccCCcccCcCHHHHHHHHHHHHHc
Confidence 445577899999999999999999999999999998753
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-41 Score=366.92 Aligned_cols=262 Identities=25% Similarity=0.382 Sum_probs=210.9
Q ss_pred cCCCCCceeeeeCCeEEEEEEEC-CCcEEEEEEeccC---ChhcHHHHHHHHHHHHccCCCCcceEEEEEEeCCeEEEEE
Q 002158 625 AYFSSSTQVGQGGYGKVYKGILS-DNTTVAIKRAEEG---SLQGQNEFLTEIKLLSRLHHRNLVSLLGYCDEEGEQMLVY 700 (958)
Q Consensus 625 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~ 700 (958)
++|...+.||+|+||.||+|.+. +++.||+|++... .....+.|.+|+.++++++||||+++++++..++..++||
T Consensus 11 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 90 (294)
T 4eqm_A 11 ERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLVM 90 (294)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEEEE
T ss_pred ccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEEEE
Confidence 46778899999999999999976 6899999998543 2334567999999999999999999999999999999999
Q ss_pred EecCCCCHHHHhccCCCCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEecCCCCeEEeeeeeecccccCC
Q 002158 701 EFVPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSRLAPVLD 780 (958)
Q Consensus 701 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~ 780 (958)
||+++++|.+++.... .+++.++..++.|+++||+|||+.+ |+||||||+||+++.++.+||+|||+++......
T Consensus 91 e~~~g~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 165 (294)
T 4eqm_A 91 EYIEGPTLSEYIESHG--PLSVDTAINFTNQILDGIKHAHDMR---IVHRDIKPQNILIDSNKTLKIFDFGIAKALSETS 165 (294)
T ss_dssp ECCCSCBHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCSSSTTC----
T ss_pred eCCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEEeCCCcccccccc
Confidence 9999999999997654 4899999999999999999999999 9999999999999999999999999998653211
Q ss_pred CCCCccceeeeeccCCCCccChhhhccCCCCCcchhhhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcCcchhhhcccC
Q 002158 781 DEGTMPTHVSTIVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVLLELLTGMQPISHGKNIVREVNVARDSGMVFSIIDNRM 860 (958)
Q Consensus 781 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gv~l~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~i~~~~ 860 (958)
........||+.|+|||++.+..++.++||||+|+++|||++|+.||.................. ...
T Consensus 166 ------~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~--~~~---- 233 (294)
T 4eqm_A 166 ------LTQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHIQDSVP--NVT---- 233 (294)
T ss_dssp ---------------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHHHHHHHHSSCCC--CHH----
T ss_pred ------ccccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhccCC--Ccc----
Confidence 11223456999999999999999999999999999999999999999865543332222211110 000
Q ss_pred CCCChHHHHHHHHHHHHccccCCCCCC-CHHHHHHHHHHhHhhC
Q 002158 861 GSYPSECVERFVTLALRCCHDKPEHRP-SMSDVVRELENILKMF 903 (958)
Q Consensus 861 ~~~~~~~~~~l~~li~~cl~~dP~~RP-s~~evl~~L~~~~~~~ 903 (958)
...+..++..+.+++.+||+.||++|| +++++.+.|+.++...
T Consensus 234 ~~~~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~~~~ 277 (294)
T 4eqm_A 234 TDVRKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSSVLHEN 277 (294)
T ss_dssp HHSCTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSSSSS
T ss_pred hhcccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHHHhhc
Confidence 112334567899999999999999998 8999999888876443
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-41 Score=363.19 Aligned_cols=257 Identities=27% Similarity=0.465 Sum_probs=214.7
Q ss_pred HcCCCCCceeeeeCCeEEEEEEECCCcEEEEEEeccCChhcHHHHHHHHHHHHccCCCCcceEEEEEEeCCeEEEEEEec
Q 002158 624 TAYFSSSTQVGQGGYGKVYKGILSDNTTVAIKRAEEGSLQGQNEFLTEIKLLSRLHHRNLVSLLGYCDEEGEQMLVYEFV 703 (958)
Q Consensus 624 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E~~ 703 (958)
.++|...+.||+|+||+||+|.++++..||||++.... ...+++.+|++++++++||||+++++++..++..++||||+
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 85 (268)
T 3sxs_A 7 REEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGS-MSEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEYI 85 (268)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECBTT-BCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEECC
T ss_pred hhheeeeeeeccCCCceEEEEEecCceeEEEEEeccCC-CcHHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEEEcc
Confidence 35677889999999999999999888899999997643 33467999999999999999999999999999999999999
Q ss_pred CCCCHHHHhccCCCCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEecCCCCeEEeeeeeecccccCCCCC
Q 002158 704 PNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSRLAPVLDDEG 783 (958)
Q Consensus 704 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 783 (958)
++++|.+++.... ..+++.++..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+++......
T Consensus 86 ~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~--- 158 (268)
T 3sxs_A 86 SNGCLLNYLRSHG-KGLEPSQLLEMCYDVCEGMAFLESHQ---FIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQ--- 158 (268)
T ss_dssp TTCBHHHHHHHHG-GGCCHHHHHHHHHHHHHHHHHHHHTT---EEESSCSGGGEEECTTCCEEECCTTCEEECCTTC---
T ss_pred CCCcHHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCcCcceEEECCCCCEEEccCccceecchhh---
Confidence 9999999997543 34899999999999999999999999 9999999999999999999999999998653211
Q ss_pred CccceeeeeccCCCCccChhhhccCCCCCcchhhhHHHHHHHHHh-CCCCCCCCchhHHHHHHHhhcCcchhhhcccCCC
Q 002158 784 TMPTHVSTIVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVLLELLT-GMQPISHGKNIVREVNVARDSGMVFSIIDNRMGS 862 (958)
Q Consensus 784 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gv~l~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~ 862 (958)
........||+.|+|||++.+..++.++||||||+++|||++ |+.||.............. .....
T Consensus 159 ---~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~----------~~~~~ 225 (268)
T 3sxs_A 159 ---YVSSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVSQ----------GHRLY 225 (268)
T ss_dssp ---EEECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHT----------TCCCC
T ss_pred ---hhcccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChHHHHHHHHc----------CCCCC
Confidence 122233456778999999999999999999999999999999 9999975543322221111 11122
Q ss_pred CChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHh
Q 002158 863 YPSECVERFVTLALRCCHDKPEHRPSMSDVVRELENILK 901 (958)
Q Consensus 863 ~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~ 901 (958)
.+...++.+.+++.+||+.||++||+++|++++|+.+.+
T Consensus 226 ~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~ 264 (268)
T 3sxs_A 226 RPHLASDTIYQIMYSCWHELPEKRPTFQQLLSSIEPLRE 264 (268)
T ss_dssp CCTTSCHHHHHHHHHTTCSSGGGSCCHHHHHHHHGGGCC
T ss_pred CCCcChHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhh
Confidence 244456789999999999999999999999999988754
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-41 Score=382.12 Aligned_cols=272 Identities=27% Similarity=0.444 Sum_probs=221.6
Q ss_pred ccChHHHHHHHcCCCCCceeeeeCCeEEEEEEEC------CCcEEEEEEeccCC-hhcHHHHHHHHHHHHcc-CCCCcce
Q 002158 614 GFKFKELAMATAYFSSSTQVGQGGYGKVYKGILS------DNTTVAIKRAEEGS-LQGQNEFLTEIKLLSRL-HHRNLVS 685 (958)
Q Consensus 614 ~~~~~el~~~~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~H~niv~ 685 (958)
.+...+++...++|...+.||+|+||.||+|.+. +++.||||+++... ....+.+.+|+++++++ +||||++
T Consensus 11 ~~~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~ 90 (359)
T 3vhe_A 11 PYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVN 90 (359)
T ss_dssp CCCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred CCCcccccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceee
Confidence 3555666777889999999999999999999842 46899999997653 34456799999999999 7999999
Q ss_pred EEEEEEeCC-eEEEEEEecCCCCHHHHhccCCC-----------------------------------------------
Q 002158 686 LLGYCDEEG-EQMLVYEFVPNGTLRDWLSGRTK----------------------------------------------- 717 (958)
Q Consensus 686 l~~~~~~~~-~~~lV~E~~~~gsL~~~l~~~~~----------------------------------------------- 717 (958)
+++++...+ ..++||||+++|+|.++++....
T Consensus 91 ~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 170 (359)
T 3vhe_A 91 LLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEE 170 (359)
T ss_dssp EEEEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC-----------------------------------------
T ss_pred eeeeeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccc
Confidence 999998755 48999999999999999976532
Q ss_pred -----------------CCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEecCCCCeEEeeeeeecccccCC
Q 002158 718 -----------------ENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSRLAPVLD 780 (958)
Q Consensus 718 -----------------~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~ 780 (958)
..+++..+..++.|+++||+|||+++ |+||||||+|||++.++.+||+|||+++......
T Consensus 171 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~ 247 (359)
T 3vhe_A 171 KSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSEKNVVKICDFGLARDIYKDP 247 (359)
T ss_dssp -------------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCT
T ss_pred cccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEEcCCCcEEEEeccceeeecccc
Confidence 12899999999999999999999999 9999999999999999999999999998653221
Q ss_pred CCCCccceeeeeccCCCCccChhhhccCCCCCcchhhhHHHHHHHHHh-CCCCCCCCchhHHHHHHHhhcCcchhhhccc
Q 002158 781 DEGTMPTHVSTIVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVLLELLT-GMQPISHGKNIVREVNVARDSGMVFSIIDNR 859 (958)
Q Consensus 781 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gv~l~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~i~~~ 859 (958)
. ........||+.|+|||++.+..++.++||||||+++|||++ |+.||............... ..
T Consensus 248 ~-----~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~---------~~ 313 (359)
T 3vhe_A 248 D-----YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKE---------GT 313 (359)
T ss_dssp T-----CEEC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHH---------TC
T ss_pred c-----chhccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHHHHHHHHc---------CC
Confidence 1 222344568999999999999999999999999999999999 99999754432222211111 11
Q ss_pred CCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHhh
Q 002158 860 MGSYPSECVERFVTLALRCCHDKPEHRPSMSDVVRELENILKM 902 (958)
Q Consensus 860 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~ 902 (958)
....+..++.++.+++.+||+.||++||+++|++++|+++++.
T Consensus 314 ~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~ 356 (359)
T 3vhe_A 314 RMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA 356 (359)
T ss_dssp CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHHH
Confidence 2233455677899999999999999999999999999998864
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-41 Score=385.27 Aligned_cols=261 Identities=28% Similarity=0.459 Sum_probs=214.2
Q ss_pred HHcCCCCCceeeeeCCeEEEEEEEC-CCcEEEEEEeccCC-hhcHHHHHHHHHHHHccCCCCcceEEEEEEeCCeEEEEE
Q 002158 623 ATAYFSSSTQVGQGGYGKVYKGILS-DNTTVAIKRAEEGS-LQGQNEFLTEIKLLSRLHHRNLVSLLGYCDEEGEQMLVY 700 (958)
Q Consensus 623 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~ 700 (958)
..++|...+.||+|+||+||+|.+. +++.||||+++... ....++|.+|++++++++||||+++++++..++..++||
T Consensus 112 ~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 191 (377)
T 3cbl_A 112 NHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVM 191 (377)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEEEE
T ss_pred chHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEEEE
Confidence 3457778899999999999999987 78999999987643 333457899999999999999999999999999999999
Q ss_pred EecCCCCHHHHhccCCCCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEecCCCCeEEeeeeeecccccCC
Q 002158 701 EFVPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSRLAPVLD 780 (958)
Q Consensus 701 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~ 780 (958)
||+++|+|.++++... ..+++.++..++.|+++||+|||+++ |+||||||+|||++.++.+||+|||+++......
T Consensus 192 e~~~~g~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~~~ 267 (377)
T 3cbl_A 192 ELVQGGDFLTFLRTEG-ARLRVKTLLQMVGDAAAGMEYLESKC---CIHRDLAARNCLVTEKNVLKISDFGMSREEADGV 267 (377)
T ss_dssp ECCTTCBHHHHHHHHG-GGCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCGGGCEECTTSE
T ss_pred EcCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCC---cCCcccCHHHEEEcCCCcEEECcCCCceecCCCc
Confidence 9999999999997543 34899999999999999999999999 9999999999999999999999999997532110
Q ss_pred CCCCccceeeeeccCCCCccChhhhccCCCCCcchhhhHHHHHHHHHh-CCCCCCCCchhHHHHHHHhhcCcchhhhccc
Q 002158 781 DEGTMPTHVSTIVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVLLELLT-GMQPISHGKNIVREVNVARDSGMVFSIIDNR 859 (958)
Q Consensus 781 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gv~l~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~i~~~ 859 (958)
. ........+++.|+|||++.+..++.++|||||||++|||++ |..||......... .... ...
T Consensus 268 ----~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~~~~-~~~~---------~~~ 332 (377)
T 3cbl_A 268 ----Y-AASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQTR-EFVE---------KGG 332 (377)
T ss_dssp ----E-ECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHHHHH-HHHH---------TTC
T ss_pred ----e-eecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHH-HHHH---------cCC
Confidence 0 000111235678999999999999999999999999999999 99999765432211 1111 111
Q ss_pred CCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHhh
Q 002158 860 MGSYPSECVERFVTLALRCCHDKPEHRPSMSDVVRELENILKM 902 (958)
Q Consensus 860 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~ 902 (958)
....+..++..+.+++.+||+.||++|||++++++.|+++.+.
T Consensus 333 ~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i~~~ 375 (377)
T 3cbl_A 333 RLPCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSIRKR 375 (377)
T ss_dssp CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHhh
Confidence 2234556778899999999999999999999999999998754
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-41 Score=373.32 Aligned_cols=266 Identities=23% Similarity=0.302 Sum_probs=206.5
Q ss_pred HcCCCCCceeeeeCCeEEEEEEECCCcEEEEEEeccCChhcHHHHHHHHHHHHccCCCCcceEEEEEEeCC----eEEEE
Q 002158 624 TAYFSSSTQVGQGGYGKVYKGILSDNTTVAIKRAEEGSLQGQNEFLTEIKLLSRLHHRNLVSLLGYCDEEG----EQMLV 699 (958)
Q Consensus 624 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~----~~~lV 699 (958)
.++|+..+.||+|+||+||+|++. ++.||||++.... .....+.+|+.++++++||||+++++++.... ..++|
T Consensus 23 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~lv 100 (322)
T 3soc_A 23 SMPLQLLEVKARGRFGCVWKAQLL-NEYVAVKIFPIQD-KQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLI 100 (322)
T ss_dssp TEEEEEEEEEECSTTCEEEEEEET-TEEEEEEEECGGG-HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEE
T ss_pred hhhchhhheecccCceEEEEEEEC-CCEEEEEEeecCc-hHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEEEE
Confidence 357788899999999999999985 7899999997533 33345667999999999999999999998754 47999
Q ss_pred EEecCCCCHHHHhccCCCCCchHHHHHHHHHHHHHHHHHhhhc----------CCCCeeccCCCccceEecCCCCeEEee
Q 002158 700 YEFVPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTE----------AHPPVFHRDIKASNILLDSNLNAKVAD 769 (958)
Q Consensus 700 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~----------~~~~iiH~Dikp~NILl~~~~~~kl~D 769 (958)
|||+++|+|.++++... +++.++..++.|+++||+|||+. + |+||||||+|||++.++.+||+|
T Consensus 101 ~e~~~~g~L~~~l~~~~---~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~---ivH~Dlkp~Nill~~~~~~kL~D 174 (322)
T 3soc_A 101 TAFHEKGSLSDFLKANV---VSWNELCHIAETMARGLAYLHEDIPGLKDGHKPA---ISHRDIKSKNVLLKNNLTACIAD 174 (322)
T ss_dssp EECCTTCBHHHHHHHCC---BCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECE---EECSCCSGGGEEECTTCCEEECC
T ss_pred EecCCCCCHHHHHHhcC---CCHHHHHHHHHHHHHHHHHHHhhccccccccCCC---EEeCCCChHhEEECCCCeEEEcc
Confidence 99999999999997643 89999999999999999999998 7 99999999999999999999999
Q ss_pred eeeecccccCCCCCCccceeeeeccCCCCccChhhhccC-----CCCCcchhhhHHHHHHHHHhCCCCCCCCchhH--HH
Q 002158 770 FGLSRLAPVLDDEGTMPTHVSTIVKGTPGYLDPEYFLTH-----KLTDKSDVYSLGVVLLELLTGMQPISHGKNIV--RE 842 (958)
Q Consensus 770 FGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~DV~S~Gv~l~elltG~~P~~~~~~~~--~~ 842 (958)
||+++........ .......||+.|+|||++.+. .++.++|||||||++|||+||+.||....... ..
T Consensus 175 Fg~a~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~ 249 (322)
T 3soc_A 175 FGLALKFEAGKSA-----GDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPF 249 (322)
T ss_dssp CTTCEEECTTSCC-----CCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTT
T ss_pred CCcccccccccCc-----cccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccch
Confidence 9999865432221 112235699999999999863 45668999999999999999999996432100 00
Q ss_pred HHHHhhcCcch---hh-hcccC-CC-----CChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHhh
Q 002158 843 VNVARDSGMVF---SI-IDNRM-GS-----YPSECVERFVTLALRCCHDKPEHRPSMSDVVRELENILKM 902 (958)
Q Consensus 843 ~~~~~~~~~~~---~~-i~~~~-~~-----~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~ 902 (958)
........... .. ..... +. ....++..+.+++.+||+.||++|||++|+++.|+++.+.
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~l~~~ 319 (322)
T 3soc_A 250 EEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQMQRL 319 (322)
T ss_dssp HHHHCSSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred hhhhccCCchhhhhhhhhcccCCCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHH
Confidence 00000000000 00 00000 11 1235677899999999999999999999999999998754
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-41 Score=388.66 Aligned_cols=253 Identities=28% Similarity=0.428 Sum_probs=212.1
Q ss_pred HcCCCCCceeeeeCCeEEEEEEECCCcEEEEEEeccCChhcHHHHHHHHHHHHccCCCCcceEEEEEEeCC-eEEEEEEe
Q 002158 624 TAYFSSSTQVGQGGYGKVYKGILSDNTTVAIKRAEEGSLQGQNEFLTEIKLLSRLHHRNLVSLLGYCDEEG-EQMLVYEF 702 (958)
Q Consensus 624 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~-~~~lV~E~ 702 (958)
.++|...+.||+|+||+||+|.++ ++.||||+++... ..+.|.+|++++++++||||+++++++...+ ..++||||
T Consensus 192 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv~e~ 268 (450)
T 1k9a_A 192 MKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY 268 (450)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEET-TEEEEEEEESSCT--TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEEEEC
T ss_pred hHHeEEEeeecCcCCeeEEEEEec-CCeEEEEEeCCch--HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEEEEe
Confidence 456777889999999999999985 7899999998653 4567999999999999999999999987665 79999999
Q ss_pred cCCCCHHHHhccCCCCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEecCCCCeEEeeeeeecccccCCCC
Q 002158 703 VPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSRLAPVLDDE 782 (958)
Q Consensus 703 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~ 782 (958)
+++|+|.++++......+++..++.++.|+++||+|||+++ |+||||||+|||++.++.+||+|||+++.....
T Consensus 269 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~--- 342 (450)
T 1k9a_A 269 MAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASST--- 342 (450)
T ss_dssp CTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTSCEEECCCTTCEECC-----
T ss_pred cCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHhhEEECCCCCEEEeeCCCccccccc---
Confidence 99999999998765555899999999999999999999999 999999999999999999999999999853211
Q ss_pred CCccceeeeeccCCCCccChhhhccCCCCCcchhhhHHHHHHHHHh-CCCCCCCCchhHHHHHHHhhcCcchhhhcccCC
Q 002158 783 GTMPTHVSTIVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVLLELLT-GMQPISHGKNIVREVNVARDSGMVFSIIDNRMG 861 (958)
Q Consensus 783 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gv~l~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~i~~~~~ 861 (958)
.....++..|+|||++.+..++.++|||||||++|||+| |+.||........ .... ......
T Consensus 343 -------~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~-~~~i---------~~~~~~ 405 (450)
T 1k9a_A 343 -------QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDV-VPRV---------EKGYKM 405 (450)
T ss_dssp -----------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTTH-HHHH---------HTTCCC
T ss_pred -------ccCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHH-HHHH---------HcCCCC
Confidence 112357889999999999999999999999999999999 9999975432111 1111 111123
Q ss_pred CCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHhh
Q 002158 862 SYPSECVERFVTLALRCCHDKPEHRPSMSDVVRELENILKM 902 (958)
Q Consensus 862 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~ 902 (958)
..|..++..+.+++.+||+.||++||++.++++.|+++...
T Consensus 406 ~~p~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~~L~~i~~~ 446 (450)
T 1k9a_A 406 DAPDGCPPAVYDVMKNCWHLDAATRPTFLQLREQLEHIRTH 446 (450)
T ss_dssp CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred CCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHh
Confidence 34667788999999999999999999999999999998753
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=367.10 Aligned_cols=264 Identities=28% Similarity=0.475 Sum_probs=208.6
Q ss_pred cCCCCCceeeeeCCeEEEEEEECCCcEEEEEEeccCChhcHHHHHHHHHHHHccCCCCcceEEEEEEeCCeEEEEEEecC
Q 002158 625 AYFSSSTQVGQGGYGKVYKGILSDNTTVAIKRAEEGSLQGQNEFLTEIKLLSRLHHRNLVSLLGYCDEEGEQMLVYEFVP 704 (958)
Q Consensus 625 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E~~~ 704 (958)
++|...+.||+|+||+||+|.+. ++.||||++... ...+.|.+|++++++++||||+++++++.+ ..++||||++
T Consensus 8 ~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~lv~e~~~ 82 (307)
T 2eva_A 8 KEIEVEEVVGRGAFGVVCKAKWR-AKDVAIKQIESE--SERKAFIVELRQLSRVNHPNIVKLYGACLN--PVCLVMEYAE 82 (307)
T ss_dssp GGEEEEEEEECCSSSEEEEEEET-TEEEEEEECSST--THHHHHHHHHHHHHHCCCTTBCCEEEBCTT--TTEEEEECCT
T ss_pred hHeeeeeEeecCCCceEEEEEEC-CeeEEEEEecCh--hHHHHHHHHHHHHhcCCCCCcCeEEEEEcC--CcEEEEEcCC
Confidence 35677789999999999999984 788999999753 345679999999999999999999998874 4799999999
Q ss_pred CCCHHHHhccCCC-CCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEecCCCC-eEEeeeeeecccccCCCC
Q 002158 705 NGTLRDWLSGRTK-ENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSNLN-AKVADFGLSRLAPVLDDE 782 (958)
Q Consensus 705 ~gsL~~~l~~~~~-~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~~~-~kl~DFGla~~~~~~~~~ 782 (958)
+|+|.+++..... ..+++..++.++.|+++||+|||+.+..+|+||||||+||+++.++. +||+|||+++....
T Consensus 83 ~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~---- 158 (307)
T 2eva_A 83 GGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQT---- 158 (307)
T ss_dssp TCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC----------
T ss_pred CCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEccccccccccc----
Confidence 9999999986543 24788999999999999999999932223999999999999998887 79999999875421
Q ss_pred CCccceeeeeccCCCCccChhhhccCCCCCcchhhhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcCcchhhhcccCCC
Q 002158 783 GTMPTHVSTIVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVLLELLTGMQPISHGKNIVREVNVARDSGMVFSIIDNRMGS 862 (958)
Q Consensus 783 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gv~l~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~ 862 (958)
......||+.|+|||++.+..++.++||||||+++|||++|+.||............... ......
T Consensus 159 ------~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~--------~~~~~~ 224 (307)
T 2eva_A 159 ------HMTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVH--------NGTRPP 224 (307)
T ss_dssp ------------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHHHHHHHHH--------TTCCCC
T ss_pred ------ccccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHHHHHHHHh--------cCCCCC
Confidence 112345999999999999999999999999999999999999999753322111111111 111223
Q ss_pred CChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHhhCCCCCcccc
Q 002158 863 YPSECVERFVTLALRCCHDKPEHRPSMSDVVRELENILKMFPETDTMFS 911 (958)
Q Consensus 863 ~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~~~~~~~~~ 911 (958)
.+..++..+.+++.+||+.||++||+++++++.|+.+.+.++..+.+..
T Consensus 225 ~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~~~~~~~~ 273 (307)
T 2eva_A 225 LIKNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMRYFPGADEPLQ 273 (307)
T ss_dssp CBTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHGGGCCCTTSCCC
T ss_pred cccccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhccCCCCccc
Confidence 3445677899999999999999999999999999999988887655443
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-41 Score=377.28 Aligned_cols=268 Identities=27% Similarity=0.439 Sum_probs=218.5
Q ss_pred HHHHHHcCCCCCceeeeeCCeEEEEEEEC------CCcEEEEEEeccCC-hhcHHHHHHHHHHHHccCCCCcceEEEEEE
Q 002158 619 ELAMATAYFSSSTQVGQGGYGKVYKGILS------DNTTVAIKRAEEGS-LQGQNEFLTEIKLLSRLHHRNLVSLLGYCD 691 (958)
Q Consensus 619 el~~~~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~ 691 (958)
++....++|...+.||+|+||.||+|.+. +++.||||+++... ....+.|.+|++++++++||||+++++++.
T Consensus 41 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~ 120 (343)
T 1luf_A 41 SLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCA 120 (343)
T ss_dssp HTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC
T ss_pred eeEecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEc
Confidence 33445678889999999999999999974 34889999998653 334567999999999999999999999999
Q ss_pred eCCeEEEEEEecCCCCHHHHhccCC----------------------CCCchHHHHHHHHHHHHHHHHHhhhcCCCCeec
Q 002158 692 EEGEQMLVYEFVPNGTLRDWLSGRT----------------------KENLNFAMRLRVALDSAKGILYLHTEAHPPVFH 749 (958)
Q Consensus 692 ~~~~~~lV~E~~~~gsL~~~l~~~~----------------------~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH 749 (958)
..+..++||||+++|+|.+++.... ...+++.+++.++.|+++||+|||+++ |+|
T Consensus 121 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~---ivH 197 (343)
T 1luf_A 121 VGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK---FVH 197 (343)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCC
T ss_pred cCCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eec
Confidence 9999999999999999999997642 145899999999999999999999999 999
Q ss_pred cCCCccceEecCCCCeEEeeeeeecccccCCCCCCccceeeeeccCCCCccChhhhccCCCCCcchhhhHHHHHHHHHh-
Q 002158 750 RDIKASNILLDSNLNAKVADFGLSRLAPVLDDEGTMPTHVSTIVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVLLELLT- 828 (958)
Q Consensus 750 ~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gv~l~ellt- 828 (958)
|||||+|||++.++.+||+|||+++....... ........||+.|+|||++.+..++.++||||||+++|||++
T Consensus 198 ~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~-----~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~ 272 (343)
T 1luf_A 198 RDLATRNCLVGENMVVKIADFGLSRNIYSADY-----YKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSY 272 (343)
T ss_dssp SCCSGGGEEECGGGCEEECCCSCHHHHTGGGC-----BC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTT
T ss_pred CCCCcceEEECCCCeEEEeecCCCcccccCcc-----ccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhc
Confidence 99999999999999999999999976532211 112233468899999999999999999999999999999999
Q ss_pred CCCCCCCCchhHHHHHHHhhcCcchhhhcccCCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHhhCC
Q 002158 829 GMQPISHGKNIVREVNVARDSGMVFSIIDNRMGSYPSECVERFVTLALRCCHDKPEHRPSMSDVVRELENILKMFP 904 (958)
Q Consensus 829 G~~P~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~~ 904 (958)
|..||....... ..... ........+..++..+.+++.+||+.||++||++.+++++|+++.+...
T Consensus 273 g~~p~~~~~~~~-~~~~~---------~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~L~~~~~~~~ 338 (343)
T 1luf_A 273 GLQPYYGMAHEE-VIYYV---------RDGNILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCERAE 338 (343)
T ss_dssp TCCTTTTSCHHH-HHHHH---------HTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC---
T ss_pred CCCcCCCCChHH-HHHHH---------hCCCcCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHHHHHhhhh
Confidence 999997544321 11111 1122233455677889999999999999999999999999999876543
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-40 Score=370.00 Aligned_cols=268 Identities=17% Similarity=0.227 Sum_probs=214.5
Q ss_pred cCCCCCceeeeeCCeEEEEEEEC-CCcEEEEEEeccCChhcHHHHHHHHHHHHcc-CCCCcceEEEEEEeCCeEEEEEEe
Q 002158 625 AYFSSSTQVGQGGYGKVYKGILS-DNTTVAIKRAEEGSLQGQNEFLTEIKLLSRL-HHRNLVSLLGYCDEEGEQMLVYEF 702 (958)
Q Consensus 625 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lV~E~ 702 (958)
.+|...+.||+|+||+||+|... +++.||||++..... .+.+.+|+++++++ +||||+++++++..++..++||||
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~ 86 (330)
T 2izr_A 9 PNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSR--APQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVLEL 86 (330)
T ss_dssp TTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCS--SCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEEEC
T ss_pred CCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccc--hHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEEEe
Confidence 46778899999999999999974 789999999875432 23588999999999 999999999999999999999999
Q ss_pred cCCCCHHHHhccCCCCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEecCCCC-----eEEeeeeeecccc
Q 002158 703 VPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSNLN-----AKVADFGLSRLAP 777 (958)
Q Consensus 703 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~~~-----~kl~DFGla~~~~ 777 (958)
+ +++|.+++... ...+++.++..++.|++.||+|||+.+ |+||||||+|||++.++. +||+|||+++...
T Consensus 87 ~-~~~L~~~~~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~---iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~~~ 161 (330)
T 2izr_A 87 L-GPSLEDLFDLC-DRTFSLKTVLMIAIQLISRMEYVHSKN---LIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYI 161 (330)
T ss_dssp C-CCBHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECCGGGTCTTSEEECCCTTCEESB
T ss_pred C-CCCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeeeccCCCCCCceEEEEEcccceeee
Confidence 9 99999999864 335999999999999999999999999 999999999999998887 9999999998764
Q ss_pred cCCCCCCccceeeeeccCCCCccChhhhccCCCCCcchhhhHHHHHHHHHhCCCCCCCCc--hhHHHHHHHhhcCcchhh
Q 002158 778 VLDDEGTMPTHVSTIVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVLLELLTGMQPISHGK--NIVREVNVARDSGMVFSI 855 (958)
Q Consensus 778 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gv~l~elltG~~P~~~~~--~~~~~~~~~~~~~~~~~~ 855 (958)
........+........||+.|+|||++.+..++.++|||||||++|||++|+.||.... ................ .
T Consensus 162 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~-~ 240 (330)
T 2izr_A 162 DPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGDTKRAT-P 240 (330)
T ss_dssp CTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHHHHHHHS-C
T ss_pred cCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHHhhhccC-C
Confidence 433322222223345679999999999999999999999999999999999999997532 2222211111000000 0
Q ss_pred hcccCCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHhhCCC
Q 002158 856 IDNRMGSYPSECVERFVTLALRCCHDKPEHRPSMSDVVRELENILKMFPE 905 (958)
Q Consensus 856 i~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~~~ 905 (958)
. ......++ ++.+++.+||+.||.+||+++++++.|+++.+....
T Consensus 241 ~----~~~~~~~p-~~~~li~~~l~~~p~~RP~~~~l~~~l~~~~~~~~~ 285 (330)
T 2izr_A 241 I----EVLCENFP-EMATYLRYVRRLDFFEKPDYDYLRKLFTDLFDRKGY 285 (330)
T ss_dssp H----HHHTTTCH-HHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTTC
T ss_pred H----HHHhccCh-HHHHHHHHHHhCCCCCCCCHHHHHHHHHHHHHHcCC
Confidence 0 00011234 899999999999999999999999999999877654
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-41 Score=392.32 Aligned_cols=263 Identities=25% Similarity=0.450 Sum_probs=217.7
Q ss_pred HHHHHcCCCCCceeeeeCCeEEEEEEECCCcEEEEEEeccCChhcHHHHHHHHHHHHccCCCCcceEEEEEEeCCeEEEE
Q 002158 620 LAMATAYFSSSTQVGQGGYGKVYKGILSDNTTVAIKRAEEGSLQGQNEFLTEIKLLSRLHHRNLVSLLGYCDEEGEQMLV 699 (958)
Q Consensus 620 l~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV 699 (958)
++...++|...+.||+|+||+||+|.++++..||||+++... ...+.|.+|++++++++||||+++++++. .+..++|
T Consensus 183 ~~i~~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~lv 260 (454)
T 1qcf_A 183 WEIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIYII 260 (454)
T ss_dssp SBCCGGGEEEEEEEECCSSEEEEEEEETTTEEEEEEEECTTS-BCHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEE
T ss_pred eeechHHeEEEEEcccCCceEEEEEEECCccEEEEEEecCCC-ccHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCccEEE
Confidence 344556788889999999999999999889999999998643 45678999999999999999999999987 5678999
Q ss_pred EEecCCCCHHHHhccCCCCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEecCCCCeEEeeeeeecccccC
Q 002158 700 YEFVPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSRLAPVL 779 (958)
Q Consensus 700 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~~~~~ 779 (958)
|||+++|+|.++++......+++.+++.++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+++.....
T Consensus 261 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~ 337 (454)
T 1qcf_A 261 TEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRN---YIHRDLRAANILVSASLVCKIADFGLARVIEDN 337 (454)
T ss_dssp ECCCTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCSGGGEEECTTCCEEECSTTGGGGBCCH
T ss_pred EeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCHHHEEECCCCcEEEeeCCCceEcCCC
Confidence 99999999999997654445889999999999999999999999 999999999999999999999999999865321
Q ss_pred CCCCCccceeeeeccCCCCccChhhhccCCCCCcchhhhHHHHHHHHHh-CCCCCCCCchhHHHHHHHhhcCcchhhhcc
Q 002158 780 DDEGTMPTHVSTIVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVLLELLT-GMQPISHGKNIVREVNVARDSGMVFSIIDN 858 (958)
Q Consensus 780 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gv~l~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~i~~ 858 (958)
. ........++..|+|||++....++.++|||||||++|||+| |+.||.+...... ...... .
T Consensus 338 ~------~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~~~-~~~i~~---------~ 401 (454)
T 1qcf_A 338 E------YTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEV-IRALER---------G 401 (454)
T ss_dssp H------HHTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHH-HHHHHH---------T
T ss_pred c------eeccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHHHH-HHHHHc---------C
Confidence 1 111123346788999999999999999999999999999999 9999975443221 111111 1
Q ss_pred cCCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHhhC
Q 002158 859 RMGSYPSECVERFVTLALRCCHDKPEHRPSMSDVVRELENILKMF 903 (958)
Q Consensus 859 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~ 903 (958)
.....+..++..+.+++.+||+.||++||++++|++.|+++....
T Consensus 402 ~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~i~~~L~~~~~~~ 446 (454)
T 1qcf_A 402 YRMPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFYTAT 446 (454)
T ss_dssp CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSSSS
T ss_pred CCCCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHhcc
Confidence 112335567889999999999999999999999999999876543
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-41 Score=370.62 Aligned_cols=253 Identities=24% Similarity=0.355 Sum_probs=205.3
Q ss_pred cCCCCCceeeeeCCeEEEEEEEC-CCcEEEEEEeccCCh-hcHHHHHHHHHHHHccCCCCcceEEEEEEeCCeEEEEEEe
Q 002158 625 AYFSSSTQVGQGGYGKVYKGILS-DNTTVAIKRAEEGSL-QGQNEFLTEIKLLSRLHHRNLVSLLGYCDEEGEQMLVYEF 702 (958)
Q Consensus 625 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E~ 702 (958)
++|+..+.||+|+||+||+|.+. +++.||||++..... ...+.+.+|+.+++.++||||+++++++.+++..++||||
T Consensus 7 ~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~ 86 (323)
T 3tki_A 7 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEY 86 (323)
T ss_dssp TCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred hhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEEc
Confidence 46888899999999999999987 789999999875432 2345688999999999999999999999999999999999
Q ss_pred cCCCCHHHHhccCCCCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEecCCCCeEEeeeeeecccccCCCC
Q 002158 703 VPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSRLAPVLDDE 782 (958)
Q Consensus 703 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~ 782 (958)
+++|+|.+++.... .+++.++..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++.......
T Consensus 87 ~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~- 160 (323)
T 3tki_A 87 CSGGELFDRIEPDI--GMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNR- 160 (323)
T ss_dssp CTTEEGGGGSBTTT--BCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEECEETTE-
T ss_pred CCCCcHHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHHHCC---ccccccchHHEEEeCCCCEEEEEeeccceeccCCc-
Confidence 99999999997543 4899999999999999999999999 99999999999999999999999999986532221
Q ss_pred CCccceeeeeccCCCCccChhhhccCCC-CCcchhhhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcCcchhhhcccCC
Q 002158 783 GTMPTHVSTIVKGTPGYLDPEYFLTHKL-TDKSDVYSLGVVLLELLTGMQPISHGKNIVREVNVARDSGMVFSIIDNRMG 861 (958)
Q Consensus 783 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DV~S~Gv~l~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~i~~~~~ 861 (958)
........||+.|+|||++.+..+ +.++|||||||++|||++|+.||................... .
T Consensus 161 ----~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~--------~ 228 (323)
T 3tki_A 161 ----ERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTY--------L 228 (323)
T ss_dssp ----ECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHHHHHHHTTCTT--------S
T ss_pred ----ccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhccccc--------C
Confidence 111234579999999999988776 679999999999999999999997654332222221111111 1
Q ss_pred CCChHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 002158 862 SYPSECVERFVTLALRCCHDKPEHRPSMSDVVRE 895 (958)
Q Consensus 862 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 895 (958)
.....++..+.+++.+||+.||++||+++|++++
T Consensus 229 ~~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~h 262 (323)
T 3tki_A 229 NPWKKIDSAPLALLHKILVENPSARITIPDIKKD 262 (323)
T ss_dssp TTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred CccccCCHHHHHHHHHHccCChhhCcCHHHHhhC
Confidence 1123456778899999999999999999999864
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-40 Score=378.37 Aligned_cols=266 Identities=26% Similarity=0.492 Sum_probs=219.5
Q ss_pred HcCCCCCceeeeeCCeEEEEEEEC--------CCcEEEEEEeccCC-hhcHHHHHHHHHHHHcc-CCCCcceEEEEEEeC
Q 002158 624 TAYFSSSTQVGQGGYGKVYKGILS--------DNTTVAIKRAEEGS-LQGQNEFLTEIKLLSRL-HHRNLVSLLGYCDEE 693 (958)
Q Consensus 624 ~~~~~~~~~lg~G~~g~Vy~~~~~--------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~ 693 (958)
.++|...+.||+|+||+||+|.+. .+..||||++.... ....+++.+|+++++++ +||||+++++++..+
T Consensus 68 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 147 (382)
T 3tt0_A 68 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD 147 (382)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred hhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeeeccC
Confidence 457788899999999999999862 24679999997653 34457799999999999 899999999999999
Q ss_pred CeEEEEEEecCCCCHHHHhccCC--------------CCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEe
Q 002158 694 GEQMLVYEFVPNGTLRDWLSGRT--------------KENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILL 759 (958)
Q Consensus 694 ~~~~lV~E~~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl 759 (958)
+..++||||+++|+|.+++.... ...+++.+++.++.|++.||+|||+.+ |+||||||+|||+
T Consensus 148 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll 224 (382)
T 3tt0_A 148 GPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK---CIHRDLAARNVLV 224 (382)
T ss_dssp SSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEE
T ss_pred CceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCcceEEE
Confidence 99999999999999999997654 235899999999999999999999999 9999999999999
Q ss_pred cCCCCeEEeeeeeecccccCCCCCCccceeeeeccCCCCccChhhhccCCCCCcchhhhHHHHHHHHHh-CCCCCCCCch
Q 002158 760 DSNLNAKVADFGLSRLAPVLDDEGTMPTHVSTIVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVLLELLT-GMQPISHGKN 838 (958)
Q Consensus 760 ~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gv~l~ellt-G~~P~~~~~~ 838 (958)
+.++.+||+|||+++........ .......||+.|+|||++.+..++.++|||||||++|||++ |..||.....
T Consensus 225 ~~~~~~kL~DFG~a~~~~~~~~~-----~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~~ 299 (382)
T 3tt0_A 225 TEDNVMKIADFGLARDIHHIDYY-----KKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV 299 (382)
T ss_dssp CTTCCEEECSCSCCCCSSCCCTT-----CCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH
T ss_pred cCCCcEEEcccCccccccccccc-----ccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCH
Confidence 99999999999999865332211 11223457889999999999999999999999999999999 9999975432
Q ss_pred hHHHHHHHhhcCcchhhhcccCCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHhhCCCCC
Q 002158 839 IVREVNVARDSGMVFSIIDNRMGSYPSECVERFVTLALRCCHDKPEHRPSMSDVVRELENILKMFPETD 907 (958)
Q Consensus 839 ~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~~~~~ 907 (958)
. ........ ......+..++.++.+++.+||+.||++||+++|++++|+++.......+
T Consensus 300 ~-~~~~~~~~---------~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~~~~~ 358 (382)
T 3tt0_A 300 E-ELFKLLKE---------GHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVALTSNQE 358 (382)
T ss_dssp H-HHHHHHHT---------TCCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHSCSCC
T ss_pred H-HHHHHHHc---------CCCCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHHhcCC
Confidence 2 22111111 11223355667889999999999999999999999999999998776554
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-41 Score=363.62 Aligned_cols=258 Identities=26% Similarity=0.436 Sum_probs=212.1
Q ss_pred HcCCCCCceeeeeCCeEEEEEEECCCcEEEEEEeccCChhcHHHHHHHHHHHHccCCCCcceEEEEEEeCCeEEEEEEec
Q 002158 624 TAYFSSSTQVGQGGYGKVYKGILSDNTTVAIKRAEEGSLQGQNEFLTEIKLLSRLHHRNLVSLLGYCDEEGEQMLVYEFV 703 (958)
Q Consensus 624 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E~~ 703 (958)
.++|...+.||+|+||+||+|.+.++..||||++.... ...+++.+|++++++++||||+++++++...+..++||||+
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 101 (283)
T 3gen_A 23 PKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYM 101 (283)
T ss_dssp GGGEEEEEECC---CEEEEEEEETTTEEEEEEEECTTS-BCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEECCC
T ss_pred HHHHHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCCC-CCHHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEEEecc
Confidence 45677788999999999999999888899999998643 23467999999999999999999999999999999999999
Q ss_pred CCCCHHHHhccCCCCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEecCCCCeEEeeeeeecccccCCCCC
Q 002158 704 PNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSRLAPVLDDEG 783 (958)
Q Consensus 704 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 783 (958)
++++|.+++.... ..+++.++..++.|++.||+|||+++ |+||||||+||+++.++.+||+|||+++......
T Consensus 102 ~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~--- 174 (283)
T 3gen_A 102 ANGCLLNYLREMR-HRFQTQQLLEMCKDVCEAMEYLESKQ---FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDE--- 174 (283)
T ss_dssp TTCBHHHHHHCGG-GCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCSGGGEEECTTSCEEECSTTGGGGBCCHH---
T ss_pred CCCcHHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCccceEEEcCCCCEEEccccccccccccc---
Confidence 9999999997532 34999999999999999999999999 9999999999999999999999999998653211
Q ss_pred CccceeeeeccCCCCccChhhhccCCCCCcchhhhHHHHHHHHHh-CCCCCCCCchhHHHHHHHhhcCcchhhhcccCCC
Q 002158 784 TMPTHVSTIVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVLLELLT-GMQPISHGKNIVREVNVARDSGMVFSIIDNRMGS 862 (958)
Q Consensus 784 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gv~l~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~ 862 (958)
........||+.|+|||++.+..++.++||||+|+++|||++ |+.||........... ... .....
T Consensus 175 ---~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~~~~~-~~~---------~~~~~ 241 (283)
T 3gen_A 175 ---YTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEH-IAQ---------GLRLY 241 (283)
T ss_dssp ---HHSTTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHH-HHT---------TCCCC
T ss_pred ---cccccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChhHHHHH-Hhc---------ccCCC
Confidence 111223446788999999999999999999999999999999 9999976443222111 111 11122
Q ss_pred CChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHhh
Q 002158 863 YPSECVERFVTLALRCCHDKPEHRPSMSDVVRELENILKM 902 (958)
Q Consensus 863 ~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~ 902 (958)
.+...+..+.+++.+||+.||++||++++++++|+++.+.
T Consensus 242 ~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~~~~~ 281 (283)
T 3gen_A 242 RPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDVMDE 281 (283)
T ss_dssp CCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CCCcCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHhhc
Confidence 3444567899999999999999999999999999998754
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-40 Score=370.27 Aligned_cols=248 Identities=23% Similarity=0.286 Sum_probs=208.5
Q ss_pred cCCCCCceeeeeCCeEEEEEEEC-CCcEEEEEEeccCC---hhcHHHHHHHHHHHHccCCCCcceEEEEEEeCCeEEEEE
Q 002158 625 AYFSSSTQVGQGGYGKVYKGILS-DNTTVAIKRAEEGS---LQGQNEFLTEIKLLSRLHHRNLVSLLGYCDEEGEQMLVY 700 (958)
Q Consensus 625 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~ 700 (958)
++|...+.||+|+||+||+|+.+ +|+.||||+++... ......+.+|+++++.++||||+++++++...+..++||
T Consensus 5 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~ 84 (337)
T 1o6l_A 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVM 84 (337)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEEE
Confidence 46788899999999999999986 68999999987532 234567889999999999999999999999999999999
Q ss_pred EecCCCCHHHHhccCCCCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEecCCCCeEEeeeeeecccccCC
Q 002158 701 EFVPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSRLAPVLD 780 (958)
Q Consensus 701 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~ 780 (958)
||+++|+|.+++.... .+++.++..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+++......
T Consensus 85 E~~~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~ 159 (337)
T 1o6l_A 85 EYANGGELFFHLSRER--VFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG 159 (337)
T ss_dssp ECCTTCBHHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTT
T ss_pred eCCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC---eecCcCCHHHEEECCCCCEEEeeccchhhcccCC
Confidence 9999999999997543 4899999999999999999999999 9999999999999999999999999997532111
Q ss_pred CCCCccceeeeeccCCCCccChhhhccCCCCCcchhhhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcCcchhhhcccC
Q 002158 781 DEGTMPTHVSTIVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVLLELLTGMQPISHGKNIVREVNVARDSGMVFSIIDNRM 860 (958)
Q Consensus 781 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gv~l~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~i~~~~ 860 (958)
.......||+.|+|||++.+..++.++|||||||++|||++|+.||...... ........ ..
T Consensus 160 -------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~-~~~~~i~~----------~~ 221 (337)
T 1o6l_A 160 -------ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE-RLFELILM----------EE 221 (337)
T ss_dssp -------CCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHH-HHHHHHHH----------CC
T ss_pred -------CcccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCHH-HHHHHHHc----------CC
Confidence 1223467999999999999999999999999999999999999999754322 11111111 11
Q ss_pred CCCChHHHHHHHHHHHHccccCCCCCC-----CHHHHHHH
Q 002158 861 GSYPSECVERFVTLALRCCHDKPEHRP-----SMSDVVRE 895 (958)
Q Consensus 861 ~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~~ 895 (958)
..+|...+.++.+++.+||+.||++|| +++|++++
T Consensus 222 ~~~p~~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~h 261 (337)
T 1o6l_A 222 IRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH 261 (337)
T ss_dssp CCCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred CCCCCCCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHcC
Confidence 234556678899999999999999999 89999875
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-40 Score=371.85 Aligned_cols=248 Identities=22% Similarity=0.328 Sum_probs=206.8
Q ss_pred HcCCCCCceeeeeCCeEEEEEEEC-CCcEEEEEEeccCChh------cHHHHHHHHHHHHccCCCCcceEEEEEEeCCeE
Q 002158 624 TAYFSSSTQVGQGGYGKVYKGILS-DNTTVAIKRAEEGSLQ------GQNEFLTEIKLLSRLHHRNLVSLLGYCDEEGEQ 696 (958)
Q Consensus 624 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~------~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~ 696 (958)
.+.|...+.||+|+||+||+|..+ +|+.||||++...... ..+.+.+|++++++++||||+++++++.+.+..
T Consensus 11 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~ 90 (361)
T 2yab_A 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTDV 90 (361)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred hhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCEE
Confidence 356888899999999999999986 6899999998764322 356799999999999999999999999999999
Q ss_pred EEEEEecCCCCHHHHhccCCCCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEecCCC----CeEEeeeee
Q 002158 697 MLVYEFVPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSNL----NAKVADFGL 772 (958)
Q Consensus 697 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~~----~~kl~DFGl 772 (958)
++||||+++|+|.+++... ..+++..+..++.|++.||+|||+.+ |+||||||+|||++.++ .+||+|||+
T Consensus 91 ~lv~e~~~gg~L~~~l~~~--~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~~~~vkl~DFG~ 165 (361)
T 2yab_A 91 VLILELVSGGELFDFLAQK--ESLSEEEATSFIKQILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFGL 165 (361)
T ss_dssp EEEEECCCSCBHHHHHTTC--SCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCTTSSSCCEEECCCSS
T ss_pred EEEEEcCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEeCCCCCccCEEEEecCC
Confidence 9999999999999999654 35999999999999999999999999 99999999999998877 799999999
Q ss_pred ecccccCCCCCCccceeeeeccCCCCccChhhhccCCCCCcchhhhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcCcc
Q 002158 773 SRLAPVLDDEGTMPTHVSTIVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVLLELLTGMQPISHGKNIVREVNVARDSGMV 852 (958)
Q Consensus 773 a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gv~l~elltG~~P~~~~~~~~~~~~~~~~~~~~ 852 (958)
++...... ......||+.|+|||++.+..++.++||||+||++|||++|..||.+...... .......
T Consensus 166 a~~~~~~~--------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~~~-~~~i~~~--- 233 (361)
T 2yab_A 166 AHEIEDGV--------EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQET-LANITAV--- 233 (361)
T ss_dssp CEECCTTC--------CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHH-HHHHHTT---
T ss_pred ceEcCCCC--------ccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHhc---
Confidence 98653211 12345699999999999999999999999999999999999999976443221 1111111
Q ss_pred hhhhcccCCCCC----hHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 002158 853 FSIIDNRMGSYP----SECVERFVTLALRCCHDKPEHRPSMSDVVRE 895 (958)
Q Consensus 853 ~~~i~~~~~~~~----~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 895 (958)
...++ ...+..+.+++.+||..||++||+++|++++
T Consensus 234 -------~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~h 273 (361)
T 2yab_A 234 -------SYDFDEEFFSQTSELAKDFIRKLLVKETRKRLTIQEALRH 273 (361)
T ss_dssp -------CCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred -------CCCCCchhccCCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 11112 2345678999999999999999999999864
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-40 Score=359.26 Aligned_cols=253 Identities=34% Similarity=0.533 Sum_probs=201.0
Q ss_pred cCCCCCceeeeeCCeEEEEEEECCCcEEEEEEeccCCh----hcHHHHHHHHHHHHccCCCCcceEEEEEEeCCeEEEEE
Q 002158 625 AYFSSSTQVGQGGYGKVYKGILSDNTTVAIKRAEEGSL----QGQNEFLTEIKLLSRLHHRNLVSLLGYCDEEGEQMLVY 700 (958)
Q Consensus 625 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~----~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~ 700 (958)
++|...+.||+|+||.||+|.+. ++.||||++..... ...+.+.+|+++++.++||||+++++++..++..++||
T Consensus 7 ~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 85 (271)
T 3dtc_A 7 AELTLEEIIGIGGFGKVYRAFWI-GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLVM 85 (271)
T ss_dssp TSEEEEEEEEEETTEEEEEEEET-TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEEEE
T ss_pred hheeeeeeeccCCCeEEEEEEEc-CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEEE
Confidence 46777889999999999999984 88999999875432 23467899999999999999999999999999999999
Q ss_pred EecCCCCHHHHhccCCCCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEecC--------CCCeEEeeeee
Q 002158 701 EFVPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDS--------NLNAKVADFGL 772 (958)
Q Consensus 701 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~--------~~~~kl~DFGl 772 (958)
||+++++|.+++... .+++..+..++.|+++||+|||+++..+|+||||||+||+++. ++.+||+|||+
T Consensus 86 e~~~~~~L~~~~~~~---~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Dfg~ 162 (271)
T 3dtc_A 86 EFARGGPLNRVLSGK---RIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGL 162 (271)
T ss_dssp ECCTTEEHHHHHTSS---CCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECCCCC
T ss_pred EcCCCCCHHHHhhcC---CCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEccCCc
Confidence 999999999999643 4899999999999999999999998666899999999999986 77899999999
Q ss_pred ecccccCCCCCCccceeeeeccCCCCccChhhhccCCCCCcchhhhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcCcc
Q 002158 773 SRLAPVLDDEGTMPTHVSTIVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVLLELLTGMQPISHGKNIVREVNVARDSGMV 852 (958)
Q Consensus 773 a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gv~l~elltG~~P~~~~~~~~~~~~~~~~~~~~ 852 (958)
++..... ......||+.|+|||++.+..++.++||||||+++|||++|+.||...............
T Consensus 163 ~~~~~~~---------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~---- 229 (271)
T 3dtc_A 163 AREWHRT---------TKMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMN---- 229 (271)
T ss_dssp ----------------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHTS----
T ss_pred ccccccc---------cccCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhhhcC----
Confidence 9754321 112346999999999999999999999999999999999999999765443222211111
Q ss_pred hhhhcccCCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHh
Q 002158 853 FSIIDNRMGSYPSECVERFVTLALRCCHDKPEHRPSMSDVVRELENI 899 (958)
Q Consensus 853 ~~~i~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 899 (958)
......+..++..+.+++.+||+.||++||++.|++++|+++
T Consensus 230 -----~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~L~~l 271 (271)
T 3dtc_A 230 -----KLALPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTTI 271 (271)
T ss_dssp -----CCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHC-
T ss_pred -----CCCCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHHHHHhcC
Confidence 111234556778899999999999999999999999999753
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-40 Score=358.94 Aligned_cols=254 Identities=21% Similarity=0.357 Sum_probs=211.6
Q ss_pred cCCCCCceeeeeCCeEEEEEEECCCcEEEEEEeccC--ChhcHHHHHHHHHHHHccCCCCcceEEEEEEeC--CeEEEEE
Q 002158 625 AYFSSSTQVGQGGYGKVYKGILSDNTTVAIKRAEEG--SLQGQNEFLTEIKLLSRLHHRNLVSLLGYCDEE--GEQMLVY 700 (958)
Q Consensus 625 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~--~~~~lV~ 700 (958)
++|...+.||+|+||+||+|+++ ++.||||++... .....+.|.+|++++++++||||+++++++... +..++||
T Consensus 10 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~ 88 (271)
T 3kmu_A 10 KQLNFLTKLNENHSGELWKGRWQ-GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLIT 88 (271)
T ss_dssp GGCEEEEEEEEETTEEEEEEEET-TEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEEEE
T ss_pred HHhHHHHHhcCCCcceEEEEEEC-CeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEeee
Confidence 46777889999999999999984 889999998764 334456799999999999999999999999887 7889999
Q ss_pred EecCCCCHHHHhccCCCCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEecCCCCeEEeeeeeecccccCC
Q 002158 701 EFVPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSRLAPVLD 780 (958)
Q Consensus 701 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~ 780 (958)
||+++|+|.+++.......+++.++..++.|+++||+|||+.+ ++|+||||||+||+++.++.++|+|||++.....
T Consensus 89 e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~-~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~~~-- 165 (271)
T 3kmu_A 89 HWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLE-PLIPRHALNSRSVMIDEDMTARISMADVKFSFQS-- 165 (271)
T ss_dssp ECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTTSS-SCCTTCCCSGGGEEECTTSCEEEEGGGSCCTTSC--
T ss_pred cccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCC-CceecCCCccceEEEcCCcceeEEeccceeeecc--
Confidence 9999999999998766556999999999999999999999875 5699999999999999999999999998753211
Q ss_pred CCCCccceeeeeccCCCCccChhhhccCCCCC---cchhhhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcCcchhhhc
Q 002158 781 DEGTMPTHVSTIVKGTPGYLDPEYFLTHKLTD---KSDVYSLGVVLLELLTGMQPISHGKNIVREVNVARDSGMVFSIID 857 (958)
Q Consensus 781 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~---~~DV~S~Gv~l~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~i~ 857 (958)
....||+.|+|||++.+..++. ++||||||+++|||++|+.||.............. .
T Consensus 166 ----------~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~---------~ 226 (271)
T 3kmu_A 166 ----------PGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVAL---------E 226 (271)
T ss_dssp ----------TTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHHHHHHHH---------S
T ss_pred ----------cCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHHHHHHHHh---------c
Confidence 1235899999999998766555 79999999999999999999976544322221111 1
Q ss_pred ccCCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHh
Q 002158 858 NRMGSYPSECVERFVTLALRCCHDKPEHRPSMSDVVRELENILK 901 (958)
Q Consensus 858 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~ 901 (958)
......+..++..+.+++.+||+.||++||+++|+++.|+++.+
T Consensus 227 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~L~~l~~ 270 (271)
T 3kmu_A 227 GLRPTIPPGISPHVSKLMKICMNEDPAKRPKFDMIVPILEKMQD 270 (271)
T ss_dssp CCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHCC
T ss_pred CCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhc
Confidence 11233455677889999999999999999999999999998753
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-40 Score=361.26 Aligned_cols=270 Identities=18% Similarity=0.248 Sum_probs=216.6
Q ss_pred cCCCCCceeeeeCCeEEEEEEEC-CCcEEEEEEeccCChhcHHHHHHHHHHHHcc-CCCCcceEEEEEEeCCeEEEEEEe
Q 002158 625 AYFSSSTQVGQGGYGKVYKGILS-DNTTVAIKRAEEGSLQGQNEFLTEIKLLSRL-HHRNLVSLLGYCDEEGEQMLVYEF 702 (958)
Q Consensus 625 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lV~E~ 702 (958)
++|...+.||+|+||+||+|.+. +++.||||++.... ..+.+.+|+++++.+ +|+|++++++++......++||||
T Consensus 10 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e~ 87 (298)
T 1csn_A 10 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDL 87 (298)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT--TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEEC
T ss_pred cceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCC--ccHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEEEEe
Confidence 46788899999999999999974 78999999987543 223578999999999 799999999999999999999999
Q ss_pred cCCCCHHHHhccCCCCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEecCCCC-----eEEeeeeeecccc
Q 002158 703 VPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSNLN-----AKVADFGLSRLAP 777 (958)
Q Consensus 703 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~~~-----~kl~DFGla~~~~ 777 (958)
+ +++|.+++.... ..+++.++..++.|+++||+|||+++ |+||||||+||+++.++. +||+|||+++...
T Consensus 88 ~-~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~~~ 162 (298)
T 1csn_A 88 L-GPSLEDLLDLCG-RKFSVKTVAMAAKQMLARVQSIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYR 162 (298)
T ss_dssp C-CCBHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESB
T ss_pred c-CCCHHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEeccCCCCCCCeEEEEECccccccc
Confidence 9 999999997643 34899999999999999999999999 999999999999987776 9999999998765
Q ss_pred cCCCCCCccceeeeeccCCCCccChhhhccCCCCCcchhhhHHHHHHHHHhCCCCCCCCch--hHHHHHHHhhcCcchhh
Q 002158 778 VLDDEGTMPTHVSTIVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVLLELLTGMQPISHGKN--IVREVNVARDSGMVFSI 855 (958)
Q Consensus 778 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gv~l~elltG~~P~~~~~~--~~~~~~~~~~~~~~~~~ 855 (958)
........+........||+.|+|||++.+..++.++||||||+++|||++|+.||..... .............
T Consensus 163 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~---- 238 (298)
T 1csn_A 163 DPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQ---- 238 (298)
T ss_dssp CTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHH----
T ss_pred cccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHhhcc----
Confidence 4333222222234456799999999999999999999999999999999999999976331 1111111110000
Q ss_pred hcccCCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHhhCCCC
Q 002158 856 IDNRMGSYPSECVERFVTLALRCCHDKPEHRPSMSDVVRELENILKMFPET 906 (958)
Q Consensus 856 i~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~~~~ 906 (958)
..........++..+.+++.+||+.||++||+++++++.|+++.+.....
T Consensus 239 -~~~~~~~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~~~~~~~~ 288 (298)
T 1csn_A 239 -STPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLNTT 288 (298)
T ss_dssp -HSCHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTTCC
T ss_pred -CccHHHHHhhCcHHHHHHHHHHhcCCcccCCCHHHHHHHHHHHHHhcCCC
Confidence 00000112245678999999999999999999999999999999876543
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-40 Score=366.88 Aligned_cols=261 Identities=29% Similarity=0.493 Sum_probs=215.9
Q ss_pred HcCCCCCceeeeeCCeEEEEEEE------CCCcEEEEEEeccC-ChhcHHHHHHHHHHHHccCCCCcceEEEEEEeCCeE
Q 002158 624 TAYFSSSTQVGQGGYGKVYKGIL------SDNTTVAIKRAEEG-SLQGQNEFLTEIKLLSRLHHRNLVSLLGYCDEEGEQ 696 (958)
Q Consensus 624 ~~~~~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~ 696 (958)
.++|...+.||+|+||.||+|.+ .+++.||||++... .....+.+.+|++++++++||||+++++++...+..
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 101 (314)
T 2ivs_A 22 RKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPL 101 (314)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSC
T ss_pred hhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEecCCce
Confidence 45677889999999999999986 24588999999764 344457799999999999999999999999999999
Q ss_pred EEEEEecCCCCHHHHhccCCC----------------------CCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCc
Q 002158 697 MLVYEFVPNGTLRDWLSGRTK----------------------ENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKA 754 (958)
Q Consensus 697 ~lV~E~~~~gsL~~~l~~~~~----------------------~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp 754 (958)
++||||+++++|.+++..... ..+++.++..++.|+++||+|||+++ |+||||||
T Consensus 102 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dikp 178 (314)
T 2ivs_A 102 LLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMK---LVHRDLAA 178 (314)
T ss_dssp EEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTT---EECCCCSG
T ss_pred EEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCC---Ccccccch
Confidence 999999999999999976432 34899999999999999999999999 99999999
Q ss_pred cceEecCCCCeEEeeeeeecccccCCCCCCccceeeeeccCCCCccChhhhccCCCCCcchhhhHHHHHHHHHh-CCCCC
Q 002158 755 SNILLDSNLNAKVADFGLSRLAPVLDDEGTMPTHVSTIVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVLLELLT-GMQPI 833 (958)
Q Consensus 755 ~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gv~l~ellt-G~~P~ 833 (958)
+||+++.++.+||+|||+++....... ........||+.|+|||++.+..++.++||||||+++|||++ |..||
T Consensus 179 ~NIli~~~~~~kl~Dfg~~~~~~~~~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~ 253 (314)
T 2ivs_A 179 RNILVAEGRKMKISDFGLSRDVYEEDS-----YVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPY 253 (314)
T ss_dssp GGEEEETTTEEEECCCTTCEECTTTSC-----EECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSS
T ss_pred heEEEcCCCCEEEcccccccccccccc-----ceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCC
Confidence 999999999999999999986532211 111223457889999999999999999999999999999999 99999
Q ss_pred CCCchhHHHHHHHhhcCcchhhhcccCCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHhh
Q 002158 834 SHGKNIVREVNVARDSGMVFSIIDNRMGSYPSECVERFVTLALRCCHDKPEHRPSMSDVVRELENILKM 902 (958)
Q Consensus 834 ~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~ 902 (958)
........ ..... .......+..++..+.+++.+||+.||++||+++|++++|++++..
T Consensus 254 ~~~~~~~~-~~~~~---------~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~ 312 (314)
T 2ivs_A 254 PGIPPERL-FNLLK---------TGHRMERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKMMVK 312 (314)
T ss_dssp TTCCGGGH-HHHHH---------TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred CCCCHHHH-HHHhh---------cCCcCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhh
Confidence 75433211 11111 1112234556778899999999999999999999999999998764
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-40 Score=366.07 Aligned_cols=264 Identities=27% Similarity=0.422 Sum_probs=217.4
Q ss_pred HcCCCCCceeeeeCCeEEEEEEE------CCCcEEEEEEeccCC-hhcHHHHHHHHHHHHcc-CCCCcceEEEEEEeCCe
Q 002158 624 TAYFSSSTQVGQGGYGKVYKGIL------SDNTTVAIKRAEEGS-LQGQNEFLTEIKLLSRL-HHRNLVSLLGYCDEEGE 695 (958)
Q Consensus 624 ~~~~~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~ 695 (958)
.++|...+.||+|+||+||+|.+ .+++.||||++.... ....+.+.+|+++++++ +||||+++++++..++.
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~ 101 (313)
T 1t46_A 22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGP 101 (313)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred hhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEecCCC
Confidence 45677889999999999999985 246899999997653 34457799999999999 99999999999999999
Q ss_pred EEEEEEecCCCCHHHHhccCCC----------------CCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEe
Q 002158 696 QMLVYEFVPNGTLRDWLSGRTK----------------ENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILL 759 (958)
Q Consensus 696 ~~lV~E~~~~gsL~~~l~~~~~----------------~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl 759 (958)
.++||||+++|+|.+++..... ..+++.++..++.|+++||+|||+++ |+||||||+||++
T Consensus 102 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~ 178 (313)
T 1t46_A 102 TLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNILL 178 (313)
T ss_dssp CEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEE
T ss_pred cEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCccceEEE
Confidence 9999999999999999976542 24899999999999999999999999 9999999999999
Q ss_pred cCCCCeEEeeeeeecccccCCCCCCccceeeeeccCCCCccChhhhccCCCCCcchhhhHHHHHHHHHh-CCCCCCCCch
Q 002158 760 DSNLNAKVADFGLSRLAPVLDDEGTMPTHVSTIVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVLLELLT-GMQPISHGKN 838 (958)
Q Consensus 760 ~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gv~l~ellt-G~~P~~~~~~ 838 (958)
+.++.+||+|||+++....... ........||+.|+|||++.+..++.++||||||+++|||++ |+.||.....
T Consensus 179 ~~~~~~kl~Dfg~~~~~~~~~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~ 253 (313)
T 1t46_A 179 THGRITKICDFGLARDIKNDSN-----YVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPV 253 (313)
T ss_dssp ETTTEEEECCCGGGSCTTSCTT-----SEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCS
T ss_pred cCCCCEEEcccccccccccccc-----ceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcccc
Confidence 9999999999999986533221 122233457889999999999999999999999999999999 9999975443
Q ss_pred hHHHHHHHhhcCcchhhhcccCCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHhhCC
Q 002158 839 IVREVNVARDSGMVFSIIDNRMGSYPSECVERFVTLALRCCHDKPEHRPSMSDVVRELENILKMFP 904 (958)
Q Consensus 839 ~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~~ 904 (958)
.......... . .....+..++..+.+++.+||+.||.+||+++|++++|++++....
T Consensus 254 ~~~~~~~~~~-~--------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~ 310 (313)
T 1t46_A 254 DSKFYKMIKE-G--------FRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISEST 310 (313)
T ss_dssp SHHHHHHHHH-T--------CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTC
T ss_pred hhHHHHHhcc-C--------CCCCCcccCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHHhh
Confidence 2222111111 0 1112244567889999999999999999999999999999887654
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-40 Score=387.73 Aligned_cols=261 Identities=31% Similarity=0.481 Sum_probs=212.5
Q ss_pred HHHcCCCCCceeeeeCCeEEEEEEECCCcEEEEEEeccCChhcHHHHHHHHHHHHccCCCCcceEEEEEEeCCeEEEEEE
Q 002158 622 MATAYFSSSTQVGQGGYGKVYKGILSDNTTVAIKRAEEGSLQGQNEFLTEIKLLSRLHHRNLVSLLGYCDEEGEQMLVYE 701 (958)
Q Consensus 622 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E 701 (958)
...++|...+.||+|+||+||+|.++++..||||+++... ...++|.+|++++++++||||+++++++.. +..++|||
T Consensus 181 i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~iv~e 258 (452)
T 1fmk_A 181 IPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTE 258 (452)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEC
T ss_pred cChhHceeeeeecCCCCeEEEEEEECCCceEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceEEEeh
Confidence 3456778889999999999999999888889999998643 345689999999999999999999999876 67899999
Q ss_pred ecCCCCHHHHhccCCCCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEecCCCCeEEeeeeeecccccCCC
Q 002158 702 FVPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSRLAPVLDD 781 (958)
Q Consensus 702 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~ 781 (958)
|+++|+|.++++......+++.++..++.|+++||+|||+++ |+||||||+|||+++++.+||+|||+++......
T Consensus 259 ~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~- 334 (452)
T 1fmk_A 259 YMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNE- 334 (452)
T ss_dssp CCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCTTC-------
T ss_pred hhcCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChhhEEECCCCCEEECCCccceecCCCc-
Confidence 999999999997544455899999999999999999999999 9999999999999999999999999998653211
Q ss_pred CCCccceeeeeccCCCCccChhhhccCCCCCcchhhhHHHHHHHHHh-CCCCCCCCchhHHHHHHHhhcCcchhhhcccC
Q 002158 782 EGTMPTHVSTIVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVLLELLT-GMQPISHGKNIVREVNVARDSGMVFSIIDNRM 860 (958)
Q Consensus 782 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gv~l~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~i~~~~ 860 (958)
........++..|+|||++....++.++||||||+++|||++ |+.||.+..... ...... ....
T Consensus 335 -----~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~-~~~~i~---------~~~~ 399 (452)
T 1fmk_A 335 -----YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE-VLDQVE---------RGYR 399 (452)
T ss_dssp -------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH-HHHHHH---------TTCC
T ss_pred -----eecccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCHHH-HHHHHH---------cCCC
Confidence 111223457889999999999999999999999999999999 999997544322 111111 1112
Q ss_pred CCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHhhC
Q 002158 861 GSYPSECVERFVTLALRCCHDKPEHRPSMSDVVRELENILKMF 903 (958)
Q Consensus 861 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~ 903 (958)
...+..++..+.+++.+||+.||++|||++++++.|+++....
T Consensus 400 ~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~~~~ 442 (452)
T 1fmk_A 400 MPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTST 442 (452)
T ss_dssp CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCS
T ss_pred CCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhccC
Confidence 2345667889999999999999999999999999999876543
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-40 Score=374.62 Aligned_cols=277 Identities=17% Similarity=0.190 Sum_probs=213.8
Q ss_pred HHcCCCCCceeeeeCCeEEEEEEECC------CcEEEEEEeccCChhcH-----------HHHHHHHHHHHccCCCCcce
Q 002158 623 ATAYFSSSTQVGQGGYGKVYKGILSD------NTTVAIKRAEEGSLQGQ-----------NEFLTEIKLLSRLHHRNLVS 685 (958)
Q Consensus 623 ~~~~~~~~~~lg~G~~g~Vy~~~~~~------~~~vavK~~~~~~~~~~-----------~~~~~E~~~l~~l~H~niv~ 685 (958)
..++|...+.||+|+||+||+|.+.. ++.||||++........ ..+..|+..++.++||||++
T Consensus 33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~ 112 (364)
T 3op5_A 33 AAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPK 112 (364)
T ss_dssp TCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCC
T ss_pred CCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCe
Confidence 34578888999999999999999864 47899999876542211 12445666778889999999
Q ss_pred EEEEEEeC----CeEEEEEEecCCCCHHHHhccCCCCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEec-
Q 002158 686 LLGYCDEE----GEQMLVYEFVPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLD- 760 (958)
Q Consensus 686 l~~~~~~~----~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~- 760 (958)
+++++... ...++||||+ +++|.+++.... ..+++.+++.++.|++.||+|||+.+ |+||||||+|||++
T Consensus 113 ~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~-~~l~~~~~~~i~~qi~~~l~~lH~~~---iiHrDlkp~Nill~~ 187 (364)
T 3op5_A 113 YWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANA-KRFSRKTVLQLSLRILDILEYIHEHE---YVHGDIKASNLLLNY 187 (364)
T ss_dssp EEEEEEEEETTEEEEEEEEECE-EEEHHHHHHHTT-SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEES
T ss_pred EEeeeeeccCCcceEEEEEeCC-CCCHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eEEecCCHHHEEEec
Confidence 99998764 4589999999 999999997643 45999999999999999999999999 99999999999999
Q ss_pred -CCCCeEEeeeeeecccccCCCCCCccceeeeeccCCCCccChhhhccCCCCCcchhhhHHHHHHHHHhCCCCCCCCchh
Q 002158 761 -SNLNAKVADFGLSRLAPVLDDEGTMPTHVSTIVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVLLELLTGMQPISHGKNI 839 (958)
Q Consensus 761 -~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gv~l~elltG~~P~~~~~~~ 839 (958)
.++.+||+|||+++.+..................||+.|+|||++.+..++.++|||||||++|||++|+.||.+....
T Consensus 188 ~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~~~ 267 (364)
T 3op5_A 188 KNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLKD 267 (364)
T ss_dssp SCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTC
T ss_pred CCCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCccccccC
Confidence 8899999999999876543322222222234456999999999999999999999999999999999999999753222
Q ss_pred HHHHHHH--hhcCcchhhhcccCCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHhhCCCC
Q 002158 840 VREVNVA--RDSGMVFSIIDNRMGSYPSECVERFVTLALRCCHDKPEHRPSMSDVVRELENILKMFPET 906 (958)
Q Consensus 840 ~~~~~~~--~~~~~~~~~i~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~~~~ 906 (958)
....... .........++..+. +..++.++.+++..||+.||++||+++++++.|+++++.....
T Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~li~~cl~~~p~~RP~~~~l~~~l~~~~~~~~~~ 334 (364)
T 3op5_A 268 PKYVRDSKIRYRENIASLMDKCFP--AANAPGEIAKYMETVKLLDYTEKPLYENLRDILLQGLKAIGSK 334 (364)
T ss_dssp HHHHHHHHHHHHHCHHHHHHHHSC--TTCCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTTCC
T ss_pred HHHHHHHHHHhhhhHHHHHHHhcc--cccCHHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcCCC
Confidence 2211111 111112222222221 1234678999999999999999999999999999999876543
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-40 Score=365.88 Aligned_cols=252 Identities=23% Similarity=0.352 Sum_probs=206.8
Q ss_pred HcCCCCCceeeeeCCeEEEEEEEC-CCcEEEEEEeccCChh------cHHHHHHHHHHHHccCCCCcceEEEEEEeCCeE
Q 002158 624 TAYFSSSTQVGQGGYGKVYKGILS-DNTTVAIKRAEEGSLQ------GQNEFLTEIKLLSRLHHRNLVSLLGYCDEEGEQ 696 (958)
Q Consensus 624 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~------~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~ 696 (958)
.++|...+.||+|+||.||+|... +++.||||++...... ..+.+.+|++++++++||||+++++++...+..
T Consensus 10 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 89 (326)
T 2y0a_A 10 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV 89 (326)
T ss_dssp HHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred ccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEE
Confidence 346888899999999999999986 6899999998764321 356799999999999999999999999999999
Q ss_pred EEEEEecCCCCHHHHhccCCCCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEecCCC----CeEEeeeee
Q 002158 697 MLVYEFVPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSNL----NAKVADFGL 772 (958)
Q Consensus 697 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~~----~~kl~DFGl 772 (958)
++||||+++|+|.+++... ..+++.++..++.|++.||+|||+.+ |+||||||+|||++.++ .+||+|||+
T Consensus 90 ~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~ 164 (326)
T 2y0a_A 90 ILILELVAGGELFDFLAEK--ESLTEEEATEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFGL 164 (326)
T ss_dssp EEEEECCCSCBHHHHHTTS--SCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESCSSSSSCCEEECCCTT
T ss_pred EEEEEcCCCCCHHHHHHhc--CCcCHHHHHHHHHHHHHHHHHHHHCC---eEcCCCCHHHEEEecCCCCCCCEEEEECCC
Confidence 9999999999999999654 34999999999999999999999999 99999999999999887 899999999
Q ss_pred ecccccCCCCCCccceeeeeccCCCCccChhhhccCCCCCcchhhhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcCcc
Q 002158 773 SRLAPVLDDEGTMPTHVSTIVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVLLELLTGMQPISHGKNIVREVNVARDSGMV 852 (958)
Q Consensus 773 a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gv~l~elltG~~P~~~~~~~~~~~~~~~~~~~~ 852 (958)
++...... ......||+.|+|||++.+..++.++|||||||++|||++|..||...................
T Consensus 165 a~~~~~~~--------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~ 236 (326)
T 2y0a_A 165 AHKIDFGN--------EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEF 236 (326)
T ss_dssp CEECCTTS--------CCCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHTCCCC
T ss_pred CeECCCCC--------ccccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHhcCCCc
Confidence 98653221 1223569999999999999999999999999999999999999997544322211111110000
Q ss_pred hhhhcccCCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 002158 853 FSIIDNRMGSYPSECVERFVTLALRCCHDKPEHRPSMSDVVRE 895 (958)
Q Consensus 853 ~~~i~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 895 (958)
.. ......+..+.+++.+||+.||++|||++|++++
T Consensus 237 ~~-------~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 272 (326)
T 2y0a_A 237 ED-------EYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQH 272 (326)
T ss_dssp CH-------HHHTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred Cc-------cccccCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 00 0012345678999999999999999999999974
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-40 Score=365.95 Aligned_cols=251 Identities=19% Similarity=0.305 Sum_probs=207.3
Q ss_pred cCCCCCceeeeeCCeEEEEEEEC-CCcEEEEEEeccCChhcHHHHHHHHHHHHccCCCCcceEEEEEEeCCeEEEEEEec
Q 002158 625 AYFSSSTQVGQGGYGKVYKGILS-DNTTVAIKRAEEGSLQGQNEFLTEIKLLSRLHHRNLVSLLGYCDEEGEQMLVYEFV 703 (958)
Q Consensus 625 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E~~ 703 (958)
++|...+.||+|+||+||+|.+. +++.||+|.+.... .....+.+|+++++.++||||+++++++.+.+..++||||+
T Consensus 5 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~ 83 (321)
T 1tki_A 5 EKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG-TDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEFI 83 (321)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT-HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred hceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCc-ccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEEeC
Confidence 56788899999999999999986 68899999987543 34567889999999999999999999999999999999999
Q ss_pred CCCCHHHHhccCCCCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEecC--CCCeEEeeeeeecccccCCC
Q 002158 704 PNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDS--NLNAKVADFGLSRLAPVLDD 781 (958)
Q Consensus 704 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~--~~~~kl~DFGla~~~~~~~~ 781 (958)
++|+|.+++.... ..+++.++..++.|+++||+|||+.+ |+||||||+|||++. ++.+||+|||+++....
T Consensus 84 ~g~~L~~~l~~~~-~~~~~~~~~~i~~qi~~al~~lH~~g---ivH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~--- 156 (321)
T 1tki_A 84 SGLDIFERINTSA-FELNEREIVSYVHQVCEALQFLHSHN---IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKP--- 156 (321)
T ss_dssp CCCBHHHHHTSSS-CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCTTCEECCT---
T ss_pred CCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCC---CCcCCCCHHHEEEccCCCCCEEEEECCCCeECCC---
Confidence 9999999997543 35899999999999999999999999 999999999999987 78999999999986532
Q ss_pred CCCccceeeeeccCCCCccChhhhccCCCCCcchhhhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcCcchhhhcccCC
Q 002158 782 EGTMPTHVSTIVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVLLELLTGMQPISHGKNIVREVNVARDSGMVFSIIDNRMG 861 (958)
Q Consensus 782 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gv~l~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~i~~~~~ 861 (958)
........||+.|+|||++.+..++.++||||+||++|||++|..||....... ............. ..
T Consensus 157 -----~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~-~~~~i~~~~~~~~--~~--- 225 (321)
T 1tki_A 157 -----GDNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQ-IIENIMNAEYTFD--EE--- 225 (321)
T ss_dssp -----TCEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHH-HHHHHHHTCCCCC--HH---
T ss_pred -----CCccccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCHHH-HHHHHHcCCCCCC--hh---
Confidence 122344679999999999998889999999999999999999999997644322 2211111110000 00
Q ss_pred CCChHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 002158 862 SYPSECVERFVTLALRCCHDKPEHRPSMSDVVRE 895 (958)
Q Consensus 862 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 895 (958)
....++.++.+++.+||+.||++|||+.|++++
T Consensus 226 -~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~h 258 (321)
T 1tki_A 226 -AFKEISIEAMDFVDRLLVKERKSRMTASEALQH 258 (321)
T ss_dssp -HHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred -hhccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 011345788999999999999999999999986
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-41 Score=377.64 Aligned_cols=260 Identities=27% Similarity=0.426 Sum_probs=213.3
Q ss_pred cCCCCCceeeeeCCeEEEEEEEC------CCcEEEEEEeccC-ChhcHHHHHHHHHHHHccCCCCcceEEEEEEeCCeEE
Q 002158 625 AYFSSSTQVGQGGYGKVYKGILS------DNTTVAIKRAEEG-SLQGQNEFLTEIKLLSRLHHRNLVSLLGYCDEEGEQM 697 (958)
Q Consensus 625 ~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~ 697 (958)
++|...+.||+|+||+||+|.+. +++.||||++... ......++.+|+.++++++||||+++++++...+..+
T Consensus 71 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~ 150 (367)
T 3l9p_A 71 KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRF 150 (367)
T ss_dssp GGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred hHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCE
Confidence 46778889999999999999953 4678999999754 3445567999999999999999999999999999999
Q ss_pred EEEEecCCCCHHHHhccCC-----CCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEecCCC---CeEEee
Q 002158 698 LVYEFVPNGTLRDWLSGRT-----KENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSNL---NAKVAD 769 (958)
Q Consensus 698 lV~E~~~~gsL~~~l~~~~-----~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~~---~~kl~D 769 (958)
+||||+++|+|.+++.... ...+++.+++.++.|+++||+|||+++ |+||||||+|||++.++ .+||+|
T Consensus 151 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~~~~kL~D 227 (367)
T 3l9p_A 151 ILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKIGD 227 (367)
T ss_dssp EEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEEECC
T ss_pred EEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChhhEEEecCCCCceEEECC
Confidence 9999999999999997543 235899999999999999999999999 99999999999999555 599999
Q ss_pred eeeecccccCCCCCCccceeeeeccCCCCccChhhhccCCCCCcchhhhHHHHHHHHHh-CCCCCCCCchhHHHHHHHhh
Q 002158 770 FGLSRLAPVLDDEGTMPTHVSTIVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVLLELLT-GMQPISHGKNIVREVNVARD 848 (958)
Q Consensus 770 FGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gv~l~ellt-G~~P~~~~~~~~~~~~~~~~ 848 (958)
||+++........ .......||+.|+|||++.+..++.++|||||||++|||++ |..||....... ......
T Consensus 228 FG~a~~~~~~~~~-----~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~~~-~~~~i~- 300 (367)
T 3l9p_A 228 FGMARDIYRAGYY-----RKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQE-VLEFVT- 300 (367)
T ss_dssp CHHHHHHHHHSSC-----TTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH-HHHHHH-
T ss_pred Ccccccccccccc-----ccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHH-HHHHHH-
Confidence 9999855322211 11223568999999999999999999999999999999998 999997544322 111111
Q ss_pred cCcchhhhcccCCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHhh
Q 002158 849 SGMVFSIIDNRMGSYPSECVERFVTLALRCCHDKPEHRPSMSDVVRELENILKM 902 (958)
Q Consensus 849 ~~~~~~~i~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~ 902 (958)
.......+..++..+.+++.+||+.||++||++++++++|+.+.+.
T Consensus 301 --------~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~~~ 346 (367)
T 3l9p_A 301 --------SGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQD 346 (367)
T ss_dssp --------TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred --------cCCCCCCCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhhC
Confidence 1112233556678899999999999999999999999999987753
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-41 Score=363.62 Aligned_cols=258 Identities=27% Similarity=0.418 Sum_probs=202.6
Q ss_pred HcCCCCCceeeeeCCeEEEEEEECC----CcEEEEEEeccCC-hhcHHHHHHHHHHHHccCCCCcceEEEEEEeCCeEEE
Q 002158 624 TAYFSSSTQVGQGGYGKVYKGILSD----NTTVAIKRAEEGS-LQGQNEFLTEIKLLSRLHHRNLVSLLGYCDEEGEQML 698 (958)
Q Consensus 624 ~~~~~~~~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~l 698 (958)
.++|...+.||+|+||.||+|.+.. +..||+|++.... ....+.+.+|+.++++++||||+++++++. ++..++
T Consensus 14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~l 92 (281)
T 1mp8_A 14 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWI 92 (281)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEE
T ss_pred hHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEEc-cCccEE
Confidence 4577788999999999999999753 4579999987643 344567999999999999999999999985 467899
Q ss_pred EEEecCCCCHHHHhccCCCCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEecCCCCeEEeeeeeeccccc
Q 002158 699 VYEFVPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSRLAPV 778 (958)
Q Consensus 699 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~~~~ 778 (958)
||||+++++|.+++.... ..+++.++..++.|+++||+|||+.+ |+||||||+|||++.++.+||+|||+++....
T Consensus 93 v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 168 (281)
T 1mp8_A 93 IMELCTLGELRSFLQVRK-YSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYMED 168 (281)
T ss_dssp EEECCTTEEHHHHHHHTT-TTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECC---------
T ss_pred EEecCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCC---eecccccHHHEEECCCCCEEECccccccccCc
Confidence 999999999999997543 34899999999999999999999999 99999999999999999999999999986532
Q ss_pred CCCCCCccceeeeeccCCCCccChhhhccCCCCCcchhhhHHHHHHHHHh-CCCCCCCCchhHHHHHHHhhcCcchhhhc
Q 002158 779 LDDEGTMPTHVSTIVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVLLELLT-GMQPISHGKNIVREVNVARDSGMVFSIID 857 (958)
Q Consensus 779 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gv~l~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~i~ 857 (958)
.. ........+|+.|+|||++.+..++.++||||||+++|||++ |..||.......... .. ..
T Consensus 169 ~~------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~~~~-~i---------~~ 232 (281)
T 1mp8_A 169 ST------YYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIG-RI---------EN 232 (281)
T ss_dssp ----------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHH-HH---------HT
T ss_pred cc------ccccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHHHHH-HH---------Hc
Confidence 11 111223457789999999999999999999999999999997 999997544322111 11 11
Q ss_pred ccCCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHhh
Q 002158 858 NRMGSYPSECVERFVTLALRCCHDKPEHRPSMSDVVRELENILKM 902 (958)
Q Consensus 858 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~ 902 (958)
......+..++..+.+++.+||+.||++||++.|+++.|+++++.
T Consensus 233 ~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~ 277 (281)
T 1mp8_A 233 GERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEE 277 (281)
T ss_dssp TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHH
Confidence 112234556778899999999999999999999999999998753
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-40 Score=368.81 Aligned_cols=258 Identities=26% Similarity=0.439 Sum_probs=204.8
Q ss_pred cCCCCCceeeeeCCeEEEEEEEC-CCc----EEEEEEeccC-ChhcHHHHHHHHHHHHccCCCCcceEEEEEEeCCeEEE
Q 002158 625 AYFSSSTQVGQGGYGKVYKGILS-DNT----TVAIKRAEEG-SLQGQNEFLTEIKLLSRLHHRNLVSLLGYCDEEGEQML 698 (958)
Q Consensus 625 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~----~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~l 698 (958)
++|...+.||+|+||+||+|++. +++ .||+|.+... .....++|.+|++++++++||||++++++|..+ ..++
T Consensus 15 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-~~~~ 93 (327)
T 3poz_A 15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL 93 (327)
T ss_dssp GGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESS-SEEE
T ss_pred HHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecC-CeEE
Confidence 45777889999999999999975 344 3688887643 334567899999999999999999999999876 4789
Q ss_pred EEEecCCCCHHHHhccCCCCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEecCCCCeEEeeeeeeccccc
Q 002158 699 VYEFVPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSRLAPV 778 (958)
Q Consensus 699 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~~~~ 778 (958)
||||+++|+|.+++.... ..+++..++.++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+++....
T Consensus 94 v~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~ 169 (327)
T 3poz_A 94 ITQLMPFGCLLDYVREHK-DNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGA 169 (327)
T ss_dssp EEECCTTCBHHHHHHHST-TSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCTTHHHHHTT
T ss_pred EEEecCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCChheEEECCCCCEEEccCcceeEccC
Confidence 999999999999998654 34899999999999999999999999 99999999999999999999999999987643
Q ss_pred CCCCCCccceeeeeccCCCCccChhhhccCCCCCcchhhhHHHHHHHHHh-CCCCCCCCchhHHHHHHHhhcCcchhhhc
Q 002158 779 LDDEGTMPTHVSTIVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVLLELLT-GMQPISHGKNIVREVNVARDSGMVFSIID 857 (958)
Q Consensus 779 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gv~l~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~i~ 857 (958)
... ........||+.|+|||++.+..++.++|||||||++|||++ |+.||......... .... .
T Consensus 170 ~~~-----~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~-~~~~---------~ 234 (327)
T 3poz_A 170 EEK-----EYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS-SILE---------K 234 (327)
T ss_dssp TCC------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHH-HHHH---------T
T ss_pred Ccc-----cccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHHHH-HHHH---------c
Confidence 221 112233457889999999999999999999999999999999 99999754332111 1111 1
Q ss_pred ccCCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHhh
Q 002158 858 NRMGSYPSECVERFVTLALRCCHDKPEHRPSMSDVVRELENILKM 902 (958)
Q Consensus 858 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~ 902 (958)
......+..++..+.+++.+||+.||++||++.|++++|+.+.+.
T Consensus 235 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~~~~ 279 (327)
T 3poz_A 235 GERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARD 279 (327)
T ss_dssp TCCCCCCTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHHHHHHHTS
T ss_pred CCCCCCCccCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhh
Confidence 111233556678899999999999999999999999999998753
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-40 Score=364.52 Aligned_cols=245 Identities=23% Similarity=0.356 Sum_probs=207.6
Q ss_pred cCCCCCceeeeeCCeEEEEEEEC-CCcEEEEEEeccCC---hhcHHHHHHHHHHHHccCCCCcceEEEEEEeCCeEEEEE
Q 002158 625 AYFSSSTQVGQGGYGKVYKGILS-DNTTVAIKRAEEGS---LQGQNEFLTEIKLLSRLHHRNLVSLLGYCDEEGEQMLVY 700 (958)
Q Consensus 625 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~ 700 (958)
++|...+.||+|+||+||+|+.+ +|+.||+|+++... ....+.+.+|+.+++.++||||+++++++.+.+..++||
T Consensus 6 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv~ 85 (318)
T 1fot_A 6 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM 85 (318)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred HHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEEE
Confidence 46778899999999999999986 68999999987532 233567889999999999999999999999999999999
Q ss_pred EecCCCCHHHHhccCCCCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEecCCCCeEEeeeeeecccccCC
Q 002158 701 EFVPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSRLAPVLD 780 (958)
Q Consensus 701 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~ 780 (958)
||+++|+|.+++.... .+++..+..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+++....
T Consensus 86 e~~~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~-- 158 (318)
T 1fot_A 86 DYIEGGELFSLLRKSQ--RFPNPVAKFYAAEVCLALEYLHSKD---IIYRDLKPENILLDKNGHIKITDFGFAKYVPD-- 158 (318)
T ss_dssp CCCCSCBHHHHHHHTS--SCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTSCEEECCCSSCEECSS--
T ss_pred eCCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChheEEEcCCCCEEEeecCcceecCC--
Confidence 9999999999997644 4899999999999999999999999 99999999999999999999999999986421
Q ss_pred CCCCccceeeeeccCCCCccChhhhccCCCCCcchhhhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcCcchhhhcccC
Q 002158 781 DEGTMPTHVSTIVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVLLELLTGMQPISHGKNIVREVNVARDSGMVFSIIDNRM 860 (958)
Q Consensus 781 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gv~l~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~i~~~~ 860 (958)
......||+.|+|||++.+..++.++|||||||++|||++|+.||......... ..... ..
T Consensus 159 --------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~-~~i~~----------~~ 219 (318)
T 1fot_A 159 --------VTYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTY-EKILN----------AE 219 (318)
T ss_dssp --------CBCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHH-HHHHH----------CC
T ss_pred --------ccccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHH-HHHHh----------CC
Confidence 123457999999999999999999999999999999999999999765432221 11111 11
Q ss_pred CCCChHHHHHHHHHHHHccccCCCCCC-----CHHHHHHH
Q 002158 861 GSYPSECVERFVTLALRCCHDKPEHRP-----SMSDVVRE 895 (958)
Q Consensus 861 ~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~~ 895 (958)
..+|...+.++.+++.+|++.||++|| +++|++++
T Consensus 220 ~~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~h 259 (318)
T 1fot_A 220 LRFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNH 259 (318)
T ss_dssp CCCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTS
T ss_pred CCCCCCCCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhcC
Confidence 233555678899999999999999999 88888864
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-40 Score=371.57 Aligned_cols=268 Identities=26% Similarity=0.401 Sum_probs=213.6
Q ss_pred HHHcCCCCCceeeeeCCeEEEEEEE------CCCcEEEEEEeccCC-hhcHHHHHHHHHHHHcc-CCCCcceEEEEEEeC
Q 002158 622 MATAYFSSSTQVGQGGYGKVYKGIL------SDNTTVAIKRAEEGS-LQGQNEFLTEIKLLSRL-HHRNLVSLLGYCDEE 693 (958)
Q Consensus 622 ~~~~~~~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~ 693 (958)
...++|...+.||+|+||+||+|.+ .++..||||++.... ....+.+.+|+++++++ +||||+++++++...
T Consensus 42 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~ 121 (344)
T 1rjb_A 42 FPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLS 121 (344)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred cCHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEeeC
Confidence 3456788889999999999999996 246689999997542 23346799999999999 899999999999999
Q ss_pred CeEEEEEEecCCCCHHHHhccCCC---------------------CCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCC
Q 002158 694 GEQMLVYEFVPNGTLRDWLSGRTK---------------------ENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDI 752 (958)
Q Consensus 694 ~~~~lV~E~~~~gsL~~~l~~~~~---------------------~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Di 752 (958)
+..++||||+++|+|.+++..... ..+++..++.++.|+++||+|||+++ |+||||
T Consensus 122 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Di 198 (344)
T 1rjb_A 122 GPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS---CVHRDL 198 (344)
T ss_dssp SSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT---EEETTC
T ss_pred CccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCC
Confidence 999999999999999999976532 23789999999999999999999999 999999
Q ss_pred CccceEecCCCCeEEeeeeeecccccCCCCCCccceeeeeccCCCCccChhhhccCCCCCcchhhhHHHHHHHHHh-CCC
Q 002158 753 KASNILLDSNLNAKVADFGLSRLAPVLDDEGTMPTHVSTIVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVLLELLT-GMQ 831 (958)
Q Consensus 753 kp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gv~l~ellt-G~~ 831 (958)
||+||+++.++.+||+|||+++....... ........||+.|+|||++.+..++.++||||||+++|||+| |..
T Consensus 199 kp~NIll~~~~~~kL~Dfg~~~~~~~~~~-----~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~ 273 (344)
T 1rjb_A 199 AARNVLVTHGKVVKICDFGLARDIMSDSN-----YVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVN 273 (344)
T ss_dssp SGGGEEEETTTEEEECCCGGGSCGGGCTT-----SEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCC
T ss_pred ChhhEEEcCCCcEEeCCCccCcccccCcc-----ceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCC
Confidence 99999999999999999999986533221 122334557889999999999999999999999999999998 999
Q ss_pred CCCCCchhHHHHHHHhhcCcchhhhcccCCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHhhCCCC
Q 002158 832 PISHGKNIVREVNVARDSGMVFSIIDNRMGSYPSECVERFVTLALRCCHDKPEHRPSMSDVVRELENILKMFPET 906 (958)
Q Consensus 832 P~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~~~~ 906 (958)
||............... + .....+..++..+.+++.+||+.||.+||++.+++++|+.+++..++.
T Consensus 274 p~~~~~~~~~~~~~~~~-~--------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~~~~ 339 (344)
T 1rjb_A 274 PYPGIPVDANFYKLIQN-G--------FKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQLADAEEA 339 (344)
T ss_dssp SSTTCCCSHHHHHHHHT-T--------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC------
T ss_pred CcccCCcHHHHHHHHhc-C--------CCCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHHHHHH
Confidence 99764432221111111 1 112334556788999999999999999999999999999988765543
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=391.61 Aligned_cols=259 Identities=30% Similarity=0.478 Sum_probs=217.0
Q ss_pred HHcCCCCCceeeeeCCeEEEEEEECC-CcEEEEEEeccCChhcHHHHHHHHHHHHccCCCCcceEEEEEEeCCeEEEEEE
Q 002158 623 ATAYFSSSTQVGQGGYGKVYKGILSD-NTTVAIKRAEEGSLQGQNEFLTEIKLLSRLHHRNLVSLLGYCDEEGEQMLVYE 701 (958)
Q Consensus 623 ~~~~~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E 701 (958)
...+|...+.||+|+||.||+|.++. +..||||+++... ...++|.+|++++++++||||++++++|...+..++|||
T Consensus 218 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~E 296 (495)
T 1opk_A 218 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITE 296 (495)
T ss_dssp CGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred CHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcc-cchHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEEEEE
Confidence 44567788899999999999999874 8899999997643 346789999999999999999999999999999999999
Q ss_pred ecCCCCHHHHhccCCCCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEecCCCCeEEeeeeeecccccCCC
Q 002158 702 FVPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSRLAPVLDD 781 (958)
Q Consensus 702 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~ 781 (958)
|+++|+|.++++......+++..++.++.|+++||+|||+++ |+||||||+|||++.++.+||+|||+++......
T Consensus 297 ~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~- 372 (495)
T 1opk_A 297 FMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN---FIHRNLAARNCLVGENHLVKVADFGLSRLMTGDT- 372 (495)
T ss_dssp CCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCEEECCTTCEECCTTCC-
T ss_pred ccCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChhhEEECCCCcEEEeecccceeccCCc-
Confidence 999999999998766666999999999999999999999999 9999999999999999999999999998653211
Q ss_pred CCCccceeeeeccCCCCccChhhhccCCCCCcchhhhHHHHHHHHHh-CCCCCCCCchhHHHHHHHhhcCcchhhhcccC
Q 002158 782 EGTMPTHVSTIVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVLLELLT-GMQPISHGKNIVREVNVARDSGMVFSIIDNRM 860 (958)
Q Consensus 782 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gv~l~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~i~~~~ 860 (958)
........+++.|+|||++....++.++|||||||++|||++ |+.||....... ...... ....
T Consensus 373 -----~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~-~~~~~~---------~~~~ 437 (495)
T 1opk_A 373 -----YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ-VYELLE---------KDYR 437 (495)
T ss_dssp -----EECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG-HHHHHH---------TTCC
T ss_pred -----eeecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHH-HHHHHH---------cCCC
Confidence 111223446788999999999999999999999999999999 999997543221 111111 1111
Q ss_pred CCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHh
Q 002158 861 GSYPSECVERFVTLALRCCHDKPEHRPSMSDVVRELENILK 901 (958)
Q Consensus 861 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~ 901 (958)
...+..++..+.+++.+||+.||++||+++++++.|+.+..
T Consensus 438 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~el~~~L~~~~~ 478 (495)
T 1opk_A 438 MERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ 478 (495)
T ss_dssp CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSCS
T ss_pred CCCCCCCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHh
Confidence 23456678899999999999999999999999999988753
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-40 Score=360.63 Aligned_cols=262 Identities=28% Similarity=0.461 Sum_probs=215.1
Q ss_pred HHcCCCCCceeeeeCCeEEEEEEECCCcEEEEEEeccCChhcHHHHHHHHHHHHccCCCCcceEEEEEEeCCeEEEEEEe
Q 002158 623 ATAYFSSSTQVGQGGYGKVYKGILSDNTTVAIKRAEEGSLQGQNEFLTEIKLLSRLHHRNLVSLLGYCDEEGEQMLVYEF 702 (958)
Q Consensus 623 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E~ 702 (958)
..++|...+.||+|+||.||+|.+++++.||||++.... ...+.+.+|++++++++||||+++++++.. +..++||||
T Consensus 11 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~v~e~ 88 (279)
T 1qpc_A 11 PRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEY 88 (279)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEEC
T ss_pred CHHhhhheeeecCCCCeEEEEEEEcCCcEEEEEEecCCc-ccHHHHHHHHHHHHhCCCcCcceEEEEEcC-CCcEEEEec
Confidence 345677889999999999999999888899999997643 345679999999999999999999999874 568999999
Q ss_pred cCCCCHHHHhccCCCCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEecCCCCeEEeeeeeecccccCCCC
Q 002158 703 VPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSRLAPVLDDE 782 (958)
Q Consensus 703 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~ 782 (958)
+++++|.+++.......+++.++..++.|+++||+|||+++ |+||||||+||++++++.+||+|||+++......
T Consensus 89 ~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~-- 163 (279)
T 1qpc_A 89 MENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNE-- 163 (279)
T ss_dssp CTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECSSSC--
T ss_pred CCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHhhEEEcCCCCEEECCCcccccccCcc--
Confidence 99999999997544335899999999999999999999999 9999999999999999999999999998653211
Q ss_pred CCccceeeeeccCCCCccChhhhccCCCCCcchhhhHHHHHHHHHh-CCCCCCCCchhHHHHHHHhhcCcchhhhcccCC
Q 002158 783 GTMPTHVSTIVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVLLELLT-GMQPISHGKNIVREVNVARDSGMVFSIIDNRMG 861 (958)
Q Consensus 783 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gv~l~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~i~~~~~ 861 (958)
........++..|+|||++.+..++.++||||||+++|||++ |+.||....... ....... ....
T Consensus 164 ----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~-~~~~~~~---------~~~~ 229 (279)
T 1qpc_A 164 ----YTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPE-VIQNLER---------GYRM 229 (279)
T ss_dssp ----EECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH-HHHHHHT---------TCCC
T ss_pred ----cccccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCHHH-HHHHHhc---------ccCC
Confidence 111223457889999999998899999999999999999999 999997544322 1111111 1112
Q ss_pred CCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHhhCCC
Q 002158 862 SYPSECVERFVTLALRCCHDKPEHRPSMSDVVRELENILKMFPE 905 (958)
Q Consensus 862 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~~~ 905 (958)
..+..++..+.+++.+||+.||++||+++++++.|+++......
T Consensus 230 ~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~~ 273 (279)
T 1qpc_A 230 VRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTATEG 273 (279)
T ss_dssp CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC--
T ss_pred CCcccccHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHHhccC
Confidence 23455678899999999999999999999999999998876543
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-40 Score=372.22 Aligned_cols=250 Identities=23% Similarity=0.328 Sum_probs=204.4
Q ss_pred HHcCCCCCceeeeeCCeEEEEEEEC-CCcEEEEEEeccC---ChhcHHHHHHHHHHHHcc-CCCCcceEEEEEEeCCeEE
Q 002158 623 ATAYFSSSTQVGQGGYGKVYKGILS-DNTTVAIKRAEEG---SLQGQNEFLTEIKLLSRL-HHRNLVSLLGYCDEEGEQM 697 (958)
Q Consensus 623 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~ 697 (958)
..++|...+.||+|+||+||+|+++ +++.||||+++.. .....+.+.+|.++++.+ +||||+++++++.+.+..+
T Consensus 21 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~ 100 (353)
T 3txo_A 21 GIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLF 100 (353)
T ss_dssp --CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEE
T ss_pred chhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEEE
Confidence 3467888999999999999999986 6899999998753 223345688999999998 7999999999999999999
Q ss_pred EEEEecCCCCHHHHhccCCCCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEecCCCCeEEeeeeeecccc
Q 002158 698 LVYEFVPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSRLAP 777 (958)
Q Consensus 698 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~~~ 777 (958)
+||||+++|+|.+++.... .+++.++..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+++...
T Consensus 101 lv~E~~~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NILl~~~g~ikL~DFG~a~~~~ 175 (353)
T 3txo_A 101 FVMEFVNGGDLMFHIQKSR--RFDEARARFYAAEIISALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCKEGI 175 (353)
T ss_dssp EEEECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCSC
T ss_pred EEEeCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC---CcccCCCHHHEEECCCCCEEEccccceeecc
Confidence 9999999999999997643 4899999999999999999999999 9999999999999999999999999997532
Q ss_pred cCCCCCCccceeeeeccCCCCccChhhhccCCCCCcchhhhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcCcchhhhc
Q 002158 778 VLDDEGTMPTHVSTIVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVLLELLTGMQPISHGKNIVREVNVARDSGMVFSIID 857 (958)
Q Consensus 778 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gv~l~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~i~ 857 (958)
.. .......+||+.|+|||++.+..++.++||||+||++|||++|+.||...... .......
T Consensus 176 ~~-------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~-~~~~~i~---------- 237 (353)
T 3txo_A 176 CN-------GVTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENED-DLFEAIL---------- 237 (353)
T ss_dssp C----------------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHH-HHHHHHH----------
T ss_pred cC-------CccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCHH-HHHHHHH----------
Confidence 11 12234567999999999999999999999999999999999999999754432 2221111
Q ss_pred ccCCCCChHHHHHHHHHHHHccccCCCCCCCH------HHHHHH
Q 002158 858 NRMGSYPSECVERFVTLALRCCHDKPEHRPSM------SDVVRE 895 (958)
Q Consensus 858 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~------~evl~~ 895 (958)
.....+|...+..+.+++.+|++.||.+||++ +|++++
T Consensus 238 ~~~~~~p~~~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~h 281 (353)
T 3txo_A 238 NDEVVYPTWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILRH 281 (353)
T ss_dssp HCCCCCCTTSCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHTS
T ss_pred cCCCCCCCCCCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhhC
Confidence 11223455567789999999999999999998 777764
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=363.45 Aligned_cols=261 Identities=30% Similarity=0.476 Sum_probs=219.5
Q ss_pred HHHcCCCCCceeeeeCCeEEEEEEEC-CCcEEEEEEeccCChhcHHHHHHHHHHHHccCCCCcceEEEEEEeCCeEEEEE
Q 002158 622 MATAYFSSSTQVGQGGYGKVYKGILS-DNTTVAIKRAEEGSLQGQNEFLTEIKLLSRLHHRNLVSLLGYCDEEGEQMLVY 700 (958)
Q Consensus 622 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~ 700 (958)
...++|...+.||+|+||+||+|.+. ++..||||++.... ...+.+.+|++++++++||||+++++++..++..++||
T Consensus 10 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 88 (288)
T 3kfa_A 10 MERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIIT 88 (288)
T ss_dssp CCGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCS-THHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEE
T ss_pred ccccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCH-HHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEEEEE
Confidence 34567888899999999999999987 48899999997643 34567999999999999999999999999999999999
Q ss_pred EecCCCCHHHHhccCCCCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEecCCCCeEEeeeeeecccccCC
Q 002158 701 EFVPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSRLAPVLD 780 (958)
Q Consensus 701 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~ 780 (958)
||+++++|.+++.......+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+++......
T Consensus 89 e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~ 165 (288)
T 3kfa_A 89 EFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT 165 (288)
T ss_dssp ECCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHHHT---CCCSCCSGGGEEECGGGCEEECCCCGGGTSCSSS
T ss_pred EcCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHHCC---ccCCCCCcceEEEcCCCCEEEccCccceeccCCc
Confidence 9999999999998766667999999999999999999999999 9999999999999999999999999998653211
Q ss_pred CCCCccceeeeeccCCCCccChhhhccCCCCCcchhhhHHHHHHHHHh-CCCCCCCCchhHHHHHHHhhcCcchhhhccc
Q 002158 781 DEGTMPTHVSTIVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVLLELLT-GMQPISHGKNIVREVNVARDSGMVFSIIDNR 859 (958)
Q Consensus 781 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gv~l~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~i~~~ 859 (958)
........||+.|+|||++.+..++.++||||||+++|||++ |..||........ ..... ...
T Consensus 166 ------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~~-~~~~~---------~~~ 229 (288)
T 3kfa_A 166 ------YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQV-YELLE---------KDY 229 (288)
T ss_dssp ------SEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGH-HHHHH---------TTC
T ss_pred ------cccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHH-HHHHh---------ccC
Confidence 222334557889999999999999999999999999999999 9999975432211 11111 111
Q ss_pred CCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHhh
Q 002158 860 MGSYPSECVERFVTLALRCCHDKPEHRPSMSDVVRELENILKM 902 (958)
Q Consensus 860 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~ 902 (958)
....+..++..+.+++.+|++.||.+||+++++++.|+.+...
T Consensus 230 ~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~~l~~~~~~ 272 (288)
T 3kfa_A 230 RMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQE 272 (288)
T ss_dssp CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CCCCCCCCCHHHHHHHHHHhCCChhhCcCHHHHHHHHHHHHHh
Confidence 1233556678899999999999999999999999999998764
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=371.81 Aligned_cols=266 Identities=24% Similarity=0.408 Sum_probs=215.9
Q ss_pred HHHHHcCCCCCceeeeeCCeEEEEEEECC-C-----cEEEEEEeccCC-hhcHHHHHHHHHHHHcc-CCCCcceEEEEEE
Q 002158 620 LAMATAYFSSSTQVGQGGYGKVYKGILSD-N-----TTVAIKRAEEGS-LQGQNEFLTEIKLLSRL-HHRNLVSLLGYCD 691 (958)
Q Consensus 620 l~~~~~~~~~~~~lg~G~~g~Vy~~~~~~-~-----~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~ 691 (958)
.+...++|...+.||+|+||+||+|.+.. + ..||||.+.... ....+.+.+|+++++++ +||||+++++++.
T Consensus 41 ~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~ 120 (333)
T 2i1m_A 41 WEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACT 120 (333)
T ss_dssp GBCCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred ccCCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEe
Confidence 44456778889999999999999999752 2 479999997653 34456799999999999 8999999999999
Q ss_pred eCCeEEEEEEecCCCCHHHHhccCC------------CCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEe
Q 002158 692 EEGEQMLVYEFVPNGTLRDWLSGRT------------KENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILL 759 (958)
Q Consensus 692 ~~~~~~lV~E~~~~gsL~~~l~~~~------------~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl 759 (958)
..+..++||||+++|+|.+++.... ...+++..+..++.|++.||+|||+++ |+||||||+|||+
T Consensus 121 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~NIl~ 197 (333)
T 2i1m_A 121 HGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKN---CIHRDVAARNVLL 197 (333)
T ss_dssp SSSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGCEE
T ss_pred cCCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCC---cccCCcccceEEE
Confidence 9999999999999999999997532 234789999999999999999999999 9999999999999
Q ss_pred cCCCCeEEeeeeeecccccCCCCCCccceeeeeccCCCCccChhhhccCCCCCcchhhhHHHHHHHHHh-CCCCCCCCch
Q 002158 760 DSNLNAKVADFGLSRLAPVLDDEGTMPTHVSTIVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVLLELLT-GMQPISHGKN 838 (958)
Q Consensus 760 ~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gv~l~ellt-G~~P~~~~~~ 838 (958)
+.++.+||+|||+++....... ........||+.|+|||++.+..++.++||||||+++|||+| |..||.....
T Consensus 198 ~~~~~~kl~Dfg~~~~~~~~~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~ 272 (333)
T 2i1m_A 198 TNGHVAKIGDFGLARDIMNDSN-----YIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILV 272 (333)
T ss_dssp EGGGEEEBCCCGGGCCGGGCTT-----SEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCS
T ss_pred CCCCeEEECccccccccccccc-----eeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccch
Confidence 9999999999999986533221 112233457889999999999999999999999999999999 9999975432
Q ss_pred hHHHHHHHhhcCcchhhhcccCCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHhh
Q 002158 839 IVREVNVARDSGMVFSIIDNRMGSYPSECVERFVTLALRCCHDKPEHRPSMSDVVRELENILKM 902 (958)
Q Consensus 839 ~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~ 902 (958)
.......... ......+..++..+.+++.+||+.||.+||++.|+++.|+++...
T Consensus 273 ~~~~~~~~~~---------~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~ 327 (333)
T 2i1m_A 273 NSKFYKLVKD---------GYQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQAQE 327 (333)
T ss_dssp SHHHHHHHHH---------TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred hHHHHHHHhc---------CCCCCCCCCCCHHHHHHHHHHhccChhhCcCHHHHHHHHHHHHHh
Confidence 2221111111 011123445567899999999999999999999999999987753
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-40 Score=371.65 Aligned_cols=252 Identities=19% Similarity=0.318 Sum_probs=210.1
Q ss_pred cCCCCCceeeeeCCeEEEEEEEC-CCcEEEEEEeccCChhcHHHHHHHHHHHHccCCCCcceEEEEEEeCCeEEEEEEec
Q 002158 625 AYFSSSTQVGQGGYGKVYKGILS-DNTTVAIKRAEEGSLQGQNEFLTEIKLLSRLHHRNLVSLLGYCDEEGEQMLVYEFV 703 (958)
Q Consensus 625 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E~~ 703 (958)
++|...+.||+|+||+||+|... +++.||+|++..........+.+|++++++++||||+++++++.+.+..++||||+
T Consensus 51 ~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E~~ 130 (387)
T 1kob_A 51 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFL 130 (387)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEECC
T ss_pred cceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEEcC
Confidence 57888899999999999999986 68999999998776666678999999999999999999999999999999999999
Q ss_pred CCCCHHHHhccCCCCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEecC--CCCeEEeeeeeecccccCCC
Q 002158 704 PNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDS--NLNAKVADFGLSRLAPVLDD 781 (958)
Q Consensus 704 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~--~~~~kl~DFGla~~~~~~~~ 781 (958)
++|+|.+++.... ..+++.++..++.|++.||+|||+.+ |+||||||+|||++. ++.+||+|||+++.....
T Consensus 131 ~gg~L~~~l~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~-- 204 (387)
T 1kob_A 131 SGGELFDRIAAED-YKMSEAEVINYMRQACEGLKHMHEHS---IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPD-- 204 (387)
T ss_dssp CCCBHHHHTTCTT-CCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTCCCEEECCCTTCEECCTT--
T ss_pred CCCcHHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccchHHeEEecCCCCceEEEecccceecCCC--
Confidence 9999999997543 35999999999999999999999999 999999999999974 477999999999865321
Q ss_pred CCCccceeeeeccCCCCccChhhhccCCCCCcchhhhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcCcchhhhcccCC
Q 002158 782 EGTMPTHVSTIVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVLLELLTGMQPISHGKNIVREVNVARDSGMVFSIIDNRMG 861 (958)
Q Consensus 782 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gv~l~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~i~~~~~ 861 (958)
.......||+.|+|||++.+..++.++|||||||++|||++|..||......... ......... ...
T Consensus 205 ------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~-~~i~~~~~~------~~~ 271 (387)
T 1kob_A 205 ------EIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETL-QNVKRCDWE------FDE 271 (387)
T ss_dssp ------SCEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHH-HHHHHCCCC------CCS
T ss_pred ------cceeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCHHHHH-HHHHhCCCC------CCc
Confidence 1123456999999999999999999999999999999999999999765433222 111111100 001
Q ss_pred CCChHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 002158 862 SYPSECVERFVTLALRCCHDKPEHRPSMSDVVRE 895 (958)
Q Consensus 862 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 895 (958)
.....++.++.+++.+||+.||++||+++|++++
T Consensus 272 ~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h 305 (387)
T 1kob_A 272 DAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEH 305 (387)
T ss_dssp STTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred cccccCCHHHHHHHHHHcCCChhHCcCHHHHhhC
Confidence 1223456789999999999999999999999974
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-40 Score=369.68 Aligned_cols=253 Identities=22% Similarity=0.317 Sum_probs=207.4
Q ss_pred HHcCCCCCceeeeeCCeEEEEEEEC-CCcEEEEEEeccCC--hhcHHHHHHHHHHHHccCCCCcceEEEEEEeCCeEEEE
Q 002158 623 ATAYFSSSTQVGQGGYGKVYKGILS-DNTTVAIKRAEEGS--LQGQNEFLTEIKLLSRLHHRNLVSLLGYCDEEGEQMLV 699 (958)
Q Consensus 623 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV 699 (958)
..++|...+.||+|+||.||+|.++ +++.||||++.... ....+.+.+|++++++++||||+++++++.+++..++|
T Consensus 27 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv 106 (362)
T 2bdw_A 27 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV 106 (362)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred cccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence 3567888999999999999999986 68999999997543 34456789999999999999999999999999999999
Q ss_pred EEecCCCCHHHHhccCCCCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEecCC---CCeEEeeeeeeccc
Q 002158 700 YEFVPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSN---LNAKVADFGLSRLA 776 (958)
Q Consensus 700 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~---~~~kl~DFGla~~~ 776 (958)
|||+++|+|.+++.... .+++.++..++.|+++||+|||+++ |+||||||+|||++.+ +.+||+|||+++..
T Consensus 107 ~e~~~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~al~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~ 181 (362)
T 2bdw_A 107 FDLVTGGELFEDIVARE--FYSEADASHCIQQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIEV 181 (362)
T ss_dssp ECCCCSCBHHHHHTTCS--CCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEESCSSTTCCEEECCCTTCBCC
T ss_pred EecCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCchHHEEEecCCCCCCEEEeecCcceEe
Confidence 99999999999997543 4899999999999999999999999 9999999999999865 45999999999865
Q ss_pred ccCCCCCCccceeeeeccCCCCccChhhhccCCCCCcchhhhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcCcchhhh
Q 002158 777 PVLDDEGTMPTHVSTIVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVLLELLTGMQPISHGKNIVREVNVARDSGMVFSII 856 (958)
Q Consensus 777 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gv~l~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~i 856 (958)
.... ......||+.|+|||++.+..++.++|||||||++|||++|..||.+...... ...........
T Consensus 182 ~~~~--------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~-~~~i~~~~~~~--- 249 (362)
T 2bdw_A 182 NDSE--------AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRL-YAQIKAGAYDY--- 249 (362)
T ss_dssp TTCC--------SCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH-HHHHHHTCCCC---
T ss_pred cCCc--------ccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHH-HHHHHhCCCCC---
Confidence 3211 12345699999999999999999999999999999999999999976543221 11111110000
Q ss_pred cccCCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 002158 857 DNRMGSYPSECVERFVTLALRCCHDKPEHRPSMSDVVRE 895 (958)
Q Consensus 857 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 895 (958)
.......++..+.+++.+||+.||++||++.|++++
T Consensus 250 ---~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 285 (362)
T 2bdw_A 250 ---PSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKV 285 (362)
T ss_dssp ---CTTGGGGSCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred ---CcccccCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 000112456789999999999999999999999875
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-40 Score=382.09 Aligned_cols=265 Identities=22% Similarity=0.279 Sum_probs=212.7
Q ss_pred cChHHHHHHHcCCCCCceeeeeCCeEEEEEEEC-CCcEEEEEEeccCCh---hcHHHHHHHHHHHHccCCCCcceEEEEE
Q 002158 615 FKFKELAMATAYFSSSTQVGQGGYGKVYKGILS-DNTTVAIKRAEEGSL---QGQNEFLTEIKLLSRLHHRNLVSLLGYC 690 (958)
Q Consensus 615 ~~~~el~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~H~niv~l~~~~ 690 (958)
.+++++....++|+..+.||+|+||+||+|+++ +++.||||++..... .....+.+|..+++.++||||+++++++
T Consensus 64 ~~~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~ 143 (437)
T 4aw2_A 64 SKVKQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAF 143 (437)
T ss_dssp HHHHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEE
T ss_pred chhhcccCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEE
Confidence 345666677789999999999999999999987 578999999865321 1123488999999999999999999999
Q ss_pred EeCCeEEEEEEecCCCCHHHHhccCCCCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEecCCCCeEEeee
Q 002158 691 DEEGEQMLVYEFVPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSNLNAKVADF 770 (958)
Q Consensus 691 ~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~~~~kl~DF 770 (958)
.+++..++||||+++|+|.+++.... ..+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+||
T Consensus 144 ~~~~~~~lV~Ey~~gg~L~~~l~~~~-~~l~e~~~~~~~~qi~~aL~~LH~~g---iiHrDLKp~NILl~~~g~vkL~DF 219 (437)
T 4aw2_A 144 QDDNNLYLVMDYYVGGDLLTLLSKFE-DRLPEEMARFYLAEMVIAIDSVHQLH---YVHRDIKPDNILMDMNGHIRLADF 219 (437)
T ss_dssp ECSSEEEEEECCCTTCBHHHHHHTTT-TCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCC
T ss_pred eeCCEEEEEEecCCCCcHHHHHHHcc-CCCCHHHHHHHHHHHHHHHHHHHhCC---eEecccCHHHeeEcCCCCEEEcch
Confidence 99999999999999999999997532 34999999999999999999999999 999999999999999999999999
Q ss_pred eeecccccCCCCCCccceeeeeccCCCCccChhhhc-----cCCCCCcchhhhHHHHHHHHHhCCCCCCCCchhHHHHHH
Q 002158 771 GLSRLAPVLDDEGTMPTHVSTIVKGTPGYLDPEYFL-----THKLTDKSDVYSLGVVLLELLTGMQPISHGKNIVREVNV 845 (958)
Q Consensus 771 Gla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DV~S~Gv~l~elltG~~P~~~~~~~~~~~~~ 845 (958)
|+|+...... ........||+.|+|||++. ...++.++|||||||++|||++|+.||............
T Consensus 220 Gla~~~~~~~------~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~i 293 (437)
T 4aw2_A 220 GSCLKLMEDG------TVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKI 293 (437)
T ss_dssp TTCEECCTTS------CEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHH
T ss_pred hhhhhcccCC------CcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhHHHHhh
Confidence 9997653211 12233467999999999997 457899999999999999999999999765432222111
Q ss_pred HhhcCcchhhhcccCCCCChHHHHHHHHHHHHccccCCCC--CCCHHHHHHH
Q 002158 846 ARDSGMVFSIIDNRMGSYPSECVERFVTLALRCCHDKPEH--RPSMSDVVRE 895 (958)
Q Consensus 846 ~~~~~~~~~~i~~~~~~~~~~~~~~l~~li~~cl~~dP~~--RPs~~evl~~ 895 (958)
..... ....+......+..+.+++.+|+..+|++ ||+++|++++
T Consensus 294 ~~~~~------~~~~p~~~~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~H 339 (437)
T 4aw2_A 294 MNHKE------RFQFPTQVTDVSENAKDLIRRLICSREHRLGQNGIEDFKKH 339 (437)
T ss_dssp HTHHH------HCCCCSSCCCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHTS
T ss_pred hhccc------cccCCcccccCCHHHHHHHHHHhcccccccCCCCHHHHhCC
Confidence 11000 00111222335678899999999888888 9999999875
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-40 Score=366.27 Aligned_cols=265 Identities=28% Similarity=0.433 Sum_probs=201.8
Q ss_pred HHHcCCCCCceeeeeCCeEEEEEEECC-C---cEEEEEEeccC--ChhcHHHHHHHHHHHHccCCCCcceEEEEEEeCCe
Q 002158 622 MATAYFSSSTQVGQGGYGKVYKGILSD-N---TTVAIKRAEEG--SLQGQNEFLTEIKLLSRLHHRNLVSLLGYCDEEGE 695 (958)
Q Consensus 622 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~-~---~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~ 695 (958)
...++|...+.||+|+||+||+|.+.. + ..||||++... .....+++.+|++++++++||||+++++++.....
T Consensus 20 i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 99 (323)
T 3qup_A 20 IPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRA 99 (323)
T ss_dssp CC---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC--
T ss_pred cChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeecccc
Confidence 345678889999999999999999754 3 27999998764 33445789999999999999999999999987765
Q ss_pred E------EEEEEecCCCCHHHHhccCC----CCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEecCCCCe
Q 002158 696 Q------MLVYEFVPNGTLRDWLSGRT----KENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSNLNA 765 (958)
Q Consensus 696 ~------~lV~E~~~~gsL~~~l~~~~----~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~~~~ 765 (958)
. ++||||+++|+|.+++.... ...+++.++..++.|+++||+|||+.+ |+||||||+|||++.++.+
T Consensus 100 ~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~---ivH~Dikp~NIli~~~~~~ 176 (323)
T 3qup_A 100 KGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRN---FIHRDLAARNCMLAEDMTV 176 (323)
T ss_dssp -----CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCE
T ss_pred ccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCC---cccCCCCcceEEEcCCCCE
Confidence 5 99999999999999996432 225899999999999999999999999 9999999999999999999
Q ss_pred EEeeeeeecccccCCCCCCccceeeeeccCCCCccChhhhccCCCCCcchhhhHHHHHHHHHh-CCCCCCCCchhHHHHH
Q 002158 766 KVADFGLSRLAPVLDDEGTMPTHVSTIVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVLLELLT-GMQPISHGKNIVREVN 844 (958)
Q Consensus 766 kl~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gv~l~ellt-G~~P~~~~~~~~~~~~ 844 (958)
||+|||+++....... ........+++.|+|||++.+..++.++|||||||++|||++ |+.||...........
T Consensus 177 kl~Dfg~a~~~~~~~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~ 251 (323)
T 3qup_A 177 CVADFGLSRKIYSGDY-----YRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNY 251 (323)
T ss_dssp EECCCCC----------------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHH
T ss_pred EEeecccccccccccc-----ccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChHHHHHH
Confidence 9999999986532211 112233457889999999999999999999999999999999 9999976443222111
Q ss_pred HHhhcCcchhhhcccCCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHhhCC
Q 002158 845 VARDSGMVFSIIDNRMGSYPSECVERFVTLALRCCHDKPEHRPSMSDVVRELENILKMFP 904 (958)
Q Consensus 845 ~~~~~~~~~~~i~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~~ 904 (958)
+........+..++..+.+++.+||+.||++||++.++++.|++++....
T Consensus 252 ----------~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~~~ 301 (323)
T 3qup_A 252 ----------LIGGNRLKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHLS 301 (323)
T ss_dssp ----------HHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC--
T ss_pred ----------HhcCCCCCCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHhh
Confidence 11112233455667889999999999999999999999999999987543
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-40 Score=364.15 Aligned_cols=262 Identities=25% Similarity=0.348 Sum_probs=200.9
Q ss_pred cCCCCCceeeeeCCeEEEEEEEC-CCcEEEEEEeccCCh---hcHHHHHHHHHHHHccCCCCcceEEEEEEeCCe----E
Q 002158 625 AYFSSSTQVGQGGYGKVYKGILS-DNTTVAIKRAEEGSL---QGQNEFLTEIKLLSRLHHRNLVSLLGYCDEEGE----Q 696 (958)
Q Consensus 625 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~----~ 696 (958)
++|...+.||+|+||+||+|.+. +++.||||++..... .....+.+|++++++++||||+++++++..... .
T Consensus 12 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~ 91 (311)
T 3ork_A 12 DRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLP 91 (311)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEEE
T ss_pred CcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCccc
Confidence 46788899999999999999974 789999999976532 334578999999999999999999999876543 4
Q ss_pred EEEEEecCCCCHHHHhccCCCCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEecCCCCeEEeeeeeeccc
Q 002158 697 MLVYEFVPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSRLA 776 (958)
Q Consensus 697 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~~ 776 (958)
++||||+++++|.++++... .+++.++..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+++..
T Consensus 92 ~lv~e~~~g~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~ 166 (311)
T 3ork_A 92 YIVMEYVDGVTLRDIVHTEG--PMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIARAI 166 (311)
T ss_dssp EEEEECCCEEEHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEETTSCEEECCCSCC---
T ss_pred EEEEecCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC---CCcCCCCHHHEEEcCCCCEEEeeccCcccc
Confidence 99999999999999997543 4899999999999999999999999 999999999999999999999999999865
Q ss_pred ccCCCCCCccceeeeeccCCCCccChhhhccCCCCCcchhhhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcCcchhhh
Q 002158 777 PVLDDEGTMPTHVSTIVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVLLELLTGMQPISHGKNIVREVNVARDSGMVFSII 856 (958)
Q Consensus 777 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gv~l~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~i 856 (958)
...... ........||+.|+|||++.+..++.++||||||+++|||++|+.||......................
T Consensus 167 ~~~~~~----~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~- 241 (311)
T 3ork_A 167 ADSGNS----VTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSA- 241 (311)
T ss_dssp -------------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCHHH-
T ss_pred cccccc----cccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCCccc-
Confidence 332211 122234569999999999999999999999999999999999999997655433222222211111100
Q ss_pred cccCCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHH-HHHHhHhh
Q 002158 857 DNRMGSYPSECVERFVTLALRCCHDKPEHRPSMSDVVR-ELENILKM 902 (958)
Q Consensus 857 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~-~L~~~~~~ 902 (958)
....++..+.+++.+||+.||++||++.+++. .+.+....
T Consensus 242 ------~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~~~ 282 (311)
T 3ork_A 242 ------RHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVHNG 282 (311)
T ss_dssp ------HSTTCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHHTT
T ss_pred ------ccCCCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHHHhcC
Confidence 01235678999999999999999997776654 45555433
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-40 Score=375.19 Aligned_cols=266 Identities=19% Similarity=0.261 Sum_probs=207.9
Q ss_pred cCCCCCceeeee--CCeEEEEEEEC-CCcEEEEEEeccC--ChhcHHHHHHHHHHHHccCCCCcceEEEEEEeCCeEEEE
Q 002158 625 AYFSSSTQVGQG--GYGKVYKGILS-DNTTVAIKRAEEG--SLQGQNEFLTEIKLLSRLHHRNLVSLLGYCDEEGEQMLV 699 (958)
Q Consensus 625 ~~~~~~~~lg~G--~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV 699 (958)
.+|+..+.||+| +||+||+|++. +++.||||++... .....+.+.+|++++++++||||+++++++..++..++|
T Consensus 25 ~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 104 (389)
T 3gni_B 25 GCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVV 104 (389)
T ss_dssp GGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred CcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEEEEE
Confidence 467788999999 99999999987 6999999998754 233456788999999999999999999999999999999
Q ss_pred EEecCCCCHHHHhccCCCCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEecCCCCeEEeeeeeecccccC
Q 002158 700 YEFVPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSRLAPVL 779 (958)
Q Consensus 700 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~~~~~ 779 (958)
|||+++|+|.+++.......+++..+..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||.+......
T Consensus 105 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~NIll~~~~~~kl~dfg~~~~~~~~ 181 (389)
T 3gni_B 105 TSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHMG---YVHRSVKASHILISVDGKVYLSGLRSNLSMISH 181 (389)
T ss_dssp EECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCGGGCEECEET
T ss_pred EEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEcccccceeeccc
Confidence 99999999999998765566999999999999999999999999 999999999999999999999999998654322
Q ss_pred CCCCCccceeeeeccCCCCccChhhhcc--CCCCCcchhhhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcCcchhhh-
Q 002158 780 DDEGTMPTHVSTIVKGTPGYLDPEYFLT--HKLTDKSDVYSLGVVLLELLTGMQPISHGKNIVREVNVARDSGMVFSII- 856 (958)
Q Consensus 780 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DV~S~Gv~l~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~i- 856 (958)
...............||+.|+|||++.+ ..++.++|||||||++|||++|+.||.+.............. .....
T Consensus 182 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~--~~~~~~ 259 (389)
T 3gni_B 182 GQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGT--VPCLLD 259 (389)
T ss_dssp TEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC------------
T ss_pred cccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCC--CCcccc
Confidence 2111111112223468999999999987 678999999999999999999999997644322221111000 00000
Q ss_pred ------------------------------------cccCCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 002158 857 ------------------------------------DNRMGSYPSECVERFVTLALRCCHDKPEHRPSMSDVVRE 895 (958)
Q Consensus 857 ------------------------------------~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 895 (958)
.......+..++..+.+++.+||+.||++|||++|++++
T Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~h 334 (389)
T 3gni_B 260 TSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNH 334 (389)
T ss_dssp ----------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTTS
T ss_pred ccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhcC
Confidence 000011233456779999999999999999999999975
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-40 Score=354.58 Aligned_cols=256 Identities=30% Similarity=0.483 Sum_probs=213.6
Q ss_pred cCCCCCceeeeeCCeEEEEEEECCCcEEEEEEeccCChhcHHHHHHHHHHHHccCCCCcceEEEEEEeCCeEEEEEEecC
Q 002158 625 AYFSSSTQVGQGGYGKVYKGILSDNTTVAIKRAEEGSLQGQNEFLTEIKLLSRLHHRNLVSLLGYCDEEGEQMLVYEFVP 704 (958)
Q Consensus 625 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E~~~ 704 (958)
++|...+.||+|+||.||+|.+.+++.||+|++..... ..+.+.+|++++++++||||+++++++..++..++||||++
T Consensus 8 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 86 (267)
T 3t9t_A 8 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAM-SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEFME 86 (267)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTTB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEECCCT
T ss_pred hheeeeeEecCCCceeEEEEEecCCCeEEEEEccccCC-CHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEeCCC
Confidence 46777889999999999999998889999999986533 34679999999999999999999999999999999999999
Q ss_pred CCCHHHHhccCCCCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEecCCCCeEEeeeeeecccccCCCCCC
Q 002158 705 NGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSRLAPVLDDEGT 784 (958)
Q Consensus 705 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 784 (958)
+++|.+++.... ..+++..+..++.|+++||+|||+.+ |+||||||+||+++.++.+||+|||+++......
T Consensus 87 ~~~L~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~---- 158 (267)
T 3t9t_A 87 HGCLSDYLRTQR-GLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ---- 158 (267)
T ss_dssp TCBHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHH----
T ss_pred CCcHHHHHhhCc-ccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCchheEEECCCCCEEEccccccccccccc----
Confidence 999999997643 34899999999999999999999999 9999999999999999999999999997642211
Q ss_pred ccceeeeeccCCCCccChhhhccCCCCCcchhhhHHHHHHHHHh-CCCCCCCCchhHHHHHHHhhcCcchhhhcccCCCC
Q 002158 785 MPTHVSTIVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVLLELLT-GMQPISHGKNIVREVNVARDSGMVFSIIDNRMGSY 863 (958)
Q Consensus 785 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gv~l~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~ 863 (958)
........|+..|+|||++.+..++.++||||||+++|||++ |+.||....... ....... ......
T Consensus 159 --~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~-~~~~i~~---------~~~~~~ 226 (267)
T 3t9t_A 159 --YTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSE-VVEDIST---------GFRLYK 226 (267)
T ss_dssp --HHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH-HHHHHHT---------TCCCCC
T ss_pred --ccccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCHHH-HHHHHhc---------CCcCCC
Confidence 111123457788999999999999999999999999999999 899997544322 1111111 111223
Q ss_pred ChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHh
Q 002158 864 PSECVERFVTLALRCCHDKPEHRPSMSDVVRELENILK 901 (958)
Q Consensus 864 ~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~ 901 (958)
+...+..+.+++.+||+.||++||++++++++|+++.+
T Consensus 227 ~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~ 264 (267)
T 3t9t_A 227 PRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAE 264 (267)
T ss_dssp CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CccCcHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 44556789999999999999999999999999999875
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-40 Score=369.82 Aligned_cols=274 Identities=27% Similarity=0.393 Sum_probs=214.9
Q ss_pred cCCCCCceeeeeCCeEEEEEEE-----CCCcEEEEEEeccCChhcHHHHHHHHHHHHccCCCCcceEEEEEE--eCCeEE
Q 002158 625 AYFSSSTQVGQGGYGKVYKGIL-----SDNTTVAIKRAEEGSLQGQNEFLTEIKLLSRLHHRNLVSLLGYCD--EEGEQM 697 (958)
Q Consensus 625 ~~~~~~~~lg~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~--~~~~~~ 697 (958)
++|...+.||+|+||.||+|++ .+++.||||++........+.+.+|++++++++||||+++++++. .....+
T Consensus 23 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 102 (327)
T 3lxl_A 23 RHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLR 102 (327)
T ss_dssp GGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCEEE
T ss_pred hhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCceEE
Confidence 4677788999999999999985 368899999998877777778999999999999999999999986 456789
Q ss_pred EEEEecCCCCHHHHhccCCCCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEecCCCCeEEeeeeeecccc
Q 002158 698 LVYEFVPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSRLAP 777 (958)
Q Consensus 698 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~~~ 777 (958)
+||||+++++|.+++.... ..+++.++..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+++...
T Consensus 103 lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~ 178 (327)
T 3lxl_A 103 LVMEYLPSGCLRDFLQRHR-ARLDASRLLLYSSQICKGMEYLGSRR---CVHRDLAARNILVESEAHVKIADFGLAKLLP 178 (327)
T ss_dssp EEEECCTTCBHHHHHHHHG-GGCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCGGGCEECC
T ss_pred EEEeecCCCCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCChhhEEECCCCCEEEcccccceecc
Confidence 9999999999999997533 24899999999999999999999999 9999999999999999999999999998653
Q ss_pred cCCCCCCccceeeeeccCCCCccChhhhccCCCCCcchhhhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhc----Ccch
Q 002158 778 VLDDEGTMPTHVSTIVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVLLELLTGMQPISHGKNIVREVNVARDS----GMVF 853 (958)
Q Consensus 778 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gv~l~elltG~~P~~~~~~~~~~~~~~~~~----~~~~ 853 (958)
.... .........||..|+|||++.+..++.++||||||+++|||++|+.||................ ....
T Consensus 179 ~~~~----~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (327)
T 3lxl_A 179 LDKD----YYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLL 254 (327)
T ss_dssp TTCS----EEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC----CCHHHHHH
T ss_pred cCCc----cceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhcccccccccHHHHH
Confidence 3221 1112233458888999999999999999999999999999999999986432211100000000 0011
Q ss_pred hhh-cccCCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHhhCCCC
Q 002158 854 SII-DNRMGSYPSECVERFVTLALRCCHDKPEHRPSMSDVVRELENILKMFPET 906 (958)
Q Consensus 854 ~~i-~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~~~~ 906 (958)
..+ .......+..++..+.+++.+||+.||++||+++|++++|+.+.......
T Consensus 255 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~~~~ 308 (327)
T 3lxl_A 255 ELLEEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWSGSRGC 308 (327)
T ss_dssp HHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC-------
T ss_pred HHhhcccCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhhhcCc
Confidence 111 12223446677889999999999999999999999999999987655433
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-40 Score=374.64 Aligned_cols=257 Identities=21% Similarity=0.311 Sum_probs=205.6
Q ss_pred cCCCCCceeeeeCCeEEEEEEEC-CCcEEEEEEeccCC---hhcHHHHHHHHHHHHcc-CCCCcceEEEEEEeCCeEEEE
Q 002158 625 AYFSSSTQVGQGGYGKVYKGILS-DNTTVAIKRAEEGS---LQGQNEFLTEIKLLSRL-HHRNLVSLLGYCDEEGEQMLV 699 (958)
Q Consensus 625 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lV 699 (958)
++|...+.||+|+||+||+|+++ +++.||||+++... ....+.+.+|..+++++ +||||+++++++.+++..++|
T Consensus 52 ~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~lV 131 (396)
T 4dc2_A 52 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFV 131 (396)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred hHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEEEE
Confidence 46888899999999999999987 58899999987542 22234578999999887 899999999999999999999
Q ss_pred EEecCCCCHHHHhccCCCCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEecCCCCeEEeeeeeecccccC
Q 002158 700 YEFVPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSRLAPVL 779 (958)
Q Consensus 700 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~~~~~ 779 (958)
|||+++|+|.+++.... .+++..+..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+++.....
T Consensus 132 ~E~~~gg~L~~~l~~~~--~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDLKp~NILl~~~g~ikL~DFGla~~~~~~ 206 (396)
T 4dc2_A 132 IEYVNGGDLMFHMQRQR--KLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRP 206 (396)
T ss_dssp EECCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCCCCT
T ss_pred EEcCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC---EEeccCCHHHEEECCCCCEEEeecceeeecccC
Confidence 99999999999997643 4999999999999999999999999 999999999999999999999999999753211
Q ss_pred CCCCCccceeeeeccCCCCccChhhhccCCCCCcchhhhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcCcchhhhccc
Q 002158 780 DDEGTMPTHVSTIVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVLLELLTGMQPISHGKNIVREVNVARDSGMVFSIIDNR 859 (958)
Q Consensus 780 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gv~l~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~i~~~ 859 (958)
.......+||+.|+|||++.+..++.++|||||||++|||++|+.||.......... ........+.+...
T Consensus 207 -------~~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~--~~~~~~~~~~i~~~ 277 (396)
T 4dc2_A 207 -------GDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPD--QNTEDYLFQVILEK 277 (396)
T ss_dssp -------TCCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC--------CCHHHHHHHHHHC
T ss_pred -------CCccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccc--hhhHHHHHHHHhcc
Confidence 122345679999999999999999999999999999999999999996322110000 00000111222222
Q ss_pred CCCCChHHHHHHHHHHHHccccCCCCCCCH------HHHHHH
Q 002158 860 MGSYPSECVERFVTLALRCCHDKPEHRPSM------SDVVRE 895 (958)
Q Consensus 860 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~------~evl~~ 895 (958)
...+|...+..+.+++.+||+.||++||++ +|++++
T Consensus 278 ~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~ei~~H 319 (396)
T 4dc2_A 278 QIRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGH 319 (396)
T ss_dssp CCCCCTTSCHHHHHHHHHHTCSCTTTSTTCSTTTHHHHHHHS
T ss_pred ccCCCCcCCHHHHHHHHHHhcCCHhHcCCCCCCCCHHHHhcC
Confidence 334566677889999999999999999985 566653
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-40 Score=361.34 Aligned_cols=259 Identities=25% Similarity=0.313 Sum_probs=201.7
Q ss_pred cCCCCCceeeeeCCeEEEEEEECCCcEEEEEEeccCCh--hcHHHHHHHHHHHHccCCCCcceEEEEEEeCCeEEEEEEe
Q 002158 625 AYFSSSTQVGQGGYGKVYKGILSDNTTVAIKRAEEGSL--QGQNEFLTEIKLLSRLHHRNLVSLLGYCDEEGEQMLVYEF 702 (958)
Q Consensus 625 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E~ 702 (958)
++|...+.||+|+||+||+|.+.+++.||||++..... ...+.+.+|++++++++||||+++++++.+++..++||||
T Consensus 21 ~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 100 (311)
T 3niz_A 21 EKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVFEF 100 (311)
T ss_dssp CEEEEEEEEEECSSCEEEEEEETTSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEEEEC
T ss_pred hhhHhhhhccCCCCeEEEEEEECCCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEEEcC
Confidence 56788899999999999999998899999999875422 2246788999999999999999999999999999999999
Q ss_pred cCCCCHHHHhccCCCCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEecCCCCeEEeeeeeecccccCCCC
Q 002158 703 VPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSRLAPVLDDE 782 (958)
Q Consensus 703 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~ 782 (958)
++ ++|.+++.... ..+++.++..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++......
T Consensus 101 ~~-~~l~~~~~~~~-~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~-- 173 (311)
T 3niz_A 101 ME-KDLKKVLDENK-TGLQDSQIKIYLYQLLRGVAHCHQHR---ILHRDLKPQNLLINSDGALKLADFGLARAFGIPV-- 173 (311)
T ss_dssp CS-EEHHHHHHTCT-TCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEETTSCC--
T ss_pred CC-CCHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCchHhEEECCCCCEEEccCcCceecCCCc--
Confidence 97 58888887543 34899999999999999999999999 9999999999999999999999999998653211
Q ss_pred CCccceeeeeccCCCCccChhhhcc-CCCCCcchhhhHHHHHHHHHhCCCCCCCCchhHHHHHHHh--hcCcc---hh--
Q 002158 783 GTMPTHVSTIVKGTPGYLDPEYFLT-HKLTDKSDVYSLGVVLLELLTGMQPISHGKNIVREVNVAR--DSGMV---FS-- 854 (958)
Q Consensus 783 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DV~S~Gv~l~elltG~~P~~~~~~~~~~~~~~~--~~~~~---~~-- 854 (958)
.......||+.|+|||++.+ ..++.++||||+||++|||++|+.||.............. ..... ..
T Consensus 174 -----~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 248 (311)
T 3niz_A 174 -----RSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQ 248 (311)
T ss_dssp -----C---CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHHHHHCCCCTTTSGGGT
T ss_pred -----ccccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHCCCChHHhhhhh
Confidence 11233468999999999976 5689999999999999999999999975443222111111 00000 00
Q ss_pred ----hhcccC---CC-----CChHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 002158 855 ----IIDNRM---GS-----YPSECVERFVTLALRCCHDKPEHRPSMSDVVRE 895 (958)
Q Consensus 855 ----~i~~~~---~~-----~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 895 (958)
...... .. ....++.++.+++.+||+.||++|||++|++++
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 301 (311)
T 3niz_A 249 ELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNH 301 (311)
T ss_dssp TSHHHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred ccchhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence 000000 00 112345678999999999999999999999974
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-40 Score=358.23 Aligned_cols=261 Identities=26% Similarity=0.494 Sum_probs=201.7
Q ss_pred HcCCCCCceeeeeCCeEEEEEEECCCcEEEEEEeccC--ChhcHHHHHHHHHHHHccCCCCcceEEEEEEeCCeEEEEEE
Q 002158 624 TAYFSSSTQVGQGGYGKVYKGILSDNTTVAIKRAEEG--SLQGQNEFLTEIKLLSRLHHRNLVSLLGYCDEEGEQMLVYE 701 (958)
Q Consensus 624 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E 701 (958)
..+|...+.||+|+||+||+|.+. ..||||+++.. .....+.|.+|++++++++||||+++++++. .+..++|||
T Consensus 23 ~~~y~~~~~lG~G~~g~Vy~~~~~--~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-~~~~~lv~e 99 (289)
T 3og7_A 23 DGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYST-APQLAIVTQ 99 (289)
T ss_dssp TTSCEEEEEEEECSSEEEEEEESS--SEEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEEE
T ss_pred ccceeeeeEecCCCCeEEEEEEEc--CceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeecc-CCccEEEEE
Confidence 457888899999999999999864 35999998754 3344567999999999999999999999764 557899999
Q ss_pred ecCCCCHHHHhccCCCCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEecCCCCeEEeeeeeecccccCCC
Q 002158 702 FVPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSRLAPVLDD 781 (958)
Q Consensus 702 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~ 781 (958)
|+++++|.+++.... ..+++.++..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+++.......
T Consensus 100 ~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~L~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 175 (289)
T 3og7_A 100 WCEGSSLYHHLHASE-TKFEMKKLIDIARQTARGMDYLHAKS---IIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSG 175 (289)
T ss_dssp CCCEEEHHHHHTTC----CCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTTEEEECCCC----------
T ss_pred ecCCCcHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHHhCC---cccccCccceEEECCCCCEEEccceeccccccccc
Confidence 999999999996543 45899999999999999999999999 99999999999999999999999999975532221
Q ss_pred CCCccceeeeeccCCCCccChhhhc---cCCCCCcchhhhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcCcchhhhcc
Q 002158 782 EGTMPTHVSTIVKGTPGYLDPEYFL---THKLTDKSDVYSLGVVLLELLTGMQPISHGKNIVREVNVARDSGMVFSIIDN 858 (958)
Q Consensus 782 ~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DV~S~Gv~l~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~i~~ 858 (958)
........||+.|+|||++. +..++.++||||||+++|||++|+.||.................. ..
T Consensus 176 -----~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~-----~~ 245 (289)
T 3og7_A 176 -----SHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSL-----SP 245 (289)
T ss_dssp -------------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHHHHHHHHHHTSC-----CC
T ss_pred -----cccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHHHHHHHhccccc-----Cc
Confidence 11223456999999999997 566888999999999999999999999765544333322222111 11
Q ss_pred cCCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHh
Q 002158 859 RMGSYPSECVERFVTLALRCCHDKPEHRPSMSDVVRELENILK 901 (958)
Q Consensus 859 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~ 901 (958)
........++..+.+++.+||+.||++||+++++++.|+++.+
T Consensus 246 ~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~l~~ 288 (289)
T 3og7_A 246 DLSKVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELAR 288 (289)
T ss_dssp CTTSSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC
T ss_pred chhhccccCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHhh
Confidence 1223345667889999999999999999999999999998764
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=401.81 Aligned_cols=337 Identities=23% Similarity=0.321 Sum_probs=249.0
Q ss_pred CCCHhHHHHHHHHHHHcccCccccCCCCCC------CCCCCCC------------CceeeCccccCCCceeeEEEEccCC
Q 002158 35 TTDPQEASALRAIKNSLVDSMNHLRNWNKG------DPCMSNW------------TGVLCFDTVETDGHLHVRELQLLSM 96 (958)
Q Consensus 35 ~~~~~~~~al~~~k~~~~~~~~~l~~W~~~------~~c~~~w------------~gV~C~~~~~~~~~~~v~~L~L~~~ 96 (958)
++..+|+.||++||+++.+| +|+.. ++|+|+| .||+|.. ..+|+.|+|.++
T Consensus 265 ~~~~~d~~ALl~~k~~l~~~-----~W~~~~~~~~~~~~~C~W~~~~~~~~w~~~~GV~C~~------~~~V~~L~Ls~~ 333 (876)
T 4ecn_A 265 AEYIKDYKALKAIWEALDGK-----NWRYYSGTINNTIHSLNWNFNKELDMWGDQPGVDLDN------NGRVTGLSLAGF 333 (876)
T ss_dssp CHHHHHHHHHHHHHHHTTGG-----GCCCCCSSCSSCCCCCSCCCSSCGGGTTCCTTEEECT------TSCEEEEECTTT
T ss_pred ccchHHHHHHHHHHHHcCCC-----CCCcCCCcccccCCccccccccccccccCcCceEecC------CCCEEEEECccC
Confidence 34568999999999999876 67643 4666899 9999964 358999999999
Q ss_pred cCCCCccccccCCCCcceeec-cCc-ccCC--------------------------------------------------
Q 002158 97 NLSGNLAPELGQLSRLQYYFM-WND-LTGT-------------------------------------------------- 124 (958)
Q Consensus 97 ~l~~~~~~~l~~L~~L~~L~l-~n~-~~~~-------------------------------------------------- 124 (958)
++.|.+|++|++|++|+.|++ ++| +.|.
T Consensus 334 ~L~G~ip~~l~~L~~L~~LdLss~N~lsG~~~~~~~~~~~~l~~~~l~~lr~~~~~~~l~~~~~~~~s~l~~~~l~~~~~ 413 (876)
T 4ecn_A 334 GAKGRVPDAIGQLTELKVLSFGTHSETVSGRLFGDEELTPDMSEERKHRIRMHYKKMFLDYDQRLNLSDLLQDAINRNPE 413 (876)
T ss_dssp CCEEEECGGGGGCTTCCEEESCCTTHHHHTTCBTTBCCCSSCCHHHHHHHHTHHHHHHTCCCGGGGSCHHHHHHHHTCTT
T ss_pred CCCCcCchHHhccccceEeeecccccccccccccccccccccchhHHHHHHHhhhhhhhccCcchhhhHHHHHHhhhCcc
Confidence 999999999999999999999 543 2222
Q ss_pred --------------------------CCccccCCCCCcEEEeeCCCCCC-----------------CCChhhc--CCCCC
Q 002158 125 --------------------------IPKEIGNISSLIFLLLNGNKLSG-----------------SLPDELG--YLSNL 159 (958)
Q Consensus 125 --------------------------ip~~i~~l~~L~~L~Ls~n~l~~-----------------~~p~~l~--~l~~L 159 (958)
+|..|+++++|++|+|++|.++| .+|..++ ++++|
T Consensus 414 ~~~i~~~~~l~l~~l~l~~~~N~L~~IP~~l~~L~~L~~L~Ls~N~Lsg~~i~~~~~~~s~n~~~g~iP~~l~f~~L~~L 493 (876)
T 4ecn_A 414 MKPIKKDSRISLKDTQIGNLTNRITFISKAIQRLTKLQIIYFANSPFTYDNIAVDWEDANSDYAKQYENEELSWSNLKDL 493 (876)
T ss_dssp SCCCCCCCCCCCCTTTTTCCSCEEEEECGGGGGCTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTSCCCGGGCTTC
T ss_pred ccccccccccchhhceeccccCcccchhHHHhcCCCCCEEECcCCcCCCCcccccccccccccccccCChhhhhccCCCC
Confidence 88899999999999999999998 3899987 99999
Q ss_pred CEEecccccccccCccccccccccceEeccccc-ccc-cCchhhcCCc-------cchhhhccCCccccCCCc--ccCCC
Q 002158 160 NRLQVDENNITGTIPKSFANLSRVRHLHLNNNS-IGG-QIPSELSKLS-------TLIHLLVDNNNLSGNLPP--ELSEL 228 (958)
Q Consensus 160 ~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~-l~~-~~p~~l~~l~-------~L~~L~L~~N~l~~~~~~--~l~~l 228 (958)
++|+|++|++.+.+|..|.++++|+.|+|++|+ +++ .+|..+..++ +|+.|+|++|+++ .+|. .+.++
T Consensus 494 ~~L~Ls~N~l~~~iP~~l~~L~~L~~L~Ls~N~~lsg~~iP~~i~~L~~~~~~l~~L~~L~Ls~N~L~-~ip~~~~l~~L 572 (876)
T 4ecn_A 494 TDVELYNCPNMTQLPDFLYDLPELQSLNIACNRGISAAQLKADWTRLADDEDTGPKIQIFYMGYNNLE-EFPASASLQKM 572 (876)
T ss_dssp CEEEEESCTTCCSCCGGGGGCSSCCEEECTTCTTSCHHHHHHHHHHHHHCTTTTTTCCEEECCSSCCC-BCCCHHHHTTC
T ss_pred CEEECcCCCCCccChHHHhCCCCCCEEECcCCCCcccccchHHHHhhhhcccccCCccEEEeeCCcCC-ccCChhhhhcC
Confidence 999999999999999999999999999999998 888 7887776655 8999999999998 6777 88888
Q ss_pred CCccEEEccCCCCCCCCccccccCCCCCCEEEcccCCCCCCCCCCCCCCC-cCEEeccCCcCCCcCCCCCC-C--CCcCE
Q 002158 229 PQLCILQLDNNNFSASEIPATYGNFSKLVKLSLRNCNLQGAVPDLSRIPN-LYYLDLSWNHLTGSIPSKKL-S--ENVTT 304 (958)
Q Consensus 229 ~~L~~L~L~~N~l~~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~l~~l~~-L~~L~Ls~N~l~~~~~~~~~-~--~~L~~ 304 (958)
++|+.|+|++|+++ .+| .|+++++|+.|+|++|+++.++..+..+++ |+.|+|++|.++ .+|.... . ++|+.
T Consensus 573 ~~L~~L~Ls~N~l~--~lp-~~~~L~~L~~L~Ls~N~l~~lp~~l~~l~~~L~~L~Ls~N~L~-~lp~~~~~~~~~~L~~ 648 (876)
T 4ecn_A 573 VKLGLLDCVHNKVR--HLE-AFGTNVKLTDLKLDYNQIEEIPEDFCAFTDQVEGLGFSHNKLK-YIPNIFNAKSVYVMGS 648 (876)
T ss_dssp TTCCEEECTTSCCC--BCC-CCCTTSEESEEECCSSCCSCCCTTSCEECTTCCEEECCSSCCC-SCCSCCCTTCSSCEEE
T ss_pred CCCCEEECCCCCcc--cch-hhcCCCcceEEECcCCccccchHHHhhccccCCEEECcCCCCC-cCchhhhccccCCCCE
Confidence 99999999998886 567 788888888888888888855556777777 888888888877 4444322 2 23666
Q ss_pred EEccCCcCCCccc-----------------------------hhccCCCCCCeEeeecccCCCccchhhhccccc---Cc
Q 002158 305 IDLSDNYLNGSIL-----------------------------ESISNLPFLQTLSLENNFLTGSIPATIWQNKSF---ST 352 (958)
Q Consensus 305 L~Ls~N~l~~~~~-----------------------------~~~~~l~~L~~L~L~~N~l~~~ip~~l~~~~~~---~~ 352 (958)
|+|++|++++.+| ..+..+++|+.|+|++|+|+ .+|..++....- ..
T Consensus 649 L~Ls~N~l~g~ip~l~~~l~~~~~~~L~~L~Ls~N~L~~lp~~~~~~l~~L~~L~Ls~N~L~-~ip~~~~~~~~~~l~nl 727 (876)
T 4ecn_A 649 VDFSYNKIGSEGRNISCSMDDYKGINASTVTLSYNEIQKFPTELFATGSPISTIILSNNLMT-SIPENSLKPKDGNYKNT 727 (876)
T ss_dssp EECCSSCTTTTSSSCSSCTTTCCCCCEEEEECCSSCCCSCCHHHHHTTCCCSEEECCSCCCS-CCCTTSSSCTTSCCTTG
T ss_pred EECcCCcCCCccccchhhhccccCCCcCEEEccCCcCCccCHHHHccCCCCCEEECCCCcCC-ccChHHhcccccccccc
Confidence 6666666655433 22334444444444444444 444443332110 01
Q ss_pred cccceEeccCCCCCCCccCC---CCCCcceEEeCCCCCC
Q 002158 353 KARLKIDLRNNSFSNIVGDL---TLPNNVTLRLGGNPIC 388 (958)
Q Consensus 353 ~~l~~L~Ls~N~l~~l~~~~---~l~~L~~L~l~~N~l~ 388 (958)
+.|+.|+|++|+|+.++... .+++|+.|+|++|++.
T Consensus 728 ~~L~~L~Ls~N~L~~lp~~l~~~~l~~L~~L~Ls~N~L~ 766 (876)
T 4ecn_A 728 YLLTTIDLRFNKLTSLSDDFRATTLPYLSNMDVSYNCFS 766 (876)
T ss_dssp GGCCEEECCSSCCCCCCGGGSTTTCTTCCEEECCSSCCS
T ss_pred CCccEEECCCCCCccchHHhhhccCCCcCEEEeCCCCCC
Confidence 14445555555555554433 4555555555555554
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-40 Score=364.23 Aligned_cols=272 Identities=27% Similarity=0.447 Sum_probs=220.0
Q ss_pred cChHHHHHHHcCCCCCceeeeeCCeEEEEEEE------CCCcEEEEEEeccCC-hhcHHHHHHHHHHHHcc-CCCCcceE
Q 002158 615 FKFKELAMATAYFSSSTQVGQGGYGKVYKGIL------SDNTTVAIKRAEEGS-LQGQNEFLTEIKLLSRL-HHRNLVSL 686 (958)
Q Consensus 615 ~~~~el~~~~~~~~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l 686 (958)
+...+.....++|...+.||+|+||+||+|.+ .+++.||||++.... ....+.+.+|+++++++ +||||+++
T Consensus 17 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~ 96 (316)
T 2xir_A 17 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNL 96 (316)
T ss_dssp CCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred ccccceecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeE
Confidence 34445555677899999999999999999985 246899999997653 33456799999999999 79999999
Q ss_pred EEEEEeCC-eEEEEEEecCCCCHHHHhccCCC--------------CCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccC
Q 002158 687 LGYCDEEG-EQMLVYEFVPNGTLRDWLSGRTK--------------ENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRD 751 (958)
Q Consensus 687 ~~~~~~~~-~~~lV~E~~~~gsL~~~l~~~~~--------------~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~D 751 (958)
++++...+ ..++||||+++|+|.+++..... ..+++.++..++.|+++||+|||+.+ |+|||
T Consensus 97 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~d 173 (316)
T 2xir_A 97 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRD 173 (316)
T ss_dssp EEEECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTT---CCCSC
T ss_pred EEEEecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCC---ccccc
Confidence 99987754 58999999999999999976542 22899999999999999999999999 99999
Q ss_pred CCccceEecCCCCeEEeeeeeecccccCCCCCCccceeeeeccCCCCccChhhhccCCCCCcchhhhHHHHHHHHHh-CC
Q 002158 752 IKASNILLDSNLNAKVADFGLSRLAPVLDDEGTMPTHVSTIVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVLLELLT-GM 830 (958)
Q Consensus 752 ikp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gv~l~ellt-G~ 830 (958)
|||+||+++.++.+||+|||+++....... ........||+.|+|||++.+..++.++||||||+++|||++ |.
T Consensus 174 ikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-----~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~ 248 (316)
T 2xir_A 174 LAARNILLSEKNVVKICDFGLARDIYKDPD-----YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGA 248 (316)
T ss_dssp CSGGGEEECGGGCEEECCCGGGSCTTTCTT-----SEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSC
T ss_pred CccceEEECCCCCEEECCCccccccccCcc-----ceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCC
Confidence 999999999999999999999986532211 122234567899999999999999999999999999999998 99
Q ss_pred CCCCCCchhHHHHHHHhhcCcchhhhcccCCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHhhC
Q 002158 831 QPISHGKNIVREVNVARDSGMVFSIIDNRMGSYPSECVERFVTLALRCCHDKPEHRPSMSDVVRELENILKMF 903 (958)
Q Consensus 831 ~P~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~ 903 (958)
.||............... ......+..++..+.+++.+||+.||.+||++.|++++|+.+++..
T Consensus 249 ~p~~~~~~~~~~~~~~~~---------~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~ 312 (316)
T 2xir_A 249 SPYPGVKIDEEFCRRLKE---------GTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQAN 312 (316)
T ss_dssp CSSTTCCCSHHHHHHHHH---------TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred CCCcccchhHHHHHHhcc---------CccCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhhh
Confidence 999754422222211111 1112234456678999999999999999999999999999988653
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-40 Score=362.41 Aligned_cols=251 Identities=25% Similarity=0.433 Sum_probs=207.2
Q ss_pred cCCCCCceeeeeCCeEEEEEEECC-C-------cEEEEEEeccCChhcHHHHHHHHHHHHccCCCCcceEEEEEEeCCeE
Q 002158 625 AYFSSSTQVGQGGYGKVYKGILSD-N-------TTVAIKRAEEGSLQGQNEFLTEIKLLSRLHHRNLVSLLGYCDEEGEQ 696 (958)
Q Consensus 625 ~~~~~~~~lg~G~~g~Vy~~~~~~-~-------~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~ 696 (958)
++|...+.||+|+||+||+|.+.. + ..||+|++........+.+.+|++++++++||||+++++++..++..
T Consensus 8 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 87 (289)
T 4fvq_A 8 EDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGDEN 87 (289)
T ss_dssp GGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCTTCC
T ss_pred hHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeCCCC
Confidence 467778899999999999998753 3 57999999776666678899999999999999999999999999999
Q ss_pred EEEEEecCCCCHHHHhccCCCCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEecCCCC--------eEEe
Q 002158 697 MLVYEFVPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSNLN--------AKVA 768 (958)
Q Consensus 697 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~~~--------~kl~ 768 (958)
++||||+++|+|.+++.... ..+++..+..++.|+++||+|||+++ |+||||||+|||++.++. +||+
T Consensus 88 ~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~~~~~kl~ 163 (289)
T 4fvq_A 88 ILVQEFVKFGSLDTYLKKNK-NCINILWKLEVAKQLAAAMHFLEENT---LIHGNVCAKNILLIREEDRKTGNPPFIKLS 163 (289)
T ss_dssp EEEEECCTTCBHHHHHHHTG-GGCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEEECCBGGGTBCCEEEEC
T ss_pred EEEEECCCCCCHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHhhCC---eECCCcCcceEEEecCCcccccccceeeec
Confidence 99999999999999997643 34899999999999999999999999 999999999999998887 9999
Q ss_pred eeeeecccccCCCCCCccceeeeeccCCCCccChhhhcc-CCCCCcchhhhHHHHHHHHHhCCCCCCCCchhHHHHHHHh
Q 002158 769 DFGLSRLAPVLDDEGTMPTHVSTIVKGTPGYLDPEYFLT-HKLTDKSDVYSLGVVLLELLTGMQPISHGKNIVREVNVAR 847 (958)
Q Consensus 769 DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DV~S~Gv~l~elltG~~P~~~~~~~~~~~~~~~ 847 (958)
|||+++.... .....||+.|+|||++.+ ..++.++||||||+++|||++|..|+..............
T Consensus 164 Dfg~~~~~~~-----------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~~~~~~~ 232 (289)
T 4fvq_A 164 DPGISITVLP-----------KDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQFYE 232 (289)
T ss_dssp CCCSCTTTSC-----------HHHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHH
T ss_pred cCcccccccC-----------ccccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchHHHHHHhh
Confidence 9999864311 123458999999999987 6789999999999999999996555543333222222111
Q ss_pred hcCcchhhhcccCCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHh
Q 002158 848 DSGMVFSIIDNRMGSYPSECVERFVTLALRCCHDKPEHRPSMSDVVRELENILK 901 (958)
Q Consensus 848 ~~~~~~~~i~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~ 901 (958)
. ....+...+..+.+++.+||+.||++||+++|++++|+++..
T Consensus 233 ~-----------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~l~~ 275 (289)
T 4fvq_A 233 D-----------RHQLPAPKAAELANLINNCMDYEPDHRPSFRAIIRDLNSLFT 275 (289)
T ss_dssp T-----------TCCCCCCSSCTTHHHHHHHSCSSGGGSCCHHHHHHHHHTCC-
T ss_pred c-----------cCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcC
Confidence 1 112233345678999999999999999999999999998764
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-40 Score=362.34 Aligned_cols=256 Identities=23% Similarity=0.375 Sum_probs=201.5
Q ss_pred HcCCCCCceeeeeCCeEEEEEEECCCcEEEEEEeccCChhcHHHHHHHHHHHHc--cCCCCcceEEEEEEe----CCeEE
Q 002158 624 TAYFSSSTQVGQGGYGKVYKGILSDNTTVAIKRAEEGSLQGQNEFLTEIKLLSR--LHHRNLVSLLGYCDE----EGEQM 697 (958)
Q Consensus 624 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~--l~H~niv~l~~~~~~----~~~~~ 697 (958)
.++|...+.||+|+||+||+|.+ +++.||||++... ....+.+|.+++.. ++||||+++++++.. ....+
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~~ 82 (301)
T 3q4u_A 7 ARDITLLECVGKGRYGEVWRGSW-QGENVAVKIFSSR---DEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQLW 82 (301)
T ss_dssp GGGCEEEEEEEECSSEEEEEEEE-TTEEEEEEEECGG---GHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEEE
T ss_pred cCcEEEEEeeccCCCcEEEEEEE-CCEEEEEEEeccc---cchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCceeE
Confidence 35788889999999999999998 6899999998643 34566677777776 799999999999754 34689
Q ss_pred EEEEecCCCCHHHHhccCCCCCchHHHHHHHHHHHHHHHHHhh--------hcCCCCeeccCCCccceEecCCCCeEEee
Q 002158 698 LVYEFVPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLH--------TEAHPPVFHRDIKASNILLDSNLNAKVAD 769 (958)
Q Consensus 698 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH--------~~~~~~iiH~Dikp~NILl~~~~~~kl~D 769 (958)
+||||+++|+|.++++.. .+++..+.+++.|++.||+||| +.+ |+||||||+|||++.++.+||+|
T Consensus 83 lv~e~~~~g~L~~~l~~~---~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~---ivH~Dlkp~Nill~~~~~~kl~D 156 (301)
T 3q4u_A 83 LITHYHEMGSLYDYLQLT---TLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPA---IAHRDLKSKNILVKKNGQCCIAD 156 (301)
T ss_dssp EEECCCTTCBHHHHHTTC---CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCE---EECSCCCGGGEEECTTSCEEECC
T ss_pred EehhhccCCCHHHHHhhc---ccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCC---eecCCCChHhEEEcCCCCEEEee
Confidence 999999999999999643 4999999999999999999999 777 99999999999999999999999
Q ss_pred eeeecccccCCCCCCccceeeeeccCCCCccChhhhccC------CCCCcchhhhHHHHHHHHHhC----------CCCC
Q 002158 770 FGLSRLAPVLDDEGTMPTHVSTIVKGTPGYLDPEYFLTH------KLTDKSDVYSLGVVLLELLTG----------MQPI 833 (958)
Q Consensus 770 FGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~------~~~~~~DV~S~Gv~l~elltG----------~~P~ 833 (958)
||+++........ .........||+.|+|||++.+. .++.++|||||||++|||++| +.||
T Consensus 157 fg~a~~~~~~~~~---~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf 233 (301)
T 3q4u_A 157 LGLAVMHSQSTNQ---LDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPF 233 (301)
T ss_dssp CTTCEEEETTTTE---EECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTT
T ss_pred CCCeeeccccccc---ccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccccc
Confidence 9999765332211 01112234699999999999876 455799999999999999999 7888
Q ss_pred CCCch---hHHHHHHHhhcCcchhhhcccCCC-----CChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHh
Q 002158 834 SHGKN---IVREVNVARDSGMVFSIIDNRMGS-----YPSECVERFVTLALRCCHDKPEHRPSMSDVVRELENI 899 (958)
Q Consensus 834 ~~~~~---~~~~~~~~~~~~~~~~~i~~~~~~-----~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 899 (958)
..... ........... ...... .+..++..+.+++.+||+.||++|||++|+++.|+++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~-------~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i 300 (301)
T 3q4u_A 234 YDVVPNDPSFEDMRKVVCV-------DQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKI 300 (301)
T ss_dssp TTTSCSSCCHHHHHHHHTT-------SCCCCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHH
T ss_pred cccCCCCcchhhhhHHHhc-------cCCCCCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHHhcc
Confidence 54221 11111111100 111111 2346788999999999999999999999999999875
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-40 Score=357.64 Aligned_cols=259 Identities=24% Similarity=0.327 Sum_probs=202.9
Q ss_pred cCCCCCceeeeeCCeEEEEEEECCCcEEEEEEeccCChh--cHHHHHHHHHHHHccCCCCcceEEEEEEeCCeEEEEEEe
Q 002158 625 AYFSSSTQVGQGGYGKVYKGILSDNTTVAIKRAEEGSLQ--GQNEFLTEIKLLSRLHHRNLVSLLGYCDEEGEQMLVYEF 702 (958)
Q Consensus 625 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E~ 702 (958)
++|...+.||+|+||+||+|.+.+++.||||++...... ..+.+.+|++++++++||||+++++++..++..++||||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (288)
T 1ob3_A 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (288)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred ccchhhhhcccCCCEEEEEEEcCCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEEe
Confidence 367788999999999999999988999999998754322 236788999999999999999999999999999999999
Q ss_pred cCCCCHHHHhccCCCCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEecCCCCeEEeeeeeecccccCCCC
Q 002158 703 VPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSRLAPVLDDE 782 (958)
Q Consensus 703 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~ 782 (958)
++ ++|.+++.... ..+++.++..++.|+++||+|||+++ |+||||||+||+++.++.+||+|||+++......
T Consensus 82 ~~-~~l~~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-- 154 (288)
T 1ob3_A 82 LD-QDLKKLLDVCE-GGLESVTAKSFLLQLLNGIAYCHDRR---VLHRDLKPQNLLINREGELKIADFGLARAFGIPV-- 154 (288)
T ss_dssp CS-EEHHHHHHTST-TCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCTTHHHHHCC----
T ss_pred cC-CCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEEeECccccccCccc--
Confidence 97 49999997543 34899999999999999999999999 9999999999999999999999999998653211
Q ss_pred CCccceeeeeccCCCCccChhhhccC-CCCCcchhhhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcCcc-----hh--
Q 002158 783 GTMPTHVSTIVKGTPGYLDPEYFLTH-KLTDKSDVYSLGVVLLELLTGMQPISHGKNIVREVNVARDSGMV-----FS-- 854 (958)
Q Consensus 783 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DV~S~Gv~l~elltG~~P~~~~~~~~~~~~~~~~~~~~-----~~-- 854 (958)
.......||+.|+|||++.+. .++.++||||+||++|||++|+.||................+.. ..
T Consensus 155 -----~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (288)
T 1ob3_A 155 -----RKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVT 229 (288)
T ss_dssp ------------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGG
T ss_pred -----cccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHCCCChhhchhhh
Confidence 112334689999999999764 58999999999999999999999997655433222221110000 00
Q ss_pred ---hhcccC--------CCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 002158 855 ---IIDNRM--------GSYPSECVERFVTLALRCCHDKPEHRPSMSDVVRE 895 (958)
Q Consensus 855 ---~i~~~~--------~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 895 (958)
..+... .......+..+.+++.+||+.||++|||++|++++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 281 (288)
T 1ob3_A 230 ELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEH 281 (288)
T ss_dssp GSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred cccccccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 000000 01123456788999999999999999999999864
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-40 Score=365.06 Aligned_cols=266 Identities=26% Similarity=0.509 Sum_probs=216.6
Q ss_pred HHcCCCCCceeeeeCCeEEEEEEEC--------CCcEEEEEEeccCC-hhcHHHHHHHHHHHHcc-CCCCcceEEEEEEe
Q 002158 623 ATAYFSSSTQVGQGGYGKVYKGILS--------DNTTVAIKRAEEGS-LQGQNEFLTEIKLLSRL-HHRNLVSLLGYCDE 692 (958)
Q Consensus 623 ~~~~~~~~~~lg~G~~g~Vy~~~~~--------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~ 692 (958)
..++|...+.||+|+||+||+|.+. ++..||||++.... ....+++.+|+++++++ +||||+++++++..
T Consensus 33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~ 112 (334)
T 2pvf_A 33 PRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ 112 (334)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred CHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEcc
Confidence 3467888899999999999999873 46789999997653 34456799999999999 89999999999999
Q ss_pred CCeEEEEEEecCCCCHHHHhccCCC--------------CCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceE
Q 002158 693 EGEQMLVYEFVPNGTLRDWLSGRTK--------------ENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNIL 758 (958)
Q Consensus 693 ~~~~~lV~E~~~~gsL~~~l~~~~~--------------~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NIL 758 (958)
.+..++||||+++|+|.+++..... ..+++.+++.++.|+++||+|||+.+ |+||||||+||+
T Consensus 113 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIl 189 (334)
T 2pvf_A 113 DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK---CIHRDLAARNVL 189 (334)
T ss_dssp SSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEE
T ss_pred CCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCccceEE
Confidence 9999999999999999999976432 24899999999999999999999999 999999999999
Q ss_pred ecCCCCeEEeeeeeecccccCCCCCCccceeeeeccCCCCccChhhhccCCCCCcchhhhHHHHHHHHHh-CCCCCCCCc
Q 002158 759 LDSNLNAKVADFGLSRLAPVLDDEGTMPTHVSTIVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVLLELLT-GMQPISHGK 837 (958)
Q Consensus 759 l~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gv~l~ellt-G~~P~~~~~ 837 (958)
++.++.+||+|||+++....... ........+|+.|+|||++.+..++.++||||||+++|||++ |..||....
T Consensus 190 l~~~~~~kL~Dfg~~~~~~~~~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~ 264 (334)
T 2pvf_A 190 VTENNVMKIADFGLARDINNIDY-----YKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIP 264 (334)
T ss_dssp ECTTCCEEECCCTTCEECTTTSS-----EECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred EcCCCCEEEcccccccccccccc-----ccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCC
Confidence 99999999999999986532211 112233457889999999999999999999999999999999 999997543
Q ss_pred hhHHHHHHHhhcCcchhhhcccCCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHhhCCCC
Q 002158 838 NIVREVNVARDSGMVFSIIDNRMGSYPSECVERFVTLALRCCHDKPEHRPSMSDVVRELENILKMFPET 906 (958)
Q Consensus 838 ~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~~~~ 906 (958)
. ......... ......+..++..+.+++.+||+.||.+||+++|+++.|++++...+..
T Consensus 265 ~-~~~~~~~~~---------~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~l~~~~~~~ 323 (334)
T 2pvf_A 265 V-EELFKLLKE---------GHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLTTNE 323 (334)
T ss_dssp H-HHHHHHHHH---------TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC--
T ss_pred H-HHHHHHHhc---------CCCCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhccccC
Confidence 2 221111111 1112334566788999999999999999999999999999998765543
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=363.73 Aligned_cols=261 Identities=29% Similarity=0.473 Sum_probs=207.1
Q ss_pred CCCCCceeeeeCCeEEEEEEECC-----CcEEEEEEeccCC-hhcHHHHHHHHHHHHccCCCCcceEEEEEEeCCeEEEE
Q 002158 626 YFSSSTQVGQGGYGKVYKGILSD-----NTTVAIKRAEEGS-LQGQNEFLTEIKLLSRLHHRNLVSLLGYCDEEGEQMLV 699 (958)
Q Consensus 626 ~~~~~~~lg~G~~g~Vy~~~~~~-----~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV 699 (958)
+|...+.||+|+||+||+|.+.. +..||||++.... ......+.+|++++++++||||+++++++...+..++|
T Consensus 45 ~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 124 (333)
T 1mqb_A 45 CVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMII 124 (333)
T ss_dssp TEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEE
T ss_pred HhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCCcEEE
Confidence 45567899999999999998753 2469999997653 34456799999999999999999999999999999999
Q ss_pred EEecCCCCHHHHhccCCCCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEecCCCCeEEeeeeeecccccC
Q 002158 700 YEFVPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSRLAPVL 779 (958)
Q Consensus 700 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~~~~~ 779 (958)
|||+++|+|.+++.... ..+++.+++.++.|+++||+|||+.+ |+||||||+||+++.++.+||+|||+++.....
T Consensus 125 ~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~~ 200 (333)
T 1mqb_A 125 TEYMENGALDKFLREKD-GEFSVLQLVGMLRGIAAGMKYLANMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDD 200 (333)
T ss_dssp EECCTTEEHHHHHHHTT-TCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC-------
T ss_pred EeCCCCCcHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChheEEECCCCcEEECCCCcchhhccc
Confidence 99999999999997543 35899999999999999999999999 999999999999999999999999999865322
Q ss_pred CCCCCccceeeeeccCCCCccChhhhccCCCCCcchhhhHHHHHHHHHh-CCCCCCCCchhHHHHHHHhhcCcchhhhcc
Q 002158 780 DDEGTMPTHVSTIVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVLLELLT-GMQPISHGKNIVREVNVARDSGMVFSIIDN 858 (958)
Q Consensus 780 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gv~l~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~i~~ 858 (958)
... ........+|+.|+|||++.+..++.++||||||+++|||++ |+.||....... ...... ..
T Consensus 201 ~~~----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~-~~~~~~---------~~ 266 (333)
T 1mqb_A 201 PEA----TYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHE-VMKAIN---------DG 266 (333)
T ss_dssp --------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH-HHHHHH---------TT
T ss_pred ccc----ccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCHHH-HHHHHH---------CC
Confidence 111 111223346788999999999999999999999999999999 999997544321 111111 11
Q ss_pred cCCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHhhCC
Q 002158 859 RMGSYPSECVERFVTLALRCCHDKPEHRPSMSDVVRELENILKMFP 904 (958)
Q Consensus 859 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~~ 904 (958)
.....+..++..+.+++.+||+.||++||++.++++.|+++.+...
T Consensus 267 ~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~~~ 312 (333)
T 1mqb_A 267 FRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAPD 312 (333)
T ss_dssp CCCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHSGG
T ss_pred CcCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhcch
Confidence 1122345667889999999999999999999999999999886543
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-39 Score=359.59 Aligned_cols=265 Identities=23% Similarity=0.297 Sum_probs=211.1
Q ss_pred cCCCCCceeeeeCCeEEEEEEEC-CCcEEEEEEeccCC-hhcHHHHHHHHHHHHccCCCCcceEEEEEEeCC--eEEEEE
Q 002158 625 AYFSSSTQVGQGGYGKVYKGILS-DNTTVAIKRAEEGS-LQGQNEFLTEIKLLSRLHHRNLVSLLGYCDEEG--EQMLVY 700 (958)
Q Consensus 625 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~--~~~lV~ 700 (958)
.+|...+.||+|+||+||+|.+. +++.||||++.... ....+.+.+|++++++++||||+++++++...+ ..++||
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~ 88 (319)
T 4euu_A 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIM 88 (319)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEE
T ss_pred CCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEEEE
Confidence 46778889999999999999987 58999999997543 334567889999999999999999999998765 789999
Q ss_pred EecCCCCHHHHhccCCC-CCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEe----cCCCCeEEeeeeeecc
Q 002158 701 EFVPNGTLRDWLSGRTK-ENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILL----DSNLNAKVADFGLSRL 775 (958)
Q Consensus 701 E~~~~gsL~~~l~~~~~-~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl----~~~~~~kl~DFGla~~ 775 (958)
||+++++|.+++..... ..+++.++..++.|++.||+|||+.+ |+||||||+|||+ +.++.+||+|||+++.
T Consensus 89 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~~ 165 (319)
T 4euu_A 89 EFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARE 165 (319)
T ss_dssp ECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEECTTSCEEEEECCCTTCEE
T ss_pred eCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEEeccCCCCceEEEccCCCcee
Confidence 99999999999976432 33899999999999999999999999 9999999999999 7888899999999986
Q ss_pred cccCCCCCCccceeeeeccCCCCccChhhhc--------cCCCCCcchhhhHHHHHHHHHhCCCCCCCCc---hhHHHHH
Q 002158 776 APVLDDEGTMPTHVSTIVKGTPGYLDPEYFL--------THKLTDKSDVYSLGVVLLELLTGMQPISHGK---NIVREVN 844 (958)
Q Consensus 776 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~--------~~~~~~~~DV~S~Gv~l~elltG~~P~~~~~---~~~~~~~ 844 (958)
..... ......||+.|+|||++. +..++.++|||||||++|||++|+.||.... .....+.
T Consensus 166 ~~~~~--------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~ 237 (319)
T 4euu_A 166 LEDDE--------QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMY 237 (319)
T ss_dssp CCTTC--------CBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHH
T ss_pred cCCCC--------ceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHH
Confidence 53321 122356999999999986 4678999999999999999999999996322 1111111
Q ss_pred HHhhcC---cchhh---------hc---ccCCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhH
Q 002158 845 VARDSG---MVFSI---------ID---NRMGSYPSECVERFVTLALRCCHDKPEHRPSMSDVVRELENIL 900 (958)
Q Consensus 845 ~~~~~~---~~~~~---------i~---~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~ 900 (958)
...... ..... .. +.....+...+..+.+++.+||+.||++||+++|++++..+..
T Consensus 238 ~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~d~~ 308 (319)
T 4euu_A 238 KIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDIL 308 (319)
T ss_dssp HHHHHCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHT
T ss_pred HHhcCCCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccHHHh
Confidence 111100 00000 00 0112345788999999999999999999999999999988743
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-40 Score=367.70 Aligned_cols=245 Identities=22% Similarity=0.293 Sum_probs=207.7
Q ss_pred cCCCCCceeeeeCCeEEEEEEEC-CCcEEEEEEeccCC---hhcHHHHHHHHHHHHccCCCCcceEEEEEEeCCeEEEEE
Q 002158 625 AYFSSSTQVGQGGYGKVYKGILS-DNTTVAIKRAEEGS---LQGQNEFLTEIKLLSRLHHRNLVSLLGYCDEEGEQMLVY 700 (958)
Q Consensus 625 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~ 700 (958)
++|...+.||+|+||+||+|++. +|+.||||++.... ....+.+.+|+++++.++||||+++++++.+.+..++||
T Consensus 41 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 120 (350)
T 1rdq_E 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM 120 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEE
Confidence 46778899999999999999986 68999999986532 233567889999999999999999999999999999999
Q ss_pred EecCCCCHHHHhccCCCCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEecCCCCeEEeeeeeecccccCC
Q 002158 701 EFVPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSRLAPVLD 780 (958)
Q Consensus 701 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~ 780 (958)
||+++|+|.+++.... .+++.++..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+++....
T Consensus 121 e~~~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~-- 193 (350)
T 1rdq_E 121 EYVAGGEMFSHLRRIG--RFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG-- 193 (350)
T ss_dssp ECCTTCBHHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECSS--
T ss_pred cCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC---cccccCccceEEECCCCCEEEcccccceeccC--
Confidence 9999999999997643 3899999999999999999999999 99999999999999999999999999986521
Q ss_pred CCCCccceeeeeccCCCCccChhhhccCCCCCcchhhhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcCcchhhhcccC
Q 002158 781 DEGTMPTHVSTIVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVLLELLTGMQPISHGKNIVREVNVARDSGMVFSIIDNRM 860 (958)
Q Consensus 781 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gv~l~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~i~~~~ 860 (958)
......||+.|+|||++.+..++.++|||||||++|||++|+.||....... ....... ..
T Consensus 194 --------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~-~~~~i~~----------~~ 254 (350)
T 1rdq_E 194 --------RTWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQ-IYEKIVS----------GK 254 (350)
T ss_dssp --------CBCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHHHHH----------CC
T ss_pred --------CcccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCHHH-HHHHHHc----------CC
Confidence 1223569999999999999999999999999999999999999997544322 2111111 11
Q ss_pred CCCChHHHHHHHHHHHHccccCCCCCCC-----HHHHHHH
Q 002158 861 GSYPSECVERFVTLALRCCHDKPEHRPS-----MSDVVRE 895 (958)
Q Consensus 861 ~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~evl~~ 895 (958)
..+|..++..+.+++.+||+.||.+||+ ++|++++
T Consensus 255 ~~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~h 294 (350)
T 1rdq_E 255 VRFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNH 294 (350)
T ss_dssp CCCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTS
T ss_pred CCCCCCCCHHHHHHHHHHhhcCHHhccCCccCCHHHHHhC
Confidence 2345566788999999999999999998 8888764
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-40 Score=363.31 Aligned_cols=271 Identities=26% Similarity=0.432 Sum_probs=214.4
Q ss_pred CCCCCceeeeeCCeEEEEEEEC-----CCcEEEEEEeccCC-hhcHHHHHHHHHHHHccCCCCcceEEEEEEeC--CeEE
Q 002158 626 YFSSSTQVGQGGYGKVYKGILS-----DNTTVAIKRAEEGS-LQGQNEFLTEIKLLSRLHHRNLVSLLGYCDEE--GEQM 697 (958)
Q Consensus 626 ~~~~~~~lg~G~~g~Vy~~~~~-----~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~--~~~~ 697 (958)
+|...+.||+|+||+||++.++ +++.||||++.... ....+.+.+|++++++++||||+++++++... ...+
T Consensus 32 ~~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 111 (318)
T 3lxp_A 32 YLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQ 111 (318)
T ss_dssp GEEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTEEE
T ss_pred HHhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCceEE
Confidence 3477889999999999998753 58899999998653 34456799999999999999999999999874 6789
Q ss_pred EEEEecCCCCHHHHhccCCCCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEecCCCCeEEeeeeeecccc
Q 002158 698 LVYEFVPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSRLAP 777 (958)
Q Consensus 698 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~~~ 777 (958)
+||||+++|+|.+++.... +++.+++.++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+++...
T Consensus 112 lv~e~~~~~~L~~~l~~~~---~~~~~~~~i~~~l~~~l~~LH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~ 185 (318)
T 3lxp_A 112 LVMEYVPLGSLRDYLPRHS---IGLAQLLLFAQQICEGMAYLHAQH---YIHRDLAARNVLLDNDRLVKIGDFGLAKAVP 185 (318)
T ss_dssp EEECCCTTCBHHHHGGGSC---CCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCGGGCEECC
T ss_pred EEEecccCCcHHHHHhhCC---CCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCchheEEEcCCCCEEECCcccccccc
Confidence 9999999999999997543 899999999999999999999999 9999999999999999999999999998653
Q ss_pred cCCCCCCccceeeeeccCCCCccChhhhccCCCCCcchhhhHHHHHHHHHhCCCCCCCCchhHHHHHHH----hhcCcch
Q 002158 778 VLDDEGTMPTHVSTIVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVLLELLTGMQPISHGKNIVREVNVA----RDSGMVF 853 (958)
Q Consensus 778 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gv~l~elltG~~P~~~~~~~~~~~~~~----~~~~~~~ 853 (958)
.... .........||..|+|||++.+..++.++||||||+++|||++|+.||............. .......
T Consensus 186 ~~~~----~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 261 (318)
T 3lxp_A 186 EGHE----YYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLT 261 (318)
T ss_dssp TTCS----EEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCHHHHHHHHH
T ss_pred cccc----ccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhhhhhcccccchhHHHHH
Confidence 3211 1122334568888999999999999999999999999999999999996432111100000 0000011
Q ss_pred hhhc-ccCCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHhhCCCC
Q 002158 854 SIID-NRMGSYPSECVERFVTLALRCCHDKPEHRPSMSDVVRELENILKMFPET 906 (958)
Q Consensus 854 ~~i~-~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~~~~ 906 (958)
+.+. ......+..++..+.+++.+||+.||++||+++|+++.|+.+.+.+...
T Consensus 262 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~~~~ 315 (318)
T 3lxp_A 262 ELLERGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVHEKYQGQ 315 (318)
T ss_dssp HHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHHC-
T ss_pred HHHhcccCCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHhhccC
Confidence 1111 1123445667889999999999999999999999999999998766543
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-40 Score=367.50 Aligned_cols=251 Identities=24% Similarity=0.350 Sum_probs=193.5
Q ss_pred HcCCCCCceeeeeCCeEEEEEEEC-CCcEEEEEEeccCChhcHHHHHHHHHHHHccCCCCcceEEEEEEeCCeEEEEEEe
Q 002158 624 TAYFSSSTQVGQGGYGKVYKGILS-DNTTVAIKRAEEGSLQGQNEFLTEIKLLSRLHHRNLVSLLGYCDEEGEQMLVYEF 702 (958)
Q Consensus 624 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E~ 702 (958)
.++|...+.||+|+||+||+|.+. +++.||||++.... ..+.+.+|++++++++||||+++++++...+..++||||
T Consensus 52 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 129 (349)
T 2w4o_A 52 SDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV--DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLEL 129 (349)
T ss_dssp GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC------------CHHHHHCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred cCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch--hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEEEEe
Confidence 457888899999999999999987 58899999997643 345688999999999999999999999999999999999
Q ss_pred cCCCCHHHHhccCCCCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEecC---CCCeEEeeeeeecccccC
Q 002158 703 VPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDS---NLNAKVADFGLSRLAPVL 779 (958)
Q Consensus 703 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~---~~~~kl~DFGla~~~~~~ 779 (958)
+++|+|.+++.... .+++.++..++.|+++||+|||+.+ |+||||||+|||++. ++.+||+|||+++.....
T Consensus 130 ~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~~~ 204 (349)
T 2w4o_A 130 VTGGELFDRIVEKG--YYSERDAADAVKQILEAVAYLHENG---IVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQ 204 (349)
T ss_dssp CCSCBHHHHHTTCS--SCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEESSSSTTCCEEECCCC--------
T ss_pred CCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCcccEEEecCCCCCCEEEccCccccccCcc
Confidence 99999999997543 4899999999999999999999999 999999999999975 889999999999864321
Q ss_pred CCCCCccceeeeeccCCCCccChhhhccCCCCCcchhhhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcCcchhhhccc
Q 002158 780 DDEGTMPTHVSTIVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVLLELLTGMQPISHGKNIVREVNVARDSGMVFSIIDNR 859 (958)
Q Consensus 780 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gv~l~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~i~~~ 859 (958)
.......||+.|+|||++.+..++.++|||||||++|||++|+.||................... .
T Consensus 205 --------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~i~~~~~~------~ 270 (349)
T 2w4o_A 205 --------VLMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRILNCEYY------F 270 (349)
T ss_dssp ----------------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHHHHHHHHTTCCC------C
T ss_pred --------cccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcccHHHHHHHHhCCCc------c
Confidence 11234569999999999999999999999999999999999999997654433222222111100 0
Q ss_pred CCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 002158 860 MGSYPSECVERFVTLALRCCHDKPEHRPSMSDVVRE 895 (958)
Q Consensus 860 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 895 (958)
........+..+.+++.+||+.||++||++.|++++
T Consensus 271 ~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 306 (349)
T 2w4o_A 271 ISPWWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQH 306 (349)
T ss_dssp CTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred CCchhhhCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 011223456789999999999999999999999874
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-39 Score=375.21 Aligned_cols=254 Identities=22% Similarity=0.301 Sum_probs=206.9
Q ss_pred HHcCCCCCceeeeeCCeEEEEEEEC-CCcEEEEEEeccCC--hhcHHHHHHHHHHHHccCCCCcceEEEEEEeCCeEEEE
Q 002158 623 ATAYFSSSTQVGQGGYGKVYKGILS-DNTTVAIKRAEEGS--LQGQNEFLTEIKLLSRLHHRNLVSLLGYCDEEGEQMLV 699 (958)
Q Consensus 623 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV 699 (958)
..++|...+.||+|+||+||+|... +|+.||+|++.... ....+.+.+|+++++.++||||+++++++.+++..++|
T Consensus 9 ~~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv 88 (444)
T 3soa_A 9 FTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLI 88 (444)
T ss_dssp HHHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEEE
T ss_pred ccCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEEE
Confidence 4567888999999999999999976 78999999987653 23345789999999999999999999999999999999
Q ss_pred EEecCCCCHHHHhccCCCCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEec---CCCCeEEeeeeeeccc
Q 002158 700 YEFVPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLD---SNLNAKVADFGLSRLA 776 (958)
Q Consensus 700 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~---~~~~~kl~DFGla~~~ 776 (958)
|||+++|+|.+++.... .+++..+..++.|++.||+|||+++ |+||||||+|||++ .++.+||+|||+++..
T Consensus 89 ~E~~~gg~L~~~i~~~~--~~~e~~~~~i~~qil~aL~~lH~~g---ivHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~ 163 (444)
T 3soa_A 89 FDLVTGGELFEDIVARE--YYSEADASHCIQQILEAVLHCHQMG---VVHRNLKPENLLLASKLKGAAVKLADFGLAIEV 163 (444)
T ss_dssp ECCCBCCBHHHHHHHCS--CCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSSTTEEESBSSTTCCEEECCCSSCBCC
T ss_pred EEeCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEeccCCCCcEEEccCceeEEe
Confidence 99999999999997654 4899999999999999999999999 99999999999998 4678999999999765
Q ss_pred ccCCCCCCccceeeeeccCCCCccChhhhccCCCCCcchhhhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcCcchhhh
Q 002158 777 PVLDDEGTMPTHVSTIVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVLLELLTGMQPISHGKNIVREVNVARDSGMVFSII 856 (958)
Q Consensus 777 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gv~l~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~i 856 (958)
.... .......||+.|+|||++.+..++.++||||+||++|||++|..||.+...... ...........
T Consensus 164 ~~~~-------~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~~~~-~~~i~~~~~~~--- 232 (444)
T 3soa_A 164 EGEQ-------QAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHRL-YQQIKAGAYDF--- 232 (444)
T ss_dssp CTTC-------CBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH-HHHHHHTCCCC---
T ss_pred cCCC-------ceeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccHHHH-HHHHHhCCCCC---
Confidence 3211 112345799999999999999999999999999999999999999976543222 11111111000
Q ss_pred cccCCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 002158 857 DNRMGSYPSECVERFVTLALRCCHDKPEHRPSMSDVVRE 895 (958)
Q Consensus 857 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 895 (958)
.......++..+.+++.+||+.||++||+++|++++
T Consensus 233 ---~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~L~h 268 (444)
T 3soa_A 233 ---PSPEWDTVTPEAKDLINKMLTINPSKRITAAEALKH 268 (444)
T ss_dssp ---CTTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred ---CccccccCCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence 001112456789999999999999999999999975
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-40 Score=369.19 Aligned_cols=246 Identities=25% Similarity=0.364 Sum_probs=205.2
Q ss_pred cCCCCCceeeeeCCeEEEEEEEC-CCcEEEEEEeccCC---hhcHHHHHHHHHHHHccCCCCcceEEEEEEeCCeEEEEE
Q 002158 625 AYFSSSTQVGQGGYGKVYKGILS-DNTTVAIKRAEEGS---LQGQNEFLTEIKLLSRLHHRNLVSLLGYCDEEGEQMLVY 700 (958)
Q Consensus 625 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~ 700 (958)
.+|...+.||+|+||+||+|.+. +++.||||++.... ......+.+|+++++.++||||+++++++..++..++||
T Consensus 9 ~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 88 (336)
T 3h4j_B 9 GPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMVI 88 (336)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred CCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 36777889999999999999974 78999999986432 122357889999999999999999999999999999999
Q ss_pred EecCCCCHHHHhccCCCCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEecCCCCeEEeeeeeecccccCC
Q 002158 701 EFVPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSRLAPVLD 780 (958)
Q Consensus 701 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~ 780 (958)
||+ +|+|.+++.... .+++.++..++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||+++......
T Consensus 89 E~~-~g~l~~~l~~~~--~l~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~~~ 162 (336)
T 3h4j_B 89 EYA-GGELFDYIVEKK--RMTEDEGRRFFQQIICAIEYCHRHK---IVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGN 162 (336)
T ss_dssp CCC-CEEHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHHT---CCCCCCSTTTEEECTTCCEEECCSSCTBTTTTSB
T ss_pred ECC-CCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCchhhEEEcCCCCEEEEEeccceeccCCc
Confidence 999 789999987544 4899999999999999999999999 9999999999999999999999999998653211
Q ss_pred CCCCccceeeeeccCCCCccChhhhccCCC-CCcchhhhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcCcchhhhccc
Q 002158 781 DEGTMPTHVSTIVKGTPGYLDPEYFLTHKL-TDKSDVYSLGVVLLELLTGMQPISHGKNIVREVNVARDSGMVFSIIDNR 859 (958)
Q Consensus 781 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DV~S~Gv~l~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~i~~~ 859 (958)
......||+.|+|||++.+..+ +.++||||+||++|||++|+.||.+... ......+...
T Consensus 163 --------~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~-----------~~~~~~i~~~ 223 (336)
T 3h4j_B 163 --------FLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFI-----------PNLFKKVNSC 223 (336)
T ss_dssp --------TTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSS-----------TTCBCCCCSS
T ss_pred --------ccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccH-----------HHHHHHHHcC
Confidence 1233569999999999988776 6799999999999999999999964321 1111222222
Q ss_pred CCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 002158 860 MGSYPSECVERFVTLALRCCHDKPEHRPSMSDVVRE 895 (958)
Q Consensus 860 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 895 (958)
....|...+..+.+++.+||+.||.+|||++|++++
T Consensus 224 ~~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~h 259 (336)
T 3h4j_B 224 VYVMPDFLSPGAQSLIRRMIVADPMQRITIQEIRRD 259 (336)
T ss_dssp CCCCCTTSCHHHHHHHHTTSCSSGGGSCCHHHHTTC
T ss_pred CCCCcccCCHHHHHHHHHHcCCChhHCcCHHHHHhC
Confidence 334466677889999999999999999999999975
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-40 Score=368.06 Aligned_cols=250 Identities=22% Similarity=0.294 Sum_probs=204.5
Q ss_pred HcCCCCCceeeeeCCeEEEEEEEC-CCcEEEEEEeccCC-----hhcHHHHHHHHHHHHccCCCCcceEEEEEEeCCeEE
Q 002158 624 TAYFSSSTQVGQGGYGKVYKGILS-DNTTVAIKRAEEGS-----LQGQNEFLTEIKLLSRLHHRNLVSLLGYCDEEGEQM 697 (958)
Q Consensus 624 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~ 697 (958)
.+.|...+.||+|+||+||+|.++ +++.||||++.... ....+.+.+|+++++.++||||+++++++..++..+
T Consensus 23 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~ 102 (351)
T 3c0i_A 23 EDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLY 102 (351)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred ccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence 346888899999999999999986 68999999985421 124567999999999999999999999999999999
Q ss_pred EEEEecCCCCHHHHhccCC--CCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEecCCCC---eEEeeeee
Q 002158 698 LVYEFVPNGTLRDWLSGRT--KENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSNLN---AKVADFGL 772 (958)
Q Consensus 698 lV~E~~~~gsL~~~l~~~~--~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~~~---~kl~DFGl 772 (958)
+||||+++++|.+++.... ...+++..+..++.|+++||+|||+++ |+||||||+|||++.++. +||+|||+
T Consensus 103 lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~ 179 (351)
T 3c0i_A 103 MVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNN---IIHRDVKPHCVLLASKENSAPVKLGGFGV 179 (351)
T ss_dssp EEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECSSSTTCCEEECCCTT
T ss_pred EEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCChHHeEEecCCCCCcEEEecCcc
Confidence 9999999999998886432 335899999999999999999999999 999999999999987655 99999999
Q ss_pred ecccccCCCCCCccceeeeeccCCCCccChhhhccCCCCCcchhhhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcCcc
Q 002158 773 SRLAPVLDDEGTMPTHVSTIVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVLLELLTGMQPISHGKNIVREVNVARDSGMV 852 (958)
Q Consensus 773 a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gv~l~elltG~~P~~~~~~~~~~~~~~~~~~~~ 852 (958)
++...... .......||+.|+|||++.+..++.++|||||||++|||++|+.||..... .........
T Consensus 180 a~~~~~~~-------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~--~~~~~i~~~--- 247 (351)
T 3c0i_A 180 AIQLGESG-------LVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTKE--RLFEGIIKG--- 247 (351)
T ss_dssp CEECCTTS-------CBCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSHH--HHHHHHHHT---
T ss_pred eeEecCCC-------eeecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcHH--HHHHHHHcC---
Confidence 98653211 112345699999999999999999999999999999999999999976432 111111110
Q ss_pred hhhhcccCCCCC----hHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 002158 853 FSIIDNRMGSYP----SECVERFVTLALRCCHDKPEHRPSMSDVVRE 895 (958)
Q Consensus 853 ~~~i~~~~~~~~----~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 895 (958)
.. ..+ ..++..+.+++.+||+.||++||++.|++++
T Consensus 248 ------~~-~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~h 287 (351)
T 3c0i_A 248 ------KY-KMNPRQWSHISESAKDLVRRMLMLDPAERITVYEALNH 287 (351)
T ss_dssp ------CC-CCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred ------CC-CCCccccccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 00 111 1345788999999999999999999999874
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-40 Score=361.86 Aligned_cols=269 Identities=26% Similarity=0.450 Sum_probs=210.5
Q ss_pred cCCCCCceeeeeCCeEEEEEEE-----CCCcEEEEEEeccCC-hhcHHHHHHHHHHHHccCCCCcceEEEEEEeC--CeE
Q 002158 625 AYFSSSTQVGQGGYGKVYKGIL-----SDNTTVAIKRAEEGS-LQGQNEFLTEIKLLSRLHHRNLVSLLGYCDEE--GEQ 696 (958)
Q Consensus 625 ~~~~~~~~lg~G~~g~Vy~~~~-----~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~--~~~ 696 (958)
.+|...+.||+|+||.||+|++ .+++.||||++.... ....+.+.+|++++++++||||+++++++... ...
T Consensus 21 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 100 (302)
T 4e5w_A 21 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI 100 (302)
T ss_dssp GGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---CCE
T ss_pred hhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCceE
Confidence 3577788999999999999984 368999999987543 33457799999999999999999999999876 678
Q ss_pred EEEEEecCCCCHHHHhccCCCCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEecCCCCeEEeeeeeeccc
Q 002158 697 MLVYEFVPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSRLA 776 (958)
Q Consensus 697 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~~ 776 (958)
++||||+++|+|.+++.... ..+++.++..++.|++.||+|||+++ |+||||||+||+++.++.+||+|||+++..
T Consensus 101 ~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~ 176 (302)
T 4e5w_A 101 KLIMEFLPSGSLKEYLPKNK-NKINLKQQLKYAVQICKGMDYLGSRQ---YVHRDLAARNVLVESEHQVKIGDFGLTKAI 176 (302)
T ss_dssp EEEEECCTTCBHHHHHHHHT-TTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCEEC
T ss_pred EEEEEeCCCCcHHHHHHhcc-ccCCHHHHHHHHHHHHHHHHHhhcCC---cccCCCchheEEEcCCCCEEECcccccccc
Confidence 99999999999999996543 34899999999999999999999999 999999999999999999999999999865
Q ss_pred ccCCCCCCccceeeeeccCCCCccChhhhccCCCCCcchhhhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcC----cc
Q 002158 777 PVLDDEGTMPTHVSTIVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVLLELLTGMQPISHGKNIVREVNVARDSG----MV 852 (958)
Q Consensus 777 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gv~l~elltG~~P~~~~~~~~~~~~~~~~~~----~~ 852 (958)
..... .........||..|+|||++.+..++.++||||+|+++|||++|..|+................. ..
T Consensus 177 ~~~~~----~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 252 (302)
T 4e5w_A 177 ETDKE----YYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRL 252 (302)
T ss_dssp CTTCC----EEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGGGHHHHH
T ss_pred cCCCc----ceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcccccCHHHH
Confidence 43221 11223345688889999999999999999999999999999999998743221111100000000 00
Q ss_pred hh-hhcccCCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHh
Q 002158 853 FS-IIDNRMGSYPSECVERFVTLALRCCHDKPEHRPSMSDVVRELENILK 901 (958)
Q Consensus 853 ~~-~i~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~ 901 (958)
.. .........+..++..+.+++.+||+.||.+|||++++++.|+++++
T Consensus 253 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ll~ 302 (302)
T 4e5w_A 253 VNTLKEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEALLK 302 (302)
T ss_dssp HHHHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHC
T ss_pred HHHHhccCCCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHhC
Confidence 01 11112233456677899999999999999999999999999998763
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-39 Score=356.08 Aligned_cols=253 Identities=34% Similarity=0.581 Sum_probs=205.1
Q ss_pred cCCCCCceeeeeCCeEEEEEEEC-CCcEEEEEEeccCChhc-------HHHHHHHHHHHHccCCCCcceEEEEEEeCCeE
Q 002158 625 AYFSSSTQVGQGGYGKVYKGILS-DNTTVAIKRAEEGSLQG-------QNEFLTEIKLLSRLHHRNLVSLLGYCDEEGEQ 696 (958)
Q Consensus 625 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~-------~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~ 696 (958)
++|...+.||+|+||+||+|.+. +++.||||++....... .+.+.+|++++++++||||+++++++.+..
T Consensus 19 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~-- 96 (287)
T 4f0f_A 19 NEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP-- 96 (287)
T ss_dssp TTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTT--
T ss_pred ccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCC--
Confidence 46777889999999999999985 78999999986543221 157899999999999999999999997654
Q ss_pred EEEEEecCCCCHHHHhccCCCCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEecCCCC-----eEEeeee
Q 002158 697 MLVYEFVPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSNLN-----AKVADFG 771 (958)
Q Consensus 697 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~~~-----~kl~DFG 771 (958)
++||||+++|+|.+++.... ..+++..+..++.|++.||+|||+++ ++|+||||||+||+++.++. +||+|||
T Consensus 97 ~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~l~~~l~~lH~~~-~~ivH~dikp~Nil~~~~~~~~~~~~kl~Dfg 174 (287)
T 4f0f_A 97 RMVMEFVPCGDLYHRLLDKA-HPIKWSVKLRLMLDIALGIEYMQNQN-PPIVHRDLRSPNIFLQSLDENAPVCAKVADFG 174 (287)
T ss_dssp EEEEECCTTCBHHHHHHCTT-SCCCHHHHHHHHHHHHHHHHHHHTSS-SCCBCSCCSGGGEEESCCCTTCSCCEEECCCT
T ss_pred eEEEEecCCCCHHHHHhccc-CCccHHHHHHHHHHHHHHHHHHHhCC-CCeecCCCCcceEEEeccCCCCceeEEeCCCC
Confidence 79999999999999987543 35999999999999999999999876 46999999999999988776 9999999
Q ss_pred eecccccCCCCCCccceeeeeccCCCCccChhhhc--cCCCCCcchhhhHHHHHHHHHhCCCCCCCCchhHHH-HHHHhh
Q 002158 772 LSRLAPVLDDEGTMPTHVSTIVKGTPGYLDPEYFL--THKLTDKSDVYSLGVVLLELLTGMQPISHGKNIVRE-VNVARD 848 (958)
Q Consensus 772 la~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~~DV~S~Gv~l~elltG~~P~~~~~~~~~~-~~~~~~ 848 (958)
+++... .......||+.|+|||++. ...++.++||||||+++|||++|+.||......... ......
T Consensus 175 ~~~~~~----------~~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~ 244 (287)
T 4f0f_A 175 LSQQSV----------HSVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIRE 244 (287)
T ss_dssp TCBCCS----------SCEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHHHHHHHHH
T ss_pred cccccc----------ccccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHHHHHHHhc
Confidence 987431 1233456999999999984 455788999999999999999999999754322111 111111
Q ss_pred cCcchhhhcccCCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHh
Q 002158 849 SGMVFSIIDNRMGSYPSECVERFVTLALRCCHDKPEHRPSMSDVVRELENI 899 (958)
Q Consensus 849 ~~~~~~~i~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 899 (958)
. ......+..++..+.+++.+||+.||++||+++|+++.|+++
T Consensus 245 ~--------~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~l 287 (287)
T 4f0f_A 245 E--------GLRPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSEL 287 (287)
T ss_dssp S--------CCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTC
T ss_pred c--------CCCCCCCcccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhC
Confidence 1 111234566778999999999999999999999999998763
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-40 Score=372.00 Aligned_cols=265 Identities=32% Similarity=0.511 Sum_probs=203.3
Q ss_pred CCCCCceeeeeCCeEEEEEEEC--CC--cEEEEEEeccC-ChhcHHHHHHHHHHHHccCCCCcceEEEEEEe-CCeEEEE
Q 002158 626 YFSSSTQVGQGGYGKVYKGILS--DN--TTVAIKRAEEG-SLQGQNEFLTEIKLLSRLHHRNLVSLLGYCDE-EGEQMLV 699 (958)
Q Consensus 626 ~~~~~~~lg~G~~g~Vy~~~~~--~~--~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~-~~~~~lV 699 (958)
.|...+.||+|+||+||+|.+. ++ ..||||.++.. .....++|.+|+.++++++||||+++++++.. ++..++|
T Consensus 90 ~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~lv 169 (373)
T 3c1x_A 90 IVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVV 169 (373)
T ss_dssp EEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEEE
T ss_pred eeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEEE
Confidence 3455678999999999999864 22 46899998754 33456789999999999999999999999754 5678999
Q ss_pred EEecCCCCHHHHhccCCCCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEecCCCCeEEeeeeeecccccC
Q 002158 700 YEFVPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSRLAPVL 779 (958)
Q Consensus 700 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~~~~~ 779 (958)
|||+++|+|.++++... ..+++.++..++.|+++||+|||+++ |+||||||+|||++.++.+||+|||+++.....
T Consensus 170 ~e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~ 245 (373)
T 3c1x_A 170 LPYMKHGDLRNFIRNET-HNPTVKDLIGFGLQVAKGMKFLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDMYDK 245 (373)
T ss_dssp EECCTTCBHHHHHHCTT-CCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC---------
T ss_pred EECCCCCCHHHHHhhcc-cCCCHHHHHHHHHHHHHHHHHHHHCC---EecCccchheEEECCCCCEEEeecccccccccc
Confidence 99999999999997543 34889999999999999999999999 999999999999999999999999999865322
Q ss_pred CCCCCccceeeeeccCCCCccChhhhccCCCCCcchhhhHHHHHHHHHh-CCCCCCCCchhHHHHHHHhhcCcchhhhcc
Q 002158 780 DDEGTMPTHVSTIVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVLLELLT-GMQPISHGKNIVREVNVARDSGMVFSIIDN 858 (958)
Q Consensus 780 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gv~l~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~i~~ 858 (958)
... .........||+.|+|||++.+..++.++||||||+++|||++ |..||........... . ...
T Consensus 246 ~~~---~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~~~~~-~---------~~~ 312 (373)
T 3c1x_A 246 EFD---SVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVY-L---------LQG 312 (373)
T ss_dssp ---------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSCHHHH-H---------HTT
T ss_pred ccc---cccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHHHHHH-H---------HcC
Confidence 111 1112234567889999999999999999999999999999999 6777764332111111 1 111
Q ss_pred cCCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHhhCCCCC
Q 002158 859 RMGSYPSECVERFVTLALRCCHDKPEHRPSMSDVVRELENILKMFPETD 907 (958)
Q Consensus 859 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~~~~~ 907 (958)
.....+..++..+.+++.+||+.||++||+++|+++.|+++...+....
T Consensus 313 ~~~~~p~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~i~~~~~~~~ 361 (373)
T 3c1x_A 313 RRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIGEH 361 (373)
T ss_dssp CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTCCSCC
T ss_pred CCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhccccc
Confidence 1223355677889999999999999999999999999999998777543
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-40 Score=365.88 Aligned_cols=257 Identities=21% Similarity=0.318 Sum_probs=206.1
Q ss_pred cCCCCCceeeeeCCeEEEEEEEC-CCcEEEEEEeccC---ChhcHHHHHHHHHHHHcc-CCCCcceEEEEEEeCCeEEEE
Q 002158 625 AYFSSSTQVGQGGYGKVYKGILS-DNTTVAIKRAEEG---SLQGQNEFLTEIKLLSRL-HHRNLVSLLGYCDEEGEQMLV 699 (958)
Q Consensus 625 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lV 699 (958)
++|...+.||+|+||+||+|+++ +++.||||++... .....+.+.+|..+++++ +||||+++++++.+.+..++|
T Consensus 9 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv 88 (345)
T 3a8x_A 9 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFV 88 (345)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEEE
Confidence 46778899999999999999986 5889999999754 233445688999999988 899999999999999999999
Q ss_pred EEecCCCCHHHHhccCCCCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEecCCCCeEEeeeeeecccccC
Q 002158 700 YEFVPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSRLAPVL 779 (958)
Q Consensus 700 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~~~~~ 779 (958)
|||+++|+|.+++.... .+++..+..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+++.....
T Consensus 89 ~e~~~gg~L~~~l~~~~--~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~~~ 163 (345)
T 3a8x_A 89 IEYVNGGDLMFHMQRQR--KLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRP 163 (345)
T ss_dssp ECCCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCGGGCBCSCCT
T ss_pred EeCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEECCCCCEEEEeccccccccCC
Confidence 99999999999997543 4899999999999999999999999 999999999999999999999999999753211
Q ss_pred CCCCCccceeeeeccCCCCccChhhhccCCCCCcchhhhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcCcchhhhccc
Q 002158 780 DDEGTMPTHVSTIVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVLLELLTGMQPISHGKNIVREVNVARDSGMVFSIIDNR 859 (958)
Q Consensus 780 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gv~l~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~i~~~ 859 (958)
. .......||+.|+|||++.+..++.++|||||||++|||++|+.||........... .......+.+...
T Consensus 164 ~-------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~--~~~~~~~~~i~~~ 234 (345)
T 3a8x_A 164 G-------DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQ--NTEDYLFQVILEK 234 (345)
T ss_dssp T-------CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC---------CHHHHHHHHHHC
T ss_pred C-------CcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCccccccccc--ccHHHHHHHHHcC
Confidence 1 123346799999999999999999999999999999999999999964211100000 0000011112222
Q ss_pred CCCCChHHHHHHHHHHHHccccCCCCCCCH------HHHHHH
Q 002158 860 MGSYPSECVERFVTLALRCCHDKPEHRPSM------SDVVRE 895 (958)
Q Consensus 860 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~------~evl~~ 895 (958)
...+|...+..+.+++.+||+.||++||++ +|++++
T Consensus 235 ~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~h 276 (345)
T 3a8x_A 235 QIRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGH 276 (345)
T ss_dssp CCCCCTTSCHHHHHHHHHHTCSSTTTSTTCCTTTHHHHHHTS
T ss_pred CCCCCCCCCHHHHHHHHHHhcCCHhHCCCCCCcCCHHHHhcC
Confidence 234456677889999999999999999995 566653
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-40 Score=367.35 Aligned_cols=258 Identities=26% Similarity=0.424 Sum_probs=206.0
Q ss_pred cCCCCCceeeeeCCeEEEEEEEC-CCcE----EEEEEeccCC-hhcHHHHHHHHHHHHccCCCCcceEEEEEEeCCeEEE
Q 002158 625 AYFSSSTQVGQGGYGKVYKGILS-DNTT----VAIKRAEEGS-LQGQNEFLTEIKLLSRLHHRNLVSLLGYCDEEGEQML 698 (958)
Q Consensus 625 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~----vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~l 698 (958)
++|...+.||+|+||+||+|.+. +++. ||+|.+.... ......+.+|+.++++++||||+++++++. ++..++
T Consensus 13 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~ 91 (325)
T 3kex_A 13 TELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-GSSLQL 91 (325)
T ss_dssp TTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-BSSEEE
T ss_pred hHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-CCccEE
Confidence 35777889999999999999975 3443 7888875432 223346788999999999999999999986 457899
Q ss_pred EEEecCCCCHHHHhccCCCCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEecCCCCeEEeeeeeeccccc
Q 002158 699 VYEFVPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSRLAPV 778 (958)
Q Consensus 699 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~~~~ 778 (958)
||||+++|+|.+++... ...+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++....
T Consensus 92 v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~ 167 (325)
T 3kex_A 92 VTQYLPLGSLLDHVRQH-RGALGPQLLLNWGVQIAKGMYYLEEHG---MVHRNLAARNVLLKSPSQVQVADFGVADLLPP 167 (325)
T ss_dssp EEECCTTCBSHHHHHSS-GGGSCTTHHHHHHHHHHHHHHHHHHTT---CCCSCCSSTTEEESSSSCEEECSCSGGGGSCC
T ss_pred EEEeCCCCCHHHHHHHc-cccCCHHHHHHHHHHHHHHHHHHHhCC---CCCCccchheEEECCCCeEEECCCCcccccCc
Confidence 99999999999999754 335899999999999999999999999 99999999999999999999999999987643
Q ss_pred CCCCCCccceeeeeccCCCCccChhhhccCCCCCcchhhhHHHHHHHHHh-CCCCCCCCchhHHHHHHHhhcCcchhhhc
Q 002158 779 LDDEGTMPTHVSTIVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVLLELLT-GMQPISHGKNIVREVNVARDSGMVFSIID 857 (958)
Q Consensus 779 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gv~l~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~i~ 857 (958)
... ........||..|+|||++.+..++.++||||||+++|||++ |+.||......... .....
T Consensus 168 ~~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~-~~~~~--------- 232 (325)
T 3kex_A 168 DDK-----QLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVP-DLLEK--------- 232 (325)
T ss_dssp CTT-----CCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTHHH-HHHHT---------
T ss_pred ccc-----cccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHHHHH-HHHHc---------
Confidence 222 112234568889999999999999999999999999999999 99999754322111 11111
Q ss_pred ccCCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHhh
Q 002158 858 NRMGSYPSECVERFVTLALRCCHDKPEHRPSMSDVVRELENILKM 902 (958)
Q Consensus 858 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~ 902 (958)
......+..++..+.+++.+||+.||.+||++++++++|+.+.+.
T Consensus 233 ~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~el~~~l~~~~~~ 277 (325)
T 3kex_A 233 GERLAQPQICTIDVYMVMVKCWMIDENIRPTFKELANEFTRMARD 277 (325)
T ss_dssp TCBCCCCTTBCTTTTHHHHHHTCSCTTTSCCHHHHHHHHHHHTTS
T ss_pred CCCCCCCCcCcHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence 111223445566789999999999999999999999999998643
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-39 Score=354.90 Aligned_cols=261 Identities=26% Similarity=0.435 Sum_probs=212.9
Q ss_pred CCCCCc-eeeeeCCeEEEEEEEC---CCcEEEEEEeccC-ChhcHHHHHHHHHHHHccCCCCcceEEEEEEeCCeEEEEE
Q 002158 626 YFSSST-QVGQGGYGKVYKGILS---DNTTVAIKRAEEG-SLQGQNEFLTEIKLLSRLHHRNLVSLLGYCDEEGEQMLVY 700 (958)
Q Consensus 626 ~~~~~~-~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~ 700 (958)
+|...+ .||+|+||.||+|.+. ++..||||+++.. .....+++.+|++++++++||||+++++++ ..+..++||
T Consensus 10 ~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~lv~ 88 (287)
T 1u59_A 10 NLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALMLVM 88 (287)
T ss_dssp GEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESSSEEEEE
T ss_pred HhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCCCcEEEE
Confidence 344444 8999999999999864 5788999999875 344567799999999999999999999999 456799999
Q ss_pred EecCCCCHHHHhccCCCCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEecCCCCeEEeeeeeecccccCC
Q 002158 701 EFVPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSRLAPVLD 780 (958)
Q Consensus 701 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~ 780 (958)
||+++++|.+++... ...+++.++..++.|+++||+|||+.+ |+||||||+||+++.++.+||+|||+++......
T Consensus 89 e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~ 164 (287)
T 1u59_A 89 EMAGGGPLHKFLVGK-REEIPVSNVAELLHQVSMGMKYLEEKN---FVHRDLAARNVLLVNRHYAKISDFGLSKALGADD 164 (287)
T ss_dssp ECCTTEEHHHHHTTC-TTTSCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEEETTEEEECCCTTCEECTTCS
T ss_pred EeCCCCCHHHHHHhC-CccCCHHHHHHHHHHHHHHHHHHHHCC---EeeCCCchheEEEcCCCCEEECcccceeeeccCc
Confidence 999999999999744 345899999999999999999999999 9999999999999999999999999998653222
Q ss_pred CCCCccceeeeeccCCCCccChhhhccCCCCCcchhhhHHHHHHHHHh-CCCCCCCCchhHHHHHHHhhcCcchhhhccc
Q 002158 781 DEGTMPTHVSTIVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVLLELLT-GMQPISHGKNIVREVNVARDSGMVFSIIDNR 859 (958)
Q Consensus 781 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gv~l~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~i~~~ 859 (958)
.. ........||+.|+|||++.+..++.++||||||+++|||++ |+.||........ ..... ...
T Consensus 165 ~~----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~-~~~i~---------~~~ 230 (287)
T 1u59_A 165 SY----YTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEV-MAFIE---------QGK 230 (287)
T ss_dssp CE----ECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHH-HHHHH---------TTC
T ss_pred ce----eeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHH-HHHHh---------cCC
Confidence 11 111223457889999999998899999999999999999999 9999975443221 11111 111
Q ss_pred CCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHhhCCC
Q 002158 860 MGSYPSECVERFVTLALRCCHDKPEHRPSMSDVVRELENILKMFPE 905 (958)
Q Consensus 860 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~~~ 905 (958)
....+..++..+.+++.+||+.||++||++.+++++|+++......
T Consensus 231 ~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~~ 276 (287)
T 1u59_A 231 RMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLAS 276 (287)
T ss_dssp CCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHHHT
T ss_pred cCCCCCCcCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcCC
Confidence 2334566778999999999999999999999999999999866543
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-40 Score=368.09 Aligned_cols=250 Identities=25% Similarity=0.383 Sum_probs=207.4
Q ss_pred HHHcCCCCCceeeeeCCeEEEEEEEC-CCcEEEEEEeccCC---hhcHHHHHHHHHHHHcc-CCCCcceEEEEEEeCCeE
Q 002158 622 MATAYFSSSTQVGQGGYGKVYKGILS-DNTTVAIKRAEEGS---LQGQNEFLTEIKLLSRL-HHRNLVSLLGYCDEEGEQ 696 (958)
Q Consensus 622 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~ 696 (958)
...++|...+.||+|+||+||+|+++ +++.||||+++... ....+.+..|.++++.+ +||||+++++++.+.+..
T Consensus 14 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~~ 93 (345)
T 1xjd_A 14 LKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENL 93 (345)
T ss_dssp --CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEE
T ss_pred CChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCEE
Confidence 44567888999999999999999986 68999999997532 23355678899999987 899999999999999999
Q ss_pred EEEEEecCCCCHHHHhccCCCCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEecCCCCeEEeeeeeeccc
Q 002158 697 MLVYEFVPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSRLA 776 (958)
Q Consensus 697 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~~ 776 (958)
++||||+++|+|.+++.... .+++.++..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+++..
T Consensus 94 ~lv~E~~~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~ 168 (345)
T 1xjd_A 94 FFVMEYLNGGDLMYHIQSCH--KFDLSRATFYAAEIILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCKEN 168 (345)
T ss_dssp EEEEECCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCC
T ss_pred EEEEeCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCChhhEEECCCCCEEEeEChhhhhc
Confidence 99999999999999997543 4899999999999999999999999 999999999999999999999999999753
Q ss_pred ccCCCCCCccceeeeeccCCCCccChhhhccCCCCCcchhhhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcCcchhhh
Q 002158 777 PVLDDEGTMPTHVSTIVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVLLELLTGMQPISHGKNIVREVNVARDSGMVFSII 856 (958)
Q Consensus 777 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gv~l~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~i 856 (958)
.... .......||+.|+|||++.+..++.++||||+||++|||++|+.||...... .......
T Consensus 169 ~~~~-------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~-~~~~~i~--------- 231 (345)
T 1xjd_A 169 MLGD-------AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEE-ELFHSIR--------- 231 (345)
T ss_dssp CCTT-------CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-HHHHHHH---------
T ss_pred ccCC-------CcccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCHH-HHHHHHH---------
Confidence 2211 1233467999999999999999999999999999999999999999754432 2221111
Q ss_pred cccCCCCChHHHHHHHHHHHHccccCCCCCCCHH-HHHH
Q 002158 857 DNRMGSYPSECVERFVTLALRCCHDKPEHRPSMS-DVVR 894 (958)
Q Consensus 857 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~-evl~ 894 (958)
.....+|...+..+.+++.+||+.||++||++. ++.+
T Consensus 232 -~~~~~~p~~~s~~~~~li~~lL~~dp~~R~~~~~~i~~ 269 (345)
T 1xjd_A 232 -MDNPFYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQ 269 (345)
T ss_dssp -HCCCCCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGG
T ss_pred -hCCCCCCcccCHHHHHHHHHHhcCCHhHcCCChHHHHc
Confidence 111234555678899999999999999999997 6664
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-40 Score=370.04 Aligned_cols=271 Identities=20% Similarity=0.266 Sum_probs=215.7
Q ss_pred CCccccChHHHHHHHcCCCCCceeeeeCCeEEEEEEEC-CCcEEEEEEeccCChhcHHHHHHHHHHHHccC-----CCCc
Q 002158 610 DGVKGFKFKELAMATAYFSSSTQVGQGGYGKVYKGILS-DNTTVAIKRAEEGSLQGQNEFLTEIKLLSRLH-----HRNL 683 (958)
Q Consensus 610 ~~~~~~~~~el~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----H~ni 683 (958)
+....+++++.....++|...+.||+|+||+||+|.+. +++.||||++.. .....+.+..|+++++.++ ||||
T Consensus 20 ~~~~~~~~~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~-~~~~~~~~~~e~~~l~~l~~~~~~h~~i 98 (360)
T 3llt_A 20 DEIVHFSWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRN-IKKYTRSAKIEADILKKIQNDDINNNNI 98 (360)
T ss_dssp CGGGSCCCCTTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECS-CHHHHHHHHHHHHHHHHTCCCSTTGGGB
T ss_pred ccceeeeeecceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEecc-chhhhhhhHHHHHHHHHhcccCCCCCCe
Confidence 34566777777777889999999999999999999985 689999999975 3344566788999999996 9999
Q ss_pred ceEEEEEEeCCeEEEEEEecCCCCHHHHhccCCCCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEecC--
Q 002158 684 VSLLGYCDEEGEQMLVYEFVPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDS-- 761 (958)
Q Consensus 684 v~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~-- 761 (958)
+++++++...+..++||||+ +++|.+++.......+++.++..++.|++.||+|||+.+ |+||||||+|||++.
T Consensus 99 v~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~ 174 (360)
T 3llt_A 99 VKYHGKFMYYDHMCLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKMS---LTHTDLKPENILLDDPY 174 (360)
T ss_dssp CCEEEEEEETTEEEEEECCC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCTT
T ss_pred ecccceeeECCeeEEEEcCC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCcccEEEcccc
Confidence 99999999999999999999 999999998776666999999999999999999999999 999999999999975
Q ss_pred -----------------------CCCeEEeeeeeecccccCCCCCCccceeeeeccCCCCccChhhhccCCCCCcchhhh
Q 002158 762 -----------------------NLNAKVADFGLSRLAPVLDDEGTMPTHVSTIVKGTPGYLDPEYFLTHKLTDKSDVYS 818 (958)
Q Consensus 762 -----------------------~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S 818 (958)
++.+||+|||+++.... ......||+.|+|||++.+..++.++||||
T Consensus 175 ~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~----------~~~~~~gt~~y~aPE~~~~~~~~~~~Diws 244 (360)
T 3llt_A 175 FEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSD----------YHGSIINTRQYRAPEVILNLGWDVSSDMWS 244 (360)
T ss_dssp CCEEEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTS----------CCCSCCSCGGGCCHHHHTTCCCCTTHHHHH
T ss_pred ccccccchhcccccccccccccCCCCEEEEeccCceecCC----------CCcCccCcccccCcHHHcCCCCCCccchHH
Confidence 78999999999985422 112356899999999999999999999999
Q ss_pred HHHHHHHHHhCCCCCCCCchhHHHHHHHhhcCcch-hh------------hc-----ccCCCCC----------------
Q 002158 819 LGVVLLELLTGMQPISHGKNIVREVNVARDSGMVF-SI------------ID-----NRMGSYP---------------- 864 (958)
Q Consensus 819 ~Gv~l~elltG~~P~~~~~~~~~~~~~~~~~~~~~-~~------------i~-----~~~~~~~---------------- 864 (958)
|||++|||++|+.||................+... .. .. ...+...
T Consensus 245 lG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~ 324 (360)
T 3llt_A 245 FGCVLAELYTGSLLFRTHEHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLY 324 (360)
T ss_dssp HHHHHHHHHHSSCSCCCSSHHHHHHHHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHH
T ss_pred HHHHHHHHHHCCCCCCCCcHHHHHHHHHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhccccc
Confidence 99999999999999976543322111111000000 00 00 0000000
Q ss_pred -hHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 002158 865 -SECVERFVTLALRCCHDKPEHRPSMSDVVRE 895 (958)
Q Consensus 865 -~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 895 (958)
....+.+.+++.+||+.||++|||++|++++
T Consensus 325 ~~~~~~~l~~li~~~L~~dP~~Rpta~elL~h 356 (360)
T 3llt_A 325 KIIKHELFCDFLYSILQIDPTLRPSPAELLKH 356 (360)
T ss_dssp HHCCCHHHHHHHHHHCCSSGGGSCCHHHHTTS
T ss_pred ccchHHHHHHHHHHHhcCChhhCCCHHHHhcC
Confidence 0012567899999999999999999999863
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-40 Score=359.05 Aligned_cols=249 Identities=27% Similarity=0.384 Sum_probs=197.4
Q ss_pred cCCCCCceeeeeCCeEEEEEEEC-CCcEEEEEEeccCChh--------------------------cHHHHHHHHHHHHc
Q 002158 625 AYFSSSTQVGQGGYGKVYKGILS-DNTTVAIKRAEEGSLQ--------------------------GQNEFLTEIKLLSR 677 (958)
Q Consensus 625 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--------------------------~~~~~~~E~~~l~~ 677 (958)
++|...+.||+|+||.||+|.+. +++.||||++...... ..+.+.+|++++++
T Consensus 13 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~ 92 (298)
T 2zv2_A 13 NQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILKK 92 (298)
T ss_dssp TTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHHT
T ss_pred cceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHHh
Confidence 46778889999999999999976 6889999998654311 12468899999999
Q ss_pred cCCCCcceEEEEEEe--CCeEEEEEEecCCCCHHHHhccCCCCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCcc
Q 002158 678 LHHRNLVSLLGYCDE--EGEQMLVYEFVPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKAS 755 (958)
Q Consensus 678 l~H~niv~l~~~~~~--~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~ 755 (958)
++||||+++++++.. .+..++||||+++++|.+++.. ..+++.++..++.|+++||+|||+++ |+||||||+
T Consensus 93 l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~ 166 (298)
T 2zv2_A 93 LDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTL---KPLSEDQARFYFQDLIKGIEYLHYQK---IIHRDIKPS 166 (298)
T ss_dssp CCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSCS---SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGG
T ss_pred CCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHH
Confidence 999999999999986 5689999999999999887643 34899999999999999999999999 999999999
Q ss_pred ceEecCCCCeEEeeeeeecccccCCCCCCccceeeeeccCCCCccChhhhccCC---CCCcchhhhHHHHHHHHHhCCCC
Q 002158 756 NILLDSNLNAKVADFGLSRLAPVLDDEGTMPTHVSTIVKGTPGYLDPEYFLTHK---LTDKSDVYSLGVVLLELLTGMQP 832 (958)
Q Consensus 756 NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~~~DV~S~Gv~l~elltG~~P 832 (958)
|||++.++.+||+|||+++...... .......||+.|+|||++.+.. ++.++|||||||++|||++|+.|
T Consensus 167 Nil~~~~~~~kl~Dfg~~~~~~~~~-------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p 239 (298)
T 2zv2_A 167 NLLVGEDGHIKIADFGVSNEFKGSD-------ALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCP 239 (298)
T ss_dssp GEEECTTSCEEECCCTTCEECSSSS-------CEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCS
T ss_pred HEEECCCCCEEEecCCCcccccccc-------ccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCC
Confidence 9999999999999999998653211 1223456999999999997765 36789999999999999999999
Q ss_pred CCCCchhHHHHHHHhhcCcchhhhcccCCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 002158 833 ISHGKNIVREVNVARDSGMVFSIIDNRMGSYPSECVERFVTLALRCCHDKPEHRPSMSDVVRE 895 (958)
Q Consensus 833 ~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 895 (958)
|....... ........... ......++..+.+++.+||+.||++||+++|++++
T Consensus 240 f~~~~~~~-~~~~~~~~~~~--------~~~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~h 293 (298)
T 2zv2_A 240 FMDERIMC-LHSKIKSQALE--------FPDQPDIAEDLKDLITRMLDKNPESRIVVPEIKLH 293 (298)
T ss_dssp SCCSSHHH-HHHHHHHCCCC--------CCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTC
T ss_pred CCCccHHH-HHHHHhcccCC--------CCCccccCHHHHHHHHHHhhcChhhCCCHHHHhcC
Confidence 97544321 11111111000 01123456789999999999999999999999864
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-40 Score=370.29 Aligned_cols=247 Identities=26% Similarity=0.393 Sum_probs=205.8
Q ss_pred cCCCCCceeeeeCCeEEEEEEEC-CCcEEEEEEeccCC---hhcHHHHHHHHHHHHccCCCCcceEEEEEEeCCeEEEEE
Q 002158 625 AYFSSSTQVGQGGYGKVYKGILS-DNTTVAIKRAEEGS---LQGQNEFLTEIKLLSRLHHRNLVSLLGYCDEEGEQMLVY 700 (958)
Q Consensus 625 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~ 700 (958)
++|...+.||+|+||+||+|... +++.||+|++.... ....+.+.+|+++++.++||||+++++++.+.+..++||
T Consensus 15 ~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~ 94 (384)
T 4fr4_A 15 DHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMVV 94 (384)
T ss_dssp GGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEE
Confidence 46788899999999999999986 58899999986532 233567889999999999999999999999999999999
Q ss_pred EecCCCCHHHHhccCCCCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEecCCCCeEEeeeeeecccccCC
Q 002158 701 EFVPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSRLAPVLD 780 (958)
Q Consensus 701 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~ 780 (958)
||+++|+|.+++.... .+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 95 e~~~gg~L~~~l~~~~--~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~- 168 (384)
T 4fr4_A 95 DLLLGGDLRYHLQQNV--HFKEETVKLFICELVMALDYLQNQR---IIHRDMKPDNILLDEHGHVHITDFNIAAMLPRE- 168 (384)
T ss_dssp CCCTTEEHHHHHHTTC--CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECCTT-
T ss_pred ecCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCcHHHeEECCCCCEEEeccceeeeccCC-
Confidence 9999999999997543 4999999999999999999999999 999999999999999999999999999865321
Q ss_pred CCCCccceeeeeccCCCCccChhhhcc---CCCCCcchhhhHHHHHHHHHhCCCCCCCCch--hHHHHHHHhhcCcchhh
Q 002158 781 DEGTMPTHVSTIVKGTPGYLDPEYFLT---HKLTDKSDVYSLGVVLLELLTGMQPISHGKN--IVREVNVARDSGMVFSI 855 (958)
Q Consensus 781 ~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DV~S~Gv~l~elltG~~P~~~~~~--~~~~~~~~~~~~~~~~~ 855 (958)
.......||+.|+|||++.. ..++.++|||||||++|||++|+.||..... .......
T Consensus 169 -------~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~---------- 231 (384)
T 4fr4_A 169 -------TQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHT---------- 231 (384)
T ss_dssp -------CCBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHHH----------
T ss_pred -------CceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHHHH----------
Confidence 12234679999999999974 4588999999999999999999999974322 1111111
Q ss_pred hcccCCCCChHHHHHHHHHHHHccccCCCCCCC-HHHHHH
Q 002158 856 IDNRMGSYPSECVERFVTLALRCCHDKPEHRPS-MSDVVR 894 (958)
Q Consensus 856 i~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs-~~evl~ 894 (958)
+......+|..++..+.+++.+||+.||.+||+ ++++.+
T Consensus 232 ~~~~~~~~p~~~s~~~~~li~~lL~~dP~~R~s~~~~l~~ 271 (384)
T 4fr4_A 232 FETTVVTYPSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQN 271 (384)
T ss_dssp HHHCCCCCCTTSCHHHHHHHHHHSCSSGGGSCCSHHHHHT
T ss_pred HhhcccCCCCcCCHHHHHHHHHHhcCCHhHhcccHHHHHc
Confidence 112223446667788999999999999999998 677664
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-39 Score=354.67 Aligned_cols=259 Identities=23% Similarity=0.349 Sum_probs=204.1
Q ss_pred cCCCCCceeeeeCCeEEEEEEEC-CCcEEEEEEeccCC--hhcHHHHHHHHHHHHccCCCCcceEEEEEEeCCeEEEEEE
Q 002158 625 AYFSSSTQVGQGGYGKVYKGILS-DNTTVAIKRAEEGS--LQGQNEFLTEIKLLSRLHHRNLVSLLGYCDEEGEQMLVYE 701 (958)
Q Consensus 625 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E 701 (958)
++|+..+.||+|+||+||+|.+. +++.||||++.... ....+.+.+|++++++++||||+++++++.+++..++|||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 81 (292)
T 3o0g_A 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEe
Confidence 36778899999999999999986 68999999987543 2334678899999999999999999999999999999999
Q ss_pred ecCCCCHHHHhccCCCCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEecCCCCeEEeeeeeecccccCCC
Q 002158 702 FVPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSRLAPVLDD 781 (958)
Q Consensus 702 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~ 781 (958)
|+++ ++.+++.... ..+++.++..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+++......
T Consensus 82 ~~~~-~l~~~~~~~~-~~l~~~~~~~~~~ql~~~l~~lH~~~---ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~- 155 (292)
T 3o0g_A 82 FCDQ-DLKKYFDSCN-GDLDPEIVKSFLFQLLKGLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLARAFGIPV- 155 (292)
T ss_dssp CCSE-EHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECCSCC-
T ss_pred cCCC-CHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeecccceecCCcc-
Confidence 9975 6666665433 34999999999999999999999999 9999999999999999999999999998653211
Q ss_pred CCCccceeeeeccCCCCccChhhhccCC-CCCcchhhhHHHHHHHHHhCCCCCCCCchhHHHHHHHhh-cCcc----hhh
Q 002158 782 EGTMPTHVSTIVKGTPGYLDPEYFLTHK-LTDKSDVYSLGVVLLELLTGMQPISHGKNIVREVNVARD-SGMV----FSI 855 (958)
Q Consensus 782 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DV~S~Gv~l~elltG~~P~~~~~~~~~~~~~~~~-~~~~----~~~ 855 (958)
.......||+.|+|||++.+.. ++.++||||+||++|||++|..||..+............ .+.. ...
T Consensus 156 ------~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~ 229 (292)
T 3o0g_A 156 ------RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPS 229 (292)
T ss_dssp ------SCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTT
T ss_pred ------ccccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhhhh
Confidence 1123356899999999998766 799999999999999999998887655544333322211 0000 000
Q ss_pred h--------------cccCCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 002158 856 I--------------DNRMGSYPSECVERFVTLALRCCHDKPEHRPSMSDVVRE 895 (958)
Q Consensus 856 i--------------~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 895 (958)
. ...........+..+.+++.+|++.||++|||++|++++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 283 (292)
T 3o0g_A 230 MTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQH 283 (292)
T ss_dssp GGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred hcccccccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhcC
Confidence 0 000111223466788999999999999999999999874
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-39 Score=361.59 Aligned_cols=248 Identities=21% Similarity=0.297 Sum_probs=198.6
Q ss_pred cCCCCCceeeeeCCeEEEEEEE----CCCcEEEEEEeccCC----hhcHHHHHHHHHHHHccCCCCcceEEEEEEeCCeE
Q 002158 625 AYFSSSTQVGQGGYGKVYKGIL----SDNTTVAIKRAEEGS----LQGQNEFLTEIKLLSRLHHRNLVSLLGYCDEEGEQ 696 (958)
Q Consensus 625 ~~~~~~~~lg~G~~g~Vy~~~~----~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~ 696 (958)
++|...+.||+|+||.||+|+. .+++.||+|+++... ......+.+|++++++++||||+++++++..++..
T Consensus 17 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 96 (327)
T 3a62_A 17 ECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGKL 96 (327)
T ss_dssp GGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSSCE
T ss_pred HHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCCEE
Confidence 5688889999999999999997 478999999997642 22345678999999999999999999999999999
Q ss_pred EEEEEecCCCCHHHHhccCCCCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEecCCCCeEEeeeeeeccc
Q 002158 697 MLVYEFVPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSRLA 776 (958)
Q Consensus 697 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~~ 776 (958)
++||||+++++|.+++.... .+++.++..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+++..
T Consensus 97 ~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~al~~lH~~~---ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~ 171 (327)
T 3a62_A 97 YLILEYLSGGELFMQLEREG--IFMEDTACFYLAEISMALGHLHQKG---IIYRDLKPENIMLNHQGHVKLTDFGLCKES 171 (327)
T ss_dssp EEEEECCTTEEHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCTTTEEECTTSCEEECCCSCC---
T ss_pred EEEEeCCCCCcHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCC---EEcccCCHHHeEECCCCcEEEEeCCccccc
Confidence 99999999999999997543 4889999999999999999999999 999999999999999999999999998753
Q ss_pred ccCCCCCCccceeeeeccCCCCccChhhhccCCCCCcchhhhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcCcchhhh
Q 002158 777 PVLDDEGTMPTHVSTIVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVLLELLTGMQPISHGKNIVREVNVARDSGMVFSII 856 (958)
Q Consensus 777 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gv~l~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~i 856 (958)
.... .......||+.|+|||++.+..++.++||||||+++|||++|+.||........ ......
T Consensus 172 ~~~~-------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~-~~~i~~-------- 235 (327)
T 3a62_A 172 IHDG-------TVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKT-IDKILK-------- 235 (327)
T ss_dssp --------------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH-HHHHHH--------
T ss_pred ccCC-------ccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCHHHH-HHHHHh--------
Confidence 2111 122345799999999999999999999999999999999999999975443221 111111
Q ss_pred cccCCCCChHHHHHHHHHHHHccccCCCCCC-----CHHHHHHH
Q 002158 857 DNRMGSYPSECVERFVTLALRCCHDKPEHRP-----SMSDVVRE 895 (958)
Q Consensus 857 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~~ 895 (958)
.....+...+..+.+++.+||+.||++|| +++|++++
T Consensus 236 --~~~~~p~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~h 277 (327)
T 3a62_A 236 --CKLNLPPYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQAH 277 (327)
T ss_dssp --TCCCCCTTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHHS
T ss_pred --CCCCCCCCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHcC
Confidence 11233555678899999999999999999 77888764
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-40 Score=370.76 Aligned_cols=271 Identities=15% Similarity=0.177 Sum_probs=212.2
Q ss_pred cCCCCCceeeeeCCeEEEEEEECC---------CcEEEEEEeccCChhcHHHHHHHHHHHHccCCCCcce----------
Q 002158 625 AYFSSSTQVGQGGYGKVYKGILSD---------NTTVAIKRAEEGSLQGQNEFLTEIKLLSRLHHRNLVS---------- 685 (958)
Q Consensus 625 ~~~~~~~~lg~G~~g~Vy~~~~~~---------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~---------- 685 (958)
++|...+.||+|+||+||+|.+.. ++.||||++... +.+.+|++++++++||||++
T Consensus 42 ~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 116 (352)
T 2jii_A 42 RQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-----GRLFNEQNFFQRAAKPLQVNKWKKLYSTPL 116 (352)
T ss_dssp CEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-----STHHHHHHHHHHHCCHHHHHHHHHHTTCTT
T ss_pred CeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-----chHHHHHHHHHHhcccchhhhhhhhccCCc
Confidence 578888999999999999999864 789999998754 35789999999999999987
Q ss_pred -----EEEEEEe-CCeEEEEEEecCCCCHHHHhccCCCCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEe
Q 002158 686 -----LLGYCDE-EGEQMLVYEFVPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILL 759 (958)
Q Consensus 686 -----l~~~~~~-~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl 759 (958)
+++++.. ++..++||||+ +++|.+++.......+++.++..++.|++.||+|||+++ |+||||||+|||+
T Consensus 117 ~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dikp~NIl~ 192 (352)
T 2jii_A 117 LAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHENE---YVHGNVTAENIFV 192 (352)
T ss_dssp CSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCCGGGEEE
T ss_pred cCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCHHHEEE
Confidence 6778776 67899999999 999999998764456999999999999999999999999 9999999999999
Q ss_pred cCCC--CeEEeeeeeecccccCCCCCCccceeeeeccCCCCccChhhhccCCCCCcchhhhHHHHHHHHHhCCCCCCCCc
Q 002158 760 DSNL--NAKVADFGLSRLAPVLDDEGTMPTHVSTIVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVLLELLTGMQPISHGK 837 (958)
Q Consensus 760 ~~~~--~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gv~l~elltG~~P~~~~~ 837 (958)
+.++ .+||+|||+++....................||+.|+|||++.+..++.++||||||+++|||++|+.||....
T Consensus 193 ~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~ 272 (352)
T 2jii_A 193 DPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWTNCL 272 (352)
T ss_dssp ETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGT
T ss_pred cCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCcccCC
Confidence 9998 89999999998764433221111222234579999999999999999999999999999999999999997543
Q ss_pred hhHHHHHHHhh--cCcchhhhcccCCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHhhCCCC
Q 002158 838 NIVREVNVARD--SGMVFSIIDNRMGSYPSECVERFVTLALRCCHDKPEHRPSMSDVVRELENILKMFPET 906 (958)
Q Consensus 838 ~~~~~~~~~~~--~~~~~~~i~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~~~~ 906 (958)
.....+..... ........... ......+..+.+++.+||+.||++||+++++++.|+++++.....
T Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~~~~ 341 (352)
T 2jii_A 273 PNTEDIMKQKQKFVDKPGPFVGPC--GHWIRPSETLQKYLKVVMALTYEEKPPYAMLRNNLEALLQDLRVS 341 (352)
T ss_dssp TCHHHHHHHHHHHHHSCCCEECTT--SCEECCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTTCC
T ss_pred cCHHHHHHHHHhccCChhhhhhhc--cccCCCcHHHHHHHHHHHhCChhhCCCHHHHHHHHHHHHHhcCCC
Confidence 11111111110 00000000000 001134678999999999999999999999999999999776543
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-39 Score=356.94 Aligned_cols=265 Identities=32% Similarity=0.511 Sum_probs=209.8
Q ss_pred cCCCCCceeeeeCCeEEEEEEECC----CcEEEEEEeccC-ChhcHHHHHHHHHHHHccCCCCcceEEEEEE-eCCeEEE
Q 002158 625 AYFSSSTQVGQGGYGKVYKGILSD----NTTVAIKRAEEG-SLQGQNEFLTEIKLLSRLHHRNLVSLLGYCD-EEGEQML 698 (958)
Q Consensus 625 ~~~~~~~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~-~~~~~~l 698 (958)
.+|...+.||+|+||+||+|.+.+ ...||||.+... .....+.+.+|++++++++||||+++++++. .++..++
T Consensus 25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 104 (298)
T 3f66_A 25 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLV 104 (298)
T ss_dssp EEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEE
T ss_pred eehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceEE
Confidence 356677899999999999999643 236899998764 3344567999999999999999999999964 4568899
Q ss_pred EEEecCCCCHHHHhccCCCCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEecCCCCeEEeeeeeeccccc
Q 002158 699 VYEFVPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSRLAPV 778 (958)
Q Consensus 699 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~~~~ 778 (958)
||||+++|+|.+++.... ..+++.++..++.|+++||+|||+++ |+||||||+||+++.++.+||+|||+++....
T Consensus 105 v~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~ql~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~~~ 180 (298)
T 3f66_A 105 VLPYMKHGDLRNFIRNET-HNPTVKDLIGFGLQVAKGMKYLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDMYD 180 (298)
T ss_dssp EEECCTTCBHHHHHHCTT-CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECSCGGGCCCSC
T ss_pred EEeCCCCCCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCchheEEECCCCCEEECcccccccccc
Confidence 999999999999997543 45899999999999999999999999 99999999999999999999999999986532
Q ss_pred CCCCCCccceeeeeccCCCCccChhhhccCCCCCcchhhhHHHHHHHHHh-CCCCCCCCchhHHHHHHHhhcCcchhhhc
Q 002158 779 LDDEGTMPTHVSTIVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVLLELLT-GMQPISHGKNIVREVNVARDSGMVFSIID 857 (958)
Q Consensus 779 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gv~l~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~i~ 857 (958)
... ..........||+.|+|||.+.+..++.++||||+|+++|||++ |.+||........... . ..
T Consensus 181 ~~~---~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~~~~-~---------~~ 247 (298)
T 3f66_A 181 KEY---YSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVY-L---------LQ 247 (298)
T ss_dssp GGG---CBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTTHHHH-H---------HT
T ss_pred cch---hccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHHHHHH-H---------hc
Confidence 221 11222334568889999999999999999999999999999999 5555543332211111 1 11
Q ss_pred ccCCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHhhCCCC
Q 002158 858 NRMGSYPSECVERFVTLALRCCHDKPEHRPSMSDVVRELENILKMFPET 906 (958)
Q Consensus 858 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~~~~ 906 (958)
......+..++..+.+++.+||+.||++||+++|+++.|+++.+.+...
T Consensus 248 ~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~~~~~ 296 (298)
T 3f66_A 248 GRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIGE 296 (298)
T ss_dssp TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTSCCS
T ss_pred CCCCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhccC
Confidence 1122234556778999999999999999999999999999999877654
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-39 Score=369.28 Aligned_cols=247 Identities=23% Similarity=0.322 Sum_probs=200.0
Q ss_pred CceeeeeCCeEEEEEEEC-CCcEEEEEEeccCChhcHHHHHHHHHHHHccCCCCcceEEEEEEeCCeEEEEEEecCCCCH
Q 002158 630 STQVGQGGYGKVYKGILS-DNTTVAIKRAEEGSLQGQNEFLTEIKLLSRLHHRNLVSLLGYCDEEGEQMLVYEFVPNGTL 708 (958)
Q Consensus 630 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E~~~~gsL 708 (958)
.+.||+|+||.||+|... +|+.||||+++.......+.+.+|++++++++||||+++++++...+..++||||+++++|
T Consensus 94 ~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~~~L 173 (373)
T 2x4f_A 94 TEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGEL 173 (373)
T ss_dssp EEECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTCEE
T ss_pred ceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCCcH
Confidence 467999999999999975 6899999999887666777899999999999999999999999999999999999999999
Q ss_pred HHHhccCCCCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEe--cCCCCeEEeeeeeecccccCCCCCCcc
Q 002158 709 RDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILL--DSNLNAKVADFGLSRLAPVLDDEGTMP 786 (958)
Q Consensus 709 ~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl--~~~~~~kl~DFGla~~~~~~~~~~~~~ 786 (958)
.+++.... ..+++..+..++.|+++||+|||+.+ |+||||||+|||+ +.++.+||+|||+++......
T Consensus 174 ~~~l~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~------ 243 (373)
T 2x4f_A 174 FDRIIDES-YNLTELDTILFMKQICEGIRHMHQMY---ILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPRE------ 243 (373)
T ss_dssp HHHHHHTG-GGCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTC------
T ss_pred HHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEEecCCCCcEEEEeCCCceecCCcc------
Confidence 99987543 34899999999999999999999999 9999999999999 567899999999998653221
Q ss_pred ceeeeeccCCCCccChhhhccCCCCCcchhhhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcCcchhhhcccCCCCChH
Q 002158 787 THVSTIVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVLLELLTGMQPISHGKNIVREVNVARDSGMVFSIIDNRMGSYPSE 866 (958)
Q Consensus 787 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gv~l~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~ 866 (958)
......||+.|+|||++.+..++.++|||||||++|||++|+.||................... . ......
T Consensus 244 --~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~---~----~~~~~~ 314 (373)
T 2x4f_A 244 --KLKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILACRWDL---E----DEEFQD 314 (373)
T ss_dssp --BCCCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCS---C----SGGGTT
T ss_pred --ccccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCC---C----hhhhcc
Confidence 1223469999999999998899999999999999999999999997654332221111110000 0 001123
Q ss_pred HHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 002158 867 CVERFVTLALRCCHDKPEHRPSMSDVVRE 895 (958)
Q Consensus 867 ~~~~l~~li~~cl~~dP~~RPs~~evl~~ 895 (958)
++.++.+++.+||+.||++||+++|++++
T Consensus 315 ~~~~~~~li~~~L~~dp~~Rps~~e~l~h 343 (373)
T 2x4f_A 315 ISEEAKEFISKLLIKEKSWRISASEALKH 343 (373)
T ss_dssp SCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred CCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 46788999999999999999999999974
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-40 Score=376.43 Aligned_cols=260 Identities=20% Similarity=0.284 Sum_probs=210.0
Q ss_pred hHHHHHHHcCCCCCceeeeeCCeEEEEEEEC-CCcEEEEEEeccCCh---hcHHHHHHHHHHHHccCCCCcceEEEEEEe
Q 002158 617 FKELAMATAYFSSSTQVGQGGYGKVYKGILS-DNTTVAIKRAEEGSL---QGQNEFLTEIKLLSRLHHRNLVSLLGYCDE 692 (958)
Q Consensus 617 ~~el~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~H~niv~l~~~~~~ 692 (958)
++++....++|...+.||+|+||+||+|+++ +++.||+|++..... ...+.+.+|+.+++.++||||+++++++.+
T Consensus 61 ~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~ 140 (410)
T 3v8s_A 61 IRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQD 140 (410)
T ss_dssp HHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred HHhcccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEE
Confidence 4455566788999999999999999999987 588999999865211 122357899999999999999999999999
Q ss_pred CCeEEEEEEecCCCCHHHHhccCCCCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEecCCCCeEEeeeee
Q 002158 693 EGEQMLVYEFVPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSNLNAKVADFGL 772 (958)
Q Consensus 693 ~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~~~~kl~DFGl 772 (958)
++..++||||+++|+|.++++.. .+++..+..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+
T Consensus 141 ~~~~~lV~E~~~gg~L~~~l~~~---~~~e~~~~~~~~qi~~aL~~LH~~g---ivHrDLKp~NILl~~~g~ikL~DFG~ 214 (410)
T 3v8s_A 141 DRYLYMVMEYMPGGDLVNLMSNY---DVPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGT 214 (410)
T ss_dssp SSEEEEEECCCTTEEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTT
T ss_pred CCEEEEEEeCCCCCcHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeeECCCCCEEEeccce
Confidence 99999999999999999999754 3889999999999999999999999 99999999999999999999999999
Q ss_pred ecccccCCCCCCccceeeeeccCCCCccChhhhccCC----CCCcchhhhHHHHHHHHHhCCCCCCCCchhHHHHHHHhh
Q 002158 773 SRLAPVLDDEGTMPTHVSTIVKGTPGYLDPEYFLTHK----LTDKSDVYSLGVVLLELLTGMQPISHGKNIVREVNVARD 848 (958)
Q Consensus 773 a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~~DV~S~Gv~l~elltG~~P~~~~~~~~~~~~~~~~ 848 (958)
++...... ........||+.|+|||++.+.. ++.++|||||||++|||++|+.||........ ......
T Consensus 215 a~~~~~~~------~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~-~~~i~~ 287 (410)
T 3v8s_A 215 CMKMNKEG------MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGT-YSKIMN 287 (410)
T ss_dssp CEECCTTS------EEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHHH-HHHHHT
T ss_pred eEeeccCC------cccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhhH-HHHHHh
Confidence 98653211 12233567999999999998765 78899999999999999999999975443222 111111
Q ss_pred cCcchhhhcccCCCCChHHHHHHHHHHHHccccCCCC--CCCHHHHHHH
Q 002158 849 SGMVFSIIDNRMGSYPSECVERFVTLALRCCHDKPEH--RPSMSDVVRE 895 (958)
Q Consensus 849 ~~~~~~~i~~~~~~~~~~~~~~l~~li~~cl~~dP~~--RPs~~evl~~ 895 (958)
... . ... .....++.++.+++.+|++.+|.+ ||+++||+++
T Consensus 288 ~~~--~---~~~-p~~~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~H 330 (410)
T 3v8s_A 288 HKN--S---LTF-PDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRH 330 (410)
T ss_dssp HHH--H---CCC-CTTCCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHTS
T ss_pred ccc--c---ccC-CCcccccHHHHHHHHHHccChhhhCCCCCHHHHhcC
Confidence 000 0 000 111245678899999999999988 9999999976
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-39 Score=360.51 Aligned_cols=261 Identities=22% Similarity=0.361 Sum_probs=192.1
Q ss_pred HcCCCCCceeeeeCCeEEEEEEEC-CCcEEEEEEeccCCh-hcHHHHHHHHHHHHccCCCCcceEEEEEEeCCeEEEEEE
Q 002158 624 TAYFSSSTQVGQGGYGKVYKGILS-DNTTVAIKRAEEGSL-QGQNEFLTEIKLLSRLHHRNLVSLLGYCDEEGEQMLVYE 701 (958)
Q Consensus 624 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E 701 (958)
..+|...+.||+|+||+||+|.+. +++.||||++..... ...+.+.+|++++++++||||+++++++..++..++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 83 (317)
T 2pmi_A 4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVFE 83 (317)
T ss_dssp ---------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEEE
T ss_pred ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEEE
Confidence 357888899999999999999976 689999999875432 234678899999999999999999999999999999999
Q ss_pred ecCCCCHHHHhccCC----CCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEecCCCCeEEeeeeeecccc
Q 002158 702 FVPNGTLRDWLSGRT----KENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSRLAP 777 (958)
Q Consensus 702 ~~~~gsL~~~l~~~~----~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~~~ 777 (958)
|++ |+|.+++.... ...+++..+..++.|+++||+|||+.+ |+||||||+|||++.++.+||+|||+++...
T Consensus 84 ~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~ 159 (317)
T 2pmi_A 84 FMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENK---ILHRDLKPQNLLINKRGQLKLGDFGLARAFG 159 (317)
T ss_dssp CCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCSSCEETT
T ss_pred ecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCChHHeEEcCCCCEEECcCccceecC
Confidence 997 69999986432 235899999999999999999999999 9999999999999999999999999998653
Q ss_pred cCCCCCCccceeeeeccCCCCccChhhhccC-CCCCcchhhhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcCc----c
Q 002158 778 VLDDEGTMPTHVSTIVKGTPGYLDPEYFLTH-KLTDKSDVYSLGVVLLELLTGMQPISHGKNIVREVNVARDSGM----V 852 (958)
Q Consensus 778 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DV~S~Gv~l~elltG~~P~~~~~~~~~~~~~~~~~~~----~ 852 (958)
... .......||+.|+|||++.+. .++.++|||||||++|||++|+.||................+. .
T Consensus 160 ~~~-------~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 232 (317)
T 2pmi_A 160 IPV-------NTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESL 232 (317)
T ss_dssp SCC-------CCCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCTTT
T ss_pred CCc-------ccCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhH
Confidence 211 112234689999999999764 6899999999999999999999999765543222111111000 0
Q ss_pred hhhhc------ccC-------------CCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 002158 853 FSIID------NRM-------------GSYPSECVERFVTLALRCCHDKPEHRPSMSDVVRE 895 (958)
Q Consensus 853 ~~~i~------~~~-------------~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 895 (958)
...+. ... ...+...+..+.+++.+||+.||++|||++|++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~h 294 (317)
T 2pmi_A 233 WPSVTKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHH 294 (317)
T ss_dssp CGGGGGCTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred hhhhhhhhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhCC
Confidence 00000 000 00111345689999999999999999999999864
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-39 Score=363.74 Aligned_cols=257 Identities=25% Similarity=0.405 Sum_probs=200.1
Q ss_pred HcCCCCCceeeeeCCeEEEEEEEC-CCcEEEEEEeccCC-hhcHHHHHHHHHHHHccCCCCcceEEEEEEeCC-------
Q 002158 624 TAYFSSSTQVGQGGYGKVYKGILS-DNTTVAIKRAEEGS-LQGQNEFLTEIKLLSRLHHRNLVSLLGYCDEEG------- 694 (958)
Q Consensus 624 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~------- 694 (958)
.++|+..+.||+|+||.||+|++. +++.||||++.... ....+.+.+|++++++++||||+++++++.+..
T Consensus 5 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~ 84 (332)
T 3qd2_B 5 LTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEE 84 (332)
T ss_dssp HHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHH
T ss_pred hhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhh
Confidence 346788899999999999999987 79999999997543 334567999999999999999999999986543
Q ss_pred --------------------------------------------------eEEEEEEecCCCCHHHHhccCCC-CCchHH
Q 002158 695 --------------------------------------------------EQMLVYEFVPNGTLRDWLSGRTK-ENLNFA 723 (958)
Q Consensus 695 --------------------------------------------------~~~lV~E~~~~gsL~~~l~~~~~-~~l~~~ 723 (958)
..++||||+++++|.+++..... ...++.
T Consensus 85 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~ 164 (332)
T 3qd2_B 85 MDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHG 164 (332)
T ss_dssp HHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSCHH
T ss_pred hhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchhhH
Confidence 37999999999999999986542 335667
Q ss_pred HHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEecCCCCeEEeeeeeecccccCCCCCCc-----cceeeeeccCCCC
Q 002158 724 MRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSRLAPVLDDEGTM-----PTHVSTIVKGTPG 798 (958)
Q Consensus 724 ~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~-----~~~~~~~~~gt~~ 798 (958)
.+++++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+++........... .........||+.
T Consensus 165 ~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~ 241 (332)
T 3qd2_B 165 VCLHIFIQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKL 241 (332)
T ss_dssp HHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CGG
T ss_pred HHHHHHHHHHHHHHHHHhCC---eeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCcC
Confidence 78999999999999999999 999999999999999999999999999876433211110 0112234569999
Q ss_pred ccChhhhccCCCCCcchhhhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcCcchhhhcccCCCCChHHHHHHHHHHHHc
Q 002158 799 YLDPEYFLTHKLTDKSDVYSLGVVLLELLTGMQPISHGKNIVREVNVARDSGMVFSIIDNRMGSYPSECVERFVTLALRC 878 (958)
Q Consensus 799 y~aPE~~~~~~~~~~~DV~S~Gv~l~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~l~~li~~c 878 (958)
|+|||++.+..++.++||||||+++|||++|..|+.... ........ ...+......+..+.+++.+|
T Consensus 242 y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~~~---~~~~~~~~---------~~~~~~~~~~~~~~~~li~~~ 309 (332)
T 3qd2_B 242 YMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQMERV---RIITDVRN---------LKFPLLFTQKYPQEHMMVQDM 309 (332)
T ss_dssp GSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHHHH---HHHHHHHT---------TCCCHHHHHHCHHHHHHHHHH
T ss_pred ccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhHHH---HHHHHhhc---------cCCCcccccCChhHHHHHHHH
Confidence 999999999999999999999999999999877653111 11111111 111111234556789999999
Q ss_pred cccCCCCCCCHHHHHHH
Q 002158 879 CHDKPEHRPSMSDVVRE 895 (958)
Q Consensus 879 l~~dP~~RPs~~evl~~ 895 (958)
|+.||++||+++|++++
T Consensus 310 l~~~p~~Rps~~~~l~~ 326 (332)
T 3qd2_B 310 LSPSPTERPEATDIIEN 326 (332)
T ss_dssp HCSSGGGSCCHHHHHHS
T ss_pred ccCCCCcCCCHHHHhhc
Confidence 99999999999999974
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-39 Score=357.84 Aligned_cols=261 Identities=26% Similarity=0.328 Sum_probs=203.3
Q ss_pred HHcCCCCCceeeeeCCeEEEEEEEC-CCcEEEEEEeccCC-----hhcHHHHHHHHHHHHcc---CCCCcceEEEEEEeC
Q 002158 623 ATAYFSSSTQVGQGGYGKVYKGILS-DNTTVAIKRAEEGS-----LQGQNEFLTEIKLLSRL---HHRNLVSLLGYCDEE 693 (958)
Q Consensus 623 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l---~H~niv~l~~~~~~~ 693 (958)
..++|...+.||+|+||+||+|++. +++.||||++.... ......+.+|+++++++ +||||+++++++...
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~ 86 (308)
T 3g33_A 7 ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATS 86 (308)
T ss_dssp ---CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEEC
T ss_pred cccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeecc
Confidence 4678999999999999999999974 78999999986422 11134567788777776 499999999999876
Q ss_pred C-----eEEEEEEecCCCCHHHHhccCCCCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEecCCCCeEEe
Q 002158 694 G-----EQMLVYEFVPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSNLNAKVA 768 (958)
Q Consensus 694 ~-----~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~~~~kl~ 768 (958)
. ..++||||++ ++|.+++.......+++.++..++.|++.||+|||+++ |+||||||+|||++.++.+||+
T Consensus 87 ~~~~~~~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~Nil~~~~~~~kl~ 162 (308)
T 3g33_A 87 RTDREIKVTLVFEHVD-QDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLA 162 (308)
T ss_dssp CSSSEEEEEEEEECCC-CBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCTTTEEECTTSCEEEC
T ss_pred CCCCceeEEEEehhhh-cCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCEEEe
Confidence 5 5799999996 69999998776666999999999999999999999999 9999999999999999999999
Q ss_pred eeeeecccccCCCCCCccceeeeeccCCCCccChhhhccCCCCCcchhhhHHHHHHHHHhCCCCCCCCchhHHHHHHHhh
Q 002158 769 DFGLSRLAPVLDDEGTMPTHVSTIVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVLLELLTGMQPISHGKNIVREVNVARD 848 (958)
Q Consensus 769 DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gv~l~elltG~~P~~~~~~~~~~~~~~~~ 848 (958)
|||+++..... .......||+.|+|||++.+..++.++|||||||++|||++|+.||...............
T Consensus 163 Dfg~a~~~~~~--------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~ 234 (308)
T 3g33_A 163 DFGLARIYSYQ--------MALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDL 234 (308)
T ss_dssp SCSCTTTSTTC--------CCSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHHHHHHHHH
T ss_pred eCccccccCCC--------cccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHH
Confidence 99999865321 1123457999999999999999999999999999999999999999765543322222111
Q ss_pred cCcchhh-h-------cccCC--------CCChHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 002158 849 SGMVFSI-I-------DNRMG--------SYPSECVERFVTLALRCCHDKPEHRPSMSDVVRE 895 (958)
Q Consensus 849 ~~~~~~~-i-------~~~~~--------~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 895 (958)
.+..... . ..... ......+..+.+++.+||+.||++|||+.|++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 297 (308)
T 3g33_A 235 IGLPPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQH 297 (308)
T ss_dssp HCCCCTTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred hCCCChhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhcC
Confidence 1100000 0 00000 0112355788999999999999999999999964
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-40 Score=406.74 Aligned_cols=339 Identities=27% Similarity=0.339 Sum_probs=253.0
Q ss_pred hhcCCCCHhHHHHHHHHHHHcccCccccCCCCCCCCCCCCCCceeeCccccCCCceeeEEEEccCCcCCCC---cccccc
Q 002158 31 AAAQTTDPQEASALRAIKNSLVDSMNHLRNWNKGDPCMSNWTGVLCFDTVETDGHLHVRELQLLSMNLSGN---LAPELG 107 (958)
Q Consensus 31 ~~~~~~~~~~~~al~~~k~~~~~~~~~l~~W~~~~~c~~~w~gV~C~~~~~~~~~~~v~~L~L~~~~l~~~---~~~~l~ 107 (958)
++++...++|++||++||+++.||. .+++|+.+++|| .|.||+|. ..+|+.|+|+++++.|. ++++++
T Consensus 4 ~~~~~~~~~~~~all~~k~~~~~~~-~l~~W~~~~~~C-~w~gv~C~-------~~~v~~L~L~~~~l~g~~~~l~~~l~ 74 (768)
T 3rgz_A 4 ASPSQSLYREIHQLISFKDVLPDKN-LLPDWSSNKNPC-TFDGVTCR-------DDKVTSIDLSSKPLNVGFSAVSSSLL 74 (768)
T ss_dssp ----CCHHHHHHHHHHHHTTCSCTT-SSTTCCTTSCGG-GSTTEEEE-------TTEEEEEECTTSCCCEEHHHHHHHTT
T ss_pred CccccCCHHHHHHHHHHHhhCCCcc-cccCCCCCCCCc-CCcceEEC-------CCcEEEEECCCCCcCCccCccChhHh
Confidence 4455557899999999999999987 899998666654 89999995 24899999999999998 888898
Q ss_pred CCCCcceeeccCcccCCCCccccCCCCCcEEEeeCCCCCCCCCh--hhcCCCCCCEEecccccccccCcccc-ccccccc
Q 002158 108 QLSRLQYYFMWNDLTGTIPKEIGNISSLIFLLLNGNKLSGSLPD--ELGYLSNLNRLQVDENNITGTIPKSF-ANLSRVR 184 (958)
Q Consensus 108 ~L~~L~~L~l~n~~~~~ip~~i~~l~~L~~L~Ls~n~l~~~~p~--~l~~l~~L~~L~L~~N~l~~~~p~~~-~~l~~L~ 184 (958)
+|++|+.++++.+....+|..|+++++|++|+|++|.++|.+|. .++++++|++|+|++|.+++.+|..+ .++++|+
T Consensus 75 ~L~~L~~l~~~~~~~~~l~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~ 154 (768)
T 3rgz_A 75 SLTGLESLFLSNSHINGSVSGFKCSASLTSLDLSRNSLSGPVTTLTSLGSCSGLKFLNVSSNTLDFPGKVSGGLKLNSLE 154 (768)
T ss_dssp TCTTCCEEECTTSCEEECCCCCCCCTTCCEEECCSSEEEEEGGGGGGGGGCTTCCEEECCSSEEECCSSCCSCCCCTTCS
T ss_pred ccCcccccCCcCCCcCCCchhhccCCCCCEEECCCCcCCCcCCChHHHhCCCCCCEEECcCCccCCcCCHHHhccCCCCC
Confidence 88888888887666556778888888999999999988888888 88888889999999888888777765 7888888
Q ss_pred eEecccccccccCchh---hcCCccchhhhccCCccccCCCcccCCCCCccEEEccCCCCCCCCccccccCCCCCCEEEc
Q 002158 185 HLHLNNNSIGGQIPSE---LSKLSTLIHLLVDNNNLSGNLPPELSELPQLCILQLDNNNFSASEIPATYGNFSKLVKLSL 261 (958)
Q Consensus 185 ~L~Ls~N~l~~~~p~~---l~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~p~~~~~l~~L~~L~L 261 (958)
+|+|++|.+++..|.. +.++++|++|++++|++++..+. ..+++|++|+|++|++++ .+|. ++++++|++|+|
T Consensus 155 ~L~Ls~n~l~~~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~--~~l~~L~~L~Ls~n~l~~-~~~~-l~~l~~L~~L~L 230 (768)
T 3rgz_A 155 VLDLSANSISGANVVGWVLSDGCGELKHLAISGNKISGDVDV--SRCVNLEFLDVSSNNFST-GIPF-LGDCSALQHLDI 230 (768)
T ss_dssp EEECCSSCCEEETHHHHHHTTCCTTCCEEECCSSEEESCCBC--TTCTTCCEEECCSSCCCS-CCCB-CTTCCSCCEEEC
T ss_pred EEECCCCccCCcCChhhhhhccCCCCCEEECCCCcccccCCc--ccCCcCCEEECcCCcCCC-CCcc-cccCCCCCEEEC
Confidence 8888888888777766 67777777777777777765443 667777777777777763 3444 777777777777
Q ss_pred ccCCCCCCCCC-CCCCCCcCEEeccCCcCCCcCCCCCCCCCcCEEEccCCcCCCccchhccCC-CCCCeEeeecccCCCc
Q 002158 262 RNCNLQGAVPD-LSRIPNLYYLDLSWNHLTGSIPSKKLSENVTTIDLSDNYLNGSILESISNL-PFLQTLSLENNFLTGS 339 (958)
Q Consensus 262 ~~N~l~~~~~~-l~~l~~L~~L~Ls~N~l~~~~~~~~~~~~L~~L~Ls~N~l~~~~~~~~~~l-~~L~~L~L~~N~l~~~ 339 (958)
++|++++..+. +..+++|++|+|++|.+++.+|.. .+++|++|+|++|++++.+|..+..+ ++|++|+|++|.+++.
T Consensus 231 s~n~l~~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~-~l~~L~~L~L~~n~l~~~ip~~~~~~~~~L~~L~Ls~n~l~~~ 309 (768)
T 3rgz_A 231 SGNKLSGDFSRAISTCTELKLLNISSNQFVGPIPPL-PLKSLQYLSLAENKFTGEIPDFLSGACDTLTGLDLSGNHFYGA 309 (768)
T ss_dssp CSSCCCSCHHHHTTTCSSCCEEECCSSCCEESCCCC-CCTTCCEEECCSSEEEESCCCCSCTTCTTCSEEECCSSEEEEC
T ss_pred cCCcCCCcccHHHhcCCCCCEEECCCCcccCccCcc-ccCCCCEEECcCCccCCccCHHHHhhcCcCCEEECcCCcCCCc
Confidence 77777765553 777777777777777776655554 55677777777777776666666554 6777777777777766
Q ss_pred cchhhhcccccCccccceEeccCCCCC-CCccC--CCCCCcceEEeCCCCCC
Q 002158 340 IPATIWQNKSFSTKARLKIDLRNNSFS-NIVGD--LTLPNNVTLRLGGNPIC 388 (958)
Q Consensus 340 ip~~l~~~~~~~~~~l~~L~Ls~N~l~-~l~~~--~~l~~L~~L~l~~N~l~ 388 (958)
+|..+..+. .|++|+|++|+++ .++.. ..+++|+.|++++|.+.
T Consensus 310 ~p~~~~~l~-----~L~~L~L~~n~l~~~ip~~~l~~l~~L~~L~Ls~n~l~ 356 (768)
T 3rgz_A 310 VPPFFGSCS-----LLESLALSSNNFSGELPMDTLLKMRGLKVLDLSFNEFS 356 (768)
T ss_dssp CCGGGGGCT-----TCCEEECCSSEEEEECCHHHHTTCTTCCEEECCSSEEE
T ss_pred cchHHhcCC-----CccEEECCCCcccCcCCHHHHhcCCCCCEEeCcCCccC
Confidence 666665543 3446777777666 45543 26666677777666653
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-39 Score=360.52 Aligned_cols=295 Identities=27% Similarity=0.492 Sum_probs=217.9
Q ss_pred CCCHhHHHHHHHHHHHcccCccccCCCCCCCCCC-CCCCceeeCccccCCCceeeEEEEccCCcCCC--CccccccCCCC
Q 002158 35 TTDPQEASALRAIKNSLVDSMNHLRNWNKGDPCM-SNWTGVLCFDTVETDGHLHVRELQLLSMNLSG--NLAPELGQLSR 111 (958)
Q Consensus 35 ~~~~~~~~al~~~k~~~~~~~~~l~~W~~~~~c~-~~w~gV~C~~~~~~~~~~~v~~L~L~~~~l~~--~~~~~l~~L~~ 111 (958)
.|.++|++||++||+++.||. .+++|+.+++|| +.|.||+|.... ...+|+.|+|+++++.+ .+|+.++++++
T Consensus 2 ~c~~~~~~aL~~~k~~~~~~~-~l~~W~~~~~~C~~~w~gv~C~~~~---~~~~l~~L~L~~~~l~~~~~~~~~l~~l~~ 77 (313)
T 1ogq_A 2 LCNPQDKQALLQIKKDLGNPT-TLSSWLPTTDCCNRTWLGVLCDTDT---QTYRVNNLDLSGLNLPKPYPIPSSLANLPY 77 (313)
T ss_dssp CSCHHHHHHHHHHHHHTTCCG-GGTTCCTTSCTTTTCSTTEEECCSS---SCCCEEEEEEECCCCSSCEECCGGGGGCTT
T ss_pred CCCHHHHHHHHHHHHhcCCcc-cccCCCCCCCCCcCCCcceEeCCCC---CCceEEEEECCCCCccCCcccChhHhCCCC
Confidence 588999999999999998876 789998654443 459999996431 12589999999999999 88888888888
Q ss_pred cceeecc--CcccCCCCccccCCCCCcEEEeeCCCCCCCCChhhcCCCCCCEEecccccccccCccccccccccceEecc
Q 002158 112 LQYYFMW--NDLTGTIPKEIGNISSLIFLLLNGNKLSGSLPDELGYLSNLNRLQVDENNITGTIPKSFANLSRVRHLHLN 189 (958)
Q Consensus 112 L~~L~l~--n~~~~~ip~~i~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls 189 (958)
|++|+++ |++.+.+|..|+++++|++|+|++|.+++.+|..|.++++|++|+|++|++++.+|..|..+++|++|+|+
T Consensus 78 L~~L~L~~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~ 157 (313)
T 1ogq_A 78 LNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFD 157 (313)
T ss_dssp CSEEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCEEECCSSEEESCCCGGGGGCTTCCEEECC
T ss_pred CCeeeCCCCCcccccCChhHhcCCCCCEEECcCCeeCCcCCHHHhCCCCCCEEeCCCCccCCcCChHHhcCCCCCeEECc
Confidence 8888886 66777888888888888888888888888888888888888888888888888888888888888888888
Q ss_pred cccccccCchhhcCCc-cchhhhccCCccccCCCcccCCCCCccEEEccCCCCCCCCccccccCCCCCCEEEcccCCCCC
Q 002158 190 NNSIGGQIPSELSKLS-TLIHLLVDNNNLSGNLPPELSELPQLCILQLDNNNFSASEIPATYGNFSKLVKLSLRNCNLQG 268 (958)
Q Consensus 190 ~N~l~~~~p~~l~~l~-~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~p~~~~~l~~L~~L~L~~N~l~~ 268 (958)
+|.+++.+|..+..++ +|++|++++|++++.+|..+..++ |++|+|++|+++ ...|..+..+++|+.|+|++|++++
T Consensus 158 ~N~l~~~~p~~l~~l~~~L~~L~L~~N~l~~~~~~~~~~l~-L~~L~Ls~N~l~-~~~~~~~~~l~~L~~L~L~~N~l~~ 235 (313)
T 1ogq_A 158 GNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLN-LAFVDLSRNMLE-GDASVLFGSDKNTQKIHLAKNSLAF 235 (313)
T ss_dssp SSCCEEECCGGGGCCCTTCCEEECCSSEEEEECCGGGGGCC-CSEEECCSSEEE-ECCGGGCCTTSCCSEEECCSSEECC
T ss_pred CCcccCcCCHHHhhhhhcCcEEECcCCeeeccCChHHhCCc-ccEEECcCCccc-CcCCHHHhcCCCCCEEECCCCceee
Confidence 8888888888888887 788888888888877777777776 777777777776 3456666666666666666666665
Q ss_pred CCCCCCCCCCcCEEeccCCcCCCcCCCCCCCCCcCEEEccCCcCCCccchhccCCCCCCeEeeecccCCCccchhhhccc
Q 002158 269 AVPDLSRIPNLYYLDLSWNHLTGSIPSKKLSENVTTIDLSDNYLNGSILESISNLPFLQTLSLENNFLTGSIPATIWQNK 348 (958)
Q Consensus 269 ~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~ip~~l~~~~ 348 (958)
.++.+..+++|++|+|++|+++ +.+|..|..+++|++|+|++|+++|.+|.. ..
T Consensus 236 ~~~~~~~l~~L~~L~Ls~N~l~-----------------------~~~p~~l~~l~~L~~L~Ls~N~l~~~ip~~-~~-- 289 (313)
T 1ogq_A 236 DLGKVGLSKNLNGLDLRNNRIY-----------------------GTLPQGLTQLKFLHSLNVSFNNLCGEIPQG-GN-- 289 (313)
T ss_dssp BGGGCCCCTTCCEEECCSSCCE-----------------------ECCCGGGGGCTTCCEEECCSSEEEEECCCS-TT--
T ss_pred ecCcccccCCCCEEECcCCccc-----------------------CcCChHHhcCcCCCEEECcCCcccccCCCC-cc--
Confidence 5544544555555555555554 445555555555555555555555555543 11
Q ss_pred ccCccccceEeccCCC
Q 002158 349 SFSTKARLKIDLRNNS 364 (958)
Q Consensus 349 ~~~~~~l~~L~Ls~N~ 364 (958)
.+.++.|++++|+
T Consensus 290 ---l~~L~~l~l~~N~ 302 (313)
T 1ogq_A 290 ---LQRFDVSAYANNK 302 (313)
T ss_dssp ---GGGSCGGGTCSSS
T ss_pred ---ccccChHHhcCCC
Confidence 2233455555555
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-40 Score=365.74 Aligned_cols=269 Identities=25% Similarity=0.442 Sum_probs=218.7
Q ss_pred cChHHHHHHHcCCCCCceeeeeCCeEEEEEEEC------CCcEEEEEEeccCC-hhcHHHHHHHHHHHHccCCCCcceEE
Q 002158 615 FKFKELAMATAYFSSSTQVGQGGYGKVYKGILS------DNTTVAIKRAEEGS-LQGQNEFLTEIKLLSRLHHRNLVSLL 687 (958)
Q Consensus 615 ~~~~el~~~~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~ 687 (958)
+..+++....++|...+.||+|+||.||+|.+. .++.||||++.... .....+|.+|++++++++||||++++
T Consensus 15 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~ 94 (322)
T 1p4o_A 15 YVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLL 94 (322)
T ss_dssp CCCCTTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEE
T ss_pred cChhhhcchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeE
Confidence 334455556778999999999999999999864 36789999997643 34456799999999999999999999
Q ss_pred EEEEeCCeEEEEEEecCCCCHHHHhccCC--------CCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEe
Q 002158 688 GYCDEEGEQMLVYEFVPNGTLRDWLSGRT--------KENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILL 759 (958)
Q Consensus 688 ~~~~~~~~~~lV~E~~~~gsL~~~l~~~~--------~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl 759 (958)
+++...+..++||||+++|+|.+++.... ...+++..+++++.|++.||+|||+++ |+||||||+||++
T Consensus 95 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~NIli 171 (322)
T 1p4o_A 95 GVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMV 171 (322)
T ss_dssp EEECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCSGGGEEE
T ss_pred EEEccCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---CccCCCccceEEE
Confidence 99999999999999999999999997532 134789999999999999999999999 9999999999999
Q ss_pred cCCCCeEEeeeeeecccccCCCCCCccceeeeeccCCCCccChhhhccCCCCCcchhhhHHHHHHHHHh-CCCCCCCCch
Q 002158 760 DSNLNAKVADFGLSRLAPVLDDEGTMPTHVSTIVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVLLELLT-GMQPISHGKN 838 (958)
Q Consensus 760 ~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gv~l~ellt-G~~P~~~~~~ 838 (958)
+.++.+||+|||+++....... ........||+.|+|||++.+..++.++||||||+++|||++ |+.||.....
T Consensus 172 ~~~~~~kl~Dfg~~~~~~~~~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~ 246 (322)
T 1p4o_A 172 AEDFTVKIGDFGMTRDIYETDY-----YRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSN 246 (322)
T ss_dssp CTTCCEEECCTTCCCGGGGGGC-----EEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCH
T ss_pred cCCCeEEECcCccccccccccc-----cccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCH
Confidence 9999999999999975432111 111223356889999999999999999999999999999999 8899875433
Q ss_pred hHHHHHHHhhcCcchhhhcccCCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHh
Q 002158 839 IVREVNVARDSGMVFSIIDNRMGSYPSECVERFVTLALRCCHDKPEHRPSMSDVVRELENILK 901 (958)
Q Consensus 839 ~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~ 901 (958)
. ....... .......+..++..+.+++.+||+.||.+||++.|++++|++++.
T Consensus 247 ~-~~~~~~~---------~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~~ 299 (322)
T 1p4o_A 247 E-QVLRFVM---------EGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME 299 (322)
T ss_dssp H-HHHHHHH---------TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred H-HHHHHHH---------cCCcCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhhc
Confidence 2 1111111 112223455677889999999999999999999999999988764
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-39 Score=364.29 Aligned_cols=250 Identities=21% Similarity=0.305 Sum_probs=207.2
Q ss_pred HHcCCCCCceeeeeCCeEEEEEEEC-CCcEEEEEEeccCC---hhcHHHHHHHHHHHHcc-CCCCcceEEEEEEeCCeEE
Q 002158 623 ATAYFSSSTQVGQGGYGKVYKGILS-DNTTVAIKRAEEGS---LQGQNEFLTEIKLLSRL-HHRNLVSLLGYCDEEGEQM 697 (958)
Q Consensus 623 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~ 697 (958)
..++|...+.||+|+||+||+|+.+ +++.||||+++... ....+.+..|..+++.+ +||||+++++++.+.+..+
T Consensus 18 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~ 97 (353)
T 2i0e_A 18 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLY 97 (353)
T ss_dssp -CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEE
T ss_pred chHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEE
Confidence 3457888899999999999999987 47899999987532 23356788999999988 7999999999999999999
Q ss_pred EEEEecCCCCHHHHhccCCCCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEecCCCCeEEeeeeeecccc
Q 002158 698 LVYEFVPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSRLAP 777 (958)
Q Consensus 698 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~~~ 777 (958)
+||||+++|+|.+++.... .+++.++..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+++...
T Consensus 98 lv~E~~~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~ 172 (353)
T 2i0e_A 98 FVMEYVNGGDLMYHIQQVG--RFKEPHAVFYAAEIAIGLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENI 172 (353)
T ss_dssp EEEECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCCC
T ss_pred EEEeCCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC---EEeccCCHHHEEEcCCCcEEEEeCCcccccc
Confidence 9999999999999997543 3899999999999999999999999 9999999999999999999999999997532
Q ss_pred cCCCCCCccceeeeeccCCCCccChhhhccCCCCCcchhhhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcCcchhhhc
Q 002158 778 VLDDEGTMPTHVSTIVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVLLELLTGMQPISHGKNIVREVNVARDSGMVFSIID 857 (958)
Q Consensus 778 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gv~l~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~i~ 857 (958)
... .......||+.|+|||++.+..++.++|||||||++|||++|+.||...... .......
T Consensus 173 ~~~-------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~-~~~~~i~---------- 234 (353)
T 2i0e_A 173 WDG-------VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDED-ELFQSIM---------- 234 (353)
T ss_dssp CTT-------CCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHH-HHHHHHH----------
T ss_pred cCC-------cccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCHH-HHHHHHH----------
Confidence 111 1233467999999999999999999999999999999999999999754332 2221111
Q ss_pred ccCCCCChHHHHHHHHHHHHccccCCCCCCC-----HHHHHHH
Q 002158 858 NRMGSYPSECVERFVTLALRCCHDKPEHRPS-----MSDVVRE 895 (958)
Q Consensus 858 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~evl~~ 895 (958)
.....+|...+.++.+++.+||+.||++||+ +++++++
T Consensus 235 ~~~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~h 277 (353)
T 2i0e_A 235 EHNVAYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEH 277 (353)
T ss_dssp HCCCCCCTTSCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHTS
T ss_pred hCCCCCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence 1122345567788999999999999999995 5777654
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-40 Score=361.45 Aligned_cols=270 Identities=27% Similarity=0.454 Sum_probs=207.8
Q ss_pred HHHHHHHcCCCCCceeeeeCCeEEEEEEEC----CCcEEEEEEeccC--ChhcHHHHHHHHHHHHccCCCCcceEEEEEE
Q 002158 618 KELAMATAYFSSSTQVGQGGYGKVYKGILS----DNTTVAIKRAEEG--SLQGQNEFLTEIKLLSRLHHRNLVSLLGYCD 691 (958)
Q Consensus 618 ~el~~~~~~~~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~ 691 (958)
+++....++|...+.||+|+||.||+|.+. .+..||||++... .....+.+.+|++++++++||||+++++++.
T Consensus 27 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~ 106 (313)
T 3brb_A 27 EDVVIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCI 106 (313)
T ss_dssp TTTBCCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEE
T ss_pred HhcccCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEe
Confidence 334445667888899999999999999864 2458999998754 3344567999999999999999999999997
Q ss_pred eCC-----eEEEEEEecCCCCHHHHhccC----CCCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEecCC
Q 002158 692 EEG-----EQMLVYEFVPNGTLRDWLSGR----TKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSN 762 (958)
Q Consensus 692 ~~~-----~~~lV~E~~~~gsL~~~l~~~----~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~ 762 (958)
..+ ..++||||+++|+|.+++... ....+++.+++.++.|+++||+|||+.+ |+||||||+||+++.+
T Consensus 107 ~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dikp~NIli~~~ 183 (313)
T 3brb_A 107 EMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRN---FLHRDLAARNCMLRDD 183 (313)
T ss_dssp C-------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTT---CCCCCCSGGGEEECTT
T ss_pred eccccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCC
Confidence 755 359999999999999998532 2345999999999999999999999999 9999999999999999
Q ss_pred CCeEEeeeeeecccccCCCCCCccceeeeeccCCCCccChhhhccCCCCCcchhhhHHHHHHHHHh-CCCCCCCCchhHH
Q 002158 763 LNAKVADFGLSRLAPVLDDEGTMPTHVSTIVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVLLELLT-GMQPISHGKNIVR 841 (958)
Q Consensus 763 ~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gv~l~ellt-G~~P~~~~~~~~~ 841 (958)
+.+||+|||+++....... ........+++.|+|||.+.+..++.++||||||+++|||++ |..||........
T Consensus 184 ~~~kl~Dfg~~~~~~~~~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~ 258 (313)
T 3brb_A 184 MTVCVADFGLSKKIYSGDY-----YRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEM 258 (313)
T ss_dssp SCEEECSCSCC---------------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGH
T ss_pred CcEEEeecCcceecccccc-----cCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHHHH
Confidence 9999999999976532211 112234457889999999999999999999999999999999 8889875443221
Q ss_pred HHHHHhhcCcchhhhcccCCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHhhCCC
Q 002158 842 EVNVARDSGMVFSIIDNRMGSYPSECVERFVTLALRCCHDKPEHRPSMSDVVRELENILKMFPE 905 (958)
Q Consensus 842 ~~~~~~~~~~~~~~i~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~~~ 905 (958)
... . ........+..++..+.+++.+||+.||.+||++.+++++|+++++..|.
T Consensus 259 ~~~-~---------~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~l~~~lp~ 312 (313)
T 3brb_A 259 YDY-L---------LHGHRLKQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLLESLPD 312 (313)
T ss_dssp HHH-H---------HTTCCCCCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHC--
T ss_pred HHH-H---------HcCCCCCCCccccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcCC
Confidence 111 1 11112233556678899999999999999999999999999999988764
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-40 Score=390.28 Aligned_cols=261 Identities=31% Similarity=0.481 Sum_probs=215.9
Q ss_pred HHHcCCCCCceeeeeCCeEEEEEEECCCcEEEEEEeccCChhcHHHHHHHHHHHHccCCCCcceEEEEEEeCCeEEEEEE
Q 002158 622 MATAYFSSSTQVGQGGYGKVYKGILSDNTTVAIKRAEEGSLQGQNEFLTEIKLLSRLHHRNLVSLLGYCDEEGEQMLVYE 701 (958)
Q Consensus 622 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E 701 (958)
...++|...+.||+|+||+||+|.++++..||||+++... ...++|.+|+++|++++|+||+++++++.. +..++|||
T Consensus 264 i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~lv~e 341 (535)
T 2h8h_A 264 IPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTE 341 (535)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEC
T ss_pred cchhhhhhheecccCCCeEEEEEEECCCceEEEEEeCCCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEee-ccceEeee
Confidence 3456778889999999999999999888899999998644 345689999999999999999999999876 67899999
Q ss_pred ecCCCCHHHHhccCCCCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEecCCCCeEEeeeeeecccccCCC
Q 002158 702 FVPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSRLAPVLDD 781 (958)
Q Consensus 702 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~ 781 (958)
|+++|+|.++++......+++.+++.++.|+++||+|||+++ |+||||||+|||+++++.+||+|||+++......
T Consensus 342 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~- 417 (535)
T 2h8h_A 342 YMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNE- 417 (535)
T ss_dssp CCTTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCTTSTTTCCCHH-
T ss_pred hhcCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHhhEEEcCCCcEEEcccccceecCCCc-
Confidence 999999999997544445899999999999999999999999 9999999999999999999999999998653210
Q ss_pred CCCccceeeeeccCCCCccChhhhccCCCCCcchhhhHHHHHHHHHh-CCCCCCCCchhHHHHHHHhhcCcchhhhcccC
Q 002158 782 EGTMPTHVSTIVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVLLELLT-GMQPISHGKNIVREVNVARDSGMVFSIIDNRM 860 (958)
Q Consensus 782 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gv~l~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~i~~~~ 860 (958)
........++..|+|||++....++.++|||||||++|||++ |+.||.+..... ....... ...
T Consensus 418 -----~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~~-~~~~i~~---------~~~ 482 (535)
T 2h8h_A 418 -----YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE-VLDQVER---------GYR 482 (535)
T ss_dssp -----HHTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHHH-HHHHHHT---------TCC
T ss_pred -----eecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH-HHHHHHc---------CCC
Confidence 111123457788999999999999999999999999999999 999997544321 1111111 111
Q ss_pred CCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHhhC
Q 002158 861 GSYPSECVERFVTLALRCCHDKPEHRPSMSDVVRELENILKMF 903 (958)
Q Consensus 861 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~ 903 (958)
...+..++..+.++|.+||+.||++||+++++++.|+++....
T Consensus 483 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~~~ 525 (535)
T 2h8h_A 483 MPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTST 525 (535)
T ss_dssp CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSCCC
T ss_pred CCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHhhcc
Confidence 2335567788999999999999999999999999999876443
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-39 Score=350.29 Aligned_cols=247 Identities=22% Similarity=0.359 Sum_probs=206.8
Q ss_pred HcCCCCCceeeeeCCeEEEEEEEC-CCcEEEEEEeccCChhcHHHHHHHHHHHHccCCCCcceEEEEEEeCCeEEEEEEe
Q 002158 624 TAYFSSSTQVGQGGYGKVYKGILS-DNTTVAIKRAEEGSLQGQNEFLTEIKLLSRLHHRNLVSLLGYCDEEGEQMLVYEF 702 (958)
Q Consensus 624 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E~ 702 (958)
.++|...+.||+|+||+||+|.+. ++..||+|++........+.+.+|++++++++||||+++++++...+..++||||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 87 (277)
T 3f3z_A 8 NQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVMEL 87 (277)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred hhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEEec
Confidence 456888899999999999999986 5779999999876556677899999999999999999999999999999999999
Q ss_pred cCCCCHHHHhccCCCCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEe---cCCCCeEEeeeeeecccccC
Q 002158 703 VPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILL---DSNLNAKVADFGLSRLAPVL 779 (958)
Q Consensus 703 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl---~~~~~~kl~DFGla~~~~~~ 779 (958)
+++++|.+++.... .+++.++..++.|++.||+|||+.+ |+||||||+||++ +.++.+||+|||+++.....
T Consensus 88 ~~~~~L~~~~~~~~--~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~~~ 162 (277)
T 3f3z_A 88 CTGGELFERVVHKR--VFRESDAARIMKDVLSAVAYCHKLN---VAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPG 162 (277)
T ss_dssp CCSCBHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSTTCCEEECCCTTCEECCTT
T ss_pred cCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCCHHHEEEecCCCCCcEEEEecccceeccCc
Confidence 99999999997643 3899999999999999999999999 9999999999999 78899999999999765321
Q ss_pred CCCCCccceeeeeccCCCCccChhhhccCCCCCcchhhhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcCcchhhhccc
Q 002158 780 DDEGTMPTHVSTIVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVLLELLTGMQPISHGKNIVREVNVARDSGMVFSIIDNR 859 (958)
Q Consensus 780 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gv~l~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~i~~~ 859 (958)
. ......||+.|+|||++.+. ++.++||||||+++|||++|+.||...............
T Consensus 163 ~--------~~~~~~~t~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~----------- 222 (277)
T 3f3z_A 163 K--------MMRTKVGTPYYVSPQVLEGL-YGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKIREG----------- 222 (277)
T ss_dssp S--------CBCCCCSCTTTCCHHHHTTC-BCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC-----------
T ss_pred c--------chhccCCCCCccChHHhccc-CCchhhehhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhC-----------
Confidence 1 12234699999999998654 899999999999999999999999765433222111111
Q ss_pred CCCCCh----HHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 002158 860 MGSYPS----ECVERFVTLALRCCHDKPEHRPSMSDVVRE 895 (958)
Q Consensus 860 ~~~~~~----~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 895 (958)
....+. .++..+.+++.+||+.||++||++.|++++
T Consensus 223 ~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~h 262 (277)
T 3f3z_A 223 TFTFPEKDWLNVSPQAESLIRRLLTKSPKQRITSLQALEH 262 (277)
T ss_dssp CCCCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTS
T ss_pred CCCCCchhhhcCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 111122 346789999999999999999999999874
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-39 Score=352.15 Aligned_cols=258 Identities=28% Similarity=0.467 Sum_probs=208.2
Q ss_pred HcCCCCCceeeeeCCeEEEEEEECC----CcEEEEEEeccC-ChhcHHHHHHHHHHHHccCCCCcceEEEEEEeCCeEEE
Q 002158 624 TAYFSSSTQVGQGGYGKVYKGILSD----NTTVAIKRAEEG-SLQGQNEFLTEIKLLSRLHHRNLVSLLGYCDEEGEQML 698 (958)
Q Consensus 624 ~~~~~~~~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~l 698 (958)
.++|...+.||+|+||+||+|.+.+ +..||||.+... .....+.|.+|++++++++||||+++++++..+ ..++
T Consensus 11 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-~~~~ 89 (281)
T 3cc6_A 11 REDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEEE-PTWI 89 (281)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECSS-SCEE
T ss_pred ccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcCC-CCEE
Confidence 3567788999999999999998643 346999998765 344567899999999999999999999998754 5689
Q ss_pred EEEecCCCCHHHHhccCCCCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEecCCCCeEEeeeeeeccccc
Q 002158 699 VYEFVPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSRLAPV 778 (958)
Q Consensus 699 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~~~~ 778 (958)
||||+++++|.+++.... ..+++..+..++.|+++||+|||+++ |+||||||+||+++.++.+||+|||+++....
T Consensus 90 v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 165 (281)
T 3cc6_A 90 IMELYPYGELGHYLERNK-NSLKVLTLVLYSLQICKAMAYLESIN---CVHRDIAVRNILVASPECVKLGDFGLSRYIED 165 (281)
T ss_dssp EEECCTTCBHHHHHHHHT-TTCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEEEETTEEEECCCCGGGCC--
T ss_pred EEecCCCCCHHHHHHhcc-ccCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCccceEEECCCCcEEeCccCCCccccc
Confidence 999999999999997543 34899999999999999999999999 99999999999999999999999999986532
Q ss_pred CCCCCCccceeeeeccCCCCccChhhhccCCCCCcchhhhHHHHHHHHHh-CCCCCCCCchhHHHHHHHhhcCcchhhhc
Q 002158 779 LDDEGTMPTHVSTIVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVLLELLT-GMQPISHGKNIVREVNVARDSGMVFSIID 857 (958)
Q Consensus 779 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gv~l~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~i~ 857 (958)
.. ........||+.|+|||++.+..++.++||||||+++|||++ |+.||.......... ... .
T Consensus 166 ~~------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~~~~-~~~---------~ 229 (281)
T 3cc6_A 166 ED------YYKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIG-VLE---------K 229 (281)
T ss_dssp -------------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGGHHH-HHH---------H
T ss_pred cc------ccccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChHHHHH-HHh---------c
Confidence 11 111233457889999999999999999999999999999998 999997543322111 111 1
Q ss_pred ccCCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHhh
Q 002158 858 NRMGSYPSECVERFVTLALRCCHDKPEHRPSMSDVVRELENILKM 902 (958)
Q Consensus 858 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~ 902 (958)
......+..++..+.+++.+||+.||++||++.|++++|+++.+.
T Consensus 230 ~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~ 274 (281)
T 3cc6_A 230 GDRLPKPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDVYQM 274 (281)
T ss_dssp TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CCCCCCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHHHHHHh
Confidence 111223445678899999999999999999999999999988753
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-39 Score=360.21 Aligned_cols=265 Identities=22% Similarity=0.324 Sum_probs=214.2
Q ss_pred cccChHHHHHHHcCCCCC-ceeeeeCCeEEEEEEEC-CCcEEEEEEeccC--ChhcHHHHHHHHHHHHcc-CCCCcceEE
Q 002158 613 KGFKFKELAMATAYFSSS-TQVGQGGYGKVYKGILS-DNTTVAIKRAEEG--SLQGQNEFLTEIKLLSRL-HHRNLVSLL 687 (958)
Q Consensus 613 ~~~~~~el~~~~~~~~~~-~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l-~H~niv~l~ 687 (958)
..+.++..+...++|... +.||+|+||+||+|... +++.||||++... .......+.+|+.+++.+ +||||++++
T Consensus 16 ~n~~~~~~~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~ 95 (327)
T 3lm5_A 16 ENLYFQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLH 95 (327)
T ss_dssp CCCCSBCHHHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEE
T ss_pred hhhHHHHHHhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEE
Confidence 445566666677777776 88999999999999986 6899999998753 233467899999999999 569999999
Q ss_pred EEEEeCCeEEEEEEecCCCCHHHHhccCCCCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEecC---CCC
Q 002158 688 GYCDEEGEQMLVYEFVPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDS---NLN 764 (958)
Q Consensus 688 ~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~---~~~ 764 (958)
+++...+..++||||+++|+|.+++.......+++.++..++.|++.||+|||+++ |+||||||+|||++. ++.
T Consensus 96 ~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~~g---ivH~Dikp~NIl~~~~~~~~~ 172 (327)
T 3lm5_A 96 EVYENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNN---IVHLDLKPQNILLSSIYPLGD 172 (327)
T ss_dssp EEEECSSEEEEEEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESCBTTBCC
T ss_pred EEEEeCCeEEEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC---eecCcCChHHEEEecCCCCCc
Confidence 99999999999999999999999997665566999999999999999999999999 999999999999988 789
Q ss_pred eEEeeeeeecccccCCCCCCccceeeeeccCCCCccChhhhccCCCCCcchhhhHHHHHHHHHhCCCCCCCCchhHHHHH
Q 002158 765 AKVADFGLSRLAPVLDDEGTMPTHVSTIVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVLLELLTGMQPISHGKNIVREVN 844 (958)
Q Consensus 765 ~kl~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gv~l~elltG~~P~~~~~~~~~~~~ 844 (958)
+||+|||+++...... ......||+.|+|||++.+..++.++||||||+++|||++|+.||...........
T Consensus 173 ~kL~Dfg~a~~~~~~~--------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~ 244 (327)
T 3lm5_A 173 IKIVDFGMSRKIGHAC--------ELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLN 244 (327)
T ss_dssp EEECCGGGCEEC-----------------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH
T ss_pred EEEeeCccccccCCcc--------ccccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHH
Confidence 9999999998653211 12335699999999999999999999999999999999999999976544332222
Q ss_pred HHhhcCcchhhhcccCCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 002158 845 VARDSGMVFSIIDNRMGSYPSECVERFVTLALRCCHDKPEHRPSMSDVVRE 895 (958)
Q Consensus 845 ~~~~~~~~~~~i~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 895 (958)
...... .........++..+.+++.+||+.||++||+++|++++
T Consensus 245 i~~~~~-------~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~h 288 (327)
T 3lm5_A 245 ISQVNV-------DYSEETFSSVSQLATDFIQSLLVKNPEKRPTAEICLSH 288 (327)
T ss_dssp HHHTCC-------CCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTC
T ss_pred HHhccc-------ccCchhhcccCHHHHHHHHHHcCCChhhCcCHHHHhCC
Confidence 111110 11112234566789999999999999999999999864
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-39 Score=364.67 Aligned_cols=253 Identities=23% Similarity=0.350 Sum_probs=201.4
Q ss_pred cCCCCCceeeeeCCeEEEEEEECCCcEEEEEEeccC--ChhcHHHHHHHHHHHHccCC--CCcceEEEEEEeCCeEEEEE
Q 002158 625 AYFSSSTQVGQGGYGKVYKGILSDNTTVAIKRAEEG--SLQGQNEFLTEIKLLSRLHH--RNLVSLLGYCDEEGEQMLVY 700 (958)
Q Consensus 625 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H--~niv~l~~~~~~~~~~~lV~ 700 (958)
+.|...+.||+|+||+||+|...+++.||||++... .....+.+.+|++++++++| +||+++++++..++..++||
T Consensus 9 ~~y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~ 88 (343)
T 3dbq_A 9 RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVM 88 (343)
T ss_dssp CEEEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred CEEEEEEEEecCCCeEEEEEEeCCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEEEEE
Confidence 457788999999999999999988999999998754 33445679999999999976 99999999999999999999
Q ss_pred EecCCCCHHHHhccCCCCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEecCCCCeEEeeeeeecccccCC
Q 002158 701 EFVPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSRLAPVLD 780 (958)
Q Consensus 701 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~ 780 (958)
|+ .+++|.+++.... .+++.++..++.|++.||+|||+.+ |+||||||+|||++ ++.+||+|||+++......
T Consensus 89 e~-~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~al~~lH~~~---iiHrDikp~NIll~-~~~~kl~DFG~a~~~~~~~ 161 (343)
T 3dbq_A 89 EC-GNIDLNSWLKKKK--SIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDT 161 (343)
T ss_dssp CC-CSEEHHHHHHHSC--CCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEE-TTEEEECCCSSSCCC----
T ss_pred eC-CCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCcceEEEE-CCcEEEeecccccccCccc
Confidence 95 5889999998654 4899999999999999999999999 99999999999997 6789999999998653221
Q ss_pred CCCCccceeeeeccCCCCccChhhhcc-----------CCCCCcchhhhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhc
Q 002158 781 DEGTMPTHVSTIVKGTPGYLDPEYFLT-----------HKLTDKSDVYSLGVVLLELLTGMQPISHGKNIVREVNVARDS 849 (958)
Q Consensus 781 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-----------~~~~~~~DV~S~Gv~l~elltG~~P~~~~~~~~~~~~~~~~~ 849 (958)
. ........||+.|+|||++.+ ..++.++|||||||++|||++|+.||................
T Consensus 162 ~-----~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~ 236 (343)
T 3dbq_A 162 T-----SVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDP 236 (343)
T ss_dssp -------------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHCT
T ss_pred c-----cccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhHHHHHHHHhcC
Confidence 1 112234579999999999975 678889999999999999999999997644332222221111
Q ss_pred CcchhhhcccCCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 002158 850 GMVFSIIDNRMGSYPSECVERFVTLALRCCHDKPEHRPSMSDVVRELE 897 (958)
Q Consensus 850 ~~~~~~i~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 897 (958)
......+...+..+.+++.+||+.||++|||+.|++++-.
T Consensus 237 --------~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~hp~ 276 (343)
T 3dbq_A 237 --------NHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPY 276 (343)
T ss_dssp --------TSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHH
T ss_pred --------CcccCCcccCCHHHHHHHHHHcCCChhHCCCHHHHHhCcc
Confidence 1112334445678899999999999999999999998743
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-39 Score=355.98 Aligned_cols=261 Identities=26% Similarity=0.391 Sum_probs=209.6
Q ss_pred HcCCCCCc-eeeeeCCeEEEEEEEC---CCcEEEEEEeccCCh--hcHHHHHHHHHHHHccCCCCcceEEEEEEeCCeEE
Q 002158 624 TAYFSSST-QVGQGGYGKVYKGILS---DNTTVAIKRAEEGSL--QGQNEFLTEIKLLSRLHHRNLVSLLGYCDEEGEQM 697 (958)
Q Consensus 624 ~~~~~~~~-~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~ 697 (958)
..+|...+ .||+|+||+||+|.+. .++.||||++..... ...+++.+|+++++.++||||+++++++ ..+..+
T Consensus 15 ~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~~ 93 (291)
T 1xbb_A 15 RKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAESWM 93 (291)
T ss_dssp GGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESSSEE
T ss_pred chhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCCCcE
Confidence 34566666 8999999999999653 468899999976432 2356799999999999999999999999 566889
Q ss_pred EEEEecCCCCHHHHhccCCCCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEecCCCCeEEeeeeeecccc
Q 002158 698 LVYEFVPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSRLAP 777 (958)
Q Consensus 698 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~~~ 777 (958)
+||||+++++|.+++.... .+++.++..++.|+++||+|||+.+ |+||||||+||+++.++.+||+|||+++...
T Consensus 94 lv~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~ 168 (291)
T 1xbb_A 94 LVMEMAELGPLNKYLQQNR--HVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALR 168 (291)
T ss_dssp EEEECCTTEEHHHHHHHCT--TCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCEECC
T ss_pred EEEEeCCCCCHHHHHHhCc--CCCHHHHHHHHHHHHHHHHHHHhCC---eEcCCCCcceEEEeCCCcEEEccCCcceeec
Confidence 9999999999999997653 3899999999999999999999999 9999999999999999999999999998653
Q ss_pred cCCCCCCccceeeeeccCCCCccChhhhccCCCCCcchhhhHHHHHHHHHh-CCCCCCCCchhHHHHHHHhhcCcchhhh
Q 002158 778 VLDDEGTMPTHVSTIVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVLLELLT-GMQPISHGKNIVREVNVARDSGMVFSII 856 (958)
Q Consensus 778 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gv~l~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~i 856 (958)
..... ........|++.|+|||++.+..++.++||||||+++|||++ |+.||........ .....
T Consensus 169 ~~~~~----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~-~~~~~--------- 234 (291)
T 1xbb_A 169 ADENY----YKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEV-TAMLE--------- 234 (291)
T ss_dssp TTCSE----EEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHH-HHHHH---------
T ss_pred cCCCc----ccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHHHH-HHHHH---------
Confidence 32210 111223446788999999999889999999999999999999 9999976443221 11111
Q ss_pred cccCCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHhhCC
Q 002158 857 DNRMGSYPSECVERFVTLALRCCHDKPEHRPSMSDVVRELENILKMFP 904 (958)
Q Consensus 857 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~~ 904 (958)
.......+..++..+.+++.+||+.||++||++.++++.|+++....+
T Consensus 235 ~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~~ 282 (291)
T 1xbb_A 235 KGERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDVV 282 (291)
T ss_dssp TTCCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHHHH
T ss_pred cCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHHh
Confidence 111223455677889999999999999999999999999999886543
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-39 Score=356.90 Aligned_cols=269 Identities=24% Similarity=0.361 Sum_probs=208.6
Q ss_pred cChHHHHHHHcCCCCCceeeeeCCeEEEEEEECCCcEEEEEEeccCChhcHHHHHHHHHHHHcc--CCCCcceEEEEEEe
Q 002158 615 FKFKELAMATAYFSSSTQVGQGGYGKVYKGILSDNTTVAIKRAEEGSLQGQNEFLTEIKLLSRL--HHRNLVSLLGYCDE 692 (958)
Q Consensus 615 ~~~~el~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l--~H~niv~l~~~~~~ 692 (958)
.....-....++|...+.||+|+||.||+|.+. ++.||||++... ....+.+|.+++... +||||+++++++..
T Consensus 27 ~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~---~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~ 102 (337)
T 3mdy_A 27 LPLLVQRTIAKQIQMVKQIGKGRYGEVWMGKWR-GEKVAVKVFFTT---EEASWFRETEIYQTVLMRHENILGFIAADIK 102 (337)
T ss_dssp SCHHHHTTHHHHCEEEEEEEEETTEEEEEEEET-TEEEEEEEEEGG---GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEE
T ss_pred CCcccccccccceEEEeEeecCCCeEEEEEEEC-CceEEEEEEecc---ccchhhhHHHHHHHHhhcCCCeeeEEEEEcc
Confidence 333444455678999999999999999999985 899999998643 334556677766665 89999999999988
Q ss_pred C----CeEEEEEEecCCCCHHHHhccCCCCCchHHHHHHHHHHHHHHHHHhhhc--------CCCCeeccCCCccceEec
Q 002158 693 E----GEQMLVYEFVPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTE--------AHPPVFHRDIKASNILLD 760 (958)
Q Consensus 693 ~----~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~--------~~~~iiH~Dikp~NILl~ 760 (958)
. ...++||||+++|+|.++++.. .+++.+++.++.|++.||+|||+. + |+||||||+|||++
T Consensus 103 ~~~~~~~~~lv~e~~~~g~L~~~l~~~---~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~---ivH~Dikp~Nill~ 176 (337)
T 3mdy_A 103 GTGSWTQLYLITDYHENGSLYDYLKST---TLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPA---IAHRDLKSKNILVK 176 (337)
T ss_dssp SCGGGCEEEEEECCCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCC---EECSCCCGGGEEEC
T ss_pred CCCCCCceEEEEeccCCCcHHHHhhcc---CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCC---EEecccchHHEEEC
Confidence 7 7899999999999999999754 389999999999999999999998 6 99999999999999
Q ss_pred CCCCeEEeeeeeecccccCCCCCCccceeeeeccCCCCccChhhhccCCCCCc------chhhhHHHHHHHHHhC-----
Q 002158 761 SNLNAKVADFGLSRLAPVLDDEGTMPTHVSTIVKGTPGYLDPEYFLTHKLTDK------SDVYSLGVVLLELLTG----- 829 (958)
Q Consensus 761 ~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~------~DV~S~Gv~l~elltG----- 829 (958)
.++.+||+|||+++......... ........||+.|+|||++.+.....+ +|||||||++|||++|
T Consensus 177 ~~~~~kl~Dfg~a~~~~~~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~ 253 (337)
T 3mdy_A 177 KNGTCCIADLGLAVKFISDTNEV---DIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGG 253 (337)
T ss_dssp TTSCEEECCCTTCEECC------------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTT
T ss_pred CCCCEEEEeCCCceeeccccccc---cCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCccc
Confidence 99999999999997653322111 111224569999999999988776665 9999999999999999
Q ss_pred -----CCCCCCCch---hHHHHHHHhhcCcchhhhcccCCCCC-----hHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 002158 830 -----MQPISHGKN---IVREVNVARDSGMVFSIIDNRMGSYP-----SECVERFVTLALRCCHDKPEHRPSMSDVVREL 896 (958)
Q Consensus 830 -----~~P~~~~~~---~~~~~~~~~~~~~~~~~i~~~~~~~~-----~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 896 (958)
+.||..... ........... .......+ ..++..+.+++.+||+.||++||+++|++++|
T Consensus 254 ~~~~~~~p~~~~~~~~~~~~~~~~~~~~-------~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L 326 (337)
T 3mdy_A 254 IVEEYQLPYHDLVPSDPSYEDMREIVCI-------KKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTL 326 (337)
T ss_dssp BCCCCCCTTTTTSCSSCCHHHHHHHHTT-------SCCCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHH
T ss_pred ccccccccHhhhcCCCCchhhhHHHHhh-------hccCccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHHH
Confidence 666643211 11111111100 01111222 37889999999999999999999999999999
Q ss_pred HHhHhhC
Q 002158 897 ENILKMF 903 (958)
Q Consensus 897 ~~~~~~~ 903 (958)
+++.+..
T Consensus 327 ~~l~~~~ 333 (337)
T 3mdy_A 327 AKMSESQ 333 (337)
T ss_dssp HHHHHTT
T ss_pred HHHHhhc
Confidence 9988654
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-39 Score=388.45 Aligned_cols=254 Identities=27% Similarity=0.447 Sum_probs=206.6
Q ss_pred eeeeeCCeEEEEEEEC---CCcEEEEEEeccCC-hhcHHHHHHHHHHHHccCCCCcceEEEEEEeCCeEEEEEEecCCCC
Q 002158 632 QVGQGGYGKVYKGILS---DNTTVAIKRAEEGS-LQGQNEFLTEIKLLSRLHHRNLVSLLGYCDEEGEQMLVYEFVPNGT 707 (958)
Q Consensus 632 ~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E~~~~gs 707 (958)
.||+|+||+||+|.+. ++..||||+++... ....++|.+|++++++++||||+++++++.. +..++||||+++|+
T Consensus 343 ~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv~E~~~~g~ 421 (613)
T 2ozo_A 343 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVMEMAGGGP 421 (613)
T ss_dssp EEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEEEEEECCTTCB
T ss_pred EEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeEEEEEeCCCCc
Confidence 7999999999999874 46679999998653 3456789999999999999999999999976 56999999999999
Q ss_pred HHHHhccCCCCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEecCCCCeEEeeeeeecccccCCCCCCccc
Q 002158 708 LRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSRLAPVLDDEGTMPT 787 (958)
Q Consensus 708 L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~ 787 (958)
|.+++... ...+++.++..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+++........ .
T Consensus 422 L~~~l~~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~---iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~~~~~----~ 493 (613)
T 2ozo_A 422 LHKFLVGK-REEIPVSNVAELLHQVSMGMKYLEEKN---FVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSY----Y 493 (613)
T ss_dssp HHHHHTTC-TTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCSTTTTCC----------
T ss_pred HHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHHCC---EEcCcCCHHHEEEcCCCcEEEeeccCcccccCCCce----e
Confidence 99999754 345899999999999999999999999 999999999999999999999999999865322211 1
Q ss_pred eeeeeccCCCCccChhhhccCCCCCcchhhhHHHHHHHHHh-CCCCCCCCchhHHHHHHHhhcCcchhhhcccCCCCChH
Q 002158 788 HVSTIVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVLLELLT-GMQPISHGKNIVREVNVARDSGMVFSIIDNRMGSYPSE 866 (958)
Q Consensus 788 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gv~l~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~ 866 (958)
.......+++.|+|||++.+..++.++|||||||++|||++ |+.||........ ..... .......+..
T Consensus 494 ~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~-~~~i~---------~~~~~~~p~~ 563 (613)
T 2ozo_A 494 TARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEV-MAFIE---------QGKRMECPPE 563 (613)
T ss_dssp --------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHHH-HHHHH---------TTCCCCCCTT
T ss_pred eeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHHH-HHHHH---------cCCCCCCCCc
Confidence 11223346789999999999999999999999999999998 9999976543221 11111 1112344667
Q ss_pred HHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHhhCC
Q 002158 867 CVERFVTLALRCCHDKPEHRPSMSDVVRELENILKMFP 904 (958)
Q Consensus 867 ~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~~ 904 (958)
++..+.+++.+||+.||++||+++++++.|+.+.....
T Consensus 564 ~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~~~~ 601 (613)
T 2ozo_A 564 CPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLA 601 (613)
T ss_dssp CCHHHHHHHHHTTCSSTTTSCCHHHHHHHHHHHHHHHS
T ss_pred CCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHHhc
Confidence 88999999999999999999999999999999876554
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-40 Score=375.10 Aligned_cols=264 Identities=23% Similarity=0.252 Sum_probs=210.7
Q ss_pred cChHHHHHHHcCCCCCceeeeeCCeEEEEEEEC-CCcEEEEEEeccCCh---hcHHHHHHHHHHHHccCCCCcceEEEEE
Q 002158 615 FKFKELAMATAYFSSSTQVGQGGYGKVYKGILS-DNTTVAIKRAEEGSL---QGQNEFLTEIKLLSRLHHRNLVSLLGYC 690 (958)
Q Consensus 615 ~~~~el~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~H~niv~l~~~~ 690 (958)
+.+++.....++|...+.||+|+||+||+|+.+ +++.||||++..... ...+.+.+|.+++..++||||+++++++
T Consensus 51 ~~~~~~~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~ 130 (412)
T 2vd5_A 51 VRLKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAF 130 (412)
T ss_dssp HHHHHHSCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEE
T ss_pred hhhhhccCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEE
Confidence 345566667788999999999999999999986 699999999975321 1223588999999999999999999999
Q ss_pred EeCCeEEEEEEecCCCCHHHHhccCCCCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEecCCCCeEEeee
Q 002158 691 DEEGEQMLVYEFVPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSNLNAKVADF 770 (958)
Q Consensus 691 ~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~~~~kl~DF 770 (958)
.+.+..|+||||+++|+|.+++.... ..+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+||
T Consensus 131 ~~~~~~~lVmE~~~gg~L~~~l~~~~-~~l~~~~~~~~~~qi~~aL~~LH~~g---iiHrDLKp~NILld~~g~vkL~DF 206 (412)
T 2vd5_A 131 QDENYLYLVMEYYVGGDLLTLLSKFG-ERIPAEMARFYLAEIVMAIDSVHRLG---YVHRDIKPDNILLDRCGHIRLADF 206 (412)
T ss_dssp ECSSEEEEEECCCCSCBHHHHHHHHS-SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCC
T ss_pred eeCCEEEEEEcCCCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccCHHHeeecCCCCEEEeec
Confidence 99999999999999999999997543 34899999999999999999999999 999999999999999999999999
Q ss_pred eeecccccCCCCCCccceeeeeccCCCCccChhhhc-------cCCCCCcchhhhHHHHHHHHHhCCCCCCCCchhHHHH
Q 002158 771 GLSRLAPVLDDEGTMPTHVSTIVKGTPGYLDPEYFL-------THKLTDKSDVYSLGVVLLELLTGMQPISHGKNIVREV 843 (958)
Q Consensus 771 Gla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-------~~~~~~~~DV~S~Gv~l~elltG~~P~~~~~~~~~~~ 843 (958)
|+++...... ........||+.|+|||++. ...++.++|||||||++|||++|+.||..........
T Consensus 207 Gla~~~~~~~------~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~ 280 (412)
T 2vd5_A 207 GSCLKLRADG------TVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYG 280 (412)
T ss_dssp TTCEECCTTS------CEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHH
T ss_pred hhheeccCCC------ccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHHHHH
Confidence 9998653211 11223467999999999997 3568999999999999999999999997654322211
Q ss_pred HHHhhcCcchhhhcccCCCCChHHHHHHHHHHHHccccCCCCC---CCHHHHHHH
Q 002158 844 NVARDSGMVFSIIDNRMGSYPSECVERFVTLALRCCHDKPEHR---PSMSDVVRE 895 (958)
Q Consensus 844 ~~~~~~~~~~~~i~~~~~~~~~~~~~~l~~li~~cl~~dP~~R---Ps~~evl~~ 895 (958)
...... .....+..+..++.++.+++.+||. +|.+| |+++|++++
T Consensus 281 ~i~~~~------~~~~~p~~~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~H 328 (412)
T 2vd5_A 281 KIVHYK------EHLSLPLVDEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRTH 328 (412)
T ss_dssp HHHTHH------HHCCCC----CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHTS
T ss_pred HHHhcc------cCcCCCccccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhcC
Confidence 111100 0001111223466789999999999 99998 689999875
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-40 Score=354.98 Aligned_cols=252 Identities=29% Similarity=0.445 Sum_probs=203.7
Q ss_pred cCCCCCceeeeeCCeEEEEEEECCCcEEEEEEeccCChhcHHHHHHHHHHHHccCCCCcceEEEEEEeC-CeEEEEEEec
Q 002158 625 AYFSSSTQVGQGGYGKVYKGILSDNTTVAIKRAEEGSLQGQNEFLTEIKLLSRLHHRNLVSLLGYCDEE-GEQMLVYEFV 703 (958)
Q Consensus 625 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~-~~~~lV~E~~ 703 (958)
++|...+.||+|+||+||+|.+ .|+.||||+++... ..+.+.+|++++++++||||+++++++... +..++||||+
T Consensus 21 ~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~ 97 (278)
T 1byg_A 21 KELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM 97 (278)
T ss_dssp GGEEEEEEEEECSSCEEEEEEE-TTEEEEEEECCCCC----HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCC
T ss_pred hhceEEeEEecCCCceEEEEEE-cCCEEEEEEecchh--HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEEecC
Confidence 4677888999999999999988 58899999997643 456799999999999999999999997554 4789999999
Q ss_pred CCCCHHHHhccCCCCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEecCCCCeEEeeeeeecccccCCCCC
Q 002158 704 PNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSRLAPVLDDEG 783 (958)
Q Consensus 704 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 783 (958)
++++|.+++.......+++..+..++.|+++||+|||+++ |+||||||+||+++.++.+||+|||+++.....
T Consensus 98 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~---- 170 (278)
T 1byg_A 98 AKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASST---- 170 (278)
T ss_dssp TTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEEECCCCC-----------
T ss_pred CCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCCcceEEEeCCCcEEEeecccccccccc----
Confidence 9999999997654444788999999999999999999999 999999999999999999999999998754211
Q ss_pred CccceeeeeccCCCCccChhhhccCCCCCcchhhhHHHHHHHHHh-CCCCCCCCchhHHHHHHHhhcCcchhhhcccCCC
Q 002158 784 TMPTHVSTIVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVLLELLT-GMQPISHGKNIVREVNVARDSGMVFSIIDNRMGS 862 (958)
Q Consensus 784 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gv~l~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~ 862 (958)
.....+++.|+|||++.+..++.++||||||+++|||++ |+.||....... ...... ......
T Consensus 171 ------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~-~~~~~~---------~~~~~~ 234 (278)
T 1byg_A 171 ------QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD-VVPRVE---------KGYKMD 234 (278)
T ss_dssp -----------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGG-HHHHHT---------TTCCCC
T ss_pred ------ccCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHH-HHHHHh---------cCCCCC
Confidence 122357889999999999999999999999999999998 999997543211 111111 111223
Q ss_pred CChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHhh
Q 002158 863 YPSECVERFVTLALRCCHDKPEHRPSMSDVVRELENILKM 902 (958)
Q Consensus 863 ~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~ 902 (958)
.+..++..+.+++.+||+.||++||++.|+++.|+++...
T Consensus 235 ~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~i~~~ 274 (278)
T 1byg_A 235 APDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKTH 274 (278)
T ss_dssp CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CcccCCHHHHHHHHHHhcCChhhCCCHHHHHHHHHHHHhh
Confidence 4556678899999999999999999999999999998653
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-39 Score=362.37 Aligned_cols=263 Identities=25% Similarity=0.305 Sum_probs=206.3
Q ss_pred HHHHHcCCCCCceeeeeCCeEEEEEEEC-CCcEEEEEEeccC-----ChhcHHHHHHHHHHHHccCCCCcceEEEEEEeC
Q 002158 620 LAMATAYFSSSTQVGQGGYGKVYKGILS-DNTTVAIKRAEEG-----SLQGQNEFLTEIKLLSRLHHRNLVSLLGYCDEE 693 (958)
Q Consensus 620 l~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~ 693 (958)
+....++|...+.||+|+||+||+|.+. +++.||+|++... .....+.+.+|++++++++||||+++++++.+.
T Consensus 21 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~ 100 (345)
T 3hko_A 21 LLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDE 100 (345)
T ss_dssp HHHHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred hhhhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccC
Confidence 3445678999999999999999999985 6889999998643 234456799999999999999999999999999
Q ss_pred CeEEEEEEecCCCCHHHHhccC--------------------------------------CCCCchHHHHHHHHHHHHHH
Q 002158 694 GEQMLVYEFVPNGTLRDWLSGR--------------------------------------TKENLNFAMRLRVALDSAKG 735 (958)
Q Consensus 694 ~~~~lV~E~~~~gsL~~~l~~~--------------------------------------~~~~l~~~~~~~i~~~ia~a 735 (958)
+..++||||+++|+|.+++... ....+++..+..++.|+++|
T Consensus 101 ~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~ 180 (345)
T 3hko_A 101 QYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSA 180 (345)
T ss_dssp SEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHH
T ss_pred CeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHH
Confidence 9999999999999999999521 01235788889999999999
Q ss_pred HHHhhhcCCCCeeccCCCccceEecCCC--CeEEeeeeeecccccCCCCCCccceeeeeccCCCCccChhhhcc--CCCC
Q 002158 736 ILYLHTEAHPPVFHRDIKASNILLDSNL--NAKVADFGLSRLAPVLDDEGTMPTHVSTIVKGTPGYLDPEYFLT--HKLT 811 (958)
Q Consensus 736 L~yLH~~~~~~iiH~Dikp~NILl~~~~--~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~ 811 (958)
|+|||+.+ |+||||||+||+++.++ .+||+|||+++......... ........||+.|+|||++.+ ..++
T Consensus 181 l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~ 254 (345)
T 3hko_A 181 LHYLHNQG---ICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGE---YYGMTTKAGTPYFVAPEVLNTTNESYG 254 (345)
T ss_dssp HHHHHHTT---EECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC-----------CCCGGGCCHHHHTCSSSCCC
T ss_pred HHHHHHCC---ccccCCChhhEEEecCCCceEEEeeccccccccccCccc---cccccccCCCccccCchhhccCCCCCC
Confidence 99999999 99999999999998776 89999999998654322211 112234569999999999975 6788
Q ss_pred CcchhhhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcCcchhhhcccCCCCChHHHHHHHHHHHHccccCCCCCCCHHH
Q 002158 812 DKSDVYSLGVVLLELLTGMQPISHGKNIVREVNVARDSGMVFSIIDNRMGSYPSECVERFVTLALRCCHDKPEHRPSMSD 891 (958)
Q Consensus 812 ~~~DV~S~Gv~l~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~e 891 (958)
.++||||||+++|||++|+.||............... ..... .......+..+.+++.+||+.||++||++.|
T Consensus 255 ~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~-~~~~~------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ 327 (345)
T 3hko_A 255 PKCDAWSAGVLLHLLLMGAVPFPGVNDADTISQVLNK-KLCFE------NPNYNVLSPLARDLLSNLLNRNVDERFDAMR 327 (345)
T ss_dssp THHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC-CCCTT------SGGGGGSCHHHHHHHHHHSCSCTTTSCCHHH
T ss_pred cHHHHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHhc-ccccC------CcccccCCHHHHHHHHHHcCCChhHCCCHHH
Confidence 9999999999999999999999765543322222111 11100 0011235678999999999999999999999
Q ss_pred HHHH
Q 002158 892 VVRE 895 (958)
Q Consensus 892 vl~~ 895 (958)
++++
T Consensus 328 ~l~h 331 (345)
T 3hko_A 328 ALQH 331 (345)
T ss_dssp HHHS
T ss_pred HhcC
Confidence 9975
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-39 Score=354.12 Aligned_cols=266 Identities=27% Similarity=0.390 Sum_probs=212.1
Q ss_pred CCCCCceeeeeCCeEEEEEEECC----CcEEEEEEeccCC-hhcHHHHHHHHHHHHccCCCCcceEEEEEEeCCeE-EEE
Q 002158 626 YFSSSTQVGQGGYGKVYKGILSD----NTTVAIKRAEEGS-LQGQNEFLTEIKLLSRLHHRNLVSLLGYCDEEGEQ-MLV 699 (958)
Q Consensus 626 ~~~~~~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~-~lV 699 (958)
.|...+.||+|+||+||+|.+.+ +..||+|++.... ....+.|.+|++++++++||||+++++++...+.. ++|
T Consensus 22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v 101 (298)
T 3pls_A 22 VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVL 101 (298)
T ss_dssp EEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEE
T ss_pred EEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEEE
Confidence 34456789999999999998642 2379999987643 34457899999999999999999999999776655 999
Q ss_pred EEecCCCCHHHHhccCCCCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEecCCCCeEEeeeeeecccccC
Q 002158 700 YEFVPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSRLAPVL 779 (958)
Q Consensus 700 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~~~~~ 779 (958)
|||+.+|+|.+++.... ..+++.++..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+++.....
T Consensus 102 ~e~~~~~~L~~~~~~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~ 177 (298)
T 3pls_A 102 LPYMCHGDLLQFIRSPQ-RNPTVKDLISFGLQVARGMEYLAEQK---FVHRDLAARNCMLDESFTVKVADFGLARDILDR 177 (298)
T ss_dssp ECCCTTCBHHHHHHCTT-CCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECCTTSSCTTTTG
T ss_pred EecccCCCHHHHHhccc-cCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCcEEeCcCCCcccccCC
Confidence 99999999999997643 45899999999999999999999999 999999999999999999999999999754321
Q ss_pred CCCCCccceeeeeccCCCCccChhhhccCCCCCcchhhhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcCcchhhhccc
Q 002158 780 DDEGTMPTHVSTIVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVLLELLTGMQPISHGKNIVREVNVARDSGMVFSIIDNR 859 (958)
Q Consensus 780 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gv~l~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~i~~~ 859 (958)
.. ..........||+.|+|||.+.+..++.++||||||+++|||++|..|+............... ..
T Consensus 178 ~~---~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~---------~~ 245 (298)
T 3pls_A 178 EY---YSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLAQ---------GR 245 (298)
T ss_dssp GG---GCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGGGHHHHHHT---------TC
T ss_pred cc---cccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCHHHHHHHhhc---------CC
Confidence 11 1112223456888999999999999999999999999999999966665433322222111111 11
Q ss_pred CCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHhhCCCCC
Q 002158 860 MGSYPSECVERFVTLALRCCHDKPEHRPSMSDVVRELENILKMFPETD 907 (958)
Q Consensus 860 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~~~~~ 907 (958)
....+..++..+.+++.+||+.||.+|||++++++.|+++++.+....
T Consensus 246 ~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~l~~~~ 293 (298)
T 3pls_A 246 RLPQPEYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQIVSALLGDH 293 (298)
T ss_dssp CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHCCSCC
T ss_pred CCCCCccchHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHHhccc
Confidence 122345567889999999999999999999999999999998876543
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-40 Score=366.18 Aligned_cols=269 Identities=16% Similarity=0.180 Sum_probs=202.8
Q ss_pred cCCCCCceeeeeCCeEEEEEEEC----CCcEEEEEEeccCChh-----------cHHHHHHHHHHHHccCCCCcceEEEE
Q 002158 625 AYFSSSTQVGQGGYGKVYKGILS----DNTTVAIKRAEEGSLQ-----------GQNEFLTEIKLLSRLHHRNLVSLLGY 689 (958)
Q Consensus 625 ~~~~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~-----------~~~~~~~E~~~l~~l~H~niv~l~~~ 689 (958)
++|...+.||+|+||+||+|.+. .+..||||++...... ....+.+|+..++.++||||++++++
T Consensus 37 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~~ 116 (345)
T 2v62_A 37 NQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYGS 116 (345)
T ss_dssp CEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEEE
T ss_pred ceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeecc
Confidence 56778899999999999999986 5788999998764321 11246788999999999999999999
Q ss_pred EEe----CCeEEEEEEecCCCCHHHHhccCCCCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEecCCC--
Q 002158 690 CDE----EGEQMLVYEFVPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSNL-- 763 (958)
Q Consensus 690 ~~~----~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~~-- 763 (958)
+.. ....++||||+ +++|.+++.... .+++.+++.++.|++.||+|||+.+ |+||||||+|||++.++
T Consensus 117 ~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~ 190 (345)
T 2v62_A 117 GLTEFKGRSYRFMVMERL-GIDLQKISGQNG--TFKKSTVLQLGIRMLDVLEYIHENE---YVHGDIKAANLLLGYKNPD 190 (345)
T ss_dssp EEEESSSCEEEEEEEECE-EEEHHHHCBGGG--BCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEESSSTT
T ss_pred cccccCCCcEEEEEEecc-CCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCcCHHHEEEccCCCC
Confidence 987 67899999999 999999997654 5999999999999999999999999 99999999999999887
Q ss_pred CeEEeeeeeecccccCCCCCCccceeeeeccCCCCccChhhhccCCCCCcchhhhHHHHHHHHHhCCCCCCCCchhHHHH
Q 002158 764 NAKVADFGLSRLAPVLDDEGTMPTHVSTIVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVLLELLTGMQPISHGKNIVREV 843 (958)
Q Consensus 764 ~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gv~l~elltG~~P~~~~~~~~~~~ 843 (958)
.+||+|||+++.+..................||+.|+|||++.+..++.++|||||||++|||++|+.||..........
T Consensus 191 ~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~ 270 (345)
T 2v62_A 191 QVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKDPVAV 270 (345)
T ss_dssp SEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCHHHH
T ss_pred cEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCccccccccHHH
Confidence 99999999998764333222211222245679999999999999999999999999999999999999995422111111
Q ss_pred HHHhh--cCcchhhhcccCCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHh
Q 002158 844 NVARD--SGMVFSIIDNRMGSYPSECVERFVTLALRCCHDKPEHRPSMSDVVRELENILK 901 (958)
Q Consensus 844 ~~~~~--~~~~~~~i~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~ 901 (958)
..... .......+..... ...++.++.+++.+||+.||++||+++++++.|+++..
T Consensus 271 ~~~~~~~~~~~~~~~~~~~~--~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~ 328 (345)
T 2v62_A 271 QTAKTNLLDELPQSVLKWAP--SGSSCCEIAQFLVCAHSLAYDEKPNYQALKKILNPHGI 328 (345)
T ss_dssp HHHHHHHHHTTTHHHHHHSC--TTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHCTTCC
T ss_pred HHHHHhhcccccHHHHhhcc--ccccHHHHHHHHHHHhhcCcccCCCHHHHHHHHhccCC
Confidence 11000 0000000000000 11455789999999999999999999999999987543
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-39 Score=350.84 Aligned_cols=247 Identities=28% Similarity=0.405 Sum_probs=204.9
Q ss_pred HcCCCCCceeeeeCCeEEEEEEEC-CCcEEEEEEeccCC---hhcHHHHHHHHHHHHccCCCCcceEEEEEEeCCeEEEE
Q 002158 624 TAYFSSSTQVGQGGYGKVYKGILS-DNTTVAIKRAEEGS---LQGQNEFLTEIKLLSRLHHRNLVSLLGYCDEEGEQMLV 699 (958)
Q Consensus 624 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV 699 (958)
.++|...+.||+|+||+||+|.+. +++.||||++.... ......+.+|++++++++||||+++++++.+.+..++|
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 87 (279)
T 3fdn_A 8 LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLI 87 (279)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred cccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEEE
Confidence 356788899999999999999986 57799999986532 22345788999999999999999999999999999999
Q ss_pred EEecCCCCHHHHhccCCCCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEecCCCCeEEeeeeeecccccC
Q 002158 700 YEFVPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSRLAPVL 779 (958)
Q Consensus 700 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~~~~~ 779 (958)
|||+++++|.+++.... .+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||++.....
T Consensus 88 ~e~~~~~~l~~~l~~~~--~~~~~~~~~~~~qi~~~l~~LH~~~---i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~- 161 (279)
T 3fdn_A 88 LEYAPLGTVYRELQKLS--KFDEQRTATYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAPS- 161 (279)
T ss_dssp ECCCTTEEHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHTTT---CEECCCCGGGEEECTTSCEEECSCCEESCC---
T ss_pred EecCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCC---EecccCChHhEEEcCCCCEEEEeccccccCCc-
Confidence 99999999999997543 3899999999999999999999999 99999999999999999999999999864321
Q ss_pred CCCCCccceeeeeccCCCCccChhhhccCCCCCcchhhhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcCcchhhhccc
Q 002158 780 DDEGTMPTHVSTIVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVLLELLTGMQPISHGKNIVREVNVARDSGMVFSIIDNR 859 (958)
Q Consensus 780 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gv~l~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~i~~~ 859 (958)
.......||+.|+|||++.+..++.++||||||+++|||++|+.||........ ..... ..
T Consensus 162 --------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~-~~~~~----------~~ 222 (279)
T 3fdn_A 162 --------SRRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQET-YKRIS----------RV 222 (279)
T ss_dssp --------------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHH-HHHHH----------HT
T ss_pred --------ccccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcHHHH-HHHHH----------hC
Confidence 112345689999999999999999999999999999999999999975443221 11111 11
Q ss_pred CCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 002158 860 MGSYPSECVERFVTLALRCCHDKPEHRPSMSDVVRE 895 (958)
Q Consensus 860 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 895 (958)
....+...+..+.+++.+||+.||++||+++|++++
T Consensus 223 ~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~h 258 (279)
T 3fdn_A 223 EFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLEH 258 (279)
T ss_dssp CCCCCTTSCHHHHHHHHHHCCSSGGGSCCHHHHHHC
T ss_pred CCCCCCcCCHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 123345567889999999999999999999999986
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-39 Score=356.67 Aligned_cols=248 Identities=22% Similarity=0.325 Sum_probs=206.7
Q ss_pred HcCCCCCceeeeeCCeEEEEEEEC-CCcEEEEEEeccCChh------cHHHHHHHHHHHHccCCCCcceEEEEEEeCCeE
Q 002158 624 TAYFSSSTQVGQGGYGKVYKGILS-DNTTVAIKRAEEGSLQ------GQNEFLTEIKLLSRLHHRNLVSLLGYCDEEGEQ 696 (958)
Q Consensus 624 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~------~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~ 696 (958)
.++|...+.||+|+||.||+|.+. +|+.||||++...... ..+.+.+|++++++++||||+++++++...+..
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 90 (321)
T 2a2a_A 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDV 90 (321)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred hccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEE
Confidence 456888899999999999999986 6899999998764321 356799999999999999999999999999999
Q ss_pred EEEEEecCCCCHHHHhccCCCCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEecCCC----CeEEeeeee
Q 002158 697 MLVYEFVPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSNL----NAKVADFGL 772 (958)
Q Consensus 697 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~~----~~kl~DFGl 772 (958)
++||||+++++|.+++... ..+++..+..++.|++.||+|||+.+ |+||||||+||+++.++ .+||+|||+
T Consensus 91 ~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~lH~~~---ivH~dikp~NIl~~~~~~~~~~~kl~Dfg~ 165 (321)
T 2a2a_A 91 VLILELVSGGELFDFLAQK--ESLSEEEATSFIKQILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFGL 165 (321)
T ss_dssp EEEECCCCSCBHHHHHHTC--SCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCTTSSSCCEEECCCTT
T ss_pred EEEEEcCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCChHHEEEecCCCCcCCEEEccCcc
Confidence 9999999999999999754 34999999999999999999999999 99999999999999888 799999999
Q ss_pred ecccccCCCCCCccceeeeeccCCCCccChhhhccCCCCCcchhhhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcCcc
Q 002158 773 SRLAPVLDDEGTMPTHVSTIVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVLLELLTGMQPISHGKNIVREVNVARDSGMV 852 (958)
Q Consensus 773 a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gv~l~elltG~~P~~~~~~~~~~~~~~~~~~~~ 852 (958)
++...... ......||+.|+|||++.+..++.++||||||+++|||++|+.||.......... .....
T Consensus 166 ~~~~~~~~--------~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~-~i~~~--- 233 (321)
T 2a2a_A 166 AHEIEDGV--------EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLA-NITSV--- 233 (321)
T ss_dssp CEECCTTC--------CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHH-HHHTT---
T ss_pred ceecCccc--------cccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCHHHHHH-HHHhc---
Confidence 98653211 1123469999999999999999999999999999999999999997544322211 11110
Q ss_pred hhhhcccCCCCC----hHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 002158 853 FSIIDNRMGSYP----SECVERFVTLALRCCHDKPEHRPSMSDVVRE 895 (958)
Q Consensus 853 ~~~i~~~~~~~~----~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 895 (958)
....+ ...+..+.+++.+||+.||++||+++|++++
T Consensus 234 -------~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~h 273 (321)
T 2a2a_A 234 -------SYDFDEEFFSHTSELAKDFIRKLLVKETRKRLTIQEALRH 273 (321)
T ss_dssp -------CCCCCHHHHTTCCHHHHHHHHTTSCSSTTTSCCHHHHHHS
T ss_pred -------ccccChhhhcccCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 01111 2345678999999999999999999999974
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-39 Score=364.17 Aligned_cols=247 Identities=26% Similarity=0.426 Sum_probs=203.6
Q ss_pred cCCCCCceeeeeCCeEEEEEEEC-CCcEEEEEEeccCC---hhcHHHHHHHHHHHHccCCCCcceEEEEEEeCCeEEEEE
Q 002158 625 AYFSSSTQVGQGGYGKVYKGILS-DNTTVAIKRAEEGS---LQGQNEFLTEIKLLSRLHHRNLVSLLGYCDEEGEQMLVY 700 (958)
Q Consensus 625 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~ 700 (958)
..|...+.||+|+||+||+|... +++.||||++.... ....+++.+|++++++++||||+++++++..++..++||
T Consensus 54 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 133 (348)
T 1u5q_A 54 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 133 (348)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEEE
Confidence 45777889999999999999974 78999999987542 223457899999999999999999999999999999999
Q ss_pred EecCCCCHHHHhccCCCCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEecCCCCeEEeeeeeecccccCC
Q 002158 701 EFVPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSRLAPVLD 780 (958)
Q Consensus 701 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~ 780 (958)
||++ |+|.+++.... ..+++.++..++.|+++||+|||+.+ |+||||||+|||++.++.+||+|||+++....
T Consensus 134 e~~~-g~l~~~l~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~-- 206 (348)
T 1u5q_A 134 EYCL-GSASDLLEVHK-KPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAP-- 206 (348)
T ss_dssp ECCS-EEHHHHHHHHT-SCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTEEEECCCTTCBSSSS--
T ss_pred ecCC-CCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEeeccCceecCC--
Confidence 9996 68888886433 34899999999999999999999999 99999999999999999999999999975421
Q ss_pred CCCCccceeeeeccCCCCccChhhhc---cCCCCCcchhhhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcCcchhhhc
Q 002158 781 DEGTMPTHVSTIVKGTPGYLDPEYFL---THKLTDKSDVYSLGVVLLELLTGMQPISHGKNIVREVNVARDSGMVFSIID 857 (958)
Q Consensus 781 ~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DV~S~Gv~l~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~i~ 857 (958)
.....||+.|+|||++. ...++.++|||||||++|||++|+.||............... .
T Consensus 207 ---------~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~-~------- 269 (348)
T 1u5q_A 207 ---------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQN-E------- 269 (348)
T ss_dssp ---------BCCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHS-C-------
T ss_pred ---------CCcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhc-C-------
Confidence 12346999999999985 567899999999999999999999999765543322221111 0
Q ss_pred ccCCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 002158 858 NRMGSYPSECVERFVTLALRCCHDKPEHRPSMSDVVREL 896 (958)
Q Consensus 858 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 896 (958)
.....+..++..+.+++.+||+.||++||++++++++.
T Consensus 270 -~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~h~ 307 (348)
T 1u5q_A 270 -SPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHR 307 (348)
T ss_dssp -CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTCH
T ss_pred -CCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHhhCh
Confidence 01112334567889999999999999999999998753
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=360.89 Aligned_cols=266 Identities=23% Similarity=0.328 Sum_probs=199.3
Q ss_pred cCCCC-CceeeeeCCeEEEEEEEC-CCcEEEEEEeccCChhcHHHHHHHHHHHHcc-CCCCcceEEEEEEeCCeEEEEEE
Q 002158 625 AYFSS-STQVGQGGYGKVYKGILS-DNTTVAIKRAEEGSLQGQNEFLTEIKLLSRL-HHRNLVSLLGYCDEEGEQMLVYE 701 (958)
Q Consensus 625 ~~~~~-~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lV~E 701 (958)
+.|.+ .+.||+|+||+||+|.+. +++.||||++........+.+.+|++++.++ +||||+++++++.+++..++|||
T Consensus 12 ~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e 91 (316)
T 2ac3_A 12 DVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFE 91 (316)
T ss_dssp TSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred eeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEEE
Confidence 35555 367999999999999965 7899999999876555677899999999995 79999999999999999999999
Q ss_pred ecCCCCHHHHhccCCCCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEecCCCC---eEEeeeeeeccccc
Q 002158 702 FVPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSNLN---AKVADFGLSRLAPV 778 (958)
Q Consensus 702 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~~~---~kl~DFGla~~~~~ 778 (958)
|+++|+|.+++.... .+++.++..++.|+++||+|||+++ |+||||||+|||++.++. +||+|||+++....
T Consensus 92 ~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~~ 166 (316)
T 2ac3_A 92 KMRGGSILSHIHKRR--HFNELEASVVVQDVASALDFLHNKG---IAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKL 166 (316)
T ss_dssp CCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEESCSSSSCSEEECCTTCCC----
T ss_pred cCCCCcHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHhCC---ceeCCCCHHHEEEccCCCcCceEEEEccCcccccc
Confidence 999999999997643 4899999999999999999999999 999999999999998776 99999999876533
Q ss_pred CCCCCCccceeeeeccCCCCccChhhhcc-----CCCCCcchhhhHHHHHHHHHhCCCCCCCCchhH---HHHHH-Hhhc
Q 002158 779 LDDEGTMPTHVSTIVKGTPGYLDPEYFLT-----HKLTDKSDVYSLGVVLLELLTGMQPISHGKNIV---REVNV-ARDS 849 (958)
Q Consensus 779 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DV~S~Gv~l~elltG~~P~~~~~~~~---~~~~~-~~~~ 849 (958)
................||+.|+|||++.. ..++.++|||||||++|||++|+.||....... ..... ....
T Consensus 167 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~ 246 (316)
T 2ac3_A 167 NGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQ 246 (316)
T ss_dssp ---------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCHHHH
T ss_pred CCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccccchhHH
Confidence 22211111122234569999999999975 568899999999999999999999997532110 00000 0000
Q ss_pred CcchhhhcccCCCCCh----HHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 002158 850 GMVFSIIDNRMGSYPS----ECVERFVTLALRCCHDKPEHRPSMSDVVRE 895 (958)
Q Consensus 850 ~~~~~~i~~~~~~~~~----~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 895 (958)
....+.+.......+. .++..+.+++.+||+.||++||+++|++++
T Consensus 247 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h 296 (316)
T 2ac3_A 247 NMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQH 296 (316)
T ss_dssp HHHHHHHHHCCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred HHHHHHHhccCcccCchhcccCCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence 0001111111112222 245789999999999999999999999974
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-39 Score=383.86 Aligned_cols=252 Identities=25% Similarity=0.356 Sum_probs=211.0
Q ss_pred HcCCCCCceeeeeCCeEEEEEEEC-CCcEEEEEEeccCC---hhcHHHHHHHHHHHHccCCCCcceEEEEEEeCCeEEEE
Q 002158 624 TAYFSSSTQVGQGGYGKVYKGILS-DNTTVAIKRAEEGS---LQGQNEFLTEIKLLSRLHHRNLVSLLGYCDEEGEQMLV 699 (958)
Q Consensus 624 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV 699 (958)
.++|...+.||+|+||.||+|..+ +|+.||||++.... ......+.+|++++++++||||+++++++.+.+..++|
T Consensus 183 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV 262 (576)
T 2acx_A 183 KNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLV 262 (576)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEEE
Confidence 456888899999999999999986 69999999986532 22345688999999999999999999999999999999
Q ss_pred EEecCCCCHHHHhccCCCCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEecCCCCeEEeeeeeecccccC
Q 002158 700 YEFVPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSRLAPVL 779 (958)
Q Consensus 700 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~~~~~ 779 (958)
|||+++|+|.+++.......+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++.....
T Consensus 263 mEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~~g---IvHrDLKPeNILld~~g~vKL~DFGla~~~~~~ 339 (576)
T 2acx_A 263 LTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRER---IVYRDLKPENILLDDHGHIRISDLGLAVHVPEG 339 (576)
T ss_dssp ECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred EEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeccCCchheEEEeCCCCeEEEecccceecccC
Confidence 99999999999998766556999999999999999999999999 999999999999999999999999999865321
Q ss_pred CCCCCccceeeeeccCCCCccChhhhccCCCCCcchhhhHHHHHHHHHhCCCCCCCCchh--HHHHHHHhhcCcchhhhc
Q 002158 780 DDEGTMPTHVSTIVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVLLELLTGMQPISHGKNI--VREVNVARDSGMVFSIID 857 (958)
Q Consensus 780 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gv~l~elltG~~P~~~~~~~--~~~~~~~~~~~~~~~~i~ 857 (958)
.......||+.|+|||++.+..++.++|||||||++|||++|+.||...... ...+. ..+.
T Consensus 340 --------~~~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~---------~~i~ 402 (576)
T 2acx_A 340 --------QTIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVE---------RLVK 402 (576)
T ss_dssp --------CCEECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHH---------HHHH
T ss_pred --------ccccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchhHHHHH---------HHhh
Confidence 1123457999999999999999999999999999999999999999754311 11111 1111
Q ss_pred ccCCCCChHHHHHHHHHHHHccccCCCCCC-----CHHHHHHH
Q 002158 858 NRMGSYPSECVERFVTLALRCCHDKPEHRP-----SMSDVVRE 895 (958)
Q Consensus 858 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~~ 895 (958)
.....++...+..+.+++.+||+.||.+|| +++|++++
T Consensus 403 ~~~~~~p~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~H 445 (576)
T 2acx_A 403 EVPEEYSERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKEH 445 (576)
T ss_dssp HCCCCCCTTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHTS
T ss_pred cccccCCccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHhC
Confidence 122234556678899999999999999999 78888865
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-39 Score=355.61 Aligned_cols=262 Identities=21% Similarity=0.250 Sum_probs=203.8
Q ss_pred HcCCCCCceeeeeCCeEEEEEEEC-CCcEEEEEEeccCCh---hcHHHHHHHHHHHHccCCCCcceEEEEEEeCCeEEEE
Q 002158 624 TAYFSSSTQVGQGGYGKVYKGILS-DNTTVAIKRAEEGSL---QGQNEFLTEIKLLSRLHHRNLVSLLGYCDEEGEQMLV 699 (958)
Q Consensus 624 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV 699 (958)
-++|...+.||+|+||.||+|.+. +++.||||++..... ...+.+.+|++++++++||||+++++++..++..++|
T Consensus 33 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 112 (309)
T 2h34_A 33 FGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYVD 112 (309)
T ss_dssp -CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred eccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEEE
Confidence 357888899999999999999986 688999999876432 2346789999999999999999999999999999999
Q ss_pred EEecCCCCHHHHhccCCCCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEecCCCCeEEeeeeeecccccC
Q 002158 700 YEFVPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSRLAPVL 779 (958)
Q Consensus 700 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~~~~~ 779 (958)
|||+++++|.+++.... .+++.++..++.|+++||+|||+.+ |+||||||+||+++.++.+||+|||+++.....
T Consensus 113 ~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~ 187 (309)
T 2h34_A 113 MRLINGVDLAAMLRRQG--PLAPPRAVAIVRQIGSALDAAHAAG---ATHRDVKPENILVSADDFAYLVDFGIASATTDE 187 (309)
T ss_dssp EECCCCEEHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSCCC-------
T ss_pred EEecCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCc---CCcCCCChHHEEEcCCCCEEEecCccCcccccc
Confidence 99999999999997543 4899999999999999999999999 999999999999999999999999998764321
Q ss_pred CCCCCccceeeeeccCCCCccChhhhccCCCCCcchhhhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcCcchhhhccc
Q 002158 780 DDEGTMPTHVSTIVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVLLELLTGMQPISHGKNIVREVNVARDSGMVFSIIDNR 859 (958)
Q Consensus 780 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gv~l~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~i~~~ 859 (958)
. ........||+.|+|||++.+..++.++||||||+++|||++|+.||...... ........... .
T Consensus 188 ~------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~-~~~~~~~~~~~-------~ 253 (309)
T 2h34_A 188 K------LTQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLS-VMGAHINQAIP-------R 253 (309)
T ss_dssp ---------------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHHH-HHHHHHHSCCC-------C
T ss_pred c------cccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchHH-HHHHHhccCCC-------C
Confidence 1 11123456899999999999999999999999999999999999999764432 11111111100 0
Q ss_pred CCCCChHHHHHHHHHHHHccccCCCCCC-CHHHHHHHHHHhHhhCC
Q 002158 860 MGSYPSECVERFVTLALRCCHDKPEHRP-SMSDVVRELENILKMFP 904 (958)
Q Consensus 860 ~~~~~~~~~~~l~~li~~cl~~dP~~RP-s~~evl~~L~~~~~~~~ 904 (958)
....+..++..+.+++.+||+.||++|| +++++++.|++.++...
T Consensus 254 ~~~~~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~~l~~~l~~~~ 299 (309)
T 2h34_A 254 PSTVRPGIPVAFDAVIARGMAKNPEDRYVTCGDLSAAAHAALATAD 299 (309)
T ss_dssp GGGTSTTCCTHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHTCC---
T ss_pred ccccCCCCCHHHHHHHHHhccCCHHHHHHhHHHHHHHHHHHHHhhc
Confidence 1122345667899999999999999999 99999999998765443
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=362.74 Aligned_cols=258 Identities=26% Similarity=0.433 Sum_probs=204.2
Q ss_pred cCCCCCceeeeeCCeEEEEEEEC-CCc----EEEEEEeccC-ChhcHHHHHHHHHHHHccCCCCcceEEEEEEeCCeEEE
Q 002158 625 AYFSSSTQVGQGGYGKVYKGILS-DNT----TVAIKRAEEG-SLQGQNEFLTEIKLLSRLHHRNLVSLLGYCDEEGEQML 698 (958)
Q Consensus 625 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~----~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~l 698 (958)
.+|...+.||+|+||+||+|.+. +++ .||+|.+... .....+++.+|+.++++++||||+++++++..+. .++
T Consensus 15 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~~~ 93 (327)
T 3lzb_A 15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQL 93 (327)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS-EEE
T ss_pred hHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC-ceE
Confidence 46778899999999999999975 444 3577777543 3445678999999999999999999999998764 889
Q ss_pred EEEecCCCCHHHHhccCCCCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEecCCCCeEEeeeeeeccccc
Q 002158 699 VYEFVPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSRLAPV 778 (958)
Q Consensus 699 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~~~~ 778 (958)
||||+++|+|.+++.... ..+++..++.++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+++....
T Consensus 94 v~~~~~~g~L~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~~~ 169 (327)
T 3lzb_A 94 ITQLMPFGCLLDYVREHK-DNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGA 169 (327)
T ss_dssp EECCCSSCBHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCTTC------
T ss_pred EEEecCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHhhCC---CcCCCCCHHHEEEcCCCCEEEccCcceeEccC
Confidence 999999999999997653 34899999999999999999999999 99999999999999999999999999986533
Q ss_pred CCCCCCccceeeeeccCCCCccChhhhccCCCCCcchhhhHHHHHHHHHh-CCCCCCCCchhHHHHHHHhhcCcchhhhc
Q 002158 779 LDDEGTMPTHVSTIVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVLLELLT-GMQPISHGKNIVREVNVARDSGMVFSIID 857 (958)
Q Consensus 779 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gv~l~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~i~ 857 (958)
... ........||+.|+|||++.+..++.++||||||+++|||++ |+.||......... .... .
T Consensus 170 ~~~-----~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~-~~~~---------~ 234 (327)
T 3lzb_A 170 EEK-----EYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS-SILE---------K 234 (327)
T ss_dssp ---------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHH-HHHH---------T
T ss_pred ccc-----cccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHH-HHHH---------c
Confidence 221 112223457889999999999999999999999999999999 99999754332111 1111 1
Q ss_pred ccCCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHhh
Q 002158 858 NRMGSYPSECVERFVTLALRCCHDKPEHRPSMSDVVRELENILKM 902 (958)
Q Consensus 858 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~ 902 (958)
......+..++..+.+++.+||+.||.+||++.|+++.|+++.+.
T Consensus 235 ~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~ 279 (327)
T 3lzb_A 235 GERLPQPPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMARD 279 (327)
T ss_dssp TCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHTS
T ss_pred CCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhC
Confidence 111233555678899999999999999999999999999998743
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-39 Score=349.15 Aligned_cols=252 Identities=22% Similarity=0.314 Sum_probs=206.8
Q ss_pred HcCCCCCceeeeeCCeEEEEEEEC-CCcEEEEEEeccC--ChhcHHHHHHHHHHHHccCCCCcceEEEEEEeCCeEEEEE
Q 002158 624 TAYFSSSTQVGQGGYGKVYKGILS-DNTTVAIKRAEEG--SLQGQNEFLTEIKLLSRLHHRNLVSLLGYCDEEGEQMLVY 700 (958)
Q Consensus 624 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~ 700 (958)
.++|...+.||+|+||.||+|.+. +++.||+|++... .....+.+.+|++++++++||||+++++++..++..++||
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 84 (284)
T 3kk8_A 5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF 84 (284)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEEE
Confidence 357888899999999999999986 6899999998653 3344567889999999999999999999999999999999
Q ss_pred EecCCCCHHHHhccCCCCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEecCCCC---eEEeeeeeecccc
Q 002158 701 EFVPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSNLN---AKVADFGLSRLAP 777 (958)
Q Consensus 701 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~~~---~kl~DFGla~~~~ 777 (958)
||+++++|.+++.... .+++..+..++.|++.||+|||+.+ |+||||||+||+++.++. +||+|||++....
T Consensus 85 e~~~~~~l~~~~~~~~--~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~ 159 (284)
T 3kk8_A 85 DLVTGGELFEDIVARE--FYSEADASHCIQQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVN 159 (284)
T ss_dssp CCCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESSSSTTCCEEECCCTTCEECC
T ss_pred ecCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC---cCcCCCCHHHEEEecCCCCCcEEEeeceeeEEcc
Confidence 9999999999987543 4899999999999999999999999 999999999999987655 9999999997653
Q ss_pred cCCCCCCccceeeeeccCCCCccChhhhccCCCCCcchhhhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcCcchhhhc
Q 002158 778 VLDDEGTMPTHVSTIVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVLLELLTGMQPISHGKNIVREVNVARDSGMVFSIID 857 (958)
Q Consensus 778 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gv~l~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~i~ 857 (958)
... ......||+.|+|||++.+..++.++||||+|+++|||++|+.||..................
T Consensus 160 ~~~--------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~------ 225 (284)
T 3kk8_A 160 DSE--------AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYD------ 225 (284)
T ss_dssp SSC--------BCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCC------
T ss_pred cCc--------cccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCchhHHHHHHHhcccc------
Confidence 211 122356999999999999999999999999999999999999999765433222111111000
Q ss_pred ccCCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 002158 858 NRMGSYPSECVERFVTLALRCCHDKPEHRPSMSDVVRE 895 (958)
Q Consensus 858 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 895 (958)
........++..+.+++.+||+.||++||+++|++++
T Consensus 226 -~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h 262 (284)
T 3kk8_A 226 -YPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKV 262 (284)
T ss_dssp -CCTTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred -CCchhhcccCHHHHHHHHHHcccChhhCCCHHHHhcC
Confidence 0011123456789999999999999999999999975
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-39 Score=377.55 Aligned_cols=248 Identities=22% Similarity=0.277 Sum_probs=198.8
Q ss_pred cCCCCCceeeeeCCeEEEEEEEC-CCcEEEEEEeccC---ChhcHHHHHHHHHHHHccCCCCcceEEEEEEeCCeEEEEE
Q 002158 625 AYFSSSTQVGQGGYGKVYKGILS-DNTTVAIKRAEEG---SLQGQNEFLTEIKLLSRLHHRNLVSLLGYCDEEGEQMLVY 700 (958)
Q Consensus 625 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~ 700 (958)
++|...+.||+|+||.||+|... +++.||||++... .......+.+|+++++.++||||+++++++...+..++||
T Consensus 148 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv~ 227 (446)
T 4ejn_A 148 NEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVM 227 (446)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEEEE
T ss_pred HHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEEEE
Confidence 46888899999999999999976 6899999998753 2233456889999999999999999999999999999999
Q ss_pred EecCCCCHHHHhccCCCCCchHHHHHHHHHHHHHHHHHhhh-cCCCCeeccCCCccceEecCCCCeEEeeeeeecccccC
Q 002158 701 EFVPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHT-EAHPPVFHRDIKASNILLDSNLNAKVADFGLSRLAPVL 779 (958)
Q Consensus 701 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~-~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~~~~~ 779 (958)
||+++|+|.+++.... .+++..+..++.|++.||+|||+ .+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 228 e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~g---iiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~ 302 (446)
T 4ejn_A 228 EYANGGELFFHLSRER--VFSEDRARFYGAEIVSALDYLHSEKN---VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKD 302 (446)
T ss_dssp CCCSSCBHHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHHHTC---CCCCCCCGGGEEECSSSCEEECCCCCCCTTCC-
T ss_pred eeCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHhhcCC---EEECCCCHHHEEECCCCCEEEccCCCceeccCC
Confidence 9999999999997543 48999999999999999999998 78 999999999999999999999999999753221
Q ss_pred CCCCCccceeeeeccCCCCccChhhhccCCCCCcchhhhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcCcchhhhccc
Q 002158 780 DDEGTMPTHVSTIVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVLLELLTGMQPISHGKNIVREVNVARDSGMVFSIIDNR 859 (958)
Q Consensus 780 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gv~l~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~i~~~ 859 (958)
........||+.|+|||++.+..++.++|||||||++|||++|+.||........ ..... ..
T Consensus 303 -------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~-~~~i~----------~~ 364 (446)
T 4ejn_A 303 -------GATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKL-FELIL----------ME 364 (446)
T ss_dssp -----------CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH-HHHHH----------HC
T ss_pred -------CcccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHH-HHHHH----------hC
Confidence 1122346799999999999999999999999999999999999999975443221 11111 11
Q ss_pred CCCCChHHHHHHHHHHHHccccCCCCCC-----CHHHHHHH
Q 002158 860 MGSYPSECVERFVTLALRCCHDKPEHRP-----SMSDVVRE 895 (958)
Q Consensus 860 ~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~~ 895 (958)
...+|...+..+.+++.+||+.||++|| +++|++++
T Consensus 365 ~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~h 405 (446)
T 4ejn_A 365 EIRFPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQH 405 (446)
T ss_dssp CCCCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred CCCCCccCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHhC
Confidence 1234555678899999999999999999 99999874
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-39 Score=358.83 Aligned_cols=246 Identities=22% Similarity=0.327 Sum_probs=197.2
Q ss_pred HcCCCCCceeeeeCCeEEEEEEEC-CCcEEEEEEeccCC--hhcHHHHHHHHHHHHcc-CCCCcceEEEEEEeCCeEEEE
Q 002158 624 TAYFSSSTQVGQGGYGKVYKGILS-DNTTVAIKRAEEGS--LQGQNEFLTEIKLLSRL-HHRNLVSLLGYCDEEGEQMLV 699 (958)
Q Consensus 624 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lV 699 (958)
.++|+..+.||+|+||+||+|.+. +++.||||++.... .....++..|+..+.++ +||||+++++++.+++..++|
T Consensus 56 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~lv 135 (311)
T 3p1a_A 56 QQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQ 135 (311)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred hhheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEEE
Confidence 357888999999999999999987 79999999986542 33344566677666666 899999999999999999999
Q ss_pred EEecCCCCHHHHhccCCCCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEecCCCCeEEeeeeeecccccC
Q 002158 700 YEFVPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSRLAPVL 779 (958)
Q Consensus 700 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~~~~~ 779 (958)
|||+ +++|.+++.... ..+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 136 ~e~~-~~~L~~~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~~ 210 (311)
T 3p1a_A 136 TELC-GPSLQQHCEAWG-ASLPEAQVWGYLRDTLLALAHLHSQG---LVHLDVKPANIFLGPRGRCKLGDFGLLVELGTA 210 (311)
T ss_dssp EECC-CCBHHHHHHHHC-SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECGGGCEEECCCTTCEECC--
T ss_pred Eecc-CCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEECCCCCEEEccceeeeecccC
Confidence 9999 779999987643 35999999999999999999999999 999999999999999999999999998765321
Q ss_pred CCCCCccceeeeeccCCCCccChhhhccCCCCCcchhhhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcCcchhhhccc
Q 002158 780 DDEGTMPTHVSTIVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVLLELLTGMQPISHGKNIVREVNVARDSGMVFSIIDNR 859 (958)
Q Consensus 780 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gv~l~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~i~~~ 859 (958)
.......||++|+|||++.+ .++.++|||||||++|||++|..|+........ ... +...
T Consensus 211 --------~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~----~~~-~~~~------ 270 (311)
T 3p1a_A 211 --------GAGEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGGEGWQQ----LRQ-GYLP------ 270 (311)
T ss_dssp ------------CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSHHHHHH----HTT-TCCC------
T ss_pred --------CCCcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCccHHHH----Hhc-cCCC------
Confidence 12234569999999999875 789999999999999999999777654322111 111 1000
Q ss_pred CCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 002158 860 MGSYPSECVERFVTLALRCCHDKPEHRPSMSDVVRE 895 (958)
Q Consensus 860 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 895 (958)
...+..++..+.+++.+||+.||++||+++|++++
T Consensus 271 -~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~h 305 (311)
T 3p1a_A 271 -PEFTAGLSSELRSVLVMMLEPDPKLRATAEALLAL 305 (311)
T ss_dssp -HHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred -cccccCCCHHHHHHHHHHcCCChhhCcCHHHHHhC
Confidence 01122345789999999999999999999999863
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-38 Score=347.53 Aligned_cols=267 Identities=20% Similarity=0.279 Sum_probs=211.5
Q ss_pred cCCCCCceeeeeCCeEEEEEEEC-CCcEEEEEEeccCChhcHHHHHHHHHHHHccCCCCcceEEEEE-EeCCeEEEEEEe
Q 002158 625 AYFSSSTQVGQGGYGKVYKGILS-DNTTVAIKRAEEGSLQGQNEFLTEIKLLSRLHHRNLVSLLGYC-DEEGEQMLVYEF 702 (958)
Q Consensus 625 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~-~~~~~~~lV~E~ 702 (958)
++|...+.||+|+||+||+|++. +++.||||++...... +++.+|+++++.++|+++++.+.++ ...+..++||||
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~ 86 (296)
T 3uzp_A 9 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH--PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMEL 86 (296)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSSC--CHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEEC
T ss_pred cEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcch--hHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEEEe
Confidence 56788899999999999999974 7999999998764332 3588999999999988877666665 567788999999
Q ss_pred cCCCCHHHHhccCCCCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEe---cCCCCeEEeeeeeecccccC
Q 002158 703 VPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILL---DSNLNAKVADFGLSRLAPVL 779 (958)
Q Consensus 703 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl---~~~~~~kl~DFGla~~~~~~ 779 (958)
+ +++|.+++.... ..+++.++..++.|++.||+|||+++ |+||||||+|||+ +.++.+||+|||+++.....
T Consensus 87 ~-~~~L~~~~~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~ 161 (296)
T 3uzp_A 87 L-GPSLEDLFNFCS-RKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDA 161 (296)
T ss_dssp C-CCBHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECCGGGTTCEEECCCTTCEECBCT
T ss_pred c-CCCHHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHeEEecCCCCCeEEEeeCCCccccccc
Confidence 9 999999997433 34999999999999999999999999 9999999999999 58899999999999876543
Q ss_pred CCCCCccceeeeeccCCCCccChhhhccCCCCCcchhhhHHHHHHHHHhCCCCCCCCch-----hHHHHHHHhhcCcchh
Q 002158 780 DDEGTMPTHVSTIVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVLLELLTGMQPISHGKN-----IVREVNVARDSGMVFS 854 (958)
Q Consensus 780 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gv~l~elltG~~P~~~~~~-----~~~~~~~~~~~~~~~~ 854 (958)
......+........||+.|+|||++.+..++.++||||||+++|||++|+.||..... ....+........
T Consensus 162 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~--- 238 (296)
T 3uzp_A 162 RTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTP--- 238 (296)
T ss_dssp TTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSC---
T ss_pred ccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccccCCc---
Confidence 33222222223456799999999999999999999999999999999999999975321 1111110000000
Q ss_pred hhcccCCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHhhCCCC
Q 002158 855 IIDNRMGSYPSECVERFVTLALRCCHDKPEHRPSMSDVVRELENILKMFPET 906 (958)
Q Consensus 855 ~i~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~~~~ 906 (958)
....+..++..+.+++.+||+.||++||+++++++.|+++.......
T Consensus 239 -----~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~~~~ 285 (296)
T 3uzp_A 239 -----IEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFS 285 (296)
T ss_dssp -----HHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHTTCC
T ss_pred -----hHHHHhhCCHHHHHHHHHHHhcCcCcCCCHHHHHHHHHHHHHhcCCc
Confidence 00012345678999999999999999999999999999998766543
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=354.62 Aligned_cols=252 Identities=30% Similarity=0.448 Sum_probs=208.0
Q ss_pred HHcCCCCCceeeeeCCeEEEEEEEC-CCcEEEEEEeccCChhcHHHHHHHHHHHHccCCCCcceEEEEEEe---------
Q 002158 623 ATAYFSSSTQVGQGGYGKVYKGILS-DNTTVAIKRAEEGSLQGQNEFLTEIKLLSRLHHRNLVSLLGYCDE--------- 692 (958)
Q Consensus 623 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~--------- 692 (958)
...+|...+.||+|+||.||+|.+. +++.||||++.... +.+.+|++++++++||||+++++++..
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~ 84 (284)
T 2a19_B 9 FGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN----EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSS 84 (284)
T ss_dssp HHHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS----GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC-----
T ss_pred hccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc----HHHHHHHHHHHhCCCCCEEEEeeeEeccccCccccc
Confidence 3456888899999999999999986 79999999997643 246789999999999999999999854
Q ss_pred -------CCeEEEEEEecCCCCHHHHhccCCCCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEecCCCCe
Q 002158 693 -------EGEQMLVYEFVPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSNLNA 765 (958)
Q Consensus 693 -------~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~~~~ 765 (958)
....++||||+++++|.+++.......+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+
T Consensus 85 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~ 161 (284)
T 2a19_B 85 KNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKK---LINRDLKPSNIFLVDTKQV 161 (284)
T ss_dssp ----CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEE
T ss_pred ccccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCCHHHEEEcCCCCE
Confidence 445899999999999999998665556999999999999999999999999 9999999999999999999
Q ss_pred EEeeeeeecccccCCCCCCccceeeeeccCCCCccChhhhccCCCCCcchhhhHHHHHHHHHhCCCCCCCCchhHHHHHH
Q 002158 766 KVADFGLSRLAPVLDDEGTMPTHVSTIVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVLLELLTGMQPISHGKNIVREVNV 845 (958)
Q Consensus 766 kl~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gv~l~elltG~~P~~~~~~~~~~~~~ 845 (958)
||+|||+++...... ......||+.|+|||++.+..++.++||||||+++|||++|..|+........ .
T Consensus 162 kl~Dfg~~~~~~~~~--------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~---~ 230 (284)
T 2a19_B 162 KIGDFGLVTSLKNDG--------KRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETSKFFT---D 230 (284)
T ss_dssp EECCCTTCEESSCCS--------CCCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHHHHHHH---H
T ss_pred EECcchhheeccccc--------cccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhHHHHHH---H
Confidence 999999988653321 11234599999999999999999999999999999999999988742211111 1
Q ss_pred HhhcCcchhhhcccCCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHhhCC
Q 002158 846 ARDSGMVFSIIDNRMGSYPSECVERFVTLALRCCHDKPEHRPSMSDVVRELENILKMFP 904 (958)
Q Consensus 846 ~~~~~~~~~~i~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~~ 904 (958)
.. . ...+..++..+.+++.+||+.||++||++.|++++|+.+.+...
T Consensus 231 ~~---------~---~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~~~~~ 277 (284)
T 2a19_B 231 LR---------D---GIISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKSPE 277 (284)
T ss_dssp HH---------T---TCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHTC---
T ss_pred hh---------c---ccccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhhCCC
Confidence 10 0 11233455678999999999999999999999999998765443
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-39 Score=353.95 Aligned_cols=262 Identities=23% Similarity=0.352 Sum_probs=203.1
Q ss_pred cCCCCCceeeeeCCeEEEEEEEC-CCcEEEEEEeccC---ChhcHHHHHHHHHHHHccCCCCcceEEEEEEeCCeEEEEE
Q 002158 625 AYFSSSTQVGQGGYGKVYKGILS-DNTTVAIKRAEEG---SLQGQNEFLTEIKLLSRLHHRNLVSLLGYCDEEGEQMLVY 700 (958)
Q Consensus 625 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~ 700 (958)
.+|...+.||+|+||.||+|... +++.||||++... ......++.+|++++++++||||+++++++...+..++||
T Consensus 32 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 111 (310)
T 2wqm_A 32 ANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL 111 (310)
T ss_dssp GGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred cceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEEEE
Confidence 36778899999999999999975 7899999998753 3344567899999999999999999999999999999999
Q ss_pred EecCCCCHHHHhccC--CCCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEecCCCCeEEeeeeeeccccc
Q 002158 701 EFVPNGTLRDWLSGR--TKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSRLAPV 778 (958)
Q Consensus 701 E~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~~~~ 778 (958)
||+++++|.+++... ....+++..+..++.|+++||+|||+.+ |+||||||+||+++.++.+||+|||+++....
T Consensus 112 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~~ 188 (310)
T 2wqm_A 112 ELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSS 188 (310)
T ss_dssp ECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCC--------
T ss_pred ecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCcHHHEEEcCCCCEEEEeccceeeecC
Confidence 999999999999642 2345899999999999999999999999 99999999999999999999999999876532
Q ss_pred CCCCCCccceeeeeccCCCCccChhhhccCCCCCcchhhhHHHHHHHHHhCCCCCCCCchh-HHHHHHHhhcCcchhhhc
Q 002158 779 LDDEGTMPTHVSTIVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVLLELLTGMQPISHGKNI-VREVNVARDSGMVFSIID 857 (958)
Q Consensus 779 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gv~l~elltG~~P~~~~~~~-~~~~~~~~~~~~~~~~i~ 857 (958)
.. .......|++.|+|||++.+..++.++||||||+++|||++|+.||...... ......... .
T Consensus 189 ~~-------~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~-~------- 253 (310)
T 2wqm_A 189 KT-------TAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQ-C------- 253 (310)
T ss_dssp -----------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---CCHHHHHHHHHT-T-------
T ss_pred CC-------ccccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchhHHHHHHHhhc-c-------
Confidence 11 1122356899999999999999999999999999999999999999754321 111111111 1
Q ss_pred ccCCC-CChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHhhCCC
Q 002158 858 NRMGS-YPSECVERFVTLALRCCHDKPEHRPSMSDVVRELENILKMFPE 905 (958)
Q Consensus 858 ~~~~~-~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~~~ 905 (958)
.... .+..++..+.+++.+||+.||++||+++++++.|+++......
T Consensus 254 -~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~il~~l~~l~~~~~~ 301 (310)
T 2wqm_A 254 -DYPPLPSDHYSEELRQLVNMCINPDPEKRPDVTYVYDVAKRMHACTAS 301 (310)
T ss_dssp -CSCCCCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC-
T ss_pred -cCCCCcccccCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHhhhh
Confidence 1111 1234567899999999999999999999999999998865543
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-39 Score=364.76 Aligned_cols=250 Identities=22% Similarity=0.309 Sum_probs=195.5
Q ss_pred HcCCCCCceeeeeCCeEEEEEEEC-CCcEEEEEEeccCChhcHHHHHHHHHHHHccCCCCcceEEEEEEeCCeEEEEEEe
Q 002158 624 TAYFSSSTQVGQGGYGKVYKGILS-DNTTVAIKRAEEGSLQGQNEFLTEIKLLSRLHHRNLVSLLGYCDEEGEQMLVYEF 702 (958)
Q Consensus 624 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E~ 702 (958)
.++|...+.||+|+||+||+|+.. +++.||||++..... ..+.+.+|+.+++.++||||+++++++...+..++||||
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 97 (361)
T 3uc3_A 19 SDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAA-IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIMEY 97 (361)
T ss_dssp TTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTT-SCHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred CCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCcc-ccHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEEEe
Confidence 346888899999999999999987 789999999976433 235688999999999999999999999999999999999
Q ss_pred cCCCCHHHHhccCCCCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEecCCCC--eEEeeeeeecccccCC
Q 002158 703 VPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSNLN--AKVADFGLSRLAPVLD 780 (958)
Q Consensus 703 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~~~--~kl~DFGla~~~~~~~ 780 (958)
+++|+|.+++.... .+++..+..++.|++.||+|||+++ |+||||||+|||++.++. +||+|||+++....
T Consensus 98 ~~~~~L~~~l~~~~--~~~~~~~~~i~~ql~~~L~~LH~~~---ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~-- 170 (361)
T 3uc3_A 98 ASGGELYERICNAG--RFSEDEARFFFQQLLSGVSYCHSMQ---ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL-- 170 (361)
T ss_dssp CCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTT---CCSCCCCGGGEEECSSSSCCEEECCCCCC-------
T ss_pred CCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCceEEEeecCccccccc--
Confidence 99999999997543 4899999999999999999999999 999999999999987765 99999999874321
Q ss_pred CCCCccceeeeeccCCCCccChhhhccCCCCCc-chhhhHHHHHHHHHhCCCCCCCCchh---HHHHHHHhhcCcchhhh
Q 002158 781 DEGTMPTHVSTIVKGTPGYLDPEYFLTHKLTDK-SDVYSLGVVLLELLTGMQPISHGKNI---VREVNVARDSGMVFSII 856 (958)
Q Consensus 781 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~DV~S~Gv~l~elltG~~P~~~~~~~---~~~~~~~~~~~~~~~~i 856 (958)
........||+.|+|||++.+..++.+ +||||+||++|||++|+.||...... ............
T Consensus 171 ------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~----- 239 (361)
T 3uc3_A 171 ------HSQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVKY----- 239 (361)
T ss_dssp ----------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCHHHHHHHHHTTCC-----
T ss_pred ------cCCCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhcCCC-----
Confidence 111234569999999999988887765 89999999999999999999753321 111111111000
Q ss_pred cccCCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 002158 857 DNRMGSYPSECVERFVTLALRCCHDKPEHRPSMSDVVRE 895 (958)
Q Consensus 857 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 895 (958)
. .......+..+.+++.+||+.||++|||+.|++++
T Consensus 240 --~-~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~h 275 (361)
T 3uc3_A 240 --S-IPDDIRISPECCHLISRIFVADPATRISIPEIKTH 275 (361)
T ss_dssp --C-CCTTSCCCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred --C-CCCcCCCCHHHHHHHHHHccCChhHCcCHHHHHhC
Confidence 0 00111345788999999999999999999999986
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-38 Score=348.56 Aligned_cols=271 Identities=19% Similarity=0.276 Sum_probs=208.8
Q ss_pred HHcCCCCCceeeeeCCeEEEEEEEC-CCcEEEEEEeccCChhcHHHHHHHHHHHHccCCCCcceEEEEE-EeCCeEEEEE
Q 002158 623 ATAYFSSSTQVGQGGYGKVYKGILS-DNTTVAIKRAEEGSLQGQNEFLTEIKLLSRLHHRNLVSLLGYC-DEEGEQMLVY 700 (958)
Q Consensus 623 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~-~~~~~~~lV~ 700 (958)
..++|...+.||+|+||+||+|++. +++.||||++...... .++.+|+++++.++|++++..++++ ...+..++||
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~ 84 (296)
T 4hgt_A 7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH--PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVM 84 (296)
T ss_dssp ----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC---C--CCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEE
T ss_pred cCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccccc--hHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEEE
Confidence 3467899999999999999999974 7899999987654322 3578999999999988877776665 6677889999
Q ss_pred EecCCCCHHHHhccCCCCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEe---cCCCCeEEeeeeeecccc
Q 002158 701 EFVPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILL---DSNLNAKVADFGLSRLAP 777 (958)
Q Consensus 701 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl---~~~~~~kl~DFGla~~~~ 777 (958)
||+ +++|.+++.... ..+++.++..++.|++.||+|||+++ |+||||||+|||+ +.++.+||+|||+++...
T Consensus 85 e~~-~~~L~~~~~~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~~ 159 (296)
T 4hgt_A 85 ELL-GPSLEDLFNFCS-RKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYR 159 (296)
T ss_dssp ECC-CCBHHHHHHHTT-SCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECCGGGTTCEEECCCTTCEECB
T ss_pred Ecc-CCCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeeeeccCCCCeEEEecCccceecc
Confidence 999 999999997543 34999999999999999999999999 9999999999999 789999999999998765
Q ss_pred cCCCCCCccceeeeeccCCCCccChhhhccCCCCCcchhhhHHHHHHHHHhCCCCCCCCchh--HHHHHHHhhcCcchhh
Q 002158 778 VLDDEGTMPTHVSTIVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVLLELLTGMQPISHGKNI--VREVNVARDSGMVFSI 855 (958)
Q Consensus 778 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gv~l~elltG~~P~~~~~~~--~~~~~~~~~~~~~~~~ 855 (958)
........+........||+.|+|||++.+..++.++|||||||++|||++|+.||...... ...........
T Consensus 160 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~----- 234 (296)
T 4hgt_A 160 DARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKK----- 234 (296)
T ss_dssp CTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHH-----
T ss_pred CcccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhccc-----
Confidence 44332222222334567999999999999999999999999999999999999999753211 00000000000
Q ss_pred hcccCCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHhhCCC
Q 002158 856 IDNRMGSYPSECVERFVTLALRCCHDKPEHRPSMSDVVRELENILKMFPE 905 (958)
Q Consensus 856 i~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~~~ 905 (958)
...........++..+.+++.+||+.||++||+++++++.|+++......
T Consensus 235 ~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~~~~~~~ 284 (296)
T 4hgt_A 235 MSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGF 284 (296)
T ss_dssp HHSCHHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHHTC
T ss_pred ccchhhhhhccCCHHHHHHHHHHHhcCCCCCCCHHHHHHHHHHHHHHhCC
Confidence 00000001123467899999999999999999999999999999876543
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-39 Score=357.43 Aligned_cols=259 Identities=31% Similarity=0.483 Sum_probs=210.1
Q ss_pred cCCCCCceeeeeCCeEEEEEEEC-CCcE--EEEEEeccC-ChhcHHHHHHHHHHHHcc-CCCCcceEEEEEEeCCeEEEE
Q 002158 625 AYFSSSTQVGQGGYGKVYKGILS-DNTT--VAIKRAEEG-SLQGQNEFLTEIKLLSRL-HHRNLVSLLGYCDEEGEQMLV 699 (958)
Q Consensus 625 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~--vavK~~~~~-~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lV 699 (958)
++|...+.||+|+||.||+|.+. ++.. ||||.+... .....+.+.+|+++++++ +||||+++++++...+..++|
T Consensus 25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 104 (327)
T 1fvr_A 25 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 104 (327)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred HHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceEEE
Confidence 46778899999999999999975 5654 499988753 233445789999999999 899999999999999999999
Q ss_pred EEecCCCCHHHHhccCC--------------CCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEecCCCCe
Q 002158 700 YEFVPNGTLRDWLSGRT--------------KENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSNLNA 765 (958)
Q Consensus 700 ~E~~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~~~~ 765 (958)
|||+++|+|.+++.... ...+++.+++.++.|+++||+|||+++ |+||||||+||+++.++.+
T Consensus 105 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~~~~~ 181 (327)
T 1fvr_A 105 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVA 181 (327)
T ss_dssp ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCE
T ss_pred EecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCccceEEEcCCCeE
Confidence 99999999999997643 245899999999999999999999999 9999999999999999999
Q ss_pred EEeeeeeecccccCCCCCCccceeeeeccCCCCccChhhhccCCCCCcchhhhHHHHHHHHHh-CCCCCCCCchhHHHHH
Q 002158 766 KVADFGLSRLAPVLDDEGTMPTHVSTIVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVLLELLT-GMQPISHGKNIVREVN 844 (958)
Q Consensus 766 kl~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gv~l~ellt-G~~P~~~~~~~~~~~~ 844 (958)
||+|||+++..... .......+++.|+|||++.+..++.++||||||+++|||++ |+.||....... ...
T Consensus 182 kL~Dfg~~~~~~~~--------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~-~~~ 252 (327)
T 1fvr_A 182 KIADFGLSRGQEVY--------VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE-LYE 252 (327)
T ss_dssp EECCTTCEESSCEE--------CCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH-HHH
T ss_pred EEcccCcCcccccc--------ccccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcHHH-HHH
Confidence 99999998743211 11223457889999999999889999999999999999998 999997544321 111
Q ss_pred HHhhcCcchhhhcccCCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHhhCC
Q 002158 845 VARDSGMVFSIIDNRMGSYPSECVERFVTLALRCCHDKPEHRPSMSDVVRELENILKMFP 904 (958)
Q Consensus 845 ~~~~~~~~~~~i~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~~ 904 (958)
... .......+..++..+.+++.+||+.||++||+++|++++|+++++...
T Consensus 253 ~~~---------~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~ 303 (327)
T 1fvr_A 253 KLP---------QGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERK 303 (327)
T ss_dssp HGG---------GTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSSS
T ss_pred Hhh---------cCCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhhc
Confidence 111 111123345667889999999999999999999999999999887543
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-39 Score=360.58 Aligned_cols=268 Identities=26% Similarity=0.451 Sum_probs=213.6
Q ss_pred cCCCCCceeeeeCCeEEEEEEE-----CCCcEEEEEEeccCChhcHHHHHHHHHHHHccCCCCcceEEEEEEeCC--eEE
Q 002158 625 AYFSSSTQVGQGGYGKVYKGIL-----SDNTTVAIKRAEEGSLQGQNEFLTEIKLLSRLHHRNLVSLLGYCDEEG--EQM 697 (958)
Q Consensus 625 ~~~~~~~~lg~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~--~~~ 697 (958)
.+|...+.||+|+||.||+|.+ .+++.||||++........+.+.+|++++++++||||+++++++...+ ..+
T Consensus 41 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 120 (326)
T 2w1i_A 41 RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLK 120 (326)
T ss_dssp GGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----CCE
T ss_pred HHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCCceE
Confidence 4567788999999999999984 368899999998776666778999999999999999999999987654 789
Q ss_pred EEEEecCCCCHHHHhccCCCCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEecCCCCeEEeeeeeecccc
Q 002158 698 LVYEFVPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSRLAP 777 (958)
Q Consensus 698 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~~~ 777 (958)
+||||+++++|.+++.... ..+++.+++.++.|+++||+|||+.+ |+||||||+||+++.++.+||+|||+++...
T Consensus 121 lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dikp~NIli~~~~~~kL~Dfg~~~~~~ 196 (326)
T 2w1i_A 121 LIMEYLPYGSLRDYLQKHK-ERIDHIKLLQYTSQICKGMEYLGTKR---YIHRDLATRNILVENENRVKIGDFGLTKVLP 196 (326)
T ss_dssp EEECCCTTCBHHHHHHHST-TSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCEECC
T ss_pred EEEECCCCCCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHhCC---EeccCCCcceEEEcCCCcEEEecCcchhhcc
Confidence 9999999999999997653 34899999999999999999999999 9999999999999999999999999998654
Q ss_pred cCCCCCCccceeeeeccCCCCccChhhhccCCCCCcchhhhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcC-------
Q 002158 778 VLDDEGTMPTHVSTIVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVLLELLTGMQPISHGKNIVREVNVARDSG------- 850 (958)
Q Consensus 778 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gv~l~elltG~~P~~~~~~~~~~~~~~~~~~------- 850 (958)
..... ........++..|+|||++.+..++.++||||||+++|||++|..|+...... .........
T Consensus 197 ~~~~~----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~--~~~~~~~~~~~~~~~~ 270 (326)
T 2w1i_A 197 QDKEY----YKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAE--FMRMIGNDKQGQMIVF 270 (326)
T ss_dssp SSCSE----EECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHH--HHHHHCTTCCTHHHHH
T ss_pred ccccc----cccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHH--HHHhhccccchhhhHH
Confidence 32210 11122345778899999999988999999999999999999999998532111 111000000
Q ss_pred cchhhhc-ccCCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHhh
Q 002158 851 MVFSIID-NRMGSYPSECVERFVTLALRCCHDKPEHRPSMSDVVRELENILKM 902 (958)
Q Consensus 851 ~~~~~i~-~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~ 902 (958)
...+.+. ......+..++..+.+++.+||+.||++||++.|+++.|+++.+.
T Consensus 271 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~l~~~ 323 (326)
T 2w1i_A 271 HLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDQ 323 (326)
T ss_dssp HHHHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHHHhhcCCCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHH
Confidence 0011111 112234566788999999999999999999999999999998764
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-39 Score=375.99 Aligned_cols=247 Identities=25% Similarity=0.381 Sum_probs=206.4
Q ss_pred cCCCCCceeeeeCCeEEEEEEEC-CCcEEEEEEeccCCh---hcHHHHHHHHHHHHccCCCCcceEEEEEEeCCeEEEEE
Q 002158 625 AYFSSSTQVGQGGYGKVYKGILS-DNTTVAIKRAEEGSL---QGQNEFLTEIKLLSRLHHRNLVSLLGYCDEEGEQMLVY 700 (958)
Q Consensus 625 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~ 700 (958)
.+|...+.||+|+||.||+|.+. +|+.||||++..... .....+.+|+++++.++||||+++++++...+..++||
T Consensus 16 ~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~ 95 (476)
T 2y94_A 16 GHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMVM 95 (476)
T ss_dssp TTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence 35777889999999999999986 799999999865321 23457899999999999999999999999999999999
Q ss_pred EecCCCCHHHHhccCCCCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEecCCCCeEEeeeeeecccccCC
Q 002158 701 EFVPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSRLAPVLD 780 (958)
Q Consensus 701 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~ 780 (958)
||+++|+|.+++... ..+++.++..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 96 E~~~gg~L~~~l~~~--~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDLkp~NIll~~~~~vkL~DFG~a~~~~~~- 169 (476)
T 2y94_A 96 EYVSGGELFDYICKN--GRLDEKESRRLFQQILSGVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDG- 169 (476)
T ss_dssp ECCSSEEHHHHTTSS--SSCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCSGGGEEECTTCCEEECCCSSCEECCTT-
T ss_pred eCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---CCcccccHHHEEEecCCCeEEEeccchhhcccc-
Confidence 999999999999754 34999999999999999999999999 999999999999999999999999999865321
Q ss_pred CCCCccceeeeeccCCCCccChhhhccCCC-CCcchhhhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcCcchhhhccc
Q 002158 781 DEGTMPTHVSTIVKGTPGYLDPEYFLTHKL-TDKSDVYSLGVVLLELLTGMQPISHGKNIVREVNVARDSGMVFSIIDNR 859 (958)
Q Consensus 781 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DV~S~Gv~l~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~i~~~ 859 (958)
.......||+.|+|||++.+..+ +.++||||+||++|||++|+.||.+.... ....... ..
T Consensus 170 -------~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~-~~~~~i~----------~~ 231 (476)
T 2y94_A 170 -------EFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVP-TLFKKIC----------DG 231 (476)
T ss_dssp -------CCBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSH-HHHHHHH----------TT
T ss_pred -------ccccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHH-HHHHHHh----------cC
Confidence 11234569999999999988776 67999999999999999999999754322 2211111 11
Q ss_pred CCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 002158 860 MGSYPSECVERFVTLALRCCHDKPEHRPSMSDVVRE 895 (958)
Q Consensus 860 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 895 (958)
....|...+..+.+++.+||+.||++|||++|++++
T Consensus 232 ~~~~p~~~s~~~~~Li~~~L~~dP~~Rpt~~eil~h 267 (476)
T 2y94_A 232 IFYTPQYLNPSVISLLKHMLQVDPMKRATIKDIREH 267 (476)
T ss_dssp CCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTC
T ss_pred CcCCCccCCHHHHHHHHHHcCCCchhCcCHHHHHhC
Confidence 122344556789999999999999999999999975
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-39 Score=367.22 Aligned_cols=252 Identities=23% Similarity=0.347 Sum_probs=201.1
Q ss_pred cCCCCCceeeeeCCeEEEEEEECCCcEEEEEEeccC--ChhcHHHHHHHHHHHHccC--CCCcceEEEEEEeCCeEEEEE
Q 002158 625 AYFSSSTQVGQGGYGKVYKGILSDNTTVAIKRAEEG--SLQGQNEFLTEIKLLSRLH--HRNLVSLLGYCDEEGEQMLVY 700 (958)
Q Consensus 625 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~--H~niv~l~~~~~~~~~~~lV~ 700 (958)
..|...+.||+|+||+||+|...+++.||||++... .....+.+.+|++++++++ ||||+++++++..++..++||
T Consensus 56 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~ 135 (390)
T 2zmd_A 56 RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVM 135 (390)
T ss_dssp EEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred CceEEEEEEccCCCeEEEEEEcCCCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEEE
Confidence 358888999999999999999888999999998654 3344577999999999996 599999999999999999999
Q ss_pred EecCCCCHHHHhccCCCCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEecCCCCeEEeeeeeecccccCC
Q 002158 701 EFVPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSRLAPVLD 780 (958)
Q Consensus 701 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~ 780 (958)
| +.+++|.+++.... .+++.++..++.|++.||+|||+.+ |+||||||+|||++ ++.+||+|||+++......
T Consensus 136 E-~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~lH~~~---ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~~~ 208 (390)
T 2zmd_A 136 E-CGNIDLNSWLKKKK--SIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDT 208 (390)
T ss_dssp E-CCSEEHHHHHHHCS--SCCHHHHHHHHHHHHHHHHHHHTTT---CCCCCCCGGGEEES-SSCEEECCCSSSCCC----
T ss_pred e-cCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHEEEE-CCeEEEEecCccccccCCC
Confidence 9 55889999997654 4888999999999999999999999 99999999999995 5899999999998653221
Q ss_pred CCCCccceeeeeccCCCCccChhhhcc-----------CCCCCcchhhhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhc
Q 002158 781 DEGTMPTHVSTIVKGTPGYLDPEYFLT-----------HKLTDKSDVYSLGVVLLELLTGMQPISHGKNIVREVNVARDS 849 (958)
Q Consensus 781 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-----------~~~~~~~DV~S~Gv~l~elltG~~P~~~~~~~~~~~~~~~~~ 849 (958)
. ........||+.|+|||++.+ ..++.++|||||||++|||++|+.||................
T Consensus 209 ~-----~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~ 283 (390)
T 2zmd_A 209 T-----SVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDP 283 (390)
T ss_dssp ----------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHCT
T ss_pred c-----cccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHHHHHHHHHhCc
Confidence 1 111234569999999999975 368889999999999999999999997543322222221111
Q ss_pred CcchhhhcccCCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 002158 850 GMVFSIIDNRMGSYPSECVERFVTLALRCCHDKPEHRPSMSDVVREL 896 (958)
Q Consensus 850 ~~~~~~i~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 896 (958)
. .....+...+..+.+++.+||+.||++||++.|++++-
T Consensus 284 ~--------~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp 322 (390)
T 2zmd_A 284 N--------HEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHP 322 (390)
T ss_dssp T--------SCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSH
T ss_pred c--------ccCCCCccchHHHHHHHHHHcccChhhCCCHHHHhhCc
Confidence 1 01122333467889999999999999999999999763
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-39 Score=391.89 Aligned_cols=361 Identities=19% Similarity=0.250 Sum_probs=280.8
Q ss_pred CCHhHHHHHHHHHHHcccCcc--------ccCCCCCCCCCCCCC---CceeeCccccCCCceeeEEEEccCCcCCCCccc
Q 002158 36 TDPQEASALRAIKNSLVDSMN--------HLRNWNKGDPCMSNW---TGVLCFDTVETDGHLHVRELQLLSMNLSGNLAP 104 (958)
Q Consensus 36 ~~~~~~~al~~~k~~~~~~~~--------~l~~W~~~~~c~~~w---~gV~C~~~~~~~~~~~v~~L~L~~~~l~~~~~~ 104 (958)
....|+.||.++++++.++.. ...+|+...+| |.| .||+|.+. .+|+.|+|.++++.|.+|+
T Consensus 27 ~~~~d~~aL~~~~~~~~~~~w~~~~~~~~~~~~W~~~~~~-c~w~~~~GV~C~~~------~~V~~L~L~~~~l~g~lp~ 99 (636)
T 4eco_A 27 EYIKDYLALKEIWDALNGKNWSQQGFGTQPGANWNFNKEL-DMWGAQPGVSLNSN------GRVTGLSLEGFGASGRVPD 99 (636)
T ss_dssp HHHHHHHHHHHHHHHTTGGGCCCCC------CCCCCSSCG-GGTTCCTTEEECTT------CCEEEEECTTSCCEEEECG
T ss_pred hHHHHHHHHHHHHHHcCCCCcccCCcCCccCCCCCCCCCc-ccccCCCCeEEcCC------CCEEEEEecCcccCCcCCh
Confidence 345799999999999875522 23479876555 489 99999542 5899999999999999999
Q ss_pred cccCCCCcceeeccCcc---------------------------------------------------------------
Q 002158 105 ELGQLSRLQYYFMWNDL--------------------------------------------------------------- 121 (958)
Q Consensus 105 ~l~~L~~L~~L~l~n~~--------------------------------------------------------------- 121 (958)
+|++|++|++|++++|.
T Consensus 100 ~l~~L~~L~~L~Ls~N~~~~~~~~~~~~~~~~~~~~~~~~~l~l~l~~~~l~~~~~~~~~~~~~~l~~~~l~~~~~~~~~ 179 (636)
T 4eco_A 100 AIGQLTELEVLALGSHGEKVNERLFGPKGISANMSDEQKQKMRMHYQKTFVDYDPREDFSDLIKDCINSDPQQKSIKKSS 179 (636)
T ss_dssp GGGGCTTCCEEESCCGGGGGTCCSBSTTSBCTTCCHHHHHHHHTHHHHHHTCCCGGGGSCHHHHHHHHHCTTSCCCCCCC
T ss_pred HHhcCccceEEECcCCccccCCccccccccccCchHHHHHHHHhhHHHhhhccCchhhHHHHHHHHhhcCcccccccccc
Confidence 99999999999997552
Q ss_pred ----------------cCCCCccccCCCCCcEEEeeCCCCCCC-----------------CChhhc--CCCCCCEEeccc
Q 002158 122 ----------------TGTIPKEIGNISSLIFLLLNGNKLSGS-----------------LPDELG--YLSNLNRLQVDE 166 (958)
Q Consensus 122 ----------------~~~ip~~i~~l~~L~~L~Ls~n~l~~~-----------------~p~~l~--~l~~L~~L~L~~ 166 (958)
.+ +|..|+++++|++|+|++|.++|. +|..++ ++++|++|+|++
T Consensus 180 ~~~l~~l~l~~~~n~l~~-ip~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~~~~~~~~ip~~l~~~~l~~L~~L~L~~ 258 (636)
T 4eco_A 180 RITLKDTQIGQLSNNITF-VSKAVMRLTKLRQFYMGNSPFVAENICEAWENENSEYAQQYKTEDLKWDNLKDLTDVEVYN 258 (636)
T ss_dssp CCCCCTTTTTCCSCEEEE-ECGGGGGCTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTSCCCGGGCTTCCEEEEEC
T ss_pred ccchhhhhhccccCCCcc-CCHHHhcccCCCEEECcCCccccccccccccccccchhcccCchhhhhcccCCCCEEEecC
Confidence 23 889999999999999999999985 999999 999999999999
Q ss_pred ccccccCccccccccccceEeccccc-ccc-cCchhhcCC------ccchhhhccCCccccCCCc--ccCCCCCccEEEc
Q 002158 167 NNITGTIPKSFANLSRVRHLHLNNNS-IGG-QIPSELSKL------STLIHLLVDNNNLSGNLPP--ELSELPQLCILQL 236 (958)
Q Consensus 167 N~l~~~~p~~~~~l~~L~~L~Ls~N~-l~~-~~p~~l~~l------~~L~~L~L~~N~l~~~~~~--~l~~l~~L~~L~L 236 (958)
|++.+.+|..|.++++|++|+|++|+ ++| .+|..++.+ ++|++|+|++|+++ .+|. .+..+++|++|+|
T Consensus 259 n~l~~~~p~~l~~l~~L~~L~Ls~n~~l~~~~lp~~~~~L~~~~~l~~L~~L~L~~n~l~-~ip~~~~l~~l~~L~~L~L 337 (636)
T 4eco_A 259 CPNLTKLPTFLKALPEMQLINVACNRGISGEQLKDDWQALADAPVGEKIQIIYIGYNNLK-TFPVETSLQKMKKLGMLEC 337 (636)
T ss_dssp CTTCSSCCTTTTTCSSCCEEECTTCTTSCHHHHHHHHHHHHHSGGGGTCCEEECCSSCCS-SCCCHHHHTTCTTCCEEEC
T ss_pred CcCCccChHHHhcCCCCCEEECcCCCCCccccchHHHHhhhccccCCCCCEEECCCCcCC-ccCchhhhccCCCCCEEeC
Confidence 99999999999999999999999998 998 889888876 89999999999999 7888 8999999999999
Q ss_pred cCCCCCCCCccccccCCCCCCEEEcccCCCCCCCCCCCCCCC-cCEEeccCCcCCCcCCCCCC-C--CCcCEEEccCCcC
Q 002158 237 DNNNFSASEIPATYGNFSKLVKLSLRNCNLQGAVPDLSRIPN-LYYLDLSWNHLTGSIPSKKL-S--ENVTTIDLSDNYL 312 (958)
Q Consensus 237 ~~N~l~~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~l~~l~~-L~~L~Ls~N~l~~~~~~~~~-~--~~L~~L~Ls~N~l 312 (958)
++|+++ +.+| .+.++++|+.|+|++|+++..+..+..+++ |++|+|++|.++ .+|.... . ++|+.|+|++|.+
T Consensus 338 ~~N~l~-g~ip-~~~~l~~L~~L~L~~N~l~~lp~~l~~l~~~L~~L~Ls~N~l~-~lp~~~~~~~l~~L~~L~Ls~N~l 414 (636)
T 4eco_A 338 LYNQLE-GKLP-AFGSEIKLASLNLAYNQITEIPANFCGFTEQVENLSFAHNKLK-YIPNIFDAKSVSVMSAIDFSYNEI 414 (636)
T ss_dssp CSCCCE-EECC-CCEEEEEESEEECCSSEEEECCTTSEEECTTCCEEECCSSCCS-SCCSCCCTTCSSCEEEEECCSSCT
T ss_pred cCCcCc-cchh-hhCCCCCCCEEECCCCccccccHhhhhhcccCcEEEccCCcCc-ccchhhhhcccCccCEEECcCCcC
Confidence 999997 3567 788888888888888888866666788888 888888888887 5554422 2 3688888888888
Q ss_pred CCccchhcc-------CCCCCCeEeeecccCCCccchhhhcccccCccccceEeccCCCCCCCccCC--CCC-------C
Q 002158 313 NGSILESIS-------NLPFLQTLSLENNFLTGSIPATIWQNKSFSTKARLKIDLRNNSFSNIVGDL--TLP-------N 376 (958)
Q Consensus 313 ~~~~~~~~~-------~l~~L~~L~L~~N~l~~~ip~~l~~~~~~~~~~l~~L~Ls~N~l~~l~~~~--~l~-------~ 376 (958)
++..|..|. .+++|++|+|++|+++ .+|..++.. .+.|+.|+|++|+++.++... ... +
T Consensus 415 ~~~~p~~l~~~~~~~~~~~~L~~L~Ls~N~l~-~lp~~~~~~----l~~L~~L~Ls~N~l~~i~~~~~~~~~~~~~~l~~ 489 (636)
T 4eco_A 415 GSVDGKNFDPLDPTPFKGINVSSINLSNNQIS-KFPKELFST----GSPLSSINLMGNMLTEIPKNSLKDENENFKNTYL 489 (636)
T ss_dssp TTTTTCSSCTTCSSCCCCCCEEEEECCSSCCC-SCCTHHHHT----TCCCSEEECCSSCCSBCCSSSSEETTEECTTGGG
T ss_pred CCcchhhhcccccccccCCCCCEEECcCCccC-cCCHHHHcc----CCCCCEEECCCCCCCCcCHHHhccccccccccCC
Confidence 887777777 6777888888888887 666665541 234557777777777666544 221 6
Q ss_pred cceEEeCCCCCCCCCCCCCCCcccccCCCCCccccccCCC
Q 002158 377 NVTLRLGGNPICTSANIPNTGRFCGSDAGGDETLTNSKVN 416 (958)
Q Consensus 377 L~~L~l~~N~l~~~~~~~~~~~~~~~~~~~~~~L~~n~~~ 416 (958)
|+.|+|++|.+.. ++...........+.+.|.+|.+.
T Consensus 490 L~~L~Ls~N~l~~---lp~~~~~~~l~~L~~L~Ls~N~l~ 526 (636)
T 4eco_A 490 LTSIDLRFNKLTK---LSDDFRATTLPYLVGIDLSYNSFS 526 (636)
T ss_dssp CCEEECCSSCCCB---CCGGGSTTTCTTCCEEECCSSCCS
T ss_pred ccEEECcCCcCCc---cChhhhhccCCCcCEEECCCCCCC
Confidence 7777777777652 111100013344455666666543
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-39 Score=387.10 Aligned_cols=252 Identities=27% Similarity=0.406 Sum_probs=204.7
Q ss_pred ceeeeeCCeEEEEEEEC---CCcEEEEEEeccCC--hhcHHHHHHHHHHHHccCCCCcceEEEEEEeCCeEEEEEEecCC
Q 002158 631 TQVGQGGYGKVYKGILS---DNTTVAIKRAEEGS--LQGQNEFLTEIKLLSRLHHRNLVSLLGYCDEEGEQMLVYEFVPN 705 (958)
Q Consensus 631 ~~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E~~~~ 705 (958)
+.||+|+||+||+|.+. .++.||||+++... ....++|.+|++++++++||||+++++++.. +..++||||+++
T Consensus 375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~lv~E~~~~ 453 (635)
T 4fl3_A 375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL 453 (635)
T ss_dssp EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCEEEEEEccCC
Confidence 47999999999999763 46789999997642 3346789999999999999999999999975 468899999999
Q ss_pred CCHHHHhccCCCCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEecCCCCeEEeeeeeecccccCCCCCCc
Q 002158 706 GTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSRLAPVLDDEGTM 785 (958)
Q Consensus 706 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~ 785 (958)
|+|.++++... .+++.++..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++........
T Consensus 454 g~L~~~l~~~~--~l~~~~~~~i~~qi~~~L~yLH~~~---iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~--- 525 (635)
T 4fl3_A 454 GPLNKYLQQNR--HVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENY--- 525 (635)
T ss_dssp EEHHHHHHHCT--TCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCTTHHHHTTC-------
T ss_pred CCHHHHHhhCC--CCCHHHHHHHHHHHHHHHHHHHHCC---EeCCCCChHhEEEeCCCCEEEEEcCCccccccCccc---
Confidence 99999997543 4899999999999999999999999 999999999999999999999999999876432211
Q ss_pred cceeeeeccCCCCccChhhhccCCCCCcchhhhHHHHHHHHHh-CCCCCCCCchhHHHHHHHhhcCcchhhhcccCCCCC
Q 002158 786 PTHVSTIVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVLLELLT-GMQPISHGKNIVREVNVARDSGMVFSIIDNRMGSYP 864 (958)
Q Consensus 786 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gv~l~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~ 864 (958)
........||+.|+|||++.+..++.++|||||||++|||++ |+.||.+...... ..... .......+
T Consensus 526 -~~~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~-~~~i~---------~~~~~~~p 594 (635)
T 4fl3_A 526 -YKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEV-TAMLE---------KGERMGCP 594 (635)
T ss_dssp ----------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHH-HHHHH---------TTCCCCCC
T ss_pred -cccccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHH-HHHHH---------cCCCCCCC
Confidence 112233457889999999999999999999999999999999 9999976543221 11111 11123346
Q ss_pred hHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHhh
Q 002158 865 SECVERFVTLALRCCHDKPEHRPSMSDVVRELENILKM 902 (958)
Q Consensus 865 ~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~ 902 (958)
..++.++.+++.+||+.||++||+++++++.|+++...
T Consensus 595 ~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~~ 632 (635)
T 4fl3_A 595 AGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYD 632 (635)
T ss_dssp TTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHH
T ss_pred CCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHH
Confidence 67788999999999999999999999999999988754
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-39 Score=367.57 Aligned_cols=249 Identities=22% Similarity=0.307 Sum_probs=192.2
Q ss_pred CCCCC-ceeeeeCCeEEEEEEEC-CCcEEEEEEeccCChhcHHHHHHHHHHHHc-cCCCCcceEEEEEEe----CCeEEE
Q 002158 626 YFSSS-TQVGQGGYGKVYKGILS-DNTTVAIKRAEEGSLQGQNEFLTEIKLLSR-LHHRNLVSLLGYCDE----EGEQML 698 (958)
Q Consensus 626 ~~~~~-~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~-l~H~niv~l~~~~~~----~~~~~l 698 (958)
+|... +.||+|+||+||+|.+. +++.||||++... ..+.+|++++.+ .+||||+++++++.. .+..++
T Consensus 62 ~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~-----~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~~l 136 (400)
T 1nxk_A 62 DYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLI 136 (400)
T ss_dssp TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEE
T ss_pred cceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc-----hhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEEEE
Confidence 34443 68999999999999986 6899999999642 356788888754 589999999999875 567899
Q ss_pred EEEecCCCCHHHHhccCCCCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEecC---CCCeEEeeeeeecc
Q 002158 699 VYEFVPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDS---NLNAKVADFGLSRL 775 (958)
Q Consensus 699 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~---~~~~kl~DFGla~~ 775 (958)
||||+++|+|.+++.......+++.++..++.|++.||+|||+.+ |+||||||+|||++. ++.+||+|||+++.
T Consensus 137 v~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~~~~kl~DFG~a~~ 213 (400)
T 1nxk_A 137 VMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFAKE 213 (400)
T ss_dssp EEECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSTTCCEEECCCTTCEE
T ss_pred EEEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCcCcceEEEecCCCCccEEEEecccccc
Confidence 999999999999998765556999999999999999999999999 999999999999998 78999999999985
Q ss_pred cccCCCCCCccceeeeeccCCCCccChhhhccCCCCCcchhhhHHHHHHHHHhCCCCCCCCchhH---HHHHHHhhcCcc
Q 002158 776 APVLDDEGTMPTHVSTIVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVLLELLTGMQPISHGKNIV---REVNVARDSGMV 852 (958)
Q Consensus 776 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gv~l~elltG~~P~~~~~~~~---~~~~~~~~~~~~ 852 (958)
.... .......||+.|+|||++.+..++.++|||||||++|||++|+.||....... ............
T Consensus 214 ~~~~--------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i~~~~~~ 285 (400)
T 1nxk_A 214 TTSH--------NSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYE 285 (400)
T ss_dssp CC-------------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHHHHTCCC
T ss_pred cCCC--------CccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHHHcCccc
Confidence 4321 11234568999999999999999999999999999999999999997543211 000000000000
Q ss_pred hhhhcccCCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 002158 853 FSIIDNRMGSYPSECVERFVTLALRCCHDKPEHRPSMSDVVREL 896 (958)
Q Consensus 853 ~~~i~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 896 (958)
. .......++.++.+++.+||+.||++|||++|++++-
T Consensus 286 ~------~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp 323 (400)
T 1nxk_A 286 F------PNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHP 323 (400)
T ss_dssp C------CTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSH
T ss_pred C------CCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCc
Confidence 0 0011134567899999999999999999999999863
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-39 Score=353.97 Aligned_cols=259 Identities=23% Similarity=0.334 Sum_probs=201.5
Q ss_pred cCCCCCceeeeeCCeEEEEEEEC-CCcEEEEEEeccCCh--hcHHHHHHHHHHHHccCCCCcceEEEEEEeCCeEEEEEE
Q 002158 625 AYFSSSTQVGQGGYGKVYKGILS-DNTTVAIKRAEEGSL--QGQNEFLTEIKLLSRLHHRNLVSLLGYCDEEGEQMLVYE 701 (958)
Q Consensus 625 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E 701 (958)
++|...+.||+|+||+||+|.+. +++.||||++..... ...+.+.+|++++++++||||+++++++...+..++|||
T Consensus 3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (311)
T 4agu_A 3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVFE 82 (311)
T ss_dssp CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred ccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEEE
Confidence 46788899999999999999986 589999999865432 234678899999999999999999999999999999999
Q ss_pred ecCCCCHHHHhccCCCCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEecCCCCeEEeeeeeecccccCCC
Q 002158 702 FVPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSRLAPVLDD 781 (958)
Q Consensus 702 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~ 781 (958)
|+++++|.+++.... .+++..+..++.|+++||+|||+.+ |+||||||+||+++.++.+||+|||+++......
T Consensus 83 ~~~~~~l~~~~~~~~--~~~~~~~~~i~~~l~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~- 156 (311)
T 4agu_A 83 YCDHTVLHELDRYQR--GVPEHLVKSITWQTLQAVNFCHKHN---CIHRDVKPENILITKHSVIKLCDFGFARLLTGPS- 156 (311)
T ss_dssp CCSEEHHHHHHHTSS--CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECC----
T ss_pred eCCCchHHHHHhhhc--CCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCChhhEEEcCCCCEEEeeCCCchhccCcc-
Confidence 999999999986543 4899999999999999999999999 9999999999999999999999999998653211
Q ss_pred CCCccceeeeeccCCCCccChhhhcc-CCCCCcchhhhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcCcc--------
Q 002158 782 EGTMPTHVSTIVKGTPGYLDPEYFLT-HKLTDKSDVYSLGVVLLELLTGMQPISHGKNIVREVNVARDSGMV-------- 852 (958)
Q Consensus 782 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DV~S~Gv~l~elltG~~P~~~~~~~~~~~~~~~~~~~~-------- 852 (958)
.......||+.|+|||++.+ ..++.++||||+|+++|||++|+.||................+..
T Consensus 157 ------~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (311)
T 4agu_A 157 ------DYYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVF 230 (311)
T ss_dssp ---------------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHH
T ss_pred ------cccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhccccccccccc
Confidence 11234468999999999976 568999999999999999999999997655433322211111100
Q ss_pred -----hhhhc-ccCCCC------ChHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 002158 853 -----FSIID-NRMGSY------PSECVERFVTLALRCCHDKPEHRPSMSDVVRE 895 (958)
Q Consensus 853 -----~~~i~-~~~~~~------~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 895 (958)
..... +..... ....+..+.+++.+||+.||++|||++|++++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 285 (311)
T 4agu_A 231 STNQYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHH 285 (311)
T ss_dssp HTCGGGTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTS
T ss_pred ccccccccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcC
Confidence 00000 000000 02355678999999999999999999999974
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-39 Score=364.68 Aligned_cols=247 Identities=22% Similarity=0.289 Sum_probs=195.9
Q ss_pred cCCCCCceeeeeCCeEEEEEEEC-CCcEEEEEEeccCC---hhcHHHHHHHHHH-HHccCCCCcceEEEEEEeCCeEEEE
Q 002158 625 AYFSSSTQVGQGGYGKVYKGILS-DNTTVAIKRAEEGS---LQGQNEFLTEIKL-LSRLHHRNLVSLLGYCDEEGEQMLV 699 (958)
Q Consensus 625 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~-l~~l~H~niv~l~~~~~~~~~~~lV 699 (958)
++|...+.||+|+||+||+|+.+ +++.||||++.... ......+.+|..+ ++.++||||+++++++.+.+..|+|
T Consensus 38 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~lv 117 (373)
T 2r5t_A 38 SDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFV 117 (373)
T ss_dssp GGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEEEE
T ss_pred hheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEEEE
Confidence 46788899999999999999987 58899999987542 2233456777776 5778999999999999999999999
Q ss_pred EEecCCCCHHHHhccCCCCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEecCCCCeEEeeeeeecccccC
Q 002158 700 YEFVPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSRLAPVL 779 (958)
Q Consensus 700 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~~~~~ 779 (958)
|||+++|+|.+++.... .+++..+..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+++.....
T Consensus 118 ~E~~~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~ikL~DFG~a~~~~~~ 192 (373)
T 2r5t_A 118 LDYINGGELFYHLQRER--CFLEPRARFYAAEIASALGYLHSLN---IVYRDLKPENILLDSQGHIVLTDFGLCKENIEH 192 (373)
T ss_dssp EECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCBCGGGBCC
T ss_pred EeCCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEECCCCCEEEeeCccccccccC
Confidence 99999999999997543 4889999999999999999999999 999999999999999999999999999853221
Q ss_pred CCCCCccceeeeeccCCCCccChhhhccCCCCCcchhhhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcCcchhhhccc
Q 002158 780 DDEGTMPTHVSTIVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVLLELLTGMQPISHGKNIVREVNVARDSGMVFSIIDNR 859 (958)
Q Consensus 780 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gv~l~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~i~~~ 859 (958)
. .......||+.|+|||++.+..++.++|||||||++|||++|+.||....... ....... .
T Consensus 193 ~-------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~-~~~~i~~----------~ 254 (373)
T 2r5t_A 193 N-------STTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAE-MYDNILN----------K 254 (373)
T ss_dssp C-------CCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBHHH-HHHHHHH----------S
T ss_pred C-------CccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHH-HHHHHHh----------c
Confidence 1 12334679999999999999999999999999999999999999997544322 2211111 1
Q ss_pred CCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002158 860 MGSYPSECVERFVTLALRCCHDKPEHRPSMSDVVR 894 (958)
Q Consensus 860 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 894 (958)
...++...+..+.+++.+||+.||.+||++.+.++
T Consensus 255 ~~~~~~~~~~~~~~li~~lL~~dp~~R~~~~~~~~ 289 (373)
T 2r5t_A 255 PLQLKPNITNSARHLLEGLLQKDRTKRLGAKDDFM 289 (373)
T ss_dssp CCCCCSSSCHHHHHHHHHHTCSSGGGSTTTTTTHH
T ss_pred ccCCCCCCCHHHHHHHHHHcccCHHhCCCCCCCHH
Confidence 12234456778999999999999999999864433
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-39 Score=349.70 Aligned_cols=251 Identities=24% Similarity=0.340 Sum_probs=199.3
Q ss_pred cCCCCCceeeeeCCeEEEEEEEC-CCcEEEEEEeccCC-hhcHHHHHHHHHHHHccCCCCcceEEEEEEeCCeEEEEEEe
Q 002158 625 AYFSSSTQVGQGGYGKVYKGILS-DNTTVAIKRAEEGS-LQGQNEFLTEIKLLSRLHHRNLVSLLGYCDEEGEQMLVYEF 702 (958)
Q Consensus 625 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E~ 702 (958)
++|...+.||+|+||+||+|... ++..||+|++.... ....+.+.+|++++++++||||+++++++.+.+..++||||
T Consensus 22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 101 (285)
T 3is5_A 22 DLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVMET 101 (285)
T ss_dssp HHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred hheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEEEe
Confidence 46788899999999999999986 68999999987542 33467899999999999999999999999999999999999
Q ss_pred cCCCCHHHHhccC--CCCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEe---cCCCCeEEeeeeeecccc
Q 002158 703 VPNGTLRDWLSGR--TKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILL---DSNLNAKVADFGLSRLAP 777 (958)
Q Consensus 703 ~~~gsL~~~l~~~--~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl---~~~~~~kl~DFGla~~~~ 777 (958)
+++|+|.+++... ....+++..+..++.|+++||+|||+.+ |+||||||+||++ +.++.+||+|||+++...
T Consensus 102 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~~ 178 (285)
T 3is5_A 102 CEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQH---VVHKDLKPENILFQDTSPHSPIKIIDFGLAELFK 178 (285)
T ss_dssp CSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEESSSSTTCCEEECCCCCCCC--
T ss_pred CCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCC---EEECCCCHHHEEEecCCCCCCEEEEeeecceecC
Confidence 9999999998643 2345899999999999999999999999 9999999999999 456789999999997653
Q ss_pred cCCCCCCccceeeeeccCCCCccChhhhccCCCCCcchhhhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcCcchhhhc
Q 002158 778 VLDDEGTMPTHVSTIVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVLLELLTGMQPISHGKNIVREVNVARDSGMVFSIID 857 (958)
Q Consensus 778 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gv~l~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~i~ 857 (958)
.. .......||+.|+|||++. ..++.++||||||+++|||++|+.||............... .
T Consensus 179 ~~--------~~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~~~~~~~~~-~------- 241 (285)
T 3is5_A 179 SD--------EHSTNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATYK-E------- 241 (285)
T ss_dssp ----------------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC-C-------
T ss_pred Cc--------ccCcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCCHHHHHhhhccC-C-------
Confidence 21 1123456999999999985 56889999999999999999999999754432211111111 0
Q ss_pred ccCCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 002158 858 NRMGSYPSECVERFVTLALRCCHDKPEHRPSMSDVVRE 895 (958)
Q Consensus 858 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 895 (958)
..........++.+.+++.+||+.||++||+++|++++
T Consensus 242 ~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h 279 (285)
T 3is5_A 242 PNYAVECRPLTPQAVDLLKQMLTKDPERRPSAAQVLHH 279 (285)
T ss_dssp CCCCC--CCCCHHHHHHHHHHTCSCTTTSCCHHHHHTS
T ss_pred cccccccCcCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 00001111245778899999999999999999999863
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-39 Score=357.89 Aligned_cols=273 Identities=23% Similarity=0.380 Sum_probs=201.2
Q ss_pred cCCCCCceeeeeCCeEEEEEEECCCcEEEEEEeccCChhcHHHHHHHHHH--HHccCCCCcceEEEEEEe-----CCeEE
Q 002158 625 AYFSSSTQVGQGGYGKVYKGILSDNTTVAIKRAEEGSLQGQNEFLTEIKL--LSRLHHRNLVSLLGYCDE-----EGEQM 697 (958)
Q Consensus 625 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~--l~~l~H~niv~l~~~~~~-----~~~~~ 697 (958)
++|...+.||+|+||+||+|++ +++.||||++... ....+..|.++ +..++||||+++++++.. ....+
T Consensus 13 ~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~---~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~~ 88 (336)
T 3g2f_A 13 DNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFA---NRQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEYL 88 (336)
T ss_dssp TSEEEEEEEEECSSEEEEEEEE-TTEEEEEEEEEGG---GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEEEE
T ss_pred HHhheeeecccCCCeEEEEEEE-CCeEEEEEEeecc---chhhHHHHHHHHHHHhccCcchhhheecccccccCCCceEE
Confidence 4677888999999999999987 6899999999753 23445555555 445899999999986643 23578
Q ss_pred EEEEecCCCCHHHHhccCCCCCchHHHHHHHHHHHHHHHHHhhhc---------CCCCeeccCCCccceEecCCCCeEEe
Q 002158 698 LVYEFVPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTE---------AHPPVFHRDIKASNILLDSNLNAKVA 768 (958)
Q Consensus 698 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~---------~~~~iiH~Dikp~NILl~~~~~~kl~ 768 (958)
+||||+++|+|.+++.... .++..+.+++.|+++||+|||+. + |+||||||+|||++.++.+||+
T Consensus 89 lv~e~~~~g~L~~~l~~~~---~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~---ivH~Dikp~Nill~~~~~~kL~ 162 (336)
T 3g2f_A 89 LVMEYYPNGSLXKYLSLHT---SDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPA---ISHRDLNSRNVLVKNDGTCVIS 162 (336)
T ss_dssp EEECCCTTCBHHHHHHHCC---BCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCC---EECSSCSGGGEEECTTSCEEEC
T ss_pred EEEecCCCCcHHHHHhhcc---cchhHHHHHHHHHHHHHHHHHhhhccccccccc---eeecccccceEEEcCCCcEEEe
Confidence 9999999999999997554 58899999999999999999998 7 9999999999999999999999
Q ss_pred eeeeecccccCCCCCC-ccceeeeeccCCCCccChhhhcc-------CCCCCcchhhhHHHHHHHHHhCCCCCCCCchhH
Q 002158 769 DFGLSRLAPVLDDEGT-MPTHVSTIVKGTPGYLDPEYFLT-------HKLTDKSDVYSLGVVLLELLTGMQPISHGKNIV 840 (958)
Q Consensus 769 DFGla~~~~~~~~~~~-~~~~~~~~~~gt~~y~aPE~~~~-------~~~~~~~DV~S~Gv~l~elltG~~P~~~~~~~~ 840 (958)
|||+++.......... ..........||+.|+|||++.+ ..++.++|||||||++|||++|..||.......
T Consensus 163 DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~ 242 (336)
T 3g2f_A 163 DFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVP 242 (336)
T ss_dssp CCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSCCC
T ss_pred eccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccchh
Confidence 9999986543221100 11122234569999999999986 456679999999999999999988775432210
Q ss_pred ----------------HHHHHHhhcCcchhhhcccCCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHhhCC
Q 002158 841 ----------------REVNVARDSGMVFSIIDNRMGSYPSECVERFVTLALRCCHDKPEHRPSMSDVVRELENILKMFP 904 (958)
Q Consensus 841 ----------------~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~~ 904 (958)
...............+.. .......++..+.+++.+||+.||++|||++|+++.|++++....
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~ll~~~~ 321 (336)
T 3g2f_A 243 EYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPE-AWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAELMMIWE 321 (336)
T ss_dssp CCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCT-TCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHCCC
T ss_pred HHHHhhhcccCCCchHHHHHhhhcccccCCCCCc-ccccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHHHHHHHH
Confidence 000000000000000000 001123577889999999999999999999999999999998776
Q ss_pred CCCc
Q 002158 905 ETDT 908 (958)
Q Consensus 905 ~~~~ 908 (958)
....
T Consensus 322 ~~~~ 325 (336)
T 3g2f_A 322 RNKS 325 (336)
T ss_dssp C---
T ss_pred hccc
Confidence 6543
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-39 Score=373.02 Aligned_cols=255 Identities=23% Similarity=0.295 Sum_probs=198.1
Q ss_pred cCCCCCceeeeeCCeEEEEEEEC-CCcEEEEEEeccC--ChhcHHHHHHHHHHHHccCCCCcceEEEEEEeC------Ce
Q 002158 625 AYFSSSTQVGQGGYGKVYKGILS-DNTTVAIKRAEEG--SLQGQNEFLTEIKLLSRLHHRNLVSLLGYCDEE------GE 695 (958)
Q Consensus 625 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~------~~ 695 (958)
++|...+.||+|+||+||+|.+. +++.||||++... .....+++.+|+.+++.++||||+++++++... ..
T Consensus 62 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~~ 141 (464)
T 3ttj_A 62 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQD 141 (464)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCE
T ss_pred CCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCCe
Confidence 56888899999999999999976 6899999999754 334456789999999999999999999999654 35
Q ss_pred EEEEEEecCCCCHHHHhccCCCCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEecCCCCeEEeeeeeecc
Q 002158 696 QMLVYEFVPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSRL 775 (958)
Q Consensus 696 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~ 775 (958)
.++||||+++ +|.+.+.. .+++.++..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++.
T Consensus 142 ~~lv~E~~~~-~l~~~~~~----~l~~~~~~~~~~qil~aL~~lH~~~---iiHrDlkp~NIll~~~~~~kl~DFG~a~~ 213 (464)
T 3ttj_A 142 VYLVMELMDA-NLCQVIQM----ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLART 213 (464)
T ss_dssp EEEEEECCSE-EHHHHHTS----CCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCCC--
T ss_pred EEEEEeCCCC-CHHHHHhh----cCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChHhEEEeCCCCEEEEEEEeeee
Confidence 7999999965 57777743 2889999999999999999999999 99999999999999999999999999986
Q ss_pred cccCCCCCCccceeeeeccCCCCccChhhhccCCCCCcchhhhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcCcc---
Q 002158 776 APVLDDEGTMPTHVSTIVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVLLELLTGMQPISHGKNIVREVNVARDSGMV--- 852 (958)
Q Consensus 776 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gv~l~elltG~~P~~~~~~~~~~~~~~~~~~~~--- 852 (958)
.... .......||+.|+|||++.+..++.++||||+||++|||++|+.||.+..............+..
T Consensus 214 ~~~~--------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~lg~p~~~ 285 (464)
T 3ttj_A 214 AGTS--------FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPE 285 (464)
T ss_dssp ---C--------CCC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHH
T ss_pred cCCC--------cccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHH
Confidence 5321 12234679999999999999999999999999999999999999998665443332222111110
Q ss_pred ---------hhhhcccC--CC-----------------CChHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 002158 853 ---------FSIIDNRM--GS-----------------YPSECVERFVTLALRCCHDKPEHRPSMSDVVRE 895 (958)
Q Consensus 853 ---------~~~i~~~~--~~-----------------~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 895 (958)
...+.... .. .....+.++.+++.+||+.||++|||++|++++
T Consensus 286 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H 356 (464)
T 3ttj_A 286 FMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH 356 (464)
T ss_dssp HHTTSCHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred HHHHcchhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 00000000 00 001226678999999999999999999999976
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-38 Score=346.48 Aligned_cols=248 Identities=22% Similarity=0.369 Sum_probs=208.2
Q ss_pred cCCCCCceeeeeCCeEEEEEEEC-CCcEEEEEEeccC---ChhcHHHHHHHHHHHHccCCCCcceEEEEEEeCCeEEEEE
Q 002158 625 AYFSSSTQVGQGGYGKVYKGILS-DNTTVAIKRAEEG---SLQGQNEFLTEIKLLSRLHHRNLVSLLGYCDEEGEQMLVY 700 (958)
Q Consensus 625 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~ 700 (958)
.+|...+.||+|+||+||+|.+. +++.||+|++... .....+.+.+|+++++.++||||+++++++.+.+..++||
T Consensus 15 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 94 (294)
T 2rku_A 15 RRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVL 94 (294)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEEEE
Confidence 46777889999999999999987 5889999998653 2344567899999999999999999999999999999999
Q ss_pred EecCCCCHHHHhccCCCCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEecCCCCeEEeeeeeecccccCC
Q 002158 701 EFVPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSRLAPVLD 780 (958)
Q Consensus 701 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~ 780 (958)
||+++++|.+++.... .+++.++..++.|+++||+|||+++ |+||||||+||+++.++.+||+|||+++......
T Consensus 95 e~~~~~~L~~~~~~~~--~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~ 169 (294)
T 2rku_A 95 ELCRRRSLLELHKRRK--ALTEPEARYYLRQIVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDG 169 (294)
T ss_dssp ECCTTCBHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECCSTT
T ss_pred ecCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEcCCCCEEEEeccCceecccCc
Confidence 9999999999987543 4899999999999999999999999 9999999999999999999999999998653221
Q ss_pred CCCCccceeeeeccCCCCccChhhhccCCCCCcchhhhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcCcchhhhcccC
Q 002158 781 DEGTMPTHVSTIVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVLLELLTGMQPISHGKNIVREVNVARDSGMVFSIIDNRM 860 (958)
Q Consensus 781 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gv~l~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~i~~~~ 860 (958)
. ......||+.|+|||++.+..++.++||||||+++|||++|+.||.......... .... ..
T Consensus 170 ~-------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~-~~~~----------~~ 231 (294)
T 2rku_A 170 E-------RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYL-RIKK----------NE 231 (294)
T ss_dssp C-------CBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHH-HHHT----------TC
T ss_pred c-------ccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH-HHhh----------cc
Confidence 1 1233569999999999999999999999999999999999999997544322211 1111 11
Q ss_pred CCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 002158 861 GSYPSECVERFVTLALRCCHDKPEHRPSMSDVVRE 895 (958)
Q Consensus 861 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 895 (958)
...+...+..+.+++.+||+.||++||+++|++++
T Consensus 232 ~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~ 266 (294)
T 2rku_A 232 YSIPKHINPVAASLIQKMLQTDPTARPTINELLND 266 (294)
T ss_dssp CCCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred CCCccccCHHHHHHHHHHcccChhhCcCHHHHhhC
Confidence 22344566789999999999999999999999975
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=353.14 Aligned_cols=269 Identities=23% Similarity=0.299 Sum_probs=209.0
Q ss_pred HcCCCCCceeeeeCCeEEEEEEEC-CCcEEEEEEeccCChhcHHHHHHHHHHHHccCCCCcceEEEEEEe----CCeEEE
Q 002158 624 TAYFSSSTQVGQGGYGKVYKGILS-DNTTVAIKRAEEGSLQGQNEFLTEIKLLSRLHHRNLVSLLGYCDE----EGEQML 698 (958)
Q Consensus 624 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~----~~~~~l 698 (958)
.++|...+.||+|+||.||+|... +++.||||++........+.+.+|+++++.++||||+++++++.. ....++
T Consensus 28 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~l 107 (317)
T 2buj_A 28 NKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAWL 107 (317)
T ss_dssp TEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEEEE
T ss_pred CeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCceeEE
Confidence 356888899999999999999984 789999999977666677789999999999999999999999863 347899
Q ss_pred EEEecCCCCHHHHhccC--CCCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEecCCCCeEEeeeeeeccc
Q 002158 699 VYEFVPNGTLRDWLSGR--TKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSRLA 776 (958)
Q Consensus 699 V~E~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~~ 776 (958)
||||+++|+|.+++... ....+++.+++.++.|+++||+|||+.+ |+||||||+||+++.++.+||+|||+++..
T Consensus 108 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~dfg~~~~~ 184 (317)
T 2buj_A 108 LLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKG---YAHRDLKPTNILLGDEGQPVLMDLGSMNQA 184 (317)
T ss_dssp EEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCSSCEES
T ss_pred EEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEcCCCCEEEEecCcchhc
Confidence 99999999999999752 2345899999999999999999999999 999999999999999999999999998754
Q ss_pred ccCCCCCC--ccceeeeeccCCCCccChhhhccCC---CCCcchhhhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcCc
Q 002158 777 PVLDDEGT--MPTHVSTIVKGTPGYLDPEYFLTHK---LTDKSDVYSLGVVLLELLTGMQPISHGKNIVREVNVARDSGM 851 (958)
Q Consensus 777 ~~~~~~~~--~~~~~~~~~~gt~~y~aPE~~~~~~---~~~~~DV~S~Gv~l~elltG~~P~~~~~~~~~~~~~~~~~~~ 851 (958)
........ ..........||+.|+|||++.+.. ++.++||||||+++|||++|+.||..... ....
T Consensus 185 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~---------~~~~ 255 (317)
T 2buj_A 185 CIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQ---------KGDS 255 (317)
T ss_dssp CEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHH---------TTSC
T ss_pred ccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhc---------ccch
Confidence 21110000 0000112345799999999987554 68899999999999999999999952110 0000
Q ss_pred chhhhccc-CCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHhhCC
Q 002158 852 VFSIIDNR-MGSYPSECVERFVTLALRCCHDKPEHRPSMSDVVRELENILKMFP 904 (958)
Q Consensus 852 ~~~~i~~~-~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~~ 904 (958)
....+... ....+..++..+.+++.+||+.||.+||++++++++|+.+....|
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~~~ 309 (317)
T 2buj_A 256 VALAVQNQLSIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQPPAP 309 (317)
T ss_dssp HHHHHHCC--CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTCCCCC
T ss_pred hhHHhhccCCCCccccCCHHHHHHHHHHhhcChhhCCCHHHHHHHhhhcCCCCC
Confidence 01111111 112234556789999999999999999999999999998764444
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-39 Score=347.74 Aligned_cols=254 Identities=24% Similarity=0.357 Sum_probs=206.8
Q ss_pred HcCCCCCceeeeeCCeEEEEEEEC-CCcEEEEEEeccC-ChhcHHHHHHHHHHHHccCCCCcceEEEEEEeCCeEEEEEE
Q 002158 624 TAYFSSSTQVGQGGYGKVYKGILS-DNTTVAIKRAEEG-SLQGQNEFLTEIKLLSRLHHRNLVSLLGYCDEEGEQMLVYE 701 (958)
Q Consensus 624 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E 701 (958)
.++|+..+.||+|+||.||+|.+. +++.||||++... .....+.+.+|+++++.++||||+++++++.+++..++|||
T Consensus 6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 85 (276)
T 2yex_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 85 (276)
T ss_dssp HHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred ecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEEE
Confidence 356788899999999999999986 6899999998653 23345678999999999999999999999999999999999
Q ss_pred ecCCCCHHHHhccCCCCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEecCCCCeEEeeeeeecccccCCC
Q 002158 702 FVPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSRLAPVLDD 781 (958)
Q Consensus 702 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~ 781 (958)
|+++++|.+++... ..+++.++..++.|+++||+|||+.+ |+||||||+||+++.++.+||+|||+++.......
T Consensus 86 ~~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~ 160 (276)
T 2yex_A 86 YCSGGELFDRIEPD--IGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNR 160 (276)
T ss_dssp CCTTEEGGGGSBTT--TBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEECEETTE
T ss_pred ecCCCcHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCChHHEEEccCCCEEEeeCCCccccCCCcc
Confidence 99999999999654 34899999999999999999999999 99999999999999999999999999976532211
Q ss_pred CCCccceeeeeccCCCCccChhhhccCCC-CCcchhhhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcCcchhhhcccC
Q 002158 782 EGTMPTHVSTIVKGTPGYLDPEYFLTHKL-TDKSDVYSLGVVLLELLTGMQPISHGKNIVREVNVARDSGMVFSIIDNRM 860 (958)
Q Consensus 782 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DV~S~Gv~l~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~i~~~~ 860 (958)
........||+.|+|||++.+..+ +.++||||||+++|||++|+.||...................
T Consensus 161 -----~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~-------- 227 (276)
T 2yex_A 161 -----ERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTY-------- 227 (276)
T ss_dssp -----ECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHHHHHHHTTCTT--------
T ss_pred -----hhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHHHHhhhcccc--------
Confidence 111234568999999999987765 679999999999999999999997644322222211111100
Q ss_pred CCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 002158 861 GSYPSECVERFVTLALRCCHDKPEHRPSMSDVVRE 895 (958)
Q Consensus 861 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 895 (958)
.......+..+.+++.+||+.||++||+++|++++
T Consensus 228 ~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 262 (276)
T 2yex_A 228 LNPWKKIDSAPLALLHKILVENPSARITIPDIKKD 262 (276)
T ss_dssp STTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred cCchhhcCHHHHHHHHHHCCCCchhCCCHHHHhcC
Confidence 01123456788999999999999999999999863
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-39 Score=349.70 Aligned_cols=249 Identities=27% Similarity=0.420 Sum_probs=185.8
Q ss_pred cCCCCCceeeeeCCeEEEEEEEC-CCcEEEEEEeccCCh---hcHHHHHHHHHHHHccCCCCcceEEEEEEeCCeEEEEE
Q 002158 625 AYFSSSTQVGQGGYGKVYKGILS-DNTTVAIKRAEEGSL---QGQNEFLTEIKLLSRLHHRNLVSLLGYCDEEGEQMLVY 700 (958)
Q Consensus 625 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~ 700 (958)
++|...+.||+|+||.||+|.+. +++.||||++..... ...+.+.+|++++++++||||+++++++.+.+..++||
T Consensus 11 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 90 (278)
T 3cok_A 11 EDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLVL 90 (278)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEEE
T ss_pred ccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEEE
Confidence 45777889999999999999985 789999999865321 22467899999999999999999999999999999999
Q ss_pred EecCCCCHHHHhccCCCCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEecCCCCeEEeeeeeecccccCC
Q 002158 701 EFVPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSRLAPVLD 780 (958)
Q Consensus 701 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~ 780 (958)
||+++++|.+++.... ..+++.++..++.|+++||+|||+.+ |+||||||+||+++.++.+||+|||+++......
T Consensus 91 e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~ 166 (278)
T 3cok_A 91 EMCHNGEMNRYLKNRV-KPFSENEARHFMHQIITGMLYLHSHG---ILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPH 166 (278)
T ss_dssp ECCTTEEHHHHHHTCS-SCCCHHHHHHHHHHHHHHHHHHHHTT---EECSSCCGGGEEECTTCCEEECCCTTCEECC---
T ss_pred ecCCCCcHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEEEeecceeeccCCC
Confidence 9999999999997543 45899999999999999999999999 9999999999999999999999999997653211
Q ss_pred CCCCccceeeeeccCCCCccChhhhccCCCCCcchhhhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcCcchhhhcccC
Q 002158 781 DEGTMPTHVSTIVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVLLELLTGMQPISHGKNIVREVNVARDSGMVFSIIDNRM 860 (958)
Q Consensus 781 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gv~l~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~i~~~~ 860 (958)
.......||+.|+|||++.+..++.++||||||+++|||++|+.||........ .. ... ...
T Consensus 167 -------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~-~~---------~~~-~~~ 228 (278)
T 3cok_A 167 -------EKHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNT-LN---------KVV-LAD 228 (278)
T ss_dssp --------------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC---------------CC-SSC
T ss_pred -------CcceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHH-HH---------HHh-hcc
Confidence 112235689999999999998999999999999999999999999975332111 10 000 011
Q ss_pred CCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 002158 861 GSYPSECVERFVTLALRCCHDKPEHRPSMSDVVRE 895 (958)
Q Consensus 861 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 895 (958)
...+...+.++.+++.+||+.||++||++++++++
T Consensus 229 ~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h 263 (278)
T 3cok_A 229 YEMPSFLSIEAKDLIHQLLRRNPADRLSLSSVLDH 263 (278)
T ss_dssp CCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred cCCccccCHHHHHHHHHHcccCHhhCCCHHHHhcC
Confidence 12344567789999999999999999999999863
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-39 Score=356.19 Aligned_cols=260 Identities=27% Similarity=0.436 Sum_probs=209.3
Q ss_pred HcCCCCCceeeeeCCeEEEEEEE------CCCcEEEEEEeccC-ChhcHHHHHHHHHHHHccCCCCcceEEEEEEeCCeE
Q 002158 624 TAYFSSSTQVGQGGYGKVYKGIL------SDNTTVAIKRAEEG-SLQGQNEFLTEIKLLSRLHHRNLVSLLGYCDEEGEQ 696 (958)
Q Consensus 624 ~~~~~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~ 696 (958)
.++|...+.||+|+||.||+|.+ .+++.||||++... ......++.+|+.++++++||||+++++++...+..
T Consensus 29 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 108 (327)
T 2yfx_A 29 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPR 108 (327)
T ss_dssp GGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred hhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCCCc
Confidence 45788889999999999999984 24778999999754 344556799999999999999999999999999999
Q ss_pred EEEEEecCCCCHHHHhccCCC-----CCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEecC---CCCeEEe
Q 002158 697 MLVYEFVPNGTLRDWLSGRTK-----ENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDS---NLNAKVA 768 (958)
Q Consensus 697 ~lV~E~~~~gsL~~~l~~~~~-----~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~---~~~~kl~ 768 (958)
++||||+++++|.+++..... ..+++.+++.++.|++.||+|||+.+ |+||||||+|||++. +..+||+
T Consensus 109 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~---i~H~dlkp~NIli~~~~~~~~~kl~ 185 (327)
T 2yfx_A 109 FILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKIG 185 (327)
T ss_dssp EEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEEEC
T ss_pred EEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC---eecCcCCHhHEEEecCCCcceEEEC
Confidence 999999999999999976532 34899999999999999999999999 999999999999984 4469999
Q ss_pred eeeeecccccCCCCCCccceeeeeccCCCCccChhhhccCCCCCcchhhhHHHHHHHHHh-CCCCCCCCchhHHHHHHHh
Q 002158 769 DFGLSRLAPVLDDEGTMPTHVSTIVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVLLELLT-GMQPISHGKNIVREVNVAR 847 (958)
Q Consensus 769 DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gv~l~ellt-G~~P~~~~~~~~~~~~~~~ 847 (958)
|||+++....... ........||+.|+|||++.+..++.++||||||+++|||++ |..||...... .......
T Consensus 186 Dfg~~~~~~~~~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~-~~~~~~~ 259 (327)
T 2yfx_A 186 DFGMARDIYRASY-----YRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQ-EVLEFVT 259 (327)
T ss_dssp CCHHHHHHHC-----------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH-HHHHHHH
T ss_pred ccccccccccccc-----cccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCHH-HHHHHHh
Confidence 9999975432211 111233568899999999999999999999999999999998 99999754432 1111111
Q ss_pred hcCcchhhhcccCCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHh
Q 002158 848 DSGMVFSIIDNRMGSYPSECVERFVTLALRCCHDKPEHRPSMSDVVRELENILK 901 (958)
Q Consensus 848 ~~~~~~~~i~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~ 901 (958)
.......+..++..+.+++.+||+.||.+||++.+++++|+.+..
T Consensus 260 ---------~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~ 304 (327)
T 2yfx_A 260 ---------SGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQ 304 (327)
T ss_dssp ---------TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ---------cCCCCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHhc
Confidence 111223345667889999999999999999999999999998764
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-38 Score=353.84 Aligned_cols=248 Identities=22% Similarity=0.373 Sum_probs=208.3
Q ss_pred cCCCCCceeeeeCCeEEEEEEEC-CCcEEEEEEeccC---ChhcHHHHHHHHHHHHccCCCCcceEEEEEEeCCeEEEEE
Q 002158 625 AYFSSSTQVGQGGYGKVYKGILS-DNTTVAIKRAEEG---SLQGQNEFLTEIKLLSRLHHRNLVSLLGYCDEEGEQMLVY 700 (958)
Q Consensus 625 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~ 700 (958)
.+|...+.||+|+||.||+|.+. +++.||+|++... .....+.+.+|+.+++.++||||+++++++.+.+..++||
T Consensus 41 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 120 (335)
T 2owb_A 41 RRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVL 120 (335)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred CceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEE
Confidence 46777899999999999999986 5789999998653 2344567899999999999999999999999999999999
Q ss_pred EecCCCCHHHHhccCCCCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEecCCCCeEEeeeeeecccccCC
Q 002158 701 EFVPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSRLAPVLD 780 (958)
Q Consensus 701 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~ 780 (958)
||+++++|.+++.... .+++.++..++.|+++||+|||+++ |+||||||+||+++.++.+||+|||+++......
T Consensus 121 e~~~~~~L~~~~~~~~--~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~ 195 (335)
T 2owb_A 121 ELCRRRSLLELHKRRK--ALTEPEARYYLRQIVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDG 195 (335)
T ss_dssp CCCTTCBHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCEECCSTT
T ss_pred ecCCCCCHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHHCC---CEecCCCchhEEEcCCCCEEEeeccCceecccCc
Confidence 9999999999987543 4899999999999999999999999 9999999999999999999999999998653221
Q ss_pred CCCCccceeeeeccCCCCccChhhhccCCCCCcchhhhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcCcchhhhcccC
Q 002158 781 DEGTMPTHVSTIVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVLLELLTGMQPISHGKNIVREVNVARDSGMVFSIIDNRM 860 (958)
Q Consensus 781 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gv~l~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~i~~~~ 860 (958)
. ......||+.|+|||++.+..++.++||||||+++|||++|+.||............. . ..
T Consensus 196 ~-------~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~-~----------~~ 257 (335)
T 2owb_A 196 E-------RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIK-K----------NE 257 (335)
T ss_dssp C-------CBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHH-H----------TC
T ss_pred c-------cccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHh-c----------CC
Confidence 1 1233569999999999999999999999999999999999999997544322211111 1 11
Q ss_pred CCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 002158 861 GSYPSECVERFVTLALRCCHDKPEHRPSMSDVVRE 895 (958)
Q Consensus 861 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 895 (958)
...+..++..+.+++.+||+.||++||+++|++++
T Consensus 258 ~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~ 292 (335)
T 2owb_A 258 YSIPKHINPVAASLIQKMLQTDPTARPTINELLND 292 (335)
T ss_dssp CCCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred CCCCccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 12344566788999999999999999999999975
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-39 Score=365.26 Aligned_cols=266 Identities=24% Similarity=0.291 Sum_probs=212.5
Q ss_pred cCCCCCceeeeeCCeEEEEEEEC-CCcEEEEEEeccCC-hhcHHHHHHHHHHHHccCCCCcceEEEEEEeCC--eEEEEE
Q 002158 625 AYFSSSTQVGQGGYGKVYKGILS-DNTTVAIKRAEEGS-LQGQNEFLTEIKLLSRLHHRNLVSLLGYCDEEG--EQMLVY 700 (958)
Q Consensus 625 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~--~~~lV~ 700 (958)
++|...+.||+|+||+||+|.+. +++.||||++.... ....+.+.+|++++++++||||+++++++...+ ..++||
T Consensus 9 ~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv~ 88 (396)
T 4eut_A 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIM 88 (396)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEE
T ss_pred CceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEEEE
Confidence 46778889999999999999987 58999999997543 234567889999999999999999999998755 789999
Q ss_pred EecCCCCHHHHhccCCC-CCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEe----cCCCCeEEeeeeeecc
Q 002158 701 EFVPNGTLRDWLSGRTK-ENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILL----DSNLNAKVADFGLSRL 775 (958)
Q Consensus 701 E~~~~gsL~~~l~~~~~-~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl----~~~~~~kl~DFGla~~ 775 (958)
||+++|+|.+++..... ..+++.++..++.|++.||+|||+.+ |+||||||+|||+ +.++.+||+|||+++.
T Consensus 89 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~~ 165 (396)
T 4eut_A 89 EFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARE 165 (396)
T ss_dssp CCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEECTTSCEEEEECCGGGCEE
T ss_pred ecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCC---EEECCcCHHHEEEeecCCCceeEEEecCCCceE
Confidence 99999999999976432 33899999999999999999999999 9999999999999 7788899999999986
Q ss_pred cccCCCCCCccceeeeeccCCCCccChhhhcc--------CCCCCcchhhhHHHHHHHHHhCCCCCCCCc---hhHHHHH
Q 002158 776 APVLDDEGTMPTHVSTIVKGTPGYLDPEYFLT--------HKLTDKSDVYSLGVVLLELLTGMQPISHGK---NIVREVN 844 (958)
Q Consensus 776 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~DV~S~Gv~l~elltG~~P~~~~~---~~~~~~~ 844 (958)
..... ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||.... .....+.
T Consensus 166 ~~~~~--------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~ 237 (396)
T 4eut_A 166 LEDDE--------QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMY 237 (396)
T ss_dssp CCCGG--------GSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHHH
T ss_pred ccCCC--------ccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHHH
Confidence 53221 1223569999999999875 567789999999999999999999996322 1111111
Q ss_pred HHhhcCcchhhh-------------c---ccCCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHhh
Q 002158 845 VARDSGMVFSII-------------D---NRMGSYPSECVERFVTLALRCCHDKPEHRPSMSDVVRELENILKM 902 (958)
Q Consensus 845 ~~~~~~~~~~~i-------------~---~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~ 902 (958)
...... ....+ . +.....+...+..+.+++.+||+.||++||+++|+++.+++++..
T Consensus 238 ~~~~~~-p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~~il~~ 310 (396)
T 4eut_A 238 KIITGK-PSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILHR 310 (396)
T ss_dssp HHHHSC-CTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHHTC
T ss_pred HHhcCC-CcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHHHHhhc
Confidence 111110 00000 0 011234578899999999999999999999999999999998754
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-38 Score=347.11 Aligned_cols=249 Identities=25% Similarity=0.459 Sum_probs=201.9
Q ss_pred CCCCCceeeeeCCeEEEEEEEC-CCcEEEEEEeccC--ChhcHHHHHHHHHHHHccCCCCcceEEEEEEe----CCeEEE
Q 002158 626 YFSSSTQVGQGGYGKVYKGILS-DNTTVAIKRAEEG--SLQGQNEFLTEIKLLSRLHHRNLVSLLGYCDE----EGEQML 698 (958)
Q Consensus 626 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~----~~~~~l 698 (958)
.|...+.||+|+||+||+|.+. ++..||+|++... .....+.+.+|++++++++||||+++++++.. ....++
T Consensus 27 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~l 106 (290)
T 1t4h_A 27 FLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVL 106 (290)
T ss_dssp EEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEE
T ss_pred eEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceEEE
Confidence 3556678999999999999986 6889999998653 34455679999999999999999999999865 356899
Q ss_pred EEEecCCCCHHHHhccCCCCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEec-CCCCeEEeeeeeecccc
Q 002158 699 VYEFVPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLD-SNLNAKVADFGLSRLAP 777 (958)
Q Consensus 699 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~-~~~~~kl~DFGla~~~~ 777 (958)
||||+++++|.+++.... .+++..+..++.|++.||+|||+.+ ++|+||||||+||+++ .++.+||+|||+++...
T Consensus 107 v~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~-~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~~~~ 183 (290)
T 1t4h_A 107 VTELMTSGTLKTYLKRFK--VMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR 183 (290)
T ss_dssp EEECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCC
T ss_pred EEEecCCCCHHHHHHHcc--CCCHHHHHHHHHHHHHHHHHHHcCC-CCEEECCCCHHHEEEECCCCCEEEeeCCCccccc
Confidence 999999999999997543 4899999999999999999999875 4599999999999997 78999999999997532
Q ss_pred cCCCCCCccceeeeeccCCCCccChhhhccCCCCCcchhhhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcCcchhhhc
Q 002158 778 VLDDEGTMPTHVSTIVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVLLELLTGMQPISHGKNIVREVNVARDSGMVFSIID 857 (958)
Q Consensus 778 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gv~l~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~i~ 857 (958)
. .......||+.|+|||++. ..++.++||||+|+++|||++|+.||....................
T Consensus 184 ~---------~~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~---- 249 (290)
T 1t4h_A 184 A---------SFAKAVIGTPEFMAPEMYE-EKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPA---- 249 (290)
T ss_dssp T---------TSBEESCSSCCCCCGGGGG-TCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCG----
T ss_pred c---------cccccccCCcCcCCHHHHh-ccCCCcchHHHHHHHHHHHHhCCCCCCCcCcHHHHHHHHhccCCcc----
Confidence 1 1123456999999999876 4589999999999999999999999986555444433322211111
Q ss_pred ccCCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 002158 858 NRMGSYPSECVERFVTLALRCCHDKPEHRPSMSDVVRE 895 (958)
Q Consensus 858 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 895 (958)
..+...+..+.+++.+||+.||++||+++|++++
T Consensus 250 ----~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h 283 (290)
T 1t4h_A 250 ----SFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNH 283 (290)
T ss_dssp ----GGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred ----ccCCCCCHHHHHHHHHHccCChhhCCCHHHHhhC
Confidence 1122334678999999999999999999999864
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-39 Score=360.64 Aligned_cols=243 Identities=22% Similarity=0.361 Sum_probs=204.1
Q ss_pred HHcCCCCCceeeeeCCeEEEEEEEC-CCcEEEEEEeccCChh--------cHHHHHHHHHHHHccCCCCcceEEEEEEeC
Q 002158 623 ATAYFSSSTQVGQGGYGKVYKGILS-DNTTVAIKRAEEGSLQ--------GQNEFLTEIKLLSRLHHRNLVSLLGYCDEE 693 (958)
Q Consensus 623 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--------~~~~~~~E~~~l~~l~H~niv~l~~~~~~~ 693 (958)
..++|...+.||+|+||+||+|.+. +++.||||++...... ....+.+|++++++++||||+++++++...
T Consensus 22 ~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~ 101 (335)
T 3dls_A 22 YSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQ 101 (335)
T ss_dssp HHHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECS
T ss_pred cccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeC
Confidence 4567888999999999999999975 6899999998764311 223577899999999999999999999999
Q ss_pred CeEEEEEEecCCC-CHHHHhccCCCCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEecCCCCeEEeeeee
Q 002158 694 GEQMLVYEFVPNG-TLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSNLNAKVADFGL 772 (958)
Q Consensus 694 ~~~~lV~E~~~~g-sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~~~~kl~DFGl 772 (958)
+..++||||+.+| +|.+++.... .+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 102 ~~~~lv~e~~~~g~~l~~~~~~~~--~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~Dfg~ 176 (335)
T 3dls_A 102 GFFQLVMEKHGSGLDLFAFIDRHP--RLDEPLASYIFRQLVSAVGYLRLKD---IIHRDIKDENIVIAEDFTIKLIDFGS 176 (335)
T ss_dssp SEEEEEEECCTTSCBHHHHHHTCC--CCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTT
T ss_pred CEEEEEEEeCCCCccHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCC---eEEeccCHHHEEEcCCCcEEEeeccc
Confidence 9999999999777 9999997554 4899999999999999999999999 99999999999999999999999999
Q ss_pred ecccccCCCCCCccceeeeeccCCCCccChhhhccCCC-CCcchhhhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcCc
Q 002158 773 SRLAPVLDDEGTMPTHVSTIVKGTPGYLDPEYFLTHKL-TDKSDVYSLGVVLLELLTGMQPISHGKNIVREVNVARDSGM 851 (958)
Q Consensus 773 a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DV~S~Gv~l~elltG~~P~~~~~~~~~~~~~~~~~~~ 851 (958)
++...... ......||+.|+|||++.+..+ +.++||||||+++|||++|+.||......
T Consensus 177 a~~~~~~~--------~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~------------ 236 (335)
T 3dls_A 177 AAYLERGK--------LFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEET------------ 236 (335)
T ss_dssp CEECCTTC--------CBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGGG------------
T ss_pred ceECCCCC--------ceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHHH------------
Confidence 98653211 1233569999999999988877 77999999999999999999999642210
Q ss_pred chhhhcccCCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 002158 852 VFSIIDNRMGSYPSECVERFVTLALRCCHDKPEHRPSMSDVVRE 895 (958)
Q Consensus 852 ~~~~i~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 895 (958)
.. .....+..++..+.+++.+||+.||++||+++|++++
T Consensus 237 ----~~-~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~h 275 (335)
T 3dls_A 237 ----VE-AAIHPPYLVSKELMSLVSGLLQPVPERRTTLEKLVTD 275 (335)
T ss_dssp ----TT-TCCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHHC
T ss_pred ----Hh-hccCCCcccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 00 1112233456789999999999999999999999985
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-38 Score=345.93 Aligned_cols=256 Identities=22% Similarity=0.335 Sum_probs=205.8
Q ss_pred cCCCCCceeeeeCCeEEEEEEEC-CCcEEEEEEeccCCh------hcHHHHHHHHHHHHccCCCCcceEEEEEEeCCeEE
Q 002158 625 AYFSSSTQVGQGGYGKVYKGILS-DNTTVAIKRAEEGSL------QGQNEFLTEIKLLSRLHHRNLVSLLGYCDEEGEQM 697 (958)
Q Consensus 625 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~ 697 (958)
++|...+.||+|+||+||+|.+. +++.||||++..... ...+.+.+|++++++++||||+++++++...+..+
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 84 (283)
T 3bhy_A 5 DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDVV 84 (283)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred hhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeEE
Confidence 46788899999999999999987 689999999875422 13578999999999999999999999999999999
Q ss_pred EEEEecCCCCHHHHhccCCCCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEecCCC----CeEEeeeeee
Q 002158 698 LVYEFVPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSNL----NAKVADFGLS 773 (958)
Q Consensus 698 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~~----~~kl~DFGla 773 (958)
+||||+++++|.+++.... .+++.++..++.|++.||+|||+.+ |+||||||+||+++.++ .+||+|||++
T Consensus 85 lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~~ 159 (283)
T 3bhy_A 85 LILELVSGGELFDFLAEKE--SLTEDEATQFLKQILDGVHYLHSKR---IAHFDLKPENIMLLDKNVPNPRIKLIDFGIA 159 (283)
T ss_dssp EEEECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSSSSCCEEECCCTTC
T ss_pred EEEeecCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCChHHEEEecCCCCCCceEEEecccc
Confidence 9999999999999997543 4899999999999999999999999 99999999999998877 8999999999
Q ss_pred cccccCCCCCCccceeeeeccCCCCccChhhhccCCCCCcchhhhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcCcch
Q 002158 774 RLAPVLDDEGTMPTHVSTIVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVLLELLTGMQPISHGKNIVREVNVARDSGMVF 853 (958)
Q Consensus 774 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gv~l~elltG~~P~~~~~~~~~~~~~~~~~~~~~ 853 (958)
+...... ......||+.|+|||++.+..++.++||||||+++|||++|+.||....................
T Consensus 160 ~~~~~~~--------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~ 231 (283)
T 3bhy_A 160 HKIEAGN--------EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNISAVNYDFD 231 (283)
T ss_dssp EECC----------------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCC
T ss_pred eeccCCC--------cccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcchHHHHHHhHhcccCCc
Confidence 7653211 12234689999999999999999999999999999999999999976543222111111100000
Q ss_pred hhhcccCCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHH--HHHhH
Q 002158 854 SIIDNRMGSYPSECVERFVTLALRCCHDKPEHRPSMSDVVRE--LENIL 900 (958)
Q Consensus 854 ~~i~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~--L~~~~ 900 (958)
.......+..+.+++.+||+.||++||+++|++++ ++.+.
T Consensus 232 -------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~ 273 (283)
T 3bhy_A 232 -------EEYFSNTSELAKDFIRRLLVKDPKRRMTIAQSLEHSWIKAIR 273 (283)
T ss_dssp -------HHHHTTCCHHHHHHHHTTSCSSGGGSCCHHHHHHCHHHHHHH
T ss_pred -------chhcccCCHHHHHHHHHHccCCHhHCcCHHHHHhCHHHHHHH
Confidence 00012345678999999999999999999999984 44443
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-38 Score=347.97 Aligned_cols=251 Identities=25% Similarity=0.387 Sum_probs=203.5
Q ss_pred CCCCceeeeeCCeEEEEEEEC-CCcEEEEEEeccCChhcHHHHHHHHHHHHccCCCCcceEEEEEEeCCeEEEEEEecCC
Q 002158 627 FSSSTQVGQGGYGKVYKGILS-DNTTVAIKRAEEGSLQGQNEFLTEIKLLSRLHHRNLVSLLGYCDEEGEQMLVYEFVPN 705 (958)
Q Consensus 627 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E~~~~ 705 (958)
|.....||+|+||.||+|.+. +++.||||.+........+.+.+|+.+++.++||||+++++++...+..++||||+++
T Consensus 24 ~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 103 (295)
T 2clq_A 24 NGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVPG 103 (295)
T ss_dssp TSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCSE
T ss_pred CCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEeCCC
Confidence 445568999999999999975 6889999999876666667899999999999999999999999999999999999999
Q ss_pred CCHHHHhccCC-CCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEecC-CCCeEEeeeeeecccccCCCCC
Q 002158 706 GTLRDWLSGRT-KENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDS-NLNAKVADFGLSRLAPVLDDEG 783 (958)
Q Consensus 706 gsL~~~l~~~~-~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~-~~~~kl~DFGla~~~~~~~~~~ 783 (958)
++|.+++.... ...+++..+..++.|++.||+|||+.+ |+||||||+||+++. ++.+||+|||+++......
T Consensus 104 ~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~--- 177 (295)
T 2clq_A 104 GSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQ---IVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGIN--- 177 (295)
T ss_dssp EEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTCCEEECCTTTCEESCC-----
T ss_pred CCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCC---EEccCCChhhEEEECCCCCEEEeecccccccCCCC---
Confidence 99999997653 334678899999999999999999999 999999999999987 8999999999997653211
Q ss_pred CccceeeeeccCCCCccChhhhccCC--CCCcchhhhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcCcchhhhcccCC
Q 002158 784 TMPTHVSTIVKGTPGYLDPEYFLTHK--LTDKSDVYSLGVVLLELLTGMQPISHGKNIVREVNVARDSGMVFSIIDNRMG 861 (958)
Q Consensus 784 ~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DV~S~Gv~l~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~i~~~~~ 861 (958)
.......||+.|+|||++.+.. ++.++||||||+++|||++|+.||.............. ......
T Consensus 178 ----~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~--------~~~~~~ 245 (295)
T 2clq_A 178 ----PCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVG--------MFKVHP 245 (295)
T ss_dssp -------CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHHHHHHH--------HHCCCC
T ss_pred ----CcccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHHHHhhc--------cccccc
Confidence 1122456899999999997654 78899999999999999999999964332221111110 111123
Q ss_pred CCChHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 002158 862 SYPSECVERFVTLALRCCHDKPEHRPSMSDVVRE 895 (958)
Q Consensus 862 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 895 (958)
..+..++..+.+++.+||+.||++||+++|++++
T Consensus 246 ~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~ 279 (295)
T 2clq_A 246 EIPESMSAEAKAFILKCFEPDPDKRACANDLLVD 279 (295)
T ss_dssp CCCTTSCHHHHHHHHHTTCSSTTTSCCHHHHHTS
T ss_pred cccccCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 3455677889999999999999999999999863
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=363.25 Aligned_cols=266 Identities=26% Similarity=0.371 Sum_probs=196.3
Q ss_pred HHcCCCCCceeeeeCCeEEEEEEEC-CCcEEEEEEeccC--ChhcHHHHHHHHHHHHccC-CCCcceEEEEEEeCC--eE
Q 002158 623 ATAYFSSSTQVGQGGYGKVYKGILS-DNTTVAIKRAEEG--SLQGQNEFLTEIKLLSRLH-HRNLVSLLGYCDEEG--EQ 696 (958)
Q Consensus 623 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~~--~~ 696 (958)
..++|...+.||+|+||.||+|.+. +++.||||++... ......++.+|+.+++++. ||||+++++++..++ ..
T Consensus 7 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~ 86 (388)
T 3oz6_A 7 VLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRDV 86 (388)
T ss_dssp HHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSCE
T ss_pred ccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCEE
Confidence 4567888999999999999999976 6899999998653 3445567889999999997 999999999997544 78
Q ss_pred EEEEEecCCCCHHHHhccCCCCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEecCCCCeEEeeeeeeccc
Q 002158 697 MLVYEFVPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSRLA 776 (958)
Q Consensus 697 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~~ 776 (958)
++||||++ ++|.+++... .+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+|+..
T Consensus 87 ~lv~e~~~-~~L~~~~~~~---~~~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~ 159 (388)
T 3oz6_A 87 YLVFDYME-TDLHAVIRAN---ILEPVHKQYVVYQLIKVIKYLHSGG---LLHRDMKPSNILLNAECHVKVADFGLSRSF 159 (388)
T ss_dssp EEEEECCS-EEHHHHHHHT---CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEES
T ss_pred EEEecccC-cCHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHeEEcCCCCEEecCCcccccc
Confidence 99999996 6999999753 4889999999999999999999999 999999999999999999999999999865
Q ss_pred ccCCCCC--------------CccceeeeeccCCCCccChhhhcc-CCCCCcchhhhHHHHHHHHHhCCCCCCCCchhHH
Q 002158 777 PVLDDEG--------------TMPTHVSTIVKGTPGYLDPEYFLT-HKLTDKSDVYSLGVVLLELLTGMQPISHGKNIVR 841 (958)
Q Consensus 777 ~~~~~~~--------------~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DV~S~Gv~l~elltG~~P~~~~~~~~~ 841 (958)
....... ...........||+.|+|||++.+ ..++.++||||+||++|||++|+.||.+......
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~ 239 (388)
T 3oz6_A 160 VNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMNQ 239 (388)
T ss_dssp SSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH
T ss_pred cccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence 3211100 001122344679999999999987 6789999999999999999999999986554333
Q ss_pred HHHHHhhcCcch-hhh----------------------cccCCC-------------CChHHHHHHHHHHHHccccCCCC
Q 002158 842 EVNVARDSGMVF-SII----------------------DNRMGS-------------YPSECVERFVTLALRCCHDKPEH 885 (958)
Q Consensus 842 ~~~~~~~~~~~~-~~i----------------------~~~~~~-------------~~~~~~~~l~~li~~cl~~dP~~ 885 (958)
........+... +.+ ...... .+..++..+.+++.+||+.||++
T Consensus 240 ~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~dP~~ 319 (388)
T 3oz6_A 240 LERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQFNPNK 319 (388)
T ss_dssp HHHHHHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCSSGGG
T ss_pred HHHHHHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhccCccc
Confidence 222111100000 000 000000 01134567899999999999999
Q ss_pred CCCHHHHHHH
Q 002158 886 RPSMSDVVRE 895 (958)
Q Consensus 886 RPs~~evl~~ 895 (958)
|||++|++++
T Consensus 320 R~t~~e~l~H 329 (388)
T 3oz6_A 320 RISANDALKH 329 (388)
T ss_dssp SCCHHHHTTS
T ss_pred CCCHHHHhCC
Confidence 9999999975
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-38 Score=369.99 Aligned_cols=267 Identities=21% Similarity=0.306 Sum_probs=211.2
Q ss_pred cCCCCCceeeeeCCeEEEEEEEC-CCcEEEEEEeccCChhcHHHHHHHHHHHHccCC-CCcceEEEEEEeCCeEEEEEEe
Q 002158 625 AYFSSSTQVGQGGYGKVYKGILS-DNTTVAIKRAEEGSLQGQNEFLTEIKLLSRLHH-RNLVSLLGYCDEEGEQMLVYEF 702 (958)
Q Consensus 625 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H-~niv~l~~~~~~~~~~~lV~E~ 702 (958)
++|...+.||+|+||.||+|.+. +++.||||++...... .++.+|+++++.++| +++..+..++...+..++||||
T Consensus 7 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~--~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvme~ 84 (483)
T 3sv0_A 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH--PQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVMDL 84 (483)
T ss_dssp TTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCSS--CCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEEEC
T ss_pred CcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEecccccc--HHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEEEC
Confidence 57888999999999999999974 6899999988754322 357899999999976 5666666777788899999999
Q ss_pred cCCCCHHHHhccCCCCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEe---cCCCCeEEeeeeeecccccC
Q 002158 703 VPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILL---DSNLNAKVADFGLSRLAPVL 779 (958)
Q Consensus 703 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl---~~~~~~kl~DFGla~~~~~~ 779 (958)
+ +++|.+++.... ..+++.+++.++.||+.||+|||+++ |+||||||+|||+ +.++.+||+|||+++.+...
T Consensus 85 ~-g~sL~~ll~~~~-~~l~~~~~~~i~~qi~~aL~yLH~~g---IvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~ 159 (483)
T 3sv0_A 85 L-GPSLEDLFNFCS-RKLSLKTVLMLADQMINRVEFVHSKS---FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDT 159 (483)
T ss_dssp C-CCBHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECCGGGTTCEEECCCTTCEECBCT
T ss_pred C-CCCHHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccCcceEEEecCCCCCeEEEEeCCcceeccCC
Confidence 9 999999997543 34999999999999999999999999 9999999999999 68899999999999876544
Q ss_pred CCCCCccceeeeeccCCCCccChhhhccCCCCCcchhhhHHHHHHHHHhCCCCCCCCch--hHHHHHHHhhcCcchhhhc
Q 002158 780 DDEGTMPTHVSTIVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVLLELLTGMQPISHGKN--IVREVNVARDSGMVFSIID 857 (958)
Q Consensus 780 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gv~l~elltG~~P~~~~~~--~~~~~~~~~~~~~~~~~i~ 857 (958)
......+........||+.|+|||++.+..++.++|||||||++|||++|+.||..... ....+...... .....+
T Consensus 160 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~-~~~~~~- 237 (483)
T 3sv0_A 160 STHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEK-KVATSI- 237 (483)
T ss_dssp TTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHH-HHHSCH-
T ss_pred ccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhc-cccccH-
Confidence 33222222333456799999999999999999999999999999999999999976432 11111111100 000000
Q ss_pred ccCCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHhhC
Q 002158 858 NRMGSYPSECVERFVTLALRCCHDKPEHRPSMSDVVRELENILKMF 903 (958)
Q Consensus 858 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~ 903 (958)
...+..++.++.+++.+||+.+|++||++++|++.|++++...
T Consensus 238 ---~~l~~~~p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l~~~~ 280 (483)
T 3sv0_A 238 ---EALCRGYPTEFASYFHYCRSLRFDDKPDYSYLKRLFRDLFIRE 280 (483)
T ss_dssp ---HHHHTTSCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHT
T ss_pred ---HHHhcCCcHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHHc
Confidence 0111234578999999999999999999999999999987654
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=350.93 Aligned_cols=251 Identities=22% Similarity=0.338 Sum_probs=205.0
Q ss_pred HcCCCCCceeeeeCCeEEEEEEEC-CCcEEEEEEeccCChhcHHHHHHHHHHHHccCCCCcceEEEEEEeCCeEEEEEEe
Q 002158 624 TAYFSSSTQVGQGGYGKVYKGILS-DNTTVAIKRAEEGSLQGQNEFLTEIKLLSRLHHRNLVSLLGYCDEEGEQMLVYEF 702 (958)
Q Consensus 624 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E~ 702 (958)
.++|...+.||+|+||+||+|... +|+.||||++........+.+.+|++++++++||||+++++++...+..++||||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 87 (304)
T 2jam_A 8 RKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQL 87 (304)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred hccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEEEc
Confidence 456888899999999999999986 7899999999876555556789999999999999999999999999999999999
Q ss_pred cCCCCHHHHhccCCCCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEe---cCCCCeEEeeeeeecccccC
Q 002158 703 VPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILL---DSNLNAKVADFGLSRLAPVL 779 (958)
Q Consensus 703 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl---~~~~~~kl~DFGla~~~~~~ 779 (958)
+++++|.+++.... .+++.++..++.|++.||+|||+.+ |+||||||+||++ +.++.+||+|||+++....
T Consensus 88 ~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~~- 161 (304)
T 2jam_A 88 VSGGELFDRILERG--VYTEKDASLVIQQVLSAVKYLHENG---IVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQN- 161 (304)
T ss_dssp CCSCBHHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHHTT---CCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCCC-
T ss_pred CCCccHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEecCCCCCCEEEccCCcceecCC-
Confidence 99999999997543 4899999999999999999999999 9999999999999 7889999999999875321
Q ss_pred CCCCCccceeeeeccCCCCccChhhhccCCCCCcchhhhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcCcchhhhccc
Q 002158 780 DDEGTMPTHVSTIVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVLLELLTGMQPISHGKNIVREVNVARDSGMVFSIIDNR 859 (958)
Q Consensus 780 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gv~l~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~i~~~ 859 (958)
.......||+.|+|||++.+..++.++||||+|+++|||++|+.||....... ........... .
T Consensus 162 --------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~-~~~~i~~~~~~------~ 226 (304)
T 2jam_A 162 --------GIMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETESK-LFEKIKEGYYE------F 226 (304)
T ss_dssp --------BTTHHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHHH-HHHHHHHCCCC------C
T ss_pred --------CccccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHH-HHHHHHcCCCC------C
Confidence 11123469999999999999999999999999999999999999997544322 11111111000 0
Q ss_pred CCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 002158 860 MGSYPSECVERFVTLALRCCHDKPEHRPSMSDVVRE 895 (958)
Q Consensus 860 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 895 (958)
........+..+.+++.+||+.||++||+++|++++
T Consensus 227 ~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h 262 (304)
T 2jam_A 227 ESPFWDDISESAKDFICHLLEKDPNERYTCEKALSH 262 (304)
T ss_dssp CTTTTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred CccccccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 012234556789999999999999999999999975
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-39 Score=348.87 Aligned_cols=246 Identities=23% Similarity=0.364 Sum_probs=203.2
Q ss_pred HHcCCCCCceeeeeCCeEEEEEEEC-CCcEEEEEEeccCC--hhcHHHHHHHHHHHHcc-CCCCcceEEEEEEeCCeEEE
Q 002158 623 ATAYFSSSTQVGQGGYGKVYKGILS-DNTTVAIKRAEEGS--LQGQNEFLTEIKLLSRL-HHRNLVSLLGYCDEEGEQML 698 (958)
Q Consensus 623 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~l 698 (958)
..++|...+.||+|+||+||+|.+. +++.||||++.... .....++.+|+..+..+ +||||+++++++.+++..++
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~l 88 (289)
T 1x8b_A 9 YTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLI 88 (289)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEE
T ss_pred ccchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEE
Confidence 3457888899999999999999986 79999999987642 33456788999999999 99999999999999999999
Q ss_pred EEEecCCCCHHHHhccCC--CCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEecCC--------------
Q 002158 699 VYEFVPNGTLRDWLSGRT--KENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSN-------------- 762 (958)
Q Consensus 699 V~E~~~~gsL~~~l~~~~--~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~-------------- 762 (958)
||||+++++|.+++.... ...+++.++..++.|+++||+|||+++ |+||||||+||+++.+
T Consensus 89 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~ 165 (289)
T 1x8b_A 89 QNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMS---LVHMDIKPSNIFISRTSIPNAASEEGDEDD 165 (289)
T ss_dssp EEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEC----------------
T ss_pred EEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCC---EeecCCCHHHEEEcCCCCCccccccccccc
Confidence 999999999999997542 245899999999999999999999999 9999999999999844
Q ss_pred -----CCeEEeeeeeecccccCCCCCCccceeeeeccCCCCccChhhhccC-CCCCcchhhhHHHHHHHHHhCCCCCCCC
Q 002158 763 -----LNAKVADFGLSRLAPVLDDEGTMPTHVSTIVKGTPGYLDPEYFLTH-KLTDKSDVYSLGVVLLELLTGMQPISHG 836 (958)
Q Consensus 763 -----~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DV~S~Gv~l~elltG~~P~~~~ 836 (958)
..+||+|||.++..... ....||+.|+|||++.+. .++.++||||||+++|||++|..|+...
T Consensus 166 ~~~~~~~~kl~Dfg~~~~~~~~-----------~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~ 234 (289)
T 1x8b_A 166 WASNKVMFKIGDLGHVTRISSP-----------QVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNG 234 (289)
T ss_dssp ----CCCEEECCCTTCEETTCS-----------CCCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSS
T ss_pred ccCCceEEEEcccccccccCCc-----------cccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcch
Confidence 47999999998865321 123489999999999876 5667999999999999999998877544
Q ss_pred chhHHHHHHHhhcCcchhhhcccCCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 002158 837 KNIVREVNVARDSGMVFSIIDNRMGSYPSECVERFVTLALRCCHDKPEHRPSMSDVVRE 895 (958)
Q Consensus 837 ~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 895 (958)
..... +........+..++..+.+++.+||+.||++||++.|++++
T Consensus 235 ~~~~~-------------~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h 280 (289)
T 1x8b_A 235 DQWHE-------------IRQGRLPRIPQVLSQEFTELLKVMIHPDPERRPSAMALVKH 280 (289)
T ss_dssp HHHHH-------------HHTTCCCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTC
T ss_pred hHHHH-------------HHcCCCCCCCcccCHHHHHHHHHHhCCCcccCCCHHHHhhC
Confidence 32211 11122233455667889999999999999999999999864
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=347.07 Aligned_cols=246 Identities=26% Similarity=0.379 Sum_probs=206.6
Q ss_pred cCCCCCceeeeeCCeEEEEEEEC-CCcEEEEEEeccCC---hhcHHHHHHHHHHHHccCCCCcceEEEEEEeCCeEEEEE
Q 002158 625 AYFSSSTQVGQGGYGKVYKGILS-DNTTVAIKRAEEGS---LQGQNEFLTEIKLLSRLHHRNLVSLLGYCDEEGEQMLVY 700 (958)
Q Consensus 625 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~ 700 (958)
++|...+.||+|+||.||+|... +++.||||++.... ....+.+.+|++++++++||||+++++++.+.+..++||
T Consensus 14 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 93 (284)
T 2vgo_A 14 DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLML 93 (284)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEEE
Confidence 46778889999999999999986 57899999986432 123467899999999999999999999999999999999
Q ss_pred EecCCCCHHHHhccCCCCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEecCCCCeEEeeeeeecccccCC
Q 002158 701 EFVPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSRLAPVLD 780 (958)
Q Consensus 701 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~ 780 (958)
||+++++|.+++.... .+++..+..++.|+++||+|||+.+ |+||||||+||+++.++.+||+|||++......
T Consensus 94 e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~- 167 (284)
T 2vgo_A 94 EFAPRGELYKELQKHG--RFDEQRSATFMEELADALHYCHERK---VIHRDIKPENLLMGYKGELKIADFGWSVHAPSL- 167 (284)
T ss_dssp CCCTTEEHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECTTCCEEECCCTTCEECSSS-
T ss_pred EeCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEEcCCCCEEEecccccccCccc-
Confidence 9999999999997643 4899999999999999999999999 999999999999999999999999998754321
Q ss_pred CCCCccceeeeeccCCCCccChhhhccCCCCCcchhhhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcCcchhhhcccC
Q 002158 781 DEGTMPTHVSTIVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVLLELLTGMQPISHGKNIVREVNVARDSGMVFSIIDNRM 860 (958)
Q Consensus 781 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gv~l~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~i~~~~ 860 (958)
......|++.|+|||++.+..++.++||||||+++|||++|+.||........... .. ...
T Consensus 168 --------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~-~~----------~~~ 228 (284)
T 2vgo_A 168 --------RRRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRR-IV----------NVD 228 (284)
T ss_dssp --------CBCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHH-HH----------TTC
T ss_pred --------ccccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCHhHHHHH-Hh----------ccc
Confidence 11235689999999999999999999999999999999999999976543222111 11 111
Q ss_pred CCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 002158 861 GSYPSECVERFVTLALRCCHDKPEHRPSMSDVVRE 895 (958)
Q Consensus 861 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 895 (958)
..++...+..+.+++.+|++.||.+||+++|++++
T Consensus 229 ~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~h 263 (284)
T 2vgo_A 229 LKFPPFLSDGSKDLISKLLRYHPPQRLPLKGVMEH 263 (284)
T ss_dssp CCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTC
T ss_pred cCCCCcCCHHHHHHHHHHhhcCHhhCCCHHHHhhC
Confidence 23345567889999999999999999999999975
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-39 Score=356.88 Aligned_cols=259 Identities=22% Similarity=0.332 Sum_probs=196.7
Q ss_pred HcCCCCCceeeeeCCeEEEEEEEC-CCcEEEEEEeccCChh--cHHHHHHHHHHHHccCCCCcceEEEEEEeCCeEEEEE
Q 002158 624 TAYFSSSTQVGQGGYGKVYKGILS-DNTTVAIKRAEEGSLQ--GQNEFLTEIKLLSRLHHRNLVSLLGYCDEEGEQMLVY 700 (958)
Q Consensus 624 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~ 700 (958)
.++|...+.||+|+||+||+|.+. +++.||||++...... ..+.+.+|++++++++||||+++++++..++..++||
T Consensus 33 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 112 (329)
T 3gbz_A 33 IDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHLIF 112 (329)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEEEEE
Confidence 356888899999999999999976 7899999999754332 2456789999999999999999999999999999999
Q ss_pred EecCCCCHHHHhccCCCCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEec-----CCCCeEEeeeeeecc
Q 002158 701 EFVPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLD-----SNLNAKVADFGLSRL 775 (958)
Q Consensus 701 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~-----~~~~~kl~DFGla~~ 775 (958)
||++ |+|.+++..... +++..+..++.|++.||+|||+++ |+||||||+|||++ +++.+||+|||+++.
T Consensus 113 e~~~-~~L~~~~~~~~~--~~~~~~~~i~~ql~~~l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~~ 186 (329)
T 3gbz_A 113 EYAE-NDLKKYMDKNPD--VSMRVIKSFLYQLINGVNFCHSRR---CLHRDLKPQNLLLSVSDASETPVLKIGDFGLARA 186 (329)
T ss_dssp ECCS-EEHHHHHHHCTT--CCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEC-----CCEEEECCTTHHHH
T ss_pred ecCC-CCHHHHHhhcCC--CCHHHHHHHHHHHHHHHHHHHhCC---EECCCCCHHHEEEecCCCCccceEEECcCCCccc
Confidence 9997 599999976543 899999999999999999999999 99999999999994 455699999999986
Q ss_pred cccCCCCCCccceeeeeccCCCCccChhhhccC-CCCCcchhhhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcCcchh
Q 002158 776 APVLDDEGTMPTHVSTIVKGTPGYLDPEYFLTH-KLTDKSDVYSLGVVLLELLTGMQPISHGKNIVREVNVARDSGMVFS 854 (958)
Q Consensus 776 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DV~S~Gv~l~elltG~~P~~~~~~~~~~~~~~~~~~~~~~ 854 (958)
..... .......||+.|+|||++.+. .++.++|||||||++|||++|+.||................+....
T Consensus 187 ~~~~~-------~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~ 259 (329)
T 3gbz_A 187 FGIPI-------RQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDD 259 (329)
T ss_dssp HC------------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCT
T ss_pred cCCcc-------cccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHHHHHHHhCCCch
Confidence 53211 122334689999999999875 4899999999999999999999999766544333222211110000
Q ss_pred h----h------cccCCC---------CChHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 002158 855 I----I------DNRMGS---------YPSECVERFVTLALRCCHDKPEHRPSMSDVVRE 895 (958)
Q Consensus 855 ~----i------~~~~~~---------~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 895 (958)
. . ...... .+...+.++.+++.+||+.||++|||++|++++
T Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 319 (329)
T 3gbz_A 260 TTWPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEH 319 (329)
T ss_dssp TTSTTGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred hhhhhhhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhCC
Confidence 0 0 000000 011245778999999999999999999999863
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-39 Score=359.12 Aligned_cols=266 Identities=22% Similarity=0.359 Sum_probs=194.7
Q ss_pred HcCCCCCceeeeeCCeEEEEEEEC-CCcEEEEEEeccCChhcHHHHHHHHHHHHccC-CCCcceEEEEEE--------eC
Q 002158 624 TAYFSSSTQVGQGGYGKVYKGILS-DNTTVAIKRAEEGSLQGQNEFLTEIKLLSRLH-HRNLVSLLGYCD--------EE 693 (958)
Q Consensus 624 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~~~~~--------~~ 693 (958)
..+|...+.||+|+||.||+|.+. +++.||||++........+.+.+|+.+++++. ||||+++++++. ..
T Consensus 27 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~ 106 (337)
T 3ll6_A 27 ELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQ 106 (337)
T ss_dssp TEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTTSS
T ss_pred CceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhccccccccccccccCC
Confidence 346788899999999999999976 68999999997776666778999999999996 999999999994 33
Q ss_pred CeEEEEEEecCCCCHHHHhccC-CCCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEecCCCCeEEeeeee
Q 002158 694 GEQMLVYEFVPNGTLRDWLSGR-TKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSNLNAKVADFGL 772 (958)
Q Consensus 694 ~~~~lV~E~~~~gsL~~~l~~~-~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~~~~kl~DFGl 772 (958)
...++||||++ |+|.+++... ....+++.++..++.|++.||+|||+.+ ++|+||||||+|||++.++.+||+|||+
T Consensus 107 ~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~-~~ivH~Dikp~NIl~~~~~~~kl~Dfg~ 184 (337)
T 3ll6_A 107 AEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQK-PPIIHRDLKVENLLLSNQGTIKLCDFGS 184 (337)
T ss_dssp EEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSS-SCCBCCCCCGGGCEECTTSCEEBCCCTT
T ss_pred ceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCC-CCEEEccCCcccEEECCCCCEEEecCcc
Confidence 45899999995 7999988642 2345999999999999999999999875 4599999999999999999999999999
Q ss_pred ecccccCCCCCCc-----cceeeeeccCCCCccChhhh---ccCCCCCcchhhhHHHHHHHHHhCCCCCCCCchhHHHHH
Q 002158 773 SRLAPVLDDEGTM-----PTHVSTIVKGTPGYLDPEYF---LTHKLTDKSDVYSLGVVLLELLTGMQPISHGKNIVREVN 844 (958)
Q Consensus 773 a~~~~~~~~~~~~-----~~~~~~~~~gt~~y~aPE~~---~~~~~~~~~DV~S~Gv~l~elltG~~P~~~~~~~~~~~~ 844 (958)
++........... .........||+.|+|||++ .+..++.++||||||+++|||++|+.||........
T Consensus 185 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~--- 261 (337)
T 3ll6_A 185 ATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKLRI--- 261 (337)
T ss_dssp CBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC-----------
T ss_pred ceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhHHHh---
Confidence 9865432211100 00112245699999999998 566788899999999999999999999964332110
Q ss_pred HHhhcCcchhhhcccC-CCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHhhCCC
Q 002158 845 VARDSGMVFSIIDNRM-GSYPSECVERFVTLALRCCHDKPEHRPSMSDVVRELENILKMFPE 905 (958)
Q Consensus 845 ~~~~~~~~~~~i~~~~-~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~~~ 905 (958)
..... ...+...+..+.+++.+||+.||++||+++|++++|+.+......
T Consensus 262 -----------~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~~~~~~~~ 312 (337)
T 3ll6_A 262 -----------VNGKYSIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAAARNV 312 (337)
T ss_dssp ---------------CCCCTTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHHTTC
T ss_pred -----------hcCcccCCcccccchHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhccCC
Confidence 00001 111223345688999999999999999999999999998876543
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-39 Score=359.79 Aligned_cols=241 Identities=22% Similarity=0.317 Sum_probs=181.0
Q ss_pred CceeeeeCCeEEEEEEEC-CCcEEEEEEeccCChhcHHHHHHHHHHHHccC-CCCcceEEEEEEeCCeEEEEEEecCCCC
Q 002158 630 STQVGQGGYGKVYKGILS-DNTTVAIKRAEEGSLQGQNEFLTEIKLLSRLH-HRNLVSLLGYCDEEGEQMLVYEFVPNGT 707 (958)
Q Consensus 630 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~~~~~lV~E~~~~gs 707 (958)
.+.||+|+||+||+|.++ +++.||||++... ....+.+|+.+++.+. ||||+++++++.+++..++||||+++|+
T Consensus 16 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~~~~ 92 (325)
T 3kn6_A 16 DKPLGEGSFSICRKCVHKKSNQAFAVKIISKR---MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGE 92 (325)
T ss_dssp SCCSEEETTEEEEEEEETTTCCEEEEEEEEGG---GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCSCB
T ss_pred CCccccCCCeEEEEEEECCCCCEEEEEEEChh---hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccCCCc
Confidence 478999999999999986 6899999999653 3456789999999997 9999999999999999999999999999
Q ss_pred HHHHhccCCCCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEecCCC---CeEEeeeeeecccccCCCCCC
Q 002158 708 LRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSNL---NAKVADFGLSRLAPVLDDEGT 784 (958)
Q Consensus 708 L~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~~---~~kl~DFGla~~~~~~~~~~~ 784 (958)
|.+++.... .+++.++..++.|++.||+|||+++ |+||||||+|||++.++ .+||+|||+++......
T Consensus 93 L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~---- 163 (325)
T 3kn6_A 93 LFERIKKKK--HFSETEASYIMRKLVSAVSHMHDVG---VVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDN---- 163 (325)
T ss_dssp HHHHHHHCS--CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEC----CEEEECCCTTCEECCC------
T ss_pred HHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC---CeecCCCHHHEEEecCCCcccEEEeccccceecCCCC----
Confidence 999997653 4999999999999999999999999 99999999999997765 89999999998643211
Q ss_pred ccceeeeeccCCCCccChhhhccCCCCCcchhhhHHHHHHHHHhCCCCCCCCch------hHHHHHHHhhcCcchhhhcc
Q 002158 785 MPTHVSTIVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVLLELLTGMQPISHGKN------IVREVNVARDSGMVFSIIDN 858 (958)
Q Consensus 785 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gv~l~elltG~~P~~~~~~------~~~~~~~~~~~~~~~~~i~~ 858 (958)
.......||+.|+|||++.+..++.++||||||+++|||++|+.||..... ....... +..
T Consensus 164 ---~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~----------i~~ 230 (325)
T 3kn6_A 164 ---QPLKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKK----------IKK 230 (325)
T ss_dssp -----------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHH----------HTT
T ss_pred ---CcccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHH----------HHc
Confidence 112345689999999999999999999999999999999999999975321 1111111 111
Q ss_pred cCCCCC----hHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 002158 859 RMGSYP----SECVERFVTLALRCCHDKPEHRPSMSDVVRE 895 (958)
Q Consensus 859 ~~~~~~----~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 895 (958)
.....+ ..++.++.+++.+||+.||++||+++|++++
T Consensus 231 ~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h 271 (325)
T 3kn6_A 231 GDFSFEGEAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRYN 271 (325)
T ss_dssp TCCCCCSHHHHTSCHHHHHHHHHHHCCCTTTCCCTTTSTTC
T ss_pred CCCCCCcccccCCCHHHHHHHHHHCCCChhHCCCHHHHhcC
Confidence 111112 2346789999999999999999999998853
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-39 Score=375.70 Aligned_cols=250 Identities=22% Similarity=0.353 Sum_probs=207.6
Q ss_pred cCCCCCceeeeeCCeEEEEEEEC-CCcEEEEEEeccCC---hhcHHHHHHHHHHHHccCCCCcceEEEEEEeCCeEEEEE
Q 002158 625 AYFSSSTQVGQGGYGKVYKGILS-DNTTVAIKRAEEGS---LQGQNEFLTEIKLLSRLHHRNLVSLLGYCDEEGEQMLVY 700 (958)
Q Consensus 625 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~ 700 (958)
++|...+.||+|+||+||+|+++ +|+.||||++.... ......+.+|++++++++||||+++++++...+..++||
T Consensus 185 ~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lVm 264 (543)
T 3c4z_A 185 DWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLVM 264 (543)
T ss_dssp GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEEE
Confidence 56778889999999999999986 69999999986532 123467889999999999999999999999999999999
Q ss_pred EecCCCCHHHHhccCC--CCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEecCCCCeEEeeeeeeccccc
Q 002158 701 EFVPNGTLRDWLSGRT--KENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSRLAPV 778 (958)
Q Consensus 701 E~~~~gsL~~~l~~~~--~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~~~~ 778 (958)
||+++|+|.+++.... ...+++..+..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+++....
T Consensus 265 E~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~g---IvHrDLKP~NILl~~~g~vkL~DFGla~~~~~ 341 (543)
T 3c4z_A 265 TIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRN---IIYRDLKPENVLLDDDGNVRISDLGLAVELKA 341 (543)
T ss_dssp CCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCTTCEECCT
T ss_pred EeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcC---CcccCCChHHEEEeCCCCEEEeecceeeeccC
Confidence 9999999999997643 345999999999999999999999999 99999999999999999999999999986532
Q ss_pred CCCCCCccceeeeeccCCCCccChhhhccCCCCCcchhhhHHHHHHHHHhCCCCCCCCch---hHHHHHHHhhcCcchhh
Q 002158 779 LDDEGTMPTHVSTIVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVLLELLTGMQPISHGKN---IVREVNVARDSGMVFSI 855 (958)
Q Consensus 779 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gv~l~elltG~~P~~~~~~---~~~~~~~~~~~~~~~~~ 855 (958)
.. .......||+.|+|||++.+..++.++|||||||++|||++|+.||..... .......
T Consensus 342 ~~-------~~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~~~~~~~---------- 404 (543)
T 3c4z_A 342 GQ-------TKTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQR---------- 404 (543)
T ss_dssp TC-------CCBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCHHHHHHH----------
T ss_pred CC-------cccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccchhHHHHHHH----------
Confidence 11 112345799999999999999999999999999999999999999975421 1111111
Q ss_pred hcccCCCCChHHHHHHHHHHHHccccCCCCCCCH-----HHHHH
Q 002158 856 IDNRMGSYPSECVERFVTLALRCCHDKPEHRPSM-----SDVVR 894 (958)
Q Consensus 856 i~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~-----~evl~ 894 (958)
+......+|..++..+.+++.+||+.||++||++ +++++
T Consensus 405 i~~~~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~ 448 (543)
T 3c4z_A 405 VLEQAVTYPDKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRT 448 (543)
T ss_dssp HHHCCCCCCTTSCHHHHHHHHHHSCSSGGGSCCCBTTBSHHHHT
T ss_pred HhhcccCCCcccCHHHHHHHHHhccCCHhHCCCCcccCHHHHHc
Confidence 1111223456677889999999999999999975 56664
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-38 Score=355.45 Aligned_cols=261 Identities=25% Similarity=0.336 Sum_probs=200.2
Q ss_pred HHcCCCCCceeeeeCCeEEEEEEEC-CCcEEEEEEeccCChhc-----HHHHHHHHHHHHccCCCCcceEEEEEEeCCeE
Q 002158 623 ATAYFSSSTQVGQGGYGKVYKGILS-DNTTVAIKRAEEGSLQG-----QNEFLTEIKLLSRLHHRNLVSLLGYCDEEGEQ 696 (958)
Q Consensus 623 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~-----~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~ 696 (958)
...+|...+.||+|+||.||+|.+. +|+.||||++....... .+.+.+|++++++++||||+++++++...+..
T Consensus 8 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 87 (346)
T 1ua2_A 8 RAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNI 87 (346)
T ss_dssp -----CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCC
T ss_pred HhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCce
Confidence 4567899999999999999999986 68999999987532221 23688999999999999999999999999999
Q ss_pred EEEEEecCCCCHHHHhccCCCCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEecCCCCeEEeeeeeeccc
Q 002158 697 MLVYEFVPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSRLA 776 (958)
Q Consensus 697 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~~ 776 (958)
++||||+++ +|.+++.... ..+++.++..++.|+++||+|||+.+ |+||||||+|||++.++.+||+|||+++..
T Consensus 88 ~lv~e~~~~-~l~~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~ 162 (346)
T 1ua2_A 88 SLVFDFMET-DLEVIIKDNS-LVLTPSHIKAYMLMTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAKSF 162 (346)
T ss_dssp EEEEECCSE-EHHHHHTTCC-SSCCSSHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCCGGGSTT
T ss_pred EEEEEcCCC-CHHHHHHhcC-cCCCHHHHHHHHHHHHHHHHHHHHCC---EECCCCCHHHEEEcCCCCEEEEecccceec
Confidence 999999975 8999987543 45889999999999999999999999 999999999999999999999999999865
Q ss_pred ccCCCCCCccceeeeeccCCCCccChhhhccC-CCCCcchhhhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcCcchh-
Q 002158 777 PVLDDEGTMPTHVSTIVKGTPGYLDPEYFLTH-KLTDKSDVYSLGVVLLELLTGMQPISHGKNIVREVNVARDSGMVFS- 854 (958)
Q Consensus 777 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DV~S~Gv~l~elltG~~P~~~~~~~~~~~~~~~~~~~~~~- 854 (958)
.... .......||+.|+|||++.+. .++.++|||||||++|||++|..||................+....
T Consensus 163 ~~~~-------~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~~~~i~~~~~~~~~~ 235 (346)
T 1ua2_A 163 GSPN-------RAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEE 235 (346)
T ss_dssp TSCC-------CCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTT
T ss_pred cCCc-------ccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHcCCCChh
Confidence 3211 112345689999999999764 4788999999999999999999999765543332222211111000
Q ss_pred hh-------c----ccCCCCC-----hHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 002158 855 II-------D----NRMGSYP-----SECVERFVTLALRCCHDKPEHRPSMSDVVRE 895 (958)
Q Consensus 855 ~i-------~----~~~~~~~-----~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 895 (958)
.. + ......+ ...+..+.+++.+||+.||++|||++|++++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 292 (346)
T 1ua2_A 236 QWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM 292 (346)
T ss_dssp TSSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred hhhhhccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcC
Confidence 00 0 0000111 3345789999999999999999999999975
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=359.81 Aligned_cols=257 Identities=23% Similarity=0.365 Sum_probs=206.1
Q ss_pred cCCCCCceeeeeCCeEEEEEEEC-CCcEEEEEEeccC-ChhcHHHHHHHHHHHHccCCCCcceEEEEEEeCCeEEEEEEe
Q 002158 625 AYFSSSTQVGQGGYGKVYKGILS-DNTTVAIKRAEEG-SLQGQNEFLTEIKLLSRLHHRNLVSLLGYCDEEGEQMLVYEF 702 (958)
Q Consensus 625 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E~ 702 (958)
++|...+.||+|+||+||+|.+. +++.||+|++... .....+.+.+|++++++++||||+++++++..++..++||||
T Consensus 33 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 112 (360)
T 3eqc_A 33 DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEH 112 (360)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEEECC
T ss_pred ccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEEEEC
Confidence 46788899999999999999986 6899999998765 334456799999999999999999999999999999999999
Q ss_pred cCCCCHHHHhccCCCCCchHHHHHHHHHHHHHHHHHhhhc-CCCCeeccCCCccceEecCCCCeEEeeeeeecccccCCC
Q 002158 703 VPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTE-AHPPVFHRDIKASNILLDSNLNAKVADFGLSRLAPVLDD 781 (958)
Q Consensus 703 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~-~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~ 781 (958)
+++++|.+++.... .+++..+..++.|++.||+|||+. + |+||||||+|||++.++.+||+|||+++....
T Consensus 113 ~~~~~L~~~l~~~~--~~~~~~~~~i~~~i~~~l~~lh~~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~--- 184 (360)
T 3eqc_A 113 MDGGSLDQVLKKAG--RIPEQILGKVSIAVIKGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLID--- 184 (360)
T ss_dssp CTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHHHC---CCCSCCSGGGEEECTTCCEEECCCCCCHHHHH---
T ss_pred CCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHhCC---EEcCCccHHHEEECCCCCEEEEECCCCccccc---
Confidence 99999999997643 389999999999999999999996 8 99999999999999999999999999875421
Q ss_pred CCCccceeeeeccCCCCccChhhhccCCCCCcchhhhHHHHHHHHHhCCCCCCCCchhHHHHHHHh--------------
Q 002158 782 EGTMPTHVSTIVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVLLELLTGMQPISHGKNIVREVNVAR-------------- 847 (958)
Q Consensus 782 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gv~l~elltG~~P~~~~~~~~~~~~~~~-------------- 847 (958)
.......||+.|+|||++.+..++.++||||||+++|||++|+.||..............
T Consensus 185 ------~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (360)
T 3eqc_A 185 ------SMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPR 258 (360)
T ss_dssp ------HC----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC---------------
T ss_pred ------ccccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCcc
Confidence 112335699999999999999999999999999999999999999975443211110000
Q ss_pred --------------hcCcchh----hhcccCCCC-ChHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 002158 848 --------------DSGMVFS----IIDNRMGSY-PSECVERFVTLALRCCHDKPEHRPSMSDVVRE 895 (958)
Q Consensus 848 --------------~~~~~~~----~i~~~~~~~-~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 895 (958)
......+ ......... +..++..+.+++.+||+.||++|||++|++++
T Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 325 (360)
T 3eqc_A 259 TPGRPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVH 325 (360)
T ss_dssp ---------------CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred cCCCcccccccCCCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhhC
Confidence 0000000 001111111 22356789999999999999999999999976
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-39 Score=356.99 Aligned_cols=259 Identities=24% Similarity=0.334 Sum_probs=197.2
Q ss_pred cCCCCCceeeeeCCeEEEEEEEC-CCcEEEEEEeccCChhc-HHHHHHHHHHHHccCCCCcceEEEEEEeCCeEEEEEEe
Q 002158 625 AYFSSSTQVGQGGYGKVYKGILS-DNTTVAIKRAEEGSLQG-QNEFLTEIKLLSRLHHRNLVSLLGYCDEEGEQMLVYEF 702 (958)
Q Consensus 625 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~-~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E~ 702 (958)
++|...+.||+|+||+||+|.+. +++.||||++....... ...+.+|++++++++||||+++++++..++..++||||
T Consensus 2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (324)
T 3mtl_A 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY 81 (324)
T ss_dssp CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEecc
Confidence 46778899999999999999986 78999999987543222 12456899999999999999999999999999999999
Q ss_pred cCCCCHHHHhccCCCCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEecCCCCeEEeeeeeecccccCCCC
Q 002158 703 VPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSRLAPVLDDE 782 (958)
Q Consensus 703 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~ 782 (958)
++ |+|.+++.... ..+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 82 ~~-~~l~~~~~~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~--- 153 (324)
T 3mtl_A 82 LD-KDLKQYLDDCG-NIINMHNVKLFLFQLLRGLAYCHRQK---VLHRDLKPQNLLINERGELKLADFGLARAKSIP--- 153 (324)
T ss_dssp CS-EEHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHHTT---EEESSCCGGGEEECTTCCEEECSSSEEECC------
T ss_pred cc-cCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCcCHHHEEECCCCCEEEccCcccccccCC---
Confidence 96 69999987653 34899999999999999999999999 999999999999999999999999999754321
Q ss_pred CCccceeeeeccCCCCccChhhhcc-CCCCCcchhhhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcCc-----chhhh
Q 002158 783 GTMPTHVSTIVKGTPGYLDPEYFLT-HKLTDKSDVYSLGVVLLELLTGMQPISHGKNIVREVNVARDSGM-----VFSII 856 (958)
Q Consensus 783 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DV~S~Gv~l~elltG~~P~~~~~~~~~~~~~~~~~~~-----~~~~i 856 (958)
........||+.|+|||++.+ ..++.++||||+||++|||++|+.||................+. .....
T Consensus 154 ----~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 229 (324)
T 3mtl_A 154 ----TKTYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGIL 229 (324)
T ss_dssp -------------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGG
T ss_pred ----ccccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHhchhhh
Confidence 112233468999999999976 56899999999999999999999999765433222211111000 00000
Q ss_pred c---------ccC-----CCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 002158 857 D---------NRM-----GSYPSECVERFVTLALRCCHDKPEHRPSMSDVVRE 895 (958)
Q Consensus 857 ~---------~~~-----~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 895 (958)
. ... .......+..+.+++.+||+.||++|||++|++++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 282 (324)
T 3mtl_A 230 SNEEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKH 282 (324)
T ss_dssp GCHHHHHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred cchhhcccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcC
Confidence 0 000 00112345678999999999999999999999974
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-38 Score=351.28 Aligned_cols=271 Identities=20% Similarity=0.342 Sum_probs=213.2
Q ss_pred cChHHHHHHHcCCCCCceeeeeCCeEEEEEEECCCcEEEEEEeccCChhcHHHHHHHHHHHHc--cCCCCcceEEEEEEe
Q 002158 615 FKFKELAMATAYFSSSTQVGQGGYGKVYKGILSDNTTVAIKRAEEGSLQGQNEFLTEIKLLSR--LHHRNLVSLLGYCDE 692 (958)
Q Consensus 615 ~~~~el~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~--l~H~niv~l~~~~~~ 692 (958)
.++..-....++|...+.||+|+||+||+|.+ +++.||||++.. .....+.+|+++++. ++||||+++++++..
T Consensus 32 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~---~~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~ 107 (342)
T 1b6c_B 32 LPLLVQRTIARTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSS---REERSWFREAEIYQTVMLRHENILGFIAADNK 107 (342)
T ss_dssp SCHHHHHHHHHHCEEEEEEEEETTEEEEEEEE-TTEEEEEEEECG---GGHHHHHHHHHHHHHSCCCCTTBCCEEEEEEC
T ss_pred CceeecccccccEEEEeeecCCCCcEEEEEEE-cCccEEEEEeCc---hhHHHHHHHHHHHHHhhcCCCcEEEEEeeecc
Confidence 44444455677899999999999999999998 589999999964 335568889999988 789999999999988
Q ss_pred CC----eEEEEEEecCCCCHHHHhccCCCCCchHHHHHHHHHHHHHHHHHhh--------hcCCCCeeccCCCccceEec
Q 002158 693 EG----EQMLVYEFVPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLH--------TEAHPPVFHRDIKASNILLD 760 (958)
Q Consensus 693 ~~----~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH--------~~~~~~iiH~Dikp~NILl~ 760 (958)
.. ..++||||+++|+|.+++... .+++.+++.++.|++.||+||| +.+ |+||||||+|||++
T Consensus 108 ~~~~~~~~~lv~e~~~~g~L~~~l~~~---~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~---ivH~Dlkp~NIll~ 181 (342)
T 1b6c_B 108 DNGTWTQLWLVSDYHEHGSLFDYLNRY---TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPA---IAHRDLKSKNILVK 181 (342)
T ss_dssp CCSSCCCEEEEECCCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCE---EECSCCSGGGEEEC
T ss_pred cCCccceeEEEEeecCCCcHHHHHhcc---CccHHHHHHHHHHHHHHHHHHHHHHhhhcccCC---eeeCCCCHHHEEEC
Confidence 76 789999999999999999754 3899999999999999999999 777 99999999999999
Q ss_pred CCCCeEEeeeeeecccccCCCCCCccceeeeeccCCCCccChhhhccCC------CCCcchhhhHHHHHHHHHhC-----
Q 002158 761 SNLNAKVADFGLSRLAPVLDDEGTMPTHVSTIVKGTPGYLDPEYFLTHK------LTDKSDVYSLGVVLLELLTG----- 829 (958)
Q Consensus 761 ~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~------~~~~~DV~S~Gv~l~elltG----- 829 (958)
.++.+||+|||+++........ .........||+.|+|||++.+.. ++.++||||||+++|||++|
T Consensus 182 ~~~~~kL~Dfg~~~~~~~~~~~---~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~ 258 (342)
T 1b6c_B 182 KNGTCCIADLGLAVRHDSATDT---IDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGG 258 (342)
T ss_dssp TTSCEEECCCTTCEEEETTTTE---EEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTT
T ss_pred CCCCEEEEECCCceeccccccc---cccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCC
Confidence 9999999999999765332210 011223456999999999997762 33689999999999999999
Q ss_pred -----CCCCCCCc----hhHHHHHHHhhcCcchhhhcccCCC--CChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 002158 830 -----MQPISHGK----NIVREVNVARDSGMVFSIIDNRMGS--YPSECVERFVTLALRCCHDKPEHRPSMSDVVRELEN 898 (958)
Q Consensus 830 -----~~P~~~~~----~~~~~~~~~~~~~~~~~~i~~~~~~--~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 898 (958)
..||.... .............. ...... ....++..+.+++.+||+.||++||+++|++++|++
T Consensus 259 ~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~L~~ 333 (342)
T 1b6c_B 259 IHEDYQLPYYDLVPSDPSVEEMRKVVCEQKL-----RPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQ 333 (342)
T ss_dssp BCCCCCCTTTTTSCSSCCHHHHHHHHTTSCC-----CCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHH
T ss_pred cccccccCccccCcCcccHHHHHHHHHHHHh-----CCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHHHHH
Confidence 77886432 11111111111110 011100 124678899999999999999999999999999999
Q ss_pred hHhhC
Q 002158 899 ILKMF 903 (958)
Q Consensus 899 ~~~~~ 903 (958)
+.+..
T Consensus 334 i~~~~ 338 (342)
T 1b6c_B 334 LSQQE 338 (342)
T ss_dssp HHHTT
T ss_pred HHHHh
Confidence 87653
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-38 Score=347.44 Aligned_cols=249 Identities=25% Similarity=0.408 Sum_probs=209.2
Q ss_pred cCCCCCceeeeeCCeEEEEEEEC-CCcEEEEEEeccCC-hhcHHHHHHHHHHHHccCCCCcceEEEEEEeCCeEEEEEEe
Q 002158 625 AYFSSSTQVGQGGYGKVYKGILS-DNTTVAIKRAEEGS-LQGQNEFLTEIKLLSRLHHRNLVSLLGYCDEEGEQMLVYEF 702 (958)
Q Consensus 625 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E~ 702 (958)
+.|...+.||+|+||.||+|++. +++.||||++.... ....+.+.+|+.++++++||||+++++++...+..++||||
T Consensus 22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 101 (303)
T 3a7i_A 22 ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEY 101 (303)
T ss_dssp GTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred HHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEEe
Confidence 45778899999999999999975 68999999987543 34467899999999999999999999999999999999999
Q ss_pred cCCCCHHHHhccCCCCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEecCCCCeEEeeeeeecccccCCCC
Q 002158 703 VPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSRLAPVLDDE 782 (958)
Q Consensus 703 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~ 782 (958)
+++++|.+++... .+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+++......
T Consensus 102 ~~~~~L~~~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~-- 173 (303)
T 3a7i_A 102 LGGGSALDLLEPG---PLDETQIATILREILKGLDYLHSEK---KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQ-- 173 (303)
T ss_dssp CTTEEHHHHHTTS---CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECBTTB--
T ss_pred CCCCcHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCChheEEECCCCCEEEeecccceecCccc--
Confidence 9999999999643 4899999999999999999999999 9999999999999999999999999997653211
Q ss_pred CCccceeeeeccCCCCccChhhhccCCCCCcchhhhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcCcchhhhcccCCC
Q 002158 783 GTMPTHVSTIVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVLLELLTGMQPISHGKNIVREVNVARDSGMVFSIIDNRMGS 862 (958)
Q Consensus 783 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gv~l~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~ 862 (958)
.......||+.|+|||++.+..++.++||||||+++|||++|+.||............. ......
T Consensus 174 -----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~----------~~~~~~ 238 (303)
T 3a7i_A 174 -----IKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIP----------KNNPPT 238 (303)
T ss_dssp -----CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHH----------HSCCCC
T ss_pred -----cccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCHHHHHHHhh----------cCCCCC
Confidence 11234568999999999999999999999999999999999999997544322211111 111223
Q ss_pred CChHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 002158 863 YPSECVERFVTLALRCCHDKPEHRPSMSDVVREL 896 (958)
Q Consensus 863 ~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 896 (958)
.+..++..+.+++.+||+.||++||++.|++++.
T Consensus 239 ~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~ 272 (303)
T 3a7i_A 239 LEGNYSKPLKEFVEACLNKEPSFRPTAKELLKHK 272 (303)
T ss_dssp CCSSCCHHHHHHHHHHCCSSGGGSCCHHHHTTCH
T ss_pred CccccCHHHHHHHHHHcCCChhhCcCHHHHhhCh
Confidence 3445667899999999999999999999999864
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=356.25 Aligned_cols=251 Identities=24% Similarity=0.350 Sum_probs=202.4
Q ss_pred HHcCCCCCceeeeeCCeEEEEEEEC-CCcEEEEEEeccCChhcHHHHHHHHHHHHcc-CCCCcceEEEEEEeCCeEEEEE
Q 002158 623 ATAYFSSSTQVGQGGYGKVYKGILS-DNTTVAIKRAEEGSLQGQNEFLTEIKLLSRL-HHRNLVSLLGYCDEEGEQMLVY 700 (958)
Q Consensus 623 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lV~ 700 (958)
..++|...+.||+|+||+||+|.++ +++.||||++...... +.+|++++.++ +||||+++++++.+++..++||
T Consensus 20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~----~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ 95 (342)
T 2qr7_A 20 FTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRD----PTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVT 95 (342)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTCC----CHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEE
T ss_pred ccccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccCC----hHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEEE
Confidence 3457888899999999999999986 6899999999764322 34788888888 7999999999999999999999
Q ss_pred EecCCCCHHHHhccCCCCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEecCC----CCeEEeeeeeeccc
Q 002158 701 EFVPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSN----LNAKVADFGLSRLA 776 (958)
Q Consensus 701 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~----~~~kl~DFGla~~~ 776 (958)
||+++|+|.+++.... .+++.++..++.|++.||+|||+++ |+||||||+|||+.++ +.+||+|||+++..
T Consensus 96 E~~~gg~L~~~i~~~~--~~~~~~~~~~~~qi~~al~~lH~~g---ivHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~ 170 (342)
T 2qr7_A 96 ELMKGGELLDKILRQK--FFSEREASAVLFTITKTVEYLHAQG---VVHRDLKPSNILYVDESGNPESIRICDFGFAKQL 170 (342)
T ss_dssp CCCCSCBHHHHHHTCT--TCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESSSSCSGGGEEECCCTTCEEC
T ss_pred eCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC---cEeccCCHHHEEEecCCCCcCeEEEEECCCcccC
Confidence 9999999999997543 4899999999999999999999999 9999999999998443 35999999999865
Q ss_pred ccCCCCCCccceeeeeccCCCCccChhhhccCCCCCcchhhhHHHHHHHHHhCCCCCCCCc--hhHHHHHHHhhcCcchh
Q 002158 777 PVLDDEGTMPTHVSTIVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVLLELLTGMQPISHGK--NIVREVNVARDSGMVFS 854 (958)
Q Consensus 777 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gv~l~elltG~~P~~~~~--~~~~~~~~~~~~~~~~~ 854 (958)
..... ......||+.|+|||++.+..++.++|||||||++|||++|..||.... ...............
T Consensus 171 ~~~~~-------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~-- 241 (342)
T 2qr7_A 171 RAENG-------LLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSGKFS-- 241 (342)
T ss_dssp BCTTC-------CBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHHHHHHHCCCC--
T ss_pred cCCCC-------ceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHHHHHccCCcc--
Confidence 32211 1234568999999999998889999999999999999999999997532 222222211111100
Q ss_pred hhcccCCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 002158 855 IIDNRMGSYPSECVERFVTLALRCCHDKPEHRPSMSDVVRE 895 (958)
Q Consensus 855 ~i~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 895 (958)
.....+...+..+.+++.+||+.||++||+++|++++
T Consensus 242 ----~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~h 278 (342)
T 2qr7_A 242 ----LSGGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLRH 278 (342)
T ss_dssp ----CCSTTTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTS
T ss_pred ----cCccccccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 0011234566789999999999999999999999976
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-38 Score=350.73 Aligned_cols=253 Identities=25% Similarity=0.391 Sum_probs=203.0
Q ss_pred HcCCCCCceeeeeCCeEEEEEEEC-CCcEEEEEEeccCChhcHHHHHHHHHHHHccCCCCcceEEEEEEeCCeEEEEEEe
Q 002158 624 TAYFSSSTQVGQGGYGKVYKGILS-DNTTVAIKRAEEGSLQGQNEFLTEIKLLSRLHHRNLVSLLGYCDEEGEQMLVYEF 702 (958)
Q Consensus 624 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E~ 702 (958)
.+.|+..+.||+|+||+||+|.+. +++.||+|++........+.+.+|+++++.++||||+++++++..++..++||||
T Consensus 18 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 97 (302)
T 2j7t_A 18 NEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIEF 97 (302)
T ss_dssp GGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEEEC
T ss_pred ccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEEEe
Confidence 357888899999999999999986 5899999999876666678899999999999999999999999999999999999
Q ss_pred cCCCCHHHHhccCCCCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEecCCCCeEEeeeeeecccccCCCC
Q 002158 703 VPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSRLAPVLDDE 782 (958)
Q Consensus 703 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~ 782 (958)
+++++|.+++.... ..+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||++......
T Consensus 98 ~~~~~l~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~--- 170 (302)
T 2j7t_A 98 CPGGAVDAIMLELD-RGLTEPQIQVVCRQMLEALNFLHSKR---IIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKT--- 170 (302)
T ss_dssp CTTEEHHHHHHHHT-SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTSCEEECCCHHHHHHHHH---
T ss_pred CCCCcHHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHHHEEECCCCCEEEEECCCCcccccc---
Confidence 99999999987533 34899999999999999999999999 999999999999999999999999997543111
Q ss_pred CCccceeeeeccCCCCccChhhhc-----cCCCCCcchhhhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcCcchhhhc
Q 002158 783 GTMPTHVSTIVKGTPGYLDPEYFL-----THKLTDKSDVYSLGVVLLELLTGMQPISHGKNIVREVNVARDSGMVFSIID 857 (958)
Q Consensus 783 ~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DV~S~Gv~l~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~i~ 857 (958)
........||+.|+|||++. ...++.++||||||+++|||++|+.||.................
T Consensus 171 ----~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~------- 239 (302)
T 2j7t_A 171 ----LQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSDP------- 239 (302)
T ss_dssp ----HHC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCC-------
T ss_pred ----ccccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHhccCC-------
Confidence 11122346899999999984 56788999999999999999999999976543322221111110
Q ss_pred ccCCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 002158 858 NRMGSYPSECVERFVTLALRCCHDKPEHRPSMSDVVRE 895 (958)
Q Consensus 858 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 895 (958)
.....+..++..+.+++.+||+.||++||++++++++
T Consensus 240 -~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h 276 (302)
T 2j7t_A 240 -PTLLTPSKWSVEFRDFLKIALDKNPETRPSAAQLLEH 276 (302)
T ss_dssp -CCCSSGGGSCHHHHHHHHHHSCSCTTTSCCHHHHTTS
T ss_pred -cccCCccccCHHHHHHHHHHcccChhhCCCHHHHhcC
Confidence 0112244567789999999999999999999999863
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-38 Score=359.78 Aligned_cols=254 Identities=23% Similarity=0.350 Sum_probs=198.0
Q ss_pred cCCCCCceeeeeCCeEEEEEEEC-CCcEEEEEEeccC--ChhcHHHHHHHHHHHHccCCCCcceEEEEEEeCC------e
Q 002158 625 AYFSSSTQVGQGGYGKVYKGILS-DNTTVAIKRAEEG--SLQGQNEFLTEIKLLSRLHHRNLVSLLGYCDEEG------E 695 (958)
Q Consensus 625 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~------~ 695 (958)
++|...+.||+|+||.||+|.+. +|+.||||++... .....+++.+|++++++++||||+++++++...+ .
T Consensus 25 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~~ 104 (367)
T 1cm8_A 25 AVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTD 104 (367)
T ss_dssp SSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCCC
T ss_pred ceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCce
Confidence 46778889999999999999985 6999999998653 2334567899999999999999999999997653 4
Q ss_pred EEEEEEecCCCCHHHHhccCCCCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEecCCCCeEEeeeeeecc
Q 002158 696 QMLVYEFVPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSRL 775 (958)
Q Consensus 696 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~ 775 (958)
.++||||+ +++|.+++... .+++..+..++.|+++||+|||+.+ |+||||||+|||++.++.+||+|||+++.
T Consensus 105 ~~lv~e~~-~~~L~~~~~~~---~l~~~~~~~~~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~ 177 (367)
T 1cm8_A 105 FYLVMPFM-GTDLGKLMKHE---KLGEDRIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLARQ 177 (367)
T ss_dssp CEEEEECC-SEEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred EEEEEecC-CCCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCcCHHHEEEcCCCCEEEEeeecccc
Confidence 69999999 88999999753 3899999999999999999999999 99999999999999999999999999986
Q ss_pred cccCCCCCCccceeeeeccCCCCccChhhhcc-CCCCCcchhhhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcCcch-
Q 002158 776 APVLDDEGTMPTHVSTIVKGTPGYLDPEYFLT-HKLTDKSDVYSLGVVLLELLTGMQPISHGKNIVREVNVARDSGMVF- 853 (958)
Q Consensus 776 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DV~S~Gv~l~elltG~~P~~~~~~~~~~~~~~~~~~~~~- 853 (958)
... ......||+.|+|||++.+ ..++.++||||+||++|||++|+.||.+..............+...
T Consensus 178 ~~~----------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~~~~ 247 (367)
T 1cm8_A 178 ADS----------EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPA 247 (367)
T ss_dssp CCS----------SCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCH
T ss_pred ccc----------ccCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCH
Confidence 421 1223568999999999987 6799999999999999999999999986554332222111111100
Q ss_pred hh------------h-------cccCCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 002158 854 SI------------I-------DNRMGSYPSECVERFVTLALRCCHDKPEHRPSMSDVVRE 895 (958)
Q Consensus 854 ~~------------i-------~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 895 (958)
+. + ...........+..+.+++.+|++.||++|||++|++++
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~h 308 (367)
T 1cm8_A 248 EFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAH 308 (367)
T ss_dssp HHHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred HHHHHhhhHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcC
Confidence 00 0 000111223456789999999999999999999999985
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-38 Score=352.75 Aligned_cols=259 Identities=22% Similarity=0.368 Sum_probs=207.8
Q ss_pred hHHHHHHHcCCCCCceeeeeCCeEEEEEEEC-CCcEEEEEEeccCCh--------hcHHHHHHHHHHHHcc-CCCCcceE
Q 002158 617 FKELAMATAYFSSSTQVGQGGYGKVYKGILS-DNTTVAIKRAEEGSL--------QGQNEFLTEIKLLSRL-HHRNLVSL 686 (958)
Q Consensus 617 ~~el~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l-~H~niv~l 686 (958)
+.......++|...+.||+|+||.||+|.+. +|+.||||++..... ...+.+.+|+.+++++ +||||+++
T Consensus 86 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~ 165 (365)
T 2y7j_A 86 WAAAKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITL 165 (365)
T ss_dssp HHHHHHHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCE
T ss_pred chhhhhhhhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEE
Confidence 3444556678999999999999999999986 799999999865431 1134678999999999 79999999
Q ss_pred EEEEEeCCeEEEEEEecCCCCHHHHhccCCCCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEecCCCCeE
Q 002158 687 LGYCDEEGEQMLVYEFVPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSNLNAK 766 (958)
Q Consensus 687 ~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~~~~k 766 (958)
++++...+..++||||+++++|.+++.... .+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+|
T Consensus 166 ~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~--~l~~~~~~~i~~qi~~~L~~LH~~g---i~H~Dlkp~NIl~~~~~~ik 240 (365)
T 2y7j_A 166 IDSYESSSFMFLVFDLMRKGELFDYLTEKV--ALSEKETRSIMRSLLEAVSFLHANN---IVHRDLKPENILLDDNMQIR 240 (365)
T ss_dssp EEEEEBSSEEEEEECCCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEE
T ss_pred EEEEeeCCEEEEEEEeCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEE
Confidence 999999999999999999999999997543 4899999999999999999999999 99999999999999999999
Q ss_pred EeeeeeecccccCCCCCCccceeeeeccCCCCccChhhhccC------CCCCcchhhhHHHHHHHHHhCCCCCCCCchhH
Q 002158 767 VADFGLSRLAPVLDDEGTMPTHVSTIVKGTPGYLDPEYFLTH------KLTDKSDVYSLGVVLLELLTGMQPISHGKNIV 840 (958)
Q Consensus 767 l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~------~~~~~~DV~S~Gv~l~elltG~~P~~~~~~~~ 840 (958)
|+|||++....... ......||+.|+|||++.+. .++.++|||||||++|||++|+.||.......
T Consensus 241 l~DfG~~~~~~~~~--------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~ 312 (365)
T 2y7j_A 241 LSDFGFSCHLEPGE--------KLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQIL 312 (365)
T ss_dssp ECCCTTCEECCTTC--------CBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH
T ss_pred EEecCcccccCCCc--------ccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHHH
Confidence 99999987653211 12345699999999998643 57889999999999999999999997644322
Q ss_pred HHHHHHhhcCcchhhhcccCCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 002158 841 REVNVARDSGMVFSIIDNRMGSYPSECVERFVTLALRCCHDKPEHRPSMSDVVRE 895 (958)
Q Consensus 841 ~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 895 (958)
.. ........... .+. ....+..+.+++.+||+.||++||+++|++++
T Consensus 313 ~~-~~i~~~~~~~~--~~~----~~~~~~~~~~li~~~L~~dP~~Rps~~ell~h 360 (365)
T 2y7j_A 313 ML-RMIMEGQYQFS--SPE----WDDRSSTVKDLISRLLQVDPEARLTAEQALQH 360 (365)
T ss_dssp HH-HHHHHTCCCCC--HHH----HSSSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred HH-HHHHhCCCCCC--Ccc----cccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 21 11111100000 000 01234678999999999999999999999874
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-39 Score=362.16 Aligned_cols=250 Identities=26% Similarity=0.303 Sum_probs=203.4
Q ss_pred cCCCCCceeeeeCCeEEEEEEE----CCCcEEEEEEeccCC----hhcHHHHHHHHHHHHcc-CCCCcceEEEEEEeCCe
Q 002158 625 AYFSSSTQVGQGGYGKVYKGIL----SDNTTVAIKRAEEGS----LQGQNEFLTEIKLLSRL-HHRNLVSLLGYCDEEGE 695 (958)
Q Consensus 625 ~~~~~~~~lg~G~~g~Vy~~~~----~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~ 695 (958)
++|...+.||+|+||+||+|+. .+++.||||+++... ....+.+.+|+++++++ +||||+++++++..++.
T Consensus 54 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~ 133 (355)
T 1vzo_A 54 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK 133 (355)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred cceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCce
Confidence 4688889999999999999997 368999999986532 12334577899999999 69999999999999999
Q ss_pred EEEEEEecCCCCHHHHhccCCCCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEecCCCCeEEeeeeeecc
Q 002158 696 QMLVYEFVPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSRL 775 (958)
Q Consensus 696 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~ 775 (958)
.++||||+++|+|.+++.... .+++.++..++.|+++||+|||+.+ |+||||||+|||++.++.+||+|||+++.
T Consensus 134 ~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~DfG~a~~ 208 (355)
T 1vzo_A 134 LHLILDYINGGELFTHLSQRE--RFTEHEVQIYVGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSKE 208 (355)
T ss_dssp EEEEECCCCSCBHHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEESCSSEEEE
T ss_pred EEEEeecCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCcEEEeeCCCCee
Confidence 999999999999999997643 4899999999999999999999999 99999999999999999999999999986
Q ss_pred cccCCCCCCccceeeeeccCCCCccChhhhcc--CCCCCcchhhhHHHHHHHHHhCCCCCCCCch---hHHHHHHHhhcC
Q 002158 776 APVLDDEGTMPTHVSTIVKGTPGYLDPEYFLT--HKLTDKSDVYSLGVVLLELLTGMQPISHGKN---IVREVNVARDSG 850 (958)
Q Consensus 776 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DV~S~Gv~l~elltG~~P~~~~~~---~~~~~~~~~~~~ 850 (958)
..... ........||+.|+|||++.+ ..++.++|||||||++|||++|+.||..... .......
T Consensus 209 ~~~~~------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~----- 277 (355)
T 1vzo_A 209 FVADE------TERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRR----- 277 (355)
T ss_dssp CCGGG------GGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHH-----
T ss_pred cccCC------CCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchHHHHHHH-----
Confidence 53211 112234579999999999986 3478899999999999999999999964321 1111111
Q ss_pred cchhhhcccCCCCChHHHHHHHHHHHHccccCCCCCC-----CHHHHHHH
Q 002158 851 MVFSIIDNRMGSYPSECVERFVTLALRCCHDKPEHRP-----SMSDVVRE 895 (958)
Q Consensus 851 ~~~~~i~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~~ 895 (958)
+.......+..++..+.+++.+||+.||++|| +++|++++
T Consensus 278 -----~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h 322 (355)
T 1vzo_A 278 -----ILKSEPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEH 322 (355)
T ss_dssp -----HHHCCCCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTS
T ss_pred -----HhccCCCCCcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcC
Confidence 11112334556678899999999999999999 99999875
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-38 Score=343.64 Aligned_cols=252 Identities=22% Similarity=0.360 Sum_probs=203.8
Q ss_pred HcCCCCCceeeeeCCeEEEEEEEC-CCcEEEEEEeccCC----hhcHHHHHHHHHHHHccCCCCcceEEEEEE--eCCeE
Q 002158 624 TAYFSSSTQVGQGGYGKVYKGILS-DNTTVAIKRAEEGS----LQGQNEFLTEIKLLSRLHHRNLVSLLGYCD--EEGEQ 696 (958)
Q Consensus 624 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~H~niv~l~~~~~--~~~~~ 696 (958)
.++|...+.||+|+||.||+|.+. +++.||||++.... ....+.+.+|++++++++||||+++++++. ..+..
T Consensus 4 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (305)
T 2wtk_C 4 IGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKM 83 (305)
T ss_dssp -CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CE
T ss_pred ccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeE
Confidence 357899999999999999999975 68899999986532 234567999999999999999999999984 45688
Q ss_pred EEEEEecCCCCHHHHhccCCCCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEecCCCCeEEeeeeeeccc
Q 002158 697 MLVYEFVPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSRLA 776 (958)
Q Consensus 697 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~~ 776 (958)
++||||++++ |.+++.......+++..+..++.|+++||+|||+++ |+||||||+||+++.++.+||+|||+++..
T Consensus 84 ~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~---i~H~dlkp~NIl~~~~~~~kl~dfg~~~~~ 159 (305)
T 2wtk_C 84 YMVMEYCVCG-MQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQG---IVHKDIKPGNLLLTTGGTLKISALGVAEAL 159 (305)
T ss_dssp EEEEECCSEE-HHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred EEEehhccCC-HHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCcccEEEcCCCcEEeecccccccc
Confidence 9999999766 888887665667999999999999999999999999 999999999999999999999999999865
Q ss_pred ccCCCCCCccceeeeeccCCCCccChhhhccCC--CCCcchhhhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcCcchh
Q 002158 777 PVLDDEGTMPTHVSTIVKGTPGYLDPEYFLTHK--LTDKSDVYSLGVVLLELLTGMQPISHGKNIVREVNVARDSGMVFS 854 (958)
Q Consensus 777 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DV~S~Gv~l~elltG~~P~~~~~~~~~~~~~~~~~~~~~~ 854 (958)
..... ........||+.|+|||++.+.. ++.++||||||+++|||++|+.||...... .......
T Consensus 160 ~~~~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~-~~~~~i~------- 226 (305)
T 2wtk_C 160 HPFAA-----DDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIY-KLFENIG------- 226 (305)
T ss_dssp CTTCS-----SCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHH-HHHHHHH-------
T ss_pred Ccccc-----ccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHH-HHHHHHh-------
Confidence 32221 12223456999999999997654 367999999999999999999999754322 2211111
Q ss_pred hhcccCCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 002158 855 IIDNRMGSYPSECVERFVTLALRCCHDKPEHRPSMSDVVRE 895 (958)
Q Consensus 855 ~i~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 895 (958)
......+..++..+.+++.+||+.||++||+++|++++
T Consensus 227 ---~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 264 (305)
T 2wtk_C 227 ---KGSYAIPGDCGPPLSDLLKGMLEYEPAKRFSIRQIRQH 264 (305)
T ss_dssp ---HCCCCCCSSSCHHHHHHHHHHTCSSTTTSCCHHHHHHS
T ss_pred ---cCCCCCCCccCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 11123345567889999999999999999999999985
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=345.54 Aligned_cols=247 Identities=25% Similarity=0.370 Sum_probs=198.7
Q ss_pred cCCCCCceeeeeCCeEEEEEEEC-CCcEEEEEEeccCC---hhcHHHHHHHHHHHHccCCCCcceEEEEEEeCCeEEEEE
Q 002158 625 AYFSSSTQVGQGGYGKVYKGILS-DNTTVAIKRAEEGS---LQGQNEFLTEIKLLSRLHHRNLVSLLGYCDEEGEQMLVY 700 (958)
Q Consensus 625 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~ 700 (958)
++|...+.||+|+||.||+|.+. +++.||||++.... ....+.+.+|+++++.++||||+++++++...+..++||
T Consensus 11 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 90 (276)
T 2h6d_A 11 GHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMVM 90 (276)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred ccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEEEE
Confidence 46777889999999999999987 79999999986532 223457899999999999999999999999999999999
Q ss_pred EecCCCCHHHHhccCCCCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEecCCCCeEEeeeeeecccccCC
Q 002158 701 EFVPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSRLAPVLD 780 (958)
Q Consensus 701 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~ 780 (958)
||+++++|.+++.... .+++.++..++.|+++||+|||+.+ |+||||||+||+++.++.+||+|||+++.....
T Consensus 91 e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~- 164 (276)
T 2h6d_A 91 EYVSGGELFDYICKHG--RVEEMEARRLFQQILSAVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDG- 164 (276)
T ss_dssp ECCCSCBHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHHC---SSCCCCCGGGEEECTTSCEEECCCCGGGCCCC--
T ss_pred eccCCCcHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCChhhEEECCCCCEEEeecccccccCCC-
Confidence 9999999999997543 3899999999999999999999999 999999999999999999999999999765321
Q ss_pred CCCCccceeeeeccCCCCccChhhhccCCC-CCcchhhhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcCcchhhhccc
Q 002158 781 DEGTMPTHVSTIVKGTPGYLDPEYFLTHKL-TDKSDVYSLGVVLLELLTGMQPISHGKNIVREVNVARDSGMVFSIIDNR 859 (958)
Q Consensus 781 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DV~S~Gv~l~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~i~~~ 859 (958)
.......||+.|+|||.+.+..+ +.++||||||+++|||++|+.||...... ...... ...
T Consensus 165 -------~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~-~~~~~~----------~~~ 226 (276)
T 2h6d_A 165 -------EFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVP-TLFKKI----------RGG 226 (276)
T ss_dssp -------------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHH-HHHHHH----------HHC
T ss_pred -------cceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHH-HHHHHh----------hcC
Confidence 11223468999999999987765 57999999999999999999999754322 111111 111
Q ss_pred CCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 002158 860 MGSYPSECVERFVTLALRCCHDKPEHRPSMSDVVRE 895 (958)
Q Consensus 860 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 895 (958)
....+...+..+.+++.+||+.||++||+++|++++
T Consensus 227 ~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~h 262 (276)
T 2h6d_A 227 VFYIPEYLNRSVATLLMHMLQVDPLKRATIKDIREH 262 (276)
T ss_dssp CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred cccCchhcCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 222344566789999999999999999999999985
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-38 Score=364.30 Aligned_cols=256 Identities=21% Similarity=0.269 Sum_probs=203.6
Q ss_pred cCCCCCceeeeeCCeEEEEEEEC-CCcEEEEEEeccCChhcHHHHHHHHHHHHcc------CCCCcceEEEEEEeCCeEE
Q 002158 625 AYFSSSTQVGQGGYGKVYKGILS-DNTTVAIKRAEEGSLQGQNEFLTEIKLLSRL------HHRNLVSLLGYCDEEGEQM 697 (958)
Q Consensus 625 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l------~H~niv~l~~~~~~~~~~~ 697 (958)
.+|...+.||+|+||+||+|.+. +++.||||++... ....+.+.+|+++++.+ +|+||+++++++...+..+
T Consensus 97 ~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~~ 175 (429)
T 3kvw_A 97 YRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNE-KRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNHIC 175 (429)
T ss_dssp TTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETTEEE
T ss_pred CcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCc-cchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCCeEE
Confidence 46788899999999999999976 5899999999763 33345678898888887 5779999999999999999
Q ss_pred EEEEecCCCCHHHHhccCCCCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEecCCCC--eEEeeeeeecc
Q 002158 698 LVYEFVPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSNLN--AKVADFGLSRL 775 (958)
Q Consensus 698 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~~~--~kl~DFGla~~ 775 (958)
+||||++ ++|.+++.......+++..+..++.|++.||+|||+.+ |+||||||+|||++.++. +||+|||+++.
T Consensus 176 lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlKp~NILl~~~~~~~vkL~DFG~a~~ 251 (429)
T 3kvw_A 176 MTFELLS-MNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNR---IIHCDLKPENILLKQQGRSGIKVIDFGSSCY 251 (429)
T ss_dssp EEECCCC-CBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHHT---EECSCCSGGGEEESSTTSCCEEECCCTTCEE
T ss_pred EEEeccC-CCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEEccCCCcceEEeeccccee
Confidence 9999995 79999998776666999999999999999999999999 999999999999999987 99999999975
Q ss_pred cccCCCCCCccceeeeeccCCCCccChhhhccCCCCCcchhhhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcCcch--
Q 002158 776 APVLDDEGTMPTHVSTIVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVLLELLTGMQPISHGKNIVREVNVARDSGMVF-- 853 (958)
Q Consensus 776 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gv~l~elltG~~P~~~~~~~~~~~~~~~~~~~~~-- 853 (958)
... ......||+.|+|||++.+..++.++|||||||++|||++|+.||................+...
T Consensus 252 ~~~----------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~l~~i~~~~~~p~~~ 321 (429)
T 3kvw_A 252 EHQ----------RVYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMPSQK 321 (429)
T ss_dssp TTC----------CCCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHH
T ss_pred cCC----------cccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHH
Confidence 421 12235689999999999999999999999999999999999999976544322211111100000
Q ss_pred ---------hhhccc------------------------C------C-------CCChHHHHHHHHHHHHccccCCCCCC
Q 002158 854 ---------SIIDNR------------------------M------G-------SYPSECVERFVTLALRCCHDKPEHRP 887 (958)
Q Consensus 854 ---------~~i~~~------------------------~------~-------~~~~~~~~~l~~li~~cl~~dP~~RP 887 (958)
..++.. . . ..+...+..+.+++.+||+.||++||
T Consensus 322 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~dli~~~L~~dP~~Rp 401 (429)
T 3kvw_A 322 LLDASKRAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDFLKQCLEWDPAVRM 401 (429)
T ss_dssp HHHTBTTHHHHBCTTSCBTTSCEECCCC--CEECCEECTTCCEECSTTCSCHHHHTTTCCCHHHHHHHHHHTCSSTTTSC
T ss_pred HHHhhhhhhhccCCCCCcccccccccccccccccccccchhhccCCccchhhHhhccccchHHHHHHHHHHCCCChhhCC
Confidence 000000 0 0 00111256789999999999999999
Q ss_pred CHHHHHHH
Q 002158 888 SMSDVVRE 895 (958)
Q Consensus 888 s~~evl~~ 895 (958)
|++|++++
T Consensus 402 ta~e~L~H 409 (429)
T 3kvw_A 402 TPGQALRH 409 (429)
T ss_dssp CHHHHHTS
T ss_pred CHHHHhCC
Confidence 99999974
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-39 Score=347.15 Aligned_cols=255 Identities=25% Similarity=0.399 Sum_probs=205.5
Q ss_pred cCCCCCceeeeeCCeEEEEEEEC-CCcEEEEEEeccC--ChhcHHHHHHHHHHHHccCCCCcceEEEEEEe--CCeEEEE
Q 002158 625 AYFSSSTQVGQGGYGKVYKGILS-DNTTVAIKRAEEG--SLQGQNEFLTEIKLLSRLHHRNLVSLLGYCDE--EGEQMLV 699 (958)
Q Consensus 625 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~--~~~~~lV 699 (958)
++|...+.||+|+||+||+|.+. +++.||+|++... .....+.+.+|++++++++||||+++++++.. .+..++|
T Consensus 6 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv 85 (279)
T 2w5a_A 6 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIV 85 (279)
T ss_dssp GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEEE
T ss_pred hheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEEE
Confidence 46778899999999999999986 6899999998754 33445679999999999999999999998854 5789999
Q ss_pred EEecCCCCHHHHhccCC--CCCchHHHHHHHHHHHHHHHHHhhhcC--CCCeeccCCCccceEecCCCCeEEeeeeeecc
Q 002158 700 YEFVPNGTLRDWLSGRT--KENLNFAMRLRVALDSAKGILYLHTEA--HPPVFHRDIKASNILLDSNLNAKVADFGLSRL 775 (958)
Q Consensus 700 ~E~~~~gsL~~~l~~~~--~~~l~~~~~~~i~~~ia~aL~yLH~~~--~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~ 775 (958)
|||+++++|.+++.... ...+++..++.++.|++.||+|||+.+ ..+|+||||||+||+++.++.+||+|||+++.
T Consensus 86 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg~~~~ 165 (279)
T 2w5a_A 86 MEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARI 165 (279)
T ss_dssp EECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSCEEECCCCHHHH
T ss_pred EeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCCEEEecCchhee
Confidence 99999999999997532 344899999999999999999999986 24599999999999999999999999999976
Q ss_pred cccCCCCCCccceeeeeccCCCCccChhhhccCCCCCcchhhhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcCcchhh
Q 002158 776 APVLDDEGTMPTHVSTIVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVLLELLTGMQPISHGKNIVREVNVARDSGMVFSI 855 (958)
Q Consensus 776 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gv~l~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~ 855 (958)
.... ........||+.|+|||++.+..++.++||||||+++|||++|+.||...... ......
T Consensus 166 ~~~~-------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~-~~~~~i--------- 228 (279)
T 2w5a_A 166 LNHD-------TSFAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQK-ELAGKI--------- 228 (279)
T ss_dssp C----------CHHHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHH-HHHHHH---------
T ss_pred eccc-------cccccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCHH-HHHHHH---------
Confidence 4321 11122356999999999999999999999999999999999999999754422 111111
Q ss_pred hcccCCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 002158 856 IDNRMGSYPSECVERFVTLALRCCHDKPEHRPSMSDVVREL 896 (958)
Q Consensus 856 i~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 896 (958)
........+..++..+.+++.+||+.||++||+++|+++++
T Consensus 229 ~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~ 269 (279)
T 2w5a_A 229 REGKFRRIPYRYSDELNEIITRMLNLKDYHRPSVEEILENP 269 (279)
T ss_dssp HHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTST
T ss_pred hhcccccCCcccCHHHHHHHHHHcCCCcccCCCHHHHHhCh
Confidence 11122234556678899999999999999999999999754
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-38 Score=356.96 Aligned_cols=256 Identities=16% Similarity=0.206 Sum_probs=208.9
Q ss_pred HHcCCCCCceeeeeCCeEEEEEE------ECCCcEEEEEEeccCChhcHHHHHHHHHHHHccC---CCCcceEEEEEEeC
Q 002158 623 ATAYFSSSTQVGQGGYGKVYKGI------LSDNTTVAIKRAEEGSLQGQNEFLTEIKLLSRLH---HRNLVSLLGYCDEE 693 (958)
Q Consensus 623 ~~~~~~~~~~lg~G~~g~Vy~~~------~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---H~niv~l~~~~~~~ 693 (958)
..++|...+.||+|+||+||+|. ..+++.||||++.... ..++.+|++++++++ |+||+++++++...
T Consensus 63 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~~ 139 (365)
T 3e7e_A 63 GSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPAN---PWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQ 139 (365)
T ss_dssp SSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCC---HHHHHHHHHHHHHSCGGGGGGBCCEEEEEECS
T ss_pred CCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCC---hhHHHHHHHHHHHhhhhhhhhhhhhheeeecC
Confidence 34578888999999999999994 3468899999997643 446788888888886 99999999999999
Q ss_pred CeEEEEEEecCCCCHHHHhccC---CCCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEecC---------
Q 002158 694 GEQMLVYEFVPNGTLRDWLSGR---TKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDS--------- 761 (958)
Q Consensus 694 ~~~~lV~E~~~~gsL~~~l~~~---~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~--------- 761 (958)
+..++||||+++|+|.+++... ....+++.+++.++.|+++||+|||+++ |+||||||+|||++.
T Consensus 140 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~---ivHrDiKp~NIll~~~~~~~~~~~ 216 (365)
T 3e7e_A 140 NGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCE---IIHGDIKPDNFILGNGFLEQDDED 216 (365)
T ss_dssp SCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECGGGTCC----
T ss_pred CCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCC---eecCCCCHHHEEecccccCccccc
Confidence 9999999999999999999742 2345999999999999999999999999 999999999999998
Q ss_pred --CCCeEEeeeeeecccccCCCCCCccceeeeeccCCCCccChhhhccCCCCCcchhhhHHHHHHHHHhCCCCCCCCchh
Q 002158 762 --NLNAKVADFGLSRLAPVLDDEGTMPTHVSTIVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVLLELLTGMQPISHGKNI 839 (958)
Q Consensus 762 --~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gv~l~elltG~~P~~~~~~~ 839 (958)
++.+||+|||+|+....... ........||++|+|||++.+..++.++|||||||++|||+||+.||......
T Consensus 217 ~~~~~~kl~DFG~a~~~~~~~~-----~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~ 291 (365)
T 3e7e_A 217 DLSAGLALIDLGQSIDMKLFPK-----GTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGG 291 (365)
T ss_dssp --CTTEEECCCTTCEEGGGSCT-----TEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEETT
T ss_pred cccCCEEEeeCchhhhhhccCC-----CceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCCC
Confidence 89999999999976532221 23344567999999999999999999999999999999999999999532210
Q ss_pred HHHHHHHhhcCcchhhhcccCCCCChHHHHHHHHHHHHccccCCCCC-CCHHHHHHHHHHhHhhCC
Q 002158 840 VREVNVARDSGMVFSIIDNRMGSYPSECVERFVTLALRCCHDKPEHR-PSMSDVVRELENILKMFP 904 (958)
Q Consensus 840 ~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~l~~li~~cl~~dP~~R-Ps~~evl~~L~~~~~~~~ 904 (958)
. . .+.......+ ..+.+.+++..|++.+|.+| |+++++.+.|++.+....
T Consensus 292 -----------~-~-~~~~~~~~~~--~~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l~~~l~~~~ 342 (365)
T 3e7e_A 292 -----------E-C-KPEGLFRRLP--HLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHY 342 (365)
T ss_dssp -----------E-E-EECSCCTTCS--SHHHHHHHHHHHHCCCCTTCCCCHHHHHHHHHHHHHHHT
T ss_pred -----------c-e-eechhccccC--cHHHHHHHHHHHcCCCCCCcchHHHHHHHHHHHHHHHhh
Confidence 0 0 0111111112 35678899999999999999 788899999998886543
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-39 Score=356.02 Aligned_cols=262 Identities=26% Similarity=0.414 Sum_probs=205.2
Q ss_pred ccChHHHHHHHcCCCCCceeeeeCCeEEEEEEEC-CCcEEEEEEeccCChhcHHHHHHHHHHHHcc-CCCCcceEEEEEE
Q 002158 614 GFKFKELAMATAYFSSSTQVGQGGYGKVYKGILS-DNTTVAIKRAEEGSLQGQNEFLTEIKLLSRL-HHRNLVSLLGYCD 691 (958)
Q Consensus 614 ~~~~~el~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~ 691 (958)
.+.+.++....++|...+.||+|+||.||+|.+. +++.||||++.... ...+.+.+|+++++++ +||||+++++++.
T Consensus 13 ~~~~~~l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~ 91 (326)
T 2x7f_A 13 EIDLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFI 91 (326)
T ss_dssp ---CCCCCCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS-STTHHHHHHHHHHHHHCCSTTBCCEEEEEE
T ss_pred hccchhccCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCc-ccHHHHHHHHHHHHhccCCCCeeeeeeEEe
Confidence 3444455556778899999999999999999985 78999999987543 3346788999999999 7999999999997
Q ss_pred e------CCeEEEEEEecCCCCHHHHhccCCCCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEecCCCCe
Q 002158 692 E------EGEQMLVYEFVPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSNLNA 765 (958)
Q Consensus 692 ~------~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~~~~ 765 (958)
. .+..++||||+++|+|.+++.......+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+
T Consensus 92 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~ 168 (326)
T 2x7f_A 92 KKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHK---VIHRDIKGQNVLLTENAEV 168 (326)
T ss_dssp ECC--CCCCEEEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTCCE
T ss_pred eccCccccceEEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCcHHHEEEcCCCCE
Confidence 6 468899999999999999998765556899999999999999999999999 9999999999999999999
Q ss_pred EEeeeeeecccccCCCCCCccceeeeeccCCCCccChhhhc-----cCCCCCcchhhhHHHHHHHHHhCCCCCCCCchhH
Q 002158 766 KVADFGLSRLAPVLDDEGTMPTHVSTIVKGTPGYLDPEYFL-----THKLTDKSDVYSLGVVLLELLTGMQPISHGKNIV 840 (958)
Q Consensus 766 kl~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DV~S~Gv~l~elltG~~P~~~~~~~~ 840 (958)
||+|||+++...... .......||+.|+|||++. +..++.++||||||+++|||++|+.||.......
T Consensus 169 kl~Dfg~~~~~~~~~-------~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~ 241 (326)
T 2x7f_A 169 KLVDFGVSAQLDRTV-------GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMR 241 (326)
T ss_dssp EECCCTTTC--------------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHH
T ss_pred EEeeCcCceecCcCc-------cccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHH
Confidence 999999987543211 1123356899999999997 5678899999999999999999999997654432
Q ss_pred HHHHHHhhcCcchhhhcccCCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 002158 841 REVNVARDSGMVFSIIDNRMGSYPSECVERFVTLALRCCHDKPEHRPSMSDVVRE 895 (958)
Q Consensus 841 ~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 895 (958)
........ . .....+..++..+.+++.+||+.||.+||++++++++
T Consensus 242 ~~~~~~~~-~--------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h 287 (326)
T 2x7f_A 242 ALFLIPRN-P--------APRLKSKKWSKKFQSFIESCLVKNHSQRPATEQLMKH 287 (326)
T ss_dssp HHHHHHHS-C--------CCCCSCSCSCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred HHHHhhcC-c--------cccCCccccCHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 22211111 0 0111133456789999999999999999999999974
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-39 Score=349.60 Aligned_cols=259 Identities=27% Similarity=0.426 Sum_probs=200.2
Q ss_pred cCCCCCceeeeeCCeEEEEEEEC--CCc--EEEEEEeccCC---hhcHHHHHHHHHHHHccCCCCcceEEEEEEeCCeEE
Q 002158 625 AYFSSSTQVGQGGYGKVYKGILS--DNT--TVAIKRAEEGS---LQGQNEFLTEIKLLSRLHHRNLVSLLGYCDEEGEQM 697 (958)
Q Consensus 625 ~~~~~~~~lg~G~~g~Vy~~~~~--~~~--~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~ 697 (958)
++|...+.||+|+||+||+|.+. +++ .||||+++... ....+.+.+|++++++++||||+++++++..+. .+
T Consensus 18 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~ 96 (291)
T 1u46_A 18 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-MK 96 (291)
T ss_dssp GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-CE
T ss_pred hHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-ce
Confidence 46777889999999999999864 233 68999887542 334567999999999999999999999998765 88
Q ss_pred EEEEecCCCCHHHHhccCCCCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEecCCCCeEEeeeeeecccc
Q 002158 698 LVYEFVPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSRLAP 777 (958)
Q Consensus 698 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~~~ 777 (958)
+||||+++++|.+++.... ..+++.++..++.|+++||+|||+++ |+||||||+||+++.++.+||+|||+++...
T Consensus 97 ~v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~ 172 (291)
T 1u46_A 97 MVTELAPLGSLLDRLRKHQ-GHFLLGTLSRYAVQVAEGMGYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLMRALP 172 (291)
T ss_dssp EEEECCTTCBHHHHHHHHG-GGSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCEECC
T ss_pred eeEecccCCCHHHHHHhcc-CCcCHHHHHHHHHHHHHHHHHHHhCC---cccCCCchheEEEcCCCCEEEcccccccccc
Confidence 9999999999999997542 34899999999999999999999999 9999999999999999999999999998653
Q ss_pred cCCCCCCccceeeeeccCCCCccChhhhccCCCCCcchhhhHHHHHHHHHh-CCCCCCCCchhHHHHHHHhhcCcchhhh
Q 002158 778 VLDDEGTMPTHVSTIVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVLLELLT-GMQPISHGKNIVREVNVARDSGMVFSII 856 (958)
Q Consensus 778 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gv~l~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~i 856 (958)
..... ........+|..|+|||++.+..++.++||||||+++|||++ |+.||...... ..........
T Consensus 173 ~~~~~----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~-~~~~~~~~~~------ 241 (291)
T 1u46_A 173 QNDDH----YVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGS-QILHKIDKEG------ 241 (291)
T ss_dssp C-CCE----EEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHH-HHHHHHHTSC------
T ss_pred ccccc----hhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCHH-HHHHHHHccC------
Confidence 32211 112234457889999999999889999999999999999999 99999755432 2221111111
Q ss_pred cccCCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHh
Q 002158 857 DNRMGSYPSECVERFVTLALRCCHDKPEHRPSMSDVVRELENILK 901 (958)
Q Consensus 857 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~ 901 (958)
.....+..++..+.+++.+||+.||++||++.++++.|+++..
T Consensus 242 --~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~ 284 (291)
T 1u46_A 242 --ERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQP 284 (291)
T ss_dssp --CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC-
T ss_pred --CCCCCCcCcCHHHHHHHHHHccCCcccCcCHHHHHHHHHHhCc
Confidence 1112344567889999999999999999999999999988754
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-38 Score=354.99 Aligned_cols=255 Identities=22% Similarity=0.295 Sum_probs=195.6
Q ss_pred cCCCCCceeeeeCCeEEEEEEEC-CCcEEEEEEeccC--ChhcHHHHHHHHHHHHccCCCCcceEEEEEEeCC------e
Q 002158 625 AYFSSSTQVGQGGYGKVYKGILS-DNTTVAIKRAEEG--SLQGQNEFLTEIKLLSRLHHRNLVSLLGYCDEEG------E 695 (958)
Q Consensus 625 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~------~ 695 (958)
++|...+.||+|+||.||+|.+. +++.||||++... .....+.+.+|+.+++.++||||+++++++...+ .
T Consensus 25 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~ 104 (371)
T 2xrw_A 25 KRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQD 104 (371)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCCE
T ss_pred hheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeeccccccccccc
Confidence 46788899999999999999976 6899999998753 3344567899999999999999999999997655 7
Q ss_pred EEEEEEecCCCCHHHHhccCCCCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEecCCCCeEEeeeeeecc
Q 002158 696 QMLVYEFVPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSRL 775 (958)
Q Consensus 696 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~ 775 (958)
.++||||++ ++|.+++.. .+++..+..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+++.
T Consensus 105 ~~lv~e~~~-~~l~~~~~~----~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~ 176 (371)
T 2xrw_A 105 VYIVMELMD-ANLCQVIQM----ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLART 176 (371)
T ss_dssp EEEEEECCS-EEHHHHHHS----CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCCCC---
T ss_pred eEEEEEcCC-CCHHHHHhh----ccCHHHHHHHHHHHHHHHHHHHHCC---eecccCCHHHEEEcCCCCEEEEEeecccc
Confidence 899999996 589888853 3889999999999999999999999 99999999999999999999999999975
Q ss_pred cccCCCCCCccceeeeeccCCCCccChhhhccCCCCCcchhhhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcCcch-h
Q 002158 776 APVLDDEGTMPTHVSTIVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVLLELLTGMQPISHGKNIVREVNVARDSGMVF-S 854 (958)
Q Consensus 776 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gv~l~elltG~~P~~~~~~~~~~~~~~~~~~~~~-~ 854 (958)
... ........||+.|+|||++.+..++.++|||||||++|||++|+.||.+..............+... +
T Consensus 177 ~~~--------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~ 248 (371)
T 2xrw_A 177 AGT--------SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPE 248 (371)
T ss_dssp ---------------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-CCCCCHH
T ss_pred ccc--------ccccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHH
Confidence 422 1112345699999999999999999999999999999999999999986554433322221111000 0
Q ss_pred -----------hhcc---------------cC-CC---CChHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 002158 855 -----------IIDN---------------RM-GS---YPSECVERFVTLALRCCHDKPEHRPSMSDVVRE 895 (958)
Q Consensus 855 -----------~i~~---------------~~-~~---~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 895 (958)
.... .. +. .+...+..+.+++.+||+.||++|||++|++++
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 319 (371)
T 2xrw_A 249 FMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH 319 (371)
T ss_dssp HHTTSCHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred HHHHhhhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCC
Confidence 0000 00 00 012346789999999999999999999999985
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-39 Score=368.55 Aligned_cols=242 Identities=14% Similarity=0.143 Sum_probs=192.1
Q ss_pred HcCCCCCceeeeeCCeEEEEEEEC-CCcEEEEEEeccC---ChhcHHHHHHHH---HHHHccCCCCcceEE-------EE
Q 002158 624 TAYFSSSTQVGQGGYGKVYKGILS-DNTTVAIKRAEEG---SLQGQNEFLTEI---KLLSRLHHRNLVSLL-------GY 689 (958)
Q Consensus 624 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~---~~l~~l~H~niv~l~-------~~ 689 (958)
.++|...+.||+|+||+||+|++. +|+.||||++... .....+.|.+|+ +.+++++||||++++ ++
T Consensus 72 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~ 151 (377)
T 3byv_A 72 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL 151 (377)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEE
T ss_pred CceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhh
Confidence 356777899999999999999974 6999999998743 334457799999 455556899999998 77
Q ss_pred EEeCCe-----------------EEEEEEecCCCCHHHHhccCC-----CCCchHHHHHHHHHHHHHHHHHhhhcCCCCe
Q 002158 690 CDEEGE-----------------QMLVYEFVPNGTLRDWLSGRT-----KENLNFAMRLRVALDSAKGILYLHTEAHPPV 747 (958)
Q Consensus 690 ~~~~~~-----------------~~lV~E~~~~gsL~~~l~~~~-----~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~i 747 (958)
+...+. .++||||+ +|+|.+++.... ...+++..++.++.|+++||+|||+++ |
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---i 227 (377)
T 3byv_A 152 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG---L 227 (377)
T ss_dssp EECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTT---E
T ss_pred hhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhCC---e
Confidence 665542 89999999 689999997532 123557889999999999999999999 9
Q ss_pred eccCCCccceEecCCCCeEEeeeeeecccccCCCCCCccceeeeeccCCCCccChhhhccC-----------CCCCcchh
Q 002158 748 FHRDIKASNILLDSNLNAKVADFGLSRLAPVLDDEGTMPTHVSTIVKGTPGYLDPEYFLTH-----------KLTDKSDV 816 (958)
Q Consensus 748 iH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----------~~~~~~DV 816 (958)
+||||||+|||++.++.+||+|||+++... .......| +.|+|||++.+. .++.++||
T Consensus 228 vHrDikp~NIll~~~~~~kL~DFG~a~~~~----------~~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Dv 296 (377)
T 3byv_A 228 VHTYLRPVDIVLDQRGGVFLTGFEHLVRDG----------ARVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDA 296 (377)
T ss_dssp ECSCCCGGGEEECTTCCEEECCGGGCEETT----------CEEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHH
T ss_pred ecCCCCHHHEEEcCCCCEEEEechhheecC----------CcccCCCC-cCccChhhhcccccccccccccccCChhhhH
Confidence 999999999999999999999999998531 12334567 999999999887 89999999
Q ss_pred hhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcCcchhhhcccCCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 002158 817 YSLGVVLLELLTGMQPISHGKNIVREVNVARDSGMVFSIIDNRMGSYPSECVERFVTLALRCCHDKPEHRPSMSDVVRE 895 (958)
Q Consensus 817 ~S~Gv~l~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 895 (958)
|||||++|||++|+.||...... . ....+... ...++..+.+++.+||+.||++||++.|++++
T Consensus 297 wSlG~il~elltg~~Pf~~~~~~----------~-~~~~~~~~----~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h 360 (377)
T 3byv_A 297 WALGLVIYWIWCADLPITKDAAL----------G-GSEWIFRS----CKNIPQPVRALLEGFLRYPKEDRLLPLQAMET 360 (377)
T ss_dssp HHHHHHHHHHHHSSCCC----------------C-CSGGGGSS----CCCCCHHHHHHHHHHTCSSGGGCCCHHHHHTS
T ss_pred HHHHHHHHHHHHCCCCCcccccc----------c-chhhhhhh----ccCCCHHHHHHHHHHcCCCchhCCCHHHHhhC
Confidence 99999999999999999643211 0 11111111 12345788999999999999999999999863
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-38 Score=346.25 Aligned_cols=252 Identities=21% Similarity=0.309 Sum_probs=191.0
Q ss_pred HcCCCCCceeeeeCCeEEEEEEEC-CCcEEEEEEeccCC-hhcH-HHHHHHHHHHHccCCCCcceEEEEEEeCCeEEEEE
Q 002158 624 TAYFSSSTQVGQGGYGKVYKGILS-DNTTVAIKRAEEGS-LQGQ-NEFLTEIKLLSRLHHRNLVSLLGYCDEEGEQMLVY 700 (958)
Q Consensus 624 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~-~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~ 700 (958)
.++|+..+.||+|+||+||+|.+. +++.||||++.... .... +.+.++...++.++||||+++++++..++..++||
T Consensus 6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv~ 85 (290)
T 3fme_A 6 ADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWICM 85 (290)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEEEE
T ss_pred HHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEEEE
Confidence 356788899999999999999985 78999999997642 2222 33455556688889999999999999999999999
Q ss_pred EecCCCCHHHHhccC--CCCCchHHHHHHHHHHHHHHHHHhhhc-CCCCeeccCCCccceEecCCCCeEEeeeeeecccc
Q 002158 701 EFVPNGTLRDWLSGR--TKENLNFAMRLRVALDSAKGILYLHTE-AHPPVFHRDIKASNILLDSNLNAKVADFGLSRLAP 777 (958)
Q Consensus 701 E~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~~ia~aL~yLH~~-~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~~~ 777 (958)
||++ |+|.+++... ....+++..+..++.|++.||+|||++ + |+||||||+||+++.++.+||+|||+++...
T Consensus 86 e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 161 (290)
T 3fme_A 86 ELMD-TSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLS---VIHRDVKPSNVLINALGQVKMCDFGISGYLV 161 (290)
T ss_dssp ECCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSC---CCCCCCSGGGCEECTTCCEEBCCC-------
T ss_pred ehhc-cchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCC---eecCCCCHHHEEECCCCCEEEeecCCccccc
Confidence 9996 5988887541 234599999999999999999999998 8 9999999999999999999999999997653
Q ss_pred cCCCCCCccceeeeeccCCCCccChhhh----ccCCCCCcchhhhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcCcch
Q 002158 778 VLDDEGTMPTHVSTIVKGTPGYLDPEYF----LTHKLTDKSDVYSLGVVLLELLTGMQPISHGKNIVREVNVARDSGMVF 853 (958)
Q Consensus 778 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~----~~~~~~~~~DV~S~Gv~l~elltG~~P~~~~~~~~~~~~~~~~~~~~~ 853 (958)
... ......||+.|+|||++ .+..++.++||||+|+++|||++|+.||.................
T Consensus 162 ~~~--------~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~--- 230 (290)
T 3fme_A 162 DDV--------AKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEP--- 230 (290)
T ss_dssp ----------------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHHHHHHHHHSC---
T ss_pred ccc--------cccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHHHHHHHhccC---
Confidence 211 12234699999999996 456788899999999999999999999975443333222221111
Q ss_pred hhhcccCCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 002158 854 SIIDNRMGSYPSECVERFVTLALRCCHDKPEHRPSMSDVVRE 895 (958)
Q Consensus 854 ~~i~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 895 (958)
.....+..++..+.+++.+||+.||++|||++|++++
T Consensus 231 -----~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~h 267 (290)
T 3fme_A 231 -----SPQLPADKFSAEFVDFTSQCLKKNSKERPTYPELMQH 267 (290)
T ss_dssp -----CCCCCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred -----CCCcccccCCHHHHHHHHHHhhcChhhCcCHHHHHhC
Confidence 1111123456789999999999999999999999974
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-38 Score=363.86 Aligned_cols=250 Identities=26% Similarity=0.389 Sum_probs=193.8
Q ss_pred HHHcCCCCCceeeeeCCeEEEEEEEC-CCcEEEEEEeccCCh--------hcHHHHHHHHHHHHccCCCCcceEEEEEEe
Q 002158 622 MATAYFSSSTQVGQGGYGKVYKGILS-DNTTVAIKRAEEGSL--------QGQNEFLTEIKLLSRLHHRNLVSLLGYCDE 692 (958)
Q Consensus 622 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l~H~niv~l~~~~~~ 692 (958)
...++|...+.||+|+||+||+|.+. +++.||||++..... .....+.+|++++++++||||+++++++..
T Consensus 132 ~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~ 211 (419)
T 3i6u_A 132 ALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA 211 (419)
T ss_dssp HHHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEES
T ss_pred hhhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEec
Confidence 35678999999999999999999986 689999999865311 112348899999999999999999999864
Q ss_pred CCeEEEEEEecCCCCHHHHhccCCCCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEecCC---CCeEEee
Q 002158 693 EGEQMLVYEFVPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSN---LNAKVAD 769 (958)
Q Consensus 693 ~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~---~~~kl~D 769 (958)
+..++||||+++|+|.+++.... .+++.++..++.|+++||+|||+++ |+||||||+|||++.+ +.+||+|
T Consensus 212 -~~~~lv~e~~~~g~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~LH~~~---ivHrDlkp~NIll~~~~~~~~~kl~D 285 (419)
T 3i6u_A 212 -EDYYIVLELMEGGELFDKVVGNK--RLKEATCKLYFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITD 285 (419)
T ss_dssp -SEEEEEEECCTTCBGGGGTSSSC--CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSSSCCEEECC
T ss_pred -CceEEEEEcCCCCcHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEecCCCcceEEEee
Confidence 46899999999999999997543 4899999999999999999999999 9999999999999754 4599999
Q ss_pred eeeecccccCCCCCCccceeeeeccCCCCccChhhhcc---CCCCCcchhhhHHHHHHHHHhCCCCCCCCchhHHHHHHH
Q 002158 770 FGLSRLAPVLDDEGTMPTHVSTIVKGTPGYLDPEYFLT---HKLTDKSDVYSLGVVLLELLTGMQPISHGKNIVREVNVA 846 (958)
Q Consensus 770 FGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DV~S~Gv~l~elltG~~P~~~~~~~~~~~~~~ 846 (958)
||+++.... ........||+.|+|||++.+ ..++.++|||||||++|||++|+.||.............
T Consensus 286 FG~a~~~~~--------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~i 357 (419)
T 3i6u_A 286 FGHSKILGE--------TSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQI 357 (419)
T ss_dssp SSTTTSCC-------------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCCHHHHH
T ss_pred cccceecCC--------CccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHHHHHHH
Confidence 999986532 112234679999999999864 567889999999999999999999997543211111111
Q ss_pred hhcCcchhhhcccCCCCC----hHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 002158 847 RDSGMVFSIIDNRMGSYP----SECVERFVTLALRCCHDKPEHRPSMSDVVRE 895 (958)
Q Consensus 847 ~~~~~~~~~i~~~~~~~~----~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 895 (958)
........ ..++..+.+++.+||+.||++||+++|++++
T Consensus 358 ----------~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h 400 (419)
T 3i6u_A 358 ----------TSGKYNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRH 400 (419)
T ss_dssp ----------HTTCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred ----------hcCCCCCCchhhcccCHHHHHHHHHHccCChhHCcCHHHHhCC
Confidence 11111111 1346788999999999999999999999974
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-38 Score=347.79 Aligned_cols=252 Identities=26% Similarity=0.407 Sum_probs=203.8
Q ss_pred HHcCCCCCceeeeeCCeEEEEEEEC-CCcEEEEEEeccCChhcHHHHHHHHHHHHccCCCCcceEEEEEEeCCeEEEEEE
Q 002158 623 ATAYFSSSTQVGQGGYGKVYKGILS-DNTTVAIKRAEEGSLQGQNEFLTEIKLLSRLHHRNLVSLLGYCDEEGEQMLVYE 701 (958)
Q Consensus 623 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E 701 (958)
..+.|...+.||+|+||.||+|.+. +|+.||||++.... ..+++.+|++++++++||||+++++++...+..++|||
T Consensus 27 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 104 (314)
T 3com_A 27 PEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES--DLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVME 104 (314)
T ss_dssp ---CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTS--CCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred chhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchH--HHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEee
Confidence 4567888999999999999999986 58999999997643 34578899999999999999999999999999999999
Q ss_pred ecCCCCHHHHhccCCCCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEecCCCCeEEeeeeeecccccCCC
Q 002158 702 FVPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSRLAPVLDD 781 (958)
Q Consensus 702 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~ 781 (958)
|+++++|.+++.... ..+++.++..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+++......
T Consensus 105 ~~~~~~L~~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~- 179 (314)
T 3com_A 105 YCGAGSVSDIIRLRN-KTLTEDEIATILQSTLKGLEYLHFMR---KIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTM- 179 (314)
T ss_dssp CCTTEEHHHHHHHHT-CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECBTTB-
T ss_pred cCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCC---CcCCCcCHHHEEECCCCCEEEeecccchhhhhhc-
Confidence 999999999996432 34899999999999999999999999 9999999999999999999999999997653211
Q ss_pred CCCccceeeeeccCCCCccChhhhccCCCCCcchhhhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcCcchhhhcccCC
Q 002158 782 EGTMPTHVSTIVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVLLELLTGMQPISHGKNIVREVNVARDSGMVFSIIDNRMG 861 (958)
Q Consensus 782 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gv~l~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~i~~~~~ 861 (958)
.......||+.|+|||++.+..++.++||||||+++|||++|+.||................. ...
T Consensus 180 ------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~--------~~~ 245 (314)
T 3com_A 180 ------AKRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMRAIFMIPTNPP--------PTF 245 (314)
T ss_dssp ------SCBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCC--------CCC
T ss_pred ------cccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCC--------ccc
Confidence 112234689999999999999999999999999999999999999976544332221111110 001
Q ss_pred CCChHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 002158 862 SYPSECVERFVTLALRCCHDKPEHRPSMSDVVRE 895 (958)
Q Consensus 862 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 895 (958)
..+..++..+.+++.+||+.||.+||++.+++++
T Consensus 246 ~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~ 279 (314)
T 3com_A 246 RKPELWSDNFTDFVKQCLVKSPEQRATATQLLQH 279 (314)
T ss_dssp SSGGGSCHHHHHHHHHHTCSCTTTSCCHHHHTTS
T ss_pred CCcccCCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 1234456789999999999999999999999874
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-39 Score=351.25 Aligned_cols=267 Identities=24% Similarity=0.370 Sum_probs=190.7
Q ss_pred HHcCCCCCceeeeeCCeEEEEEEEC-CCcEEEEEEeccCC-hhcHHHHHHHHHHHHccCCCCcceEEEEEEeCCeEEEEE
Q 002158 623 ATAYFSSSTQVGQGGYGKVYKGILS-DNTTVAIKRAEEGS-LQGQNEFLTEIKLLSRLHHRNLVSLLGYCDEEGEQMLVY 700 (958)
Q Consensus 623 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~ 700 (958)
..++|...+.||+|+||.||+|.+. +++.||||++.... ....+++.+|++++++++||||+++++++...+..++||
T Consensus 13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 92 (303)
T 2vwi_A 13 NRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLVM 92 (303)
T ss_dssp CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSSCEEEEE
T ss_pred chhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcEEEe
Confidence 4567888999999999999999965 68999999986543 234567889999999999999999999999999999999
Q ss_pred EecCCCCHHHHhcc------CCCCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEecCCCCeEEeeeeeec
Q 002158 701 EFVPNGTLRDWLSG------RTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSR 774 (958)
Q Consensus 701 E~~~~gsL~~~l~~------~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~ 774 (958)
||+++++|.+++.. .....+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+++
T Consensus 93 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~ 169 (303)
T 2vwi_A 93 KLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNG---QIHRDVKAGNILLGEDGSVQIADFGVSA 169 (303)
T ss_dssp ECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTCCEEECCCHHHH
T ss_pred hhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---CCCCCCChhhEEEcCCCCEEEEeccchh
Confidence 99999999999964 12345899999999999999999999999 9999999999999999999999999997
Q ss_pred ccccCCCCCCccceeeeeccCCCCccChhhhcc-CCCCCcchhhhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcCcch
Q 002158 775 LAPVLDDEGTMPTHVSTIVKGTPGYLDPEYFLT-HKLTDKSDVYSLGVVLLELLTGMQPISHGKNIVREVNVARDSGMVF 853 (958)
Q Consensus 775 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DV~S~Gv~l~elltG~~P~~~~~~~~~~~~~~~~~~~~~ 853 (958)
......... .........||+.|+|||++.+ ..++.++||||||+++|||++|+.||....................
T Consensus 170 ~~~~~~~~~--~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~ 247 (303)
T 2vwi_A 170 FLATGGDIT--RNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQNDPPSL 247 (303)
T ss_dssp HCC-----------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHTSSCCCT
T ss_pred eeccCCCcc--chhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHHHHHhccCCCcc
Confidence 653322111 1112234569999999999976 5689999999999999999999999976544333222211111000
Q ss_pred hhhcccCCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 002158 854 SIIDNRMGSYPSECVERFVTLALRCCHDKPEHRPSMSDVVRE 895 (958)
Q Consensus 854 ~~i~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 895 (958)
.. ..........++..+.+++.+||+.||++||+++|++++
T Consensus 248 ~~-~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h 288 (303)
T 2vwi_A 248 ET-GVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRH 288 (303)
T ss_dssp TC------CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred cc-ccccchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhhC
Confidence 00 000012223456788999999999999999999999974
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-38 Score=354.71 Aligned_cols=259 Identities=27% Similarity=0.401 Sum_probs=202.0
Q ss_pred cCCCCCceeeeeCCeEEEEEEEC-CCcEEEEEEeccCC--hhcHHHHHHHHHHHHccCCCCcceEEEEEEeCCeEEEEEE
Q 002158 625 AYFSSSTQVGQGGYGKVYKGILS-DNTTVAIKRAEEGS--LQGQNEFLTEIKLLSRLHHRNLVSLLGYCDEEGEQMLVYE 701 (958)
Q Consensus 625 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E 701 (958)
++|...+.||+|+||.||+|.+. +++.||||++.... ....+.+.+|++++++++||||+++++++...+..++|||
T Consensus 25 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 104 (331)
T 4aaa_A 25 EKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVFE 104 (331)
T ss_dssp GGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred hhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEEEe
Confidence 46777889999999999999986 58999999986543 2334568899999999999999999999999999999999
Q ss_pred ecCCCCHHHHhccCCCCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEecCCCCeEEeeeeeecccccCCC
Q 002158 702 FVPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSRLAPVLDD 781 (958)
Q Consensus 702 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~ 781 (958)
|+++++|.+++.... .+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+++......
T Consensus 105 ~~~~~~l~~~~~~~~--~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~- 178 (331)
T 4aaa_A 105 FVDHTILDDLELFPN--GLDYQVVQKYLFQIINGIGFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPG- 178 (331)
T ss_dssp CCSEEHHHHHHHSTT--CCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCTTC--------
T ss_pred cCCcchHHHHHhhcc--CCCHHHHHHHHHHHHHHHHHHHHCC---EEccCcChheEEEcCCCcEEEEeCCCceeecCCc-
Confidence 999999998876443 3899999999999999999999999 9999999999999999999999999997543211
Q ss_pred CCCccceeeeeccCCCCccChhhhccC-CCCCcchhhhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcCcch-------
Q 002158 782 EGTMPTHVSTIVKGTPGYLDPEYFLTH-KLTDKSDVYSLGVVLLELLTGMQPISHGKNIVREVNVARDSGMVF------- 853 (958)
Q Consensus 782 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DV~S~Gv~l~elltG~~P~~~~~~~~~~~~~~~~~~~~~------- 853 (958)
.......||+.|+|||++.+. .++.++||||+|+++|||++|+.||................+...
T Consensus 179 ------~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 252 (331)
T 4aaa_A 179 ------EVYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELF 252 (331)
T ss_dssp -----------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHH
T ss_pred ------cccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhHh
Confidence 112334689999999999875 688999999999999999999999986654333222211111000
Q ss_pred -------hhhcccC-CC-----CChHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 002158 854 -------SIIDNRM-GS-----YPSECVERFVTLALRCCHDKPEHRPSMSDVVRE 895 (958)
Q Consensus 854 -------~~i~~~~-~~-----~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 895 (958)
....+.. .. ....++..+.+++.+||+.||++||+++|++++
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~h 307 (331)
T 4aaa_A 253 NKNPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHH 307 (331)
T ss_dssp HHCGGGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred hhccccccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 0000000 00 012356789999999999999999999999874
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-38 Score=368.64 Aligned_cols=265 Identities=23% Similarity=0.327 Sum_probs=187.1
Q ss_pred cCCCCCceeeeeCCeEEEEEEEC-CCcEEEEEEeccC--ChhcHHHHHHHHHHHHccCCCCcceEEEEEEeC-----CeE
Q 002158 625 AYFSSSTQVGQGGYGKVYKGILS-DNTTVAIKRAEEG--SLQGQNEFLTEIKLLSRLHHRNLVSLLGYCDEE-----GEQ 696 (958)
Q Consensus 625 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~-----~~~ 696 (958)
++|...+.||+|+||+||+|.+. +++.||||++... .....+++.+|++++++++||||+++++++... ...
T Consensus 53 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~ 132 (458)
T 3rp9_A 53 DRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDEL 132 (458)
T ss_dssp TTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCCE
T ss_pred CCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCceE
Confidence 57888999999999999999976 6899999998653 334457899999999999999999999999443 578
Q ss_pred EEEEEecCCCCHHHHhccCCCCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEecCCCCeEEeeeeeeccc
Q 002158 697 MLVYEFVPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSRLA 776 (958)
Q Consensus 697 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~~ 776 (958)
|+||||+ +++|.+++.... .+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++..
T Consensus 133 ~lv~e~~-~~~L~~~~~~~~--~l~~~~~~~~~~qi~~aL~~LH~~~---iiHrDlKp~NILl~~~~~~kl~DFGla~~~ 206 (458)
T 3rp9_A 133 YVVLEIA-DSDFKKLFRTPV--YLTELHIKTLLYNLLVGVKYVHSAG---ILHRDLKPANCLVNQDCSVKVCDFGLARTV 206 (458)
T ss_dssp EEEECCC-SEEHHHHHHSSC--CCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTCCEEECCCTTCBCT
T ss_pred EEEEecc-ccchhhhcccCC--CCCHHHHHHHHHHHHHHHHHHHhCC---cCCCCCChhhEEECCCCCEeecccccchhc
Confidence 9999998 579999997543 4999999999999999999999999 999999999999999999999999999876
Q ss_pred ccCCCCCCc--------------------cceeeeeccCCCCccChhhh-ccCCCCCcchhhhHHHHHHHHHh-------
Q 002158 777 PVLDDEGTM--------------------PTHVSTIVKGTPGYLDPEYF-LTHKLTDKSDVYSLGVVLLELLT------- 828 (958)
Q Consensus 777 ~~~~~~~~~--------------------~~~~~~~~~gt~~y~aPE~~-~~~~~~~~~DV~S~Gv~l~ellt------- 828 (958)
......... .........||+.|+|||++ ....++.++|||||||++|||++
T Consensus 207 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg~~~~~~ 286 (458)
T 3rp9_A 207 DYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKENVA 286 (458)
T ss_dssp TSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTTSTTTCS
T ss_pred cCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHhcccccc
Confidence 432211000 01123456789999999987 45679999999999999999999
Q ss_pred ----CCCCCCCCchh-------------------HHHHHH-HhhcCcc-h------------hhhc---c----cCCCCC
Q 002158 829 ----GMQPISHGKNI-------------------VREVNV-ARDSGMV-F------------SIID---N----RMGSYP 864 (958)
Q Consensus 829 ----G~~P~~~~~~~-------------------~~~~~~-~~~~~~~-~------------~~i~---~----~~~~~~ 864 (958)
|+.+|.+.... ...+.. ....+.. . ..+. . .+....
T Consensus 287 ~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 366 (458)
T 3rp9_A 287 YHADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAKRYIRIFPKREGTDLAERF 366 (458)
T ss_dssp SGGGCCCSCC--------------------CHHHHHHHHHHHHHHCCCCHHHHHTSSCHHHHHHHTTSCCCCCCCGGGGS
T ss_pred ccccccccCCCCccccccccccccccccccccCCHHHHHHHHHHcCCCCHHHHhhcCCHHHHHHHHhcCCCCCCCHHHHC
Confidence 55555432210 000000 0000000 0 0000 0 000111
Q ss_pred hHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 002158 865 SECVERFVTLALRCCHDKPEHRPSMSDVVRE 895 (958)
Q Consensus 865 ~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 895 (958)
...+..+.+|+.+||..||++|||++|++++
T Consensus 367 ~~~s~~~~dLl~~mL~~dP~~R~t~~e~L~H 397 (458)
T 3rp9_A 367 PASSADAIHLLKRMLVFNPNKRITINECLAH 397 (458)
T ss_dssp TTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred CCCCHHHHHHHHHHhccCccccCCHHHHhcC
Confidence 2346778999999999999999999999985
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-38 Score=359.40 Aligned_cols=259 Identities=21% Similarity=0.305 Sum_probs=199.3
Q ss_pred HHHHcCCCCCceeeeeCCeEEEEEEEC-CCcEEEEEEeccCChhcHHHHHHHHHHHHccCCCCcceEEEEEEeC------
Q 002158 621 AMATAYFSSSTQVGQGGYGKVYKGILS-DNTTVAIKRAEEGSLQGQNEFLTEIKLLSRLHHRNLVSLLGYCDEE------ 693 (958)
Q Consensus 621 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~------ 693 (958)
+....+|...+.||+|+||+||+|.+. +|+.||||++...... ..+|+++++.++||||+++++++...
T Consensus 3 ~~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~----~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~ 78 (383)
T 3eb0_A 3 ETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRY----KNRELDIMKVLDHVNIIKLVDYFYTTGDEEPK 78 (383)
T ss_dssp ---CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTTS----CCHHHHHHTTCCCTTBCCEEEEEEEC------
T ss_pred ccccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcch----HHHHHHHHHHcCCCCccchhheeeecCccccc
Confidence 345668889999999999999999975 7899999998754322 23799999999999999999998443
Q ss_pred --------------------------------CeEEEEEEecCCCCHHHHhcc--CCCCCchHHHHHHHHHHHHHHHHHh
Q 002158 694 --------------------------------GEQMLVYEFVPNGTLRDWLSG--RTKENLNFAMRLRVALDSAKGILYL 739 (958)
Q Consensus 694 --------------------------------~~~~lV~E~~~~gsL~~~l~~--~~~~~l~~~~~~~i~~~ia~aL~yL 739 (958)
...++||||++ |+|.+.+.. .....+++..+..++.|+++||+||
T Consensus 79 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~L 157 (383)
T 3eb0_A 79 PPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFI 157 (383)
T ss_dssp -------------------------------CCEEEEEECCCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHH
T ss_pred ccccccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHH
Confidence 34889999997 588877753 2234599999999999999999999
Q ss_pred hhcCCCCeeccCCCccceEec-CCCCeEEeeeeeecccccCCCCCCccceeeeeccCCCCccChhhhccC-CCCCcchhh
Q 002158 740 HTEAHPPVFHRDIKASNILLD-SNLNAKVADFGLSRLAPVLDDEGTMPTHVSTIVKGTPGYLDPEYFLTH-KLTDKSDVY 817 (958)
Q Consensus 740 H~~~~~~iiH~Dikp~NILl~-~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DV~ 817 (958)
|+.+ |+||||||+|||++ .++.+||+|||+++...... ......||+.|+|||++.+. .++.++|||
T Consensus 158 H~~g---i~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~--------~~~~~~~t~~y~aPE~~~~~~~~~~~~Diw 226 (383)
T 3eb0_A 158 HSLG---ICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSE--------PSVAYICSRFYRAPELMLGATEYTPSIDLW 226 (383)
T ss_dssp HTTT---EECSCCCGGGEEEETTTTEEEECCCTTCEECCTTS--------CCCCCCCCSSCCCHHHHTTCSSCCTHHHHH
T ss_pred HHCc---CccCccCHHHEEEcCCCCcEEEEECCCCcccCCCC--------CCcCcccCCCccCHHHhcCCCCCCcchhhh
Confidence 9999 99999999999998 68899999999998653222 12234689999999998875 489999999
Q ss_pred hHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcCcc--hhhh--cc--------cC------CCCChHHHHHHHHHHHHcc
Q 002158 818 SLGVVLLELLTGMQPISHGKNIVREVNVARDSGMV--FSII--DN--------RM------GSYPSECVERFVTLALRCC 879 (958)
Q Consensus 818 S~Gv~l~elltG~~P~~~~~~~~~~~~~~~~~~~~--~~~i--~~--------~~------~~~~~~~~~~l~~li~~cl 879 (958)
|+||++|||++|+.||.+..............+.. ..+. .. .. ..++...+..+.+++.+||
T Consensus 227 slG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L 306 (383)
T 3eb0_A 227 SIGCVFGELILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQIL 306 (383)
T ss_dssp HHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHC
T ss_pred hHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHc
Confidence 99999999999999998765443333222111110 0000 00 00 0123446678999999999
Q ss_pred ccCCCCCCCHHHHHHH
Q 002158 880 HDKPEHRPSMSDVVRE 895 (958)
Q Consensus 880 ~~dP~~RPs~~evl~~ 895 (958)
+.||++|||+.|++++
T Consensus 307 ~~dP~~R~t~~e~l~h 322 (383)
T 3eb0_A 307 RYEPDLRINPYEAMAH 322 (383)
T ss_dssp CSSGGGSCCHHHHHTS
T ss_pred cCChhhCCCHHHHhcC
Confidence 9999999999999964
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-37 Score=347.89 Aligned_cols=256 Identities=22% Similarity=0.329 Sum_probs=205.6
Q ss_pred cCCCCCceeeeeCCeEEEEEEE-C-CCcEEEEEEeccCChhcHHHHHHHHHHHHccCCC------CcceEEEEEEeCCeE
Q 002158 625 AYFSSSTQVGQGGYGKVYKGIL-S-DNTTVAIKRAEEGSLQGQNEFLTEIKLLSRLHHR------NLVSLLGYCDEEGEQ 696 (958)
Q Consensus 625 ~~~~~~~~lg~G~~g~Vy~~~~-~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~------niv~l~~~~~~~~~~ 696 (958)
++|...+.||+|+||+||+|.+ . +++.||||+++.. ....+.+.+|+++++.++|+ +++++++++...+..
T Consensus 14 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~~~~ 92 (339)
T 1z57_A 14 ARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNV-DRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHGHI 92 (339)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEETTEE
T ss_pred CceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecC-CchhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccCCcE
Confidence 4678889999999999999997 3 6889999999753 34456788999999998665 499999999999999
Q ss_pred EEEEEecCCCCHHHHhccCCCCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEecC---------------
Q 002158 697 MLVYEFVPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDS--------------- 761 (958)
Q Consensus 697 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~--------------- 761 (958)
++||||+ +++|.+++.......+++.++..++.|+++||+|||+++ |+||||||+|||++.
T Consensus 93 ~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~~~~~~~~~ 168 (339)
T 1z57_A 93 CIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNK---LTHTDLKPENILFVQSDYTEAYNPKIKRDE 168 (339)
T ss_dssp EEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESCCCEEEEEC----CEE
T ss_pred EEEEcCC-CCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHEEEeccccccccCCcccccc
Confidence 9999999 899999998776566899999999999999999999999 999999999999987
Q ss_pred ----CCCeEEeeeeeecccccCCCCCCccceeeeeccCCCCccChhhhccCCCCCcchhhhHHHHHHHHHhCCCCCCCCc
Q 002158 762 ----NLNAKVADFGLSRLAPVLDDEGTMPTHVSTIVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVLLELLTGMQPISHGK 837 (958)
Q Consensus 762 ----~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gv~l~elltG~~P~~~~~ 837 (958)
++.+||+|||+++.... ......||+.|+|||++.+..++.++|||||||++|||++|..||....
T Consensus 169 ~~~~~~~~kl~Dfg~~~~~~~----------~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~ 238 (339)
T 1z57_A 169 RTLINPDIKVVDFGSATYDDE----------HHSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHD 238 (339)
T ss_dssp EEESCCCEEECCCSSCEETTS----------CCCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSC
T ss_pred ccccCCCceEeeCcccccCcc----------ccccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCC
Confidence 66899999999975421 1123468999999999999999999999999999999999999997654
Q ss_pred hhHHHHHHHhhcCcc-hhhh------------------------------c--ccCCCCChHHHHHHHHHHHHccccCCC
Q 002158 838 NIVREVNVARDSGMV-FSII------------------------------D--NRMGSYPSECVERFVTLALRCCHDKPE 884 (958)
Q Consensus 838 ~~~~~~~~~~~~~~~-~~~i------------------------------~--~~~~~~~~~~~~~l~~li~~cl~~dP~ 884 (958)
............+.. ...+ . ......+...++.+.+++.+||+.||+
T Consensus 239 ~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~ 318 (339)
T 1z57_A 239 SKEHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPA 318 (339)
T ss_dssp HHHHHHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTT
T ss_pred hHHHHHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCcc
Confidence 322211111100000 0000 0 001122446778899999999999999
Q ss_pred CCCCHHHHHHH
Q 002158 885 HRPSMSDVVRE 895 (958)
Q Consensus 885 ~RPs~~evl~~ 895 (958)
+|||++|++++
T Consensus 319 ~Rpt~~ell~h 329 (339)
T 1z57_A 319 KRITLREALKH 329 (339)
T ss_dssp TSCCHHHHTTS
T ss_pred cccCHHHHhcC
Confidence 99999999864
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-38 Score=357.87 Aligned_cols=267 Identities=22% Similarity=0.270 Sum_probs=203.3
Q ss_pred ChHHHHHHHcCCCCCceeeeeCCeEEEEEEECCCcEEEEEEeccCCh-----------hcHHHHHHHHHHHHccCCCCcc
Q 002158 616 KFKELAMATAYFSSSTQVGQGGYGKVYKGILSDNTTVAIKRAEEGSL-----------QGQNEFLTEIKLLSRLHHRNLV 684 (958)
Q Consensus 616 ~~~el~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~-----------~~~~~~~~E~~~l~~l~H~niv 684 (958)
.++++....++|...+.||+|+||.||+|.+.+|+.||||++..... ...+.+.+|++++++++||||+
T Consensus 13 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv 92 (362)
T 3pg1_A 13 LIAELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNIL 92 (362)
T ss_dssp HHHHHHHTTCSCEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBC
T ss_pred HHHHHHHhccceEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCcc
Confidence 45678888899999999999999999999988899999998854221 1236799999999999999999
Q ss_pred eEEEEEEe-----CCeEEEEEEecCCCCHHHHhccCCCCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEe
Q 002158 685 SLLGYCDE-----EGEQMLVYEFVPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILL 759 (958)
Q Consensus 685 ~l~~~~~~-----~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl 759 (958)
++++++.. ....++||||++ |+|.+++.... ..+++..+..++.|++.||+|||+.+ |+||||||+||++
T Consensus 93 ~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~NIl~ 167 (362)
T 3pg1_A 93 GLRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHDQR-IVISPQHIQYFMYHILLGLHVLHEAG---VVHRDLHPGNILL 167 (362)
T ss_dssp CCSEEEEECCTTTCCEEEEEEECCS-EEHHHHHHCTT-SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEE
T ss_pred ceeeeEEeccCCCcceEEEEEccCC-CCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHCc---CEecCCChHHEEE
Confidence 99999854 336899999997 68988887543 45899999999999999999999999 9999999999999
Q ss_pred cCCCCeEEeeeeeecccccCCCCCCccceeeeeccCCCCccChhhhcc-CCCCCcchhhhHHHHHHHHHhCCCCCCCCch
Q 002158 760 DSNLNAKVADFGLSRLAPVLDDEGTMPTHVSTIVKGTPGYLDPEYFLT-HKLTDKSDVYSLGVVLLELLTGMQPISHGKN 838 (958)
Q Consensus 760 ~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DV~S~Gv~l~elltG~~P~~~~~~ 838 (958)
+.++.+||+|||+++..... .......||+.|+|||++.+ ..++.++|||||||++|||++|+.||.....
T Consensus 168 ~~~~~~kl~Dfg~~~~~~~~--------~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~ 239 (362)
T 3pg1_A 168 ADNNDITICDFNLAREDTAD--------ANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTF 239 (362)
T ss_dssp CTTCCEEECCTTC-----------------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSH
T ss_pred cCCCCEEEEecCcccccccc--------cccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCH
Confidence 99999999999999743221 12234568999999999987 6789999999999999999999999976543
Q ss_pred hHHHHHHHhhcC--cc-----------hhhhcccCCC--------CChHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 002158 839 IVREVNVARDSG--MV-----------FSIIDNRMGS--------YPSECVERFVTLALRCCHDKPEHRPSMSDVVRE 895 (958)
Q Consensus 839 ~~~~~~~~~~~~--~~-----------~~~i~~~~~~--------~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 895 (958)
...........+ .. ...+...... .+...+..+.+++.+||+.||++|||++|++++
T Consensus 240 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 317 (362)
T 3pg1_A 240 YNQLNKIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRH 317 (362)
T ss_dssp HHHHHHHHHHHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred HHHHHHHHHHcCCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHcC
Confidence 222211111000 00 0001011110 122345678999999999999999999999974
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-38 Score=342.28 Aligned_cols=251 Identities=24% Similarity=0.351 Sum_probs=204.4
Q ss_pred HcCCCCCceeeeeCCeEEEEEEEC-CCcEEEEEEeccCC---------hhcHHHHHHHHHHHHccC-CCCcceEEEEEEe
Q 002158 624 TAYFSSSTQVGQGGYGKVYKGILS-DNTTVAIKRAEEGS---------LQGQNEFLTEIKLLSRLH-HRNLVSLLGYCDE 692 (958)
Q Consensus 624 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---------~~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~ 692 (958)
.++|...+.||+|+||.||+|.++ +++.||||++.... ....+.+.+|+++++++. ||||+++++++..
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~ 95 (298)
T 1phk_A 16 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET 95 (298)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred hhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeecc
Confidence 357888899999999999999986 68999999987543 122356889999999995 9999999999999
Q ss_pred CCeEEEEEEecCCCCHHHHhccCCCCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEecCCCCeEEeeeee
Q 002158 693 EGEQMLVYEFVPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSNLNAKVADFGL 772 (958)
Q Consensus 693 ~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~~~~kl~DFGl 772 (958)
.+..++||||+++++|.+++.... .+++.++..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+
T Consensus 96 ~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~ 170 (298)
T 1phk_A 96 NTFFFLVFDLMKKGELFDYLTEKV--TLSEKETRKIMRALLEVICALHKLN---IVHRDLKPENILLDDDMNIKLTDFGF 170 (298)
T ss_dssp SSEEEEEEECCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTT
T ss_pred CCeEEEEEeccCCCcHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEEcCCCcEEEecccc
Confidence 999999999999999999997543 4899999999999999999999999 99999999999999999999999999
Q ss_pred ecccccCCCCCCccceeeeeccCCCCccChhhhc------cCCCCCcchhhhHHHHHHHHHhCCCCCCCCchhHHHHHHH
Q 002158 773 SRLAPVLDDEGTMPTHVSTIVKGTPGYLDPEYFL------THKLTDKSDVYSLGVVLLELLTGMQPISHGKNIVREVNVA 846 (958)
Q Consensus 773 a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~~DV~S~Gv~l~elltG~~P~~~~~~~~~~~~~~ 846 (958)
++...... ......||+.|+|||++. ...++.++||||||+++|||++|+.||......... ...
T Consensus 171 ~~~~~~~~--------~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~-~~~ 241 (298)
T 1phk_A 171 SCQLDPGE--------KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLML-RMI 241 (298)
T ss_dssp CEECCTTC--------CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH-HHH
T ss_pred hhhcCCCc--------ccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHHHHH-HHH
Confidence 97653211 122346899999999985 456788999999999999999999999765432221 111
Q ss_pred hhcCcchhhhcccCCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002158 847 RDSGMVFSIIDNRMGSYPSECVERFVTLALRCCHDKPEHRPSMSDVVR 894 (958)
Q Consensus 847 ~~~~~~~~~i~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 894 (958)
....... .......++..+.+++.+||+.||++||+++|+++
T Consensus 242 ~~~~~~~------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 283 (298)
T 1phk_A 242 MSGNYQF------GSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA 283 (298)
T ss_dssp HHTCCCC------CTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred hcCCccc------CcccccccCHHHHHHHHHHccCCcccCCCHHHHHh
Confidence 1111000 00112346678999999999999999999999986
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-38 Score=347.68 Aligned_cols=252 Identities=18% Similarity=0.307 Sum_probs=201.2
Q ss_pred cCCCCCceeeeeCCeEEEEEEEC-CCcEEEEEEeccCChhcHHHHHHHHHHHHccC-CCCcceEEEEEEe--CCeEEEEE
Q 002158 625 AYFSSSTQVGQGGYGKVYKGILS-DNTTVAIKRAEEGSLQGQNEFLTEIKLLSRLH-HRNLVSLLGYCDE--EGEQMLVY 700 (958)
Q Consensus 625 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~--~~~~~lV~ 700 (958)
++|+..+.||+|+||+||+|.+. +++.||||++.... .+.+.+|++++++++ ||||+++++++.. ....++||
T Consensus 36 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv~ 112 (330)
T 3nsz_A 36 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK---KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVF 112 (330)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCC---HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEEE
T ss_pred CceEEEEEecccCCeEEEEEEECCCCcEEEEEEecccc---hHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEEE
Confidence 46788899999999999999975 78999999997533 467889999999997 9999999999987 66789999
Q ss_pred EecCCCCHHHHhccCCCCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEecCCC-CeEEeeeeeecccccC
Q 002158 701 EFVPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSNL-NAKVADFGLSRLAPVL 779 (958)
Q Consensus 701 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~~-~~kl~DFGla~~~~~~ 779 (958)
||+++++|.+++.. +++.++..++.|++.||+|||+++ |+||||||+|||++.++ .+||+|||+++.....
T Consensus 113 e~~~~~~l~~~~~~-----~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~ 184 (330)
T 3nsz_A 113 EHVNNTDFKQLYQT-----LTDYDIRFYMYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPG 184 (330)
T ss_dssp ECCCCCCHHHHGGG-----CCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEECCCTTCEECCTT
T ss_pred eccCchhHHHHHHh-----CCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEEcCCCCEEEEEeCCCceEcCCC
Confidence 99999999999853 788999999999999999999999 99999999999999777 8999999999865322
Q ss_pred CCCCCccceeeeeccCCCCccChhhhcc-CCCCCcchhhhHHHHHHHHHhCCCCCCCCchhHHHHHHHhh---cCcchhh
Q 002158 780 DDEGTMPTHVSTIVKGTPGYLDPEYFLT-HKLTDKSDVYSLGVVLLELLTGMQPISHGKNIVREVNVARD---SGMVFSI 855 (958)
Q Consensus 780 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DV~S~Gv~l~elltG~~P~~~~~~~~~~~~~~~~---~~~~~~~ 855 (958)
.. .....||..|+|||++.+ ..++.++|||||||++|||++|+.||..+............ .....+.
T Consensus 185 ~~--------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~ 256 (330)
T 3nsz_A 185 QE--------YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDY 256 (330)
T ss_dssp CC--------CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHH
T ss_pred Cc--------cccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHhcCCchhhhH
Confidence 11 223468999999999987 67899999999999999999999999655433222211100 0000011
Q ss_pred hcccC------------------------CCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 002158 856 IDNRM------------------------GSYPSECVERFVTLALRCCHDKPEHRPSMSDVVRE 895 (958)
Q Consensus 856 i~~~~------------------------~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 895 (958)
++... ...+...+..+.+++.+||+.||++|||++|++++
T Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~h 320 (330)
T 3nsz_A 257 IDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEH 320 (330)
T ss_dssp HHHTTCCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred HHHhccccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 10000 11122356889999999999999999999999974
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-38 Score=361.57 Aligned_cols=203 Identities=27% Similarity=0.377 Sum_probs=166.6
Q ss_pred cCCCCCceeeeeCCeEEEEEEEC-CCcEEEEEEeccC--ChhcHHHHHHHHHHHHccCCCCcceEEEEEEeC-----CeE
Q 002158 625 AYFSSSTQVGQGGYGKVYKGILS-DNTTVAIKRAEEG--SLQGQNEFLTEIKLLSRLHHRNLVSLLGYCDEE-----GEQ 696 (958)
Q Consensus 625 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~-----~~~ 696 (958)
++|...+.||+|+||+||+|.+. +++.||||++... .....+++.+|++++++++||||+++++++... ...
T Consensus 26 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~ 105 (432)
T 3n9x_A 26 DNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDEL 105 (432)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCCE
T ss_pred CCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCeE
Confidence 47888899999999999999986 6889999999763 334456899999999999999999999999766 578
Q ss_pred EEEEEecCCCCHHHHhccCCCCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEecCCCCeEEeeeeeeccc
Q 002158 697 MLVYEFVPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSRLA 776 (958)
Q Consensus 697 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~~ 776 (958)
|+||||++ ++|.+++... ..+++..+..++.|+++||+|||+.+ |+||||||+|||++.++.+||+|||+++..
T Consensus 106 ~lv~e~~~-~~L~~~~~~~--~~l~~~~~~~i~~qil~aL~~LH~~g---ivHrDlkp~NILl~~~~~~kL~DFGla~~~ 179 (432)
T 3n9x_A 106 YIVLEIAD-SDLKKLFKTP--IFLTEEHIKTILYNLLLGENFIHESG---IIHRDLKPANCLLNQDCSVKVCDFGLARTI 179 (432)
T ss_dssp EEEEECCS-EEHHHHHHSS--CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred EEEEecCC-cCHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCHHHeEECCCCCEEEccCCCcccc
Confidence 99999995 6999999754 34899999999999999999999999 999999999999999999999999999876
Q ss_pred ccCCCCCCc---------------cceeeeeccCCCCccChhhh-ccCCCCCcchhhhHHHHHHHHHhCCCCC
Q 002158 777 PVLDDEGTM---------------PTHVSTIVKGTPGYLDPEYF-LTHKLTDKSDVYSLGVVLLELLTGMQPI 833 (958)
Q Consensus 777 ~~~~~~~~~---------------~~~~~~~~~gt~~y~aPE~~-~~~~~~~~~DV~S~Gv~l~elltG~~P~ 833 (958)
......... .........||+.|+|||++ ....++.++||||+||++|||++|..||
T Consensus 180 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~ 252 (432)
T 3n9x_A 180 NSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSH 252 (432)
T ss_dssp -------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTT
T ss_pred cccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhccccc
Confidence 432211000 00123456799999999986 4566999999999999999999864444
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-38 Score=368.48 Aligned_cols=251 Identities=25% Similarity=0.376 Sum_probs=200.2
Q ss_pred HcCCCCCceeeeeCCeEEEEEEEC-CCcEEEEEEeccCC--hhcHHHHHHHHHHHHccCCCCcceEEEEEEeCCeEEEEE
Q 002158 624 TAYFSSSTQVGQGGYGKVYKGILS-DNTTVAIKRAEEGS--LQGQNEFLTEIKLLSRLHHRNLVSLLGYCDEEGEQMLVY 700 (958)
Q Consensus 624 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~ 700 (958)
.+.|...+.||+|+||+||+|+++ ++..||||++.... ......+.+|+++++.++||||+++++++.+.+..++||
T Consensus 36 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 115 (494)
T 3lij_A 36 SEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVM 115 (494)
T ss_dssp HHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 446888899999999999999986 68899999987643 233567899999999999999999999999999999999
Q ss_pred EecCCCCHHHHhccCCCCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEecC---CCCeEEeeeeeecccc
Q 002158 701 EFVPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDS---NLNAKVADFGLSRLAP 777 (958)
Q Consensus 701 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~---~~~~kl~DFGla~~~~ 777 (958)
||+++|+|.+++.... .+++..+..++.|++.||+|||+.+ |+||||||+|||++. ++.+||+|||+++...
T Consensus 116 e~~~~g~L~~~~~~~~--~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~ 190 (494)
T 3lij_A 116 ECYKGGELFDEIIHRM--KFNEVDAAVIIKQVLSGVTYLHKHN---IVHRDLKPENLLLESKEKDALIKIVDFGLSAVFE 190 (494)
T ss_dssp ECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSTTCCEEECCCTTCEECB
T ss_pred ecCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCChhhEEEeCCCCCCcEEEEECCCCeECC
Confidence 9999999999986543 4899999999999999999999999 999999999999976 4559999999998653
Q ss_pred cCCCCCCccceeeeeccCCCCccChhhhccCCCCCcchhhhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcCcchhhhc
Q 002158 778 VLDDEGTMPTHVSTIVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVLLELLTGMQPISHGKNIVREVNVARDSGMVFSIID 857 (958)
Q Consensus 778 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gv~l~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~i~ 857 (958)
... ......||+.|+|||++. ..++.++||||+||++|||++|..||...... .............. .
T Consensus 191 ~~~--------~~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~-~~~~~i~~~~~~~~--~ 258 (494)
T 3lij_A 191 NQK--------KMKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQTDQ-EILRKVEKGKYTFD--S 258 (494)
T ss_dssp TTB--------CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-HHHHHHHHTCCCCC--S
T ss_pred CCc--------cccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHhCCCCCC--c
Confidence 211 123356999999999986 56899999999999999999999999764432 22222111111000 0
Q ss_pred ccCCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 002158 858 NRMGSYPSECVERFVTLALRCCHDKPEHRPSMSDVVRE 895 (958)
Q Consensus 858 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 895 (958)
+ ....++..+.+++.+||+.||.+|||+.|++++
T Consensus 259 ~----~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h 292 (494)
T 3lij_A 259 P----EWKNVSEGAKDLIKQMLQFDSQRRISAQQALEH 292 (494)
T ss_dssp G----GGTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTC
T ss_pred h----hcccCCHHHHHHHHHHCCCChhhCccHHHHhcC
Confidence 0 012346778999999999999999999999975
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-38 Score=369.84 Aligned_cols=251 Identities=25% Similarity=0.372 Sum_probs=206.7
Q ss_pred HcCCCCCceeeeeCCeEEEEEEEC-CCcEEEEEEeccCC---hhcHHHHHHHHHHHHccCCCCcceEEEEEEeCCeEEEE
Q 002158 624 TAYFSSSTQVGQGGYGKVYKGILS-DNTTVAIKRAEEGS---LQGQNEFLTEIKLLSRLHHRNLVSLLGYCDEEGEQMLV 699 (958)
Q Consensus 624 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV 699 (958)
.++|...+.||+|+||+||+|... +++.||||++.... ....+.+.+|++++++++||||+++++++...+..++|
T Consensus 25 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 104 (484)
T 3nyv_A 25 SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLV 104 (484)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred cCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEE
Confidence 456888899999999999999986 78999999986542 33467899999999999999999999999999999999
Q ss_pred EEecCCCCHHHHhccCCCCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEe---cCCCCeEEeeeeeeccc
Q 002158 700 YEFVPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILL---DSNLNAKVADFGLSRLA 776 (958)
Q Consensus 700 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl---~~~~~~kl~DFGla~~~ 776 (958)
|||+.+|+|.+++.... .+++..+..++.|++.||+|||+++ |+||||||+|||+ +.++.+||+|||+++..
T Consensus 105 ~e~~~~~~L~~~~~~~~--~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~ 179 (484)
T 3nyv_A 105 GEVYTGGELFDEIISRK--RFSEVDAARIIRQVLSGITYMHKNK---IVHRDLKPENLLLESKSKDANIRIIDFGLSTHF 179 (484)
T ss_dssp ECCCCSCBHHHHHHTCS--CCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSTTCCEEECCTTHHHHB
T ss_pred EecCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEEecCCCCCcEEEEeeeeeEEc
Confidence 99999999999997543 4899999999999999999999999 9999999999999 56789999999999865
Q ss_pred ccCCCCCCccceeeeeccCCCCccChhhhccCCCCCcchhhhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcCcchhhh
Q 002158 777 PVLDDEGTMPTHVSTIVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVLLELLTGMQPISHGKNIVREVNVARDSGMVFSII 856 (958)
Q Consensus 777 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gv~l~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~i 856 (958)
.... ......||+.|+|||++.+ .++.++||||+||++|||++|+.||....... .............
T Consensus 180 ~~~~--------~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~-~~~~i~~~~~~~~-- 247 (484)
T 3nyv_A 180 EASK--------KMKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANEYD-ILKKVEKGKYTFE-- 247 (484)
T ss_dssp CCCC--------SHHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHHHHHCCCCCC--
T ss_pred cccc--------ccccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCHHH-HHHHHHcCCCCCC--
Confidence 3211 1234569999999999866 68999999999999999999999997654322 2222211111000
Q ss_pred cccCCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 002158 857 DNRMGSYPSECVERFVTLALRCCHDKPEHRPSMSDVVRE 895 (958)
Q Consensus 857 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 895 (958)
......++..+.+++.+||+.||.+|||++|++++
T Consensus 248 ----~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h 282 (484)
T 3nyv_A 248 ----LPQWKKVSESAKDLIRKMLTYVPSMRISARDALDH 282 (484)
T ss_dssp ----SGGGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred ----CcccccCCHHHHHHHHHHCCCChhHCcCHHHHhhC
Confidence 00113456789999999999999999999999975
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-38 Score=351.86 Aligned_cols=263 Identities=24% Similarity=0.356 Sum_probs=201.6
Q ss_pred cCCCCCceeeeeCCeEEEEEEEC-CCcEEEEEEeccCCh--hcHHHHHHHHHHHHccCCCCcceEEEEEEe--------C
Q 002158 625 AYFSSSTQVGQGGYGKVYKGILS-DNTTVAIKRAEEGSL--QGQNEFLTEIKLLSRLHHRNLVSLLGYCDE--------E 693 (958)
Q Consensus 625 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~~~~~~--------~ 693 (958)
.+|...+.||+|+||+||+|++. +|+.||||++..... .....+.+|+++++.++||||+++++++.. .
T Consensus 17 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 96 (351)
T 3mi9_A 17 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCK 96 (351)
T ss_dssp GGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC--------
T ss_pred cceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccCC
Confidence 46788899999999999999985 789999999865432 224578899999999999999999999977 4
Q ss_pred CeEEEEEEecCCCCHHHHhccCCCCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEecCCCCeEEeeeeee
Q 002158 694 GEQMLVYEFVPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSNLNAKVADFGLS 773 (958)
Q Consensus 694 ~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla 773 (958)
+..++||||++ ++|.+.+.... ..+++.++..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||++
T Consensus 97 ~~~~lv~e~~~-~~l~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~a 171 (351)
T 3mi9_A 97 GSIYLVFDFCE-HDLAGLLSNVL-VKFTLSEIKRVMQMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFGLA 171 (351)
T ss_dssp CEEEEEEECCS-EEHHHHHHCTT-SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTC
T ss_pred ceEEEEEeccC-CCHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCHHHEEEcCCCCEEEccchhc
Confidence 46899999996 58888876543 34999999999999999999999999 999999999999999999999999999
Q ss_pred cccccCCCCCCccceeeeeccCCCCccChhhhcc-CCCCCcchhhhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcCcc
Q 002158 774 RLAPVLDDEGTMPTHVSTIVKGTPGYLDPEYFLT-HKLTDKSDVYSLGVVLLELLTGMQPISHGKNIVREVNVARDSGMV 852 (958)
Q Consensus 774 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DV~S~Gv~l~elltG~~P~~~~~~~~~~~~~~~~~~~~ 852 (958)
+......... ........||+.|+|||++.+ ..++.++|||||||++|||++|+.||................+..
T Consensus 172 ~~~~~~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~ 248 (351)
T 3mi9_A 172 RAFSLAKNSQ---PNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSI 248 (351)
T ss_dssp EECCCCSSSS---CCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCC
T ss_pred cccccccccc---ccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCC
Confidence 8664322211 122234568999999999976 457999999999999999999999998655432222211111110
Q ss_pred h----hhhcc-----cC----C---CCChH-----HHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 002158 853 F----SIIDN-----RM----G---SYPSE-----CVERFVTLALRCCHDKPEHRPSMSDVVRE 895 (958)
Q Consensus 853 ~----~~i~~-----~~----~---~~~~~-----~~~~l~~li~~cl~~dP~~RPs~~evl~~ 895 (958)
. ...+. .. . ..... .+..+.+++.+||+.||++|||++|++++
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 312 (351)
T 3mi9_A 249 TPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH 312 (351)
T ss_dssp CTTTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred ChhhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCC
Confidence 0 00000 00 0 00000 13568899999999999999999999974
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-38 Score=347.32 Aligned_cols=261 Identities=25% Similarity=0.368 Sum_probs=204.7
Q ss_pred HHcCCCCCceeeeeCCeEEEEEEEC--CCcEEEEEEeccCC--hhcHHHHHHHHHHHHcc---CCCCcceEEEEEE----
Q 002158 623 ATAYFSSSTQVGQGGYGKVYKGILS--DNTTVAIKRAEEGS--LQGQNEFLTEIKLLSRL---HHRNLVSLLGYCD---- 691 (958)
Q Consensus 623 ~~~~~~~~~~lg~G~~g~Vy~~~~~--~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l---~H~niv~l~~~~~---- 691 (958)
..++|...+.||+|+||+||+|.+. +++.||||++.... ......+.+|+++++.+ +||||+++++++.
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~ 88 (326)
T 1blx_A 9 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT 88 (326)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEEC
T ss_pred chhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeeccc
Confidence 3467888999999999999999983 68899999886432 12223566788777766 8999999999987
Q ss_pred -eCCeEEEEEEecCCCCHHHHhccCCCCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEecCCCCeEEeee
Q 002158 692 -EEGEQMLVYEFVPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSNLNAKVADF 770 (958)
Q Consensus 692 -~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~~~~kl~DF 770 (958)
.....++||||++ |+|.+++.......+++.++..++.|+++||+|||+.+ |+||||||+||+++.++.+||+||
T Consensus 89 ~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~g---i~H~dlkp~Nili~~~~~~kl~Df 164 (326)
T 1blx_A 89 DRETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADF 164 (326)
T ss_dssp SSEEEEEEEEECCS-CBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECSC
T ss_pred CCCceEEEEEecCC-CCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCCHHHeEEcCCCCEEEecC
Confidence 5567899999997 69999998766566999999999999999999999999 999999999999999999999999
Q ss_pred eeecccccCCCCCCccceeeeeccCCCCccChhhhccCCCCCcchhhhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcC
Q 002158 771 GLSRLAPVLDDEGTMPTHVSTIVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVLLELLTGMQPISHGKNIVREVNVARDSG 850 (958)
Q Consensus 771 Gla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gv~l~elltG~~P~~~~~~~~~~~~~~~~~~ 850 (958)
|+++..... .......||..|+|||++.+..++.++||||||+++|||++|+.||................+
T Consensus 165 g~~~~~~~~--------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~ 236 (326)
T 1blx_A 165 GLARIYSFQ--------MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIG 236 (326)
T ss_dssp CSCCCCCGG--------GGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHC
T ss_pred cccccccCC--------CCccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcC
Confidence 999764321 112345689999999999999999999999999999999999999986554332222111100
Q ss_pred cc--hh----------hh----cccCCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 002158 851 MV--FS----------II----DNRMGSYPSECVERFVTLALRCCHDKPEHRPSMSDVVRE 895 (958)
Q Consensus 851 ~~--~~----------~i----~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 895 (958)
.. .. .. ..........++..+.+++.+||+.||++||++.|++++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 297 (326)
T 1blx_A 237 LPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH 297 (326)
T ss_dssp CCCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred CCCcccCccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 00 00 00 000111234466788999999999999999999999863
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-38 Score=367.94 Aligned_cols=252 Identities=24% Similarity=0.341 Sum_probs=204.3
Q ss_pred HHcCCCCCceeeeeCCeEEEEEEEC-CCcEEEEEEeccC--ChhcHHHHHHHHHHHHccCCCCcceEEEEEEeCCeEEEE
Q 002158 623 ATAYFSSSTQVGQGGYGKVYKGILS-DNTTVAIKRAEEG--SLQGQNEFLTEIKLLSRLHHRNLVSLLGYCDEEGEQMLV 699 (958)
Q Consensus 623 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV 699 (958)
..++|...+.||+|+||+||+|.+. +++.||||++... .......+.+|++++++++||||+++++++...+..++|
T Consensus 20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 99 (486)
T 3mwu_A 20 FAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIV 99 (486)
T ss_dssp HHHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEE
Confidence 3457888999999999999999986 7899999998643 223456789999999999999999999999999999999
Q ss_pred EEecCCCCHHHHhccCCCCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEec---CCCCeEEeeeeeeccc
Q 002158 700 YEFVPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLD---SNLNAKVADFGLSRLA 776 (958)
Q Consensus 700 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~---~~~~~kl~DFGla~~~ 776 (958)
|||+++|+|.+++.... .+++.++..++.|++.||+|||+.+ |+||||||+|||++ .++.+||+|||+++..
T Consensus 100 ~e~~~~~~L~~~~~~~~--~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~ 174 (486)
T 3mwu_A 100 GELYTGGELFDEIIKRK--RFSEHDAARIIKQVFSGITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLSTCF 174 (486)
T ss_dssp ECCCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEESSSSTTCCEEECSCSCTTTB
T ss_pred EEcCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCchHHEEEecCCCCCCEEEEECCcCeEC
Confidence 99999999999987543 4899999999999999999999999 99999999999995 4567999999999765
Q ss_pred ccCCCCCCccceeeeeccCCCCccChhhhccCCCCCcchhhhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcCcchhhh
Q 002158 777 PVLDDEGTMPTHVSTIVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVLLELLTGMQPISHGKNIVREVNVARDSGMVFSII 856 (958)
Q Consensus 777 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gv~l~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~i 856 (958)
... .......||+.|+|||++.+ .++.++||||+||++|||++|+.||....... .............
T Consensus 175 ~~~--------~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~-~~~~i~~~~~~~~-- 242 (486)
T 3mwu_A 175 QQN--------TKMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYD-ILKRVETGKYAFD-- 242 (486)
T ss_dssp CCC------------CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHHHHHTCCCSC--
T ss_pred CCC--------CccCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHhCCCCCC--
Confidence 321 11234569999999999875 58999999999999999999999997654322 2221111111000
Q ss_pred cccCCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 002158 857 DNRMGSYPSECVERFVTLALRCCHDKPEHRPSMSDVVRE 895 (958)
Q Consensus 857 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 895 (958)
......++..+.+++.+||+.||.+|||+.|++++
T Consensus 243 ----~~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~h 277 (486)
T 3mwu_A 243 ----LPQWRTISDDAKDLIRKMLTFHPSLRITATQCLEH 277 (486)
T ss_dssp ----SGGGGGSCHHHHHHHHHHTCSSTTTSCCHHHHHHC
T ss_pred ----CcccCCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 00113456788999999999999999999999986
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-37 Score=356.78 Aligned_cols=256 Identities=22% Similarity=0.283 Sum_probs=202.6
Q ss_pred cCCCCCceeeeeCCeEEEEEEEC-CCcEEEEEEeccCChhcHHHHHHHHHHHHccC--------CCCcceEEEEEE----
Q 002158 625 AYFSSSTQVGQGGYGKVYKGILS-DNTTVAIKRAEEGSLQGQNEFLTEIKLLSRLH--------HRNLVSLLGYCD---- 691 (958)
Q Consensus 625 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~--------H~niv~l~~~~~---- 691 (958)
.+|...+.||+|+||+||+|++. +++.||||++... ....+.+.+|++++++++ |+||+++++++.
T Consensus 37 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~~~ 115 (397)
T 1wak_A 37 GRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA-EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISGV 115 (397)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEEET
T ss_pred CeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecC-CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeecCC
Confidence 56888899999999999999975 6889999999753 344567899999999985 788999999987
Q ss_pred eCCeEEEEEEecCCCCHHHHhccCCCCCchHHHHHHHHHHHHHHHHHhhhc-CCCCeeccCCCccceEecCCC-------
Q 002158 692 EEGEQMLVYEFVPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTE-AHPPVFHRDIKASNILLDSNL------- 763 (958)
Q Consensus 692 ~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~-~~~~iiH~Dikp~NILl~~~~------- 763 (958)
.....++||||+ +++|.+++.......+++..+..++.|++.||+|||++ + |+||||||+|||++.++
T Consensus 116 ~~~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~g---ivHrDikp~NIll~~~~~~~~~~~ 191 (397)
T 1wak_A 116 NGTHICMVFEVL-GHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCR---IIHTDIKPENILLSVNEQYIRRLA 191 (397)
T ss_dssp TEEEEEEEECCC-CCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECCCCSGGGEEECCCHHHHHHHH
T ss_pred CCceEEEEEecc-CccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHeeEeccchhhhhhh
Confidence 456889999999 67777777655555699999999999999999999998 8 99999999999999775
Q ss_pred ------------------------------------------CeEEeeeeeecccccCCCCCCccceeeeeccCCCCccC
Q 002158 764 ------------------------------------------NAKVADFGLSRLAPVLDDEGTMPTHVSTIVKGTPGYLD 801 (958)
Q Consensus 764 ------------------------------------------~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~a 801 (958)
.+||+|||+++..... .....||+.|+|
T Consensus 192 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~----------~~~~~gt~~y~a 261 (397)
T 1wak_A 192 AEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH----------FTEDIQTRQYRS 261 (397)
T ss_dssp HHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC----------SCSCCSCGGGCC
T ss_pred hhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc----------CccCCCCCcccC
Confidence 7999999999865321 123468999999
Q ss_pred hhhhccCCCCCcchhhhHHHHHHHHHhCCCCCCCCch------hHHHHHHHhhcCcc-hhhh----------c-------
Q 002158 802 PEYFLTHKLTDKSDVYSLGVVLLELLTGMQPISHGKN------IVREVNVARDSGMV-FSII----------D------- 857 (958)
Q Consensus 802 PE~~~~~~~~~~~DV~S~Gv~l~elltG~~P~~~~~~------~~~~~~~~~~~~~~-~~~i----------~------- 857 (958)
||++.+..++.++|||||||++|||++|+.||..... ...........+.. ...+ .
T Consensus 262 PE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~ 341 (397)
T 1wak_A 262 LEVLIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKH 341 (397)
T ss_dssp HHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSS
T ss_pred ChhhcCCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCcccccc
Confidence 9999999999999999999999999999999964321 11110000000000 0000 0
Q ss_pred -------------ccCCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 002158 858 -------------NRMGSYPSECVERFVTLALRCCHDKPEHRPSMSDVVRE 895 (958)
Q Consensus 858 -------------~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 895 (958)
......+...+..+.+++.+||+.||++|||++|++++
T Consensus 342 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 392 (397)
T 1wak_A 342 ITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRH 392 (397)
T ss_dssp CCCCCCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHTS
T ss_pred ccccCCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhhC
Confidence 00113456788899999999999999999999999864
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-37 Score=366.22 Aligned_cols=251 Identities=26% Similarity=0.366 Sum_probs=201.8
Q ss_pred HcCCCCCceeeeeCCeEEEEEEEC-CCcEEEEEEeccCCh-------------hcHHHHHHHHHHHHccCCCCcceEEEE
Q 002158 624 TAYFSSSTQVGQGGYGKVYKGILS-DNTTVAIKRAEEGSL-------------QGQNEFLTEIKLLSRLHHRNLVSLLGY 689 (958)
Q Consensus 624 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-------------~~~~~~~~E~~~l~~l~H~niv~l~~~ 689 (958)
.++|...+.||+|+||+||+|... +++.||||++..... ...+.+.+|++++++++||||++++++
T Consensus 35 ~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~ 114 (504)
T 3q5i_A 35 GESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDV 114 (504)
T ss_dssp GGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred ccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEEE
Confidence 467888899999999999999986 588999999875421 234678999999999999999999999
Q ss_pred EEeCCeEEEEEEecCCCCHHHHhccCCCCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEecCCC---CeE
Q 002158 690 CDEEGEQMLVYEFVPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSNL---NAK 766 (958)
Q Consensus 690 ~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~~---~~k 766 (958)
+.+.+..++||||+++|+|.+++.... .+++..+..++.|++.||+|||+.+ |+||||||+|||++.++ .+|
T Consensus 115 ~~~~~~~~lv~e~~~gg~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~k 189 (504)
T 3q5i_A 115 FEDKKYFYLVTEFYEGGELFEQIINRH--KFDECDAANIMKQILSGICYLHKHN---IVHRDIKPENILLENKNSLLNIK 189 (504)
T ss_dssp EECSSEEEEEEECCTTCBHHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESSTTCCSSEE
T ss_pred EEcCCEEEEEEecCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCcHHHEEEecCCCCccEE
Confidence 999999999999999999999997543 4899999999999999999999999 99999999999998776 699
Q ss_pred EeeeeeecccccCCCCCCccceeeeeccCCCCccChhhhccCCCCCcchhhhHHHHHHHHHhCCCCCCCCchhHHHHHHH
Q 002158 767 VADFGLSRLAPVLDDEGTMPTHVSTIVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVLLELLTGMQPISHGKNIVREVNVA 846 (958)
Q Consensus 767 l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gv~l~elltG~~P~~~~~~~~~~~~~~ 846 (958)
|+|||+++...... ......||+.|+|||++. ..++.++||||+||++|||++|..||...... ......
T Consensus 190 l~Dfg~a~~~~~~~--------~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~-~~~~~i 259 (504)
T 3q5i_A 190 IVDFGLSSFFSKDY--------KLRDRLGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGYPPFGGQNDQ-DIIKKV 259 (504)
T ss_dssp ECCCTTCEECCTTS--------CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-HHHHHH
T ss_pred EEECCCCEEcCCCC--------ccccccCCcCCCCHHHhc-cCCCchHHHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHH
Confidence 99999998653211 123356999999999986 56899999999999999999999999754432 222222
Q ss_pred hhcCcchhhhcccCCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 002158 847 RDSGMVFSIIDNRMGSYPSECVERFVTLALRCCHDKPEHRPSMSDVVRE 895 (958)
Q Consensus 847 ~~~~~~~~~i~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 895 (958)
......... .. ...++..+.+++.+||+.||.+|||++|++++
T Consensus 260 ~~~~~~~~~--~~----~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~h 302 (504)
T 3q5i_A 260 EKGKYYFDF--ND----WKNISDEAKELIKLMLTYDYNKRCTAEEALNS 302 (504)
T ss_dssp HHCCCCCCH--HH----HTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred HcCCCCCCc--cc----cCCCCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence 111110000 00 02345788999999999999999999999975
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-38 Score=355.50 Aligned_cols=254 Identities=22% Similarity=0.335 Sum_probs=186.0
Q ss_pred cCCCCCceeeeeCCeEEEEEEEC-CCcEEEEEEeccC--ChhcHHHHHHHHHHHHccCCCCcceEEEEEEeC------Ce
Q 002158 625 AYFSSSTQVGQGGYGKVYKGILS-DNTTVAIKRAEEG--SLQGQNEFLTEIKLLSRLHHRNLVSLLGYCDEE------GE 695 (958)
Q Consensus 625 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~------~~ 695 (958)
++|...+.||+|+||.||+|.+. +|+.||||++... .....+++.+|+++++.++||||+++++++... ..
T Consensus 29 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~ 108 (367)
T 2fst_X 29 ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFND 108 (367)
T ss_dssp TTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCC
T ss_pred CceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCCe
Confidence 57888899999999999999975 6899999998753 334456789999999999999999999998654 56
Q ss_pred EEEEEEecCCCCHHHHhccCCCCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEecCCCCeEEeeeeeecc
Q 002158 696 QMLVYEFVPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSRL 775 (958)
Q Consensus 696 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~ 775 (958)
.++||||+ +++|.+++.. ..+++..+..++.|+++||+|||+.+ |+||||||+|||++.++.+||+|||+++.
T Consensus 109 ~~lv~e~~-~~~L~~~~~~---~~l~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kL~DFG~a~~ 181 (367)
T 2fst_X 109 VYLVTHLM-GADLNNIVKC---QKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARH 181 (367)
T ss_dssp CEEEEECC-CEECC--------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECC------
T ss_pred EEEEeccc-CCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHhhEEECCCCCEEEeecccccc
Confidence 79999999 7899999865 34899999999999999999999999 99999999999999999999999999985
Q ss_pred cccCCCCCCccceeeeeccCCCCccChhhhcc-CCCCCcchhhhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcCcc-h
Q 002158 776 APVLDDEGTMPTHVSTIVKGTPGYLDPEYFLT-HKLTDKSDVYSLGVVLLELLTGMQPISHGKNIVREVNVARDSGMV-F 853 (958)
Q Consensus 776 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DV~S~Gv~l~elltG~~P~~~~~~~~~~~~~~~~~~~~-~ 853 (958)
... ......||+.|+|||++.+ ..++.++||||+||++|||++|+.||.+..............+.. .
T Consensus 182 ~~~----------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~ 251 (367)
T 2fst_X 182 TAD----------EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGA 251 (367)
T ss_dssp -------------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCH
T ss_pred ccc----------cCCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCH
Confidence 421 1234569999999999987 678999999999999999999999997655433222211111100 0
Q ss_pred hhhc-----------ccCC---CC-----ChHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 002158 854 SIID-----------NRMG---SY-----PSECVERFVTLALRCCHDKPEHRPSMSDVVRE 895 (958)
Q Consensus 854 ~~i~-----------~~~~---~~-----~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 895 (958)
+.+. ..+. .. ....+..+.+++.+||+.||++|||++|++++
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~h 312 (367)
T 2fst_X 252 ELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 312 (367)
T ss_dssp HHHTTCCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred HHHHHhhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcC
Confidence 0000 0000 00 11235678999999999999999999999975
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-37 Score=345.57 Aligned_cols=253 Identities=26% Similarity=0.387 Sum_probs=197.1
Q ss_pred HHcCCCCCceeeeeCCeEEEEEEEC-CCcEEEEEEeccCCh--------hcHHHHHHHHHHHHccCCCCcceEEEEEEeC
Q 002158 623 ATAYFSSSTQVGQGGYGKVYKGILS-DNTTVAIKRAEEGSL--------QGQNEFLTEIKLLSRLHHRNLVSLLGYCDEE 693 (958)
Q Consensus 623 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~ 693 (958)
..++|...+.||+|+||.||+|.+. +++.||||++..... .....+.+|++++++++||||+++++++..+
T Consensus 8 l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 87 (322)
T 2ycf_A 8 LRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAE 87 (322)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESS
T ss_pred hhhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCC
Confidence 3457888999999999999999986 588999999865321 1223588999999999999999999999766
Q ss_pred CeEEEEEEecCCCCHHHHhccCCCCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEecCCCC---eEEeee
Q 002158 694 GEQMLVYEFVPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSNLN---AKVADF 770 (958)
Q Consensus 694 ~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~~~---~kl~DF 770 (958)
+ .++||||+++++|.+++.... .+++.++..++.|++.||+|||+++ |+||||||+||+++.++. +||+||
T Consensus 88 ~-~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~~~~kl~Df 161 (322)
T 2ycf_A 88 D-YYIVLELMEGGELFDKVVGNK--RLKEATCKLYFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDF 161 (322)
T ss_dssp S-EEEEEECCTTEETHHHHSTTC--CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSSSCCEEECCC
T ss_pred c-eEEEEecCCCCcHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEecCCCCCeEEEccC
Confidence 5 899999999999999997543 4899999999999999999999999 999999999999987664 999999
Q ss_pred eeecccccCCCCCCccceeeeeccCCCCccChhhhc---cCCCCCcchhhhHHHHHHHHHhCCCCCCCCchhHHHHHHHh
Q 002158 771 GLSRLAPVLDDEGTMPTHVSTIVKGTPGYLDPEYFL---THKLTDKSDVYSLGVVLLELLTGMQPISHGKNIVREVNVAR 847 (958)
Q Consensus 771 Gla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DV~S~Gv~l~elltG~~P~~~~~~~~~~~~~~~ 847 (958)
|+++.... ........||+.|+|||++. ...++.++||||||+++|||++|..||..............
T Consensus 162 g~~~~~~~--------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~ 233 (322)
T 2ycf_A 162 GHSKILGE--------TSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQIT 233 (322)
T ss_dssp TTCEECCC--------CHHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSCHHHHHH
T ss_pred ccceeccc--------ccccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHHHHHHHH
Confidence 99986421 11123456999999999974 46688999999999999999999999975332111111111
Q ss_pred hcCcchhhhcccCCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 002158 848 DSGMVFSIIDNRMGSYPSECVERFVTLALRCCHDKPEHRPSMSDVVRE 895 (958)
Q Consensus 848 ~~~~~~~~i~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 895 (958)
..... . .......++..+.+++.+||+.||++||+++|++++
T Consensus 234 ~~~~~--~----~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~h 275 (322)
T 2ycf_A 234 SGKYN--F----IPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRH 275 (322)
T ss_dssp HTCCC--C----CHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred hCccc--c----CchhhhhcCHHHHHHHHHHcccCHhhCCCHHHHhhC
Confidence 10000 0 000012345788999999999999999999999863
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-38 Score=346.69 Aligned_cols=260 Identities=23% Similarity=0.324 Sum_probs=197.6
Q ss_pred cCCCCCceeeeeCCeEEEEEEEC-CCcEEEEEEeccCChhcHHHHHHHHHHHHccCCCCcceEEEEEE------------
Q 002158 625 AYFSSSTQVGQGGYGKVYKGILS-DNTTVAIKRAEEGSLQGQNEFLTEIKLLSRLHHRNLVSLLGYCD------------ 691 (958)
Q Consensus 625 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~------------ 691 (958)
.+|...+.||+|+||.||+|.+. +++.||||++........+++.+|++++++++||||+++++++.
T Consensus 11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~ 90 (320)
T 2i6l_A 11 SRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVGS 90 (320)
T ss_dssp TTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC----
T ss_pred CceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEecccccccccccccc
Confidence 46778899999999999999987 48999999998777667788999999999999999999999874
Q ss_pred --eCCeEEEEEEecCCCCHHHHhccCCCCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEec-CCCCeEEe
Q 002158 692 --EEGEQMLVYEFVPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLD-SNLNAKVA 768 (958)
Q Consensus 692 --~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~-~~~~~kl~ 768 (958)
.....++||||++ |+|.+++... .+++..+..++.|+++||+|||+++ |+||||||+||+++ +++.+||+
T Consensus 91 ~~~~~~~~lv~e~~~-~~L~~~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~kl~ 163 (320)
T 2i6l_A 91 LTELNSVYIVQEYME-TDLANVLEQG---PLLEEHARLFMYQLLRGLKYIHSAN---VLHRDLKPANLFINTEDLVLKIG 163 (320)
T ss_dssp CCSCSEEEEEEECCS-EEHHHHHTTC---CCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTTEEEEC
T ss_pred ccccCceeEEeeccC-CCHHHHhhcC---CccHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCeEEEc
Confidence 3467899999997 6999999643 4889999999999999999999999 99999999999997 56799999
Q ss_pred eeeeecccccCCCCCCccceeeeeccCCCCccChhhhcc-CCCCCcchhhhHHHHHHHHHhCCCCCCCCchhHHHHHHHh
Q 002158 769 DFGLSRLAPVLDDEGTMPTHVSTIVKGTPGYLDPEYFLT-HKLTDKSDVYSLGVVLLELLTGMQPISHGKNIVREVNVAR 847 (958)
Q Consensus 769 DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DV~S~Gv~l~elltG~~P~~~~~~~~~~~~~~~ 847 (958)
|||+++........ ........||..|+|||++.+ ..++.++||||||+++|||++|+.||..............
T Consensus 164 Dfg~~~~~~~~~~~----~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~ 239 (320)
T 2i6l_A 164 DFGLARIMDPHYSH----KGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILE 239 (320)
T ss_dssp CCTTCBCC------------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH
T ss_pred cCccccccCCCccc----ccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence 99999865322111 111233468999999999876 6788999999999999999999999986554332221111
Q ss_pred hcCcch------------hhhcccC--C-----CCChHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 002158 848 DSGMVF------------SIIDNRM--G-----SYPSECVERFVTLALRCCHDKPEHRPSMSDVVRE 895 (958)
Q Consensus 848 ~~~~~~------------~~i~~~~--~-----~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 895 (958)
...... ..+.... . .....++..+.+++.+||+.||++||+++|++++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 306 (320)
T 2i6l_A 240 SIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSH 306 (320)
T ss_dssp HSCCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred hcCCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhCC
Confidence 111000 0000000 0 0112356789999999999999999999999975
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-37 Score=376.67 Aligned_cols=260 Identities=27% Similarity=0.434 Sum_probs=210.6
Q ss_pred HHHcCCCCCceeeeeCCeEEEEEEECC----CcEEEEEEeccC-ChhcHHHHHHHHHHHHccCCCCcceEEEEEEeCCeE
Q 002158 622 MATAYFSSSTQVGQGGYGKVYKGILSD----NTTVAIKRAEEG-SLQGQNEFLTEIKLLSRLHHRNLVSLLGYCDEEGEQ 696 (958)
Q Consensus 622 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~ 696 (958)
...++|...+.||+|+||+||+|.+.. +..||||++... .....+.|.+|+.++++++||||+++++++. ++..
T Consensus 387 i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~ 465 (656)
T 2j0j_A 387 IQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPV 465 (656)
T ss_dssp CCGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSC
T ss_pred cccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-cCce
Confidence 344678888999999999999999742 467999998764 3344567999999999999999999999985 4578
Q ss_pred EEEEEecCCCCHHHHhccCCCCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEecCCCCeEEeeeeeeccc
Q 002158 697 MLVYEFVPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSRLA 776 (958)
Q Consensus 697 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~~ 776 (958)
++||||+++|+|.++++... ..+++..++.++.|+++||+|||+++ |+||||||+|||++.++.+||+|||+++..
T Consensus 466 ~lv~E~~~~g~L~~~l~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDikp~NILl~~~~~vkL~DFG~a~~~ 541 (656)
T 2j0j_A 466 WIIMELCTLGELRSFLQVRK-FSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYM 541 (656)
T ss_dssp EEEEECCTTCBHHHHHHHTT-TTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCCCCCSC
T ss_pred EEEEEcCCCCcHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchHhEEEeCCCCEEEEecCCCeec
Confidence 99999999999999997543 34899999999999999999999999 999999999999999999999999999865
Q ss_pred ccCCCCCCccceeeeeccCCCCccChhhhccCCCCCcchhhhHHHHHHHHHh-CCCCCCCCchhHHHHHHHhhcCcchhh
Q 002158 777 PVLDDEGTMPTHVSTIVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVLLELLT-GMQPISHGKNIVREVNVARDSGMVFSI 855 (958)
Q Consensus 777 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gv~l~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~ 855 (958)
.... ........||+.|+|||++.+..++.++||||||+++|||++ |..||.+...... .....
T Consensus 542 ~~~~------~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~-~~~i~-------- 606 (656)
T 2j0j_A 542 EDST------YYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDV-IGRIE-------- 606 (656)
T ss_dssp CC----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHH-HHHHH--------
T ss_pred CCCc------ceeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHHHH-HHHHH--------
Confidence 3211 111223457889999999999999999999999999999997 9999975443221 11111
Q ss_pred hcccCCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHhh
Q 002158 856 IDNRMGSYPSECVERFVTLALRCCHDKPEHRPSMSDVVRELENILKM 902 (958)
Q Consensus 856 i~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~ 902 (958)
.......+..++..+.+++.+||+.||++||++.++++.|+++++.
T Consensus 607 -~~~~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~el~~~L~~il~~ 652 (656)
T 2j0j_A 607 -NGERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEE 652 (656)
T ss_dssp -HTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred -cCCCCCCCccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHH
Confidence 1122234566778999999999999999999999999999998753
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-38 Score=383.30 Aligned_cols=250 Identities=21% Similarity=0.305 Sum_probs=208.5
Q ss_pred HHcCCCCCceeeeeCCeEEEEEEEC-CCcEEEEEEeccCC---hhcHHHHHHHHHHHHcc-CCCCcceEEEEEEeCCeEE
Q 002158 623 ATAYFSSSTQVGQGGYGKVYKGILS-DNTTVAIKRAEEGS---LQGQNEFLTEIKLLSRL-HHRNLVSLLGYCDEEGEQM 697 (958)
Q Consensus 623 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~ 697 (958)
..++|...+.||+|+||+||+|.++ +++.||||+++... ....+.+..|.+++..+ +||+|+++++++.+.+..|
T Consensus 339 ~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~ 418 (674)
T 3pfq_A 339 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLY 418 (674)
T ss_dssp -CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEE
T ss_pred cccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEE
Confidence 3457888899999999999999986 68899999987531 22345688999999988 7999999999999999999
Q ss_pred EEEEecCCCCHHHHhccCCCCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEecCCCCeEEeeeeeecccc
Q 002158 698 LVYEFVPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSRLAP 777 (958)
Q Consensus 698 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~~~ 777 (958)
+||||+++|+|.++++... .+++.++..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++...
T Consensus 419 lV~E~~~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~g---IiHrDLKp~NILl~~~g~ikL~DFGla~~~~ 493 (674)
T 3pfq_A 419 FVMEYVNGGDLMYHIQQVG--RFKEPHAVFYAAEIAIGLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENI 493 (674)
T ss_dssp EEEECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTS---EECCCCCSTTEEECSSSCEEECCCTTCEECC
T ss_pred EEEeCcCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCC---eEeccCChhhEEEcCCCcEEEeecceeeccc
Confidence 9999999999999997654 4899999999999999999999999 9999999999999999999999999998532
Q ss_pred cCCCCCCccceeeeeccCCCCccChhhhccCCCCCcchhhhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcCcchhhhc
Q 002158 778 VLDDEGTMPTHVSTIVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVLLELLTGMQPISHGKNIVREVNVARDSGMVFSIID 857 (958)
Q Consensus 778 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gv~l~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~i~ 857 (958)
... .......||+.|+|||++.+..++.++|||||||++|||++|+.||...... ...... .
T Consensus 494 ~~~-------~~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~-~~~~~i----------~ 555 (674)
T 3pfq_A 494 WDG-------VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDED-ELFQSI----------M 555 (674)
T ss_dssp CTT-------CCBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHH-HHHHHH----------H
T ss_pred cCC-------cccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCHH-HHHHHH----------H
Confidence 211 1234567999999999999999999999999999999999999999764432 222111 1
Q ss_pred ccCCCCChHHHHHHHHHHHHccccCCCCCCCH-----HHHHHH
Q 002158 858 NRMGSYPSECVERFVTLALRCCHDKPEHRPSM-----SDVVRE 895 (958)
Q Consensus 858 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~-----~evl~~ 895 (958)
.....+|...+.++.+++.+||+.||++||++ +||.++
T Consensus 556 ~~~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~h 598 (674)
T 3pfq_A 556 EHNVAYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEH 598 (674)
T ss_dssp SSCCCCCTTSCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHHSS
T ss_pred hCCCCCCccCCHHHHHHHHHHccCCHHHCCCCCCCcHHHHhcC
Confidence 12234566677889999999999999999997 666653
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-38 Score=355.46 Aligned_cols=258 Identities=21% Similarity=0.341 Sum_probs=206.6
Q ss_pred cCCCCCceeeeeCCeEEEEEEECCCcEEEEEEeccCChhc-----------------HHHHHHHHHHHHccCCCCcceEE
Q 002158 625 AYFSSSTQVGQGGYGKVYKGILSDNTTVAIKRAEEGSLQG-----------------QNEFLTEIKLLSRLHHRNLVSLL 687 (958)
Q Consensus 625 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~-----------------~~~~~~E~~~l~~l~H~niv~l~ 687 (958)
++|...+.||+|+||.||+|.+ +++.||||++....... .+.+.+|++++++++||||++++
T Consensus 31 ~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~ 109 (348)
T 2pml_X 31 NDYRIIRTLNQGKFNKIILCEK-DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTCE 109 (348)
T ss_dssp TTEEEEEEEECCSSCCEEEEEE-TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCCS
T ss_pred CceEEEEEEcCCCCeEEEEEEc-CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceEE
Confidence 4788889999999999999999 99999999986532111 16899999999999999999999
Q ss_pred EEEEeCCeEEEEEEecCCCCHHHH------hccCCCCCchHHHHHHHHHHHHHHHHHhhh-cCCCCeeccCCCccceEec
Q 002158 688 GYCDEEGEQMLVYEFVPNGTLRDW------LSGRTKENLNFAMRLRVALDSAKGILYLHT-EAHPPVFHRDIKASNILLD 760 (958)
Q Consensus 688 ~~~~~~~~~~lV~E~~~~gsL~~~------l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~-~~~~~iiH~Dikp~NILl~ 760 (958)
+++.+.+..++||||+++|+|.++ +.......+++..+..++.|++.||+|||+ .+ |+||||||+||+++
T Consensus 110 ~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~---i~H~dl~p~Nil~~ 186 (348)
T 2pml_X 110 GIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKN---ICHRDVKPSNILMD 186 (348)
T ss_dssp EEEESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTSC---EECCCCCGGGEEEC
T ss_pred EEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccCC---EeecCCChHhEEEc
Confidence 999999999999999999999999 665445669999999999999999999999 88 99999999999999
Q ss_pred CCCCeEEeeeeeecccccCCCCCCccceeeeeccCCCCccChhhhccC-CCCC-cchhhhHHHHHHHHHhCCCCCCCCch
Q 002158 761 SNLNAKVADFGLSRLAPVLDDEGTMPTHVSTIVKGTPGYLDPEYFLTH-KLTD-KSDVYSLGVVLLELLTGMQPISHGKN 838 (958)
Q Consensus 761 ~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~-~~DV~S~Gv~l~elltG~~P~~~~~~ 838 (958)
.++.+||+|||+++..... ......||+.|+|||++.+. .++. ++||||||+++|||++|+.||.....
T Consensus 187 ~~~~~kl~dfg~~~~~~~~---------~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~ 257 (348)
T 2pml_X 187 KNGRVKLSDFGESEYMVDK---------KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKIS 257 (348)
T ss_dssp TTSCEEECCCTTCEECBTT---------EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSC
T ss_pred CCCcEEEeccccccccccc---------cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCc
Confidence 9999999999999864321 22345699999999999887 6666 99999999999999999999976544
Q ss_pred hHHHHHHHhhcCcchhhhc---------ccCCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 002158 839 IVREVNVARDSGMVFSIID---------NRMGSYPSECVERFVTLALRCCHDKPEHRPSMSDVVRE 895 (958)
Q Consensus 839 ~~~~~~~~~~~~~~~~~i~---------~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 895 (958)
................... .........++..+.+++.+||+.||.+||+++|++++
T Consensus 258 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~h 323 (348)
T 2pml_X 258 LVELFNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKH 323 (348)
T ss_dssp SHHHHHHHTSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred HHHHHHHHhccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 2333222221111000000 00000113456789999999999999999999999973
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-37 Score=351.58 Aligned_cols=260 Identities=22% Similarity=0.312 Sum_probs=202.6
Q ss_pred cCCCCCceeeeeCCeEEEEEEEC-CCcEEEEEEeccCC-hhcHHHHHHHHHHHHccCCCCcceEEEEEEeC-----CeEE
Q 002158 625 AYFSSSTQVGQGGYGKVYKGILS-DNTTVAIKRAEEGS-LQGQNEFLTEIKLLSRLHHRNLVSLLGYCDEE-----GEQM 697 (958)
Q Consensus 625 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~-----~~~~ 697 (958)
.+|...+.||+|+||.||+|.+. +++.||||++.... ....+.+.+|++++++++||||+++++++... ...+
T Consensus 27 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 106 (364)
T 3qyz_A 27 PRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVY 106 (364)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCEE
T ss_pred ccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccceEE
Confidence 46888899999999999999976 68899999997543 33446799999999999999999999999765 4689
Q ss_pred EEEEecCCCCHHHHhccCCCCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEecCCCCeEEeeeeeecccc
Q 002158 698 LVYEFVPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSRLAP 777 (958)
Q Consensus 698 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~~~ 777 (958)
+||||++ |+|.+++... .+++.++..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++...
T Consensus 107 iv~e~~~-~~L~~~l~~~---~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~ 179 (364)
T 3qyz_A 107 IVQDLME-TDLYKLLKTQ---HLSNDHICYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVAD 179 (364)
T ss_dssp EEEECCS-EEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred EEEcccC-cCHHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCChHhEEECCCCCEEEEeCcceEecC
Confidence 9999996 6999999754 3899999999999999999999999 9999999999999999999999999998654
Q ss_pred cCCCCCCccceeeeeccCCCCccChhhhccC-CCCCcchhhhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcCcc-hhh
Q 002158 778 VLDDEGTMPTHVSTIVKGTPGYLDPEYFLTH-KLTDKSDVYSLGVVLLELLTGMQPISHGKNIVREVNVARDSGMV-FSI 855 (958)
Q Consensus 778 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DV~S~Gv~l~elltG~~P~~~~~~~~~~~~~~~~~~~~-~~~ 855 (958)
...... .......||+.|+|||++.+. .++.++||||+||++|||++|+.||................+.. .+.
T Consensus 180 ~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 255 (364)
T 3qyz_A 180 PDHDHT----GFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQED 255 (364)
T ss_dssp GGGCBC----CTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHHHHHCSCCHHH
T ss_pred CCCCcc----ccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHHHhCCCCHHH
Confidence 322111 112335799999999987654 58999999999999999999999997654332222111100000 000
Q ss_pred h------------c--ccCCC-----CChHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 002158 856 I------------D--NRMGS-----YPSECVERFVTLALRCCHDKPEHRPSMSDVVRE 895 (958)
Q Consensus 856 i------------~--~~~~~-----~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 895 (958)
+ . ..... .....+..+.+++.+||+.||++|||++|++++
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 314 (364)
T 3qyz_A 256 LNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH 314 (364)
T ss_dssp HHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred HHHhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 0 0 00000 112345678999999999999999999999974
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=353.09 Aligned_cols=265 Identities=23% Similarity=0.333 Sum_probs=202.3
Q ss_pred HHHcCCCCCceeeeeCCeEEEEEEECCCcEEEEEEeccCC--hhcHHHHHHHHHHHHccCCCCcceEEEEEEeCCeEEEE
Q 002158 622 MATAYFSSSTQVGQGGYGKVYKGILSDNTTVAIKRAEEGS--LQGQNEFLTEIKLLSRLHHRNLVSLLGYCDEEGEQMLV 699 (958)
Q Consensus 622 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV 699 (958)
...++|...+.||+|+||.||+|.+++ .||+|++.... ....+.|.+|+.++++++||||+++++++...+..++|
T Consensus 30 i~~~~~~~~~~lg~G~~g~V~~~~~~~--~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv 107 (319)
T 2y4i_B 30 IPFEQLEIGELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAII 107 (319)
T ss_dssp SCCSCEECCCBCCCSSSSEEEEEEESS--SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSSCEEEE
T ss_pred CCHHHeEEeeEeccCCceEEEEEEEcC--eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCceEEE
Confidence 345678888999999999999999854 49999986532 22334678899999999999999999999999999999
Q ss_pred EEecCCCCHHHHhccCCCCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEecCCCCeEEeeeeeecccccC
Q 002158 700 YEFVPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSRLAPVL 779 (958)
Q Consensus 700 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~~~~~ 779 (958)
|||+++++|.+++.... ..+++.++..++.|+++||+|||+++ |+||||||+||+++ ++.+||+|||+++.....
T Consensus 108 ~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~~~~ 182 (319)
T 2y4i_B 108 TSLCKGRTLYSVVRDAK-IVLDVNKTRQIAQEIVKGMGYLHAKG---ILHKDLKSKNVFYD-NGKVVITDFGLFSISGVL 182 (319)
T ss_dssp CBCCCSEEHHHHTTSSC-CCCCSHHHHHHHHHHHHHHHHHHHTT---CCCCCCCSTTEEEC---CCEECCCSCCC-----
T ss_pred eecccCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCChhhEEEe-CCCEEEeecCCccccccc
Confidence 99999999999997543 35899999999999999999999999 99999999999998 689999999998754322
Q ss_pred CCCCCccceeeeeccCCCCccChhhhcc---------CCCCCcchhhhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcC
Q 002158 780 DDEGTMPTHVSTIVKGTPGYLDPEYFLT---------HKLTDKSDVYSLGVVLLELLTGMQPISHGKNIVREVNVARDSG 850 (958)
Q Consensus 780 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~---------~~~~~~~DV~S~Gv~l~elltG~~P~~~~~~~~~~~~~~~~~~ 850 (958)
.... .........||+.|+|||++.. ..++.++||||||+++|||++|+.||......... ..... +
T Consensus 183 ~~~~--~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~-~~~~~-~ 258 (319)
T 2y4i_B 183 QAGR--REDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAII-WQMGT-G 258 (319)
T ss_dssp -------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHHHH-HHHHT-T
T ss_pred cccc--cccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH-HHhcc-C
Confidence 1111 1112233458999999999975 34788999999999999999999999754432211 11111 1
Q ss_pred cchhhhcccCCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHhhCC
Q 002158 851 MVFSIIDNRMGSYPSECVERFVTLALRCCHDKPEHRPSMSDVVRELENILKMFP 904 (958)
Q Consensus 851 ~~~~~i~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~~ 904 (958)
.. . ...+..++..+.+++.+||+.||++||+++++++.|+++.+...
T Consensus 259 ~~-----~--~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~~~~~ 305 (319)
T 2y4i_B 259 MK-----P--NLSQIGMGKEISDILLFCWAFEQEERPTFTKLMDMLEKLPKRNR 305 (319)
T ss_dssp CC-----C--CCCCSSCCTTHHHHHHHHHCSSTTTSCCHHHHHHHHTTC-----
T ss_pred CC-----C--CCCcCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhhc
Confidence 00 0 11122345678999999999999999999999999998776543
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-37 Score=349.40 Aligned_cols=258 Identities=22% Similarity=0.267 Sum_probs=202.9
Q ss_pred HHcCCCCCceeeeeCCeEEEEEEEC-CCcEEEEEEeccCChhcHHHHHHHHHHHHccC-CC-----CcceEEEEEEeCCe
Q 002158 623 ATAYFSSSTQVGQGGYGKVYKGILS-DNTTVAIKRAEEGSLQGQNEFLTEIKLLSRLH-HR-----NLVSLLGYCDEEGE 695 (958)
Q Consensus 623 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-H~-----niv~l~~~~~~~~~ 695 (958)
..++|...+.||+|+||+||+|.+. +++.||||+++.. .....++..|+++++.++ |+ +++++++++...+.
T Consensus 52 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~ 130 (382)
T 2vx3_A 52 WMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNK-KAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRNH 130 (382)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEETTE
T ss_pred eeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEecc-HHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccCCc
Confidence 3568888999999999999999986 6889999999753 333566788999998885 55 49999999999999
Q ss_pred EEEEEEecCCCCHHHHhccCCCCCchHHHHHHHHHHHHHHHHHhhh--cCCCCeeccCCCccceEec--CCCCeEEeeee
Q 002158 696 QMLVYEFVPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHT--EAHPPVFHRDIKASNILLD--SNLNAKVADFG 771 (958)
Q Consensus 696 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~--~~~~~iiH~Dikp~NILl~--~~~~~kl~DFG 771 (958)
.++||||++ ++|.+++.......+++..+..++.|++.||+|||+ .+ |+||||||+|||++ .++.+||+|||
T Consensus 131 ~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~---ivHrDlkp~NIll~~~~~~~~kL~DFG 206 (382)
T 2vx3_A 131 LCLVFEMLS-YNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELS---IIHCDLKPENILLCNPKRSAIKIVDFG 206 (382)
T ss_dssp EEEEEECCC-CBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTSTTTC---EECCCCSGGGEEESSTTSCCEEECCCT
T ss_pred eEEEEecCC-CCHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccCCCC---EEcCCCCcccEEEecCCCCcEEEEecc
Confidence 999999995 699999987665569999999999999999999995 45 99999999999994 47889999999
Q ss_pred eecccccCCCCCCccceeeeeccCCCCccChhhhccCCCCCcchhhhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcCc
Q 002158 772 LSRLAPVLDDEGTMPTHVSTIVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVLLELLTGMQPISHGKNIVREVNVARDSGM 851 (958)
Q Consensus 772 la~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gv~l~elltG~~P~~~~~~~~~~~~~~~~~~~ 851 (958)
+++.... ......||+.|+|||++.+..++.++|||||||++|||++|+.||................+.
T Consensus 207 ~a~~~~~----------~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~ 276 (382)
T 2vx3_A 207 SSCQLGQ----------RIYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGI 276 (382)
T ss_dssp TCEETTC----------CCCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCS
T ss_pred Cceeccc----------ccccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCC
Confidence 9986521 112356899999999999999999999999999999999999999865543222211111110
Q ss_pred chh-----------hhccc------------------------------------------CCCCChHHHHHHHHHHHHc
Q 002158 852 VFS-----------IIDNR------------------------------------------MGSYPSECVERFVTLALRC 878 (958)
Q Consensus 852 ~~~-----------~i~~~------------------------------------------~~~~~~~~~~~l~~li~~c 878 (958)
... ..... ...........+.+++.+|
T Consensus 277 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~m 356 (382)
T 2vx3_A 277 PPAHILDQAPKARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTVADYLKFKDLILRM 356 (382)
T ss_dssp CCHHHHTTCTTHHHHEEECTTSCEEECCCCTTCCCSCCTTCSCHHHHHTTTTTSGGGTTTTCTTCCHHHHHHHHHHHHHH
T ss_pred CCHHHHHhhHHHHHHHHhccccccccccccccccccCCcchhhHHHHhhccccCCCccccccccccchhhHHHHHHHHHh
Confidence 000 00000 0001123446889999999
Q ss_pred cccCCCCCCCHHHHHHH
Q 002158 879 CHDKPEHRPSMSDVVRE 895 (958)
Q Consensus 879 l~~dP~~RPs~~evl~~ 895 (958)
|+.||++|||++|++++
T Consensus 357 L~~dP~~Rpta~e~L~h 373 (382)
T 2vx3_A 357 LDYDPKTRIQPYYALQH 373 (382)
T ss_dssp TCSCTTTSCCHHHHTTS
T ss_pred cCCChhhCCCHHHHhcC
Confidence 99999999999999864
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-37 Score=339.66 Aligned_cols=258 Identities=24% Similarity=0.366 Sum_probs=197.0
Q ss_pred HcCCCCCceeeeeCCeEEEEEEEC-CCcEEEEEEeccCChhcHHHHHHHHHHHHccCCCCcceEEEEEEe----------
Q 002158 624 TAYFSSSTQVGQGGYGKVYKGILS-DNTTVAIKRAEEGSLQGQNEFLTEIKLLSRLHHRNLVSLLGYCDE---------- 692 (958)
Q Consensus 624 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~---------- 692 (958)
.++|+..+.||+|+||.||+|+.. +++.||||++.. .....+.+.+|++++++++||||+++++++.+
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~ 83 (303)
T 1zy4_A 5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRH-TEEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTA 83 (303)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEE-EHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC----
T ss_pred cccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEec-cHHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhcc
Confidence 456888899999999999999985 789999999865 23445678999999999999999999998865
Q ss_pred ---CCeEEEEEEecCCCCHHHHhccCCCCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEecCCCCeEEee
Q 002158 693 ---EGEQMLVYEFVPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSNLNAKVAD 769 (958)
Q Consensus 693 ---~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~~~~kl~D 769 (958)
.+..++||||+++|+|.+++.... ..+++.++..++.|+++||+|||+++ |+||||||+||+++.++.+||+|
T Consensus 84 ~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dlkp~Nil~~~~~~~kl~d 159 (303)
T 1zy4_A 84 VKKKSTLFIQMEYCENGTLYDLIHSEN-LNQQRDEYWRLFRQILEALSYIHSQG---IIHRDLKPMNIFIDESRNVKIGD 159 (303)
T ss_dssp --CEEEEEEEEECCCSCBHHHHHHHSC-GGGCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECC
T ss_pred cccCCceEEEEecCCCCCHHHhhhccc-cccchHHHHHHHHHHHHHHHHHHhCC---eecccCCHHhEEEcCCCCEEEee
Confidence 356899999999999999997543 34788999999999999999999999 99999999999999999999999
Q ss_pred eeeecccccCCCCC-------CccceeeeeccCCCCccChhhhccC-CCCCcchhhhHHHHHHHHHhCCCCCCCCchhHH
Q 002158 770 FGLSRLAPVLDDEG-------TMPTHVSTIVKGTPGYLDPEYFLTH-KLTDKSDVYSLGVVLLELLTGMQPISHGKNIVR 841 (958)
Q Consensus 770 FGla~~~~~~~~~~-------~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DV~S~Gv~l~elltG~~P~~~~~~~~~ 841 (958)
||+++......... ...........||+.|+|||++.+. .++.++||||||+++|||++ ||........
T Consensus 160 fg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~~~~~ 236 (303)
T 1zy4_A 160 FGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGMERVN 236 (303)
T ss_dssp CCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHHHHHH
T ss_pred CcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCchhHHH
Confidence 99998653211100 0001122345699999999999864 68999999999999999998 5643322222
Q ss_pred HHHHHhhcCcchhhhcccCCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 002158 842 EVNVARDSGMVFSIIDNRMGSYPSECVERFVTLALRCCHDKPEHRPSMSDVVRE 895 (958)
Q Consensus 842 ~~~~~~~~~~~~~~i~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 895 (958)
......... .......+...+..+.+++.+||+.||.+||++++++++
T Consensus 237 ~~~~~~~~~------~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h 284 (303)
T 1zy4_A 237 ILKKLRSVS------IEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNS 284 (303)
T ss_dssp HHHHHHSTT------CCCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred HHHhccccc------cccCccccccchHHHHHHHHHHHhcCcccCcCHHHHhCC
Confidence 222111100 011123345566788999999999999999999999974
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-37 Score=350.92 Aligned_cols=253 Identities=23% Similarity=0.326 Sum_probs=198.8
Q ss_pred cCCCCCceeeeeCCeEEEEEEEC-CCcEEEEEEeccCC--hhcHHHHHHHHHHHHccCCCCcceEEEEEEeCCeE-----
Q 002158 625 AYFSSSTQVGQGGYGKVYKGILS-DNTTVAIKRAEEGS--LQGQNEFLTEIKLLSRLHHRNLVSLLGYCDEEGEQ----- 696 (958)
Q Consensus 625 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~----- 696 (958)
++|...+.||+|+||+||+|.+. +|+.||||++.... ....+++.+|+.+++.++||||+++++++...+..
T Consensus 42 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 121 (371)
T 4exu_A 42 KTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYD 121 (371)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCCC
T ss_pred ccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCccccee
Confidence 46777889999999999999976 68999999997642 33356789999999999999999999999877654
Q ss_pred -EEEEEecCCCCHHHHhccCCCCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEecCCCCeEEeeeeeecc
Q 002158 697 -MLVYEFVPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSRL 775 (958)
Q Consensus 697 -~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~ 775 (958)
++||||++ ++|.+++.. .+++.++..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++.
T Consensus 122 ~~lv~e~~~-~~l~~~~~~----~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kL~Dfg~a~~ 193 (371)
T 4exu_A 122 FYLVMPFMQ-TDLQKIMGM----EFSEEKIQYLVYQMLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGLARH 193 (371)
T ss_dssp CEEEEECCC-EEHHHHTTS----CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECSTTCC--
T ss_pred EEEEEcccc-ccHHHHhhc----CCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCcCHHHeEECCCCCEEEEecCcccc
Confidence 99999996 789888842 3899999999999999999999999 99999999999999999999999999975
Q ss_pred cccCCCCCCccceeeeeccCCCCccChhhhcc-CCCCCcchhhhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcCcchh
Q 002158 776 APVLDDEGTMPTHVSTIVKGTPGYLDPEYFLT-HKLTDKSDVYSLGVVLLELLTGMQPISHGKNIVREVNVARDSGMVFS 854 (958)
Q Consensus 776 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DV~S~Gv~l~elltG~~P~~~~~~~~~~~~~~~~~~~~~~ 854 (958)
... ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||................+....
T Consensus 194 ~~~----------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~ 263 (371)
T 4exu_A 194 ADA----------EMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGT 263 (371)
T ss_dssp ----------------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCH
T ss_pred ccc----------CcCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCcH
Confidence 421 1234568999999999987 67899999999999999999999999765533322222111111000
Q ss_pred -hh-----------cccCC--------CCChHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 002158 855 -II-----------DNRMG--------SYPSECVERFVTLALRCCHDKPEHRPSMSDVVRE 895 (958)
Q Consensus 855 -~i-----------~~~~~--------~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 895 (958)
.. ..... .....++..+.+++.+||+.||++|||++|++++
T Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 324 (371)
T 4exu_A 264 EFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTH 324 (371)
T ss_dssp HHHTTCSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred HHHHHhhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcC
Confidence 00 00000 0112346789999999999999999999999974
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-37 Score=358.53 Aligned_cols=254 Identities=23% Similarity=0.325 Sum_probs=195.0
Q ss_pred CCCCCceeeeeCCeEEEEEEEC-CCcEEEEEEeccCChhcHHHHHHHHHHHHccCCCCcceEEEEEEeC------CeEEE
Q 002158 626 YFSSSTQVGQGGYGKVYKGILS-DNTTVAIKRAEEGSLQGQNEFLTEIKLLSRLHHRNLVSLLGYCDEE------GEQML 698 (958)
Q Consensus 626 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~------~~~~l 698 (958)
.|...+.||+|+||+||+|++. +++.||||++..... .+.+|++++++++||||+++++++... ...++
T Consensus 55 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~----~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~~l 130 (420)
T 1j1b_A 55 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNL 130 (420)
T ss_dssp EEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTT----SCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEEEE
T ss_pred eEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccch----hHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeEEe
Confidence 5777889999999999999986 689999999875422 234799999999999999999998542 23679
Q ss_pred EEEecCCCCHHHHhcc--CCCCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEecCC-CCeEEeeeeeecc
Q 002158 699 VYEFVPNGTLRDWLSG--RTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSN-LNAKVADFGLSRL 775 (958)
Q Consensus 699 V~E~~~~gsL~~~l~~--~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~-~~~kl~DFGla~~ 775 (958)
||||+++ ++.+.+.. .....+++..+..++.|+++||+|||+++ |+||||||+|||++.+ +.+||+|||+++.
T Consensus 131 v~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NILl~~~~~~~kl~DFG~a~~ 206 (420)
T 1j1b_A 131 VLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQ 206 (420)
T ss_dssp EEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCSGGGEEEETTTTEEEECCCTTCEE
T ss_pred ehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChhhEEEeCCCCeEEeccchhhhh
Confidence 9999975 77766643 22345999999999999999999999999 9999999999999965 5689999999986
Q ss_pred cccCCCCCCccceeeeeccCCCCccChhhhccC-CCCCcchhhhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcCcc-h
Q 002158 776 APVLDDEGTMPTHVSTIVKGTPGYLDPEYFLTH-KLTDKSDVYSLGVVLLELLTGMQPISHGKNIVREVNVARDSGMV-F 853 (958)
Q Consensus 776 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DV~S~Gv~l~elltG~~P~~~~~~~~~~~~~~~~~~~~-~ 853 (958)
..... ......||+.|+|||++.+. .++.++|||||||++|||++|+.||.+..............+.. .
T Consensus 207 ~~~~~--------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~l~~i~~~lg~p~~ 278 (420)
T 1j1b_A 207 LVRGE--------PNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTR 278 (420)
T ss_dssp CCTTC--------CCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCH
T ss_pred cccCC--------CceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCH
Confidence 53221 11235689999999999765 78999999999999999999999998665433332222111100 0
Q ss_pred h---hhccc-----CCC---------CChHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 002158 854 S---IIDNR-----MGS---------YPSECVERFVTLALRCCHDKPEHRPSMSDVVRE 895 (958)
Q Consensus 854 ~---~i~~~-----~~~---------~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 895 (958)
+ ..... .+. ++...+.++.+|+.+||+.||++||++.|++++
T Consensus 279 ~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~h 337 (420)
T 1j1b_A 279 EQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAH 337 (420)
T ss_dssp HHHHHHCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred HHHHhhChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCC
Confidence 0 00000 000 123456789999999999999999999999975
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-37 Score=343.44 Aligned_cols=256 Identities=23% Similarity=0.352 Sum_probs=201.6
Q ss_pred HHHHHcCCCCCceeeeeCCeEEEEEEECCCcEEEEEEeccC--ChhcHHHHHHHHHHHHccC--CCCcceEEEEEEeCCe
Q 002158 620 LAMATAYFSSSTQVGQGGYGKVYKGILSDNTTVAIKRAEEG--SLQGQNEFLTEIKLLSRLH--HRNLVSLLGYCDEEGE 695 (958)
Q Consensus 620 l~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~--H~niv~l~~~~~~~~~ 695 (958)
+....++|...+.||+|+||.||+|.+.+++.||||++... .....+.+.+|++++++++ |+||+++++++..++.
T Consensus 23 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~ 102 (313)
T 3cek_A 23 MSVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQY 102 (313)
T ss_dssp EEETTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECSSE
T ss_pred eeeccceEEEEEEecCCCCEEEEEEEcCCCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeecCCE
Confidence 33445678888999999999999999988999999998653 3344567999999999997 5999999999999999
Q ss_pred EEEEEEecCCCCHHHHhccCCCCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEecCCCCeEEeeeeeecc
Q 002158 696 QMLVYEFVPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSRL 775 (958)
Q Consensus 696 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~ 775 (958)
.++||| +.+++|.+++.... .+++.++..++.|+++||+|||+.+ |+||||||+||+++ ++.+||+|||+++.
T Consensus 103 ~~lv~e-~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~-~~~~kL~Dfg~~~~ 175 (313)
T 3cek_A 103 IYMVME-CGNIDLNSWLKKKK--SIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIV-DGMLKLIDFGIANQ 175 (313)
T ss_dssp EEEEEC-CCSEEHHHHHHHCS--SCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEE-TTEEEECCCSSSCC
T ss_pred EEEEEe-cCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcccEEEE-CCeEEEeecccccc
Confidence 999999 55889999997654 4899999999999999999999999 99999999999996 48999999999986
Q ss_pred cccCCCCCCccceeeeeccCCCCccChhhhcc-----------CCCCCcchhhhHHHHHHHHHhCCCCCCCCchhHHHHH
Q 002158 776 APVLDDEGTMPTHVSTIVKGTPGYLDPEYFLT-----------HKLTDKSDVYSLGVVLLELLTGMQPISHGKNIVREVN 844 (958)
Q Consensus 776 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----------~~~~~~~DV~S~Gv~l~elltG~~P~~~~~~~~~~~~ 844 (958)
...... ........||+.|+|||++.+ ..++.++||||||+++|||++|+.||...........
T Consensus 176 ~~~~~~-----~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~ 250 (313)
T 3cek_A 176 MQPDTT-----SVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLH 250 (313)
T ss_dssp -------------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHH
T ss_pred ccCccc-----cccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHHHHHHH
Confidence 532211 111234569999999999875 4678899999999999999999999976543322222
Q ss_pred HHhhcCcchhhhcccCCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 002158 845 VARDSGMVFSIIDNRMGSYPSECVERFVTLALRCCHDKPEHRPSMSDVVRE 895 (958)
Q Consensus 845 ~~~~~~~~~~~i~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 895 (958)
...... .....+...+..+.+++.+||+.||++||+++|++++
T Consensus 251 ~~~~~~--------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h 293 (313)
T 3cek_A 251 AIIDPN--------HEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAH 293 (313)
T ss_dssp HHHCTT--------SCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred HHHhcc--------cccCCcccchHHHHHHHHHHccCCcccCcCHHHHhcC
Confidence 211111 1122334446789999999999999999999999975
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-38 Score=356.66 Aligned_cols=253 Identities=10% Similarity=0.007 Sum_probs=182.7
Q ss_pred cCCCCCceeeeeCCeEEEEEEEC-CCcEEEEEEeccCCh---hcHHHHHHHHHHHHcc--CCCCcceEE-------EEEE
Q 002158 625 AYFSSSTQVGQGGYGKVYKGILS-DNTTVAIKRAEEGSL---QGQNEFLTEIKLLSRL--HHRNLVSLL-------GYCD 691 (958)
Q Consensus 625 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l--~H~niv~l~-------~~~~ 691 (958)
..|...+.||+|+||+||+|.+. +++.||||++..... ...+.+.+|+++++.+ +||||++++ +++.
T Consensus 62 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~~ 141 (371)
T 3q60_A 62 RKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVA 141 (371)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEEE
T ss_pred eeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehhee
Confidence 34777889999999999999986 789999999987543 2345677885544444 699988755 5554
Q ss_pred eC-----------------CeEEEEEEecCCCCHHHHhccCCCCCchHHHH------HHHHHHHHHHHHHhhhcCCCCee
Q 002158 692 EE-----------------GEQMLVYEFVPNGTLRDWLSGRTKENLNFAMR------LRVALDSAKGILYLHTEAHPPVF 748 (958)
Q Consensus 692 ~~-----------------~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~------~~i~~~ia~aL~yLH~~~~~~ii 748 (958)
.. ...++||||++ |+|.+++..... .+.+..+ ..++.|+++||+|||+++ |+
T Consensus 142 ~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~-~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~---iv 216 (371)
T 3q60_A 142 VQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDF-VYVFRGDEGILALHILTAQLIRLAANLQSKG---LV 216 (371)
T ss_dssp ETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHH-SCCCCHHHHHHHHHHHHHHHHHHHHHHHHTT---EE
T ss_pred cCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhcc-ccchhhhhhhhhHHHHHHHHHHHHHHHHHCC---Cc
Confidence 33 23799999998 899999976422 2455555 788899999999999999 99
Q ss_pred ccCCCccceEecCCCCeEEeeeeeecccccCCCCCCccceeeeeccCCCCccChhhhcc--CCCCCcchhhhHHHHHHHH
Q 002158 749 HRDIKASNILLDSNLNAKVADFGLSRLAPVLDDEGTMPTHVSTIVKGTPGYLDPEYFLT--HKLTDKSDVYSLGVVLLEL 826 (958)
Q Consensus 749 H~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DV~S~Gv~l~el 826 (958)
||||||+|||++.++.+||+|||+++... .......||+.|+|||++.+ ..++.++|||||||++|||
T Consensus 217 HrDikp~NIll~~~~~~kL~DFG~a~~~~----------~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~el 286 (371)
T 3q60_A 217 HGHFTPDNLFIMPDGRLMLGDVSALWKVG----------TRGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRV 286 (371)
T ss_dssp ETTCSGGGEEECTTSCEEECCGGGEEETT----------CEEEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHH
T ss_pred cCcCCHHHEEECCCCCEEEEecceeeecC----------CCccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHH
Confidence 99999999999999999999999998542 11224557799999999987 6789999999999999999
Q ss_pred HhCCCCCCCCchhHHHHHHHhhcCcchhhhcccC-CCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 002158 827 LTGMQPISHGKNIVREVNVARDSGMVFSIIDNRM-GSYPSECVERFVTLALRCCHDKPEHRPSMSDVVRE 895 (958)
Q Consensus 827 ltG~~P~~~~~~~~~~~~~~~~~~~~~~~i~~~~-~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 895 (958)
++|+.||......... ............... ......++..+.+++.+||+.||++||++.|++++
T Consensus 287 ltg~~Pf~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 353 (371)
T 3q60_A 287 WCLFLPFGLVTPGIKG---SWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAMET 353 (371)
T ss_dssp HHSSCSTTBCCTTCTT---CCCBCCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTTS
T ss_pred HhCCCCCCCcCccccc---chhhhhhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 9999999754321000 000000000000000 11123567889999999999999999999999863
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-37 Score=348.16 Aligned_cols=264 Identities=23% Similarity=0.285 Sum_probs=201.8
Q ss_pred cCCCCCceeeeeCCeEEEEEEEC-CCcEEEEEEeccCC-hhcHHHHHHHHHHHHccCCCCcceEEEEEEeC-----CeEE
Q 002158 625 AYFSSSTQVGQGGYGKVYKGILS-DNTTVAIKRAEEGS-LQGQNEFLTEIKLLSRLHHRNLVSLLGYCDEE-----GEQM 697 (958)
Q Consensus 625 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~-----~~~~ 697 (958)
++|...+.||+|+||+||+|.+. +|+.||||++.... .....++.+|++++++++||||+++++++... ...+
T Consensus 11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 90 (353)
T 2b9h_A 11 SDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNEVY 90 (353)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCCEE
T ss_pred cceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccceEE
Confidence 57888899999999999999986 68999999997543 33456788999999999999999999998764 6789
Q ss_pred EEEEecCCCCHHHHhccCCCCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEecCCCCeEEeeeeeecccc
Q 002158 698 LVYEFVPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSRLAP 777 (958)
Q Consensus 698 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~~~ 777 (958)
+||||++ ++|.+++... .+++..+..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+++...
T Consensus 91 lv~e~~~-~~L~~~~~~~---~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~ 163 (353)
T 2b9h_A 91 IIQELMQ-TDLHRVISTQ---MLSDDHIQYFIYQTLRAVKVLHGSN---VIHRDLKPSNLLINSNCDLKVCDFGLARIID 163 (353)
T ss_dssp EEECCCS-EEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred EEEeccC-ccHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEEcCCCcEEEEecccccccc
Confidence 9999996 6999999753 4899999999999999999999999 9999999999999999999999999998664
Q ss_pred cCCCCCCc---cceeeeeccCCCCccChhhhcc-CCCCCcchhhhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcCcc-
Q 002158 778 VLDDEGTM---PTHVSTIVKGTPGYLDPEYFLT-HKLTDKSDVYSLGVVLLELLTGMQPISHGKNIVREVNVARDSGMV- 852 (958)
Q Consensus 778 ~~~~~~~~---~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DV~S~Gv~l~elltG~~P~~~~~~~~~~~~~~~~~~~~- 852 (958)
........ .........||+.|+|||++.+ ..++.++|||||||++|||++|+.||................+..
T Consensus 164 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~ 243 (353)
T 2b9h_A 164 ESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTPH 243 (353)
T ss_dssp ----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCC
T ss_pred cccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCc
Confidence 32211110 0111233568999999998765 678899999999999999999999997654332221111100000
Q ss_pred -------------hhhhccc--CC-----CCChHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 002158 853 -------------FSIIDNR--MG-----SYPSECVERFVTLALRCCHDKPEHRPSMSDVVRE 895 (958)
Q Consensus 853 -------------~~~i~~~--~~-----~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 895 (958)
.+.+... .. .....++..+.+++.+||+.||++||+++|++++
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 306 (353)
T 2b9h_A 244 SDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEH 306 (353)
T ss_dssp STTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred hhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence 0000000 00 0112456788999999999999999999999974
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-37 Score=344.86 Aligned_cols=256 Identities=21% Similarity=0.303 Sum_probs=203.5
Q ss_pred cCCCCCceeeeeCCeEEEEEEEC-CC-cEEEEEEeccCChhcHHHHHHHHHHHHccCCCC------cceEEEEEEeCCeE
Q 002158 625 AYFSSSTQVGQGGYGKVYKGILS-DN-TTVAIKRAEEGSLQGQNEFLTEIKLLSRLHHRN------LVSLLGYCDEEGEQ 696 (958)
Q Consensus 625 ~~~~~~~~lg~G~~g~Vy~~~~~-~~-~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~n------iv~l~~~~~~~~~~ 696 (958)
++|...+.||+|+||+||+|.+. ++ +.||||+++.. ....+.+.+|++++++++|++ ++.+++++...+..
T Consensus 19 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~ 97 (355)
T 2eu9_A 19 ERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNV-GKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHGHM 97 (355)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEETTEE
T ss_pred ccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEccc-ccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeCCeE
Confidence 57888899999999999999975 34 68999999753 344567889999999997665 99999999999999
Q ss_pred EEEEEecCCCCHHHHhccCCCCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEe-----------------
Q 002158 697 MLVYEFVPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILL----------------- 759 (958)
Q Consensus 697 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl----------------- 759 (958)
++||||+ ++++.+++.......+++.++..++.|++.||+|||+++ |+||||||+|||+
T Consensus 98 ~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~~~~~~~~~ 173 (355)
T 2eu9_A 98 CIAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQ---LTHTDLKPENILFVNSEFETLYNEHKSCEE 173 (355)
T ss_dssp EEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEESCCCEEEEECCC-CCCE
T ss_pred EEEEecc-CCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEecccccccccccccccc
Confidence 9999999 678888887665556999999999999999999999999 9999999999999
Q ss_pred --cCCCCeEEeeeeeecccccCCCCCCccceeeeeccCCCCccChhhhccCCCCCcchhhhHHHHHHHHHhCCCCCCCCc
Q 002158 760 --DSNLNAKVADFGLSRLAPVLDDEGTMPTHVSTIVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVLLELLTGMQPISHGK 837 (958)
Q Consensus 760 --~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gv~l~elltG~~P~~~~~ 837 (958)
+.++.+||+|||+++.... ......||+.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus 174 ~~~~~~~~kl~Dfg~~~~~~~----------~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~ 243 (355)
T 2eu9_A 174 KSVKNTSIRVADFGSATFDHE----------HHTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHE 243 (355)
T ss_dssp EEESCCCEEECCCTTCEETTS----------CCCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred cccCCCcEEEeecCccccccc----------cccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCCC
Confidence 5688999999999975321 1123569999999999999999999999999999999999999997654
Q ss_pred hhHHHHHHHhhcCcchh-hh--------------------------c------ccCCCCChHHHHHHHHHHHHccccCCC
Q 002158 838 NIVREVNVARDSGMVFS-II--------------------------D------NRMGSYPSECVERFVTLALRCCHDKPE 884 (958)
Q Consensus 838 ~~~~~~~~~~~~~~~~~-~i--------------------------~------~~~~~~~~~~~~~l~~li~~cl~~dP~ 884 (958)
............+.... .. . ..........+..+.+++.+||+.||+
T Consensus 244 ~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~ 323 (355)
T 2eu9_A 244 NREHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPA 323 (355)
T ss_dssp HHHHHHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTT
T ss_pred HHHHHHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCChh
Confidence 33222111111010000 00 0 000112335567899999999999999
Q ss_pred CCCCHHHHHHH
Q 002158 885 HRPSMSDVVRE 895 (958)
Q Consensus 885 ~RPs~~evl~~ 895 (958)
+|||++|++++
T Consensus 324 ~Rpt~~e~l~h 334 (355)
T 2eu9_A 324 QRITLAEALLH 334 (355)
T ss_dssp TSCCHHHHTTS
T ss_pred hCcCHHHHhcC
Confidence 99999999863
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-37 Score=348.29 Aligned_cols=265 Identities=23% Similarity=0.292 Sum_probs=193.3
Q ss_pred HHHHHHHcCCCCCceeeeeCCeEEEEEEEC-CCcEEEEEEeccCChhcHHHHHHHHHHHHccCCCCcceEEEEEEeCCe-
Q 002158 618 KELAMATAYFSSSTQVGQGGYGKVYKGILS-DNTTVAIKRAEEGSLQGQNEFLTEIKLLSRLHHRNLVSLLGYCDEEGE- 695 (958)
Q Consensus 618 ~el~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~- 695 (958)
.+.....++|...+.||+|+||+||+|.+. +++.||||++.... ....++.+|++.++.++||||+++++++...+.
T Consensus 16 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~ 94 (360)
T 3e3p_A 16 ERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDP-RFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGER 94 (360)
T ss_dssp HHHHHHHTTEEEC----------CEEEEETTTCCEEEEEEEECCT-TCCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSS
T ss_pred hhchhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCc-cccHHHHHHHHHHHhcCCCCcccHHHhhhccccc
Confidence 445567789999999999999999999986 68999999986542 223456788899999999999999999966443
Q ss_pred ------EEEEEEecCCCCHHHHhcc--CCCCCchHHHHHHHHHHHHHHHHHhh--hcCCCCeeccCCCccceEecC-CCC
Q 002158 696 ------QMLVYEFVPNGTLRDWLSG--RTKENLNFAMRLRVALDSAKGILYLH--TEAHPPVFHRDIKASNILLDS-NLN 764 (958)
Q Consensus 696 ------~~lV~E~~~~gsL~~~l~~--~~~~~l~~~~~~~i~~~ia~aL~yLH--~~~~~~iiH~Dikp~NILl~~-~~~ 764 (958)
.++||||+++ +|.+.+.. .....+++..+..++.|++.||.||| +.+ |+||||||+|||++. ++.
T Consensus 95 ~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~---ivH~Dlkp~NIll~~~~~~ 170 (360)
T 3e3p_A 95 DRRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVN---VCHRDIKPHNVLVNEADGT 170 (360)
T ss_dssp CTTCEEEEEEEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTC---CBCSCCCGGGEEEETTTTE
T ss_pred cccceeEEEEeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCC---eecCcCCHHHEEEeCCCCc
Confidence 7899999975 55554432 23345889999999999999999999 888 999999999999997 899
Q ss_pred eEEeeeeeecccccCCCCCCccceeeeeccCCCCccChhhhccCC-CCCcchhhhHHHHHHHHHhCCCCCCCCchhHHHH
Q 002158 765 AKVADFGLSRLAPVLDDEGTMPTHVSTIVKGTPGYLDPEYFLTHK-LTDKSDVYSLGVVLLELLTGMQPISHGKNIVREV 843 (958)
Q Consensus 765 ~kl~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DV~S~Gv~l~elltG~~P~~~~~~~~~~~ 843 (958)
+||+|||+++...... ......||+.|+|||++.+.. ++.++|||||||++|||++|+.||..........
T Consensus 171 ~kl~Dfg~a~~~~~~~--------~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~ 242 (360)
T 3e3p_A 171 LKLCDFGSAKKLSPSE--------PNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLH 242 (360)
T ss_dssp EEECCCTTCBCCCTTS--------CCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH
T ss_pred EEEeeCCCceecCCCC--------CcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHHH
Confidence 9999999998653221 123456899999999997654 8999999999999999999999998655432222
Q ss_pred HHHhhcCcc----hhhh-----------------cccCCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 002158 844 NVARDSGMV----FSII-----------------DNRMGSYPSECVERFVTLALRCCHDKPEHRPSMSDVVRE 895 (958)
Q Consensus 844 ~~~~~~~~~----~~~i-----------------~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 895 (958)
......+.. ...+ .......+...+..+.+++.+||+.||++|||+.|++++
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 315 (360)
T 3e3p_A 243 EIVRVLGCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCH 315 (360)
T ss_dssp HHHHHHCCCCHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred HHHHHcCCCCHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcC
Confidence 211110000 0000 000112223357889999999999999999999999974
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-37 Score=350.54 Aligned_cols=256 Identities=20% Similarity=0.268 Sum_probs=202.2
Q ss_pred cCCCCCceeeeeCCeEEEEEEEC-CCcEEEEEEeccCChhcHHHHHHHHHHHHccC-----------CCCcceEEEEEEe
Q 002158 625 AYFSSSTQVGQGGYGKVYKGILS-DNTTVAIKRAEEGSLQGQNEFLTEIKLLSRLH-----------HRNLVSLLGYCDE 692 (958)
Q Consensus 625 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----------H~niv~l~~~~~~ 692 (958)
.+|...+.||+|+||+||+|.+. +++.||||++... ....+.+.+|++++++++ |+||+++++++..
T Consensus 19 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~~ 97 (373)
T 1q8y_A 19 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD-KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNH 97 (373)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEE
T ss_pred CeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCC-ccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhhc
Confidence 46788899999999999999975 7899999999753 334567889999999886 8999999999876
Q ss_pred CC----eEEEEEEecCCCCHHHHhccCCCCCchHHHHHHHHHHHHHHHHHhhhc-CCCCeeccCCCccceEec------C
Q 002158 693 EG----EQMLVYEFVPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTE-AHPPVFHRDIKASNILLD------S 761 (958)
Q Consensus 693 ~~----~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~-~~~~iiH~Dikp~NILl~------~ 761 (958)
.+ ..++||||+ +++|.+++.......+++..+..++.|++.||+|||++ + |+||||||+|||++ .
T Consensus 98 ~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~~---ivH~Dikp~NIll~~~~~~~~ 173 (373)
T 1q8y_A 98 KGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCG---IIHTDIKPENVLMEIVDSPEN 173 (373)
T ss_dssp EETTEEEEEEEECCC-CEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECSCCSGGGEEEEEEETTTT
T ss_pred cCCCCceEEEEEecC-CCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHhcCC---EEecCCChHHeEEeccCCCcC
Confidence 54 789999999 89999999876556699999999999999999999998 8 99999999999994 3
Q ss_pred CCCeEEeeeeeecccccCCCCCCccceeeeeccCCCCccChhhhccCCCCCcchhhhHHHHHHHHHhCCCCCCCCch---
Q 002158 762 NLNAKVADFGLSRLAPVLDDEGTMPTHVSTIVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVLLELLTGMQPISHGKN--- 838 (958)
Q Consensus 762 ~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gv~l~elltG~~P~~~~~~--- 838 (958)
.+.+||+|||+++..... .....||+.|+|||++.+..++.++|||||||++|||++|+.||.....
T Consensus 174 ~~~~kl~Dfg~a~~~~~~----------~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~ 243 (373)
T 1q8y_A 174 LIQIKIADLGNACWYDEH----------YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSY 243 (373)
T ss_dssp EEEEEECCCTTCEETTBC----------CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC--------
T ss_pred cceEEEcccccccccCCC----------CCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCccccc
Confidence 447999999999865321 1234689999999999999999999999999999999999999975321
Q ss_pred ---hHHHHHHHhhcCcch-------------------------------hhhcccCCCCChHHHHHHHHHHHHccccCCC
Q 002158 839 ---IVREVNVARDSGMVF-------------------------------SIIDNRMGSYPSECVERFVTLALRCCHDKPE 884 (958)
Q Consensus 839 ---~~~~~~~~~~~~~~~-------------------------------~~i~~~~~~~~~~~~~~l~~li~~cl~~dP~ 884 (958)
...........+... ..+......++...+..+.+++.+||+.||+
T Consensus 244 ~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~ 323 (373)
T 1q8y_A 244 TKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPR 323 (373)
T ss_dssp -CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTT
T ss_pred CChHHHHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCcc
Confidence 001000000000000 0000111235678889999999999999999
Q ss_pred CCCCHHHHHHH
Q 002158 885 HRPSMSDVVRE 895 (958)
Q Consensus 885 ~RPs~~evl~~ 895 (958)
+|||++|++++
T Consensus 324 ~Rpt~~ell~h 334 (373)
T 1q8y_A 324 KRADAGGLVNH 334 (373)
T ss_dssp TCBCHHHHHTC
T ss_pred ccCCHHHHhhC
Confidence 99999999874
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-37 Score=353.70 Aligned_cols=256 Identities=21% Similarity=0.342 Sum_probs=195.0
Q ss_pred cCCCCCceeeeeCCeEEEEEEECCCcEEEEEEeccCChhcHHHHHHHHHHHHccCCCCcceEEEEEEeCC------eEEE
Q 002158 625 AYFSSSTQVGQGGYGKVYKGILSDNTTVAIKRAEEGSLQGQNEFLTEIKLLSRLHHRNLVSLLGYCDEEG------EQML 698 (958)
Q Consensus 625 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~------~~~l 698 (958)
.+|...+.||+|+||+||+|.+..+..||+|++...... ..+|+++++.++||||+++++++...+ ..++
T Consensus 40 ~~Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~~~----~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~l 115 (394)
T 4e7w_A 40 IAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKRF----KNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNL 115 (394)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCTTS----CCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEEE
T ss_pred ceEEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCcch----HHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEEEE
Confidence 357778999999999999999987777999988654322 237999999999999999999986543 3789
Q ss_pred EEEecCCCCHHHHhc-cCCCCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEec-CCCCeEEeeeeeeccc
Q 002158 699 VYEFVPNGTLRDWLS-GRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLD-SNLNAKVADFGLSRLA 776 (958)
Q Consensus 699 V~E~~~~gsL~~~l~-~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~-~~~~~kl~DFGla~~~ 776 (958)
||||++++.+..... ......+++..+..++.|+++||+|||+.+ |+||||||+|||++ .++.+||+|||+++..
T Consensus 116 v~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~~kL~DFG~a~~~ 192 (394)
T 4e7w_A 116 VLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIG---ICHRDIKPQNLLLDPPSGVLKLIDFGSAKIL 192 (394)
T ss_dssp EEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCCTTCEEC
T ss_pred EeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCCHHHEEEcCCCCcEEEeeCCCcccc
Confidence 999997644333322 112345899999999999999999999999 99999999999999 7999999999999865
Q ss_pred ccCCCCCCccceeeeeccCCCCccChhhhccC-CCCCcchhhhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcCcc--h
Q 002158 777 PVLDDEGTMPTHVSTIVKGTPGYLDPEYFLTH-KLTDKSDVYSLGVVLLELLTGMQPISHGKNIVREVNVARDSGMV--F 853 (958)
Q Consensus 777 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DV~S~Gv~l~elltG~~P~~~~~~~~~~~~~~~~~~~~--~ 853 (958)
.... ......||+.|+|||++.+. .++.++||||+||++|||++|+.||.+..............+.. .
T Consensus 193 ~~~~--------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~ 264 (394)
T 4e7w_A 193 IAGE--------PNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSRE 264 (394)
T ss_dssp CTTC--------CCCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHH
T ss_pred cCCC--------CCcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHH
Confidence 3221 12235689999999999765 58999999999999999999999998765433332222111100 0
Q ss_pred -------hhhcccCC---------CCChHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 002158 854 -------SIIDNRMG---------SYPSECVERFVTLALRCCHDKPEHRPSMSDVVRE 895 (958)
Q Consensus 854 -------~~i~~~~~---------~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 895 (958)
.......+ .++...+.++.+++.+||+.||.+||++.|++++
T Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 322 (394)
T 4e7w_A 265 QIKTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCH 322 (394)
T ss_dssp HHHHHCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred HHHhhChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcC
Confidence 00000000 1122356789999999999999999999999975
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-37 Score=346.19 Aligned_cols=253 Identities=23% Similarity=0.322 Sum_probs=198.8
Q ss_pred cCCCCCceeeeeCCeEEEEEEEC-CCcEEEEEEeccCC--hhcHHHHHHHHHHHHccCCCCcceEEEEEEeCCe------
Q 002158 625 AYFSSSTQVGQGGYGKVYKGILS-DNTTVAIKRAEEGS--LQGQNEFLTEIKLLSRLHHRNLVSLLGYCDEEGE------ 695 (958)
Q Consensus 625 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~------ 695 (958)
.+|...+.||+|+||.||+|.+. +|+.||||++.... ....+++.+|+.++++++||||+++++++...+.
T Consensus 24 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 103 (353)
T 3coi_A 24 KTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYD 103 (353)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCC
T ss_pred ceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEeccccccccee
Confidence 46777889999999999999986 68999999997642 3335678999999999999999999999987654
Q ss_pred EEEEEEecCCCCHHHHhccCCCCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEecCCCCeEEeeeeeecc
Q 002158 696 QMLVYEFVPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSRL 775 (958)
Q Consensus 696 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~ 775 (958)
.++||||++ ++|.+++.. .+++.++..++.|++.||+|||+++ |+||||||+||+++.++.+||+|||+++.
T Consensus 104 ~~lv~e~~~-~~l~~~~~~----~~~~~~~~~i~~qi~~al~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~ 175 (353)
T 3coi_A 104 FYLVMPFMQ-TDLQKIMGL----KFSEEKIQYLVYQMLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGLARH 175 (353)
T ss_dssp CEEEEECCS-EEGGGTTTS----CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECTTCCEEECSTTCTTC
T ss_pred EEEEecccc-CCHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEeECCCCcEEEeecccccC
Confidence 499999996 688888742 3899999999999999999999999 99999999999999999999999999875
Q ss_pred cccCCCCCCccceeeeeccCCCCccChhhhcc-CCCCCcchhhhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcCcch-
Q 002158 776 APVLDDEGTMPTHVSTIVKGTPGYLDPEYFLT-HKLTDKSDVYSLGVVLLELLTGMQPISHGKNIVREVNVARDSGMVF- 853 (958)
Q Consensus 776 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DV~S~Gv~l~elltG~~P~~~~~~~~~~~~~~~~~~~~~- 853 (958)
... ......||+.|+|||++.+ ..++.++||||||+++|||++|+.||................+...
T Consensus 176 ~~~----------~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~ 245 (353)
T 3coi_A 176 ADA----------EMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGT 245 (353)
T ss_dssp ------------------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHHHHHHHHCBCCH
T ss_pred CCC----------CccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCH
Confidence 421 1223568999999999987 6789999999999999999999999976543322211111100000
Q ss_pred ---------------hhh----cccCCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 002158 854 ---------------SII----DNRMGSYPSECVERFVTLALRCCHDKPEHRPSMSDVVRE 895 (958)
Q Consensus 854 ---------------~~i----~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 895 (958)
..+ ...........+..+.+++.+||+.||++||+++|++++
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h 306 (353)
T 3coi_A 246 EFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTH 306 (353)
T ss_dssp HHHTTCSCHHHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred HHHHHHhhHHHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 000 011122234567889999999999999999999999874
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-37 Score=352.24 Aligned_cols=259 Identities=25% Similarity=0.323 Sum_probs=182.2
Q ss_pred CCC-CceeeeeCCeEEEEEEEC---CCcEEEEEEeccCChhcHHHHHHHHHHHHccCCCCcceEEEEEEe--CCeEEEEE
Q 002158 627 FSS-STQVGQGGYGKVYKGILS---DNTTVAIKRAEEGSLQGQNEFLTEIKLLSRLHHRNLVSLLGYCDE--EGEQMLVY 700 (958)
Q Consensus 627 ~~~-~~~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~--~~~~~lV~ 700 (958)
|.. .++||+|+||+||+|.++ +++.||||++..... ...+.+|++++++++||||+++++++.. ....++||
T Consensus 22 y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~lv~ 99 (405)
T 3rgf_A 22 FEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGI--SMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLF 99 (405)
T ss_dssp EECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSSC--CHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEEEEE
T ss_pred hhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCC--CHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEEEEE
Confidence 443 458999999999999975 578999999975432 3468899999999999999999999954 67899999
Q ss_pred EecCCCCHHHHhccC-------CCCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEe----cCCCCeEEee
Q 002158 701 EFVPNGTLRDWLSGR-------TKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILL----DSNLNAKVAD 769 (958)
Q Consensus 701 E~~~~gsL~~~l~~~-------~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl----~~~~~~kl~D 769 (958)
||++ ++|.+++... ....+++..+..++.|++.||+|||+.+ |+||||||+|||+ +.++.+||+|
T Consensus 100 e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kl~D 175 (405)
T 3rgf_A 100 DYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIAD 175 (405)
T ss_dssp ECCS-EEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECCSSTTTTCEEECC
T ss_pred eCCC-CCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---EeCCCcCHHHeEEecCCCCCCcEEEEE
Confidence 9995 6888887532 1224899999999999999999999999 9999999999999 7789999999
Q ss_pred eeeecccccCCCCCCccceeeeeccCCCCccChhhhccC-CCCCcchhhhHHHHHHHHHhCCCCCCCCchh---------
Q 002158 770 FGLSRLAPVLDDEGTMPTHVSTIVKGTPGYLDPEYFLTH-KLTDKSDVYSLGVVLLELLTGMQPISHGKNI--------- 839 (958)
Q Consensus 770 FGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DV~S~Gv~l~elltG~~P~~~~~~~--------- 839 (958)
||+++....... .........||+.|+|||++.+. .++.++|||||||++|||++|+.||......
T Consensus 176 fg~a~~~~~~~~----~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~ 251 (405)
T 3rgf_A 176 MGFARLFNSPLK----PLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHH 251 (405)
T ss_dssp TTCCC--------------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCCCH
T ss_pred CCCceecCCCCc----ccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccchH
Confidence 999986532111 11223346799999999999874 5889999999999999999999999643321
Q ss_pred HHHHHHHhhcCcc----hhhhc--------------ccCCC---------CChHHHHHHHHHHHHccccCCCCCCCHHHH
Q 002158 840 VREVNVARDSGMV----FSIID--------------NRMGS---------YPSECVERFVTLALRCCHDKPEHRPSMSDV 892 (958)
Q Consensus 840 ~~~~~~~~~~~~~----~~~i~--------------~~~~~---------~~~~~~~~l~~li~~cl~~dP~~RPs~~ev 892 (958)
..........+.. ...+. ..... .....+..+.+|+.+||+.||.+|||++|+
T Consensus 252 ~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~e~ 331 (405)
T 3rgf_A 252 DQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQA 331 (405)
T ss_dssp HHHHHHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCHHHH
T ss_pred HHHHHHHHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCHHHH
Confidence 0000000000000 00000 00000 000114568899999999999999999999
Q ss_pred HHH
Q 002158 893 VRE 895 (958)
Q Consensus 893 l~~ 895 (958)
+++
T Consensus 332 L~h 334 (405)
T 3rgf_A 332 MQD 334 (405)
T ss_dssp HTS
T ss_pred hcC
Confidence 985
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-37 Score=342.27 Aligned_cols=246 Identities=28% Similarity=0.417 Sum_probs=194.9
Q ss_pred HHHHHHcCCCCCceeeeeCCeEEEEEEEC-CCcEEEEEEeccCChh------cHHHHHHHHHHHHcc----CCCCcceEE
Q 002158 619 ELAMATAYFSSSTQVGQGGYGKVYKGILS-DNTTVAIKRAEEGSLQ------GQNEFLTEIKLLSRL----HHRNLVSLL 687 (958)
Q Consensus 619 el~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~------~~~~~~~E~~~l~~l----~H~niv~l~ 687 (958)
+.....++|...+.||+|+||.||+|.+. +++.||||++...... ....+.+|+.+++++ +|+||++++
T Consensus 25 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~ 104 (312)
T 2iwi_A 25 DREAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLL 104 (312)
T ss_dssp --------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEE
T ss_pred chhhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEE
Confidence 34455678999999999999999999875 6889999999764322 223466799999998 899999999
Q ss_pred EEEEeCCeEEEEEEe-cCCCCHHHHhccCCCCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEec-CCCCe
Q 002158 688 GYCDEEGEQMLVYEF-VPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLD-SNLNA 765 (958)
Q Consensus 688 ~~~~~~~~~~lV~E~-~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~-~~~~~ 765 (958)
+++...+..++|||| +++++|.+++.... .+++..+..++.|+++||+|||+.+ |+||||||+||+++ .++.+
T Consensus 105 ~~~~~~~~~~~v~e~~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~ 179 (312)
T 2iwi_A 105 DWFETQEGFMLVLERPLPAQDLFDYITEKG--PLGEGPSRCFFGQVVAAIQHCHSRG---VVHRDIKDENILIDLRRGCA 179 (312)
T ss_dssp EEC-----CEEEEECCSSEEEHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHHT---EECCCCSGGGEEEETTTTEE
T ss_pred EEEecCCeEEEEEEecCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChhhEEEeCCCCeE
Confidence 999999999999999 78999999997643 4899999999999999999999999 99999999999999 88999
Q ss_pred EEeeeeeecccccCCCCCCccceeeeeccCCCCccChhhhccCCCC-CcchhhhHHHHHHHHHhCCCCCCCCchhHHHHH
Q 002158 766 KVADFGLSRLAPVLDDEGTMPTHVSTIVKGTPGYLDPEYFLTHKLT-DKSDVYSLGVVLLELLTGMQPISHGKNIVREVN 844 (958)
Q Consensus 766 kl~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DV~S~Gv~l~elltG~~P~~~~~~~~~~~~ 844 (958)
||+|||+++..... ......||..|+|||++.+..+. .++||||||+++|||++|+.||.......
T Consensus 180 kl~dfg~~~~~~~~---------~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~---- 246 (312)
T 2iwi_A 180 KLIDFGSGALLHDE---------PYTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQEIL---- 246 (312)
T ss_dssp EECCCSSCEECCSS---------CBCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHHHH----
T ss_pred EEEEcchhhhcccC---------cccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChHHHh----
Confidence 99999999865321 12235699999999999877765 48999999999999999999996422110
Q ss_pred HHhhcCcchhhhcccCCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 002158 845 VARDSGMVFSIIDNRMGSYPSECVERFVTLALRCCHDKPEHRPSMSDVVRE 895 (958)
Q Consensus 845 ~~~~~~~~~~~i~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 895 (958)
......+..++..+.+++.+||+.||++||+++|++++
T Consensus 247 -------------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~ 284 (312)
T 2iwi_A 247 -------------EAELHFPAHVSPDCCALIRRCLAPKPSSRPSLEEILLD 284 (312)
T ss_dssp -------------HTCCCCCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHHS
T ss_pred -------------hhccCCcccCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 01112344566789999999999999999999999974
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-37 Score=334.12 Aligned_cols=253 Identities=24% Similarity=0.340 Sum_probs=204.2
Q ss_pred HHHcCCCCCceeeeeCCeEEEEEEEC-CCcEEEEEEeccC--ChhcHHHHHHHHHHHHccCCCCcceEEEEEEeCCeEEE
Q 002158 622 MATAYFSSSTQVGQGGYGKVYKGILS-DNTTVAIKRAEEG--SLQGQNEFLTEIKLLSRLHHRNLVSLLGYCDEEGEQML 698 (958)
Q Consensus 622 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~l 698 (958)
...++|...+.||+|+||+||+|... +++.||||++... .....+.+.+|++++++++||||+++++++...+..++
T Consensus 19 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 98 (287)
T 2wei_A 19 TFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYI 98 (287)
T ss_dssp HHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred HHhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEEE
Confidence 34567889999999999999999986 6899999998653 23346789999999999999999999999999999999
Q ss_pred EEEecCCCCHHHHhccCCCCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEecCC---CCeEEeeeeeecc
Q 002158 699 VYEFVPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSN---LNAKVADFGLSRL 775 (958)
Q Consensus 699 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~---~~~kl~DFGla~~ 775 (958)
||||+++++|.+++.... .+++.++..++.|++.||+|||+.+ |+||||||+||+++.+ +.+||+|||+++.
T Consensus 99 v~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~ 173 (287)
T 2wei_A 99 VGELYTGGELFDEIIKRK--RFSEHDAARIIKQVFSGITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLSTC 173 (287)
T ss_dssp EECCCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEEECSTTGGGT
T ss_pred EEEccCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCChhhEEEecCCCcccEEEeccCccee
Confidence 999999999999986543 4899999999999999999999999 9999999999999764 4699999999976
Q ss_pred cccCCCCCCccceeeeeccCCCCccChhhhccCCCCCcchhhhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcCcchhh
Q 002158 776 APVLDDEGTMPTHVSTIVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVLLELLTGMQPISHGKNIVREVNVARDSGMVFSI 855 (958)
Q Consensus 776 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gv~l~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~ 855 (958)
..... ......||+.|+|||.+.+ .++.++||||||+++|||++|+.||....... .............
T Consensus 174 ~~~~~--------~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~-~~~~~~~~~~~~~- 242 (287)
T 2wei_A 174 FQQNT--------KMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYD-ILKRVETGKYAFD- 242 (287)
T ss_dssp BCCCS--------SCSCHHHHHTTCCHHHHTT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHHHHHCCCCCC-
T ss_pred ecCCC--------ccccccCcccccChHHhcC-CCCCchhhHhHHHHHHHHHhCCCCCCCCCHHH-HHHHHHcCCCCCC-
Confidence 53211 1123458889999999865 48999999999999999999999997644322 1111111110000
Q ss_pred hcccCCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 002158 856 IDNRMGSYPSECVERFVTLALRCCHDKPEHRPSMSDVVRE 895 (958)
Q Consensus 856 i~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 895 (958)
......++..+.+++.+||+.||++||+++|++++
T Consensus 243 -----~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h 277 (287)
T 2wei_A 243 -----LPQWRTISDDAKDLIRKMLTFHPSLRITATQCLEH 277 (287)
T ss_dssp -----SGGGTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred -----chhhhhcCHHHHHHHHHHcccChhhCcCHHHHhcC
Confidence 00012346788999999999999999999999984
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-37 Score=341.88 Aligned_cols=250 Identities=24% Similarity=0.381 Sum_probs=181.3
Q ss_pred cCCCCCceeeeeCCeEEEEEEEC-CCcEEEEEEeccCC-hhcHHHHHHHHH-HHHccCCCCcceEEEEEEeCCeEEEEEE
Q 002158 625 AYFSSSTQVGQGGYGKVYKGILS-DNTTVAIKRAEEGS-LQGQNEFLTEIK-LLSRLHHRNLVSLLGYCDEEGEQMLVYE 701 (958)
Q Consensus 625 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~-~l~~l~H~niv~l~~~~~~~~~~~lV~E 701 (958)
++|...+.||+|+||.||+|.+. +++.||||++.... .....++..|+. +++.++||||+++++++..++..++|||
T Consensus 22 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv~e 101 (327)
T 3aln_A 22 EDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICME 101 (327)
T ss_dssp CSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred HHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEEEEe
Confidence 56778899999999999999986 68999999997653 334456666766 7777899999999999999999999999
Q ss_pred ecCCCCHHHHhcc---CCCCCchHHHHHHHHHHHHHHHHHhhhc-CCCCeeccCCCccceEecCCCCeEEeeeeeecccc
Q 002158 702 FVPNGTLRDWLSG---RTKENLNFAMRLRVALDSAKGILYLHTE-AHPPVFHRDIKASNILLDSNLNAKVADFGLSRLAP 777 (958)
Q Consensus 702 ~~~~gsL~~~l~~---~~~~~l~~~~~~~i~~~ia~aL~yLH~~-~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~~~ 777 (958)
|++ |+|.+++.. .....+++..+..++.|++.||.|||+. + |+||||||+||+++.++.+||+|||+++...
T Consensus 102 ~~~-~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~---ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~ 177 (327)
T 3aln_A 102 LMS-TSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLK---IIHRDIKPSNILLDRSGNIKLCDFGISGQLV 177 (327)
T ss_dssp CCS-EEHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHS---CCCSCCCGGGEEEETTTEEEECCCSSSCC--
T ss_pred ecC-CChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCC---EeECCCCHHHEEEcCCCCEEEccCCCceecc
Confidence 997 588887753 2234589999999999999999999998 8 9999999999999999999999999997653
Q ss_pred cCCCCCCccceeeeeccCCCCccChhhh----ccCCCCCcchhhhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcCcch
Q 002158 778 VLDDEGTMPTHVSTIVKGTPGYLDPEYF----LTHKLTDKSDVYSLGVVLLELLTGMQPISHGKNIVREVNVARDSGMVF 853 (958)
Q Consensus 778 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~----~~~~~~~~~DV~S~Gv~l~elltG~~P~~~~~~~~~~~~~~~~~~~~~ 853 (958)
... ......||+.|+|||++ .+..++.++||||||+++|||++|+.||...........
T Consensus 178 ~~~--------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~--------- 240 (327)
T 3aln_A 178 DSI--------AKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLT--------- 240 (327)
T ss_dssp ------------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC-------C---------
T ss_pred ccc--------ccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHHHHH---------
Confidence 211 12234699999999998 456789999999999999999999999975432211111
Q ss_pred hhhcccC----CCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 002158 854 SIIDNRM----GSYPSECVERFVTLALRCCHDKPEHRPSMSDVVRE 895 (958)
Q Consensus 854 ~~i~~~~----~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 895 (958)
....... ......++..+.+++.+||+.||++||++.|++++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h 286 (327)
T 3aln_A 241 QVVKGDPPQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLKH 286 (327)
T ss_dssp CCCCSCCCCCCCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred HHhcCCCCCCCCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHhC
Confidence 1111111 11123456789999999999999999999999874
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-37 Score=342.54 Aligned_cols=253 Identities=20% Similarity=0.264 Sum_probs=175.8
Q ss_pred HcCCCCC-ceeeeeCCeEEEEEEEC-CCcEEEEEEeccCChhcHHHHHHHHHHHHccCCCCcceEEEEEEe----CCeEE
Q 002158 624 TAYFSSS-TQVGQGGYGKVYKGILS-DNTTVAIKRAEEGSLQGQNEFLTEIKLLSRLHHRNLVSLLGYCDE----EGEQM 697 (958)
Q Consensus 624 ~~~~~~~-~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~----~~~~~ 697 (958)
.++|... +.||+|+||+||+|.+. +++.||||++.... . ...+....++.++||||+++++++.. ....+
T Consensus 27 ~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-~---~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~ 102 (336)
T 3fhr_A 27 TDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSP-K---ARQEVDHHWQASGGPHIVCILDVYENMHHGKRCLL 102 (336)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESSH-H---HHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred cceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCcH-H---HHHHHHHHHHhcCCCChHHHHHHHhhccCCCceEE
Confidence 3467664 46999999999999987 68999999987531 1 12223344667799999999999876 44689
Q ss_pred EEEEecCCCCHHHHhccCCCCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEecC---CCCeEEeeeeeec
Q 002158 698 LVYEFVPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDS---NLNAKVADFGLSR 774 (958)
Q Consensus 698 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~---~~~~kl~DFGla~ 774 (958)
+||||+++|+|.+++.......+++.++..++.|++.||+|||+.+ |+||||||+||+++. ++.+||+|||+++
T Consensus 103 lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~---ivH~dlkp~NIll~~~~~~~~~kl~Dfg~~~ 179 (336)
T 3fhr_A 103 IIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHN---IAHRDVKPENLLYTSKEKDAVLKLTDFGFAK 179 (336)
T ss_dssp EEEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSTTCCEEECCCTTCE
T ss_pred EEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEEecCCCceEEEeccccce
Confidence 9999999999999998766567999999999999999999999999 999999999999976 4559999999997
Q ss_pred ccccCCCCCCccceeeeeccCCCCccChhhhccCCCCCcchhhhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcCcchh
Q 002158 775 LAPVLDDEGTMPTHVSTIVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVLLELLTGMQPISHGKNIVREVNVARDSGMVFS 854 (958)
Q Consensus 775 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gv~l~elltG~~P~~~~~~~~~~~~~~~~~~~~~~ 854 (958)
.... .......||+.|+|||++.+..++.++||||||+++|||++|+.||............. . .....
T Consensus 180 ~~~~---------~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~-~-~~~~~ 248 (336)
T 3fhr_A 180 ETTQ---------NALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMK-R-RIRLG 248 (336)
T ss_dssp EC-------------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC---------------------
T ss_pred eccc---------cccccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhhHH-H-hhhcc
Confidence 5421 11223568999999999988889999999999999999999999996433211100000 0 00000
Q ss_pred hhcccCCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 002158 855 IIDNRMGSYPSECVERFVTLALRCCHDKPEHRPSMSDVVRE 895 (958)
Q Consensus 855 ~i~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 895 (958)
. ..........++..+.+++.+||+.||++||+++|++++
T Consensus 249 ~-~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 288 (336)
T 3fhr_A 249 Q-YGFPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNH 288 (336)
T ss_dssp ---CCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred c-cccCchhhccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 0 000011123467789999999999999999999999985
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-36 Score=354.41 Aligned_cols=323 Identities=21% Similarity=0.217 Sum_probs=255.3
Q ss_pred CCCCCCCceeeCcc----ccCCCceeeEEEEccCCcCCCCccccccCCCCcceeeccCcccCC-CCccccCCCCCcEEEe
Q 002158 66 PCMSNWTGVLCFDT----VETDGHLHVRELQLLSMNLSGNLAPELGQLSRLQYYFMWNDLTGT-IPKEIGNISSLIFLLL 140 (958)
Q Consensus 66 ~c~~~w~gV~C~~~----~~~~~~~~v~~L~L~~~~l~~~~~~~l~~L~~L~~L~l~n~~~~~-ip~~i~~l~~L~~L~L 140 (958)
.|...|..|.|... ++.....+++.|+|++|++++..+..|.++++|++|++++|.... .|..|.++++|++|+|
T Consensus 8 ~C~~~~~~v~c~~~~l~~ip~~~~~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L 87 (477)
T 2id5_A 8 ECSAQDRAVLCHRKRFVAVPEGIPTETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVSAVEPGAFNNLFNLRTLGL 87 (477)
T ss_dssp EEETTTTEEECCSCCCSSCCSCCCTTCSEEECCSSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEEC
T ss_pred eECCCCCEEEeCCCCcCcCCCCCCCCCcEEECCCCccceECHhHccCCCCCCEEECCCCccCEeChhhhhCCccCCEEEC
Confidence 34445789999653 223334578889999999888888888889999999887655444 4778888899999999
Q ss_pred eCCCCCCCCChhhcCCCCCCEEecccccccccCccccccccccceEecccccccccCchhhcCCccchhhhccCCccccC
Q 002158 141 NGNKLSGSLPDELGYLSNLNRLQVDENNITGTIPKSFANLSRVRHLHLNNNSIGGQIPSELSKLSTLIHLLVDNNNLSGN 220 (958)
Q Consensus 141 s~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~ 220 (958)
++|.+++..+..|.++++|++|+|++|++++..+..|..+++|+.|+|++|.+++..+..|.++++|+.|+|++|++++.
T Consensus 88 ~~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~ 167 (477)
T 2id5_A 88 RSNRLKLIPLGVFTGLSNLTKLDISENKIVILLDYMFQDLYNLKSLEVGDNDLVYISHRAFSGLNSLEQLTLEKCNLTSI 167 (477)
T ss_dssp CSSCCCSCCTTSSTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEEECCTTCCEECTTSSTTCTTCCEEEEESCCCSSC
T ss_pred CCCcCCccCcccccCCCCCCEEECCCCccccCChhHccccccCCEEECCCCccceeChhhccCCCCCCEEECCCCcCccc
Confidence 99988865556678888999999999998888888888888999999999988888888888888999999999988877
Q ss_pred CCcccCCCCCccEEEccCCCCCCCCccccccCCCCCCEEEcccCCCCCCCC-CCCCCCCcCEEeccCCcCCCcCCC--CC
Q 002158 221 LPPELSELPQLCILQLDNNNFSASEIPATYGNFSKLVKLSLRNCNLQGAVP-DLSRIPNLYYLDLSWNHLTGSIPS--KK 297 (958)
Q Consensus 221 ~~~~l~~l~~L~~L~L~~N~l~~~~~p~~~~~l~~L~~L~L~~N~l~~~~~-~l~~l~~L~~L~Ls~N~l~~~~~~--~~ 297 (958)
.+..|..+++|+.|+|++|.++. ..+..|..+++|+.|++++|.+.+..+ ......+|+.|+|++|.+++ +|. ..
T Consensus 168 ~~~~l~~l~~L~~L~l~~n~i~~-~~~~~~~~l~~L~~L~l~~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~-~~~~~~~ 245 (477)
T 2id5_A 168 PTEALSHLHGLIVLRLRHLNINA-IRDYSFKRLYRLKVLEISHWPYLDTMTPNCLYGLNLTSLSITHCNLTA-VPYLAVR 245 (477)
T ss_dssp CHHHHTTCTTCCEEEEESCCCCE-ECTTCSCSCTTCCEEEEECCTTCCEECTTTTTTCCCSEEEEESSCCCS-CCHHHHT
T ss_pred ChhHhcccCCCcEEeCCCCcCcE-eChhhcccCcccceeeCCCCccccccCcccccCccccEEECcCCcccc-cCHHHhc
Confidence 77778888899999999988873 445578888889999998887665544 45555688899999998884 442 35
Q ss_pred CCCCcCEEEccCCcCCCccchhccCCCCCCeEeeecccCCCccchhhhcccccCccccceEeccCCCCCCCccCC--CCC
Q 002158 298 LSENVTTIDLSDNYLNGSILESISNLPFLQTLSLENNFLTGSIPATIWQNKSFSTKARLKIDLRNNSFSNIVGDL--TLP 375 (958)
Q Consensus 298 ~~~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~ip~~l~~~~~~~~~~l~~L~Ls~N~l~~l~~~~--~l~ 375 (958)
.+++|+.|+|++|.|++..+..|..+++|+.|+|++|++++..|..+..+ +.|+.|+|++|+|+.++... .++
T Consensus 246 ~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l-----~~L~~L~L~~N~l~~~~~~~~~~l~ 320 (477)
T 2id5_A 246 HLVYLRFLNLSYNPISTIEGSMLHELLRLQEIQLVGGQLAVVEPYAFRGL-----NYLRVLNVSGNQLTTLEESVFHSVG 320 (477)
T ss_dssp TCTTCCEEECCSSCCCEECTTSCTTCTTCCEEECCSSCCSEECTTTBTTC-----TTCCEEECCSSCCSCCCGGGBSCGG
T ss_pred CccccCeeECCCCcCCccChhhccccccCCEEECCCCccceECHHHhcCc-----ccCCEEECCCCcCceeCHhHcCCCc
Confidence 56888999999998888888888888899999999998887767666544 35668888888888887654 678
Q ss_pred CcceEEeCCCCCCCCCCCCC
Q 002158 376 NNVTLRLGGNPICTSANIPN 395 (958)
Q Consensus 376 ~L~~L~l~~N~l~~~~~~~~ 395 (958)
+|+.|+|++|||.|+|.+.|
T Consensus 321 ~L~~L~l~~N~l~c~c~~~~ 340 (477)
T 2id5_A 321 NLETLILDSNPLACDCRLLW 340 (477)
T ss_dssp GCCEEECCSSCEECSGGGHH
T ss_pred ccCEEEccCCCccCccchHh
Confidence 88888888888866665443
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-37 Score=343.38 Aligned_cols=244 Identities=26% Similarity=0.427 Sum_probs=200.7
Q ss_pred HHHHcCCCCCceeeeeCCeEEEEEEEC-CCcEEEEEEeccCChh------cHHHHHHHHHHHHccC--CCCcceEEEEEE
Q 002158 621 AMATAYFSSSTQVGQGGYGKVYKGILS-DNTTVAIKRAEEGSLQ------GQNEFLTEIKLLSRLH--HRNLVSLLGYCD 691 (958)
Q Consensus 621 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~------~~~~~~~E~~~l~~l~--H~niv~l~~~~~ 691 (958)
....++|...+.||+|+||.||+|.+. +++.||||++...... ..+.+.+|+.++++++ |+||+++++++.
T Consensus 39 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~ 118 (320)
T 3a99_A 39 EPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFE 118 (320)
T ss_dssp -CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEE
T ss_pred CCccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEe
Confidence 334567888899999999999999975 6899999998654211 2245678999999996 599999999999
Q ss_pred eCCeEEEEEEecCC-CCHHHHhccCCCCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEec-CCCCeEEee
Q 002158 692 EEGEQMLVYEFVPN-GTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLD-SNLNAKVAD 769 (958)
Q Consensus 692 ~~~~~~lV~E~~~~-gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~-~~~~~kl~D 769 (958)
.++..++||||+.+ ++|.+++.... .+++..+..++.|+++||+|||+.+ |+||||||+|||++ +++.+||+|
T Consensus 119 ~~~~~~lv~e~~~~~~~L~~~l~~~~--~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~kL~D 193 (320)
T 3a99_A 119 RPDSFVLILERPEPVQDLFDFITERG--ALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKLID 193 (320)
T ss_dssp CSSEEEEEEECCSSEEEHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEECC
T ss_pred cCCcEEEEEEcCCCCccHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHHCC---cEeCCCCHHHEEEeCCCCCEEEee
Confidence 99999999999976 89999997643 4899999999999999999999999 99999999999999 789999999
Q ss_pred eeeecccccCCCCCCccceeeeeccCCCCccChhhhccCCC-CCcchhhhHHHHHHHHHhCCCCCCCCchhHHHHHHHhh
Q 002158 770 FGLSRLAPVLDDEGTMPTHVSTIVKGTPGYLDPEYFLTHKL-TDKSDVYSLGVVLLELLTGMQPISHGKNIVREVNVARD 848 (958)
Q Consensus 770 FGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DV~S~Gv~l~elltG~~P~~~~~~~~~~~~~~~~ 848 (958)
||+++..... ......||+.|+|||++.+..+ +.++||||||+++|||++|+.||...... . .
T Consensus 194 fg~~~~~~~~---------~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~------~-~ 257 (320)
T 3a99_A 194 FGSGALLKDT---------VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEI------I-R 257 (320)
T ss_dssp CTTCEECCSS---------CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHHH------H-H
T ss_pred Cccccccccc---------cccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChhhh------h-c
Confidence 9999865321 1123469999999999987776 67899999999999999999999643211 0 0
Q ss_pred cCcchhhhcccCCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 002158 849 SGMVFSIIDNRMGSYPSECVERFVTLALRCCHDKPEHRPSMSDVVRE 895 (958)
Q Consensus 849 ~~~~~~~i~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 895 (958)
.....+..++..+.+++.+||+.||++||+++|++++
T Consensus 258 ----------~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h 294 (320)
T 3a99_A 258 ----------GQVFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNH 294 (320)
T ss_dssp ----------CCCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred ----------ccccccccCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0111233456788999999999999999999999874
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-36 Score=350.00 Aligned_cols=254 Identities=23% Similarity=0.288 Sum_probs=189.2
Q ss_pred CCCCCceeeeeCCeEEEEEEECCCcEEEEEEeccCChhcHHHHHHHHHHHHcc-CCCCcceEEEEEEeCCeEEEEEEecC
Q 002158 626 YFSSSTQVGQGGYGKVYKGILSDNTTVAIKRAEEGSLQGQNEFLTEIKLLSRL-HHRNLVSLLGYCDEEGEQMLVYEFVP 704 (958)
Q Consensus 626 ~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lV~E~~~ 704 (958)
.|...+.||+|+||+||.+...+|+.||||++... ..+.+.+|+++++++ +||||+++++++.+++..++||||++
T Consensus 16 ~~~~~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~---~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~~~ 92 (434)
T 2rio_A 16 LVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLID---FCDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELCN 92 (434)
T ss_dssp CEEEEEEEEECSTTCEEEEEESSSSEEEEEEEEGG---GHHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCCS
T ss_pred eeeccCeEeeCCCeEEEEEEEECCeEEEEEEEcHH---HHHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEecCC
Confidence 34445789999999998776678999999998653 245678999999987 89999999999999999999999995
Q ss_pred CCCHHHHhccCCCCC-----chHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEecCC-------------CCeE
Q 002158 705 NGTLRDWLSGRTKEN-----LNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSN-------------LNAK 766 (958)
Q Consensus 705 ~gsL~~~l~~~~~~~-----l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~-------------~~~k 766 (958)
|+|.+++....... .++..++.++.|++.||+|||+++ |+||||||+|||++.+ +.+|
T Consensus 93 -gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~k 168 (434)
T 2rio_A 93 -LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLK---IIHRDLKPQNILVSTSSRFTADQQTGAENLRIL 168 (434)
T ss_dssp -EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEECCHHHHSCCTTCCCSCEEE
T ss_pred -CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEecCcccccccccCCCceEEE
Confidence 69999997654211 133346789999999999999999 9999999999999754 4899
Q ss_pred EeeeeeecccccCCCCCCccceeeeeccCCCCccChhhhcc-------CCCCCcchhhhHHHHHHHHHh-CCCCCCCCch
Q 002158 767 VADFGLSRLAPVLDDEGTMPTHVSTIVKGTPGYLDPEYFLT-------HKLTDKSDVYSLGVVLLELLT-GMQPISHGKN 838 (958)
Q Consensus 767 l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-------~~~~~~~DV~S~Gv~l~ellt-G~~P~~~~~~ 838 (958)
|+|||+++......... ........||+.|+|||++.+ ..++.++|||||||++|||++ |+.||.....
T Consensus 169 L~DFG~a~~~~~~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~ 245 (434)
T 2rio_A 169 ISDFGLCKKLDSGQSSF---RTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYS 245 (434)
T ss_dssp ECCCTTCEECCC-----------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTT
T ss_pred EcccccceecCCCCccc---eeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchh
Confidence 99999998754322110 111234579999999999976 568899999999999999999 9999975433
Q ss_pred hHHHHHHHhhcCcchhhhcccCCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 002158 839 IVREVNVARDSGMVFSIIDNRMGSYPSECVERFVTLALRCCHDKPEHRPSMSDVVRE 895 (958)
Q Consensus 839 ~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 895 (958)
....+ ....... .......+..++.++.+++.+||+.||.+||++.|++++
T Consensus 246 ~~~~i--~~~~~~~----~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h 296 (434)
T 2rio_A 246 RESNI--IRGIFSL----DEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRH 296 (434)
T ss_dssp HHHHH--HHTCCCC----CCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred hHHHH--hcCCCCc----ccccccccccchHHHHHHHHHHhhCChhhCCCHHHHHhC
Confidence 22111 1110000 000111245678899999999999999999999999863
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-36 Score=335.70 Aligned_cols=251 Identities=20% Similarity=0.290 Sum_probs=183.4
Q ss_pred cCCCCCceeeeeCCeEEEEEEEC-CCcEEEEEEeccCCh-hcHH-HHHHHHHHHHccCCCCcceEEEEEEeCCeEEEEEE
Q 002158 625 AYFSSSTQVGQGGYGKVYKGILS-DNTTVAIKRAEEGSL-QGQN-EFLTEIKLLSRLHHRNLVSLLGYCDEEGEQMLVYE 701 (958)
Q Consensus 625 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~-~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E 701 (958)
++|...+.||+|+||.||+|.+. +|+.||||++..... .... .+.++..+++.++||||+++++++..++..++|||
T Consensus 25 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv~e 104 (318)
T 2dyl_A 25 NDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAME 104 (318)
T ss_dssp GGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEEC
T ss_pred ccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEEe
Confidence 45777889999999999999986 689999999976532 2223 34455567888899999999999999999999999
Q ss_pred ecCCCCHHHHhccCCCCCchHHHHHHHHHHHHHHHHHhhhc-CCCCeeccCCCccceEecCCCCeEEeeeeeecccccCC
Q 002158 702 FVPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTE-AHPPVFHRDIKASNILLDSNLNAKVADFGLSRLAPVLD 780 (958)
Q Consensus 702 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~-~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~ 780 (958)
|+ ++.+..+.... ...+++..+..++.|+++||+|||+. + |+||||||+||+++.++.+||+|||+++......
T Consensus 105 ~~-~~~~~~l~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~ 179 (318)
T 2dyl_A 105 LM-GTCAEKLKKRM-QGPIPERILGKMTVAIVKALYYLKEKHG---VIHRDVKPSNILLDERGQIKLCDFGISGRLVDDK 179 (318)
T ss_dssp CC-SEEHHHHHHHH-TSCCCHHHHHHHHHHHHHHHHHHHHHHC---CCCCCCCGGGEEECTTSCEEECCCTTC-------
T ss_pred cc-CCcHHHHHHHh-ccCCCHHHHHHHHHHHHHHHHHHHhhCC---EEeCCCCHHHEEECCCCCEEEEECCCchhccCCc
Confidence 99 55666665432 34589999999999999999999995 8 9999999999999999999999999987543211
Q ss_pred CCCCccceeeeeccCCCCccChhhhc-----cCCCCCcchhhhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcCcchhh
Q 002158 781 DEGTMPTHVSTIVKGTPGYLDPEYFL-----THKLTDKSDVYSLGVVLLELLTGMQPISHGKNIVREVNVARDSGMVFSI 855 (958)
Q Consensus 781 ~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DV~S~Gv~l~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~ 855 (958)
......||+.|+|||++. ...++.++||||||+++|||++|+.||..................
T Consensus 180 --------~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~---- 247 (318)
T 2dyl_A 180 --------AKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQEEP---- 247 (318)
T ss_dssp ---------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHHSCC----
T ss_pred --------cccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccHHHHHHHhccCC----
Confidence 122346999999999994 556888999999999999999999999764433332222211110
Q ss_pred hcccCCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 002158 856 IDNRMGSYPSECVERFVTLALRCCHDKPEHRPSMSDVVRE 895 (958)
Q Consensus 856 i~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 895 (958)
... .....++..+.+++.+||+.||.+||+++|++++
T Consensus 248 --~~~-~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h 284 (318)
T 2dyl_A 248 --PLL-PGHMGFSGDFQSFVKDCLTKDHRKRPKYNKLLEH 284 (318)
T ss_dssp --CCC-CSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTS
T ss_pred --CCC-CccCCCCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence 000 1112356789999999999999999999999975
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-36 Score=347.79 Aligned_cols=251 Identities=22% Similarity=0.298 Sum_probs=189.5
Q ss_pred cCCCCCceeeeeCCeEEEEEEECCCcEEEEEEeccCChhcHHHHHHHHHHHHcc-CCCCcceEEEEEEeCCeEEEEEEec
Q 002158 625 AYFSSSTQVGQGGYGKVYKGILSDNTTVAIKRAEEGSLQGQNEFLTEIKLLSRL-HHRNLVSLLGYCDEEGEQMLVYEFV 703 (958)
Q Consensus 625 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lV~E~~ 703 (958)
.+|...+.||+|+||+||.....+++.||||++...... .+.+|+++++++ +||||+++++++.+.+..++||||+
T Consensus 24 ~~y~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~~~---~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~E~~ 100 (432)
T 3p23_A 24 ISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECFS---FADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIELC 100 (432)
T ss_dssp EEEEEEEEEEECGGGCEEEEEESSSSEEEEEEECTTTEE---ECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred EEEecCCeeecCcCEEEEEEEEeCCeEEEEEEECHHHHH---HHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEEECC
Confidence 457777899999999966555568999999999754332 356899999999 7999999999999999999999999
Q ss_pred CCCCHHHHhccCCCCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEecC-----CCCeEEeeeeeeccccc
Q 002158 704 PNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDS-----NLNAKVADFGLSRLAPV 778 (958)
Q Consensus 704 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~-----~~~~kl~DFGla~~~~~ 778 (958)
+ |+|.+++..... .....++..++.|+++||+|||+.+ |+||||||+|||++. ...+||+|||+++....
T Consensus 101 ~-g~L~~~l~~~~~-~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~~~ 175 (432)
T 3p23_A 101 A-ATLQEYVEQKDF-AHLGLEPITLLQQTTSGLAHLHSLN---IVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAV 175 (432)
T ss_dssp S-EEHHHHHHSSSC-CCCSSCHHHHHHHHHHHHHHHHHTT---CCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC--
T ss_pred C-CCHHHHHHhcCC-CccchhHHHHHHHHHHHHHHHHHCc---CEeCCCCHHHEEEecCCCCCceeEEEecccceeeccC
Confidence 5 699999976542 2455567899999999999999999 999999999999953 23588999999986543
Q ss_pred CCCCCCccceeeeeccCCCCccChhhhc---cCCCCCcchhhhHHHHHHHHHh-CCCCCCCCchhHHHHHHHhhcCcchh
Q 002158 779 LDDEGTMPTHVSTIVKGTPGYLDPEYFL---THKLTDKSDVYSLGVVLLELLT-GMQPISHGKNIVREVNVARDSGMVFS 854 (958)
Q Consensus 779 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DV~S~Gv~l~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~ 854 (958)
.... ........||+.|+|||++. ...++.++|||||||++|||++ |..||........ ........
T Consensus 176 ~~~~----~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~~--~~~~~~~~--- 246 (432)
T 3p23_A 176 GRHS----FSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQA--NILLGACS--- 246 (432)
T ss_dssp --------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHHH--HHHTTCCC---
T ss_pred CCcc----eeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHHH--HHHhccCC---
Confidence 2111 12233467999999999997 4567889999999999999999 9999854332211 11111000
Q ss_pred hhcccCCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 002158 855 IIDNRMGSYPSECVERFVTLALRCCHDKPEHRPSMSDVVRE 895 (958)
Q Consensus 855 ~i~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 895 (958)
......+......+.+++.+||+.||++||+++|++++
T Consensus 247 ---~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~h 284 (432)
T 3p23_A 247 ---LDCLHPEKHEDVIARELIEKMIAMDPQKRPSAKHVLKH 284 (432)
T ss_dssp ---CTTSCTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred ---ccccCccccccHHHHHHHHHHHhCCHhhCCCHHHHHhC
Confidence 01111234566778999999999999999999999953
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-36 Score=352.31 Aligned_cols=370 Identities=17% Similarity=0.191 Sum_probs=286.6
Q ss_pred CCCCCCCCceeeCcccc---CCCceeeEEEEccCCcCCCCccccccCCCCcceeeccCccc-CCC-CccccCCCCCcEEE
Q 002158 65 DPCMSNWTGVLCFDTVE---TDGHLHVRELQLLSMNLSGNLAPELGQLSRLQYYFMWNDLT-GTI-PKEIGNISSLIFLL 139 (958)
Q Consensus 65 ~~c~~~w~gV~C~~~~~---~~~~~~v~~L~L~~~~l~~~~~~~l~~L~~L~~L~l~n~~~-~~i-p~~i~~l~~L~~L~ 139 (958)
..|.|.+..|.|....- .....+++.|+|++|.+++..+..|+++++|++|++++|.. +.+ |..|.++++|++|+
T Consensus 6 ~~c~~~~~~~~c~~~~l~~lp~l~~~l~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n~~~~~i~~~~~~~l~~L~~L~ 85 (455)
T 3v47_A 6 SECSVIGYNAICINRGLHQVPELPAHVNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILK 85 (455)
T ss_dssp -CCEEETTEEECCSSCCSSCCCCCTTCCEEECCSSCCCEECTTTTSSCTTCCEEECCCCSTTCEECTTTTTTCTTCCEEE
T ss_pred ceeEEEccccCcCCCCcccCCCCCCccCEEEecCCccCcCChhHhccCccccEEECcCCcccceECcccccccccCCEEe
Confidence 44554555688865311 11345799999999999999999999999999999987754 456 46699999999999
Q ss_pred eeCCCCCCCCChhhcCCCCCCEEecccccccccCccc--cccccccceEecccccccccCchh-hcCCccchhhhccCCc
Q 002158 140 LNGNKLSGSLPDELGYLSNLNRLQVDENNITGTIPKS--FANLSRVRHLHLNNNSIGGQIPSE-LSKLSTLIHLLVDNNN 216 (958)
Q Consensus 140 Ls~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~--~~~l~~L~~L~Ls~N~l~~~~p~~-l~~l~~L~~L~L~~N~ 216 (958)
|++|.+++..|..|+++++|++|+|++|++++.++.. |..+++|++|+|++|.+++..|.. +.++++|++|++++|+
T Consensus 86 Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~l~~L~~L~L~~n~ 165 (455)
T 3v47_A 86 LDYNQFLQLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIKKIQPASFFLNMRRFHVLDLTFNK 165 (455)
T ss_dssp CTTCTTCEECTTTTTTCTTCCEEECTTSCCBTHHHHSSTTTTCTTCCEEECCSSBCCSCCCCGGGGGCTTCCEEECTTCC
T ss_pred CCCCccCccChhhccCcccCCEEeCCCCCCCccccCcccccCcccCCEEECCCCccCccCcccccCCCCcccEEeCCCCc
Confidence 9999999888999999999999999999999866655 999999999999999999887876 8999999999999999
Q ss_pred cccCCCcccCCC--CCccEEEccCCCCCCCCccc--------cccCCCCCCEEEcccCCCCCCCC---------------
Q 002158 217 LSGNLPPELSEL--PQLCILQLDNNNFSASEIPA--------TYGNFSKLVKLSLRNCNLQGAVP--------------- 271 (958)
Q Consensus 217 l~~~~~~~l~~l--~~L~~L~L~~N~l~~~~~p~--------~~~~l~~L~~L~L~~N~l~~~~~--------------- 271 (958)
+++..+..+..+ .+|+.|++++|.+.... +. .+..+++|+.|+|++|++++..+
T Consensus 166 l~~~~~~~l~~l~~~~L~~L~l~~n~l~~~~-~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~~~~~~~L~~L 244 (455)
T 3v47_A 166 VKSICEEDLLNFQGKHFTLLRLSSITLQDMN-EYWLGWEKCGNPFKNTSITTLDLSGNGFKESMAKRFFDAIAGTKIQSL 244 (455)
T ss_dssp BSCCCTTTSGGGTTCEEEEEECTTCBCTTCS-TTCTTHHHHCCTTTTCEEEEEECTTSCCCHHHHHHHHHHTTTCCEEEE
T ss_pred ccccChhhhhccccccccccccccCcccccc-hhhccccccccccccceeeeEecCCCcccccchhhhhccccccceeeE
Confidence 999888887765 56667777776665311 11 12244566666666666543111
Q ss_pred -----------------------CCC--CCCCcCEEeccCCcCCCcCCCC-CCCCCcCEEEccCCcCCCccchhccCCCC
Q 002158 272 -----------------------DLS--RIPNLYYLDLSWNHLTGSIPSK-KLSENVTTIDLSDNYLNGSILESISNLPF 325 (958)
Q Consensus 272 -----------------------~l~--~l~~L~~L~Ls~N~l~~~~~~~-~~~~~L~~L~Ls~N~l~~~~~~~~~~l~~ 325 (958)
.+. ..++|+.|+|++|.+++.++.. ..+++|++|+|++|++++..+..|.++++
T Consensus 245 ~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~ 324 (455)
T 3v47_A 245 ILSNSYNMGSSFGHTNFKDPDNFTFKGLEASGVKTCDLSKSKIFALLKSVFSHFTDLEQLTLAQNEINKIDDNAFWGLTH 324 (455)
T ss_dssp ECTTCTTTSCCTTCCSSCCCCTTTTGGGTTSCCCEEECCSSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTT
T ss_pred eeccccccccccchhhhccCcccccccccccCceEEEecCccccccchhhcccCCCCCEEECCCCcccccChhHhcCccc
Confidence 011 2368999999999998776654 55689999999999999999999999999
Q ss_pred CCeEeeecccCCCccchhhhcccccCccccceEeccCCCCCCCccC-C-CCCCcceEEeCCCCCCCCCCCCCCCcccccC
Q 002158 326 LQTLSLENNFLTGSIPATIWQNKSFSTKARLKIDLRNNSFSNIVGD-L-TLPNNVTLRLGGNPICTSANIPNTGRFCGSD 403 (958)
Q Consensus 326 L~~L~L~~N~l~~~ip~~l~~~~~~~~~~l~~L~Ls~N~l~~l~~~-~-~l~~L~~L~l~~N~l~~~~~~~~~~~~~~~~ 403 (958)
|++|+|++|++++..|..+..+ +.|+.|+|++|+++.+... . .+++|+.|+|++|++...... .+....
T Consensus 325 L~~L~Ls~N~l~~~~~~~~~~l-----~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~----~~~~l~ 395 (455)
T 3v47_A 325 LLKLNLSQNFLGSIDSRMFENL-----DKLEVLDLSYNHIRALGDQSFLGLPNLKELALDTNQLKSVPDG----IFDRLT 395 (455)
T ss_dssp CCEEECCSSCCCEECGGGGTTC-----TTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCTT----TTTTCT
T ss_pred CCEEECCCCccCCcChhHhcCc-----ccCCEEECCCCcccccChhhccccccccEEECCCCccccCCHh----HhccCC
Confidence 9999999999987667666544 4567999999999988543 3 899999999999999753321 123345
Q ss_pred CCCCccccccCCCCCCC-CCCCCCcccccCCCCC-Cceeeeec
Q 002158 404 AGGDETLTNSKVNCPVQ-ACPVDNFFEYVPASPE-PCFCAAPL 444 (958)
Q Consensus 404 ~~~~~~L~~n~~~C~c~-~~~~~~~~~~~~~~~~-~~~c~sp~ 444 (958)
..+.+.|.+|+|.|+|+ ..++..|++....... ...|.+|.
T Consensus 396 ~L~~L~l~~N~l~~~~~~~~~l~~~l~~~~~~~~~~~~c~~~~ 438 (455)
T 3v47_A 396 SLQKIWLHTNPWDCSCPRIDYLSRWLNKNSQKEQGSAKCSGSG 438 (455)
T ss_dssp TCCEEECCSSCBCCCTTTTHHHHHHHHHTTTTEESCCBBTTTC
T ss_pred cccEEEccCCCcccCCCcchHHHHHHHhCccceeeeeeecCCC
Confidence 66788999999999998 5667789876544433 35676653
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-36 Score=359.47 Aligned_cols=266 Identities=24% Similarity=0.350 Sum_probs=206.9
Q ss_pred cCCCCCceeeeeCCeEEEEEEEC-CCcEEEEEEeccC-ChhcHHHHHHHHHHHHccCCCCcceEEEEEEe------CCeE
Q 002158 625 AYFSSSTQVGQGGYGKVYKGILS-DNTTVAIKRAEEG-SLQGQNEFLTEIKLLSRLHHRNLVSLLGYCDE------EGEQ 696 (958)
Q Consensus 625 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~------~~~~ 696 (958)
.+|...+.||+|+||+||+|.+. +|+.||||++... .....+.+.+|++++++++||||+++++++.. .+..
T Consensus 14 grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~~ 93 (676)
T 3qa8_A 14 GPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDLP 93 (676)
T ss_dssp ---CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSSC
T ss_pred CCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCeE
Confidence 57999999999999999999975 6899999998764 44456779999999999999999999999765 6778
Q ss_pred EEEEEecCCCCHHHHhccCC-CCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEecCCCC---eEEeeeee
Q 002158 697 MLVYEFVPNGTLRDWLSGRT-KENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSNLN---AKVADFGL 772 (958)
Q Consensus 697 ~lV~E~~~~gsL~~~l~~~~-~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~~~---~kl~DFGl 772 (958)
++||||+++|+|.+++.... ...+++..+..++.|++.||+|||+.+ |+||||||+||+++.++. +||+|||+
T Consensus 94 ~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~g---IVHrDLKP~NILl~~~g~~~~vKL~DFG~ 170 (676)
T 3qa8_A 94 LLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENR---IIHRDLKPENIVLQPGPQRLIHKIIDLGY 170 (676)
T ss_dssp CCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTT---BCCCCCCSTTEEEECCSSSCEEEECSCCC
T ss_pred EEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHeEeecCCCceeEEEccccc
Confidence 99999999999999997643 235899999999999999999999999 999999999999997765 99999999
Q ss_pred ecccccCCCCCCccceeeeeccCCCCccChhhhccCCCCCcchhhhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcC--
Q 002158 773 SRLAPVLDDEGTMPTHVSTIVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVLLELLTGMQPISHGKNIVREVNVARDSG-- 850 (958)
Q Consensus 773 a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gv~l~elltG~~P~~~~~~~~~~~~~~~~~~-- 850 (958)
++...... ......||+.|+|||++.+..++.++||||||+++|||++|..||........+........
T Consensus 171 a~~~~~~~--------~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~~~~~~~i~~~~~~ 242 (676)
T 3qa8_A 171 AKELDQGE--------LCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNE 242 (676)
T ss_dssp CCBTTSCC--------CCCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHHHHSSTTCC-----
T ss_pred cccccccc--------ccccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccchhhhhhhhhcccch
Confidence 98653221 12345699999999999999999999999999999999999999976543322211110000
Q ss_pred --cchhhhc---------ccCCCCChHHHHHHHHHHHHccccCCCCCCCHHH-----HHHHHHHhHh
Q 002158 851 --MVFSIID---------NRMGSYPSECVERFVTLALRCCHDKPEHRPSMSD-----VVRELENILK 901 (958)
Q Consensus 851 --~~~~~i~---------~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~e-----vl~~L~~~~~ 901 (958)
....... +.........+..+.+++.+||+.||++||+++| .++.+++++.
T Consensus 243 ~~~~~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL~hp~F~~l~~iL~ 309 (676)
T 3qa8_A 243 HIVVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQALDSILS 309 (676)
T ss_dssp -CCSCCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCCCCTTHHHHHHHHC
T ss_pred hhhhhhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHhcCHHHHHHHHHHh
Confidence 0000000 1112345568899999999999999999999988 4566666654
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-35 Score=366.45 Aligned_cols=361 Identities=20% Similarity=0.178 Sum_probs=242.3
Q ss_pred CceeeEEEEccCCcCCCCccccccCCCCcceeeccCc-ccCCC-CccccCCCCCcEEEeeCCCCCCCCChhhcCCCCCCE
Q 002158 84 GHLHVRELQLLSMNLSGNLAPELGQLSRLQYYFMWND-LTGTI-PKEIGNISSLIFLLLNGNKLSGSLPDELGYLSNLNR 161 (958)
Q Consensus 84 ~~~~v~~L~L~~~~l~~~~~~~l~~L~~L~~L~l~n~-~~~~i-p~~i~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~ 161 (958)
...+++.|+|++|.+++..+..|.++++|++|++++| ..+.+ |..|.++++|++|+|++|.+++..|..|.++++|++
T Consensus 22 lp~~l~~LdLs~N~i~~i~~~~~~~l~~L~~LdLs~n~~~~~i~~~~f~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~ 101 (844)
T 3j0a_A 22 VLNTTERLLLSFNYIRTVTASSFPFLEQLQLLELGSQYTPLTIDKEAFRNLPNLRILDLGSSKIYFLHPDAFQGLFHLFE 101 (844)
T ss_dssp SCTTCCEEEEESCCCCEECSSSCSSCCSCSEEEECTTCCCCEECTTTTSSCTTCCEEECTTCCCCEECTTSSCSCSSCCC
T ss_pred CCCCcCEEECCCCcCCccChhHCcccccCeEEeCCCCCCccccCHHHhcCCCCCCEEECCCCcCcccCHhHccCCcccCE
Confidence 3457889999999998888888888888888888766 66666 667888888888888888888777888888888888
Q ss_pred EecccccccccCccc--cccccccceEecccccccccCc-hhhcCCccchhhhccCCccccCCCcccCC-----------
Q 002158 162 LQVDENNITGTIPKS--FANLSRVRHLHLNNNSIGGQIP-SELSKLSTLIHLLVDNNNLSGNLPPELSE----------- 227 (958)
Q Consensus 162 L~L~~N~l~~~~p~~--~~~l~~L~~L~Ls~N~l~~~~p-~~l~~l~~L~~L~L~~N~l~~~~~~~l~~----------- 227 (958)
|+|++|++++.+|.. |.++++|++|+|++|.+++..+ ..|+++++|++|+|++|.+++..+..+..
T Consensus 102 L~Ls~n~l~~~~~~~~~~~~L~~L~~L~Ls~N~l~~~~~~~~~~~L~~L~~L~Ls~N~i~~~~~~~l~~l~~~~L~~L~L 181 (844)
T 3j0a_A 102 LRLYFCGLSDAVLKDGYFRNLKALTRLDLSKNQIRSLYLHPSFGKLNSLKSIDFSSNQIFLVCEHELEPLQGKTLSFFSL 181 (844)
T ss_dssp EECTTCCCSSCCSTTCCCSSCSSCCEEEEESCCCCCCCCCGGGGTCSSCCEEEEESSCCCCCCSGGGHHHHHCSSCCCEE
T ss_pred eeCcCCCCCcccccCccccccCCCCEEECCCCcccccccchhHhhCCCCCEEECCCCcCCeeCHHHcccccCCccceEEC
Confidence 888888888766554 7888888888888888876544 46778888888888777776544433221
Q ss_pred ---------------C----------------------------------------------------------------
Q 002158 228 ---------------L---------------------------------------------------------------- 228 (958)
Q Consensus 228 ---------------l---------------------------------------------------------------- 228 (958)
+
T Consensus 182 ~~n~l~~~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~~l~~~~l~~L~l~~~~~~~~~~~~~l~~~~~~~f~ 261 (844)
T 3j0a_A 182 AANSLYSRVSVDWGKCMNPFRNMVLEILDVSGNGWTVDITGNFSNAISKSQAFSLILAHHIMGAGFGFHNIKDPDQNTFA 261 (844)
T ss_dssp CCSBSCCCCCCCCCSSSCTTTTCCBSEEBCSSCCSSTTTTSGGGGTSCSCCBSEEECCSSCCBCSSSCSSSTTGGGTTTT
T ss_pred CCCccccccccchhhcCCccccCceeEEecCCCcCchhHHHHHHhhcCcccccceecccccccccccccccCCCChhhhh
Confidence 1
Q ss_pred ----CCccEEEccCCCCCCCCccccccCCCCCCEEEcccCCCCCCCCC-CCCCCCcCEEeccCCcCCCcCCC-CCCCCCc
Q 002158 229 ----PQLCILQLDNNNFSASEIPATYGNFSKLVKLSLRNCNLQGAVPD-LSRIPNLYYLDLSWNHLTGSIPS-KKLSENV 302 (958)
Q Consensus 229 ----~~L~~L~L~~N~l~~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~-l~~l~~L~~L~Ls~N~l~~~~~~-~~~~~~L 302 (958)
++|+.|+|++|.++ ...+..|..+++|+.|+|++|++++..+. |..+++|++|+|++|.+++..+. ...+++|
T Consensus 262 ~l~~~~L~~L~Ls~n~l~-~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L 340 (844)
T 3j0a_A 262 GLARSSVRHLDLSHGFVF-SLNSRVFETLKDLKVLNLAYNKINKIADEAFYGLDNLQVLNLSYNLLGELYSSNFYGLPKV 340 (844)
T ss_dssp TTTTSCCCEEECTTCCCC-EECSCCSSSCCCCCEEEEESCCCCEECTTTTTTCSSCCEEEEESCCCSCCCSCSCSSCTTC
T ss_pred ccccCCccEEECCCCccc-ccChhhhhcCCCCCEEECCCCcCCCCChHHhcCCCCCCEEECCCCCCCccCHHHhcCCCCC
Confidence 23334444444443 12244566677777788888877777663 77777888888888877755443 3445777
Q ss_pred CEEEccCCcCCCccchhccCCCCCCeEeeecccCCCc------------------cchh---------------------
Q 002158 303 TTIDLSDNYLNGSILESISNLPFLQTLSLENNFLTGS------------------IPAT--------------------- 343 (958)
Q Consensus 303 ~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~------------------ip~~--------------------- 343 (958)
+.|+|++|.|++..+..|..+++|+.|+|++|.+++. +|..
T Consensus 341 ~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~i~~~~~L~~L~l~~N~l~~l~~~~~~l~~L~ls~N~l~~l~~~~ 420 (844)
T 3j0a_A 341 AYIDLQKNHIAIIQDQTFKFLEKLQTLDLRDNALTTIHFIPSIPDIFLSGNKLVTLPKINLTANLIHLSENRLENLDILY 420 (844)
T ss_dssp CEEECCSCCCCCCCSSCSCSCCCCCEEEEETCCSCCCSSCCSCSEEEEESCCCCCCCCCCTTCCEEECCSCCCCSSTTHH
T ss_pred CEEECCCCCCCccChhhhcCCCCCCEEECCCCCCCcccCCCCcchhccCCCCcccccccccccceeecccCccccCchhh
Confidence 7777777777777777777777777777777766531 0000
Q ss_pred -hhcccc------------------------------------------------c-CccccceEeccCCCCCCCccCC-
Q 002158 344 -IWQNKS------------------------------------------------F-STKARLKIDLRNNSFSNIVGDL- 372 (958)
Q Consensus 344 -l~~~~~------------------------------------------------~-~~~~l~~L~Ls~N~l~~l~~~~- 372 (958)
+..+.. + ..+.|+.|+|++|+|+.++...
T Consensus 421 ~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~L~~L~Ls~N~l~~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~ 500 (844)
T 3j0a_A 421 FLLRVPHLQILILNQNRFSSCSGDQTPSENPSLEQLFLGENMLQLAWETELCWDVFEGLSHLQVLYLNHNYLNSLPPGVF 500 (844)
T ss_dssp HHTTCTTCCEEEEESCCCCCCCSSSSSCSCTTCCBCEEESCCCSSSCCSCCCSSCSSCBCCEECCCCCHHHHTTCCTTSS
T ss_pred hhhcCCccceeeCCCCcccccccccccccCCccccccCCCCccccccccccchhhhcCcccccEEECCCCcccccChhHc
Confidence 000000 0 0134455555555555555443
Q ss_pred -CCCCcceEEeCCCCCCCCCCCCCCCcc---------------cccCCCCCccccccCCCCCCCCCCCCCcccccCCCCC
Q 002158 373 -TLPNNVTLRLGGNPICTSANIPNTGRF---------------CGSDAGGDETLTNSKVNCPVQACPVDNFFEYVPASPE 436 (958)
Q Consensus 373 -~l~~L~~L~l~~N~l~~~~~~~~~~~~---------------~~~~~~~~~~L~~n~~~C~c~~~~~~~~~~~~~~~~~ 436 (958)
.+++|+.|+|++|.+...........+ -.......+.+.+|||.|+|+..++..|+........
T Consensus 501 ~~l~~L~~L~Ls~N~l~~l~~~~~~~~L~~L~Ls~N~l~~~~~~~~~~L~~l~l~~Np~~C~c~~~~f~~~~~~~~~~~~ 580 (844)
T 3j0a_A 501 SHLTALRGLSLNSNRLTVLSHNDLPANLEILDISRNQLLAPNPDVFVSLSVLDITHNKFICECELSTFINWLNHTNVTIA 580 (844)
T ss_dssp SSCCSCSEEEEESCCCSSCCCCCCCSCCCEEEEEEECCCCCCSCCCSSCCEEEEEEECCCCSSSCCSHHHHHHHTTTTTC
T ss_pred cchhhhheeECCCCCCCccChhhhhccccEEECCCCcCCCCChhHhCCcCEEEecCCCcccccccHHHHHHHHhcCcccc
Confidence 778888888888888754432211100 0012346678999999999999999999876544332
Q ss_pred ----Cceeeeece
Q 002158 437 ----PCFCAAPLR 445 (958)
Q Consensus 437 ----~~~c~sp~~ 445 (958)
...|++|..
T Consensus 581 ~~~~~~~C~~p~~ 593 (844)
T 3j0a_A 581 GPPADIYCVYPDS 593 (844)
T ss_dssp CCGGGCCCSSCSS
T ss_pred cccccCccCCchh
Confidence 256766643
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-35 Score=357.34 Aligned_cols=366 Identities=20% Similarity=0.200 Sum_probs=235.5
Q ss_pred CceeeCcc----ccCCCceeeEEEEccCCcCCCCccccccCCCCcceeeccCcccCC-CCccccCCCCCcEEEeeCCCCC
Q 002158 72 TGVLCFDT----VETDGHLHVRELQLLSMNLSGNLAPELGQLSRLQYYFMWNDLTGT-IPKEIGNISSLIFLLLNGNKLS 146 (958)
Q Consensus 72 ~gV~C~~~----~~~~~~~~v~~L~L~~~~l~~~~~~~l~~L~~L~~L~l~n~~~~~-ip~~i~~l~~L~~L~Ls~n~l~ 146 (958)
..|.|.+. ++.+...+++.|+|++|.+++..+..|.++++|++|++++|.... .|..|.++++|++|+|++|.++
T Consensus 14 ~~~~c~~~~l~~ip~~~~~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~i~~~~~~~l~~L~~L~Ls~n~l~ 93 (606)
T 3vq2_A 14 ITYQCMDQKLSKVPDDIPSSTKNIDLSFNPLKILKSYSFSNFSELQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNPIQ 93 (606)
T ss_dssp TEEECTTSCCSSCCTTSCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCC
T ss_pred CceEccCCCcccCCCCCCCCcCEEECCCCCcCEeChhhccCCccCcEEeCCCCcccccCHHHhhchhhcCEeECCCCccc
Confidence 35777542 233344678899999999988888888889999999887654444 4667888888999999988888
Q ss_pred CCCChhhcCCCCCCEEecccccccccCccccccccccceEecccccccc-cCchhhcCCccchhhhccCCccccCCCccc
Q 002158 147 GSLPDELGYLSNLNRLQVDENNITGTIPKSFANLSRVRHLHLNNNSIGG-QIPSELSKLSTLIHLLVDNNNLSGNLPPEL 225 (958)
Q Consensus 147 ~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~-~~p~~l~~l~~L~~L~L~~N~l~~~~~~~l 225 (958)
+..|..|+++++|++|+|++|++++..+..++++++|++|+|++|.+++ .+|..++++++|++|++++|++++..+..+
T Consensus 94 ~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~lp~~~~~l~~L~~L~Ls~n~l~~~~~~~~ 173 (606)
T 3vq2_A 94 SFSPGSFSGLTSLENLVAVETKLASLESFPIGQLITLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQTITVNDL 173 (606)
T ss_dssp CCCTTSSTTCTTCCEEECTTSCCCCSSSSCCTTCTTCCEEECCSSCCCCCCCCGGGGTCTTCCEEECCSSCCCEECTTTT
T ss_pred ccChhhcCCcccCCEEEccCCccccccccccCCCCCCCEEeCCCCcccceechHhHhhcCCCCEEEccCCcceecChhhh
Confidence 7778888888888888888888887776778888888888888888875 567788888888888888777665433211
Q ss_pred C-------------------------------------------------------------------------------
Q 002158 226 S------------------------------------------------------------------------------- 226 (958)
Q Consensus 226 ~------------------------------------------------------------------------------- 226 (958)
.
T Consensus 174 ~~l~~L~~~l~~L~l~~n~l~~~~~~~~~~~~L~~L~L~~n~~~~~~~~~~~~~l~~L~~l~l~~~~~~~~~~l~~~~~~ 253 (606)
T 3vq2_A 174 QFLRENPQVNLSLDMSLNPIDFIQDQAFQGIKLHELTLRGNFNSSNIMKTCLQNLAGLHVHRLILGEFKDERNLEIFEPS 253 (606)
T ss_dssp HHHHHCTTCCCEEECTTCCCCEECTTTTTTCEEEEEEEESCCSCHHHHHHHHHTTTTCEEEEEEEECCTTSCCCSCCCGG
T ss_pred hhhhccccccceeeccCCCcceeCcccccCceeeeeeccCCccchhHHHHHhccccccccccccccccccCCcccccChH
Confidence 1
Q ss_pred --------------------------------------------------------------------------------
Q 002158 227 -------------------------------------------------------------------------------- 226 (958)
Q Consensus 227 -------------------------------------------------------------------------------- 226 (958)
T Consensus 254 ~~~~l~~l~l~~l~l~~~~~~~~~~~~~~~l~~L~~L~l~~~~~~~l~~l~~~~~L~~L~l~~n~l~~lp~~~l~~L~~L 333 (606)
T 3vq2_A 254 IMEGLCDVTIDEFRLTYTNDFSDDIVKFHCLANVSAMSLAGVSIKYLEDVPKHFKWQSLSIIRCQLKQFPTLDLPFLKSL 333 (606)
T ss_dssp GGTTGGGSEEEEEEECCCTTCCGGGGSCGGGTTCSEEEEESCCCCCCCCCCTTCCCSEEEEESCCCSSCCCCCCSSCCEE
T ss_pred HhhhhhhccHhheeccccccccccccccccCCCCCEEEecCccchhhhhccccccCCEEEcccccCcccccCCCCcccee
Confidence
Q ss_pred --------------CCCCccEEEccCCCCCCCC-ccccccCCCCCCEEEcccC-----------------------CCCC
Q 002158 227 --------------ELPQLCILQLDNNNFSASE-IPATYGNFSKLVKLSLRNC-----------------------NLQG 268 (958)
Q Consensus 227 --------------~l~~L~~L~L~~N~l~~~~-~p~~~~~l~~L~~L~L~~N-----------------------~l~~ 268 (958)
.+++|++|++++|+++... .+..+..+++|+.|+|++| ++.+
T Consensus 334 ~l~~n~~~~~~~~~~l~~L~~L~ls~n~l~~~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~l~~L~~L~l~~n~l~~ 413 (606)
T 3vq2_A 334 TLTMNKGSISFKKVALPSLSYLDLSRNALSFSGCCSYSDLGTNSLRHLDLSFNGAIIMSANFMGLEELQHLDFQHSTLKR 413 (606)
T ss_dssp EEESCSSCEECCCCCCTTCCEEECCSSCEEEEEECCHHHHCCSCCCEEECCSCSEEEECCCCTTCTTCCEEECTTSEEES
T ss_pred eccCCcCccchhhccCCCCCEEECcCCccCCCcchhhhhccCCcccEeECCCCccccchhhccCCCCCCeeECCCCccCC
Confidence 1233333333333332110 1223333344444444444 4443
Q ss_pred CCC--CCCCCCCcCEEeccCCcCCCcCCCC-CCCCCcCEEEccCCcCCC-ccchhccCCCCCCeEeeecccCCCccchhh
Q 002158 269 AVP--DLSRIPNLYYLDLSWNHLTGSIPSK-KLSENVTTIDLSDNYLNG-SILESISNLPFLQTLSLENNFLTGSIPATI 344 (958)
Q Consensus 269 ~~~--~l~~l~~L~~L~Ls~N~l~~~~~~~-~~~~~L~~L~Ls~N~l~~-~~~~~~~~l~~L~~L~L~~N~l~~~ip~~l 344 (958)
.++ .+..+++|++|++++|.+++..|.. ..+++|++|+|++|.+++ ..|..|..+++|++|+|++|++++..|..+
T Consensus 414 ~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~ 493 (606)
T 3vq2_A 414 VTEFSAFLSLEKLLYLDISYTNTKIDFDGIFLGLTSLNTLKMAGNSFKDNTLSNVFANTTNLTFLDLSKCQLEQISWGVF 493 (606)
T ss_dssp TTTTTTTTTCTTCCEEECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTT
T ss_pred ccChhhhhccccCCEEECcCCCCCccchhhhcCCCCCCEEECCCCcCCCcchHHhhccCCCCCEEECCCCcCCccChhhh
Confidence 333 2444445555555555544433332 334566666666666655 356666666666666666666665555555
Q ss_pred hcccccCccccceEeccCCCCCCCcc-CC-CCCCcceEEeCCCCCCCCCCCCCCCcccccC-CCCCccccccCCCCCCCC
Q 002158 345 WQNKSFSTKARLKIDLRNNSFSNIVG-DL-TLPNNVTLRLGGNPICTSANIPNTGRFCGSD-AGGDETLTNSKVNCPVQA 421 (958)
Q Consensus 345 ~~~~~~~~~~l~~L~Ls~N~l~~l~~-~~-~l~~L~~L~l~~N~l~~~~~~~~~~~~~~~~-~~~~~~L~~n~~~C~c~~ 421 (958)
..+ +.|+.|+|++|+++++.. .. .+++|+.|++++|++...+. . +.... ..+.+.+.+|+|.|+|+.
T Consensus 494 ~~l-----~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~p~---~--~~~l~~~L~~l~l~~N~~~c~c~~ 563 (606)
T 3vq2_A 494 DTL-----HRLQLLNMSHNNLLFLDSSHYNQLYSLSTLDCSFNRIETSKG---I--LQHFPKSLAFFNLTNNSVACICEH 563 (606)
T ss_dssp TTC-----TTCCEEECCSSCCSCEEGGGTTTCTTCCEEECTTSCCCCEES---C--GGGSCTTCCEEECCSCCCCCSSTT
T ss_pred ccc-----ccCCEEECCCCcCCCcCHHHccCCCcCCEEECCCCcCcccCH---h--HhhhcccCcEEEccCCCcccCCcc
Confidence 433 456688888888888743 33 78888888888888863221 1 22222 367889999999999999
Q ss_pred CCCCCcccccCCCC---CCceeeeeceee
Q 002158 422 CPVDNFFEYVPASP---EPCFCAAPLRIG 447 (958)
Q Consensus 422 ~~~~~~~~~~~~~~---~~~~c~sp~~~~ 447 (958)
.++..|++...... +...|++|....
T Consensus 564 ~~~~~~l~~~~~~~~~~~~~~C~~p~~~~ 592 (606)
T 3vq2_A 564 QKFLQWVKEQKQFLVNVEQMTCATPVEMN 592 (606)
T ss_dssp HHHHTTTTTSSSSBSSGGGCCCC------
T ss_pred HHHHHHHHcCcccccCCccceeCCChHhC
Confidence 99999997654433 347898886643
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-36 Score=344.07 Aligned_cols=239 Identities=15% Similarity=0.133 Sum_probs=181.4
Q ss_pred CCCCCceeeeeCCeEEEEEEEC-CCcEEEEEEeccCCh---hcHHHHHHHHHHHHccCC-CCc----------ce-----
Q 002158 626 YFSSSTQVGQGGYGKVYKGILS-DNTTVAIKRAEEGSL---QGQNEFLTEIKLLSRLHH-RNL----------VS----- 685 (958)
Q Consensus 626 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~H-~ni----------v~----- 685 (958)
.|...+.||+|+||+||+|.+. +|+.||||++..... ...+.|.+|+.+++.++| +|. +.
T Consensus 79 ~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 158 (413)
T 3dzo_A 79 TLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVK 158 (413)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEEEE
T ss_pred eEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhhcc
Confidence 4556789999999999999975 699999999874322 235679999999999987 321 11
Q ss_pred ------EEEEEEe-----CCeEEEEEEecCCCCHHHHhc-----cCCCCCchHHHHHHHHHHHHHHHHHhhhcCCCCeec
Q 002158 686 ------LLGYCDE-----EGEQMLVYEFVPNGTLRDWLS-----GRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFH 749 (958)
Q Consensus 686 ------l~~~~~~-----~~~~~lV~E~~~~gsL~~~l~-----~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH 749 (958)
+..++.. ....+++|+++ +++|.++++ ......+++..++.++.|+++||+|||+++ |+|
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---iiH 234 (413)
T 3dzo_A 159 DPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG---LVH 234 (413)
T ss_dssp CCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTT---EEC
T ss_pred cCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccc
Confidence 1111111 22467788876 689999985 233445899999999999999999999999 999
Q ss_pred cCCCccceEecCCCCeEEeeeeeecccccCCCCCCccceeeeeccCCCCccChhhh----------ccCCCCCcchhhhH
Q 002158 750 RDIKASNILLDSNLNAKVADFGLSRLAPVLDDEGTMPTHVSTIVKGTPGYLDPEYF----------LTHKLTDKSDVYSL 819 (958)
Q Consensus 750 ~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~----------~~~~~~~~~DV~S~ 819 (958)
|||||+|||++.++.+||+|||+++.... ......| +.|+|||++ ....++.++|||||
T Consensus 235 rDiKp~NILl~~~~~~kL~DFG~a~~~~~----------~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSl 303 (413)
T 3dzo_A 235 TYLRPVDIVLDQRGGVFLTGFEHLVRDGA----------SAVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTL 303 (413)
T ss_dssp SCCCGGGEEECTTCCEEECCGGGCEETTE----------EECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHH
T ss_pred CCcccceEEEecCCeEEEEeccceeecCC----------ccccCCC-CceeCchhhhccccccccccCcCCCchhhHHHH
Confidence 99999999999999999999999875421 1334567 999999999 55568889999999
Q ss_pred HHHHHHHHhCCCCCCCCchhHHHHHHHhhcCcchhhhcccCCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002158 820 GVVLLELLTGMQPISHGKNIVREVNVARDSGMVFSIIDNRMGSYPSECVERFVTLALRCCHDKPEHRPSMSDVVR 894 (958)
Q Consensus 820 Gv~l~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 894 (958)
||++|||++|+.||...... .. ...+..... .++..+.+++.+||+.||++||++.++++
T Consensus 304 Gvil~elltg~~Pf~~~~~~----------~~-~~~~~~~~~----~~~~~~~~li~~~l~~dP~~Rpt~~~~l~ 363 (413)
T 3dzo_A 304 GLAIYWIWCADLPNTDDAAL----------GG-SEWIFRSCK----NIPQPVRALLEGFLRYPKEDRLLPLQAME 363 (413)
T ss_dssp HHHHHHHHHSSCCCCTTGGG----------SC-SGGGGSSCC----CCCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred HHHHHHHHHCCCCCCCcchh----------hh-HHHHHhhcc----cCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence 99999999999999753321 11 111111111 33577999999999999999999888764
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-35 Score=350.24 Aligned_cols=332 Identities=19% Similarity=0.171 Sum_probs=261.9
Q ss_pred ceeeEEEEccCCcCCCCccccccCCCCcceeeccCcccCCC-CccccCCCCCcEEEeeCCCCCCCCChhhcCCCCCCEEe
Q 002158 85 HLHVRELQLLSMNLSGNLAPELGQLSRLQYYFMWNDLTGTI-PKEIGNISSLIFLLLNGNKLSGSLPDELGYLSNLNRLQ 163 (958)
Q Consensus 85 ~~~v~~L~L~~~~l~~~~~~~l~~L~~L~~L~l~n~~~~~i-p~~i~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~ 163 (958)
..+++.|+|++|.+++..+..|+++++|++|++++|....+ |..|.++++|++|+|++|.++ .+|.. .+++|++|+
T Consensus 51 ~~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~-~lp~~--~l~~L~~L~ 127 (562)
T 3a79_B 51 PPRTKALSLSQNSISELRMPDISFLSELRVLRLSHNRIRSLDFHVFLFNQDLEYLDVSHNRLQ-NISCC--PMASLRHLD 127 (562)
T ss_dssp CTTCCEEECCSSCCCCCCGGGTTTCTTCCEEECCSCCCCEECTTTTTTCTTCCEEECTTSCCC-EECSC--CCTTCSEEE
T ss_pred CCCcCEEECCCCCccccChhhhccCCCccEEECCCCCCCcCCHHHhCCCCCCCEEECCCCcCC-ccCcc--ccccCCEEE
Confidence 35789999999999998889999999999999986655554 777999999999999999998 67766 899999999
Q ss_pred cccccccc-cCccccccccccceEecccccccccCchhhcCCccchhhhccCCcc--ccCCCcccCCCC-----------
Q 002158 164 VDENNITG-TIPKSFANLSRVRHLHLNNNSIGGQIPSELSKLSTLIHLLVDNNNL--SGNLPPELSELP----------- 229 (958)
Q Consensus 164 L~~N~l~~-~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l--~~~~~~~l~~l~----------- 229 (958)
|++|++++ .+|..|.++++|++|+|++|.+++.....+..+ +|+.|++++|++ ++..|..+..+.
T Consensus 128 Ls~N~l~~l~~p~~~~~l~~L~~L~L~~n~l~~~~~~~l~~L-~L~~L~L~~n~l~~~~~~~~~l~~l~~~~l~l~l~~n 206 (562)
T 3a79_B 128 LSFNDFDVLPVCKEFGNLTKLTFLGLSAAKFRQLDLLPVAHL-HLSCILLDLVSYHIKGGETESLQIPNTTVLHLVFHPN 206 (562)
T ss_dssp CCSSCCSBCCCCGGGGGCTTCCEEEEECSBCCTTTTGGGTTS-CEEEEEEEESSCCCCSSSCCEEEECCEEEEEEEECSS
T ss_pred CCCCCccccCchHhhcccCcccEEecCCCccccCchhhhhhc-eeeEEEeecccccccccCcccccccCcceEEEEecCc
Confidence 99999986 356889999999999999999885333333333 338888888877 655555554433
Q ss_pred ----------------------------------------------------------------------CccEEEccCC
Q 002158 230 ----------------------------------------------------------------------QLCILQLDNN 239 (958)
Q Consensus 230 ----------------------------------------------------------------------~L~~L~L~~N 239 (958)
+|++|++++|
T Consensus 207 ~~~~~~~~~~~~~l~~L~~L~l~~n~~~~~~l~~~~~~l~~l~~L~~L~L~~~~l~~~~~~~~~~~~~~~~L~~L~l~~n 286 (562)
T 3a79_B 207 SLFSVQVNMSVNALGHLQLSNIKLNDENCQRLMTFLSELTRGPTLLNVTLQHIETTWKCSVKLFQFFWPRPVEYLNIYNL 286 (562)
T ss_dssp SCCCCCCEEEESSEEEEEEEEEECCSTTHHHHHHHHHHHHSCSSCEEEEEEEEEECHHHHHHHHHHHTTSSEEEEEEEEE
T ss_pred cchhhhhhhcccccceEEEecccccccccchHHHHHHHHhccCcceEEEecCCcCcHHHHHHHHHhhhcccccEEEEecc
Confidence 5566666666
Q ss_pred CCCCCCccccc-----------------------------------------------------cCCCCCCEEEcccCCC
Q 002158 240 NFSASEIPATY-----------------------------------------------------GNFSKLVKLSLRNCNL 266 (958)
Q Consensus 240 ~l~~~~~p~~~-----------------------------------------------------~~l~~L~~L~L~~N~l 266 (958)
.+++ .+|..+ ..+++|++|+|++|++
T Consensus 287 ~l~~-~ip~~~~~~~~~~L~~L~~~~~~~~~~~~p~~~~~~~~~~~~L~~L~l~~n~~~~~~~~~~l~~L~~L~l~~n~l 365 (562)
T 3a79_B 287 TITE-RIDREEFTYSETALKSLMIEHVKNQVFLFSKEALYSVFAEMNIKMLSISDTPFIHMVCPPSPSSFTFLNFTQNVF 365 (562)
T ss_dssp EECS-CCCCCCCCCCSCSCCEEEEEEEEECCCSSCHHHHHHHHHTCCCSEEEEESSCCCCCCCCSSCCCCCEEECCSSCC
T ss_pred Eeec-cccchhhhcccccchheehhhcccceeecChhhhhhhhccCcceEEEccCCCcccccCccCCCCceEEECCCCcc
Confidence 6542 334332 6778999999999999
Q ss_pred CCCCC-CCCCCCCcCEEeccCCcCCCcC--C-CCCCCCCcCEEEccCCcCCC-ccchhccCCCCCCeEeeecccCCCccc
Q 002158 267 QGAVP-DLSRIPNLYYLDLSWNHLTGSI--P-SKKLSENVTTIDLSDNYLNG-SILESISNLPFLQTLSLENNFLTGSIP 341 (958)
Q Consensus 267 ~~~~~-~l~~l~~L~~L~Ls~N~l~~~~--~-~~~~~~~L~~L~Ls~N~l~~-~~~~~~~~l~~L~~L~L~~N~l~~~ip 341 (958)
++..+ .+..+++|++|+|++|++++.. | ....+++|++|+|++|++++ ..+..+..+++|++|+|++|++++.+|
T Consensus 366 ~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~ 445 (562)
T 3a79_B 366 TDSVFQGCSTLKRLQTLILQRNGLKNFFKVALMTKNMSSLETLDVSLNSLNSHAYDRTCAWAESILVLNLSSNMLTGSVF 445 (562)
T ss_dssp CTTTTTTCCSCSSCCEEECCSSCCCBTTHHHHTTTTCTTCCEEECTTSCCBSCCSSCCCCCCTTCCEEECCSSCCCGGGG
T ss_pred ccchhhhhcccCCCCEEECCCCCcCCcccchhhhcCCCCCCEEECCCCcCCCccChhhhcCcccCCEEECCCCCCCcchh
Confidence 98665 5899999999999999998532 2 24566899999999999998 555568899999999999999988777
Q ss_pred hhhhcccccCccccceEeccCCCCCCCccCC-CCCCcceEEeCCCCCCCCCCCCCCCcccccCCCCCccccccCCCCCCC
Q 002158 342 ATIWQNKSFSTKARLKIDLRNNSFSNIVGDL-TLPNNVTLRLGGNPICTSANIPNTGRFCGSDAGGDETLTNSKVNCPVQ 420 (958)
Q Consensus 342 ~~l~~~~~~~~~~l~~L~Ls~N~l~~l~~~~-~l~~L~~L~l~~N~l~~~~~~~~~~~~~~~~~~~~~~L~~n~~~C~c~ 420 (958)
..+. +.++.|+|++|+|+.++... .+++|+.|+|++|.+...+.. .+......+.+.|.+|+|.|+|+
T Consensus 446 ~~l~-------~~L~~L~L~~N~l~~ip~~~~~l~~L~~L~L~~N~l~~l~~~----~~~~l~~L~~L~l~~N~~~c~c~ 514 (562)
T 3a79_B 446 RCLP-------PKVKVLDLHNNRIMSIPKDVTHLQALQELNVASNQLKSVPDG----VFDRLTSLQYIWLHDNPWDCTCP 514 (562)
T ss_dssp SSCC-------TTCSEEECCSSCCCCCCTTTTSSCCCSEEECCSSCCCCCCTT----STTTCTTCCCEECCSCCBCCCHH
T ss_pred hhhc-------CcCCEEECCCCcCcccChhhcCCCCCCEEECCCCCCCCCCHH----HHhcCCCCCEEEecCCCcCCCcc
Confidence 6542 57889999999999999876 899999999999999753322 23344566789999999999999
Q ss_pred CCCCCC-cccccC
Q 002158 421 ACPVDN-FFEYVP 432 (958)
Q Consensus 421 ~~~~~~-~~~~~~ 432 (958)
..++.. |++...
T Consensus 515 ~~~~~~~~~~~~~ 527 (562)
T 3a79_B 515 GIRYLSEWINKHS 527 (562)
T ss_dssp HHHHHHHHHHHTT
T ss_pred hHHHHHHHHHhcC
Confidence 998855 876544
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-35 Score=320.88 Aligned_cols=229 Identities=13% Similarity=0.100 Sum_probs=185.1
Q ss_pred cCCCCCceeeeeCCeEEEEEEEC-CCcEEEEEEeccCCh---hcHHHHHHHHHHHHccCCCCcceEEEEEEeCCeEEEEE
Q 002158 625 AYFSSSTQVGQGGYGKVYKGILS-DNTTVAIKRAEEGSL---QGQNEFLTEIKLLSRLHHRNLVSLLGYCDEEGEQMLVY 700 (958)
Q Consensus 625 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~ 700 (958)
.+|...+.||+|+||.||+|.+. +++.||||++..... ...+.|.+|+..+++++||||+++++++..++..|+||
T Consensus 31 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 110 (286)
T 3uqc_A 31 GRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVVA 110 (286)
T ss_dssp TTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred CcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEEEE
Confidence 46778889999999999999986 489999999976532 33467999999999999999999999999999999999
Q ss_pred EecCCCCHHHHhccCCCCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEecCCCCeEEeeeeeecccccCC
Q 002158 701 EFVPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSRLAPVLD 780 (958)
Q Consensus 701 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~ 780 (958)
||+++++|.++++.. ....++.+++.|+++||+|||+++ |+||||||+|||++.++.+||+++|
T Consensus 111 e~~~g~~L~~~l~~~----~~~~~~~~i~~ql~~aL~~lH~~g---ivH~Dikp~NIll~~~g~~kl~~~~--------- 174 (286)
T 3uqc_A 111 EWIRGGSLQEVADTS----PSPVGAIRAMQSLAAAADAAHRAG---VALSIDHPSRVRVSIDGDVVLAYPA--------- 174 (286)
T ss_dssp ECCCEEEHHHHHTTC----CCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEEETTSCEEECSCC---------
T ss_pred EecCCCCHHHHHhcC----CChHHHHHHHHHHHHHHHHHHHCC---CccCCCCcccEEEcCCCCEEEEecc---------
Confidence 999999999999542 344568899999999999999999 9999999999999999999998544
Q ss_pred CCCCccceeeeeccCCCCccChhhhccCCCCCcchhhhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcCcchhhhcccC
Q 002158 781 DEGTMPTHVSTIVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVLLELLTGMQPISHGKNIVREVNVARDSGMVFSIIDNRM 860 (958)
Q Consensus 781 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gv~l~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~i~~~~ 860 (958)
|++ .++.++|||||||++|||+||+.||......... ......+....
T Consensus 175 ------------------~~~-------~~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~-------~~~~~~~~~~~ 222 (286)
T 3uqc_A 175 ------------------TMP-------DANPQDDIRGIGASLYALLVNRWPLPEAGVRSGL-------APAERDTAGQP 222 (286)
T ss_dssp ------------------CCT-------TCCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCS-------EECCBCTTSCB
T ss_pred ------------------ccC-------CCCchhHHHHHHHHHHHHHHCCCCCCcCCcchhh-------HHHHHHhccCC
Confidence 333 2678999999999999999999999754321100 00000000000
Q ss_pred ---CCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHhh
Q 002158 861 ---GSYPSECVERFVTLALRCCHDKPEHRPSMSDVVRELENILKM 902 (958)
Q Consensus 861 ---~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~ 902 (958)
......++..+.+++.+||+.||++| |++|+++.|+++...
T Consensus 223 ~~~~~~~~~~~~~l~~li~~~l~~dP~~R-s~~el~~~L~~~~~~ 266 (286)
T 3uqc_A 223 IEPADIDRDIPFQISAVAARSVQGDGGIR-SASTLLNLMQQATAV 266 (286)
T ss_dssp CCHHHHCTTSCHHHHHHHHHHHCTTSSCC-CHHHHHHHHHHHHC-
T ss_pred CChhhcccCCCHHHHHHHHHHcccCCccC-CHHHHHHHHHHHhcc
Confidence 01123466789999999999999999 999999999998754
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-35 Score=346.84 Aligned_cols=343 Identities=20% Similarity=0.220 Sum_probs=228.3
Q ss_pred eeeEEEEccCCcCCCCccccccCCCCcceeeccCcccCCC-CccccCCCCCcEEEeeCCCCCCCCChhhcCCCCCCEEec
Q 002158 86 LHVRELQLLSMNLSGNLAPELGQLSRLQYYFMWNDLTGTI-PKEIGNISSLIFLLLNGNKLSGSLPDELGYLSNLNRLQV 164 (958)
Q Consensus 86 ~~v~~L~L~~~~l~~~~~~~l~~L~~L~~L~l~n~~~~~i-p~~i~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~L 164 (958)
.+++.|+|++|.+++..+..|.++++|++|++++|....+ |..|.++++|++|+|++|.++ .+|.. .+++|++|+|
T Consensus 21 ~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~-~lp~~--~l~~L~~L~L 97 (520)
T 2z7x_B 21 QKTTILNISQNYISELWTSDILSLSKLRILIISHNRIQYLDISVFKFNQELEYLDLSHNKLV-KISCH--PTVNLKHLDL 97 (520)
T ss_dssp TTCSEEECCSSCCCCCCHHHHTTCTTCCEEECCSSCCCEEEGGGGTTCTTCCEEECCSSCCC-EEECC--CCCCCSEEEC
T ss_pred ccccEEECCCCcccccChhhccccccccEEecCCCccCCcChHHhhcccCCCEEecCCCcee-ecCcc--ccCCccEEec
Confidence 3566666666666666666666666666666664443333 556666666666666666666 45544 5666666666
Q ss_pred ccccccc-cCccccccccccceEecccccccc-------------------------cCchhhcCCc-------------
Q 002158 165 DENNITG-TIPKSFANLSRVRHLHLNNNSIGG-------------------------QIPSELSKLS------------- 205 (958)
Q Consensus 165 ~~N~l~~-~~p~~~~~l~~L~~L~Ls~N~l~~-------------------------~~p~~l~~l~------------- 205 (958)
++|++++ .+|..|+++++|++|+|++|.+++ ..|..+..+.
T Consensus 98 ~~N~l~~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~l~~L~L~~L~l~~n~l~~~~~~~~~l~~l~~~~l~l~l~~n~~ 177 (520)
T 2z7x_B 98 SFNAFDALPICKEFGNMSQLKFLGLSTTHLEKSSVLPIAHLNISKVLLVLGETYGEKEDPEGLQDFNTESLHIVFPTNKE 177 (520)
T ss_dssp CSSCCSSCCCCGGGGGCTTCCEEEEEESSCCGGGGGGGTTSCEEEEEEEECTTTTSSCCTTTTTTCCEEEEEEECCSSSC
T ss_pred cCCccccccchhhhccCCcceEEEecCcccchhhccccccceeeEEEeecccccccccccccccccccceEEEEeccCcc
Confidence 6666665 355666666666666666666543 3333333311
Q ss_pred ----------------------------------------------------------------------cchhhhccCC
Q 002158 206 ----------------------------------------------------------------------TLIHLLVDNN 215 (958)
Q Consensus 206 ----------------------------------------------------------------------~L~~L~L~~N 215 (958)
+|++|++++|
T Consensus 178 ~~~~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~~l~~l~~L~~L~l~~~~l~~~~~~~~~~~~~~~~L~~L~l~~n 257 (520)
T 2z7x_B 178 FHFILDVSVKTVANLELSNIKCVLEDNKCSYFLSILAKLQTNPKLSNLTLNNIETTWNSFIRILQLVWHTTVWYFSISNV 257 (520)
T ss_dssp CCCCCCCCCTTCSEEEECCEEECCSTTTTHHHHHHHHGGGGCTTCCEEEEEEEEEEHHHHHHHHHHHHTSSCSEEEEEEE
T ss_pred hhhhhhhhhhcccceeeccccccccccccceeecchhhhccccchhhccccccccCHHHHHHHHHHhhhCcccEEEeecc
Confidence 3444444444
Q ss_pred ccccCCCccc-----CCCCCccEEEccCCCCCCCCcc-cc-------------------------ccCCCCCCEEEcccC
Q 002158 216 NLSGNLPPEL-----SELPQLCILQLDNNNFSASEIP-AT-------------------------YGNFSKLVKLSLRNC 264 (958)
Q Consensus 216 ~l~~~~~~~l-----~~l~~L~~L~L~~N~l~~~~~p-~~-------------------------~~~l~~L~~L~L~~N 264 (958)
++++.+|..+ ..+++|+.+++++|.+ .+| .. +..+++|++|++++|
T Consensus 258 ~l~~~~p~~~~~~~~~~l~~L~~l~l~~n~~---~~p~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~l~~L~~L~Ls~n 334 (520)
T 2z7x_B 258 KLQGQLDFRDFDYSGTSLKALSIHQVVSDVF---GFPQSYIYEIFSNMNIKNFTVSGTRMVHMLCPSKISPFLHLDFSNN 334 (520)
T ss_dssp EEESCCCCCCCCCCSCCCCEEEEEEEEECCC---CSCTHHHHHHHHTCCCSEEEEESSCCCCCCCCSSCCCCCEEECCSS
T ss_pred cccCccccchhhcccccCceeEeccccccce---ecchhhhhcccccCceeEEEcCCCccccccchhhCCcccEEEeECC
Confidence 4544555554 4444444444444443 112 00 156778888888888
Q ss_pred CCCCCCC-CCCCCCCcCEEeccCCcCCC--cCCC-CCCCCCcCEEEccCCcCCCccc-hhccCCCCCCeEeeecccCCCc
Q 002158 265 NLQGAVP-DLSRIPNLYYLDLSWNHLTG--SIPS-KKLSENVTTIDLSDNYLNGSIL-ESISNLPFLQTLSLENNFLTGS 339 (958)
Q Consensus 265 ~l~~~~~-~l~~l~~L~~L~Ls~N~l~~--~~~~-~~~~~~L~~L~Ls~N~l~~~~~-~~~~~l~~L~~L~L~~N~l~~~ 339 (958)
++++..+ .+..+++|++|+|++|++++ .+|. ...+++|++|+|++|.+++.+| ..+..+++|++|+|++|++++.
T Consensus 335 ~l~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~~~l~~L~~L~Ls~N~l~~~l~~~~~~~l~~L~~L~Ls~N~l~~~ 414 (520)
T 2z7x_B 335 LLTDTVFENCGHLTELETLILQMNQLKELSKIAEMTTQMKSLQQLDISQNSVSYDEKKGDCSWTKSLLSLNMSSNILTDT 414 (520)
T ss_dssp CCCTTTTTTCCCCSSCCEEECCSSCCCBHHHHHHHHTTCTTCCEEECCSSCCBCCGGGCSCCCCTTCCEEECCSSCCCGG
T ss_pred ccChhhhhhhccCCCCCEEEccCCccCccccchHHHhhCCCCCEEECCCCcCCcccccchhccCccCCEEECcCCCCCcc
Confidence 8887554 47888888888888888874 2222 3456788888888888887344 4577888888888888888877
Q ss_pred cchhhhcccccCccccceEeccCCCCCCCccCC-CCCCcceEEeCCCCCCCCCCCCCCCcccccCCCCCccccccCCCCC
Q 002158 340 IPATIWQNKSFSTKARLKIDLRNNSFSNIVGDL-TLPNNVTLRLGGNPICTSANIPNTGRFCGSDAGGDETLTNSKVNCP 418 (958)
Q Consensus 340 ip~~l~~~~~~~~~~l~~L~Ls~N~l~~l~~~~-~l~~L~~L~l~~N~l~~~~~~~~~~~~~~~~~~~~~~L~~n~~~C~ 418 (958)
+|..+. +.++.|+|++|+|+.++... .+++|+.|++++|++...+.. .+......+.+.+.+|+|.|+
T Consensus 415 ~~~~l~-------~~L~~L~Ls~N~l~~ip~~~~~l~~L~~L~L~~N~l~~l~~~----~~~~l~~L~~L~l~~N~~~c~ 483 (520)
T 2z7x_B 415 IFRCLP-------PRIKVLDLHSNKIKSIPKQVVKLEALQELNVASNQLKSVPDG----IFDRLTSLQKIWLHTNPWDCS 483 (520)
T ss_dssp GGGSCC-------TTCCEEECCSSCCCCCCGGGGGCTTCCEEECCSSCCCCCCTT----TTTTCTTCCEEECCSSCBCCC
T ss_pred hhhhhc-------ccCCEEECCCCcccccchhhhcCCCCCEEECCCCcCCccCHH----HhccCCcccEEECcCCCCccc
Confidence 776542 57889999999999999866 999999999999999753322 233445677899999999999
Q ss_pred CCCCCC-CCcccccCCC-CCCceeeeece
Q 002158 419 VQACPV-DNFFEYVPAS-PEPCFCAAPLR 445 (958)
Q Consensus 419 c~~~~~-~~~~~~~~~~-~~~~~c~sp~~ 445 (958)
|+..++ ..|++..... .....|++|.+
T Consensus 484 c~~~~~~~~~~~~~~~~~~~~~~C~~p~~ 512 (520)
T 2z7x_B 484 CPRIDYLSRWLNKNSQKEQGSAKCSGSGK 512 (520)
T ss_dssp HHHHHHHHHHHHHTTTTEESCCBBTTTCC
T ss_pred CCchHHHHHHHHhccccCCCCCCcCCccc
Confidence 999999 8999765543 23578988854
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-34 Score=330.98 Aligned_cols=360 Identities=16% Similarity=0.145 Sum_probs=284.4
Q ss_pred cCCCCCCCCCCCCCCceeeCc---cccC-----------CCceeeEEEEccCCcCCCCccccccCCCCcceeeccCcccC
Q 002158 58 LRNWNKGDPCMSNWTGVLCFD---TVET-----------DGHLHVRELQLLSMNLSGNLAPELGQLSRLQYYFMWNDLTG 123 (958)
Q Consensus 58 l~~W~~~~~c~~~w~gV~C~~---~~~~-----------~~~~~v~~L~L~~~~l~~~~~~~l~~L~~L~~L~l~n~~~~ 123 (958)
+++|.....|++.|.+..|.- .... ....+++.|++.++.+....+..+..+++|++|+++++...
T Consensus 3 ~~~~~~~~~C~~~~~~~~c~~~~~~i~~~~~~~~~~~~~~~l~~l~~l~l~~~~l~~l~~~~~~~l~~L~~L~L~~n~i~ 82 (390)
T 3o6n_A 3 VKPRQPEYKCIDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQIE 82 (390)
T ss_dssp ----CCEECBCC------EEEESCEECSSCCCCEESCSSGGGCCCSEEEEESCEESEECTHHHHHCCCCSEEECTTSCCC
T ss_pred cCCCCCccceehhhhhhccceeeeeeecccccccccccccccCCceEEEecCCchhhCChhHhcccccCcEEECCCCccc
Confidence 578999999998766666621 1110 01246888999999888766666889999999999877666
Q ss_pred CCC-ccccCCCCCcEEEeeCCCCCCCCChhhcCCCCCCEEecccccccccCccccccccccceEecccccccccCchhhc
Q 002158 124 TIP-KEIGNISSLIFLLLNGNKLSGSLPDELGYLSNLNRLQVDENNITGTIPKSFANLSRVRHLHLNNNSIGGQIPSELS 202 (958)
Q Consensus 124 ~ip-~~i~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~ 202 (958)
.++ ..|.++++|++|+|++|.+++..|..|+++++|++|+|++|+++...+..|.++++|++|+|++|.+++..+..+.
T Consensus 83 ~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~ 162 (390)
T 3o6n_A 83 EIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLSSLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQ 162 (390)
T ss_dssp EECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCBCCTTTTS
T ss_pred ccChhhccCCCCcCEEECCCCCCCcCCHHHhcCCCCCCEEECCCCccCcCCHHHhcCCCCCcEEECCCCccCccChhhcc
Confidence 555 5799999999999999999988888899999999999999999955555578999999999999999988888899
Q ss_pred CCccchhhhccCCccccCCCcccCCCCCccEEEccCCCCCCCCccccccCCCCCCEEEcccCCCCCCCCCCCCCCCcCEE
Q 002158 203 KLSTLIHLLVDNNNLSGNLPPELSELPQLCILQLDNNNFSASEIPATYGNFSKLVKLSLRNCNLQGAVPDLSRIPNLYYL 282 (958)
Q Consensus 203 ~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~l~~l~~L~~L 282 (958)
.+++|++|++++|++++. .+..+++|+.|++++|.++. +...++|+.|++++|.++..+... .++|+.|
T Consensus 163 ~l~~L~~L~l~~n~l~~~---~~~~l~~L~~L~l~~n~l~~------~~~~~~L~~L~l~~n~l~~~~~~~--~~~L~~L 231 (390)
T 3o6n_A 163 ATTSLQNLQLSSNRLTHV---DLSLIPSLFHANVSYNLLST------LAIPIAVEELDASHNSINVVRGPV--NVELTIL 231 (390)
T ss_dssp SCTTCCEEECCSSCCSBC---CGGGCTTCSEEECCSSCCSE------EECCSSCSEEECCSSCCCEEECCC--CSSCCEE
T ss_pred CCCCCCEEECCCCcCCcc---ccccccccceeecccccccc------cCCCCcceEEECCCCeeeeccccc--cccccEE
Confidence 999999999999999865 35667899999999999863 234468999999999998775543 4799999
Q ss_pred eccCCcCCCcCCCCCCCCCcCEEEccCCcCCCccchhccCCCCCCeEeeecccCCCccchhhhcccccCccccceEeccC
Q 002158 283 DLSWNHLTGSIPSKKLSENVTTIDLSDNYLNGSILESISNLPFLQTLSLENNFLTGSIPATIWQNKSFSTKARLKIDLRN 362 (958)
Q Consensus 283 ~Ls~N~l~~~~~~~~~~~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~ip~~l~~~~~~~~~~l~~L~Ls~ 362 (958)
+|++|.+++ ++....+++|++|+|++|.+++..+..|..+++|++|+|++|++++ +|..+. ..+.|+.|+|++
T Consensus 232 ~l~~n~l~~-~~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~-~~~~~~-----~l~~L~~L~L~~ 304 (390)
T 3o6n_A 232 KLQHNNLTD-TAWLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLVA-LNLYGQ-----PIPTLKVLDLSH 304 (390)
T ss_dssp ECCSSCCCC-CGGGGGCTTCSEEECCSSCCCEEESGGGTTCSSCCEEECCSSCCCE-EECSSS-----CCTTCCEEECCS
T ss_pred ECCCCCCcc-cHHHcCCCCccEEECCCCcCCCcChhHccccccCCEEECCCCcCcc-cCcccC-----CCCCCCEEECCC
Confidence 999999985 4666777999999999999999999999999999999999999984 555442 245788999999
Q ss_pred CCCCCCccCC-CCCCcceEEeCCCCCCCCCCCCCCCcccccCCCCCccccccCCCCCCCCCCCCCcccccCCCCCCceee
Q 002158 363 NSFSNIVGDL-TLPNNVTLRLGGNPICTSANIPNTGRFCGSDAGGDETLTNSKVNCPVQACPVDNFFEYVPASPEPCFCA 441 (958)
Q Consensus 363 N~l~~l~~~~-~l~~L~~L~l~~N~l~~~~~~~~~~~~~~~~~~~~~~L~~n~~~C~c~~~~~~~~~~~~~~~~~~~~c~ 441 (958)
|+++.++... .+++|+.|++++|++.... +......+.+.+.+|+|.|+|...++..|-+...... ...|.
T Consensus 305 n~l~~~~~~~~~l~~L~~L~L~~N~i~~~~-------~~~~~~L~~L~l~~N~~~~~~~~~~~~~~~~~~~~~~-~~~c~ 376 (390)
T 3o6n_A 305 NHLLHVERNQPQFDRLENLYLDHNSIVTLK-------LSTHHTLKNLTLSHNDWDCNSLRALFRNVARPAVDDA-DQHCK 376 (390)
T ss_dssp SCCCCCGGGHHHHTTCSEEECCSSCCCCCC-------CCTTCCCSEEECCSSCEEHHHHHHHTTTCCTTTBCCC-CSCCC
T ss_pred CcceecCccccccCcCCEEECCCCccceeC-------chhhccCCEEEcCCCCccchhHHHHHHHHHhhccccc-Cceec
Confidence 9999998776 8899999999999996542 2334566789999999999998877777765443332 34555
Q ss_pred ee
Q 002158 442 AP 443 (958)
Q Consensus 442 sp 443 (958)
.|
T Consensus 377 ~~ 378 (390)
T 3o6n_A 377 ID 378 (390)
T ss_dssp TT
T ss_pred cc
Confidence 44
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-34 Score=318.20 Aligned_cols=226 Identities=22% Similarity=0.331 Sum_probs=180.9
Q ss_pred CCCCC-ceeeeeCCeEEEEEEEC-CCcEEEEEEeccCChhcHHHHHHHHHHH-HccCCCCcceEEEEEEe----CCeEEE
Q 002158 626 YFSSS-TQVGQGGYGKVYKGILS-DNTTVAIKRAEEGSLQGQNEFLTEIKLL-SRLHHRNLVSLLGYCDE----EGEQML 698 (958)
Q Consensus 626 ~~~~~-~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l-~~l~H~niv~l~~~~~~----~~~~~l 698 (958)
+|... +.||+|+||.||+|... +++.||||++.. ...+.+|++++ +..+||||+++++++.. ....++
T Consensus 18 ~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~-----~~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~l 92 (299)
T 3m2w_A 18 DYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLI 92 (299)
T ss_dssp TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEE
T ss_pred chhhcCcccccCCCeEEEEEEEcCCCcEEEEEEecc-----cHHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceEEE
Confidence 44444 67999999999999985 689999999964 23567899888 55689999999999977 678899
Q ss_pred EEEecCCCCHHHHhccCCCCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEecC---CCCeEEeeeeeecc
Q 002158 699 VYEFVPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDS---NLNAKVADFGLSRL 775 (958)
Q Consensus 699 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~---~~~~kl~DFGla~~ 775 (958)
||||+++|+|.+++.......+++.++..++.|++.||+|||+.+ |+||||||+||+++. ++.+||+|||+++.
T Consensus 93 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~a~~ 169 (299)
T 3m2w_A 93 VMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFAKE 169 (299)
T ss_dssp EECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSTTCCEEECCCTTCEE
T ss_pred EEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEecCCCCCcEEEeccccccc
Confidence 999999999999998776567999999999999999999999999 999999999999998 78899999999864
Q ss_pred cccCCCCCCccceeeeeccCCCCccChhhhccCCCCCcchhhhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcCcchhh
Q 002158 776 APVLDDEGTMPTHVSTIVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVLLELLTGMQPISHGKNIVREVNVARDSGMVFSI 855 (958)
Q Consensus 776 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gv~l~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~ 855 (958)
.. +..++.++|||||||++|||++|+.||......... ......
T Consensus 170 ~~-----------------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~-------~~~~~~ 213 (299)
T 3m2w_A 170 TT-----------------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAIS-------PGMKTR 213 (299)
T ss_dssp CT-----------------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC--------------CCSCCS
T ss_pred cc-----------------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhh-------HHHHHH
Confidence 31 234678999999999999999999999653321100 000011
Q ss_pred hcccCCCCC----hHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 002158 856 IDNRMGSYP----SECVERFVTLALRCCHDKPEHRPSMSDVVRE 895 (958)
Q Consensus 856 i~~~~~~~~----~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 895 (958)
+.......+ ..++..+.+++.+||+.||++||+++|++++
T Consensus 214 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~h 257 (299)
T 3m2w_A 214 IRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH 257 (299)
T ss_dssp SCTTCCSSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred HhhccccCCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhcC
Confidence 111111222 2356789999999999999999999999975
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-35 Score=360.32 Aligned_cols=322 Identities=31% Similarity=0.491 Sum_probs=257.1
Q ss_pred eeEEEEccCCcCCCCcccc-ccCCCCcceeeccCc-ccCCCCccccC---------------------------CCCCcE
Q 002158 87 HVRELQLLSMNLSGNLAPE-LGQLSRLQYYFMWND-LTGTIPKEIGN---------------------------ISSLIF 137 (958)
Q Consensus 87 ~v~~L~L~~~~l~~~~~~~-l~~L~~L~~L~l~n~-~~~~ip~~i~~---------------------------l~~L~~ 137 (958)
.++.|+|.+|.++|.+|.. ++.+++|++|++++| +.+.+|..+.+ +++|++
T Consensus 319 ~L~~L~L~~n~l~~~ip~~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~~L~~L~Ls~N~l~~~~~~~~~~~~~~~L~~ 398 (768)
T 3rgz_A 319 LLESLALSSNNFSGELPMDTLLKMRGLKVLDLSFNEFSGELPESLTNLSASLLTLDLSSNNFSGPILPNLCQNPKNTLQE 398 (768)
T ss_dssp TCCEEECCSSEEEEECCHHHHTTCTTCCEEECCSSEEEECCCTTHHHHTTTCSEEECCSSEEEEECCTTTTCSTTCCCCE
T ss_pred CccEEECCCCcccCcCCHHHHhcCCCCCEEeCcCCccCccccHHHHhhhcCCcEEEccCCCcCCCcChhhhhcccCCccE
Confidence 5677777777777666655 677777777766543 33455554443 456677
Q ss_pred EEeeCCCCCCCCChhhcCCCCCCEEecccccccccCccccccccccceEecccccccccCchhhcCCccchhhhccCCcc
Q 002158 138 LLLNGNKLSGSLPDELGYLSNLNRLQVDENNITGTIPKSFANLSRVRHLHLNNNSIGGQIPSELSKLSTLIHLLVDNNNL 217 (958)
Q Consensus 138 L~Ls~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l 217 (958)
|+|++|.+++.+|..+.++++|++|+|++|++++.+|..+..+++|+.|+|++|.+++.+|..+..+++|++|+|++|++
T Consensus 399 L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l 478 (768)
T 3rgz_A 399 LYLQNNGFTGKIPPTLSNCSELVSLHLSFNYLSGTIPSSLGSLSKLRDLKLWLNMLEGEIPQELMYVKTLETLILDFNDL 478 (768)
T ss_dssp EECCSSEEEEECCGGGGGCTTCCEEECCSSEEESCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCC
T ss_pred EECCCCccccccCHHHhcCCCCCEEECcCCcccCcccHHHhcCCCCCEEECCCCcccCcCCHHHcCCCCceEEEecCCcc
Confidence 77777777777888888888899999999999888888898999999999999999988898899999999999999999
Q ss_pred ccCCCcccCCCCCccEEEccCCCCCCCCccccccCCCCCCEEEcccCCCCCCCC-CCCCCCCcCEEeccCCcCCCcCCCC
Q 002158 218 SGNLPPELSELPQLCILQLDNNNFSASEIPATYGNFSKLVKLSLRNCNLQGAVP-DLSRIPNLYYLDLSWNHLTGSIPSK 296 (958)
Q Consensus 218 ~~~~~~~l~~l~~L~~L~L~~N~l~~~~~p~~~~~l~~L~~L~L~~N~l~~~~~-~l~~l~~L~~L~Ls~N~l~~~~~~~ 296 (958)
++.+|..+..+++|++|+|++|+++ ..+|..++++++|+.|+|++|++++..| .+..+++|+.|+|++|+++|.+|..
T Consensus 479 ~~~~p~~l~~l~~L~~L~L~~N~l~-~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~g~ip~~ 557 (768)
T 3rgz_A 479 TGEIPSGLSNCTNLNWISLSNNRLT-GEIPKWIGRLENLAILKLSNNSFSGNIPAELGDCRSLIWLDLNTNLFNGTIPAA 557 (768)
T ss_dssp CSCCCGGGGGCTTCCEEECCSSCCC-SCCCGGGGGCTTCCEEECCSSCCEEECCGGGGGCTTCCEEECCSSEEESBCCGG
T ss_pred cCcCCHHHhcCCCCCEEEccCCccC-CcCChHHhcCCCCCEEECCCCcccCcCCHHHcCCCCCCEEECCCCccCCcCChH
Confidence 9888999999999999999999997 4678899999999999999999988777 4889999999999999988776642
Q ss_pred C-----------------------------------------------------------------------CCCCcCEE
Q 002158 297 K-----------------------------------------------------------------------LSENVTTI 305 (958)
Q Consensus 297 ~-----------------------------------------------------------------------~~~~L~~L 305 (958)
. .+++|+.|
T Consensus 558 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~~~g~~~~~~~~l~~L~~L 637 (768)
T 3rgz_A 558 MFKQSGKIAANFIAGKRYVYIKNDGMKKECHGAGNLLEFQGIRSEQLNRLSTRNPCNITSRVYGGHTSPTFDNNGSMMFL 637 (768)
T ss_dssp GGTTTTCBCCSTTCSCEEEEEECCSCCTTCCSSEEEEECTTCCGGGGGGGGGTCCSCTTSCEEEEECCCSCSSSBCCCEE
T ss_pred HhcccchhhhhccccccccccccccccccccccccccccccccchhhhccccccccccccceecccCchhhhccccccEE
Confidence 1 13578999
Q ss_pred EccCCcCCCccchhccCCCCCCeEeeecccCCCccchhhhcccccCccccceEeccCCCCCC-CccCC-CCCCcceEEeC
Q 002158 306 DLSDNYLNGSILESISNLPFLQTLSLENNFLTGSIPATIWQNKSFSTKARLKIDLRNNSFSN-IVGDL-TLPNNVTLRLG 383 (958)
Q Consensus 306 ~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~ip~~l~~~~~~~~~~l~~L~Ls~N~l~~-l~~~~-~l~~L~~L~l~ 383 (958)
||++|++++.+|..|+++++|+.|+|++|+++|.+|..+..+.. |+.|||++|+++. +|... .++.|+.|+++
T Consensus 638 dLs~N~l~g~ip~~l~~l~~L~~L~Ls~N~l~g~ip~~l~~L~~-----L~~LdLs~N~l~g~ip~~l~~l~~L~~L~ls 712 (768)
T 3rgz_A 638 DMSYNMLSGYIPKEIGSMPYLFILNLGHNDISGSIPDEVGDLRG-----LNILDLSSNKLDGRIPQAMSALTMLTEIDLS 712 (768)
T ss_dssp ECCSSCCBSCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTT-----CCEEECCSSCCEECCCGGGGGCCCCSEEECC
T ss_pred ECcCCcccccCCHHHhccccCCEEeCcCCccCCCCChHHhCCCC-----CCEEECCCCcccCcCChHHhCCCCCCEEECc
Confidence 99999999999999999999999999999999999999987654 5599999999995 56555 89999999999
Q ss_pred CCCCCCCCCCCCCCcccccCCCCCccccccCCCCCC
Q 002158 384 GNPICTSANIPNTGRFCGSDAGGDETLTNSKVNCPV 419 (958)
Q Consensus 384 ~N~l~~~~~~~~~~~~~~~~~~~~~~L~~n~~~C~c 419 (958)
+|+++.. +|....+. ......+.||+.-|.-
T Consensus 713 ~N~l~g~--iP~~~~~~---~~~~~~~~gN~~Lcg~ 743 (768)
T 3rgz_A 713 NNNLSGP--IPEMGQFE---TFPPAKFLNNPGLCGY 743 (768)
T ss_dssp SSEEEEE--CCSSSSGG---GSCGGGGCSCTEEEST
T ss_pred CCccccc--CCCchhhc---cCCHHHhcCCchhcCC
Confidence 9998642 22222221 1123456678777753
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-35 Score=358.32 Aligned_cols=240 Identities=20% Similarity=0.356 Sum_probs=194.1
Q ss_pred cCCCCCceeeeeCCeEEEEEEEC--CCcEEEEEEeccC-ChhcHHHHHHHHHHHHccCCCCcceEEEEEEeCCe-----E
Q 002158 625 AYFSSSTQVGQGGYGKVYKGILS--DNTTVAIKRAEEG-SLQGQNEFLTEIKLLSRLHHRNLVSLLGYCDEEGE-----Q 696 (958)
Q Consensus 625 ~~~~~~~~lg~G~~g~Vy~~~~~--~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~-----~ 696 (958)
++|.+.+.||+|+||+||+|.+. +++.||||++... .......|.+|++++++++||||+++++++...+. .
T Consensus 80 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~ 159 (681)
T 2pzi_A 80 GQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPVG 159 (681)
T ss_dssp TTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEEE
T ss_pred CceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCcee
Confidence 56888899999999999999986 5899999998654 34445678999999999999999999999987665 7
Q ss_pred EEEEEecCCCCHHHHhccCCCCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEecCCCCeEEeeeeeeccc
Q 002158 697 MLVYEFVPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSRLA 776 (958)
Q Consensus 697 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~~ 776 (958)
|+||||+++++|.+++.. .+++.+++.++.|+++||+|||+++ |+||||||+|||++.+ .+||+|||+++..
T Consensus 160 ~lv~E~~~g~~L~~~~~~----~l~~~~~~~~~~qi~~aL~~lH~~g---iiHrDlkp~NIll~~~-~~kl~DFG~a~~~ 231 (681)
T 2pzi_A 160 YIVMEYVGGQSLKRSKGQ----KLPVAEAIAYLLEILPALSYLHSIG---LVYNDLKPENIMLTEE-QLKLIDLGAVSRI 231 (681)
T ss_dssp EEEEECCCCEECC----C----CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECSS-CEEECCCTTCEET
T ss_pred EEEEEeCCCCcHHHHHhC----CCCHHHHHHHHHHHHHHHHHHHHCC---CeecccChHHeEEeCC-cEEEEecccchhc
Confidence 999999999999998754 4899999999999999999999999 9999999999999985 8999999999864
Q ss_pred ccCCCCCCccceeeeeccCCCCccChhhhccCCCCCcchhhhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcCcchhhh
Q 002158 777 PVLDDEGTMPTHVSTIVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVLLELLTGMQPISHGKNIVREVNVARDSGMVFSII 856 (958)
Q Consensus 777 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gv~l~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~i 856 (958)
... ....||++|+|||++.+.. +.++|||||||++|||++|..||..... ...
T Consensus 232 ~~~-----------~~~~gt~~y~aPE~~~~~~-~~~sDi~slG~~l~~l~~g~~~~~~~~~----------~~~----- 284 (681)
T 2pzi_A 232 NSF-----------GYLYGTPGFQAPEIVRTGP-TVATDIYTVGRTLAALTLDLPTRNGRYV----------DGL----- 284 (681)
T ss_dssp TCC-----------SCCCCCTTTSCTTHHHHCS-CHHHHHHHHHHHHHHHHSCCCEETTEEC----------SSC-----
T ss_pred ccC-----------CccCCCccccCHHHHcCCC-CCceehhhhHHHHHHHHhCCCCCccccc----------ccc-----
Confidence 321 2346999999999997664 8899999999999999999988753110 000
Q ss_pred cccCCCCChHHHHHHHHHHHHccccCCCCCCC-HHHHHHHHHHhHh
Q 002158 857 DNRMGSYPSECVERFVTLALRCCHDKPEHRPS-MSDVVRELENILK 901 (958)
Q Consensus 857 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs-~~evl~~L~~~~~ 901 (958)
.. .......+..+.+++.+||+.||++||+ ++++.+.|..+++
T Consensus 285 ~~--~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~~ 328 (681)
T 2pzi_A 285 PE--DDPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTGVLR 328 (681)
T ss_dssp CT--TCHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHHH
T ss_pred cc--cccccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHHHHH
Confidence 00 0001234567899999999999999995 6666677776653
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-34 Score=347.99 Aligned_cols=327 Identities=21% Similarity=0.256 Sum_probs=286.3
Q ss_pred eeEEEEccCCcCCCCccccccCCCCcceeeccCcccCCCCccccCCCCCcEEEeeCCCCCCCCChhhcCCCCCCEEeccc
Q 002158 87 HVRELQLLSMNLSGNLAPELGQLSRLQYYFMWNDLTGTIPKEIGNISSLIFLLLNGNKLSGSLPDELGYLSNLNRLQVDE 166 (958)
Q Consensus 87 ~v~~L~L~~~~l~~~~~~~l~~L~~L~~L~l~n~~~~~ip~~i~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~L~~ 166 (958)
.++.|++++|.+++..+..++.+++|+.|++++|....+|..+.++++|++|+|++|.+++..|..+..+++|++|++++
T Consensus 255 ~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~lp~~l~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~ 334 (606)
T 3t6q_A 255 SVESINLQKHYFFNISSNTFHCFSGLQELDLTATHLSELPSGLVGLSTLKKLVLSANKFENLCQISASNFPSLTHLSIKG 334 (606)
T ss_dssp EEEEEECTTCCCSSCCTTTTTTCTTCSEEECTTSCCSCCCSSCCSCTTCCEEECTTCCCSBGGGGCGGGCTTCSEEECCS
T ss_pred ceeEEEeecCccCccCHHHhccccCCCEEeccCCccCCCChhhcccccCCEEECccCCcCcCchhhhhccCcCCEEECCC
Confidence 79999999999999888889999999999999888889999999999999999999999988888999999999999999
Q ss_pred ccccccCcc-ccccccccceEecccccccccC--chhhcCCccchhhhccCCccccCCCcccCCCCCccEEEccCCCCCC
Q 002158 167 NNITGTIPK-SFANLSRVRHLHLNNNSIGGQI--PSELSKLSTLIHLLVDNNNLSGNLPPELSELPQLCILQLDNNNFSA 243 (958)
Q Consensus 167 N~l~~~~p~-~~~~l~~L~~L~Ls~N~l~~~~--p~~l~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~ 243 (958)
|.+.+.++. .+..+++|++|++++|.+++.. +..+..+++|++|++++|++.+..+..|..+++|++|++++|+++.
T Consensus 335 n~~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~ 414 (606)
T 3t6q_A 335 NTKRLELGTGCLENLENLRELDLSHDDIETSDCCNLQLRNLSHLQSLNLSYNEPLSLKTEAFKECPQLELLDLAFTRLKV 414 (606)
T ss_dssp CSSCCBCCSSTTTTCTTCCEEECCSSCCCEEEESTTTTTTCTTCCEEECCSCSCEEECTTTTTTCTTCSEEECTTCCEEC
T ss_pred CCcccccchhhhhccCcCCEEECCCCccccccCcchhcccCCCCCEEECCCCcCCcCCHHHhcCCccCCeEECCCCcCCC
Confidence 999977765 4899999999999999999665 7789999999999999999999999999999999999999999985
Q ss_pred CCccccccCCCCCCEEEcccCCCCCCCCC-CCCCCCcCEEeccCCcCCCc-CC---CCCCCCCcCEEEccCCcCCCccch
Q 002158 244 SEIPATYGNFSKLVKLSLRNCNLQGAVPD-LSRIPNLYYLDLSWNHLTGS-IP---SKKLSENVTTIDLSDNYLNGSILE 318 (958)
Q Consensus 244 ~~~p~~~~~l~~L~~L~L~~N~l~~~~~~-l~~l~~L~~L~Ls~N~l~~~-~~---~~~~~~~L~~L~Ls~N~l~~~~~~ 318 (958)
...+..+.++++|+.|++++|.+++.++. +..+++|++|+|++|++++. ++ ....+++|++|+|++|++++..|.
T Consensus 415 ~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~ 494 (606)
T 3t6q_A 415 KDAQSPFQNLHLLKVLNLSHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTLGRLEILVLSFCDLSSIDQH 494 (606)
T ss_dssp CTTCCTTTTCTTCCEEECTTCCCBTTCTTTTTTCTTCCEEECTTCBCGGGEECSSCGGGGCTTCCEEECTTSCCCEECTT
T ss_pred cccchhhhCcccCCEEECCCCccCCcCHHHHhCCCCCCEEECCCCCCCccccccchhhccCCCccEEECCCCccCccChh
Confidence 44455699999999999999999988775 89999999999999999862 22 235568999999999999999999
Q ss_pred hccCCCCCCeEeeecccCCCccchhhhcccccCccccceEeccCCCCCCCccCC--CCCCcceEEeCCCCCCCCCCCCCC
Q 002158 319 SISNLPFLQTLSLENNFLTGSIPATIWQNKSFSTKARLKIDLRNNSFSNIVGDL--TLPNNVTLRLGGNPICTSANIPNT 396 (958)
Q Consensus 319 ~~~~l~~L~~L~L~~N~l~~~ip~~l~~~~~~~~~~l~~L~Ls~N~l~~l~~~~--~l~~L~~L~l~~N~l~~~~~~~~~ 396 (958)
.|..+++|++|+|++|++++..|..+..+ ..+ .|+|++|+++.++... .+++|+.|++++|||
T Consensus 495 ~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l-----~~L-~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~--------- 559 (606)
T 3t6q_A 495 AFTSLKMMNHVDLSHNRLTSSSIEALSHL-----KGI-YLNLASNHISIILPSLLPILSQQRTINLRQNPL--------- 559 (606)
T ss_dssp TTTTCTTCCEEECCSSCCCGGGGGGGTTC-----CSC-EEECCSSCCCCCCGGGHHHHHTSSEEECTTCCE---------
T ss_pred hhccccCCCEEECCCCccCcCChhHhCcc-----ccc-EEECcCCcccccCHhhcccCCCCCEEeCCCCCc---------
Confidence 99999999999999999999888887654 345 8999999999987764 788999999999888
Q ss_pred CcccccCCCCCccccccCCCCCCCCCCCCCcccccCCC---CCCceeeeeceee
Q 002158 397 GRFCGSDAGGDETLTNSKVNCPVQACPVDNFFEYVPAS---PEPCFCAAPLRIG 447 (958)
Q Consensus 397 ~~~~~~~~~~~~~L~~n~~~C~c~~~~~~~~~~~~~~~---~~~~~c~sp~~~~ 447 (958)
.|+|+..++..|++..... .....|++|...+
T Consensus 560 -------------------~c~c~~~~~~~w~~~~~~~~~~~~~~~C~~p~~~~ 594 (606)
T 3t6q_A 560 -------------------DCTCSNIYFLEWYKENMQKLEDTEDTLCENPPLLR 594 (606)
T ss_dssp -------------------ECSGGGHHHHHHHHHCGGGEECGGGCBEEESGGGT
T ss_pred -------------------cccCCcHHHHHHHHhCcccccCCCCCeeCCchHhC
Confidence 6777777788888654322 2347899997644
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-35 Score=348.58 Aligned_cols=369 Identities=18% Similarity=0.200 Sum_probs=240.2
Q ss_pred CCCCCceeeCcc------ccCCCceeeEEEEccCCcCCCCccccccCCCCcceeeccCcccCC-CCccccCCCCCcEEEe
Q 002158 68 MSNWTGVLCFDT------VETDGHLHVRELQLLSMNLSGNLAPELGQLSRLQYYFMWNDLTGT-IPKEIGNISSLIFLLL 140 (958)
Q Consensus 68 ~~~w~gV~C~~~------~~~~~~~~v~~L~L~~~~l~~~~~~~l~~L~~L~~L~l~n~~~~~-ip~~i~~l~~L~~L~L 140 (958)
.|.|.|+ |+.. .+.....+++.|+|++|++++..+..|+++++|++|++++|.... .|..|.++++|++|+|
T Consensus 3 ~C~~~~~-c~~~~~~l~~ip~~~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L 81 (549)
T 2z81_A 3 SCDASGV-CDGRSRSFTSIPSGLTAAMKSLDLSFNKITYIGHGDLRACANLQVLILKSSRINTIEGDAFYSLGSLEHLDL 81 (549)
T ss_dssp EECTTSE-EECTTSCCSSCCSCCCTTCCEEECCSSCCCEECSSTTSSCTTCCEEECTTSCCCEECTTTTTTCTTCCEEEC
T ss_pred cCCCCce-EECCCCccccccccCCCCccEEECcCCccCccChhhhhcCCcccEEECCCCCcCccChhhccccccCCEEEC
Confidence 3578888 7432 222334589999999999999999999999999999998665554 4578999999999999
Q ss_pred eCCCCCCCCChhhcCCCCCCEEecccccccc-cCccccccccccceEecccccccccC-chhhcCCccchhhhccCCccc
Q 002158 141 NGNKLSGSLPDELGYLSNLNRLQVDENNITG-TIPKSFANLSRVRHLHLNNNSIGGQI-PSELSKLSTLIHLLVDNNNLS 218 (958)
Q Consensus 141 s~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~-~~p~~~~~l~~L~~L~Ls~N~l~~~~-p~~l~~l~~L~~L~L~~N~l~ 218 (958)
++|.+++..|..|+++++|++|+|++|++++ ..|..+.++++|++|++++|.+.+.+ +..+.++++|++|++++|+++
T Consensus 82 s~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~L~~n~~~~~~~~~~~~~l~~L~~L~L~~n~l~ 161 (549)
T 2z81_A 82 SDNHLSSLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQTLRIGNVETFSEIRRIDFAGLTSLNELEIKALSLR 161 (549)
T ss_dssp TTSCCCSCCHHHHTTCTTCCEEECTTCCCSSSCSSCSCTTCTTCCEEEEEESSSCCEECTTTTTTCCEEEEEEEEETTCC
T ss_pred CCCccCccCHHHhccCCCCcEEECCCCcccccchhhhhhccCCccEEECCCCccccccCHhhhhcccccCeeeccCCccc
Confidence 9999998777789999999999999999996 36778999999999999999944445 468999999999999999999
Q ss_pred cCCCcccCCC------------------------CCccEEEccCCCCCCCCc----------------------------
Q 002158 219 GNLPPELSEL------------------------PQLCILQLDNNNFSASEI---------------------------- 246 (958)
Q Consensus 219 ~~~~~~l~~l------------------------~~L~~L~L~~N~l~~~~~---------------------------- 246 (958)
+..|..+..+ ++|++|++++|++++...
T Consensus 162 ~~~~~~l~~l~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~ 241 (549)
T 2z81_A 162 NYQSQSLKSIRDIHHLTLHLSESAFLLEIFADILSSVRYLELRDTNLARFQFSPLPVDEVSSPMKKLAFRGSVLTDESFN 241 (549)
T ss_dssp EECTTTTTTCSEEEEEEEECSBSTTHHHHHHHSTTTBSEEEEESCBCTTCCCCCCSSCCCCCCCCEEEEESCEEEHHHHH
T ss_pred ccChhhhhccccCceEecccCcccccchhhHhhcccccEEEccCCccccccccccchhhhhhcccceeccccccchhHHH
Confidence 8888877654 556666666666543100
Q ss_pred --------------------------------------------------------------------------------
Q 002158 247 -------------------------------------------------------------------------------- 246 (958)
Q Consensus 247 -------------------------------------------------------------------------------- 246 (958)
T Consensus 242 ~l~~~~~~~~~L~~l~l~~~~~~~~~~~~~~~~~~~~~l~~L~~L~l~~~~i~~~~~~~~l~~~~~~~~~L~~L~l~~n~ 321 (549)
T 2z81_A 242 ELLKLLRYILELSEVEFDDCTLNGLGDFNPSESDVVSELGKVETVTIRRLHIPQFYLFYDLSTVYSLLEKVKRITVENSK 321 (549)
T ss_dssp HHHGGGGGCTTCCEEEEESCEEECCSCCCCCTTTCCCCCTTCCEEEEESCBCSCGGGSCCCCHHHHHSTTCCEEEEESSC
T ss_pred HHHHHhhhhccccccccccccccccccccccchhhhhhhcccccccccccccchhhhcccchhhhhhcccceEEEeccCc
Confidence
Q ss_pred ----cccc-cCCCCCCEEEcccCCCCCCCC----CCCCCCCcCEEeccCCcCCCcCC---CCCCCCCcCEEEccCCcCCC
Q 002158 247 ----PATY-GNFSKLVKLSLRNCNLQGAVP----DLSRIPNLYYLDLSWNHLTGSIP---SKKLSENVTTIDLSDNYLNG 314 (958)
Q Consensus 247 ----p~~~-~~l~~L~~L~L~~N~l~~~~~----~l~~l~~L~~L~Ls~N~l~~~~~---~~~~~~~L~~L~Ls~N~l~~ 314 (958)
|..+ .++++|+.|+|++|++++..+ .+..+++|++|+|++|++++..+ ....+++|++|+|++|+|+
T Consensus 322 l~~ip~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~l~~L~~L~Ls~N~l~- 400 (549)
T 2z81_A 322 VFLVPCSFSQHLKSLEFLDLSENLMVEEYLKNSACKGAWPSLQTLVLSQNHLRSMQKTGEILLTLKNLTSLDISRNTFH- 400 (549)
T ss_dssp CCCCCHHHHHHCTTCCEEECCSSCCCHHHHHHHTCTTSSTTCCEEECTTSCCCCHHHHHHHGGGCTTCCEEECTTCCCC-
T ss_pred cccCCHHHHhcCccccEEEccCCccccccccchhhhhccccCcEEEccCCcccccccchhhhhcCCCCCEEECCCCCCc-
Confidence 0000 123334444444444433211 13334444444444444432111 0223344555555555554
Q ss_pred ccchhccCCCCCCeEeeecccCCCccchhhhc-ccc------------cCccccceEeccCCCCCCCccCCCCCCcceEE
Q 002158 315 SILESISNLPFLQTLSLENNFLTGSIPATIWQ-NKS------------FSTKARLKIDLRNNSFSNIVGDLTLPNNVTLR 381 (958)
Q Consensus 315 ~~~~~~~~l~~L~~L~L~~N~l~~~ip~~l~~-~~~------------~~~~~l~~L~Ls~N~l~~l~~~~~l~~L~~L~ 381 (958)
.+|..+..+++|++|+|++|+|+ .+|..+.. +.. ...+.|+.|+|++|+|+.++....+++|+.|+
T Consensus 401 ~lp~~~~~~~~L~~L~Ls~N~l~-~l~~~~~~~L~~L~Ls~N~l~~~~~~l~~L~~L~Ls~N~l~~ip~~~~l~~L~~L~ 479 (549)
T 2z81_A 401 PMPDSCQWPEKMRFLNLSSTGIR-VVKTCIPQTLEVLDVSNNNLDSFSLFLPRLQELYISRNKLKTLPDASLFPVLLVMK 479 (549)
T ss_dssp CCCSCCCCCTTCCEEECTTSCCS-CCCTTSCTTCSEEECCSSCCSCCCCCCTTCCEEECCSSCCSSCCCGGGCTTCCEEE
T ss_pred cCChhhcccccccEEECCCCCcc-cccchhcCCceEEECCCCChhhhcccCChhcEEECCCCccCcCCCcccCccCCEEe
Confidence 23444444455555555555544 22222110 000 02345667777777777776655677777777
Q ss_pred eCCCCCCCCCCCCCCCcccccCCCCCccccccCCCCCCC-CCCCCCcccccCCCC-CCceeeee
Q 002158 382 LGGNPICTSANIPNTGRFCGSDAGGDETLTNSKVNCPVQ-ACPVDNFFEYVPASP-EPCFCAAP 443 (958)
Q Consensus 382 l~~N~l~~~~~~~~~~~~~~~~~~~~~~L~~n~~~C~c~-~~~~~~~~~~~~~~~-~~~~c~sp 443 (958)
|++|++..... ..+......+.+.+.+|+|.|+|+ ..++..|++...... +...|++|
T Consensus 480 Ls~N~l~~~~~----~~~~~l~~L~~L~l~~N~~~~~~~~~~~l~~~l~~~~~~~~~~~~C~~~ 539 (549)
T 2z81_A 480 ISRNQLKSVPD----GIFDRLTSLQKIWLHTNPWDCSCPRIDYLSRWLNKNSQKEQGSAKCSGS 539 (549)
T ss_dssp CCSSCCCCCCT----TGGGGCTTCCEEECCSSCBCCCHHHHHHHHHHHHHCTTTEESCCBBTTT
T ss_pred cCCCccCCcCH----HHHhcCcccCEEEecCCCccCCCccHHHHHHHHHhcccccCCCCeECCC
Confidence 77777753221 123344566789999999999999 566667886543332 23667766
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-34 Score=343.13 Aligned_cols=362 Identities=15% Similarity=0.145 Sum_probs=292.1
Q ss_pred cccCCCCCCCCCCCC---CCceeeCccccC-----------CCceeeEEEEccCCcCCCCccccccCCCCcceeeccCcc
Q 002158 56 NHLRNWNKGDPCMSN---WTGVLCFDTVET-----------DGHLHVRELQLLSMNLSGNLAPELGQLSRLQYYFMWNDL 121 (958)
Q Consensus 56 ~~l~~W~~~~~c~~~---w~gV~C~~~~~~-----------~~~~~v~~L~L~~~~l~~~~~~~l~~L~~L~~L~l~n~~ 121 (958)
..+++|..+..|+.. |.++.|...... ....+++.|++.++.+....+..+..+++|+.|++++|.
T Consensus 7 ~~l~~~~~~~~C~~~~~~~~c~~~~~~i~~~~~~~~~~~~~l~l~~l~~l~l~~~~l~~lp~~~~~~l~~L~~L~L~~n~ 86 (597)
T 3oja_B 7 YNVKPRQPEYKCIDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQ 86 (597)
T ss_dssp ----CCCSEECCCCC--CCSEEECSCEECSSCCCCEESCSSGGGCCCSEEEESSCEESEECTHHHHHCCCCSEEECTTSC
T ss_pred ccccCCCCCCcCcccCcCceeEecCceecccccccccCcccccCCCceEEEeeCCCCCCcCHHHHccCCCCcEEECCCCC
Confidence 457899988888865 555554321111 012357888999998888777778999999999998665
Q ss_pred cCCC-CccccCCCCCcEEEeeCCCCCCCCChhhcCCCCCCEEecccccccccCccccccccccceEecccccccccCchh
Q 002158 122 TGTI-PKEIGNISSLIFLLLNGNKLSGSLPDELGYLSNLNRLQVDENNITGTIPKSFANLSRVRHLHLNNNSIGGQIPSE 200 (958)
Q Consensus 122 ~~~i-p~~i~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~ 200 (958)
...+ |..|+++++|++|+|++|.+++..|..|+++++|++|+|++|.+++..+..|.++++|++|+|++|.+++..|..
T Consensus 87 l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~ 166 (597)
T 3oja_B 87 IEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLSSLPRGIFHNTPKLTTLSMSNNNLERIEDDT 166 (597)
T ss_dssp CCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCBCCTTT
T ss_pred CCCCChHHhcCCCCCCEEECCCCcCCCCCHHHHcCCCCCCEEEeeCCCCCCCCHHHhccCCCCCEEEeeCCcCCCCChhh
Confidence 5555 458999999999999999999888888999999999999999999666666899999999999999999888889
Q ss_pred hcCCccchhhhccCCccccCCCcccCCCCCccEEEccCCCCCCCCccccccCCCCCCEEEcccCCCCCCCCCCCCCCCcC
Q 002158 201 LSKLSTLIHLLVDNNNLSGNLPPELSELPQLCILQLDNNNFSASEIPATYGNFSKLVKLSLRNCNLQGAVPDLSRIPNLY 280 (958)
Q Consensus 201 l~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~l~~l~~L~ 280 (958)
|.++++|+.|+|++|++++.. +..+++|+.|++++|.++. +...++|+.|++++|.++..+..+. ++|+
T Consensus 167 ~~~l~~L~~L~L~~N~l~~~~---~~~l~~L~~L~l~~n~l~~------l~~~~~L~~L~ls~n~l~~~~~~~~--~~L~ 235 (597)
T 3oja_B 167 FQATTSLQNLQLSSNRLTHVD---LSLIPSLFHANVSYNLLST------LAIPIAVEELDASHNSINVVRGPVN--VELT 235 (597)
T ss_dssp TTTCTTCCEEECTTSCCSBCC---GGGCTTCSEEECCSSCCSE------EECCTTCSEEECCSSCCCEEECSCC--SCCC
T ss_pred hhcCCcCcEEECcCCCCCCcC---hhhhhhhhhhhcccCcccc------ccCCchhheeeccCCcccccccccC--CCCC
Confidence 999999999999999998753 5667899999999999863 3445689999999999987766543 6899
Q ss_pred EEeccCCcCCCcCCCCCCCCCcCEEEccCCcCCCccchhccCCCCCCeEeeecccCCCccchhhhcccccCccccceEec
Q 002158 281 YLDLSWNHLTGSIPSKKLSENVTTIDLSDNYLNGSILESISNLPFLQTLSLENNFLTGSIPATIWQNKSFSTKARLKIDL 360 (958)
Q Consensus 281 ~L~Ls~N~l~~~~~~~~~~~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~ip~~l~~~~~~~~~~l~~L~L 360 (958)
.|+|++|.+++ ++....+++|+.|+|++|.|++..|..|..+++|+.|+|++|.+++ +|..+.. .+.|+.|+|
T Consensus 236 ~L~L~~n~l~~-~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~-l~~~~~~-----l~~L~~L~L 308 (597)
T 3oja_B 236 ILKLQHNNLTD-TAWLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLVA-LNLYGQP-----IPTLKVLDL 308 (597)
T ss_dssp EEECCSSCCCC-CGGGGGCTTCSEEECCSSCCCEEESGGGTTCSSCCEEECTTSCCCE-EECSSSC-----CTTCCEEEC
T ss_pred EEECCCCCCCC-ChhhccCCCCCEEECCCCccCCCCHHHhcCccCCCEEECCCCCCCC-CCccccc-----CCCCcEEEC
Confidence 99999999995 4666778999999999999999999999999999999999999995 5655432 456789999
Q ss_pred cCCCCCCCccCC-CCCCcceEEeCCCCCCCCCCCCCCCcccccCCCCCccccccCCCCCCCCCCCCCcccccCCCCCCce
Q 002158 361 RNNSFSNIVGDL-TLPNNVTLRLGGNPICTSANIPNTGRFCGSDAGGDETLTNSKVNCPVQACPVDNFFEYVPASPEPCF 439 (958)
Q Consensus 361 s~N~l~~l~~~~-~l~~L~~L~l~~N~l~~~~~~~~~~~~~~~~~~~~~~L~~n~~~C~c~~~~~~~~~~~~~~~~~~~~ 439 (958)
++|+++.++... .+++|+.|+|++|++.... +........+.|.+|+|.|+|...++..|........ ...
T Consensus 309 s~N~l~~i~~~~~~l~~L~~L~L~~N~l~~~~-------~~~~~~L~~L~l~~N~~~~~~~~~~~~~~~~~~~~~~-~~~ 380 (597)
T 3oja_B 309 SHNHLLHVERNQPQFDRLENLYLDHNSIVTLK-------LSTHHTLKNLTLSHNDWDCNSLRALFRNVARPAVDDA-DQH 380 (597)
T ss_dssp CSSCCCCCGGGHHHHTTCSEEECCSSCCCCCC-------CCTTCCCSEEECCSSCEEHHHHHHHTTTCCTTTBCCC-CCC
T ss_pred CCCCCCccCcccccCCCCCEEECCCCCCCCcC-------hhhcCCCCEEEeeCCCCCChhHHHHHHHHhhhccccc-ccc
Confidence 999999998776 8999999999999996542 2333466789999999999998877777665433322 244
Q ss_pred eeee
Q 002158 440 CAAP 443 (958)
Q Consensus 440 c~sp 443 (958)
|..+
T Consensus 381 C~~~ 384 (597)
T 3oja_B 381 CKID 384 (597)
T ss_dssp CCTT
T ss_pred CCcc
Confidence 5543
|
| >4g8a_A TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, immune system; HET: NAG LP4 LP5 DAO MYR KDO; 2.40A {Homo sapiens} PDB: 3fxi_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-34 Score=345.31 Aligned_cols=367 Identities=19% Similarity=0.185 Sum_probs=275.8
Q ss_pred CceeeCc----cccCCCceeeEEEEccCCcCCCCccccccCCCCcceeeccCcccCCCC-ccccCCCCCcEEEeeCCCCC
Q 002158 72 TGVLCFD----TVETDGHLHVRELQLLSMNLSGNLAPELGQLSRLQYYFMWNDLTGTIP-KEIGNISSLIFLLLNGNKLS 146 (958)
Q Consensus 72 ~gV~C~~----~~~~~~~~~v~~L~L~~~~l~~~~~~~l~~L~~L~~L~l~n~~~~~ip-~~i~~l~~L~~L~Ls~n~l~ 146 (958)
..|.|.. .++.+-+..++.|||++|+|++..+.+|.++++|++|++++|.+..+| .+|.++++|++|+|++|+|+
T Consensus 34 ~~~~c~~~~l~~vP~~lp~~~~~LdLs~N~i~~l~~~~f~~l~~L~~L~Ls~N~i~~i~~~~f~~L~~L~~L~Ls~N~l~ 113 (635)
T 4g8a_A 34 ITYQCMELNFYKIPDNLPFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQ 113 (635)
T ss_dssp TEEECTTSCCSSCCSSSCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCC
T ss_pred CEEECCCCCcCccCCCCCcCCCEEEeeCCCCCCCCHHHHhCCCCCCEEECCCCcCCCcChhHhcCCCCCCEEEccCCcCC
Confidence 3567854 234444568999999999999988889999999999999987776665 46999999999999999999
Q ss_pred CCCChhhcCCCCCCEEecccccccccCccccccccccceEecccccccc-cCchhhcCCccchhhhccCCccccCCCccc
Q 002158 147 GSLPDELGYLSNLNRLQVDENNITGTIPKSFANLSRVRHLHLNNNSIGG-QIPSELSKLSTLIHLLVDNNNLSGNLPPEL 225 (958)
Q Consensus 147 ~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~-~~p~~l~~l~~L~~L~L~~N~l~~~~~~~l 225 (958)
+..+..|.++++|++|+|++|++++..+..|+++++|++|+|++|.+++ ..|..+..+++|++|+|++|+|++..+..|
T Consensus 114 ~l~~~~f~~L~~L~~L~Ls~N~l~~l~~~~~~~L~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l 193 (635)
T 4g8a_A 114 SLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDL 193 (635)
T ss_dssp EECGGGGTTCTTCCEEECTTSCCCCSTTCCCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECCSSCCCEECGGGG
T ss_pred CCCHHHhcCCCCCCEEECCCCcCCCCChhhhhcCcccCeeccccCccccCCCchhhccchhhhhhcccCccccccccccc
Confidence 7667789999999999999999998777889999999999999999985 467888999999999999998876544333
Q ss_pred CCCC----------------------------------------------------------------------------
Q 002158 226 SELP---------------------------------------------------------------------------- 229 (958)
Q Consensus 226 ~~l~---------------------------------------------------------------------------- 229 (958)
..+.
T Consensus 194 ~~L~~l~~~~~~~~ls~n~l~~i~~~~~~~~~~~~l~l~~n~~~~~~~~~~~~~l~~l~~~~l~~~~~~~~~~l~~~~~~ 273 (635)
T 4g8a_A 194 RVLHQMPLLNLSLDLSLNPMNFIQPGAFKEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKS 273 (635)
T ss_dssp HHHHTCTTCCCEEECTTCCCCEECTTTTTTCEEEEEEEESCCSSHHHHHHHHHTTTTCEEEEEEEECCTTSCCCSCCCTT
T ss_pred cchhhhhhhhhhhhcccCcccccCcccccchhhhhhhhhcccccccccchhhcCCccccccccccccccccccccccccc
Confidence 2111
Q ss_pred -------------------------------------------------------CccEEEccCCCCCCCC---------
Q 002158 230 -------------------------------------------------------QLCILQLDNNNFSASE--------- 245 (958)
Q Consensus 230 -------------------------------------------------------~L~~L~L~~N~l~~~~--------- 245 (958)
+|+.|++.+|.+....
T Consensus 274 ~~~~~~~l~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~~~~~~~~~~~~~~~~L~~L~l~~~~~~~~~~~~l~~L~~ 353 (635)
T 4g8a_A 274 ALEGLCNLTIEEFRLAYLDYYLDGIIDLFNCLTNVSSFSLVSVTIERVKDFSYNFGWQHLELVNCKFGQFPTLKLKSLKR 353 (635)
T ss_dssp TTGGGGGSEEEEEEEECCCSCEEECTTTTGGGTTCSEEEEESCEEEECGGGGSCCCCSEEEEESCEESSCCCCBCTTCCE
T ss_pred ccccccchhhhhhhhhhhcccccchhhhhhhhcccccccccccccccccccccchhhhhhhcccccccCcCcccchhhhh
Confidence 1222222222221100
Q ss_pred ---------ccccccCCCCCCEEEcccCCCC-------------------------------------------------
Q 002158 246 ---------IPATYGNFSKLVKLSLRNCNLQ------------------------------------------------- 267 (958)
Q Consensus 246 ---------~p~~~~~l~~L~~L~L~~N~l~------------------------------------------------- 267 (958)
.+.....+++|+.|++++|.+.
T Consensus 354 l~l~~n~~~~~~~~~~l~~L~~L~ls~n~l~~~~~~~~~~~~~~~L~~L~~~~~~~~~~~~~~~~l~~L~~l~l~~~~~~ 433 (635)
T 4g8a_A 354 LTFTSNKGGNAFSEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTISLKYLDLSFNGVITMSSNFLGLEQLEHLDFQHSNLK 433 (635)
T ss_dssp EEEESCCSCCBCCCCBCTTCCEEECCSSCCBEEEECCHHHHSCSCCCEEECCSCSEEEECSCCTTCTTCCEEECTTSEEE
T ss_pred cccccccCCCCcccccccccccchhhccccccccccccchhhhhhhhhhhccccccccccccccccccccchhhhhcccc
Confidence 0001112445556666555542
Q ss_pred CCCC--CCCCCCCcCEEeccCCcCCCcCCCC-CCCCCcCEEEccCCcC-CCccchhccCCCCCCeEeeecccCCCccchh
Q 002158 268 GAVP--DLSRIPNLYYLDLSWNHLTGSIPSK-KLSENVTTIDLSDNYL-NGSILESISNLPFLQTLSLENNFLTGSIPAT 343 (958)
Q Consensus 268 ~~~~--~l~~l~~L~~L~Ls~N~l~~~~~~~-~~~~~L~~L~Ls~N~l-~~~~~~~~~~l~~L~~L~L~~N~l~~~ip~~ 343 (958)
...+ .+..+++|+.++++.|.+.+..+.. ..++.|+.|+|++|.+ .+..|..|..+++|++|+|++|+|++..|..
T Consensus 434 ~~~~~~~~~~l~~l~~l~ls~n~l~~~~~~~~~~~~~L~~L~Ls~N~~~~~~~~~~~~~l~~L~~L~Ls~N~L~~l~~~~ 513 (635)
T 4g8a_A 434 QMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTA 513 (635)
T ss_dssp STTSSCTTTTCTTCCEEECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTT
T ss_pred ccccccccccccccccccccccccccccccccccchhhhhhhhhhcccccccCchhhhhccccCEEECCCCccCCcChHH
Confidence 2222 2556677777788888877655544 4458999999999985 5568889999999999999999999877777
Q ss_pred hhcccccCccccceEeccCCCCCCCccCC--CCCCcceEEeCCCCCCCCCCCCCCCcccc-cCCCCCccccccCCCCCCC
Q 002158 344 IWQNKSFSTKARLKIDLRNNSFSNIVGDL--TLPNNVTLRLGGNPICTSANIPNTGRFCG-SDAGGDETLTNSKVNCPVQ 420 (958)
Q Consensus 344 l~~~~~~~~~~l~~L~Ls~N~l~~l~~~~--~l~~L~~L~l~~N~l~~~~~~~~~~~~~~-~~~~~~~~L~~n~~~C~c~ 420 (958)
+..+. .|+.|+|++|+|+.++... .+++|+.|+|++|.+...... .+.. ....+.+.|.+|||.|||+
T Consensus 514 f~~l~-----~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~----~l~~l~~~L~~L~L~~Np~~C~C~ 584 (635)
T 4g8a_A 514 FNSLS-----SLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQ----ELQHFPSSLAFLNLTQNDFACTCE 584 (635)
T ss_dssp TTTCT-----TCCEEECTTSCCCBCCCGGGTTCTTCCEEECTTSCCCBCCSS----CTTCCCTTCCEEECTTCCBCCSGG
T ss_pred HcCCC-----CCCEEECCCCcCCCCChhHHhCCCCCCEEECCCCcCCCCCHH----HHHhhhCcCCEEEeeCCCCcccCC
Confidence 76543 5669999999999998764 899999999999999754321 1111 1356778999999999999
Q ss_pred CCCCCCcccccCCCC---CCceeeeeceee
Q 002158 421 ACPVDNFFEYVPASP---EPCFCAAPLRIG 447 (958)
Q Consensus 421 ~~~~~~~~~~~~~~~---~~~~c~sp~~~~ 447 (958)
..++..|++...... +..+|++|...+
T Consensus 585 ~~~~~~wl~~~~~~~~~~~~~~C~~P~~~~ 614 (635)
T 4g8a_A 585 HQSFLQWIKDQRQLLVEVERMECATPSDKQ 614 (635)
T ss_dssp GHHHHHHHHHTTTTBSCGGGCBBCSSTTTT
T ss_pred cHHHHHHHHhCCCccCCCCCceeCCchHHC
Confidence 999999997765443 247899997654
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-35 Score=327.52 Aligned_cols=244 Identities=18% Similarity=0.183 Sum_probs=186.4
Q ss_pred HcCCCCCceeeeeCCeEEEEEEECCCcEEEEEEeccCC--------hhcHHHHHHHHHHHHccC---------CCCcceE
Q 002158 624 TAYFSSSTQVGQGGYGKVYKGILSDNTTVAIKRAEEGS--------LQGQNEFLTEIKLLSRLH---------HRNLVSL 686 (958)
Q Consensus 624 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~--------~~~~~~~~~E~~~l~~l~---------H~niv~l 686 (958)
.++|...+.||+|+||+||+|++ +|+.||||++.... ....+.+.+|++++++++ ||||+++
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l 97 (336)
T 2vuw_A 19 TEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGL 97 (336)
T ss_dssp HHHHHTCEEEEEETTEEEEEEEE-TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCE
T ss_pred cccchheeeecccCceEEEEEEe-CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhhh
Confidence 34677889999999999999998 78999999987642 223467889999999885 8888888
Q ss_pred EEEEE------------------------------eCCeEEEEEEecCCCCHHHHhccCCCCCchHHHHHHHHHHHHHHH
Q 002158 687 LGYCD------------------------------EEGEQMLVYEFVPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGI 736 (958)
Q Consensus 687 ~~~~~------------------------------~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL 736 (958)
.+++. ..+..++||||+++|++.+.+.. ..+++.++..++.|++.||
T Consensus 98 ~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~---~~~~~~~~~~i~~qi~~aL 174 (336)
T 2vuw_A 98 NSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT---KLSSLATAKSILHQLTASL 174 (336)
T ss_dssp EEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT---TCCCHHHHHHHHHHHHHHH
T ss_pred cceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh---cCCCHHHHHHHHHHHHHHH
Confidence 88753 26789999999999977666643 3489999999999999999
Q ss_pred HHhh-hcCCCCeeccCCCccceEecCCC--------------------CeEEeeeeeecccccCCCCCCccceeeeeccC
Q 002158 737 LYLH-TEAHPPVFHRDIKASNILLDSNL--------------------NAKVADFGLSRLAPVLDDEGTMPTHVSTIVKG 795 (958)
Q Consensus 737 ~yLH-~~~~~~iiH~Dikp~NILl~~~~--------------------~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~g 795 (958)
+||| +.+ |+||||||+|||++.++ .+||+|||+|+.... ....|
T Consensus 175 ~~lH~~~~---ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~------------~~~~g 239 (336)
T 2vuw_A 175 AVAEASLR---FEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERD------------GIVVF 239 (336)
T ss_dssp HHHHHHHC---CBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEET------------TEEEC
T ss_pred HHHHHhCC---EeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCC------------CcEEE
Confidence 9999 899 99999999999999887 899999999986531 12469
Q ss_pred CCCccChhhhccCCCCCcchhhhHHHH-HHHHHhCCCCCCCCchhHHHHHHHhhcCcchhhhcccCCCCChHHHHHHHHH
Q 002158 796 TPGYLDPEYFLTHKLTDKSDVYSLGVV-LLELLTGMQPISHGKNIVREVNVARDSGMVFSIIDNRMGSYPSECVERFVTL 874 (958)
Q Consensus 796 t~~y~aPE~~~~~~~~~~~DV~S~Gv~-l~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~l~~l 874 (958)
|+.|+|||++.+.. +.++||||+|++ .+++++|..||.................... .......+..++.++.++
T Consensus 240 t~~y~aPE~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~s~~~~dl 315 (336)
T 2vuw_A 240 CDVSMDEDLFTGDG-DYQFDIYRLMKKENNNRWGEYHPYSNVLWLHYLTDKMLKQMTFK---TKCNTPAMKQIKRKIQEF 315 (336)
T ss_dssp CCCTTCSGGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHHHHHHHHHHHHHHHTCCCS---SCCCSHHHHHHHHHHHHH
T ss_pred eecccChhhhcCCC-ccceehhhhhCCCCcccccccCCCcchhhhhHHHHhhhhhhccC---cccchhhhhhcCHHHHHH
Confidence 99999999998766 889999998777 7888899999843111000110100000000 000011234688899999
Q ss_pred HHHccccCCCCCCCHHHHH-HH
Q 002158 875 ALRCCHDKPEHRPSMSDVV-RE 895 (958)
Q Consensus 875 i~~cl~~dP~~RPs~~evl-~~ 895 (958)
+.+||+.| |++|++ ++
T Consensus 316 i~~~L~~d-----sa~e~l~~H 332 (336)
T 2vuw_A 316 HRTMLNFS-----SATDLLCQH 332 (336)
T ss_dssp HHHGGGSS-----SHHHHHHHC
T ss_pred HHHHhccC-----CHHHHHhcC
Confidence 99999976 899888 53
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-32 Score=335.65 Aligned_cols=351 Identities=21% Similarity=0.249 Sum_probs=249.1
Q ss_pred eeEEEEccCCcCCCCccccccCCCCcceeeccCcccC------CCCc----cccCCCCCcEEEeeCCCCCCCCChhhcCC
Q 002158 87 HVRELQLLSMNLSGNLAPELGQLSRLQYYFMWNDLTG------TIPK----EIGNISSLIFLLLNGNKLSGSLPDELGYL 156 (958)
Q Consensus 87 ~v~~L~L~~~~l~~~~~~~l~~L~~L~~L~l~n~~~~------~ip~----~i~~l~~L~~L~Ls~n~l~~~~p~~l~~l 156 (958)
+++.|+|.+|.+.+..+..+..+++|+.|.++++..+ .+|. .|..+++|++|+|++|.+++..+..|..+
T Consensus 273 ~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~~~~~~~~~~~~lp~i~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l 352 (680)
T 1ziw_A 273 QLEYFFLEYNNIQHLFSHSLHGLFNVRYLNLKRSFTKQSISLASLPKIDDFSFQWLKCLEHLNMEDNDIPGIKSNMFTGL 352 (680)
T ss_dssp TCCEEECCSCCBSEECTTTTTTCTTCCEEECTTCBCCC------CCEECTTTTTTCTTCCEEECCSCCBCCCCTTTTTTC
T ss_pred cccEeeCCCCccCccChhhhcCCCCccEEeccchhhhcccccccccccChhhcccCCCCCEEECCCCccCCCChhHhccc
Confidence 3444444444444444444444444444444433322 2332 45566667777777777776666667777
Q ss_pred CCCCEEeccccccccc--Cccccccc--cccceEecccccccccCchhhcCCccchhhhccCCccccCCC-cccCCCCCc
Q 002158 157 SNLNRLQVDENNITGT--IPKSFANL--SRVRHLHLNNNSIGGQIPSELSKLSTLIHLLVDNNNLSGNLP-PELSELPQL 231 (958)
Q Consensus 157 ~~L~~L~L~~N~l~~~--~p~~~~~l--~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~-~~l~~l~~L 231 (958)
++|++|++++|.+... ....|..+ ++|+.|+|++|++++..|..|..+++|+.|+|++|++++.++ ..+.++++|
T Consensus 353 ~~L~~L~Ls~n~~~~~~l~~~~f~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L 432 (680)
T 1ziw_A 353 INLKYLSLSNSFTSLRTLTNETFVSLAHSPLHILNLTKNKISKIESDAFSWLGHLEVLDLGLNEIGQELTGQEWRGLENI 432 (680)
T ss_dssp TTCCEEECTTCBSCCCEECTTTTGGGTTSCCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCEEECCSGGGTTCTTC
T ss_pred cCCcEEECCCCchhhhhcchhhhcccccCcCceEECCCCCCCeEChhhhhCCCCCCEEeCCCCcCccccCcccccCcccc
Confidence 7777777777764422 12223332 467788888888888888999999999999999999987655 789999999
Q ss_pred cEEEccCCCCCCCCccccccCCCCCCEEEcccCCCCC--CCC-CCCCCCCcCEEeccCCcCCCcCCC-CCCCCCcCEEEc
Q 002158 232 CILQLDNNNFSASEIPATYGNFSKLVKLSLRNCNLQG--AVP-DLSRIPNLYYLDLSWNHLTGSIPS-KKLSENVTTIDL 307 (958)
Q Consensus 232 ~~L~L~~N~l~~~~~p~~~~~l~~L~~L~L~~N~l~~--~~~-~l~~l~~L~~L~Ls~N~l~~~~~~-~~~~~~L~~L~L 307 (958)
++|++++|+++ ...+..|..+++|+.|++++|.+++ ..+ .+..+++|+.|+|++|++++..+. ...+++|++|+|
T Consensus 433 ~~L~Ls~n~l~-~~~~~~~~~~~~L~~L~l~~n~l~~~~~~p~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~L 511 (680)
T 1ziw_A 433 FEIYLSYNKYL-QLTRNSFALVPSLQRLMLRRVALKNVDSSPSPFQPLRNLTILDLSNNNIANINDDMLEGLEKLEILDL 511 (680)
T ss_dssp CEEECCSCSEE-ECCTTTTTTCTTCCEEECTTSCCBCTTCSSCTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEEC
T ss_pred cEEecCCCCcc-eeChhhhhcCcccccchhccccccccccCCcccccCCCCCEEECCCCCCCcCChhhhccccccCEEeC
Confidence 99999999997 3557789999999999999999873 333 589999999999999999966554 356799999999
Q ss_pred cCCcCCCccc--------hhccCCCCCCeEeeecccCCCccchhhhcccccCccccceEeccCCCCCCCccCC--CCCCc
Q 002158 308 SDNYLNGSIL--------ESISNLPFLQTLSLENNFLTGSIPATIWQNKSFSTKARLKIDLRNNSFSNIVGDL--TLPNN 377 (958)
Q Consensus 308 s~N~l~~~~~--------~~~~~l~~L~~L~L~~N~l~~~ip~~l~~~~~~~~~~l~~L~Ls~N~l~~l~~~~--~l~~L 377 (958)
++|++++..+ ..|.++++|+.|+|++|+|+ .+|...+. ..+.|+.|+|++|+|+.++... .+++|
T Consensus 512 s~N~l~~~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~-~i~~~~~~----~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L 586 (680)
T 1ziw_A 512 QHNNLARLWKHANPGGPIYFLKGLSHLHILNLESNGFD-EIPVEVFK----DLFELKIIDLGLNNLNTLPASVFNNQVSL 586 (680)
T ss_dssp CSSCCGGGGSTTSTTSCCCTTTTCTTCCEEECCSSCCC-CCCTTTTT----TCTTCCEEECCSSCCCCCCTTTTTTCTTC
T ss_pred CCCCccccchhhccCCcchhhcCCCCCCEEECCCCCCC-CCCHHHcc----cccCcceeECCCCCCCcCCHhHhCCCCCC
Confidence 9999987533 34789999999999999999 67765432 1346779999999999998875 88999
Q ss_pred ceEEeCCCCCCCCCCCCCCCccc-ccCCCCCccccccCCCCCCCC-CCCCCcccccCCCC----CCceeeeeceee
Q 002158 378 VTLRLGGNPICTSANIPNTGRFC-GSDAGGDETLTNSKVNCPVQA-CPVDNFFEYVPASP----EPCFCAAPLRIG 447 (958)
Q Consensus 378 ~~L~l~~N~l~~~~~~~~~~~~~-~~~~~~~~~L~~n~~~C~c~~-~~~~~~~~~~~~~~----~~~~c~sp~~~~ 447 (958)
+.|+|++|.++.... ..+- .......+.+.+|||.|+|+. .++..|++...... ....|++|+..+
T Consensus 587 ~~L~L~~N~l~~~~~----~~~~~~~~~L~~l~l~~N~~~c~c~~~~~~~~~~~~~~~~~~~~~~~~~C~~p~~~~ 658 (680)
T 1ziw_A 587 KSLNLQKNLITSVEK----KVFGPAFRNLTELDMRFNPFDCTCESIAWFVNWINETHTNIPELSSHYLCNTPPHYH 658 (680)
T ss_dssp CEEECTTSCCCBCCH----HHHHHHHTTCSEEECTTCCCCBCCCCCSSEECCSSCC--------------------
T ss_pred CEEECCCCcCCccCh----hHhcccccccCEEEccCCCcccCCccHHHHHHHHHhcCcccccccCCcEECCchHHC
Confidence 999999999865321 0111 235567889999999999996 99999997654432 246899998755
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-33 Score=334.55 Aligned_cols=352 Identities=17% Similarity=0.176 Sum_probs=228.6
Q ss_pred ceeeEEEEccCCcCCCCccccccCCCCcceeeccCcccCCC-CccccCCCCCcEEEeeCCCCCCCCChhhcCCCCCCEEe
Q 002158 85 HLHVRELQLLSMNLSGNLAPELGQLSRLQYYFMWNDLTGTI-PKEIGNISSLIFLLLNGNKLSGSLPDELGYLSNLNRLQ 163 (958)
Q Consensus 85 ~~~v~~L~L~~~~l~~~~~~~l~~L~~L~~L~l~n~~~~~i-p~~i~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~ 163 (958)
..+++.|+|++|++++..+..|.++++|+.|++++|....+ |..|.++++|++|+|++|.+++..|..|.++++|++|+
T Consensus 27 ~~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~i~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~ 106 (570)
T 2z63_A 27 PFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLV 106 (570)
T ss_dssp CSSCCEEECCSCCCCEECTTTTTTCSSCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEE
T ss_pred cccccEEEccCCccCccChhHhhCCCCceEEECCCCcCCccCcccccCchhCCEEeCcCCcCCccCHhhhcCcccccccc
Confidence 34566777777777666666667777777776665544333 34566666666666666666655555666666666666
Q ss_pred cccccccccCccccccccccceEecccccccc-cCchhhcCCccchhhhccCCccccCCCcc------------------
Q 002158 164 VDENNITGTIPKSFANLSRVRHLHLNNNSIGG-QIPSELSKLSTLIHLLVDNNNLSGNLPPE------------------ 224 (958)
Q Consensus 164 L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~-~~p~~l~~l~~L~~L~L~~N~l~~~~~~~------------------ 224 (958)
+++|++++..+..++++++|++|+|++|.+++ .+|..|.++++|++|++++|++++..+..
T Consensus 107 L~~n~l~~l~~~~~~~l~~L~~L~L~~n~l~~~~lp~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~~~~~L~l~~ 186 (570)
T 2z63_A 107 AVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSL 186 (570)
T ss_dssp CTTSCCCCSTTCSCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECTTSCCCEECGGGGHHHHTCTTCCCEEECTT
T ss_pred ccccccccCCCccccccccccEEecCCCccceecChhhhcccCCCCEEeCcCCccceecHHHccchhccchhhhhcccCC
Confidence 66666664444455666666666666666654 24555666666666655555544322211
Q ss_pred --------------------------------------------------------------------------------
Q 002158 225 -------------------------------------------------------------------------------- 224 (958)
Q Consensus 225 -------------------------------------------------------------------------------- 224 (958)
T Consensus 187 n~l~~~~~~~~~~~~L~~L~l~~n~~~~~~~~~~~~~l~~l~~~~l~~~~~~~~~~l~~~~~~~~~~l~~l~l~~l~l~~ 266 (570)
T 2z63_A 187 NPMNFIQPGAFKEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAY 266 (570)
T ss_dssp CCCCEECTTTTTTCEEEEEEEESCCSCTTHHHHHHHTTTTCEEEEEEEEECCCCSSCEECCTTTTGGGGGSEEEEEEEEE
T ss_pred CCceecCHHHhccCcceeEecccccccccchhhhhcCccccceeeeccccccCchhhhhcchhhhccccccchhhhhhhc
Confidence
Q ss_pred -----------cCCCCCccEE-----------------------------------------------------------
Q 002158 225 -----------LSELPQLCIL----------------------------------------------------------- 234 (958)
Q Consensus 225 -----------l~~l~~L~~L----------------------------------------------------------- 234 (958)
+..+++|+.|
T Consensus 267 ~~~~~~~~~~~~~~l~~L~~L~l~~~~l~~l~~~~~~~~L~~L~l~~n~~~~l~~~~l~~L~~L~l~~n~~~~~~~~~~~ 346 (570)
T 2z63_A 267 LDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKDFSYNFGWQHLELVNCKFGQFPTLKLKSLKRLTFTSNKGGNAFSEVDL 346 (570)
T ss_dssp TTEEESCSTTTTGGGTTCSEEEEESCEECSCCBCCSCCCCSEEEEESCBCSSCCBCBCSSCCEEEEESCBSCCBCCCCBC
T ss_pred chhhhhhchhhhcCcCcccEEEecCccchhhhhhhccCCccEEeeccCcccccCcccccccCEEeCcCCccccccccccC
Confidence 1112223333
Q ss_pred ------EccCCCCCCC-CccccccCCCCCCEEEcccCCCCCCCCCCCCCCCcCEEeccCCcCCCcCC--CCCCCCCcCEE
Q 002158 235 ------QLDNNNFSAS-EIPATYGNFSKLVKLSLRNCNLQGAVPDLSRIPNLYYLDLSWNHLTGSIP--SKKLSENVTTI 305 (958)
Q Consensus 235 ------~L~~N~l~~~-~~p~~~~~l~~L~~L~L~~N~l~~~~~~l~~l~~L~~L~Ls~N~l~~~~~--~~~~~~~L~~L 305 (958)
++++|+++.. ..+..+.++++|+.|++++|.+++.++.+..+++|+.|++++|.+.+..+ ....+++|++|
T Consensus 347 ~~L~~L~l~~n~l~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L 426 (570)
T 2z63_A 347 PSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVITMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYL 426 (570)
T ss_dssp TTCCEEECCSSCCBEEEEEEHHHHTCSCCCEEECCSCSEEEEEEEEETCTTCCEEECTTSEEESCTTSCTTTTCTTCCEE
T ss_pred CCCCEEeCcCCccCccccccccccccCccCEEECCCCccccccccccccCCCCEEEccCCccccccchhhhhcCCCCCEE
Confidence 3333333210 00233444555555555555555554446677888888888888876555 23456899999
Q ss_pred EccCCcCCCccchhccCCCCCCeEeeecccCC-CccchhhhcccccCccccceEeccCCCCCCCcc-CC-CCCCcceEEe
Q 002158 306 DLSDNYLNGSILESISNLPFLQTLSLENNFLT-GSIPATIWQNKSFSTKARLKIDLRNNSFSNIVG-DL-TLPNNVTLRL 382 (958)
Q Consensus 306 ~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~-~~ip~~l~~~~~~~~~~l~~L~Ls~N~l~~l~~-~~-~l~~L~~L~l 382 (958)
+|++|.+++..+..|.++++|++|+|++|.++ +.+|..+..+ +.|+.|+|++|+++++.. .. .+++|+.|++
T Consensus 427 ~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~p~~~~~l-----~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l 501 (570)
T 2z63_A 427 DISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTEL-----RNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNM 501 (570)
T ss_dssp ECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCCTTC-----TTCCEEECTTSCCCEECTTTTTTCTTCCEEEC
T ss_pred eCcCCcccccchhhhhcCCcCcEEECcCCcCccccchhhhhcc-----cCCCEEECCCCccccCChhhhhcccCCCEEeC
Confidence 99999999888999999999999999999997 5788766554 456799999999999844 44 8999999999
Q ss_pred CCCCCCCCCCCCCCCcccccCCCCCccccccCCCCCCCCCCCC-CcccccCCCCC-Cceeeeece
Q 002158 383 GGNPICTSANIPNTGRFCGSDAGGDETLTNSKVNCPVQACPVD-NFFEYVPASPE-PCFCAAPLR 445 (958)
Q Consensus 383 ~~N~l~~~~~~~~~~~~~~~~~~~~~~L~~n~~~C~c~~~~~~-~~~~~~~~~~~-~~~c~sp~~ 445 (958)
++|.+..... ..+......+.+.+.+|+|.|+|+..++. .|++....... ...|++|.+
T Consensus 502 ~~n~l~~~~~----~~~~~l~~L~~L~l~~N~~~~~~~~~~~~~~wl~~~~~~~~~~~~C~~~~~ 562 (570)
T 2z63_A 502 ASNQLKSVPD----GIFDRLTSLQKIWLHTNPWDCSCPRIDYLSRWLNKNSQKEQGSAKCSGSGK 562 (570)
T ss_dssp CSSCCSCCCT----TTTTTCTTCCEEECCSSCBCCCTTTTHHHHHHHHHTGGGEESCCBBTTTCC
T ss_pred CCCcCCCCCH----HHhhcccCCcEEEecCCcccCCCcchHHHHHHHHhccccCCCchhhCCCCC
Confidence 9999976432 12333456678999999999999998887 89876432221 237877743
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-32 Score=330.95 Aligned_cols=313 Identities=19% Similarity=0.277 Sum_probs=269.3
Q ss_pred ceeeEEEEccCCcCCCCccccccCCCCcceeeccCc--ccC-CCCccccCC------CCCcEEEeeCCCCCCCCCh--hh
Q 002158 85 HLHVRELQLLSMNLSGNLAPELGQLSRLQYYFMWND--LTG-TIPKEIGNI------SSLIFLLLNGNKLSGSLPD--EL 153 (958)
Q Consensus 85 ~~~v~~L~L~~~~l~~~~~~~l~~L~~L~~L~l~n~--~~~-~ip~~i~~l------~~L~~L~Ls~n~l~~~~p~--~l 153 (958)
..+++.|+|++|++.+.+|..++++++|+.|++++| +.| .+|..++++ ++|++|+|++|.++ .+|. .+
T Consensus 248 l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n~~l~~~~lp~~~~~L~~~~~l~~L~~L~L~~n~l~-~ip~~~~l 326 (636)
T 4eco_A 248 LKDLTDVEVYNCPNLTKLPTFLKALPEMQLINVACNRGISGEQLKDDWQALADAPVGEKIQIIYIGYNNLK-TFPVETSL 326 (636)
T ss_dssp CTTCCEEEEECCTTCSSCCTTTTTCSSCCEEECTTCTTSCHHHHHHHHHHHHHSGGGGTCCEEECCSSCCS-SCCCHHHH
T ss_pred cCCCCEEEecCCcCCccChHHHhcCCCCCEEECcCCCCCccccchHHHHhhhccccCCCCCEEECCCCcCC-ccCchhhh
Confidence 347999999999999999999999999999999866 666 799999887 99999999999999 8998 99
Q ss_pred cCCCCCCEEecccccccccCccccccccccceEecccccccccCchhhcCCcc-chhhhccCCccccCCCcccCCCC--C
Q 002158 154 GYLSNLNRLQVDENNITGTIPKSFANLSRVRHLHLNNNSIGGQIPSELSKLST-LIHLLVDNNNLSGNLPPELSELP--Q 230 (958)
Q Consensus 154 ~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~-L~~L~L~~N~l~~~~~~~l~~l~--~ 230 (958)
+++++|++|+|++|+++|.+| .|..+++|++|+|++|+++ .+|..+..+++ |++|++++|+++ .+|..+..++ +
T Consensus 327 ~~l~~L~~L~L~~N~l~g~ip-~~~~l~~L~~L~L~~N~l~-~lp~~l~~l~~~L~~L~Ls~N~l~-~lp~~~~~~~l~~ 403 (636)
T 4eco_A 327 QKMKKLGMLECLYNQLEGKLP-AFGSEIKLASLNLAYNQIT-EIPANFCGFTEQVENLSFAHNKLK-YIPNIFDAKSVSV 403 (636)
T ss_dssp TTCTTCCEEECCSCCCEEECC-CCEEEEEESEEECCSSEEE-ECCTTSEEECTTCCEEECCSSCCS-SCCSCCCTTCSSC
T ss_pred ccCCCCCEEeCcCCcCccchh-hhCCCCCCCEEECCCCccc-cccHhhhhhcccCcEEEccCCcCc-ccchhhhhcccCc
Confidence 999999999999999999999 9999999999999999999 88989999999 999999999999 7888887765 9
Q ss_pred ccEEEccCCCCCCCCcccccc-------CCCCCCEEEcccCCCCCCCCC-CCCCCCcCEEeccCCcCCCcCCCCCCC-C-
Q 002158 231 LCILQLDNNNFSASEIPATYG-------NFSKLVKLSLRNCNLQGAVPD-LSRIPNLYYLDLSWNHLTGSIPSKKLS-E- 300 (958)
Q Consensus 231 L~~L~L~~N~l~~~~~p~~~~-------~l~~L~~L~L~~N~l~~~~~~-l~~l~~L~~L~Ls~N~l~~~~~~~~~~-~- 300 (958)
|++|++++|+++ ...|..+. .+++|+.|+|++|+++..++. +..+++|++|+|++|+++ .+|...+. .
T Consensus 404 L~~L~Ls~N~l~-~~~p~~l~~~~~~~~~~~~L~~L~Ls~N~l~~lp~~~~~~l~~L~~L~Ls~N~l~-~i~~~~~~~~~ 481 (636)
T 4eco_A 404 MSAIDFSYNEIG-SVDGKNFDPLDPTPFKGINVSSINLSNNQISKFPKELFSTGSPLSSINLMGNMLT-EIPKNSLKDEN 481 (636)
T ss_dssp EEEEECCSSCTT-TTTTCSSCTTCSSCCCCCCEEEEECCSSCCCSCCTHHHHTTCCCSEEECCSSCCS-BCCSSSSEETT
T ss_pred cCEEECcCCcCC-CcchhhhcccccccccCCCCCEEECcCCccCcCCHHHHccCCCCCEEECCCCCCC-CcCHHHhcccc
Confidence 999999999998 46677777 788999999999999977665 567899999999999999 66654332 2
Q ss_pred -------CcCEEEccCCcCCCccchhcc--CCCCCCeEeeecccCCCccchhhhcccccCccccceEecc------CCCC
Q 002158 301 -------NVTTIDLSDNYLNGSILESIS--NLPFLQTLSLENNFLTGSIPATIWQNKSFSTKARLKIDLR------NNSF 365 (958)
Q Consensus 301 -------~L~~L~Ls~N~l~~~~~~~~~--~l~~L~~L~L~~N~l~~~ip~~l~~~~~~~~~~l~~L~Ls------~N~l 365 (958)
+|+.|+|++|+|+ .+|..+. .+++|+.|+|++|+|++ +|..++.+ +.|+.|+|+ +|++
T Consensus 482 ~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~~~l~~L~~L~Ls~N~l~~-ip~~~~~l-----~~L~~L~Ls~N~~ls~N~l 554 (636)
T 4eco_A 482 ENFKNTYLLTSIDLRFNKLT-KLSDDFRATTLPYLVGIDLSYNSFSK-FPTQPLNS-----STLKGFGIRNQRDAQGNRT 554 (636)
T ss_dssp EECTTGGGCCEEECCSSCCC-BCCGGGSTTTCTTCCEEECCSSCCSS-CCCGGGGC-----SSCCEEECCSCBCTTCCBC
T ss_pred ccccccCCccEEECcCCcCC-ccChhhhhccCCCcCEEECCCCCCCC-cChhhhcC-----CCCCEEECCCCcccccCcc
Confidence 8999999999999 6777776 99999999999999997 89988765 456699995 4655
Q ss_pred CC-CccCC-CCCCcceEEeCCCCCCCCCCCCCCCcccccCCCCCccccccCCCC
Q 002158 366 SN-IVGDL-TLPNNVTLRLGGNPICTSANIPNTGRFCGSDAGGDETLTNSKVNC 417 (958)
Q Consensus 366 ~~-l~~~~-~l~~L~~L~l~~N~l~~~~~~~~~~~~~~~~~~~~~~L~~n~~~C 417 (958)
.. ++... .+++|+.|+|++|++...+ .. +. .....+.|.+|++.|
T Consensus 555 ~~~~p~~l~~l~~L~~L~Ls~N~l~~ip---~~--~~--~~L~~L~Ls~N~l~~ 601 (636)
T 4eco_A 555 LREWPEGITLCPSLTQLQIGSNDIRKVN---EK--IT--PNISVLDIKDNPNIS 601 (636)
T ss_dssp CCCCCTTGGGCSSCCEEECCSSCCCBCC---SC--CC--TTCCEEECCSCTTCE
T ss_pred cccChHHHhcCCCCCEEECCCCcCCccC---Hh--Hh--CcCCEEECcCCCCcc
Confidence 54 55555 8999999999999994432 21 11 567888899998865
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=8e-32 Score=325.72 Aligned_cols=215 Identities=16% Similarity=0.145 Sum_probs=168.1
Q ss_pred chhhcCCccchhhhccCCccccCCCcccCCCCCccEEEccCCCCCCCCcc-ccccCCCCCCEEEcccCCCCCCCCC-CCC
Q 002158 198 PSELSKLSTLIHLLVDNNNLSGNLPPELSELPQLCILQLDNNNFSASEIP-ATYGNFSKLVKLSLRNCNLQGAVPD-LSR 275 (958)
Q Consensus 198 p~~l~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~p-~~~~~l~~L~~L~L~~N~l~~~~~~-l~~ 275 (958)
|..+..+++|++|++++|.+++ +|..+..+++|+.|++++|+++. ..+ ..+.++++|+.|++++|++++..+. +..
T Consensus 369 ~~~~~~~~~L~~L~L~~n~l~~-~~~~~~~l~~L~~L~l~~n~l~~-~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~ 446 (606)
T 3vq2_A 369 SYSDLGTNSLRHLDLSFNGAII-MSANFMGLEELQHLDFQHSTLKR-VTEFSAFLSLEKLLYLDISYTNTKIDFDGIFLG 446 (606)
T ss_dssp CHHHHCCSCCCEEECCSCSEEE-ECCCCTTCTTCCEEECTTSEEES-TTTTTTTTTCTTCCEEECTTSCCEECCTTTTTT
T ss_pred hhhhccCCcccEeECCCCcccc-chhhccCCCCCCeeECCCCccCC-ccChhhhhccccCCEEECcCCCCCccchhhhcC
Confidence 3344444555555555555553 34667778888888888888864 334 6889999999999999999987775 899
Q ss_pred CCCcCEEeccCCcCCCc-CCC-CCCCCCcCEEEccCCcCCCccchhccCCCCCCeEeeecccCCCccchhhhcccccCcc
Q 002158 276 IPNLYYLDLSWNHLTGS-IPS-KKLSENVTTIDLSDNYLNGSILESISNLPFLQTLSLENNFLTGSIPATIWQNKSFSTK 353 (958)
Q Consensus 276 l~~L~~L~Ls~N~l~~~-~~~-~~~~~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~ip~~l~~~~~~~~~ 353 (958)
+++|++|+|++|.+++. +|. ...+++|++|+|++|++++..|..|..+++|++|+|++|++++.+|..+..+.
T Consensus 447 l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~----- 521 (606)
T 3vq2_A 447 LTSLNTLKMAGNSFKDNTLSNVFANTTNLTFLDLSKCQLEQISWGVFDTLHRLQLLNMSHNNLLFLDSSHYNQLY----- 521 (606)
T ss_dssp CTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSCEEGGGTTTCT-----
T ss_pred CCCCCEEECCCCcCCCcchHHhhccCCCCCEEECCCCcCCccChhhhcccccCCEEECCCCcCCCcCHHHccCCC-----
Confidence 99999999999999873 454 45679999999999999999999999999999999999999988888886654
Q ss_pred ccceEeccCCCCCCCccCC-CCC-CcceEEeCCCCCCCCCCCCCCCcccccCCCCCccccccCCCCCCCC
Q 002158 354 ARLKIDLRNNSFSNIVGDL-TLP-NNVTLRLGGNPICTSANIPNTGRFCGSDAGGDETLTNSKVNCPVQA 421 (958)
Q Consensus 354 ~l~~L~Ls~N~l~~l~~~~-~l~-~L~~L~l~~N~l~~~~~~~~~~~~~~~~~~~~~~L~~n~~~C~c~~ 421 (958)
.|+.|||++|+|+.++... .++ +|+.|++++|||.|+|...++..+...... .......+.|.-+.
T Consensus 522 ~L~~L~l~~N~l~~~p~~~~~l~~~L~~l~l~~N~~~c~c~~~~~~~~l~~~~~--~~~~~~~~~C~~p~ 589 (606)
T 3vq2_A 522 SLSTLDCSFNRIETSKGILQHFPKSLAFFNLTNNSVACICEHQKFLQWVKEQKQ--FLVNVEQMTCATPV 589 (606)
T ss_dssp TCCEEECTTSCCCCEESCGGGSCTTCCEEECCSCCCCCSSTTHHHHTTTTTSSS--SBSSGGGCCCC---
T ss_pred cCCEEECCCCcCcccCHhHhhhcccCcEEEccCCCcccCCccHHHHHHHHcCcc--cccCCccceeCCCh
Confidence 5669999999999999876 676 699999999999999998877666543321 22234456666544
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.98 E-value=3.4e-32 Score=322.69 Aligned_cols=320 Identities=18% Similarity=0.242 Sum_probs=259.5
Q ss_pred ceeeEEEEccCCcCCCCccccccCCCCcceeeccCcccCCCCccccCCCCCcEEEeeCCCCCC-CCChhhcCCCCCCEEe
Q 002158 85 HLHVRELQLLSMNLSGNLAPELGQLSRLQYYFMWNDLTGTIPKEIGNISSLIFLLLNGNKLSG-SLPDELGYLSNLNRLQ 163 (958)
Q Consensus 85 ~~~v~~L~L~~~~l~~~~~~~l~~L~~L~~L~l~n~~~~~ip~~i~~l~~L~~L~Ls~n~l~~-~~p~~l~~l~~L~~L~ 163 (958)
..+++.|+|++|.+++..|..|+++++|++|++++|....+|.. .+++|++|+|++|.+++ .+|..|+++++|++|+
T Consensus 44 l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~lp~~--~l~~L~~L~L~~N~l~~~~~p~~~~~l~~L~~L~ 121 (520)
T 2z7x_B 44 LSKLRILIISHNRIQYLDISVFKFNQELEYLDLSHNKLVKISCH--PTVNLKHLDLSFNAFDALPICKEFGNMSQLKFLG 121 (520)
T ss_dssp CTTCCEEECCSSCCCEEEGGGGTTCTTCCEEECCSSCCCEEECC--CCCCCSEEECCSSCCSSCCCCGGGGGCTTCCEEE
T ss_pred cccccEEecCCCccCCcChHHhhcccCCCEEecCCCceeecCcc--ccCCccEEeccCCccccccchhhhccCCcceEEE
Confidence 34789999999999998899999999999999998887788877 88999999999999986 4788899999998888
Q ss_pred cccccccc-------------------------cCcccccccc-------------------------------------
Q 002158 164 VDENNITG-------------------------TIPKSFANLS------------------------------------- 181 (958)
Q Consensus 164 L~~N~l~~-------------------------~~p~~~~~l~------------------------------------- 181 (958)
+++|++++ ..|..+..+.
T Consensus 122 L~~n~l~~~~~~~l~~L~L~~L~l~~n~l~~~~~~~~~l~~l~~~~l~l~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~ 201 (520)
T 2z7x_B 122 LSTTHLEKSSVLPIAHLNISKVLLVLGETYGEKEDPEGLQDFNTESLHIVFPTNKEFHFILDVSVKTVANLELSNIKCVL 201 (520)
T ss_dssp EEESSCCGGGGGGGTTSCEEEEEEEECTTTTSSCCTTTTTTCCEEEEEEECCSSSCCCCCCCCCCTTCSEEEECCEEECC
T ss_pred ecCcccchhhccccccceeeEEEeecccccccccccccccccccceEEEEeccCcchhhhhhhhhhcccceeeccccccc
Confidence 88887742 2344443322
Q ss_pred ----------------------------------------------ccceEecccccccccCchhh-----cCCccchhh
Q 002158 182 ----------------------------------------------RVRHLHLNNNSIGGQIPSEL-----SKLSTLIHL 210 (958)
Q Consensus 182 ----------------------------------------------~L~~L~Ls~N~l~~~~p~~l-----~~l~~L~~L 210 (958)
+|++|++++|+++|.+|..+ ..+++|+.+
T Consensus 202 ~~~~~~~~~~~~~~l~~l~~L~~L~l~~~~l~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~p~~~~~~~~~~l~~L~~l 281 (520)
T 2z7x_B 202 EDNKCSYFLSILAKLQTNPKLSNLTLNNIETTWNSFIRILQLVWHTTVWYFSISNVKLQGQLDFRDFDYSGTSLKALSIH 281 (520)
T ss_dssp STTTTHHHHHHHHGGGGCTTCCEEEEEEEEEEHHHHHHHHHHHHTSSCSEEEEEEEEEESCCCCCCCCCCSCCCCEEEEE
T ss_pred cccccceeecchhhhccccchhhccccccccCHHHHHHHHHHhhhCcccEEEeecccccCccccchhhcccccCceeEec
Confidence 68888888888988889888 778877777
Q ss_pred hccCCccccCCC-cc-------------------------cCCCCCccEEEccCCCCCCCCccccccCCCCCCEEEcccC
Q 002158 211 LVDNNNLSGNLP-PE-------------------------LSELPQLCILQLDNNNFSASEIPATYGNFSKLVKLSLRNC 264 (958)
Q Consensus 211 ~L~~N~l~~~~~-~~-------------------------l~~l~~L~~L~L~~N~l~~~~~p~~~~~l~~L~~L~L~~N 264 (958)
++++|.+ .+| .. +..+++|++|++++|+++ ...|..+.++++|+.|+|++|
T Consensus 282 ~l~~n~~--~~p~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~l~~L~~L~Ls~n~l~-~~~~~~~~~l~~L~~L~L~~N 358 (520)
T 2z7x_B 282 QVVSDVF--GFPQSYIYEIFSNMNIKNFTVSGTRMVHMLCPSKISPFLHLDFSNNLLT-DTVFENCGHLTELETLILQMN 358 (520)
T ss_dssp EEEECCC--CSCTHHHHHHHHTCCCSEEEEESSCCCCCCCCSSCCCCCEEECCSSCCC-TTTTTTCCCCSSCCEEECCSS
T ss_pred cccccce--ecchhhhhcccccCceeEEEcCCCccccccchhhCCcccEEEeECCccC-hhhhhhhccCCCCCEEEccCC
Confidence 7777776 222 11 268899999999999998 457889999999999999999
Q ss_pred CCCCCC--C-CCCCCCCcCEEeccCCcCCCcCCC--CCCCCCcCEEEccCCcCCCccchhccCCCCCCeEeeecccCCCc
Q 002158 265 NLQGAV--P-DLSRIPNLYYLDLSWNHLTGSIPS--KKLSENVTTIDLSDNYLNGSILESISNLPFLQTLSLENNFLTGS 339 (958)
Q Consensus 265 ~l~~~~--~-~l~~l~~L~~L~Ls~N~l~~~~~~--~~~~~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~ 339 (958)
++++.+ + .+..+++|++|+|++|.+++.+|. ...+++|++|+|++|++++..+..+. ++|+.|+|++|+|+ .
T Consensus 359 ~l~~l~~~~~~~~~l~~L~~L~Ls~N~l~~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~--~~L~~L~Ls~N~l~-~ 435 (520)
T 2z7x_B 359 QLKELSKIAEMTTQMKSLQQLDISQNSVSYDEKKGDCSWTKSLLSLNMSSNILTDTIFRCLP--PRIKVLDLHSNKIK-S 435 (520)
T ss_dssp CCCBHHHHHHHHTTCTTCCEEECCSSCCBCCGGGCSCCCCTTCCEEECCSSCCCGGGGGSCC--TTCCEEECCSSCCC-C
T ss_pred ccCccccchHHHhhCCCCCEEECCCCcCCcccccchhccCccCCEEECcCCCCCcchhhhhc--ccCCEEECCCCccc-c
Confidence 999743 2 388999999999999999975664 35568999999999999988877765 79999999999999 8
Q ss_pred cchhhhcccccCccccceEeccCCCCCCCccC-C-CCCCcceEEeCCCCCCCCCCCCCC-CcccccCCCCCccccccCCC
Q 002158 340 IPATIWQNKSFSTKARLKIDLRNNSFSNIVGD-L-TLPNNVTLRLGGNPICTSANIPNT-GRFCGSDAGGDETLTNSKVN 416 (958)
Q Consensus 340 ip~~l~~~~~~~~~~l~~L~Ls~N~l~~l~~~-~-~l~~L~~L~l~~N~l~~~~~~~~~-~~~~~~~~~~~~~L~~n~~~ 416 (958)
+|..++.+ +.|+.|+|++|+|++++.. . .+++|+.|++++|||.|+|...++ ..+....... ......
T Consensus 436 ip~~~~~l-----~~L~~L~L~~N~l~~l~~~~~~~l~~L~~L~l~~N~~~c~c~~~~~~~~~~~~~~~~----~~~~~~ 506 (520)
T 2z7x_B 436 IPKQVVKL-----EALQELNVASNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCPRIDYLSRWLNKNSQK----EQGSAK 506 (520)
T ss_dssp CCGGGGGC-----TTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCBCCCHHHHHHHHHHHHHTTTT----EESCCB
T ss_pred cchhhhcC-----CCCCEEECCCCcCCccCHHHhccCCcccEEECcCCCCcccCCchHHHHHHHHhcccc----CCCCCC
Confidence 99988754 4566999999999999986 3 899999999999999999998777 5554333221 234556
Q ss_pred CCCCC
Q 002158 417 CPVQA 421 (958)
Q Consensus 417 C~c~~ 421 (958)
|.-+.
T Consensus 507 C~~p~ 511 (520)
T 2z7x_B 507 CSGSG 511 (520)
T ss_dssp BTTTC
T ss_pred cCCcc
Confidence 66653
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.97 E-value=8.4e-32 Score=322.25 Aligned_cols=300 Identities=19% Similarity=0.212 Sum_probs=256.2
Q ss_pred ceeeEEEEccCCcCCCCccccccCCCCcceeeccCcccCCCCccccCCCCCcEEEeeCCCCCC-CCChhhcCCCCCCEEe
Q 002158 85 HLHVRELQLLSMNLSGNLAPELGQLSRLQYYFMWNDLTGTIPKEIGNISSLIFLLLNGNKLSG-SLPDELGYLSNLNRLQ 163 (958)
Q Consensus 85 ~~~v~~L~L~~~~l~~~~~~~l~~L~~L~~L~l~n~~~~~ip~~i~~l~~L~~L~Ls~n~l~~-~~p~~l~~l~~L~~L~ 163 (958)
..+++.|+|++|.+++..|..|+.+++|++|++++|....+|.. .+++|++|+|++|.+++ .+|..|+++++|++|+
T Consensus 75 l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~lp~~--~l~~L~~L~Ls~N~l~~l~~p~~~~~l~~L~~L~ 152 (562)
T 3a79_B 75 LSELRVLRLSHNRIRSLDFHVFLFNQDLEYLDVSHNRLQNISCC--PMASLRHLDLSFNDFDVLPVCKEFGNLTKLTFLG 152 (562)
T ss_dssp CTTCCEEECCSCCCCEECTTTTTTCTTCCEEECTTSCCCEECSC--CCTTCSEEECCSSCCSBCCCCGGGGGCTTCCEEE
T ss_pred CCCccEEECCCCCCCcCCHHHhCCCCCCCEEECCCCcCCccCcc--ccccCCEEECCCCCccccCchHhhcccCcccEEe
Confidence 45799999999999999999999999999999998888899987 89999999999999996 4568999999999999
Q ss_pred cccccccccCcccccccccc--ceEecccccc--cccCchhhcCCc----------------------------------
Q 002158 164 VDENNITGTIPKSFANLSRV--RHLHLNNNSI--GGQIPSELSKLS---------------------------------- 205 (958)
Q Consensus 164 L~~N~l~~~~p~~~~~l~~L--~~L~Ls~N~l--~~~~p~~l~~l~---------------------------------- 205 (958)
|++|++++. .+..+++| +.|+|++|.+ ++..|..+..+.
T Consensus 153 L~~n~l~~~---~~~~l~~L~L~~L~L~~n~l~~~~~~~~~l~~l~~~~l~l~l~~n~~~~~~~~~~~~~l~~L~~L~l~ 229 (562)
T 3a79_B 153 LSAAKFRQL---DLLPVAHLHLSCILLDLVSYHIKGGETESLQIPNTTVLHLVFHPNSLFSVQVNMSVNALGHLQLSNIK 229 (562)
T ss_dssp EECSBCCTT---TTGGGTTSCEEEEEEEESSCCCCSSSCCEEEECCEEEEEEEECSSSCCCCCCEEEESSEEEEEEEEEE
T ss_pred cCCCccccC---chhhhhhceeeEEEeecccccccccCcccccccCcceEEEEecCccchhhhhhhcccccceEEEeccc
Confidence 999999863 45555555 8899998888 666665555433
Q ss_pred -----------------------------------------------cchhhhccCCccccCCCccc-------------
Q 002158 206 -----------------------------------------------TLIHLLVDNNNLSGNLPPEL------------- 225 (958)
Q Consensus 206 -----------------------------------------------~L~~L~L~~N~l~~~~~~~l------------- 225 (958)
+|++|++++|++++.+|..+
T Consensus 230 ~n~~~~~~l~~~~~~l~~l~~L~~L~L~~~~l~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~ip~~~~~~~~~~L~~L~~ 309 (562)
T 3a79_B 230 LNDENCQRLMTFLSELTRGPTLLNVTLQHIETTWKCSVKLFQFFWPRPVEYLNIYNLTITERIDREEFTYSETALKSLMI 309 (562)
T ss_dssp CCSTTHHHHHHHHHHHHSCSSCEEEEEEEEEECHHHHHHHHHHHTTSSEEEEEEEEEEECSCCCCCCCCCCSCSCCEEEE
T ss_pred ccccccchHHHHHHHHhccCcceEEEecCCcCcHHHHHHHHHhhhcccccEEEEeccEeeccccchhhhcccccchheeh
Confidence 67777778888877666654
Q ss_pred ----------------------------------------CCCCCccEEEccCCCCCCCCccccccCCCCCCEEEcccCC
Q 002158 226 ----------------------------------------SELPQLCILQLDNNNFSASEIPATYGNFSKLVKLSLRNCN 265 (958)
Q Consensus 226 ----------------------------------------~~l~~L~~L~L~~N~l~~~~~p~~~~~l~~L~~L~L~~N~ 265 (958)
..+++|++|++++|+++ ...|..+.++++|+.|+|++|+
T Consensus 310 ~~~~~~~~~~p~~~~~~~~~~~~L~~L~l~~n~~~~~~~~~~l~~L~~L~l~~n~l~-~~~~~~~~~l~~L~~L~L~~N~ 388 (562)
T 3a79_B 310 EHVKNQVFLFSKEALYSVFAEMNIKMLSISDTPFIHMVCPPSPSSFTFLNFTQNVFT-DSVFQGCSTLKRLQTLILQRNG 388 (562)
T ss_dssp EEEEECCCSSCHHHHHHHHHTCCCSEEEEESSCCCCCCCCSSCCCCCEEECCSSCCC-TTTTTTCCSCSSCCEEECCSSC
T ss_pred hhcccceeecChhhhhhhhccCcceEEEccCCCcccccCccCCCCceEEECCCCccc-cchhhhhcccCCCCEEECCCCC
Confidence 67899999999999998 4678899999999999999999
Q ss_pred CCCCCC---CCCCCCCcCEEeccCCcCCCcCCCC--CCCCCcCEEEccCCcCCCccchhccCCCCCCeEeeecccCCCcc
Q 002158 266 LQGAVP---DLSRIPNLYYLDLSWNHLTGSIPSK--KLSENVTTIDLSDNYLNGSILESISNLPFLQTLSLENNFLTGSI 340 (958)
Q Consensus 266 l~~~~~---~l~~l~~L~~L~Ls~N~l~~~~~~~--~~~~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~i 340 (958)
+++.+. .+..+++|++|+|++|++++.+|.. ..+++|++|+|++|+|++..+..+. ++|+.|+|++|+|+ .+
T Consensus 389 l~~~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~--~~L~~L~L~~N~l~-~i 465 (562)
T 3a79_B 389 LKNFFKVALMTKNMSSLETLDVSLNSLNSHAYDRTCAWAESILVLNLSSNMLTGSVFRCLP--PKVKVLDLHNNRIM-SI 465 (562)
T ss_dssp CCBTTHHHHTTTTCTTCCEEECTTSCCBSCCSSCCCCCCTTCCEEECCSSCCCGGGGSSCC--TTCSEEECCSSCCC-CC
T ss_pred cCCcccchhhhcCCCCCCEEECCCCcCCCccChhhhcCcccCCEEECCCCCCCcchhhhhc--CcCCEEECCCCcCc-cc
Confidence 998653 4899999999999999999756653 4569999999999999987776654 79999999999999 89
Q ss_pred chhhhcccccCccccceEeccCCCCCCCccC-C-CCCCcceEEeCCCCCCCCCCCCCCCc
Q 002158 341 PATIWQNKSFSTKARLKIDLRNNSFSNIVGD-L-TLPNNVTLRLGGNPICTSANIPNTGR 398 (958)
Q Consensus 341 p~~l~~~~~~~~~~l~~L~Ls~N~l~~l~~~-~-~l~~L~~L~l~~N~l~~~~~~~~~~~ 398 (958)
|..++.+ +.|+.|+|++|+|++++.. . .+++|+.|++++|||.|+|...++..
T Consensus 466 p~~~~~l-----~~L~~L~L~~N~l~~l~~~~~~~l~~L~~L~l~~N~~~c~c~~~~~~~ 520 (562)
T 3a79_B 466 PKDVTHL-----QALQELNVASNQLKSVPDGVFDRLTSLQYIWLHDNPWDCTCPGIRYLS 520 (562)
T ss_dssp CTTTTSS-----CCCSEEECCSSCCCCCCTTSTTTCTTCCCEECCSCCBCCCHHHHHHHH
T ss_pred ChhhcCC-----CCCCEEECCCCCCCCCCHHHHhcCCCCCEEEecCCCcCCCcchHHHHH
Confidence 9888644 4567999999999999986 3 89999999999999999998777643
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} | Back alignment and structure |
|---|
Probab=99.97 E-value=2.6e-32 Score=303.05 Aligned_cols=288 Identities=21% Similarity=0.238 Sum_probs=183.2
Q ss_pred CCCHhHHHHHHHHHHHcc-cCccccCCCC---CCCCCCCCCCceeeCccccCCCceeeEEEEccCCcCCCCccccccCCC
Q 002158 35 TTDPQEASALRAIKNSLV-DSMNHLRNWN---KGDPCMSNWTGVLCFDTVETDGHLHVRELQLLSMNLSGNLAPELGQLS 110 (958)
Q Consensus 35 ~~~~~~~~al~~~k~~~~-~~~~~l~~W~---~~~~c~~~w~gV~C~~~~~~~~~~~v~~L~L~~~~l~~~~~~~l~~L~ 110 (958)
....+|+.||++||.++. |+.+++.+|. .....+|.|.|+.|...... + .-...+
T Consensus 23 ~~~~~~~~aLl~~k~~~~~~~~~~~~~w~~~~~~~~~~~~~~g~~~~~~~~~-------------------l--~~~~~~ 81 (328)
T 4fcg_A 23 TALRPYHDVLSQWQRHYNADRNRWHSAWRQANSNNPQIETRTGRALKATADL-------------------L--EDATQP 81 (328)
T ss_dssp CCCCCHHHHHHHHHHHHHHCCTTHHHHHHHHTTTCTTSCCSHHHHHHHHHHH-------------------H--HHHTST
T ss_pred ccCchHHHHHHHHHHhccCCchhhhhhhcccccccccccccCCcchhhhHHH-------------------H--hccccc
Confidence 345789999999999994 7778888994 33444458999999431100 0 001234
Q ss_pred CcceeeccCcccCCCCccccCCCCCcEEEeeCCCCCCCCChhhcCCCCCCEEecccccccccCccccccccccceEeccc
Q 002158 111 RLQYYFMWNDLTGTIPKEIGNISSLIFLLLNGNKLSGSLPDELGYLSNLNRLQVDENNITGTIPKSFANLSRVRHLHLNN 190 (958)
Q Consensus 111 ~L~~L~l~n~~~~~ip~~i~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~ 190 (958)
+++.|+++++....+|..++++++|++|+|++|.++ .+|..++++++|++|+|++|+++ .+|..+.++++|++|+|++
T Consensus 82 ~l~~L~L~~n~l~~lp~~l~~l~~L~~L~L~~n~l~-~lp~~~~~l~~L~~L~Ls~n~l~-~lp~~l~~l~~L~~L~L~~ 159 (328)
T 4fcg_A 82 GRVALELRSVPLPQFPDQAFRLSHLQHMTIDAAGLM-ELPDTMQQFAGLETLTLARNPLR-ALPASIASLNRLRELSIRA 159 (328)
T ss_dssp TCCEEEEESSCCSSCCSCGGGGTTCSEEEEESSCCC-CCCSCGGGGTTCSEEEEESCCCC-CCCGGGGGCTTCCEEEEEE
T ss_pred ceeEEEccCCCchhcChhhhhCCCCCEEECCCCCcc-chhHHHhccCCCCEEECCCCccc-cCcHHHhcCcCCCEEECCC
Confidence 455555555555567777778888888888888888 78888888888888888888888 6777888888888888888
Q ss_pred ccccccCchhhcCCccchhhhccCCccccCCCcccCCCCCccEEEccCCCCCCCCccccccCCCCCCEEEcccCCCCCCC
Q 002158 191 NSIGGQIPSELSKLSTLIHLLVDNNNLSGNLPPELSELPQLCILQLDNNNFSASEIPATYGNFSKLVKLSLRNCNLQGAV 270 (958)
Q Consensus 191 N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~p~~~~~l~~L~~L~L~~N~l~~~~ 270 (958)
|++.+.+|..+... ..+..|.++++|++|+|++|+++ .+|..+.++++|++|+|++|++++.+
T Consensus 160 n~~~~~~p~~~~~~---------------~~~~~~~~l~~L~~L~L~~n~l~--~lp~~l~~l~~L~~L~L~~N~l~~l~ 222 (328)
T 4fcg_A 160 CPELTELPEPLAST---------------DASGEHQGLVNLQSLRLEWTGIR--SLPASIANLQNLKSLKIRNSPLSALG 222 (328)
T ss_dssp ETTCCCCCSCSEEE---------------C-CCCEEESTTCCEEEEEEECCC--CCCGGGGGCTTCCEEEEESSCCCCCC
T ss_pred CCCccccChhHhhc---------------cchhhhccCCCCCEEECcCCCcC--cchHhhcCCCCCCEEEccCCCCCcCc
Confidence 87777777665430 01122344555555555555554 44555555556666666666665555
Q ss_pred CCCCCCCCcCEEeccCCcCCCcCCCC-CCCCCcCEEEccCCcCCCccchhccCCCCCCeEeeecccCCCccchhhhcccc
Q 002158 271 PDLSRIPNLYYLDLSWNHLTGSIPSK-KLSENVTTIDLSDNYLNGSILESISNLPFLQTLSLENNFLTGSIPATIWQNKS 349 (958)
Q Consensus 271 ~~l~~l~~L~~L~Ls~N~l~~~~~~~-~~~~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~ip~~l~~~~~ 349 (958)
+.+..+++|++|+|++|.+.+.+|.. ..+++|++|+|++|.+.+.+|..+..+++|++|+|++|++.+.+|..+..+..
T Consensus 223 ~~l~~l~~L~~L~Ls~n~~~~~~p~~~~~l~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~L~~n~~~~~iP~~l~~L~~ 302 (328)
T 4fcg_A 223 PAIHHLPKLEELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLLTLPLDIHRLTQLEKLDLRGCVNLSRLPSLIAQLPA 302 (328)
T ss_dssp GGGGGCTTCCEEECTTCTTCCBCCCCTTCCCCCCEEECTTCTTCCBCCTTGGGCTTCCEEECTTCTTCCCCCGGGGGSCT
T ss_pred hhhccCCCCCEEECcCCcchhhhHHHhcCCCCCCEEECCCCCchhhcchhhhcCCCCCEEeCCCCCchhhccHHHhhccC
Confidence 45555566666666665555555443 33456666666666666666666666666666666666666666666655433
Q ss_pred cCccccceEeccCCCCCC
Q 002158 350 FSTKARLKIDLRNNSFSN 367 (958)
Q Consensus 350 ~~~~~l~~L~Ls~N~l~~ 367 (958)
+..+++..|.+..
T Consensus 303 -----L~~l~l~~~~~~~ 315 (328)
T 4fcg_A 303 -----NCIILVPPHLQAQ 315 (328)
T ss_dssp -----TCEEECCGGGSCC
T ss_pred -----ceEEeCCHHHHHH
Confidence 2245555444433
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=99.97 E-value=1.6e-31 Score=329.32 Aligned_cols=253 Identities=19% Similarity=0.286 Sum_probs=179.3
Q ss_pred ceeeEEEEccCCcCCCCccccccCCCCcceeeccCc--ccC-CCCccccCCC-------CCcEEEeeCCCCCCCCCh--h
Q 002158 85 HLHVRELQLLSMNLSGNLAPELGQLSRLQYYFMWND--LTG-TIPKEIGNIS-------SLIFLLLNGNKLSGSLPD--E 152 (958)
Q Consensus 85 ~~~v~~L~L~~~~l~~~~~~~l~~L~~L~~L~l~n~--~~~-~ip~~i~~l~-------~L~~L~Ls~n~l~~~~p~--~ 152 (958)
..+++.|+|++|++.+.+|..|++|++|+.|++++| +.+ .+|..+++++ +|++|+|++|.++ .+|. .
T Consensus 490 L~~L~~L~Ls~N~l~~~iP~~l~~L~~L~~L~Ls~N~~lsg~~iP~~i~~L~~~~~~l~~L~~L~Ls~N~L~-~ip~~~~ 568 (876)
T 4ecn_A 490 LKDLTDVELYNCPNMTQLPDFLYDLPELQSLNIACNRGISAAQLKADWTRLADDEDTGPKIQIFYMGYNNLE-EFPASAS 568 (876)
T ss_dssp CTTCCEEEEESCTTCCSCCGGGGGCSSCCEEECTTCTTSCHHHHHHHHHHHHHCTTTTTTCCEEECCSSCCC-BCCCHHH
T ss_pred CCCCCEEECcCCCCCccChHHHhCCCCCCEEECcCCCCcccccchHHHHhhhhcccccCCccEEEeeCCcCC-ccCChhh
Confidence 357999999999999999999999999999999866 566 7888777666 9999999999999 8888 8
Q ss_pred hcCCCCCCEEecccccccccCccccccccccceEecccccccccCchhhcCCcc-chhhhccCCccccCCCcccCCCCC-
Q 002158 153 LGYLSNLNRLQVDENNITGTIPKSFANLSRVRHLHLNNNSIGGQIPSELSKLST-LIHLLVDNNNLSGNLPPELSELPQ- 230 (958)
Q Consensus 153 l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~-L~~L~L~~N~l~~~~~~~l~~l~~- 230 (958)
|+++++|++|+|++|+++ .+| .|..+++|+.|+|++|+++ .+|..+.++++ |+.|+|++|+++ .+|..+..++.
T Consensus 569 l~~L~~L~~L~Ls~N~l~-~lp-~~~~L~~L~~L~Ls~N~l~-~lp~~l~~l~~~L~~L~Ls~N~L~-~lp~~~~~~~~~ 644 (876)
T 4ecn_A 569 LQKMVKLGLLDCVHNKVR-HLE-AFGTNVKLTDLKLDYNQIE-EIPEDFCAFTDQVEGLGFSHNKLK-YIPNIFNAKSVY 644 (876)
T ss_dssp HTTCTTCCEEECTTSCCC-BCC-CCCTTSEESEEECCSSCCS-CCCTTSCEECTTCCEEECCSSCCC-SCCSCCCTTCSS
T ss_pred hhcCCCCCEEECCCCCcc-cch-hhcCCCcceEEECcCCccc-cchHHHhhccccCCEEECcCCCCC-cCchhhhccccC
Confidence 999999999999999999 778 8999999999999999999 88888888888 999999999988 67777766544
Q ss_pred -ccEEEccCCCCCCCCccc---ccc--CCCCCCEEEcccCCCCCCCCC-CCCCCCcCEEeccCCcCCCcCCCCCC-C---
Q 002158 231 -LCILQLDNNNFSASEIPA---TYG--NFSKLVKLSLRNCNLQGAVPD-LSRIPNLYYLDLSWNHLTGSIPSKKL-S--- 299 (958)
Q Consensus 231 -L~~L~L~~N~l~~~~~p~---~~~--~l~~L~~L~L~~N~l~~~~~~-l~~l~~L~~L~Ls~N~l~~~~~~~~~-~--- 299 (958)
|+.|+|++|++++ .+|. .+. .+++|+.|+|++|+++.++.. +..+++|+.|+|++|+|+ .+|...+ .
T Consensus 645 ~L~~L~Ls~N~l~g-~ip~l~~~l~~~~~~~L~~L~Ls~N~L~~lp~~~~~~l~~L~~L~Ls~N~L~-~ip~~~~~~~~~ 722 (876)
T 4ecn_A 645 VMGSVDFSYNKIGS-EGRNISCSMDDYKGINASTVTLSYNEIQKFPTELFATGSPISTIILSNNLMT-SIPENSLKPKDG 722 (876)
T ss_dssp CEEEEECCSSCTTT-TSSSCSSCTTTCCCCCEEEEECCSSCCCSCCHHHHHTTCCCSEEECCSCCCS-CCCTTSSSCTTS
T ss_pred CCCEEECcCCcCCC-ccccchhhhccccCCCcCEEEccCCcCCccCHHHHccCCCCCEEECCCCcCC-ccChHHhccccc
Confidence 7777777777753 2221 112 223555555555555543333 234555555555555555 3332211 1
Q ss_pred -----CCcCEEEccCCcCCCccchhcc--CCCCCCeEeeecccCCCccchhhhc
Q 002158 300 -----ENVTTIDLSDNYLNGSILESIS--NLPFLQTLSLENNFLTGSIPATIWQ 346 (958)
Q Consensus 300 -----~~L~~L~Ls~N~l~~~~~~~~~--~l~~L~~L~L~~N~l~~~ip~~l~~ 346 (958)
++|+.|+|++|+|+ .+|..+. .+++|+.|+|++|+|++ +|..++.
T Consensus 723 ~l~nl~~L~~L~Ls~N~L~-~lp~~l~~~~l~~L~~L~Ls~N~L~~-lp~~l~~ 774 (876)
T 4ecn_A 723 NYKNTYLLTTIDLRFNKLT-SLSDDFRATTLPYLSNMDVSYNCFSS-FPTQPLN 774 (876)
T ss_dssp CCTTGGGCCEEECCSSCCC-CCCGGGSTTTCTTCCEEECCSSCCSS-CCCGGGG
T ss_pred cccccCCccEEECCCCCCc-cchHHhhhccCCCcCEEEeCCCCCCc-cchhhhc
Confidence 15555555555555 3444443 55555555555555554 4544443
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=2.4e-31 Score=308.23 Aligned_cols=264 Identities=23% Similarity=0.284 Sum_probs=172.1
Q ss_pred CCCccccCCCCCcEEEeeCCCCCCCCChhhcCCCCCCEEecccccccccCccccccccccceEecccccccccCchhhcC
Q 002158 124 TIPKEIGNISSLIFLLLNGNKLSGSLPDELGYLSNLNRLQVDENNITGTIPKSFANLSRVRHLHLNNNSIGGQIPSELSK 203 (958)
Q Consensus 124 ~ip~~i~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~ 203 (958)
.+|..+. ++++.|+|++|++++..+..|.++++|++|+|++|++++..+..|.++++|++|+|++|+|++..+..|..
T Consensus 57 ~iP~~~~--~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~i~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~ 134 (440)
T 3zyj_A 57 EVPDGIS--TNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIRTIEIGAFNGLANLNTLELFDNRLTTIPNGAFVY 134 (440)
T ss_dssp SCCSCCC--TTCSEEECCSCCCCEECTTTTSSCSSCCEEECCSSCCCEECGGGGTTCSSCCEEECCSSCCSSCCTTTSCS
T ss_pred cCCCCCC--CCCcEEEccCCcCCeeCHHHhhCCCCCCEEECCCCcCCccChhhccCCccCCEEECCCCcCCeeCHhHhhc
Confidence 4454443 57788888888888777777888888888888888888777777888888888888888888665666777
Q ss_pred CccchhhhccCCccccCCCcccCCCCCccEEEccCCCCCCCCccccccCCCCCCEEEcccCCCCCCCCCCCCCCCcCEEe
Q 002158 204 LSTLIHLLVDNNNLSGNLPPELSELPQLCILQLDNNNFSASEIPATYGNFSKLVKLSLRNCNLQGAVPDLSRIPNLYYLD 283 (958)
Q Consensus 204 l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~l~~l~~L~~L~ 283 (958)
+++|++|+|++|+|+...+..|..+++|++|+|++|+......+..|.++++|+.|+|++|+++.. +.+..+++|+.|+
T Consensus 135 l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~~~~l~~i~~~~~~~l~~L~~L~L~~n~l~~~-~~~~~l~~L~~L~ 213 (440)
T 3zyj_A 135 LSKLKELWLRNNPIESIPSYAFNRIPSLRRLDLGELKRLSYISEGAFEGLSNLRYLNLAMCNLREI-PNLTPLIKLDELD 213 (440)
T ss_dssp CSSCCEEECCSCCCCEECTTTTTTCTTCCEEECCCCTTCCEECTTTTTTCSSCCEEECTTSCCSSC-CCCTTCSSCCEEE
T ss_pred cccCceeeCCCCcccccCHHHhhhCcccCEeCCCCCCCcceeCcchhhcccccCeecCCCCcCccc-cccCCCcccCEEE
Confidence 778888888888777666667777777777777774433222233566666666666666666533 2455555555555
Q ss_pred ccCCcCCCcCCCC-CCCCCcCEEEccCCcCCCccchhccCCCCCCeEeeecccCCCccchhhhcccccCccccceEeccC
Q 002158 284 LSWNHLTGSIPSK-KLSENVTTIDLSDNYLNGSILESISNLPFLQTLSLENNFLTGSIPATIWQNKSFSTKARLKIDLRN 362 (958)
Q Consensus 284 Ls~N~l~~~~~~~-~~~~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~ip~~l~~~~~~~~~~l~~L~Ls~ 362 (958)
|++|++++..+.. ..+++|+.|+|++|+|++..+..|.++++|+.|+|++|+|
T Consensus 214 Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l-------------------------- 267 (440)
T 3zyj_A 214 LSGNHLSAIRPGSFQGLMHLQKLWMIQSQIQVIERNAFDNLQSLVEINLAHNNL-------------------------- 267 (440)
T ss_dssp CTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTSSTTCTTCCEEECTTSCC--------------------------
T ss_pred CCCCccCccChhhhccCccCCEEECCCCceeEEChhhhcCCCCCCEEECCCCCC--------------------------
Confidence 5555555433322 2334555555555555555455555555555555555444
Q ss_pred CCCCCCccCC--CCCCcceEEeCCCCCCCCCCCCCCCcccccCCCCCccccccCCCCCCCCCCCCCcccccCCCCC--Cc
Q 002158 363 NSFSNIVGDL--TLPNNVTLRLGGNPICTSANIPNTGRFCGSDAGGDETLTNSKVNCPVQACPVDNFFEYVPASPE--PC 438 (958)
Q Consensus 363 N~l~~l~~~~--~l~~L~~L~l~~N~l~~~~~~~~~~~~~~~~~~~~~~L~~n~~~C~c~~~~~~~~~~~~~~~~~--~~ 438 (958)
+.++... .+++|+.|+|++||| .|||...++..|++....... ..
T Consensus 268 ---~~~~~~~~~~l~~L~~L~L~~Np~----------------------------~CdC~l~~l~~~~~~~~~~~~~~~~ 316 (440)
T 3zyj_A 268 ---TLLPHDLFTPLHHLERIHLHHNPW----------------------------NCNCDILWLSWWIKDMAPSNTACCA 316 (440)
T ss_dssp ---CCCCTTTTSSCTTCCEEECCSSCE----------------------------ECSSTTHHHHHHHHTTSCSSCSCCC
T ss_pred ---CccChhHhccccCCCEEEcCCCCc----------------------------cCCCCchHHHHHHHhccccCCcccc
Confidence 4444432 577888888888877 677777777788766543322 36
Q ss_pred eeeeeceee
Q 002158 439 FCAAPLRIG 447 (958)
Q Consensus 439 ~c~sp~~~~ 447 (958)
.|++|+..+
T Consensus 317 ~C~~P~~l~ 325 (440)
T 3zyj_A 317 RCNTPPNLK 325 (440)
T ss_dssp BEEESTTTT
T ss_pred CCCChhHhc
Confidence 799998765
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 | Back alignment and structure |
|---|
Probab=99.97 E-value=2.8e-32 Score=300.85 Aligned_cols=251 Identities=29% Similarity=0.441 Sum_probs=188.3
Q ss_pred CCCcEEEeeCCCCCC--CCChhhcCCCCCCEEeccc-ccccccCccccccccccceEecccccccccCchhhcCCccchh
Q 002158 133 SSLIFLLLNGNKLSG--SLPDELGYLSNLNRLQVDE-NNITGTIPKSFANLSRVRHLHLNNNSIGGQIPSELSKLSTLIH 209 (958)
Q Consensus 133 ~~L~~L~Ls~n~l~~--~~p~~l~~l~~L~~L~L~~-N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~ 209 (958)
.+++.|+|++|.+++ .+|..|.++++|++|+|++ |++++.+|..|.++++|++|+|++|.+++.+|..|.++++|++
T Consensus 50 ~~l~~L~L~~~~l~~~~~~~~~l~~l~~L~~L~L~~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~ 129 (313)
T 1ogq_A 50 YRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVT 129 (313)
T ss_dssp CCEEEEEEECCCCSSCEECCGGGGGCTTCSEEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCE
T ss_pred ceEEEEECCCCCccCCcccChhHhCCCCCCeeeCCCCCcccccCChhHhcCCCCCEEECcCCeeCCcCCHHHhCCCCCCE
Confidence 356677777777776 6677777777777777773 7777677777777777777777777777677777777777777
Q ss_pred hhccCCccccCCCcccCCCCCccEEEccCCCCCCCCccccccCCC-CCCEEEcccCCCCCCCCC-CCCCCCcCEEeccCC
Q 002158 210 LLVDNNNLSGNLPPELSELPQLCILQLDNNNFSASEIPATYGNFS-KLVKLSLRNCNLQGAVPD-LSRIPNLYYLDLSWN 287 (958)
Q Consensus 210 L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~p~~~~~l~-~L~~L~L~~N~l~~~~~~-l~~l~~L~~L~Ls~N 287 (958)
|+|++|++++.+|..+..+++|++|+|++|+++ ..+|..+..++ +|+.|+|++|++++..+. +..++ |++|+|++|
T Consensus 130 L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~-~~~p~~l~~l~~~L~~L~L~~N~l~~~~~~~~~~l~-L~~L~Ls~N 207 (313)
T 1ogq_A 130 LDFSYNALSGTLPPSISSLPNLVGITFDGNRIS-GAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLN-LAFVDLSRN 207 (313)
T ss_dssp EECCSSEEESCCCGGGGGCTTCCEEECCSSCCE-EECCGGGGCCCTTCCEEECCSSEEEEECCGGGGGCC-CSEEECCSS
T ss_pred EeCCCCccCCcCChHHhcCCCCCeEECcCCccc-CcCCHHHhhhhhcCcEEECcCCeeeccCChHHhCCc-ccEEECcCC
Confidence 777777777677777777777777777777775 35566777776 777777777777765553 55555 778888888
Q ss_pred cCCCcCCCC-CCCCCcCEEEccCCcCCCccchhccCCCCCCeEeeecccCCCccchhhhcccccCccccceEeccCCCCC
Q 002158 288 HLTGSIPSK-KLSENVTTIDLSDNYLNGSILESISNLPFLQTLSLENNFLTGSIPATIWQNKSFSTKARLKIDLRNNSFS 366 (958)
Q Consensus 288 ~l~~~~~~~-~~~~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~ip~~l~~~~~~~~~~l~~L~Ls~N~l~ 366 (958)
.+++.++.. ..+++|+.|+|++|.+++..+. +..+++|++|+|++|+|++.+|..+..+. .|+.|+|++|+++
T Consensus 208 ~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~-~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~-----~L~~L~Ls~N~l~ 281 (313)
T 1ogq_A 208 MLEGDASVLFGSDKNTQKIHLAKNSLAFDLGK-VGLSKNLNGLDLRNNRIYGTLPQGLTQLK-----FLHSLNVSFNNLC 281 (313)
T ss_dssp EEEECCGGGCCTTSCCSEEECCSSEECCBGGG-CCCCTTCCEEECCSSCCEECCCGGGGGCT-----TCCEEECCSSEEE
T ss_pred cccCcCCHHHhcCCCCCEEECCCCceeeecCc-ccccCCCCEEECcCCcccCcCChHHhcCc-----CCCEEECcCCccc
Confidence 777655543 4457888888888888776666 88899999999999999999999887654 5669999999999
Q ss_pred -CCccCCCCCCcceEEeCCCCCCCCC
Q 002158 367 -NIVGDLTLPNNVTLRLGGNPICTSA 391 (958)
Q Consensus 367 -~l~~~~~l~~L~~L~l~~N~l~~~~ 391 (958)
.++....+++|+.+++.+||+.|..
T Consensus 282 ~~ip~~~~l~~L~~l~l~~N~~lc~~ 307 (313)
T 1ogq_A 282 GEIPQGGNLQRFDVSAYANNKCLCGS 307 (313)
T ss_dssp EECCCSTTGGGSCGGGTCSSSEEEST
T ss_pred ccCCCCccccccChHHhcCCCCccCC
Confidence 4666668999999999999986643
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=9.6e-31 Score=316.28 Aligned_cols=313 Identities=18% Similarity=0.105 Sum_probs=248.9
Q ss_pred CCceeeCcc----ccCCCceeeEEEEccCCcCCCCccccccCCCCcceeeccCcc-cCCCCccccCCCCCcEEEeeCCCC
Q 002158 71 WTGVLCFDT----VETDGHLHVRELQLLSMNLSGNLAPELGQLSRLQYYFMWNDL-TGTIPKEIGNISSLIFLLLNGNKL 145 (958)
Q Consensus 71 w~gV~C~~~----~~~~~~~~v~~L~L~~~~l~~~~~~~l~~L~~L~~L~l~n~~-~~~ip~~i~~l~~L~~L~Ls~n~l 145 (958)
+..|.|.+. ++.....+++.|+|++|.+++..+..|+++++|++|++++|. .+..|..|.++++|++|+|++|.+
T Consensus 14 ~~~~~c~~~~l~~iP~~l~~~l~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l 93 (606)
T 3t6q_A 14 NKTYNCENLGLNEIPGTLPNSTECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWIHEDTFQSQHRLDTLVLTANPL 93 (606)
T ss_dssp TTEEECTTSCCSSCCTTSCTTCCEEECTTCCCSEECTTTSTTCTTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTCCC
T ss_pred CceEECCCCCcccCcCCCCCcCcEEEccCCccCcCChhHhccCccceEEECCCCccceeChhhccCccccCeeeCCCCcc
Confidence 567888652 233344579999999999999999999999999999998664 555688899999999999999999
Q ss_pred CCCCChhhcCCCCCCEEecccccccccCccccccccccceEecccccccccCchhhcCCccchhhhccCCccccCCCccc
Q 002158 146 SGSLPDELGYLSNLNRLQVDENNITGTIPKSFANLSRVRHLHLNNNSIGGQIPSELSKLSTLIHLLVDNNNLSGNLPPEL 225 (958)
Q Consensus 146 ~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~l 225 (958)
++..|..|+++++|++|+|++|++++..+..+.++++|++|+|++|.+++.....+..+++|++|++++|++++..+..+
T Consensus 94 ~~~~~~~~~~l~~L~~L~L~~n~i~~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~ 173 (606)
T 3t6q_A 94 IFMAETALSGPKALKHLFFIQTGISSIDFIPLHNQKTLESLYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIHYLSKEDM 173 (606)
T ss_dssp SEECTTTTSSCTTCCEEECTTSCCSCGGGSCCTTCTTCCEEECCSSCCCCCCCCTTCCCTTCCEEECCSSCCCEECHHHH
T ss_pred cccChhhhcccccccEeeccccCcccCCcchhccCCcccEEECCCCcccccCcccccCCcccCEEEcccCcccccChhhh
Confidence 98889999999999999999999998778889999999999999999997544455569999999999999998888889
Q ss_pred CCCCCcc--EEEccCCCCCCCCccccccCC--------------------------------------------------
Q 002158 226 SELPQLC--ILQLDNNNFSASEIPATYGNF-------------------------------------------------- 253 (958)
Q Consensus 226 ~~l~~L~--~L~L~~N~l~~~~~p~~~~~l-------------------------------------------------- 253 (958)
..+++|+ .|++++|.++. ..|..+...
T Consensus 174 ~~l~~L~~l~L~l~~n~l~~-~~~~~~~~~~L~~L~l~~~~~~~~~~~~l~~~~l~~l~~~~~~~~~~~~i~~~~~~~l~ 252 (606)
T 3t6q_A 174 SSLQQATNLSLNLNGNDIAG-IEPGAFDSAVFQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDMDDEDISPAVFEGLC 252 (606)
T ss_dssp HTTTTCCSEEEECTTCCCCE-ECTTTTTTCEEEEEECTTCSCHHHHHHHTTTCEEEEEECCCCTTSCCCCCCGGGGGGGG
T ss_pred hhhcccceeEEecCCCccCc-cChhHhhhccccccccCCchhHHHHhhhccccchhheechhhccccccccChhHhchhh
Confidence 9999999 89999998863 223332210
Q ss_pred -CCCCEEEcccCCCCCCCCC-CCCCCCcCEEeccCCcCCCcCCCCCCCCCcCEEEccCCcCCCccchhccCCCCCCeEee
Q 002158 254 -SKLVKLSLRNCNLQGAVPD-LSRIPNLYYLDLSWNHLTGSIPSKKLSENVTTIDLSDNYLNGSILESISNLPFLQTLSL 331 (958)
Q Consensus 254 -~~L~~L~L~~N~l~~~~~~-l~~l~~L~~L~Ls~N~l~~~~~~~~~~~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L 331 (958)
.+|+.|++++|.+++.++. |..+++|++|+|++|.++...+....+++|++|+|++|.+++..+..+..+++|++|++
T Consensus 253 ~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~lp~~l~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l 332 (606)
T 3t6q_A 253 EMSVESINLQKHYFFNISSNTFHCFSGLQELDLTATHLSELPSGLVGLSTLKKLVLSANKFENLCQISASNFPSLTHLSI 332 (606)
T ss_dssp GSEEEEEECTTCCCSSCCTTTTTTCTTCSEEECTTSCCSCCCSSCCSCTTCCEEECTTCCCSBGGGGCGGGCTTCSEEEC
T ss_pred cCceeEEEeecCccCccCHHHhccccCCCEEeccCCccCCCChhhcccccCCEEECccCCcCcCchhhhhccCcCCEEEC
Confidence 1577788888888877775 78888888888888888843334455688888888888888887888888888888888
Q ss_pred ecccCCCccchhhhcccccCccccceEeccCCCCCCCc---cCC-CCCCcceEEeCCCCCC
Q 002158 332 ENNFLTGSIPATIWQNKSFSTKARLKIDLRNNSFSNIV---GDL-TLPNNVTLRLGGNPIC 388 (958)
Q Consensus 332 ~~N~l~~~ip~~l~~~~~~~~~~l~~L~Ls~N~l~~l~---~~~-~l~~L~~L~l~~N~l~ 388 (958)
++|.+.+.+|...+. ..+.|+.|++++|+++.+. ... .+++|+.|++++|.+.
T Consensus 333 ~~n~~~~~~~~~~~~----~l~~L~~L~l~~n~l~~~~~~~~~~~~l~~L~~L~l~~n~l~ 389 (606)
T 3t6q_A 333 KGNTKRLELGTGCLE----NLENLRELDLSHDDIETSDCCNLQLRNLSHLQSLNLSYNEPL 389 (606)
T ss_dssp CSCSSCCBCCSSTTT----TCTTCCEEECCSSCCCEEEESTTTTTTCTTCCEEECCSCSCE
T ss_pred CCCCcccccchhhhh----ccCcCCEEECCCCccccccCcchhcccCCCCCEEECCCCcCC
Confidence 888888777765322 1345667777777777764 222 6777777777777764
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=1.3e-30 Score=326.25 Aligned_cols=94 Identities=20% Similarity=0.195 Sum_probs=64.9
Q ss_pred CCcCEEEccCCcCCCccchhccCCCCCCeEeeecccCCCccchhhhcccccCccccceEeccCCCCCCCccCCCCCCcce
Q 002158 300 ENVTTIDLSDNYLNGSILESISNLPFLQTLSLENNFLTGSIPATIWQNKSFSTKARLKIDLRNNSFSNIVGDLTLPNNVT 379 (958)
Q Consensus 300 ~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~ip~~l~~~~~~~~~~l~~L~Ls~N~l~~l~~~~~l~~L~~ 379 (958)
++|+.|+|++|+|++..+..|.++++|+.|+|++|+|++..|..+ . +.|+.|||++|+|+.++... +.+|+.
T Consensus 480 ~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~-~------~~L~~L~Ls~N~l~~~~~~~-~~~L~~ 551 (844)
T 3j0a_A 480 SHLQVLYLNHNYLNSLPPGVFSHLTALRGLSLNSNRLTVLSHNDL-P------ANLEILDISRNQLLAPNPDV-FVSLSV 551 (844)
T ss_dssp CCEECCCCCHHHHTTCCTTSSSSCCSCSEEEEESCCCSSCCCCCC-C------SCCCEEEEEEECCCCCCSCC-CSSCCE
T ss_pred ccccEEECCCCcccccChhHccchhhhheeECCCCCCCccChhhh-h------ccccEEECCCCcCCCCChhH-hCCcCE
Confidence 455555555555555566666667777777777777764333322 1 45677888888887766543 668999
Q ss_pred EEeCCCCCCCCCCCCCCCcccc
Q 002158 380 LRLGGNPICTSANIPNTGRFCG 401 (958)
Q Consensus 380 L~l~~N~l~~~~~~~~~~~~~~ 401 (958)
|++++|||.|+|+..++..+..
T Consensus 552 l~l~~Np~~C~c~~~~f~~~~~ 573 (844)
T 3j0a_A 552 LDITHNKFICECELSTFINWLN 573 (844)
T ss_dssp EEEEEECCCCSSSCCSHHHHHH
T ss_pred EEecCCCcccccccHHHHHHHH
Confidence 9999999999999888776543
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=2e-31 Score=299.53 Aligned_cols=277 Identities=20% Similarity=0.264 Sum_probs=181.0
Q ss_pred CCcEEEeeCCCCCCCCChhhcCCCCCCEEecccccccccCccccccccccceEecccccccccCchhhcCCccchhhhcc
Q 002158 134 SLIFLLLNGNKLSGSLPDELGYLSNLNRLQVDENNITGTIPKSFANLSRVRHLHLNNNSIGGQIPSELSKLSTLIHLLVD 213 (958)
Q Consensus 134 ~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~ 213 (958)
+|++|+|++|.+++..+..+.++++|++|+|++|++++..+..|.++++|++|+|++|++++..+..+.++++|++|+++
T Consensus 53 ~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~ 132 (353)
T 2z80_A 53 AVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGINTIEEDSFSSLGSLEHLDLSYNYLSNLSSSWFKPLSSLTFLNLL 132 (353)
T ss_dssp TCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSSCCHHHHTTCTTCSEEECT
T ss_pred cCcEEECCCCcCcccCHHHhccCCCCCEEECCCCccCccCHhhcCCCCCCCEEECCCCcCCcCCHhHhCCCccCCEEECC
Confidence 66677777777765444466677777777777777776666667777777777777777775444446677777777777
Q ss_pred CCccccCCC-cccCCCCCccEEEccCCC-CCCCCccccccCCCCCCEEEcccCCCCCCCC-CCCCCCCcCEEeccCCcCC
Q 002158 214 NNNLSGNLP-PELSELPQLCILQLDNNN-FSASEIPATYGNFSKLVKLSLRNCNLQGAVP-DLSRIPNLYYLDLSWNHLT 290 (958)
Q Consensus 214 ~N~l~~~~~-~~l~~l~~L~~L~L~~N~-l~~~~~p~~~~~l~~L~~L~L~~N~l~~~~~-~l~~l~~L~~L~Ls~N~l~ 290 (958)
+|++++... ..+..+++|++|++++|+ ++ ...+..+.++++|++|++++|++++..+ .+..+++|++|++++|.++
T Consensus 133 ~n~l~~l~~~~~~~~l~~L~~L~l~~n~~~~-~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~l~~n~l~ 211 (353)
T 2z80_A 133 GNPYKTLGETSLFSHLTKLQILRVGNMDTFT-KIQRKDFAGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHI 211 (353)
T ss_dssp TCCCSSSCSSCSCTTCTTCCEEEEEESSSCC-EECTTTTTTCCEEEEEEEEETTCCEECTTTTTTCSEEEEEEEECSCST
T ss_pred CCCCcccCchhhhccCCCCcEEECCCCcccc-ccCHHHccCCCCCCEEECCCCCcCccCHHHHhccccCCeecCCCCccc
Confidence 777764433 466677777777777764 43 2334566777777777777777776654 3677777777777777765
Q ss_pred CcCCCC--CCCCCcCEEEccCCcCCCccchhcc---CCCCCCeEeeecccCCC----ccchhhhcccccCccccceEecc
Q 002158 291 GSIPSK--KLSENVTTIDLSDNYLNGSILESIS---NLPFLQTLSLENNFLTG----SIPATIWQNKSFSTKARLKIDLR 361 (958)
Q Consensus 291 ~~~~~~--~~~~~L~~L~Ls~N~l~~~~~~~~~---~l~~L~~L~L~~N~l~~----~ip~~l~~~~~~~~~~l~~L~Ls 361 (958)
. ++.. ..+++|+.|+|++|.+++..+..+. ....++.++|++|.+++ .+|..+..+ +.|+.|||+
T Consensus 212 ~-~~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~~~~~~~l~~l~L~~~~l~~~~l~~l~~~l~~l-----~~L~~L~Ls 285 (353)
T 2z80_A 212 L-LLEIFVDVTSSVECLELRDTDLDTFHFSELSTGETNSLIKKFTFRNVKITDESLFQVMKLLNQI-----SGLLELEFS 285 (353)
T ss_dssp T-HHHHHHHHTTTEEEEEEESCBCTTCCCC------CCCCCCEEEEESCBCCHHHHHHHHHHHHTC-----TTCCEEECC
T ss_pred c-chhhhhhhcccccEEECCCCccccccccccccccccchhhccccccccccCcchhhhHHHHhcc-----cCCCEEECC
Confidence 3 3322 1246777777777777765544433 35667778888887775 355555443 345578888
Q ss_pred CCCCCCCccCC--CCCCcceEEeCCCCCCCCCCCCCCCcccccCCCCCccccccCCCCCCC-CCCCCCcccccCCCC-CC
Q 002158 362 NNSFSNIVGDL--TLPNNVTLRLGGNPICTSANIPNTGRFCGSDAGGDETLTNSKVNCPVQ-ACPVDNFFEYVPASP-EP 437 (958)
Q Consensus 362 ~N~l~~l~~~~--~l~~L~~L~l~~N~l~~~~~~~~~~~~~~~~~~~~~~L~~n~~~C~c~-~~~~~~~~~~~~~~~-~~ 437 (958)
+|+|+.++... .+++|++|+|++||| .|+|+ +.++..|++...... ..
T Consensus 286 ~N~l~~i~~~~~~~l~~L~~L~L~~N~~----------------------------~~~~~~l~~l~~~~~~~~~~~~~~ 337 (353)
T 2z80_A 286 RNQLKSVPDGIFDRLTSLQKIWLHTNPW----------------------------DCSCPRIDYLSRWLNKNSQKEQGS 337 (353)
T ss_dssp SSCCCCCCTTTTTTCTTCCEEECCSSCB----------------------------CCCHHHHHHHHHHHHHTTTTEESC
T ss_pred CCCCCccCHHHHhcCCCCCEEEeeCCCc----------------------------cCcCCCcHHHHHHHHhccccCCCC
Confidence 88888877764 788999999999988 45664 555666775544333 24
Q ss_pred ceeeeece
Q 002158 438 CFCAAPLR 445 (958)
Q Consensus 438 ~~c~sp~~ 445 (958)
..|++|.+
T Consensus 338 ~~C~~p~~ 345 (353)
T 2z80_A 338 AKCSGSGK 345 (353)
T ss_dssp CBBTTTCC
T ss_pred cccCCCCC
Confidence 67777643
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A | Back alignment and structure |
|---|
Probab=99.97 E-value=3e-30 Score=300.11 Aligned_cols=275 Identities=22% Similarity=0.246 Sum_probs=176.5
Q ss_pred CcEEEeeCCCCCCCCChhhcCCCCCCEEecccccccccCccccccccccceEecccccccccCchhhcCCccchhhhccC
Q 002158 135 LIFLLLNGNKLSGSLPDELGYLSNLNRLQVDENNITGTIPKSFANLSRVRHLHLNNNSIGGQIPSELSKLSTLIHLLVDN 214 (958)
Q Consensus 135 L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~ 214 (958)
...++.+++.++ .+|..+. ++|++|+|++|+|++..+..|.++++|+.|+|++|+|++..+..|.++++|++|+|++
T Consensus 56 ~~~v~c~~~~l~-~iP~~~~--~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~ 132 (452)
T 3zyi_A 56 FSKVVCTRRGLS-EVPQGIP--SNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSIRQIEVGAFNGLASLNTLELFD 132 (452)
T ss_dssp SCEEECCSSCCS-SCCSCCC--TTCSEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCS
T ss_pred CcEEEECCCCcC-ccCCCCC--CCccEEECcCCcCceECHHHcCCCCCCCEEECCCCccCCcChhhccCcccCCEEECCC
Confidence 344555555555 4444333 4555666666666555555555666666666666666555555566666666666666
Q ss_pred CccccCCCcccCCCCCccEEEccCCCCCCCCccccccCCCCCCEEEccc-CCCCCCCCC-CCCCCCcCEEeccCCcCCCc
Q 002158 215 NNLSGNLPPELSELPQLCILQLDNNNFSASEIPATYGNFSKLVKLSLRN-CNLQGAVPD-LSRIPNLYYLDLSWNHLTGS 292 (958)
Q Consensus 215 N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~p~~~~~l~~L~~L~L~~-N~l~~~~~~-l~~l~~L~~L~Ls~N~l~~~ 292 (958)
|+|++..+..|..+++|++|+|++|+++. ..+..|.++++|+.|+|++ |.+...++. |..+++|++|+|++|+++ .
T Consensus 133 n~l~~~~~~~~~~l~~L~~L~L~~N~l~~-~~~~~~~~l~~L~~L~l~~~~~l~~i~~~~~~~l~~L~~L~L~~n~l~-~ 210 (452)
T 3zyi_A 133 NWLTVIPSGAFEYLSKLRELWLRNNPIES-IPSYAFNRVPSLMRLDLGELKKLEYISEGAFEGLFNLKYLNLGMCNIK-D 210 (452)
T ss_dssp SCCSBCCTTTSSSCTTCCEEECCSCCCCE-ECTTTTTTCTTCCEEECCCCTTCCEECTTTTTTCTTCCEEECTTSCCS-S
T ss_pred CcCCccChhhhcccCCCCEEECCCCCcce-eCHhHHhcCCcccEEeCCCCCCccccChhhccCCCCCCEEECCCCccc-c
Confidence 66665555556666666666666666642 2233566666666666666 344434432 666777777777777776 4
Q ss_pred CCCCCCCCCcCEEEccCCcCCCccchhccCCCCCCeEeeecccCCCccchhhhcccccCccccceEeccCCCCCCCccCC
Q 002158 293 IPSKKLSENVTTIDLSDNYLNGSILESISNLPFLQTLSLENNFLTGSIPATIWQNKSFSTKARLKIDLRNNSFSNIVGDL 372 (958)
Q Consensus 293 ~~~~~~~~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~ip~~l~~~~~~~~~~l~~L~Ls~N~l~~l~~~~ 372 (958)
+|....+++|+.|+|++|+|++..+..|.++++|+.|+|++|+|++..|..+..+ +.|+.|+|++|+|+.++...
T Consensus 211 ~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l-----~~L~~L~L~~N~l~~~~~~~ 285 (452)
T 3zyi_A 211 MPNLTPLVGLEELEMSGNHFPEIRPGSFHGLSSLKKLWVMNSQVSLIERNAFDGL-----ASLVELNLAHNNLSSLPHDL 285 (452)
T ss_dssp CCCCTTCTTCCEEECTTSCCSEECGGGGTTCTTCCEEECTTSCCCEECTTTTTTC-----TTCCEEECCSSCCSCCCTTS
T ss_pred cccccccccccEEECcCCcCcccCcccccCccCCCEEEeCCCcCceECHHHhcCC-----CCCCEEECCCCcCCccChHH
Confidence 4556666777777777777777777788888888888888888876656555433 34557888888888777654
Q ss_pred --CCCCcceEEeCCCCCCCCCCCCCCCcccccCCCCCccccccCCCCCCCCCCCCCcccccCCCCC--Cceeeeeceee
Q 002158 373 --TLPNNVTLRLGGNPICTSANIPNTGRFCGSDAGGDETLTNSKVNCPVQACPVDNFFEYVPASPE--PCFCAAPLRIG 447 (958)
Q Consensus 373 --~l~~L~~L~l~~N~l~~~~~~~~~~~~~~~~~~~~~~L~~n~~~C~c~~~~~~~~~~~~~~~~~--~~~c~sp~~~~ 447 (958)
.+++|+.|+|++||| .|||...++..|++....... ...|++|...+
T Consensus 286 ~~~l~~L~~L~L~~Np~----------------------------~CdC~~~~l~~~l~~~~~~~~~~~~~C~~P~~l~ 336 (452)
T 3zyi_A 286 FTPLRYLVELHLHHNPW----------------------------NCDCDILWLAWWLREYIPTNSTCCGRCHAPMHMR 336 (452)
T ss_dssp STTCTTCCEEECCSSCE----------------------------ECSTTTHHHHHHHHHHC---CCSSCBEEESTTTT
T ss_pred hccccCCCEEEccCCCc----------------------------CCCCCchHHHHHHHHhCccCCccCcEeCCchHhc
Confidence 688899999888887 677788788888876543322 35899998755
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.3e-29 Score=310.75 Aligned_cols=321 Identities=21% Similarity=0.214 Sum_probs=254.3
Q ss_pred CCCCCCCceeeCcc----ccCCCceeeEEEEccCCcCCCCccccccCCCCcceeeccCc-ccCCCCccccCCCCCcEEEe
Q 002158 66 PCMSNWTGVLCFDT----VETDGHLHVRELQLLSMNLSGNLAPELGQLSRLQYYFMWND-LTGTIPKEIGNISSLIFLLL 140 (958)
Q Consensus 66 ~c~~~w~gV~C~~~----~~~~~~~~v~~L~L~~~~l~~~~~~~l~~L~~L~~L~l~n~-~~~~ip~~i~~l~~L~~L~L 140 (958)
+|.|.+..|.|... ++.+...+++.|+|++|++++..+..|+++++|++|++++| +.+..|..|+++++|++|+|
T Consensus 1 ~C~~~~~~~~cs~~~L~~ip~~~~~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L 80 (680)
T 1ziw_A 1 KCTVSHEVADCSHLKLTQVPDDLPTNITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTISKLEPELCQKLPMLKVLNL 80 (680)
T ss_dssp ---CBSSEEECCSSCCSSCCSCSCTTCSEEECCSSCCCCCCGGGGGGGTTCSEEECCSSCCCCCCTTHHHHCTTCCEEEC
T ss_pred CceeECCeeECCCCCccccccccCCCCcEEECCCCCCCCcCHHHHhCCCcCcEEECCCCccCccCHHHHhcccCcCEEEC
Confidence 36667778888642 23334568999999999999988889999999999999855 55556788999999999999
Q ss_pred eCCCCCCCCChhhcCCCCCCEEecccccccccCccccccccccceEecccccccccCchhhcCCccchhhhccCCccccC
Q 002158 141 NGNKLSGSLPDELGYLSNLNRLQVDENNITGTIPKSFANLSRVRHLHLNNNSIGGQIPSELSKLSTLIHLLVDNNNLSGN 220 (958)
Q Consensus 141 s~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~ 220 (958)
++|.+++..+..|+++++|++|+|++|++++..|..|.++++|++|+|++|.+++..|..+.++++|++|++++|++++.
T Consensus 81 ~~n~l~~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~ 160 (680)
T 1ziw_A 81 QHNELSQLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQKNLITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQAL 160 (680)
T ss_dssp CSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCSCTTTTCTTCCEEECCSSCCSCCCCCSSSCCTTCCEEECCSSCCCCB
T ss_pred CCCccCccChhhhccCCCCCEEECCCCccCccChhHccccCCCCEEECCCCcccccCchhhcccccCCEEEccCCccccc
Confidence 99999965555799999999999999999988888999999999999999999998899999999999999999999987
Q ss_pred CCcccC--CCCCccEEEccCCCCCCCCccccccCC---------------------------CCCCEEEcccCCCCCCCC
Q 002158 221 LPPELS--ELPQLCILQLDNNNFSASEIPATYGNF---------------------------SKLVKLSLRNCNLQGAVP 271 (958)
Q Consensus 221 ~~~~l~--~l~~L~~L~L~~N~l~~~~~p~~~~~l---------------------------~~L~~L~L~~N~l~~~~~ 271 (958)
.+..+. .+++|++|++++|+++. ..|..+..+ ++|+.|++++|.+++..+
T Consensus 161 ~~~~~~~~~~~~L~~L~L~~n~l~~-~~~~~~~~l~~L~~L~l~~~~l~~~~~~~~~~~l~~~~L~~L~L~~n~l~~~~~ 239 (680)
T 1ziw_A 161 KSEELDIFANSSLKKLELSSNQIKE-FSPGCFHAIGRLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQLSTTSN 239 (680)
T ss_dssp CHHHHGGGTTCEESEEECTTCCCCC-BCTTGGGGSSEECEEECTTCCCHHHHHHHHHHHHTTSCCCEEECTTSCCCEECT
T ss_pred CHHHhhccccccccEEECCCCcccc-cChhhhhhhhhhhhhhccccccChhhHHHHHHHhhhccccEEEccCCcccccCh
Confidence 777654 56899999999999974 445555443 567778888888887766
Q ss_pred C-CCCCCC--cCEEeccCCcCCCcCCC-CCCCCCcCEEEccCCcCCCccchhccCCCCCCeEeeecccCCCccchh----
Q 002158 272 D-LSRIPN--LYYLDLSWNHLTGSIPS-KKLSENVTTIDLSDNYLNGSILESISNLPFLQTLSLENNFLTGSIPAT---- 343 (958)
Q Consensus 272 ~-l~~l~~--L~~L~Ls~N~l~~~~~~-~~~~~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~ip~~---- 343 (958)
. +..++. |+.|+|++|.+++..+. ...+++|++|+|++|++++..+..|.++++|+.|+|++|...+.++..
T Consensus 240 ~~~~~l~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~~~~~~~~~~~~lp~ 319 (680)
T 1ziw_A 240 TTFLGLKWTNLTMLDLSYNNLNVVGNDSFAWLPQLEYFFLEYNNIQHLFSHSLHGLFNVRYLNLKRSFTKQSISLASLPK 319 (680)
T ss_dssp TTTGGGGGSCCCEEECTTSCCCEECTTTTTTCTTCCEEECCSCCBSEECTTTTTTCTTCCEEECTTCBCCC------CCE
T ss_pred hHhhccCcCCCCEEECCCCCcCccCcccccCcccccEeeCCCCccCccChhhhcCCCCccEEeccchhhhcccccccccc
Confidence 4 666644 88888888888866554 355688888899888888888888888888888888887766533210
Q ss_pred hhcccccCccccceEeccCCCCCCCccCC--CCCCcceEEeCCCCC
Q 002158 344 IWQNKSFSTKARLKIDLRNNSFSNIVGDL--TLPNNVTLRLGGNPI 387 (958)
Q Consensus 344 l~~~~~~~~~~l~~L~Ls~N~l~~l~~~~--~l~~L~~L~l~~N~l 387 (958)
+....--..+.++.|++++|+++.++... .+++|++|++++|.+
T Consensus 320 i~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~~ 365 (680)
T 1ziw_A 320 IDDFSFQWLKCLEHLNMEDNDIPGIKSNMFTGLINLKYLSLSNSFT 365 (680)
T ss_dssp ECTTTTTTCTTCCEEECCSCCBCCCCTTTTTTCTTCCEEECTTCBS
T ss_pred cChhhcccCCCCCEEECCCCccCCCChhHhccccCCcEEECCCCch
Confidence 00001112456778999999999887654 788999999998875
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.97 E-value=8.2e-30 Score=290.56 Aligned_cols=310 Identities=20% Similarity=0.199 Sum_probs=259.2
Q ss_pred eeeEEEEccCCcCCCCccccccCCCCcceeeccCcccCCC-CccccCCCCCcEEEeeCCCCCCCCChhhcCCCCCCEEec
Q 002158 86 LHVRELQLLSMNLSGNLAPELGQLSRLQYYFMWNDLTGTI-PKEIGNISSLIFLLLNGNKLSGSLPDELGYLSNLNRLQV 164 (958)
Q Consensus 86 ~~v~~L~L~~~~l~~~~~~~l~~L~~L~~L~l~n~~~~~i-p~~i~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~L 164 (958)
.+++.|+|++|.+.+..+..++.+++|++|++++|....+ |..|+++++|++|+|++|.++...+..|.++++|++|++
T Consensus 69 ~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~l~~L~~L~L 148 (390)
T 3o6n_A 69 RQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLSSLPRGIFHNTPKLTTLSM 148 (390)
T ss_dssp CCCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEEC
T ss_pred ccCcEEECCCCcccccChhhccCCCCcCEEECCCCCCCcCCHHHhcCCCCCCEEECCCCccCcCCHHHhcCCCCCcEEEC
Confidence 4799999999999988888999999999999987666555 566899999999999999999444444689999999999
Q ss_pred ccccccccCccccccccccceEecccccccccCchhhcCCccchhhhccCCccccCCCcccCCCCCccEEEccCCCCCCC
Q 002158 165 DENNITGTIPKSFANLSRVRHLHLNNNSIGGQIPSELSKLSTLIHLLVDNNNLSGNLPPELSELPQLCILQLDNNNFSAS 244 (958)
Q Consensus 165 ~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~ 244 (958)
++|++++..+..|..+++|++|+|++|.+++. + +..+++|+.|++++|.+++ +...++|++|++++|.++.
T Consensus 149 ~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~-~--~~~l~~L~~L~l~~n~l~~-----~~~~~~L~~L~l~~n~l~~- 219 (390)
T 3o6n_A 149 SNNNLERIEDDTFQATTSLQNLQLSSNRLTHV-D--LSLIPSLFHANVSYNLLST-----LAIPIAVEELDASHNSINV- 219 (390)
T ss_dssp CSSCCCBCCTTTTSSCTTCCEEECCSSCCSBC-C--GGGCTTCSEEECCSSCCSE-----EECCSSCSEEECCSSCCCE-
T ss_pred CCCccCccChhhccCCCCCCEEECCCCcCCcc-c--cccccccceeecccccccc-----cCCCCcceEEECCCCeeee-
Confidence 99999988888999999999999999999954 2 6678899999999999874 3445789999999999963
Q ss_pred CccccccCCCCCCEEEcccCCCCCCCCCCCCCCCcCEEeccCCcCCCcCCCC-CCCCCcCEEEccCCcCCCccchhccCC
Q 002158 245 EIPATYGNFSKLVKLSLRNCNLQGAVPDLSRIPNLYYLDLSWNHLTGSIPSK-KLSENVTTIDLSDNYLNGSILESISNL 323 (958)
Q Consensus 245 ~~p~~~~~l~~L~~L~L~~N~l~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~-~~~~~L~~L~Ls~N~l~~~~~~~~~~l 323 (958)
+|.. .+++|+.|+|++|++++. +.+..+++|++|+|++|.+++..+.. ..+++|++|+|++|++++ ++..+..+
T Consensus 220 -~~~~--~~~~L~~L~l~~n~l~~~-~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~-~~~~~~~l 294 (390)
T 3o6n_A 220 -VRGP--VNVELTILKLQHNNLTDT-AWLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLVA-LNLYGQPI 294 (390)
T ss_dssp -EECC--CCSSCCEEECCSSCCCCC-GGGGGCTTCSEEECCSSCCCEEESGGGTTCSSCCEEECCSSCCCE-EECSSSCC
T ss_pred -cccc--ccccccEEECCCCCCccc-HHHcCCCCccEEECCCCcCCCcChhHccccccCCEEECCCCcCcc-cCcccCCC
Confidence 3443 357999999999999975 56889999999999999999765543 567999999999999986 46667889
Q ss_pred CCCCeEeeecccCCCccchhhhcccccCccccceEeccCCCCCCCccCCCCCCcceEEeCCCCCCCCCCCCCCCcccccC
Q 002158 324 PFLQTLSLENNFLTGSIPATIWQNKSFSTKARLKIDLRNNSFSNIVGDLTLPNNVTLRLGGNPICTSANIPNTGRFCGSD 403 (958)
Q Consensus 324 ~~L~~L~L~~N~l~~~ip~~l~~~~~~~~~~l~~L~Ls~N~l~~l~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~~~ 403 (958)
++|++|+|++|+++ .+|..+..+ +.|+.|+|++|+|+.++ ...+++|+.|++++|||.|+|...+...+
T Consensus 295 ~~L~~L~L~~n~l~-~~~~~~~~l-----~~L~~L~L~~N~i~~~~-~~~~~~L~~L~l~~N~~~~~~~~~~~~~~---- 363 (390)
T 3o6n_A 295 PTLKVLDLSHNHLL-HVERNQPQF-----DRLENLYLDHNSIVTLK-LSTHHTLKNLTLSHNDWDCNSLRALFRNV---- 363 (390)
T ss_dssp TTCCEEECCSSCCC-CCGGGHHHH-----TTCSEEECCSSCCCCCC-CCTTCCCSEEECCSSCEEHHHHHHHTTTC----
T ss_pred CCCCEEECCCCcce-ecCcccccc-----CcCCEEECCCCccceeC-chhhccCCEEEcCCCCccchhHHHHHHHH----
Confidence 99999999999999 678777654 45679999999999986 44889999999999999998754443322
Q ss_pred CCCCccccccCCCCCCCCC
Q 002158 404 AGGDETLTNSKVNCPVQAC 422 (958)
Q Consensus 404 ~~~~~~L~~n~~~C~c~~~ 422 (958)
....+.+++..|.+..+
T Consensus 364 --~~~~~~~~~~~c~~~~~ 380 (390)
T 3o6n_A 364 --ARPAVDDADQHCKIDYQ 380 (390)
T ss_dssp --CTTTBCCCCSCCCTTCE
T ss_pred --HhhcccccCceeccccc
Confidence 23345677778886543
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.97 E-value=2.2e-30 Score=284.93 Aligned_cols=257 Identities=20% Similarity=0.211 Sum_probs=144.1
Q ss_pred CCcEEEeeCCCCCCCCChhhcCCCCCCEEecccccccc--cCccccccccccceEecccccccccCchhhcCCccchhhh
Q 002158 134 SLIFLLLNGNKLSGSLPDELGYLSNLNRLQVDENNITG--TIPKSFANLSRVRHLHLNNNSIGGQIPSELSKLSTLIHLL 211 (958)
Q Consensus 134 ~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~--~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~ 211 (958)
+|++|+|++|.++...+..|.++++|++|+|++|+++. ..+..+..+++|++|+|++|.++ .+|..+..+++|++|+
T Consensus 29 ~l~~L~L~~n~l~~i~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~~L~~L~Ls~n~i~-~l~~~~~~l~~L~~L~ 107 (306)
T 2z66_A 29 SATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFKGCCSQSDFGTTSLKYLDLSFNGVI-TMSSNFLGLEQLEHLD 107 (306)
T ss_dssp TCCEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCEEEEEEHHHHSCSCCCEEECCSCSEE-EEEEEEETCTTCCEEE
T ss_pred CCCEEECCCCccCccCHhHhhccccCCEEECCCCccCcccCcccccccccccCEEECCCCccc-cChhhcCCCCCCCEEE
Confidence 45555555555552222234555555555555555542 12344444555555555555555 3344455555555555
Q ss_pred ccCCccccCCC-cccCCCCCccEEEccCCCCCCCCccccccCCCCCCEEEcccCCCCC--CCCCCCCCCCcCEEeccCCc
Q 002158 212 VDNNNLSGNLP-PELSELPQLCILQLDNNNFSASEIPATYGNFSKLVKLSLRNCNLQG--AVPDLSRIPNLYYLDLSWNH 288 (958)
Q Consensus 212 L~~N~l~~~~~-~~l~~l~~L~~L~L~~N~l~~~~~p~~~~~l~~L~~L~L~~N~l~~--~~~~l~~l~~L~~L~Ls~N~ 288 (958)
+++|++++..+ ..+..+++|++|++++|.++ ...+..+.++++|++|+|++|.+++ .+..+..+++|++|+|++|.
T Consensus 108 l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~-~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~Ls~n~ 186 (306)
T 2z66_A 108 FQHSNLKQMSEFSVFLSLRNLIYLDISHTHTR-VAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQ 186 (306)
T ss_dssp CTTSEEESSTTTTTTTTCTTCCEEECTTSCCE-ECSTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSC
T ss_pred CCCCcccccccchhhhhccCCCEEECCCCcCC-ccchhhcccCcCCCEEECCCCccccccchhHHhhCcCCCEEECCCCC
Confidence 55555554333 34555555555555555554 2334445555555555555555554 22235555666666666666
Q ss_pred CCCcCCCC-CCCCCcCEEEccCCcCCCccchhccCCCCCCeEeeecccCCCccchhhhcccccCccccceEeccCCCCCC
Q 002158 289 LTGSIPSK-KLSENVTTIDLSDNYLNGSILESISNLPFLQTLSLENNFLTGSIPATIWQNKSFSTKARLKIDLRNNSFSN 367 (958)
Q Consensus 289 l~~~~~~~-~~~~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~ip~~l~~~~~~~~~~l~~L~Ls~N~l~~ 367 (958)
+++..+.. ..+++|++|+|++|++++..+..|..+++|+.|+|++|++++..|..+.
T Consensus 187 l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~---------------------- 244 (306)
T 2z66_A 187 LEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQ---------------------- 244 (306)
T ss_dssp CCEECTTTTTTCTTCCEEECTTSCCSBCCSGGGTTCTTCCEEECTTSCCCBCSSSSCC----------------------
T ss_pred cCCcCHHHhcCCCCCCEEECCCCccCccChhhccCcccCCEeECCCCCCcccCHHHHH----------------------
Confidence 65443322 3345666666666666666666677778888888888887765555432
Q ss_pred CccCCCC-CCcceEEeCCCCCCCCCCCCCCCcccccCCCCCccccccCCCCCCCCCCCCCcccccCC---CCCCceeeee
Q 002158 368 IVGDLTL-PNNVTLRLGGNPICTSANIPNTGRFCGSDAGGDETLTNSKVNCPVQACPVDNFFEYVPA---SPEPCFCAAP 443 (958)
Q Consensus 368 l~~~~~l-~~L~~L~l~~N~l~~~~~~~~~~~~~~~~~~~~~~L~~n~~~C~c~~~~~~~~~~~~~~---~~~~~~c~sp 443 (958)
.+ ++|+.|+|++|+| .|+|...++..|++..+. ......|++|
T Consensus 245 -----~~~~~L~~L~L~~N~~----------------------------~~~c~~~~~~~~l~~~~~~~~~~~~~~C~~p 291 (306)
T 2z66_A 245 -----HFPSSLAFLNLTQNDF----------------------------ACTCEHQSFLQWIKDQRQLLVEVERMECATP 291 (306)
T ss_dssp -----CCCTTCCEEECTTCCE----------------------------ECSGGGHHHHHHHHHTGGGBSCGGGCBEEES
T ss_pred -----hhhccCCEEEccCCCe----------------------------ecccChHHHHHHHHhhhhhhccccccccCCc
Confidence 23 3677888888877 567777777777754332 2335789988
Q ss_pred ceee
Q 002158 444 LRIG 447 (958)
Q Consensus 444 ~~~~ 447 (958)
...+
T Consensus 292 ~~~~ 295 (306)
T 2z66_A 292 SDKQ 295 (306)
T ss_dssp GGGT
T ss_pred hhhC
Confidence 7643
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=3.2e-30 Score=309.28 Aligned_cols=206 Identities=17% Similarity=0.200 Sum_probs=164.3
Q ss_pred ccchhhhccCCccccCC--CcccCCCCCccEEEccCCCCCCCCccccccCCCCCCEEEcccCCCCCCCC--CCCCCCCcC
Q 002158 205 STLIHLLVDNNNLSGNL--PPELSELPQLCILQLDNNNFSASEIPATYGNFSKLVKLSLRNCNLQGAVP--DLSRIPNLY 280 (958)
Q Consensus 205 ~~L~~L~L~~N~l~~~~--~~~l~~l~~L~~L~L~~N~l~~~~~p~~~~~l~~L~~L~L~~N~l~~~~~--~l~~l~~L~ 280 (958)
++|+.|++++|++++.. +..+..+++|++|++++|.++ .++..+..+++|+.|++++|.+++.++ .+..+++|+
T Consensus 347 ~~L~~L~l~~n~l~~~~~~~~~~~~~~~L~~L~l~~n~l~--~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~ 424 (570)
T 2z63_A 347 PSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVI--TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLI 424 (570)
T ss_dssp TTCCEEECCSSCCBEEEEEEHHHHTCSCCCEEECCSCSEE--EEEEEEETCTTCCEEECTTSEEESCTTSCTTTTCTTCC
T ss_pred CCCCEEeCcCCccCccccccccccccCccCEEECCCCccc--cccccccccCCCCEEEccCCccccccchhhhhcCCCCC
Confidence 44555555555555332 456778899999999999996 356669999999999999999998876 489999999
Q ss_pred EEeccCCcCCCcCCCC-CCCCCcCEEEccCCcCC-CccchhccCCCCCCeEeeecccCCCccchhhhcccccCccccceE
Q 002158 281 YLDLSWNHLTGSIPSK-KLSENVTTIDLSDNYLN-GSILESISNLPFLQTLSLENNFLTGSIPATIWQNKSFSTKARLKI 358 (958)
Q Consensus 281 ~L~Ls~N~l~~~~~~~-~~~~~L~~L~Ls~N~l~-~~~~~~~~~l~~L~~L~L~~N~l~~~ip~~l~~~~~~~~~~l~~L 358 (958)
+|+|++|.+.+..+.. ..+++|++|+|++|.++ +.+|..|..+++|++|+|++|++++..|..+..+ +.|+.|
T Consensus 425 ~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l-----~~L~~L 499 (570)
T 2z63_A 425 YLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSL-----SSLQVL 499 (570)
T ss_dssp EEECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTC-----TTCCEE
T ss_pred EEeCcCCcccccchhhhhcCCcCcEEECcCCcCccccchhhhhcccCCCEEECCCCccccCChhhhhcc-----cCCCEE
Confidence 9999999998766654 55799999999999998 5789999999999999999999998778877654 456799
Q ss_pred eccCCCCCCCccCC--CCCCcceEEeCCCCCCCCCCCCCCC-cccccCCCCCccccccCCCCCCCC
Q 002158 359 DLRNNSFSNIVGDL--TLPNNVTLRLGGNPICTSANIPNTG-RFCGSDAGGDETLTNSKVNCPVQA 421 (958)
Q Consensus 359 ~Ls~N~l~~l~~~~--~l~~L~~L~l~~N~l~~~~~~~~~~-~~~~~~~~~~~~L~~n~~~C~c~~ 421 (958)
+|++|++++++... .+++|+.|++++|||.|+|...++. .+..... ..+.+.+ .|..+.
T Consensus 500 ~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~~~~~~~~wl~~~~---~~~~~~~-~C~~~~ 561 (570)
T 2z63_A 500 NMASNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCPRIDYLSRWLNKNS---QKEQGSA-KCSGSG 561 (570)
T ss_dssp ECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCTTTTHHHHHHHHHTG---GGEESCC-BBTTTC
T ss_pred eCCCCcCCCCCHHHhhcccCCcEEEecCCcccCCCcchHHHHHHHHhcc---ccCCCch-hhCCCC
Confidence 99999999988654 8999999999999999999876654 4433221 2334444 565543
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=6.1e-30 Score=299.83 Aligned_cols=299 Identities=20% Similarity=0.199 Sum_probs=256.0
Q ss_pred ceeeEEEEccCCcCCCCccccccCCCCcceeeccCcccCCCCcc-ccCCCCCcEEEeeCCCCCCCCChhhcCCCCCCEEe
Q 002158 85 HLHVRELQLLSMNLSGNLAPELGQLSRLQYYFMWNDLTGTIPKE-IGNISSLIFLLLNGNKLSGSLPDELGYLSNLNRLQ 163 (958)
Q Consensus 85 ~~~v~~L~L~~~~l~~~~~~~l~~L~~L~~L~l~n~~~~~ip~~-i~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~ 163 (958)
..+++.|+|++|.+++..|..|+++++|++|++++|....+|.. |.++++|++|+|++|.+++..|..|..+++|++|+
T Consensus 55 l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~ 134 (477)
T 2id5_A 55 FPHLEELELNENIVSAVEPGAFNNLFNLRTLGLRSNRLKLIPLGVFTGLSNLTKLDISENKIVILLDYMFQDLYNLKSLE 134 (477)
T ss_dssp CTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCSCCTTSSTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEE
T ss_pred CCCCCEEECCCCccCEeChhhhhCCccCCEEECCCCcCCccCcccccCCCCCCEEECCCCccccCChhHccccccCCEEE
Confidence 45799999999999999999999999999999998877778764 79999999999999999988899999999999999
Q ss_pred cccccccccCccccccccccceEecccccccccCchhhcCCccchhhhccCCccccCCCcccCCCCCccEEEccCCCCCC
Q 002158 164 VDENNITGTIPKSFANLSRVRHLHLNNNSIGGQIPSELSKLSTLIHLLVDNNNLSGNLPPELSELPQLCILQLDNNNFSA 243 (958)
Q Consensus 164 L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~ 243 (958)
|++|.+++..+..|.++++|+.|+|++|++++..+..+.++++|+.|+|++|++.+..+..|..+++|+.|++++|.+.
T Consensus 135 l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~~~~~- 213 (477)
T 2id5_A 135 VGDNDLVYISHRAFSGLNSLEQLTLEKCNLTSIPTEALSHLHGLIVLRLRHLNINAIRDYSFKRLYRLKVLEISHWPYL- 213 (477)
T ss_dssp ECCTTCCEECTTSSTTCTTCCEEEEESCCCSSCCHHHHTTCTTCCEEEEESCCCCEECTTCSCSCTTCCEEEEECCTTC-
T ss_pred CCCCccceeChhhccCCCCCCEEECCCCcCcccChhHhcccCCCcEEeCCCCcCcEeChhhcccCcccceeeCCCCccc-
Confidence 9999999888999999999999999999999877788999999999999999999988889999999999999999886
Q ss_pred CCccccccCCCCCCEEEcccCCCCCCCC-CCCCCCCcCEEeccCCcCCCcCCC-CCCCCCcCEEEccCCcCCCccchhcc
Q 002158 244 SEIPATYGNFSKLVKLSLRNCNLQGAVP-DLSRIPNLYYLDLSWNHLTGSIPS-KKLSENVTTIDLSDNYLNGSILESIS 321 (958)
Q Consensus 244 ~~~p~~~~~l~~L~~L~L~~N~l~~~~~-~l~~l~~L~~L~Ls~N~l~~~~~~-~~~~~~L~~L~Ls~N~l~~~~~~~~~ 321 (958)
..++.......+|+.|+|++|++++.+. .+..+++|+.|+|++|.+++..+. ...+++|+.|+|++|++++..+..|.
T Consensus 214 ~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~ 293 (477)
T 2id5_A 214 DTMTPNCLYGLNLTSLSITHCNLTAVPYLAVRHLVYLRFLNLSYNPISTIEGSMLHELLRLQEIQLVGGQLAVVEPYAFR 293 (477)
T ss_dssp CEECTTTTTTCCCSEEEEESSCCCSCCHHHHTTCTTCCEEECCSSCCCEECTTSCTTCTTCCEEECCSSCCSEECTTTBT
T ss_pred cccCcccccCccccEEECcCCcccccCHHHhcCccccCeeECCCCcCCccChhhccccccCCEEECCCCccceECHHHhc
Confidence 4566666666799999999999998775 489999999999999999965554 35568999999999999999999999
Q ss_pred CCCCCCeEeeecccCCCccchhhhcccccCccccceEeccCCCCCCCccCC-CCCCcceEEeCCCCCCC
Q 002158 322 NLPFLQTLSLENNFLTGSIPATIWQNKSFSTKARLKIDLRNNSFSNIVGDL-TLPNNVTLRLGGNPICT 389 (958)
Q Consensus 322 ~l~~L~~L~L~~N~l~~~ip~~l~~~~~~~~~~l~~L~Ls~N~l~~l~~~~-~l~~L~~L~l~~N~l~~ 389 (958)
++++|+.|+|++|+|++..+..+.. .+.|+.|+|++|.+..-.... .+..+..+.+.+|.+.|
T Consensus 294 ~l~~L~~L~L~~N~l~~~~~~~~~~-----l~~L~~L~l~~N~l~c~c~~~~~~~~~~~~~~~~~~~~C 357 (477)
T 2id5_A 294 GLNYLRVLNVSGNQLTTLEESVFHS-----VGNLETLILDSNPLACDCRLLWVFRRRWRLNFNRQQPTC 357 (477)
T ss_dssp TCTTCCEEECCSSCCSCCCGGGBSC-----GGGCCEEECCSSCEECSGGGHHHHTTTTSSCCTTCCCBE
T ss_pred CcccCCEEECCCCcCceeCHhHcCC-----CcccCEEEccCCCccCccchHhHHhhhhccccCccCcee
Confidence 9999999999999999544443333 356779999999997532221 22223334445555544
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=1.5e-29 Score=301.93 Aligned_cols=130 Identities=18% Similarity=0.246 Sum_probs=92.0
Q ss_pred ccCCCCCCEEEcccCCCCCCCCCCCCCCCcCEEeccCCcCCCcCCCCCCCCCcCEEEccCCcCCCccchhccCCCCCCeE
Q 002158 250 YGNFSKLVKLSLRNCNLQGAVPDLSRIPNLYYLDLSWNHLTGSIPSKKLSENVTTIDLSDNYLNGSILESISNLPFLQTL 329 (958)
Q Consensus 250 ~~~l~~L~~L~L~~N~l~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L 329 (958)
+..+++|+.|+|++|++++.+..+..+++|++|+|++|.+++ ++.. ..++|++|+|++|+|++.. ..+++|++|
T Consensus 383 ~~~l~~L~~L~Ls~N~l~~lp~~~~~~~~L~~L~Ls~N~l~~-l~~~-~~~~L~~L~Ls~N~l~~~~----~~l~~L~~L 456 (549)
T 2z81_A 383 LLTLKNLTSLDISRNTFHPMPDSCQWPEKMRFLNLSSTGIRV-VKTC-IPQTLEVLDVSNNNLDSFS----LFLPRLQEL 456 (549)
T ss_dssp GGGCTTCCEEECTTCCCCCCCSCCCCCTTCCEEECTTSCCSC-CCTT-SCTTCSEEECCSSCCSCCC----CCCTTCCEE
T ss_pred hhcCCCCCEEECCCCCCccCChhhcccccccEEECCCCCccc-ccch-hcCCceEEECCCCChhhhc----ccCChhcEE
Confidence 455555555555555555444445555566666666666552 2221 1246666777777666542 578999999
Q ss_pred eeecccCCCccchhhhcccccCccccceEeccCCCCCCCccCC--CCCCcceEEeCCCCCCCCCC
Q 002158 330 SLENNFLTGSIPATIWQNKSFSTKARLKIDLRNNSFSNIVGDL--TLPNNVTLRLGGNPICTSAN 392 (958)
Q Consensus 330 ~L~~N~l~~~ip~~l~~~~~~~~~~l~~L~Ls~N~l~~l~~~~--~l~~L~~L~l~~N~l~~~~~ 392 (958)
+|++|+|+ .+|.. .. .+.|+.|||++|+++.++... .+++|+.|++++|||.|+|.
T Consensus 457 ~Ls~N~l~-~ip~~-~~-----l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~ 514 (549)
T 2z81_A 457 YISRNKLK-TLPDA-SL-----FPVLLVMKISRNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCP 514 (549)
T ss_dssp ECCSSCCS-SCCCG-GG-----CTTCCEEECCSSCCCCCCTTGGGGCTTCCEEECCSSCBCCCHH
T ss_pred ECCCCccC-cCCCc-cc-----CccCCEEecCCCccCCcCHHHHhcCcccCEEEecCCCccCCCc
Confidence 99999998 78863 22 357889999999999988763 89999999999999999996
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=6.2e-30 Score=297.83 Aligned_cols=314 Identities=20% Similarity=0.231 Sum_probs=259.3
Q ss_pred EEEEccCCcCCCCccccccCCCCcceeeccCcccCC-CCccccCCCCCcEEEeeCCCCCCCC-ChhhcCCCCCCEEeccc
Q 002158 89 RELQLLSMNLSGNLAPELGQLSRLQYYFMWNDLTGT-IPKEIGNISSLIFLLLNGNKLSGSL-PDELGYLSNLNRLQVDE 166 (958)
Q Consensus 89 ~~L~L~~~~l~~~~~~~l~~L~~L~~L~l~n~~~~~-ip~~i~~l~~L~~L~Ls~n~l~~~~-p~~l~~l~~L~~L~L~~ 166 (958)
..++..+++++.. |. + .++|++|++++|.... .|..|.++++|++|+|++|.+.+.+ +..|.++++|++|+|++
T Consensus 13 ~~~~c~~~~l~~l-p~-l--~~~l~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n~~~~~i~~~~~~~l~~L~~L~Ls~ 88 (455)
T 3v47_A 13 YNAICINRGLHQV-PE-L--PAHVNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDY 88 (455)
T ss_dssp TEEECCSSCCSSC-CC-C--CTTCCEEECCSSCCCEECTTTTSSCTTCCEEECCCCSTTCEECTTTTTTCTTCCEEECTT
T ss_pred cccCcCCCCcccC-CC-C--CCccCEEEecCCccCcCChhHhccCccccEEECcCCcccceECcccccccccCCEEeCCC
Confidence 4577777777654 33 2 3789999998665555 4788999999999999999998665 56799999999999999
Q ss_pred ccccccCccccccccccceEecccccccccCchh--hcCCccchhhhccCCccccCCCcc-cCCCCCccEEEccCCCCCC
Q 002158 167 NNITGTIPKSFANLSRVRHLHLNNNSIGGQIPSE--LSKLSTLIHLLVDNNNLSGNLPPE-LSELPQLCILQLDNNNFSA 243 (958)
Q Consensus 167 N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~--l~~l~~L~~L~L~~N~l~~~~~~~-l~~l~~L~~L~L~~N~l~~ 243 (958)
|++++..|..|.++++|++|+|++|++++.++.. +..+++|++|+|++|++++..|.. +.++++|++|+|++|+++.
T Consensus 89 n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~l~~L~~L~L~~n~l~~ 168 (455)
T 3v47_A 89 NQFLQLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIKKIQPASFFLNMRRFHVLDLTFNKVKS 168 (455)
T ss_dssp CTTCEECTTTTTTCTTCCEEECTTSCCBTHHHHSSTTTTCTTCCEEECCSSBCCSCCCCGGGGGCTTCCEEECTTCCBSC
T ss_pred CccCccChhhccCcccCCEEeCCCCCCCccccCcccccCcccCCEEECCCCccCccCcccccCCCCcccEEeCCCCcccc
Confidence 9999888999999999999999999999766655 999999999999999999887876 8999999999999999973
Q ss_pred CCccccccCC--CCCCEEEcccCCCCCCCCC---------CCCCCCcCEEeccCCcCCCcCCCC----------------
Q 002158 244 SEIPATYGNF--SKLVKLSLRNCNLQGAVPD---------LSRIPNLYYLDLSWNHLTGSIPSK---------------- 296 (958)
Q Consensus 244 ~~~p~~~~~l--~~L~~L~L~~N~l~~~~~~---------l~~l~~L~~L~Ls~N~l~~~~~~~---------------- 296 (958)
..+..+..+ .+|+.|++++|.+.+..+. +..+++|+.|+|++|.+++..+..
T Consensus 169 -~~~~~l~~l~~~~L~~L~l~~n~l~~~~~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~~~~~~~L~~L~l~ 247 (455)
T 3v47_A 169 -ICEEDLLNFQGKHFTLLRLSSITLQDMNEYWLGWEKCGNPFKNTSITTLDLSGNGFKESMAKRFFDAIAGTKIQSLILS 247 (455)
T ss_dssp -CCTTTSGGGTTCEEEEEECTTCBCTTCSTTCTTHHHHCCTTTTCEEEEEECTTSCCCHHHHHHHHHHTTTCCEEEEECT
T ss_pred -cChhhhhccccccccccccccCcccccchhhccccccccccccceeeeEecCCCcccccchhhhhccccccceeeEeec
Confidence 556677666 6899999999999987653 346789999999999886532210
Q ss_pred ------------------------CCCCCcCEEEccCCcCCCccchhccCCCCCCeEeeecccCCCccchhhhcccccCc
Q 002158 297 ------------------------KLSENVTTIDLSDNYLNGSILESISNLPFLQTLSLENNFLTGSIPATIWQNKSFST 352 (958)
Q Consensus 297 ------------------------~~~~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~ip~~l~~~~~~~~ 352 (958)
...++|+.|+|++|.+++..+..|..+++|++|+|++|++++..|..+..+
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l----- 322 (455)
T 3v47_A 248 NSYNMGSSFGHTNFKDPDNFTFKGLEASGVKTCDLSKSKIFALLKSVFSHFTDLEQLTLAQNEINKIDDNAFWGL----- 322 (455)
T ss_dssp TCTTTSCCTTCCSSCCCCTTTTGGGTTSCCCEEECCSSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTC-----
T ss_pred cccccccccchhhhccCcccccccccccCceEEEecCccccccchhhcccCCCCCEEECCCCcccccChhHhcCc-----
Confidence 012589999999999999999999999999999999999997777777554
Q ss_pred cccceEeccCCCCCCCccCC--CCCCcceEEeCCCCCCCCCCCCCCCcccccCCCCCccccccCCC
Q 002158 353 KARLKIDLRNNSFSNIVGDL--TLPNNVTLRLGGNPICTSANIPNTGRFCGSDAGGDETLTNSKVN 416 (958)
Q Consensus 353 ~~l~~L~Ls~N~l~~l~~~~--~l~~L~~L~l~~N~l~~~~~~~~~~~~~~~~~~~~~~L~~n~~~ 416 (958)
+.|+.|+|++|++++++... .+++|+.|+|++|.+..... ..+......+.+.|.+|.+.
T Consensus 323 ~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~----~~~~~l~~L~~L~L~~N~l~ 384 (455)
T 3v47_A 323 THLLKLNLSQNFLGSIDSRMFENLDKLEVLDLSYNHIRALGD----QSFLGLPNLKELALDTNQLK 384 (455)
T ss_dssp TTCCEEECCSSCCCEECGGGGTTCTTCCEEECCSSCCCEECT----TTTTTCTTCCEEECCSSCCS
T ss_pred ccCCEEECCCCccCCcChhHhcCcccCCEEECCCCcccccCh----hhccccccccEEECCCCccc
Confidence 45679999999999986543 89999999999999854321 22334456677888888775
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} | Back alignment and structure |
|---|
Probab=99.96 E-value=7.7e-29 Score=277.78 Aligned_cols=279 Identities=20% Similarity=0.302 Sum_probs=141.7
Q ss_pred eeEEEEccCCcCCCCccccccCCCCcceeeccCcccCCCCccccCCCCCcEEEeeCCCCCCCCChhhcCCCCCCEEeccc
Q 002158 87 HVRELQLLSMNLSGNLAPELGQLSRLQYYFMWNDLTGTIPKEIGNISSLIFLLLNGNKLSGSLPDELGYLSNLNRLQVDE 166 (958)
Q Consensus 87 ~v~~L~L~~~~l~~~~~~~l~~L~~L~~L~l~n~~~~~ip~~i~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~L~~ 166 (958)
+++.|++++|.+++..+ +..+++|++|++++|....+| .+.++++|++|+|++|.+++ ++. +..+++|++|++++
T Consensus 67 ~L~~L~l~~n~i~~~~~--~~~l~~L~~L~L~~n~i~~~~-~~~~l~~L~~L~l~~n~i~~-~~~-~~~l~~L~~L~l~~ 141 (347)
T 4fmz_A 67 NLEYLNLNGNQITDISP--LSNLVKLTNLYIGTNKITDIS-ALQNLTNLRELYLNEDNISD-ISP-LANLTKMYSLNLGA 141 (347)
T ss_dssp TCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCCCG-GGTTCTTCSEEECTTSCCCC-CGG-GTTCTTCCEEECTT
T ss_pred CccEEEccCCccccchh--hhcCCcCCEEEccCCcccCch-HHcCCCcCCEEECcCCcccC-chh-hccCCceeEEECCC
Confidence 45555555555544322 555555555555544444443 35555555555555555552 222 55555555555555
Q ss_pred ccccccCccccccccccceEecccccccccCchhhcCCccchhhhccCCccccCCCcccCCCCCccEEEccCCCCCCCCc
Q 002158 167 NNITGTIPKSFANLSRVRHLHLNNNSIGGQIPSELSKLSTLIHLLVDNNNLSGNLPPELSELPQLCILQLDNNNFSASEI 246 (958)
Q Consensus 167 N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~ 246 (958)
|.....++ .+..+++|++|++++|.+.+..+ +..+++|+.|++++|++.+..+ +..+++|+.|++++|.++. .
T Consensus 142 n~~~~~~~-~~~~l~~L~~L~l~~~~~~~~~~--~~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~--~ 214 (347)
T 4fmz_A 142 NHNLSDLS-PLSNMTGLNYLTVTESKVKDVTP--IANLTDLYSLSLNYNQIEDISP--LASLTSLHYFTAYVNQITD--I 214 (347)
T ss_dssp CTTCCCCG-GGTTCTTCCEEECCSSCCCCCGG--GGGCTTCSEEECTTSCCCCCGG--GGGCTTCCEEECCSSCCCC--C
T ss_pred CCCccccc-chhhCCCCcEEEecCCCcCCchh--hccCCCCCEEEccCCccccccc--ccCCCccceeecccCCCCC--C
Confidence 54332222 25555555555555555553222 4555555555555555553222 4555555555555555542 1
Q ss_pred cccccCCCCCCEEEcccCCCCCCCCCCCCCCCcCEEeccCCcCCCcCCCCCCCCCcCEEEccCCcCCCccchhccCCCCC
Q 002158 247 PATYGNFSKLVKLSLRNCNLQGAVPDLSRIPNLYYLDLSWNHLTGSIPSKKLSENVTTIDLSDNYLNGSILESISNLPFL 326 (958)
Q Consensus 247 p~~~~~l~~L~~L~L~~N~l~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~~~L~~L~Ls~N~l~~~~~~~~~~l~~L 326 (958)
+. +..+++|+.|++++|++++.++ +..+++|++|++++|.+++ ++....+++|++|+|++|++++. ..+..+++|
T Consensus 215 ~~-~~~~~~L~~L~l~~n~l~~~~~-~~~l~~L~~L~l~~n~l~~-~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L 289 (347)
T 4fmz_A 215 TP-VANMTRLNSLKIGNNKITDLSP-LANLSQLTWLEIGTNQISD-INAVKDLTKLKMLNVGSNQISDI--SVLNNLSQL 289 (347)
T ss_dssp GG-GGGCTTCCEEECCSSCCCCCGG-GTTCTTCCEEECCSSCCCC-CGGGTTCTTCCEEECCSSCCCCC--GGGGGCTTC
T ss_pred ch-hhcCCcCCEEEccCCccCCCcc-hhcCCCCCEEECCCCccCC-ChhHhcCCCcCEEEccCCccCCC--hhhcCCCCC
Confidence 11 4555555555555555554443 5555555555555555552 33344445555555555555543 335555555
Q ss_pred CeEeeecccCCCccchhhhcccccCccccceEeccCCCCCCCccCCCCCCcceEEeCCCCC
Q 002158 327 QTLSLENNFLTGSIPATIWQNKSFSTKARLKIDLRNNSFSNIVGDLTLPNNVTLRLGGNPI 387 (958)
Q Consensus 327 ~~L~L~~N~l~~~ip~~l~~~~~~~~~~l~~L~Ls~N~l~~l~~~~~l~~L~~L~l~~N~l 387 (958)
+.|+|++|++++..|..+..+ +.|+.|++++|++++++....+++|+.|++++|++
T Consensus 290 ~~L~L~~n~l~~~~~~~l~~l-----~~L~~L~L~~n~l~~~~~~~~l~~L~~L~l~~N~i 345 (347)
T 4fmz_A 290 NSLFLNNNQLGNEDMEVIGGL-----TNLTTLFLSQNHITDIRPLASLSKMDSADFANQVI 345 (347)
T ss_dssp SEEECCSSCCCGGGHHHHHTC-----TTCSEEECCSSSCCCCGGGGGCTTCSEESSSCC--
T ss_pred CEEECcCCcCCCcChhHhhcc-----ccCCEEEccCCccccccChhhhhccceeehhhhcc
Confidence 555555555555544444432 23345555555555555433555555555555554
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=6.7e-29 Score=276.27 Aligned_cols=286 Identities=19% Similarity=0.269 Sum_probs=220.2
Q ss_pred EEEccCCcCCCCccccccCCCCcceeeccCcccCCCCc-cccCCCCCcEEEeeCCCCCCCCChhhcCCCCCCEEeccccc
Q 002158 90 ELQLLSMNLSGNLAPELGQLSRLQYYFMWNDLTGTIPK-EIGNISSLIFLLLNGNKLSGSLPDELGYLSNLNRLQVDENN 168 (958)
Q Consensus 90 ~L~L~~~~l~~~~~~~l~~L~~L~~L~l~n~~~~~ip~-~i~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~L~~N~ 168 (958)
.+++.++++.. +|..+. +.|+.|++++|....++. .|.++++|++|+|++|.+++..|..|.++++|++|+|++|+
T Consensus 35 ~l~~~~~~l~~-lp~~~~--~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~ 111 (330)
T 1xku_A 35 VVQCSDLGLEK-VPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQ 111 (330)
T ss_dssp EEECTTSCCCS-CCCSCC--TTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSC
T ss_pred EEEecCCCccc-cCccCC--CCCeEEECCCCcCCEeChhhhccCCCCCEEECCCCcCCeeCHHHhcCCCCCCEEECCCCc
Confidence 33444444443 444333 578888888766666654 68889999999999999997778889999999999999999
Q ss_pred ccccCccccccccccceEecccccccccCchhhcCCccchhhhccCCcccc--CCCcccCCCCCccEEEccCCCCCCCCc
Q 002158 169 ITGTIPKSFANLSRVRHLHLNNNSIGGQIPSELSKLSTLIHLLVDNNNLSG--NLPPELSELPQLCILQLDNNNFSASEI 246 (958)
Q Consensus 169 l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~--~~~~~l~~l~~L~~L~L~~N~l~~~~~ 246 (958)
++ .+|..+. ++|++|++++|.+++..+..+.++++|+.|++++|++.. ..+..+..+++|++|++++|.++ .+
T Consensus 112 l~-~l~~~~~--~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l~~L~~L~l~~n~l~--~l 186 (330)
T 1xku_A 112 LK-ELPEKMP--KTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNIT--TI 186 (330)
T ss_dssp CS-BCCSSCC--TTCCEEECCSSCCCBBCHHHHTTCTTCCEEECCSSCCCGGGBCTTGGGGCTTCCEEECCSSCCC--SC
T ss_pred CC-ccChhhc--ccccEEECCCCcccccCHhHhcCCccccEEECCCCcCCccCcChhhccCCCCcCEEECCCCccc--cC
Confidence 88 5565554 789999999999998777888999999999999999863 67788889999999999999986 45
Q ss_pred cccccCCCCCCEEEcccCCCCCCCC-CCCCCCCcCEEeccCCcCCCcCCC-CCCCCCcCEEEccCCcCCCccchhccCCC
Q 002158 247 PATYGNFSKLVKLSLRNCNLQGAVP-DLSRIPNLYYLDLSWNHLTGSIPS-KKLSENVTTIDLSDNYLNGSILESISNLP 324 (958)
Q Consensus 247 p~~~~~l~~L~~L~L~~N~l~~~~~-~l~~l~~L~~L~Ls~N~l~~~~~~-~~~~~~L~~L~Ls~N~l~~~~~~~~~~l~ 324 (958)
|..+. ++|+.|+|++|++++..+ .+..+++|+.|+|++|.+++..+. ...+++|++|+|++|+|+ .+|..+..++
T Consensus 187 ~~~~~--~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~-~lp~~l~~l~ 263 (330)
T 1xku_A 187 PQGLP--PSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHK 263 (330)
T ss_dssp CSSCC--TTCSEEECTTSCCCEECTGGGTTCTTCCEEECCSSCCCEECTTTGGGSTTCCEEECCSSCCS-SCCTTTTTCS
T ss_pred Ccccc--ccCCEEECCCCcCCccCHHHhcCCCCCCEEECCCCcCceeChhhccCCCCCCEEECCCCcCc-cCChhhccCC
Confidence 65543 789999999999998866 488899999999999999866553 455689999999999998 6777889999
Q ss_pred CCCeEeeecccCCCccchhhhccc-ccCccccceEeccCCCCCC--CccC-C-CCCCcceEEeCCCC
Q 002158 325 FLQTLSLENNFLTGSIPATIWQNK-SFSTKARLKIDLRNNSFSN--IVGD-L-TLPNNVTLRLGGNP 386 (958)
Q Consensus 325 ~L~~L~L~~N~l~~~ip~~l~~~~-~~~~~~l~~L~Ls~N~l~~--l~~~-~-~l~~L~~L~l~~N~ 386 (958)
+|++|+|++|+|++..+..+.... ......+..|++++|.+.. ++.. . .+.+++.++|++|+
T Consensus 264 ~L~~L~l~~N~i~~~~~~~f~~~~~~~~~~~l~~l~l~~N~~~~~~i~~~~f~~~~~l~~l~L~~N~ 330 (330)
T 1xku_A 264 YIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQPSTFRCVYVRAAVQLGNYK 330 (330)
T ss_dssp SCCEEECCSSCCCCCCTTSSSCSSCCTTSCCCSEEECCSSSSCGGGSCGGGGTTCCCGGGEEC----
T ss_pred CcCEEECCCCcCCccChhhcCCcccccccccccceEeecCcccccccCccccccccceeEEEecccC
Confidence 999999999999854444433221 1224567789999999875 3332 2 78899999999984
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.96 E-value=3.2e-29 Score=301.70 Aligned_cols=308 Identities=20% Similarity=0.206 Sum_probs=258.5
Q ss_pred eeeEEEEccCCcCCCCccccccCCCCcceeeccCcccCCCC-ccccCCCCCcEEEeeCCCCCCCCChhhcCCCCCCEEec
Q 002158 86 LHVRELQLLSMNLSGNLAPELGQLSRLQYYFMWNDLTGTIP-KEIGNISSLIFLLLNGNKLSGSLPDELGYLSNLNRLQV 164 (958)
Q Consensus 86 ~~v~~L~L~~~~l~~~~~~~l~~L~~L~~L~l~n~~~~~ip-~~i~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~L 164 (958)
.+++.|+|.+|.+++..+..|+.+++|+.|++++|....+| ..|+++++|++|+|++|.+++..+..|+++++|++|+|
T Consensus 75 ~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~l~~L~~L~L 154 (597)
T 3oja_B 75 RQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLSSLPRGIFHNTPKLTTLSM 154 (597)
T ss_dssp CCCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEEC
T ss_pred CCCcEEECCCCCCCCCChHHhcCCCCCCEEECCCCcCCCCCHHHHcCCCCCCEEEeeCCCCCCCCHHHhccCCCCCEEEe
Confidence 47999999999999998889999999999999866555554 56899999999999999999655556799999999999
Q ss_pred ccccccccCccccccccccceEecccccccccCchhhcCCccchhhhccCCccccCCCcccCCCCCccEEEccCCCCCCC
Q 002158 165 DENNITGTIPKSFANLSRVRHLHLNNNSIGGQIPSELSKLSTLIHLLVDNNNLSGNLPPELSELPQLCILQLDNNNFSAS 244 (958)
Q Consensus 165 ~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~ 244 (958)
++|.+++..|..|..+++|++|+|++|.+++. + +..+++|+.|++++|.+++ +...++|+.|++++|.++.
T Consensus 155 s~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~-~--~~~l~~L~~L~l~~n~l~~-----l~~~~~L~~L~ls~n~l~~- 225 (597)
T 3oja_B 155 SNNNLERIEDDTFQATTSLQNLQLSSNRLTHV-D--LSLIPSLFHANVSYNLLST-----LAIPIAVEELDASHNSINV- 225 (597)
T ss_dssp CSSCCCBCCTTTTTTCTTCCEEECTTSCCSBC-C--GGGCTTCSEEECCSSCCSE-----EECCTTCSEEECCSSCCCE-
T ss_pred eCCcCCCCChhhhhcCCcCcEEECcCCCCCCc-C--hhhhhhhhhhhcccCcccc-----ccCCchhheeeccCCcccc-
Confidence 99999999999999999999999999999964 3 5678899999999999875 3455789999999999963
Q ss_pred CccccccCCCCCCEEEcccCCCCCCCCCCCCCCCcCEEeccCCcCCCcCCCC-CCCCCcCEEEccCCcCCCccchhccCC
Q 002158 245 EIPATYGNFSKLVKLSLRNCNLQGAVPDLSRIPNLYYLDLSWNHLTGSIPSK-KLSENVTTIDLSDNYLNGSILESISNL 323 (958)
Q Consensus 245 ~~p~~~~~l~~L~~L~L~~N~l~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~-~~~~~L~~L~Ls~N~l~~~~~~~~~~l 323 (958)
++..+ .++|+.|+|++|.+++. +.+..+++|+.|+|++|.+++.+|.. ..+++|+.|+|++|.|++ +|..+..+
T Consensus 226 -~~~~~--~~~L~~L~L~~n~l~~~-~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~-l~~~~~~l 300 (597)
T 3oja_B 226 -VRGPV--NVELTILKLQHNNLTDT-AWLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLVA-LNLYGQPI 300 (597)
T ss_dssp -EECSC--CSCCCEEECCSSCCCCC-GGGGGCTTCSEEECCSSCCCEEESGGGTTCSSCCEEECTTSCCCE-EECSSSCC
T ss_pred -ccccc--CCCCCEEECCCCCCCCC-hhhccCCCCCEEECCCCccCCCCHHHhcCccCCCEEECCCCCCCC-CCcccccC
Confidence 34333 36899999999999974 56889999999999999999876654 567999999999999997 46777889
Q ss_pred CCCCeEeeecccCCCccchhhhcccccCccccceEeccCCCCCCCccCCCCCCcceEEeCCCCCCCCCCCCCCCcccccC
Q 002158 324 PFLQTLSLENNFLTGSIPATIWQNKSFSTKARLKIDLRNNSFSNIVGDLTLPNNVTLRLGGNPICTSANIPNTGRFCGSD 403 (958)
Q Consensus 324 ~~L~~L~L~~N~l~~~ip~~l~~~~~~~~~~l~~L~Ls~N~l~~l~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~~~ 403 (958)
++|+.|+|++|.++ .+|..+..+ +.|+.|+|++|+|+.++ ...+++|+.|++++|||.|+|...++..+.
T Consensus 301 ~~L~~L~Ls~N~l~-~i~~~~~~l-----~~L~~L~L~~N~l~~~~-~~~~~~L~~L~l~~N~~~~~~~~~~~~~~~--- 370 (597)
T 3oja_B 301 PTLKVLDLSHNHLL-HVERNQPQF-----DRLENLYLDHNSIVTLK-LSTHHTLKNLTLSHNDWDCNSLRALFRNVA--- 370 (597)
T ss_dssp TTCCEEECCSSCCC-CCGGGHHHH-----TTCSEEECCSSCCCCCC-CCTTCCCSEEECCSSCEEHHHHHHHTTTCC---
T ss_pred CCCcEEECCCCCCC-ccCcccccC-----CCCCEEECCCCCCCCcC-hhhcCCCCEEEeeCCCCCChhHHHHHHHHh---
Confidence 99999999999999 788887655 45669999999999885 447899999999999999987544433222
Q ss_pred CCCCccccccCCCCCCC
Q 002158 404 AGGDETLTNSKVNCPVQ 420 (958)
Q Consensus 404 ~~~~~~L~~n~~~C~c~ 420 (958)
...+.+++..|...
T Consensus 371 ---~~~~~~~~~~C~~~ 384 (597)
T 3oja_B 371 ---RPAVDDADQHCKID 384 (597)
T ss_dssp ---TTTBCCCCCCCCTT
T ss_pred ---hhccccccccCCcc
Confidence 23345666667653
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=1.7e-28 Score=273.06 Aligned_cols=264 Identities=22% Similarity=0.288 Sum_probs=140.0
Q ss_pred CCCCCCceeeCccc----cCCCceeeEEEEccCCcCCCCccccccCCCCcceeeccCcccCCC-CccccCCCCCcEEEee
Q 002158 67 CMSNWTGVLCFDTV----ETDGHLHVRELQLLSMNLSGNLAPELGQLSRLQYYFMWNDLTGTI-PKEIGNISSLIFLLLN 141 (958)
Q Consensus 67 c~~~w~gV~C~~~~----~~~~~~~v~~L~L~~~~l~~~~~~~l~~L~~L~~L~l~n~~~~~i-p~~i~~l~~L~~L~Ls 141 (958)
|.|+|+.+.|.+.. +......++.|+|++|++++..+..|+++++|++|++++|....+ |..|.++++|++|+|+
T Consensus 29 c~c~l~~l~~~~~~l~~lp~~~~~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls 108 (330)
T 1xku_A 29 CQCHLRVVQCSDLGLEKVPKDLPPDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLS 108 (330)
T ss_dssp CEEETTEEECTTSCCCSCCCSCCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECC
T ss_pred CcCCCeEEEecCCCccccCccCCCCCeEEECCCCcCCEeChhhhccCCCCCEEECCCCcCCeeCHHHhcCCCCCCEEECC
Confidence 44455555554311 111223455556666555555555555566666665554433333 5555556666666666
Q ss_pred CCCCCCCCChhhcCCCCCCEEecccccccccCccccccccccceEeccccccc--ccCchhhcCCccchhhhccCCcccc
Q 002158 142 GNKLSGSLPDELGYLSNLNRLQVDENNITGTIPKSFANLSRVRHLHLNNNSIG--GQIPSELSKLSTLIHLLVDNNNLSG 219 (958)
Q Consensus 142 ~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~--~~~p~~l~~l~~L~~L~L~~N~l~~ 219 (958)
+|.++ .+|..+. ++|++|++++|++++..+..|.++++|+.|++++|.++ +..+..+.++++|++|++++|+++.
T Consensus 109 ~n~l~-~l~~~~~--~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l~~L~~L~l~~n~l~~ 185 (330)
T 1xku_A 109 KNQLK-ELPEKMP--KTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNITT 185 (330)
T ss_dssp SSCCS-BCCSSCC--TTCCEEECCSSCCCBBCHHHHTTCTTCCEEECCSSCCCGGGBCTTGGGGCTTCCEEECCSSCCCS
T ss_pred CCcCC-ccChhhc--ccccEEECCCCcccccCHhHhcCCccccEEECCCCcCCccCcChhhccCCCCcCEEECCCCcccc
Confidence 66555 4444333 45666666666655555555555566666666666554 2445555555566666666665553
Q ss_pred CCCcccCCCCCccEEEccCCCCCCCCccccccCCCCCCEEEcccCCCCCCCC-CCCCCCCcCEEeccCCcCCCcCCCCCC
Q 002158 220 NLPPELSELPQLCILQLDNNNFSASEIPATYGNFSKLVKLSLRNCNLQGAVP-DLSRIPNLYYLDLSWNHLTGSIPSKKL 298 (958)
Q Consensus 220 ~~~~~l~~l~~L~~L~L~~N~l~~~~~p~~~~~l~~L~~L~L~~N~l~~~~~-~l~~l~~L~~L~Ls~N~l~~~~~~~~~ 298 (958)
+|..+. ++|++|+|++|+++. ..+..+..+++|+.|+|++|++++.++ .+..+++|++|+|++|+++........
T Consensus 186 -l~~~~~--~~L~~L~l~~n~l~~-~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~lp~~l~~ 261 (330)
T 1xku_A 186 -IPQGLP--PSLTELHLDGNKITK-VDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLVKVPGGLAD 261 (330)
T ss_dssp -CCSSCC--TTCSEEECTTSCCCE-ECTGGGTTCTTCCEEECCSSCCCEECTTTGGGSTTCCEEECCSSCCSSCCTTTTT
T ss_pred -CCcccc--ccCCEEECCCCcCCc-cCHHHhcCCCCCCEEECCCCcCceeChhhccCCCCCCEEECCCCcCccCChhhcc
Confidence 333332 555666666665542 234455555566666666666555544 255555566666666655522222334
Q ss_pred CCCcCEEEccCCcCCCccchhccCC------CCCCeEeeecccCC
Q 002158 299 SENVTTIDLSDNYLNGSILESISNL------PFLQTLSLENNFLT 337 (958)
Q Consensus 299 ~~~L~~L~Ls~N~l~~~~~~~~~~l------~~L~~L~L~~N~l~ 337 (958)
+++|++|+|++|+|++..+..|... +.|+.|++++|++.
T Consensus 262 l~~L~~L~l~~N~i~~~~~~~f~~~~~~~~~~~l~~l~l~~N~~~ 306 (330)
T 1xku_A 262 HKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQ 306 (330)
T ss_dssp CSSCCEEECCSSCCCCCCTTSSSCSSCCTTSCCCSEEECCSSSSC
T ss_pred CCCcCEEECCCCcCCccChhhcCCcccccccccccceEeecCccc
Confidence 4556666666666655555555432 45555666666554
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A | Back alignment and structure |
|---|
Probab=99.96 E-value=2.1e-28 Score=285.65 Aligned_cols=302 Identities=26% Similarity=0.326 Sum_probs=191.4
Q ss_pred eeeEEEEccCCcCCCCccccccCCCCcceeeccCcccCCCCccccCCCCCcEEEeeCCCCCCCCChhhcCCCCCCEEecc
Q 002158 86 LHVRELQLLSMNLSGNLAPELGQLSRLQYYFMWNDLTGTIPKEIGNISSLIFLLLNGNKLSGSLPDELGYLSNLNRLQVD 165 (958)
Q Consensus 86 ~~v~~L~L~~~~l~~~~~~~l~~L~~L~~L~l~n~~~~~ip~~i~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~L~ 165 (958)
.+++.|+|++|.+++..+ ++++++|++|++++|....++. ++++++|++|+|++|.+++. +. +.++++|++|+++
T Consensus 68 ~~L~~L~Ls~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~~~-~~~l~~L~~L~L~~n~l~~~-~~-~~~l~~L~~L~l~ 142 (466)
T 1o6v_A 68 NNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIADITP-LANLTNLTGLTLFNNQITDI-DP-LKNLTNLNRLELS 142 (466)
T ss_dssp TTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCCCGG-GTTCTTCCEEECCSSCCCCC-GG-GTTCTTCSEEEEE
T ss_pred cCCCEEECCCCccCCchh--hhccccCCEEECCCCccccChh-hcCCCCCCEEECCCCCCCCC-hH-HcCCCCCCEEECC
Confidence 468899999998887654 8899999999998877777776 88999999999999999854 43 8889999999999
Q ss_pred cccccccCcc--------------------ccccccccceEecccccccccCchhhcCCccchhhhccCCccccCCCccc
Q 002158 166 ENNITGTIPK--------------------SFANLSRVRHLHLNNNSIGGQIPSELSKLSTLIHLLVDNNNLSGNLPPEL 225 (958)
Q Consensus 166 ~N~l~~~~p~--------------------~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~l 225 (958)
+|.+++. +. .+.++++|+.|++++|.+++. ..+..+++|++|++++|++++..+ +
T Consensus 143 ~n~l~~~-~~~~~l~~L~~L~l~~~~~~~~~~~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~l~~n~l~~~~~--~ 217 (466)
T 1o6v_A 143 SNTISDI-SALSGLTSLQQLSFGNQVTDLKPLANLTTLERLDISSNKVSDI--SVLAKLTNLESLIATNNQISDITP--L 217 (466)
T ss_dssp EEEECCC-GGGTTCTTCSEEEEEESCCCCGGGTTCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCCCGG--G
T ss_pred CCccCCC-hhhccCCcccEeecCCcccCchhhccCCCCCEEECcCCcCCCC--hhhccCCCCCEEEecCCccccccc--c
Confidence 9988753 21 134445555555555555532 235555566666666666554433 4
Q ss_pred CCCCCccEEEccCCCCCCCCccccccCCCCCCEEEcccCCCCCCCCCCCCCCCcCEEeccCCcCCCcCCCCCCCCCcCEE
Q 002158 226 SELPQLCILQLDNNNFSASEIPATYGNFSKLVKLSLRNCNLQGAVPDLSRIPNLYYLDLSWNHLTGSIPSKKLSENVTTI 305 (958)
Q Consensus 226 ~~l~~L~~L~L~~N~l~~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~~~L~~L 305 (958)
..+++|++|++++|+++. + ..+..+++|+.|++++|.+++.++ +..+++|+.|++++|.+++..+ ...+++|+.|
T Consensus 218 ~~l~~L~~L~l~~n~l~~--~-~~l~~l~~L~~L~l~~n~l~~~~~-~~~l~~L~~L~l~~n~l~~~~~-~~~l~~L~~L 292 (466)
T 1o6v_A 218 GILTNLDELSLNGNQLKD--I-GTLASLTNLTDLDLANNQISNLAP-LSGLTKLTELKLGANQISNISP-LAGLTALTNL 292 (466)
T ss_dssp GGCTTCCEEECCSSCCCC--C-GGGGGCTTCSEEECCSSCCCCCGG-GTTCTTCSEEECCSSCCCCCGG-GTTCTTCSEE
T ss_pred cccCCCCEEECCCCCccc--c-hhhhcCCCCCEEECCCCccccchh-hhcCCCCCEEECCCCccCcccc-ccCCCccCeE
Confidence 555666666666666542 1 245556666666666666665544 5666666666666666664332 4455666666
Q ss_pred EccCCcCCCccchhccCCCCCCeEeeecccCCCccchhhhcccccCccccceEeccCCCCCCCccCCCCCCcceEEeCCC
Q 002158 306 DLSDNYLNGSILESISNLPFLQTLSLENNFLTGSIPATIWQNKSFSTKARLKIDLRNNSFSNIVGDLTLPNNVTLRLGGN 385 (958)
Q Consensus 306 ~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~ip~~l~~~~~~~~~~l~~L~Ls~N~l~~l~~~~~l~~L~~L~l~~N 385 (958)
+|++|++++..+ +..+++|+.|+|++|++++..| +.. .+.|+.|++++|++++++....+++|+.|++++|
T Consensus 293 ~L~~n~l~~~~~--~~~l~~L~~L~L~~n~l~~~~~--~~~-----l~~L~~L~l~~n~l~~~~~l~~l~~L~~L~l~~n 363 (466)
T 1o6v_A 293 ELNENQLEDISP--ISNLKNLTYLTLYFNNISDISP--VSS-----LTKLQRLFFYNNKVSDVSSLANLTNINWLSAGHN 363 (466)
T ss_dssp ECCSSCCSCCGG--GGGCTTCSEEECCSSCCSCCGG--GGG-----CTTCCEEECCSSCCCCCGGGTTCTTCCEEECCSS
T ss_pred EcCCCcccCchh--hcCCCCCCEEECcCCcCCCchh--hcc-----CccCCEeECCCCccCCchhhccCCCCCEEeCCCC
Confidence 666666665443 5666666666666666665444 221 2345566666666666654446666667777666
Q ss_pred CCCCCCCCCCCCcccccCCCCCccccccCCCC
Q 002158 386 PICTSANIPNTGRFCGSDAGGDETLTNSKVNC 417 (958)
Q Consensus 386 ~l~~~~~~~~~~~~~~~~~~~~~~L~~n~~~C 417 (958)
++..... +........+.+.+|+|..
T Consensus 364 ~l~~~~~------~~~l~~L~~L~l~~n~~~~ 389 (466)
T 1o6v_A 364 QISDLTP------LANLTRITQLGLNDQAWTN 389 (466)
T ss_dssp CCCBCGG------GTTCTTCCEEECCCEEEEC
T ss_pred ccCccch------hhcCCCCCEEeccCCcccC
Confidence 6643221 2222334455566665543
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} | Back alignment and structure |
|---|
Probab=99.96 E-value=8.4e-29 Score=275.69 Aligned_cols=287 Identities=20% Similarity=0.287 Sum_probs=222.8
Q ss_pred eEEEEccCCcCCCCccccccCCCCcceeeccCcccCCC-CccccCCCCCcEEEeeCCCCCCCCChhhcCCCCCCEEeccc
Q 002158 88 VRELQLLSMNLSGNLAPELGQLSRLQYYFMWNDLTGTI-PKEIGNISSLIFLLLNGNKLSGSLPDELGYLSNLNRLQVDE 166 (958)
Q Consensus 88 v~~L~L~~~~l~~~~~~~l~~L~~L~~L~l~n~~~~~i-p~~i~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~L~~ 166 (958)
++.+++.+++++ .+|..+. ++|+.|++++|....+ |..|.++++|++|+|++|.+++..|..|.++++|++|+|++
T Consensus 35 l~~l~~~~~~l~-~ip~~~~--~~l~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~ 111 (332)
T 2ft3_A 35 LRVVQCSDLGLK-AVPKEIS--PDTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKISKIHEKAFSPLRKLQKLYISK 111 (332)
T ss_dssp TTEEECCSSCCS-SCCSCCC--TTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECGGGSTTCTTCCEEECCS
T ss_pred CCEEECCCCCcc-ccCCCCC--CCCeEEECCCCcCCccCHhHhhCCCCCcEEECCCCccCccCHhHhhCcCCCCEEECCC
Confidence 344555555655 4555543 6788888886665555 45788999999999999999977788899999999999999
Q ss_pred ccccccCccccccccccceEecccccccccCchhhcCCccchhhhccCCccc--cCCCcccCCCCCccEEEccCCCCCCC
Q 002158 167 NNITGTIPKSFANLSRVRHLHLNNNSIGGQIPSELSKLSTLIHLLVDNNNLS--GNLPPELSELPQLCILQLDNNNFSAS 244 (958)
Q Consensus 167 N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~--~~~~~~l~~l~~L~~L~L~~N~l~~~ 244 (958)
|+++ .+|..+. ++|++|++++|.+++..+..|.++++|+.|++++|.++ +..+..+..+ +|++|++++|+++.
T Consensus 112 n~l~-~l~~~~~--~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l-~L~~L~l~~n~l~~- 186 (332)
T 2ft3_A 112 NHLV-EIPPNLP--SSLVELRIHDNRIRKVPKGVFSGLRNMNCIEMGGNPLENSGFEPGAFDGL-KLNYLRISEAKLTG- 186 (332)
T ss_dssp SCCC-SCCSSCC--TTCCEEECCSSCCCCCCSGGGSSCSSCCEEECCSCCCBGGGSCTTSSCSC-CCSCCBCCSSBCSS-
T ss_pred CcCC-ccCcccc--ccCCEEECCCCccCccCHhHhCCCccCCEEECCCCccccCCCCcccccCC-ccCEEECcCCCCCc-
Confidence 9988 5665554 78999999999999777777889999999999999986 4677888888 99999999999863
Q ss_pred CccccccCCCCCCEEEcccCCCCCCCC-CCCCCCCcCEEeccCCcCCCcCCC-CCCCCCcCEEEccCCcCCCccchhccC
Q 002158 245 EIPATYGNFSKLVKLSLRNCNLQGAVP-DLSRIPNLYYLDLSWNHLTGSIPS-KKLSENVTTIDLSDNYLNGSILESISN 322 (958)
Q Consensus 245 ~~p~~~~~l~~L~~L~L~~N~l~~~~~-~l~~l~~L~~L~Ls~N~l~~~~~~-~~~~~~L~~L~Ls~N~l~~~~~~~~~~ 322 (958)
+|..+. ++|++|+|++|++++.++ .+..+++|+.|+|++|.+++..+. ...+++|++|+|++|+|+ .+|..+..
T Consensus 187 -l~~~~~--~~L~~L~l~~n~i~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~-~lp~~l~~ 262 (332)
T 2ft3_A 187 -IPKDLP--ETLNELHLDHNKIQAIELEDLLRYSKLYRLGLGHNQIRMIENGSLSFLPTLRELHLDNNKLS-RVPAGLPD 262 (332)
T ss_dssp -CCSSSC--SSCSCCBCCSSCCCCCCTTSSTTCTTCSCCBCCSSCCCCCCTTGGGGCTTCCEEECCSSCCC-BCCTTGGG
T ss_pred -cCcccc--CCCCEEECCCCcCCccCHHHhcCCCCCCEEECCCCcCCcCChhHhhCCCCCCEEECCCCcCe-ecChhhhc
Confidence 566544 789999999999998876 488999999999999999866553 455689999999999998 67777999
Q ss_pred CCCCCeEeeecccCCCccchhhhccc-ccCccccceEeccCCCCC--CCccCC--CCCCcceEEeCCCC
Q 002158 323 LPFLQTLSLENNFLTGSIPATIWQNK-SFSTKARLKIDLRNNSFS--NIVGDL--TLPNNVTLRLGGNP 386 (958)
Q Consensus 323 l~~L~~L~L~~N~l~~~ip~~l~~~~-~~~~~~l~~L~Ls~N~l~--~l~~~~--~l~~L~~L~l~~N~ 386 (958)
+++|+.|+|++|+|++..+..+.... ......++.|++++|.+. .+.... .+++|+.|++++|.
T Consensus 263 l~~L~~L~l~~N~l~~~~~~~~~~~~~~~~~~~l~~L~l~~N~~~~~~~~~~~~~~l~~L~~l~l~~n~ 331 (332)
T 2ft3_A 263 LKLLQVVYLHTNNITKVGVNDFCPVGFGVKRAYYNGISLFNNPVPYWEVQPATFRCVTDRLAIQFGNYK 331 (332)
T ss_dssp CTTCCEEECCSSCCCBCCTTSSSCSSCCSSSCCBSEEECCSSSSCGGGSCGGGGTTBCCSTTEEC----
T ss_pred CccCCEEECCCCCCCccChhHccccccccccccccceEeecCcccccccCcccccccchhhhhhccccc
Confidence 99999999999999854444443321 122456789999999998 444433 78999999999984
|
| >4g8a_A TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, immune system; HET: NAG LP4 LP5 DAO MYR KDO; 2.40A {Homo sapiens} PDB: 3fxi_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=4.7e-29 Score=302.86 Aligned_cols=331 Identities=19% Similarity=0.190 Sum_probs=256.2
Q ss_pred ceeeEEEEccCCcCCCCccccccCCCCcceeeccCcccCCCCc-cccCCCCCcEEEeeCCCCCCCCChhhcCCCCCCEEe
Q 002158 85 HLHVRELQLLSMNLSGNLAPELGQLSRLQYYFMWNDLTGTIPK-EIGNISSLIFLLLNGNKLSGSLPDELGYLSNLNRLQ 163 (958)
Q Consensus 85 ~~~v~~L~L~~~~l~~~~~~~l~~L~~L~~L~l~n~~~~~ip~-~i~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~ 163 (958)
..+++.|+|++|++++..+..|.+|++|++|++++|....+|. .|.++++|++|+|++|++++..+..|+++++|++|+
T Consensus 75 l~~L~~L~Ls~N~i~~i~~~~f~~L~~L~~L~Ls~N~l~~l~~~~f~~L~~L~~L~Ls~N~l~~l~~~~~~~L~~L~~L~ 154 (635)
T 4g8a_A 75 FPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELN 154 (635)
T ss_dssp CTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECGGGGTTCTTCCEEECTTSCCCCSTTCCCTTCTTCCEEE
T ss_pred CCCCCEEECCCCcCCCcChhHhcCCCCCCEEEccCCcCCCCCHHHhcCCCCCCEEECCCCcCCCCChhhhhcCcccCeec
Confidence 4579999999999999888899999999999999887777775 589999999999999999977777899999999999
Q ss_pred cccccccc-cCccccccccccceEecccccccccCchhhcCCcc------------------------------------
Q 002158 164 VDENNITG-TIPKSFANLSRVRHLHLNNNSIGGQIPSELSKLST------------------------------------ 206 (958)
Q Consensus 164 L~~N~l~~-~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~------------------------------------ 206 (958)
|++|++++ .+|..+..+++|++|+|++|+|++..+..+..+.+
T Consensus 155 Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~L~~l~~~~~~~~ls~n~l~~i~~~~~~~~~~~~l~l~~n 234 (635)
T 4g8a_A 155 VAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEIRLHKLTLRNN 234 (635)
T ss_dssp CCSSCCCCCCCCGGGGGCTTCCEEECCSSCCCEECGGGGHHHHTCTTCCCEEECTTCCCCEECTTTTTTCEEEEEEEESC
T ss_pred cccCccccCCCchhhccchhhhhhcccCccccccccccccchhhhhhhhhhhhcccCcccccCcccccchhhhhhhhhcc
Confidence 99999986 46788899999999999999988665554332211
Q ss_pred --------------------------------------------------------------------------------
Q 002158 207 -------------------------------------------------------------------------------- 206 (958)
Q Consensus 207 -------------------------------------------------------------------------------- 206 (958)
T Consensus 235 ~~~~~~~~~~~~~l~~l~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~ 314 (635)
T 4g8a_A 235 FDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDGIIDLFNCLTNVSSFSLV 314 (635)
T ss_dssp CSSHHHHHHHHHTTTTCEEEEEEEECCTTSCCCSCCCTTTTGGGGGSEEEEEEEECCCSCEEECTTTTGGGTTCSEEEEE
T ss_pred cccccccchhhcCCcccccccccccccccccccccccccccccccchhhhhhhhhhhcccccchhhhhhhhccccccccc
Confidence
Q ss_pred ---------------chhhhccCCccccCCCc-------------------ccCCCCCccEEEccCCCCCC---------
Q 002158 207 ---------------LIHLLVDNNNLSGNLPP-------------------ELSELPQLCILQLDNNNFSA--------- 243 (958)
Q Consensus 207 ---------------L~~L~L~~N~l~~~~~~-------------------~l~~l~~L~~L~L~~N~l~~--------- 243 (958)
|+.|++.+|.+....+. ....+++|+.|++++|.+..
T Consensus 315 ~~~~~~~~~~~~~~~L~~L~l~~~~~~~~~~~~l~~L~~l~l~~n~~~~~~~~~~l~~L~~L~ls~n~l~~~~~~~~~~~ 394 (635)
T 4g8a_A 315 SVTIERVKDFSYNFGWQHLELVNCKFGQFPTLKLKSLKRLTFTSNKGGNAFSEVDLPSLEFLDLSRNGLSFKGCCSQSDF 394 (635)
T ss_dssp SCEEEECGGGGSCCCCSEEEEESCEESSCCCCBCTTCCEEEEESCCSCCBCCCCBCTTCCEEECCSSCCBEEEECCHHHH
T ss_pred ccccccccccccchhhhhhhcccccccCcCcccchhhhhcccccccCCCCcccccccccccchhhccccccccccccchh
Confidence 12222333322211111 11245677777777776631
Q ss_pred ----------------------------------------CCccccccCCCCCCEEEcccCCCCCCCCC-CCCCCCcCEE
Q 002158 244 ----------------------------------------SEIPATYGNFSKLVKLSLRNCNLQGAVPD-LSRIPNLYYL 282 (958)
Q Consensus 244 ----------------------------------------~~~p~~~~~l~~L~~L~L~~N~l~~~~~~-l~~l~~L~~L 282 (958)
...+..+..+.+|+.++++.|.+.+..+. +..+++|+.|
T Consensus 395 ~~~~L~~L~~~~~~~~~~~~~~~~l~~L~~l~l~~~~~~~~~~~~~~~~l~~l~~l~ls~n~l~~~~~~~~~~~~~L~~L 474 (635)
T 4g8a_A 395 GTISLKYLDLSFNGVITMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVL 474 (635)
T ss_dssp SCSCCCEEECCSCSEEEECSCCTTCTTCCEEECTTSEEESTTSSCTTTTCTTCCEEECTTSCCEECCTTTTTTCTTCCEE
T ss_pred hhhhhhhhhccccccccccccccccccccchhhhhccccccccccccccccccccccccccccccccccccccchhhhhh
Confidence 01123456778889999999999988875 8889999999
Q ss_pred eccCCcCCC-cCCC-CCCCCCcCEEEccCCcCCCccchhccCCCCCCeEeeecccCCCccchhhhcccccCccccceEec
Q 002158 283 DLSWNHLTG-SIPS-KKLSENVTTIDLSDNYLNGSILESISNLPFLQTLSLENNFLTGSIPATIWQNKSFSTKARLKIDL 360 (958)
Q Consensus 283 ~Ls~N~l~~-~~~~-~~~~~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~ip~~l~~~~~~~~~~l~~L~L 360 (958)
+|++|.+.. .+|. ...+++|++|+|++|+|++..|..|.++++|++|+|++|+|++..|..+..+ +.|+.|||
T Consensus 475 ~Ls~N~~~~~~~~~~~~~l~~L~~L~Ls~N~L~~l~~~~f~~l~~L~~L~Ls~N~l~~l~~~~~~~l-----~~L~~L~L 549 (635)
T 4g8a_A 475 KMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCL-----NSLQVLDY 549 (635)
T ss_dssp ECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCBCCCGGGTTC-----TTCCEEEC
T ss_pred hhhhcccccccCchhhhhccccCEEECCCCccCCcChHHHcCCCCCCEEECCCCcCCCCChhHHhCC-----CCCCEEEC
Confidence 999998643 3444 3556899999999999999999999999999999999999997767666544 45679999
Q ss_pred cCCCCCCCccCC--CC-CCcceEEeCCCCCCCCCCCCCCCcccccCCCCCccccccCCCCCCCCC
Q 002158 361 RNNSFSNIVGDL--TL-PNNVTLRLGGNPICTSANIPNTGRFCGSDAGGDETLTNSKVNCPVQAC 422 (958)
Q Consensus 361 s~N~l~~l~~~~--~l-~~L~~L~l~~N~l~~~~~~~~~~~~~~~~~~~~~~L~~n~~~C~c~~~ 422 (958)
++|+|+.++... .+ ++|+.|+|++|||.|+|++.|+..+........ .....+.|.-+..
T Consensus 550 s~N~l~~~~~~~l~~l~~~L~~L~L~~Np~~C~C~~~~~~~wl~~~~~~~--~~~~~~~C~~P~~ 612 (635)
T 4g8a_A 550 SLNHIMTSKKQELQHFPSSLAFLNLTQNDFACTCEHQSFLQWIKDQRQLL--VEVERMECATPSD 612 (635)
T ss_dssp TTSCCCBCCSSCTTCCCTTCCEEECTTCCBCCSGGGHHHHHHHHHTTTTB--SCGGGCBBCSSTT
T ss_pred CCCcCCCCCHHHHHhhhCcCCEEEeeCCCCcccCCcHHHHHHHHhCCCcc--CCCCCceeCCchH
Confidence 999999987664 55 689999999999999999988887765433222 2234566766543
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} | Back alignment and structure |
|---|
Probab=99.96 E-value=1.6e-28 Score=273.52 Aligned_cols=264 Identities=23% Similarity=0.284 Sum_probs=153.3
Q ss_pred CcceeeccCcccCCCCccccCCCCCcEEEeeCCCCCCCCChhhcCCCCCCEEecccccccccCccccccccccceEeccc
Q 002158 111 RLQYYFMWNDLTGTIPKEIGNISSLIFLLLNGNKLSGSLPDELGYLSNLNRLQVDENNITGTIPKSFANLSRVRHLHLNN 190 (958)
Q Consensus 111 ~L~~L~l~n~~~~~ip~~i~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~ 190 (958)
+|+.++++++....+|..+. ++|++|+|++|.+++..|..|.++++|++|+|++|++++..|..|.++++|++|+|++
T Consensus 34 ~l~~l~~~~~~l~~ip~~~~--~~l~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~ 111 (332)
T 2ft3_A 34 HLRVVQCSDLGLKAVPKEIS--PDTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKISKIHEKAFSPLRKLQKLYISK 111 (332)
T ss_dssp ETTEEECCSSCCSSCCSCCC--TTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECGGGSTTCTTCCEEECCS
T ss_pred cCCEEECCCCCccccCCCCC--CCCeEEECCCCcCCccCHhHhhCCCCCcEEECCCCccCccCHhHhhCcCCCCEEECCC
Confidence 45555565555555665543 4566666666666655555566666666666666666655566666666666666666
Q ss_pred ccccccCchhhcCCccchhhhccCCccccCCCcccCCCCCccEEEccCCCCCC-CCccccccCCCCCCEEEcccCCCCCC
Q 002158 191 NSIGGQIPSELSKLSTLIHLLVDNNNLSGNLPPELSELPQLCILQLDNNNFSA-SEIPATYGNFSKLVKLSLRNCNLQGA 269 (958)
Q Consensus 191 N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~-~~~p~~~~~l~~L~~L~L~~N~l~~~ 269 (958)
|.++ .+|..+. ++|++|++++|++++..+..|..+++|++|++++|.++. ...+..+..+ +|+.|++++|++++.
T Consensus 112 n~l~-~l~~~~~--~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l-~L~~L~l~~n~l~~l 187 (332)
T 2ft3_A 112 NHLV-EIPPNLP--SSLVELRIHDNRIRKVPKGVFSGLRNMNCIEMGGNPLENSGFEPGAFDGL-KLNYLRISEAKLTGI 187 (332)
T ss_dssp SCCC-SCCSSCC--TTCCEEECCSSCCCCCCSGGGSSCSSCCEEECCSCCCBGGGSCTTSSCSC-CCSCCBCCSSBCSSC
T ss_pred CcCC-ccCcccc--ccCCEEECCCCccCccCHhHhCCCccCCEEECCCCccccCCCCcccccCC-ccCEEECcCCCCCcc
Confidence 6666 3443333 566666666666665555556666666666666666642 1334455555 666666666666655
Q ss_pred CCCCCCCCCcCEEeccCCcCCCcCCC-CCCCCCcCEEEccCCcCCCccchhccCCCCCCeEeeecccCCCccchhhhccc
Q 002158 270 VPDLSRIPNLYYLDLSWNHLTGSIPS-KKLSENVTTIDLSDNYLNGSILESISNLPFLQTLSLENNFLTGSIPATIWQNK 348 (958)
Q Consensus 270 ~~~l~~l~~L~~L~Ls~N~l~~~~~~-~~~~~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~ip~~l~~~~ 348 (958)
+..+. ++|++|+|++|.+++..+. ...+++|+.|+|++|++++..+..|..+++|++|+|++|+|+ .+|..+..+
T Consensus 188 ~~~~~--~~L~~L~l~~n~i~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~-~lp~~l~~l- 263 (332)
T 2ft3_A 188 PKDLP--ETLNELHLDHNKIQAIELEDLLRYSKLYRLGLGHNQIRMIENGSLSFLPTLRELHLDNNKLS-RVPAGLPDL- 263 (332)
T ss_dssp CSSSC--SSCSCCBCCSSCCCCCCTTSSTTCTTCSCCBCCSSCCCCCCTTGGGGCTTCCEEECCSSCCC-BCCTTGGGC-
T ss_pred Ccccc--CCCCEEECCCCcCCccCHHHhcCCCCCCEEECCCCcCCcCChhHhhCCCCCCEEECCCCcCe-ecChhhhcC-
Confidence 44433 4666666666666644332 234456666666666666666666666666666666666666 555554433
Q ss_pred ccCccccceEeccCCCCCCCccCC--------CCCCcceEEeCCCCCC
Q 002158 349 SFSTKARLKIDLRNNSFSNIVGDL--------TLPNNVTLRLGGNPIC 388 (958)
Q Consensus 349 ~~~~~~l~~L~Ls~N~l~~l~~~~--------~l~~L~~L~l~~N~l~ 388 (958)
+.|+.|++++|+|++++... ..+.|+.|++.+||+.
T Consensus 264 ----~~L~~L~l~~N~l~~~~~~~~~~~~~~~~~~~l~~L~l~~N~~~ 307 (332)
T 2ft3_A 264 ----KLLQVVYLHTNNITKVGVNDFCPVGFGVKRAYYNGISLFNNPVP 307 (332)
T ss_dssp ----TTCCEEECCSSCCCBCCTTSSSCSSCCSSSCCBSEEECCSSSSC
T ss_pred ----ccCCEEECCCCCCCccChhHccccccccccccccceEeecCccc
Confidence 23446666666666655432 1345566666666664
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} | Back alignment and structure |
|---|
Probab=99.96 E-value=5.3e-28 Score=270.98 Aligned_cols=299 Identities=21% Similarity=0.301 Sum_probs=251.0
Q ss_pred eeEEEEccCCcCCCCccccccCCCCcceeeccCcccCCCCccccCCCCCcEEEeeCCCCCCCCChhhcCCCCCCEEeccc
Q 002158 87 HVRELQLLSMNLSGNLAPELGQLSRLQYYFMWNDLTGTIPKEIGNISSLIFLLLNGNKLSGSLPDELGYLSNLNRLQVDE 166 (958)
Q Consensus 87 ~v~~L~L~~~~l~~~~~~~l~~L~~L~~L~l~n~~~~~ip~~i~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~L~~ 166 (958)
+++.|++.++.+... +.+..+++|++|++++|....+|. +.++++|++|+|++|.+++ +| .+..+++|++|++++
T Consensus 45 ~L~~L~l~~~~i~~~--~~~~~~~~L~~L~l~~n~i~~~~~-~~~l~~L~~L~L~~n~i~~-~~-~~~~l~~L~~L~l~~ 119 (347)
T 4fmz_A 45 SITKLVVAGEKVASI--QGIEYLTNLEYLNLNGNQITDISP-LSNLVKLTNLYIGTNKITD-IS-ALQNLTNLRELYLNE 119 (347)
T ss_dssp TCSEEECCSSCCCCC--TTGGGCTTCCEEECCSSCCCCCGG-GTTCTTCCEEECCSSCCCC-CG-GGTTCTTCSEEECTT
T ss_pred cccEEEEeCCccccc--hhhhhcCCccEEEccCCccccchh-hhcCCcCCEEEccCCcccC-ch-HHcCCCcCCEEECcC
Confidence 689999999998764 348999999999999888888877 9999999999999999984 54 699999999999999
Q ss_pred ccccccCccccccccccceEecccccccccCchhhcCCccchhhhccCCccccCCCcccCCCCCccEEEccCCCCCCCCc
Q 002158 167 NNITGTIPKSFANLSRVRHLHLNNNSIGGQIPSELSKLSTLIHLLVDNNNLSGNLPPELSELPQLCILQLDNNNFSASEI 246 (958)
Q Consensus 167 N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~ 246 (958)
|++++. +. +..+++|+.|++++|.....++ .+..+++|++|++++|.+.+..+ +..+++|++|++++|.++. +
T Consensus 120 n~i~~~-~~-~~~l~~L~~L~l~~n~~~~~~~-~~~~l~~L~~L~l~~~~~~~~~~--~~~l~~L~~L~l~~n~l~~--~ 192 (347)
T 4fmz_A 120 DNISDI-SP-LANLTKMYSLNLGANHNLSDLS-PLSNMTGLNYLTVTESKVKDVTP--IANLTDLYSLSLNYNQIED--I 192 (347)
T ss_dssp SCCCCC-GG-GTTCTTCCEEECTTCTTCCCCG-GGTTCTTCCEEECCSSCCCCCGG--GGGCTTCSEEECTTSCCCC--C
T ss_pred CcccCc-hh-hccCCceeEEECCCCCCccccc-chhhCCCCcEEEecCCCcCCchh--hccCCCCCEEEccCCcccc--c
Confidence 999954 33 8999999999999997664554 49999999999999999986544 8899999999999999963 3
Q ss_pred cccccCCCCCCEEEcccCCCCCCCCCCCCCCCcCEEeccCCcCCCcCCCCCCCCCcCEEEccCCcCCCccchhccCCCCC
Q 002158 247 PATYGNFSKLVKLSLRNCNLQGAVPDLSRIPNLYYLDLSWNHLTGSIPSKKLSENVTTIDLSDNYLNGSILESISNLPFL 326 (958)
Q Consensus 247 p~~~~~l~~L~~L~L~~N~l~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~~~L~~L~Ls~N~l~~~~~~~~~~l~~L 326 (958)
+. +..+++|+.|++++|.+++..+ +..+++|+.|+|++|.+++..+ ...+++|++|+|++|.+++. ..+..+++|
T Consensus 193 ~~-~~~l~~L~~L~l~~n~l~~~~~-~~~~~~L~~L~l~~n~l~~~~~-~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L 267 (347)
T 4fmz_A 193 SP-LASLTSLHYFTAYVNQITDITP-VANMTRLNSLKIGNNKITDLSP-LANLSQLTWLEIGTNQISDI--NAVKDLTKL 267 (347)
T ss_dssp GG-GGGCTTCCEEECCSSCCCCCGG-GGGCTTCCEEECCSSCCCCCGG-GTTCTTCCEEECCSSCCCCC--GGGTTCTTC
T ss_pred cc-ccCCCccceeecccCCCCCCch-hhcCCcCCEEEccCCccCCCcc-hhcCCCCCEEECCCCccCCC--hhHhcCCCc
Confidence 44 8899999999999999997765 8889999999999999985444 67779999999999999875 579999999
Q ss_pred CeEeeecccCCCccchhhhcccccCccccceEeccCCCCCCCccCC--CCCCcceEEeCCCCCCCCCCCCCCCcccccCC
Q 002158 327 QTLSLENNFLTGSIPATIWQNKSFSTKARLKIDLRNNSFSNIVGDL--TLPNNVTLRLGGNPICTSANIPNTGRFCGSDA 404 (958)
Q Consensus 327 ~~L~L~~N~l~~~ip~~l~~~~~~~~~~l~~L~Ls~N~l~~l~~~~--~l~~L~~L~l~~N~l~~~~~~~~~~~~~~~~~ 404 (958)
++|++++|++++ +| .+.. .+.++.|++++|+++...... .+++|+.|++++|++..... +.....
T Consensus 268 ~~L~l~~n~l~~-~~-~~~~-----l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~------~~~l~~ 334 (347)
T 4fmz_A 268 KMLNVGSNQISD-IS-VLNN-----LSQLNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNHITDIRP------LASLSK 334 (347)
T ss_dssp CEEECCSSCCCC-CG-GGGG-----CTTCSEEECCSSCCCGGGHHHHHTCTTCSEEECCSSSCCCCGG------GGGCTT
T ss_pred CEEEccCCccCC-Ch-hhcC-----CCCCCEEECcCCcCCCcChhHhhccccCCEEEccCCccccccC------hhhhhc
Confidence 999999999995 33 2332 356789999999999876553 89999999999999976432 333445
Q ss_pred CCCccccccCC
Q 002158 405 GGDETLTNSKV 415 (958)
Q Consensus 405 ~~~~~L~~n~~ 415 (958)
.+.+.+.+|++
T Consensus 335 L~~L~l~~N~i 345 (347)
T 4fmz_A 335 MDSADFANQVI 345 (347)
T ss_dssp CSEESSSCC--
T ss_pred cceeehhhhcc
Confidence 56677777764
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.96 E-value=1.3e-27 Score=277.16 Aligned_cols=232 Identities=22% Similarity=0.220 Sum_probs=143.8
Q ss_pred eeEEEEccCCcCCCCccccccCCCCcceeeccCcccCCCCccccCCCCCcEEEeeCCCCCCCCChhhcCCCCCCEEeccc
Q 002158 87 HVRELQLLSMNLSGNLAPELGQLSRLQYYFMWNDLTGTIPKEIGNISSLIFLLLNGNKLSGSLPDELGYLSNLNRLQVDE 166 (958)
Q Consensus 87 ~v~~L~L~~~~l~~~~~~~l~~L~~L~~L~l~n~~~~~ip~~i~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~L~~ 166 (958)
+++.|+++++++++. | .++.+++|++|++++|....+| ++++++|++|+|++|.+++. + ++++++|++|++++
T Consensus 43 ~L~~L~Ls~n~l~~~-~-~l~~l~~L~~L~Ls~n~l~~~~--~~~l~~L~~L~Ls~N~l~~~-~--~~~l~~L~~L~L~~ 115 (457)
T 3bz5_A 43 TLTSLDCHNSSITDM-T-GIEKLTGLTKLICTSNNITTLD--LSQNTNLTYLACDSNKLTNL-D--VTPLTKLTYLNCDT 115 (457)
T ss_dssp TCCEEECCSSCCCCC-T-TGGGCTTCSEEECCSSCCSCCC--CTTCTTCSEEECCSSCCSCC-C--CTTCTTCCEEECCS
T ss_pred CCCEEEccCCCcccC-h-hhcccCCCCEEEccCCcCCeEc--cccCCCCCEEECcCCCCcee-e--cCCCCcCCEEECCC
Confidence 466777777777664 3 5677777777777666555554 66777777777777777643 3 66777777777777
Q ss_pred ccccccCccccccccccceEecccccccccCchhhcCCccchhhhccCCccccCCCcccCCCCCccEEEccCCCCCCCCc
Q 002158 167 NNITGTIPKSFANLSRVRHLHLNNNSIGGQIPSELSKLSTLIHLLVDNNNLSGNLPPELSELPQLCILQLDNNNFSASEI 246 (958)
Q Consensus 167 N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~ 246 (958)
|++++. + +..+++|++|++++|++++ ++ ++.+++|++|++++|+..+.+ .+..+++|++|++++|+++. +
T Consensus 116 N~l~~l-~--~~~l~~L~~L~l~~N~l~~-l~--l~~l~~L~~L~l~~n~~~~~~--~~~~l~~L~~L~ls~n~l~~--l 185 (457)
T 3bz5_A 116 NKLTKL-D--VSQNPLLTYLNCARNTLTE-ID--VSHNTQLTELDCHLNKKITKL--DVTPQTQLTTLDCSFNKITE--L 185 (457)
T ss_dssp SCCSCC-C--CTTCTTCCEEECTTSCCSC-CC--CTTCTTCCEEECTTCSCCCCC--CCTTCTTCCEEECCSSCCCC--C
T ss_pred CcCCee-c--CCCCCcCCEEECCCCccce-ec--cccCCcCCEEECCCCCccccc--ccccCCcCCEEECCCCccce--e
Confidence 777653 3 6667777777777777775 32 566666777777666444333 35666666666666666653 3
Q ss_pred cccccCCCCCCEEEcccCCCCCCCCCCCCCCCcCEEeccCCcCCCcCCCCCCCCCcCEEEccCCcCCCccchhccCCC--
Q 002158 247 PATYGNFSKLVKLSLRNCNLQGAVPDLSRIPNLYYLDLSWNHLTGSIPSKKLSENVTTIDLSDNYLNGSILESISNLP-- 324 (958)
Q Consensus 247 p~~~~~l~~L~~L~L~~N~l~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~~~L~~L~Ls~N~l~~~~~~~~~~l~-- 324 (958)
| +..+++|+.|++++|++++. .+..+++|++|+|++|++++ +| ...+++|+.|+|++|++++..+..+..+.
T Consensus 186 ~--l~~l~~L~~L~l~~N~l~~~--~l~~l~~L~~L~Ls~N~l~~-ip-~~~l~~L~~L~l~~N~l~~~~~~~l~~L~~L 259 (457)
T 3bz5_A 186 D--VSQNKLLNRLNCDTNNITKL--DLNQNIQLTFLDCSSNKLTE-ID-VTPLTQLTYFDCSVNPLTELDVSTLSKLTTL 259 (457)
T ss_dssp C--CTTCTTCCEEECCSSCCSCC--CCTTCTTCSEEECCSSCCSC-CC-CTTCTTCSEEECCSSCCSCCCCTTCTTCCEE
T ss_pred c--cccCCCCCEEECcCCcCCee--ccccCCCCCEEECcCCcccc-cC-ccccCCCCEEEeeCCcCCCcCHHHCCCCCEE
Confidence 3 55666666666666666654 35666666666666666664 34 44456666666666666665544444433
Q ss_pred -----CCCeEeeecccCCCccc
Q 002158 325 -----FLQTLSLENNFLTGSIP 341 (958)
Q Consensus 325 -----~L~~L~L~~N~l~~~ip 341 (958)
+|+.|++++|.+.+.+|
T Consensus 260 ~l~~n~L~~L~l~~n~~~~~~~ 281 (457)
T 3bz5_A 260 HCIQTDLLEIDLTHNTQLIYFQ 281 (457)
T ss_dssp ECTTCCCSCCCCTTCTTCCEEE
T ss_pred eccCCCCCEEECCCCccCCccc
Confidence 33444444444444443
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A | Back alignment and structure |
|---|
Probab=99.95 E-value=4.4e-27 Score=274.47 Aligned_cols=277 Identities=27% Similarity=0.347 Sum_probs=187.1
Q ss_pred eeeEEEEccCCcCCCCccccccCCCCcceeeccCcccCCCCccccCCCCCcEEEeeCCCCCCCCChhhcCCCCCCEEecc
Q 002158 86 LHVRELQLLSMNLSGNLAPELGQLSRLQYYFMWNDLTGTIPKEIGNISSLIFLLLNGNKLSGSLPDELGYLSNLNRLQVD 165 (958)
Q Consensus 86 ~~v~~L~L~~~~l~~~~~~~l~~L~~L~~L~l~n~~~~~ip~~i~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~L~ 165 (958)
.+++.|++.++++.. ++ .+..+++|++|++++|....+|. +.++++|++|+|++|.+++..+ ++++++|++|+++
T Consensus 46 ~~l~~L~l~~~~i~~-l~-~~~~l~~L~~L~Ls~n~l~~~~~-~~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~L~ 120 (466)
T 1o6v_A 46 DQVTTLQADRLGIKS-ID-GVEYLNNLTQINFSNNQLTDITP-LKNLTKLVDILMNNNQIADITP--LANLTNLTGLTLF 120 (466)
T ss_dssp HTCCEEECCSSCCCC-CT-TGGGCTTCCEEECCSSCCCCCGG-GTTCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECC
T ss_pred ccccEEecCCCCCcc-Cc-chhhhcCCCEEECCCCccCCchh-hhccccCCEEECCCCccccChh--hcCCCCCCEEECC
Confidence 368999999998876 33 58899999999999888888877 9999999999999999995544 9999999999999
Q ss_pred cccccccCccccccccccceEecccccccccCchhhcCCccchhhhccCCccccCCCcccCCCCCccEEEccCCCCCCCC
Q 002158 166 ENNITGTIPKSFANLSRVRHLHLNNNSIGGQIPSELSKLSTLIHLLVDNNNLSGNLPPELSELPQLCILQLDNNNFSASE 245 (958)
Q Consensus 166 ~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~ 245 (958)
+|++++..+ +.++++|++|+|++|.+++ ++ .+..+++|+.|+++ |.+.+.. .+..+++|++|++++|.++.
T Consensus 121 ~n~l~~~~~--~~~l~~L~~L~l~~n~l~~-~~-~~~~l~~L~~L~l~-~~~~~~~--~~~~l~~L~~L~l~~n~l~~-- 191 (466)
T 1o6v_A 121 NNQITDIDP--LKNLTNLNRLELSSNTISD-IS-ALSGLTSLQQLSFG-NQVTDLK--PLANLTTLERLDISSNKVSD-- 191 (466)
T ss_dssp SSCCCCCGG--GTTCTTCSEEEEEEEEECC-CG-GGTTCTTCSEEEEE-ESCCCCG--GGTTCTTCCEEECCSSCCCC--
T ss_pred CCCCCCChH--HcCCCCCCEEECCCCccCC-Ch-hhccCCcccEeecC-CcccCch--hhccCCCCCEEECcCCcCCC--
Confidence 999996543 9999999999999999985 43 36666666666664 3443322 26666666666666666642
Q ss_pred ccccccCCCCCCEEEcccCCCCCCCCCCCCCCCcCEEeccCCcCCCcCCCCCCCCCcCEEEccCCcCCCccchhccCCCC
Q 002158 246 IPATYGNFSKLVKLSLRNCNLQGAVPDLSRIPNLYYLDLSWNHLTGSIPSKKLSENVTTIDLSDNYLNGSILESISNLPF 325 (958)
Q Consensus 246 ~p~~~~~l~~L~~L~L~~N~l~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~~~L~~L~Ls~N~l~~~~~~~~~~l~~ 325 (958)
+ ..+..+++|+.|++++|.+++..+ +..+++|+.|++++|.+++ ++....+++|+.|+|++|.+++..+ +..+++
T Consensus 192 ~-~~l~~l~~L~~L~l~~n~l~~~~~-~~~l~~L~~L~l~~n~l~~-~~~l~~l~~L~~L~l~~n~l~~~~~--~~~l~~ 266 (466)
T 1o6v_A 192 I-SVLAKLTNLESLIATNNQISDITP-LGILTNLDELSLNGNQLKD-IGTLASLTNLTDLDLANNQISNLAP--LSGLTK 266 (466)
T ss_dssp C-GGGGGCTTCSEEECCSSCCCCCGG-GGGCTTCCEEECCSSCCCC-CGGGGGCTTCSEEECCSSCCCCCGG--GTTCTT
T ss_pred C-hhhccCCCCCEEEecCCccccccc-ccccCCCCEEECCCCCccc-chhhhcCCCCCEEECCCCccccchh--hhcCCC
Confidence 2 235566666666666666665443 4555666666666666652 3344445566666666666655443 555666
Q ss_pred CCeEeeecccCCCccchhhhcccccCccccceEeccCCCCCCCccCCCCCCcceEEeCCCCCC
Q 002158 326 LQTLSLENNFLTGSIPATIWQNKSFSTKARLKIDLRNNSFSNIVGDLTLPNNVTLRLGGNPIC 388 (958)
Q Consensus 326 L~~L~L~~N~l~~~ip~~l~~~~~~~~~~l~~L~Ls~N~l~~l~~~~~l~~L~~L~l~~N~l~ 388 (958)
|+.|+|++|.+++..| +.. .+.|+.|+|++|++++++....+++|+.|++++|++.
T Consensus 267 L~~L~l~~n~l~~~~~--~~~-----l~~L~~L~L~~n~l~~~~~~~~l~~L~~L~L~~n~l~ 322 (466)
T 1o6v_A 267 LTELKLGANQISNISP--LAG-----LTALTNLELNENQLEDISPISNLKNLTYLTLYFNNIS 322 (466)
T ss_dssp CSEEECCSSCCCCCGG--GTT-----CTTCSEEECCSSCCSCCGGGGGCTTCSEEECCSSCCS
T ss_pred CCEEECCCCccCcccc--ccC-----CCccCeEEcCCCcccCchhhcCCCCCCEEECcCCcCC
Confidence 6666666666654322 221 2344455555555555554345555555555555554
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=9.3e-28 Score=261.12 Aligned_cols=253 Identities=22% Similarity=0.242 Sum_probs=174.5
Q ss_pred cEEEeeCCCCCCCCChhhcCCCCCCEEecccccccccCccccccccccceEecccccccccCchhhcCCccchhhhccCC
Q 002158 136 IFLLLNGNKLSGSLPDELGYLSNLNRLQVDENNITGTIPKSFANLSRVRHLHLNNNSIGGQIPSELSKLSTLIHLLVDNN 215 (958)
Q Consensus 136 ~~L~Ls~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N 215 (958)
+.++++++.++ .+|..+ .++|++|+|++|++++..+..|..+++|++|+|++|.+++..|..|.++++|++|++++|
T Consensus 14 ~~~~c~~~~l~-~ip~~~--~~~l~~L~l~~n~i~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n 90 (285)
T 1ozn_A 14 VTTSCPQQGLQ-AVPVGI--PAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDN 90 (285)
T ss_dssp CEEECCSSCCS-SCCTTC--CTTCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSC
T ss_pred eEEEcCcCCcc-cCCcCC--CCCceEEEeeCCcCCccCHHHcccCCCCCEEECCCCccceeCHhhcCCccCCCEEeCCCC
Confidence 45666666666 455433 356667777777666555566666677777777777766666666666777777777777
Q ss_pred c-cccCCCcccCCCCCccEEEccCCCCCCCCccccccCCCCCCEEEcccCCCCCCCCC-CCCCCCcCEEeccCCcCCCcC
Q 002158 216 N-LSGNLPPELSELPQLCILQLDNNNFSASEIPATYGNFSKLVKLSLRNCNLQGAVPD-LSRIPNLYYLDLSWNHLTGSI 293 (958)
Q Consensus 216 ~-l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~-l~~l~~L~~L~Ls~N~l~~~~ 293 (958)
+ +....+..+..+++|++|+|++|+++ ...+..+.++++|++|+|++|++++.++. +..+++|++|+|++|++++..
T Consensus 91 ~~l~~~~~~~~~~l~~L~~L~l~~n~l~-~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~ 169 (285)
T 1ozn_A 91 AQLRSVDPATFHGLGRLHTLHLDRCGLQ-ELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVP 169 (285)
T ss_dssp TTCCCCCTTTTTTCTTCCEEECTTSCCC-CCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCEEC
T ss_pred CCccccCHHHhcCCcCCCEEECCCCcCC-EECHhHhhCCcCCCEEECCCCcccccCHhHhccCCCccEEECCCCcccccC
Confidence 5 66555666777777777777777775 23355667777777777777777766654 677777777777777777444
Q ss_pred CC-CCCCCCcCEEEccCCcCCCccchhccCCCCCCeEeeecccCCCccchhhhcccccCccccceEeccCCCCCCCccCC
Q 002158 294 PS-KKLSENVTTIDLSDNYLNGSILESISNLPFLQTLSLENNFLTGSIPATIWQNKSFSTKARLKIDLRNNSFSNIVGDL 372 (958)
Q Consensus 294 ~~-~~~~~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~ip~~l~~~~~~~~~~l~~L~Ls~N~l~~l~~~~ 372 (958)
+. ...+++|++|+|++|.+++..+..|..+++|+.|+|++|++++..+..+.
T Consensus 170 ~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~--------------------------- 222 (285)
T 1ozn_A 170 ERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALA--------------------------- 222 (285)
T ss_dssp TTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCHHHHT---------------------------
T ss_pred HHHhcCccccCEEECCCCcccccCHhHccCcccccEeeCCCCcCCcCCHHHcc---------------------------
Confidence 33 34457777777777777777777888888888888888888753333331
Q ss_pred CCCCcceEEeCCCCCCCCCCCCCCCcccccCCCCCccccccCCCCCCCCCCCCCcccccCCCCCCceeeeeceee
Q 002158 373 TLPNNVTLRLGGNPICTSANIPNTGRFCGSDAGGDETLTNSKVNCPVQACPVDNFFEYVPASPEPCFCAAPLRIG 447 (958)
Q Consensus 373 ~l~~L~~L~l~~N~l~~~~~~~~~~~~~~~~~~~~~~L~~n~~~C~c~~~~~~~~~~~~~~~~~~~~c~sp~~~~ 447 (958)
.+++|+.|++++||| .|+|+..++..|++..........|..|...+
T Consensus 223 ~l~~L~~L~l~~N~~----------------------------~c~~~~~~~~~~l~~~~~~~~~~~c~~p~~l~ 269 (285)
T 1ozn_A 223 PLRALQYLRLNDNPW----------------------------VCDCRARPLWAWLQKFRGSSSEVPCSLPQRLA 269 (285)
T ss_dssp TCTTCCEEECCSSCE----------------------------ECSGGGHHHHHHHHHCCSEECCCBEEESGGGT
T ss_pred cCcccCEEeccCCCc----------------------------cCCCCcHHHHHHHHhcccccCccccCCchHhC
Confidence 456777888888877 67888888888988877777778899997643
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A | Back alignment and structure |
|---|
Probab=99.95 E-value=3.3e-27 Score=274.44 Aligned_cols=203 Identities=22% Similarity=0.247 Sum_probs=102.8
Q ss_pred CCcEEEeeCCCCCCCCChhhcCCCCCCEEecccccccccCccccccccccceEecccccccccCchhhcCCccchhhhcc
Q 002158 134 SLIFLLLNGNKLSGSLPDELGYLSNLNRLQVDENNITGTIPKSFANLSRVRHLHLNNNSIGGQIPSELSKLSTLIHLLVD 213 (958)
Q Consensus 134 ~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~ 213 (958)
+|++|+|++|++++..|..|.++++|++|+|++|++++..+..|.++++|++|+|++|+|++..+..|..+++|++|+|+
T Consensus 76 ~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~ 155 (452)
T 3zyi_A 76 NTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSIRQIEVGAFNGLASLNTLELFDNWLTVIPSGAFEYLSKLRELWLR 155 (452)
T ss_dssp TCSEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSBCCTTTSSSCTTCCEEECC
T ss_pred CccEEECcCCcCceECHHHcCCCCCCCEEECCCCccCCcChhhccCcccCCEEECCCCcCCccChhhhcccCCCCEEECC
Confidence 44555555555554444455555555555555555554444555555555555555555554444445555555555555
Q ss_pred CCccccCCCcccCCCCCccEEEccCCCCCCCCccccccCCCCCCEEEcccCCCCCCCCCCCCCCCcCEEeccCCcCCCcC
Q 002158 214 NNNLSGNLPPELSELPQLCILQLDNNNFSASEIPATYGNFSKLVKLSLRNCNLQGAVPDLSRIPNLYYLDLSWNHLTGSI 293 (958)
Q Consensus 214 ~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~l~~l~~L~~L~Ls~N~l~~~~ 293 (958)
+|+|+...+..|..+++|++|+|++|+......+..|.++++|+.|+|++|++++. +.+..+++|+.|+|++|.+++..
T Consensus 156 ~N~l~~~~~~~~~~l~~L~~L~l~~~~~l~~i~~~~~~~l~~L~~L~L~~n~l~~~-~~~~~l~~L~~L~Ls~N~l~~~~ 234 (452)
T 3zyi_A 156 NNPIESIPSYAFNRVPSLMRLDLGELKKLEYISEGAFEGLFNLKYLNLGMCNIKDM-PNLTPLVGLEELEMSGNHFPEIR 234 (452)
T ss_dssp SCCCCEECTTTTTTCTTCCEEECCCCTTCCEECTTTTTTCTTCCEEECTTSCCSSC-CCCTTCTTCCEEECTTSCCSEEC
T ss_pred CCCcceeCHhHHhcCCcccEEeCCCCCCccccChhhccCCCCCCEEECCCCccccc-ccccccccccEEECcCCcCcccC
Confidence 55555444445555555555555553222111122455555555555555555543 33455555555555555555433
Q ss_pred CCC-CCCCCcCEEEccCCcCCCccchhccCCCCCCeEeeecccCC
Q 002158 294 PSK-KLSENVTTIDLSDNYLNGSILESISNLPFLQTLSLENNFLT 337 (958)
Q Consensus 294 ~~~-~~~~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~ 337 (958)
+.. ..+++|+.|+|++|+|++..+..|.++++|+.|+|++|+|+
T Consensus 235 ~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~ 279 (452)
T 3zyi_A 235 PGSFHGLSSLKKLWVMNSQVSLIERNAFDGLASLVELNLAHNNLS 279 (452)
T ss_dssp GGGGTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCS
T ss_pred cccccCccCCCEEEeCCCcCceECHHHhcCCCCCCEEECCCCcCC
Confidence 322 33455555555555555555555555555555555555555
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=1.6e-28 Score=291.26 Aligned_cols=183 Identities=17% Similarity=0.111 Sum_probs=128.6
Q ss_pred eeeeCCeEEEEEEEC-CCcEEEEEEeccCC----------hhcHHHHHHHHHHHHcc-CCCCcceEEEEEEeCCeEEEEE
Q 002158 633 VGQGGYGKVYKGILS-DNTTVAIKRAEEGS----------LQGQNEFLTEIKLLSRL-HHRNLVSLLGYCDEEGEQMLVY 700 (958)
Q Consensus 633 lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~----------~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lV~ 700 (958)
.+.|++|.+..++.. -|+.||||++.... ....++|.+|+++|+++ .|+||+++++++++++..||||
T Consensus 242 ~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLVM 321 (569)
T 4azs_A 242 PYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLVM 321 (569)
T ss_dssp -C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEEE
T ss_pred cccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEEE
Confidence 456667666655432 58889999986532 12235699999999999 7999999999999999999999
Q ss_pred EecCCCCHHHHhccCCCCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEecCCCCeEEeeeeeecccccCC
Q 002158 701 EFVPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSRLAPVLD 780 (958)
Q Consensus 701 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~ 780 (958)
||++|++|.++|.... +++.. +|+.||++||+|+|++| ||||||||+|||++++|.+||+|||+|+......
T Consensus 322 Eyv~G~~L~d~i~~~~--~l~~~---~I~~QIl~AL~ylH~~G---IIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~~~ 393 (569)
T 4azs_A 322 EKLPGRLLSDMLAAGE--EIDRE---KILGSLLRSLAALEKQG---FWHDDVRPWNVMVDARQHARLIDFGSIVTTPQDC 393 (569)
T ss_dssp ECCCSEEHHHHHHTTC--CCCHH---HHHHHHHHHHHHHHHTT---CEESCCCGGGEEECTTSCEEECCCTTEESCC---
T ss_pred ecCCCCcHHHHHHhCC--CCCHH---HHHHHHHHHHHHHHHCC---ceeccCchHhEEECCCCCEEEeecccCeeCCCCC
Confidence 9999999999997654 35544 58899999999999999 9999999999999999999999999998653211
Q ss_pred CCCCccceeeeeccCCCCccChhhhccCCCCCcchhhhHHHHHHHHHhCCC
Q 002158 781 DEGTMPTHVSTIVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVLLELLTGMQ 831 (958)
Q Consensus 781 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gv~l~elltG~~ 831 (958)
.......||++|||||++.+ .+..++|+||+|++++++.++..
T Consensus 394 -------~~~~t~vGTp~YmAPE~l~g-~~~~~~d~~s~g~~~~~l~~~~~ 436 (569)
T 4azs_A 394 -------SWPTNLVQSFFVFVNELFAE-NKSWNGFWRSAPVHPFNLPQPWS 436 (569)
T ss_dssp -------CCSHHHHHHHHHHHHHHC------------------CCCCTTHH
T ss_pred -------ccccCceechhhccHHHhCC-CCCCcccccccccchhhhccccc
Confidence 12234679999999999865 46778999999999887766543
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} | Back alignment and structure |
|---|
Probab=99.95 E-value=4.1e-27 Score=280.99 Aligned_cols=287 Identities=24% Similarity=0.284 Sum_probs=232.3
Q ss_pred cccCCCCCCCCCCCCCCceeeCccccCC-CceeeEEEEccCCcCCCCccccccCCCCcceeeccCcccCCCCccccCCCC
Q 002158 56 NHLRNWNKGDPCMSNWTGVLCFDTVETD-GHLHVRELQLLSMNLSGNLAPELGQLSRLQYYFMWNDLTGTIPKEIGNISS 134 (958)
Q Consensus 56 ~~l~~W~~~~~c~~~w~gV~C~~~~~~~-~~~~v~~L~L~~~~l~~~~~~~l~~L~~L~~L~l~n~~~~~ip~~i~~l~~ 134 (958)
..++.|....+|| .|+|..|.-..... ....++.|++++++++ .+|..+. ++|+.|++++|....+|. .+++
T Consensus 10 ~~w~~W~~~~~~~-~~~~r~~~~~~~~~c~~~~l~~L~ls~n~L~-~lp~~l~--~~L~~L~L~~N~l~~lp~---~l~~ 82 (622)
T 3g06_A 10 AVWSAWRRAAPAE-ESRGRAAVVQKMRACLNNGNAVLNVGESGLT-TLPDCLP--AHITTLVIPDNNLTSLPA---LPPE 82 (622)
T ss_dssp CHHHHHHHTCCGG-GHHHHHHHHHHHHHHHHHCCCEEECCSSCCS-CCCSCCC--TTCSEEEECSCCCSCCCC---CCTT
T ss_pred HHHHHHHhcCCcc-hhccccccCcccccccCCCCcEEEecCCCcC-ccChhhC--CCCcEEEecCCCCCCCCC---cCCC
Confidence 3456787666654 78765432100000 0124889999999998 6777666 899999999888888988 6789
Q ss_pred CcEEEeeCCCCCCCCChhhcCCCCCCEEecccccccccCccccccccccceEecccccccccCchhhcCCccchhhhccC
Q 002158 135 LIFLLLNGNKLSGSLPDELGYLSNLNRLQVDENNITGTIPKSFANLSRVRHLHLNNNSIGGQIPSELSKLSTLIHLLVDN 214 (958)
Q Consensus 135 L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~ 214 (958)
|++|+|++|.++ .+|. .+++|++|+|++|++++ +|. .+++|+.|+|++|+|++ +|.. +++|++|+|++
T Consensus 83 L~~L~Ls~N~l~-~lp~---~l~~L~~L~Ls~N~l~~-l~~---~l~~L~~L~L~~N~l~~-lp~~---l~~L~~L~Ls~ 150 (622)
T 3g06_A 83 LRTLEVSGNQLT-SLPV---LPPGLLELSIFSNPLTH-LPA---LPSGLCKLWIFGNQLTS-LPVL---PPGLQELSVSD 150 (622)
T ss_dssp CCEEEECSCCCS-CCCC---CCTTCCEEEECSCCCCC-CCC---CCTTCCEEECCSSCCSC-CCCC---CTTCCEEECCS
T ss_pred CCEEEcCCCcCC-cCCC---CCCCCCEEECcCCcCCC-CCC---CCCCcCEEECCCCCCCc-CCCC---CCCCCEEECcC
Confidence 999999999999 5776 78999999999999995 454 57899999999999994 6653 48999999999
Q ss_pred CccccCCCcccCCCCCccEEEccCCCCCCCCccccccCCCCCCEEEcccCCCCCCCCCCCCCCCcCEEeccCCcCCCcCC
Q 002158 215 NNLSGNLPPELSELPQLCILQLDNNNFSASEIPATYGNFSKLVKLSLRNCNLQGAVPDLSRIPNLYYLDLSWNHLTGSIP 294 (958)
Q Consensus 215 N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~l~~l~~L~~L~Ls~N~l~~~~~ 294 (958)
|++++. |. .+++|+.|++++|.++. +| ..+++|+.|+|++|+|++++.. +++|+.|++++|.++ .+|
T Consensus 151 N~l~~l-~~---~~~~L~~L~L~~N~l~~--l~---~~~~~L~~L~Ls~N~l~~l~~~---~~~L~~L~L~~N~l~-~l~ 217 (622)
T 3g06_A 151 NQLASL-PA---LPSELCKLWAYNNQLTS--LP---MLPSGLQELSVSDNQLASLPTL---PSELYKLWAYNNRLT-SLP 217 (622)
T ss_dssp SCCSCC-CC---CCTTCCEEECCSSCCSC--CC---CCCTTCCEEECCSSCCSCCCCC---CTTCCEEECCSSCCS-SCC
T ss_pred CcCCCc-CC---ccCCCCEEECCCCCCCC--Cc---ccCCCCcEEECCCCCCCCCCCc---cchhhEEECcCCccc-ccC
Confidence 999963 43 35789999999999974 55 5578999999999999986653 478999999999998 455
Q ss_pred CCCCCCCcCEEEccCCcCCCccchhccCCCCCCeEeeecccCCCccchhhhcccccCccccceEeccCCCCCCCccCC-C
Q 002158 295 SKKLSENVTTIDLSDNYLNGSILESISNLPFLQTLSLENNFLTGSIPATIWQNKSFSTKARLKIDLRNNSFSNIVGDL-T 373 (958)
Q Consensus 295 ~~~~~~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~ip~~l~~~~~~~~~~l~~L~Ls~N~l~~l~~~~-~ 373 (958)
. .+++|+.|+|++|+|++.. ..+++|+.|+|++|.|+ .+|. ..+.|+.|+|++|+|+.++... .
T Consensus 218 ~--~~~~L~~L~Ls~N~L~~lp----~~l~~L~~L~Ls~N~L~-~lp~--------~~~~L~~L~Ls~N~L~~lp~~l~~ 282 (622)
T 3g06_A 218 A--LPSGLKELIVSGNRLTSLP----VLPSELKELMVSGNRLT-SLPM--------LPSGLLSLSVYRNQLTRLPESLIH 282 (622)
T ss_dssp C--CCTTCCEEECCSSCCSCCC----CCCTTCCEEECCSSCCS-CCCC--------CCTTCCEEECCSSCCCSCCGGGGG
T ss_pred C--CCCCCCEEEccCCccCcCC----CCCCcCcEEECCCCCCC-cCCc--------ccccCcEEeCCCCCCCcCCHHHhh
Confidence 3 3589999999999999743 56799999999999999 6776 2356889999999999998766 8
Q ss_pred CCCcceEEeCCCCCCC
Q 002158 374 LPNNVTLRLGGNPICT 389 (958)
Q Consensus 374 l~~L~~L~l~~N~l~~ 389 (958)
+++|+.|+|++|++..
T Consensus 283 l~~L~~L~L~~N~l~~ 298 (622)
T 3g06_A 283 LSSETTVNLEGNPLSE 298 (622)
T ss_dssp SCTTCEEECCSCCCCH
T ss_pred ccccCEEEecCCCCCC
Confidence 9999999999999953
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.94 E-value=2.2e-28 Score=269.71 Aligned_cols=243 Identities=21% Similarity=0.222 Sum_probs=167.3
Q ss_pred eeEEEEccCCcCCCCccccccCCCCcceeeccCccc--CCCCcccc-------CCCCCcEEEeeCCCCCCCCChhh--cC
Q 002158 87 HVRELQLLSMNLSGNLAPELGQLSRLQYYFMWNDLT--GTIPKEIG-------NISSLIFLLLNGNKLSGSLPDEL--GY 155 (958)
Q Consensus 87 ~v~~L~L~~~~l~~~~~~~l~~L~~L~~L~l~n~~~--~~ip~~i~-------~l~~L~~L~Ls~n~l~~~~p~~l--~~ 155 (958)
+++.|++.+|.+ .+|..+... |+.|+++++.. ..+|..+. ++++|++|+|++|.+++.+|..+ ..
T Consensus 44 ~L~~l~l~~n~l--~~p~~~~~~--L~~L~L~~n~l~~~~~~~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~ 119 (312)
T 1wwl_A 44 SLEYLLKRVDTE--ADLGQFTDI--IKSLSLKRLTVRAARIPSRILFGALRVLGISGLQELTLENLEVTGTAPPPLLEAT 119 (312)
T ss_dssp ECTTHHHHCCTT--CCCHHHHHH--HHHCCCCEEEEEEEECBHHHHHHHHHHHTTSCCCEEEEEEEBCBSCCCCCSSSCC
T ss_pred CceeEeeccccc--ccHHHHHHH--HhhcccccccccCCCcCHHHHHHHHHhcCcCCccEEEccCCcccchhHHHHHHhc
Confidence 466667777777 566655544 77777765443 34666555 67778888888887777777765 67
Q ss_pred CCCCCEEecccccccccCccccccc-----cccceEecccccccccCchhhcCCccchhhhccCCccccC--CCccc--C
Q 002158 156 LSNLNRLQVDENNITGTIPKSFANL-----SRVRHLHLNNNSIGGQIPSELSKLSTLIHLLVDNNNLSGN--LPPEL--S 226 (958)
Q Consensus 156 l~~L~~L~L~~N~l~~~~p~~~~~l-----~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~--~~~~l--~ 226 (958)
+++|++|+|++|++++. |..+..+ ++|++|+|++|++++..|..|..+++|++|+|++|++.+. .+..+ .
T Consensus 120 l~~L~~L~Ls~N~l~~~-~~~~~~l~~~~~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~ 198 (312)
T 1wwl_A 120 GPDLNILNLRNVSWATR-DAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLISALCPL 198 (312)
T ss_dssp SCCCSEEEEESCBCSSS-SSHHHHHHTTCCTTCCEEEEESCSCCCCCTTTCCCCSSCCEEECCSCTTCHHHHHHHHSCTT
T ss_pred CCCccEEEccCCCCcch-hHHHHHHHHhhcCCCcEEEeeCCCCccchHHHhccCCCCCEEECCCCCcCcchHHHHHHHhc
Confidence 77788888888877765 6667666 7777788888877776667777777777777777776653 22333 6
Q ss_pred CCCCccEEEccCCCCCCC-Ccc-ccccCCCCCCEEEcccCCCCCCCC--CCCCCCCcCEEeccCCcCCCcCCCCCCCCCc
Q 002158 227 ELPQLCILQLDNNNFSAS-EIP-ATYGNFSKLVKLSLRNCNLQGAVP--DLSRIPNLYYLDLSWNHLTGSIPSKKLSENV 302 (958)
Q Consensus 227 ~l~~L~~L~L~~N~l~~~-~~p-~~~~~l~~L~~L~L~~N~l~~~~~--~l~~l~~L~~L~Ls~N~l~~~~~~~~~~~~L 302 (958)
.+++|++|+|++|+++.. .++ ..+.++++|+.|+|++|++++.++ .+..+++|++|+|++|+|+ .+|.... ++|
T Consensus 199 ~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~Ls~N~l~-~ip~~~~-~~L 276 (312)
T 1wwl_A 199 KFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLK-QVPKGLP-AKL 276 (312)
T ss_dssp SCTTCCEEECTTSCCCCHHHHHHHHHHTTCCCSEEECTTSCCCSSCCCSCCCCCTTCCEEECTTSCCS-SCCSSCC-SEE
T ss_pred cCCCCCEEECCCCcCcchHHHHHHHHhcCCCCCEEECCCCcCCcccchhhhhhcCCCCEEECCCCccC-hhhhhcc-CCc
Confidence 777777777777777521 112 234566777777777777777653 3566777777777777777 5555444 677
Q ss_pred CEEEccCCcCCCccchhccCCCCCCeEeeecccCCC
Q 002158 303 TTIDLSDNYLNGSILESISNLPFLQTLSLENNFLTG 338 (958)
Q Consensus 303 ~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~ 338 (958)
++|+|++|+|++. |. +..+++|++|+|++|++++
T Consensus 277 ~~L~Ls~N~l~~~-p~-~~~l~~L~~L~L~~N~l~~ 310 (312)
T 1wwl_A 277 SVLDLSYNRLDRN-PS-PDELPQVGNLSLKGNPFLD 310 (312)
T ss_dssp EEEECCSSCCCSC-CC-TTTSCEEEEEECTTCTTTC
T ss_pred eEEECCCCCCCCC-hh-HhhCCCCCEEeccCCCCCC
Confidence 7777777777766 44 7777777777777777764
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A | Back alignment and structure |
|---|
Probab=99.94 E-value=7.7e-26 Score=262.02 Aligned_cols=265 Identities=26% Similarity=0.320 Sum_probs=145.6
Q ss_pred eeEEEEccCCcCCCCccccccCCCCcceeeccCcccCCCCccccCCCCCcEEEeeCCCCCCCCChhhcCCCCCCEEeccc
Q 002158 87 HVRELQLLSMNLSGNLAPELGQLSRLQYYFMWNDLTGTIPKEIGNISSLIFLLLNGNKLSGSLPDELGYLSNLNRLQVDE 166 (958)
Q Consensus 87 ~v~~L~L~~~~l~~~~~~~l~~L~~L~~L~l~n~~~~~ip~~i~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~L~~ 166 (958)
+++.|++++|.+++ +|.. +++|+.|++++|....+|... ++|++|+|++|.+++ +| .++++++|++|++++
T Consensus 92 ~L~~L~l~~n~l~~-lp~~---~~~L~~L~l~~n~l~~l~~~~---~~L~~L~L~~n~l~~-lp-~~~~l~~L~~L~l~~ 162 (454)
T 1jl5_A 92 HLESLVASCNSLTE-LPEL---PQSLKSLLVDNNNLKALSDLP---PLLEYLGVSNNQLEK-LP-ELQNSSFLKIIDVDN 162 (454)
T ss_dssp TCSEEECCSSCCSS-CCCC---CTTCCEEECCSSCCSCCCSCC---TTCCEEECCSSCCSS-CC-CCTTCTTCCEEECCS
T ss_pred CCCEEEccCCcCCc-cccc---cCCCcEEECCCCccCcccCCC---CCCCEEECcCCCCCC-Cc-ccCCCCCCCEEECCC
Confidence 56777777777776 4432 356666666655544444311 466666666666663 55 366666666666666
Q ss_pred ccccccCccccccccccceEecccccccccCchhhcCCccchhhhccCCccccCCCcccCCCCCccEEEccCCCCCCCCc
Q 002158 167 NNITGTIPKSFANLSRVRHLHLNNNSIGGQIPSELSKLSTLIHLLVDNNNLSGNLPPELSELPQLCILQLDNNNFSASEI 246 (958)
Q Consensus 167 N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~ 246 (958)
|++++ +|..+ .+|++|++++|++++ +| .+.++++|+.|++++|++++ +|... ++|++|++++|+++ .+
T Consensus 163 N~l~~-lp~~~---~~L~~L~L~~n~l~~-l~-~~~~l~~L~~L~l~~N~l~~-l~~~~---~~L~~L~l~~n~l~--~l 230 (454)
T 1jl5_A 163 NSLKK-LPDLP---PSLEFIAAGNNQLEE-LP-ELQNLPFLTAIYADNNSLKK-LPDLP---LSLESIVAGNNILE--EL 230 (454)
T ss_dssp SCCSC-CCCCC---TTCCEEECCSSCCSS-CC-CCTTCTTCCEEECCSSCCSS-CCCCC---TTCCEEECCSSCCS--SC
T ss_pred CcCcc-cCCCc---ccccEEECcCCcCCc-Cc-cccCCCCCCEEECCCCcCCc-CCCCc---CcccEEECcCCcCC--cc
Confidence 66663 44332 366666666666664 44 36666666666666666664 22221 45666666666664 34
Q ss_pred cccccCCCCCCEEEcccCCCCCCCCCCCCCCCcCEEeccCCcCCCcCCCCCCCCCcCEEEccCCcCCCc--cchh-----
Q 002158 247 PATYGNFSKLVKLSLRNCNLQGAVPDLSRIPNLYYLDLSWNHLTGSIPSKKLSENVTTIDLSDNYLNGS--ILES----- 319 (958)
Q Consensus 247 p~~~~~l~~L~~L~L~~N~l~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~~~L~~L~Ls~N~l~~~--~~~~----- 319 (958)
|. ++.+++|+.|++++|++++.+.. +++|+.|++++|++++ +|.. +++|+.|+|++|++++. .|..
T Consensus 231 p~-~~~l~~L~~L~l~~N~l~~l~~~---~~~L~~L~l~~N~l~~-l~~~--~~~L~~L~ls~N~l~~l~~~~~~L~~L~ 303 (454)
T 1jl5_A 231 PE-LQNLPFLTTIYADNNLLKTLPDL---PPSLEALNVRDNYLTD-LPEL--PQSLTFLDVSENIFSGLSELPPNLYYLN 303 (454)
T ss_dssp CC-CTTCTTCCEEECCSSCCSSCCSC---CTTCCEEECCSSCCSC-CCCC--CTTCCEEECCSSCCSEESCCCTTCCEEE
T ss_pred cc-cCCCCCCCEEECCCCcCCccccc---ccccCEEECCCCcccc-cCcc--cCcCCEEECcCCccCcccCcCCcCCEEE
Confidence 42 55666666666666666654321 2455566666665553 2221 24555555555555541 1100
Q ss_pred --------ccCC-CCCCeEeeecccCCCccchhhhcccccCccccceEeccCCCCCCCccCCCCCCcceEEeCCCCCCCC
Q 002158 320 --------ISNL-PFLQTLSLENNFLTGSIPATIWQNKSFSTKARLKIDLRNNSFSNIVGDLTLPNNVTLRLGGNPICTS 390 (958)
Q Consensus 320 --------~~~l-~~L~~L~L~~N~l~~~ip~~l~~~~~~~~~~l~~L~Ls~N~l~~l~~~~~l~~L~~L~l~~N~l~~~ 390 (958)
+..+ ++|+.|++++|++++ +|.. .+.++.|++++|+++.++. .+++|+.|++++|++.+.
T Consensus 304 l~~N~l~~i~~~~~~L~~L~Ls~N~l~~-lp~~--------~~~L~~L~L~~N~l~~lp~--~l~~L~~L~L~~N~l~~l 372 (454)
T 1jl5_A 304 ASSNEIRSLCDLPPSLEELNVSNNKLIE-LPAL--------PPRLERLIASFNHLAEVPE--LPQNLKQLHVEYNPLREF 372 (454)
T ss_dssp CCSSCCSEECCCCTTCCEEECCSSCCSC-CCCC--------CTTCCEEECCSSCCSCCCC--CCTTCCEEECCSSCCSSC
T ss_pred CcCCcCCcccCCcCcCCEEECCCCcccc-cccc--------CCcCCEEECCCCccccccc--hhhhccEEECCCCCCCcC
Confidence 1122 355556666665553 4432 1345566666666666555 456666666666666553
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A | Back alignment and structure |
|---|
Probab=99.94 E-value=1.6e-26 Score=267.64 Aligned_cols=287 Identities=23% Similarity=0.304 Sum_probs=213.3
Q ss_pred ceeeEEEEccCCcCCCCccccccCCCCcceeecc-CcccCCCCccccCCCCC-------------cEEEeeCCCCCCCCC
Q 002158 85 HLHVRELQLLSMNLSGNLAPELGQLSRLQYYFMW-NDLTGTIPKEIGNISSL-------------IFLLLNGNKLSGSLP 150 (958)
Q Consensus 85 ~~~v~~L~L~~~~l~~~~~~~l~~L~~L~~L~l~-n~~~~~ip~~i~~l~~L-------------~~L~Ls~n~l~~~~p 150 (958)
..++++|++++|++ |.+|+++++|++|++|+++ |.+.|.+|..++++++| ++|++++|.+++ +|
T Consensus 10 ~~~L~~L~l~~n~l-~~iP~~i~~L~~L~~L~l~~n~~~~~~p~~~~~l~~L~~l~l~~c~~~~l~~L~l~~~~l~~-lp 87 (454)
T 1jl5_A 10 NTFLQEPLRHSSNL-TEMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMAVSRLRDCLDRQAHELELNNLGLSS-LP 87 (454)
T ss_dssp -------------------------CCHHHHHHHHHHHHHTSCTTSCCCHHHHHHHHHHHHHHTCSEEECTTSCCSC-CC
T ss_pred cccchhhhcccCch-hhCChhHhcccchhhhhccCCcccccCCcccccchhcchhhhhhhhccCCCEEEecCCcccc-CC
Confidence 35789999999999 8999999999999999987 55678999999998875 999999999995 55
Q ss_pred hhhcCCCCCCEEecccccccccCccccccccccceEecccccccccCchhhcCCccchhhhccCCccccCCCcccCCCCC
Q 002158 151 DELGYLSNLNRLQVDENNITGTIPKSFANLSRVRHLHLNNNSIGGQIPSELSKLSTLIHLLVDNNNLSGNLPPELSELPQ 230 (958)
Q Consensus 151 ~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~l~~l~~ 230 (958)
.. .++|++|++++|++++ +|.. +++|++|++++|++++ ++.. .++|++|++++|++++ +| .+..+++
T Consensus 88 ~~---~~~L~~L~l~~n~l~~-lp~~---~~~L~~L~l~~n~l~~-l~~~---~~~L~~L~L~~n~l~~-lp-~~~~l~~ 154 (454)
T 1jl5_A 88 EL---PPHLESLVASCNSLTE-LPEL---PQSLKSLLVDNNNLKA-LSDL---PPLLEYLGVSNNQLEK-LP-ELQNSSF 154 (454)
T ss_dssp SC---CTTCSEEECCSSCCSS-CCCC---CTTCCEEECCSSCCSC-CCSC---CTTCCEEECCSSCCSS-CC-CCTTCTT
T ss_pred CC---cCCCCEEEccCCcCCc-cccc---cCCCcEEECCCCccCc-ccCC---CCCCCEEECcCCCCCC-Cc-ccCCCCC
Confidence 42 4789999999999996 6654 4799999999999995 4432 2689999999999996 66 6999999
Q ss_pred ccEEEccCCCCCCCCccccccCCCCCCEEEcccCCCCCCCCCCCCCCCcCEEeccCCcCCCcCCCCCCCCCcCEEEccCC
Q 002158 231 LCILQLDNNNFSASEIPATYGNFSKLVKLSLRNCNLQGAVPDLSRIPNLYYLDLSWNHLTGSIPSKKLSENVTTIDLSDN 310 (958)
Q Consensus 231 L~~L~L~~N~l~~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~~~L~~L~Ls~N 310 (958)
|++|++++|+++. +|..+ .+|++|++++|++++.+ .+..+++|+.|++++|.+++ +|.. ..+|++|+|++|
T Consensus 155 L~~L~l~~N~l~~--lp~~~---~~L~~L~L~~n~l~~l~-~~~~l~~L~~L~l~~N~l~~-l~~~--~~~L~~L~l~~n 225 (454)
T 1jl5_A 155 LKIIDVDNNSLKK--LPDLP---PSLEFIAAGNNQLEELP-ELQNLPFLTAIYADNNSLKK-LPDL--PLSLESIVAGNN 225 (454)
T ss_dssp CCEEECCSSCCSC--CCCCC---TTCCEEECCSSCCSSCC-CCTTCTTCCEEECCSSCCSS-CCCC--CTTCCEEECCSS
T ss_pred CCEEECCCCcCcc--cCCCc---ccccEEECcCCcCCcCc-cccCCCCCCEEECCCCcCCc-CCCC--cCcccEEECcCC
Confidence 9999999999973 56543 58999999999999854 79999999999999999985 4432 369999999999
Q ss_pred cCCCccchhccCCCCCCeEeeecccCCCccchhhhcccccCccccceEeccCCCCCCCccCCCCCCcceEEeCCCCCCCC
Q 002158 311 YLNGSILESISNLPFLQTLSLENNFLTGSIPATIWQNKSFSTKARLKIDLRNNSFSNIVGDLTLPNNVTLRLGGNPICTS 390 (958)
Q Consensus 311 ~l~~~~~~~~~~l~~L~~L~L~~N~l~~~ip~~l~~~~~~~~~~l~~L~Ls~N~l~~l~~~~~l~~L~~L~l~~N~l~~~ 390 (958)
.++ .+| .+..+++|++|++++|++++ +|.. ...++.|++++|+++.++.. +++|+.|++++|.+...
T Consensus 226 ~l~-~lp-~~~~l~~L~~L~l~~N~l~~-l~~~--------~~~L~~L~l~~N~l~~l~~~--~~~L~~L~ls~N~l~~l 292 (454)
T 1jl5_A 226 ILE-ELP-ELQNLPFLTTIYADNNLLKT-LPDL--------PPSLEALNVRDNYLTDLPEL--PQSLTFLDVSENIFSGL 292 (454)
T ss_dssp CCS-SCC-CCTTCTTCCEEECCSSCCSS-CCSC--------CTTCCEEECCSSCCSCCCCC--CTTCCEEECCSSCCSEE
T ss_pred cCC-ccc-ccCCCCCCCEEECCCCcCCc-cccc--------ccccCEEECCCCcccccCcc--cCcCCEEECcCCccCcc
Confidence 999 455 48999999999999999984 5542 25678999999999987764 48899999999988653
Q ss_pred CCCCCCCcccccCCCCCccccccCCC
Q 002158 391 ANIPNTGRFCGSDAGGDETLTNSKVN 416 (958)
Q Consensus 391 ~~~~~~~~~~~~~~~~~~~L~~n~~~ 416 (958)
+..+ .....+.+.+|.+.
T Consensus 293 ~~~~--------~~L~~L~l~~N~l~ 310 (454)
T 1jl5_A 293 SELP--------PNLYYLNASSNEIR 310 (454)
T ss_dssp SCCC--------TTCCEEECCSSCCS
T ss_pred cCcC--------CcCCEEECcCCcCC
Confidence 3222 23445566666554
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} | Back alignment and structure |
|---|
Probab=99.94 E-value=1.5e-26 Score=256.64 Aligned_cols=232 Identities=21% Similarity=0.241 Sum_probs=170.6
Q ss_pred eeeEEEEccCCcCCCCccccccCCCCcceeeccCcccCCCCccccCCCCCcEEEeeCCCCCCCCChhhcCCCCCCEEecc
Q 002158 86 LHVRELQLLSMNLSGNLAPELGQLSRLQYYFMWNDLTGTIPKEIGNISSLIFLLLNGNKLSGSLPDELGYLSNLNRLQVD 165 (958)
Q Consensus 86 ~~v~~L~L~~~~l~~~~~~~l~~L~~L~~L~l~n~~~~~ip~~i~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~L~ 165 (958)
.+++.|+|+++++. .+|+.++++++|++|++++|....+|..++++++|++|+|++|.++ .+|..++++++|++|+|+
T Consensus 81 ~~l~~L~L~~n~l~-~lp~~l~~l~~L~~L~L~~n~l~~lp~~~~~l~~L~~L~Ls~n~l~-~lp~~l~~l~~L~~L~L~ 158 (328)
T 4fcg_A 81 PGRVALELRSVPLP-QFPDQAFRLSHLQHMTIDAAGLMELPDTMQQFAGLETLTLARNPLR-ALPASIASLNRLRELSIR 158 (328)
T ss_dssp TTCCEEEEESSCCS-SCCSCGGGGTTCSEEEEESSCCCCCCSCGGGGTTCSEEEEESCCCC-CCCGGGGGCTTCCEEEEE
T ss_pred cceeEEEccCCCch-hcChhhhhCCCCCEEECCCCCccchhHHHhccCCCCEEECCCCccc-cCcHHHhcCcCCCEEECC
Confidence 37999999999998 7888999999999999998877799999999999999999999999 889999999999999999
Q ss_pred cccccccCccccccccccceEecccccccccCchhhcCCccchhhhccCCccccCCCcccCCCCCccEEEccCCCCCCCC
Q 002158 166 ENNITGTIPKSFANLSRVRHLHLNNNSIGGQIPSELSKLSTLIHLLVDNNNLSGNLPPELSELPQLCILQLDNNNFSASE 245 (958)
Q Consensus 166 ~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~ 245 (958)
+|++.+.+|..+... ..+..+.++++|++|+|++|+++ .+|..+..+++|++|+|++|+++ .
T Consensus 159 ~n~~~~~~p~~~~~~---------------~~~~~~~~l~~L~~L~L~~n~l~-~lp~~l~~l~~L~~L~L~~N~l~--~ 220 (328)
T 4fcg_A 159 ACPELTELPEPLAST---------------DASGEHQGLVNLQSLRLEWTGIR-SLPASIANLQNLKSLKIRNSPLS--A 220 (328)
T ss_dssp EETTCCCCCSCSEEE---------------C-CCCEEESTTCCEEEEEEECCC-CCCGGGGGCTTCCEEEEESSCCC--C
T ss_pred CCCCccccChhHhhc---------------cchhhhccCCCCCEEECcCCCcC-cchHhhcCCCCCCEEEccCCCCC--c
Confidence 999998999877640 01122334444444444444444 34444445555555555555553 2
Q ss_pred ccccccCCCCCCEEEcccCCCCCCCCC-CCCCCCcCEEeccCCcCCCcCCCC-CCCCCcCEEEccCCcCCCccchhccCC
Q 002158 246 IPATYGNFSKLVKLSLRNCNLQGAVPD-LSRIPNLYYLDLSWNHLTGSIPSK-KLSENVTTIDLSDNYLNGSILESISNL 323 (958)
Q Consensus 246 ~p~~~~~l~~L~~L~L~~N~l~~~~~~-l~~l~~L~~L~Ls~N~l~~~~~~~-~~~~~L~~L~Ls~N~l~~~~~~~~~~l 323 (958)
+|..+..+++|+.|+|++|.+.+..+. +..+++|++|+|++|++.+.+|.. ..+++|++|+|++|++.+.+|..+.++
T Consensus 221 l~~~l~~l~~L~~L~Ls~n~~~~~~p~~~~~l~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~L~~n~~~~~iP~~l~~L 300 (328)
T 4fcg_A 221 LGPAIHHLPKLEELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLLTLPLDIHRLTQLEKLDLRGCVNLSRLPSLIAQL 300 (328)
T ss_dssp CCGGGGGCTTCCEEECTTCTTCCBCCCCTTCCCCCCEEECTTCTTCCBCCTTGGGCTTCCEEECTTCTTCCCCCGGGGGS
T ss_pred CchhhccCCCCCEEECcCCcchhhhHHHhcCCCCCCEEECCCCCchhhcchhhhcCCCCCEEeCCCCCchhhccHHHhhc
Confidence 344455555556666665555555543 666667777777776666666643 445778888888888888888899999
Q ss_pred CCCCeEeeecccCC
Q 002158 324 PFLQTLSLENNFLT 337 (958)
Q Consensus 324 ~~L~~L~L~~N~l~ 337 (958)
++|+.+++..|.+.
T Consensus 301 ~~L~~l~l~~~~~~ 314 (328)
T 4fcg_A 301 PANCIILVPPHLQA 314 (328)
T ss_dssp CTTCEEECCGGGSC
T ss_pred cCceEEeCCHHHHH
Confidence 99999999888776
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.94 E-value=8.3e-26 Score=261.94 Aligned_cols=268 Identities=20% Similarity=0.152 Sum_probs=216.1
Q ss_pred cCCCCccccccCCCCcceeeccCcccCCCCccccCCCCCcEEEeeCCCCCCCCChhhcCCCCCCEEecccccccccCccc
Q 002158 97 NLSGNLAPELGQLSRLQYYFMWNDLTGTIPKEIGNISSLIFLLLNGNKLSGSLPDELGYLSNLNRLQVDENNITGTIPKS 176 (958)
Q Consensus 97 ~l~~~~~~~l~~L~~L~~L~l~n~~~~~ip~~i~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~ 176 (958)
+..+..+..++++++|+.|+++++....+| .++.+++|++|+|++|.+++ +| ++.+++|++|++++|++++. +
T Consensus 29 ~~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~-~l~~l~~L~~L~Ls~n~l~~-~~--~~~l~~L~~L~Ls~N~l~~~-~-- 101 (457)
T 3bz5_A 29 EMQATDTISEEQLATLTSLDCHNSSITDMT-GIEKLTGLTKLICTSNNITT-LD--LSQNTNLTYLACDSNKLTNL-D-- 101 (457)
T ss_dssp TCCTTSEEEHHHHTTCCEEECCSSCCCCCT-TGGGCTTCSEEECCSSCCSC-CC--CTTCTTCSEEECCSSCCSCC-C--
T ss_pred CcCcccccChhHcCCCCEEEccCCCcccCh-hhcccCCCCEEEccCCcCCe-Ec--cccCCCCCEEECcCCCCcee-e--
Confidence 444555668899999999999988777777 79999999999999999996 45 89999999999999999975 3
Q ss_pred cccccccceEecccccccccCchhhcCCccchhhhccCCccccCCCcccCCCCCccEEEccCCCCCCCCccccccCCCCC
Q 002158 177 FANLSRVRHLHLNNNSIGGQIPSELSKLSTLIHLLVDNNNLSGNLPPELSELPQLCILQLDNNNFSASEIPATYGNFSKL 256 (958)
Q Consensus 177 ~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~p~~~~~l~~L 256 (958)
++++++|++|+|++|++++ ++ +..+++|++|++++|++++. .+..+++|++|++++|+..+ .+ .+..+++|
T Consensus 102 ~~~l~~L~~L~L~~N~l~~-l~--~~~l~~L~~L~l~~N~l~~l---~l~~l~~L~~L~l~~n~~~~-~~--~~~~l~~L 172 (457)
T 3bz5_A 102 VTPLTKLTYLNCDTNKLTK-LD--VSQNPLLTYLNCARNTLTEI---DVSHNTQLTELDCHLNKKIT-KL--DVTPQTQL 172 (457)
T ss_dssp CTTCTTCCEEECCSSCCSC-CC--CTTCTTCCEEECTTSCCSCC---CCTTCTTCCEEECTTCSCCC-CC--CCTTCTTC
T ss_pred cCCCCcCCEEECCCCcCCe-ec--CCCCCcCCEEECCCCcccee---ccccCCcCCEEECCCCCccc-cc--ccccCCcC
Confidence 8999999999999999996 45 89999999999999999974 38899999999999996542 33 58889999
Q ss_pred CEEEcccCCCCCCCCCCCCCCCcCEEeccCCcCCCcCCCCCCCCCcCEEEccCCcCCCccchhccCCCCCCeEeeecccC
Q 002158 257 VKLSLRNCNLQGAVPDLSRIPNLYYLDLSWNHLTGSIPSKKLSENVTTIDLSDNYLNGSILESISNLPFLQTLSLENNFL 336 (958)
Q Consensus 257 ~~L~L~~N~l~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l 336 (958)
+.|++++|++++.+ +..+++|+.|++++|++++. ....+++|+.|+|++|+|++. | +..+++|+.|++++|++
T Consensus 173 ~~L~ls~n~l~~l~--l~~l~~L~~L~l~~N~l~~~--~l~~l~~L~~L~Ls~N~l~~i-p--~~~l~~L~~L~l~~N~l 245 (457)
T 3bz5_A 173 TTLDCSFNKITELD--VSQNKLLNRLNCDTNNITKL--DLNQNIQLTFLDCSSNKLTEI-D--VTPLTQLTYFDCSVNPL 245 (457)
T ss_dssp CEEECCSSCCCCCC--CTTCTTCCEEECCSSCCSCC--CCTTCTTCSEEECCSSCCSCC-C--CTTCTTCSEEECCSSCC
T ss_pred CEEECCCCccceec--cccCCCCCEEECcCCcCCee--ccccCCCCCEEECcCCccccc-C--ccccCCCCEEEeeCCcC
Confidence 99999999999864 88999999999999999964 356679999999999999984 4 88999999999999999
Q ss_pred CCccchhhhcccc--cCccccceEeccCCCCCCCccCCCCCCcceEEeCCCCC
Q 002158 337 TGSIPATIWQNKS--FSTKARLKIDLRNNSFSNIVGDLTLPNNVTLRLGGNPI 387 (958)
Q Consensus 337 ~~~ip~~l~~~~~--~~~~~l~~L~Ls~N~l~~l~~~~~l~~L~~L~l~~N~l 387 (958)
++..+..+..+.. +....++.|++++|.+..--....+++|+.|++++|+.
T Consensus 246 ~~~~~~~l~~L~~L~l~~n~L~~L~l~~n~~~~~~~~~~l~~L~~L~Ls~n~~ 298 (457)
T 3bz5_A 246 TELDVSTLSKLTTLHCIQTDLLEIDLTHNTQLIYFQAEGCRKIKELDVTHNTQ 298 (457)
T ss_dssp SCCCCTTCTTCCEEECTTCCCSCCCCTTCTTCCEEECTTCTTCCCCCCTTCTT
T ss_pred CCcCHHHCCCCCEEeccCCCCCEEECCCCccCCcccccccccCCEEECCCCcc
Confidence 9754433322211 11223344455554433211223567777888887764
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.94 E-value=4.2e-28 Score=267.45 Aligned_cols=246 Identities=22% Similarity=0.229 Sum_probs=136.1
Q ss_pred cCCCCcceeeccCcccCCCCccccCCCCCcEEEeeCCCC-CCCCChhhc-------CCCCCCEEecccccccccCcccc-
Q 002158 107 GQLSRLQYYFMWNDLTGTIPKEIGNISSLIFLLLNGNKL-SGSLPDELG-------YLSNLNRLQVDENNITGTIPKSF- 177 (958)
Q Consensus 107 ~~L~~L~~L~l~n~~~~~ip~~i~~l~~L~~L~Ls~n~l-~~~~p~~l~-------~l~~L~~L~L~~N~l~~~~p~~~- 177 (958)
+..++|+.|.+++|.. .+|..+... |+.|+|++|.+ .+.+|..+. ++++|++|+|++|++++.+|..+
T Consensus 40 ~~~~~L~~l~l~~n~l-~~p~~~~~~--L~~L~L~~n~l~~~~~~~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~ 116 (312)
T 1wwl_A 40 GGGRSLEYLLKRVDTE-ADLGQFTDI--IKSLSLKRLTVRAARIPSRILFGALRVLGISGLQELTLENLEVTGTAPPPLL 116 (312)
T ss_dssp EEEEECTTHHHHCCTT-CCCHHHHHH--HHHCCCCEEEEEEEECBHHHHHHHHHHHTTSCCCEEEEEEEBCBSCCCCCSS
T ss_pred ccCCCceeEeeccccc-ccHHHHHHH--HhhcccccccccCCCcCHHHHHHHHHhcCcCCccEEEccCCcccchhHHHHH
Confidence 3344445554444433 445444433 55555555555 223444433 45555555555555554444443
Q ss_pred -ccccccceEecccccccccCchhhcCC-----ccchhhhccCCccccCCCcccCCCCCccEEEccCCCCCCCCcccccc
Q 002158 178 -ANLSRVRHLHLNNNSIGGQIPSELSKL-----STLIHLLVDNNNLSGNLPPELSELPQLCILQLDNNNFSASEIPATYG 251 (958)
Q Consensus 178 -~~l~~L~~L~Ls~N~l~~~~p~~l~~l-----~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~p~~~~ 251 (958)
..+++|++|+|++|++++. |..+..+ ++|++|+|++|++++..+. .|+
T Consensus 117 ~~~l~~L~~L~Ls~N~l~~~-~~~~~~l~~~~~~~L~~L~L~~N~l~~~~~~-------------------------~~~ 170 (312)
T 1wwl_A 117 EATGPDLNILNLRNVSWATR-DAWLAELQQWLKPGLKVLSIAQAHSLNFSCE-------------------------QVR 170 (312)
T ss_dssp SCCSCCCSEEEEESCBCSSS-SSHHHHHHTTCCTTCCEEEEESCSCCCCCTT-------------------------TCC
T ss_pred HhcCCCccEEEccCCCCcch-hHHHHHHHHhhcCCCcEEEeeCCCCccchHH-------------------------Hhc
Confidence 4455555555555555533 4444433 4444444444444444444 445
Q ss_pred CCCCCCEEEcccCCCCCC---CCC--CCCCCCcCEEeccCCcCCCc--CCCC--CCCCCcCEEEccCCcCCCccc-hhcc
Q 002158 252 NFSKLVKLSLRNCNLQGA---VPD--LSRIPNLYYLDLSWNHLTGS--IPSK--KLSENVTTIDLSDNYLNGSIL-ESIS 321 (958)
Q Consensus 252 ~l~~L~~L~L~~N~l~~~---~~~--l~~l~~L~~L~Ls~N~l~~~--~~~~--~~~~~L~~L~Ls~N~l~~~~~-~~~~ 321 (958)
++++|++|+|++|++.+. ++. +..+++|++|+|++|++++. ++.. ..+++|++|+|++|+|++..| ..+.
T Consensus 171 ~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~ 250 (312)
T 1wwl_A 171 VFPALSTLDLSDNPELGERGLISALCPLKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCD 250 (312)
T ss_dssp CCSSCCEEECCSCTTCHHHHHHHHSCTTSCTTCCEEECTTSCCCCHHHHHHHHHHTTCCCSEEECTTSCCCSSCCCSCCC
T ss_pred cCCCCCEEECCCCCcCcchHHHHHHHhccCCCCCEEECCCCcCcchHHHHHHHHhcCCCCCEEECCCCcCCcccchhhhh
Confidence 555555555555554432 111 24555566666666655521 1111 123566666666666666553 4455
Q ss_pred CCCCCCeEeeecccCCCccchhhhcccccCccccceEeccCCCCCCCccCCCCCCcceEEeCCCCCCC
Q 002158 322 NLPFLQTLSLENNFLTGSIPATIWQNKSFSTKARLKIDLRNNSFSNIVGDLTLPNNVTLRLGGNPICT 389 (958)
Q Consensus 322 ~l~~L~~L~L~~N~l~~~ip~~l~~~~~~~~~~l~~L~Ls~N~l~~l~~~~~l~~L~~L~l~~N~l~~ 389 (958)
.+++|++|+|++|+|+ .+|..++ +.|+.|||++|+|++++....+++|+.|++++|+|+.
T Consensus 251 ~l~~L~~L~Ls~N~l~-~ip~~~~-------~~L~~L~Ls~N~l~~~p~~~~l~~L~~L~L~~N~l~~ 310 (312)
T 1wwl_A 251 WPSQLNSLNLSFTGLK-QVPKGLP-------AKLSVLDLSYNRLDRNPSPDELPQVGNLSLKGNPFLD 310 (312)
T ss_dssp CCTTCCEEECTTSCCS-SCCSSCC-------SEEEEEECCSSCCCSCCCTTTSCEEEEEECTTCTTTC
T ss_pred hcCCCCEEECCCCccC-hhhhhcc-------CCceEEECCCCCCCCChhHhhCCCCCEEeccCCCCCC
Confidence 6777888888888887 6777653 4677888888888888664488899999999999853
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=4.2e-27 Score=255.95 Aligned_cols=253 Identities=19% Similarity=0.209 Sum_probs=199.2
Q ss_pred EEEEccCCcCCCCccccccCCCCcceeeccCcccCCCC-ccccCCCCCcEEEeeCCCCCCCCChhhcCCCCCCEEecccc
Q 002158 89 RELQLLSMNLSGNLAPELGQLSRLQYYFMWNDLTGTIP-KEIGNISSLIFLLLNGNKLSGSLPDELGYLSNLNRLQVDEN 167 (958)
Q Consensus 89 ~~L~L~~~~l~~~~~~~l~~L~~L~~L~l~n~~~~~ip-~~i~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~L~~N 167 (958)
+.++..+++++.. |.. ..++|+.|+++++....++ ..|.++++|++|+|++|.+++..|..|..+++|++|+|++|
T Consensus 14 ~~~~c~~~~l~~i-p~~--~~~~l~~L~l~~n~i~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n 90 (285)
T 1ozn_A 14 VTTSCPQQGLQAV-PVG--IPAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDN 90 (285)
T ss_dssp CEEECCSSCCSSC-CTT--CCTTCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSC
T ss_pred eEEEcCcCCcccC-CcC--CCCCceEEEeeCCcCCccCHHHcccCCCCCEEECCCCccceeCHhhcCCccCCCEEeCCCC
Confidence 4555666666643 333 2468888888876666665 56888999999999999998777888999999999999999
Q ss_pred c-ccccCccccccccccceEecccccccccCchhhcCCccchhhhccCCccccCCCcccCCCCCccEEEccCCCCCCCCc
Q 002158 168 N-ITGTIPKSFANLSRVRHLHLNNNSIGGQIPSELSKLSTLIHLLVDNNNLSGNLPPELSELPQLCILQLDNNNFSASEI 246 (958)
Q Consensus 168 ~-l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~ 246 (958)
. ++...+..|..+++|++|+|++|.+++..|..+.++++|++|++++|++++..+..|..+++|++|+|++|+++. ..
T Consensus 91 ~~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~-~~ 169 (285)
T 1ozn_A 91 AQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISS-VP 169 (285)
T ss_dssp TTCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCE-EC
T ss_pred CCccccCHHHhcCCcCCCEEECCCCcCCEECHhHhhCCcCCCEEECCCCcccccCHhHhccCCCccEEECCCCcccc-cC
Confidence 7 776668888899999999999999998778888899999999999999988777788899999999999999862 33
Q ss_pred cccccCCCCCCEEEcccCCCCCCCC-CCCCCCCcCEEeccCCcCCCcCCC-CCCCCCcCEEEccCCcCCCccchhccCCC
Q 002158 247 PATYGNFSKLVKLSLRNCNLQGAVP-DLSRIPNLYYLDLSWNHLTGSIPS-KKLSENVTTIDLSDNYLNGSILESISNLP 324 (958)
Q Consensus 247 p~~~~~l~~L~~L~L~~N~l~~~~~-~l~~l~~L~~L~Ls~N~l~~~~~~-~~~~~~L~~L~Ls~N~l~~~~~~~~~~l~ 324 (958)
+..+..+++|+.|+|++|++++..+ .+..+++|+.|+|++|++++..+. ...+++|+.|+|++|.+....+.. .-..
T Consensus 170 ~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~~~c~~~~~-~~~~ 248 (285)
T 1ozn_A 170 ERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCRAR-PLWA 248 (285)
T ss_dssp TTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCHHHHTTCTTCCEEECCSSCEECSGGGH-HHHH
T ss_pred HHHhcCccccCEEECCCCcccccCHhHccCcccccEeeCCCCcCCcCCHHHcccCcccCEEeccCCCccCCCCcH-HHHH
Confidence 4468889999999999999988866 488899999999999999865443 355689999999999987533221 1123
Q ss_pred CCCeEeeecccCCCccchhhhc
Q 002158 325 FLQTLSLENNFLTGSIPATIWQ 346 (958)
Q Consensus 325 ~L~~L~L~~N~l~~~ip~~l~~ 346 (958)
.|+.+..+.|.+.+..|..+.+
T Consensus 249 ~l~~~~~~~~~~~c~~p~~l~g 270 (285)
T 1ozn_A 249 WLQKFRGSSSEVPCSLPQRLAG 270 (285)
T ss_dssp HHHHCCSEECCCBEEESGGGTT
T ss_pred HHHhcccccCccccCCchHhCC
Confidence 4566668889998888887643
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.93 E-value=4.2e-26 Score=250.80 Aligned_cols=255 Identities=20% Similarity=0.282 Sum_probs=217.2
Q ss_pred CCCCCCCCceeeCccccCCCceeeEEEEccCCcCCCCccccccCCCCcceeeccCcccCCCCcc-ccCCCCCcEEEeeCC
Q 002158 65 DPCMSNWTGVLCFDTVETDGHLHVRELQLLSMNLSGNLAPELGQLSRLQYYFMWNDLTGTIPKE-IGNISSLIFLLLNGN 143 (958)
Q Consensus 65 ~~c~~~w~gV~C~~~~~~~~~~~v~~L~L~~~~l~~~~~~~l~~L~~L~~L~l~n~~~~~ip~~-i~~l~~L~~L~Ls~n 143 (958)
+.|.|.|.+|.|.+. +++ .+|..+. ++|+.|++++|....+|.. |.++++|++|+|++|
T Consensus 3 ~~C~C~~~~l~c~~~-----------------~l~-~ip~~~~--~~l~~L~L~~n~l~~i~~~~~~~l~~L~~L~L~~n 62 (306)
T 2z66_A 3 SRCSCSGTEIRCNSK-----------------GLT-SVPTGIP--SSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSN 62 (306)
T ss_dssp TTCEEETTEEECCSS-----------------CCS-SCCSCCC--TTCCEEECCSSCCCCCCTTTTTTCTTCSEEECCSS
T ss_pred CCCeeCCCEEEcCCC-----------------Ccc-cCCCCCC--CCCCEEECCCCccCccCHhHhhccccCCEEECCCC
Confidence 568889999999542 222 2333332 5788898888777788765 789999999999999
Q ss_pred CCCC--CCChhhcCCCCCCEEecccccccccCccccccccccceEecccccccccCc-hhhcCCccchhhhccCCccccC
Q 002158 144 KLSG--SLPDELGYLSNLNRLQVDENNITGTIPKSFANLSRVRHLHLNNNSIGGQIP-SELSKLSTLIHLLVDNNNLSGN 220 (958)
Q Consensus 144 ~l~~--~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p-~~l~~l~~L~~L~L~~N~l~~~ 220 (958)
.++. ..|..+..+++|++|+|++|.++ .+|..+..+++|++|+|++|.+++..+ ..+..+++|++|++++|++.+.
T Consensus 63 ~l~~~~~~~~~~~~~~~L~~L~Ls~n~i~-~l~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~ 141 (306)
T 2z66_A 63 GLSFKGCCSQSDFGTTSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVA 141 (306)
T ss_dssp CCCEEEEEEHHHHSCSCCCEEECCSCSEE-EEEEEEETCTTCCEEECTTSEEESSTTTTTTTTCTTCCEEECTTSCCEEC
T ss_pred ccCcccCcccccccccccCEEECCCCccc-cChhhcCCCCCCCEEECCCCcccccccchhhhhccCCCEEECCCCcCCcc
Confidence 9983 33677888999999999999998 577789999999999999999996655 5789999999999999999988
Q ss_pred CCcccCCCCCccEEEccCCCCCCCCccccccCCCCCCEEEcccCCCCCCCC-CCCCCCCcCEEeccCCcCCCcCCC-CCC
Q 002158 221 LPPELSELPQLCILQLDNNNFSASEIPATYGNFSKLVKLSLRNCNLQGAVP-DLSRIPNLYYLDLSWNHLTGSIPS-KKL 298 (958)
Q Consensus 221 ~~~~l~~l~~L~~L~L~~N~l~~~~~p~~~~~l~~L~~L~L~~N~l~~~~~-~l~~l~~L~~L~Ls~N~l~~~~~~-~~~ 298 (958)
.+..+..+++|++|+|++|.++....|..+..+++|+.|+|++|++++.++ .+..+++|+.|+|++|.+++..+. ...
T Consensus 142 ~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~ 221 (306)
T 2z66_A 142 FNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKC 221 (306)
T ss_dssp STTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCSBCCSGGGTT
T ss_pred chhhcccCcCCCEEECCCCccccccchhHHhhCcCCCEEECCCCCcCCcCHHHhcCCCCCCEEECCCCccCccChhhccC
Confidence 899999999999999999999744578899999999999999999999876 489999999999999999865442 355
Q ss_pred CCCcCEEEccCCcCCCccchhccCCC-CCCeEeeecccCCCcc
Q 002158 299 SENVTTIDLSDNYLNGSILESISNLP-FLQTLSLENNFLTGSI 340 (958)
Q Consensus 299 ~~~L~~L~Ls~N~l~~~~~~~~~~l~-~L~~L~L~~N~l~~~i 340 (958)
+++|+.|+|++|++++..+..+..++ +|++|+|++|++++.-
T Consensus 222 l~~L~~L~L~~N~l~~~~~~~~~~~~~~L~~L~L~~N~~~~~c 264 (306)
T 2z66_A 222 LNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFACTC 264 (306)
T ss_dssp CTTCCEEECTTSCCCBCSSSSCCCCCTTCCEEECTTCCEECSG
T ss_pred cccCCEeECCCCCCcccCHHHHHhhhccCCEEEccCCCeeccc
Confidence 68999999999999999999999995 9999999999998643
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.93 E-value=1.4e-26 Score=260.11 Aligned_cols=273 Identities=19% Similarity=0.160 Sum_probs=153.4
Q ss_pred CCCCCCCceeeCcc------ccCCCceeeEEEEccCCcCCCCccccccCCCCcceeeccCcccCCC-CccccCCCCCcEE
Q 002158 66 PCMSNWTGVLCFDT------VETDGHLHVRELQLLSMNLSGNLAPELGQLSRLQYYFMWNDLTGTI-PKEIGNISSLIFL 138 (958)
Q Consensus 66 ~c~~~w~gV~C~~~------~~~~~~~~v~~L~L~~~~l~~~~~~~l~~L~~L~~L~l~n~~~~~i-p~~i~~l~~L~~L 138 (958)
.|.|.|.|+ |... .+.....+++.|+|++|++++..+..+.++++|+.|++++|....+ |..|.++++|++|
T Consensus 27 ~~~C~~~~~-c~~~~~~l~~iP~~~~~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L 105 (353)
T 2z80_A 27 SLSCDRNGI-CKGSSGSLNSIPSGLTEAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGINTIEEDSFSSLGSLEHL 105 (353)
T ss_dssp CCEECTTSE-EECCSTTCSSCCTTCCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEE
T ss_pred CCCCCCCeE-eeCCCCCcccccccccccCcEEECCCCcCcccCHHHhccCCCCCEEECCCCccCccCHhhcCCCCCCCEE
Confidence 455689887 6321 1112223566666666666665555666666666666654443333 4456666666666
Q ss_pred EeeCCCCCCCCChhhcCCCCCCEEecccccccccCc-cccccccccceEecccc-cccccCchhhcCCccchhhhccCCc
Q 002158 139 LLNGNKLSGSLPDELGYLSNLNRLQVDENNITGTIP-KSFANLSRVRHLHLNNN-SIGGQIPSELSKLSTLIHLLVDNNN 216 (958)
Q Consensus 139 ~Ls~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p-~~~~~l~~L~~L~Ls~N-~l~~~~p~~l~~l~~L~~L~L~~N~ 216 (958)
+|++|.+++..+..+.++++|++|+|++|++++..+ ..|.++++|++|++++| .+++..+..+.++++|++|++++|+
T Consensus 106 ~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~ 185 (353)
T 2z80_A 106 DLSYNYLSNLSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNMDTFTKIQRKDFAGLTFLEELEIDASD 185 (353)
T ss_dssp ECCSSCCSSCCHHHHTTCTTCSEEECTTCCCSSSCSSCSCTTCTTCCEEEEEESSSCCEECTTTTTTCCEEEEEEEEETT
T ss_pred ECCCCcCCcCCHhHhCCCccCCEEECCCCCCcccCchhhhccCCCCcEEECCCCccccccCHHHccCCCCCCEEECCCCC
Confidence 666666664333336666666666666666663322 35666666666666666 3554455566666666666666666
Q ss_pred cccCCCcccCCCCCccEEEccCCCCCCCCccc-cccCCCCCCEEEcccCCCCCCCCC----CCCCCCcCEEeccCCcCCC
Q 002158 217 LSGNLPPELSELPQLCILQLDNNNFSASEIPA-TYGNFSKLVKLSLRNCNLQGAVPD----LSRIPNLYYLDLSWNHLTG 291 (958)
Q Consensus 217 l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~p~-~~~~l~~L~~L~L~~N~l~~~~~~----l~~l~~L~~L~Ls~N~l~~ 291 (958)
+++..|..+..+++|++|++++|+++ .+|. .+..+++|+.|+|++|++++.... ......++.++|++|.+++
T Consensus 186 l~~~~~~~l~~l~~L~~L~l~~n~l~--~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~~~~~~~l~~l~L~~~~l~~ 263 (353)
T 2z80_A 186 LQSYEPKSLKSIQNVSHLILHMKQHI--LLLEIFVDVTSSVECLELRDTDLDTFHFSELSTGETNSLIKKFTFRNVKITD 263 (353)
T ss_dssp CCEECTTTTTTCSEEEEEEEECSCST--THHHHHHHHTTTEEEEEEESCBCTTCCCC------CCCCCCEEEEESCBCCH
T ss_pred cCccCHHHHhccccCCeecCCCCccc--cchhhhhhhcccccEEECCCCccccccccccccccccchhhccccccccccC
Confidence 66666666666666666666666663 2333 233456666666666666654432 2234455555665555543
Q ss_pred c----CCC-CCCCCCcCEEEccCCcCCCccchhccCCCCCCeEeeecccCCCccc
Q 002158 292 S----IPS-KKLSENVTTIDLSDNYLNGSILESISNLPFLQTLSLENNFLTGSIP 341 (958)
Q Consensus 292 ~----~~~-~~~~~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~ip 341 (958)
. +|. ...+++|++|+|++|+|+...+..|..+++|++|+|++|++++..|
T Consensus 264 ~~l~~l~~~l~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~L~~N~~~~~~~ 318 (353)
T 2z80_A 264 ESLFQVMKLLNQISGLLELEFSRNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCP 318 (353)
T ss_dssp HHHHHHHHHHHTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCBCCCHH
T ss_pred cchhhhHHHHhcccCCCEEECCCCCCCccCHHHHhcCCCCCEEEeeCCCccCcCC
Confidence 1 111 1234555555555555554333334555555555555555554443
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.93 E-value=1.6e-24 Score=233.50 Aligned_cols=183 Identities=27% Similarity=0.362 Sum_probs=82.4
Q ss_pred CCEEecccccccccCccccccccccceEecccccccccCchhhcCCccchhhhccCCccccCCCcccCCCCCccEEEccC
Q 002158 159 LNRLQVDENNITGTIPKSFANLSRVRHLHLNNNSIGGQIPSELSKLSTLIHLLVDNNNLSGNLPPELSELPQLCILQLDN 238 (958)
Q Consensus 159 L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~ 238 (958)
|++|+|++|++++..+..|.++++|++|+|++|.++...+..|.++++|++|+|++|++++..+..|..+++|++|+|++
T Consensus 39 l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~i~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~ 118 (270)
T 2o6q_A 39 TKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQTLPAGIFKELKNLETLWVTDNKLQALPIGVFDQLVNLAELRLDR 118 (270)
T ss_dssp CSEEECCSSCCSCCCTTSSSSCTTCCEEECCSSCCSCCCTTTTSSCTTCCEEECCSSCCCCCCTTTTTTCSSCCEEECCS
T ss_pred CCEEECcCCCCCeeCHHHhcCCCCCCEEECCCCccCeeChhhhcCCCCCCEEECCCCcCCcCCHhHcccccCCCEEECCC
Confidence 34444444444433333344444444444444444432223333444444444444444433333444444444444444
Q ss_pred CCCCCCCccccccCCCCCCEEEcccCCCCCCCCC-CCCCCCcCEEeccCCcCCCcCCCCCCCCCcCEEEccCCcCCCccc
Q 002158 239 NNFSASEIPATYGNFSKLVKLSLRNCNLQGAVPD-LSRIPNLYYLDLSWNHLTGSIPSKKLSENVTTIDLSDNYLNGSIL 317 (958)
Q Consensus 239 N~l~~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~-l~~l~~L~~L~Ls~N~l~~~~~~~~~~~~L~~L~Ls~N~l~~~~~ 317 (958)
|+++. ..+..|.++++|+.|+|++|++++.++. +..+++|+.|+|++|.++ +..+
T Consensus 119 n~l~~-~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~-----------------------~~~~ 174 (270)
T 2o6q_A 119 NQLKS-LPPRVFDSLTKLTYLSLGYNELQSLPKGVFDKLTSLKELRLYNNQLK-----------------------RVPE 174 (270)
T ss_dssp SCCCC-CCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCS-----------------------CCCT
T ss_pred CccCe-eCHHHhCcCcCCCEEECCCCcCCccCHhHccCCcccceeEecCCcCc-----------------------EeCh
Confidence 44431 1223334444444444444444443332 344444444444444443 3334
Q ss_pred hhccCCCCCCeEeeecccCCCccchhhhcccccCccccceEeccCCCCCCCccCCCCCCcceEEeCCCCCCCCCC
Q 002158 318 ESISNLPFLQTLSLENNFLTGSIPATIWQNKSFSTKARLKIDLRNNSFSNIVGDLTLPNNVTLRLGGNPICTSAN 392 (958)
Q Consensus 318 ~~~~~l~~L~~L~L~~N~l~~~ip~~l~~~~~~~~~~l~~L~Ls~N~l~~l~~~~~l~~L~~L~l~~N~l~~~~~ 392 (958)
..|..+++|++|+|++|+|++ +|...+. .+++|+.|+|++|||.|+|.
T Consensus 175 ~~~~~l~~L~~L~L~~N~l~~-~~~~~~~--------------------------~l~~L~~L~l~~N~~~c~c~ 222 (270)
T 2o6q_A 175 GAFDKLTELKTLKLDNNQLKR-VPEGAFD--------------------------SLEKLKMLQLQENPWDCTCN 222 (270)
T ss_dssp TTTTTCTTCCEEECCSSCCSC-CCTTTTT--------------------------TCTTCCEEECCSSCBCCSSS
T ss_pred hHhccCCCcCEEECCCCcCCc-CCHHHhc--------------------------cccCCCEEEecCCCeeCCCc
Confidence 445555555555555555552 2222110 34566777777777777764
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.93 E-value=5.3e-25 Score=254.90 Aligned_cols=233 Identities=21% Similarity=0.235 Sum_probs=199.1
Q ss_pred CccccccCCCCcceeeccCcccCCC-CccccCCCCCcEEEeeCCCCCCCCChhhcCCCCCCEEecccccccccCcccccc
Q 002158 101 NLAPELGQLSRLQYYFMWNDLTGTI-PKEIGNISSLIFLLLNGNKLSGSLPDELGYLSNLNRLQVDENNITGTIPKSFAN 179 (958)
Q Consensus 101 ~~~~~l~~L~~L~~L~l~n~~~~~i-p~~i~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~ 179 (958)
.+|..+. ++++.|++++|....+ +..|.++++|++|+|++|.+++..+..|.++++|++|+|++|+++...+..|..
T Consensus 57 ~iP~~~~--~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~i~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~ 134 (440)
T 3zyj_A 57 EVPDGIS--TNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIRTIEIGAFNGLANLNTLELFDNRLTTIPNGAFVY 134 (440)
T ss_dssp SCCSCCC--TTCSEEECCSCCCCEECTTTTSSCSSCCEEECCSSCCCEECGGGGTTCSSCCEEECCSSCCSSCCTTTSCS
T ss_pred cCCCCCC--CCCcEEEccCCcCCeeCHHHhhCCCCCCEEECCCCcCCccChhhccCCccCCEEECCCCcCCeeCHhHhhc
Confidence 3444443 6788888876655554 467899999999999999999777788999999999999999999777778999
Q ss_pred ccccceEecccccccccCchhhcCCccchhhhccC-CccccCCCcccCCCCCccEEEccCCCCCCCCccccccCCCCCCE
Q 002158 180 LSRVRHLHLNNNSIGGQIPSELSKLSTLIHLLVDN-NNLSGNLPPELSELPQLCILQLDNNNFSASEIPATYGNFSKLVK 258 (958)
Q Consensus 180 l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~-N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~p~~~~~l~~L~~ 258 (958)
+++|++|+|++|.|+...+..|.++++|+.|+|++ |.+....+..|.++++|++|+|++|+++ .+| .+..+++|+.
T Consensus 135 l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~~~~l~~i~~~~~~~l~~L~~L~L~~n~l~--~~~-~~~~l~~L~~ 211 (440)
T 3zyj_A 135 LSKLKELWLRNNPIESIPSYAFNRIPSLRRLDLGELKRLSYISEGAFEGLSNLRYLNLAMCNLR--EIP-NLTPLIKLDE 211 (440)
T ss_dssp CSSCCEEECCSCCCCEECTTTTTTCTTCCEEECCCCTTCCEECTTTTTTCSSCCEEECTTSCCS--SCC-CCTTCSSCCE
T ss_pred cccCceeeCCCCcccccCHHHhhhCcccCEeCCCCCCCcceeCcchhhcccccCeecCCCCcCc--ccc-ccCCCcccCE
Confidence 99999999999999977777899999999999998 4555555668999999999999999996 445 4788999999
Q ss_pred EEcccCCCCCCCCC-CCCCCCcCEEeccCCcCCCcCCCC-CCCCCcCEEEccCCcCCCccchhccCCCCCCeEeeecccC
Q 002158 259 LSLRNCNLQGAVPD-LSRIPNLYYLDLSWNHLTGSIPSK-KLSENVTTIDLSDNYLNGSILESISNLPFLQTLSLENNFL 336 (958)
Q Consensus 259 L~L~~N~l~~~~~~-l~~l~~L~~L~Ls~N~l~~~~~~~-~~~~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l 336 (958)
|+|++|++++..+. |..+++|+.|+|++|++++..+.. ..+++|+.|+|++|+|++..+..|..+++|+.|+|++|++
T Consensus 212 L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~Np~ 291 (440)
T 3zyj_A 212 LDLSGNHLSAIRPGSFQGLMHLQKLWMIQSQIQVIERNAFDNLQSLVEINLAHNNLTLLPHDLFTPLHHLERIHLHHNPW 291 (440)
T ss_dssp EECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTSSTTCTTCCEEECTTSCCCCCCTTTTSSCTTCCEEECCSSCE
T ss_pred EECCCCccCccChhhhccCccCCEEECCCCceeEEChhhhcCCCCCCEEECCCCCCCccChhHhccccCCCEEEcCCCCc
Confidence 99999999998774 999999999999999999665543 4568999999999999999999999999999999999998
Q ss_pred CC
Q 002158 337 TG 338 (958)
Q Consensus 337 ~~ 338 (958)
..
T Consensus 292 ~C 293 (440)
T 3zyj_A 292 NC 293 (440)
T ss_dssp EC
T ss_pred cC
Confidence 63
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=2.5e-25 Score=240.73 Aligned_cols=218 Identities=23% Similarity=0.204 Sum_probs=190.1
Q ss_pred cCCCCccccCCCCCcEEEeeCCCCCCCCChhhcCCCCCCEEecccccccccCccccccccccceEecccccccccCchhh
Q 002158 122 TGTIPKEIGNISSLIFLLLNGNKLSGSLPDELGYLSNLNRLQVDENNITGTIPKSFANLSRVRHLHLNNNSIGGQIPSEL 201 (958)
Q Consensus 122 ~~~ip~~i~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l 201 (958)
...+|..+. ++|++|+|++|.+++..+..|.++++|++|+|++|++++..+..|.++++|++|+|++|.+++..+..|
T Consensus 19 l~~ip~~l~--~~l~~L~ls~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~ 96 (276)
T 2z62_A 19 FYKIPDNLP--FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAF 96 (276)
T ss_dssp CSSCCSSSC--TTCCEEECTTCCCCEECTTTTTTCTTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTT
T ss_pred ccccCCCCC--CCccEEECCCCcccccCHhHhccccCCcEEECCCCcCCccCHHHccCCcCCCEEECCCCccCccChhhh
Confidence 345565543 479999999999997777789999999999999999997777889999999999999999998888889
Q ss_pred cCCccchhhhccCCccccCCCcccCCCCCccEEEccCCCCCCCCccccccCCCCCCEEEcccCCCCCCCCC-CCCCCCcC
Q 002158 202 SKLSTLIHLLVDNNNLSGNLPPELSELPQLCILQLDNNNFSASEIPATYGNFSKLVKLSLRNCNLQGAVPD-LSRIPNLY 280 (958)
Q Consensus 202 ~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~-l~~l~~L~ 280 (958)
.++++|++|++++|++++..+..+..+++|++|+|++|+++...+|..+.++++|+.|+|++|++++.++. +..+++|+
T Consensus 97 ~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~l~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~ 176 (276)
T 2z62_A 97 SGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMP 176 (276)
T ss_dssp TTCTTCCEEECTTSCCCCSTTCCCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECCSSCCCEECGGGGHHHHTCT
T ss_pred cCCccccEEECCCCCccccCchhcccCCCCCEEECcCCccceecCchhhccCCCCCEEECCCCCCCcCCHHHhhhhhhcc
Confidence 99999999999999999887778999999999999999998656789999999999999999999987763 55555555
Q ss_pred ----EEeccCCcCCCcCCCCCCCCCcCEEEccCCcCCCccchhccCCCCCCeEeeecccCCCccc
Q 002158 281 ----YLDLSWNHLTGSIPSKKLSENVTTIDLSDNYLNGSILESISNLPFLQTLSLENNFLTGSIP 341 (958)
Q Consensus 281 ----~L~Ls~N~l~~~~~~~~~~~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~ip 341 (958)
.|++++|.+++..+......+|+.|+|++|+|++..+..|..+++|+.|+|++|++++..|
T Consensus 177 ~l~l~L~ls~n~l~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~N~~~c~c~ 241 (276)
T 2z62_A 177 LLNLSLDLSLNPMNFIQPGAFKEIRLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCP 241 (276)
T ss_dssp TCCEEEECCSSCCCEECTTSSCSCCEEEEECCSSCCSCCCTTTTTTCCSCCEEECCSSCBCCCTT
T ss_pred ccceeeecCCCcccccCccccCCCcccEEECCCCceeecCHhHhcccccccEEEccCCcccccCC
Confidence 8999999999766666666799999999999999888889999999999999999997554
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.92 E-value=3.3e-26 Score=267.74 Aligned_cols=197 Identities=25% Similarity=0.206 Sum_probs=138.4
Q ss_pred CCCcEEEeeCCCCCCCCChhhcCCCCCCEEecccccccccCccccccccccceEecccccccccCchhhcCCccchhhhc
Q 002158 133 SSLIFLLLNGNKLSGSLPDELGYLSNLNRLQVDENNITGTIPKSFANLSRVRHLHLNNNSIGGQIPSELSKLSTLIHLLV 212 (958)
Q Consensus 133 ~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L 212 (958)
++|++|+|++|.+++..|..|..+++|++|+|++|.+++..| |..+++|++|+|++|.|++..+ .++|+.|++
T Consensus 34 ~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~Ls~N~l~~l~~-----~~~L~~L~L 106 (487)
T 3oja_A 34 WNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYETLD--LESLSTLRTLDLNNNYVQELLV-----GPSIETLHA 106 (487)
T ss_dssp GGCCEEECCSSCCCCCCGGGGTTCTTCCEEECTTSCCEEEEE--CTTCTTCCEEECCSSEEEEEEE-----CTTCCEEEC
T ss_pred CCccEEEeeCCcCCCCCHHHHhCCCCCCEEEeeCCCCCCCcc--cccCCCCCEEEecCCcCCCCCC-----CCCcCEEEC
Confidence 378888888888887777788888888888888888876555 7788888888888888874322 267778888
Q ss_pred cCCccccCCCcccCCCCCccEEEccCCCCCCCCccccccCCCCCCEEEcccCCCCCCCCC-CC-CCCCcCEEeccCCcCC
Q 002158 213 DNNNLSGNLPPELSELPQLCILQLDNNNFSASEIPATYGNFSKLVKLSLRNCNLQGAVPD-LS-RIPNLYYLDLSWNHLT 290 (958)
Q Consensus 213 ~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~-l~-~l~~L~~L~Ls~N~l~ 290 (958)
++|+|++..+. .+++|+.|+|++|.++ ...|..++++++|+.|+|++|.+++.++. +. .+++|+.|+|++|.|+
T Consensus 107 ~~N~l~~~~~~---~l~~L~~L~L~~N~l~-~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~~l~~L~~L~Ls~N~l~ 182 (487)
T 3oja_A 107 ANNNISRVSCS---RGQGKKNIYLANNKIT-MLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIY 182 (487)
T ss_dssp CSSCCCCEEEC---CCSSCEEEECCSSCCC-SGGGBCGGGGSSEEEEECTTSCCCEEEGGGGGGGTTTCCEEECTTSCCC
T ss_pred cCCcCCCCCcc---ccCCCCEEECCCCCCC-CCCchhhcCCCCCCEEECCCCCCCCcChHHHhhhCCcccEEecCCCccc
Confidence 88887765443 3467777777777776 34456677777777777777777775553 43 5777777777777777
Q ss_pred CcCCCCCCCCCcCEEEccCCcCCCccchhccCCCCCCeEeeecccCCCccchh
Q 002158 291 GSIPSKKLSENVTTIDLSDNYLNGSILESISNLPFLQTLSLENNFLTGSIPAT 343 (958)
Q Consensus 291 ~~~~~~~~~~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~ip~~ 343 (958)
+. +....+++|+.|+|++|.|++..+. |..+++|+.|+|++|.|++ +|..
T Consensus 183 ~~-~~~~~l~~L~~L~Ls~N~l~~~~~~-~~~l~~L~~L~Ls~N~l~~-lp~~ 232 (487)
T 3oja_A 183 DV-KGQVVFAKLKTLDLSSNKLAFMGPE-FQSAAGVTWISLRNNKLVL-IEKA 232 (487)
T ss_dssp EE-ECCCCCTTCCEEECCSSCCCEECGG-GGGGTTCSEEECTTSCCCE-ECTT
T ss_pred cc-cccccCCCCCEEECCCCCCCCCCHh-HcCCCCccEEEecCCcCcc-cchh
Confidence 43 4444566777777777777754443 6666777777777777663 4444
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=4.1e-26 Score=269.14 Aligned_cols=194 Identities=14% Similarity=0.186 Sum_probs=146.8
Q ss_pred cCCCCCceeeeeCCeEEEEEEECCCcEEEEEEeccCChh--------cHHHHHHHHHHHHccCCCCcceEEEEEEeCCeE
Q 002158 625 AYFSSSTQVGQGGYGKVYKGILSDNTTVAIKRAEEGSLQ--------GQNEFLTEIKLLSRLHHRNLVSLLGYCDEEGEQ 696 (958)
Q Consensus 625 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~--------~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~ 696 (958)
..+...+.||+|+||+||+|.+ .++.+++|+....... ..++|.+|++++++++||||+++..++...+..
T Consensus 336 ~~~~~~~~LG~G~fg~Vy~~~~-~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~ 414 (540)
T 3en9_A 336 KRKIPEHLIGKGAEADIKRDSY-LDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNK 414 (540)
T ss_dssp ------------CCEEEEEEEC-SSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTT
T ss_pred ccCCCCCEEeeCCCEEEEEEEE-CCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCcc
Confidence 3334567899999999999954 6788999986442211 134589999999999999999666666677788
Q ss_pred EEEEEecCCCCHHHHhccCCCCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEecCCCCeEEeeeeeeccc
Q 002158 697 MLVYEFVPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSRLA 776 (958)
Q Consensus 697 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~~ 776 (958)
++||||+++++|.++++. +..++.|+++||+|||+++ |+||||||+|||++. .+||+|||+++..
T Consensus 415 ~lVmE~~~ggsL~~~l~~----------~~~i~~qi~~aL~~LH~~g---IiHrDiKp~NILl~~--~~kL~DFGla~~~ 479 (540)
T 3en9_A 415 RIMMSYINGKLAKDVIED----------NLDIAYKIGEIVGKLHKND---VIHNDLTTSNFIFDK--DLYIIDFGLGKIS 479 (540)
T ss_dssp EEEEECCCSEEHHHHSTT----------CTHHHHHHHHHHHHHHHTT---EECTTCCTTSEEESS--SEEECCCTTCEEC
T ss_pred EEEEECCCCCCHHHHHHH----------HHHHHHHHHHHHHHHHHCc---CccCCCCHHHEEECC--eEEEEECccCEEC
Confidence 999999999999999965 4689999999999999999 999999999999998 9999999999875
Q ss_pred ccCCCCCCccceeeeeccCCCCccChhhhcc--CCCCCcchhhhHHHHHHHHHhCCCCCC
Q 002158 777 PVLDDEGTMPTHVSTIVKGTPGYLDPEYFLT--HKLTDKSDVYSLGVVLLELLTGMQPIS 834 (958)
Q Consensus 777 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DV~S~Gv~l~elltG~~P~~ 834 (958)
..................||+.|||||++.. ..|+...|+|+..+-..+-+.++.+|.
T Consensus 480 ~~~~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY~ 539 (540)
T 3en9_A 480 NLDEDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARYV 539 (540)
T ss_dssp CCHHHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCCC
T ss_pred CCccccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhccccC
Confidence 3211100000001235679999999999987 567888999999999999888887763
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=6.5e-25 Score=237.44 Aligned_cols=221 Identities=19% Similarity=0.199 Sum_probs=138.7
Q ss_pred EEEeeCCCCCCCCChhhcCCCCCCEEecccccccccCccccccccccceEecccccccccCchhhcCCccchhhhccCCc
Q 002158 137 FLLLNGNKLSGSLPDELGYLSNLNRLQVDENNITGTIPKSFANLSRVRHLHLNNNSIGGQIPSELSKLSTLIHLLVDNNN 216 (958)
Q Consensus 137 ~L~Ls~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~ 216 (958)
.++..+..++ .+|..+. ++|++|+|++|++++..+..|.++++|++|+|++|++++..+..|.++++|++|+|++|+
T Consensus 11 ~~~c~~~~l~-~ip~~l~--~~l~~L~ls~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~ 87 (276)
T 2z62_A 11 TYQCMELNFY-KIPDNLP--FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNP 87 (276)
T ss_dssp EEECTTSCCS-SCCSSSC--TTCCEEECTTCCCCEECTTTTTTCTTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTCC
T ss_pred eEEecCCCcc-ccCCCCC--CCccEEECCCCcccccCHhHhccccCCcEEECCCCcCCccCHHHccCCcCCCEEECCCCc
Confidence 4566666666 5665543 467777777777776555567777777777777777765555566666666666666666
Q ss_pred cccCCCcccCCCCCccEEEccCCCCCCCCccccccCCCCCCEEEcccCCCCCCCC-CCCCCCCcCEEeccCCcCCCc-CC
Q 002158 217 LSGNLPPELSELPQLCILQLDNNNFSASEIPATYGNFSKLVKLSLRNCNLQGAVP-DLSRIPNLYYLDLSWNHLTGS-IP 294 (958)
Q Consensus 217 l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~p~~~~~l~~L~~L~L~~N~l~~~~~-~l~~l~~L~~L~Ls~N~l~~~-~~ 294 (958)
+++..+..|.++++|++|++++|+++ +..+ .+..+++|++|+|++|.+++. +|
T Consensus 88 l~~~~~~~~~~l~~L~~L~l~~n~l~-------------------------~~~~~~~~~l~~L~~L~l~~n~l~~~~l~ 142 (276)
T 2z62_A 88 IQSLALGAFSGLSSLQKLVAVETNLA-------------------------SLENFPIGHLKTLKELNVAHNLIQSFKLP 142 (276)
T ss_dssp CCEECTTTTTTCTTCCEEECTTSCCC-------------------------CSTTCCCTTCTTCCEEECCSSCCCCCCCC
T ss_pred cCccChhhhcCCccccEEECCCCCcc-------------------------ccCchhcccCCCCCEEECcCCccceecCc
Confidence 66555555666666666666665554 3333 244445555555555555431 22
Q ss_pred C-CCCCCCcCEEEccCCcCCCccchhccCCCCCC----eEeeecccCCCccchhhhcccccCccccceEeccCCCCCCCc
Q 002158 295 S-KKLSENVTTIDLSDNYLNGSILESISNLPFLQ----TLSLENNFLTGSIPATIWQNKSFSTKARLKIDLRNNSFSNIV 369 (958)
Q Consensus 295 ~-~~~~~~L~~L~Ls~N~l~~~~~~~~~~l~~L~----~L~L~~N~l~~~ip~~l~~~~~~~~~~l~~L~Ls~N~l~~l~ 369 (958)
. ...+++|++|+|++|++++..+..|..+++|+ .|++++|+++ .+|...+.. ..++.|+|++|+++.++
T Consensus 143 ~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~l~l~L~ls~n~l~-~~~~~~~~~-----~~L~~L~L~~n~l~~~~ 216 (276)
T 2z62_A 143 EYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMN-FIQPGAFKE-----IRLKELALDTNQLKSVP 216 (276)
T ss_dssp GGGGGCTTCCEEECCSSCCCEECGGGGHHHHTCTTCCEEEECCSSCCC-EECTTSSCS-----CCEEEEECCSSCCSCCC
T ss_pred hhhccCCCCCEEECCCCCCCcCCHHHhhhhhhccccceeeecCCCccc-ccCccccCC-----CcccEEECCCCceeecC
Confidence 2 23345566666666666655566666555555 7788888887 444444332 25678888888888887
Q ss_pred cCC--CCCCcceEEeCCCCCCCCC
Q 002158 370 GDL--TLPNNVTLRLGGNPICTSA 391 (958)
Q Consensus 370 ~~~--~l~~L~~L~l~~N~l~~~~ 391 (958)
... .+++|+.|+|++|||.|+|
T Consensus 217 ~~~~~~l~~L~~L~l~~N~~~c~c 240 (276)
T 2z62_A 217 DGIFDRLTSLQKIWLHTNPWDCSC 240 (276)
T ss_dssp TTTTTTCCSCCEEECCSSCBCCCT
T ss_pred HhHhcccccccEEEccCCcccccC
Confidence 654 7899999999999985544
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A | Back alignment and structure |
|---|
Probab=99.92 E-value=1.2e-24 Score=236.65 Aligned_cols=204 Identities=22% Similarity=0.242 Sum_probs=125.6
Q ss_pred ccCCCCCcEEEeeCCCCCCCCChhhcCCCCCCEEecccccccccCccccccccccceEecccccccccCchhhcCCccch
Q 002158 129 IGNISSLIFLLLNGNKLSGSLPDELGYLSNLNRLQVDENNITGTIPKSFANLSRVRHLHLNNNSIGGQIPSELSKLSTLI 208 (958)
Q Consensus 129 i~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~ 208 (958)
++++++|+++++++|.++ .+|..+. ++|++|+|++|++++..+..|.++++|++|+|++|.|++
T Consensus 6 ~~~l~~l~~l~~~~~~l~-~ip~~~~--~~l~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~------------- 69 (290)
T 1p9a_G 6 VSKVASHLEVNCDKRNLT-ALPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTK------------- 69 (290)
T ss_dssp EECSTTCCEEECTTSCCS-SCCSCCC--TTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCCE-------------
T ss_pred ccccCCccEEECCCCCCC-cCCCCCC--CCCCEEEcCCCcCCccCHHHhhcCCCCCEEECCCCccCc-------------
Confidence 455666666666666666 4554443 455666666666655555555555555555555555552
Q ss_pred hhhccCCccccCCCcccCCCCCccEEEccCCCCCCCCccccccCCCCCCEEEcccCCCCCCCCC-CCCCCCcCEEeccCC
Q 002158 209 HLLVDNNNLSGNLPPELSELPQLCILQLDNNNFSASEIPATYGNFSKLVKLSLRNCNLQGAVPD-LSRIPNLYYLDLSWN 287 (958)
Q Consensus 209 ~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~-l~~l~~L~~L~Ls~N 287 (958)
..+ ...+++|++|+|++|+++ .+|..+..+++|+.|+|++|+|++.++. |..+++|++|+|++|
T Consensus 70 -----------~~~--~~~l~~L~~L~Ls~N~l~--~l~~~~~~l~~L~~L~l~~N~l~~l~~~~~~~l~~L~~L~L~~N 134 (290)
T 1p9a_G 70 -----------LQV--DGTLPVLGTLDLSHNQLQ--SLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGN 134 (290)
T ss_dssp -----------EEC--CSCCTTCCEEECCSSCCS--SCCCCTTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEEECTTS
T ss_pred -----------ccC--CCCCCcCCEEECCCCcCC--cCchhhccCCCCCEEECCCCcCcccCHHHHcCCCCCCEEECCCC
Confidence 211 134556666666666664 4555566666666666666666666653 666777777777777
Q ss_pred cCCCcCCCC-CCCCCcCEEEccCCcCCCccchhccCCCCCCeEeeecccCCCccchhhhcccccCccccceEeccCCCCC
Q 002158 288 HLTGSIPSK-KLSENVTTIDLSDNYLNGSILESISNLPFLQTLSLENNFLTGSIPATIWQNKSFSTKARLKIDLRNNSFS 366 (958)
Q Consensus 288 ~l~~~~~~~-~~~~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~ip~~l~~~~~~~~~~l~~L~Ls~N~l~ 366 (958)
++++..+.. ..+++|+.|+|++|+|+...+..|..+++|+.|+|++|+|+ .+|..++.
T Consensus 135 ~l~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~l~~L~~L~L~~N~l~-~ip~~~~~-------------------- 193 (290)
T 1p9a_G 135 ELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLY-TIPKGFFG-------------------- 193 (290)
T ss_dssp CCCCCCTTTTTTCTTCCEEECTTSCCSCCCTTTTTTCTTCCEEECCSSCCC-CCCTTTTT--------------------
T ss_pred CCCccChhhcccccCCCEEECCCCcCCccCHHHhcCcCCCCEEECCCCcCC-ccChhhcc--------------------
Confidence 776443332 33466777777777777666677777888888888888887 56665533
Q ss_pred CCccCCCCCCcceEEeCCCCCCCCC
Q 002158 367 NIVGDLTLPNNVTLRLGGNPICTSA 391 (958)
Q Consensus 367 ~l~~~~~l~~L~~L~l~~N~l~~~~ 391 (958)
.++|+.|+|.+|||.|+|
T Consensus 194 -------~~~L~~l~L~~Np~~C~c 211 (290)
T 1p9a_G 194 -------SHLLPFAFLHGNPWLCNC 211 (290)
T ss_dssp -------TCCCSEEECCSCCBCCSG
T ss_pred -------cccCCeEEeCCCCccCcC
Confidence 345677777777774433
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.92 E-value=1.2e-25 Score=248.34 Aligned_cols=237 Identities=23% Similarity=0.196 Sum_probs=134.4
Q ss_pred cCCCCCcEEEeeCCCCCCCCChhhcCCCCCCEEecccccccccCccccccccccceEecccccccccCchhhcCCccchh
Q 002158 130 GNISSLIFLLLNGNKLSGSLPDELGYLSNLNRLQVDENNITGTIPKSFANLSRVRHLHLNNNSIGGQIPSELSKLSTLIH 209 (958)
Q Consensus 130 ~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~ 209 (958)
..+++|++|+|++|.+++..|..|..+++|++|+|++|++++..+ +..+++|++|+|++|.+++.. ..++|++
T Consensus 31 ~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~--~~~l~~L~~L~Ls~n~l~~l~-----~~~~L~~ 103 (317)
T 3o53_A 31 QSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYETLD--LESLSTLRTLDLNNNYVQELL-----VGPSIET 103 (317)
T ss_dssp TTGGGCSEEECTTSCCCCCCHHHHTTCTTCCEEECTTSCCEEEEE--ETTCTTCCEEECCSSEEEEEE-----ECTTCCE
T ss_pred ccCCCCCEEECcCCccCcCCHHHhhCCCcCCEEECCCCcCCcchh--hhhcCCCCEEECcCCcccccc-----CCCCcCE
Confidence 344556666666666665555556666666666666666654433 556666666666666665321 2256666
Q ss_pred hhccCCccccCCCcccCCCCCccEEEccCCCCCCCCccccccCCCCCCEEEcccCCCCCCCCC-C-CCCCCcCEEeccCC
Q 002158 210 LLVDNNNLSGNLPPELSELPQLCILQLDNNNFSASEIPATYGNFSKLVKLSLRNCNLQGAVPD-L-SRIPNLYYLDLSWN 287 (958)
Q Consensus 210 L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~-l-~~l~~L~~L~Ls~N 287 (958)
|++++|++++..+.. +++|++|++++|+++. ..+..+..+++|+.|+|++|++++..+. + ..+++|++|+|++|
T Consensus 104 L~l~~n~l~~~~~~~---~~~L~~L~l~~N~l~~-~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N 179 (317)
T 3o53_A 104 LHAANNNISRVSCSR---GQGKKNIYLANNKITM-LRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYN 179 (317)
T ss_dssp EECCSSCCSEEEECC---CSSCEEEECCSSCCCS-GGGBCTGGGSSEEEEECTTSCCCEEEGGGGGGGTTTCCEEECTTS
T ss_pred EECCCCccCCcCccc---cCCCCEEECCCCCCCC-ccchhhhccCCCCEEECCCCCCCcccHHHHhhccCcCCEEECCCC
Confidence 666666665443322 3556666666666652 2344555666666666666666655442 3 34566666666666
Q ss_pred cCCCcCCCCCCCCCcCEEEccCCcCCCccchhccCCCCCCeEeeecccCCCccchhhhcccccCccccceEeccCCCCC-
Q 002158 288 HLTGSIPSKKLSENVTTIDLSDNYLNGSILESISNLPFLQTLSLENNFLTGSIPATIWQNKSFSTKARLKIDLRNNSFS- 366 (958)
Q Consensus 288 ~l~~~~~~~~~~~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~ip~~l~~~~~~~~~~l~~L~Ls~N~l~- 366 (958)
.+++ ++....+++|++|+|++|+|++..+. +..+++|+.|+|++|+|+ .+|..+..+ +.++.|+|++|.++
T Consensus 180 ~l~~-~~~~~~l~~L~~L~Ls~N~l~~l~~~-~~~l~~L~~L~L~~N~l~-~l~~~~~~l-----~~L~~L~l~~N~~~~ 251 (317)
T 3o53_A 180 FIYD-VKGQVVFAKLKTLDLSSNKLAFMGPE-FQSAAGVTWISLRNNKLV-LIEKALRFS-----QNLEHFDLRGNGFHC 251 (317)
T ss_dssp CCCE-EECCCCCTTCCEEECCSSCCCEECGG-GGGGTTCSEEECTTSCCC-EECTTCCCC-----TTCCEEECTTCCCBH
T ss_pred cCcc-cccccccccCCEEECCCCcCCcchhh-hcccCcccEEECcCCccc-chhhHhhcC-----CCCCEEEccCCCccC
Confidence 6653 23344456666666666666644333 666666666666666666 455544322 34456666666666
Q ss_pred C-CccCC-CCCCcceEEeCCC
Q 002158 367 N-IVGDL-TLPNNVTLRLGGN 385 (958)
Q Consensus 367 ~-l~~~~-~l~~L~~L~l~~N 385 (958)
. ++... .+++|+.|++.+|
T Consensus 252 ~~~~~~~~~~~~L~~l~l~~~ 272 (317)
T 3o53_A 252 GTLRDFFSKNQRVQTVAKQTV 272 (317)
T ss_dssp HHHHHHHHTCHHHHHHHHHHH
T ss_pred cCHHHHHhccccceEEECCCc
Confidence 2 22222 5667777777644
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.91 E-value=6.1e-26 Score=250.69 Aligned_cols=258 Identities=20% Similarity=0.150 Sum_probs=210.6
Q ss_pred eeEEEEccCCcCCCCccccccCCCCcceeeccCcccCCCC-ccccCCCCCcEEEeeCCCCCCCCChhhcCCCCCCEEecc
Q 002158 87 HVRELQLLSMNLSGNLAPELGQLSRLQYYFMWNDLTGTIP-KEIGNISSLIFLLLNGNKLSGSLPDELGYLSNLNRLQVD 165 (958)
Q Consensus 87 ~v~~L~L~~~~l~~~~~~~l~~L~~L~~L~l~n~~~~~ip-~~i~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~L~ 165 (958)
....++++.+++...+...+..+++|+.|++++|....++ ..|.++++|++|+|++|.+++..+ +..+++|++|+|+
T Consensus 11 ~l~i~~ls~~~l~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~--~~~l~~L~~L~Ls 88 (317)
T 3o53_A 11 RYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYETLD--LESLSTLRTLDLN 88 (317)
T ss_dssp EEEEESCCTTTHHHHHHHHHTTGGGCSEEECTTSCCCCCCHHHHTTCTTCCEEECTTSCCEEEEE--ETTCTTCCEEECC
T ss_pred ceeEeeccccchhhhHHHHhccCCCCCEEECcCCccCcCCHHHhhCCCcCCEEECCCCcCCcchh--hhhcCCCCEEECc
Confidence 4556677777776666666677889999999876665554 679999999999999999986554 8999999999999
Q ss_pred cccccccCccccccccccceEecccccccccCchhhcCCccchhhhccCCccccCCCcccCCCCCccEEEccCCCCCCCC
Q 002158 166 ENNITGTIPKSFANLSRVRHLHLNNNSIGGQIPSELSKLSTLIHLLVDNNNLSGNLPPELSELPQLCILQLDNNNFSASE 245 (958)
Q Consensus 166 ~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~ 245 (958)
+|++++. ...++|++|++++|++++..+. .+++|+.|++++|++++..+..+..+++|++|+|++|.++..
T Consensus 89 ~n~l~~l-----~~~~~L~~L~l~~n~l~~~~~~---~~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~- 159 (317)
T 3o53_A 89 NNYVQEL-----LVGPSIETLHAANNNISRVSCS---RGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTV- 159 (317)
T ss_dssp SSEEEEE-----EECTTCCEEECCSSCCSEEEEC---CCSSCEEEECCSSCCCSGGGBCTGGGSSEEEEECTTSCCCEE-
T ss_pred CCccccc-----cCCCCcCEEECCCCccCCcCcc---ccCCCCEEECCCCCCCCccchhhhccCCCCEEECCCCCCCcc-
Confidence 9999843 2448999999999999966544 367899999999999988888899999999999999999743
Q ss_pred ccccc-cCCCCCCEEEcccCCCCCCCCCCCCCCCcCEEeccCCcCCCcCCCCCCCCCcCEEEccCCcCCCccchhccCCC
Q 002158 246 IPATY-GNFSKLVKLSLRNCNLQGAVPDLSRIPNLYYLDLSWNHLTGSIPSKKLSENVTTIDLSDNYLNGSILESISNLP 324 (958)
Q Consensus 246 ~p~~~-~~l~~L~~L~L~~N~l~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~~~L~~L~Ls~N~l~~~~~~~~~~l~ 324 (958)
.+..+ ..+++|+.|+|++|++++.+ ....+++|++|+|++|++++..+....+++|+.|+|++|+|+. +|..+..++
T Consensus 160 ~~~~~~~~l~~L~~L~L~~N~l~~~~-~~~~l~~L~~L~Ls~N~l~~l~~~~~~l~~L~~L~L~~N~l~~-l~~~~~~l~ 237 (317)
T 3o53_A 160 NFAELAASSDTLEHLNLQYNFIYDVK-GQVVFAKLKTLDLSSNKLAFMGPEFQSAAGVTWISLRNNKLVL-IEKALRFSQ 237 (317)
T ss_dssp EGGGGGGGTTTCCEEECTTSCCCEEE-CCCCCTTCCEEECCSSCCCEECGGGGGGTTCSEEECTTSCCCE-ECTTCCCCT
T ss_pred cHHHHhhccCcCCEEECCCCcCcccc-cccccccCCEEECCCCcCCcchhhhcccCcccEEECcCCcccc-hhhHhhcCC
Confidence 34444 57899999999999998774 4445899999999999999766666667999999999999994 677899999
Q ss_pred CCCeEeeecccCC-CccchhhhcccccCccccceEeccC
Q 002158 325 FLQTLSLENNFLT-GSIPATIWQNKSFSTKARLKIDLRN 362 (958)
Q Consensus 325 ~L~~L~L~~N~l~-~~ip~~l~~~~~~~~~~l~~L~Ls~ 362 (958)
+|+.|+|++|+++ +.+|..+..+ +.++.|++++
T Consensus 238 ~L~~L~l~~N~~~~~~~~~~~~~~-----~~L~~l~l~~ 271 (317)
T 3o53_A 238 NLEHFDLRGNGFHCGTLRDFFSKN-----QRVQTVAKQT 271 (317)
T ss_dssp TCCEEECTTCCCBHHHHHHHHHTC-----HHHHHHHHHH
T ss_pred CCCEEEccCCCccCcCHHHHHhcc-----ccceEEECCC
Confidence 9999999999998 6777776554 3455777773
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.91 E-value=3.2e-25 Score=259.31 Aligned_cols=234 Identities=21% Similarity=0.167 Sum_probs=182.5
Q ss_pred CCcceeeccCcccCCC-CccccCCCCCcEEEeeCCCCCCCCChhhcCCCCCCEEecccccccccCccccccccccceEec
Q 002158 110 SRLQYYFMWNDLTGTI-PKEIGNISSLIFLLLNGNKLSGSLPDELGYLSNLNRLQVDENNITGTIPKSFANLSRVRHLHL 188 (958)
Q Consensus 110 ~~L~~L~l~n~~~~~i-p~~i~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L 188 (958)
++|+.|++++|....+ |..|.++++|++|+|++|.+++..| +..+++|++|+|++|.|++.. ..++|+.|+|
T Consensus 34 ~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~Ls~N~l~~l~-----~~~~L~~L~L 106 (487)
T 3oja_A 34 WNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYETLD--LESLSTLRTLDLNNNYVQELL-----VGPSIETLHA 106 (487)
T ss_dssp GGCCEEECCSSCCCCCCGGGGTTCTTCCEEECTTSCCEEEEE--CTTCTTCCEEECCSSEEEEEE-----ECTTCCEEEC
T ss_pred CCccEEEeeCCcCCCCCHHHHhCCCCCCEEEeeCCCCCCCcc--cccCCCCCEEEecCCcCCCCC-----CCCCcCEEEC
Confidence 3788888876555444 4678888888999999888886555 888888999999999888433 2378889999
Q ss_pred ccccccccCchhhcCCccchhhhccCCccccCCCcccCCCCCccEEEccCCCCCCCCcccccc-CCCCCCEEEcccCCCC
Q 002158 189 NNNSIGGQIPSELSKLSTLIHLLVDNNNLSGNLPPELSELPQLCILQLDNNNFSASEIPATYG-NFSKLVKLSLRNCNLQ 267 (958)
Q Consensus 189 s~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~p~~~~-~l~~L~~L~L~~N~l~ 267 (958)
++|.|++..+. .+++|+.|+|++|++++..|..+..+++|+.|+|++|.+++ ..|..+. .+++|+.|+|++|.|+
T Consensus 107 ~~N~l~~~~~~---~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~-~~~~~l~~~l~~L~~L~Ls~N~l~ 182 (487)
T 3oja_A 107 ANNNISRVSCS---RGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDT-VNFAELAASSDTLEHLNLQYNFIY 182 (487)
T ss_dssp CSSCCCCEEEC---CCSSCEEEECCSSCCCSGGGBCGGGGSSEEEEECTTSCCCE-EEGGGGGGGTTTCCEEECTTSCCC
T ss_pred cCCcCCCCCcc---ccCCCCEEECCCCCCCCCCchhhcCCCCCCEEECCCCCCCC-cChHHHhhhCCcccEEecCCCccc
Confidence 99988865553 45788889999999988888888888999999999998874 3455554 7889999999999988
Q ss_pred CCCCCCCCCCCcCEEeccCCcCCCcCCCCCCCCCcCEEEccCCcCCCccchhccCCCCCCeEeeecccCC-Cccchhhhc
Q 002158 268 GAVPDLSRIPNLYYLDLSWNHLTGSIPSKKLSENVTTIDLSDNYLNGSILESISNLPFLQTLSLENNFLT-GSIPATIWQ 346 (958)
Q Consensus 268 ~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~-~~ip~~l~~ 346 (958)
+.+ .+..+++|+.|+|++|.+++.++....+++|+.|+|++|.|++ +|..+..+++|+.|+|++|++. +.+|..+..
T Consensus 183 ~~~-~~~~l~~L~~L~Ls~N~l~~~~~~~~~l~~L~~L~Ls~N~l~~-lp~~l~~l~~L~~L~l~~N~l~c~~~~~~~~~ 260 (487)
T 3oja_A 183 DVK-GQVVFAKLKTLDLSSNKLAFMGPEFQSAAGVTWISLRNNKLVL-IEKALRFSQNLEHFDLRGNGFHCGTLRDFFSK 260 (487)
T ss_dssp EEE-CCCCCTTCCEEECCSSCCCEECGGGGGGTTCSEEECTTSCCCE-ECTTCCCCTTCCEEECTTCCBCHHHHHHHHTT
T ss_pred ccc-ccccCCCCCEEECCCCCCCCCCHhHcCCCCccEEEecCCcCcc-cchhhccCCCCCEEEcCCCCCcCcchHHHHHh
Confidence 774 3446889999999999998776766667899999999999985 5667888899999999999987 566666654
Q ss_pred ccccCccccceEecc
Q 002158 347 NKSFSTKARLKIDLR 361 (958)
Q Consensus 347 ~~~~~~~~l~~L~Ls 361 (958)
+. .+..|+++
T Consensus 261 l~-----~L~~l~~~ 270 (487)
T 3oja_A 261 NQ-----RVQTVAKQ 270 (487)
T ss_dssp CH-----HHHHHHHH
T ss_pred CC-----CCcEEecc
Confidence 33 33455554
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I | Back alignment and structure |
|---|
Probab=99.90 E-value=7.2e-27 Score=272.41 Aligned_cols=302 Identities=18% Similarity=0.155 Sum_probs=196.6
Q ss_pred eeEEEEccCCcCCCCcccccc-CCC----CcceeeccCcccC-----CCCccccCCCCCcEEEeeCCCCCCCCChhhc--
Q 002158 87 HVRELQLLSMNLSGNLAPELG-QLS----RLQYYFMWNDLTG-----TIPKEIGNISSLIFLLLNGNKLSGSLPDELG-- 154 (958)
Q Consensus 87 ~v~~L~L~~~~l~~~~~~~l~-~L~----~L~~L~l~n~~~~-----~ip~~i~~l~~L~~L~Ls~n~l~~~~p~~l~-- 154 (958)
+++.|+|++|.+.+..+..+. .++ +|++|++++|..+ .+|..+.++++|++|+|++|.+++..+..+.
T Consensus 57 ~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~ 136 (461)
T 1z7x_W 57 ALAELNLRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLGDAGLQLLCEG 136 (461)
T ss_dssp TCCEEECTTCCCHHHHHHHHHHTTCSTTCCCCEEECTTSCCBGGGHHHHHHHTTSCTTCCEEECCSSBCHHHHHHHHHHH
T ss_pred CcCEEeCCCCcCChHHHHHHHHHHhhCCCceeEEEccCCCCCHHHHHHHHHHHccCCceeEEECCCCcCchHHHHHHHHH
Confidence 577777777777664443332 344 5777777765544 4566777777777777777777643333332
Q ss_pred ---CCCCCCEEeccccccccc----CccccccccccceEecccccccccCchhhc-----CCccchhhhccCCccccC--
Q 002158 155 ---YLSNLNRLQVDENNITGT----IPKSFANLSRVRHLHLNNNSIGGQIPSELS-----KLSTLIHLLVDNNNLSGN-- 220 (958)
Q Consensus 155 ---~l~~L~~L~L~~N~l~~~----~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~-----~l~~L~~L~L~~N~l~~~-- 220 (958)
.+++|++|+|++|++++. ++..+..+++|++|+|++|.+++..+..+. .+++|++|++++|++++.
T Consensus 137 l~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~ 216 (461)
T 1z7x_W 137 LLDPQCRLEKLQLEYCSLSAASCEPLASVLRAKPDFKELTVSNNDINEAGVRVLCQGLKDSPCQLEALKLESCGVTSDNC 216 (461)
T ss_dssp HTSTTCCCCEEECTTSCCBGGGHHHHHHHHHHCTTCCEEECCSSBCHHHHHHHHHHHHHHSCCCCCEEECTTSCCBTTHH
T ss_pred HhcCCCcceEEECCCCCCCHHHHHHHHHHHhhCCCCCEEECcCCCcchHHHHHHHHHHhcCCCCceEEEccCCCCcHHHH
Confidence 245677777777777753 345556667788888888777654443332 255777888888877753
Q ss_pred --CCcccCCCCCccEEEccCCCCCCCCc----cccccCCCCCCEEEcccCCCCCC-----CCCCCCCCCcCEEeccCCcC
Q 002158 221 --LPPELSELPQLCILQLDNNNFSASEI----PATYGNFSKLVKLSLRNCNLQGA-----VPDLSRIPNLYYLDLSWNHL 289 (958)
Q Consensus 221 --~~~~l~~l~~L~~L~L~~N~l~~~~~----p~~~~~l~~L~~L~L~~N~l~~~-----~~~l~~l~~L~~L~Ls~N~l 289 (958)
++..+..+++|++|+|++|.++.... +..+..+++|++|+|++|+++.. +..+..+++|++|+|++|.+
T Consensus 217 ~~l~~~l~~~~~L~~L~Ls~n~l~~~~~~~l~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~i 296 (461)
T 1z7x_W 217 RDLCGIVASKASLRELALGSNKLGDVGMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNEL 296 (461)
T ss_dssp HHHHHHHHHCTTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCTTCCEEECTTCCC
T ss_pred HHHHHHHHhCCCccEEeccCCcCChHHHHHHHHHHhcCCCCceEEECcCCCCCHHHHHHHHHHHhhCCCcceEECCCCCC
Confidence 35566677888888888887753111 22334577788888888877763 22355677888888888877
Q ss_pred CCcCCCC------CCCCCcCEEEccCCcCCCc----cchhccCCCCCCeEeeecccCCCccchhhhcccccCccccceEe
Q 002158 290 TGSIPSK------KLSENVTTIDLSDNYLNGS----ILESISNLPFLQTLSLENNFLTGSIPATIWQNKSFSTKARLKID 359 (958)
Q Consensus 290 ~~~~~~~------~~~~~L~~L~Ls~N~l~~~----~~~~~~~l~~L~~L~L~~N~l~~~ip~~l~~~~~~~~~~l~~L~ 359 (958)
++..+.. ...++|++|+|++|.+++. ++..+..+++|++|+|++|++++..+..+.....-..+.++.|+
T Consensus 297 ~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~ 376 (461)
T 1z7x_W 297 GDEGARLLCETLLEPGCQLESLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLW 376 (461)
T ss_dssp HHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGGHHHHHHHHHHCSSCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEE
T ss_pred chHHHHHHHHHhccCCccceeeEcCCCCCchHHHHHHHHHHhhCCCccEEEccCCccccccHHHHHHHHcCCCCceEEEE
Confidence 5321111 1125788888888888765 45666677888888888888876666655543222245677888
Q ss_pred ccCCCCCC-----CccCC-CCCCcceEEeCCCCCC
Q 002158 360 LRNNSFSN-----IVGDL-TLPNNVTLRLGGNPIC 388 (958)
Q Consensus 360 Ls~N~l~~-----l~~~~-~l~~L~~L~l~~N~l~ 388 (958)
|++|++++ ++... .+++|+.|++++|++.
T Consensus 377 L~~n~i~~~~~~~l~~~l~~~~~L~~L~l~~N~i~ 411 (461)
T 1z7x_W 377 LADCDVSDSSCSSLAATLLANHSLRELDLSNNCLG 411 (461)
T ss_dssp CTTSCCCHHHHHHHHHHHHHCCCCCEEECCSSSCC
T ss_pred CCCCCCChhhHHHHHHHHHhCCCccEEECCCCCCC
Confidence 88888873 44433 6788888888888874
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} | Back alignment and structure |
|---|
Probab=99.90 E-value=2.2e-22 Score=240.19 Aligned_cols=259 Identities=22% Similarity=0.242 Sum_probs=214.3
Q ss_pred CCcceeeccCcccCCCCccccCCCCCcEEEeeCCCCCCCCChhhcCCCCCCEEecccccccccCccccccccccceEecc
Q 002158 110 SRLQYYFMWNDLTGTIPKEIGNISSLIFLLLNGNKLSGSLPDELGYLSNLNRLQVDENNITGTIPKSFANLSRVRHLHLN 189 (958)
Q Consensus 110 ~~L~~L~l~n~~~~~ip~~i~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls 189 (958)
.+++.|+++++....+|..+. ++|++|+|++|.++ .+|. .+++|++|+|++|+|+ .+|. .+++|++|+|+
T Consensus 40 ~~l~~L~ls~n~L~~lp~~l~--~~L~~L~L~~N~l~-~lp~---~l~~L~~L~Ls~N~l~-~lp~---~l~~L~~L~Ls 109 (622)
T 3g06_A 40 NGNAVLNVGESGLTTLPDCLP--AHITTLVIPDNNLT-SLPA---LPPELRTLEVSGNQLT-SLPV---LPPGLLELSIF 109 (622)
T ss_dssp HCCCEEECCSSCCSCCCSCCC--TTCSEEEECSCCCS-CCCC---CCTTCCEEEECSCCCS-CCCC---CCTTCCEEEEC
T ss_pred CCCcEEEecCCCcCccChhhC--CCCcEEEecCCCCC-CCCC---cCCCCCEEEcCCCcCC-cCCC---CCCCCCEEECc
Confidence 458899999888889998876 89999999999999 6776 5799999999999999 4665 67999999999
Q ss_pred cccccccCchhhcCCccchhhhccCCccccCCCcccCCCCCccEEEccCCCCCCCCccccccCCCCCCEEEcccCCCCCC
Q 002158 190 NNSIGGQIPSELSKLSTLIHLLVDNNNLSGNLPPELSELPQLCILQLDNNNFSASEIPATYGNFSKLVKLSLRNCNLQGA 269 (958)
Q Consensus 190 ~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~p~~~~~l~~L~~L~L~~N~l~~~ 269 (958)
+|+|++ +|. .+++|+.|++++|+|++ +|.. +++|++|+|++|+++. +|. .+.+|+.|++++|+++++
T Consensus 110 ~N~l~~-l~~---~l~~L~~L~L~~N~l~~-lp~~---l~~L~~L~Ls~N~l~~--l~~---~~~~L~~L~L~~N~l~~l 176 (622)
T 3g06_A 110 SNPLTH-LPA---LPSGLCKLWIFGNQLTS-LPVL---PPGLQELSVSDNQLAS--LPA---LPSELCKLWAYNNQLTSL 176 (622)
T ss_dssp SCCCCC-CCC---CCTTCCEEECCSSCCSC-CCCC---CTTCCEEECCSSCCSC--CCC---CCTTCCEEECCSSCCSCC
T ss_pred CCcCCC-CCC---CCCCcCEEECCCCCCCc-CCCC---CCCCCEEECcCCcCCC--cCC---ccCCCCEEECCCCCCCCC
Confidence 999995 554 67899999999999996 4443 4899999999999973 454 357899999999999987
Q ss_pred CCCCCCCCCcCEEeccCCcCCCcCCCCCCCCCcCEEEccCCcCCCccchhccCCCCCCeEeeecccCCCccchhhhcccc
Q 002158 270 VPDLSRIPNLYYLDLSWNHLTGSIPSKKLSENVTTIDLSDNYLNGSILESISNLPFLQTLSLENNFLTGSIPATIWQNKS 349 (958)
Q Consensus 270 ~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~ip~~l~~~~~ 349 (958)
+ ..+++|+.|+|++|.+++ +|. .+++|+.|++++|.|+... . .+++|+.|+|++|.|++ +|..
T Consensus 177 ~---~~~~~L~~L~Ls~N~l~~-l~~--~~~~L~~L~L~~N~l~~l~-~---~~~~L~~L~Ls~N~L~~-lp~~------ 239 (622)
T 3g06_A 177 P---MLPSGLQELSVSDNQLAS-LPT--LPSELYKLWAYNNRLTSLP-A---LPSGLKELIVSGNRLTS-LPVL------ 239 (622)
T ss_dssp C---CCCTTCCEEECCSSCCSC-CCC--CCTTCCEEECCSSCCSSCC-C---CCTTCCEEECCSSCCSC-CCCC------
T ss_pred c---ccCCCCcEEECCCCCCCC-CCC--ccchhhEEECcCCcccccC-C---CCCCCCEEEccCCccCc-CCCC------
Confidence 6 557899999999999995 443 3589999999999998544 2 35899999999999995 6622
Q ss_pred cCccccceEeccCCCCCCCccCCCCCCcceEEeCCCCCCCCCCCCCCCcccccCCCCCccccccCCCC
Q 002158 350 FSTKARLKIDLRNNSFSNIVGDLTLPNNVTLRLGGNPICTSANIPNTGRFCGSDAGGDETLTNSKVNC 417 (958)
Q Consensus 350 ~~~~~l~~L~Ls~N~l~~l~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~~~~~~~~~L~~n~~~C 417 (958)
.+.|+.|+|++|+|+.++. .+++|+.|+|++|.+... + ..+........+.|.+|++..
T Consensus 240 --l~~L~~L~Ls~N~L~~lp~--~~~~L~~L~Ls~N~L~~l---p--~~l~~l~~L~~L~L~~N~l~~ 298 (622)
T 3g06_A 240 --PSELKELMVSGNRLTSLPM--LPSGLLSLSVYRNQLTRL---P--ESLIHLSSETTVNLEGNPLSE 298 (622)
T ss_dssp --CTTCCEEECCSSCCSCCCC--CCTTCCEEECCSSCCCSC---C--GGGGGSCTTCEEECCSCCCCH
T ss_pred --CCcCcEEECCCCCCCcCCc--ccccCcEEeCCCCCCCcC---C--HHHhhccccCEEEecCCCCCC
Confidence 2578899999999999988 789999999999999732 2 224445666778889988753
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I | Back alignment and structure |
|---|
Probab=99.90 E-value=3.5e-26 Score=266.61 Aligned_cols=302 Identities=19% Similarity=0.161 Sum_probs=223.1
Q ss_pred eeeEEEEccCCcCCCCcccc-ccCCCCcceeeccCcccC-----CCCccccCCCCCcEEEeeCCCCCCCCChhhc-CCC-
Q 002158 86 LHVRELQLLSMNLSGNLAPE-LGQLSRLQYYFMWNDLTG-----TIPKEIGNISSLIFLLLNGNKLSGSLPDELG-YLS- 157 (958)
Q Consensus 86 ~~v~~L~L~~~~l~~~~~~~-l~~L~~L~~L~l~n~~~~-----~ip~~i~~l~~L~~L~Ls~n~l~~~~p~~l~-~l~- 157 (958)
.+++.|+|++++++...... +..+++|+.|+++++..+ .++..+..+++|++|+|++|.+++..+..+. .++
T Consensus 3 ~~l~~L~Ls~~~l~~~~~~~~~~~~~~L~~L~L~~~~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~ 82 (461)
T 1z7x_W 3 LDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQT 82 (461)
T ss_dssp EEEEEEEEESCCCCHHHHHHHHHHHTTCSEEEEESSCCCHHHHHHHHHHHHTCTTCCEEECTTCCCHHHHHHHHHHTTCS
T ss_pred ccceehhhhhcccCchhHHHHHhhcCCccEEEccCCCCCHHHHHHHHHHHHhCCCcCEEeCCCCcCChHHHHHHHHHHhh
Confidence 47889999988887765444 777889999988876655 4577788889999999999988754444443 355
Q ss_pred ---CCCEEecccccccc----cCccccccccccceEecccccccccCchhhc-----CCccchhhhccCCccccCC----
Q 002158 158 ---NLNRLQVDENNITG----TIPKSFANLSRVRHLHLNNNSIGGQIPSELS-----KLSTLIHLLVDNNNLSGNL---- 221 (958)
Q Consensus 158 ---~L~~L~L~~N~l~~----~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~-----~l~~L~~L~L~~N~l~~~~---- 221 (958)
+|++|+|++|+++. .++..+..+++|++|+|++|.+++..+..+. ..++|++|+|++|++++..
T Consensus 83 ~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~l 162 (461)
T 1z7x_W 83 PSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEPL 162 (461)
T ss_dssp TTCCCCEEECTTSCCBGGGHHHHHHHTTSCTTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGGHHHH
T ss_pred CCCceeEEEccCCCCCHHHHHHHHHHHccCCceeEEECCCCcCchHHHHHHHHHHhcCCCcceEEECCCCCCCHHHHHHH
Confidence 69999999999884 5678888899999999999998754444332 3567999999999888643
Q ss_pred CcccCCCCCccEEEccCCCCCCCCcccccc-----CCCCCCEEEcccCCCCCCC----C-CCCCCCCcCEEeccCCcCCC
Q 002158 222 PPELSELPQLCILQLDNNNFSASEIPATYG-----NFSKLVKLSLRNCNLQGAV----P-DLSRIPNLYYLDLSWNHLTG 291 (958)
Q Consensus 222 ~~~l~~l~~L~~L~L~~N~l~~~~~p~~~~-----~l~~L~~L~L~~N~l~~~~----~-~l~~l~~L~~L~Ls~N~l~~ 291 (958)
+..+..+++|++|+|++|.++. ..+..+. ..++|+.|+|++|.+++.. + .+..+++|+.|+|++|.+++
T Consensus 163 ~~~l~~~~~L~~L~L~~n~i~~-~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~l~~ 241 (461)
T 1z7x_W 163 ASVLRAKPDFKELTVSNNDINE-AGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDLCGIVASKASLRELALGSNKLGD 241 (461)
T ss_dssp HHHHHHCTTCCEEECCSSBCHH-HHHHHHHHHHHHSCCCCCEEECTTSCCBTTHHHHHHHHHHHCTTCCEEECCSSBCHH
T ss_pred HHHHhhCCCCCEEECcCCCcch-HHHHHHHHHHhcCCCCceEEEccCCCCcHHHHHHHHHHHHhCCCccEEeccCCcCCh
Confidence 5566677899999999998863 2122222 3568999999999888642 2 36678889999999998864
Q ss_pred cC-----CCC-CCCCCcCEEEccCCcCCCc----cchhccCCCCCCeEeeecccCCCccchhhhcccccCccccceEecc
Q 002158 292 SI-----PSK-KLSENVTTIDLSDNYLNGS----ILESISNLPFLQTLSLENNFLTGSIPATIWQNKSFSTKARLKIDLR 361 (958)
Q Consensus 292 ~~-----~~~-~~~~~L~~L~Ls~N~l~~~----~~~~~~~l~~L~~L~L~~N~l~~~ip~~l~~~~~~~~~~l~~L~Ls 361 (958)
.. +.. ..+++|++|+|++|.++.. ++..+..+++|++|+|++|.+++..+..+.....-..+.++.|+|+
T Consensus 242 ~~~~~l~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~ 321 (461)
T 1z7x_W 242 VGMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGARLLCETLLEPGCQLESLWVK 321 (461)
T ss_dssp HHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCTTCCEEECTTCCCHHHHHHHHHHHHTSTTCCCCEEECT
T ss_pred HHHHHHHHHHhcCCCCceEEECcCCCCCHHHHHHHHHHHhhCCCcceEECCCCCCchHHHHHHHHHhccCCccceeeEcC
Confidence 21 111 2357899999999998875 5667777899999999999987666666655433334578889999
Q ss_pred CCCCCCCc-----cCC-CCCCcceEEeCCCCCC
Q 002158 362 NNSFSNIV-----GDL-TLPNNVTLRLGGNPIC 388 (958)
Q Consensus 362 ~N~l~~l~-----~~~-~l~~L~~L~l~~N~l~ 388 (958)
+|.++... ... .+++|+.|++++|++.
T Consensus 322 ~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~ 354 (461)
T 1z7x_W 322 SCSFTAACCSHFSSVLAQNRFLLELQISNNRLE 354 (461)
T ss_dssp TSCCBGGGHHHHHHHHHHCSSCCEEECCSSBCH
T ss_pred CCCCchHHHHHHHHHHhhCCCccEEEccCCccc
Confidence 99888642 222 5688899999998874
|
| >4glp_A Monocyte differentiation antigen CD14; alpha beta BENT solenoid, LRR, lipopolysaccharide, serum, CD leucine-rich repeat, pattern recognition; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.89 E-value=2.5e-23 Score=228.99 Aligned_cols=200 Identities=20% Similarity=0.199 Sum_probs=121.5
Q ss_pred CCCCcEEEeeCCCCCCCCChhh--cCCCCCCEEecccccccccCc----cccccccccceEecccccccccCchhhcCCc
Q 002158 132 ISSLIFLLLNGNKLSGSLPDEL--GYLSNLNRLQVDENNITGTIP----KSFANLSRVRHLHLNNNSIGGQIPSELSKLS 205 (958)
Q Consensus 132 l~~L~~L~Ls~n~l~~~~p~~l--~~l~~L~~L~L~~N~l~~~~p----~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~ 205 (958)
+++|++|+|++|.+++..|..+ ..+++|++|+|++|++++..+ ..+..+++|++|+|++|.+++..+..+..++
T Consensus 90 ~~~L~~L~l~~n~l~~~~~~~~~~~~~~~L~~L~Ls~n~i~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~l~ 169 (310)
T 4glp_A 90 YSRLKELTLEDLKITGTMPPLPLEATGLALSSLRLRNVSWATGRSWLAELQQWLKPGLKVLSIAQAHSPAFSCEQVRAFP 169 (310)
T ss_dssp HSCCCEEEEESCCCBSCCCCCSSSCCCBCCSSCEEESCCCSSTTSSHHHHHTTBCSCCCEEEEECCSSCCCCTTSCCCCT
T ss_pred cCceeEEEeeCCEeccchhhhhhhccCCCCCEEEeecccccchhhhhHHHHhhhccCCCEEEeeCCCcchhhHHHhccCC
Confidence 3457777777777766666666 666677777777777665433 2334566777777777777666666666677
Q ss_pred cchhhhccCCccccC----CCcccCCCCCccEEEccCCCCCCCCccc----cccCCCCCCEEEcccCCCCCCCC-CCCCC
Q 002158 206 TLIHLLVDNNNLSGN----LPPELSELPQLCILQLDNNNFSASEIPA----TYGNFSKLVKLSLRNCNLQGAVP-DLSRI 276 (958)
Q Consensus 206 ~L~~L~L~~N~l~~~----~~~~l~~l~~L~~L~L~~N~l~~~~~p~----~~~~l~~L~~L~L~~N~l~~~~~-~l~~l 276 (958)
+|++|+|++|++.+. .+..+..+++|++|+|++|+++ .++. .+.++++|++|+|++|++++..| .+..+
T Consensus 170 ~L~~L~Ls~N~l~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~--~l~~~~~~l~~~l~~L~~L~Ls~N~l~~~~p~~~~~~ 247 (310)
T 4glp_A 170 ALTSLDLSDNPGLGERGLMAALCPHKFPAIQNLALRNTGME--TPTGVCAALAAAGVQPHSLDLSHNSLRATVNPSAPRC 247 (310)
T ss_dssp TCCEEECCSCTTCHHHHHHTTSCTTSSCCCCSCBCCSSCCC--CHHHHHHHHHHHTCCCSSEECTTSCCCCCCCSCCSSC
T ss_pred CCCEEECCCCCCccchhhhHHHhhhcCCCCCEEECCCCCCC--chHHHHHHHHhcCCCCCEEECCCCCCCccchhhHHhc
Confidence 777777777765531 1223356666777777777664 2232 24566667777777777766633 34333
Q ss_pred ---CCcCEEeccCCcCCCcCCCCCCCCCcCEEEccCCcCCCccchhccCCCCCCeEeeecccCC
Q 002158 277 ---PNLYYLDLSWNHLTGSIPSKKLSENVTTIDLSDNYLNGSILESISNLPFLQTLSLENNFLT 337 (958)
Q Consensus 277 ---~~L~~L~Ls~N~l~~~~~~~~~~~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~ 337 (958)
++|++|+|++|+|+ .+|.... ++|++|+|++|+|++. |. +..+++|+.|+|++|+|+
T Consensus 248 ~~~~~L~~L~Ls~N~l~-~lp~~~~-~~L~~L~Ls~N~l~~~-~~-~~~l~~L~~L~L~~N~l~ 307 (310)
T 4glp_A 248 MWSSALNSLNLSFAGLE-QVPKGLP-AKLRVLDLSSNRLNRA-PQ-PDELPEVDNLTLDGNPFL 307 (310)
T ss_dssp CCCTTCCCEECCSSCCC-SCCSCCC-SCCSCEECCSCCCCSC-CC-TTSCCCCSCEECSSTTTS
T ss_pred cCcCcCCEEECCCCCCC-chhhhhc-CCCCEEECCCCcCCCC-ch-hhhCCCccEEECcCCCCC
Confidence 56666777766666 4443332 5666666666666654 22 455666666666666665
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A | Back alignment and structure |
|---|
Probab=99.89 E-value=1.8e-23 Score=225.51 Aligned_cols=209 Identities=21% Similarity=0.245 Sum_probs=158.7
Q ss_pred ccCCCCCcEEEeeCCCCCCCCChhhcCCCCCCEEecccccccccCccccccccccceEecccccccccCchhhcCCccch
Q 002158 129 IGNISSLIFLLLNGNKLSGSLPDELGYLSNLNRLQVDENNITGTIPKSFANLSRVRHLHLNNNSIGGQIPSELSKLSTLI 208 (958)
Q Consensus 129 i~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~ 208 (958)
+..+++|+.|++++|.++ .++ .+..+++|++|+|++|++++. ..+..+++|++|+|++|.+++..+..+.++++|+
T Consensus 37 ~~~l~~L~~L~l~~~~i~-~~~-~l~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~ 112 (272)
T 3rfs_A 37 QNELNSIDQIIANNSDIK-SVQ-GIQYLPNVRYLALGGNKLHDI--SALKELTNLTYLILTGNQLQSLPNGVFDKLTNLK 112 (272)
T ss_dssp HHHHTTCCEEECTTSCCC-CCT-TGGGCTTCCEEECTTSCCCCC--GGGTTCTTCCEEECTTSCCCCCCTTTTTTCTTCC
T ss_pred cccccceeeeeeCCCCcc-ccc-ccccCCCCcEEECCCCCCCCc--hhhcCCCCCCEEECCCCccCccChhHhcCCcCCC
Confidence 456677777777777776 333 477777888888888877752 3677777888888888888766666677788888
Q ss_pred hhhccCCccccCCCcccCCCCCccEEEccCCCCCCCCccccccCCCCCCEEEcccCCCCCCCCC-CCCCCCcCEEeccCC
Q 002158 209 HLLVDNNNLSGNLPPELSELPQLCILQLDNNNFSASEIPATYGNFSKLVKLSLRNCNLQGAVPD-LSRIPNLYYLDLSWN 287 (958)
Q Consensus 209 ~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~-l~~l~~L~~L~Ls~N 287 (958)
+|+|++|++++..+..|..+++|++|+|++|+++ ...+..+..+++|+.|+|++|++++.++. +..+++|+.|+|++|
T Consensus 113 ~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~-~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N 191 (272)
T 3rfs_A 113 ELVLVENQLQSLPDGVFDKLTNLTYLNLAHNQLQ-SLPKGVFDKLTNLTELDLSYNQLQSLPEGVFDKLTQLKDLRLYQN 191 (272)
T ss_dssp EEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred EEECCCCcCCccCHHHhccCCCCCEEECCCCccC-ccCHHHhccCccCCEEECCCCCcCccCHHHhcCCccCCEEECCCC
Confidence 8888888887777777788888888888888876 33345567788888888888888877765 677888888888888
Q ss_pred cCCCcCCCC-CCCCCcCEEEccCCcCCCccchhccCCCCCCeEeeecccCCCccchhhhcccc
Q 002158 288 HLTGSIPSK-KLSENVTTIDLSDNYLNGSILESISNLPFLQTLSLENNFLTGSIPATIWQNKS 349 (958)
Q Consensus 288 ~l~~~~~~~-~~~~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~ip~~l~~~~~ 349 (958)
++++..+.. ..+++|+.|+|++|.+.+ .+++|+.|+++.|.++|.+|.++..+..
T Consensus 192 ~l~~~~~~~~~~l~~L~~L~l~~N~~~~-------~~~~l~~l~~~~n~~~g~ip~~~~~~~~ 247 (272)
T 3rfs_A 192 QLKSVPDGVFDRLTSLQYIWLHDNPWDC-------TCPGIRYLSEWINKHSGVVRNSAGSVAP 247 (272)
T ss_dssp CCSCCCTTTTTTCTTCCEEECCSSCBCC-------CTTTTHHHHHHHHHTGGGBBCTTSCBCG
T ss_pred cCCccCHHHHhCCcCCCEEEccCCCccc-------cCcHHHHHHHHHHhCCCcccCcccccCC
Confidence 888655543 456888888888888763 4667999999999999999998877655
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A | Back alignment and structure |
|---|
Probab=99.89 E-value=7.2e-23 Score=220.81 Aligned_cols=209 Identities=21% Similarity=0.269 Sum_probs=114.4
Q ss_pred ccCCCCcceeeccCcccCCCCccccCCCCCcEEEeeCCCCCCCCChhhcCCCCCCEEecccccccccCccccccccccce
Q 002158 106 LGQLSRLQYYFMWNDLTGTIPKEIGNISSLIFLLLNGNKLSGSLPDELGYLSNLNRLQVDENNITGTIPKSFANLSRVRH 185 (958)
Q Consensus 106 l~~L~~L~~L~l~n~~~~~ip~~i~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~ 185 (958)
+..+++|+.|.++++....++ .+..+++|++|+|++|.+++ + ..+..+++|++|+|++|++++..+..|.++++|++
T Consensus 37 ~~~l~~L~~L~l~~~~i~~~~-~l~~l~~L~~L~l~~n~l~~-~-~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~ 113 (272)
T 3rfs_A 37 QNELNSIDQIIANNSDIKSVQ-GIQYLPNVRYLALGGNKLHD-I-SALKELTNLTYLILTGNQLQSLPNGVFDKLTNLKE 113 (272)
T ss_dssp HHHHTTCCEEECTTSCCCCCT-TGGGCTTCCEEECTTSCCCC-C-GGGTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCE
T ss_pred cccccceeeeeeCCCCccccc-ccccCCCCcEEECCCCCCCC-c-hhhcCCCCCCEEECCCCccCccChhHhcCCcCCCE
Confidence 344555555555555444443 35555556666666655553 2 24555555666666666555554545555556666
Q ss_pred EecccccccccCchhhcCCccchhhhccCCccccCCCcccCCCCCccEEEccCCCCCCCCccccccCCCCCCEEEcccCC
Q 002158 186 LHLNNNSIGGQIPSELSKLSTLIHLLVDNNNLSGNLPPELSELPQLCILQLDNNNFSASEIPATYGNFSKLVKLSLRNCN 265 (958)
Q Consensus 186 L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~p~~~~~l~~L~~L~L~~N~ 265 (958)
|+|++|++++..+..+..+++|++|+|++|++++..+..+..+++|++|+|++|+++ ...+..+.++++|+.|+|++|+
T Consensus 114 L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~-~~~~~~~~~l~~L~~L~L~~N~ 192 (272)
T 3rfs_A 114 LVLVENQLQSLPDGVFDKLTNLTYLNLAHNQLQSLPKGVFDKLTNLTELDLSYNQLQ-SLPEGVFDKLTQLKDLRLYQNQ 192 (272)
T ss_dssp EECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCTTCCEEECCSSC
T ss_pred EECCCCcCCccCHHHhccCCCCCEEECCCCccCccCHHHhccCccCCEEECCCCCcC-ccCHHHhcCCccCCEEECCCCc
Confidence 666666655544445555555666666666555555555555556666666666554 2223345555556666666665
Q ss_pred CCCCCCC-CCCCCCcCEEeccCCcCCCcCCCCCCCCCcCEEEccCCcCCCccchhccCCC
Q 002158 266 LQGAVPD-LSRIPNLYYLDLSWNHLTGSIPSKKLSENVTTIDLSDNYLNGSILESISNLP 324 (958)
Q Consensus 266 l~~~~~~-l~~l~~L~~L~Ls~N~l~~~~~~~~~~~~L~~L~Ls~N~l~~~~~~~~~~l~ 324 (958)
+++.++. +..+++|+.|+|++|.+.+.. ++|+.|+++.|.++|.+|..++.++
T Consensus 193 l~~~~~~~~~~l~~L~~L~l~~N~~~~~~------~~l~~l~~~~n~~~g~ip~~~~~~~ 246 (272)
T 3rfs_A 193 LKSVPDGVFDRLTSLQYIWLHDNPWDCTC------PGIRYLSEWINKHSGVVRNSAGSVA 246 (272)
T ss_dssp CSCCCTTTTTTCTTCCEEECCSSCBCCCT------TTTHHHHHHHHHTGGGBBCTTSCBC
T ss_pred CCccCHHHHhCCcCCCEEEccCCCccccC------cHHHHHHHHHHhCCCcccCcccccC
Confidence 5555543 455555666666665554332 2455555555555555555555443
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A | Back alignment and structure |
|---|
Probab=99.89 E-value=2.1e-22 Score=219.00 Aligned_cols=203 Identities=24% Similarity=0.172 Sum_probs=154.9
Q ss_pred cccCCCCcceeeccCcccCCCCccccCCCCCcEEEeeCCCCCCCCChhhcCCCCCCEEecccccccccCccccccccccc
Q 002158 105 ELGQLSRLQYYFMWNDLTGTIPKEIGNISSLIFLLLNGNKLSGSLPDELGYLSNLNRLQVDENNITGTIPKSFANLSRVR 184 (958)
Q Consensus 105 ~l~~L~~L~~L~l~n~~~~~ip~~i~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~ 184 (958)
.++++++|+.++++++....+|..+. ++|++|+|++|.+++..+..|..+++|++|+|++|++++..+ ...+++|+
T Consensus 5 ~~~~l~~l~~l~~~~~~l~~ip~~~~--~~l~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~--~~~l~~L~ 80 (290)
T 1p9a_G 5 EVSKVASHLEVNCDKRNLTALPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTKLQV--DGTLPVLG 80 (290)
T ss_dssp EEECSTTCCEEECTTSCCSSCCSCCC--TTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCCEEEC--CSCCTTCC
T ss_pred cccccCCccEEECCCCCCCcCCCCCC--CCCCEEEcCCCcCCccCHHHhhcCCCCCEEECCCCccCcccC--CCCCCcCC
Confidence 36678888888888888888888775 689999999999998888899999999999999999995433 37889999
Q ss_pred eEecccccccccCchhhcCCccchhhhccCCccccCCCcccCCCCCccEEEccCCCCCCCCccccccCCCCCCEEEcccC
Q 002158 185 HLHLNNNSIGGQIPSELSKLSTLIHLLVDNNNLSGNLPPELSELPQLCILQLDNNNFSASEIPATYGNFSKLVKLSLRNC 264 (958)
Q Consensus 185 ~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~p~~~~~l~~L~~L~L~~N 264 (958)
+|+|++|+|+ .+|..+..+++|++|+|++|+|++..+..|..+++|++|+|++|+++. ..+..|..+++|+.|+|++|
T Consensus 81 ~L~Ls~N~l~-~l~~~~~~l~~L~~L~l~~N~l~~l~~~~~~~l~~L~~L~L~~N~l~~-~~~~~~~~l~~L~~L~L~~N 158 (290)
T 1p9a_G 81 TLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKT-LPPGLLTPTPKLEKLSLANN 158 (290)
T ss_dssp EEECCSSCCS-SCCCCTTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEEECTTSCCCC-CCTTTTTTCTTCCEEECTTS
T ss_pred EEECCCCcCC-cCchhhccCCCCCEEECCCCcCcccCHHHHcCCCCCCEEECCCCCCCc-cChhhcccccCCCEEECCCC
Confidence 9999999998 677778888888888888888887777778888888888888888762 33445667777777777777
Q ss_pred CCCCCCCC-CCCCCCcCEEeccCCcCCCcCCCCCCCCCcCEEEccCCcCCCccchhccCCCCCCeEeeecccCC
Q 002158 265 NLQGAVPD-LSRIPNLYYLDLSWNHLTGSIPSKKLSENVTTIDLSDNYLNGSILESISNLPFLQTLSLENNFLT 337 (958)
Q Consensus 265 ~l~~~~~~-l~~l~~L~~L~Ls~N~l~~~~~~~~~~~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~ 337 (958)
+|++.++. +..+++|+.|+|++|+|+. +|..+..+++|+.|+|++|++.
T Consensus 159 ~l~~l~~~~~~~l~~L~~L~L~~N~l~~------------------------ip~~~~~~~~L~~l~L~~Np~~ 208 (290)
T 1p9a_G 159 NLTELPAGLLNGLENLDTLLLQENSLYT------------------------IPKGFFGSHLLPFAFLHGNPWL 208 (290)
T ss_dssp CCSCCCTTTTTTCTTCCEEECCSSCCCC------------------------CCTTTTTTCCCSEEECCSCCBC
T ss_pred cCCccCHHHhcCcCCCCEEECCCCcCCc------------------------cChhhcccccCCeEEeCCCCcc
Confidence 77766654 5666666666666666662 3333444556666666666665
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.88 E-value=8.2e-22 Score=212.28 Aligned_cols=214 Identities=22% Similarity=0.278 Sum_probs=151.2
Q ss_pred CCCCceeeCccccCCCceeeEEEEccCCcCCCCccccccCCCCcceeeccCcccCCCCccccCCCCCcEEEeeCCCCCCC
Q 002158 69 SNWTGVLCFDTVETDGHLHVRELQLLSMNLSGNLAPELGQLSRLQYYFMWNDLTGTIPKEIGNISSLIFLLLNGNKLSGS 148 (958)
Q Consensus 69 ~~w~gV~C~~~~~~~~~~~v~~L~L~~~~l~~~~~~~l~~L~~L~~L~l~n~~~~~ip~~i~~l~~L~~L~Ls~n~l~~~ 148 (958)
|.|.|+.|... ...+.+++++++++. +|..+. ++|++|+|++|.+++.
T Consensus 5 C~~~~~~C~c~------~~~~~l~~~~~~l~~------------------------ip~~~~--~~l~~L~l~~n~l~~~ 52 (270)
T 2o6q_A 5 CKKDGGVCSCN------NNKNSVDCSSKKLTA------------------------IPSNIP--ADTKKLDLQSNKLSSL 52 (270)
T ss_dssp BGGGTCSBEEE------TTTTEEECTTSCCSS------------------------CCSCCC--TTCSEEECCSSCCSCC
T ss_pred CCCCCCCCEeC------CCCCEEEccCCCCCc------------------------cCCCCC--CCCCEEECcCCCCCee
Confidence 47999999532 124566666666553 333332 4677778888877765
Q ss_pred CChhhcCCCCCCEEecccccccccCccccccccccceEecccccccccCchhhcCCccchhhhccCCccccCCCcccCCC
Q 002158 149 LPDELGYLSNLNRLQVDENNITGTIPKSFANLSRVRHLHLNNNSIGGQIPSELSKLSTLIHLLVDNNNLSGNLPPELSEL 228 (958)
Q Consensus 149 ~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~l~~l 228 (958)
.+..|.++++|++|+|++|+++...+..|.++++|++|+|++|.+++..+..|..+++|++|+|++|++++..+..|..+
T Consensus 53 ~~~~~~~l~~L~~L~l~~n~l~~i~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l 132 (270)
T 2o6q_A 53 PSKAFHRLTKLRLLYLNDNKLQTLPAGIFKELKNLETLWVTDNKLQALPIGVFDQLVNLAELRLDRNQLKSLPPRVFDSL 132 (270)
T ss_dssp CTTSSSSCTTCCEEECCSSCCSCCCTTTTSSCTTCCEEECCSSCCCCCCTTTTTTCSSCCEEECCSSCCCCCCTTTTTTC
T ss_pred CHHHhcCCCCCCEEECCCCccCeeChhhhcCCCCCCEEECCCCcCCcCCHhHcccccCCCEEECCCCccCeeCHHHhCcC
Confidence 55677778888888888888775555566777888888888888876666677778888888888888887777778888
Q ss_pred CCccEEEccCCCCCCCCccccccCCCCCCEEEcccCCCCCCCCC-CCCCCCcCEEeccCCcCCCcCCCCCCCCCcCEEEc
Q 002158 229 PQLCILQLDNNNFSASEIPATYGNFSKLVKLSLRNCNLQGAVPD-LSRIPNLYYLDLSWNHLTGSIPSKKLSENVTTIDL 307 (958)
Q Consensus 229 ~~L~~L~L~~N~l~~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~-l~~l~~L~~L~Ls~N~l~~~~~~~~~~~~L~~L~L 307 (958)
++|++|+|++|+++. ..+..|..+++|+.|+|++|++++.++. |..+++|+.|+|++|++++
T Consensus 133 ~~L~~L~Ls~n~l~~-~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~---------------- 195 (270)
T 2o6q_A 133 TKLTYLSLGYNELQS-LPKGVFDKLTSLKELRLYNNQLKRVPEGAFDKLTELKTLKLDNNQLKR---------------- 195 (270)
T ss_dssp TTCCEEECCSSCCCC-CCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCCSC----------------
T ss_pred cCCCEEECCCCcCCc-cCHhHccCCcccceeEecCCcCcEeChhHhccCCCcCEEECCCCcCCc----------------
Confidence 888888888888863 3344578888888888888888877764 6777777777777777663
Q ss_pred cCCcCCCccchhccCCCCCCeEeeecccCCC
Q 002158 308 SDNYLNGSILESISNLPFLQTLSLENNFLTG 338 (958)
Q Consensus 308 s~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~ 338 (958)
..+..|..+++|+.|+|++|++..
T Consensus 196 -------~~~~~~~~l~~L~~L~l~~N~~~c 219 (270)
T 2o6q_A 196 -------VPEGAFDSLEKLKMLQLQENPWDC 219 (270)
T ss_dssp -------CCTTTTTTCTTCCEEECCSSCBCC
T ss_pred -------CCHHHhccccCCCEEEecCCCeeC
Confidence 223345556666666666666653
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.87 E-value=9.9e-23 Score=220.24 Aligned_cols=153 Identities=13% Similarity=0.075 Sum_probs=122.3
Q ss_pred HHHHHHHcCCCCCceeeeeCCeEEEEEEECCCcEEEEEEeccCCh------------------hcHHHHHHHHHHHHccC
Q 002158 618 KELAMATAYFSSSTQVGQGGYGKVYKGILSDNTTVAIKRAEEGSL------------------QGQNEFLTEIKLLSRLH 679 (958)
Q Consensus 618 ~el~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~------------------~~~~~~~~E~~~l~~l~ 679 (958)
..+......|...+.||+|+||.||+|.+.+|+.||||+++.... .....+.+|++++++++
T Consensus 83 ~~~~~~~~~~~~~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~ 162 (282)
T 1zar_A 83 HRLVRSGKVDAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ 162 (282)
T ss_dssp HHHHHTTSCSEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT
T ss_pred HHHHhCCeEEEecCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc
Confidence 344444555667799999999999999997799999999864321 13456899999999999
Q ss_pred CCCcceEEEEEEeCCeEEEEEEecCCCCHHHHhccCCCCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEe
Q 002158 680 HRNLVSLLGYCDEEGEQMLVYEFVPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILL 759 (958)
Q Consensus 680 H~niv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl 759 (958)
| +++.+++.. +..++||||+++++|.+ +.. .....++.|+++||+|||+.+ |+||||||+|||+
T Consensus 163 --~-~~v~~~~~~-~~~~lvmE~~~g~~L~~-l~~--------~~~~~i~~qi~~~l~~lH~~g---iiHrDlkp~NILl 226 (282)
T 1zar_A 163 --G-LAVPKVYAW-EGNAVLMELIDAKELYR-VRV--------ENPDEVLDMILEEVAKFYHRG---IVHGDLSQYNVLV 226 (282)
T ss_dssp --T-SSSCCEEEE-ETTEEEEECCCCEEGGG-CCC--------SCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEE
T ss_pred --C-CCcCeEEec-cceEEEEEecCCCcHHH-cch--------hhHHHHHHHHHHHHHHHHHCC---CEeCCCCHHHEEE
Confidence 4 666665544 45699999999999998 532 123479999999999999999 9999999999999
Q ss_pred cCCCCeEEeeeeeecccccCCCCCCccceeeeeccCCCCccChhhhcc
Q 002158 760 DSNLNAKVADFGLSRLAPVLDDEGTMPTHVSTIVKGTPGYLDPEYFLT 807 (958)
Q Consensus 760 ~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 807 (958)
+ ++.+||+|||+|+. +..|+|||++..
T Consensus 227 ~-~~~vkl~DFG~a~~--------------------~~~~~a~e~l~r 253 (282)
T 1zar_A 227 S-EEGIWIIDFPQSVE--------------------VGEEGWREILER 253 (282)
T ss_dssp E-TTEEEECCCTTCEE--------------------TTSTTHHHHHHH
T ss_pred E-CCcEEEEECCCCeE--------------------CCCCCHHHHHHH
Confidence 9 99999999999863 345789998853
|
| >4glp_A Monocyte differentiation antigen CD14; alpha beta BENT solenoid, LRR, lipopolysaccharide, serum, CD leucine-rich repeat, pattern recognition; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.87 E-value=1.6e-22 Score=222.46 Aligned_cols=222 Identities=21% Similarity=0.209 Sum_probs=137.2
Q ss_pred CCcEEEeeCCCCCCCCCh---hhcCCCCCCEEecccccccccCcccc--ccccccceEecccccccccCc----hhhcCC
Q 002158 134 SLIFLLLNGNKLSGSLPD---ELGYLSNLNRLQVDENNITGTIPKSF--ANLSRVRHLHLNNNSIGGQIP----SELSKL 204 (958)
Q Consensus 134 ~L~~L~Ls~n~l~~~~p~---~l~~l~~L~~L~L~~N~l~~~~p~~~--~~l~~L~~L~Ls~N~l~~~~p----~~l~~l 204 (958)
.++.|.+.++.++...-. .+..+++|++|+|++|++++..|..+ ..+++|++|+|++|.+++..+ ..+..+
T Consensus 65 ~l~~l~l~~~~~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~~~~~~L~~L~Ls~n~i~~~~~~~~~~~~~~~ 144 (310)
T 4glp_A 65 RVRRLTVGAAQVPAQLLVGALRVLAYSRLKELTLEDLKITGTMPPLPLEATGLALSSLRLRNVSWATGRSWLAELQQWLK 144 (310)
T ss_dssp CCCEEEECSCCCBHHHHHHHHHHHHHSCCCEEEEESCCCBSCCCCCSSSCCCBCCSSCEEESCCCSSTTSSHHHHHTTBC
T ss_pred ceeEEEEeCCcCCHHHHHHHHHhcccCceeEEEeeCCEeccchhhhhhhccCCCCCEEEeecccccchhhhhHHHHhhhc
Confidence 466677776666421000 12234557777777777666666666 666666666666666665433 223345
Q ss_pred ccchhhhccCCccccCCCcccCCCCCccEEEccCCCCCCCCccccccCCCCCCEEEcccCCCCC---CCCC--CCCCCCc
Q 002158 205 STLIHLLVDNNNLSGNLPPELSELPQLCILQLDNNNFSASEIPATYGNFSKLVKLSLRNCNLQG---AVPD--LSRIPNL 279 (958)
Q Consensus 205 ~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~p~~~~~l~~L~~L~L~~N~l~~---~~~~--l~~l~~L 279 (958)
++|++|+|++|++.+..+..|..+++|++|+|++|++ .+ .+.. +..+++|
T Consensus 145 ~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l-------------------------~~~~~~~~~~~~~~l~~L 199 (310)
T 4glp_A 145 PGLKVLSIAQAHSPAFSCEQVRAFPALTSLDLSDNPG-------------------------LGERGLMAALCPHKFPAI 199 (310)
T ss_dssp SCCCEEEEECCSSCCCCTTSCCCCTTCCEEECCSCTT-------------------------CHHHHHHTTSCTTSSCCC
T ss_pred cCCCEEEeeCCCcchhhHHHhccCCCCCEEECCCCCC-------------------------ccchhhhHHHhhhcCCCC
Confidence 5555555555555544445555555555555555544 33 1111 3455666
Q ss_pred CEEeccCCcCCCcCCC-----CCCCCCcCEEEccCCcCCCccchhccCC---CCCCeEeeecccCCCccchhhhcccccC
Q 002158 280 YYLDLSWNHLTGSIPS-----KKLSENVTTIDLSDNYLNGSILESISNL---PFLQTLSLENNFLTGSIPATIWQNKSFS 351 (958)
Q Consensus 280 ~~L~Ls~N~l~~~~~~-----~~~~~~L~~L~Ls~N~l~~~~~~~~~~l---~~L~~L~L~~N~l~~~ip~~l~~~~~~~ 351 (958)
++|+|++|+++. ++. ...+++|++|+|++|+|++..|..+..+ ++|++|+|++|+|+ .+|..++
T Consensus 200 ~~L~Ls~N~l~~-l~~~~~~l~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~~~L~~L~Ls~N~l~-~lp~~~~------ 271 (310)
T 4glp_A 200 QNLALRNTGMET-PTGVCAALAAAGVQPHSLDLSHNSLRATVNPSAPRCMWSSALNSLNLSFAGLE-QVPKGLP------ 271 (310)
T ss_dssp CSCBCCSSCCCC-HHHHHHHHHHHTCCCSSEECTTSCCCCCCCSCCSSCCCCTTCCCEECCSSCCC-SCCSCCC------
T ss_pred CEEECCCCCCCc-hHHHHHHHHhcCCCCCEEECCCCCCCccchhhHHhccCcCcCCEEECCCCCCC-chhhhhc------
Confidence 666666666652 222 1234677777777777776666666655 68888888888888 6777653
Q ss_pred ccccceEeccCCCCCCCccCCCCCCcceEEeCCCCCCC
Q 002158 352 TKARLKIDLRNNSFSNIVGDLTLPNNVTLRLGGNPICT 389 (958)
Q Consensus 352 ~~~l~~L~Ls~N~l~~l~~~~~l~~L~~L~l~~N~l~~ 389 (958)
+.|+.|||++|+|+.++....+++|+.|+|++|+|..
T Consensus 272 -~~L~~L~Ls~N~l~~~~~~~~l~~L~~L~L~~N~l~~ 308 (310)
T 4glp_A 272 -AKLRVLDLSSNRLNRAPQPDELPEVDNLTLDGNPFLV 308 (310)
T ss_dssp -SCCSCEECCSCCCCSCCCTTSCCCCSCEECSSTTTSC
T ss_pred -CCCCEEECCCCcCCCCchhhhCCCccEEECcCCCCCC
Confidence 4677888888888888766688999999999999853
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A | Back alignment and structure |
|---|
Probab=99.87 E-value=9.9e-22 Score=209.19 Aligned_cols=165 Identities=22% Similarity=0.271 Sum_probs=118.0
Q ss_pred CCCccccCCCCCcEEEeeCCCCCCCCChhhcCCCCCCEEecccccccccCccccccccccceEecccccccccCchhhcC
Q 002158 124 TIPKEIGNISSLIFLLLNGNKLSGSLPDELGYLSNLNRLQVDENNITGTIPKSFANLSRVRHLHLNNNSIGGQIPSELSK 203 (958)
Q Consensus 124 ~ip~~i~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~ 203 (958)
.+|..+. ++|+.|+|++|.+++..+..|.++++|++|+|++|++++..+..|..+++|++|+|++|+|++..+..|..
T Consensus 28 ~~p~~~~--~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~ 105 (251)
T 3m19_A 28 SVPSGIP--ADTEKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSAGVFDDLTELGTLGLANNQLASLPLGVFDH 105 (251)
T ss_dssp SCCSCCC--TTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTT
T ss_pred ccCCCCC--CCCCEEEccCCCcCccCHhHhcCcccCCEEECCCCcCCccCHhHhccCCcCCEEECCCCcccccChhHhcc
Confidence 3444443 46778888888888777777888888888888888888777777778888888888888887666666777
Q ss_pred CccchhhhccCCccccCCCcccCCCCCccEEEccCCCCCCCCccccccCCCCCCEEEcccCCCCCCCCC-CCCCCCcCEE
Q 002158 204 LSTLIHLLVDNNNLSGNLPPELSELPQLCILQLDNNNFSASEIPATYGNFSKLVKLSLRNCNLQGAVPD-LSRIPNLYYL 282 (958)
Q Consensus 204 l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~-l~~l~~L~~L 282 (958)
+++|++|+|++|+|++..+..|..+++|++|+|++|+++. ..+..|..+++|+.|+|++|++++.++. +..+++|+.|
T Consensus 106 l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~-~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L 184 (251)
T 3m19_A 106 LTQLDKLYLGGNQLKSLPSGVFDRLTKLKELRLNTNQLQS-IPAGAFDKLTNLQTLSLSTNQLQSVPHGAFDRLGKLQTI 184 (251)
T ss_dssp CTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCC-CCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEE
T ss_pred cCCCCEEEcCCCcCCCcChhHhccCCcccEEECcCCcCCc-cCHHHcCcCcCCCEEECCCCcCCccCHHHHhCCCCCCEE
Confidence 7777777777777776666667777777777777777752 2233566677777777777777766653 6666667777
Q ss_pred eccCCcCCC
Q 002158 283 DLSWNHLTG 291 (958)
Q Consensus 283 ~Ls~N~l~~ 291 (958)
+|++|.+.+
T Consensus 185 ~l~~N~~~c 193 (251)
T 3m19_A 185 TLFGNQFDC 193 (251)
T ss_dssp ECCSCCBCT
T ss_pred EeeCCceeC
Confidence 766666654
|
| >2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A | Back alignment and structure |
|---|
Probab=99.87 E-value=2.8e-24 Score=239.42 Aligned_cols=263 Identities=17% Similarity=0.181 Sum_probs=167.6
Q ss_pred CCCCceeeCccccCCCceeeEEEEccCCcCCCCccccccCC--CCcceeeccCcccCCCCccccCCCCCcEEEeeCCCCC
Q 002158 69 SNWTGVLCFDTVETDGHLHVRELQLLSMNLSGNLAPELGQL--SRLQYYFMWNDLTGTIPKEIGNISSLIFLLLNGNKLS 146 (958)
Q Consensus 69 ~~w~gV~C~~~~~~~~~~~v~~L~L~~~~l~~~~~~~l~~L--~~L~~L~l~n~~~~~ip~~i~~l~~L~~L~Ls~n~l~ 146 (958)
..|.++.|.+. .++.|+++++++. +..+..+ ++++.|.+.++..+..+..+.++++|++|+|++|.++
T Consensus 37 ~~W~~~~~~~~-------~~~~l~l~~~~~~---~~~~~~~~~~~l~~L~l~~n~l~~~~~~~~~~~~L~~L~L~~~~l~ 106 (336)
T 2ast_B 37 KRWYRLASDES-------LWQTLDLTGKNLH---PDVTGRLLSQGVIAFRCPRSFMDQPLAEHFSPFRVQHMDLSNSVIE 106 (336)
T ss_dssp HHHHHHHTCST-------TSSEEECTTCBCC---HHHHHHHHHTTCSEEECTTCEECSCCCSCCCCBCCCEEECTTCEEC
T ss_pred HHHHHHhcCch-------hheeeccccccCC---HHHHHhhhhccceEEEcCCccccccchhhccCCCCCEEEccCCCcC
Confidence 36988887432 3678889888776 4556666 7777887776665555555677788888888888776
Q ss_pred CC-CChhhcCCCCCCEEecccccccccCccccccccccceEecccc-cccc-cCchhhcCCccchhhhccCC-ccccC-C
Q 002158 147 GS-LPDELGYLSNLNRLQVDENNITGTIPKSFANLSRVRHLHLNNN-SIGG-QIPSELSKLSTLIHLLVDNN-NLSGN-L 221 (958)
Q Consensus 147 ~~-~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N-~l~~-~~p~~l~~l~~L~~L~L~~N-~l~~~-~ 221 (958)
+. +|..+..+++|++|+|++|++++..+..++.+++|++|+|++| .+++ .++..+.++++|++|++++| .+++. +
T Consensus 107 ~~~~~~~~~~~~~L~~L~L~~~~l~~~~~~~l~~~~~L~~L~L~~~~~l~~~~l~~~~~~~~~L~~L~l~~~~~l~~~~~ 186 (336)
T 2ast_B 107 VSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDELNLSWCFDFTEKHV 186 (336)
T ss_dssp HHHHHHHHTTBCCCSEEECTTCBCCHHHHHHHTTCTTCSEEECTTCBSCCHHHHHHHHHHCTTCCEEECCCCTTCCHHHH
T ss_pred HHHHHHHHhhCCCCCEEeCcCcccCHHHHHHHhcCCCCCEEECCCCCCCCHHHHHHHHhcCCCCCEEcCCCCCCcChHHH
Confidence 54 6667777888888888888777777777777788888888887 5664 25566777777777777777 77643 4
Q ss_pred CcccCCCC-CccEEEccCC--CCCCCCccccccCCCCCCEEEcccCC-CCCCCC-CCCCCCCcCEEeccCCc-CCCc-CC
Q 002158 222 PPELSELP-QLCILQLDNN--NFSASEIPATYGNFSKLVKLSLRNCN-LQGAVP-DLSRIPNLYYLDLSWNH-LTGS-IP 294 (958)
Q Consensus 222 ~~~l~~l~-~L~~L~L~~N--~l~~~~~p~~~~~l~~L~~L~L~~N~-l~~~~~-~l~~l~~L~~L~Ls~N~-l~~~-~~ 294 (958)
+..+..++ +|++|+|++| .++...++..+.++++|+.|+|++|. +++..+ .+..+++|+.|+|++|. +... +.
T Consensus 187 ~~~~~~l~~~L~~L~l~~~~~~~~~~~l~~~~~~~~~L~~L~l~~~~~l~~~~~~~l~~l~~L~~L~l~~~~~~~~~~~~ 266 (336)
T 2ast_B 187 QVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLL 266 (336)
T ss_dssp HHHHHHSCTTCCEEECCSCGGGSCHHHHHHHHHHCTTCSEEECTTCTTCCGGGGGGGGGCTTCCEEECTTCTTCCGGGGG
T ss_pred HHHHHhcccCCCEEEeCCCcccCCHHHHHHHHhhCCCCCEEeCCCCCcCCHHHHHHHhCCCCCCEeeCCCCCCCCHHHHH
Confidence 55566677 7777777777 44433455666677777777777777 543332 46666777777777764 2110 11
Q ss_pred CCCCCCCcCEEEccCCcCCCccchhccCCCCCCeEeeecccCCCccchhh
Q 002158 295 SKKLSENVTTIDLSDNYLNGSILESISNLPFLQTLSLENNFLTGSIPATI 344 (958)
Q Consensus 295 ~~~~~~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~ip~~l 344 (958)
....+++|+.|+|++| ++......+. .+|+.|++++|++++..|..+
T Consensus 267 ~l~~~~~L~~L~l~~~-i~~~~~~~l~--~~l~~L~l~~n~l~~~~~~~~ 313 (336)
T 2ast_B 267 ELGEIPTLKTLQVFGI-VPDGTLQLLK--EALPHLQINCSHFTTIARPTI 313 (336)
T ss_dssp GGGGCTTCCEEECTTS-SCTTCHHHHH--HHSTTSEESCCCSCCTTCSSC
T ss_pred HHhcCCCCCEEeccCc-cCHHHHHHHH--hhCcceEEecccCccccCCcc
Confidence 1233455666666655 3322222221 124444455555555555443
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 | Back alignment and structure |
|---|
Probab=99.86 E-value=1.2e-21 Score=215.08 Aligned_cols=195 Identities=23% Similarity=0.378 Sum_probs=155.7
Q ss_pred ccCCCCCcEEEeeCCCCCCCCChhhcCCCCCCEEecccccccccCccccccccccceEecccccccccCchhhcCCccch
Q 002158 129 IGNISSLIFLLLNGNKLSGSLPDELGYLSNLNRLQVDENNITGTIPKSFANLSRVRHLHLNNNSIGGQIPSELSKLSTLI 208 (958)
Q Consensus 129 i~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~ 208 (958)
+.++++|++|++++|.++ .+| .+..+++|++|+|++|++++..+ +..+++|++|+|++|.+++ ++ .+..+++|+
T Consensus 37 ~~~l~~L~~L~l~~~~i~-~l~-~~~~l~~L~~L~L~~n~i~~~~~--~~~l~~L~~L~L~~n~l~~-~~-~~~~l~~L~ 110 (308)
T 1h6u_A 37 QADLDGITTLSAFGTGVT-TIE-GVQYLNNLIGLELKDNQITDLAP--LKNLTKITELELSGNPLKN-VS-AIAGLQSIK 110 (308)
T ss_dssp HHHHHTCCEEECTTSCCC-CCT-TGGGCTTCCEEECCSSCCCCCGG--GTTCCSCCEEECCSCCCSC-CG-GGTTCTTCC
T ss_pred HHHcCCcCEEEeeCCCcc-Cch-hhhccCCCCEEEccCCcCCCChh--HccCCCCCEEEccCCcCCC-ch-hhcCCCCCC
Confidence 445778888888888887 455 57888888888888888885443 8888888888888888884 33 588888888
Q ss_pred hhhccCCccccCCCcccCCCCCccEEEccCCCCCCCCccccccCCCCCCEEEcccCCCCCCCCCCCCCCCcCEEeccCCc
Q 002158 209 HLLVDNNNLSGNLPPELSELPQLCILQLDNNNFSASEIPATYGNFSKLVKLSLRNCNLQGAVPDLSRIPNLYYLDLSWNH 288 (958)
Q Consensus 209 ~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~l~~l~~L~~L~Ls~N~ 288 (958)
.|+|++|++++. + .+..+++|++|+|++|+++. ++. +..+++|+.|+|++|++++.++ +..+++|+.|+|++|.
T Consensus 111 ~L~l~~n~l~~~-~-~l~~l~~L~~L~l~~n~l~~--~~~-l~~l~~L~~L~l~~n~l~~~~~-l~~l~~L~~L~l~~n~ 184 (308)
T 1h6u_A 111 TLDLTSTQITDV-T-PLAGLSNLQVLYLDLNQITN--ISP-LAGLTNLQYLSIGNAQVSDLTP-LANLSKLTTLKADDNK 184 (308)
T ss_dssp EEECTTSCCCCC-G-GGTTCTTCCEEECCSSCCCC--CGG-GGGCTTCCEEECCSSCCCCCGG-GTTCTTCCEEECCSSC
T ss_pred EEECCCCCCCCc-h-hhcCCCCCCEEECCCCccCc--Ccc-ccCCCCccEEEccCCcCCCChh-hcCCCCCCEEECCCCc
Confidence 888888888864 2 38888889999999888863 333 7888889999999998887655 8888899999999999
Q ss_pred CCCcCCCCCCCCCcCEEEccCCcCCCccchhccCCCCCCeEeeecccCCC
Q 002158 289 LTGSIPSKKLSENVTTIDLSDNYLNGSILESISNLPFLQTLSLENNFLTG 338 (958)
Q Consensus 289 l~~~~~~~~~~~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~ 338 (958)
+++ ++....+++|++|+|++|++++..+ +..+++|+.|+|++|++++
T Consensus 185 l~~-~~~l~~l~~L~~L~L~~N~l~~~~~--l~~l~~L~~L~l~~N~i~~ 231 (308)
T 1h6u_A 185 ISD-ISPLASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLTNQTITN 231 (308)
T ss_dssp CCC-CGGGGGCTTCCEEECTTSCCCBCGG--GTTCTTCCEEEEEEEEEEC
T ss_pred cCc-ChhhcCCCCCCEEEccCCccCcccc--ccCCCCCCEEEccCCeeec
Confidence 884 4446667889999999999987663 8889999999999999973
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* | Back alignment and structure |
|---|
Probab=99.86 E-value=1.2e-21 Score=206.82 Aligned_cols=106 Identities=26% Similarity=0.319 Sum_probs=62.0
Q ss_pred CCcEEEeeCCCCCCCCChhhcCCCCCCEEeccccc-ccccCccccccccccceEeccc-ccccccCchhhcCCccchhhh
Q 002158 134 SLIFLLLNGNKLSGSLPDELGYLSNLNRLQVDENN-ITGTIPKSFANLSRVRHLHLNN-NSIGGQIPSELSKLSTLIHLL 211 (958)
Q Consensus 134 ~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~L~~N~-l~~~~p~~~~~l~~L~~L~Ls~-N~l~~~~p~~l~~l~~L~~L~ 211 (958)
+|++|+|++|++++..+..|.++++|++|++++|+ ++...+..|.++++|++|+|++ |++++..+..|.++++|++|+
T Consensus 32 ~l~~L~l~~n~l~~i~~~~~~~l~~L~~L~l~~n~~l~~i~~~~f~~l~~L~~L~l~~~n~l~~i~~~~f~~l~~L~~L~ 111 (239)
T 2xwt_C 32 STQTLKLIETHLRTIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTRNLTYIDPDALKELPLLKFLG 111 (239)
T ss_dssp TCCEEEEESCCCSEECTTTTTTCTTCCEEEEECCSSCCEECTTTEESCTTCCEEEEEEETTCCEECTTSEECCTTCCEEE
T ss_pred cccEEEEeCCcceEECHHHccCCCCCcEEeCCCCCCcceeCHhHcCCCcCCcEEECCCCCCeeEcCHHHhCCCCCCCEEe
Confidence 56666677666665555566666666666666665 6544445566666666666666 666654445555566666666
Q ss_pred ccCCccccCCCcccCCCCCcc---EEEccCC-CC
Q 002158 212 VDNNNLSGNLPPELSELPQLC---ILQLDNN-NF 241 (958)
Q Consensus 212 L~~N~l~~~~~~~l~~l~~L~---~L~L~~N-~l 241 (958)
+++|++++ +|. +..+++|+ +|++++| ++
T Consensus 112 l~~n~l~~-lp~-~~~l~~L~~L~~L~l~~N~~l 143 (239)
T 2xwt_C 112 IFNTGLKM-FPD-LTKVYSTDIFFILEITDNPYM 143 (239)
T ss_dssp EEEECCCS-CCC-CTTCCBCCSEEEEEEESCTTC
T ss_pred CCCCCCcc-ccc-cccccccccccEEECCCCcch
Confidence 66665554 333 44444444 5555544 44
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* | Back alignment and structure |
|---|
Probab=99.86 E-value=9.7e-22 Score=207.62 Aligned_cols=195 Identities=20% Similarity=0.232 Sum_probs=158.8
Q ss_pred CcceeeccCcccCCCCc-cccCCCCCcEEEeeCCC-CCCCCChhhcCCCCCCEEeccc-ccccccCccccccccccceEe
Q 002158 111 RLQYYFMWNDLTGTIPK-EIGNISSLIFLLLNGNK-LSGSLPDELGYLSNLNRLQVDE-NNITGTIPKSFANLSRVRHLH 187 (958)
Q Consensus 111 ~L~~L~l~n~~~~~ip~-~i~~l~~L~~L~Ls~n~-l~~~~p~~l~~l~~L~~L~L~~-N~l~~~~p~~~~~l~~L~~L~ 187 (958)
+|+.|++++|....+|. .|.++++|++|+|++|. +++..+..|.++++|++|++++ |++++..+..|.++++|++|+
T Consensus 32 ~l~~L~l~~n~l~~i~~~~~~~l~~L~~L~l~~n~~l~~i~~~~f~~l~~L~~L~l~~~n~l~~i~~~~f~~l~~L~~L~ 111 (239)
T 2xwt_C 32 STQTLKLIETHLRTIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTRNLTYIDPDALKELPLLKFLG 111 (239)
T ss_dssp TCCEEEEESCCCSEECTTTTTTCTTCCEEEEECCSSCCEECTTTEESCTTCCEEEEEEETTCCEECTTSEECCTTCCEEE
T ss_pred cccEEEEeCCcceEECHHHccCCCCCcEEeCCCCCCcceeCHhHcCCCcCCcEEECCCCCCeeEcCHHHhCCCCCCCEEe
Confidence 78888887766666665 68889999999999997 8755666788899999999998 899877777888999999999
Q ss_pred cccccccccCchhhcCCccch---hhhccCC-ccccCCCcccCCCCCcc-EEEccCCCCCCCCccccccCCCCCCEEEcc
Q 002158 188 LNNNSIGGQIPSELSKLSTLI---HLLVDNN-NLSGNLPPELSELPQLC-ILQLDNNNFSASEIPATYGNFSKLVKLSLR 262 (958)
Q Consensus 188 Ls~N~l~~~~p~~l~~l~~L~---~L~L~~N-~l~~~~~~~l~~l~~L~-~L~L~~N~l~~~~~p~~~~~l~~L~~L~L~ 262 (958)
|++|.+++ +|. +..+++|+ +|++++| ++++..+..|.++++|+ +|++++|+++ .+|......++|+.|+|+
T Consensus 112 l~~n~l~~-lp~-~~~l~~L~~L~~L~l~~N~~l~~i~~~~~~~l~~L~~~L~l~~n~l~--~i~~~~~~~~~L~~L~L~ 187 (239)
T 2xwt_C 112 IFNTGLKM-FPD-LTKVYSTDIFFILEITDNPYMTSIPVNAFQGLCNETLTLKLYNNGFT--SVQGYAFNGTKLDAVYLN 187 (239)
T ss_dssp EEEECCCS-CCC-CTTCCBCCSEEEEEEESCTTCCEECTTTTTTTBSSEEEEECCSCCCC--EECTTTTTTCEEEEEECT
T ss_pred CCCCCCcc-ccc-cccccccccccEEECCCCcchhhcCcccccchhcceeEEEcCCCCCc--ccCHhhcCCCCCCEEEcC
Confidence 99999985 665 88888887 9999999 88887778899999999 9999999986 455543333889999999
Q ss_pred cCC-CCCCCCC-CCCC-CCcCEEeccCCcCCCcCCCCCCCCCcCEEEccCCc
Q 002158 263 NCN-LQGAVPD-LSRI-PNLYYLDLSWNHLTGSIPSKKLSENVTTIDLSDNY 311 (958)
Q Consensus 263 ~N~-l~~~~~~-l~~l-~~L~~L~Ls~N~l~~~~~~~~~~~~L~~L~Ls~N~ 311 (958)
+|+ +++.++. |..+ ++|+.|+|++|++++ +|.. .+++|+.|+++++.
T Consensus 188 ~n~~l~~i~~~~~~~l~~~L~~L~l~~N~l~~-l~~~-~~~~L~~L~l~~~~ 237 (239)
T 2xwt_C 188 KNKYLTVIDKDAFGGVYSGPSLLDVSQTSVTA-LPSK-GLEHLKELIARNTW 237 (239)
T ss_dssp TCTTCCEECTTTTTTCSBCCSEEECTTCCCCC-CCCT-TCTTCSEEECTTC-
T ss_pred CCCCcccCCHHHhhccccCCcEEECCCCcccc-CChh-HhccCceeeccCcc
Confidence 995 8887765 8888 999999999999984 4443 67899999998763
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A | Back alignment and structure |
|---|
Probab=99.86 E-value=1.1e-23 Score=239.44 Aligned_cols=223 Identities=21% Similarity=0.304 Sum_probs=125.9
Q ss_pred cCCCCccccCCCCCcEEEeeCCCCCCCCC----hhhcCCCCCCEEecccc---cccccCcccc-------ccccccceEe
Q 002158 122 TGTIPKEIGNISSLIFLLLNGNKLSGSLP----DELGYLSNLNRLQVDEN---NITGTIPKSF-------ANLSRVRHLH 187 (958)
Q Consensus 122 ~~~ip~~i~~l~~L~~L~Ls~n~l~~~~p----~~l~~l~~L~~L~L~~N---~l~~~~p~~~-------~~l~~L~~L~ 187 (958)
...++..+..+++|++|+|++|.+++..+ ..+..+++|++|+|++| ++++.+|..+ ..+++|++|+
T Consensus 21 ~~~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~Ls~~~~~~l~~~~~~~~~~l~~~l~~~~~L~~L~ 100 (386)
T 2ca6_A 21 EKSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVR 100 (386)
T ss_dssp HHTTSHHHHHCSCCCEEECTTSEECHHHHHHHHHTTTTCTTCCEEECCSCCTTSCGGGSHHHHHHHHHHHTTCTTCCEEE
T ss_pred HHHHHHHHhcCCCccEEECCCCCCCHHHHHHHHHHHHhCCCccEEeCcccccCccccchhHHHHHHHHHHhhCCcccEEE
Confidence 33455555566666666666666654322 22445666666666664 3333444433 4556666666
Q ss_pred cccccccc----cCchhhcCCccchhhhccCCccccCCCccc----CCC---------CCccEEEccCCCCCCCCcc---
Q 002158 188 LNNNSIGG----QIPSELSKLSTLIHLLVDNNNLSGNLPPEL----SEL---------PQLCILQLDNNNFSASEIP--- 247 (958)
Q Consensus 188 Ls~N~l~~----~~p~~l~~l~~L~~L~L~~N~l~~~~~~~l----~~l---------~~L~~L~L~~N~l~~~~~p--- 247 (958)
|++|.+++ .++..+..+++|++|+|++|.++...+..+ ..+ ++|++|+|++|+++...++
T Consensus 101 Ls~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~l~~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~ 180 (386)
T 2ca6_A 101 LSDNAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWA 180 (386)
T ss_dssp CCSCCCCTTTHHHHHHHHHHCTTCCEEECCSSCCHHHHHHHHHHHHHHHHHHHHHHTCCCCCEEECCSSCCTGGGHHHHH
T ss_pred CCCCcCCHHHHHHHHHHHHhCCCCCEEECcCCCCCHHHHHHHHHHHHHHhhhhhcccCCCCcEEECCCCCCCcHHHHHHH
Confidence 66666664 345555566666666666666643222222 222 6777777777777643444
Q ss_pred ccccCCCCCCEEEcccCCCC--C---CCC-CCCCCCCcCEEeccCCcCC----CcCCC-CCCCCCcCEEEccCCcCCCc-
Q 002158 248 ATYGNFSKLVKLSLRNCNLQ--G---AVP-DLSRIPNLYYLDLSWNHLT----GSIPS-KKLSENVTTIDLSDNYLNGS- 315 (958)
Q Consensus 248 ~~~~~l~~L~~L~L~~N~l~--~---~~~-~l~~l~~L~~L~Ls~N~l~----~~~~~-~~~~~~L~~L~Ls~N~l~~~- 315 (958)
..+..+++|+.|+|++|+++ + ..+ .+..+++|+.|+|++|.++ +.++. ...+++|++|+|++|.|++.
T Consensus 181 ~~l~~~~~L~~L~L~~n~l~~~g~~~l~~~~l~~~~~L~~L~Ls~n~l~~~g~~~l~~~l~~~~~L~~L~L~~n~i~~~~ 260 (386)
T 2ca6_A 181 KTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLSARG 260 (386)
T ss_dssp HHHHHCTTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHHHGGGCTTCCEEECTTCCCCHHH
T ss_pred HHHHhCCCcCEEECcCCCCCHhHHHHHHHHHhhcCCCccEEECcCCCCCcHHHHHHHHHHccCCCcCEEECCCCCCchhh
Confidence 35556677777777777776 2 223 4666677777777777764 22222 23345666666666666654
Q ss_pred ---cchhccC--CCCCCeEeeecccCCC----ccchhh
Q 002158 316 ---ILESISN--LPFLQTLSLENNFLTG----SIPATI 344 (958)
Q Consensus 316 ---~~~~~~~--l~~L~~L~L~~N~l~~----~ip~~l 344 (958)
++..+.. +++|+.|+|++|.|++ .+|..+
T Consensus 261 ~~~l~~~l~~~~~~~L~~L~L~~n~i~~~g~~~l~~~l 298 (386)
T 2ca6_A 261 AAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVI 298 (386)
T ss_dssp HHHHHHHHHTCSSCCCCEEECCSSCCBHHHHHHHHHHH
T ss_pred HHHHHHHHhhccCCCeEEEECcCCcCCHHHHHHHHHHH
Confidence 3444422 6666666666666665 355544
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A | Back alignment and structure |
|---|
Probab=99.85 E-value=8.5e-21 Score=201.96 Aligned_cols=179 Identities=23% Similarity=0.294 Sum_probs=120.3
Q ss_pred CCcEEEeeCCCCCCCCChhhcCCCCCCEEecccccccccCccccccccccceEecccccccccCchhhcCCccchhhhcc
Q 002158 134 SLIFLLLNGNKLSGSLPDELGYLSNLNRLQVDENNITGTIPKSFANLSRVRHLHLNNNSIGGQIPSELSKLSTLIHLLVD 213 (958)
Q Consensus 134 ~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~ 213 (958)
+.++++++++.++ .+|..+. ++|++|+|++|++++..+..|.++++|++|+|++|.|++..+..|..+++|++|+|+
T Consensus 15 ~~~~l~~~~~~l~-~~p~~~~--~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~ 91 (251)
T 3m19_A 15 GKKEVDCQGKSLD-SVPSGIP--ADTEKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSAGVFDDLTELGTLGLA 91 (251)
T ss_dssp GGTEEECTTCCCS-SCCSCCC--TTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECT
T ss_pred CCeEEecCCCCcc-ccCCCCC--CCCCEEEccCCCcCccCHhHhcCcccCCEEECCCCcCCccCHhHhccCCcCCEEECC
Confidence 5678889988888 6776655 578888888888887777777788888888888888777666667777777777777
Q ss_pred CCccccCCCcccCCCCCccEEEccCCCCCCCCccccccCCCCCCEEEcccCCCCCCCCC-CCCCCCcCEEeccCCcCCCc
Q 002158 214 NNNLSGNLPPELSELPQLCILQLDNNNFSASEIPATYGNFSKLVKLSLRNCNLQGAVPD-LSRIPNLYYLDLSWNHLTGS 292 (958)
Q Consensus 214 ~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~-l~~l~~L~~L~Ls~N~l~~~ 292 (958)
+|++++..+..|..+++|++|+|++|+++. ..+..|..+++|+.|+|++|+|++.++. +..+
T Consensus 92 ~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~-~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l---------------- 154 (251)
T 3m19_A 92 NNQLASLPLGVFDHLTQLDKLYLGGNQLKS-LPSGVFDRLTKLKELRLNTNQLQSIPAGAFDKL---------------- 154 (251)
T ss_dssp TSCCCCCCTTTTTTCTTCCEEECCSSCCCC-CCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTC----------------
T ss_pred CCcccccChhHhcccCCCCEEEcCCCcCCC-cChhHhccCCcccEEECcCCcCCccCHHHcCcC----------------
Confidence 777776555666666666666666666642 2222344455555555555555444432 4444
Q ss_pred CCCCCCCCCcCEEEccCCcCCCccchhccCCCCCCeEeeecccCCCc
Q 002158 293 IPSKKLSENVTTIDLSDNYLNGSILESISNLPFLQTLSLENNFLTGS 339 (958)
Q Consensus 293 ~~~~~~~~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~ 339 (958)
++|++|+|++|+|++..+..|..+++|+.|+|++|++++.
T Consensus 155 -------~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~ 194 (251)
T 3m19_A 155 -------TNLQTLSLSTNQLQSVPHGAFDRLGKLQTITLFGNQFDCS 194 (251)
T ss_dssp -------TTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSCCBCTT
T ss_pred -------cCCCEEECCCCcCCccCHHHHhCCCCCCEEEeeCCceeCC
Confidence 5555555555555556666777888888888888888765
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* | Back alignment and structure |
|---|
Probab=99.85 E-value=3.6e-21 Score=215.53 Aligned_cols=247 Identities=17% Similarity=0.144 Sum_probs=153.5
Q ss_pred cEEEeeCCCCCCCCChhhcCCCCCCEEecccccccccCccccccccccceEecccccccccCc-hhhcCCccchh-hhcc
Q 002158 136 IFLLLNGNKLSGSLPDELGYLSNLNRLQVDENNITGTIPKSFANLSRVRHLHLNNNSIGGQIP-SELSKLSTLIH-LLVD 213 (958)
Q Consensus 136 ~~L~Ls~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p-~~l~~l~~L~~-L~L~ 213 (958)
+.++.++++++ .+|..+ .++|++|+|++|+|+...+..|.++++|++|+|++|++.+.+| .+|.++++|.. +.++
T Consensus 12 ~~v~C~~~~Lt-~iP~~l--~~~l~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N~i~~~i~~~~f~~L~~l~~~l~~~ 88 (350)
T 4ay9_X 12 RVFLCQESKVT-EIPSDL--PRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEK 88 (350)
T ss_dssp TEEEEESTTCC-SCCTTC--CTTCSEEEEESCCCSEECTTSSTTCTTCCEEEEECCTTCCEECTTSBCSCTTCCEEEEEE
T ss_pred CEEEecCCCCC-ccCcCc--CCCCCEEEccCCcCCCcCHHHHcCCCCCCEEECcCCCCCCccChhHhhcchhhhhhhccc
Confidence 34556666666 555544 2456666666666664444456666666666666666544333 34556655543 4445
Q ss_pred CCccccCCCcccCCCCCccEEEccCCCCCCCCccccccCCCCCCEEEccc-CCCCCCCCC-CCCCC-CcCEEeccCCcCC
Q 002158 214 NNNLSGNLPPELSELPQLCILQLDNNNFSASEIPATYGNFSKLVKLSLRN-CNLQGAVPD-LSRIP-NLYYLDLSWNHLT 290 (958)
Q Consensus 214 ~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~p~~~~~l~~L~~L~L~~-N~l~~~~~~-l~~l~-~L~~L~Ls~N~l~ 290 (958)
+|+|+...+..|..+++|++|++++|+++. ..+..+....++..|++.+ |++..++.. |..+. .|+.|+|++|+|+
T Consensus 89 ~N~l~~l~~~~f~~l~~L~~L~l~~n~l~~-~~~~~~~~~~~l~~l~l~~~~~i~~l~~~~f~~~~~~l~~L~L~~N~i~ 167 (350)
T 4ay9_X 89 ANNLLYINPEAFQNLPNLQYLLISNTGIKH-LPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQ 167 (350)
T ss_dssp ETTCCEECTTSBCCCTTCCEEEEEEECCSS-CCCCTTCCBSSCEEEEEESCTTCCEECTTSSTTSBSSCEEEECCSSCCC
T ss_pred CCcccccCchhhhhcccccccccccccccc-CCchhhcccchhhhhhhccccccccccccchhhcchhhhhhcccccccc
Confidence 566666666666666666666666666652 2233444555666666644 456555543 55543 5777888888887
Q ss_pred CcCCCCCCCCCcCEEEccC-CcCCCccchhccCCCCCCeEeeecccCCCccchhhhcccccCccccceEec-cCCCCCCC
Q 002158 291 GSIPSKKLSENVTTIDLSD-NYLNGSILESISNLPFLQTLSLENNFLTGSIPATIWQNKSFSTKARLKIDL-RNNSFSNI 368 (958)
Q Consensus 291 ~~~~~~~~~~~L~~L~Ls~-N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~ip~~l~~~~~~~~~~l~~L~L-s~N~l~~l 368 (958)
...+......+|++|++++ |.++.+.++.|.++++|++|+|++|+|+ .+|...+. .++.|.+ +.++++.+
T Consensus 168 ~i~~~~f~~~~L~~l~l~~~n~l~~i~~~~f~~l~~L~~LdLs~N~l~-~lp~~~~~-------~L~~L~~l~~~~l~~l 239 (350)
T 4ay9_X 168 EIHNSAFNGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIH-SLPSYGLE-------NLKKLRARSTYNLKKL 239 (350)
T ss_dssp EECTTSSTTEEEEEEECTTCTTCCCCCTTTTTTEECCSEEECTTSCCC-CCCSSSCT-------TCCEEECTTCTTCCCC
T ss_pred CCChhhccccchhHHhhccCCcccCCCHHHhccCcccchhhcCCCCcC-ccChhhhc-------cchHhhhccCCCcCcC
Confidence 4444444456788888864 6677666677888888888888888888 66654322 3445554 33567788
Q ss_pred ccCCCCCCcceEEeCCCCCCCCCCCCC
Q 002158 369 VGDLTLPNNVTLRLGGNPICTSANIPN 395 (958)
Q Consensus 369 ~~~~~l~~L~~L~l~~N~l~~~~~~~~ 395 (958)
|....+++|+.+++. |++.|.+-..|
T Consensus 240 P~l~~l~~L~~l~l~-~~~~c~~~~~~ 265 (350)
T 4ay9_X 240 PTLEKLVALMEASLT-YPSHCCAFANW 265 (350)
T ss_dssp CCTTTCCSCCEEECS-CHHHHHHHHHS
T ss_pred CCchhCcChhhCcCC-CCccccchhhh
Confidence 876689999999985 66766554433
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} | Back alignment and structure |
|---|
Probab=99.85 E-value=7.6e-23 Score=230.32 Aligned_cols=258 Identities=20% Similarity=0.182 Sum_probs=116.2
Q ss_pred EEccCCcCCCCccccccCCCCcceeeccCcccCCCC-----ccccCCC-CCcEEEeeCCCCCCCCChhhcCC-----CCC
Q 002158 91 LQLLSMNLSGNLAPELGQLSRLQYYFMWNDLTGTIP-----KEIGNIS-SLIFLLLNGNKLSGSLPDELGYL-----SNL 159 (958)
Q Consensus 91 L~L~~~~l~~~~~~~l~~L~~L~~L~l~n~~~~~ip-----~~i~~l~-~L~~L~Ls~n~l~~~~p~~l~~l-----~~L 159 (958)
.+|+.+++++.+|..+...++|+.|++++|..+.++ ..+.+++ +|++|+|++|.+++..+..+..+ ++|
T Consensus 3 ~~ls~n~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L 82 (362)
T 3goz_A 3 YKLTLHPGSNPVEEFTSIPHGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELVQILAAIPANV 82 (362)
T ss_dssp EECCCCTTCCHHHHHHTSCTTCCEEECTTSCGGGSCHHHHHHHHHTCCTTCCEEECCSSCGGGSCHHHHHHHHHTSCTTC
T ss_pred cccccccchHHHHHHHhCCCCceEEEccCCCCChHHHHHHHHHHHhCCCceeEEECcCCCCCHHHHHHHHHHHhccCCCc
Confidence 345555566555554444444555555444333333 3344444 45555555555544444444332 445
Q ss_pred CEEecccccccccCccccccccccceEecccccccccCchhhcCC-ccchhhhccCCccccCCCccc----CC-CCCccE
Q 002158 160 NRLQVDENNITGTIPKSFANLSRVRHLHLNNNSIGGQIPSELSKL-STLIHLLVDNNNLSGNLPPEL----SE-LPQLCI 233 (958)
Q Consensus 160 ~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l-~~L~~L~L~~N~l~~~~~~~l----~~-l~~L~~ 233 (958)
++|+|++|++++..+..+... +..+ ++|++|+|++|++++..+..+ .. .++|++
T Consensus 83 ~~L~Ls~n~l~~~~~~~l~~~--------------------l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~ 142 (362)
T 3goz_A 83 TSLNLSGNFLSYKSSDELVKT--------------------LAAIPFTITVLDLGWNDFSSKSSSEFKQAFSNLPASITS 142 (362)
T ss_dssp CEEECCSSCGGGSCHHHHHHH--------------------HHTSCTTCCEEECCSSCGGGSCHHHHHHHHTTSCTTCCE
T ss_pred cEEECcCCcCChHHHHHHHHH--------------------HHhCCCCccEEECcCCcCCcHHHHHHHHHHHhCCCceeE
Confidence 555555555444433332222 2222 444444455444443333222 22 135555
Q ss_pred EEccCCCCCCC---CccccccCCC-CCCEEEcccCCCCCCCCC-----CCCC-CCcCEEeccCCcCCCc----CCCC-CC
Q 002158 234 LQLDNNNFSAS---EIPATYGNFS-KLVKLSLRNCNLQGAVPD-----LSRI-PNLYYLDLSWNHLTGS----IPSK-KL 298 (958)
Q Consensus 234 L~L~~N~l~~~---~~p~~~~~l~-~L~~L~L~~N~l~~~~~~-----l~~l-~~L~~L~Ls~N~l~~~----~~~~-~~ 298 (958)
|+|++|+++.. .++..+..++ +|++|+|++|++++..+. +..+ ++|+.|+|++|.+++. ++.. ..
T Consensus 143 L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~i~~~~~~~l~~~l~~ 222 (362)
T 3goz_A 143 LNLRGNDLGIKSSDELIQILAAIPANVNSLNLRGNNLASKNCAELAKFLASIPASVTSLDLSANLLGLKSYAELAYIFSS 222 (362)
T ss_dssp EECTTSCGGGSCHHHHHHHHHTSCTTCCEEECTTSCGGGSCHHHHHHHHHTSCTTCCEEECTTSCGGGSCHHHHHHHHHH
T ss_pred EEccCCcCCHHHHHHHHHHHhcCCccccEeeecCCCCchhhHHHHHHHHHhCCCCCCEEECCCCCCChhHHHHHHHHHhc
Confidence 55555555421 1122233333 555555555555544331 2233 3556666666655531 1111 11
Q ss_pred -CCCcCEEEccCCcCCCccc----hhccCCCCCCeEeeecccCCCccchhhhcccc--cCccccceEeccCCCCCCC
Q 002158 299 -SENVTTIDLSDNYLNGSIL----ESISNLPFLQTLSLENNFLTGSIPATIWQNKS--FSTKARLKIDLRNNSFSNI 368 (958)
Q Consensus 299 -~~~L~~L~Ls~N~l~~~~~----~~~~~l~~L~~L~L~~N~l~~~ip~~l~~~~~--~~~~~l~~L~Ls~N~l~~l 368 (958)
.++|++|+|++|.|++..+ ..+..+++|+.|+|++|.+.+..+..+..+.. -....++.||+++|++...
T Consensus 223 ~~~~L~~L~Ls~N~l~~~~~~~l~~~~~~l~~L~~L~L~~n~l~~i~~~~~~~l~~~~~~l~~L~~LdL~~N~l~~~ 299 (362)
T 3goz_A 223 IPNHVVSLNLCLNCLHGPSLENLKLLKDSLKHLQTVYLDYDIVKNMSKEQCKALGAAFPNIQKIILVDKNGKEIHPS 299 (362)
T ss_dssp SCTTCCEEECCSSCCCCCCHHHHHHTTTTTTTCSEEEEEHHHHTTCCHHHHHHHHTTSTTCCEEEEECTTSCBCCGG
T ss_pred CCCCceEEECcCCCCCcHHHHHHHHHHhcCCCccEEEeccCCccccCHHHHHHHHHHhccCCceEEEecCCCcCCCc
Confidence 2356666666666655443 23345566666666666644333322211110 1223455666666666543
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} | Back alignment and structure |
|---|
Probab=99.85 E-value=4.4e-21 Score=226.08 Aligned_cols=189 Identities=31% Similarity=0.377 Sum_probs=133.2
Q ss_pred CCcEEEeeCCCCCCCCChhhcCCCCCCEEecccccccccCccccccccccceEecccccccccCchhhcCCccchhhhcc
Q 002158 134 SLIFLLLNGNKLSGSLPDELGYLSNLNRLQVDENNITGTIPKSFANLSRVRHLHLNNNSIGGQIPSELSKLSTLIHLLVD 213 (958)
Q Consensus 134 ~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~ 213 (958)
+|+.|+|++|.+++ +|..+. ++|++|+|++|+|+ .+| ..+++|++|+|++|+|++ +|. +.+ +|+.|+|+
T Consensus 60 ~L~~L~Ls~n~L~~-lp~~l~--~~L~~L~Ls~N~l~-~ip---~~l~~L~~L~Ls~N~l~~-ip~-l~~--~L~~L~Ls 128 (571)
T 3cvr_A 60 QFSELQLNRLNLSS-LPDNLP--PQITVLEITQNALI-SLP---ELPASLEYLDACDNRLST-LPE-LPA--SLKHLDVD 128 (571)
T ss_dssp TCSEEECCSSCCSC-CCSCCC--TTCSEEECCSSCCS-CCC---CCCTTCCEEECCSSCCSC-CCC-CCT--TCCEEECC
T ss_pred CccEEEeCCCCCCc-cCHhHc--CCCCEEECcCCCCc-ccc---cccCCCCEEEccCCCCCC-cch-hhc--CCCEEECC
Confidence 56666666666664 555442 56666666666666 445 335667777777777764 555 443 67777777
Q ss_pred CCccccCCCcccCCCCCccEEEccCCCCCCCCccccccCCCCCCEEEcccCCCCCCCCCCCCCCCcCEEeccCCcCCCcC
Q 002158 214 NNNLSGNLPPELSELPQLCILQLDNNNFSASEIPATYGNFSKLVKLSLRNCNLQGAVPDLSRIPNLYYLDLSWNHLTGSI 293 (958)
Q Consensus 214 ~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~l~~l~~L~~L~Ls~N~l~~~~ 293 (958)
+|+|++ +|. .+++|+.|+|++|+|+. +|. .+++|+.|+|++|+|++++. +. ++|+.|+|++|+|+ .+
T Consensus 129 ~N~l~~-lp~---~l~~L~~L~Ls~N~l~~--lp~---~l~~L~~L~Ls~N~L~~lp~-l~--~~L~~L~Ls~N~L~-~l 195 (571)
T 3cvr_A 129 NNQLTM-LPE---LPALLEYINADNNQLTM--LPE---LPTSLEVLSVRNNQLTFLPE-LP--ESLEALDVSTNLLE-SL 195 (571)
T ss_dssp SSCCSC-CCC---CCTTCCEEECCSSCCSC--CCC---CCTTCCEEECCSSCCSCCCC-CC--TTCCEEECCSSCCS-SC
T ss_pred CCcCCC-CCC---cCccccEEeCCCCccCc--CCC---cCCCcCEEECCCCCCCCcch-hh--CCCCEEECcCCCCC-ch
Confidence 777775 444 46777777777777763 454 46778888888888877555 55 78888888888888 55
Q ss_pred CCCCCCCCc-------CEEEccCCcCCCccchhccCCCCCCeEeeecccCCCccchhhhcccc
Q 002158 294 PSKKLSENV-------TTIDLSDNYLNGSILESISNLPFLQTLSLENNFLTGSIPATIWQNKS 349 (958)
Q Consensus 294 ~~~~~~~~L-------~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~ip~~l~~~~~ 349 (958)
|. +..+| +.|+|++|+|+. +|..+..+++|+.|+|++|+|++.+|..+..+..
T Consensus 196 p~--~~~~L~~~~~~L~~L~Ls~N~l~~-lp~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~ 255 (571)
T 3cvr_A 196 PA--VPVRNHHSEETEIFFRCRENRITH-IPENILSLDPTCTIILEDNPLSSRIRESLSQQTA 255 (571)
T ss_dssp CC--CC--------CCEEEECCSSCCCC-CCGGGGGSCTTEEEECCSSSCCHHHHHHHHHHHH
T ss_pred hh--HHHhhhcccccceEEecCCCccee-cCHHHhcCCCCCEEEeeCCcCCCcCHHHHHHhhc
Confidence 55 23367 999999999995 6777777999999999999999999998877544
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.84 E-value=3.9e-21 Score=198.30 Aligned_cols=161 Identities=20% Similarity=0.239 Sum_probs=94.5
Q ss_pred CCCcEEEeeCCCCCCCCChhhcCCCCCCEEecccccccccCccccccccccceEecccccccccCchhhcCCccchhhhc
Q 002158 133 SSLIFLLLNGNKLSGSLPDELGYLSNLNRLQVDENNITGTIPKSFANLSRVRHLHLNNNSIGGQIPSELSKLSTLIHLLV 212 (958)
Q Consensus 133 ~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L 212 (958)
++|++|+|++|.+++..+..+..+++|++|+|++|++++..+..|..+++|++|+|++|++++..+..|.++++|++|+|
T Consensus 28 ~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L 107 (208)
T 2o6s_A 28 AQTTYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQSLPNGVFNKLTSLTYLNLSTNQLQSLPNGVFDKLTQLKELAL 107 (208)
T ss_dssp TTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEEC
T ss_pred CCCcEEEcCCCccCcCChhhhcccccCcEEECCCCccCccChhhcCCCCCcCEEECCCCcCCccCHhHhcCccCCCEEEc
Confidence 46788888888888655556777778888888877777555555666777777777777666544444555555555555
Q ss_pred cCCccccCCCcccCCCCCccEEEccCCCCCCCCccccccCCCCCCEEEcccCCCCCCCCC-CCCCCCcCEEeccCCcCCC
Q 002158 213 DNNNLSGNLPPELSELPQLCILQLDNNNFSASEIPATYGNFSKLVKLSLRNCNLQGAVPD-LSRIPNLYYLDLSWNHLTG 291 (958)
Q Consensus 213 ~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~-l~~l~~L~~L~Ls~N~l~~ 291 (958)
++|++++..+..|..++ +|+.|+|++|++++.++. +..+++|+.|+|++|.+.+
T Consensus 108 ~~N~l~~~~~~~~~~l~-------------------------~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~ 162 (208)
T 2o6s_A 108 NTNQLQSLPDGVFDKLT-------------------------QLKDLRLYQNQLKSVPDGVFDRLTSLQYIWLHDNPWDC 162 (208)
T ss_dssp CSSCCCCCCTTTTTTCT-------------------------TCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSCCBCC
T ss_pred CCCcCcccCHhHhccCC-------------------------cCCEEECCCCccceeCHHHhccCCCccEEEecCCCeec
Confidence 55555544444444444 444444444444444443 4555566666666665543
Q ss_pred cCCCCCCCCCcCEEEccCCcCCCccchhccCCC
Q 002158 292 SIPSKKLSENVTTIDLSDNYLNGSILESISNLP 324 (958)
Q Consensus 292 ~~~~~~~~~~L~~L~Ls~N~l~~~~~~~~~~l~ 324 (958)
.. ++|+.|+++.|+++|.+|..++.++
T Consensus 163 ~~------~~l~~L~~~~n~~~g~ip~~~~~l~ 189 (208)
T 2o6s_A 163 TC------PGIRYLSEWINKHSGVVRNSAGSVA 189 (208)
T ss_dssp CT------TTTHHHHHHHHHCTTTBBCTTSSBC
T ss_pred CC------CCHHHHHHHHHhCCceeeccCcccc
Confidence 22 2444455555555555555554443
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} | Back alignment and structure |
|---|
Probab=99.84 E-value=1.4e-22 Score=228.22 Aligned_cols=251 Identities=24% Similarity=0.267 Sum_probs=193.0
Q ss_pred EEEeeCCCCCCCCChhhcCCCCCCEEecccccccccCc----ccccccc-ccceEecccccccccCchhhcCC-----cc
Q 002158 137 FLLLNGNKLSGSLPDELGYLSNLNRLQVDENNITGTIP----KSFANLS-RVRHLHLNNNSIGGQIPSELSKL-----ST 206 (958)
Q Consensus 137 ~L~Ls~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p----~~~~~l~-~L~~L~Ls~N~l~~~~p~~l~~l-----~~ 206 (958)
++.|+.|.++|.+|..+...++|++|+|++|.+++..+ ..|..++ +|++|+|++|.|++..+..+..+ ++
T Consensus 2 ~~~ls~n~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~ 81 (362)
T 3goz_A 2 NYKLTLHPGSNPVEEFTSIPHGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELVQILAAIPAN 81 (362)
T ss_dssp EEECCCCTTCCHHHHHHTSCTTCCEEECTTSCGGGSCHHHHHHHHHTCCTTCCEEECCSSCGGGSCHHHHHHHHHTSCTT
T ss_pred ccccccccchHHHHHHHhCCCCceEEEccCCCCChHHHHHHHHHHHhCCCceeEEECcCCCCCHHHHHHHHHHHhccCCC
Confidence 46788889988888877777779999999999887766 6777888 89999999999987777777665 89
Q ss_pred chhhhccCCccccCCCccc----CCC-CCccEEEccCCCCCCCCcccc----ccC-CCCCCEEEcccCCCCCCCCC----
Q 002158 207 LIHLLVDNNNLSGNLPPEL----SEL-PQLCILQLDNNNFSASEIPAT----YGN-FSKLVKLSLRNCNLQGAVPD---- 272 (958)
Q Consensus 207 L~~L~L~~N~l~~~~~~~l----~~l-~~L~~L~L~~N~l~~~~~p~~----~~~-l~~L~~L~L~~N~l~~~~~~---- 272 (958)
|++|+|++|++++..+..+ ..+ ++|++|+|++|+++.. .+.. +.. .++|++|+|++|++++....
T Consensus 82 L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~-~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~ 160 (362)
T 3goz_A 82 VTSLNLSGNFLSYKSSDELVKTLAAIPFTITVLDLGWNDFSSK-SSSEFKQAFSNLPASITSLNLRGNDLGIKSSDELIQ 160 (362)
T ss_dssp CCEEECCSSCGGGSCHHHHHHHHHTSCTTCCEEECCSSCGGGS-CHHHHHHHHTTSCTTCCEEECTTSCGGGSCHHHHHH
T ss_pred ccEEECcCCcCChHHHHHHHHHHHhCCCCccEEECcCCcCCcH-HHHHHHHHHHhCCCceeEEEccCCcCCHHHHHHHHH
Confidence 9999999999987766644 444 8999999999999743 2333 444 36999999999999865432
Q ss_pred -CCCCC-CcCEEeccCCcCCCcCCC-----CCCC-CCcCEEEccCCcCCCc----cchhccC-CCCCCeEeeecccCCCc
Q 002158 273 -LSRIP-NLYYLDLSWNHLTGSIPS-----KKLS-ENVTTIDLSDNYLNGS----ILESISN-LPFLQTLSLENNFLTGS 339 (958)
Q Consensus 273 -l~~l~-~L~~L~Ls~N~l~~~~~~-----~~~~-~~L~~L~Ls~N~l~~~----~~~~~~~-l~~L~~L~L~~N~l~~~ 339 (958)
+..++ +|++|+|++|++++..+. .... ++|++|+|++|.|++. ++..+.. .++|++|+|++|+|++.
T Consensus 161 ~l~~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~i~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~ 240 (362)
T 3goz_A 161 ILAAIPANVNSLNLRGNNLASKNCAELAKFLASIPASVTSLDLSANLLGLKSYAELAYIFSSIPNHVVSLNLCLNCLHGP 240 (362)
T ss_dssp HHHTSCTTCCEEECTTSCGGGSCHHHHHHHHHTSCTTCCEEECTTSCGGGSCHHHHHHHHHHSCTTCCEEECCSSCCCCC
T ss_pred HHhcCCccccEeeecCCCCchhhHHHHHHHHHhCCCCCCEEECCCCCCChhHHHHHHHHHhcCCCCceEEECcCCCCCcH
Confidence 34554 999999999999854432 1223 5999999999999874 4455555 45999999999999977
Q ss_pred cchhhhcccccCccccceEeccCCCCCCCccC--------C-CCCCcceEEeCCCCCCC
Q 002158 340 IPATIWQNKSFSTKARLKIDLRNNSFSNIVGD--------L-TLPNNVTLRLGGNPICT 389 (958)
Q Consensus 340 ip~~l~~~~~~~~~~l~~L~Ls~N~l~~l~~~--------~-~l~~L~~L~l~~N~l~~ 389 (958)
.+..+.... -..+.|+.|+|++|.+..+... . .+++|+.|++++|++..
T Consensus 241 ~~~~l~~~~-~~l~~L~~L~L~~n~l~~i~~~~~~~l~~~~~~l~~L~~LdL~~N~l~~ 298 (362)
T 3goz_A 241 SLENLKLLK-DSLKHLQTVYLDYDIVKNMSKEQCKALGAAFPNIQKIILVDKNGKEIHP 298 (362)
T ss_dssp CHHHHHHTT-TTTTTCSEEEEEHHHHTTCCHHHHHHHHTTSTTCCEEEEECTTSCBCCG
T ss_pred HHHHHHHHH-hcCCCccEEEeccCCccccCHHHHHHHHHHhccCCceEEEecCCCcCCC
Confidence 665554321 1245688999999996665432 2 78889999999999854
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A | Back alignment and structure |
|---|
Probab=99.84 E-value=4.7e-23 Score=234.26 Aligned_cols=240 Identities=18% Similarity=0.244 Sum_probs=167.2
Q ss_pred ccccccCCCCcceeeccCcccCC-----CCccccCCCCCcEEEeeCC---CCCCCCChhh-------cCCCCCCEEeccc
Q 002158 102 LAPELGQLSRLQYYFMWNDLTGT-----IPKEIGNISSLIFLLLNGN---KLSGSLPDEL-------GYLSNLNRLQVDE 166 (958)
Q Consensus 102 ~~~~l~~L~~L~~L~l~n~~~~~-----ip~~i~~l~~L~~L~Ls~n---~l~~~~p~~l-------~~l~~L~~L~L~~ 166 (958)
++..+..+++|+.|++++|..+. ++..+.++++|++|+|++| ++++.+|..+ ..+++|++|+|++
T Consensus 24 l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~Ls~~~~~~l~~~~~~~~~~l~~~l~~~~~L~~L~Ls~ 103 (386)
T 2ca6_A 24 VFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSD 103 (386)
T ss_dssp TSHHHHHCSCCCEEECTTSEECHHHHHHHHHTTTTCTTCCEEECCSCCTTSCGGGSHHHHHHHHHHHTTCTTCCEEECCS
T ss_pred HHHHHhcCCCccEEECCCCCCCHHHHHHHHHHHHhCCCccEEeCcccccCccccchhHHHHHHHHHHhhCCcccEEECCC
Confidence 45556667777777776554432 3344667777777777775 3444555544 5677778888888
Q ss_pred ccccc----cCccccccccccceEecccccccccCchhh----cCC---------ccchhhhccCCccc-cCCC---ccc
Q 002158 167 NNITG----TIPKSFANLSRVRHLHLNNNSIGGQIPSEL----SKL---------STLIHLLVDNNNLS-GNLP---PEL 225 (958)
Q Consensus 167 N~l~~----~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l----~~l---------~~L~~L~L~~N~l~-~~~~---~~l 225 (958)
|.+++ .++..+..+++|++|+|++|.+++..+..+ ..+ ++|++|+|++|+++ +.++ ..+
T Consensus 104 n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~l~~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~~l 183 (386)
T 2ca6_A 104 NAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTF 183 (386)
T ss_dssp CCCCTTTHHHHHHHHHHCTTCCEEECCSSCCHHHHHHHHHHHHHHHHHHHHHHTCCCCCEEECCSSCCTGGGHHHHHHHH
T ss_pred CcCCHHHHHHHHHHHHhCCCCCEEECcCCCCCHHHHHHHHHHHHHHhhhhhcccCCCCcEEECCCCCCCcHHHHHHHHHH
Confidence 77776 366677777778888888887764333333 333 77888888888876 3333 356
Q ss_pred CCCCCccEEEccCCCCCCC----CccccccCCCCCCEEEcccCCCC----CCC-CCCCCCCCcCEEeccCCcCCCc----
Q 002158 226 SELPQLCILQLDNNNFSAS----EIPATYGNFSKLVKLSLRNCNLQ----GAV-PDLSRIPNLYYLDLSWNHLTGS---- 292 (958)
Q Consensus 226 ~~l~~L~~L~L~~N~l~~~----~~p~~~~~l~~L~~L~L~~N~l~----~~~-~~l~~l~~L~~L~Ls~N~l~~~---- 292 (958)
..+++|++|+|++|+++.. ..+..+..+++|+.|+|++|.++ ... ..+..+++|+.|+|++|.+++.
T Consensus 184 ~~~~~L~~L~L~~n~l~~~g~~~l~~~~l~~~~~L~~L~Ls~n~l~~~g~~~l~~~l~~~~~L~~L~L~~n~i~~~~~~~ 263 (386)
T 2ca6_A 184 QSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLSARGAAA 263 (386)
T ss_dssp HHCTTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHHHGGGCTTCCEEECTTCCCCHHHHHH
T ss_pred HhCCCcCEEECcCCCCCHhHHHHHHHHHhhcCCCccEEECcCCCCCcHHHHHHHHHHccCCCcCEEECCCCCCchhhHHH
Confidence 6778888888888887521 23336777888888888888884 222 2477788888999999888753
Q ss_pred CCCC---CCCCCcCEEEccCCcCCC----ccchhc-cCCCCCCeEeeecccCCCccc
Q 002158 293 IPSK---KLSENVTTIDLSDNYLNG----SILESI-SNLPFLQTLSLENNFLTGSIP 341 (958)
Q Consensus 293 ~~~~---~~~~~L~~L~Ls~N~l~~----~~~~~~-~~l~~L~~L~L~~N~l~~~ip 341 (958)
++.. ..+++|+.|+|++|.|++ .++..+ .++++|+.|+|++|++++..+
T Consensus 264 l~~~l~~~~~~~L~~L~L~~n~i~~~g~~~l~~~l~~~l~~L~~L~l~~N~l~~~~~ 320 (386)
T 2ca6_A 264 VVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFSEEDD 320 (386)
T ss_dssp HHHHHHTCSSCCCCEEECCSSCCBHHHHHHHHHHHHHHCTTCCEEECTTSBSCTTSH
T ss_pred HHHHHhhccCCCeEEEECcCCcCCHHHHHHHHHHHHhcCCCceEEEccCCcCCcchh
Confidence 2222 236889999999999988 477777 678999999999999997775
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 | Back alignment and structure |
|---|
Probab=99.84 E-value=5.5e-21 Score=209.89 Aligned_cols=195 Identities=24% Similarity=0.372 Sum_probs=148.4
Q ss_pred cCCCCcceeeccCcccCCCCccccCCCCCcEEEeeCCCCCCCCChhhcCCCCCCEEecccccccccCccccccccccceE
Q 002158 107 GQLSRLQYYFMWNDLTGTIPKEIGNISSLIFLLLNGNKLSGSLPDELGYLSNLNRLQVDENNITGTIPKSFANLSRVRHL 186 (958)
Q Consensus 107 ~~L~~L~~L~l~n~~~~~ip~~i~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L 186 (958)
..+++|+.|.++++....+| .+..+++|++|+|++|.+++ ++. +..+++|++|+|++|++++. +.+..+++|++|
T Consensus 38 ~~l~~L~~L~l~~~~i~~l~-~~~~l~~L~~L~L~~n~i~~-~~~-~~~l~~L~~L~L~~n~l~~~--~~~~~l~~L~~L 112 (308)
T 1h6u_A 38 ADLDGITTLSAFGTGVTTIE-GVQYLNNLIGLELKDNQITD-LAP-LKNLTKITELELSGNPLKNV--SAIAGLQSIKTL 112 (308)
T ss_dssp HHHHTCCEEECTTSCCCCCT-TGGGCTTCCEEECCSSCCCC-CGG-GTTCCSCCEEECCSCCCSCC--GGGTTCTTCCEE
T ss_pred HHcCCcCEEEeeCCCccCch-hhhccCCCCEEEccCCcCCC-Chh-HccCCCCCEEEccCCcCCCc--hhhcCCCCCCEE
Confidence 45666777777766666665 57778888888888888874 444 78888888888888888753 367788888888
Q ss_pred ecccccccccCchhhcCCccchhhhccCCccccCCCcccCCCCCccEEEccCCCCCCCCccccccCCCCCCEEEcccCCC
Q 002158 187 HLNNNSIGGQIPSELSKLSTLIHLLVDNNNLSGNLPPELSELPQLCILQLDNNNFSASEIPATYGNFSKLVKLSLRNCNL 266 (958)
Q Consensus 187 ~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~p~~~~~l~~L~~L~L~~N~l 266 (958)
+|++|++++ ++. +..+++|+.|++++|++++..+ +..+++|++|+|++|+++. ++. +..+++|+.|+|++|++
T Consensus 113 ~l~~n~l~~-~~~-l~~l~~L~~L~l~~n~l~~~~~--l~~l~~L~~L~l~~n~l~~--~~~-l~~l~~L~~L~l~~n~l 185 (308)
T 1h6u_A 113 DLTSTQITD-VTP-LAGLSNLQVLYLDLNQITNISP--LAGLTNLQYLSIGNAQVSD--LTP-LANLSKLTTLKADDNKI 185 (308)
T ss_dssp ECTTSCCCC-CGG-GTTCTTCCEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCC--CGG-GTTCTTCCEEECCSSCC
T ss_pred ECCCCCCCC-chh-hcCCCCCCEEECCCCccCcCcc--ccCCCCccEEEccCCcCCC--Chh-hcCCCCCCEEECCCCcc
Confidence 888888875 343 7888888888888888875433 7788888888888888863 344 78888888888888888
Q ss_pred CCCCCCCCCCCCcCEEeccCCcCCCcCCCCCCCCCcCEEEccCCcCCCc
Q 002158 267 QGAVPDLSRIPNLYYLDLSWNHLTGSIPSKKLSENVTTIDLSDNYLNGS 315 (958)
Q Consensus 267 ~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~~~L~~L~Ls~N~l~~~ 315 (958)
++.++ +..+++|++|+|++|++++.. ....+++|+.|+|++|.+++.
T Consensus 186 ~~~~~-l~~l~~L~~L~L~~N~l~~~~-~l~~l~~L~~L~l~~N~i~~~ 232 (308)
T 1h6u_A 186 SDISP-LASLPNLIEVHLKNNQISDVS-PLANTSNLFIVTLTNQTITNQ 232 (308)
T ss_dssp CCCGG-GGGCTTCCEEECTTSCCCBCG-GGTTCTTCCEEEEEEEEEECC
T ss_pred CcChh-hcCCCCCCEEEccCCccCccc-cccCCCCCCEEEccCCeeecC
Confidence 86654 778888888888888888544 466678888999998888753
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* | Back alignment and structure |
|---|
Probab=99.84 E-value=1.3e-20 Score=211.03 Aligned_cols=246 Identities=20% Similarity=0.193 Sum_probs=169.9
Q ss_pred CCCCCCCceeeCccccCCCceeeEEEEccCCcCCCCccccccCCCCcceeeccCcccCCCCc-cccCCCCCcEEEeeCCC
Q 002158 66 PCMSNWTGVLCFDTVETDGHLHVRELQLLSMNLSGNLAPELGQLSRLQYYFMWNDLTGTIPK-EIGNISSLIFLLLNGNK 144 (958)
Q Consensus 66 ~c~~~w~gV~C~~~~~~~~~~~v~~L~L~~~~l~~~~~~~l~~L~~L~~L~l~n~~~~~ip~-~i~~l~~L~~L~Ls~n~ 144 (958)
.|.|.|+.|.|.+ ++++ .+|..+ .++++.|++++|.+..+|. .|.++++|++|+|++|.
T Consensus 6 ~C~C~~~~v~C~~-----------------~~Lt-~iP~~l--~~~l~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N~ 65 (350)
T 4ay9_X 6 ICHCSNRVFLCQE-----------------SKVT-EIPSDL--PRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQND 65 (350)
T ss_dssp SSEEETTEEEEES-----------------TTCC-SCCTTC--CTTCSEEEEESCCCSEECTTSSTTCTTCCEEEEECCT
T ss_pred ccEeeCCEEEecC-----------------CCCC-ccCcCc--CCCCCEEEccCCcCCCcCHHHHcCCCCCCEEECcCCC
Confidence 3777888888843 3344 345444 2567778787777777775 47888888888888888
Q ss_pred CCCCCCh-hhcCCCCCCE-EecccccccccCccccccccccceEecccccccccCchhhcCCccchhhhccC-CccccCC
Q 002158 145 LSGSLPD-ELGYLSNLNR-LQVDENNITGTIPKSFANLSRVRHLHLNNNSIGGQIPSELSKLSTLIHLLVDN-NNLSGNL 221 (958)
Q Consensus 145 l~~~~p~-~l~~l~~L~~-L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~-N~l~~~~ 221 (958)
+.+.+|. .|.++++|++ +.+..|+++...|..|..+++|++|++++|+|++..+..+....++..|++.+ |++....
T Consensus 66 i~~~i~~~~f~~L~~l~~~l~~~~N~l~~l~~~~f~~l~~L~~L~l~~n~l~~~~~~~~~~~~~l~~l~l~~~~~i~~l~ 145 (350)
T 4ay9_X 66 VLEVIEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIE 145 (350)
T ss_dssp TCCEECTTSBCSCTTCCEEEEEEETTCCEECTTSBCCCTTCCEEEEEEECCSSCCCCTTCCBSSCEEEEEESCTTCCEEC
T ss_pred CCCccChhHhhcchhhhhhhcccCCcccccCchhhhhccccccccccccccccCCchhhcccchhhhhhhcccccccccc
Confidence 7655553 4677777665 55666888877777788888888888888888866665666666777777754 5666666
Q ss_pred CcccCCCC-CccEEEccCCCCCCCCccccccCCCCCCEEEccc-CCCCCCCCC-CCCCCCcCEEeccCCcCCCcCCCCCC
Q 002158 222 PPELSELP-QLCILQLDNNNFSASEIPATYGNFSKLVKLSLRN-CNLQGAVPD-LSRIPNLYYLDLSWNHLTGSIPSKKL 298 (958)
Q Consensus 222 ~~~l~~l~-~L~~L~L~~N~l~~~~~p~~~~~l~~L~~L~L~~-N~l~~~~~~-l~~l~~L~~L~Ls~N~l~~~~~~~~~ 298 (958)
+..|..+. .++.|+|++|+|+ .++.......+|+.|++++ |.++.++++ |..+++|++|+|++|+|+ .+|. ..
T Consensus 146 ~~~f~~~~~~l~~L~L~~N~i~--~i~~~~f~~~~L~~l~l~~~n~l~~i~~~~f~~l~~L~~LdLs~N~l~-~lp~-~~ 221 (350)
T 4ay9_X 146 RNSFVGLSFESVILWLNKNGIQ--EIHNSAFNGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIH-SLPS-YG 221 (350)
T ss_dssp TTSSTTSBSSCEEEECCSSCCC--EECTTSSTTEEEEEEECTTCTTCCCCCTTTTTTEECCSEEECTTSCCC-CCCS-SS
T ss_pred ccchhhcchhhhhhcccccccc--CCChhhccccchhHHhhccCCcccCCCHHHhccCcccchhhcCCCCcC-ccCh-hh
Confidence 66666664 5778888888885 4555555567788888864 667666654 778888888888888887 4443 23
Q ss_pred CCCcCEEEccCCcCCCccchhccCCCCCCeEeeecccC
Q 002158 299 SENVTTIDLSDNYLNGSILESISNLPFLQTLSLENNFL 336 (958)
Q Consensus 299 ~~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l 336 (958)
+.+|+.|.+.++.--..+| .+..+++|+.+++.++.-
T Consensus 222 ~~~L~~L~~l~~~~l~~lP-~l~~l~~L~~l~l~~~~~ 258 (350)
T 4ay9_X 222 LENLKKLRARSTYNLKKLP-TLEKLVALMEASLTYPSH 258 (350)
T ss_dssp CTTCCEEECTTCTTCCCCC-CTTTCCSCCEEECSCHHH
T ss_pred hccchHhhhccCCCcCcCC-CchhCcChhhCcCCCCcc
Confidence 5677777766654333444 367778888888776543
|
| >2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A | Back alignment and structure |
|---|
Probab=99.82 E-value=4.4e-22 Score=221.67 Aligned_cols=243 Identities=23% Similarity=0.307 Sum_probs=127.1
Q ss_pred CcEEEeeCCCCCCCCChhhcCC--CCCCEEecccccccccCccccccccccceEeccccccccc-CchhhcCCccchhhh
Q 002158 135 LIFLLLNGNKLSGSLPDELGYL--SNLNRLQVDENNITGTIPKSFANLSRVRHLHLNNNSIGGQ-IPSELSKLSTLIHLL 211 (958)
Q Consensus 135 L~~L~Ls~n~l~~~~p~~l~~l--~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~-~p~~l~~l~~L~~L~ 211 (958)
++.|++++|.+. +..+..+ ++|+.|++++|.+++..+. +..+++|++|+|++|.+++. ++..+..+++|++|+
T Consensus 49 ~~~l~l~~~~~~---~~~~~~~~~~~l~~L~l~~n~l~~~~~~-~~~~~~L~~L~L~~~~l~~~~~~~~~~~~~~L~~L~ 124 (336)
T 2ast_B 49 WQTLDLTGKNLH---PDVTGRLLSQGVIAFRCPRSFMDQPLAE-HFSPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLS 124 (336)
T ss_dssp SSEEECTTCBCC---HHHHHHHHHTTCSEEECTTCEECSCCCS-CCCCBCCCEEECTTCEECHHHHHHHHTTBCCCSEEE
T ss_pred heeeccccccCC---HHHHHhhhhccceEEEcCCccccccchh-hccCCCCCEEEccCCCcCHHHHHHHHhhCCCCCEEe
Confidence 555566555554 3444444 5566666666666544433 34456666666666665543 555555566666666
Q ss_pred ccCCccccCCCcccCCCCCccEEEccCC-CCCCCCccccccCCCCCCEEEcccC-CCCCC-CC-CCCCCC-CcCEEeccC
Q 002158 212 VDNNNLSGNLPPELSELPQLCILQLDNN-NFSASEIPATYGNFSKLVKLSLRNC-NLQGA-VP-DLSRIP-NLYYLDLSW 286 (958)
Q Consensus 212 L~~N~l~~~~~~~l~~l~~L~~L~L~~N-~l~~~~~p~~~~~l~~L~~L~L~~N-~l~~~-~~-~l~~l~-~L~~L~Ls~ 286 (958)
|++|++++..+..+..+++|++|+|++| .++...++..+.++++|++|+|++| .+++. .+ .+..++ +|++|+|++
T Consensus 125 L~~~~l~~~~~~~l~~~~~L~~L~L~~~~~l~~~~l~~~~~~~~~L~~L~l~~~~~l~~~~~~~~~~~l~~~L~~L~l~~ 204 (336)
T 2ast_B 125 LEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSG 204 (336)
T ss_dssp CTTCBCCHHHHHHHTTCTTCSEEECTTCBSCCHHHHHHHHHHCTTCCEEECCCCTTCCHHHHHHHHHHSCTTCCEEECCS
T ss_pred CcCcccCHHHHHHHhcCCCCCEEECCCCCCCCHHHHHHHHhcCCCCCEEcCCCCCCcChHHHHHHHHhcccCCCEEEeCC
Confidence 6666655555555555666666666666 4442224445555666666666666 55542 11 244555 666666666
Q ss_pred C--cCC-CcCCCC-CCCCCcCEEEccCCc-CCCccchhccCCCCCCeEeeecccCCCccchhhhcccccCccccceEecc
Q 002158 287 N--HLT-GSIPSK-KLSENVTTIDLSDNY-LNGSILESISNLPFLQTLSLENNFLTGSIPATIWQNKSFSTKARLKIDLR 361 (958)
Q Consensus 287 N--~l~-~~~~~~-~~~~~L~~L~Ls~N~-l~~~~~~~~~~l~~L~~L~L~~N~l~~~ip~~l~~~~~~~~~~l~~L~Ls 361 (958)
| .++ +.++.. ..+++|++|+|++|. +++..+..+..+++|++|+|++|. +..+..+..+.. .+.|+.|+++
T Consensus 205 ~~~~~~~~~l~~~~~~~~~L~~L~l~~~~~l~~~~~~~l~~l~~L~~L~l~~~~--~~~~~~~~~l~~--~~~L~~L~l~ 280 (336)
T 2ast_B 205 YRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCY--DIIPETLLELGE--IPTLKTLQVF 280 (336)
T ss_dssp CGGGSCHHHHHHHHHHCTTCSEEECTTCTTCCGGGGGGGGGCTTCCEEECTTCT--TCCGGGGGGGGG--CTTCCEEECT
T ss_pred CcccCCHHHHHHHHhhCCCCCEEeCCCCCcCCHHHHHHHhCCCCCCEeeCCCCC--CCCHHHHHHHhc--CCCCCEEecc
Confidence 6 332 122211 234566666666666 555555566666666666666664 222332212211 2345566666
Q ss_pred CCCCCCCccCC--CC-CCcceEEeCCCCCCC
Q 002158 362 NNSFSNIVGDL--TL-PNNVTLRLGGNPICT 389 (958)
Q Consensus 362 ~N~l~~l~~~~--~l-~~L~~L~l~~N~l~~ 389 (958)
+| + +... .+ ..++.|++++|.++.
T Consensus 281 ~~-i---~~~~~~~l~~~l~~L~l~~n~l~~ 307 (336)
T 2ast_B 281 GI-V---PDGTLQLLKEALPHLQINCSHFTT 307 (336)
T ss_dssp TS-S---CTTCHHHHHHHSTTSEESCCCSCC
T ss_pred Cc-c---CHHHHHHHHhhCcceEEecccCcc
Confidence 66 2 2211 12 234555566666643
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} | Back alignment and structure |
|---|
Probab=99.82 E-value=4.5e-21 Score=226.04 Aligned_cols=212 Identities=26% Similarity=0.342 Sum_probs=126.1
Q ss_pred ccCCCCC-CCCCCC---CCCce-eeCccccCCCceeeEEEEccCCcCCCCccccccCCCCcceeeccCcccCCCCccccC
Q 002158 57 HLRNWNK-GDPCMS---NWTGV-LCFDTVETDGHLHVRELQLLSMNLSGNLAPELGQLSRLQYYFMWNDLTGTIPKEIGN 131 (958)
Q Consensus 57 ~l~~W~~-~~~c~~---~w~gV-~C~~~~~~~~~~~v~~L~L~~~~l~~~~~~~l~~L~~L~~L~l~n~~~~~ip~~i~~ 131 (958)
.+.+|.. .++|.. .|.|+ .|... +++.|+|++|++++ +|..+. ++
T Consensus 32 ~l~~W~~~~~~~~~~~~~~~~l~~C~~~-------~L~~L~Ls~n~L~~-lp~~l~--~~-------------------- 81 (571)
T 3cvr_A 32 AWDKWEKQALPGENRNEAVSLLKECLIN-------QFSELQLNRLNLSS-LPDNLP--PQ-------------------- 81 (571)
T ss_dssp HHHHHHTTCCTTCCHHHHHHHHHHHHHT-------TCSEEECCSSCCSC-CCSCCC--TT--------------------
T ss_pred HHHHHhccCCccccccchhhhccccccC-------CccEEEeCCCCCCc-cCHhHc--CC--------------------
Confidence 3556743 355533 58999 78532 57788888887776 444332 44
Q ss_pred CCCCcEEEeeCCCCCCCCChhhcCCCCCCEEecccccccccCccccccccccceEecccccccccCchhhcCCccchhhh
Q 002158 132 ISSLIFLLLNGNKLSGSLPDELGYLSNLNRLQVDENNITGTIPKSFANLSRVRHLHLNNNSIGGQIPSELSKLSTLIHLL 211 (958)
Q Consensus 132 l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~ 211 (958)
|++|+|++|.|+ .+| ..+++|++|+|++|+|++ +|. +.+ +|++|+|++|+|++ +|. .+++|+.|+
T Consensus 82 ---L~~L~Ls~N~l~-~ip---~~l~~L~~L~Ls~N~l~~-ip~-l~~--~L~~L~Ls~N~l~~-lp~---~l~~L~~L~ 146 (571)
T 3cvr_A 82 ---ITVLEITQNALI-SLP---ELPASLEYLDACDNRLST-LPE-LPA--SLKHLDVDNNQLTM-LPE---LPALLEYIN 146 (571)
T ss_dssp ---CSEEECCSSCCS-CCC---CCCTTCCEEECCSSCCSC-CCC-CCT--TCCEEECCSSCCSC-CCC---CCTTCCEEE
T ss_pred ---CCEEECcCCCCc-ccc---cccCCCCEEEccCCCCCC-cch-hhc--CCCEEECCCCcCCC-CCC---cCccccEEe
Confidence 555555555555 344 234555555555555553 443 333 55555555555553 333 445555556
Q ss_pred ccCCccccCCCcccCCCCCccEEEccCCCCCCCCccccccCCCCCCEEEcccCCCCCCCCCCCCCCCc-------CEEec
Q 002158 212 VDNNNLSGNLPPELSELPQLCILQLDNNNFSASEIPATYGNFSKLVKLSLRNCNLQGAVPDLSRIPNL-------YYLDL 284 (958)
Q Consensus 212 L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~l~~l~~L-------~~L~L 284 (958)
|++|+|++ +|. .+++|++|+|++|+|+. +|. |. ++|+.|+|++|+|+.++. +.. +| +.|+|
T Consensus 147 Ls~N~l~~-lp~---~l~~L~~L~Ls~N~L~~--lp~-l~--~~L~~L~Ls~N~L~~lp~-~~~--~L~~~~~~L~~L~L 214 (571)
T 3cvr_A 147 ADNNQLTM-LPE---LPTSLEVLSVRNNQLTF--LPE-LP--ESLEALDVSTNLLESLPA-VPV--RNHHSEETEIFFRC 214 (571)
T ss_dssp CCSSCCSC-CCC---CCTTCCEEECCSSCCSC--CCC-CC--TTCCEEECCSSCCSSCCC-CC----------CCEEEEC
T ss_pred CCCCccCc-CCC---cCCCcCEEECCCCCCCC--cch-hh--CCCCEEECcCCCCCchhh-HHH--hhhcccccceEEec
Confidence 66665554 333 34566666666666652 444 43 666666666666665544 433 55 88888
Q ss_pred cCCcCCCcCCCCCCCCCcCEEEccCCcCCCccchhccCCCC
Q 002158 285 SWNHLTGSIPSKKLSENVTTIDLSDNYLNGSILESISNLPF 325 (958)
Q Consensus 285 s~N~l~~~~~~~~~~~~L~~L~Ls~N~l~~~~~~~~~~l~~ 325 (958)
++|+|+...+....+++|+.|+|++|.|++..|..|..++.
T Consensus 215 s~N~l~~lp~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~ 255 (571)
T 3cvr_A 215 RENRITHIPENILSLDPTCTIILEDNPLSSRIRESLSQQTA 255 (571)
T ss_dssp CSSCCCCCCGGGGGSCTTEEEECCSSSCCHHHHHHHHHHHH
T ss_pred CCCcceecCHHHhcCCCCCEEEeeCCcCCCcCHHHHHHhhc
Confidence 88888843333455788999999999999888888877644
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A | Back alignment and structure |
|---|
Probab=99.82 E-value=3.6e-20 Score=192.74 Aligned_cols=120 Identities=23% Similarity=0.238 Sum_probs=74.9
Q ss_pred CCCCCCcCEEeccCCcCCCcCCCC-CCCCCcCEEEccCCcCCCccchhccCCCCCCeEeeecccCCCccchhhhcccccC
Q 002158 273 LSRIPNLYYLDLSWNHLTGSIPSK-KLSENVTTIDLSDNYLNGSILESISNLPFLQTLSLENNFLTGSIPATIWQNKSFS 351 (958)
Q Consensus 273 l~~l~~L~~L~Ls~N~l~~~~~~~-~~~~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~ip~~l~~~~~~~ 351 (958)
|.++++|++|+|++|.|++..+.. ..+++|++|+|++|+|++..+..|..+++|+.|+|++|+|++..+..+.
T Consensus 76 ~~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~------ 149 (220)
T 2v9t_B 76 FQGLRSLNSLVLYGNKITELPKSLFEGLFSLQLLLLNANKINCLRVDAFQDLHNLNLLSLYDNKLQTIAKGTFS------ 149 (220)
T ss_dssp TTTCSSCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTT------
T ss_pred hhCCcCCCEEECCCCcCCccCHhHccCCCCCCEEECCCCCCCEeCHHHcCCCCCCCEEECCCCcCCEECHHHHh------
Confidence 344444444444444444222221 2335555555555555556667777788888888888887743332221
Q ss_pred ccccceEeccCCCCCCCccCCCCCCcceEEeCCCCCCCCCCCCCCCcccccCCCCCccccccCCCCCCCCCCCCCccccc
Q 002158 352 TKARLKIDLRNNSFSNIVGDLTLPNNVTLRLGGNPICTSANIPNTGRFCGSDAGGDETLTNSKVNCPVQACPVDNFFEYV 431 (958)
Q Consensus 352 ~~~l~~L~Ls~N~l~~l~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~~~~~~~~~L~~n~~~C~c~~~~~~~~~~~~ 431 (958)
.+++|+.|+|++||| .|+|...++..|+...
T Consensus 150 ---------------------~l~~L~~L~L~~N~~----------------------------~c~c~l~~l~~~l~~~ 180 (220)
T 2v9t_B 150 ---------------------PLRAIQTMHLAQNPF----------------------------ICDCHLKWLADYLHTN 180 (220)
T ss_dssp ---------------------TCTTCCEEECCSSCE----------------------------ECSGGGHHHHHHHHHC
T ss_pred ---------------------CCCCCCEEEeCCCCc----------------------------CCCCccHHHHHHHHhC
Confidence 345677777777766 6788888888888877
Q ss_pred CCCCCCceeeeeceee
Q 002158 432 PASPEPCFCAAPLRIG 447 (958)
Q Consensus 432 ~~~~~~~~c~sp~~~~ 447 (958)
+.......|++|...+
T Consensus 181 ~~~~~~~~C~~P~~l~ 196 (220)
T 2v9t_B 181 PIETSGARCTSPRRLA 196 (220)
T ss_dssp CCBCSCCBEEESGGGT
T ss_pred CCCccCCCcCCchHHc
Confidence 7666678999998765
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.81 E-value=6.6e-20 Score=190.76 Aligned_cols=162 Identities=22% Similarity=0.247 Sum_probs=99.9
Q ss_pred ccEEEccCCCCCCCCccccccCCCCCCEEEcccCCCCCCCC-CCCCCCCcCEEeccCCcCCCcCCC-CCCCCCcCEEEcc
Q 002158 231 LCILQLDNNNFSASEIPATYGNFSKLVKLSLRNCNLQGAVP-DLSRIPNLYYLDLSWNHLTGSIPS-KKLSENVTTIDLS 308 (958)
Q Consensus 231 L~~L~L~~N~l~~~~~p~~~~~l~~L~~L~L~~N~l~~~~~-~l~~l~~L~~L~Ls~N~l~~~~~~-~~~~~~L~~L~Ls 308 (958)
+++|+|++|+++....+..|.++++|+.|+|++|+|++.++ .|..+++|++|+|++|.+++..+. ...+++|++|+|+
T Consensus 34 ~~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls 113 (220)
T 2v70_A 34 TAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGASGVNEILLTSNRLENVQHKMFKGLESLKTLMLR 113 (220)
T ss_dssp CSEEECCSSCCCEECCCCCGGGCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCCCCGGGGTTCSSCCEEECT
T ss_pred CCEEEcCCCcCCccCchhhhccCCCCCEEECCCCcCCEECHHHhCCCCCCCEEECCCCccCccCHhHhcCCcCCCEEECC
Confidence 34555555555422122335555555555555555555554 355666666666666666543333 2334566666666
Q ss_pred CCcCCCccchhccCCCCCCeEeeecccCCCccchhhhcccccCccccceEeccCCCCCCCccCCCCCCcceEEeCCCCCC
Q 002158 309 DNYLNGSILESISNLPFLQTLSLENNFLTGSIPATIWQNKSFSTKARLKIDLRNNSFSNIVGDLTLPNNVTLRLGGNPIC 388 (958)
Q Consensus 309 ~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~ip~~l~~~~~~~~~~l~~L~Ls~N~l~~l~~~~~l~~L~~L~l~~N~l~ 388 (958)
+|+|++..+..|..+++|++|+|++|+|++..|..+. .+++|+.|+|++|||
T Consensus 114 ~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~---------------------------~l~~L~~L~L~~N~l- 165 (220)
T 2v70_A 114 SNRITCVGNDSFIGLSSVRLLSLYDNQITTVAPGAFD---------------------------TLHSLSTLNLLANPF- 165 (220)
T ss_dssp TSCCCCBCTTSSTTCTTCSEEECTTSCCCCBCTTTTT---------------------------TCTTCCEEECCSCCE-
T ss_pred CCcCCeECHhHcCCCccCCEEECCCCcCCEECHHHhc---------------------------CCCCCCEEEecCcCC-
Confidence 6666666666666777777777777776654444331 456777888877777
Q ss_pred CCCCCCCCCcccccCCCCCccccccCCCCCCCCCCCCCcccccCCCCCCceeeeeceee
Q 002158 389 TSANIPNTGRFCGSDAGGDETLTNSKVNCPVQACPVDNFFEYVPASPEPCFCAAPLRIG 447 (958)
Q Consensus 389 ~~~~~~~~~~~~~~~~~~~~~L~~n~~~C~c~~~~~~~~~~~~~~~~~~~~c~sp~~~~ 447 (958)
.|+|+..++..|++..........|++|...+
T Consensus 166 ---------------------------~c~c~l~~l~~~~~~~~~~~~~~~C~~P~~l~ 197 (220)
T 2v70_A 166 ---------------------------NCNCYLAWLGEWLRKKRIVTGNPRCQKPYFLK 197 (220)
T ss_dssp ---------------------------ECSGGGHHHHHHHHHSCCBCCCCEEEESGGGT
T ss_pred ---------------------------cCCCchHHHHHHHHhcCccccCCccCCChHHC
Confidence 67888888888888766666667899998755
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.78 E-value=1.8e-19 Score=202.58 Aligned_cols=79 Identities=24% Similarity=0.364 Sum_probs=37.2
Q ss_pred CEEecccccccccCccccccccccceEecccccccccCchhhc-CCccchhhhccCCccccCCCcccCCCCCccEEEccC
Q 002158 160 NRLQVDENNITGTIPKSFANLSRVRHLHLNNNSIGGQIPSELS-KLSTLIHLLVDNNNLSGNLPPELSELPQLCILQLDN 238 (958)
Q Consensus 160 ~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~-~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~ 238 (958)
+.+++++|+++ .+|..+. ..++.|+|++|+|++..+..+. ++++|+.|+|++|+|++..+..|..+++|++|+|++
T Consensus 21 ~~l~c~~~~l~-~iP~~~~--~~l~~L~Ls~N~l~~l~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~ 97 (361)
T 2xot_A 21 NILSCSKQQLP-NVPQSLP--SYTALLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHLNFISSEAFVPVPNLRYLDLSS 97 (361)
T ss_dssp TEEECCSSCCS-SCCSSCC--TTCSEEECCSSCCCEECTTSSSSCCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCS
T ss_pred CEEEeCCCCcC-ccCccCC--CCCCEEECCCCCCCccChhhhhhcccccCEEECCCCcCCccChhhccCCCCCCEEECCC
Confidence 35555555555 3343332 2345555555555544444443 444445555544444444444444444444444444
Q ss_pred CCC
Q 002158 239 NNF 241 (958)
Q Consensus 239 N~l 241 (958)
|+|
T Consensus 98 N~l 100 (361)
T 2xot_A 98 NHL 100 (361)
T ss_dssp SCC
T ss_pred CcC
Confidence 444
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.78 E-value=1.2e-18 Score=179.65 Aligned_cols=158 Identities=22% Similarity=0.222 Sum_probs=110.0
Q ss_pred ccceEecccccccccCchhhcCCccchhhhccCCccccCCCcccCCCCCccEEEccCCCCCCCCccccccCCCCCCEEEc
Q 002158 182 RVRHLHLNNNSIGGQIPSELSKLSTLIHLLVDNNNLSGNLPPELSELPQLCILQLDNNNFSASEIPATYGNFSKLVKLSL 261 (958)
Q Consensus 182 ~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~p~~~~~l~~L~~L~L 261 (958)
+|++|+|++|++++..+..|..+++|++|++++|++++..+..|..+++|++|+|++|+++ ...+..|.++++|+.|+|
T Consensus 29 ~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~-~~~~~~~~~l~~L~~L~L 107 (208)
T 2o6s_A 29 QTTYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQSLPNGVFNKLTSLTYLNLSTNQLQ-SLPNGVFDKLTQLKELAL 107 (208)
T ss_dssp TCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCTTCCEEEC
T ss_pred CCcEEEcCCCccCcCChhhhcccccCcEEECCCCccCccChhhcCCCCCcCEEECCCCcCC-ccCHhHhcCccCCCEEEc
Confidence 3444444444444333334444555555555555555444445566666666666666665 223345677777888888
Q ss_pred ccCCCCCCCCC-CCCCCCcCEEeccCCcCCCcCCC-CCCCCCcCEEEccCCcCCCccchhccCCCCCCeEeeecccCCCc
Q 002158 262 RNCNLQGAVPD-LSRIPNLYYLDLSWNHLTGSIPS-KKLSENVTTIDLSDNYLNGSILESISNLPFLQTLSLENNFLTGS 339 (958)
Q Consensus 262 ~~N~l~~~~~~-l~~l~~L~~L~Ls~N~l~~~~~~-~~~~~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~ 339 (958)
++|++++.++. +..+++|+.|+|++|.+++..+. ...+++|+.|+|++|.+. +.+++|++|+++.|+++|.
T Consensus 108 ~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~-------~~~~~l~~L~~~~n~~~g~ 180 (208)
T 2o6s_A 108 NTNQLQSLPDGVFDKLTQLKDLRLYQNQLKSVPDGVFDRLTSLQYIWLHDNPWD-------CTCPGIRYLSEWINKHSGV 180 (208)
T ss_dssp CSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSCCBC-------CCTTTTHHHHHHHHHCTTT
T ss_pred CCCcCcccCHhHhccCCcCCEEECCCCccceeCHHHhccCCCccEEEecCCCee-------cCCCCHHHHHHHHHhCCce
Confidence 88888777775 78899999999999999965554 355789999999999886 3567899999999999999
Q ss_pred cchhhhcc
Q 002158 340 IPATIWQN 347 (958)
Q Consensus 340 ip~~l~~~ 347 (958)
+|..+..+
T Consensus 181 ip~~~~~l 188 (208)
T 2o6s_A 181 VRNSAGSV 188 (208)
T ss_dssp BBCTTSSB
T ss_pred eeccCccc
Confidence 99887654
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A | Back alignment and structure |
|---|
Probab=99.78 E-value=2.9e-19 Score=194.40 Aligned_cols=172 Identities=26% Similarity=0.372 Sum_probs=91.1
Q ss_pred cCCCCCcEEEeeCCCCCCCCChhhcCCCCCCEEecccccccccCccccccccccceEecccccccccCchhhcCCccchh
Q 002158 130 GNISSLIFLLLNGNKLSGSLPDELGYLSNLNRLQVDENNITGTIPKSFANLSRVRHLHLNNNSIGGQIPSELSKLSTLIH 209 (958)
Q Consensus 130 ~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~ 209 (958)
..+++|++|++++|.++ .++ .+..+++|++|+|++|++++..+ +..+++|++|+|++|.+++ ++ .+..+++|++
T Consensus 43 ~~l~~L~~L~l~~~~i~-~~~-~~~~l~~L~~L~L~~n~l~~~~~--l~~l~~L~~L~l~~n~l~~-~~-~l~~l~~L~~ 116 (291)
T 1h6t_A 43 NELNSIDQIIANNSDIK-SVQ-GIQYLPNVTKLFLNGNKLTDIKP--LANLKNLGWLFLDENKVKD-LS-SLKDLKKLKS 116 (291)
T ss_dssp HHHHTCCEEECTTSCCC-CCT-TGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCC-GG-GGTTCTTCCE
T ss_pred hhcCcccEEEccCCCcc-cCh-hHhcCCCCCEEEccCCccCCCcc--cccCCCCCEEECCCCcCCC-Ch-hhccCCCCCE
Confidence 34555666666666655 233 25555666666666666654332 5555555555555555553 22 2444444444
Q ss_pred hhccCCccccCCCcccCCCCCccEEEccCCCCCCCCccccccCCCCCCEEEcccCCCCCCCCCCCCCCCcCEEeccCCcC
Q 002158 210 LLVDNNNLSGNLPPELSELPQLCILQLDNNNFSASEIPATYGNFSKLVKLSLRNCNLQGAVPDLSRIPNLYYLDLSWNHL 289 (958)
Q Consensus 210 L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~l~~l~~L~~L~Ls~N~l 289 (958)
|+|++|++++. ..+..++ +|+.|+|++|++++. +.+..+++|+.|+|++|.+
T Consensus 117 L~L~~n~i~~~--~~l~~l~-------------------------~L~~L~l~~n~l~~~-~~l~~l~~L~~L~L~~N~l 168 (291)
T 1h6t_A 117 LSLEHNGISDI--NGLVHLP-------------------------QLESLYLGNNKITDI-TVLSRLTKLDTLSLEDNQI 168 (291)
T ss_dssp EECTTSCCCCC--GGGGGCT-------------------------TCCEEECCSSCCCCC-GGGGGCTTCSEEECCSSCC
T ss_pred EECCCCcCCCC--hhhcCCC-------------------------CCCEEEccCCcCCcc-hhhccCCCCCEEEccCCcc
Confidence 44444444432 2344444 444444444444433 3344455555555555555
Q ss_pred CCcCCCCCCCCCcCEEEccCCcCCCccchhccCCCCCCeEeeecccCCC
Q 002158 290 TGSIPSKKLSENVTTIDLSDNYLNGSILESISNLPFLQTLSLENNFLTG 338 (958)
Q Consensus 290 ~~~~~~~~~~~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~ 338 (958)
++..+ ...+++|+.|+|++|.|++. + .+..+++|+.|+|++|+++.
T Consensus 169 ~~~~~-l~~l~~L~~L~L~~N~i~~l-~-~l~~l~~L~~L~l~~n~i~~ 214 (291)
T 1h6t_A 169 SDIVP-LAGLTKLQNLYLSKNHISDL-R-ALAGLKNLDVLELFSQECLN 214 (291)
T ss_dssp CCCGG-GTTCTTCCEEECCSSCCCBC-G-GGTTCTTCSEEEEEEEEEEC
T ss_pred ccchh-hcCCCccCEEECCCCcCCCC-h-hhccCCCCCEEECcCCcccC
Confidence 53322 44445556666666666543 2 36777777778887777763
|
| >3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* | Back alignment and structure |
|---|
Probab=99.77 E-value=1.4e-20 Score=226.55 Aligned_cols=295 Identities=15% Similarity=0.090 Sum_probs=166.8
Q ss_pred eeEEEEccCCcCCCC----ccccccCCCCcceeeccCcccC-----CCCccccCCCCCcEEEeeCCCCCCCCChhhcCCC
Q 002158 87 HVRELQLLSMNLSGN----LAPELGQLSRLQYYFMWNDLTG-----TIPKEIGNISSLIFLLLNGNKLSGSLPDELGYLS 157 (958)
Q Consensus 87 ~v~~L~L~~~~l~~~----~~~~l~~L~~L~~L~l~n~~~~-----~ip~~i~~l~~L~~L~Ls~n~l~~~~p~~l~~l~ 157 (958)
++++|+|.+|.+++. ++..+..+++|+.|+++++... .++..+.++++|++|+|++|.+.+ +|..+..++
T Consensus 165 ~L~~L~L~~~~~~~~~~~~l~~~~~~~~~L~~L~L~~n~~~~~~~~~l~~~~~~~~~L~~L~L~~~~~~~-l~~~~~~~~ 243 (592)
T 3ogk_B 165 KIKTLLMEESSFSEKDGKWLHELAQHNTSLEVLNFYMTEFAKISPKDLETIARNCRSLVSVKVGDFEILE-LVGFFKAAA 243 (592)
T ss_dssp TCSEEECTTCEEECCCSHHHHHHHHHCCCCCEEECTTCCCSSCCHHHHHHHHHHCTTCCEEECSSCBGGG-GHHHHHHCT
T ss_pred CCCEEECccccccCcchhHHHHHHhcCCCccEEEeeccCCCccCHHHHHHHHhhCCCCcEEeccCccHHH-HHHHHhhhh
Confidence 566777777766554 3334455666666666644432 233344566667777776666653 455555556
Q ss_pred CCCEEecccccc--------------------------cccCccccccccccceEecccccccccCc-hhhcCCccchhh
Q 002158 158 NLNRLQVDENNI--------------------------TGTIPKSFANLSRVRHLHLNNNSIGGQIP-SELSKLSTLIHL 210 (958)
Q Consensus 158 ~L~~L~L~~N~l--------------------------~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p-~~l~~l~~L~~L 210 (958)
+|++|+++.+.. .+.+|..+..+++|++|+|++|.+++... ..+..+++|+.|
T Consensus 244 ~L~~L~l~~~~~~~~~~~~~~~l~~~~~L~~L~l~~~~~~~l~~~~~~~~~L~~L~Ls~~~l~~~~~~~~~~~~~~L~~L 323 (592)
T 3ogk_B 244 NLEEFCGGSLNEDIGMPEKYMNLVFPRKLCRLGLSYMGPNEMPILFPFAAQIRKLDLLYALLETEDHCTLIQKCPNLEVL 323 (592)
T ss_dssp TCCEEEECBCCCCTTCTTSSSCCCCCTTCCEEEETTCCTTTGGGGGGGGGGCCEEEETTCCCCHHHHHHHHTTCTTCCEE
T ss_pred HHHhhcccccccccchHHHHHHhhccccccccCccccchhHHHHHHhhcCCCcEEecCCCcCCHHHHHHHHHhCcCCCEE
Confidence 666665553211 12445555666667777777766553322 334666677777
Q ss_pred hccCCccc-cCCCcccCCCCCccEEEcc-----------CCCCCCCCccccccCCCCCCEEEcccCCCCCCCCC-CCC-C
Q 002158 211 LVDNNNLS-GNLPPELSELPQLCILQLD-----------NNNFSASEIPATYGNFSKLVKLSLRNCNLQGAVPD-LSR-I 276 (958)
Q Consensus 211 ~L~~N~l~-~~~~~~l~~l~~L~~L~L~-----------~N~l~~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~-l~~-l 276 (958)
+++ |.+. +.++..+..+++|++|+|+ .|.++...++.....+++|++|+++.|++++.... +.. +
T Consensus 324 ~L~-~~~~~~~l~~~~~~~~~L~~L~L~~g~~~~~~~~~~~~~~~~~~~~l~~~~~~L~~L~l~~~~l~~~~~~~l~~~~ 402 (592)
T 3ogk_B 324 ETR-NVIGDRGLEVLAQYCKQLKRLRIERGADEQGMEDEEGLVSQRGLIALAQGCQELEYMAVYVSDITNESLESIGTYL 402 (592)
T ss_dssp EEE-GGGHHHHHHHHHHHCTTCCEEEEECCCCSSTTSSTTCCCCHHHHHHHHHHCTTCSEEEEEESCCCHHHHHHHHHHC
T ss_pred ecc-CccCHHHHHHHHHhCCCCCEEEeecCccccccccccCccCHHHHHHHHhhCccCeEEEeecCCccHHHHHHHHhhC
Confidence 766 3333 2223333456677777777 34554322333345567777777777776654332 332 6
Q ss_pred CCcCEEecc----CCcCCCcCCC------CCCCCCcCEEEccCCc--CCCccchhccC-CCCCCeEeeecccCCCcc-ch
Q 002158 277 PNLYYLDLS----WNHLTGSIPS------KKLSENVTTIDLSDNY--LNGSILESISN-LPFLQTLSLENNFLTGSI-PA 342 (958)
Q Consensus 277 ~~L~~L~Ls----~N~l~~~~~~------~~~~~~L~~L~Ls~N~--l~~~~~~~~~~-l~~L~~L~L~~N~l~~~i-p~ 342 (958)
++|+.|+|+ .|.+++.... ...+++|++|+|++|. +++..+..+.. +++|++|+|++|++++.. +.
T Consensus 403 ~~L~~L~l~~~~~~n~l~~~p~~~~~~~~~~~~~~L~~L~L~~~~~~l~~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~ 482 (592)
T 3ogk_B 403 KNLCDFRLVLLDREERITDLPLDNGVRSLLIGCKKLRRFAFYLRQGGLTDLGLSYIGQYSPNVRWMLLGYVGESDEGLME 482 (592)
T ss_dssp CSCCEEEEEECSCCSCCSSCCCHHHHHHHHHHCTTCCEEEEECCGGGCCHHHHHHHHHSCTTCCEEEECSCCSSHHHHHH
T ss_pred CCCcEEEEeecCCCccccCchHHHHHHHHHHhCCCCCEEEEecCCCCccHHHHHHHHHhCccceEeeccCCCCCHHHHHH
Confidence 677777775 5566532111 1235677777776433 66555555443 677777777777776532 22
Q ss_pred hhhcccccCccccceEeccCCCCCCC--ccCC-CCCCcceEEeCCCCCC
Q 002158 343 TIWQNKSFSTKARLKIDLRNNSFSNI--VGDL-TLPNNVTLRLGGNPIC 388 (958)
Q Consensus 343 ~l~~~~~~~~~~l~~L~Ls~N~l~~l--~~~~-~l~~L~~L~l~~N~l~ 388 (958)
.+.. .+.|+.|+|++|.|+.. +... .+++|+.|+|++|+++
T Consensus 483 ~~~~-----~~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~ls~n~it 526 (592)
T 3ogk_B 483 FSRG-----CPNLQKLEMRGCCFSERAIAAAVTKLPSLRYLWVQGYRAS 526 (592)
T ss_dssp HHTC-----CTTCCEEEEESCCCBHHHHHHHHHHCSSCCEEEEESCBCC
T ss_pred HHhc-----CcccCeeeccCCCCcHHHHHHHHHhcCccCeeECcCCcCC
Confidence 2222 24566777777776542 2222 5677777777777764
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A | Back alignment and structure |
|---|
Probab=99.77 E-value=8.3e-19 Score=190.75 Aligned_cols=191 Identities=23% Similarity=0.313 Sum_probs=141.9
Q ss_pred CEEecccccccccCccccccccccceEecccccccccCchhhcCCccchhhhccCCccccCCCcccCCCCCccEEEccCC
Q 002158 160 NRLQVDENNITGTIPKSFANLSRVRHLHLNNNSIGGQIPSELSKLSTLIHLLVDNNNLSGNLPPELSELPQLCILQLDNN 239 (958)
Q Consensus 160 ~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N 239 (958)
..+.+..+.+++.. .+..+++|+.|++++|.++. ++ .+..+++|+.|+|++|++++..+ +..+++|++|+|++|
T Consensus 27 ~~~~l~~~~~~~~~--~~~~l~~L~~L~l~~~~i~~-~~-~~~~l~~L~~L~L~~n~l~~~~~--l~~l~~L~~L~l~~n 100 (291)
T 1h6t_A 27 IKDNLKKKSVTDAV--TQNELNSIDQIIANNSDIKS-VQ-GIQYLPNVTKLFLNGNKLTDIKP--LANLKNLGWLFLDEN 100 (291)
T ss_dssp HHHHTTCSCTTSEE--CHHHHHTCCEEECTTSCCCC-CT-TGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSS
T ss_pred HHHHhcCCCccccc--chhhcCcccEEEccCCCccc-Ch-hHhcCCCCCEEEccCCccCCCcc--cccCCCCCEEECCCC
Confidence 33444444444321 23456666666666666663 33 36666777777777777765433 777788888888888
Q ss_pred CCCCCCccccccCCCCCCEEEcccCCCCCCCCCCCCCCCcCEEeccCCcCCCcCCCCCCCCCcCEEEccCCcCCCccchh
Q 002158 240 NFSASEIPATYGNFSKLVKLSLRNCNLQGAVPDLSRIPNLYYLDLSWNHLTGSIPSKKLSENVTTIDLSDNYLNGSILES 319 (958)
Q Consensus 240 ~l~~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~~~L~~L~Ls~N~l~~~~~~~ 319 (958)
+++. ++ .+..+++|+.|+|++|++++. +.+..+++|+.|+|++|++++. +....+++|+.|+|++|+|++..+
T Consensus 101 ~l~~--~~-~l~~l~~L~~L~L~~n~i~~~-~~l~~l~~L~~L~l~~n~l~~~-~~l~~l~~L~~L~L~~N~l~~~~~-- 173 (291)
T 1h6t_A 101 KVKD--LS-SLKDLKKLKSLSLEHNGISDI-NGLVHLPQLESLYLGNNKITDI-TVLSRLTKLDTLSLEDNQISDIVP-- 173 (291)
T ss_dssp CCCC--GG-GGTTCTTCCEEECTTSCCCCC-GGGGGCTTCCEEECCSSCCCCC-GGGGGCTTCSEEECCSSCCCCCGG--
T ss_pred cCCC--Ch-hhccCCCCCEEECCCCcCCCC-hhhcCCCCCCEEEccCCcCCcc-hhhccCCCCCEEEccCCccccchh--
Confidence 8753 33 478888888888888888875 5688899999999999999954 666778999999999999998766
Q ss_pred ccCCCCCCeEeeecccCCCccchhhhcccccCccccceEeccCCCCCCCcc
Q 002158 320 ISNLPFLQTLSLENNFLTGSIPATIWQNKSFSTKARLKIDLRNNSFSNIVG 370 (958)
Q Consensus 320 ~~~l~~L~~L~L~~N~l~~~ip~~l~~~~~~~~~~l~~L~Ls~N~l~~l~~ 370 (958)
+..+++|+.|+|++|+|++ +|. +.. .+.|+.|++++|+++..+.
T Consensus 174 l~~l~~L~~L~L~~N~i~~-l~~-l~~-----l~~L~~L~l~~n~i~~~~~ 217 (291)
T 1h6t_A 174 LAGLTKLQNLYLSKNHISD-LRA-LAG-----LKNLDVLELFSQECLNKPI 217 (291)
T ss_dssp GTTCTTCCEEECCSSCCCB-CGG-GTT-----CTTCSEEEEEEEEEECCCE
T ss_pred hcCCCccCEEECCCCcCCC-Chh-hcc-----CCCCCEEECcCCcccCCcc
Confidence 9999999999999999984 443 433 3467799999999987553
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A | Back alignment and structure |
|---|
Probab=99.77 E-value=2.8e-19 Score=213.10 Aligned_cols=147 Identities=31% Similarity=0.485 Sum_probs=60.4
Q ss_pred CCCCCcEEEeeCCCCCCCCChhhcCCCCCCEEecccccccccCccccccccccceEecccccccccCchhhcCCccchhh
Q 002158 131 NISSLIFLLLNGNKLSGSLPDELGYLSNLNRLQVDENNITGTIPKSFANLSRVRHLHLNNNSIGGQIPSELSKLSTLIHL 210 (958)
Q Consensus 131 ~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L 210 (958)
.+++|+.|+|++|.+. .+| .+..+++|++|+|++|+|++..+ +..+++|+.|+|++|.|++ ++ .+..+++|+.|
T Consensus 41 ~L~~L~~L~l~~n~i~-~l~-~l~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~Ls~N~l~~-l~-~l~~l~~L~~L 114 (605)
T 1m9s_A 41 ELNSIDQIIANNSDIK-SVQ-GIQYLPNVTKLFLNGNKLTDIKP--LTNLKNLGWLFLDENKIKD-LS-SLKDLKKLKSL 114 (605)
T ss_dssp HHTTCCCCBCTTCCCC-CCT-TGGGCTTCCEEECTTSCCCCCGG--GGGCTTCCEEECCSSCCCC-CT-TSTTCTTCCEE
T ss_pred cCCCCCEEECcCCCCC-CCh-HHccCCCCCEEEeeCCCCCCChh--hccCCCCCEEECcCCCCCC-Ch-hhccCCCCCEE
Confidence 3444444444444444 222 24444444444444444443322 4444444444444444442 11 23444444444
Q ss_pred hccCCccccCCCcccCCCCCccEEEccCCCCCCCCccccccCCCCCCEEEcccCCCCCCCCCCCCCCCcCEEeccCCcC
Q 002158 211 LVDNNNLSGNLPPELSELPQLCILQLDNNNFSASEIPATYGNFSKLVKLSLRNCNLQGAVPDLSRIPNLYYLDLSWNHL 289 (958)
Q Consensus 211 ~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~l~~l~~L~~L~Ls~N~l 289 (958)
+|++|+|++. ..+..+++|+.|+|++|+++. + ..+..+++|+.|+|++|+|++.++ +..+++|+.|+|++|.|
T Consensus 115 ~Ls~N~l~~l--~~l~~l~~L~~L~Ls~N~l~~--l-~~l~~l~~L~~L~Ls~N~l~~~~~-l~~l~~L~~L~Ls~N~i 187 (605)
T 1m9s_A 115 SLEHNGISDI--NGLVHLPQLESLYLGNNKITD--I-TVLSRLTKLDTLSLEDNQISDIVP-LAGLTKLQNLYLSKNHI 187 (605)
T ss_dssp ECTTSCCCCC--GGGGGCTTCSEEECCSSCCCC--C-GGGGSCTTCSEEECCSSCCCCCGG-GTTCTTCCEEECCSSCC
T ss_pred EecCCCCCCC--ccccCCCccCEEECCCCccCC--c-hhhcccCCCCEEECcCCcCCCchh-hccCCCCCEEECcCCCC
Confidence 4444444321 223344444444444444431 1 233334444444444444433333 33333333333333333
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A | Back alignment and structure |
|---|
Probab=99.76 E-value=1.5e-18 Score=180.50 Aligned_cols=133 Identities=22% Similarity=0.286 Sum_probs=75.8
Q ss_pred CCCcEEEeeCCCCCCCCChhhcCCCCCCEEecccccccccCccccccccccceEecccccccccCchhhcCCccchhhhc
Q 002158 133 SSLIFLLLNGNKLSGSLPDELGYLSNLNRLQVDENNITGTIPKSFANLSRVRHLHLNNNSIGGQIPSELSKLSTLIHLLV 212 (958)
Q Consensus 133 ~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L 212 (958)
++|++|+|++|.+++..+..|..+++|++|+|++|+|++..|..|.++++|++|+|++|+|+...+..|.++++|++|+|
T Consensus 32 ~~l~~L~l~~n~i~~i~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L 111 (220)
T 2v9t_B 32 ETITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISELAPDAFQGLRSLNSLVLYGNKITELPKSLFEGLFSLQLLLL 111 (220)
T ss_dssp TTCCEEECCSSCCCEECTTSSTTCTTCCEEECCSSCCCEECTTTTTTCSSCCEEECCSSCCCCCCTTTTTTCTTCCEEEC
T ss_pred cCCCEEECCCCcCCCcCHhHhhCCCCCCEEECCCCcCCCcCHHHhhCCcCCCEEECCCCcCCccCHhHccCCCCCCEEEC
Confidence 45666666666666544445666666666666666666555555666666666666666555433333444444554444
Q ss_pred cCCccccCCCcccCCCCCccEEEccCCCCCCCCccccccCCCCCCEEEcccCCCCCCCCC-CCCCCCcCEEeccCCcCC
Q 002158 213 DNNNLSGNLPPELSELPQLCILQLDNNNFSASEIPATYGNFSKLVKLSLRNCNLQGAVPD-LSRIPNLYYLDLSWNHLT 290 (958)
Q Consensus 213 ~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~-l~~l~~L~~L~Ls~N~l~ 290 (958)
++|+|++..+. .|.++++|+.|+|++|+|++.++. +..+++|+.|+|++|.+.
T Consensus 112 ~~N~l~~~~~~-------------------------~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~ 165 (220)
T 2v9t_B 112 NANKINCLRVD-------------------------AFQDLHNLNLLSLYDNKLQTIAKGTFSPLRAIQTMHLAQNPFI 165 (220)
T ss_dssp CSSCCCCCCTT-------------------------TTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCEE
T ss_pred CCCCCCEeCHH-------------------------HcCCCCCCCEEECCCCcCCEECHHHHhCCCCCCEEEeCCCCcC
Confidence 44444444444 444455555555555555555543 566667777777777765
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.76 E-value=3.4e-18 Score=179.00 Aligned_cols=142 Identities=21% Similarity=0.269 Sum_probs=88.2
Q ss_pred CCCccccCCCCCcEEEeeCCCCCCCCChhhcCCCCCCEEecccccccccCccccccccccceEecccccccccCchhhcC
Q 002158 124 TIPKEIGNISSLIFLLLNGNKLSGSLPDELGYLSNLNRLQVDENNITGTIPKSFANLSRVRHLHLNNNSIGGQIPSELSK 203 (958)
Q Consensus 124 ~ip~~i~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~ 203 (958)
.+|..+. ++|++|+|++|.+++..|..|..+++|++|+|++|+|+...+..|..+++|+.|+|++|+|++.
T Consensus 33 ~ip~~~~--~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~~~~l~~L~~L~Ls~N~l~~l------- 103 (229)
T 3e6j_A 33 SVPAGIP--TNAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQLGALPVGVFDSLTQLTVLDLGTNQLTVL------- 103 (229)
T ss_dssp SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCC-------
T ss_pred ccCCCCC--CCCCEEEcCCCccCccCHHHhhCccCCcEEECCCCCCCCcChhhcccCCCcCEEECCCCcCCcc-------
Confidence 4444332 5677777777777766666666677777777777766644444455555555555555555533
Q ss_pred CccchhhhccCCccccCCCcccCCCCCccEEEccCCCCCCCCccccccCCCCCCEEEcccCCCCCCCCC-CCCCCCcCEE
Q 002158 204 LSTLIHLLVDNNNLSGNLPPELSELPQLCILQLDNNNFSASEIPATYGNFSKLVKLSLRNCNLQGAVPD-LSRIPNLYYL 282 (958)
Q Consensus 204 l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~-l~~l~~L~~L 282 (958)
.+..|..+++|++|+|++|+|+ .+|..+..+++|+.|+|++|+|++.++. +..+++|+.|
T Consensus 104 -----------------~~~~~~~l~~L~~L~Ls~N~l~--~lp~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L 164 (229)
T 3e6j_A 104 -----------------PSAVFDRLVHLKELFMCCNKLT--ELPRGIERLTHLTHLALDQNQLKSIPHGAFDRLSSLTHA 164 (229)
T ss_dssp -----------------CTTTTTTCTTCCEEECCSSCCC--SCCTTGGGCTTCSEEECCSSCCCCCCTTTTTTCTTCCEE
T ss_pred -----------------ChhHhCcchhhCeEeccCCccc--ccCcccccCCCCCEEECCCCcCCccCHHHHhCCCCCCEE
Confidence 3344445555555555555554 4455566666666666666666666654 6777778888
Q ss_pred eccCCcCCCcC
Q 002158 283 DLSWNHLTGSI 293 (958)
Q Consensus 283 ~Ls~N~l~~~~ 293 (958)
+|++|.+....
T Consensus 165 ~l~~N~~~c~c 175 (229)
T 3e6j_A 165 YLFGNPWDCEC 175 (229)
T ss_dssp ECTTSCBCTTB
T ss_pred EeeCCCccCCc
Confidence 88888776543
|
| >4b8c_D Glucose-repressible alcohol dehydrogenase transcr effector; hydrolase-cell cycle complex; 3.41A {Saccharomyces cerevisiae S288C} | Back alignment and structure |
|---|
Probab=99.76 E-value=6.5e-20 Score=224.19 Aligned_cols=194 Identities=19% Similarity=0.191 Sum_probs=69.8
Q ss_pred CHhHHHHHHHHHHHccc-CccccCCCCCCCCCCCCCCceeeCccccCCCceeeEEEEccCCcCCCCccccccCCCCccee
Q 002158 37 DPQEASALRAIKNSLVD-SMNHLRNWNKGDPCMSNWTGVLCFDTVETDGHLHVRELQLLSMNLSGNLAPELGQLSRLQYY 115 (958)
Q Consensus 37 ~~~~~~al~~~k~~~~~-~~~~l~~W~~~~~c~~~w~gV~C~~~~~~~~~~~v~~L~L~~~~l~~~~~~~l~~L~~L~~L 115 (958)
...+..+|.++..++.. ....-..|.....-.+.|.++.+.. .+++.|+|..+++... +..+.....|..+
T Consensus 130 ~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~-------~~~~~l~L~~n~~~~~-~~~~l~~l~Ls~~ 201 (727)
T 4b8c_D 130 VDCTKQALMEMADTLTDSKTAKKQQPTGDSTPSGTATNSAVST-------PLTPKIELFANGKDEA-NQALLQHKKLSQY 201 (727)
T ss_dssp --CCCHHHHHHHHHHHHHHTTC----------------------------------------------------------
T ss_pred cccchhhhhhhhhhcccccCcccCCCcCCCCccccCCCceecC-------CccceEEeeCCCCCcc-hhhHhhcCccCcc
Confidence 34567788888877642 2233355643322233688887743 3688999988887763 3333333333332
Q ss_pred ec-----cCcccCCCCccccCCCCCcEEEeeCCCCCCCCChhhcCCCCCCEEecccccccccCccccccccccceEeccc
Q 002158 116 FM-----WNDLTGTIPKEIGNISSLIFLLLNGNKLSGSLPDELGYLSNLNRLQVDENNITGTIPKSFANLSRVRHLHLNN 190 (958)
Q Consensus 116 ~l-----~n~~~~~ip~~i~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~ 190 (958)
.+ .++.....|..+..+++|+.|+|++|.+. .+|..+.++++|++|+|++|.|+ .+|..|.+|++|++|+|++
T Consensus 202 ~i~~~~~~~n~~~~~~~~~~~l~~L~~L~Ls~n~l~-~l~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~Ls~ 279 (727)
T 4b8c_D 202 SIDEDDDIENRMVMPKDSKYDDQLWHALDLSNLQIF-NISANIFKYDFLTRLYLNGNSLT-ELPAEIKNLSNLRVLDLSH 279 (727)
T ss_dssp --------------------CCCCCCEEECTTSCCS-CCCGGGGGCCSCSCCBCTTSCCS-CCCGGGGGGTTCCEEECTT
T ss_pred cccCccccccceecChhhhccCCCCcEEECCCCCCC-CCChhhcCCCCCCEEEeeCCcCc-ccChhhhCCCCCCEEeCcC
Confidence 21 22222233444555555555555555555 45555555555555555555555 4555555555555555555
Q ss_pred ccccccCchhhcCCccchhhhccCCccccCCCcccCCCCCccEEEccCCCCC
Q 002158 191 NSIGGQIPSELSKLSTLIHLLVDNNNLSGNLPPELSELPQLCILQLDNNNFS 242 (958)
Q Consensus 191 N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~ 242 (958)
|.|+ .+|..|.++++|++|+|++|.|+ .+|..|..+++|+.|+|++|+|+
T Consensus 280 N~l~-~lp~~~~~l~~L~~L~L~~N~l~-~lp~~~~~l~~L~~L~L~~N~l~ 329 (727)
T 4b8c_D 280 NRLT-SLPAELGSCFQLKYFYFFDNMVT-TLPWEFGNLCNLQFLGVEGNPLE 329 (727)
T ss_dssp SCCS-SCCSSGGGGTTCSEEECCSSCCC-CCCSSTTSCTTCCCEECTTSCCC
T ss_pred CcCC-ccChhhcCCCCCCEEECCCCCCC-ccChhhhcCCCccEEeCCCCccC
Confidence 5555 44555555555555555555554 33444555555555555555554
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.75 E-value=1.2e-18 Score=185.80 Aligned_cols=136 Identities=17% Similarity=0.119 Sum_probs=107.7
Q ss_pred CCCCceeeeeCCeEEEEEEE-CCCcE--EEEEEeccCChh------------------------cHHHHHHHHHHHHccC
Q 002158 627 FSSSTQVGQGGYGKVYKGIL-SDNTT--VAIKRAEEGSLQ------------------------GQNEFLTEIKLLSRLH 679 (958)
Q Consensus 627 ~~~~~~lg~G~~g~Vy~~~~-~~~~~--vavK~~~~~~~~------------------------~~~~~~~E~~~l~~l~ 679 (958)
|...+.||+|+||.||+|.+ .+|+. ||||+++..... ....+.+|++++++++
T Consensus 49 ~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~ 128 (258)
T 1zth_A 49 TAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERAK 128 (258)
T ss_dssp EEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHHH
T ss_pred hhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHHH
Confidence 45678999999999999998 68888 999987543111 1136889999999998
Q ss_pred CCCc--ceEEEEEEeCCeEEEEEEecCC-C----CHHHHhccCCCCCchHHHHHHHHHHHHHHHHHhh-hcCCCCeeccC
Q 002158 680 HRNL--VSLLGYCDEEGEQMLVYEFVPN-G----TLRDWLSGRTKENLNFAMRLRVALDSAKGILYLH-TEAHPPVFHRD 751 (958)
Q Consensus 680 H~ni--v~l~~~~~~~~~~~lV~E~~~~-g----sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH-~~~~~~iiH~D 751 (958)
|+++ ..++++ +..+|||||+.+ | +|.++... .++..+..++.|++.||.||| +.+ |+|||
T Consensus 129 ~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~-----~~~~~~~~i~~qi~~~l~~lH~~~g---ivHrD 196 (258)
T 1zth_A 129 EAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE-----LKELDVEGIFNDVVENVKRLYQEAE---LVHAD 196 (258)
T ss_dssp HTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG-----GGGSCHHHHHHHHHHHHHHHHHTSC---EECSS
T ss_pred hCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc-----cChHHHHHHHHHHHHHHHHHHHHCC---EEeCC
Confidence 8754 445543 356899999942 4 78777532 235567899999999999999 888 99999
Q ss_pred CCccceEecCCCCeEEeeeeeeccc
Q 002158 752 IKASNILLDSNLNAKVADFGLSRLA 776 (958)
Q Consensus 752 ikp~NILl~~~~~~kl~DFGla~~~ 776 (958)
|||+|||++. .++|+|||+|...
T Consensus 197 lkp~NILl~~--~~~liDFG~a~~~ 219 (258)
T 1zth_A 197 LSEYNIMYID--KVYFIDMGQAVTL 219 (258)
T ss_dssp CSTTSEEESS--SEEECCCTTCEET
T ss_pred CCHHHEEEcC--cEEEEECcccccC
Confidence 9999999998 9999999998743
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.75 E-value=2.7e-18 Score=178.57 Aligned_cols=133 Identities=20% Similarity=0.242 Sum_probs=67.9
Q ss_pred CcEEEeeCCCCCCCCC-hhhcCCCCCCEEecccccccccCccccccccccceEecccccccccCchhhcCCccchhhhcc
Q 002158 135 LIFLLLNGNKLSGSLP-DELGYLSNLNRLQVDENNITGTIPKSFANLSRVRHLHLNNNSIGGQIPSELSKLSTLIHLLVD 213 (958)
Q Consensus 135 L~~L~Ls~n~l~~~~p-~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~ 213 (958)
+++|+|++|.+++..| ..|..+++|++|+|++|+|++..+..|.++++|++|+|++|+|++..+..|.++++|++|+|+
T Consensus 34 ~~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls 113 (220)
T 2v70_A 34 TAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGASGVNEILLTSNRLENVQHKMFKGLESLKTLMLR 113 (220)
T ss_dssp CSEEECCSSCCCEECCCCCGGGCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCCCCGGGGTTCSSCCEEECT
T ss_pred CCEEEcCCCcCCccCchhhhccCCCCCEEECCCCcCCEECHHHhCCCCCCCEEECCCCccCccCHhHhcCCcCCCEEECC
Confidence 3455555555554322 234455555555555555554444445555555555555555544444444444444444444
Q ss_pred CCccccCCCcccCCCCCccEEEccCCCCCCCCccccccCCCCCCEEEcccCCCCCCCC-CCCCCCCcCEEeccCCcCCCc
Q 002158 214 NNNLSGNLPPELSELPQLCILQLDNNNFSASEIPATYGNFSKLVKLSLRNCNLQGAVP-DLSRIPNLYYLDLSWNHLTGS 292 (958)
Q Consensus 214 ~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~p~~~~~l~~L~~L~L~~N~l~~~~~-~l~~l~~L~~L~Ls~N~l~~~ 292 (958)
+|+|++..| ..|.++++|+.|+|++|+|++.++ .|..+++|+.|+|++|.+.+.
T Consensus 114 ~N~l~~~~~-------------------------~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c~ 168 (220)
T 2v70_A 114 SNRITCVGN-------------------------DSFIGLSSVRLLSLYDNQITTVAPGAFDTLHSLSTLNLLANPFNCN 168 (220)
T ss_dssp TSCCCCBCT-------------------------TSSTTCTTCSEEECTTSCCCCBCTTTTTTCTTCCEEECCSCCEECS
T ss_pred CCcCCeECH-------------------------hHcCCCccCCEEECCCCcCCEECHHHhcCCCCCCEEEecCcCCcCC
Confidence 444444333 444455555555555555555544 356666666666666666543
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A | Back alignment and structure |
|---|
Probab=99.75 E-value=2.8e-18 Score=204.51 Aligned_cols=189 Identities=28% Similarity=0.378 Sum_probs=154.6
Q ss_pred EEEEccCCcCCCCccccccCCCCcceeeccCcccCCCCccccCCCCCcEEEeeCCCCCCCCChhhcCCCCCCEEeccccc
Q 002158 89 RELQLLSMNLSGNLAPELGQLSRLQYYFMWNDLTGTIPKEIGNISSLIFLLLNGNKLSGSLPDELGYLSNLNRLQVDENN 168 (958)
Q Consensus 89 ~~L~L~~~~l~~~~~~~l~~L~~L~~L~l~n~~~~~ip~~i~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~L~~N~ 168 (958)
..+.|..+.+.+.++ +..|++|+.|.++++....+| .|..+++|+.|+|++|.+++..| +..+++|++|+|++|+
T Consensus 24 ~~l~l~~~~i~~~~~--~~~L~~L~~L~l~~n~i~~l~-~l~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~Ls~N~ 98 (605)
T 1m9s_A 24 IKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIKSVQ-GIQYLPNVTKLFLNGNKLTDIKP--LTNLKNLGWLFLDENK 98 (605)
T ss_dssp HHHHTTCSCTTSEEC--HHHHTTCCCCBCTTCCCCCCT-TGGGCTTCCEEECTTSCCCCCGG--GGGCTTCCEEECCSSC
T ss_pred HHHhccCCCcccccc--hhcCCCCCEEECcCCCCCCCh-HHccCCCCCEEEeeCCCCCCChh--hccCCCCCEEECcCCC
Confidence 334455555554433 567888889989888777776 58899999999999999985444 8899999999999999
Q ss_pred ccccCccccccccccceEecccccccccCchhhcCCccchhhhccCCccccCCCcccCCCCCccEEEccCCCCCCCCccc
Q 002158 169 ITGTIPKSFANLSRVRHLHLNNNSIGGQIPSELSKLSTLIHLLVDNNNLSGNLPPELSELPQLCILQLDNNNFSASEIPA 248 (958)
Q Consensus 169 l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~p~ 248 (958)
|++ ++ .+..+++|+.|+|++|.|++ + ..+..+++|+.|+|++|+|++. ..+..+++|+.|+|++|+|+. ++.
T Consensus 99 l~~-l~-~l~~l~~L~~L~Ls~N~l~~-l-~~l~~l~~L~~L~Ls~N~l~~l--~~l~~l~~L~~L~Ls~N~l~~--~~~ 170 (605)
T 1m9s_A 99 IKD-LS-SLKDLKKLKSLSLEHNGISD-I-NGLVHLPQLESLYLGNNKITDI--TVLSRLTKLDTLSLEDNQISD--IVP 170 (605)
T ss_dssp CCC-CT-TSTTCTTCCEEECTTSCCCC-C-GGGGGCTTCSEEECCSSCCCCC--GGGGSCTTCSEEECCSSCCCC--CGG
T ss_pred CCC-Ch-hhccCCCCCEEEecCCCCCC-C-ccccCCCccCEEECCCCccCCc--hhhcccCCCCEEECcCCcCCC--chh
Confidence 985 33 78899999999999999985 3 4588899999999999999865 678899999999999999973 233
Q ss_pred cccCCCCCCEEEcccCCCCCCCCCCCCCCCcCEEeccCCcCCCc
Q 002158 249 TYGNFSKLVKLSLRNCNLQGAVPDLSRIPNLYYLDLSWNHLTGS 292 (958)
Q Consensus 249 ~~~~l~~L~~L~L~~N~l~~~~~~l~~l~~L~~L~Ls~N~l~~~ 292 (958)
+..+++|+.|+|++|+|++. +.+..+++|+.|+|++|.+.+.
T Consensus 171 -l~~l~~L~~L~Ls~N~i~~l-~~l~~l~~L~~L~L~~N~l~~~ 212 (605)
T 1m9s_A 171 -LAGLTKLQNLYLSKNHISDL-RALAGLKNLDVLELFSQECLNK 212 (605)
T ss_dssp -GTTCTTCCEEECCSSCCCBC-GGGTTCTTCSEEECCSEEEECC
T ss_pred -hccCCCCCEEECcCCCCCCC-hHHccCCCCCEEEccCCcCcCC
Confidence 88999999999999999876 5688899999999999998753
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* | Back alignment and structure |
|---|
Probab=99.74 E-value=1.8e-20 Score=222.06 Aligned_cols=190 Identities=17% Similarity=0.175 Sum_probs=130.5
Q ss_pred cCCCCCcEEEeeCCCCCCCCChhhcCCCCCCEEeccccc-------------ccccCccccccccccceEe-cccccccc
Q 002158 130 GNISSLIFLLLNGNKLSGSLPDELGYLSNLNRLQVDENN-------------ITGTIPKSFANLSRVRHLH-LNNNSIGG 195 (958)
Q Consensus 130 ~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~L~~N~-------------l~~~~p~~~~~l~~L~~L~-Ls~N~l~~ 195 (958)
..+++|+.|+|++|.++ .+|..++++++|++|++++|. +.+.+|..++++++|+.|+ ++.|.+
T Consensus 346 ~~~~~L~~L~Ls~n~L~-~Lp~~i~~l~~L~~L~l~~n~~l~~l~~ll~~~~~~~~~~~~l~~l~~L~~L~~l~~n~~-- 422 (567)
T 1dce_A 346 ATDEQLFRCELSVEKST-VLQSELESCKELQELEPENKWCLLTIILLMRALDPLLYEKETLQYFSTLKAVDPMRAAYL-- 422 (567)
T ss_dssp STTTTSSSCCCCHHHHH-HHHHHHHHHHHHHHHCTTCHHHHHHHHHHHHHHCTGGGHHHHHHHHHHHHHHCGGGHHHH--
T ss_pred ccCccceeccCChhhHH-hhHHHHHHHHHHHHhccccchhhhhHHHHHHhcccccCCHHHHHHHHhcccCcchhhccc--
Confidence 44556666666666665 566666666666666665553 3344555555555555555 444433
Q ss_pred cCchhhcCCccchhhhccCCccccCCCcccCCCCCccEEEccCCCCCCCCccccccCCCCCCEEEcccCCCCCCCCCCCC
Q 002158 196 QIPSELSKLSTLIHLLVDNNNLSGNLPPELSELPQLCILQLDNNNFSASEIPATYGNFSKLVKLSLRNCNLQGAVPDLSR 275 (958)
Q Consensus 196 ~~p~~l~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~l~~ 275 (958)
.+|..+.+++|.++...+ ..|+.|+|++|+|+. +|. ++++++|+.|+|++|+|+.++..+..
T Consensus 423 ---------~~L~~l~l~~n~i~~l~~------~~L~~L~Ls~n~l~~--lp~-~~~l~~L~~L~Ls~N~l~~lp~~~~~ 484 (567)
T 1dce_A 423 ---------DDLRSKFLLENSVLKMEY------ADVRVLHLAHKDLTV--LCH-LEQLLLVTHLDLSHNRLRALPPALAA 484 (567)
T ss_dssp ---------HHHHHHHHHHHHHHHHHH------TTCSEEECTTSCCSS--CCC-GGGGTTCCEEECCSSCCCCCCGGGGG
T ss_pred ---------chhhhhhhhcccccccCc------cCceEEEecCCCCCC--CcC-ccccccCcEeecCcccccccchhhhc
Confidence 244555556666653222 247888888888863 566 88888888888888888866556888
Q ss_pred CCCcCEEeccCCcCCCcCCCCCCCCCcCEEEccCCcCCCcc-chhccCCCCCCeEeeecccCCCccc
Q 002158 276 IPNLYYLDLSWNHLTGSIPSKKLSENVTTIDLSDNYLNGSI-LESISNLPFLQTLSLENNFLTGSIP 341 (958)
Q Consensus 276 l~~L~~L~Ls~N~l~~~~~~~~~~~~L~~L~Ls~N~l~~~~-~~~~~~l~~L~~L~L~~N~l~~~ip 341 (958)
+++|+.|+|++|.|++ +|....+++|+.|+|++|+|++.. |..|..+++|+.|+|++|+|++..|
T Consensus 485 l~~L~~L~Ls~N~l~~-lp~l~~l~~L~~L~Ls~N~l~~~~~p~~l~~l~~L~~L~L~~N~l~~~~~ 550 (567)
T 1dce_A 485 LRCLEVLQASDNALEN-VDGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEG 550 (567)
T ss_dssp CTTCCEEECCSSCCCC-CGGGTTCSSCCEEECCSSCCCSSSTTGGGGGCTTCCEEECTTSGGGGSSS
T ss_pred CCCCCEEECCCCCCCC-CcccCCCCCCcEEECCCCCCCCCCCcHHHhcCCCCCEEEecCCcCCCCcc
Confidence 8888888888888885 566666788888888888888776 8888888888888888888875433
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.74 E-value=1.3e-17 Score=174.51 Aligned_cols=135 Identities=21% Similarity=0.219 Sum_probs=105.9
Q ss_pred cccceEecccccccccCchhhcCCccchhhhccCCccccCCCcccCCCCCccEEEccCCCCCCCCccccccCCCCCCEEE
Q 002158 181 SRVRHLHLNNNSIGGQIPSELSKLSTLIHLLVDNNNLSGNLPPELSELPQLCILQLDNNNFSASEIPATYGNFSKLVKLS 260 (958)
Q Consensus 181 ~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~p~~~~~l~~L~~L~ 260 (958)
++|++|+|++|+|++..|..|.++++|++|+|++|+|+...+..|..+++|++|+|++|+|+. ..+..|..+++|+.|+
T Consensus 40 ~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~~~~l~~L~~L~Ls~N~l~~-l~~~~~~~l~~L~~L~ 118 (229)
T 3e6j_A 40 TNAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQLGALPVGVFDSLTQLTVLDLGTNQLTV-LPSAVFDRLVHLKELF 118 (229)
T ss_dssp TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCC-CCTTTTTTCTTCCEEE
T ss_pred CCCCEEEcCCCccCccCHHHhhCccCCcEEECCCCCCCCcChhhcccCCCcCEEECCCCcCCc-cChhHhCcchhhCeEe
Confidence 455555566666655555666666666666666666665556677888999999999999973 3455789999999999
Q ss_pred cccCCCCCCCCCCCCCCCcCEEeccCCcCCCcCCC-CCCCCCcCEEEccCCcCCCcc
Q 002158 261 LRNCNLQGAVPDLSRIPNLYYLDLSWNHLTGSIPS-KKLSENVTTIDLSDNYLNGSI 316 (958)
Q Consensus 261 L~~N~l~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~-~~~~~~L~~L~Ls~N~l~~~~ 316 (958)
|++|+|+.++..+..+++|+.|+|++|+|++..+. ...+++|+.|+|++|.+....
T Consensus 119 Ls~N~l~~lp~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~c 175 (229)
T 3e6j_A 119 MCCNKLTELPRGIERLTHLTHLALDQNQLKSIPHGAFDRLSSLTHAYLFGNPWDCEC 175 (229)
T ss_dssp CCSSCCCSCCTTGGGCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECTTSCBCTTB
T ss_pred ccCCcccccCcccccCCCCCEEECCCCcCCccCHHHHhCCCCCCEEEeeCCCccCCc
Confidence 99999998877899999999999999999965543 345689999999999998654
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.74 E-value=3.9e-18 Score=191.57 Aligned_cols=179 Identities=22% Similarity=0.231 Sum_probs=137.7
Q ss_pred cEEEeeCCCCCCCCChhhcCCCCCCEEecccccccccCccccc-cccccceEecccccccccCchhhcCCccchhhhccC
Q 002158 136 IFLLLNGNKLSGSLPDELGYLSNLNRLQVDENNITGTIPKSFA-NLSRVRHLHLNNNSIGGQIPSELSKLSTLIHLLVDN 214 (958)
Q Consensus 136 ~~L~Ls~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~-~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~ 214 (958)
+.+++++|.++ .+|..+. ..|++|+|++|+|++..+..|. ++++|+.|+|++|+|++..+..|.++++|++|+|++
T Consensus 21 ~~l~c~~~~l~-~iP~~~~--~~l~~L~Ls~N~l~~l~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~ 97 (361)
T 2xot_A 21 NILSCSKQQLP-NVPQSLP--SYTALLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHLNFISSEAFVPVPNLRYLDLSS 97 (361)
T ss_dssp TEEECCSSCCS-SCCSSCC--TTCSEEECCSSCCCEECTTSSSSCCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCS
T ss_pred CEEEeCCCCcC-ccCccCC--CCCCEEECCCCCCCccChhhhhhcccccCEEECCCCcCCccChhhccCCCCCCEEECCC
Confidence 68999999999 6887664 4699999999999988888887 999999999999999988888999999999999999
Q ss_pred CccccCCCcccCCCCCccEEEccCCCCCCCCccccccCCCCCCEEEcccCCCCCCCCC-CCCCCCcCEEeccCCcCCCcC
Q 002158 215 NNLSGNLPPELSELPQLCILQLDNNNFSASEIPATYGNFSKLVKLSLRNCNLQGAVPD-LSRIPNLYYLDLSWNHLTGSI 293 (958)
Q Consensus 215 N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~-l~~l~~L~~L~Ls~N~l~~~~ 293 (958)
|+|++..+..|..+++|++|+|++|+|+. ..+..|.++++|+.|+|++|+|++++.. +..
T Consensus 98 N~l~~~~~~~~~~l~~L~~L~L~~N~i~~-~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~------------------ 158 (361)
T 2xot_A 98 NHLHTLDEFLFSDLQALEVLLLYNNHIVV-VDRNAFEDMAQLQKLYLSQNQISRFPVELIKD------------------ 158 (361)
T ss_dssp SCCCEECTTTTTTCTTCCEEECCSSCCCE-ECTTTTTTCTTCCEEECCSSCCCSCCGGGTC-------------------
T ss_pred CcCCcCCHHHhCCCcCCCEEECCCCcccE-ECHHHhCCcccCCEEECCCCcCCeeCHHHhcC------------------
Confidence 99998888889999999999999998863 3356677777777777777777655443 210
Q ss_pred CCCCCCCCcCEEEccCCcCCCccchhccCCCC--CCeEeeecccCCC
Q 002158 294 PSKKLSENVTTIDLSDNYLNGSILESISNLPF--LQTLSLENNFLTG 338 (958)
Q Consensus 294 ~~~~~~~~L~~L~Ls~N~l~~~~~~~~~~l~~--L~~L~L~~N~l~~ 338 (958)
...+++|+.|+|++|+|+...+..|..++. |+.|+|++|++..
T Consensus 159 --~~~l~~L~~L~L~~N~l~~l~~~~~~~l~~~~l~~l~l~~N~~~C 203 (361)
T 2xot_A 159 --GNKLPKLMLLDLSSNKLKKLPLTDLQKLPAWVKNGLYLHNNPLEC 203 (361)
T ss_dssp -----CTTCCEEECCSSCCCCCCHHHHHHSCHHHHTTEECCSSCEEC
T ss_pred --cccCCcCCEEECCCCCCCccCHHHhhhccHhhcceEEecCCCccC
Confidence 012345555555555555555666676766 3778888887763
|
| >3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* | Back alignment and structure |
|---|
Probab=99.74 E-value=5e-20 Score=221.67 Aligned_cols=295 Identities=13% Similarity=0.060 Sum_probs=177.2
Q ss_pred eeEEEEccCCc-CCC-CccccccCCCCcceeeccCccc-CC----CCccccCCCCCcEEEeeCCCCCC----CCChhhcC
Q 002158 87 HVRELQLLSMN-LSG-NLAPELGQLSRLQYYFMWNDLT-GT----IPKEIGNISSLIFLLLNGNKLSG----SLPDELGY 155 (958)
Q Consensus 87 ~v~~L~L~~~~-l~~-~~~~~l~~L~~L~~L~l~n~~~-~~----ip~~i~~l~~L~~L~Ls~n~l~~----~~p~~l~~ 155 (958)
++++|+|.++. ++. .++.....+++|+.|+++++.. +. ++..+.++++|++|+|++|.+++ .++..+.+
T Consensus 139 ~L~~L~L~~~~~~~~~~l~~~~~~~~~L~~L~L~~~~~~~~~~~~l~~~~~~~~~L~~L~L~~n~~~~~~~~~l~~~~~~ 218 (592)
T 3ogk_B 139 DLETLKLDKCSGFTTDGLLSIVTHCRKIKTLLMEESSFSEKDGKWLHELAQHNTSLEVLNFYMTEFAKISPKDLETIARN 218 (592)
T ss_dssp GCCEEEEESCEEEEHHHHHHHHHHCTTCSEEECTTCEEECCCSHHHHHHHHHCCCCCEEECTTCCCSSCCHHHHHHHHHH
T ss_pred cCcEEECcCCCCcCHHHHHHHHhhCCCCCEEECccccccCcchhHHHHHHhcCCCccEEEeeccCCCccCHHHHHHHHhh
Confidence 49999999886 221 1233345789999999986643 22 34456778999999999999983 34445678
Q ss_pred CCCCCEEecccccccccCccccccccccceEeccccccc--------------------------ccCchhhcCCccchh
Q 002158 156 LSNLNRLQVDENNITGTIPKSFANLSRVRHLHLNNNSIG--------------------------GQIPSELSKLSTLIH 209 (958)
Q Consensus 156 l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~--------------------------~~~p~~l~~l~~L~~ 209 (958)
+++|++|+|++|.+.+ ++..+..+++|+.|+++++... +.+|..+..+++|++
T Consensus 219 ~~~L~~L~L~~~~~~~-l~~~~~~~~~L~~L~l~~~~~~~~~~~~~~~l~~~~~L~~L~l~~~~~~~l~~~~~~~~~L~~ 297 (592)
T 3ogk_B 219 CRSLVSVKVGDFEILE-LVGFFKAAANLEEFCGGSLNEDIGMPEKYMNLVFPRKLCRLGLSYMGPNEMPILFPFAAQIRK 297 (592)
T ss_dssp CTTCCEEECSSCBGGG-GHHHHHHCTTCCEEEECBCCCCTTCTTSSSCCCCCTTCCEEEETTCCTTTGGGGGGGGGGCCE
T ss_pred CCCCcEEeccCccHHH-HHHHHhhhhHHHhhcccccccccchHHHHHHhhccccccccCccccchhHHHHHHhhcCCCcE
Confidence 9999999999999985 6778888889999988753322 122333344445555
Q ss_pred hhccCCccccCCC-cccCCCCCccEEEccCCCCCCCCccccccCCCCCCEEEccc-----------CCCCCCCC-C-CCC
Q 002158 210 LLVDNNNLSGNLP-PELSELPQLCILQLDNNNFSASEIPATYGNFSKLVKLSLRN-----------CNLQGAVP-D-LSR 275 (958)
Q Consensus 210 L~L~~N~l~~~~~-~~l~~l~~L~~L~L~~N~l~~~~~p~~~~~l~~L~~L~L~~-----------N~l~~~~~-~-l~~ 275 (958)
|+|++|.+++... ..+..+++|++|+++ |.+....++..+..+++|++|+|++ |.+++... . ...
T Consensus 298 L~Ls~~~l~~~~~~~~~~~~~~L~~L~L~-~~~~~~~l~~~~~~~~~L~~L~L~~g~~~~~~~~~~~~~~~~~~~~l~~~ 376 (592)
T 3ogk_B 298 LDLLYALLETEDHCTLIQKCPNLEVLETR-NVIGDRGLEVLAQYCKQLKRLRIERGADEQGMEDEEGLVSQRGLIALAQG 376 (592)
T ss_dssp EEETTCCCCHHHHHHHHTTCTTCCEEEEE-GGGHHHHHHHHHHHCTTCCEEEEECCCCSSTTSSTTCCCCHHHHHHHHHH
T ss_pred EecCCCcCCHHHHHHHHHhCcCCCEEecc-CccCHHHHHHHHHhCCCCCEEEeecCccccccccccCccCHHHHHHHHhh
Confidence 5555555432221 223445555555555 3332222333334455566666652 33332211 1 233
Q ss_pred CCCcCEEeccCCcCCCcCCCC-C-CCCCcCEEEcc----CCcCCCc-----cchhccCCCCCCeEeeecc--cCCCccch
Q 002158 276 IPNLYYLDLSWNHLTGSIPSK-K-LSENVTTIDLS----DNYLNGS-----ILESISNLPFLQTLSLENN--FLTGSIPA 342 (958)
Q Consensus 276 l~~L~~L~Ls~N~l~~~~~~~-~-~~~~L~~L~Ls----~N~l~~~-----~~~~~~~l~~L~~L~L~~N--~l~~~ip~ 342 (958)
+++|++|+++.|.+++..... . .+++|+.|+|+ .|.+++. ++..+.++++|+.|+|++| .+++..+.
T Consensus 377 ~~~L~~L~l~~~~l~~~~~~~l~~~~~~L~~L~l~~~~~~n~l~~~p~~~~~~~~~~~~~~L~~L~L~~~~~~l~~~~~~ 456 (592)
T 3ogk_B 377 CQELEYMAVYVSDITNESLESIGTYLKNLCDFRLVLLDREERITDLPLDNGVRSLLIGCKKLRRFAFYLRQGGLTDLGLS 456 (592)
T ss_dssp CTTCSEEEEEESCCCHHHHHHHHHHCCSCCEEEEEECSCCSCCSSCCCHHHHHHHHHHCTTCCEEEEECCGGGCCHHHHH
T ss_pred CccCeEEEeecCCccHHHHHHHHhhCCCCcEEEEeecCCCccccCchHHHHHHHHHHhCCCCCEEEEecCCCCccHHHHH
Confidence 566666666666665422211 1 24566777774 5566653 3333556677777777643 35555544
Q ss_pred hhhcccccCccccceEeccCCCCCCC--ccC-CCCCCcceEEeCCCCC
Q 002158 343 TIWQNKSFSTKARLKIDLRNNSFSNI--VGD-LTLPNNVTLRLGGNPI 387 (958)
Q Consensus 343 ~l~~~~~~~~~~l~~L~Ls~N~l~~l--~~~-~~l~~L~~L~l~~N~l 387 (958)
.+.. ..+.|+.|+|++|++++. +.. ..+++|+.|++++|++
T Consensus 457 ~~~~----~~~~L~~L~L~~n~l~~~~~~~~~~~~~~L~~L~l~~n~l 500 (592)
T 3ogk_B 457 YIGQ----YSPNVRWMLLGYVGESDEGLMEFSRGCPNLQKLEMRGCCF 500 (592)
T ss_dssp HHHH----SCTTCCEEEECSCCSSHHHHHHHHTCCTTCCEEEEESCCC
T ss_pred HHHH----hCccceEeeccCCCCCHHHHHHHHhcCcccCeeeccCCCC
Confidence 4432 134577888988888762 222 2678899999999886
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.72 E-value=1e-17 Score=171.02 Aligned_cols=154 Identities=17% Similarity=0.289 Sum_probs=108.7
Q ss_pred ccCCCCCcEEEeeCCCCCCCCChhhcCCCCCCEEecccccccccCccccccccccceEecccccccccCchhhcCCccch
Q 002158 129 IGNISSLIFLLLNGNKLSGSLPDELGYLSNLNRLQVDENNITGTIPKSFANLSRVRHLHLNNNSIGGQIPSELSKLSTLI 208 (958)
Q Consensus 129 i~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~ 208 (958)
...+++|++|++++|.++ .+| .+..+++|++|++++|.++ .+..+..+++|++|+|++|.+++..+..+..+++|+
T Consensus 40 ~~~l~~L~~L~l~~n~i~-~l~-~l~~l~~L~~L~l~~n~~~--~~~~l~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~ 115 (197)
T 4ezg_A 40 EAQMNSLTYITLANINVT-DLT-GIEYAHNIKDLTINNIHAT--NYNPISGLSNLERLRIMGKDVTSDKIPNLSGLTSLT 115 (197)
T ss_dssp HHHHHTCCEEEEESSCCS-CCT-TGGGCTTCSEEEEESCCCS--CCGGGTTCTTCCEEEEECTTCBGGGSCCCTTCTTCC
T ss_pred hhhcCCccEEeccCCCcc-ChH-HHhcCCCCCEEEccCCCCC--cchhhhcCCCCCEEEeECCccCcccChhhcCCCCCC
Confidence 356777888888888887 566 5777888888888888665 234677777888888888887766667777777777
Q ss_pred hhhccCCccccCCCcccCCCCCccEEEccCCC-CCCCCccccccCCCCCCEEEcccCCCCCCCCCCCCCCCcCEEeccCC
Q 002158 209 HLLVDNNNLSGNLPPELSELPQLCILQLDNNN-FSASEIPATYGNFSKLVKLSLRNCNLQGAVPDLSRIPNLYYLDLSWN 287 (958)
Q Consensus 209 ~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~-l~~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~l~~l~~L~~L~Ls~N 287 (958)
+|++++|++++..+..+..+++|++|+|++|+ ++ .++ .+..+++|+.|++++|++++.. .+..+++|+.|++++|
T Consensus 116 ~L~Ls~n~i~~~~~~~l~~l~~L~~L~L~~n~~i~--~~~-~l~~l~~L~~L~l~~n~i~~~~-~l~~l~~L~~L~l~~N 191 (197)
T 4ezg_A 116 LLDISHSAHDDSILTKINTLPKVNSIDLSYNGAIT--DIM-PLKTLPELKSLNIQFDGVHDYR-GIEDFPKLNQLYAFSQ 191 (197)
T ss_dssp EEECCSSBCBGGGHHHHTTCSSCCEEECCSCTBCC--CCG-GGGGCSSCCEEECTTBCCCCCT-TGGGCSSCCEEEECBC
T ss_pred EEEecCCccCcHhHHHHhhCCCCCEEEccCCCCcc--ccH-hhcCCCCCCEEECCCCCCcChH-HhccCCCCCEEEeeCc
Confidence 77777777776666777777777777777776 54 333 5666777777777777776543 5666666777777776
Q ss_pred cCC
Q 002158 288 HLT 290 (958)
Q Consensus 288 ~l~ 290 (958)
++.
T Consensus 192 ~i~ 194 (197)
T 4ezg_A 192 TIG 194 (197)
T ss_dssp ---
T ss_pred ccC
Confidence 664
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* | Back alignment and structure |
|---|
Probab=99.72 E-value=2.9e-20 Score=220.28 Aligned_cols=204 Identities=18% Similarity=0.141 Sum_probs=157.3
Q ss_pred ccCCCCcceeeccCcccCCCCccccCCCCCcEEEeeCCC-------------CCCCCChhhcCCCCCCEEe-cccccccc
Q 002158 106 LGQLSRLQYYFMWNDLTGTIPKEIGNISSLIFLLLNGNK-------------LSGSLPDELGYLSNLNRLQ-VDENNITG 171 (958)
Q Consensus 106 l~~L~~L~~L~l~n~~~~~ip~~i~~l~~L~~L~Ls~n~-------------l~~~~p~~l~~l~~L~~L~-L~~N~l~~ 171 (958)
+..+++|+.|++++|....+|+.|+++++|+.|++++|. +.+.+|..++++++|+.|+ ++.|.+
T Consensus 345 ~~~~~~L~~L~Ls~n~L~~Lp~~i~~l~~L~~L~l~~n~~l~~l~~ll~~~~~~~~~~~~l~~l~~L~~L~~l~~n~~-- 422 (567)
T 1dce_A 345 SATDEQLFRCELSVEKSTVLQSELESCKELQELEPENKWCLLTIILLMRALDPLLYEKETLQYFSTLKAVDPMRAAYL-- 422 (567)
T ss_dssp CSTTTTSSSCCCCHHHHHHHHHHHHHHHHHHHHCTTCHHHHHHHHHHHHHHCTGGGHHHHHHHHHHHHHHCGGGHHHH--
T ss_pred cccCccceeccCChhhHHhhHHHHHHHHHHHHhccccchhhhhHHHHHHhcccccCCHHHHHHHHhcccCcchhhccc--
Confidence 367899999999999888999999999999999997775 6678888899999999999 777754
Q ss_pred cCccccccccccceEecccccccccCchhhcCCccchhhhccCCccccCCCcccCCCCCccEEEccCCCCCCCCcccccc
Q 002158 172 TIPKSFANLSRVRHLHLNNNSIGGQIPSELSKLSTLIHLLVDNNNLSGNLPPELSELPQLCILQLDNNNFSASEIPATYG 251 (958)
Q Consensus 172 ~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~p~~~~ 251 (958)
.+|+.+.+++|.|+.. +. ..|+.|+|++|+|++ +|. +..+++|+.|+|++|+|+ .+|..++
T Consensus 423 ---------~~L~~l~l~~n~i~~l-~~-----~~L~~L~Ls~n~l~~-lp~-~~~l~~L~~L~Ls~N~l~--~lp~~~~ 483 (567)
T 1dce_A 423 ---------DDLRSKFLLENSVLKM-EY-----ADVRVLHLAHKDLTV-LCH-LEQLLLVTHLDLSHNRLR--ALPPALA 483 (567)
T ss_dssp ---------HHHHHHHHHHHHHHHH-HH-----TTCSEEECTTSCCSS-CCC-GGGGTTCCEEECCSSCCC--CCCGGGG
T ss_pred ---------chhhhhhhhccccccc-Cc-----cCceEEEecCCCCCC-CcC-ccccccCcEeecCccccc--ccchhhh
Confidence 3566677777777632 22 247778888888875 454 777888888888888886 5677888
Q ss_pred CCCCCCEEEcccCCCCCCCCCCCCCCCcCEEeccCCcCCCcC-C-CCCCCCCcCEEEccCCcCCCccch---hccCCCCC
Q 002158 252 NFSKLVKLSLRNCNLQGAVPDLSRIPNLYYLDLSWNHLTGSI-P-SKKLSENVTTIDLSDNYLNGSILE---SISNLPFL 326 (958)
Q Consensus 252 ~l~~L~~L~L~~N~l~~~~~~l~~l~~L~~L~Ls~N~l~~~~-~-~~~~~~~L~~L~Ls~N~l~~~~~~---~~~~l~~L 326 (958)
++++|+.|+|++|+|++++ .+..+++|+.|+|++|+|++.. | ....+++|+.|+|++|.|++.++. .+..+++|
T Consensus 484 ~l~~L~~L~Ls~N~l~~lp-~l~~l~~L~~L~Ls~N~l~~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~l~~~lp~L 562 (567)
T 1dce_A 484 ALRCLEVLQASDNALENVD-GVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAEMLPSV 562 (567)
T ss_dssp GCTTCCEEECCSSCCCCCG-GGTTCSSCCEEECCSSCCCSSSTTGGGGGCTTCCEEECTTSGGGGSSSCTTHHHHHCTTC
T ss_pred cCCCCCEEECCCCCCCCCc-ccCCCCCCcEEECCCCCCCCCCCcHHHhcCCCCCEEEecCCcCCCCccHHHHHHHHCccc
Confidence 8888888888888888754 7778888888888888887663 3 345568888888888888776543 24457888
Q ss_pred CeEee
Q 002158 327 QTLSL 331 (958)
Q Consensus 327 ~~L~L 331 (958)
+.|++
T Consensus 563 ~~L~l 567 (567)
T 1dce_A 563 SSILT 567 (567)
T ss_dssp SEEEC
T ss_pred CccCC
Confidence 88864
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.72 E-value=4.1e-18 Score=182.33 Aligned_cols=169 Identities=22% Similarity=0.373 Sum_probs=109.4
Q ss_pred CCCcceeeccCcccCCCCccccCCCCCcEEEeeCCCCCCCCChhhcCCCCCCEEecccccccccCccccccccccceEec
Q 002158 109 LSRLQYYFMWNDLTGTIPKEIGNISSLIFLLLNGNKLSGSLPDELGYLSNLNRLQVDENNITGTIPKSFANLSRVRHLHL 188 (958)
Q Consensus 109 L~~L~~L~l~n~~~~~ip~~i~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L 188 (958)
+.++..+.+.++....++ .+..+++|++|++++|.++ .+| .+..+++|++|+|++|++++..+ +..+++|++|+|
T Consensus 18 l~~l~~l~l~~~~i~~~~-~~~~l~~L~~L~l~~n~i~-~l~-~l~~l~~L~~L~L~~N~i~~~~~--l~~l~~L~~L~L 92 (263)
T 1xeu_A 18 LANAVKQNLGKQSVTDLV-SQKELSGVQNFNGDNSNIQ-SLA-GMQFFTNLKELHLSHNQISDLSP--LKDLTKLEELSV 92 (263)
T ss_dssp HHHHHHHHHTCSCTTSEE-CHHHHTTCSEEECTTSCCC-CCT-TGGGCTTCCEEECCSSCCCCCGG--GTTCSSCCEEEC
T ss_pred HHHHHHHHhcCCCccccc-chhhcCcCcEEECcCCCcc-cch-HHhhCCCCCEEECCCCccCCChh--hccCCCCCEEEC
Confidence 344445555555555554 4666777777777777776 455 56777777777777777774433 777777777777
Q ss_pred ccccccccCchhhcCCccchhhhccCCccccCCCcccCCCCCccEEEccCCCCCCCCccccccCCCCCCEEEcccCCCCC
Q 002158 189 NNNSIGGQIPSELSKLSTLIHLLVDNNNLSGNLPPELSELPQLCILQLDNNNFSASEIPATYGNFSKLVKLSLRNCNLQG 268 (958)
Q Consensus 189 s~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~p~~~~~l~~L~~L~L~~N~l~~ 268 (958)
++|++++ +|. +.. ++|+.|+|++|++++. ..+..+++|+.|+|++|+++. ++ .+..+++|+.|+|++|++++
T Consensus 93 ~~N~l~~-l~~-~~~-~~L~~L~L~~N~l~~~--~~l~~l~~L~~L~Ls~N~i~~--~~-~l~~l~~L~~L~L~~N~i~~ 164 (263)
T 1xeu_A 93 NRNRLKN-LNG-IPS-ACLSRLFLDNNELRDT--DSLIHLKNLEILSIRNNKLKS--IV-MLGFLSKLEVLDLHGNEITN 164 (263)
T ss_dssp CSSCCSC-CTT-CCC-SSCCEEECCSSCCSBS--GGGTTCTTCCEEECTTSCCCB--CG-GGGGCTTCCEEECTTSCCCB
T ss_pred CCCccCC-cCc-ccc-CcccEEEccCCccCCC--hhhcCcccccEEECCCCcCCC--Ch-HHccCCCCCEEECCCCcCcc
Confidence 7777774 333 222 6777777777777653 346677777777777777753 23 56666777777777777766
Q ss_pred CCCCCCCCCCcCEEeccCCcCCC
Q 002158 269 AVPDLSRIPNLYYLDLSWNHLTG 291 (958)
Q Consensus 269 ~~~~l~~l~~L~~L~Ls~N~l~~ 291 (958)
. ..+..+++|+.|+|++|.+++
T Consensus 165 ~-~~l~~l~~L~~L~l~~N~~~~ 186 (263)
T 1xeu_A 165 T-GGLTRLKKVNWIDLTGQKCVN 186 (263)
T ss_dssp C-TTSTTCCCCCEEEEEEEEEEC
T ss_pred h-HHhccCCCCCEEeCCCCcccC
Confidence 5 456666777777777776653
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.71 E-value=5.1e-18 Score=181.58 Aligned_cols=170 Identities=21% Similarity=0.305 Sum_probs=94.3
Q ss_pred CCCCcEEEeeCCCCCCCCChhhcCCCCCCEEecccccccccCccccccccccceEecccccccccCchhhcCCccchhhh
Q 002158 132 ISSLIFLLLNGNKLSGSLPDELGYLSNLNRLQVDENNITGTIPKSFANLSRVRHLHLNNNSIGGQIPSELSKLSTLIHLL 211 (958)
Q Consensus 132 l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~ 211 (958)
+.++..+++++|.++ .++ .+..+++|++|++++|+++ .++ .+..+++|+.|+|++|+|+
T Consensus 18 l~~l~~l~l~~~~i~-~~~-~~~~l~~L~~L~l~~n~i~-~l~-~l~~l~~L~~L~L~~N~i~----------------- 76 (263)
T 1xeu_A 18 LANAVKQNLGKQSVT-DLV-SQKELSGVQNFNGDNSNIQ-SLA-GMQFFTNLKELHLSHNQIS----------------- 76 (263)
T ss_dssp HHHHHHHHHTCSCTT-SEE-CHHHHTTCSEEECTTSCCC-CCT-TGGGCTTCCEEECCSSCCC-----------------
T ss_pred HHHHHHHHhcCCCcc-ccc-chhhcCcCcEEECcCCCcc-cch-HHhhCCCCCEEECCCCccC-----------------
Confidence 334445555555554 222 3444555555555555554 222 3444455555555555544
Q ss_pred ccCCccccCCCcccCCCCCccEEEccCCCCCCCCccccccCCCCCCEEEcccCCCCCCCCCCCCCCCcCEEeccCCcCCC
Q 002158 212 VDNNNLSGNLPPELSELPQLCILQLDNNNFSASEIPATYGNFSKLVKLSLRNCNLQGAVPDLSRIPNLYYLDLSWNHLTG 291 (958)
Q Consensus 212 L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~l~~l~~L~~L~Ls~N~l~~ 291 (958)
+..+ +..+++|++|+|++|+++. ++.... ++|+.|+|++|++++. +.+..+++|+.|+|++|++++
T Consensus 77 -------~~~~--l~~l~~L~~L~L~~N~l~~--l~~~~~--~~L~~L~L~~N~l~~~-~~l~~l~~L~~L~Ls~N~i~~ 142 (263)
T 1xeu_A 77 -------DLSP--LKDLTKLEELSVNRNRLKN--LNGIPS--ACLSRLFLDNNELRDT-DSLIHLKNLEILSIRNNKLKS 142 (263)
T ss_dssp -------CCGG--GTTCSSCCEEECCSSCCSC--CTTCCC--SSCCEEECCSSCCSBS-GGGTTCTTCCEEECTTSCCCB
T ss_pred -------CChh--hccCCCCCEEECCCCccCC--cCcccc--CcccEEEccCCccCCC-hhhcCcccccEEECCCCcCCC
Confidence 3222 4444555555555555532 222111 5555555655555543 245666666666666666663
Q ss_pred cCCCCCCCCCcCEEEccCCcCCCccchhccCCCCCCeEeeecccCCCc
Q 002158 292 SIPSKKLSENVTTIDLSDNYLNGSILESISNLPFLQTLSLENNFLTGS 339 (958)
Q Consensus 292 ~~~~~~~~~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~ 339 (958)
++....+++|+.|+|++|+|++. ..+..+++|+.|+|++|++++.
T Consensus 143 -~~~l~~l~~L~~L~L~~N~i~~~--~~l~~l~~L~~L~l~~N~~~~~ 187 (263)
T 1xeu_A 143 -IVMLGFLSKLEVLDLHGNEITNT--GGLTRLKKVNWIDLTGQKCVNE 187 (263)
T ss_dssp -CGGGGGCTTCCEEECTTSCCCBC--TTSTTCCCCCEEEEEEEEEECC
T ss_pred -ChHHccCCCCCEEECCCCcCcch--HHhccCCCCCEEeCCCCcccCC
Confidence 34445556777777777777665 6678888888888888888743
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.71 E-value=3.5e-17 Score=166.31 Aligned_cols=155 Identities=21% Similarity=0.249 Sum_probs=98.4
Q ss_pred cEEEccCCCCCCCCccccccCCCCCCEEEcccCCCCCCCCCCCCCCCcCEEeccCCcCCCcCCC-CCCCCCcCEEEccCC
Q 002158 232 CILQLDNNNFSASEIPATYGNFSKLVKLSLRNCNLQGAVPDLSRIPNLYYLDLSWNHLTGSIPS-KKLSENVTTIDLSDN 310 (958)
Q Consensus 232 ~~L~L~~N~l~~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~-~~~~~~L~~L~Ls~N 310 (958)
+.+++++|.++ .+|..+. ++|+.|+|++|+|+.++..|..+++|+.|+|++|.|++..+. ...+++|++|+|++|
T Consensus 13 ~~l~~~~~~l~--~ip~~~~--~~l~~L~L~~n~i~~ip~~~~~l~~L~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N 88 (193)
T 2wfh_A 13 TVVRCSNKGLK--VLPKGIP--RDVTELYLDGNQFTLVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYN 88 (193)
T ss_dssp TEEECTTSCCS--SCCSCCC--TTCCEEECCSSCCCSCCGGGGGCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred CEEEcCCCCCC--cCCCCCC--CCCCEEECCCCcCchhHHHhhcccCCCEEECCCCcCCEeCHhHccCCCCCCEEECCCC
Confidence 45677777764 3454332 456666666666665544466666666666666666643332 233455666666666
Q ss_pred cCCCccchhccCCCCCCeEeeecccCCCccchhhhcccccCccccceEeccCCCCCCCccCC--CCCCcceEEeCCCCCC
Q 002158 311 YLNGSILESISNLPFLQTLSLENNFLTGSIPATIWQNKSFSTKARLKIDLRNNSFSNIVGDL--TLPNNVTLRLGGNPIC 388 (958)
Q Consensus 311 ~l~~~~~~~~~~l~~L~~L~L~~N~l~~~ip~~l~~~~~~~~~~l~~L~Ls~N~l~~l~~~~--~l~~L~~L~l~~N~l~ 388 (958)
+|++..+..|.++++|+.|+|++|+|+ .++... .+++|+.|+|++|||
T Consensus 89 ~l~~i~~~~f~~l~~L~~L~L~~N~l~-----------------------------~~~~~~~~~l~~L~~L~L~~N~~- 138 (193)
T 2wfh_A 89 RLRCIPPRTFDGLKSLRLLSLHGNDIS-----------------------------VVPEGAFNDLSALSHLAIGANPL- 138 (193)
T ss_dssp CCCBCCTTTTTTCTTCCEEECCSSCCC-----------------------------BCCTTTTTTCTTCCEEECCSSCE-
T ss_pred ccCEeCHHHhCCCCCCCEEECCCCCCC-----------------------------eeChhhhhcCccccEEEeCCCCe-
Confidence 665555555555555555555555555 443322 567788888888777
Q ss_pred CCCCCCCCCcccccCCCCCccccccCCCCCCCCCCCCCcccccCCCCCCceeeeeceee
Q 002158 389 TSANIPNTGRFCGSDAGGDETLTNSKVNCPVQACPVDNFFEYVPASPEPCFCAAPLRIG 447 (958)
Q Consensus 389 ~~~~~~~~~~~~~~~~~~~~~L~~n~~~C~c~~~~~~~~~~~~~~~~~~~~c~sp~~~~ 447 (958)
.|+|...++..|+...........|++|...+
T Consensus 139 ---------------------------~C~c~l~~l~~~~~~~~~~~~~~~C~~P~~l~ 170 (193)
T 2wfh_A 139 ---------------------------YCDCNMQWLSDWVKSEYKEPGIARCAGPGEMA 170 (193)
T ss_dssp ---------------------------ECSGGGHHHHHHHHHSSCCCSCCBEEESGGGT
T ss_pred ---------------------------ecCCcCHHHHHHHHhccCCCCCcCcCCchHHC
Confidence 78888888999998776666668999998765
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.70 E-value=2.8e-17 Score=167.77 Aligned_cols=154 Identities=19% Similarity=0.284 Sum_probs=129.3
Q ss_pred cCCCCcceeeccCcccCCCCccccCCCCCcEEEeeCCCCCCCCChhhcCCCCCCEEecccccccccCccccccccccceE
Q 002158 107 GQLSRLQYYFMWNDLTGTIPKEIGNISSLIFLLLNGNKLSGSLPDELGYLSNLNRLQVDENNITGTIPKSFANLSRVRHL 186 (958)
Q Consensus 107 ~~L~~L~~L~l~n~~~~~ip~~i~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L 186 (958)
+.+++|+.|+++++....+| .+..+++|++|++++|.++ .+ ..+..+++|++|++++|++++..+..+..+++|++|
T Consensus 41 ~~l~~L~~L~l~~n~i~~l~-~l~~l~~L~~L~l~~n~~~-~~-~~l~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L 117 (197)
T 4ezg_A 41 AQMNSLTYITLANINVTDLT-GIEYAHNIKDLTINNIHAT-NY-NPISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLL 117 (197)
T ss_dssp HHHHTCCEEEEESSCCSCCT-TGGGCTTCSEEEEESCCCS-CC-GGGTTCTTCCEEEEECTTCBGGGSCCCTTCTTCCEE
T ss_pred hhcCCccEEeccCCCccChH-HHhcCCCCCEEEccCCCCC-cc-hhhhcCCCCCEEEeECCccCcccChhhcCCCCCCEE
Confidence 56778888888877777777 6889999999999999776 33 478899999999999999998788889999999999
Q ss_pred ecccccccccCchhhcCCccchhhhccCCc-cccCCCcccCCCCCccEEEccCCCCCCCCccccccCCCCCCEEEcccCC
Q 002158 187 HLNNNSIGGQIPSELSKLSTLIHLLVDNNN-LSGNLPPELSELPQLCILQLDNNNFSASEIPATYGNFSKLVKLSLRNCN 265 (958)
Q Consensus 187 ~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~-l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~p~~~~~l~~L~~L~L~~N~ 265 (958)
+|++|.+++..+..+..+++|++|++++|+ ++ .++ .+..+++|++|++++|+++. ++ .+..+++|+.|++++|+
T Consensus 118 ~Ls~n~i~~~~~~~l~~l~~L~~L~L~~n~~i~-~~~-~l~~l~~L~~L~l~~n~i~~--~~-~l~~l~~L~~L~l~~N~ 192 (197)
T 4ezg_A 118 DISHSAHDDSILTKINTLPKVNSIDLSYNGAIT-DIM-PLKTLPELKSLNIQFDGVHD--YR-GIEDFPKLNQLYAFSQT 192 (197)
T ss_dssp ECCSSBCBGGGHHHHTTCSSCCEEECCSCTBCC-CCG-GGGGCSSCCEEECTTBCCCC--CT-TGGGCSSCCEEEECBC-
T ss_pred EecCCccCcHhHHHHhhCCCCCEEEccCCCCcc-ccH-hhcCCCCCCEEECCCCCCcC--hH-HhccCCCCCEEEeeCcc
Confidence 999999998788889999999999999998 65 444 68899999999999999974 34 78889999999999999
Q ss_pred CCC
Q 002158 266 LQG 268 (958)
Q Consensus 266 l~~ 268 (958)
+.+
T Consensus 193 i~~ 195 (197)
T 4ezg_A 193 IGG 195 (197)
T ss_dssp ---
T ss_pred cCC
Confidence 864
|
| >2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* | Back alignment and structure |
|---|
Probab=99.67 E-value=4.2e-19 Score=213.63 Aligned_cols=244 Identities=15% Similarity=0.126 Sum_probs=144.5
Q ss_pred eeEEEEccCCcCCCCcccccc-CCCCcceeeccCc-ccCC--CCccccCCCCCcEEEeeCCCCCCCCChhhc----CCCC
Q 002158 87 HVRELQLLSMNLSGNLAPELG-QLSRLQYYFMWND-LTGT--IPKEIGNISSLIFLLLNGNKLSGSLPDELG----YLSN 158 (958)
Q Consensus 87 ~v~~L~L~~~~l~~~~~~~l~-~L~~L~~L~l~n~-~~~~--ip~~i~~l~~L~~L~Ls~n~l~~~~p~~l~----~l~~ 158 (958)
++++|+|+++.+++..+..+. .+++|+.|.++++ ..+. ++..+.++++|++|+|++|.+++..+..+. .+++
T Consensus 106 ~L~~L~L~~~~~~~~~~~~l~~~~~~L~~L~L~~~~~~~~~~l~~~~~~~~~L~~L~L~~~~i~~~~~~~l~~~~~~~~~ 185 (594)
T 2p1m_B 106 WLEEIRLKRMVVTDDCLELIAKSFKNFKVLVLSSCEGFSTDGLAAIAATCRNLKELDLRESDVDDVSGHWLSHFPDTYTS 185 (594)
T ss_dssp TCCEEEEESCBCCHHHHHHHHHHCTTCCEEEEESCEEEEHHHHHHHHHHCTTCCEEECTTCEEECCCGGGGGGSCTTCCC
T ss_pred CCCeEEeeCcEEcHHHHHHHHHhCCCCcEEeCCCcCCCCHHHHHHHHHhCCCCCEEeCcCCccCCcchHHHHHHhhcCCc
Confidence 688899999988887777775 6889999988765 3333 445556788999999999988765555444 5668
Q ss_pred CCEEeccccc--cccc-CccccccccccceEecccc-cccccCchhhcCCccchhhhccCCc------------------
Q 002158 159 LNRLQVDENN--ITGT-IPKSFANLSRVRHLHLNNN-SIGGQIPSELSKLSTLIHLLVDNNN------------------ 216 (958)
Q Consensus 159 L~~L~L~~N~--l~~~-~p~~~~~l~~L~~L~Ls~N-~l~~~~p~~l~~l~~L~~L~L~~N~------------------ 216 (958)
|++|++++|. ++.. +...+.++++|++|+|++| .+. .++..+..+++|+.|+++.+.
T Consensus 186 L~~L~l~~~~~~~~~~~l~~l~~~~~~L~~L~L~~~~~~~-~l~~~~~~~~~L~~L~l~~~~~~~~~~~~~~l~~~l~~~ 264 (594)
T 2p1m_B 186 LVSLNISCLASEVSFSALERLVTRCPNLKSLKLNRAVPLE-KLATLLQRAPQLEELGTGGYTAEVRPDVYSGLSVALSGC 264 (594)
T ss_dssp CCEEECTTCCSCCCHHHHHHHHHHCTTCCEEECCTTSCHH-HHHHHHHHCTTCSEEECSBCCCCCCHHHHHHHHHHHHTC
T ss_pred CcEEEecccCCcCCHHHHHHHHHhCCCCcEEecCCCCcHH-HHHHHHhcCCcceEcccccccCccchhhHHHHHHHHhcC
Confidence 9999999886 3211 2222345688888888888 333 355666666666666644331
Q ss_pred --------ccc----CCCcccCCCCCccEEEccCCCCCCCCccccccCCCCCCEEEcccCCCCCCC-CC-CCCCCCcCEE
Q 002158 217 --------LSG----NLPPELSELPQLCILQLDNNNFSASEIPATYGNFSKLVKLSLRNCNLQGAV-PD-LSRIPNLYYL 282 (958)
Q Consensus 217 --------l~~----~~~~~l~~l~~L~~L~L~~N~l~~~~~p~~~~~l~~L~~L~L~~N~l~~~~-~~-l~~l~~L~~L 282 (958)
+.. .++..+..+++|++|+|++|.++...+...+.++++|+.|++++| ++... .. ...+++|+.|
T Consensus 265 ~~L~~Ls~~~~~~~~~l~~~~~~~~~L~~L~L~~~~l~~~~l~~~~~~~~~L~~L~l~~~-~~~~~l~~l~~~~~~L~~L 343 (594)
T 2p1m_B 265 KELRCLSGFWDAVPAYLPAVYSVCSRLTTLNLSYATVQSYDLVKLLCQCPKLQRLWVLDY-IEDAGLEVLASTCKDLREL 343 (594)
T ss_dssp TTCCEEECCBTCCGGGGGGGHHHHTTCCEEECTTCCCCHHHHHHHHTTCTTCCEEEEEGG-GHHHHHHHHHHHCTTCCEE
T ss_pred CCcccccCCcccchhhHHHHHHhhCCCCEEEccCCCCCHHHHHHHHhcCCCcCEEeCcCc-cCHHHHHHHHHhCCCCCEE
Confidence 111 122222356788888888887654333444567777777777776 32111 11 1235566666
Q ss_pred eccC---------CcCCCcCC-CC-CCCCCcCEEEccCCcCCCccchhcc-CCCCCCeEeee
Q 002158 283 DLSW---------NHLTGSIP-SK-KLSENVTTIDLSDNYLNGSILESIS-NLPFLQTLSLE 332 (958)
Q Consensus 283 ~Ls~---------N~l~~~~~-~~-~~~~~L~~L~Ls~N~l~~~~~~~~~-~l~~L~~L~L~ 332 (958)
+|++ |.+++... .. ..+++|+.|+++.|.+++.....+. .+++|+.|+|+
T Consensus 344 ~L~~~~~~g~~~~~~l~~~~l~~l~~~~~~L~~L~~~~~~l~~~~~~~l~~~~~~L~~L~L~ 405 (594)
T 2p1m_B 344 RVFPSEPFVMEPNVALTEQGLVSVSMGCPKLESVLYFCRQMTNAALITIARNRPNMTRFRLC 405 (594)
T ss_dssp EEECSCTTCSSCSSCCCHHHHHHHHHHCTTCCEEEEEESCCCHHHHHHHHHHCTTCCEEEEE
T ss_pred EEecCcccccccCCCCCHHHHHHHHHhchhHHHHHHhcCCcCHHHHHHHHhhCCCcceeEee
Confidence 6632 23321100 00 1134555555555555544444443 35555555555
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 | Back alignment and structure |
|---|
Probab=99.67 E-value=1e-16 Score=162.73 Aligned_cols=157 Identities=23% Similarity=0.358 Sum_probs=106.5
Q ss_pred cEEEccCCCCCCCCccccccCCCCCCEEEcccCCCCCCCCC--CCCCCCcCEEeccCCcCCCcCCC-CCCCCCcCEEEcc
Q 002158 232 CILQLDNNNFSASEIPATYGNFSKLVKLSLRNCNLQGAVPD--LSRIPNLYYLDLSWNHLTGSIPS-KKLSENVTTIDLS 308 (958)
Q Consensus 232 ~~L~L~~N~l~~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~--l~~l~~L~~L~Ls~N~l~~~~~~-~~~~~~L~~L~Ls 308 (958)
+.|++++|.++ .+|..+.. +|+.|+|++|++++.++. +..+++|++|+|++|+|++..|. ...+++|++|+|+
T Consensus 11 ~~l~~s~~~l~--~ip~~~~~--~l~~L~l~~n~i~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls 86 (192)
T 1w8a_A 11 TTVDCTGRGLK--EIPRDIPL--HTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLG 86 (192)
T ss_dssp TEEECTTSCCS--SCCSCCCT--TCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECC
T ss_pred CEEEcCCCCcC--cCccCCCC--CCCEEECCCCcCCccCCccccccCCCCCEEECCCCCCCCcCHhHcCCcccCCEEECC
Confidence 57777877774 45654432 777777777777776653 66777777777777777765443 3445677777777
Q ss_pred CCcCCCccchhccCCCCCCeEeeecccCCCccchhhhcccccCccccceEeccCCCCCCCccCCCCCCcceEEeCCCCCC
Q 002158 309 DNYLNGSILESISNLPFLQTLSLENNFLTGSIPATIWQNKSFSTKARLKIDLRNNSFSNIVGDLTLPNNVTLRLGGNPIC 388 (958)
Q Consensus 309 ~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~ip~~l~~~~~~~~~~l~~L~Ls~N~l~~l~~~~~l~~L~~L~l~~N~l~ 388 (958)
+|+|++..+..|.++++|++|+|++|+|++..|..+. .+++|+.|+|++|+|
T Consensus 87 ~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~---------------------------~l~~L~~L~L~~N~l- 138 (192)
T 1w8a_A 87 ENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFE---------------------------HLNSLTSLNLASNPF- 138 (192)
T ss_dssp SCCCCEECSSSSTTCTTCCEEECCSSCCCEECTTSST---------------------------TCTTCCEEECTTCCB-
T ss_pred CCcCCccCHHHhcCCCCCCEEECCCCcCCeeCHHHhh---------------------------cCCCCCEEEeCCCCc-
Confidence 7777776666677777777777777777654444331 567788888888887
Q ss_pred CCCCCCCCCcccccCCCCCccccccCCCCCCCCCCCCCcccccCCCCCCceeeeeceee
Q 002158 389 TSANIPNTGRFCGSDAGGDETLTNSKVNCPVQACPVDNFFEYVPASPEPCFCAAPLRIG 447 (958)
Q Consensus 389 ~~~~~~~~~~~~~~~~~~~~~L~~n~~~C~c~~~~~~~~~~~~~~~~~~~~c~sp~~~~ 447 (958)
.|+|+..++..|++..........|++|...+
T Consensus 139 ---------------------------~c~c~l~~~~~~l~~~~~~~~~~~C~~P~~l~ 170 (192)
T 1w8a_A 139 ---------------------------NCNCHLAWFAEWLRKKSLNGGAARCGAPSKVR 170 (192)
T ss_dssp ---------------------------CCSGGGHHHHHHHHHHCCSGGGCBBCSSTTTT
T ss_pred ---------------------------cCcCcchHHHHHHHHcCCCCCCCCCCCChHHc
Confidence 56777777777776665555556788886654
|
| >2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* | Back alignment and structure |
|---|
Probab=99.67 E-value=1.1e-18 Score=209.90 Aligned_cols=294 Identities=15% Similarity=0.123 Sum_probs=141.9
Q ss_pred eeeEEEEccCC-cCCCC-ccccccCCCCcceeeccCccc-CCCC----ccccCCCCCcEEEeeCCCCCCCCC-hh----h
Q 002158 86 LHVRELQLLSM-NLSGN-LAPELGQLSRLQYYFMWNDLT-GTIP----KEIGNISSLIFLLLNGNKLSGSLP-DE----L 153 (958)
Q Consensus 86 ~~v~~L~L~~~-~l~~~-~~~~l~~L~~L~~L~l~n~~~-~~ip----~~i~~l~~L~~L~Ls~n~l~~~~p-~~----l 153 (958)
.+++.|+|.+| .++.. ++..+.++++|+.|+++++.. +..+ .....+++|++|+|++|. . .+. .. +
T Consensus 130 ~~L~~L~L~~~~~~~~~~l~~~~~~~~~L~~L~L~~~~i~~~~~~~l~~~~~~~~~L~~L~l~~~~-~-~~~~~~l~~l~ 207 (594)
T 2p1m_B 130 KNFKVLVLSSCEGFSTDGLAAIAATCRNLKELDLRESDVDDVSGHWLSHFPDTYTSLVSLNISCLA-S-EVSFSALERLV 207 (594)
T ss_dssp TTCCEEEEESCEEEEHHHHHHHHHHCTTCCEEECTTCEEECCCGGGGGGSCTTCCCCCEEECTTCC-S-CCCHHHHHHHH
T ss_pred CCCcEEeCCCcCCCCHHHHHHHHHhCCCCCEEeCcCCccCCcchHHHHHHhhcCCcCcEEEecccC-C-cCCHHHHHHHH
Confidence 36788888877 44433 334445688888888875542 2222 223356678888888776 1 222 22 2
Q ss_pred cCCCCCCEEecccc-cccccCccccccccccceEeccccc--------------------------cc----ccCchhhc
Q 002158 154 GYLSNLNRLQVDEN-NITGTIPKSFANLSRVRHLHLNNNS--------------------------IG----GQIPSELS 202 (958)
Q Consensus 154 ~~l~~L~~L~L~~N-~l~~~~p~~~~~l~~L~~L~Ls~N~--------------------------l~----~~~p~~l~ 202 (958)
.++++|++|+|++| .+++ ++..+..+++|+.|+++.+. +. +.++..+.
T Consensus 208 ~~~~~L~~L~L~~~~~~~~-l~~~~~~~~~L~~L~l~~~~~~~~~~~~~~l~~~l~~~~~L~~Ls~~~~~~~~~l~~~~~ 286 (594)
T 2p1m_B 208 TRCPNLKSLKLNRAVPLEK-LATLLQRAPQLEELGTGGYTAEVRPDVYSGLSVALSGCKELRCLSGFWDAVPAYLPAVYS 286 (594)
T ss_dssp HHCTTCCEEECCTTSCHHH-HHHHHHHCTTCSEEECSBCCCCCCHHHHHHHHHHHHTCTTCCEEECCBTCCGGGGGGGHH
T ss_pred HhCCCCcEEecCCCCcHHH-HHHHHhcCCcceEcccccccCccchhhHHHHHHHHhcCCCcccccCCcccchhhHHHHHH
Confidence 34577788877776 2222 34444444444444432221 00 01122222
Q ss_pred CCccchhhhccCCccccCC-CcccCCCCCccEEEccCC---------------------------------CCCCCCccc
Q 002158 203 KLSTLIHLLVDNNNLSGNL-PPELSELPQLCILQLDNN---------------------------------NFSASEIPA 248 (958)
Q Consensus 203 ~l~~L~~L~L~~N~l~~~~-~~~l~~l~~L~~L~L~~N---------------------------------~l~~~~~p~ 248 (958)
.+++|+.|+|++|.+++.. ...+..+++|++|++++| .++...+..
T Consensus 287 ~~~~L~~L~L~~~~l~~~~l~~~~~~~~~L~~L~l~~~~~~~~l~~l~~~~~~L~~L~L~~~~~~g~~~~~~l~~~~l~~ 366 (594)
T 2p1m_B 287 VCSRLTTLNLSYATVQSYDLVKLLCQCPKLQRLWVLDYIEDAGLEVLASTCKDLRELRVFPSEPFVMEPNVALTEQGLVS 366 (594)
T ss_dssp HHTTCCEEECTTCCCCHHHHHHHHTTCTTCCEEEEEGGGHHHHHHHHHHHCTTCCEEEEECSCTTCSSCSSCCCHHHHHH
T ss_pred hhCCCCEEEccCCCCCHHHHHHHHhcCCCcCEEeCcCccCHHHHHHHHHhCCCCCEEEEecCcccccccCCCCCHHHHHH
Confidence 3344555555555443211 111334444444444444 332111111
Q ss_pred cccCCCCCCEEEcccCCCCCCCCC-C-CCCCCcCEEecc--C----CcCCCcCCC------CCCCCCcCEEEccCCcCCC
Q 002158 249 TYGNFSKLVKLSLRNCNLQGAVPD-L-SRIPNLYYLDLS--W----NHLTGSIPS------KKLSENVTTIDLSDNYLNG 314 (958)
Q Consensus 249 ~~~~l~~L~~L~L~~N~l~~~~~~-l-~~l~~L~~L~Ls--~----N~l~~~~~~------~~~~~~L~~L~Ls~N~l~~ 314 (958)
...++++|+.|.+..|.+++.... + ..+++|+.|+|+ + |.+++.... ...+++|+.|+|++ .+++
T Consensus 367 l~~~~~~L~~L~~~~~~l~~~~~~~l~~~~~~L~~L~L~~~~~~~~~~l~~~~~~~~~~~l~~~~~~L~~L~L~~-~l~~ 445 (594)
T 2p1m_B 367 VSMGCPKLESVLYFCRQMTNAALITIARNRPNMTRFRLCIIEPKAPDYLTLEPLDIGFGAIVEHCKDLRRLSLSG-LLTD 445 (594)
T ss_dssp HHHHCTTCCEEEEEESCCCHHHHHHHHHHCTTCCEEEEEESSTTCCCTTTCCCTHHHHHHHHHHCTTCCEEECCS-SCCH
T ss_pred HHHhchhHHHHHHhcCCcCHHHHHHHHhhCCCcceeEeecccCCCcccccCCchhhHHHHHHhhCCCccEEeecC-cccH
Confidence 112345555555555555433221 2 235566666666 2 334311100 12235666666655 5555
Q ss_pred ccchhccC-CCCCCeEeeecccCCCccchhhhcccccCccccceEeccCCCCCCCcc--CC-CCCCcceEEeCCCCC
Q 002158 315 SILESISN-LPFLQTLSLENNFLTGSIPATIWQNKSFSTKARLKIDLRNNSFSNIVG--DL-TLPNNVTLRLGGNPI 387 (958)
Q Consensus 315 ~~~~~~~~-l~~L~~L~L~~N~l~~~ip~~l~~~~~~~~~~l~~L~Ls~N~l~~l~~--~~-~l~~L~~L~l~~N~l 387 (958)
..+..+.. +++|+.|+|++|.+++..+..+... .+.|+.|+|++|.+++... .. .+++|+.|++++|++
T Consensus 446 ~~~~~l~~~~~~L~~L~L~~~~i~~~~~~~l~~~----~~~L~~L~L~~n~~~~~~~~~~~~~l~~L~~L~l~~~~~ 518 (594)
T 2p1m_B 446 KVFEYIGTYAKKMEMLSVAFAGDSDLGMHHVLSG----CDSLRKLEIRDCPFGDKALLANASKLETMRSLWMSSCSV 518 (594)
T ss_dssp HHHHHHHHHCTTCCEEEEESCCSSHHHHHHHHHH----CTTCCEEEEESCSCCHHHHHHTGGGGGGSSEEEEESSCC
T ss_pred HHHHHHHHhchhccEeeccCCCCcHHHHHHHHhc----CCCcCEEECcCCCCcHHHHHHHHHhCCCCCEEeeeCCCC
Confidence 44444444 6666666666666655444333211 2345566666666643221 11 456666666666665
|
| >4b8c_D Glucose-repressible alcohol dehydrogenase transcr effector; hydrolase-cell cycle complex; 3.41A {Saccharomyces cerevisiae S288C} | Back alignment and structure |
|---|
Probab=99.66 E-value=1.8e-17 Score=202.48 Aligned_cols=178 Identities=21% Similarity=0.175 Sum_probs=92.8
Q ss_pred CCcEEEeeCCCCCCCCChhhcCCCCCC-----EEecccccccccCccccccccccceEecccccccccCchhhcCCccch
Q 002158 134 SLIFLLLNGNKLSGSLPDELGYLSNLN-----RLQVDENNITGTIPKSFANLSRVRHLHLNNNSIGGQIPSELSKLSTLI 208 (958)
Q Consensus 134 ~L~~L~Ls~n~l~~~~p~~l~~l~~L~-----~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~ 208 (958)
.++.|+|.+|.+.. .+..+.....|. .++++.|++. ..+..|..+++|+.|+|++|.+. .+|..+.++++|+
T Consensus 174 ~~~~l~L~~n~~~~-~~~~~l~~l~Ls~~~i~~~~~~~n~~~-~~~~~~~~l~~L~~L~Ls~n~l~-~l~~~~~~l~~L~ 250 (727)
T 4b8c_D 174 LTPKIELFANGKDE-ANQALLQHKKLSQYSIDEDDDIENRMV-MPKDSKYDDQLWHALDLSNLQIF-NISANIFKYDFLT 250 (727)
T ss_dssp --------------------------------------------------CCCCCCEEECTTSCCS-CCCGGGGGCCSCS
T ss_pred ccceEEeeCCCCCc-chhhHhhcCccCcccccCcccccccee-cChhhhccCCCCcEEECCCCCCC-CCChhhcCCCCCC
Confidence 45566666666653 333222222222 2233344444 45667777888888888888887 6666666778888
Q ss_pred hhhccCCccccCCCcccCCCCCccEEEccCCCCCCCCccccccCCCCCCEEEcccCCCCCCCCCCCCCCCcCEEeccCCc
Q 002158 209 HLLVDNNNLSGNLPPELSELPQLCILQLDNNNFSASEIPATYGNFSKLVKLSLRNCNLQGAVPDLSRIPNLYYLDLSWNH 288 (958)
Q Consensus 209 ~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~l~~l~~L~~L~Ls~N~ 288 (958)
+|+|++|+|+ .+|..|..+++|++|+|++|+|+ .+|..|+++++|+.|+|++|.|+.++..|..+++|+.|+|++|.
T Consensus 251 ~L~Ls~N~l~-~lp~~~~~l~~L~~L~Ls~N~l~--~lp~~~~~l~~L~~L~L~~N~l~~lp~~~~~l~~L~~L~L~~N~ 327 (727)
T 4b8c_D 251 RLYLNGNSLT-ELPAEIKNLSNLRVLDLSHNRLT--SLPAELGSCFQLKYFYFFDNMVTTLPWEFGNLCNLQFLGVEGNP 327 (727)
T ss_dssp CCBCTTSCCS-CCCGGGGGGTTCCEEECTTSCCS--SCCSSGGGGTTCSEEECCSSCCCCCCSSTTSCTTCCCEECTTSC
T ss_pred EEEeeCCcCc-ccChhhhCCCCCCEEeCcCCcCC--ccChhhcCCCCCCEEECCCCCCCccChhhhcCCCccEEeCCCCc
Confidence 8888888887 66777777888888888888875 56777777777777777777777665567777777777777777
Q ss_pred CCCcCCCCCCC--CCcCEEEccCCcCCCccc
Q 002158 289 LTGSIPSKKLS--ENVTTIDLSDNYLNGSIL 317 (958)
Q Consensus 289 l~~~~~~~~~~--~~L~~L~Ls~N~l~~~~~ 317 (958)
|++.+|..... ..+..|+|++|.+++.+|
T Consensus 328 l~~~~p~~~~~~~~~~~~l~l~~N~l~~~~p 358 (727)
T 4b8c_D 328 LEKQFLKILTEKSVTGLIFYLRDNRPEIPLP 358 (727)
T ss_dssp CCSHHHHHHHHHHHHHHHHHHHHCCCCCCCC
T ss_pred cCCCChHHHhhcchhhhHHhhccCcccCcCc
Confidence 76555443221 111224455555554443
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 | Back alignment and structure |
|---|
Probab=99.64 E-value=3e-16 Score=159.29 Aligned_cols=109 Identities=30% Similarity=0.420 Sum_probs=71.2
Q ss_pred CCcEEEeeCCCCCCCCCh-hhcCCCCCCEEecccccccccCccccccccccceEecccccccccCchhhcCCccchhhhc
Q 002158 134 SLIFLLLNGNKLSGSLPD-ELGYLSNLNRLQVDENNITGTIPKSFANLSRVRHLHLNNNSIGGQIPSELSKLSTLIHLLV 212 (958)
Q Consensus 134 ~L~~L~Ls~n~l~~~~p~-~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L 212 (958)
+|++|+|++|.+++..+. .+..+++|++|+|++|+|++..|..|.++++|++|+|++|+|++..+..|.++++|++|+|
T Consensus 30 ~l~~L~l~~n~i~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L 109 (192)
T 1w8a_A 30 HTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGENKIKEISNKMFLGLHQLKTLNL 109 (192)
T ss_dssp TCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSCCCCEECSSSSTTCTTCCEEEC
T ss_pred CCCEEECCCCcCCccCCccccccCCCCCEEECCCCCCCCcCHhHcCCcccCCEEECCCCcCCccCHHHhcCCCCCCEEEC
Confidence 666777777777644443 3666677777777777776666666666666777777777666666656666666666666
Q ss_pred cCCccccCCCcccCCCCCccEEEccCCCCC
Q 002158 213 DNNNLSGNLPPELSELPQLCILQLDNNNFS 242 (958)
Q Consensus 213 ~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~ 242 (958)
++|+|++..|..|..+++|++|+|++|.++
T Consensus 110 ~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~ 139 (192)
T 1w8a_A 110 YDNQISCVMPGSFEHLNSLTSLNLASNPFN 139 (192)
T ss_dssp CSSCCCEECTTSSTTCTTCCEEECTTCCBC
T ss_pred CCCcCCeeCHHHhhcCCCCCEEEeCCCCcc
Confidence 666666666666666666666666666654
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.62 E-value=1.5e-15 Score=151.94 Aligned_cols=110 Identities=25% Similarity=0.298 Sum_probs=78.8
Q ss_pred CCCcEEEeeCCCCCCCCChhhcCCCCCCEEecccccccccCccccccccccceEecccccccccCchhhcCCccchhhhc
Q 002158 133 SSLIFLLLNGNKLSGSLPDELGYLSNLNRLQVDENNITGTIPKSFANLSRVRHLHLNNNSIGGQIPSELSKLSTLIHLLV 212 (958)
Q Consensus 133 ~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L 212 (958)
++|++|+|++|.+++..+..+..+++|++|+|++|++++..+..|..+++|++|+|++|+|++..+..+..+++|++|+|
T Consensus 28 ~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l 107 (177)
T 2o6r_A 28 SSATRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQSLPDGVFDKLTKLTILYLHENKLQSLPNGVFDKLTQLKELAL 107 (177)
T ss_dssp TTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEEC
T ss_pred CCCcEEEeCCCcccEeCHHHhcCcccccEEECCCCcceEeChhHccCCCccCEEECCCCCccccCHHHhhCCcccCEEEC
Confidence 46777888888887655556677778888888888777665666677777777777777777665556677777777777
Q ss_pred cCCccccCCCcccCCCCCccEEEccCCCCC
Q 002158 213 DNNNLSGNLPPELSELPQLCILQLDNNNFS 242 (958)
Q Consensus 213 ~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~ 242 (958)
++|++++..+..+..+++|++|+|++|.++
T Consensus 108 ~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~ 137 (177)
T 2o6r_A 108 DTNQLKSVPDGIFDRLTSLQKIWLHTNPWD 137 (177)
T ss_dssp CSSCCSCCCTTTTTTCTTCCEEECCSSCBC
T ss_pred cCCcceEeCHHHhcCCcccCEEEecCCCee
Confidence 777777655555666677777777777665
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.61 E-value=2.1e-16 Score=174.85 Aligned_cols=135 Identities=16% Similarity=0.188 Sum_probs=100.4
Q ss_pred cCCCCCceeeeeCCeEEEEEEECCCcEEEEEEeccCCh--------------hcHH--------HHHHHHHHHHccCCCC
Q 002158 625 AYFSSSTQVGQGGYGKVYKGILSDNTTVAIKRAEEGSL--------------QGQN--------EFLTEIKLLSRLHHRN 682 (958)
Q Consensus 625 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~--------------~~~~--------~~~~E~~~l~~l~H~n 682 (958)
.-|.+..+||+|+||.||+|...+|+.||||+++.... .... ...+|...|.++.+.+
T Consensus 95 ~iY~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~g 174 (397)
T 4gyi_A 95 DVYSVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEG 174 (397)
T ss_dssp SCSEEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTT
T ss_pred CEEEecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcC
Confidence 34788899999999999999998999999998753210 0001 1235677777775544
Q ss_pred cc--eEEEEEEeCCeEEEEEEecCCCCHHHHhccCCCCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEec
Q 002158 683 LV--SLLGYCDEEGEQMLVYEFVPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLD 760 (958)
Q Consensus 683 iv--~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~ 760 (958)
+. ..+++ . ..+|||||++|++|.++... +....++.|++.+|.|||+.| ||||||||.|||++
T Consensus 175 v~vp~p~~~--~--~~~LVME~i~G~~L~~l~~~--------~~~~~l~~qll~~l~~lH~~g---IVHrDLKp~NILl~ 239 (397)
T 4gyi_A 175 FPVPEPIAQ--S--RHTIVMSLVDALPMRQVSSV--------PDPASLYADLIALILRLAKHG---LIHGDFNEFNILIR 239 (397)
T ss_dssp CSCCCEEEE--E--TTEEEEECCSCEEGGGCCCC--------SCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEEE
T ss_pred CCCCeeeec--c--CceEEEEecCCccHhhhccc--------HHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHEEEe
Confidence 32 23322 1 23799999999888765431 123568899999999999999 99999999999998
Q ss_pred CCCC----------eEEeeeeeec
Q 002158 761 SNLN----------AKVADFGLSR 774 (958)
Q Consensus 761 ~~~~----------~kl~DFGla~ 774 (958)
+++. +.|+||+-+.
T Consensus 240 ~dgd~~d~~~~~~~~~iID~~Q~V 263 (397)
T 4gyi_A 240 EEKDAEDPSSITLTPIIIXFPQMV 263 (397)
T ss_dssp EEECSSCTTSEEEEEEECCCTTCE
T ss_pred CCCCcccccccccceEEEEeCCcc
Confidence 8763 8999999664
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A | Back alignment and structure |
|---|
Probab=99.60 E-value=1e-15 Score=151.84 Aligned_cols=132 Identities=22% Similarity=0.290 Sum_probs=64.8
Q ss_pred CCCcEEEeeCCCCC-CCCChhhcCCCCCCEEecccccccccCccccccccccceEecccccccccCchhhcCCccchhhh
Q 002158 133 SSLIFLLLNGNKLS-GSLPDELGYLSNLNRLQVDENNITGTIPKSFANLSRVRHLHLNNNSIGGQIPSELSKLSTLIHLL 211 (958)
Q Consensus 133 ~~L~~L~Ls~n~l~-~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~ 211 (958)
++|++|+|++|.++ +.+|..+..+++|++|+|++|.+++. ..+..+++|++|+|++|.+++.+|..+.
T Consensus 24 ~~L~~L~l~~n~l~~~~i~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~N~l~~~~~~~~~--------- 92 (168)
T 2ell_A 24 AAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLISV--SNLPKLPKLKKLELSENRIFGGLDMLAE--------- 92 (168)
T ss_dssp TSCSEEECCSCBCBTTBCSSCCGGGGGCCEEEEESSCCCCC--SSCCCCSSCCEEEEESCCCCSCCCHHHH---------
T ss_pred ccCCEEECCCCCCChhhHHHHHHhCCCCCEEeCcCCCCCCh--hhhccCCCCCEEECcCCcCchHHHHHHh---------
Confidence 44555555555554 44444445555555555555555433 4444445555555555554443444444
Q ss_pred ccCCccccCCCcccCCCCCccEEEccCCCCCCCCccccccCCCCCCEEEcccCCCCCCCC----CCCCCCCcCEEeccCC
Q 002158 212 VDNNNLSGNLPPELSELPQLCILQLDNNNFSASEIPATYGNFSKLVKLSLRNCNLQGAVP----DLSRIPNLYYLDLSWN 287 (958)
Q Consensus 212 L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~p~~~~~l~~L~~L~L~~N~l~~~~~----~l~~l~~L~~L~Ls~N 287 (958)
.+++|++|+|++|+++....+..+..+++|+.|+|++|.+++.++ .+..+++|++|++++|
T Consensus 93 ---------------~l~~L~~L~Ls~N~l~~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~L~l~~n 157 (168)
T 2ell_A 93 ---------------KLPNLTHLNLSGNKLKDISTLEPLKKLECLKSLDLFNCEVTNLNDYRESVFKLLPQLTYLDGYDR 157 (168)
T ss_dssp ---------------HCTTCCEEECBSSSCCSSGGGGGGSSCSCCCEEECCSSGGGTSTTHHHHHHTTCSSCCEETTEET
T ss_pred ---------------hCCCCCEEeccCCccCcchhHHHHhcCCCCCEEEeeCCcCcchHHHHHHHHHhCccCcEecCCCC
Confidence 444444444444444321112344455555555555555554444 2455555555555555
Q ss_pred cCC
Q 002158 288 HLT 290 (958)
Q Consensus 288 ~l~ 290 (958)
.+.
T Consensus 158 ~~~ 160 (168)
T 2ell_A 158 EDQ 160 (168)
T ss_dssp TSC
T ss_pred Chh
Confidence 554
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A | Back alignment and structure |
|---|
Probab=99.59 E-value=1.2e-15 Score=151.23 Aligned_cols=134 Identities=23% Similarity=0.215 Sum_probs=114.5
Q ss_pred cCCCCcceeeccCcccC--CCCccccCCCCCcEEEeeCCCCCCCCChhhcCCCCCCEEecccccccccCccccccccccc
Q 002158 107 GQLSRLQYYFMWNDLTG--TIPKEIGNISSLIFLLLNGNKLSGSLPDELGYLSNLNRLQVDENNITGTIPKSFANLSRVR 184 (958)
Q Consensus 107 ~~L~~L~~L~l~n~~~~--~ip~~i~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~ 184 (958)
...++|+.|++++|... .+|..+..+++|++|+|++|.+++. ..+..+++|++|+|++|++++.+|..+..+++|+
T Consensus 21 ~~~~~L~~L~l~~n~l~~~~i~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~ 98 (168)
T 2ell_A 21 RTPAAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLISV--SNLPKLPKLKKLELSENRIFGGLDMLAEKLPNLT 98 (168)
T ss_dssp SCTTSCSEEECCSCBCBTTBCSSCCGGGGGCCEEEEESSCCCCC--SSCCCCSSCCEEEEESCCCCSCCCHHHHHCTTCC
T ss_pred CCcccCCEEECCCCCCChhhHHHHHHhCCCCCEEeCcCCCCCCh--hhhccCCCCCEEECcCCcCchHHHHHHhhCCCCC
Confidence 34588999999877665 8999999999999999999999965 7799999999999999999988888888899999
Q ss_pred eEecccccccccC-chhhcCCccchhhhccCCccccCCC---cccCCCCCccEEEccCCCCC
Q 002158 185 HLHLNNNSIGGQI-PSELSKLSTLIHLLVDNNNLSGNLP---PELSELPQLCILQLDNNNFS 242 (958)
Q Consensus 185 ~L~Ls~N~l~~~~-p~~l~~l~~L~~L~L~~N~l~~~~~---~~l~~l~~L~~L~L~~N~l~ 242 (958)
+|+|++|.|++.. +..+..+++|+.|++++|++++..+ ..+..+++|++|++++|.+.
T Consensus 99 ~L~Ls~N~l~~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~L~l~~n~~~ 160 (168)
T 2ell_A 99 HLNLSGNKLKDISTLEPLKKLECLKSLDLFNCEVTNLNDYRESVFKLLPQLTYLDGYDREDQ 160 (168)
T ss_dssp EEECBSSSCCSSGGGGGGSSCSCCCEEECCSSGGGTSTTHHHHHHTTCSSCCEETTEETTSC
T ss_pred EEeccCCccCcchhHHHHhcCCCCCEEEeeCCcCcchHHHHHHHHHhCccCcEecCCCCChh
Confidence 9999999999532 2678888888888888888886555 47778888888888888774
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.58 E-value=6.5e-15 Score=149.46 Aligned_cols=109 Identities=24% Similarity=0.363 Sum_probs=73.2
Q ss_pred CCCcEEEeeCCCCCCCCChhhcCCCCCCEEecccccccccCccccccccccceEecccccccccCchhhcCCccchhhhc
Q 002158 133 SSLIFLLLNGNKLSGSLPDELGYLSNLNRLQVDENNITGTIPKSFANLSRVRHLHLNNNSIGGQIPSELSKLSTLIHLLV 212 (958)
Q Consensus 133 ~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L 212 (958)
++|++|+|++|.++ .+|..|.++++|++|+|++|+|++..+..|.++++|++|+|++|+|++..+..|.++++|+.|+|
T Consensus 31 ~~l~~L~L~~n~i~-~ip~~~~~l~~L~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~~L~L 109 (193)
T 2wfh_A 31 RDVTELYLDGNQFT-LVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYNRLRCIPPRTFDGLKSLRLLSL 109 (193)
T ss_dssp TTCCEEECCSSCCC-SCCGGGGGCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEEC
T ss_pred CCCCEEECCCCcCc-hhHHHhhcccCCCEEECCCCcCCEeCHhHccCCCCCCEEECCCCccCEeCHHHhCCCCCCCEEEC
Confidence 35677777777776 56666777777777777777777666666667777777777777776665666666666666666
Q ss_pred cCCccccCCCcccCCCCCccEEEccCCCCC
Q 002158 213 DNNNLSGNLPPELSELPQLCILQLDNNNFS 242 (958)
Q Consensus 213 ~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~ 242 (958)
++|+|+...+..|..+++|+.|+|++|.+.
T Consensus 110 ~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~ 139 (193)
T 2wfh_A 110 HGNDISVVPEGAFNDLSALSHLAIGANPLY 139 (193)
T ss_dssp CSSCCCBCCTTTTTTCTTCCEEECCSSCEE
T ss_pred CCCCCCeeChhhhhcCccccEEEeCCCCee
Confidence 666666555555666666666666666654
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A | Back alignment and structure |
|---|
Probab=99.54 E-value=1.5e-15 Score=147.34 Aligned_cols=108 Identities=22% Similarity=0.302 Sum_probs=62.9
Q ss_pred CCCcEEEeeCCCCC-CCCChhhcCCCCCCEEecccccccccCccccccccccceEecccccccccCchhhcCCccchhhh
Q 002158 133 SSLIFLLLNGNKLS-GSLPDELGYLSNLNRLQVDENNITGTIPKSFANLSRVRHLHLNNNSIGGQIPSELSKLSTLIHLL 211 (958)
Q Consensus 133 ~~L~~L~Ls~n~l~-~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~ 211 (958)
++|+.|++++|.++ +.+|..+..+++|++|++++|++++. ..+..+++|++|+|++|.+++.+|..+..+++|++|+
T Consensus 17 ~~l~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~ 94 (149)
T 2je0_A 17 SDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLTSI--ANLPKLNKLKKLELSDNRVSGGLEVLAEKCPNLTHLN 94 (149)
T ss_dssp GGCSEEECTTCBCBTTBCCSCCTTCTTCCEEECTTSCCCCC--TTCCCCTTCCEEECCSSCCCSCTHHHHHHCTTCCEEE
T ss_pred ccCeEEEccCCcCChhHHHHHHhhcCCCcEEECcCCCCCCc--hhhhcCCCCCEEECCCCcccchHHHHhhhCCCCCEEE
Confidence 45666666666666 55666666666666666666666644 5566666666666666666654555555555555555
Q ss_pred ccCCccccC-CCcccCCCCCccEEEccCCCCC
Q 002158 212 VDNNNLSGN-LPPELSELPQLCILQLDNNNFS 242 (958)
Q Consensus 212 L~~N~l~~~-~~~~l~~l~~L~~L~L~~N~l~ 242 (958)
+++|++++. .+..+..+++|++|++++|+++
T Consensus 95 ls~N~i~~~~~~~~~~~l~~L~~L~l~~N~l~ 126 (149)
T 2je0_A 95 LSGNKIKDLSTIEPLKKLENLKSLDLFNCEVT 126 (149)
T ss_dssp CTTSCCCSHHHHGGGGGCTTCCEEECTTCGGG
T ss_pred CCCCcCCChHHHHHHhhCCCCCEEeCcCCccc
Confidence 555555532 1244455555555555555543
|
| >3sb4_A Hypothetical leucine rich repeat protein; LRR, right-handed beta-alpha superhelix, leucine-rich repeat structural genomics; HET: MSE PG4; 1.99A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=99.53 E-value=4.9e-15 Score=164.02 Aligned_cols=90 Identities=14% Similarity=0.203 Sum_probs=72.2
Q ss_pred CCCCCEEEcccCCCCCCCCC-CCCCCCcCEEeccCCcCCCcCCCC--CCCCCcC-EEEccCCcCCCccchhccCCCCCCe
Q 002158 253 FSKLVKLSLRNCNLQGAVPD-LSRIPNLYYLDLSWNHLTGSIPSK--KLSENVT-TIDLSDNYLNGSILESISNLPFLQT 328 (958)
Q Consensus 253 l~~L~~L~L~~N~l~~~~~~-l~~l~~L~~L~Ls~N~l~~~~~~~--~~~~~L~-~L~Ls~N~l~~~~~~~~~~l~~L~~ 328 (958)
+++|+.|+|++|+++.++.. |.++++|+.|+|.+| ++ .++.. ..+.+|+ .|+|.+ .++.+.+.+|.++++|+.
T Consensus 225 ~~~L~~l~L~~n~i~~I~~~aF~~~~~L~~l~l~~n-i~-~I~~~aF~~~~~L~~~l~l~~-~l~~I~~~aF~~c~~L~~ 301 (329)
T 3sb4_A 225 MPNLVSLDISKTNATTIPDFTFAQKKYLLKIKLPHN-LK-TIGQRVFSNCGRLAGTLELPA-SVTAIEFGAFMGCDNLRY 301 (329)
T ss_dssp CTTCCEEECTTBCCCEECTTTTTTCTTCCEEECCTT-CC-EECTTTTTTCTTCCEEEEECT-TCCEECTTTTTTCTTEEE
T ss_pred cCCCeEEECCCCCcceecHhhhhCCCCCCEEECCcc-cc-eehHHHhhCChhccEEEEEcc-cceEEchhhhhCCccCCE
Confidence 68899999999988887774 888999999999988 65 45544 3457898 999988 788888899999999999
Q ss_pred EeeecccCCCccchhhhc
Q 002158 329 LSLENNFLTGSIPATIWQ 346 (958)
Q Consensus 329 L~L~~N~l~~~ip~~l~~ 346 (958)
|++++|.++ .++...|.
T Consensus 302 l~l~~n~i~-~I~~~aF~ 318 (329)
T 3sb4_A 302 VLATGDKIT-TLGDELFG 318 (329)
T ss_dssp EEECSSCCC-EECTTTTC
T ss_pred EEeCCCccC-ccchhhhc
Confidence 999999998 55554443
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.52 E-value=4.4e-14 Score=141.20 Aligned_cols=132 Identities=23% Similarity=0.310 Sum_probs=74.2
Q ss_pred CcEEEeeCCCCCCCCChhhcCCCCCCEEecccccccccCccccccccccceEecccccccccCchhhcCCccchhhhccC
Q 002158 135 LIFLLLNGNKLSGSLPDELGYLSNLNRLQVDENNITGTIPKSFANLSRVRHLHLNNNSIGGQIPSELSKLSTLIHLLVDN 214 (958)
Q Consensus 135 L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~ 214 (958)
.+.+++++|+++ .+|..+. ++|++|++++|++++..+..|..+++|++|+|++|+|++..+..|..+++|++|+|++
T Consensus 9 ~~~l~~~~~~l~-~~p~~~~--~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~ 85 (177)
T 2o6r_A 9 GTEIRCNSKGLT-SVPTGIP--SSATRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQSLPDGVFDKLTKLTILYLHE 85 (177)
T ss_dssp TTEEECCSSCCS-SCCTTCC--TTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCS
T ss_pred CCEEEecCCCCc-cCCCCCC--CCCcEEEeCCCcccEeCHHHhcCcccccEEECCCCcceEeChhHccCCCccCEEECCC
Confidence 456677777766 4554332 4666666666666654444555556666666666655544444444444444444444
Q ss_pred CccccCCCcccCCCCCccEEEccCCCCCCCCccccccCCCCCCEEEcccCCCCCCCCC-CCCCCCcCEEeccCCcCCCcC
Q 002158 215 NNLSGNLPPELSELPQLCILQLDNNNFSASEIPATYGNFSKLVKLSLRNCNLQGAVPD-LSRIPNLYYLDLSWNHLTGSI 293 (958)
Q Consensus 215 N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~-l~~l~~L~~L~Ls~N~l~~~~ 293 (958)
|+|++..+. .+..+++|+.|+|++|++++.++. +..+++|++|+|++|.+.+..
T Consensus 86 N~l~~~~~~-------------------------~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~ 140 (177)
T 2o6r_A 86 NKLQSLPNG-------------------------VFDKLTQLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSC 140 (177)
T ss_dssp SCCCCCCTT-------------------------TTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCH
T ss_pred CCccccCHH-------------------------HhhCCcccCEEECcCCcceEeCHHHhcCCcccCEEEecCCCeeccC
Confidence 444443333 345555555555555555555554 456677777777777766544
Q ss_pred C
Q 002158 294 P 294 (958)
Q Consensus 294 ~ 294 (958)
+
T Consensus 141 ~ 141 (177)
T 2o6r_A 141 P 141 (177)
T ss_dssp H
T ss_pred c
Confidence 3
|
| >3sb4_A Hypothetical leucine rich repeat protein; LRR, right-handed beta-alpha superhelix, leucine-rich repeat structural genomics; HET: MSE PG4; 1.99A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=99.52 E-value=5.1e-15 Score=163.89 Aligned_cols=259 Identities=15% Similarity=0.108 Sum_probs=168.6
Q ss_pred CCCcceeeccCcccCCCCccccC-CCCCcEEEeeCCCCC--CCCChhhcCCCCCCEEecccccccccCcccccc------
Q 002158 109 LSRLQYYFMWNDLTGTIPKEIGN-ISSLIFLLLNGNKLS--GSLPDELGYLSNLNRLQVDENNITGTIPKSFAN------ 179 (958)
Q Consensus 109 L~~L~~L~l~n~~~~~ip~~i~~-l~~L~~L~Ls~n~l~--~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~------ 179 (958)
+.+|+.|.+.+++...--..+.. +++|++|||++|++. ...+. .++.++.+.+..|.|. ...|.+
T Consensus 24 ~~~l~~L~l~g~i~~~~~~~l~~~l~~L~~LdLs~n~i~~~~~~~~---~~~~~~~~~~~~~~I~---~~aF~~~~~~~~ 97 (329)
T 3sb4_A 24 ANSITHLTLTGKLNAEDFRHLRDEFPSLKVLDISNAEIKMYSGKAG---TYPNGKFYIYMANFVP---AYAFSNVVNGVT 97 (329)
T ss_dssp HHHCSEEEEEEEECHHHHHHHHHSCTTCCEEEEEEEEECCEEESSS---SSGGGCCEEECTTEEC---TTTTEEEETTEE
T ss_pred hCceeEEEEeccccHHHHHHHHHhhccCeEEecCcceeEEecCccc---cccccccccccccccC---HHHhcccccccc
Confidence 56677776665443222223333 778888888888887 11111 1222444555555332 345556
Q ss_pred --ccccceEecccccccccCchhhcCCccchhhhccCCccccCCCcccCCCCCccEEEccCCCC--CC-CCccccccCCC
Q 002158 180 --LSRVRHLHLNNNSIGGQIPSELSKLSTLIHLLVDNNNLSGNLPPELSELPQLCILQLDNNNF--SA-SEIPATYGNFS 254 (958)
Q Consensus 180 --l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l--~~-~~~p~~~~~l~ 254 (958)
+++|+.|+|.+ .++...+.+|.++++|+.|++.+|.+..+.+.+|.++.++..+.+..+.. .. ..-...|.++.
T Consensus 98 ~g~~~L~~l~L~~-~i~~I~~~aF~~~~~L~~l~l~~n~i~~i~~~aF~~~~~l~~l~~~~~~~~~~~~~i~~~~f~~~~ 176 (329)
T 3sb4_A 98 KGKQTLEKVILSE-KIKNIEDAAFKGCDNLKICQIRKKTAPNLLPEALADSVTAIFIPLGSSDAYRFKNRWEHFAFIEGE 176 (329)
T ss_dssp EECTTCCC-CBCT-TCCEECTTTTTTCTTCCEEEBCCSSCCEECTTSSCTTTCEEEECTTCTHHHHTSTTTTTSCEEESC
T ss_pred cccCCCcEEECCc-cccchhHHHhhcCcccceEEcCCCCccccchhhhcCCCceEEecCcchhhhhcccccccccccccc
Confidence 78888888887 77766667788888888888888887777777787777777776655221 00 01122344444
Q ss_pred CCC--------------------------EEEcccCCCCCCCCCC-CCCCCcCEEeccCCcCCCcCCCC--CCCCCcCEE
Q 002158 255 KLV--------------------------KLSLRNCNLQGAVPDL-SRIPNLYYLDLSWNHLTGSIPSK--KLSENVTTI 305 (958)
Q Consensus 255 ~L~--------------------------~L~L~~N~l~~~~~~l-~~l~~L~~L~Ls~N~l~~~~~~~--~~~~~L~~L 305 (958)
.|+ .+.+.++-.......+ ..+++|+.|+|++|+++ .++.. ..+.+|+.|
T Consensus 177 ~L~~~i~~~~~~~l~~~~~~~~~~~~~~~~l~~~~~l~~~~~~~l~~~~~~L~~l~L~~n~i~-~I~~~aF~~~~~L~~l 255 (329)
T 3sb4_A 177 PLETTIQVGAMGKLEDEIMKAGLQPRDINFLTIEGKLDNADFKLIRDYMPNLVSLDISKTNAT-TIPDFTFAQKKYLLKI 255 (329)
T ss_dssp CCEEEEEECTTCCHHHHHHHTTCCGGGCSEEEEEECCCHHHHHHHHHHCTTCCEEECTTBCCC-EECTTTTTTCTTCCEE
T ss_pred ccceeEEecCCCcHHHHHhhcccCccccceEEEeeeecHHHHHHHHHhcCCCeEEECCCCCcc-eecHhhhhCCCCCCEE
Confidence 444 3333222100000001 13789999999999998 55554 445899999
Q ss_pred EccCCcCCCccchhccCCCCCC-eEeeecccCCCccchhhhcccccCccccceEeccCCCCCCCccCC--CCCCcceEEe
Q 002158 306 DLSDNYLNGSILESISNLPFLQ-TLSLENNFLTGSIPATIWQNKSFSTKARLKIDLRNNSFSNIVGDL--TLPNNVTLRL 382 (958)
Q Consensus 306 ~Ls~N~l~~~~~~~~~~l~~L~-~L~L~~N~l~~~ip~~l~~~~~~~~~~l~~L~Ls~N~l~~l~~~~--~l~~L~~L~l 382 (958)
+|.+| ++.+...+|.++++|+ .|+|.+ .++ .|+...|.. ...|+.|+++.|+++.++... ++++|+.|+.
T Consensus 256 ~l~~n-i~~I~~~aF~~~~~L~~~l~l~~-~l~-~I~~~aF~~----c~~L~~l~l~~n~i~~I~~~aF~~~~~L~~ly~ 328 (329)
T 3sb4_A 256 KLPHN-LKTIGQRVFSNCGRLAGTLELPA-SVT-AIEFGAFMG----CDNLRYVLATGDKITTLGDELFGNGVPSKLIYK 328 (329)
T ss_dssp ECCTT-CCEECTTTTTTCTTCCEEEEECT-TCC-EECTTTTTT----CTTEEEEEECSSCCCEECTTTTCTTCCCCEEEC
T ss_pred ECCcc-cceehHHHhhCChhccEEEEEcc-cce-EEchhhhhC----CccCCEEEeCCCccCccchhhhcCCcchhhhcc
Confidence 99998 8889999999999999 999999 777 555544432 346779999999999999876 8889998875
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A | Back alignment and structure |
|---|
Probab=99.51 E-value=2e-14 Score=139.35 Aligned_cols=112 Identities=23% Similarity=0.254 Sum_probs=55.2
Q ss_pred CCCccccCCCCCcEEEeeCCCCCCCCChhhcCCCCCCEEecccccccccCccccccccccceEeccccccccc-Cchhhc
Q 002158 124 TIPKEIGNISSLIFLLLNGNKLSGSLPDELGYLSNLNRLQVDENNITGTIPKSFANLSRVRHLHLNNNSIGGQ-IPSELS 202 (958)
Q Consensus 124 ~ip~~i~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~-~p~~l~ 202 (958)
.+|..+..+++|++|+|++|.+++. ..++.+++|++|+|++|++++.+|..+..+++|++|++++|.+++. .+..+.
T Consensus 33 ~~~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~ls~N~i~~~~~~~~~~ 110 (149)
T 2je0_A 33 KLEGLTDEFEELEFLSTINVGLTSI--ANLPKLNKLKKLELSDNRVSGGLEVLAEKCPNLTHLNLSGNKIKDLSTIEPLK 110 (149)
T ss_dssp BCCSCCTTCTTCCEEECTTSCCCCC--TTCCCCTTCCEEECCSSCCCSCTHHHHHHCTTCCEEECTTSCCCSHHHHGGGG
T ss_pred HHHHHHhhcCCCcEEECcCCCCCCc--hhhhcCCCCCEEECCCCcccchHHHHhhhCCCCCEEECCCCcCCChHHHHHHh
Confidence 3444444445555555555555433 3444555555555555555544444444455555555555555532 224455
Q ss_pred CCccchhhhccCCccccCCC---cccCCCCCccEEEcc
Q 002158 203 KLSTLIHLLVDNNNLSGNLP---PELSELPQLCILQLD 237 (958)
Q Consensus 203 ~l~~L~~L~L~~N~l~~~~~---~~l~~l~~L~~L~L~ 237 (958)
.+++|++|++++|++++..+ ..+..+++|+.|+++
T Consensus 111 ~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~L~l~ 148 (149)
T 2je0_A 111 KLENLKSLDLFNCEVTNLNDYRENVFKLLPQLTYLDGY 148 (149)
T ss_dssp GCTTCCEEECTTCGGGGSTTHHHHHHHHCTTCCEETTB
T ss_pred hCCCCCEEeCcCCcccchHHHHHHHHHHCCCcccccCC
Confidence 55555555555555554433 345555555555554
|
| >4fdw_A Leucine rich hypothetical protein; putative cell surface protein, BIG3 domain, LRR domain, STRU genomics; 2.05A {Bacteroides ovatus} PDB: 4fd0_A | Back alignment and structure |
|---|
Probab=99.46 E-value=1.8e-12 Score=146.83 Aligned_cols=261 Identities=11% Similarity=0.123 Sum_probs=192.5
Q ss_pred CCCcceeeccCcccCCCCccccCCCCCcEEEeeCCCCCCCCChhhcCCCCCCEEecccccccccCccccccccccceEec
Q 002158 109 LSRLQYYFMWNDLTGTIPKEIGNISSLIFLLLNGNKLSGSLPDELGYLSNLNRLQVDENNITGTIPKSFANLSRVRHLHL 188 (958)
Q Consensus 109 L~~L~~L~l~n~~~~~ip~~i~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L 188 (958)
...++.+.+.++....-..+|.+. +|+.+.|..| ++..-..+|.+ .+|+.+.|.+ .++.+....|.++++|+.++|
T Consensus 112 ~~~l~~i~ip~~i~~I~~~aF~~~-~L~~i~l~~~-i~~I~~~aF~~-~~L~~i~lp~-~l~~I~~~aF~~c~~L~~l~l 187 (401)
T 4fdw_A 112 LKGYNEIILPNSVKSIPKDAFRNS-QIAKVVLNEG-LKSIGDMAFFN-STVQEIVFPS-TLEQLKEDIFYYCYNLKKADL 187 (401)
T ss_dssp CSSCSEEECCTTCCEECTTTTTTC-CCSEEECCTT-CCEECTTTTTT-CCCCEEECCT-TCCEECSSTTTTCTTCCEEEC
T ss_pred cCCccEEEECCccCEehHhhcccC-CccEEEeCCC-ccEECHHhcCC-CCceEEEeCC-CccEehHHHhhCcccCCeeec
Confidence 356667777666665555667775 7999998876 66455566777 4799999986 677677788999999999999
Q ss_pred ccccccccCchhhcCCccchhhhccCCccccCCCcccCCCCCccEEEccCCCCCCCCccccccCCCCCCEEEcccCCCCC
Q 002158 189 NNNSIGGQIPSELSKLSTLIHLLVDNNNLSGNLPPELSELPQLCILQLDNNNFSASEIPATYGNFSKLVKLSLRNCNLQG 268 (958)
Q Consensus 189 s~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~p~~~~~l~~L~~L~L~~N~l~~ 268 (958)
++|+++.....+|. ..+|+.+.|.++ ++.+...+|.++++|+.++|.+| ++ ..-...|.+ .+|+.+.| .+.++.
T Consensus 188 ~~n~l~~I~~~aF~-~~~L~~l~lp~~-l~~I~~~aF~~~~~L~~l~l~~~-l~-~I~~~aF~~-~~L~~i~l-p~~i~~ 261 (401)
T 4fdw_A 188 SKTKITKLPASTFV-YAGIEEVLLPVT-LKEIGSQAFLKTSQLKTIEIPEN-VS-TIGQEAFRE-SGITTVKL-PNGVTN 261 (401)
T ss_dssp TTSCCSEECTTTTT-TCCCSEEECCTT-CCEECTTTTTTCTTCCCEECCTT-CC-EECTTTTTT-CCCSEEEE-ETTCCE
T ss_pred CCCcceEechhhEe-ecccCEEEeCCc-hheehhhHhhCCCCCCEEecCCC-cc-Ccccccccc-CCccEEEe-CCCccE
Confidence 99999966566666 589999999854 77777889999999999999875 43 122446666 78999999 456776
Q ss_pred CCC-CCCCCCCcCEEeccCCcCCC----cCCCC--CCCCCcCEEEccCCcCCCccchhccCCCCCCeEeeecccCCCccc
Q 002158 269 AVP-DLSRIPNLYYLDLSWNHLTG----SIPSK--KLSENVTTIDLSDNYLNGSILESISNLPFLQTLSLENNFLTGSIP 341 (958)
Q Consensus 269 ~~~-~l~~l~~L~~L~Ls~N~l~~----~~~~~--~~~~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~ip 341 (958)
+.. .|.++++|+.+++.+|.+.. .++.. ..+.+|+.++|. |.++.+...+|.++++|+.|.|..| ++ .|+
T Consensus 262 I~~~aF~~c~~L~~l~l~~~~~~~~~~~~I~~~aF~~c~~L~~l~l~-~~i~~I~~~aF~~c~~L~~l~lp~~-l~-~I~ 338 (401)
T 4fdw_A 262 IASRAFYYCPELAEVTTYGSTFNDDPEAMIHPYCLEGCPKLARFEIP-ESIRILGQGLLGGNRKVTQLTIPAN-VT-QIN 338 (401)
T ss_dssp ECTTTTTTCTTCCEEEEESSCCCCCTTCEECTTTTTTCTTCCEECCC-TTCCEECTTTTTTCCSCCEEEECTT-CC-EEC
T ss_pred EChhHhhCCCCCCEEEeCCccccCCcccEECHHHhhCCccCCeEEeC-CceEEEhhhhhcCCCCccEEEECcc-cc-EEc
Confidence 665 48999999999999887751 23333 445789999998 5588888889999999999999655 55 455
Q ss_pred hhhhcccccCccccceEeccCCCCCCCccCC--CCC-CcceEEeCCCCC
Q 002158 342 ATIWQNKSFSTKARLKIDLRNNSFSNIVGDL--TLP-NNVTLRLGGNPI 387 (958)
Q Consensus 342 ~~l~~~~~~~~~~l~~L~Ls~N~l~~l~~~~--~l~-~L~~L~l~~N~l 387 (958)
...|.. ..|+.|++++|.+..+.... +++ +++.|++..|.+
T Consensus 339 ~~aF~~-----~~L~~l~l~~n~~~~l~~~~F~~~~~~l~~l~vp~~~~ 382 (401)
T 4fdw_A 339 FSAFNN-----TGIKEVKVEGTTPPQVFEKVWYGFPDDITVIRVPAESV 382 (401)
T ss_dssp TTSSSS-----SCCCEEEECCSSCCBCCCSSCCCSCTTCCEEEECGGGH
T ss_pred HHhCCC-----CCCCEEEEcCCCCcccccccccCCCCCccEEEeCHHHH
Confidence 544432 25668888888888876654 443 567777766654
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 | Back alignment and structure |
|---|
Probab=99.45 E-value=4.6e-14 Score=140.95 Aligned_cols=109 Identities=27% Similarity=0.300 Sum_probs=62.9
Q ss_pred ccCCCCCcEEEeeCCCCCCCCChhhcCCC-CCCEEecccccccccCccccccccccceEecccccccccCchhhcCCccc
Q 002158 129 IGNISSLIFLLLNGNKLSGSLPDELGYLS-NLNRLQVDENNITGTIPKSFANLSRVRHLHLNNNSIGGQIPSELSKLSTL 207 (958)
Q Consensus 129 i~~l~~L~~L~Ls~n~l~~~~p~~l~~l~-~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L 207 (958)
+.++.+|++|+|++|.++ .+|. +..+. +|++|+|++|++++. ..|..+++|++|+|++|.|++..+..+..+++|
T Consensus 15 ~~~~~~L~~L~l~~n~l~-~i~~-~~~~~~~L~~L~Ls~N~l~~~--~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L 90 (176)
T 1a9n_A 15 YTNAVRDRELDLRGYKIP-VIEN-LGATLDQFDAIDFSDNEIRKL--DGFPLLRRLKTLLVNNNRICRIGEGLDQALPDL 90 (176)
T ss_dssp EECTTSCEEEECTTSCCC-SCCC-GGGGTTCCSEEECCSSCCCEE--CCCCCCSSCCEEECCSSCCCEECSCHHHHCTTC
T ss_pred cCCcCCceEEEeeCCCCc-hhHH-hhhcCCCCCEEECCCCCCCcc--cccccCCCCCEEECCCCcccccCcchhhcCCCC
Confidence 455667777777777776 3443 44333 677777777776643 456666666666666666664443444555555
Q ss_pred hhhhccCCccccCCCc--ccCCCCCccEEEccCCCCC
Q 002158 208 IHLLVDNNNLSGNLPP--ELSELPQLCILQLDNNNFS 242 (958)
Q Consensus 208 ~~L~L~~N~l~~~~~~--~l~~l~~L~~L~L~~N~l~ 242 (958)
++|+|++|+|+. +|. .+..+++|+.|++++|.++
T Consensus 91 ~~L~L~~N~i~~-~~~~~~l~~l~~L~~L~l~~N~i~ 126 (176)
T 1a9n_A 91 TELILTNNSLVE-LGDLDPLASLKSLTYLCILRNPVT 126 (176)
T ss_dssp CEEECCSCCCCC-GGGGGGGGGCTTCCEEECCSSGGG
T ss_pred CEEECCCCcCCc-chhhHhhhcCCCCCEEEecCCCCC
Confidence 555555555542 232 4445555555555555553
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A | Back alignment and structure |
|---|
Probab=99.45 E-value=2.3e-16 Score=161.09 Aligned_cols=132 Identities=25% Similarity=0.312 Sum_probs=72.8
Q ss_pred CCCcEEEeeCCCCCCCCCh------hhcCCCCCCEEecccccccccCccccccccccceEecccccccccCchhhcCCcc
Q 002158 133 SSLIFLLLNGNKLSGSLPD------ELGYLSNLNRLQVDENNITGTIPKSFANLSRVRHLHLNNNSIGGQIPSELSKLST 206 (958)
Q Consensus 133 ~~L~~L~Ls~n~l~~~~p~------~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~ 206 (958)
..++.++++.+.++|.+|. .+..+++|++|+|++|++++ +| .+.++++|++|+|++|.++ .+|..+..+++
T Consensus 18 ~~l~~l~l~~~~l~~~~~~l~~l~~~~~~l~~L~~L~ls~n~l~~-l~-~~~~l~~L~~L~l~~n~l~-~l~~~~~~~~~ 94 (198)
T 1ds9_A 18 KSVVATEAEKVELHGMIPPIEKMDATLSTLKACKHLALSTNNIEK-IS-SLSGMENLRILSLGRNLIK-KIENLDAVADT 94 (198)
T ss_dssp TCCCCTTCSEEECCBCCTTCCCCHHHHHHTTTCSEEECSEEEESC-CC-CHHHHTTCCEEEEEEEEEC-SCSSHHHHHHH
T ss_pred ccccCcchheeEeccccCcHhhhhHHHhcCCCCCEEECCCCCCcc-cc-ccccCCCCCEEECCCCCcc-cccchhhcCCc
Confidence 3444444444444444443 56666666666666666664 44 5666666666666666666 45555555566
Q ss_pred chhhhccCCccccCCCcccCCCCCccEEEccCCCCCCCCccccccCCCCCCEEEcccCCCCCC
Q 002158 207 LIHLLVDNNNLSGNLPPELSELPQLCILQLDNNNFSASEIPATYGNFSKLVKLSLRNCNLQGA 269 (958)
Q Consensus 207 L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~p~~~~~l~~L~~L~L~~N~l~~~ 269 (958)
|+.|+|++|++++ +| .+..+++|++|+|++|+++.......+..+++|+.|++++|.+++.
T Consensus 95 L~~L~L~~N~l~~-l~-~~~~l~~L~~L~l~~N~i~~~~~~~~l~~l~~L~~L~l~~N~l~~~ 155 (198)
T 1ds9_A 95 LEELWISYNQIAS-LS-GIEKLVNLRVLYMSNNKITNWGEIDKLAALDKLEDLLLAGNPLYND 155 (198)
T ss_dssp CSEEEEEEEECCC-HH-HHHHHHHSSEEEESEEECCCHHHHHHHTTTTTCSEEEECSCHHHHH
T ss_pred CCEEECcCCcCCc-CC-ccccCCCCCEEECCCCcCCchhHHHHHhcCCCCCEEEecCCccccc
Confidence 6666666666654 22 4555556666666666654211112455555555555555555444
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 | Back alignment and structure |
|---|
Probab=99.42 E-value=9.1e-14 Score=138.79 Aligned_cols=134 Identities=19% Similarity=0.206 Sum_probs=101.8
Q ss_pred ccccCCCCcceeeccCcccCCCCccccCCC-CCcEEEeeCCCCCCCCChhhcCCCCCCEEecccccccccCccccccccc
Q 002158 104 PELGQLSRLQYYFMWNDLTGTIPKEIGNIS-SLIFLLLNGNKLSGSLPDELGYLSNLNRLQVDENNITGTIPKSFANLSR 182 (958)
Q Consensus 104 ~~l~~L~~L~~L~l~n~~~~~ip~~i~~l~-~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~ 182 (958)
+.+.+..+|+.|++++|....+|. +..+. +|++|+|++|.+++. ..+..+++|++|+|++|+|++..+..|..+++
T Consensus 13 ~~~~~~~~L~~L~l~~n~l~~i~~-~~~~~~~L~~L~Ls~N~l~~~--~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~ 89 (176)
T 1a9n_A 13 AQYTNAVRDRELDLRGYKIPVIEN-LGATLDQFDAIDFSDNEIRKL--DGFPLLRRLKTLLVNNNRICRIGEGLDQALPD 89 (176)
T ss_dssp CEEECTTSCEEEECTTSCCCSCCC-GGGGTTCCSEEECCSSCCCEE--CCCCCCSSCCEEECCSSCCCEECSCHHHHCTT
T ss_pred HhcCCcCCceEEEeeCCCCchhHH-hhhcCCCCCEEECCCCCCCcc--cccccCCCCCEEECCCCcccccCcchhhcCCC
Confidence 345567777888777766666654 44444 888888888888854 56888888888888888888654455688888
Q ss_pred cceEecccccccccCch--hhcCCccchhhhccCCccccCCCc----ccCCCCCccEEEccCCCCC
Q 002158 183 VRHLHLNNNSIGGQIPS--ELSKLSTLIHLLVDNNNLSGNLPP----ELSELPQLCILQLDNNNFS 242 (958)
Q Consensus 183 L~~L~Ls~N~l~~~~p~--~l~~l~~L~~L~L~~N~l~~~~~~----~l~~l~~L~~L~L~~N~l~ 242 (958)
|++|+|++|.|+ .+|. .+..+++|+.|++++|.++. .|. .+..+++|+.|++++|.+.
T Consensus 90 L~~L~L~~N~i~-~~~~~~~l~~l~~L~~L~l~~N~i~~-~~~~~~~~~~~l~~L~~Ld~~~n~~~ 153 (176)
T 1a9n_A 90 LTELILTNNSLV-ELGDLDPLASLKSLTYLCILRNPVTN-KKHYRLYVIYKVPQVRVLDFQKVKLK 153 (176)
T ss_dssp CCEEECCSCCCC-CGGGGGGGGGCTTCCEEECCSSGGGG-STTHHHHHHHHCTTCSEETTEECCHH
T ss_pred CCEEECCCCcCC-cchhhHhhhcCCCCCEEEecCCCCCC-cHhHHHHHHHHCCccceeCCCcCCHH
Confidence 888888888886 4555 78888888888888888874 444 3778888888888888764
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A | Back alignment and structure |
|---|
Probab=99.42 E-value=1.2e-15 Score=155.71 Aligned_cols=110 Identities=24% Similarity=0.288 Sum_probs=60.3
Q ss_pred cccCCCCCcEEEeeCCCCCCCCChhhcCCCCCCEEecccccccccCccccccccccceEecccccccccCchhhcCCccc
Q 002158 128 EIGNISSLIFLLLNGNKLSGSLPDELGYLSNLNRLQVDENNITGTIPKSFANLSRVRHLHLNNNSIGGQIPSELSKLSTL 207 (958)
Q Consensus 128 ~i~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L 207 (958)
.+.++++|++|+|++|.+++ +| .+..+++|++|++++|+++ .+|..+..+++|++|+|++|++++ +| .+..+++|
T Consensus 43 ~~~~l~~L~~L~ls~n~l~~-l~-~~~~l~~L~~L~l~~n~l~-~l~~~~~~~~~L~~L~L~~N~l~~-l~-~~~~l~~L 117 (198)
T 1ds9_A 43 TLSTLKACKHLALSTNNIEK-IS-SLSGMENLRILSLGRNLIK-KIENLDAVADTLEELWISYNQIAS-LS-GIEKLVNL 117 (198)
T ss_dssp HHHHTTTCSEEECSEEEESC-CC-CHHHHTTCCEEEEEEEEEC-SCSSHHHHHHHCSEEEEEEEECCC-HH-HHHHHHHS
T ss_pred HHhcCCCCCEEECCCCCCcc-cc-ccccCCCCCEEECCCCCcc-cccchhhcCCcCCEEECcCCcCCc-CC-ccccCCCC
Confidence 55555555555555555553 44 5555555555555555555 445455555555556665555553 23 35555555
Q ss_pred hhhhccCCccccCCC-cccCCCCCccEEEccCCCCC
Q 002158 208 IHLLVDNNNLSGNLP-PELSELPQLCILQLDNNNFS 242 (958)
Q Consensus 208 ~~L~L~~N~l~~~~~-~~l~~l~~L~~L~L~~N~l~ 242 (958)
+.|++++|++++..+ ..+..+++|++|++++|.++
T Consensus 118 ~~L~l~~N~i~~~~~~~~l~~l~~L~~L~l~~N~l~ 153 (198)
T 1ds9_A 118 RVLYMSNNKITNWGEIDKLAALDKLEDLLLAGNPLY 153 (198)
T ss_dssp SEEEESEEECCCHHHHHHHTTTTTCSEEEECSCHHH
T ss_pred CEEECCCCcCCchhHHHHHhcCCCCCEEEecCCccc
Confidence 566666655553221 34555666666666666554
|
| >4fdw_A Leucine rich hypothetical protein; putative cell surface protein, BIG3 domain, LRR domain, STRU genomics; 2.05A {Bacteroides ovatus} PDB: 4fd0_A | Back alignment and structure |
|---|
Probab=99.42 E-value=1.8e-12 Score=146.71 Aligned_cols=256 Identities=13% Similarity=0.146 Sum_probs=194.8
Q ss_pred cCCCCccccccCCCCcceeeccCcccCCCCccccCCCCCcEEEeeCCCCCCCCChhhcCCCCCCEEecccccccccCccc
Q 002158 97 NLSGNLAPELGQLSRLQYYFMWNDLTGTIPKEIGNISSLIFLLLNGNKLSGSLPDELGYLSNLNRLQVDENNITGTIPKS 176 (958)
Q Consensus 97 ~l~~~~~~~l~~L~~L~~L~l~n~~~~~ip~~i~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~ 176 (958)
+++..-...|.+ .+|+.+.+.+++...-..+|.+. +|+.+.|.+ .++..-+.+|.++++|+.++|.+|+++......
T Consensus 123 ~i~~I~~~aF~~-~~L~~i~l~~~i~~I~~~aF~~~-~L~~i~lp~-~l~~I~~~aF~~c~~L~~l~l~~n~l~~I~~~a 199 (401)
T 4fdw_A 123 SVKSIPKDAFRN-SQIAKVVLNEGLKSIGDMAFFNS-TVQEIVFPS-TLEQLKEDIFYYCYNLKKADLSKTKITKLPAST 199 (401)
T ss_dssp TCCEECTTTTTT-CCCSEEECCTTCCEECTTTTTTC-CCCEEECCT-TCCEECSSTTTTCTTCCEEECTTSCCSEECTTT
T ss_pred ccCEehHhhccc-CCccEEEeCCCccEECHHhcCCC-CceEEEeCC-CccEehHHHhhCcccCCeeecCCCcceEechhh
Confidence 344444556666 47999988887655555667774 799999986 677566678999999999999999999655566
Q ss_pred cccccccceEecccccccccCchhhcCCccchhhhccCCccccCCCcccCCCCCccEEEccCCCCCCCCccccccCCCCC
Q 002158 177 FANLSRVRHLHLNNNSIGGQIPSELSKLSTLIHLLVDNNNLSGNLPPELSELPQLCILQLDNNNFSASEIPATYGNFSKL 256 (958)
Q Consensus 177 ~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~p~~~~~l~~L 256 (958)
|. ..+|+.+.|.++ ++.....+|.++++|+.+++.+| ++.+...+|.+ .+|+.+.|. |.++ ..-...|.++++|
T Consensus 200 F~-~~~L~~l~lp~~-l~~I~~~aF~~~~~L~~l~l~~~-l~~I~~~aF~~-~~L~~i~lp-~~i~-~I~~~aF~~c~~L 273 (401)
T 4fdw_A 200 FV-YAGIEEVLLPVT-LKEIGSQAFLKTSQLKTIEIPEN-VSTIGQEAFRE-SGITTVKLP-NGVT-NIASRAFYYCPEL 273 (401)
T ss_dssp TT-TCCCSEEECCTT-CCEECTTTTTTCTTCCCEECCTT-CCEECTTTTTT-CCCSEEEEE-TTCC-EECTTTTTTCTTC
T ss_pred Ee-ecccCEEEeCCc-hheehhhHhhCCCCCCEEecCCC-ccCcccccccc-CCccEEEeC-CCcc-EEChhHhhCCCCC
Confidence 66 689999999855 77677788999999999999875 66677788888 899999995 4454 2235689999999
Q ss_pred CEEEcccCCCC-----CCCC-CCCCCCCcCEEeccCCcCCCcCCCC--CCCCCcCEEEccCCcCCCccchhccCCCCCCe
Q 002158 257 VKLSLRNCNLQ-----GAVP-DLSRIPNLYYLDLSWNHLTGSIPSK--KLSENVTTIDLSDNYLNGSILESISNLPFLQT 328 (958)
Q Consensus 257 ~~L~L~~N~l~-----~~~~-~l~~l~~L~~L~Ls~N~l~~~~~~~--~~~~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~ 328 (958)
+.+.+.+|.+. .+.. .|.++++|+.++|.. .++ .++.. ..+.+|+.|+|..| ++.+...+|.++ +|+.
T Consensus 274 ~~l~l~~~~~~~~~~~~I~~~aF~~c~~L~~l~l~~-~i~-~I~~~aF~~c~~L~~l~lp~~-l~~I~~~aF~~~-~L~~ 349 (401)
T 4fdw_A 274 AEVTTYGSTFNDDPEAMIHPYCLEGCPKLARFEIPE-SIR-ILGQGLLGGNRKVTQLTIPAN-VTQINFSAFNNT-GIKE 349 (401)
T ss_dssp CEEEEESSCCCCCTTCEECTTTTTTCTTCCEECCCT-TCC-EECTTTTTTCCSCCEEEECTT-CCEECTTSSSSS-CCCE
T ss_pred CEEEeCCccccCCcccEECHHHhhCCccCCeEEeCC-ceE-EEhhhhhcCCCCccEEEECcc-ccEEcHHhCCCC-CCCE
Confidence 99999998876 3444 399999999999994 466 45544 33589999999655 888889999999 9999
Q ss_pred EeeecccCCCccchhhhcccccCccccceEeccCCCCCCCc
Q 002158 329 LSLENNFLTGSIPATIWQNKSFSTKARLKIDLRNNSFSNIV 369 (958)
Q Consensus 329 L~L~~N~l~~~ip~~l~~~~~~~~~~l~~L~Ls~N~l~~l~ 369 (958)
|++++|.+. .++...|... ...+..|.+..|.+....
T Consensus 350 l~l~~n~~~-~l~~~~F~~~---~~~l~~l~vp~~~~~~y~ 386 (401)
T 4fdw_A 350 VKVEGTTPP-QVFEKVWYGF---PDDITVIRVPAESVEKYK 386 (401)
T ss_dssp EEECCSSCC-BCCCSSCCCS---CTTCCEEEECGGGHHHHH
T ss_pred EEEcCCCCc-ccccccccCC---CCCccEEEeCHHHHHHhh
Confidence 999999987 4444433321 124567888887765543
|
| >3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D | Back alignment and structure |
|---|
Probab=99.38 E-value=6.3e-13 Score=131.79 Aligned_cols=105 Identities=25% Similarity=0.324 Sum_probs=68.0
Q ss_pred CcEEEeeCCCCCCCCChhhcCCCCCCEEecccccccccCccccccccccceEecccccccccCchhhcCCccchhhhccC
Q 002158 135 LIFLLLNGNKLSGSLPDELGYLSNLNRLQVDENNITGTIPKSFANLSRVRHLHLNNNSIGGQIPSELSKLSTLIHLLVDN 214 (958)
Q Consensus 135 L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~ 214 (958)
.+.|++++|.++ .+|..+. ++|++|+|++|+|++..|..|.++++|++|+|++|+|++..+..|.++++|++|+|++
T Consensus 11 ~~~l~~s~n~l~-~ip~~~~--~~l~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~ 87 (170)
T 3g39_A 11 GTTVDCSGKSLA-SVPTGIP--TTTQVLYLYDNQITKLEPGVFDRLTQLTRLDLDNNQLTVLPAGVFDKLTQLTQLSLND 87 (170)
T ss_dssp TTEEECTTSCCS-SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCS
T ss_pred CCEEEeCCCCcC-ccCccCC--CCCcEEEcCCCcCCccChhhhcCcccCCEEECCCCCcCccChhhccCCCCCCEEECCC
Confidence 456777777776 4665443 6667777777777766666666667777777777776655555566666666666666
Q ss_pred CccccCCCcccCCCCCccEEEccCCCCC
Q 002158 215 NNLSGNLPPELSELPQLCILQLDNNNFS 242 (958)
Q Consensus 215 N~l~~~~~~~l~~l~~L~~L~L~~N~l~ 242 (958)
|+|++..+..|..+++|++|+|++|.++
T Consensus 88 N~l~~~~~~~~~~l~~L~~L~L~~N~~~ 115 (170)
T 3g39_A 88 NQLKSIPRGAFDNLKSLTHIWLLNNPWD 115 (170)
T ss_dssp SCCCCCCTTTTTTCTTCCEEECCSSCBC
T ss_pred CccCEeCHHHhcCCCCCCEEEeCCCCCC
Confidence 6666555555666666666666666654
|
| >2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.36 E-value=1.2e-12 Score=130.19 Aligned_cols=104 Identities=24% Similarity=0.356 Sum_probs=58.2
Q ss_pred cEEEeeCCCCCCCCChhhcCCCCCCEEecccccccccCccccccccccceEecccccccccCchhhcCCccchhhhccCC
Q 002158 136 IFLLLNGNKLSGSLPDELGYLSNLNRLQVDENNITGTIPKSFANLSRVRHLHLNNNSIGGQIPSELSKLSTLIHLLVDNN 215 (958)
Q Consensus 136 ~~L~Ls~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N 215 (958)
+.+++++|.++ .+|..+. ++|++|+|++|+|++..|..|.++++|++|+|++|+|++..+..|.++++|++|+|++|
T Consensus 15 ~~l~~~~n~l~-~iP~~~~--~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~L~~N 91 (174)
T 2r9u_A 15 TLVNCQNIRLA-SVPAGIP--TDKQRLWLNNNQITKLEPGVFDHLVNLQQLYFNSNKLTAIPTGVFDKLTQLTQLDLNDN 91 (174)
T ss_dssp SEEECCSSCCS-SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred cEEEeCCCCCC-ccCCCcC--CCCcEEEeCCCCccccCHHHhcCCcCCCEEECCCCCCCccChhHhCCcchhhEEECCCC
Confidence 45566666654 4554443 55666666666665555555555666666666666665444444455555555555555
Q ss_pred ccccCCCcccCCCCCccEEEccCCCCC
Q 002158 216 NLSGNLPPELSELPQLCILQLDNNNFS 242 (958)
Q Consensus 216 ~l~~~~~~~l~~l~~L~~L~L~~N~l~ 242 (958)
+|++..+..|..+++|++|+|++|.+.
T Consensus 92 ~l~~l~~~~~~~l~~L~~L~L~~N~~~ 118 (174)
T 2r9u_A 92 HLKSIPRGAFDNLKSLTHIYLYNNPWD 118 (174)
T ss_dssp CCCCCCTTTTTTCTTCSEEECCSSCBC
T ss_pred ccceeCHHHhccccCCCEEEeCCCCcc
Confidence 555444444555555555555555554
|
| >3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D | Back alignment and structure |
|---|
Probab=99.33 E-value=2.5e-12 Score=127.42 Aligned_cols=86 Identities=26% Similarity=0.395 Sum_probs=50.9
Q ss_pred CCCcEEEeeCCCCCCCCChhhcCCCCCCEEecccccccccCccccccccccceEecccccccccCchhhcCCccchhhhc
Q 002158 133 SSLIFLLLNGNKLSGSLPDELGYLSNLNRLQVDENNITGTIPKSFANLSRVRHLHLNNNSIGGQIPSELSKLSTLIHLLV 212 (958)
Q Consensus 133 ~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L 212 (958)
++|++|+|++|.|++..|..|..+++|++|+|++|+|++..+..|..+++|++|+|++|+|++..+..|..+++|+.|+|
T Consensus 30 ~~l~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L 109 (170)
T 3g39_A 30 TTTQVLYLYDNQITKLEPGVFDRLTQLTRLDLDNNQLTVLPAGVFDKLTQLTQLSLNDNQLKSIPRGAFDNLKSLTHIWL 109 (170)
T ss_dssp TTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEEC
T ss_pred CCCcEEEcCCCcCCccChhhhcCcccCCEEECCCCCcCccChhhccCCCCCCEEECCCCccCEeCHHHhcCCCCCCEEEe
Confidence 45556666666666555555666666666666666666554445556666666666666666544445566666666666
Q ss_pred cCCccc
Q 002158 213 DNNNLS 218 (958)
Q Consensus 213 ~~N~l~ 218 (958)
++|.+.
T Consensus 110 ~~N~~~ 115 (170)
T 3g39_A 110 LNNPWD 115 (170)
T ss_dssp CSSCBC
T ss_pred CCCCCC
Confidence 666555
|
| >2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.33 E-value=2.8e-12 Score=127.58 Aligned_cols=94 Identities=26% Similarity=0.397 Sum_probs=55.5
Q ss_pred CCCCccccCCCCCcEEEeeCCCCCCCCChhhcCCCCCCEEecccccccccCccccccccccceEecccccccccCchhhc
Q 002158 123 GTIPKEIGNISSLIFLLLNGNKLSGSLPDELGYLSNLNRLQVDENNITGTIPKSFANLSRVRHLHLNNNSIGGQIPSELS 202 (958)
Q Consensus 123 ~~ip~~i~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~ 202 (958)
+.+|..+. ++|++|+|++|.|++..|..|.++++|++|+|++|+|++..+..|.++++|++|+|++|+|++..+..|.
T Consensus 25 ~~iP~~~~--~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~ 102 (174)
T 2r9u_A 25 ASVPAGIP--TDKQRLWLNNNQITKLEPGVFDHLVNLQQLYFNSNKLTAIPTGVFDKLTQLTQLDLNDNHLKSIPRGAFD 102 (174)
T ss_dssp SSCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTT
T ss_pred CccCCCcC--CCCcEEEeCCCCccccCHHHhcCCcCCCEEECCCCCCCccChhHhCCcchhhEEECCCCccceeCHHHhc
Confidence 34444332 4566666666666655555666666666666666666654444456666666666666666644444466
Q ss_pred CCccchhhhccCCccc
Q 002158 203 KLSTLIHLLVDNNNLS 218 (958)
Q Consensus 203 ~l~~L~~L~L~~N~l~ 218 (958)
.+++|+.|+|++|.+.
T Consensus 103 ~l~~L~~L~L~~N~~~ 118 (174)
T 2r9u_A 103 NLKSLTHIYLYNNPWD 118 (174)
T ss_dssp TCTTCSEEECCSSCBC
T ss_pred cccCCCEEEeCCCCcc
Confidence 6666666666666665
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.28 E-value=6.6e-12 Score=133.94 Aligned_cols=144 Identities=15% Similarity=0.107 Sum_probs=112.6
Q ss_pred HHcCCCCCceeeeeCCeEEEEEEECCCcEEEEEEeccCChhcHHHHHHHHHHHHccC-CCCcceEEEEEEeCCeEEEEEE
Q 002158 623 ATAYFSSSTQVGQGGYGKVYKGILSDNTTVAIKRAEEGSLQGQNEFLTEIKLLSRLH-HRNLVSLLGYCDEEGEQMLVYE 701 (958)
Q Consensus 623 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~~~~~lV~E 701 (958)
.-..|.....++.|+.+.||++.. +++.+++|+...........+.+|+++++.+. |..+.++++++...+..|+|||
T Consensus 12 ~l~~~~~~~~~~g~s~~~v~~~~~-~~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e 90 (263)
T 3tm0_A 12 LIEKYRCVKDTEGMSPAKVYKLVG-ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMS 90 (263)
T ss_dssp HHTTSEEEECCSCCSSSEEEEEEC-SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEE
T ss_pred HhccceeEeeccCCCCCeEEEEEC-CCCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEEEE
Confidence 345676667788888899999975 46899999987532122335889999999984 6788899999999999999999
Q ss_pred ecCCCCHHHHhccCCCCCchHHHHHHHHHHHHHHHHHhhhc---------------------------------------
Q 002158 702 FVPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTE--------------------------------------- 742 (958)
Q Consensus 702 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~--------------------------------------- 742 (958)
|++|.+|.+.+.. ......++.+++++|+.||+.
T Consensus 91 ~i~G~~l~~~~~~-------~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (263)
T 3tm0_A 91 EADGVLCSEEYED-------EQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTP 163 (263)
T ss_dssp CCSSEEHHHHCCT-------TTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTTCS
T ss_pred ecCCeehhhccCC-------cccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhcccccccccccccccc
Confidence 9999999887421 122347888999999999981
Q ss_pred -----------------CCCCeeccCCCccceEecCCCCeEEeeeeeec
Q 002158 743 -----------------AHPPVFHRDIKASNILLDSNLNAKVADFGLSR 774 (958)
Q Consensus 743 -----------------~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~ 774 (958)
..+.++|+|++|.||+++++..+.|+||+.+.
T Consensus 164 ~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T 3tm0_A 164 FKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp SSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCE
T ss_pred CCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcc
Confidence 01349999999999999876667799999765
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 | Back alignment and structure |
|---|
Probab=99.21 E-value=1.7e-11 Score=136.56 Aligned_cols=12 Identities=25% Similarity=0.647 Sum_probs=8.0
Q ss_pred CC-CCCCCceeeC
Q 002158 66 PC-MSNWTGVLCF 77 (958)
Q Consensus 66 ~c-~~~w~gV~C~ 77 (958)
.| .|.|.+|.|.
T Consensus 4 ~c~~C~~~~v~~~ 16 (347)
T 2ifg_A 4 ACCPHGSSGLRCT 16 (347)
T ss_dssp SSCCSSSSCEECC
T ss_pred cCccccCCEEEcC
Confidence 46 5677777773
|
| >3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.20 E-value=2.2e-13 Score=152.69 Aligned_cols=47 Identities=15% Similarity=0.167 Sum_probs=26.2
Q ss_pred CCcCEEEccCCcCCCc----cchhccCCCCCCeEeeecccCCCccchhhhc
Q 002158 300 ENVTTIDLSDNYLNGS----ILESISNLPFLQTLSLENNFLTGSIPATIWQ 346 (958)
Q Consensus 300 ~~L~~L~Ls~N~l~~~----~~~~~~~l~~L~~L~L~~N~l~~~ip~~l~~ 346 (958)
++|+.|+|++|.|+.. +...+...++|++|+|++|.|++.....+..
T Consensus 211 ~~L~~L~Ls~N~i~~~g~~~l~~~L~~~~~L~~L~Ls~N~i~~~g~~~L~~ 261 (372)
T 3un9_A 211 RQLQELNVAYNGAGDTAALALARAAREHPSLELLHLYFNELSSEGRQVLRD 261 (372)
T ss_dssp SCCCEEECCSSCCCHHHHHHHHHHHHHCSSCCEEECTTSSCCHHHHHHHHH
T ss_pred CCcCeEECCCCCCCHHHHHHHHHHHHhCCCCCEEeccCCCCCHHHHHHHHH
Confidence 3455555555555442 2333445667777777777776554444443
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 | Back alignment and structure |
|---|
Probab=99.17 E-value=3.5e-11 Score=133.96 Aligned_cols=103 Identities=20% Similarity=0.193 Sum_probs=75.7
Q ss_pred EEEeeCC-CCCCCCChhhcCCCCCCEEeccc-ccccccCccccccccccceEecccccccccCchhhcCCccchhhhccC
Q 002158 137 FLLLNGN-KLSGSLPDELGYLSNLNRLQVDE-NNITGTIPKSFANLSRVRHLHLNNNSIGGQIPSELSKLSTLIHLLVDN 214 (958)
Q Consensus 137 ~L~Ls~n-~l~~~~p~~l~~l~~L~~L~L~~-N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~ 214 (958)
.++++++ +|+ .+|. |..+++|++|+|++ |+|++..+..|.+|++|+.|+|++|+|++..|..|.++++|+.|+|++
T Consensus 12 ~v~~~~~n~l~-~ip~-l~~~~~L~~L~l~~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~ 89 (347)
T 2ifg_A 12 GLRCTRDGALD-SLHH-LPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSF 89 (347)
T ss_dssp CEECCSSCCCT-TTTT-SCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECCS
T ss_pred EEEcCCCCCCC-ccCC-CCCCCCeeEEEccCCCCCCCcChhHhccccCCCEEECCCCccceeCHHHhcCCcCCCEEeCCC
Confidence 4577776 777 5676 77777777888875 777766667777777777777777777777777777777777777777
Q ss_pred CccccCCCcccCCCCCccEEEccCCCCC
Q 002158 215 NNLSGNLPPELSELPQLCILQLDNNNFS 242 (958)
Q Consensus 215 N~l~~~~~~~l~~l~~L~~L~L~~N~l~ 242 (958)
|+|++..+..|..++ |+.|+|.+|.+.
T Consensus 90 N~l~~~~~~~~~~~~-L~~l~l~~N~~~ 116 (347)
T 2ifg_A 90 NALESLSWKTVQGLS-LQELVLSGNPLH 116 (347)
T ss_dssp SCCSCCCSTTTCSCC-CCEEECCSSCCC
T ss_pred CccceeCHHHcccCC-ceEEEeeCCCcc
Confidence 777766555565555 777777777775
|
| >3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.15 E-value=6.1e-13 Score=149.16 Aligned_cols=171 Identities=19% Similarity=0.204 Sum_probs=92.0
Q ss_pred CCCCcEEEeeCCCCCCCCChhhcC-----CCCCCEEecccccccccCcccc-ccccccceEecccccccccCchhh----
Q 002158 132 ISSLIFLLLNGNKLSGSLPDELGY-----LSNLNRLQVDENNITGTIPKSF-ANLSRVRHLHLNNNSIGGQIPSEL---- 201 (958)
Q Consensus 132 l~~L~~L~Ls~n~l~~~~p~~l~~-----l~~L~~L~L~~N~l~~~~p~~~-~~l~~L~~L~Ls~N~l~~~~p~~l---- 201 (958)
+++|++|+|++|.++......+.. .++|++|+|++|.++......+ ..+++|+.|+|++|.|+......+
T Consensus 71 ~~~L~~L~Ls~n~l~~~~~~~l~~~L~~~~~~L~~L~Ls~n~l~~~~~~~l~~~L~~L~~L~Ls~n~l~~~~~~~L~~~L 150 (372)
T 3un9_A 71 LSSLRQLNLAGVRMTPVKCTVVAAVLGSGRHALDEVNLASCQLDPAGLRTLLPVFLRARKLGLQLNSLGPEACKDLRDLL 150 (372)
T ss_dssp HTTCCEEECTTSCCCHHHHHHHHHHHSSCSSCEEEEECTTCCCCHHHHHHTHHHHHTEEEEECCSSCCCHHHHHHHHHHH
T ss_pred HhhCCEEEecCCCCCHHHHHHHHHHHhhCCCCceEEEecCCCCCHHHHHHHHHHHHhccHhhcCCCCCCHHHHHHHHHHH
Confidence 356778888888877433333332 2577888888887764433333 245677777777777764333332
Q ss_pred -cCCccchhhhccCCccccCCCcccCCCCCccEEEccCCCCCCCCccccccCCCCCCEEEcccCCCCCCC-----CCCCC
Q 002158 202 -SKLSTLIHLLVDNNNLSGNLPPELSELPQLCILQLDNNNFSASEIPATYGNFSKLVKLSLRNCNLQGAV-----PDLSR 275 (958)
Q Consensus 202 -~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~p~~~~~l~~L~~L~L~~N~l~~~~-----~~l~~ 275 (958)
...++|++|+|++|.|+..... .++..+..+++|++|+|++|.|+... ..+..
T Consensus 151 ~~~~~~L~~L~Ls~n~l~~~~~~---------------------~l~~~L~~~~~L~~L~Ls~N~l~~~g~~~L~~~L~~ 209 (372)
T 3un9_A 151 LHDQCQITTLRLSNNPLTAAGVA---------------------VLMEGLAGNTSVTHLSLLHTGLGDEGLELLAAQLDR 209 (372)
T ss_dssp HSTTCCCCEEECCSSCCHHHHHH---------------------HHHHHHHTCSSCCEEECTTSSCHHHHHHHHHHHGGG
T ss_pred HhcCCccceeeCCCCCCChHHHH---------------------HHHHHHhcCCCcCEEeCCCCCCCcHHHHHHHHHHhc
Confidence 1234455555555544321100 12223344455555555555554321 11444
Q ss_pred CCCcCEEeccCCcCCCcCC-----CCCCCCCcCEEEccCCcCCCccchhccCC
Q 002158 276 IPNLYYLDLSWNHLTGSIP-----SKKLSENVTTIDLSDNYLNGSILESISNL 323 (958)
Q Consensus 276 l~~L~~L~Ls~N~l~~~~~-----~~~~~~~L~~L~Ls~N~l~~~~~~~~~~l 323 (958)
.++|+.|+|++|.|+.... .....++|++|+|++|.|+......+..+
T Consensus 210 ~~~L~~L~Ls~N~i~~~g~~~l~~~L~~~~~L~~L~Ls~N~i~~~g~~~L~~~ 262 (372)
T 3un9_A 210 NRQLQELNVAYNGAGDTAALALARAAREHPSLELLHLYFNELSSEGRQVLRDL 262 (372)
T ss_dssp CSCCCEEECCSSCCCHHHHHHHHHHHHHCSSCCEEECTTSSCCHHHHHHHHHC
T ss_pred CCCcCeEECCCCCCCHHHHHHHHHHHHhCCCCCEEeccCCCCCHHHHHHHHHH
Confidence 5566677777776653111 01223678888888888877666666554
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.09 E-value=8.3e-11 Score=125.03 Aligned_cols=131 Identities=23% Similarity=0.194 Sum_probs=98.8
Q ss_pred eee-eeCCeEEEEEEECCCcEEEEEEeccCChhcHHHHHHHHHHHHccCCCC--cceEEEEEEeCCeEEEEEEecCCCCH
Q 002158 632 QVG-QGGYGKVYKGILSDNTTVAIKRAEEGSLQGQNEFLTEIKLLSRLHHRN--LVSLLGYCDEEGEQMLVYEFVPNGTL 708 (958)
Q Consensus 632 ~lg-~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~n--iv~l~~~~~~~~~~~lV~E~~~~gsL 708 (958)
.++ .|..+.||++...+|+.+++|...... ...+.+|+++++.+.+.+ +.+++++...++..++||||++|.+|
T Consensus 26 ~~~~gg~~~~v~~~~~~~g~~~vlK~~~~~~---~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e~i~G~~l 102 (264)
T 1nd4_A 26 QQTIGCSDAAVFRLSAQGRPVLFVKTDLSGA---LNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDL 102 (264)
T ss_dssp ECSCTTSSCEEEEEECTTSCCEEEEEECSCT---TSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEET
T ss_pred ecccCCCCceEEEEecCCCCeEEEEeCCccc---chhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEEecCCccc
Confidence 344 455689999987778889999976542 235778999999986444 56699998888889999999999888
Q ss_pred HHHhccCCCCCchHHHHHHHHHHHHHHHHHhhhcC---------------------------------------------
Q 002158 709 RDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEA--------------------------------------------- 743 (958)
Q Consensus 709 ~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~--------------------------------------------- 743 (958)
. ... .+ ...++.++++.|..||+..
T Consensus 103 ~--~~~-----~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 172 (264)
T 1nd4_A 103 L--SSH-----LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFA 172 (264)
T ss_dssp T--TSC-----CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHH
T ss_pred C--cCc-----CC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCccHHHHHH
Confidence 4 221 11 2356777888888888643
Q ss_pred ----------CCCeeccCCCccceEecCCCCeEEeeeeeecc
Q 002158 744 ----------HPPVFHRDIKASNILLDSNLNAKVADFGLSRL 775 (958)
Q Consensus 744 ----------~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~ 775 (958)
.+.++|+|++|.||++++++.+.|+|||.+..
T Consensus 173 ~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~~ 214 (264)
T 1nd4_A 173 RLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV 214 (264)
T ss_dssp HHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred HHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhccc
Confidence 12399999999999998776677999998753
|
| >4fs7_A Uncharacterized protein; leucine-rich repeats, protein binding, extracellular protein structural genomics; HET: MSE; 1.19A {Bacteroides ovatus} | Back alignment and structure |
|---|
Probab=99.02 E-value=5.2e-09 Score=118.51 Aligned_cols=199 Identities=13% Similarity=0.047 Sum_probs=110.9
Q ss_pred cccccccccceEecccccccccCchhhcCCccchhhhccCCccccCCCcccCCCCCccEEEccCCCCCC-----------
Q 002158 175 KSFANLSRVRHLHLNNNSIGGQIPSELSKLSTLIHLLVDNNNLSGNLPPELSELPQLCILQLDNNNFSA----------- 243 (958)
Q Consensus 175 ~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~----------- 243 (958)
.+|.++++|+.+.+.++..+ ....+|.++.+|+.+.+..| ++.+...+|.++..|+.+.+..+....
T Consensus 156 ~aF~~c~~L~~i~l~~~~~~-I~~~~F~~c~~L~~i~l~~~-~~~I~~~~F~~~~~L~~i~~~~~~~~i~~~~~~~~~l~ 233 (394)
T 4fs7_A 156 EAFATCESLEYVSLPDSMET-LHNGLFSGCGKLKSIKLPRN-LKIIRDYCFAECILLENMEFPNSLYYLGDFALSKTGVK 233 (394)
T ss_dssp TTTTTCTTCCEEECCTTCCE-ECTTTTTTCTTCCBCCCCTT-CCEECTTTTTTCTTCCBCCCCTTCCEECTTTTTTCCCC
T ss_pred hhhcccCCCcEEecCCccce-eccccccCCCCceEEEcCCC-ceEeCchhhccccccceeecCCCceEeehhhcccCCCc
Confidence 44666666666666554332 44455666666666666554 443445556666666655554443210
Q ss_pred ---------CCccccccCCCCCCEEEcccCCCCCCCCCCCCCCCcCEEeccCCcCCCcCCCCCCCCCcCEEEccCCcCCC
Q 002158 244 ---------SEIPATYGNFSKLVKLSLRNCNLQGAVPDLSRIPNLYYLDLSWNHLTGSIPSKKLSENVTTIDLSDNYLNG 314 (958)
Q Consensus 244 ---------~~~p~~~~~l~~L~~L~L~~N~l~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~~~L~~L~Ls~N~l~~ 314 (958)
..-...|.++.+|+.+.+..+...-....|..+..|+.+.+..+.+.. .....+.+|+.+.+.++ ++.
T Consensus 234 ~i~ip~~~~~i~~~~f~~~~~l~~~~~~~~~~~i~~~~F~~~~~l~~~~~~~~~i~~--~~F~~~~~L~~i~l~~~-i~~ 310 (394)
T 4fs7_A 234 NIIIPDSFTELGKSVFYGCTDLESISIQNNKLRIGGSLFYNCSGLKKVIYGSVIVPE--KTFYGCSSLTEVKLLDS-VKF 310 (394)
T ss_dssp EEEECTTCCEECSSTTTTCSSCCEEEECCTTCEECSCTTTTCTTCCEEEECSSEECT--TTTTTCTTCCEEEECTT-CCE
T ss_pred eEEECCCceecccccccccccceeEEcCCCcceeeccccccccccceeccCceeecc--ccccccccccccccccc-cce
Confidence 011223445555555555544332111235555556655555443211 11233467888887654 666
Q ss_pred ccchhccCCCCCCeEeeecccCCCccchhhhcccccCccccceEeccCCCCCCCccCC--CCCCcceEEeCCC
Q 002158 315 SILESISNLPFLQTLSLENNFLTGSIPATIWQNKSFSTKARLKIDLRNNSFSNIVGDL--TLPNNVTLRLGGN 385 (958)
Q Consensus 315 ~~~~~~~~l~~L~~L~L~~N~l~~~ip~~l~~~~~~~~~~l~~L~Ls~N~l~~l~~~~--~l~~L~~L~l~~N 385 (958)
+...+|.++.+|+.++|.++ ++ .|+...|.. ...|+.+++..| ++.|.... +..+|+.+++..|
T Consensus 311 I~~~aF~~c~~L~~i~lp~~-v~-~I~~~aF~~----c~~L~~i~lp~~-l~~I~~~aF~~C~~L~~i~lp~~ 376 (394)
T 4fs7_A 311 IGEEAFESCTSLVSIDLPYL-VE-EIGKRSFRG----CTSLSNINFPLS-LRKIGANAFQGCINLKKVELPKR 376 (394)
T ss_dssp ECTTTTTTCTTCCEECCCTT-CC-EECTTTTTT----CTTCCEECCCTT-CCEECTTTBTTCTTCCEEEEEGG
T ss_pred echhhhcCCCCCCEEEeCCc-cc-EEhHHhccC----CCCCCEEEECcc-ccEehHHHhhCCCCCCEEEECCC
Confidence 77777888888888888644 55 454443321 234557777766 77776655 6677888877544
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=98.97 E-value=7.9e-10 Score=123.62 Aligned_cols=142 Identities=20% Similarity=0.311 Sum_probs=107.3
Q ss_pred CceeeeeCCeEEEEEEECCCcEEEEEEec--cCC-hhcHHHHHHHHHHHHccC--CCCcceEEEEEEeC---CeEEEEEE
Q 002158 630 STQVGQGGYGKVYKGILSDNTTVAIKRAE--EGS-LQGQNEFLTEIKLLSRLH--HRNLVSLLGYCDEE---GEQMLVYE 701 (958)
Q Consensus 630 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~--~~~-~~~~~~~~~E~~~l~~l~--H~niv~l~~~~~~~---~~~~lV~E 701 (958)
.+.|+.|.++.||+.... +..+++|+.. ... ......+.+|+++++.+. +..+.++++++.+. +..++|||
T Consensus 43 ~~~l~~G~sn~~y~v~~~-~~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~vme 121 (359)
T 3dxp_A 43 VEQFKGGQSNPTFKLVTP-GQTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYIME 121 (359)
T ss_dssp EEECCC-CCSCEEEEECS-SCEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEEEE
T ss_pred EEEcCCcccceEEEEEEC-CceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEEEE
Confidence 457899999999998875 4678888876 322 122346789999999996 45688999998876 45899999
Q ss_pred ecCCCCHHHHhccCCCCCchHHHHHHHHHHHHHHHHHhhhcC--------------------------------------
Q 002158 702 FVPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEA-------------------------------------- 743 (958)
Q Consensus 702 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~-------------------------------------- 743 (958)
|++|..+.+.. ...++..++..++.++++.|+.||+..
T Consensus 122 ~v~G~~l~~~~----~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 197 (359)
T 3dxp_A 122 FVSGRVLWDQS----LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIPAM 197 (359)
T ss_dssp CCCCBCCCCTT----CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCHHH
T ss_pred ecCCeecCCCc----cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCChHH
Confidence 99987775422 123677888899999999999999731
Q ss_pred -----------------CCCeeccCCCccceEecCCCC--eEEeeeeeeccc
Q 002158 744 -----------------HPPVFHRDIKASNILLDSNLN--AKVADFGLSRLA 776 (958)
Q Consensus 744 -----------------~~~iiH~Dikp~NILl~~~~~--~kl~DFGla~~~ 776 (958)
.+.++|||+++.||+++.++. +.|+||+.+...
T Consensus 198 ~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~g 249 (359)
T 3dxp_A 198 DSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTLG 249 (359)
T ss_dssp HHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEEE
T ss_pred HHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECccccccC
Confidence 245999999999999997753 689999988753
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=98.91 E-value=1.3e-09 Score=118.75 Aligned_cols=192 Identities=18% Similarity=0.186 Sum_probs=124.2
Q ss_pred CceeeeeCCeEEEEEEECCCcEEEEEEeccCChhcHHHHHHHHHHHHccC-CCC--cceEEEEEEeCC---eEEEEEEec
Q 002158 630 STQVGQGGYGKVYKGILSDNTTVAIKRAEEGSLQGQNEFLTEIKLLSRLH-HRN--LVSLLGYCDEEG---EQMLVYEFV 703 (958)
Q Consensus 630 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-H~n--iv~l~~~~~~~~---~~~lV~E~~ 703 (958)
.+.++.|.+..||+.. +.+++|+.... .....+.+|+++++.+. +.. +.+++......+ ..|+||||+
T Consensus 25 i~~~~~G~~n~v~~v~----~~~vlR~~~~~--~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~i 98 (304)
T 3sg8_A 25 IEISGEGNDCIAYEIN----RDFIFKFPKHS--RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTKI 98 (304)
T ss_dssp CCEEEECSSEEEEEST----TSEEEEEESSH--HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEECC
T ss_pred eEecCCCCcceEEEEC----CEEEEEecCCc--chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEccc
Confidence 4568999999999863 56889986532 34567889999999883 333 445555544333 458999999
Q ss_pred CCCCHHHHhccCCCCCchHHHHHHHHHHHHHHHHHhhhc-----------------------------------------
Q 002158 704 PNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTE----------------------------------------- 742 (958)
Q Consensus 704 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~----------------------------------------- 742 (958)
+|.++.+.... .++.+++..++.++++.++.||+.
T Consensus 99 ~G~~l~~~~~~----~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 174 (304)
T 3sg8_A 99 KGVPLTPLLLN----NLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKVD 174 (304)
T ss_dssp CCEECCHHHHH----TSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHHH
T ss_pred CCeECCccccc----cCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHHH
Confidence 99888654321 266777788888888888888861
Q ss_pred --------------CCCCeeccCCCccceEecC--CCCeEEeeeeeecccccCCCCCCccc-------eeeeeccCCCCc
Q 002158 743 --------------AHPPVFHRDIKASNILLDS--NLNAKVADFGLSRLAPVLDDEGTMPT-------HVSTIVKGTPGY 799 (958)
Q Consensus 743 --------------~~~~iiH~Dikp~NILl~~--~~~~kl~DFGla~~~~~~~~~~~~~~-------~~~~~~~gt~~y 799 (958)
..+.++|+|++|.||++++ +..+.|+||+.+...+...+-..... .....+....++
T Consensus 175 ~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl~~~~~~~~~~~~~~~~~~l~~Y~~ 254 (304)
T 3sg8_A 175 DFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDFISLMEDDEEYGMEFVSKILNHYKH 254 (304)
T ss_dssp HHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHHHHTTCCTTTSCCHHHHHHHHHHHTC
T ss_pred HHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHHHHHHHhhccccCHHHHHHHHHHcCC
Confidence 1245899999999999998 45688999998875432111000000 000000000111
Q ss_pred cC-hhhhccCCCCCcchhhhHHHHHHHHHhCCCCC
Q 002158 800 LD-PEYFLTHKLTDKSDVYSLGVVLLELLTGMQPI 833 (958)
Q Consensus 800 ~a-PE~~~~~~~~~~~DV~S~Gv~l~elltG~~P~ 833 (958)
.. |+..... ....+.|++|.++|++.+|..+|
T Consensus 255 ~~~~~~~~r~--~~~~~~~~l~~~~~~~~~g~~~~ 287 (304)
T 3sg8_A 255 KDIPTVLEKY--RMKEKYWSFEKIIYGKEYGYMDW 287 (304)
T ss_dssp SCHHHHHHHH--HHHHHHHHHHHHHHHHHTTCHHH
T ss_pred CCcHHHHHHH--HHHHHHHHHHHHHHHHHcCCHHH
Confidence 22 2222111 12368999999999999998776
|
| >4fs7_A Uncharacterized protein; leucine-rich repeats, protein binding, extracellular protein structural genomics; HET: MSE; 1.19A {Bacteroides ovatus} | Back alignment and structure |
|---|
Probab=98.89 E-value=2.2e-08 Score=113.37 Aligned_cols=266 Identities=8% Similarity=-0.041 Sum_probs=155.9
Q ss_pred ccccccCCCCcceeeccCcccCCCCccccCCCCCcEEEeeCCCCCCCCChhhcCCCCCCEEecccccccccCcccccccc
Q 002158 102 LAPELGQLSRLQYYFMWNDLTGTIPKEIGNISSLIFLLLNGNKLSGSLPDELGYLSNLNRLQVDENNITGTIPKSFANLS 181 (958)
Q Consensus 102 ~~~~l~~L~~L~~L~l~n~~~~~ip~~i~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~ 181 (958)
-..+|.+.++|+.+.+.++....-..+|.++++|+.++|.++ ++..-..+|.++.+|+.+.+..+ +......+|.++.
T Consensus 63 g~~AF~~c~~L~~i~lp~~i~~I~~~aF~~c~~L~~i~lp~~-l~~I~~~aF~~c~~L~~i~~p~~-l~~i~~~aF~~~~ 140 (394)
T 4fs7_A 63 GYAAFQGCRKVTEIKIPSTVREIGEFAFENCSKLEIINIPDS-VKMIGRCTFSGCYALKSILLPLM-LKSIGVEAFKGCD 140 (394)
T ss_dssp CTTTTTTCTTEEEEECCTTCCEECTTTTTTCTTCCEECCCTT-CCEECTTTTTTCTTCCCCCCCTT-CCEECTTTTTTCC
T ss_pred HHHHhhCCCCceEEEeCCCccCcchhHhhCCCCCcEEEeCCC-ceEccchhhcccccchhhcccCc-eeeecceeeeccc
Confidence 345677788888888876655444566888889999988755 55344566888888888877655 4435556677665
Q ss_pred ccceEecccccccccCchhhcCCccchhhhccCCccccCCCcccCCCCCccEEEccCCCCCCCCccccccCCCCCCEEEc
Q 002158 182 RVRHLHLNNNSIGGQIPSELSKLSTLIHLLVDNNNLSGNLPPELSELPQLCILQLDNNNFSASEIPATYGNFSKLVKLSL 261 (958)
Q Consensus 182 ~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~p~~~~~l~~L~~L~L 261 (958)
.++......... ....+|.++++|+.+.+.++- ......+|.++++|+.+.+..| ++ ..-...|.++..|+.+.+
T Consensus 141 ~~~~~~~~~~~~--i~~~aF~~c~~L~~i~l~~~~-~~I~~~~F~~c~~L~~i~l~~~-~~-~I~~~~F~~~~~L~~i~~ 215 (394)
T 4fs7_A 141 FKEITIPEGVTV--IGDEAFATCESLEYVSLPDSM-ETLHNGLFSGCGKLKSIKLPRN-LK-IIRDYCFAECILLENMEF 215 (394)
T ss_dssp CSEEECCTTCCE--ECTTTTTTCTTCCEEECCTTC-CEECTTTTTTCTTCCBCCCCTT-CC-EECTTTTTTCTTCCBCCC
T ss_pred ccccccCccccc--cchhhhcccCCCcEEecCCcc-ceeccccccCCCCceEEEcCCC-ce-EeCchhhccccccceeec
Confidence 544444333322 345679999999999998664 4466788999999999999877 32 122446777777777666
Q ss_pred ccCCCCCCCCC-----------------------CCCCCCcCEEeccCCcCCCcCCCCCCCCCcCEEEccCCcCCCccch
Q 002158 262 RNCNLQGAVPD-----------------------LSRIPNLYYLDLSWNHLTGSIPSKKLSENVTTIDLSDNYLNGSILE 318 (958)
Q Consensus 262 ~~N~l~~~~~~-----------------------l~~l~~L~~L~Ls~N~l~~~~~~~~~~~~L~~L~Ls~N~l~~~~~~ 318 (958)
..+... .... +..+.+|+.+.+..+...-..........|+.+.+..+.+ ...
T Consensus 216 ~~~~~~-i~~~~~~~~~l~~i~ip~~~~~i~~~~f~~~~~l~~~~~~~~~~~i~~~~F~~~~~l~~~~~~~~~i---~~~ 291 (394)
T 4fs7_A 216 PNSLYY-LGDFALSKTGVKNIIIPDSFTELGKSVFYGCTDLESISIQNNKLRIGGSLFYNCSGLKKVIYGSVIV---PEK 291 (394)
T ss_dssp CTTCCE-ECTTTTTTCCCCEEEECTTCCEECSSTTTTCSSCCEEEECCTTCEECSCTTTTCTTCCEEEECSSEE---CTT
T ss_pred CCCceE-eehhhcccCCCceEEECCCceecccccccccccceeEEcCCCcceeeccccccccccceeccCceee---ccc
Confidence 554322 1111 3334444444444433220111112224444444443322 234
Q ss_pred hccCCCCCCeEeeecccCCCccchhhhcccccCccccceEeccCCCCCCCccCC--CCCCcceEEeCCC
Q 002158 319 SISNLPFLQTLSLENNFLTGSIPATIWQNKSFSTKARLKIDLRNNSFSNIVGDL--TLPNNVTLRLGGN 385 (958)
Q Consensus 319 ~~~~l~~L~~L~L~~N~l~~~ip~~l~~~~~~~~~~l~~L~Ls~N~l~~l~~~~--~l~~L~~L~l~~N 385 (958)
.|..+.+|+.+.+.++ ++ .|+...|.. ...|+.++|.+ .++.|.... +..+|+.+.|..|
T Consensus 292 ~F~~~~~L~~i~l~~~-i~-~I~~~aF~~----c~~L~~i~lp~-~v~~I~~~aF~~c~~L~~i~lp~~ 353 (394)
T 4fs7_A 292 TFYGCSSLTEVKLLDS-VK-FIGEEAFES----CTSLVSIDLPY-LVEEIGKRSFRGCTSLSNINFPLS 353 (394)
T ss_dssp TTTTCTTCCEEEECTT-CC-EECTTTTTT----CTTCCEECCCT-TCCEECTTTTTTCTTCCEECCCTT
T ss_pred cccccccccccccccc-cc-eechhhhcC----CCCCCEEEeCC-cccEEhHHhccCCCCCCEEEECcc
Confidence 4556666666666544 33 343333221 23445666653 366665544 5566676666544
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} | Back alignment and structure |
|---|
Probab=98.80 E-value=1.2e-09 Score=121.43 Aligned_cols=188 Identities=17% Similarity=0.237 Sum_probs=93.5
Q ss_pred CCCcEEEeeCCCCCC-CC-------ChhhcCCCCCCEEecccccccccCccccccccccceEecccccccccCchhhcCC
Q 002158 133 SSLIFLLLNGNKLSG-SL-------PDELGYLSNLNRLQVDENNITGTIPKSFANLSRVRHLHLNNNSIGGQIPSELSKL 204 (958)
Q Consensus 133 ~~L~~L~Ls~n~l~~-~~-------p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l 204 (958)
.+++.|.+......| .. ..++..+++|+.|.+..+..... .++... .+.+...+..+
T Consensus 107 ~~v~~L~lg~~~~~~~~~~~~~~~L~~s~~~l~~L~~L~l~~~~~e~~--------------~is~~~-~~~L~~ll~~~ 171 (362)
T 2ra8_A 107 PSLKQITIGXWGYEGEDCSDIADGIVENKEKFAHFEGLFWGDIDFEEQ--------------EISWIE-QVDLSPVLDAM 171 (362)
T ss_dssp GGCSEEEECCCCSSSCCSHHHHHHHHTTHHHHTTCSEEEECCCCTTTC--------------CGGGCB-CCBCHHHHHTC
T ss_pred hhcceEEEcccccCCCcHHHHHHHHHHhhhhcchhhheeecCcchhhc--------------cccccc-ccCHHHHHhcC
Confidence 456778887665442 11 22244566777776655432100 000000 01233444555
Q ss_pred ccchhhhccCCc-cccCCCcccCCCCCccEEEccCCCCCCCCccccc--cCCCCCCEEEccc--CCCCCC------CCCC
Q 002158 205 STLIHLLVDNNN-LSGNLPPELSELPQLCILQLDNNNFSASEIPATY--GNFSKLVKLSLRN--CNLQGA------VPDL 273 (958)
Q Consensus 205 ~~L~~L~L~~N~-l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~p~~~--~~l~~L~~L~L~~--N~l~~~------~~~l 273 (958)
++|+.|+|++|. +. ++. +. +++|+.|+|..|.++... ...+ ..+++|+.|+|+. |...+. .+.+
T Consensus 172 P~L~~L~L~g~~~l~--l~~-~~-~~~L~~L~L~~~~l~~~~-l~~l~~~~lp~L~~L~L~~~~~~~~~~~~~~~l~~~l 246 (362)
T 2ra8_A 172 PLLNNLKIKGTNNLS--IGK-KP-RPNLKSLEIISGGLPDSV-VEDILGSDLPNLEKLVLYVGVEDYGFDGDMNVFRPLF 246 (362)
T ss_dssp TTCCEEEEECCBTCB--CCS-CB-CTTCSEEEEECSBCCHHH-HHHHHHSBCTTCCEEEEECBCGGGTCCSCGGGTGGGS
T ss_pred CCCcEEEEeCCCCce--ecc-cc-CCCCcEEEEecCCCChHH-HHHHHHccCCCCcEEEEeccccccccchhHHHHHHHH
Confidence 666666665552 21 122 22 567777777766664211 1122 2566777776642 211111 0111
Q ss_pred --CCCCCcCEEeccCCcCCCcCC----CCCCCCCcCEEEccCCcCCCcc----chhccCCCCCCeEeeecccCCCcc
Q 002158 274 --SRIPNLYYLDLSWNHLTGSIP----SKKLSENVTTIDLSDNYLNGSI----LESISNLPFLQTLSLENNFLTGSI 340 (958)
Q Consensus 274 --~~l~~L~~L~Ls~N~l~~~~~----~~~~~~~L~~L~Ls~N~l~~~~----~~~~~~l~~L~~L~L~~N~l~~~i 340 (958)
..+++|+.|+|++|.+..... ....+++|++|+|+.|.|++.. +..+..+++|+.|+|++|.|+...
T Consensus 247 ~~~~~p~Lr~L~L~~~~i~~~~~~~la~a~~~~~L~~LdLs~n~L~d~G~~~L~~~L~~l~~L~~L~L~~n~i~d~~ 323 (362)
T 2ra8_A 247 SKDRFPNLKWLGIVDAEEQNVVVEMFLESDILPQLETMDISAGVLTDEGARLLLDHVDKIKHLKFINMKYNYLSDEM 323 (362)
T ss_dssp CTTTCTTCCEEEEESCTTHHHHHHHHHHCSSGGGCSEEECCSSCCBHHHHHHHHTTHHHHTTCSEEECCSBBCCHHH
T ss_pred hcCCCCCcCEEeCCCCCCchHHHHHHHhCccCCCCCEEECCCCCCChHHHHHHHhhcccCCcceEEECCCCcCCHHH
Confidence 245677777777776653211 1123467777777777776543 223344577777777777766433
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} | Back alignment and structure |
|---|
Probab=98.77 E-value=1.5e-09 Score=120.51 Aligned_cols=184 Identities=16% Similarity=0.220 Sum_probs=101.8
Q ss_pred ccccCCCCCcEEEeeCCCCC---------CCCChhhcCCCCCCEEecccccccccCccccccccccceEecccccccccC
Q 002158 127 KEIGNISSLIFLLLNGNKLS---------GSLPDELGYLSNLNRLQVDENNITGTIPKSFANLSRVRHLHLNNNSIGGQI 197 (958)
Q Consensus 127 ~~i~~l~~L~~L~Ls~n~l~---------~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~ 197 (958)
.++.++++|+.|.+..+... +.+...+..+++|+.|+|++|.-. .++. + .+++|+.|+|..|.++...
T Consensus 133 ~s~~~l~~L~~L~l~~~~~e~~~is~~~~~~L~~ll~~~P~L~~L~L~g~~~l-~l~~-~-~~~~L~~L~L~~~~l~~~~ 209 (362)
T 2ra8_A 133 ENKEKFAHFEGLFWGDIDFEEQEISWIEQVDLSPVLDAMPLLNNLKIKGTNNL-SIGK-K-PRPNLKSLEIISGGLPDSV 209 (362)
T ss_dssp TTHHHHTTCSEEEECCCCTTTCCGGGCBCCBCHHHHHTCTTCCEEEEECCBTC-BCCS-C-BCTTCSEEEEECSBCCHHH
T ss_pred HhhhhcchhhheeecCcchhhcccccccccCHHHHHhcCCCCcEEEEeCCCCc-eecc-c-cCCCCcEEEEecCCCChHH
Confidence 44667889999999776432 124455566777888877776311 1222 3 2667777777776665332
Q ss_pred chhhc--CCccchhhhccC--CccccCCCcccCCCCCccEEEccCCCCCCCCccccc--cCCCCCCEEEcccCCCCCCCC
Q 002158 198 PSELS--KLSTLIHLLVDN--NNLSGNLPPELSELPQLCILQLDNNNFSASEIPATY--GNFSKLVKLSLRNCNLQGAVP 271 (958)
Q Consensus 198 p~~l~--~l~~L~~L~L~~--N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~p~~~--~~l~~L~~L~L~~N~l~~~~~ 271 (958)
...+. .+++|+.|+|+. |...+.. . + ..+...+ ..+++|+.|+|.+|.+.....
T Consensus 210 l~~l~~~~lp~L~~L~L~~~~~~~~~~~--~----------------~--~~l~~~l~~~~~p~Lr~L~L~~~~i~~~~~ 269 (362)
T 2ra8_A 210 VEDILGSDLPNLEKLVLYVGVEDYGFDG--D----------------M--NVFRPLFSKDRFPNLKWLGIVDAEEQNVVV 269 (362)
T ss_dssp HHHHHHSBCTTCCEEEEECBCGGGTCCS--C----------------G--GGTGGGSCTTTCTTCCEEEEESCTTHHHHH
T ss_pred HHHHHHccCCCCcEEEEeccccccccch--h----------------H--HHHHHHHhcCCCCCcCEEeCCCCCCchHHH
Confidence 23332 455666665542 1111100 0 0 0000111 235666666666666553211
Q ss_pred -C---CCCCCCcCEEeccCCcCCCc----CCC-CCCCCCcCEEEccCCcCCCccchhccC-CCCCCeEeeeccc
Q 002158 272 -D---LSRIPNLYYLDLSWNHLTGS----IPS-KKLSENVTTIDLSDNYLNGSILESISN-LPFLQTLSLENNF 335 (958)
Q Consensus 272 -~---l~~l~~L~~L~Ls~N~l~~~----~~~-~~~~~~L~~L~Ls~N~l~~~~~~~~~~-l~~L~~L~L~~N~ 335 (958)
. ...+++|+.|+|+.|.+++. +.. ...+++|+.|+|++|.|+......+.. + ...+++++|+
T Consensus 270 ~~la~a~~~~~L~~LdLs~n~L~d~G~~~L~~~L~~l~~L~~L~L~~n~i~d~~~~~l~~al--g~~~~~~~~~ 341 (362)
T 2ra8_A 270 EMFLESDILPQLETMDISAGVLTDEGARLLLDHVDKIKHLKFINMKYNYLSDEMKKELQKSL--PMKIDVSDSQ 341 (362)
T ss_dssp HHHHHCSSGGGCSEEECCSSCCBHHHHHHHHTTHHHHTTCSEEECCSBBCCHHHHHHHHHHC--CSEEECCSBC
T ss_pred HHHHhCccCCCCCEEECCCCCCChHHHHHHHhhcccCCcceEEECCCCcCCHHHHHHHHHHc--CCEEEecCCc
Confidence 1 13467788888888877642 111 134578888888888887665555554 3 4557777776
|
| >4gt6_A Cell surface protein; leucine rich repeats, putative protein binding, extracellula protein, structural genomics; HET: MSE; 1.80A {Faecalibacterium prausnitzii a2-165} | Back alignment and structure |
|---|
Probab=98.74 E-value=2.6e-07 Score=104.51 Aligned_cols=267 Identities=9% Similarity=0.089 Sum_probs=157.8
Q ss_pred cccCCC-CcceeeccCcccCCCCccccCCCCCcEEEeeCCC---CCCCCChhhcCCCCCCEEecccccccccCccccccc
Q 002158 105 ELGQLS-RLQYYFMWNDLTGTIPKEIGNISSLIFLLLNGNK---LSGSLPDELGYLSNLNRLQVDENNITGTIPKSFANL 180 (958)
Q Consensus 105 ~l~~L~-~L~~L~l~n~~~~~ip~~i~~l~~L~~L~Ls~n~---l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l 180 (958)
+|.+.. .|+.+.+-++....-..+|.++++|+.+.+..|. ++..-..+|..+.+|+.+.+..+ ++......|..+
T Consensus 58 aF~~~~~~L~sI~iP~svt~Ig~~AF~~C~~L~~i~~~~n~p~~l~~Ig~~aF~~c~~L~~i~~~~~-~~~I~~~aF~~c 136 (394)
T 4gt6_A 58 VFCNYKYVLTSVQIPDTVTEIGSNAFYNCTSLKRVTIQDNKPSCVKKIGRQAFMFCSELTDIPILDS-VTEIDSEAFHHC 136 (394)
T ss_dssp TTTTCCSCCCEEEECTTCCEECTTTTTTCTTCCEEEEGGGCCCCCCEECTTTTTTCTTCCBCGGGTT-CSEECTTTTTTC
T ss_pred hccCCCCcCEEEEECCCeeEEhHHHhhCCccCceEeecCCCCCeeeEechhhchhcccceeeccCCc-cceehhhhhhhh
Confidence 344442 4666666655554445667777788888777653 44334456677777777776654 443445567777
Q ss_pred cccceEecccccccccCchhhcCCccchhhhccCCccccCCCcccCCCCCccEEEccCCCCCCCCccccccCCCCCCEEE
Q 002158 181 SRVRHLHLNNNSIGGQIPSELSKLSTLIHLLVDNNNLSGNLPPELSELPQLCILQLDNNNFSASEIPATYGNFSKLVKLS 260 (958)
Q Consensus 181 ~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~p~~~~~l~~L~~L~ 260 (958)
.+|+.+.+..+. .......|..+.+|+.+.+.++ +..+...+|.+ .+|+.+.+..+-.. .-...|.++.+|+...
T Consensus 137 ~~L~~i~lp~~~-~~I~~~~F~~c~~L~~i~~~~~-~~~I~~~aF~~-~~l~~i~ip~~~~~--i~~~af~~c~~l~~~~ 211 (394)
T 4gt6_A 137 EELDTVTIPEGV-TSVADGMFSYCYSLHTVTLPDS-VTAIEERAFTG-TALTQIHIPAKVTR--IGTNAFSECFALSTIT 211 (394)
T ss_dssp TTCCEEECCTTC-CEECTTTTTTCTTCCEEECCTT-CCEECTTTTTT-CCCSEEEECTTCCE--ECTTTTTTCTTCCEEE
T ss_pred ccccccccccee-eeecccceecccccccccccce-eeEeccccccc-cceeEEEECCcccc--cccchhhhccccceec
Confidence 777777776443 3244556666777777666544 33333444443 45666655443321 1123344444444433
Q ss_pred cccCC------------------------------------CCCCCC-CCCCCCCcCEEeccCCcCCCcCCCC--CCCCC
Q 002158 261 LRNCN------------------------------------LQGAVP-DLSRIPNLYYLDLSWNHLTGSIPSK--KLSEN 301 (958)
Q Consensus 261 L~~N~------------------------------------l~~~~~-~l~~l~~L~~L~Ls~N~l~~~~~~~--~~~~~ 301 (958)
...+. ++.+.. .|.++.+|+.+.+..+..+ +... ..+.+
T Consensus 212 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ip~~v~~i~~~aF~~c~~L~~i~lp~~~~~--I~~~aF~~c~~ 289 (394)
T 4gt6_A 212 SDSESYPAIDNVLYEKSANGDYALIRYPSQREDPAFKIPNGVARIETHAFDSCAYLASVKMPDSVVS--IGTGAFMNCPA 289 (394)
T ss_dssp ECCSSSCBSSSCEEEECTTSCEEEEECCTTCCCSEEECCTTEEEECTTTTTTCSSCCEEECCTTCCE--ECTTTTTTCTT
T ss_pred ccccccccccceeecccccccccccccccccccceEEcCCcceEcccceeeecccccEEecccccce--ecCcccccccc
Confidence 32211 111122 2677788888888766543 3332 33578
Q ss_pred cCEEEccCCcCCCccchhccCCCCCCeEeeecccCCCccchhhhcccccCccccceEeccCCCCCCCccCC--CCCCcce
Q 002158 302 VTTIDLSDNYLNGSILESISNLPFLQTLSLENNFLTGSIPATIWQNKSFSTKARLKIDLRNNSFSNIVGDL--TLPNNVT 379 (958)
Q Consensus 302 L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~ip~~l~~~~~~~~~~l~~L~Ls~N~l~~l~~~~--~l~~L~~ 379 (958)
|+.+.+. +.++.+....|.++.+|+.++|..+ ++ .|....|.. ...|+.+.|..+ ++.|.... +..+|+.
T Consensus 290 L~~i~l~-~~i~~I~~~aF~~c~~L~~i~lp~~-v~-~I~~~aF~~----C~~L~~i~ip~s-v~~I~~~aF~~C~~L~~ 361 (394)
T 4gt6_A 290 LQDIEFS-SRITELPESVFAGCISLKSIDIPEG-IT-QILDDAFAG----CEQLERIAIPSS-VTKIPESAFSNCTALNN 361 (394)
T ss_dssp CCEEECC-TTCCEECTTTTTTCTTCCEEECCTT-CC-EECTTTTTT----CTTCCEEEECTT-CCBCCGGGGTTCTTCCE
T ss_pred cccccCC-CcccccCceeecCCCCcCEEEeCCc-cc-EehHhHhhC----CCCCCEEEECcc-cCEEhHhHhhCCCCCCE
Confidence 8888886 5577777788888888888888765 54 454444331 235567888644 77777654 7788888
Q ss_pred EEeCCCCC
Q 002158 380 LRLGGNPI 387 (958)
Q Consensus 380 L~l~~N~l 387 (958)
+++.+|..
T Consensus 362 i~~~~~~~ 369 (394)
T 4gt6_A 362 IEYSGSRS 369 (394)
T ss_dssp EEESSCHH
T ss_pred EEECCcee
Confidence 88888754
|
| >4gt6_A Cell surface protein; leucine rich repeats, putative protein binding, extracellula protein, structural genomics; HET: MSE; 1.80A {Faecalibacterium prausnitzii a2-165} | Back alignment and structure |
|---|
Probab=98.59 E-value=7.8e-07 Score=100.49 Aligned_cols=283 Identities=12% Similarity=0.171 Sum_probs=150.5
Q ss_pred eEEEEccCCcCCCCccccccCCCCcceeeccCcc---cCCC-CccccCCCCCcEEEeeCCCCCCCCChhhcCCCCCCEEe
Q 002158 88 VRELQLLSMNLSGNLAPELGQLSRLQYYFMWNDL---TGTI-PKEIGNISSLIFLLLNGNKLSGSLPDELGYLSNLNRLQ 163 (958)
Q Consensus 88 v~~L~L~~~~l~~~~~~~l~~L~~L~~L~l~n~~---~~~i-p~~i~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~ 163 (958)
++++.+.+ +++..-..+|.+.++|+.+.+.++. ...| ..+|.++.+|+.+.+..+ ++..-...|..+.+|+.+.
T Consensus 66 L~sI~iP~-svt~Ig~~AF~~C~~L~~i~~~~n~p~~l~~Ig~~aF~~c~~L~~i~~~~~-~~~I~~~aF~~c~~L~~i~ 143 (394)
T 4gt6_A 66 LTSVQIPD-TVTEIGSNAFYNCTSLKRVTIQDNKPSCVKKIGRQAFMFCSELTDIPILDS-VTEIDSEAFHHCEELDTVT 143 (394)
T ss_dssp CCEEEECT-TCCEECTTTTTTCTTCCEEEEGGGCCCCCCEECTTTTTTCTTCCBCGGGTT-CSEECTTTTTTCTTCCEEE
T ss_pred CEEEEECC-CeeEEhHHHhhCCccCceEeecCCCCCeeeEechhhchhcccceeeccCCc-cceehhhhhhhhccccccc
Confidence 45555543 3444445667788888888776543 2233 345677777777766544 3324445567777777777
Q ss_pred cccccccccCccccccccccceEecccccccccCchhhcCCccchhhhccCCccccCCCcccCCCCCccEEEccCCCCCC
Q 002158 164 VDENNITGTIPKSFANLSRVRHLHLNNNSIGGQIPSELSKLSTLIHLLVDNNNLSGNLPPELSELPQLCILQLDNNNFSA 243 (958)
Q Consensus 164 L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~ 243 (958)
+..+ +..+....|..+.+|+.+.+.++ ++..-..+|.+ .+|+.+.+..+-.. ....+|..+.+|+......+....
T Consensus 144 lp~~-~~~I~~~~F~~c~~L~~i~~~~~-~~~I~~~aF~~-~~l~~i~ip~~~~~-i~~~af~~c~~l~~~~~~~~~~~~ 219 (394)
T 4gt6_A 144 IPEG-VTSVADGMFSYCYSLHTVTLPDS-VTAIEERAFTG-TALTQIHIPAKVTR-IGTNAFSECFALSTITSDSESYPA 219 (394)
T ss_dssp CCTT-CCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTT-CCCSEEEECTTCCE-ECTTTTTTCTTCCEEEECCSSSCB
T ss_pred ccce-eeeecccceecccccccccccce-eeEeccccccc-cceeEEEECCcccc-cccchhhhccccceeccccccccc
Confidence 7644 33345556777777777777654 33233344433 45665555443222 333445555555444333221110
Q ss_pred ---------------------------CCc--------cccccCCCCCCEEEcccCCCCCCCC-CCCCCCCcCEEeccCC
Q 002158 244 ---------------------------SEI--------PATYGNFSKLVKLSLRNCNLQGAVP-DLSRIPNLYYLDLSWN 287 (958)
Q Consensus 244 ---------------------------~~~--------p~~~~~l~~L~~L~L~~N~l~~~~~-~l~~l~~L~~L~Ls~N 287 (958)
..+ ...|.++.+|+.+.+.++..+ +.. .|.++++|+.+.+. +
T Consensus 220 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ip~~v~~i~~~aF~~c~~L~~i~lp~~~~~-I~~~aF~~c~~L~~i~l~-~ 297 (394)
T 4gt6_A 220 IDNVLYEKSANGDYALIRYPSQREDPAFKIPNGVARIETHAFDSCAYLASVKMPDSVVS-IGTGAFMNCPALQDIEFS-S 297 (394)
T ss_dssp SSSCEEEECTTSCEEEEECCTTCCCSEEECCTTEEEECTTTTTTCSSCCEEECCTTCCE-ECTTTTTTCTTCCEEECC-T
T ss_pred ccceeecccccccccccccccccccceEEcCCcceEcccceeeecccccEEecccccce-ecCcccccccccccccCC-C
Confidence 011 224666777777777655433 333 37777777777775 3
Q ss_pred cCCCcCCCCC--CCCCcCEEEccCCcCCCccchhccCCCCCCeEeeecccCCCccchhhhcccccCccccceEeccCCCC
Q 002158 288 HLTGSIPSKK--LSENVTTIDLSDNYLNGSILESISNLPFLQTLSLENNFLTGSIPATIWQNKSFSTKARLKIDLRNNSF 365 (958)
Q Consensus 288 ~l~~~~~~~~--~~~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~ip~~l~~~~~~~~~~l~~L~Ls~N~l 365 (958)
.++ .++... .+.+|+.++|..+ ++.+...+|.++.+|+.+.|..+ ++ .|....|.. ...|+.+++.+|..
T Consensus 298 ~i~-~I~~~aF~~c~~L~~i~lp~~-v~~I~~~aF~~C~~L~~i~ip~s-v~-~I~~~aF~~----C~~L~~i~~~~~~~ 369 (394)
T 4gt6_A 298 RIT-ELPESVFAGCISLKSIDIPEG-ITQILDDAFAGCEQLERIAIPSS-VT-KIPESAFSN----CTALNNIEYSGSRS 369 (394)
T ss_dssp TCC-EECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCEEEECTT-CC-BCCGGGGTT----CTTCCEEEESSCHH
T ss_pred ccc-ccCceeecCCCCcCEEEeCCc-ccEehHhHhhCCCCCCEEEECcc-cC-EEhHhHhhC----CCCCCEEEECCcee
Confidence 344 344332 3467777777654 66666777777777887777544 54 444444331 23455777776643
Q ss_pred CCCccCCCCCCcceEEeCCCCC
Q 002158 366 SNIVGDLTLPNNVTLRLGGNPI 387 (958)
Q Consensus 366 ~~l~~~~~l~~L~~L~l~~N~l 387 (958)
. +..-....+|+.|.+..|.+
T Consensus 370 ~-~~~~~~~~~L~~i~i~~~~~ 390 (394)
T 4gt6_A 370 Q-WNAISTDSGLQNLPVAPGSI 390 (394)
T ss_dssp H-HHTCBCCCCC----------
T ss_pred e-hhhhhccCCCCEEEeCCCCE
Confidence 2 22222455666666665543
|
| >3rfe_A Platelet glycoprotein IB beta chain; platelet surface receptor, GPIX, cell adhesion; HET: NAG; 1.25A {Homo sapiens} PDB: 3rez_A* | Back alignment and structure |
|---|
Probab=98.47 E-value=6.2e-08 Score=90.59 Aligned_cols=85 Identities=24% Similarity=0.387 Sum_probs=57.4
Q ss_pred eEeeecccCC-CccchhhhcccccCccccceEeccCCCCCCCccCC--CCCCcceEEeCCCCCCCCCCCCCCCcccccCC
Q 002158 328 TLSLENNFLT-GSIPATIWQNKSFSTKARLKIDLRNNSFSNIVGDL--TLPNNVTLRLGGNPICTSANIPNTGRFCGSDA 404 (958)
Q Consensus 328 ~L~L~~N~l~-~~ip~~l~~~~~~~~~~l~~L~Ls~N~l~~l~~~~--~l~~L~~L~l~~N~l~~~~~~~~~~~~~~~~~ 404 (958)
.++.+++.|+ ..+|..+ ...++.|+|++|+|+.++... .+++|+.|+|.+|||
T Consensus 12 ~v~Cs~~~L~~~~vP~~l-------p~~l~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~NP~----------------- 67 (130)
T 3rfe_A 12 LVDCGRRGLTWASLPTAF-------PVDTTELVLTGNNLTALPPGLLDALPALRTAHLGANPW----------------- 67 (130)
T ss_dssp EEECCSSCCCTTTSCSCC-------CTTCSEEECTTSCCSSCCTTTGGGCTTCCEEECCSSCC-----------------
T ss_pred EEEeCCCCCccccCCCCC-------CcCCCEEECCCCcCCccChhhhhhccccCEEEecCCCe-----------------
Confidence 4555555554 3455443 234567777777777777654 678888888877777
Q ss_pred CCCccccccCCCCCCCCCCCCCcccccCCC--CCCceeeeeceee
Q 002158 405 GGDETLTNSKVNCPVQACPVDNFFEYVPAS--PEPCFCAAPLRIG 447 (958)
Q Consensus 405 ~~~~~L~~n~~~C~c~~~~~~~~~~~~~~~--~~~~~c~sp~~~~ 447 (958)
.|||.+.++..|++..... .....|++|...+
T Consensus 68 -----------~CdC~l~~l~~wl~~~~~~~~~~~~~C~~P~~l~ 101 (130)
T 3rfe_A 68 -----------RCDCRLVPLRAWLAGRPERAPYRDLRCVAPPALR 101 (130)
T ss_dssp -----------BCSGGGHHHHHHHHTSSCSGGGTTCBCCBSTTTT
T ss_pred -----------eccCccHHHHHHHHhCcccccccCcEeCcChHHc
Confidence 7888888888898765432 2357899987643
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.46 E-value=6.3e-07 Score=95.55 Aligned_cols=135 Identities=17% Similarity=0.168 Sum_probs=98.8
Q ss_pred eeeeeCCe-EEEEEEEC-CCcEEEEEEeccCChhcHHHHHHHHHHHHccC-CCCcceEEEEEEeCCeEEEEEEecCCCCH
Q 002158 632 QVGQGGYG-KVYKGILS-DNTTVAIKRAEEGSLQGQNEFLTEIKLLSRLH-HRNLVSLLGYCDEEGEQMLVYEFVPNGTL 708 (958)
Q Consensus 632 ~lg~G~~g-~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~~~~~lV~E~~~~gsL 708 (958)
.+..|..| .||+.... ++..+++|+-... ....+.+|...|+.+. +--+.++++++.+.+..++|||+++|.++
T Consensus 31 ~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~---~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~~~ 107 (272)
T 4gkh_A 31 RDNVGQSGATIYRLYGKPNAPELFLKHGKGS---VANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGKTA 107 (272)
T ss_dssp EEECSSSSCEEEEEECCTTCCCEEEEEEETH---HHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSEEH
T ss_pred EccCCCcCCeEEEEEecCCCeEEEEEECCCC---CHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCccc
Confidence 46667666 69998765 4677999987542 3446788999998884 44477899999999999999999999888
Q ss_pred HHHhccCCCCCchHHHHHHHHHHHHHHHHHhhhcC---------------------------------------------
Q 002158 709 RDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEA--------------------------------------------- 743 (958)
Q Consensus 709 ~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~--------------------------------------------- 743 (958)
.+..... ......++.++++.|..||+..
T Consensus 108 ~~~~~~~------~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 181 (272)
T 4gkh_A 108 FQVLEEY------PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVWK 181 (272)
T ss_dssp HHHHHHC------GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHHHH
T ss_pred cccccCC------HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHHHH
Confidence 7765321 1223345566666666666421
Q ss_pred ----------CCCeeccCCCccceEecCCCCeEEeeeeeecc
Q 002158 744 ----------HPPVFHRDIKASNILLDSNLNAKVADFGLSRL 775 (958)
Q Consensus 744 ----------~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~ 775 (958)
.+.++|+|+.+.|||++.++.+-|+||+.+..
T Consensus 182 ~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~~ 223 (272)
T 4gkh_A 182 EMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGI 223 (272)
T ss_dssp HHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred HHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECccccc
Confidence 12389999999999999877778999998753
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.46 E-value=1e-06 Score=95.80 Aligned_cols=136 Identities=22% Similarity=0.221 Sum_probs=96.0
Q ss_pred CceeeeeCCeEEEEEEECCCcEEEEEEeccCChhcHHHHHHHHHHHHccCCC---CcceEEEEEE-eCCeEEEEEEecCC
Q 002158 630 STQVGQGGYGKVYKGILSDNTTVAIKRAEEGSLQGQNEFLTEIKLLSRLHHR---NLVSLLGYCD-EEGEQMLVYEFVPN 705 (958)
Q Consensus 630 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~---niv~l~~~~~-~~~~~~lV~E~~~~ 705 (958)
.+.++.|....||+. ++.+++|+.. .......+.+|+++|+.+.+. .+.+++.++. ..+..++||||++|
T Consensus 24 v~~l~~G~~n~v~~v----g~~~VlR~~~--~~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~G 97 (306)
T 3tdw_A 24 VESLGEGFRNYAILV----NGDWVFRFPK--SQQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQG 97 (306)
T ss_dssp EEEEEECSSEEEEEE----TTTEEEEEES--SHHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCCS
T ss_pred eeecCCCcceeEEEE----CCEEEEEecC--CchHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccCC
Confidence 356888888999997 5678888853 233456788999999999652 3667777774 45668899999999
Q ss_pred CCHHHHhccCCCCCchHHHHHHHHHHHHHHHHHhhhc-------------------------------------------
Q 002158 706 GTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTE------------------------------------------- 742 (958)
Q Consensus 706 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~------------------------------------------- 742 (958)
.++.+.... .++..++..++.++++.|+.||+.
T Consensus 98 ~~l~~~~~~----~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~l~ 173 (306)
T 3tdw_A 98 QILGEDGMA----VLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDYLT 173 (306)
T ss_dssp EECHHHHHT----TSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHHHH
T ss_pred eECchhhhh----hCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHHHH
Confidence 888663211 134445555555555555555542
Q ss_pred --------------CCCCeeccCCCccceEecC---CCC-eEEeeeeeecc
Q 002158 743 --------------AHPPVFHRDIKASNILLDS---NLN-AKVADFGLSRL 775 (958)
Q Consensus 743 --------------~~~~iiH~Dikp~NILl~~---~~~-~kl~DFGla~~ 775 (958)
..+.++|+|++|.||+++. ++. +.|+||+.+..
T Consensus 174 ~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~ 224 (306)
T 3tdw_A 174 LRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI 224 (306)
T ss_dssp HHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred HHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence 2234799999999999987 455 48999998764
|
| >1io0_A Tropomodulin; LRR protein, right-handed super-helix, protein binding; 1.45A {Gallus gallus} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=98.29 E-value=6.3e-08 Score=96.92 Aligned_cols=91 Identities=15% Similarity=0.206 Sum_probs=48.4
Q ss_pred cccCCCCCcEEEeeCC-CCCCC----CChhhcCCCCCCEEeccccccccc----CccccccccccceEeccccccccc--
Q 002158 128 EIGNISSLIFLLLNGN-KLSGS----LPDELGYLSNLNRLQVDENNITGT----IPKSFANLSRVRHLHLNNNSIGGQ-- 196 (958)
Q Consensus 128 ~i~~l~~L~~L~Ls~n-~l~~~----~p~~l~~l~~L~~L~L~~N~l~~~----~p~~~~~l~~L~~L~Ls~N~l~~~-- 196 (958)
.+...++|++|+|++| .+... +...+...++|++|+|++|+|... +...+...++|++|+|++|.|+..
T Consensus 31 ~l~~~~~L~~L~L~~n~~i~~~g~~~l~~~L~~~~~L~~L~Ls~n~i~~~g~~~l~~~L~~n~~L~~L~L~~N~i~~~g~ 110 (185)
T 1io0_A 31 IQNNDPDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISGSGI 110 (185)
T ss_dssp HHTTCTTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCHHHH
T ss_pred HHhcCCCCCEEEecCCCCCCHHHHHHHHHHHHhCCCcCEEECcCCCCChHHHHHHHHHHHhCCCcCEEECcCCcCCHHHH
Confidence 3555666777777776 66521 233445556677777777766532 233344445666666666666532
Q ss_pred --CchhhcCCccchhhhc--cCCccc
Q 002158 197 --IPSELSKLSTLIHLLV--DNNNLS 218 (958)
Q Consensus 197 --~p~~l~~l~~L~~L~L--~~N~l~ 218 (958)
+...+...++|++|+| ++|.|.
T Consensus 111 ~~l~~~L~~n~~L~~L~L~~~~N~i~ 136 (185)
T 1io0_A 111 LALVEALQSNTSLIELRIDNQSQPLG 136 (185)
T ss_dssp HHHHHGGGGCSSCCEEECCCCSSCCC
T ss_pred HHHHHHHHhCCCceEEEecCCCCCCC
Confidence 2233333444444444 444444
|
| >1io0_A Tropomodulin; LRR protein, right-handed super-helix, protein binding; 1.45A {Gallus gallus} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=98.28 E-value=6.9e-08 Score=96.64 Aligned_cols=92 Identities=17% Similarity=0.216 Sum_probs=53.6
Q ss_pred hhhcCCCCCCEEecccc-ccccc----CccccccccccceEeccccccccc----CchhhcCCccchhhhccCCccccC-
Q 002158 151 DELGYLSNLNRLQVDEN-NITGT----IPKSFANLSRVRHLHLNNNSIGGQ----IPSELSKLSTLIHLLVDNNNLSGN- 220 (958)
Q Consensus 151 ~~l~~l~~L~~L~L~~N-~l~~~----~p~~~~~l~~L~~L~Ls~N~l~~~----~p~~l~~l~~L~~L~L~~N~l~~~- 220 (958)
..+...++|++|+|++| .+... +...+...++|++|+|++|.|... +...+...++|++|+|++|.|...
T Consensus 30 ~~l~~~~~L~~L~L~~n~~i~~~g~~~l~~~L~~~~~L~~L~Ls~n~i~~~g~~~l~~~L~~n~~L~~L~L~~N~i~~~g 109 (185)
T 1io0_A 30 RIQNNDPDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISGSG 109 (185)
T ss_dssp HHHTTCTTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCHHH
T ss_pred HHHhcCCCCCEEEecCCCCCCHHHHHHHHHHHHhCCCcCEEECcCCCCChHHHHHHHHHHHhCCCcCEEECcCCcCCHHH
Confidence 44666788888888888 77632 334455567788888888877632 223334445566666666655532
Q ss_pred ---CCcccCCCCCccEEEc--cCCCCC
Q 002158 221 ---LPPELSELPQLCILQL--DNNNFS 242 (958)
Q Consensus 221 ---~~~~l~~l~~L~~L~L--~~N~l~ 242 (958)
+...+...++|++|+| ++|.|+
T Consensus 110 ~~~l~~~L~~n~~L~~L~L~~~~N~i~ 136 (185)
T 1io0_A 110 ILALVEALQSNTSLIELRIDNQSQPLG 136 (185)
T ss_dssp HHHHHHGGGGCSSCCEEECCCCSSCCC
T ss_pred HHHHHHHHHhCCCceEEEecCCCCCCC
Confidence 2334444455555555 445543
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=98.22 E-value=9.7e-07 Score=98.25 Aligned_cols=79 Identities=6% Similarity=0.012 Sum_probs=56.1
Q ss_pred cee-eeeCCeEEEEEEEC-------CCcEEEEEEeccCC---hhcHHHHHHHHHHHHccC-C--CCcceEEEEEEeC---
Q 002158 631 TQV-GQGGYGKVYKGILS-------DNTTVAIKRAEEGS---LQGQNEFLTEIKLLSRLH-H--RNLVSLLGYCDEE--- 693 (958)
Q Consensus 631 ~~l-g~G~~g~Vy~~~~~-------~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~-H--~niv~l~~~~~~~--- 693 (958)
+.| +.|....+|+.... +++.+++|+..... ......+.+|+.+++.+. + -.+.++++++.+.
T Consensus 26 ~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~~ 105 (357)
T 3ats_A 26 SGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDVL 105 (357)
T ss_dssp EEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTTT
T ss_pred EECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCcc
Confidence 457 78888999998764 26778899865422 101235678999988884 3 3577888888665
Q ss_pred CeEEEEEEecCCCCHH
Q 002158 694 GEQMLVYEFVPNGTLR 709 (958)
Q Consensus 694 ~~~~lV~E~~~~gsL~ 709 (958)
+..++||||++|..+.
T Consensus 106 g~~~~v~e~l~G~~l~ 121 (357)
T 3ats_A 106 GTPFFLMDYVEGVVPP 121 (357)
T ss_dssp SSCEEEEECCCCBCCC
T ss_pred CCceEEEEecCCCChh
Confidence 4578999999887654
|
| >4h09_A Hypothetical leucine rich repeat protein; two LRR_5 domains, PF13306 family, structural genomics, JOIN for structural genomics, JCSG; 2.50A {Eubacterium ventriosum} | Back alignment and structure |
|---|
Probab=98.22 E-value=4e-05 Score=85.81 Aligned_cols=126 Identities=12% Similarity=0.102 Sum_probs=63.6
Q ss_pred cccCCCCCCEEEcccCCCCCCCC-CCCCCCCcCEEeccCCcCCCcCCCC--CCCCCcCEEEccCCcCCCccchhccCCCC
Q 002158 249 TYGNFSKLVKLSLRNCNLQGAVP-DLSRIPNLYYLDLSWNHLTGSIPSK--KLSENVTTIDLSDNYLNGSILESISNLPF 325 (958)
Q Consensus 249 ~~~~l~~L~~L~L~~N~l~~~~~-~l~~l~~L~~L~Ls~N~l~~~~~~~--~~~~~L~~L~Ls~N~l~~~~~~~~~~l~~ 325 (958)
.+....+|+.+.+..+ ++.+.. .+.++.+|+.+.+..+ ++ .+... ..+.+|+.+.+..+ ++......|.++.+
T Consensus 212 ~f~~~~~l~~i~~~~~-~~~i~~~~f~~~~~L~~i~lp~~-v~-~I~~~aF~~~~~l~~i~l~~~-i~~i~~~aF~~c~~ 287 (379)
T 4h09_A 212 GFSYGKNLKKITITSG-VTTLGDGAFYGMKALDEIAIPKN-VT-SIGSFLLQNCTALKTLNFYAK-VKTVPYLLCSGCSN 287 (379)
T ss_dssp TTTTCSSCSEEECCTT-CCEECTTTTTTCSSCCEEEECTT-CC-EECTTTTTTCTTCCEEEECCC-CSEECTTTTTTCTT
T ss_pred ccccccccceeeeccc-eeEEccccccCCccceEEEcCCC-cc-EeCccccceeehhcccccccc-ceeccccccccccc
Confidence 3444555555555433 222222 2555666666666554 33 22222 22356666666433 54455556666666
Q ss_pred CCeEeeecccCCCccchhhhcccccCccccceEeccCCCCCCCccCC--CCCCcceEEeCC
Q 002158 326 LQTLSLENNFLTGSIPATIWQNKSFSTKARLKIDLRNNSFSNIVGDL--TLPNNVTLRLGG 384 (958)
Q Consensus 326 L~~L~L~~N~l~~~ip~~l~~~~~~~~~~l~~L~Ls~N~l~~l~~~~--~l~~L~~L~l~~ 384 (958)
|+.+.+.++.++ .|+...|.. ...|+.++|.++ ++.|.... +..+|+.+.+..
T Consensus 288 L~~i~l~~~~i~-~I~~~aF~~----c~~L~~i~lp~~-l~~I~~~aF~~C~~L~~i~ip~ 342 (379)
T 4h09_A 288 LTKVVMDNSAIE-TLEPRVFMD----CVKLSSVTLPTA-LKTIQVYAFKNCKALSTISYPK 342 (379)
T ss_dssp CCEEEECCTTCC-EECTTTTTT----CTTCCEEECCTT-CCEECTTTTTTCTTCCCCCCCT
T ss_pred cccccccccccc-eehhhhhcC----CCCCCEEEcCcc-ccEEHHHHhhCCCCCCEEEECC
Confidence 666666666665 444433321 123445666533 55555443 455666665543
|
| >3rw6_A Nuclear RNA export factor 1; retroviral constitutive transport element (CTE), RNA recogni motif (RRM); HET: GTP CCC; 2.30A {Homo sapiens} PDB: 3rw7_A 1koo_A 1koh_A 1ft8_A 1fo1_A | Back alignment and structure |
|---|
Probab=98.18 E-value=2.6e-07 Score=97.22 Aligned_cols=104 Identities=19% Similarity=0.283 Sum_probs=61.3
Q ss_pred ccCCCCCcE--EEeeCCCCCCCCCh----hhcCCCCCCEEecccccccc--cCccccccccccceEecccccccccCchh
Q 002158 129 IGNISSLIF--LLLNGNKLSGSLPD----ELGYLSNLNRLQVDENNITG--TIPKSFANLSRVRHLHLNNNSIGGQIPSE 200 (958)
Q Consensus 129 i~~l~~L~~--L~Ls~n~l~~~~p~----~l~~l~~L~~L~L~~N~l~~--~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~ 200 (958)
+...+.|.. ++++.|... .++. ...++++|++|+|++|+|++ .++..+..+++|+.|+|++|+|++. ..
T Consensus 137 l~~dp~L~~~~l~l~~N~~~-~~~~~l~i~~~~l~~L~~L~Ls~N~l~~l~~l~~~~~~l~~L~~L~Ls~N~i~~~--~~ 213 (267)
T 3rw6_A 137 LRSDPDLVAQNIDVVLNRRS-CMAATLRIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSE--RE 213 (267)
T ss_dssp GGGCHHHHHTTCCCCTTSHH-HHHHHHHHHHHHCTTCCEEECTTSCCCCCGGGTTHHHHSTTCCEEECTTSCCCSG--GG
T ss_pred cCCCcchhhcCccccCCHHH-HHHHHHHHHHhhCCCCCEEECCCCCCCCCccchhHHhhCCCCCEEECCCCccCCc--hh
Confidence 444444544 555666432 2222 12356677777777777775 3445566677777777777777743 22
Q ss_pred hcCCc--cchhhhccCCccccCCC-------cccCCCCCccEEE
Q 002158 201 LSKLS--TLIHLLVDNNNLSGNLP-------PELSELPQLCILQ 235 (958)
Q Consensus 201 l~~l~--~L~~L~L~~N~l~~~~~-------~~l~~l~~L~~L~ 235 (958)
+..+. +|++|+|++|.+.+..| ..+..+|+|+.||
T Consensus 214 l~~l~~l~L~~L~L~~Npl~~~~~~~~~y~~~il~~~P~L~~LD 257 (267)
T 3rw6_A 214 LDKIKGLKLEELWLDGNSLCDTFRDQSTYISAIRERFPKLLRLD 257 (267)
T ss_dssp GGGGTTSCCSEEECTTSTTGGGCSSHHHHHHHHHHHCTTCCEES
T ss_pred hhhcccCCcceEEccCCcCccccCcchhHHHHHHHHCcccCeEC
Confidence 33333 77777777777775544 2356677787776
|
| >3rw6_A Nuclear RNA export factor 1; retroviral constitutive transport element (CTE), RNA recogni motif (RRM); HET: GTP CCC; 2.30A {Homo sapiens} PDB: 3rw7_A 1koo_A 1koh_A 1ft8_A 1fo1_A | Back alignment and structure |
|---|
Probab=98.15 E-value=1.5e-07 Score=99.04 Aligned_cols=7 Identities=0% Similarity=-0.320 Sum_probs=3.5
Q ss_pred CCCceee
Q 002158 70 NWTGVLC 76 (958)
Q Consensus 70 ~w~gV~C 76 (958)
+|.|+.|
T Consensus 79 ~~~g~i~ 85 (267)
T 3rw6_A 79 AVNYKIL 85 (267)
T ss_dssp HTTSSCB
T ss_pred hcCcEEE
Confidence 3555555
|
| >4h09_A Hypothetical leucine rich repeat protein; two LRR_5 domains, PF13306 family, structural genomics, JOIN for structural genomics, JCSG; 2.50A {Eubacterium ventriosum} | Back alignment and structure |
|---|
Probab=98.13 E-value=9.1e-05 Score=82.89 Aligned_cols=265 Identities=9% Similarity=0.041 Sum_probs=174.7
Q ss_pred cccCCCCcceeeccCcccCCCCccccCCCCCcEEEeeCCCCCCCCChhhcCCCCCCEEecccccccccCccccccccccc
Q 002158 105 ELGQLSRLQYYFMWNDLTGTIPKEIGNISSLIFLLLNGNKLSGSLPDELGYLSNLNRLQVDENNITGTIPKSFANLSRVR 184 (958)
Q Consensus 105 ~l~~L~~L~~L~l~n~~~~~ip~~i~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~ 184 (958)
.+..-.+|+.+.+....+..-..+|.++.+|+.++|..+ ++..-..+|.++ +|+.+.+..+ ++.+...+|.. .+|+
T Consensus 41 ~~~~~~~i~~v~ip~~vt~Ig~~aF~~C~~L~~I~lp~~-v~~Ig~~aF~~c-~l~~i~~~~~-l~~I~~~aF~~-~~L~ 116 (379)
T 4h09_A 41 WYKDRDRISEVRVNSGITSIGEANFNSCYNMTKVTVAST-VTSIGDGAFADT-KLQSYTGMER-VKKFGDYVFQG-TDLD 116 (379)
T ss_dssp TGGGGGGCSEEEECTTEEEECTTTTTTCTTCCEEEECTT-CCEECTTTTTTC-CCCEEEECTT-CCEECTTTTTT-CCCS
T ss_pred ccccccCCEEEEeCCCccChHHHHhhCCCCCCEEEeCCc-ceEechhhhcCC-CCceEECCce-eeEeccceecc-CCcc
Confidence 344556677777766665555567888899999998754 654445566665 6777777654 44344445554 4788
Q ss_pred eEecccccccccCchhhcCCccchhhhccCCccccCCCcccCCCCCccEEEccCCCCCC-----------CCccccccCC
Q 002158 185 HLHLNNNSIGGQIPSELSKLSTLIHLLVDNNNLSGNLPPELSELPQLCILQLDNNNFSA-----------SEIPATYGNF 253 (958)
Q Consensus 185 ~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~-----------~~~p~~~~~l 253 (958)
.+.+.++... ....+|.+. +|+.+.+.. .++......|..+.+|+.+.+..+.... ......+...
T Consensus 117 ~i~lp~~~~~-i~~~~F~~~-~l~~~~~~~-~v~~i~~~~f~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 193 (379)
T 4h09_A 117 DFEFPGATTE-IGNYIFYNS-SVKRIVIPK-SVTTIKDGIGYKAENLEKIEVSSNNKNYVAENYVLYNKNKTILESYPAA 193 (379)
T ss_dssp EEECCTTCCE-ECTTTTTTC-CCCEEEECT-TCCEECSCTTTTCTTCCEEEECTTCSSEEEETTEEEETTSSEEEECCTT
T ss_pred cccCCCcccc-ccccccccc-eeeeeeccc-eeeccccchhcccccccccccccccceeecccceecccccceecccccc
Confidence 8888765332 344455554 555555543 3444556778888888888877654321 1122334455
Q ss_pred CCCCEEEcccCCCCCCCCCCCCCCCcCEEeccCCcCCCcCCCC--CCCCCcCEEEccCCcCCCccchhccCCCCCCeEee
Q 002158 254 SKLVKLSLRNCNLQGAVPDLSRIPNLYYLDLSWNHLTGSIPSK--KLSENVTTIDLSDNYLNGSILESISNLPFLQTLSL 331 (958)
Q Consensus 254 ~~L~~L~L~~N~l~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~--~~~~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L 331 (958)
..+..+.+..+.-.-....+....+|+.+.+..+- . .+... ..+..|+.+.+..+ ++.+....|.++.+|+.+.+
T Consensus 194 ~~~~~~~~~~~~~~i~~~~f~~~~~l~~i~~~~~~-~-~i~~~~f~~~~~L~~i~lp~~-v~~I~~~aF~~~~~l~~i~l 270 (379)
T 4h09_A 194 KTGTEFTIPSTVKTVTAYGFSYGKNLKKITITSGV-T-TLGDGAFYGMKALDEIAIPKN-VTSIGSFLLQNCTALKTLNF 270 (379)
T ss_dssp CCCSEEECCTTCCEECTTTTTTCSSCSEEECCTTC-C-EECTTTTTTCSSCCEEEECTT-CCEECTTTTTTCTTCCEEEE
T ss_pred ccccccccccceeEEeecccccccccceeeeccce-e-EEccccccCCccceEEEcCCC-ccEeCccccceeehhccccc
Confidence 66666666554433223347788899999987663 2 23332 44589999999876 77788889999999999999
Q ss_pred ecccCCCccchhhhcccccCccccceEeccCCCCCCCccCC--CCCCcceEEeCCC
Q 002158 332 ENNFLTGSIPATIWQNKSFSTKARLKIDLRNNSFSNIVGDL--TLPNNVTLRLGGN 385 (958)
Q Consensus 332 ~~N~l~~~ip~~l~~~~~~~~~~l~~L~Ls~N~l~~l~~~~--~l~~L~~L~l~~N 385 (958)
..+ +. .++...|.. ...|+.+++.++.++.|.... +..+|+.+.|..|
T Consensus 271 ~~~-i~-~i~~~aF~~----c~~L~~i~l~~~~i~~I~~~aF~~c~~L~~i~lp~~ 320 (379)
T 4h09_A 271 YAK-VK-TVPYLLCSG----CSNLTKVVMDNSAIETLEPRVFMDCVKLSSVTLPTA 320 (379)
T ss_dssp CCC-CS-EECTTTTTT----CTTCCEEEECCTTCCEECTTTTTTCTTCCEEECCTT
T ss_pred ccc-ce-ecccccccc----ccccccccccccccceehhhhhcCCCCCCEEEcCcc
Confidence 765 54 455554432 346779999999999998766 7789999998654
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=97.98 E-value=1.4e-05 Score=90.22 Aligned_cols=75 Identities=15% Similarity=0.103 Sum_probs=49.9
Q ss_pred CceeeeeCCeEEEEEEEC-CCcEEEEEEeccCCh-------hcHHHHHHHHHHHHccCC--CC-cceEEEEEEeCCeEEE
Q 002158 630 STQVGQGGYGKVYKGILS-DNTTVAIKRAEEGSL-------QGQNEFLTEIKLLSRLHH--RN-LVSLLGYCDEEGEQML 698 (958)
Q Consensus 630 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-------~~~~~~~~E~~~l~~l~H--~n-iv~l~~~~~~~~~~~l 698 (958)
.+.||.|.++.||++... +++.|+||....... ....++..|.++++.+.. +. +.+++.+ +.+..++
T Consensus 35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~l 112 (397)
T 2olc_A 35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT 112 (397)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccEE
Confidence 357899999999999754 468899998653211 123456789999988742 33 4456654 3445689
Q ss_pred EEEecCCC
Q 002158 699 VYEFVPNG 706 (958)
Q Consensus 699 V~E~~~~g 706 (958)
||||+++.
T Consensus 113 vmE~l~g~ 120 (397)
T 2olc_A 113 VMEDLSHL 120 (397)
T ss_dssp EECCCTTS
T ss_pred EEEeCCCc
Confidence 99999763
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=97.86 E-value=6.9e-05 Score=81.05 Aligned_cols=137 Identities=17% Similarity=0.200 Sum_probs=92.6
Q ss_pred CceeeeeCCeEEEEEEECCCcEEEEEEeccCChhcHHHHHHHHHHHHccC---CCCcceEEEEEEeCCeEEEEEEecCCC
Q 002158 630 STQVGQGGYGKVYKGILSDNTTVAIKRAEEGSLQGQNEFLTEIKLLSRLH---HRNLVSLLGYCDEEGEQMLVYEFVPNG 706 (958)
Q Consensus 630 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---H~niv~l~~~~~~~~~~~lV~E~~~~g 706 (958)
.+.|+.|.+..+|+... +++.+++|+.... ....|.+|++.|+.+. ...+.++++++...+..++||||+++.
T Consensus 41 ~~~l~gG~~n~~y~v~~-~~~~~vlK~~~~~---~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~G~ 116 (312)
T 3jr1_A 41 KEKLYSGEMNEIWLIND-EVQTVFVKINERS---YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALNKS 116 (312)
T ss_dssp EEEECCSSSSEEEEEES-SSCEEEEEEEEGG---GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCCCC
T ss_pred eEEeCCccceeeeEEEE-CCCeEEEEeCCcc---cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEeccCC
Confidence 45789999999999876 5678899987642 3556889999998883 366889999998888999999999987
Q ss_pred CHH--------H---HhccCCC-C-------------------CchHHHHH---HHH--HH--------------HHHH-
Q 002158 707 TLR--------D---WLSGRTK-E-------------------NLNFAMRL---RVA--LD--------------SAKG- 735 (958)
Q Consensus 707 sL~--------~---~l~~~~~-~-------------------~l~~~~~~---~i~--~~--------------ia~a- 735 (958)
.+. + .||.... . .-+|.... ++. .+ +.+.
T Consensus 117 ~~~~~~~~~lG~~LA~LH~~~~~~~fG~~~~~~~G~~~q~n~w~~~W~~f~~~~Rl~~~l~~a~~~g~~~~~~~~l~~~l 196 (312)
T 3jr1_A 117 KNKQSSFTIFAEKIAQLHQIQGPDKYGLDFDTWLGPIYQPNDWQTSWAKFFSENRIGWQLQICKEKGLIFGNIDLIVQIV 196 (312)
T ss_dssp CCCTTHHHHHHHHHHHHHHCCCCSSBBCSSCEEETTEEECCCCBSCHHHHHHHHTHHHHHHHHHHHTCCCSCHHHHHHHH
T ss_pred CCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCCCcCCCCCCcCCHHHHHHHHHHHHHHHHHHHcCCChHHHHHHHHHH
Confidence 541 1 2232211 0 01343321 111 11 1111
Q ss_pred HHHhhh-cCCCCeeccCCCccceEecCCCCeEEeeee
Q 002158 736 ILYLHT-EAHPPVFHRDIKASNILLDSNLNAKVADFG 771 (958)
Q Consensus 736 L~yLH~-~~~~~iiH~Dikp~NILl~~~~~~kl~DFG 771 (958)
...|.. ...+.++|+|+.+.|++++.++ +.|.||+
T Consensus 197 ~~~L~~~~~~~~l~HgD~~~~N~l~~~~~-~~~iD~~ 232 (312)
T 3jr1_A 197 ADTLSKHNPKPSILHGNLWIENCIQVDDK-IFVCNPA 232 (312)
T ss_dssp HHHHTTCCCCCEEECSSCSGGGEEEETTE-EEECSCC
T ss_pred HHHhccCCCCceeEeCCCCcCcEeecCCC-eEEEcCc
Confidence 223332 2356799999999999999887 8899984
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=97.82 E-value=5e-05 Score=83.61 Aligned_cols=139 Identities=17% Similarity=0.161 Sum_probs=79.4
Q ss_pred ceeeeeCCeEEEEEEECCCcEEEEEEeccCChhcHHHHHHHHHHHHccC--CCCcceEEE------EEEeCCeEEEEEEe
Q 002158 631 TQVGQGGYGKVYKGILSDNTTVAIKRAEEGSLQGQNEFLTEIKLLSRLH--HRNLVSLLG------YCDEEGEQMLVYEF 702 (958)
Q Consensus 631 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~--H~niv~l~~------~~~~~~~~~lV~E~ 702 (958)
+.|+.|..+.||+....+| .+++|+.... ..++..|+++++.+. .-.+.+++. +....+..++||||
T Consensus 38 ~~l~gG~~n~~~~v~~~~~-~~vlk~~~~~----~~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l~~~ 112 (346)
T 2q83_A 38 DVIQGNQMALVWKVHTDSG-AVCLKRIHRP----EKKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVVYDW 112 (346)
T ss_dssp EECC----CEEEEEEETTE-EEEEEEECSC----HHHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEEEEC
T ss_pred eeccccccCcEEEEEeCCC-CEEEEecCCC----HHHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEEEe
Confidence 3466677889999987555 5899998752 223344555555542 112334443 12346678999999
Q ss_pred cCCCCHH--------------HHhccC--C---C-------CCchHHHH-------------------------------
Q 002158 703 VPNGTLR--------------DWLSGR--T---K-------ENLNFAMR------------------------------- 725 (958)
Q Consensus 703 ~~~gsL~--------------~~l~~~--~---~-------~~l~~~~~------------------------------- 725 (958)
++|..+. ..+|.. . . ..-.|...
T Consensus 113 i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 192 (346)
T 2q83_A 113 IEGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQLYLQEI 192 (346)
T ss_dssp CCCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHHHHHHH
T ss_pred ecCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHHHHHHH
Confidence 9986532 111210 0 0 00112110
Q ss_pred HHHHHHHHHHHHHhhh----------cCCCCeeccCCCccceEecCCCCeEEeeeeeec
Q 002158 726 LRVALDSAKGILYLHT----------EAHPPVFHRDIKASNILLDSNLNAKVADFGLSR 774 (958)
Q Consensus 726 ~~i~~~ia~aL~yLH~----------~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~ 774 (958)
..+..++.+++++|++ ...+.++|+|+++.||+++.++.+.|+||+.+.
T Consensus 193 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~ 251 (346)
T 2q83_A 193 DGFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVS 251 (346)
T ss_dssp HHHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCE
T ss_pred HHHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhcc
Confidence 0111223445666763 123459999999999999888899999999765
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=97.82 E-value=8.4e-05 Score=79.73 Aligned_cols=76 Identities=18% Similarity=0.222 Sum_probs=57.1
Q ss_pred CCceeeeeCCeEEEEEEECCCcEEEEEEeccCChhcHHHHHHHHHHHHccCC---CCcceEEEEEEeCCeEEEEEEecCC
Q 002158 629 SSTQVGQGGYGKVYKGILSDNTTVAIKRAEEGSLQGQNEFLTEIKLLSRLHH---RNLVSLLGYCDEEGEQMLVYEFVPN 705 (958)
Q Consensus 629 ~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H---~niv~l~~~~~~~~~~~lV~E~~~~ 705 (958)
..+.+|.|..+.||+.+..||+.|+||+...........|.+|++.|+.+.- --+.+++++. ..++||||+++
T Consensus 19 ~v~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~----~~~lv~e~l~~ 94 (288)
T 3f7w_A 19 AVAERGHSHRWHLYRVELADGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGWD----DRTLAMEWVDE 94 (288)
T ss_dssp EEEEEEEETTEEEEEEEETTSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEEE----TTEEEEECCCC
T ss_pred EEEecCCCCCeEEEEEEECCCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEecc----CceEEEEeecc
Confidence 3467999999999999999999999998765544444467899999998842 2355666543 34789999987
Q ss_pred CCH
Q 002158 706 GTL 708 (958)
Q Consensus 706 gsL 708 (958)
+..
T Consensus 95 ~~~ 97 (288)
T 3f7w_A 95 RPP 97 (288)
T ss_dssp CCC
T ss_pred cCC
Confidence 643
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.60 E-value=0.00014 Score=82.53 Aligned_cols=73 Identities=15% Similarity=0.185 Sum_probs=46.5
Q ss_pred CceeeeeCCeEEEEEEECCCcEEEEEEeccC------C---hhcHHHHHHHHHHHHc-cCCCCcceEEEEEEeCCeEEEE
Q 002158 630 STQVGQGGYGKVYKGILSDNTTVAIKRAEEG------S---LQGQNEFLTEIKLLSR-LHHRNLVSLLGYCDEEGEQMLV 699 (958)
Q Consensus 630 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~------~---~~~~~~~~~E~~~l~~-l~H~niv~l~~~~~~~~~~~lV 699 (958)
.+.||.|....||++.. +++.++||..... . ......+..|+..+.. .....+.+++.+. .+..++|
T Consensus 39 i~~l~~G~~n~vyrv~~-~~~~~vvK~~~p~~~~~~~~~~~~~~~~~~E~e~l~~~~~~~~~~vP~v~~~~--~~~~~lv 115 (420)
T 2pyw_A 39 IKEVGDGNLNFVFIVVG-SSGSLVIKQALPYIRCIGESWPMTKERAYFEATTLRKHGNLSPDHVPEVYHFD--RTMALIG 115 (420)
T ss_dssp EEECCCSSSCEEEEEEC-SSCEEEEEECCSBCTTTCTTSBCCTTHHHHHHHHHHHHHHHSGGGSCCEEEEE--TTTTEEE
T ss_pred EEEccCCCcEEEEEEEc-CCceEEEEECchhhcccCcccccchhHHHHHHHHHHHHHhhCCCCCCeEEEEC--CCccEEE
Confidence 35689999999999964 5678999943210 1 1123344444443332 2335667777775 5678999
Q ss_pred EEec-CC
Q 002158 700 YEFV-PN 705 (958)
Q Consensus 700 ~E~~-~~ 705 (958)
|||+ ++
T Consensus 116 ~e~l~~g 122 (420)
T 2pyw_A 116 MRYLEPP 122 (420)
T ss_dssp ECCCCTT
T ss_pred EeecCCc
Confidence 9999 76
|
| >3e4g_A ATP synthase subunit S, mitochondrial; leucine-rich repeat, CF0, hydrogen ION transport, inner membrane, ION transport, membrane, mitochondrion; 0.96A {Bos taurus} PDB: 3e3z_A 3dze_A 3e2j_A | Back alignment and structure |
|---|
Probab=97.60 E-value=1.7e-05 Score=77.30 Aligned_cols=83 Identities=8% Similarity=0.079 Sum_probs=46.8
Q ss_pred CCCcEEEeeCCCCCCCCChhhcCCCCCCEEeccccc-ccccCccccccc----cccceEeccccc-ccccCchhhcCCcc
Q 002158 133 SSLIFLLLNGNKLSGSLPDELGYLSNLNRLQVDENN-ITGTIPKSFANL----SRVRHLHLNNNS-IGGQIPSELSKLST 206 (958)
Q Consensus 133 ~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~L~~N~-l~~~~p~~~~~l----~~L~~L~Ls~N~-l~~~~p~~l~~l~~ 206 (958)
-+|++|||+++.++..--..+..+++|++|+|++|. |+..--..++.+ ++|++|+|++|. |+..--..+..+++
T Consensus 61 ~~L~~LDLs~~~Itd~GL~~L~~~~~L~~L~L~~C~~ItD~gL~~L~~~~~~~~~L~~L~Ls~C~~ITD~Gl~~L~~~~~ 140 (176)
T 3e4g_A 61 YKIQAIDATDSCIMSIGFDHMEGLQYVEKIRLCKCHYIEDGCLERLSQLENLQKSMLEMEIISCGNVTDKGIIALHHFRN 140 (176)
T ss_dssp CCEEEEEEESCCCCGGGGGGGTTCSCCCEEEEESCTTCCHHHHHHHHTCHHHHHHCCEEEEESCTTCCHHHHHHGGGCTT
T ss_pred ceEeEEeCcCCCccHHHHHHhcCCCCCCEEEeCCCCccCHHHHHHHHhcccccCCCCEEEcCCCCcCCHHHHHHHhcCCC
Confidence 357788888877765444456677777777777764 554333344443 356666666653 55322233444444
Q ss_pred chhhhccCC
Q 002158 207 LIHLLVDNN 215 (958)
Q Consensus 207 L~~L~L~~N 215 (958)
|+.|+|+++
T Consensus 141 L~~L~L~~c 149 (176)
T 3e4g_A 141 LKYLFLSDL 149 (176)
T ss_dssp CCEEEEESC
T ss_pred CCEEECCCC
Confidence 444444444
|
| >3e4g_A ATP synthase subunit S, mitochondrial; leucine-rich repeat, CF0, hydrogen ION transport, inner membrane, ION transport, membrane, mitochondrion; 0.96A {Bos taurus} PDB: 3e3z_A 3dze_A 3e2j_A | Back alignment and structure |
|---|
Probab=97.54 E-value=1.4e-05 Score=77.86 Aligned_cols=84 Identities=14% Similarity=0.156 Sum_probs=54.8
Q ss_pred CCCCEEecccccccccCccccccccccceEeccccc-ccccCchhhcCC----ccchhhhccCCc-cccCCCcccCCCCC
Q 002158 157 SNLNRLQVDENNITGTIPKSFANLSRVRHLHLNNNS-IGGQIPSELSKL----STLIHLLVDNNN-LSGNLPPELSELPQ 230 (958)
Q Consensus 157 ~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~-l~~~~p~~l~~l----~~L~~L~L~~N~-l~~~~~~~l~~l~~ 230 (958)
.+|++|||+++.++..--..+.++++|+.|+|++|. |+..--..+..+ ++|++|+|++|. |+...-..+..+++
T Consensus 61 ~~L~~LDLs~~~Itd~GL~~L~~~~~L~~L~L~~C~~ItD~gL~~L~~~~~~~~~L~~L~Ls~C~~ITD~Gl~~L~~~~~ 140 (176)
T 3e4g_A 61 YKIQAIDATDSCIMSIGFDHMEGLQYVEKIRLCKCHYIEDGCLERLSQLENLQKSMLEMEIISCGNVTDKGIIALHHFRN 140 (176)
T ss_dssp CCEEEEEEESCCCCGGGGGGGTTCSCCCEEEEESCTTCCHHHHHHHHTCHHHHHHCCEEEEESCTTCCHHHHHHGGGCTT
T ss_pred ceEeEEeCcCCCccHHHHHHhcCCCCCCEEEeCCCCccCHHHHHHHHhcccccCCCCEEEcCCCCcCCHHHHHHHhcCCC
Confidence 468888888888886656667788888888888885 664433445543 356677776663 55433344555666
Q ss_pred ccEEEccCCC
Q 002158 231 LCILQLDNNN 240 (958)
Q Consensus 231 L~~L~L~~N~ 240 (958)
|++|+|+++.
T Consensus 141 L~~L~L~~c~ 150 (176)
T 3e4g_A 141 LKYLFLSDLP 150 (176)
T ss_dssp CCEEEEESCT
T ss_pred CCEEECCCCC
Confidence 6666666554
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=97.35 E-value=0.00095 Score=73.02 Aligned_cols=141 Identities=13% Similarity=0.092 Sum_probs=74.9
Q ss_pred ceeeeeCCeE-EEEEEECCCcEEEEEEeccCChhcHHHHHHHHHHHHccC-C-CCcceEEEEEEeCCeEEEEEEecCCCC
Q 002158 631 TQVGQGGYGK-VYKGILSDNTTVAIKRAEEGSLQGQNEFLTEIKLLSRLH-H-RNLVSLLGYCDEEGEQMLVYEFVPNGT 707 (958)
Q Consensus 631 ~~lg~G~~g~-Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-H-~niv~l~~~~~~~~~~~lV~E~~~~gs 707 (958)
+.|+.|+... +|+....+++.+++|....... ..+..|+.+++.+. + -.+.+++.+....+ ++|||++++..
T Consensus 24 ~~l~gg~s~~~~~r~~~~~~~~~vlk~~~~~~~---~~~~~e~~~l~~L~~~g~~vP~v~~~d~~~g--~ll~e~l~~~~ 98 (333)
T 3csv_A 24 TPLAGDASSRRYQRLRSPTGAKAVLMDWSPEEG---GDTQPFVDLAQYLRNLDISAPEIYAEEHARG--LLLIEDLGDAL 98 (333)
T ss_dssp CC--------CCEEEECTTCCEEEEEECCTTTT---CCSHHHHHHHHHHHHTTCBCCCEEEEETTTT--EEEECCCCSCB
T ss_pred eECCCCCCCceEEEEEcCCCCeEEEEECCCCCC---ccccHHHHHHHHHHhCCCCCCceeeecCCCC--EEEEeeCCCcc
Confidence 3465565554 6677654467788876544321 22345677776663 2 33567777754443 78999998777
Q ss_pred HHHHhccCCC------------------------CCchHHHHH-------H-------------HHHHHHHHHHHhh---
Q 002158 708 LRDWLSGRTK------------------------ENLNFAMRL-------R-------------VALDSAKGILYLH--- 740 (958)
Q Consensus 708 L~~~l~~~~~------------------------~~l~~~~~~-------~-------------i~~~ia~aL~yLH--- 740 (958)
+.+++..... ..++..... . ....+.+.++.+.
T Consensus 99 l~~~l~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~l~~~~ 178 (333)
T 3csv_A 99 FTEVINNDPAQEMPLYRAAVDLLIHLHDAQTPELARLDPETLSEMTRLAFSEYRYAILGDAAEDNRKRFEHRFAQILSAQ 178 (333)
T ss_dssp HHHHHHHCGGGHHHHHHHHHHHHHHHHTSCCCCCCBCCHHHHHHTTTHHHHTHHHHHHSSCCHHHHHHHHHHHHHHHHHH
T ss_pred hHHHhcCCCccHHHHHHHHHHHHHHHhcCCCccCCccCHHHHHHHHHHHHHHHHHHhcCCCcHHHHHHHHHHHHHHHHhc
Confidence 7655432110 001111000 0 0001111222221
Q ss_pred hcCCCCeeccCCCccceEecCC----CCeEEeeeeeeccc
Q 002158 741 TEAHPPVFHRDIKASNILLDSN----LNAKVADFGLSRLA 776 (958)
Q Consensus 741 ~~~~~~iiH~Dikp~NILl~~~----~~~kl~DFGla~~~ 776 (958)
....+.++|||+.+.|||++.+ +.+.|+||+.+...
T Consensus 179 ~~~~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~G 218 (333)
T 3csv_A 179 LEGDMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKLG 218 (333)
T ss_dssp CCSCCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEEE
T ss_pred ccCCCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCcC
Confidence 1123459999999999999875 67999999988653
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.23 E-value=0.0018 Score=70.38 Aligned_cols=157 Identities=13% Similarity=0.102 Sum_probs=86.8
Q ss_pred cChHHHHHHHcCCCC-----CceeeeeCCeEEEEEEECCCcEEEEEEeccCChhcHHHHHHHHHHHHccCCCC--cceEE
Q 002158 615 FKFKELAMATAYFSS-----STQVGQGGYGKVYKGILSDNTTVAIKRAEEGSLQGQNEFLTEIKLLSRLHHRN--LVSLL 687 (958)
Q Consensus 615 ~~~~el~~~~~~~~~-----~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~n--iv~l~ 687 (958)
++.+++...-..|.. .+.|+.|....+|+....+| .+++|...... ....+..|+++++.+.... +.+++
T Consensus 7 ~~~~~l~~~l~~~~~~~~~~~~~i~~G~~n~~~~v~~~~g-~~vlk~~~~~~--~~~~l~~e~~~l~~L~~~g~~vP~~~ 83 (322)
T 2ppq_A 7 ITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKD-PLILTLYEKRV--EKNDLPFFLGLMQHLAAKGLSCPLPL 83 (322)
T ss_dssp CCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSC-CEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBC
T ss_pred CCHHHHHHHHHhCCCCcceEeeccCCCcccceEEEEeCCc-cEEEEEeCCCC--CHHHHHHHHHHHHHHHHCCCCCCccc
Confidence 444555555555554 23466788889999987655 68899887531 1224556777777763212 33333
Q ss_pred EE------EEeCCeEEEEEEecCCCCHHH--------------HhccC----CC------CCchHHHHHHH---------
Q 002158 688 GY------CDEEGEQMLVYEFVPNGTLRD--------------WLSGR----TK------ENLNFAMRLRV--------- 728 (958)
Q Consensus 688 ~~------~~~~~~~~lV~E~~~~gsL~~--------------~l~~~----~~------~~l~~~~~~~i--------- 728 (958)
.. ....+..++||||++|..+.. .+|.. .. ....|.....-
T Consensus 84 ~~~~g~~~~~~~g~~~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~ 163 (322)
T 2ppq_A 84 PRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVE 163 (322)
T ss_dssp CBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTS
T ss_pred CCCCCCEEEEECCEEEEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhh
Confidence 21 123466799999998865311 11211 00 00123221110
Q ss_pred ---HHHHHHHHHHhhhc----CCCCeeccCCCccceEecCCCCeEEeeeeeec
Q 002158 729 ---ALDSAKGILYLHTE----AHPPVFHRDIKASNILLDSNLNAKVADFGLSR 774 (958)
Q Consensus 729 ---~~~ia~aL~yLH~~----~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~ 774 (958)
...+.+.++++++. ....++|+|+.+.|||++.+..+.|+||+.+.
T Consensus 164 ~~l~~~l~~~~~~l~~~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~ 216 (322)
T 2ppq_A 164 KGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC 216 (322)
T ss_dssp TTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred hhhHHHHHHHHHHHHhhCcccCCcccCCCCCCccCEEEeCCceEEEecchhcc
Confidence 01133445555532 12349999999999999987666899998765
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.14 E-value=0.0022 Score=69.83 Aligned_cols=141 Identities=14% Similarity=0.171 Sum_probs=81.7
Q ss_pred ceeeeeCCeEEEEEEECCCcEEEEEEeccCChhcHHHHHHHHHHHHccCCC--CcceEEEE-----EEeCCeEEEEEEec
Q 002158 631 TQVGQGGYGKVYKGILSDNTTVAIKRAEEGSLQGQNEFLTEIKLLSRLHHR--NLVSLLGY-----CDEEGEQMLVYEFV 703 (958)
Q Consensus 631 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~--niv~l~~~-----~~~~~~~~lV~E~~ 703 (958)
..++ |....||+....+|+.+++|...... .....+..|..+++.+... .+++++.. ....+..++||||+
T Consensus 32 ~~l~-g~~n~~y~v~~~~g~~~vlK~~~~~~-~~~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l~~~i 109 (328)
T 1zyl_A 32 TPLN-SYENRVYQFQDEDRRRFVVKFYRPER-WTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSV 109 (328)
T ss_dssp EEEC-CSSSEEEEECCTTCCCEEEEEECTTT-SCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECC
T ss_pred Eeec-CcccceEEEEcCCCCEEEEEEcCCCC-CCHHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEEEEec
Confidence 4566 88889999877777789999986432 2344566788888877421 24444443 22355678999999
Q ss_pred CCCCHH-----H------H---hcc----CC---CCCchHHHH----HHHH---------------HHHHHHHHHhhhc-
Q 002158 704 PNGTLR-----D------W---LSG----RT---KENLNFAMR----LRVA---------------LDSAKGILYLHTE- 742 (958)
Q Consensus 704 ~~gsL~-----~------~---l~~----~~---~~~l~~~~~----~~i~---------------~~ia~aL~yLH~~- 742 (958)
+|..+. . . +|. .. ....++... ..+. ..+.+.++.+.+.
T Consensus 110 ~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 189 (328)
T 1zyl_A 110 GGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHW 189 (328)
T ss_dssp CCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHC
T ss_pred CCCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCCHHHHHHHHHHHHHHHHHHHHHh
Confidence 875431 1 1 111 00 011221111 0010 0111122222211
Q ss_pred ---CCCCeeccCCCccceEecCCCCeEEeeeeeecc
Q 002158 743 ---AHPPVFHRDIKASNILLDSNLNAKVADFGLSRL 775 (958)
Q Consensus 743 ---~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~ 775 (958)
....++|+|+++.|||++ + .+.|+||+.+..
T Consensus 190 ~~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~ 223 (328)
T 1zyl_A 190 REDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDARN 223 (328)
T ss_dssp CSCSCCEECCSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred hhcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCCc
Confidence 234489999999999999 4 899999987754
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=97.12 E-value=0.00074 Score=74.94 Aligned_cols=140 Identities=22% Similarity=0.241 Sum_probs=84.2
Q ss_pred ceeeeeCCeEEEEEEEC--------CCcEEEEEEeccCChhcHHHHHHHHHHHHccC-CCCcceEEEEEEeCCeEEEEEE
Q 002158 631 TQVGQGGYGKVYKGILS--------DNTTVAIKRAEEGSLQGQNEFLTEIKLLSRLH-HRNLVSLLGYCDEEGEQMLVYE 701 (958)
Q Consensus 631 ~~lg~G~~g~Vy~~~~~--------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~~~~~lV~E 701 (958)
+.|..|-...+|+.... +++.+++|+... .......+.+|.++++.+. +.-..++++++.+ .+|||
T Consensus 56 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~-~~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----g~v~e 130 (379)
T 3feg_A 56 YPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGA-ILQGVDSLVLESVMFAILAERSLGPQLYGVFPE----GRLEQ 130 (379)
T ss_dssp EEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC----CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT----EEEEE
T ss_pred EEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCC-ccchHHHHHHHHHHHHHHHhcCCCCeEEEEcCC----ccEEE
Confidence 45777888899998864 247899998643 2233456678999998884 3334677777654 39999
Q ss_pred ecCCCCHHH--------------H---hccCC----CCCc-hHHHHHHHHHHHHH-------------------HHHHhh
Q 002158 702 FVPNGTLRD--------------W---LSGRT----KENL-NFAMRLRVALDSAK-------------------GILYLH 740 (958)
Q Consensus 702 ~~~~gsL~~--------------~---l~~~~----~~~l-~~~~~~~i~~~ia~-------------------aL~yLH 740 (958)
|++|.+|.. . ||... +... -+.++.++..++.. .++.|.
T Consensus 131 ~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~L~ 210 (379)
T 3feg_A 131 YIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGNLR 210 (379)
T ss_dssp CCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHHHH
T ss_pred EecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHHHH
Confidence 998865421 1 12211 1111 24455555443321 223332
Q ss_pred ----hc-CCCCeeccCCCccceEecCC----CCeEEeeeeeecc
Q 002158 741 ----TE-AHPPVFHRDIKASNILLDSN----LNAKVADFGLSRL 775 (958)
Q Consensus 741 ----~~-~~~~iiH~Dikp~NILl~~~----~~~kl~DFGla~~ 775 (958)
.. ....++|+|+.+.||+++.+ +.+.|+||..+..
T Consensus 211 ~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~ 254 (379)
T 3feg_A 211 KLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY 254 (379)
T ss_dssp HHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred HHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence 21 22359999999999999876 7899999998753
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=97.10 E-value=0.00069 Score=76.90 Aligned_cols=72 Identities=15% Similarity=0.206 Sum_probs=50.5
Q ss_pred ceeeeeCCeEEEEEEECC--------CcEEEEEEeccCChhcHHHHHHHHHHHHccC-CCCcceEEEEEEeCCeEEEEEE
Q 002158 631 TQVGQGGYGKVYKGILSD--------NTTVAIKRAEEGSLQGQNEFLTEIKLLSRLH-HRNLVSLLGYCDEEGEQMLVYE 701 (958)
Q Consensus 631 ~~lg~G~~g~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~~~~~lV~E 701 (958)
+.|+.|-...||+....+ ++.+++|+...... ...+.+|..+++.+. +.-..++++.+.+ .+|||
T Consensus 79 ~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~~~--~~~li~E~~~l~~L~~~g~~P~l~~~~~~----g~v~e 152 (429)
T 1nw1_A 79 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPET--ESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLEE 152 (429)
T ss_dssp EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCCC--HHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEEC
T ss_pred EEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCCCc--HHHHHHHHHHHHHHHhCCCCCcEEEEeCC----CEEEE
Confidence 467888889999998753 57899998854211 245668999998884 3334677776543 38999
Q ss_pred ecCCCCH
Q 002158 702 FVPNGTL 708 (958)
Q Consensus 702 ~~~~gsL 708 (958)
|++|.++
T Consensus 153 ~l~G~~l 159 (429)
T 1nw1_A 153 YIPSRPL 159 (429)
T ss_dssp CCCEEEC
T ss_pred EeCCccc
Confidence 9986443
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=97.06 E-value=0.001 Score=71.65 Aligned_cols=71 Identities=10% Similarity=0.093 Sum_probs=45.7
Q ss_pred CceeeeeCCeEEEEEEECCCcEEEEEEeccCChhcHHHHHHHHHHHHccCCCCc-ceEEEEEEeCCeEEEEEEec-CCCC
Q 002158 630 STQVGQGGYGKVYKGILSDNTTVAIKRAEEGSLQGQNEFLTEIKLLSRLHHRNL-VSLLGYCDEEGEQMLVYEFV-PNGT 707 (958)
Q Consensus 630 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~ni-v~l~~~~~~~~~~~lV~E~~-~~gs 707 (958)
.+.|+.|....+|+. +.+++|+........ ....+|+.+++.+....+ .++++++ .+.-++|+||+ ++.+
T Consensus 23 i~~l~gG~tN~~~~~-----~~~vlR~~~~~~~~~-~~r~~E~~~l~~l~~~g~~P~~~~~~--~~~~~~v~e~i~~g~~ 94 (301)
T 3dxq_A 23 PLERLGGLTNLVFRA-----GDLCLRIPGKGTEEY-INRANEAVAAREAAKAGVSPEVLHVD--PATGVMVTRYIAGAQT 94 (301)
T ss_dssp CEEEESCSSEEEEEE-----TTEEEEEECC----C-CCHHHHHHHHHHHHHTTSSCCEEEEC--TTTCCEEEECCTTCEE
T ss_pred eeEcCCcccccccee-----eeEEEECCCCCccce-eCHHHHHHHHHHHHHcCCCCceEEEE--CCCCEEEEeecCCCcc
Confidence 578999999999998 568899876532111 123468888877742222 5666553 33457899999 6544
Q ss_pred H
Q 002158 708 L 708 (958)
Q Consensus 708 L 708 (958)
+
T Consensus 95 l 95 (301)
T 3dxq_A 95 M 95 (301)
T ss_dssp C
T ss_pred C
Confidence 4
|
| >1pgv_A TMD-1, tropomodulin TMD-1; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics secsg; 1.80A {Caenorhabditis elegans} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=97.03 E-value=0.00016 Score=71.94 Aligned_cols=66 Identities=14% Similarity=0.196 Sum_probs=37.2
Q ss_pred ccCCCCCcEEEeeCC-CCCC----CCChhhcCCCCCCEEeccccccccc----CccccccccccceEeccccccc
Q 002158 129 IGNISSLIFLLLNGN-KLSG----SLPDELGYLSNLNRLQVDENNITGT----IPKSFANLSRVRHLHLNNNSIG 194 (958)
Q Consensus 129 i~~l~~L~~L~Ls~n-~l~~----~~p~~l~~l~~L~~L~L~~N~l~~~----~p~~~~~l~~L~~L~Ls~N~l~ 194 (958)
+.+-+.|++|+|++| .|.. .+-..+..-+.|++|+|++|+|... +...+..-+.|++|+|++|.|+
T Consensus 37 l~~n~~L~~L~L~~nn~igd~ga~~la~aL~~N~~L~~L~L~~n~igd~ga~alA~aL~~N~tL~~L~L~~N~Ig 111 (197)
T 1pgv_A 37 REDDTDLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLT 111 (197)
T ss_dssp HTTCSSCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCC
T ss_pred HhcCCCccEEECCCCCCCCHHHHHHHHHHHhhCCCcCEEEccCCCCChHHHHHHHHHHhcCCccCeEecCCCcCC
Confidence 344566777777764 5542 1233455556677777777776632 2223334455666666666665
|
| >1pgv_A TMD-1, tropomodulin TMD-1; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics secsg; 1.80A {Caenorhabditis elegans} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=96.96 E-value=0.00011 Score=73.04 Aligned_cols=62 Identities=19% Similarity=0.213 Sum_probs=25.9
Q ss_pred cccccccceEeccccccccc----CchhhcCCccchhhhccCCccccC----CCcccCCCCCccEEEccC
Q 002158 177 FANLSRVRHLHLNNNSIGGQ----IPSELSKLSTLIHLLVDNNNLSGN----LPPELSELPQLCILQLDN 238 (958)
Q Consensus 177 ~~~l~~L~~L~Ls~N~l~~~----~p~~l~~l~~L~~L~L~~N~l~~~----~~~~l~~l~~L~~L~L~~ 238 (958)
+..-+.|+.|+|++|.|... +...+..-+.|+.|+|+.|.|... +..++..-+.|++|+|++
T Consensus 66 L~~N~~L~~L~L~~n~igd~ga~alA~aL~~N~tL~~L~L~~N~Ig~~Ga~ala~aL~~N~tL~~L~L~n 135 (197)
T 1pgv_A 66 ACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELLARLLRSTLVTQSIVEFKADN 135 (197)
T ss_dssp HTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHHHHHHHHHTTTTCCCSEEECCC
T ss_pred HhhCCCcCEEEccCCCCChHHHHHHHHHHhcCCccCeEecCCCcCCHHHHHHHHHHHhhCCceeEEECCC
Confidence 33334455555555554421 112222334455555555554421 222333344455555543
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=96.89 E-value=0.002 Score=73.54 Aligned_cols=73 Identities=14% Similarity=0.020 Sum_probs=48.1
Q ss_pred ceeeeeCCeEEEEEEECC-CcEEEEEEeccCChhcHHHHHHHHHHHHccCCCCc-ceEEEEEEeCCeEEEEEEecCCCCH
Q 002158 631 TQVGQGGYGKVYKGILSD-NTTVAIKRAEEGSLQGQNEFLTEIKLLSRLHHRNL-VSLLGYCDEEGEQMLVYEFVPNGTL 708 (958)
Q Consensus 631 ~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~ni-v~l~~~~~~~~~~~lV~E~~~~gsL 708 (958)
+.|+.|-...+|+....+ +..+++|+........ -...+|..+++.+...++ .++++++. + .+||||++|.+|
T Consensus 114 ~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~~-idR~~E~~vl~~L~~~gl~P~ll~~~~--~--G~v~e~I~G~~l 188 (458)
T 2qg7_A 114 QIINGGITNILIKVKDMSKQAKYLIRLYGPKTDEI-INREREKKISCILYNKNIAKKIYVFFT--N--GRIEEFMDGYAL 188 (458)
T ss_dssp EEECC--CEEEEEEEETTTTEEEEEEEECC-CCSC-SCHHHHHHHHHHHTTSSSBCCEEEEET--T--EEEEECCCSEEC
T ss_pred EEcCCCeEeEEEEEEECCCCceEEEEECCCChhhh-cCHHHHHHHHHHHHhcCCCCCEEEEeC--C--eEEEEeeCCccC
Confidence 568888889999998865 4788899875432111 112479999998864444 57777763 2 359999987544
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=96.67 E-value=0.0056 Score=67.07 Aligned_cols=66 Identities=11% Similarity=0.081 Sum_probs=43.2
Q ss_pred eCCeEEEEEEECCCcEEEEEEeccCChhcHHHHHHHHHHHHccC---CCCcceEEEE------EEeCCeEEEEEEecCCC
Q 002158 636 GGYGKVYKGILSDNTTVAIKRAEEGSLQGQNEFLTEIKLLSRLH---HRNLVSLLGY------CDEEGEQMLVYEFVPNG 706 (958)
Q Consensus 636 G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---H~niv~l~~~------~~~~~~~~lV~E~~~~g 706 (958)
|....||+....+| .+++|+...... .+|+.+++.+. -+.+++++.. ....+..++||||++|.
T Consensus 34 g~~N~vy~v~~~~g-~~vLK~~~~~~~------~~E~~~l~~L~~~g~~~vp~pi~~~~G~~~~~~~g~~~~l~~~i~G~ 106 (339)
T 3i1a_A 34 DTNAFAYQADSESK-SYFIKLKYGYHD------EINLSIIRLLHDSGIKEIIFPIHTLEAKLFQQLKHFKIIAYPFIHAP 106 (339)
T ss_dssp CSSCEEEEEECSSC-EEEEEEEECSSC------CHHHHHHHHHHHTTCCSSCCCCCCTTSCSSEECSSEEEEEEECCCCC
T ss_pred ccccceEEEEeCCC-CEEEEEecCccc------hHHHHHHHHHHhcCCcccccceecCCCCEEEEECCEEEEEEeccCCC
Confidence 33579999987667 899998765432 24556665552 2324455432 23457789999999987
Q ss_pred CH
Q 002158 707 TL 708 (958)
Q Consensus 707 sL 708 (958)
.+
T Consensus 107 ~~ 108 (339)
T 3i1a_A 107 NG 108 (339)
T ss_dssp BT
T ss_pred cC
Confidence 55
|
| >3rfe_A Platelet glycoprotein IB beta chain; platelet surface receptor, GPIX, cell adhesion; HET: NAG; 1.25A {Homo sapiens} PDB: 3rez_A* | Back alignment and structure |
|---|
Probab=96.61 E-value=0.0034 Score=58.14 Aligned_cols=57 Identities=26% Similarity=0.297 Sum_probs=45.0
Q ss_pred CEEeccCCcCC-CcCCCCCCCCCcCEEEccCCcCCCccchhccCCCCCCeEeeecccCC
Q 002158 280 YYLDLSWNHLT-GSIPSKKLSENVTTIDLSDNYLNGSILESISNLPFLQTLSLENNFLT 337 (958)
Q Consensus 280 ~~L~Ls~N~l~-~~~~~~~~~~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~ 337 (958)
..++.+++.++ ..+|. ....+|++|+|++|+|+.+.+..|..+++|+.|+|++|++.
T Consensus 11 ~~v~Cs~~~L~~~~vP~-~lp~~l~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~NP~~ 68 (130)
T 3rfe_A 11 TLVDCGRRGLTWASLPT-AFPVDTTELVLTGNNLTALPPGLLDALPALRTAHLGANPWR 68 (130)
T ss_dssp TEEECCSSCCCTTTSCS-CCCTTCSEEECTTSCCSSCCTTTGGGCTTCCEEECCSSCCB
T ss_pred CEEEeCCCCCccccCCC-CCCcCCCEEECCCCcCCccChhhhhhccccCEEEecCCCee
Confidence 36777777775 23442 24467899999999999888899999999999999999986
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=96.51 E-value=0.0023 Score=71.15 Aligned_cols=73 Identities=14% Similarity=0.120 Sum_probs=44.7
Q ss_pred ceeeeeCCeEEEEEEECC---------CcEEEEEEeccCChhcHHHHHHHHHHHHccCCCC-cceEEEEEEeCCeEEEEE
Q 002158 631 TQVGQGGYGKVYKGILSD---------NTTVAIKRAEEGSLQGQNEFLTEIKLLSRLHHRN-LVSLLGYCDEEGEQMLVY 700 (958)
Q Consensus 631 ~~lg~G~~g~Vy~~~~~~---------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~n-iv~l~~~~~~~~~~~lV~ 700 (958)
+.|+.|..-.+|+....+ ++.+++|+...... .......|.++++.+...+ ..++++.. . -++||
T Consensus 39 ~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~-~~~~~~~E~~~l~~L~~~g~~P~~~~~~--~--~~~v~ 113 (369)
T 3c5i_A 39 KQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVD-ELYNTISEFEVYKTMSKYKIAPQLLNTF--N--GGRIE 113 (369)
T ss_dssp EEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGG-GTSCHHHHHHHHHHHHHTTSSCCEEEEE--T--TEEEE
T ss_pred EEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCcc-ceecHHHHHHHHHHHHhcCCCCceEEec--C--CcEEE
Confidence 457778888999998754 26888888764321 1112357888888874333 45777654 2 36899
Q ss_pred EecCCCCH
Q 002158 701 EFVPNGTL 708 (958)
Q Consensus 701 E~~~~gsL 708 (958)
||++|..+
T Consensus 114 e~i~G~~l 121 (369)
T 3c5i_A 114 EWLYGDPL 121 (369)
T ss_dssp ECCCSEEC
T ss_pred EEecCCcC
Confidence 99987543
|
| >2k1k_A Ephrin type-A receptor 1; EPHA1, receptor tyrosine kinase, dimeric transmembrane domain, ATP-binding, glycoprotein, nucleotide-binding; NMR {Homo sapiens} PDB: 2k1l_A | Back alignment and structure |
|---|
Probab=96.37 E-value=0.0012 Score=45.80 Aligned_cols=32 Identities=22% Similarity=0.479 Sum_probs=24.3
Q ss_pred CCCCcccceeeeehhHHHHHHHHHHHHHHHHH
Q 002158 554 QSKGISGGILAAIVVGAVASAVAITAAVTLLV 585 (958)
Q Consensus 554 ~~~~~~~~~~~~ivv~~~~~~~~i~~~~~~~~ 585 (958)
.+++.++++++++++|+++.++++++++++++
T Consensus 4 ~~~~ls~GaIAGiVvG~v~gv~li~~l~~~~~ 35 (38)
T 2k1k_A 4 VSRGLTGGEIVAVIFGLLLGAALLLGILVFRS 35 (38)
T ss_dssp SSTTCCHHHHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred CCCCCCCCceeeeehHHHHHHHHHHHHHHHHe
Confidence 45678999999999999887776665555444
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=96.01 E-value=0.021 Score=56.97 Aligned_cols=102 Identities=16% Similarity=0.124 Sum_probs=65.6
Q ss_pred CCHHHHhccCCCCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEecCCCCeEEeeeeeecccccCCCCCCc
Q 002158 706 GTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSRLAPVLDDEGTM 785 (958)
Q Consensus 706 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~ 785 (958)
-+|.+.|...+ .++++++++.++.|.+.+|.-+-....+ ..+=+.|..|++..+|.|.+.+ +.+.
T Consensus 33 vSL~eIL~~~~-~PlsEEqaWALc~Qc~~~L~~~~~~~~~--~~~i~~~~~i~l~~dG~V~f~~-~~s~----------- 97 (229)
T 2yle_A 33 LSLEEILRLYN-QPINEEQAWAVCYQCCGSLRAAARRRQP--RHRVRSAAQIRVWRDGAVTLAP-AADD----------- 97 (229)
T ss_dssp EEHHHHHHHHT-SCCCHHHHHHHHHHHHHHHHHHHHTTCC--CCCCCSGGGEEEETTSCEEECC-C--------------
T ss_pred ccHHHHHHHcC-CCcCHHHHHHHHHHHHHHHHhhhhcccC--CceecCCcceEEecCCceeccc-cccc-----------
Confidence 37999998654 4699999999999999998776221111 1222457999999999998764 2111
Q ss_pred cceeeeeccCCCCccChhhhccCCCCCcchhhhHHHHHHHHHhCCC
Q 002158 786 PTHVSTIVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVLLELLTGMQ 831 (958)
Q Consensus 786 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gv~l~elltG~~ 831 (958)
.....+.|||... ...+.+.=|||+|+++|.-+--..
T Consensus 98 --------~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALDygL 134 (229)
T 2yle_A 98 --------AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALDYGL 134 (229)
T ss_dssp -----------------CCSS-SSSCHHHHHHHHHHHHHHHHTTTC
T ss_pred --------ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhhcCC
Confidence 0122366888753 234567889999999999887433
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=95.11 E-value=0.043 Score=61.65 Aligned_cols=73 Identities=10% Similarity=0.088 Sum_probs=48.6
Q ss_pred ceeeeeCCeEEEEEEECC--------CcEEEEEEeccCChhcHHHHHHHHHHHHccC-CCCcceEEEEEEeCCeEEEEEE
Q 002158 631 TQVGQGGYGKVYKGILSD--------NTTVAIKRAEEGSLQGQNEFLTEIKLLSRLH-HRNLVSLLGYCDEEGEQMLVYE 701 (958)
Q Consensus 631 ~~lg~G~~g~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~~~~~lV~E 701 (958)
+.+..|-...+|+....+ ++.+++|+....... .....+|.++++.+. +.-..++++.+. -++|||
T Consensus 76 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t~~-~idR~~E~~~l~~L~~~gi~P~l~~~~~----~~~I~e 150 (424)
T 3mes_A 76 KQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHVGK-FYDSKVELDVFRYLSNINIAPNIIADFP----EGRIEE 150 (424)
T ss_dssp EEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC-C-CCCHHHHHHHHHHHHHTTSSCCEEEEET----TEEEEE
T ss_pred EEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCcch-hcCHHHHHHHHHHHHhcCCCCCEEEEcC----CCEEEE
Confidence 457777788999998753 578999987543211 112347888888884 333566776442 278999
Q ss_pred ecCCCCH
Q 002158 702 FVPNGTL 708 (958)
Q Consensus 702 ~~~~gsL 708 (958)
|++|.+|
T Consensus 151 fI~G~~l 157 (424)
T 3mes_A 151 FIDGEPL 157 (424)
T ss_dssp CCCSEEC
T ss_pred EeCCccC
Confidence 9998654
|
| >2l2t_A Receptor tyrosine-protein kinase ERBB-4; transmembrane dimer, membrane domain, membrane protei; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=94.26 E-value=0.028 Score=40.05 Aligned_cols=32 Identities=22% Similarity=0.290 Sum_probs=15.7
Q ss_pred ccceeeeehhHHHHHHHHHHHHHHHHHHhhhh
Q 002158 559 SGGILAAIVVGAVASAVAITAAVTLLVMRRHA 590 (958)
Q Consensus 559 ~~~~~~~ivv~~~~~~~~i~~~~~~~~~~r~~ 590 (958)
....|++.++|.+++++++.+.++++++||+.
T Consensus 8 ~~~aIA~gVVgGv~~v~ii~~~~~~~~RRRr~ 39 (44)
T 2l2t_A 8 RTPLIAAGVIGGLFILVIVGLTFAVYVRRKSI 39 (44)
T ss_dssp SSHHHHHHHHHHHHHHHHHHHHHHHHHHTTCS
T ss_pred CcceEEEeehHHHHHHHHHHHHHHHHhhhhhh
Confidence 34455555555555554444444444444433
|
| >2ks1_B Epidermal growth factor receptor; ERBB1, ERBB2, transmembrane, heterodimer, complex, tyrosine receptor, bicelles, transferase; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=93.76 E-value=0.052 Score=38.84 Aligned_cols=29 Identities=28% Similarity=0.431 Sum_probs=13.6
Q ss_pred ceeeeehhHHHHHHHHHHHHHHHHHHhhh
Q 002158 561 GILAAIVVGAVASAVAITAAVTLLVMRRH 589 (958)
Q Consensus 561 ~~~~~ivv~~~~~~~~i~~~~~~~~~~r~ 589 (958)
..||+.++|.++++++++++++++++||+
T Consensus 11 ~~IA~gVVgGv~~~~ii~~~~~~~~RRr~ 39 (44)
T 2ks1_B 11 PSIATGMVGALLLLLVVALGIGLFMRRRH 39 (44)
T ss_dssp SSSTHHHHHHHHHHHHHHHHHHHHHHTTT
T ss_pred ceEEeehhHHHHHHHHHHHHHHHHhhhhH
Confidence 34555555544444444444444444443
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=90.25 E-value=0.71 Score=51.40 Aligned_cols=29 Identities=31% Similarity=0.448 Sum_probs=24.9
Q ss_pred eeccCCCccceEe------cCCCCeEEeeeeeecc
Q 002158 747 VFHRDIKASNILL------DSNLNAKVADFGLSRL 775 (958)
Q Consensus 747 iiH~Dikp~NILl------~~~~~~kl~DFGla~~ 775 (958)
++|+|+.+.|||+ +++..++++||.+|..
T Consensus 246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~ 280 (401)
T 3g15_A 246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY 280 (401)
T ss_dssp EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred eEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence 6899999999999 4567799999998764
|
| >2jwa_A Receptor tyrosine-protein kinase ERBB-2; transmembrane helix dimer, protein kinase receptor membrane domain, ATP-binding, glycoprotein; NMR {Homo sapiens} PDB: 2ks1_A | Back alignment and structure |
|---|
Probab=89.12 E-value=0.18 Score=35.88 Aligned_cols=28 Identities=25% Similarity=0.432 Sum_probs=13.1
Q ss_pred ceeeeehhHHHHHHHHHHHHHHHHHHhhh
Q 002158 561 GILAAIVVGAVASAVAITAAVTLLVMRRH 589 (958)
Q Consensus 561 ~~~~~ivv~~~~~~~~i~~~~~~~~~~r~ 589 (958)
..++++++| +.+++++.+.++++++||+
T Consensus 12 ~~Ia~~vVG-vll~vi~~l~~~~~~RRR~ 39 (44)
T 2jwa_A 12 TSIISAVVG-ILLVVVLGVVFGILIKRRQ 39 (44)
T ss_dssp HHHHHHHHH-HHHHHHHHHHHHHHHHHHC
T ss_pred cchHHHHHH-HHHHHHHHHHHHhheehhh
Confidence 346666777 3333333333344444443
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 958 | ||||
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 1e-75 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 3e-70 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 4e-68 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 1e-67 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 7e-67 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 9e-67 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 3e-66 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 4e-66 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 4e-66 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 4e-66 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 4e-65 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 4e-65 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 4e-63 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 1e-62 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 6e-62 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 1e-60 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 2e-60 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 7e-60 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 2e-59 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 2e-59 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 6e-59 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 7e-59 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 1e-58 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 2e-58 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 3e-58 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 3e-57 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 4e-57 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 7e-57 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 5e-56 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 9e-56 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 3e-55 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 2e-51 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 1e-50 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 1e-49 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 3e-48 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 7e-48 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 2e-47 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 5e-47 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 1e-46 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 3e-45 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 1e-44 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 2e-44 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 3e-44 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 4e-43 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 2e-42 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 3e-42 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 1e-41 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 6e-41 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 7e-41 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 3e-40 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 3e-40 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 4e-39 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 1e-38 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 1e-38 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 3e-37 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 5e-37 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 9e-34 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 1e-33 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 4e-32 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 2e-31 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 2e-30 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 5e-29 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 3e-25 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 8e-21 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 3e-18 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 2e-15 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 2e-11 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 3e-10 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 2e-07 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 5e-07 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 0.001 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 0.003 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 4e-20 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 5e-20 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 2e-11 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 2e-14 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 2e-10 | |
| d2astb2 | 284 | c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1 | 9e-09 | |
| d2astb2 | 284 | c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1 | 5e-08 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 1e-08 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 3e-06 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 3e-04 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 2e-07 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 1e-06 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 1e-06 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 1e-06 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 6e-06 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 7e-06 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 6e-05 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 8e-05 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 9e-05 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 1e-04 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 5e-04 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 2e-07 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 4e-07 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 4e-05 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 0.001 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 0.001 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 0.002 | |
| d1koha1 | 162 | c.10.2.3 (A:201-362) mRNA export factor tap {Human | 2e-07 | |
| d1koha1 | 162 | c.10.2.3 (A:201-362) mRNA export factor tap {Human | 2e-05 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 3e-07 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 7e-07 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 4e-04 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 4e-07 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 1e-06 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 5e-05 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 1e-04 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 0.003 | |
| d1h6ta2 | 210 | c.10.2.1 (A:31-240) Internalin B {Listeria monocyt | 5e-07 | |
| d2omxa2 | 199 | c.10.2.1 (A:37-235) Internalin B {Listeria monocyt | 1e-06 | |
| d2omxa2 | 199 | c.10.2.1 (A:37-235) Internalin B {Listeria monocyt | 4e-04 | |
| d1a9na_ | 162 | c.10.2.4 (A:) Splicesomal U2A' protein {Human (Hom | 4e-06 | |
| d1a9na_ | 162 | c.10.2.4 (A:) Splicesomal U2A' protein {Human (Hom | 1e-04 | |
| d1a9na_ | 162 | c.10.2.4 (A:) Splicesomal U2A' protein {Human (Hom | 2e-04 | |
| d1w8aa_ | 192 | c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanoga | 6e-06 | |
| d1xwdc1 | 242 | c.10.2.7 (C:18-259) Follicle-stimulating hormone r | 8e-04 | |
| d1xwdc1 | 242 | c.10.2.7 (C:18-259) Follicle-stimulating hormone r | 8e-04 | |
| d1xwdc1 | 242 | c.10.2.7 (C:18-259) Follicle-stimulating hormone r | 9e-04 | |
| d1xwdc1 | 242 | c.10.2.7 (C:18-259) Follicle-stimulating hormone r | 0.002 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 0.002 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 0.002 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 0.003 | |
| d2ifga3 | 156 | c.10.2.7 (A:36-191) High affinity nerve growth fac | 0.002 | |
| d1m9la_ | 198 | c.10.3.1 (A:) Outer arm dynein light chain 1 {Gree | 0.003 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 246 bits (630), Expect = 1e-75
Identities = 65/277 (23%), Positives = 120/277 (43%), Gaps = 18/277 (6%)
Query: 632 QVGQGGYGKVYKGILSDNTTVAIKRAEEGSLQGQNEFLTEIKLLSRLHHRNLVSLLGYCD 691
++G G +G VYKG + V + + Q F E+ +L + H N++ +GY
Sbjct: 15 RIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYST 74
Query: 692 EEGEQMLVYEFVPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRD 751
+ +V ++ +L L + + +A +A+G+ YLH + HRD
Sbjct: 75 -APQLAIVTQWCEGSSLYHHLHII-ETKFEMIKLIDIARQTAQGMDYLH---AKSIIHRD 129
Query: 752 IKASNILLDSNLNAKVADFGLSRLAPVLDDEGTMPTHVSTIVKGTPGYLDPEYFLTHK-- 809
+K++NI L +L K+ DFGL+ + +H + G+ ++ PE
Sbjct: 130 LKSNNIFLHEDLTVKIGDFGLATVKSRWSG-----SHQFEQLSGSILWMAPEVIRMQDKN 184
Query: 810 -LTDKSDVYSLGVVLLELLTGMQPISHGKNIVREVNVARDSGMVFSIIDNRMGSYPSECV 868
+ +SDVY+ G+VL EL+TG P S+ N + + + + + S C
Sbjct: 185 PYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGR-----GYLSPDLSKVRSNCP 239
Query: 869 ERFVTLALRCCHDKPEHRPSMSDVVRELENILKMFPE 905
+ L C K + RP ++ +E + + P+
Sbjct: 240 KAMKRLMAECLKKKRDERPLFPQILASIELLARSLPK 276
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 232 bits (592), Expect = 3e-70
Identities = 72/269 (26%), Positives = 123/269 (45%), Gaps = 20/269 (7%)
Query: 632 QVGQGGYGKVYKGILSDNTTVAIKRAEEGSLQGQNEFLTEIKLLSRLHHRNLVSLLGYCD 691
++G G +G+V+ G + +T VA+K ++GS + FL E L+ +L H+ LV L
Sbjct: 20 RLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVV- 77
Query: 692 EEGEQMLVYEFVPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRD 751
+ ++ E++ NG+L D+L + L L +A A+G+ ++ HRD
Sbjct: 78 TQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE---ERNYIHRD 134
Query: 752 IKASNILLDSNLNAKVADFGLSRLAPVLDDEGTMPTHVSTIVKGTPGYLDPEYFLTHKLT 811
++A+NIL+ L+ K+ADFGL+RL K + PE T
Sbjct: 135 LRAANILVSDTLSCKIADFGLARLIE------DNEYTAREGAKFPIKWTAPEAINYGTFT 188
Query: 812 DKSDVYSLGVVLLELLTGMQPISHGKNIVREVNVARDSGMVFSIIDNRMGSYPSECVERF 871
KSDV+S G++L E++T + G + ++ ++ P C E
Sbjct: 189 IKSDVWSFGILLTEIVTHGRIPYPGMT---------NPEVIQNLERGYRMVRPDNCPEEL 239
Query: 872 VTLALRCCHDKPEHRPSMSDVVRELENIL 900
L C ++PE RP+ + LE+
Sbjct: 240 YQLMRLCWKERPEDRPTFDYLRSVLEDFF 268
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 226 bits (576), Expect = 4e-68
Identities = 74/270 (27%), Positives = 122/270 (45%), Gaps = 20/270 (7%)
Query: 632 QVGQGGYGKVYKGILSDNTTVAIKRAEEGSLQGQNEFLTEIKLLSRLHHRNLVSLLGYCD 691
++G G +G V+ G + VAIK EG+ + +F+ E +++ +L H LV L G C
Sbjct: 12 EIGSGQFGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCL 70
Query: 692 EEGEQMLVYEFVPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRD 751
E+ LV+EF+ +G L D+L + L + LD +G + V HRD
Sbjct: 71 EQAPICLVFEFMEHGCLSDYLRTQRGLF-AAETLLGMCLDVCEG---MAYLEEACVIHRD 126
Query: 752 IKASNILLDSNLNAKVADFGLSRLAPVLDDEGTMPTHVSTIVKGTPGYLDPEYFLTHKLT 811
+ A N L+ N KV+DFG++R ST K + PE F + +
Sbjct: 127 LAARNCLVGENQVIKVSDFGMTRFVL------DDQYTSSTGTKFPVKWASPEVFSFSRYS 180
Query: 812 DKSDVYSLGVVLLELLTGMQPISHGKNIVREVNVARDSGMVFSIIDNRMGSYPSECVERF 871
KSDV+S GV++ E+ + + ++ +S +V I P
Sbjct: 181 SKSDVWSFGVLMWEVFSEGKIPYENRS---------NSEVVEDISTGFRLYKPRLASTHV 231
Query: 872 VTLALRCCHDKPEHRPSMSDVVRELENILK 901
+ C ++PE RP+ S ++R+L I +
Sbjct: 232 YQIMNHCWKERPEDRPAFSRLLRQLAEIAE 261
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 226 bits (577), Expect = 1e-67
Identities = 87/278 (31%), Positives = 128/278 (46%), Gaps = 22/278 (7%)
Query: 633 VGQGGYGKVYKGILSDNTT----VAIKRAEEGSLQGQ-NEFLTEIKLLSRLHHRNLVSLL 687
+G+G +G VY G L DN A+K + G+ ++FLTE ++ H N++SLL
Sbjct: 35 IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 94
Query: 688 GYC-DEEGEQMLVYEFVPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPP 746
G C EG ++V ++ +G LR+++ T N + L AKG + A
Sbjct: 95 GICLRSEGSPLVVLPYMKHGDLRNFIRNETH-NPTVKDLIGFGLQVAKG---MKFLASKK 150
Query: 747 VFHRDIKASNILLDSNLNAKVADFGLSRLAPVLDDEGTMPTHVSTIVKGTPGYLDPEYFL 806
HRD+ A N +LD KVADFGL+R + D+ H T K ++ E
Sbjct: 151 FVHRDLAARNCMLDEKFTVKVADFGLARD---MYDKEFDSVHNKTGAKLPVKWMALESLQ 207
Query: 807 THKLTDKSDVYSLGVVLLELLTGMQPISHGKNIVREVNVARDSGMVFSIIDNRMGSYPSE 866
T K T KSDV+S GV+L EL+T P N + ++ R P
Sbjct: 208 TQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD---------ITVYLLQGRRLLQPEY 258
Query: 867 CVERFVTLALRCCHDKPEHRPSMSDVVRELENILKMFP 904
C + + L+C H K E RPS S++V + I F
Sbjct: 259 CPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFI 296
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 222 bits (567), Expect = 7e-67
Identities = 67/268 (25%), Positives = 114/268 (42%), Gaps = 20/268 (7%)
Query: 632 QVGQGGYGKVYKGILSDNTTVAIKRAEEGSLQGQNEFLTEIKLLSRLHHRNLVSLLGYCD 691
++G G +G V G VAIK +EGS ++EF+ E K++ L H LV L G C
Sbjct: 11 ELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQLYGVCT 69
Query: 692 EEGEQMLVYEFVPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRD 751
++ ++ E++ NG L ++L + L + D + + YL HRD
Sbjct: 70 KQRPIFIITEYMANGCLLNYLREM-RHRFQTQQLLEMCKDVCEAMEYLE---SKQFLHRD 125
Query: 752 IKASNILLDSNLNAKVADFGLSRLAPVLDDEGTMPTHVSTIVKGTPGYLDPEYFLTHKLT 811
+ A N L++ KV+DFGLSR S K + PE + K +
Sbjct: 126 LAARNCLVNDQGVVKVSDFGLSRYVL------DDEYTSSVGSKFPVRWSPPEVLMYSKFS 179
Query: 812 DKSDVYSLGVVLLELLTGMQPISHGKNIVREVNVARDSGMVFSIIDNRMGSYPSECVERF 871
KSD+++ GV++ E+ + + +S I P E+
Sbjct: 180 SKSDIWAFGVLMWEIYSLGKMPYERFT---------NSETAEHIAQGLRLYRPHLASEKV 230
Query: 872 VTLALRCCHDKPEHRPSMSDVVRELENI 899
T+ C H+K + RP+ ++ + ++
Sbjct: 231 YTIMYSCWHEKADERPTFKILLSNILDV 258
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 223 bits (570), Expect = 9e-67
Identities = 79/302 (26%), Positives = 133/302 (44%), Gaps = 31/302 (10%)
Query: 615 FKFKELAMATAYFSSSTQ---------VGQGGYGKVYKGIL----SDNTTVAIKRAEEG- 660
F F++ A F+ +G G +G+V G L VAIK + G
Sbjct: 7 FTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY 66
Query: 661 SLQGQNEFLTEIKLLSRLHHRNLVSLLGYCDEEGEQMLVYEFVPNGTLRDWLSGRTKENL 720
+ + + +FL+E ++ + H N++ L G + M++ EF+ NG+L D +
Sbjct: 67 TEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSL-DSFLRQNDGQF 125
Query: 721 NFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSRLAPVLD 780
+ + A G+ YL HRD+ A NIL++SNL KV+DFGLSR L+
Sbjct: 126 TVIQLVGMLRGIAAGMKYLA---DMNYVHRDLAARNILVNSNLVCKVSDFGLSRF---LE 179
Query: 781 DEGTMPTHVSTI-VKGTPGYLDPEYFLTHKLTDKSDVYSLGVVLLELLTGMQPISHGKNI 839
D+ + PT+ S + K + PE K T SDV+S G+V+ E+++ +
Sbjct: 180 DDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMT- 238
Query: 840 VREVNVARDSGMVFSIIDNRMGSYPSECVERFVTLALRCCHDKPEHRPSMSDVVRELENI 899
+ ++ +I + P +C L L C HRP +V L+ +
Sbjct: 239 --------NQDVINAIEQDYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKM 290
Query: 900 LK 901
++
Sbjct: 291 IR 292
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 221 bits (565), Expect = 3e-66
Identities = 80/270 (29%), Positives = 121/270 (44%), Gaps = 20/270 (7%)
Query: 632 QVGQGGYGKVYKGILSDNTTVAIKRAEEGSLQGQNEFLTEIKLLSRLHHRNLVSLLGYCD 691
++GQG +G+V+ G + T VAIK + G+ FL E +++ +L H LV L
Sbjct: 24 KLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVV- 81
Query: 692 EEGEQMLVYEFVPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRD 751
E +V E++ G+L D+L G T + L + +A A G+ Y+ HRD
Sbjct: 82 SEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRD 138
Query: 752 IKASNILLDSNLNAKVADFGLSRLAPVLDDEGTMPTHVSTIVKGTPGYLDPEYFLTHKLT 811
++A+NIL+ NL KVADFGL+RL K + PE L + T
Sbjct: 139 LRAANILVGENLVCKVADFGLARLIE------DNEYTARQGAKFPIKWTAPEAALYGRFT 192
Query: 812 DKSDVYSLGVVLLELLTGMQPISHGKNIVREVNVARDSGMVFSIIDNRMGSYPSECVERF 871
KSDV+S G++L EL T + G ++ + P EC E
Sbjct: 193 IKSDVWSFGILLTELTTKGRVPYPGMVNRE---------VLDQVERGYRMPCPPECPESL 243
Query: 872 VTLALRCCHDKPEHRPSMSDVVRELENILK 901
L +C +PE RP+ + LE+
Sbjct: 244 HDLMCQCWRKEPEERPTFEYLQAFLEDYFT 273
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 221 bits (564), Expect = 4e-66
Identities = 77/272 (28%), Positives = 127/272 (46%), Gaps = 22/272 (8%)
Query: 632 QVGQGGYGKVYKGILSD-NTTVAIKRAEEGSLQGQNEFLTEIKLLSRLHHRNLVSLLGYC 690
++G G YG+VY+G+ + TVA+K +E +++ + EFL E ++ + H NLV LLG C
Sbjct: 24 KLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQLLGVC 82
Query: 691 DEEGEQMLVYEFVPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHR 750
E ++ EF+ G L D+L ++ ++ + L +A + + YL HR
Sbjct: 83 TREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE---KKNFIHR 139
Query: 751 DIKASNILLDSNLNAKVADFGLSRLAPVLDDEGTMPTHVSTIVKGTPGYLDPEYFLTHKL 810
D+ A N L+ N KVADFGLSRL K + PE +K
Sbjct: 140 DLAARNCLVGENHLVKVADFGLSRLMT------GDTYTAHAGAKFPIKWTAPESLAYNKF 193
Query: 811 TDKSDVYSLGVVLLELLTGMQPISHGKNIVREVNVARDSGMVFSIIDNRM-GSYPSECVE 869
+ KSDV++ GV+L E+ T G ++ + V+ +++ P C E
Sbjct: 194 SIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ----------VYELLEKDYRMERPEGCPE 243
Query: 870 RFVTLALRCCHDKPEHRPSMSDVVRELENILK 901
+ L C P RPS +++ + E + +
Sbjct: 244 KVYELMRACWQWNPSDRPSFAEIHQAFETMFQ 275
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 222 bits (565), Expect = 4e-66
Identities = 74/315 (23%), Positives = 121/315 (38%), Gaps = 46/315 (14%)
Query: 616 KFKELAMATAYFSSSTQVGQGGYGKVYKGIL------SDNTTVAIKR-AEEGSLQGQNEF 668
K L +G+G +G+V++ T VA+K EE S Q +F
Sbjct: 4 KLLSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADF 63
Query: 669 LTEIKLLSRLHHRNLVSLLGYCDEEGEQMLVYEFVPNGTLRDWLSGRTKEN--------- 719
E L++ + N+V LLG C L++E++ G L ++L +
Sbjct: 64 QREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDL 123
Query: 720 -------------LNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSNLNAK 766
L+ A +L +A A G+ YL HRD+ N L+ N+ K
Sbjct: 124 STRARVSSPGPPPLSCAEQLCIARQVAAGMAYLS---ERKFVHRDLATRNCLVGENMVVK 180
Query: 767 VADFGLSRLAPVLDDEGTMPTHVSTIVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVLLEL 826
+ADFGLSR D ++ PE ++ T +SDV++ GVVL E+
Sbjct: 181 IADFGLSRNIYSAD-----YYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEI 235
Query: 827 LTGMQPISHGKNIVREVNVARDSGMVFSIIDNRMGSYPSECVERFVTLALRCCHDKPEHR 886
+ +G +++ + D + + P C L C P R
Sbjct: 236 FSYGLQPYYGMAHEE---------VIYYVRDGNILACPENCPLELYNLMRLCWSKLPADR 286
Query: 887 PSMSDVVRELENILK 901
PS + R L+ + +
Sbjct: 287 PSFCSIHRILQRMCE 301
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 220 bits (562), Expect = 4e-66
Identities = 71/269 (26%), Positives = 115/269 (42%), Gaps = 26/269 (9%)
Query: 632 QVGQGGYGKVYKGILSDNTTVAIKRAEEGSLQGQNEFLTEIKLLSRLHHRNLVSLLGYC- 690
+G+G +G V G VA+K + + FL E ++++L H NLV LLG
Sbjct: 14 TIGKGEFGDVMLGDY-RGNKVAVKCIKNDATA--QAFLAEASVMTQLRHSNLVQLLGVIV 70
Query: 691 DEEGEQMLVYEFVPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHR 750
+E+G +V E++ G+L D+L R + L L+ +LD + + YL HR
Sbjct: 71 EEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE---GNNFVHR 127
Query: 751 DIKASNILLDSNLNAKVADFGLSRLAPVLDDEGTMPTHVSTIVKGTPGYLDPEYFLTHKL 810
D+ A N+L+ + AKV+DFGL++ A K + PE K
Sbjct: 128 DLAARNVLVSEDNVAKVSDFGLTKEAS----------STQDTGKLPVKWTAPEALREKKF 177
Query: 811 TDKSDVYSLGVVLLELLTGMQPISHGKNIVREVNVARDSGMVFSIIDNRMGSYPSECVER 870
+ KSDV+S G++L E+ + + + +V + P C
Sbjct: 178 STKSDVWSFGILLWEIYSFGRVPYPRIPLKD---------VVPRVEKGYKMDAPDGCPPA 228
Query: 871 FVTLALRCCHDKPEHRPSMSDVVRELENI 899
+ C H RPS + +LE+I
Sbjct: 229 VYEVMKNCWHLDAAMRPSFLQLREQLEHI 257
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 218 bits (557), Expect = 4e-65
Identities = 75/289 (25%), Positives = 134/289 (46%), Gaps = 23/289 (7%)
Query: 627 FSSSTQVGQGGYGKVYKGILSDNT-----TVAIKRAEEGSLQGQ-NEFLTEIKLLSRLHH 680
+ +G G +G+VYKG+L ++ VAIK + G + Q +FL E ++ + H
Sbjct: 9 VTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSH 68
Query: 681 RNLVSLLGYCDEEGEQMLVYEFVPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLH 740
N++ L G + M++ E++ NG L +L + + + + A G+ YL
Sbjct: 69 HNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDG-EFSVLQLVGMLRGIAAGMKYLA 127
Query: 741 TEAHPPVFHRDIKASNILLDSNLNAKVADFGLSRLAPVLDDEGTMPTHVSTIVKGTPGYL 800
+ HRD+ A NIL++SNL KV+DFGLSR+ + T+ ++ K +
Sbjct: 128 ---NMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLE----DDPEATYTTSGGKIPIRWT 180
Query: 801 DPEYFLTHKLTDKSDVYSLGVVLLELLTGMQPISHGKNIVREVNVARDSGMVFSIIDNRM 860
PE K T SDV+S G+V+ E++T + + + ++ +I D
Sbjct: 181 APEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELS---------NHEVMKAINDGFR 231
Query: 861 GSYPSECVERFVTLALRCCHDKPEHRPSMSDVVRELENILKMFPETDTM 909
P +C L ++C + RP +D+V L+ +++ T+
Sbjct: 232 LPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAPDSLKTL 280
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 218 bits (557), Expect = 4e-65
Identities = 69/288 (23%), Positives = 116/288 (40%), Gaps = 23/288 (7%)
Query: 618 KELAMATAYFS-SSTQVGQGGYGKVYKGIL---SDNTTVAIKRAEEGSLQGQ-NEFLTEI 672
K+L + + ++G G +G V +G+ VAIK ++G+ + E + E
Sbjct: 1 KKLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREA 60
Query: 673 KLLSRLHHRNLVSLLGYCDEEGEQMLVYEFVPNGTLRDWLSGRTKENLNFAMRLRVALDS 732
+++ +L + +V L+G C + MLV E G L +L G+ +E + + +
Sbjct: 61 QIMHQLDNPYIVRLIGVC-QAEALMLVMEMAGGGPLHKFLVGK-REEIPVSNVAELLHQV 118
Query: 733 AKGILYLHTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSRLAPVLDDEGTMPTHVSTI 792
+ G+ YL HRD+ A N+LL + AK++DFGLS+ +
Sbjct: 119 SMGMKYLE---EKNFVHRDLAARNVLLVNRHYAKISDFGLSKAL----GADDSYYTARSA 171
Query: 793 VKGTPGYLDPEYFLTHKLTDKSDVYSLGVVLLELLTGMQPISHGKNIVREVNVARDSGMV 852
K + PE K + +SDV+S GV + E L+ Q ++
Sbjct: 172 GKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPE---------VM 222
Query: 853 FSIIDNRMGSYPSECVERFVTLALRCCHDKPEHRPSMSDVVRELENIL 900
I + P EC L C K E RP V + +
Sbjct: 223 AFIEQGKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACY 270
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 212 bits (541), Expect = 4e-63
Identities = 68/275 (24%), Positives = 107/275 (38%), Gaps = 24/275 (8%)
Query: 632 QVGQGGYGKVYKGILSDNTT---VAIK--RAEEGSLQGQNEFLTEIKLLSRLHHRNLVSL 686
++G G +G V KG VA+K + E ++E L E ++ +L + +V +
Sbjct: 14 ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM 73
Query: 687 LGYCDEEGEQMLVYEFVPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPP 746
+G C+ E MLV E G L +L + + + + G+ YL
Sbjct: 74 IGICEAE-SWMLVMEMAELGPLNKYLQQNRH--VKDKNIIELVHQVSMGMKYLE---ESN 127
Query: 747 VFHRDIKASNILLDSNLNAKVADFGLSRLAPVLDDEGTMPTHVSTIVKGTPGYLDPEYFL 806
HRD+ A N+LL + AK++DFGLS+ T K + PE
Sbjct: 128 FVHRDLAARNVLLVTQHYAKISDFGLSKALR----ADENYYKAQTHGKWPVKWYAPECIN 183
Query: 807 THKLTDKSDVYSLGVVLLELLTGMQPISHGKNIVREVNVARDSGMVFSIIDNRMGSYPSE 866
+K + KSDV+S GV++ E + Q G S + + P+
Sbjct: 184 YYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMK---------GSEVTAMLEKGERMGCPAG 234
Query: 867 CVERFVTLALRCCHDKPEHRPSMSDVVRELENILK 901
C L C E+RP + V L N
Sbjct: 235 CPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYY 269
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 212 bits (541), Expect = 1e-62
Identities = 54/297 (18%), Positives = 110/297 (37%), Gaps = 34/297 (11%)
Query: 632 QVGQGGYGKVYKGILSDNTTVAIKRAEEGSLQGQNEFLTEIKLLSRLHHRNLVSLLGYCD 691
+G+G +G+V++G VA+K + EI L H N++ + +
Sbjct: 10 SIGKGRFGEVWRGKW-RGEEVAVKIFSSREERSW-FREAEIYQTVMLRHENILGFIAADN 67
Query: 692 EEGEQ----MLVYEFVPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEA---- 743
++ LV ++ +G+L D+L+ + + +++AL +A G+ +LH E
Sbjct: 68 KDNGTWTQLWLVSDYHEHGSLFDYLN---RYTVTVEGMIKLALSTASGLAHLHMEIVGTQ 124
Query: 744 -HPPVFHRDIKASNILLDSNLNAKVADFGLSRLAPVLDDEGTMPTHVSTIVKGTPGYLDP 802
P + HRD+K+ NIL+ N +AD GL+ D GT Y+ P
Sbjct: 125 GKPAIAHRDLKSKNILVKKNGTCCIADLGLAVR---HDSATDTIDIAPNHRVGTKRYMAP 181
Query: 803 EYFLTH------KLTDKSDVYSLGVVLLELLTGMQPIS---------HGKNIVREVNVAR 847
E + ++D+Y++G+V E+ +
Sbjct: 182 EVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEM 241
Query: 848 DSGMVFSIIDNRMGS--YPSECVERFVTLALRCCHDKPEHRPSMSDVVRELENILKM 902
+ + + + E + + C + R + + + L + +
Sbjct: 242 RKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQ 298
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 210 bits (536), Expect = 6e-62
Identities = 82/313 (26%), Positives = 129/313 (41%), Gaps = 41/313 (13%)
Query: 627 FSSSTQVGQGGYGKVYKGILSDN---TTVAIKR-AEEGSLQGQNEFLTEIKLLSRL-HHR 681
+G+G +G+V K + + AIKR E S +F E+++L +L HH
Sbjct: 12 IKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHP 71
Query: 682 NLVSLLGYCDEEGEQMLVYEFVPNGTLRDWLSGR--------------TKENLNFAMRLR 727
N+++LLG C+ G L E+ P+G L D+L T L+ L
Sbjct: 72 NIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLH 131
Query: 728 VALDSAKGILYLHTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSRLAPVLDDEGTMPT 787
A D A+G+ YL HRD+ A NIL+ N AK+ADFGLSR G
Sbjct: 132 FAADVARGMDYLS---QKQFIHRDLAARNILVGENYVAKIADFGLSR--------GQEVY 180
Query: 788 HVSTIVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVLLELLTGMQPISHGKNIVREVNVAR 847
T+ + ++ E T SDV+S GV+L E+++ G
Sbjct: 181 VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE------ 234
Query: 848 DSGMVFSIIDNRMGSYPSECVERFVTLALRCCHDKPEHRPSMSDVVRELENILKMFPE-- 905
+ + P C + L +C +KP RPS + ++ L +L+
Sbjct: 235 ---LYEKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERKTYV 291
Query: 906 TDTMFSKSESSSL 918
T++ K + +
Sbjct: 292 NTTLYEKFTYAGI 304
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 205 bits (524), Expect = 1e-60
Identities = 71/272 (26%), Positives = 111/272 (40%), Gaps = 26/272 (9%)
Query: 632 QVGQGGYGKVYKGI-LSDNTTVAIKRAEEGSLQGQN--EFLTEIKLLSRLHHRNLVSLLG 688
+G G YG+ K SD + K + GS+ ++E+ LL L H N+V
Sbjct: 11 TIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYD 70
Query: 689 YCDEEGEQML--VYEFVPNGTLRDWLSGRTKEN--LNFAMRLRVALDSAKGILYLH--TE 742
+ L V E+ G L ++ TKE L+ LRV + H ++
Sbjct: 71 RIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSD 130
Query: 743 AHPPVFHRDIKASNILLDSNLNAKVADFGLSRLAPVLDDEGTMPTHVSTIVKGTPGYLDP 802
V HRD+K +N+ LD N K+ DFGL+R+ T + GTP Y+ P
Sbjct: 131 GGHTVLHRDLKPANVFLDGKQNVKLGDFGLARIL-------NHDTSFAKAFVGTPYYMSP 183
Query: 803 EYFLTHKLTDKSDVYSLGVVLLELLTGMQPISHGKNIVREVNVARDSGMVFSIIDNRMGS 862
E +KSD++SLG +L EL M P + + I + +
Sbjct: 184 EQMNRMSYNEKSDIWSLGCLLYELCALMPPF-TAFSQKE---------LAGKIREGKFRR 233
Query: 863 YPSECVERFVTLALRCCHDKPEHRPSMSDVVR 894
P + + R + K HRPS+ +++
Sbjct: 234 IPYRYSDELNEIITRMLNLKDYHRPSVEEILE 265
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 204 bits (521), Expect = 2e-60
Identities = 62/277 (22%), Positives = 114/277 (41%), Gaps = 29/277 (10%)
Query: 626 YFSSSTQVGQGGYGKVYKGILSDNTT-VAIK--RAEEGSLQGQNEFLTEIKLLSRLHHRN 682
+ ++G+G + VYKG+ ++ T VA + + + + F E ++L L H N
Sbjct: 10 FLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPN 69
Query: 683 LVSLLGYCDEEGEQ----MLVYEFVPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILY 738
+V + + +LV E + +GTL+ +L + + + + KG+ +
Sbjct: 70 IVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYL--KRFKVMKIKVLRSWCRQILKGLQF 127
Query: 739 LHTEAHPPVFHRDIKASNILLDS-NLNAKVADFGLSRLAPVLDDEGTMPTHVSTIVKGTP 797
LH PP+ HRD+K NI + + K+ D GL+ L + V GTP
Sbjct: 128 LH-TRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATL---------KRASFAKAVIGTP 177
Query: 798 GYLDPEYFLTHKLTDKSDVYSLGVVLLELLTGMQPISHGKNIVREVNVARDSGMVFSIID 857
++ PE K + DVY+ G+ +LE+ T P S +N +
Sbjct: 178 EFMAPEM-YEEKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTS--------G 228
Query: 858 NRMGSYPSECVERFVTLALRCCHDKPEHRPSMSDVVR 894
+ S+ + + C + R S+ D++
Sbjct: 229 VKPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN 265
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 205 bits (521), Expect = 7e-60
Identities = 68/294 (23%), Positives = 112/294 (38%), Gaps = 40/294 (13%)
Query: 632 QVGQGGYGKVYKGIL------SDNTTVAIKRAEEGSLQGQNE-FLTEIKLLSRL-HHRNL 683
+G G +GKV + TVA+K + + + E ++E+K+LS L +H N+
Sbjct: 30 TLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNI 89
Query: 684 VSLLGYCDEEGEQMLVYEFVPNGTLRDWLSGRTKEN----------------LNFAMRLR 727
V+LLG C G +++ E+ G L ++L + L+ L
Sbjct: 90 VNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLS 149
Query: 728 VALDSAKGILYLHTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSRLAPVLDDEGTMPT 787
+ AKG+ +L HRD+ A NILL K+ DFGL+R +
Sbjct: 150 FSYQVAKGMAFLA---SKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSN-----Y 201
Query: 788 HVSTIVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVLLELLTGMQPISHGKNIVREVNVAR 847
V + ++ PE T +SDV+S G+ L EL + G + +
Sbjct: 202 VVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMI 261
Query: 848 DSGMVFSIIDNRMGSYPSECVERFVTLALRCCHDKPEHRPSMSDVVRELENILK 901
G P + C P RP+ +V+ +E +
Sbjct: 262 KEGFRMLS--------PEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQIS 307
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 203 bits (518), Expect = 2e-59
Identities = 70/311 (22%), Positives = 127/311 (40%), Gaps = 26/311 (8%)
Query: 627 FSSSTQVGQGGYGKVYKGI-LSDNTTVAIKRA-----EEGSLQGQNEFLTEIKLLSRLHH 680
F +G G +G VYKG+ + + V I A E S + E L E +++ + +
Sbjct: 11 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 70
Query: 681 RNLVSLLGYCDEEGEQMLVYEFVPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLH 740
++ LLG C L+ + +P G L D++ K+N+ L + AKG+ YL
Sbjct: 71 PHVCRLLGIC-LTSTVQLITQLMPFGCLLDYVREH-KDNIGSQYLLNWCVQIAKGMNYLE 128
Query: 741 TEAHPPVFHRDIKASNILLDSNLNAKVADFGLSRLAPVLDDEGTMPTHVSTIVKGTPGYL 800
+ HRD+ A N+L+ + + K+ DFGL++L + + + K ++
Sbjct: 129 ---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEK-----EYHAEGGKVPIKWM 180
Query: 801 DPEYFLTHKLTDKSDVYSLGVVLLELLTGMQPISHGKNIVREVNVARDSGMVFSIIDNRM 860
E L T +SDV+S GV + EL+T G S + +
Sbjct: 181 ALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIP---------ASEISSILEKGER 231
Query: 861 GSYPSECVERFVTLALRCCHDKPEHRPSMSDVVRELENILKMFPETDTMFSKSESSSLLS 920
P C + ++C + RP +++ E + + P+ + E L S
Sbjct: 232 LPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMAR-DPQRYLVIQGDERMHLPS 290
Query: 921 GKSASTSSSFL 931
++ + +
Sbjct: 291 PTDSNFYRALM 301
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 202 bits (514), Expect = 2e-59
Identities = 69/275 (25%), Positives = 113/275 (41%), Gaps = 25/275 (9%)
Query: 632 QVGQGGYGKVYKGILSDN----TTVAIKRAEEGSLQGQNE-FLTEIKLLSRLHHRNLVSL 686
+G+G +G V++GI VAIK + + E FL E + + H ++V L
Sbjct: 14 CIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKL 73
Query: 687 LGYCDEEGEQMLVYEFVPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPP 746
+G E ++ E G LR +L R +L+ A + A + + YL
Sbjct: 74 IGVI-TENPVWIIMELCTLGELRSFLQVRKY-SLDLASLILYAYQLSTALAYLE---SKR 128
Query: 747 VFHRDIKASNILLDSNLNAKVADFGLSRLAPVLDDEGTMPTHVSTIVKGTPGYLDPEYFL 806
HRDI A N+L+ SN K+ DFGLSR + ++ K ++ PE
Sbjct: 129 FVHRDIAARNVLVSSNDCVKLGDFGLSRYME------DSTYYKASKGKLPIKWMAPESIN 182
Query: 807 THKLTDKSDVYSLGVVLLELLTGMQPISHGKNIVREVNVARDSGMVFSIIDNRMGSYPSE 866
+ T SDV+ GV + E+L G ++ ++ I + P
Sbjct: 183 FRRFTSASDVWMFGVCMWEILMHGVKPFQGVK---------NNDVIGRIENGERLPMPPN 233
Query: 867 CVERFVTLALRCCHDKPEHRPSMSDVVRELENILK 901
C +L +C P RP +++ +L IL+
Sbjct: 234 CPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILE 268
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 203 bits (516), Expect = 6e-59
Identities = 67/296 (22%), Positives = 113/296 (38%), Gaps = 47/296 (15%)
Query: 632 QVGQGGYGKVYKGILSD------NTTVAIKRAEEGSLQGQ-NEFLTEIKLLSRL-HHRNL 683
+G G +GKV + VA+K +E + + ++E+K++++L H N+
Sbjct: 44 VLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENI 103
Query: 684 VSLLGYCDEEGEQMLVYEFVPNGTLRDWLSGRTKEN---------------------LNF 722
V+LLG C G L++E+ G L ++L + ++ L F
Sbjct: 104 VNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTF 163
Query: 723 AMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSRLAPVLDDE 782
L A AKG+ +L HRD+ A N+L+ K+ DFGL+R +
Sbjct: 164 EDLLCFAYQVAKGMEFLE---FKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSN- 219
Query: 783 GTMPTHVSTIVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVLLELLTGMQPISHGKNIVRE 842
V + ++ PE T KSDV+S G++L E+ + G +
Sbjct: 220 ----YVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDAN 275
Query: 843 VNVARDSGMVFSIIDNRM-GSYPSECVERFVTLALRCCHDKPEHRPSMSDVVRELE 897
+ +I N P E + C RPS ++ L
Sbjct: 276 ---------FYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG 322
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 200 bits (510), Expect = 7e-59
Identities = 72/275 (26%), Positives = 110/275 (40%), Gaps = 24/275 (8%)
Query: 632 QVGQGGYGKVYKGIL----SDNTTVAIKR---AEEGSLQGQNEFLTEIKLLSRLHHRNLV 684
++G G +G V +G +VA+K + ++F+ E+ + L HRNL+
Sbjct: 15 KLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLI 74
Query: 685 SLLGYCDEEGEQMLVYEFVPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAH 744
L G +V E P G+L D L + + R A+ A+G+ YL
Sbjct: 75 RLYGVV-LTPPMKMVTELAPLGSLLDRLRKH-QGHFLLGTLSRYAVQVAEGMGYLE---S 129
Query: 745 PPVFHRDIKASNILLDSNLNAKVADFGLSRLAPVLDDEGTMPTHVSTIVKGTPGYLDPEY 804
HRD+ A N+LL + K+ DFGL R P DD M H K + PE
Sbjct: 130 KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEH----RKVPFAWCAPES 185
Query: 805 FLTHKLTDKSDVYSLGVVLLELLTGMQPISHGKNIVREVNVARDSGMVFSIIDNRMGSYP 864
T + SD + GV L E+ T Q G N + ++ G P
Sbjct: 186 LKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPR--------P 237
Query: 865 SECVERFVTLALRCCHDKPEHRPSMSDVVRELENI 899
+C + + ++C KPE RP+ + L
Sbjct: 238 EDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEA 272
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 201 bits (513), Expect = 1e-58
Identities = 63/311 (20%), Positives = 122/311 (39%), Gaps = 34/311 (10%)
Query: 627 FSSSTQVGQGGYGKVYKGI-LSDNTTVAIKRAEEGSLQG-QNEFLTEIKLLSRLHHRNLV 684
F +++G G G V+K +A K +N+ + E+++L + +V
Sbjct: 8 FEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIV 67
Query: 685 SLLGYCDEEGEQMLVYEFVPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAH 744
G +GE + E + G+L L + + + +V++ KG+ YL +
Sbjct: 68 GFYGAFYSDGEISICMEHMDGGSLDQVLKKAGR--IPEQILGKVSIAVIKGLTYLREKH- 124
Query: 745 PPVFHRDIKASNILLDSNLNAKVADFGLSRLAPVLDDEGTMPTHVSTIVKGTPGYLDPEY 804
+ HRD+K SNIL++S K+ DFG+S + ++ GT Y+ PE
Sbjct: 125 -KIMHRDVKPSNILVNSRGEIKLCDFGVSGQ---------LIDSMANSFVGTRSYMSPER 174
Query: 805 FLTHKLTDKSDVYSLGVVLLELLTGMQPISHGKNIVREVNVARDSGMVFSIIDNRMGSYP 864
+ +SD++S+G+ L+E+ G PI D+ + + ++
Sbjct: 175 LQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPP-----------DAKELELMFGCQVEGDA 223
Query: 865 SECVERFVTLALRCCHDKPEHRPSMSDVVRELENILKMFPETDTMFSKSESSSLLSGKSA 924
+E R T + RP M+ + + P+ + E +
Sbjct: 224 AETPPRPRTPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFV----- 278
Query: 925 STSSSFLTRDP 935
+ L ++P
Sbjct: 279 ---NKCLIKNP 286
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 200 bits (511), Expect = 2e-58
Identities = 64/276 (23%), Positives = 106/276 (38%), Gaps = 32/276 (11%)
Query: 626 YFSSSTQVGQGGYGKVYKGI-LSDNTTVAIKRAEEGSLQGQN---EFLTEIKLLSRLHHR 681
FS ++G G +G VY + ++ VAIK+ Q + + E++ L +L H
Sbjct: 16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHP 75
Query: 682 NLVSLLGYCDEEGEQMLVYEFVPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHT 741
N + G E LV E+ K+ L V + +G+ YLH
Sbjct: 76 NTIQYRGCYLREHTAWLVMEYCLGSASDLLE--VHKKPLQEVEIAAVTHGALQGLAYLH- 132
Query: 742 EAHPPVFHRDIKASNILLDSNLNAKVADFGLSRLAPVLDDEGTMPTHVSTIVKGTPGYLD 801
+ HRD+KA NILL K+ DFG + + + GTP ++
Sbjct: 133 --SHNMIHRDVKAGNILLSEPGLVKLGDFGSASI-----------MAPANSFVGTPYWMA 179
Query: 802 PEYFLTH---KLTDKSDVYSLGVVLLELLTGMQPISHGKNIVREVNVARDSGMVFSIIDN 858
PE L + K DV+SLG+ +EL P+ + + ++A++
Sbjct: 180 PEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQ---- 235
Query: 859 RMGSYPSECVERFVTLALRCCHDKPEHRPSMSDVVR 894
E F C P+ RP+ +++
Sbjct: 236 -----SGHWSEYFRNFVDSCLQKIPQDRPTSEVLLK 266
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 198 bits (505), Expect = 3e-58
Identities = 70/267 (26%), Positives = 105/267 (39%), Gaps = 29/267 (10%)
Query: 632 QVGQGGYGKVYKGIL-SDNTTVAIKRAEEGSLQGQN---EFLTEIKLLSRLHHRNLVSLL 687
+G+G +G VY +A+K + L+ + E+++ S L H N++ L
Sbjct: 13 PLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLY 72
Query: 688 GYCDEEGEQMLVYEFVPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPV 747
GY + L+ E+ P GT+ L +K + + A + Y H V
Sbjct: 73 GYFHDATRVYLILEYAPLGTVYRELQKLSK--FDEQRTATYITELANALSYCH---SKRV 127
Query: 748 FHRDIKASNILLDSNLNAKVADFGLSRLAPVLDDEGTMPTHVSTIVKGTPGYLDPEYFLT 807
HRDIK N+LL S K+ADFG S P+ T + GT YL PE
Sbjct: 128 IHRDIKPENLLLGSAGELKIADFGWSVH---------APSSRRTTLCGTLDYLPPEMIEG 178
Query: 808 HKLTDKSDVYSLGVVLLELLTGMQPISHGKNIVREVNVARDSGMVFSIIDNRMGSYPSEC 867
+K D++SLGV+ E L G P A + I ++P
Sbjct: 179 RMHDEKVDLWSLGVLCYEFLVGKPPFE-----------ANTYQETYKRISRVEFTFPDFV 227
Query: 868 VERFVTLALRCCHDKPEHRPSMSDVVR 894
E L R P RP + +V+
Sbjct: 228 TEGARDLISRLLKHNPSQRPMLREVLE 254
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 197 bits (502), Expect = 3e-57
Identities = 65/298 (21%), Positives = 124/298 (41%), Gaps = 32/298 (10%)
Query: 632 QVGQGGYGKVYKGIL------SDNTTVAIKR-AEEGSLQGQNEFLTEIKLLSRLHHRNLV 684
++GQG +G VY+G+ T VAIK E S++ + EFL E ++ + ++V
Sbjct: 27 ELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVV 86
Query: 685 SLLGYCDEEGEQMLVYEFVPNGTLRDWLSGRTKEN--------LNFAMRLRVALDSAKGI 736
LLG + +++ E + G L+ +L + + +++A + A G+
Sbjct: 87 RLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGM 146
Query: 737 LYLHTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSRLAPVLDDEGTMPTHVSTIVKGT 796
YL+ HRD+ A N ++ + K+ DFG++R T
Sbjct: 147 AYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIY-----ETDYYRKGGKGLLP 198
Query: 797 PGYLDPEYFLTHKLTDKSDVYSLGVVLLELLTGMQPISHGKNIVREVNVARDSGMVFSII 856
++ PE T SDV+S GVVL E+ T + G + + ++ ++
Sbjct: 199 VRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLS---------NEQVLRFVM 249
Query: 857 DNRMGSYPSECVERFVTLALRCCHDKPEHRPSMSDVVRELENILKMFPETDTMFSKSE 914
+ + P C + L C P+ RPS +++ ++ ++ + + E
Sbjct: 250 EGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPGFREVSFYYSEE 307
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 196 bits (500), Expect = 4e-57
Identities = 64/269 (23%), Positives = 110/269 (40%), Gaps = 25/269 (9%)
Query: 632 QVGQGGYGKVYKGI-LSDNTTVAIKRAEEGSLQGQNEFLTEIKLLSRLHHRNLVSLLGYC 690
++G G +GKVYK + A K + S + +++ EI +L+ H N+V LL
Sbjct: 19 ELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAF 78
Query: 691 DEEGEQMLVYEFVPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHR 750
E ++ EF G + + + L + V + + YLH + HR
Sbjct: 79 YYENNLWILIEFCAGGAVDAVML-ELERPLTESQIQVVCKQTLDALNYLH---DNKIIHR 134
Query: 751 DIKASNILLDSNLNAKVADFGLSRLAPVLDDEGTMPTHVSTIVKGTPGYLDPEYFLTHKL 810
D+KA NIL + + K+ADFG+S + T GTP ++ PE +
Sbjct: 135 DLKAGNILFTLDGDIKLADFGVSA-------KNTRTIQRRDSFIGTPYWMAPEVVMCETS 187
Query: 811 TD-----KSDVYSLGVVLLELLTGMQPISHGKNIVREVNVARDSGMVFSIIDNRMGSYPS 865
D K+DV+SLG+ L+E+ P + + +A+ + PS
Sbjct: 188 KDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTLAQ--------PS 239
Query: 866 ECVERFVTLALRCCHDKPEHRPSMSDVVR 894
F +C + R + S +++
Sbjct: 240 RWSSNFKDFLKKCLEKNVDARWTTSQLLQ 268
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 195 bits (496), Expect = 7e-57
Identities = 63/266 (23%), Positives = 107/266 (40%), Gaps = 21/266 (7%)
Query: 632 QVGQGGYGKVYKGI-LSDNTTVAIKRAE-EGSLQGQNEFLTEIKLLSRLHHRNLVSLLGY 689
+G+G YG+V + VA+K + + ++ EI + L+H N+V G+
Sbjct: 12 TLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH 71
Query: 690 CDEEGEQMLVYEFVPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFH 749
E Q L E+ G L D + + R G++YLH + H
Sbjct: 72 RREGNIQYLFLEYCSGGELFDRI--EPDIGMPEPDAQRFFHQLMAGVVYLH---GIGITH 126
Query: 750 RDIKASNILLDSNLNAKVADFGLSRLAPVLDDEGTMPTHVSTIVKGTPGYLDPEYFLTHK 809
RDIK N+LLD N K++DFGL+ + + E + GT Y+ PE +
Sbjct: 127 RDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC-----GTLPYVAPELLKRRE 181
Query: 810 LTD-KSDVYSLGVVLLELLTGMQPISHGKNIVREVNVARDSGMVFSIIDNRMGSYPSECV 868
DV+S G+VL +L G P + +E + ++ + S +
Sbjct: 182 FHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKK----IDSAPL 237
Query: 869 ERFVTLALRCCHDKPEHRPSMSDVVR 894
L + + P R ++ D+ +
Sbjct: 238 A----LLHKILVENPSARITIPDIKK 259
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 193 bits (491), Expect = 5e-56
Identities = 76/293 (25%), Positives = 120/293 (40%), Gaps = 39/293 (13%)
Query: 632 QVGQGGYGKVYKGI------LSDNTTVAIKRAEEGSLQGQN-EFLTEIKLLSR-LHHRNL 683
+G+G +G+V + + TVA+K +EG+ ++ ++E+K+L HH N+
Sbjct: 20 PLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNV 79
Query: 684 VSLLGYCDEEGEQ-MLVYEFVPNGTLRDWLSGR--------------TKENLNFAMRLRV 728
V+LLG C + G M++ EF G L +L + K+ L +
Sbjct: 80 VNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICY 139
Query: 729 ALDSAKGILYLHTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSRLAPVLDDEGTMPTH 788
+ AKG+ +L HRD+ A NILL K+ DFGL+R D
Sbjct: 140 SFQVAKGMEFLA---SRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD-----YV 191
Query: 789 VSTIVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVLLELLTGMQPISHGKNIVREVNVARD 848
+ ++ PE T +SDV+S GV+L E+ + G I E
Sbjct: 192 RKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLK 251
Query: 849 SGMVFSIIDNRMGSYPSECVERFVTLALRCCHDKPEHRPSMSDVVRELENILK 901
G P L C H +P RP+ S++V L N+L+
Sbjct: 252 EGTRMRA--------PDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 296
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 192 bits (490), Expect = 9e-56
Identities = 60/264 (22%), Positives = 111/264 (42%), Gaps = 22/264 (8%)
Query: 632 QVGQGGYGKVYKGI-LSDNTTVAIKRAEEGSLQGQNEFLTEIKLLSRLHHRNLVSLLGYC 690
++GQG G VY + ++ VAI++ + + EI ++ + N+V+ L
Sbjct: 27 KIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSY 86
Query: 691 DEEGEQMLVYEFVPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHR 750
E +V E++ G+L D + T+ ++ V + + + +LH+ V HR
Sbjct: 87 LVGDELWVVMEYLAGGSLTDVV---TETCMDEGQIAAVCRECLQALEFLHSN---QVIHR 140
Query: 751 DIKASNILLDSNLNAKVADFGLSRLAPVLDDEGTMPTHVSTIVKGTPGYLDPEYFLTHKL 810
DIK+ NILL + + K+ DFG T + + GTP ++ PE
Sbjct: 141 DIKSDNILLGMDGSVKLTDFGFCAQI-------TPEQSKRSTMVGTPYWMAPEVVTRKAY 193
Query: 811 TDKSDVYSLGVVLLELLTGMQPISHGKNIVREVNVARDSGMVFSIIDNRMGSYPSECVER 870
K D++SLG++ +E++ G P + + +A + P +
Sbjct: 194 GPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQN--------PEKLSAI 245
Query: 871 FVTLALRCCHDKPEHRPSMSDVVR 894
F RC E R S ++++
Sbjct: 246 FRDFLNRCLDMDVEKRGSAKELLQ 269
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 191 bits (486), Expect = 3e-55
Identities = 67/295 (22%), Positives = 126/295 (42%), Gaps = 41/295 (13%)
Query: 632 QVGQGGYGKVYKGIL--------SDNTTVAIKR-AEEGSLQGQNEFLTEIKLLSRL-HHR 681
+G+G +G+V + T VA+K + + + ++ ++E++++ + H+
Sbjct: 20 PLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHK 79
Query: 682 NLVSLLGYCDEEGEQMLVYEFVPNGTLRDWL--------------SGRTKENLNFAMRLR 727
N+++LLG C ++G ++ E+ G LR++L S +E L+ +
Sbjct: 80 NIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVS 139
Query: 728 VALDSAKGILYLHTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSRLAPVLDDEGTMPT 787
A A+G+ YL HRD+ A N+L+ + K+ADFGL+R +D
Sbjct: 140 CAYQVARGMEYLA---SKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTN 196
Query: 788 HVSTIVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVLLELLTGMQPISHGKNIVREVNVAR 847
+ ++ PE T +SDV+S GV+L E+ T G +
Sbjct: 197 G-----RLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE------ 245
Query: 848 DSGMVFSIIDNRMGSYPSECVERFVTLALRCCHDKPEHRPSMSDVVRELENILKM 902
+ + + PS C + C H P RP+ +V +L+ I+ +
Sbjct: 246 ---LFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVAL 297
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 180 bits (458), Expect = 2e-51
Identities = 50/265 (18%), Positives = 99/265 (37%), Gaps = 25/265 (9%)
Query: 632 QVGQGGYGKVYKGI-LSDNTTVAIKRAEEGSLQGQN---EFLTEIKLLSRLHHRNLVSLL 687
+G+G + V L+ + AIK E+ + +N E ++SRL H V L
Sbjct: 15 ILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLY 74
Query: 688 GYCDEEGEQMLVYEFVPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPV 747
++ + + NG L ++ + +A+ + L +
Sbjct: 75 FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFY-----TAEIVSALEYLHGKGI 129
Query: 748 FHRDIKASNILLDSNLNAKVADFGLSRLAPVLDDEGTMPTHVSTIVKGTPGYLDPEYFLT 807
HRD+K NILL+ +++ ++ DFG +++ + GT Y+ PE
Sbjct: 130 IHRDLKPENILLNEDMHIQITDFGTAKV-----LSPESKQARANSFVGTAQYVSPELLTE 184
Query: 808 HKLTDKSDVYSLGVVLLELLTGMQPISHGKNIVREVNVARDSGMVFSIIDNRMGSYPSEC 867
SD+++LG ++ +L+ G+ P G + +F I +P +
Sbjct: 185 KSACKSSDLWALGCIIYQLVAGLPPFRAGNEYL-----------IFQKIIKLEYDFPEKF 233
Query: 868 VERFVTLALRCCHDKPEHRPSMSDV 892
+ L + R ++
Sbjct: 234 FPKARDLVEKLLVLDATKRLGCEEM 258
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 180 bits (457), Expect = 1e-50
Identities = 56/264 (21%), Positives = 103/264 (39%), Gaps = 22/264 (8%)
Query: 632 QVGQGGYGKVYKGI-LSDNTTVAIKRAEEGSLQGQNEFLTEIKLLSRLHHRNLVSLLGYC 690
++G G +G V++ + A K + EI+ +S L H LV+L
Sbjct: 33 ELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAF 92
Query: 691 DEEGEQMLVYEFVPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHR 750
+++ E +++YEF+ G L + ++ ++ + KG+ ++H H
Sbjct: 93 EDDNEMVMIYEFMSGGELFEKVA-DEHNKMSEDEAVEYMRQVCKGLCHMHEN---NYVHL 148
Query: 751 DIKASNILLDSNLN--AKVADFGLSRLAPVLDDEGTMPTHVSTIVKGTPGYLDPEYFLTH 808
D+K NI+ + + K+ DFGL+ P + GT + PE
Sbjct: 149 DLKPENIMFTTKRSNELKLIDFGLTAHLD--------PKQSVKVTTGTAEFAAPEVAEGK 200
Query: 809 KLTDKSDVYSLGVVLLELLTGMQPISHGKNIVREVNVARDSGMVFSIIDNRMGSYPSECV 868
+ +D++S+GV+ LL+G+ P G+N + V S N S S
Sbjct: 201 PVGYYTDMWSVGVLSYILLSGLSPF-GGENDDETLR------NVKSCDWNMDDSAFSGIS 253
Query: 869 ERFVTLALRCCHDKPEHRPSMSDV 892
E + P R ++
Sbjct: 254 EDGKDFIRKLLLADPNTRMTIHQA 277
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 177 bits (449), Expect = 1e-49
Identities = 52/266 (19%), Positives = 112/266 (42%), Gaps = 22/266 (8%)
Query: 632 QVGQGGYGKVYKGI-LSDNTTVAIKRAEEGSLQGQNEFLTEIKLLSRLHHRNLVSLLGYC 690
++G G +G V++ + + K + EI ++++LHH L++L
Sbjct: 36 ELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAF 95
Query: 691 DEEGEQMLVYEFVPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHR 750
+++ E +L+ EF+ G L D ++ ++ A + + +G+ ++H + H
Sbjct: 96 EDKYEMVLILEFLSGGELFDRIAAE-DYKMSEAEVINYMRQACEGLKHMH---EHSIVHL 151
Query: 751 DIKASNILLDSNLNA--KVADFGLSRLAPVLDDEGTMPTHVSTIVKGTPGYLDPEYFLTH 808
DIK NI+ ++ + K+ DFGL+ P + + T + PE
Sbjct: 152 DIKPENIMCETKKASSVKIIDFGLATKLN--------PDEIVKVTTATAEFAAPEIVDRE 203
Query: 809 KLTDKSDVYSLGVVLLELLTGMQPISHGKNIVREVNVARDSGMVFSIIDNRMGSYPSECV 868
+ +D++++GV+ LL+G+ P + ++ NV R + ++ S E
Sbjct: 204 PVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKR---CDWEFDEDAFSSVSPEAK 260
Query: 869 ERFVTLALRCCHDKPEHRPSMSDVVR 894
+ +P R ++ D +
Sbjct: 261 D----FIKNLLQKEPRKRLTVHDALE 282
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 170 bits (432), Expect = 3e-48
Identities = 67/278 (24%), Positives = 120/278 (43%), Gaps = 25/278 (8%)
Query: 632 QVGQGGYGKVYKGI-LSDNTTVAIKRAEEGSLQGQN---EFLTEIKLLSRLHHRNLVSLL 687
+G GG +V+ L + VA+K + + F E + + L+H +V++
Sbjct: 14 ILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVY 73
Query: 688 GYCDEEGEQ----MLVYEFVPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEA 743
+ E +V E+V TLRD + T+ + + V D+ + + + H
Sbjct: 74 DTGEAETPAGPLPYIVMEYVDGVTLRDIV--HTEGPMTPKRAIEVIADACQALNFSH--- 128
Query: 744 HPPVFHRDIKASNILLDSNLNAKVADFGLSRLAPVLDDEGTMPTHVSTIVKGTPGYLDPE 803
+ HRD+K +NI++ + KV DFG++R + D G T + ++ GT YL PE
Sbjct: 129 QNGIIHRDVKPANIMISATNAVKVMDFGIAR---AIADSGNSVTQTAAVI-GTAQYLSPE 184
Query: 804 YFLTHKLTDKSDVYSLGVVLLELLTGMQPISHGKNIVREVNVARDSGMVFSIIDNRMGSY 863
+ +SDVYSLG VL E+LTG P + + R+ + S +
Sbjct: 185 QARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPS-------AR 237
Query: 864 PSECVERFVTLALRCCHDKPEHRP-SMSDVVRELENIL 900
+ L+ PE+R + +++ +L +
Sbjct: 238 HEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVH 275
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 171 bits (434), Expect = 7e-48
Identities = 54/314 (17%), Positives = 121/314 (38%), Gaps = 36/314 (11%)
Query: 632 QVGQGGYGKVYKGI-LSDNTTVAIKRAEEGSLQGQNEFLTEIKLLSRLHHRNLVSLLGYC 690
+G+G +G V++ + S T K + Q EI +L+ HRN++ L
Sbjct: 12 DLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTD-QVLVKKEISILNIARHRNILHLHESF 70
Query: 691 DEEGEQMLVYEFVPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHR 750
+ E ++++EF+ + + ++ + LN + + + +LH + H
Sbjct: 71 ESMEELVMIFEFISGLDIFERIN-TSAFELNEREIVSYVHQVCEALQFLH---SHNIGHF 126
Query: 751 DIKASNILLDSNLNA--KVADFGLSRLAPVLDDEGTMPTHVSTIVKGTPGYLDPEYFLTH 808
DI+ NI+ + ++ K+ +FG +R D+ + P Y PE
Sbjct: 127 DIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLF--------TAPEYYAPEVHQHD 178
Query: 809 KLTDKSDVYSLGVVLLELLTGMQPISHGKNIVREVNVARDSGMVFSIIDNRMGSYPSECV 868
++ +D++SLG ++ LL+G+ P N N+ ++ + E +
Sbjct: 179 VVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAE---YTFDEEAFKEISIEAM 235
Query: 869 ERFVTLALRCCHDKPEHRPSMSDVVR-------------ELENILKMFPETDTMFSKSES 915
+ R + + R + S+ ++ ++ LK T+ K +
Sbjct: 236 D----FVDRLLVKERKSRMTASEALQHPWLKQKIERVSTKVIRTLKHRRYYHTLIKKDLN 291
Query: 916 SSLLSGKSASTSSS 929
+ + + + +
Sbjct: 292 MVVSAARISCGGAI 305
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 168 bits (427), Expect = 2e-47
Identities = 54/275 (19%), Positives = 97/275 (35%), Gaps = 15/275 (5%)
Query: 632 QVGQGGYGKVYKGI-LSDNTTVAIKRAEEGSLQGQNEFLTEIKLLSRLHHRNLVSLLGYC 690
++G G +G +Y G ++ VAIK + + E K+ + + + +C
Sbjct: 14 KIGSGSFGDIYLGTDIAAGEEVAIKLECVKT--KHPQLHIESKIYKMMQGGVGIPTIRWC 71
Query: 691 DEEGEQ-MLVYEFVPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFH 749
EG+ ++V E + + + L +A I Y+H++ H
Sbjct: 72 GAEGDYNVMVMELLGPSLEDLFN--FCSRKFSLKTVLLLADQMISRIEYIHSKN---FIH 126
Query: 750 RDIKASNIL---LDSNLNAKVADFGLSRLAPVLDDEGTMPTHVSTIVKGTPGYLDPEYFL 806
RD+K N L + DFGL++ +P + + GT Y L
Sbjct: 127 RDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHL 186
Query: 807 THKLTDKSDVYSLGVVLLELLTGMQPISHGKNIVREVNVARDSGMVFSIIDNRMGSYPSE 866
+ + + D+ SLG VL+ G P K + R S S +
Sbjct: 187 GIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVL---CKG 243
Query: 867 CVERFVTLALRCCHDKPEHRPSMSDVVRELENILK 901
F T C + + +P S + + N+
Sbjct: 244 YPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFH 278
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 168 bits (426), Expect = 5e-47
Identities = 57/265 (21%), Positives = 96/265 (36%), Gaps = 19/265 (7%)
Query: 632 QVGQGGYGKVYKGI-LSDNTTVAIKRAEEGSLQGQNE-FLTEIKLLSRLHHRNLVSLLGY 689
+G G + +V VAIK + +L+G+ EI +L ++ H N+V+L
Sbjct: 16 VLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDI 75
Query: 690 CDEEGEQMLVYEFVPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFH 749
+ G L+ + V G L D + K R+ + YLH
Sbjct: 76 YESGGHLYLIMQLVSGGELFDRI--VEKGFYTERDASRLIFQVLDAVKYLHDLGIVHRDL 133
Query: 750 RDIKASNILLDSNLNAKVADFGLSRLAPVLDDEGTMPTHVSTIVKGTPGYLDPEYFLTHK 809
+ LD + ++DFGLS++ P V + GTPGY+ PE
Sbjct: 134 KPENLLYYSLDEDSKIMISDFGLSKM--------EDPGSVLSTACGTPGYVAPEVLAQKP 185
Query: 810 LTDKSDVYSLGVVLLELLTGMQPISHGKNIVREVNVARDSGMVFSIIDNRMGSYPSECVE 869
+ D +S+GV+ LL G P + +N + + F Y + +
Sbjct: 186 YSKAVDCWSIGVIAYILLCGYPPF-YDENDAKLFEQILKAEYEFDS------PYWDDISD 238
Query: 870 RFVTLALRCCHDKPEHRPSMSDVVR 894
PE R + ++
Sbjct: 239 SAKDFIRHLMEKDPEKRFTCEQALQ 263
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 166 bits (420), Expect = 1e-46
Identities = 63/278 (22%), Positives = 105/278 (37%), Gaps = 37/278 (13%)
Query: 632 QVGQGGYGKVYKGI-LSDNTTVAIKR---------AEEGSLQGQNEFLTEIKLLSRLH-H 680
+G+G V + I A+K + E + + L E+ +L ++ H
Sbjct: 10 ILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGH 69
Query: 681 RNLVSLLGYCDEEGEQMLVYEFVPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLH 740
N++ L + LV++ + G L D+L K L+ ++ + I LH
Sbjct: 70 PNIIQLKDTYETNTFFFLVFDLMKKGELFDYL--TEKVTLSEKETRKIMRALLEVICALH 127
Query: 741 TEAHPPVFHRDIKASNILLDSNLNAKVADFGLSRLAPVLDDEGTMPTHVSTIVKGTPGYL 800
+ HRD+K NILLD ++N K+ DFG S P V GTP YL
Sbjct: 128 ---KLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLD--------PGEKLREVCGTPSYL 176
Query: 801 DPEYFLT------HKLTDKSDVYSLGVVLLELLTGMQPISHGKNIVREVNVARDSGMVFS 854
PE + D++S GV++ LL G P H K ++ + + +
Sbjct: 177 APEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGN---YQ 233
Query: 855 IIDNRMGSYPSECVERFVTLALRCCHDKPEHRPSMSDV 892
Y + L R +P+ R + +
Sbjct: 234 FGSPEWDDYSDTVKD----LVSRFLVVQPQKRYTAEEA 267
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 163 bits (414), Expect = 3e-45
Identities = 55/261 (21%), Positives = 97/261 (37%), Gaps = 30/261 (11%)
Query: 632 QVGQGGYGKVYKGI-LSDNTTVAIK---RAEEGSLQGQNEFLTEIKLLSRLHHRNLVSLL 687
+G G +G+V+ + A+K + L+ E +LS + H ++ +
Sbjct: 11 TLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMW 70
Query: 688 GYCDEEGEQMLVYEFVPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPV 747
G + + ++ +++ G L L + A + L L +
Sbjct: 71 GTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEV-----CLALEYLHSKDI 125
Query: 748 FHRDIKASNILLDSNLNAKVADFGLSRLAPVLDDEGTMPTHVSTIVKGTPGYLDPEYFLT 807
+RD+K NILLD N + K+ DFG ++ P V+ + GTP Y+ PE T
Sbjct: 126 IYRDLKPENILLDKNGHIKITDFGFAKYVP----------DVTYTLCGTPDYIAPEVVST 175
Query: 808 HKLTDKSDVYSLGVVLLELLTGMQPISHGKNIVREVNVARDSGMVFSIIDNRMGSYPSEC 867
D +S G+++ E+L G P + N ++ + I N +P
Sbjct: 176 KPYNKSIDWWSFGILIYEMLAGYTPF-YDSNTMK----------TYEKILNAELRFPPFF 224
Query: 868 VERFVTLALRCCHDKPEHRPS 888
E L R R
Sbjct: 225 NEDVKDLLSRLITRDLSQRLG 245
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 161 bits (407), Expect = 1e-44
Identities = 49/276 (17%), Positives = 93/276 (33%), Gaps = 15/276 (5%)
Query: 632 QVGQGGYGKVYKGI-LSDNTTVAIKRAEEGSLQGQNEFLTEIKLLSRLHHRNLVSLLGYC 690
++G+G +G +++G L +N VAIK + E + L + + Y
Sbjct: 12 RIGEGSFGVIFEGTNLLNNQQVAIKFEPR--RSDAPQLRDEYRTYKLLAGCTGIPNVYYF 69
Query: 691 DEEGEQMLVYEFVPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHR 750
+EG ++ + +L D L + A + +H + +R
Sbjct: 70 GQEGLHNVLVIDLLGPSLEDLLD-LCGRKFSVKTVAMAAKQMLARVQSIH---EKSLVYR 125
Query: 751 DIKASNILLDSNLN-----AKVADFGLSRLAPVLDDEGTMPTHVSTIVKGTPGYLDPEYF 805
DIK N L+ + V DFG+ + + +P + GT Y+
Sbjct: 126 DIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTH 185
Query: 806 LTHKLTDKSDVYSLGVVLLELLTGMQPISHGKNIVREVNVARDSGMVFSIIDNRMGSYPS 865
L + + + D+ +LG V + L G P K + R S + +
Sbjct: 186 LGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLREL---CA 242
Query: 866 ECVERFVTLALRCCHDKPEHRPSMSDVVRELENILK 901
E F + + P + +L+
Sbjct: 243 GFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLE 278
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 161 bits (407), Expect = 2e-44
Identities = 64/269 (23%), Positives = 112/269 (41%), Gaps = 28/269 (10%)
Query: 632 QVGQGGYGKVYKGI-LSDNTTVAIKRAEEGSLQGQNE---FLTEIKLLSR-LHHRNLVSL 686
+G+G +GKV+ N AIK ++ + ++ + E ++LS H L +
Sbjct: 9 MLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHM 68
Query: 687 LGYCDEEGEQMLVYEFVPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPP 746
+ V E++ G L + ++ + + A + G+ +LH
Sbjct: 69 FCTFQTKENLFFVMEYLNGGDLMYHI--QSCHKFDLSRATFYAAEIILGLQFLH---SKG 123
Query: 747 VFHRDIKASNILLDSNLNAKVADFGLSRLAPVLDDEGTMPTHVSTIVKGTPGYLDPEYFL 806
+ +RD+K NILLD + + K+ADFG+ + E + + GTP Y+ PE L
Sbjct: 124 IVYRDLKLDNILLDKDGHIKIADFGMCK-------ENMLGDAKTNTFCGTPDYIAPEILL 176
Query: 807 THKLTDKSDVYSLGVVLLELLTGMQPISHGKNIVREVNVARDSGMVFSIIDNRMGSYPSE 866
K D +S GV+L E+L G P HG++ +F I YP
Sbjct: 177 GQKYNHSVDWWSFGVLLYEMLIGQSPF-HGQDEEE----------LFHSIRMDNPFYPRW 225
Query: 867 CVERFVTLALRCCHDKPEHRPSMSDVVRE 895
+ L ++ +PE R + +R+
Sbjct: 226 LEKEAKDLLVKLFVREPEKRLGVRGDIRQ 254
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 162 bits (410), Expect = 3e-44
Identities = 57/271 (21%), Positives = 99/271 (36%), Gaps = 30/271 (11%)
Query: 627 FSSSTQVGQGGYGKVYKGILSD-NTTVAIKRAEEGSL---QGQNEFLTE---IKLLSRLH 679
FS +G+GG+G+VY +D A+K ++ + QG+ L E + L+S
Sbjct: 6 FSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGD 65
Query: 680 HRNLVSLLGYCDEEGEQMLVYEFVPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYL 739
+V + + + + + G L LS + + G+ ++
Sbjct: 66 CPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEI--ILGLEHM 123
Query: 740 HTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSRLAPVLDDEGTMPTHVSTIVKGTPGY 799
H + V +RD+K +NILLD + + +++D GL+ GT GY
Sbjct: 124 H---NRFVVYRDLKPANILLDEHGHVRISDLGLACD---------FSKKKPHASVGTHGY 171
Query: 800 LDPEYFLTHKLTD-KSDVYSLGVVLLELLTGMQPISHGKNIVREVNVARDSGMVFSIIDN 858
+ PE D +D +SLG +L +LL G P K +D + +
Sbjct: 172 MAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKT--------KDKHEIDRMTLT 223
Query: 859 RMGSYPSECVERFVTLALRCCHDKPEHRPSM 889
P +L R
Sbjct: 224 MAVELPDSFSPELRSLLEGLLQRDVNRRLGC 254
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 156 bits (394), Expect = 4e-43
Identities = 66/274 (24%), Positives = 105/274 (38%), Gaps = 41/274 (14%)
Query: 632 QVGQGGYGKVYKGI-LSDNTTVAIKR------AEEGSLQGQNEFLTEIKLLSRLH--HRN 682
+G GG+G VY GI +SDN VAIK ++ G L E+ LL ++
Sbjct: 11 LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 70
Query: 683 LVSLLGYCDEEGEQMLVYEFVPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTE 742
++ LL + + +L+ E + L + + + + H
Sbjct: 71 VIRLLDWFERPDSFVLILERPEPVQDLFDFI-TERGALQEELARSFFWQVLEAVRHCH-- 127
Query: 743 AHPPVFHRDIKASNILLDSN-LNAKVADFGLSRLAPVLDDEGTMPTHVSTIVKGTPGYLD 801
+ V HRDIK NIL+D N K+ DFG L + V T GT Y
Sbjct: 128 -NCGVLHRDIKDENILIDLNRGELKLIDFGSGAL---------LKDTVYTDFDGTRVYSP 177
Query: 802 PEYFLTHKLTDKS-DVYSLGVVLLELLTGMQPISHGKNIVREVNVARDSGMVFSIIDNRM 860
PE+ H+ +S V+SLG++L +++ G P H + I+R
Sbjct: 178 PEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVF--------------- 222
Query: 861 GSYPSECVERFVTLALRCCHDKPEHRPSMSDVVR 894
+ L C +P RP+ ++
Sbjct: 223 --FRQRVSSECQHLIRWCLALRPSDRPTFEEIQN 254
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 155 bits (392), Expect = 2e-42
Identities = 68/301 (22%), Positives = 113/301 (37%), Gaps = 45/301 (14%)
Query: 632 QVGQGGYGKVYKG--ILSDNTTVAIK--RAEEGSLQGQNEFLTEIKLLSRL---HHRNLV 684
++G+G YGKV+K + + VA+K R + G + E+ +L L H N+V
Sbjct: 14 EIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVV 73
Query: 685 SLLGYC-----DEEGEQMLVYEFVPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYL 739
L C D E + LV+E V +L + + + +G+ +L
Sbjct: 74 RLFDVCTVSRTDRETKLTLVFEHVDQDLT-TYLDKVPEPGVPTETIKDMMFQLLRGLDFL 132
Query: 740 HTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSRLAPVLDDEGTMPTHVSTIVKGTPGY 799
H+ V HRD+K NIL+ S+ K+ADFGL+R+ T V T Y
Sbjct: 133 HSH---RVVHRDLKPQNILVTSSGQIKLADFGLARI--------YSFQMALTSVVVTLWY 181
Query: 800 LDPEYFLTHKLTDKSDVYSLGVVLLELLTGMQPISHGKNIVREVNVARDSGM-------- 851
PE L D++S+G + E+ ++ + + G+
Sbjct: 182 RAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPR 241
Query: 852 --------VFSIIDNRMGSYPSECVERFVTLALRCCHDKPEHRPSMSDV-----VRELEN 898
S + + ++ E L L+C P R S ++LE
Sbjct: 242 DVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDLER 301
Query: 899 I 899
Sbjct: 302 C 302
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 154 bits (390), Expect = 3e-42
Identities = 53/274 (19%), Positives = 100/274 (36%), Gaps = 31/274 (11%)
Query: 632 QVGQGGYGKVYKGI-LSDNTTVAIKR------AEEGSLQGQNEFLTEIKLLSRLHHRNLV 684
++G G + V K S A K + + E+ +L + H N++
Sbjct: 17 ELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVI 76
Query: 685 SLLGYCDEEGEQMLVYEFVPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAH 744
+L + + + +L+ E V G L D+L+ + A + + ++
Sbjct: 77 TLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQI-----LNGVYYLHS 131
Query: 745 PPVFHRDIKASNILLDSN----LNAKVADFGLSRLAPVLDDEGTMPTHVSTIVKGTPGYL 800
+ H D+K NI+L K+ DFGL+ + + GTP ++
Sbjct: 132 LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKID--------FGNEFKNIFGTPEFV 183
Query: 801 DPEYFLTHKLTDKSDVYSLGVVLLELLTGMQPISHGKNIVREVNVARDSGMVFSIIDNRM 860
PE L ++D++S+GV+ LL+G P G + V ++
Sbjct: 184 APEIVNYEPLGLEADMWSIGVITYILLSGASPF-LGDTKQETLA------NVSAVNYEFE 236
Query: 861 GSYPSECVERFVTLALRCCHDKPEHRPSMSDVVR 894
Y S R P+ R ++ D ++
Sbjct: 237 DEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ 270
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 153 bits (388), Expect = 1e-41
Identities = 59/287 (20%), Positives = 101/287 (35%), Gaps = 22/287 (7%)
Query: 614 GFKFKELAMATAYFSSSTQVGQGGYGKVYKGI-LSDNTTVAIKRAEEGSLQGQNEFLTEI 672
G + K+ A+ Y +S +G G GKV + A+K LQ + E+
Sbjct: 1 GLQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKM-----LQDCPKARREV 55
Query: 673 KLLSRL-HHRNLVSLLGYCD----EEGEQMLVYEFVPNGTLRDWLSGRTKENLNFAMRLR 727
+L R ++V ++ + ++V E + G L + R +
Sbjct: 56 ELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASE 115
Query: 728 VALDSAKGILYLHTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSRLAPVLDDEGTMPT 787
+ + I YLH+ + HRD+K N+L S + A ++ T
Sbjct: 116 IMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTT 172
Query: 788 HVSTIVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVLLELLTGMQPISHGKNIVREVNVAR 847
TP Y+ PE K D++SLGV++ LL G P + +
Sbjct: 173 -----PCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKT 227
Query: 848 DSGMVFSIIDNRMGSYPSECVERFVTLALRCCHDKPEHRPSMSDVVR 894
M N SE E L +P R ++++ +
Sbjct: 228 RIRMGQYEFPNP---EWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN 271
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 151 bits (383), Expect = 6e-41
Identities = 60/262 (22%), Positives = 96/262 (36%), Gaps = 27/262 (10%)
Query: 632 QVGQGGYGKVYKGI-LSDNTTVAIKRAEEGSLQGQNE---FLTEIKLLSRLHHRNLVSLL 687
+G+G +GKV + A+K + + ++E +TE ++L H L +L
Sbjct: 12 LLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALK 71
Query: 688 GYCDEEGEQMLVYEFVPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPV 747
V E+ G L LS A A+ + L V
Sbjct: 72 YAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFY-----GAEIVSALEYLHSRDV 126
Query: 748 FHRDIKASNILLDSNLNAKVADFGLSRLAPVLDDEGTMPTHVSTIVKGTPGYLDPEYFLT 807
+RDIK N++LD + + K+ DFGL + EG GTP YL PE
Sbjct: 127 VYRDIKLENLMLDKDGHIKITDFGLCK-------EGISDGATMKTFCGTPEYLAPEVLED 179
Query: 808 HKLTDKSDVYSLGVVLLELLTGMQPISHGKNIVREVNVARDSGMVFSIIDNRMGSYPSEC 867
+ D + LGVV+ E++ G P + ++ R +F +I +P
Sbjct: 180 NDYGRAVDWWGLGVVMYEMMCGRLPF-YNQDHER----------LFELILMEEIRFPRTL 228
Query: 868 VERFVTLALRCCHDKPEHRPSM 889
+L P+ R
Sbjct: 229 SPEAKSLLAGLLKKDPKQRLGG 250
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 150 bits (379), Expect = 7e-41
Identities = 64/286 (22%), Positives = 106/286 (37%), Gaps = 36/286 (12%)
Query: 633 VGQGGYGKVYKGI-LSDNTTVAIKRAEEGSLQGQNE-----FLTEIKLLSRLHHRNLVSL 686
+G+G + VYK + N VAIK+ + G + L EIKLL L H N++ L
Sbjct: 6 LGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGL 65
Query: 687 LGYCDEEGEQMLVYEFVPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPP 746
L + LV++F+ + L + +G+ YLH
Sbjct: 66 LDAFGHKSNISLVFDFMETDLEVIIKDNSLVLTPSHIK--AYMLMTLQGLEYLH---QHW 120
Query: 747 VFHRDIKASNILLDSNLNAKVADFGLSRLAPVLDDEGTMPTHVSTIVKGTPGYLDPEYFL 806
+ HRD+K +N+LLD N K+ADFGL++ P T T Y PE
Sbjct: 121 ILHRDLKPNNLLLDENGVLKLADFGLAK-------SFGSPNRAYTHQVVTRWYRAPELLF 173
Query: 807 THKLTD-KSDVYSLGVVLLELLTGMQP------ISHGKNIVR-----------EVNVARD 848
++ D++++G +L ELL + + I ++ D
Sbjct: 174 GARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPD 233
Query: 849 SGMVFSIIDNRMGSYPSECVERFVTLALRCCHDKPEHRPSMSDVVR 894
S + S + + L P R + + ++
Sbjct: 234 YVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALK 279
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 149 bits (378), Expect = 3e-40
Identities = 63/287 (21%), Positives = 113/287 (39%), Gaps = 31/287 (10%)
Query: 632 QVGQGGYGKVYKGI-LSDNTTVAIKRAEEGSLQGQ-NEFLTEIKLLSRLHHRNLVSLLGY 689
+G+G YG V + VAIK+ Q L EIK+L R H N++ +
Sbjct: 15 YIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDI 74
Query: 690 CDEEGEQMLVYEFVPNGTL-RDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVF 748
+ + ++ + D ++L+ +G+ Y+H+ V
Sbjct: 75 IRAPTIEQMKDVYLVTHLMGADLYKLLKTQHLSNDHICYFLYQILRGLKYIHSA---NVL 131
Query: 749 HRDIKASNILLDSNLNAKVADFGLSRLAPVLDDEGTMPTHVSTIVKGTPGYLDPEYFLTH 808
HRD+K SN+LL++ + K+ DFGL+R V D + ++ V T Y PE L
Sbjct: 132 HRDLKPSNLLLNTTCDLKICDFGLAR---VADPDHDHTGFLTEYV-ATRWYRAPEIMLNS 187
Query: 809 KLTDKS-DVYSLGVVLLELLTGMQP---------ISHGKNIVREVNVARDSGMVFSIIDN 858
K KS D++S+G +L E+L+ ++H I+ + + ++ N
Sbjct: 188 KGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARN 247
Query: 859 RMGSYPSECV-----------ERFVTLALRCCHDKPEHRPSMSDVVR 894
+ S P + + + L + P R + +
Sbjct: 248 YLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA 294
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 148 bits (374), Expect = 3e-40
Identities = 63/287 (21%), Positives = 104/287 (36%), Gaps = 31/287 (10%)
Query: 627 FSSSTQVGQGGYGKVYKGI-LSDNTTVAIK--RAEEGSLQGQNEFLTEIKLLSRLHHRNL 683
F ++G+G YG VYK VA+K R + + + + EI LL L+H N+
Sbjct: 4 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 63
Query: 684 VSLLGYCDEEGEQMLVYEFVPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEA 743
V LL E + LV+EF+ L+ ++ + + +G+ + H
Sbjct: 64 VKLLDVIHTENKLYLVFEFLHQD-LKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH--- 119
Query: 744 HPPVFHRDIKASNILLDSNLNAKVADFGLSRLAPVLDDEGTMPTHVSTIVKGTPGYLDPE 803
V HRD+K N+L+++ K+ADFGL+R T V
Sbjct: 120 SHRVLHRDLKPQNLLINTEGAIKLADFGLAR---AFGVPVRTYT---HEVVTLWYRAPEI 173
Query: 804 YFLTHKLTDKSDVYSLGVVLLELLTGMQPISHGKNIVREVNVARDSGMVFSIIDNRMGSY 863
+ D++SLG + E++T I + + R G ++ + S
Sbjct: 174 LLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSM 233
Query: 864 P------------------SECVERFVTLALRCCHDKPEHRPSMSDV 892
P E +L + H P R S
Sbjct: 234 PDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAA 280
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 145 bits (365), Expect = 4e-39
Identities = 60/284 (21%), Positives = 102/284 (35%), Gaps = 33/284 (11%)
Query: 632 QVGQGGYGKVYKGILSDNTTVAIK--RAEEGSLQGQNEFLTEIKLLSRLHHRNLVSLLGY 689
++G+G YG VYK + T A+K R E+ + + EI +L L H N+V L
Sbjct: 9 KIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDV 68
Query: 690 CDEEGEQMLVYEFVPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFH 749
+ +LV+E + + + L L GI Y H V H
Sbjct: 69 IHTKKRLVLVFEHLDQDLKKLLD--VCEGGLESVTAKSFLLQLLNGIAYCH---DRRVLH 123
Query: 750 RDIKASNILLDSNLNAKVADFGLSRLAPVLDDEGTMPTHVSTIVKGTPGYLDPEYFL-TH 808
RD+K N+L++ K+ADFGL+R + T Y P+ + +
Sbjct: 124 RDLKPQNLLINREGELKIADFGLARA--FGIPVRKYTHEIV-----TLWYRAPDVLMGSK 176
Query: 809 KLTDKSDVYSLGVVLLELLTGMQPISHGKNIVREVNVARDSGMVFSIIDNRMG------- 861
K + D++S+G + E++ G + + + R G S +
Sbjct: 177 KYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDP 236
Query: 862 -----------SYPSECVERFVTLALRCCHDKPEHRPSMSDVVR 894
S+ E + L + P R + +
Sbjct: 237 NFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 143 bits (362), Expect = 1e-38
Identities = 57/286 (19%), Positives = 102/286 (35%), Gaps = 35/286 (12%)
Query: 632 QVGQGGYGKVYKGI-LSDNTTVAIK--RAEEGSLQGQNEFLTEIKLLSRLHHRNLVSLLG 688
++G+G YG V+K + VA+K R ++ + L EI LL L H+N+V L
Sbjct: 9 KIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHD 68
Query: 689 YCDEEGEQMLVYEFVPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVF 748
+ + LV+EF + + S + + + L V
Sbjct: 69 VLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSF-----LFQLLKGLGFCHSRNVL 123
Query: 749 HRDIKASNILLDSNLNAKVADFGLSRLAPVLDDEGTMPTHVSTIVKGTPGYLDPEYFLTH 808
HRD+K N+L++ N K+A+FGL+R +P + T Y P+
Sbjct: 124 HRDLKPQNLLINRNGELKLANFGLARAF-------GIPVRCYSAEVVTLWYRPPDVLFGA 176
Query: 809 KLTD-KSDVYSLGVVLLELLTGMQPISHGKNIVREVNVARDSGMVFSIID---------- 857
KL D++S G + EL +P+ G ++ ++ +
Sbjct: 177 KLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDY 236
Query: 858 ---------NRMGSYPSECVERFVTLALRCCHDKPEHRPSMSDVVR 894
+ + + L P R S + ++
Sbjct: 237 KPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 144 bits (364), Expect = 1e-38
Identities = 61/294 (20%), Positives = 105/294 (35%), Gaps = 41/294 (13%)
Query: 632 QVGQGGYGKVYKGI-LSDNTTVAIK--RAEEGSLQGQNEFLTEIKLLSRLHHRNLVSLLG 688
++GQG +G+V+K VA+K E L EIK+L L H N+V+L+
Sbjct: 17 KIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIE 76
Query: 689 YCDE--------EGEQMLVYEFVPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLH 740
C +G LV++F + + K L+ R+ L + L+
Sbjct: 77 ICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQML-----LNGLY 131
Query: 741 TEAHPPVFHRDIKASNILLDSNLNAKVADFGLSRLAPVLDDEGTMPTHVSTIVKGTPGYL 800
+ HRD+KA+N+L+ + K+ADFGL+R + T T Y
Sbjct: 132 YIHRNKILHRDMKAANVLITRDGVLKLADFGLARA---FSLAKNSQPNRYTNRVVTLWYR 188
Query: 801 DPEYFLTHKL-TDKSDVYSLGVVLLELLTGMQPISHGKNIVREVNVARDSGMVFSIIDNR 859
PE L + D++ G ++ E+ T + + +++ G + +
Sbjct: 189 PPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPN 248
Query: 860 MGSYPSECVERFVT---------------------LALRCCHDKPEHRPSMSDV 892
+ +Y V L + P R D
Sbjct: 249 VDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDA 302
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 141 bits (355), Expect = 3e-37
Identities = 64/294 (21%), Positives = 107/294 (36%), Gaps = 43/294 (14%)
Query: 627 FSSSTQVGQGGYGKVYKGIL-SDNTTVAIKRAEEGSLQGQNEFLTEIKLLSRLHHRNLVS 685
++ + +G G +G VY+ L VAIK+ LQ + E++++ +L H N+V
Sbjct: 22 YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV----LQDKRFKNRELQIMRKLDHCNIVR 77
Query: 686 LLGYCDEEGEQM------LVYEFVPNGTLRDWLS-GRTKENLNFAMRLRVALDSAKGILY 738
L + GE+ LV ++VP R R K+ L + + Y
Sbjct: 78 LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAY 137
Query: 739 LHTEAHPPVFHRDIKASNILLDSN-LNAKVADFGLSRLAPVLDDEGTMPTHVSTIVKGTP 797
+H + HRDIK N+LLD + K+ DFG ++ L +++ +
Sbjct: 138 IH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQ---LVRGEPNVSYIC-----SR 186
Query: 798 GYLDPEYFL-THKLTDKSDVYSLGVVLLELLTGMQP------ISHGKNIVREVNVARDSG 850
Y PE T DV+S G VL ELL G + I++ +
Sbjct: 187 YYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQ 246
Query: 851 MVFSIIDNRMGSYPS------------ECVERFVTLALRCCHDKPEHRPSMSDV 892
+ + +P + L R P R + +
Sbjct: 247 IREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEA 300
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 140 bits (354), Expect = 5e-37
Identities = 51/260 (19%), Positives = 89/260 (34%), Gaps = 30/260 (11%)
Query: 632 QVGQGGYGKVYKGI-LSDNTTVAIK---RAEEGSLQGQNEFLTEIKLLSRLHHRNLVSLL 687
+G G +G+V A+K + + L+ L E ++L ++ LV L
Sbjct: 48 TLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLE 107
Query: 688 GYCDEEGEQMLVYEFVPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPV 747
+ +V E+V G + L + + A YLH+ +
Sbjct: 108 FSFKDNSNLYMVMEYVAGGEMFSHLRRIGR--FSEPHARFYAAQIVLTFEYLHSL---DL 162
Query: 748 FHRDIKASNILLDSNLNAKVADFGLSRLAPVLDDEGTMPTHVSTIVKGTPGYLDPEYFLT 807
+RD+K N+L+D +V DFG ++ + + GTP L PE L+
Sbjct: 163 IYRDLKPENLLIDQQGYIQVTDFGFAK----------RVKGRTWTLCGTPEALAPEIILS 212
Query: 808 HKLTDKSDVYSLGVVLLELLTGMQPISHGKNIVREVNVARDSGMVFSIIDNRMGSYPSEC 867
D ++LGV++ E+ G P ++ I + +PS
Sbjct: 213 KGYNKAVDWWALGVLIYEMAAGYPPFFA-----------DQPIQIYEKIVSGKVRFPSHF 261
Query: 868 VERFVTLALRCCHDKPEHRP 887
L R
Sbjct: 262 SSDLKDLLRNLLQVDLTKRF 281
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 131 bits (329), Expect = 9e-34
Identities = 52/286 (18%), Positives = 94/286 (32%), Gaps = 37/286 (12%)
Query: 632 QVGQGGYGKVYKGI-LSDNTTVAIK--RAEEGSLQGQNEFLTEIKLLSRLHHRNLVSLLG 688
VG G YG V + VAIK S E++LL + H N++ LL
Sbjct: 25 PVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLD 84
Query: 689 YCDEEGEQMLVYEFVPNGTLRDWLSGR--TKENLNFAMRLRVALDSAKGILYLHTEAHPP 746
+ +F G+ E L + KG+ Y+H
Sbjct: 85 VFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRIQFLVYQMLKGLRYIHAAGI-- 142
Query: 747 VFHRDIKASNILLDSNLNAKVADFGLSRLAPVLDDEGTMPTHVSTIVKGTPGYLDPEYFL 806
HRD+K N+ ++ + K+ DFGL+R + ++ V
Sbjct: 143 -IHRDLKPGNLAVNEDCELKILDFGLAR---------QADSEMTGYVVTRWYRAPEVILN 192
Query: 807 THKLTDKSDVYSLGVVLLELLTGMQPISHGKNIVREVNVARDSGMVFSIIDNRMG----- 861
+ T D++S+G ++ E++TG ++ + + + +G + R+
Sbjct: 193 WMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAK 252
Query: 862 ---------------SYPSECVERFVTLALRCCHDKPEHRPSMSDV 892
S + V L + E R + +
Sbjct: 253 NYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEA 298
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 130 bits (327), Expect = 1e-33
Identities = 71/309 (22%), Positives = 116/309 (37%), Gaps = 43/309 (13%)
Query: 593 QHSLSRKRLSTKISMKIDGVKGFKFKELAMATAYFSSSTQVGQGGYGKVYKGIL----SD 648
+H L L T + K+ G++ F+ ++ +G G YGKV+
Sbjct: 6 KHELRTANL-TGHAEKV-GIENFELLKV------------LGTGAYGKVFLVRKISGHDT 51
Query: 649 NTTVAIKRAEEGSL----QGQNEFLTEIKLLSRL-HHRNLVSLLGYCDEEGEQMLVYEFV 703
A+K ++ ++ + TE ++L + LV+L E + L+ +++
Sbjct: 52 GKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETKLHLILDYI 111
Query: 704 PNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSNL 763
G L LS R + + + +L L + +RDIK NILLDSN
Sbjct: 112 NGGELFTHLSQRERFTEHEVQI-----YVGEIVLALEHLHKLGIIYRDIKLENILLDSNG 166
Query: 764 NAKVADFGLSRLAPVLDDEGTMPTHVSTIVKGTPGYLDPEYFLTHK--LTDKSDVYSLGV 821
+ + DFGLS+ T + GT Y+ P+ D +SLGV
Sbjct: 167 HVVLTDFGLSKEFV------ADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGV 220
Query: 822 VLLELLTGMQPISHGKNIVREVNVARDSGMVFSIIDNRMGSYPSECVERFVTLALRCCHD 881
++ ELLTG P + + ++R I YP E L R
Sbjct: 221 LMYELLTGASPFTVDGEKNSQAEISR-------RILKSEPPYPQEMSALAKDLIQRLLMK 273
Query: 882 KPEHRPSMS 890
P+ R
Sbjct: 274 DPKKRLGCG 282
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 125 bits (315), Expect = 4e-32
Identities = 55/294 (18%), Positives = 116/294 (39%), Gaps = 52/294 (17%)
Query: 632 QVGQGGYGKVYKGI-LSDNTTVAIKRAEEGSLQGQNEFLTEIKLLSRL-HHRNLVSLLGY 689
++G+G Y +V++ I +++N V +K + + + EIK+L L N+++L
Sbjct: 42 KLGRGKYSEVFEAINITNNEKVVVKILKPVKKK---KIKREIKILENLRGGPNIITLADI 98
Query: 690 CDEEGEQM--LVYEFVPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPV 747
+ + LV+E V N + T ++ F M + K + Y H +
Sbjct: 99 VKDPVSRTPALVFEHVNNTDFKQLYQTLTDYDIRFYMY-----EILKALDYCH---SMGI 150
Query: 748 FHRDIKASNILLDS-NLNAKVADFGLSRLAPVLDDEGTMPTHVSTIVKGTPGYLDPEYFL 806
HRD+K N+++D + ++ D+GL+ P + + + PE +
Sbjct: 151 MHRDVKPHNVMIDHEHRKLRLIDWGLAEF--------YHPGQEYNVRVASRYFKGPELLV 202
Query: 807 THKLTD-KSDVYSLGVVLLELLTGMQPISHGKNIVREVNVARD---SGMVFSIIDNR--- 859
+++ D D++SLG +L ++ +P HG + ++ + ++ ID
Sbjct: 203 DYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIE 262
Query: 860 --------MGSYPSECVERFVT-------------LALRCCHDKPEHRPSMSDV 892
+G + + ERFV + + R + +
Sbjct: 263 LDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREA 316
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 124 bits (311), Expect = 2e-31
Identities = 63/313 (20%), Positives = 120/313 (38%), Gaps = 46/313 (14%)
Query: 632 QVGQGGYGKVYKGI-LSDNTTVAIK--RAEEGSLQGQNEFLTEIKLLSRLHHRNLVSLLG 688
+G G G V + VAIK + E+ L+ ++H+N++SLL
Sbjct: 24 PIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLN 83
Query: 689 YC------DEEGEQMLVYEFVPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTE 742
+E + LV E + + E +++ + GI +LH
Sbjct: 84 VFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLY-----QMLCGIKHLH-- 136
Query: 743 AHPPVFHRDIKASNILLDSNLNAKVADFGLSRLAPVLDDEGTMPTHVSTIVKGTPGYLDP 802
+ HRD+K SNI++ S+ K+ DFGL+R + + T T Y P
Sbjct: 137 -SAGIIHRDLKPSNIVVKSDCTLKILDFGLART--------AGTSFMMTPYVVTRYYRAP 187
Query: 803 EYFLTHKLTDKSDVYSLGVVLLELLTGMQPISHGKNIVREVNVARDSGMVFSIIDNRMGS 862
E L + D++S+G ++ E++ RD ++ + ++G+
Sbjct: 188 EVILGMGYKENVDIWSVGCIMGEMVRHKILFPG-----------RDYIDQWNKVIEQLGT 236
Query: 863 YPSECVERFVTLALRCCHDKPEHRPSMSDVVRELENILKMFPETDTMFSKSESSSLLSGK 922
E +++ ++P++ K+FP++ + SE + L + +
Sbjct: 237 PCPEFMKKLQPTVRNYVENRPKYAG---------LTFPKLFPDSLFP-ADSEHNKLKASQ 286
Query: 923 SASTSSSFLTRDP 935
+ S L DP
Sbjct: 287 ARDLLSKMLVIDP 299
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 120 bits (301), Expect = 2e-30
Identities = 76/312 (24%), Positives = 123/312 (39%), Gaps = 14/312 (4%)
Query: 37 DPQEASALRAIKNSLVDSMNHLRNWNKG-DPCMSNWTGVLCFDTVETDGHLHVRELQLLS 95
+PQ+ AL IK L + L +W D C W GVLC V L L
Sbjct: 4 NPQDKQALLQIKKDLGNP-TTLSSWLPTTDCCNRTWLGVLCDTD---TQTYRVNNLDLSG 59
Query: 96 MNLSGN--LAPELGQLSRLQYYFMWN--DLTGTIPKEIGNISSLIFLLLNGNKLSGSLPD 151
+NL + L L L + ++ +L G IP I ++ L +L + +SG++PD
Sbjct: 60 LNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPD 119
Query: 152 ELGYLSNLNRLQVDENNITGTIPKSFANLSRVRHLHLNNNSIGGQIPSELSKLSTLIHLL 211
L + L L N ++GT+P S ++L + + + N I G IP S L +
Sbjct: 120 FLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSM 179
Query: 212 VDNNNLSGNLPPELSELPQLCILQLDNNNFSASEIPATYGNFSKLVKLSLRNCNLQGAVP 271
+ N + + N + +G+ K+ L +L +
Sbjct: 180 TISRN-RLTGKIPPTFANLNLAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLG 238
Query: 272 DLSRIPNLYYLDLSWNHLTGSIPS--KKLSENVTTIDLSDNYLNGSILESISNLPFLQTL 329
+ NL LDL N + G++P +L + ++++S N L G I NL
Sbjct: 239 KVGLSKNLNGLDLRNNRIYGTLPQGLTQLK-FLHSLNVSFNNLCGEI-PQGGNLQRFDVS 296
Query: 330 SLENNFLTGSIP 341
+ NN P
Sbjct: 297 AYANNKCLCGSP 308
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 117 bits (293), Expect = 5e-29
Identities = 56/268 (20%), Positives = 96/268 (35%), Gaps = 36/268 (13%)
Query: 632 QVGQGGYGKVYKGI-LSDNTTVAIK--RAEEGSLQGQNEFLTEIKLLSRLHHRNLVSLLG 688
VG G YG V VA+K S+ E++LL + H N++ LL
Sbjct: 25 PVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLD 84
Query: 689 YCDE-----EGEQMLVYEFVPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEA 743
E + + + L + + L + +G+ Y+H+
Sbjct: 85 VFTPARSLEEFNDVYLVTHLMGADLNNI---VKCQKLTDDHVQFLIYQILRGLKYIHSAD 141
Query: 744 HPPVFHRDIKASNILLDSNLNAKVADFGLSRLAPVLDDEGTMPTHVSTIVKGTPGYLDPE 803
HRD+K SN+ ++ + K+ DFGL+R T T Y PE
Sbjct: 142 I---IHRDLKPSNLAVNEDCELKILDFGLAR----------HTDDEMTGYVATRWYRAPE 188
Query: 804 YFLTHKLTD-KSDVYSLGVVLLELLTGMQPISHGKNIVREVNVARDSGMVFSIIDNRMGS 862
L + D++S+G ++ ELLTG D +I +G+
Sbjct: 189 IMLNWMHYNQTVDIWSVGCIMAELLTGRTLFP-----------GTDHIDQLKLILRLVGT 237
Query: 863 YPSECVERFVTLALRCCHDKPEHRPSMS 890
+E +++ + + R P M+
Sbjct: 238 PGAELLKKISSESARNYIQSLTQMPKMN 265
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 106 bits (265), Expect = 3e-25
Identities = 59/320 (18%), Positives = 107/320 (33%), Gaps = 39/320 (12%)
Query: 632 QVGQGGYGKVYKGI-LSDNTTVAIKRAEEGSLQGQNEFLTEIKLLSRLHHRNL------- 683
++G G + V+ + +NT VA+K G EIKLL R++ +
Sbjct: 20 KLGWGHFSTVWLAKDMVNNTHVAMKIVR-GDKVYTEAAEDEIKLLQRVNDADNTKEDSMG 78
Query: 684 ----VSLLGYCDEEGEQMLVYEFVPNGTLRDWLS---GRTKENLNFAMRLRVALDSAKGI 736
+ LL + + +G + V + L+ + +++ G+
Sbjct: 79 ANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGL 138
Query: 737 LYLHTEAHPPVFHRDIKASNILLDSN-LNAKVADFGLSRLAPVLDDEGTMPTHVSTIVKG 795
Y+H + H DIK N+L++ + ++ L T
Sbjct: 139 DYMHR--RCGIIHTDIKPENVLMEIVDSPENLIQIKIADLG-----NACWYDEHYTNSIQ 191
Query: 796 TPGYLDPEYFLTHKLTDKSDVYSLGVVLLELLTGMQPISHGKNIVREVNVARDSGMVFSI 855
T Y PE L +D++S ++ EL+TG E + +
Sbjct: 192 TREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEP-----DEGHSYTKDDDHIAQ 246
Query: 856 IDNRMGSYPSECVERFVTLALRCCHDKPEHRPSMSDVVRELENILKMFPETDTMFSKSES 915
I +G PS + K S + + LK +P D + K +
Sbjct: 247 IIELLGELPSYLLRN----------GKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKF 296
Query: 916 SSLLSGKSASTSSSFLTRDP 935
S + + + S L DP
Sbjct: 297 SKDEAKEISDFLSPMLQLDP 316
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 93.5 bits (231), Expect = 8e-21
Identities = 53/251 (21%), Positives = 94/251 (37%), Gaps = 15/251 (5%)
Query: 60 NWNKGDPCMSNWTGVLCFDTVETDGHLHVRELQLLSMNLSGNLAPELGQLSRLQYYFMWN 119
+ G + + ++ +L E +S N +++ + N
Sbjct: 148 SALSGLTSLQQLSFGNQVTDLKPLANLTTLERLDISSNKVSDISVLAKLTNLESLIATNN 207
Query: 120 DLTGTIPKEIGNISSLIFLLLNGNKLSGSLPDELGYLSNLNRLQVDENNITGTIPKSFAN 179
++ P I +++L L LNGN+L L L+NL L + N I+ P +
Sbjct: 208 QISDITPLGI--LTNLDELSLNGNQLKD--IGTLASLTNLTDLDLANNQISNLAP--LSG 261
Query: 180 LSRVRHLHLNNNSIGGQIPSELSKLSTLIHLLVDNNNLSGNLPPELSELPQLCILQLDNN 239
L+++ L L N I P ++ N +S L L L L N
Sbjct: 262 LTKLTELKLGANQISNISPLA----GLTALTNLELNENQLEDISPISNLKNLTYLTLYFN 317
Query: 240 NFSASEIPATYGNFSKLVKLSLRNCNLQGAVPDLSRIPNLYYLDLSWNHLTGSIPSKKLS 299
N S P + +KL +L N + V L+ + N+ +L N ++ P L+
Sbjct: 318 NIS-DISP--VSSLTKLQRLFFANNKVSD-VSSLANLTNINWLSAGHNQISDLTPLANLT 373
Query: 300 ENVTTIDLSDN 310
+T + L+D
Sbjct: 374 -RITQLGLNDQ 383
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 85.4 bits (210), Expect = 3e-18
Identities = 49/209 (23%), Positives = 86/209 (41%), Gaps = 22/209 (10%)
Query: 156 LSNLNRLQVDENNITGTIPKSFANLSRVRHLHLNNNSIGGQIPSELSKLSTLIHLLVDNN 215
L+NL L N I+ P + + L LN N + L+ L+ L L + NN
Sbjct: 196 LTNLESLIATNNQISDITPLGIL--TNLDELSLNGNQLKD--IGTLASLTNLTDLDLANN 251
Query: 216 NLSGNLPPELSELPQLCILQLDNNNFSASEIPATYGNFSKLVKLSLRNCNLQGAVPDLSR 275
+S LS L +L L+L N S I G + N N + +S
Sbjct: 252 QISN--LAPLSGLTKLTELKLGANQIS--NISPLAGLTAL--TNLELNENQLEDISPISN 305
Query: 276 IPNLYYLDLSWNHLTGSIPSKKLSENVTTIDLSDNYLNGSILESISNLPFLQTLSLENNF 335
+ NL YL L +N+++ P L+ + + ++N ++ + S++NL + LS +N
Sbjct: 306 LKNLTYLTLYFNNISDISPVSSLT-KLQRLFFANNKVSD--VSSLANLTNINWLSAGHNQ 362
Query: 336 LTGSIPATIWQNKSFSTKARLK-IDLRNN 363
++ P + R+ + L +
Sbjct: 363 ISDLTP--------LANLTRITQLGLNDQ 383
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 77.3 bits (189), Expect = 2e-15
Identities = 48/209 (22%), Positives = 82/209 (39%), Gaps = 18/209 (8%)
Query: 177 FANLSRVRHLHLNNNSIGGQIPSELSKLSTLIHLLVDNNNLSGNLPPELSELPQLCILQL 236
A L+ + L NN I P + + L L ++ N L L+ L L L L
Sbjct: 193 LAKLTNLESLIATNNQISDITPLGIL--TNLDELSLNGNQLKD--IGTLASLTNLTDLDL 248
Query: 237 DNNNFSASEIPATYGNFSKLVKLSLRNCNLQGAVPDLSRIPNLYYLDLSWNHLTGSIPSK 296
NN S + P +KL +L L + + L+ + L L+L+ N L P
Sbjct: 249 ANNQIS-NLAP--LSGLTKLTELKLGANQISN-ISPLAGLTALTNLELNENQLEDISPIS 304
Query: 297 KLSENVTTIDLSDNYLNGSILESISNLPFLQTLSLENNFLTGSIPATIWQNKSFSTKARL 356
L +N+T + L N ++ +S+L LQ L NN ++ +++ + +
Sbjct: 305 NL-KNLTYLTLYFNNISDIS--PVSSLTKLQRLFFANNKVSD--VSSLANLTNINW---- 355
Query: 357 KIDLRNNSFSNIVGDLTLPNNVTLRLGGN 385
+ +N S++ L L L
Sbjct: 356 -LSAGHNQISDLTPLANLTRITQLGLNDQ 383
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 64.6 bits (156), Expect = 2e-11
Identities = 47/195 (24%), Positives = 72/195 (36%), Gaps = 18/195 (9%)
Query: 202 SKLSTLIHLLVDNNNLSGNLPPELSELPQLCILQLDNNNFSASEIPATYGNFSKLVKLSL 261
+KL+ L L+ NN +S P + L L L+ N T + + L L L
Sbjct: 194 AKLTNLESLIATNNQISDITPLGIL--TNLDELSLNGNQLKD---IGTLASLTNLTDLDL 248
Query: 262 RNCNLQGAVPDLSRIPNLYYLDLSWNHLTGSIPSKKLSENVTTIDLSDNYLNGSILESIS 321
N + + LS + L L L N ++ P L+ N + IS
Sbjct: 249 ANNQISN-LAPLSGLTKLTELKLGANQISNISPLAGLTALTNL---ELNENQLEDISPIS 304
Query: 322 NLPFLQTLSLENNFLTGSIPATIWQNKSFSTKARLK-IDLRNNSFSNIVGDLTLPNNVTL 380
NL L L+L N ++ P S+ +L+ + NN S++ L N L
Sbjct: 305 NLKNLTYLTLYFNNISDISP--------VSSLTKLQRLFFANNKVSDVSSLANLTNINWL 356
Query: 381 RLGGNPICTSANIPN 395
G N I + N
Sbjct: 357 SAGHNQISDLTPLAN 371
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 60.8 bits (146), Expect = 3e-10
Identities = 60/328 (18%), Positives = 112/328 (34%), Gaps = 61/328 (18%)
Query: 119 NDLTGTIPKEIGNISSLIFLLLNGNKLSGSLPDELGYLSNLNRLQVDENNITGTIPKSFA 178
++T T+ + ++ + L + + S+ D + YL+NL ++ N +T P
Sbjct: 32 TNVTDTVSQT--DLDQVTTLQADRLGIK-SI-DGVEYLNNLTQINFSNNQLTDITP--LK 85
Query: 179 NLSRVRHLHLNNNSIGGQIP------------------------------------SELS 202
NL+++ + +NNN I P + +S
Sbjct: 86 NLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDIDPLKNLTNLNRLELSSNTIS 145
Query: 203 KLSTLIHLLVDNNNLSGNLPPELSELPQLCILQLDNNNFSASEIPATYGNFSKLVKLSLR 262
+S L L GN +L L L L+ + + + + + L L
Sbjct: 146 DISALSGLTSLQQLSFGNQVTDLKPLANLTTLERLDISSNKVSDISVLAKLTNLESLIAT 205
Query: 263 NCNLQGAVPDLSRIPNLYYLDLSWNHLTGSIPSKKLSENVTTIDLSDNYLNGSILESISN 322
N + P + NL L L+ N L I + N+T +DL++N ++ +S
Sbjct: 206 NNQISDITPL-GILTNLDELSLNGNQLKD-IGTLASLTNLTDLDLANNQISNLA--PLSG 261
Query: 323 LPFLQTLSLENNFLTGSIPATIWQNKSFSTKAR---------------LKIDLRNNSFSN 367
L L L L N ++ P + + L N+ S+
Sbjct: 262 LTKLTELKLGANQISNISPLAGLTALTNLELNENQLEDISPISNLKNLTYLTLYFNNISD 321
Query: 368 IVGDLTLPNNVTLRLGGNPICTSANIPN 395
I +L L N + +++ N
Sbjct: 322 ISPVSSLTKLQRLFFANNKVSDVSSLAN 349
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 51.5 bits (122), Expect = 2e-07
Identities = 44/254 (17%), Positives = 86/254 (33%), Gaps = 27/254 (10%)
Query: 156 LSNLNRLQVDENNITGTIPKSFANLSRVRHLHLNNNSIGGQIPSELSKLSTLIHLLVDNN 215
L+ + + + N+T T+ ++ +L +V L + I + + L+ L + NN
Sbjct: 21 LAEKMKTVLGKTNVTDTVSQT--DLDQVTTLQADRLGI--KSIDGVEYLNNLTQINFSNN 76
Query: 216 NLSGNLPPELSELPQLCILQLDNNNFSASEIPATYGNFSKLVKLSLRNCNLQGAVPDLSR 275
L+ L L +L + ++NN + A N + L + + ++ +
Sbjct: 77 QLTD--ITPLKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDIDPLKNLTNL 134
Query: 276 IPNLYYL--------------DLSWNHLTGSIPSKKLSENVTTIDLSDNYLNGSILESIS 321
+ K L+ T L + S + ++
Sbjct: 135 NRLELSSNTISDISALSGLTSLQQLSFGNQVTDLKPLANLTTLERLDISSNKVSDISVLA 194
Query: 322 NLPFLQTLSLENNFLTGSIPATIWQNKSFSTKARLKIDLRNNSFSNIVGDLTLPNNVTLR 381
L L++L NN ++ P I N ++ L N +I +L N L
Sbjct: 195 KLTNLESLIATNNQISDITPLGILTNLD-------ELSLNGNQLKDIGTLASLTNLTDLD 247
Query: 382 LGGNPICTSANIPN 395
L N I A +
Sbjct: 248 LANNQISNLAPLSG 261
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 50.8 bits (120), Expect = 5e-07
Identities = 40/254 (15%), Positives = 86/254 (33%), Gaps = 46/254 (18%)
Query: 131 NISSLIFLLLNGNKLSGSLPDELGYLSNLNRLQVDENNITGTIPKSFANLSRVRHLHLNN 190
++ + +L ++ ++ L + LQ D I L+ + ++ +N
Sbjct: 20 ALAEKMKTVLGKTNVTDTVSQT--DLDQVTTLQADRLGIKSI--DGVEYLNNLTQINFSN 75
Query: 191 NSIGGQIPSELSKLSTLIHLLVDNNNLSGNLPPELSELPQLCILQLDNNNFSASEIPATY 250
N + P L L+ L+ +L++NN ++ P L + T
Sbjct: 76 NQLTDITP--LKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDIDPLKNLTN 133
Query: 251 GNFSKLVKLSL-------------------------------------RNCNLQGAVPDL 273
N +L ++ + N + L
Sbjct: 134 LNRLELSSNTISDISALSGLTSLQQLSFGNQVTDLKPLANLTTLERLDISSNKVSDISVL 193
Query: 274 SRIPNLYYLDLSWNHLTGSIPSKKLSENVTTIDLSDNYLNGSILESISNLPFLQTLSLEN 333
+++ NL L + N ++ P L+ N+ + L+ N L + ++++L L L L N
Sbjct: 194 AKLTNLESLIATNNQISDITPLGILT-NLDELSLNGNQLKD--IGTLASLTNLTDLDLAN 250
Query: 334 NFLTGSIPATIWQN 347
N ++ P +
Sbjct: 251 NQISNLAPLSGLTK 264
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 40.0 bits (92), Expect = 0.001
Identities = 13/75 (17%), Positives = 30/75 (40%), Gaps = 4/75 (5%)
Query: 226 SELPQLCILQLDNNNFSASEIPATYGNFSKLVKLSLRNCNLQGAVPDLSRIPNLYYLDLS 285
+ L + L N + + + ++ L ++ ++ + + NL ++ S
Sbjct: 19 TALAEKMKTVLGKTNVTD---TVSQTDLDQVTTLQADRLGIK-SIDGVEYLNNLTQINFS 74
Query: 286 WNHLTGSIPSKKLSE 300
N LT P K L++
Sbjct: 75 NNQLTDITPLKNLTK 89
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 38.4 bits (88), Expect = 0.003
Identities = 13/87 (14%), Positives = 35/87 (40%), Gaps = 6/87 (6%)
Query: 202 SKLSTLIHLLVDNNNLSGNLPPELSELPQLCILQLDNNNFSASEIPATYGNFSKLVKLSL 261
+ L+ + ++ N++ + ++L Q+ LQ D + + + L +++
Sbjct: 19 TALAEKMKTVLGKTNVTDTVS--QTDLDQVTTLQADRLGIKSID---GVEYLNNLTQINF 73
Query: 262 RNCNLQGAVPDLSRIPNLYYLDLSWNH 288
N L + L + L + ++ N
Sbjct: 74 SNNQLTD-ITPLKNLTKLVDILMNNNQ 99
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 87.1 bits (215), Expect = 4e-20
Identities = 25/153 (16%), Positives = 45/153 (29%), Gaps = 19/153 (12%)
Query: 632 QVGQGGYGKVYKGILSDNTTVAIKRAEEGSL----------QGQNEFLTEIKLLSRLHHR 681
+G+G V+ +K + G G F +R R
Sbjct: 7 LMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFR 66
Query: 682 NLVSLLGYCDEEGEQMLVYEFVPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHT 741
L L G + VY + N L + + + + V + + +
Sbjct: 67 ALQKLQGLAVPK-----VYAWEGNAVLMELIDAKELYRVRVENPDEVLDMILEEVAKFY- 120
Query: 742 EAHPPVFHRDIKASNILLDSNLNAKVADFGLSR 774
H + H D+ N+L+ + DF S
Sbjct: 121 --HRGIVHGDLSQYNVLVS-EEGIWIIDFPQSV 150
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 89.7 bits (221), Expect = 5e-20
Identities = 65/285 (22%), Positives = 116/285 (40%), Gaps = 23/285 (8%)
Query: 124 TIPKEIGNISSLIFLLLNGNKLSGSLPDELGYLSNLNRLQVDENNITGTIPKSFANLSRV 183
+PK++ L L NK++ + L NL+ L + N I+ P +FA L ++
Sbjct: 24 KVPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKL 81
Query: 184 RHLHLNNNSIGGQIPSELSKLSTLIHLLVDNNNLSGNLPPELSELPQLCILQLDNNNFSA 243
L+L+ N + +P ++ K L V N ++ + L Q+ +++L N +
Sbjct: 82 ERLYLSKNQLKE-LPEKMPKTLQ--ELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKS 138
Query: 244 S-EIPATYGNFSKLVKLSLRNCNLQGAVPDLSRIPNLYYLDLSWNHLTGSIPSKKLS-EN 301
S + KL + + + N+ L P+L L L N +T + N
Sbjct: 139 SGIENGAFQGMKKLSYIRIADTNITTIPQGLP--PSLTELHLDGNKITKVDAASLKGLNN 196
Query: 302 VTTIDLSDNYLNGSILESISNLPFLQTLSLENNFLTGSIPATIWQNKSFSTKARLKIDLR 361
+ + LS N ++ S++N P L+ L L NN L +P + +K + L
Sbjct: 197 LAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQV-----VYLH 250
Query: 362 NNSFSNIVGD--------LTLPNNVTLRLGGNPICTSANIPNTGR 398
NN+ S I + + + L NP+ P+T R
Sbjct: 251 NNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQPSTFR 295
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 63.5 bits (153), Expect = 2e-11
Identities = 47/284 (16%), Positives = 86/284 (30%), Gaps = 64/284 (22%)
Query: 66 PCMSNWTGVLC----FDTVETDGHLHVRELQLLSMNLSGNLAPELGQLSRLQY-YFMWND 120
C + V C + V D L L + ++ + L L + N
Sbjct: 7 RCQCHLRVVQCSDLGLEKVPKDLPPDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNK 66
Query: 121 LTGTIPKEIGNISSLIFLLLNG-------------------------------------- 142
++ P + L L L+
Sbjct: 67 ISKISPGAFAPLVKLERLYLSKNQLKELPEKMPKTLQELRVHENEITKVRKSVFNGLNQM 126
Query: 143 ---------NKLSGSLPDELGYLSNLNRLQVDENNITGTIPKSFANLSRVRHLHLNNNSI 193
K SG + L+ +++ + NIT TIP+ + LHL+ N I
Sbjct: 127 IVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNIT-TIPQGL--PPSLTELHLDGNKI 183
Query: 194 GGQIPSELSKLSTLIHLLVDNNNLSGNLPPELSELPQLCILQLDNNNFSASEIPATYGNF 253
+ L L+ L L + N++S L+ P L +L NN ++P +
Sbjct: 184 TKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLR--ELHLNNNKLVKVPGGLADH 241
Query: 254 SKLVKLSLRNCNLQGAVPD-------LSRIPNLYYLDLSWNHLT 290
+ + L N N+ + ++ + + L N +
Sbjct: 242 KYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQ 285
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 72.5 bits (176), Expect = 2e-14
Identities = 44/254 (17%), Positives = 77/254 (30%), Gaps = 5/254 (1%)
Query: 87 HVRELQLLSMNLSGNLAPELGQLSRLQ--YYFMWNDLTGTIPKEIGNISSLIFLLLNGNK 144
+ + L +S A L + G L + +
Sbjct: 33 ASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQ 92
Query: 145 LSGSLPDELGYLSNLNRLQVDENNITGTIPKSFANLSRVRHLHLNNNSIGGQIPSELSKL 204
L P L L+ L +D + P F L+ +++L+L +N++ L
Sbjct: 93 LRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDL 152
Query: 205 STLIHLLVDNNNLSGNLPPELSELPQLCILQLDNNNFSASEIPATYGNFSKLVKLSLRNC 264
L HL + N +S L L L L N + A + N
Sbjct: 153 GNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANN 212
Query: 265 NLQGAVPDLSRIPNLYYLDLSWNHLTGSIPSKKLSENVTTIDLSDNYLNGSILESISNLP 324
L+ + L YL L+ N ++ L + S + + S+ + ++
Sbjct: 213 LSALPTEALAPLRALQYLRLNDNPWVCDCRARPLWAWLQKFRGSSSEVPCSLPQRLAGRD 272
Query: 325 FLQTLSLENNFLTG 338
L N L G
Sbjct: 273 L---KRLAANDLQG 283
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 60.6 bits (145), Expect = 2e-10
Identities = 48/227 (21%), Positives = 83/227 (36%), Gaps = 7/227 (3%)
Query: 118 WNDLTGTIPKEIGNISSLIFLLLNGNKLSGSLPDELGYLSNLNRLQVDENNITGTIPKSF 177
L +P I ++ + L+GN++S NL L + N + +F
Sbjct: 20 QQGLQ-AVPVGIP--AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAF 76
Query: 178 ANLSRVRHLHLNNNSIGGQI-PSELSKLSTLIHLLVDNNNLSGNLPPELSELPQLCILQL 236
L+ + L L++N+ + P+ L L L +D L P L L L L
Sbjct: 77 TGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYL 136
Query: 237 DNNNFSASEIPATYGNFSKLVKLSLRNCNLQGAVPD-LSRIPNLYYLDLSWNHLTGSIP- 294
+N + T+ + L L L + + +L L L N + P
Sbjct: 137 QDNALQ-ALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPH 195
Query: 295 SKKLSENVTTIDLSDNYLNGSILESISNLPFLQTLSLENNFLTGSIP 341
+ + + T+ L N L+ E+++ L LQ L L +N
Sbjct: 196 AFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCR 242
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 55.5 bits (132), Expect = 9e-09
Identities = 48/271 (17%), Positives = 92/271 (33%), Gaps = 30/271 (11%)
Query: 120 DLTGT--IPKEIGNISS--LIFLLLNGNKLSGSLPDELGYLSNLNRLQVDENNITG-TIP 174
DLTG P G + S +I + + L + + + + + I T+
Sbjct: 6 DLTGKNLHPDVTGRLLSQGVIAFRCPRSFMDQPLAEHFS-PFRVQHMDLSNSVIEVSTLH 64
Query: 175 KSFANLSRVRHLHLNNNSIGGQIPSELSKLSTLIHLLVDNNNLSGNLPPELSELPQLCIL 234
+ S++++L L + I + L+K S L+ L N + +
Sbjct: 65 GILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRL---NLSGCSGFSEFALQTLLSSCS 121
Query: 235 QLDNNNFSASEIPATYGNFSKL-----------VKLSLRNCNLQGAVPDLSRIPNLYYLD 283
+LD N S + + +N + R PNL +LD
Sbjct: 122 RLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLD 181
Query: 284 LSWNHLTGSIPSKKLSEN--VTTIDLSD-NYLNGSILESISNLPFLQTLSLENNFLTGSI 340
LS + + + ++ + + + LS + L + +P L+TL + G++
Sbjct: 182 LSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGIVPDGTL 241
Query: 341 PATIWQ-------NKSFSTKARLKIDLRNNS 364
F+T AR I + N
Sbjct: 242 QLLKEALPHLQINCSHFTTIARPTIGNKKNQ 272
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 53.2 bits (126), Expect = 5e-08
Identities = 46/275 (16%), Positives = 90/275 (32%), Gaps = 16/275 (5%)
Query: 89 RELQLLSMNLSGNLAPELGQLSRLQYYFMWNDLTGTIPKEIGNISSLIFLLLNGNKLSG- 147
+ L L NL ++ L + + + + + E + + + L+ + +
Sbjct: 3 QTLDLTGKNLHPDVTGRLLSQGVIAFRCPRSFMDQPLA-EHFSPFRVQHMDLSNSVIEVS 61
Query: 148 SLPDELGYLSNLNRLQVDENNITGTIPKSFANLSRVRHL--HLNNNSIGGQIPSELSKLS 205
+L L S L L ++ ++ I + A S + L + + + LS S
Sbjct: 62 TLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCS 121
Query: 206 TLIHL-----LVDNNNLSGNLPPELSELPQLCILQLDNNNFSASEIPATYGNFSKLVKLS 260
L L +SE L N S++ LV L
Sbjct: 122 RLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLD 181
Query: 261 LRNCNLQG--AVPDLSRIPNLYYLDLSWNHLTGSIPSKKLSE--NVTTIDLSDNYLNGSI 316
L + + + ++ L +L LS + +L E + T+ + +G++
Sbjct: 182 LSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGIVPDGTL 241
Query: 317 LESISNLPFLQTLSLENNFLTGSIPATIWQNKSFS 351
LP LQ + + T TI K+
Sbjct: 242 QLLKEALPHLQ---INCSHFTTIARPTIGNKKNQE 273
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 55.1 bits (131), Expect = 1e-08
Identities = 28/204 (13%), Positives = 52/204 (25%), Gaps = 47/204 (23%)
Query: 128 EIGNISSLIFLLLNGNKLSGSLPDELGYLSNLNRLQVDENNITGTIPKSFANLSRVRHLH 187
E+ ++S + + + L+ +LP +L + L + EN + + +R+ L+
Sbjct: 5 EVSKVASHLEVNCDKRNLT-ALPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLN 61
Query: 188 LNNNSIGGQ--------------------------------------------IPSELSK 203
L+ + +P +
Sbjct: 62 LDRAELTKLQVDGTLPVLGTLDLSHNQLQSLPLLGQTLPALTVLDVSFNRLTSLPLGALR 121
Query: 204 LSTLIHLLVDNNNLSGNLPPELSELPQLCILQLDNNNFSASEIPATYGNFSKLVKLSLRN 263
+ L N LPP L NN L L L+
Sbjct: 122 GLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQE 181
Query: 264 CNLQGAVPDLSRIPNLYYLDLSWN 287
+L L + L N
Sbjct: 182 NSLYTIPKGFFGSHLLPFAFLHGN 205
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 47.4 bits (111), Expect = 3e-06
Identities = 40/213 (18%), Positives = 66/213 (30%), Gaps = 13/213 (6%)
Query: 176 SFANLSRVRHLHLNNNSIGGQIPSELSKLSTLIHLLVDNNNLSGNLPPELSELPQLCILQ 235
+ ++ ++ + ++ +P +L K +T++HL N L L +L L
Sbjct: 5 EVSKVASHLEVNCDKRNLT-ALPPDLPKDTTILHL--SENLLYTFSLATLMPYTRLTQLN 61
Query: 236 LDNNNFSASEIPATYGNFSKLVKLSLRNCNLQGAVPDLSRIPNLYYLDLSWNHLTGSIPS 295
LD G L L L + LQ +P L LD+S+N LT
Sbjct: 62 LDRAEL---TKLQVDGTLPVLGTLDLSHNQLQSLPLLGQTLPALTVLDVSFNRLTSLPLG 118
Query: 296 KKLSENVTTIDLSDNYLNGSILESISNLPFLQTLSL-ENNFLTGSIPATIWQNKSFSTKA 354
++ + NN LT + ++ T
Sbjct: 119 ALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDT-- 176
Query: 355 RLKIDLRNNSFSNIVGDLT-LPNNVTLRLGGNP 386
+ L+ NS I L GNP
Sbjct: 177 ---LLLQENSLYTIPKGFFGSHLLPFAFLHGNP 206
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 41.2 bits (95), Expect = 3e-04
Identities = 28/134 (20%), Positives = 50/134 (37%), Gaps = 1/134 (0%)
Query: 108 QLSRLQYYFMWNDLTGTIPKEIGNISSLIFLLLNGNKLSGSLPDELGYLSNLNRLQVDEN 167
L L + ++ ++P + +L L ++ N+L+ L L L L + N
Sbjct: 75 TLPVLGTLDLSHNQLQSLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGN 134
Query: 168 NITGTIPKSFANLSRVRHLHLNNNSIGGQIPSELSKLSTLIHLLVDNNNLSGNLPPELSE 227
+ P ++ L L NN++ L+ L L LL+ N+L +P
Sbjct: 135 ELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLY-TIPKGFFG 193
Query: 228 LPQLCILQLDNNNF 241
L L N +
Sbjct: 194 SHLLPFAFLHGNPW 207
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 52.3 bits (123), Expect = 2e-07
Identities = 17/91 (18%), Positives = 36/91 (39%), Gaps = 13/91 (14%)
Query: 157 SNLNRLQVDENNITGT----IPKSFANLSRVRHLHLNNNSIGGQIPSELSK-----LSTL 207
S L L + + +++ + + + +R L L+NN +G +L + L
Sbjct: 369 SVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLL 428
Query: 208 IHLLVDNNNLSGNLPPELSEL----PQLCIL 234
L++ + S + L L P L ++
Sbjct: 429 EQLVLYDIYWSEEMEDRLQALEKDKPSLRVI 459
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 49.6 bits (116), Expect = 1e-06
Identities = 20/102 (19%), Positives = 36/102 (35%), Gaps = 15/102 (14%)
Query: 244 SEIPATYGNFSKLVKLSLRNCNLQGAVPD-----LSRIPNLYYLDLSWNHLTGSIPS--- 295
S L L L +C++ + L +L LDLS N L +
Sbjct: 359 ELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLV 418
Query: 296 ---KKLSENVTTIDLSDNYLNGSILESISNL----PFLQTLS 330
++ + + L D Y + + + + L P L+ +S
Sbjct: 419 ESVRQPGCLLEQLVLYDIYWSEEMEDRLQALEKDKPSLRVIS 460
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 49.6 bits (116), Expect = 1e-06
Identities = 18/161 (11%), Positives = 30/161 (18%), Gaps = 9/161 (5%)
Query: 53 DSMNHLRNWNKGDPCMSNWTGVLCFDTVETDGHLHVRELQLLSMNLSGNLAPELGQLSRL 112
+ C + L +L
Sbjct: 289 SLAGNELGDEGARLLCETLLEPGCQLESLWVKSCSFTAACCSHFSSVLAQNRFLLELQIS 348
Query: 113 QYYFMWNDLTGTIPKEIGNISSLIFLLLNGNKLSG----SLPDELGYLSNLNRLQVDENN 168
+ S L L L +S SL L +L L + N
Sbjct: 349 NNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNC 408
Query: 169 ITGTIPKSFA-----NLSRVRHLHLNNNSIGGQIPSELSKL 204
+ + L L + ++ L L
Sbjct: 409 LGDAGILQLVESVRQPGCLLEQLVLYDIYWSEEMEDRLQAL 449
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 49.6 bits (116), Expect = 1e-06
Identities = 18/92 (19%), Positives = 35/92 (38%), Gaps = 6/92 (6%)
Query: 278 NLYYLDLSWNHLTGSIPSKKLS--ENVTTIDLSDNYLNG----SILESISNLPFLQTLSL 331
++ LD+ L+ + ++ L + + L D L I ++ P L L+L
Sbjct: 3 DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNL 62
Query: 332 ENNFLTGSIPATIWQNKSFSTKARLKIDLRNN 363
+N L + Q + K+ L+N
Sbjct: 63 RSNELGDVGVHCVLQGLQTPSCKIQKLSLQNC 94
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 47.3 bits (110), Expect = 6e-06
Identities = 12/86 (13%), Positives = 30/86 (34%), Gaps = 5/86 (5%)
Query: 140 LNGNKLSGS-LPDELGYLSNLNRLQVDENNITG----TIPKSFANLSRVRHLHLNNNSIG 194
+ +LS + + L L +++D+ +T I + + L+L +N +G
Sbjct: 9 IQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELG 68
Query: 195 GQIPSELSKLSTLIHLLVDNNNLSGN 220
+ + + +L
Sbjct: 69 DVGVHCVLQGLQTPSCKIQKLSLQNC 94
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 47.3 bits (110), Expect = 7e-06
Identities = 15/89 (16%), Positives = 25/89 (28%), Gaps = 11/89 (12%)
Query: 234 LQLDNNNFSASEIPATYGNFSKLVKLSLRNCNLQGAVPD-----LSRIPNLYYLDLSWNH 288
L + S + + + L +C L A L P L L+L N
Sbjct: 7 LDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNE 66
Query: 289 LTGSIPS------KKLSENVTTIDLSDNY 311
L + S + + L +
Sbjct: 67 LGDVGVHCVLQGLQTPSCKIQKLSLQNCC 95
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 44.2 bits (102), Expect = 6e-05
Identities = 10/98 (10%), Positives = 27/98 (27%), Gaps = 7/98 (7%)
Query: 256 LVKLSLRNCNL--QGAVPDLSRIPNLYYLDLSWNHLTGSIPSK-----KLSENVTTIDLS 308
+ L ++ L L + + L LT + +++ + ++L
Sbjct: 4 IQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLR 63
Query: 309 DNYLNGSILESISNLPFLQTLSLENNFLTGSIPATIWQ 346
N L + + + ++ L
Sbjct: 64 SNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGC 101
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 43.8 bits (101), Expect = 8e-05
Identities = 19/92 (20%), Positives = 34/92 (36%), Gaps = 9/92 (9%)
Query: 183 VRHLHLNNNSIGGQIPSEL-SKLSTLIHLLVDNNNLSG----NLPPELSELPQLCILQLD 237
++ L + + +EL L + +D+ L+ ++ L P L L L
Sbjct: 4 IQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLR 63
Query: 238 NNNFSASEIP----ATYGNFSKLVKLSLRNCN 265
+N + K+ KLSL+NC
Sbjct: 64 SNELGDVGVHCVLQGLQTPSCKIQKLSLQNCC 95
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 43.8 bits (101), Expect = 9e-05
Identities = 13/71 (18%), Positives = 32/71 (45%), Gaps = 2/71 (2%)
Query: 299 SENVTTIDLSDNYLNGS-ILESISNLPFLQTLSLENNFLTGSIPATIWQNKSFSTKARLK 357
S ++ ++D+ L+ + E + L Q + L++ LT + I + +
Sbjct: 1 SLDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALA-E 59
Query: 358 IDLRNNSFSNI 368
++LR+N ++
Sbjct: 60 LNLRSNELGDV 70
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 43.4 bits (100), Expect = 1e-04
Identities = 13/82 (15%), Positives = 30/82 (36%), Gaps = 10/82 (12%)
Query: 273 LSRIPNLYYLDLSWNHLTGSIPSK-----KLSENVTTIDLSDNYLNGSILESIS-----N 322
L L L+ ++ S S + ++ +DLS+N L + + +
Sbjct: 365 GQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQP 424
Query: 323 LPFLQTLSLENNFLTGSIPATI 344
L+ L L + + + + +
Sbjct: 425 GCLLEQLVLYDIYWSEEMEDRL 446
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 41.1 bits (94), Expect = 5e-04
Identities = 12/76 (15%), Positives = 30/76 (39%), Gaps = 4/76 (5%)
Query: 301 NVTTIDLSDNYLNG----SILESISNLPFLQTLSLENNFLTGSIPATIWQNKSFSTKARL 356
+ + L+D ++ S+ ++ L+ L L NN L + + ++
Sbjct: 370 VLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLLE 429
Query: 357 KIDLRNNSFSNIVGDL 372
++ L + +S + D
Sbjct: 430 QLVLYDIYWSEEMEDR 445
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 51.7 bits (122), Expect = 2e-07
Identities = 18/99 (18%), Positives = 32/99 (32%), Gaps = 12/99 (12%)
Query: 140 LNGNKLSGSLPDELGYLSNLNRLQVDENNITGTIPKSFANLSRVRHLHLNNNSIGGQIPS 199
N S + +L L V N + +P L L + N + ++P
Sbjct: 267 YYLNASSNEIRSLCDLPPSLEELNVSNNKLI-ELPALPPRL---ERLIASFNHL-AEVPE 321
Query: 200 ELSKLSTLIHLLVDNNNLSGNLPPELSELPQLCILQLDN 238
L L V+ N L P + L++++
Sbjct: 322 LPQNLKQLH---VEYNPLRE-FPDIPESVED---LRMNS 353
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 51.0 bits (120), Expect = 4e-07
Identities = 23/90 (25%), Positives = 40/90 (44%), Gaps = 7/90 (7%)
Query: 238 NNNFSASEIPATYGNFSKLVKLSLRNCNLQGAVPDLSRIPNLYYLDLSWNHLTGSIPSKK 297
N S++EI + L +L++ N L +P L P L L S+NHL +P
Sbjct: 268 YLNASSNEIRSLCDLPPSLEELNVSNNKLI-ELPAL--PPRLERLIASFNHLA-EVPE-- 321
Query: 298 LSENVTTIDLSDNYLNGSILESISNLPFLQ 327
L +N+ + + N L + ++ L+
Sbjct: 322 LPQNLKQLHVEYNPLR-EFPDIPESVEDLR 350
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 44.4 bits (103), Expect = 4e-05
Identities = 22/96 (22%), Positives = 35/96 (36%), Gaps = 9/96 (9%)
Query: 185 HLHLNNNSIGGQIPSELSKLSTLIHLLVDNNNLSGNLPPELSELPQLCILQLDNNNFSAS 244
N+ +I S +L L V NN L LP + P+L L N+ +
Sbjct: 264 PNLYYLNASSNEIRSLCDLPPSLEELNVSNNKLI-ELP---ALPPRLERLIASFNHL--A 317
Query: 245 EIPATYGNFSKLVKLSLRNCNLQGAVPDLSRIPNLY 280
E+P N L +L + L+ + +L
Sbjct: 318 EVPELPQN---LKQLHVEYNPLREFPDIPESVEDLR 350
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 40.2 bits (92), Expect = 0.001
Identities = 17/61 (27%), Positives = 31/61 (50%), Gaps = 6/61 (9%)
Query: 254 SKLVKLSLRNCNLQGAVPDLSRIPNLYYLDLSWNHLTGSIPSKKLSENVTTIDLSDNYLN 313
+ +L L N L ++P+L P+L L S N LT +P L +++ ++ + +N L
Sbjct: 38 RQAHELELNNLGLS-SLPEL--PPHLESLVASCNSLT-ELPE--LPQSLKSLLVDNNNLK 91
Query: 314 G 314
Sbjct: 92 A 92
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 39.8 bits (91), Expect = 0.001
Identities = 19/111 (17%), Positives = 33/111 (29%), Gaps = 12/111 (10%)
Query: 55 MNHLRNWNKGDPCMSNWTGVLCFDTVETDGHLHVREL-QLLSMNLSGN----LAPELGQL 109
+ N + + + L +N+S N L +L
Sbjct: 247 TFLDVSENIFSGLSELPPNLYYLNASSNEIRSLCDLPPSLEELNVSNNKLIELPALPPRL 306
Query: 110 SRLQYYFMWNDLTGTIPKEIGNISSLIFLLLNGNKLSGSLPDELGYLSNLN 160
RL +N L +P+ N+ L + N L PD + +L
Sbjct: 307 ERL--IASFNHLA-EVPELPQNLKQLH---VEYNPLR-EFPDIPESVEDLR 350
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 39.4 bits (90), Expect = 0.002
Identities = 17/90 (18%), Positives = 32/90 (35%), Gaps = 11/90 (12%)
Query: 307 LSDNYLNGSILESISNLPFLQTLSLENNFLTGSIPATIWQNKSFSTKARLKIDLRNNSFS 366
N + I P L+ L++ NN L +PA + + ++ N +
Sbjct: 267 YYLNASSNEIRSLCDLPPSLEELNVSNNKLI-ELPALPPRLE--------RLIASFNHLA 317
Query: 367 NIVGDLTLPNNVTLRLGGNPICTSANIPNT 396
+ N L + NP+ +IP +
Sbjct: 318 EVPE--LPQNLKQLHVEYNPLREFPDIPES 345
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Score = 49.4 bits (117), Expect = 2e-07
Identities = 26/140 (18%), Positives = 52/140 (37%), Gaps = 4/140 (2%)
Query: 91 LQLLSMNLSGN-LAPELGQLSRLQYYFMWNDLTGTIPKEIGNISSLIFLLLNGNKLSG-- 147
+++L G P+L + + + T+ NI L+ L L+ N+L
Sbjct: 22 GSQQALDLKGLRSDPDLVAQNIDVVLNRRSSMAATLRIIEENIPELLSLNLSNNRLYRLD 81
Query: 148 SLPDELGYLSNLNRLQVDENNITGTIPKSFANLSRVRHLHLNNNSIGGQIPSELSKLSTL 207
+ + NL L + N + ++ L L+ NS+ + + +S +
Sbjct: 82 DMSSIVQKAPNLKILNLSGNELKSERELDKIKGLKLEELWLDGNSLSDTFRDQSTYISAI 141
Query: 208 IHLLVDNNNLSGN-LPPELS 226
L G+ LPP ++
Sbjct: 142 RERFPKLLRLDGHELPPPIA 161
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Score = 43.7 bits (102), Expect = 2e-05
Identities = 25/125 (20%), Positives = 40/125 (32%), Gaps = 6/125 (4%)
Query: 220 NLPPELSELPQLCILQLDNNNFSASEIPATYGNFSKLVKLSLRNCNLQGAVPDLSRIPNL 279
L +S+ LD + L + S L+ IP L
Sbjct: 11 QLKLIMSKRYDGSQQALDLKGLRSDPDLVAQNIDVVLNRRSSMAATLRII---EENIPEL 67
Query: 280 YYLDLSWNHLTGSIPSKKLSE---NVTTIDLSDNYLNGSILESISNLPFLQTLSLENNFL 336
L+LS N L + + N+ ++LS N L L+ L L+ N L
Sbjct: 68 LSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSERELDKIKGLKLEELWLDGNSL 127
Query: 337 TGSIP 341
+ +
Sbjct: 128 SDTFR 132
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 50.0 bits (118), Expect = 3e-07
Identities = 33/207 (15%), Positives = 72/207 (34%), Gaps = 23/207 (11%)
Query: 150 PDELGYLSNLNRLQVDENNITGTIPKSFANLSRVRHLHLNNNSIGGQIPSELSKLSTLIH 209
PD L+N ++ ++N+T T+ + A+L + L + + L+ LI
Sbjct: 14 PDP--ALANAIKIAAGKSNVTDTV--TQADLDGITTLSAFGTGVTTI--EGVQYLNNLIG 67
Query: 210 LLVDNNNL----------SGNLPPELSELPQLCILQLDNNNFSASEIPATYGNFSKLVKL 259
L + +N + + + ++ +T +
Sbjct: 68 LELKDNQITDLAPLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDVTPLAG 127
Query: 260 SLRNCNLQGAVPDLSRIPNLYYLDLSWNHLTGSIPSKKLSE-----NVTTIDLSDNYLNG 314
L + ++ I L L G+ L+ +TT+ DN ++
Sbjct: 128 LSNLQVLYLDLNQITNISPLAGLTNLQYLSIGNAQVSDLTPLANLSKLTTLKADDNKISD 187
Query: 315 SILESISNLPFLQTLSLENNFLTGSIP 341
+ +++LP L + L+NN ++ P
Sbjct: 188 --ISPLASLPNLIEVHLKNNQISDVSP 212
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 49.3 bits (116), Expect = 7e-07
Identities = 39/219 (17%), Positives = 75/219 (34%), Gaps = 21/219 (9%)
Query: 104 PELGQLSRLQYYFMWNDLTGTIPKEIGNISSLIFLLLNGNKLSGSLPDELGYLSNLNRLQ 163
P L ++ +++T T+ + ++ + L G ++ ++ + YL+NL L+
Sbjct: 16 PALANAIKIAAG--KSNVTDTVTQA--DLDGITTLSAFGTGVT-TIEG-VQYLNNLIGLE 69
Query: 164 VDENNITGTIPKSFANLSRVRHLHLNNNSIGGQIPSELSKLSTLIHLLVDNNNLSGNLPP 223
+ +N IT P L N I S + + +
Sbjct: 70 LKDNQITDLAPLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDVTPLAGLS 129
Query: 224 ELSEL-------------PQLCILQLDNNNFSASEIPATYGNFSKLVKLSLRNCNLQGAV 270
L L L LQ + + N SKL L + + +
Sbjct: 130 NLQVLYLDLNQITNISPLAGLTNLQYLSIGNAQVSDLTPLANLSKLTTLKADDNKISD-I 188
Query: 271 PDLSRIPNLYYLDLSWNHLTGSIPSKKLSENVTTIDLSD 309
L+ +PNL + L N ++ P S N+ + L++
Sbjct: 189 SPLASLPNLIEVHLKNNQISDVSPLANTS-NLFIVTLTN 226
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 40.8 bits (94), Expect = 4e-04
Identities = 30/165 (18%), Positives = 54/165 (32%), Gaps = 5/165 (3%)
Query: 50 SLVDSMNHLRNWNKGDPCMSNWTGVLCFDTVETDGHLHVRELQLLSMNLSGNLAPELGQL 109
L N + + L + ++ + +++L+ ++ L
Sbjct: 67 GLELKDNQITDLAPLKNLTKITELELSGNPLKNVSA-IAGLQSIKTLDLTSTQITDVTPL 125
Query: 110 SRLQYYFMWNDLTGTIPKEIGNISSLIFLLLNGNKLSGSLPDELGYLSNLNRLQVDENNI 169
+ L + I L+ S L LS L L+ D+N I
Sbjct: 126 AGLSNLQVLYLDLNQITNISPLAGLTNLQYLSIGNAQVSDLTPLANLSKLTTLKADDNKI 185
Query: 170 TGTIPKSFANLSRVRHLHLNNNSIGGQIPSELSKLSTLIHLLVDN 214
+ P A+L + +HL NN I P L+ S L + + N
Sbjct: 186 SDISP--LASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLTN 226
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 47.8 bits (113), Expect = 4e-07
Identities = 19/103 (18%), Positives = 38/103 (36%), Gaps = 24/103 (23%)
Query: 259 LSLRNCNLQGAVPDLSRIPNLYYLDLSWNHLTG----------------------SIPSK 296
L L + +L + L ++ + +LDLS N L ++
Sbjct: 3 LHLAHKDLTV-LCHLEQLLLVTHLDLSHNRLRALPPALAALRCLEVLQASDNALENVDGV 61
Query: 297 KLSENVTTIDLSDNYLNG-SILESISNLPFLQTLSLENNFLTG 338
+ + L +N L + ++ + + P L L+L+ N L
Sbjct: 62 ANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQ 104
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 46.2 bits (109), Expect = 1e-06
Identities = 26/119 (21%), Positives = 50/119 (42%), Gaps = 7/119 (5%)
Query: 162 LQVDENNITGTIPKSFANLSRVRHLHLNNNSIGGQIPSELSKLSTLIHL-LVDNNNLSGN 220
L + ++T + L V HL L++N + P+ L+ L L ++ ++ +
Sbjct: 3 LHLAHKDLT--VLCHLEQLLLVTHLDLSHNRLRALPPA----LAALRCLEVLQASDNALE 56
Query: 221 LPPELSELPQLCILQLDNNNFSASEIPATYGNFSKLVKLSLRNCNLQGAVPDLSRIPNL 279
++ LP+L L L NN S + +LV L+L+ +L R+ +
Sbjct: 57 NVDGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAEM 115
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 41.6 bits (97), Expect = 5e-05
Identities = 20/105 (19%), Positives = 35/105 (33%), Gaps = 4/105 (3%)
Query: 138 LLLNGNKLSGSLPDELGYLSNLNRLQVDENNITGTIPKSFANLSRVRHLHLNNNSIGGQI 197
L L L+ L L + L + N + P + A L + L +++ +
Sbjct: 3 LHLAHKDLTV--LCHLEQLLLVTHLDLSHNRLRALPP-ALAALRCLEVLQ-ASDNALENV 58
Query: 198 PSELSKLSTLIHLLVDNNNLSGNLPPELSELPQLCILQLDNNNFS 242
+ LL +N L P+L +L L N+
Sbjct: 59 DGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLC 103
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 40.9 bits (95), Expect = 1e-04
Identities = 21/111 (18%), Positives = 33/111 (29%), Gaps = 21/111 (18%)
Query: 304 TIDLSDNYLNGSILESISNLPFLQTLSLENNFLTGSIPA----------------TIWQN 347
+ L+ L ++L + L + L L +N L PA +
Sbjct: 2 VLHLAHKDL--TVLCHLEQLLLVTHLDLSHNRLRALPPALAALRCLEVLQASDNALENVD 59
Query: 348 KSFSTKARLKIDLRNNSFSNIVGDLT---LPNNVTLRLGGNPICTSANIPN 395
+ ++ L NN P V L L GN +C I
Sbjct: 60 GVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQE 110
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 36.6 bits (84), Expect = 0.003
Identities = 17/102 (16%), Positives = 30/102 (29%), Gaps = 7/102 (6%)
Query: 92 QLLSMNLSGNL----APELGQLSRLQYYFMWNDLTGTIPKEIGNISSLIFLLLNGNKLSG 147
+ ++LS N P L L L+ ++ + LL N
Sbjct: 21 LVTHLDLSHNRLRALPPALAALRCLEVLQASDNALENVDGVANLPRLQELLLCNNRLQQS 80
Query: 148 SLPDELGYLSNLNRLQVDENNIT---GTIPKSFANLSRVRHL 186
+ L L L + N++ G + L V +
Sbjct: 81 AAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAEMLPSVSSI 122
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 49.2 bits (116), Expect = 5e-07
Identities = 39/219 (17%), Positives = 75/219 (34%), Gaps = 32/219 (14%)
Query: 124 TIPKEIGNISSLIFLLLNGNKLSGSLPDELGYLSNLNRLQVDENNITGTIPKSFANLSRV 183
T+P I I D+ + + + + ++T + ++ L+ +
Sbjct: 9 TVPTPIKQI----------------FSDD--AFAETIKDNLKKKSVTDAVTQN--ELNSI 48
Query: 184 RHLHLNNNSIGGQIPSELSKLSTLIHLLVDNNNLSGNLPPELSELPQLCILQLDNNNFSA 243
+ NN+ I + L + L ++ N L+ L+ L L L LD N
Sbjct: 49 DQIIANNSDIKSVQG--IQYLPNVTKLFLNGNKLTDI--KPLANLKNLGWLFLDENKVKD 104
Query: 244 SEIPATYGNFSKLVKLSLRNCNLQGAVPDLSRIPNLYYLDLSWNHLTGSIPSKKLSENVT 303
L ++ G L +P L L L N +T +L++ T
Sbjct: 105 LSSLKDLKKLKSLSLEHNGISDING----LVHLPQLESLYLGNNKITDITVLSRLTKLDT 160
Query: 304 TIDLSDNYLNGSILESISNLPFLQTLSLENNFLTGSIPA 342
+ + + ++ L LQ L L N ++ + A
Sbjct: 161 LSLEDNQISD---IVPLAGLTKLQNLYLSKNHIS-DLRA 195
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 199 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 47.7 bits (112), Expect = 1e-06
Identities = 38/189 (20%), Positives = 76/189 (40%), Gaps = 15/189 (7%)
Query: 150 PDELGYLSNLNRLQVDENNITGTIPKSFANLSRVRHLHLNNNSIGGQIPSELSKLSTLIH 209
D L+ + + + N+T T+ ++ +L +V L + I + + L+ L
Sbjct: 13 TDT--ALAEKMKTVLGKTNVTDTVSQT--DLDQVTTLQADRLGI--KSIDGVEYLNNLTQ 66
Query: 210 LLVDNNNLSGNLPPELSELPQLCILQLDNNNFSASEIPATYGNFSKLVKLSLRNCNLQGA 269
+ NN L+ L L +L + ++NN + A N + L N
Sbjct: 67 INFSNNQLTDI--TPLKNLTKLVDILMNNNQIADITPLANLTNLTGLT----LFNNQITD 120
Query: 270 VPDLSRIPNLYYLDLSWNHLTGSIPSKKLSENVTTIDLSDNYLNGSILESISNLPFLQTL 329
+ L + NL L+LS N ++ L+ S+ + L+ ++NL L+ L
Sbjct: 121 IDPLKNLTNLNRLELSSNTISDISALSGLTSLQQLNFSSNQVTD---LKPLANLTTLERL 177
Query: 330 SLENNFLTG 338
+ +N ++
Sbjct: 178 DISSNKVSD 186
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 199 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 40.4 bits (93), Expect = 4e-04
Identities = 32/199 (16%), Positives = 71/199 (35%), Gaps = 15/199 (7%)
Query: 131 NISSLIFLLLNGNKLSGSLPDELGYLSNLNRLQVDENNITGTIPKSFANLSRVRHLHLNN 190
++ + +L ++ ++ L + LQ D I L+ + ++ +N
Sbjct: 16 ALAEKMKTVLGKTNVTDTVS--QTDLDQVTTLQADRLGIKSI--DGVEYLNNLTQINFSN 71
Query: 191 NSIGGQIPSELSKLSTLIHLLVDNNNLSGNLPPELSELPQLCILQLDNNNFSASEIPATY 250
N + P + I + + L L +
Sbjct: 72 NQLTDITPLKNLTKLVDILMNNNQIADITPLANL-------TNLTGLTLFNNQITDIDPL 124
Query: 251 GNFSKLVKLSLRNCNLQGAVPDLSRIPNLYYLDLSWNHLTGSIPSKKLSENVTTIDLSDN 310
N + L +L L + + + LS + +L L+ S N +T P L+ + +D+S N
Sbjct: 125 KNLTNLNRLELSSNTISD-ISALSGLTSLQQLNFSSNQVTDLKPLANLT-TLERLDISSN 182
Query: 311 YLNGSILESISNLPFLQTL 329
++ + ++ L L++L
Sbjct: 183 KVSD--ISVLAKLTNLESL 199
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Score = 45.7 bits (107), Expect = 4e-06
Identities = 30/149 (20%), Positives = 50/149 (33%), Gaps = 10/149 (6%)
Query: 144 KLSGSLPDELGYLSNLNRLQV---DENNITGTIPKSFANLSRVRHLHLNNNSIGGQIPSE 200
KL+ L ++ +N R + I I A L + + ++N I +
Sbjct: 2 KLTAELIEQAAQYTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEI--RKLDG 58
Query: 201 LSKLSTLIHLLVDNNNLSGNLPPELSELPQLCILQLDNNNFSASEIPATYGNFSKLVKLS 260
L L LLV+NN + LP L L L NN+ + L L
Sbjct: 59 FPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELILTNNSLVELGDLDPLASLKSLTYLC 118
Query: 261 LRNCNLQGAVPD----LSRIPNLYYLDLS 285
+ + + ++P + LD
Sbjct: 119 ILRNPVTNKKHYRLYVIYKVPQVRVLDFQ 147
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Score = 41.5 bits (96), Expect = 1e-04
Identities = 27/154 (17%), Positives = 43/154 (27%), Gaps = 22/154 (14%)
Query: 176 SFANLSRVRHLHLNNNSIGGQIPSELSKLSTLIHLLVDNNNLSGNLPPELSELPQLCILQ 235
+ N R R L L I I + + L + +N + L +L L
Sbjct: 13 QYTNAVRDRELDLRGYKI-PVIENLGATLDQFDAIDFSDNEI--RKLDGFPLLRRLKTLL 69
Query: 236 LDNNNFSASEIPATYGNFSKLVKLSLRNCNLQGAVPDLSRIPNLYYLDLSWNHLTGSIPS 295
++NN L +L L N +L +L + L L P
Sbjct: 70 VNNNRIC-RIGEGLDQALPDLTELILTNNSLV----ELGDLDPLASLKSLTYLCILRNP- 123
Query: 296 KKLSENVTTIDLSDNYLNGSILESISNLPFLQTL 329
L I +P ++ L
Sbjct: 124 -------------VTNKKHYRLYVIYKVPQVRVL 144
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Score = 40.7 bits (94), Expect = 2e-04
Identities = 24/136 (17%), Positives = 41/136 (30%), Gaps = 7/136 (5%)
Query: 257 VKLSLRNCNLQGAVPDLSRIPNLYYLDLSWNHLTGSIPSKKLSENVTTIDLSDNYLNGSI 316
VKL+ L + LDL + + ID SDN +
Sbjct: 1 VKLTA---ELIEQAAQYTNAVRDRELDLRGYKIPVIENLGATLDQFDAIDFSDNEIR--K 55
Query: 317 LESISNLPFLQTLSLENNFLTGSIPATIWQNKSFSTKARLKIDLRNNSFSNIVGDLTLPN 376
L+ L L+TL + NN + + L ++ +L +
Sbjct: 56 LDGFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELILTNNSL--VELGDLDPLASLKS 113
Query: 377 NVTLRLGGNPICTSAN 392
L + NP+ +
Sbjct: 114 LTYLCILRNPVTNKKH 129
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} Length = 192 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Score = 46.0 bits (107), Expect = 6e-06
Identities = 47/178 (26%), Positives = 71/178 (39%), Gaps = 8/178 (4%)
Query: 119 NDLTGTIPKEIGNISSLIFLLLNGNKLSGSLPDEL-GYLSNLNRLQVDENNITGTIPKSF 177
L IP++I LLLN N+L D L G L +L +L++ N +TG P +F
Sbjct: 18 RGLK-EIPRDIP--LHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAF 74
Query: 178 ANLSRVRHLHLNNNSIGGQIPSELSKLSTLIHLLVDNNNLSGNLPPELSELPQLCILQLD 237
S ++ L L N I L L L + +N +S +P L L L L
Sbjct: 75 EGASHIQELQLGENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLA 134
Query: 238 NNNFSASEIPATYGNFSKLVKLSLRNCNLQGAVPDLSRIPNLYYLDLSWNHLTGSIPS 295
+N F+ L K SL + P S++ ++ DL + S +
Sbjct: 135 SNPFN--CNCHLAWFAEWLRKKSLNGGAARCGAP--SKVRDVQIKDLPHSEFKCSSEN 188
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 39.9 bits (91), Expect = 8e-04
Identities = 14/66 (21%), Positives = 17/66 (25%), Gaps = 3/66 (4%)
Query: 158 NLNRLQVDENNITGTIPKSFANLSRVRHLHLNNNSIGGQIPSELSKLSTLIHLLVDNNNL 217
D NN+ F S L ++ I L L L NL
Sbjct: 178 LDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRAR--STYNL 235
Query: 218 SGNLPP 223
LP
Sbjct: 236 K-KLPT 240
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 39.9 bits (91), Expect = 8e-04
Identities = 31/226 (13%), Positives = 67/226 (29%), Gaps = 32/226 (14%)
Query: 138 LLLNGNKLSGSLPDELGYLSNLNRLQVDENNITGTIPKSFANLSRVRHLHLNNNSIGGQI 197
L +K++ +P +L N L+ + +F+ + + ++ N + I
Sbjct: 13 FLCQESKVT-EIPSDL--PRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVI 69
Query: 198 PSELSKLSTLIHLLVDNNNLSGNLPPELSELPQLCILQLDNNNFSASEIPA--------- 248
+++ +H + + + + L +N +P
Sbjct: 70 EADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQK 129
Query: 249 ------------------TYGNFSKLVKLSLRNCNLQGAVPDLSRIPNLYYLDLSWNHLT 290
G + V L L +Q L L+LS N+
Sbjct: 130 VLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQEIHNCAFNGTQLDELNLSDNNNL 189
Query: 291 GSIPSKKLS--ENVTTIDLSDNYLNGSILESISNLPFLQTLSLENN 334
+P+ +D+S ++ + NL L+ S N
Sbjct: 190 EELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARSTYNL 235
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 39.9 bits (91), Expect = 9e-04
Identities = 9/49 (18%), Positives = 15/49 (30%), Gaps = 3/49 (6%)
Query: 151 DELGYLSNLNRLQVDENNITGTIPKSFANLSRVRHLHLNNNSIGGQIPS 199
D S L + I NL ++R N ++P+
Sbjct: 195 DVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARSTYNLK---KLPT 240
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 38.4 bits (87), Expect = 0.002
Identities = 15/121 (12%), Positives = 29/121 (23%), Gaps = 4/121 (3%)
Query: 55 MNHLRNWNKGDPCMSNWTGVLCFDTVETDGHLHVRELQLLSMNLSGNLAPELGQLSRLQY 114
N L L + +
Sbjct: 122 HKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQEIHNCAFNGTQLDEL 181
Query: 115 YFMWNDLTGTIPKEI-GNISSLIFLLLNGNKLSGSLPDELGYLSNLNRLQVDENNITGTI 173
N+ +P ++ S + L ++ ++ SLP L NL +L+ +
Sbjct: 182 NLSDNNNLEELPNDVFHGASGPVILDISRTRIH-SLPSYG--LENLKKLRARSTYNLKKL 238
Query: 174 P 174
P
Sbjct: 239 P 239
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 39.1 bits (89), Expect = 0.002
Identities = 11/82 (13%), Positives = 27/82 (32%), Gaps = 8/82 (9%)
Query: 158 NLNRLQVDENNITGTIPKSFANLSRVRHLHLNNNSIGGQ----IPSELSKLSTLIHLLVD 213
+L + + ++ V+ + L+ N+IG + + ++ L
Sbjct: 9 SLKLDAITTEDEK-SVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFS 67
Query: 214 NN---NLSGNLPPELSELPQLC 232
+ + +P L L Q
Sbjct: 68 DIFTGRVKDEIPEALRLLLQAL 89
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 39.1 bits (89), Expect = 0.002
Identities = 16/90 (17%), Positives = 30/90 (33%), Gaps = 13/90 (14%)
Query: 185 HLHLNNNSIGGQIPSELS------KLSTLIHLLVDNNNLSGNLPPELSE-----LPQLCI 233
L LN+ + + + + + L L + N + + L +P L
Sbjct: 247 ELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLF 306
Query: 234 LQLDNNNFSASEIPATYGNFSKLVKLSLRN 263
L+L+ N F SE ++ R
Sbjct: 307 LELNGNRF--SEEDDVVDEIREVFSTRGRG 334
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 38.3 bits (87), Expect = 0.003
Identities = 19/105 (18%), Positives = 37/105 (35%), Gaps = 13/105 (12%)
Query: 113 QYYFMWNDLTGTIPKEIGNISSLIFLLLNGNKLSG----SLPDELGYLSN--LNRLQVDE 166
Q + + + + + +L L LN LS ++ D L N L L++
Sbjct: 223 QDNTFTHLGSSALAIALKSWPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQY 282
Query: 167 NNITGTIPKSFA-----NLSRVRHLHLNNNSIG--GQIPSELSKL 204
N I ++ + + L LN N + E+ ++
Sbjct: 283 NEIELDAVRTLKTVIDEKMPDLLFLELNGNRFSEEDDVVDEIREV 327
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} Length = 156 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 37.8 bits (86), Expect = 0.002
Identities = 22/136 (16%), Positives = 38/136 (27%), Gaps = 3/136 (2%)
Query: 209 HLLVDNNNLSGNLPPELSELPQLCILQLDNNNFSASEIPATYGNFSKLVKLSLRNCNLQG 268
L + + L L L ++N +L L++ L+
Sbjct: 12 GLRCTRDGAL-DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRF 70
Query: 269 A-VPDLSRIPNLYYLDLSWNHLTGSIPSKKLSENVTTIDLSDNYLNGSI-LESISNLPFL 326
P L L+LS+N L ++ + LS N L+ S L +
Sbjct: 71 VAPDAFHFTPRLSRLNLSFNALESLSWKTVQGLSLQELVLSGNPLHCSCALRWLQRWEEE 130
Query: 327 QTLSLENNFLTGSIPA 342
+ L
Sbjct: 131 GLGGVPEQKLQCHGQG 146
|
| >d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]} Length = 198 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: Outer arm dynein light chain 1 family: Outer arm dynein light chain 1 domain: Outer arm dynein light chain 1 species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]
Score = 37.4 bits (85), Expect = 0.003
Identities = 31/177 (17%), Positives = 52/177 (29%), Gaps = 21/177 (11%)
Query: 118 WNDLTGTIPKEIGNISSLIFLLLNGNKLSGSLPDELGYLSNLNRLQVDENNITGTIPKSF 177
+ + + E + L + + L L L + NNI I S
Sbjct: 14 FEERKSVVATEAEKVE----LHGMIPPIE-KMDATLSTLKACKHLALSTNNIE-KIS-SL 66
Query: 178 ANLSRVRHLHLNNNSIGGQIPSELSKLSTLIHLLVDNNNLSGNLPPELSELPQLCILQLD 237
+ + +R L L N I + + + + +L L +L +
Sbjct: 67 SGMENLRILSLGRNLIKKIENLDAVADTLEEL---WISYNQIASLSGIEKLVNLRVLYMS 123
Query: 238 NNNFSASEIPATYGNFSKLVKLSLRNCNLQGAVPD-----------LSRIPNLYYLD 283
NN + KL L L L + + R+PNL LD
Sbjct: 124 NNKITNWGEIDKLAALDKLEDLLLAGNPLYNDYKENNATSEYRIEVVKRLPNLKKLD 180
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 958 | |||
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1ogqa_ | 313 | Polygalacturonase inhibiting protein PGIP {Kidney | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1ogqa_ | 313 | Polygalacturonase inhibiting protein PGIP {Kidney | 99.95 | |
| d1xkua_ | 305 | Decorin {Cow (Bos taurus) [TaxId: 9913]} | 99.93 | |
| d1ozna_ | 284 | Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma | 99.92 | |
| d2omza2 | 384 | Internalin A {Listeria monocytogenes [TaxId: 1639] | 99.92 | |
| d1p9ag_ | 266 | von Willebrand factor binding domain of glycoprote | 99.91 | |
| d2omza2 | 384 | Internalin A {Listeria monocytogenes [TaxId: 1639] | 99.9 | |
| d1xkua_ | 305 | Decorin {Cow (Bos taurus) [TaxId: 9913]} | 99.89 | |
| d1ozna_ | 284 | Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma | 99.88 | |
| d1p9ag_ | 266 | von Willebrand factor binding domain of glycoprote | 99.86 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.86 | |
| d1h6ua2 | 227 | Internalin H {Listeria monocytogenes [TaxId: 1639] | 99.75 | |
| d1jl5a_ | 353 | Leucine rich effector protein YopM {Yersinia pesti | 99.74 | |
| d1xwdc1 | 242 | Follicle-stimulating hormone receptor {Human (Homo | 99.71 | |
| d1h6ua2 | 227 | Internalin H {Listeria monocytogenes [TaxId: 1639] | 99.71 | |
| d1xwdc1 | 242 | Follicle-stimulating hormone receptor {Human (Homo | 99.7 | |
| d1w8aa_ | 192 | Slit {Fruit fly (Drosophila melanogaster) [TaxId: | 99.7 | |
| d2omxa2 | 199 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.69 | |
| d1h6ta2 | 210 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.69 | |
| d1h6ta2 | 210 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.69 | |
| d1w8aa_ | 192 | Slit {Fruit fly (Drosophila melanogaster) [TaxId: | 99.68 | |
| d2omxa2 | 199 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.67 | |
| d1jl5a_ | 353 | Leucine rich effector protein YopM {Yersinia pesti | 99.65 | |
| d1z7xw1 | 460 | Ribonuclease inhibitor {Human (Homo sapiens) [TaxI | 99.52 | |
| d2ca6a1 | 344 | Rna1p (RanGAP1), N-terminal domain {Fission yeast | 99.47 | |
| d1dcea3 | 124 | Rab geranylgeranyltransferase alpha-subunit, C-ter | 99.46 | |
| d2ca6a1 | 344 | Rna1p (RanGAP1), N-terminal domain {Fission yeast | 99.46 | |
| d1a9na_ | 162 | Splicesomal U2A' protein {Human (Homo sapiens) [Ta | 99.45 | |
| d2astb2 | 284 | Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sa | 99.44 | |
| d1dcea3 | 124 | Rab geranylgeranyltransferase alpha-subunit, C-ter | 99.44 | |
| d2ifga3 | 156 | High affinity nerve growth factor receptor, N-term | 99.42 | |
| d1a9na_ | 162 | Splicesomal U2A' protein {Human (Homo sapiens) [Ta | 99.42 | |
| d1z7xw1 | 460 | Ribonuclease inhibitor {Human (Homo sapiens) [TaxI | 99.42 | |
| d2astb2 | 284 | Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sa | 99.39 | |
| d1m9la_ | 198 | Outer arm dynein light chain 1 {Green algae (Chlam | 99.28 | |
| d2ifga3 | 156 | High affinity nerve growth factor receptor, N-term | 99.21 | |
| d1m9la_ | 198 | Outer arm dynein light chain 1 {Green algae (Chlam | 99.17 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.46 | |
| d1koha1 | 162 | mRNA export factor tap {Human (Homo sapiens) [TaxI | 98.32 | |
| d1koha1 | 162 | mRNA export factor tap {Human (Homo sapiens) [TaxI | 98.24 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 97.98 | |
| d1pgva_ | 167 | Tropomodulin C-terminal domain {nematode (Caenorha | 97.58 | |
| d1pgva_ | 167 | Tropomodulin C-terminal domain {nematode (Caenorha | 97.51 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 97.45 | |
| d1io0a_ | 166 | Tropomodulin C-terminal domain {Chicken (Gallus ga | 96.85 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 96.82 | |
| d1io0a_ | 166 | Tropomodulin C-terminal domain {Chicken (Gallus ga | 96.66 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 96.33 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 95.37 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.1e-51 Score=435.84 Aligned_cols=265 Identities=26% Similarity=0.481 Sum_probs=212.7
Q ss_pred HcCCCCCceeeeeCCeEEEEEEECCCcEEEEEEeccC--ChhcHHHHHHHHHHHHccCCCCcceEEEEEEeCCeEEEEEE
Q 002158 624 TAYFSSSTQVGQGGYGKVYKGILSDNTTVAIKRAEEG--SLQGQNEFLTEIKLLSRLHHRNLVSLLGYCDEEGEQMLVYE 701 (958)
Q Consensus 624 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E 701 (958)
.++|...+.||+|+||+||+|+++ ..||||+++.. .....+.|.+|++++++++|||||+++|++.. +..++|||
T Consensus 7 ~~~~~~~~~lG~G~fg~Vy~~~~~--~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~~~~lv~E 83 (276)
T d1uwha_ 7 DGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQLAIVTQ 83 (276)
T ss_dssp TTCCCCCSEEEECSSCEEEEEESS--SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEE
T ss_pred cccEEEEEEEeeCCCcEEEEEEEC--CEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec-cEEEEEEe
Confidence 457888999999999999999864 36999998654 34456789999999999999999999999865 56899999
Q ss_pred ecCCCCHHHHhccCCCCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEecCCCCeEEeeeeeecccccCCC
Q 002158 702 FVPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSRLAPVLDD 781 (958)
Q Consensus 702 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~ 781 (958)
||++|+|.++++... ..+++.+++.++.|+|+||+|||+++ ||||||||+|||++.++.+||+|||+|+.......
T Consensus 84 y~~~g~L~~~l~~~~-~~~~~~~~~~i~~qi~~gl~yLH~~~---ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~~~ 159 (276)
T d1uwha_ 84 WCEGSSLYHHLHIIE-TKFEMIKLIDIARQTAQGMDYLHAKS---IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSG 159 (276)
T ss_dssp CCCEEEHHHHHHTSC-CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTSSEEECCCCCSCC------
T ss_pred cCCCCCHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHhcCC---EeccccCHHHEEEcCCCCEEEccccceeeccccCC
Confidence 999999999997543 34999999999999999999999998 99999999999999999999999999986543221
Q ss_pred CCCccceeeeeccCCCCccChhhhccC---CCCCcchhhhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcCcchhhhcc
Q 002158 782 EGTMPTHVSTIVKGTPGYLDPEYFLTH---KLTDKSDVYSLGVVLLELLTGMQPISHGKNIVREVNVARDSGMVFSIIDN 858 (958)
Q Consensus 782 ~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~DV~S~Gv~l~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~i~~ 858 (958)
........||+.|||||++.+. .|+.++|||||||++|||+||+.||.+............. +.. .+
T Consensus 160 -----~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~~~~~~~-~~~----~p 229 (276)
T d1uwha_ 160 -----SHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGR-GYL----SP 229 (276)
T ss_dssp -----------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHH-TSC----CC
T ss_pred -----cccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHHHHHHHhc-CCC----CC
Confidence 1223456799999999999653 4788999999999999999999999765543332222211 111 11
Q ss_pred cCCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHhhCCC
Q 002158 859 RMGSYPSECVERFVTLALRCCHDKPEHRPSMSDVVRELENILKMFPE 905 (958)
Q Consensus 859 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~~~ 905 (958)
.....+..+++.+.+++.+||+.||++|||++||+++|+.+.+..|.
T Consensus 230 ~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l~~~~Pk 276 (276)
T d1uwha_ 230 DLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLARSLPK 276 (276)
T ss_dssp CGGGSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTCCC
T ss_pred cchhccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHcCCC
Confidence 11233556778999999999999999999999999999999887763
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-50 Score=432.20 Aligned_cols=258 Identities=29% Similarity=0.456 Sum_probs=207.2
Q ss_pred cCCCCCceeeeeCCeEEEEEEECCCcEEEEEEeccCChhcHHHHHHHHHHHHccCCCCcceEEEEEEeCCeEEEEEEecC
Q 002158 625 AYFSSSTQVGQGGYGKVYKGILSDNTTVAIKRAEEGSLQGQNEFLTEIKLLSRLHHRNLVSLLGYCDEEGEQMLVYEFVP 704 (958)
Q Consensus 625 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E~~~ 704 (958)
++|+..+.||+|+||+||+|.+.+++.||||+++... ...++|.+|++++++++||||++++|+|..++..++||||++
T Consensus 5 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~~ 83 (263)
T d1sm2a_ 5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFME 83 (263)
T ss_dssp SCEEEEEEEECCSSCCEEEEEETTTEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCT
T ss_pred HHcEEEEEEeeCCCeEEEEEEECCCCEEEEEEECCCc-CcHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEecC
Confidence 3567778999999999999999989999999997643 445689999999999999999999999999999999999999
Q ss_pred CCCHHHHhccCCCCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEecCCCCeEEeeeeeecccccCCCCCC
Q 002158 705 NGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSRLAPVLDDEGT 784 (958)
Q Consensus 705 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 784 (958)
+|+|.+++.... ..+++..++.++.|+|+||+|||+++ |+||||||+|||+++++.+||+|||+++......
T Consensus 84 ~g~L~~~l~~~~-~~~~~~~~~~i~~qia~gl~~lH~~~---iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~---- 155 (263)
T d1sm2a_ 84 HGCLSDYLRTQR-GLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ---- 155 (263)
T ss_dssp TCBHHHHHHTTT-TCCCHHHHHHHHHHHHHHHHHHHHTT---CCCTTCSGGGEEECGGGCEEECSCC-------------
T ss_pred CCcHHHHhhccc-cCCCHHHHHHHHHHHHHHHHhhhccc---eeecccchhheeecCCCCeEecccchheeccCCC----
Confidence 999999987543 45899999999999999999999999 9999999999999999999999999998653222
Q ss_pred ccceeeeeccCCCCccChhhhccCCCCCcchhhhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcCcchhhhcccCCCCC
Q 002158 785 MPTHVSTIVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVLLELLTGMQPISHGKNIVREVNVARDSGMVFSIIDNRMGSYP 864 (958)
Q Consensus 785 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gv~l~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~ 864 (958)
........||+.|+|||++.+..++.++|||||||++|||+|+..|+.......+....... ......|
T Consensus 156 --~~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~~~~~~i~~---------~~~~~~p 224 (263)
T d1sm2a_ 156 --YTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDIST---------GFRLYKP 224 (263)
T ss_dssp -----------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCHHHHHHHHHH---------TCCCCCC
T ss_pred --ceeecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCCHHHHHHHHHh---------cCCCCCc
Confidence 11223456999999999999999999999999999999999965554444433333222211 1122345
Q ss_pred hHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHhh
Q 002158 865 SECVERFVTLALRCCHDKPEHRPSMSDVVRELENILKM 902 (958)
Q Consensus 865 ~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~ 902 (958)
..+++++.+++.+||+.||++|||++||+++|+++.+.
T Consensus 225 ~~~~~~l~~li~~cl~~~p~~Rps~~~il~~L~~i~es 262 (263)
T d1sm2a_ 225 RLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEIAES 262 (263)
T ss_dssp TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred cccCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhC
Confidence 56778899999999999999999999999999998753
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.7e-50 Score=430.97 Aligned_cols=259 Identities=28% Similarity=0.451 Sum_probs=216.0
Q ss_pred HcCCCCCceeeeeCCeEEEEEEECCCcEEEEEEeccCChhcHHHHHHHHHHHHccCCCCcceEEEEEEeCCeEEEEEEec
Q 002158 624 TAYFSSSTQVGQGGYGKVYKGILSDNTTVAIKRAEEGSLQGQNEFLTEIKLLSRLHHRNLVSLLGYCDEEGEQMLVYEFV 703 (958)
Q Consensus 624 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E~~ 703 (958)
.++|+..+.||+|+||+||+|.+++++.||||+++... ...++|.+|++++++++|||||+++|++.+ +..++||||+
T Consensus 12 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~iv~Ey~ 89 (272)
T d1qpca_ 12 RETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYM 89 (272)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEECC
T ss_pred HHHeEEeEEEecCCCcEEEEEEECCCCEEEEEEEccCc-CCHHHHHHHHHHHHhCCCCCEeEEEeeecc-CCeEEEEEeC
Confidence 35677788999999999999999888999999997643 345689999999999999999999998865 5679999999
Q ss_pred CCCCHHHHhccCCCCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEecCCCCeEEeeeeeecccccCCCCC
Q 002158 704 PNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSRLAPVLDDEG 783 (958)
Q Consensus 704 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 783 (958)
++|+|.+++.......+++.++++++.|||+||+|||+++ |+||||||+|||+++++.+||+|||+|+......
T Consensus 90 ~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~~---ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~~--- 163 (272)
T d1qpca_ 90 ENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNE--- 163 (272)
T ss_dssp TTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECSSSC---
T ss_pred CCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCccchhheeeecccceeeccccceEEccCCc---
Confidence 9999999987655556999999999999999999999999 9999999999999999999999999998763211
Q ss_pred CccceeeeeccCCCCccChhhhccCCCCCcchhhhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcCcchhhhcccCCCC
Q 002158 784 TMPTHVSTIVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVLLELLTGMQPISHGKNIVREVNVARDSGMVFSIIDNRMGSY 863 (958)
Q Consensus 784 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gv~l~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~ 863 (958)
........||+.|||||++.+..++.++|||||||++|||+||..|+............... ......
T Consensus 164 ---~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~~~~~~i~~---------~~~~~~ 231 (272)
T d1qpca_ 164 ---YTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLER---------GYRMVR 231 (272)
T ss_dssp ---EECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHT---------TCCCCC
T ss_pred ---cccccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCCHHHHHHHHHh---------cCCCCC
Confidence 12223456899999999999999999999999999999999976665544443333222211 122334
Q ss_pred ChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHhh
Q 002158 864 PSECVERFVTLALRCCHDKPEHRPSMSDVVRELENILKM 902 (958)
Q Consensus 864 ~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~ 902 (958)
|..+++++.+++.+||+.||++|||++||++.|++...+
T Consensus 232 p~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~fts 270 (272)
T d1qpca_ 232 PDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTA 270 (272)
T ss_dssp CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred cccChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhhhhhc
Confidence 566778899999999999999999999999999987643
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=7.5e-50 Score=434.19 Aligned_cols=272 Identities=29% Similarity=0.465 Sum_probs=209.4
Q ss_pred cChHHHHHHHcCC---------CCCceeeeeCCeEEEEEEECC-C---cEEEEEEeccC-ChhcHHHHHHHHHHHHccCC
Q 002158 615 FKFKELAMATAYF---------SSSTQVGQGGYGKVYKGILSD-N---TTVAIKRAEEG-SLQGQNEFLTEIKLLSRLHH 680 (958)
Q Consensus 615 ~~~~el~~~~~~~---------~~~~~lg~G~~g~Vy~~~~~~-~---~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H 680 (958)
++|++...++.+| ...+.||+|+||+||+|.++. + ..||||++... .....++|.+|+++|++++|
T Consensus 7 ~t~~d~~~a~~~f~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H 86 (299)
T d1jpaa_ 7 FTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDH 86 (299)
T ss_dssp GGSSSHHHHHHHHSCBCCGGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCC
T ss_pred CCHHHHHHHHhhhchhhChhhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCC
Confidence 4455555554444 445789999999999999752 3 36899998764 44456789999999999999
Q ss_pred CCcceEEEEEEeCCeEEEEEEecCCCCHHHHhccCCCCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEec
Q 002158 681 RNLVSLLGYCDEEGEQMLVYEFVPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLD 760 (958)
Q Consensus 681 ~niv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~ 760 (958)
||||+++|+|..++..++|||||++|+|.+++.... ..+++.++++++.|+|+||+|||+++ |+||||||+|||++
T Consensus 87 pnIv~l~g~~~~~~~~~iv~Ey~~~g~L~~~~~~~~-~~l~~~~~~~i~~qia~gl~yLH~~~---iiHrDlKp~NILl~ 162 (299)
T d1jpaa_ 87 PNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQND-GQFTVIQLVGMLRGIAAGMKYLADMN---YVHRDLAARNILVN 162 (299)
T ss_dssp TTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHTTT-TCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEC
T ss_pred CCCccEEEEEeeCCEEEEEEEecCCCcceeeecccc-CCCCHHHHHHHHHHHHHHHHHHhhCC---CccCccccceEEEC
Confidence 999999999999999999999999999999987543 35899999999999999999999999 99999999999999
Q ss_pred CCCCeEEeeeeeecccccCCCCCCccceeeeeccCCCCccChhhhccCCCCCcchhhhHHHHHHHHHh-CCCCCCCCchh
Q 002158 761 SNLNAKVADFGLSRLAPVLDDEGTMPTHVSTIVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVLLELLT-GMQPISHGKNI 839 (958)
Q Consensus 761 ~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gv~l~ellt-G~~P~~~~~~~ 839 (958)
.++.+||+|||+|+.......... ........||+.|||||++.+..++.++|||||||++|||+| |+.||.+....
T Consensus 163 ~~~~~Kl~DFGla~~~~~~~~~~~--~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~ 240 (299)
T d1jpaa_ 163 SNLVCKVSDFGLSRFLEDDTSDPT--YTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQ 240 (299)
T ss_dssp TTCCEEECCC-------------------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH
T ss_pred CCCcEEECCcccceEccCCCCcce--eeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCHH
Confidence 999999999999987643222111 112233568999999999999999999999999999999998 89999754432
Q ss_pred HHHHHHHhhcCcchhhhcccCCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHhh
Q 002158 840 VREVNVARDSGMVFSIIDNRMGSYPSECVERFVTLALRCCHDKPEHRPSMSDVVRELENILKM 902 (958)
Q Consensus 840 ~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~ 902 (958)
....... .......+..++..+.+++.+||+.||++|||++||++.|+++++.
T Consensus 241 -~~~~~i~---------~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~l~~ 293 (299)
T d1jpaa_ 241 -DVINAIE---------QDYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIRN 293 (299)
T ss_dssp -HHHHHHH---------TTCCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred -HHHHHHH---------cCCCCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhcC
Confidence 2211111 1122334567788999999999999999999999999999998763
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.5e-50 Score=436.97 Aligned_cols=261 Identities=30% Similarity=0.466 Sum_probs=221.0
Q ss_pred HHHcCCCCCceeeeeCCeEEEEEEEC-CCcEEEEEEeccCChhcHHHHHHHHHHHHccCCCCcceEEEEEEeCCeEEEEE
Q 002158 622 MATAYFSSSTQVGQGGYGKVYKGILS-DNTTVAIKRAEEGSLQGQNEFLTEIKLLSRLHHRNLVSLLGYCDEEGEQMLVY 700 (958)
Q Consensus 622 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~ 700 (958)
...++|...+.||+|+||+||+|+++ +++.||||+++... ...++|.+|++++++++|||||+++|+|.+++..++||
T Consensus 14 i~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~-~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv~ 92 (287)
T d1opja_ 14 MERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIIT 92 (287)
T ss_dssp CCGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTC-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEE
T ss_pred ecHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCcc-chHHHHHHHHHHHHhCCCCCEecCCccEeeCCeeEEEe
Confidence 34567788889999999999999986 58899999987643 44668999999999999999999999999999999999
Q ss_pred EecCCCCHHHHhccCCCCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEecCCCCeEEeeeeeecccccCC
Q 002158 701 EFVPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSRLAPVLD 780 (958)
Q Consensus 701 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~ 780 (958)
|||++|+|.+++.......+++..+..++.|+|+||+|||+++ |+||||||+|||+++++.+||+|||+|+......
T Consensus 93 E~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~---iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~~~ 169 (287)
T d1opja_ 93 EFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT 169 (287)
T ss_dssp ECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCCTTTCCSSS
T ss_pred ecccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHHCC---cccCccccCeEEECCCCcEEEccccceeecCCCC
Confidence 9999999999998776667999999999999999999999999 9999999999999999999999999998653211
Q ss_pred CCCCccceeeeeccCCCCccChhhhccCCCCCcchhhhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcCcchhhhcccC
Q 002158 781 DEGTMPTHVSTIVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVLLELLTGMQPISHGKNIVREVNVARDSGMVFSIIDNRM 860 (958)
Q Consensus 781 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gv~l~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~i~~~~ 860 (958)
........||+.|+|||++.+..++.++|||||||++|||++|..|+....+.......... ...
T Consensus 170 ------~~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~~~~~~i~~---------~~~ 234 (287)
T d1opja_ 170 ------YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEK---------DYR 234 (287)
T ss_dssp ------SEEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHT---------TCC
T ss_pred ------ceeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcchHHHHHHHHhc---------CCC
Confidence 22333456899999999999999999999999999999999987777655544333222211 112
Q ss_pred CCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHh
Q 002158 861 GSYPSECVERFVTLALRCCHDKPEHRPSMSDVVRELENILK 901 (958)
Q Consensus 861 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~ 901 (958)
...+..+++++.+++.+||+.||++|||++|+++.|+.+.+
T Consensus 235 ~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~~~ 275 (287)
T d1opja_ 235 MERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ 275 (287)
T ss_dssp CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTS
T ss_pred CCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence 34456678899999999999999999999999999987653
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.9e-50 Score=426.26 Aligned_cols=252 Identities=24% Similarity=0.353 Sum_probs=206.3
Q ss_pred cCCCCCceeeeeCCeEEEEEEEC-CCcEEEEEEeccCCh-hcHHHHHHHHHHHHccCCCCcceEEEEEEeCCeEEEEEEe
Q 002158 625 AYFSSSTQVGQGGYGKVYKGILS-DNTTVAIKRAEEGSL-QGQNEFLTEIKLLSRLHHRNLVSLLGYCDEEGEQMLVYEF 702 (958)
Q Consensus 625 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E~ 702 (958)
++|+..+.||+|+||+||+|+++ +|+.||||++..... ...+++.+|++++++++||||+++++++.+++..++||||
T Consensus 5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmEy 84 (271)
T d1nvra_ 5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEY 84 (271)
T ss_dssp TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred cceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEec
Confidence 46788899999999999999986 689999999876432 3345789999999999999999999999999999999999
Q ss_pred cCCCCHHHHhccCCCCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEecCCCCeEEeeeeeecccccCCCC
Q 002158 703 VPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSRLAPVLDDE 782 (958)
Q Consensus 703 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~ 782 (958)
|++|+|.+++.... .+++.++..++.|+++||+|||+++ |+||||||+|||+++++.+||+|||+|+.......
T Consensus 85 ~~gg~L~~~l~~~~--~l~e~~~~~i~~qi~~al~ylH~~~---IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~~- 158 (271)
T d1nvra_ 85 CSGGELFDRIEPDI--GMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNR- 158 (271)
T ss_dssp CTTEEGGGGSBTTT--BCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCEECEETTE-
T ss_pred cCCCcHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHHcC---CccCcccHHHEEECCCCCEEEccchhheeeccCCc-
Confidence 99999999997543 4999999999999999999999999 99999999999999999999999999987643221
Q ss_pred CCccceeeeeccCCCCccChhhhccCCC-CCcchhhhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcCcchhhhcccCC
Q 002158 783 GTMPTHVSTIVKGTPGYLDPEYFLTHKL-TDKSDVYSLGVVLLELLTGMQPISHGKNIVREVNVARDSGMVFSIIDNRMG 861 (958)
Q Consensus 783 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DV~S~Gv~l~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~i~~~~~ 861 (958)
........||+.|||||++.+..+ +.++||||+||++|||++|+.||................... .
T Consensus 159 ----~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~~~~~~~~~--------~ 226 (271)
T d1nvra_ 159 ----ERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTY--------L 226 (271)
T ss_dssp ----ECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHHHHHTTCTT--------S
T ss_pred ----cccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCC--------C
Confidence 122345679999999999988876 568999999999999999999997654333322222211111 1
Q ss_pred CCChHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 002158 862 SYPSECVERFVTLALRCCHDKPEHRPSMSDVVR 894 (958)
Q Consensus 862 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 894 (958)
.....++.++.+++.+||+.||++|||++|+++
T Consensus 227 ~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~ 259 (271)
T d1nvra_ 227 NPWKKIDSAPLALLHKILVENPSARITIPDIKK 259 (271)
T ss_dssp TTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred CccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 112345678889999999999999999999975
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.6e-49 Score=426.16 Aligned_cols=250 Identities=23% Similarity=0.369 Sum_probs=212.5
Q ss_pred cCCCCCceeeeeCCeEEEEEEEC-CCcEEEEEEeccCChhcHHHHHHHHHHHHccCCCCcceEEEEEEeCCeEEEEEEec
Q 002158 625 AYFSSSTQVGQGGYGKVYKGILS-DNTTVAIKRAEEGSLQGQNEFLTEIKLLSRLHHRNLVSLLGYCDEEGEQMLVYEFV 703 (958)
Q Consensus 625 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E~~ 703 (958)
++|+..+.||+|+||+||+|++. +|+.||||++........+.+.+|++++++++|||||++++++.+++..|+|||||
T Consensus 20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy~ 99 (293)
T d1yhwa1 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL 99 (293)
T ss_dssp TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEEec
Confidence 46889999999999999999975 69999999987655555678999999999999999999999999999999999999
Q ss_pred CCCCHHHHhccCCCCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEecCCCCeEEeeeeeecccccCCCCC
Q 002158 704 PNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSRLAPVLDDEG 783 (958)
Q Consensus 704 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 783 (958)
++|+|.+++... .+++.++..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+|+......
T Consensus 100 ~gg~L~~~~~~~---~l~~~~~~~i~~qi~~aL~yLH~~~---iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~--- 170 (293)
T d1yhwa1 100 AGGSLTDVVTET---CMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ--- 170 (293)
T ss_dssp TTCBHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSTT---
T ss_pred CCCcHHHHhhcc---CCCHHHHHHHHHHHHHHHHHHHHCC---CcccCCcHHHeEECCCCcEeeccchhheeecccc---
Confidence 999999998754 3899999999999999999999999 9999999999999999999999999998653221
Q ss_pred CccceeeeeccCCCCccChhhhccCCCCCcchhhhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcCcchhhhcccCCCC
Q 002158 784 TMPTHVSTIVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVLLELLTGMQPISHGKNIVREVNVARDSGMVFSIIDNRMGSY 863 (958)
Q Consensus 784 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gv~l~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~ 863 (958)
.......||+.|+|||++.+..++.++||||+||++|||+||+.||.+................ ....
T Consensus 171 ----~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~~--------~~~~ 238 (293)
T d1yhwa1 171 ----SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTP--------ELQN 238 (293)
T ss_dssp ----CCBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSC--------CCSS
T ss_pred ----ccccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCC--------CCCC
Confidence 1223457999999999999999999999999999999999999999765543332222111110 1123
Q ss_pred ChHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 002158 864 PSECVERFVTLALRCCHDKPEHRPSMSDVVRE 895 (958)
Q Consensus 864 ~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 895 (958)
+..++..+.+++.+||+.||++|||++|++++
T Consensus 239 ~~~~s~~~~~li~~~L~~dP~~R~s~~eil~H 270 (293)
T d1yhwa1 239 PEKLSAIFRDFLNRCLDMDVEKRGSAKELLQH 270 (293)
T ss_dssp GGGSCHHHHHHHHHHTCSSTTTSCCHHHHTTC
T ss_pred cccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 45667889999999999999999999999864
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.3e-49 Score=420.27 Aligned_cols=246 Identities=28% Similarity=0.416 Sum_probs=209.4
Q ss_pred cCCCCCceeeeeCCeEEEEEEEC-CCcEEEEEEeccCC---hhcHHHHHHHHHHHHccCCCCcceEEEEEEeCCeEEEEE
Q 002158 625 AYFSSSTQVGQGGYGKVYKGILS-DNTTVAIKRAEEGS---LQGQNEFLTEIKLLSRLHHRNLVSLLGYCDEEGEQMLVY 700 (958)
Q Consensus 625 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~ 700 (958)
++|+..+.||+|+||+||+|+++ +++.||||++.... ....+.+.+|++++++++|||||++++++.+++..++||
T Consensus 6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivm 85 (263)
T d2j4za1 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLIL 85 (263)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEEE
Confidence 35788899999999999999986 68999999986432 233567899999999999999999999999999999999
Q ss_pred EecCCCCHHHHhccCCCCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEecCCCCeEEeeeeeecccccCC
Q 002158 701 EFVPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSRLAPVLD 780 (958)
Q Consensus 701 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~ 780 (958)
|||++|+|.+++.... .+++.++..++.|+++||+|||+++ |+||||||+|||++.++.+||+|||+|+....
T Consensus 86 Ey~~~g~L~~~l~~~~--~l~e~~~~~i~~qi~~al~~lH~~~---ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~-- 158 (263)
T d2j4za1 86 EYAPLGTVYRELQKLS--KFDEQRTATYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAPS-- 158 (263)
T ss_dssp ECCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCSCSCCCC--
T ss_pred eecCCCcHHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHHHCC---eeeeeeccccceecCCCCEeecccceeeecCC--
Confidence 9999999999997543 4999999999999999999999999 99999999999999999999999999975431
Q ss_pred CCCCccceeeeeccCCCCccChhhhccCCCCCcchhhhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcCcchhhhcccC
Q 002158 781 DEGTMPTHVSTIVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVLLELLTGMQPISHGKNIVREVNVARDSGMVFSIIDNRM 860 (958)
Q Consensus 781 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gv~l~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~i~~~~ 860 (958)
.......||+.|||||++.+..++.++|||||||++|||++|+.||.+.... ....... ...
T Consensus 159 -------~~~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~-~~~~~i~----------~~~ 220 (263)
T d2j4za1 159 -------SRRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQ-ETYKRIS----------RVE 220 (263)
T ss_dssp -------CCCEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHH-HHHHHHH----------TTC
T ss_pred -------CcccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCHH-HHHHHHH----------cCC
Confidence 1123467999999999999999999999999999999999999999754332 2222111 111
Q ss_pred CCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 002158 861 GSYPSECVERFVTLALRCCHDKPEHRPSMSDVVRE 895 (958)
Q Consensus 861 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 895 (958)
..+|..+++++.+++.+||+.||++|||++|++++
T Consensus 221 ~~~p~~~s~~~~~li~~~L~~dp~~R~t~~eil~h 255 (263)
T d2j4za1 221 FTFPDFVTEGARDLISRLLKHNPSQRPMLREVLEH 255 (263)
T ss_dssp CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTC
T ss_pred CCCCccCCHHHHHHHHHHccCCHhHCcCHHHHHcC
Confidence 23455677889999999999999999999999874
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.2e-49 Score=416.24 Aligned_cols=253 Identities=27% Similarity=0.440 Sum_probs=215.2
Q ss_pred cCCCCCceeeeeCCeEEEEEEECCCcEEEEEEeccCChhcHHHHHHHHHHHHccCCCCcceEEEEEEeCCeEEEEEEecC
Q 002158 625 AYFSSSTQVGQGGYGKVYKGILSDNTTVAIKRAEEGSLQGQNEFLTEIKLLSRLHHRNLVSLLGYCDEEGEQMLVYEFVP 704 (958)
Q Consensus 625 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E~~~ 704 (958)
++|+..++||+|+||+||+|++++++.||||+++... ...++|.+|++++++++||||++++|+|.+++..++||||++
T Consensus 4 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~-~~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~~ 82 (258)
T d1k2pa_ 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMA 82 (258)
T ss_dssp CCCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESSS-SCHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEECCT
T ss_pred HHCEEeEEEecCCCeEEEEEEECCCCEEEEEEECcCc-CCHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEccC
Confidence 5788899999999999999999989999999998643 345689999999999999999999999999999999999999
Q ss_pred CCCHHHHhccCCCCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEecCCCCeEEeeeeeecccccCCCCCC
Q 002158 705 NGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSRLAPVLDDEGT 784 (958)
Q Consensus 705 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 784 (958)
+|+|.+++.... ..+++..+.+++.|+|+||+|||+.+ |+||||||+|||+++++.+||+|||+++.......
T Consensus 83 ~g~l~~~~~~~~-~~~~~~~~~~i~~qi~~gl~~LH~~~---iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~--- 155 (258)
T d1k2pa_ 83 NGCLLNYLREMR-HRFQTQQLLEMCKDVCEAMEYLESKQ---FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEY--- 155 (258)
T ss_dssp TEEHHHHHHSGG-GCCCHHHHHHHHHHHHHHHHHHHHTT---BCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSC---
T ss_pred CCcHHHhhhccc-cCCcHHHHHHHHHHHHHHHHHHhhcC---cccccccceeEEEcCCCcEEECcchhheeccCCCc---
Confidence 999999986543 34889999999999999999999999 99999999999999999999999999986543221
Q ss_pred ccceeeeeccCCCCccChhhhccCCCCCcchhhhHHHHHHHHHh-CCCCCCCCchhHHHHHHHhhcCcchhhhcccCCCC
Q 002158 785 MPTHVSTIVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVLLELLT-GMQPISHGKNIVREVNVARDSGMVFSIIDNRMGSY 863 (958)
Q Consensus 785 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gv~l~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~ 863 (958)
.......||+.|+|||++.+..++.++|||||||++|||+| |+.||...... +...... .......
T Consensus 156 ---~~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~-~~~~~i~---------~~~~~~~ 222 (258)
T d1k2pa_ 156 ---TSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNS-ETAEHIA---------QGLRLYR 222 (258)
T ss_dssp ---CCCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHH-HHHHHHH---------TTCCCCC
T ss_pred ---eeecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHH-HHHHHHH---------hCCCCCC
Confidence 12234569999999999999999999999999999999998 89999755432 2221111 1122334
Q ss_pred ChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 002158 864 PSECVERFVTLALRCCHDKPEHRPSMSDVVRELEN 898 (958)
Q Consensus 864 ~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 898 (958)
|..+++++.+++.+||+.||++|||++|++++|.+
T Consensus 223 p~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~d 257 (258)
T d1k2pa_ 223 PHLASEKVYTIMYSCWHEKADERPTFKILLSNILD 257 (258)
T ss_dssp CTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHC
T ss_pred cccccHHHHHHHHHHccCCHhHCcCHHHHHHHhhC
Confidence 56677899999999999999999999999999865
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-48 Score=422.57 Aligned_cols=261 Identities=28% Similarity=0.454 Sum_probs=209.2
Q ss_pred cCCCCCceeeeeCCeEEEEEEECCC-----cEEEEEEeccC-ChhcHHHHHHHHHHHHccCCCCcceEEEEEEeCCeEEE
Q 002158 625 AYFSSSTQVGQGGYGKVYKGILSDN-----TTVAIKRAEEG-SLQGQNEFLTEIKLLSRLHHRNLVSLLGYCDEEGEQML 698 (958)
Q Consensus 625 ~~~~~~~~lg~G~~g~Vy~~~~~~~-----~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~l 698 (958)
+.|+..++||+|+||+||+|.+++. ..||||++... ......+|.+|++++++++|||||+++|++.+.+..++
T Consensus 7 ~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~~ 86 (283)
T d1mqba_ 7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMI 86 (283)
T ss_dssp TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCceEE
Confidence 3566778999999999999997632 47999999764 33445679999999999999999999999999999999
Q ss_pred EEEecCCCCHHHHhccCCCCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEecCCCCeEEeeeeeeccccc
Q 002158 699 VYEFVPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSRLAPV 778 (958)
Q Consensus 699 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~~~~ 778 (958)
||||+.++++.+++.... ..+++.++++++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+|+....
T Consensus 87 v~e~~~~~~l~~~~~~~~-~~~~~~~~~~i~~~i~~gl~~lH~~~---iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~ 162 (283)
T d1mqba_ 87 ITEYMENGALDKFLREKD-GEFSVLQLVGMLRGIAAGMKYLANMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVLED 162 (283)
T ss_dssp EEECCTTEEHHHHHHHTT-TCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC------
T ss_pred EEEecccCcchhhhhccc-ccccHHHHHHHHHHHHHhhhhccccc---cccCccccceEEECCCCeEEEcccchhhcccC
Confidence 999999999999887543 35999999999999999999999999 99999999999999999999999999987643
Q ss_pred CCCCCCccceeeeeccCCCCccChhhhccCCCCCcchhhhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcCcchhhhcc
Q 002158 779 LDDEGTMPTHVSTIVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVLLELLTGMQPISHGKNIVREVNVARDSGMVFSIIDN 858 (958)
Q Consensus 779 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gv~l~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~i~~ 858 (958)
.... ........||+.|||||++.+..++.++|||||||++|||++|..|+.......+...... +.
T Consensus 163 ~~~~----~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~~~~~~~i~---------~~ 229 (283)
T d1mqba_ 163 DPEA----TYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAIN---------DG 229 (283)
T ss_dssp ---------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHH---------TT
T ss_pred CCcc----ceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCCHHHHHHHHh---------cc
Confidence 2211 2223345689999999999999999999999999999999997676655444333332221 12
Q ss_pred cCCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHhh
Q 002158 859 RMGSYPSECVERFVTLALRCCHDKPEHRPSMSDVVRELENILKM 902 (958)
Q Consensus 859 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~ 902 (958)
.....+..++..+.+|+.+||+.||++||+|+||++.|+++++.
T Consensus 230 ~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l~~~ 273 (283)
T d1mqba_ 230 FRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRA 273 (283)
T ss_dssp CCCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred CCCCCchhhHHHHHHHHHHHCcCCHhHCcCHHHHHHHHHHHhhC
Confidence 22345667788999999999999999999999999999998764
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.4e-49 Score=424.42 Aligned_cols=257 Identities=27% Similarity=0.435 Sum_probs=211.7
Q ss_pred CCCCCc-eeeeeCCeEEEEEEEC---CCcEEEEEEeccC-ChhcHHHHHHHHHHHHccCCCCcceEEEEEEeCCeEEEEE
Q 002158 626 YFSSST-QVGQGGYGKVYKGILS---DNTTVAIKRAEEG-SLQGQNEFLTEIKLLSRLHHRNLVSLLGYCDEEGEQMLVY 700 (958)
Q Consensus 626 ~~~~~~-~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~ 700 (958)
+|...+ +||+|+||+||+|.++ ++..||||+++.. .....++|.+|+++|++++|||||+++|+|.. +..++||
T Consensus 9 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~~lvm 87 (285)
T d1u59a_ 9 NLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVM 87 (285)
T ss_dssp GEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEE
T ss_pred CeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-CeEEEEE
Confidence 444445 4999999999999874 3557999999765 34456789999999999999999999999975 4689999
Q ss_pred EecCCCCHHHHhccCCCCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEecCCCCeEEeeeeeecccccCC
Q 002158 701 EFVPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSRLAPVLD 780 (958)
Q Consensus 701 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~ 780 (958)
|||++|+|.+++.... ..+++.++.+++.|+|+||+|||+++ |+||||||+|||++.++.+||+|||+|+......
T Consensus 88 E~~~~g~L~~~l~~~~-~~l~~~~~~~i~~qi~~gL~ylH~~~---iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~ 163 (285)
T d1u59a_ 88 EMAGGGPLHKFLVGKR-EEIPVSNVAELLHQVSMGMKYLEEKN---FVHRDLAARNVLLVNRHYAKISDFGLSKALGADD 163 (285)
T ss_dssp ECCTTEEHHHHHTTCT-TTSCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEEETTEEEECCCTTCEECTTCS
T ss_pred EeCCCCcHHHHhhccc-cCCCHHHHHHHHHHHHHHHHHHHhCC---eecCcCchhheeeccCCceeeccchhhhcccccc
Confidence 9999999999986443 35999999999999999999999999 9999999999999999999999999998764322
Q ss_pred CCCCccceeeeeccCCCCccChhhhccCCCCCcchhhhHHHHHHHHHh-CCCCCCCCchhHHHHHHHhhcCcchhhhccc
Q 002158 781 DEGTMPTHVSTIVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVLLELLT-GMQPISHGKNIVREVNVARDSGMVFSIIDNR 859 (958)
Q Consensus 781 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gv~l~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~i~~~ 859 (958)
.. ........||+.|+|||++.+..++.++|||||||++|||+| |+.||.+.... +..... ....
T Consensus 164 ~~----~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~-~~~~~i---------~~~~ 229 (285)
T d1u59a_ 164 SY----YTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGP-EVMAFI---------EQGK 229 (285)
T ss_dssp CE----ECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTH-HHHHHH---------HTTC
T ss_pred cc----cccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCHH-HHHHHH---------HcCC
Confidence 11 122234568999999999999999999999999999999998 99999765432 111111 1122
Q ss_pred CCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHh
Q 002158 860 MGSYPSECVERFVTLALRCCHDKPEHRPSMSDVVRELENILK 901 (958)
Q Consensus 860 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~ 901 (958)
....|..+++++.+|+.+||+.||++||++.+|++.|+....
T Consensus 230 ~~~~p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~~ 271 (285)
T d1u59a_ 230 RMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYY 271 (285)
T ss_dssp CCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCCCCCcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence 334567788999999999999999999999999999988664
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.7e-49 Score=424.21 Aligned_cols=252 Identities=25% Similarity=0.382 Sum_probs=210.5
Q ss_pred cCCCCCceeeeeCCeEEEEEEEC-CCcEEEEEEeccCChhcHHHHHHHHHHHHccCCCCcceEEEEEEeCCeEEEEEEec
Q 002158 625 AYFSSSTQVGQGGYGKVYKGILS-DNTTVAIKRAEEGSLQGQNEFLTEIKLLSRLHHRNLVSLLGYCDEEGEQMLVYEFV 703 (958)
Q Consensus 625 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E~~ 703 (958)
+.|+..+.||+|+||+||+|++. +++.||||++........+.|.+|++++++++|||||++++++.+++..++|||||
T Consensus 12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy~ 91 (288)
T d2jfla1 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFC 91 (288)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEecC
Confidence 45788899999999999999986 68999999998766666778999999999999999999999999999999999999
Q ss_pred CCCCHHHHhccCCCCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEecCCCCeEEeeeeeecccccCCCCC
Q 002158 704 PNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSRLAPVLDDEG 783 (958)
Q Consensus 704 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 783 (958)
++|+|.+++.... ..+++.++..++.|+++||+|||+++ |+||||||+|||++.++.+||+|||+|+.....
T Consensus 92 ~~g~L~~~~~~~~-~~l~e~~~~~i~~qi~~gL~ylH~~~---ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~---- 163 (288)
T d2jfla1 92 AGGAVDAVMLELE-RPLTESQIQVVCKQTLDALNYLHDNK---IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRT---- 163 (288)
T ss_dssp TTEEHHHHHHHHT-SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECHHH----
T ss_pred CCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCC---EEEeecChhheeECCCCCEEEEechhhhccCCC----
Confidence 9999999986543 34999999999999999999999999 999999999999999999999999999754221
Q ss_pred CccceeeeeccCCCCccChhhhc-----cCCCCCcchhhhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcCcchhhhcc
Q 002158 784 TMPTHVSTIVKGTPGYLDPEYFL-----THKLTDKSDVYSLGVVLLELLTGMQPISHGKNIVREVNVARDSGMVFSIIDN 858 (958)
Q Consensus 784 ~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DV~S~Gv~l~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~i~~ 858 (958)
........||+.|||||++. ...|+.++|||||||++|||+||+.||.+...............
T Consensus 164 ---~~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~~~~i~~~~~-------- 232 (288)
T d2jfla1 164 ---IQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEP-------- 232 (288)
T ss_dssp ---HHHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHHSCC--------
T ss_pred ---cccccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCC--------
Confidence 11123457999999999984 45688999999999999999999999976544332222111110
Q ss_pred cCCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 002158 859 RMGSYPSECVERFVTLALRCCHDKPEHRPSMSDVVRE 895 (958)
Q Consensus 859 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 895 (958)
.....+..++.++.+++.+||+.||++|||++|++++
T Consensus 233 ~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~h 269 (288)
T d2jfla1 233 PTLAQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQH 269 (288)
T ss_dssp CCCSSGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred CCCCccccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 0112345667889999999999999999999999863
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.4e-49 Score=419.29 Aligned_cols=254 Identities=25% Similarity=0.397 Sum_probs=199.1
Q ss_pred cCCCCCceeeeeCCeEEEEEEEC-CCcEEEEEEeccCC--hhcHHHHHHHHHHHHccCCCCcceEEEEEEe--CCeEEEE
Q 002158 625 AYFSSSTQVGQGGYGKVYKGILS-DNTTVAIKRAEEGS--LQGQNEFLTEIKLLSRLHHRNLVSLLGYCDE--EGEQMLV 699 (958)
Q Consensus 625 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~--~~~~~lV 699 (958)
++|+..+.||+|+||+||+|+++ +|+.||||++.... ....+.|.+|++++++++|||||++++++.+ .+..|+|
T Consensus 4 edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~iv 83 (269)
T d2java1 4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIV 83 (269)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEE
T ss_pred hhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEEE
Confidence 46888899999999999999986 68999999987653 3345679999999999999999999999865 4568999
Q ss_pred EEecCCCCHHHHhccC--CCCCchHHHHHHHHHHHHHHHHHhhhcC--CCCeeccCCCccceEecCCCCeEEeeeeeecc
Q 002158 700 YEFVPNGTLRDWLSGR--TKENLNFAMRLRVALDSAKGILYLHTEA--HPPVFHRDIKASNILLDSNLNAKVADFGLSRL 775 (958)
Q Consensus 700 ~E~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~~ia~aL~yLH~~~--~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~ 775 (958)
||||++|+|.+++... ....+++.+++.++.|++.||+|||+++ ..+|+||||||+|||++.++.+||+|||+|+.
T Consensus 84 mEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~~ 163 (269)
T d2java1 84 MEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARI 163 (269)
T ss_dssp EECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHHH
T ss_pred EecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccceee
Confidence 9999999999999643 2345999999999999999999999875 23599999999999999999999999999987
Q ss_pred cccCCCCCCccceeeeeccCCCCccChhhhccCCCCCcchhhhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcCcchhh
Q 002158 776 APVLDDEGTMPTHVSTIVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVLLELLTGMQPISHGKNIVREVNVARDSGMVFSI 855 (958)
Q Consensus 776 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gv~l~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~ 855 (958)
..... .......||+.|||||++.+..++.++|||||||++|||+||+.||...... +.....
T Consensus 164 ~~~~~-------~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~-~~~~~i--------- 226 (269)
T d2java1 164 LNHDT-------SFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQK-ELAGKI--------- 226 (269)
T ss_dssp C------------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHH-HHHHHH---------
T ss_pred cccCC-------CccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCHH-HHHHHH---------
Confidence 53211 1223467999999999999999999999999999999999999999754332 211111
Q ss_pred hcccCCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 002158 856 IDNRMGSYPSECVERFVTLALRCCHDKPEHRPSMSDVVRE 895 (958)
Q Consensus 856 i~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 895 (958)
........+..+++++.+++.+||+.||++|||++|++++
T Consensus 227 ~~~~~~~~~~~~s~~l~~li~~~L~~dp~~Rps~~ell~h 266 (269)
T d2java1 227 REGKFRRIPYRYSDELNEIITRMLNLKDYHRPSVEEILEN 266 (269)
T ss_dssp HHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred HcCCCCCCCcccCHHHHHHHHHHcCCChhHCcCHHHHHhC
Confidence 1122233455677889999999999999999999999863
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.2e-48 Score=416.47 Aligned_cols=250 Identities=27% Similarity=0.419 Sum_probs=204.4
Q ss_pred ceeeeeCCeEEEEEEECC---CcEEEEEEeccCC--hhcHHHHHHHHHHHHccCCCCcceEEEEEEeCCeEEEEEEecCC
Q 002158 631 TQVGQGGYGKVYKGILSD---NTTVAIKRAEEGS--LQGQNEFLTEIKLLSRLHHRNLVSLLGYCDEEGEQMLVYEFVPN 705 (958)
Q Consensus 631 ~~lg~G~~g~Vy~~~~~~---~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E~~~~ 705 (958)
++||+|+||+||+|.+++ ++.||||+++... ....++|.+|++++++++|||||+++|+|.. +..++||||+++
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~lvmE~~~~ 91 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL 91 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc-CCEEEEEEcCCC
Confidence 479999999999998743 5689999986542 3335679999999999999999999999965 467899999999
Q ss_pred CCHHHHhccCCCCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEecCCCCeEEeeeeeecccccCCCCCCc
Q 002158 706 GTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSRLAPVLDDEGTM 785 (958)
Q Consensus 706 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~ 785 (958)
|+|.++++... .+++.++++++.|||+||+|||+++ |+||||||+|||++.++.+||+|||+|+.......
T Consensus 92 g~L~~~l~~~~--~l~~~~~~~i~~qi~~gl~ylH~~~---iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~---- 162 (277)
T d1xbba_ 92 GPLNKYLQQNR--HVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADEN---- 162 (277)
T ss_dssp EEHHHHHHHCT--TCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCEECCTTCS----
T ss_pred CcHHHHHhhcc--CCCHHHHHHHHHHHHHHHhhHHhCC---cccCCCcchhhcccccCcccccchhhhhhcccccc----
Confidence 99999997654 4999999999999999999999999 99999999999999999999999999986533221
Q ss_pred cceeeeeccCCCCccChhhhccCCCCCcchhhhHHHHHHHHHh-CCCCCCCCchhHHHHHHHhhcCcchhhhcccCCCCC
Q 002158 786 PTHVSTIVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVLLELLT-GMQPISHGKNIVREVNVARDSGMVFSIIDNRMGSYP 864 (958)
Q Consensus 786 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gv~l~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~ 864 (958)
.........||++|||||++.+..++.++|||||||++|||+| |+.||.+.... +...... .......|
T Consensus 163 ~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~-~~~~~i~---------~~~~~~~p 232 (277)
T d1xbba_ 163 YYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGS-EVTAMLE---------KGERMGCP 232 (277)
T ss_dssp EEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHH-HHHHHHH---------TTCCCCCC
T ss_pred ccccccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCHH-HHHHHHH---------cCCCCCCC
Confidence 1222334579999999999999999999999999999999998 89999764432 2111111 12223456
Q ss_pred hHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhH
Q 002158 865 SECVERFVTLALRCCHDKPEHRPSMSDVVRELENIL 900 (958)
Q Consensus 865 ~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~ 900 (958)
..++.++.+|+.+||+.||++|||+++|++.|+...
T Consensus 233 ~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~~~ 268 (277)
T d1xbba_ 233 AGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYY 268 (277)
T ss_dssp TTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHH
T ss_pred cccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhCHH
Confidence 677889999999999999999999999999888754
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-48 Score=419.31 Aligned_cols=257 Identities=31% Similarity=0.466 Sum_probs=211.8
Q ss_pred cCCCCCceeeeeCCeEEEEEEECCCcEEEEEEeccCChhcHHHHHHHHHHHHccCCCCcceEEEEEEeCCeEEEEEEecC
Q 002158 625 AYFSSSTQVGQGGYGKVYKGILSDNTTVAIKRAEEGSLQGQNEFLTEIKLLSRLHHRNLVSLLGYCDEEGEQMLVYEFVP 704 (958)
Q Consensus 625 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E~~~ 704 (958)
++|+..+.||+|+||+||+|++++++.||||+++.. ....+.|.+|+.++++++|||||+++|+|.+ +..++||||++
T Consensus 17 ~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~-~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~-~~~~lv~Ey~~ 94 (285)
T d1fmka3 17 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPG-TMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMS 94 (285)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTT-SSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCCT
T ss_pred HHEEEeeEEeeCCCeEEEEEEECCCCEEEEEEECcc-cCCHHHHHHHHHHHHhcccCCEeEEEEEEec-CCeEEEEEecC
Confidence 568888999999999999999998889999999754 3445789999999999999999999999854 56899999999
Q ss_pred CCCHHHHhccCCCCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEecCCCCeEEeeeeeecccccCCCCCC
Q 002158 705 NGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSRLAPVLDDEGT 784 (958)
Q Consensus 705 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 784 (958)
+|+|.+++.......+++.+++.++.|||+||+|||+.+ |+||||||+|||+|.++.+||+|||+|+......
T Consensus 95 ~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~---ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~---- 167 (285)
T d1fmka3 95 KGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNE---- 167 (285)
T ss_dssp TCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCTTC----------
T ss_pred CCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhhhh---eecccccceEEEECCCCcEEEcccchhhhccCCC----
Confidence 999999998665556999999999999999999999999 9999999999999999999999999998653211
Q ss_pred ccceeeeeccCCCCccChhhhccCCCCCcchhhhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcCcchhhhcccCCCCC
Q 002158 785 MPTHVSTIVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVLLELLTGMQPISHGKNIVREVNVARDSGMVFSIIDNRMGSYP 864 (958)
Q Consensus 785 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gv~l~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~ 864 (958)
........||+.|+|||++..+.++.++|||||||++|||++|..|+.......+....... ......+
T Consensus 168 --~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~~~~~~i~~---------~~~~~~~ 236 (285)
T d1fmka3 168 --YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVER---------GYRMPCP 236 (285)
T ss_dssp ----------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHT---------TCCCCCC
T ss_pred --ceeeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHh---------cCCCCCC
Confidence 11223456999999999999999999999999999999999977776655544433332221 1122346
Q ss_pred hHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHh
Q 002158 865 SECVERFVTLALRCCHDKPEHRPSMSDVVRELENILK 901 (958)
Q Consensus 865 ~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~ 901 (958)
..+++++.+++.+||+.||++||++++|++.|++...
T Consensus 237 ~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~ 273 (285)
T d1fmka3 237 PECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFT 273 (285)
T ss_dssp TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTS
T ss_pred cccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhhc
Confidence 6778899999999999999999999999998888654
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.2e-48 Score=413.37 Aligned_cols=247 Identities=25% Similarity=0.456 Sum_probs=200.8
Q ss_pred CCCceeeeeCCeEEEEEEEC-CCcEEEEEEeccC--ChhcHHHHHHHHHHHHccCCCCcceEEEEEEe----CCeEEEEE
Q 002158 628 SSSTQVGQGGYGKVYKGILS-DNTTVAIKRAEEG--SLQGQNEFLTEIKLLSRLHHRNLVSLLGYCDE----EGEQMLVY 700 (958)
Q Consensus 628 ~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~----~~~~~lV~ 700 (958)
...+.||+|+||+||+|++. +++.||+|++... .....+.|.+|++++++++|||||++++++.+ +...++||
T Consensus 12 ~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~ivm 91 (270)
T d1t4ha_ 12 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT 91 (270)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEE
T ss_pred EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEEE
Confidence 34457999999999999986 6889999998653 34445679999999999999999999999865 34679999
Q ss_pred EecCCCCHHHHhccCCCCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEec-CCCCeEEeeeeeecccccC
Q 002158 701 EFVPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLD-SNLNAKVADFGLSRLAPVL 779 (958)
Q Consensus 701 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~-~~~~~kl~DFGla~~~~~~ 779 (958)
||+++|+|.+++.... .+++.++..++.|+++||+|||+++ ++|+||||||+|||++ +++.+||+|||+|+....
T Consensus 92 E~~~~g~L~~~l~~~~--~~~~~~~~~~~~qi~~gl~yLH~~~-~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~~- 167 (270)
T d1t4ha_ 92 ELMTSGTLKTYLKRFK--VMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA- 167 (270)
T ss_dssp ECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCT-
T ss_pred eCCCCCcHHHHHhccc--cccHHHHHHHHHHHHHHHHHHHHCC-CCEEeCCcChhhceeeCCCCCEEEeecCcceeccC-
Confidence 9999999999997543 4899999999999999999999875 5699999999999996 578999999999985321
Q ss_pred CCCCCccceeeeeccCCCCccChhhhccCCCCCcchhhhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcCcchhhhccc
Q 002158 780 DDEGTMPTHVSTIVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVLLELLTGMQPISHGKNIVREVNVARDSGMVFSIIDNR 859 (958)
Q Consensus 780 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gv~l~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~i~~~ 859 (958)
.......||+.|||||++.+ .++.++|||||||++|||++|+.||.+..+..............
T Consensus 168 --------~~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~~~~~i~~~~~~------- 231 (270)
T d1t4ha_ 168 --------SFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKP------- 231 (270)
T ss_dssp --------TSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCC-------
T ss_pred --------CccCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCcccHHHHHHHHHcCCCC-------
Confidence 12235679999999998865 69999999999999999999999997655444433322221111
Q ss_pred CCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 002158 860 MGSYPSECVERFVTLALRCCHDKPEHRPSMSDVVRE 895 (958)
Q Consensus 860 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 895 (958)
...+...++++.+++.+||+.||++|||++|++++
T Consensus 232 -~~~~~~~~~~~~~li~~~l~~dp~~R~s~~ell~H 266 (270)
T d1t4ha_ 232 -ASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNH 266 (270)
T ss_dssp -GGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred -cccCccCCHHHHHHHHHHccCCHhHCcCHHHHhCC
Confidence 11223345678999999999999999999999864
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.6e-48 Score=425.76 Aligned_cols=258 Identities=26% Similarity=0.415 Sum_probs=210.3
Q ss_pred HcCCCCCceeeeeCCeEEEEEEECC-C-----cEEEEEEeccC-ChhcHHHHHHHHHHHHcc-CCCCcceEEEEEEeCCe
Q 002158 624 TAYFSSSTQVGQGGYGKVYKGILSD-N-----TTVAIKRAEEG-SLQGQNEFLTEIKLLSRL-HHRNLVSLLGYCDEEGE 695 (958)
Q Consensus 624 ~~~~~~~~~lg~G~~g~Vy~~~~~~-~-----~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~ 695 (958)
.++|+..+.||+|+||+||+|++.. + ..||||++... .......|.+|+.+++++ +|||||++++++.+.+.
T Consensus 36 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~ 115 (325)
T d1rjba_ 36 RENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGP 115 (325)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred HHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCCe
Confidence 3577888999999999999999753 2 36999998654 333446799999999998 89999999999999999
Q ss_pred EEEEEEecCCCCHHHHhccCCC---------------------CCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCc
Q 002158 696 QMLVYEFVPNGTLRDWLSGRTK---------------------ENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKA 754 (958)
Q Consensus 696 ~~lV~E~~~~gsL~~~l~~~~~---------------------~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp 754 (958)
.++|||||++|+|.++|+.+.. ..+++.+++.++.|+++||+|||+++ ||||||||
T Consensus 116 ~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~---IiHRDlKp 192 (325)
T d1rjba_ 116 IYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS---CVHRDLAA 192 (325)
T ss_dssp CEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT---EEETTCSG
T ss_pred EEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCch
Confidence 9999999999999999975432 34899999999999999999999999 99999999
Q ss_pred cceEecCCCCeEEeeeeeecccccCCCCCCccceeeeeccCCCCccChhhhccCCCCCcchhhhHHHHHHHHHh-CCCCC
Q 002158 755 SNILLDSNLNAKVADFGLSRLAPVLDDEGTMPTHVSTIVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVLLELLT-GMQPI 833 (958)
Q Consensus 755 ~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gv~l~ellt-G~~P~ 833 (958)
+|||++.++.+||+|||+|+....... ........||+.|||||++.+..++.++|||||||++|||+| |+.||
T Consensus 193 ~Nill~~~~~~Kl~DFGla~~~~~~~~-----~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf 267 (325)
T d1rjba_ 193 RNVLVTHGKVVKICDFGLARDIMSDSN-----YVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPY 267 (325)
T ss_dssp GGEEEETTTEEEECCCGGGSCGGGCTT-----SEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSS
T ss_pred hccccccCCeEEEeeccccccccCCCc-----eeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCC
Confidence 999999999999999999986543221 122334568999999999999999999999999999999998 89999
Q ss_pred CCCchhHHHHHHHhhcCcchhhhcccCCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHH
Q 002158 834 SHGKNIVREVNVARDSGMVFSIIDNRMGSYPSECVERFVTLALRCCHDKPEHRPSMSDVVRELEN 898 (958)
Q Consensus 834 ~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 898 (958)
.+............. + .....|..+++++.+|+.+||+.||++|||++||+++|..
T Consensus 268 ~~~~~~~~~~~~~~~-~--------~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~ 323 (325)
T d1rjba_ 268 PGIPVDANFYKLIQN-G--------FKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGC 323 (325)
T ss_dssp TTCCCSHHHHHHHHT-T--------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred CCCCHHHHHHHHHhc-C--------CCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHhC
Confidence 754432222211111 1 1124466678899999999999999999999999999864
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=7.1e-48 Score=419.99 Aligned_cols=265 Identities=27% Similarity=0.428 Sum_probs=217.8
Q ss_pred HHHHHHHcCCCCCceeeeeCCeEEEEEEEC------CCcEEEEEEeccCC-hhcHHHHHHHHHHHHccCCCCcceEEEEE
Q 002158 618 KELAMATAYFSSSTQVGQGGYGKVYKGILS------DNTTVAIKRAEEGS-LQGQNEFLTEIKLLSRLHHRNLVSLLGYC 690 (958)
Q Consensus 618 ~el~~~~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~ 690 (958)
.+++..+++|+..+.||+|+||+||+|+++ +++.||||+++... ....++|.+|++++++++||||++++++|
T Consensus 6 ~~~e~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~ 85 (301)
T d1lufa_ 6 LSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVC 85 (301)
T ss_dssp HHTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred hhccCCHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeee
Confidence 445556678999999999999999999974 35789999997653 33456799999999999999999999999
Q ss_pred EeCCeEEEEEEecCCCCHHHHhccCC----------------------CCCchHHHHHHHHHHHHHHHHHhhhcCCCCee
Q 002158 691 DEEGEQMLVYEFVPNGTLRDWLSGRT----------------------KENLNFAMRLRVALDSAKGILYLHTEAHPPVF 748 (958)
Q Consensus 691 ~~~~~~~lV~E~~~~gsL~~~l~~~~----------------------~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ii 748 (958)
...+..++||||+++|+|.++++... ...+++.+++.++.|+|.||+|||+++ ||
T Consensus 86 ~~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~---iv 162 (301)
T d1lufa_ 86 AVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK---FV 162 (301)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CC
T ss_pred ccCCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCC---eE
Confidence 99999999999999999999996432 224889999999999999999999999 99
Q ss_pred ccCCCccceEecCCCCeEEeeeeeecccccCCCCCCccceeeeeccCCCCccChhhhccCCCCCcchhhhHHHHHHHHHh
Q 002158 749 HRDIKASNILLDSNLNAKVADFGLSRLAPVLDDEGTMPTHVSTIVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVLLELLT 828 (958)
Q Consensus 749 H~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gv~l~ellt 828 (958)
||||||+|||+|.++.+||+|||+|+....... ........||+.|+|||.+.+..++.++|||||||++|||++
T Consensus 163 HrDlKp~NILld~~~~~Kl~DFGls~~~~~~~~-----~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~ 237 (301)
T d1lufa_ 163 HRDLATRNCLVGENMVVKIADFGLSRNIYSADY-----YKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFS 237 (301)
T ss_dssp CSCCSGGGEEECGGGCEEECCCSCHHHHTGGGC-----BC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHT
T ss_pred eeEEcccceEECCCCcEEEccchhheeccCCcc-----ccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHc
Confidence 999999999999999999999999986533221 222334568999999999999999999999999999999999
Q ss_pred CCC-CCCCCchhHHHHHHHhhcCcchhhhcccCCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhH
Q 002158 829 GMQ-PISHGKNIVREVNVARDSGMVFSIIDNRMGSYPSECVERFVTLALRCCHDKPEHRPSMSDVVRELENIL 900 (958)
Q Consensus 829 G~~-P~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~ 900 (958)
|.. ||.... ..+...... +......|..++.++.+|+.+||+.||++||||.||++.|+++.
T Consensus 238 ~~~~p~~~~~-~~e~~~~v~---------~~~~~~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~~L~~i~ 300 (301)
T d1lufa_ 238 YGLQPYYGMA-HEEVIYYVR---------DGNILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMC 300 (301)
T ss_dssp TTCCTTTTSC-HHHHHHHHH---------TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred cCCCCCCCCC-HHHHHHHHH---------cCCCCCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhc
Confidence 864 565433 333222221 22233446677789999999999999999999999999999875
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.8e-48 Score=417.37 Aligned_cols=250 Identities=19% Similarity=0.310 Sum_probs=207.8
Q ss_pred cCCCCCceeeeeCCeEEEEEEEC-CCcEEEEEEeccCC---hhcHHHHHHHHHHHHccCCCCcceEEEEEEeCCeEEEEE
Q 002158 625 AYFSSSTQVGQGGYGKVYKGILS-DNTTVAIKRAEEGS---LQGQNEFLTEIKLLSRLHHRNLVSLLGYCDEEGEQMLVY 700 (958)
Q Consensus 625 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~ 700 (958)
++|+..+.||+|+||+||+|++. +|+.||||++.... ....+.+.+|++++++++||||+++++++.+++..|+||
T Consensus 8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivm 87 (288)
T d1uu3a_ 8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 87 (288)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEE
T ss_pred CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEE
Confidence 46888899999999999999985 68999999986432 233467999999999999999999999999999999999
Q ss_pred EecCCCCHHHHhccCCCCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEecCCCCeEEeeeeeecccccCC
Q 002158 701 EFVPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSRLAPVLD 780 (958)
Q Consensus 701 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~ 780 (958)
|||++|+|.+++.... .+++..+..++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||+|+......
T Consensus 88 Ey~~gg~L~~~~~~~~--~l~e~~~~~~~~qi~~al~ylH~~~---iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~ 162 (288)
T d1uu3a_ 88 SYAKNGELLKYIRKIG--SFDETCTRFYTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPES 162 (288)
T ss_dssp CCCTTEEHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECC---
T ss_pred EccCCCCHHHhhhccC--CCCHHHHHHHHHHHHHHHHhhcccc---EEcCcCCccccccCCCceEEecccccceecccCC
Confidence 9999999999987654 4999999999999999999999999 9999999999999999999999999998764322
Q ss_pred CCCCccceeeeeccCCCCccChhhhccCCCCCcchhhhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcCcchhhhcccC
Q 002158 781 DEGTMPTHVSTIVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVLLELLTGMQPISHGKNIVREVNVARDSGMVFSIIDNRM 860 (958)
Q Consensus 781 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gv~l~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~i~~~~ 860 (958)
. ........||+.|||||++.+..++.++||||+||++|||++|+.||....... ...... ...
T Consensus 163 ~-----~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~-~~~~i~----------~~~ 226 (288)
T d1uu3a_ 163 K-----QARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYL-IFQKII----------KLE 226 (288)
T ss_dssp ------------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHHHH----------TTC
T ss_pred c-----ccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCHHH-HHHHHH----------cCC
Confidence 1 112234579999999999999999999999999999999999999997544322 111111 111
Q ss_pred CCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 002158 861 GSYPSECVERFVTLALRCCHDKPEHRPSMSDVVRE 895 (958)
Q Consensus 861 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 895 (958)
..+|..+++++.+++.+||+.||++|||++|++++
T Consensus 227 ~~~p~~~s~~~~~li~~~L~~dP~~R~t~~e~~~~ 261 (288)
T d1uu3a_ 227 YDFPEKFFPKARDLVEKLLVLDATKRLGCEEMEGY 261 (288)
T ss_dssp CCCCTTCCHHHHHHHHTTSCSSGGGSTTSGGGTCH
T ss_pred CCCCccCCHHHHHHHHHHccCCHhHCcCHHHHcCC
Confidence 23455667889999999999999999999998654
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=4e-48 Score=421.54 Aligned_cols=252 Identities=22% Similarity=0.352 Sum_probs=194.7
Q ss_pred HcCCCCCceeeeeCCeEEEEEEEC-CCcEEEEEEeccCCh-hcHHHHHHHHHHHHccCCCCcceEEEEEEeCCeEEEEEE
Q 002158 624 TAYFSSSTQVGQGGYGKVYKGILS-DNTTVAIKRAEEGSL-QGQNEFLTEIKLLSRLHHRNLVSLLGYCDEEGEQMLVYE 701 (958)
Q Consensus 624 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E 701 (958)
.+.|+..+.||+|+||+||+|+++ +++.||||++..... ...+.+.+|++++++++|||||++++++.+++..|+|||
T Consensus 8 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvmE 87 (307)
T d1a06a_ 8 RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQ 87 (307)
T ss_dssp GGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred ccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEe
Confidence 456888899999999999999986 689999999876432 234568899999999999999999999999999999999
Q ss_pred ecCCCCHHHHhccCCCCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEec---CCCCeEEeeeeeeccccc
Q 002158 702 FVPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLD---SNLNAKVADFGLSRLAPV 778 (958)
Q Consensus 702 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~---~~~~~kl~DFGla~~~~~ 778 (958)
||++|+|.+++.... .+++.++..++.|++.||+|||+++ |+||||||+|||+. +++.+||+|||+|+....
T Consensus 88 ~~~gg~L~~~l~~~~--~l~e~~~~~~~~qi~~al~ylH~~~---iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~~ 162 (307)
T d1a06a_ 88 LVSGGELFDRIVEKG--FYTERDASRLIFQVLDAVKYLHDLG---IVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDP 162 (307)
T ss_dssp CCCSCBHHHHHHTCS--CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSTTCCEEECCC--------
T ss_pred ccCCCcHHHhhhccc--CCCHHHHHHHHHHHHHHHHhhhhce---eeeEEecccceeecccCCCceEEEeccceeEEccC
Confidence 999999999997543 4999999999999999999999999 99999999999994 578999999999986432
Q ss_pred CCCCCCccceeeeeccCCCCccChhhhccCCCCCcchhhhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcCcchhhhcc
Q 002158 779 LDDEGTMPTHVSTIVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVLLELLTGMQPISHGKNIVREVNVARDSGMVFSIIDN 858 (958)
Q Consensus 779 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gv~l~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~i~~ 858 (958)
. .......||+.|||||++.+..++.++||||+||++|||++|+.||.+............. ...
T Consensus 163 ~--------~~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~-~~~------ 227 (307)
T d1a06a_ 163 G--------SVLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKA-EYE------ 227 (307)
T ss_dssp ------------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHTT-CCC------
T ss_pred C--------CeeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHhcc-CCC------
Confidence 1 1223457999999999999999999999999999999999999999765433222211111 100
Q ss_pred cCCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 002158 859 RMGSYPSECVERFVTLALRCCHDKPEHRPSMSDVVRE 895 (958)
Q Consensus 859 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 895 (958)
.....+..+++++.+++.+||+.||++|||++|++++
T Consensus 228 ~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 264 (307)
T d1a06a_ 228 FDSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQH 264 (307)
T ss_dssp CCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred CCCccccCCCHHHHHHHHHHccCCHhHCcCHHHHhcC
Confidence 0012234567889999999999999999999999875
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.4e-48 Score=423.10 Aligned_cols=258 Identities=23% Similarity=0.379 Sum_probs=206.9
Q ss_pred HcCCCCCceeeeeCCeEEEEEEEC-CCcEEEEEEeccCC-hhcHHHHHHHHHHHHccCCCCcceEEEEEEeCCeEEEEEE
Q 002158 624 TAYFSSSTQVGQGGYGKVYKGILS-DNTTVAIKRAEEGS-LQGQNEFLTEIKLLSRLHHRNLVSLLGYCDEEGEQMLVYE 701 (958)
Q Consensus 624 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E 701 (958)
.++|+..+.||+|+||+||+|++. +|+.||||+++... ....+++.+|++++++++|||||+++++|.+++..++|||
T Consensus 5 ~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVmE 84 (322)
T d1s9ja_ 5 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 84 (322)
T ss_dssp GGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred ccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEE
Confidence 467888999999999999999986 68999999987643 3335679999999999999999999999999999999999
Q ss_pred ecCCCCHHHHhccCCCCCchHHHHHHHHHHHHHHHHHhhhc-CCCCeeccCCCccceEecCCCCeEEeeeeeecccccCC
Q 002158 702 FVPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTE-AHPPVFHRDIKASNILLDSNLNAKVADFGLSRLAPVLD 780 (958)
Q Consensus 702 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~-~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~ 780 (958)
||++|+|.+++.+.. .+++..+..++.|++.||+|||++ + |+||||||+|||+++++.+||+|||+|+....
T Consensus 85 y~~gg~L~~~l~~~~--~l~~~~~~~~~~qil~aL~yLH~~~~---IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~-- 157 (322)
T d1s9ja_ 85 HMDGGSLDQVLKKAG--RIPEQILGKVSIAVIKGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLID-- 157 (322)
T ss_dssp CCTTEEHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHHHC---CCCSCCSGGGEEECTTCCEEECCCCCCHHHHH--
T ss_pred cCCCCcHHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHHHhCC---EEccccCHHHeeECCCCCEEEeeCCCccccCC--
Confidence 999999999997544 489999999999999999999974 8 99999999999999999999999999986532
Q ss_pred CCCCccceeeeeccCCCCccChhhhccCCCCCcchhhhHHHHHHHHHhCCCCCCCCchhHHHHHHHh-hcC---------
Q 002158 781 DEGTMPTHVSTIVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVLLELLTGMQPISHGKNIVREVNVAR-DSG--------- 850 (958)
Q Consensus 781 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gv~l~elltG~~P~~~~~~~~~~~~~~~-~~~--------- 850 (958)
.......||+.|+|||++.+..|+.++||||+||++|||++|+.||.............. ..+
T Consensus 158 -------~~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (322)
T d1s9ja_ 158 -------SMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRP 230 (322)
T ss_dssp -------HTC---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC---------------
T ss_pred -------CccccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCccc
Confidence 112346799999999999999999999999999999999999999976443211110000 000
Q ss_pred ------------------cchhhh----cccCCCCC-hHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 002158 851 ------------------MVFSII----DNRMGSYP-SECVERFVTLALRCCHDKPEHRPSMSDVVRE 895 (958)
Q Consensus 851 ------------------~~~~~i----~~~~~~~~-~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 895 (958)
...+.. ....+..+ ...+.++.+++.+||+.||++|||++|++++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~H 298 (322)
T d1s9ja_ 231 RTPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVH 298 (322)
T ss_dssp ---------------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred ccccccccccccccccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhhC
Confidence 000000 00001111 1235678999999999999999999999985
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=9.8e-48 Score=418.51 Aligned_cols=246 Identities=25% Similarity=0.405 Sum_probs=205.0
Q ss_pred cCCCCCceeeeeCCeEEEEEEEC-CCcEEEEEEeccCCh---hcHHHHHHHHHHHHccCCCCcceEEEEEEeCCeEEEEE
Q 002158 625 AYFSSSTQVGQGGYGKVYKGILS-DNTTVAIKRAEEGSL---QGQNEFLTEIKLLSRLHHRNLVSLLGYCDEEGEQMLVY 700 (958)
Q Consensus 625 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~ 700 (958)
..|+..+.||+|+||+||+|++. +++.||||++..... ...+.|.+|++++++++|||||++++++.+++..++||
T Consensus 15 ~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~ 94 (309)
T d1u5ra_ 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 94 (309)
T ss_dssp HHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred HhcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEE
Confidence 45888899999999999999975 688999999876432 23457899999999999999999999999999999999
Q ss_pred EecCCCCHHHHhccCCCCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEecCCCCeEEeeeeeecccccCC
Q 002158 701 EFVPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSRLAPVLD 780 (958)
Q Consensus 701 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~ 780 (958)
|||++|+|..++..+. .+++.++..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+|+....
T Consensus 95 E~~~~g~l~~~~~~~~--~l~e~~~~~i~~qi~~aL~yLH~~~---iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~-- 167 (309)
T d1u5ra_ 95 EYCLGSASDLLEVHKK--PLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAP-- 167 (309)
T ss_dssp ECCSEEHHHHHHHHTS--CCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTEEEECCCTTCBSSSS--
T ss_pred EecCCCchHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCC---EeccCCCcceEEECCCCCEEEeecccccccCC--
Confidence 9999999987775443 4999999999999999999999999 99999999999999999999999999985421
Q ss_pred CCCCccceeeeeccCCCCccChhhhcc---CCCCCcchhhhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcCcchhhhc
Q 002158 781 DEGTMPTHVSTIVKGTPGYLDPEYFLT---HKLTDKSDVYSLGVVLLELLTGMQPISHGKNIVREVNVARDSGMVFSIID 857 (958)
Q Consensus 781 ~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DV~S~Gv~l~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~i~ 857 (958)
.....||+.|||||++.+ ..|+.++|||||||++|||++|+.||.+..............
T Consensus 168 ---------~~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~~~~~i~~~~-------- 230 (309)
T d1u5ra_ 168 ---------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNE-------- 230 (309)
T ss_dssp ---------BCCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSC--------
T ss_pred ---------CCccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCC--------
Confidence 123569999999999964 458899999999999999999999997655433222211110
Q ss_pred ccCCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 002158 858 NRMGSYPSECVERFVTLALRCCHDKPEHRPSMSDVVRE 895 (958)
Q Consensus 858 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 895 (958)
.....+..+++.+.+++.+||+.||++|||++|++++
T Consensus 231 -~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~H 267 (309)
T d1u5ra_ 231 -SPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKH 267 (309)
T ss_dssp -CCCCSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTC
T ss_pred -CCCCCCCCCCHHHHHHHHHHCcCChhHCcCHHHHHhC
Confidence 0111233456789999999999999999999999874
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=6.1e-47 Score=419.28 Aligned_cols=252 Identities=20% Similarity=0.308 Sum_probs=211.5
Q ss_pred cCCCCCceeeeeCCeEEEEEEEC-CCcEEEEEEeccCChhcHHHHHHHHHHHHccCCCCcceEEEEEEeCCeEEEEEEec
Q 002158 625 AYFSSSTQVGQGGYGKVYKGILS-DNTTVAIKRAEEGSLQGQNEFLTEIKLLSRLHHRNLVSLLGYCDEEGEQMLVYEFV 703 (958)
Q Consensus 625 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E~~ 703 (958)
++|++.+.||+|+||+||+|++. +|+.||||++........+.+.+|++++++++|||||++++++.+++..++|||||
T Consensus 26 ~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~ 105 (350)
T d1koaa2 26 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFM 105 (350)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcC
Confidence 47888999999999999999986 68999999998777677778999999999999999999999999999999999999
Q ss_pred CCCCHHHHhccCCCCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEecC--CCCeEEeeeeeecccccCCC
Q 002158 704 PNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDS--NLNAKVADFGLSRLAPVLDD 781 (958)
Q Consensus 704 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~--~~~~kl~DFGla~~~~~~~~ 781 (958)
++|+|.+++.... ..+++.++..++.||+.||+|||+++ ||||||||+|||++. ++.+||+|||+|+....
T Consensus 106 ~gg~L~~~l~~~~-~~l~e~~~~~i~~qi~~aL~ylH~~~---iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~--- 178 (350)
T d1koaa2 106 SGGELFEKVADEH-NKMSEDEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDP--- 178 (350)
T ss_dssp CSCBHHHHHTCTT-SCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTSCCEEECCCTTCEECCT---
T ss_pred CCCCHHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhcC---CeeeeechhHeeeccCCCCeEEEeecchheeccc---
Confidence 9999999996543 34999999999999999999999999 999999999999954 67899999999986532
Q ss_pred CCCccceeeeeccCCCCccChhhhccCCCCCcchhhhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcCcchhhhcccCC
Q 002158 782 EGTMPTHVSTIVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVLLELLTGMQPISHGKNIVREVNVARDSGMVFSIIDNRMG 861 (958)
Q Consensus 782 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gv~l~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~i~~~~~ 861 (958)
........||+.|||||++.+..++.++||||+||++|||++|+.||.+... ...+.......... ..
T Consensus 179 -----~~~~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~-~~~~~~i~~~~~~~------~~ 246 (350)
T d1koaa2 179 -----KQSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGEND-DETLRNVKSCDWNM------DD 246 (350)
T ss_dssp -----TSCEEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSH-HHHHHHHHHTCCCS------CC
T ss_pred -----ccccceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCH-HHHHHHHHhCCCCC------Cc
Confidence 1223456799999999999999999999999999999999999999975433 22222221111000 01
Q ss_pred CCChHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 002158 862 SYPSECVERFVTLALRCCHDKPEHRPSMSDVVRE 895 (958)
Q Consensus 862 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 895 (958)
.....+++++.+++.+||+.||++|||++|++++
T Consensus 247 ~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~h 280 (350)
T d1koaa2 247 SAFSGISEDGKDFIRKLLLADPNTRMTIHQALEH 280 (350)
T ss_dssp GGGGGCCHHHHHHHHHHCCSSGGGSCCHHHHHHS
T ss_pred ccccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 1123456788999999999999999999999875
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-47 Score=408.04 Aligned_cols=251 Identities=29% Similarity=0.447 Sum_probs=203.4
Q ss_pred cCCCCCceeeeeCCeEEEEEEECCCcEEEEEEeccCChhcHHHHHHHHHHHHccCCCCcceEEEEEEe-CCeEEEEEEec
Q 002158 625 AYFSSSTQVGQGGYGKVYKGILSDNTTVAIKRAEEGSLQGQNEFLTEIKLLSRLHHRNLVSLLGYCDE-EGEQMLVYEFV 703 (958)
Q Consensus 625 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~-~~~~~lV~E~~ 703 (958)
++|+..+.||+|+||.||+|++ .|+.||||+++... ..+.|.+|++++++++||||++++|+|.+ .+..++||||+
T Consensus 7 ~~~~~~~~lG~G~fg~Vy~~~~-~~~~vAvK~i~~~~--~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ey~ 83 (262)
T d1byga_ 7 KELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM 83 (262)
T ss_dssp GGEEEEEEEEECSSCEEEEEEE-TTEEEEEEECCCCC----HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCC
T ss_pred HHeEEeEEEecCCCeEEEEEEE-CCeEEEEEEECcHH--HHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEEecc
Confidence 3566678899999999999998 57889999997643 34679999999999999999999999854 46689999999
Q ss_pred CCCCHHHHhccCCCCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEecCCCCeEEeeeeeecccccCCCCC
Q 002158 704 PNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSRLAPVLDDEG 783 (958)
Q Consensus 704 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 783 (958)
++|+|.+++..+....+++..+++++.|+|.||+|||+.+ |+||||||+|||++.++.+||+|||+++....
T Consensus 84 ~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~~---ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~----- 155 (262)
T d1byga_ 84 AKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASS----- 155 (262)
T ss_dssp TTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEEECCCCC-----------
T ss_pred CCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccccCc---eeccccchHhheecCCCCEeecccccceecCC-----
Confidence 9999999997655556899999999999999999999998 99999999999999999999999999985421
Q ss_pred CccceeeeeccCCCCccChhhhccCCCCCcchhhhHHHHHHHHHh-CCCCCCCCchhHHHHHHHhhcCcchhhhcccCCC
Q 002158 784 TMPTHVSTIVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVLLELLT-GMQPISHGKNIVREVNVARDSGMVFSIIDNRMGS 862 (958)
Q Consensus 784 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gv~l~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~ 862 (958)
......+|..|+|||++.+..++.++|||||||++|||+| |+.||..... .+..... .......
T Consensus 156 -----~~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~-~~~~~~i---------~~~~~~~ 220 (262)
T d1byga_ 156 -----TQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL-KDVVPRV---------EKGYKMD 220 (262)
T ss_dssp -----------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCG-GGHHHHH---------TTTCCCC
T ss_pred -----CCccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCH-HHHHHHH---------HcCCCCC
Confidence 1223458899999999999999999999999999999999 6777764332 1211111 1122344
Q ss_pred CChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHh
Q 002158 863 YPSECVERFVTLALRCCHDKPEHRPSMSDVVRELENILK 901 (958)
Q Consensus 863 ~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~ 901 (958)
.+..++.++.+++.+||+.||++|||+.+++++|+++..
T Consensus 221 ~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~L~~i~~ 259 (262)
T d1byga_ 221 APDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKT 259 (262)
T ss_dssp CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCccCCHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHh
Confidence 566777899999999999999999999999999998753
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=1e-46 Score=417.81 Aligned_cols=252 Identities=19% Similarity=0.319 Sum_probs=212.4
Q ss_pred cCCCCCceeeeeCCeEEEEEEEC-CCcEEEEEEeccCChhcHHHHHHHHHHHHccCCCCcceEEEEEEeCCeEEEEEEec
Q 002158 625 AYFSSSTQVGQGGYGKVYKGILS-DNTTVAIKRAEEGSLQGQNEFLTEIKLLSRLHHRNLVSLLGYCDEEGEQMLVYEFV 703 (958)
Q Consensus 625 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E~~ 703 (958)
++|+..+.||+|+||+||+|++. +|+.||||++......+.+.+.+|++++++++|||||++++++.+++..|+|||||
T Consensus 29 d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~ 108 (352)
T d1koba_ 29 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFL 108 (352)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEECC
T ss_pred cceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcC
Confidence 46888999999999999999985 79999999998776666778999999999999999999999999999999999999
Q ss_pred CCCCHHHHhccCCCCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEec--CCCCeEEeeeeeecccccCCC
Q 002158 704 PNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLD--SNLNAKVADFGLSRLAPVLDD 781 (958)
Q Consensus 704 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~--~~~~~kl~DFGla~~~~~~~~ 781 (958)
++|+|.+++.... ..+++.++..++.||+.||+|||+++ |+||||||+|||++ .++.+||+|||+|+....
T Consensus 109 ~gg~L~~~~~~~~-~~l~e~~~~~i~~qi~~aL~ylH~~~---iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~--- 181 (352)
T d1koba_ 109 SGGELFDRIAAED-YKMSEAEVINYMRQACEGLKHMHEHS---IVHLDIKPENIMCETKKASSVKIIDFGLATKLNP--- 181 (352)
T ss_dssp CCCBHHHHTTCTT-CCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTCCCEEECCCTTCEECCT---
T ss_pred CCChHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccccccccccccCCCeEEEeecccceecCC---
Confidence 9999999886443 35999999999999999999999999 99999999999998 578999999999987532
Q ss_pred CCCccceeeeeccCCCCccChhhhccCCCCCcchhhhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcCcchhhhcccCC
Q 002158 782 EGTMPTHVSTIVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVLLELLTGMQPISHGKNIVREVNVARDSGMVFSIIDNRMG 861 (958)
Q Consensus 782 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gv~l~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~i~~~~~ 861 (958)
........||+.|+|||++.+..++.++||||+||++|||+||+.||.+........ ........ ...
T Consensus 182 -----~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~-~i~~~~~~------~~~ 249 (352)
T d1koba_ 182 -----DEIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQ-NVKRCDWE------FDE 249 (352)
T ss_dssp -----TSCEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHH-HHHHCCCC------CCS
T ss_pred -----CCceeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHH-HHHhCCCC------CCc
Confidence 122345679999999999999999999999999999999999999997654432221 11111100 011
Q ss_pred CCChHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 002158 862 SYPSECVERFVTLALRCCHDKPEHRPSMSDVVRE 895 (958)
Q Consensus 862 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 895 (958)
.....++.++.+++.+||+.||.+|||++|++++
T Consensus 250 ~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~H 283 (352)
T d1koba_ 250 DAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEH 283 (352)
T ss_dssp STTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred ccccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 2234566788999999999999999999999875
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.8e-47 Score=407.50 Aligned_cols=258 Identities=28% Similarity=0.436 Sum_probs=203.8
Q ss_pred HcCCCCCceeeeeCCeEEEEEEECC----CcEEEEEEeccCC-hhcHHHHHHHHHHHHccCCCCcceEEEEEEeCCeEEE
Q 002158 624 TAYFSSSTQVGQGGYGKVYKGILSD----NTTVAIKRAEEGS-LQGQNEFLTEIKLLSRLHHRNLVSLLGYCDEEGEQML 698 (958)
Q Consensus 624 ~~~~~~~~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~l 698 (958)
.++|+..+.||+|+||+||+|++.. +..||||+++... ....+.|.+|++++++++||||++++|++. ++..++
T Consensus 6 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~i 84 (273)
T d1mp8a_ 6 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWI 84 (273)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEE
T ss_pred HHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCeEEE
Confidence 3567788999999999999999753 4578999987543 334567999999999999999999999996 467899
Q ss_pred EEEecCCCCHHHHhccCCCCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEecCCCCeEEeeeeeeccccc
Q 002158 699 VYEFVPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSRLAPV 778 (958)
Q Consensus 699 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~~~~ 778 (958)
||||+++|+|.+++.... ..+++.+++.++.|+++||+|||+++ |+||||||+||++++++.+||+|||+|+....
T Consensus 85 v~E~~~~g~l~~~~~~~~-~~l~~~~~~~~~~qi~~gl~ylH~~~---iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~~~ 160 (273)
T d1mp8a_ 85 IMELCTLGELRSFLQVRK-YSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYMED 160 (273)
T ss_dssp EEECCTTEEHHHHHHHTT-TTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECC---------
T ss_pred EEEeccCCcHHhhhhccC-CCCCHHHHHHHHHHHHHHhhhhcccC---eeccccchhheeecCCCcEEEccchhheeccC
Confidence 999999999999886543 35899999999999999999999999 99999999999999999999999999986532
Q ss_pred CCCCCCccceeeeeccCCCCccChhhhccCCCCCcchhhhHHHHHHHHHh-CCCCCCCCchhHHHHHHHhhcCcchhhhc
Q 002158 779 LDDEGTMPTHVSTIVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVLLELLT-GMQPISHGKNIVREVNVARDSGMVFSIID 857 (958)
Q Consensus 779 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gv~l~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~i~ 857 (958)
.. ........||+.|+|||++.+..++.++|||||||++|||+| |..||........ ... +..
T Consensus 161 ~~------~~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~~-~~~---------i~~ 224 (273)
T d1mp8a_ 161 ST------YYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDV-IGR---------IEN 224 (273)
T ss_dssp ----------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGH-HHH---------HHT
T ss_pred Cc------ceeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHHHH-HHH---------HHc
Confidence 21 122334568999999999999999999999999999999998 8889875443221 111 111
Q ss_pred ccCCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHhh
Q 002158 858 NRMGSYPSECVERFVTLALRCCHDKPEHRPSMSDVVRELENILKM 902 (958)
Q Consensus 858 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~ 902 (958)
......+..+++.+.+++.+||+.||++|||++||+++|+.+++.
T Consensus 225 ~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~ 269 (273)
T d1mp8a_ 225 GERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEE 269 (273)
T ss_dssp TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CCCCCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHH
Confidence 222345667888999999999999999999999999999988753
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-46 Score=407.56 Aligned_cols=251 Identities=23% Similarity=0.345 Sum_probs=206.9
Q ss_pred cCCCCCceeeeeCCeEEEEEEEC-CCcEEEEEEeccCCh------hcHHHHHHHHHHHHccCCCCcceEEEEEEeCCeEE
Q 002158 625 AYFSSSTQVGQGGYGKVYKGILS-DNTTVAIKRAEEGSL------QGQNEFLTEIKLLSRLHHRNLVSLLGYCDEEGEQM 697 (958)
Q Consensus 625 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~ 697 (958)
++|+..+.||+|+||+||+|+++ +|+.||||++..... ...+.|.+|++++++++|||||++++++.+++..+
T Consensus 10 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ 89 (293)
T d1jksa_ 10 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVI 89 (293)
T ss_dssp GTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred cCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEE
Confidence 57888999999999999999985 799999999865321 23567999999999999999999999999999999
Q ss_pred EEEEecCCCCHHHHhccCCCCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEecCCC----CeEEeeeeee
Q 002158 698 LVYEFVPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSNL----NAKVADFGLS 773 (958)
Q Consensus 698 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~~----~~kl~DFGla 773 (958)
+|||||++|+|.+++.... .+++.++..++.|++.||+|||+++ |+||||||+|||++.++ .+|++|||+|
T Consensus 90 iv~E~~~gg~L~~~i~~~~--~l~~~~~~~~~~qi~~al~yLH~~~---ivHrDiKp~Nill~~~~~~~~~vkl~DfG~a 164 (293)
T d1jksa_ 90 LILELVAGGELFDFLAEKE--SLTEEEATEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFGLA 164 (293)
T ss_dssp EEEECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCSSSSSCCEEECCCTTC
T ss_pred EEEEcCCCccccchhcccc--ccchhHHHHHHHHHHHHHHhhhhcc---eeecccccceEEEecCCCcccceEecchhhh
Confidence 9999999999999997653 4999999999999999999999999 99999999999998876 4999999999
Q ss_pred cccccCCCCCCccceeeeeccCCCCccChhhhccCCCCCcchhhhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcCcch
Q 002158 774 RLAPVLDDEGTMPTHVSTIVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVLLELLTGMQPISHGKNIVREVNVARDSGMVF 853 (958)
Q Consensus 774 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gv~l~elltG~~P~~~~~~~~~~~~~~~~~~~~~ 853 (958)
+...... ......||+.|+|||++.+..++.++||||+||++|||++|+.||.+..................
T Consensus 165 ~~~~~~~--------~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~~ 236 (293)
T d1jksa_ 165 HKIDFGN--------EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFE 236 (293)
T ss_dssp EECTTSC--------BCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTCCCCC
T ss_pred hhcCCCc--------cccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCC
Confidence 8653221 22345689999999999999999999999999999999999999975443222111111100000
Q ss_pred hhhcccCCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 002158 854 SIIDNRMGSYPSECVERFVTLALRCCHDKPEHRPSMSDVVRE 895 (958)
Q Consensus 854 ~~i~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 895 (958)
. ..+..++..+.+++.+||+.||++|||++|++++
T Consensus 237 ~-------~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 271 (293)
T d1jksa_ 237 D-------EYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQH 271 (293)
T ss_dssp H-------HHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred c-------hhcCCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 0 0112345778999999999999999999999874
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.1e-46 Score=406.69 Aligned_cols=261 Identities=33% Similarity=0.511 Sum_probs=212.2
Q ss_pred CceeeeeCCeEEEEEEECCC----cEEEEEEeccC-ChhcHHHHHHHHHHHHccCCCCcceEEEEEEe-CCeEEEEEEec
Q 002158 630 STQVGQGGYGKVYKGILSDN----TTVAIKRAEEG-SLQGQNEFLTEIKLLSRLHHRNLVSLLGYCDE-EGEQMLVYEFV 703 (958)
Q Consensus 630 ~~~lg~G~~g~Vy~~~~~~~----~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~-~~~~~lV~E~~ 703 (958)
.++||+|+||+||+|++.++ ..||||+++.. .....++|.+|++++++++||||++++|++.. ++..++|||||
T Consensus 32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~~ 111 (311)
T d1r0pa_ 32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYM 111 (311)
T ss_dssp EEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEECC
T ss_pred ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEEEe
Confidence 35799999999999997532 36899999753 45556789999999999999999999999875 56899999999
Q ss_pred CCCCHHHHhccCCCCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEecCCCCeEEeeeeeecccccCCCCC
Q 002158 704 PNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSRLAPVLDDEG 783 (958)
Q Consensus 704 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 783 (958)
++|+|.++++... ..+++..+++++.|+|+||.|||+.+ |+||||||+|||+++++.+||+|||+++.........
T Consensus 112 ~~g~l~~~~~~~~-~~~~~~~~~~i~~qia~gL~~lH~~~---iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~~~ 187 (311)
T d1r0pa_ 112 KHGDLRNFIRNET-HNPTVKDLIGFGLQVAKGMKFLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDS 187 (311)
T ss_dssp TTCBHHHHHHCTT-CCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTCCC
T ss_pred ecCchhhhhcccc-ccchHHHHHHHHHHHHHhhhhhcccC---cccCCccHHhEeECCCCCEEEecccchhhcccccccc
Confidence 9999999997554 34788899999999999999999999 9999999999999999999999999998764332211
Q ss_pred CccceeeeeccCCCCccChhhhccCCCCCcchhhhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcCcchhhhcccCCCC
Q 002158 784 TMPTHVSTIVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVLLELLTGMQPISHGKNIVREVNVARDSGMVFSIIDNRMGSY 863 (958)
Q Consensus 784 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gv~l~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~ 863 (958)
........||+.|+|||.+.+..++.++||||||+++|||+||..||............ +........
T Consensus 188 ---~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~~~~~~---------i~~g~~~~~ 255 (311)
T d1r0pa_ 188 ---VHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVY---------LLQGRRLLQ 255 (311)
T ss_dssp ---TTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC------CHHH---------HHTTCCCCC
T ss_pred ---ceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHHHHHHH---------HHcCCCCCC
Confidence 12223457999999999999999999999999999999999988888654332222211 122223344
Q ss_pred ChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHhhCCCC
Q 002158 864 PSECVERFVTLALRCCHDKPEHRPSMSDVVRELENILKMFPET 906 (958)
Q Consensus 864 ~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~~~~ 906 (958)
|..+++++.+++.+||+.||++||++.||+++|+++.+.+...
T Consensus 256 p~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i~~~~~~~ 298 (311)
T d1r0pa_ 256 PEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIGE 298 (311)
T ss_dssp CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTCCSC
T ss_pred cccCcHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHhhhhh
Confidence 5667789999999999999999999999999999998766544
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.4e-47 Score=412.52 Aligned_cols=267 Identities=28% Similarity=0.436 Sum_probs=206.5
Q ss_pred HHHHHHcCCCCCceeeeeCCeEEEEEEEC------CCcEEEEEEeccC-ChhcHHHHHHHHHHHHcc-CCCCcceEEEEE
Q 002158 619 ELAMATAYFSSSTQVGQGGYGKVYKGILS------DNTTVAIKRAEEG-SLQGQNEFLTEIKLLSRL-HHRNLVSLLGYC 690 (958)
Q Consensus 619 el~~~~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~ 690 (958)
+++...++|+..+.||+|+||+||+|.+. +++.||||+++.. .....+.+.+|...+.++ +|+||+++++++
T Consensus 7 ~wei~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~ 86 (299)
T d1ywna1 7 KWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGAC 86 (299)
T ss_dssp HHBCCGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred cccccHHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeeee
Confidence 33344567888999999999999999964 2468999999764 334456788899888887 689999999998
Q ss_pred EeC-CeEEEEEEecCCCCHHHHhccCC--------------CCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCcc
Q 002158 691 DEE-GEQMLVYEFVPNGTLRDWLSGRT--------------KENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKAS 755 (958)
Q Consensus 691 ~~~-~~~~lV~E~~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~ 755 (958)
... ...++|||||++|+|.++++... ...+++.++..++.|+++||+|||+++ |+||||||+
T Consensus 87 ~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~---ivHrDlKp~ 163 (299)
T d1ywna1 87 TKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAAR 163 (299)
T ss_dssp CSTTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGG
T ss_pred ccCCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCC---CcCCcCCcc
Confidence 764 46899999999999999997542 234899999999999999999999999 999999999
Q ss_pred ceEecCCCCeEEeeeeeecccccCCCCCCccceeeeeccCCCCccChhhhccCCCCCcchhhhHHHHHHHHHhCC-CCCC
Q 002158 756 NILLDSNLNAKVADFGLSRLAPVLDDEGTMPTHVSTIVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVLLELLTGM-QPIS 834 (958)
Q Consensus 756 NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gv~l~elltG~-~P~~ 834 (958)
|||+++++.+||+|||+|+........ .......||+.|||||++.+..++.++|||||||++|||+||. .||.
T Consensus 164 NILl~~~~~~Kl~DFGla~~~~~~~~~-----~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~ 238 (299)
T d1ywna1 164 NILLSEKNVVKICDFGLARDIYKDPDY-----VRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYP 238 (299)
T ss_dssp GEEECGGGCEEECC------CCSCTTS-----CCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSST
T ss_pred ceeECCCCcEEEccCcchhhccccccc-----cccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCC
Confidence 999999999999999999865432221 1223457999999999999999999999999999999999975 5675
Q ss_pred CCchhHHHHHHHhhcCcchhhhcccCCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHhh
Q 002158 835 HGKNIVREVNVARDSGMVFSIIDNRMGSYPSECVERFVTLALRCCHDKPEHRPSMSDVVRELENILKM 902 (958)
Q Consensus 835 ~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~ 902 (958)
.............. ......|..+++++.+++.+||+.||++|||++|++++|+++++.
T Consensus 239 ~~~~~~~~~~~~~~---------~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~ilq~ 297 (299)
T d1ywna1 239 GVKIDEEFCRRLKE---------GTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA 297 (299)
T ss_dssp TCCCSHHHHHHHHH---------TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CCCHHHHHHHHHhc---------CCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhC
Confidence 44332222211111 112334566778899999999999999999999999999998753
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-46 Score=411.89 Aligned_cols=256 Identities=26% Similarity=0.447 Sum_probs=206.1
Q ss_pred CCCCCceeeeeCCeEEEEEEEC-CCc----EEEEEEeccC-ChhcHHHHHHHHHHHHccCCCCcceEEEEEEeCCeEEEE
Q 002158 626 YFSSSTQVGQGGYGKVYKGILS-DNT----TVAIKRAEEG-SLQGQNEFLTEIKLLSRLHHRNLVSLLGYCDEEGEQMLV 699 (958)
Q Consensus 626 ~~~~~~~lg~G~~g~Vy~~~~~-~~~----~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV 699 (958)
+|+..+.||+|+||+||+|.+. +|+ .||||+++.. .....++|.+|++++++++|||||+++|+|.++ ..+++
T Consensus 10 dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~~~v 88 (317)
T d1xkka_ 10 EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQLI 88 (317)
T ss_dssp TEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEEEE
T ss_pred HCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-CeeEE
Confidence 5788899999999999999975 343 6899988654 344567899999999999999999999999865 57788
Q ss_pred EEecCCCCHHHHhccCCCCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEecCCCCeEEeeeeeecccccC
Q 002158 700 YEFVPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSRLAPVL 779 (958)
Q Consensus 700 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~~~~~ 779 (958)
|||+.+|+|.+++.... ..+++..+++++.|||+||+|||+++ |+||||||+|||++.++.+||+|||+|+.....
T Consensus 89 ~e~~~~~~l~~~~~~~~-~~~~~~~~~~i~~qi~~gl~yLH~~~---iiHrDlKp~NIll~~~~~~kl~DFGla~~~~~~ 164 (317)
T d1xkka_ 89 TQLMPFGCLLDYVREHK-DNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAE 164 (317)
T ss_dssp EECCTTCBHHHHHHHTS-SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCCSHHHHTTTT
T ss_pred EEeccCCcccccccccc-cCCCHHHHHHHHHHHHHHHHHHHHcC---cccCcchhhcceeCCCCCeEeeccccceecccc
Confidence 99999999999887653 45999999999999999999999999 999999999999999999999999999876432
Q ss_pred CCCCCccceeeeeccCCCCccChhhhccCCCCCcchhhhHHHHHHHHHh-CCCCCCCCchhHHHHHHHhhcCcchhhhcc
Q 002158 780 DDEGTMPTHVSTIVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVLLELLT-GMQPISHGKNIVREVNVARDSGMVFSIIDN 858 (958)
Q Consensus 780 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gv~l~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~i~~ 858 (958)
.. ........||+.|+|||++.++.++.++|||||||++|||+| |..||.+.... +...... ..
T Consensus 165 ~~-----~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~-~~~~~i~---------~~ 229 (317)
T d1xkka_ 165 EK-----EYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS-EISSILE---------KG 229 (317)
T ss_dssp CC-------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGG-GHHHHHH---------HT
T ss_pred cc-----cccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHH-HHHHHHH---------cC
Confidence 21 122234569999999999999999999999999999999999 78888653321 1111111 11
Q ss_pred cCCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHh
Q 002158 859 RMGSYPSECVERFVTLALRCCHDKPEHRPSMSDVVRELENILK 901 (958)
Q Consensus 859 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~ 901 (958)
.....|..++..+.+++.+||+.||++|||++|++++|+++.+
T Consensus 230 ~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l~~~~~ 272 (317)
T d1xkka_ 230 ERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMAR 272 (317)
T ss_dssp CCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCCCCCcccCHHHHHHHHHhCCCChhhCcCHHHHHHHHHHHHh
Confidence 2234466778899999999999999999999999999988764
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.8e-46 Score=408.62 Aligned_cols=258 Identities=32% Similarity=0.492 Sum_probs=210.1
Q ss_pred cCCCCCceeeeeCCeEEEEEEEC-CCc--EEEEEEeccC-ChhcHHHHHHHHHHHHcc-CCCCcceEEEEEEeCCeEEEE
Q 002158 625 AYFSSSTQVGQGGYGKVYKGILS-DNT--TVAIKRAEEG-SLQGQNEFLTEIKLLSRL-HHRNLVSLLGYCDEEGEQMLV 699 (958)
Q Consensus 625 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~--~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lV 699 (958)
++|+..++||+|+||+||+|+++ +|. .||||++... .....++|.+|+++|+++ +|||||+++|+|.+++..++|
T Consensus 10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~iV 89 (309)
T d1fvra_ 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 89 (309)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred HHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEEE
Confidence 46777889999999999999986 344 5788887654 333456799999999999 799999999999999999999
Q ss_pred EEecCCCCHHHHhccC--------------CCCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEecCCCCe
Q 002158 700 YEFVPNGTLRDWLSGR--------------TKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSNLNA 765 (958)
Q Consensus 700 ~E~~~~gsL~~~l~~~--------------~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~~~~ 765 (958)
|||+++|+|.++++.. ....+++.++.+++.|||+||.|||+.+ |+||||||+|||++.++.+
T Consensus 90 ~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~---iiHrDlkp~NIL~~~~~~~ 166 (309)
T d1fvra_ 90 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVA 166 (309)
T ss_dssp ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCE
T ss_pred EEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCC---ccccccccceEEEcCCCce
Confidence 9999999999999754 2355999999999999999999999999 9999999999999999999
Q ss_pred EEeeeeeecccccCCCCCCccceeeeeccCCCCccChhhhccCCCCCcchhhhHHHHHHHHHhCCC-CCCCCchhHHHHH
Q 002158 766 KVADFGLSRLAPVLDDEGTMPTHVSTIVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVLLELLTGMQ-PISHGKNIVREVN 844 (958)
Q Consensus 766 kl~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gv~l~elltG~~-P~~~~~~~~~~~~ 844 (958)
||+|||+|+...... ......||..|+|||.+.+..++.++|||||||++|||++|.. ||. +.+..+...
T Consensus 167 kl~DfG~a~~~~~~~--------~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~-~~~~~~~~~ 237 (309)
T d1fvra_ 167 KIADFGLSRGQEVYV--------KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYC-GMTCAELYE 237 (309)
T ss_dssp EECCTTCEESSCEEC--------CC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTT-TCCHHHHHH
T ss_pred EEccccccccccccc--------cccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCC-CCCHHHHHH
Confidence 999999998543211 1223568999999999999999999999999999999999765 554 333333322
Q ss_pred HHhhcCcchhhhcccCCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHhhC
Q 002158 845 VARDSGMVFSIIDNRMGSYPSECVERFVTLALRCCHDKPEHRPSMSDVVRELENILKMF 903 (958)
Q Consensus 845 ~~~~~~~~~~~i~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~ 903 (958)
... .......+..+++++.+++.+||+.||++||||+||+++|+++.+..
T Consensus 238 ~i~---------~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i~~~~ 287 (309)
T d1fvra_ 238 KLP---------QGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEER 287 (309)
T ss_dssp HGG---------GTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSS
T ss_pred HHH---------hcCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhcC
Confidence 221 12223456677889999999999999999999999999999988643
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=5.4e-46 Score=406.35 Aligned_cols=245 Identities=23% Similarity=0.362 Sum_probs=208.1
Q ss_pred cCCCCCceeeeeCCeEEEEEEEC-CCcEEEEEEeccCC---hhcHHHHHHHHHHHHccCCCCcceEEEEEEeCCeEEEEE
Q 002158 625 AYFSSSTQVGQGGYGKVYKGILS-DNTTVAIKRAEEGS---LQGQNEFLTEIKLLSRLHHRNLVSLLGYCDEEGEQMLVY 700 (958)
Q Consensus 625 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~ 700 (958)
++|+..+.||+|+||+||+|+++ +|+.||||+++... ....+.+.+|+.++++++||||+++++++.+++..|+||
T Consensus 4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm 83 (316)
T d1fota_ 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM 83 (316)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEe
Confidence 45788899999999999999985 69999999986532 234567999999999999999999999999999999999
Q ss_pred EecCCCCHHHHhccCCCCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEecCCCCeEEeeeeeecccccCC
Q 002158 701 EFVPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSRLAPVLD 780 (958)
Q Consensus 701 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~ 780 (958)
|||+||+|.+++..... +++..+..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+|+....
T Consensus 84 E~~~gg~l~~~~~~~~~--~~~~~~~~~~~qi~~al~~lH~~~---iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~-- 156 (316)
T d1fota_ 84 DYIEGGELFSLLRKSQR--FPNPVAKFYAAEVCLALEYLHSKD---IIYRDLKPENILLDKNGHIKITDFGFAKYVPD-- 156 (316)
T ss_dssp CCCCSCBHHHHHHHTSS--CCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTSCEEECCCSSCEECSS--
T ss_pred eecCCcccccccccccc--ccccHHHHHHHHHHHhhhhhccCc---EEccccCchheeEcCCCCEEEecCccceEecc--
Confidence 99999999999976554 788889999999999999999999 99999999999999999999999999986532
Q ss_pred CCCCccceeeeeccCCCCccChhhhccCCCCCcchhhhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcCcchhhhcccC
Q 002158 781 DEGTMPTHVSTIVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVLLELLTGMQPISHGKNIVREVNVARDSGMVFSIIDNRM 860 (958)
Q Consensus 781 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gv~l~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~i~~~~ 860 (958)
......||+.|||||++.+..++.++||||+||++|||++|+.||.+...... ...... ..
T Consensus 157 --------~~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~-~~~i~~----------~~ 217 (316)
T d1fota_ 157 --------VTYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKT-YEKILN----------AE 217 (316)
T ss_dssp --------CBCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHH-HHHHHH----------CC
T ss_pred --------ccccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCHHHH-HHHHHc----------CC
Confidence 12346799999999999999999999999999999999999999976443222 211111 11
Q ss_pred CCCChHHHHHHHHHHHHccccCCCCCC-----CHHHHHHH
Q 002158 861 GSYPSECVERFVTLALRCCHDKPEHRP-----SMSDVVRE 895 (958)
Q Consensus 861 ~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~~ 895 (958)
..+|...+.++.+++.+||+.||.+|+ +++|++++
T Consensus 218 ~~~p~~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~H 257 (316)
T d1fota_ 218 LRFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNH 257 (316)
T ss_dssp CCCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTS
T ss_pred CCCCCCCCHHHHHHHHHHhhhCHHhccccchhhHHHHHcC
Confidence 234556678899999999999999996 89999875
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-46 Score=401.48 Aligned_cols=257 Identities=27% Similarity=0.432 Sum_probs=200.1
Q ss_pred cCCCCCceeeeeCCeEEEEEEECC--C--cEEEEEEeccC---ChhcHHHHHHHHHHHHccCCCCcceEEEEEEeCCeEE
Q 002158 625 AYFSSSTQVGQGGYGKVYKGILSD--N--TTVAIKRAEEG---SLQGQNEFLTEIKLLSRLHHRNLVSLLGYCDEEGEQM 697 (958)
Q Consensus 625 ~~~~~~~~lg~G~~g~Vy~~~~~~--~--~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~ 697 (958)
++|+..+.||+|+||+||+|++.. + ..||||+++.. .....++|.+|++++++++||||++++|+|.+ +..+
T Consensus 8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~~~ 86 (273)
T d1u46a_ 8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PPMK 86 (273)
T ss_dssp GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCE
T ss_pred HHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-cchh
Confidence 457778899999999999998642 2 37899988654 23335689999999999999999999999976 4678
Q ss_pred EEEEecCCCCHHHHhccCCCCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEecCCCCeEEeeeeeecccc
Q 002158 698 LVYEFVPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSRLAP 777 (958)
Q Consensus 698 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~~~ 777 (958)
+||||+++|++.+++.... ..+++..+++++.|+|+||+|||+++ |+||||||+||+++.++.+||+|||+++...
T Consensus 87 lv~e~~~~~~l~~~~~~~~-~~l~~~~~~~~~~qi~~gl~ylH~~~---iiHrDikp~NIll~~~~~vkl~DfGl~~~~~ 162 (273)
T d1u46a_ 87 MVTELAPLGSLLDRLRKHQ-GHFLLGTLSRYAVQVAEGMGYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLMRALP 162 (273)
T ss_dssp EEEECCTTCBHHHHHHHHG-GGSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCEECC
T ss_pred eeeeeecCcchhhhhhccc-CCCCHHHHHHHHHHHHHHHHHhhhCC---EeeeeecHHHhccccccceeeccchhhhhcc
Confidence 9999999999999887543 34999999999999999999999998 9999999999999999999999999998763
Q ss_pred cCCCCCCccceeeeeccCCCCccChhhhccCCCCCcchhhhHHHHHHHHHh-CCCCCCCCchhHHHHHHHhhcCcchhhh
Q 002158 778 VLDDEGTMPTHVSTIVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVLLELLT-GMQPISHGKNIVREVNVARDSGMVFSII 856 (958)
Q Consensus 778 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gv~l~ellt-G~~P~~~~~~~~~~~~~~~~~~~~~~~i 856 (958)
..... ........|+..|+|||++.+..++.++|||||||++|||+| |+.||.+.... .........+
T Consensus 163 ~~~~~----~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~-~~~~~i~~~~------ 231 (273)
T d1u46a_ 163 QNDDH----YVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGS-QILHKIDKEG------ 231 (273)
T ss_dssp C-CCE----EEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHH-HHHHHHHTSC------
T ss_pred cCCCc----ceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHH-HHHHHHHhCC------
Confidence 32211 222334568889999999999999999999999999999998 89999754432 2222222211
Q ss_pred cccCCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHh
Q 002158 857 DNRMGSYPSECVERFVTLALRCCHDKPEHRPSMSDVVRELENI 899 (958)
Q Consensus 857 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 899 (958)
.....+..++..+.+++.+||+.||++|||++||++.|+++
T Consensus 232 --~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~~ 272 (273)
T d1u46a_ 232 --ERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEA 272 (273)
T ss_dssp --CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred --CCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence 11233556678899999999999999999999999988764
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=8.8e-46 Score=398.69 Aligned_cols=260 Identities=24% Similarity=0.340 Sum_probs=205.3
Q ss_pred cCCCCCceeeeeCCeEEEEEEEC-CCcEEEEEEeccCC---hhcHHHHHHHHHHHHccCCCCcceEEEEEEeCC----eE
Q 002158 625 AYFSSSTQVGQGGYGKVYKGILS-DNTTVAIKRAEEGS---LQGQNEFLTEIKLLSRLHHRNLVSLLGYCDEEG----EQ 696 (958)
Q Consensus 625 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~----~~ 696 (958)
++|...+.||+|+||+||+|++. +|+.||||+++... ....++|.+|+++++.++||||+++++++...+ ..
T Consensus 7 drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~~ 86 (277)
T d1o6ya_ 7 DRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLP 86 (277)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEEE
T ss_pred ceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCceE
Confidence 46888899999999999999975 79999999997643 233457999999999999999999999987654 47
Q ss_pred EEEEEecCCCCHHHHhccCCCCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEecCCCCeEEeeeeeeccc
Q 002158 697 MLVYEFVPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSRLA 776 (958)
Q Consensus 697 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~~ 776 (958)
|+||||+++++|.+++.... .+++.++..++.|+++||+|||+++ |+||||||+|||++.++..+|+|||.++..
T Consensus 87 ~lvmE~~~g~~L~~~~~~~~--~l~~~~~~~i~~qi~~al~~lH~~~---iiHrDiKP~NIll~~~~~~~l~d~~~~~~~ 161 (277)
T d1o6ya_ 87 YIVMEYVDGVTLRDIVHTEG--PMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIARAI 161 (277)
T ss_dssp EEEEECCCEEEHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTSCEEECCCTTCEEC
T ss_pred EEEEECCCCCEehhhhcccC--CCCHHHHHHHHHHHHHHHHHHHhCC---ccCccccCcccccCccccceeehhhhhhhh
Confidence 99999999999999997654 4899999999999999999999999 999999999999999999999999998755
Q ss_pred ccCCCCCCccceeeeeccCCCCccChhhhccCCCCCcchhhhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcCcchhhh
Q 002158 777 PVLDDEGTMPTHVSTIVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVLLELLTGMQPISHGKNIVREVNVARDSGMVFSII 856 (958)
Q Consensus 777 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gv~l~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~i 856 (958)
...... ........||+.|+|||++.+..++.++||||+||++|||+||+.||.....................
T Consensus 162 ~~~~~~----~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~~~~~~~~~~~-- 235 (277)
T d1o6ya_ 162 ADSGNS----VTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPS-- 235 (277)
T ss_dssp C--------------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCGG--
T ss_pred cccccc----ccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCHHHHHHHHHhcCCCCCc--
Confidence 332211 22334567999999999999999999999999999999999999999765543332222222111110
Q ss_pred cccCCCCChHHHHHHHHHHHHccccCCCCCC-CHHHHHHHHHHhH
Q 002158 857 DNRMGSYPSECVERFVTLALRCCHDKPEHRP-SMSDVVRELENIL 900 (958)
Q Consensus 857 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-s~~evl~~L~~~~ 900 (958)
.....+++++.+++.+||+.||++|| +++++.+.|.++.
T Consensus 236 -----~~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r~~ 275 (277)
T d1o6ya_ 236 -----ARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVH 275 (277)
T ss_dssp -----GTSSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred -----hhccCCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHHHHh
Confidence 11234567899999999999999999 8999999888764
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4e-46 Score=410.16 Aligned_cols=248 Identities=23% Similarity=0.286 Sum_probs=210.2
Q ss_pred cCCCCCceeeeeCCeEEEEEEEC-CCcEEEEEEeccCC---hhcHHHHHHHHHHHHccCCCCcceEEEEEEeCCeEEEEE
Q 002158 625 AYFSSSTQVGQGGYGKVYKGILS-DNTTVAIKRAEEGS---LQGQNEFLTEIKLLSRLHHRNLVSLLGYCDEEGEQMLVY 700 (958)
Q Consensus 625 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~ 700 (958)
++|+..+.||+|+||+||+|+.+ +|+.||||+++... ....+.+.+|+++|++++||||+++++++.+++..|+||
T Consensus 5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv~ 84 (337)
T d1o6la_ 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVM 84 (337)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccce
Confidence 46888899999999999999985 79999999987532 234567899999999999999999999999999999999
Q ss_pred EecCCCCHHHHhccCCCCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEecCCCCeEEeeeeeecccccCC
Q 002158 701 EFVPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSRLAPVLD 780 (958)
Q Consensus 701 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~ 780 (958)
|||++|+|.+++.... .+++..+..++.|++.||+|||+++ |+||||||+|||++++|.+||+|||+|+......
T Consensus 85 ey~~gg~L~~~~~~~~--~~~e~~~~~~~~qil~al~ylH~~~---iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~~~ 159 (337)
T d1o6la_ 85 EYANGGELFFHLSRER--VFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG 159 (337)
T ss_dssp ECCTTCBHHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTT
T ss_pred eccCCCchhhhhhccc--CCcHHHHHHHHHHHhhhhhhhhhcC---ccccccCHHHeEecCCCCEEEeecccccccccCC
Confidence 9999999999997654 3899999999999999999999999 9999999999999999999999999998643211
Q ss_pred CCCCccceeeeeccCCCCccChhhhccCCCCCcchhhhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcCcchhhhcccC
Q 002158 781 DEGTMPTHVSTIVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVLLELLTGMQPISHGKNIVREVNVARDSGMVFSIIDNRM 860 (958)
Q Consensus 781 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gv~l~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~i~~~~ 860 (958)
......+||+.|+|||++.+..|+.++||||+||++|||++|+.||.+... ....... ....
T Consensus 160 -------~~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~-~~~~~~i----------~~~~ 221 (337)
T d1o6la_ 160 -------ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH-ERLFELI----------LMEE 221 (337)
T ss_dssp -------CCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSH-HHHHHHH----------HHCC
T ss_pred -------cccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCH-HHHHHHH----------hcCC
Confidence 122346799999999999999999999999999999999999999976443 2222111 1112
Q ss_pred CCCChHHHHHHHHHHHHccccCCCCCCC-----HHHHHHH
Q 002158 861 GSYPSECVERFVTLALRCCHDKPEHRPS-----MSDVVRE 895 (958)
Q Consensus 861 ~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~evl~~ 895 (958)
..+|..++.++.+++.+||+.||.+||+ ++|++++
T Consensus 222 ~~~p~~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~H 261 (337)
T d1o6la_ 222 IRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH 261 (337)
T ss_dssp CCCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred CCCCccCCHHHHHHHHhhccCCchhhcccccccHHHHHcC
Confidence 3446667788999999999999999995 7888764
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.9e-46 Score=404.69 Aligned_cols=263 Identities=26% Similarity=0.395 Sum_probs=215.0
Q ss_pred HcCCCCCceeeeeCCeEEEEEEEC------CCcEEEEEEeccCC-hhcHHHHHHHHHHHHcc-CCCCcceEEEEEEeCCe
Q 002158 624 TAYFSSSTQVGQGGYGKVYKGILS------DNTTVAIKRAEEGS-LQGQNEFLTEIKLLSRL-HHRNLVSLLGYCDEEGE 695 (958)
Q Consensus 624 ~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~ 695 (958)
.++|+..++||+|+||.||+|++. +++.||||+++... .....+|.+|+.+++++ +|||||+++|+|.+++.
T Consensus 22 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~~~ 101 (311)
T d1t46a_ 22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGP 101 (311)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred HHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeCCE
Confidence 457777889999999999999862 46789999997643 44456799999999999 69999999999999999
Q ss_pred EEEEEEecCCCCHHHHhccCC----------------CCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEe
Q 002158 696 QMLVYEFVPNGTLRDWLSGRT----------------KENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILL 759 (958)
Q Consensus 696 ~~lV~E~~~~gsL~~~l~~~~----------------~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl 759 (958)
.++|||||++|+|.++++... ...+++..+.+++.|||+||+|||+++ |+||||||+||++
T Consensus 102 ~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~---ivHrDLKp~NIl~ 178 (311)
T d1t46a_ 102 TLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNILL 178 (311)
T ss_dssp CEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEE
T ss_pred EEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccccccccc
Confidence 999999999999999997543 235889999999999999999999999 9999999999999
Q ss_pred cCCCCeEEeeeeeecccccCCCCCCccceeeeeccCCCCccChhhhccCCCCCcchhhhHHHHHHHHHhCCCCCCCCchh
Q 002158 760 DSNLNAKVADFGLSRLAPVLDDEGTMPTHVSTIVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVLLELLTGMQPISHGKNI 839 (958)
Q Consensus 760 ~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gv~l~elltG~~P~~~~~~~ 839 (958)
+.++.+|++|||+++....... ........||+.|+|||++.+..++.++|||||||++|||+|+..|+....+.
T Consensus 179 ~~~~~~ki~DfG~~~~~~~~~~-----~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~ 253 (311)
T d1t46a_ 179 THGRITKICDFGLARDIKNDSN-----YVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPV 253 (311)
T ss_dssp ETTTEEEECCCGGGSCTTSCTT-----SEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCS
T ss_pred cccCcccccccchheeccCCCc-----ceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCCH
Confidence 9999999999999986543221 23344567999999999999999999999999999999999954444333322
Q ss_pred HHHHHHHhhcCcchhhhcccCCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHhh
Q 002158 840 VREVNVARDSGMVFSIIDNRMGSYPSECVERFVTLALRCCHDKPEHRPSMSDVVRELENILKM 902 (958)
Q Consensus 840 ~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~ 902 (958)
...+...... +.....+..++..+.+|+.+||+.||++|||++||++.|++++..
T Consensus 254 ~~~~~~~i~~--------~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~~i~~ 308 (311)
T d1t46a_ 254 DSKFYKMIKE--------GFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISE 308 (311)
T ss_dssp SHHHHHHHHH--------TCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHHHHHHhc--------CCCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhhcc
Confidence 2222211111 112234556778899999999999999999999999999987754
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.1e-45 Score=401.53 Aligned_cols=247 Identities=19% Similarity=0.304 Sum_probs=206.6
Q ss_pred cCCCCCceeeeeCCeEEEEEEEC-CCcEEEEEEeccCChhcHHHHHHHHHHHHccCCCCcceEEEEEEeCCeEEEEEEec
Q 002158 625 AYFSSSTQVGQGGYGKVYKGILS-DNTTVAIKRAEEGSLQGQNEFLTEIKLLSRLHHRNLVSLLGYCDEEGEQMLVYEFV 703 (958)
Q Consensus 625 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E~~ 703 (958)
++|.+.+.||+|+||+||+|+++ +++.||||+++... .+...+.+|+++|++++||||+++++++.+++..|+|||||
T Consensus 5 ~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~-~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE~~ 83 (321)
T d1tkia_ 5 EKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG-TDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEFI 83 (321)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT-HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred cceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCc-ccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEecC
Confidence 46788899999999999999986 68899999997654 33456889999999999999999999999999999999999
Q ss_pred CCCCHHHHhccCCCCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEecCC--CCeEEeeeeeecccccCCC
Q 002158 704 PNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSN--LNAKVADFGLSRLAPVLDD 781 (958)
Q Consensus 704 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~--~~~kl~DFGla~~~~~~~~ 781 (958)
++|+|.+++.... ..+++.++..++.|++.||+|||+++ |+||||||+|||++.+ +.+||+|||+++....
T Consensus 84 ~gg~L~~~i~~~~-~~l~e~~~~~i~~qi~~al~yLH~~~---iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~--- 156 (321)
T d1tkia_ 84 SGLDIFERINTSA-FELNEREIVSYVHQVCEALQFLHSHN---IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKP--- 156 (321)
T ss_dssp CCCBHHHHHTSSS-CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCTTCEECCT---
T ss_pred CCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHcC---CCcccccccceeecCCCceEEEEcccchhhcccc---
Confidence 9999999997543 34899999999999999999999999 9999999999999854 5799999999986422
Q ss_pred CCCccceeeeeccCCCCccChhhhccCCCCCcchhhhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcCcchhhhcccCC
Q 002158 782 EGTMPTHVSTIVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVLLELLTGMQPISHGKNIVREVNVARDSGMVFSIIDNRMG 861 (958)
Q Consensus 782 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gv~l~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~i~~~~~ 861 (958)
........||+.|+|||.+.+..++.++||||+||++|||++|+.||........ ....... ..
T Consensus 157 -----~~~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~~-~~~i~~~----------~~ 220 (321)
T d1tkia_ 157 -----GDNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQI-IENIMNA----------EY 220 (321)
T ss_dssp -----TCEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHH-HHHHHHT----------CC
T ss_pred -----CCcccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCHHHH-HHHHHhC----------CC
Confidence 1223446799999999999999999999999999999999999999976543222 1111111 11
Q ss_pred CCCh----HHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 002158 862 SYPS----ECVERFVTLALRCCHDKPEHRPSMSDVVRE 895 (958)
Q Consensus 862 ~~~~----~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 895 (958)
.++. .++.++.+++.+|++.||++|||++|++++
T Consensus 221 ~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~h 258 (321)
T d1tkia_ 221 TFDEEAFKEISIEAMDFVDRLLVKERKSRMTASEALQH 258 (321)
T ss_dssp CCCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred CCChhhccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 1121 345678999999999999999999999985
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=3.4e-45 Score=392.19 Aligned_cols=251 Identities=24% Similarity=0.331 Sum_probs=206.1
Q ss_pred cCCCCCceeeeeCCeEEEEEEEC-CCcEEEEEEeccCChh---------cHHHHHHHHHHHHccC-CCCcceEEEEEEeC
Q 002158 625 AYFSSSTQVGQGGYGKVYKGILS-DNTTVAIKRAEEGSLQ---------GQNEFLTEIKLLSRLH-HRNLVSLLGYCDEE 693 (958)
Q Consensus 625 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~---------~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~ 693 (958)
++|+..+.||+|+||+||+|+.. +|+.||||++...... ..+.+.+|+.++++++ ||||+++++++.++
T Consensus 3 ~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 82 (277)
T d1phka_ 3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETN 82 (277)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECS
T ss_pred ccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecccC
Confidence 57888899999999999999985 7899999998654211 1246889999999997 99999999999999
Q ss_pred CeEEEEEEecCCCCHHHHhccCCCCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEecCCCCeEEeeeeee
Q 002158 694 GEQMLVYEFVPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSNLNAKVADFGLS 773 (958)
Q Consensus 694 ~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla 773 (958)
+..|+|||||++|+|.++++... .+++.++..++.||++||+|||+++ |+||||||+|||++.++.+||+|||++
T Consensus 83 ~~~~ivmE~~~~g~L~~~l~~~~--~l~e~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nill~~~~~~kl~DFG~a 157 (277)
T d1phka_ 83 TFFFLVFDLMKKGELFDYLTEKV--TLSEKETRKIMRALLEVICALHKLN---IVHRDLKPENILLDDDMNIKLTDFGFS 157 (277)
T ss_dssp SEEEEEEECCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTC
T ss_pred cceEEEEEcCCCchHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHcC---CcccccccceEEEcCCCCeEEccchhe
Confidence 99999999999999999997544 4999999999999999999999999 999999999999999999999999999
Q ss_pred cccccCCCCCCccceeeeeccCCCCccChhhhcc------CCCCCcchhhhHHHHHHHHHhCCCCCCCCchhHHHHHHHh
Q 002158 774 RLAPVLDDEGTMPTHVSTIVKGTPGYLDPEYFLT------HKLTDKSDVYSLGVVLLELLTGMQPISHGKNIVREVNVAR 847 (958)
Q Consensus 774 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~~DV~S~Gv~l~elltG~~P~~~~~~~~~~~~~~~ 847 (958)
+...... ......||+.|+|||++.+ ..++.++||||+||++|||++|+.||.+............
T Consensus 158 ~~~~~~~--------~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~~~~~i~~ 229 (277)
T d1phka_ 158 CQLDPGE--------KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMS 229 (277)
T ss_dssp EECCTTC--------CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH
T ss_pred eEccCCC--------ceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHHHHHHHHh
Confidence 8653211 1234569999999999964 3467899999999999999999999986543322211111
Q ss_pred hcCcchhhhcccCCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 002158 848 DSGMVFSIIDNRMGSYPSECVERFVTLALRCCHDKPEHRPSMSDVVRE 895 (958)
Q Consensus 848 ~~~~~~~~i~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 895 (958)
..... .......+++++.+++.+||+.||++|||++|++++
T Consensus 230 ~~~~~-------~~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~h 270 (277)
T d1phka_ 230 GNYQF-------GSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAH 270 (277)
T ss_dssp TCCCC-------CTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTS
T ss_pred CCCCC-------CCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence 11000 011233567889999999999999999999999864
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.5e-46 Score=404.39 Aligned_cols=260 Identities=26% Similarity=0.452 Sum_probs=214.9
Q ss_pred HcCCCCCceeeeeCCeEEEEEEEC------CCcEEEEEEeccC-ChhcHHHHHHHHHHHHccCCCCcceEEEEEEeCCeE
Q 002158 624 TAYFSSSTQVGQGGYGKVYKGILS------DNTTVAIKRAEEG-SLQGQNEFLTEIKLLSRLHHRNLVSLLGYCDEEGEQ 696 (958)
Q Consensus 624 ~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~ 696 (958)
.++|...+.||+|+||+||+|.++ +++.||||+++.. .......|.+|++++++++||||++++|+|..++..
T Consensus 19 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~ 98 (308)
T d1p4oa_ 19 REKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPT 98 (308)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSSC
T ss_pred HHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEecCCce
Confidence 457778899999999999999873 3578999999754 344456799999999999999999999999999999
Q ss_pred EEEEEecCCCCHHHHhccCC--------CCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEecCCCCeEEe
Q 002158 697 MLVYEFVPNGTLRDWLSGRT--------KENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSNLNAKVA 768 (958)
Q Consensus 697 ~lV~E~~~~gsL~~~l~~~~--------~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~~~~kl~ 768 (958)
++||||+++|+|.+++.... ...+++..+.+++.|+|+||.|||+++ |+||||||+|||+++++++||+
T Consensus 99 ~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~---ivHrDlk~~NiLld~~~~~Kl~ 175 (308)
T d1p4oa_ 99 LVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKIG 175 (308)
T ss_dssp EEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCSGGGEEECTTCCEEEC
T ss_pred eEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCC---eeeceEcCCceeecCCceEEEe
Confidence 99999999999999986431 234789999999999999999999998 9999999999999999999999
Q ss_pred eeeeecccccCCCCCCccceeeeeccCCCCccChhhhccCCCCCcchhhhHHHHHHHHHhCC-CCCCCCchhHHHHHHHh
Q 002158 769 DFGLSRLAPVLDDEGTMPTHVSTIVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVLLELLTGM-QPISHGKNIVREVNVAR 847 (958)
Q Consensus 769 DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gv~l~elltG~-~P~~~~~~~~~~~~~~~ 847 (958)
|||+|+....... ........||+.|+|||.+.+..++.++||||||+++|||+||. .||. +.+..+......
T Consensus 176 DFGla~~~~~~~~-----~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~-~~~~~~~~~~i~ 249 (308)
T d1p4oa_ 176 DFGMTRDIYETDY-----YRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQ-GLSNEQVLRFVM 249 (308)
T ss_dssp CTTCCCGGGGGGC-----EEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTT-TSCHHHHHHHHH
T ss_pred ecccceeccCCcc-----eeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCC-CCCHHHHHHHHH
Confidence 9999986543221 12223346899999999999999999999999999999999985 5554 333333332222
Q ss_pred hcCcchhhhcccCCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHh
Q 002158 848 DSGMVFSIIDNRMGSYPSECVERFVTLALRCCHDKPEHRPSMSDVVRELENILK 901 (958)
Q Consensus 848 ~~~~~~~~i~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~ 901 (958)
+......|..++..+.+++.+||+.||++|||+++|+++|++.++
T Consensus 250 ---------~~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~~ 294 (308)
T d1p4oa_ 250 ---------EGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME 294 (308)
T ss_dssp ---------TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred ---------hCCCCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcC
Confidence 222334466777899999999999999999999999999988653
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=2.6e-45 Score=406.52 Aligned_cols=245 Identities=22% Similarity=0.294 Sum_probs=208.4
Q ss_pred cCCCCCceeeeeCCeEEEEEEEC-CCcEEEEEEeccCC---hhcHHHHHHHHHHHHccCCCCcceEEEEEEeCCeEEEEE
Q 002158 625 AYFSSSTQVGQGGYGKVYKGILS-DNTTVAIKRAEEGS---LQGQNEFLTEIKLLSRLHHRNLVSLLGYCDEEGEQMLVY 700 (958)
Q Consensus 625 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~ 700 (958)
++|+..+.||+|+||+||+|+++ +|+.||||++.... ....+.+.+|+++|+.++|||||++++++...+..++||
T Consensus 41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~ 120 (350)
T d1rdqe_ 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM 120 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccccccccccc
Confidence 46888999999999999999986 69999999986432 233567899999999999999999999999999999999
Q ss_pred EecCCCCHHHHhccCCCCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEecCCCCeEEeeeeeecccccCC
Q 002158 701 EFVPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSRLAPVLD 780 (958)
Q Consensus 701 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~ 780 (958)
||+.+|+|.+++.... .+++.++..++.|++.||+|||+++ ||||||||+|||++.++.+||+|||+|+....
T Consensus 121 e~~~~g~l~~~l~~~~--~l~e~~~~~i~~qi~~aL~yLH~~~---iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~-- 193 (350)
T d1rdqe_ 121 EYVAGGEMFSHLRRIG--RFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG-- 193 (350)
T ss_dssp ECCTTCBHHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECSS--
T ss_pred ccccccchhhhHhhcC--CCCHHHHHHHHHHHHHHHHHHHhCC---EecCcCCHHHcccCCCCCEEeeeceeeeeccc--
Confidence 9999999999997654 4899999999999999999999999 99999999999999999999999999986532
Q ss_pred CCCCccceeeeeccCCCCccChhhhccCCCCCcchhhhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcCcchhhhcccC
Q 002158 781 DEGTMPTHVSTIVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVLLELLTGMQPISHGKNIVREVNVARDSGMVFSIIDNRM 860 (958)
Q Consensus 781 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gv~l~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~i~~~~ 860 (958)
......||+.|||||++.+..++.++|||||||++|||+||+.||.+..... ...... ...
T Consensus 194 --------~~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~-~~~~i~----------~~~ 254 (350)
T d1rdqe_ 194 --------RTWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQ-IYEKIV----------SGK 254 (350)
T ss_dssp --------CBCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHHHH----------HCC
T ss_pred --------ccccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcCHHH-HHHHHh----------cCC
Confidence 1224569999999999999999999999999999999999999997544322 221111 112
Q ss_pred CCCChHHHHHHHHHHHHccccCCCCCC-----CHHHHHHH
Q 002158 861 GSYPSECVERFVTLALRCCHDKPEHRP-----SMSDVVRE 895 (958)
Q Consensus 861 ~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~~ 895 (958)
...+..++.++.+++.+||+.||.+|+ +++|++++
T Consensus 255 ~~~p~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~H 294 (350)
T d1rdqe_ 255 VRFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNH 294 (350)
T ss_dssp CCCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTS
T ss_pred CCCCccCCHHHHHHHHHHhhhCHHhccccccccHHHHHcC
Confidence 234556778899999999999999994 89998864
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-45 Score=399.48 Aligned_cols=261 Identities=26% Similarity=0.501 Sum_probs=211.3
Q ss_pred HcCCCCCceeeeeCCeEEEEEEECC--------CcEEEEEEeccCC-hhcHHHHHHHHHHHHcc-CCCCcceEEEEEEeC
Q 002158 624 TAYFSSSTQVGQGGYGKVYKGILSD--------NTTVAIKRAEEGS-LQGQNEFLTEIKLLSRL-HHRNLVSLLGYCDEE 693 (958)
Q Consensus 624 ~~~~~~~~~lg~G~~g~Vy~~~~~~--------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~ 693 (958)
.++|...+.||+|+||.||+|+... +..||||+++... .....++.+|+..+.++ +|||||+++++|.++
T Consensus 12 ~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~~ 91 (299)
T d1fgka_ 12 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD 91 (299)
T ss_dssp GGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred HHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccccccC
Confidence 3467778899999999999998632 3479999997654 34457899999999998 899999999999999
Q ss_pred CeEEEEEEecCCCCHHHHhccCC--------------CCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEe
Q 002158 694 GEQMLVYEFVPNGTLRDWLSGRT--------------KENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILL 759 (958)
Q Consensus 694 ~~~~lV~E~~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl 759 (958)
+..++||||+++|+|.+++..+. ...+++.++++++.|+|.||+|||+++ ||||||||+|||+
T Consensus 92 ~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~---ivHrDiKp~NiLl 168 (299)
T d1fgka_ 92 GPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK---CIHRDLAARNVLV 168 (299)
T ss_dssp SSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEE
T ss_pred CeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCC---EEeeeecccceee
Confidence 99999999999999999997553 235899999999999999999999999 9999999999999
Q ss_pred cCCCCeEEeeeeeecccccCCCCCCccceeeeeccCCCCccChhhhccCCCCCcchhhhHHHHHHHHHh-CCCCCCCCch
Q 002158 760 DSNLNAKVADFGLSRLAPVLDDEGTMPTHVSTIVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVLLELLT-GMQPISHGKN 838 (958)
Q Consensus 760 ~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gv~l~ellt-G~~P~~~~~~ 838 (958)
+.++.+||+|||+++........ .......||+.|+|||.+.++.|+.++|||||||++|||++ |..||.+...
T Consensus 169 ~~~~~~kl~dfg~~~~~~~~~~~-----~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~ 243 (299)
T d1fgka_ 169 TEDNVMKIADFGLARDIHHIDYY-----KKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV 243 (299)
T ss_dssp CTTCCEEECSTTCCCCGGGCCTT-----CCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH
T ss_pred cCCCCeEeccchhhccccccccc-----cccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCCH
Confidence 99999999999999876443321 22334568999999999999999999999999999999998 6888864433
Q ss_pred hHHHHHHHhhcCcchhhhcccCCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHhh
Q 002158 839 IVREVNVARDSGMVFSIIDNRMGSYPSECVERFVTLALRCCHDKPEHRPSMSDVVRELENILKM 902 (958)
Q Consensus 839 ~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~ 902 (958)
........ .......|..+++.+.+++.+||+.||.+|||++||++.|+++++.
T Consensus 244 -~~~~~~i~---------~~~~~~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i~a~ 297 (299)
T d1fgka_ 244 -EELFKLLK---------EGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVAL 297 (299)
T ss_dssp -HHHHHHHH---------TTCCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred -HHHHHHHH---------cCCCCCCCccchHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHhhc
Confidence 22222111 1222344566778899999999999999999999999999998764
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=9e-45 Score=404.38 Aligned_cols=249 Identities=22% Similarity=0.279 Sum_probs=201.5
Q ss_pred cCCCCCceeeeeCCeEEEEEEEC-CCcEEEEEEeccCC---hhcHHHHHH---HHHHHHccCCCCcceEEEEEEeCCeEE
Q 002158 625 AYFSSSTQVGQGGYGKVYKGILS-DNTTVAIKRAEEGS---LQGQNEFLT---EIKLLSRLHHRNLVSLLGYCDEEGEQM 697 (958)
Q Consensus 625 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~---E~~~l~~l~H~niv~l~~~~~~~~~~~ 697 (958)
++|++.+.||+|+||+||+|++. +|+.||||++.... ......+.+ |+++++.++|||||++++++.+++..|
T Consensus 4 ddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~~ 83 (364)
T d1omwa3 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLS 83 (364)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEE
T ss_pred HhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEEE
Confidence 46888899999999999999986 69999999986422 112233444 467777889999999999999999999
Q ss_pred EEEEecCCCCHHHHhccCCCCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEecCCCCeEEeeeeeecccc
Q 002158 698 LVYEFVPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSRLAP 777 (958)
Q Consensus 698 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~~~ 777 (958)
+|||||++|+|.+++.... .+++.++..++.||+.||+|||+++ ||||||||+|||++.++.+||+|||+|+...
T Consensus 84 ivmE~~~gg~L~~~l~~~~--~~~e~~~~~~~~qi~~aL~ylH~~~---iiHrDlKP~NILl~~~g~iKl~DFGla~~~~ 158 (364)
T d1omwa3 84 FILDLMNGGDLHYHLSQHG--VFSEADMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFS 158 (364)
T ss_dssp EEECCCCSCBHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECSSSCEEECCCTTCEECS
T ss_pred EEEEecCCCcHHHHHHhcc--cccHHHHHHHHHHHHHHHHHHHHCC---ccceeeccceeEEcCCCcEEEeeeceeeecC
Confidence 9999999999999997654 4889999999999999999999999 9999999999999999999999999998653
Q ss_pred cCCCCCCccceeeeeccCCCCccChhhhcc-CCCCCcchhhhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcCcchhhh
Q 002158 778 VLDDEGTMPTHVSTIVKGTPGYLDPEYFLT-HKLTDKSDVYSLGVVLLELLTGMQPISHGKNIVREVNVARDSGMVFSII 856 (958)
Q Consensus 778 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DV~S~Gv~l~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~i 856 (958)
.. ......||+.|+|||++.. ..++.++||||+||++|||+||+.||........... ...+
T Consensus 159 ~~---------~~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~--------~~~~ 221 (364)
T d1omwa3 159 KK---------KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEI--------DRMT 221 (364)
T ss_dssp SS---------CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHHH--------HHHS
T ss_pred CC---------cccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHHH--------HHhc
Confidence 21 1233569999999999975 4689999999999999999999999975432111100 0111
Q ss_pred cccCCCCChHHHHHHHHHHHHccccCCCCCCC-----HHHHHHH
Q 002158 857 DNRMGSYPSECVERFVTLALRCCHDKPEHRPS-----MSDVVRE 895 (958)
Q Consensus 857 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~evl~~ 895 (958)
.......+..+++++.+++.+||+.||++||+ ++|++++
T Consensus 222 ~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~H 265 (364)
T d1omwa3 222 LTMAVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKES 265 (364)
T ss_dssp SSCCCCCCSSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHTS
T ss_pred ccCCCCCCCCCCHHHHHHHHHHcccCHHHhCCCcccCHHHHHcC
Confidence 11122345567788999999999999999999 6888764
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-44 Score=394.58 Aligned_cols=263 Identities=21% Similarity=0.352 Sum_probs=198.4
Q ss_pred CCCCCceeeeeCCeEEEEEEECCCcEEEEEEeccCChhcHHHHHH--HHHHHHccCCCCcceEEEEEEeCC----eEEEE
Q 002158 626 YFSSSTQVGQGGYGKVYKGILSDNTTVAIKRAEEGSLQGQNEFLT--EIKLLSRLHHRNLVSLLGYCDEEG----EQMLV 699 (958)
Q Consensus 626 ~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~--E~~~l~~l~H~niv~l~~~~~~~~----~~~lV 699 (958)
.|...+.||+|+||+||+|++ +|+.||||++... ..+++.+ |+..+.+++||||++++++|.+++ ..++|
T Consensus 4 ~~~l~~~iG~G~fg~Vy~~~~-~g~~vAvK~~~~~---~~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~lv 79 (303)
T d1vjya_ 4 TIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSR---EERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLV 79 (303)
T ss_dssp GEEEEEEEECCSSSEEEEEEE-TTEEEEEEEECGG---GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEE
T ss_pred EEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECcc---chhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEEE
Confidence 455567899999999999997 6889999999653 2334444 455556789999999999997654 57999
Q ss_pred EEecCCCCHHHHhccCCCCCchHHHHHHHHHHHHHHHHHhhhcC-----CCCeeccCCCccceEecCCCCeEEeeeeeec
Q 002158 700 YEFVPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEA-----HPPVFHRDIKASNILLDSNLNAKVADFGLSR 774 (958)
Q Consensus 700 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~-----~~~iiH~Dikp~NILl~~~~~~kl~DFGla~ 774 (958)
||||++|+|.+++++. .+++.++++++.|+|.||+|+|+.+ .++|+||||||+|||++.++.+||+|||+++
T Consensus 80 ~Ey~~~g~L~~~l~~~---~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~~ 156 (303)
T d1vjya_ 80 SDYHEHGSLFDYLNRY---TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAV 156 (303)
T ss_dssp EECCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTCE
T ss_pred EecccCCCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCccc
Confidence 9999999999999764 3899999999999999999999741 2349999999999999999999999999998
Q ss_pred ccccCCCCCCccceeeeeccCCCCccChhhhccCC------CCCcchhhhHHHHHHHHHhCCCCCCCCchh---------
Q 002158 775 LAPVLDDEGTMPTHVSTIVKGTPGYLDPEYFLTHK------LTDKSDVYSLGVVLLELLTGMQPISHGKNI--------- 839 (958)
Q Consensus 775 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~------~~~~~DV~S~Gv~l~elltG~~P~~~~~~~--------- 839 (958)
........ .........||++|+|||++.+.. ++.++|||||||++|||+||..|+......
T Consensus 157 ~~~~~~~~---~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~ 233 (303)
T d1vjya_ 157 RHDSATDT---IDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVP 233 (303)
T ss_dssp EEETTTTE---ECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSC
T ss_pred cccCCCcc---eeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhccc
Confidence 76433221 111233467999999999987643 567899999999999999998887432110
Q ss_pred ----HHHHHHHhhcCcchhhhcccCCC--CChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHhh
Q 002158 840 ----VREVNVARDSGMVFSIIDNRMGS--YPSECVERFVTLALRCCHDKPEHRPSMSDVVRELENILKM 902 (958)
Q Consensus 840 ----~~~~~~~~~~~~~~~~i~~~~~~--~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~ 902 (958)
..........+ ..++..+. .+.+.+..+.+++.+||+.||++|||+.||++.|+++.+.
T Consensus 234 ~~~~~~~~~~~~~~~----~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~ 298 (303)
T d1vjya_ 234 SDPSVEEMRKVVCEQ----KLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQ 298 (303)
T ss_dssp SSCCHHHHHHHHTTS----CCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred ccchHHHHHHHHhcc----ccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHh
Confidence 01111110000 00111111 1235677899999999999999999999999999988754
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.1e-45 Score=399.28 Aligned_cols=247 Identities=26% Similarity=0.391 Sum_probs=205.7
Q ss_pred cCCCCCceeeeeCCeEEEEEEEC-CCcEEEEEEeccCC---hhcHHHHHHHHHHHH-ccCCCCcceEEEEEEeCCeEEEE
Q 002158 625 AYFSSSTQVGQGGYGKVYKGILS-DNTTVAIKRAEEGS---LQGQNEFLTEIKLLS-RLHHRNLVSLLGYCDEEGEQMLV 699 (958)
Q Consensus 625 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~-~l~H~niv~l~~~~~~~~~~~lV 699 (958)
++|...+.||+|+||+||+|+++ +++.||||+++... ....+.+..|..++. .++|||||++++++.+++..|+|
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yiv 81 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV 81 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEE
Confidence 46788899999999999999986 68999999996532 233456777777765 68999999999999999999999
Q ss_pred EEecCCCCHHHHhccCCCCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEecCCCCeEEeeeeeecccccC
Q 002158 700 YEFVPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSRLAPVL 779 (958)
Q Consensus 700 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~~~~~ 779 (958)
||||++|+|.++++.... +++.++..++.||+.||+|||+++ |+||||||+|||+++++.+||+|||+++.....
T Consensus 82 mEy~~~g~L~~~i~~~~~--~~e~~~~~~~~qi~~al~ylH~~~---iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~~ 156 (320)
T d1xjda_ 82 MEYLNGGDLMYHIQSCHK--FDLSRATFYAAEIILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCKENMLG 156 (320)
T ss_dssp EECCTTCBHHHHHHHHSS--CCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCCCCT
T ss_pred EeecCCCcHHHHhhccCC--CCHHHHHHHHHHHHHHHHHHHhCC---eeeccCcccceeecCCCceeccccchhhhcccc
Confidence 999999999999976543 889999999999999999999999 999999999999999999999999999854322
Q ss_pred CCCCCccceeeeeccCCCCccChhhhccCCCCCcchhhhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcCcchhhhccc
Q 002158 780 DDEGTMPTHVSTIVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVLLELLTGMQPISHGKNIVREVNVARDSGMVFSIIDNR 859 (958)
Q Consensus 780 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gv~l~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~i~~~ 859 (958)
. .......||+.|+|||++.+..++.++||||+||++|||++|+.||.+.... ....... ..
T Consensus 157 ~-------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~-~~~~~i~----------~~ 218 (320)
T d1xjda_ 157 D-------AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEE-ELFHSIR----------MD 218 (320)
T ss_dssp T-------CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-HHHHHHH----------HC
T ss_pred c-------ccccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCHH-HHHHHHH----------cC
Confidence 1 1223457999999999999999999999999999999999999999754432 2221111 11
Q ss_pred CCCCChHHHHHHHHHHHHccccCCCCCCCHH-HHHH
Q 002158 860 MGSYPSECVERFVTLALRCCHDKPEHRPSMS-DVVR 894 (958)
Q Consensus 860 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~-evl~ 894 (958)
...+|..++.++.+++.+||+.||++||++. |+++
T Consensus 219 ~~~~p~~~s~~~~dli~~~L~~dP~~R~s~~~~l~~ 254 (320)
T d1xjda_ 219 NPFYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQ 254 (320)
T ss_dssp CCCCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGG
T ss_pred CCCCCccCCHHHHHHHHHhcccCCCCCcCHHHHHHh
Confidence 2234566778899999999999999999995 6765
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-44 Score=398.86 Aligned_cols=248 Identities=23% Similarity=0.331 Sum_probs=199.0
Q ss_pred cCCCCCc-eeeeeCCeEEEEEEEC-CCcEEEEEEeccCChhcHHHHHHHHHHHHcc-CCCCcceEEEEEEe----CCeEE
Q 002158 625 AYFSSST-QVGQGGYGKVYKGILS-DNTTVAIKRAEEGSLQGQNEFLTEIKLLSRL-HHRNLVSLLGYCDE----EGEQM 697 (958)
Q Consensus 625 ~~~~~~~-~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~----~~~~~ 697 (958)
++|.+.. .||+|+||+||+|++. +++.||||+++. ...+.+|++++.++ +|||||++++++.+ +...|
T Consensus 11 ~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~-----~~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~~ 85 (335)
T d2ozaa1 11 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLL 85 (335)
T ss_dssp GTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred cCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECC-----cHHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEEE
Confidence 4566654 6999999999999985 689999999864 23567899987655 89999999999865 45789
Q ss_pred EEEEecCCCCHHHHhccCCCCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEecC---CCCeEEeeeeeec
Q 002158 698 LVYEFVPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDS---NLNAKVADFGLSR 774 (958)
Q Consensus 698 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~---~~~~kl~DFGla~ 774 (958)
+|||||+||+|.+++..+....+++.++..++.|++.||+|||+.+ |+||||||+|||++. ++.+||+|||+|+
T Consensus 86 ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~---iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a~ 162 (335)
T d2ozaa1 86 IVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFAK 162 (335)
T ss_dssp EEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCSSTTCCEEECCCTTCE
T ss_pred EEEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHHcC---Cccccccccccccccccccccccccccceee
Confidence 9999999999999998765567999999999999999999999999 999999999999985 5679999999998
Q ss_pred ccccCCCCCCccceeeeeccCCCCccChhhhccCCCCCcchhhhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcCcchh
Q 002158 775 LAPVLDDEGTMPTHVSTIVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVLLELLTGMQPISHGKNIVREVNVARDSGMVFS 854 (958)
Q Consensus 775 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gv~l~elltG~~P~~~~~~~~~~~~~~~~~~~~~~ 854 (958)
...... ......||+.|||||++.+..|+.++||||+||++|||+||+.||.+......... ...
T Consensus 163 ~~~~~~--------~~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~-------~~~ 227 (335)
T d2ozaa1 163 ETTSHN--------SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPG-------MKT 227 (335)
T ss_dssp ECCCCC--------CCCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC---------------
T ss_pred eccCCC--------ccccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHHH-------HHH
Confidence 653322 12345699999999999999999999999999999999999999964332111000 000
Q ss_pred hhcccCCCCC----hHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 002158 855 IIDNRMGSYP----SECVERFVTLALRCCHDKPEHRPSMSDVVRE 895 (958)
Q Consensus 855 ~i~~~~~~~~----~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 895 (958)
.+......+| ..+++++.+++.+||+.||++|||+.|++++
T Consensus 228 ~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 272 (335)
T d2ozaa1 228 RIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH 272 (335)
T ss_dssp CCCSCSSSCCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred HHhcCCCCCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence 1111111122 3456789999999999999999999999885
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.2e-44 Score=391.12 Aligned_cols=254 Identities=25% Similarity=0.311 Sum_probs=196.0
Q ss_pred CceeeeeCCeEEEEEEEC-CCcEEEEEEeccCChhc-----HHHHHHHHHHHHccCCCCcceEEEEEEeCCeEEEEEEec
Q 002158 630 STQVGQGGYGKVYKGILS-DNTTVAIKRAEEGSLQG-----QNEFLTEIKLLSRLHHRNLVSLLGYCDEEGEQMLVYEFV 703 (958)
Q Consensus 630 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~-----~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E~~ 703 (958)
.++||+|+||+||+|+++ +|+.||||+++...... .+.+.+|++++++++|||||++++++..++..++||||+
T Consensus 3 l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~~ 82 (299)
T d1ua2a_ 3 LDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFM 82 (299)
T ss_dssp EEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEECC
T ss_pred ceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhhh
Confidence 468999999999999975 68999999986543221 246889999999999999999999999999999999999
Q ss_pred CCCCHHHHhccCCCCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEecCCCCeEEeeeeeecccccCCCCC
Q 002158 704 PNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSRLAPVLDDEG 783 (958)
Q Consensus 704 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 783 (958)
+++++..+.... ..+++.++..++.||+.||+|||+++ |+||||||+|||+++++.+||+|||+|+......
T Consensus 83 ~~~~~~~~~~~~--~~l~~~~~~~~~~qil~aL~~lH~~~---iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~--- 154 (299)
T d1ua2a_ 83 ETDLEVIIKDNS--LVLTPSHIKAYMLMTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPN--- 154 (299)
T ss_dssp SEEHHHHHTTCC--SSCCSSHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCC---
T ss_pred cchHHhhhhhcc--cCCCHHHHHHHHHHHHHHHHHhhccc---eecccCCcceEEecCCCccccccCccccccCCCc---
Confidence 888777766433 34899999999999999999999999 9999999999999999999999999997653221
Q ss_pred CccceeeeeccCCCCccChhhhccC-CCCCcchhhhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcCcc-----hhhh-
Q 002158 784 TMPTHVSTIVKGTPGYLDPEYFLTH-KLTDKSDVYSLGVVLLELLTGMQPISHGKNIVREVNVARDSGMV-----FSII- 856 (958)
Q Consensus 784 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DV~S~Gv~l~elltG~~P~~~~~~~~~~~~~~~~~~~~-----~~~i- 856 (958)
.......||+.|+|||++... .++.++||||+||++|||++|+.||................+.. ....
T Consensus 155 ----~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~~~~~~~~~~~~~~~~ 230 (299)
T d1ua2a_ 155 ----RAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCS 230 (299)
T ss_dssp ----CCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTS
T ss_pred ----ccccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHHHHHhcCCCChhhccchhc
Confidence 112235699999999998755 57899999999999999999999997655433222211110000 0000
Q ss_pred ------cccCCCCC-----hHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 002158 857 ------DNRMGSYP-----SECVERFVTLALRCCHDKPEHRPSMSDVVRE 895 (958)
Q Consensus 857 ------~~~~~~~~-----~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 895 (958)
.......+ ...++++.+++.+||+.||++|||++|++++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~H 280 (299)
T d1ua2a_ 231 LPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM 280 (299)
T ss_dssp STTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred cchhhhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhCC
Confidence 00001111 1345678999999999999999999999864
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-44 Score=391.34 Aligned_cols=260 Identities=26% Similarity=0.366 Sum_probs=203.0
Q ss_pred cCCCCCceeeeeCCeEEEEEEEC-CCcEEEEEEeccCCh--hcHHHHHHHHHHHHccCCCCcceEEEEEEeCCeEEEEEE
Q 002158 625 AYFSSSTQVGQGGYGKVYKGILS-DNTTVAIKRAEEGSL--QGQNEFLTEIKLLSRLHHRNLVSLLGYCDEEGEQMLVYE 701 (958)
Q Consensus 625 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E 701 (958)
++|+..+.||+|+||+||+|++. +|+.||||+++.... ...+++.+|++++++++|||||++++++.+++..++|||
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e 81 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE 81 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEe
Confidence 47888899999999999999985 699999999965432 234678999999999999999999999999999999999
Q ss_pred ecCCCCHHHHhccCCCCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEecCCCCeEEeeeeeecccccCCC
Q 002158 702 FVPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSRLAPVLDD 781 (958)
Q Consensus 702 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~ 781 (958)
|+. +++.+++.......+++.++..++.|++.||+|||+++ ||||||||+|||++.++.+||+|||+|+......
T Consensus 82 ~~~-~~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~~---IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~- 156 (298)
T d1gz8a_ 82 FLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV- 156 (298)
T ss_dssp CCS-EEHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSTTHHHHHCCCS-
T ss_pred ecC-CchhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcCC---EEccccCchheeecccCcceeccCCcceeccCCc-
Confidence 996 55666665555556999999999999999999999999 9999999999999999999999999998653221
Q ss_pred CCCccceeeeeccCCCCccChhhhccCC-CCCcchhhhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcCcchh----hh
Q 002158 782 EGTMPTHVSTIVKGTPGYLDPEYFLTHK-LTDKSDVYSLGVVLLELLTGMQPISHGKNIVREVNVARDSGMVFS----II 856 (958)
Q Consensus 782 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DV~S~Gv~l~elltG~~P~~~~~~~~~~~~~~~~~~~~~~----~i 856 (958)
.......||+.|+|||.+.... ++.++||||+||++|||++|+.||.+..............+...+ ..
T Consensus 157 ------~~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 230 (298)
T d1gz8a_ 157 ------RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGV 230 (298)
T ss_dssp ------BCTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTG
T ss_pred ------ccceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHHHHHhcCCCchhhcccc
Confidence 1223356999999999987766 478999999999999999999999765543332222111111000 00
Q ss_pred ---cccCCCC-----------ChHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 002158 857 ---DNRMGSY-----------PSECVERFVTLALRCCHDKPEHRPSMSDVVRE 895 (958)
Q Consensus 857 ---~~~~~~~-----------~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 895 (958)
....... ....+.++.+++.+||+.||++|||++|++++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H 283 (298)
T d1gz8a_ 231 TSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAH 283 (298)
T ss_dssp GGSTTCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred ccccccccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCC
Confidence 0000000 11334678999999999999999999999975
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-44 Score=387.80 Aligned_cols=240 Identities=27% Similarity=0.446 Sum_probs=198.5
Q ss_pred cCCCCCceeeeeCCeEEEEEEEC-CCcEEEEEEeccCCh------hcHHHHHHHHHHHHccC--CCCcceEEEEEEeCCe
Q 002158 625 AYFSSSTQVGQGGYGKVYKGILS-DNTTVAIKRAEEGSL------QGQNEFLTEIKLLSRLH--HRNLVSLLGYCDEEGE 695 (958)
Q Consensus 625 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~--H~niv~l~~~~~~~~~ 695 (958)
++|++.+.||+|+||+||+|++. +|+.||||++..... ....++.+|++++++++ ||||+++++++.+++.
T Consensus 4 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~~ 83 (273)
T d1xwsa_ 4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDS 83 (273)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSE
T ss_pred CeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCCe
Confidence 46888899999999999999986 789999999864321 11234678999999996 8999999999999999
Q ss_pred EEEEEEecCC-CCHHHHhccCCCCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEecCC-CCeEEeeeeee
Q 002158 696 QMLVYEFVPN-GTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSN-LNAKVADFGLS 773 (958)
Q Consensus 696 ~~lV~E~~~~-gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~-~~~kl~DFGla 773 (958)
.++||||+.+ +++.+++.... .+++.++..++.|+++||+|||+++ |+||||||+|||++.+ +.+||+|||+|
T Consensus 84 ~~lv~e~~~~~~~l~~~~~~~~--~l~e~~~~~~~~qi~~al~~lH~~~---iiHrDiKp~NIll~~~~~~vkl~DFG~a 158 (273)
T d1xwsa_ 84 FVLILERPEPVQDLFDFITERG--ALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKLIDFGSG 158 (273)
T ss_dssp EEEEEECCSSEEEHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCCTTC
T ss_pred EEEEEEeccCcchHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHHCC---CccccCcccceEEecCCCeEEECccccc
Confidence 9999999975 68888886543 4899999999999999999999999 9999999999999854 79999999999
Q ss_pred cccccCCCCCCccceeeeeccCCCCccChhhhccCCC-CCcchhhhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcCcc
Q 002158 774 RLAPVLDDEGTMPTHVSTIVKGTPGYLDPEYFLTHKL-TDKSDVYSLGVVLLELLTGMQPISHGKNIVREVNVARDSGMV 852 (958)
Q Consensus 774 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DV~S~Gv~l~elltG~~P~~~~~~~~~~~~~~~~~~~~ 852 (958)
+.... .......||+.|+|||++.+..+ +.++||||+||++|||++|+.||....... .
T Consensus 159 ~~~~~---------~~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~i~-------~---- 218 (273)
T d1xwsa_ 159 ALLKD---------TVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEII-------R---- 218 (273)
T ss_dssp EECCS---------SCBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHHHH-------H----
T ss_pred eeccc---------ccccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCchHHh-------h----
Confidence 86422 11234579999999999988776 567899999999999999999997532110 0
Q ss_pred hhhhcccCCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 002158 853 FSIIDNRMGSYPSECVERFVTLALRCCHDKPEHRPSMSDVVRE 895 (958)
Q Consensus 853 ~~~i~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 895 (958)
....++..++.++.+++.+||+.||++|||++|++++
T Consensus 219 ------~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~h 255 (273)
T d1xwsa_ 219 ------GQVFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNH 255 (273)
T ss_dssp ------CCCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred ------cccCCCCCCCHHHHHHHHHHccCCHhHCcCHHHHhcC
Confidence 1112334456789999999999999999999999874
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=2.2e-43 Score=381.91 Aligned_cols=259 Identities=23% Similarity=0.314 Sum_probs=202.9
Q ss_pred cCCCCCceeeeeCCeEEEEEEECCCcEEEEEEeccCChh--cHHHHHHHHHHHHccCCCCcceEEEEEEeCCeEEEEEEe
Q 002158 625 AYFSSSTQVGQGGYGKVYKGILSDNTTVAIKRAEEGSLQ--GQNEFLTEIKLLSRLHHRNLVSLLGYCDEEGEQMLVYEF 702 (958)
Q Consensus 625 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E~ 702 (958)
++|+..+.||+|+||+||+|++++|+.||||++...... ..+++.+|+.+|++++||||+++++++..++..+++|||
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~ 81 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred CCceeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEEe
Confidence 468888999999999999999999999999999765322 246899999999999999999999999999999999999
Q ss_pred cCCCCHHHHhccCCCCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEecCCCCeEEeeeeeecccccCCCC
Q 002158 703 VPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSRLAPVLDDE 782 (958)
Q Consensus 703 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~ 782 (958)
+.++.+..+.... ..+++.++..++.|++.||+|||+.+ ||||||||+|||++.++.+||+|||.|.......
T Consensus 82 ~~~~~~~~~~~~~--~~l~~~~~~~i~~qi~~~L~~LH~~~---IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~-- 154 (286)
T d1ob3a_ 82 LDQDLKKLLDVCE--GGLESVTAKSFLLQLLNGIAYCHDRR---VLHRDLKPQNLLINREGELKIADFGLARAFGIPV-- 154 (286)
T ss_dssp CSEEHHHHHHTST--TCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCTTHHHHHCC----
T ss_pred ehhhhHHHHHhhc--CCcchhhhHHHHHHHHHHHHHhccCc---EEecCCCCceeeEcCCCCEEecccccceecccCc--
Confidence 9877777776543 44999999999999999999999999 9999999999999999999999999998653211
Q ss_pred CCccceeeeeccCCCCccChhhhccC-CCCCcchhhhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcCcc-----hhhh
Q 002158 783 GTMPTHVSTIVKGTPGYLDPEYFLTH-KLTDKSDVYSLGVVLLELLTGMQPISHGKNIVREVNVARDSGMV-----FSII 856 (958)
Q Consensus 783 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DV~S~Gv~l~elltG~~P~~~~~~~~~~~~~~~~~~~~-----~~~i 856 (958)
.......|++.|+|||.+.+. .++.++||||+||++|||++|+.||.+........+.....+.. ....
T Consensus 155 -----~~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 229 (286)
T d1ob3a_ 155 -----RKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVT 229 (286)
T ss_dssp ------------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGG
T ss_pred -----cccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCChhhccchh
Confidence 122344689999999999765 46899999999999999999999997654333222211110000 0000
Q ss_pred -----cccC--------CCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 002158 857 -----DNRM--------GSYPSECVERFVTLALRCCHDKPEHRPSMSDVVRE 895 (958)
Q Consensus 857 -----~~~~--------~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 895 (958)
.... .......+..+.+++.+||+.||++|||++|++++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~H 281 (286)
T d1ob3a_ 230 ELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEH 281 (286)
T ss_dssp GSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred hhhhcccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 0000 11223456788999999999999999999999864
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.6e-43 Score=384.20 Aligned_cols=260 Identities=24% Similarity=0.344 Sum_probs=199.3
Q ss_pred HcCCCCCceeeeeCCeEEEEEEEC-C-CcEEEEEEeccCC--hhcHHHHHHHHHHHHcc---CCCCcceEEEEEEe----
Q 002158 624 TAYFSSSTQVGQGGYGKVYKGILS-D-NTTVAIKRAEEGS--LQGQNEFLTEIKLLSRL---HHRNLVSLLGYCDE---- 692 (958)
Q Consensus 624 ~~~~~~~~~lg~G~~g~Vy~~~~~-~-~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l---~H~niv~l~~~~~~---- 692 (958)
.++|+..+.||+|+||+||+|++. + ++.||||+++... ......+.+|+++++.+ +||||+++++++..
T Consensus 6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~ 85 (305)
T d1blxa_ 6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD 85 (305)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccc
Confidence 357888999999999999999974 4 6779999986432 22233466788777766 79999999999853
Q ss_pred -CCeEEEEEEecCCCCHHHHhccCCCCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEecCCCCeEEeeee
Q 002158 693 -EGEQMLVYEFVPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSNLNAKVADFG 771 (958)
Q Consensus 693 -~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~~~~kl~DFG 771 (958)
....+++|||++++.+..... .....+++..+..++.|++.||+|||+++ |+||||||+|||+++++.+||+|||
T Consensus 86 ~~~~~~~~~e~~~~~~~~~~~~-~~~~~~~~~~~~~~~~qi~~aL~yLH~~~---ivHrDiKp~NILi~~~~~~kl~dfg 161 (305)
T d1blxa_ 86 RETKLTLVFEHVDQDLTTYLDK-VPEPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFG 161 (305)
T ss_dssp SEEEEEEEEECCSCBHHHHHHH-SCTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECSCC
T ss_pred cCceEEEEEEeccCCchhhhhh-ccCCCCCHHHHHHHHHHHHHHHHHHHhCC---EEecCCCccEEEEcCCCCeeecchh
Confidence 346899999998776655443 33445899999999999999999999999 9999999999999999999999999
Q ss_pred eecccccCCCCCCccceeeeeccCCCCccChhhhccCCCCCcchhhhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcCc
Q 002158 772 LSRLAPVLDDEGTMPTHVSTIVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVLLELLTGMQPISHGKNIVREVNVARDSGM 851 (958)
Q Consensus 772 la~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gv~l~elltG~~P~~~~~~~~~~~~~~~~~~~ 851 (958)
+++.... ........||+.|+|||++.+..|+.++||||+||++|||++|+.||.+..............+.
T Consensus 162 ~~~~~~~--------~~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~ 233 (305)
T d1blxa_ 162 LARIYSF--------QMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGL 233 (305)
T ss_dssp SCCCCCG--------GGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCC
T ss_pred hhhhhcc--------cccCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHHHHHHHHHHhhCC
Confidence 9875432 12234567999999999999999999999999999999999999999865543322221111000
Q ss_pred c------------hhhhc----ccCCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 002158 852 V------------FSIID----NRMGSYPSECVERFVTLALRCCHDKPEHRPSMSDVVRE 895 (958)
Q Consensus 852 ~------------~~~i~----~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 895 (958)
. ..... ......+...++.+.+++.+||+.||++|||++|++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~H 293 (305)
T d1blxa_ 234 PGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH 293 (305)
T ss_dssp CCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred CchhcccccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 0 00000 00011233456788999999999999999999999874
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.9e-42 Score=377.16 Aligned_cols=267 Identities=20% Similarity=0.266 Sum_probs=203.8
Q ss_pred cCCCCCceeeeeCCeEEEEEEEC-CCcEEEEEEeccCChhcHHHHHHHHHHHHccCCCCcce-EEEEEEeCCeEEEEEEe
Q 002158 625 AYFSSSTQVGQGGYGKVYKGILS-DNTTVAIKRAEEGSLQGQNEFLTEIKLLSRLHHRNLVS-LLGYCDEEGEQMLVYEF 702 (958)
Q Consensus 625 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~-l~~~~~~~~~~~lV~E~ 702 (958)
++|+..+.||+|+||+||+|++. +|+.||||++..... ..++..|+++++.++|+|++. +.++....+..++||||
T Consensus 7 ~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme~ 84 (299)
T d1ckia_ 7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMEL 84 (299)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTT--SCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEEC
T ss_pred CEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhcc--CHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEEE
Confidence 35788899999999999999985 689999999876432 235789999999998776554 45556778889999999
Q ss_pred cCCCCHHHHhccCCCCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEec---CCCCeEEeeeeeecccccC
Q 002158 703 VPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLD---SNLNAKVADFGLSRLAPVL 779 (958)
Q Consensus 703 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~---~~~~~kl~DFGla~~~~~~ 779 (958)
+ ++++.+.+.... ..+++..+..++.|++.||+|||+++ |+||||||+|||++ .+..+||+|||+|+.....
T Consensus 85 ~-~~~l~~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~---iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~~ 159 (299)
T d1ckia_ 85 L-GPSLEDLFNFCS-RKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDA 159 (299)
T ss_dssp C-CCBHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECCGGGTTCEEECCCSSCEECBCT
T ss_pred c-CCchhhhhhhcc-CCCcHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHhhccccccCCCceeeeeccCcceecccc
Confidence 9 567777665433 34999999999999999999999999 99999999999985 4567999999999977544
Q ss_pred CCCCCccceeeeeccCCCCccChhhhccCCCCCcchhhhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcCcchhhhccc
Q 002158 780 DDEGTMPTHVSTIVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVLLELLTGMQPISHGKNIVREVNVARDSGMVFSIIDNR 859 (958)
Q Consensus 780 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gv~l~elltG~~P~~~~~~~~~~~~~~~~~~~~~~~i~~~ 859 (958)
...............||+.|||||++.+..++.++|||||||++|||+||+.||.................... ...
T Consensus 160 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~---~~~ 236 (299)
T d1ckia_ 160 RTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKM---STP 236 (299)
T ss_dssp TTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHH---HSC
T ss_pred ccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcccC---CCC
Confidence 33333333344567799999999999999999999999999999999999999975432211111100000000 000
Q ss_pred CCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHh
Q 002158 860 MGSYPSECVERFVTLALRCCHDKPEHRPSMSDVVRELENILK 901 (958)
Q Consensus 860 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~ 901 (958)
.......+++++.+++.+||+.+|++||+++++.+.|+++..
T Consensus 237 ~~~~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~ 278 (299)
T d1ckia_ 237 IEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFH 278 (299)
T ss_dssp HHHHTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHH
T ss_pred hhHhccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHH
Confidence 011123456789999999999999999999999999988754
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=2.7e-42 Score=373.95 Aligned_cols=268 Identities=18% Similarity=0.238 Sum_probs=213.7
Q ss_pred cCCCCCceeeeeCCeEEEEEEEC-CCcEEEEEEeccCChhcHHHHHHHHHHHHccCC-CCcceEEEEEEeCCeEEEEEEe
Q 002158 625 AYFSSSTQVGQGGYGKVYKGILS-DNTTVAIKRAEEGSLQGQNEFLTEIKLLSRLHH-RNLVSLLGYCDEEGEQMLVYEF 702 (958)
Q Consensus 625 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H-~niv~l~~~~~~~~~~~lV~E~ 702 (958)
++|.+.+.||+|+||+||+|++. +|+.||||++..... ...+.+|++.++.++| +|++.+++++..+...++||||
T Consensus 5 ~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme~ 82 (293)
T d1csna_ 5 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD--APQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDL 82 (293)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT--SCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEEC
T ss_pred CceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccC--cHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEEEe
Confidence 46888899999999999999976 689999998865432 2347789999999965 8999999999999999999999
Q ss_pred cCCCCHHHHhccCCCCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEecC-----CCCeEEeeeeeecccc
Q 002158 703 VPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDS-----NLNAKVADFGLSRLAP 777 (958)
Q Consensus 703 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~-----~~~~kl~DFGla~~~~ 777 (958)
+ +++|.++++... ..++..++..++.|++.||+|||+.+ |+||||||+|||++. ++.+||+|||+|+.+.
T Consensus 83 ~-~~~l~~~~~~~~-~~~~~~~~~~i~~q~~~~l~~lH~~g---iiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~~ 157 (293)
T d1csna_ 83 L-GPSLEDLLDLCG-RKFSVKTVAMAAKQMLARVQSIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYR 157 (293)
T ss_dssp C-CCBHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESB
T ss_pred c-CCCHHHHHHhhc-cchhhHHHHHHHHHHHHHHHHHHHCC---ceeccCCccceeecCcccccCCceEEcccceeEEcc
Confidence 9 789999987544 35899999999999999999999999 999999999999974 5789999999999875
Q ss_pred cCCCCCCccceeeeeccCCCCccChhhhccCCCCCcchhhhHHHHHHHHHhCCCCCCCCchh--HHHHHHHhhcCcchhh
Q 002158 778 VLDDEGTMPTHVSTIVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVLLELLTGMQPISHGKNI--VREVNVARDSGMVFSI 855 (958)
Q Consensus 778 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gv~l~elltG~~P~~~~~~~--~~~~~~~~~~~~~~~~ 855 (958)
........+........||+.|||||++.+..++.++|||||||++|||+||+.||.+.... ............ .
T Consensus 158 ~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~~-~-- 234 (293)
T d1csna_ 158 DPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQ-S-- 234 (293)
T ss_dssp CTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHH-H--
T ss_pred cCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhccC-C--
Confidence 44333333333445678999999999999999999999999999999999999999753321 111111110000 0
Q ss_pred hcccCCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHHhHhhCC
Q 002158 856 IDNRMGSYPSECVERFVTLALRCCHDKPEHRPSMSDVVRELENILKMFP 904 (958)
Q Consensus 856 i~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~~ 904 (958)
.........+|+++.+++..|+..+|++||+++.+.+.|+++++...
T Consensus 235 --~~~~~l~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~~~~~~~ 281 (293)
T d1csna_ 235 --TPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLN 281 (293)
T ss_dssp --SCHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTT
T ss_pred --CChHHhcCCCCHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHHHHcC
Confidence 00001123356789999999999999999999999999999886654
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-41 Score=371.41 Aligned_cols=263 Identities=22% Similarity=0.295 Sum_probs=196.7
Q ss_pred cCCCCCceeeeeCCeEEEEEEEC-CCcEEEEEEeccC--ChhcHHHHHHHHHHHHccCCCCcceEEEEEEe--------C
Q 002158 625 AYFSSSTQVGQGGYGKVYKGILS-DNTTVAIKRAEEG--SLQGQNEFLTEIKLLSRLHHRNLVSLLGYCDE--------E 693 (958)
Q Consensus 625 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~--------~ 693 (958)
++|+..+.||+|+||+||+|++. +|+.||||++... .....+++.+|+++|++++|||++++++++.. +
T Consensus 10 ~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~~ 89 (318)
T d3blha1 10 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCK 89 (318)
T ss_dssp GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC---------
T ss_pred CCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeecccccccccC
Confidence 46788899999999999999985 7999999998643 23335678999999999999999999999855 3
Q ss_pred CeEEEEEEecCCCCHHHHhccCCCCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEecCCCCeEEeeeeee
Q 002158 694 GEQMLVYEFVPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSNLNAKVADFGLS 773 (958)
Q Consensus 694 ~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla 773 (958)
+..++||||++++.+..+.... ..++...+..++.|+++||+|||+++ |+||||||+|||++.++.+||+|||++
T Consensus 90 ~~~~iv~e~~~~~~~~~~~~~~--~~~~~~~~~~i~~qil~~l~~lH~~~---ivHrDlKp~NILl~~~~~~kl~dfg~~ 164 (318)
T d3blha1 90 GSIYLVFDFCEHDLAGLLSNVL--VKFTLSEIKRVMQMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFGLA 164 (318)
T ss_dssp -CEEEEEECCCEEHHHHHTCTT--CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCTTC
T ss_pred ceEEEEEeccCCCccchhhhcc--cccccHHHHHHHHHHHHHHHHhccCC---EEecCcCchheeecCCCcEEeeeccee
Confidence 4689999999877666555433 34888999999999999999999999 999999999999999999999999999
Q ss_pred cccccCCCCCCccceeeeeccCCCCccChhhhccC-CCCCcchhhhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcCcc
Q 002158 774 RLAPVLDDEGTMPTHVSTIVKGTPGYLDPEYFLTH-KLTDKSDVYSLGVVLLELLTGMQPISHGKNIVREVNVARDSGMV 852 (958)
Q Consensus 774 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DV~S~Gv~l~elltG~~P~~~~~~~~~~~~~~~~~~~~ 852 (958)
+......... ........||+.|+|||++.+. .++.++||||+||++|||++|+.||.+..............+..
T Consensus 165 ~~~~~~~~~~---~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~~~~ 241 (318)
T d3blha1 165 RAFSLAKNSQ---PNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSI 241 (318)
T ss_dssp EECCC--------CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCC
T ss_pred eecccccccc---cccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHHhcCCC
Confidence 8654322211 1122335699999999999765 68899999999999999999999997654332222111111111
Q ss_pred hhhhccc------------CCCCCh---------HHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 002158 853 FSIIDNR------------MGSYPS---------ECVERFVTLALRCCHDKPEHRPSMSDVVRE 895 (958)
Q Consensus 853 ~~~i~~~------------~~~~~~---------~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 895 (958)
....... ....+. .....+.+++.+||+.||++|||++|++++
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~H 305 (318)
T d3blha1 242 TPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH 305 (318)
T ss_dssp CTTTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred ChhhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcC
Confidence 0000000 000000 113456789999999999999999999974
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.2e-42 Score=379.60 Aligned_cols=254 Identities=23% Similarity=0.351 Sum_probs=196.5
Q ss_pred cCCCCCceeeeeCCeEEEEEEEC-CCcEEEEEEeccC--ChhcHHHHHHHHHHHHccCCCCcceEEEEEEeCC------e
Q 002158 625 AYFSSSTQVGQGGYGKVYKGILS-DNTTVAIKRAEEG--SLQGQNEFLTEIKLLSRLHHRNLVSLLGYCDEEG------E 695 (958)
Q Consensus 625 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~------~ 695 (958)
++|+..+.||+|+||+||+|++. +|+.||||+++.. .....+.+.+|+++|++++|||||+++++|...+ .
T Consensus 18 ~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~~ 97 (346)
T d1cm8a_ 18 AVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTD 97 (346)
T ss_dssp SSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCCC
T ss_pred CcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccce
Confidence 57888899999999999999986 6999999999754 3334567899999999999999999999997654 5
Q ss_pred EEEEEEecCCCCHHHHhccCCCCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEecCCCCeEEeeeeeecc
Q 002158 696 QMLVYEFVPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSRL 775 (958)
Q Consensus 696 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~ 775 (958)
.++||||+ +.+|.++++.. .+++..+..++.|++.||+|||+++ |+||||||+|||++.++.+|++|||+|+.
T Consensus 98 ~~lv~e~~-~~~l~~~~~~~---~l~~~~~~~~~~qi~~aL~~LH~~~---IiHrDiKp~NIL~~~~~~~kl~Dfg~a~~ 170 (346)
T d1cm8a_ 98 FYLVMPFM-GTDLGKLMKHE---KLGEDRIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLARQ 170 (346)
T ss_dssp CEEEEECC-SEEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred EEEEEecc-cccHHHHHHhc---cccHHHHHHHHHHHHHHHHHHHhCC---CcccccCcchhhcccccccccccccceec
Confidence 79999999 67888888643 3999999999999999999999999 99999999999999999999999999986
Q ss_pred cccCCCCCCccceeeeeccCCCCccChhhhccC-CCCCcchhhhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcCcch-
Q 002158 776 APVLDDEGTMPTHVSTIVKGTPGYLDPEYFLTH-KLTDKSDVYSLGVVLLELLTGMQPISHGKNIVREVNVARDSGMVF- 853 (958)
Q Consensus 776 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DV~S~Gv~l~elltG~~P~~~~~~~~~~~~~~~~~~~~~- 853 (958)
... ..+...||+.|+|||++.+. .++.++||||+||++|||++|+.||.+..............+...
T Consensus 171 ~~~----------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~ 240 (346)
T d1cm8a_ 171 ADS----------EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPA 240 (346)
T ss_dssp CCS----------SCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCH
T ss_pred cCC----------ccccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCCcH
Confidence 422 12345699999999999875 568899999999999999999999986654332221111111000
Q ss_pred hh---------------h----cccCCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 002158 854 SI---------------I----DNRMGSYPSECVERFVTLALRCCHDKPEHRPSMSDVVRE 895 (958)
Q Consensus 854 ~~---------------i----~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 895 (958)
+. . ...........+..+.+|+.+||+.||++|||++|++++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~H 301 (346)
T d1cm8a_ 241 EFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAH 301 (346)
T ss_dssp HHHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred HHHhhhcchhhhhhhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 00 0 000011223445678899999999999999999999985
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-41 Score=376.70 Aligned_cols=261 Identities=22% Similarity=0.311 Sum_probs=197.4
Q ss_pred cCCCCCceeeeeCCeEEEEEEEC-CCcEEEEEEeccC-ChhcHHHHHHHHHHHHccCCCCcceEEEEEEeCC----eEEE
Q 002158 625 AYFSSSTQVGQGGYGKVYKGILS-DNTTVAIKRAEEG-SLQGQNEFLTEIKLLSRLHHRNLVSLLGYCDEEG----EQML 698 (958)
Q Consensus 625 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~----~~~l 698 (958)
.+|...+.||+|+||+||+|++. +|+.||||++... .....+++.+|+++|++++||||+++++++.... ..++
T Consensus 8 ~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~~ 87 (345)
T d1pmea_ 8 PRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVY 87 (345)
T ss_dssp TTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCEE
T ss_pred CCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceEE
Confidence 46788899999999999999975 7999999999754 3344567999999999999999999999997643 2345
Q ss_pred EEEecCCCCHHHHhccCCCCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEecCCCCeEEeeeeeeccccc
Q 002158 699 VYEFVPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSRLAPV 778 (958)
Q Consensus 699 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~~~~ 778 (958)
+++|+.+|+|.+++..+ .+++..+..++.|++.||+|||+++ ||||||||+|||++.++.+||+|||+|+....
T Consensus 88 l~~~~~~g~L~~~l~~~---~l~~~~i~~i~~qil~al~yLH~~~---iiHRDIKp~NILl~~~~~~kl~DfG~a~~~~~ 161 (345)
T d1pmea_ 88 LVTHLMGADLYKLLKTQ---HLSNDHICYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADP 161 (345)
T ss_dssp EEEECCCEEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECCG
T ss_pred EEEeecCCchhhhhhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCcceEEECCCCCEEEcccCceeeccC
Confidence 55667799999999754 3899999999999999999999999 99999999999999999999999999986543
Q ss_pred CCCCCCccceeeeeccCCCCccChhhhcc-CCCCCcchhhhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcCcch-h--
Q 002158 779 LDDEGTMPTHVSTIVKGTPGYLDPEYFLT-HKLTDKSDVYSLGVVLLELLTGMQPISHGKNIVREVNVARDSGMVF-S-- 854 (958)
Q Consensus 779 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DV~S~Gv~l~elltG~~P~~~~~~~~~~~~~~~~~~~~~-~-- 854 (958)
.... ........||+.|+|||++.. ..++.++||||+||++|||++|+.||.................... .
T Consensus 162 ~~~~----~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 237 (345)
T d1pmea_ 162 DHDH----TGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDL 237 (345)
T ss_dssp GGCB----CCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHH
T ss_pred CCcc----ceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCCChhhh
Confidence 2221 111234569999999999854 4678899999999999999999999976543222211111000000 0
Q ss_pred ----------hh--cccCCCC-----ChHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 002158 855 ----------II--DNRMGSY-----PSECVERFVTLALRCCHDKPEHRPSMSDVVRE 895 (958)
Q Consensus 855 ----------~i--~~~~~~~-----~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 895 (958)
.. ....... ......++.+++.+|++.||++|||++|++++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~h 295 (345)
T d1pmea_ 238 NCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH 295 (345)
T ss_dssp HTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred hhhhhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 00 0000000 11234578899999999999999999999975
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-41 Score=376.77 Aligned_cols=255 Identities=24% Similarity=0.323 Sum_probs=193.8
Q ss_pred CCCCCceeeeeCCeEEEEEEEC-CCcEEEEEEeccCChhcHHHHHHHHHHHHccCCCCcceEEEEEEeC------CeEEE
Q 002158 626 YFSSSTQVGQGGYGKVYKGILS-DNTTVAIKRAEEGSLQGQNEFLTEIKLLSRLHHRNLVSLLGYCDEE------GEQML 698 (958)
Q Consensus 626 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~------~~~~l 698 (958)
.|+..++||+|+||+||+|++. +|+.||||++...... +.+|+++|++++||||+++++++... .+.++
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~----~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~l 96 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRF----KNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNL 96 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSS----CCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEE
T ss_pred CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccchH----HHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEE
Confidence 4666789999999999999986 6999999999764322 34799999999999999999998543 35789
Q ss_pred EEEecCCCCHHHHhcc-CCCCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEecCCC-CeEEeeeeeeccc
Q 002158 699 VYEFVPNGTLRDWLSG-RTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSNL-NAKVADFGLSRLA 776 (958)
Q Consensus 699 V~E~~~~gsL~~~l~~-~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~~-~~kl~DFGla~~~ 776 (958)
|||||+++.+..+.+. .....+++.++..++.|++.||+|||+++ |+||||||+|||++.++ .+||+|||+++..
T Consensus 97 v~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~---IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~ 173 (350)
T d1q5ka_ 97 VLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 173 (350)
T ss_dssp EEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTTCCEEECCCTTCEEC
T ss_pred EEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcC---CcccCCCcceEEEecCCCceeEecccchhhc
Confidence 9999976544433321 23345999999999999999999999999 99999999999999775 8999999999865
Q ss_pred ccCCCCCCccceeeeeccCCCCccChhhhcc-CCCCCcchhhhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcCc-chh
Q 002158 777 PVLDDEGTMPTHVSTIVKGTPGYLDPEYFLT-HKLTDKSDVYSLGVVLLELLTGMQPISHGKNIVREVNVARDSGM-VFS 854 (958)
Q Consensus 777 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DV~S~Gv~l~elltG~~P~~~~~~~~~~~~~~~~~~~-~~~ 854 (958)
.... ......||..|+|||.+.+ ..++.++||||+||++|||++|+.||................+. ..+
T Consensus 174 ~~~~--------~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~ 245 (350)
T d1q5ka_ 174 VRGE--------PNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTRE 245 (350)
T ss_dssp CTTS--------CCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCHH
T ss_pred cCCc--------ccccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCCChHH
Confidence 3221 1223569999999999875 46899999999999999999999999765543322221111000 000
Q ss_pred hh--------cccC---------CCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 002158 855 II--------DNRM---------GSYPSECVERFVTLALRCCHDKPEHRPSMSDVVRE 895 (958)
Q Consensus 855 ~i--------~~~~---------~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 895 (958)
.+ .... .......++++.+|+.+||+.||++|||++|++++
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H 303 (350)
T d1q5ka_ 246 QIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAH 303 (350)
T ss_dssp HHHHHCC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred hhhhhccchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 00 0000 01122456778999999999999999999999975
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.2e-41 Score=364.73 Aligned_cols=259 Identities=23% Similarity=0.318 Sum_probs=207.6
Q ss_pred cCCCCCceeeeeCCeEEEEEEEC-CCcEEEEEEeccCC--hhcHHHHHHHHHHHHccCCCCcceEEEEEEeCCeEEEEEE
Q 002158 625 AYFSSSTQVGQGGYGKVYKGILS-DNTTVAIKRAEEGS--LQGQNEFLTEIKLLSRLHHRNLVSLLGYCDEEGEQMLVYE 701 (958)
Q Consensus 625 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E 701 (958)
++|+..+.||+|+||+||+|++. +++.||||+++... ....+++.+|+.+++.++||||+++++++.+....++|||
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~ 81 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEee
Confidence 46888899999999999999985 78999999986543 3345789999999999999999999999999999999999
Q ss_pred ecCCCCHHHHhccCCCCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEecCCCCeEEeeeeeecccccCCC
Q 002158 702 FVPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSRLAPVLDD 781 (958)
Q Consensus 702 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~~~~~~~ 781 (958)
++.++++..++.... .+++..+..++.|+++||+|||+++ |+||||||+|||++.++.+||+|||.|+.......
T Consensus 82 ~~~~~~l~~~~~~~~--~~~~~~~~~~~~q~~~aL~~lH~~~---IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~~ 156 (292)
T d1unla_ 82 FCDQDLKKYFDSCNG--DLDPEIVKSFLFQLLKGLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLARAFGIPVR 156 (292)
T ss_dssp CCSEEHHHHHHHTTT--CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSCCS
T ss_pred ecccccccccccccc--ccchhHHHHHHHHHHHHHHHhhcCC---EeeecccCcccccccCCceeeeecchhhcccCCCc
Confidence 999999988886543 4889999999999999999999999 99999999999999999999999999986543221
Q ss_pred CCCccceeeeeccCCCCccChhhhccCC-CCCcchhhhHHHHHHHHHhCCCCCCCCchhHHHHHHHhh-cCcc-------
Q 002158 782 EGTMPTHVSTIVKGTPGYLDPEYFLTHK-LTDKSDVYSLGVVLLELLTGMQPISHGKNIVREVNVARD-SGMV------- 852 (958)
Q Consensus 782 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DV~S~Gv~l~elltG~~P~~~~~~~~~~~~~~~~-~~~~------- 852 (958)
......++..|+|||.+.... ++.++||||+||++|||++|+.||..+.+.......... .+..
T Consensus 157 -------~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (292)
T d1unla_ 157 -------CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPS 229 (292)
T ss_dssp -------CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTT
T ss_pred -------cceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcCCCChhhhhh
Confidence 122345778899999988765 688999999999999999999998766654444332111 0000
Q ss_pred -hhhh----------cccCCCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 002158 853 -FSII----------DNRMGSYPSECVERFVTLALRCCHDKPEHRPSMSDVVRE 895 (958)
Q Consensus 853 -~~~i----------~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 895 (958)
.... ..............+.+++.+|++.||++|||++|++++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~H 283 (292)
T d1unla_ 230 MTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQH 283 (292)
T ss_dssp GGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred hhhcccccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 0000 011112234456778999999999999999999999864
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-41 Score=370.23 Aligned_cols=251 Identities=25% Similarity=0.303 Sum_probs=202.2
Q ss_pred cCCCCCceeeeeCCeEEEEEEEC----CCcEEEEEEeccCC----hhcHHHHHHHHHHHHccCC-CCcceEEEEEEeCCe
Q 002158 625 AYFSSSTQVGQGGYGKVYKGILS----DNTTVAIKRAEEGS----LQGQNEFLTEIKLLSRLHH-RNLVSLLGYCDEEGE 695 (958)
Q Consensus 625 ~~~~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~H-~niv~l~~~~~~~~~ 695 (958)
++|+..+.||+|+||+||+|... +|+.||||+++... ....+.+.+|++++++++| |||+++++++.+...
T Consensus 24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~ 103 (322)
T d1vzoa_ 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK 103 (322)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred hceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCCc
Confidence 56888999999999999999862 47899999986432 2234568899999999966 899999999999999
Q ss_pred EEEEEEecCCCCHHHHhccCCCCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEecCCCCeEEeeeeeecc
Q 002158 696 QMLVYEFVPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSRL 775 (958)
Q Consensus 696 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~ 775 (958)
.++||||+.+|+|.+++..... ++...+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++.
T Consensus 104 ~~~v~e~~~~~~L~~~i~~~~~--~~e~~~~~~~~Qi~~al~~lH~~~---ivHrDiKp~Nill~~~~~vkL~DFG~a~~ 178 (322)
T d1vzoa_ 104 LHLILDYINGGELFTHLSQRER--FTEHEVQIYVGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSKE 178 (322)
T ss_dssp EEEEECCCCSCBHHHHHHHHSC--CCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEESCSSEEEE
T ss_pred eeeeeecccccHHHHHHHhccc--ccHHHHHHHHHHHHHHHHHhhcCC---EEeccCCccceeecCCCCEEEeeccchhh
Confidence 9999999999999999976543 678889999999999999999999 99999999999999999999999999986
Q ss_pred cccCCCCCCccceeeeeccCCCCccChhhhccC--CCCCcchhhhHHHHHHHHHhCCCCCCCCch--hHHHHHHHhhcCc
Q 002158 776 APVLDDEGTMPTHVSTIVKGTPGYLDPEYFLTH--KLTDKSDVYSLGVVLLELLTGMQPISHGKN--IVREVNVARDSGM 851 (958)
Q Consensus 776 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DV~S~Gv~l~elltG~~P~~~~~~--~~~~~~~~~~~~~ 851 (958)
..... ........|++.|+|||.+.+. .++.++||||+||++|||++|+.||..... ....+....
T Consensus 179 ~~~~~------~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~~~---- 248 (322)
T d1vzoa_ 179 FVADE------TERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRI---- 248 (322)
T ss_dssp CCGGG------GGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHH----
T ss_pred hcccc------cccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhc----
Confidence 53322 2223346799999999999765 467799999999999999999999965432 111111110
Q ss_pred chhhhcccCCCCChHHHHHHHHHHHHccccCCCCCCC-----HHHHHHH
Q 002158 852 VFSIIDNRMGSYPSECVERFVTLALRCCHDKPEHRPS-----MSDVVRE 895 (958)
Q Consensus 852 ~~~~i~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~evl~~ 895 (958)
.......+..++.++.+++.+||+.||++||| ++|++++
T Consensus 249 -----~~~~~~~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~H 292 (322)
T d1vzoa_ 249 -----LKSEPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEH 292 (322)
T ss_dssp -----HHCCCCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTS
T ss_pred -----ccCCCCCcccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHcC
Confidence 01112345667889999999999999999995 7888753
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=2.6e-40 Score=365.14 Aligned_cols=252 Identities=18% Similarity=0.303 Sum_probs=197.8
Q ss_pred cCCCCCceeeeeCCeEEEEEEEC-CCcEEEEEEeccCChhcHHHHHHHHHHHHccC-CCCcceEEEEEEe--CCeEEEEE
Q 002158 625 AYFSSSTQVGQGGYGKVYKGILS-DNTTVAIKRAEEGSLQGQNEFLTEIKLLSRLH-HRNLVSLLGYCDE--EGEQMLVY 700 (958)
Q Consensus 625 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~--~~~~~lV~ 700 (958)
++|++.+.||+|+||+||+|++. +|+.||||+++... .+++.+|+++|++++ ||||+++++++.. ....++||
T Consensus 35 d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~---~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v~ 111 (328)
T d3bqca1 35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK---KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVF 111 (328)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSSC---HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEEE
T ss_pred cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHHH---HHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEEE
Confidence 47889999999999999999985 68999999997543 457889999999995 9999999999974 45689999
Q ss_pred EecCCCCHHHHhccCCCCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEecCCC-CeEEeeeeeecccccC
Q 002158 701 EFVPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSNL-NAKVADFGLSRLAPVL 779 (958)
Q Consensus 701 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~~-~~kl~DFGla~~~~~~ 779 (958)
||+++++|.++.+ .+++.++..++.||+.||+|||+++ |+||||||+|||++.++ .+||+|||+|+.....
T Consensus 112 e~~~~~~L~~~~~-----~l~e~~i~~i~~qil~aL~~LH~~g---IvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~~ 183 (328)
T d3bqca1 112 EHVNNTDFKQLYQ-----TLTDYDIRFYMYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPG 183 (328)
T ss_dssp ECCCSCBGGGTTT-----SCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEECCGGGCEECCTT
T ss_pred eecCCCcHHHHhc-----CCCHHHHHHHHHHHHHHHHHHhhcc---cccccccccceEEcCCCCeeeecccccceeccCC
Confidence 9999999977642 3899999999999999999999999 99999999999998655 6999999999865332
Q ss_pred CCCCCccceeeeeccCCCCccChhhhccCC-CCCcchhhhHHHHHHHHHhCCCCCCCCchhHHHHHHH-hh---------
Q 002158 780 DDEGTMPTHVSTIVKGTPGYLDPEYFLTHK-LTDKSDVYSLGVVLLELLTGMQPISHGKNIVREVNVA-RD--------- 848 (958)
Q Consensus 780 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DV~S~Gv~l~elltG~~P~~~~~~~~~~~~~~-~~--------- 848 (958)
. ......||+.|+|||.+.+.. ++.++||||+||++|||++|+.||............. ..
T Consensus 184 ~--------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~ 255 (328)
T d3bqca1 184 Q--------EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDY 255 (328)
T ss_dssp C--------CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHH
T ss_pred C--------cccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhh
Confidence 1 123456899999999988764 7899999999999999999999997654322211110 00
Q ss_pred -----cCcc--h-hhhcc--------cC-CCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 002158 849 -----SGMV--F-SIIDN--------RM-GSYPSECVERFVTLALRCCHDKPEHRPSMSDVVRE 895 (958)
Q Consensus 849 -----~~~~--~-~~i~~--------~~-~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 895 (958)
.... . ..... .. .......++++.+++.+|++.||++|||++|++++
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~H 319 (328)
T d3bqca1 256 IDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEH 319 (328)
T ss_dssp HHHTTCCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred hhhcccccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 0000 0 00000 00 01122355778999999999999999999999863
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.7e-40 Score=366.55 Aligned_cols=255 Identities=22% Similarity=0.289 Sum_probs=191.7
Q ss_pred cCCCCCceeeeeCCeEEEEEEEC-CCcEEEEEEeccC--ChhcHHHHHHHHHHHHccCCCCcceEEEEEEe------CCe
Q 002158 625 AYFSSSTQVGQGGYGKVYKGILS-DNTTVAIKRAEEG--SLQGQNEFLTEIKLLSRLHHRNLVSLLGYCDE------EGE 695 (958)
Q Consensus 625 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~------~~~ 695 (958)
++|.+.+.||+|+||+||+|++. +|+.||||++... ......++.+|+.++++++||||+++++++.. ...
T Consensus 17 ~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~ 96 (355)
T d2b1pa1 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQD 96 (355)
T ss_dssp TTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCE
T ss_pred CCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCce
Confidence 46788899999999999999986 6999999999754 23445678999999999999999999999964 367
Q ss_pred EEEEEEecCCCCHHHHhccCCCCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEecCCCCeEEeeeeeecc
Q 002158 696 QMLVYEFVPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSRL 775 (958)
Q Consensus 696 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~ 775 (958)
.|+||||+.++ +.+.+.. .+++..+..++.|++.||+|||+.| |+||||||+|||++.++.+|++|||+++.
T Consensus 97 ~~iv~Ey~~~~-l~~~~~~----~~~~~~i~~~~~qil~gl~~LH~~g---iiHrDlKP~Nil~~~~~~~kl~df~~~~~ 168 (355)
T d2b1pa1 97 VYLVMELMDAN-LCQVIQM----ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLART 168 (355)
T ss_dssp EEEEEECCSEE-HHHHHTS----CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC---
T ss_pred eEEEEeccchH-HHHhhhc----CCCHHHHHHHHHHHHHHHHHhhhcc---cccccCCccccccccccceeeechhhhhc
Confidence 89999999654 5455532 3889999999999999999999999 99999999999999999999999999875
Q ss_pred cccCCCCCCccceeeeeccCCCCccChhhhccCCCCCcchhhhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcCc-c--
Q 002158 776 APVLDDEGTMPTHVSTIVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVLLELLTGMQPISHGKNIVREVNVARDSGM-V-- 852 (958)
Q Consensus 776 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gv~l~elltG~~P~~~~~~~~~~~~~~~~~~~-~-- 852 (958)
... ........||+.|+|||++.+..++.++||||+||++|||++|+.||.+................ .
T Consensus 169 ~~~--------~~~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~ 240 (355)
T d2b1pa1 169 AGT--------SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPE 240 (355)
T ss_dssp --------------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHH
T ss_pred ccc--------ccccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHH
Confidence 432 12234456999999999999999999999999999999999999999765433222111110000 0
Q ss_pred ------------------------hhhhcccC----CCCChHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 002158 853 ------------------------FSIIDNRM----GSYPSECVERFVTLALRCCHDKPEHRPSMSDVVRE 895 (958)
Q Consensus 853 ------------------------~~~i~~~~----~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 895 (958)
........ ...+...+..+.+++.+|++.||++|||++|++++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~H 311 (355)
T d2b1pa1 241 FMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH 311 (355)
T ss_dssp HHTTSCHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred HHHHhhhhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 00000000 01123457789999999999999999999999975
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-40 Score=368.47 Aligned_cols=256 Identities=21% Similarity=0.304 Sum_probs=196.9
Q ss_pred HcCCCCCceeeeeCCeEEEEEEEC-CCcEEEEEEeccC--ChhcHHHHHHHHHHHHccCCCCcceEEEEEEeC-----Ce
Q 002158 624 TAYFSSSTQVGQGGYGKVYKGILS-DNTTVAIKRAEEG--SLQGQNEFLTEIKLLSRLHHRNLVSLLGYCDEE-----GE 695 (958)
Q Consensus 624 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~-----~~ 695 (958)
.++|+..+.||+|+||+||+|++. +|+.||||++... .....+++.+|++++++++|||+|++++++... ..
T Consensus 17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~ 96 (348)
T d2gfsa1 17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 96 (348)
T ss_dssp ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCC
T ss_pred CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCc
Confidence 346888899999999999999975 7999999999754 334456789999999999999999999998643 34
Q ss_pred EEEEEEecCCCCHHHHhccCCCCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEecCCCCeEEeeeeeecc
Q 002158 696 QMLVYEFVPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSNLNAKVADFGLSRL 775 (958)
Q Consensus 696 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~~ 775 (958)
.++||||+.+|+|.+++..+ .+++.++..++.|++.||+|||+++ |+||||||+|||++.++.+|++|||++..
T Consensus 97 ~~~i~~~~~gg~L~~~~~~~---~l~e~~~~~i~~qil~aL~~LH~~g---iiHrDiKp~NILi~~~~~~kl~dfg~a~~ 170 (348)
T d2gfsa1 97 DVYLVTHLMGADLNNIVKCQ---KLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARH 170 (348)
T ss_dssp CCEEEEECCSEEHHHHHTTC---CCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCC----C
T ss_pred eEEEEEeecCCchhhhcccc---cccHHHHHHHHHHHHHHHHHHHhCC---CcccccCCccccccccccccccccchhcc
Confidence 56777888899999999643 3999999999999999999999999 99999999999999999999999999875
Q ss_pred cccCCCCCCccceeeeeccCCCCccChhhhccCC-CCCcchhhhHHHHHHHHHhCCCCCCCCchhHHHHHHHhhcCcchh
Q 002158 776 APVLDDEGTMPTHVSTIVKGTPGYLDPEYFLTHK-LTDKSDVYSLGVVLLELLTGMQPISHGKNIVREVNVARDSGMVFS 854 (958)
Q Consensus 776 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DV~S~Gv~l~elltG~~P~~~~~~~~~~~~~~~~~~~~~~ 854 (958)
... ......||+.|+|||.+.+.. ++.++||||+||++|||++|+.||.+..............+....
T Consensus 171 ~~~----------~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~~~ 240 (348)
T d2gfsa1 171 TDD----------EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGA 240 (348)
T ss_dssp CTG----------GGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCH
T ss_pred cCc----------ccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCh
Confidence 421 123356889999999987764 578999999999999999999999765543322221111111000
Q ss_pred -hh-----------cccC---CCC-----ChHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 002158 855 -II-----------DNRM---GSY-----PSECVERFVTLALRCCHDKPEHRPSMSDVVRE 895 (958)
Q Consensus 855 -~i-----------~~~~---~~~-----~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 895 (958)
.. .... ... ....+..+.+++.+|++.||.+|||++|++++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~H 301 (348)
T d2gfsa1 241 ELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 301 (348)
T ss_dssp HHHTTCCCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred HHhhhccchhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcC
Confidence 00 0000 000 11245678899999999999999999999974
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Probab=100.00 E-value=6.5e-39 Score=351.75 Aligned_cols=294 Identities=27% Similarity=0.479 Sum_probs=205.8
Q ss_pred CCCHhHHHHHHHHHHHcccCccccCCCCCCCCCC-CCCCceeeCccccCCCceeeEEEEccCCcCCCC--ccccccCCCC
Q 002158 35 TTDPQEASALRAIKNSLVDSMNHLRNWNKGDPCM-SNWTGVLCFDTVETDGHLHVRELQLLSMNLSGN--LAPELGQLSR 111 (958)
Q Consensus 35 ~~~~~~~~al~~~k~~~~~~~~~l~~W~~~~~c~-~~w~gV~C~~~~~~~~~~~v~~L~L~~~~l~~~--~~~~l~~L~~ 111 (958)
-|.|+|++||++||+++.|| +.+++|..+++|| +.|.||+|.+. ....||++|+|.++++.|. +|+++++|++
T Consensus 2 ~c~~~e~~aLl~~k~~~~~~-~~l~sW~~~~d~C~~~w~gv~C~~~---~~~~~v~~L~L~~~~l~g~~~lp~~l~~L~~ 77 (313)
T d1ogqa_ 2 LCNPQDKQALLQIKKDLGNP-TTLSSWLPTTDCCNRTWLGVLCDTD---TQTYRVNNLDLSGLNLPKPYPIPSSLANLPY 77 (313)
T ss_dssp CSCHHHHHHHHHHHHHTTCC-GGGTTCCTTSCTTTTCSTTEEECCS---SSCCCEEEEEEECCCCSSCEECCGGGGGCTT
T ss_pred CCCHHHHHHHHHHHHHCCCC-CcCCCCCCCCCCCCCcCCCeEEeCC---CCcEEEEEEECCCCCCCCCCCCChHHhcCcc
Confidence 38999999999999999987 5789997655554 46999999653 3345899999999999984 6788888888
Q ss_pred cceeecc--CcccCCCCccccCCCCCcEEEeeCCCCCCCCChhhcCCCCCCEEecccccccccCccccccccccceEecc
Q 002158 112 LQYYFMW--NDLTGTIPKEIGNISSLIFLLLNGNKLSGSLPDELGYLSNLNRLQVDENNITGTIPKSFANLSRVRHLHLN 189 (958)
Q Consensus 112 L~~L~l~--n~~~~~ip~~i~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls 189 (958)
|++|+++ |++.|.+|+.|+++++|++|+|++|++.+..+..+..+.+|+++++++|.+.+.+|..+.++++|+.++++
T Consensus 78 L~~L~Ls~~N~l~g~iP~~i~~L~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~l~l~~N~~~~~~p~~l~~l~~L~~l~l~ 157 (313)
T d1ogqa_ 78 LNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFD 157 (313)
T ss_dssp CSEEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCEEECCSSEEESCCCGGGGGCTTCCEEECC
T ss_pred ccccccccccccccccccccccccccchhhhccccccccccccccchhhhcccccccccccccCchhhccCcccceeecc
Confidence 8888875 45777888888888888888888888887777778888888888888888887888888888888888888
Q ss_pred cccccccCchhhcCCccc-hhhhccCCccccCCCcccCCCCCccEEEccCCCCCCCCccccccCCCCCCEEEcccCCCCC
Q 002158 190 NNSIGGQIPSELSKLSTL-IHLLVDNNNLSGNLPPELSELPQLCILQLDNNNFSASEIPATYGNFSKLVKLSLRNCNLQG 268 (958)
Q Consensus 190 ~N~l~~~~p~~l~~l~~L-~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~p~~~~~l~~L~~L~L~~N~l~~ 268 (958)
+|.+++.+|..+..+.++ +.+++++|++++..+..+..+..+ .+++++|.+. ..+|..+..+++|+.|++++|.+.+
T Consensus 158 ~n~l~~~ip~~~~~l~~l~~~l~~~~n~l~~~~~~~~~~l~~~-~l~l~~~~~~-~~~~~~~~~~~~l~~l~~~~~~l~~ 235 (313)
T d1ogqa_ 158 GNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLNLA-FVDLSRNMLE-GDASVLFGSDKNTQKIHLAKNSLAF 235 (313)
T ss_dssp SSCCEEECCGGGGCCCTTCCEEECCSSEEEEECCGGGGGCCCS-EEECCSSEEE-ECCGGGCCTTSCCSEEECCSSEECC
T ss_pred ccccccccccccccccccccccccccccccccccccccccccc-cccccccccc-ccccccccccccccccccccccccc
Confidence 888887788777777665 677777777777777766665443 5666666665 3455566666666666666666655
Q ss_pred CCCCCCCCCCcCEEeccCCcCCCcCCCC-CCCCCcCEEEccCCcCCCccchhccCCCCCCeEeeeccc
Q 002158 269 AVPDLSRIPNLYYLDLSWNHLTGSIPSK-KLSENVTTIDLSDNYLNGSILESISNLPFLQTLSLENNF 335 (958)
Q Consensus 269 ~~~~l~~l~~L~~L~Ls~N~l~~~~~~~-~~~~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~ 335 (958)
.++.+..+++|+.|+|++|+++|.+|.. ..+++|++|+|++|+|+|.+|. ++++++|+.+++++|+
T Consensus 236 ~~~~~~~~~~L~~L~Ls~N~l~g~iP~~l~~L~~L~~L~Ls~N~l~g~iP~-~~~L~~L~~l~l~~N~ 302 (313)
T d1ogqa_ 236 DLGKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQ-GGNLQRFDVSAYANNK 302 (313)
T ss_dssp BGGGCCCCTTCCEEECCSSCCEECCCGGGGGCTTCCEEECCSSEEEEECCC-STTGGGSCGGGTCSSS
T ss_pred cccccccccccccccCccCeecccCChHHhCCCCCCEEECcCCcccccCCC-cccCCCCCHHHhCCCc
Confidence 5555555555555555555555444432 2334444444444444444442 3444444444444443
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=4.6e-35 Score=327.76 Aligned_cols=256 Identities=19% Similarity=0.229 Sum_probs=191.1
Q ss_pred CCCCCceeeeeCCeEEEEEEEC-CCcEEEEEEeccCChhcHHHHHHHHHHHHccC-----------CCCcceEEEEEEe-
Q 002158 626 YFSSSTQVGQGGYGKVYKGILS-DNTTVAIKRAEEGSLQGQNEFLTEIKLLSRLH-----------HRNLVSLLGYCDE- 692 (958)
Q Consensus 626 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----------H~niv~l~~~~~~- 692 (958)
+|.+.+.||+|+||+||+|++. +|+.||||+++... ...+.+.+|++++++++ |+||+++++++..
T Consensus 14 rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~-~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~~ 92 (362)
T d1q8ya_ 14 RYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK-VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHK 92 (362)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEE
T ss_pred cEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccc-cchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeeec
Confidence 4788899999999999999985 79999999997643 33457788999988875 5789999998754
Q ss_pred -CCeEEEEEEecCCC-CHHHHhccCCCCCchHHHHHHHHHHHHHHHHHhhh-cCCCCeeccCCCccceEecCCCC-----
Q 002158 693 -EGEQMLVYEFVPNG-TLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHT-EAHPPVFHRDIKASNILLDSNLN----- 764 (958)
Q Consensus 693 -~~~~~lV~E~~~~g-sL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~-~~~~~iiH~Dikp~NILl~~~~~----- 764 (958)
....+++|+++..+ .............+++..+..++.|++.||+|||+ .+ |+||||||+|||++.++.
T Consensus 93 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~---IvHrDlKp~NIll~~~~~~~~~~ 169 (362)
T d1q8ya_ 93 GPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCG---IIHTDIKPENVLMEIVDSPENLI 169 (362)
T ss_dssp ETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECSCCSGGGEEEEEEETTTTEE
T ss_pred cccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhcC---cccccCChhHeeeeccCcccccc
Confidence 35667777776544 34444444455568999999999999999999998 77 999999999999987653
Q ss_pred -eEEeeeeeecccccCCCCCCccceeeeeccCCCCccChhhhccCCCCCcchhhhHHHHHHHHHhCCCCCCCCchh----
Q 002158 765 -AKVADFGLSRLAPVLDDEGTMPTHVSTIVKGTPGYLDPEYFLTHKLTDKSDVYSLGVVLLELLTGMQPISHGKNI---- 839 (958)
Q Consensus 765 -~kl~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~S~Gv~l~elltG~~P~~~~~~~---- 839 (958)
++++|||.++.... ......||+.|+|||++....++.++||||+||+++||++|+.||......
T Consensus 170 ~~kl~dfg~s~~~~~----------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~ 239 (362)
T d1q8ya_ 170 QIKIADLGNACWYDE----------HYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTK 239 (362)
T ss_dssp EEEECCCTTCEETTB----------CCCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------C
T ss_pred eeeEeeccccccccc----------ccccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCccccccc
Confidence 99999999875421 123456999999999999999999999999999999999999999643211
Q ss_pred --HHHHHHHhhcCc-----------ch--------------------hhhcccCCCCChHHHHHHHHHHHHccccCCCCC
Q 002158 840 --VREVNVARDSGM-----------VF--------------------SIIDNRMGSYPSECVERFVTLALRCCHDKPEHR 886 (958)
Q Consensus 840 --~~~~~~~~~~~~-----------~~--------------------~~i~~~~~~~~~~~~~~l~~li~~cl~~dP~~R 886 (958)
.........-+. .. ..........+...+..+.+++.+|++.||.+|
T Consensus 240 ~~~~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R 319 (362)
T d1q8ya_ 240 DDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKR 319 (362)
T ss_dssp HHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTC
T ss_pred hhHHHHHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHC
Confidence 000000000000 00 000001123356778899999999999999999
Q ss_pred CCHHHHHHH
Q 002158 887 PSMSDVVRE 895 (958)
Q Consensus 887 Ps~~evl~~ 895 (958)
||++|++++
T Consensus 320 pta~e~L~H 328 (362)
T d1q8ya_ 320 ADAGGLVNH 328 (362)
T ss_dssp BCHHHHHTC
T ss_pred cCHHHHhcC
Confidence 999999864
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Probab=99.95 E-value=4.3e-29 Score=272.95 Aligned_cols=231 Identities=26% Similarity=0.497 Sum_probs=196.4
Q ss_pred CCcceeeccC-cccC--CCCccccCCCCCcEEEeeC-CCCCCCCChhhcCCCCCCEEecccccccccCccccccccccce
Q 002158 110 SRLQYYFMWN-DLTG--TIPKEIGNISSLIFLLLNG-NKLSGSLPDELGYLSNLNRLQVDENNITGTIPKSFANLSRVRH 185 (958)
Q Consensus 110 ~~L~~L~l~n-~~~~--~ip~~i~~l~~L~~L~Ls~-n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~ 185 (958)
.+++.|++++ +..| .+|++|+++++|++|+|++ |+++|.+|.+|++|++|++|+|++|++.+..+..+..+.+|+.
T Consensus 50 ~~v~~L~L~~~~l~g~~~lp~~l~~L~~L~~L~Ls~~N~l~g~iP~~i~~L~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~ 129 (313)
T d1ogqa_ 50 YRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVT 129 (313)
T ss_dssp CCEEEEEEECCCCSSCEECCGGGGGCTTCSEEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCE
T ss_pred EEEEEEECCCCCCCCCCCCChHHhcCccccccccccccccccccccccccccccchhhhccccccccccccccchhhhcc
Confidence 3577787764 4444 5888999999999999986 8888899999999999999999999999888888889999999
Q ss_pred EecccccccccCchhhcCCccchhhhccCCccccCCCcccCCCCCc-cEEEccCCCCCCCCccccccCCCCCCEEEcccC
Q 002158 186 LHLNNNSIGGQIPSELSKLSTLIHLLVDNNNLSGNLPPELSELPQL-CILQLDNNNFSASEIPATYGNFSKLVKLSLRNC 264 (958)
Q Consensus 186 L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L-~~L~L~~N~l~~~~~p~~~~~l~~L~~L~L~~N 264 (958)
+++++|.+.+.+|..+.++++|+.+++++|.+.+.+|..+..+..+ +.+++++|+++ ...|..+.++..+ .+++++|
T Consensus 130 l~l~~N~~~~~~p~~l~~l~~L~~l~l~~n~l~~~ip~~~~~l~~l~~~l~~~~n~l~-~~~~~~~~~l~~~-~l~l~~~ 207 (313)
T d1ogqa_ 130 LDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLT-GKIPPTFANLNLA-FVDLSRN 207 (313)
T ss_dssp EECCSSEEESCCCGGGGGCTTCCEEECCSSCCEEECCGGGGCCCTTCCEEECCSSEEE-EECCGGGGGCCCS-EEECCSS
T ss_pred cccccccccccCchhhccCcccceeecccccccccccccccccccccccccccccccc-ccccccccccccc-ccccccc
Confidence 9999999988889999999999999999999998888888888776 78899999887 3556777776544 6888888
Q ss_pred CCCCCCCC-CCCCCCcCEEeccCCcCCCcCCCCCCCCCcCEEEccCCcCCCccchhccCCCCCCeEeeecccCCCccch
Q 002158 265 NLQGAVPD-LSRIPNLYYLDLSWNHLTGSIPSKKLSENVTTIDLSDNYLNGSILESISNLPFLQTLSLENNFLTGSIPA 342 (958)
Q Consensus 265 ~l~~~~~~-l~~l~~L~~L~Ls~N~l~~~~~~~~~~~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~ip~ 342 (958)
.+.+.++. +..+++|+.|++++|.+.+.++....+++|+.|+|++|+|++.+|..|+++++|++|+|++|+|+|.+|.
T Consensus 208 ~~~~~~~~~~~~~~~l~~l~~~~~~l~~~~~~~~~~~~L~~L~Ls~N~l~g~iP~~l~~L~~L~~L~Ls~N~l~g~iP~ 286 (313)
T d1ogqa_ 208 MLEGDASVLFGSDKNTQKIHLAKNSLAFDLGKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQ 286 (313)
T ss_dssp EEEECCGGGCCTTSCCSEEECCSSEECCBGGGCCCCTTCCEEECCSSCCEECCCGGGGGCTTCCEEECCSSEEEEECCC
T ss_pred cccccccccccccccccccccccccccccccccccccccccccCccCeecccCChHHhCCCCCCEEECcCCcccccCCC
Confidence 88887775 7788889999999999888887777778899999999999888888899999999999999999888874
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Probab=99.93 E-value=6.3e-25 Score=238.63 Aligned_cols=245 Identities=25% Similarity=0.323 Sum_probs=125.8
Q ss_pred CCcEEEeeCCCCCCCCChhhcCCCCCCEEecccccccccCccccccccccceEecccccccccCchhhcCCccchhhhcc
Q 002158 134 SLIFLLLNGNKLSGSLPDELGYLSNLNRLQVDENNITGTIPKSFANLSRVRHLHLNNNSIGGQIPSELSKLSTLIHLLVD 213 (958)
Q Consensus 134 ~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~ 213 (958)
+|++|+|++|+|+...+.+|.++++|++|++++|.+....|..|.++++|+.|++++|+|+ .+|..+ ...|..|++.
T Consensus 32 ~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~l~~n~~~~i~~~~f~~l~~L~~L~l~~n~l~-~l~~~~--~~~l~~L~~~ 108 (305)
T d1xkua_ 32 DTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQLK-ELPEKM--PKTLQELRVH 108 (305)
T ss_dssp TCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCS-BCCSSC--CTTCCEEECC
T ss_pred CCCEEECcCCcCCCcChhHhhccccccccccccccccccchhhhhCCCccCEecccCCccC-cCccch--hhhhhhhhcc
Confidence 4455555555554222234455555555555555555444444555555555555555554 233221 2344445555
Q ss_pred CCccccCCCcccCCCCCccEEEccCCCCCC-CCccccccCCCCCCEEEcccCCCCCCCCCCCCCCCcCEEeccCCcCCCc
Q 002158 214 NNNLSGNLPPELSELPQLCILQLDNNNFSA-SEIPATYGNFSKLVKLSLRNCNLQGAVPDLSRIPNLYYLDLSWNHLTGS 292 (958)
Q Consensus 214 ~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~-~~~p~~~~~l~~L~~L~L~~N~l~~~~~~l~~l~~L~~L~Ls~N~l~~~ 292 (958)
+|.+.+..+..+.....+..++...|.... ...+..+..+++|+.+++++|.++..+..+ +++|+.|++++|.+++.
T Consensus 109 ~n~l~~l~~~~~~~~~~~~~l~~~~n~~~~~~~~~~~~~~l~~L~~l~l~~n~l~~l~~~~--~~~L~~L~l~~n~~~~~ 186 (305)
T d1xkua_ 109 ENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNITTIPQGL--PPSLTELHLDGNKITKV 186 (305)
T ss_dssp SSCCCBBCHHHHTTCTTCCEEECCSSCCCGGGBCTTGGGGCTTCCEEECCSSCCCSCCSSC--CTTCSEEECTTSCCCEE
T ss_pred ccchhhhhhhhhhccccccccccccccccccCCCccccccccccCccccccCCccccCccc--CCccCEEECCCCcCCCC
Confidence 555554444444444555555555544322 122234455555555555555555433222 34555555555555543
Q ss_pred CCCC-CCCCCcCEEEccCCcCCCccchhccCCCCCCeEeeecccCCCccchhhhcccccCccccceEeccCCCCCCCccC
Q 002158 293 IPSK-KLSENVTTIDLSDNYLNGSILESISNLPFLQTLSLENNFLTGSIPATIWQNKSFSTKARLKIDLRNNSFSNIVGD 371 (958)
Q Consensus 293 ~~~~-~~~~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~ip~~l~~~~~~~~~~l~~L~Ls~N~l~~l~~~ 371 (958)
.+.. ..++.++.|++++|.+++..+..|.++++|++|+|++|+|+ .+|.++..+ +.|+.|+|++|+|+.++..
T Consensus 187 ~~~~~~~~~~l~~L~~s~n~l~~~~~~~~~~l~~L~~L~L~~N~L~-~lp~~l~~l-----~~L~~L~Ls~N~i~~i~~~ 260 (305)
T d1xkua_ 187 DAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADH-----KYIQVVYLHNNNISAIGSN 260 (305)
T ss_dssp CTGGGTTCTTCCEEECCSSCCCEECTTTGGGSTTCCEEECCSSCCS-SCCTTTTTC-----SSCCEEECCSSCCCCCCTT
T ss_pred ChhHhhccccccccccccccccccccccccccccceeeeccccccc-ccccccccc-----cCCCEEECCCCccCccChh
Confidence 3322 23355556666666665555556666666666666666665 455554333 2344666666666655432
Q ss_pred --------CCCCCcceEEeCCCCCCC
Q 002158 372 --------LTLPNNVTLRLGGNPICT 389 (958)
Q Consensus 372 --------~~l~~L~~L~l~~N~l~~ 389 (958)
..+++|+.|+|+||||.+
T Consensus 261 ~f~~~~~~~~~~~L~~L~L~~N~~~~ 286 (305)
T d1xkua_ 261 DFCPPGYNTKKASYSGVSLFSNPVQY 286 (305)
T ss_dssp SSSCSSCCTTSCCCSEEECCSSSSCG
T ss_pred hccCcchhcccCCCCEEECCCCcCcc
Confidence 156778999999999854
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.92 E-value=2.9e-25 Score=238.65 Aligned_cols=250 Identities=22% Similarity=0.251 Sum_probs=167.4
Q ss_pred EEeeCCCCCCCCChhhcCCCCCCEEecccccccccCccccccccccceEecccccccccCchhhcCCccchhhhc-cCCc
Q 002158 138 LLLNGNKLSGSLPDELGYLSNLNRLQVDENNITGTIPKSFANLSRVRHLHLNNNSIGGQIPSELSKLSTLIHLLV-DNNN 216 (958)
Q Consensus 138 L~Ls~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L-~~N~ 216 (958)
++.++++++ .+|..+. +++++|+|++|+|+...+..|.++++|++|++++|++....+..+..+..++.+.. ..|.
T Consensus 16 v~c~~~~L~-~iP~~ip--~~~~~L~Ls~N~i~~i~~~~f~~l~~L~~L~ls~n~l~~i~~~~~~~~~~~~~l~~~~~~~ 92 (284)
T d1ozna_ 16 TSCPQQGLQ-AVPVGIP--AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQ 92 (284)
T ss_dssp EECCSSCCS-SCCTTCC--TTCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSCTT
T ss_pred EEcCCCCCC-ccCCCCC--CCCCEEECcCCcCCCCCHHHhhccccccccccccccccccccccccccccccccccccccc
Confidence 445555555 5554443 45666666666666444455666666666666666666555555666666666544 3445
Q ss_pred cccCCCcccCCCCCccEEEccCCCCCCCCccccccCCCCCCEEEcccCCCCCCCCC-CCCCCCcCEEeccCCcCCCcCCC
Q 002158 217 LSGNLPPELSELPQLCILQLDNNNFSASEIPATYGNFSKLVKLSLRNCNLQGAVPD-LSRIPNLYYLDLSWNHLTGSIPS 295 (958)
Q Consensus 217 l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~-l~~l~~L~~L~Ls~N~l~~~~~~ 295 (958)
++...+..|.++++|++|++++|.+. ...+..+..+.+|+.+++++|+|+++++. |..+++|+.|+|++|++++..+.
T Consensus 93 ~~~l~~~~~~~l~~L~~L~l~~n~~~-~~~~~~~~~~~~L~~l~l~~N~l~~i~~~~f~~~~~L~~L~l~~N~l~~l~~~ 171 (284)
T d1ozna_ 93 LRSVDPATFHGLGRLHTLHLDRCGLQ-ELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPER 171 (284)
T ss_dssp CCCCCTTTTTTCTTCCEEECTTSCCC-CCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCEECTT
T ss_pred cccccchhhcccccCCEEecCCcccc-cccccccchhcccchhhhccccccccChhHhccccchhhcccccCcccccchh
Confidence 55555666777777777777777765 23344566667777777777777766654 66777777777777777644333
Q ss_pred C-CCCCCcCEEEccCCcCCCccchhccCCCCCCeEeeecccCCCccchhhhcccccCccccceEeccCCCCCCCccCCCC
Q 002158 296 K-KLSENVTTIDLSDNYLNGSILESISNLPFLQTLSLENNFLTGSIPATIWQNKSFSTKARLKIDLRNNSFSNIVGDLTL 374 (958)
Q Consensus 296 ~-~~~~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~ip~~l~~~~~~~~~~l~~L~Ls~N~l~~l~~~~~l 374 (958)
. ..+++|+.|++++|++++..|..|..+++|++|++++|++.+..|..+. .+
T Consensus 172 ~f~~l~~L~~l~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~i~~~~~~~~~---------------------------~~ 224 (284)
T d1ozna_ 172 AFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALA---------------------------PL 224 (284)
T ss_dssp TTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCHHHHT---------------------------TC
T ss_pred hhccccccchhhhhhccccccChhHhhhhhhcccccccccccccccccccc---------------------------cc
Confidence 2 3456777777777777777777888888888888888888754444432 34
Q ss_pred CCcceEEeCCCCCCCCCCCCCCCcccccCCCCCccccccCCCCCCCCCCCCCcccccCCCCCCceeeeecee
Q 002158 375 PNNVTLRLGGNPICTSANIPNTGRFCGSDAGGDETLTNSKVNCPVQACPVDNFFEYVPASPEPCFCAAPLRI 446 (958)
Q Consensus 375 ~~L~~L~l~~N~l~~~~~~~~~~~~~~~~~~~~~~L~~n~~~C~c~~~~~~~~~~~~~~~~~~~~c~sp~~~ 446 (958)
++|++|+|++||| .|+|+..++..|+++.........|+.|...
T Consensus 225 ~~L~~L~l~~N~l----------------------------~C~C~~~~l~~~l~~~~~~~~~~~C~~p~~l 268 (284)
T d1ozna_ 225 RALQYLRLNDNPW----------------------------VCDCRARPLWAWLQKFRGSSSEVPCSLPQRL 268 (284)
T ss_dssp TTCCEEECCSSCE----------------------------ECSGGGHHHHHHHHHCCSEECCCBEEESGGG
T ss_pred cccCEEEecCCCC----------------------------CCCccchHHHHHHHhCcCCCCceEeCCchHH
Confidence 5677788777776 7888888899999988877777899988764
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Probab=99.92 E-value=4.8e-24 Score=239.23 Aligned_cols=276 Identities=25% Similarity=0.308 Sum_probs=169.9
Q ss_pred eeEEEEccCCcCCCCccccccCCCCcceeeccCcccCCCCccccCCCCCcEEEeeCCCCCCCCChhhcCCCCCCEEeccc
Q 002158 87 HVRELQLLSMNLSGNLAPELGQLSRLQYYFMWNDLTGTIPKEIGNISSLIFLLLNGNKLSGSLPDELGYLSNLNRLQVDE 166 (958)
Q Consensus 87 ~v~~L~L~~~~l~~~~~~~l~~L~~L~~L~l~n~~~~~ip~~i~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~L~~ 166 (958)
++++|++.+++++.. +.+..|++|++|++++|....+|+ |+++++|++|+|++|.+.+ ++ .++++++|+.|++++
T Consensus 45 ~l~~L~l~~~~I~~l--~gl~~L~nL~~L~Ls~N~l~~l~~-l~~L~~L~~L~L~~n~i~~-i~-~l~~l~~L~~L~~~~ 119 (384)
T d2omza2 45 QVTTLQADRLGIKSI--DGVEYLNNLTQINFSNNQLTDITP-LKNLTKLVDILMNNNQIAD-IT-PLANLTNLTGLTLFN 119 (384)
T ss_dssp TCCEEECCSSCCCCC--TTGGGCTTCCEEECCSSCCCCCGG-GTTCTTCCEEECCSSCCCC-CG-GGTTCTTCCEEECCS
T ss_pred CCCEEECCCCCCCCc--cccccCCCCCEEeCcCCcCCCCcc-ccCCccccccccccccccc-cc-ccccccccccccccc
Confidence 588999999988763 457889999999999888877774 8999999999999999985 43 388999999999998
Q ss_pred ccccccCcc---------------------------------------------------------------cccccccc
Q 002158 167 NNITGTIPK---------------------------------------------------------------SFANLSRV 183 (958)
Q Consensus 167 N~l~~~~p~---------------------------------------------------------------~~~~l~~L 183 (958)
|.+++..+. .+..++++
T Consensus 120 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 199 (384)
T d2omza2 120 NQITDIDPLKNLTNLNRLELSSNTISDISALSGLTSLQQLSFGNQVTDLKPLANLTTLERLDISSNKVSDISVLAKLTNL 199 (384)
T ss_dssp SCCCCCGGGTTCTTCSEEEEEEEEECCCGGGTTCTTCSEEEEEESCCCCGGGTTCTTCCEEECCSSCCCCCGGGGGCTTC
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccchhhhhcccccccccccccccccccccccccccc
Confidence 887743221 23334455
Q ss_pred ceEecccccccccCchhhcCCccchhhhccCCccccCCCcccCCCCCccEEEccCCCCCCCCccccccCCCCCCEEEccc
Q 002158 184 RHLHLNNNSIGGQIPSELSKLSTLIHLLVDNNNLSGNLPPELSELPQLCILQLDNNNFSASEIPATYGNFSKLVKLSLRN 263 (958)
Q Consensus 184 ~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~p~~~~~l~~L~~L~L~~ 263 (958)
+.+++++|.+++..| +..+++|+.|++++|+++.. ..+..+++|+.|++++|.+++ ++ .+..+++|+.|++++
T Consensus 200 ~~l~l~~n~i~~~~~--~~~~~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~l~~n~l~~--~~-~~~~~~~L~~L~l~~ 272 (384)
T d2omza2 200 ESLIATNNQISDITP--LGILTNLDELSLNGNQLKDI--GTLASLTNLTDLDLANNQISN--LA-PLSGLTKLTELKLGA 272 (384)
T ss_dssp SEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCC--CG-GGTTCTTCSEEECCS
T ss_pred ceeeccCCccCCCCc--ccccCCCCEEECCCCCCCCc--chhhcccccchhccccCccCC--CC-cccccccCCEeeccC
Confidence 555555555554332 33445555566666655532 245555566666666665542 11 245555566666666
Q ss_pred CCCCCCCCCCCCCCCcCEEeccCCcCCCcCCCCCCCCCcCEEEccCCcCCCccchhccCCCCCCeEeeecccCCCccchh
Q 002158 264 CNLQGAVPDLSRIPNLYYLDLSWNHLTGSIPSKKLSENVTTIDLSDNYLNGSILESISNLPFLQTLSLENNFLTGSIPAT 343 (958)
Q Consensus 264 N~l~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~ip~~ 343 (958)
|++++.. .+..++.++.++++.|.+++ ++....+++++.|+|++|++++.. .+..+++|++|+|++|+|++ ++ .
T Consensus 273 ~~l~~~~-~~~~~~~l~~l~~~~n~l~~-~~~~~~~~~l~~L~ls~n~l~~l~--~l~~l~~L~~L~L~~n~l~~-l~-~ 346 (384)
T d2omza2 273 NQISNIS-PLAGLTALTNLELNENQLED-ISPISNLKNLTYLTLYFNNISDIS--PVSSLTKLQRLFFANNKVSD-VS-S 346 (384)
T ss_dssp SCCCCCG-GGTTCTTCSEEECCSSCCSC-CGGGGGCTTCSEEECCSSCCSCCG--GGGGCTTCCEEECCSSCCCC-CG-G
T ss_pred cccCCCC-cccccccccccccccccccc-ccccchhcccCeEECCCCCCCCCc--ccccCCCCCEEECCCCCCCC-Ch-h
Confidence 6555432 24455555666666665552 333444556666666666665543 25556666666666666652 33 2
Q ss_pred hhcccccCccccceEeccCCCCCCCccCCCCCCcceEEeCCC
Q 002158 344 IWQNKSFSTKARLKIDLRNNSFSNIVGDLTLPNNVTLRLGGN 385 (958)
Q Consensus 344 l~~~~~~~~~~l~~L~Ls~N~l~~l~~~~~l~~L~~L~l~~N 385 (958)
+.. .+.|++|++++|+|+++++...+++|+.|+|++|
T Consensus 347 l~~-----l~~L~~L~l~~N~l~~l~~l~~l~~L~~L~L~~N 383 (384)
T d2omza2 347 LAN-----LTNINWLSAGHNQISDLTPLANLTRITQLGLNDQ 383 (384)
T ss_dssp GGG-----CTTCCEEECCSSCCCBCGGGTTCTTCSEEECCCE
T ss_pred HcC-----CCCCCEEECCCCcCCCChhhccCCCCCEeeCCCC
Confidence 322 2345566666666666555445666666666655
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.91 E-value=3.1e-24 Score=228.09 Aligned_cols=214 Identities=22% Similarity=0.246 Sum_probs=146.5
Q ss_pred cCCCCCCEEecccccccccCccccccccccceEecccccccccCchhhcCCccchhhhccCCccccCCCcccCCCCCccE
Q 002158 154 GYLSNLNRLQVDENNITGTIPKSFANLSRVRHLHLNNNSIGGQIPSELSKLSTLIHLLVDNNNLSGNLPPELSELPQLCI 233 (958)
Q Consensus 154 ~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~ 233 (958)
.+...+.+++.++++++ .+|..+. ++|++|+|++|+|++..+..|.++++|++|+|++|+|+.. ..++.+++|++
T Consensus 7 ~~~~~~~~v~C~~~~L~-~iP~~lp--~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~L~~N~l~~l--~~~~~l~~L~~ 81 (266)
T d1p9ag_ 7 SKVASHLEVNCDKRNLT-ALPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTKL--QVDGTLPVLGT 81 (266)
T ss_dssp ECSTTCCEEECTTSCCS-SCCSCCC--TTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCCEE--ECCSCCTTCCE
T ss_pred cccCCCeEEEccCCCCC-eeCcCcC--cCCCEEECcCCcCCCcCHHHhhcccccccccccccccccc--ccccccccccc
Confidence 44566677788888887 4666553 4678888888888766566777788888888888877743 23566777777
Q ss_pred EEccCCCCCCCCccccccCCCCCCEEEcccCCCCCCCCC-CCCCCCcCEEeccCCcCCCcCCCC-CCCCCcCEEEccCCc
Q 002158 234 LQLDNNNFSASEIPATYGNFSKLVKLSLRNCNLQGAVPD-LSRIPNLYYLDLSWNHLTGSIPSK-KLSENVTTIDLSDNY 311 (958)
Q Consensus 234 L~L~~N~l~~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~-l~~l~~L~~L~Ls~N~l~~~~~~~-~~~~~L~~L~Ls~N~ 311 (958)
|+|++|+++ ..+..+.++++|+.|++++|.+.+..+. +..+.+|+.|++++|.++...+.. ..+++|+.|++++|+
T Consensus 82 L~Ls~N~l~--~~~~~~~~l~~L~~L~l~~~~~~~~~~~~~~~l~~l~~L~l~~n~l~~l~~~~~~~l~~l~~l~l~~N~ 159 (266)
T d1p9ag_ 82 LDLSHNQLQ--SLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNN 159 (266)
T ss_dssp EECCSSCCS--SCCCCTTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSC
T ss_pred ccccccccc--ccccccccccccccccccccccceeeccccccccccccccccccccceeccccccccccchhccccccc
Confidence 777777775 3466677777777777777777766553 666777777777777776433333 234667777777777
Q ss_pred CCCccchhccCCCCCCeEeeecccCCCccchhhhcccccCccccceEeccCCCCCCCccCCCCCCcceEEeCCCCCCCCC
Q 002158 312 LNGSILESISNLPFLQTLSLENNFLTGSIPATIWQNKSFSTKARLKIDLRNNSFSNIVGDLTLPNNVTLRLGGNPICTSA 391 (958)
Q Consensus 312 l~~~~~~~~~~l~~L~~L~L~~N~l~~~ip~~l~~~~~~~~~~l~~L~Ls~N~l~~l~~~~~l~~L~~L~l~~N~l~~~~ 391 (958)
|++..+..|..+++|++|+|++|+|+ .+|.+++ .+++|+.|+|+||||
T Consensus 160 l~~~~~~~~~~l~~L~~L~Ls~N~L~-~lp~~~~---------------------------~~~~L~~L~L~~Np~---- 207 (266)
T d1p9ag_ 160 LTELPAGLLNGLENLDTLLLQENSLY-TIPKGFF---------------------------GSHLLPFAFLHGNPW---- 207 (266)
T ss_dssp CSCCCTTTTTTCTTCCEEECCSSCCC-CCCTTTT---------------------------TTCCCSEEECCSCCB----
T ss_pred ccccCccccccccccceeecccCCCc-ccChhHC---------------------------CCCCCCEEEecCCCC----
Confidence 77666666777777777777776666 5665543 345677787777776
Q ss_pred CCCCCCcccccCCCCCccccccCCCCCCCCCCCCCcccc
Q 002158 392 NIPNTGRFCGSDAGGDETLTNSKVNCPVQACPVDNFFEY 430 (958)
Q Consensus 392 ~~~~~~~~~~~~~~~~~~L~~n~~~C~c~~~~~~~~~~~ 430 (958)
.|||.+.++..|++.
T Consensus 208 ------------------------~CdC~~~~l~~wl~~ 222 (266)
T d1p9ag_ 208 ------------------------LCNCEILYFRRWLQD 222 (266)
T ss_dssp ------------------------CCSGGGHHHHHHHHH
T ss_pred ------------------------CCCcchHHHHHHHHh
Confidence 677777777777753
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Probab=99.90 E-value=1e-22 Score=228.20 Aligned_cols=275 Identities=26% Similarity=0.305 Sum_probs=214.1
Q ss_pred EccCCcCCCCccccccCCCCcceeeccCcccCCCCccccCCCCCcEEEeeCCCCCCCCChhhcCCCCCCEEecccccccc
Q 002158 92 QLLSMNLSGNLAPELGQLSRLQYYFMWNDLTGTIPKEIGNISSLIFLLLNGNKLSGSLPDELGYLSNLNRLQVDENNITG 171 (958)
Q Consensus 92 ~L~~~~l~~~~~~~l~~L~~L~~L~l~n~~~~~ip~~i~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~ 171 (958)
.+...++++.+. ...+.+|+.|.++++.+..+ ++|..+++|++|+|++|+|++ +|. ++++++|++|++++|++.+
T Consensus 28 ~l~~~~~~~~~~--~~~l~~l~~L~l~~~~I~~l-~gl~~L~nL~~L~Ls~N~l~~-l~~-l~~L~~L~~L~L~~n~i~~ 102 (384)
T d2omza2 28 VLGKTNVTDTVS--QTDLDQVTTLQADRLGIKSI-DGVEYLNNLTQINFSNNQLTD-ITP-LKNLTKLVDILMNNNQIAD 102 (384)
T ss_dssp HTTCSSTTSEEC--HHHHTTCCEEECCSSCCCCC-TTGGGCTTCCEEECCSSCCCC-CGG-GTTCTTCCEEECCSSCCCC
T ss_pred HhCCCCCCCccC--HHHhCCCCEEECCCCCCCCc-cccccCCCCCEEeCcCCcCCC-Ccc-ccCCccccccccccccccc
Confidence 455556666554 34677899999988777766 578999999999999999994 553 9999999999999999986
Q ss_pred cCccccccccccceEecccccccccCc-----------------------------------------------------
Q 002158 172 TIPKSFANLSRVRHLHLNNNSIGGQIP----------------------------------------------------- 198 (958)
Q Consensus 172 ~~p~~~~~l~~L~~L~Ls~N~l~~~~p----------------------------------------------------- 198 (958)
.. .++++++|+.|++++|.+++..+
T Consensus 103 i~--~l~~l~~L~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 180 (384)
T d2omza2 103 IT--PLANLTNLTGLTLFNNQITDIDPLKNLTNLNRLELSSNTISDISALSGLTSLQQLSFGNQVTDLKPLANLTTLERL 180 (384)
T ss_dssp CG--GGTTCTTCCEEECCSSCCCCCGGGTTCTTCSEEEEEEEEECCCGGGTTCTTCSEEEEEESCCCCGGGTTCTTCCEE
T ss_pred cc--cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccchhhhhccccccccc
Confidence 43 38899999999999988763211
Q ss_pred ----------hhhcCCccchhhhccCCccccCCCcccCCCCCccEEEccCCCCCCCCccccccCCCCCCEEEcccCCCCC
Q 002158 199 ----------SELSKLSTLIHLLVDNNNLSGNLPPELSELPQLCILQLDNNNFSASEIPATYGNFSKLVKLSLRNCNLQG 268 (958)
Q Consensus 199 ----------~~l~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~p~~~~~l~~L~~L~L~~N~l~~ 268 (958)
..+..+++++.+++++|.+++..+ +..+++|++|++++|+++. ...+..+++|+.|++++|++++
T Consensus 181 ~~~~~~~~~~~~~~~l~~~~~l~l~~n~i~~~~~--~~~~~~L~~L~l~~n~l~~---~~~l~~l~~L~~L~l~~n~l~~ 255 (384)
T d2omza2 181 DISSNKVSDISVLAKLTNLESLIATNNQISDITP--LGILTNLDELSLNGNQLKD---IGTLASLTNLTDLDLANNQISN 255 (384)
T ss_dssp ECCSSCCCCCGGGGGCTTCSEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCC---CGGGGGCTTCSEEECCSSCCCC
T ss_pred cccccccccccccccccccceeeccCCccCCCCc--ccccCCCCEEECCCCCCCC---cchhhcccccchhccccCccCC
Confidence 234445667777888888876543 4556888888888888863 3467788889999999998886
Q ss_pred CCCCCCCCCCcCEEeccCCcCCCcCCCCCCCCCcCEEEccCCcCCCccchhccCCCCCCeEeeecccCCCccchhhhccc
Q 002158 269 AVPDLSRIPNLYYLDLSWNHLTGSIPSKKLSENVTTIDLSDNYLNGSILESISNLPFLQTLSLENNFLTGSIPATIWQNK 348 (958)
Q Consensus 269 ~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~ip~~l~~~~ 348 (958)
.+ .+..+++|+.|++++|++++ ++....+..++.+++++|.+++. ..+..+++++.|++++|++++..| +..
T Consensus 256 ~~-~~~~~~~L~~L~l~~~~l~~-~~~~~~~~~l~~l~~~~n~l~~~--~~~~~~~~l~~L~ls~n~l~~l~~--l~~-- 327 (384)
T d2omza2 256 LA-PLSGLTKLTELKLGANQISN-ISPLAGLTALTNLELNENQLEDI--SPISNLKNLTYLTLYFNNISDISP--VSS-- 327 (384)
T ss_dssp CG-GGTTCTTCSEEECCSSCCCC-CGGGTTCTTCSEEECCSSCCSCC--GGGGGCTTCSEEECCSSCCSCCGG--GGG--
T ss_pred CC-cccccccCCEeeccCcccCC-CCccccccccccccccccccccc--cccchhcccCeEECCCCCCCCCcc--ccc--
Confidence 54 37778889999999888874 44466677888899999988763 457888999999999999986433 322
Q ss_pred ccCccccceEeccCCCCCCCccCCCCCCcceEEeCCCCCCC
Q 002158 349 SFSTKARLKIDLRNNSFSNIVGDLTLPNNVTLRLGGNPICT 389 (958)
Q Consensus 349 ~~~~~~l~~L~Ls~N~l~~l~~~~~l~~L~~L~l~~N~l~~ 389 (958)
.+.|++|++++|+|++++....+++|+.|++++|+++.
T Consensus 328 ---l~~L~~L~L~~n~l~~l~~l~~l~~L~~L~l~~N~l~~ 365 (384)
T d2omza2 328 ---LTKLQRLFFANNKVSDVSSLANLTNINWLSAGHNQISD 365 (384)
T ss_dssp ---CTTCCEEECCSSCCCCCGGGGGCTTCCEEECCSSCCCB
T ss_pred ---CCCCCEEECCCCCCCCChhHcCCCCCCEEECCCCcCCC
Confidence 34677999999999998865589999999999999864
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Probab=99.89 E-value=2.6e-22 Score=217.70 Aligned_cols=270 Identities=20% Similarity=0.271 Sum_probs=221.9
Q ss_pred CCcEEEeeCCCCCCCCChhhcCCCCCCEEecccccccccCccccccccccceEecccccccccCchhhcCCccchhhhcc
Q 002158 134 SLIFLLLNGNKLSGSLPDELGYLSNLNRLQVDENNITGTIPKSFANLSRVRHLHLNNNSIGGQIPSELSKLSTLIHLLVD 213 (958)
Q Consensus 134 ~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~ 213 (958)
.++.++-++++++ .+|..+. ++|++|+|++|+|+...+.+|.++++|++|++++|.+....|..|.++++|+.|+++
T Consensus 11 ~~~~~~C~~~~L~-~lP~~l~--~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~l~~n~~~~i~~~~f~~l~~L~~L~l~ 87 (305)
T d1xkua_ 11 HLRVVQCSDLGLE-KVPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLS 87 (305)
T ss_dssp ETTEEECTTSCCC-SCCCSCC--TTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECC
T ss_pred cCCEEEecCCCCC-ccCCCCC--CCCCEEECcCCcCCCcChhHhhccccccccccccccccccchhhhhCCCccCEeccc
Confidence 5678899999999 7887774 689999999999996666789999999999999999998888999999999999999
Q ss_pred CCccccCCCcccCCCCCccEEEccCCCCCCCCccccccCCCCCCEEEcccCCCCCCCC---CCCCCCCcCEEeccCCcCC
Q 002158 214 NNNLSGNLPPELSELPQLCILQLDNNNFSASEIPATYGNFSKLVKLSLRNCNLQGAVP---DLSRIPNLYYLDLSWNHLT 290 (958)
Q Consensus 214 ~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~p~~~~~l~~L~~L~L~~N~l~~~~~---~l~~l~~L~~L~Ls~N~l~ 290 (958)
+|+++. +|..+ ...|+.|++.+|.+.. ..+..+.....+..+....|....... .+..+++|+.+++++|.++
T Consensus 88 ~n~l~~-l~~~~--~~~l~~L~~~~n~l~~-l~~~~~~~~~~~~~l~~~~n~~~~~~~~~~~~~~l~~L~~l~l~~n~l~ 163 (305)
T d1xkua_ 88 KNQLKE-LPEKM--PKTLQELRVHENEITK-VRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNIT 163 (305)
T ss_dssp SSCCSB-CCSSC--CTTCCEEECCSSCCCB-BCHHHHTTCTTCCEEECCSSCCCGGGBCTTGGGGCTTCCEEECCSSCCC
T ss_pred CCccCc-Cccch--hhhhhhhhccccchhh-hhhhhhhccccccccccccccccccCCCccccccccccCccccccCCcc
Confidence 999995 44443 3689999999999973 334567788889999999987654432 3788999999999999998
Q ss_pred CcCCCCCCCCCcCEEEccCCcCCCccchhccCCCCCCeEeeecccCCCccchhhhcccccCccccceEeccCCCCCCCcc
Q 002158 291 GSIPSKKLSENVTTIDLSDNYLNGSILESISNLPFLQTLSLENNFLTGSIPATIWQNKSFSTKARLKIDLRNNSFSNIVG 370 (958)
Q Consensus 291 ~~~~~~~~~~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~ip~~l~~~~~~~~~~l~~L~Ls~N~l~~l~~ 370 (958)
.++.. ..++|+.|++++|.++...+..|.+++.++.|++++|.+++..+..+..+ +.|++|+|++|+|++++.
T Consensus 164 -~l~~~-~~~~L~~L~l~~n~~~~~~~~~~~~~~~l~~L~~s~n~l~~~~~~~~~~l-----~~L~~L~L~~N~L~~lp~ 236 (305)
T d1xkua_ 164 -TIPQG-LPPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANT-----PHLRELHLNNNKLVKVPG 236 (305)
T ss_dssp -SCCSS-CCTTCSEEECTTSCCCEECTGGGTTCTTCCEEECCSSCCCEECTTTGGGS-----TTCCEEECCSSCCSSCCT
T ss_pred -ccCcc-cCCccCEEECCCCcCCCCChhHhhcccccccccccccccccccccccccc-----ccceeeeccccccccccc
Confidence 45433 46899999999999999999999999999999999999996666655443 457799999999999987
Q ss_pred CC-CCCCcceEEeCCCCCCCCCCCCC--CCcccccCCCCCccccccCCCC
Q 002158 371 DL-TLPNNVTLRLGGNPICTSANIPN--TGRFCGSDAGGDETLTNSKVNC 417 (958)
Q Consensus 371 ~~-~l~~L~~L~l~~N~l~~~~~~~~--~~~~~~~~~~~~~~L~~n~~~C 417 (958)
.. .+++|+.|+|++|+++.-....- ............+.|.+|+|.+
T Consensus 237 ~l~~l~~L~~L~Ls~N~i~~i~~~~f~~~~~~~~~~~L~~L~L~~N~~~~ 286 (305)
T d1xkua_ 237 GLADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQY 286 (305)
T ss_dssp TTTTCSSCCEEECCSSCCCCCCTTSSSCSSCCTTSCCCSEEECCSSSSCG
T ss_pred ccccccCCCEEECCCCccCccChhhccCcchhcccCCCCEEECCCCcCcc
Confidence 66 89999999999999976432211 1122334556778899999865
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.88 E-value=1.4e-23 Score=225.33 Aligned_cols=249 Identities=19% Similarity=0.224 Sum_probs=177.6
Q ss_pred EccCCcCCCCccccccCCCCcceeeccCcccCCCCc-cccCCCCCcEEEeeCCCCCCCCChhhcCCCCCCEEecc-cccc
Q 002158 92 QLLSMNLSGNLAPELGQLSRLQYYFMWNDLTGTIPK-EIGNISSLIFLLLNGNKLSGSLPDELGYLSNLNRLQVD-ENNI 169 (958)
Q Consensus 92 ~L~~~~l~~~~~~~l~~L~~L~~L~l~n~~~~~ip~-~i~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~L~-~N~l 169 (958)
+.++++++ .+|..+. +.+++|++++|....+|. .|.++++|++|++++|.+.+..+..+..+..++.++.. .|.+
T Consensus 17 ~c~~~~L~-~iP~~ip--~~~~~L~Ls~N~i~~i~~~~f~~l~~L~~L~ls~n~l~~i~~~~~~~~~~~~~l~~~~~~~~ 93 (284)
T d1ozna_ 17 SCPQQGLQ-AVPVGIP--AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQL 93 (284)
T ss_dssp ECCSSCCS-SCCTTCC--TTCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSCTTC
T ss_pred EcCCCCCC-ccCCCCC--CCCCEEECcCCcCCCCCHHHhhcccccccccccccccccccccccccccccccccccccccc
Confidence 33444555 3444443 457778887776666664 47788888888888888887777777777888887654 5666
Q ss_pred cccCccccccccccceEecccccccccCchhhcCCccchhhhccCCccccCCCcccCCCCCccEEEccCCCCCCCCcccc
Q 002158 170 TGTIPKSFANLSRVRHLHLNNNSIGGQIPSELSKLSTLIHLLVDNNNLSGNLPPELSELPQLCILQLDNNNFSASEIPAT 249 (958)
Q Consensus 170 ~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~p~~ 249 (958)
+...+..|.++++|++|++++|.+....+..+..+.+|+.+++++|+|++..+..|..+++|+.|+|++|+++. ..+..
T Consensus 94 ~~l~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~~L~~l~l~~N~l~~i~~~~f~~~~~L~~L~l~~N~l~~-l~~~~ 172 (284)
T d1ozna_ 94 RSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISS-VPERA 172 (284)
T ss_dssp CCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCE-ECTTT
T ss_pred ccccchhhcccccCCEEecCCcccccccccccchhcccchhhhccccccccChhHhccccchhhcccccCcccc-cchhh
Confidence 66667778888888888888888876666677777888888888888887777778888888888888888863 34567
Q ss_pred ccCCCCCCEEEcccCCCCCCCCC-CCCCCCcCEEeccCCcCCCcCCCC-CCCCCcCEEEccCCcCCCccchhccCCCCCC
Q 002158 250 YGNFSKLVKLSLRNCNLQGAVPD-LSRIPNLYYLDLSWNHLTGSIPSK-KLSENVTTIDLSDNYLNGSILESISNLPFLQ 327 (958)
Q Consensus 250 ~~~l~~L~~L~L~~N~l~~~~~~-l~~l~~L~~L~Ls~N~l~~~~~~~-~~~~~L~~L~Ls~N~l~~~~~~~~~~l~~L~ 327 (958)
|.++++|+.|++++|++++..+. |..+++|++|++++|++.+..+.. ..+++|++|+|++|.+...-+. ..-...++
T Consensus 173 f~~l~~L~~l~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~i~~~~~~~~~~~~~L~~L~l~~N~l~C~C~~-~~l~~~l~ 251 (284)
T d1ozna_ 173 FRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCRA-RPLWAWLQ 251 (284)
T ss_dssp TTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCHHHHTTCTTCCEEECCSSCEECSGGG-HHHHHHHH
T ss_pred hccccccchhhhhhccccccChhHhhhhhhcccccccccccccccccccccccccCEEEecCCCCCCCccc-hHHHHHHH
Confidence 77888888888888888877664 788888888888888887554433 4557888888888887643221 11123455
Q ss_pred eEeeecccCCCccchhhh
Q 002158 328 TLSLENNFLTGSIPATIW 345 (958)
Q Consensus 328 ~L~L~~N~l~~~ip~~l~ 345 (958)
.+....+++....|..+.
T Consensus 252 ~~~~~~~~~~C~~p~~l~ 269 (284)
T d1ozna_ 252 KFRGSSSEVPCSLPQRLA 269 (284)
T ss_dssp HCCSEECCCBEEESGGGT
T ss_pred hCcCCCCceEeCCchHHc
Confidence 666677788777777664
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.86 E-value=1.7e-21 Score=206.70 Aligned_cols=201 Identities=23% Similarity=0.266 Sum_probs=153.9
Q ss_pred cCCCCCcEEEeeCCCCCCCCChhhcCCCCCCEEecccccccccCccccccccccceEecccccccccCchhhcCCccchh
Q 002158 130 GNISSLIFLLLNGNKLSGSLPDELGYLSNLNRLQVDENNITGTIPKSFANLSRVRHLHLNNNSIGGQIPSELSKLSTLIH 209 (958)
Q Consensus 130 ~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~ 209 (958)
.+..++.+++.++++++ .+|..+. ++|++|+|++|+|++..+..|.++++|++|+|++|+|+ .++ .++.+++|++
T Consensus 7 ~~~~~~~~v~C~~~~L~-~iP~~lp--~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~L~~N~l~-~l~-~~~~l~~L~~ 81 (266)
T d1p9ag_ 7 SKVASHLEVNCDKRNLT-ALPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELT-KLQ-VDGTLPVLGT 81 (266)
T ss_dssp ECSTTCCEEECTTSCCS-SCCSCCC--TTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCC-EEE-CCSCCTTCCE
T ss_pred cccCCCeEEEccCCCCC-eeCcCcC--cCCCEEECcCCcCCCcCHHHhhcccccccccccccccc-ccc-cccccccccc
Confidence 44556667788888887 5676554 56788888888887666677888888888888888887 343 3567788888
Q ss_pred hhccCCccccCCCcccCCCCCccEEEccCCCCCCCCccccccCCCCCCEEEcccCCCCCCCCC-CCCCCCcCEEeccCCc
Q 002158 210 LLVDNNNLSGNLPPELSELPQLCILQLDNNNFSASEIPATYGNFSKLVKLSLRNCNLQGAVPD-LSRIPNLYYLDLSWNH 288 (958)
Q Consensus 210 L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~-l~~l~~L~~L~Ls~N~ 288 (958)
|+|++|+++. .+..+..+++|+.|++++|.+.. ..+..+..+.+++.|++++|.++..++. +..+++|+.|++++|+
T Consensus 82 L~Ls~N~l~~-~~~~~~~l~~L~~L~l~~~~~~~-~~~~~~~~l~~l~~L~l~~n~l~~l~~~~~~~l~~l~~l~l~~N~ 159 (266)
T d1p9ag_ 82 LDLSHNQLQS-LPLLGQTLPALTVLDVSFNRLTS-LPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNN 159 (266)
T ss_dssp EECCSSCCSS-CCCCTTTCTTCCEEECCSSCCCC-CCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSC
T ss_pred cccccccccc-cccccccccccccccccccccce-eeccccccccccccccccccccceeccccccccccchhccccccc
Confidence 8888888874 46677788888888888888863 3455677788888888888888877765 6778888888888888
Q ss_pred CCCcCCCC-CCCCCcCEEEccCCcCCCccchhccCCCCCCeEeeecccCCC
Q 002158 289 LTGSIPSK-KLSENVTTIDLSDNYLNGSILESISNLPFLQTLSLENNFLTG 338 (958)
Q Consensus 289 l~~~~~~~-~~~~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~ 338 (958)
+++..+.. ..+++|++|+|++|+|+ .+|..+..+++|+.|+|++|++..
T Consensus 160 l~~~~~~~~~~l~~L~~L~Ls~N~L~-~lp~~~~~~~~L~~L~L~~Np~~C 209 (266)
T d1p9ag_ 160 LTELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGNPWLC 209 (266)
T ss_dssp CSCCCTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCCCSEEECCSCCBCC
T ss_pred ccccCccccccccccceeecccCCCc-ccChhHCCCCCCCEEEecCCCCCC
Confidence 88655543 44688888999988888 667777789999999999999864
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.86 E-value=1.4e-22 Score=203.61 Aligned_cols=162 Identities=14% Similarity=0.144 Sum_probs=119.5
Q ss_pred CCceeeeeCCeEEEEEEECCCcEEEEEEeccCChh------------------cHHHHHHHHHHHHccCCCCcceEEEEE
Q 002158 629 SSTQVGQGGYGKVYKGILSDNTTVAIKRAEEGSLQ------------------GQNEFLTEIKLLSRLHHRNLVSLLGYC 690 (958)
Q Consensus 629 ~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~------------------~~~~~~~E~~~l~~l~H~niv~l~~~~ 690 (958)
+.++||+|+||+||+|++.+|+.||||+++..... ....+..|+..+.++.|.+++..+++.
T Consensus 4 vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~~~ 83 (191)
T d1zara2 4 IGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAWE 83 (191)
T ss_dssp EEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEEEE
T ss_pred hCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEEec
Confidence 46789999999999999989999999987532110 112356789999999999999988764
Q ss_pred EeCCeEEEEEEecCCCCHHHHhccCCCCCchHHHHHHHHHHHHHHHHHhhhcCCCCeeccCCCccceEecCCCCeEEeee
Q 002158 691 DEEGEQMLVYEFVPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEAHPPVFHRDIKASNILLDSNLNAKVADF 770 (958)
Q Consensus 691 ~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH~Dikp~NILl~~~~~~kl~DF 770 (958)
. .++||||+++..+.+ ++...+..++.|+++|++|||+++ |+||||||+|||++++ .++|+||
T Consensus 84 ~----~~lvme~~~~~~~~~---------l~~~~~~~i~~ql~~~l~~lH~~g---iiHrDiKP~NILv~~~-~~~liDF 146 (191)
T d1zara2 84 G----NAVLMELIDAKELYR---------VRVENPDEVLDMILEEVAKFYHRG---IVHGDLSQYNVLVSEE-GIWIIDF 146 (191)
T ss_dssp T----TEEEEECCCCEEGGG---------CCCSCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEEETT-EEEECCC
T ss_pred C----CEEEEEeeccccccc---------hhhHHHHHHHHHHHHHHHHHhhCC---EEEccCChhheeeeCC-CEEEEEC
Confidence 2 379999998755433 334445689999999999999999 9999999999999865 4899999
Q ss_pred eeecccccCCCCCCccceeeeeccCCCCccCh------hhhccCCCCCcchhhhHHHHH
Q 002158 771 GLSRLAPVLDDEGTMPTHVSTIVKGTPGYLDP------EYFLTHKLTDKSDVYSLGVVL 823 (958)
Q Consensus 771 Gla~~~~~~~~~~~~~~~~~~~~~gt~~y~aP------E~~~~~~~~~~~DV~S~Gv~l 823 (958)
|+|+....... ..|... |. ....|..++|+||..--+
T Consensus 147 G~a~~~~~~~~---------------~~~l~rd~~~~~~~-f~r~y~~~~d~~s~~~~~ 189 (191)
T d1zara2 147 PQSVEVGEEGW---------------REILERDVRNIITY-FSRTYRTEKDINSAIDRI 189 (191)
T ss_dssp TTCEETTSTTH---------------HHHHHHHHHHHHHH-HHHHHCCCCCHHHHHHHH
T ss_pred CCcccCCCCCc---------------HHHHHHHHHHHHHH-HcCCCCCcccHHHHHHHH
Confidence 99875421110 011111 11 245678899999976444
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Probab=99.75 E-value=5.8e-18 Score=174.54 Aligned_cols=190 Identities=22% Similarity=0.357 Sum_probs=142.4
Q ss_pred ccCCCCCcEEEeeCCCCCCCCChhhcCCCCCCEEecccccccccCccccccccccceEecccccccccCchhhcCCccch
Q 002158 129 IGNISSLIFLLLNGNKLSGSLPDELGYLSNLNRLQVDENNITGTIPKSFANLSRVRHLHLNNNSIGGQIPSELSKLSTLI 208 (958)
Q Consensus 129 i~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~ 208 (958)
+..+.+|++|++.+|+++ .++ .+.++++|++|++++|++++..+ +..+++|+.|++++|.++ .++ .+.++++|+
T Consensus 37 ~~~l~~L~~L~l~~~~i~-~l~-~l~~l~~L~~L~ls~n~i~~~~~--l~~l~~l~~l~~~~n~~~-~i~-~l~~l~~L~ 110 (227)
T d1h6ua2 37 QADLDGITTLSAFGTGVT-TIE-GVQYLNNLIGLELKDNQITDLAP--LKNLTKITELELSGNPLK-NVS-AIAGLQSIK 110 (227)
T ss_dssp HHHHHTCCEEECTTSCCC-CCT-TGGGCTTCCEEECCSSCCCCCGG--GTTCCSCCEEECCSCCCS-CCG-GGTTCTTCC
T ss_pred HHHcCCcCEEECCCCCCC-cch-hHhcCCCCcEeecCCceeecccc--cccccccccccccccccc-ccc-ccccccccc
Confidence 455677888888888887 453 47888888888888888875433 778888888888888877 343 477788888
Q ss_pred hhhccCCccccCCCcccCCCCCccEEEccCCCCCCCCccccccCCCCCCEEEcccCCCCCCCCCCCCCCCcCEEeccCCc
Q 002158 209 HLLVDNNNLSGNLPPELSELPQLCILQLDNNNFSASEIPATYGNFSKLVKLSLRNCNLQGAVPDLSRIPNLYYLDLSWNH 288 (958)
Q Consensus 209 ~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~l~~l~~L~~L~Ls~N~ 288 (958)
.+++++|...+. ..+...+.++.+.++++.+.. ...+.++++|+.|++++|.++... .+.++++|+.|+|++|+
T Consensus 111 ~l~l~~~~~~~~--~~~~~~~~~~~l~~~~~~~~~---~~~~~~~~~L~~L~l~~n~~~~~~-~l~~l~~L~~L~Ls~n~ 184 (227)
T d1h6ua2 111 TLDLTSTQITDV--TPLAGLSNLQVLYLDLNQITN---ISPLAGLTNLQYLSIGNAQVSDLT-PLANLSKLTTLKADDNK 184 (227)
T ss_dssp EEECTTSCCCCC--GGGTTCTTCCEEECCSSCCCC---CGGGGGCTTCCEEECCSSCCCCCG-GGTTCTTCCEEECCSSC
T ss_pred cccccccccccc--chhccccchhhhhchhhhhch---hhhhccccccccccccccccccch-hhcccccceecccCCCc
Confidence 888888877643 346667888888888888752 334667788888888888887443 37788888888888888
Q ss_pred CCCcCCCCCCCCCcCEEEccCCcCCCccchhccCCCCCCeEeeec
Q 002158 289 LTGSIPSKKLSENVTTIDLSDNYLNGSILESISNLPFLQTLSLEN 333 (958)
Q Consensus 289 l~~~~~~~~~~~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~ 333 (958)
++ .++....+++|++|+|++|+|++..+ +.++++|+.|+|++
T Consensus 185 l~-~l~~l~~l~~L~~L~Ls~N~lt~i~~--l~~l~~L~~L~lsn 226 (227)
T d1h6ua2 185 IS-DISPLASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLTN 226 (227)
T ss_dssp CC-CCGGGGGCTTCCEEECTTSCCCBCGG--GTTCTTCCEEEEEE
T ss_pred cC-CChhhcCCCCCCEEECcCCcCCCCcc--cccCCCCCEEEeeC
Confidence 87 45556667888888888888886543 78888888888874
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Probab=99.74 E-value=1.8e-16 Score=174.22 Aligned_cols=272 Identities=27% Similarity=0.312 Sum_probs=178.6
Q ss_pred eeEEEEccCCcCCCCccccccCCCCcceeeccCcccCCCCccccCCCCCcEEEeeCCCCCCCCChhhcCCCCCCEEeccc
Q 002158 87 HVRELQLLSMNLSGNLAPELGQLSRLQYYFMWNDLTGTIPKEIGNISSLIFLLLNGNKLSGSLPDELGYLSNLNRLQVDE 166 (958)
Q Consensus 87 ~v~~L~L~~~~l~~~~~~~l~~L~~L~~L~l~n~~~~~ip~~i~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~L~~ 166 (958)
++++|||++++++. +|+. +++|++|++++|....+|+.+ .+|+.|++++|+++ .++. + .+.|++|++++
T Consensus 39 ~l~~LdLs~~~L~~-lp~~---~~~L~~L~Ls~N~l~~lp~~~---~~L~~L~l~~n~l~-~l~~-l--p~~L~~L~L~~ 107 (353)
T d1jl5a_ 39 QAHELELNNLGLSS-LPEL---PPHLESLVASCNSLTELPELP---QSLKSLLVDNNNLK-ALSD-L--PPLLEYLGVSN 107 (353)
T ss_dssp TCSEEECTTSCCSC-CCSC---CTTCSEEECCSSCCSSCCCCC---TTCCEEECCSSCCS-CCCS-C--CTTCCEEECCS
T ss_pred CCCEEEeCCCCCCC-CCCC---CCCCCEEECCCCCCcccccch---hhhhhhhhhhcccc-hhhh-h--ccccccccccc
Confidence 47789999999885 5643 568899999988888898764 57899999999988 4443 2 14699999999
Q ss_pred ccccccCccccccccccceEecccccccccCchhhcCCccchhhhccCCccccCCCcccCCCCCccEEEccCCCCCCCC-
Q 002158 167 NNITGTIPKSFANLSRVRHLHLNNNSIGGQIPSELSKLSTLIHLLVDNNNLSGNLPPELSELPQLCILQLDNNNFSASE- 245 (958)
Q Consensus 167 N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~- 245 (958)
|.++ .+| .++.+++|+.|++++|.+.. .+.. ...+..+.+.++... ....+..++.++.|++++|.+....
T Consensus 108 n~l~-~lp-~~~~l~~L~~L~l~~~~~~~-~~~~---~~~l~~l~~~~~~~~--~~~~l~~l~~l~~L~l~~n~~~~~~~ 179 (353)
T d1jl5a_ 108 NQLE-KLP-ELQNSSFLKIIDVDNNSLKK-LPDL---PPSLEFIAAGNNQLE--ELPELQNLPFLTAIYADNNSLKKLPD 179 (353)
T ss_dssp SCCS-SCC-CCTTCTTCCEEECCSSCCSC-CCCC---CTTCCEEECCSSCCS--SCCCCTTCTTCCEEECCSSCCSSCCC
T ss_pred cccc-ccc-chhhhccceeeccccccccc-cccc---cccccchhhcccccc--ccccccccccceeccccccccccccc
Confidence 9998 455 36789999999999999883 3332 234455555555443 3345666777777777777664210
Q ss_pred ----------------ccccccCCCCCCEEEcccCCCCCCCCCCCCCCCcCEEeccCCcCCCcCCCCCCCCCcCEEEccC
Q 002158 246 ----------------IPATYGNFSKLVKLSLRNCNLQGAVPDLSRIPNLYYLDLSWNHLTGSIPSKKLSENVTTIDLSD 309 (958)
Q Consensus 246 ----------------~p~~~~~l~~L~~L~L~~N~l~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~~~L~~L~Ls~ 309 (958)
....+..++.|+.+++++|.....+. ...++..+.+.+|.+..... ....+..+++..
T Consensus 180 ~~~~~~~l~~~~~~~~~~~~~~~l~~L~~l~l~~n~~~~~~~---~~~~l~~~~~~~~~~~~~~~---~~~~l~~~~~~~ 253 (353)
T d1jl5a_ 180 LPLSLESIVAGNNILEELPELQNLPFLTTIYADNNLLKTLPD---LPPSLEALNVRDNYLTDLPE---LPQSLTFLDVSE 253 (353)
T ss_dssp CCTTCCEEECCSSCCSSCCCCTTCTTCCEEECCSSCCSSCCS---CCTTCCEEECCSSCCSCCCC---CCTTCCEEECCS
T ss_pred cccccccccccccccccccccccccccccccccccccccccc---cccccccccccccccccccc---cccccccccccc
Confidence 01123455666777777666554332 23345556666665542211 112333344333
Q ss_pred CcCCCc----------------cchhccCCCCCCeEeeecccCCCccchhhhcccccCccccceEeccCCCCCCCccCCC
Q 002158 310 NYLNGS----------------ILESISNLPFLQTLSLENNFLTGSIPATIWQNKSFSTKARLKIDLRNNSFSNIVGDLT 373 (958)
Q Consensus 310 N~l~~~----------------~~~~~~~l~~L~~L~L~~N~l~~~ip~~l~~~~~~~~~~l~~L~Ls~N~l~~l~~~~~ 373 (958)
|.+.+. +......+++|++|+|++|+|+ .+|..+ +.|+.|+|++|+|++++..
T Consensus 254 ~~~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~L~~L~Ls~N~l~-~lp~~~--------~~L~~L~L~~N~L~~l~~~-- 322 (353)
T d1jl5a_ 254 NIFSGLSELPPNLYYLNASSNEIRSLCDLPPSLEELNVSNNKLI-ELPALP--------PRLERLIASFNHLAEVPEL-- 322 (353)
T ss_dssp SCCSEESCCCTTCCEEECCSSCCSEECCCCTTCCEEECCSSCCS-CCCCCC--------TTCCEEECCSSCCSCCCCC--
T ss_pred ccccccccccchhcccccccCccccccccCCCCCEEECCCCccC-cccccc--------CCCCEEECCCCcCCccccc--
Confidence 332211 0111234678999999999998 677542 4677899999999988764
Q ss_pred CCCcceEEeCCCCCCCCCCCC
Q 002158 374 LPNNVTLRLGGNPICTSANIP 394 (958)
Q Consensus 374 l~~L~~L~l~~N~l~~~~~~~ 394 (958)
+++|++|++++|++...++.+
T Consensus 323 ~~~L~~L~L~~N~L~~lp~~~ 343 (353)
T d1jl5a_ 323 PQNLKQLHVEYNPLREFPDIP 343 (353)
T ss_dssp CTTCCEEECCSSCCSSCCCCC
T ss_pred cCCCCEEECcCCcCCCCCccc
Confidence 568999999999997655433
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.71 E-value=1.5e-17 Score=173.06 Aligned_cols=197 Identities=19% Similarity=0.196 Sum_probs=97.1
Q ss_pred CCCcEEEeeCCCCCCCCChhhcCCCCCCEEecccccccccC-ccccccccccceEecc-cccccccCchhhcCCccchhh
Q 002158 133 SSLIFLLLNGNKLSGSLPDELGYLSNLNRLQVDENNITGTI-PKSFANLSRVRHLHLN-NNSIGGQIPSELSKLSTLIHL 210 (958)
Q Consensus 133 ~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~-p~~~~~l~~L~~L~Ls-~N~l~~~~p~~l~~l~~L~~L 210 (958)
+++++|+|++|.++...+..|.++++|++|+|++|.+...+ +..|.+++++++|.+. .|++....+..|.++++|+.|
T Consensus 29 ~~l~~L~Ls~n~i~~l~~~~f~~l~~L~~L~ls~n~~~~~i~~~~f~~l~~l~~l~~~~~n~l~~~~~~~~~~l~~L~~l 108 (242)
T d1xwdc1 29 RNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYL 108 (242)
T ss_dssp SCCSEEEEESCCCCEECTTTTTTCTTCCEEEEESCTTCCEECSSSEESCTTCCEEEEECCTTCCEECTTSEECCTTCCEE
T ss_pred CCCCEEECcCCcCCccChhHhhccchhhhhhhccccccceeecccccccccccccccccccccccccccccccccccccc
Confidence 35666777777766433445666677777777776665433 3345666666666654 345555555556666666666
Q ss_pred hccCCccccCCC-cccCCCCCccEEEccCCCCCCCCccccccCCC-CCCEEEcccCCCCCCCCCCCCCCCcCEE-eccCC
Q 002158 211 LVDNNNLSGNLP-PELSELPQLCILQLDNNNFSASEIPATYGNFS-KLVKLSLRNCNLQGAVPDLSRIPNLYYL-DLSWN 287 (958)
Q Consensus 211 ~L~~N~l~~~~~-~~l~~l~~L~~L~L~~N~l~~~~~p~~~~~l~-~L~~L~L~~N~l~~~~~~l~~l~~L~~L-~Ls~N 287 (958)
++++|++....+ ..+..+..+..+..+++.+... .+..|..++ .++.|++++|+++.+.......+++..+ ++++|
T Consensus 109 ~l~~~~l~~~~~~~~~~~l~~l~~~~~~n~~l~~i-~~~~~~~~~~~l~~L~l~~n~l~~i~~~~~~~~~l~~~~~l~~n 187 (242)
T d1xwdc1 109 LISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTI-ERNSFVGLSFESVILWLNKNGIQEIHNCAFNGTQLDELNLSDNN 187 (242)
T ss_dssp EEESCCCCSCCCCTTTCBSSCEEEEEESCTTCCEE-CTTSSTTSBSSCEEEECCSSCCCEECTTTTTTCCEEEEECTTCT
T ss_pred ccchhhhcccccccccccccccccccccccccccc-cccccccccccceeeecccccccccccccccchhhhcccccccc
Confidence 666666553222 1223334444444455554321 122333332 4455555555555444433333333333 33444
Q ss_pred cCCCcCCC--CCCCCCcCEEEccCCcCCCccchhccCCCCCCeEee
Q 002158 288 HLTGSIPS--KKLSENVTTIDLSDNYLNGSILESISNLPFLQTLSL 331 (958)
Q Consensus 288 ~l~~~~~~--~~~~~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L 331 (958)
+++ .+|. ...+++|++|+|++|+|+...+..|.++++|+.|++
T Consensus 188 ~l~-~l~~~~f~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~l~~ 232 (242)
T d1xwdc1 188 NLE-ELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARST 232 (242)
T ss_dssp TCC-CCCTTTTTTSCCCSEEECTTSCCCCCCSSSCTTCCEEESSSE
T ss_pred ccc-cccHHHhcCCCCCCEEECCCCcCCccCHHHHcCCcccccCcC
Confidence 444 2222 122344555555555444444444444444444444
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Probab=99.71 E-value=4.2e-17 Score=168.00 Aligned_cols=204 Identities=20% Similarity=0.290 Sum_probs=102.7
Q ss_pred cEEEeeCCCCCCCCChhhcCCCCCCEEecccccccccCccccccccccceEecccccccccCchhhcCCccchhhhccCC
Q 002158 136 IFLLLNGNKLSGSLPDELGYLSNLNRLQVDENNITGTIPKSFANLSRVRHLHLNNNSIGGQIPSELSKLSTLIHLLVDNN 215 (958)
Q Consensus 136 ~~L~Ls~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N 215 (958)
..++++.+++++.+ .+..+.+|++|++.+|+|+. + ..+..+++|++|++++|.+++..| +..+++|+.+++++|
T Consensus 22 ~~~~l~~~~~~d~~--~~~~l~~L~~L~l~~~~i~~-l-~~l~~l~~L~~L~ls~n~i~~~~~--l~~l~~l~~l~~~~n 95 (227)
T d1h6ua2 22 IKIAAGKSNVTDTV--TQADLDGITTLSAFGTGVTT-I-EGVQYLNNLIGLELKDNQITDLAP--LKNLTKITELELSGN 95 (227)
T ss_dssp HHHHTTCSSTTSEE--CHHHHHTCCEEECTTSCCCC-C-TTGGGCTTCCEEECCSSCCCCCGG--GTTCCSCCEEECCSC
T ss_pred HHHHhCCCCcCCcC--CHHHcCCcCEEECCCCCCCc-c-hhHhcCCCCcEeecCCceeecccc--ccccccccccccccc
Confidence 33445555555322 23445555666666555553 2 235555555555555555553222 455555555555555
Q ss_pred ccccCCCcccCCCCCccEEEccCCCCCCCCccccccCCCCCCEEEcccCCCCCCCCCCCCCCCcCEEeccCCcCCCcCCC
Q 002158 216 NLSGNLPPELSELPQLCILQLDNNNFSASEIPATYGNFSKLVKLSLRNCNLQGAVPDLSRIPNLYYLDLSWNHLTGSIPS 295 (958)
Q Consensus 216 ~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~ 295 (958)
.++.. ..+.++++|+.++++++.. .+. ..+...+.+..+.++.+.+.. ...
T Consensus 96 ~~~~i--~~l~~l~~L~~l~l~~~~~-------------------------~~~-~~~~~~~~~~~l~~~~~~~~~-~~~ 146 (227)
T d1h6ua2 96 PLKNV--SAIAGLQSIKTLDLTSTQI-------------------------TDV-TPLAGLSNLQVLYLDLNQITN-ISP 146 (227)
T ss_dssp CCSCC--GGGTTCTTCCEEECTTSCC-------------------------CCC-GGGTTCTTCCEEECCSSCCCC-CGG
T ss_pred ccccc--ccccccccccccccccccc-------------------------ccc-chhccccchhhhhchhhhhch-hhh
Confidence 54421 2344445555555554444 322 123344455555555555442 222
Q ss_pred CCCCCCcCEEEccCCcCCCccchhccCCCCCCeEeeecccCCCccchhhhcccccCccccceEeccCCCCCCCccCCCCC
Q 002158 296 KKLSENVTTIDLSDNYLNGSILESISNLPFLQTLSLENNFLTGSIPATIWQNKSFSTKARLKIDLRNNSFSNIVGDLTLP 375 (958)
Q Consensus 296 ~~~~~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~ip~~l~~~~~~~~~~l~~L~Ls~N~l~~l~~~~~l~ 375 (958)
....++|+.|++++|.++... .+.++++|+.|+|++|++++ +|. +..+ +.|++|+|++|+|++++....++
T Consensus 147 ~~~~~~L~~L~l~~n~~~~~~--~l~~l~~L~~L~Ls~n~l~~-l~~-l~~l-----~~L~~L~Ls~N~lt~i~~l~~l~ 217 (227)
T d1h6ua2 147 LAGLTNLQYLSIGNAQVSDLT--PLANLSKLTTLKADDNKISD-ISP-LASL-----PNLIEVHLKNNQISDVSPLANTS 217 (227)
T ss_dssp GGGCTTCCEEECCSSCCCCCG--GGTTCTTCCEEECCSSCCCC-CGG-GGGC-----TTCCEEECTTSCCCBCGGGTTCT
T ss_pred hccccccccccccccccccch--hhcccccceecccCCCccCC-Chh-hcCC-----CCCCEEECcCCcCCCCcccccCC
Confidence 333455555555555554322 25556666666666666653 322 2222 34556666666666666544777
Q ss_pred CcceEEeC
Q 002158 376 NNVTLRLG 383 (958)
Q Consensus 376 ~L~~L~l~ 383 (958)
+|+.|+++
T Consensus 218 ~L~~L~ls 225 (227)
T d1h6ua2 218 NLFIVTLT 225 (227)
T ss_dssp TCCEEEEE
T ss_pred CCCEEEee
Confidence 78887775
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.70 E-value=2.5e-17 Score=171.48 Aligned_cols=205 Identities=16% Similarity=0.166 Sum_probs=163.4
Q ss_pred CcEEEeeCCCCCCCCChhhcCCCCCCEEecccccccccCccccccccccceEecccccccccC-chhhcCCccchhhhcc
Q 002158 135 LIFLLLNGNKLSGSLPDELGYLSNLNRLQVDENNITGTIPKSFANLSRVRHLHLNNNSIGGQI-PSELSKLSTLIHLLVD 213 (958)
Q Consensus 135 L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~-p~~l~~l~~L~~L~L~ 213 (958)
.+.++.++++++ .+|..+. +++++|+|++|+|+...+..|.++++|++|+|++|.+...+ +..|.+++++++|.+.
T Consensus 10 ~~~i~c~~~~l~-~iP~~l~--~~l~~L~Ls~n~i~~l~~~~f~~l~~L~~L~ls~n~~~~~i~~~~f~~l~~l~~l~~~ 86 (242)
T d1xwdc1 10 NRVFLCQESKVT-EIPSDLP--RNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIE 86 (242)
T ss_dssp SSEEEEESCSCS-SCCSCSC--SCCSEEEEESCCCCEECTTTTTTCTTCCEEEEESCTTCCEECSSSEESCTTCCEEEEE
T ss_pred CCEEEEeCCCCC-CcCCCCC--CCCCEEECcCCcCCccChhHhhccchhhhhhhccccccceeecccccccccccccccc
Confidence 367899999998 7887664 58999999999999666668999999999999999987544 4578899999999876
Q ss_pred C-CccccCCCcccCCCCCccEEEccCCCCCCCCccccccCCCCCCEEEcccCCCCCCCCC-CCCCC-CcCEEeccCCcCC
Q 002158 214 N-NNLSGNLPPELSELPQLCILQLDNNNFSASEIPATYGNFSKLVKLSLRNCNLQGAVPD-LSRIP-NLYYLDLSWNHLT 290 (958)
Q Consensus 214 ~-N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~-l~~l~-~L~~L~Ls~N~l~ 290 (958)
. |++....+..|.++++|++|++++|.+........+..+..+..+...++++...... +..++ .++.|++++|+++
T Consensus 87 ~~n~l~~~~~~~~~~l~~L~~l~l~~~~l~~~~~~~~~~~l~~l~~~~~~n~~l~~i~~~~~~~~~~~l~~L~l~~n~l~ 166 (242)
T d1xwdc1 87 KANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQ 166 (242)
T ss_dssp CCTTCCEECTTSEECCTTCCEEEEESCCCCSCCCCTTTCBSSCEEEEEESCTTCCEECTTSSTTSBSSCEEEECCSSCCC
T ss_pred ccccccccccccccccccccccccchhhhcccccccccccccccccccccccccccccccccccccccceeeeccccccc
Confidence 4 7788888889999999999999999997543334556667777778888888877654 66654 7889999999998
Q ss_pred CcCCCCCCCCCcCEE-EccCCcCCCccchhccCCCCCCeEeeecccCCCccchh
Q 002158 291 GSIPSKKLSENVTTI-DLSDNYLNGSILESISNLPFLQTLSLENNFLTGSIPAT 343 (958)
Q Consensus 291 ~~~~~~~~~~~L~~L-~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~ip~~ 343 (958)
...+......+++.+ ++++|+|+...+..|.++++|++|+|++|+|+ .+|..
T Consensus 167 ~i~~~~~~~~~l~~~~~l~~n~l~~l~~~~f~~l~~L~~L~Ls~N~l~-~l~~~ 219 (242)
T d1xwdc1 167 EIHNCAFNGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIH-SLPSY 219 (242)
T ss_dssp EECTTTTTTCCEEEEECTTCTTCCCCCTTTTTTSCCCSEEECTTSCCC-CCCSS
T ss_pred ccccccccchhhhccccccccccccccHHHhcCCCCCCEEECCCCcCC-ccCHH
Confidence 544444445665555 57888898877888999999999999999998 56654
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Probab=99.70 E-value=4.5e-18 Score=170.35 Aligned_cols=161 Identities=27% Similarity=0.366 Sum_probs=112.8
Q ss_pred CCCccccCCCCCcEEEeeCCCCCCCC-ChhhcCCCCCCEEecccccccccCccccccccccceEecccccccccCchhhc
Q 002158 124 TIPKEIGNISSLIFLLLNGNKLSGSL-PDELGYLSNLNRLQVDENNITGTIPKSFANLSRVRHLHLNNNSIGGQIPSELS 202 (958)
Q Consensus 124 ~ip~~i~~l~~L~~L~Ls~n~l~~~~-p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~ 202 (958)
.+|..+. +++++|+|++|.|++.+ +..|.++++|++|+|++|++....+..|..+++|++|+|++|+|+...+.+|.
T Consensus 22 ~iP~~lp--~~l~~L~Ls~N~i~~~~~~~~f~~l~~L~~L~L~~N~i~~~~~~~~~~~~~L~~L~Ls~N~l~~l~~~~F~ 99 (192)
T d1w8aa_ 22 EIPRDIP--LHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGENKIKEISNKMFL 99 (192)
T ss_dssp SCCSCCC--TTCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSCCCCEECSSSST
T ss_pred ccCCCCC--CCCCEEEeCCCCCcccccccccCCCceEeeeeccccccccccccccccccccceeeeccccccccCHHHHh
Confidence 4455443 57888888888887534 55677888888888888888888888888888888888888888877777888
Q ss_pred CCccchhhhccCCccccCCCcccCCCCCccEEEccCCCCCCCCccccccCCCCCCEEEcccCCCCCCCCCCCCCCCcCEE
Q 002158 203 KLSTLIHLLVDNNNLSGNLPPELSELPQLCILQLDNNNFSASEIPATYGNFSKLVKLSLRNCNLQGAVPDLSRIPNLYYL 282 (958)
Q Consensus 203 ~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~l~~l~~L~~L 282 (958)
++++|++|+|++|+|++..+++|..+++|++|+|++|.+....-...+. ..++.+.+..|.++...| ..+.+++.+
T Consensus 100 ~l~~L~~L~L~~N~l~~i~~~~f~~l~~L~~l~L~~N~~~~~~~~~~~~--~~l~~~~l~~~~~~c~~p--~~l~~~~l~ 175 (192)
T d1w8aa_ 100 GLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCNCHLAWFA--EWLRKKSLNGGAARCGAP--SKVRDVQIK 175 (192)
T ss_dssp TCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCCSGGGHHHH--HHHHHHCCSGGGCBBCSS--TTTTTSBGG
T ss_pred CCCcccccccCCccccccCHHHhcCCcccccccccccccccccchHHHh--hhhhhhcccCCCeEeCCC--hhhcCCEee
Confidence 8888888888888888888888888888888888888875321111111 124444455555553322 223445555
Q ss_pred eccCCcCC
Q 002158 283 DLSWNHLT 290 (958)
Q Consensus 283 ~Ls~N~l~ 290 (958)
+|+.|.+.
T Consensus 176 ~L~~n~l~ 183 (192)
T d1w8aa_ 176 DLPHSEFK 183 (192)
T ss_dssp GSCTTTCC
T ss_pred ecCHhhCc
Confidence 66666654
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.69 E-value=6.7e-17 Score=162.70 Aligned_cols=161 Identities=24% Similarity=0.380 Sum_probs=71.7
Q ss_pred CCCCCEEecccccccccCccccccccccceEecccccccccCchhhcCCccchhhhccCCccccCCCcccCCCCCccEEE
Q 002158 156 LSNLNRLQVDENNITGTIPKSFANLSRVRHLHLNNNSIGGQIPSELSKLSTLIHLLVDNNNLSGNLPPELSELPQLCILQ 235 (958)
Q Consensus 156 l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~ 235 (958)
+.+|++|++++|.++. + +.+..+++|++|+|++|++++. +. +.++++|++|++++|.+... ..+.++++|+.|+
T Consensus 39 l~~l~~L~l~~~~i~~-l-~~l~~l~nL~~L~Ls~N~l~~~-~~-l~~l~~L~~L~l~~n~~~~~--~~l~~l~~L~~L~ 112 (199)
T d2omxa2 39 LDQVTTLQADRLGIKS-I-DGVEYLNNLTQINFSNNQLTDI-TP-LKNLTKLVDILMNNNQIADI--TPLANLTNLTGLT 112 (199)
T ss_dssp HTTCCEEECTTSCCCC-C-TTGGGCTTCCEEECCSSCCCCC-GG-GTTCTTCCEEECCSSCCCCC--GGGTTCTTCSEEE
T ss_pred hcCCCEEECCCCCCCC-c-cccccCCCcCcCccccccccCc-cc-ccCCcccccccccccccccc--ccccccccccccc
Confidence 3444444444444442 1 1233444444444444444422 11 44444444444444444321 1244445555555
Q ss_pred ccCCCCCCCCccccccCCCCCCEEEcccCCCCCCCCCCCCCCCcCEEeccCCcCCCcCCCCCCCCCcCEEEccCCcCCCc
Q 002158 236 LDNNNFSASEIPATYGNFSKLVKLSLRNCNLQGAVPDLSRIPNLYYLDLSWNHLTGSIPSKKLSENVTTIDLSDNYLNGS 315 (958)
Q Consensus 236 L~~N~l~~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~~~L~~L~Ls~N~l~~~ 315 (958)
+++|.+.. ...+..+++|+.|++++|++... +.+..+++|++|++++|++++ ++....+++|++|+|++|+|++.
T Consensus 113 l~~~~~~~---~~~~~~l~~L~~L~l~~n~l~~~-~~l~~~~~L~~L~l~~n~l~~-l~~l~~l~~L~~L~ls~N~i~~i 187 (199)
T d2omxa2 113 LFNNQITD---IDPLKNLTNLNRLELSSNTISDI-SALSGLTSLQQLNFSSNQVTD-LKPLANLTTLERLDISSNKVSDI 187 (199)
T ss_dssp CCSSCCCC---CGGGTTCTTCSEEECCSSCCCCC-GGGTTCTTCSEEECCSSCCCC-CGGGTTCTTCCEEECCSSCCCCC
T ss_pred cccccccc---ccccchhhhhHHhhhhhhhhccc-ccccccccccccccccccccC-CccccCCCCCCEEECCCCCCCCC
Confidence 55544431 12244445555555555554422 234445555555555555542 23333445555555555555432
Q ss_pred cchhccCCCCCCeE
Q 002158 316 ILESISNLPFLQTL 329 (958)
Q Consensus 316 ~~~~~~~l~~L~~L 329 (958)
..++.+++|++|
T Consensus 188 --~~l~~L~~L~~L 199 (199)
T d2omxa2 188 --SVLAKLTNLESL 199 (199)
T ss_dssp --GGGGGCTTCSEE
T ss_pred --ccccCCCCCCcC
Confidence 235555555554
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.69 E-value=5.9e-17 Score=164.56 Aligned_cols=165 Identities=24% Similarity=0.340 Sum_probs=81.1
Q ss_pred CCCCcEEEeeCCCCCCCCChhhcCCCCCCEEecccccccccCccccccccccceEecccccccccCchhhcCCccchhhh
Q 002158 132 ISSLIFLLLNGNKLSGSLPDELGYLSNLNRLQVDENNITGTIPKSFANLSRVRHLHLNNNSIGGQIPSELSKLSTLIHLL 211 (958)
Q Consensus 132 l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~ 211 (958)
+.+|++|++++|.++. ++ .+..+++|++|+|++|+|++. + .++.+++|++|++++|+|++ ++ .+.++++|+.|+
T Consensus 45 L~~L~~L~l~~~~i~~-l~-~l~~l~~L~~L~L~~n~i~~l-~-~~~~l~~L~~L~l~~n~i~~-l~-~l~~l~~L~~L~ 118 (210)
T d1h6ta2 45 LNSIDQIIANNSDIKS-VQ-GIQYLPNVTKLFLNGNKLTDI-K-PLANLKNLGWLFLDENKVKD-LS-SLKDLKKLKSLS 118 (210)
T ss_dssp HHTCCEEECTTSCCCC-CT-TGGGCTTCCEEECCSSCCCCC-G-GGTTCTTCCEEECCSSCCCC-GG-GGTTCTTCCEEE
T ss_pred hcCccEEECcCCCCCC-ch-hHhhCCCCCEEeCCCccccCc-c-ccccCccccccccccccccc-cc-cccccccccccc
Confidence 3445555555555542 22 244555555555555555532 1 23445555555555555542 22 244444444444
Q ss_pred ccCCccccCCCcccCCCCCccEEEccCCCCCCCCccccccCCCCCCEEEcccCCCCCCCCCCCCCCCcCEEeccCCcCCC
Q 002158 212 VDNNNLSGNLPPELSELPQLCILQLDNNNFSASEIPATYGNFSKLVKLSLRNCNLQGAVPDLSRIPNLYYLDLSWNHLTG 291 (958)
Q Consensus 212 L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~l~~l~~L~~L~Ls~N~l~~ 291 (958)
+++|.+.. ...+..+++|+.+++++|.+++. ..+..+++|+.+++++|++++
T Consensus 119 l~~~~~~~---------------------------~~~l~~l~~l~~l~~~~n~l~~~-~~~~~l~~L~~l~l~~n~l~~ 170 (210)
T d1h6ta2 119 LEHNGISD---------------------------INGLVHLPQLESLYLGNNKITDI-TVLSRLTKLDTLSLEDNQISD 170 (210)
T ss_dssp CTTSCCCC---------------------------CGGGGGCTTCCEEECCSSCCCCC-GGGGGCTTCSEEECCSSCCCC
T ss_pred cccccccc---------------------------ccccccccccccccccccccccc-ccccccccccccccccccccc
Confidence 44444431 12344444445555554444422 123444555555555555552
Q ss_pred cCCCCCCCCCcCEEEccCCcCCCccchhccCCCCCCeEeeec
Q 002158 292 SIPSKKLSENVTTIDLSDNYLNGSILESISNLPFLQTLSLEN 333 (958)
Q Consensus 292 ~~~~~~~~~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~ 333 (958)
++....+++|++|+|++|+|+.. + .|.++++|++|+|++
T Consensus 171 -i~~l~~l~~L~~L~Ls~N~i~~l-~-~l~~l~~L~~L~Ls~ 209 (210)
T d1h6ta2 171 -IVPLAGLTKLQNLYLSKNHISDL-R-ALAGLKNLDVLELFS 209 (210)
T ss_dssp -CGGGTTCTTCCEEECCSSCCCBC-G-GGTTCTTCSEEEEEE
T ss_pred -cccccCCCCCCEEECCCCCCCCC-h-hhcCCCCCCEEEccC
Confidence 33344455666666666666543 2 477777777777764
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.69 E-value=5.8e-17 Score=164.61 Aligned_cols=182 Identities=23% Similarity=0.359 Sum_probs=139.6
Q ss_pred EEecccccccccCccccccccccceEecccccccccCchhhcCCccchhhhccCCccccCCCcccCCCCCccEEEccCCC
Q 002158 161 RLQVDENNITGTIPKSFANLSRVRHLHLNNNSIGGQIPSELSKLSTLIHLLVDNNNLSGNLPPELSELPQLCILQLDNNN 240 (958)
Q Consensus 161 ~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~ 240 (958)
..++..+.+++.++. ..+.+|+.|++++|.++. ++ .+..+++|++|+|++|+|++.. .+..+++|++|++++|+
T Consensus 28 ~~~l~~~~~~~~~~~--~~L~~L~~L~l~~~~i~~-l~-~l~~l~~L~~L~L~~n~i~~l~--~~~~l~~L~~L~l~~n~ 101 (210)
T d1h6ta2 28 KDNLKKKSVTDAVTQ--NELNSIDQIIANNSDIKS-VQ-GIQYLPNVTKLFLNGNKLTDIK--PLANLKNLGWLFLDENK 101 (210)
T ss_dssp HHHTTCSCTTSEECH--HHHHTCCEEECTTSCCCC-CT-TGGGCTTCCEEECCSSCCCCCG--GGTTCTTCCEEECCSSC
T ss_pred HHHhCcCccCCccCH--HHhcCccEEECcCCCCCC-ch-hHhhCCCCCEEeCCCccccCcc--ccccCcccccccccccc
Confidence 345555655544432 346677777777777773 33 3677888888888888887543 46788999999999999
Q ss_pred CCCCCccccccCCCCCCEEEcccCCCCCCCCCCCCCCCcCEEeccCCcCCCcCCCCCCCCCcCEEEccCCcCCCccchhc
Q 002158 241 FSASEIPATYGNFSKLVKLSLRNCNLQGAVPDLSRIPNLYYLDLSWNHLTGSIPSKKLSENVTTIDLSDNYLNGSILESI 320 (958)
Q Consensus 241 l~~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~~~L~~L~Ls~N~l~~~~~~~~ 320 (958)
++ .++ .+.++++|+.|++++|.+.. .+.+..+++|+.+++++|.++ ..+....+++|+.+++++|++++.. .+
T Consensus 102 i~--~l~-~l~~l~~L~~L~l~~~~~~~-~~~l~~l~~l~~l~~~~n~l~-~~~~~~~l~~L~~l~l~~n~l~~i~--~l 174 (210)
T d1h6ta2 102 VK--DLS-SLKDLKKLKSLSLEHNGISD-INGLVHLPQLESLYLGNNKIT-DITVLSRLTKLDTLSLEDNQISDIV--PL 174 (210)
T ss_dssp CC--CGG-GGTTCTTCCEEECTTSCCCC-CGGGGGCTTCCEEECCSSCCC-CCGGGGGCTTCSEEECCSSCCCCCG--GG
T ss_pred cc--ccc-cccccccccccccccccccc-ccccccccccccccccccccc-ccccccccccccccccccccccccc--cc
Confidence 86 344 58889999999999999874 346888999999999999998 4555667799999999999998754 38
Q ss_pred cCCCCCCeEeeecccCCCccchhhhcccccCccccceEeccC
Q 002158 321 SNLPFLQTLSLENNFLTGSIPATIWQNKSFSTKARLKIDLRN 362 (958)
Q Consensus 321 ~~l~~L~~L~L~~N~l~~~ip~~l~~~~~~~~~~l~~L~Ls~ 362 (958)
.++++|++|+|++|+|+ .+| .+..+ +.|+.|+|++
T Consensus 175 ~~l~~L~~L~Ls~N~i~-~l~-~l~~l-----~~L~~L~Ls~ 209 (210)
T d1h6ta2 175 AGLTKLQNLYLSKNHIS-DLR-ALAGL-----KNLDVLELFS 209 (210)
T ss_dssp TTCTTCCEEECCSSCCC-BCG-GGTTC-----TTCSEEEEEE
T ss_pred cCCCCCCEEECCCCCCC-CCh-hhcCC-----CCCCEEEccC
Confidence 99999999999999998 455 34443 4567898874
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Probab=99.68 E-value=1.2e-17 Score=167.33 Aligned_cols=172 Identities=17% Similarity=0.207 Sum_probs=93.4
Q ss_pred CcEEEeeCCCCCCCCChhhcCCCCCCEEecccccccccC-ccccccccccceEecccccccccCchhhcCCccchhhhcc
Q 002158 135 LIFLLLNGNKLSGSLPDELGYLSNLNRLQVDENNITGTI-PKSFANLSRVRHLHLNNNSIGGQIPSELSKLSTLIHLLVD 213 (958)
Q Consensus 135 L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~-p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~ 213 (958)
.+.+++++++++ .+|..+. +++++|+|++|+|++.+ +..|.++++|+.|+|++|++.+..+..+..+++|++|+|+
T Consensus 10 ~~~v~Cs~~~L~-~iP~~lp--~~l~~L~Ls~N~i~~~~~~~~f~~l~~L~~L~L~~N~i~~~~~~~~~~~~~L~~L~Ls 86 (192)
T d1w8aa_ 10 GTTVDCTGRGLK-EIPRDIP--LHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLG 86 (192)
T ss_dssp TTEEECTTSCCS-SCCSCCC--TTCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECC
T ss_pred CCEEEEeCCCcC-ccCCCCC--CCCCEEEeCCCCCcccccccccCCCceEeeeeccccccccccccccccccccceeeec
Confidence 346777777777 6666553 56777777777776433 4455666666666666666665555556656666666666
Q ss_pred CCccccCCCcccCCCCCccEEEccCCCCCCCCccccccCCCCCCEEEcccCCCCCCCCC-CCCCCCcCEEeccCCcCCCc
Q 002158 214 NNNLSGNLPPELSELPQLCILQLDNNNFSASEIPATYGNFSKLVKLSLRNCNLQGAVPD-LSRIPNLYYLDLSWNHLTGS 292 (958)
Q Consensus 214 ~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~-l~~l~~L~~L~Ls~N~l~~~ 292 (958)
+|+|+...+.+|.++++|++|+|++|+| ++++++ |..+++|++|+|++|.+...
T Consensus 87 ~N~l~~l~~~~F~~l~~L~~L~L~~N~l-------------------------~~i~~~~f~~l~~L~~l~L~~N~~~~~ 141 (192)
T d1w8aa_ 87 ENKIKEISNKMFLGLHQLKTLNLYDNQI-------------------------SCVMPGSFEHLNSLTSLNLASNPFNCN 141 (192)
T ss_dssp SCCCCEECSSSSTTCTTCCEEECCSSCC-------------------------CEECTTSSTTCTTCCEEECTTCCBCCS
T ss_pred cccccccCHHHHhCCCcccccccCCccc-------------------------cccCHHHhcCCcccccccccccccccc
Confidence 6655555555555555555555555554 444443 55555666666666655533
Q ss_pred CCCCCCCCCcCEEEccCCcCCCccchhccCCCCCCeEeeecccCC
Q 002158 293 IPSKKLSENVTTIDLSDNYLNGSILESISNLPFLQTLSLENNFLT 337 (958)
Q Consensus 293 ~~~~~~~~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~ 337 (958)
.........++.+.+..|.++...|.. +..++.++|+.|.+.
T Consensus 142 ~~~~~~~~~l~~~~l~~~~~~c~~p~~---l~~~~l~~L~~n~l~ 183 (192)
T d1w8aa_ 142 CHLAWFAEWLRKKSLNGGAARCGAPSK---VRDVQIKDLPHSEFK 183 (192)
T ss_dssp GGGHHHHHHHHHHCCSGGGCBBCSSTT---TTTSBGGGSCTTTCC
T ss_pred cchHHHhhhhhhhcccCCCeEeCCChh---hcCCEeeecCHhhCc
Confidence 222222223344444445444433332 233444455555554
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.67 E-value=2.1e-16 Score=159.01 Aligned_cols=163 Identities=25% Similarity=0.398 Sum_probs=113.0
Q ss_pred cCCCCCcEEEeeCCCCCCCCChhhcCCCCCCEEecccccccccCccccccccccceEecccccccccCchhhcCCccchh
Q 002158 130 GNISSLIFLLLNGNKLSGSLPDELGYLSNLNRLQVDENNITGTIPKSFANLSRVRHLHLNNNSIGGQIPSELSKLSTLIH 209 (958)
Q Consensus 130 ~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~ 209 (958)
..+.+|++|++++|.++ .++ .+..+++|++|+|++|++++..+ +.++++|++|++++|.+. .++ .+.++++|+.
T Consensus 37 ~~l~~l~~L~l~~~~i~-~l~-~l~~l~nL~~L~Ls~N~l~~~~~--l~~l~~L~~L~l~~n~~~-~~~-~l~~l~~L~~ 110 (199)
T d2omxa2 37 TDLDQVTTLQADRLGIK-SID-GVEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIA-DIT-PLANLTNLTG 110 (199)
T ss_dssp HHHTTCCEEECTTSCCC-CCT-TGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCC-CCG-GGTTCTTCSE
T ss_pred HHhcCCCEEECCCCCCC-Ccc-ccccCCCcCcCccccccccCccc--ccCCcccccccccccccc-ccc-cccccccccc
Confidence 34566777777777776 343 36777777777777777774432 777777777777777776 333 3677777777
Q ss_pred hhccCCccccCCCcccCCCCCccEEEccCCCCCCCCccccccCCCCCCEEEcccCCCCCCCCCCCCCCCcCEEeccCCcC
Q 002158 210 LLVDNNNLSGNLPPELSELPQLCILQLDNNNFSASEIPATYGNFSKLVKLSLRNCNLQGAVPDLSRIPNLYYLDLSWNHL 289 (958)
Q Consensus 210 L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~l~~l~~L~~L~Ls~N~l 289 (958)
|++++|.+... ..+..+++|+.|++++|++.. + ..+..+++|+.|++.+|++++.. .+.++++|+.|++++|++
T Consensus 111 L~l~~~~~~~~--~~~~~l~~L~~L~l~~n~l~~--~-~~l~~~~~L~~L~l~~n~l~~l~-~l~~l~~L~~L~ls~N~i 184 (199)
T d2omxa2 111 LTLFNNQITDI--DPLKNLTNLNRLELSSNTISD--I-SALSGLTSLQQLNFSSNQVTDLK-PLANLTTLERLDISSNKV 184 (199)
T ss_dssp EECCSSCCCCC--GGGTTCTTCSEEECCSSCCCC--C-GGGTTCTTCSEEECCSSCCCCCG-GGTTCTTCCEEECCSSCC
T ss_pred ccccccccccc--cccchhhhhHHhhhhhhhhcc--c-ccccccccccccccccccccCCc-cccCCCCCCEEECCCCCC
Confidence 77777777643 346777788888888887752 2 34677778888888888877643 477778888888888887
Q ss_pred CCcCCCCCCCCCcCEE
Q 002158 290 TGSIPSKKLSENVTTI 305 (958)
Q Consensus 290 ~~~~~~~~~~~~L~~L 305 (958)
+ .++....+++|++|
T Consensus 185 ~-~i~~l~~L~~L~~L 199 (199)
T d2omxa2 185 S-DISVLAKLTNLESL 199 (199)
T ss_dssp C-CCGGGGGCTTCSEE
T ss_pred C-CCccccCCCCCCcC
Confidence 7 45555556677665
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Probab=99.65 E-value=1.1e-14 Score=159.64 Aligned_cols=270 Identities=21% Similarity=0.266 Sum_probs=182.5
Q ss_pred CCcceeeccCcccCCCCccccCCCCCcEEEeeCCCCCCCCChhhcCCCCCCEEecccccccccCccccccccccceEecc
Q 002158 110 SRLQYYFMWNDLTGTIPKEIGNISSLIFLLLNGNKLSGSLPDELGYLSNLNRLQVDENNITGTIPKSFANLSRVRHLHLN 189 (958)
Q Consensus 110 ~~L~~L~l~n~~~~~ip~~i~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls 189 (958)
.+|+.|+++++..+.+|+. +++|++|+|++|+|+ .+|.. +.+|++|++++|+++ .++. + .+.|++|+++
T Consensus 38 ~~l~~LdLs~~~L~~lp~~---~~~L~~L~Ls~N~l~-~lp~~---~~~L~~L~l~~n~l~-~l~~-l--p~~L~~L~L~ 106 (353)
T d1jl5a_ 38 RQAHELELNNLGLSSLPEL---PPHLESLVASCNSLT-ELPEL---PQSLKSLLVDNNNLK-ALSD-L--PPLLEYLGVS 106 (353)
T ss_dssp HTCSEEECTTSCCSCCCSC---CTTCSEEECCSSCCS-SCCCC---CTTCCEEECCSSCCS-CCCS-C--CTTCCEEECC
T ss_pred cCCCEEEeCCCCCCCCCCC---CCCCCEEECCCCCCc-ccccc---hhhhhhhhhhhcccc-hhhh-h--cccccccccc
Confidence 3678899998888889964 468999999999999 78865 468999999999998 3332 1 1469999999
Q ss_pred cccccccCchhhcCCccchhhhccCCccccCCCcccCCCCCccEEEccCCCCCCCCccccccCCCCCCEEEcccCCCCCC
Q 002158 190 NNSIGGQIPSELSKLSTLIHLLVDNNNLSGNLPPELSELPQLCILQLDNNNFSASEIPATYGNFSKLVKLSLRNCNLQGA 269 (958)
Q Consensus 190 ~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~p~~~~~l~~L~~L~L~~N~l~~~ 269 (958)
+|.+. .+|. ++.+++|+.|++++|.+... +. ....+..+.+..+... ....+..++.++.|++++|.+...
T Consensus 107 ~n~l~-~lp~-~~~l~~L~~L~l~~~~~~~~-~~---~~~~l~~l~~~~~~~~---~~~~l~~l~~l~~L~l~~n~~~~~ 177 (353)
T d1jl5a_ 107 NNQLE-KLPE-LQNSSFLKIIDVDNNSLKKL-PD---LPPSLEFIAAGNNQLE---ELPELQNLPFLTAIYADNNSLKKL 177 (353)
T ss_dssp SSCCS-SCCC-CTTCTTCCEEECCSSCCSCC-CC---CCTTCCEEECCSSCCS---SCCCCTTCTTCCEEECCSSCCSSC
T ss_pred ccccc-cccc-hhhhccceeecccccccccc-cc---ccccccchhhcccccc---ccccccccccceeccccccccccc
Confidence 99998 5664 67899999999999998743 22 3467788888877764 245677888899999998877653
Q ss_pred CC-------------------CCCCCCCcCEEeccCCcCCCcCCCCCCCCCcCEEEccCCcCCCccchhccCCCCCCeEe
Q 002158 270 VP-------------------DLSRIPNLYYLDLSWNHLTGSIPSKKLSENVTTIDLSDNYLNGSILESISNLPFLQTLS 330 (958)
Q Consensus 270 ~~-------------------~l~~l~~L~~L~Ls~N~l~~~~~~~~~~~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~ 330 (958)
+. .+..++.|+.+++++|.... ++ ....++..+.+.+|.+.... .....+..++
T Consensus 178 ~~~~~~~~~l~~~~~~~~~~~~~~~l~~L~~l~l~~n~~~~-~~--~~~~~l~~~~~~~~~~~~~~----~~~~~l~~~~ 250 (353)
T d1jl5a_ 178 PDLPLSLESIVAGNNILEELPELQNLPFLTTIYADNNLLKT-LP--DLPPSLEALNVRDNYLTDLP----ELPQSLTFLD 250 (353)
T ss_dssp CCCCTTCCEEECCSSCCSSCCCCTTCTTCCEEECCSSCCSS-CC--SCCTTCCEEECCSSCCSCCC----CCCTTCCEEE
T ss_pred ccccccccccccccccccccccccccccccccccccccccc-cc--cccccccccccccccccccc----cccccccccc
Confidence 32 23445666666666666542 22 22345666666666664321 1123444444
Q ss_pred eecccCCC--ccchhhhcccc---------cCccccceEeccCCCCCCCccCCCCCCcceEEeCCCCCCCCCCCCCCCcc
Q 002158 331 LENNFLTG--SIPATIWQNKS---------FSTKARLKIDLRNNSFSNIVGDLTLPNNVTLRLGGNPICTSANIPNTGRF 399 (958)
Q Consensus 331 L~~N~l~~--~ip~~l~~~~~---------~~~~~l~~L~Ls~N~l~~l~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~ 399 (958)
+..|.+.+ .++...+.... -..+.|++|+|++|+|++++. .+++|+.|+|++|.++..+..
T Consensus 251 ~~~~~~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~L~~L~Ls~N~l~~lp~--~~~~L~~L~L~~N~L~~l~~~------ 322 (353)
T d1jl5a_ 251 VSENIFSGLSELPPNLYYLNASSNEIRSLCDLPPSLEELNVSNNKLIELPA--LPPRLERLIASFNHLAEVPEL------ 322 (353)
T ss_dssp CCSSCCSEESCCCTTCCEEECCSSCCSEECCCCTTCCEEECCSSCCSCCCC--CCTTCCEEECCSSCCSCCCCC------
T ss_pred cccccccccccccchhcccccccCccccccccCCCCCEEECCCCccCcccc--ccCCCCEEECCCCcCCccccc------
Confidence 44444432 11111111000 013578999999999999885 478999999999998754322
Q ss_pred cccCCCCCccccccCCC
Q 002158 400 CGSDAGGDETLTNSKVN 416 (958)
Q Consensus 400 ~~~~~~~~~~L~~n~~~ 416 (958)
....+.+.|.+|+..
T Consensus 323 --~~~L~~L~L~~N~L~ 337 (353)
T d1jl5a_ 323 --PQNLKQLHVEYNPLR 337 (353)
T ss_dssp --CTTCCEEECCSSCCS
T ss_pred --cCCCCEEECcCCcCC
Confidence 123566777877764
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.52 E-value=7.8e-17 Score=183.78 Aligned_cols=303 Identities=19% Similarity=0.173 Sum_probs=195.9
Q ss_pred eeeEEEEccCCcCCCCc-cccccCCCCcceeeccCcccC-----CCCccccCCCCCcEEEeeCCCCCCC----CChhhc-
Q 002158 86 LHVRELQLLSMNLSGNL-APELGQLSRLQYYFMWNDLTG-----TIPKEIGNISSLIFLLLNGNKLSGS----LPDELG- 154 (958)
Q Consensus 86 ~~v~~L~L~~~~l~~~~-~~~l~~L~~L~~L~l~n~~~~-----~ip~~i~~l~~L~~L~Ls~n~l~~~----~p~~l~- 154 (958)
.++++||++.+++++.. ..-+..+++|+.|.++++... .+...+..+++|++|+|++|.|+.. +...+.
T Consensus 2 ~~l~~ld~~~~~i~~~~~~~l~~~l~~l~~L~L~~~~i~~~~~~~l~~~L~~~~~L~~LdLs~N~i~~~~~~~l~~~l~~ 81 (460)
T d1z7xw1 2 LDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQT 81 (460)
T ss_dssp EEEEEEEEESCCCCHHHHHHHHHHHTTCSEEEEESSCCCHHHHHHHHHHHHTCTTCCEEECTTCCCHHHHHHHHHHTTCS
T ss_pred CCCCEEEeeCCcCChHHHHHHHHhCCCCCEEEeCCCCCCHHHHHHHHHHHhcCCCCCEEECcCCcCChHHHHHHHHHHhc
Confidence 36899999999998853 444567888899999877543 3456678899999999999988621 122222
Q ss_pred CCCCCCEEeccccccccc----CccccccccccceEecccccccccCchh------------------------------
Q 002158 155 YLSNLNRLQVDENNITGT----IPKSFANLSRVRHLHLNNNSIGGQIPSE------------------------------ 200 (958)
Q Consensus 155 ~l~~L~~L~L~~N~l~~~----~p~~~~~l~~L~~L~Ls~N~l~~~~p~~------------------------------ 200 (958)
...+|++|+|++|+++.. ++..+..+++|++|+|++|.++......
T Consensus 82 ~~~~L~~L~L~~n~it~~~~~~l~~~l~~~~~L~~L~L~~N~i~~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (460)
T d1z7xw1 82 PSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEPL 161 (460)
T ss_dssp TTCCCCEEECTTSCCBGGGHHHHHHHTTSCTTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGGHHHH
T ss_pred CCCCCCEEECCCCCccccccccccchhhccccccccccccccchhhhhhhhhhcccccccccccccccccccchhhhccc
Confidence 235799999999999854 4556778899999999999876321111
Q ss_pred ---hcCCccchhhhccCCcccc-----------------------------C----CCcccCCCCCccEEEccCCCCCCC
Q 002158 201 ---LSKLSTLIHLLVDNNNLSG-----------------------------N----LPPELSELPQLCILQLDNNNFSAS 244 (958)
Q Consensus 201 ---l~~l~~L~~L~L~~N~l~~-----------------------------~----~~~~l~~l~~L~~L~L~~N~l~~~ 244 (958)
+.....++.++++++.+.. . ....+...+.++.+++++|.+...
T Consensus 162 ~~~l~~~~~~~~~~ls~~~~~~~~~~~~~~~l~~~~~~~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~~l~~~~n~~~~~ 241 (460)
T d1z7xw1 162 ASVLRAKPDFKELTVSNNDINEAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDLCGIVASKASLRELALGSNKLGDV 241 (460)
T ss_dssp HHHHHHCTTCCEEECCSSBCHHHHHHHHHHHHHHSCCCCCEEECTTSCCBTTHHHHHHHHHHHCTTCCEEECCSSBCHHH
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccccchhhhcccccccccccccccchhhcccccc
Confidence 1111233333333332210 0 001122356677777777766321
Q ss_pred ----CccccccCCCCCCEEEcccCCCCCCCC-----CCCCCCCcCEEeccCCcCCCcCCC------CCCCCCcCEEEccC
Q 002158 245 ----EIPATYGNFSKLVKLSLRNCNLQGAVP-----DLSRIPNLYYLDLSWNHLTGSIPS------KKLSENVTTIDLSD 309 (958)
Q Consensus 245 ----~~p~~~~~l~~L~~L~L~~N~l~~~~~-----~l~~l~~L~~L~Ls~N~l~~~~~~------~~~~~~L~~L~Ls~ 309 (958)
...........|+.|++++|.+..... .+...+.++.+++++|.++..... ......|+.+++++
T Consensus 242 ~~~~~~~~~~~~~~~l~~l~l~~n~i~~~~~~~~~~~l~~~~~l~~l~l~~n~i~~~~~~~l~~~l~~~~~~L~~l~l~~ 321 (460)
T d1z7xw1 242 GMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGARLLCETLLEPGCQLESLWVKS 321 (460)
T ss_dssp HHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCTTCCEEECTTCCCHHHHHHHHHHHHTSTTCCCCEEECTT
T ss_pred ccchhhcccccccccccccccccccccccccccccccccccccccccccccccccccccchhhccccccccccccccccc
Confidence 112334456778888888888765432 145677888888888887531110 11235789999999
Q ss_pred CcCCCccchhc----cCCCCCCeEeeecccCCCccchhhhcccccCccccceEeccCCCCCCCc-----cCC-CCCCcce
Q 002158 310 NYLNGSILESI----SNLPFLQTLSLENNFLTGSIPATIWQNKSFSTKARLKIDLRNNSFSNIV-----GDL-TLPNNVT 379 (958)
Q Consensus 310 N~l~~~~~~~~----~~l~~L~~L~L~~N~l~~~ip~~l~~~~~~~~~~l~~L~Ls~N~l~~l~-----~~~-~l~~L~~ 379 (958)
|.++......+ ...++|++|+|++|+|++.....+.....-....|++|+|++|+|++.. ... ..++|++
T Consensus 322 ~~l~~~~~~~l~~~~~~~~~L~~L~Ls~N~i~~~g~~~l~~~l~~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~L~~ 401 (460)
T d1z7xw1 322 CSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRE 401 (460)
T ss_dssp SCCBGGGHHHHHHHHHHCSSCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCCCCCE
T ss_pred cchhhhhhhhcccccccccchhhhheeeecccCcccchhhhhhhcccCCCCEEECCCCCCChHHHHHHHHHHhcCCCCCE
Confidence 99887654444 4567899999999999754433333222222346789999999997632 222 5688999
Q ss_pred EEeCCCCCC
Q 002158 380 LRLGGNPIC 388 (958)
Q Consensus 380 L~l~~N~l~ 388 (958)
|+|++|++.
T Consensus 402 L~Ls~N~i~ 410 (460)
T d1z7xw1 402 LDLSNNCLG 410 (460)
T ss_dssp EECCSSSCC
T ss_pred EECCCCcCC
Confidence 999999884
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=99.47 E-value=9.4e-16 Score=168.34 Aligned_cols=90 Identities=19% Similarity=0.300 Sum_probs=44.3
Q ss_pred CCcCEEEccCCcCCCc----cchhccCCCCCCeEeeecccCCCccchhhhcc-cccCccccceEeccCCCCCCC-----c
Q 002158 300 ENVTTIDLSDNYLNGS----ILESISNLPFLQTLSLENNFLTGSIPATIWQN-KSFSTKARLKIDLRNNSFSNI-----V 369 (958)
Q Consensus 300 ~~L~~L~Ls~N~l~~~----~~~~~~~l~~L~~L~L~~N~l~~~ip~~l~~~-~~~~~~~l~~L~Ls~N~l~~l-----~ 369 (958)
++|+.|+|++|.++.. +...+..+++|++|+|++|.|++.....+... .......+++||+++|+|+.- .
T Consensus 215 ~~L~~L~Ls~N~i~~~g~~~L~~~l~~~~~L~~L~Ls~n~i~~~g~~~l~~~l~~~~~~~L~~L~ls~N~i~~~~~~~l~ 294 (344)
T d2ca6a1 215 QELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLK 294 (344)
T ss_dssp TTCCEEECCSSCCHHHHHHHHHHHGGGCTTCCEEECTTCCCCHHHHHHHHHHHHTCSSCCCCEEECCSSCCBHHHHHHHH
T ss_pred hhhcccccccccccccccccccccccccccchhhhhhcCccCchhhHHHHHHhhhccCCCCCEEECCCCcCChHHHHHHH
Confidence 4444444444444322 23334455556666666666554433333321 112234455666666665441 1
Q ss_pred cCC--CCCCcceEEeCCCCCCC
Q 002158 370 GDL--TLPNNVTLRLGGNPICT 389 (958)
Q Consensus 370 ~~~--~l~~L~~L~l~~N~l~~ 389 (958)
... ..++|+.|+|+||.+..
T Consensus 295 ~~l~~~~~~L~~L~l~~N~~~~ 316 (344)
T d2ca6a1 295 TVIDEKMPDLLFLELNGNRFSE 316 (344)
T ss_dssp HHHHHHCTTCCEEECTTSBSCT
T ss_pred HHHHccCCCCCEEECCCCcCCC
Confidence 111 35667777777777744
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.46 E-value=4.6e-14 Score=129.43 Aligned_cols=102 Identities=25% Similarity=0.390 Sum_probs=60.7
Q ss_pred cEEEeeCCCCCCCCChhhcCCCCCCEEecccccccccCccccccccccceEecccccccccCchhhcCCccchhhhccCC
Q 002158 136 IFLLLNGNKLSGSLPDELGYLSNLNRLQVDENNITGTIPKSFANLSRVRHLHLNNNSIGGQIPSELSKLSTLIHLLVDNN 215 (958)
Q Consensus 136 ~~L~Ls~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N 215 (958)
++|+|++|+++ .++. +..+++|++|++++|+|+ .+|..|+.+++|+.|++++|.|++ +| .+..+++|++|++++|
T Consensus 1 R~L~Ls~n~l~-~l~~-l~~l~~L~~L~ls~N~l~-~lp~~~~~l~~L~~L~l~~N~i~~-l~-~~~~l~~L~~L~l~~N 75 (124)
T d1dcea3 1 RVLHLAHKDLT-VLCH-LEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALEN-VD-GVANLPRLQELLLCNN 75 (124)
T ss_dssp SEEECTTSCCS-SCCC-GGGGTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCC-CG-GGTTCSSCCEEECCSS
T ss_pred CEEEcCCCCCC-CCcc-cccCCCCCEEECCCCccC-cchhhhhhhhcccccccccccccc-cC-ccccccccCeEECCCC
Confidence 45666777666 4443 666666666666666666 455566666666666666666663 33 3556666666666666
Q ss_pred ccccCC-CcccCCCCCccEEEccCCCCC
Q 002158 216 NLSGNL-PPELSELPQLCILQLDNNNFS 242 (958)
Q Consensus 216 ~l~~~~-~~~l~~l~~L~~L~L~~N~l~ 242 (958)
+|+... ...+..+++|+.|++++|+++
T Consensus 76 ~i~~~~~~~~l~~~~~L~~L~l~~N~i~ 103 (124)
T d1dcea3 76 RLQQSAAIQPLVSCPRLVLLNLQGNSLC 103 (124)
T ss_dssp CCCSSSTTGGGGGCTTCCEEECTTSGGG
T ss_pred ccCCCCCchhhcCCCCCCEEECCCCcCC
Confidence 665332 234555556666666666554
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=99.46 E-value=4.3e-15 Score=162.97 Aligned_cols=247 Identities=19% Similarity=0.206 Sum_probs=180.0
Q ss_pred cCCCCccccCCCCCcEEEeeCCCCCCC----CChhhcCCCCCCEEeccccccccc----------CccccccccccceEe
Q 002158 122 TGTIPKEIGNISSLIFLLLNGNKLSGS----LPDELGYLSNLNRLQVDENNITGT----------IPKSFANLSRVRHLH 187 (958)
Q Consensus 122 ~~~ip~~i~~l~~L~~L~Ls~n~l~~~----~p~~l~~l~~L~~L~L~~N~l~~~----------~p~~~~~l~~L~~L~ 187 (958)
...+...+.+..+|++|+|++|.+... +-..+...++|+.|+++++.+... +...+..+++|+.|+
T Consensus 20 ~~~l~~~L~~~~~l~~L~Ls~n~i~~~~~~~l~~~l~~~~~L~~l~l~~~~~~~~~~~~~~~~~~l~~~l~~~~~L~~L~ 99 (344)
T d2ca6a1 20 EKSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVR 99 (344)
T ss_dssp HHTTSHHHHHCSCCCEEECTTSEECHHHHHHHHHTTTTCTTCCEEECCSCCTTSCGGGSHHHHHHHHHHHTTCTTCCEEE
T ss_pred HHHHHHHHhhCCCCCEEECcCCcCCHHHHHHHHHHHHhCCCCCEEECCCCcccccccccchHHHHHHHHHhhCCCccccc
Confidence 345667788899999999999988632 233466789999999998765422 223355678999999
Q ss_pred ccccccccc----CchhhcCCccchhhhccCCccccCCCc----c---------cCCCCCccEEEccCCCCCCCC---cc
Q 002158 188 LNNNSIGGQ----IPSELSKLSTLIHLLVDNNNLSGNLPP----E---------LSELPQLCILQLDNNNFSASE---IP 247 (958)
Q Consensus 188 Ls~N~l~~~----~p~~l~~l~~L~~L~L~~N~l~~~~~~----~---------l~~l~~L~~L~L~~N~l~~~~---~p 247 (958)
|++|.++.. +...+...++|+.|++++|.+...... . ....+.|+.|++++|+++... +.
T Consensus 100 L~~n~i~~~~~~~l~~~l~~~~~L~~L~l~~n~l~~~~~~~l~~~l~~~~~~~~~~~~~~L~~l~l~~n~i~~~~~~~l~ 179 (344)
T d2ca6a1 100 LSDNAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWA 179 (344)
T ss_dssp CCSCCCCTTTHHHHHHHHHHCTTCCEEECCSSCCHHHHHHHHHHHHHHHHHHHHHHTCCCCCEEECCSSCCTGGGHHHHH
T ss_pred ccccccccccccchhhhhcccccchheecccccccccccccccccccccccccccccCcccceeeccccccccccccccc
Confidence 999999854 334456778999999999987521111 1 135688999999999986422 23
Q ss_pred ccccCCCCCCEEEcccCCCCCC------CCCCCCCCCcCEEeccCCcCCCc----C-CCCCCCCCcCEEEccCCcCCCcc
Q 002158 248 ATYGNFSKLVKLSLRNCNLQGA------VPDLSRIPNLYYLDLSWNHLTGS----I-PSKKLSENVTTIDLSDNYLNGSI 316 (958)
Q Consensus 248 ~~~~~l~~L~~L~L~~N~l~~~------~~~l~~l~~L~~L~Ls~N~l~~~----~-~~~~~~~~L~~L~Ls~N~l~~~~ 316 (958)
..+..++.|+.|+|++|+++.. ...+..+++|+.|+|++|.++.. + ......++|++|+|++|.|++..
T Consensus 180 ~~l~~~~~L~~L~L~~n~i~~~g~~~~l~~~l~~~~~L~~L~Ls~N~i~~~g~~~L~~~l~~~~~L~~L~Ls~n~i~~~g 259 (344)
T d2ca6a1 180 KTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLSARG 259 (344)
T ss_dssp HHHHHCTTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHHHGGGCTTCCEEECTTCCCCHHH
T ss_pred chhhhhhhhcccccccccccccccccchhhhhcchhhhcccccccccccccccccccccccccccchhhhhhcCccCchh
Confidence 3456788999999999999752 12367889999999999998632 1 12345689999999999998754
Q ss_pred chhc----cC--CCCCCeEeeecccCCCccchhhhcccccCccccceEeccCCCCCCC
Q 002158 317 LESI----SN--LPFLQTLSLENNFLTGSIPATIWQNKSFSTKARLKIDLRNNSFSNI 368 (958)
Q Consensus 317 ~~~~----~~--l~~L~~L~L~~N~l~~~ip~~l~~~~~~~~~~l~~L~Ls~N~l~~l 368 (958)
...+ .. .+.|++|+|++|+|+......+.....-..+.++.|+|++|.+.+.
T Consensus 260 ~~~l~~~l~~~~~~~L~~L~ls~N~i~~~~~~~l~~~l~~~~~~L~~L~l~~N~~~~~ 317 (344)
T d2ca6a1 260 AAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFSEE 317 (344)
T ss_dssp HHHHHHHHHTCSSCCCCEEECCSSCCBHHHHHHHHHHHHHHCTTCCEEECTTSBSCTT
T ss_pred hHHHHHHhhhccCCCCCEEECCCCcCChHHHHHHHHHHHccCCCCCEEECCCCcCCCc
Confidence 4444 33 4679999999999986555555543222235688999999999763
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.45 E-value=2.3e-14 Score=138.20 Aligned_cols=111 Identities=24% Similarity=0.248 Sum_probs=68.3
Q ss_pred ccCCCCCcEEEeeCCCCCCCCChhhcCCCCCCEEecccccccccCccccccccccceEecccccccccCchhhcCCccch
Q 002158 129 IGNISSLIFLLLNGNKLSGSLPDELGYLSNLNRLQVDENNITGTIPKSFANLSRVRHLHLNNNSIGGQIPSELSKLSTLI 208 (958)
Q Consensus 129 i~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~ 208 (958)
+.+..+|++|+|++|+|+ .++..+..+++|++|+|++|+|+. + +.|..+++|++|++++|+++...+..+..+++|+
T Consensus 14 ~~n~~~lr~L~L~~n~I~-~i~~~~~~l~~L~~L~Ls~N~i~~-l-~~~~~l~~L~~L~ls~N~i~~l~~~~~~~l~~L~ 90 (162)
T d1a9na_ 14 YTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIRK-L-DGFPLLRRLKTLLVNNNRICRIGEGLDQALPDLT 90 (162)
T ss_dssp EECTTSCEEEECTTSCCC-SCCCGGGGTTCCSEEECCSSCCCE-E-CCCCCCSSCCEEECCSSCCCEECSCHHHHCTTCC
T ss_pred ccCcCcCcEEECCCCCCC-ccCccccccccCCEEECCCCCCCc-c-CCcccCcchhhhhcccccccCCCccccccccccc
Confidence 456667777777777777 456555667777777777777763 3 2466666777777777777654444455566666
Q ss_pred hhhccCCccccCCC-cccCCCCCccEEEccCCCCC
Q 002158 209 HLLVDNNNLSGNLP-PELSELPQLCILQLDNNNFS 242 (958)
Q Consensus 209 ~L~L~~N~l~~~~~-~~l~~l~~L~~L~L~~N~l~ 242 (958)
.|++++|+|+.... ..+..+++|++|++++|.++
T Consensus 91 ~L~L~~N~i~~~~~l~~l~~l~~L~~L~l~~N~i~ 125 (162)
T d1a9na_ 91 ELILTNNSLVELGDLDPLASLKSLTYLCILRNPVT 125 (162)
T ss_dssp EEECCSCCCCCGGGGGGGGGCTTCCEEECCSSGGG
T ss_pred cceeccccccccccccccccccccchhhcCCCccc
Confidence 66666666653211 34555555555555555553
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.44 E-value=4.6e-15 Score=157.81 Aligned_cols=222 Identities=20% Similarity=0.170 Sum_probs=101.9
Q ss_pred EEEEccCCcCCCCccccccCCCCcceeeccCcccCCCCccccCCCCCcEEEeeCCCCCCC-CChhhcCCCCCCEEecccc
Q 002158 89 RELQLLSMNLSGNLAPELGQLSRLQYYFMWNDLTGTIPKEIGNISSLIFLLLNGNKLSGS-LPDELGYLSNLNRLQVDEN 167 (958)
Q Consensus 89 ~~L~L~~~~l~~~~~~~l~~L~~L~~L~l~n~~~~~ip~~i~~l~~L~~L~Ls~n~l~~~-~p~~l~~l~~L~~L~L~~N 167 (958)
+.|||+++++.......+... .+..+.+................+|++|||+++.++.. ++..+.++++|++|+|++|
T Consensus 3 ~~lDLs~~~l~~~~l~~l~~~-~~~~lrl~~~~~~~~~~~~~~~~~L~~LdLs~~~i~~~~l~~l~~~c~~L~~L~L~~~ 81 (284)
T d2astb2 3 QTLDLTGKNLHPDVTGRLLSQ-GVIAFRCPRSFMDQPLAEHFSPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGL 81 (284)
T ss_dssp SEEECTTCBCCHHHHHHHHHT-TCSEEECTTCEECSCCCSCCCCBCCCEEECTTCEECHHHHHHHHTTBCCCSEEECTTC
T ss_pred CEEECCCCCCCchHHHHHHhc-cceEeeccccccccchhhhccCCCCCEEECCCCccCHHHHHHHHHhCCCccccccccc
Confidence 356777766643322222111 12223333222222222233444666666666665432 2233455666666666666
Q ss_pred cccccCccccccccccceEecccc-ccccc-CchhhcCCccchhhhccCCccccCCCcccCCCCCccEEEccCCCCCCCC
Q 002158 168 NITGTIPKSFANLSRVRHLHLNNN-SIGGQ-IPSELSKLSTLIHLLVDNNNLSGNLPPELSELPQLCILQLDNNNFSASE 245 (958)
Q Consensus 168 ~l~~~~p~~~~~l~~L~~L~Ls~N-~l~~~-~p~~l~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~ 245 (958)
.+++..+..++.+++|++|+|+++ .++.. +...+.++++|++|+++++. .++...
T Consensus 82 ~l~~~~~~~l~~~~~L~~L~Ls~c~~itd~~l~~l~~~~~~L~~L~ls~c~-----------------------~~~~~~ 138 (284)
T d2astb2 82 RLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDELNLSWCF-----------------------DFTEKH 138 (284)
T ss_dssp BCCHHHHHHHTTCTTCSEEECTTCBSCCHHHHHHHHHHCTTCCEEECCCCT-----------------------TCCHHH
T ss_pred CCCcHHHHHHhcCCCCcCccccccccccccccchhhHHHHhcccccccccc-----------------------cccccc
Confidence 665555555666666666666653 34311 11122344455555554431 222111
Q ss_pred cccccc-CCCCCCEEEcccCC--CCCCCC-C-CCCCCCcCEEeccCCc-CCCc-CCCCCCCCCcCEEEccCC-cCCCccc
Q 002158 246 IPATYG-NFSKLVKLSLRNCN--LQGAVP-D-LSRIPNLYYLDLSWNH-LTGS-IPSKKLSENVTTIDLSDN-YLNGSIL 317 (958)
Q Consensus 246 ~p~~~~-~l~~L~~L~L~~N~--l~~~~~-~-l~~l~~L~~L~Ls~N~-l~~~-~~~~~~~~~L~~L~Ls~N-~l~~~~~ 317 (958)
+...+. ..++|+.|+++++. ++.... . +.++++|++|+|++|. +++. +.....+++|++|+|++| .+++...
T Consensus 139 ~~~~~~~~~~~L~~L~l~~~~~~i~~~~l~~l~~~~~~L~~L~L~~~~~itd~~~~~l~~~~~L~~L~L~~C~~i~~~~l 218 (284)
T d2astb2 139 VQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETL 218 (284)
T ss_dssp HHHHHHHSCTTCCEEECCSCGGGSCHHHHHHHHHHCTTCSEEECTTCTTCCGGGGGGGGGCTTCCEEECTTCTTCCGGGG
T ss_pred chhhhcccccccchhhhcccccccccccccccccccccccccccccccCCCchhhhhhcccCcCCEEECCCCCCCChHHH
Confidence 111111 12344455444331 221100 1 2334555555555542 3321 222233456666666663 4555555
Q ss_pred hhccCCCCCCeEeeecc
Q 002158 318 ESISNLPFLQTLSLENN 334 (958)
Q Consensus 318 ~~~~~l~~L~~L~L~~N 334 (958)
..++++++|+.|+++++
T Consensus 219 ~~L~~~~~L~~L~l~~~ 235 (284)
T d2astb2 219 LELGEIPTLKTLQVFGI 235 (284)
T ss_dssp GGGGGCTTCCEEECTTS
T ss_pred HHHhcCCCCCEEeeeCC
Confidence 66677777777777766
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.44 E-value=9.8e-14 Score=127.19 Aligned_cols=105 Identities=27% Similarity=0.355 Sum_probs=71.4
Q ss_pred CEEecccccccccCccccccccccceEecccccccccCchhhcCCccchhhhccCCccccCCCcccCCCCCccEEEccCC
Q 002158 160 NRLQVDENNITGTIPKSFANLSRVRHLHLNNNSIGGQIPSELSKLSTLIHLLVDNNNLSGNLPPELSELPQLCILQLDNN 239 (958)
Q Consensus 160 ~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N 239 (958)
+.|+|++|+++ .++ .+..+++|++|++++|.|+ .+|..+..+++|+.|++++|+|++. + .+..+++|++|++++|
T Consensus 1 R~L~Ls~n~l~-~l~-~l~~l~~L~~L~ls~N~l~-~lp~~~~~l~~L~~L~l~~N~i~~l-~-~~~~l~~L~~L~l~~N 75 (124)
T d1dcea3 1 RVLHLAHKDLT-VLC-HLEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALENV-D-GVANLPRLQELLLCNN 75 (124)
T ss_dssp SEEECTTSCCS-SCC-CGGGGTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCCC-G-GGTTCSSCCEEECCSS
T ss_pred CEEEcCCCCCC-CCc-ccccCCCCCEEECCCCccC-cchhhhhhhhccccccccccccccc-C-ccccccccCeEECCCC
Confidence 46788888887 344 4777778888888888887 5666677777777777777777743 2 4677777777777777
Q ss_pred CCCCCCccccccCCCCCCEEEcccCCCCCC
Q 002158 240 NFSASEIPATYGNFSKLVKLSLRNCNLQGA 269 (958)
Q Consensus 240 ~l~~~~~p~~~~~l~~L~~L~L~~N~l~~~ 269 (958)
+|+.......+..+++|+.|++++|.++..
T Consensus 76 ~i~~~~~~~~l~~~~~L~~L~l~~N~i~~~ 105 (124)
T d1dcea3 76 RLQQSAAIQPLVSCPRLVLLNLQGNSLCQE 105 (124)
T ss_dssp CCCSSSTTGGGGGCTTCCEEECTTSGGGGS
T ss_pred ccCCCCCchhhcCCCCCCEEECCCCcCCcC
Confidence 775433234556666666666666666543
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.42 E-value=1.5e-13 Score=131.54 Aligned_cols=132 Identities=16% Similarity=0.101 Sum_probs=73.9
Q ss_pred CCEEEcccCCCCCCCCCCCCCCCcCEEeccCCc-CCCcCCC--CCCCCCcCEEEccCCcCCCccchhccCCCCCCeEeee
Q 002158 256 LVKLSLRNCNLQGAVPDLSRIPNLYYLDLSWNH-LTGSIPS--KKLSENVTTIDLSDNYLNGSILESISNLPFLQTLSLE 332 (958)
Q Consensus 256 L~~L~L~~N~l~~~~~~l~~l~~L~~L~Ls~N~-l~~~~~~--~~~~~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~ 332 (958)
.+.++++++.+...+..+..+++|++|++++|+ |+ .++. +..+++|+.|+|++|+|+.+.+..|..+++|++|+|+
T Consensus 10 ~~~l~c~~~~~~~~p~~l~~l~~l~~L~l~~n~~l~-~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~~L~Ls 88 (156)
T d2ifga3 10 SSGLRCTRDGALDSLHHLPGAENLTELYIENQQHLQ-HLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLS 88 (156)
T ss_dssp SSCEECCSSCCCTTTTTSCSCSCCSEEECCSCSSCC-EECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECC
T ss_pred CCeEEecCCCCccCcccccCccccCeeecCCCcccc-ccCchhhccccccCcceeeccccCCcccccccccccccceecc
Confidence 445666666666555556666666666665443 44 2222 2334555555555555555555555555555555555
Q ss_pred cccCCCccchhhhcccccCccccceEeccCCCCCCCccCC-CCCCcceEEeCCCCCCCCCCCCCCCcccccCCCCCcccc
Q 002158 333 NNFLTGSIPATIWQNKSFSTKARLKIDLRNNSFSNIVGDL-TLPNNVTLRLGGNPICTSANIPNTGRFCGSDAGGDETLT 411 (958)
Q Consensus 333 ~N~l~~~ip~~l~~~~~~~~~~l~~L~Ls~N~l~~l~~~~-~l~~L~~L~l~~N~l~~~~~~~~~~~~~~~~~~~~~~L~ 411 (958)
+|+|+ .++... ...+|+.|+|++|||
T Consensus 89 ~N~l~-----------------------------~l~~~~~~~~~l~~L~L~~Np~------------------------ 115 (156)
T d2ifga3 89 FNALE-----------------------------SLSWKTVQGLSLQELVLSGNPL------------------------ 115 (156)
T ss_dssp SSCCS-----------------------------CCCSTTTCSCCCCEEECCSSCC------------------------
T ss_pred CCCCc-----------------------------ccChhhhccccccccccCCCcc------------------------
Confidence 55554 444333 334577888888877
Q ss_pred ccCCCCCCCCCCCCCcccccCCCC--CCceeeeece
Q 002158 412 NSKVNCPVQACPVDNFFEYVPASP--EPCFCAAPLR 445 (958)
Q Consensus 412 ~n~~~C~c~~~~~~~~~~~~~~~~--~~~~c~sp~~ 445 (958)
.|+|...++..|++...... +...|.+|..
T Consensus 116 ----~C~C~~~~l~~~~~~~~~~~~~~~~~C~~p~~ 147 (156)
T d2ifga3 116 ----HCSCALRWLQRWEEEGLGGVPEQKLQCHGQGP 147 (156)
T ss_dssp ----CCCGGGHHHHHHHHTTCSSCGGGCCCCSSSSC
T ss_pred ----cCCchHHHHHHHHHhccCccCcCCcEECcChH
Confidence 56677666777765443332 2366777643
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.42 E-value=3.1e-14 Score=137.31 Aligned_cols=128 Identities=20% Similarity=0.213 Sum_probs=80.5
Q ss_pred hcCCCCCCEEecccccccccCccccccccccceEecccccccccCchhhcCCccchhhhccCCccccCCCcccCCCCCcc
Q 002158 153 LGYLSNLNRLQVDENNITGTIPKSFANLSRVRHLHLNNNSIGGQIPSELSKLSTLIHLLVDNNNLSGNLPPELSELPQLC 232 (958)
Q Consensus 153 l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~ 232 (958)
+.+..+|++|+|++|+|+ .++..+..+++|+.|+|++|.|+. ++ .+..+++|++|++++|+++...+..+..+++|+
T Consensus 14 ~~n~~~lr~L~L~~n~I~-~i~~~~~~l~~L~~L~Ls~N~i~~-l~-~~~~l~~L~~L~ls~N~i~~l~~~~~~~l~~L~ 90 (162)
T d1a9na_ 14 YTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIRK-LD-GFPLLRRLKTLLVNNNRICRIGEGLDQALPDLT 90 (162)
T ss_dssp EECTTSCEEEECTTSCCC-SCCCGGGGTTCCSEEECCSSCCCE-EC-CCCCCSSCCEEECCSSCCCEECSCHHHHCTTCC
T ss_pred ccCcCcCcEEECCCCCCC-ccCccccccccCCEEECCCCCCCc-cC-CcccCcchhhhhcccccccCCCccccccccccc
Confidence 556667777777777777 345555667777777777777773 33 366777777777777777765555556667777
Q ss_pred EEEccCCCCCCCCccccccCCCCCCEEEcccCCCCCCCC----CCCCCCCcCEEe
Q 002158 233 ILQLDNNNFSASEIPATYGNFSKLVKLSLRNCNLQGAVP----DLSRIPNLYYLD 283 (958)
Q Consensus 233 ~L~L~~N~l~~~~~p~~~~~l~~L~~L~L~~N~l~~~~~----~l~~l~~L~~L~ 283 (958)
+|+|++|+++...--..+..+++|++|++++|.++..+. .+..+++|++||
T Consensus 91 ~L~L~~N~i~~~~~l~~l~~l~~L~~L~l~~N~i~~~~~~r~~~i~~lp~L~~LD 145 (162)
T d1a9na_ 91 ELILTNNSLVELGDLDPLASLKSLTYLCILRNPVTNKKHYRLYVIYKVPQVRVLD 145 (162)
T ss_dssp EEECCSCCCCCGGGGGGGGGCTTCCEEECCSSGGGGSTTHHHHHHHHCTTCSEET
T ss_pred cceeccccccccccccccccccccchhhcCCCccccccchHHHHHHHCCCcCeeC
Confidence 777777776532111345566666666666666654432 144455555554
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.42 E-value=1.5e-15 Score=172.89 Aligned_cols=301 Identities=17% Similarity=0.132 Sum_probs=194.0
Q ss_pred eeEEEEccCCcCCC----CccccccCCCCcceeeccCcccCC-----CCccccC-CCCCcEEEeeCCCCCCC----CChh
Q 002158 87 HVRELQLLSMNLSG----NLAPELGQLSRLQYYFMWNDLTGT-----IPKEIGN-ISSLIFLLLNGNKLSGS----LPDE 152 (958)
Q Consensus 87 ~v~~L~L~~~~l~~----~~~~~l~~L~~L~~L~l~n~~~~~-----ip~~i~~-l~~L~~L~Ls~n~l~~~----~p~~ 152 (958)
+++.|+|.+|+++. .+...+...++|+.|++++|.++. +...+.. ..+|++|+|++|.++.. ++..
T Consensus 28 ~l~~L~L~~~~i~~~~~~~l~~~L~~~~~L~~LdLs~N~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~it~~~~~~l~~~ 107 (460)
T d1z7xw1 28 QCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCGVLSST 107 (460)
T ss_dssp TCSEEEEESSCCCHHHHHHHHHHHHTCTTCCEEECTTCCCHHHHHHHHHHTTCSTTCCCCEEECTTSCCBGGGHHHHHHH
T ss_pred CCCEEEeCCCCCCHHHHHHHHHHHhcCCCCCEEECcCCcCChHHHHHHHHHHhcCCCCCCEEECCCCCccccccccccch
Confidence 45678888888774 345667788889999888775542 2233332 34789999999988743 4456
Q ss_pred hcCCCCCCEEecccccccccCccc---------------------------------cccccccceEeccccccc-----
Q 002158 153 LGYLSNLNRLQVDENNITGTIPKS---------------------------------FANLSRVRHLHLNNNSIG----- 194 (958)
Q Consensus 153 l~~l~~L~~L~L~~N~l~~~~p~~---------------------------------~~~l~~L~~L~Ls~N~l~----- 194 (958)
+..+++|++|+|++|.++...... +.....++.++++++.+.
T Consensus 108 l~~~~~L~~L~L~~N~i~~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ls~~~~~~~~~~ 187 (460)
T d1z7xw1 108 LRTLPTLQELHLSDNLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEPLASVLRAKPDFKELTVSNNDINEAGVR 187 (460)
T ss_dssp TTSCTTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGGHHHHHHHHHHCTTCCEEECCSSBCHHHHHH
T ss_pred hhccccccccccccccchhhhhhhhhhcccccccccccccccccccchhhhccccccccccccccccccccccccccccc
Confidence 777888999999888765210000 112234555555544322
Q ss_pred ------------------------cc----CchhhcCCccchhhhccCCcccc-----CCCcccCCCCCccEEEccCCCC
Q 002158 195 ------------------------GQ----IPSELSKLSTLIHLLVDNNNLSG-----NLPPELSELPQLCILQLDNNNF 241 (958)
Q Consensus 195 ------------------------~~----~p~~l~~l~~L~~L~L~~N~l~~-----~~~~~l~~l~~L~~L~L~~N~l 241 (958)
.. ....+...+.++.+++++|++.. ...........|+.|++++|.+
T Consensus 188 ~~~~~l~~~~~~~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~~l~~~~n~~~~~~~~~~~~~~~~~~~~l~~l~l~~n~i 267 (460)
T d1z7xw1 188 VLCQGLKDSPCQLEALKLESCGVTSDNCRDLCGIVASKASLRELALGSNKLGDVGMAELCPGLLHPSSRLRTLWIWECGI 267 (460)
T ss_dssp HHHHHHHHSCCCCCEEECTTSCCBTTHHHHHHHHHHHCTTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCC
T ss_pred ccccccccccccccccccccccccchhhhcccccccccccccccchhhccccccccchhhcccccccccccccccccccc
Confidence 00 01123345677888888887642 2234455678999999999998
Q ss_pred CCCC---ccccccCCCCCCEEEcccCCCCCCCCC------CCCCCCcCEEeccCCcCCCcCCC-----CCCCCCcCEEEc
Q 002158 242 SASE---IPATYGNFSKLVKLSLRNCNLQGAVPD------LSRIPNLYYLDLSWNHLTGSIPS-----KKLSENVTTIDL 307 (958)
Q Consensus 242 ~~~~---~p~~~~~l~~L~~L~L~~N~l~~~~~~------l~~l~~L~~L~Ls~N~l~~~~~~-----~~~~~~L~~L~L 307 (958)
.... ....+...+.++.+++++|.++..... ......|+.+++++|.++..... .....+|++|+|
T Consensus 268 ~~~~~~~~~~~l~~~~~l~~l~l~~n~i~~~~~~~l~~~l~~~~~~L~~l~l~~~~l~~~~~~~l~~~~~~~~~L~~L~L 347 (460)
T d1z7xw1 268 TAKGCGDLCRVLRAKESLKELSLAGNELGDEGARLLCETLLEPGCQLESLWVKSCSFTAACCSHFSSVLAQNRFLLELQI 347 (460)
T ss_dssp CHHHHHHHHHHHHHCTTCCEEECTTCCCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGGHHHHHHHHHHCSSCCEEEC
T ss_pred cccccccccccccccccccccccccccccccccchhhccccccccccccccccccchhhhhhhhcccccccccchhhhhe
Confidence 6321 223456678999999999998642211 23456899999999998743211 122368999999
Q ss_pred cCCcCCCcc----chhcc-CCCCCCeEeeecccCCCccchhhhcccccCccccceEeccCCCCCCCc-----cCC--CCC
Q 002158 308 SDNYLNGSI----LESIS-NLPFLQTLSLENNFLTGSIPATIWQNKSFSTKARLKIDLRNNSFSNIV-----GDL--TLP 375 (958)
Q Consensus 308 s~N~l~~~~----~~~~~-~l~~L~~L~L~~N~l~~~ip~~l~~~~~~~~~~l~~L~Ls~N~l~~l~-----~~~--~l~ 375 (958)
++|+|++.. ...+. ..+.|++|+|++|.|+......+..... ..+.|++|||++|+|++-. ... ...
T Consensus 348 s~N~i~~~g~~~l~~~l~~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~-~~~~L~~L~Ls~N~i~~~g~~~l~~~l~~~~~ 426 (460)
T d1z7xw1 348 SNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLL-ANHSLRELDLSNNCLGDAGILQLVESVRQPGC 426 (460)
T ss_dssp CSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHH-HCCCCCEEECCSSSCCHHHHHHHHHHHTSTTC
T ss_pred eeecccCcccchhhhhhhcccCCCCEEECCCCCCChHHHHHHHHHHh-cCCCCCEEECCCCcCCHHHHHHHHHHHHhCCC
Confidence 999997643 33333 4678999999999998543333322110 1246779999999998621 111 345
Q ss_pred CcceEEeCCCCCC
Q 002158 376 NNVTLRLGGNPIC 388 (958)
Q Consensus 376 ~L~~L~l~~N~l~ 388 (958)
.|+.|++.+|.+.
T Consensus 427 ~L~~l~l~~~~~~ 439 (460)
T d1z7xw1 427 LLEQLVLYDIYWS 439 (460)
T ss_dssp CCCEEECTTCCCC
T ss_pred ccCEEECCCCCCC
Confidence 7999999999985
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.39 E-value=1.5e-14 Score=153.85 Aligned_cols=242 Identities=20% Similarity=0.223 Sum_probs=161.6
Q ss_pred cEEEeeCCCCCCCCChhhcCCCCCCEEecccccccccCccccccccccceEeccccccccc-CchhhcCCccchhhhccC
Q 002158 136 IFLLLNGNKLSGSLPDELGYLSNLNRLQVDENNITGTIPKSFANLSRVRHLHLNNNSIGGQ-IPSELSKLSTLIHLLVDN 214 (958)
Q Consensus 136 ~~L~Ls~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~-~p~~l~~l~~L~~L~L~~ 214 (958)
+.|||+++.+.......+.. ..+..+.++...+..... ......+|++|||++|.++.. +...+..+++|++|+|++
T Consensus 3 ~~lDLs~~~l~~~~l~~l~~-~~~~~lrl~~~~~~~~~~-~~~~~~~L~~LdLs~~~i~~~~l~~l~~~c~~L~~L~L~~ 80 (284)
T d2astb2 3 QTLDLTGKNLHPDVTGRLLS-QGVIAFRCPRSFMDQPLA-EHFSPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEG 80 (284)
T ss_dssp SEEECTTCBCCHHHHHHHHH-TTCSEEECTTCEECSCCC-SCCCCBCCCEEECTTCEECHHHHHHHHTTBCCCSEEECTT
T ss_pred CEEECCCCCCCchHHHHHHh-ccceEeeccccccccchh-hhccCCCCCEEECCCCccCHHHHHHHHHhCCCcccccccc
Confidence 36788877765222222221 235566666666553332 334556888899988887743 345578888999999999
Q ss_pred CccccCCCcccCCCCCccEEEccCC-CCCCCCccccccCCCCCCEEEcccC-CCCCCCC--CC-CCCCCcCEEeccCC--
Q 002158 215 NNLSGNLPPELSELPQLCILQLDNN-NFSASEIPATYGNFSKLVKLSLRNC-NLQGAVP--DL-SRIPNLYYLDLSWN-- 287 (958)
Q Consensus 215 N~l~~~~~~~l~~l~~L~~L~L~~N-~l~~~~~p~~~~~l~~L~~L~L~~N-~l~~~~~--~l-~~l~~L~~L~Ls~N-- 287 (958)
|.+++..+..+..+++|++|+|+++ .++...+.....++++|++|+|++| .++.... .+ ...++|+.|+++++
T Consensus 81 ~~l~~~~~~~l~~~~~L~~L~Ls~c~~itd~~l~~l~~~~~~L~~L~ls~c~~~~~~~~~~~~~~~~~~L~~L~l~~~~~ 160 (284)
T d2astb2 81 LRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRK 160 (284)
T ss_dssp CBCCHHHHHHHTTCTTCSEEECTTCBSCCHHHHHHHHHHCTTCCEEECCCCTTCCHHHHHHHHHHSCTTCCEEECCSCGG
T ss_pred cCCCcHHHHHHhcCCCCcCccccccccccccccchhhHHHHhccccccccccccccccchhhhcccccccchhhhccccc
Confidence 9888777778888999999999985 5653333444567899999999997 4442211 12 23478999999975
Q ss_pred cCCCc-CCCC-CCCCCcCEEEccCC-cCCCccchhccCCCCCCeEeeecc-cCCCccchhhhcccccCccccceEeccCC
Q 002158 288 HLTGS-IPSK-KLSENVTTIDLSDN-YLNGSILESISNLPFLQTLSLENN-FLTGSIPATIWQNKSFSTKARLKIDLRNN 363 (958)
Q Consensus 288 ~l~~~-~~~~-~~~~~L~~L~Ls~N-~l~~~~~~~~~~l~~L~~L~L~~N-~l~~~ip~~l~~~~~~~~~~l~~L~Ls~N 363 (958)
.++.. +... ..+++|++|+|++| .+++.....+.++++|++|+|++| .+++.....+.+ .+.|+.|+++++
T Consensus 161 ~i~~~~l~~l~~~~~~L~~L~L~~~~~itd~~~~~l~~~~~L~~L~L~~C~~i~~~~l~~L~~-----~~~L~~L~l~~~ 235 (284)
T d2astb2 161 NLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGE-----IPTLKTLQVFGI 235 (284)
T ss_dssp GSCHHHHHHHHHHCTTCSEEECTTCTTCCGGGGGGGGGCTTCCEEECTTCTTCCGGGGGGGGG-----CTTCCEEECTTS
T ss_pred ccccccccccccccccccccccccccCCCchhhhhhcccCcCCEEECCCCCCCChHHHHHHhc-----CCCCCEEeeeCC
Confidence 34321 1111 34589999999996 588888889999999999999995 677655555543 356789999887
Q ss_pred CCCCCc--cCC-CCCCcceEEeCCCCCC
Q 002158 364 SFSNIV--GDL-TLPNNVTLRLGGNPIC 388 (958)
Q Consensus 364 ~l~~l~--~~~-~l~~L~~L~l~~N~l~ 388 (958)
+++-. ... .+|+| .+..++++
T Consensus 236 -~~d~~l~~l~~~lp~L---~i~~~~ls 259 (284)
T d2astb2 236 -VPDGTLQLLKEALPHL---QINCSHFT 259 (284)
T ss_dssp -SCTTCHHHHHHHSTTS---EESCCCSC
T ss_pred -CCHHHHHHHHHhCccc---cccCccCC
Confidence 33211 111 45554 45666654
|
| >d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: Outer arm dynein light chain 1 family: Outer arm dynein light chain 1 domain: Outer arm dynein light chain 1 species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]
Probab=99.28 E-value=2.5e-14 Score=143.03 Aligned_cols=114 Identities=25% Similarity=0.314 Sum_probs=60.0
Q ss_pred CCChhhcCCCCCCEEecccccccccCccccccccccceEecccccccccCchhhcCCccchhhhccCCccccCCCcccCC
Q 002158 148 SLPDELGYLSNLNRLQVDENNITGTIPKSFANLSRVRHLHLNNNSIGGQIPSELSKLSTLIHLLVDNNNLSGNLPPELSE 227 (958)
Q Consensus 148 ~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~l~~ 227 (958)
.+|.++..+++|++|+|++|+|+. ++ .+..+++|+.|+|++|.|+ .+|..+..+++|+.|++++|+|+.. ..+..
T Consensus 39 ~l~~sl~~L~~L~~L~Ls~n~I~~-i~-~l~~l~~L~~L~Ls~N~i~-~i~~~~~~~~~L~~L~l~~N~i~~l--~~~~~ 113 (198)
T d1m9la_ 39 KMDATLSTLKACKHLALSTNNIEK-IS-SLSGMENLRILSLGRNLIK-KIENLDAVADTLEELWISYNQIASL--SGIEK 113 (198)
T ss_dssp CCHHHHHHTTTCCEEECSEEEESC-CC-CHHHHTTCCEEECCEEEEC-SCSSHHHHHHHCCEEECSEEECCCH--HHHHH
T ss_pred hhhhHHhcccccceeECcccCCCC-cc-cccCCccccChhhcccccc-ccccccccccccccccccccccccc--ccccc
Confidence 444555666666666666666652 22 3555666666666666655 3444344444555555555555532 23444
Q ss_pred CCCccEEEccCCCCCCCCcc--ccccCCCCCCEEEcccCCCCC
Q 002158 228 LPQLCILQLDNNNFSASEIP--ATYGNFSKLVKLSLRNCNLQG 268 (958)
Q Consensus 228 l~~L~~L~L~~N~l~~~~~p--~~~~~l~~L~~L~L~~N~l~~ 268 (958)
+++|+.|+|++|+|+. ++ ..+..+++|+.|+|++|.+..
T Consensus 114 l~~L~~L~L~~N~i~~--~~~~~~l~~l~~L~~L~L~~N~l~~ 154 (198)
T d1m9la_ 114 LVNLRVLYMSNNKITN--WGEIDKLAALDKLEDLLLAGNPLYN 154 (198)
T ss_dssp HHHSSEEEESEEECCC--HHHHHHHTTTTTCSEEEECSSHHHH
T ss_pred cccccccccccchhcc--ccccccccCCCccceeecCCCcccc
Confidence 5555555555555542 22 234555555555555555443
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.21 E-value=8.5e-12 Score=119.06 Aligned_cols=108 Identities=17% Similarity=0.120 Sum_probs=80.2
Q ss_pred CCCcEEEeeCCCCCCCCChhhcCCCCCCEEecccc-cccccCccccccccccceEecccccccccCchhhcCCccchhhh
Q 002158 133 SSLIFLLLNGNKLSGSLPDELGYLSNLNRLQVDEN-NITGTIPKSFANLSRVRHLHLNNNSIGGQIPSELSKLSTLIHLL 211 (958)
Q Consensus 133 ~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~L~~N-~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~ 211 (958)
.....++++++.+. ..|..+..+++|++|++++| .|+...+.+|.++++|+.|+|++|+|+...+.+|..+++|++|+
T Consensus 8 ~~~~~l~c~~~~~~-~~p~~l~~l~~l~~L~l~~n~~l~~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~~L~ 86 (156)
T d2ifga3 8 HGSSGLRCTRDGAL-DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLN 86 (156)
T ss_dssp SSSSCEECCSSCCC-TTTTTSCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEE
T ss_pred CCCCeEEecCCCCc-cCcccccCccccCeeecCCCccccccCchhhccccccCcceeeccccCCccccccccccccccee
Confidence 34556777777777 66777777888888888665 47766666788888888888888888877777788888888888
Q ss_pred ccCCccccCCCcccCCCCCccEEEccCCCCC
Q 002158 212 VDNNNLSGNLPPELSELPQLCILQLDNNNFS 242 (958)
Q Consensus 212 L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~ 242 (958)
|++|+|+...+..|..+ +|+.|+|++|.+.
T Consensus 87 Ls~N~l~~l~~~~~~~~-~l~~L~L~~Np~~ 116 (156)
T d2ifga3 87 LSFNALESLSWKTVQGL-SLQELVLSGNPLH 116 (156)
T ss_dssp CCSSCCSCCCSTTTCSC-CCCEEECCSSCCC
T ss_pred ccCCCCcccChhhhccc-cccccccCCCccc
Confidence 88888885555555443 6888888888875
|
| >d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: Outer arm dynein light chain 1 family: Outer arm dynein light chain 1 domain: Outer arm dynein light chain 1 species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]
Probab=99.17 E-value=2e-13 Score=136.35 Aligned_cols=113 Identities=24% Similarity=0.293 Sum_probs=64.6
Q ss_pred CCccccCCCCCcEEEeeCCCCCCCCChhhcCCCCCCEEecccccccccCccccccccccceEecccccccccCchhhcCC
Q 002158 125 IPKEIGNISSLIFLLLNGNKLSGSLPDELGYLSNLNRLQVDENNITGTIPKSFANLSRVRHLHLNNNSIGGQIPSELSKL 204 (958)
Q Consensus 125 ip~~i~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l 204 (958)
+|..+..+++|++|+|++|+|+ .++ .|..+++|++|+|++|+|+ .++..+..+++|++|++++|+|+. + ..+..+
T Consensus 40 l~~sl~~L~~L~~L~Ls~n~I~-~i~-~l~~l~~L~~L~Ls~N~i~-~i~~~~~~~~~L~~L~l~~N~i~~-l-~~~~~l 114 (198)
T d1m9la_ 40 MDATLSTLKACKHLALSTNNIE-KIS-SLSGMENLRILSLGRNLIK-KIENLDAVADTLEELWISYNQIAS-L-SGIEKL 114 (198)
T ss_dssp CHHHHHHTTTCCEEECSEEEES-CCC-CHHHHTTCCEEECCEEEEC-SCSSHHHHHHHCCEEECSEEECCC-H-HHHHHH
T ss_pred hhhHHhcccccceeECcccCCC-Ccc-cccCCccccChhhcccccc-cccccccccccccccccccccccc-c-cccccc
Confidence 3444555666666666666665 343 3566666666666666665 344444444566666666666663 2 235556
Q ss_pred ccchhhhccCCccccCCC-cccCCCCCccEEEccCCCCC
Q 002158 205 STLIHLLVDNNNLSGNLP-PELSELPQLCILQLDNNNFS 242 (958)
Q Consensus 205 ~~L~~L~L~~N~l~~~~~-~~l~~l~~L~~L~L~~N~l~ 242 (958)
++|+.|++++|+|+.... ..+..+++|+.|+|++|++.
T Consensus 115 ~~L~~L~L~~N~i~~~~~~~~l~~l~~L~~L~L~~N~l~ 153 (198)
T d1m9la_ 115 VNLRVLYMSNNKITNWGEIDKLAALDKLEDLLLAGNPLY 153 (198)
T ss_dssp HHSSEEEESEEECCCHHHHHHHTTTTTCSEEEECSSHHH
T ss_pred ccccccccccchhccccccccccCCCccceeecCCCccc
Confidence 666666666666653211 34566666666666666653
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.46 E-value=1.7e-07 Score=96.91 Aligned_cols=148 Identities=16% Similarity=0.126 Sum_probs=98.9
Q ss_pred HHHHHHcCCCCCceeeeeCCeEEEEEEECCCcEEEEEEeccCChhcHHHHHHHHHHHHccC-CCCcceEEEEEEeCCeEE
Q 002158 619 ELAMATAYFSSSTQVGQGGYGKVYKGILSDNTTVAIKRAEEGSLQGQNEFLTEIKLLSRLH-HRNLVSLLGYCDEEGEQM 697 (958)
Q Consensus 619 el~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~~~~~ 697 (958)
|+...-+.|...+..+-++.+.||+... +++.++||+...........+.+|...++.+. +--+.+++.++..++..+
T Consensus 8 ~l~~~~~~~~~~~~~~G~s~~~v~rv~~-~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~ 86 (263)
T d1j7la_ 8 ELKKLIEKYRCVKDTEGMSPAKVYKLVG-ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSN 86 (263)
T ss_dssp HHHHHHTTSEEEECSCCCSSSEEEEEEC-SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEE
T ss_pred HHHHhhhceEEEEcCCCCCCCcEEEEEe-CCCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEEecCCceE
Confidence 3444444554433333333468999864 56678888876543333445678998888774 444678899998899999
Q ss_pred EEEEecCCCCHHHHhccCCCCCchHHHHHHHHHHHHHHHHHhhhcC----------------------------------
Q 002158 698 LVYEFVPNGTLRDWLSGRTKENLNFAMRLRVALDSAKGILYLHTEA---------------------------------- 743 (958)
Q Consensus 698 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~---------------------------------- 743 (958)
+|||+++|.++.+...... ...+++.++++.++.||+..
T Consensus 87 lv~~~l~G~~~~~~~~~~~-------~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (263)
T d1j7la_ 87 LLMSEADGVLCSEEYEDEQ-------SPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWE 159 (263)
T ss_dssp EEEECCSSEEHHHHTTTCS-------CHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGS
T ss_pred EEEEecccccccccccccc-------cHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhccc
Confidence 9999999988866542211 12234455555555555321
Q ss_pred ----------------------CCCeeccCCCccceEecCCCCeEEeeeeeec
Q 002158 744 ----------------------HPPVFHRDIKASNILLDSNLNAKVADFGLSR 774 (958)
Q Consensus 744 ----------------------~~~iiH~Dikp~NILl~~~~~~kl~DFGla~ 774 (958)
.+.++|+|+.|.|||+++++.+-|+||+.+.
T Consensus 160 ~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T d1j7la_ 160 EDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp TTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred ccccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhcc
Confidence 1238999999999999987667799999775
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.32 E-value=2.1e-08 Score=95.58 Aligned_cols=89 Identities=22% Similarity=0.126 Sum_probs=45.5
Q ss_pred hcCCCCCCEEecccccccccCccccccccccceEeccccccccc--CchhhcCCccchhhhccCCccccCCCcccCCCCC
Q 002158 153 LGYLSNLNRLQVDENNITGTIPKSFANLSRVRHLHLNNNSIGGQ--IPSELSKLSTLIHLLVDNNNLSGNLPPELSELPQ 230 (958)
Q Consensus 153 l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~--~p~~l~~l~~L~~L~L~~N~l~~~~~~~l~~l~~ 230 (958)
+..+..+..|+..++... .++..+..+++|++|+|++|+|+.. ++..+..+++|+.|+|++|+|+....-.+....+
T Consensus 38 l~~~~~~~~l~~~~~~~~-~l~~~~~~~~~L~~L~Ls~N~i~~l~~~~~~~~~l~~L~~L~Ls~N~i~~l~~l~~l~~~~ 116 (162)
T d1koha1 38 LVAQNIDVVLNRRSSMAA-TLRIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSERELDKIKGLK 116 (162)
T ss_dssp TTTTTCCCCTTSHHHHHH-HHHHHHHHCTTCCCCCCCSSCCCCCSGGGTHHHHSTTCCCCCCTTSCCCCGGGHHHHTTCC
T ss_pred hhhccchhhcchhhhHhh-hhHHHHHhCCCCCEeeCCCccccCCchhHHHHhhCCcccccccccCccccchhhhhhhccc
Confidence 334444444554444433 3344445566666666666666632 1234455666666666666665433222223344
Q ss_pred ccEEEccCCCCC
Q 002158 231 LCILQLDNNNFS 242 (958)
Q Consensus 231 L~~L~L~~N~l~ 242 (958)
|+.|++++|.+.
T Consensus 117 L~~L~L~~Npl~ 128 (162)
T d1koha1 117 LEELWLDGNSLS 128 (162)
T ss_dssp CSSCCCTTSTTS
T ss_pred cceeecCCCCcC
Confidence 555555555554
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.24 E-value=3.1e-08 Score=94.40 Aligned_cols=59 Identities=20% Similarity=0.180 Sum_probs=27.7
Q ss_pred cceeeccCcccCCCCccccCCCCCcEEEeeCCCCCCC--CChhhcCCCCCCEEeccccccc
Q 002158 112 LQYYFMWNDLTGTIPKEIGNISSLIFLLLNGNKLSGS--LPDELGYLSNLNRLQVDENNIT 170 (958)
Q Consensus 112 L~~L~l~n~~~~~ip~~i~~l~~L~~L~Ls~n~l~~~--~p~~l~~l~~L~~L~L~~N~l~ 170 (958)
+..+...++....++..+.++++|++|+|++|+|+.. ++..+..+++|+.|+|++|+|+
T Consensus 44 ~~~l~~~~~~~~~l~~~~~~~~~L~~L~Ls~N~i~~l~~~~~~~~~l~~L~~L~Ls~N~i~ 104 (162)
T d1koha1 44 DVVLNRRSSMAATLRIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELK 104 (162)
T ss_dssp CCCTTSHHHHHHHHHHHHHHCTTCCCCCCCSSCCCCCSGGGTHHHHSTTCCCCCCTTSCCC
T ss_pred hhhcchhhhHhhhhHHHHHhCCCCCEeeCCCccccCCchhHHHHhhCCcccccccccCccc
Confidence 3333333333333333334555666666666666532 1223444555555555555554
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=97.98 E-value=1.2e-05 Score=81.99 Aligned_cols=74 Identities=24% Similarity=0.267 Sum_probs=55.1
Q ss_pred eeeeeCC-eEEEEEEECCCcEEEEEEeccCChhcHHHHHHHHHHHHccC--CCCcceEEEEEEeCCeEEEEEEecCCCCH
Q 002158 632 QVGQGGY-GKVYKGILSDNTTVAIKRAEEGSLQGQNEFLTEIKLLSRLH--HRNLVSLLGYCDEEGEQMLVYEFVPNGTL 708 (958)
Q Consensus 632 ~lg~G~~-g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~--H~niv~l~~~~~~~~~~~lV~E~~~~gsL 708 (958)
.+..|.. +.||+...+++..+++|........ .+..|+..++.+. .-.+.++++++.+++..++||||++|.++
T Consensus 17 ~~~~G~s~~~v~r~~~~~~~~~vlK~~~~~~~~---~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~~ 93 (255)
T d1nd4a_ 17 QQTIGCSDAAVFRLSAQGRPVLFVKTDLSGALN---ELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDL 93 (255)
T ss_dssp ECSCTTSSCEEEEEECTTSCCEEEEEECSCTTS---CHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEET
T ss_pred EcCCcccCCeEEEEEeCCCCEEEEEeCCccCHh---HHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeecccc
Confidence 3455554 5899998878888999987654332 3567888887763 33467889888888899999999988665
|
| >d1pgva_ c.10.1.1 (A:) Tropomodulin C-terminal domain {nematode (Caenorhabditis elegans) [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: nematode (Caenorhabditis elegans) [TaxId: 6239]
Probab=97.58 E-value=7.1e-06 Score=77.98 Aligned_cols=64 Identities=13% Similarity=0.209 Sum_probs=34.5
Q ss_pred CCCCCcEEEeeCC-CCCCC----CChhhcCCCCCCEEeccccccccc----CccccccccccceEeccccccc
Q 002158 131 NISSLIFLLLNGN-KLSGS----LPDELGYLSNLNRLQVDENNITGT----IPKSFANLSRVRHLHLNNNSIG 194 (958)
Q Consensus 131 ~l~~L~~L~Ls~n-~l~~~----~p~~l~~l~~L~~L~L~~N~l~~~----~p~~~~~l~~L~~L~Ls~N~l~ 194 (958)
+.++|++|+|+++ .++.. +-..+...+.|++|+|++|.++.. +...+...+.|+.|+|++|.|+
T Consensus 13 n~~~L~~L~L~~~~~i~~~~~~~l~~~L~~n~~L~~L~Ls~n~l~~~~~~~la~~L~~n~~L~~L~L~~n~i~ 85 (167)
T d1pgva_ 13 DDTDLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLT 85 (167)
T ss_dssp TCSSCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCC
T ss_pred CCCCCcEEEeCCCCCCCHHHHHHHHHHHhhCCccceeeccccccchhHHHHHhhhhhhcccccceeeehhhcc
Confidence 3456777777653 34321 222345556677777777666522 2223344456666666666665
|
| >d1pgva_ c.10.1.1 (A:) Tropomodulin C-terminal domain {nematode (Caenorhabditis elegans) [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: nematode (Caenorhabditis elegans) [TaxId: 6239]
Probab=97.51 E-value=1.2e-05 Score=76.22 Aligned_cols=86 Identities=15% Similarity=0.215 Sum_probs=44.5
Q ss_pred CCCCCCEEecccc-ccccc----CccccccccccceEeccccccccc----CchhhcCCccchhhhccCCccccC----C
Q 002158 155 YLSNLNRLQVDEN-NITGT----IPKSFANLSRVRHLHLNNNSIGGQ----IPSELSKLSTLIHLLVDNNNLSGN----L 221 (958)
Q Consensus 155 ~l~~L~~L~L~~N-~l~~~----~p~~~~~l~~L~~L~Ls~N~l~~~----~p~~l~~l~~L~~L~L~~N~l~~~----~ 221 (958)
+.++|++|+|+++ .++.. +-..+...++|+.|+|++|.+... +...+...+.|+.|+|++|.|+.. +
T Consensus 13 n~~~L~~L~L~~~~~i~~~~~~~l~~~L~~n~~L~~L~Ls~n~l~~~~~~~la~~L~~n~~L~~L~L~~n~i~~~g~~~l 92 (167)
T d1pgva_ 13 DDTDLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELLARL 92 (167)
T ss_dssp TCSSCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHHHHHH
T ss_pred CCCCCcEEEeCCCCCCCHHHHHHHHHHHhhCCccceeeccccccchhHHHHHhhhhhhcccccceeeehhhcchHHHHHH
Confidence 4567888888763 45522 233455566777777777777622 112233344555555555555421 1
Q ss_pred CcccCCCCCccEEEccCCC
Q 002158 222 PPELSELPQLCILQLDNNN 240 (958)
Q Consensus 222 ~~~l~~l~~L~~L~L~~N~ 240 (958)
..++...++|++|+|++|+
T Consensus 93 ~~aL~~n~sL~~L~l~~n~ 111 (167)
T d1pgva_ 93 LRSTLVTQSIVEFKADNQR 111 (167)
T ss_dssp HHHTTTTCCCSEEECCCCS
T ss_pred HHHHHhCCcCCEEECCCCc
Confidence 2233444444444444443
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=97.45 E-value=0.00013 Score=79.25 Aligned_cols=75 Identities=16% Similarity=0.109 Sum_probs=48.4
Q ss_pred ceeeeeCCeEEEEEEEC-CCcEEEEEEecc------C-ChhcHHHHHHHHHHHHccC-C--CCcceEEEEEEeCCeEEEE
Q 002158 631 TQVGQGGYGKVYKGILS-DNTTVAIKRAEE------G-SLQGQNEFLTEIKLLSRLH-H--RNLVSLLGYCDEEGEQMLV 699 (958)
Q Consensus 631 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~------~-~~~~~~~~~~E~~~l~~l~-H--~niv~l~~~~~~~~~~~lV 699 (958)
+.||.|....||+.... +++.|+||.-.. . -.....+...|.++|+.+. + ..+.+++.+ +++..++|
T Consensus 32 ~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~lv 109 (392)
T d2pula1 32 QEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVTV 109 (392)
T ss_dssp EECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEEE
T ss_pred EEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cCCCCEEE
Confidence 46899999999999865 467899996432 1 1112234557888887762 3 345666655 34566899
Q ss_pred EEecCCCC
Q 002158 700 YEFVPNGT 707 (958)
Q Consensus 700 ~E~~~~gs 707 (958)
||++++..
T Consensus 110 mE~L~~~~ 117 (392)
T d2pula1 110 MEDLSHLK 117 (392)
T ss_dssp ECCCTTSE
T ss_pred EeccCCcc
Confidence 99997644
|
| >d1io0a_ c.10.1.1 (A:) Tropomodulin C-terminal domain {Chicken (Gallus gallus) [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: Chicken (Gallus gallus) [TaxId: 9031]
Probab=96.85 E-value=7.2e-05 Score=70.64 Aligned_cols=65 Identities=12% Similarity=0.152 Sum_probs=35.6
Q ss_pred cCCCCCcEEEeeC-CCCCCC----CChhhcCCCCCCEEeccccccccc----CccccccccccceEeccccccc
Q 002158 130 GNISSLIFLLLNG-NKLSGS----LPDELGYLSNLNRLQVDENNITGT----IPKSFANLSRVRHLHLNNNSIG 194 (958)
Q Consensus 130 ~~l~~L~~L~Ls~-n~l~~~----~p~~l~~l~~L~~L~L~~N~l~~~----~p~~~~~l~~L~~L~Ls~N~l~ 194 (958)
.+.++|++|+|++ +.++.. +-..+...++|++|+|++|.++.. +-..+...++|+.|++++|.++
T Consensus 14 ~~~~~L~~L~L~~~~~i~~~~~~~l~~al~~n~~L~~L~Ls~n~l~~~~~~~L~~~l~~~~~l~~l~l~~~~~~ 87 (166)
T d1io0a_ 14 NNDPDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFIS 87 (166)
T ss_dssp TTCTTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCC
T ss_pred hcCCCCcEEEcCCCCCCCHHHHHHHHHHHhcCCccCeeeccCCcccHHHHHHHHHHHhhcccchhhhhcccccc
Confidence 3456677777765 345421 222344566677777777766532 2223444556666666666665
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=96.82 E-value=0.0016 Score=68.29 Aligned_cols=67 Identities=15% Similarity=0.175 Sum_probs=46.3
Q ss_pred eEEEEEEECCCcEEEEEEeccCChhcHHHHHHHHHHHHccCCCCc--ceEEE-----EEEeCCeEEEEEEecCCC
Q 002158 639 GKVYKGILSDNTTVAIKRAEEGSLQGQNEFLTEIKLLSRLHHRNL--VSLLG-----YCDEEGEQMLVYEFVPNG 706 (958)
Q Consensus 639 g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~ni--v~l~~-----~~~~~~~~~lV~E~~~~g 706 (958)
=.||++..++|+.|++|+.+... ...+++..|.+.+..+....+ +..+. .....+..+.+++|++|.
T Consensus 36 N~vy~v~~~dg~~~VlK~~rp~~-~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~ 109 (325)
T d1zyla1 36 NRVYQFQDEDRRRFVVKFYRPER-WTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGR 109 (325)
T ss_dssp SEEEEECCTTCCCEEEEEECTTT-SCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCE
T ss_pred ceeEEEEcCCCCEEEEEEeCCCC-CCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCc
Confidence 48999999999999999987542 345567789888888742222 11111 234566789999999764
|
| >d1io0a_ c.10.1.1 (A:) Tropomodulin C-terminal domain {Chicken (Gallus gallus) [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: Chicken (Gallus gallus) [TaxId: 9031]
Probab=96.66 E-value=8.1e-05 Score=70.26 Aligned_cols=66 Identities=17% Similarity=0.202 Sum_probs=38.8
Q ss_pred hcCCCCCCEEeccc-cccccc----CccccccccccceEecccccccccCc----hhhcCCccchhhhccCCccc
Q 002158 153 LGYLSNLNRLQVDE-NNITGT----IPKSFANLSRVRHLHLNNNSIGGQIP----SELSKLSTLIHLLVDNNNLS 218 (958)
Q Consensus 153 l~~l~~L~~L~L~~-N~l~~~----~p~~~~~l~~L~~L~Ls~N~l~~~~p----~~l~~l~~L~~L~L~~N~l~ 218 (958)
..+.++|++|+|++ +.++.. +-..+...++|++|+|++|.++.... ..+...++|+.|++++|.+.
T Consensus 13 ~~~~~~L~~L~L~~~~~i~~~~~~~l~~al~~n~~L~~L~Ls~n~l~~~~~~~L~~~l~~~~~l~~l~l~~~~~~ 87 (166)
T d1io0a_ 13 QNNDPDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFIS 87 (166)
T ss_dssp HTTCTTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCC
T ss_pred HhcCCCCcEEEcCCCCCCCHHHHHHHHHHHhcCCccCeeeccCCcccHHHHHHHHHHHhhcccchhhhhcccccc
Confidence 34567888888887 456522 23344566777888888877763222 23344455555555555554
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=96.33 E-value=0.0032 Score=67.97 Aligned_cols=72 Identities=15% Similarity=0.214 Sum_probs=49.4
Q ss_pred ceeeeeCCeEEEEEEECC--------CcEEEEEEeccCChhcHHHHHHHHHHHHccC-CCCcceEEEEEEeCCeEEEEEE
Q 002158 631 TQVGQGGYGKVYKGILSD--------NTTVAIKRAEEGSLQGQNEFLTEIKLLSRLH-HRNLVSLLGYCDEEGEQMLVYE 701 (958)
Q Consensus 631 ~~lg~G~~g~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~~~~~lV~E 701 (958)
+.|+.|-.=.+|+...++ .+.|.+++.... .......+|..+++.+. +.-..++++++.. ++|||
T Consensus 48 ~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~~--~~~idr~~E~~i~~~ls~~gl~Pkll~~~~~----g~I~e 121 (395)
T d1nw1a_ 48 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP--ETESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLEE 121 (395)
T ss_dssp EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC--CCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEEC
T ss_pred EEcCCccccceEEEEeCCCCccccCCCCcEEEEecCCc--chhhHHHHHHHHHHHHHhCCCCCeEEEEcCC----ceEEE
Confidence 467778888999998754 345777766532 22334568999998884 4445688888753 68999
Q ss_pred ecCCCCH
Q 002158 702 FVPNGTL 708 (958)
Q Consensus 702 ~~~~gsL 708 (958)
|++|.++
T Consensus 122 fi~g~~l 128 (395)
T d1nw1a_ 122 YIPSRPL 128 (395)
T ss_dssp CCCEEEC
T ss_pred EeccccC
Confidence 9987544
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=95.37 E-value=0.054 Score=55.69 Aligned_cols=157 Identities=11% Similarity=0.037 Sum_probs=82.8
Q ss_pred cChHHHHHHHcCCCCCcee-----eeeCCeEEEEEEECCCcEEEEEEeccCChhcHHHHHHHHHHHHccCC-----CCcc
Q 002158 615 FKFKELAMATAYFSSSTQV-----GQGGYGKVYKGILSDNTTVAIKRAEEGSLQGQNEFLTEIKLLSRLHH-----RNLV 684 (958)
Q Consensus 615 ~~~~el~~~~~~~~~~~~l-----g~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H-----~niv 684 (958)
++-+|++.....|...+.. ..|---+.|+...++|+ +++|++...... ++...|++++..+.. |..+
T Consensus 3 ls~~el~~~l~~Y~lg~~~~~~~i~~G~~N~ny~v~t~~g~-yVLri~~~~~~~--~~l~~~~~~l~~L~~~g~pvp~pi 79 (316)
T d2ppqa1 3 ITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKDP-LILTLYEKRVEK--NDLPFFLGLMQHLAAKGLSCPLPL 79 (316)
T ss_dssp CCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSCC-EEEEEECC---C--CHHHHHHHHHHHHHHTTCCCCCBC
T ss_pred CCHHHHHHHHHhCCCCCceEeecCCCCcccCeEEEEECCCc-EEEEEcCCCCCH--HHHHHHHHHHHhhhhccccccccc
Confidence 4567777778888775543 34555788999886665 899998653222 234456666666632 2222
Q ss_pred eEEE---EEEeCCeEEEEEEecCCCCHHH--------------Hhcc----CC-----CCCch----------------H
Q 002158 685 SLLG---YCDEEGEQMLVYEFVPNGTLRD--------------WLSG----RT-----KENLN----------------F 722 (958)
Q Consensus 685 ~l~~---~~~~~~~~~lV~E~~~~gsL~~--------------~l~~----~~-----~~~l~----------------~ 722 (958)
+..+ +....+..+.++.++.+..... .++. .. ..... .
T Consensus 80 ~~~~g~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (316)
T d2ppqa1 80 PRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVE 159 (316)
T ss_dssp CBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTS
T ss_pred eecCCCcceeeecccceeeeecccccccccchhHHHHHHHHHHhhhhhhhhcccccccccchhhcchhhhHHHHhhhhcc
Confidence 1100 1233456677787776643310 0000 00 00000 0
Q ss_pred HHHHHHHHHHHHHHHHhhhc-CCCCeeccCCCccceEecCCCCeEEeeeeeec
Q 002158 723 AMRLRVALDSAKGILYLHTE-AHPPVFHRDIKASNILLDSNLNAKVADFGLSR 774 (958)
Q Consensus 723 ~~~~~i~~~ia~aL~yLH~~-~~~~iiH~Dikp~NILl~~~~~~kl~DFGla~ 774 (958)
......+......+...+.. -...+||+|+.++||+++.+...-|.||+.+.
T Consensus 160 ~~~~~~l~~~~~~~~~~~~~~L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~ 212 (316)
T d2ppqa1 160 KGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC 212 (316)
T ss_dssp TTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred hhHHHHHHHHHHhhhccCccccccccccCCcchhhhhcccccceeEecccccc
Confidence 00111122222222222211 12349999999999999988777899999875
|